Entry,Entry name,Protein names,Length,Mass,Annotation,Date of creation,Protein existence
Q9H479,FN3K_HUMAN,Fructosamine-3-kinase (EC 2.7.1.-),309,"35,171",4 out of 5,2001-05-04,Evidence at protein level
Q8N3X1,FNBP4_HUMAN,Formin-binding protein 4 (Formin-binding protein 30),1017,"110,266",4 out of 5,2007-05-29,Evidence at protein level
Q9Y2H6,FND3A_HUMAN,Fibronectin type-III domain-containing protein 3A (Human gene expressed in odontoblasts),1198,"131,852",5 out of 5,2004-07-19,Evidence at protein level
Q5VTL7,FNDC7_HUMAN,Fibronectin type III domain-containing protein 7,733,"78,236",2 out of 5,2008-04-08,Evidence at transcript level
Q8TF40,FNIP1_HUMAN,Folliculin-interacting protein 1,1166,"130,555",5 out of 5,2007-10-23,Evidence at protein level
P15408,FOSL2_HUMAN,Fos-related antigen 2 (FRA-2),326,"35,193",5 out of 5,1990-04-01,Evidence at protein level
P55317,FOXA1_HUMAN,Hepatocyte nuclear factor 3-alpha (HNF-3-alpha) (HNF-3A) (Forkhead box protein A1) (Transcription factor 3A) (TCF-3A),472,"49,148",5 out of 5,1996-10-01,Evidence at protein level
P55316,FOXG1_HUMAN,Forkhead box protein G1 (Brain factor 1) (BF-1) (BF1) (Brain factor 2) (BF-2) (BF2) (hBF-2) (Forkhead box protein G1A) (Forkhead box protein G1B) (Forkhead box protein G1C) (Forkhead-related protein FKHL1) (HFK1) (Forkhead-related protein FKHL2) (HFK2) (Forkhead-related protein FKHL3) (HFK3),489,"52,352",5 out of 5,1996-10-01,Evidence at protein level
Q9P0K8,FOXJ2_HUMAN,Forkhead box protein J2 (Fork head homologous X),574,"62,395",5 out of 5,2001-04-27,Evidence at protein level
A8MYZ6,FOXO6_HUMAN,Forkhead box protein O6,492,"50,595",3 out of 5,2008-02-05,Evidence at protein level
O15409,FOXP2_HUMAN,Forkhead box protein P2 (CAG repeat protein 44) (Trinucleotide repeat-containing gene 10 protein),715,"79,919",5 out of 5,2001-12-05,Evidence at protein level
Q9BZS1,FOXP3_HUMAN,"Forkhead box protein P3 (Scurfin) [Cleaved into: Forkhead box protein P3, C-terminally processed; Forkhead box protein P3 41 kDa form]",431,"47,244",5 out of 5,2001-06-20,Evidence at protein level
P25089,FPR3_HUMAN,N-formyl peptide receptor 3 (FMLP-related receptor II) (FMLP-R-II) (Formyl peptide receptor-like 2),353,"39,965",5 out of 5,1992-05-01,Evidence at transcript level
Q6IN97,FRP2L_HUMAN,Putative protein FRMPD2-like (FERM and PDZ domain-containing protein 2 pseudogene 1) (FERM and PDZ domain-containing protein 2B pseudogene) (PDZ domain-containing protein 5A),320,"35,161",3 out of 5,2007-10-02,Uncertain
Q14CM0,FRPD4_HUMAN,FERM and PDZ domain-containing protein 4 (PDZ domain-containing protein 10) (PSD-95-interacting regulator of spine morphogenesis) (Preso),1322,"144,379",5 out of 5,2007-10-23,Evidence at protein level
Q9BTY2,FUCO2_HUMAN,Plasma alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucoside fucohydrolase 2) (Alpha-L-fucosidase 2),467,"54,067",5 out of 5,2005-05-10,Evidence at protein level
Q8IVP5,FUND1_HUMAN,FUN14 domain-containing protein 1,155,"17,178",5 out of 5,2007-01-09,Evidence at protein level
Q11128,FUT5_HUMAN,"Alpha-(1,3)-fucosyltransferase 5 (EC 2.4.1.65) (Fucosyltransferase 5) (Fucosyltransferase V) (Fuc-TV) (FucT-V) (Galactoside 3-L-fucosyltransferase)",374,"43,008",5 out of 5,1996-10-01,Evidence at transcript level
P51116,FXR2_HUMAN,Fragile X mental retardation syndrome-related protein 2,673,"74,223",5 out of 5,1996-10-01,Evidence at protein level
Q9H0Q3,FXYD6_HUMAN,FXYD domain-containing ion transport regulator 6 (Phosphohippolin),95,"10,542",4 out of 5,2002-01-23,Evidence at protein level
O00144,FZD9_HUMAN,Frizzled-9 (Fz-9) (hFz9) (FzE6) (CD antigen CD349),591,"64,466",5 out of 5,2001-12-05,Evidence at transcript level
Q9UM11,FZR1_HUMAN,Fizzy-related protein homolog (Fzr) (CDC20-like protein 1) (Cdh1/Hct1 homolog) (hCDH1),496,"55,179",5 out of 5,2003-10-03,Evidence at protein level
Q9UBA6,G8_HUMAN,Protein G8,75,"8,344",1 out of 5,2001-01-11,Predicted
Q4V326,GAG2E_HUMAN,G antigen 2E (GAGE-2E),116,"12,763",1 out of 5,2010-07-13,Inferred from homology
Q13065,GAGE1_HUMAN,G antigen 1 (GAGE-1) (Antigen MZ2-F) (Cancer/testis antigen 4.1) (CT4.1),139,"15,610",3 out of 5,1998-07-15,Evidence at protein level
P63145,GAK24_HUMAN,Endogenous retrovirus group K member 24 Gag polyprotein (HERV-K101 Gag protein) (HERV-K_22q11.21 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,040",4 out of 5,2004-09-13,Evidence at protein level
P63126,GAK9_HUMAN,Endogenous retrovirus group K member 9 Gag polyprotein (HERV-K(C6) Gag protein) (HERV-K109 Gag protein) (HERV-K_6q14.1 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,005",4 out of 5,2004-09-13,Evidence at protein level
Q14376,GALE_HUMAN,UDP-glucose 4-epimerase (EC 5.1.3.2) (Galactowaldenase) (UDP-N-acetylgalactosamine 4-epimerase) (UDP-GalNAc 4-epimerase) (UDP-N-acetylglucosamine 4-epimerase) (UDP-GlcNAc 4-epimerase) (EC 5.1.3.7) (UDP-galactose 4-epimerase),348,"38,282",5 out of 5,1997-11-01,Evidence at protein level
Q14435,GALT3_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase 3) (GalNAc-T3) (pp-GaNTase 3) (Protein-UDP acetylgalactosaminyltransferase 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3),633,"72,610",5 out of 5,2004-08-16,Evidence at protein level
O60318,GANP_HUMAN,Germinal-center associated nuclear protein (GANP) (80 kDa MCM3-associated protein) (MCM3 acetylating protein) (MCM3AP) (EC 2.3.1.-) (MCM3 acetyltransferase),1980,"218,405",5 out of 5,2000-05-30,Evidence at protein level
Q75VX8,GARE2_HUMAN,GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like),874,"92,882",3 out of 5,2008-06-10,Evidence at protein level
Q9BWX5,GATA5_HUMAN,Transcription factor GATA-5 (GATA-binding factor 5),397,"41,299",5 out of 5,2002-01-31,Evidence at protein level
O75344,FKBP6_HUMAN,Inactive peptidyl-prolyl cis-trans isomerase FKBP6 (Inactive PPIase FKBP6) (36 kDa FK506-binding protein) (36 kDa FKBP) (FKBP-36) (FK506-binding protein 6) (FKBP-6) (Immunophilin FKBP36),327,"37,214",5 out of 5,2001-02-21,Evidence at protein level
Q14318,FKBP8_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP8 (PPIase FKBP8) (EC 5.2.1.8) (38 kDa FK506-binding protein) (38 kDa FKBP) (FKBP-38) (hFKBP38) (FK506-binding protein 8) (FKBP-8) (FKBPR38) (Rotamase),412,"44,562",5 out of 5,2000-05-30,Evidence at protein level
Q9UIM3,FKBPL_HUMAN,FK506-binding protein-like (WAF-1/CIP1 stabilizing protein 39) (WISp39),349,"38,176",4 out of 5,2007-05-29,Evidence at protein level
Q7Z7B0,FLIP1_HUMAN,Filamin-A-interacting protein 1 (FILIP),1213,"138,109",4 out of 5,2006-05-16,Evidence at protein level
O75369,FLNB_HUMAN,Filamin-B (FLN-B) (ABP-278) (ABP-280 homolog) (Actin-binding-like protein) (Beta-filamin) (Filamin homolog 1) (Fh1) (Filamin-3) (Thyroid autoantigen) (Truncated actin-binding protein) (Truncated ABP),2602,"278,164",5 out of 5,2003-11-07,Evidence at protein level
Q9NZU0,FLRT3_HUMAN,Leucine-rich repeat transmembrane protein FLRT3 (Fibronectin-like domain-containing leucine-rich transmembrane protein 3),649,"73,004",5 out of 5,2002-03-27,Evidence at protein level
Q96HJ9,FMC1_HUMAN,"Protein FMC1 homolog (ATP synthase assembly factor FMC1, mitochondrial) (Formation of mitochondrial complex V assembly factor 1 homolog)",113,"12,749",2 out of 5,2008-04-08,Evidence at protein level
Q68DA7,FMN1_HUMAN,Formin-1 (Limb deformity protein homolog),1419,"157,578",5 out of 5,2007-07-24,Evidence at protein level
Q9NZ56,FMN2_HUMAN,Formin-2,1722,"180,106",5 out of 5,2001-02-21,Evidence at protein level
Q06787,FMR1_HUMAN,Synaptic functional regulator FMR1 (Fragile X mental retardation protein 1) (FMRP) (Protein FMR-1),632,"71,174",5 out of 5,1994-06-01,Evidence at protein level
P49354,FNTA_HUMAN,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha (EC 2.5.1.58) (EC 2.5.1.59) (CAAX farnesyltransferase subunit alpha) (FTase-alpha) (Ras proteins prenyltransferase subunit alpha) (Type I protein geranyl-geranyltransferase subunit alpha) (GGTase-I-alpha),379,"44,409",5 out of 5,1996-02-01,Evidence at protein level
Q05932,FOLC_HUMAN,"Folylpolyglutamate synthase, mitochondrial (EC 6.3.2.17) (Folylpoly-gamma-glutamate synthetase) (FPGS) (Tetrahydrofolylpolyglutamate synthase) (Tetrahydrofolate synthase)",587,"64,609",5 out of 5,1994-06-01,Evidence at protein level
P53539,FOSB_HUMAN,Protein fosB (G0/G1 switch regulatory protein 3),338,"35,928",5 out of 5,1996-10-01,Evidence at transcript level
Q5VYV0,FOXB2_HUMAN,Forkhead box protein B2,432,"45,581",2 out of 5,2006-12-12,Predicted
Q99958,FOXC2_HUMAN,Forkhead box protein C2 (Forkhead-related protein FKHL14) (Mesenchyme fork head protein 1) (MFH-1 protein) (Transcription factor FKH-14),501,"53,719",5 out of 5,1998-07-15,Evidence at protein level
O60548,FOXD2_HUMAN,Forkhead box protein D2 (Forkhead-related protein FKHL17) (Forkhead-related transcription factor 9) (FREAC-9),495,"48,748",3 out of 5,2000-05-30,Evidence at protein level
O00358,FOXE1_HUMAN,Forkhead box protein E1 (Forkhead box protein E2) (Forkhead-related protein FKHL15) (HFKH4) (HNF-3/fork head-like protein 5) (HFKL5) (Thyroid transcription factor 2) (TTF-2),373,"38,076",5 out of 5,1998-07-15,Evidence at protein level
Q5SZK8,FREM2_HUMAN,FRAS1-related extracellular matrix protein 2 (ECM3 homolog),3169,"351,157",5 out of 5,2005-08-16,Evidence at protein level
Q8N475,FSTL5_HUMAN,Follistatin-related protein 5 (Follistatin-like protein 5),847,"95,751",3 out of 5,2005-04-12,Evidence at transcript level
Q9C0B1,FTO_HUMAN,Alpha-ketoglutarate-dependent dioxygenase FTO (EC 1.14.11.-) (Fat mass and obesity-associated protein),505,"58,282",5 out of 5,2007-05-01,Evidence at protein level
P04066,FUCO_HUMAN,Tissue alpha-L-fucosidase (EC 3.2.1.51) (Alpha-L-fucosidase I) (Alpha-L-fucoside fucohydrolase 1) (Alpha-L-fucosidase 1),466,"53,689",5 out of 5,1986-11-01,Evidence at protein level
Q12841,FSTL1_HUMAN,Follistatin-related protein 1 (Follistatin-like protein 1),308,"34,986",5 out of 5,1997-11-01,Evidence at protein level
O95633,FSTL3_HUMAN,Follistatin-related protein 3 (Follistatin-like protein 3) (Follistatin-related gene protein),263,"27,663",5 out of 5,2002-10-10,Evidence at protein level
A2VDF0,FUCM_HUMAN,Fucose mutarotase (EC 5.1.3.29),154,"16,765",4 out of 5,2007-05-15,Evidence at protein level
Q495W5,FUT11_HUMAN,"Alpha-(1,3)-fucosyltransferase 11 (EC 2.4.1.-) (Fucosyltransferase XI) (Fuc-TXI) (FucT-XI) (Galactoside 3-L-fucosyltransferase 11) (Fucosyltransferase 11)",492,"55,816",4 out of 5,2007-08-21,Evidence at protein level
P22083,FUT4_HUMAN,"Alpha-(1,3)-fucosyltransferase 4 (EC 2.4.1.-) (ELAM-1 ligand fucosyltransferase) (Fucosyltransferase 4) (Fucosyltransferase IV) (Fuc-TIV) (FucT-IV) (Galactoside 3-L-fucosyltransferase)",530,"59,084",5 out of 5,1991-08-01,Evidence at transcript level
Q4VC44,FWCH1_HUMAN,FLYWCH-type zinc finger-containing protein 1,716,"80,108",3 out of 5,2008-01-15,Evidence at protein level
Q5VV16,FX4L5_HUMAN,Forkhead box protein D4-like 5 (FOXD4-like 5),416,"45,780",2 out of 5,2007-09-11,Inferred from homology
Q96DB9,FXYD5_HUMAN,FXYD domain-containing ion transport regulator 5 (Dysadherin),178,"19,472",5 out of 5,2002-01-23,Evidence at protein level
P06241,FYN_HUMAN,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn),537,"60,762",5 out of 5,1988-01-01,Evidence at protein level
O75084,FZD7_HUMAN,Frizzled-7 (Fz-7) (hFz7) (FzE3),574,"63,620",5 out of 5,2001-12-05,Evidence at protein level
Q9NQR9,G6PC2_HUMAN,Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein),355,"40,580",5 out of 5,2008-05-20,Evidence at protein level
P06744,G6PI_HUMAN,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36),558,"63,147",5 out of 5,1988-01-01,Evidence at protein level
P63211,GBG1_HUMAN,Guanine nucleotide-binding protein G(T) subunit gamma-T1 (Transducin gamma chain),74,"8,496",5 out of 5,2004-09-27,Evidence at protein level
Q8N5D6,GBGT1_HUMAN,"Globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (EC 2.4.1.-) (Forssman glycolipid synthase-like protein)",347,"40,127",5 out of 5,2005-05-10,Evidence at transcript level
Q96PP9,GBP4_HUMAN,Guanylate-binding protein 4 (EC 3.6.5.-) (GTP-binding protein 4) (GBP-4) (Guanine nucleotide-binding protein 4),640,"73,165",5 out of 5,2003-10-24,Evidence at transcript level
Q6ZN66,GBP6_HUMAN,Guanylate-binding protein 6 (GTP-binding protein 6) (GBP-6) (Guanine nucleotide-binding protein 6),633,"72,427",4 out of 5,2008-01-15,Evidence at transcript level
Q8WUP2,FBLI1_HUMAN,Filamin-binding LIM protein 1 (FBLP-1) (Migfilin) (Mitogen-inducible 2-interacting protein) (MIG2-interacting protein),373,"40,670",5 out of 5,2003-11-07,Evidence at protein level
Q9HCM7,FBSL_HUMAN,Fibrosin-1-like protein (AUTS2-like protein) (HBV X-transactivated gene 9 protein) (HBV XAg-transactivated protein 9),1045,"110,907",3 out of 5,2008-02-26,Evidence at protein level
Q6ZV73,FGD6_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 6 (Zinc finger FYVE domain-containing protein 24)",1430,"160,816",4 out of 5,2005-03-15,Evidence at protein level
Q8TAT2,FGFP3_HUMAN,Fibroblast growth factor-binding protein 3 (FGF-BP3) (FGF-binding protein 3) (FGFBP-3),258,"27,590",4 out of 5,2006-06-27,Evidence at protein level
Q9BXU8,FHL17_HUMAN,Ferritin heavy polypeptide-like 17 (Cancer/testis antigen 38) (CT38),183,"21,142",3 out of 5,2001-09-26,Evidence at transcript level
Q5HY92,FIGN_HUMAN,Fidgetin,759,"82,146",4 out of 5,2006-10-03,Evidence at protein level
Q13451,FKBP5_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP5 (PPIase FKBP5) (EC 5.2.1.8) (51 kDa FK506-binding protein) (51 kDa FKBP) (FKBP-51) (54 kDa progesterone receptor-associated immunophilin) (Androgen-regulated protein 6) (FF1 antigen) (FK506-binding protein 5) (FKBP-5) (FKBP54) (p54) (HSP90-binding immunophilin) (Rotamase),457,"51,212",5 out of 5,1997-11-01,Evidence at protein level
Q9Y680,FKBP7_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP7 (PPIase FKBP7) (EC 5.2.1.8) (23 kDa FK506-binding protein) (23 kDa FKBP) (FKBP-23) (FK506-binding protein 7) (FKBP-7) (Rotamase),259,"30,009",5 out of 5,2002-09-19,Evidence at protein level
O75072,FKTN_HUMAN,Fukutin (EC 2.-.-.-) (Fukuyama-type congenital muscular dystrophy protein),461,"53,724",5 out of 5,2001-02-21,Evidence at protein level
Q8NFG4,FLCN_HUMAN,Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein),579,"64,473",5 out of 5,2006-02-21,Evidence at protein level
Q9UPI3,FLVC2_HUMAN,Feline leukemia virus subgroup C receptor-related protein 2 (Calcium-chelate transporter) (CCT),526,"57,241",5 out of 5,2004-04-13,Evidence at protein level
B3EWG3,FM25A_HUMAN,Protein FAM25A,89,"9,320",1 out of 5,2012-03-21,Inferred from homology
P0C7T7,FMAS1_HUMAN,Putative uncharacterized protein FRMD6-AS1 (FRMD6 antisense RNA 1) (FRMD6 antisense gene protein 1),363,"38,799",2 out of 5,2008-07-22,Uncertain
Q96PY5,FMNL2_HUMAN,Formin-like protein 2 (Formin homology 2 domain-containing protein 2),1086,"123,321",5 out of 5,2007-05-29,Evidence at protein level
P25090,FPR2_HUMAN,N-formyl peptide receptor 2 (FMLP-related receptor I) (FMLP-R-I) (Formyl peptide receptor-like 1) (HM63) (Lipoxin A4 receptor) (LXA4 receptor) (RFP),351,"38,964",5 out of 5,1992-05-01,Evidence at transcript level
A6NGY1,FRG2C_HUMAN,Protein FRG2-like-2 (FSHD region gene 2 protein family member C) (HSA3-FRG2),282,"30,798",2 out of 5,2007-09-11,Inferred from homology
P02792,FRIL_HUMAN,Ferritin light chain (Ferritin L subunit),175,"20,020",5 out of 5,1986-07-21,Evidence at protein level
A2A2Y4,FRMD3_HUMAN,FERM domain-containing protein 3 (Band 4.1-like protein 4O) (Ovary type protein 4.1) (4.1O),597,"68,772",4 out of 5,2008-02-05,Evidence at transcript level
Q6ZUT3,FRMD7_HUMAN,FERM domain-containing protein 7,714,"81,614",5 out of 5,2006-10-31,Evidence at protein level
Q68DX3,FRPD2_HUMAN,FERM and PDZ domain-containing protein 2 (PDZ domain-containing protein 4) (PDZ domain-containing protein 5C),1309,"144,282",5 out of 5,2007-10-02,Evidence at protein level
Q5TBA9,FRY_HUMAN,Protein furry homolog,3013,"338,875",4 out of 5,2007-03-20,Evidence at protein level
O95073,FSBP_HUMAN,Fibrinogen silencer-binding protein,299,"34,768",5 out of 5,2004-07-19,Evidence at protein level
Q5H9T9,FSCB_HUMAN,Fibrous sheath CABYR-binding protein,825,"87,956",3 out of 5,2005-08-30,Evidence at transcript level
Q16658,FSCN1_HUMAN,Fascin (55 kDa actin-bundling protein) (Singed-like protein) (p55),493,"54,530",5 out of 5,1997-11-01,Evidence at protein level
Q96I24,FUBP3_HUMAN,Far upstream element-binding protein 3 (FUSE-binding protein 3),572,"61,640",5 out of 5,2003-09-26,Evidence at protein level
P07954,FUMH_HUMAN,"Fumarate hydratase, mitochondrial (Fumarase) (EC 4.2.1.2)",510,"54,637",5 out of 5,1988-08-01,Evidence at protein level
P09958,FURIN_HUMAN,Furin (EC 3.4.21.75) (Dibasic-processing enzyme) (Paired basic amino acid residue-cleaving enzyme) (PACE),794,"86,678",5 out of 5,1989-07-01,Evidence at protein level
Q10981,FUT2_HUMAN,"Galactoside 2-alpha-L-fucosyltransferase 2 (EC 2.4.1.69) (Alpha(1,2)FT 2) (Fucosyltransferase 2) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 2) (SE2) (Secretor blood group alpha-2-fucosyltransferase) (Secretor factor) (Se)",343,"39,017",5 out of 5,1996-10-01,Evidence at protein level
Q3SYB3,FX4L6_HUMAN,Forkhead box protein D4-like 6 (FOXD4-like 6),417,"45,787",2 out of 5,2007-09-11,Evidence at protein level
Q8NEE6,FXL13_HUMAN,F-box/LRR-repeat protein 13 (F-box and leucine-rich repeat protein 13),735,"83,924",4 out of 5,2005-03-15,Evidence at transcript level
Q9H469,FXL15_HUMAN,F-box/LRR-repeat protein 15 (F-box only protein 37),300,"32,998",5 out of 5,2004-08-31,Evidence at protein level
Q96ME1,FXL18_HUMAN,F-box/LRR-repeat protein 18 (F-box and leucine-rich repeat protein 18),805,"88,341",4 out of 5,2005-03-15,Evidence at protein level
Q96IG2,FXL20_HUMAN,F-box/LRR-repeat protein 20 (F-box and leucine-rich repeat protein 20) (F-box/LRR-repeat protein 2-like),436,"48,423",3 out of 5,2003-11-21,Evidence at protein level
Q6P050,FXL22_HUMAN,F-box and leucine-rich protein 22,247,"27,269",5 out of 5,2006-07-25,Evidence at protein level
P58549,FXYD7_HUMAN,FXYD domain-containing ion transport regulator 7,80,"8,524",3 out of 5,2002-01-23,Evidence at protein level
Q9Y2I7,FYV1_HUMAN,1-phosphatidylinositol 3-phosphate 5-kinase (Phosphatidylinositol 3-phosphate 5-kinase) (EC 2.7.1.150) (FYVE finger-containing phosphoinositide kinase) (PIKfyve) (Phosphatidylinositol 3-phosphate 5-kinase type III) (PIPkin-III) (Type III PIP kinase),2098,"237,136",5 out of 5,2000-12-01,Evidence at protein level
P15328,FOLR1_HUMAN,"Folate receptor alpha (FR-alpha) (Adult folate-binding protein) (FBP) (Folate receptor 1) (Folate receptor, adult) (KB cells FBP) (Ovarian tumor-associated antigen MOv18)",257,"29,819",5 out of 5,1990-04-01,Evidence at protein level
Q9UJU5,FOXD3_HUMAN,Forkhead box protein D3 (HNF3/FH transcription factor genesis),478,"47,630",5 out of 5,2000-05-30,Evidence at protein level
Q12946,FOXF1_HUMAN,Forkhead box protein F1 (Forkhead-related activator 1) (FREAC-1) (Forkhead-related protein FKHL5) (Forkhead-related transcription factor 1),379,"40,122",5 out of 5,1997-11-01,Evidence at protein level
Q08050,FOXM1_HUMAN,Forkhead box protein M1 (Forkhead-related protein FKHL16) (Hepatocyte nuclear factor 3 forkhead homolog 11) (HFH-11) (HNF-3/fork-head homolog 11) (M-phase phosphoprotein 2) (MPM-2 reactive phosphoprotein 2) (Transcription factor Trident) (Winged-helix factor from INS-1 cells),763,"84,283",5 out of 5,2000-05-30,Evidence at protein level
O43524,FOXO3_HUMAN,Forkhead box protein O3 (AF6q21 protein) (Forkhead in rhabdomyosarcoma-like 1),673,"71,277",5 out of 5,2000-05-30,Evidence at protein level
O43638,FOXS1_HUMAN,Forkhead box protein S1 (Forkhead-like 18 protein) (Forkhead-related transcription factor 10) (FREAC-10),330,"35,434",3 out of 5,1998-12-15,Evidence at transcript level
P21462,FPR1_HUMAN,fMet-Leu-Phe receptor (fMLP receptor) (N-formyl peptide receptor) (FPR) (N-formylpeptide chemoattractant receptor),350,"38,446",5 out of 5,1991-05-01,Evidence at protein level
A9Z1Z3,FR1L4_HUMAN,Fer-1-like protein 4,1794,"200,980",3 out of 5,2008-09-02,Evidence at transcript level
Q9BZ68,FR8P1_HUMAN,Putative FERM domain-containing protein FRMD8P1 (FERM domain-containing 8 pseudogene 1),369,"41,136",2 out of 5,2007-07-24,Uncertain
Q5H8C1,FREM1_HUMAN,FRAS1-related extracellular matrix protein 1 (Protein QBRICK),2179,"244,154",5 out of 5,2005-08-16,Evidence at protein level
Q14331,FRG1_HUMAN,Protein FRG1 (FSHD region gene 1 protein),258,"29,172",5 out of 5,2001-09-26,Evidence at protein level
P02794,FRIH_HUMAN,"Ferritin heavy chain (Ferritin H subunit) (EC 1.16.3.1) (Cell proliferation-inducing gene 15 protein) [Cleaved into: Ferritin heavy chain, N-terminally processed]",183,"21,226",5 out of 5,1986-07-21,Evidence at protein level
O95876,FRITZ_HUMAN,WD repeat-containing and planar cell polarity effector protein fritz homolog (hFRTZ) (Bardet-Biedl syndrome 15 protein) (WD repeat-containing and planar cell polarity effector protein),746,"85,084",5 out of 5,2008-03-18,Evidence at protein level
P42685,FRK_HUMAN,Tyrosine-protein kinase FRK (EC 2.7.10.2) (FYN-related kinase) (Nuclear tyrosine protein kinase RAK) (Protein-tyrosine kinase 5),505,"58,254",5 out of 5,1995-11-01,Evidence at protein level
Q7Z6J6,FRMD5_HUMAN,FERM domain-containing protein 5,570,"65,065",3 out of 5,2006-07-25,Evidence at protein level
Q9BZ67,FRMD8_HUMAN,FERM domain-containing protein 8,464,"51,218",2 out of 5,2007-07-24,Evidence at protein level
Q9P0K9,FRS1L_HUMAN,DOMON domain-containing protein FRRS1L (Brain protein CG-6) (Ferric-chelate reductase 1-like protein),344,"37,270",4 out of 5,2006-03-21,Evidence at protein level
O43559,FRS3_HUMAN,Fibroblast growth factor receptor substrate 3 (FGFR substrate 3) (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2) (SNT-2),492,"54,462",5 out of 5,2005-07-19,Evidence at protein level
Q9NQT6,FSCN3_HUMAN,Fascin-3 (Testis fascin),498,"56,624",4 out of 5,2001-09-26,Evidence at transcript level
P23945,FSHR_HUMAN,Follicle-stimulating hormone receptor (FSH-R) (Follitropin receptor),695,"78,265",5 out of 5,1992-03-01,Evidence at protein level
Q6MZW2,FSTL4_HUMAN,Follistatin-related protein 4 (Follistatin-like protein 4),842,"93,096",3 out of 5,2006-10-03,Evidence at transcript level
P19883,FST_HUMAN,Follistatin (FS) (Activin-binding protein),344,"38,007",5 out of 5,1991-02-01,Evidence at protein level
Q9NU39,FX4L1_HUMAN,Forkhead box protein D4-like 1 (FOXD4-like 1),408,"43,610",2 out of 5,2003-01-27,Evidence at transcript level
Q96IV6,FXDC2_HUMAN,Fatty acid hydroxylase domain-containing protein 2,333,"39,002",3 out of 5,2006-09-19,Evidence at transcript level
Q8N1E6,FXL14_HUMAN,F-box/LRR-repeat protein 14 (F-box and leucine-rich repeat protein 14),418,"45,886",5 out of 5,2004-06-07,Evidence at protein level
Q8IWF2,FXRD2_HUMAN,FAD-dependent oxidoreductase domain-containing protein 2 (Endoplasmic reticulum flavoprotein associated with degradation),684,"77,791",5 out of 5,2008-05-20,Evidence at protein level
P59646,FXYD4_HUMAN,FXYD domain-containing ion transport regulator 4,89,"9,373",3 out of 5,2003-04-30,Inferred from homology
Q14332,FZD2_HUMAN,Frizzled-2 (Fz-2) (hFz2) (FzE2),565,"63,554",5 out of 5,2001-12-05,Evidence at protein level
O60353,FZD6_HUMAN,Frizzled-6 (Fz-6) (hFz6),706,"79,292",5 out of 5,2001-12-05,Evidence at protein level
Q9H461,FZD8_HUMAN,Frizzled-8 (Fz-8) (hFz8),694,"73,300",5 out of 5,2001-12-05,Evidence at protein level
P04406,G3P_HUMAN,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),335,"36,053",5 out of 5,1986-07-21,Evidence at protein level
Q96RP7,G3ST4_HUMAN,"Galactose-3-O-sulfotransferase 4 (Gal3ST-4) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 4) (Gal-beta-1,3-GalNAc 3'-sulfotransferase)",486,"54,166",5 out of 5,2004-05-10,Evidence at protein level
P35575,G6PC_HUMAN,Glucose-6-phosphatase (G-6-Pase) (G6Pase) (EC 3.1.3.9) (Glucose-6-phosphatase alpha) (G6Pase-alpha),357,"40,484",5 out of 5,1994-06-01,Evidence at protein level
P49771,FLT3L_HUMAN,Fms-related tyrosine kinase 3 ligand (Flt3 ligand) (Flt3L) (SL cytokine),235,"26,416",5 out of 5,1996-10-01,Evidence at protein level
Q9Y5Y0,FLVC1_HUMAN,Feline leukemia virus subgroup C receptor-related protein 1 (Feline leukemia virus subgroup C receptor) (hFLVCR),555,"59,863",5 out of 5,2004-04-13,Evidence at protein level
Q06828,FMOD_HUMAN,Fibromodulin (FM) (Collagen-binding 59 kDa protein) (Keratan sulfate proteoglycan fibromodulin) (KSPG fibromodulin),376,"43,179",5 out of 5,1994-06-01,Evidence at protein level
F2Z333,FND10_HUMAN,Fibronectin type III domain-containing protein 10,226,"24,218",2 out of 5,2012-03-21,Inferred from homology
P14207,FOLR2_HUMAN,"Folate receptor beta (FR-beta) (Folate receptor 2) (Folate receptor, fetal/placental) (Placental folate-binding protein) (FBP)",255,"29,280",5 out of 5,1990-01-01,Evidence at protein level
P15407,FOSL1_HUMAN,Fos-related antigen 1 (FRA-1),271,"29,413",5 out of 5,1990-04-01,Evidence at protein level
Q12951,FOXI1_HUMAN,Forkhead box protein I1 (Forkhead-related protein FKHL10) (Forkhead-related transcription factor 6) (FREAC-6) (Hepatocyte nuclear factor 3 forkhead homolog 3) (HFH-3) (HNF-3/fork-head homolog 3),378,"40,973",5 out of 5,1997-11-01,Evidence at protein level
A8MTJ6,FOXI3_HUMAN,Forkhead box protein I3,420,"43,326",2 out of 5,2008-06-10,Evidence at transcript level
Q92949,FOXJ1_HUMAN,Forkhead box protein J1 (Forkhead-related protein FKHL13) (Hepatocyte nuclear factor 3 forkhead homolog 4) (HFH-4),421,"45,247",5 out of 5,1997-11-01,Evidence at protein level
Q96NZ1,FOXN4_HUMAN,Forkhead box protein N4,517,"55,215",4 out of 5,2003-01-27,Evidence at protein level
Q12778,FOXO1_HUMAN,Forkhead box protein O1 (Forkhead box protein O1A) (Forkhead in rhabdomyosarcoma),655,"69,662",5 out of 5,1997-11-01,Evidence at protein level
Q92837,FRAT1_HUMAN,Proto-oncogene FRAT1 (Frequently rearranged in advanced T-cell lymphomas 1) (FRAT-1),279,"29,093",4 out of 5,1998-07-15,Evidence at protein level
Q6P4F1,FUT10_HUMAN,"Alpha-(1,3)-fucosyltransferase 10 (EC 2.4.1.-) (Fucosyltransferase X) (Fuc-TX) (FucT-X) (Galactoside 3-L-fucosyltransferase 10) (Fucosyltransferase 10)",479,"56,094",5 out of 5,2007-08-21,Evidence at transcript level
Q11130,FUT7_HUMAN,"Alpha-(1,3)-fucosyltransferase 7 (EC 2.4.1.-) (Fucosyltransferase 7) (Fucosyltransferase VII) (Fuc-TVII) (FucT-VII) (Galactoside 3-L-fucosyltransferase) (Selectin ligand synthase)",342,"39,239",5 out of 5,1996-10-01,Evidence at protein level
Q9Y231,FUT9_HUMAN,"Alpha-(1,3)-fucosyltransferase 9 (EC 2.4.1.-) (Fucosyltransferase 9) (Fucosyltransferase IX) (Fuc-TIX) (FucT-IX) (Galactoside 3-L-fucosyltransferase)",359,"42,071",5 out of 5,2004-11-09,Evidence at transcript level
O43826,G6PT1_HUMAN,Glucose-6-phosphate exchanger SLC37A4 (Glucose-5-phosphate transporter) (Glucose-6-phosphate translocase) (Solute carrier family 37 member 4) (Transformation-related gene 19 protein) (TRG-19),429,"46,360",5 out of 5,1998-12-15,Evidence at protein level
Q86XJ1,GA2L3_HUMAN,GAS2-like protein 3 (Growth arrest-specific protein 2-like 3),694,"75,214",5 out of 5,2005-08-30,Evidence at protein level
P24522,GA45A_HUMAN,Growth arrest and DNA damage-inducible protein GADD45 alpha (DNA damage-inducible transcript 1 protein) (DDIT-1),165,"18,336",5 out of 5,1992-03-01,Evidence at protein level
Q06547,GABP1_HUMAN,GA-binding protein subunit beta-1 (GABP subunit beta-1) (GABPB-1) (GABP subunit beta-2) (GABPB-2) (Nuclear respiratory factor 2) (Transcription factor E4TF1-47) (Transcription factor E4TF1-53),395,"42,483",5 out of 5,1995-11-01,Evidence at protein level
Q6NT46,GAG2A_HUMAN,G antigen 2A (GAGE-2A),116,"12,785",2 out of 5,2010-07-13,Evidence at protein level
Q8N4A0,GALT4_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 4 (EC 2.4.1.41) (Polypeptide GalNAc transferase 4) (GalNAc-T4) (pp-GaNTase 4) (Protein-UDP acetylgalactosaminyltransferase 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 4),578,"66,666",5 out of 5,2004-08-16,Evidence at protein level
Q8NCL4,GALT6_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 6) (GalNAc-T6) (pp-GaNTase 6) (Protein-UDP acetylgalactosaminyltransferase 6) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 6),622,"71,159",5 out of 5,2004-08-16,Evidence at transcript level
Q14697,GANAB_HUMAN,Neutral alpha-glucosidase AB (EC 3.2.1.84) (Alpha-glucosidase 2) (Glucosidase II subunit alpha),944,"106,874",5 out of 5,2004-07-05,Evidence at protein level
O76093,FGF18_HUMAN,Fibroblast growth factor 18 (FGF-18) (zFGF5),207,"23,989",5 out of 5,1999-07-15,Evidence at protein level
P05230,FGF1_HUMAN,Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1),155,"17,460",5 out of 5,1987-08-13,Evidence at protein level
P08620,FGF4_HUMAN,Fibroblast growth factor 4 (FGF-4) (Heparin secretory-transforming protein 1) (HST) (HST-1) (HSTF-1) (Heparin-binding growth factor 4) (HBGF-4) (Transforming protein KS3),206,"22,048",5 out of 5,1988-08-01,Evidence at protein level
P10767,FGF6_HUMAN,Fibroblast growth factor 6 (FGF-6) (Heparin secretory-transforming protein 2) (HST-2) (HSTF-2) (Heparin-binding growth factor 6) (HBGF-6),208,"22,905",5 out of 5,1989-07-01,Evidence at protein level
Q14512,FGFP1_HUMAN,Fibroblast growth factor-binding protein 1 (FGF-BP) (FGF-BP1) (FGF-binding protein 1) (FGFBP-1) (17 kDa heparin-binding growth factor-binding protein) (17 kDa HBGF-binding protein) (HBp17),234,"26,264",5 out of 5,2006-07-11,Evidence at protein level
P11362,FGFR1_HUMAN,Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr) (CD antigen CD331),822,"91,868",5 out of 5,1989-07-01,Evidence at protein level
P21802,FGFR2_HUMAN,Fibroblast growth factor receptor 2 (FGFR-2) (EC 2.7.10.1) (K-sam) (KGFR) (Keratinocyte growth factor receptor) (CD antigen CD332),821,"92,025",5 out of 5,1991-05-01,Evidence at protein level
P22455,FGFR4_HUMAN,Fibroblast growth factor receptor 4 (FGFR-4) (EC 2.7.10.1) (CD antigen CD334),802,"87,954",5 out of 5,1991-08-01,Evidence at protein level
Q14192,FHL2_HUMAN,Four and a half LIM domains protein 2 (FHL-2) (LIM domain protein DRAL) (Skeletal muscle LIM-protein 3) (SLIM-3),279,"32,193",5 out of 5,1997-11-01,Evidence at protein level
Q2V2M9,FHOD3_HUMAN,FH1/FH2 domain-containing protein 3 (Formactin-2) (Formin homolog overexpressed in spleen 2) (hFHOS2),1422,"158,613",5 out of 5,2007-04-17,Evidence at protein level
P36980,FHR2_HUMAN,Complement factor H-related protein 2 (FHR-2) (DDESK59) (H factor-like 3) (H factor-like protein 2),270,"30,651",5 out of 5,1994-06-01,Evidence at protein level
Q92562,FIG4_HUMAN,"Polyphosphoinositide phosphatase (EC 3.1.3.-) (Phosphatidylinositol 3,5-bisphosphate 5-phosphatase) (SAC domain-containing protein 3)",907,"103,635",5 out of 5,1997-11-01,Evidence at protein level
P26885,FKBP2_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP2 (PPIase FKBP2) (EC 5.2.1.8) (13 kDa FK506-binding protein) (13 kDa FKBP) (FKBP-13) (FK506-binding protein 2) (FKBP-2) (Immunophilin FKBP13) (Rotamase),142,"15,649",5 out of 5,1992-08-01,Evidence at protein level
Q9BVV2,FND11_HUMAN,Fibronectin type III domain-containing protein 11,318,"36,526",4 out of 5,2006-04-18,Evidence at protein level
Q12950,FOXD4_HUMAN,Forkhead box protein D4 (Forkhead-related protein FKHL9) (Forkhead-related transcription factor 5) (FREAC-5) (Myeloid factor-alpha),439,"47,309",3 out of 5,1997-11-01,Evidence at transcript level
Q0VG06,FP100_HUMAN,Fanconi anemia core complex-associated protein 100 (Fanconi anemia-associated protein of 100 kDa),881,"93,433",5 out of 5,2007-05-29,Evidence at protein level
A0AVI2,FR1L5_HUMAN,Fer-1-like protein 5,2093,"241,963",3 out of 5,2007-09-11,Evidence at transcript level
Q9BWH2,FUND2_HUMAN,FUN14 domain-containing protein 2 (Cervical cancer proto-oncogene 3 protein) (HCC-3) (Hepatitis C virus core-binding protein 6),189,"20,676",3 out of 5,2008-01-15,Evidence at protein level
P51993,FUT6_HUMAN,"Alpha-(1,3)-fucosyltransferase 6 (EC 2.4.1.65) (Fucosyltransferase 6) (Fucosyltransferase VI) (Fuc-TVI) (FucT-VI) (Galactoside 3-L-fucosyltransferase)",359,"41,860",5 out of 5,1996-10-01,Evidence at protein level
Q9BYC5,FUT8_HUMAN,"Alpha-(1,6)-fucosyltransferase (Alpha1-6FucT) (EC 2.4.1.68) (Fucosyltransferase 8) (GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1,6-fucosyltransferase) (GDP-fucose--glycoprotein fucosyltransferase) (Glycoprotein 6-alpha-L-fucosyltransferase)",575,"66,516",5 out of 5,2002-03-05,Evidence at protein level
Q9UF56,FXL17_HUMAN,F-box/LRR-repeat protein 17 (F-box and leucine-rich repeat protein 17) (F-box only protein 13),701,"75,695",3 out of 5,2004-03-01,Evidence at transcript level
Q9UKT6,FXL21_HUMAN,F-box/LRR-repeat protein 21 (F-box and leucine-rich repeat protein 21) (F-box and leucine-rich repeat protein 3B) (F-box/LRR-repeat protein 3B),434,"49,152",4 out of 5,2003-10-03,Evidence at protein level
Q96CU9,FXRD1_HUMAN,FAD-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-),486,"53,812",5 out of 5,2007-01-23,Evidence at protein level
Q9BQS8,FYCO1_HUMAN,FYVE and coiled-coil domain-containing protein 1 (Zinc finger FYVE domain-containing protein 7),1478,"166,983",5 out of 5,2006-07-11,Evidence at protein level
Q8TED4,G6PT3_HUMAN,Glucose-6-phosphate exchanger SLC37A2 (Solute carrier family 37 member 2),501,"54,436",5 out of 5,2007-10-23,Evidence at transcript level
Q9UBS5,GABR1_HUMAN,Gamma-aminobutyric acid type B receptor subunit 1 (GABA-B receptor 1) (GABA-B-R1) (GABA-BR1) (GABABR1) (Gb1),961,"108,320",5 out of 5,2001-01-11,Evidence at protein level
O75899,GABR2_HUMAN,Gamma-aminobutyric acid type B receptor subunit 2 (GABA-B receptor 2) (GABA-B-R2) (GABA-BR2) (GABABR2) (Gb2) (G-protein coupled receptor 51) (HG20),941,"105,821",5 out of 5,2001-01-11,Evidence at protein level
Q13067,GAGE3_HUMAN,G antigen 3 (GAGE-3) (Cancer/testis antigen 4.3) (CT4.3),118,"12,937",2 out of 5,1998-07-15,Evidence at protein level
Q13069,GAGE5_HUMAN,G antigen 5 (GAGE-5) (Cancer/testis antigen 4.5) (CT4.5),117,"12,924",2 out of 5,1998-07-15,Evidence at protein level
P62683,GAK21_HUMAN,Endogenous retrovirus group K member 21 Gag polyprotein (HERV-K_12q14.1 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,000",3 out of 5,2004-07-19,Evidence at protein level
P22466,GALA_HUMAN,Galanin peptides [Cleaved into: Galanin; Galanin message-associated peptide (GMAP)],123,"13,302",5 out of 5,1991-08-01,Evidence at protein level
P54803,GALC_HUMAN,Galactocerebrosidase (GALCERase) (EC 3.2.1.46) (Galactocerebroside beta-galactosidase) (Galactosylceramidase) (Galactosylceramide beta-galactosidase),685,"77,063",5 out of 5,1996-10-01,Evidence at protein level
P51570,GALK1_HUMAN,Galactokinase (EC 2.7.1.6) (Galactose kinase),392,"42,272",5 out of 5,1996-10-01,Evidence at protein level
O60755,GALR3_HUMAN,Galanin receptor type 3 (GAL3-R) (GALR-3),368,"39,573",5 out of 5,1999-07-15,Evidence at protein level
P07902,GALT_HUMAN,Galactose-1-phosphate uridylyltransferase (Gal-1-P uridylyltransferase) (EC 2.7.7.12) (UDP-glucose--hexose-1-phosphate uridylyltransferase),379,"43,363",5 out of 5,1988-08-01,Evidence at protein level
P01350,GAST_HUMAN,Gastrin [Cleaved into: Gastrin-71 (Gastrin component I); Gastrin-52 (G52); Big gastrin (Gastrin component II) (Gastrin-34) (G34); Gastrin (Gastrin component III) (Gastrin-17) (G17); Gastrin-14 (G14); Gastrin-6 (G6)],101,"11,394",5 out of 5,1986-07-21,Evidence at protein level
Q96DP5,FMT_HUMAN,"Methionyl-tRNA formyltransferase, mitochondrial (MtFMT) (EC 2.1.2.9)",389,"43,832",4 out of 5,2003-01-27,Evidence at protein level
P41439,FOLR3_HUMAN,Folate receptor gamma (FR-gamma) (Folate receptor 3),243,"27,638",5 out of 5,1995-11-01,Evidence at protein level
E5RQL4,FONG_HUMAN,Formiminotransferase N-terminal subdomain-containing protein (Formiminotransferase-cyclodeaminase N-terminal-like protein),147,"16,268",2 out of 5,2011-12-14,Evidence at transcript level
P58012,FOXL2_HUMAN,Forkhead box protein L2,376,"38,772",5 out of 5,2001-04-27,Evidence at protein level
Q9H334,FOXP1_HUMAN,Forkhead box protein P1 (Mac-1-regulated forkhead) (MFH),677,"75,317",5 out of 5,2001-06-20,Evidence at protein level
Q8IVH2,FOXP4_HUMAN,Forkhead box protein P4 (Fork head-related protein-like A),680,"73,488",4 out of 5,2004-04-13,Evidence at protein level
Q86XX4,FRAS1_HUMAN,Extracellular matrix protein FRAS1,4008,"443,214",5 out of 5,2004-08-16,Evidence at protein level
O75474,FRAT2_HUMAN,GSK-3-binding protein FRAT2 (Frequently rearranged in advanced T-cell lymphomas 2) (FRAT-2),233,"24,051",3 out of 5,2000-05-30,Evidence at transcript level
Q16595,FRDA_HUMAN,"Frataxin, mitochondrial (EC 1.16.3.1) (Friedreich ataxia protein) (Fxn) [Cleaved into: Frataxin intermediate form (i-FXN); Frataxin(56-210) (m56-FXN); Frataxin(78-210) (d-FXN) (m78-FXN); Frataxin mature form (Frataxin(81-210)) (m81-FXN)]",210,"23,135",5 out of 5,1999-07-15,Evidence at protein level
P0C091,FREM3_HUMAN,FRAS1-related extracellular matrix protein 3,2139,"238,179",3 out of 5,2005-08-16,Inferred from homology
Q5SYB0,FRPD1_HUMAN,FERM and PDZ domain-containing protein 1 (FERM domain-containing protein 2),1578,"173,437",5 out of 5,2007-10-02,Evidence at protein level
O94915,FRYL_HUMAN,Protein furry homolog-like (ALL1-fused gene from chromosome 4p12 protein),3013,"339,598",5 out of 5,2007-02-06,Evidence at protein level
O14926,FSCN2_HUMAN,Fascin-2 (Retinal fascin),492,"55,057",5 out of 5,2001-09-26,Evidence at protein level
Q9BTV5,FSD1_HUMAN,Fibronectin type III and SPRY domain-containing protein 1 (MID1-related protein 1) (Microtubule-associated protein GLFND),496,"55,820",5 out of 5,2008-02-05,Evidence at protein level
Q6VB84,FX4L3_HUMAN,Forkhead box protein D4-like 3 (FOXD4-like 3),417,"45,820",2 out of 5,2007-09-11,Evidence at transcript level
P51114,FXR1_HUMAN,Fragile X mental retardation syndrome-related protein 1 (hFXR1p),621,"69,721",5 out of 5,1996-10-01,Evidence at protein level
Q8NGA4,G32P1_HUMAN,Putative G-protein coupled receptor GPR32P1 (G-protein coupled 32 pseudogene) (G-protein coupled 32 pseudogene 1) (G-protein coupled receptor GPCR39) (hGPCR39),272,"30,291",4 out of 5,2008-09-02,Uncertain
Q13283,G3BP1_HUMAN,Ras GTPase-activating protein-binding protein 1 (G3BP-1) (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent DNA helicase VIII) (hDH VIII) (GAP SH3 domain-binding protein 1),466,"52,164",5 out of 5,2001-07-11,Evidence at protein level
Q99999,G3ST1_HUMAN,Galactosylceramide sulfotransferase (GalCer sulfotransferase) (EC 2.8.2.11) (3'-phosphoadenosine-5'-phosphosulfate:GalCer sulfotransferase) (3'-phosphoadenylylsulfate:galactosylceramide 3'-sulfotransferase) (Cerebroside sulfotransferase),423,"48,764",5 out of 5,2002-07-26,Evidence at protein level
Q96A11,G3ST3_HUMAN,"Galactose-3-O-sulfotransferase 3 (Gal3ST-3) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 3) (Gal3ST3) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 3)",431,"48,956",5 out of 5,2004-05-10,Evidence at protein level
O95866,G6B_HUMAN,Protein G6b,241,"26,163",5 out of 5,2005-06-21,Evidence at protein level
O95257,GA45G_HUMAN,Growth arrest and DNA damage-inducible protein GADD45 gamma (Cytokine-responsive protein CR6) (DNA damage-inducible transcript 2 protein) (DDIT-2),159,"17,121",5 out of 5,2000-05-30,Evidence at protein level
Q9UQC2,GAB2_HUMAN,GRB2-associated-binding protein 2 (GRB2-associated binder 2) (Growth factor receptor bound protein 2-associated protein 2) (pp100),676,"74,458",5 out of 5,2004-04-13,Evidence at protein level
A6NGK3,GAG10_HUMAN,G antigen 10 (GAGE-10),116,"12,651",2 out of 5,2008-05-20,Evidence at protein level
P01358,GAJU_HUMAN,Gastric juice peptide 1 [Cleaved into: Gastric juice peptide 2],10,"1,004",1 out of 5,1986-07-21,Evidence at protein level
Q9YNA8,GAK19_HUMAN,Endogenous retrovirus group K member 19 Gag polyprotein (HERV-K(C19) Gag protein) (HERV-K_19q11 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,183",4 out of 5,2004-07-19,Evidence at protein level
P63130,GAK7_HUMAN,Endogenous retrovirus group K member 7 Gag polyprotein (HERV-K(III) Gag protein) (HERV-K102 Gag protein) (HERV-K_1q22 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,111",4 out of 5,2004-09-13,Inferred from homology
Q15007,FL2D_HUMAN,Pre-mRNA-splicing regulator WTAP (Female-lethal(2)D homolog) (hFL(2)D) (WT1-associated protein) (Wilms tumor 1-associating protein),396,"44,244",5 out of 5,1998-07-15,Evidence at protein level
Q9NZU1,FLRT1_HUMAN,Leucine-rich repeat transmembrane protein FLRT1 (Fibronectin-like domain-containing leucine-rich transmembrane protein 1),646,"71,358",5 out of 5,2002-03-27,Evidence at protein level
Q53EP0,FND3B_HUMAN,Fibronectin type III domain-containing protein 3B (Factor for adipocyte differentiation 104) (HCV NS5A-binding protein 37),1204,"132,888",5 out of 5,2007-05-01,Evidence at protein level
Q9H6D8,FNDC4_HUMAN,Fibronectin type III domain-containing protein 4 (Fibronectin type III repeat-containing protein 1),234,"25,159",2 out of 5,2007-01-09,Evidence at transcript level
Q9P278,FNIP2_HUMAN,Folliculin-interacting protein 2 (FNIP1-like protein) (O6-methylguanine-induced apoptosis 1 protein),1114,"122,115",5 out of 5,2008-02-26,Evidence at protein level
P55318,FOXA3_HUMAN,Hepatocyte nuclear factor 3-gamma (HNF-3-gamma) (HNF-3G) (Fork head-related protein FKH H3) (Forkhead box protein A3) (Transcription factor 3G) (TCF-3G),350,"37,140",5 out of 5,1996-10-01,Evidence at protein level
Q9Y261,FOXA2_HUMAN,Hepatocyte nuclear factor 3-beta (HNF-3-beta) (HNF-3B) (Forkhead box protein A2) (Transcription factor 3B) (TCF-3B),457,"48,306",5 out of 5,2000-05-30,Evidence at protein level
Q12948,FOXC1_HUMAN,Forkhead box protein C1 (Forkhead-related protein FKHL7) (Forkhead-related transcription factor 3) (FREAC-3),553,"56,789",5 out of 5,1997-11-01,Evidence at protein level
Q13461,FOXE3_HUMAN,Forkhead box protein E3 (Forkhead-related protein FKHL12) (Forkhead-related transcription factor 8) (FREAC-8),319,"33,234",5 out of 5,1997-11-01,Evidence at protein level
O00409,FOXN3_HUMAN,Forkhead box protein N3 (Checkpoint suppressor 1),490,"53,835",5 out of 5,2000-05-30,Evidence at protein level
P14324,FPPS_HUMAN,"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)",419,"48,275",5 out of 5,1990-01-01,Evidence at protein level
Q2WGJ9,FR1L6_HUMAN,Fer-1-like protein 6,1857,"209,308",2 out of 5,2008-03-18,Evidence at transcript level
O95684,FR1OP_HUMAN,FGFR1 oncogene partner,399,"43,065",5 out of 5,2006-05-02,Evidence at protein level
Q96QU4,FRG2B_HUMAN,Protein FRG2-like-1 (FSHD region gene 2 protein family member B) (HSA10-FRG2),278,"30,564",2 out of 5,2007-09-11,Evidence at transcript level
Q96NE9,FRMD6_HUMAN,FERM domain-containing protein 6 (Willin),622,"72,044",5 out of 5,2003-08-15,Evidence at protein level
Q6ZNA5,FRRS1_HUMAN,Ferric-chelate reductase 1 (EC 1.-.-.-) (Stromal cell-derived receptor 2) (SDR-2),592,"66,114",3 out of 5,2008-01-15,Evidence at transcript level
Q96AE4,FUBP1_HUMAN,Far upstream element-binding protein 1 (FBP) (FUSE-binding protein 1) (DNA helicase V) (hDH V),644,"67,560",5 out of 5,2003-09-26,Evidence at protein level
Q92945,FUBP2_HUMAN,Far upstream element-binding protein 2 (FUSE-binding protein 2) (KH type-splicing regulatory protein) (KSRP) (p75),711,"73,115",5 out of 5,2003-09-26,Evidence at protein level
Q8WXT5,FX4L4_HUMAN,Forkhead box protein D4-like 4 (FOXD4-like 4) (Forkhead box protein D4-like 2) (Forkhead box protein D4B) (Myeloid factor-gamma),416,"45,892",2 out of 5,2003-01-27,Evidence at transcript level
Q8N461,FXL16_HUMAN,F-box/LRR-repeat protein 16 (F-box and leucine-rich repeat protein 16),479,"51,658",4 out of 5,2004-07-19,Evidence at transcript level
Q6PCT2,FXL19_HUMAN,F-box/LRR-repeat protein 19 (F-box and leucine-rich repeat protein 19),694,"75,707",4 out of 5,2005-03-15,Evidence at protein level
O15117,FYB_HUMAN,FYN-binding protein (Adhesion and degranulation promoting adaptor protein) (ADAP) (FYB-120/130) (p120/p130) (FYN-T-binding protein) (SLAP-130) (SLP-76-associated phosphoprotein),783,"85,387",5 out of 5,1999-07-15,Evidence at protein level
Q9ULW2,FZD10_HUMAN,Frizzled-10 (Fz-10) (hFz10) (FzE7) (CD antigen CD350),581,"65,336",5 out of 5,2001-12-05,Evidence at protein level
Q9UP38,FZD1_HUMAN,Frizzled-1 (Fz-1) (hFz1) (FzE1),647,"71,158",5 out of 5,2001-12-05,Evidence at protein level
Q9ULV1,FZD4_HUMAN,Frizzled-4 (Fz-4) (hFz4) (FzE4) (CD antigen CD344),537,"59,881",5 out of 5,2001-12-05,Evidence at protein level
A8MWK0,FS2P1_HUMAN,Putative fatty acid desaturase 2-like protein FADS2P1 (Fatty acid desaturase 2 pseudogene 1),482,"56,358",3 out of 5,2008-09-02,Uncertain
Q5CZC0,FSIP2_HUMAN,Fibrous sheath-interacting protein 2,6907,"780,607",2 out of 5,2008-04-29,Evidence at transcript level
O95954,FTCD_HUMAN,Formimidoyltransferase-cyclodeaminase (Formiminotransferase-cyclodeaminase) (FTCD) (LCHC1) [Includes: Glutamate formimidoyltransferase (EC 2.1.2.5) (Glutamate formiminotransferase) (Glutamate formyltransferase); Formimidoyltetrahydrofolate cyclodeaminase (EC 4.3.1.4) (Formiminotetrahydrofolate cyclodeaminase)],541,"58,927",5 out of 5,2000-05-30,Evidence at protein level
Q68CZ1,FTM_HUMAN,Protein fantom (Nephrocystin-8) (RPGR-interacting protein 1-like protein) (RPGRIP1-like protein),1315,"151,201",5 out of 5,2007-06-12,Evidence at protein level
Q8N0W3,FUK_HUMAN,L-fucose kinase (Fucokinase) (EC 2.7.1.52),1084,"117,623",4 out of 5,2002-11-28,Evidence at transcript level
O60478,G137B_HUMAN,Integral membrane protein GPR137B (Transmembrane 7 superfamily member 1 protein),399,"45,599",3 out of 5,2003-11-07,Evidence at transcript level
Q8N3F9,G137C_HUMAN,Integral membrane protein GPR137C (Transmembrane 7 superfamily member 1-like 2 protein),429,"47,075",2 out of 5,2007-09-11,Evidence at transcript level
Q8TAE8,G45IP_HUMAN,"Growth arrest and DNA damage-inducible proteins-interacting protein 1 (39S ribosomal protein L59, mitochondrial) (MRP-L59) (CKII beta-associating protein) (CR6-interacting factor 1) (CRIF1) (Mitochondrial large ribosomal subunit protein mL64) (Papillomavirus L2-interacting nuclear protein 1) (PLINP) (PLINP-1) (p53-responsive gene 6 protein)",222,"25,384",5 out of 5,2006-03-21,Evidence at protein level
P11413,G6PD_HUMAN,Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49),515,"59,257",5 out of 5,1989-10-01,Evidence at protein level
P57057,G6PT2_HUMAN,Glucose-6-phosphate exchanger SLC37A1 (Glycerol-3-phosphate permease) (G-3-P permease) (Solute carrier family 37 member 1),533,"57,648",5 out of 5,2000-12-01,Evidence at transcript level
P62684,GA113_HUMAN,Endogenous retrovirus group K member 113 Gag polyprotein (HERV-K113 Gag protein) (HERV-K_19p13.11 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,038",4 out of 5,2004-07-19,Evidence at protein level
Q13480,GAB1_HUMAN,GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1),694,"76,616",5 out of 5,2004-04-13,Evidence at protein level
Q14C86,GAPD1_HUMAN,GTPase-activating protein and VPS9 domain-containing protein 1 (GAPex-5) (Rab5-activating protein 6),1478,"164,980",5 out of 5,2008-03-18,Evidence at protein level
Q9H4G4,GAPR1_HUMAN,Golgi-associated plant pathogenesis-related protein 1 (GAPR-1) (Golgi-associated PR-1 protein) (Glioma pathogenesis-related protein 2) (GliPR 2),154,"17,218",5 out of 5,2004-03-29,Evidence at protein level
Q9H706,GARE1_HUMAN,GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1),876,"97,186",5 out of 5,2007-02-06,Evidence at protein level
P41250,GARS_HUMAN,Glycine--tRNA ligase (EC 3.6.1.17) (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (AP-4-A synthetase) (Glycyl-tRNA synthetase) (GlyRS),739,"83,166",5 out of 5,1995-02-01,Evidence at protein level
O43903,GAS2_HUMAN,Growth arrest-specific protein 2 (GAS-2),313,"34,945",4 out of 5,1998-12-15,Evidence at protein level
O60861,GAS7_HUMAN,Growth arrest-specific protein 7 (GAS-7),476,"54,371",5 out of 5,2001-01-11,Evidence at protein level
Q92947,GCDH_HUMAN,"Glutaryl-CoA dehydrogenase, mitochondrial (GCD) (EC 1.3.8.6)",438,"48,127",5 out of 5,1997-11-01,Evidence at protein level
Q9NP62,GCM1_HUMAN,Chorion-specific transcription factor GCMa (hGCMa) (GCM motif protein 1) (Glial cells missing homolog 1),436,"49,268",5 out of 5,2003-07-25,Evidence at transcript level
Q02742,GCNT1_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (EC 2.4.1.102) (Core 2-branching enzyme) (Core2-GlcNAc-transferase) (C2GNT) (Core 2 GNT)",428,"49,799",5 out of 5,1994-06-01,Evidence at protein level
Q96RT7,GCP6_HUMAN,Gamma-tubulin complex component 6 (GCP-6),1819,"200,498",5 out of 5,2002-05-02,Evidence at protein level
Q8N878,FRMD1_HUMAN,FERM domain-containing protein 1,549,"62,523",2 out of 5,2006-07-25,Evidence at transcript level
A1L4K1,FSD2_HUMAN,Fibronectin type III and SPRY domain-containing protein 2 (SPRY domain-containing protein 1),749,"85,385",5 out of 5,2008-02-05,Evidence at protein level
P01225,FSHB_HUMAN,Follitropin subunit beta (Follicle-stimulating hormone beta subunit) (FSH-B) (FSH-beta) (Follitropin beta chain),129,"14,700",5 out of 5,1986-07-21,Evidence at protein level
Q8NA03,FSIP1_HUMAN,Fibrous sheath-interacting protein 1,581,"66,121",2 out of 5,2008-01-15,Evidence at transcript level
Q8N4E7,FTMT_HUMAN,"Ferritin, mitochondrial (EC 1.16.3.1)",242,"27,538",5 out of 5,2005-04-26,Evidence at protein level
P35637,FUS_HUMAN,RNA-binding protein FUS (75 kDa DNA-pairing protein) (Oncogene FUS) (Oncogene TLS) (POMp75) (Translocated in liposarcoma protein),526,"53,426",5 out of 5,1994-06-01,Evidence at protein level
P21217,FUT3_HUMAN,Galactoside 3(4)-L-fucosyltransferase (EC 2.4.1.65) (Blood group Lewis alpha-4-fucosyltransferase) (Lewis FT) (Fucosyltransferase 3) (Fucosyltransferase III) (FucT-III),361,"42,117",5 out of 5,1991-05-01,Evidence at transcript level
Q9BT04,FUZZY_HUMAN,Protein fuzzy homolog,418,"45,679",5 out of 5,2008-01-15,Evidence at protein level
Q7L622,G2E3_HUMAN,G2/M phase-specific E3 ubiquitin-protein ligase (EC 2.3.2.26) (G2/M phase-specific HECT-type E3 ubiquitin transferase),706,"80,504",5 out of 5,2006-09-05,Evidence at protein level
Q9UN86,G3BP2_HUMAN,Ras GTPase-activating protein-binding protein 2 (G3BP-2) (GAP SH3 domain-binding protein 2),482,"54,121",5 out of 5,2001-07-11,Evidence at protein level
Q9BUM1,G6PC3_HUMAN,Glucose-6-phosphatase 3 (G-6-Pase 3) (G6Pase 3) (EC 3.1.3.9) (Glucose-6-phosphatase beta) (G6Pase-beta) (Ubiquitous glucose-6-phosphatase catalytic subunit-related protein),346,"38,735",5 out of 5,2008-05-20,Evidence at protein level
Q8WWW8,GAB3_HUMAN,GRB2-associated-binding protein 3 (GRB2-associated binder 3) (Growth factor receptor bound protein 2-associated protein 3),586,"65,589",3 out of 5,2008-02-26,Evidence at protein level
Q4V321,GAG13_HUMAN,G antigen 13 (GAGE-13) (G antigen 12A) (GAGE-12A),117,"12,873",2 out of 5,2006-10-17,Inferred from homology
O76087,GAGE7_HUMAN,G antigen 7 (GAGE-7) (AL4) (Cancer/testis antigen 4.7) (CT4.7) (GAGE-12I) (GAGE-7B) (GAGE-8),117,"12,978",2 out of 5,2000-05-30,Evidence at transcript level
Q9HDB9,GAK5_HUMAN,Endogenous retrovirus group K member 5 Gag polyprotein (HERV-K(II) Gag protein) (HERV-K_3q12.3 provirus ancestral Gag polyprotein) (Gag polyprotein),667,"73,588",4 out of 5,2004-07-19,Evidence at protein level
P62685,GAK8_HUMAN,Endogenous retrovirus group K member 8 Gag polyprotein (HERV-K115 Gag protein) (HERV-K_8p23.1 provirus ancestral Gag polyprotein) (Gag polyprotein),647,"72,181",3 out of 5,2004-07-19,Evidence at protein level
Q01415,GALK2_HUMAN,N-acetylgalactosamine kinase (EC 2.7.1.157) (GalNAc kinase) (Galactokinase 2),458,"50,378",5 out of 5,1993-07-01,Evidence at protein level
Q9UBC7,GALP_HUMAN,Galanin-like peptide,116,"12,545",4 out of 5,2002-02-11,Evidence at transcript level
O43603,GALR2_HUMAN,Galanin receptor type 2 (GAL2-R) (GALR-2),387,"41,700",5 out of 5,1999-07-15,Evidence at protein level
O43716,GATC_HUMAN,"Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial (Glu-AdT subunit C) (EC 6.3.5.-) (Protein 15E1.2)",136,"15,086",5 out of 5,2000-05-30,Evidence at protein level
Q8WUU5,GATD1_HUMAN,GATA zinc finger domain-containing protein 1 (Ocular development-associated gene protein),269,"28,690",5 out of 5,2007-05-29,Evidence at protein level
Q8NAP1,GATS_HUMAN,Putative protein GATS (STAG3 opposite strand transcript protein),163,"17,846",2 out of 5,2008-03-18,Uncertain
P62879,GBB2_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 (G protein subunit beta-2) (Transducin beta chain 2),340,"37,331",5 out of 5,2004-08-16,Evidence at protein level
Q92538,GBF1_HUMAN,Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (BFA-resistant GEF 1),1859,"206,446",5 out of 5,2001-02-21,Evidence at protein level
P32455,GBP1_HUMAN,Guanylate-binding protein 1 (EC 3.6.5.-) (GTP-binding protein 1) (GBP-1) (HuGBP-1) (Guanine nucleotide-binding protein 1) (Interferon-induced guanylate-binding protein 1),592,"67,931",5 out of 5,1993-10-01,Evidence at protein level
Q96PP8,GBP5_HUMAN,Guanylate-binding protein 5 (EC 3.6.5.-) (GBP-TA antigen) (GTP-binding protein 5) (GBP-5) (Guanine nucleotide-binding protein 5),586,"66,617",5 out of 5,2003-10-24,Evidence at protein level
P48169,GBRA4_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-4 (GABA(A) receptor subunit alpha-4),554,"61,623",5 out of 5,1996-02-01,Evidence at transcript level
Q16445,GBRA6_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-6 (GABA(A) receptor subunit alpha-6),453,"51,024",5 out of 5,1997-11-01,Evidence at transcript level
O95166,GBRAP_HUMAN,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) (MM46),117,"13,918",5 out of 5,2004-03-01,Evidence at protein level
P18505,GBRB1_HUMAN,Gamma-aminobutyric acid receptor subunit beta-1 (GABA(A) receptor subunit beta-1),474,"54,235",5 out of 5,1990-11-01,Evidence at protein level
Q9BY60,GBRL3_HUMAN,Gamma-aminobutyric acid receptor-associated protein-like 3 (GABA(A) receptor-associated protein-like 3),117,"13,976",3 out of 5,2004-03-01,Evidence at transcript level
O00591,GBRP_HUMAN,Gamma-aminobutyric acid receptor subunit pi (GABA(A) receptor subunit pi),440,"50,640",5 out of 5,1999-07-15,Evidence at transcript level
P30793,GCH1_HUMAN,GTP cyclohydrolase 1 (EC 3.5.4.16) (GTP cyclohydrolase I) (GTP-CH-I),250,"27,903",5 out of 5,1993-07-01,Evidence at protein level
P80404,GABT_HUMAN,"4-aminobutyrate aminotransferase, mitochondrial (EC 2.6.1.19) ((S)-3-amino-2-methylpropionate transaminase) (EC 2.6.1.22) (GABA aminotransferase) (GABA-AT) (Gamma-amino-N-butyrate transaminase) (GABA transaminase) (GABA-T) (L-AIBAT)",500,"56,439",5 out of 5,1995-11-01,Evidence at protein level
P54826,GAS1_HUMAN,Growth arrest-specific protein 1 (GAS-1),345,"35,693",4 out of 5,1996-10-01,Evidence at transcript level
Q96D09,GASP2_HUMAN,G-protein coupled receptor-associated sorting protein 2 (GASP-2),838,"93,773",4 out of 5,2006-05-30,Evidence at protein level
P32239,GASR_HUMAN,Gastrin/cholecystokinin type B receptor (CCK-B receptor) (CCK-BR) (Cholecystokinin-2 receptor) (CCK2-R),447,"48,419",5 out of 5,1993-10-01,Evidence at protein level
Q9HAV0,GBB4_HUMAN,Guanine nucleotide-binding protein subunit beta-4 (Transducin beta chain 4),340,"37,567",5 out of 5,2002-08-13,Evidence at protein level
P14867,GBRA1_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-1 (GABA(A) receptor subunit alpha-1),456,"51,802",5 out of 5,1990-04-01,Evidence at protein level
P47869,GBRA2_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-2 (GABA(A) receptor subunit alpha-2),451,"51,326",5 out of 5,1996-02-01,Evidence at transcript level
P47870,GBRB2_HUMAN,Gamma-aminobutyric acid receptor subunit beta-2 (GABA(A) receptor subunit beta-2),512,"59,150",5 out of 5,1996-02-01,Evidence at protein level
P78334,GBRE_HUMAN,Gamma-aminobutyric acid receptor subunit epsilon (GABA(A) receptor subunit epsilon),506,"57,972",5 out of 5,1999-07-15,Evidence at transcript level
P18507,GBRG2_HUMAN,Gamma-aminobutyric acid receptor subunit gamma-2 (GABA(A) receptor subunit gamma-2),467,"54,162",5 out of 5,1990-11-01,Evidence at protein level
P33402,GCYA2_HUMAN,Guanylate cyclase soluble subunit alpha-2 (GCS-alpha-2) (EC 4.6.1.2),732,"81,750",5 out of 5,1994-02-01,Evidence at protein level
Q9NQX3,GEPH_HUMAN,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],736,"79,748",5 out of 5,2001-04-27,Evidence at protein level
Q9NXC2,GFOD1_HUMAN,Glucose-fructose oxidoreductase domain-containing protein 1 (EC 1.-.-.-),390,"43,158",3 out of 5,2007-04-03,Evidence at protein level
Q06210,GFPT1_HUMAN,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1),699,"78,806",5 out of 5,1994-06-01,Evidence at protein level
O00451,GFRA2_HUMAN,GDNF family receptor alpha-2 (GDNF receptor alpha-2) (GDNFR-alpha-2) (GFR-alpha-2) (GDNF receptor beta) (GDNFR-beta) (Neurturin receptor alpha) (NRTNR-alpha) (NTNR-alpha) (RET ligand 2) (TGF-beta-related neurotrophic factor receptor 2),464,"51,544",5 out of 5,1997-11-01,Evidence at transcript level
P30047,GFRP_HUMAN,GTP cyclohydrolase 1 feedback regulatory protein (GFRP) (GTP cyclohydrolase I feedback regulatory protein) (p35),84,"9,698",5 out of 5,1993-04-01,Evidence at protein level
A6NER3,GG12J_HUMAN,G antigen 12J (GAGE-12J),117,"12,896",2 out of 5,2008-06-10,Inferred from homology
Q8N9W4,GG6L2_HUMAN,Golgin subfamily A member 6-like protein 2,650,"79,343",3 out of 5,2008-02-26,Evidence at protein level
Q9UEU5,GGE2D_HUMAN,G antigen 2D (GAGE-2D) (Cancer/testis antigen 4.8) (CT4.8) (G antigen 8) (GAGE-8),116,"12,764",2 out of 5,2002-07-11,Evidence at protein level
P19440,GGT1_HUMAN,Gamma-glutamyltranspeptidase 1 (GGT 1) (EC 2.3.2.2) (Gamma-glutamyltransferase 1) (Glutathione hydrolase 1) (EC 3.4.19.13) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) (CD antigen CD224) [Cleaved into: Gamma-glutamyltranspeptidase 1 heavy chain; Gamma-glutamyltranspeptidase 1 light chain],569,"61,410",5 out of 5,1991-02-01,Evidence at protein level
Q6P531,GGT6_HUMAN,Gamma-glutamyltransferase 6 (GGT 6) (EC 2.3.2.2) (Gamma-glutamyltranspeptidase 6) (Glutathione hydrolase 6) (EC 3.4.19.13) [Cleaved into: Gamma-glutamyltransferase 6 heavy chain; Gamma-glutamyltransferase 6 light chain],493,"50,509",5 out of 5,2008-01-15,Evidence at transcript level
Q02643,GHRHR_HUMAN,Growth hormone-releasing hormone receptor (GHRH receptor) (Growth hormone-releasing factor receptor) (GRF receptor) (GRFR),423,"47,402",5 out of 5,1993-10-01,Evidence at protein level
Q8IVV7,GID4_HUMAN,Glucose-induced degradation protein 4 homolog (Vacuolar import and degradation protein 24 homolog),300,"33,514",2 out of 5,2005-08-16,Evidence at transcript level
Q99501,GA2L1_HUMAN,GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1),681,"72,717",5 out of 5,1998-07-15,Evidence at protein level
Q2WGN9,GAB4_HUMAN,GRB2-associated-binding protein 4 (GRB2-associated binder 2-like) (GAB2-like) (GRB2-associated binder 4) (GRB2-associated-binding protein 2-like) (Growth factor receptor bound protein 2-associated protein 4),574,"62,367",2 out of 5,2007-01-09,Evidence at transcript level
P47211,GALR1_HUMAN,Galanin receptor type 1 (GAL1-R) (GALR-1),349,"38,953",5 out of 5,1996-02-01,Evidence at protein level
Q10471,GALT2_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 2 (EC 2.4.1.41) (Polypeptide GalNAc transferase 2) (GalNAc-T2) (pp-GaNTase 2) (Protein-UDP acetylgalactosaminyltransferase 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 2) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 2 soluble form],571,"64,733",5 out of 5,2004-08-16,Evidence at protein level
Q86SF2,GALT7_HUMAN,N-acetylgalactosaminyltransferase 7 (EC 2.4.1.-) (Polypeptide GalNAc transferase 7) (GalNAc-T7) (pp-GaNTase 7) (Protein-UDP acetylgalactosaminyltransferase 7) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 7),657,"75,389",5 out of 5,2004-08-16,Evidence at protein level
Q9NY28,GALT8_HUMAN,Probable polypeptide N-acetylgalactosaminyltransferase 8 (EC 2.4.1.41) (Polypeptide GalNAc transferase 8) (GalNAc-T8) (pp-GaNTase 8) (Protein-UDP acetylgalactosaminyltransferase 8) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 8),637,"72,851",5 out of 5,2004-08-16,Evidence at transcript level
Q14353,GAMT_HUMAN,Guanidinoacetate N-methyltransferase (EC 2.1.1.2),236,"26,318",5 out of 5,1997-11-01,Evidence at protein level
Q8TET4,GANC_HUMAN,Neutral alpha-glucosidase C (EC 3.2.1.20),914,"104,334",3 out of 5,2004-06-07,Evidence at transcript level
Q8N292,GAPT_HUMAN,"Protein GAPT (Growth factor receptor-bound protein 2-binding adapter protein, transmembrane)",157,"17,883",4 out of 5,2007-01-09,Evidence at protein level
Q5JY77,GASP1_HUMAN,G-protein coupled receptor-associated sorting protein 1 (GASP-1),1395,"156,865",5 out of 5,2006-05-30,Evidence at protein level
P23769,GATA2_HUMAN,Endothelial transcription factor GATA-2 (GATA-binding protein 2),480,"50,500",5 out of 5,1991-11-01,Evidence at protein level
P43694,GATA4_HUMAN,Transcription factor GATA-4 (GATA-binding factor 4),442,"44,565",5 out of 5,1995-11-01,Evidence at protein level
Q9UBI6,GBG12_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12,72,"8,006",5 out of 5,2000-12-01,Evidence at protein level
P63218,GBG5_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5,68,"7,318",5 out of 5,2004-09-27,Evidence at protein level
O14610,GBGT2_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2 (G gamma-C) (G-gamma-8) (G-gamma-9) (Guanine nucleotide binding protein gamma transducing activity polypeptide 2),69,"7,747",4 out of 5,1998-07-15,Evidence at transcript level
Q9UN88,GBRT_HUMAN,Gamma-aminobutyric acid receptor subunit theta (GABA(A) receptor subunit theta),632,"72,022",5 out of 5,2001-05-04,Evidence at transcript level
P23434,GCSH_HUMAN,"Glycine cleavage system H protein, mitochondrial (Lipoic acid-containing protein)",173,"18,885",5 out of 5,1991-11-01,Evidence at protein level
P48728,GCST_HUMAN,"Aminomethyltransferase, mitochondrial (EC 2.1.2.10) (Glycine cleavage system T protein) (GCVT)",403,"43,946",5 out of 5,1996-02-01,Evidence at protein level
O75343,GCYB2_HUMAN,Guanylate cyclase soluble subunit beta-2 (GCS-beta-2) (EC 4.6.1.2),617,"70,368",4 out of 5,1999-07-15,Uncertain
Q5U4N7,GDF5O_HUMAN,"Protein GDF5OS, mitochondrial (Growth/differentiation factor 5 opposite strand transcript protein)",250,"28,211",2 out of 5,2007-05-29,Evidence at transcript level
P43026,GDF5_HUMAN,Growth/differentiation factor 5 (GDF-5) (Bone morphogenetic protein 14) (BMP-14) (Cartilage-derived morphogenetic protein 1) (CDMP-1) (Lipopolysaccharide-associated protein 4) (LAP-4) (LPS-associated protein 4) (Radotermin),501,"55,411",5 out of 5,1995-11-01,Evidence at protein level
P52565,GDIR1_HUMAN,Rho GDP-dissociation inhibitor 1 (Rho GDI 1) (Rho-GDI alpha),204,"23,207",5 out of 5,1996-10-01,Evidence at protein level
Q9H840,GEMI7_HUMAN,Gem-associated protein 7 (Gemin-7) (SIP3),131,"14,537",5 out of 5,2003-09-19,Evidence at protein level
Q6UXV0,GFRAL_HUMAN,GDNF family receptor alpha-like,394,"44,518",3 out of 5,2006-06-13,Evidence at transcript level
I3L273,GFY_HUMAN,Golgi-associated olfactory signaling regulator (Protein Goofy),518,"56,104",3 out of 5,2013-12-11,Inferred from homology
A8MZA4,GG6L6_HUMAN,Golgin subfamily A member 6-like protein 6,724,"90,952",1 out of 5,2008-04-29,Inferred from homology
Q9UJ14,GGT7_HUMAN,Gamma-glutamyltransferase 7 (GGT 7) (EC 2.3.2.2) (Gamma-glutamyltransferase-like 3) (Gamma-glutamyltransferase-like 5) (Gamma-glutamyltranspeptidase 7) (Glutathione hydrolase 7) (EC 3.4.19.13) [Cleaved into: Gamma-glutamyltransferase 7 heavy chain; Gamma-glutamyltransferase 7 light chain],662,"70,467",5 out of 5,2003-08-29,Evidence at protein level
P27469,G0S2_HUMAN,G0/G1 switch protein 2 (G0/G1 switch regulatory protein 2) (Putative lymphocyte G0/G1 switch gene),103,"11,321",5 out of 5,1992-08-01,Evidence at protein level
Q9H3Q3,G3ST2_HUMAN,"Galactose-3-O-sulfotransferase 2 (Gal3ST-2) (EC 2.8.2.-) (Beta-galactose-3-O-sulfotransferase 2) (Gal-beta-1, 3-GalNAc 3'-sulfotransferase 2) (Glycoprotein beta-Gal 3'-sulfotransferase 2)",398,"46,110",5 out of 5,2004-05-10,Evidence at protein level
O95479,G6PE_HUMAN,GDH/6PGL endoplasmic bifunctional protein [Includes: Glucose 1-dehydrogenase (EC 1.1.1.47) (Hexose-6-phosphate dehydrogenase); 6-phosphogluconolactonase (6PGL) (EC 3.1.1.31)],791,"88,893",5 out of 5,2000-05-30,Evidence at protein level
Q8NHY3,GA2L2_HUMAN,GAS2-like protein 2 (GAS2-related protein on chromosome 17) (Growth arrest-specific protein 2-like 2),880,"96,520",5 out of 5,2005-08-30,Evidence at protein level
O75293,GA45B_HUMAN,Growth arrest and DNA damage-inducible protein GADD45 beta (Myeloid differentiation primary response protein MyD118) (Negative growth regulatory protein MyD118),160,"17,818",5 out of 5,1999-07-15,Evidence at protein level
O95177,GAAS1_HUMAN,Uncharacterized protein GAS8-AS1 (GAS8 antisense RNA 1) (GAS8 antisense gene protein 1),125,"12,619",2 out of 5,2001-01-24,Evidence at transcript level
Q06546,GABPA_HUMAN,GA-binding protein alpha chain (GABP subunit alpha) (Nuclear respiratory factor 2 subunit alpha) (Transcription factor E4TF1-60),454,"51,295",5 out of 5,1995-02-01,Evidence at protein level
P15976,GATA1_HUMAN,Erythroid transcription factor (Eryf1) (GATA-binding factor 1) (GATA-1) (GF-1) (NF-E1 DNA-binding protein),413,"42,751",5 out of 5,1990-04-01,Evidence at protein level
Q92908,GATA6_HUMAN,Transcription factor GATA-6 (GATA-binding factor 6),595,"60,033",5 out of 5,1997-11-01,Evidence at protein level
A6NHX0,GATL2_HUMAN,GATS-like protein 2 (Cellular arginine sensor for mTORC1 protein 2) (CASTOR2),329,"36,056",4 out of 5,2008-06-10,Evidence at protein level
Q9H227,GBA3_HUMAN,Cytosolic beta-glucosidase (EC 3.2.1.21) (Cytosolic beta-glucosidase-like protein 1),469,"53,696",5 out of 5,2005-10-11,Evidence at protein level
P16520,GBB3_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3 (Transducin beta chain 3),340,"37,221",5 out of 5,1990-08-01,Evidence at protein level
P61952,GBG11_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11,73,"8,481",4 out of 5,2004-06-07,Evidence at protein level
Q9UK08,GBG8_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8 (Gamma-9),70,"7,841",4 out of 5,2000-12-01,Evidence at protein level
P28472,GBRB3_HUMAN,Gamma-aminobutyric acid receptor subunit beta-3 (GABA(A) receptor subunit beta-3),473,"54,116",5 out of 5,1992-12-01,Evidence at protein level
P60520,GBRL2_HUMAN,Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein),117,"13,667",5 out of 5,2004-03-01,Evidence at protein level
Q96CN9,GCC1_HUMAN,GRIP and coiled-coil domain-containing protein 1 (Golgi coiled-coil protein 1),775,"87,811",5 out of 5,2003-07-11,Evidence at protein level
Q9UGJ1,GCP4_HUMAN,Gamma-tubulin complex component 4 (GCP-4) (hGCP4) (Gamma-ring complex protein 76 kDa) (h76p) (hGrip76),667,"76,089",5 out of 5,2002-08-02,Evidence at protein level
Q9NXN4,GDAP2_HUMAN,Ganglioside-induced differentiation-associated protein 2,497,"56,225",3 out of 5,2008-04-29,Evidence at protein level
P50395,GDIB_HUMAN,Rab GDP dissociation inhibitor beta (Rab GDI beta) (Guanosine diphosphate dissociation inhibitor 2) (GDI-2),445,"50,663",5 out of 5,1996-10-01,Evidence at protein level
P52566,GDIR2_HUMAN,Rho GDP-dissociation inhibitor 2 (Rho GDI 2) (Ly-GDI) (Rho-GDI beta),201,"22,988",5 out of 5,1996-10-01,Evidence at protein level
Q9HCC8,GDPD2_HUMAN,Glycerophosphoinositol inositolphosphodiesterase GDPD2 (EC 3.1.4.43) (Glycerophosphodiester phosphodiesterase 3) (Glycerophosphodiester phosphodiesterase domain-containing protein 2) (Osteoblast differentiation promoting factor),539,"61,729",5 out of 5,2006-10-03,Evidence at transcript level
A6NCL1,GEMC1_HUMAN,Geminin coiled-coil domain-containing protein 1,334,"37,887",2 out of 5,2008-09-02,Evidence at protein level
O14893,GEMI2_HUMAN,Gem-associated protein 2 (Gemin-2) (Component of gems 2) (Survival of motor neuron protein-interacting protein 1) (SMN-interacting protein 1),280,"31,585",5 out of 5,1999-07-15,Evidence at protein level
Q8TEQ6,GEMI5_HUMAN,Gem-associated protein 5 (Gemin5),1508,"168,589",5 out of 5,2003-09-19,Evidence at protein level
Q17RS7,GEN_HUMAN,Flap endonuclease GEN homolog 1 (EC 3.1.-.-),908,"102,884",5 out of 5,2008-01-15,Evidence at protein level
O60609,GFRA3_HUMAN,GDNF family receptor alpha-3 (GDNF receptor alpha-3) (GDNFR-alpha-3) (GFR-alpha-3),400,"44,511",5 out of 5,2001-01-11,Evidence at protein level
H0YKK7,GG6LS_HUMAN,Putative golgin subfamily A member 6-like protein 19,550,"64,493",2 out of 5,2014-01-22,Uncertain
Q9UJY5,GGA1_HUMAN,"ADP-ribosylation factor-binding protein GGA1 (Gamma-adaptin-related protein 1) (Golgi-localized, gamma ear-containing, ARF-binding protein 1)",639,"70,384",5 out of 5,2001-06-20,Evidence at protein level
Q9NXK8,FXL12_HUMAN,F-box/LRR-repeat protein 12 (F-box and leucine-rich repeat protein 12) (F-box protein FBL12),326,"37,026",4 out of 5,2003-11-07,Evidence at protein level
Q14802,FXYD3_HUMAN,FXYD domain-containing ion transport regulator 3 (Chloride conductance inducer protein Mat-8) (Mammary tumor 8 kDa protein) (Phospholemman-like),87,"9,263",5 out of 5,1998-07-15,Evidence at transcript level
P58550,FXYD8_HUMAN,Putative FXYD domain-containing ion transport regulator 8,94,"10,590",2 out of 5,2002-01-23,Uncertain
Q9NPG1,FZD3_HUMAN,Frizzled-3 (Fz-3) (hFz3),666,"76,263",5 out of 5,2001-12-05,Evidence at protein level
Q13467,FZD5_HUMAN,Frizzled-5 (Fz-5) (hFz5) (FzE5),585,"64,507",5 out of 5,2001-12-05,Evidence at protein level
Q96N19,G137A_HUMAN,Integral membrane protein GPR137 (Transmembrane 7 superfamily member 1-like 1 protein),417,"46,059",3 out of 5,2007-01-09,Evidence at transcript level
Q96PS6,GAFA1_HUMAN,Putative uncharacterized protein GAFA-1 (Gene associated with FGF-2 activity protein 1),74,"8,425",1 out of 5,2008-03-18,Predicted
Q13070,GAGE6_HUMAN,G antigen 6 (GAGE-6) (Cancer/testis antigen 4.6) (CT4.6),117,"12,892",2 out of 5,1998-07-15,Evidence at protein level
Q7Z7M9,GALT5_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 5 (EC 2.4.1.41) (Polypeptide GalNAc transferase 5) (GalNAc-T5) (pp-GaNTase 5) (Protein-UDP acetylgalactosaminyltransferase 5) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 5),940,"106,266",5 out of 5,2004-08-16,Evidence at protein level
Q9HCQ5,GALT9_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 9 (EC 2.4.1.41) (Polypeptide GalNAc transferase 9) (GalNAc-T9) (pp-GaNTase 9) (Protein-UDP acetylgalactosaminyltransferase 9) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 9),603,"68,359",5 out of 5,2004-08-16,Evidence at transcript level
Q9H2C0,GAN_HUMAN,Gigaxonin (Kelch-like protein 16),597,"67,638",5 out of 5,2001-04-27,Evidence at protein level
Q9NY12,GAR1_HUMAN,H/ACA ribonucleoprotein complex subunit 1 (Nucleolar protein family A member 1) (snoRNP protein GAR1),217,"22,348",5 out of 5,2004-08-31,Evidence at protein level
Q14393,GAS6_HUMAN,Growth arrest-specific protein 6 (GAS-6) (AXL receptor tyrosine kinase ligand),721,"79,677",5 out of 5,2004-06-07,Evidence at protein level
P32456,GBP2_HUMAN,Guanylate-binding protein 2 (EC 3.6.5.-) (GTP-binding protein 2) (GBP-2) (HuGBP-2) (Guanine nucleotide-binding protein 2) (Interferon-induced guanylate-binding protein 2),591,"67,209",5 out of 5,1993-10-01,Evidence at protein level
Q8N8V2,GBP7_HUMAN,Guanylate-binding protein 7 (GTP-binding protein 7) (GBP-7) (Guanine nucleotide-binding protein 7) (Guanylate-binding protein 4-like),638,"72,513",3 out of 5,2008-01-15,Evidence at transcript level
O14764,GBRD_HUMAN,Gamma-aminobutyric acid receptor subunit delta (GABA(A) receptor subunit delta),452,"50,708",5 out of 5,1998-07-15,Evidence at protein level
P52951,GBX2_HUMAN,Homeobox protein GBX-2 (Gastrulation and brain-specific homeobox protein 2),348,"37,348",4 out of 5,1996-10-01,Evidence at transcript level
Q8IWJ2,GCC2_HUMAN,GRIP and coiled-coil domain-containing protein 2 (185 kDa Golgi coiled-coil protein) (GCC185) (CLL-associated antigen KW-11) (CTCL tumor antigen se1-1) (Ran-binding protein 2-like 4) (RanBP2L4) (Renal carcinoma antigen NY-REN-53),1684,"195,910",5 out of 5,2003-07-03,Evidence at protein level
Q92616,GCN1_HUMAN,eIF-2-alpha kinase activator GCN1 (GCN1 eIF-2-alpha kinase activator homolog) (GCN1-like protein 1) (General control of amino-acid synthesis 1-like protein 1) (Translational activator GCN1) (HsGCN1),2671,"292,758",5 out of 5,2005-03-01,Evidence at protein level
Q9BSJ2,GCP2_HUMAN,Gamma-tubulin complex component 2 (GCP-2) (hGCP2) (Gamma-ring complex protein 103 kDa) (h103p) (hGrip103) (Spindle pole body protein Spc97 homolog) (hSpc97),902,"102,534",5 out of 5,2002-06-06,Evidence at protein level
Q8N6F7,GCSAM_HUMAN,Germinal center-associated signaling and motility protein (Germinal center B-cell-expressed transcript 2 protein) (Germinal center-associated lymphoma protein) (hGAL),178,"21,005",5 out of 5,2006-10-31,Evidence at protein level
Q9NZC3,GDE1_HUMAN,Glycerophosphodiester phosphodiesterase 1 (EC 3.1.4.44) (Membrane-interacting protein of RGS16) (RGS16-interacting membrane protein),331,"37,718",5 out of 5,2006-10-03,Evidence at protein level
Q9UK05,GDF2_HUMAN,Growth/differentiation factor 2 (GDF-2) (Bone morphogenetic protein 9) (BMP-9),429,"47,320",5 out of 5,2001-02-21,Evidence at protein level
P07093,GDN_HUMAN,Glia-derived nexin (GDN) (Peptidase inhibitor 7) (PI-7) (Protease nexin 1) (PN-1) (Protease nexin I) (Serpin E2),398,"44,002",5 out of 5,1988-04-01,Evidence at protein level
Q6W3E5,GDPD4_HUMAN,Glycerophosphodiester phosphodiesterase domain-containing protein 4 (EC 3.1.-.-) (Glycerophosphodiester phosphodiesterase 6) (UgpQ),623,"71,996",4 out of 5,2006-10-03,Evidence at transcript level
Q8WXD5,GEMI6_HUMAN,Gem-associated protein 6 (Gemin-6) (SIP2),167,"18,824",5 out of 5,2003-09-19,Evidence at protein level
Q9H3C7,GGNB2_HUMAN,Gametogenetin-binding protein 2 (Laryngeal carcinoma-related protein 1) (Protein ZNF403),697,"79,086",4 out of 5,2006-06-13,Evidence at protein level
Q9H936,GHC1_HUMAN,Mitochondrial glutamate carrier 1 (GC-1) (Glutamate/H(+) symporter 1) (Solute carrier family 25 member 22),323,"34,470",5 out of 5,2003-08-22,Evidence at protein level
Q9H3K2,GHITM_HUMAN,Growth hormone-inducible transmembrane protein (Dermal papilla-derived protein 2) (Mitochondrial morphology and cristae structure 1) (MICS1) (Transmembrane BAX inhibitor motif-containing protein 5),345,"37,205",4 out of 5,2001-08-14,Evidence at protein level
Q9BZE0,GLIS2_HUMAN,Zinc finger protein GLIS2 (GLI-similar 2) (Neuronal Krueppel-like protein),524,"55,689",5 out of 5,2007-05-15,Evidence at protein level
O14556,G3PT_HUMAN,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific (EC 1.2.1.12) (Spermatogenic cell-specific glyceraldehyde 3-phosphate dehydrogenase 2) (GAPDH-2) (Spermatogenic glyceraldehyde-3-phosphate dehydrogenase)",408,"44,501",5 out of 5,2000-05-30,Evidence at protein level
Q6ZQY3,GADL1_HUMAN,Acidic amino acid decarboxylase GADL1 (Aspartate 1-decarboxylase) (ADC) (HuADC) (EC 4.1.1.11) (Cysteine sulfinic acid decarboxylase) (CSADC) (HuCSADC) (EC 4.1.1.29) (Glutamate decarboxylase-like protein 1),521,"59,246",5 out of 5,2007-12-04,Evidence at protein level
Q13066,GAG2B_HUMAN,G antigen 2B/2C (GAGE-2B) (GAGE-2C) (Cancer/testis antigen 4.2) (CT4.2) (G antigen 2C),116,"12,786",3 out of 5,1998-07-15,Evidence at protein level
Q13068,GAGE4_HUMAN,G antigen 4 (GAGE-4) (Cancer/testis antigen 4.4) (CT4.4),117,"12,885",2 out of 5,1998-07-15,Evidence at protein level
O95995,GAS8_HUMAN,Growth arrest-specific protein 8 (GAS-8) (Growth arrest-specific protein 11) (GAS-11),478,"56,356",5 out of 5,2003-07-19,Evidence at protein level
P23771,GATA3_HUMAN,Trans-acting T-cell-specific transcription factor GATA-3 (GATA-binding factor 3),443,"47,916",5 out of 5,1991-11-01,Evidence at protein level
Q9H0R6,GATA_HUMAN,"Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrial (Glu-AdT subunit A) (EC 6.3.5.7) (Glutaminyl-tRNA synthase-like protein 1)",528,"57,460",5 out of 5,2008-02-05,Evidence at protein level
Q8WTX7,GATL3_HUMAN,GATS-like protein 3 (Cellular arginine sensor for mTORC1 protein 1) (CASTOR1),329,"36,275",5 out of 5,2008-09-02,Evidence at protein level
P50440,GATM_HUMAN,"Glycine amidinotransferase, mitochondrial (EC 2.1.4.1) (L-arginine:glycine amidinotransferase) (Transamidinase)",423,"48,455",5 out of 5,1996-10-01,Evidence at protein level
Q9H0R5,GBP3_HUMAN,Guanylate-binding protein 3 (EC 3.6.5.-) (GTP-binding protein 3) (GBP-3) (Guanine nucleotide-binding protein 3),595,"68,114",5 out of 5,2006-11-28,Evidence at protein level
P34903,GBRA3_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-3 (GABA(A) receptor subunit alpha-3),492,"55,165",5 out of 5,1994-02-01,Evidence at protein level
P31644,GBRA5_HUMAN,Gamma-aminobutyric acid receptor subunit alpha-5 (GABA(A) receptor subunit alpha-5),462,"52,146",5 out of 5,1993-07-01,Evidence at protein level
Q9H0R8,GBRL1_HUMAN,Gamma-aminobutyric acid receptor-associated protein-like 1 (Early estrogen-regulated protein) (GABA(A) receptor-associated protein-like 1) (Glandular epithelial cell protein 1) (GEC-1),117,"14,044",5 out of 5,2004-03-01,Evidence at protein level
P24046,GBRR1_HUMAN,Gamma-aminobutyric acid receptor subunit rho-1 (GABA(A) receptor subunit rho-1) (GABA(C) receptor),479,"55,883",5 out of 5,1992-03-01,Evidence at transcript level
Q14549,GBX1_HUMAN,Homeobox protein GBX-1 (Gastrulation and brain-specific homeobox protein 1),363,"37,629",3 out of 5,2001-01-11,Evidence at protein level
P35573,GDE_HUMAN,"Glycogen debranching enzyme (Glycogen debrancher) [Includes: 4-alpha-glucanotransferase (EC 2.4.1.25) (Oligo-1,4-1,4-glucantransferase); Amylo-alpha-1,6-glucosidase (Amylo-1,6-glucosidase) (EC 3.2.1.33) (Dextrin 6-alpha-D-glucosidase)]",1532,"174,764",5 out of 5,1994-06-01,Evidence at protein level
P39905,GDNF_HUMAN,Glial cell line-derived neurotrophic factor (hGDNF) (Astrocyte-derived trophic factor) (ATF),211,"23,720",5 out of 5,1995-02-01,Evidence at protein level
Q6ZNW5,GDPP1_HUMAN,GDP-D-glucose phosphorylase 1 (EC 2.7.7.78),385,"42,362",4 out of 5,2008-05-20,Evidence at protein level
P55040,GEM_HUMAN,GTP-binding protein GEM (GTP-binding mitogen-induced T-cell protein) (RAS-like protein KIR),296,"33,949",5 out of 5,1996-10-01,Evidence at protein level
Q9P2Q2,FRM4A_HUMAN,FERM domain-containing protein 4A,1039,"115,458",3 out of 5,2001-07-11,Evidence at protein level
Q96A29,FUCT1_HUMAN,GDP-fucose transporter 1 (Solute carrier family 35 member C1),364,"39,809",5 out of 5,2002-01-23,Evidence at protein level
P19526,FUT1_HUMAN,"Galactoside 2-alpha-L-fucosyltransferase 1 (EC 2.4.1.69) (Alpha(1,2)FT 1) (Blood group H alpha 2-fucosyltransferase) (Fucosyltransferase 1) (GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase 1)",365,"41,251",5 out of 5,1991-02-01,Evidence at transcript level
Q96CP2,FWCH2_HUMAN,FLYWCH family member 2,140,"14,564",2 out of 5,2008-02-05,Evidence at protein level
Q8TAK5,GABP2_HUMAN,GA-binding protein subunit beta-2 (GABP subunit beta-2) (GABPB-2),448,"48,650",4 out of 5,2008-03-18,Evidence at protein level
P87889,GAK10_HUMAN,Endogenous retrovirus group K member 10 Gag polyprotein (HERV-K10 Gag protein) (HERV-K107 Gag protein) (HERV-K_5q33.3 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,139",4 out of 5,2004-07-19,Evidence at protein level
Q7LDI9,GAK6_HUMAN,Endogenous retrovirus group K member 6 Gag polyprotein (HERV-K(C7) Gag protein) (HERV-K(HML-2.HOM) Gag protein) (HERV-K108 Gag protein) (HERV-K_7p22.1 provirus ancestral Gag polyprotein) (Gag polyprotein),666,"74,079",4 out of 5,2004-07-19,Evidence at protein level
O14976,GAK_HUMAN,Cyclin-G-associated kinase (EC 2.7.11.1),1311,"143,191",5 out of 5,2001-08-29,Evidence at protein level
Q96C23,GALM_HUMAN,Aldose 1-epimerase (EC 5.1.3.3) (Galactose mutarotase),342,"37,766",5 out of 5,2005-05-10,Evidence at protein level
P34059,GALNS_HUMAN,N-acetylgalactosamine-6-sulfatase (EC 3.1.6.4) (Chondroitinsulfatase) (Chondroitinase) (Galactose-6-sulfate sulfatase) (GalN6S) (N-acetylgalactosamine-6-sulfate sulfatase) (GalNAc6S sulfatase),522,"58,026",5 out of 5,1994-02-01,Evidence at protein level
Q10472,GALT1_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 1 (EC 2.4.1.41) (Polypeptide GalNAc transferase 1) (GalNAc-T1) (pp-GaNTase 1) (Protein-UDP acetylgalactosaminyltransferase 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1) [Cleaved into: Polypeptide N-acetylgalactosaminyltransferase 1 soluble form],559,"64,219",5 out of 5,1996-10-01,Evidence at protein level
Q5VVW2,GARL3_HUMAN,GTPase-activating Rap/Ran-GAP domain-like protein 3,1013,"112,852",3 out of 5,2007-12-04,Evidence at transcript level
Q14397,GCKR_HUMAN,Glucokinase regulatory protein (GKRP) (Glucokinase regulator),625,"68,685",5 out of 5,1997-11-01,Evidence at protein level
O95395,GCNT3_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 3 (EC 2.4.1.102) (EC 2.4.1.150) (C2GnT-mucin type) (C2GnT-M) (hC2GnT-M) (Core 2/core 4 beta-1,6-N-acetylglucosaminyltransferase) (C2/4GnT)",438,"50,864",5 out of 5,2007-05-29,Evidence at transcript level
Q02153,GCYB1_HUMAN,Guanylate cyclase soluble subunit beta-1 (GCS-beta-1) (EC 4.6.1.2) (Guanylate cyclase soluble subunit beta-3) (GCS-beta-3) (Soluble guanylate cyclase small subunit),619,"70,514",5 out of 5,1993-07-01,Evidence at protein level
Q9NR23,GDF3_HUMAN,Growth/differentiation factor 3 (GDF-3),364,"41,387",5 out of 5,2001-02-21,Evidence at protein level
Q9HCG7,GBA2_HUMAN,Non-lysosomal glucosylceramidase (NLGase) (EC 3.2.1.45) (Beta-glucocerebrosidase 2) (Beta-glucosidase 2) (Glucosylceramidase 2),927,"104,649",5 out of 5,2007-04-03,Evidence at protein level
P50151,GBG10_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10,68,"7,205",5 out of 5,1996-10-01,Evidence at protein level
Q9P2W3,GBG13_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13,67,"7,949",4 out of 5,2002-01-31,Inferred from homology
P59768,GBG2_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 (G gamma-I),71,"7,850",5 out of 5,2003-07-11,Evidence at protein level
P50150,GBG4_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4,75,"8,389",5 out of 5,1996-10-01,Evidence at protein level
P28476,GBRR2_HUMAN,Gamma-aminobutyric acid receptor subunit rho-2 (GABA(A) receptor subunit rho-2) (GABA(C) receptor),465,"54,151",5 out of 5,1992-12-01,Evidence at transcript level
Q8WZA8,GC224_HUMAN,Putative gastric cancer-related gene 224 protein (GCRG-224) (GCRG-p224),35,"3,819",1 out of 5,2008-03-18,Uncertain
Q9P109,GCNT4_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 4 (EC 2.4.1.102) (Core 2-branching enzyme 3) (Core2-GlcNAc-transferase 3) (C2GnT3)",453,"53,052",5 out of 5,2007-05-29,Evidence at transcript level
Q96CW5,GCP3_HUMAN,Gamma-tubulin complex component 3 (GCP-3) (hGCP3) (Gamma-ring complex protein 104 kDa) (h104p) (hGrip104) (Spindle pole body protein Spc98 homolog) (hSpc98),907,"103,571",5 out of 5,2002-06-06,Evidence at protein level
P23378,GCSP_HUMAN,"Glycine dehydrogenase (decarboxylating), mitochondrial (EC 1.4.4.2) (Glycine cleavage system P protein) (Glycine decarboxylase) (Glycine dehydrogenase (aminomethyl-transferring))",1020,"112,730",5 out of 5,1991-11-01,Evidence at protein level
P16260,GDC_HUMAN,Graves disease carrier protein (GDC) (Graves disease autoantigen) (GDA) (Mitochondrial solute carrier protein homolog) (Solute carrier family 25 member 16),332,"36,224",4 out of 5,1990-08-01,Evidence at protein level
O95390,GDF11_HUMAN,Growth/differentiation factor 11 (GDF-11) (Bone morphogenetic protein 11) (BMP-11),407,"45,091",5 out of 5,2001-01-24,Evidence at protein level
Q7Z4P5,GDF7_HUMAN,Growth/differentiation factor 7 (GDF-7),450,"46,950",5 out of 5,2004-07-19,Evidence at transcript level
O60383,GDF9_HUMAN,Growth/differentiation factor 9 (GDF-9),454,"51,444",5 out of 5,1999-07-15,Evidence at protein level
Q8N9F7,GDPD1_HUMAN,Glycerophosphodiester phosphodiesterase domain-containing protein 1 (EC 3.1.-.-) (Glycerophosphodiester phosphodiesterase 4),314,"36,167",4 out of 5,2006-10-03,Evidence at protein level
P57678,GEMI4_HUMAN,Gem-associated protein 4 (Gemin-4) (Component of gems 4) (p97),1058,"120,037",5 out of 5,2000-12-01,Evidence at protein level
Q9GZZ7,GFRA4_HUMAN,GDNF family receptor alpha-4 (GDNF receptor alpha-4) (GDNFR-alpha-4) (GFR-alpha-4) (Persephin receptor),299,"31,670",5 out of 5,2003-04-23,Evidence at protein level
A1L429,GG12C_HUMAN,G antigen 12B/C/D/E (GAGE-12B) (GAGE-12C) (GAGE-12D) (GAGE-12E),117,"12,925",2 out of 5,2007-12-04,Evidence at protein level
A6NEY3,GG6L3_HUMAN,Putative golgin subfamily A member 6-like protein 3,463,"55,643",2 out of 5,2008-04-29,Uncertain
A6NI86,GG6LA_HUMAN,Golgin subfamily A member 6-like protein 10,522,"60,902",2 out of 5,2008-07-01,Inferred from homology
Q9UJY4,GGA2_HUMAN,"ADP-ribosylation factor-binding protein GGA2 (Gamma-adaptin-related protein 2) (Golgi-localized, gamma ear-containing, ARF-binding protein 2) (VHS domain and ear domain of gamma-adaptin) (Vear)",613,"67,150",5 out of 5,2001-06-20,Evidence at protein level
Q8NHV1,GIMA7_HUMAN,GTPase IMAP family member 7 (Immunity-associated nucleotide 7 protein) (IAN-7),300,"34,509",5 out of 5,2004-11-23,Evidence at protein level
Q8TF64,GIPC3_HUMAN,PDZ domain-containing protein GIPC3,312,"33,982",3 out of 5,2006-07-25,Evidence at protein level
Q9Y2X7,GIT1_HUMAN,ARF GTPase-activating protein GIT1 (ARF GAP GIT1) (Cool-associated and tyrosine-phosphorylated protein 1) (CAT-1) (CAT1) (G protein-coupled receptor kinase-interactor 1) (GRK-interacting protein 1),761,"84,341",5 out of 5,2001-10-18,Evidence at protein level
P0CG01,GKN3_HUMAN,Gastrokine-3,181,"20,221",2 out of 5,2010-06-15,Inferred from homology
Q68CQ7,GL8D1_HUMAN,Glycosyltransferase 8 domain-containing protein 1 (EC 2.4.1.-),371,"41,935",4 out of 5,2007-05-29,Evidence at protein level
O94923,GLCE_HUMAN,D-glucuronyl C5-epimerase (EC 5.1.3.17) (Heparan sulfate C5-epimerase) (Hsepi) (Heparin/heparan sulfate:glucuronic acid C5-epimerase) (Heparosan-N-sulfate-glucuronate 5-epimerase),617,"70,101",5 out of 5,2002-11-15,Evidence at protein level
Q7L5D6,GET4_HUMAN,Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35),327,"36,504",5 out of 5,2006-03-21,Evidence at protein level
Q5VTD9,GFI1B_HUMAN,Zinc finger protein Gfi-1b (Growth factor independent protein 1B) (Potential regulator of CDKN1A translocated in CML),330,"37,492",5 out of 5,2007-10-02,Evidence at protein level
P0CL81,GG12G_HUMAN,G antigen 12G (GAGE-12G),117,"12,978",2 out of 5,2011-05-03,Inferred from homology
O75223,GGCT_HUMAN,Gamma-glutamylcyclotransferase (EC 2.3.2.4) (Cytochrome c-releasing factor 21),188,"21,008",5 out of 5,2003-08-22,Evidence at protein level
P36269,GGT5_HUMAN,Gamma-glutamyltransferase 5 (GGT 5) (EC 2.3.2.2) (Gamma-glutamyl transpeptidase-related enzyme) (GGT-rel) (Gamma-glutamyltransferase-like activity 1) (Gamma-glutamyltranspeptidase 5) (Glutathione hydrolase 5) (EC 3.4.19.13) (Leukotriene-C4 hydrolase) (EC 3.4.19.14) [Cleaved into: Gamma-glutamyltransferase 5 heavy chain; Gamma-glutamyltransferase 5 light chain],586,"62,261",5 out of 5,1994-06-01,Evidence at protein level
B5MD39,GGTL3_HUMAN,Putative gamma-glutamyltransferase light chain 3,225,"24,102",3 out of 5,2008-11-25,Uncertain
Q6Y7W6,GGYF2_HUMAN,GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein),1299,"150,070",5 out of 5,2007-01-09,Evidence at protein level
Q9NWU2,GID8_HUMAN,Glucose-induced degradation protein 8 homolog (Two hybrid-associated protein 1 with RanBPM) (Twa1),228,"26,749",3 out of 5,2003-02-01,Evidence at protein level
P48546,GIPR_HUMAN,Gastric inhibitory polypeptide receptor (GIP-R) (Glucose-dependent insulinotropic polypeptide receptor),466,"53,157",5 out of 5,1996-02-01,Evidence at protein level
Q86VQ1,GLCI1_HUMAN,Glucocorticoid-induced transcript 1 protein,547,"58,024",2 out of 5,2006-10-31,Evidence at protein level
Q9Y223,GLCNE_HUMAN,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (UDP-GlcNAc-2-epimerase/ManAc kinase) [Includes: UDP-N-acetylglucosamine 2-epimerase (hydrolyzing) (EC 3.2.1.183) (UDP-GlcNAc-2-epimerase) (Uridine diphosphate-N-acetylglucosamine-2-epimerase); N-acetylmannosamine kinase (EC 2.7.1.60) (ManAc kinase)],722,"79,275",5 out of 5,2004-03-15,Evidence at protein level
Q04446,GLGB_HUMAN,"1,4-alpha-glucan-branching enzyme (EC 2.4.1.18) (Brancher enzyme) (Glycogen-branching enzyme)",702,"80,474",5 out of 5,1994-06-01,Evidence at protein level
Q9HC38,GLOD4_HUMAN,Glyoxalase domain-containing protein 4,313,"34,793",4 out of 5,2007-03-20,Evidence at protein level
O60547,GMDS_HUMAN,"GDP-mannose 4,6 dehydratase (EC 4.2.1.47) (GDP-D-mannose dehydratase) (GMD)",372,"41,950",5 out of 5,2000-12-01,Evidence at protein level
O95467,GNAS3_HUMAN,Neuroendocrine secretory protein 55 (NESP55) [Cleaved into: LHAL tetrapeptide; GPIPIRRH peptide],245,"28,029",5 out of 5,2006-10-17,Evidence at transcript level
O14653,GOSR2_HUMAN,Golgi SNAP receptor complex member 2 (27 kDa Golgi SNARE protein) (Membrin),212,"24,775",5 out of 5,2000-12-01,Evidence at protein level
Q9UNW8,GP132_HUMAN,Probable G-protein coupled receptor 132 (G2 accumulation protein),380,"42,499",5 out of 5,2003-10-03,Evidence at protein level
Q86SP6,GP149_HUMAN,Probable G-protein coupled receptor 149 (G-protein coupled receptor PGR10),731,"80,984",4 out of 5,2005-12-20,Evidence at transcript level
Q14439,GP176_HUMAN,G-protein coupled receptor 176 (HB-954),515,"56,998",3 out of 5,2005-11-22,Evidence at transcript level
O15218,GP182_HUMAN,G-protein coupled receptor 182,404,"45,323",4 out of 5,2000-12-01,Evidence at transcript level
P32249,GP183_HUMAN,G-protein coupled receptor 183 (Epstein-Barr virus-induced G-protein coupled receptor 2) (EBI2) (EBV-induced G-protein coupled receptor 2) (hEBI2),361,"41,224",5 out of 5,1993-10-01,Evidence at protein level
P07359,GP1BA_HUMAN,Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin],652,"71,540",5 out of 5,1988-04-01,Evidence at protein level
Q6NUI2,GPAT2_HUMAN,"Glycerol-3-phosphate acyltransferase 2, mitochondrial (GPAT-2) (EC 2.3.1.15) (xGPAT1)",795,"87,835",5 out of 5,2008-03-18,Evidence at transcript level
Q53EU6,GPAT3_HUMAN,Glycerol-3-phosphate acyltransferase 3 (GPAT-3) (EC 2.3.1.15) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 10) (AGPAT 10) (1-acyl-sn-glycerol-3-phosphate O-acyltransferase 9) (1-AGP acyltransferase 9) (1-AGPAT 9) (EC 2.3.1.51) (Acyl-CoA:glycerol-3-phosphate acyltransferase 3) (hGPAT3) (Lung cancer metastasis-associated protein 1) (Lysophosphatidic acid acyltransferase theta) (LPAAT-theta) (MAG-1),434,"48,705",5 out of 5,2007-06-26,Evidence at protein level
Q9NQ84,GPC5C_HUMAN,G-protein coupled receptor family C group 5 member C (Retinoic acid-induced gene 3 protein) (RAIG-3),441,"48,193",5 out of 5,2004-04-13,Evidence at protein level
Q9Y625,GPC6_HUMAN,Glypican-6 [Cleaved into: Secreted glypican-6],555,"62,736",5 out of 5,2000-12-01,Evidence at protein level
P16383,GCFC2_HUMAN,GC-rich sequence DNA-binding factor 2 (GC-rich sequence DNA-binding factor) (Transcription factor 9) (TCF-9),781,"89,385",5 out of 5,1990-08-01,Evidence at protein level
Q96RT8,GCP5_HUMAN,Gamma-tubulin complex component 5 (GCP-5),1024,"118,321",5 out of 5,2002-05-02,Evidence at protein level
Q8WTR4,GDPD5_HUMAN,Glycerophosphodiester phosphodiesterase domain-containing protein 5 (EC 3.1.-.-) (Glycerophosphodiester phosphodiesterase 2),605,"68,586",5 out of 5,2006-10-03,Evidence at protein level
P06396,GELS_HUMAN,Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin),782,"85,698",5 out of 5,1988-01-01,Evidence at protein level
P0CL82,GG12I_HUMAN,G antigen 12I (GAGE-12I),117,"12,978",2 out of 5,2011-05-03,Evidence at protein level
Q8N7Z2,GG6L1_HUMAN,Golgin subfamily A member 6-like protein 1,621,"77,076",1 out of 5,2008-03-18,Evidence at transcript level
O95749,GGPPS_HUMAN,"Geranylgeranyl pyrophosphate synthase (GGPP synthase) (GGPPSase) (EC 2.5.1.-) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Farnesyltranstransferase) (EC 2.5.1.29) (Geranylgeranyl diphosphate synthase) (Geranyltranstransferase) (EC 2.5.1.10)",300,"34,871",5 out of 5,2000-05-30,Evidence at protein level
Q8N2G8,GHDC_HUMAN,GH3 domain-containing protein,530,"57,523",4 out of 5,2004-07-19,Evidence at protein level
P04062,GLCM_HUMAN,Glucosylceramidase (EC 3.2.1.45) (Acid beta-glucosidase) (Alglucerase) (Beta-glucocerebrosidase) (Beta-GC) (D-glucosyl-N-acylsphingosine glucohydrolase) (Imiglucerase),536,"59,716",5 out of 5,1986-11-01,Evidence at protein level
P01215,GLHA_HUMAN,Glycoprotein hormones alpha chain (Anterior pituitary glycoprotein hormones common subunit alpha) (Choriogonadotropin alpha chain) (Chorionic gonadotrophin subunit alpha) (CG-alpha) (Follicle-stimulating hormone alpha chain) (FSH-alpha) (Follitropin alpha chain) (Luteinizing hormone alpha chain) (LSH-alpha) (Lutropin alpha chain) (Thyroid-stimulating hormone alpha chain) (TSH-alpha) (Thyrotropin alpha chain),116,"13,075",5 out of 5,1986-07-21,Evidence at protein level
Q8NBF1,GLIS1_HUMAN,Zinc finger protein GLIS1 (GLI-similar 1),620,"65,976",3 out of 5,2004-12-21,Evidence at transcript level
A6NK44,GLOD5_HUMAN,Glyoxalase domain-containing protein 5,160,"18,322",2 out of 5,2007-10-02,Evidence at protein level
P15421,GLPE_HUMAN,Glycophorin-E,78,"8,463",3 out of 5,1990-04-01,Evidence at transcript level
Q6UWU2,GLB1L_HUMAN,Beta-galactosidase-1-like protein (EC 3.2.1.-),654,"74,158",3 out of 5,2008-01-15,Evidence at transcript level
Q6PIY7,GLD2_HUMAN,Poly(A) RNA polymerase GLD2 (hGLD-2) (EC 2.7.7.19) (PAP-associated domain-containing protein 4) (Terminal uridylyltransferase 2) (TUTase 2),484,"56,028",5 out of 5,2008-06-10,Evidence at protein level
Q6ZMI3,GLDN_HUMAN,Gliomedin [Cleaved into: Gliomedin shedded ectodomain],551,"58,957",4 out of 5,2006-07-25,Evidence at transcript level
Q8WWB7,GLMP_HUMAN,Glycosylated lysosomal membrane protein (Lysosomal protein NCU-G1),406,"43,864",5 out of 5,2007-04-17,Evidence at protein level
Q14410,GLPK2_HUMAN,"Glycerol kinase 2 (GK 2) (Glycerokinase 2) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 2) (Glycerol kinase, testis specific 2)",553,"60,594",4 out of 5,2001-01-11,Evidence at transcript level
O75311,GLRA3_HUMAN,Glycine receptor subunit alpha-3,464,"53,800",5 out of 5,1998-12-15,Evidence at protein level
Q5JXX5,GLRA4_HUMAN,Glycine receptor subunit alpha-4,417,"47,728",4 out of 5,2008-06-10,Evidence at transcript level
O60234,GMFG_HUMAN,Glia maturation factor gamma (GMF-gamma),142,"16,801",4 out of 5,2000-05-30,Evidence at protein level
Q96IJ6,GMPPA_HUMAN,Mannose-1-phosphate guanyltransferase alpha (GDP-mannose pyrophosphorylase A) (GMPP-alpha) (GTP-mannose-1-phosphate guanylyltransferase alpha),420,"46,291",5 out of 5,2008-04-08,Evidence at protein level
Q9P2T1,GMPR2_HUMAN,GMP reductase 2 (GMPR 2) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 2) (Guanosine monophosphate reductase 2),348,"37,874",5 out of 5,2002-11-08,Evidence at protein level
Q14344,GNA13_HUMAN,Guanine nucleotide-binding protein subunit alpha-13 (G alpha-13) (G-protein subunit alpha-13),377,"44,050",5 out of 5,1997-11-01,Evidence at protein level
P11488,GNAT1_HUMAN,Guanine nucleotide-binding protein G(t) subunit alpha-1 (Transducin alpha-1 chain),350,"40,041",5 out of 5,1989-10-01,Evidence at protein level
O75879,GATB_HUMAN,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (Glu-AdT subunit B) (EC 6.3.5.-) (Cytochrome c oxidase assembly factor PET112 homolog)",557,"61,864",5 out of 5,2000-05-30,Evidence at protein level
Q8N1C3,GBRG1_HUMAN,Gamma-aminobutyric acid receptor subunit gamma-1 (GABA(A) receptor subunit gamma-1),465,"53,595",5 out of 5,2003-01-17,Evidence at transcript level
A8MPY1,GBRR3_HUMAN,Gamma-aminobutyric acid receptor subunit rho-3 (GABA(A) receptor subunit rho-3) (GABA(C) receptor),467,"54,272",4 out of 5,2008-04-29,Inferred from homology
Q9H3P7,GCP60_HUMAN,"Golgi resident protein GCP60 (Acyl-CoA-binding domain-containing protein 3) (Golgi complex-associated protein 1) (GOCAP1) (Golgi phosphoprotein 1) (GOLPH1) (PBR- and PKA-associated protein 7) (Peripheral benzodiazepine receptor-associated protein PAP7) [Cleaved into: Golgi resident protein GCP60, N-terminally processed]",528,"60,593",5 out of 5,2004-08-16,Evidence at protein level
P04150,GCR_HUMAN,Glucocorticoid receptor (GR) (Nuclear receptor subfamily 3 group C member 1),777,"85,659",5 out of 5,1986-11-01,Evidence at protein level
Q96F15,GIMA5_HUMAN,GTPase IMAP family member 5 (Immunity-associated nucleotide 4-like 1 protein) (Immunity-associated nucleotide 5 protein) (IAN-5) (hIAN5) (Immunity-associated protein 3),307,"34,846",5 out of 5,2003-11-14,Evidence at protein level
P08151,GLI1_HUMAN,Zinc finger protein GLI1 (Glioma-associated oncogene) (Oncogene GLI),1106,"117,904",5 out of 5,1988-08-01,Evidence at protein level
P10071,GLI3_HUMAN,Transcriptional activator GLI3 (GLI3 form of 190 kDa) (GLI3-190) (GLI3 full length protein) (GLI3FL) [Cleaved into: Transcriptional repressor GLI3R (GLI3 C-terminally truncated form) (GLI3 form of 83 kDa) (GLI3-83)],1580,"169,863",5 out of 5,1989-07-01,Evidence at protein level
P15104,GLNA_HUMAN,Glutamine synthetase (GS) (EC 6.3.1.2) (Glutamate decarboxylase) (EC 4.1.1.15) (Glutamate--ammonia ligase),373,"42,064",5 out of 5,1990-04-01,Evidence at protein level
Q14161,GIT2_HUMAN,ARF GTPase-activating protein GIT2 (ARF GAP GIT2) (Cool-interacting tyrosine-phosphorylated protein 2) (CAT-2) (CAT2) (G protein-coupled receptor kinase-interactor 2) (GRK-interacting protein 2),759,"84,543",5 out of 5,1997-11-01,Evidence at protein level
Q8NCI6,GLBL3_HUMAN,Beta-galactosidase-1-like protein 3 (EC 3.2.1.-),653,"74,823",3 out of 5,2007-04-03,Evidence at transcript level
Q8IVK1,GLCM1_HUMAN,Putative glycosylation-dependent cell adhesion molecule 1 (GlyCAM-1),47,"5,018",2 out of 5,2008-07-01,Uncertain
O95838,GLP2R_HUMAN,Glucagon-like peptide 2 receptor (GLP-2 receptor) (GLP-2-R) (GLP-2R),553,"63,001",4 out of 5,2001-01-11,Evidence at transcript level
P06028,GLPB_HUMAN,Glycophorin-B (PAS-3) (SS-active sialoglycoprotein) (Sialoglycoprotein delta) (CD antigen CD235b),91,"9,782",5 out of 5,1987-08-13,Evidence at protein level
Q969I3,GLYL1_HUMAN,Glycine N-acyltransferase-like protein 1 (EC 2.3.1.68) (Acyl-CoA:glycine N-acyltransferase-like protein 1) (Glutamine N-acyltransferase),302,"35,101",3 out of 5,2007-04-03,Evidence at protein level
Q99445,GML_HUMAN,Glycosyl-phosphatidylinositol-anchored molecule-like protein,158,"17,730",4 out of 5,1998-07-15,Evidence at transcript level
P38405,GNAL_HUMAN,"Guanine nucleotide-binding protein G(olf) subunit alpha (Adenylate cyclase-stimulating G alpha protein, olfactory type)",381,"44,308",5 out of 5,1994-10-01,Evidence at protein level
Q5JWF2,GNAS1_HUMAN,Guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas (Adenylate cyclase-stimulating G alpha protein) (Extra large alphas protein) (XLalphas),1037,"111,025",5 out of 5,2006-10-17,Evidence at protein level
P19087,GNAT2_HUMAN,Guanine nucleotide-binding protein G(t) subunit alpha-2 (Transducin alpha-2 chain),354,"40,176",5 out of 5,1990-11-01,Evidence at transcript level
O15228,GNPAT_HUMAN,Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase),680,"77,188",5 out of 5,1998-12-15,Evidence at protein level
Q9UJJ9,GNPTG_HUMAN,N-acetylglucosamine-1-phosphotransferase subunit gamma (GlcNAc-1-phosphotransferase subunit gamma) (UDP-N-acetylglucosamine-1-phosphotransferase subunit gamma),305,"33,974",5 out of 5,2005-07-19,Evidence at protein level
Q8N0V5,GNT2A_HUMAN,"N-acetyllactosaminide beta-1,6-N-acetylglucosaminyl-transferase (N-acetylglucosaminyltransferase) (EC 2.4.1.150) (I-branching enzyme) (IGNT)",402,"45,873",5 out of 5,2010-06-15,Evidence at protein level
Q9NYA3,GOG6A_HUMAN,Golgin subfamily A member 6A (Golgin linked to PML) (Golgin-like protein),693,"79,946",2 out of 5,2003-07-03,Evidence at transcript level
P0CJ92,GOG8H_HUMAN,Golgin subfamily A member 8H,632,"71,342",2 out of 5,2011-03-08,Inferred from homology
F8WBI6,GOG8N_HUMAN,Golgin subfamily A member 8N,632,"71,524",2 out of 5,2013-01-09,Inferred from homology
Q08378,GOGA3_HUMAN,Golgin subfamily A member 3 (Golgi complex-associated protein of 170 kDa) (GCP170) (Golgin-160),1498,"167,355",5 out of 5,1997-11-01,Evidence at protein level
Q8WWP7,GIMA1_HUMAN,GTPase IMAP family member 1 (Immunity-associated protein 1) (hIMAP1),306,"34,369",4 out of 5,2003-11-14,Evidence at protein level
Q6P9H5,GIMA6_HUMAN,GTPase IMAP family member 6 (Immunity-associated nucleotide 2 protein) (IAN-2) (hIAN2) (Immunity-associated nucleotide 6 protein) (IAN-6) (hIAN6),292,"32,949",4 out of 5,2008-05-20,Evidence at transcript level
Q8IW92,GLBL2_HUMAN,Beta-galactosidase-1-like protein 2 (EC 3.2.1.-),636,"72,079",2 out of 5,2008-02-05,Evidence at transcript level
P10075,GLI4_HUMAN,Zinc finger protein GLI4 (Krueppel-related zinc finger protein 4) (Protein HKR4),376,"41,145",3 out of 5,1989-07-01,Evidence at protein level
P43220,GLP1R_HUMAN,Glucagon-like peptide 1 receptor (GLP-1 receptor) (GLP-1-R) (GLP-1R),463,"53,026",5 out of 5,1995-11-01,Evidence at protein level
Q9H4A5,GLP3L_HUMAN,Golgi phosphoprotein 3-like (GPP34-related protein),285,"32,767",5 out of 5,2008-03-18,Evidence at protein level
Q86SR1,GLT10_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10),603,"68,992",5 out of 5,2004-08-16,Evidence at protein level
Q6P9A2,GLT18_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 18 (EC 2.4.1.41) (Polypeptide GalNAc transferase 18) (GalNAc-T18) (Polypeptide GalNAc transferase-like protein 4) (GalNAc-T-like protein 4) (pp-GaNTase-like protein 4) (Polypeptide N-acetylgalactosaminyltransferase-like protein 4) (Protein-UDP acetylgalactosaminyltransferase-like protein 4) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 4),607,"69,561",5 out of 5,2004-08-16,Evidence at transcript level
Q6IS24,GLTL3_HUMAN,Putative polypeptide N-acetylgalactosaminyltransferase-like protein 3 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 3) (GalNAc-T-like protein 3) (pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein),598,"67,751",5 out of 5,2004-08-16,Evidence at transcript level
Q49A17,GLTL6_HUMAN,Polypeptide N-acetylgalactosaminyltransferase-like 6 (EC 2.4.1.41) (Polypeptide GalNAc transferase 17) (GalNAc-T17) (pp-GaNTase 17) (Protein-UDP acetylgalactosaminyltransferase 17) (Putative polypeptide N-acetylgalactosaminyltransferase 17) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 17),601,"69,788",5 out of 5,2008-03-18,Evidence at transcript level
P14314,GLU2B_HUMAN,Glucosidase 2 subunit beta (80K-H protein) (Glucosidase II subunit beta) (Protein kinase C substrate 60.1 kDa protein heavy chain) (PKCSH),528,"59,425",5 out of 5,1990-01-01,Evidence at protein level
O15488,GLYG2_HUMAN,Glycogenin-2 (GN-2) (GN2) (EC 2.4.1.186),501,"55,184",5 out of 5,2000-05-30,Evidence at protein level
O75603,GCM2_HUMAN,Chorion-specific transcription factor GCMb (hGCMb) (GCM motif protein 2) (Glial cells missing homolog 2),506,"56,610",5 out of 5,2003-07-25,Evidence at protein level
Q6ZNI0,GCNT7_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 7 (EC 2.4.1.-)",430,"49,319",3 out of 5,2007-08-21,Evidence at transcript level
Q9BZD3,GCOM2_HUMAN,Putative GRINL1B complex locus protein 2 (Glutamate receptor-like protein 1B),368,"41,713",2 out of 5,2008-03-18,Uncertain
Q02108,GCYA3_HUMAN,Guanylate cyclase soluble subunit alpha-3 (GCS-alpha-3) (EC 4.6.1.2) (GCS-alpha-1) (Soluble guanylate cyclase large subunit),690,"77,452",5 out of 5,1993-07-01,Evidence at protein level
P55107,GDF10_HUMAN,Growth/differentiation factor 10 (GDF-10) (Bone morphogenetic protein 3B) (BMP-3B) (Bone-inducing protein) (BIP),478,"53,122",5 out of 5,1996-10-01,Evidence at transcript level
P27539,GDF1_HUMAN,Embryonic growth/differentiation factor 1 (GDF-1),372,"39,475",5 out of 5,1992-08-01,Evidence at protein level
Q7L5L3,GDPD3_HUMAN,Glycerophosphodiester phosphodiesterase domain-containing protein 3 (EC 3.1.-.-),318,"36,596",3 out of 5,2006-10-03,Evidence at transcript level
P52306,GDS1_HUMAN,Rap1 GTPase-GDP dissociation stimulator 1 (Exchange factor smgGDS) (SMG GDS protein) (SMG P21 stimulatory GDP/GTP exchange protein),607,"66,317",5 out of 5,1996-10-01,Evidence at protein level
O75496,GEMI_HUMAN,Geminin,209,"23,565",5 out of 5,2002-05-02,Evidence at protein level
P56159,GFRA1_HUMAN,GDNF family receptor alpha-1 (GDNF receptor alpha-1) (GDNFR-alpha-1) (GFR-alpha-1) (RET ligand 1) (TGF-beta-related neurotrophic factor receptor 1),465,"51,456",5 out of 5,1997-11-01,Evidence at transcript level
P0CL80,GG12F_HUMAN,G antigen 12F (GAGE-12F),117,"12,978",2 out of 5,2011-05-03,Evidence at protein level
A6NEM1,GG6L9_HUMAN,Golgin subfamily A member 6-like protein 9,432,"49,193",2 out of 5,2008-05-20,Evidence at transcript level
Q5YKI7,GGNB1_HUMAN,Putative gametogenetin-binding protein 1,109,"12,309",3 out of 5,2006-06-13,Uncertain
A6NGU5,GGT3_HUMAN,Putative gamma-glutamyltranspeptidase 3 (GGT 3) (EC 2.3.2.2) (Gamma-glutamyltransferase 3) (Glutathione hydrolase 3) (EC 3.4.19.13) [Cleaved into: Putative gamma-glutamyltranspeptidase 3 heavy chain; Putative gamma-glutamyltranspeptidase 3 light chain],568,"61,502",5 out of 5,2008-05-20,Uncertain
O75420,GGYF1_HUMAN,GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1),1035,"114,601",3 out of 5,2002-09-19,Evidence at protein level
Q86XP6,GKN2_HUMAN,Gastrokine-2 (Blottin) (Down-regulated in gastric cancer) (Trefoil factor interactions(z) 1),184,"20,487",3 out of 5,2006-10-03,Evidence at protein level
Q6EEV4,GL1AD_HUMAN,"DNA-directed RNA polymerase II subunit GRINL1A, isoforms 4/5 (DNA-directed RNA polymerase II subunit M, isoforms 4/5)",148,"15,131",2 out of 5,2008-03-18,Evidence at protein level
Q9H1C3,GL8D2_HUMAN,Glycosyltransferase 8 domain-containing protein 2 (EC 2.4.1.-),349,"40,026",3 out of 5,2007-01-09,Evidence at transcript level
Q8IVS8,GLCTK_HUMAN,Glycerate kinase (EC 2.7.1.31) (HBeAg-binding protein 4),523,"55,253",5 out of 5,2007-05-15,Evidence at protein level
P10070,GLI2_HUMAN,Zinc finger protein GLI2 (GLI family zinc finger protein 2) (Tax helper protein),1586,"167,783",5 out of 5,1989-07-01,Evidence at protein level
P48060,GLIP1_HUMAN,Glioma pathogenesis-related protein 1 (GliPR 1) (Protein RTVP-1),266,"30,366",4 out of 5,1996-02-01,Evidence at protein level
Q8NEA6,GLIS3_HUMAN,Zinc finger protein GLIS3 (GLI-similar 3) (Zinc finger protein 515),775,"83,636",4 out of 5,2004-04-13,Evidence at transcript level
Q5T4J0,GCNT6_HUMAN,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase 6 (EC 2.4.1.-)",391,"44,527",3 out of 5,2007-08-21,Inferred from homology
Q99988,GDF15_HUMAN,Growth/differentiation factor 15 (GDF-15) (Macrophage inhibitory cytokine 1) (MIC-1) (NSAID-activated gene 1 protein) (NAG-1) (NSAID-regulated gene 1 protein) (NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor),308,"34,140",5 out of 5,2001-02-21,Evidence at protein level
Q6KF10,GDF6_HUMAN,Growth/differentiation factor 6 (GDF-6) (Bone morphogenetic protein 13) (BMP-13) (Growth/differentiation factor 16),455,"50,662",5 out of 5,2005-10-11,Evidence at protein level
O14793,GDF8_HUMAN,Growth/differentiation factor 8 (GDF-8) (Myostatin),375,"42,750",5 out of 5,1999-07-15,Evidence at protein level
P31150,GDIA_HUMAN,Rab GDP dissociation inhibitor alpha (Rab GDI alpha) (Guanosine diphosphate dissociation inhibitor 1) (GDI-1) (Oligophrenin-2) (Protein XAP-4),447,"50,583",5 out of 5,1993-07-01,Evidence at protein level
Q9NWZ8,GEMI8_HUMAN,Gem-associated protein 8 (Gemin-8) (Protein FAM51A1),242,"28,637",5 out of 5,2004-09-27,Evidence at protein level
P14136,GFAP_HUMAN,Glial fibrillary acidic protein (GFAP),432,"49,880",5 out of 5,1990-01-01,Evidence at protein level
Q3B7J2,GFOD2_HUMAN,Glucose-fructose oxidoreductase domain-containing protein 2 (EC 1.-.-.-),385,"42,255",3 out of 5,2007-04-03,Evidence at transcript level
O94808,GFPT2_HUMAN,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 2) (Glutamine:fructose-6-phosphate amidotransferase 2) (GFAT 2) (GFAT2) (Hexosephosphate aminotransferase 2),682,"76,931",5 out of 5,2000-05-30,Evidence at protein level
Q9NZ52,GGA3_HUMAN,"ADP-ribosylation factor-binding protein GGA3 (Golgi-localized, gamma ear-containing, ARF-binding protein 3)",723,"78,315",5 out of 5,2001-06-20,Evidence at protein level
P36268,GGT2_HUMAN,Inactive gamma-glutamyltranspeptidase 2 (GGT 2) (Gamma-glutamyltransferase 2) (Glutathione hydrolase 2),569,"61,771",5 out of 5,1994-06-01,Evidence at protein level
Q4G0N0,GGTA1_HUMAN,"Inactive N-acetyllactosaminide alpha-1,3-galactosyltransferase (Glycoprotein alpha-galactosyltransferase 1 pseudogene)",100,"11,568",3 out of 5,2008-05-20,Evidence at protein level
Q9H1K4,GHC2_HUMAN,Mitochondrial glutamate carrier 2 (GC-2) (Glutamate/H(+) symporter 2) (Solute carrier family 25 member 18),315,"33,849",4 out of 5,2002-02-11,Evidence at protein level
Q9UBU3,GHRL_HUMAN,Appetite-regulating hormone (Growth hormone secretagogue) (Growth hormone-releasing peptide) (Motilin-related peptide) (Protein M46) [Cleaved into: Ghrelin-27; Ghrelin-28 (Ghrelin); Obestatin],117,"12,911",5 out of 5,2001-12-13,Evidence at protein level
Q16775,GLO2_HUMAN,"Hydroxyacylglutathione hydrolase, mitochondrial (EC 3.1.2.6) (Glyoxalase II) (Glx II)",308,"33,806",5 out of 5,1997-11-01,Evidence at protein level
O94925,GLSK_HUMAN,"Glutaminase kidney isoform, mitochondrial (GLS) (EC 3.5.1.2) (K-glutaminase) (L-glutamine amidohydrolase)",669,"73,461",5 out of 5,2001-01-24,Evidence at protein level
Q9UI32,GLSL_HUMAN,"Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase)",602,"66,323",5 out of 5,2001-01-24,Evidence at protein level
Q8IUC8,GLT13_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 13 (EC 2.4.1.41) (Polypeptide GalNAc transferase 13) (GalNAc-T13) (pp-GaNTase 13) (Protein-UDP acetylgalactosaminyltransferase 13) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 13),556,"64,051",5 out of 5,2004-08-16,Evidence at transcript level
Q8N3T1,GLT15_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 15 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 2) (GalNAc-T-like protein 2) (pp-GaNTase-like protein 2) (Polypeptide N-acetylgalactosaminyltransferase-like protein 2) (Protein-UDP acetylgalactosaminyltransferase-like protein 2) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 2),639,"73,063",5 out of 5,2004-08-16,Evidence at transcript level
Q99684,GFI1_HUMAN,Zinc finger protein Gfi-1 (Growth factor independent protein 1) (Zinc finger protein 163),422,"45,297",5 out of 5,1999-07-15,Evidence at protein level
A6NDE8,GG12H_HUMAN,G antigen 12H (GAGE-12H),117,"12,924",1 out of 5,2008-06-10,Inferred from homology
A6NEF3,GG6L4_HUMAN,Golgin subfamily A member 6-like protein 4,574,"67,563",2 out of 5,2008-04-29,Inferred from homology
H0YM25,GG6LV_HUMAN,Golgin subfamily A member 6-like protein 22,854,"107,774",1 out of 5,2014-06-11,Inferred from homology
Q9HBQ8,GGA2B_HUMAN,Putative golgin subfamily A member 2B (Golgin subfamily A member 2-like protein 1),144,"15,482",2 out of 5,2008-01-15,Uncertain
Q92820,GGH_HUMAN,Gamma-glutamyl hydrolase (EC 3.4.19.9) (Conjugase) (GH) (Gamma-Glu-X carboxypeptidase),318,"35,964",5 out of 5,1999-07-15,Evidence at protein level
Q9BX51,GGTL1_HUMAN,Gamma-glutamyltransferase light chain 1 (Gamma-glutamyltransferase-like activity 4) (Gamma-glutamyltransferase-like protein 6),225,"24,274",3 out of 5,2003-08-29,Evidence at transcript level
P10912,GHR_HUMAN,Growth hormone receptor (GH receptor) (Somatotropin receptor) [Cleaved into: Growth hormone-binding protein (GH-binding protein) (GHBP) (Serum-binding protein)],638,"71,500",5 out of 5,1989-07-01,Evidence at protein level
P13284,GILT_HUMAN,Gamma-interferon-inducible lysosomal thiol reductase (EC 1.8.-.-) (Gamma-interferon-inducible protein IP-30) (Legumaturain),250,"27,964",5 out of 5,1990-01-01,Evidence at protein level
Q9UG22,GIMA2_HUMAN,GTPase IMAP family member 2 (Immunity-associated protein 2) (hIMAP2),337,"38,017",5 out of 5,2003-11-14,Evidence at protein level
P0DJR0,GIMD1_HUMAN,GTPase IMAP family member GIMD1 (GIMAP family P-loop NTPase domain-containing protein 1),217,"24,463",2 out of 5,2012-10-03,Evidence at transcript level
O14908,GIPC1_HUMAN,PDZ domain-containing protein GIPC1 (GAIP C-terminus-interacting protein) (RGS-GAIP-interacting protein) (RGS19-interacting protein 1) (Synectin) (Tax interaction protein 2) (TIP-2),333,"36,049",5 out of 5,2001-10-18,Evidence at protein level
P09681,GIP_HUMAN,Gastric inhibitory polypeptide (GIP) (Glucose-dependent insulinotropic polypeptide) (Incretin hormone),153,"17,108",5 out of 5,1989-07-01,Evidence at protein level
Q9NS71,GKN1_HUMAN,Gastrokine-1 (18 kDa antrum mucosa protein) (AMP-18) (Protein CA11),199,"21,999",4 out of 5,2001-11-16,Evidence at transcript level
Q7Z4J2,GL6D1_HUMAN,Glycosyltransferase 6 domain-containing protein 1 (EC 2.4.1.-) (Galactosyltransferase family 6 domain-containing 1),308,"36,274",4 out of 5,2007-12-04,Evidence at transcript level
Q53GS7,GLE1_HUMAN,Nucleoporin GLE1 (hGLE1) (GLE1-like protein),698,"79,836",5 out of 5,2005-12-06,Evidence at protein level
P02728,GLEM_HUMAN,Erythrocyte membrane glycopeptide,10,"1,049",2 out of 5,1986-07-21,Evidence at protein level
P02724,GLPA_HUMAN,Glycophorin-A (MN sialoglycoprotein) (PAS-2) (Sialoglycoprotein alpha) (CD antigen CD235a),150,"16,331",5 out of 5,1986-07-21,Evidence at protein level
Q14409,GLPK3_HUMAN,"Glycerol kinase 3 (GK 3) (Glycerokinase 3) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 3) (Glycerol kinase 3 pseudogene) (Glycerol kinase, testis specific 1)",553,"60,598",4 out of 5,2001-01-11,Evidence at transcript level
Q9NS18,GLRX2_HUMAN,"Glutaredoxin-2, mitochondrial",164,"18,052",5 out of 5,2005-08-30,Evidence at protein level
A6NDK9,GOG6C_HUMAN,Golgin subfamily A member 6C,693,"79,884",2 out of 5,2008-04-29,Inferred from homology
A8MQT2,GOG8B_HUMAN,Golgin subfamily A member 8B (Golgin-67),603,"67,278",3 out of 5,2008-01-15,Evidence at transcript level
A6NCC3,GOG8O_HUMAN,Golgin subfamily A member 8O,632,"71,536",2 out of 5,2008-07-01,Evidence at protein level
Q86XS8,GOLI_HUMAN,E3 ubiquitin-protein ligase RNF130 (EC 2.3.2.27) (Goliath homolog) (H-Goliath) (RING finger protein 130) (RING-type E3 ubiquitin transferase RNF130),419,"46,405",5 out of 5,2004-12-21,Evidence at protein level
O43555,GON2_HUMAN,Progonadoliberin-2 (Progonadoliberin II) [Cleaved into: Gonadoliberin-2 (Gonadoliberin II) (Gonadotropin-releasing hormone II) (GnRH II) (Luliberin II) (Luteinizing hormone-releasing hormone II) (LH-RH II); GnRH-associated peptide 2 (GnRH-associated peptide II)],120,"12,918",4 out of 5,1998-12-15,Evidence at transcript level
Q9NPR9,GP108_HUMAN,Protein GPR108 (Lung seven transmembrane receptor 2),543,"60,633",2 out of 5,2005-12-20,Evidence at transcript level
Q7Z3F1,GP155_HUMAN,Integral membrane protein GPR155 (G-protein coupled receptor PGR22),870,"96,919",3 out of 5,2005-06-21,Evidence at transcript level
Q9UJ42,GP160_HUMAN,Probable G-protein coupled receptor 160 (G-protein coupled receptor GPCR1) (hGPCR1),338,"39,787",3 out of 5,2004-06-07,Evidence at transcript level
Q9BXC1,GP174_HUMAN,Probable G-protein coupled receptor 174,333,"38,503",3 out of 5,2002-05-27,Evidence at transcript level
P55259,GP2_HUMAN,Pancreatic secretory granule membrane major glycoprotein GP2 (Pancreatic zymogen granule membrane protein GP-2) (ZAP75),537,"59,480",5 out of 5,1996-10-01,Evidence at transcript level
O75487,GPC4_HUMAN,Glypican-4 (K-glypican) [Cleaved into: Secreted glypican-4],556,"62,412",5 out of 5,2000-05-30,Evidence at protein level
Q5T6X5,GPC6A_HUMAN,G-protein coupled receptor family C group 6 member A (hGPRC6A) (G-protein coupled receptor GPCR33) (hGPCR33),926,"104,753",5 out of 5,2005-12-06,Evidence at protein level
Q9NPB8,GPCP1_HUMAN,Glycerophosphocholine phosphodiesterase GPCPD1 (EC 3.1.4.2) (Glycerophosphodiester phosphodiesterase 5),672,"76,035",4 out of 5,2002-10-10,Evidence at protein level
Q8NDV2,GPR26_HUMAN,G-protein coupled receptor 26,337,"37,604",4 out of 5,2003-10-03,Evidence at protein level
O75388,GPR32_HUMAN,Probable G-protein coupled receptor 32,356,"40,087",4 out of 5,2000-05-30,Evidence at transcript level
Q9HC97,GPR35_HUMAN,G-protein coupled receptor 35 (Kynurenic acid receptor) (KYNA receptor),309,"34,072",5 out of 5,2001-08-14,Evidence at transcript level
Q9Y2T6,GPR55_HUMAN,G-protein coupled receptor 55,319,"36,637",5 out of 5,2005-05-10,Evidence at protein level
Q9BZJ7,GPR62_HUMAN,Probable G-protein coupled receptor 62 (G-protein coupled receptor GPCR8) (hGPCR8) (G-protein coupled receptor KPG_005),368,"37,614",4 out of 5,2002-05-27,Evidence at transcript level
P46095,GPR6_HUMAN,G-protein coupled receptor 6 (Sphingosine 1-phosphate receptor GPR6),362,"37,881",4 out of 5,1995-11-01,Evidence at protein level
Q96P67,GPR82_HUMAN,Probable G-protein coupled receptor 82,336,"38,409",3 out of 5,2003-01-10,Evidence at transcript level
Q6UWM5,GPRL1_HUMAN,GLIPR1-like protein 1,242,"27,151",3 out of 5,2007-01-23,Evidence at protein level
Q13227,GPS2_HUMAN,G protein pathway suppressor 2 (GPS-2),327,"36,689",5 out of 5,1997-11-01,Evidence at protein level
P81274,GPSM2_HUMAN,G-protein-signaling modulator 2 (Mosaic protein LGN),684,"76,662",5 out of 5,2000-05-30,Evidence at protein level
Q8N954,GPT11_HUMAN,G patch domain-containing protein 11 (Coiled-coil domain-containing protein 75),259,"30,199",3 out of 5,2007-03-06,Evidence at protein level
Q9NW75,GPTC2_HUMAN,G patch domain-containing protein 2,528,"58,944",4 out of 5,2004-06-07,Evidence at protein level
P40197,GPV_HUMAN,Platelet glycoprotein V (GPV) (Glycoprotein 5) (CD antigen CD42d),560,"60,959",5 out of 5,1995-02-01,Evidence at protein level
O75791,GRAP2_HUMAN,GRB2-related adapter protein 2 (Adapter protein GRID) (GRB-2-like protein) (GRB2L) (GRBLG) (GRBX) (Grf40 adapter protein) (Grf-40) (Growth factor receptor-binding protein) (Hematopoietic cell-associated adapter protein GrpL) (P38) (Protein GADS) (SH3-SH2-SH3 adapter Mona),330,"37,909",5 out of 5,2000-05-30,Evidence at protein level
Q14449,GRB14_HUMAN,Growth factor receptor-bound protein 14 (GRB14 adapter protein),540,"60,988",5 out of 5,1999-07-15,Evidence at protein level
A4D1Z8,GRIFN_HUMAN,Grifin (Galectin-related inter-fiber protein),144,"15,999",2 out of 5,2008-01-15,Evidence at transcript level
Q9Y3R0,GRIP1_HUMAN,Glutamate receptor-interacting protein 1 (GRIP-1),1128,"122,422",5 out of 5,2004-03-29,Evidence at protein level
Q8WTQ7,GRK7_HUMAN,Rhodopsin kinase (EC 2.7.11.14) (G protein-coupled receptor kinase 7) (G protein-coupled receptor kinase GRK7),553,"62,212",5 out of 5,2002-05-27,Evidence at protein level
P0CAP2,GRL1A_HUMAN,DNA-directed RNA polymerase II subunit GRINL1A (DNA-directed RNA polymerase II subunit M) (Glutamate receptor-like protein 1A),368,"41,740",5 out of 5,2009-05-26,Evidence at protein level
Q5TC63,GRTP1_HUMAN,Growth hormone-regulated TBC protein 1 (TBC1 domain family member 6),336,"38,554",3 out of 5,2007-05-29,Evidence at protein level
Q9BQ67,GRWD1_HUMAN,Glutamate-rich WD repeat-containing protein 1,446,"49,419",5 out of 5,2001-09-26,Evidence at protein level
P49840,GSK3A_HUMAN,Glycogen synthase kinase-3 alpha (GSK-3 alpha) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3A) (EC 2.7.11.1),483,"50,981",5 out of 5,1996-10-01,Evidence at protein level
P09488,GSTM1_HUMAN,Glutathione S-transferase Mu 1 (EC 2.5.1.18) (GST HB subunit 4) (GST class-mu 1) (GSTM1-1) (GSTM1a-1a) (GSTM1b-1b) (GTH4),218,"25,712",5 out of 5,1989-07-01,Evidence at protein level
Q5T4B2,GT253_HUMAN,Probable inactive glycosyltransferase 25 family member 3 (Cerebral endothelial cell adhesion molecule),595,"67,592",4 out of 5,2007-11-13,Evidence at protein level
Q6EKJ0,GTD2B_HUMAN,General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta),949,"107,233",4 out of 5,2008-02-26,Evidence at protein level
O43824,GTPB6_HUMAN,Putative GTP-binding protein 6 (Pseudoautosomal GTP-binding protein-like),516,"56,883",3 out of 5,2007-09-11,Evidence at transcript level
O95528,GTR10_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 10 (Glucose transporter type 10) (GLUT-10)",541,"56,911",5 out of 5,2001-11-16,Evidence at protein level
Q8WW33,GTSF1_HUMAN,Gametocyte-specific factor 1 (Protein FAM112B),167,"19,266",2 out of 5,2003-01-10,Evidence at protein level
P04921,GLPC_HUMAN,Glycophorin-C (Glycoconnectin) (Glycophorin-D) (GPD) (Glycoprotein beta) (PAS-2') (Sialoglycoprotein D) (CD antigen CD236),128,"13,811",5 out of 5,1987-08-13,Evidence at protein level
P32189,GLPK_HUMAN,Glycerol kinase (GK) (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase),559,"61,245",5 out of 5,1993-10-01,Evidence at protein level
Q9NZD2,GLTP_HUMAN,Glycolipid transfer protein (GLTP),209,"23,850",5 out of 5,2002-03-27,Evidence at protein level
Q6IB77,GLYAT_HUMAN,Glycine N-acyltransferase (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase) (AAc) (Aralkyl acyl-CoA N-acyltransferase) (Aralkyl acyl-CoA:amino acid N-acyltransferase) (Benzoyl-coenzyme A:glycine N-acyltransferase) (Glycine N-benzoyltransferase) (EC 2.3.1.71) (HRP-1(CLP)),296,"33,924",5 out of 5,2007-04-03,Evidence at protein level
P63092,GNAS2_HUMAN,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short (Adenylate cyclase-stimulating G alpha protein),394,"45,665",5 out of 5,1987-08-13,Evidence at protein level
P19086,GNAZ_HUMAN,Guanine nucleotide-binding protein G(z) subunit alpha (G(x) alpha chain) (Gz-alpha),355,"40,924",5 out of 5,1990-11-01,Evidence at transcript level
Q14749,GNMT_HUMAN,Glycine N-methyltransferase (EC 2.1.1.20),295,"32,742",5 out of 5,1998-07-15,Evidence at protein level
P30968,GNRHR_HUMAN,Gonadotropin-releasing hormone receptor (GnRH receptor) (GnRH-R),328,"37,731",5 out of 5,1993-07-01,Evidence at protein level
Q96P88,GNRR2_HUMAN,Putative gonadotropin-releasing hormone II receptor (GnRH II receptor) (GnRH-II-R) (Type II GnRH receptor),292,"32,537",4 out of 5,2003-02-12,Uncertain
P15586,GNS_HUMAN,N-acetylglucosamine-6-sulfatase (EC 3.1.6.14) (Glucosamine-6-sulfatase) (G6S),552,"62,082",5 out of 5,1990-04-01,Evidence at protein level
A6NMD2,GOG8J_HUMAN,Golgin subfamily A member 8J,632,"71,775",2 out of 5,2008-04-29,Inferred from homology
I6L899,GOG8R_HUMAN,Golgin subfamily A member 8R,631,"71,490",2 out of 5,2013-01-09,Inferred from homology
Q08379,GOGA2_HUMAN,Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95),1002,"113,086",5 out of 5,1997-11-01,Evidence at protein level
Q7Z5G4,GOGA7_HUMAN,Golgin subfamily A member 7 (Golgi complex-associated protein of 16 kDa),137,"15,824",5 out of 5,2005-11-22,Evidence at protein level
Q3T8J9,GON4L_HUMAN,GON-4-like protein (GON-4 homolog),2241,"248,620",5 out of 5,2005-12-20,Evidence at protein level
Q5VW38,GP107_HUMAN,Protein GPR107 (Lung seven transmembrane receptor 1),600,"66,990",5 out of 5,2005-07-05,Evidence at protein level
Q7Z601,GP142_HUMAN,Probable G-protein coupled receptor 142 (G-protein coupled receptor PGR2),462,"51,106",4 out of 5,2005-05-10,Evidence at transcript level
P51810,GP143_HUMAN,G-protein coupled receptor 143 (Ocular albinism type 1 protein),404,"43,878",5 out of 5,1996-10-01,Evidence at protein level
Q8NFN8,GP156_HUMAN,Probable G-protein coupled receptor 156 (G-protein coupled receptor PGR28) (GABAB-related G-protein coupled receptor),814,"89,097",4 out of 5,2005-08-16,Evidence at transcript level
Q99795,GPA33_HUMAN,Cell surface A33 antigen (Glycoprotein A33),319,"35,632",5 out of 5,1997-11-01,Evidence at protein level
Q99527,GPER1_HUMAN,G-protein coupled estrogen receptor 1 (Chemoattractant receptor-like 2) (Flow-induced endothelial G-protein coupled receptor 1) (FEG-1) (G protein-coupled estrogen receptor 1) (G-protein coupled receptor 30) (GPCR-Br) (IL8-related receptor DRY12) (Lymphocyte-derived G-protein coupled receptor) (LYGPR) (Membrane estrogen receptor) (mER),375,"42,248",5 out of 5,1998-07-15,Evidence at protein level
Q96T91,GPHA2_HUMAN,Glycoprotein hormone alpha-2 (Putative secreted protein Zsig51) (Thyrostimulin subunit alpha),129,"14,163",5 out of 5,2003-10-10,Evidence at protein level
Q9H9Y4,GPN2_HUMAN,GPN-loop GTPase 2 (ATP-binding domain 1 family member B),310,"34,561",4 out of 5,2006-07-25,Evidence at protein level
P49685,GPR15_HUMAN,G-protein coupled receptor 15 (Brother of Bonzo) (BoB),360,"40,787",3 out of 5,1996-02-01,Evidence at transcript level
P07203,GPX1_HUMAN,Glutathione peroxidase 1 (GPx-1) (GSHPx-1) (EC 1.11.1.9) (Cellular glutathione peroxidase),203,"22,088",5 out of 5,1988-04-01,Evidence at protein level
P10144,GRAB_HUMAN,Granzyme B (EC 3.4.21.79) (C11) (CTLA-1) (Cathepsin G-like 1) (CTSGL1) (Cytotoxic T-lymphocyte proteinase 2) (Lymphocyte protease) (Fragmentin-2) (Granzyme-2) (Human lymphocyte protein) (HLP) (SECT) (T-cell serine protease 1-3E),247,"27,716",5 out of 5,1989-07-01,Evidence at protein level
Q8IUY3,GRAM2_HUMAN,GRAM domain-containing protein 2,354,"40,249",2 out of 5,2007-05-15,Evidence at transcript level
Q3V6T2,GRDN_HUMAN,Girdin (Akt phosphorylation enhancer) (APE) (Coiled-coil domain-containing protein 88A) (G alpha-interacting vesicle-associated protein) (GIV) (Girders of actin filament) (Hook-related protein 1) (HkRP1),1871,"216,042",5 out of 5,2007-05-15,Evidence at protein level
Q9NZI5,GRHL1_HUMAN,Grainyhead-like protein 1 homolog (Mammalian grainyhead) (NH32) (Transcription factor CP2-like 2) (Transcription factor LBP-32),618,"70,113",5 out of 5,2006-03-21,Evidence at protein level
Q13003,GRIK3_HUMAN,"Glutamate receptor ionotropic, kainate 3 (GluK3) (Excitatory amino acid receptor 5) (EAA5) (Glutamate receptor 7) (GluR-7) (GluR7)",919,"104,037",5 out of 5,1997-11-01,Evidence at transcript level
O60269,GRIN2_HUMAN,G protein-regulated inducer of neurite outgrowth 2 (GRIN2),458,"47,450",4 out of 5,1999-07-15,Evidence at protein level
P43250,GRK6_HUMAN,G protein-coupled receptor kinase 6 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK6),576,"65,991",5 out of 5,1995-11-01,Evidence at protein level
Q3KR37,GRM1B_HUMAN,GRAM domain-containing protein 1B,738,"85,400",3 out of 5,2007-05-15,Evidence at protein level
O15303,GRM6_HUMAN,Metabotropic glutamate receptor 6 (mGluR6),877,"95,468",5 out of 5,1998-07-15,Evidence at protein level
Q5T7V8,GORAB_HUMAN,RAB6-interacting golgin (N-terminal kinase-like-binding protein 1) (NTKL-BP1) (NTKL-binding protein 1) (hNTKL-BP1) (SCY1-like 1-binding protein 1) (SCYL1-BP1) (SCYL1-binding protein 1),394,"44,993",5 out of 5,2006-10-17,Evidence at protein level
Q9Y3E0,GOT1B_HUMAN,Vesicle transport protein GOT1B (Germ cell tumor 2) (Golgi transport 1 homolog B) (Putative NF-kappa-B-activating protein 470) (hGOT1a),138,"15,426",5 out of 5,2002-05-10,Evidence at protein level
Q96P66,GP101_HUMAN,Probable G-protein coupled receptor 101,508,"56,716",4 out of 5,2003-10-10,Evidence at protein level
Q8TDV5,GP119_HUMAN,Glucose-dependent insulinotropic receptor (G-protein coupled receptor 119),335,"36,889",3 out of 5,2005-04-12,Evidence at protein level
Q7Z602,GP141_HUMAN,Probable G-protein coupled receptor 141 (G-protein coupled receptor PGR13),305,"35,464",3 out of 5,2005-04-26,Evidence at transcript level
Q96CH1,GP146_HUMAN,Probable G-protein coupled receptor 146 (G-protein coupled receptor PGR8),333,"36,580",3 out of 5,2005-06-07,Evidence at transcript level
O14626,GP171_HUMAN,Probable G-protein coupled receptor 171 (G-protein coupled receptor H963),319,"36,754",3 out of 5,2000-05-30,Evidence at transcript level
Q9NS66,GP173_HUMAN,Probable G-protein coupled receptor 173 (Super conserved receptor expressed in brain 3),373,"41,481",4 out of 5,2001-08-14,Evidence at transcript level
Q6PRD1,GP179_HUMAN,Probable G-protein coupled receptor 179 (Probable G-protein coupled receptor 158-like 1) (GPR158-like),2367,"257,363",5 out of 5,2006-01-10,Evidence at protein level
Q9NZD1,GPC5D_HUMAN,G-protein coupled receptor family C group 5 member D,345,"38,791",3 out of 5,2004-04-13,Evidence at transcript level
Q92643,GPI8_HUMAN,GPI-anchor transamidase (GPI transamidase) (EC 3.-.-.-) (GPI8 homolog) (hGPI8) (Phosphatidylinositol-glycan biosynthesis class K protein) (PIG-K),395,"45,252",5 out of 5,2002-07-11,Evidence at protein level
Q86YR5,GPSM1_HUMAN,G-protein-signaling modulator 1 (Activator of G-protein signaling 3),675,"74,510",5 out of 5,2006-10-17,Evidence at protein level
Q9Y4H4,GPSM3_HUMAN,G-protein-signaling modulator 3 (Activator of G-protein signaling 4) (G18.1b) (Protein G18),160,"17,866",5 out of 5,2006-05-02,Evidence at protein level
P22352,GPX3_HUMAN,Glutathione peroxidase 3 (GPx-3) (GSHPx-3) (EC 1.11.1.9) (Extracellular glutathione peroxidase) (Plasma glutathione peroxidase) (GPx-P) (GSHPx-P),226,"25,552",5 out of 5,1991-08-01,Evidence at protein level
Q7Z6J2,GRASP_HUMAN,General receptor for phosphoinositides 1-associated scaffold protein (GRP1-associated scaffold protein),395,"42,623",3 out of 5,2005-09-27,Evidence at protein level
Q13322,GRB10_HUMAN,Growth factor receptor-bound protein 10 (GRB10 adapter protein) (Insulin receptor-binding protein Grb-IR),594,"67,231",5 out of 5,1999-07-15,Evidence at protein level
P62993,GRB2_HUMAN,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2),217,"25,206",5 out of 5,2004-08-31,Evidence at protein level
P32298,GRK4_HUMAN,G protein-coupled receptor kinase 4 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK4) (ITI1),578,"66,583",5 out of 5,1993-10-01,Evidence at protein level
P34947,GRK5_HUMAN,G protein-coupled receptor kinase 5 (EC 2.7.11.16) (G protein-coupled receptor kinase GRK5),590,"67,787",5 out of 5,1994-02-01,Evidence at protein level
Q8IYS0,GRM1C_HUMAN,GRAM domain-containing protein 1C,662,"76,035",2 out of 5,2007-05-15,Evidence at protein level
Q14416,GRM2_HUMAN,Metabotropic glutamate receptor 2 (mGluR2),872,"95,568",5 out of 5,1997-11-01,Evidence at protein level
Q14832,GRM3_HUMAN,Metabotropic glutamate receptor 3 (mGluR3),879,"98,879",5 out of 5,1997-11-01,Evidence at protein level
Q8TDF6,GRP4_HUMAN,RAS guanyl-releasing protein 4,673,"74,882",5 out of 5,2008-01-15,Evidence at protein level
Q4G1C9,GRPL2_HUMAN,GLIPR1-like protein 2,344,"40,179",3 out of 5,2008-03-18,Evidence at transcript level
O15499,GSC2_HUMAN,Homeobox protein goosecoid-2 (GSC-2) (Homeobox protein goosecoid-like) (GSC-L),205,"21,545",4 out of 5,2000-05-30,Evidence at transcript level
Q86UQ5,GTSC1_HUMAN,Gilles de la Tourette syndrome chromosomal region candidate gene 1 protein,136,"15,623",1 out of 5,2007-01-09,Uncertain
Q6ZS86,GLPK5_HUMAN,Putative glycerol kinase 5 (GK 5) (Glycerokinase 5) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase 5),529,"59,156",3 out of 5,2008-03-18,Evidence at transcript level
P35754,GLRX1_HUMAN,Glutaredoxin-1 (Thioltransferase-1) (TTase-1),106,"11,776",5 out of 5,1994-06-01,Evidence at protein level
P47871,GLR_HUMAN,Glucagon receptor (GL-R),477,"54,009",5 out of 5,1996-02-01,Evidence at protein level
Q8IXK2,GLT12_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12),581,"66,938",5 out of 5,2004-08-16,Evidence at protein level
Q96FL9,GLT14_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 14 (EC 2.4.1.41) (Polypeptide GalNAc transferase 14) (GalNAc-T14) (pp-GaNTase 14) (Protein-UDP acetylgalactosaminyltransferase 14) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 14),552,"64,321",5 out of 5,2004-08-16,Evidence at protein level
P46976,GLYG_HUMAN,Glycogenin-1 (GN-1) (GN1) (EC 2.4.1.186),350,"39,384",5 out of 5,1995-11-01,Evidence at protein level
P34897,GLYM_HUMAN,"Serine hydroxymethyltransferase, mitochondrial (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",504,"55,993",5 out of 5,1994-02-01,Evidence at protein level
Q96IK5,GMCL1_HUMAN,Germ cell-less protein-like 1,515,"58,685",5 out of 5,2004-05-24,Evidence at protein level
Q9Y5P6,GMPPB_HUMAN,Mannose-1-phosphate guanyltransferase beta (EC 2.7.7.13) (GDP-mannose pyrophosphorylase B) (GTP-mannose-1-phosphate guanylyltransferase beta),360,"39,834",5 out of 5,2007-10-23,Evidence at protein level
O95837,GNA14_HUMAN,Guanine nucleotide-binding protein subunit alpha-14 (G alpha-14) (G-protein subunit alpha-14),355,"41,571",5 out of 5,1999-07-15,Evidence at protein level
P50148,GNAQ_HUMAN,Guanine nucleotide-binding protein G(q) subunit alpha (Guanine nucleotide-binding protein alpha-q),359,"42,142",5 out of 5,1996-10-01,Evidence at protein level
A8MTJ3,GNAT3_HUMAN,Guanine nucleotide-binding protein G(t) subunit alpha-3 (Gustducin alpha-3 chain),354,"40,357",5 out of 5,2008-07-01,Evidence at transcript level
A7E2F4,GOG8A_HUMAN,Golgin subfamily A member 8A (88 kDa Golgi matrix protein) (GM88) (GM88 autoantigen),631,"70,117",4 out of 5,2008-01-15,Evidence at transcript level
D6RF30,GOG8K_HUMAN,Golgin subfamily A member 8K,607,"68,878",1 out of 5,2013-01-09,Inferred from homology
Q9H4A6,GOLP3_HUMAN,Golgi phosphoprotein 3 (Coat protein GPP34) (Mitochondrial DNA absence factor) (MIDAS),298,"33,811",5 out of 5,2004-07-19,Evidence at protein level
Q86UL3,GPAT4_HUMAN,Glycerol-3-phosphate acyltransferase 4 (EC 2.3.1.15) (1-acylglycerol-3-phosphate O-acyltransferase 6) (1-AGP acyltransferase 6) (1-AGPAT 6) (Acyl-CoA:glycerol-3-phosphate acyltransferase 4) (Lysophosphatidic acid acyltransferase zeta) (LPAAT-zeta),456,"52,071",5 out of 5,2005-06-21,Evidence at protein level
Q9HCN4,GPN1_HUMAN,GPN-loop GTPase 1 (EC 3.6.5.-) (MBD2-interacting protein) (MBDin) (RNAPII-associated protein 4) (XPA-binding protein 1),374,"41,740",5 out of 5,2003-09-19,Evidence at protein level
P62873,GBB1_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 (Transducin beta chain 1),340,"37,377",5 out of 5,1987-08-13,Evidence at protein level
O14775,GBB5_HUMAN,Guanine nucleotide-binding protein subunit beta-5 (Gbeta5) (Transducin beta chain 5),395,"43,566",5 out of 5,1998-07-15,Evidence at protein level
P63215,GBG3_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3,75,"8,305",4 out of 5,2004-09-27,Evidence at protein level
O60262,GBG7_HUMAN,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7,68,"7,522",4 out of 5,1999-07-15,Evidence at protein level
Q99928,GBRG3_HUMAN,Gamma-aminobutyric acid receptor subunit gamma-3 (GABA(A) receptor subunit gamma-3),467,"54,289",5 out of 5,1998-07-15,Evidence at transcript level
Q96MZ0,GD1L1_HUMAN,Ganglioside-induced differentiation-associated protein 1-like 1 (GDAP1-L1),367,"41,973",2 out of 5,2003-11-07,Evidence at transcript level
Q8TB36,GDAP1_HUMAN,Ganglioside-induced differentiation-associated protein 1 (GDAP1),358,"41,346",5 out of 5,2003-11-07,Evidence at protein level
Q99819,GDIR3_HUMAN,Rho GDP-dissociation inhibitor 3 (Rho GDI 3) (Rho-GDI gamma),225,"25,098",4 out of 5,1998-12-15,Evidence at protein level
P01275,GLUC_HUMAN,Glucagon [Cleaved into: Glicentin; Glicentin-related polypeptide (GRPP); Oxyntomodulin (OXM) (OXY); Glucagon; Glucagon-like peptide 1 (GLP-1) (Incretin hormone); Glucagon-like peptide 1(7-37) (GLP-1(7-37)); Glucagon-like peptide 1(7-36) (GLP-1(7-36)); Glucagon-like peptide 2 (GLP-2)],180,"20,909",5 out of 5,1986-07-21,Evidence at protein level
Q5SZD4,GLYL3_HUMAN,Glycine N-acyltransferase-like protein 3 (EC 2.3.1.-),288,"32,704",2 out of 5,2008-05-20,Evidence at transcript level
Q49A26,GLYR1_HUMAN,Putative oxidoreductase GLYR1 (EC 1.-.-.-) (3-hydroxyisobutyrate dehydrogenase-like protein) (Cytokine-like nuclear factor N-PAC) (Glyoxylate reductase 1 homolog) (Nuclear protein NP60) (Nuclear protein of 60 kDa),553,"60,556",5 out of 5,2007-12-04,Evidence at protein level
Q9Y692,GMEB1_HUMAN,Glucocorticoid modulatory element-binding protein 1 (GMEB-1) (DNA-binding protein p96PIF) (Parvovirus initiation factor p96) (PIF p96),573,"62,591",5 out of 5,2002-07-26,Evidence at protein level
Q9P107,GMIP_HUMAN,GEM-interacting protein (GMIP),970,"106,683",5 out of 5,2005-03-29,Evidence at protein level
Q96EK6,GNA1_HUMAN,Glucosamine 6-phosphate N-acetyltransferase (EC 2.3.1.4) (Phosphoglucosamine acetylase) (Phosphoglucosamine transacetylase),184,"20,749",5 out of 5,2004-05-10,Evidence at protein level
P04899,GNAI2_HUMAN,Guanine nucleotide-binding protein G(i) subunit alpha-2 (Adenylate cyclase-inhibiting G alpha protein),355,"40,451",5 out of 5,1987-08-13,Evidence at protein level
O00270,GPR31_HUMAN,"12-(S)-hydroxy-5,8,10,14-eicosatetraenoic acid receptor (12-(S)-HETE receptor) (12-HETER) (G-protein coupled receptor 31)",319,"35,075",3 out of 5,1998-07-15,Evidence at transcript level
Q9Y5Y3,GPR45_HUMAN,Probable G-protein coupled receptor 45 (PSP24-1) (PSP24-alpha),372,"41,967",3 out of 5,2002-05-27,Evidence at transcript level
P46093,GPR4_HUMAN,G-protein coupled receptor 4 (G-protein coupled receptor 19),362,"40,982",4 out of 5,1995-11-01,Evidence at transcript level
Q9BZJ8,GPR61_HUMAN,Probable G-protein coupled receptor 61 (Biogenic amine receptor-like G-protein coupled receptor),451,"49,292",4 out of 5,2002-05-27,Evidence at protein level
Q5T3I0,GPTC4_HUMAN,G patch domain-containing protein 4,446,"50,381",3 out of 5,2007-05-15,Evidence at protein level
Q9UKJ3,GPTC8_HUMAN,G patch domain-containing protein 8,1502,"164,197",4 out of 5,2000-12-01,Evidence at protein level
Q9H3H5,GPT_HUMAN,UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (EC 2.7.8.15) (GlcNAc-1-P transferase) (G1PT) (GPT) (N-acetylglucosamine-1-phosphate transferase),408,"46,090",5 out of 5,2001-08-29,Evidence at protein level
P18283,GPX2_HUMAN,Glutathione peroxidase 2 (GPx-2) (GSHPx-2) (EC 1.11.1.9) (Gastrointestinal glutathione peroxidase) (Glutathione peroxidase-gastrointestinal) (GPx-GI) (GSHPx-GI) (Glutathione peroxidase-related protein 2) (GPRP-2),190,"21,954",5 out of 5,1990-11-01,Evidence at protein level
O15544,GR6_HUMAN,Protein GR6,149,"16,056",1 out of 5,1999-07-15,Evidence at transcript level
Q14451,GRB7_HUMAN,Growth factor receptor-bound protein 7 (B47) (Epidermal growth factor receptor GRB-7) (GRB7 adapter protein),532,"59,681",5 out of 5,1999-07-15,Evidence at protein level
Q9BVM4,GGACT_HUMAN,Gamma-glutamylaminecyclotransferase (GGACT) (EC 2.3.2.4) (AIG2-like domain-containing protein 1) (Gamma-glutamylamine cyclotransferase),153,"17,329",5 out of 5,2008-02-26,Evidence at protein level
Q5JRK9,GGEE3_HUMAN,Putative G antigen family E member 3 (Prostate-associated gene 2B protein) (PAGE-2B),111,"12,041",2 out of 5,2006-07-25,Inferred from homology
Q86UU5,GGN_HUMAN,Gametogenetin,652,"66,699",3 out of 5,2006-06-13,Evidence at protein level
Q14390,GGTL2_HUMAN,Gamma-glutamyltransferase light chain 2 (Gamma-glutamyltransferase-like protein 4),218,"23,661",4 out of 5,2003-08-29,Evidence at transcript level
Q92847,GHSR_HUMAN,Growth hormone secretagogue receptor type 1 (GHS-R) (GH-releasing peptide receptor) (GHRP) (Ghrelin receptor),366,"41,329",5 out of 5,1997-11-01,Evidence at protein level
Q9NUV9,GIMA4_HUMAN,GTPase IMAP family member 4 (Immunity-associated nucleotide 1 protein) (IAN-1) (hIAN1) (Immunity-associated protein 4),329,"37,534",4 out of 5,2003-11-14,Evidence at protein level
Q8ND71,GIMA8_HUMAN,GTPase IMAP family member 8 (Immune-associated nucleotide-binding protein 9) (IAN-9) (Protein IanT),665,"74,890",4 out of 5,2008-07-01,Evidence at transcript level
Q9NXP7,GIN1_HUMAN,Gypsy retrotransposon integrase-like protein 1 (GIN-1) (Ty3/Gypsy integrase 1) (Zinc finger H2C2 domain-containing protein),522,"59,842",3 out of 5,2008-05-20,Evidence at protein level
Q9NU53,GINM1_HUMAN,Glycoprotein integral membrane protein 1,330,"36,840",2 out of 5,2005-07-05,Evidence at transcript level
Q8TF65,GIPC2_HUMAN,PDZ domain-containing protein GIPC2,315,"34,354",3 out of 5,2006-07-25,Evidence at protein level
Q5VSY0,GKAP1_HUMAN,G kinase-anchoring protein 1 (cGMP-dependent protein kinase-anchoring protein of 42 kDa),366,"42,078",4 out of 5,2008-01-15,Evidence at protein level
Q96MS3,GL1D1_HUMAN,Glycosyltransferase 1 domain-containing protein 1 (EC 2.4.-.-),346,"38,507",3 out of 5,2007-12-04,Evidence at transcript level
Q86SX6,GLRX5_HUMAN,"Glutaredoxin-related protein 5, mitochondrial (Monothiol glutaredoxin-5)",157,"16,628",5 out of 5,2005-02-01,Evidence at protein level
P29992,GNA11_HUMAN,Guanine nucleotide-binding protein subunit alpha-11 (G alpha-11) (G-protein subunit alpha-11) (Guanine nucleotide-binding protein G(y) subunit alpha),359,"42,123",5 out of 5,1993-04-01,Evidence at protein level
P09471,GNAO_HUMAN,Guanine nucleotide-binding protein G(o) subunit alpha,354,"40,051",5 out of 5,1989-07-01,Evidence at protein level
Q99680,GPR22_HUMAN,Probable G-protein coupled receptor 22,433,"49,265",3 out of 5,1997-11-01,Evidence at transcript level
Q9NS67,GPR27_HUMAN,Probable G-protein coupled receptor 27 (Super conserved receptor expressed in brain 1),375,"39,818",3 out of 5,2001-08-14,Evidence at transcript level
Q49SQ1,GPR33_HUMAN,Probable G-protein coupled receptor 33,333,"38,232",4 out of 5,2005-11-22,Evidence at transcript level
Q9BRR8,GPTC1_HUMAN,G patch domain-containing protein 1 (Evolutionarily conserved G-patch domain-containing protein),931,"103,345",3 out of 5,2007-05-15,Evidence at protein level
P36969,GPX4_HUMAN,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4)",197,"22,175",5 out of 5,1994-06-01,Evidence at protein level
P59796,GPX6_HUMAN,Glutathione peroxidase 6 (GPx-6) (GSHPx-6) (EC 1.11.1.9),221,"24,971",4 out of 5,2003-08-04,Evidence at transcript level
Q8TED1,GPX8_HUMAN,Probable glutathione peroxidase 8 (GPx-8) (GSHPx-8) (EC 1.11.1.9),209,"23,881",3 out of 5,2008-02-05,Evidence at protein level
P12544,GRAA_HUMAN,Granzyme A (EC 3.4.21.78) (CTL tryptase) (Cytotoxic T-lymphocyte proteinase 1) (Fragmentin-1) (Granzyme-1) (Hanukkah factor) (H factor) (HF),262,"28,999",5 out of 5,1989-10-01,Evidence at protein level
P49863,GRAK_HUMAN,Granzyme K (EC 3.4.21.-) (Fragmentin-3) (Granzyme-3) (NK-tryptase-2) (NK-Tryp-2),264,"28,882",4 out of 5,1996-10-01,Evidence at protein level
A6NFK2,GRCR2_HUMAN,Glutaredoxin domain-containing cysteine-rich protein 2 (GRXCR1-like protein) (Glutaredoxin domain-containing cysteine-rich protein 1-like protein),248,"28,284",3 out of 5,2008-09-02,Inferred from homology
P30550,GRPR_HUMAN,Gastrin-releasing peptide receptor (GRP-R) (GRP-preferring bombesin receptor),384,"43,199",4 out of 5,1993-04-01,Evidence at transcript level
Q8TAX9,GSDMB_HUMAN,Gasdermin-B (Gasdermin-like protein),411,"46,786",5 out of 5,2008-04-08,Evidence at protein level
Q2KHT4,GSG1_HUMAN,Germ cell-specific gene 1 protein,349,"39,248",4 out of 5,2008-04-29,Evidence at protein level
P00390,GSHR_HUMAN,"Glutathione reductase, mitochondrial (GR) (GRase) (EC 1.8.1.7)",522,"56,257",5 out of 5,1986-07-21,Evidence at protein level
P49841,GSK3B_HUMAN,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),420,"46,744",5 out of 5,1996-10-01,Evidence at protein level
Q9Y2Q3,GSTK1_HUMAN,Glutathione S-transferase kappa 1 (EC 2.5.1.18) (GST 13-13) (GST class-kappa) (GSTK1-1) (hGSTK1) (Glutathione S-transferase subunit 13),226,"25,497",5 out of 5,2001-01-24,Evidence at protein level
P78417,GSTO1_HUMAN,Glutathione S-transferase omega-1 (GSTO-1) (EC 2.5.1.18) (Glutathione S-transferase omega 1-1) (GSTO 1-1) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2) (S-(Phenacyl)glutathione reductase) (SPG-R),241,"27,566",5 out of 5,1999-07-15,Evidence at protein level
P23415,GLRA1_HUMAN,Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit),457,"52,624",5 out of 5,1991-11-01,Evidence at protein level
O76003,GLRX3_HUMAN,Glutaredoxin-3 (PKC-interacting cousin of thioredoxin) (PICOT) (PKC-theta-interacting protein) (PKCq-interacting protein) (Thioredoxin-like protein 2),335,"37,432",5 out of 5,2003-09-26,Evidence at protein level
P34896,GLYC_HUMAN,"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",483,"53,083",5 out of 5,1994-02-01,Evidence at protein level
P36959,GMPR1_HUMAN,GMP reductase 1 (GMPR 1) (EC 1.7.1.7) (Guanosine 5'-monophosphate oxidoreductase 1) (Guanosine monophosphate reductase 1),345,"37,419",5 out of 5,1994-06-01,Evidence at protein level
Q03113,GNA12_HUMAN,Guanine nucleotide-binding protein subunit alpha-12 (G alpha-12) (G-protein subunit alpha-12),381,"44,279",5 out of 5,1993-10-01,Evidence at protein level
Q12967,GNDS_HUMAN,Ral guanine nucleotide dissociation stimulator (RalGDS) (Ral guanine nucleotide exchange factor) (RalGEF),914,"100,607",5 out of 5,1998-07-15,Evidence at protein level
Q8NGU9,GP150_HUMAN,Probable G-protein coupled receptor 150,434,"46,353",3 out of 5,2004-07-05,Inferred from homology
Q8TDV0,GP151_HUMAN,Probable G-protein coupled receptor 151 (G-protein coupled receptor PGR7) (GPCR-2037),419,"46,637",4 out of 5,2004-06-07,Evidence at transcript level
Q5T848,GP158_HUMAN,Probable G-protein coupled receptor 158,1215,"135,489",4 out of 5,2005-06-07,Evidence at protein level
Q8N6U8,GP161_HUMAN,G-protein coupled receptor 161 (G-protein coupled receptor RE2),529,"58,559",4 out of 5,2004-06-07,Evidence at transcript level
Q86WP2,GPBP1_HUMAN,Vasculin (GC-rich promoter-binding protein 1) (Vascular wall-linked protein),473,"53,339",5 out of 5,2008-03-18,Evidence at protein level
P35052,GPC1_HUMAN,Glypican-1 [Cleaved into: Secreted glypican-1],558,"61,680",5 out of 5,1994-02-01,Evidence at protein level
Q9NZH0,GPC5B_HUMAN,G-protein coupled receptor family C group 5 member B (A-69G12.1) (Retinoic acid-induced gene 2 protein) (RAIG-2),403,"44,795",5 out of 5,2004-04-13,Evidence at transcript level
Q86YW7,GPHB5_HUMAN,Glycoprotein hormone beta-5 (Thyrostimulin subunit beta),130,"14,232",5 out of 5,2003-10-10,Evidence at protein level
P47775,GPR12_HUMAN,G-protein coupled receptor 12,334,"36,730",4 out of 5,1996-02-01,Evidence at protein level
Q15760,GPR19_HUMAN,Probable G-protein coupled receptor 19 (GPR-NGA),415,"47,687",4 out of 5,1997-11-01,Evidence at transcript level
Q9HAV7,GRPE1_HUMAN,"GrpE protein homolog 1, mitochondrial (HMGE) (Mt-GrpE#1)",217,"24,279",4 out of 5,2001-07-11,Evidence at protein level
Q7Z4T8,GLTL5_HUMAN,Inactive polypeptide N-acetylgalactosaminyltransferase-like protein 5 (Polypeptide GalNAc transferase 15) (GalNAc-T15) (pp-GaNTase 15) (Protein-UDP acetylgalactosaminyltransferase 15) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 15),443,"51,427",5 out of 5,2004-08-16,Evidence at transcript level
Q9UKD1,GMEB2_HUMAN,Glucocorticoid modulatory element-binding protein 2 (GMEB-2) (DNA-binding protein p79PIF) (Parvovirus initiation factor p79) (PIF p79),530,"56,421",5 out of 5,2002-07-26,Evidence at protein level
P30679,GNA15_HUMAN,Guanine nucleotide-binding protein subunit alpha-15 (G alpha-15) (G-protein subunit alpha-15) (Epididymis tissue protein Li 17E) (Guanine nucleotide-binding protein subunit alpha-16) (G alpha-16) (G-protein subunit alpha-16),374,"43,568",5 out of 5,1993-04-01,Evidence at protein level
P63096,GNAI1_HUMAN,Guanine nucleotide-binding protein G(i) subunit alpha-1 (Adenylate cyclase-inhibiting G alpha protein),354,"40,361",5 out of 5,1987-08-13,Evidence at protein level
Q9NVN8,GNL3L_HUMAN,Guanine nucleotide-binding protein-like 3-like protein,582,"65,573",5 out of 5,2007-04-17,Evidence at protein level
Q2TAP0,GOG7B_HUMAN,Golgin subfamily A member 7B,167,"18,335",3 out of 5,2006-06-27,Evidence at transcript level
Q0D2H9,GOG8D_HUMAN,Putative golgin subfamily A member 8D,430,"48,423",5 out of 5,2008-01-15,Uncertain
H3BSY2,GOG8M_HUMAN,Golgin subfamily A member 8M,632,"71,498",2 out of 5,2013-01-09,Inferred from homology
Q13439,GOGA4_HUMAN,Golgin subfamily A member 4 (256 kDa golgin) (Golgin-245) (Protein 72.1) (Trans-Golgi p230),2230,"261,140",5 out of 5,2000-12-01,Evidence at protein level
Q8NBJ4,GOLM1_HUMAN,Golgi membrane protein 1 (Golgi membrane protein GP73) (Golgi phosphoprotein 2),401,"45,333",5 out of 5,2004-08-16,Evidence at protein level
Q8IX06,GOR_HUMAN,Putative exonuclease GOR (EC 3.1.-.-) (Antigen GOR homolog) (RNA exonuclease 1 homolog-like 1),675,"73,855",4 out of 5,2003-11-28,Uncertain
O95249,GOSR1_HUMAN,Golgi SNAP receptor complex member 1 (28 kDa Golgi SNARE protein) (28 kDa cis-Golgi SNARE p28) (GOS-28),250,"28,613",5 out of 5,2000-12-01,Evidence at protein level
Q8TDT2,GP152_HUMAN,Probable G-protein coupled receptor 152 (G-protein coupled receptor PGR5),470,"50,962",3 out of 5,2004-06-07,Evidence at transcript level
Q6NV75,GP153_HUMAN,Probable G-protein coupled receptor 153 (G-protein coupled receptor PGR1),609,"65,361",3 out of 5,2005-11-08,Evidence at transcript level
Q86V85,GP180_HUMAN,Integral membrane protein GPR180 (Intimal thickness-related receptor),440,"49,395",2 out of 5,2006-06-13,Evidence at transcript level
P13224,GP1BB_HUMAN,Platelet glycoprotein Ib beta chain (GP-Ib beta) (GPIb-beta) (GPIbB) (Antigen CD42b-beta) (CD antigen CD42c),206,"21,718",5 out of 5,1990-01-01,Evidence at protein level
O95872,GPAN1_HUMAN,G patch domain and ankyrin repeat-containing protein 1 (Ankyrin repeat domain-containing protein 59) (G patch domain-containing protein 10) (HLA-B-associated transcript 4) (Protein G5),356,"39,314",4 out of 5,2002-10-25,Evidence at protein level
P43304,GPDM_HUMAN,"Glycerol-3-phosphate dehydrogenase, mitochondrial (GPD-M) (GPDH-M) (EC 1.1.5.3) (mtGPD)",727,"80,853",5 out of 5,1995-11-01,Evidence at protein level
P51674,GPM6A_HUMAN,Neuronal membrane glycoprotein M6-a (M6a),278,"31,210",5 out of 5,1996-10-01,Evidence at protein level
Q14330,GPR18_HUMAN,N-arachidonyl glycine receptor (NAGly receptor) (G-protein coupled receptor 18),331,"38,134",5 out of 5,1997-11-01,Evidence at protein level
O00155,GPR25_HUMAN,Probable G-protein coupled receptor 25,361,"38,779",4 out of 5,1998-07-15,Evidence at protein level
Q96SL4,GPX7_HUMAN,Glutathione peroxidase 7 (GPx-7) (GSHPx-7) (EC 1.11.1.9) (CL683),187,"20,996",5 out of 5,2003-08-04,Evidence at protein level
P20718,GRAH_HUMAN,Granzyme H (EC 3.4.21.-) (CCP-X) (Cathepsin G-like 2) (CTSGL2) (Cytotoxic T-lymphocyte proteinase) (Cytotoxic serine protease C) (CSP-C),246,"27,315",5 out of 5,1991-02-01,Evidence at protein level
Q6IC98,GRAM4_HUMAN,GRAM domain-containing protein 4 (Death-inducing protein),578,"66,408",4 out of 5,2008-04-08,Evidence at protein level
Q4V328,GRAP1_HUMAN,GRIP1-associated protein 1 (GRASP-1),841,"95,990",5 out of 5,2005-09-27,Evidence at protein level
Q13588,GRAP_HUMAN,GRB2-related adapter protein,217,"25,337",5 out of 5,1998-12-15,Evidence at protein level
A8MXD5,GRCR1_HUMAN,Glutaredoxin domain-containing cysteine-rich protein 1,290,"32,294",4 out of 5,2008-09-02,Evidence at protein level
Q4ZG55,GREB1_HUMAN,Protein GREB1 (Gene regulated in breast cancer 1 protein),1949,"216,467",5 out of 5,2008-02-26,Evidence at transcript level
Q6ISB3,GRHL2_HUMAN,Grainyhead-like protein 2 homolog (Brother of mammalian grainyhead) (Transcription factor CP2-like 3),625,"71,105",5 out of 5,2006-03-21,Evidence at protein level
P42263,GRIA3_HUMAN,"Glutamate receptor 3 (GluR-3) (AMPA-selective glutamate receptor 3) (GluR-C) (GluR-K3) (Glutamate receptor ionotropic, AMPA 3) (GluA3)",894,"101,157",5 out of 5,1995-11-01,Evidence at protein level
Q9ULK0,GRID1_HUMAN,"Glutamate receptor ionotropic, delta-1 (GluD1) (GluR delta-1 subunit)",1009,"112,131",4 out of 5,2003-11-14,Evidence at transcript level
O43424,GRID2_HUMAN,"Glutamate receptor ionotropic, delta-2 (GluD2) (GluR delta-2 subunit)",1007,"113,356",5 out of 5,2002-11-15,Evidence at protein level
Q92990,GLMN_HUMAN,Glomulin (FK506-binding protein-associated protein) (FAP) (FKBP-associated protein),594,"68,208",5 out of 5,2000-12-01,Evidence at protein level
P23416,GLRA2_HUMAN,Glycine receptor subunit alpha-2,452,"52,002",5 out of 5,1991-11-01,Evidence at protein level
P48167,GLRB_HUMAN,Glycine receptor subunit beta (Glycine receptor 58 kDa subunit),497,"56,122",5 out of 5,1996-02-01,Evidence at protein level
Q8NCW6,GLT11_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 11 (EC 2.4.1.41) (Polypeptide GalNAc transferase 11) (GalNAc-T11) (pp-GaNTase 11) (Protein-UDP acetylgalactosaminyltransferase 11) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 11),608,"68,919",5 out of 5,2004-08-16,Evidence at protein level
Q8N428,GLT16_HUMAN,Polypeptide N-acetylgalactosaminyltransferase 16 (EC 2.4.1.41) (Polypeptide GalNAc transferase 16) (GalNAc-T16) (Polypeptide GalNAc transferase-like protein 1) (GalNAc-T-like protein 1) (pp-GaNTase-like protein 1) (Polypeptide N-acetylgalactosaminyltransferase-like protein 1) (Protein-UDP acetylgalactosaminyltransferase-like protein 1) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1),558,"63,074",5 out of 5,2004-08-16,Evidence at protein level
A6NH11,GLTD2_HUMAN,Glycolipid transfer protein domain-containing protein 2,291,"31,642",2 out of 5,2008-02-05,Evidence at protein level
P02729,GLUR_HUMAN,Urine glycopeptide,8,855,2 out of 5,1986-07-21,Evidence at protein level
Q8WU03,GLYL2_HUMAN,Glycine N-acyltransferase-like protein 2 (EC 2.3.1.13) (Acyl-CoA:glycine N-acyltransferase-like protein 2),294,"34,277",4 out of 5,2007-04-03,Evidence at protein level
Q8NEA9,GMCLL_HUMAN,Putative germ cell-less protein-like 1-like,526,"60,201",5 out of 5,2004-05-24,Evidence at protein level
P60983,GMFB_HUMAN,Glia maturation factor beta (GMF-beta),142,"16,713",4 out of 5,2004-04-26,Evidence at protein level
P08754,GNAI3_HUMAN,Guanine nucleotide-binding protein G(k) subunit alpha (G(i) alpha-3),354,"40,532",5 out of 5,1988-11-01,Evidence at protein level
Q9BYB4,GNB1L_HUMAN,Guanine nucleotide-binding protein subunit beta-like protein 1 (G protein subunit beta-like protein 1) (DGCRK3) (WD repeat-containing protein 14) (WD40 repeat-containing protein deleted in VCFS) (WDVCF),327,"35,618",4 out of 5,2002-12-13,Evidence at protein level
A6NDN3,GOG6B_HUMAN,Golgin subfamily A member 6B,693,"79,913",2 out of 5,2008-04-29,Inferred from homology
Q9HD26,GOPC_HUMAN,Golgi-associated PDZ and coiled-coil motif-containing protein (CFTR-associated ligand) (Fused in glioblastoma) (PDZ protein interacting specifically with TC10) (PIST),462,"50,520",5 out of 5,2005-11-08,Evidence at protein level
Q9H8Y8,GORS2_HUMAN,Golgi reassembly-stacking protein 2 (GRS2) (Golgi phosphoprotein 6) (GOLPH6) (Golgi reassembly-stacking protein of 55 kDa) (GRASP55) (p59),452,"47,145",5 out of 5,2004-08-16,Evidence at protein level
Q6ZVE7,GOT1A_HUMAN,Vesicle transport protein GOT1A (Golgi transport 1 homolog A) (hGOT1b),132,"14,887",3 out of 5,2006-05-30,Evidence at transcript level
Q8IZ08,GP135_HUMAN,Probable G-protein coupled receptor 135,494,"51,736",3 out of 5,2005-04-26,Evidence at transcript level
Q6DWJ6,GP139_HUMAN,Probable G-protein coupled receptor 139 (G(q)-coupled orphan receptor GPRg1) (G-protein-coupled receptor PGR3),353,"40,679",4 out of 5,2006-01-10,Evidence at transcript level
Q8TDV2,GP148_HUMAN,Probable G-protein coupled receptor 148 (Brain and testis restricted GPCR) (G-protein coupled receptor PGR6),347,"38,288",3 out of 5,2005-06-07,Evidence at transcript level
Q8IXQ4,GPAM1_HUMAN,GPALPP motifs-containing protein 1 (Lipopolysaccharide-specific response protein 7),340,"38,142",3 out of 5,2007-07-10,Evidence at protein level
P0CG08,GPHRB_HUMAN,Golgi pH regulator B (Protein GPR89B),455,"52,917",3 out of 5,2010-06-15,Evidence at protein level
Q5JQS6,GSAML_HUMAN,Germinal center-associated signaling and motility-like protein,135,"15,712",2 out of 5,2007-07-10,Evidence at transcript level
Q96QA5,GSDMA_HUMAN,Gasdermin-A (Gasdermin-1),445,"49,365",5 out of 5,2005-07-19,Evidence at protein level
P57764,GSDMD_HUMAN,"Gasdermin-D (Gasdermin domain-containing protein 1) [Cleaved into: Gasdermin-D, N-terminal (GSDMD-NT); Gasdermin-D, C-terminal (GSDMD-CT)]",484,"52,801",5 out of 5,2001-02-21,Evidence at protein level
P48637,GSHB_HUMAN,Glutathione synthetase (GSH synthetase) (GSH-S) (EC 6.3.2.3) (Glutathione synthase),474,"52,385",5 out of 5,1996-02-01,Evidence at protein level
Q4AE62,GTDC1_HUMAN,Glycosyltransferase-like domain-containing protein 1 (Mannosyltransferase-like protein Xa) (Mat-Xa),458,"52,597",3 out of 5,2007-11-13,Evidence at transcript level
Q02846,GUC2D_HUMAN,"Retinal guanylyl cyclase 1 (RETGC-1) (EC 4.6.1.2) (Guanylate cyclase 2D, retinal) (Rod outer segment membrane guanylate cyclase) (ROS-GC)",1103,"120,059",5 out of 5,1993-07-01,Evidence at protein level
P16401,H15_HUMAN,Histone H1.5 (Histone H1a) (Histone H1b) (Histone H1s-3),226,"22,580",5 out of 5,1990-08-01,Evidence at protein level
Q53T59,H1BP3_HUMAN,HCLS1-binding protein 3 (HS1-binding protein 3) (HSP1BP-3),392,"42,780",3 out of 5,2008-01-15,Evidence at protein level
Q96KK5,H2A1H_HUMAN,Histone H2A type 1-H (Histone H2A/s),128,"13,906",5 out of 5,2006-04-04,Evidence at protein level
Q71UI9,H2AV_HUMAN,Histone H2A.V (H2A.F/Z),128,"13,509",5 out of 5,2006-05-30,Evidence at protein level
Q96A08,H2B1A_HUMAN,"Histone H2B type 1-A (Histone H2B, testis) (TSH2B.1) (Testis-specific histone H2B)",127,"14,167",5 out of 5,2004-08-16,Evidence at protein level
P49019,HCAR3_HUMAN,Hydroxycarboxylic acid receptor 3 (G-protein coupled receptor 109B) (G-protein coupled receptor HM74) (G-protein coupled receptor HM74B) (Niacin receptor 2) (Nicotinic acid receptor 2),387,"44,478",5 out of 5,1996-02-01,Evidence at protein level
Q99714,HCD2_HUMAN,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-hydroxysteroid dehydrogenase 10) (17-beta-HSD 10) (EC 1.1.1.51) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),261,"26,923",5 out of 5,1997-11-01,Evidence at protein level
Q969S8,HDA10_HUMAN,Histone deacetylase 10 (HD10) (EC 3.5.1.98),669,"71,445",5 out of 5,2003-01-10,Evidence at protein level
Q5T447,HECD3_HUMAN,E3 ubiquitin-protein ligase HECTD3 (EC 2.3.2.26) (HECT domain-containing protein 3) (HECT-type E3 ubiquitin transferase HECTD3),861,"97,113",5 out of 5,2006-06-27,Evidence at protein level
Q9BXL5,HEMGN_HUMAN,Hemogen (Erythroid differentiation-associated gene protein) (EDAG-1) (Hemopoietic gene protein) (Negative differentiation regulator protein),484,"55,341",4 out of 5,2006-07-11,Evidence at protein level
Q6WQI6,HEPN1_HUMAN,Putative cancer susceptibility gene HEPN1 protein,88,"10,305",2 out of 5,2008-02-05,Uncertain
Q9NQ87,HEYL_HUMAN,Hairy/enhancer-of-split related with YRPW motif-like protein (hHeyL) (Class B basic helix-loop-helix protein 33) (bHLHb33) (Hairy-related transcription factor 3) (HRT-3) (hHRT3),328,"35,087",5 out of 5,2007-05-01,Evidence at protein level
P08263,GSTA1_HUMAN,"Glutathione S-transferase A1 (EC 2.5.1.18) (GST HA subunit 1) (GST class-alpha member 1) (GST-epsilon) (GSTA1-1) (GTH1) [Cleaved into: Glutathione S-transferase A1, N-terminally processed]",222,"25,631",5 out of 5,1988-08-01,Evidence at protein level
P09210,GSTA2_HUMAN,Glutathione S-transferase A2 (EC 2.5.1.18) (GST HA subunit 2) (GST class-alpha member 2) (GST-gamma) (GSTA2-2) (GTH2),222,"25,664",5 out of 5,1989-07-01,Evidence at protein level
Q16772,GSTA3_HUMAN,Glutathione S-transferase A3 (EC 2.5.1.18) (GST class-alpha member 3) (Glutathione S-transferase A3-3),222,"25,302",5 out of 5,1999-07-15,Evidence at protein level
Q8IYK4,GT252_HUMAN,Procollagen galactosyltransferase 2 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 2) (Glycosyltransferase 25 family member 2) (Hydroxylysine galactosyltransferase 2),626,"72,924",4 out of 5,2007-11-13,Evidence at protein level
Q9UHL9,GT2D1_HUMAN,General transcription factor II-I repeat domain-containing protein 1 (GTF2I repeat domain-containing protein 1) (General transcription factor III) (MusTRD1/BEN) (Muscle TFII-I repeat domain-containing protein 1) (Slow-muscle-fiber enhancer-binding protein) (USE B1-binding protein) (Williams-Beuren syndrome chromosomal region 11 protein) (Williams-Beuren syndrome chromosomal region 12 protein),959,"106,057",5 out of 5,2002-05-27,Evidence at protein level
Q9H1H1,GTSFL_HUMAN,Gametocyte-specific factor 1-like (Protein FAM112A),148,"16,872",2 out of 5,2003-01-10,Evidence at transcript level
P49915,GUAA_HUMAN,GMP synthase [glutamine-hydrolyzing] (EC 6.3.5.2) (GMP synthetase) (Glutamine amidotransferase),693,"76,715",5 out of 5,1996-10-01,Evidence at protein level
Q8N442,GUF1_HUMAN,"Translation factor GUF1, mitochondrial (EC 3.6.5.-) (Elongation factor 4 homolog) (EF-4) (GTPase GUF1) (Ribosomal back-translocase)",669,"74,328",4 out of 5,2006-10-31,Evidence at protein level
P16403,H12_HUMAN,Histone H1.2 (Histone H1c) (Histone H1d) (Histone H1s-1),213,"21,365",5 out of 5,1990-08-01,Evidence at protein level
Q92522,H1X_HUMAN,Histone H1x,213,"22,487",5 out of 5,1999-07-15,Evidence at protein level
Q6DN03,H2B2C_HUMAN,Putative histone H2B type 2-C (Histone H2B.t) (H2B/t),193,"21,472",4 out of 5,2006-07-11,Uncertain
Q58FF6,H90B4_HUMAN,Putative heat shock protein HSP 90-beta 4,505,"58,264",2 out of 5,2008-09-02,Uncertain
Q5VWC8,HACD4_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 4) (HACD4) (Protein-tyrosine phosphatase-like A domain-containing protein 2),232,"27,520",5 out of 5,2008-01-15,Evidence at protein level
Q8TF76,HASP_HUMAN,Serine/threonine-protein kinase haspin (EC 2.7.11.1) (Germ cell-specific gene 2 protein) (H-haspin) (Haploid germ cell-specific nuclear protein kinase),798,"88,495",5 out of 5,2004-03-01,Evidence at protein level
O60741,HCN1_HUMAN,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 (Brain cyclic nucleotide-gated channel 1) (BCNG-1),890,"98,796",5 out of 5,2003-02-28,Evidence at protein level
Q96DB2,HDA11_HUMAN,Histone deacetylase 11 (HD11) (EC 3.5.1.98),347,"39,183",5 out of 5,2002-12-06,Evidence at protein level
Q92769,HDAC2_HUMAN,Histone deacetylase 2 (HD2) (EC 3.5.1.98),488,"55,364",5 out of 5,1998-07-15,Evidence at protein level
P56524,HDAC4_HUMAN,Histone deacetylase 4 (HD4) (EC 3.5.1.98),1084,"119,040",5 out of 5,1998-07-15,Evidence at protein level
Q9UKV0,HDAC9_HUMAN,Histone deacetylase 9 (HD9) (EC 3.5.1.98) (Histone deacetylase 7B) (HD7) (HD7b) (Histone deacetylase-related protein) (MEF2-interacting transcription repressor MITR),1011,"111,297",5 out of 5,2000-12-01,Evidence at protein level
P13716,HEM2_HUMAN,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),330,"36,295",5 out of 5,1990-01-01,Evidence at protein level
P22830,HEMH_HUMAN,"Ferrochelatase, mitochondrial (EC 4.99.1.1) (Heme synthase) (Protoheme ferro-lyase)",423,"47,862",5 out of 5,1991-08-01,Evidence at protein level
Q9BQS7,HEPH_HUMAN,Hephaestin (EC 1.-.-.-),1158,"130,449",5 out of 5,2004-09-27,Evidence at protein level
O95714,HERC2_HUMAN,E3 ubiquitin-protein ligase HERC2 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 2) (HECT-type E3 ubiquitin transferase HERC2),4834,"527,228",5 out of 5,2006-04-04,Evidence at protein level
P28161,GSTM2_HUMAN,Glutathione S-transferase Mu 2 (EC 2.5.1.18) (GST class-mu 2) (GSTM2-2),218,"25,745",5 out of 5,1993-04-01,Evidence at protein level
P46439,GSTM5_HUMAN,Glutathione S-transferase Mu 5 (EC 2.5.1.18) (GST class-mu 5) (GSTM5-5),218,"25,675",5 out of 5,1995-11-01,Evidence at protein level
P30711,GSTT1_HUMAN,Glutathione S-transferase theta-1 (EC 2.5.1.18) (GST class-theta-1) (Glutathione transferase T1-1),240,"27,335",5 out of 5,1993-04-01,Evidence at protein level
Q969Y2,GTPB3_HUMAN,"tRNA modification GTPase GTPBP3, mitochondrial (GTP-binding protein 3) (Mitochondrial GTP-binding protein 1)",492,"52,058",5 out of 5,2007-03-20,Evidence at protein level
P11168,GTR2_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 2 (Glucose transporter type 2, liver) (GLUT-2)",524,"57,490",5 out of 5,1989-07-01,Evidence at protein level
Q96NT3,GUCD1_HUMAN,Protein GUCD1 (Guanylyl cyclase domain-containing protein 1) (Protein LLN4),240,"27,207",3 out of 5,2005-07-19,Evidence at protein level
Q15486,GUSP1_HUMAN,Putative inactive beta-glucuronidase-like protein SMA3,140,"15,381",2 out of 5,2002-03-05,Uncertain
P13807,GYS1_HUMAN,"Glycogen [starch] synthase, muscle (EC 2.4.1.11)",737,"83,786",5 out of 5,1990-01-01,Evidence at protein level
P10412,H14_HUMAN,Histone H1.4 (Histone H1b) (Histone H1s-4),219,"21,865",5 out of 5,1989-07-01,Evidence at protein level
Q96QV6,H2A1A_HUMAN,Histone H2A type 1-A (Histone H2A/r),131,"14,234",5 out of 5,2006-04-04,Evidence at protein level
Q6DRA6,H2B2D_HUMAN,Putative histone H2B type 2-D,164,"18,018",5 out of 5,2006-07-11,Uncertain
Q16695,H31T_HUMAN,Histone H3.1t (H3/t) (H3t) (H3/g),136,"15,508",5 out of 5,2001-09-26,Evidence at protein level
P61296,HAND2_HUMAN,"Heart- and neural crest derivatives-expressed protein 2 (Class A basic helix-loop-helix protein 26) (bHLHa26) (Deciduum, heart, autonomic nervous system and neural crest derivatives-expressed protein 2) (dHAND)",217,"23,666",5 out of 5,2004-05-10,Evidence at protein level
Q9NYQ3,HAOX2_HUMAN,"Hydroxyacid oxidase 2 (HAOX2) (EC 1.1.3.15) ((S)-2-hydroxy-acid oxidase, peroxisomal) (Cell growth-inhibiting gene 16 protein) (Long chain alpha-hydroxy acid oxidase) (Long-chain L-2-hydroxy acid oxidase)",351,"38,839",5 out of 5,2001-02-21,Evidence at protein level
P54257,HAP1_HUMAN,Huntingtin-associated protein 1 (HAP-1) (Neuroan 1),671,"75,506",5 out of 5,1996-10-01,Evidence at protein level
Q86WZ0,HEAT4_HUMAN,HEAT repeat-containing protein 4,1026,"117,175",2 out of 5,2006-10-31,Evidence at transcript level
A8MVW5,HECA2_HUMAN,HEPACAM family member 2 (Mitotic kinetics regulator),462,"51,407",5 out of 5,2008-04-29,Evidence at protein level
Q76N89,HECW1_HUMAN,"E3 ubiquitin-protein ligase HECW1 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECW1) (NEDD4-like E3 ubiquitin-protein ligase 1) (hNEDL1)",1606,"179,554",5 out of 5,2007-02-20,Evidence at protein level
Q9BYK8,HELZ2_HUMAN,"Helicase with zinc finger domain 2 (ATP-dependent helicase PRIC285) (Helicase with zinc finger 2, transcriptional coactivator) (PPAR-alpha-interacting complex protein 285) (PPAR-gamma DNA-binding domain-interacting protein 1) (PDIP1) (PPAR-gamma DBD-interacting protein 1) (Peroxisomal proliferator-activated receptor A-interacting complex 285 kDa protein) (EC 3.6.4.-)",2649,"294,651",5 out of 5,2003-04-30,Evidence at protein level
P10746,HEM4_HUMAN,Uroporphyrinogen-III synthase (UROIIIS) (UROS) (EC 4.2.1.75) (Hydroxymethylbilane hydrolyase [cyclizing]) (Uroporphyrinogen-III cosynthase),265,"28,628",5 out of 5,1989-07-01,Evidence at protein level
O60565,GREM1_HUMAN,"Gremlin-1 (Cell proliferation-inducing gene 2 protein) (Cysteine knot superfamily 1, BMP antagonist 1) (DAN domain family member 2) (Down-regulated in Mos-transformed cells protein) (Increased in high glucose protein 2) (IHG-2)",184,"20,697",5 out of 5,2005-04-12,Evidence at protein level
A4D1B5,GSAP_HUMAN,Gamma-secretase-activating protein (GSAP) (Protein pigeon homolog) [Cleaved into: Gamma-secretase-activating protein 16 kDa C-terminal form (GSAP-16K)],854,"97,802",5 out of 5,2008-05-20,Evidence at protein level
Q6AI39,GSC1L_HUMAN,GLTSCR1-like protein (Glioma tumor suppressor candidate region gene 1 protein-like),1079,"115,084",2 out of 5,2006-09-05,Evidence at protein level
Q6UXU4,GSG1L_HUMAN,Germ cell-specific gene 1-like protein (GSG1-like protein),331,"36,774",3 out of 5,2008-04-29,Evidence at protein level
P0CG29,GST2_HUMAN,Glutathione S-transferase theta-2 (EC 2.5.1.18) (GST class-theta-2),244,"27,506",4 out of 5,2010-07-13,Evidence at protein level
Q7RTV2,GSTA5_HUMAN,Glutathione S-transferase A5 (EC 2.5.1.18) (GST class-alpha member 5) (Glutathione S-transferase A5-5),222,"25,722",4 out of 5,2004-07-19,Evidence at protein level
P09211,GSTP1_HUMAN,Glutathione S-transferase P (EC 2.5.1.18) (GST class-pi) (GSTP1-1),210,"23,356",5 out of 5,1989-07-01,Evidence at protein level
Q86UP8,GTD2A_HUMAN,General transcription factor II-I repeat domain-containing protein 2A (GTF2I repeat domain-containing protein 2A) (Transcription factor GTF2IRD2-alpha),949,"107,231",4 out of 5,2008-02-26,Evidence at protein level
A4D1E9,GTPBA_HUMAN,GTP-binding protein 10 (Protein obg homolog 2) (ObgH2),387,"42,933",5 out of 5,2007-12-04,Evidence at protein level
P14672,GTR4_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 4 (Glucose transporter type 4, insulin-responsive) (GLUT-4)",509,"54,787",5 out of 5,1990-04-01,Evidence at protein level
Q9UGQ3,GTR6_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 6 (Glucose transporter type 6) (GLUT-6) (Glucose transporter type 9) (GLUT-9)",507,"54,539",5 out of 5,2001-11-16,Evidence at protein level
Q9UMX6,GUC1B_HUMAN,Guanylyl cyclase-activating protein 2 (GCAP 2) (Guanylate cyclase activator 1B),200,"23,420",5 out of 5,2000-12-01,Evidence at protein level
Q9UBP9,GULP1_HUMAN,PTB domain-containing engulfment adapter protein 1 (Cell death protein 6 homolog) (PTB domain adapter protein CED-6) (Protein GULP),304,"34,490",5 out of 5,2007-07-24,Evidence at protein level
Q4G0G2,H1AS1_HUMAN,Putative uncharacterized protein H1FX-AS1 (H1FX antisense RNA 1),97,"11,005",1 out of 5,2006-12-12,Uncertain
P57053,H2BFS_HUMAN,Histone H2B type F-S (Histone H2B.s) (H2B/s),126,"13,944",5 out of 5,2000-12-01,Evidence at protein level
Q5JVS0,HABP4_HUMAN,Intracellular hyaluronan-binding protein 4 (IHABP-4) (IHABP4) (Ki-1/57 intracellular antigen),413,"45,785",5 out of 5,2006-10-31,Evidence at protein level
Q6Y1H2,HACD2_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 2 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 2) (HACD2) (Protein-tyrosine phosphatase-like member B),254,"28,368",5 out of 5,2008-09-02,Evidence at protein level
Q9P035,HACD3_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 3 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 3) (HACD3) (Butyrate-induced protein 1) (B-ind1) (hB-ind1) (Protein-tyrosine phosphatase-like A domain-containing protein 1),362,"43,160",5 out of 5,2008-01-15,Evidence at protein level
Q8IYU2,HACE1_HUMAN,E3 ubiquitin-protein ligase HACE1 (EC 2.3.2.26) (HECT domain and ankyrin repeat-containing E3 ubiquitin-protein ligase 1) (HECT-type E3 ubiquitin transferase HACE1),909,"102,342",5 out of 5,2007-03-20,Evidence at protein level
Q96MB7,HARB1_HUMAN,Putative nuclease HARBI1 (EC 3.1.-.-) (Harbinger transposase-derived nuclease),349,"39,146",4 out of 5,2006-12-12,Evidence at protein level
Q96CS2,HAUS1_HUMAN,HAUS augmin-like complex subunit 1 (Coiled-coil domain-containing protein 5) (Enhancer of invasion-cluster) (HEI-C),278,"31,863",5 out of 5,2004-07-19,Evidence at protein level
Q9H6D7,HAUS4_HUMAN,HAUS augmin-like complex subunit 4,363,"42,400",5 out of 5,2003-07-25,Evidence at protein level
P68871,HBB_HUMAN,Hemoglobin subunit beta (Beta-globin) (Hemoglobin beta chain) [Cleaved into: LVV-hemorphin-7; Spinorphin],147,"15,998",5 out of 5,1986-07-21,Evidence at protein level
Q99075,HBEGF_HUMAN,Proheparin-binding EGF-like growth factor [Cleaved into: Heparin-binding EGF-like growth factor (HB-EGF) (HBEGF) (Diphtheria toxin receptor) (DT-R)],208,"23,067",5 out of 5,1994-06-01,Evidence at protein level
P36915,GNL1_HUMAN,Guanine nucleotide-binding protein-like 1 (GTP-binding protein HSR1),607,"68,661",4 out of 5,1994-06-01,Evidence at protein level
P22749,GNLY_HUMAN,Granulysin (Lymphokine LAG-2) (Protein NKG5) (T-cell activation protein 519),145,"16,374",5 out of 5,1991-08-01,Evidence at protein level
Q8TDQ7,GNPI2_HUMAN,Glucosamine-6-phosphate isomerase 2 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 2) (GNPDA 2) (GlcN6P deaminase 2) (Glucosamine-6-phosphate isomerase SB52),276,"31,085",5 out of 5,2008-07-01,Evidence at protein level
Q9H2G9,GO45_HUMAN,Golgin-45 (Basic leucine zipper nuclear factor 1) (JEM-1) (p45 basic leucine-zipper nuclear factor),400,"44,910",5 out of 5,2004-08-16,Evidence at protein level
Q08AF8,GOG8F_HUMAN,Putative golgin subfamily A member 8F/8G,430,"48,405",5 out of 5,2008-01-15,Uncertain
Q92805,GOGA1_HUMAN,Golgin subfamily A member 1 (Golgin-97),767,"88,184",5 out of 5,2003-07-03,Evidence at protein level
O00461,GOLI4_HUMAN,"Golgi integral membrane protein 4 (Golgi integral membrane protein, cis) (GIMPc) (Golgi phosphoprotein 4) (Golgi-localized phosphoprotein of 130 kDa) (Golgi phosphoprotein of 130 kDa)",696,"81,880",5 out of 5,2007-05-01,Evidence at protein level
Q9HCL2,GPAT1_HUMAN,"Glycerol-3-phosphate acyltransferase 1, mitochondrial (GPAT-1) (EC 2.3.1.15)",828,"93,795",5 out of 5,2001-06-01,Evidence at protein level
Q8TDU6,GPBAR_HUMAN,G-protein coupled bile acid receptor 1 (G-protein coupled receptor GPCR19) (hGPCR19) (Membrane-type receptor for bile acids) (M-BAR) (hBG37) (BG37),330,"35,248",4 out of 5,2005-12-06,Evidence at transcript level
Q8N158,GPC2_HUMAN,Glypican-2 [Cleaved into: Secreted glypican-2],579,"62,830",4 out of 5,2005-03-01,Evidence at transcript level
P51654,GPC3_HUMAN,Glypican-3 (GTR2-2) (Intestinal protein OCI-5) (MXR7) [Cleaved into: Secreted glypican-3],580,"65,563",5 out of 5,1996-10-01,Evidence at protein level
P78333,GPC5_HUMAN,Glypican-5 [Cleaved into: Secreted glypican-5],572,"63,707",4 out of 5,1997-11-01,Evidence at transcript level
Q8N335,GPD1L_HUMAN,Glycerol-3-phosphate dehydrogenase 1-like protein (GPD1-L) (EC 1.1.1.8),351,"38,419",5 out of 5,2007-05-15,Evidence at protein level
B7ZAQ6,GPHRA_HUMAN,Golgi pH regulator A (Protein GPR89A) (Putative MAPK-activating protein PM01) (Putative NF-kappa-B-activating protein 90),455,"52,917",5 out of 5,2010-06-15,Evidence at protein level
P14770,GPIX_HUMAN,Platelet glycoprotein IX (GP-IX) (GPIX) (Glycoprotein 9) (CD antigen CD42a),177,"19,046",5 out of 5,1990-04-01,Evidence at protein level
Q92917,GPKOW_HUMAN,G patch domain and KOW motifs-containing protein (G patch domain-containing protein 5) (Protein MOS2 homolog) (Protein T54),476,"52,229",5 out of 5,1997-11-01,Evidence at protein level
Q13491,GPM6B_HUMAN,Neuronal membrane glycoprotein M6-b (M6b),265,"28,989",5 out of 5,1997-11-01,Evidence at protein level
Q9UHW5,GPN3_HUMAN,GPN-loop GTPase 3 (ATP-binding domain 1 family member C),284,"32,761",5 out of 5,2007-09-11,Evidence at protein level
Q99678,GPR20_HUMAN,G-protein coupled receptor 20,358,"38,650",4 out of 5,1997-11-01,Evidence at protein level
O43194,GPR39_HUMAN,G-protein coupled receptor 39,453,"51,329",5 out of 5,1998-12-15,Evidence at protein level
Q9BZJ6,GPR63_HUMAN,Probable G-protein coupled receptor 63 (PSP24-2) (PSP24-beta),419,"47,578",4 out of 5,2002-05-27,Evidence at transcript level
O95800,GPR75_HUMAN,Probable G-protein coupled receptor 75,540,"59,359",4 out of 5,2005-06-07,Evidence at protein level
Q9NYM4,GPR83_HUMAN,Probable G-protein coupled receptor 83 (G-protein coupled receptor 72),423,"48,339",4 out of 5,2001-04-27,Evidence at transcript level
P60893,GPR85_HUMAN,Probable G-protein coupled receptor 85 (Super conserved receptor expressed in brain 2),370,"41,995",5 out of 5,2004-04-13,Evidence at protein level
Q9GZN0,GPR88_HUMAN,Probable G-protein coupled receptor 88 (Striatum-specific G-protein coupled receptor),384,"40,246",5 out of 5,2005-03-29,Evidence at transcript level
Q8WXG9,GPR98_HUMAN,G-protein coupled receptor 98 (Monogenic audiogenic seizure susceptibility protein 1 homolog) (Usher syndrome type-2C protein) (Very large G-protein coupled receptor 1),6306,"693,069",5 out of 5,2006-04-18,Evidence at protein level
O75715,GPX5_HUMAN,Epididymal secretory glutathione peroxidase (EC 1.11.1.9) (Epididymis-specific glutathione peroxidase-like protein) (EGLP) (Glutathione peroxidase 5) (GPx-5) (GSHPx-5),221,"25,202",4 out of 5,1999-07-15,Evidence at protein level
Q9UBQ7,GRHPR_HUMAN,Glyoxylate reductase/hydroxypyruvate reductase (EC 1.1.1.79) (EC 1.1.1.81),328,"35,668",5 out of 5,2004-05-10,Evidence at protein level
Q8IV61,GRP3_HUMAN,Ras guanyl-releasing protein 3 (Calcium and DAG-regulated guanine nucleotide exchange factor III) (Guanine nucleotide exchange factor for Rap1),690,"78,332",5 out of 5,2003-08-29,Evidence at protein level
Q8TAA5,GRPE2_HUMAN,"GrpE protein homolog 2, mitochondrial (Mt-GrpE#2)",225,"25,431",3 out of 5,2002-08-13,Evidence at protein level
P56915,GSC_HUMAN,Homeobox protein goosecoid,257,"28,150",5 out of 5,2000-05-30,Evidence at protein level
Q9BYG8,GSDMC_HUMAN,Gasdermin-C (Melanoma-derived leucine zipper-containing extranuclear factor),508,"57,692",5 out of 5,2005-07-19,Evidence at protein level
Q92896,GSLG1_HUMAN,Golgi apparatus protein 1 (CFR-1) (Cysteine-rich fibroblast growth factor receptor) (E-selectin ligand 1) (ESL-1) (Golgi sialoglycoprotein MG-160),1179,"134,552",5 out of 5,2001-09-26,Evidence at protein level
Q8NBJ5,GT251_HUMAN,Procollagen galactosyltransferase 1 (EC 2.4.1.50) (Collagen beta(1-O)galactosyltransferase 1) (Glycosyltransferase 25 family member 1) (Hydroxylysine galactosyltransferase 1),622,"71,636",5 out of 5,2007-12-04,Evidence at protein level
O00178,GTPB1_HUMAN,GTP-binding protein 1 (G-protein 1) (GP-1) (GP1),669,"72,454",4 out of 5,2000-05-30,Evidence at protein level
Q8TD20,GTR12_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)",617,"66,966",4 out of 5,2007-06-26,Evidence at transcript level
O95843,GUC1C_HUMAN,Guanylyl cyclase-activating protein 3 (GCAP 3) (Guanylate cyclase activator 1C),209,"23,822",5 out of 5,2000-05-30,Evidence at protein level
Q9H116,GZF1_HUMAN,GDNF-inducible zinc finger protein 1 (Zinc finger and BTB domain-containing protein 23) (Zinc finger protein 336),711,"80,492",5 out of 5,2002-09-19,Evidence at protein level
Q16777,H2A2C_HUMAN,Histone H2A type 2-C (Histone H2A-GL101) (Histone H2A/q),129,"13,988",5 out of 5,2001-01-24,Evidence at protein level
P16104,H2AX_HUMAN,Histone H2AX (H2a/x) (Histone H2A.X),143,"15,145",5 out of 5,1990-04-01,Evidence at protein level
Q99879,H2B1M_HUMAN,Histone H2B type 1-M (Histone H2B.e) (H2B/e),126,"13,989",5 out of 5,2000-05-30,Evidence at protein level
Q5QNW6,H2B2F_HUMAN,Histone H2B type 2-F,126,"13,920",5 out of 5,2006-07-11,Evidence at protein level
Q9BVP2,GNL3_HUMAN,Guanine nucleotide-binding protein-like 3 (E2-induced gene 3 protein) (Novel nucleolar protein 47) (NNP47) (Nucleolar GTP-binding protein 3) (Nucleostemin),549,"61,993",5 out of 5,2005-04-12,Evidence at protein level
P46926,GNPI1_HUMAN,Glucosamine-6-phosphate isomerase 1 (EC 3.5.99.6) (Glucosamine-6-phosphate deaminase 1) (GNPDA 1) (GlcN6P deaminase 1) (Oscillin),289,"32,669",5 out of 5,1995-11-01,Evidence at protein level
Q3T906,GNPTA_HUMAN,N-acetylglucosamine-1-phosphotransferase subunits alpha/beta (EC 2.7.8.17) (GlcNAc-1-phosphotransferase subunits alpha/beta) (Stealth protein GNPTAB) (UDP-N-acetylglucosamine-1-phosphotransferase subunits alpha/beta) [Cleaved into: N-acetylglucosamine-1-phosphotransferase subunit alpha; N-acetylglucosamine-1-phosphotransferase subunit beta],1256,"143,622",5 out of 5,2006-03-07,Evidence at protein level
Q5T6J7,GNTK_HUMAN,Probable gluconokinase (EC 2.7.1.12) (Gluconate kinase),187,"20,578",3 out of 5,2008-04-08,Evidence at protein level
A6NC78,GOG8I_HUMAN,Putative golgin subfamily A member 8I (Golgin subfamily A member 8I pseudogene),632,"71,330",2 out of 5,2008-04-08,Uncertain
Q14789,GOGB1_HUMAN,Golgin subfamily B member 1 (372 kDa Golgi complex-associated protein) (GCP372) (Giantin) (Macrogolgin),3259,"376,019",5 out of 5,2003-02-01,Evidence at protein level
P01148,GON1_HUMAN,Progonadoliberin-1 (Progonadoliberin I) [Cleaved into: Gonadoliberin-1 (Gonadoliberin I) (Gonadorelin) (Gonadotropin-releasing hormone I) (GnRH-I) (Luliberin I) (Luteinizing hormone-releasing hormone I) (LH-RH I); GnRH-associated peptide 1 (GnRH-associated peptide I)],92,"10,380",5 out of 5,1986-07-21,Evidence at protein level
Q9BQQ3,GORS1_HUMAN,Golgi reassembly-stacking protein 1 (Golgi peripheral membrane protein p65) (Golgi phosphoprotein 5) (GOLPH5) (Golgi reassembly-stacking protein of 65 kDa) (GRASP65),440,"46,482",5 out of 5,2004-08-16,Evidence at protein level
O43292,GPAA1_HUMAN,Glycosylphosphatidylinositol anchor attachment 1 protein (GPI anchor attachment protein 1) (GAA1 protein homolog) (hGAA1),621,"67,623",5 out of 5,2004-03-01,Evidence at protein level
Q9HC44,GPBL1_HUMAN,Vasculin-like protein 1 (GC-rich promoter-binding protein 1-like 1),474,"52,302",3 out of 5,2008-03-18,Evidence at protein level
P21695,GPDA_HUMAN,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD-C) (GPDH-C) (EC 1.1.1.8)",349,"37,568",5 out of 5,1991-05-01,Evidence at protein level
Q14956,GPNMB_HUMAN,Transmembrane glycoprotein NMB (Transmembrane glycoprotein HGFIN),572,"63,923",5 out of 5,1997-11-01,Evidence at protein level
Q13304,GPR17_HUMAN,Uracil nucleotide/cysteinyl leukotriene receptor (UDP/CysLT receptor) (G-protein coupled receptor 17) (P2Y-like receptor) (R12),367,"40,989",5 out of 5,1997-11-01,Evidence at transcript level
P46091,GPR1_HUMAN,G-protein coupled receptor 1,355,"41,431",4 out of 5,1995-11-01,Evidence at protein level
Q9UPC5,GPR34_HUMAN,Probable G-protein coupled receptor 34,381,"43,860",3 out of 5,2001-01-24,Evidence at transcript level
P46089,GPR3_HUMAN,G-protein coupled receptor 3 (ACCA orphan receptor),330,"35,010",4 out of 5,1995-11-01,Evidence at protein level
Q96HH9,GRAM3_HUMAN,GRAM domain-containing protein 3 (HCV NS3-transactivated protein 2),432,"47,869",4 out of 5,2005-12-06,Evidence at protein level
P51124,GRAM_HUMAN,Granzyme M (EC 3.4.21.-) (Met-1 serine protease) (Hu-Met-1) (Met-ase) (Natural killer cell granular protease),257,"27,545",5 out of 5,1996-10-01,Evidence at protein level
P28676,GRAN_HUMAN,Grancalcin,217,"24,010",5 out of 5,1992-12-01,Evidence at protein level
Q8TC17,GRAPL_HUMAN,GRB2-related adapter protein-like,118,"13,442",2 out of 5,2008-07-22,Inferred from homology
Q9C091,GRB1L_HUMAN,GREB1-like protein,1923,"214,354",3 out of 5,2008-02-26,Evidence at transcript level
A4D2P6,GRD2I_HUMAN,"Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)",1211,"132,276",3 out of 5,2008-04-29,Inferred from homology
P42261,GRIA1_HUMAN,"Glutamate receptor 1 (GluR-1) (AMPA-selective glutamate receptor 1) (GluR-A) (GluR-K1) (Glutamate receptor ionotropic, AMPA 1) (GluA1)",906,"101,506",5 out of 5,1995-11-01,Evidence at protein level
P42262,GRIA2_HUMAN,"Glutamate receptor 2 (GluR-2) (AMPA-selective glutamate receptor 2) (GluR-B) (GluR-K2) (Glutamate receptor ionotropic, AMPA 2) (GluA2)",883,"98,821",5 out of 5,1995-11-01,Evidence at protein level
Q13002,GRIK2_HUMAN,"Glutamate receptor ionotropic, kainate 2 (GluK2) (Excitatory amino acid receptor 4) (EAA4) (Glutamate receptor 6) (GluR-6) (GluR6)",908,"102,583",5 out of 5,1997-11-01,Evidence at protein level
Q16099,GRIK4_HUMAN,"Glutamate receptor ionotropic, kainate 4 (GluK4) (Excitatory amino acid receptor 1) (EAA1) (Glutamate receptor KA-1) (KA1)",956,"107,246",5 out of 5,1998-07-15,Evidence at transcript level
Q6ZVF9,GRIN3_HUMAN,G protein-regulated inducer of neurite outgrowth 3 (GRIN3),776,"82,439",2 out of 5,2006-10-03,Evidence at transcript level
Q9C0E4,GRIP2_HUMAN,Glutamate receptor-interacting protein 2 (GRIP-2),1043,"112,501",3 out of 5,2004-03-29,Evidence at protein level
Q96CP6,GRM1A_HUMAN,GRAM domain-containing protein 1A,724,"80,680",2 out of 5,2007-05-15,Evidence at protein level
Q14831,GRM7_HUMAN,Metabotropic glutamate receptor 7 (mGluR7),915,"102,251",5 out of 5,1997-11-01,Evidence at protein level
O00222,GRM8_HUMAN,Metabotropic glutamate receptor 8 (mGluR8),908,"101,741",5 out of 5,1997-11-01,Evidence at transcript level
P28799,GRN_HUMAN,Granulins (Proepithelin) (PEPI) [Cleaved into: Acrogranin (Glycoprotein of 88 Kda) (GP88) (Glycoprotein 88) (Progranulin); Paragranulin; Granulin-1 (Granulin G); Granulin-2 (Granulin F); Granulin-3 (Granulin B); Granulin-4 (Granulin A); Granulin-5 (Granulin C); Granulin-6 (Granulin D); Granulin-7 (Granulin E)],593,"63,544",5 out of 5,1992-12-01,Evidence at protein level
Q03013,GSTM4_HUMAN,Glutathione S-transferase Mu 4 (EC 2.5.1.18) (GST class-mu 4) (GST-Mu2) (GSTM4-4),218,"25,561",5 out of 5,1995-11-01,Evidence at protein level
Q9BZM3,GSX2_HUMAN,GS homeobox 2 (Genetic-screened homeobox 2) (Homeobox protein GSH-2),304,"32,031",4 out of 5,2002-01-23,Evidence at transcript level
Q02747,GUC2A_HUMAN,Guanylin (Guanylate cyclase activator 2A) (Guanylate cyclase-activating protein 1) (Guanylate cyclase-activating protein I) (GCAP-I) [Cleaved into: HMW-guanylin; Guanylin],115,"12,388",5 out of 5,1993-07-01,Evidence at protein level
P25092,GUC2C_HUMAN,Heat-stable enterotoxin receptor (STA receptor) (hSTAR) (EC 4.6.1.2) (Guanylyl cyclase C) (GC-C) (Intestinal guanylate cyclase),1073,"123,403",5 out of 5,1992-05-01,Evidence at protein level
Q7Z2Y8,GVIN1_HUMAN,Interferon-induced very large GTPase 1 (Interferon-induced very large GTPase pseudogene 1),2422,"279,048",2 out of 5,2008-03-18,Evidence at transcript level
Q8N7I0,GVQW1_HUMAN,Protein GVQW1 (GVQW motif-containing protein 1) (Tigger transposable element-derived 1-like protein 2),195,"21,479",2 out of 5,2013-06-26,Evidence at transcript level
A0PJZ3,GXLT2_HUMAN,Glucoside xylosyltransferase 2 (EC 2.4.2.n2) (Glycosyltransferase 8 domain-containing protein 4),443,"51,056",4 out of 5,2007-05-29,Evidence at transcript level
P54840,GYS2_HUMAN,"Glycogen [starch] synthase, liver (EC 2.4.1.11)",703,"80,989",5 out of 5,1996-10-01,Evidence at protein level
Q75WM6,H1FNT_HUMAN,Testis-specific H1 histone (Haploid germ cell-specific nuclear protein 1) (Histone H1t2),255,"28,116",4 out of 5,2008-07-01,Evidence at transcript level
Q9H772,GREM2_HUMAN,"Gremlin-2 (Cysteine knot superfamily 1, BMP antagonist 2) (DAN domain family member 3) (Protein related to DAN and cerberus)",168,"19,320",4 out of 5,2005-04-12,Evidence at transcript level
Q14833,GRM4_HUMAN,Metabotropic glutamate receptor 4 (mGluR4),912,"101,868",5 out of 5,1997-11-01,Evidence at transcript level
P41594,GRM5_HUMAN,Metabotropic glutamate receptor 5 (mGluR5),1212,"132,469",5 out of 5,1995-11-01,Evidence at protein level
Q7LDG7,GRP2_HUMAN,RAS guanyl-releasing protein 2 (Calcium and DAG-regulated guanine nucleotide exchange factor I) (CalDAG-GEFI) (Cdc25-like protein) (hCDC25L) (F25B3.3 kinase-like protein),609,"69,248",5 out of 5,2008-01-15,Evidence at protein level
P38646,GRP75_HUMAN,"Stress-70 protein, mitochondrial (75 kDa glucose-regulated protein) (GRP-75) (Heat shock 70 kDa protein 9) (Mortalin) (MOT) (Peptide-binding protein 74) (PBP74)",679,"73,680",5 out of 5,1995-02-01,Evidence at protein level
Q9NRJ2,GSAS1_HUMAN,Putative uncharacterized protein GSN-AS1 (GSN antisense RNA 1) (GSN antisense gene protein 1) (Protein MOST-2),163,"17,657",2 out of 5,2007-01-09,Uncertain
Q9NZM4,GSCR1_HUMAN,Glioma tumor suppressor candidate region gene 1 protein,1560,"158,490",3 out of 5,2001-09-26,Evidence at protein level
Q9NZM5,GSCR2_HUMAN,Glioma tumor suppressor candidate region gene 2 protein (p60),478,"54,389",4 out of 5,2001-09-26,Evidence at protein level
P48506,GSH1_HUMAN,Glutamate--cysteine ligase catalytic subunit (EC 6.3.2.2) (GCS heavy chain) (Gamma-ECS) (Gamma-glutamylcysteine synthetase),637,"72,766",5 out of 5,1996-02-01,Evidence at protein level
P21266,GSTM3_HUMAN,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),225,"26,560",5 out of 5,1991-05-01,Evidence at protein level
Q9H4Y5,GSTO2_HUMAN,Glutathione S-transferase omega-2 (GSTO-2) (EC 2.5.1.18) (Glutathione S-transferase omega 2-2) (GSTO 2-2) (Glutathione-dependent dehydroascorbate reductase) (EC 1.8.5.1) (Monomethylarsonic acid reductase) (MMA(V) reductase) (EC 1.20.4.2),243,"28,254",5 out of 5,2003-09-19,Evidence at protein level
P0CG30,GSTT2_HUMAN,Glutathione S-transferase theta-2B (EC 2.5.1.18) (GST class-theta-2) (Glutathione S-transferase theta-2),244,"27,507",5 out of 5,2010-07-13,Evidence at protein level
P78347,GTF2I_HUMAN,General transcription factor II-I (GTFII-I) (TFII-I) (Bruton tyrosine kinase-associated protein 135) (BAP-135) (BTK-associated protein 135) (SRF-Phox1-interacting protein) (SPIN) (Williams-Beuren syndrome chromosomal region 6 protein),998,"112,416",5 out of 5,2001-12-13,Evidence at protein level
Q8N3Z3,GTPB8_HUMAN,GTP-binding protein 8,284,"32,147",3 out of 5,2008-06-10,Evidence at transcript level
P11169,GTR3_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 3 (Glucose transporter type 3, brain) (GLUT-3)",496,"53,924",5 out of 5,1989-07-01,Evidence at protein level
P22732,GTR5_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 5 (Fructose transporter) (Glucose transporter type 5, small intestine) (GLUT-5)",501,"54,974",5 out of 5,1991-08-01,Evidence at protein level
Q9NRM0,GTR9_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 9 (Glucose transporter type 9) (GLUT-9)",540,"58,702",5 out of 5,2001-11-16,Evidence at protein level
Q9NYZ3,GTSE1_HUMAN,G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog),720,"76,645",5 out of 5,2002-07-26,Evidence at protein level
Q9Y2T3,GUAD_HUMAN,Guanine deaminase (Guanase) (Guanine aminase) (EC 3.5.4.3) (Guanine aminohydrolase) (GAH) (p51-nedasin),454,"51,003",5 out of 5,2000-12-01,Evidence at protein level
Q4G148,GXLT1_HUMAN,Glucoside xylosyltransferase 1 (EC 2.4.2.n2) (Glycosyltransferase 8 domain-containing protein 3),440,"50,567",4 out of 5,2007-05-29,Evidence at protein level
P22492,H1T_HUMAN,Histone H1t (Testicular H1 histone),207,"22,019",5 out of 5,1991-08-01,Evidence at transcript level
P04908,H2A1B_HUMAN,Histone H2A type 1-B/E (Histone H2A.2) (Histone H2A/a) (Histone H2A/m),130,"14,135",5 out of 5,1987-08-13,Evidence at protein level
Q9BTM1,H2AJ_HUMAN,Histone H2A.J (H2a/j),129,"14,019",4 out of 5,2008-07-22,Evidence at protein level
P33778,H2B1B_HUMAN,Histone H2B type 1-B (Histone H2B.1) (Histone H2B.f) (H2B/f),126,"13,950",5 out of 5,1994-02-01,Evidence at protein level
Q58FF8,H90B2_HUMAN,Putative heat shock protein HSP 90-beta 2 (Heat shock protein 90-beta b) (Heat shock protein 90Bb),381,"44,349",3 out of 5,2008-06-10,Evidence at protein level
Q75N03,HAKAI_HUMAN,E3 ubiquitin-protein ligase Hakai (EC 2.3.2.27) (Casitas B-lineage lymphoma-transforming sequence-like protein 1) (RING finger protein 188) (RING-type E3 ubiquitin transferase Hakai) (c-Cbl-like protein 1),491,"54,519",5 out of 5,2007-04-17,Evidence at protein level
Q96D42,HAVR1_HUMAN,Hepatitis A virus cellular receptor 1 (HAVcr-1) (Kidney injury molecule 1) (KIM-1) (T-cell immunoglobulin and mucin domain-containing protein 1) (TIMD-1) (T-cell immunoglobulin mucin receptor 1) (TIM) (TIM-1) (T-cell membrane protein 1),359,"38,720",5 out of 5,2005-08-30,Evidence at protein level
Q8TDQ0,HAVR2_HUMAN,Hepatitis A virus cellular receptor 2 (HAVcr-2) (T-cell immunoglobulin and mucin domain-containing protein 3) (TIMD-3) (T-cell immunoglobulin mucin receptor 3) (TIM-3) (T-cell membrane protein 3),301,"33,394",5 out of 5,2005-09-27,Evidence at protein level
P09341,GROA_HUMAN,Growth-regulated alpha protein (C-X-C motif chemokine 1) (GRO-alpha(1-73)) (Melanoma growth stimulatory activity) (MGSA) (Neutrophil-activating protein 3) (NAP-3) [Cleaved into: GRO-alpha(4-73); GRO-alpha(5-73); GRO-alpha(6-73)],107,"11,301",5 out of 5,1989-07-01,Evidence at protein level
O95267,GRP1_HUMAN,RAS guanyl-releasing protein 1 (Calcium and DAG-regulated guanine nucleotide exchange factor II) (CalDAG-GEFII) (Ras guanyl-releasing protein),797,"90,402",5 out of 5,2008-02-05,Evidence at protein level
P11021,GRP78_HUMAN,78 kDa glucose-regulated protein (GRP-78) (Endoplasmic reticulum lumenal Ca(2+)-binding protein grp78) (Heat shock 70 kDa protein 5) (Immunoglobulin heavy chain-binding protein) (BiP),654,"72,333",5 out of 5,1989-07-01,Evidence at protein level
P07492,GRP_HUMAN,Gastrin-releasing peptide (GRP) [Cleaved into: Neuromedin-C (GRP-10)],148,"16,213",4 out of 5,1988-04-01,Evidence at protein level
Q12849,GRSF1_HUMAN,G-rich sequence factor 1 (GRSF-1),480,"53,126",5 out of 5,1997-11-01,Evidence at protein level
Q9P0R6,GSKIP_HUMAN,GSK3-beta interaction protein (GSKIP),139,"15,648",3 out of 5,2003-09-09,Evidence at protein level
Q02539,H11_HUMAN,Histone H1.1 (Histone H1a),215,"21,842",5 out of 5,2001-09-26,Evidence at protein level
Q8IZA3,H1FOO_HUMAN,Histone H1oo (Oocyte-specific histone H1) (Oocyte-specific linker histone H1) (osH1),346,"35,813",4 out of 5,2008-07-01,Evidence at transcript level
P0C5Y9,H2AB1_HUMAN,Histone H2A-Bbd type 1 (H2A Barr body-deficient) (H2A.Bbd),115,"12,697",5 out of 5,2007-12-04,Evidence at transcript level
O60814,H2B1K_HUMAN,Histone H2B type 1-K (H2B K) (HIRA-interacting protein 1),126,"13,890",5 out of 5,2004-08-31,Evidence at protein level
Q71DI3,H32_HUMAN,Histone H3.2 (Histone H3/m) (Histone H3/o),136,"15,388",5 out of 5,2006-09-19,Evidence at protein level
Q99525,H4G_HUMAN,Histone H4-like protein type G,98,"11,009",3 out of 5,2008-03-18,Evidence at protein level
Q14520,HABP2_HUMAN,Hyaluronan-binding protein 2 (EC 3.4.21.-) (Factor VII-activating protease) (Factor seven-activating protease) (FSAP) (Hepatocyte growth factor activator-like protein) (Plasma hyaluronan-binding protein) [Cleaved into: Hyaluronan-binding protein 2 50 kDa heavy chain; Hyaluronan-binding protein 2 50 kDa heavy chain alternate form; Hyaluronan-binding protein 2 27 kDa light chain; Hyaluronan-binding protein 2 27 kDa light chain alternate form],560,"62,672",5 out of 5,2005-08-30,Evidence at protein level
O94927,HAUS5_HUMAN,HAUS augmin-like complex subunit 5,633,"71,682",5 out of 5,2005-06-07,Evidence at protein level
Q96EW2,HBAP1_HUMAN,HSPB1-associated protein 1 (27 kDa heat shock protein-associated protein 1) (Protein associated with small stress protein 1),488,"55,167",4 out of 5,2007-04-17,Evidence at protein level
P69905,HBA_HUMAN,Hemoglobin subunit alpha (Alpha-globin) (Hemoglobin alpha chain),142,"15,258",5 out of 5,1986-07-21,Evidence at protein level
P02042,HBD_HUMAN,Hemoglobin subunit delta (Delta-globin) (Hemoglobin delta chain),147,"16,055",5 out of 5,1986-07-21,Evidence at protein level
Q9BXC0,HCAR1_HUMAN,Hydroxycarboxylic acid receptor 1 (G-protein coupled receptor 104) (G-protein coupled receptor 81),346,"39,295",5 out of 5,2003-10-10,Evidence at protein level
P08631,HCK_HUMAN,Tyrosine-protein kinase HCK (EC 2.7.10.2) (Hematopoietic cell kinase) (Hemopoietic cell kinase) (p59-HCK/p60-HCK) (p59Hck) (p61Hck),526,"59,600",5 out of 5,1988-08-01,Evidence at protein level
Q9P1Z3,HCN3_HUMAN,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,774,"86,032",5 out of 5,2003-02-28,Evidence at transcript level
Q13547,HDAC1_HUMAN,Histone deacetylase 1 (HD1) (EC 3.5.1.98),482,"55,103",5 out of 5,1997-11-01,Evidence at protein level
Q7Z4V5,HDGR2_HUMAN,Hepatoma-derived growth factor-related protein 2 (HRP-2) (Hepatoma-derived growth factor 2) (HDGF-2),671,"74,317",5 out of 5,2008-02-05,Evidence at protein level
Q9H8Q6,HEAS1_HUMAN,Putative uncharacterized protein encoded by HEXA-AS1 (HEXA antisense RNA 1) (HEXA antisense gene protein 1),139,"16,103",1 out of 5,2006-12-12,Uncertain
Q9Y5Z4,HEBP2_HUMAN,Heme-binding protein 2 (Placental protein 23) (PP23) (Protein SOUL),205,"22,875",5 out of 5,2006-01-24,Evidence at protein level
Q8NG08,HELB_HUMAN,DNA helicase B (hDHB) (EC 3.6.4.12),1087,"123,252",5 out of 5,2008-06-10,Evidence at protein level
Q8TDG4,HELQ_HUMAN,Helicase POLQ-like (EC 3.6.4.12) (Mus308-like helicase) (POLQ-like helicase),1101,"124,131",5 out of 5,2008-04-08,Evidence at protein level
A8MUP6,GS1L2_HUMAN,Germ cell-specific gene 1-like protein 2 (GSG1-like protein 2),293,"32,443",2 out of 5,2008-07-22,Inferred from homology
Q14687,GSE1_HUMAN,Genetic suppressor element 1,1217,"136,164",4 out of 5,1997-11-01,Evidence at protein level
P48507,GSH0_HUMAN,Glutamate--cysteine ligase regulatory subunit (GCS light chain) (Gamma-ECS regulatory subunit) (Gamma-glutamylcysteine synthetase regulatory subunit) (Glutamate--cysteine ligase modifier subunit),274,"30,727",5 out of 5,1996-02-01,Evidence at protein level
Q8NEC7,GSTCD_HUMAN,Glutathione S-transferase C-terminal domain-containing protein,633,"71,079",3 out of 5,2008-02-05,Evidence at protein level
Q9BX10,GTPB2_HUMAN,GTP-binding protein 2,602,"65,768",4 out of 5,2006-09-05,Evidence at protein level
Q9BYW1,GTR11_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 11 (Glucose transporter type 10) (GLUT-10) (Glucose transporter type 11) (GLUT-11)",496,"53,703",5 out of 5,2001-11-16,Evidence at transcript level
Q8TDB8,GTR14_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)",520,"56,320",5 out of 5,2005-07-05,Evidence at transcript level
P11166,GTR1_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)",492,"54,084",5 out of 5,1989-07-01,Evidence at protein level
Q6PXP3,GTR7_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 7 (Glucose transporter type 7) (GLUT-7)",512,"55,728",4 out of 5,2008-02-05,Evidence at transcript level
Q9NY64,GTR8_HUMAN,"Solute carrier family 2, facilitated glucose transporter member 8 (Glucose transporter type 8) (GLUT-8) (Glucose transporter type X1)",477,"50,819",5 out of 5,2001-11-16,Evidence at protein level
P43080,GUC1A_HUMAN,Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A),201,"22,920",5 out of 5,1995-11-01,Evidence at protein level
P07305,H10_HUMAN,"Histone H1.0 (Histone H1') (Histone H1(0)) [Cleaved into: Histone H1.0, N-terminally processed]",194,"20,863",5 out of 5,1988-04-01,Evidence at protein level
P16402,H13_HUMAN,Histone H1.3 (Histone H1c) (Histone H1s-2),221,"22,350",5 out of 5,1990-08-01,Evidence at protein level
Q99878,H2A1J_HUMAN,Histone H2A type 1-J (Histone H2A/e),128,"13,936",5 out of 5,2001-01-24,Evidence at protein level
Q6FI13,H2A2A_HUMAN,Histone H2A type 2-A (Histone H2A.2) (Histone H2A/o),130,"14,095",5 out of 5,2005-12-20,Evidence at protein level
P0C5Z0,H2AB2_HUMAN,Histone H2A-Bbd type 2/3 (H2A Barr body-deficient) (H2A.Bbd),115,"12,713",5 out of 5,2007-12-04,Evidence at protein level
Q16778,H2B2E_HUMAN,Histone H2B type 2-E (Histone H2B-GL105) (Histone H2B.q) (H2B/q),126,"13,920",5 out of 5,2000-05-30,Evidence at protein level
P68431,H31_HUMAN,Histone H3.1 (Histone H3/a) (Histone H3/b) (Histone H3/c) (Histone H3/d) (Histone H3/f) (Histone H3/h) (Histone H3/i) (Histone H3/j) (Histone H3/k) (Histone H3/l),136,"15,404",5 out of 5,1986-07-21,Evidence at protein level
P84243,H33_HUMAN,Histone H3.3,136,"15,328",5 out of 5,1988-01-01,Evidence at protein level
P62805,H4_HUMAN,Histone H4,103,"11,367",5 out of 5,1986-07-21,Evidence at protein level
Q96MM7,H6ST2_HUMAN,Heparan-sulfate 6-O-sulfotransferase 2 (HS6ST-2) (EC 2.8.2.-),605,"69,130",5 out of 5,2005-10-11,Evidence at transcript level
O96004,HAND1_HUMAN,"Heart- and neural crest derivatives-expressed protein 1 (Class A basic helix-loop-helix protein 27) (bHLHa27) (Extraembryonic tissues, heart, autonomic nervous system and neural crest derivatives-expressed protein 1) (eHAND)",215,"23,627",5 out of 5,2000-12-01,Evidence at transcript level
P09105,HBAT_HUMAN,Hemoglobin subunit theta-1 (Hemoglobin theta-1 chain) (Theta-1-globin),142,"15,508",3 out of 5,1989-07-01,Evidence at protein level
P02008,HBAZ_HUMAN,Hemoglobin subunit zeta (HBAZ) (Hemoglobin zeta chain) (Zeta-globin),142,"15,637",5 out of 5,1986-07-21,Evidence at protein level
P0CG33,GOG6D_HUMAN,Golgin subfamily A member 6D,693,"79,896",2 out of 5,2010-07-13,Inferred from homology
A6NN73,GOG8C_HUMAN,Golgin subfamily A member 8C,597,"67,128",2 out of 5,2008-04-29,Inferred from homology
Q8TBA6,GOGA5_HUMAN,Golgin subfamily A member 5 (Cell proliferation-inducing gene 31 protein) (Golgin-84) (Protein Ret-II) (RET-fused gene 5 protein),731,"83,024",5 out of 5,2003-07-03,Evidence at protein level
Q5UAW9,GP157_HUMAN,G-protein coupled receptor 157,335,"36,623",3 out of 5,2005-08-16,Evidence at transcript level
Q16538,GP162_HUMAN,Probable G-protein coupled receptor 162 (Gene-rich cluster gene A protein),588,"63,930",3 out of 5,2005-11-22,Evidence at transcript level
Q99679,GPR21_HUMAN,Probable G-protein coupled receptor 21,349,"39,515",3 out of 5,1997-11-01,Evidence at transcript level
O15354,GPR37_HUMAN,Prosaposin receptor GPR37 (Endothelin B receptor-like protein 1) (ETBR-LP-1) (G-protein coupled receptor 37) (Parkin-associated endothelin receptor-like receptor) (PAELR),613,"67,114",5 out of 5,2001-01-11,Evidence at protein level
O15529,GPR42_HUMAN,G-protein coupled receptor 42,346,"38,695",4 out of 5,1998-07-15,Evidence at protein level
Q9Y2T5,GPR52_HUMAN,Probable G-protein coupled receptor 52,361,"41,354",3 out of 5,2000-12-01,Evidence at transcript level
Q96P69,GPR78_HUMAN,G-protein coupled receptor 78,363,"39,332",4 out of 5,2003-10-03,Evidence at protein level
Q9NQS5,GPR84_HUMAN,G-protein coupled receptor 84 (Inflammation-related G-protein coupled receptor EX33),396,"43,705",5 out of 5,2005-05-24,Evidence at transcript level
Q9BY21,GPR87_HUMAN,G-protein coupled receptor 87 (G-protein coupled receptor 95),358,"41,436",4 out of 5,2003-10-03,Evidence at transcript level
Q9NWQ4,GPT2L_HUMAN,G patch domain-containing protein 2-like,482,"54,260",5 out of 5,2005-08-02,Evidence at protein level
Q96I76,GPTC3_HUMAN,G patch domain-containing protein 3,525,"59,338",2 out of 5,2005-01-04,Evidence at transcript level
Q9HCN6,GPVI_HUMAN,Platelet glycoprotein VI (GPVI) (Glycoprotein 6),339,"36,866",5 out of 5,2006-04-04,Evidence at protein level
Q8TE85,GRHL3_HUMAN,Grainyhead-like protein 3 homolog (Sister of mammalian grainyhead) (Transcription factor CP2-like 4),626,"70,345",5 out of 5,2006-03-21,Evidence at protein level
P48058,GRIA4_HUMAN,"Glutamate receptor 4 (GluR-4) (GluR4) (AMPA-selective glutamate receptor 4) (GluR-D) (Glutamate receptor ionotropic, AMPA 4) (GluA4)",902,"100,871",5 out of 5,1996-02-01,Evidence at transcript level
P39086,GRIK1_HUMAN,"Glutamate receptor ionotropic, kainate 1 (GluK1) (Excitatory amino acid receptor 3) (EAA3) (Glutamate receptor 5) (GluR-5) (GluR5)",918,"103,981",5 out of 5,1995-02-01,Evidence at protein level
Q16478,GRIK5_HUMAN,"Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)",980,"109,265",5 out of 5,1998-07-15,Evidence at transcript level
Q7Z2K8,GRIN1_HUMAN,G protein-regulated inducer of neurite outgrowth 1 (GRIN1),1008,"102,399",4 out of 5,2006-05-16,Evidence at protein level
Q13255,GRM1_HUMAN,Metabotropic glutamate receptor 1 (mGluR1),1194,"132,357",5 out of 5,1997-11-01,Evidence at protein level
O15217,GSTA4_HUMAN,Glutathione S-transferase A4 (EC 2.5.1.18) (GST class-alpha member 4) (Glutathione S-transferase A4-4),222,"25,704",5 out of 5,1999-07-15,Evidence at protein level
Q9H4S2,GSX1_HUMAN,GS homeobox 1 (Homeobox protein GSH-1),264,"27,883",4 out of 5,2003-01-27,Evidence at transcript level
Q16661,GUC2B_HUMAN,Guanylate cyclase activator 2B [Cleaved into: Guanylate cyclase C-activating peptide 2 (Guanylate cyclase C-activating peptide II) (GCAP-II); Uroguanylin (UGN)],112,"12,069",5 out of 5,1997-11-01,Evidence at protein level
A0A096LPI5,GVQW2_HUMAN,Protein GVQW2 (GVQW motif-containing protein 2),108,"11,989",1 out of 5,2016-02-17,Predicted
Q96GX5,GWL_HUMAN,Serine/threonine-protein kinase greatwall (GW) (GWL) (hGWL) (EC 2.7.11.1) (Microtubule-associated serine/threonine-protein kinase-like) (MAST-L),879,"97,319",5 out of 5,2005-07-05,Evidence at protein level
Q93077,H2A1C_HUMAN,Histone H2A type 1-C (Histone H2A/l),130,"14,105",5 out of 5,2001-01-24,Evidence at protein level
P0C0S8,H2A1_HUMAN,Histone H2A type 1 (H2A.1) (Histone H2A/p),130,"14,091",5 out of 5,1986-07-21,Evidence at protein level
Q8IUE6,H2A2B_HUMAN,Histone H2A type 2-B,130,"13,995",5 out of 5,2006-03-07,Evidence at protein level
Q9P0M6,H2AW_HUMAN,Core histone macro-H2A.2 (Histone macroH2A2) (mH2A2),372,"40,058",5 out of 5,2001-01-24,Evidence at protein level
P62807,H2B1C_HUMAN,Histone H2B type 1-C/E/F/G/I (Histone H2B.1 A) (Histone H2B.a) (H2B/a) (Histone H2B.g) (H2B/g) (Histone H2B.h) (H2B/h) (Histone H2B.k) (H2B/k) (Histone H2B.l) (H2B/l),126,"13,906",5 out of 5,1986-07-21,Evidence at protein level
O60243,H6ST1_HUMAN,Heparan-sulfate 6-O-sulfotransferase 1 (HS6ST-1) (EC 2.8.2.-),411,"48,226",5 out of 5,2005-10-11,Evidence at protein level
Q8IZP7,H6ST3_HUMAN,Heparan-sulfate 6-O-sulfotransferase 3 (HS6ST-3) (EC 2.8.2.-),471,"54,844",3 out of 5,2005-10-11,Evidence at transcript level
Q7L7L0,H2A3_HUMAN,Histone H2A type 3,130,"14,121",5 out of 5,2006-04-04,Evidence at protein level
P58876,H2B1D_HUMAN,Histone H2B type 1-D (HIRA-interacting protein 2) (Histone H2B.1 B) (Histone H2B.b) (H2B/b),126,"13,936",5 out of 5,2002-06-20,Evidence at protein level
Q99880,H2B1L_HUMAN,Histone H2B type 1-L (Histone H2B.c) (H2B/c),126,"13,952",5 out of 5,2000-05-30,Evidence at protein level
P0C1H6,H2BFM_HUMAN,Histone H2B type F-M (Histone H2B.s) (H2B/s),154,"17,001",3 out of 5,2006-07-11,Evidence at protein level
P69892,HBG2_HUMAN,Hemoglobin subunit gamma-2 (Gamma-2-globin) (Hb F Ggamma) (Hemoglobin gamma-2 chain) (Hemoglobin gamma-G chain),147,"16,126",5 out of 5,1986-07-21,Evidence at protein level
Q6B0K9,HBM_HUMAN,Hemoglobin subunit mu (Hemoglobin mu chain) (Mu-globin),141,"15,618",3 out of 5,2007-04-03,Evidence at transcript level
P51610,HCFC1_HUMAN,Host cell factor 1 (HCF) (HCF-1) (C1 factor) (CFF) (VCAF) (VP16 accessory protein) [Cleaved into: HCF N-terminal chain 1; HCF N-terminal chain 2; HCF N-terminal chain 3; HCF N-terminal chain 4; HCF N-terminal chain 5; HCF N-terminal chain 6; HCF C-terminal chain 1; HCF C-terminal chain 2; HCF C-terminal chain 3; HCF C-terminal chain 4; HCF C-terminal chain 5; HCF C-terminal chain 6],2035,"208,732",5 out of 5,1996-10-01,Evidence at protein level
Q8WUI4,HDAC7_HUMAN,Histone deacetylase 7 (HD7) (EC 3.5.1.98) (Histone deacetylase 7A) (HD7a),952,"102,927",5 out of 5,2003-05-16,Evidence at protein level
Q5TGJ6,HDGL1_HUMAN,Hepatoma-derived growth factor-like protein 1 (PWWP domain-containing protein 1),251,"27,234",2 out of 5,2008-05-20,Evidence at transcript level
Q9Y3E1,HDGR3_HUMAN,Hepatoma-derived growth factor-related protein 3 (HRP-3) (Hepatoma-derived growth factor 2) (HDGF-2),203,"22,620",4 out of 5,2005-06-21,Evidence at protein level
Q9H0R4,HDHD2_HUMAN,Haloacid dehalogenase-like hydrolase domain-containing protein 2,259,"28,536",3 out of 5,2007-05-15,Evidence at protein level
Q9H583,HEAT1_HUMAN,"HEAT repeat-containing protein 1 (Protein BAP28) [Cleaved into: HEAT repeat-containing protein 1, N-terminally processed]",2144,"242,370",5 out of 5,2001-06-01,Evidence at protein level
Q9NRV9,HEBP1_HUMAN,Heme-binding protein 1 (p22HBP),189,"21,097",4 out of 5,2006-01-24,Evidence at protein level
Q9UBP5,HEY2_HUMAN,Hairy/enhancer-of-split related with YRPW motif protein 2 (Cardiovascular helix-loop-helix factor 1) (hCHF1) (Class B basic helix-loop-helix protein 32) (bHLHb32) (HES-related repressor protein 2) (Hairy and enhancer of split-related protein 2) (HESR-2) (Hairy-related transcription factor 2) (HRT-2) (hHRT2) (Protein gridlock homolog),337,"35,808",5 out of 5,2006-07-11,Evidence at protein level
Q2TB90,HKDC1_HUMAN,Putative hexokinase HKDC1 (EC 2.7.1.1) (Hexokinase domain-containing protein 1),917,"102,545",5 out of 5,2007-08-21,Evidence at protein level
Q9NP66,HM20A_HUMAN,High mobility group protein 20A (HMG box-containing protein 20A) (HMG domain-containing protein 1) (HMG domain-containing protein HMGX1),347,"40,144",5 out of 5,2006-05-30,Evidence at protein level
Q96FZ2,HMCES_HUMAN,Embryonic stem cell-specific 5-hydroxymethylcytosine-binding protein (ES cell-specific 5hmC-binding protein) (Putative peptidase SRAPD1) (EC 3.4.-.-) (SRAP domain-containing protein 1),354,"40,575",3 out of 5,2006-01-24,Evidence at protein level
Q96RW7,HMCN1_HUMAN,Hemicentin-1 (Fibulin-6) (FIBL-6),5635,"613,390",5 out of 5,2006-01-10,Evidence at protein level
Q9P2P5,HECW2_HUMAN,"E3 ubiquitin-protein ligase HECW2 (EC 2.3.2.26) (HECT, C2 and WW domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECW2) (NEDD4-like E3 ubiquitin-protein ligase 2)",1572,"175,769",5 out of 5,2007-02-20,Evidence at protein level
Q5TGS1,HES3_HUMAN,Transcription factor HES-3 (Class B basic helix-loop-helix protein 43) (bHLHb43) (Hairy and enhancer of split 3),186,"19,968",4 out of 5,2006-12-12,Inferred from homology
Q9HCC6,HES4_HUMAN,Transcription factor HES-4 (hHES4) (Class B basic helix-loop-helix protein 42) (bHLHb42) (Hairy and enhancer of split 4) (bHLH factor Hes4),221,"23,523",3 out of 5,2003-08-15,Evidence at transcript level
Q5TA89,HES5_HUMAN,Transcription factor HES-5 (Class B basic helix-loop-helix protein 38) (bHLHb38) (Hairy and enhancer of split 5),166,"18,226",5 out of 5,2006-12-12,Evidence at transcript level
P04233,HG2A_HUMAN,HLA class II histocompatibility antigen gamma chain (HLA-DR antigens-associated invariant chain) (Ia antigen-associated invariant chain) (Ii) (p33) (CD antigen CD74),296,"33,516",5 out of 5,1987-03-20,Evidence at protein level
Q9BTY7,HGH1_HUMAN,Protein HGH1 homolog,390,"42,129",3 out of 5,2007-01-23,Evidence at protein level
Q5VTY9,HHAT_HUMAN,Protein-cysteine N-palmitoyltransferase HHAT (EC 2.3.1.-) (Hedgehog acyltransferase) (Melanoma antigen recognized by T-cells 2) (MART-2) (Skinny hedgehog protein 1),493,"57,313",5 out of 5,2005-12-20,Evidence at protein level
Q14526,HIC1_HUMAN,Hypermethylated in cancer 1 protein (Hic-1) (Zinc finger and BTB domain-containing protein 29),733,"76,508",5 out of 5,2002-05-02,Evidence at protein level
Q8IV36,HID1_HUMAN,Protein HID1 (Down-regulated in multiple cancers 1) (HID1 domain-containing protein) (Protein hid-1 homolog),788,"88,745",5 out of 5,2005-07-05,Evidence at protein level
P15515,HIS1_HUMAN,Histatin-1 (Histidine-rich protein 1) (Post-PB protein) (PPB) [Cleaved into: His1-(31-57)-peptide (His1 31/57) (His1-(12-38)-peptide) (His1 12/38) (Histatin-2)],57,"6,963",5 out of 5,1990-04-01,Evidence at protein level
P10072,HKR1_HUMAN,Krueppel-related zinc finger protein 1 (Protein HKR1) (Zinc finger protein 875),659,"75,128",4 out of 5,1989-07-01,Evidence at transcript level
Q9Y5L2,HLPDA_HUMAN,Hypoxia-inducible lipid droplet-associated protein (Hypoxia-inducible gene 2 protein),63,"6,950",5 out of 5,2000-05-30,Evidence at protein level
Q9P0W2,HM20B_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1-related (SMARCE1-related protein) (BRCA2-associated factor 35) (HMG box-containing protein 20B) (HMG domain-containing protein 2) (HMG domain-containing protein HMGX2) (Sox-like transcriptional factor) (Structural DNA-binding protein BRAF35),317,"35,813",5 out of 5,2005-01-04,Evidence at protein level
Q01581,HMCS1_HUMAN,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)",520,"57,294",5 out of 5,1993-07-01,Evidence at protein level
P09429,HMGB1_HUMAN,High mobility group protein B1 (High mobility group protein 1) (HMG-1),215,"24,894",5 out of 5,1989-07-01,Evidence at protein level
P35914,HMGCL_HUMAN,"Hydroxymethylglutaryl-CoA lyase, mitochondrial (HL) (HMG-CoA lyase) (EC 4.1.3.4) (3-hydroxy-3-methylglutarate-CoA lyase)",325,"34,360",5 out of 5,1994-06-01,Evidence at protein level
Q15651,HMGN3_HUMAN,High mobility group nucleosome-binding domain-containing protein 3 (Thyroid receptor-interacting protein 7) (TR-interacting protein 7) (TRIP-7),99,"10,666",4 out of 5,1997-11-01,Evidence at protein level
P31942,HNRH3_HUMAN,Heterogeneous nuclear ribonucleoprotein H3 (hnRNP H3) (Heterogeneous nuclear ribonucleoprotein 2H9) (hnRNP 2H9),346,"36,926",5 out of 5,1993-07-01,Evidence at protein level
P52272,HNRPM_HUMAN,Heterogeneous nuclear ribonucleoprotein M (hnRNP M),730,"77,516",5 out of 5,1996-10-01,Evidence at protein level
O43390,HNRPR_HUMAN,Heterogeneous nuclear ribonucleoprotein R (hnRNP R),633,"70,943",5 out of 5,2001-01-11,Evidence at protein level
P23527,H2B1O_HUMAN,Histone H2B type 1-O (Histone H2B.2) (Histone H2B.n) (H2B/n),126,"13,906",5 out of 5,1991-11-01,Evidence at protein level
Q9NVX0,HAUS2_HUMAN,HAUS augmin-like complex subunit 2 (Centrosomal protein of 27 kDa) (Cep27),235,"26,933",5 out of 5,2004-12-21,Evidence at protein level
Q99871,HAUS7_HUMAN,HAUS augmin-like complex subunit 7 (26S proteasome-associated UCH37-interacting protein 1) (UCHL5-interacting protein) (X-linked protein STS1769),368,"40,778",5 out of 5,1997-11-01,Evidence at protein level
Q9BSH5,HDHD3_HUMAN,Haloacid dehalogenase-like hydrolase domain-containing protein 3,251,"28,000",2 out of 5,2007-05-15,Evidence at protein level
Q7Z4Q2,HEAT3_HUMAN,HEAT repeat-containing protein 3,680,"74,583",3 out of 5,2004-03-15,Evidence at protein level
Q9ULT8,HECD1_HUMAN,E3 ubiquitin-protein ligase HECTD1 (EC 2.3.2.26) (E3 ligase for inhibin receptor) (EULIR) (HECT domain-containing protein 1) (HECT-type E3 ubiquitin transferase HECTD1),2610,"289,384",4 out of 5,2003-02-12,Evidence at protein level
Q9Y4D8,HECD4_HUMAN,Probable E3 ubiquitin-protein ligase HECTD4 (EC 2.3.2.26) (HECT domain-containing protein 4) (HECT-type E3 ubiquitin transferase HECTD4),3996,"439,344",5 out of 5,2008-07-01,Evidence at protein level
P13196,HEM1_HUMAN,"5-aminolevulinate synthase, nonspecific, mitochondrial (ALAS-H) (EC 2.3.1.37) (5-aminolevulinic acid synthase 1) (Delta-ALA synthase 1) (Delta-aminolevulinate synthase 1)",640,"70,581",5 out of 5,1990-01-01,Evidence at protein level
P08397,HEM3_HUMAN,Porphobilinogen deaminase (PBG-D) (EC 2.5.1.61) (Hydroxymethylbilane synthase) (HMBS) (Pre-uroporphyrinogen synthase),361,"39,330",5 out of 5,1988-08-01,Evidence at protein level
P05981,HEPS_HUMAN,Serine protease hepsin (EC 3.4.21.106) (Transmembrane protease serine 1) [Cleaved into: Serine protease hepsin non-catalytic chain; Serine protease hepsin catalytic chain],417,"45,011",5 out of 5,1988-11-01,Evidence at protein level
Q15034,HERC3_HUMAN,Probable E3 ubiquitin-protein ligase HERC3 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 3) (HECT-type E3 ubiquitin transferase HERC3),1050,"117,188",4 out of 5,1997-11-01,Evidence at protein level
Q15011,HERP1_HUMAN,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein (Methyl methanesulfonate (MMF)-inducible fragment protein 1),391,"43,720",5 out of 5,1998-07-15,Evidence at protein level
P07686,HEXB_HUMAN,Beta-hexosaminidase subunit beta (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit beta) (Hexosaminidase subunit B) (Cervical cancer proto-oncogene 7 protein) (HCC-7) (N-acetyl-beta-glucosaminidase subunit beta) [Cleaved into: Beta-hexosaminidase subunit beta chain B; Beta-hexosaminidase subunit beta chain A],556,"63,111",5 out of 5,1988-04-01,Evidence at protein level
Q03014,HHEX_HUMAN,Hematopoietically-expressed homeobox protein HHEX (Homeobox protein HEX) (Homeobox protein PRH),270,"30,022",5 out of 5,1994-06-01,Evidence at protein level
Q9Y2N7,HIF3A_HUMAN,Hypoxia-inducible factor 3-alpha (HIF-3-alpha) (HIF3-alpha) (Basic-helix-loop-helix-PAS protein MOP7) (Class E basic helix-loop-helix protein 17) (bHLHe17) (HIF3-alpha-1) (Inhibitory PAS domain protein) (IPAS) (Member of PAS protein 7) (PAS domain-containing protein 7),669,"72,433",5 out of 5,2007-04-17,Evidence at protein level
A8MV81,HIG1C_HUMAN,HIG1 domain family member 1C,97,"11,079",2 out of 5,2008-07-01,Inferred from homology
Q4VC39,HIG2B_HUMAN,Putative HIG1 domain family member 2B (HIG1 domain family member 2B pseudogene),106,"11,405",2 out of 5,2008-07-22,Uncertain
O75146,HIP1R_HUMAN,Huntingtin-interacting protein 1-related protein (HIP1-related protein) (Huntingtin-interacting protein 12) (HIP-12),1068,"119,388",5 out of 5,2001-04-27,Evidence at protein level
P0C0S5,H2AZ_HUMAN,Histone H2A.Z (H2A/z),128,"13,553",5 out of 5,2005-12-06,Evidence at protein level
P06899,H2B1J_HUMAN,Histone H2B type 1-J (Histone H2B.1) (Histone H2B.r) (H2B/r),126,"13,904",5 out of 5,1988-01-01,Evidence at protein level
Q8N257,H2B3B_HUMAN,Histone H2B type 3-B (H2B type 12),126,"13,908",5 out of 5,2004-08-31,Evidence at protein level
Q6NXT2,H3C_HUMAN,Histone H3.3C (Histone H3.5),135,"15,214",5 out of 5,2006-10-17,Evidence at protein level
O14929,HAT1_HUMAN,Histone acetyltransferase type B catalytic subunit (EC 2.3.1.48) (Histone acetyltransferase 1),419,"49,513",5 out of 5,1998-07-15,Evidence at protein level
P69891,HBG1_HUMAN,Hemoglobin subunit gamma-1 (Gamma-1-globin) (Hb F Agamma) (Hemoglobin gamma-1 chain) (Hemoglobin gamma-A chain),147,"16,140",5 out of 5,1986-07-21,Evidence at protein level
O60381,HBP1_HUMAN,HMG box-containing protein 1 (HMG box transcription factor 1) (High mobility group box transcription factor 1),514,"57,645",5 out of 5,2005-07-19,Evidence at protein level
Q8TDS4,HCAR2_HUMAN,Hydroxycarboxylic acid receptor 2 (G-protein coupled receptor 109A) (G-protein coupled receptor HM74A) (Niacin receptor 1) (Nicotinic acid receptor),363,"41,850",5 out of 5,2005-12-06,Evidence at protein level
Q9Y5Z7,HCFC2_HUMAN,Host cell factor 2 (HCF-2) (C2 factor),792,"86,779",5 out of 5,2005-04-26,Evidence at protein level
Q9UBK5,HCST_HUMAN,Hematopoietic cell signal transducer (DNAX-activation protein 10) (Membrane protein DAP10) (Transmembrane adapter protein KAP10),93,"9,489",5 out of 5,2008-04-29,Evidence at protein level
Q7Z4H3,HDDC2_HUMAN,HD domain-containing protein 2 (Hepatitis C virus NS5A-transactivated protein 2) (HCV NS5A-transactivated protein 2),204,"23,390",3 out of 5,2007-12-04,Evidence at protein level
Q9NRZ9,HELLS_HUMAN,Lymphoid-specific helicase (EC 3.6.4.-) (Proliferation-associated SNF2-like protein) (SWI/SNF2-related matrix-associated actin-dependent regulator of chromatin subfamily A member 6),838,"97,074",5 out of 5,2006-11-28,Evidence at protein level
P22557,HEM0_HUMAN,"5-aminolevulinate synthase, erythroid-specific, mitochondrial (ALAS-E) (EC 2.3.1.37) (5-aminolevulinic acid synthase 2) (Delta-ALA synthase 2) (Delta-aminolevulinate synthase 2)",587,"64,633",5 out of 5,1991-08-01,Evidence at protein level
P81172,HEPC_HUMAN,Hepcidin (Liver-expressed antimicrobial peptide 1) (LEAP-1) (Putative liver tumor regressor) (PLTR) [Cleaved into: Hepcidin-25 (Hepc25); Hepcidin-20 (Hepc20)],84,"9,408",5 out of 5,1998-12-15,Evidence at protein level
Q15751,HERC1_HUMAN,Probable E3 ubiquitin-protein ligase HERC1 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 1) (HECT-type E3 ubiquitin transferase HERC1) (p532) (p619),4861,"532,228",5 out of 5,2008-04-08,Evidence at protein level
O94992,HEXI1_HUMAN,Protein HEXIM1 (Cardiac lineage protein 1) (Estrogen down-regulated gene 1 protein) (Hexamethylene bis-acetamide-inducible protein 1) (Menage a quatre protein 1),359,"40,623",5 out of 5,2007-10-02,Evidence at protein level
Q30201,HFE_HUMAN,Hereditary hemochromatosis protein (HLA-H),348,"40,108",5 out of 5,1997-11-01,Evidence at protein level
A2PYH4,HFM1_HUMAN,Probable ATP-dependent DNA helicase HFM1 (EC 3.6.4.12) (SEC63 domain-containing protein 1),1435,"162,610",4 out of 5,2008-03-18,Evidence at protein level
Q93099,HGD_HUMAN,"Homogentisate 1,2-dioxygenase (EC 1.13.11.5) (Homogentisate oxygenase) (Homogentisic acid oxidase) (Homogentisicase)",445,"49,964",5 out of 5,1997-11-01,Evidence at protein level
Q04756,HGFA_HUMAN,Hepatocyte growth factor activator (HGF activator) (HGFA) (EC 3.4.21.-) [Cleaved into: Hepatocyte growth factor activator short chain; Hepatocyte growth factor activator long chain],655,"70,682",5 out of 5,1994-06-01,Evidence at protein level
Q9Y241,HIG1A_HUMAN,"HIG1 domain family member 1A, mitochondrial (Hypoxia-inducible gene 1 protein) (RCF1 homolog A) (RCF1a)",93,"10,143",5 out of 5,2005-09-27,Evidence at protein level
Q8NE63,HIPK4_HUMAN,Homeodomain-interacting protein kinase 4 (EC 2.7.11.1),616,"69,425",5 out of 5,2006-04-04,Evidence at protein level
P51841,GUC2F_HUMAN,"Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2)",1108,"124,850",5 out of 5,1996-10-01,Evidence at transcript level
O14756,H17B6_HUMAN,17-beta-hydroxysteroid dehydrogenase type 6 (17-beta-HSD 6) (17-beta-HSD6) (EC 1.1.1.105) (EC 1.1.1.239) (EC 1.1.1.62) (3-alpha->beta-hydroxysteroid epimerase) (3-alpha->beta-HSE) (Oxidative 3-alpha hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 6),317,"35,966",5 out of 5,2007-09-11,Evidence at protein level
O75367,H2AY_HUMAN,Core histone macro-H2A.1 (Histone macroH2A1) (mH2A1) (Histone H2A.y) (H2A/y) (Medulloblastoma antigen MU-MB-50.205),372,"39,617",5 out of 5,2001-01-24,Evidence at protein level
Q93079,H2B1H_HUMAN,Histone H2B type 1-H (Histone H2B.j) (H2B/j),126,"13,892",5 out of 5,2000-05-30,Evidence at protein level
B0YJ81,HACD1_HUMAN,Very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 1 (EC 4.2.1.134) (3-hydroxyacyl-CoA dehydratase 1) (HACD1) (Cementum-attachment protein) (CAP) (Protein-tyrosine phosphatase-like member A),288,"32,388",5 out of 5,2008-09-02,Evidence at protein level
Q68CZ6,HAUS3_HUMAN,HAUS augmin-like complex subunit 3,603,"69,650",5 out of 5,2007-09-11,Evidence at protein level
Q7Z4H7,HAUS6_HUMAN,HAUS augmin-like complex subunit 6,955,"108,621",5 out of 5,2006-01-24,Evidence at protein level
O00165,HAX1_HUMAN,HCLS1-associated protein X-1 (HS1-associating protein X-1) (HAX-1) (HS1-binding protein 1) (HSP1BP-1),279,"31,621",5 out of 5,1998-07-15,Evidence at protein level
Q16836,HCDH_HUMAN,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial (HCDH) (EC 1.1.1.35) (Medium and short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase) (Short-chain 3-hydroxyacyl-CoA dehydrogenase)",314,"34,294",5 out of 5,1997-11-01,Evidence at protein level
P14317,HCLS1_HUMAN,Hematopoietic lineage cell-specific protein (Hematopoietic cell-specific LYN substrate 1) (LckBP1) (p75),486,"54,014",5 out of 5,1990-01-01,Evidence at protein level
Q9Y3Q4,HCN4_HUMAN,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,1203,"129,042",5 out of 5,2003-02-28,Evidence at protein level
O15379,HDAC3_HUMAN,Histone deacetylase 3 (HD3) (EC 3.5.1.98) (RPD3-2) (SMAP45),428,"48,848",5 out of 5,1998-07-15,Evidence at protein level
Q9UQL6,HDAC5_HUMAN,Histone deacetylase 5 (HD5) (EC 3.5.1.98) (Antigen NY-CO-9),1122,"121,978",5 out of 5,2000-12-01,Evidence at protein level
Q9BY41,HDAC8_HUMAN,Histone deacetylase 8 (HD8) (EC 3.5.1.98),377,"41,758",5 out of 5,2003-04-11,Evidence at protein level
Q9UBI9,HDC_HUMAN,Headcase protein homolog (hHDC),543,"58,837",3 out of 5,2004-03-01,Evidence at protein level
Q96HZ4,HES6_HUMAN,Transcription cofactor HES-6 (C-HAIRY1) (Class B basic helix-loop-helix protein 41) (bHLHb41) (Hairy and enhancer of split 6),224,"24,129",4 out of 5,2004-07-19,Evidence at transcript level
B2RPK0,HGB1A_HUMAN,Putative high mobility group protein B1-like 1 (High mobility group protein B1 pseudogene 1) (Putative high mobility group protein 1-like 1) (HMG-1L1),211,"24,238",3 out of 5,2008-09-02,Uncertain
P26927,HGFL_HUMAN,Hepatocyte growth factor-like protein (Macrophage stimulatory protein) (Macrophage-stimulating protein) (MSP) [Cleaved into: Hepatocyte growth factor-like protein alpha chain; Hepatocyte growth factor-like protein beta chain],711,"80,320",5 out of 5,1992-08-01,Evidence at protein level
P14210,HGF_HUMAN,Hepatocyte growth factor (Hepatopoietin-A) (Scatter factor) (SF) [Cleaved into: Hepatocyte growth factor alpha chain; Hepatocyte growth factor beta chain],728,"83,134",5 out of 5,1990-01-01,Evidence at protein level
C9JL84,HHLA1_HUMAN,HERV-H LTR-associating protein 1,531,"58,297",2 out of 5,2010-05-18,Evidence at transcript level
Q9BT25,HAUS8_HUMAN,HAUS augmin-like complex subunit 8 (HEC1/NDC80-interacting centrosome-associated protein 1) (Sarcoma antigen NY-SAR-48),410,"44,857",5 out of 5,2008-02-26,Evidence at protein level
P02100,HBE_HUMAN,Hemoglobin subunit epsilon (Epsilon-globin) (Hemoglobin epsilon chain),147,"16,203",5 out of 5,1986-07-21,Evidence at protein level
Q9Y450,HBS1L_HUMAN,HBS1-like protein (ERFS),684,"75,473",5 out of 5,2005-05-10,Evidence at protein level
Q08623,HDHD1_HUMAN,Pseudouridine-5'-phosphatase (EC 3.1.3.96) (Haloacid dehalogenase-like hydrolase domain-containing protein 1) (Haloacid dehalogenase-like hydrolase domain-containing protein 1A) (Protein GS1) (Pseudouridine-5'-monophosphatase) (5'-PsiMPase),228,"25,249",5 out of 5,1995-02-01,Evidence at protein level
Q7Z353,HDX_HUMAN,Highly divergent homeobox,690,"77,206",2 out of 5,2007-09-11,Evidence at protein level
P42858,HD_HUMAN,Huntingtin (Huntington disease protein) (HD protein),3142,"347,603",5 out of 5,1995-11-01,Evidence at protein level
A2RTY3,HEAT9_HUMAN,Protein HEATR9 (HEAT repeat-containing protein 9),570,"65,681",3 out of 5,2007-05-15,Evidence at transcript level
Q14CZ8,HECAM_HUMAN,Hepatocyte cell adhesion molecule (Protein hepaCAM),416,"46,026",5 out of 5,2007-08-21,Evidence at protein level
Q9ULI3,HEG1_HUMAN,Protein HEG homolog 1,1381,"147,461",5 out of 5,2007-05-15,Evidence at protein level
A6NFD8,HELT_HUMAN,Hairy and enhancer of split-related protein HELT (HES/HEY-like transcription factor),242,"26,913",4 out of 5,2008-09-02,Evidence at transcript level
P42694,HELZ_HUMAN,Probable helicase with zinc finger domain (EC 3.6.4.-) (Down-regulated in human cancers protein),1942,"218,970",5 out of 5,1995-11-01,Evidence at protein level
Q9Y5N5,HEMK2_HUMAN,HemK methyltransferase family member 2 (EC 2.1.1.-) (M.HsaHemK2P) (N(6)-adenine-specific DNA methyltransferase 1),214,"22,900",5 out of 5,2000-05-30,Evidence at protein level
Q02575,HEN1_HUMAN,Helix-loop-helix protein 1 (HEN-1) (Class A basic helix-loop-helix protein 35) (bHLHa35) (Nescient helix loop helix 1) (NSCL-1),133,"14,618",4 out of 5,1993-07-01,Evidence at transcript level
Q5GLZ8,HERC4_HUMAN,Probable E3 ubiquitin-protein ligase HERC4 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 4) (HECT-type E3 ubiquitin transferase HERC4),1057,"118,563",5 out of 5,2007-02-20,Evidence at protein level
Q8IVU3,HERC6_HUMAN,Probable E3 ubiquitin-protein ligase HERC6 (EC 2.3.2.26) (HECT domain and RCC1-like domain-containing protein 6) (HECT-type E3 ubiquitin transferase HERC6),1022,"115,126",5 out of 5,2007-02-20,Evidence at transcript level
Q9Y543,HES2_HUMAN,Transcription factor HES-2 (Class B basic helix-loop-helix protein 40) (bHLHb40) (Hairy and enhancer of split 2),173,"18,470",3 out of 5,2000-12-01,Evidence at transcript level
Q9BYE0,HES7_HUMAN,Transcription factor HES-7 (hHes7) (Class B basic helix-loop-helix protein 37) (bHLHb37) (Hairy and enhancer of split 7) (bHLH factor Hes7),225,"24,899",5 out of 5,2006-10-17,Evidence at protein level
P06865,HEXA_HUMAN,Beta-hexosaminidase subunit alpha (EC 3.2.1.52) (Beta-N-acetylhexosaminidase subunit alpha) (Hexosaminidase subunit A) (N-acetyl-beta-glucosaminidase subunit alpha),529,"60,703",5 out of 5,1988-01-01,Evidence at protein level
Q9H422,HIPK3_HUMAN,Homeodomain-interacting protein kinase 3 (EC 2.7.11.1) (Androgen receptor-interacting nuclear protein kinase) (ANPK) (Fas-interacting serine/threonine-protein kinase) (FIST) (Homolog of protein kinase YAK1),1215,"133,743",5 out of 5,2005-03-15,Evidence at protein level
P20671,H2A1D_HUMAN,Histone H2A type 1-D (Histone H2A.3) (Histone H2A/g),130,"14,107",5 out of 5,1991-02-01,Evidence at protein level
Q99877,H2B1N_HUMAN,Histone H2B type 1-N (Histone H2B.d) (H2B/d),126,"13,922",5 out of 5,2000-05-30,Evidence at protein level
Q7Z2G1,H2BWT_HUMAN,Histone H2B type W-T (H2B histone family member W testis-specific),175,"19,618",3 out of 5,2006-07-11,Evidence at protein level
Q58FF7,H90B3_HUMAN,Putative heat shock protein HSP 90-beta-3 (Heat shock protein 90-beta c) (Heat shock protein 90Bc),597,"68,325",3 out of 5,2008-05-20,Uncertain
Q9UJ83,HACL1_HUMAN,2-hydroxyacyl-CoA lyase 1 (EC 4.1.-.-) (2-hydroxyphytanoyl-CoA lyase) (2-HPCL) (Phytanoyl-CoA 2-hydroxylase 2),578,"63,729",5 out of 5,2002-05-02,Evidence at protein level
Q6PII5,HAGHL_HUMAN,Hydroxyacylglutathione hydrolase-like protein (EC 3.1.2.-),290,"31,557",3 out of 5,2008-01-15,Evidence at transcript level
O43593,HAIR_HUMAN,Lysine-specific demethylase hairless (EC 1.14.11.-),1189,"127,495",5 out of 5,1999-07-15,Evidence at protein level
Q9UJM8,HAOX1_HUMAN,Hydroxyacid oxidase 1 (HAOX1) (EC 1.1.3.15) (Glycolate oxidase) (GOX),370,"40,924",5 out of 5,2001-02-21,Evidence at protein level
Q13442,HAP28_HUMAN,28 kDa heat- and acid-stable phosphoprotein (PDGF-associated protein) (PAP) (PDGFA-associated protein 1) (PAP1),181,"20,630",3 out of 5,1997-11-01,Evidence at protein level
Q6MZN7,HCP5_HUMAN,HLA class I histocompatibility antigen protein P5 (HLA complex protein P5) (Protein P5-1),132,"14,098",2 out of 5,2008-04-08,Evidence at transcript level
P0DOY5,HD101_HUMAN,Immunoglobulin heavy diversity 1-1,5,435,2 out of 5,2017-03-15,Predicted
Q9UBN7,HDAC6_HUMAN,Histone deacetylase 6 (HD6) (EC 3.5.1.98),1215,"131,419",5 out of 5,2000-12-01,Evidence at protein level
Q8IV16,HDBP1_HUMAN,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPI-HBP1) (GPI-anchored HDL-binding protein 1) (High density lipoprotein-binding protein 1),184,"19,806",5 out of 5,2008-02-05,Evidence at protein level
P36551,HEM6_HUMAN,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial (COX) (Coprogen oxidase) (Coproporphyrinogenase) (EC 1.3.3.3)",454,"50,152",5 out of 5,1994-06-01,Evidence at protein level
Q9Y5R4,HEMK1_HUMAN,HemK methyltransferase family member 1 (EC 2.1.1.-) (M.HsaHemKP),338,"38,231",4 out of 5,2001-09-26,Evidence at protein level
P02790,HEMO_HUMAN,Hemopexin (Beta-1B-glycoprotein),462,"51,676",5 out of 5,1986-07-21,Evidence at protein level
Q02577,HEN2_HUMAN,Helix-loop-helix protein 2 (HEN-2) (Class A basic helix-loop-helix protein 34) (bHLHa34) (Nescient helix loop helix 2) (NSCL-2),135,"15,018",5 out of 5,1993-07-01,Evidence at protein level
Q9BSE4,HERP2_HUMAN,Homocysteine-responsive endoplasmic reticulum-resident ubiquitin-like domain member 2 protein,406,"45,147",2 out of 5,2007-03-20,Evidence at protein level
Q14469,HES1_HUMAN,Transcription factor HES-1 (Class B basic helix-loop-helix protein 39) (bHLHb39) (Hairy and enhancer of split 1) (Hairy homolog) (Hairy-like protein) (hHL),280,"29,541",5 out of 5,1998-12-15,Evidence at protein level
Q9HCP6,HHATL_HUMAN,Protein-cysteine N-palmitoyltransferase HHAT-like protein (Glycerol uptake/transporter homolog) (Hedgehog acyltransferase-like protein),504,"56,703",3 out of 5,2002-09-19,Evidence at transcript level
Q16665,HIF1A_HUMAN,Hypoxia-inducible factor 1-alpha (HIF-1-alpha) (HIF1-alpha) (ARNT-interacting protein) (Basic-helix-loop-helix-PAS protein MOP1) (Class E basic helix-loop-helix protein 78) (bHLHe78) (Member of PAS protein 1) (PAS domain-containing protein 8),826,"92,670",5 out of 5,1997-11-01,Evidence at protein level
Q53FT3,HIKES_HUMAN,Protein Hikeshi,197,"21,628",5 out of 5,2006-07-11,Evidence at protein level
Q9BQA5,HINFP_HUMAN,Histone H4 transcription factor (Histone nuclear factor P) (HiNF-P) (MBD2-interacting zinc finger protein) (Methyl-CpG-binding protein 2-interacting zinc finger protein),517,"59,678",5 out of 5,2004-07-19,Evidence at protein level
O00291,HIP1_HUMAN,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),1037,"116,221",5 out of 5,2001-04-27,Evidence at protein level
Q9UL51,HCN2_HUMAN,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 (Brain cyclic nucleotide-gated channel 2) (BCNG-2),889,"96,950",5 out of 5,2003-02-28,Evidence at protein level
P51858,HDGF_HUMAN,Hepatoma-derived growth factor (HDGF) (High mobility group protein 1-like 2) (HMG-1L2),240,"26,788",5 out of 5,1996-10-01,Evidence at protein level
Q6AI08,HEAT6_HUMAN,HEAT repeat-containing protein 6 (Amplified in breast cancer protein 1),1181,"128,781",3 out of 5,2008-05-20,Evidence at protein level
Q5U5R9,HECD2_HUMAN,Probable E3 ubiquitin-protein ligase HECTD2 (EC 2.3.2.26) (HECT domain-containing protein 2) (HECT-type E3 ubiquitin transferase HECTD2),776,"88,122",3 out of 5,2006-06-27,Evidence at transcript level
Q5T8I9,HENMT_HUMAN,Small RNA 2'-O-methyltransferase (EC 2.1.1.n8) (HEN1 methyltransferase homolog 1),393,"44,525",4 out of 5,2007-09-11,Evidence at protein level
P05546,HEP2_HUMAN,Heparin cofactor 2 (Heparin cofactor II) (HC-II) (Protease inhibitor leuserpin-2) (HLS2) (Serpin D1),499,"57,071",5 out of 5,1988-11-01,Evidence at protein level
Q9UII4,HERC5_HUMAN,E3 ISG15--protein ligase HERC5 (EC 2.3.2.-) (Cyclin-E-binding protein 1) (HECT domain and RCC1-like domain-containing protein 5),1024,"116,852",5 out of 5,2004-05-10,Evidence at protein level
Q86Z02,HIPK1_HUMAN,Homeodomain-interacting protein kinase 1 (EC 2.7.11.1) (Nuclear body-associated kinase 2),1210,"130,843",5 out of 5,2003-08-29,Evidence at protein level
Q9BW71,HIRP3_HUMAN,HIRA-interacting protein 3,556,"61,957",4 out of 5,2002-06-20,Evidence at protein level
Q8NCD3,HJURP_HUMAN,Holliday junction recognition protein (14-3-3-associated AKT substrate) (Fetal liver-expressing gene 1 protein) (Up-regulated in lung cancer 9),748,"83,539",5 out of 5,2007-05-15,Evidence at protein level
P30511,HLAF_HUMAN,"HLA class I histocompatibility antigen, alpha chain F (CDA12) (HLA F antigen) (Leukocyte antigen F) (MHC class I antigen F)",346,"39,062",5 out of 5,1993-04-01,Evidence at transcript level
Q12766,HMGX3_HUMAN,HMG domain-containing protein 3 (HMG box-containing protein 3) (Protein SMF),1538,"168,334",3 out of 5,1997-11-01,Evidence at transcript level
S4R3P1,HMN13_HUMAN,Humanin-like 13 (HN13) (MT-RNR2-like protein 13),24,"2,751",2 out of 5,2014-10-01,Inferred from homology
Q95460,HMR1_HUMAN,Major histocompatibility complex class I-related gene protein (MHC class I-related gene protein) (Class I histocompatibility antigen-like protein),341,"39,366",5 out of 5,2008-07-22,Evidence at protein level
Q9BUP3,HTAI2_HUMAN,Oxidoreductase HTATIP2 (EC 1.1.1.-) (30 kDa HIV-1 TAT-interacting protein) (HIV-1 TAT-interactive protein 2),242,"27,049",5 out of 5,2005-10-25,Evidence at protein level
Q8TDB4,HUMMR_HUMAN,Protein MGARP (Corneal endothelium-specific protein 1) (CESP-1) (Hypoxia up-regulated mitochondrial movement regulator protein) (Mitochondria-localized glutamic acid-rich protein) (Ovary-specific acidic protein),240,"25,390",5 out of 5,2008-02-26,Evidence at protein level
Q96NU7,HUTI_HUMAN,Probable imidazolonepropionase (EC 3.5.2.7) (Amidohydrolase domain-containing protein 1),426,"46,743",4 out of 5,2007-04-03,Evidence at protein level
P23083,HV102_HUMAN,Immunoglobulin heavy variable 1-2 (Ig heavy chain V-I region ND) (Ig heavy chain V-I region V35),117,"13,085",5 out of 5,1991-11-01,Evidence at protein level
A0A0C4DH39,HV158_HUMAN,Immunoglobulin heavy variable 1-58,117,"13,005",4 out of 5,2016-11-30,Inferred from homology
P01814,HV270_HUMAN,Immunoglobulin heavy variable 2-70 (Ig heavy chain V-II region COR) (Ig heavy chain V-II region DAW) (Ig heavy chain V-II region OU) (Ig heavy chain V-II region SESS),119,"13,260",5 out of 5,1986-07-21,Evidence at protein level
A0A0C4DH32,HV320_HUMAN,Immunoglobulin heavy variable 3-20,117,"12,673",4 out of 5,2017-04-12,Inferred from homology
P01772,HV333_HUMAN,Immunoglobulin heavy variable 3-33 (Ig heavy chain V-III region HIL) (Ig heavy chain V-III region KOL),117,"13,074",5 out of 5,1986-07-21,Evidence at protein level
A0A0C4DH42,HV366_HUMAN,Immunoglobulin heavy variable 3-66,116,"12,698",4 out of 5,2017-01-18,Inferred from homology
Q00444,HXC5_HUMAN,Homeobox protein Hox-C5 (Homeobox protein CP11) (Homeobox protein Hox-3D),222,"24,976",4 out of 5,1993-04-01,Inferred from homology
P28356,HXD9_HUMAN,Homeobox protein Hox-D9 (Homeobox protein Hox-4C) (Homeobox protein Hox-5.2),352,"36,495",5 out of 5,1992-12-01,Evidence at protein level
Q9H2X8,I27L2_HUMAN,Interferon alpha-inducible protein 27-like protein 2 (Interferon-stimulated gene 12b protein) (ISG12(b)) (Protein TLH29) (pIFI27-like protein),130,"12,410",2 out of 5,2003-01-17,Evidence at transcript level
Q9H1B7,I2BPL_HUMAN,Interferon regulatory factor 2-binding protein-like (Enhanced at puberty protein 1),796,"82,659",5 out of 5,2003-08-29,Evidence at protein level
P10997,IAPP_HUMAN,Islet amyloid polypeptide (Amylin) (Diabetes-associated peptide) (DAP) (Insulinoma amyloid peptide),89,"9,806",5 out of 5,1989-07-01,Evidence at protein level
Q659A1,ICE2_HUMAN,Little elongation complex subunit 2 (Interactor of little elongator complex ELL subunit 2) (NMDA receptor-regulated protein 2),982,"110,011",5 out of 5,2007-08-21,Evidence at protein level
O60725,ICMT_HUMAN,Protein-S-isoprenylcysteine O-methyltransferase (EC 2.1.1.100) (Isoprenylcysteine carboxylmethyltransferase) (Prenylated protein carboxyl methyltransferase) (PPMT) (Prenylcysteine carboxyl methyltransferase) (pcCMT),284,"31,938",5 out of 5,2001-06-20,Evidence at protein level
Q9Y6W8,ICOS_HUMAN,Inducible T-cell costimulator (Activation-inducible lymphocyte immunomediatory molecule) (CD antigen CD278),199,"22,625",5 out of 5,2004-07-19,Evidence at protein level
P41134,ID1_HUMAN,DNA-binding protein inhibitor ID-1 (Class B basic helix-loop-helix protein 24) (bHLHb24) (Inhibitor of DNA binding 1) (Inhibitor of differentiation 1),155,"16,133",5 out of 5,1995-02-01,Evidence at protein level
P20042,IF2B_HUMAN,Eukaryotic translation initiation factor 2 subunit 2 (Eukaryotic translation initiation factor 2 subunit beta) (eIF-2-beta),333,"38,388",5 out of 5,1991-02-01,Evidence at protein level
Q9H2K0,IF3M_HUMAN,"Translation initiation factor IF-3, mitochondrial (IF-3(Mt)) (IF-3Mt) (IF3(mt)) (IF3mt)",278,"31,725",4 out of 5,2007-03-06,Evidence at protein level
Q5TF58,IFFO2_HUMAN,Intermediate filament family orphan 2,517,"57,328",1 out of 5,2008-03-18,Evidence at transcript level
Q01629,IFM2_HUMAN,Interferon-induced transmembrane protein 2 (Dispanin subfamily A member 2c) (DSPA2c) (Interferon-inducible protein 1-8D),132,"14,632",5 out of 5,1993-07-01,Evidence at protein level
A6NNB3,IFM5_HUMAN,Interferon-induced transmembrane protein 5 (Bone-restricted interferon-induced transmembrane protein-like protein) (BRIL) (Dispanin subfamily A member 1) (DSPA1),132,"14,378",5 out of 5,2007-10-02,Evidence at protein level
Q8IU54,IFNL1_HUMAN,Interferon lambda-1 (IFN-lambda-1) (Cytokine Zcyto21) (Interleukin-29) (IL-29),200,"21,898",5 out of 5,2004-11-23,Evidence at protein level
Q6B9Z1,IGFL4_HUMAN,Insulin growth factor-like family member 4,124,"13,885",2 out of 5,2005-12-20,Evidence at transcript level
Q9H665,IGFR1_HUMAN,IGF-like family receptor 1 (Transmembrane protein 149) (U2 small nuclear RNA auxiliary factor 1-like 4),355,"37,895",4 out of 5,2007-06-12,Evidence at protein level
P01876,IGHA1_HUMAN,Immunoglobulin heavy constant alpha 1 (Ig alpha-1 chain C region) (Ig alpha-1 chain C region BUR) (Ig alpha-1 chain C region TRO),353,"37,655",5 out of 5,1986-07-21,Evidence at protein level
P01859,IGHG2_HUMAN,Immunoglobulin heavy constant gamma 2 (Ig gamma-2 chain C region) (Ig gamma-2 chain C region DOT) (Ig gamma-2 chain C region TIL) (Ig gamma-2 chain C region ZIE),326,"35,901",5 out of 5,1986-07-21,Evidence at protein level
P01591,IGJ_HUMAN,Immunoglobulin J chain (Joining chain of multimeric IgA and IgM),159,"18,099",5 out of 5,1986-07-21,Evidence at protein level
P0DOX7,IGK_HUMAN,Immunoglobulin kappa light chain (Immunoglobulin kappa light chain EU),214,"23,379",3 out of 5,2017-03-15,Evidence at protein level
P0CG04,IGLC1_HUMAN,Immunoglobulin lambda constant 1 (Ig lambda chain C region MGC) (Ig lambda-1 chain C region),106,"11,348",5 out of 5,2010-06-15,Evidence at protein level
P15814,IGLL1_HUMAN,Immunoglobulin lambda-like polypeptide 1 (CD179 antigen-like family member B) (Ig lambda-5) (Immunoglobulin omega polypeptide) (Immunoglobulin-related protein 14.1) (CD antigen CD179b),213,"22,963",5 out of 5,1990-04-01,Evidence at protein level
Q93033,IGSF2_HUMAN,Immunoglobulin superfamily member 2 (IgSF2) (Cell surface glycoprotein V7) (Glu-Trp-Ile EWI motif-containing protein 101) (EWI-101) (CD antigen CD101),1021,"115,109",5 out of 5,2006-10-17,Evidence at protein level
O95976,IGSF6_HUMAN,Immunoglobulin superfamily member 6 (IgSF6) (Protein DORA),241,"27,013",4 out of 5,2008-02-26,Evidence at transcript level
Q8IYA8,IHO1_HUMAN,Interactor of HORMAD1 protein 1 (Cancer/testis antigen 74) (CT74) (Coiled-coil domain-containing protein 36),594,"66,343",5 out of 5,2007-09-11,Evidence at protein level
O75330,HMMR_HUMAN,Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168),724,"84,100",5 out of 5,2000-05-30,Evidence at protein level
O60812,HNRC1_HUMAN,Heterogeneous nuclear ribonucleoprotein C-like 1 (hnRNP C-like-1) (hnRNP core protein C-like 1),293,"32,142",3 out of 5,2002-05-02,Evidence at protein level
P07910,HNRPC_HUMAN,Heterogeneous nuclear ribonucleoproteins C1/C2 (hnRNP C1/C2),306,"33,670",5 out of 5,1988-08-01,Evidence at protein level
P52597,HNRPF_HUMAN,"Heterogeneous nuclear ribonucleoprotein F (hnRNP F) (Nucleolin-like protein mcs94-1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein F, N-terminally processed]",415,"45,672",5 out of 5,1996-10-01,Evidence at protein level
Q9Y251,HPSE_HUMAN,Heparanase (EC 3.2.1.166) (Endo-glucoronidase) (Heparanase-1) (Hpa1) [Cleaved into: Heparanase 8 kDa subunit; Heparanase 50 kDa subunit],543,"61,149",5 out of 5,2005-10-11,Evidence at protein level
Q9Y663,HS3SA_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3A1) (3-OST-3A) (Heparan sulfate 3-O-sulfotransferase 3A1) (h3-OST-3A),406,"44,900",5 out of 5,2005-03-15,Evidence at protein level
P0DMV8,HS71A_HUMAN,Heat shock 70 kDa protein 1A (Heat shock 70 kDa protein 1) (HSP70-1) (HSP70.1),641,"70,052",5 out of 5,2015-05-27,Evidence at protein level
Q6YN16,HSDL2_HUMAN,Hydroxysteroid dehydrogenase-like protein 2 (EC 1.-.-.-) (Short chain dehydrogenase/reductase family 13C member 1),418,"45,395",5 out of 5,2008-02-26,Evidence at protein level
P11142,HSP7C_HUMAN,Heat shock cognate 71 kDa protein (Heat shock 70 kDa protein 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1),646,"70,898",5 out of 5,1989-07-01,Evidence at protein level
Q12988,HSPB3_HUMAN,Heat shock protein beta-3 (HspB3) (Heat shock 17 kDa protein) (HSP 17) (Protein 3),150,"16,966",4 out of 5,1999-07-15,Evidence at protein level
P0DP01,HV108_HUMAN,Immunoglobulin heavy variable 1-8,117,"12,992",3 out of 5,2017-04-12,Inferred from homology
A0A075B6R2,HV404_HUMAN,Immunoglobulin heavy variable 4-4,117,"12,848",4 out of 5,2017-01-18,Inferred from homology
A0A0J9YXX1,HV5X1_HUMAN,Immunoglobulin heavy variable 5-10-1,117,"12,773",2 out of 5,2017-04-12,Inferred from homology
P0DP08,HVD82_HUMAN,Immunoglobulin heavy variable 4-38-2,117,"13,016",3 out of 5,2017-04-12,Inferred from homology
P31267,HXA6_HUMAN,Homeobox protein Hox-A6 (Homeobox protein Hox-1B),233,"26,339",3 out of 5,1993-07-01,Evidence at transcript level
P31268,HXA7_HUMAN,Homeobox protein Hox-A7 (Homeobox protein Hox 1.1) (Homeobox protein Hox-1A),230,"25,355",5 out of 5,1993-07-01,Evidence at transcript level
P31273,HXC8_HUMAN,Homeobox protein Hox-C8 (Homeobox protein Hox-3A),242,"27,755",4 out of 5,1993-07-01,Evidence at protein level
Q5T013,HYI_HUMAN,Putative hydroxypyruvate isomerase (EC 5.3.1.22) (Endothelial cell apoptosis protein E-CE1),277,"30,406",3 out of 5,2007-05-29,Evidence at protein level
Q9Y4L1,HYOU1_HUMAN,Hypoxia up-regulated protein 1 (150 kDa oxygen-regulated protein) (ORP-150) (170 kDa glucose-regulated protein) (GRP-170),999,"111,335",5 out of 5,2000-12-01,Evidence at protein level
O75409,HYPM_HUMAN,Huntingtin-interacting protein M (Huntingtin yeast partner M),117,"13,442",3 out of 5,2006-10-31,Evidence at protein level
Q13651,I10R1_HUMAN,Interleukin-10 receptor subunit alpha (IL-10 receptor subunit alpha) (IL-10R subunit alpha) (IL-10RA) (CDw210a) (Interleukin-10 receptor subunit 1) (IL-10R subunit 1) (IL-10R1) (CD antigen CD210),578,"63,003",5 out of 5,1998-07-15,Evidence at protein level
Q14626,I11RA_HUMAN,Interleukin-11 receptor subunit alpha (IL-11 receptor subunit alpha) (IL-11R subunit alpha) (IL-11R-alpha) (IL-11RA),422,"45,222",5 out of 5,2004-11-23,Evidence at protein level
Q99665,I12R2_HUMAN,Interleukin-12 receptor subunit beta-2 (IL-12 receptor subunit beta-2) (IL-12R subunit beta-2) (IL-12R-beta-2) (IL-12RB2),862,"97,135",5 out of 5,2000-12-01,Evidence at protein level
Q8NFR9,I17RE_HUMAN,Interleukin-17 receptor E (IL-17 receptor E) (IL-17RE),667,"74,810",5 out of 5,2007-12-04,Evidence at protein level
Q9UBH0,I36RA_HUMAN,Interleukin-36 receptor antagonist protein (IL-36Ra) (FIL1 delta) (IL-1-related protein 3) (IL-1RP3) (Interleukin-1 HY1) (IL-1HY1) (Interleukin-1 delta) (IL-1 delta) (Interleukin-1 family member 5) (IL-1F5) (Interleukin-1 receptor antagonist homolog 1) (IL-1ra homolog 1) (Interleukin-1-like protein 1) (IL-1L1),155,"16,962",5 out of 5,2002-11-08,Evidence at protein level
P32019,I5P2_HUMAN,"Type II inositol 1,4,5-trisphosphate 5-phosphatase (EC 3.1.3.36) (75 kDa inositol polyphosphate-5-phosphatase) (Phosphoinositide 5-phosphatase) (5PTase)",993,"112,852",5 out of 5,1993-07-01,Evidence at protein level
P05362,ICAM1_HUMAN,Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54),532,"57,825",5 out of 5,1988-11-01,Evidence at protein level
P47928,ID4_HUMAN,DNA-binding protein inhibitor ID-4 (Class B basic helix-loop-helix protein 27) (bHLHb27) (Inhibitor of DNA binding 4) (Inhibitor of differentiation 4),161,"16,622",5 out of 5,1996-02-01,Evidence at protein level
P98153,IDD_HUMAN,Integral membrane protein DGCR2/IDD,550,"60,811",5 out of 5,1996-10-01,Evidence at protein level
P48735,IDHP_HUMAN,"Isocitrate dehydrogenase [NADP], mitochondrial (IDH) (EC 1.1.1.42) (ICD-M) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase)",452,"50,909",5 out of 5,1996-02-01,Evidence at protein level
O14645,IDLC_HUMAN,"Axonemal dynein light intermediate polypeptide 1 (Inner dynein arm light chain, axonemal) (hp28)",258,"29,662",4 out of 5,2001-06-20,Evidence at protein level
Q9BTL4,IER2_HUMAN,Immediate early response gene 2 protein (Protein ETR101),223,"24,196",4 out of 5,2005-08-30,Evidence at protein level
O97980,HMHB1_HUMAN,Minor histocompatibility protein HB-1 [Cleaved into: Minor histocompatibility antigen HB-1 (mHag HB-1)],41,"4,965",5 out of 5,2008-04-29,Evidence at protein level
P0CJ72,HMN5_HUMAN,Humanin-like 5 (HN5) (MT-RNR2-like protein 5),24,"2,666",3 out of 5,2011-02-08,Evidence at transcript level
Q9NP08,HMX1_HUMAN,Homeobox protein HMX1 (Homeobox protein H6),348,"36,155",4 out of 5,2007-02-20,Evidence at transcript level
Q14541,HNF4G_HUMAN,Hepatocyte nuclear factor 4-gamma (HNF-4-gamma) (Nuclear receptor subfamily 2 group A member 2),408,"45,877",5 out of 5,1999-07-15,Evidence at protein level
Q1KMD3,HNRL2_HUMAN,Heterogeneous nuclear ribonucleoprotein U-like protein 2 (Scaffold-attachment factor A2) (SAF-A2),747,"85,105",3 out of 5,2007-02-20,Evidence at protein level
Q86VS8,HOOK3_HUMAN,Protein Hook homolog 3 (h-hook3) (hHK3),718,"83,126",5 out of 5,2004-02-02,Evidence at protein level
Q8IWW8,HOT_HUMAN,"Hydroxyacid-oxoacid transhydrogenase, mitochondrial (HOT) (EC 1.1.99.24) (Alcohol dehydrogenase iron-containing protein 1) (ADHFe1) (Fe-containing alcohol dehydrogenase)",467,"50,308",5 out of 5,2008-03-18,Evidence at protein level
Q9UM19,HPCL4_HUMAN,Hippocalcin-like protein 4 (HLP4),191,"22,202",4 out of 5,2004-08-16,Evidence at protein level
Q9UPZ3,HPS5_HUMAN,Hermansky-Pudlak syndrome 5 protein (Alpha-integrin-binding protein 63) (Ruby-eye protein 2 homolog) (Ru2),1129,"127,449",5 out of 5,2001-02-21,Evidence at protein level
P00739,HPTR_HUMAN,Haptoglobin-related protein,348,"39,030",5 out of 5,1986-07-21,Evidence at transcript level
Q92598,HS105_HUMAN,Heat shock protein 105 kDa (Antigen NY-CO-25) (Heat shock 110 kDa protein),858,"96,865",5 out of 5,1997-11-01,Evidence at protein level
O75506,HSBP1_HUMAN,Heat shock factor-binding protein 1 (Nasopharyngeal carcinoma-associated antigen 13) (NPC-A-13),76,"8,544",5 out of 5,2000-05-30,Evidence at protein level
Q16082,HSPB2_HUMAN,Heat shock protein beta-2 (HspB2) (DMPK-binding protein) (MKBP),182,"20,233",4 out of 5,1999-07-15,Evidence at protein level
Q9UJY1,HSPB8_HUMAN,Heat shock protein beta-8 (HspB8) (Alpha-crystallin C chain) (E2-induced gene 1 protein) (Protein kinase H11) (Small stress protein-like protein HSP22),196,"21,604",5 out of 5,2001-04-27,Evidence at protein level
Q96N76,HUTU_HUMAN,Urocanate hydratase (Urocanase) (EC 4.2.1.49) (Imidazolonepropionate hydrolase),676,"74,831",4 out of 5,2002-08-13,Evidence at protein level
A0A0B4J1X5,HV374_HUMAN,Immunoglobulin heavy variable 3-74,117,"12,840",4 out of 5,2017-01-18,Inferred from homology
A0A0G2JMI3,HV692_HUMAN,Immunoglobulin heavy variable 1-69-2,117,"12,871",4 out of 5,2017-04-12,Inferred from homology
P31270,HXA11_HUMAN,Homeobox protein Hox-A11 (Homeobox protein Hox-1I),313,"34,486",5 out of 5,1993-07-01,Evidence at transcript level
P09017,HXC4_HUMAN,Homeobox protein Hox-C4 (Homeobox protein CP19) (Homeobox protein Hox-3E),264,"29,811",4 out of 5,1988-11-01,Evidence at protein level
Q96BM0,I27L1_HUMAN,Interferon alpha-inducible protein 27-like protein 1 (Interferon-stimulated gene 12c protein) (ISG12(c)),104,"9,549",2 out of 5,2003-01-17,Evidence at protein level
A6NMX2,I4E1B_HUMAN,Eukaryotic translation initiation factor 4E type 1B,242,"27,596",2 out of 5,2008-07-01,Inferred from homology
Q8WUF5,IASPP_HUMAN,RelA-associated inhibitor (Inhibitor of ASPP protein) (Protein iASPP) (NFkB-interacting protein 1) (PPP1R13B-like protein),828,"89,091",5 out of 5,2003-08-15,Evidence at protein level
P22692,IBP4_HUMAN,Insulin-like growth factor-binding protein 4 (IBP-4) (IGF-binding protein 4) (IGFBP-4),258,"27,934",5 out of 5,1991-08-01,Evidence at protein level
P24592,IBP6_HUMAN,Insulin-like growth factor-binding protein 6 (IBP-6) (IGF-binding protein 6) (IGFBP-6),240,"25,322",5 out of 5,1992-03-01,Evidence at protein level
Q6NT76,HMBX1_HUMAN,Homeobox-containing protein 1,420,"47,278",5 out of 5,2006-05-02,Evidence at protein level
Q8NDA2,HMCN2_HUMAN,Hemicentin-2,5059,"541,978",3 out of 5,2010-06-15,Evidence at transcript level
P04035,HMDH_HUMAN,3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) (EC 1.1.1.34),888,"97,476",5 out of 5,1986-11-01,Evidence at protein level
P19622,HME2_HUMAN,Homeobox protein engrailed-2 (Homeobox protein en-2) (Hu-En-2),333,"34,211",4 out of 5,1991-02-01,Evidence at transcript level
P52926,HMGA2_HUMAN,High mobility group protein HMGI-C (High mobility group AT-hook protein 2),109,"11,832",5 out of 5,1996-10-01,Evidence at protein level
P05204,HMGN2_HUMAN,Non-histone chromosomal protein HMG-17 (High mobility group nucleosome-binding domain-containing protein 2),90,"9,393",5 out of 5,1987-08-13,Evidence at protein level
P82970,HMGN5_HUMAN,High mobility group nucleosome-binding domain-containing protein 5 (Nucleosome-binding protein 1),282,"31,525",5 out of 5,2002-09-19,Evidence at protein level
P0CJ71,HMN4_HUMAN,Humanin-like 4 (HN4) (MT-RNR2-like protein 4),28,"3,247",2 out of 5,2011-02-08,Evidence at transcript level
P20823,HNF1A_HUMAN,Hepatocyte nuclear factor 1-alpha (HNF-1-alpha) (HNF-1A) (Liver-specific transcription factor LF-B1) (LFB1) (Transcription factor 1) (TCF-1),631,"67,356",5 out of 5,1991-02-01,Evidence at protein level
P41235,HNF4A_HUMAN,Hepatocyte nuclear factor 4-alpha (HNF-4-alpha) (Nuclear receptor subfamily 2 group A member 1) (Transcription factor 14) (TCF-14) (Transcription factor HNF-4),474,"52,785",5 out of 5,1995-02-01,Evidence at protein level
Q9NZL4,HPBP1_HUMAN,Hsp70-binding protein 1 (HspBP1) (Heat shock protein-binding protein 1) (Hsp70-binding protein 2) (HspBP2) (Hsp70-interacting protein 1) (Hsp70-interacting protein 2),362,"39,474",5 out of 5,2005-10-25,Evidence at protein level
Q96IR7,HPDL_HUMAN,4-hydroxyphenylpyruvate dioxygenase-like protein (EC 1.13.-.-) (Glyoxalase domain-containing protein 1),371,"39,386",3 out of 5,2007-01-09,Evidence at protein level
Q9NWY4,HPF1_HUMAN,Histone PARylation factor 1,346,"39,436",4 out of 5,2007-07-10,Evidence at protein level
O60760,HPGDS_HUMAN,Hematopoietic prostaglandin D synthase (H-PGDS) (EC 5.3.99.2) (GST class-sigma) (Glutathione S-transferase) (EC 2.5.1.18) (Glutathione-dependent PGD synthase) (Glutathione-requiring prostaglandin D synthase) (Prostaglandin-H2 D-isomerase),199,"23,344",5 out of 5,2000-05-30,Evidence at protein level
Q9NWW0,HPIP_HUMAN,Host cell factor C1 regulator 1 (HCF-1 beta-propeller-interacting protein),138,"15,291",4 out of 5,2008-06-10,Evidence at protein level
P32754,HPPD_HUMAN,4-hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27) (4-hydroxyphenylpyruvic acid oxidase) (4HPPD) (HPD) (HPPDase),393,"44,934",5 out of 5,1993-10-01,Evidence at protein level
Q00613,HSF1_HUMAN,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),529,"57,260",5 out of 5,1994-02-01,Evidence at protein level
P48741,HSP77_HUMAN,Putative heat shock 70 kDa protein 7 (Heat shock 70 kDa protein B),367,"40,244",2 out of 5,1996-02-01,Uncertain
O14558,HSPB6_HUMAN,Heat shock protein beta-6 (HspB6) (Heat shock 20 kDa-like protein p20),160,"17,136",5 out of 5,1999-07-15,Evidence at protein level
O43719,HTSF1_HUMAN,HIV Tat-specific factor 1 (Tat-SF1),755,"85,853",5 out of 5,2006-09-05,Evidence at protein level
P52789,HXK2_HUMAN,Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Muscle form hexokinase),917,"102,380",5 out of 5,1996-10-01,Evidence at protein level
P52790,HXK3_HUMAN,Hexokinase-3 (EC 2.7.1.1) (Hexokinase type III) (HK III),923,"99,025",5 out of 5,1996-10-01,Evidence at protein level
Q12794,HYAL1_HUMAN,Hyaluronidase-1 (Hyal-1) (EC 3.2.1.35) (Hyaluronoglucosaminidase-1) (Lung carcinoma protein 1) (LuCa-1),435,"48,368",5 out of 5,2005-10-25,Evidence at protein level
Q92839,HYAS1_HUMAN,Hyaluronan synthase 1 (EC 2.4.1.212) (Hyaluronate synthase 1) (Hyaluronic acid synthase 1) (HA synthase 1) (HuHAS1),578,"64,832",5 out of 5,2000-05-30,Evidence at transcript level
Q92819,HYAS2_HUMAN,Hyaluronan synthase 2 (EC 2.4.1.212) (Hyaluronate synthase 2) (Hyaluronic acid synthase 2) (HA synthase 2),552,"63,566",5 out of 5,2000-05-30,Evidence at transcript level
P07099,HYEP_HUMAN,Epoxide hydrolase 1 (EC 3.3.2.9) (Epoxide hydratase) (Microsomal epoxide hydrolase),455,"52,949",5 out of 5,1988-04-01,Evidence at protein level
P42701,I12R1_HUMAN,Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212),662,"73,109",5 out of 5,1995-11-01,Evidence at protein level
Q8NAC3,I17RC_HUMAN,Interleukin-17 receptor C (IL-17 receptor C) (IL-17RC) (Interleukin-17 receptor homolog) (IL17Rhom) (Interleukin-17 receptor-like protein) (IL-17RL) (ZcytoR14),791,"86,240",5 out of 5,2005-06-21,Evidence at protein level
O95256,I18RA_HUMAN,Interleukin-18 receptor accessory protein (IL-18 receptor accessory protein) (IL-18RAcP) (Accessory protein-like) (AcPL) (CD218 antigen-like family member B) (CDw218b) (IL-1R accessory protein-like) (IL-1RAcPL) (Interleukin-1 receptor 7) (IL-1R-7) (IL-1R7) (Interleukin-18 receptor accessory protein-like) (Interleukin-18 receptor beta) (IL-18R-beta) (IL-18Rbeta) (CD antigen CD218b),599,"68,310",5 out of 5,2005-09-27,Evidence at protein level
Q9UHF4,I20RA_HUMAN,Interleukin-20 receptor subunit alpha (IL-20 receptor subunit alpha) (IL-20R-alpha) (IL-20RA) (Cytokine receptor class-II member 8) (Cytokine receptor family 2 member 8) (CRF2-8) (IL-20R1) (ZcytoR7),553,"62,485",5 out of 5,2004-08-31,Evidence at protein level
Q969J5,I22R2_HUMAN,"Interleukin-22 receptor subunit alpha-2 (IL-22 receptor subunit alpha-2) (IL-22R-alpha-2) (IL-22RA2) (Cytokine receptor class-II member 10) (Cytokine receptor family 2 member 10) (CRF2-10) (Cytokine receptor family type 2, soluble 1) (CRF2-S1) (Interleukin-22-binding protein) (IL-22BP) (IL22BP) (ZcytoR16)",263,"30,550",5 out of 5,2005-03-15,Evidence at protein level
B1ANH7,IBAS1_HUMAN,Putative uncharacterized protein IBA57-AS1 (IBA57 antisense RNA 1) (IBA57 antisense gene protein 1),110,"12,198",1 out of 5,2011-07-27,Uncertain
Q8NDH6,ICA1L_HUMAN,Islet cell autoantigen 1-like protein (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 14 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 15 protein),482,"54,407",2 out of 5,2006-01-24,Evidence at protein level
P20810,ICAL_HUMAN,Calpastatin (Calpain inhibitor) (Sperm BS-17 component),708,"76,573",5 out of 5,1991-02-01,Evidence at protein level
P86397,HTD2_HUMAN,"Hydroxyacyl-thioester dehydratase type 2, mitochondrial (HsHTD2) (EC 4.2.1.-) (3-hydroxyacyl-[acyl-carrier-protein] dehydratase)",168,"18,559",4 out of 5,2009-12-15,Evidence at protein level
Q92743,HTRA1_HUMAN,Serine protease HTRA1 (EC 3.4.21.-) (High-temperature requirement A serine peptidase 1) (L56) (Serine protease 11),480,"51,287",5 out of 5,2001-09-26,Evidence at protein level
P83110,HTRA3_HUMAN,Serine protease HTRA3 (EC 3.4.21.-) (High-temperature requirement factor A3) (Pregnancy-related serine protease),453,"48,608",5 out of 5,2001-09-26,Evidence at protein level
P83105,HTRA4_HUMAN,Serine protease HTRA4 (EC 3.4.21.-) (High-temperature requirement factor A4),476,"50,979",3 out of 5,2001-11-16,Evidence at transcript level
Q8IVG9,HUNIN_HUMAN,Humanin (Humanin mitochondrial) (HNM),24,"2,687",5 out of 5,2004-09-27,Evidence at protein level
A0A0A0MS14,HV145_HUMAN,Immunoglobulin heavy variable 1-45,117,"13,508",4 out of 5,2016-11-30,Inferred from homology
P01742,HV169_HUMAN,Immunoglobulin heavy variable 1-69 (Ig heavy chain V-I region EU) (Ig heavy chain V-I region SIE) (Ig heavy chain V-I region WOL),117,"12,659",5 out of 5,1986-07-21,Evidence at protein level
P01763,HV348_HUMAN,Immunoglobulin heavy variable 3-48 (Ig heavy chain V-III region WEA),117,"12,813",5 out of 5,1986-07-21,Evidence at protein level
A0A087WSY4,HV432_HUMAN,Immunoglobulin heavy variable 4-30-2,118,"13,025",4 out of 5,2017-04-12,Inferred from homology
P01824,HV439_HUMAN,Immunoglobulin heavy variable 4-39 (Ig heavy chain V-II region WAH),125,"13,917",5 out of 5,1986-07-21,Evidence at protein level
A0A0C4DH38,HV551_HUMAN,Immunoglobulin heavy variable 5-51,117,"12,675",4 out of 5,2017-01-18,Inferred from homology
P0DP06,HVD34_HUMAN,Immunoglobulin heavy variable 4-30-4,118,"13,156",3 out of 5,2017-04-12,Inferred from homology
O43248,HXC11_HUMAN,Homeobox protein Hox-C11 (Homeobox protein Hox-3H),304,"33,748",5 out of 5,1998-07-15,Evidence at protein level
P09630,HXC6_HUMAN,Homeobox protein Hox-C6 (Homeobox protein CP25) (Homeobox protein HHO.C8) (Homeobox protein Hox-3C),235,"26,915",5 out of 5,1989-07-01,Evidence at transcript level
P31277,HXD11_HUMAN,Homeobox protein Hox-D11 (Homeobox protein Hox-4F),338,"35,197",3 out of 5,1993-07-01,Inferred from homology
P13378,HXD8_HUMAN,Homeobox protein Hox-D8 (Homeobox protein Hox-4E) (Homeobox protein Hox-5.4),290,"31,911",4 out of 5,1990-01-01,Evidence at transcript level
P19367,HXK1_HUMAN,Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I),917,"102,486",5 out of 5,1990-11-01,Evidence at protein level
A2RU49,HYKK_HUMAN,Hydroxylysine kinase (5-hydroxy-L-lysine kinase) (EC 2.7.1.81) (Aminoglycoside phosphotransferase domain-containing protein 1),373,"41,933",4 out of 5,2008-03-18,Evidence at protein level
Q6UWB1,I27RA_HUMAN,Interleukin-27 receptor subunit alpha (IL-27 receptor subunit alpha) (IL-27R subunit alpha) (IL-27R-alpha) (IL-27RA) (Cytokine receptor WSX-1) (Cytokine receptor-like 1) (Type I T-cell cytokine receptor) (TCCR) (ZcytoR1),636,"69,474",5 out of 5,2005-03-29,Evidence at transcript level
P08833,IBP1_HUMAN,Insulin-like growth factor-binding protein 1 (IBP-1) (IGF-binding protein 1) (IGFBP-1) (Placental protein 12) (PP12),259,"27,904",5 out of 5,1988-11-01,Evidence at protein level
P18065,IBP2_HUMAN,Insulin-like growth factor-binding protein 2 (IBP-2) (IGF-binding protein 2) (IGFBP-2),325,"34,814",5 out of 5,1990-11-01,Evidence at protein level
Q14197,ICT1_HUMAN,"Peptidyl-tRNA hydrolase ICT1, mitochondrial (EC 3.1.1.29) (39S ribosomal protein L58, mitochondrial) (MRP-L58) (Digestion substraction 1) (DS-1) (Immature colon carcinoma transcript 1 protein) (Mitochondrial large ribosomal subunit protein mL62)",206,"23,630",5 out of 5,1999-07-15,Evidence at protein level
Q02363,ID2_HUMAN,DNA-binding protein inhibitor ID-2 (Class B basic helix-loop-helix protein 26) (bHLHb26) (Inhibitor of DNA binding 2) (Inhibitor of differentiation 2),134,"14,917",5 out of 5,1995-02-01,Evidence at protein level
P14735,IDE_HUMAN,Insulin-degrading enzyme (EC 3.4.24.56) (Abeta-degrading protease) (Insulin protease) (Insulinase) (Insulysin),1019,"117,968",5 out of 5,1990-04-01,Evidence at protein level
P50213,IDH3A_HUMAN,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit alpha) (NAD(+)-specific ICDH subunit alpha)",366,"39,592",5 out of 5,1996-10-01,Evidence at protein level
Q13907,IDI1_HUMAN,Isopentenyl-diphosphate Delta-isomerase 1 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 1) (IPP isomerase 1) (IPPI1),227,"26,319",5 out of 5,2000-05-30,Evidence at protein level
Q5T953,IER5L_HUMAN,Immediate early response gene 5-like protein,404,"42,109",2 out of 5,2008-05-20,Evidence at transcript level
Q9UG01,IF172_HUMAN,Intraflagellar transport protein 172 homolog,1749,"197,576",5 out of 5,2008-04-08,Evidence at protein level
P41091,IF2G_HUMAN,Eukaryotic translation initiation factor 2 subunit 3 (Eukaryotic translation initiation factor 2 subunit gamma X) (eIF-2-gamma X) (eIF-2gX),472,"51,109",5 out of 5,1995-02-01,Evidence at protein level
Q53G44,IF44L_HUMAN,Interferon-induced protein 44-like,452,"51,322",4 out of 5,2008-06-10,Evidence at transcript level
Q14240,IF4A2_HUMAN,Eukaryotic initiation factor 4A-II (eIF-4A-II) (eIF4A-II) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-2),407,"46,402",5 out of 5,1997-11-01,Evidence at protein level
P23588,IF4B_HUMAN,Eukaryotic translation initiation factor 4B (eIF-4B),611,"69,151",5 out of 5,1991-11-01,Evidence at protein level
Q04637,IF4G1_HUMAN,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),1599,"175,491",5 out of 5,1995-02-01,Evidence at protein level
Q96M15,IFAS1_HUMAN,Putative uncharacterized protein IGF2BP2-AS1 (IGF2BP2 antisense RNA 1) (IGF2BP2 antisense gene protein 1),143,"15,995",1 out of 5,2006-12-12,Evidence at transcript level
Q9H496,IFG15_HUMAN,"Torsin-1A-interacting protein 2, isoform IFRG15 (15 kDa interferon-responsive protein) (IFRG15)",131,"15,348",2 out of 5,2013-02-06,Evidence at protein level
A6NMD0,IFM10_HUMAN,Interferon-induced transmembrane protein 10 (Dispanin subfamily A member 3) (DSPA3),228,"24,599",2 out of 5,2008-04-29,Evidence at transcript level
P01571,IFN17_HUMAN,Interferon alpha-17 (IFN-alpha-17) (Interferon alpha-88) (Interferon alpha-I') (LeIF I) (Interferon alpha-T),189,"21,728",5 out of 5,1986-07-21,Evidence at protein level
P05014,IFNA4_HUMAN,Interferon alpha-4 (IFN-alpha-4) (Interferon alpha-4B) (Interferon alpha-76) (Interferon alpha-M1),189,"21,808",5 out of 5,1987-08-13,Evidence at protein level
A0AVF1,IFT56_HUMAN,Intraflagellar transport protein 56 (Tetratricopeptide repeat protein 26) (TPR repeat protein 26),554,"64,178",4 out of 5,2007-05-29,Evidence at transcript level
Q8IVU1,IGDC3_HUMAN,Immunoglobulin superfamily DCC subclass member 3 (Putative neuronal cell adhesion molecule),814,"86,724",3 out of 5,2004-12-21,Evidence at transcript level
Q8TDY8,IGDC4_HUMAN,Immunoglobulin superfamily DCC subclass member 4 (Neighbor of punc e11) (Protein DDM36) (hDDM36),1250,"134,210",4 out of 5,2007-09-11,Evidence at protein level
Q9H2S9,IKZF4_HUMAN,Zinc finger protein Eos (Ikaros family zinc finger protein 4),585,"64,106",5 out of 5,2007-09-11,Evidence at protein level
P14778,IL1R1_HUMAN,"Interleukin-1 receptor type 1 (IL-1R-1) (IL-1RT-1) (IL-1RT1) (CD121 antigen-like family member A) (Interleukin-1 receptor alpha) (IL-1R-alpha) (Interleukin-1 receptor type I) (p80) (CD antigen CD121a) [Cleaved into: Interleukin-1 receptor type 1, membrane form (mIL-1R1) (mIL-1RI); Interleukin-1 receptor type 1, soluble form (sIL-1R1) (sIL-1RI)]",569,"65,402",5 out of 5,1990-04-01,Evidence at protein level
Q9HBE4,IL21_HUMAN,Interleukin-21 (IL-21) (Za11),155,"17,923",5 out of 5,2004-11-23,Evidence at protein level
Q9NPH9,IL26_HUMAN,Interleukin-26 (IL-26) (Protein AK155),171,"19,843",5 out of 5,2001-11-16,Evidence at protein level
P08700,IL3_HUMAN,Interleukin-3 (IL-3) (Hematopoietic growth factor) (Mast cell growth factor) (MCGF) (Multipotential colony-stimulating factor) (P-cell-stimulating factor),152,"17,233",5 out of 5,1988-01-01,Evidence at protein level
P17066,HSP76_HUMAN,Heat shock 70 kDa protein 6 (Heat shock 70 kDa protein B'),643,"71,028",5 out of 5,1990-08-01,Evidence at protein level
Q99081,HTF4_HUMAN,Transcription factor 12 (TCF-12) (Class B basic helix-loop-helix protein 20) (bHLHb20) (DNA-binding protein HTF4) (E-box-binding protein) (Transcription factor HTF-4),682,"72,965",5 out of 5,1996-10-01,Evidence at protein level
O43464,HTRA2_HUMAN,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)",458,"48,841",5 out of 5,2001-09-26,Evidence at protein level
Q8NHY5,HUS1B_HUMAN,Checkpoint protein HUS1B (hHUS1B),278,"30,982",3 out of 5,2006-03-07,Evidence at protein level
O60921,HUS1_HUMAN,Checkpoint protein HUS1 (hHUS1),280,"31,691",5 out of 5,2006-03-07,Evidence at protein level
Q7Z6Z7,HUWE1_HUMAN,"E3 ubiquitin-protein ligase HUWE1 (EC 2.3.2.26) (ARF-binding protein 1) (ARF-BP1) (HECT, UBA and WWE domain-containing protein 1) (HECT-type E3 ubiquitin transferase HUWE1) (Homologous to E6AP carboxyl terminus homologous protein 9) (HectH9) (Large structure of UREB1) (LASU1) (Mcl-1 ubiquitin ligase E3) (Mule) (Upstream regulatory element-binding protein 1) (URE-B1) (URE-binding protein 1)",4374,"481,891",5 out of 5,2004-07-19,Evidence at protein level
P01762,HV311_HUMAN,Immunoglobulin heavy variable 3-11 (Ig heavy chain V-III region TRO),117,"12,909",5 out of 5,1986-07-21,Evidence at protein level
A0A0B4J1V1,HV321_HUMAN,Immunoglobulin heavy variable 3-21,117,"12,840",4 out of 5,2016-11-30,Evidence at protein level
P01764,HV323_HUMAN,Immunoglobulin heavy variable 3-23 (Ig heavy chain V-III region LAY) (Ig heavy chain V-III region POM) (Ig heavy chain V-III region TEI) (Ig heavy chain V-III region TIL) (Ig heavy chain V-III region TUR) (Ig heavy chain V-III region VH26) (Ig heavy chain V-III region WAS) (Ig heavy chain V-III region ZAP),117,"12,582",5 out of 5,1986-07-21,Evidence at protein level
A0A0B4J1X8,HV343_HUMAN,Immunoglobulin heavy variable 3-43,118,"13,077",4 out of 5,2016-11-30,Inferred from homology
A0A0B4J1Y9,HV372_HUMAN,Immunoglobulin heavy variable 3-72,119,"13,203",4 out of 5,2017-01-18,Inferred from homology
A0A0J9YVY3,HV741_HUMAN,Immunoglobulin heavy variable 7-4-1,117,"12,849",2 out of 5,2017-04-12,Inferred from homology
Q96D96,HVCN1_HUMAN,Voltage-gated hydrogen channel 1 (Hydrogen voltage-gated channel 1) (HV1) (Voltage sensor domain-only protein),273,"31,683",5 out of 5,2008-07-01,Evidence at protein level
P17483,HXB4_HUMAN,Homeobox protein Hox-B4 (Homeobox protein Hox-2.6) (Homeobox protein Hox-2F),251,"27,604",5 out of 5,1990-08-01,Evidence at protein level
P17509,HXB6_HUMAN,Homeobox protein Hox-B6 (Homeobox protein Hox-2.2) (Homeobox protein Hox-2B) (Homeobox protein Hu-2),224,"25,432",4 out of 5,1990-08-01,Evidence at protein level
P09629,HXB7_HUMAN,Homeobox protein Hox-B7 (Homeobox protein HHO.C1) (Homeobox protein Hox-2C),217,"24,015",5 out of 5,1989-07-01,Evidence at protein level
P35452,HXD12_HUMAN,Homeobox protein Hox-D12 (Homeobox protein Hox-4H),270,"29,031",4 out of 5,1994-06-01,Evidence at protein level
Q7Z5L9,I2BP2_HUMAN,Interferon regulatory factor 2-binding protein 2 (IRF-2-binding protein 2) (IRF-2BP2),587,"61,025",5 out of 5,2008-04-08,Evidence at protein level
Q14642,I5P1_HUMAN,"Type I inositol 1,4,5-trisphosphate 5-phosphatase (5PTase) (EC 3.1.3.56)",412,"47,820",5 out of 5,1998-07-15,Evidence at protein level
Q02535,ID3_HUMAN,DNA-binding protein inhibitor ID-3 (Class B basic helix-loop-helix protein 25) (bHLHb25) (Helix-loop-helix protein HEIR-1) (ID-like protein inhibitor HLH 1R21) (Inhibitor of DNA binding 3) (Inhibitor of differentiation 3),119,"12,999",5 out of 5,1995-02-01,Evidence at protein level
O75874,IDHC_HUMAN,Isocitrate dehydrogenase [NADP] cytoplasmic (IDH) (EC 1.1.1.42) (Cytosolic NADP-isocitrate dehydrogenase) (IDP) (NADP(+)-specific ICDH) (Oxalosuccinate decarboxylase),414,"46,659",5 out of 5,2000-05-30,Evidence at protein level
Q5VY09,IER5_HUMAN,Immediate early response gene 5 protein,327,"33,704",5 out of 5,2005-08-30,Evidence at protein level
Q0D2I5,IFFO1_HUMAN,Intermediate filament family orphan 1 (Tumor antigen HOM-TES-103),559,"61,979",3 out of 5,2008-02-05,Evidence at transcript level
Q9BYX4,IFIH1_HUMAN,Interferon-induced helicase C domain-containing protein 1 (EC 3.6.4.13) (Clinically amyopathic dermatomyositis autoantigen 140 kDa) (CADM-140 autoantigen) (Helicase with 2 CARD domains) (Helicard) (Interferon-induced with helicase C domain protein 1) (Melanoma differentiation-associated protein 5) (MDA-5) (Murabutide down-regulated protein) (RIG-I-like receptor 2) (RLR-2) (RNA helicase-DEAD box protein 116),1025,"116,689",5 out of 5,2005-04-12,Evidence at protein level
P05015,IFN16_HUMAN,Interferon alpha-16 (IFN-alpha-16) (Interferon alpha-WA),189,"21,711",5 out of 5,1987-08-13,Evidence at transcript level
P01567,IFNA7_HUMAN,Interferon alpha-7 (IFN-alpha-7) (Interferon alpha-J) (LeIF J) (Interferon alpha-J1) (IFN-alpha-J1),189,"22,107",5 out of 5,1986-07-21,Evidence at protein level
Q86WN2,IFNE_HUMAN,Interferon epsilon (IFN-epsilon) (Interferon epsilon-1),208,"24,414",4 out of 5,2008-02-05,Evidence at transcript level
Q9P0W0,IFNK_HUMAN,Interferon kappa (IFN-kappa),207,"25,218",5 out of 5,2005-03-01,Evidence at protein level
Q12894,IFRD2_HUMAN,Interferon-related developmental regulator 2 (Protein SKMC15),506,"54,814",3 out of 5,2000-05-30,Evidence at protein level
Q9Y366,IFT52_HUMAN,Intraflagellar transport protein 52 homolog (Protein NGD5 homolog),437,"49,706",5 out of 5,2002-10-19,Evidence at protein level
Q9NWB7,IFT57_HUMAN,Intraflagellar transport protein 57 homolog (Dermal papilla-derived protein 8) (Estrogen-related receptor beta-like protein 1) (HIP1-interacting protein) (MHS4R2),429,"49,108",5 out of 5,2008-04-08,Evidence at protein level
Q9P2H3,IFT80_HUMAN,Intraflagellar transport protein 80 homolog (WD repeat-containing protein 56),777,"88,035",5 out of 5,2005-03-15,Evidence at protein level
P49639,HXA1_HUMAN,Homeobox protein Hox-A1 (Homeobox protein Hox-1F),335,"36,641",5 out of 5,1996-02-01,Evidence at protein level
O43364,HXA2_HUMAN,Homeobox protein Hox-A2 (Homeobox protein Hox-1K),376,"41,002",5 out of 5,1999-07-15,Evidence at protein level
O43365,HXA3_HUMAN,Homeobox protein Hox-A3 (Homeobox protein Hox-1E),443,"46,369",5 out of 5,1999-07-15,Evidence at protein level
Q9NYD6,HXC10_HUMAN,Homeobox protein Hox-C10 (Homeobox protein Hox-3I),342,"38,073",4 out of 5,2001-02-21,Evidence at protein level
P31276,HXC13_HUMAN,Homeobox protein Hox-C13 (Homeobox protein Hox-3G),330,"35,379",4 out of 5,1993-07-01,Evidence at protein level
P31249,HXD3_HUMAN,Homeobox protein Hox-D3 (Homeobox protein Hox-4A),432,"45,730",5 out of 5,1993-07-01,Evidence at protein level
Q12891,HYAL2_HUMAN,Hyaluronidase-2 (Hyal-2) (EC 3.2.1.35) (Hyaluronoglucosaminidase-2) (Lung carcinoma protein 2) (LuCa-2),473,"53,860",5 out of 5,2002-11-15,Evidence at protein level
Q4G0P3,HYDIN_HUMAN,Hydrocephalus-inducing protein homolog,5121,"575,892",5 out of 5,2007-04-17,Evidence at protein level
Q96M11,HYLS1_HUMAN,Hydrolethalus syndrome protein 1,299,"34,359",4 out of 5,2007-05-01,Evidence at protein level
Q16270,IBP7_HUMAN,Insulin-like growth factor-binding protein 7 (IBP-7) (IGF-binding protein 7) (IGFBP-7) (IGFBP-rP1) (MAC25 protein) (PGI2-stimulating factor) (Prostacyclin-stimulating factor) (Tumor-derived adhesion factor) (TAF),282,"29,130",5 out of 5,2002-09-19,Evidence at protein level
Q9UPZ9,ICK_HUMAN,Serine/threonine-protein kinase ICK (EC 2.7.11.1) (Intestinal cell kinase) (hICK) (Laryngeal cancer kinase 2) (LCK2) (MAK-related kinase) (MRK),632,"71,427",5 out of 5,2004-06-07,Evidence at protein level
P54105,ICLN_HUMAN,"Methylosome subunit pICln (Chloride channel, nucleotide sensitive 1A) (Chloride conductance regulatory protein ICln) (I(Cln)) (Chloride ion current inducer protein) (ClCI) (Reticulocyte pICln)",237,"26,215",5 out of 5,1996-10-01,Evidence at protein level
Q8N5X7,IF4E3_HUMAN,Eukaryotic translation initiation factor 4E type 3 (eIF-4E type 3) (eIF-4E3) (eIF4E type 3) (eIF4E-3),224,"24,441",3 out of 5,2007-07-24,Evidence at transcript level
Q8WYA0,IFT81_HUMAN,Intraflagellar transport protein 81 homolog (Carnitine deficiency-associated protein expressed in ventricle 1) (CDV-1),676,"79,746",5 out of 5,2004-03-29,Evidence at protein level
P78318,IGBP1_HUMAN,Immunoglobulin-binding protein 1 (B-cell signal transduction molecule alpha 4) (Protein alpha-4) (CD79a-binding protein 1) (Protein phosphatase 2/4/6 regulatory subunit) (Renal carcinoma antigen NY-REN-16),339,"39,222",5 out of 5,2001-06-01,Evidence at protein level
P01880,IGHD_HUMAN,Immunoglobulin heavy constant delta (Ig delta chain C region) (Ig delta chain C region NIG-65) (Ig delta chain C region WAH),384,"42,353",5 out of 5,1986-07-21,Evidence at protein level
P01860,IGHG3_HUMAN,Immunoglobulin heavy constant gamma 3 (HDC) (Heavy chain disease protein) (Ig gamma-3 chain C region),377,"41,287",5 out of 5,1986-07-21,Evidence at protein level
A0M8Q6,IGLC7_HUMAN,Immunoglobulin lambda constant 7 (Ig lambda-7 chain C region),106,"11,254",5 out of 5,2010-04-20,Evidence at protein level
A1L1A6,IGS23_HUMAN,Immunoglobulin superfamily member 23,192,"20,591",2 out of 5,2011-06-28,Evidence at transcript level
P25963,IKBA_HUMAN,NF-kappa-B inhibitor alpha (I-kappa-B-alpha) (IkB-alpha) (IkappaBalpha) (Major histocompatibility complex enhancer-binding protein MAD3),317,"35,609",5 out of 5,1992-05-01,Evidence at protein level
Q9UBC1,IKBL1_HUMAN,NF-kappa-B inhibitor-like protein 1 (Inhibitor of kappa B-like protein) (I-kappa-B-like protein) (IkappaBL) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1),381,"43,204",5 out of 5,2004-03-01,Evidence at protein level
Q70UQ0,IKIP_HUMAN,Inhibitor of nuclear factor kappa-B kinase-interacting protein (I kappa-B kinase-interacting protein) (IKBKB-interacting protein) (IKK-interacting protein),350,"39,309",5 out of 5,2008-07-01,Evidence at protein level
O15111,IKKA_HUMAN,Inhibitor of nuclear factor kappa-B kinase subunit alpha (I-kappa-B kinase alpha) (IKK-A) (IKK-alpha) (IkBKA) (IkappaB kinase) (EC 2.7.11.10) (Conserved helix-loop-helix ubiquitous kinase) (I-kappa-B kinase 1) (IKK1) (Nuclear factor NF-kappa-B inhibitor kinase alpha) (NFKBIKA) (Transcription factor 16) (TCF-16),745,"84,640",5 out of 5,2001-06-01,Evidence at protein level
O14920,IKKB_HUMAN,Inhibitor of nuclear factor kappa-B kinase subunit beta (I-kappa-B-kinase beta) (IKK-B) (IKK-beta) (IkBKB) (EC 2.7.11.10) (I-kappa-B kinase 2) (IKK2) (Nuclear factor NF-kappa-B inhibitor kinase beta) (NFKBIKB),756,"86,564",5 out of 5,2001-06-01,Evidence at protein level
Q9UKS7,IKZF2_HUMAN,Zinc finger protein Helios (Ikaros family zinc finger protein 2),526,"59,574",5 out of 5,2000-12-01,Evidence at protein level
Q9H5V7,IKZF5_HUMAN,Zinc finger protein Pegasus (Ikaros family zinc finger protein 5),419,"46,510",4 out of 5,2007-09-11,Evidence at protein level
Q13478,IL18R_HUMAN,Interleukin-18 receptor 1 (IL-18R-1) (IL-18R1) (CD218 antigen-like family member A) (CDw218a) (IL1 receptor-related protein) (IL-1Rrp) (IL1R-rp) (CD antigen CD218a),541,"62,304",5 out of 5,2002-12-06,Evidence at protein level
Q14116,IL18_HUMAN,Interleukin-18 (IL-18) (Iboctadekin) (Interferon gamma-inducing factor) (IFN-gamma-inducing factor) (Interleukin-1 gamma) (IL-1 gamma),193,"22,326",5 out of 5,1998-07-15,Evidence at protein level
Q9NYY1,IL20_HUMAN,Interleukin-20 (IL-20) (Cytokine Zcyto10),176,"20,072",5 out of 5,2001-11-16,Evidence at protein level
Q9GZX6,IL22_HUMAN,Interleukin-22 (IL-22) (Cytokine Zcyto18) (IL-10-related T-cell-derived-inducible factor) (IL-TIF),179,"20,011",5 out of 5,2001-11-16,Evidence at protein level
P13232,IL7_HUMAN,Interleukin-7 (IL-7),177,"20,187",5 out of 5,1990-01-01,Evidence at protein level
Q01113,IL9R_HUMAN,Interleukin-9 receptor (IL-9 receptor) (IL-9R) (CD antigen CD129),521,"57,147",5 out of 5,1993-04-01,Evidence at transcript level
P30740,ILEU_HUMAN,Leukocyte elastase inhibitor (LEI) (Monocyte/neutrophil elastase inhibitor) (EI) (M/NEI) (Peptidase inhibitor 2) (PI-2) (Serpin B1),379,"42,742",5 out of 5,1993-04-01,Evidence at protein level
Q3SXM5,HSDL1_HUMAN,Inactive hydroxysteroid dehydrogenase-like protein 1 (Short chain dehydrogenase/reductase family 12C member 3),330,"37,002",5 out of 5,2008-01-15,Evidence at protein level
Q4G112,HSF5_HUMAN,Heat shock factor protein 5 (HSF 5) (Heat shock transcription factor 5) (HSTF 5),596,"65,278",3 out of 5,2008-05-20,Evidence at transcript level
P54652,HSP72_HUMAN,Heat shock-related 70 kDa protein 2 (Heat shock 70 kDa protein 2),639,"70,021",5 out of 5,1996-10-01,Evidence at protein level
Q0VDF9,HSP7E_HUMAN,Heat shock 70 kDa protein 14 (HSP70-like protein 1) (Heat shock protein HSP60),509,"54,794",4 out of 5,2007-05-29,Evidence at protein level
Q9UBY9,HSPB7_HUMAN,Heat shock protein beta-7 (HspB7) (Cardiovascular heat shock protein) (cvHsp),170,"18,611",5 out of 5,2001-01-11,Evidence at protein level
Q9P2D3,HTR5B_HUMAN,HEAT repeat-containing protein 5B,2071,"224,302",3 out of 5,2007-12-04,Evidence at protein level
Q9GZZ0,HXD1_HUMAN,Homeobox protein Hox-D1 (Homeobox protein Hox-GG),328,"34,093",3 out of 5,2001-09-26,Evidence at transcript level
P09016,HXD4_HUMAN,Homeobox protein Hox-D4 (Homeobox protein HHO.C13) (Homeobox protein Hox-4B) (Homeobox protein Hox-5.1),255,"27,885",5 out of 5,1988-11-01,Evidence at transcript level
Q9BYI3,HYCCI_HUMAN,Hyccin (Down-regulated by CTNNB1 protein A) (Protein FAM126A),521,"57,625",5 out of 5,2005-10-11,Evidence at protein level
P34913,HYES_HUMAN,Bifunctional epoxide hydrolase 2 [Includes: Cytosolic epoxide hydrolase 2 (CEH) (EC 3.3.2.10) (Epoxide hydratase) (Soluble epoxide hydrolase) (SEH); Lipid-phosphate phosphatase (EC 3.1.3.76)],555,"62,616",5 out of 5,1994-02-01,Evidence at protein level
Q08334,I10R2_HUMAN,Interleukin-10 receptor subunit beta (IL-10 receptor subunit beta) (IL-10R subunit beta) (IL-10RB) (Cytokine receptor class-II member 4) (Cytokine receptor family 2 member 4) (CRF2-4) (Interleukin-10 receptor subunit 2) (IL-10R subunit 2) (IL-10R2) (CD antigen CDw210b),325,"36,995",5 out of 5,1995-02-01,Evidence at protein level
Q6ZVW7,I17EL_HUMAN,Putative interleukin-17 receptor E-like (IL-17 receptor E-like) (IL-17RE-like),336,"37,514",2 out of 5,2008-03-18,Evidence at transcript level
Q9NRM6,I17RB_HUMAN,Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor),502,"55,885",5 out of 5,2002-05-27,Evidence at protein level
Q6UXL0,I20RB_HUMAN,Interleukin-20 receptor subunit beta (IL-20 receptor subunit beta) (IL-20R-beta) (IL-20RB) (Fibronectin type III domain containing 6) (FNDC6) (IL-20R2),311,"35,076",5 out of 5,2004-08-31,Evidence at protein level
Q6ZQW0,I23O2_HUMAN,"Indoleamine 2,3-dioxygenase 2 (IDO-2) (EC 1.13.11.-) (Indoleamine 2,3-dioxygenase-like protein 1) (Indoleamine-pyrrole 2,3-dioxygenase-like protein 1)",420,"47,075",5 out of 5,2007-05-01,Evidence at protein level
P17936,IBP3_HUMAN,Insulin-like growth factor-binding protein 3 (IBP-3) (IGF-binding protein 3) (IGFBP-3),291,"31,674",5 out of 5,1990-11-01,Evidence at protein level
Q9P2D0,IBTK_HUMAN,Inhibitor of Bruton tyrosine kinase (IBtk),1353,"150,528",5 out of 5,2007-03-20,Evidence at protein level
P05155,IC1_HUMAN,Plasma protease C1 inhibitor (C1 Inh) (C1Inh) (C1 esterase inhibitor) (C1-inhibiting factor) (Serpin G1),500,"55,154",5 out of 5,1987-08-13,Evidence at protein level
Q14773,ICAM4_HUMAN,Intercellular adhesion molecule 4 (ICAM-4) (Landsteiner-Wiener blood group glycoprotein) (LW blood group protein) (CD antigen CD242),271,"29,265",5 out of 5,1997-11-01,Evidence at protein level
P51553,IDH3G_HUMAN,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit gamma) (NAD(+)-specific ICDH subunit gamma)",393,"42,794",5 out of 5,1996-10-01,Evidence at protein level
P22304,IDS_HUMAN,Iduronate 2-sulfatase (EC 3.1.6.13) (Alpha-L-iduronate sulfate sulfatase) (Idursulfase) [Cleaved into: Iduronate 2-sulfatase 42 kDa chain; Iduronate 2-sulfatase 14 kDa chain],550,"61,873",5 out of 5,1991-08-01,Evidence at protein level
P47813,IF1AX_HUMAN,"Eukaryotic translation initiation factor 1A, X-chromosomal (eIF-1A X isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)",144,"16,460",4 out of 5,1996-02-01,Evidence at protein level
O00425,IF2B3_HUMAN,Insulin-like growth factor 2 mRNA-binding protein 3 (IGF2 mRNA-binding protein 3) (IMP-3) (IGF-II mRNA-binding protein 3) (KH domain-containing protein overexpressed in cancer) (hKOC) (VICKZ family member 3),579,"63,705",5 out of 5,2007-04-03,Evidence at protein level
Q8TCT9,HM13_HUMAN,Minor histocompatibility antigen H13 (EC 3.4.23.-) (Intramembrane protease 1) (IMP-1) (IMPAS-1) (hIMP1) (Presenilin-like protein 3) (Signal peptide peptidase),377,"41,488",5 out of 5,2002-11-08,Evidence at protein level
O00479,HMGN4_HUMAN,High mobility group nucleosome-binding domain-containing protein 4 (Non-histone chromosomal protein HMG-17-like 3) (Non-histone chromosomal protein),90,"9,539",3 out of 5,2002-01-31,Evidence at protein level
P0CJ77,HMN10_HUMAN,Humanin-like 10 (HN10) (MT-RNR2-like protein 10),24,"2,806",2 out of 5,2011-02-08,Evidence at transcript level
P50135,HNMT_HUMAN,Histamine N-methyltransferase (HMT) (EC 2.1.1.8),292,"33,295",5 out of 5,1996-10-01,Evidence at protein level
Q9BUJ2,HNRL1_HUMAN,Heterogeneous nuclear ribonucleoprotein U-like protein 1 (Adenovirus early region 1B-associated protein 5) (E1B-55 kDa-associated protein 5) (E1B-AP5),856,"95,739",5 out of 5,2006-03-21,Evidence at protein level
Q96ED9,HOOK2_HUMAN,Protein Hook homolog 2 (h-hook2) (hHK2),719,"83,207",5 out of 5,2004-02-02,Evidence at protein level
Q8N7B1,HORM2_HUMAN,HORMA domain-containing protein 2,307,"35,284",3 out of 5,2007-04-17,Evidence at protein level
Q86YV9,HPS6_HUMAN,Hermansky-Pudlak syndrome 6 protein (Ruby-eye protein homolog) (Ru),775,"82,975",5 out of 5,2004-05-10,Evidence at protein level
Q96LI6,HSFY1_HUMAN,"Heat shock transcription factor, Y-linked (Heat shock transcription factor 2-like protein) (HSF2-like)",401,"45,107",5 out of 5,2003-01-17,Evidence at protein level
P48723,HSP13_HUMAN,Heat shock 70 kDa protein 13 (Microsomal stress-70 protein ATPase core) (Stress-70 protein chaperone microsome-associated 60 kDa protein),471,"51,927",4 out of 5,1996-02-01,Evidence at protein level
P04553,HSP1_HUMAN,Sperm protamine P1 (Cysteine-rich protamine),51,"6,823",5 out of 5,1987-08-13,Evidence at protein level
A0A0C4DH31,HV118_HUMAN,Immunoglobulin heavy variable 1-18,117,"12,820",4 out of 5,2016-11-30,Inferred from homology
P01782,HV309_HUMAN,Immunoglobulin heavy variable 3-9 (Ig heavy chain V-III region DOB),118,"12,945",5 out of 5,1986-07-21,Evidence at protein level
A0A0A0MS15,HV349_HUMAN,Immunoglobulin heavy variable 3-49,119,"13,056",4 out of 5,2016-11-30,Evidence at protein level
A0A0B4J1V6,HV373_HUMAN,Immunoglobulin heavy variable 3-73,119,"12,858",4 out of 5,2017-01-18,Inferred from homology
P06331,HV434_HUMAN,Immunoglobulin heavy variable 4-34 (Ig heavy chain V-II region ARH-77),123,"13,815",5 out of 5,1988-01-01,Evidence at protein level
P01825,HV459_HUMAN,Immunoglobulin heavy variable 4-59 (Ig heavy chain V-II region NEWM),116,"12,936",5 out of 5,1986-07-21,Evidence at protein level
A0A0B4J1U7,HV601_HUMAN,Immunoglobulin heavy variable 6-1,121,"13,481",4 out of 5,2017-01-18,Inferred from homology
P0DP02,HVC33_HUMAN,Immunoglobulin heavy variable 3-30-3,117,"12,989",3 out of 5,2017-04-12,Inferred from homology
P20719,HXA5_HUMAN,Homeobox protein Hox-A5 (Homeobox protein Hox-1C),270,"29,345",5 out of 5,1991-02-01,Evidence at protein level
P31269,HXA9_HUMAN,Homeobox protein Hox-A9 (Homeobox protein Hox-1G),272,"30,172",5 out of 5,1993-07-01,Evidence at protein level
P17482,HXB9_HUMAN,Homeobox protein Hox-B9 (Homeobox protein Hox-2.5) (Homeobox protein Hox-2E),250,"28,059",5 out of 5,1990-08-01,Evidence at protein level
P31275,HXC12_HUMAN,Homeobox protein Hox-C12 (Homeobox protein Hox-3F),282,"30,171",3 out of 5,1993-07-01,Inferred from homology
P35453,HXD13_HUMAN,Homeobox protein Hox-D13 (Homeobox protein Hox-4I),343,"36,101",5 out of 5,1994-06-01,Evidence at protein level
P38567,HYALP_HUMAN,Hyaluronidase PH-20 (Hyal-PH20) (EC 3.2.1.35) (Hyaluronoglucosaminidase PH-20) (Sperm adhesion molecule 1) (Sperm surface protein PH-20),509,"57,848",5 out of 5,1994-10-01,Evidence at protein level
O00219,HYAS3_HUMAN,Hyaluronan synthase 3 (EC 2.4.1.212) (Hyaluronate synthase 3) (Hyaluronic acid synthase 3) (HA synthase 3),553,"62,998",5 out of 5,2000-05-30,Evidence at transcript level
Q9H9L3,I20L2_HUMAN,Interferon-stimulated 20 kDa exonuclease-like 2 (EC 3.1.-.-),353,"39,154",3 out of 5,2004-02-16,Evidence at protein level
P14902,I23O1_HUMAN,"Indoleamine 2,3-dioxygenase 1 (IDO-1) (EC 1.13.11.52) (Indoleamine-pyrrole 2,3-dioxygenase)",403,"45,326",5 out of 5,1990-04-01,Evidence at protein level
P0CJ73,HMN6_HUMAN,Humanin-like 6 (HN6) (MT-RNR2-like protein 6),24,"2,719",2 out of 5,2011-02-08,Evidence at transcript level
P14866,HNRPL_HUMAN,Heterogeneous nuclear ribonucleoprotein L (hnRNP L),589,"64,133",5 out of 5,1990-04-01,Evidence at protein level
Q9BYM8,HOIL1_HUMAN,RanBP-type and C3HC4-type zinc finger-containing protein 1 (EC 2.3.2.27) (HBV-associated factor 4) (Heme-oxidized IRP2 ubiquitin ligase 1) (HOIL-1) (Hepatitis B virus X-associated protein 4) (RING finger protein 54) (RING-type E3 ubiquitin transferase HOIL-1) (Ubiquitin-conjugating enzyme 7-interacting protein 3),510,"57,572",5 out of 5,2001-09-26,Evidence at protein level
Q9BPY8,HOP_HUMAN,Homeodomain-only protein (Lung cancer-associated Y protein) (Not expressed in choriocarcinoma protein 1) (Odd homeobox protein 1),73,"8,260",5 out of 5,2005-02-01,Evidence at protein level
P25021,HRH2_HUMAN,Histamine H2 receptor (H2R) (HH2R) (Gastric receptor I),359,"40,098",5 out of 5,1992-05-01,Evidence at transcript level
Q9Y5N1,HRH3_HUMAN,Histamine H3 receptor (H3R) (HH3R) (G-protein coupled receptor 97),445,"48,671",5 out of 5,2001-11-16,Evidence at protein level
Q9UL19,HRSL4_HUMAN,Retinoic acid receptor responder protein 3 (EC 3.1.1.-) (HRAS-like suppressor 4) (HRSL4) (RAR-responsive protein TIG3) (Retinoid-inducible gene 1 protein) (Tazarotene-induced gene 3 protein),164,"18,179",5 out of 5,2002-01-31,Evidence at protein level
P34932,HSP74_HUMAN,Heat shock 70 kDa protein 4 (HSP70RY) (Heat shock 70-related protein APG-2),840,"94,331",4 out of 5,1994-02-01,Evidence at protein level
P04792,HSPB1_HUMAN,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Stress-responsive protein 27) (SRP27),205,"22,783",5 out of 5,1987-08-13,Evidence at protein level
Q8WX77,IBPL1_HUMAN,Insulin-like growth factor-binding protein-like 1 (IGFBP-related protein 10) (Insulin-like growth factor-binding-related protein 4) (IGFBP-rP4),278,"29,005",3 out of 5,2007-08-21,Evidence at transcript level
Q05084,ICA69_HUMAN,Islet cell autoantigen 1 (69 kDa islet cell autoantigen) (ICA69) (Islet cell autoantigen p69) (ICAp69) (p69),483,"54,645",5 out of 5,1995-02-01,Evidence at protein level
P13598,ICAM2_HUMAN,Intercellular adhesion molecule 2 (ICAM-2) (CD antigen CD102),275,"30,654",5 out of 5,1990-01-01,Evidence at protein level
Q9UMF0,ICAM5_HUMAN,Intercellular adhesion molecule 5 (ICAM-5) (Telencephalin),924,"97,116",5 out of 5,2001-10-18,Evidence at protein level
O75144,ICOSL_HUMAN,ICOS ligand (B7 homolog 2) (B7-H2) (B7-like protein Gl50) (B7-related protein 1) (B7RP-1) (CD antigen CD275),302,"33,349",5 out of 5,1999-07-15,Evidence at protein level
Q9BXS1,IDI2_HUMAN,Isopentenyl-diphosphate delta-isomerase 2 (EC 5.3.3.2) (Isopentenyl pyrophosphate isomerase 2) (IPP isomerase 2) (IPPI2),227,"26,753",5 out of 5,2002-05-15,Evidence at protein level
Q96RY7,IF140_HUMAN,Intraflagellar transport protein 140 homolog (WD and tetratricopeptide repeats protein 2),1462,"165,193",5 out of 5,2005-11-22,Evidence at protein level
O14602,IF1AY_HUMAN,"Eukaryotic translation initiation factor 1A, Y-chromosomal (eIF-1A Y isoform) (Eukaryotic translation initiation factor 4C) (eIF-4C)",144,"16,442",3 out of 5,1999-07-15,Evidence at protein level
P05198,IF2A_HUMAN,Eukaryotic translation initiation factor 2 subunit 1 (Eukaryotic translation initiation factor 2 subunit alpha) (eIF-2-alpha) (eIF-2A) (eIF-2alpha),315,"36,112",5 out of 5,1987-08-13,Evidence at protein level
Q9NZI8,IF2B1_HUMAN,Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2 mRNA-binding protein 1) (IMP-1) (IMP1) (Coding region determinant-binding protein) (CRD-BP) (IGF-II mRNA-binding protein 1) (VICKZ family member 1) (Zipcode-binding protein 1) (ZBP-1),577,"63,481",5 out of 5,2007-04-03,Evidence at protein level
P60842,IF4A1_HUMAN,Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1),406,"46,154",5 out of 5,1987-08-13,Evidence at protein level
P06730,IF4E_HUMAN,Eukaryotic translation initiation factor 4E (eIF-4E) (eIF4E) (eIF-4F 25 kDa subunit) (mRNA cap-binding protein),217,"25,097",5 out of 5,1988-01-01,Evidence at protein level
Q9H7X7,IFT22_HUMAN,Intraflagellar transport protein 22 homolog (Rab-like protein 5),185,"20,835",4 out of 5,2006-10-17,Evidence at protein level
P20809,IL11_HUMAN,Interleukin-11 (IL-11) (Adipogenesis inhibitory factor) (AGIF) (Oprelvekin),199,"21,429",5 out of 5,1991-02-01,Evidence at protein level
Q9NPH3,IL1AP_HUMAN,Interleukin-1 receptor accessory protein (IL-1 receptor accessory protein) (IL-1RAcP) (Interleukin-1 receptor 3) (IL-1R-3) (IL-1R3),570,"65,418",5 out of 5,2003-08-22,Evidence at protein level
Q14213,IL27B_HUMAN,Interleukin-27 subunit beta (IL-27 subunit beta) (IL-27B) (Epstein-Barr virus-induced gene 3 protein) (EBV-induced gene 3 protein),229,"25,396",5 out of 5,2004-05-24,Evidence at protein level
P15248,IL9_HUMAN,Interleukin-9 (IL-9) (Cytokine P40) (T-cell growth factor P40),144,"15,909",4 out of 5,1990-04-01,Evidence at transcript level
Q9H0C8,ILKAP_HUMAN,Integrin-linked kinase-associated serine/threonine phosphatase 2C (ILKAP) (EC 3.1.3.16),392,"42,907",5 out of 5,2007-01-23,Evidence at protein level
Q14974,IMB1_HUMAN,Importin subunit beta-1 (Importin-90) (Karyopherin subunit beta-1) (Nuclear factor p97) (Pore targeting complex 97 kDa subunit) (PTAC97),876,"97,170",5 out of 5,1997-11-01,Evidence at protein level
Q9H0H0,INT2_HUMAN,Integrator complex subunit 2 (Int2),1204,"134,323",5 out of 5,2006-05-16,Evidence at protein level
Q68E01,INT3_HUMAN,Integrator complex subunit 3 (Int3) (SOSS complex subunit A) (Sensor of single-strand DNA complex subunit A) (SOSS-A) (Sensor of ssDNA subunit A),1043,"118,070",5 out of 5,2006-10-31,Evidence at protein level
Q6P9B9,INT5_HUMAN,Integrator complex subunit 5 (Int5),1019,"107,995",5 out of 5,2006-10-31,Evidence at protein level
Q9UL03,INT6_HUMAN,Integrator complex subunit 6 (Int6) (DBI-1) (Protein DDX26) (Protein deleted in cancer 1) (DICE1),887,"100,390",5 out of 5,2006-10-31,Evidence at protein level
Q9NVH2,INT7_HUMAN,Integrator complex subunit 7 (Int7),962,"106,834",5 out of 5,2006-10-31,Evidence at protein level
Q9UHH9,IP6K2_HUMAN,Inositol hexakisphosphate kinase 2 (InsP6 kinase 2) (EC 2.7.4.21) (P(i)-uptake stimulator) (PiUS),426,"49,186",5 out of 5,2004-07-19,Evidence at protein level
P61925,IPKA_HUMAN,"cAMP-dependent protein kinase inhibitor alpha (PKI-alpha) (cAMP-dependent protein kinase inhibitor, muscle/brain isoform)",76,"7,989",4 out of 5,1987-08-13,Evidence at protein level
Q8NFU5,IPMK_HUMAN,"Inositol polyphosphate multikinase (EC 2.7.1.151) (Inositol 1,3,4,6-tetrakisphosphate 5-kinase)",416,"47,222",5 out of 5,2004-07-19,Evidence at protein level
Q8N6M8,IQCF1_HUMAN,IQ domain-containing protein F1,205,"23,699",3 out of 5,2007-04-03,Evidence at transcript level
P46940,IQGA1_HUMAN,Ras GTPase-activating-like protein IQGAP1 (p195),1657,"189,252",5 out of 5,1995-11-01,Evidence at protein level
A6NK06,IRG1_HUMAN,Cis-aconitate decarboxylase (CAD) (EC 4.1.1.6) (Aconitate decarboxylase) (Aconitate decarboxylase 1) (Cis-aconitic acid decarboxylase) (Immune-responsive gene 1 protein),481,"52,628",5 out of 5,2008-02-26,Evidence at protein level
P0DP04,HV43D_HUMAN,Immunoglobulin heavy variable 3-43D,118,"13,017",3 out of 5,2017-04-12,Inferred from homology
A0A0C4DH41,HV461_HUMAN,Immunoglobulin heavy variable 4-61,118,"13,066",4 out of 5,2017-01-18,Inferred from homology
P31260,HXA10_HUMAN,Homeobox protein Hox-A10 (Homeobox protein Hox-1.8) (Homeobox protein Hox-1H) (PL),410,"42,414",5 out of 5,1993-07-01,Evidence at protein level
P31271,HXA13_HUMAN,Homeobox protein Hox-A13 (Homeobox protein Hox-1J),388,"39,727",5 out of 5,1993-07-01,Evidence at protein level
Q00056,HXA4_HUMAN,Homeobox protein Hox-A4 (Homeobox protein Hox-1.4) (Homeobox protein Hox-1D),320,"34,499",4 out of 5,1992-12-01,Evidence at transcript level
Q92826,HXB13_HUMAN,Homeobox protein Hox-B13,284,"30,676",5 out of 5,1997-11-01,Evidence at protein level
P09067,HXB5_HUMAN,Homeobox protein Hox-B5 (Homeobox protein HHO.C10) (Homeobox protein Hox-2A) (Homeobox protein Hu-1),269,"29,434",5 out of 5,1988-11-01,Evidence at protein level
P17481,HXB8_HUMAN,Homeobox protein Hox-B8 (Homeobox protein Hox-2.4) (Homeobox protein Hox-2D),243,"27,574",4 out of 5,1990-08-01,Evidence at transcript level
P78552,I13R1_HUMAN,Interleukin-13 receptor subunit alpha-1 (IL-13 receptor subunit alpha-1) (IL-13R subunit alpha-1) (IL-13R-alpha-1) (IL-13RA1) (Cancer/testis antigen 19) (CT19) (CD antigen CD213a1),427,"48,760",5 out of 5,1997-11-01,Evidence at protein level
Q13261,I15RA_HUMAN,Interleukin-15 receptor subunit alpha (IL-15 receptor subunit alpha) (IL-15R-alpha) (IL-15RA) (CD antigen CD215) [Cleaved into: Soluble interleukin-15 receptor subunit alpha (sIL-15 receptor subunit alpha) (sIL-15R-alpha) (sIL-15RA)],267,"28,233",5 out of 5,2005-02-01,Evidence at protein level
O95998,I18BP_HUMAN,Interleukin-18-binding protein (IL-18BP) (Tadekinig-alfa),194,"21,099",5 out of 5,2000-05-30,Evidence at protein level
Q8N6P7,I22R1_HUMAN,Interleukin-22 receptor subunit alpha-1 (IL-22 receptor subunit alpha-1) (IL-22R-alpha-1) (IL-22RA1) (Cytokine receptor class-II member 9) (Cytokine receptor family 2 member 9) (CRF2-9) (ZcytoR11),574,"63,077",5 out of 5,2008-03-18,Evidence at protein level
Q8IU81,I2BP1_HUMAN,Interferon regulatory factor 2-binding protein 1 (IRF-2-binding protein 1) (IRF-2BP1) (Probable E3 ubiquitin-protein ligase IRF2BP1) (EC 2.3.2.27) (Probable RING-type E3 ubiquitin transferase IRF2BP1),584,"61,688",5 out of 5,2008-04-08,Evidence at protein level
Q9Y6M1,IF2B2_HUMAN,Insulin-like growth factor 2 mRNA-binding protein 2 (IGF2 mRNA-binding protein 2) (IMP-2) (Hepatocellular carcinoma autoantigen p62) (IGF-II mRNA-binding protein 2) (VICKZ family member 2),599,"66,121",5 out of 5,2006-06-27,Evidence at protein level
Q9Y547,IFT25_HUMAN,Intraflagellar transport protein 25 homolog (Heat shock protein beta-11) (Hspb11) (Placental protein 25) (PP25),144,"16,297",5 out of 5,2005-06-07,Evidence at protein level
Q96LB3,IFT74_HUMAN,Intraflagellar transport protein 74 homolog (Capillary morphogenesis gene 1 protein) (CMG-1) (Coiled-coil domain-containing protein 2),600,"69,239",5 out of 5,2004-07-19,Evidence at protein level
P27352,IF_HUMAN,Gastric intrinsic factor (Intrinsic factor) (IF) (INF),417,"45,416",5 out of 5,1992-08-01,Evidence at protein level
P0DOX3,IGD_HUMAN,Immunoglobulin delta heavy chain (Immunoglobulin delta heavy chain WAH),512,"56,224",3 out of 5,2017-03-15,Evidence at protein level
P08069,IGF1R_HUMAN,Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor) (CD antigen CD221) [Cleaved into: Insulin-like growth factor 1 receptor alpha chain; Insulin-like growth factor 1 receptor beta chain],1367,"154,793",5 out of 5,1988-08-01,Evidence at protein level
P05019,IGF1_HUMAN,Insulin-like growth factor I (IGF-I) (Mechano growth factor) (MGF) (Somatomedin-C),195,"21,841",5 out of 5,1987-08-13,Evidence at protein level
Q6UXB1,IGFL3_HUMAN,Insulin growth factor-like family member 3,125,"14,198",3 out of 5,2005-12-20,Evidence at protein level
Q86VF2,IGFN1_HUMAN,Immunoglobulin-like and fibronectin type III domain-containing protein 1 (EEF1A2-binding protein 1) (KY-interacting protein 1),1251,"137,763",4 out of 5,2008-09-02,Evidence at protein level
Q6NXR0,IIGP5_HUMAN,Interferon-inducible GTPase 5 (EC 3.6.5.-) (Immunity-related GTPase cinema 1),463,"50,288",3 out of 5,2007-05-01,Evidence at transcript level
Q14164,IKKE_HUMAN,Inhibitor of nuclear factor kappa-B kinase subunit epsilon (I-kappa-B kinase epsilon) (IKK-E) (IKK-epsilon) (IkBKE) (EC 2.7.11.10) (Inducible I kappa-B kinase) (IKK-i),716,"80,462",5 out of 5,2001-06-20,Evidence at protein level
P01583,IL1A_HUMAN,Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1),271,"30,607",5 out of 5,1986-07-21,Evidence at protein level
P18510,IL1RA_HUMAN,Interleukin-1 receptor antagonist protein (IL-1RN) (IL-1ra) (IRAP) (ICIL-1RA) (IL1 inhibitor) (Anakinra),177,"20,055",5 out of 5,1990-11-01,Evidence at protein level
Q13007,IL24_HUMAN,Interleukin-24 (IL-24) (Melanoma differentiation-associated gene 7 protein) (MDA-7) (Suppression of tumorigenicity 16 protein),206,"23,825",5 out of 5,1997-11-01,Evidence at protein level
P14784,IL2RB_HUMAN,Interleukin-2 receptor subunit beta (IL-2 receptor subunit beta) (IL-2R subunit beta) (IL-2RB) (High affinity IL-2 receptor subunit beta) (p70-75) (p75) (CD antigen CD122),551,"61,117",5 out of 5,1990-04-01,Evidence at protein level
P31785,IL2RG_HUMAN,Cytokine receptor common subunit gamma (Interleukin-2 receptor subunit gamma) (IL-2 receptor subunit gamma) (IL-2R subunit gamma) (IL-2RG) (gammaC) (p64) (CD antigen CD132),369,"42,287",5 out of 5,1993-07-01,Evidence at protein level
Q6EBC2,IL31_HUMAN,Interleukin-31 (IL-31),164,"18,205",3 out of 5,2007-02-06,Evidence at transcript level
Q6ZMJ4,IL34_HUMAN,Interleukin-34 (IL-34),242,"27,482",5 out of 5,2007-07-10,Evidence at protein level
P32927,IL3RB_HUMAN,Cytokine receptor common subunit beta (CDw131) (GM-CSF/IL-3/IL-5 receptor common beta subunit) (CD antigen CD131),897,"97,336",5 out of 5,1993-10-01,Evidence at protein level
P05112,IL4_HUMAN,Interleukin-4 (IL-4) (B-cell stimulatory factor 1) (BSF-1) (Binetrakin) (Lymphocyte stimulatory factor 1) (Pitrakinra),153,"17,492",5 out of 5,1987-08-13,Evidence at protein level
Q01344,IL5RA_HUMAN,Interleukin-5 receptor subunit alpha (IL-5 receptor subunit alpha) (IL-5R subunit alpha) (IL-5R-alpha) (IL-5RA) (CDw125) (CD antigen CD125),420,"47,685",5 out of 5,1993-07-01,Evidence at protein level
O00505,IMA4_HUMAN,Importin subunit alpha-4 (Importin alpha Q2) (Qip2) (Karyopherin subunit alpha-3) (SRP1-gamma),521,"57,811",5 out of 5,1997-11-01,Evidence at protein level
P20839,IMDH1_HUMAN,Inosine-5'-monophosphate dehydrogenase 1 (IMP dehydrogenase 1) (IMPD 1) (IMPDH 1) (EC 1.1.1.205) (IMPDH-I),514,"55,406",5 out of 5,1991-02-01,Evidence at protein level
P12268,IMDH2_HUMAN,Inosine-5'-monophosphate dehydrogenase 2 (IMP dehydrogenase 2) (IMPD 2) (IMPDH 2) (EC 1.1.1.205) (IMPDH-II),514,"55,805",5 out of 5,1989-10-01,Evidence at protein level
P32942,ICAM3_HUMAN,Intercellular adhesion molecule 3 (ICAM-3) (CDw50) (ICAM-R) (CD antigen CD50),547,"59,541",5 out of 5,1993-10-01,Evidence at protein level
Q9Y2F5,ICE1_HUMAN,Little elongation complex subunit 1 (Interactor of little elongator complex ELL subunit 1),2266,"247,891",5 out of 5,2007-07-24,Evidence at protein level
Q8WWN9,ICEF1_HUMAN,Interactor protein for cytohesin exchange factors 1 (Phosphoinositide-binding protein PIP3-E),437,"48,993",4 out of 5,2008-04-08,Evidence at protein level
Q14602,ID2B_HUMAN,Putative DNA-binding protein inhibitor ID-2B (Inhibitor of DNA binding 2B),36,"4,055",2 out of 5,2008-07-01,Uncertain
P35475,IDUA_HUMAN,Alpha-L-iduronidase (EC 3.2.1.76),653,"72,670",5 out of 5,1994-06-01,Evidence at protein level
Q9HBG6,IF122_HUMAN,Intraflagellar transport protein 122 homolog (WD repeat-containing protein 10) (WD repeat-containing protein 140),1241,"141,825",5 out of 5,2002-03-27,Evidence at protein level
P78344,IF4G2_HUMAN,Eukaryotic translation initiation factor 4 gamma 2 (eIF-4-gamma 2) (eIF-4G 2) (eIF4G 2) (Death-associated protein 5) (DAP-5) (p97),907,"102,362",5 out of 5,2003-04-30,Evidence at protein level
O43432,IF4G3_HUMAN,Eukaryotic translation initiation factor 4 gamma 3 (eIF-4-gamma 3) (eIF-4G 3) (eIF4G 3) (eIF-4-gamma II) (eIF4GII),1585,"176,652",5 out of 5,2004-06-07,Evidence at protein level
Q01628,IFM3_HUMAN,Interferon-induced transmembrane protein 3 (Dispanin subfamily A member 2b) (DSPA2b) (Interferon-inducible protein 1-8U),133,"14,632",5 out of 5,1993-07-01,Evidence at protein level
P01562,IFNA1_HUMAN,Interferon alpha-1/13 (IFN-alpha-1/13) (Interferon alpha-D) (LeIF D),189,"21,725",5 out of 5,1986-07-21,Evidence at protein level
O00458,IFRD1_HUMAN,Interferon-related developmental regulator 1 (Nerve growth factor-inducible protein PC4),451,"50,269",4 out of 5,2000-05-30,Evidence at protein level
Q13099,IFT88_HUMAN,Intraflagellar transport protein 88 homolog (Recessive polycystic kidney disease protein Tg737 homolog) (Tetratricopeptide repeat protein 10) (TPR repeat protein 10),833,"94,270",4 out of 5,2001-09-26,Evidence at transcript level
P0DOX2,IGA2_HUMAN,Immunoglobulin alpha-2 heavy chain (Immunoglobulin alpha-2 heavy chain BUT),455,"48,935",3 out of 5,2017-03-15,Evidence at protein level
Q6UW32,IGFL1_HUMAN,Insulin growth factor-like family member 1,110,"12,363",4 out of 5,2005-12-20,Evidence at protein level
A6NJ69,IGIP_HUMAN,IgA-inducing protein homolog,53,"5,937",2 out of 5,2008-04-29,Inferred from homology
P0DOX8,IGL1_HUMAN,Immunoglobulin lambda-1 light chain (Immunoglobulin lambda-1 light chain MCG),216,"22,830",3 out of 5,2017-03-15,Evidence at protein level
P0DOY3,IGLC3_HUMAN,Immunoglobulin lambda constant 3 (Ig lambda chain C region DOT) (Ig lambda chain C region NEWM) (Ig lambda-3 chain C regions),106,"11,266",4 out of 5,2017-03-15,Evidence at protein level
O75054,IGSF3_HUMAN,Immunoglobulin superfamily member 3 (IgSF3) (Glu-Trp-Ile EWI motif-containing protein 3) (EWI-3),1194,"135,196",5 out of 5,2008-02-26,Evidence at transcript level
O00221,IKBE_HUMAN,NF-kappa-B inhibitor epsilon (NF-kappa-BIE) (I-kappa-B-epsilon) (IkB-E) (IkB-epsilon) (IkappaBepsilon),500,"52,864",5 out of 5,2001-06-20,Evidence at protein level
P22301,IL10_HUMAN,Interleukin-10 (IL-10) (Cytokine synthesis inhibitory factor) (CSIF),178,"20,517",5 out of 5,1991-08-01,Evidence at protein level
P35225,IL13_HUMAN,Interleukin-13 (IL-13),146,"15,816",5 out of 5,1994-02-01,Evidence at protein level
O95760,IL33_HUMAN,Interleukin-33 (IL-33) (Interleukin-1 family member 11) (IL-1F11) (Nuclear factor from high endothelial venules) (NF-HEV) [Cleaved into: Interleukin-33 (95-270); Interleukin-33 (99-270); Interleukin-33 (109-270)],270,"30,759",5 out of 5,2005-07-05,Evidence at protein level
P05113,IL5_HUMAN,Interleukin-5 (IL-5) (B-cell differentiation factor I) (Eosinophil differentiation factor) (T-cell replacing factor) (TRF),134,"15,238",5 out of 5,1987-08-13,Evidence at protein level
P16871,IL7RA_HUMAN,Interleukin-7 receptor subunit alpha (IL-7 receptor subunit alpha) (IL-7R subunit alpha) (IL-7R-alpha) (IL-7RA) (CDw127) (CD antigen CD127),459,"51,581",5 out of 5,1990-08-01,Evidence at protein level
P10145,IL8_HUMAN,Interleukin-8 (IL-8) (C-X-C motif chemokine 8) (Chemokine (C-X-C motif) ligand 8) (Emoctakin) (Granulocyte chemotactic protein 1) (GCP-1) (Monocyte-derived neutrophil chemotactic factor) (MDNCF) (Monocyte-derived neutrophil-activating peptide) (MONAP) (Neutrophil-activating protein 1) (NAP-1) (Protein 3-10C) (T-cell chemotactic factor) [Cleaved into: MDNCF-a (GCP/IL-8 protein IV) (IL8/NAP1 form I); Interleukin-8 ((Ala-IL-8)77) (GCP/IL-8 protein II) (IL-8(1-77)) (IL8/NAP1 form II) (MDNCF-b); IL-8(5-77); IL-8(6-77) ((Ser-IL-8)72) (GCP/IL-8 protein I) (IL8/NAP1 form III) (Lymphocyte-derived neutrophil-activating factor) (LYNAP) (MDNCF-c) (Neutrophil-activating factor) (NAF); IL-8(7-77) (GCP/IL-8 protein V) (IL8/NAP1 form IV); IL-8(8-77) (GCP/IL-8 protein VI) (IL8/NAP1 form V); IL-8(9-77) (GCP/IL-8 protein III) (IL8/NAP1 form VI)],99,"11,098",5 out of 5,1989-07-01,Evidence at protein level
Q13418,ILK_HUMAN,Integrin-linked protein kinase (EC 2.7.11.1) (59 kDa serine/threonine-protein kinase) (ILK-1) (ILK-2) (p59ILK),452,"51,419",5 out of 5,2000-12-01,Evidence at protein level
O60684,IMA7_HUMAN,Importin subunit alpha-7 (Karyopherin subunit alpha-6),536,"60,030",5 out of 5,2004-03-15,Evidence at protein level
Q96G21,IMP4_HUMAN,U3 small nucleolar ribonucleoprotein protein IMP4 (U3 snoRNP protein IMP4) (Brix domain-containing protein 4),291,"33,757",4 out of 5,2005-08-16,Evidence at protein level
Q17R60,IMPG1_HUMAN,Interphotoreceptor matrix proteoglycan 1 (Interphotoreceptor matrix proteoglycan of 150 kDa) (IPM-150) (Sialoprotein associated with cones and rods),797,"89,387",5 out of 5,2006-10-03,Evidence at protein level
Q53TQ3,IN80D_HUMAN,INO80 complex subunit D,878,"98,174",4 out of 5,2008-02-26,Evidence at protein level
C9JVW0,INAM1_HUMAN,Putative transmembrane protein INAFM1 (InaF-motif-containing protein 1) (Proline-rich protein 24),142,"14,668",2 out of 5,2010-05-18,Predicted
P17181,INAR1_HUMAN,Interferon alpha/beta receptor 1 (IFN-R-1) (IFN-alpha/beta receptor 1) (Cytokine receptor class-II member 1) (Cytokine receptor family 2 member 1) (CRF2-1) (Type I interferon receptor 1),557,"63,525",5 out of 5,1990-08-01,Evidence at protein level
Q9H160,ING2_HUMAN,Inhibitor of growth protein 2 (Inhibitor of growth 1-like protein) (ING1Lp) (p32) (p33ING2),280,"32,808",5 out of 5,2005-02-15,Evidence at protein level
P38484,INGR2_HUMAN,Interferon gamma receptor 2 (IFN-gamma receptor 2) (IFN-gamma-R2) (Interferon gamma receptor accessory factor 1) (AF-1) (Interferon gamma receptor beta-chain) (IFN-gamma-R-beta) (Interferon gamma transducer 1),337,"37,806",5 out of 5,1994-10-01,Evidence at protein level
P05111,INHA_HUMAN,Inhibin alpha chain,366,"39,670",5 out of 5,1987-08-13,Evidence at protein level
Q9ULD6,INTU_HUMAN,Protein inturned (Inturned planar cell polarity effector homolog) (PDZ domain-containing protein 6),942,"105,648",5 out of 5,2005-08-16,Evidence at protein level
P24593,IBP5_HUMAN,Insulin-like growth factor-binding protein 5 (IBP-5) (IGF-binding protein 5) (IGFBP-5),272,"30,570",5 out of 5,1992-03-01,Evidence at protein level
P46695,IEX1_HUMAN,Radiation-inducible immediate-early gene IEX-1 (Differentiation-dependent gene 2 protein) (Protein DIF-2) (Immediate early protein GLY96) (Immediate early response 3 protein) (PACAP-responsive gene 1 protein) (Protein PRG1),156,"16,903",5 out of 5,1995-11-01,Evidence at protein level
Q16666,IF16_HUMAN,Gamma-interferon-inducible protein 16 (Ifi-16) (Interferon-inducible myeloid differentiation transcriptional activator),785,"88,256",5 out of 5,1997-11-01,Evidence at protein level
P38919,IF4A3_HUMAN,"Eukaryotic initiation factor 4A-III (eIF-4A-III) (eIF4A-III) (EC 3.6.4.13) (ATP-dependent RNA helicase DDX48) (ATP-dependent RNA helicase eIF4A-3) (DEAD box protein 48) (Eukaryotic initiation factor 4A-like NUK-34) (Eukaryotic translation initiation factor 4A isoform 3) (Nuclear matrix protein 265) (NMP 265) (hNMP 265) [Cleaved into: Eukaryotic initiation factor 4A-III, N-terminally processed]",411,"46,871",5 out of 5,1995-02-01,Evidence at protein level
P63241,IF5A1_HUMAN,Eukaryotic translation initiation factor 5A-1 (eIF-5A-1) (eIF-5A1) (Eukaryotic initiation factor 5A isoform 1) (eIF-5A) (Rev-binding factor) (eIF-4D),154,"16,832",5 out of 5,2004-10-11,Evidence at protein level
Q6IS14,IF5AL_HUMAN,Eukaryotic translation initiation factor 5A-1-like (eIF-5A-1-like) (eIF-5A1-like) (Eukaryotic initiation factor 5A isoform 1-like),154,"16,773",4 out of 5,2008-06-10,Evidence at transcript level
O14879,IFIT3_HUMAN,Interferon-induced protein with tetratricopeptide repeats 3 (IFIT-3) (CIG49) (ISG-60) (Interferon-induced 60 kDa protein) (IFI-60K) (Interferon-induced protein with tetratricopeptide repeats 4) (IFIT-4) (Retinoic acid-induced gene G protein) (P60) (RIG-G),490,"55,985",5 out of 5,2000-05-30,Evidence at protein level
K9M1U5,IFNL4_HUMAN,Interferon lambda-4 (IFN-lambda-4),179,"19,675",5 out of 5,2013-05-01,Evidence at transcript level
Q5T764,IFT1B_HUMAN,Interferon-induced protein with tetratricopeptide repeats 1B (Interferon-induced protein with tetratricopeptide repeats 1-like protein),474,"54,993",2 out of 5,2007-05-01,Evidence at protein level
Q9BW83,IFT27_HUMAN,Intraflagellar transport protein 27 homolog (Putative GTP-binding protein RAY-like) (Rab-like protein 4),186,"20,480",5 out of 5,2002-04-16,Evidence at protein level
Q9NQC8,IFT46_HUMAN,Intraflagellar transport protein 46 homolog,304,"34,286",5 out of 5,2006-01-24,Evidence at protein level
P09565,IG2R_HUMAN,Putative insulin-like growth factor 2-associated protein (Cell growth-inhibiting gene 44 protein) (Insulin-like growth factor II-associated protein),113,"12,087",1 out of 5,1989-07-01,Evidence at protein level
P0DOX4,IGE_HUMAN,Immunoglobulin epsilon heavy chain (Immunoglobulin epsilon heavy chain ND),547,"60,323",3 out of 5,2017-03-15,Evidence at protein level
Q8NBZ0,IN80E_HUMAN,INO80 complex subunit E (Coiled-coil domain-containing protein 95),244,"26,478",5 out of 5,2006-05-16,Evidence at protein level
Q0VD86,INCA1_HUMAN,Protein INCA1 (Inhibitor of CDK interacting with cyclin A1),236,"26,817",5 out of 5,2008-04-29,Evidence at protein level
Q9NQS7,INCE_HUMAN,Inner centromere protein,918,"105,429",5 out of 5,2003-04-23,Evidence at protein level
Q9UK53,ING1_HUMAN,Inhibitor of growth protein 1,422,"46,738",5 out of 5,2004-01-16,Evidence at protein level
Q9ULG1,INO80_HUMAN,DNA helicase INO80 (hINO80) (EC 3.6.4.12) (INO80 complex subunit A) (Putative DNA helicase INO80 complex homolog 1),1556,"176,753",5 out of 5,2006-09-05,Evidence at protein level
Q14641,INSL4_HUMAN,Early placenta insulin-like peptide (EPIL) (Insulin-like peptide 4) (Placentin) [Cleaved into: Early placenta insulin-like peptide B chain; Early placenta insulin-like peptide A chain],139,"15,445",5 out of 5,1997-11-01,Evidence at protein level
Q9NVR2,INT10_HUMAN,Integrator complex subunit 10 (Int10),710,"82,236",4 out of 5,2006-05-16,Evidence at protein level
Q96CB8,INT12_HUMAN,Integrator complex subunit 12 (Int12) (PHD finger protein 22),462,"48,808",4 out of 5,2005-08-16,Evidence at protein level
Q96HW7,INT4_HUMAN,Integrator complex subunit 4 (Int4),963,"108,171",5 out of 5,2006-10-31,Evidence at protein level
Q9H8X2,IPPK_HUMAN,"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)",491,"56,017",5 out of 5,2005-12-06,Evidence at protein level
Q15181,IPYR_HUMAN,Inorganic pyrophosphatase (EC 3.6.1.1) (Pyrophosphate phospho-hydrolase) (PPase),289,"32,660",4 out of 5,1997-11-01,Evidence at protein level
Q6DN90,IQEC1_HUMAN,IQ motif and SEC7 domain-containing protein 1 (ADP-ribosylation factors guanine nucleotide-exchange protein 100) (ADP-ribosylation factors guanine nucleotide-exchange protein 2) (Brefeldin-resistant Arf-GEF 2 protein) (BRAG2),963,"108,314",5 out of 5,2006-07-11,Evidence at protein level
Q8IY31,IFT20_HUMAN,Intraflagellar transport protein 20 homolog (hIFT20),132,"15,281",5 out of 5,2006-09-05,Evidence at protein level
Q6UWQ7,IGFL2_HUMAN,Insulin growth factor-like family member 2,119,"13,248",3 out of 5,2005-12-20,Evidence at transcript level
P01857,IGHG1_HUMAN,Immunoglobulin heavy constant gamma 1 (Ig gamma-1 chain C region) (Ig gamma-1 chain C region EU) (Ig gamma-1 chain C region KOL) (Ig gamma-1 chain C region NIE),330,"36,106",5 out of 5,1986-07-21,Evidence at protein level
P01834,IGKC_HUMAN,Immunoglobulin kappa constant (Ig kappa chain C region) (Ig kappa chain C region AG) (Ig kappa chain C region CUM) (Ig kappa chain C region EU) (Ig kappa chain C region OU) (Ig kappa chain C region ROY) (Ig kappa chain C region TI),107,"11,765",5 out of 5,1986-07-21,Evidence at protein level
P0CF74,IGLC6_HUMAN,Immunoglobulin lambda constant 6 (Ig lambda-6 chain C region),106,"11,277",5 out of 5,2010-04-20,Evidence at protein level
B9A064,IGLL5_HUMAN,Immunoglobulin lambda-like polypeptide 5 (G lambda-1) (Germline immunoglobulin lambda 1),214,"23,063",4 out of 5,2011-03-08,Evidence at transcript level
P0DOX6,IGM_HUMAN,Immunoglobulin mu heavy chain (Immunoglobulin mu heavy chain OU),576,"63,486",4 out of 5,2017-03-15,Evidence at protein level
Q5DX21,IGS11_HUMAN,Immunoglobulin superfamily member 11 (IgSF11) (Brain and testis-specific immunoglobulin superfamily protein) (Bt-IGSF) (V-set and immunoglobulin domain-containing protein 3),431,"46,120",5 out of 5,2008-02-05,Evidence at transcript level
Q969P0,IGSF8_HUMAN,Immunoglobulin superfamily member 8 (IgSF8) (CD81 partner 3) (Glu-Trp-Ile EWI motif-containing protein 2) (EWI-2) (Keratinocytes-associated transmembrane protein 4) (KCT-4) (LIR-D1) (Prostaglandin regulatory-like protein) (PGRL) (CD antigen CD316),613,"65,034",5 out of 5,2006-03-07,Evidence at protein level
Q8NI38,IKBD_HUMAN,NF-kappa-B inhibitor delta (I-kappa-B-delta) (IkB-delta) (IkappaBdelta) (IkappaBNS) (T-cell activation NFKB-like protein) (TA-NFKBH),313,"33,481",4 out of 5,2008-04-29,Evidence at protein level
Q9UHF5,IL17B_HUMAN,Interleukin-17B (IL-17B) (Cytokine Zcyto7) (Interleukin-20) (IL-20) (Neuronal interleukin-17-related factor),180,"20,437",4 out of 5,2002-01-31,Evidence at transcript level
Q96PD4,IL17F_HUMAN,Interleukin-17F (IL-17F) (Cytokine ML-1),163,"18,045",5 out of 5,2002-01-31,Evidence at protein level
Q9UHD0,IL19_HUMAN,Interleukin-19 (IL-19) (Melanoma differentiation-associated protein-like protein) (NG.1),177,"20,452",5 out of 5,2001-11-16,Evidence at protein level
P27930,IL1R2_HUMAN,"Interleukin-1 receptor type 2 (IL-1R-2) (IL-1RT-2) (IL-1RT2) (CD121 antigen-like family member B) (CDw121b) (IL-1 type II receptor) (Interleukin-1 receptor beta) (IL-1R-beta) (Interleukin-1 receptor type II) (CD antigen CD121b) [Cleaved into: Interleukin-1 receptor type 2, membrane form (mIL-1R2) (mIL-1RII); Interleukin-1 receptor type 2, soluble form (sIL-1R2) (sIL-1RII)]",398,"45,421",5 out of 5,1992-08-01,Evidence at protein level
Q8NEV9,IL27A_HUMAN,Interleukin-27 subunit alpha (IL-27 subunit alpha) (IL-27-A) (IL27-A) (Interleukin-30) (p28),243,"27,493",5 out of 5,2008-02-26,Evidence at protein level
P01589,IL2RA_HUMAN,Interleukin-2 receptor subunit alpha (IL-2 receptor subunit alpha) (IL-2-RA) (IL-2R subunit alpha) (IL2-RA) (TAC antigen) (p55) (CD antigen CD25),272,"30,819",5 out of 5,1986-07-21,Evidence at protein level
Q9NZH7,IL36B_HUMAN,Interleukin-36 beta (FIL1 eta) (Interleukin-1 eta) (IL-1 eta) (Interleukin-1 family member 8) (IL-1F8) (Interleukin-1 homolog 2) (IL-1H2),164,"18,522",5 out of 5,2002-11-08,Evidence at transcript level
P24394,IL4RA_HUMAN,Interleukin-4 receptor subunit alpha (IL-4 receptor subunit alpha) (IL-4R subunit alpha) (IL-4R-alpha) (IL-4RA) (CD antigen CD124) [Cleaved into: Soluble interleukin-4 receptor subunit alpha (Soluble IL-4 receptor subunit alpha) (Soluble IL-4R-alpha) (sIL4Ralpha/prot) (IL-4-binding protein) (IL4-BP)],825,"89,658",5 out of 5,1992-03-01,Evidence at protein level
Q71H61,ILDR2_HUMAN,Immunoglobulin-like domain-containing receptor 2,639,"71,200",4 out of 5,2007-02-20,Evidence at transcript level
P52294,IMA5_HUMAN,"Importin subunit alpha-5 (Karyopherin subunit alpha-1) (Nucleoprotein interactor 1) (NPI-1) (RAG cohort protein 2) (SRP1-beta) [Cleaved into: Importin subunit alpha-5, N-terminally processed]",538,"60,222",5 out of 5,1996-10-01,Evidence at protein level
Q96LU5,IMP1L_HUMAN,Mitochondrial inner membrane protease subunit 1 (EC 3.4.21.-) (IMP1-like protein),166,"18,504",3 out of 5,2006-10-31,Evidence at transcript level
Q96T52,IMP2L_HUMAN,Mitochondrial inner membrane protease subunit 2 (EC 3.4.21.-) (IMP2-like protein),175,"19,718",5 out of 5,2006-10-31,Evidence at transcript level
P29218,IMPA1_HUMAN,Inositol monophosphatase 1 (IMP 1) (IMPase 1) (EC 3.1.3.25) (D-galactose 1-phosphate phosphatase) (EC 3.1.3.94) (Inositol-1(or 4)-monophosphatase 1) (Lithium-sensitive myo-inositol monophosphatase A1),277,"30,189",5 out of 5,1992-12-01,Evidence at protein level
Q9P2X3,IMPCT_HUMAN,Protein IMPACT (Imprinted and ancient gene protein homolog),320,"36,476",5 out of 5,2008-04-29,Evidence at protein level
Q9BZV3,IMPG2_HUMAN,Interphotoreceptor matrix proteoglycan 2 (Interphotoreceptor matrix proteoglycan of 200 kDa) (IPM 200) (Sialoprotein associated with cones and rods proteoglycan) (Spacrcan),1241,"138,621",5 out of 5,2008-02-26,Evidence at protein level
P80217,IN35_HUMAN,Interferon-induced 35 kDa protein (IFP 35) (Ifi-35),286,"31,546",5 out of 5,1994-02-01,Evidence at protein level
P09529,INHBB_HUMAN,Inhibin beta B chain (Activin beta-B chain),407,"45,122",5 out of 5,1989-07-01,Evidence at protein level
Q96EL1,INKA1_HUMAN,PAK4-inhibitor INKA1 (Induced in neural crest by AP2-alpha protein homolog) (HInca),285,"31,328",5 out of 5,2006-06-13,Evidence at protein level
Q8IU57,INLR1_HUMAN,Interferon lambda receptor 1 (IFN-lambda receptor 1) (IFN-lambda-R1) (Cytokine receptor class-II member 12) (Cytokine receptor family 2 member 12) (CRF2-12) (Interleukin-28 receptor subunit alpha) (IL-28 receptor subunit alpha) (IL-28R-alpha) (IL-28RA) (Likely interleukin or cytokine receptor 2) (LICR2),520,"57,653",5 out of 5,2004-11-23,Evidence at protein level
A1A4Y4,IRGM_HUMAN,Immunity-related GTPase family M protein (EC 3.6.5.-) (Immunity-related GTPase family M protein 1) (Interferon-inducible protein 1) (LPS-stimulated RAW 264.7 macrophage protein 47 homolog) (LRG-47),181,"20,142",5 out of 5,2008-03-18,Evidence at protein level
P78415,IRX3_HUMAN,Iroquois-class homeodomain protein IRX-3 (Homeodomain protein IRXB1) (Iroquois homeobox protein 3),501,"52,119",4 out of 5,1998-07-15,Evidence at transcript level
Q9BUE6,ISCA1_HUMAN,"Iron-sulfur cluster assembly 1 homolog, mitochondrial (HESB-like domain-containing protein 2) (Iron-sulfur assembly protein IscA) (hIscA)",129,"14,179",4 out of 5,2005-11-08,Evidence at protein level
Q9NZ38,IDAS1_HUMAN,Uncharacterized protein IDI2-AS1 (IDI2 antisense RNA 1) (IDI2 antisense gene protein 1),188,"21,312",1 out of 5,2005-07-19,Evidence at transcript level
O43837,IDH3B_HUMAN,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial (EC 1.1.1.41) (Isocitric dehydrogenase subunit beta) (NAD(+)-specific ICDH subunit beta)",385,"42,184",5 out of 5,1999-07-15,Evidence at protein level
Q2VIR3,IF2GL_HUMAN,Putative eukaryotic translation initiation factor 2 subunit 3-like protein (Eukaryotic translation initiation factor 2 subunit gamma A) (eIF-2-gamma A) (eIF-2gA),472,"51,229",3 out of 5,2008-07-22,Uncertain
O60841,IF2P_HUMAN,Eukaryotic translation initiation factor 5B (eIF-5B) (EC 3.6.5.3) (Translation initiation factor IF-2),1220,"138,827",5 out of 5,1998-12-15,Evidence at protein level
O60573,IF4E2_HUMAN,Eukaryotic translation initiation factor 4E type 2 (eIF-4E type 2) (eIF4E type 2) (Eukaryotic translation initiation factor 4E homologous protein) (Eukaryotic translation initiation factor 4E-like 3) (eIF4E-like protein 4E-LP) (mRNA cap-binding protein 4EHP) (h4EHP) (mRNA cap-binding protein type 3),245,"28,362",5 out of 5,2003-04-11,Evidence at protein level
Q15056,IF4H_HUMAN,Eukaryotic translation initiation factor 4H (eIF-4H) (Williams-Beuren syndrome chromosomal region 1 protein),248,"27,385",5 out of 5,1998-07-15,Evidence at protein level
Q9GZV4,IF5A2_HUMAN,Eukaryotic translation initiation factor 5A-2 (eIF-5A-2) (eIF-5A2) (Eukaryotic initiation factor 5A isoform 2),153,"16,793",5 out of 5,2006-04-04,Evidence at protein level
P55010,IF5_HUMAN,Eukaryotic translation initiation factor 5 (eIF-5),431,"49,223",5 out of 5,1996-10-01,Evidence at protein level
P40305,IFI27_HUMAN,"Interferon alpha-inducible protein 27, mitochondrial (p27) (Interferon alpha-induced 11.5 kDa protein) (Interferon-stimulated gene 12a protein) (ISG12(a))",119,"11,268",5 out of 5,1995-02-01,Evidence at transcript level
Q8TCB0,IFI44_HUMAN,Interferon-induced protein 44 (p44) (Microtubule-associated protein 44),444,"50,491",3 out of 5,2004-06-07,Evidence at transcript level
Q6K0P9,IFIX_HUMAN,Pyrin and HIN domain-containing protein 1 (Interferon-inducible protein X),492,"55,065",5 out of 5,2008-05-20,Evidence at protein level
P01570,IFN14_HUMAN,Interferon alpha-14 (IFN-alpha-14) (Interferon alpha-H) (LeIF H) (Interferon lambda-2-H),189,"22,063",5 out of 5,1986-07-21,Evidence at protein level
P01569,IFNA5_HUMAN,Interferon alpha-5 (IFN-alpha-5) (Interferon alpha-61) (Interferon alpha-G) (LeIF G),189,"21,942",5 out of 5,1986-07-21,Evidence at protein level
P32881,IFNA8_HUMAN,Interferon alpha-8 (IFN-alpha-8) (Interferon alpha-B) (LeIF B) (Interferon alpha-B2),189,"21,989",5 out of 5,1986-07-21,Evidence at protein level
Q8IZJ0,IFNL2_HUMAN,Interferon lambda-2 (IFN-lambda-2) (Cytokine Zcyto20) (Interleukin-28A) (IL-28A),200,"22,288",4 out of 5,2004-11-23,Evidence at transcript level
Q9UHA7,IL36A_HUMAN,Interleukin-36 alpha (FIL1 epsilon) (Interleukin-1 epsilon) (IL-1 epsilon) (Interleukin-1 family member 6) (IL-1F6),158,"17,684",5 out of 5,2002-11-08,Evidence at protein level
P26951,IL3RA_HUMAN,Interleukin-3 receptor subunit alpha (IL-3 receptor subunit alpha) (IL-3R subunit alpha) (IL-3R-alpha) (IL-3RA) (CD antigen CD123),378,"43,330",5 out of 5,1993-10-01,Evidence at protein level
P08887,IL6RA_HUMAN,Interleukin-6 receptor subunit alpha (IL-6 receptor subunit alpha) (IL-6R subunit alpha) (IL-6R-alpha) (IL-6RA) (IL-6R 1) (Membrane glycoprotein 80) (gp80) (CD antigen CD126),468,"51,548",5 out of 5,1988-11-01,Evidence at protein level
P05231,IL6_HUMAN,Interleukin-6 (IL-6) (B-cell stimulatory factor 2) (BSF-2) (CTL differentiation factor) (CDF) (Hybridoma growth factor) (Interferon beta-2) (IFN-beta-2),212,"23,718",5 out of 5,1987-08-13,Evidence at protein level
A9QM74,IMA8_HUMAN,Importin subunit alpha-8 (Karyopherin subunit alpha-7),516,"56,938",4 out of 5,2008-03-18,Evidence at protein level
Q9NV31,IMP3_HUMAN,U3 small nucleolar ribonucleoprotein protein IMP3 (U3 snoRNP protein IMP3) (BRMS2),184,"21,850",5 out of 5,2004-09-27,Evidence at protein level
O14732,IMPA2_HUMAN,Inositol monophosphatase 2 (IMP 2) (IMPase 2) (EC 3.1.3.25) (Inositol-1(or 4)-monophosphatase 2) (Myo-inositol monophosphatase A2),288,"31,321",5 out of 5,1998-12-15,Evidence at protein level
O15225,INE1_HUMAN,Putative inactivation escape 1 protein,51,"5,365",1 out of 5,1999-07-15,Uncertain
P09912,IFI6_HUMAN,Interferon alpha-inducible protein 6 (Interferon-induced protein 6-16) (Ifi-6-16),130,"12,927",4 out of 5,1989-07-01,Evidence at transcript level
P09914,IFIT1_HUMAN,Interferon-induced protein with tetratricopeptide repeats 1 (IFIT-1) (Interferon-induced 56 kDa protein) (IFI-56K) (P56),478,"55,360",5 out of 5,1989-07-01,Evidence at protein level
Q13325,IFIT5_HUMAN,Interferon-induced protein with tetratricopeptide repeats 5 (IFIT-5) (Interferon-induced 58 kDa protein) (Retinoic acid- and interferon-inducible 58 kDa protein) (P58),482,"55,847",5 out of 5,2000-05-30,Evidence at protein level
P01566,IFN10_HUMAN,Interferon alpha-10 (IFN-alpha-10) (Interferon alpha-6L) (Interferon alpha-C) (LeIF C),189,"21,835",5 out of 5,1986-07-21,Evidence at protein level
P01568,IFN21_HUMAN,Interferon alpha-21 (IFN-alpha-21) (Interferon alpha-F) (LeIF F),189,"21,741",5 out of 5,1986-07-21,Evidence at protein level
P01574,IFNB_HUMAN,Interferon beta (IFN-beta) (Fibroblast interferon),187,"22,294",5 out of 5,1986-07-21,Evidence at protein level
Q96FT9,IFT43_HUMAN,Intraflagellar transport protein 43 homolog,208,"23,529",5 out of 5,2006-10-31,Evidence at protein level
Q9P0M4,IL17C_HUMAN,Interleukin-17C (IL-17C) (Cytokine CX2),197,"21,765",4 out of 5,2002-01-31,Evidence at protein level
Q8WWZ1,IL1FA_HUMAN,Interleukin-1 family member 10 (IL-1F10) (Family of interleukin 1-theta) (FIL1 theta) (Interleukin-1 HY2) (IL-1HY2) (Interleukin-1 theta) (IL-1 theta) (Interleukin-38) (IL-38),152,"16,943",4 out of 5,2002-11-08,Evidence at protein level
P24001,IL32_HUMAN,Interleukin-32 (IL-32) (Natural killer cells protein 4) (Tumor necrosis factor alpha-inducing factor),234,"26,676",5 out of 5,1992-03-01,Evidence at protein level
Q9NZH6,IL37_HUMAN,Interleukin-37 (FIL1 zeta) (IL-1X) (Interleukin-1 family member 7) (IL-1F7) (Interleukin-1 homolog 4) (IL-1H) (IL-1H4) (Interleukin-1 zeta) (IL-1 zeta) (Interleukin-1-related protein) (IL-1RP1) (Interleukin-23) (IL-37),218,"24,126",5 out of 5,2002-11-08,Evidence at protein level
Q86SU0,ILDR1_HUMAN,Immunoglobulin-like domain-containing receptor 1,546,"62,815",5 out of 5,2006-07-11,Evidence at protein level
Q9HB29,ILRL2_HUMAN,Interleukin-1 receptor-like 2 (IL-36 receptor) (IL-36R) (Interleukin-1 receptor-related protein 2) (IL-1Rrp2) (IL1R-rp2),575,"65,405",5 out of 5,2002-12-06,Evidence at protein level
A1L0T0,ILVBL_HUMAN,Acetolactate synthase-like protein (EC 2.2.1.-) (IlvB-like protein),632,"67,868",4 out of 5,2008-01-15,Evidence at protein level
P52292,IMA1_HUMAN,Importin subunit alpha-1 (Karyopherin subunit alpha-2) (RAG cohort protein 1) (SRP1-alpha),529,"57,862",5 out of 5,1996-10-01,Evidence at protein level
Q96PE3,INP4A_HUMAN,"Type I inositol 3,4-bisphosphate 4-phosphatase (EC 3.1.3.66) (Inositol polyphosphate 4-phosphatase type I)",977,"109,956",5 out of 5,2005-08-30,Evidence at protein level
P14616,INSRR_HUMAN,Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain],1297,"143,720",5 out of 5,1990-04-01,Evidence at protein level
P06213,INSR_HUMAN,Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta],1382,"156,333",5 out of 5,1988-01-01,Evidence at protein level
Q8N201,INT1_HUMAN,Integrator complex subunit 1 (Int1),2190,"244,297",5 out of 5,2006-05-16,Evidence at protein level
Q5JSJ4,INT6L_HUMAN,Integrator complex subunit 6-like (Protein DDX26B),861,"96,673",2 out of 5,2006-01-10,Evidence at protein level
Q96P70,IPO9_HUMAN,Importin-9 (Imp9) (Ran-binding protein 9) (RanBP9),1041,"115,963",5 out of 5,2004-02-02,Evidence at protein level
Q15051,IQCB1_HUMAN,IQ calmodulin-binding motif-containing protein 1 (Nephrocystin-5) (p53 and DNA damage-regulated IQ motif protein) (PIQ),598,"68,929",5 out of 5,1998-07-15,Evidence at protein level
Q1A5X6,IQCJ_HUMAN,IQ domain-containing protein J,159,"18,226",2 out of 5,2008-01-15,Evidence at transcript level
P51617,IRAK1_HUMAN,Interleukin-1 receptor-associated kinase 1 (IRAK-1) (EC 2.7.11.1),712,"76,537",5 out of 5,1996-10-01,Evidence at protein level
Q9NX55,HYPK_HUMAN,Huntingtin-interacting protein K (Huntingtin yeast partner K),129,"14,665",4 out of 5,2007-02-06,Evidence at protein level
Q14627,I13R2_HUMAN,Interleukin-13 receptor subunit alpha-2 (IL-13 receptor subunit alpha-2) (IL-13R subunit alpha-2) (IL-13R-alpha-2) (IL-13RA2) (Interleukin-13-binding protein) (CD antigen CD213a2),380,"44,176",5 out of 5,1997-11-01,Evidence at protein level
Q96F46,I17RA_HUMAN,Interleukin-17 receptor A (IL-17 receptor A) (IL-17RA) (CDw217) (CD antigen CD217),866,"96,122",5 out of 5,2002-05-02,Evidence at protein level
Q8NFM7,I17RD_HUMAN,Interleukin-17 receptor D (IL-17 receptor D) (IL-17RD) (IL17Rhom) (Interleukin-17 receptor-like protein) (Sef homolog) (hSef),739,"82,411",5 out of 5,2005-09-13,Evidence at protein level
Q2TAA2,IAH1_HUMAN,Isoamyl acetate-hydrolyzing esterase 1 homolog (EC 3.1.-.-),248,"27,599",3 out of 5,2008-01-15,Evidence at protein level
P46199,IF2M_HUMAN,"Translation initiation factor IF-2, mitochondrial (IF-2(Mt)) (IF-2Mt) (IF2(mt))",727,"81,317",5 out of 5,1995-11-01,Evidence at protein level
P09913,IFIT2_HUMAN,Interferon-induced protein with tetratricopeptide repeats 2 (IFIT-2) (ISG-54 K) (Interferon-induced 54 kDa protein) (IFI-54K) (P54),472,"54,632",5 out of 5,1989-07-01,Evidence at protein level
P13164,IFM1_HUMAN,Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD antigen CD225),125,"13,964",5 out of 5,1990-01-01,Evidence at protein level
P05013,IFNA6_HUMAN,Interferon alpha-6 (IFN-alpha-6) (Interferon alpha-54) (Interferon alpha-K) (LeIF K),189,"22,141",5 out of 5,1987-08-13,Evidence at protein level
P01579,IFNG_HUMAN,Interferon gamma (IFN-gamma) (Immune interferon),166,"19,348",5 out of 5,1986-07-21,Evidence at protein level
Q8IZI9,IFNL3_HUMAN,Interferon lambda-3 (IFN-lambda-3) (Cytokine Zcyto22) (Interleukin-28B) (IL-28B) (Interleukin-28C) (IL-28C),196,"21,706",5 out of 5,2004-11-23,Evidence at protein level
P01854,IGHE_HUMAN,Immunoglobulin heavy constant epsilon (Ig epsilon chain C region) (Ig epsilon chain C region ND),428,"47,019",5 out of 5,1986-07-21,Evidence at protein level
P01861,IGHG4_HUMAN,Immunoglobulin heavy constant gamma 4 (Ig gamma-4 chain C region),327,"35,941",5 out of 5,1986-07-21,Evidence at protein level
P01871,IGHM_HUMAN,Immunoglobulin heavy constant mu (Ig mu chain C region) (Ig mu chain C region GAL) (Ig mu chain C region OU),453,"49,440",5 out of 5,1986-07-21,Evidence at protein level
P0DOY2,IGLC2_HUMAN,Immunoglobulin lambda constant 2 (Ig lambda chain C region Kern) (Ig lambda chain C region NIG-64) (Ig lambda chain C region SH) (Ig lambda chain C region X) (Ig lambda-2 chain C region),106,"11,294",4 out of 5,2017-03-15,Evidence at protein level
Q6WRI0,IGS10_HUMAN,Immunoglobulin superfamily member 10 (IgSF10) (Calvaria mechanical force protein 608) (CMF608),2623,"290,838",4 out of 5,2007-05-15,Evidence at transcript level
Q8N9C0,IGS22_HUMAN,Immunoglobulin superfamily member 22 (IgSF22),903,"100,400",4 out of 5,2007-05-01,Evidence at transcript level
Q8N6C5,IGSF1_HUMAN,Immunoglobulin superfamily member 1 (IgSF1) (Immunoglobulin-like domain-containing protein 1) (Inhibin-binding protein) (InhBP) (Pituitary gland-specific factor 2) (p120),1336,"148,936",5 out of 5,2008-02-05,Evidence at protein level
Q9NSI5,IGSF5_HUMAN,Immunoglobulin superfamily member 5 (IgSF5) (Junctional adhesion molecule 4) (JAM-4),407,"44,593",4 out of 5,2008-02-05,Evidence at transcript level
Q14623,IHH_HUMAN,Indian hedgehog protein (IHH) (HHG-2) [Cleaved into: Indian hedgehog protein N-product; Indian hedgehog protein C-product],411,"45,251",5 out of 5,1999-07-15,Evidence at protein level
Q15653,IKBB_HUMAN,NF-kappa-B inhibitor beta (NF-kappa-BIB) (I-kappa-B-beta) (IkB-B) (IkB-beta) (IkappaBbeta) (Thyroid receptor-interacting protein 9) (TR-interacting protein 9) (TRIP-9),356,"37,771",5 out of 5,1997-11-01,Evidence at protein level
Q5VVH5,IKBP1_HUMAN,Interleukin-1 receptor-associated kinase 1-binding protein 1 (IRAK1-binding protein 1),260,"29,106",3 out of 5,2008-01-15,Evidence at protein level
Q9BYH8,IKBZ_HUMAN,NF-kappa-B inhibitor zeta (I-kappa-B-zeta) (IkB-zeta) (IkappaBzeta) (IL-1 inducible nuclear ankyrin-repeat protein) (INAP) (Molecule possessing ankyrin repeats induced by lipopolysaccharide) (MAIL),718,"78,061",5 out of 5,2008-03-18,Evidence at protein level
Q9UKT9,IKZF3_HUMAN,Zinc finger protein Aiolos (Ikaros family zinc finger protein 3),509,"58,023",5 out of 5,2002-09-19,Evidence at protein level
P40189,IL6RB_HUMAN,Interleukin-6 receptor subunit beta (IL-6 receptor subunit beta) (IL-6R subunit beta) (IL-6R-beta) (IL-6RB) (CDw130) (Interleukin-6 signal transducer) (Membrane glycoprotein 130) (gp130) (Oncostatin-M receptor subunit alpha) (CD antigen CD130),918,"103,537",5 out of 5,1995-02-01,Evidence at protein level
Q12905,ILF2_HUMAN,Interleukin enhancer-binding factor 2 (Nuclear factor of activated T-cells 45 kDa),390,"43,062",5 out of 5,2005-04-12,Evidence at protein level
Q12906,ILF3_HUMAN,Interleukin enhancer-binding factor 3 (Double-stranded RNA-binding protein 76) (DRBP76) (M-phase phosphoprotein 4) (MPP4) (Nuclear factor associated with dsRNA) (NFAR) (Nuclear factor of activated T-cells 90 kDa) (NF-AT-90) (Translational control protein 80) (TCP80),894,"95,338",5 out of 5,2002-01-31,Evidence at protein level
Q01638,ILRL1_HUMAN,Interleukin-1 receptor-like 1 (Protein ST2),556,"63,358",5 out of 5,1993-04-01,Evidence at protein level
Q9NXR8,ING3_HUMAN,Inhibitor of growth protein 3 (p47ING3),418,"46,743",5 out of 5,2005-02-15,Evidence at protein level
Q8WYH8,ING5_HUMAN,Inhibitor of growth protein 5 (p28ING5),240,"27,751",5 out of 5,2005-01-04,Evidence at protein level
P15260,INGR1_HUMAN,Interferon gamma receptor 1 (IFN-gamma receptor 1) (IFN-gamma-R1) (CDw119) (Interferon gamma receptor alpha-chain) (IFN-gamma-R-alpha) (CD antigen CD119),489,"54,405",5 out of 5,1990-04-01,Evidence at protein level
Q9Y5U4,INSI2_HUMAN,Insulin-induced gene 2 protein (INSIG-2),225,"24,778",5 out of 5,2007-05-15,Evidence at protein level
Q9Y5Q6,INSL5_HUMAN,Insulin-like peptide INSL5 (Insulin-like peptide 5) [Cleaved into: Insulin-like peptide INSL5 B chain; Insulin-like peptide INSL5 A chain],135,"15,333",5 out of 5,2000-05-30,Evidence at protein level
Q96T92,INSM2_HUMAN,Insulinoma-associated protein 2 (Zinc finger protein IA-6),566,"59,491",3 out of 5,2008-04-29,Evidence at protein level
Q9H1H9,KI13A_HUMAN,Kinesin-like protein KIF13A (Kinesin-like protein RBKIN),1805,"202,308",5 out of 5,2002-09-19,Evidence at protein level
Q96Q89,KI20B_HUMAN,Kinesin-like protein KIF20B (Cancer/testis antigen 90) (CT90) (Kinesin family member 20B) (Kinesin-related motor interacting with PIN1) (M-phase phosphoprotein 1) (MPP1),1820,"210,629",5 out of 5,2007-01-23,Evidence at protein level
Q14807,KIF22_HUMAN,Kinesin-like protein KIF22 (Kinesin-like DNA-binding protein) (Kinesin-like protein 4),665,"73,262",5 out of 5,2000-12-01,Evidence at protein level
O00139,KIF2A_HUMAN,Kinesin-like protein KIF2A (Kinesin-2) (hK2),706,"79,955",5 out of 5,1998-07-15,Evidence at protein level
O95239,KIF4A_HUMAN,Chromosome-associated kinesin KIF4A (Chromokinesin-A),1232,"139,881",5 out of 5,1999-07-15,Evidence at protein level
Q9NRX6,KISHB_HUMAN,Protein kish-B (Transmembrane protein 167B),74,"8,294",3 out of 5,2006-12-12,Inferred from homology
Q969F8,KISSR_HUMAN,KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor),398,"42,586",5 out of 5,2005-03-01,Evidence at protein level
Q8N5S9,KKCC1_HUMAN,Calcium/calmodulin-dependent protein kinase kinase 1 (CaM-KK 1) (CaM-kinase kinase 1) (CaMKK 1) (EC 2.7.11.17) (CaM-kinase IV kinase) (Calcium/calmodulin-dependent protein kinase kinase alpha) (CaM-KK alpha) (CaM-kinase kinase alpha) (CaMKK alpha),505,"55,735",5 out of 5,2004-12-07,Evidence at protein level
Q96RR4,KKCC2_HUMAN,Calcium/calmodulin-dependent protein kinase kinase 2 (CaM-KK 2) (CaM-kinase kinase 2) (CaMKK 2) (EC 2.7.11.17) (Calcium/calmodulin-dependent protein kinase kinase beta) (CaM-KK beta) (CaM-kinase kinase beta) (CaMKK beta),588,"64,746",5 out of 5,2004-12-07,Evidence at protein level
Q8IYD2,KLD8A_HUMAN,Kelch domain-containing protein 8A (Substitute for delta-EGFR expression 1) (S-delta-E1),350,"38,859",2 out of 5,2006-03-21,Evidence at transcript level
Q9BQ90,KLDC3_HUMAN,Kelch domain-containing protein 3 (Protein Peas) (Testis intracellular mediator protein),382,"43,088",3 out of 5,2006-03-21,Evidence at transcript level
Q9P2N7,KLH13_HUMAN,Kelch-like protein 13 (BTB and kelch domain-containing protein 2),655,"73,868",5 out of 5,2001-04-27,Evidence at protein level
Q9Y2M5,KLH20_HUMAN,Kelch-like protein 20 (Kelch-like ECT2-interacting protein) (Kelch-like protein X),609,"67,955",5 out of 5,2001-04-27,Evidence at protein level
Q8NBE8,KLH23_HUMAN,Kelch-like protein 23,558,"63,923",2 out of 5,2006-06-27,Evidence at protein level
Q9NXS3,KLH28_HUMAN,Kelch-like protein 28 (BTB/POZ domain-containing protein 5),571,"64,192",2 out of 5,2004-03-29,Evidence at transcript level
Q96NJ5,KLH32_HUMAN,Kelch-like protein 32 (BTB and kelch domain-containing protein 5),620,"70,362",3 out of 5,2004-01-16,Evidence at transcript level
O60662,KLH41_HUMAN,Kelch-like protein 41 (Kel-like protein 23) (Kelch repeat and BTB domain-containing protein 10) (Kelch-related protein 1) (Sarcosin),606,"68,037",5 out of 5,2001-06-01,Evidence at protein level
Q96PQ7,KLHL5_HUMAN,Kelch-like protein 5,755,"84,457",3 out of 5,2002-03-27,Evidence at transcript level
Q12918,KLRB1_HUMAN,Killer cell lectin-like receptor subfamily B member 1 (C-type lectin domain family 5 member B) (HNKR-P1a) (NKR-P1A) (Natural killer cell surface protein P1A) (CD antigen CD161),225,"25,415",5 out of 5,2006-11-14,Evidence at protein level
A4D1S0,KLRG2_HUMAN,Killer cell lectin-like receptor subfamily G member 2 (C-type lectin domain family 15 member B),409,"42,851",3 out of 5,2008-02-05,Evidence at protein level
Q03164,KMT2A_HUMAN,Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.43) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)],3969,"431,764",5 out of 5,1993-10-01,Evidence at protein level
Q8IZD2,KMT2E_HUMAN,Histone-lysine N-methyltransferase 2E (Lysine N-methyltransferase 2E) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 5),1858,"204,965",5 out of 5,2008-06-10,Evidence at protein level
P46020,KPB1_HUMAN,"Phosphorylase b kinase regulatory subunit alpha, skeletal muscle isoform (Phosphorylase kinase alpha M subunit)",1223,"137,312",5 out of 5,1995-11-01,Evidence at protein level
Q93100,KPBB_HUMAN,Phosphorylase b kinase regulatory subunit beta (Phosphorylase kinase subunit beta),1093,"124,884",5 out of 5,1997-11-01,Evidence at protein level
Q05655,KPCD_HUMAN,Protein kinase C delta type (EC 2.7.11.13) (Tyrosine-protein kinase PRKCD) (EC 2.7.10.2) (nPKC-delta) [Cleaved into: Protein kinase C delta type regulatory subunit; Protein kinase C delta type catalytic subunit (Sphingosine-dependent protein kinase-1) (SDK1)],676,"77,505",5 out of 5,1994-06-01,Evidence at protein level
P41743,KPCI_HUMAN,Protein kinase C iota type (EC 2.7.11.13) (Atypical protein kinase C-lambda/iota) (PRKC-lambda/iota) (aPKC-lambda/iota) (nPKC-iota),596,"68,262",5 out of 5,1995-11-01,Evidence at protein level
Q14558,KPRA_HUMAN,Phosphoribosyl pyrophosphate synthase-associated protein 1 (PRPP synthase-associated protein 1) (39 kDa phosphoribosypyrophosphate synthase-associated protein) (PAP39),356,"39,394",5 out of 5,2002-10-25,Evidence at protein level
P60370,KR105_HUMAN,Keratin-associated protein 10-5 (High sulfur keratin-associated protein 10.5) (Keratin-associated protein 10.5) (Keratin-associated protein 18-5) (Keratin-associated protein 18.5),271,"27,626",5 out of 5,2004-02-16,Evidence at protein level
P60410,KR108_HUMAN,Keratin-associated protein 10-8 (High sulfur keratin-associated protein 10.8) (Keratin-associated protein 10.8) (Keratin-associated protein 18-8) (Keratin-associated protein 18.8),259,"26,299",5 out of 5,2004-02-16,Evidence at protein level
Q8IUC1,KR111_HUMAN,Keratin-associated protein 11-1 (High sulfur keratin-associated protein 11.1),163,"17,085",3 out of 5,2003-06-27,Evidence at transcript level
P0C7H8,KRA23_HUMAN,Keratin-associated protein 2-3 (High sulfur keratin-associated protein 2.4) (Keratin-associated protein 2.3),128,"13,480",5 out of 5,2008-04-29,Evidence at protein level
C9JBD0,KRBX1_HUMAN,KRAB domain-containing protein 1,128,"14,906",2 out of 5,2011-02-08,Evidence at transcript level
O76014,KRT37_HUMAN,"Keratin, type I cuticular Ha7 (Hair keratin, type I Ha7) (Keratin-37) (K37)",449,"49,747",5 out of 5,2000-05-30,Inferred from homology
Q14525,KT33B_HUMAN,"Keratin, type I cuticular Ha3-II (Hair keratin, type I Ha3-II) (Keratin-33B) (K33B)",404,"46,214",5 out of 5,1998-07-15,Evidence at protein level
Q96EK9,KTI12_HUMAN,Protein KTI12 homolog,354,"38,616",2 out of 5,2007-05-01,Evidence at protein level
P01602,KV105_HUMAN,Immunoglobulin kappa variable 1-5 (Ig kappa chain V-I region CAR) (Ig kappa chain V-I region EU) (Ig kappa chain V-I region HK102) (Ig kappa chain V-I region Kue),117,"12,782",5 out of 5,1986-07-21,Evidence at protein level
A0A087WSY6,KVD15_HUMAN,Immunoglobulin kappa variable 3D-15,115,"12,534",3 out of 5,2017-01-18,Inferred from homology
A6NM11,L37A2_HUMAN,Leucine-rich repeat-containing protein 37A2,1700,"188,393",3 out of 5,2008-05-20,Evidence at transcript level
Q9Y6C7,L3R2A_HUMAN,Putative uncharacterized protein encoded by LINC00312 (Loss of heterozygosity 3 chromosomal region 2 gene A protein),94,"11,024",1 out of 5,2000-05-30,Uncertain
Q53H82,LACB2_HUMAN,Endoribonuclease LACTB2 (EC 3.1.27.-) (Beta-lactamase-like protein 2),288,"32,806",5 out of 5,2008-01-15,Evidence at protein level
Q9GZZ8,LACRT_HUMAN,Extracellular glycoprotein lacritin,138,"14,246",5 out of 5,2003-07-25,Evidence at protein level
Q6ZV70,LANC3_HUMAN,LanC-like protein 3,420,"46,319",2 out of 5,2007-05-01,Evidence at transcript level
O95461,LARG1_HUMAN,"LARGE xylosyl- and glucuronyltransferase 1 (EC 2.4.-.-) (Acetylglucosaminyltransferase-like 1A) (Glycosyltransferase-like protein) [Includes: Xylosyltransferase LARGE (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE (EC 2.4.1.-)]",756,"88,066",5 out of 5,2002-07-26,Evidence at protein level
Q9BRS8,LARP6_HUMAN,La-related protein 6 (Acheron) (Achn) (La ribonucleoprotein domain family member 6),491,"54,737",4 out of 5,2007-03-20,Evidence at protein level
Q8IWV1,LAX1_HUMAN,Lymphocyte transmembrane adapter 1 (Linker for activation of X cells) (Membrane-associated adapter protein LAX),398,"44,085",5 out of 5,2005-12-20,Evidence at protein level
Q6UX15,LAYN_HUMAN,Layilin,382,"43,108",5 out of 5,2006-11-28,Evidence at transcript level
A4D1U4,LCHN_HUMAN,Protein LCHN,455,"51,446",2 out of 5,2008-01-15,Evidence at protein level
P06239,LCK_HUMAN,Tyrosine-protein kinase Lck (EC 2.7.10.2) (Leukocyte C-terminal Src kinase) (LSK) (Lymphocyte cell-specific protein-tyrosine kinase) (Protein YT16) (Proto-oncogene Lck) (T cell-specific protein-tyrosine kinase) (p56-LCK),509,"58,001",5 out of 5,1988-01-01,Evidence at protein level
Q9UIC8,LCMT1_HUMAN,Leucine carboxyl methyltransferase 1 (EC 2.1.1.233) (Protein-leucine O-methyltransferase) ([Phosphatase 2A protein]-leucine-carboxy methyltransferase 1),334,"38,379",5 out of 5,2000-12-01,Evidence at protein level
Q6JVE5,LCN12_HUMAN,Epididymal-specific lipocalin-12,192,"21,500",3 out of 5,2005-03-29,Evidence at transcript level
Q6UWW0,LCN15_HUMAN,Lipocalin-15,184,"20,454",2 out of 5,2008-02-05,Evidence at protein level
O43679,LDB2_HUMAN,LIM domain-binding protein 2 (LDB-2) (Carboxyl-terminal LIM domain-binding protein 1) (CLIM-1) (LIM domain-binding factor CLIM1),373,"42,793",5 out of 5,2005-07-05,Evidence at protein level
O95751,LDOC1_HUMAN,Protein LDOC1 (Leucine zipper protein down-regulated in cancer cells),146,"16,968",5 out of 5,2000-05-30,Evidence at protein level
Q5T871,LELP1_HUMAN,Late cornified envelope-like proline-rich protein 1 (Novel small proline-rich protein),98,"10,697",2 out of 5,2007-01-09,Inferred from homology
Q96PV6,LENG8_HUMAN,Leukocyte receptor cluster member 8,779,"86,129",3 out of 5,2007-10-02,Evidence at protein level
Q2KJY2,KI26B_HUMAN,Kinesin-like protein KIF26B,2108,"223,883",4 out of 5,2007-10-23,Evidence at transcript level
P43626,KI2L1_HUMAN,Killer cell immunoglobulin-like receptor 2DL1 (CD158 antigen-like family member A) (MHC class I NK cell receptor) (Natural killer-associated transcript 1) (NKAT-1) (p58 natural killer cell receptor clones CL-42/47.11) (p58 NK receptor CL-42/47.11) (p58.1 MHC class-I-specific NK receptor) (CD antigen CD158a),348,"38,505",5 out of 5,1995-11-01,Evidence at protein level
P43630,KI3L2_HUMAN,Killer cell immunoglobulin-like receptor 3DL2 (CD158 antigen-like family member K) (MHC class I NK cell receptor) (Natural killer-associated transcript 4) (NKAT-4) (p70 natural killer cell receptor clone CL-5) (p70 NK receptor CL-5) (CD antigen CD158k),455,"50,230",5 out of 5,1995-11-01,Evidence at transcript level
Q9H7L2,KI3X1_HUMAN,Putative killer cell immunoglobulin-like receptor-like protein KIR3DX1 (Leukocyte receptor cluster member 12),352,"38,777",3 out of 5,2008-09-02,Uncertain
P46013,KI67_HUMAN,Proliferation marker protein Ki-67 (Antigen identified by monoclonal antibody Ki-67) (Antigen KI-67) (Antigen Ki67),3256,"358,694",5 out of 5,1995-11-01,Evidence at protein level
P52732,KIF11_HUMAN,Kinesin-like protein KIF11 (Kinesin-like protein 1) (Kinesin-like spindle protein HKSP) (Kinesin-related motor protein Eg5) (Thyroid receptor-interacting protein 5) (TR-interacting protein 5) (TRIP-5),1056,"119,159",5 out of 5,1996-10-01,Evidence at protein level
Q9NS87,KIF15_HUMAN,Kinesin-like protein KIF15 (Kinesin-like protein 2) (hKLP2) (Kinesin-like protein 7) (Serologically defined breast cancer antigen NY-BR-62),1388,"160,160",5 out of 5,2008-04-08,Evidence at protein level
O60333,KIF1B_HUMAN,Kinesin-like protein KIF1B (Klp),1816,"204,476",5 out of 5,2001-01-11,Evidence at protein level
Q5T7B8,KIF24_HUMAN,Kinesin-like protein KIF24,1368,"151,903",5 out of 5,2007-02-20,Evidence at protein level
Q8N4N8,KIF2B_HUMAN,Kinesin-like protein KIF2B,673,"76,254",5 out of 5,2006-10-17,Evidence at protein level
Q99661,KIF2C_HUMAN,Kinesin-like protein KIF2C (Kinesin-like protein 6) (Mitotic centromere-associated kinesin) (MCAK),725,"81,313",5 out of 5,2001-01-11,Evidence at protein level
O60282,KIF5C_HUMAN,Kinesin heavy chain isoform 5C (Kinesin heavy chain neuron-specific 2),957,"109,495",5 out of 5,2001-02-21,Evidence at protein level
Q6ZMV9,KIF6_HUMAN,Kinesin-like protein KIF6,814,"92,569",4 out of 5,2005-07-05,Evidence at protein level
Q9HAQ2,KIF9_HUMAN,Kinesin-like protein KIF9,790,"89,986",5 out of 5,2001-08-29,Evidence at protein level
Q15726,KISS1_HUMAN,Metastasis-suppressor KiSS-1 (Kisspeptin-1) [Cleaved into: Metastin (Kisspeptin-54); Kisspeptin-14; Kisspeptin-13; Kisspeptin-10],138,"14,705",5 out of 5,1999-07-15,Evidence at protein level
P10721,KIT_HUMAN,Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog) (CD antigen CD117),976,"109,865",5 out of 5,1989-07-01,Evidence at protein level
Q9NSK0,KLC4_HUMAN,Kinesin light chain 4 (KLC 4) (Kinesin-like protein 8),619,"68,640",5 out of 5,2001-04-27,Evidence at protein level
Q8TBB5,KLDC4_HUMAN,Kelch domain-containing protein 4,520,"57,892",3 out of 5,2006-03-21,Evidence at protein level
P60368,KR102_HUMAN,Keratin-associated protein 10-2 (High sulfur keratin-associated protein 10.2) (Keratin-associated protein 10.2) (Keratin-associated protein 18-2) (Keratin-associated protein 18.2),255,"25,616",5 out of 5,2004-02-16,Evidence at transcript level
P60413,KR10C_HUMAN,Keratin-associated protein 10-12 (High sulfur keratin-associated protein 10.12) (Keratin-associated protein 10.12) (Keratin-associated protein 18-12) (Keratin-associated protein 18.12),245,"25,107",4 out of 5,2004-02-16,Evidence at transcript level
P59991,KR122_HUMAN,Keratin-associated protein 12-2 (High sulfur keratin-associated protein 12.2) (Keratin-associated protein 12.2),146,"14,689",5 out of 5,2003-11-07,Evidence at protein level
Q8IUC0,KR131_HUMAN,Keratin-associated protein 13-1 (High sulfur keratin-associated protein 13.1),172,"18,320",4 out of 5,2003-07-19,Evidence at transcript level
Q3LI76,KR151_HUMAN,Keratin-associated protein 15-1,137,"14,979",3 out of 5,2006-02-21,Evidence at protein level
Q3LI54,KR198_HUMAN,Keratin-associated protein 19-8,63,"6,918",3 out of 5,2007-10-23,Inferred from homology
Q3LI63,KR201_HUMAN,Keratin-associated protein 20-1,56,"6,202",3 out of 5,2006-02-21,Inferred from homology
Q3MIV0,KR221_HUMAN,Keratin-associated protein 22-1,48,"5,275",3 out of 5,2006-02-21,Inferred from homology
Q9BYT5,KRA22_HUMAN,Keratin-associated protein 2-2 (High sulfur keratin-associated protein 2.2) (Keratin-associated protein 2.2),123,"12,957",3 out of 5,2008-04-29,Evidence at transcript level
Q14533,KRT81_HUMAN,"Keratin, type II cuticular Hb1 (Hair keratin K2.9) (Keratin, hair, basic, 1) (Keratin-81) (K81) (Metastatic lymph node 137 gene protein) (MLN 137) (Type II hair keratin Hb1) (Type-II keratin Kb21) (ghHKb1) (ghHb1)",505,"54,928",5 out of 5,2004-03-29,Evidence at protein level
P78386,KRT85_HUMAN,"Keratin, type II cuticular Hb5 (Hair keratin K2.12) (Keratin-85) (K85) (Type II hair keratin Hb5) (Type-II keratin Kb25)",507,"55,802",5 out of 5,2004-03-29,Evidence at protein level
P43405,KSYK_HUMAN,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk),635,"72,066",5 out of 5,1995-11-01,Evidence at protein level
Q86SY8,KTAS1_HUMAN,Putative uncharacterized protein KTN1-AS1 (KTN1 antisense RNA 1) (KTN1 antisense gene protein 1),53,"5,770",2 out of 5,2007-07-24,Uncertain
Q9H079,KTBL1_HUMAN,KATNB1-like protein 1 (Katanin p80 subunit B-like 1),304,"34,767",2 out of 5,2005-08-30,Evidence at protein level
Q8MH63,LAT1N_HUMAN,Putative L-type amino acid transporter 1-like protein MLAS (hLAT1 3-transmembrane protein MLAS) (hLAT1 3TM MLAS),180,"18,779",2 out of 5,2008-09-02,Uncertain
Q01650,LAT1_HUMAN,Large neutral amino acids transporter small subunit 1 (4F2 light chain) (4F2 LC) (4F2LC) (CD98 light chain) (Integral membrane protein E16) (L-type amino acid transporter 1) (hLAT1) (Solute carrier family 7 member 5) (y+ system cationic amino acid transporter),507,"55,010",5 out of 5,1994-06-01,Evidence at protein level
P05455,LA_HUMAN,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),408,"46,837",5 out of 5,1988-11-01,Evidence at protein level
Q6ZST4,LCNL1_HUMAN,Lipocalin-like 1 protein,164,"17,784",1 out of 5,2008-09-02,Evidence at transcript level
Q86U70,LDB1_HUMAN,LIM domain-binding protein 1 (LDB-1) (Carboxyl-terminal LIM domain-binding protein 2) (CLIM-2) (LIM domain-binding factor CLIM2) (hLdb1) (Nuclear LIM interactor),411,"46,533",5 out of 5,2005-07-05,Evidence at protein level
Q9BYZ2,LDH6B_HUMAN,L-lactate dehydrogenase A-like 6B (EC 1.1.1.27),381,"41,943",4 out of 5,2001-11-16,Evidence at protein level
P07195,LDHB_HUMAN,L-lactate dehydrogenase B chain (LDH-B) (EC 1.1.1.27) (LDH heart subunit) (LDH-H) (Renal carcinoma antigen NY-REN-46),334,"36,638",5 out of 5,1988-04-01,Evidence at protein level
Q6ICC9,LDOCL_HUMAN,Protein LDOC1L (Leucine zipper protein down-regulated in cancer cells-like) (Mammalian retrotransposon-derived protein 6),239,"26,154",2 out of 5,2007-05-29,Evidence at transcript level
O75829,LECT1_HUMAN,Leukocyte cell-derived chemotaxin 1 [Cleaved into: Chondrosurfactant protein (CH-SP); Chondromodulin-1 (Chondromodulin-I) (ChM-I)],334,"37,102",5 out of 5,2001-08-29,Evidence at protein level
Q3B8N2,LEG9B_HUMAN,Galectin-9B (Gal-9B) (Galectin-9-like protein A),356,"39,660",3 out of 5,2008-02-26,Evidence at protein level
Q68G75,LEMD1_HUMAN,LEM domain-containing protein 1 (Cancer/testis antigen 50) (CT50) (LEM domain protein 1) (LEMP-1),181,"20,326",3 out of 5,2007-05-01,Evidence at transcript level
P11801,KPSH1_HUMAN,Serine/threonine-protein kinase H1 (EC 2.7.11.1) (Protein serine kinase H1) (PSK-H1),424,"48,035",5 out of 5,1989-10-01,Evidence at protein level
P60369,KR103_HUMAN,Keratin-associated protein 10-3 (High sulfur keratin-associated protein 10.3) (Keratin-associated protein 10.3) (Keratin-associated protein 18-3) (Keratin-associated protein 18.3),221,"22,348",4 out of 5,2004-02-16,Evidence at transcript level
P60371,KR106_HUMAN,Keratin-associated protein 10-6 (High sulfur keratin-associated protein 10.6) (Keratin-associated protein 10.6) (Keratin-associated protein 18-6) (Keratin-associated protein 18.6),365,"36,791",5 out of 5,2004-02-16,Evidence at transcript level
P60014,KR10A_HUMAN,Keratin-associated protein 10-10 (High sulfur keratin-associated protein 10.10) (Keratin-associated protein 10.10) (Keratin-associated protein 18-10) (Keratin-associated protein 18.10),251,"25,571",5 out of 5,2003-11-14,Evidence at transcript level
P59990,KR121_HUMAN,Keratin-associated protein 12-1 (High sulfur keratin-associated protein 12.1) (Keratin-associated protein 12.1),96,"9,737",5 out of 5,2003-11-07,Evidence at protein level
P60328,KR123_HUMAN,Keratin-associated protein 12-3 (High sulfur keratin-associated protein 12.3) (Keratin-associated protein 12.3),96,"9,947",5 out of 5,2004-02-02,Evidence at protein level
Q52LG2,KR132_HUMAN,Keratin-associated protein 13-2,175,"18,727",3 out of 5,2005-11-22,Evidence at protein level
Q3LI61,KR202_HUMAN,Keratin-associated protein 20-2,65,"6,961",3 out of 5,2006-02-21,Inferred from homology
Q3LHN1,KR213_HUMAN,Keratin-associated protein 21-3,58,"6,456",2 out of 5,2009-10-13,Inferred from homology
Q3LHN0,KR251_HUMAN,Keratin-associated protein 25-1,102,"11,738",2 out of 5,2007-10-23,Inferred from homology
A8MX34,KR291_HUMAN,Keratin-associated protein 29-1 (Keratin-associated protein 29.2),341,"35,211",2 out of 5,2008-09-02,Inferred from homology
Q8IUG1,KRA13_HUMAN,Keratin-associated protein 1-3 (Keratin-associated protein 1.8) (Keratin-associated protein 1.9),177,"18,184",4 out of 5,2006-02-21,Evidence at transcript level
Q9BYR9,KRA24_HUMAN,Keratin-associated protein 2-4 (High sulfur keratin-associated protein 2.4) (Keratin-associated protein 2.4),128,"13,480",3 out of 5,2005-02-01,Evidence at transcript level
Q9BYR5,KRA42_HUMAN,Keratin-associated protein 4-2 (Keratin-associated protein 4.2) (Ultrahigh sulfur keratin-associated protein 4.2),136,"14,462",5 out of 5,2003-10-24,Evidence at protein level
Q9BYR0,KRA47_HUMAN,Keratin-associated protein 4-7 (Keratin-associated protein 4.7) (Ultrahigh sulfur keratin-associated protein 4.7),210,"22,535",5 out of 5,2003-10-31,Evidence at protein level
Q6L8H4,KRA51_HUMAN,"Keratin-associated protein 5-1 (Keratin, cuticle, ultrahigh sulphur 1-like) (Keratin-associated protein 5.1) (Ultrahigh sulfur keratin-associated protein 5.1)",278,"24,194",4 out of 5,2004-12-21,Evidence at transcript level
Q6L8H1,KRA54_HUMAN,Keratin-associated protein 5-4 (Keratin-associated protein 5.4) (Ultrahigh sulfur keratin-associated protein 5.4),288,"25,249",4 out of 5,2004-12-21,Evidence at protein level
Q9BYQ2,KRA94_HUMAN,Keratin-associated protein 9-4 (Keratin-associated protein 9.4) (Ultrahigh sulfur keratin-associated protein 9.4),154,"16,378",5 out of 5,2003-11-14,Evidence at protein level
Q9BYP9,KRA99_HUMAN,Keratin-associated protein 9-9 (Keratin-associated protein 9-5) (Keratin-associated protein 9.5) (Keratin-associated protein 9.9) (Ultrahigh sulfur keratin-associated protein 9.9),154,"16,266",5 out of 5,2003-11-14,Evidence at transcript level
Q96MU8,KREM1_HUMAN,Kremen protein 1 (Dickkopf receptor) (Kringle domain-containing transmembrane protein 1) (Kringle-containing protein marking the eye and the nose),473,"51,744",4 out of 5,2002-05-15,Evidence at protein level
Q9HA64,KT3K_HUMAN,Ketosamine-3-kinase (EC 2.7.1.-) (Fructosamine-3-kinase-related protein) (FN3K-RP) (FN3K-related protein),309,"34,412",3 out of 5,2001-05-04,Evidence at protein level
Q8N6L1,KTAP2_HUMAN,Keratinocyte-associated protein 2 (KCP-2),136,"14,679",4 out of 5,2006-03-07,Evidence at protein level
P60985,KTDAP_HUMAN,Keratinocyte differentiation-associated protein,99,"11,050",3 out of 5,2004-04-26,Evidence at protein level
P23919,KTHY_HUMAN,Thymidylate kinase (EC 2.7.4.9) (dTMP kinase),212,"23,819",5 out of 5,1992-03-01,Evidence at protein level
A0A075B6S5,KV127_HUMAN,Immunoglobulin kappa variable 1-27,117,"12,712",3 out of 5,2017-01-18,Inferred from homology
P01597,KV139_HUMAN,Immunoglobulin kappa variable 1-39 (Ig kappa chain V-I region DEE) (Ig kappa chain V-I region Hau) (Ig kappa chain V-I region Mev) (Ig kappa chain V-I region OU) (Ig kappa chain V-I region Walker),117,"12,737",5 out of 5,1986-07-21,Evidence at protein level
A0A087WW87,KV240_HUMAN,Immunoglobulin kappa variable 2-40,121,"13,310",3 out of 5,2017-01-18,Inferred from homology
P01624,KV315_HUMAN,Immunoglobulin kappa variable 3-15 (Ig kappa chain V-III region CLL) (Ig kappa chain V-III region POM),115,"12,496",5 out of 5,1986-07-21,Evidence at protein level
A0A087WSZ0,KVD08_HUMAN,Immunoglobulin kappa variable 1D-8,117,"12,837",3 out of 5,2017-01-18,Inferred from homology
A0A0A0MT36,KVD21_HUMAN,Immunoglobulin kappa variable 6D-21,114,"12,340",3 out of 5,2017-01-18,Inferred from homology
P01593,KVD33_HUMAN,Immunoglobulin kappa variable 1D-33 (Ig kappa chain V-I region AG) (Ig kappa chain V-I region Bi) (Ig kappa chain V-I region Lay) (Ig kappa chain V-I region Ni) (Ig kappa chain V-I region Rei) (Ig kappa chain V-I region Roy) (Ig kappa chain V-I region Scw) (Ig kappa chain V-I region WAT),117,"12,848",5 out of 5,1986-07-21,Evidence at protein level
Q659C4,LAR1B_HUMAN,La-related protein 1B (La ribonucleoprotein domain family member 1B) (La ribonucleoprotein domain family member 2) (La-related protein 2),914,"105,322",5 out of 5,2007-09-11,Evidence at protein level
Q569H4,LARGN_HUMAN,Protein Largen (Mesenchymal stem cell protein DSC54) (Proline-rich protein 16),304,"32,812",3 out of 5,2007-10-23,Evidence at protein level
Q14847,LASP1_HUMAN,LIM and SH3 domain protein 1 (LASP-1) (Metastatic lymph node gene 50 protein) (MLN 50),261,"29,717",5 out of 5,1998-07-15,Evidence at protein level
O75387,LAT3_HUMAN,Large neutral amino acids transporter small subunit 3 (L-type amino acid transporter 3) (Prostate cancer overexpressed gene 1 protein) (Solute carrier family 43 member 1),559,"61,477",5 out of 5,2004-11-23,Evidence at protein level
Q8N370,LAT4_HUMAN,Large neutral amino acids transporter small subunit 4 (L-type amino acid transporter 4) (Solute carrier family 43 member 2),569,"62,747",5 out of 5,2007-10-23,Evidence at protein level
O43561,LAT_HUMAN,Linker for activation of T-cells family member 1 (36 kDa phospho-tyrosine adapter protein) (pp36) (p36-38),262,"27,930",5 out of 5,2001-06-01,Evidence at protein level
Q5T5B0,LCE3E_HUMAN,Late cornified envelope protein 3E (Late envelope protein 17),92,"9,507",5 out of 5,2006-05-16,Evidence at protein level
Q6ZMR3,LDH6A_HUMAN,L-lactate dehydrogenase A-like 6A (EC 1.1.1.27),332,"36,507",4 out of 5,2004-08-16,Evidence at transcript level
P17931,LEG3_HUMAN,Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen),250,"26,152",5 out of 5,1990-11-01,Evidence at protein level
Q3ZCV2,LEXM_HUMAN,Lymphocyte expansion molecule,418,"47,609",3 out of 5,2007-08-21,Evidence at transcript level
P19256,LFA3_HUMAN,Lymphocyte function-associated antigen 3 (Ag3) (Surface glycoprotein LFA-3) (CD antigen CD58),250,"28,147",5 out of 5,1990-11-01,Evidence at protein level
Q9HC24,LFG4_HUMAN,Protein lifeguard 4 (Golgi anti-apoptotic protein) (Protein S1R) (Transmembrane BAX inhibitor motif-containing protein 4) (Z-protein),238,"26,971",5 out of 5,2001-08-14,Evidence at protein level
Q8N135,LGI4_HUMAN,Leucine-rich repeat LGI family member 4 (LGI1-like protein 3) (Leucine-rich glioma-inactivated protein 4),537,"59,141",3 out of 5,2003-07-03,Evidence at transcript level
P60409,KR107_HUMAN,Keratin-associated protein 10-7 (High sulfur keratin-associated protein 10.7) (Keratin-associated protein 10.7) (Keratin-associated protein 18-7) (Keratin-associated protein 18.7),375,"37,816",5 out of 5,2004-02-16,Evidence at protein level
P60411,KR109_HUMAN,Keratin-associated protein 10-9 (High sulfur keratin-associated protein 10.9) (Keratin-associated protein 10.9) (Keratin-associated protein 18-9) (Keratin-associated protein 18.9),292,"30,037",5 out of 5,2004-02-16,Evidence at protein level
Q3SY46,KR133_HUMAN,Keratin-associated protein 13-3,172,"19,236",3 out of 5,2005-11-22,Evidence at protein level
Q9BYP8,KR171_HUMAN,Keratin-associated protein 17-1 (Keratin-associated protein 16.1),105,"9,504",2 out of 5,2006-02-21,Inferred from homology
Q7Z4W3,KR193_HUMAN,Keratin-associated protein 19-3 (GTHRP) (Glycine/tyrosine-rich protein),81,"8,247",3 out of 5,2006-02-21,Inferred from homology
Q3LI62,KR204_HUMAN,Putative keratin-associated protein 20-4,44,"4,623",2 out of 5,2007-10-23,Inferred from homology
Q3LI59,KR212_HUMAN,Keratin-associated protein 21-2,83,"8,564",2 out of 5,2006-02-21,Inferred from homology
Q6L8G4,KR511_HUMAN,Keratin-associated protein 5-11 (Keratin-associated protein 5.11) (Ultrahigh sulfur keratin-associated protein 5.11),156,"14,610",4 out of 5,2004-12-21,Evidence at protein level
P0C5Y4,KRA14_HUMAN,Keratin-associated protein 1-4 (High sulfur keratin-associated protein 1.4) (Keratin-associated protein 1.4),121,"12,324",3 out of 5,2007-12-04,Evidence at transcript level
Q5JUW0,KRBX4_HUMAN,KRAB domain-containing protein 4 (KRAB box domain-containing protein 4),171,"20,100",3 out of 5,2006-05-02,Evidence at transcript level
Q13601,KRR1_HUMAN,KRR1 small subunit processome component homolog (HIV-1 Rev-binding protein 2) (KRR-R motif-containing protein 1) (Rev-interacting protein 1) (Rip-1),381,"43,665",5 out of 5,2004-07-19,Evidence at protein level
Q15418,KS6A1_HUMAN,Ribosomal protein S6 kinase alpha-1 (S6K-alpha-1) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 1) (p90-RSK 1) (p90RSK1) (p90S6K) (MAP kinase-activated protein kinase 1a) (MAPK-activated protein kinase 1a) (MAPKAP kinase 1a) (MAPKAPK-1a) (Ribosomal S6 kinase 1) (RSK-1),735,"82,723",5 out of 5,1998-12-15,Evidence at protein level
A0A0C4DH72,KV106_HUMAN,Immunoglobulin kappa variable 1-6,117,"12,697",3 out of 5,2017-01-18,Inferred from homology
A0A0C4DH68,KV224_HUMAN,Immunoglobulin kappa variable 2-24,120,"13,079",3 out of 5,2017-01-18,Inferred from homology
P06312,KV401_HUMAN,Immunoglobulin kappa variable 4-1 (Ig kappa chain V-IV region B17) (Ig kappa chain V-IV region JI) (Ig kappa chain V-IV region Len) (Ig kappa chain V-IV region STH),121,"13,380",5 out of 5,1988-01-01,Evidence at protein level
A0A0A0MRZ8,KVD11_HUMAN,Immunoglobulin kappa variable 3D-11,115,"12,625",3 out of 5,2017-01-18,Inferred from homology
A0A075B6S2,KVD29_HUMAN,Immunoglobulin kappa variable 2D-29,120,"13,143",3 out of 5,2017-01-18,Inferred from homology
P04432,KVD39_HUMAN,Immunoglobulin kappa variable 1D-39 (Ig kappa chain V-I region Daudi),117,"12,737",5 out of 5,1987-08-13,Inferred from homology
Q16719,KYNU_HUMAN,Kynureninase (EC 3.7.1.3) (L-kynurenine hydrolase),465,"52,352",5 out of 5,1998-12-15,Evidence at protein level
A6NMS7,L37A1_HUMAN,Leucine-rich repeat-containing protein 37A,1700,"188,258",2 out of 5,2008-05-20,Evidence at transcript level
Q16787,LAMA3_HUMAN,Laminin subunit alpha-3 (Epiligrin 170 kDa subunit) (E170) (Epiligrin subunit alpha) (Kalinin subunit alpha) (Laminin-5 subunit alpha) (Laminin-6 subunit alpha) (Laminin-7 subunit alpha) (Nicein subunit alpha),3333,"366,649",5 out of 5,1997-11-01,Evidence at protein level
Q16363,LAMA4_HUMAN,Laminin subunit alpha-4 (Laminin-14 subunit alpha) (Laminin-8 subunit alpha) (Laminin-9 subunit alpha),1823,"202,524",5 out of 5,1997-11-01,Evidence at protein level
Q9UQV4,LAMP3_HUMAN,Lysosome-associated membrane glycoprotein 3 (LAMP-3) (Lysosomal-associated membrane protein 3) (DC-lysosome-associated membrane glycoprotein) (DC LAMP) (Protein TSC403) (CD antigen CD208),416,"44,346",5 out of 5,2006-02-21,Evidence at protein level
O43813,LANC1_HUMAN,LanC-like protein 1 (40 kDa erythrocyte membrane protein) (p40),399,"45,283",5 out of 5,2004-05-10,Evidence at protein level
Q9NS86,LANC2_HUMAN,LanC-like protein 2 (Testis-specific adriamycin sensitivity protein),450,"50,854",5 out of 5,2004-05-10,Evidence at protein level
P42167,LAP2B_HUMAN,"Lamina-associated polypeptide 2, isoforms beta/gamma (Thymopoietin, isoforms beta/gamma) (TP beta/gamma) (Thymopoietin-related peptide isoforms beta/gamma) (TPRP isoforms beta/gamma) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",454,"50,670",5 out of 5,1995-11-01,Evidence at protein level
Q86VI4,LAP4B_HUMAN,Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta),370,"41,146",3 out of 5,2006-09-19,Evidence at protein level
Q86YQ2,LATH_HUMAN,"Putative BPIFA4P protein (BPI fold containing family A, member 4, pseudogene) (Breast cancer and salivary gland-expressed protein) (Putative latherin)",179,"19,456",3 out of 5,2003-11-07,Uncertain
Q9NRM7,LATS2_HUMAN,Serine/threonine-protein kinase LATS2 (EC 2.7.11.1) (Kinase phosphorylated during mitosis protein) (Large tumor suppressor homolog 2) (Serine/threonine-protein kinase kpm) (Warts-like kinase),1088,"120,136",5 out of 5,2004-09-27,Evidence at protein level
Q71F78,LCA10_HUMAN,Putative lung carcinoma-associated protein 10,164,"17,306",1 out of 5,2008-03-18,Evidence at transcript level
O95232,LC7L3_HUMAN,Luc7-like protein 3 (Cisplatin resistance-associated-overexpressed protein) (Luc7A) (Okadaic acid-inducible phosphoprotein OA48-18) (cAMP regulatory element-associated protein 1) (CRE-associated protein 1) (CREAP-1),432,"51,466",5 out of 5,2000-05-30,Evidence at protein level
Q5TA76,LCE3A_HUMAN,Late cornified envelope protein 3A (Late envelope protein 13),89,"9,146",5 out of 5,2006-05-16,Evidence at protein level
O75610,LFTY1_HUMAN,Left-right determination factor 1 (Left-right determination factor B) (Protein lefty-1) (Protein lefty-B),366,"40,880",5 out of 5,2001-02-21,Evidence at transcript level
Q9UPM6,LHX6_HUMAN,LIM/homeobox protein Lhx6 (LIM homeobox protein 6) (LIM/homeobox protein Lhx6.1),363,"40,045",4 out of 5,2000-05-30,Evidence at protein level
Q2Q1W2,LIN41_HUMAN,E3 ubiquitin-protein ligase TRIM71 (EC 2.3.2.27) (Protein lin-41 homolog) (RING-type E3 ubiquitin transferase TRIM71) (Tripartite motif-containing protein 71),868,"93,385",5 out of 5,2007-03-06,Evidence at protein level
Q52LA3,LIN52_HUMAN,Protein lin-52 homolog,116,"13,001",3 out of 5,2006-10-03,Evidence at protein level
Q8NG48,LINES_HUMAN,Protein Lines homolog 1 (Wnt-signaling molecule Lines homolog 1),757,"85,857",4 out of 5,2008-02-05,Evidence at transcript level
Q4VXA5,KHDC1_HUMAN,KH homology domain-containing protein 1,237,"27,160",2 out of 5,2007-11-13,Evidence at transcript level
Q99706,KI2L4_HUMAN,Killer cell immunoglobulin-like receptor 2DL4 (CD158 antigen-like family member D) (G9P) (Killer cell inhibitory receptor 103AS) (KIR-103AS) (MHC class I NK cell receptor KIR103AS) (CD antigen CD158d),377,"41,487",5 out of 5,2001-02-21,Evidence at protein level
Q14953,KI2S5_HUMAN,Killer cell immunoglobulin-like receptor 2DS5 (CD158 antigen-like family member G) (MHC class I NK cell receptor) (Natural killer-associated transcript 9) (NKAT-9) (CD antigen CD158g),304,"33,644",4 out of 5,1997-11-01,Evidence at transcript level
Q8IX03,KIBRA_HUMAN,Protein KIBRA (HBeAg-binding protein 3) (Kidney and brain protein) (KIBRA) (WW domain-containing protein 1),1113,"125,301",5 out of 5,2006-06-27,Evidence at protein level
O14782,KIF3C_HUMAN,Kinesin-like protein KIF3C,793,"89,426",5 out of 5,1998-12-15,Evidence at protein level
Q12840,KIF5A_HUMAN,Kinesin heavy chain isoform 5A (Kinesin heavy chain neuron-specific 1) (Neuronal kinesin heavy chain) (NKHC),1032,"117,378",5 out of 5,1997-11-01,Evidence at protein level
Q2M1P5,KIF7_HUMAN,Kinesin-like protein KIF7,1343,"150,587",5 out of 5,2007-10-23,Evidence at protein level
O60870,KIN17_HUMAN,"DNA/RNA-binding protein KIN17 (Binding to curved DNA) (KIN, antigenic determinant of recA protein homolog)",393,"45,374",5 out of 5,2007-05-29,Evidence at protein level
Q6UWL6,KIRR2_HUMAN,Kin of IRRE-like protein 2 (Kin of irregular chiasm-like protein 2) (Nephrin-like protein 3),708,"75,092",5 out of 5,2004-10-25,Evidence at protein level
Q5H943,KKLC1_HUMAN,Kita-kyushu lung cancer antigen 1 (KK-LC-1) (Cancer/testis antigen 83),113,"12,784",3 out of 5,2007-07-10,Evidence at protein level
Q8NEE0,KLAS1_HUMAN,Putative uncharacterized protein KLHL30-AS1 (KLHL30 antisense RNA 1),82,"9,662",1 out of 5,2006-12-12,Uncertain
Q6P597,KLC3_HUMAN,Kinesin light chain 3 (KLC2-like) (kinesin light chain 2),504,"55,364",5 out of 5,2006-04-04,Evidence at protein level
Q5VTJ3,KLD7A_HUMAN,Kelch domain-containing protein 7A,777,"84,479",3 out of 5,2007-05-01,Evidence at protein level
Q13118,KLF10_HUMAN,Krueppel-like factor 10 (EGR-alpha) (Transforming growth factor-beta-inducible early growth response protein 1) (TGFB-inducible early growth response protein 1) (TIEG-1),480,"52,555",5 out of 5,2000-12-01,Evidence at protein level
Q9Y4X4,KLF12_HUMAN,Krueppel-like factor 12 (Transcriptional repressor AP-2rep),402,"44,240",5 out of 5,2001-11-02,Evidence at protein level
Q13351,KLF1_HUMAN,Krueppel-like factor 1 (Erythroid krueppel-like transcription factor) (EKLF),362,"38,221",5 out of 5,1997-11-01,Evidence at protein level
Q13887,KLF5_HUMAN,Krueppel-like factor 5 (Basic transcription element-binding protein 2) (BTE-binding protein 2) (Colon krueppel-like factor) (GC-box-binding protein 2) (Intestinal-enriched krueppel-like factor) (Transcription factor BTEB2),457,"50,792",5 out of 5,1998-12-15,Evidence at protein level
Q9NVR0,KLH11_HUMAN,Kelch-like protein 11,708,"80,148",3 out of 5,2006-06-27,Evidence at protein level
Q9C0H6,KLHL4_HUMAN,Kelch-like protein 4,718,"80,245",3 out of 5,2001-09-26,Evidence at protein level
Q8IXQ5,KLHL7_HUMAN,Kelch-like protein 7,586,"65,992",5 out of 5,2006-03-21,Evidence at protein level
Q9UBX7,KLK11_HUMAN,Kallikrein-11 (hK11) (EC 3.4.21.-) (Hippostasin) (Serine protease 20) (Trypsin-like protease) [Cleaved into: Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2],282,"31,059",5 out of 5,2000-12-01,Evidence at protein level
Q9P0G3,KLK14_HUMAN,Kallikrein-14 (hK14) (EC 3.4.21.-) (Kallikrein-like protein 6) (KLK-L6),267,"29,122",5 out of 5,2001-01-11,Evidence at protein level
P20151,KLK2_HUMAN,Kallikrein-2 (EC 3.4.21.35) (Glandular kallikrein-1) (hGK-1) (Tissue kallikrein-2),261,"28,671",5 out of 5,1991-02-01,Evidence at protein level
Q92876,KLK6_HUMAN,Kallikrein-6 (EC 3.4.21.-) (Neurosin) (Protease M) (SP59) (Serine protease 18) (Serine protease 9) (Zyme),244,"26,856",5 out of 5,1998-12-15,Evidence at protein level
Q5SVS4,KMCP1_HUMAN,Kidney mitochondrial carrier protein 1 (Solute carrier family 25 member 30),291,"32,475",3 out of 5,2007-05-29,Evidence at protein level
O15229,KMO_HUMAN,Kynurenine 3-monooxygenase (EC 1.14.13.9) (Kynurenine 3-hydroxylase),486,"55,810",5 out of 5,2006-04-04,Evidence at protein level
Q9UMN6,KMT2B_HUMAN,Histone-lysine N-methyltransferase 2B (Lysine N-methyltransferase 2B) (EC 2.1.1.43) (Myeloid/lymphoid or mixed-lineage leukemia protein 4) (Trithorax homolog 2) (WW domain-binding protein 7) (WBP-7),2715,"293,515",5 out of 5,2000-12-01,Evidence at protein level
O14686,KMT2D_HUMAN,Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.43) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2),5537,"593,389",5 out of 5,2003-10-10,Evidence at protein level
Q04759,KPCT_HUMAN,Protein kinase C theta type (EC 2.7.11.13) (nPKC-theta),706,"81,865",5 out of 5,1993-10-01,Evidence at protein level
Q3LHN2,KR192_HUMAN,Keratin-associated protein 19-2,52,"5,737",3 out of 5,2006-02-21,Inferred from homology
Q3LI58,KR211_HUMAN,Keratin-associated protein 21-1,79,"7,937",2 out of 5,2006-02-21,Inferred from homology
Q3LI83,KR241_HUMAN,Keratin-associated protein 24-1,254,"27,719",3 out of 5,2006-02-21,Evidence at transcript level
Q9BYQ6,KR411_HUMAN,Keratin-associated protein 4-11 (Keratin-associated protein 4-14) (Keratin-associated protein 4.11) (Keratin-associated protein 4.14) (Ultrahigh sulfur keratin-associated protein 4.14),195,"20,927",5 out of 5,2003-10-31,Evidence at protein level
Q6L8G5,KR510_HUMAN,Keratin-associated protein 5-10 (Keratin-associated protein 5.10) (Ultrahigh sulfur keratin-associated protein 5.10),202,"17,984",4 out of 5,2004-12-21,Evidence at transcript level
A6NCN2,KR87P_HUMAN,"Putative keratin-87 protein (Keratin, hair, basic pseudogene 4) (Keratin-121 pseudogene)",255,"29,117",3 out of 5,2008-06-10,Uncertain
Q9BYR2,KRA45_HUMAN,Keratin-associated protein 4-5 (Keratin-associated protein 4.5) (Ultrahigh sulfur keratin-associated protein 4.5),181,"19,363",5 out of 5,2003-10-24,Evidence at protein level
Q9BYQ8,KRA49_HUMAN,Keratin-associated protein 4-9 (Keratin-associated protein 4.9) (Ultrahigh sulfur keratin-associated protein 4.9),210,"22,405",5 out of 5,2003-10-31,Evidence at transcript level
Q701N2,KRA55_HUMAN,Keratin-associated protein 5-5 (Keratin-associated protein 5-11) (Keratin-associated protein 5.11) (Keratin-associated protein 5.5) (Ultrahigh sulfur keratin-associated protein 5.5),237,"21,409",4 out of 5,2004-12-21,Evidence at transcript level
O75690,KRA58_HUMAN,"Keratin-associated protein 5-8 (Keratin, ultra high-sulfur matrix protein B) (Keratin-associated protein 5.8) (UHS keratin B) (UHS KerB) (Ultrahigh sulfur keratin-associated protein 5.8)",187,"17,519",4 out of 5,2000-12-01,Evidence at transcript level
P26371,KRA59_HUMAN,"Keratin-associated protein 5-9 (Keratin, cuticle, ultrahigh sulfur 1) (Keratin, ultra high-sulfur matrix protein A) (Keratin-associated protein 5.9) (UHS keratin A) (UHS KerA) (Ultrahigh sulfur keratin-associated protein 5.9)",169,"16,276",5 out of 5,1992-08-01,Evidence at protein level
Q8IUC2,KRA81_HUMAN,Keratin-associated protein 8-1 (High glycine-tyrosine keratin-associated protein 8.1),63,"6,826",4 out of 5,2003-06-27,Evidence at protein level
Q9BYQ3,KRA93_HUMAN,Keratin-associated protein 9-3 (Keratin-associated protein 9.3) (Ultrahigh sulfur keratin-associated protein 9.3),159,"16,854",5 out of 5,2003-11-14,Evidence at protein level
A8MVA2,KRA96_HUMAN,Keratin-associated protein 9-6,160,"16,800",3 out of 5,2008-04-29,Inferred from homology
Q6ZNG9,KRBA2_HUMAN,KRAB-A domain-containing protein 2,492,"56,205",2 out of 5,2007-09-11,Evidence at protein level
Q8NCW0,KREM2_HUMAN,Kremen protein 2 (Dickkopf receptor 2) (Kringle domain-containing transmembrane protein 2) (Kringle-containing protein marking the eye and the nose),462,"48,849",5 out of 5,2003-04-23,Evidence at transcript level
Q92764,KRT35_HUMAN,"Keratin, type I cuticular Ha5 (Hair keratin, type I Ha5) (Keratin-35) (K35)",455,"50,361",5 out of 5,1998-07-15,Evidence at transcript level
Q9NSB2,KRT84_HUMAN,"Keratin, type II cuticular Hb4 (Keratin-84) (K84) (Type II hair keratin Hb4) (Type-II keratin Kb24)",600,"64,842",5 out of 5,2004-03-29,Evidence at transcript level
O75676,KS6A4_HUMAN,Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB),772,"85,606",5 out of 5,2003-10-24,Evidence at protein level
Q8N1A0,KT222_HUMAN,Keratin-like protein KRT222 (Keratin-222) (Keratin-222 pseudogene),295,"34,158",3 out of 5,2008-07-22,Evidence at transcript level
Q9NVR5,KTU_HUMAN,"Protein kintoun (Dynein assembly factor 2, axonemal)",837,"91,114",5 out of 5,2003-09-26,Evidence at protein level
P04430,KV116_HUMAN,Immunoglobulin kappa variable 1-16 (Ig kappa chain V-I region BAN),117,"12,618",5 out of 5,1987-08-13,Evidence at protein level
P01594,KV133_HUMAN,Immunoglobulin kappa variable 1-33 (Ig kappa chain V-I region AU) (Ig kappa chain V-I region Ka),117,"12,848",5 out of 5,1986-07-21,Evidence at protein level
A2NJV5,KV229_HUMAN,Immunoglobulin kappa variable 2-29,120,"13,085",5 out of 5,2017-04-12,Inferred from homology
A0A0C4DH55,KVD07_HUMAN,Immunoglobulin kappa variable 3D-7,119,"13,148",3 out of 5,2017-01-18,Inferred from homology
P01601,KVD16_HUMAN,Immunoglobulin kappa variable 1D-16 (Ig kappa chain V-I region HK146) (Ig kappa chain V-I region HK189) (Fragment),117,"12,730",5 out of 5,1986-07-21,Inferred from homology
P01615,KVD28_HUMAN,Immunoglobulin kappa variable 2D-28 (Ig kappa chain V-II region FR) (Ig kappa chain V-II region GM607) (Ig kappa chain V-II region MIL) (Ig kappa chain V-II region TEW),120,"12,957",5 out of 5,1986-07-21,Evidence at protein level
P01614,KVD40_HUMAN,Immunoglobulin kappa variable 2D-40 (Ig kappa chain V-II region Cum),121,"13,310",5 out of 5,1986-07-21,Evidence at protein level
Q49AS3,L37A5_HUMAN,Putative protein LRRC37A5P (Leucine-rich repeat-containing 37 member A5 pseudogene),106,"12,596",1 out of 5,2007-03-20,Uncertain
Q8IV20,LACC1_HUMAN,Laccase domain-containing protein 1 (Fatty acid metabolism-immunity nexus),430,"47,780",3 out of 5,2003-06-20,Evidence at protein level
P83111,LACTB_HUMAN,"Serine beta-lactamase-like protein LACTB, mitochondrial (EC 3.4.-.-)",547,"60,694",3 out of 5,2001-09-26,Evidence at protein level
Q6GTX8,LAIR1_HUMAN,Leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) (hLAIR1) (CD antigen CD305),287,"31,412",5 out of 5,2006-10-03,Evidence at protein level
A4D0S4,LAMB4_HUMAN,Laminin subunit beta-4 (Laminin beta-1-related protein),1761,"193,540",5 out of 5,2007-12-04,Evidence at transcript level
Q86UK5,LBN_HUMAN,Limbin (Ellis-van Creveld syndrome protein 2) (EVC2),1308,"147,948",5 out of 5,2003-11-07,Evidence at protein level
Q6XYB7,LBX2_HUMAN,Transcription factor LBX2 (Ladybird homeobox protein homolog 2),198,"21,482",2 out of 5,2007-11-13,Evidence at transcript level
Q86VQ0,LCA5_HUMAN,Lebercilin (Leber congenital amaurosis 5 protein),697,"80,554",5 out of 5,2005-08-02,Evidence at protein level
Q5T7P2,LCE1A_HUMAN,Late cornified envelope protein 1A (Late envelope protein 1),110,"10,982",5 out of 5,2006-05-16,Evidence at protein level
O14633,LCE2B_HUMAN,Late cornified envelope protein 2B (Late envelope protein 10) (Skin-specific protein Xp5) (Small proline-rich-like epidermal differentiation complex protein 1B),110,"11,219",5 out of 5,2004-11-09,Evidence at protein level
Q8N3X6,LCORL_HUMAN,Ligand-dependent nuclear receptor corepressor-like protein (LCoR-like protein),602,"66,964",3 out of 5,2007-11-13,Evidence at protein level
P23276,KELL_HUMAN,Kell blood group glycoprotein (EC 3.4.24.-) (CD antigen CD238),732,"82,824",5 out of 5,1991-11-01,Evidence at protein level
Q5VWX1,KHDR2_HUMAN,"KH domain-containing, RNA-binding, signal transduction-associated protein 2 (Sam68-like mammalian protein 1) (SLM-1) (hSLM-1)",349,"38,927",5 out of 5,2007-11-13,Evidence at protein level
Q15058,KIF14_HUMAN,Kinesin-like protein KIF14,1648,"186,492",5 out of 5,2002-09-19,Evidence at protein level
B7ZC32,KIF28_HUMAN,Kinesin-like protein KIF28P (Kinesin-like protein 6),967,"108,254",3 out of 5,2012-02-22,Inferred from homology
Q2VIQ3,KIF4B_HUMAN,Chromosome-associated kinesin KIF4B (Chromokinesin-B),1234,"140,035",5 out of 5,2007-09-11,Evidence at transcript level
Q9BVG8,KIFC3_HUMAN,Kinesin-like protein KIFC3,833,"92,775",5 out of 5,2003-08-15,Evidence at protein level
Q8TBQ9,KISHA_HUMAN,Protein kish-A (Transmembrane protein 167) (Transmembrane protein 167A),72,"8,060",3 out of 5,2006-07-25,Evidence at protein level
Q2M2Z5,KIZ_HUMAN,Centrosomal protein kizuna (Polo-like kinase 1 substrate 1),673,"75,111",5 out of 5,2007-09-11,Evidence at protein level
Q8N7A1,KLDC1_HUMAN,Kelch domain-containing protein 1,406,"46,720",2 out of 5,2003-02-12,Evidence at transcript level
Q9UIH9,KLF15_HUMAN,Krueppel-like factor 15 (Kidney-enriched krueppel-like factor),416,"43,992",5 out of 5,2002-01-23,Evidence at protein level
Q5JT82,KLF17_HUMAN,Krueppel-like factor 17 (Zinc finger protein 393),389,"42,577",4 out of 5,2005-11-08,Evidence at protein level
P57682,KLF3_HUMAN,Krueppel-like factor 3 (Basic krueppel-like factor) (CACCC-box-binding protein BKLF) (TEF-2),345,"38,829",5 out of 5,2000-12-01,Evidence at protein level
O43474,KLF4_HUMAN,Krueppel-like factor 4 (Epithelial zinc finger protein EZF) (Gut-enriched krueppel-like factor),513,"54,671",5 out of 5,1998-12-15,Evidence at protein level
O95198,KLHL2_HUMAN,Kelch-like protein 2 (Actin-binding protein Mayven),593,"65,975",5 out of 5,2001-04-27,Evidence at protein level
O43240,KLK10_HUMAN,Kallikrein-10 (EC 3.4.21.-) (Normal epithelial cell-specific 1) (Protease serine-like 1),276,"30,170",4 out of 5,1998-12-15,Evidence at protein level
Q9UKR0,KLK12_HUMAN,Kallikrein-12 (EC 3.4.21.-) (Kallikrein-like protein 5) (KLK-L5),248,"26,734",5 out of 5,2000-12-01,Evidence at protein level
Q9H2R5,KLK15_HUMAN,Kallikrein-15 (EC 3.4.21.-) (ACO protease),256,"28,087",5 out of 5,2001-10-18,Evidence at protein level
P49862,KLK7_HUMAN,Kallikrein-7 (hK7) (EC 3.4.21.117) (Serine protease 6) (Stratum corneum chymotryptic enzyme) (hSCCE),253,"27,525",5 out of 5,1996-10-01,Evidence at protein level
P17252,KPCA_HUMAN,Protein kinase C alpha type (PKC-A) (PKC-alpha) (EC 2.7.11.13),672,"76,750",5 out of 5,1990-08-01,Evidence at protein level
Q05513,KPCZ_HUMAN,Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta),592,"67,660",5 out of 5,1994-02-01,Evidence at protein level
Q9Y664,KPTN_HUMAN,Kaptin (Actin-associated protein 2E4),436,"48,080",5 out of 5,2006-05-30,Evidence at protein level
Q8IUB9,KR191_HUMAN,Keratin-associated protein 19-1 (High tyrosine-glycine keratin-associated protein 19.1),90,"9,008",3 out of 5,2003-07-03,Evidence at transcript level
Q3LI70,KR196_HUMAN,Keratin-associated protein 19-6,58,"6,267",3 out of 5,2006-02-21,Inferred from homology
O76015,KRT38_HUMAN,"Keratin, type I cuticular Ha8 (Hair keratin, type I Ha8) (Keratin-38) (K38)",456,"50,480",5 out of 5,2000-05-30,Evidence at protein level
P78385,KRT83_HUMAN,"Keratin, type II cuticular Hb3 (Hair keratin K2.10) (Keratin-83) (K83) (Type II hair keratin Hb3) (Type-II keratin Kb23)",493,"54,195",5 out of 5,2004-03-29,Evidence at protein level
P51812,KS6A3_HUMAN,Ribosomal protein S6 kinase alpha-3 (S6K-alpha-3) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 3) (p90-RSK 3) (p90RSK3) (Insulin-stimulated protein kinase 1) (ISPK-1) (MAP kinase-activated protein kinase 1b) (MAPK-activated protein kinase 1b) (MAPKAP kinase 1b) (MAPKAPK-1b) (Ribosomal S6 kinase 2) (RSK-2) (pp90RSK2),740,"83,736",5 out of 5,1996-10-01,Evidence at protein level
Q96S38,KS6C1_HUMAN,Ribosomal protein S6 kinase delta-1 (S6K-delta-1) (EC 2.7.11.1) (52 kDa ribosomal protein S6 kinase) (Ribosomal S6 kinase-like protein with two PSK domains 118 kDa protein) (SPHK1-binding protein),1066,"118,682",5 out of 5,2006-05-02,Evidence at protein level
P01599,KV117_HUMAN,Immunoglobulin kappa variable 1-17 (Ig kappa chain V-I region Gal) (Ig kappa chain V-I region WEA),117,"12,779",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6P5,KV228_HUMAN,Immunoglobulin kappa variable 2-28,120,"12,957",5 out of 5,2016-11-02,Inferred from homology
P01611,KVD12_HUMAN,Immunoglobulin kappa variable 1D-12 (Ig kappa chain V-I region Wes),117,"12,620",5 out of 5,1986-07-21,Evidence at protein level
Q9BQD3,KXDL1_HUMAN,KxDL motif-containing protein 1,176,"19,668",5 out of 5,2007-07-24,Evidence at protein level
P32004,L1CAM_HUMAN,Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171),1257,"140,003",5 out of 5,1993-07-01,Evidence at protein level
Q9H9P8,L2HDH_HUMAN,"L-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.2) (Duranin)",463,"50,316",5 out of 5,2006-03-21,Evidence at protein level
Q6ZP29,LAAT1_HUMAN,Lysosomal amino acid transporter 1 homolog (PQ-loop repeat-containing protein 2),291,"31,947",5 out of 5,2007-04-03,Evidence at protein level
O15230,LAMA5_HUMAN,Laminin subunit alpha-5 (Laminin-10 subunit alpha) (Laminin-11 subunit alpha) (Laminin-15 subunit alpha),3695,"399,737",5 out of 5,2001-04-27,Evidence at protein level
P07942,LAMB1_HUMAN,Laminin subunit beta-1 (Laminin B1 chain) (Laminin-1 subunit beta) (Laminin-10 subunit beta) (Laminin-12 subunit beta) (Laminin-2 subunit beta) (Laminin-6 subunit beta) (Laminin-8 subunit beta),1786,"198,038",5 out of 5,1988-08-01,Evidence at protein level
P55268,LAMB2_HUMAN,Laminin subunit beta-2 (Laminin B1s chain) (Laminin-11 subunit beta) (Laminin-14 subunit beta) (Laminin-15 subunit beta) (Laminin-3 subunit beta) (Laminin-4 subunit beta) (Laminin-7 subunit beta) (Laminin-9 subunit beta) (S-laminin subunit beta) (S-LAM beta),1798,"195,981",5 out of 5,1996-10-01,Evidence at protein level
Q13753,LAMC2_HUMAN,Laminin subunit gamma-2 (Cell-scattering factor 140 kDa subunit) (CSF 140 kDa subunit) (Epiligrin subunit gamma) (Kalinin subunit gamma) (Kalinin/nicein/epiligrin 100 kDa subunit) (Ladsin 140 kDa subunit) (Laminin B2t chain) (Laminin-5 subunit gamma) (Large adhesive scatter factor 140 kDa subunit) (Nicein subunit gamma),1193,"130,976",5 out of 5,1997-11-01,Evidence at protein level
P13473,LAMP2_HUMAN,Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b),410,"44,961",5 out of 5,1990-01-01,Evidence at protein level
O95835,LATS1_HUMAN,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),1130,"126,870",5 out of 5,2004-09-27,Evidence at protein level
Q53QV2,LBH_HUMAN,Protein LBH (hLBH),105,"12,217",4 out of 5,2008-03-18,Evidence at protein level
P52954,LBX1_HUMAN,Transcription factor LBX1 (Ladybird homeobox protein homolog 1),281,"30,221",3 out of 5,1996-10-01,Evidence at transcript level
Q5T751,LCE1C_HUMAN,Late cornified envelope protein 1C (Late envelope protein 3),118,"11,543",3 out of 5,2006-05-16,Evidence at transcript level
Q5TA82,LCE2D_HUMAN,Late cornified envelope protein 2D (Late envelope protein 12) (Small proline-rich-like epidermal differentiation complex protein 1A),110,"11,180",5 out of 5,2006-05-16,Evidence at protein level
Q13976,KGP1_HUMAN,cGMP-dependent protein kinase 1 (cGK 1) (cGK1) (EC 2.7.11.12) (cGMP-dependent protein kinase I) (cGKI),671,"76,364",5 out of 5,2000-05-30,Evidence at protein level
Q16774,KGUA_HUMAN,Guanylate kinase (EC 2.7.4.8) (GMP kinase),197,"21,726",5 out of 5,1997-11-01,Evidence at protein level
Q587J8,KHD3L_HUMAN,KHDC3-like protein (ES cell-associated transcript 1 protein),217,"24,306",3 out of 5,2007-12-04,Evidence at protein level
O75525,KHDR3_HUMAN,"KH domain-containing, RNA-binding, signal transduction-associated protein 3 (RNA-binding protein T-Star) (Sam68-like mammalian protein 2) (SLM-2) (Sam68-like phosphotyrosine protein)",346,"38,800",5 out of 5,2006-04-18,Evidence at protein level
Q96L93,KI16B_HUMAN,Kinesin-like protein KIF16B (Sorting nexin-23),1317,"152,011",5 out of 5,2002-03-27,Evidence at protein level
Q9Y496,KIF3A_HUMAN,Kinesin-like protein KIF3A (Microtubule plus end-directed kinesin motor 3A),699,"80,041",5 out of 5,2000-05-30,Evidence at protein level
Q07866,KLC1_HUMAN,Kinesin light chain 1 (KLC 1),573,"65,310",5 out of 5,1994-10-01,Evidence at protein level
Q6PID8,KLD10_HUMAN,Kelch domain-containing protein 10,442,"49,098",5 out of 5,2008-02-26,Evidence at protein level
Q9Y2U9,KLDC2_HUMAN,Kelch domain-containing protein 2 (Hepatocellular carcinoma-associated antigen 33) (Host cell factor homolog LCP) (Host cell factor-like protein 1) (HCLP-1),406,"46,099",4 out of 5,2003-02-12,Evidence at protein level
O75840,KLF7_HUMAN,Krueppel-like factor 7 (Ubiquitous krueppel-like factor),302,"33,362",5 out of 5,1999-07-15,Evidence at transcript level
P06870,KLK1_HUMAN,Kallikrein-1 (EC 3.4.21.35) (Kidney/pancreas/salivary gland kallikrein) (Tissue kallikrein),262,"28,890",5 out of 5,1988-01-01,Evidence at protein level
Q9Y337,KLK5_HUMAN,Kallikrein-5 (EC 3.4.21.-) (Kallikrein-like protein 2) (KLK-L2) (Stratum corneum tryptic enzyme),293,"32,019",5 out of 5,2000-12-01,Evidence at protein level
Q4FZB7,KMT5B_HUMAN,Histone-lysine N-methyltransferase KMT5B (EC 2.1.1.43) (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1),885,"99,187",5 out of 5,2007-04-03,Evidence at protein level
Q1ED39,KNOP1_HUMAN,Lysine-rich nucleolar protein 1 (Protein FAM191A) (Testis-specific gene 118 protein),458,"51,589",3 out of 5,2008-02-26,Evidence at protein level
P50748,KNTC1_HUMAN,Kinetochore-associated protein 1 (Rough deal homolog) (HsROD) (Rod) (hRod),2209,"250,749",5 out of 5,1996-10-01,Evidence at protein level
P46019,KPB2_HUMAN,"Phosphorylase b kinase regulatory subunit alpha, liver isoform (Phosphorylase kinase alpha L subunit)",1235,"138,408",5 out of 5,1995-11-01,Evidence at protein level
P05771,KPCB_HUMAN,Protein kinase C beta type (PKC-B) (PKC-beta) (EC 2.7.11.13),671,"76,869",5 out of 5,1987-08-13,Evidence at protein level
O94806,KPCD3_HUMAN,Serine/threonine-protein kinase D3 (EC 2.7.11.13) (Protein kinase C nu type) (Protein kinase EPK2) (nPKC-nu),890,"100,471",5 out of 5,2001-01-11,Evidence at protein level
P24723,KPCL_HUMAN,Protein kinase C eta type (EC 2.7.11.13) (PKC-L) (nPKC-eta),683,"77,828",5 out of 5,1992-03-01,Evidence at protein level
Q9BYR8,KRA31_HUMAN,Keratin-associated protein 3-1 (High sulfur keratin-associated protein 3.1) (Keratin-associated protein 3.1),98,"10,539",4 out of 5,2003-10-10,Evidence at protein level
Q6L8H2,KRA53_HUMAN,Keratin-associated protein 5-3 (Keratin-associated protein 5-9) (Keratin-associated protein 5.3) (Keratin-associated protein 5.9) (UHS KerB-like) (Ultrahigh sulfur keratin-associated protein 5.3),238,"22,106",5 out of 5,2004-12-21,Evidence at protein level
Q6L8G9,KRA56_HUMAN,Keratin-associated protein 5-6 (Keratin-associated protein 5.6) (Ultrahigh sulfur keratin-associated protein 5.6),129,"11,784",5 out of 5,2004-12-21,Evidence at protein level
Q3LI64,KRA61_HUMAN,Keratin-associated protein 6-1,71,"7,279",3 out of 5,2006-02-21,Inferred from homology
Q9BYQ4,KRA92_HUMAN,Keratin-associated protein 9-2 (Keratin-associated protein 9.2) (Ultrahigh sulfur keratin-associated protein 9.2),174,"18,287",5 out of 5,2003-11-14,Evidence at protein level
A8MTY7,KRA97_HUMAN,Keratin-associated protein 9-7,169,"17,793",3 out of 5,2008-04-29,Inferred from homology
Q8N9T8,KRI1_HUMAN,Protein KRI1 homolog,703,"82,598",3 out of 5,2007-08-21,Evidence at protein level
O76011,KRT34_HUMAN,"Keratin, type I cuticular Ha4 (Hair keratin, type I Ha4) (Keratin-34) (K34)",436,"49,424",5 out of 5,2000-05-30,Evidence at protein level
O75449,KTNA1_HUMAN,Katanin p60 ATPase-containing subunit A1 (Katanin p60 subunit A1) (EC 3.6.4.3) (p60 katanin),491,"55,965",5 out of 5,2005-03-01,Evidence at protein level
O60309,L37A3_HUMAN,Leucine-rich repeat-containing protein 37A3,1634,"180,621",3 out of 5,2001-02-21,Evidence at transcript level
Q4G0J3,LARP7_HUMAN,La-related protein 7 (La ribonucleoprotein domain family member 7) (P-TEFb-interaction protein for 7SK stability) (PIP7S),582,"66,899",5 out of 5,2007-03-20,Evidence at protein level
Q9UIQ6,LCAP_HUMAN,"Leucyl-cystinyl aminopeptidase (Cystinyl aminopeptidase) (EC 3.4.11.3) (Insulin-regulated membrane aminopeptidase) (Insulin-responsive aminopeptidase) (IRAP) (Oxytocinase) (OTase) (Placental leucine aminopeptidase) (P-LAP) [Cleaved into: Leucyl-cystinyl aminopeptidase, pregnancy serum form]",1025,"117,349",5 out of 5,2002-03-27,Evidence at protein level
Q5TA79,LCE2A_HUMAN,Late cornified envelope protein 2A (Late envelope protein 9),106,"10,846",5 out of 5,2006-05-16,Evidence at protein level
Q6UWM7,LCTL_HUMAN,Lactase-like protein (Klotho/lactase-phlorizin hydrolase-related protein),567,"65,088",4 out of 5,2005-10-11,Evidence at protein level
Q6P5S2,LEG1H_HUMAN,Protein LEG1 homolog,330,"37,926",3 out of 5,2006-10-17,Evidence at protein level
P47929,LEG7_HUMAN,Galectin-7 (Gal-7) (HKL-14) (PI7) (p53-induced gene 1 protein),136,"15,075",5 out of 5,1996-02-01,Evidence at protein level
O00214,LEG8_HUMAN,Galectin-8 (Gal-8) (Po66 carbohydrate-binding protein) (Po66-CBP) (Prostate carcinoma tumor antigen 1) (PCTA-1),317,"35,808",5 out of 5,1997-11-01,Evidence at protein level
O00182,LEG9_HUMAN,Galectin-9 (Gal-9) (Ecalectin) (Tumor antigen HOM-HD-21),355,"39,518",5 out of 5,1997-11-01,Evidence at protein level
Q8WVC0,LEO1_HUMAN,RNA polymerase-associated protein LEO1 (Replicative senescence down-regulated leo1-like protein),666,"75,404",5 out of 5,2006-07-25,Evidence at protein level
Q15349,KS6A2_HUMAN,Ribosomal protein S6 kinase alpha-2 (S6K-alpha-2) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 2) (p90-RSK 2) (p90RSK2) (MAP kinase-activated protein kinase 1c) (MAPK-activated protein kinase 1c) (MAPKAP kinase 1c) (MAPKAPK-1c) (Ribosomal S6 kinase 3) (RSK-3) (pp90RSK3),733,"83,239",5 out of 5,1998-12-15,Evidence at protein level
O75582,KS6A5_HUMAN,Ribosomal protein S6 kinase alpha-5 (S6K-alpha-5) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 5) (Nuclear mitogen- and stress-activated protein kinase 1) (RSK-like protein kinase) (RSKL),802,"89,865",5 out of 5,2003-10-24,Evidence at protein level
P23443,KS6B1_HUMAN,Ribosomal protein S6 kinase beta-1 (S6K-beta-1) (S6K1) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 1) (P70S6K1) (p70-S6K 1) (Ribosomal protein S6 kinase I) (Serine/threonine-protein kinase 14A) (p70 ribosomal S6 kinase alpha) (p70 S6 kinase alpha) (p70 S6K-alpha) (p70 S6KA),525,"59,140",5 out of 5,1991-11-01,Evidence at protein level
Q8IVT5,KSR1_HUMAN,Kinase suppressor of Ras 1,923,"102,160",5 out of 5,2004-12-21,Evidence at protein level
Q6VAB6,KSR2_HUMAN,Kinase suppressor of Ras 2 (hKSR2) (EC 2.7.11.1),950,"107,632",5 out of 5,2004-12-21,Evidence at protein level
A0A0C4DH73,KV112_HUMAN,Immunoglobulin kappa variable 1-12,117,"12,645",5 out of 5,2016-11-02,Inferred from homology
P06310,KV230_HUMAN,Immunoglobulin kappa variable 2-30 (Ig kappa chain V-II region RPMI 6410),120,"13,185",5 out of 5,1988-01-01,Inferred from homology
P01619,KV320_HUMAN,Immunoglobulin kappa variable 3-20 (Ig kappa chain V-III region B6) (Ig kappa chain V-III region GOL) (Ig kappa chain V-III region HAH) (Ig kappa chain V-III region HIC) (Ig kappa chain V-III region IARC/BL41) (Ig kappa chain V-III region NG9) (Ig kappa chain V-III region SIE) (Ig kappa chain V-III region Ti) (Ig kappa chain V-III region WOL),116,"12,557",5 out of 5,1986-07-21,Evidence at protein level
A0A0B4J2D9,KVD13_HUMAN,Immunoglobulin kappa variable 1D-13,117,"12,569",3 out of 5,2017-01-18,Inferred from homology
A0A0C4DH25,KVD20_HUMAN,Immunoglobulin kappa variable 3D-20,116,"12,515",5 out of 5,2016-11-02,Inferred from homology
Q9UJQ1,LAMP5_HUMAN,Lysosome-associated membrane glycoprotein 5 (Brain and dendritic cell-associated LAMP) (Brain-associated LAMP-like protein) (BAD-LAMP) (Lysosome-associated membrane protein 5) (LAMP-5),280,"31,472",5 out of 5,2002-12-06,Evidence at protein level
P42166,LAP2A_HUMAN,"Lamina-associated polypeptide 2, isoform alpha (Thymopoietin isoform alpha) (TP alpha) (Thymopoietin-related peptide isoform alpha) (TPRP isoform alpha) [Cleaved into: Thymopoietin (TP) (Splenin); Thymopentin (TP5)]",694,"75,492",5 out of 5,1995-11-01,Evidence at protein level
Q92615,LAR4B_HUMAN,La-related protein 4B (La ribonucleoprotein domain family member 4B) (La ribonucleoprotein domain family member 5) (La-related protein 5),738,"80,552",5 out of 5,2007-03-20,Evidence at protein level
Q9Y4W2,LAS1L_HUMAN,Ribosomal biogenesis protein LAS1L (Protein LAS1 homolog),734,"83,065",5 out of 5,2005-08-30,Evidence at protein level
Q5VSP4,LC1L1_HUMAN,Putative lipocalin 1-like protein 1 (Lipocalin 1-like pseudogene 1),162,"17,918",2 out of 5,2008-02-26,Uncertain
Q5T752,LCE1D_HUMAN,Late cornified envelope protein 1D (Late envelope protein 4),114,"11,230",5 out of 5,2006-05-16,Evidence at protein level
Q5TA77,LCE3B_HUMAN,Late cornified envelope protein 3B (Late envelope protein 14),95,"9,812",4 out of 5,2006-05-16,Evidence at protein level
Q6JVE9,LCN8_HUMAN,Epididymal-specific lipocalin-8,175,"19,080",3 out of 5,2005-03-29,Evidence at transcript level
Q05315,LEG10_HUMAN,Galectin-10 (Gal-10) (Charcot-Leyden crystal protein) (CLC) (Eosinophil lysophospholipase) (Lysolecithin acylhydrolase),142,"16,453",5 out of 5,1994-06-01,Evidence at protein level
P05162,LEG2_HUMAN,Galectin-2 (Gal-2) (Beta-galactoside-binding lectin L-14-II) (HL14) (Lactose-binding lectin 2) (S-Lac lectin 2),132,"14,644",4 out of 5,1987-08-13,Evidence at protein level
Q6DKI2,LEG9C_HUMAN,Galectin-9C (Gal-9C) (Galectin-9-like protein B),356,"39,607",3 out of 5,2008-04-29,Evidence at protein level
O95214,LERL1_HUMAN,Leptin receptor overlapping transcript-like 1 (Endospanin-2),131,"14,428",3 out of 5,2000-05-30,Evidence at protein level
A0A0C4DH69,KV109_HUMAN,Immunoglobulin kappa variable 1-9,117,"12,715",3 out of 5,2017-01-18,Inferred from homology
Q8NBH2,KY_HUMAN,Kyphoscoliosis peptidase (EC 3.4.-.-),561,"63,855",4 out of 5,2007-05-29,Evidence at protein level
Q15334,L2GL1_HUMAN,Lethal(2) giant larvae protein homolog 1 (LLGL) (DLG4) (Hugl-1) (Human homolog to the D-lgl gene protein),1064,"115,418",5 out of 5,2006-04-18,Evidence at protein level
Q8WV93,LACE1_HUMAN,Lactation elevated protein 1 (Protein AFG1 homolog),481,"54,845",2 out of 5,2007-03-06,Evidence at protein level
Q15012,LAP4A_HUMAN,Lysosomal-associated transmembrane protein 4A (Golgi 4-transmembrane-spanning transporter MTP),233,"26,801",3 out of 5,1998-07-15,Evidence at protein level
Q71RC2,LARP4_HUMAN,La-related protein 4 (La ribonucleoprotein domain family member 4),724,"80,596",5 out of 5,2005-07-19,Evidence at protein level
Q8IYD9,LAS2_HUMAN,Lung adenoma susceptibility protein 2,372,"41,811",3 out of 5,2005-08-16,Evidence at protein level
Q9GIP4,LAT1L_HUMAN,Putative L-type amino acid transporter 1-like protein IMAA (hLAT1 3-transmembrane protein IMAA) (hLAT1 3TM IMAA) (hLAT1 3-transmembrane protein MMAA) (hLAT1 3TM MMAA),190,"19,840",3 out of 5,2008-09-02,Uncertain
Q9UHI5,LAT2_HUMAN,Large neutral amino acids transporter small subunit 2 (L-type amino acid transporter 2) (hLAT2) (Solute carrier family 7 member 8),535,"58,382",5 out of 5,2001-01-24,Evidence at protein level
P18428,LBP_HUMAN,Lipopolysaccharide-binding protein (LBP),481,"53,384",5 out of 5,1990-11-01,Evidence at protein level
Q5T754,LCE1F_HUMAN,Late cornified envelope protein 1F (Late envelope protein 6),118,"11,654",5 out of 5,2006-05-16,Evidence at protein level
Q9BYE3,LCE3D_HUMAN,Late cornified envelope protein 3D (Late envelope protein 16) (Small proline-rich-like epidermal differentiation complex protein 6A) (Small proline-rich-like epidermal differentiation complex protein 6B),92,"9,444",4 out of 5,2006-05-16,Evidence at protein level
O14960,LECT2_HUMAN,Leukocyte cell-derived chemotaxin-2 (LECT-2) (hLECT2),151,"16,390",5 out of 5,1999-07-15,Evidence at protein level
P09382,LEG1_HUMAN,Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1),135,"14,716",5 out of 5,1989-07-01,Evidence at protein level
Q96B70,LENG9_HUMAN,Leukocyte receptor cluster member 9,501,"53,167",2 out of 5,2006-12-12,Evidence at transcript level
P41159,LEP_HUMAN,Leptin (Obese protein) (Obesity factor),167,"18,641",5 out of 5,1995-02-01,Evidence at protein level
O95202,LETM1_HUMAN,"LETM1 and EF-hand domain-containing protein 1, mitochondrial (Leucine zipper-EF-hand-containing transmembrane protein 1)",739,"83,354",5 out of 5,2005-04-12,Evidence at protein level
Q8N145,LGI3_HUMAN,Leucine-rich repeat LGI family member 3 (LGI1-like protein 4) (Leucine-rich glioma-inactivated protein 3),548,"61,704",4 out of 5,2003-07-03,Evidence at transcript level
Q9HBX8,LGR6_HUMAN,Leucine-rich repeat-containing G-protein coupled receptor 6,967,"104,298",5 out of 5,2002-06-06,Evidence at protein level
Q86UP9,LHPL3_HUMAN,Lipoma HMGIC fusion partner-like 3 protein,236,"25,769",2 out of 5,2006-06-27,Evidence at transcript level
Q9H008,LHPP_HUMAN,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase (hLHPP) (EC 3.1.3.-) (EC 3.6.1.1),270,"29,165",5 out of 5,2007-10-02,Evidence at protein level
P0DOX5,IGG1_HUMAN,Immunoglobulin gamma-1 heavy chain (Immunoglobulin gamma-1 heavy chain NIE),449,"49,330",3 out of 5,2017-03-15,Evidence at protein level
A6NGN9,IGLO5_HUMAN,IgLON family member 5,336,"36,795",2 out of 5,2008-04-29,Evidence at transcript level
Q96ID5,IGS21_HUMAN,Immunoglobulin superfamily member 21 (IgSF21),467,"51,835",2 out of 5,2006-02-21,Evidence at transcript level
Q13422,IKZF1_HUMAN,DNA-binding protein Ikaros (Ikaros family zinc finger protein 1) (Lymphoid transcription factor LyF-1),519,"57,528",5 out of 5,1998-12-15,Evidence at protein level
P29459,IL12A_HUMAN,Interleukin-12 subunit alpha (IL-12A) (Cytotoxic lymphocyte maturation factor 35 kDa subunit) (CLMF p35) (IL-12 subunit p35) (NK cell stimulatory factor chain 1) (NKSF1),219,"24,874",5 out of 5,1993-04-01,Evidence at protein level
P29460,IL12B_HUMAN,Interleukin-12 subunit beta (IL-12B) (Cytotoxic lymphocyte maturation factor 40 kDa subunit) (CLMF p40) (IL-12 subunit p40) (NK cell stimulatory factor chain 2) (NKSF2),328,"37,169",5 out of 5,1993-04-01,Evidence at protein level
P40933,IL15_HUMAN,Interleukin-15 (IL-15),162,"18,086",5 out of 5,1995-02-01,Evidence at protein level
Q8TAD2,IL17D_HUMAN,Interleukin-17D (IL-17D) (Interleukin-27) (IL-27),202,"21,893",3 out of 5,2004-04-26,Evidence at transcript level
Q16552,IL17_HUMAN,Interleukin-17A (IL-17) (IL-17A) (Cytotoxic T-lymphocyte-associated antigen 8) (CTLA-8),155,"17,504",5 out of 5,1997-11-01,Evidence at protein level
P01584,IL1B_HUMAN,Interleukin-1 beta (IL-1 beta) (Catabolin),269,"30,748",5 out of 5,1986-07-21,Evidence at protein level
Q9HBE5,IL21R_HUMAN,Interleukin-21 receptor (IL-21 receptor) (IL-21R) (Novel interleukin receptor) (CD antigen CD360),538,"59,130",5 out of 5,2002-05-02,Evidence at protein level
Q5VWK5,IL23R_HUMAN,Interleukin-23 receptor (IL-23 receptor) (IL-23R),629,"71,722",5 out of 5,2006-12-12,Evidence at protein level
Q9NZH8,IL36G_HUMAN,Interleukin-36 gamma (IL-1-related protein 2) (IL-1RP2) (Interleukin-1 epsilon) (IL-1 epsilon) (Interleukin-1 family member 9) (IL-1F9) (Interleukin-1 homolog 1) (IL-1H1),169,"18,721",5 out of 5,2002-11-08,Evidence at protein level
O00629,IMA3_HUMAN,Importin subunit alpha-3 (Importin alpha Q1) (Qip1) (Karyopherin subunit alpha-4),521,"57,887",5 out of 5,1997-11-01,Evidence at protein level
O15131,IMA6_HUMAN,Importin subunit alpha-6 (Karyopherin subunit alpha-5),536,"60,349",5 out of 5,1998-07-15,Evidence at protein level
Q9NX62,IMPA3_HUMAN,Inositol monophosphatase 3 (IMP 3) (IMPase 3) (EC 3.1.3.25) (EC 3.1.3.7) (Golgi 3-prime phosphoadenosine 5-prime phosphate 3-prime phosphatase) (Golgi-resident PAP phosphatase) (gPAPP) (Inositol monophosphatase domain-containing protein 1) (Inositol-1(or 4)-monophosphatase 3) (Myo-inositol monophosphatase A3),359,"38,681",5 out of 5,2007-05-29,Evidence at protein level
Q9GZP8,IMUP_HUMAN,Immortalization up-regulated protein (Hepatocyte growth factor activator inhibitor type 2-related small protein) (H2RSP) (HAI-2-related small protein),106,"10,897",3 out of 5,2003-08-04,Evidence at protein level
Q6PI98,IN80C_HUMAN,INO80 complex subunit C (IES6 homolog) (hIes6),192,"20,643",5 out of 5,2005-07-05,Evidence at protein level
Q9UNL4,ING4_HUMAN,Inhibitor of growth protein 4 (p29ING4),249,"28,530",5 out of 5,2005-01-04,Evidence at protein level
Q9NTI7,INKA2_HUMAN,PAK4-inhibitor INKA2 (Induced in neural crest by AP2-alpha protein-related homolog) (HInca-r),297,"32,759",3 out of 5,2007-10-02,Evidence at protein level
O95050,INMT_HUMAN,Indolethylamine N-methyltransferase (Indolamine N-methyltransferase) (EC 2.1.1.49) (EC 2.1.1.96) (Aromatic alkylamine N-methyltransferase) (Amine N-methyltransferase) (Arylamine N-methyltransferase) (Thioether S-methyltransferase) (TEMT),263,"28,891",5 out of 5,2000-12-01,Evidence at protein level
Q9NPH2,INO1_HUMAN,Inositol-3-phosphate synthase 1 (IPS 1) (EC 5.5.1.4) (Myo-inositol 1-phosphate synthase) (MI-1-P synthase) (MIP synthase) (hIPS) (Myo-inositol 1-phosphate synthase A1) (hINO1),558,"61,068",5 out of 5,2008-03-18,Evidence at protein level
Q5TA45,INT11_HUMAN,Integrator complex subunit 11 (Int11) (EC 3.1.27.-) (Cleavage and polyadenylation-specific factor 3-like protein) (CPSF3-like protein) (Protein related to CPSF subunits of 68 kDa) (RC-68),600,"67,663",5 out of 5,2006-10-31,Evidence at protein level
Q9NV88,INT9_HUMAN,Integrator complex subunit 9 (Int9) (Protein related to CPSF subunits of 74 kDa) (RC-74),658,"73,814",4 out of 5,2006-10-31,Evidence at protein level
Q96DU7,IP3KC_HUMAN,"Inositol-trisphosphate 3-kinase C (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase C) (IP3 3-kinase C) (IP3K C) (InsP 3-kinase C)",683,"75,207",5 out of 5,2006-05-02,Evidence at protein level
O15397,IPO8_HUMAN,Importin-8 (Imp8) (Ran-binding protein 8) (RanBP8),1037,"119,938",5 out of 5,2004-03-15,Evidence at protein level
A8MTL0,IQCF5_HUMAN,IQ domain-containing protein F5,148,"18,048",1 out of 5,2008-09-02,Evidence at transcript level
Q8N0W5,IQCK_HUMAN,IQ domain-containing protein K,287,"33,292",2 out of 5,2007-04-03,Evidence at transcript level
Q13576,IQGA2_HUMAN,Ras GTPase-activating-like protein IQGAP2,1575,"180,578",5 out of 5,2001-05-04,Evidence at protein level
Q9Y616,IRAK3_HUMAN,Interleukin-1 receptor-associated kinase 3 (IRAK-3) (EC 2.7.11.1) (IL-1 receptor-associated kinase M) (IRAK-M),596,"67,767",5 out of 5,2004-11-09,Evidence at protein level
P48200,IREB2_HUMAN,Iron-responsive element-binding protein 2 (IRE-BP 2) (Iron regulatory protein 2) (IRP2),963,"105,045",5 out of 5,1996-02-01,Evidence at protein level
P14316,IRF2_HUMAN,Interferon regulatory factor 2 (IRF-2),349,"39,354",5 out of 5,1990-01-01,Evidence at protein level
Q9NP60,IRPL2_HUMAN,X-linked interleukin-1 receptor accessory protein-like 2 (IL-1 receptor accessory protein-like 2) (IL-1-RAPL-2) (IL-1RAPL-2) (IL1RAPL-2) (IL1RAPL-2-related protein) (Interleukin-1 receptor 9) (IL-1R-9) (IL-1R9) (Three immunoglobulin domain-containing IL-1 receptor-related 1) (TIGIRR-1),686,"78,670",4 out of 5,2003-08-22,Evidence at transcript level
P0C7L1,ISK8_HUMAN,Serine protease inhibitor Kazal-type 8,97,"10,821",3 out of 5,2008-05-20,Inferred from homology
P13612,ITA4_HUMAN,Integrin alpha-4 (CD49 antigen-like family member D) (Integrin alpha-IV) (VLA-4 subunit alpha) (CD antigen CD49d),1032,"114,900",5 out of 5,1990-01-01,Evidence at protein level
P08648,ITA5_HUMAN,Integrin alpha-5 (CD49 antigen-like family member E) (Fibronectin receptor subunit alpha) (Integrin alpha-F) (VLA-5) (CD antigen CD49e) [Cleaved into: Integrin alpha-5 heavy chain; Integrin alpha-5 light chain],1049,"114,536",5 out of 5,1988-08-01,Evidence at protein level
Q13349,ITAD_HUMAN,Integrin alpha-D (ADB2) (CD11 antigen-like family member D) (Leukointegrin alpha D) (CD antigen CD11d),1161,"126,758",5 out of 5,2000-12-01,Evidence at protein level
P06756,ITAV_HUMAN,Integrin alpha-V (Vitronectin receptor subunit alpha) (CD antigen CD51) [Cleaved into: Integrin alpha-V heavy chain; Integrin alpha-V light chain],1048,"116,038",5 out of 5,1988-01-01,Evidence at protein level
P05556,ITB1_HUMAN,Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29),798,"88,415",5 out of 5,1988-11-01,Evidence at protein level
P56537,IF6_HUMAN,Eukaryotic translation initiation factor 6 (eIF-6) (B(2)GCN homolog) (B4 integrin interactor) (CAB) (p27(BBP)),245,"26,599",5 out of 5,1998-07-15,Evidence at protein level
P01563,IFNA2_HUMAN,Interferon alpha-2 (IFN-alpha-2) (Interferon alpha-A) (LeIF A),188,"21,550",5 out of 5,1986-07-21,Evidence at protein level
P05000,IFNW1_HUMAN,Interferon omega-1 (Interferon alpha-II-1),195,"22,319",5 out of 5,1987-08-13,Evidence at protein level
Q6U949,IG2AS_HUMAN,Putative insulin-like growth factor 2 antisense gene protein (IGF2 antisense RNA 1) (IGF2 antisense gene protein 1) (PEG8/IGF2AS protein) (Putative insulin-like growth factor 2 antisense gene protein 1) (IGF2-AS1),168,"18,035",2 out of 5,2006-01-10,Evidence at transcript level
P01344,IGF2_HUMAN,Insulin-like growth factor II (IGF-II) (Somatomedin-A) (T3M-11-derived growth factor) [Cleaved into: Insulin-like growth factor II; Insulin-like growth factor II Ala-25 Del; Preptin],180,"20,140",5 out of 5,1986-07-21,Evidence at protein level
P01877,IGHA2_HUMAN,Immunoglobulin heavy constant alpha 2 (Ig alpha-2 chain C region) (Ig alpha-2 chain C region BUT) (Ig alpha-2 chain C region LAN),340,"36,591",5 out of 5,1986-07-21,Evidence at protein level
Q14005,IL16_HUMAN,Pro-interleukin-16 [Cleaved into: Interleukin-16 (IL-16) (Lymphocyte chemoattractant factor) (LCF)],1332,"141,752",5 out of 5,1997-11-01,Evidence at protein level
Q9NPF7,IL23A_HUMAN,Interleukin-23 subunit alpha (IL-23 subunit alpha) (IL-23-A) (Interleukin-23 subunit p19) (IL-23p19),189,"20,730",5 out of 5,2006-10-31,Evidence at protein level
Q9H293,IL25_HUMAN,Interleukin-25 (IL-25) (Interleukin-17E) (IL-17E),177,"20,330",5 out of 5,2002-01-31,Evidence at protein level
P60568,IL2_HUMAN,Interleukin-2 (IL-2) (T-cell growth factor) (TCGF) (Aldesleukin),153,"17,628",5 out of 5,1986-07-21,Evidence at protein level
Q8NI17,IL31R_HUMAN,Interleukin-31 receptor subunit alpha (IL-31 receptor subunit alpha) (IL-31R subunit alpha) (IL-31R-alpha) (IL-31RA) (Cytokine receptor-like 3) (GLM-R) (hGLM-R) (Gp130-like monocyte receptor) (Gp130-like receptor) (ZcytoR17),732,"82,954",5 out of 5,2007-02-06,Evidence at protein level
Q9BT40,INP5K_HUMAN,Inositol polyphosphate 5-phosphatase K (EC 3.1.3.56) (Skeletal muscle and kidney-enriched inositol phosphatase),448,"51,090",5 out of 5,2003-09-26,Evidence at protein level
Q1MX18,INSC_HUMAN,Protein inscuteable homolog,579,"63,469",5 out of 5,2006-10-17,Evidence at protein level
P51460,INSL3_HUMAN,Insulin-like 3 (Leydig insulin-like peptide) (Ley-I-L) (Relaxin-like factor) [Cleaved into: Insulin-like 3 B chain; Insulin-like 3 A chain],131,"14,502",5 out of 5,1996-10-01,Evidence at protein level
Q9Y581,INSL6_HUMAN,Insulin-like peptide INSL6 (Insulin-like peptide 6) (Relaxin/insulin-like factor 1) [Cleaved into: Insulin-like peptide INSL6 B chain; Insulin-like peptide INSL6 A chain],213,"24,860",4 out of 5,2000-12-01,Evidence at transcript level
Q01101,INSM1_HUMAN,Insulinoma-associated protein 1 (Zinc finger protein IA-1),510,"52,923",5 out of 5,1994-06-01,Evidence at protein level
P01308,INS_HUMAN,Insulin [Cleaved into: Insulin B chain; Insulin A chain],110,"11,981",5 out of 5,1986-07-21,Evidence at protein level
P07476,INVO_HUMAN,Involucrin,585,"68,479",5 out of 5,1988-04-01,Evidence at protein level
Q9Y283,INVS_HUMAN,Inversin (Inversion of embryo turning homolog) (Nephrocystin-2),1065,"117,826",5 out of 5,2005-07-05,Evidence at protein level
P49895,IOD1_HUMAN,Type I iodothyronine deiodinase (EC 1.21.99.4) (5DI) (DIOI) (Type 1 DI) (Type-I 5'-deiodinase),249,"28,924",5 out of 5,1996-10-01,Evidence at transcript level
Q92551,IP6K1_HUMAN,Inositol hexakisphosphate kinase 1 (InsP6 kinase 1) (EC 2.7.4.21) (Inositol hexaphosphate kinase 1),441,"50,236",5 out of 5,2004-07-19,Evidence at protein level
Q96PQ5,IPP2L_HUMAN,"Putative protein phosphatase inhibitor 2-like protein 1 (Protein phosphatase 1, regulatory subunit 2 pseudogene 1)",205,"22,863",2 out of 5,2007-05-01,Uncertain
P41236,IPP2_HUMAN,Protein phosphatase inhibitor 2 (IPP-2),205,"23,015",5 out of 5,1995-02-01,Evidence at protein level
Q4KMZ1,IQCC_HUMAN,IQ domain-containing protein C,466,"53,032",2 out of 5,2007-04-03,Evidence at protein level
Q6IPM2,IQCE_HUMAN,IQ domain-containing protein E,695,"77,298",4 out of 5,2007-04-17,Evidence at protein level
P0C7M6,IQCF3_HUMAN,IQ domain-containing protein F3,154,"18,251",1 out of 5,2008-06-10,Evidence at transcript level
Q86VS3,IQCH_HUMAN,IQ domain-containing protein H (Testis development protein NYD-SP5),1027,"117,349",3 out of 5,2007-04-03,Evidence at transcript level
Q9UPP2,IQEC3_HUMAN,IQ motif and SEC7 domain-containing protein 3,1182,"127,621",4 out of 5,2006-07-11,Evidence at transcript level
Q8NA54,IQUB_HUMAN,IQ and ubiquitin-like domain-containing protein,791,"92,581",5 out of 5,2007-02-06,Evidence at protein level
Q14653,IRF3_HUMAN,Interferon regulatory factor 3 (IRF-3),427,"47,219",5 out of 5,1997-11-01,Evidence at protein level
O14896,IRF6_HUMAN,Interferon regulatory factor 6 (IRF-6),467,"53,130",5 out of 5,1998-07-15,Evidence at protein level
Q00978,IRF9_HUMAN,Interferon regulatory factor 9 (IRF-9) (IFN-alpha-responsive transcription factor subunit) (ISGF3 p48 subunit) (Interferon-stimulated gene factor 3 gamma) (ISGF-3 gamma) (Transcriptional regulator ISGF3 subunit gamma),393,"43,696",5 out of 5,1993-04-01,Evidence at protein level
Q02556,IRF8_HUMAN,Interferon regulatory factor 8 (IRF-8) (Interferon consensus sequence-binding protein) (H-ICSBP) (ICSBP),426,"48,356",5 out of 5,1993-07-01,Evidence at protein level
P78414,IRX1_HUMAN,Iroquois-class homeodomain protein IRX-1 (Homeodomain protein IRXA1) (Iroquois homeobox protein 1),480,"49,621",3 out of 5,1998-07-15,Evidence at transcript level
O75578,ITA10_HUMAN,Integrin alpha-10,1167,"127,602",5 out of 5,2000-12-01,Evidence at transcript level
P20701,ITAL_HUMAN,Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a),1170,"128,770",5 out of 5,1991-02-01,Evidence at protein level
P16144,ITB4_HUMAN,Integrin beta-4 (GP150) (CD antigen CD104),1822,"202,167",5 out of 5,1990-04-01,Evidence at protein level
P18564,ITB6_HUMAN,Integrin beta-6,788,"85,936",5 out of 5,1990-11-01,Evidence at protein level
P26010,ITB7_HUMAN,Integrin beta-7 (Gut homing receptor beta subunit),798,"86,903",5 out of 5,1992-05-01,Evidence at protein level
O95965,ITGBL_HUMAN,Integrin beta-like protein 1 (Osteoblast-specific cysteine-rich protein) (Ten integrin EGF-like repeat domain-containing protein),494,"53,921",3 out of 5,2008-03-18,Evidence at transcript level
Q96ST2,IWS1_HUMAN,Protein IWS1 homolog (IWS1-like protein),819,"91,955",5 out of 5,2006-01-10,Evidence at protein level
Q9C086,IN80B_HUMAN,INO80 complex subunit B (High mobility group AT-hook 1-like 4) (IES2 homolog) (hIes2) (PAP-1-associated protein 1) (PAPA-1) (Zinc finger HIT domain-containing protein 4),356,"38,637",5 out of 5,2005-09-27,Evidence at protein level
Q8NI35,INADL_HUMAN,InaD-like protein (Inadl protein) (hINADL) (Pals1-associated tight junction protein) (Protein associated to tight junctions),1801,"196,368",5 out of 5,2005-06-21,Evidence at protein level
Q27J81,INF2_HUMAN,Inverted formin-2 (HBEBP2-binding protein C),1249,"135,624",5 out of 5,2008-01-15,Evidence at protein level
P08476,INHBA_HUMAN,Inhibin beta A chain (Activin beta-A chain) (Erythroid differentiation protein) (EDF),426,"47,442",5 out of 5,1988-08-01,Evidence at protein level
P55103,INHBC_HUMAN,Inhibin beta C chain (Activin beta-C chain),352,"38,238",4 out of 5,1996-10-01,Evidence at transcript level
O15503,INSI1_HUMAN,Insulin-induced gene 1 protein (INSIG-1),277,"29,987",5 out of 5,2000-05-30,Evidence at protein level
Q75QN2,INT8_HUMAN,Integrator complex subunit 8 (Int8) (Protein kaonashi-1),995,"113,088",4 out of 5,2006-10-31,Evidence at protein level
P23677,IP3KA_HUMAN,"Inositol-trisphosphate 3-kinase A (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase A) (IP3 3-kinase A) (IP3K A) (InsP 3-kinase A)",461,"51,009",5 out of 5,1991-11-01,Evidence at protein level
P27987,IP3KB_HUMAN,"Inositol-trisphosphate 3-kinase B (EC 2.7.1.127) (Inositol 1,4,5-trisphosphate 3-kinase B) (IP3 3-kinase B) (IP3K B) (InsP 3-kinase B)",946,"102,376",5 out of 5,1992-08-01,Evidence at protein level
Q3MIP1,IPIL2_HUMAN,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 2",535,"58,446",2 out of 5,2008-05-20,Evidence at protein level
Q9C010,IPKB_HUMAN,cAMP-dependent protein kinase inhibitor beta (PKI-beta),78,"8,468",3 out of 5,2001-09-26,Inferred from homology
Q9Y573,IPP_HUMAN,Actin-binding protein IPP (Intracisternal A particle-promoted polypeptide) (IPP) (Kelch-like protein 27),584,"65,261",3 out of 5,2001-04-27,Evidence at transcript level
Q15306,IRF4_HUMAN,Interferon regulatory factor 4 (IRF-4) (Lymphocyte-specific interferon regulatory factor) (LSIRF) (Multiple myeloma oncogene 1) (NF-EM5),451,"51,772",5 out of 5,1997-11-01,Evidence at protein level
Q9NZN1,IRPL1_HUMAN,Interleukin-1 receptor accessory protein-like 1 (IL-1-RAPL-1) (IL-1RAPL-1) (IL1RAPL-1) (Oligophrenin-4) (Three immunoglobulin domain-containing IL-1 receptor-related 2) (TIGIRR-2) (X-linked interleukin-1 receptor accessory protein-like 1),696,"79,969",5 out of 5,2003-08-22,Evidence at protein level
P35568,IRS1_HUMAN,Insulin receptor substrate 1 (IRS-1),1242,"131,591",5 out of 5,1994-06-01,Evidence at protein level
P78413,IRX4_HUMAN,Iroquois-class homeodomain protein IRX-4 (Homeodomain protein IRXA3) (Iroquois homeobox protein 4),519,"54,445",4 out of 5,1998-07-15,Evidence at protein level
Q6IE38,ISK14_HUMAN,Serine protease inhibitor Kazal-type 14,97,"11,057",3 out of 5,2008-05-20,Inferred from homology
Q9NQ38,ISK5_HUMAN,Serine protease inhibitor Kazal-type 5 (Lympho-epithelial Kazal-type-related inhibitor) (LEKTI) [Cleaved into: Hemofiltrate peptide HF6478; Hemofiltrate peptide HF7665],1064,"120,714",5 out of 5,2001-05-04,Evidence at protein level
P26006,ITA3_HUMAN,Integrin alpha-3 (CD49 antigen-like family member C) (FRP-2) (Galactoprotein B3) (GAPB3) (VLA-3 subunit alpha) (CD antigen CD49c) [Cleaved into: Integrin alpha-3 heavy chain; Integrin alpha-3 light chain],1051,"116,612",5 out of 5,1992-05-01,Evidence at protein level
Q969R8,ITFG2_HUMAN,Integrin-alpha FG-GAP repeat-containing protein 2,447,"49,313",2 out of 5,2007-05-29,Evidence at protein level
Q06033,ITIH3_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H3 (ITI heavy chain H3) (ITI-HC3) (Inter-alpha-inhibitor heavy chain 3) (Serum-derived hyaluronan-associated protein) (SHAP),890,"99,849",5 out of 5,1998-07-15,Evidence at protein level
Q86UX2,ITIH5_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H5 (ITI heavy chain H5) (ITI-HC5) (Inter-alpha-inhibitor heavy chain 5),942,"104,576",5 out of 5,2008-04-29,Evidence at transcript level
Q8WWA0,ITLN1_HUMAN,Intelectin-1 (ITLN-1) (Endothelial lectin HL-1) (Galactofuranose-binding lectin) (Intestinal lactoferrin receptor) (Omentin),313,"34,962",5 out of 5,2004-11-23,Evidence at protein level
Q9BX67,JAM3_HUMAN,Junctional adhesion molecule C (JAM-C) (JAM-2) (Junctional adhesion molecule 3) (JAM-3),310,"35,020",5 out of 5,2004-08-31,Evidence at protein level
Q9NYR9,KBRS2_HUMAN,NF-kappa-B inhibitor-interacting Ras-like protein 2 (I-kappa-B-interacting Ras-like protein 2) (Kappa B-Ras protein 2) (KappaB-Ras2),191,"21,508",4 out of 5,2006-03-07,Evidence at protein level
Q9NVX7,KBTB4_HUMAN,Kelch repeat and BTB domain-containing protein 4 (BTB and kelch domain-containing protein 4),518,"58,144",3 out of 5,2004-01-16,Evidence at protein level
Q9Y6M4,KC1G3_HUMAN,Casein kinase I isoform gamma-3 (CKI-gamma 3) (EC 2.7.11.1),447,"51,389",5 out of 5,2000-05-30,Evidence at protein level
Q96NX5,KCC1G_HUMAN,Calcium/calmodulin-dependent protein kinase type 1G (EC 2.7.11.17) (CaM kinase I gamma) (CaM kinase IG) (CaM-KI gamma) (CaMKI gamma) (CaMKIG) (CaMK-like CREB kinase III) (CLICK III),476,"53,087",5 out of 5,2004-12-07,Evidence at protein level
Q13554,KCC2B_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17),666,"72,678",5 out of 5,1997-11-01,Evidence at protein level
Q96CX2,KCD12_HUMAN,BTB/POZ domain-containing protein KCTD12 (Pfetin) (Predominantly fetal expressed T1 domain),325,"35,701",4 out of 5,2004-07-19,Evidence at protein level
P63252,KCNJ2_HUMAN,"Inward rectifier potassium channel 2 (Cardiac inward rectifier potassium channel) (Inward rectifier K(+) channel Kir2.1) (IRK-1) (hIRK1) (Potassium channel, inwardly rectifying subfamily J member 2)",427,"48,288",5 out of 5,2004-10-11,Evidence at protein level
P48050,KCNJ4_HUMAN,"Inward rectifier potassium channel 4 (HIRK2) (HRK1) (Hippocampal inward rectifier) (HIR) (Inward rectifier K(+) channel Kir2.3) (IRK-3) (Potassium channel, inwardly rectifying subfamily J member 4)",445,"49,500",5 out of 5,1996-02-01,Evidence at protein level
Q92813,IOD2_HUMAN,Type II iodothyronine deiodinase (EC 1.21.99.4) (5DII) (DIOII) (Type 2 DI) (Type-II 5'-deiodinase),273,"30,552",5 out of 5,1997-11-01,Evidence at protein level
Q96PC2,IP6K3_HUMAN,Inositol hexakisphosphate kinase 3 (InsP6 kinase 3) (EC 2.7.4.21) (Inositol hexaphosphate kinase 3),410,"46,417",5 out of 5,2004-07-19,Evidence at protein level
Q6GPH6,IPIL1_HUMAN,"Inositol 1,4,5-trisphosphate receptor-interacting protein-like 1",555,"63,395",3 out of 5,2008-02-26,Evidence at protein level
Q8TEX9,IPO4_HUMAN,Importin-4 (Imp4) (Importin-4b) (Imp4b) (Ran-binding protein 4) (RanBP4),1081,"118,715",5 out of 5,2004-02-02,Evidence at protein level
O95373,IPO7_HUMAN,Importin-7 (Imp7) (Ran-binding protein 7) (RanBP7),1038,"119,517",5 out of 5,2004-03-15,Evidence at protein level
Q9Y5U9,IR3IP_HUMAN,Immediate early response 3-interacting protein 1,82,"8,969",4 out of 5,2006-10-31,Evidence at protein level
Q9ULR0,ISY1_HUMAN,Pre-mRNA-splicing factor ISY1 homolog,285,"32,992",5 out of 5,2006-05-16,Evidence at protein level
P53708,ITA8_HUMAN,Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain],1063,"117,474",5 out of 5,1996-10-01,Evidence at protein level
P18084,ITB5_HUMAN,Integrin beta-5,799,"88,054",5 out of 5,1990-11-01,Evidence at protein level
Q9Y287,ITM2B_HUMAN,"Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)]",266,"30,338",5 out of 5,2001-01-24,Evidence at protein level
Q9BY32,ITPA_HUMAN,Inosine triphosphate pyrophosphatase (ITPase) (Inosine triphosphatase) (EC 3.6.1.9) (Non-canonical purine NTP pyrophosphatase) (Non-standard purine NTP pyrophosphatase) (Nucleoside-triphosphate diphosphatase) (Nucleoside-triphosphate pyrophosphatase) (NTPase) (Putative oncogene protein hlc14-06-p),194,"21,446",5 out of 5,2003-04-23,Evidence at protein level
Q14571,ITPR2_HUMAN,"Inositol 1,4,5-trisphosphate receptor type 2 (IP3 receptor isoform 2) (IP3R 2) (InsP3R2) (Type 2 inositol 1,4,5-trisphosphate receptor) (Type 2 InsP3 receptor)",2701,"308,064",5 out of 5,1997-11-01,Evidence at protein level
Q86VZ6,JAZF1_HUMAN,Juxtaposed with another zinc finger protein 1 (TAK1-interacting protein 27) (Zinc finger protein 802),243,"27,079",5 out of 5,2003-07-11,Evidence at protein level
Q9P266,JCAD_HUMAN,Junctional protein associated with coronary artery disease (JCAD),1359,"148,351",3 out of 5,2008-01-15,Evidence at protein level
Q8WYK2,JDP2_HUMAN,Jun dimerization protein 2,163,"18,704",5 out of 5,2008-04-29,Evidence at protein level
Q9UPT6,JIP3_HUMAN,C-Jun-amino-terminal kinase-interacting protein 3 (JIP-3) (JNK-interacting protein 3) (JNK MAP kinase scaffold protein 3) (Mitogen-activated protein kinase 8-interacting protein 3),1336,"147,457",5 out of 5,2002-11-25,Evidence at protein level
Q92628,K0232_HUMAN,Uncharacterized protein KIAA0232,1395,"154,789",2 out of 5,1997-11-01,Evidence at protein level
Q5VV43,K0319_HUMAN,Dyslexia-associated protein KIAA0319,1072,"117,763",5 out of 5,2005-11-22,Evidence at protein level
O94854,K0754_HUMAN,Uncharacterized protein KIAA0754,1291,"135,148",2 out of 5,2007-07-24,Evidence at transcript level
Q6NV74,K121L_HUMAN,Uncharacterized protein KIAA1211-like,962,"102,157",2 out of 5,2007-05-29,Evidence at protein level
Q9P272,K1456_HUMAN,Probable tRNA methyltransferase 9-like protein (TRM9L) (EC 2.1.1.-),454,"51,299",5 out of 5,2008-04-08,Evidence at transcript level
Q96PW8,K1920_HUMAN,Putative uncharacterized protein KIAA1920,444,"48,591",2 out of 5,2008-02-26,Uncertain
P19012,K1C15_HUMAN,"Keratin, type I cytoskeletal 15 (Cytokeratin-15) (CK-15) (Keratin-15) (K15)",456,"49,212",5 out of 5,1990-11-01,Evidence at protein level
P08779,K1C16_HUMAN,"Keratin, type I cytoskeletal 16 (Cytokeratin-16) (CK-16) (Keratin-16) (K16)",473,"51,268",5 out of 5,1988-11-01,Evidence at protein level
Q2M2I5,K1C24_HUMAN,"Keratin, type I cytoskeletal 24 (Cytokeratin-24) (CK-24) (Keratin-24) (K24) (Type I keratin-24)",525,"55,087",5 out of 5,2008-01-15,Evidence at protein level
Q7Z3Y9,K1C26_HUMAN,"Keratin, type I cytoskeletal 26 (Cytokeratin-26) (CK-26) (Keratin-25B) (K25B) (Keratin-26) (K26) (Type I inner root sheath-specific keratin-K25irs2)",468,"51,911",4 out of 5,2007-12-04,Evidence at protein level
Q14532,K1H2_HUMAN,"Keratin, type I cuticular Ha2 (Hair keratin, type I Ha2) (Keratin-32) (K32)",448,"50,343",5 out of 5,1998-07-15,Evidence at transcript level
P35908,K22E_HUMAN,"Keratin, type II cytoskeletal 2 epidermal (Cytokeratin-2e) (CK-2e) (Epithelial keratin-2e) (Keratin-2 epidermis) (Keratin-2e) (K2e) (Type-II keratin Kb2)",639,"65,433",5 out of 5,1994-06-01,Evidence at protein level
P04259,K2C6B_HUMAN,"Keratin, type II cytoskeletal 6B (Cytokeratin-6B) (CK-6B) (Keratin-6B) (K6B) (Type-II keratin Kb10)",564,"60,067",5 out of 5,1987-03-20,Evidence at protein level
P00568,KAD1_HUMAN,Adenylate kinase isoenzyme 1 (AK 1) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 1) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) (Myokinase),194,"21,635",5 out of 5,1986-07-21,Evidence at protein level
Q9H1K1,ISCU_HUMAN,"Iron-sulfur cluster assembly enzyme ISCU, mitochondrial (NifU-like N-terminal domain-containing protein) (NifU-like protein)",167,"17,999",5 out of 5,2005-04-26,Evidence at protein level
Q1W4C9,ISK13_HUMAN,Serine protease inhibitor Kazal-type 13 (Hepatitis B virus DNA polymerase transactivated serine protease inhibitor) (Hespintor) (Serine protease inhibitor Kazal-type 5-like 3),94,"11,051",3 out of 5,2008-07-22,Inferred from homology
O60575,ISK4_HUMAN,Serine protease inhibitor Kazal-type 4 (Peptide PEC-60 homolog),86,"9,454",2 out of 5,2000-05-30,Inferred from homology
Q96A47,ISL2_HUMAN,Insulin gene enhancer protein ISL-2 (Islet-2),359,"39,768",3 out of 5,2002-05-15,Evidence at protein level
Q96CN7,ISOC1_HUMAN,Isochorismatase domain-containing protein 1,298,"32,237",2 out of 5,2006-12-12,Evidence at protein level
Q96J02,ITCH_HUMAN,E3 ubiquitin-protein ligase Itchy homolog (Itch) (EC 2.3.2.26) (Atrophin-1-interacting protein 4) (AIP4) (HECT-type E3 ubiquitin transferase Itchy homolog) (NFE2-associated polypeptide 1) (NAPP1),903,"102,803",5 out of 5,2003-10-03,Evidence at protein level
Q6UXX5,ITIH6_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H6 (Inter-alpha-trypsin inhibitor heavy chain H5-like protein) (Inter-alpha inhibitor H5-like protein),1313,"143,187",3 out of 5,2007-05-01,Evidence at transcript level
Q9NQC1,JADE2_HUMAN,Protein Jade-2 (Jade family PHD finger protein 2) (PHD finger protein 15),790,"87,466",5 out of 5,2003-08-15,Evidence at protein level
P57087,JAM2_HUMAN,Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322),298,"33,207",5 out of 5,2000-12-01,Evidence at protein level
Q86YT9,JAML_HUMAN,Junctional adhesion molecule-like (Adhesion molecule interacting with CXADR antigen 1) (Dendritic cell-specific protein CREA7-1),394,"44,339",5 out of 5,2005-07-19,Evidence at protein level
O60268,K0513_HUMAN,Uncharacterized protein KIAA0513,411,"46,639",2 out of 5,1999-07-15,Evidence at protein level
Q8IV33,K0825_HUMAN,Uncharacterized protein KIAA0825,1275,"147,763",2 out of 5,2008-02-05,Evidence at transcript level
Q9UPP5,K1107_HUMAN,Uncharacterized protein KIAA1107,1409,"155,681",3 out of 5,2008-02-26,Evidence at protein level
Q96AT1,K1143_HUMAN,Uncharacterized protein KIAA1143,154,"17,465",2 out of 5,2006-09-05,Evidence at protein level
Q96PY0,K1908_HUMAN,Putative uncharacterized protein PSMG3-AS1 (PSMG3 antisense RNA 1),264,"28,245",2 out of 5,2008-06-10,Uncertain
P13645,K1C10_HUMAN,"Keratin, type I cytoskeletal 10 (Cytokeratin-10) (CK-10) (Keratin-10) (K10)",584,"58,827",5 out of 5,1990-01-01,Evidence at protein level
P35900,K1C20_HUMAN,"Keratin, type I cytoskeletal 20 (Cytokeratin-20) (CK-20) (Keratin-20) (K20) (Protein IT)",424,"48,487",5 out of 5,1994-06-01,Evidence at protein level
Q14CN4,K2C72_HUMAN,"Keratin, type II cytoskeletal 72 (Cytokeratin-72) (CK-72) (Keratin-72) (K72) (Type II inner root sheath-specific keratin-K6irs2) (Type-II keratin Kb35)",511,"55,877",5 out of 5,2008-01-15,Evidence at protein level
Q5TCS8,KAD9_HUMAN,Adenylate kinase 9 (AK 9) (EC 2.7.4.4) (EC 2.7.4.6) (Adenylate kinase domain-containing protein 1) (Adenylate kinase domain-containing protein 2),1911,"221,413",5 out of 5,2007-09-11,Evidence at protein level
Q14678,KANK1_HUMAN,KN motif and ankyrin repeat domain-containing protein 1 (Ankyrin repeat domain-containing protein 15) (Kidney ankyrin repeat-containing protein),1352,"147,289",5 out of 5,2003-08-29,Evidence at protein level
Q7Z3B3,KANL1_HUMAN,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),1105,"121,025",5 out of 5,2006-05-16,Evidence at protein level
P31321,KAP1_HUMAN,cAMP-dependent protein kinase type I-beta regulatory subunit,381,"43,073",5 out of 5,1993-07-01,Evidence at protein level
Q9H7Z6,KAT8_HUMAN,"Histone acetyltransferase KAT8 (EC 2.3.1.48) (Lysine acetyltransferase 8) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 1) (MYST-1) (hMOF)",458,"52,403",5 out of 5,2005-07-05,Evidence at protein level
F8WCM5,INSR2_HUMAN,"Insulin, isoform 2 (INS-IGF2 readthrough transcript protein)",200,"21,537",2 out of 5,2013-06-26,Evidence at transcript level
Q9Y2B9,IPKG_HUMAN,cAMP-dependent protein kinase inhibitor gamma (PKI-gamma),76,"7,910",2 out of 5,2000-05-30,Evidence at transcript level
Q8IWB1,IPRI_HUMAN,"Inositol 1,4,5-trisphosphate receptor-interacting protein (Protein DANGER)",547,"62,060",4 out of 5,2007-07-10,Evidence at protein level
P05154,IPSP_HUMAN,Plasma serine protease inhibitor (Acrosomal serine protease inhibitor) (Plasminogen activator inhibitor 3) (PAI-3) (PAI3) (Protein C inhibitor) (PCI) (Serpin A5),406,"45,675",5 out of 5,1987-08-13,Evidence at protein level
Q9H2U2,IPYR2_HUMAN,"Inorganic pyrophosphatase 2, mitochondrial (EC 3.6.1.1) (Pyrophosphatase SID6-306) (Pyrophosphate phospho-hydrolase 2) (PPase 2)",334,"37,920",5 out of 5,2004-09-27,Evidence at protein level
Q86XH1,IQCA1_HUMAN,IQ and AAA domain-containing protein 1,822,"95,341",3 out of 5,2007-04-03,Evidence at transcript level
Q86VI3,IQGA3_HUMAN,Ras GTPase-activating-like protein IQGAP3,1631,"184,699",4 out of 5,2004-06-21,Evidence at protein level
Q9NWZ3,IRAK4_HUMAN,Interleukin-1 receptor-associated kinase 4 (IRAK-4) (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-64),460,"51,530",5 out of 5,2004-07-19,Evidence at protein level
Q8WZA9,IRGQ_HUMAN,Immunity-related GTPase family Q protein,623,"62,717",2 out of 5,2006-12-12,Evidence at protein level
Q9Y4H2,IRS2_HUMAN,Insulin receptor substrate 2 (IRS-2),1338,"137,334",5 out of 5,2000-05-30,Evidence at protein level
P78411,IRX5_HUMAN,Iroquois-class homeodomain protein IRX-5 (Homeodomain protein IRX-2A) (Homeodomain protein IRXB2) (Iroquois homeobox protein 5),483,"50,361",5 out of 5,1998-07-15,Evidence at protein level
B1AKI9,ISM1_HUMAN,Isthmin-1,464,"52,107",3 out of 5,2008-09-02,Evidence at transcript level
Q96AB3,ISOC2_HUMAN,Isochorismatase domain-containing protein 2,205,"22,337",4 out of 5,2006-12-12,Evidence at protein level
Q6PHW0,IYD1_HUMAN,Iodotyrosine deiodinase 1 (IYD-1) (EC 1.21.1.1) (Iodotyrosine dehalogenase 1),289,"33,360",5 out of 5,2006-04-04,Evidence at protein level
Q1ZYL8,IZUM4_HUMAN,Izumo sperm-egg fusion protein 4 (Sperm 22 kDa protein c113),232,"26,510",3 out of 5,2007-02-20,Evidence at transcript level
Q6IE81,JADE1_HUMAN,Protein Jade-1 (Jade family PHD finger protein 1) (PHD finger protein 17),842,"95,533",5 out of 5,2006-10-17,Evidence at protein level
P78504,JAG1_HUMAN,Protein jagged-1 (Jagged1) (hJ1) (CD antigen CD339),1218,"133,799",5 out of 5,2002-05-02,Evidence at protein level
P23458,JAK1_HUMAN,Tyrosine-protein kinase JAK1 (EC 2.7.10.2) (Janus kinase 1) (JAK-1),1154,"133,277",5 out of 5,1991-11-01,Evidence at protein level
O60674,JAK2_HUMAN,Tyrosine-protein kinase JAK2 (EC 2.7.10.2) (Janus kinase 2) (JAK-2),1132,"130,674",5 out of 5,1998-12-15,Evidence at protein level
Q9Y624,JAM1_HUMAN,Junctional adhesion molecule A (JAM-A) (Junctional adhesion molecule 1) (JAM-1) (Platelet F11 receptor) (Platelet adhesion molecule 1) (PAM-1) (CD antigen CD321),299,"32,583",5 out of 5,2000-12-01,Evidence at protein level
Q13387,JIP2_HUMAN,C-Jun-amino-terminal kinase-interacting protein 2 (JIP-2) (JNK-interacting protein 2) (Islet-brain-2) (IB-2) (JNK MAP kinase scaffold protein 2) (Mitogen-activated protein kinase 8-interacting protein 2),824,"87,975",5 out of 5,2001-12-05,Evidence at protein level
Q6ZU35,K1211_HUMAN,Uncharacterized protein KIAA1211,1233,"136,760",2 out of 5,2008-07-01,Evidence at protein level
Q9P206,K1522_HUMAN,Uncharacterized protein KIAA1522,1035,"107,095",3 out of 5,2007-11-13,Evidence at protein level
Q3SXP7,K1644_HUMAN,Uncharacterized protein KIAA1644,199,"22,573",2 out of 5,2008-02-26,Evidence at transcript level
Q9H0B3,K1683_HUMAN,Uncharacterized protein KIAA1683,1180,"127,693",5 out of 5,2005-08-30,Evidence at protein level
Q01546,K22O_HUMAN,"Keratin, type II cytoskeletal 2 oral (Cytokeratin-2P) (CK-2P) (K2P) (Keratin-76) (K76) (Type-II keratin Kb9)",638,"65,841",5 out of 5,1994-06-01,Evidence at protein level
P19013,K2C4_HUMAN,"Keratin, type II cytoskeletal 4 (Cytokeratin-4) (CK-4) (Keratin-4) (K4) (Type-II keratin Kb4)",534,"57,285",5 out of 5,1990-11-01,Evidence at protein level
P13647,K2C5_HUMAN,"Keratin, type II cytoskeletal 5 (58 kDa cytokeratin) (Cytokeratin-5) (CK-5) (Keratin-5) (K5) (Type-II keratin Kb5)",590,"62,378",5 out of 5,1990-01-01,Evidence at protein level
P54819,KAD2_HUMAN,"Adenylate kinase 2, mitochondrial (AK 2) (EC 2.7.4.3) (ATP-AMP transphosphorylase 2) (ATP:AMP phosphotransferase) (Adenylate monophosphate kinase) [Cleaved into: Adenylate kinase 2, mitochondrial, N-terminally processed]",239,"26,478",5 out of 5,1996-10-01,Evidence at protein level
Q9UIJ7,KAD3_HUMAN,"GTP:AMP phosphotransferase AK3, mitochondrial (EC 2.7.4.10) (Adenylate kinase 3) (AK 3) (Adenylate kinase 3 alpha-like 1)",227,"25,565",5 out of 5,2000-12-01,Evidence at protein level
Q9Y6K8,KAD5_HUMAN,Adenylate kinase isoenzyme 5 (AK 5) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 5),562,"63,333",5 out of 5,2000-12-01,Evidence at protein level
P58166,INHBE_HUMAN,Inhibin beta E chain (Activin beta-E chain),350,"38,561",4 out of 5,2001-06-01,Evidence at protein level
O15327,INP4B_HUMAN,"Type II inositol 3,4-bisphosphate 4-phosphatase (EC 3.1.3.66) (Inositol polyphosphate 4-phosphatase type II)",924,"104,738",5 out of 5,2005-08-30,Evidence at transcript level
Q9NRR6,INP5E_HUMAN,"72 kDa inositol polyphosphate 5-phosphatase (EC 3.1.3.36) (Phosphatidylinositol 4,5-bisphosphate 5-phosphatase) (Phosphatidylinositol polyphosphate 5-phosphatase type IV)",644,"70,205",5 out of 5,2004-03-29,Evidence at protein level
P49441,INPP_HUMAN,Inositol polyphosphate 1-phosphatase (IPP) (IPPase) (EC 3.1.3.57),399,"43,998",5 out of 5,1996-02-01,Evidence at protein level
P55073,IOD3_HUMAN,Thyroxine 5-deiodinase (EC 1.21.99.3) (5DIII) (DIOIII) (Type 3 DI) (Type III iodothyronine deiodinase),304,"33,947",5 out of 5,1996-10-01,Evidence at protein level
Q9UI26,IPO11_HUMAN,Importin-11 (Imp11) (Ran-binding protein 11) (RanBP11),975,"112,535",5 out of 5,2004-07-19,Evidence at protein level
O94829,IPO13_HUMAN,Importin-13 (Imp13) (Karyopherin-13) (Kap13) (Ran-binding protein 13) (RanBP13),963,"108,195",5 out of 5,2004-07-19,Evidence at protein level
Q6NXS1,IPP2M_HUMAN,"Protein phosphatase inhibitor 2-like protein 3 (Protein phosphatase 1, regulatory subunit 2 pseudogene 3)",205,"23,048",4 out of 5,2007-05-01,Evidence at protein level
O14990,IPP4_HUMAN,"Putative type-1 protein phosphatase inhibitor 4 (I-4) (Protein phosphatase 1, regulatory subunit 2 pseudogene 9)",202,"22,660",2 out of 5,2004-08-16,Evidence at protein level
Q96DY2,IQCD_HUMAN,IQ domain-containing protein D,449,"52,359",2 out of 5,2007-04-03,Evidence at transcript level
A8MYZ5,IQCF6_HUMAN,IQ domain-containing protein F6,107,"13,059",1 out of 5,2008-07-01,Predicted
Q5JU85,IQEC2_HUMAN,IQ motif and SEC7 domain-containing protein 2,1478,"161,736",4 out of 5,2006-07-11,Evidence at protein level
P78412,IRX6_HUMAN,Iroquois-class homeodomain protein IRX-6 (Homeodomain protein IRXB3) (Iroquois homeobox protein 6),446,"48,240",2 out of 5,1998-07-15,Evidence at transcript level
Q86U28,ISCA2_HUMAN,"Iron-sulfur cluster assembly 2 homolog, mitochondrial (HESB-like domain-containing protein 1)",154,"16,476",4 out of 5,2007-02-06,Evidence at protein level
P20155,ISK2_HUMAN,Serine protease inhibitor Kazal-type 2 (Acrosin-trypsin inhibitor) (Epididymis tissue protein Li 172) (HUSI-II),84,"9,291",5 out of 5,1991-02-01,Evidence at protein level
Q5DT21,ISK9_HUMAN,Serine protease inhibitor Kazal-type 9 (Lymphoepithelial Kazal-type-related inhibitor 2),86,"9,756",4 out of 5,2008-05-20,Evidence at protein level
A4D126,ISPD_HUMAN,Isoprenoid synthase domain-containing protein (EC 2.7.7.-) (2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein),451,"49,873",5 out of 5,2008-07-22,Evidence at protein level
Q2M1V0,ISX_HUMAN,Intestine-specific homeobox (RAX-like homeobox),245,"27,011",3 out of 5,2007-05-29,Evidence at transcript level
Q9UKX5,ITA11_HUMAN,Integrin alpha-11,1188,"133,470",5 out of 5,2000-12-01,Evidence at protein level
P56199,ITA1_HUMAN,Integrin alpha-1 (CD49 antigen-like family member A) (Laminin and collagen receptor) (VLA-1) (CD antigen CD49a),1179,"130,848",5 out of 5,1997-11-01,Evidence at protein level
P08514,ITA2B_HUMAN,"Integrin alpha-IIb (GPalpha IIb) (GPIIb) (Platelet membrane glycoprotein IIb) (CD antigen CD41) [Cleaved into: Integrin alpha-IIb heavy chain; Integrin alpha-IIb light chain, form 1; Integrin alpha-IIb light chain, form 2]",1039,"113,377",5 out of 5,1988-08-01,Evidence at protein level
Q13683,ITA7_HUMAN,Integrin alpha-7 [Cleaved into: Integrin alpha-7 heavy chain; Integrin alpha-7 light chain; Integrin alpha-7 70 kDa form],1181,"128,948",5 out of 5,2000-12-01,Evidence at protein level
Q13797,ITA9_HUMAN,Integrin alpha-9 (Integrin alpha-RLC),1035,"114,489",5 out of 5,1997-11-01,Evidence at protein level
P38570,ITAE_HUMAN,Integrin alpha-E (HML-1 antigen) (Integrin alpha-IEL) (Mucosal lymphocyte 1 antigen) (CD antigen CD103) [Cleaved into: Integrin alpha-E light chain; Integrin alpha-E heavy chain],1179,"130,159",5 out of 5,1994-10-01,Evidence at protein level
P11215,ITAM_HUMAN,Integrin alpha-M (CD11 antigen-like family member B) (CR-3 alpha chain) (Cell surface glycoprotein MAC-1 subunit alpha) (Leukocyte adhesion receptor MO1) (Neutrophil adherence receptor) (CD antigen CD11b),1152,"127,179",5 out of 5,1989-07-01,Evidence at protein level
P20702,ITAX_HUMAN,"Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)",1163,"127,829",5 out of 5,1991-02-01,Evidence at protein level
O14713,ITBP1_HUMAN,Integrin beta-1-binding protein 1 (Integrin cytoplasmic domain-associated protein 1) (ICAP-1),200,"21,782",5 out of 5,2001-11-16,Evidence at protein level
P19823,ITIH2_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H2 (ITI heavy chain H2) (ITI-HC2) (Inter-alpha-inhibitor heavy chain 2) (Inter-alpha-trypsin inhibitor complex component II) (Serum-derived hyaluronan-associated protein) (SHAP),946,"106,463",5 out of 5,1991-02-01,Evidence at protein level
Q14624,ITIH4_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H4 (ITI heavy chain H4) (ITI-HC4) (Inter-alpha-inhibitor heavy chain 4) (Inter-alpha-trypsin inhibitor family heavy chain-related protein) (IHRP) (Plasma kallikrein sensitive glycoprotein 120) (Gp120) (PK-120) [Cleaved into: 70 kDa inter-alpha-trypsin inhibitor heavy chain H4; 35 kDa inter-alpha-trypsin inhibitor heavy chain H4],930,"103,357",5 out of 5,1998-07-15,Evidence at protein level
O43736,ITM2A_HUMAN,Integral membrane protein 2A (Protein E25),263,"29,741",3 out of 5,1999-07-15,Evidence at protein level
Q15811,ITSN1_HUMAN,Intersectin-1 (SH3 domain-containing protein 1A) (SH3P17),1721,"195,422",5 out of 5,1997-11-01,Evidence at protein level
Q08881,ITK_HUMAN,Tyrosine-protein kinase ITK/TSK (EC 2.7.10.2) (Interleukin-2-inducible T-cell kinase) (IL-2-inducible T-cell kinase) (Kinase EMT) (T-cell-specific kinase) (Tyrosine-protein kinase Lyk),620,"71,831",5 out of 5,1994-10-01,Evidence at protein level
Q8WWU7,ITLN2_HUMAN,Intelectin-2 (Endothelial lectin HL-2),325,"36,212",3 out of 5,2004-11-23,Evidence at transcript level
Q14573,ITPR3_HUMAN,"Inositol 1,4,5-trisphosphate receptor type 3 (IP3 receptor isoform 3) (IP3R 3) (InsP3R3) (Type 3 inositol 1,4,5-trisphosphate receptor) (Type 3 InsP3 receptor)",2671,"304,106",5 out of 5,2001-11-02,Evidence at protein level
Q9NZM3,ITSN2_HUMAN,Intersectin-2 (SH3 domain-containing protein 1B) (SH3P18) (SH3P18-like WASP-associated protein),1697,"193,461",5 out of 5,2002-04-03,Evidence at protein level
Q8N5M9,JAGN1_HUMAN,Protein jagunal homolog 1,183,"21,125",5 out of 5,2008-01-15,Evidence at protein level
A6ND01,JUNO_HUMAN,Sperm-egg fusion protein Juno (Folate receptor 4) (Folate receptor delta) (FR-delta) (IZUMO1 receptor protein JUNO),250,"28,672",5 out of 5,2008-05-20,Evidence at protein level
Q14667,K0100_HUMAN,Protein KIAA0100 (Antigen MLAA-22) (Breast cancer-overexpressed gene 1 protein),2235,"253,700",4 out of 5,2006-09-05,Evidence at protein level
Q9ULG3,K1257_HUMAN,Uncharacterized protein KIAA1257,409,"46,740",2 out of 5,2008-02-26,Evidence at transcript level
Q6UXG2,K1324_HUMAN,UPF0577 protein KIAA1324 (Estrogen-induced gene 121 protein),1013,"111,382",5 out of 5,2007-05-15,Evidence at transcript level
Q9HCM3,K1549_HUMAN,UPF0606 protein KIAA1549,1950,"210,755",4 out of 5,2008-07-01,Evidence at protein level
Q6NSI8,K1841_HUMAN,Uncharacterized protein KIAA1841,718,"82,007",2 out of 5,2008-03-18,Evidence at transcript level
P13646,K1C13_HUMAN,"Keratin, type I cytoskeletal 13 (Cytokeratin-13) (CK-13) (Keratin-13) (K13)",458,"49,588",5 out of 5,1990-01-01,Evidence at protein level
P02533,K1C14_HUMAN,"Keratin, type I cytoskeletal 14 (Cytokeratin-14) (CK-14) (Keratin-14) (K14)",472,"51,561",5 out of 5,1986-07-21,Evidence at protein level
P05783,K1C18_HUMAN,"Keratin, type I cytoskeletal 18 (Cell proliferation-inducing gene 46 protein) (Cytokeratin-18) (CK-18) (Keratin-18) (K18)",430,"48,058",5 out of 5,1988-11-01,Evidence at protein level
Q9C075,K1C23_HUMAN,"Keratin, type I cytoskeletal 23 (Cytokeratin-23) (CK-23) (Keratin-23) (K23)",422,"48,131",3 out of 5,2001-08-29,Evidence at protein level
Q6A163,K1C39_HUMAN,"Keratin, type I cytoskeletal 39 (Cytokeratin-39) (CK-39) (Keratin-39) (K39) (Type I hair keratin Ka35)",491,"55,651",5 out of 5,2008-01-15,Evidence at protein level
Q7Z794,K2C1B_HUMAN,"Keratin, type II cytoskeletal 1b (Cytokeratin-1B) (CK-1B) (Keratin-77) (K77) (Type-II keratin Kb39)",578,"61,901",5 out of 5,2005-05-24,Evidence at transcript level
Q5XKE5,K2C79_HUMAN,"Keratin, type II cytoskeletal 79 (Cytokeratin-79) (CK-79) (Keratin-6-like) (Keratin-6L) (Keratin-79) (K79) (Type-II keratin Kb38)",535,"57,836",5 out of 5,2008-01-15,Evidence at protein level
P05787,K2C8_HUMAN,"Keratin, type II cytoskeletal 8 (Cytokeratin-8) (CK-8) (Keratin-8) (K8) (Type-II keratin Kb8)",483,"53,704",5 out of 5,1988-11-01,Evidence at protein level
O75600,KBL_HUMAN,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial (AKB ligase) (EC 2.3.1.29) (Aminoacetone synthase) (Glycine acetyltransferase)",419,"45,285",5 out of 5,2000-05-30,Evidence at protein level
Q3ZCT8,KBTBC_HUMAN,Kelch repeat and BTB domain-containing protein 12 (Kelch domain-containing protein 6),623,"71,096",2 out of 5,2008-03-18,Evidence at transcript level
P48729,KC1A_HUMAN,Casein kinase I isoform alpha (CKI-alpha) (EC 2.7.11.1) (CK1),337,"38,915",5 out of 5,1996-02-01,Evidence at protein level
P49674,KC1E_HUMAN,Casein kinase I isoform epsilon (CKI-epsilon) (CKIe) (EC 2.7.11.1),416,"47,315",5 out of 5,1996-02-01,Evidence at protein level
Q14012,KCC1A_HUMAN,Calcium/calmodulin-dependent protein kinase type 1 (EC 2.7.11.17) (CaM kinase I) (CaM-KI) (CaM kinase I alpha) (CaMKI-alpha),370,"41,337",5 out of 5,1998-07-15,Evidence at protein level
Q693B1,KCD11_HUMAN,BTB/POZ domain-containing protein KCTD11 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase KCTD11),232,"25,887",5 out of 5,2006-09-05,Evidence at protein level
Q6PI47,KCD18_HUMAN,BTB/POZ domain-containing protein KCTD18,426,"46,739",2 out of 5,2006-09-05,Evidence at transcript level
Q4G0X4,KCD21_HUMAN,BTB/POZ domain-containing protein KCTD21,260,"29,643",2 out of 5,2007-03-20,Evidence at protein level
Q14500,KCJ12_HUMAN,"ATP-sensitive inward rectifier potassium channel 12 (Inward rectifier K(+) channel Kir2.2) (IRK-2) (Inward rectifier K(+) channel Kir2.2v) (Potassium channel, inwardly rectifying subfamily J member 12)",433,"49,001",5 out of 5,1997-11-01,Evidence at protein level
Q9UNX9,KCJ14_HUMAN,"ATP-sensitive inward rectifier potassium channel 14 (Inward rectifier K(+) channel Kir2.4) (IRK-4) (Potassium channel, inwardly rectifying subfamily J member 14)",436,"47,846",4 out of 5,2004-10-11,Evidence at protein level
B7U540,KCJ18_HUMAN,"Inward rectifier potassium channel 18 (Inward rectifier K(+) channel Kir2.6) (Potassium channel, inwardly rectifying subfamily J member 18)",433,"48,880",5 out of 5,2010-07-13,Evidence at protein level
Q12791,KCMA1_HUMAN,"Calcium-activated potassium channel subunit alpha-1 (BK channel) (BKCA alpha) (Calcium-activated potassium channel, subfamily M subunit alpha-1) (K(VCA)alpha) (KCa1.1) (Maxi K channel) (MaxiK) (Slo-alpha) (Slo1) (Slowpoke homolog) (Slo homolog) (hSlo)",1236,"137,560",5 out of 5,2004-04-13,Evidence at protein level
Q9NPA1,KCMB3_HUMAN,"Calcium-activated potassium channel subunit beta-3 (BK channel subunit beta-3) (BKbeta3) (Hbeta3) (Calcium-activated potassium channel, subfamily M subunit beta-3) (Charybdotoxin receptor subunit beta-3) (K(VCA)beta-3) (Maxi K channel subunit beta-3) (Slo-beta-3)",279,"31,604",5 out of 5,2004-04-13,Evidence at protein level
P22460,KCNA5_HUMAN,Potassium voltage-gated channel subfamily A member 5 (HPCN1) (Voltage-gated potassium channel HK2) (Voltage-gated potassium channel subunit Kv1.5),613,"67,228",5 out of 5,1991-08-01,Evidence at protein level
Q8TDN1,KCNG4_HUMAN,Potassium voltage-gated channel subfamily G member 4 (Voltage-gated potassium channel subunit Kv6.4),519,"58,979",5 out of 5,2002-11-28,Evidence at protein level
Q9ULD8,KCNH3_HUMAN,Potassium voltage-gated channel subfamily H member 3 (Brain-specific eag-like channel 1) (BEC1) (Ether-a-go-go-like potassium channel 2) (ELK channel 2) (ELK2) (Voltage-gated potassium channel subunit Kv12.2),1083,"117,129",5 out of 5,2002-11-28,Evidence at protein level
Q9H252,KCNH6_HUMAN,Potassium voltage-gated channel subfamily H member 6 (Ether-a-go-go-related gene potassium channel 2) (ERG-2) (Eag-related protein 2) (Ether-a-go-go-related protein 2) (hERG-2) (hERG2) (Voltage-gated potassium channel subunit Kv11.2),994,"109,925",5 out of 5,2002-11-28,Evidence at protein level
Q9NYG8,KCNK4_HUMAN,Potassium channel subfamily K member 4 (TWIK-related arachidonic acid-stimulated potassium channel protein) (TRAAK) (Two pore potassium channel KT4.1) (Two pore K(+) channel KT4.1),393,"42,704",5 out of 5,2001-02-21,Evidence at protein level
Q9H427,KCNKF_HUMAN,Potassium channel subfamily K member 15 (Acid-sensitive potassium channel protein TASK-5) (TWIK-related acid-sensitive K(+) channel 5) (Two pore potassium channel KT3.3) (Two pore K(+) channel KT3.3),330,"36,130",5 out of 5,2002-11-01,Evidence at protein level
Q96T54,KCNKH_HUMAN,Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2),332,"36,895",5 out of 5,2002-11-01,Evidence at transcript level
O15554,KCNN4_HUMAN,Intermediate conductance calcium-activated potassium channel protein 4 (SK4) (SKCa 4) (SKCa4) (IKCa1) (IK1) (KCa3.1) (KCa4) (Putative Gardos channel),427,"47,696",5 out of 5,2001-11-16,Evidence at protein level
P51787,KCNQ1_HUMAN,Potassium voltage-gated channel subfamily KQT member 1 (IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1) (KQT-like 1) (Voltage-gated potassium channel subunit Kv7.1),676,"74,699",5 out of 5,1996-10-01,Evidence at protein level
Q9H478,KCQ1D_HUMAN,KCNQ1 downstream neighbor protein (Beckwith-Wiedemann region transcript protein),68,"7,384",1 out of 5,2005-12-06,Evidence at transcript level
P12277,KCRB_HUMAN,Creatine kinase B-type (EC 2.7.3.2) (B-CK) (Creatine kinase B chain),381,"42,644",5 out of 5,1989-10-01,Evidence at protein level
P17540,KCRS_HUMAN,"Creatine kinase S-type, mitochondrial (EC 2.7.3.2) (Basic-type mitochondrial creatine kinase) (Mib-CK) (Sarcomeric mitochondrial creatine kinase) (S-MtCK)",419,"47,504",5 out of 5,1990-08-01,Evidence at protein level
Q8NC54,KCT2_HUMAN,Keratinocyte-associated transmembrane protein 2,265,"29,235",2 out of 5,2005-07-05,Evidence at protein level
Q8NC69,KCTD6_HUMAN,BTB/POZ domain-containing protein KCTD6,237,"27,610",5 out of 5,2006-10-03,Evidence at protein level
Q7LBC6,KDM3B_HUMAN,Lysine-specific demethylase 3B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2B) (Jumonji domain-containing protein 1B) (Nuclear protein 5qNCA),1761,"191,581",5 out of 5,2006-05-16,Evidence at protein level
Q6H9L7,ISM2_HUMAN,Isthmin-2 (Thrombospondin and AMOP domain-containing isthmin-like protein 1) (Thrombospondin type-1 domain-containing protein 3),571,"63,906",4 out of 5,2007-10-23,Evidence at transcript level
Q6UXV1,IZUM2_HUMAN,Izumo sperm-egg fusion protein 2,221,"24,856",3 out of 5,2007-07-24,Evidence at transcript level
P52333,JAK3_HUMAN,Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK),1124,"125,099",5 out of 5,1996-10-01,Evidence at protein level
Q9Y4A0,JERKL_HUMAN,Jerky protein homolog-like (Human homolog of mouse jerky gene protein) (HHMJG),524,"59,912",3 out of 5,2002-12-06,Evidence at transcript level
Q9UQF2,JIP1_HUMAN,C-Jun-amino-terminal kinase-interacting protein 1 (JIP-1) (JNK-interacting protein 1) (Islet-brain 1) (IB-1) (JNK MAP kinase scaffold protein 1) (Mitogen-activated protein kinase 8-interacting protein 1),711,"77,524",5 out of 5,2001-12-05,Evidence at protein level
O60271,JIP4_HUMAN,C-Jun-amino-terminal kinase-interacting protein 4 (JIP-4) (JNK-interacting protein 4) (Cancer/testis antigen 89) (CT89) (Human lung cancer oncogene 6 protein) (HLC-6) (JNK-associated leucine-zipper protein) (JLP) (Mitogen-activated protein kinase 8-interacting protein 4) (Proliferation-inducing protein 6) (Protein highly expressed in testis) (PHET) (Sperm surface protein) (Sperm-associated antigen 9) (Sperm-specific protein) (Sunday driver 1),1321,"146,205",5 out of 5,2006-05-02,Evidence at protein level
Q96N16,JKIP1_HUMAN,Janus kinase and microtubule-interacting protein 1 (GABA-B receptor-binding protein) (Multiple alpha-helices and RNA-linker protein 1) (Marlin-1),626,"73,209",5 out of 5,2008-03-18,Evidence at protein level
Q8TAC2,JOS2_HUMAN,Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2),188,"20,756",4 out of 5,2003-02-28,Evidence at protein level
P17535,JUND_HUMAN,Transcription factor jun-D,347,"35,174",5 out of 5,1990-08-01,Evidence at protein level
Q15053,K0040_HUMAN,Uncharacterized protein KIAA0040,153,"17,035",2 out of 5,1998-07-15,Evidence at protein level
Q6ZU52,K0408_HUMAN,Uncharacterized protein KIAA0408,694,"79,163",2 out of 5,2006-07-25,Evidence at protein level
Q8NCT3,K0895_HUMAN,Uncharacterized protein KIAA0895,520,"60,525",2 out of 5,2008-02-26,Evidence at transcript level
Q8WYB5,KAT6B_HUMAN,"Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)",2073,"231,378",5 out of 5,2005-07-05,Evidence at protein level
Q9NYS0,KBRS1_HUMAN,NF-kappa-B inhibitor-interacting Ras-like protein 1 (I-kappa-B-interacting Ras-like protein 1) (Kappa B-Ras protein 1) (KappaB-Ras1),192,"21,643",4 out of 5,2006-03-07,Evidence at protein level
Q96SI1,KCD15_HUMAN,BTB/POZ domain-containing protein KCTD15 (Potassium channel tetramerization domain-containing protein 15),283,"31,942",4 out of 5,2006-07-25,Evidence at protein level
A0A087WTH5,KCE1B_HUMAN,Potassium voltage-gated channel subfamily E member 1B,132,"15,028",2 out of 5,2016-04-13,Inferred from homology
Q99712,KCJ15_HUMAN,"ATP-sensitive inward rectifier potassium channel 15 (Inward rectifier K(+) channel Kir1.3) (Inward rectifier K(+) channel Kir4.2) (Potassium channel, inwardly rectifying subfamily J member 15)",375,"42,577",5 out of 5,1997-11-01,Evidence at protein level
Q9NPI9,KCJ16_HUMAN,"Inward rectifier potassium channel 16 (Inward rectifier K(+) channel Kir5.1) (Potassium channel, inwardly rectifying subfamily J member 16)",418,"47,949",4 out of 5,2001-04-27,Evidence at protein level
Q86W47,KCMB4_HUMAN,"Calcium-activated potassium channel subunit beta-4 (BK channel subunit beta-4) (BKbeta4) (Hbeta4) (Calcium-activated potassium channel, subfamily M subunit beta-4) (Charybdotoxin receptor subunit beta-4) (K(VCA)beta-4) (Maxi K channel subunit beta-4) (Slo-beta-4)",210,"23,949",5 out of 5,2004-04-13,Evidence at protein level
Q03721,KCNC4_HUMAN,Potassium voltage-gated channel subfamily C member 4 (KSHIIIC) (Voltage-gated potassium channel subunit Kv3.4),635,"69,767",5 out of 5,1998-07-15,Evidence at protein level
Q9UK17,KCND3_HUMAN,Potassium voltage-gated channel subfamily D member 3 (Voltage-gated potassium channel subunit Kv4.3),655,"73,451",5 out of 5,2003-11-07,Evidence at protein level
Q9Y6J6,KCNE2_HUMAN,Potassium voltage-gated channel subfamily E member 2 (MinK-related peptide 1) (Minimum potassium ion channel-related peptide 1) (Potassium channel subunit beta MiRP1),123,"14,472",5 out of 5,2000-05-30,Evidence at protein level
Q12809,KCNH2_HUMAN,Potassium voltage-gated channel subfamily H member 2 (Eag homolog) (Ether-a-go-go-related gene potassium channel 1) (ERG-1) (Eag-related protein 1) (Ether-a-go-go-related protein 1) (H-ERG) (hERG-1) (hERG1) (Voltage-gated potassium channel subunit Kv11.1),1159,"126,655",5 out of 5,2000-05-30,Evidence at protein level
Q9NS40,KCNH7_HUMAN,Potassium voltage-gated channel subfamily H member 7 (Ether-a-go-go-related gene potassium channel 3) (ERG-3) (Eag-related protein 3) (Ether-a-go-go-related protein 3) (hERG-3) (Voltage-gated potassium channel subunit Kv11.3),1196,"135,000",5 out of 5,2002-11-28,Evidence at transcript level
P48048,KCNJ1_HUMAN,"ATP-sensitive inward rectifier potassium channel 1 (ATP-regulated potassium channel ROM-K) (Inward rectifier K(+) channel Kir1.1) (Potassium channel, inwardly rectifying subfamily J member 1)",391,"44,795",5 out of 5,1996-02-01,Evidence at protein level
Q15842,KCNJ8_HUMAN,"ATP-sensitive inward rectifier potassium channel 8 (Inward rectifier K(+) channel Kir6.1) (Potassium channel, inwardly rectifying subfamily J member 8) (uKATP-1)",424,"47,968",5 out of 5,1997-11-01,Evidence at protein level
O95279,KCNK5_HUMAN,Potassium channel subfamily K member 5 (Acid-sensitive potassium channel protein TASK-2) (TWIK-related acid-sensitive K(+) channel 2),499,"55,130",5 out of 5,2001-02-21,Evidence at protein level
O43526,KCNQ2_HUMAN,Potassium voltage-gated channel subfamily KQT member 2 (KQT-like 2) (Neuroblastoma-specific potassium channel subunit alpha KvLQT2) (Voltage-gated potassium channel subunit Kv7.2),872,"95,848",5 out of 5,2001-06-01,Evidence at protein level
Q9NR82,KCNQ5_HUMAN,Potassium voltage-gated channel subfamily KQT member 5 (KQT-like 5) (Potassium channel subunit alpha KvLQT5) (Voltage-gated potassium channel subunit Kv7.5),932,"102,179",5 out of 5,2001-06-01,Evidence at protein level
Q9BQ31,KCNS3_HUMAN,Potassium voltage-gated channel subfamily S member 3 (Delayed-rectifier K(+) channel alpha subunit 3) (Voltage-gated potassium channel subunit Kv9.3),491,"56,001",5 out of 5,2002-10-25,Evidence at protein level
A8MYU2,KCNU1_HUMAN,"Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)",1149,"129,543",5 out of 5,2008-09-02,Evidence at protein level
Q53RY4,KCP3_HUMAN,Keratinocyte-associated protein 3 (KCP-3),240,"25,627",2 out of 5,2006-03-07,Evidence at transcript level
Q8WVF5,KCTD4_HUMAN,BTB/POZ domain-containing protein KCTD4,259,"29,967",2 out of 5,2004-07-19,Evidence at protein level
P0DMQ5,INAM2_HUMAN,Putative transmembrane protein INAFM2 (InaF-motif-containing protein 2) (Osteogenesis up-regulated transcript 1),153,"15,439",2 out of 5,2014-11-26,Evidence at transcript level
P48551,INAR2_HUMAN,Interferon alpha/beta receptor 2 (IFN-R-2) (IFN-alpha binding protein) (IFN-alpha/beta receptor 2) (Interferon alpha binding protein) (Type I interferon receptor 2),515,"57,759",5 out of 5,1996-02-01,Evidence at protein level
Q9H095,IQCG_HUMAN,IQ domain-containing protein G,443,"51,918",5 out of 5,2007-04-03,Evidence at protein level
P10914,IRF1_HUMAN,Interferon regulatory factor 1 (IRF-1),325,"36,502",5 out of 5,1989-07-01,Evidence at protein level
Q13568,IRF5_HUMAN,Interferon regulatory factor 5 (IRF-5),498,"56,044",5 out of 5,1997-11-01,Evidence at protein level
Q92985,IRF7_HUMAN,Interferon regulatory factor 7 (IRF-7),503,"54,278",5 out of 5,1997-11-01,Evidence at protein level
O14654,IRS4_HUMAN,Insulin receptor substrate 4 (IRS-4) (160 kDa phosphotyrosine protein) (py160) (Phosphoprotein of 160 kDa) (pp160),1257,"133,768",5 out of 5,2008-01-15,Evidence at protein level
Q9BZI1,IRX2_HUMAN,Iroquois-class homeodomain protein IRX-2 (Homeodomain protein IRXA2) (Iroquois homeobox protein 2),471,"49,129",2 out of 5,2002-04-16,Evidence at protein level
P05161,ISG15_HUMAN,Ubiquitin-like protein ISG15 (Interferon-induced 15 kDa protein) (Interferon-induced 17 kDa protein) (IP17) (Ubiquitin cross-reactive protein) (hUCRP),165,"17,888",5 out of 5,1987-08-13,Evidence at protein level
Q6UWN8,ISK6_HUMAN,Serine protease inhibitor Kazal-type 6 (Kallikrein inhibitor),80,"8,585",4 out of 5,2005-02-01,Evidence at protein level
O14498,ISLR_HUMAN,Immunoglobulin superfamily containing leucine-rich repeat protein,428,"45,997",3 out of 5,2007-12-04,Evidence at transcript level
P53990,IST1_HUMAN,IST1 homolog (hIST1) (Putative MAPK-activating protein PM28),364,"39,751",5 out of 5,1996-10-01,Evidence at protein level
P17301,ITA2_HUMAN,Integrin alpha-2 (CD49 antigen-like family member B) (Collagen receptor) (Platelet membrane glycoprotein Ia) (GPIa) (VLA-2 subunit alpha) (CD antigen CD49b),1181,"129,295",5 out of 5,1990-08-01,Evidence at protein level
P23229,ITA6_HUMAN,Integrin alpha-6 (CD49 antigen-like family member F) (VLA-6) (CD antigen CD49f) [Cleaved into: Integrin alpha-6 heavy chain; Integrin alpha-6 light chain; Processed integrin alpha-6 (Alpha6p)],1130,"126,606",5 out of 5,1991-11-01,Evidence at protein level
P15884,ITF2_HUMAN,Transcription factor 4 (TCF-4) (Class B basic helix-loop-helix protein 19) (bHLHb19) (Immunoglobulin transcription factor 2) (ITF-2) (SL3-3 enhancer factor 2) (SEF-2),667,"71,308",5 out of 5,1990-04-01,Evidence at protein level
Q9NQX7,ITM2C_HUMAN,Integral membrane protein 2C (Cerebral protein 14) (Transmembrane protein BRI3) [Cleaved into: CT-BRI3],267,"30,224",5 out of 5,2001-01-24,Evidence at protein level
Q14643,ITPR1_HUMAN,"Inositol 1,4,5-trisphosphate receptor type 1 (IP3 receptor isoform 1) (IP3R 1) (InsP3R1) (Type 1 inositol 1,4,5-trisphosphate receptor) (Type 1 InsP3 receptor)",2758,"313,929",5 out of 5,2001-11-02,Evidence at protein level
Q92833,JARD2_HUMAN,Protein Jumonji (Jumonji/ARID domain-containing protein 2),1246,"138,734",5 out of 5,2001-01-11,Evidence at protein level
Q14695,K0087_HUMAN,Uncharacterized protein KIAA0087,138,"14,937",1 out of 5,1998-07-15,Evidence at transcript level
O15063,K0355_HUMAN,Uncharacterized protein KIAA0355,1070,"116,020",2 out of 5,1998-07-15,Evidence at protein level
Q6NSJ0,K1161_HUMAN,Uncharacterized family 31 glucosidase KIAA1161 (EC 3.2.1.-),714,"81,087",4 out of 5,2007-07-24,Evidence at protein level
Q9HCM1,K1551_HUMAN,Uncharacterized protein KIAA1551,1747,"194,857",3 out of 5,2007-07-24,Evidence at protein level
Q5JYT7,K1755_HUMAN,Uncharacterized protein KIAA1755,1200,"130,846",2 out of 5,2008-02-05,Evidence at transcript level
Q8N8K9,K1958_HUMAN,Uncharacterized protein KIAA1958,716,"79,212",4 out of 5,2005-08-16,Evidence at protein level
Q7Z3Y8,K1C27_HUMAN,"Keratin, type I cytoskeletal 27 (Cytokeratin-27) (CK-27) (Keratin-25C) (K25C) (Keratin-27) (K27) (Type I inner root sheath-specific keratin-K25irs3)",459,"49,822",4 out of 5,2007-12-04,Evidence at protein level
Q7Z3Y7,K1C28_HUMAN,"Keratin, type I cytoskeletal 28 (Cytokeratin-28) (CK-28) (Keratin-25D) (K25D) (Keratin-28) (K28) (Type I inner root sheath-specific keratin-K25irs4)",464,"50,567",5 out of 5,2007-12-04,Evidence at protein level
P35527,K1C9_HUMAN,"Keratin, type I cytoskeletal 9 (Cytokeratin-9) (CK-9) (Keratin-9) (K9)",623,"62,064",5 out of 5,1994-06-01,Evidence at protein level
Q5QGS0,K2022_HUMAN,Protein KIAA2022,1516,"167,551",3 out of 5,2006-10-31,Evidence at transcript level
P02538,K2C6A_HUMAN,"Keratin, type II cytoskeletal 6A (Cytokeratin-6A) (CK-6A) (Cytokeratin-6D) (CK-6D) (Keratin-6A) (K6A) (Type-II keratin Kb6) (allergen Hom s 5)",564,"60,045",5 out of 5,1986-07-21,Evidence at protein level
Q8IZA0,K319L_HUMAN,Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR),1049,"115,658",5 out of 5,2008-04-29,Evidence at protein level
Q6NY19,KANK3_HUMAN,KN motif and ankyrin repeat domain-containing protein 3 (Ankyrin repeat domain-containing protein 47),840,"88,425",3 out of 5,2006-06-27,Evidence at protein level
Q9H9L4,KANL2_HUMAN,KAT8 regulatory NSL complex subunit 2 (NSL complex protein NSL2) (Non-specific lethal 2 homolog),492,"55,042",5 out of 5,2007-02-20,Evidence at protein level
P10644,KAP0_HUMAN,"cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher 1) (TSE1) [Cleaved into: cAMP-dependent protein kinase type I-alpha regulatory subunit, N-terminally processed]",381,"42,982",5 out of 5,1989-07-01,Evidence at protein level
P22694,KAPCB_HUMAN,cAMP-dependent protein kinase catalytic subunit beta (PKA C-beta) (EC 2.7.11.11),351,"40,623",5 out of 5,1991-08-01,Evidence at protein level
Q96I82,KAZD1_HUMAN,Kazal-type serine protease inhibitor domain-containing protein 1,304,"32,945",4 out of 5,2005-07-05,Evidence at protein level
Q86Y91,KI18B_HUMAN,Kinesin-like protein KIF18B,864,"94,223",5 out of 5,2008-02-26,Evidence at protein level
Q9UJP4,KLH21_HUMAN,Kelch-like protein 21,597,"66,617",5 out of 5,2001-06-01,Evidence at protein level
Q8N4N3,KLH36_HUMAN,Kelch-like protein 36,616,"69,896",3 out of 5,2007-02-06,Evidence at protein level
Q96E93,KLRG1_HUMAN,Killer cell lectin-like receptor subfamily G member 1 (C-type lectin domain family 15 member A) (ITIM-containing receptor MAFA-L) (MAFA-like receptor) (Mast cell function-associated antigen),195,"21,831",5 out of 5,2008-04-29,Evidence at protein level
Q86Y97,KMT5C_HUMAN,Histone-lysine N-methyltransferase KMT5C (EC 2.1.1.43) (Lysine N-methyltransferase 5C) (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2),462,"52,113",5 out of 5,2007-04-03,Evidence at protein level
Q8NG31,KNL1_HUMAN,Kinetochore scaffold 1 (ALL1-fused gene from chromosome 15q14 protein) (AF15q14) (Bub-linking kinetochore protein) (Blinkin) (Cancer susceptibility candidate gene 5 protein) (Cancer/testis antigen 29) (CT29) (Kinetochore-null protein 1) (Protein CASC5) (Protein D40/AF15q14),2342,"265,391",5 out of 5,2005-05-24,Evidence at protein level
Q15139,KPCD1_HUMAN,Serine/threonine-protein kinase D1 (EC 2.7.11.13) (Protein kinase C mu type) (Protein kinase D) (nPKC-D1) (nPKC-mu),912,"101,704",5 out of 5,1997-11-01,Evidence at protein level
P05129,KPCG_HUMAN,Protein kinase C gamma type (PKC-gamma) (EC 2.7.11.13),697,"78,448",5 out of 5,1987-08-13,Evidence at protein level
O60256,KPRB_HUMAN,Phosphoribosyl pyrophosphate synthase-associated protein 2 (PRPP synthase-associated protein 2) (41 kDa phosphoribosypyrophosphate synthetase-associated protein) (PAP41),369,"40,926",5 out of 5,2002-10-25,Evidence at protein level
P14618,KPYM_HUMAN,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (p58),531,"57,937",5 out of 5,1990-04-01,Evidence at protein level
P60331,KR101_HUMAN,Keratin-associated protein 10-1 (High sulfur keratin-associated protein 10.1) (Keratin-associated protein 10.1) (Keratin-associated protein 18-1) (Keratin-associated protein 18.1),282,"28,660",5 out of 5,2004-02-02,Evidence at transcript level
P60372,KR104_HUMAN,Keratin-associated protein 10-4 (High sulfur keratin-associated protein 10.4) (Keratin-associated protein 10.4) (Keratin-associated protein 18-4) (Keratin-associated protein 18.4),401,"40,429",5 out of 5,2004-02-16,Evidence at protein level
Q3LI72,KR195_HUMAN,Keratin-associated protein 19-5,72,"7,624",4 out of 5,2006-02-21,Evidence at protein level
A1A580,KR231_HUMAN,Keratin-associated protein 23-1,65,"6,892",3 out of 5,2007-06-12,Evidence at protein level
Q6PEX3,KR261_HUMAN,Keratin-associated protein 26-1,210,"22,554",5 out of 5,2006-02-21,Evidence at protein level
Q9BQ66,KR412_HUMAN,Keratin-associated protein 4-12 (Keratin-associated protein 4.12) (Ultrahigh sulfur keratin-associated protein 4.12),201,"21,407",5 out of 5,2003-10-31,Evidence at protein level
Q9BYU5,KRA21_HUMAN,Keratin-associated protein 2-1 (High sulfur keratin-associated protein 2.1) (Keratin-associated protein 2.1),128,"13,514",3 out of 5,2008-04-29,Evidence at transcript level
Q9BYR7,KRA32_HUMAN,Keratin-associated protein 3-2 (High sulfur keratin-associated protein 3.2) (Keratin-associated protein 3.2),98,"10,407",5 out of 5,2003-10-10,Evidence at protein level
Q9BYR6,KRA33_HUMAN,Keratin-associated protein 3-3 (High sulfur keratin-associated protein 3.3) (Keratin-associated protein 3.3),98,"10,365",4 out of 5,2003-10-10,Evidence at protein level
Q9BYQ7,KRA41_HUMAN,Keratin-associated protein 4-1 (Keratin-associated protein 4-10) (Keratin-associated protein 4.1) (Keratin-associated protein 4.10) (Ultrahigh sulfur keratin-associated protein 4.10),146,"15,241",5 out of 5,2003-10-31,Evidence at transcript level
Q9BYR3,KRA44_HUMAN,Keratin-associated protein 4-4 (Keratin-associated protein 4-13) (Keratin-associated protein 4.13) (Keratin-associated protein 4.4) (Ultrahigh sulfur keratin-associated protein 4.13) (Ultrahigh sulfur keratin-associated protein 4.4),166,"18,023",5 out of 5,2003-10-24,Evidence at protein level
Q9BYQ9,KRA48_HUMAN,Keratin-associated protein 4-8 (Keratin-associated protein 4.8) (Ultrahigh sulfur keratin-associated protein 4.8),185,"19,627",5 out of 5,2003-10-31,Evidence at transcript level
Q6L8G8,KRA57_HUMAN,Keratin-associated protein 5-7 (Keratin-associated protein 5-3) (Keratin-associated protein 5.3) (Keratin-associated protein 5.7) (Ultrahigh sulfur keratin-associated protein 5.7),165,"15,150",4 out of 5,2004-12-21,Evidence at transcript level
Q3LI67,KRA63_HUMAN,Keratin-associated protein 6-3,103,"10,409",3 out of 5,2006-02-21,Inferred from homology
Q8IUC3,KRA71_HUMAN,Keratin-associated protein 7-1 (High tyrosine-glycine keratin-associated protein 7.1),87,"9,288",3 out of 5,2003-07-19,Evidence at transcript level
A8MXZ3,KRA91_HUMAN,Keratin-associated protein 9-1,250,"26,333",3 out of 5,2008-04-29,Inferred from homology
Q107X0,KRIP1_HUMAN,Putative protein KRIP1 (Kallikrein-related in prostate protein 1) (Kallikrein-related mRNA protein) (KARMA),134,"14,401",3 out of 5,2008-06-10,Uncertain
O43790,KRT86_HUMAN,"Keratin, type II cuticular Hb6 (Hair keratin K2.11) (Keratin-86) (K86) (Type II hair keratin Hb6) (Type-II keratin Kb26)",486,"53,501",5 out of 5,2004-03-29,Evidence at protein level
Q9UBS0,KS6B2_HUMAN,Ribosomal protein S6 kinase beta-2 (S6K-beta-2) (S6K2) (EC 2.7.11.1) (70 kDa ribosomal protein S6 kinase 2) (P70S6K2) (p70-S6K 2) (S6 kinase-related kinase) (SRK) (Serine/threonine-protein kinase 14B) (p70 ribosomal S6 kinase beta) (S6K-beta) (p70 S6 kinase beta) (p70 S6K-beta) (p70 S6KB) (p70-beta),482,"53,455",5 out of 5,2000-12-01,Evidence at protein level
O76009,KT33A_HUMAN,"Keratin, type I cuticular Ha3-I (Hair keratin, type I Ha3-I) (Keratin-33A) (K33A)",404,"45,940",4 out of 5,2000-05-30,Evidence at transcript level
Q15652,JHD2C_HUMAN,Probable JmjC domain-containing histone demethylation protein 2C (EC 1.14.11.-) (Jumonji domain-containing protein 1C) (Thyroid receptor-interacting protein 8) (TR-interacting protein 8) (TRIP-8),2540,"284,525",5 out of 5,1997-11-01,Evidence at protein level
Q5VZ66,JKIP3_HUMAN,Janus kinase and microtubule-interacting protein 3 (Neuroendocrine long coiled-coil protein 2),844,"98,529",3 out of 5,2008-03-18,Evidence at transcript level
Q7Z7F0,K0907_HUMAN,UPF0469 protein KIAA0907,614,"64,845",3 out of 5,2007-07-24,Evidence at protein level
P59773,K102L_HUMAN,UPF0258 protein KIAA1024-like,190,"21,573",2 out of 5,2003-07-11,Inferred from homology
Q9ULL0,K1210_HUMAN,Uncharacterized protein KIAA1210,1709,"187,021",2 out of 5,2005-09-27,Evidence at transcript level
Q86T90,K1328_HUMAN,Protein hinderin,577,"65,373",3 out of 5,2007-12-04,Evidence at protein level
Q9P260,K1468_HUMAN,LisH domain and HEAT repeat-containing protein KIAA1468,1216,"134,630",2 out of 5,2008-01-15,Evidence at protein level
Q9BY89,K1671_HUMAN,Uncharacterized protein KIAA1671,1806,"196,711",2 out of 5,2007-05-15,Evidence at protein level
P08729,K2C7_HUMAN,"Keratin, type II cytoskeletal 7 (Cytokeratin-7) (CK-7) (Keratin-7) (K7) (Sarcolectin) (Type-II keratin Kb7)",469,"51,386",5 out of 5,1988-08-01,Evidence at protein level
P23352,KALM_HUMAN,Anosmin-1 (Adhesion molecule-like X-linked) (Kallmann syndrome protein),680,"76,112",5 out of 5,1991-11-01,Evidence at protein level
Q5T7N3,KANK4_HUMAN,KN motif and ankyrin repeat domain-containing protein 4 (Ankyrin repeat domain-containing protein 38),995,"107,342",4 out of 5,2006-06-27,Evidence at transcript level
P17612,KAPCA_HUMAN,cAMP-dependent protein kinase catalytic subunit alpha (PKA C-alpha) (EC 2.7.11.11),351,"40,590",5 out of 5,1990-08-01,Evidence at protein level
P22612,KAPCG_HUMAN,cAMP-dependent protein kinase catalytic subunit gamma (PKA C-gamma) (EC 2.7.11.11),351,"40,434",5 out of 5,1991-08-01,Evidence at protein level
Q16773,KAT1_HUMAN,Kynurenine--oxoglutarate transaminase 1 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase) (EC 4.4.1.13) (Glutamine transaminase K) (GTK) (Glutamine--phenylpyruvate transaminase) (EC 2.6.1.64) (Kynurenine aminotransferase 1) (Kynurenine aminotransferase I) (KATI) (Kynurenine--oxoglutarate transaminase I),422,"47,875",5 out of 5,2004-04-13,Evidence at protein level
Q92830,KAT2A_HUMAN,Histone acetyltransferase KAT2A (EC 2.3.1.48) (General control of amino acid synthesis protein 5-like 2) (Histone acetyltransferase GCN5) (HsGCN5) (Lysine acetyltransferase 2A) (STAF97),837,"93,926",5 out of 5,2001-04-27,Evidence at protein level
Q92993,KAT5_HUMAN,Histone acetyltransferase KAT5 (EC 2.3.1.48) (60 kDa Tat-interactive protein) (Tip60) (Histone acetyltransferase HTATIP) (HIV-1 Tat interactive protein) (Lysine acetyltransferase 5) (cPLA(2)-interacting protein),513,"58,582",5 out of 5,1998-07-15,Evidence at protein level
Q16322,KCA10_HUMAN,Potassium voltage-gated channel subfamily A member 10 (Voltage-gated potassium channel subunit Kv1.8),511,"57,785",5 out of 5,2007-10-23,Evidence at protein level
Q14722,KCAB1_HUMAN,Voltage-gated potassium channel subunit beta-1 (EC 1.1.1.-) (K(+) channel subunit beta-1) (Kv-beta-1),419,"46,563",5 out of 5,2001-10-18,Evidence at protein level
Q8IU85,KCC1D_HUMAN,Calcium/calmodulin-dependent protein kinase type 1D (EC 2.7.11.17) (CaM kinase I delta) (CaM kinase ID) (CaM-KI delta) (CaMKI delta) (CaMKID) (CaMKI-like protein kinase) (CKLiK),385,"42,914",5 out of 5,2004-12-07,Evidence at protein level
Q9BQ13,KCD14_HUMAN,BTB/POZ domain-containing protein KCTD14,255,"29,591",2 out of 5,2004-07-19,Evidence at protein level
Q6PIL6,KCIP4_HUMAN,Kv channel-interacting protein 4 (KChIP4) (A-type potassium channel modulatory protein 4) (Calsenilin-like protein) (Potassium channel-interacting protein 4),250,"28,729",5 out of 5,2005-08-16,Evidence at protein level
O60928,KCJ13_HUMAN,"Inward rectifier potassium channel 13 (Inward rectifier K(+) channel Kir7.1) (Potassium channel, inwardly rectifying subfamily J member 13)",360,"40,530",5 out of 5,2001-04-27,Evidence at protein level
Q14003,KCNC3_HUMAN,Potassium voltage-gated channel subfamily C member 3 (KSHIIID) (Voltage-gated potassium channel subunit Kv3.3),757,"80,578",5 out of 5,1998-07-15,Evidence at protein level
Q9UIX4,KCNG1_HUMAN,Potassium voltage-gated channel subfamily G member 1 (Voltage-gated potassium channel subunit Kv6.1) (kH2),513,"57,913",5 out of 5,2002-10-25,Evidence at protein level
P48051,KCNJ6_HUMAN,"G protein-activated inward rectifier potassium channel 2 (GIRK-2) (BIR1) (Inward rectifier K(+) channel Kir3.2) (KATP-2) (Potassium channel, inwardly rectifying subfamily J member 6)",423,"48,451",5 out of 5,1996-02-01,Evidence at protein level
O00180,KCNK1_HUMAN,Potassium channel subfamily K member 1 (Inward rectifying potassium channel protein TWIK-1) (Potassium channel K2P1) (Potassium channel KCNO1),336,"38,143",5 out of 5,2001-02-21,Evidence at protein level
O95069,KCNK2_HUMAN,Potassium channel subfamily K member 2 (Outward rectifying potassium channel protein TREK-1) (TREK-1 K(+) channel subunit) (Two pore domain potassium channel TREK-1) (Two pore potassium channel TPKC1),426,"47,093",5 out of 5,2001-02-21,Evidence at protein level
P57789,KCNKA_HUMAN,Potassium channel subfamily K member 10 (Outward rectifying potassium channel protein TREK-2) (TREK-2 K(+) channel subunit),538,"59,765",5 out of 5,2001-04-27,Evidence at protein level
Q96T55,KCNKG_HUMAN,Potassium channel subfamily K member 16 (2P domain potassium channel Talk-1) (TWIK-related alkaline pH-activated K(+) channel 1) (TALK-1),309,"34,153",5 out of 5,2002-11-01,Evidence at protein level
Q92952,KCNN1_HUMAN,Small conductance calcium-activated potassium channel protein 1 (SK1) (SKCa 1) (SKCa1) (KCa2.1),543,"59,987",4 out of 5,2001-11-16,Evidence at transcript level
Q5JUK3,KCNT1_HUMAN,Potassium channel subfamily T member 1 (KCa4.1),1230,"138,343",5 out of 5,2005-08-30,Evidence at protein level
Q8NAX2,KDF1_HUMAN,Keratinocyte differentiation factor 1,398,"43,642",4 out of 5,2007-05-29,Evidence at transcript level
O60341,KDM1A_HUMAN,Lysine-specific histone demethylase 1A (EC 1.-.-.-) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2),852,"92,903",5 out of 5,2004-08-16,Evidence at protein level
Q8NHM5,KDM2B_HUMAN,Lysine-specific demethylase 2B (EC 1.14.11.27) (CXXC-type zinc finger protein 2) (F-box and leucine-rich repeat protein 10) (F-box protein FBL10) (F-box/LRR-repeat protein 10) (JmjC domain-containing histone demethylation protein 1B) (Jumonji domain-containing EMSY-interactor methyltransferase motif protein) (Protein JEMMA) (Protein-containing CXXC domain 2) ([Histone-H3]-lysine-36 demethylase 1B),1336,"152,615",5 out of 5,2004-08-16,Evidence at protein level
O94953,KDM4B_HUMAN,Lysine-specific demethylase 4B (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3B) (Jumonji domain-containing protein 2B),1096,"121,897",5 out of 5,2004-02-16,Evidence at protein level
Q6B0I6,KDM4D_HUMAN,Lysine-specific demethylase 4D (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3D) (Jumonji domain-containing protein 2D),523,"58,603",5 out of 5,2006-05-16,Evidence at protein level
P29375,KDM5A_HUMAN,Lysine-specific demethylase 5A (EC 1.14.11.-) (Histone demethylase JARID1A) (Jumonji/ARID domain-containing protein 1A) (Retinoblastoma-binding protein 2) (RBBP-2),1690,"192,095",5 out of 5,1992-12-01,Evidence at protein level
O75564,JERKY_HUMAN,Jerky protein homolog,520,"57,402",2 out of 5,2003-01-17,Evidence at protein level
Q9P055,JKAMP_HUMAN,JNK1/MAPK8-associated membrane protein (JKAMP) (JNK1-associated membrane protein) (JAMP) (Medulloblastoma antigen MU-MB-50.4),326,"36,751",4 out of 5,2003-11-07,Evidence at transcript level
Q96AA8,JKIP2_HUMAN,Janus kinase and microtubule-interacting protein 2 (CTCL tumor antigen HD-CL-04) (Neuroendocrine long coiled-coil protein 1),810,"94,934",5 out of 5,2002-01-23,Evidence at protein level
O60303,K0556_HUMAN,Protein KIAA0556,1618,"180,918",5 out of 5,2008-01-15,Evidence at protein level
Q6ICG6,K0930_HUMAN,Uncharacterized protein KIAA0930,404,"45,794",2 out of 5,2006-10-31,Evidence at protein level
Q2LD37,K1109_HUMAN,Uncharacterized protein KIAA1109 (Fragile site-associated protein),5005,"555,482",4 out of 5,2008-02-05,Evidence at protein level
Q9HCI6,K1586_HUMAN,E3 SUMO-protein ligase KIAA1586 (EC 6.3.2.-),787,"89,673",4 out of 5,2008-02-26,Evidence at protein level
Q7Z3Z0,K1C25_HUMAN,"Keratin, type I cytoskeletal 25 (Cytokeratin-25) (CK-25) (Keratin-25) (K25) (Keratin-25A) (K25A) (Type I inner root sheath-specific keratin-K25irs1)",450,"49,318",5 out of 5,2007-12-04,Evidence at protein level
Q6A162,K1C40_HUMAN,"Keratin, type I cytoskeletal 40 (Cytokeratin-40) (CK-40) (Keratin-40) (K40) (Type I hair keratin Ka36)",431,"48,139",5 out of 5,2008-01-15,Evidence at protein level
P12035,K2C3_HUMAN,"Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3)",628,"64,417",5 out of 5,1989-10-01,Evidence at protein level
Q7RTS7,K2C74_HUMAN,"Keratin, type II cytoskeletal 74 (Cytokeratin-74) (CK-74) (Keratin-5c) (K5C) (Keratin-74) (K74) (Type II inner root sheath-specific keratin-K6irs4) (Type-II keratin Kb37)",529,"57,865",5 out of 5,2008-01-15,Evidence at protein level
Q8N1N4,K2C78_HUMAN,"Keratin, type II cytoskeletal 78 (Cytokeratin-78) (CK-78) (Keratin-5b) (Keratin-78) (K78) (Type-II keratin Kb40)",520,"56,866",5 out of 5,2008-01-15,Evidence at transcript level
Q68EN5,K895L_HUMAN,Uncharacterized protein KIAA0895-like,471,"53,446",2 out of 5,2008-02-26,Evidence at transcript level
A0AUZ9,KAL1L_HUMAN,KAT8 regulatory NSL complex subunit 1-like protein (MSL1v2),987,"112,253",3 out of 5,2008-02-26,Evidence at protein level
Q63ZY3,KANK2_HUMAN,KN motif and ankyrin repeat domain-containing protein 2 (Ankyrin repeat domain-containing protein 25) (Matrix-remodeling-associated protein 3) (SRC-1-interacting protein) (SIP) (SRC-interacting protein) (SRC1-interacting protein),851,"91,174",5 out of 5,2006-06-27,Evidence at protein level
P31323,KAP3_HUMAN,cAMP-dependent protein kinase type II-beta regulatory subunit,418,"46,302",5 out of 5,1993-07-01,Evidence at protein level
Q8N6L0,KASH5_HUMAN,Protein KASH5 (Coiled-coil domain-containing protein 155) (KASH domain-containing protein 5),562,"62,783",5 out of 5,2008-04-29,Evidence at protein level
Q92831,KAT2B_HUMAN,Histone acetyltransferase KAT2B (EC 2.3.1.48) (Histone acetyltransferase PCAF) (Histone acetylase PCAF) (Lysine acetyltransferase 2B) (P300/CBP-associated factor) (P/CAF),832,"93,013",5 out of 5,2002-10-19,Evidence at protein level
Q92794,KAT6A_HUMAN,"Histone acetyltransferase KAT6A (EC 2.3.1.48) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 3) (MYST-3) (Monocytic leukemia zinc finger protein) (Runt-related transcription factor-binding protein 2) (Zinc finger protein 220)",2004,"225,028",5 out of 5,1998-07-15,Evidence at protein level
O95251,KAT7_HUMAN,"Histone acetyltransferase KAT7 (EC 2.3.1.48) (Histone acetyltransferase binding to ORC1) (Lysine acetyltransferase 7) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 2) (MYST-2)",611,"70,642",5 out of 5,2005-07-05,Evidence at protein level
Q13303,KCAB2_HUMAN,Voltage-gated potassium channel subunit beta-2 (EC 1.1.1.-) (K(+) channel subunit beta-2) (Kv-beta-2) (hKvbeta2),367,"41,000",5 out of 5,2001-10-18,Evidence at protein level
O43448,KCAB3_HUMAN,Voltage-gated potassium channel subunit beta-3 (K(+) channel subunit beta-3) (Kv-beta-3),404,"43,670",4 out of 5,2001-10-18,Evidence at transcript level
Q13555,KCC2G_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit gamma (CaM kinase II subunit gamma) (CaMK-II subunit gamma) (EC 2.7.11.17),558,"62,609",5 out of 5,1997-11-01,Evidence at protein level
P48547,KCNC1_HUMAN,Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4),511,"57,942",5 out of 5,1996-02-01,Evidence at protein level
Q96PR1,KCNC2_HUMAN,Potassium voltage-gated channel subfamily C member 2 (Shaw-like potassium channel) (Voltage-gated potassium channel Kv3.2),638,"70,226",5 out of 5,2007-11-13,Evidence at protein level
Q9NSA2,KCND1_HUMAN,Potassium voltage-gated channel subfamily D member 1 (Voltage-gated potassium channel subunit Kv4.1),647,"71,330",5 out of 5,2003-11-07,Evidence at protein level
P15382,KCNE1_HUMAN,Potassium voltage-gated channel subfamily E member 1 (Delayed rectifier potassium channel subunit IsK) (IKs producing slow voltage-gated potassium channel subunit beta Mink) (Minimal potassium channel),129,"14,675",5 out of 5,1990-04-01,Evidence at protein level
Q9UJ90,KCNE5_HUMAN,Potassium voltage-gated channel subfamily E regulatory beta subunit 5 (AMME syndrome candidate gene 2 protein) (Potassium channel subunit beta MiRP4) (Potassium voltage-gated channel subfamily E member 1-like protein),142,"14,993",5 out of 5,2002-12-13,Evidence at protein level
Q9UJ96,KCNG2_HUMAN,Potassium voltage-gated channel subfamily G member 2 (Cardiac potassium channel subunit) (Voltage-gated potassium channel subunit Kv6.2),466,"51,240",5 out of 5,2002-10-25,Evidence at protein level
Q96L42,KCNH8_HUMAN,Potassium voltage-gated channel subfamily H member 8 (ELK1) (hElk1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Voltage-gated potassium channel subunit Kv12.1),1107,"123,804",5 out of 5,2002-11-28,Evidence at transcript level
Q9Y257,KCNK6_HUMAN,Potassium channel subfamily K member 6 (Inward rectifying potassium channel protein TWIK-2) (TWIK-originated similarity sequence),313,"33,747",5 out of 5,2001-02-21,Evidence at protein level
Q9HB14,KCNKD_HUMAN,Potassium channel subfamily K member 13 (Tandem pore domain halothane-inhibited potassium channel 1) (THIK-1),408,"45,391",3 out of 5,2002-11-01,Evidence at transcript level
Q9UGI6,KCNN3_HUMAN,Small conductance calcium-activated potassium channel protein 3 (SK3) (SKCa 3) (SKCa3) (KCa2.3),736,"82,026",5 out of 5,2001-11-16,Evidence at transcript level
Q719H9,KCTD1_HUMAN,BTB/POZ domain-containing protein KCTD1 (Potassium channel tetramerization domain-containing protein 1),257,"29,405",5 out of 5,2006-07-25,Evidence at protein level
Q9Y2K7,KDM2A_HUMAN,Lysine-specific demethylase 2A (EC 1.14.11.27) (CXXC-type zinc finger protein 8) (F-box and leucine-rich repeat protein 11) (F-box protein FBL7) (F-box protein Lilina) (F-box/LRR-repeat protein 11) (JmjC domain-containing histone demethylation protein 1A) ([Histone-H3]-lysine-36 demethylase 1A),1162,"132,793",5 out of 5,2003-11-07,Evidence at protein level
Q63HM1,KFA_HUMAN,Kynurenine formamidase (KFA) (KFase) (EC 3.5.1.9) (Arylformamidase) (N-formylkynurenine formamidase) (FKF),303,"33,992",4 out of 5,2006-09-05,Evidence at transcript level
Q8WXH2,JPH3_HUMAN,Junctophilin-3 (JP-3) (Junctophilin type 3) (Trinucleotide repeat-containing gene 22 protein),748,"81,469",5 out of 5,2003-01-17,Evidence at transcript level
Q86T24,KAISO_HUMAN,Transcriptional regulator Kaiso (Zinc finger and BTB domain-containing protein 33),672,"74,484",5 out of 5,2005-12-20,Evidence at protein level
O60229,KALRN_HUMAN,Kalirin (EC 2.7.11.1) (Huntingtin-associated protein-interacting protein) (Protein Duo) (Serine/threonine-protein kinase with Dbl- and pleckstrin homology domain),2985,"340,174",5 out of 5,2000-12-01,Evidence at protein level
Q9P2N6,KANL3_HUMAN,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD),904,"95,992",5 out of 5,2007-05-15,Evidence at protein level
P13861,KAP2_HUMAN,cAMP-dependent protein kinase type II-alpha regulatory subunit,404,"45,518",5 out of 5,1990-01-01,Evidence at protein level
Q8NAB2,KBTB3_HUMAN,Kelch repeat and BTB domain-containing protein 3 (BTB and kelch domain-containing protein 3),608,"69,395",2 out of 5,2003-09-19,Evidence at transcript level
Q86V97,KBTB6_HUMAN,Kelch repeat and BTB domain-containing protein 6,674,"76,138",3 out of 5,2004-03-15,Evidence at protein level
C9JR72,KBTBD_HUMAN,Kelch repeat and BTB domain-containing protein 13,458,"49,485",4 out of 5,2010-05-18,Evidence at protein level
Q68DU8,KCD16_HUMAN,BTB/POZ domain-containing protein KCTD16 (Potassium channel tetramerization domain-containing protein 16),428,"49,138",3 out of 5,2006-09-05,Evidence at protein level
Q17RG1,KCD19_HUMAN,BTB/POZ domain-containing protein KCTD19,926,"104,938",2 out of 5,2008-01-15,Evidence at transcript level
Q9NS61,KCIP2_HUMAN,Kv channel-interacting protein 2 (KChIP2) (A-type potassium channel modulatory protein 2) (Cardiac voltage-gated potassium channel modulatory subunit) (Potassium channel-interacting protein 2),270,"30,907",5 out of 5,2005-08-16,Evidence at protein level
P78508,KCJ10_HUMAN,"ATP-sensitive inward rectifier potassium channel 10 (ATP-dependent inwardly rectifying potassium channel Kir4.1) (Inward rectifier K(+) channel Kir1.2) (Potassium channel, inwardly rectifying subfamily J member 10)",379,"42,508",5 out of 5,1997-11-01,Evidence at protein level
Q14654,KCJ11_HUMAN,"ATP-sensitive inward rectifier potassium channel 11 (IKATP) (Inward rectifier K(+) channel Kir6.2) (Potassium channel, inwardly rectifying subfamily J member 11)",390,"43,541",5 out of 5,1997-11-01,Evidence at protein level
Q9Y691,KCMB2_HUMAN,"Calcium-activated potassium channel subunit beta-2 (BK channel subunit beta-2) (BKbeta2) (Hbeta2) (Calcium-activated potassium channel, subfamily M subunit beta-2) (Charybdotoxin receptor subunit beta-2) (Hbeta3) (K(VCA)beta-2) (Maxi K channel subunit beta-2) (Slo-beta-2)",235,"27,130",5 out of 5,2004-04-13,Evidence at protein level
P16389,KCNA2_HUMAN,Potassium voltage-gated channel subfamily A member 2 (NGK1) (Voltage-gated K(+) channel HuKIV) (Voltage-gated potassium channel HBK5) (Voltage-gated potassium channel subunit Kv1.2),499,"56,717",5 out of 5,1990-08-01,Evidence at protein level
P22459,KCNA4_HUMAN,Potassium voltage-gated channel subfamily A member 4 (HPCN2) (Voltage-gated K(+) channel HuKII) (Voltage-gated potassium channel HBK4) (Voltage-gated potassium channel HK1) (Voltage-gated potassium channel subunit Kv1.4),653,"73,257",5 out of 5,1991-08-01,Evidence at protein level
Q9H3M0,KCNF1_HUMAN,Potassium voltage-gated channel subfamily F member 1 (Voltage-gated potassium channel subunit Kv5.1) (kH1),494,"55,584",4 out of 5,2002-10-25,Evidence at protein level
Q8TAE7,KCNG3_HUMAN,Potassium voltage-gated channel subfamily G member 3 (Voltage-gated potassium channel subunit Kv10.1) (Voltage-gated potassium channel subunit Kv6.3),436,"49,593",5 out of 5,2002-10-25,Evidence at protein level
O95259,KCNH1_HUMAN,Potassium voltage-gated channel subfamily H member 1 (Ether-a-go-go potassium channel 1) (EAG channel 1) (h-eag) (hEAG1) (Voltage-gated potassium channel subunit Kv10.1),989,"111,423",5 out of 5,2002-11-28,Evidence at protein level
Q9UQ05,KCNH4_HUMAN,Potassium voltage-gated channel subfamily H member 4 (Brain-specific eag-like channel 2) (BEC2) (Ether-a-go-go-like potassium channel 1) (ELK channel 1) (ELK1) (Voltage-gated potassium channel subunit Kv12.3),1017,"111,693",5 out of 5,2002-11-28,Evidence at transcript level
Q8NCM2,KCNH5_HUMAN,Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2) (hEAG2) (Voltage-gated potassium channel subunit Kv10.2),988,"111,877",5 out of 5,2002-11-28,Evidence at protein level
P48544,KCNJ5_HUMAN,"G protein-activated inward rectifier potassium channel 4 (GIRK-4) (Cardiac inward rectifier) (CIR) (Heart KATP channel) (Inward rectifier K(+) channel Kir3.4) (IRK-4) (KATP-1) (Potassium channel, inwardly rectifying subfamily J member 5)",419,"47,668",5 out of 5,1996-02-01,Evidence at protein level
Q92806,KCNJ9_HUMAN,"G protein-activated inward rectifier potassium channel 3 (GIRK-3) (Inward rectifier K(+) channel Kir3.3) (Potassium channel, inwardly rectifying subfamily J member 9)",393,"44,020",4 out of 5,1997-11-01,Evidence at transcript level
O43525,KCNQ3_HUMAN,Potassium voltage-gated channel subfamily KQT member 3 (KQT-like 3) (Potassium channel subunit alpha KvLQT3) (Voltage-gated potassium channel subunit Kv7.3),872,"96,742",5 out of 5,1999-07-15,Evidence at protein level
Q6UVM3,KCNT2_HUMAN,Potassium channel subfamily T member 2 (Sequence like an intermediate conductance potassium channel subunit) (Sodium and chloride-activated ATP-sensitive potassium channel Slo2.1),1135,"130,501",5 out of 5,2007-12-04,Evidence at protein level
P12532,KCRU_HUMAN,"Creatine kinase U-type, mitochondrial (EC 2.7.3.2) (Acidic-type mitochondrial creatine kinase) (Mia-CK) (Ubiquitous mitochondrial creatine kinase) (U-MtCK)",417,"47,037",5 out of 5,1989-10-01,Evidence at protein level
P30085,KCY_HUMAN,UMP-CMP kinase (EC 2.7.4.14) (Deoxycytidylate kinase) (CK) (dCMP kinase) (Nucleoside-diphosphate kinase) (EC 2.7.4.6) (Uridine monophosphate/cytidine monophosphate kinase) (UMP/CMP kinase) (UMP/CMPK),196,"22,222",5 out of 5,1993-04-01,Evidence at protein level
Q6UW63,KDEL1_HUMAN,KDEL motif-containing protein 1 (Endoplasmic reticulum resident protein 58) (ER protein 58) (ERp58),502,"58,043",3 out of 5,2006-07-25,Evidence at protein level
Q9ULH0,KDIS_HUMAN,Kinase D-interacting substrate of 220 kDa (Ankyrin repeat-rich membrane-spanning protein),1771,"196,542",5 out of 5,2008-02-26,Evidence at protein level
Q8NB78,KDM1B_HUMAN,Lysine-specific histone demethylase 1B (EC 1.-.-.-) (Flavin-containing amine oxidase domain-containing protein 1) (Lysine-specific histone demethylase 2),822,"92,098",5 out of 5,2006-07-25,Evidence at protein level
Q9H3R0,KDM4C_HUMAN,Lysine-specific demethylase 4C (EC 1.14.11.-) (Gene amplified in squamous cell carcinoma 1 protein) (GASC-1 protein) (JmjC domain-containing histone demethylation protein 3C) (Jumonji domain-containing protein 2C),1056,"119,982",5 out of 5,2004-02-16,Evidence at protein level
Q9BY66,KDM5D_HUMAN,Lysine-specific demethylase 5D (EC 1.14.11.-) (Histocompatibility Y antigen) (H-Y) (Histone demethylase JARID1D) (Jumonji/ARID domain-containing protein 1D) (Protein SmcY),1539,"174,073",5 out of 5,2001-10-24,Evidence at protein level
Q14145,KEAP1_HUMAN,Kelch-like ECH-associated protein 1 (Cytosolic inhibitor of Nrf2) (INrf2) (Kelch-like protein 19),624,"69,666",5 out of 5,2001-04-27,Evidence at protein level
P43627,KI2L2_HUMAN,Killer cell immunoglobulin-like receptor 2DL2 (CD158 antigen-like family member B1) (MHC class I NK cell receptor) (Natural killer-associated transcript 6) (NKAT-6) (p58 natural killer cell receptor clone CL-43) (p58 NK receptor CL-43) (CD antigen CD158b1),348,"38,472",5 out of 5,1995-11-01,Evidence at protein level
Q8N109,KI2LA_HUMAN,Killer cell immunoglobulin-like receptor 2DL5A (CD antigen CD158f1),375,"40,678",4 out of 5,2007-09-11,Inferred from homology
Q14952,KI2S3_HUMAN,Killer cell immunoglobulin-like receptor 2DS3 (MHC class I NK cell receptor) (Natural killer-associated transcript 7) (NKAT-7),304,"33,717",3 out of 5,1997-11-01,Evidence at transcript level
P43632,KI2S4_HUMAN,Killer cell immunoglobulin-like receptor 2DS4 (CD158 antigen-like family member I) (MHC class I NK cell receptor) (Natural killer-associated transcript 8) (NKAT-8) (P58 natural killer cell receptor clones CL-39/CL-17) (p58 NK receptor CL-39/CL-17) (CD antigen CD158i),304,"33,583",5 out of 5,1995-11-01,Evidence at protein level
Q8N743,KI3L3_HUMAN,Killer cell immunoglobulin-like receptor 3DL3 (CD158 antigen-like family member Z) (Killer cell inhibitory receptor 1) (CD antigen CD158z),410,"44,928",5 out of 5,2004-04-26,Evidence at transcript level
Q9Y6Z4,KIAS1_HUMAN,Putative uncharacterized protein KIF25-AS1 (KIF25 antisense RNA 1) (KIF25 antisense gene protein 1) (Protein HGC6.1),181,"19,411",2 out of 5,2003-05-09,Uncertain
Q96FN5,KIF12_HUMAN,Kinesin-like protein KIF12,646,"70,660",3 out of 5,2003-07-11,Evidence at protein level
Q9P2E2,KIF17_HUMAN,Kinesin-like protein KIF17 (KIF3-related motor protein),1029,"115,068",5 out of 5,2002-09-19,Evidence at transcript level
Q9UIL4,KIF25_HUMAN,Kinesin-like protein KIF25 (Kinesin-like protein 3),384,"40,686",4 out of 5,2002-01-23,Evidence at transcript level
Q9BW19,KIFC1_HUMAN,Kinesin-like protein KIFC1 (Kinesin-like protein 2) (Kinesin-related protein HSET),673,"73,748",5 out of 5,2002-01-23,Evidence at protein level
B2CW77,KILIN_HUMAN,Killin,178,"19,958",4 out of 5,2008-09-02,Evidence at protein level
Q03426,KIME_HUMAN,Mevalonate kinase (MK) (EC 2.7.1.36),396,"42,451",5 out of 5,1993-10-01,Evidence at protein level
Q96J84,KIRR1_HUMAN,Kin of IRRE-like protein 1 (Kin of irregular chiasm-like protein 1) (Nephrin-like protein 1),757,"83,536",5 out of 5,2004-10-11,Evidence at protein level
Q8IZU9,KIRR3_HUMAN,Kin of IRRE-like protein 3 (Kin of irregular chiasm-like protein 3) (Nephrin-like protein 2) [Cleaved into: Processed kin of IRRE-like protein 3],778,"85,255",5 out of 5,2004-10-25,Evidence at protein level
P04183,KITH_HUMAN,"Thymidine kinase, cytosolic (EC 2.7.1.21)",234,"25,469",5 out of 5,1987-03-20,Evidence at protein level
O00142,KITM_HUMAN,"Thymidine kinase 2, mitochondrial (EC 2.7.1.21) (Mt-TK)",265,"31,005",5 out of 5,1997-11-01,Evidence at protein level
A0A0A0MT89,KJ01_HUMAN,Immunoglobulin kappa joining 1,13,"1,505",2 out of 5,2017-03-15,Predicted
Q8IXV7,KLD8B_HUMAN,Kelch domain-containing protein 8B,354,"37,676",3 out of 5,2005-12-20,Evidence at transcript level
Q13886,KLF9_HUMAN,Krueppel-like factor 9 (Basic transcription element-binding protein 1) (BTE-binding protein 1) (GC-box-binding protein 1) (Transcription factor BTEB1),244,"27,235",5 out of 5,1998-12-15,Evidence at protein level
Q53HC5,KLH26_HUMAN,Kelch-like protein 26,615,"68,139",2 out of 5,2006-06-27,Evidence at protein level
Q96CT2,KLH29_HUMAN,Kelch-like protein 29 (Kelch repeat and BTB domain-containing protein 9),875,"94,228",3 out of 5,2004-05-24,Evidence at transcript level
A6NCF5,KLH33_HUMAN,Kelch-like protein 33,533,"57,810",2 out of 5,2008-03-18,Predicted
Q2WGJ6,KLH38_HUMAN,Kelch-like protein 38,581,"65,541",5 out of 5,2008-03-18,Evidence at protein level
Q9P2G9,KLHL8_HUMAN,Kelch-like protein 8,620,"68,802",5 out of 5,2003-02-12,Evidence at protein level
Q9UKQ9,KLK9_HUMAN,Kallikrein-9 (EC 3.4.21.-) (Kallikrein-like protein 3) (KLK-L3),250,"27,513",3 out of 5,2000-12-01,Evidence at transcript level
Q86Z14,KLOTB_HUMAN,Beta-klotho (BKL) (BetaKlotho) (Klotho beta-like protein),1044,"119,808",5 out of 5,2005-10-11,Evidence at protein level
Q9UEF7,KLOT_HUMAN,Klotho (EC 3.2.1.31) [Cleaved into: Klotho peptide],1012,"116,181",5 out of 5,2005-10-11,Evidence at protein level
Q9NZS2,KLRF1_HUMAN,Killer cell lectin-like receptor subfamily F member 1 (Lectin-like receptor F1) (Activating coreceptor NKp80) (C-type lectin domain family 5 member C),232,"26,666",5 out of 5,2004-05-24,Evidence at protein level
Q9BYQ5,KRA46_HUMAN,Keratin-associated protein 4-6 (Keratin-associated protein 4-15) (Keratin-associated protein 4.15) (Keratin-associated protein 4.6) (Ultrahigh sulfur keratin-associated protein 4.15),205,"21,825",5 out of 5,2003-10-31,Evidence at transcript level
Q9BYQ0,KRA98_HUMAN,Keratin-associated protein 9-8 (Keratin-associated protein 9.8) (Ultrahigh sulfur keratin-associated protein 9.8),159,"16,723",5 out of 5,2003-11-14,Evidence at protein level
Q92613,JADE3_HUMAN,Protein Jade-3 (Jade family PHD finger protein 3) (PHD finger protein 16),823,"93,808",5 out of 5,2003-08-15,Evidence at protein level
Q9Y219,JAG2_HUMAN,Protein jagged-2 (Jagged2) (hJ2),1238,"133,367",5 out of 5,2002-03-27,Evidence at protein level
Q96S16,JMJD8_HUMAN,JmjC domain-containing protein 8 (Jumonji domain-containing protein 8),334,"36,870",2 out of 5,2008-07-22,Evidence at transcript level
Q8N9B5,JMY_HUMAN,Junction-mediating and -regulatory protein,988,"111,445",5 out of 5,2008-03-18,Evidence at protein level
Q9HDC5,JPH1_HUMAN,Junctophilin-1 (JP-1) (Junctophilin type 1),661,"71,686",5 out of 5,2003-01-17,Evidence at protein level
Q96MG2,JSPR1_HUMAN,Junctional sarcoplasmic reticulum protein 1 (Junctional-face membrane protein of 45 kDa homolog) (JP-45),331,"36,319",3 out of 5,2008-01-15,Evidence at protein level
P17275,JUNB_HUMAN,Transcription factor jun-B,347,"35,879",5 out of 5,1990-08-01,Evidence at protein level
A8MWY0,K132L_HUMAN,UPF0577 protein KIAA1324-like (Estrogen-induced gene 121-like protein) (hEIG121L),1029,"113,842",3 out of 5,2008-05-20,Evidence at protein level
Q6ZVL6,K154L_HUMAN,UPF0606 protein KIAA1549L,1849,"198,999",2 out of 5,2007-02-06,Evidence at transcript level
Q5VZ46,K1614_HUMAN,Uncharacterized protein KIAA1614,1190,"126,604",2 out of 5,2008-01-15,Evidence at transcript level
P08727,K1C19_HUMAN,"Keratin, type I cytoskeletal 19 (Cytokeratin-19) (CK-19) (Keratin-19) (K19)",400,"44,106",5 out of 5,1988-08-01,Evidence at protein level
Q15323,K1H1_HUMAN,"Keratin, type I cuticular Ha1 (Hair keratin, type I Ha1) (Keratin-31) (K31)",416,"47,237",5 out of 5,1998-07-15,Evidence at protein level
Q0VF49,K2012_HUMAN,Uncharacterized protein KIAA2012,1180,"135,305",2 out of 5,2008-04-29,Evidence at transcript level
Q3SY84,K2C71_HUMAN,"Keratin, type II cytoskeletal 71 (Cytokeratin-71) (CK-71) (Keratin-71) (K71) (Type II inner root sheath-specific keratin-K6irs1) (Keratin 6 irs) (hK6irs) (hK6irs1) (Type-II keratin Kb34)",523,"57,292",5 out of 5,2008-01-15,Evidence at protein level
Q9UBP8,KAAG1_HUMAN,Kidney-associated antigen 1 (RU2 antisense gene protein),84,"8,969",2 out of 5,2007-02-06,Evidence at transcript level
P27144,KAD4_HUMAN,"Adenylate kinase 4, mitochondrial (AK 4) (EC 2.7.4.10) (EC 2.7.4.6) (Adenylate kinase 3-like) (GTP:AMP phosphotransferase AK4)",223,"25,268",5 out of 5,1992-08-01,Evidence at protein level
Q9Y3D8,KAD6_HUMAN,Adenylate kinase isoenzyme 6 (AK6) (EC 2.7.4.3) (Adrenal gland protein AD-004) (Coilin-interacting nuclear ATPase protein) (hCINAP) (Dual activity adenylate kinase/ATPase) (AK/ATPase),172,"20,061",5 out of 5,2000-05-30,Evidence at protein level
Q96M32,KAD7_HUMAN,Adenylate kinase 7 (AK 7) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 7),723,"82,658",5 out of 5,2003-10-03,Evidence at protein level
Q96MA6,KAD8_HUMAN,Adenylate kinase 8 (AK 8) (EC 2.7.4.3) (EC 2.7.4.6) (ATP-AMP transphosphorylase 8),479,"54,926",5 out of 5,2007-03-06,Evidence at protein level
Q9BW62,KATL1_HUMAN,Katanin p60 ATPase-containing subunit A-like 1 (Katanin p60 subunit A-like 1) (EC 3.6.4.3) (p60 katanin-like 1),490,"55,392",5 out of 5,2005-03-01,Evidence at protein level
Q96EK5,KBP_HUMAN,KIF1-binding protein,621,"71,814",5 out of 5,2005-08-30,Evidence at protein level
Q8WVZ9,KBTB7_HUMAN,Kelch repeat and BTB domain-containing protein 7,684,"77,163",3 out of 5,2004-03-15,Evidence at protein level
P48730,KC1D_HUMAN,Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26),415,"47,330",5 out of 5,1996-02-01,Evidence at protein level
Q9HCP0,KC1G1_HUMAN,Casein kinase I isoform gamma-1 (CKI-gamma 1) (EC 2.7.11.1),422,"48,511",5 out of 5,2001-10-18,Evidence at protein level
Q9UQM7,KCC2A_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit alpha (CaM kinase II subunit alpha) (CaMK-II subunit alpha) (EC 2.7.11.17),478,"54,088",5 out of 5,2002-04-16,Evidence at protein level
Q13557,KCC2D_HUMAN,Calcium/calmodulin-dependent protein kinase type II subunit delta (CaM kinase II subunit delta) (CaMK-II subunit delta) (EC 2.7.11.17),499,"56,369",5 out of 5,1997-11-01,Evidence at protein level
Q9P0J7,KCMF1_HUMAN,E3 ubiquitin-protein ligase KCMF1 (EC 2.3.2.27) (FGF-induced in gastric cancer) (Potassium channel modulatory factor) (PCMF) (RING-type E3 ubiquitin transferase KCMF1) (ZZ-type zinc finger-containing protein 1),381,"41,945",5 out of 5,2008-09-02,Evidence at protein level
Q09470,KCNA1_HUMAN,Potassium voltage-gated channel subfamily A member 1 (Voltage-gated K(+) channel HuKI) (Voltage-gated potassium channel HBK1) (Voltage-gated potassium channel subunit Kv1.1),495,"56,466",5 out of 5,1995-11-01,Evidence at protein level
Q8WWG9,KCNE4_HUMAN,Potassium voltage-gated channel subfamily E member 4 (MinK-related peptide 3) (Minimum potassium ion channel-related peptide 3) (Potassium channel subunit beta MiRP3),221,"23,806",4 out of 5,2002-11-28,Evidence at protein level
P48549,KCNJ3_HUMAN,"G protein-activated inward rectifier potassium channel 1 (GIRK-1) (Inward rectifier K(+) channel Kir3.1) (Potassium channel, inwardly rectifying subfamily J member 3)",501,"56,603",5 out of 5,1996-02-01,Evidence at protein level
O15054,KDM6B_HUMAN,Lysine-specific demethylase 6B (EC 1.14.11.-) (JmjC domain-containing protein 3) (Jumonji domain-containing protein 3) (Lysine demethylase 6B),1643,"176,632",5 out of 5,2007-06-26,Evidence at protein level
Q06136,KDSR_HUMAN,3-ketodihydrosphingosine reductase (KDS reductase) (EC 1.1.1.102) (3-dehydrosphinganine reductase) (Follicular variant translocation protein 1) (FVT-1) (Short chain dehydrogenase/reductase family 35C member 1),332,"36,187",5 out of 5,1994-06-01,Evidence at protein level
Q13237,KGP2_HUMAN,cGMP-dependent protein kinase 2 (cGK 2) (cGK2) (EC 2.7.11.12) (cGMP-dependent protein kinase II) (cGKII),762,"87,432",5 out of 5,2000-05-30,Evidence at protein level
O95235,KI20A_HUMAN,Kinesin-like protein KIF20A (GG10_2) (Mitotic kinesin-like protein 2) (MKlp2) (Rab6-interacting kinesin-like protein) (Rabkinesin-6),890,"100,278",5 out of 5,2000-05-30,Evidence at protein level
Q2TAC6,KIF19_HUMAN,Kinesin-like protein KIF19,998,"111,332",4 out of 5,2007-02-20,Evidence at transcript level
Q12756,KIF1A_HUMAN,Kinesin-like protein KIF1A (Axonal transporter of synaptic vesicles) (Microtubule-based motor KIF1A) (Unc-104- and KIF1A-related protein) (hUnc-104),1690,"191,064",5 out of 5,1997-11-01,Evidence at protein level
O43896,KIF1C_HUMAN,Kinesin-like protein KIF1C,1103,"122,947",5 out of 5,1998-12-15,Evidence at protein level
Q9H0B6,KLC2_HUMAN,Kinesin light chain 2 (KLC 2),622,"68,935",5 out of 5,2001-04-27,Evidence at protein level
Q96G42,KLD7B_HUMAN,Kelch domain-containing protein 7B,594,"63,314",2 out of 5,2006-03-21,Evidence at transcript level
Q9BXK1,KLF16_HUMAN,Krueppel-like factor 16 (Basic transcription element-binding protein 4) (BTE-binding protein 4) (Novel Sp1-like zinc finger transcription factor 2) (Transcription factor BTEB4) (Transcription factor NSLP2),252,"25,431",3 out of 5,2001-11-02,Evidence at protein level
O95600,KLF8_HUMAN,Krueppel-like factor 8 (Basic krueppel-like factor 3) (Zinc finger protein 741),359,"39,314",5 out of 5,2001-11-02,Evidence at protein level
Q96M94,KLH15_HUMAN,Kelch-like protein 15,604,"69,775",5 out of 5,2006-02-21,Evidence at protein level
Q9NR64,KLHL1_HUMAN,Kelch-like protein 1,748,"82,680",4 out of 5,2001-04-27,Evidence at transcript level
Q9UH77,KLHL3_HUMAN,Kelch-like protein 3,587,"64,970",5 out of 5,2001-04-27,Evidence at protein level
Q9P2J3,KLHL9_HUMAN,Kelch-like protein 9,617,"69,429",4 out of 5,2001-04-27,Evidence at protein level
O00410,IPO5_HUMAN,Importin-5 (Imp5) (Importin subunit beta-3) (Karyopherin beta-3) (Ran-binding protein 5) (RanBP5),1097,"123,630",5 out of 5,1997-11-01,Evidence at protein level
A6NCM1,IQCAL_HUMAN,IQ and AAA domain-containing protein 1-like (IQ and AAA domain-containing protein 1 pseudogene 1),817,"94,931",2 out of 5,2008-06-10,Inferred from homology
Q8IXL9,IQCF2_HUMAN,IQ domain-containing protein F2,164,"19,627",2 out of 5,2007-04-03,Evidence at protein level
O43187,IRAK2_HUMAN,Interleukin-1 receptor-associated kinase-like 2 (IRAK-2),625,"69,433",5 out of 5,2001-01-11,Evidence at protein level
P61371,ISL1_HUMAN,Insulin gene enhancer protein ISL-1 (Islet-1),349,"39,036",5 out of 5,2004-05-24,Evidence at protein level
Q6UXK2,ISLR2_HUMAN,Immunoglobulin superfamily containing leucine-rich repeat protein 2 (Leucine-rich repeat domain and immunoglobulin domain-containing axon extension protein),745,"78,990",4 out of 5,2008-02-05,Evidence at transcript level
Q9H9V9,JMJD4_HUMAN,JmjC domain-containing protein 4 (Jumonji domain-containing protein 4),463,"52,493",3 out of 5,2007-06-26,Evidence at protein level
P0C870,JMJD7_HUMAN,JmjC domain-containing protein 7 (Jumonji domain-containing protein 7),316,"35,932",2 out of 5,2008-09-02,Evidence at protein level
Q9BR39,JPH2_HUMAN,Junctophilin-2 (JP-2) (Junctophilin type 2),696,"74,222",5 out of 5,2003-01-17,Evidence at protein level
Q96JJ6,JPH4_HUMAN,Junctophilin-4 (JP-4) (Junctophilin-like 1 protein),628,"65,861",4 out of 5,2003-09-09,Evidence at transcript level
Q9UPX6,K1024_HUMAN,UPF0258 protein KIAA1024,916,"102,993",2 out of 5,2003-07-11,Evidence at transcript level
Q99456,K1C12_HUMAN,"Keratin, type I cytoskeletal 12 (Cytokeratin-12) (CK-12) (Keratin-12) (K12)",494,"53,511",5 out of 5,1997-11-01,Evidence at protein level
Q04695,K1C17_HUMAN,"Keratin, type I cytoskeletal 17 (39.1) (Cytokeratin-17) (CK-17) (Keratin-17) (K17)",432,"48,106",5 out of 5,1994-06-01,Evidence at protein level
Q8IYS2,K2013_HUMAN,Uncharacterized protein KIAA2013,634,"69,157",3 out of 5,2007-07-10,Evidence at protein level
Q5HYC2,K2026_HUMAN,Uncharacterized protein KIAA2026,2103,"228,087",2 out of 5,2007-05-29,Evidence at transcript level
P04264,K2C1_HUMAN,"Keratin, type II cytoskeletal 1 (67 kDa cytokeratin) (Cytokeratin-1) (CK-1) (Hair alpha protein) (Keratin-1) (K1) (Type-II keratin Kb1)",644,"66,039",5 out of 5,1987-03-20,Evidence at protein level
P48668,K2C6C_HUMAN,"Keratin, type II cytoskeletal 6C (Cytokeratin-6C) (CK-6C) (Cytokeratin-6E) (CK-6E) (Keratin K6h) (Keratin-6C) (K6C) (Type-II keratin Kb12)",564,"60,025",5 out of 5,1996-02-01,Evidence at protein level
Q86Y46,K2C73_HUMAN,"Keratin, type II cytoskeletal 73 (Cytokeratin-73) (CK-73) (Keratin-73) (K73) (Type II inner root sheath-specific keratin-K6irs3) (Type-II keratin Kb36)",540,"58,923",5 out of 5,2008-01-15,Evidence at protein level
O95678,K2C75_HUMAN,"Keratin, type II cytoskeletal 75 (Cytokeratin-75) (CK-75) (Keratin-6 hair follicle) (hK6hf) (Keratin-75) (K75) (Type II keratin-K6hf) (Type-II keratin Kb18)",551,"59,560",5 out of 5,2008-01-15,Evidence at protein level
Q6KB66,K2C80_HUMAN,"Keratin, type II cytoskeletal 80 (Cytokeratin-80) (CK-80) (Keratin-80) (K80) (Type-II keratin Kb20)",452,"50,525",5 out of 5,2008-01-15,Evidence at protein level
O14649,KCNK3_HUMAN,Potassium channel subfamily K member 3 (Acid-sensitive potassium channel protein TASK-1) (TWIK-related acid-sensitive K(+) channel 1) (Two pore potassium channel KT3.1) (Two pore K(+) channel KT3.1),394,"43,518",5 out of 5,2001-02-21,Evidence at protein level
Q8N5I3,KCNRG_HUMAN,Potassium channel regulatory protein (Potassium channel regulator) (Protein CLLD4),272,"31,048",4 out of 5,2006-05-30,Evidence at protein level
Q96KK3,KCNS1_HUMAN,Potassium voltage-gated channel subfamily S member 1 (Delayed-rectifier K(+) channel alpha subunit 1) (Voltage-gated potassium channel subunit Kv9.1),526,"58,372",5 out of 5,2002-10-25,Evidence at protein level
Q6PIU1,KCNV1_HUMAN,Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1),500,"56,304",5 out of 5,2007-10-23,Evidence at protein level
Q8TDN2,KCNV2_HUMAN,Potassium voltage-gated channel subfamily V member 2 (Voltage-gated potassium channel subunit Kv8.2),545,"62,459",5 out of 5,2002-11-28,Evidence at protein level
P06732,KCRM_HUMAN,"Creatine kinase M-type (EC 2.7.3.2) (Creatine kinase M chain) (M-CK) [Cleaved into: Creatine kinase M-type, N-terminally processed]",381,"43,101",5 out of 5,1988-01-01,Evidence at protein level
Q9Y597,KCTD3_HUMAN,BTB/POZ domain-containing protein KCTD3 (Renal carcinoma antigen NY-REN-45),815,"88,984",3 out of 5,2006-08-22,Evidence at protein level
Q96MP8,KCTD7_HUMAN,BTB/POZ domain-containing protein KCTD7,289,"33,132",5 out of 5,2006-10-03,Evidence at protein level
O75164,KDM4A_HUMAN,Lysine-specific demethylase 4A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 3A) (Jumonji domain-containing protein 2A),1064,"120,662",5 out of 5,2003-08-22,Evidence at protein level
B2RXH2,KDM4E_HUMAN,Lysine-specific demethylase 4E (EC 1.14.11.-) (KDM4D-like protein) (Lysine-specific demethylase 4D-like),506,"56,804",5 out of 5,2010-07-13,Evidence at protein level
Q5JSQ8,KHDCL_HUMAN,Putative KHDC1-like protein,128,"14,546",1 out of 5,2010-07-13,Uncertain
Q07666,KHDR1_HUMAN,"KH domain-containing, RNA-binding, signal transduction-associated protein 1 (GAP-associated tyrosine phosphoprotein p62) (Src-associated in mitosis 68 kDa protein) (Sam68) (p21 Ras GTPase-activating protein-associated p62) (p68)",443,"48,227",5 out of 5,2005-04-12,Evidence at protein level
P50053,KHK_HUMAN,Ketohexokinase (EC 2.7.1.3) (Hepatic fructokinase),298,"32,523",5 out of 5,1996-10-01,Evidence at protein level
Q8NI77,KI18A_HUMAN,Kinesin-like protein KIF18A (Marrow stromal KIF18A) (MS-KIF18A),898,"102,281",5 out of 5,2005-05-10,Evidence at protein level
O75037,KI21B_HUMAN,Kinesin-like protein KIF21B,1637,"182,662",5 out of 5,2004-07-19,Evidence at protein level
P33176,KINH_HUMAN,Kinesin-1 heavy chain (Conventional kinesin heavy chain) (Ubiquitous kinesin heavy chain) (UKHC),963,"109,685",5 out of 5,1993-10-01,Evidence at protein level
O14901,KLF11_HUMAN,Krueppel-like factor 11 (Transforming growth factor-beta-inducible early growth response protein 2) (TGFB-inducible early growth response protein 2) (TIEG-2),512,"55,139",5 out of 5,2000-12-01,Evidence at protein level
Q8TD94,KLF14_HUMAN,Krueppel-like factor 14 (Basic transcription element-binding protein 5) (BTE-binding protein 5) (Transcription factor BTEB5),323,"33,124",2 out of 5,2003-06-16,Evidence at transcript level
Q9Y5W3,KLF2_HUMAN,Krueppel-like factor 2 (Lung krueppel-like factor),355,"37,420",5 out of 5,2000-05-30,Evidence at protein level
Q99612,KLF6_HUMAN,Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9),283,"31,865",5 out of 5,2000-05-30,Evidence at protein level
Q9P2G3,KLH14_HUMAN,Kelch-like protein 14 (Protein interactor of Torsin-1A) (Printor) (Protein interactor of torsinA),628,"70,714",4 out of 5,2001-06-01,Evidence at protein level
Q6TDP4,KLH17_HUMAN,Kelch-like protein 17 (Actinfilin),642,"69,874",4 out of 5,2004-09-27,Evidence at transcript level
Q9H0H3,KLH25_HUMAN,Kelch-like protein 25 (Ectoderm-neural cortex protein 2) (ENC-2),589,"65,923",4 out of 5,2007-01-23,Evidence at protein level
Q8N239,KLH34_HUMAN,Kelch-like protein 34,644,"70,612",2 out of 5,2007-02-06,Evidence at transcript level
Q9P2K6,KLH42_HUMAN,Kelch-like protein 42 (Cullin-3-binding protein 9) (Ctb9) (Kelch domain-containing protein 5),505,"56,868",5 out of 5,2001-06-01,Evidence at protein level
Q8WZ60,KLHL6_HUMAN,Kelch-like protein 6,621,"70,359",3 out of 5,2003-02-12,Evidence at protein level
Q9UKR3,KLK13_HUMAN,Kallikrein-13 (EC 3.4.21.-) (Kallikrein-like protein 4) (KLK-L4),277,"30,570",5 out of 5,2000-12-01,Evidence at transcript level
P07288,KLK3_HUMAN,Prostate-specific antigen (PSA) (EC 3.4.21.77) (Gamma-seminoprotein) (Seminin) (Kallikrein-3) (P-30 antigen) (Semenogelase),261,"28,741",5 out of 5,1988-04-01,Evidence at protein level
Q9Y5K2,KLK4_HUMAN,Kallikrein-4 (EC 3.4.21.-) (Enamel matrix serine proteinase 1) (Kallikrein-like protein 1) (KLK-L1) (Prostase) (Serine protease 17),254,"27,032",5 out of 5,2000-12-01,Evidence at protein level
O60259,KLK8_HUMAN,Kallikrein-8 (hK8) (EC 3.4.21.118) (Neuropsin) (NP) (Ovasin) (Serine protease 19) (Serine protease TADG-14) (Tumor-associated differentially expressed gene 14 protein),260,"28,048",5 out of 5,1999-07-15,Evidence at protein level
P03952,KLKB1_HUMAN,Plasma kallikrein (EC 3.4.21.34) (Fletcher factor) (Kininogenin) (Plasma prekallikrein) (PKK) [Cleaved into: Plasma kallikrein heavy chain; Plasma kallikrein light chain],638,"71,370",5 out of 5,1986-10-23,Evidence at protein level
Q13241,KLRD1_HUMAN,Natural killer cells antigen CD94 (KP43) (Killer cell lectin-like receptor subfamily D member 1) (NK cell receptor) (CD antigen CD94),179,"20,513",5 out of 5,1997-11-01,Evidence at protein level
D3W0D1,KLRF2_HUMAN,Killer cell lectin-like receptor subfamily F member 2 (Lectin-like receptor F2) (Activating coreceptor NKp65),207,"24,008",5 out of 5,2011-02-08,Evidence at protein level
Q8NEZ4,KMT2C_HUMAN,Histone-lysine N-methyltransferase 2C (Lysine N-methyltransferase 2C) (EC 2.1.1.43) (Homologous to ALR protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 3),4911,"541,370",5 out of 5,2003-10-10,Evidence at protein level
Q9NQR1,KMT5A_HUMAN,N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.43) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8),393,"42,890",5 out of 5,2002-11-15,Evidence at protein level
A6PVL3,KNCN_HUMAN,Kinocilin,124,"12,832",2 out of 5,2007-11-13,Evidence at transcript level
Q674X7,KAZRN_HUMAN,Kazrin,775,"86,351",5 out of 5,2008-02-26,Evidence at protein level
O94819,KBTBB_HUMAN,Kelch repeat and BTB domain-containing protein 11 (Chronic myelogenous leukemia-associated protein) (Kelch domain-containing protein 7B),623,"65,720",2 out of 5,2001-06-01,Evidence at protein level
Q8N752,KC1AL_HUMAN,Casein kinase I isoform alpha-like (CKI-alpha-like) (EC 2.7.11.1) (CK1),337,"39,086",5 out of 5,2004-05-10,Evidence at transcript level
P78368,KC1G2_HUMAN,Casein kinase I isoform gamma-2 (CKI-gamma 2) (EC 2.7.11.1),415,"47,457",5 out of 5,1998-07-15,Evidence at protein level
Q8N5Z5,KCD17_HUMAN,BTB/POZ domain-containing protein KCTD17,321,"35,670",5 out of 5,2006-07-25,Evidence at protein level
P22001,KCNA3_HUMAN,Potassium voltage-gated channel subfamily A member 3 (HGK5) (HLK3) (HPCN3) (Voltage-gated K(+) channel HuKIII) (Voltage-gated potassium channel subunit Kv1.3),575,"63,842",5 out of 5,1991-08-01,Evidence at protein level
P17658,KCNA6_HUMAN,Potassium voltage-gated channel subfamily A member 6 (Voltage-gated potassium channel HBK2) (Voltage-gated potassium channel subunit Kv1.6),529,"58,729",5 out of 5,1990-08-01,Evidence at transcript level
Q14721,KCNB1_HUMAN,Potassium voltage-gated channel subfamily B member 1 (Delayed rectifier potassium channel 1) (DRK1) (h-DRK1) (Voltage-gated potassium channel subunit Kv2.1),858,"95,878",5 out of 5,1998-07-15,Evidence at protein level
Q9NZV8,KCND2_HUMAN,Potassium voltage-gated channel subfamily D member 2 (Voltage-gated potassium channel subunit Kv4.2),630,"70,537",5 out of 5,2003-11-07,Evidence at protein level
Q9Y6H6,KCNE3_HUMAN,Potassium voltage-gated channel subfamily E member 3 (MinK-related peptide 2) (Minimum potassium ion channel-related peptide 2) (Potassium channel subunit beta MiRP2),103,"11,710",5 out of 5,2000-05-30,Evidence at protein level
Q9NPC2,KCNK9_HUMAN,Potassium channel subfamily K member 9 (Acid-sensitive potassium channel protein TASK-3) (TWIK-related acid-sensitive K(+) channel 3) (Two pore potassium channel KT3.2) (Two pore K(+) channel KT3.2),374,"42,264",5 out of 5,2001-04-27,Evidence at protein level
Q9HB15,KCNKC_HUMAN,Potassium channel subfamily K member 12 (Tandem pore domain halothane-inhibited potassium channel 2) (THIK-2),430,"46,889",3 out of 5,2002-11-01,Evidence at transcript level
Q7Z418,KCNKI_HUMAN,Potassium channel subfamily K member 18 (TWIK-related individual potassium channel) (TWIK-related spinal cord potassium channel),384,"43,671",5 out of 5,2007-12-04,Evidence at protein level
Q9H2S1,KCNN2_HUMAN,Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2),579,"63,760",5 out of 5,2001-11-16,Evidence at protein level
P56696,KCNQ4_HUMAN,Potassium voltage-gated channel subfamily KQT member 4 (KQT-like 4) (Potassium channel subunit alpha KvLQT4) (Voltage-gated potassium channel subunit Kv7.4),695,"77,101",5 out of 5,1999-07-15,Evidence at protein level
Q9ULS6,KCNS2_HUMAN,Potassium voltage-gated channel subfamily S member 2 (Delayed-rectifier K(+) channel alpha subunit 2) (Voltage-gated potassium channel subunit Kv9.2),477,"54,237",4 out of 5,2002-10-25,Evidence at protein level
Q6ZWJ8,KCP_HUMAN,Kielin/chordin-like protein (Cysteine-rich BMP regulator 2) (Cysteine-rich motor neuron 2 protein) (CRIM-2) (Kielin/chordin-like protein 1) (KCP-1),1503,"159,938",4 out of 5,2008-02-05,Evidence at transcript level
Q9NXV2,KCTD5_HUMAN,BTB/POZ domain-containing protein KCTD5,234,"26,093",5 out of 5,2004-07-19,Evidence at protein level
Q7L273,KCTD9_HUMAN,BTB/POZ domain-containing protein KCTD9,389,"42,567",5 out of 5,2004-07-19,Evidence at protein level
Q7Z4H8,KDEL2_HUMAN,KDEL motif-containing protein 2,507,"58,572",3 out of 5,2006-07-25,Evidence at protein level
Q9NQT8,KI13B_HUMAN,Kinesin-like protein KIF13B (Kinesin-like protein GAKIN),1826,"202,789",5 out of 5,2002-09-19,Evidence at protein level
Q8NHK3,KI2LB_HUMAN,Killer cell immunoglobulin-like receptor 2DL5B (CD158 antigen-like family member F2) (Killer cell immunoglobulin-like receptor 2DLX) (CD antigen CD158f2),375,"40,607",4 out of 5,2007-09-11,Inferred from homology
P43631,KI2S2_HUMAN,Killer cell immunoglobulin-like receptor 2DS2 (CD158 antigen-like family member J) (MHC class I NK cell receptor) (NK receptor 183 ActI) (Natural killer-associated transcript 5) (NKAT-5) (p58 natural killer cell receptor clone CL-49) (p58 NK receptor CL-49) (CD antigen CD158j),304,"33,502",5 out of 5,1995-11-01,Evidence at protein level
P43629,KI3L1_HUMAN,Killer cell immunoglobulin-like receptor 3DL1 (CD158 antigen-like family member E) (HLA-BW4-specific inhibitory NK cell receptor) (MHC class I NK cell receptor) (Natural killer-associated transcript 3) (NKAT-3) (p70 natural killer cell receptor clones CL-2/CL-11) (p70 NK receptor CL-2/CL-11) (CD antigen CD158e),444,"49,098",5 out of 5,1995-11-01,Evidence at protein level
Q86VH2,KIF27_HUMAN,Kinesin-like protein KIF27,1401,"160,283",5 out of 5,2007-10-23,Evidence at transcript level
Q8NEP7,KLDC9_HUMAN,Kelch domain-containing protein 9 (Kelch/ankyrin repeat-containing cyclin A1-interacting protein),349,"37,754",3 out of 5,2007-09-11,Evidence at protein level
Q9Y2Y9,KLF13_HUMAN,Krueppel-like factor 13 (Basic transcription element-binding protein 3) (BTE-binding protein 3) (Novel Sp1-like zinc finger transcription factor 1) (RANTES factor of late activated T-lymphocytes 1) (RFLAT-1) (Transcription factor BTEB3) (Transcription factor NSLP1),288,"31,180",5 out of 5,2001-11-02,Evidence at protein level
Q6JEL2,KLH10_HUMAN,Kelch-like protein 10,608,"68,942",4 out of 5,2004-09-27,Evidence at protein level
O94889,KLH18_HUMAN,Kelch-like protein 18,574,"63,638",2 out of 5,2001-04-27,Evidence at protein level
Q53GT1,KLH22_HUMAN,Kelch-like protein 22,634,"71,667",5 out of 5,2006-06-27,Evidence at protein level
Q6PF15,KLH35_HUMAN,Kelch-like protein 35,583,"62,892",3 out of 5,2008-07-22,Evidence at protein level
P01042,KNG1_HUMAN,Kininogen-1 (Alpha-2-thiol proteinase inhibitor) (Fitzgerald factor) (High molecular weight kininogen) (HMWK) (Williams-Fitzgerald-Flaujeac factor) [Cleaved into: Kininogen-1 heavy chain; T-kinin (Ile-Ser-Bradykinin); Bradykinin (Kallidin I); Lysyl-bradykinin (Kallidin II); Kininogen-1 light chain; Low molecular weight growth-promoting factor],644,"71,957",5 out of 5,1986-07-21,Evidence at protein level
Q9BZL6,KPCD2_HUMAN,Serine/threonine-protein kinase D2 (EC 2.7.11.13) (nPKC-D2),878,"96,750",5 out of 5,2002-03-27,Evidence at protein level
Q02156,KPCE_HUMAN,Protein kinase C epsilon type (EC 2.7.11.13) (nPKC-epsilon),737,"83,674",5 out of 5,1993-07-01,Evidence at protein level
Q5T749,KPRP_HUMAN,Keratinocyte proline-rich protein (hKPRP),579,"64,136",5 out of 5,2007-01-09,Evidence at protein level
Q3LI73,KR194_HUMAN,Keratin-associated protein 19-4,84,"9,106",3 out of 5,2006-02-21,Inferred from homology
Q3SYF9,KR197_HUMAN,Keratin-associated protein 19-7,63,"6,644",3 out of 5,2006-02-21,Evidence at protein level
Q9BYS1,KRA15_HUMAN,Keratin-associated protein 1-5 (High sulfur keratin-associated protein 1.5) (Keratin-associated protein 1.5),174,"18,010",4 out of 5,2004-10-25,Evidence at protein level
Q9BYR4,KRA43_HUMAN,Keratin-associated protein 4-3 (Keratin-associated protein 4.3) (Ultrahigh sulfur keratin-associated protein 4.3),195,"20,504",5 out of 5,2003-10-24,Evidence at transcript level
Q701N4,KRA52_HUMAN,Keratin-associated protein 5-2 (Keratin-associated protein 5-8) (Keratin-associated protein 5.2) (Keratin-associated protein 5.8) (Ultrahigh sulfur keratin-associated protein 5.2),177,"16,271",5 out of 5,2004-12-21,Evidence at protein level
Q3LI66,KRA62_HUMAN,Keratin-associated protein 6-2,62,"6,654",4 out of 5,2006-02-21,Evidence at protein level
A5PL33,KRBA1_HUMAN,Protein KRBA1,1030,"107,498",3 out of 5,2007-09-11,Evidence at protein level
Q9NSB4,KRT82_HUMAN,"Keratin, type II cuticular Hb2 (Keratin-82) (K82) (Type II hair keratin Hb2) (Type-II keratin Kb22)",513,"56,653",4 out of 5,2004-03-29,Inferred from homology
Q9UK32,KS6A6_HUMAN,Ribosomal protein S6 kinase alpha-6 (S6K-alpha-6) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 6) (p90-RSK 6) (p90RSK6) (Ribosomal S6 kinase 4) (RSK-4) (pp90RSK4),745,"83,872",5 out of 5,2000-12-01,Evidence at protein level
Q86UP2,KTN1_HUMAN,Kinectin (CG-1 antigen) (Kinesin receptor),1357,"156,275",5 out of 5,2003-08-15,Evidence at protein level
A0A0A0MRZ7,KVD26_HUMAN,Immunoglobulin kappa variable 2D-26,120,"13,297",3 out of 5,2017-01-18,Inferred from homology
A0A075B6S6,KVD30_HUMAN,Immunoglobulin kappa variable 2D-30,120,"13,215",5 out of 5,2016-11-02,Inferred from homology
A0A0B4J1Z2,KVD43_HUMAN,Immunoglobulin kappa variable 1D-43,117,"12,989",3 out of 5,2017-01-18,Inferred from homology
Q9UNZ5,L10K_HUMAN,Leydig cell tumor 10 kDa protein homolog,99,"10,577",2 out of 5,2001-11-02,Evidence at protein level
Q8N371,KDM8_HUMAN,Lysine-specific demethylase 8 (EC 1.14.11.27) (JmjC domain-containing protein 5) (Jumonji domain-containing protein 5),416,"47,270",5 out of 5,2007-06-26,Evidence at protein level
O60938,KERA_HUMAN,Keratocan (KTN) (Keratan sulfate proteoglycan keratocan),352,"40,509",5 out of 5,2002-02-11,Evidence at protein level
Q7Z4S6,KI21A_HUMAN,Kinesin-like protein KIF21A (Kinesin-like protein KIF2) (Renal carcinoma antigen NY-REN-62),1674,"187,179",5 out of 5,2004-07-19,Evidence at protein level
P43628,KI2L3_HUMAN,Killer cell immunoglobulin-like receptor 2DL3 (CD158 antigen-like family member B2) (KIR-023GB) (Killer inhibitory receptor cl 2-3) (MHC class I NK cell receptor) (NKAT2a) (NKAT2b) (Natural killer-associated transcript 2) (NKAT-2) (p58 natural killer cell receptor clone CL-6) (p58 NK receptor CL-6) (p58.2 MHC class-I-specific NK receptor) (CD antigen CD158b2),341,"37,886",5 out of 5,1995-11-01,Evidence at protein level
Q14954,KI2S1_HUMAN,Killer cell immunoglobulin-like receptor 2DS1 (CD158 antigen-like family member H) (MHC class I NK cell receptor Eb6 ActI) (CD antigen CD158h),304,"33,646",4 out of 5,2001-02-21,Evidence at transcript level
A8MWS1,KI3P1_HUMAN,Putative killer cell immunoglobulin-like receptor like protein KIR3DP1 (CD antigen CD158c),328,"36,055",3 out of 5,2008-09-02,Evidence at transcript level
Q14943,KI3S1_HUMAN,Killer cell immunoglobulin-like receptor 3DS1 (MHC class I NK cell receptor) (Natural killer-associated transcript 10) (NKAT-10),387,"42,902",5 out of 5,1997-11-01,Evidence at transcript level
Q8N7Y1,KIAS3_HUMAN,Putative uncharacterized protein KIRREL3-AS3 (KIRREL3 antisense RNA 1) (KIRREL3 antisense gene protein 1) (Proline-rich protein 10),241,"25,772",2 out of 5,2006-06-27,Uncertain
Q02241,KIF23_HUMAN,Kinesin-like protein KIF23 (Kinesin-like protein 5) (Mitotic kinesin-like protein 1),960,"110,059",5 out of 5,1993-07-01,Evidence at protein level
Q53G59,KLH12_HUMAN,Kelch-like protein 12 (CUL3-interacting protein 1) (DKIR homolog) (hDKIR),568,"63,277",5 out of 5,2006-05-16,Evidence at protein level
Q6TFL4,KLH24_HUMAN,Kelch-like protein 24 (Kainate receptor-interacting protein for GluR6) (KRIP6) (Protein DRE1),600,"68,361",3 out of 5,2006-11-28,Evidence at transcript level
Q0D2K2,KLH30_HUMAN,Kelch-like protein 30,578,"63,976",2 out of 5,2007-02-06,Evidence at transcript level
Q9H511,KLH31_HUMAN,Kelch-like protein 31 (BTB and kelch domain-containing protein 6) (Kelch repeat and BTB domain-containing protein 1) (Kelch-like protein KLHL),634,"70,246",4 out of 5,2007-01-09,Evidence at transcript level
Q2TBA0,KLH40_HUMAN,Kelch-like protein 40 (Kelch repeat and BTB domain-containing protein 5) (Sarcosynapsin),621,"69,257",5 out of 5,2007-02-06,Evidence at protein level
Q96QS6,KPSH2_HUMAN,Serine/threonine-protein kinase H2 (EC 2.7.11.1) (Protein serine kinase H2) (PSK-H2),385,"43,027",4 out of 5,2005-12-06,Evidence at transcript level
P30613,KPYR_HUMAN,Pyruvate kinase PKLR (EC 2.7.1.40) (Pyruvate kinase 1) (Pyruvate kinase isozymes L/R) (R-type/L-type pyruvate kinase) (Red cell/liver pyruvate kinase),574,"61,830",5 out of 5,1993-04-01,Evidence at protein level
P60412,KR10B_HUMAN,Keratin-associated protein 10-11 (High sulfur keratin-associated protein 10.11) (Keratin-associated protein 10.11) (Keratin-associated protein 18-11) (Keratin-associated protein 18.11),298,"30,243",5 out of 5,2004-02-16,Evidence at protein level
P60329,KR124_HUMAN,Keratin-associated protein 12-4 (High sulfur keratin-associated protein 12.4) (Keratin-associated protein 12.4),112,"11,433",5 out of 5,2004-02-02,Evidence at protein level
Q3LI77,KR134_HUMAN,Keratin-associated protein 13-4,160,"17,755",3 out of 5,2005-11-22,Evidence at transcript level
A8MUX0,KR161_HUMAN,Keratin-associated protein 16-1,517,"53,912",2 out of 5,2008-09-02,Inferred from homology
Q3LI60,KR203_HUMAN,Keratin-associated protein 20-3,44,"4,909",2 out of 5,2007-10-23,Inferred from homology
Q3LI68,KR222_HUMAN,Keratin-associated protein 22-2,45,"5,218",2 out of 5,2008-05-20,Inferred from homology
Q3LI81,KR271_HUMAN,Keratin-associated protein 27-1,207,"22,345",3 out of 5,2007-10-23,Evidence at transcript level
Q07627,KRA11_HUMAN,Keratin-associated protein 1-1 (High sulfur keratin-associated protein 1.1) (Keratin-associated protein 1.1) (Keratin-associated protein 1.6) (Keratin-associated protein 1.7),177,"18,235",4 out of 5,2006-02-21,Evidence at transcript level
Q9NPI7,KRCC1_HUMAN,Lysine-rich coiled-coil protein 1 (Cryptogenic hepatitis-binding protein 2),259,"30,980",2 out of 5,2007-10-02,Evidence at transcript level
O00522,KRIT1_HUMAN,Krev interaction trapped protein 1 (Krev interaction trapped 1) (Cerebral cavernous malformations 1 protein),736,"84,348",5 out of 5,2001-04-27,Evidence at protein level
P06315,KV502_HUMAN,Immunoglobulin kappa variable 5-2 (Ig kappa chain V region EV15),115,"12,728",5 out of 5,1988-01-01,Evidence at protein level
A0A0C4DH24,KV621_HUMAN,Immunoglobulin kappa variable 6-21,114,"12,430",3 out of 5,2017-01-18,Inferred from homology
A0A075B6S4,KVD17_HUMAN,Immunoglobulin kappa variable 1D-17,117,"12,835",3 out of 5,2017-01-18,Inferred from homology
Q6P1M3,L2GL2_HUMAN,Lethal(2) giant larvae protein homolog 2 (HGL),1020,"113,448",5 out of 5,2006-04-18,Evidence at protein level
P18627,LAG3_HUMAN,Lymphocyte activation gene 3 protein (LAG-3) (Protein FDC) (CD antigen CD223),525,"57,449",5 out of 5,1990-11-01,Evidence at protein level
P25391,LAMA1_HUMAN,Laminin subunit alpha-1 (Laminin A chain) (Laminin-1 subunit alpha) (Laminin-3 subunit alpha) (S-laminin subunit alpha) (S-LAM alpha),3075,"337,084",5 out of 5,1992-05-01,Evidence at protein level
P24043,LAMA2_HUMAN,Laminin subunit alpha-2 (Laminin M chain) (Laminin-12 subunit alpha) (Laminin-2 subunit alpha) (Laminin-4 subunit alpha) (Merosin heavy chain),3122,"343,905",5 out of 5,1992-03-01,Evidence at protein level
P11279,LAMP1_HUMAN,Lysosome-associated membrane glycoprotein 1 (LAMP-1) (Lysosome-associated membrane protein 1) (CD107 antigen-like family member A) (CD antigen CD107a),417,"44,882",5 out of 5,1989-07-01,Evidence at protein level
Q96AZ6,ISG20_HUMAN,Interferon-stimulated gene 20 kDa protein (EC 3.1.13.1) (Estrogen-regulated transcript 45 protein) (Promyelocytic leukemia nuclear body-associated protein ISG20),181,"20,363",5 out of 5,2005-01-04,Evidence at protein level
P00995,ISK1_HUMAN,Serine protease inhibitor Kazal-type 1 (Pancreatic secretory trypsin inhibitor) (Tumor-associated trypsin inhibitor) (TATI),79,"8,507",5 out of 5,1986-07-21,Evidence at protein level
P58062,ISK7_HUMAN,Serine protease inhibitor Kazal-type 7 (Esophagus cancer-related gene 2 protein) (ECRG-2),85,"9,232",4 out of 5,2001-05-04,Evidence at protein level
P05107,ITB2_HUMAN,"Integrin beta-2 (Cell surface adhesion glycoproteins LFA-1/CR3/p150,95 subunit beta) (Complement receptor C3 subunit beta) (CD antigen CD18)",769,"84,782",5 out of 5,1987-08-13,Evidence at protein level
P05106,ITB3_HUMAN,Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61),788,"87,058",5 out of 5,1987-08-13,Evidence at protein level
P26012,ITB8_HUMAN,Integrin beta-8,769,"85,632",5 out of 5,1992-05-01,Evidence at transcript level
Q9UKP3,ITBP2_HUMAN,Integrin beta-1-binding protein 2 (Melusin),347,"38,382",4 out of 5,2002-01-31,Evidence at protein level
P19827,ITIH1_HUMAN,Inter-alpha-trypsin inhibitor heavy chain H1 (ITI heavy chain H1) (ITI-HC1) (Inter-alpha-inhibitor heavy chain 1) (Inter-alpha-trypsin inhibitor complex component III) (Serum-derived hyaluronan-associated protein) (SHAP),911,"101,389",5 out of 5,1991-02-01,Evidence at protein level
Q13572,ITPK1_HUMAN,"Inositol-tetrakisphosphate 1-kinase (EC 2.7.1.134) (Inositol 1,3,4-trisphosphate 5/6-kinase) (Inositol-triphosphate 5/6-kinase) (Ins(1,3,4)P(3) 5/6-kinase) (EC 2.7.1.159)",414,"45,621",5 out of 5,2005-12-06,Evidence at protein level
P26440,IVD_HUMAN,"Isovaleryl-CoA dehydrogenase, mitochondrial (IVD) (EC 1.3.8.4)",423,"46,319",5 out of 5,1992-08-01,Evidence at protein level
Q8IYV9,IZUM1_HUMAN,Izumo sperm-egg fusion protein 1 (Oocyte binding/fusion factor) (OBF) (Sperm-specific protein izumo),350,"38,930",5 out of 5,2006-01-10,Evidence at protein level
Q5VZ72,IZUM3_HUMAN,Izumo sperm-egg fusion protein 3,239,"27,768",3 out of 5,2008-07-01,Inferred from homology
Q6NYC1,JMJD6_HUMAN,Bifunctional arginine demethylase and lysyl-hydroxylase JMJD6 (EC 1.14.11.-) (Histone arginine demethylase JMJD6) (JmjC domain-containing protein 6) (Jumonji domain-containing protein 6) (Lysyl-hydroxylase JMJD6) (Peptide-lysine 5-dioxygenase JMJD6) (Phosphatidylserine receptor) (Protein PTDSR),403,"46,462",5 out of 5,2005-06-07,Evidence at protein level
Q15040,JOS1_HUMAN,Josephin-1 (EC 3.4.19.12) (Josephin domain-containing protein 1),202,"23,198",5 out of 5,1998-07-15,Evidence at protein level
O76095,JTB_HUMAN,Protein JTB (Jumping translocation breakpoint protein) (Prostate androgen-regulated protein) (PAR protein),146,"16,358",5 out of 5,1999-07-15,Evidence at protein level
P05412,JUN_HUMAN,Transcription factor AP-1 (Activator protein 1) (AP1) (Proto-oncogene c-Jun) (V-jun avian sarcoma virus 17 oncogene homolog) (p39),331,"35,676",5 out of 5,1988-11-01,Evidence at protein level
P29622,KAIN_HUMAN,Kallistatin (Kallikrein inhibitor) (Peptidase inhibitor 4) (PI-4) (Serpin A4),427,"48,542",5 out of 5,1993-04-01,Evidence at protein level
Q6YP21,KAT3_HUMAN,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),454,"51,400",5 out of 5,2007-05-15,Evidence at protein level
Q8IYT4,KATL2_HUMAN,Katanin p60 ATPase-containing subunit A-like 2 (Katanin p60 subunit A-like 2) (EC 3.6.4.3) (p60 katanin-like 2),538,"61,253",3 out of 5,2008-05-20,Evidence at protein level
Q8IY47,KBTB2_HUMAN,Kelch repeat and BTB domain-containing protein 2 (BTB and kelch domain-containing protein 1),623,"71,331",3 out of 5,2003-07-25,Evidence at protein level
Q8NFY9,KBTB8_HUMAN,Kelch repeat and BTB domain-containing protein 8 (T-cell activation kelch repeat protein) (TA-KRP),601,"68,823",5 out of 5,2007-02-20,Evidence at protein level
Q6P2M8,KCC1B_HUMAN,Calcium/calmodulin-dependent protein kinase type 1B (EC 2.7.11.17) (CaM kinase I beta) (CaM kinase IB) (CaM-KI beta) (CaMKI-beta) (Pregnancy up-regulated non-ubiquitously-expressed CaM kinase),343,"38,500",5 out of 5,2005-02-01,Evidence at transcript level
Q16566,KCC4_HUMAN,Calcium/calmodulin-dependent protein kinase type IV (CaMK IV) (EC 2.7.11.17) (CaM kinase-GR),473,"51,926",5 out of 5,1997-11-01,Evidence at protein level
Q7Z5Y7,KCD20_HUMAN,BTB/POZ domain-containing protein KCTD20 (Potassium channel tetramerization domain containing 20),419,"47,480",3 out of 5,2006-10-31,Evidence at protein level
Q9NZI2,KCIP1_HUMAN,Kv channel-interacting protein 1 (KChIP1) (A-type potassium channel modulatory protein 1) (Potassium channel-interacting protein 1) (Vesicle APC-binding protein),227,"26,817",5 out of 5,2005-08-16,Evidence at protein level
Q16558,KCMB1_HUMAN,"Calcium-activated potassium channel subunit beta-1 (BK channel subunit beta-1) (BKbeta) (BKbeta1) (Hbeta1) (Calcium-activated potassium channel, subfamily M subunit beta-1) (Calcium-activated potassium channel subunit beta) (Charybdotoxin receptor subunit beta-1) (K(VCA)beta-1) (Maxi K channel subunit beta-1) (Slo-beta-1) (Slo-beta)",191,"21,797",5 out of 5,1997-11-01,Evidence at protein level
Q96RP8,KCNA7_HUMAN,Potassium voltage-gated channel subfamily A member 7 (Voltage-gated potassium channel subunit Kv1.7),456,"50,559",3 out of 5,2007-10-23,Evidence at transcript level
Q92953,KCNB2_HUMAN,Potassium voltage-gated channel subfamily B member 2 (Voltage-gated potassium channel subunit Kv2.2),911,"102,563",5 out of 5,1998-12-15,Evidence at transcript level
Q9Y2U2,KCNK7_HUMAN,Potassium channel subfamily K member 7,307,"31,947",4 out of 5,2001-02-21,Evidence at transcript level
Q14681,KCTD2_HUMAN,BTB/POZ domain-containing protein KCTD2 (Potassium channel tetramerization domain-containing protein 2),263,"28,527",3 out of 5,1997-11-01,Evidence at protein level
Q6ZWB6,KCTD8_HUMAN,BTB/POZ domain-containing protein KCTD8,473,"52,440",3 out of 5,2006-10-03,Evidence at transcript level
Q9Y4C1,KDM3A_HUMAN,Lysine-specific demethylase 3A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 2A) (Jumonji domain-containing protein 1A),1321,"147,341",5 out of 5,2005-11-22,Evidence at protein level
Q9UGL1,KDM5B_HUMAN,Lysine-specific demethylase 5B (EC 1.14.11.-) (Cancer/testis antigen 31) (CT31) (Histone demethylase JARID1B) (Jumonji/ARID domain-containing protein 1B) (PLU-1) (Retinoblastoma-binding protein 2 homolog 1) (RBP2-H1),1544,"175,658",5 out of 5,2007-06-26,Evidence at protein level
P41229,KDM5C_HUMAN,Lysine-specific demethylase 5C (EC 1.14.11.-) (Histone demethylase JARID1C) (Jumonji/ARID domain-containing protein 1C) (Protein SmcX) (Protein Xe169),1560,"175,720",5 out of 5,1995-02-01,Evidence at protein level
O15550,KDM6A_HUMAN,Lysine-specific demethylase 6A (EC 1.14.11.-) (Histone demethylase UTX) (Ubiquitously-transcribed TPR protein on the X chromosome) (Ubiquitously-transcribed X chromosome tetratricopeptide repeat protein),1401,"154,177",5 out of 5,1999-07-15,Evidence at protein level
Q6ZMT4,KDM7A_HUMAN,Lysine-specific demethylase 7A (EC 1.14.11.-) (JmjC domain-containing histone demethylation protein 1D) (Lysine-specific demethylase 7),941,"106,557",5 out of 5,2006-03-07,Evidence at protein level
O15037,KHNYN_HUMAN,Protein KHNYN (KH and NYN domain-containing protein),678,"74,534",2 out of 5,2005-03-29,Evidence at protein level
Q9ULI4,KI26A_HUMAN,Kinesin-like protein KIF26A,1882,"194,590",4 out of 5,2007-10-23,Evidence at protein level
O15066,KIF3B_HUMAN,"Kinesin-like protein KIF3B (HH0048) (Microtubule plus end-directed kinesin motor 3B) [Cleaved into: Kinesin-like protein KIF3B, N-terminally processed]",747,"85,125",5 out of 5,1998-12-15,Evidence at protein level
Q92845,KIFA3_HUMAN,Kinesin-associated protein 3 (KAP-3) (KAP3) (Smg GDS-associated protein),792,"91,205",5 out of 5,2002-05-10,Evidence at protein level
Q96AC6,KIFC2_HUMAN,Kinesin-like protein KIFC2,838,"90,147",3 out of 5,2003-08-15,Evidence at transcript level
O76013,KRT36_HUMAN,"Keratin, type I cuticular Ha6 (Hair keratin, type I Ha6) (Keratin-36) (K36)",467,"52,247",5 out of 5,2000-05-30,Evidence at transcript level
Q9BVA0,KTNB1_HUMAN,Katanin p80 WD40 repeat-containing subunit B1 (Katanin p80 subunit B1) (p80 katanin),655,"72,334",5 out of 5,2005-03-01,Evidence at protein level
A0A0C4DH67,KV108_HUMAN,Immunoglobulin kappa variable 1-8,115,"12,537",3 out of 5,2017-01-18,Inferred from homology
P11047,LAMC1_HUMAN,Laminin subunit gamma-1 (Laminin B2 chain) (Laminin-1 subunit gamma) (Laminin-10 subunit gamma) (Laminin-11 subunit gamma) (Laminin-2 subunit gamma) (Laminin-3 subunit gamma) (Laminin-4 subunit gamma) (Laminin-6 subunit gamma) (Laminin-7 subunit gamma) (Laminin-8 subunit gamma) (Laminin-9 subunit gamma) (S-laminin subunit gamma) (S-LAM gamma),1609,"177,603",5 out of 5,1989-07-01,Evidence at protein level
Q9Y6N6,LAMC3_HUMAN,Laminin subunit gamma-3 (Laminin-12 subunit gamma) (Laminin-14 subunit gamma) (Laminin-15 subunit gamma),1575,"171,227",5 out of 5,2001-12-13,Evidence at protein level
Q9Y383,LC7L2_HUMAN,Putative RNA-binding protein Luc7-like 2,392,"46,514",5 out of 5,2004-05-10,Evidence at protein level
Q5T7P3,LCE1B_HUMAN,Late cornified envelope protein 1B (Late envelope protein 2) (Small proline-rich-like epidermal differentiation complex protein 2A),118,"11,626",5 out of 5,2006-05-16,Evidence at protein level
Q5T5A8,LCE3C_HUMAN,Late cornified envelope protein 3C (Late envelope protein 15) (Small proline-rich-like epidermal differentiation complex protein 3A),94,"9,729",5 out of 5,2006-05-16,Evidence at protein level
Q6ZMV7,LEKR1_HUMAN,"Leucine-, glutamate- and lysine-rich protein 1",388,"45,158",2 out of 5,2008-03-18,Evidence at transcript level
Q9Y5L5,LENEP_HUMAN,Lens epithelial cell protein LEP503,61,"6,908",2 out of 5,2000-05-30,Evidence at transcript level
Q7Z429,LFG1_HUMAN,Protein lifeguard 1 (Glutamate [NMDA] receptor-associated protein 1) (NMDA receptor glutamate-binding subunit) (Putative MAPK-activating protein PM02) (Transmembrane BAX inhibitor motif-containing protein 3),371,"41,203",4 out of 5,2008-01-15,Evidence at transcript level
Q86WI0,LHPL1_HUMAN,Lipoma HMGIC fusion partner-like 1 protein,220,"23,777",3 out of 5,2006-06-27,Evidence at transcript level
P48742,LHX1_HUMAN,LIM/homeobox protein Lhx1 (LIM homeobox protein 1) (Homeobox protein Lim-1) (hLim-1),406,"44,808",5 out of 5,1996-02-01,Evidence at transcript level
Q96GY3,LIN37_HUMAN,Protein lin-37 homolog (Antolefinin),246,"28,383",5 out of 5,2006-05-30,Evidence at protein level
Q5TKA1,LIN9_HUMAN,Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein),542,"61,946",5 out of 5,2006-09-19,Evidence at protein level
O75334,LIPA2_HUMAN,Liprin-alpha-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-2) (PTPRF-interacting protein alpha-2),1257,"143,291",5 out of 5,2004-02-16,Evidence at protein level
Q6XZB0,LIPI_HUMAN,Lipase member I (LIPI) (EC 3.1.1.-) (Cancer/testis antigen 17) (CT17) (LPD lipase) (Membrane-associated phosphatidic acid-selective phospholipase A1-beta) (mPA-PLA1 beta),460,"52,992",5 out of 5,2005-11-08,Evidence at protein level
P54315,LIPR1_HUMAN,Inactive pancreatic lipase-related protein 1 (PL-RP1),467,"51,848",5 out of 5,1996-10-01,Evidence at protein level
Q8NHL6,LIRB1_HUMAN,Leukocyte immunoglobulin-like receptor subfamily B member 1 (LIR-1) (Leukocyte immunoglobulin-like receptor 1) (CD85 antigen-like family member J) (Immunoglobulin-like transcript 2) (ILT-2) (Monocyte/macrophage immunoglobulin-like receptor 7) (MIR-7) (CD antigen CD85j),650,"70,819",5 out of 5,2003-10-03,Evidence at protein level
Q9BRT6,LLPH_HUMAN,Protein LLP homolog (Protein LAPS18-like),129,"15,225",3 out of 5,2007-02-06,Evidence at protein level
P61968,LMO4_HUMAN,LIM domain transcription factor LMO4 (Breast tumor autoantigen) (LIM domain only protein 4) (LMO-4),165,"17,994",5 out of 5,2004-06-07,Evidence at protein level
Q9BQE6,LBHD1_HUMAN,LBH domain-containing protein 1,289,"31,565",2 out of 5,2007-04-17,Evidence at protein level
Q14739,LBR_HUMAN,Lamin-B receptor (Integral nuclear envelope inner membrane protein) (LMN2R),615,"70,703",5 out of 5,1997-11-01,Evidence at protein level
O95447,LCA5L_HUMAN,Lebercilin-like protein (Leber congenital amaurosis 5-like protein),670,"76,505",3 out of 5,2000-05-30,Evidence at protein level
Q5TA81,LCE2C_HUMAN,Late cornified envelope protein 2C (Late envelope protein 11),110,"11,224",5 out of 5,2006-05-16,Evidence at protein level
Q5TCM9,LCE5A_HUMAN,Late cornified envelope protein 5A (Late envelope protein 18) (Small proline-rich-like epidermal differentiation complex protein 5A),118,"11,795",5 out of 5,2006-05-16,Evidence at protein level
Q6UWP7,LCLT1_HUMAN,Lysocardiolipin acyltransferase 1 (EC 2.3.1.-) (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 8) (1-AGP acyltransferase 8) (1-AGPAT 8) (Acyl-CoA:lysocardiolipin acyltransferase 1),414,"48,920",5 out of 5,2007-06-26,Evidence at protein level
Q8WX39,LCN9_HUMAN,Epididymal-specific lipocalin-9 (MUP-like lipocalin),176,"20,285",3 out of 5,2002-04-16,Evidence at transcript level
Q13094,LCP2_HUMAN,Lymphocyte cytosolic protein 2 (SH2 domain-containing leukocyte protein of 76 kDa) (SLP-76 tyrosine phosphoprotein) (SLP76),533,"60,188",5 out of 5,2000-12-01,Evidence at protein level
Q9H6V9,LDAH_HUMAN,Lipid droplet-associated hydrolase (EC 3.1.1.-) (Lipid droplet-associated serine hydrolase) (hLDAH),325,"37,319",3 out of 5,2007-09-11,Evidence at protein level
P00338,LDHA_HUMAN,L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59),332,"36,689",5 out of 5,1986-07-21,Evidence at protein level
Q969E1,LEAP2_HUMAN,Liver-expressed antimicrobial peptide 2 (LEAP-2),77,"8,814",3 out of 5,2002-03-05,Evidence at protein level
Q96BZ8,LENG1_HUMAN,Leukocyte receptor cluster member 1,264,"30,529",5 out of 5,2006-10-31,Evidence at protein level
Q2VYF4,LETM2_HUMAN,"LETM1 domain-containing protein LETM2, mitochondrial (LETM1 and EF-hand domain-containing protein 2) (Leucine zipper-EF-hand-containing transmembrane protein 1-like)",491,"55,921",3 out of 5,2007-10-23,Evidence at transcript level
O43261,LEU1_HUMAN,Leukemia-associated protein 1 (Deleted in lymphocytic leukemia 1) (HBV X-transactivated gene 6 protein) (HBV XAg-transactivated protein 6),78,"8,962",2 out of 5,2000-12-01,Evidence at protein level
P16150,LEUK_HUMAN,Leukosialin (Galactoglycoprotein) (GALGP) (Leukocyte sialoglycoprotein) (Sialophorin) (CD antigen CD43),400,"40,322",5 out of 5,1990-04-01,Evidence at protein level
Q969X1,LFG3_HUMAN,Protein lifeguard 3 (Protein RECS1 homolog) (Transmembrane BAX inhibitor motif-containing protein 1),311,"34,607",5 out of 5,2003-11-21,Evidence at protein level
Q8NES3,LFNG_HUMAN,"Beta-1,3-N-acetylglucosaminyltransferase lunatic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",379,"41,773",5 out of 5,2003-01-10,Evidence at protein level
O00292,LFTY2_HUMAN,Left-right determination factor 2 (Endometrial bleeding-associated factor) (Left-right determination factor A) (Protein lefty-2) (Protein lefty-A) (Transforming growth factor beta-4) (TGF-beta-4),366,"40,920",5 out of 5,1997-11-01,Evidence at protein level
Q92604,LGAT1_HUMAN,Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 (EC 2.3.1.-),370,"43,089",4 out of 5,1999-07-15,Evidence at protein level
Q8N0V4,LGI2_HUMAN,Leucine-rich repeat LGI family member 2 (LGI1-like protein 2) (Leucine-rich glioma-inactivated protein 2),545,"62,298",3 out of 5,2003-07-03,Evidence at transcript level
Q5TDP6,LGSN_HUMAN,Lengsin (Glutamate-ammonia ligase domain-containing protein 1) (Lens glutamine synthase-like),509,"57,278",3 out of 5,2005-02-01,Evidence at protein level
Q6ZUX7,LHPL2_HUMAN,Lipoma HMGIC fusion partner-like 2 protein,228,"24,486",3 out of 5,2006-06-27,Evidence at transcript level
Q9UPQ0,LIMC1_HUMAN,LIM and calponin homology domains-containing protein 1,1083,"121,867",4 out of 5,2007-07-10,Evidence at protein level
Q9H400,LIME1_HUMAN,Lck-interacting transmembrane adapter 1 (Lck-interacting membrane protein) (Lck-interacting molecule),295,"31,288",5 out of 5,2005-12-20,Evidence at protein level
P53671,LIMK2_HUMAN,LIM domain kinase 2 (LIMK-2) (EC 2.7.11.1),638,"72,232",5 out of 5,1996-10-01,Evidence at protein level
Q9HAT1,LMA1L_HUMAN,Protein ERGIC-53-like (ERGIC53-like protein) (Lectin mannose-binding 1-like) (LMAN1-like protein),526,"57,129",4 out of 5,2002-05-27,Evidence at transcript level
P49257,LMAN1_HUMAN,Protein ERGIC-53 (ER-Golgi intermediate compartment 53 kDa protein) (Gp58) (Intracellular mannose-specific lectin MR60) (Lectin mannose-binding 1),510,"57,549",5 out of 5,1996-02-01,Evidence at protein level
Q9Y468,LMBL1_HUMAN,Lethal(3)malignant brain tumor-like protein 1 (H-l(3)mbt) (H-l(3)mbt protein) (L(3)mbt-like) (L(3)mbt protein homolog) (L3MBTL1),752,"83,884",5 out of 5,2002-09-19,Evidence at protein level
Q9BU23,LMF2_HUMAN,Lipase maturation factor 2 (Transmembrane protein 112B) (Transmembrane protein 153),707,"79,698",4 out of 5,2008-03-18,Evidence at protein level
P02545,LMNA_HUMAN,Prelamin-A/C [Cleaved into: Lamin-A/C (70 kDa lamin) (Renal carcinoma antigen NY-REN-32)],664,"74,139",5 out of 5,1986-07-21,Evidence at protein level
P29536,LMOD1_HUMAN,"Leiomodin-1 (64 kDa autoantigen 1D) (64 kDa autoantigen 1D3) (64 kDa autoantigen D1) (Leiomodin, muscle form) (Smooth muscle leiomodin) (SM-Lmod) (Thyroid-associated ophthalmopathy autoantigen)",600,"67,030",5 out of 5,1993-04-01,Evidence at protein level
P43657,LPAR6_HUMAN,Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor),344,"39,392",5 out of 5,1995-11-01,Evidence at protein level
Q643R3,LPCT4_HUMAN,Lysophospholipid acyltransferase LPCAT4 (1-acylglycerol-3-phosphate O-acyltransferase 7) (1-AGP acyltransferase 7) (1-AGPAT 7) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (1-alkenylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.121) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acyltransferase-like 3) (Lysophosphatidylcholine acyltransferase 4) (Lysophosphatidylethanolamine acyltransferase 2) (EC 2.3.1.n7) (Plasmalogen synthase),524,"57,219",5 out of 5,2006-07-25,Evidence at protein level
A0A183,LCE6A_HUMAN,Late cornified envelope protein 6A,80,"9,022",2 out of 5,2008-01-15,Inferred from homology
O75112,LDB3_HUMAN,LIM domain-binding protein 3 (Protein cypher) (Z-band alternatively spliced PDZ-motif protein),727,"77,135",5 out of 5,2005-12-06,Evidence at protein level
P07864,LDHC_HUMAN,L-lactate dehydrogenase C chain (LDH-C) (EC 1.1.1.27) (Cancer/testis antigen 32) (CT32) (LDH testis subunit) (LDH-X),332,"36,311",5 out of 5,1988-08-01,Evidence at protein level
Q96DT0,LEG12_HUMAN,Galectin-12 (Gal-12) (Galectin-related inhibitor of proliferation),336,"37,542",4 out of 5,2002-04-03,Evidence at protein level
P56470,LEG4_HUMAN,Galectin-4 (Gal-4) (Antigen NY-CO-27) (L-36 lactose-binding protein) (L36LBP) (Lactose-binding lectin 4),323,"35,941",4 out of 5,1998-07-15,Evidence at protein level
A8MZ59,LEUTX_HUMAN,Leucine-twenty homeobox,168,"18,626",2 out of 5,2008-07-22,Evidence at transcript level
Q7Z7J7,LHPL4_HUMAN,Lipoma HMGIC fusion partner-like 4 protein,247,"27,007",2 out of 5,2007-05-01,Evidence at transcript level
Q9NQ69,LHX9_HUMAN,LIM/homeobox protein Lhx9 (LIM homeobox protein 9),397,"43,976",4 out of 5,2001-01-24,Evidence at protein level
O14910,LIN7A_HUMAN,Protein lin-7 homolog A (Lin-7A) (hLin-7) (Mammalian lin-seven protein 1) (MALS-1) (Tax interaction protein 33) (TIP-33) (Vertebrate lin-7 homolog 1) (Veli-1),233,"25,997",5 out of 5,2005-02-15,Evidence at protein level
Q5VXJ0,LIPK_HUMAN,Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2),399,"45,563",4 out of 5,2007-05-15,Evidence at transcript level
Q9Y234,LIPT_HUMAN,"Lipoyltransferase 1, mitochondrial (EC 2.3.1.-) (Lipoate biosynthesis protein) (Lipoate-protein ligase) (Lipoyl ligase)",373,"42,479",5 out of 5,2002-10-10,Evidence at protein level
O75019,LIRA1_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 1 (CD85 antigen-like family member I) (Leukocyte immunoglobulin-like receptor 6) (LIR-6) (CD antigen CD85i),489,"53,275",5 out of 5,2003-10-03,Evidence at transcript level
Q8NHJ6,LIRB4_HUMAN,Leukocyte immunoglobulin-like receptor subfamily B member 4 (CD85 antigen-like family member K) (Immunoglobulin-like transcript 3) (ILT-3) (Leukocyte immunoglobulin-like receptor 5) (LIR-5) (Monocyte inhibitory receptor HM18) (CD antigen CD85k),448,"49,356",5 out of 5,2003-10-03,Evidence at protein level
Q8IVB5,LIX1L_HUMAN,LIX1-like protein,337,"36,563",1 out of 5,2006-04-18,Evidence at transcript level
Q6UX01,LMBRL_HUMAN,Protein LMBR1L (Limb region 1 protein homolog-like) (Lipocalin-1-interacting membrane receptor) (Lipocalin-interacting membrane receptor),489,"55,209",4 out of 5,2006-01-10,Evidence at protein level
Q9H9Z2,LN28A_HUMAN,Protein lin-28 homolog A (Lin-28A) (Zinc finger CCHC domain-containing protein 1),209,"22,743",5 out of 5,2006-10-17,Evidence at protein level
A1A4G5,LNP1_HUMAN,Leukemia NUP98 fusion partner 1,178,"21,321",2 out of 5,2008-06-10,Evidence at transcript level
P36776,LONM_HUMAN,"Lon protease homolog, mitochondrial (EC 3.4.21.-) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",959,"106,489",5 out of 5,1994-06-01,Evidence at protein level
Q9BWQ8,LFG2_HUMAN,Protein lifeguard 2 (Fas apoptotic inhibitory molecule 2) (Neural membrane protein 35) (Transmembrane BAX inhibitor motif-containing protein 2),316,"35,110",5 out of 5,2003-11-21,Evidence at protein level
Q99538,LGMN_HUMAN,"Legumain (EC 3.4.22.34) (Asparaginyl endopeptidase) (Protease, cysteine 1)",433,"49,411",5 out of 5,1997-11-01,Evidence at protein level
Q9BXB1,LGR4_HUMAN,Leucine-rich repeat-containing G-protein coupled receptor 4 (G-protein coupled receptor 48),951,"104,475",5 out of 5,2002-06-20,Evidence at protein level
Q04760,LGUL_HUMAN,Lactoylglutathione lyase (EC 4.4.1.5) (Aldoketomutase) (Glyoxalase I) (Glx I) (Ketone-aldehyde mutase) (Methylglyoxalase) (S-D-lactoylglutathione methylglyoxal lyase),184,"20,778",5 out of 5,1993-10-01,Evidence at protein level
Q969G2,LHX4_HUMAN,LIM/homeobox protein Lhx4 (LIM homeobox protein 4),390,"43,124",5 out of 5,2002-01-23,Evidence at protein level
Q8WWY8,LIPH_HUMAN,Lipase member H (LIPH) (EC 3.1.1.-) (LPD lipase-related protein) (Membrane-associated phosphatidic acid-selective phospholipase A1-alpha) (mPA-PLA1 alpha) (Phospholipase A1 member B),451,"50,859",5 out of 5,2007-01-23,Evidence at protein level
P43034,LIS1_HUMAN,Platelet-activating factor acetylhydrolase IB subunit alpha (Lissencephaly-1 protein) (LIS-1) (PAF acetylhydrolase 45 kDa subunit) (PAF-AH 45 kDa subunit) (PAF-AH alpha) (PAFAH alpha),410,"46,638",5 out of 5,1995-11-01,Evidence at protein level
Q96L50,LLR1_HUMAN,Leucine-rich repeat protein 1 (4-1BB-mediated-signaling molecule) (4-1BBlrr) (LRR-repeat protein 1) (LRR-1) (Peptidylprolyl isomerase-like 5),414,"46,723",5 out of 5,2003-09-26,Evidence at protein level
Q8NA19,LMBL4_HUMAN,Lethal(3)malignant brain tumor-like protein 4 (H-l(3)mbt-like protein 4) (L(3)mbt-like protein 4) (L3mbt-like 4),623,"71,122",3 out of 5,2008-05-20,Evidence at protein level
Q8WVP7,LMBR1_HUMAN,Limb region 1 protein homolog (Differentiation-related gene 14 protein),490,"55,098",5 out of 5,2006-01-10,Evidence at protein level
Q96S06,LMF1_HUMAN,Lipase maturation factor 1 (Transmembrane protein 112),567,"64,873",5 out of 5,2007-02-06,Evidence at protein level
P20700,LMNB1_HUMAN,Lamin-B1,586,"66,408",5 out of 5,1991-02-01,Evidence at protein level
Q8IXW0,LMTD2_HUMAN,Lamin tail domain-containing protein 2,634,"70,379",2 out of 5,2006-10-03,Evidence at transcript level
Q8TBB1,LNX1_HUMAN,E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX),728,"80,629",5 out of 5,2003-02-28,Evidence at protein level
Q496Y0,LONF3_HUMAN,LON peptidase N-terminal domain and RING finger protein 3 (RING finger protein 127),759,"84,490",4 out of 5,2007-02-20,Evidence at protein level
Q9H1C0,LPAR5_HUMAN,Lysophosphatidic acid receptor 5 (LPA receptor 5) (LPA-5) (G-protein coupled receptor 92) (G-protein coupled receptor 93),372,"41,347",3 out of 5,2003-10-10,Evidence at transcript level
P42704,LPPRC_HUMAN,"Leucine-rich PPR motif-containing protein, mitochondrial (130 kDa leucine-rich protein) (LRP 130) (GP130)",1394,"157,905",5 out of 5,1995-11-01,Evidence at protein level
Q5BKY1,LRC10_HUMAN,Leucine-rich repeat-containing protein 10,277,"31,642",2 out of 5,2005-09-27,Evidence at transcript level
Q8TF66,LRC15_HUMAN,Leucine-rich repeat-containing protein 15 (Leucine-rich repeat protein induced by beta-amyloid homolog) (hLib),581,"64,366",5 out of 5,2003-05-09,Evidence at transcript level
Q50LG9,LRC24_HUMAN,Leucine-rich repeat-containing protein 24,513,"55,257",2 out of 5,2006-04-04,Evidence at transcript level
Q8N386,LRC25_HUMAN,Leucine-rich repeat-containing protein 25 (Monocyte and plasmacytoid-activated protein),305,"33,179",3 out of 5,2004-05-24,Evidence at protein level
Q86X40,LRC28_HUMAN,Leucine-rich repeat-containing protein 28,367,"41,912",2 out of 5,2007-01-23,Evidence at transcript level
Q14392,LRC32_HUMAN,Leucine-rich repeat-containing protein 32 (Garpin) (Glycoprotein A repetitions predominant) (GARP),662,"71,979",4 out of 5,1997-11-01,Evidence at protein level
Q96CN5,LRC45_HUMAN,Leucine-rich repeat-containing protein 45,670,"75,951",4 out of 5,2006-02-21,Evidence at protein level
A6NM62,LRC53_HUMAN,Leucine-rich repeat-containing protein 53,1247,"140,742",2 out of 5,2008-02-05,Predicted
Q8IYG6,LRC56_HUMAN,Leucine-rich repeat-containing protein 56,542,"58,733",2 out of 5,2006-04-04,Evidence at transcript level
Q96CX6,LRC58_HUMAN,Leucine-rich repeat-containing protein 58,371,"40,586",2 out of 5,2007-12-04,Evidence at protein level
A6NIV6,LRIQ4_HUMAN,Leucine-rich repeat and IQ domain-containing protein 4 (Leucine-rich repeat-containing protein 64),560,"63,977",2 out of 5,2008-04-29,Predicted
Q6JVE6,LCN10_HUMAN,Epididymal-specific lipocalin-10,187,"20,759",3 out of 5,2005-03-29,Evidence at protein level
P62502,LCN6_HUMAN,Epididymal-specific lipocalin-6 (Lipocalin-5),163,"18,045",3 out of 5,2004-07-19,Evidence at protein level
Q96JN0,LCOR_HUMAN,Ligand-dependent corepressor (LCoR) (Mblk1-related protein 2),433,"47,007",5 out of 5,2006-05-30,Evidence at protein level
Q86WU2,LDHD_HUMAN,"Probable D-lactate dehydrogenase, mitochondrial (DLD) (Lactate dehydrogenase D) (EC 1.1.2.4)",507,"54,871",4 out of 5,2006-11-28,Evidence at protein level
Q8NC56,LEMD2_HUMAN,LEM domain-containing protein 2 (hLEM2),503,"56,975",5 out of 5,2007-05-01,Evidence at protein level
O95970,LGI1_HUMAN,Leucine-rich glioma-inactivated protein 1 (Epitempin-1),557,"63,818",5 out of 5,2003-07-03,Evidence at protein level
O75473,LGR5_HUMAN,Leucine-rich repeat-containing G-protein coupled receptor 5 (G-protein coupled receptor 49) (G-protein coupled receptor 67) (G-protein coupled receptor HG38),907,"99,998",5 out of 5,2002-06-20,Evidence at protein level
Q9UBR4,LHX3_HUMAN,LIM/homeobox protein Lhx3 (LIM homeobox protein 3),397,"43,358",5 out of 5,2000-05-30,Evidence at protein level
O75145,LIPA3_HUMAN,Liprin-alpha-3 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-3) (PTPRF-interacting protein alpha-3),1194,"133,496",5 out of 5,2004-02-16,Evidence at protein level
P16233,LIPP_HUMAN,Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3),465,"51,157",5 out of 5,1990-04-01,Evidence at protein level
Q8N149,LIRA2_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 2 (CD85 antigen-like family member H) (Immunoglobulin-like transcript 1) (ILT-1) (Leukocyte immunoglobulin-like receptor 7) (LIR-7) (CD antigen CD85h),483,"52,992",5 out of 5,2003-10-03,Evidence at protein level
P59901,LIRA4_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 4 (CD85 antigen-like family member G) (Immunoglobulin-like transcript 7) (ILT-7) (CD antigen CD85g),499,"55,165",4 out of 5,2003-10-03,Evidence at protein level
P09960,LKHA4_HUMAN,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase),611,"69,285",5 out of 5,1989-07-01,Evidence at protein level
Q8TAP4,LMO3_HUMAN,LIM domain only protein 3 (LMO-3) (Neuronal-specific transcription factor DAT1) (Rhombotin-3),145,"16,594",5 out of 5,2003-08-15,Evidence at protein level
P01130,LDLR_HUMAN,Low-density lipoprotein receptor (LDL receptor),860,"95,376",5 out of 5,1986-07-21,Evidence at protein level
Q9UJU2,LEF1_HUMAN,Lymphoid enhancer-binding factor 1 (LEF-1) (T cell-specific transcription factor 1-alpha) (TCF1-alpha),399,"44,201",5 out of 5,2000-12-01,Evidence at protein level
Q3ZCW2,LEGL_HUMAN,Galectin-related protein (Lectin galactoside-binding-like protein),172,"18,986",3 out of 5,2008-01-15,Evidence at protein level
Q6UYE1,LEU7_HUMAN,Leukemia-associated protein 7 (Deleted in lymphocytic leukemia 7),221,"23,924",2 out of 5,2007-04-03,Evidence at transcript level
Q08380,LG3BP_HUMAN,Galectin-3-binding protein (Basement membrane autoantigen p105) (Lectin galactoside-binding soluble 3-binding protein) (Mac-2-binding protein) (MAC2BP) (Mac-2 BP) (Tumor-associated antigen 90K),585,"65,331",5 out of 5,2004-05-10,Evidence at protein level
Q68G74,LHX8_HUMAN,LIM/homeobox protein Lhx8 (LIM homeobox protein 8),356,"39,301",4 out of 5,2007-07-24,Evidence at protein level
P48059,LIMS1_HUMAN,LIM and senescent cell antigen-like-containing domain protein 1 (Particularly interesting new Cys-His protein 1) (PINCH-1) (Renal carcinoma antigen NY-REN-48),325,"37,251",5 out of 5,1996-02-01,Evidence at protein level
Q6MZP7,LIN54_HUMAN,Protein lin-54 homolog (CXC domain-containing protein 1),749,"79,494",5 out of 5,2008-07-22,Evidence at protein level
Q99732,LITAF_HUMAN,Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein),161,"17,107",5 out of 5,2000-05-30,Evidence at protein level
Q96JM7,LMBL3_HUMAN,Lethal(3)malignant brain tumor-like protein 3 (H-l(3)mbt-like protein 3) (L(3)mbt-like protein 3) (MBT-1),780,"88,337",5 out of 5,2005-04-26,Evidence at protein level
Q9NZU5,LMCD1_HUMAN,LIM and cysteine-rich domains protein 1 (Dyxin),365,"40,833",5 out of 5,2002-05-15,Evidence at protein level
Q03252,LMNB2_HUMAN,Lamin-B2,620,"69,948",5 out of 5,1994-06-01,Evidence at protein level
O60663,LMX1B_HUMAN,LIM homeobox transcription factor 1-beta (LIM/homeobox protein 1.2) (LMX-1.2) (LIM/homeobox protein LMX1B),402,"44,917",5 out of 5,1998-12-15,Evidence at protein level
Q9C0E8,LNP_HUMAN,Protein lunapark,428,"47,740",5 out of 5,2006-09-05,Evidence at protein level
Q8N448,LNX2_HUMAN,Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1),690,"76,004",4 out of 5,2003-02-28,Evidence at protein level
P16050,LOX15_HUMAN,"Arachidonate 15-lipoxygenase (15-LOX) (15-LOX-1) (EC 1.13.11.33) (12/15-lipoxygenase) (Arachidonate 12-lipoxygenase, leukocyte-type) (12-LOX) (EC 1.13.11.31) (Arachidonate omega-6 lipoxygenase)",662,"74,804",5 out of 5,1990-04-01,Evidence at protein level
Q9HBW0,LPAR2_HUMAN,Lysophosphatidic acid receptor 2 (LPA receptor 2) (LPA-2) (Lysophosphatidic acid receptor Edg-4),351,"39,084",5 out of 5,2002-12-06,Evidence at protein level
Q9UBY5,LPAR3_HUMAN,Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7),353,"40,128",5 out of 5,2002-12-06,Evidence at transcript level
Q96QE4,LR37B_HUMAN,Leucine-rich repeat-containing protein 37B (C66 SLIT-like testicular protein),947,"105,567",3 out of 5,2006-04-18,Evidence at transcript level
Q8NAA5,LR75A_HUMAN,Leucine-rich repeat-containing protein 75A (Leucine-rich repeat-containing protein FAM211A),344,"37,780",2 out of 5,2007-05-15,Evidence at transcript level
Q5SZI1,LRAD2_HUMAN,Low-density lipoprotein receptor class A domain-containing protein 2,272,"28,581",3 out of 5,2007-09-11,Evidence at transcript level
O15165,LRAD4_HUMAN,Low-density lipoprotein receptor class A domain-containing protein 4,306,"33,900",5 out of 5,2001-01-24,Evidence at protein level
Q15048,LRC14_HUMAN,Leucine-rich repeat-containing protein 14,493,"54,513",2 out of 5,2000-05-30,Evidence at transcript level
Q8N6Y2,LRC17_HUMAN,Leucine-rich repeat-containing protein 17 (p37NB),441,"51,800",3 out of 5,2004-08-31,Evidence at transcript level
Q8TCA0,LRC20_HUMAN,Leucine-rich repeat-containing protein 20,184,"20,509",2 out of 5,2005-10-25,Evidence at protein level
Q8WV35,LRC29_HUMAN,Leucine-rich repeat-containing protein 29 (F-box and leucine-rich repeat protein 9) (F-box protein FBL9) (F-box/LRR-repeat protein 9),223,"23,797",3 out of 5,2003-11-07,Evidence at protein level
Q9Y546,LRC42_HUMAN,Leucine-rich repeat-containing protein 42,428,"48,571",2 out of 5,2006-02-21,Evidence at protein level
Q96E66,LRC51_HUMAN,Leucine-rich repeat-containing protein 51 (Protein LRTOMT1),192,"22,206",3 out of 5,2006-03-07,Evidence at transcript level
Q96AG4,LRC59_HUMAN,Leucine-rich repeat-containing protein 59 (Ribosome-binding protein p34) (p34),307,"34,930",5 out of 5,2006-05-16,Evidence at protein level
Q7L1W4,LRC8D_HUMAN,Volume-regulated anion channel subunit LRRC8D (Leucine-rich repeat-containing protein 5) (Leucine-rich repeat-containing protein 8D),858,"98,201",5 out of 5,2004-08-31,Evidence at protein level
Q96II8,LRCH3_HUMAN,Leucine-rich repeat and calponin homology domain-containing protein 3,777,"86,083",3 out of 5,2006-10-17,Evidence at protein level
Q9BTN0,LRFN3_HUMAN,Leucine-rich repeat and fibronectin type-III domain-containing protein 3 (Synaptic adhesion-like molecule 4),628,"66,260",5 out of 5,2005-03-29,Evidence at transcript level
Q7Z4F1,LRP10_HUMAN,Low-density lipoprotein receptor-related protein 10 (LRP-10),713,"76,193",4 out of 5,2004-04-13,Evidence at protein level
Q9Y561,LRP12_HUMAN,Low-density lipoprotein receptor-related protein 12 (LRP-12) (Suppressor of tumorigenicity 7 protein),859,"94,984",5 out of 5,2002-11-15,Evidence at protein level
Q8N967,LRTM2_HUMAN,Leucine-rich repeat and transmembrane domain-containing protein 2,370,"41,158",3 out of 5,2006-12-12,Evidence at transcript level
Q9UGP4,LIMD1_HUMAN,LIM domain-containing protein 1,676,"72,190",5 out of 5,2004-05-24,Evidence at protein level
Q7Z4I7,LIMS2_HUMAN,LIM and senescent cell antigen-like-containing domain protein 2 (LIM-like protein 2) (Particularly interesting new Cys-His protein 2) (PINCH-2),341,"38,916",5 out of 5,2006-12-12,Evidence at protein level
Q9HAP6,LIN7B_HUMAN,Protein lin-7 homolog B (Lin-7B) (hLin7B) (Mammalian lin-seven protein 2) (MALS-2) (Vertebrate lin-7 homolog 2) (Veli-2) (hVeli2),207,"22,896",5 out of 5,2005-02-15,Evidence at protein level
P06858,LIPL_HUMAN,Lipoprotein lipase (LPL) (EC 3.1.1.34),475,"53,162",5 out of 5,1988-01-01,Evidence at protein level
A6NI73,LIRA5_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 5 (CD85 antigen-like family member F) (Immunoglobulin-like transcript 11) (ILT-11) (Leukocyte immunoglobulin-like receptor 9) (LIR-9) (CD antigen CD85f),299,"32,755",5 out of 5,2008-02-26,Evidence at protein level
O75022,LIRB3_HUMAN,Leukocyte immunoglobulin-like receptor subfamily B member 3 (LIR-3) (Leukocyte immunoglobulin-like receptor 3) (CD85 antigen-like family member A) (Immunoglobulin-like transcript 5) (ILT-5) (Monocyte inhibitory receptor HL9) (CD antigen CD85a),631,"69,386",5 out of 5,2003-10-03,Evidence at transcript level
O75023,LIRB5_HUMAN,Leukocyte immunoglobulin-like receptor subfamily B member 5 (CD85 antigen-like family member C) (Leukocyte immunoglobulin-like receptor 8) (LIR-8) (CD antigen CD85c),590,"64,126",5 out of 5,2003-10-03,Evidence at protein level
Q5T7N2,LITD1_HUMAN,LINE-1 type transposase domain-containing protein 1 (ES cell-associated protein 11),865,"98,850",3 out of 5,2007-10-23,Evidence at protein level
Q8N485,LIX1_HUMAN,Protein limb expression 1 homolog,282,"31,891",2 out of 5,2006-04-18,Evidence at transcript level
Q8WWI1,LMO7_HUMAN,LIM domain only protein 7 (LMO-7) (F-box only protein 20) (LOMP),1683,"192,696",5 out of 5,2004-03-15,Evidence at protein level
Q8IVV2,LOXH1_HUMAN,Lipoxygenase homology domain-containing protein 1,1947,"221,947",4 out of 5,2007-10-23,Evidence at transcript level
P58215,LOXL3_HUMAN,Lysyl oxidase homolog 3 (EC 1.4.3.-) (EC 1.4.3.13) (Lysyl oxidase-like protein 3),753,"83,166",5 out of 5,2001-07-11,Evidence at protein level
Q16609,LPAL2_HUMAN,Putative apolipoprotein(a)-like protein 2 (Apo(a)-like protein 2) (Lp(a)-liker protein 2) (Apolipoprotein a-related gene C protein) (Apo(a)rg-C),132,"14,886",3 out of 5,2008-02-05,Uncertain
Q86U10,LPP60_HUMAN,60 kDa lysophospholipase (EC 3.1.1.5) [Includes: L-asparaginase (EC 3.5.1.1) (L-asparagine amidohydrolase); Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47)],573,"60,883",5 out of 5,2008-03-18,Evidence at transcript level
Q0VAA2,LR74A_HUMAN,Leucine-rich repeat-containing protein 74A (Leucine-rich repeat-containing protein 74),488,"54,535",2 out of 5,2007-10-02,Evidence at transcript level
Q5T700,LRAD1_HUMAN,Low-density lipoprotein receptor class A domain-containing protein 1,205,"21,834",5 out of 5,2007-09-11,Evidence at protein level
P50851,LRBA_HUMAN,Lipopolysaccharide-responsive and beige-like anchor protein (Beige-like protein) (CDC4-like protein),2863,"319,108",5 out of 5,1996-10-01,Evidence at protein level
Q96DD0,LRC39_HUMAN,Leucine-rich repeat-containing protein 39 (Densin hlg),335,"38,793",2 out of 5,2006-04-18,Evidence at transcript level
Q15345,LRC41_HUMAN,Leucine-rich repeat-containing protein 41 (Protein Muf1),812,"88,650",4 out of 5,2004-01-16,Evidence at protein level
Q9NT99,LRC4B_HUMAN,Leucine-rich repeat-containing protein 4B (Netrin-G3 ligand) (NGL-3),713,"76,434",5 out of 5,2006-04-04,Evidence at transcript level
Q9HCJ2,LRC4C_HUMAN,Leucine-rich repeat-containing protein 4C (Netrin-G1 ligand) (NGL-1),640,"71,950",5 out of 5,2005-01-04,Evidence at protein level
Q05C16,LRC63_HUMAN,Leucine-rich repeat-containing protein 63,580,"66,309",2 out of 5,2008-02-26,Evidence at transcript level
Q5T3J3,LRIF1_HUMAN,Ligand-dependent nuclear receptor-interacting factor 1 (Receptor-interacting factor 1),769,"84,568",5 out of 5,2006-10-03,Evidence at protein level
A6PVS8,LRIQ3_HUMAN,Leucine-rich repeat and IQ domain-containing protein 3 (Leucine-rich repeat-containing protein 44),624,"73,675",3 out of 5,2007-11-13,Evidence at protein level
Q86VZ4,LRP11_HUMAN,Low-density lipoprotein receptor-related protein 11 (LRP-11),500,"53,311",4 out of 5,2004-05-10,Evidence at transcript level
Q9NZR2,LRP1B_HUMAN,Low-density lipoprotein receptor-related protein 1B (LRP-1B) (Low-density lipoprotein receptor-related protein-deleted in tumor) (LRP-DIT),4599,"515,498",5 out of 5,2004-04-26,Evidence at protein level
P98164,LRP2_HUMAN,Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin),4655,"521,958",5 out of 5,1996-10-01,Evidence at protein level
O75074,LRP3_HUMAN,Low-density lipoprotein receptor-related protein 3 (LRP-3) (105 kDa low-density lipoprotein receptor-related protein) (hLRp105),770,"82,884",4 out of 5,2004-04-13,Evidence at transcript level
O75096,LRP4_HUMAN,Low-density lipoprotein receptor-related protein 4 (LRP-4) (Multiple epidermal growth factor-like domains 7),1905,"212,045",5 out of 5,2004-04-13,Evidence at protein level
A4QPB2,LRP5L_HUMAN,Low-density lipoprotein receptor-related protein 5-like protein (LRP-5-like),252,"28,483",2 out of 5,2007-07-10,Evidence at transcript level
Q8WUT4,LRRN4_HUMAN,Leucine-rich repeat neuronal protein 4 (Neuronal leucine-rich repeat protein 4) (NLRR-4),740,"78,843",3 out of 5,2003-02-28,Evidence at transcript level
Q9HBL6,LRTM1_HUMAN,Leucine-rich repeat and transmembrane domain-containing protein 1,345,"38,171",3 out of 5,2007-03-06,Evidence at transcript level
Q9BVC4,LST8_HUMAN,Target of rapamycin complex subunit LST8 (TORC subunit LST8) (G protein beta subunit-like) (Gable) (Protein GbetaL) (Mammalian lethal with SEC13 protein 8) (mLST8),326,"35,876",5 out of 5,2008-04-08,Evidence at protein level
Q9NPC1,LT4R2_HUMAN,Leukotriene B4 receptor 2 (LTB4-R 2) (LTB4-R2) (LTB4 receptor JULF2) (Leukotriene B4 receptor BLT2) (Seven transmembrane receptor BLTR2),389,"41,525",5 out of 5,2002-10-10,Evidence at transcript level
P15018,LIF_HUMAN,Leukemia inhibitory factor (LIF) (Differentiation-stimulating factor) (D factor) (Melanoma-derived LPL inhibitor) (MLPLI) (Emfilermin),202,"22,008",5 out of 5,1990-04-01,Evidence at protein level
Q96FE5,LIGO1_HUMAN,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A),620,"69,876",5 out of 5,2008-04-08,Evidence at protein level
Q7L985,LIGO2_HUMAN,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2 (Leucine-rich repeat neuronal protein 3) (Leucine-rich repeat neuronal protein 6C),606,"68,066",3 out of 5,2008-03-18,Evidence at transcript level
Q13136,LIPA1_HUMAN,Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1),1202,"135,779",5 out of 5,2004-02-16,Evidence at protein level
O75335,LIPA4_HUMAN,Liprin-alpha-4 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4) (PTPRF-interacting protein alpha-4),1185,"134,404",4 out of 5,2004-02-16,Evidence at transcript level
Q86W92,LIPB1_HUMAN,Liprin-beta-1 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 1) (PTPRF-interacting protein-binding protein 1) (hSGT2),1011,"114,024",5 out of 5,2004-02-16,Evidence at protein level
Q9Y5X9,LIPE_HUMAN,Endothelial lipase (EC 3.1.1.3) (Endothelial cell-derived lipase) (EDL) (EL),500,"56,795",5 out of 5,2002-07-26,Evidence at protein level
P07098,LIPG_HUMAN,Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3),398,"45,238",5 out of 5,1988-04-01,Evidence at protein level
Q05469,LIPS_HUMAN,Hormone-sensitive lipase (HSL) (EC 3.1.1.79),1076,"116,598",5 out of 5,1994-02-01,Evidence at protein level
A6NK58,LIPT2_HUMAN,"Putative lipoyltransferase 2, mitochondrial (EC 2.3.1.181) (Lipoate-protein ligase B) (Lipoyl/octanoyl transferase) (Octanoyl-[acyl-carrier-protein]-protein N-octanoyltransferase)",231,"25,195",4 out of 5,2008-04-29,Inferred from homology
Q8TD35,LKAM1_HUMAN,Protein LKAAEAR1 (LKAAEAR motif-containing protein 1),194,"21,508",2 out of 5,2008-04-08,Evidence at transcript level
Q96Q04,LMTK3_HUMAN,Serine/threonine-protein kinase LMTK3 (EC 2.7.11.1) (Lemur tyrosine kinase 3),1460,"153,661",5 out of 5,2006-10-31,Evidence at protein level
P18054,LOX12_HUMAN,"Arachidonate 12-lipoxygenase, 12S-type (12S-LOX) (12S-lipoxygenase) (EC 1.13.11.31) (Lipoxin synthase 12-LO) (EC 3.3.2.-) (Platelet-type lipoxygenase 12)",663,"75,694",5 out of 5,1990-11-01,Evidence at protein level
P09917,LOX5_HUMAN,Arachidonate 5-lipoxygenase (5-LO) (5-lipoxygenase) (EC 1.13.11.34),674,"77,983",5 out of 5,1989-07-01,Evidence at protein level
Q99677,LPAR4_HUMAN,Lysophosphatidic acid receptor 4 (LPA receptor 4) (LPA-4) (G-protein coupled receptor 23) (P2Y purinoceptor 9) (P2Y9) (P2Y5-like receptor) (Purinergic receptor 9),370,"41,895",4 out of 5,1997-11-01,Evidence at protein level
Q8N309,LRC43_HUMAN,Leucine-rich repeat-containing protein 43,656,"73,022",2 out of 5,2007-12-04,Evidence at transcript level
Q6ZSA7,LRC55_HUMAN,Leucine-rich repeat-containing protein 55 (BK channel auxiliary gamma subunit LRRC55),311,"34,424",4 out of 5,2006-04-18,Evidence at protein level
Q68CR7,LRC66_HUMAN,Leucine-rich repeat-containing protein 66,880,"97,778",2 out of 5,2008-04-08,Evidence at transcript level
Q8N4P6,LRC71_HUMAN,Leucine-rich repeat-containing protein 71,559,"61,825",2 out of 5,2007-05-01,Evidence at transcript level
Q8TDW0,LRC8C_HUMAN,Volume-regulated anion channel subunit LRRC8C (Factor for adipocyte differentiation 158) (Leucine-rich repeat-containing protein 8C),803,"92,450",5 out of 5,2006-02-07,Evidence at protein level
Q6NSJ5,LRC8E_HUMAN,Volume-regulated anion channel subunit LRRC8E (Leucine-rich repeat-containing protein 8E),796,"90,247",5 out of 5,2006-02-07,Evidence at protein level
Q5VUJ6,LRCH2_HUMAN,Leucine-rich repeat and calponin homology domain-containing protein 2,765,"84,588",2 out of 5,2006-10-17,Evidence at transcript level
A6NCL2,LRCL1_HUMAN,Leucine-rich colipase-like protein 1,159,"17,834",2 out of 5,2008-09-02,Evidence at transcript level
Q86UE6,LRRT1_HUMAN,Leucine-rich repeat transmembrane neuronal protein 1,522,"58,641",5 out of 5,2005-06-21,Evidence at transcript level
Q9H089,LSG1_HUMAN,Large subunit GTPase 1 homolog (hLsg1) (EC 3.6.1.-),658,"75,225",5 out of 5,2008-03-18,Evidence at protein level
O43504,LTOR5_HUMAN,Ragulator complex protein LAMTOR5 (Hepatitis B virus X-interacting protein) (HBV X-interacting protein) (HBX-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 5),91,"9,614",5 out of 5,1999-07-15,Evidence at protein level
Q96GA3,LTV1_HUMAN,Protein LTV1 homolog,475,"54,855",3 out of 5,2007-09-11,Evidence at protein level
Q96LR2,LURA1_HUMAN,Leucine rich adaptor protein 1 (Leucine repeat adapter protein 35A),239,"25,806",5 out of 5,2007-01-09,Evidence at protein level
P01721,LV657_HUMAN,Immunoglobulin lambda variable 6-57 (Ig lambda chain V-VI region AR) (Ig lambda chain V-VI region EB4) (Ig lambda chain V-VI region NIG-48) (Ig lambda chain V-VI region SUT) (Ig lambda chain V-VI region WLT),117,"12,566",5 out of 5,1986-07-21,Evidence at protein level
P0DP09,KV113_HUMAN,Immunoglobulin kappa variable 1-13,117,"12,569",2 out of 5,2017-04-12,Inferred from homology
P04433,KV311_HUMAN,Immunoglobulin kappa variable 3-11 (Ig kappa chain V-III region VG),115,"12,575",5 out of 5,1987-08-13,Evidence at protein level
O00515,LAD1_HUMAN,Ladinin-1 (Lad-1) (Linear IgA disease antigen) (LADA),517,"57,131",4 out of 5,2000-12-01,Evidence at protein level
Q14657,LAGE3_HUMAN,EKC/KEOPS complex subunit LAGE3 (L antigen family member 3) (Protein ESO-3) (Protein ITBA2),143,"14,804",4 out of 5,1997-11-01,Evidence at protein level
Q6ISS4,LAIR2_HUMAN,Leukocyte-associated immunoglobulin-like receptor 2 (LAIR-2) (CD antigen CD306),152,"16,280",3 out of 5,2006-10-03,Evidence at protein level
P00709,LALBA_HUMAN,Alpha-lactalbumin (Lactose synthase B protein) (Lysozyme-like protein 7),142,"16,225",5 out of 5,1986-07-21,Evidence at protein level
Q13751,LAMB3_HUMAN,Laminin subunit beta-3 (Epiligrin subunit bata) (Kalinin B1 chain) (Kalinin subunit beta) (Laminin B1k chain) (Laminin-5 subunit beta) (Nicein subunit beta),1172,"129,572",5 out of 5,1997-11-01,Evidence at protein level
Q13571,LAPM5_HUMAN,Lysosomal-associated transmembrane protein 5 (Lysosomal-associated multitransmembrane protein 5) (Retinoic acid-inducible E3 protein),262,"29,937",5 out of 5,1998-07-15,Evidence at protein level
Q8N3Y3,LARG2_HUMAN,"LARGE xylosyl- and glucuronyltransferase 2 (EC 2.4.-.-) (Glycosyltransferase-like 1B) [Includes: Xylosyltransferase LARGE2 (EC 2.4.2.-); Beta-1,3-glucuronyltransferase LARGE2 (EC 2.4.1.-)]",721,"81,787",5 out of 5,2006-03-07,Evidence at protein level
Q6PKG0,LARP1_HUMAN,La-related protein 1 (La ribonucleoprotein domain family member 1),1096,"123,510",5 out of 5,2005-08-16,Evidence at protein level
P04180,LCAT_HUMAN,Phosphatidylcholine-sterol acyltransferase (EC 2.3.1.43) (Lecithin-cholesterol acyltransferase) (Phospholipid-cholesterol acyltransferase),440,"49,578",5 out of 5,1987-03-20,Evidence at protein level
Q5T753,LCE1E_HUMAN,Late cornified envelope protein 1E (Late envelope protein 5),118,"11,616",5 out of 5,2006-05-16,Evidence at protein level
Q5TA78,LCE4A_HUMAN,Late cornified envelope protein 4A (Late envelope protein 8) (Small proline-rich-like epidermal differentiation complex protein 4A),99,"9,980",5 out of 5,2006-05-16,Evidence at protein level
P31025,LCN1_HUMAN,Lipocalin-1 (Tear lipocalin) (Tlc) (Tear prealbumin) (TP) (Von Ebner gland protein) (VEG protein),176,"19,250",5 out of 5,1993-07-01,Evidence at protein level
A8MUM7,LEG16_HUMAN,Galectin-16,142,"16,576",3 out of 5,2011-10-19,Evidence at transcript level
P48357,LEPR_HUMAN,Leptin receptor (LEP-R) (HuB219) (OB receptor) (OB-R) (CD antigen CD295),1165,"132,494",5 out of 5,1996-02-01,Evidence at protein level
Q9Y693,LHFP_HUMAN,Lipoma HMGIC fusion partner,200,"21,598",3 out of 5,2006-07-11,Evidence at transcript level
P50458,LHX2_HUMAN,LIM/homeobox protein Lhx2 (Homeobox protein LH-2) (LIM homeobox protein 2),406,"44,373",4 out of 5,1996-10-01,Evidence at transcript level
Q9H2C1,LHX5_HUMAN,LIM/homeobox protein Lhx5 (LIM homeobox protein 5),402,"44,406",3 out of 5,2001-08-29,Evidence at transcript level
Q6ZQX7,LIAT1_HUMAN,Protein LIAT1 (Ligand of ATE1 protein),453,"49,656",3 out of 5,2008-06-10,Evidence at transcript level
P0C6S8,LIGO3_HUMAN,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 3 (Leucine-rich repeat neuronal protein 2) (Leucine-rich repeat neuronal protein 6B),592,"64,881",3 out of 5,2008-04-08,Inferred from homology
Q9BT23,LIMD2_HUMAN,LIM domain-containing protein 2,127,"14,070",4 out of 5,2006-10-03,Evidence at protein level
Q8ND30,LIPB2_HUMAN,Liprin-beta-2 (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein-binding protein 2) (PTPRF-interacting protein-binding protein 2),876,"98,544",4 out of 5,2004-02-16,Evidence at protein level
P11150,LIPC_HUMAN,Hepatic triacylglycerol lipase (HL) (Hepatic lipase) (EC 3.1.1.3) (Lipase member C),499,"55,914",5 out of 5,1989-07-01,Evidence at protein level
P43360,MAGA6_HUMAN,Melanoma-associated antigen 6 (Cancer/testis antigen 1.6) (CT1.6) (MAGE-6 antigen) (MAGE3B antigen),314,"34,891",5 out of 5,1995-11-01,Evidence at protein level
O15480,MAGB3_HUMAN,Melanoma-associated antigen B3 (MAGE-B3 antigen),346,"39,211",2 out of 5,1998-12-15,Evidence at transcript level
Q13021,MALL_HUMAN,MAL-like protein (Protein BENE),153,"17,350",5 out of 5,1998-07-15,Evidence at protein level
Q13495,MAMD1_HUMAN,Mastermind-like domain-containing protein 1 (F18) (Protein CG1),774,"83,231",5 out of 5,1997-11-01,Evidence at protein level
Q8IZL2,MAML2_HUMAN,Mastermind-like protein 2 (Mam-2),1156,"125,197",5 out of 5,2005-07-05,Evidence at protein level
Q5VSG8,MANEL_HUMAN,"Glycoprotein endo-alpha-1,2-mannosidase-like protein (EC 3.2.1.-)",457,"51,317",3 out of 5,2007-04-03,Evidence at transcript level
A6NHS7,MANS4_HUMAN,MANSC domain-containing protein 4,340,"37,879",2 out of 5,2008-09-02,Inferred from homology
Q5T0T0,MARH8_HUMAN,E3 ubiquitin-protein ligase MARCH8 (EC 2.3.2.27) (Cellular modulator of immune recognition) (c-MIR) (Membrane-associated RING finger protein 8) (Membrane-associated RING-CH protein VIII) (MARCH-VIII) (RING finger protein 178) (RING-type E3 ubiquitin transferase MARCH8),291,"32,965",5 out of 5,2007-02-06,Evidence at protein level
P04201,MAS_HUMAN,Proto-oncogene Mas,325,"37,465",5 out of 5,1987-03-20,Evidence at protein level
P56270,MAZ_HUMAN,Myc-associated zinc finger protein (MAZI) (Pur-1) (Purine-binding transcription factor) (Serum amyloid A-activating factor-1) (SAF-1) (Transcription factor Zif87) (ZF87) (Zinc finger protein 801),477,"48,608",5 out of 5,1998-07-15,Evidence at protein level
Q9H7P6,MB12B_HUMAN,Multivesicular body subunit 12B (ESCRT-I complex subunit MVB12B) (Protein FAM125B),319,"35,620",5 out of 5,2006-09-05,Evidence at protein level
O95983,MBD3_HUMAN,Methyl-CpG-binding domain protein 3 (Methyl-CpG-binding protein MBD3),291,"32,844",5 out of 5,2004-07-19,Evidence at protein level
Q9P267,MBD5_HUMAN,Methyl-CpG-binding domain protein 5 (Methyl-CpG-binding protein MBD5),1494,"159,895",5 out of 5,2004-07-19,Evidence at protein level
Q6ZWT7,MBOA2_HUMAN,Lysophospholipid acyltransferase 2 (LPLAT 2) (EC 2.3.1.-) (1-acylglycerophosphate O-acyltransferase) (EC 2.3.1.51) (1-acylglycerophosphoethanolamine O-acyltransferase) (EC 2.3.1.n7) (Lysophosphatidic acid acyltransferase) (LPAAT) (Lyso-PA acyltransferase) (Lysophosphatidylethanolamine acyltransferase) (LPEAT) (Lyso-PE acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 2) (O-acyltransferase domain-containing protein 2),520,"59,527",5 out of 5,2007-01-23,Evidence at transcript level
A2RUH7,MBPHL_HUMAN,Myosin-binding protein H-like,354,"38,733",3 out of 5,2008-04-29,Evidence at protein level
Q8NI22,MCFD2_HUMAN,Multiple coagulation factor deficiency protein 2 (Neural stem cell-derived neuronal survival protein),146,"16,390",5 out of 5,2004-06-21,Evidence at protein level
Q16048,MCHL1_HUMAN,Putative pro-MCH-like protein 1 (Pro-MCH variant) (Pro-melanin-concentrating hormone-like protein 1),86,"9,715",2 out of 5,1999-07-15,Uncertain
Q99705,MCHR1_HUMAN,Melanin-concentrating hormone receptor 1 (MCH receptor 1) (MCH-R1) (MCHR-1) (G-protein coupled receptor 24) (MCH-1R) (MCH1R) (MCHR) (SLC-1) (Somatostatin receptor-like protein),422,"45,963",5 out of 5,1997-11-01,Evidence at protein level
P33993,MCM7_HUMAN,DNA replication licensing factor MCM7 (EC 3.6.4.12) (CDC47 homolog) (P1.1-MCM3),719,"81,308",5 out of 5,1994-02-01,Evidence at protein level
Q9NXL9,MCM9_HUMAN,DNA helicase MCM9 (hMCM9) (EC 3.6.4.12) (Mini-chromosome maintenance deficient domain-containing protein 1) (Minichromosome maintenance 9),1143,"127,313",5 out of 5,2005-07-05,Evidence at protein level
Q71F56,MD13L_HUMAN,Mediator of RNA polymerase II transcription subunit 13-like (Mediator complex subunit 13-like) (Thyroid hormone receptor-associated protein 2) (Thyroid hormone receptor-associated protein complex 240 kDa component-like),2210,"242,602",5 out of 5,2005-12-06,Evidence at protein level
Q9Y6D9,MD1L1_HUMAN,Mitotic spindle assembly checkpoint protein MAD1 (Mitotic arrest deficient 1-like protein 1) (MAD1-like protein 1) (Mitotic checkpoint MAD1 protein homolog) (HsMAD1) (hMAD1) (Tax-binding protein 181),718,"83,067",5 out of 5,2004-09-27,Evidence at protein level
Q13257,MD2L1_HUMAN,Mitotic spindle assembly checkpoint protein MAD2A (HsMAD2) (Mitotic arrest deficient 2-like protein 1) (MAD2-like protein 1),205,"23,510",5 out of 5,2001-01-11,Evidence at protein level
Q5I0G3,MDH1B_HUMAN,Putative malate dehydrogenase 1B (EC 1.1.1.-),518,"58,651",3 out of 5,2008-04-29,Evidence at transcript level
Q00987,MDM2_HUMAN,E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2),491,"55,233",5 out of 5,1993-04-01,Evidence at protein level
Q9UHV7,MED13_HUMAN,Mediator of RNA polymerase II transcription subunit 13 (Activator-recruited cofactor 250 kDa component) (ARC250) (Mediator complex subunit 13) (Thyroid hormone receptor-associated protein 1) (Thyroid hormone receptor-associated protein complex 240 kDa component) (Trap240) (Vitamin D3 receptor-interacting protein complex component DRIP250) (DRIP250),2174,"239,297",5 out of 5,2003-02-22,Evidence at protein level
Q96RN5,MED15_HUMAN,Mediator of RNA polymerase II transcription subunit 15 (Activator-recruited cofactor 105 kDa component) (ARC105) (CTG repeat protein 7a) (Mediator complex subunit 15) (Positive cofactor 2 glutamine/Q-rich-associated protein) (PC2 glutamine/Q-rich-associated protein) (TPA-inducible gene 1 protein) (TIG-1) (Trinucleotide repeat-containing gene 7 protein),788,"86,753",5 out of 5,2002-04-16,Evidence at protein level
Q06413,MEF2C_HUMAN,Myocyte-specific enhancer factor 2C,473,"51,221",5 out of 5,1997-11-01,Evidence at protein level
Q9H1U4,MEGF9_HUMAN,Multiple epidermal growth factor-like domains protein 9 (Multiple EGF-like domains protein 9) (Epidermal growth factor-like protein 5) (EGF-like protein 5),602,"62,984",3 out of 5,2004-04-13,Evidence at transcript level
Q8N635,MEIOB_HUMAN,Meiosis-specific with OB domain-containing protein (EC 3.1.-.-),442,"49,313",4 out of 5,2008-05-20,Evidence at transcript level
Q9BRJ9,MESP1_HUMAN,Mesoderm posterior protein 1 (Class C basic helix-loop-helix protein 5) (bHLHc5),268,"28,501",5 out of 5,2007-09-11,Evidence at transcript level
A8MUP2,MET12_HUMAN,"Methyltransferase-like protein 12, mitochondrial (EC 2.1.1.-)",240,"25,910",2 out of 5,2008-09-02,Evidence at transcript level
A2A368,MAGBG_HUMAN,Melanoma-associated antigen B16 (MAGE-B16 antigen),324,"36,178",2 out of 5,2007-12-04,Predicted
Q6VMQ6,MCAF1_HUMAN,Activating transcription factor 7-interacting protein 1 (ATF-interacting protein) (ATF-IP) (ATF7-interacting protein) (ATFa-associated modulator) (hAM) (MBD1-containing chromatin-associated factor 1) (P621),1270,"136,394",5 out of 5,2007-04-03,Evidence at protein level
D6RGH6,MCIN_HUMAN,Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein) (Protein Idas),385,"41,720",5 out of 5,2011-07-27,Evidence at protein level
Q8NE86,MCU_HUMAN,"Calcium uniporter protein, mitochondrial (HsMCU) (Coiled-coil domain-containing protein 109A)",351,"39,867",5 out of 5,2007-04-03,Evidence at protein level
Q9P1T7,MDFIC_HUMAN,MyoD family inhibitor domain-containing protein (I-mfa domain-containing protein) (hIC),246,"25,788",5 out of 5,2007-03-20,Evidence at protein level
Q7Z553,MDGA2_HUMAN,MAM domain-containing glycosylphosphatidylinositol anchor protein 2 (MAM domain-containing protein 1),956,"107,436",4 out of 5,2004-04-13,Evidence at protein level
P08183,MDR1_HUMAN,Multidrug resistance protein 1 (EC 3.6.3.44) (ATP-binding cassette sub-family B member 1) (P-glycoprotein 1) (CD antigen CD243),1280,"141,479",5 out of 5,1988-08-01,Evidence at protein level
P21439,MDR3_HUMAN,Phosphatidylcholine translocator ABCB4 (ATP-binding cassette sub-family B member 4) (Multidrug resistance protein 3) (EC 3.6.3.44) (P-glycoprotein 3),1286,"141,523",5 out of 5,1991-05-01,Evidence at protein level
P0C7V9,ME15P_HUMAN,Putative methyltransferase-like protein 15P1 (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 2) (Methyltransferase-like protein 15 pseudogene 1),234,"26,716",2 out of 5,2008-07-22,Uncertain
Q16626,MEA1_HUMAN,Male-enhanced antigen 1 (MEA-1),185,"19,905",3 out of 5,1997-11-01,Evidence at protein level
Q9P086,MED11_HUMAN,Mediator of RNA polymerase II transcription subunit 11 (Mediator complex subunit 11),117,"13,129",4 out of 5,2007-09-11,Evidence at protein level
A0JLT2,MED19_HUMAN,Mediator of RNA polymerase II transcription subunit 19 (Lung cancer metastasis-related protein 1) (Mediator complex subunit 19),244,"26,273",4 out of 5,2007-10-02,Evidence at protein level
Q96G25,MED8_HUMAN,Mediator of RNA polymerase II transcription subunit 8 (Activator-recruited cofactor 32 kDa component) (ARC32) (Mediator complex subunit 8),268,"29,080",5 out of 5,2003-05-23,Evidence at protein level
O75095,MEGF6_HUMAN,Multiple epidermal growth factor-like domains protein 6 (Multiple EGF-like domains protein 6) (Epidermal growth factor-like protein 3) (EGF-like protein 3),1541,"161,185",4 out of 5,2004-04-13,Evidence at protein level
Q7Z7M0,MEGF8_HUMAN,Multiple epidermal growth factor-like domains protein 8 (Multiple EGF-like domains protein 8) (Epidermal growth factor-like protein 4) (EGF-like protein 4),2845,"303,100",5 out of 5,2004-04-13,Evidence at protein level
Q7L2J0,MEPCE_HUMAN,7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog),689,"74,355",5 out of 5,2007-05-29,Evidence at protein level
Q9H1K6,MESD1_HUMAN,Mesoderm development candidate 1,362,"37,758",1 out of 5,2002-10-25,Evidence at protein level
Q8N4P3,MESH1_HUMAN,"Guanosine-3',5'-bis(diphosphate) 3'-pyrophosphohydrolase MESH1 (EC 3.1.7.2) (HD domain-containing protein 3) (Metazoan SpoT homolog 1) (MESH1) (Penta-phosphate guanosine-3'-pyrophosphohydrolase) ((ppGpp)ase)",179,"20,329",5 out of 5,2006-12-12,Evidence at protein level
Q5JXM2,MET24_HUMAN,Methyltransferase-like protein 24 (EC 2.1.1.-),366,"41,330",2 out of 5,2008-07-22,Evidence at transcript level
Q641Q3,METRL_HUMAN,Meteorin-like protein (Subfatin),311,"34,398",4 out of 5,2007-05-29,Evidence at transcript level
O15481,MAGB4_HUMAN,Melanoma-associated antigen B4 (MAGE-B4 antigen),346,"38,923",4 out of 5,1998-12-15,Evidence at protein level
Q8TD90,MAGE2_HUMAN,Melanoma-associated antigen E2 (Hepatocellular carcinoma-associated protein 3) (MAGE-E2 antigen),523,"60,378",2 out of 5,2004-07-19,Evidence at transcript level
Q86UL8,MAGI2_HUMAN,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 2 (Atrophin-1-interacting protein 1) (AIP-1) (Atrophin-1-interacting protein A) (Membrane-associated guanylate kinase inverted 2) (MAGI-2)",1455,"158,754",5 out of 5,2003-10-03,Evidence at protein level
Q96A59,MALD3_HUMAN,MARVEL domain-containing protein 3,401,"44,911",5 out of 5,2007-01-09,Evidence at transcript level
Q9UDY8,MALT1_HUMAN,Mucosa-associated lymphoid tissue lymphoma translocation protein 1 (EC 3.4.22.-) (MALT lymphoma-associated translocation) (Paracaspase),824,"92,272",5 out of 5,2002-05-02,Evidence at protein level
Q9Y2U8,MAN1_HUMAN,Inner nuclear membrane protein Man1 (LEM domain-containing protein 3),911,"99,997",5 out of 5,2001-04-27,Evidence at protein level
Q5SRI9,MANEA_HUMAN,"Glycoprotein endo-alpha-1,2-mannosidase (Endo-alpha mannosidase) (Endomannosidase) (hEndo) (EC 3.2.1.130) (Mandaselin)",462,"53,671",4 out of 5,2007-04-03,Evidence at protein level
P53582,MAP11_HUMAN,Methionine aminopeptidase 1 (MAP 1) (MetAP 1) (EC 3.4.11.18) (Peptidase M 1),386,"43,215",5 out of 5,1996-10-01,Evidence at protein level
A6NDZ8,MB3L4_HUMAN,Putative methyl-CpG-binding domain protein 3-like 4 (MBD3-like protein 4),208,"23,121",2 out of 5,2008-09-02,Uncertain
Q4ZIN3,MBRL_HUMAN,Membralin (Transmembrane protein 259),620,"67,889",4 out of 5,2005-07-05,Evidence at protein level
O43462,MBTP2_HUMAN,Membrane-bound transcription factor site-2 protease (EC 3.4.24.85) (Endopeptidase S2P) (Sterol regulatory element-binding proteins intramembrane protease) (SREBPs intramembrane protease),519,"57,444",5 out of 5,1999-07-15,Evidence at protein level
O43148,MCES_HUMAN,mRNA cap guanine-N7 methyltransferase (EC 2.1.1.56) (RG7MT1) (mRNA (guanine-N(7)-)-methyltransferase) (mRNA cap methyltransferase) (hCMT1) (hMet) (hcm1p),476,"54,844",5 out of 5,2006-09-05,Evidence at protein level
Q969V1,MCHR2_HUMAN,Melanin-concentrating hormone receptor 2 (MCH receptor 2) (MCH-R2) (MCHR-2) (G-protein coupled receptor 145) (GPRv17) (MCH-2R) (MCH2) (MCH2R),340,"38,849",4 out of 5,2003-08-15,Evidence at protein level
Q6DN12,MCTP2_HUMAN,Multiple C2 and transmembrane domain-containing protein 2,878,"99,596",5 out of 5,2007-07-10,Evidence at protein level
Q9ULC4,MCTS1_HUMAN,Malignant T-cell-amplified sequence 1 (MCT-1) (Multiple copies T-cell malignancies),181,"20,555",5 out of 5,2008-07-22,Evidence at protein level
Q15013,MD2BP_HUMAN,MAD2L1-binding protein (Caught by MAD2 protein),274,"31,052",5 out of 5,1998-07-15,Evidence at protein level
Q9UI95,MD2L2_HUMAN,Mitotic spindle assembly checkpoint protein MAD2B (Mitotic arrest deficient 2-like protein 2) (MAD2-like protein 2) (REV7 homolog) (hREV7),211,"24,334",5 out of 5,2001-01-11,Evidence at protein level
O15151,MDM4_HUMAN,Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4),490,"54,864",5 out of 5,2000-05-30,Evidence at protein level
Q13465,MDS1_HUMAN,MDS1 and EVI1 complex locus protein MDS1 (Myelodysplasia syndrome 1 protein) (Myelodysplasia syndrome-associated protein 1),169,"18,696",3 out of 5,2002-10-19,Evidence at protein level
A8K0S8,ME3L2_HUMAN,Putative homeobox protein Meis3-like 2,358,"39,220",2 out of 5,2008-09-02,Evidence at transcript level
Q9H944,MED20_HUMAN,Mediator of RNA polymerase II transcription subunit 20 (Mediator complex subunit 20) (TRF-proximal protein homolog) (hTRFP),212,"23,222",5 out of 5,2003-03-28,Evidence at protein level
Q13503,MED21_HUMAN,Mediator of RNA polymerase II transcription subunit 21 (Mediator complex subunit 21) (RNA polymerase II holoenzyme component SRB7) (RNAPII complex component SRB7) (hSrb7),144,"15,564",5 out of 5,2000-05-30,Evidence at protein level
Q15528,MED22_HUMAN,Mediator of RNA polymerase II transcription subunit 22 (Mediator complex subunit 22) (Surfeit locus protein 5) (Surf-5),200,"22,221",5 out of 5,1997-11-01,Evidence at protein level
Q71SY5,MED25_HUMAN,Mediator of RNA polymerase II transcription subunit 25 (Activator interaction domain-containing protein 1) (Activator-recruited cofactor 92 kDa component) (ARC92) (Mediator complex subunit 25) (p78),747,"78,171",5 out of 5,2007-10-02,Evidence at protein level
Q9NWA0,MED9_HUMAN,Mediator of RNA polymerase II transcription subunit 9 (Mediator complex subunit 9),146,"16,403",4 out of 5,2007-09-11,Evidence at protein level
Q5TIA1,MEI1_HUMAN,Meiosis inhibitor protein 1 (Meiosis defective protein 1),1274,"141,161",4 out of 5,2008-09-02,Evidence at transcript level
A2RUB1,MEIOC_HUMAN,Meiosis-specific coiled-coil domain-containing protein MEIOC (Meiosis-specific with coiled-coil domain protein),952,"107,559",4 out of 5,2008-03-18,Evidence at transcript level
Q99687,MEIS3_HUMAN,Homeobox protein Meis3 (Meis1-related protein 2),375,"41,115",3 out of 5,1998-07-15,Evidence at transcript level
O95772,MENTO_HUMAN,MLN64 N-terminal domain homolog (STARD3 N-terminal-like protein),234,"26,655",4 out of 5,2002-11-15,Evidence at protein level
Q8N6R0,MET13_HUMAN,Methyltransferase-like protein 13 (EC 2.1.1.-),699,"78,768",3 out of 5,2005-06-07,Evidence at protein level
O95568,MET18_HUMAN,Histidine protein methyltransferase 1 homolog (EC 2.1.1.-) (Arsenic-transactivated protein 2) (AsTP2) (Methyltransferase-like protein 18),372,"42,148",3 out of 5,2006-07-25,Evidence at protein level
Q6P1Q9,MET2B_HUMAN,Methyltransferase-like protein 2B (EC 2.1.1.-),378,"43,426",4 out of 5,2008-04-08,Evidence at protein level
P01705,LV223_HUMAN,Immunoglobulin lambda variable 2-23 (Ig lambda chain V-II region NEI),113,"11,893",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6J1,LV537_HUMAN,Immunoglobulin lambda variable 5-37,123,"13,277",3 out of 5,2017-01-18,Inferred from homology
A0A0B4J1Y8,LV949_HUMAN,Immunoglobulin lambda variable 9-49,123,"13,024",3 out of 5,2017-01-18,Evidence at protein level
Q9BS40,LXN_HUMAN,Latexin (Endogenous carboxypeptidase inhibitor) (ECI) (Protein MUM) (Tissue carboxypeptidase inhibitor) (TCI),222,"25,750",4 out of 5,2004-07-05,Evidence at protein level
Q86SG7,LYG2_HUMAN,Lysozyme g-like protein 2 (EC 3.2.1.-),212,"23,498",3 out of 5,2004-05-10,Evidence at protein level
Q8N2G4,LYPD1_HUMAN,Ly6/PLAUR domain-containing protein 1 (Putative HeLa tumor suppressor) (PHTS),141,"15,240",4 out of 5,2006-03-07,Evidence at transcript level
Q86Y78,LYPD6_HUMAN,Ly6/PLAUR domain-containing protein 6,171,"19,118",5 out of 5,2004-11-09,Evidence at protein level
O43325,LYRM1_HUMAN,LYR motif-containing protein 1,122,"14,282",3 out of 5,2001-01-24,Evidence at transcript level
Q9BY19,M4A8_HUMAN,Membrane-spanning 4-domains subfamily A member 8 (Four-span transmembrane protein 4) (Membrane-spanning 4-domains subfamily A member 8B),250,"26,290",3 out of 5,2003-04-04,Evidence at transcript level
P43355,MAGA1_HUMAN,Melanoma-associated antigen 1 (Antigen MZ2-E) (Cancer/testis antigen 1.1) (CT1.1) (MAGE-1 antigen),309,"34,342",5 out of 5,1995-11-01,Evidence at protein level
O00462,MANBA_HUMAN,Beta-mannosidase (EC 3.2.1.25) (Lysosomal beta A mannosidase) (Mannanase) (Mannase),879,"100,895",5 out of 5,1998-07-15,Evidence at transcript level
Q96JE9,MAP6_HUMAN,Microtubule-associated protein 6 (MAP-6) (Stable tubule-only polypeptide) (STOP),813,"86,505",5 out of 5,2008-07-22,Evidence at protein level
Q96T53,MBOA4_HUMAN,Ghrelin O-acyltransferase (EC 2.3.1.-) (Membrane-bound O-acyltransferase domain-containing protein 4) (O-acyltransferase domain-containing protein 4),435,"49,716",4 out of 5,2007-01-23,Evidence at protein level
P20382,MCH_HUMAN,Pro-MCH [Cleaved into: Neuropeptide-glycine-glutamic acid (NGE) (Neuropeptide G-E); Neuropeptide-glutamic acid-isoleucine (NEI) (Neuropeptide E-I); Melanin-concentrating hormone (MCH)],165,"18,679",4 out of 5,1991-02-01,Evidence at protein level
P33992,MCM5_HUMAN,DNA replication licensing factor MCM5 (EC 3.6.4.12) (CDC46 homolog) (P1-CDC46),734,"82,286",5 out of 5,1994-02-01,Evidence at protein level
Q9UJA3,MCM8_HUMAN,DNA helicase MCM8 (EC 3.6.4.12) (Minichromosome maintenance 8),840,"93,697",5 out of 5,2003-01-17,Evidence at protein level
Q4G0Z9,MCMD2_HUMAN,MCM domain-containing protein 2,681,"76,219",3 out of 5,2006-10-31,Evidence at protein level
Q6DN14,MCTP1_HUMAN,Multiple C2 and transmembrane domain-containing protein 1,999,"111,624",4 out of 5,2007-07-10,Evidence at transcript level
A6NDR6,ME3L1_HUMAN,Putative homeobox protein Meis3-like 1,274,"30,204",2 out of 5,2008-09-02,Uncertain
Q9BV79,MECR_HUMAN,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial (EC 1.3.1.104) (2-enoyl thioester reductase) (Nuclear receptor-binding factor 1) (HsNrbf-1) (NRBF-1)",373,"40,462",5 out of 5,2005-04-26,Evidence at protein level
O60244,MED14_HUMAN,Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150),1454,"160,607",5 out of 5,2003-02-22,Evidence at protein level
Q6P2C8,MED27_HUMAN,Mediator of RNA polymerase II transcription subunit 27 (Cofactor required for Sp1 transcriptional activation subunit 8) (CRSP complex subunit 8) (Mediator complex subunit 27) (P37 TRAP/SMCC/PC2 subunit) (Transcriptional coactivator CRSP34),311,"35,432",5 out of 5,2005-11-08,Evidence at protein level
Q9Y3C7,MED31_HUMAN,Mediator of RNA polymerase II transcription subunit 31 (Mediator complex subunit 31) (Mediator complex subunit SOH1) (hSOH1),131,"15,805",5 out of 5,2003-10-31,Evidence at protein level
Q9NPJ6,MED4_HUMAN,Mediator of RNA polymerase II transcription subunit 4 (Activator-recruited cofactor 36 kDa component) (ARC36) (Mediator complex subunit 4) (TRAP/SMCC/PC2 subunit p36 subunit) (Vitamin D3 receptor-interacting protein complex 36 kDa component) (DRIP36),270,"29,745",5 out of 5,2003-02-28,Evidence at protein level
Q5VYS4,MEDAG_HUMAN,Mesenteric estrogen-dependent adipogenesis protein (Activated in W/Wv mouse stomach 3 homolog) (hAWMS3) (Mesenteric estrogen-dependent adipose 4) (MEDA-4),303,"34,190",3 out of 5,2007-02-06,Evidence at transcript level
Q14814,MEF2D_HUMAN,Myocyte-specific enhancer factor 2D,521,"55,938",5 out of 5,1997-11-01,Evidence at protein level
Q9Y4Z0,LSM4_HUMAN,U6 snRNA-associated Sm-like protein LSm4 (Glycine-rich protein) (GRP),139,"15,350",5 out of 5,2000-12-01,Evidence at protein level
Q9Y2Q5,LTOR2_HUMAN,Ragulator complex protein LAMTOR2 (Endosomal adaptor protein p14) (Late endosomal/lysosomal Mp1-interacting protein) (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 2) (Mitogen-activated protein-binding protein-interacting protein) (MAPBP-interacting protein) (Roadblock domain-containing protein 3),125,"13,508",5 out of 5,2001-01-24,Evidence at protein level
P01714,LV319_HUMAN,Immunoglobulin lambda variable 3-19 (Ig lambda chain V-III region SH),112,"12,042",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6K6,LV403_HUMAN,Immunoglobulin lambda variable 4-3,122,"13,330",3 out of 5,2017-01-18,Inferred from homology
Q5SQ64,LY66F_HUMAN,Lymphocyte antigen 6 complex locus protein G6f,297,"32,465",5 out of 5,2008-02-26,Evidence at protein level
Q7Z4W2,LYZL2_HUMAN,Lysozyme-like protein 2 (Lysozyme-2) (EC 3.2.1.17),148,"16,656",3 out of 5,2006-06-27,Evidence at transcript level
O60299,LZTS3_HUMAN,Leucine zipper putative tumor suppressor 3 (ProSAP-interacting protein 1) (ProSAPiP1),673,"71,791",3 out of 5,1999-07-15,Evidence at transcript level
O60476,MA1A2_HUMAN,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB (EC 3.2.1.113) (Mannosidase alpha class 1A member 2) (Processing alpha-1,2-mannosidase IB) (Alpha-1,2-mannosidase IB)",641,"73,004",5 out of 5,2001-11-16,Evidence at protein level
Q16706,MA2A1_HUMAN,"Alpha-mannosidase 2 (EC 3.2.1.114) (Golgi alpha-mannosidase II) (AMan II) (Man II) (Mannosidase alpha class 2A member 1) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",1144,"131,141",5 out of 5,1998-07-15,Evidence at protein level
O00754,MA2B1_HUMAN,Lysosomal alpha-mannosidase (Laman) (EC 3.2.1.24) (Lysosomal acid alpha-mannosidase) (Mannosidase alpha class 2B member 1) (Mannosidase alpha-B) [Cleaved into: Lysosomal alpha-mannosidase A peptide; Lysosomal alpha-mannosidase B peptide; Lysosomal alpha-mannosidase C peptide; Lysosomal alpha-mannosidase D peptide; Lysosomal alpha-mannosidase E peptide],1011,"113,744",5 out of 5,1998-07-15,Evidence at protein level
Q3KQU3,MA7D1_HUMAN,MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1),841,"92,820",4 out of 5,2007-10-02,Evidence at protein level
O43708,MAAI_HUMAN,Maleylacetoacetate isomerase (MAAI) (EC 5.2.1.2) (GSTZ1-1) (Glutathione S-transferase zeta 1) (EC 2.5.1.18),216,"24,212",5 out of 5,1998-12-15,Evidence at protein level
Q6ZN28,MACC1_HUMAN,Metastasis-associated in colon cancer protein 1 (SH3 domain-containing protein 7a5),852,"96,639",4 out of 5,2008-04-08,Evidence at protein level
Q05195,MAD1_HUMAN,Max dimerization protein 1 (Max dimerizer 1) (Protein MAD),221,"25,254",5 out of 5,1995-02-01,Evidence at protein level
Q8WXG6,MADD_HUMAN,MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor),1647,"183,303",5 out of 5,2007-02-20,Evidence at protein level
Q8NHW3,MAFA_HUMAN,Transcription factor MafA (Pancreatic beta-cell-specific transcriptional activator) (Transcription factor RIPE3b1) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog A),353,"36,982",5 out of 5,2008-02-26,Evidence at protein level
P43365,MAGAC_HUMAN,Melanoma-associated antigen 12 (Cancer/testis antigen 1.12) (CT1.12) (MAGE-12 antigen) (MAGE12F antigen),314,"34,836",3 out of 5,1995-11-01,Evidence at transcript level
Q969L2,MAL2_HUMAN,Protein MAL2,176,"19,125",5 out of 5,2002-05-27,Evidence at protein level
Q9BSK0,MALD1_HUMAN,MARVEL domain-containing protein 1,173,"18,914",4 out of 5,2007-01-09,Evidence at protein level
Q96JK9,MAML3_HUMAN,Mastermind-like protein 3 (Mam-3),1138,"122,293",5 out of 5,2005-07-05,Evidence at protein level
Q8NA82,MARHA_HUMAN,Probable E3 ubiquitin-protein ligase MARCH10 (EC 2.3.2.27) (Membrane-associated RING finger protein 10) (Membrane-associated RING-CH protein X) (MARCH-X) (RING finger protein 190) (RING-type E3 ubiquitin transferase MARCH10),808,"90,511",4 out of 5,2006-11-28,Evidence at protein level
Q7KZI7,MARK2_HUMAN,Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b),788,"87,911",5 out of 5,2005-04-12,Evidence at protein level
O00187,MASP2_HUMAN,Mannan-binding lectin serine protease 2 (EC 3.4.21.104) (MBL-associated serine protease 2) (Mannose-binding protein-associated serine protease 2) (MASP-2) [Cleaved into: Mannan-binding lectin serine protease 2 A chain; Mannan-binding lectin serine protease 2 B chain],686,"75,702",5 out of 5,2000-05-30,Evidence at protein level
Q6P0Q8,MAST2_HUMAN,Microtubule-associated serine/threonine-protein kinase 2 (EC 2.7.11.1),1798,"196,436",5 out of 5,2005-03-29,Evidence at protein level
O00339,MATN2_HUMAN,Matrilin-2,956,"106,837",5 out of 5,2000-05-30,Evidence at protein level
O95460,MATN4_HUMAN,Matrilin-4,622,"68,487",5 out of 5,2001-06-20,Evidence at protein level
Q9Y586,MB212_HUMAN,Protein mab-21-like 2,359,"40,923",4 out of 5,2007-12-04,Evidence at protein level
Q96DN6,MBD6_HUMAN,Methyl-CpG-binding domain protein 6 (Methyl-CpG-binding protein MBD6),1003,"101,201",4 out of 5,2003-03-25,Evidence at protein level
P43366,MAGB1_HUMAN,Melanoma-associated antigen B1 (Cancer/testis antigen 3.1) (CT3.1) (DSS-AHC critical interval MAGE superfamily 10) (DAM10) (MAGE-B1 antigen) (MAGE-XP antigen),347,"39,037",2 out of 5,1995-11-01,Evidence at protein level
O60732,MAGC1_HUMAN,Melanoma-associated antigen C1 (Cancer/testis antigen 7.1) (CT7.1) (MAGE-C1 antigen),1142,"123,643",3 out of 5,2001-09-26,Evidence at protein level
Q96QZ7,MAGI1_HUMAN,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 (Atrophin-1-interacting protein 3) (AIP-3) (BAI1-associated protein 1) (BAP-1) (Membrane-associated guanylate kinase inverted 1) (MAGI-1) (Trinucleotide repeat-containing gene 19 protein) (WW domain-containing protein 3) (WWP3)",1491,"164,581",5 out of 5,2004-09-27,Evidence at protein level
Q5TCQ9,MAGI3_HUMAN,"Membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 (Membrane-associated guanylate kinase inverted 3) (MAGI-3)",1506,"165,608",5 out of 5,2008-06-10,Evidence at protein level
Q5VYJ5,MALR1_HUMAN,MAM and LDL-receptor class A domain-containing protein 1,2156,"241,008",5 out of 5,2008-04-08,Evidence at protein level
Q7Z304,MAMC2_HUMAN,MAM domain-containing protein 2 (MAM domain-containing proteoglycan) (Mamcan),686,"77,556",3 out of 5,2004-04-13,Evidence at transcript level
Q9NQG1,MANBL_HUMAN,Protein MANBAL,85,"9,467",2 out of 5,2003-04-30,Evidence at protein level
Q9P2G4,MAP10_HUMAN,Microtubule-associated protein 10 (Microtubule regulator of 120 KDa),905,"100,345",5 out of 5,2001-06-01,Evidence at protein level
Q8TCQ1,MARH1_HUMAN,E3 ubiquitin-protein ligase MARCH1 (EC 2.3.2.27) (Membrane-associated RING finger protein 1) (Membrane-associated RING-CH protein I) (MARCH-I) (RING finger protein 171) (RING-type E3 ubiquitin transferase MARCH1),289,"32,308",5 out of 5,2007-02-06,Evidence at protein level
Q9NZL9,MAT2B_HUMAN,Methionine adenosyltransferase 2 subunit beta (Methionine adenosyltransferase II beta) (MAT II beta) (Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase),334,"37,552",5 out of 5,2007-05-15,Evidence at protein level
P21941,MATN1_HUMAN,Cartilage matrix protein (Matrilin-1),496,"53,701",5 out of 5,1991-05-01,Evidence at protein level
O15232,MATN3_HUMAN,Matrilin-3,486,"52,817",5 out of 5,2001-06-20,Evidence at protein level
P43243,MATR3_HUMAN,Matrin-3,847,"94,623",5 out of 5,1995-11-01,Evidence at protein level
Q8N8R3,MCATL_HUMAN,Mitochondrial basic amino acids transporter (Carnitine/acylcarnitine translocase-like) (CACT-like) (Mitochondrial carnitine/acylcarnitine carrier protein CACL) (Mitochondrial ornithine transporter 3) (Solute carrier family 25 member 29),303,"32,062",4 out of 5,2003-05-30,Evidence at protein level
Q96RQ3,MCCA_HUMAN,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial (MCCase subunit alpha) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 1) (3-methylcrotonyl-CoA carboxylase biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit alpha)",725,"80,473",5 out of 5,2002-03-05,Evidence at protein level
Q9HCC0,MCCB_HUMAN,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial (MCCase subunit beta) (EC 6.4.1.4) (3-methylcrotonyl-CoA carboxylase 2) (3-methylcrotonyl-CoA carboxylase non-biotin-containing subunit) (3-methylcrotonyl-CoA:carbon dioxide ligase subunit beta)",563,"61,333",5 out of 5,2002-03-05,Evidence at protein level
Q9GZU1,MCLN1_HUMAN,Mucolipin-1 (MG-2) (Mucolipidin),580,"65,022",5 out of 5,2004-07-19,Evidence at protein level
P08235,MCR_HUMAN,Mineralocorticoid receptor (MR) (Nuclear receptor subfamily 3 group C member 2),984,"107,067",5 out of 5,1988-08-01,Evidence at protein level
Q96AQ8,MCUR1_HUMAN,"Mitochondrial calcium uniporter regulator 1 (MCU regulator 1) (Coiled-coil domain-containing protein 90A, mitochondrial)",359,"39,694",5 out of 5,2007-07-24,Evidence at protein level
Q14676,MDC1_HUMAN,Mediator of DNA damage checkpoint protein 1 (Nuclear factor with BRCT domains 1),2089,"226,666",5 out of 5,2005-07-05,Evidence at protein level
P40926,MDHM_HUMAN,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",338,"35,503",5 out of 5,1995-02-01,Evidence at protein level
Q9NX70,MED29_HUMAN,Mediator of RNA polymerase II transcription subunit 29 (Intersex-like protein) (Mediator complex subunit 29),200,"21,073",5 out of 5,2007-05-29,Evidence at protein level
Q96HR3,MED30_HUMAN,Mediator of RNA polymerase II transcription subunit 30 (Mediator complex subunit 30) (TRAP/Mediator complex component TRAP25) (Thyroid hormone receptor-associated protein 6) (Thyroid hormone receptor-associated protein complex 25 kDa component) (Trap25),178,"20,277",5 out of 5,2006-06-13,Evidence at protein level
A8MXT2,MAGBH_HUMAN,Melanoma-associated antigen B17,336,"37,578",2 out of 5,2008-04-29,Predicted
Q9UNF1,MAGD2_HUMAN,Melanoma-associated antigen D2 (11B6) (Breast cancer-associated gene 1 protein) (BCG-1) (Hepatocellular carcinoma-associated protein JCL-1) (MAGE-D2 antigen),606,"64,954",5 out of 5,2001-09-26,Evidence at protein level
P20794,MAK_HUMAN,Serine/threonine-protein kinase MAK (EC 2.7.11.1) (Male germ cell-associated kinase),623,"70,581",5 out of 5,1991-02-01,Evidence at protein level
P78559,MAP1A_HUMAN,Microtubule-associated protein 1A (MAP-1A) (Proliferation-related protein p80) [Cleaved into: MAP1A heavy chain; MAP1 light chain LC2],2803,"305,485",5 out of 5,1998-07-15,Evidence at protein level
Q66K74,MAP1S_HUMAN,Microtubule-associated protein 1S (MAP-1S) (BPY2-interacting protein 1) (Microtubule-associated protein 8) (Variable charge Y chromosome 2-interacting protein 1) (VCY2-interacting protein 1) (VCY2IP-1) [Cleaved into: MAP1S heavy chain; MAP1S light chain],1059,"112,211",5 out of 5,2007-11-13,Evidence at protein level
P50579,MAP2_HUMAN,Methionine aminopeptidase 2 (MAP 2) (MetAP 2) (EC 3.4.11.18) (Initiation factor 2-associated 67 kDa glycoprotein) (p67) (p67eIF2) (Peptidase M),478,"52,892",5 out of 5,1996-10-01,Evidence at protein level
P27816,MAP4_HUMAN,Microtubule-associated protein 4 (MAP-4),1152,"121,005",5 out of 5,1992-08-01,Evidence at protein level
Q8IW41,MAPK5_HUMAN,MAP kinase-activated protein kinase 5 (MAPK-activated protein kinase 5) (MAPKAP kinase 5) (MAPKAP-K5) (MAPKAPK-5) (MK-5) (MK5) (EC 2.7.11.1) (p38-regulated/activated protein kinase) (PRAK),473,"54,220",5 out of 5,2004-09-13,Evidence at protein level
Q15555,MARE2_HUMAN,Microtubule-associated protein RP/EB family member 2 (APC-binding protein EB2) (End-binding protein 2) (EB2),327,"37,031",5 out of 5,2005-03-01,Evidence at protein level
Q9P2E8,MARH4_HUMAN,E3 ubiquitin-protein ligase MARCH4 (EC 2.3.2.27) (Membrane-associated RING finger protein 4) (Membrane-associated RING-CH protein IV) (MARCH-IV) (RING finger protein 174) (RING-type E3 ubiquitin transferase MARCH4),410,"45,528",5 out of 5,2005-02-15,Evidence at transcript level
Q96EH3,MASU1_HUMAN,Mitochondrial assembly of ribosomal large subunit protein 1,234,"26,170",4 out of 5,2006-03-21,Evidence at protein level
A4D2B0,MBLC1_HUMAN,Metallo-beta-lactamase domain-containing protein 1 (EC 3.-.-.-),266,"27,202",2 out of 5,2008-05-20,Evidence at protein level
Q6ZNC8,MBOA1_HUMAN,Lysophospholipid acyltransferase 1 (LPLAT 1) (EC 2.3.1.-) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 1) (O-acyltransferase domain-containing protein 1),495,"56,557",5 out of 5,2007-01-23,Evidence at protein level
Q5U623,MCAF2_HUMAN,Activating transcription factor 7-interacting protein 2 (ATF7-interacting protein 2) (MBD1-containing chromatin-associated factor 2),682,"75,764",4 out of 5,2007-04-03,Evidence at protein level
P59942,MCCD1_HUMAN,Mitochondrial coiled-coil domain protein 1,119,"13,259",2 out of 5,2003-10-31,Evidence at transcript level
O60942,MCE1_HUMAN,mRNA-capping enzyme (HCAP1) (HCE) [Includes: Polynucleotide 5'-triphosphatase (EC 3.1.3.33) (mRNA 5'-triphosphatase) (TPase); mRNA guanylyltransferase (EC 2.7.7.50) (GTP--RNA guanylyltransferase) (GTase)],597,"68,557",5 out of 5,2000-05-30,Evidence at protein level
Q96PE7,MCEE_HUMAN,"Methylmalonyl-CoA epimerase, mitochondrial (EC 5.1.99.1) (DL-methylmalonyl-CoA racemase)",176,"18,749",5 out of 5,2004-07-19,Evidence at protein level
Q8TDD5,MCLN3_HUMAN,Mucolipin-3,553,"64,248",3 out of 5,2004-07-19,Evidence at transcript level
P15529,MCP_HUMAN,Membrane cofactor protein (TLX) (Trophoblast leukocyte common antigen) (CD antigen CD46),392,"43,747",5 out of 5,1990-04-01,Evidence at protein level
Q99750,MDFI_HUMAN,MyoD family inhibitor (Myogenic repressor I-mf),246,"25,029",5 out of 5,2002-11-15,Evidence at protein level
P40925,MDHC_HUMAN,"Malate dehydrogenase, cytoplasmic (EC 1.1.1.37) (Cytosolic malate dehydrogenase) (Diiodophenylpyruvate reductase) (EC 1.1.1.96)",334,"36,426",5 out of 5,1995-02-01,Evidence at protein level
Q9Y4Y9,LSM5_HUMAN,U6 snRNA-associated Sm-like protein LSm5,91,"9,937",5 out of 5,2000-12-01,Evidence at protein level
Q8N112,LSME2_HUMAN,Leucine-rich single-pass membrane protein 2,164,"17,868",2 out of 5,2006-06-27,Evidence at protein level
Q5SRR4,LY65C_HUMAN,Lymphocyte antigen 6 complex locus protein G5c,150,"16,650",4 out of 5,2008-03-18,Evidence at protein level
O95868,LY66D_HUMAN,Lymphocyte antigen 6 complex locus protein G6d (Protein Ly6-D) (Megakaryocyte-enhanced gene transcript 1 protein),133,"13,691",5 out of 5,2008-03-18,Evidence at protein level
Q14210,LY6D_HUMAN,Lymphocyte antigen 6D (Ly-6D) (E48 antigen),128,"13,286",5 out of 5,1997-11-01,Evidence at protein level
O94772,LY6H_HUMAN,Lymphocyte antigen 6H (Ly-6H),140,"14,669",4 out of 5,2000-12-01,Evidence at protein level
P10253,LYAG_HUMAN,Lysosomal alpha-glucosidase (EC 3.2.1.20) (Acid maltase) (Aglucosidase alfa) [Cleaved into: 76 kDa lysosomal alpha-glucosidase; 70 kDa lysosomal alpha-glucosidase],952,"105,324",5 out of 5,1989-07-01,Evidence at protein level
P16109,LYAM3_HUMAN,P-selectin (CD62 antigen-like family member P) (Granule membrane protein 140) (GMP-140) (Leukocyte-endothelial cell adhesion molecule 3) (LECAM3) (Platelet activation dependent granule-external membrane protein) (PADGEM) (CD antigen CD62P),830,"90,834",5 out of 5,1990-04-01,Evidence at protein level
Q6UWN5,LYPD5_HUMAN,Ly6/PLAUR domain-containing protein 5,251,"26,936",4 out of 5,2006-03-07,Evidence at protein level
Q02978,M2OM_HUMAN,Mitochondrial 2-oxoglutarate/malate carrier protein (OGCP) (Solute carrier family 25 member 11),314,"34,062",5 out of 5,1993-07-01,Evidence at protein level
O43283,M3K13_HUMAN,Mitogen-activated protein kinase kinase kinase 13 (EC 2.7.11.25) (Leucine zipper-bearing kinase) (Mixed lineage kinase) (MLK),966,"108,296",5 out of 5,2005-06-21,Evidence at protein level
Q6ZN16,M3K15_HUMAN,Mitogen-activated protein kinase kinase kinase 15 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 3) (MAPK/ERK kinase kinase 15) (MEK kinase 15) (MEKK 15),1313,"147,437",5 out of 5,2006-10-17,Evidence at protein level
Q13233,M3K1_HUMAN,Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1),1512,"164,470",5 out of 5,1997-11-01,Evidence at protein level
Q9Y6R4,M3K4_HUMAN,Mitogen-activated protein kinase kinase kinase 4 (EC 2.7.11.25) (MAP three kinase 1) (MAPK/ERK kinase kinase 4) (MEK kinase 4) (MEKK 4),1608,"181,685",5 out of 5,2000-05-30,Evidence at protein level
Q99683,M3K5_HUMAN,Mitogen-activated protein kinase kinase kinase 5 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 1) (ASK-1) (MAPK/ERK kinase kinase 5) (MEK kinase 5) (MEKK 5),1374,"154,537",5 out of 5,2000-05-30,Evidence at protein level
Q8N8E1,MAAS1_HUMAN,Putative uncharacterized protein encoded by MAPKAPK5-AS1 (MAPKAPK5 antisense RNA 1) (MAPKAPK5 antisense gene protein 1),139,"13,175",2 out of 5,2008-05-20,Uncertain
Q9ULX9,MAFF_HUMAN,Transcription factor MafF (U-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog F),164,"17,760",5 out of 5,2002-06-20,Evidence at protein level
P43362,MAGA9_HUMAN,Melanoma-associated antigen 9 (Cancer/testis antigen 1.9) (CT1.9) (MAGE-9 antigen),315,"35,088",3 out of 5,1995-11-01,Evidence at protein level
Q8TD91,MAGC3_HUMAN,Melanoma-associated antigen C3 (Cancer/testis antigen 7.2) (CT7.2) (Hepatocellular carcinoma-associated antigen 2) (MAGE-C3 antigen),643,"71,909",3 out of 5,2004-01-16,Evidence at protein level
Q9HCI5,MAGE1_HUMAN,Melanoma-associated antigen E1 (Alpha-dystrobrevin-associated MAGE Protein) (DAMAGE) (Hepatocellular carcinoma-associated protein 1) (MAGE-E1 antigen),957,"103,254",4 out of 5,2004-07-19,Evidence at protein level
Q9H0U3,MAGT1_HUMAN,Magnesium transporter protein 1 (MagT1) (Implantation-associated protein) (IAP),335,"38,037",5 out of 5,2006-07-11,Evidence at protein level
Q9BXY0,MAK16_HUMAN,Protein MAK16 homolog (NNP78) (Protein RBM13),300,"35,369",3 out of 5,2005-07-19,Evidence at protein level
Q16644,MAPK3_HUMAN,MAP kinase-activated protein kinase 3 (MAPK-activated protein kinase 3) (MAPKAP kinase 3) (MAPKAP-K3) (MAPKAPK-3) (MK-3) (EC 2.7.11.1) (Chromosome 3p kinase) (3pK),382,"42,987",5 out of 5,2005-12-06,Evidence at protein level
Q16655,MAR1_HUMAN,Melanoma antigen recognized by T-cells 1 (MART-1) (Antigen LB39-AA) (Antigen SK29-AA) (Protein Melan-A),118,"13,157",5 out of 5,1997-11-01,Evidence at protein level
O60337,MARH6_HUMAN,E3 ubiquitin-protein ligase MARCH6 (EC 2.3.2.27) (Doa10 homolog) (Membrane-associated RING finger protein 6) (Membrane-associated RING-CH protein VI) (MARCH-VI) (Protein TEB-4) (RING finger protein 176) (RING-type E3 ubiquitin transferase MARCH6),910,"102,545",5 out of 5,2007-02-06,Evidence at protein level
Q9Y2H9,MAST1_HUMAN,Microtubule-associated serine/threonine-protein kinase 1 (EC 2.7.11.1) (Syntrophin-associated serine/threonine-protein kinase),1570,"170,677",5 out of 5,2005-03-01,Evidence at protein level
Q14566,MCM6_HUMAN,DNA replication licensing factor MCM6 (EC 3.6.4.12) (p105MCM),821,"92,889",5 out of 5,1997-11-01,Evidence at protein level
Q9BTE3,MCMBP_HUMAN,Mini-chromosome maintenance complex-binding protein (MCM-BP) (MCM-binding protein),642,"72,980",5 out of 5,2005-07-19,Evidence at protein level
P0CW71,MCP1_HUMAN,Putative metaphase chromosome protein 1 (Metaphase chromosome protein 30),290,"32,982",4 out of 5,2011-05-03,Uncertain
Q86YW9,MD12L_HUMAN,Mediator of RNA polymerase II transcription subunit 12-like protein (Mediator complex subunit 12-like protein) (Thyroid hormone receptor-associated-like protein) (Trinucleotide repeat-containing gene 11 protein-like),2145,"240,120",4 out of 5,2008-01-15,Evidence at protein level
O75448,MED24_HUMAN,Mediator of RNA polymerase II transcription subunit 24 (Activator-recruited cofactor 100 kDa component) (ARC100) (Cofactor required for Sp1 transcriptional activation subunit 4) (CRSP complex subunit 4) (Mediator complex subunit 24) (Thyroid hormone receptor-associated protein 4) (Thyroid hormone receptor-associated protein complex 100 kDa component) (Trap100) (hTRAP100) (Vitamin D3 receptor-interacting protein complex 100 kDa component) (DRIP100),989,"110,305",5 out of 5,2002-06-24,Evidence at protein level
Q5JSS6,MEIG1_HUMAN,Meiosis expressed gene 1 protein homolog,88,"10,795",2 out of 5,2008-01-15,Inferred from homology
Q9H825,METL8_HUMAN,Methyltransferase-like protein 8 (EC 2.1.1.-),291,"33,387",3 out of 5,2007-11-13,Evidence at transcript level
Q5U5Q3,MEX3C_HUMAN,RNA-binding E3 ubiquitin-protein ligase MEX3C (EC 2.3.2.27) (RING finger and KH domain-containing protein 2) (RING finger protein 194) (RING-type E3 ubiquitin transferase MEX3C),659,"69,366",5 out of 5,2007-02-20,Evidence at protein level
Q8N468,MFD4A_HUMAN,Major facilitator superfamily domain-containing protein 4A (Major facilitator superfamily domain-containing protein 4),514,"56,265",3 out of 5,2007-01-23,Evidence at transcript level
Q99685,MGLL_HUMAN,Monoglyceride lipase (MGL) (EC 3.1.1.23) (HU-K5) (Lysophospholipase homolog) (Lysophospholipase-like) (Monoacylglycerol lipase) (MAGL),303,"33,261",5 out of 5,2004-05-10,Evidence at protein level
P16455,MGMT_HUMAN,Methylated-DNA--protein-cysteine methyltransferase (EC 2.1.1.63) (6-O-methylguanine-DNA methyltransferase) (MGMT) (O-6-methylguanine-DNA-alkyltransferase),207,"21,646",5 out of 5,1990-08-01,Evidence at protein level
P61326,MGN_HUMAN,Protein mago nashi homolog,146,"17,164",5 out of 5,2004-05-10,Evidence at protein level
Q16674,MIA_HUMAN,Melanoma-derived growth regulatory protein (Melanoma inhibitory activity protein),131,"14,509",5 out of 5,1997-11-01,Evidence at protein level
Q16891,MIC60_HUMAN,MICOS complex subunit MIC60 (Cell proliferation-inducing gene 4/52 protein) (Mitochondrial inner membrane protein) (Mitofilin) (p87/89),758,"83,678",5 out of 5,2003-03-28,Evidence at protein level
Q8TDZ2,MICA1_HUMAN,[F-actin]-methionine sulfoxide oxidase MICAL1 (EC 1.14.13.225) (Molecule interacting with CasL protein 1) (MICAL-1) (NEDD9-interacting protein with calponin homology and LIM domains),1067,"117,875",5 out of 5,2002-11-08,Evidence at protein level
Q7RTP6,MICA3_HUMAN,[F-actin]-methionine sulfoxide oxidase MICAL3 (EC 1.14.13.225) (Molecule interacting with CasL protein 3) (MICAL-3),2002,"224,295",5 out of 5,2004-04-13,Evidence at protein level
Q6ZW33,MICLK_HUMAN,MICAL C-terminal-like protein (Mical-cL) (ERK2-binding testicular protein 1) (Ebitein-1),695,"77,277",4 out of 5,2007-04-17,Evidence at protein level
Q96C03,MID49_HUMAN,Mitochondrial dynamics protein MID49 (Mitochondrial dynamics protein of 49 kDa) (Mitochondrial elongation factor 2) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein),454,"49,269",5 out of 5,2007-11-13,Evidence at protein level
Q6NVV0,MKRN5_HUMAN,Putative makorin-5 (Makorin ring finger protein pseudogene 6) (Makorin ring finger protein pseudogene 9) (Putative RING finger protein 65),33,"3,805",2 out of 5,2008-07-01,Uncertain
O14950,ML12B_HUMAN,"Myosin regulatory light chain 12B (MLC-2A) (MLC-2) (Myosin regulatory light chain 2-B, smooth muscle isoform) (Myosin regulatory light chain 20 kDa) (MLC20) (Myosin regulatory light chain MRLC2) (SHUJUN-1)",172,"19,779",5 out of 5,2008-09-02,Evidence at protein level
Q9GZQ8,MLP3B_HUMAN,Microtubule-associated proteins 1A/1B light chain 3B (Autophagy-related protein LC3 B) (Autophagy-related ubiquitin-like modifier LC3 B) (MAP1 light chain 3-like protein 2) (MAP1A/MAP1B light chain 3 B) (MAP1A/MAP1B LC3 B) (Microtubule-associated protein 1 light chain 3 beta),125,"14,688",5 out of 5,2001-12-05,Evidence at protein level
Q01449,MLRA_HUMAN,"Myosin regulatory light chain 2, atrial isoform (MLC-2a) (MLC2a) (Myosin light chain 2a) (Myosin regulatory light chain 7)",175,"19,448",4 out of 5,2003-11-28,Evidence at protein level
P10916,MLRV_HUMAN,"Myosin regulatory light chain 2, ventricular/cardiac muscle isoform (MLC-2) (MLC-2v) (Cardiac myosin light chain 2) (Myosin light chain 2, slow skeletal/ventricular muscle isoform) (MLC-2s/v) (Ventricular myosin light chain 2)",166,"18,789",5 out of 5,1989-07-01,Evidence at protein level
P51511,MMP15_HUMAN,Matrix metalloproteinase-15 (MMP-15) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 2) (MT-MMP 2) (MTMMP2) (Membrane-type-2 matrix metalloproteinase) (MT2-MMP) (MT2MMP) (SMCP-2),669,"75,807",5 out of 5,1996-10-01,Evidence at protein level
Q13201,MMRN1_HUMAN,Multimerin-1 (EMILIN-4) (Elastin microfibril interface located protein 4) (Elastin microfibril interfacer 4) (Endothelial cell multimerin) [Cleaved into: Platelet glycoprotein Ia*; 155 kDa platelet multimerin (p-155) (p155)],1228,"138,110",5 out of 5,1998-07-15,Evidence at protein level
O15553,MEFV_HUMAN,Pyrin (Marenostrin),781,"86,444",5 out of 5,2000-12-01,Evidence at protein level
P50221,MEOX1_HUMAN,Homeobox protein MOX-1 (Mesenchyme homeobox 1),254,"27,997",5 out of 5,1996-10-01,Evidence at protein level
Q16820,MEP1B_HUMAN,Meprin A subunit beta (EC 3.4.24.63) (Endopeptidase-2) (Meprin B) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit beta) (PABA peptide hydrolase) (PPH beta),701,"79,571",5 out of 5,1997-11-01,Evidence at protein level
Q86W50,MET16_HUMAN,Methyltransferase-like protein 16 (EC 2.1.1.-) (Methyltransferase 10 domain-containing protein),562,"63,621",3 out of 5,2007-11-13,Evidence at protein level
P31153,METK2_HUMAN,S-adenosylmethionine synthase isoform type-2 (AdoMet synthase 2) (EC 2.5.1.6) (Methionine adenosyltransferase 2) (MAT 2) (Methionine adenosyltransferase II) (MAT-II),395,"43,661",5 out of 5,1993-07-01,Evidence at protein level
Q8TCB7,METL6_HUMAN,Methyltransferase-like protein 6 (EC 2.1.1.-),284,"33,251",2 out of 5,2003-10-03,Evidence at transcript level
Q9H019,MFR1L_HUMAN,Mitochondrial fission regulator 1-like,292,"31,957",3 out of 5,2008-06-10,Evidence at protein level
Q9NYZ2,MFRN1_HUMAN,Mitoferrin-1 (Mitochondrial iron transporter 1) (Mitochondrial solute carrier protein) (Solute carrier family 25 member 37),338,"37,323",4 out of 5,2006-05-16,Evidence at transcript level
Q96ES6,MFSD3_HUMAN,Major facilitator superfamily domain-containing protein 3,412,"42,696",2 out of 5,2007-01-23,Evidence at transcript level
Q6UXD7,MFSD7_HUMAN,Major facilitator superfamily domain-containing protein 7 (Myosin light polypeptide 5 regulatory protein) (MYL5),560,"58,427",2 out of 5,2007-01-23,Evidence at transcript level
P26572,MGAT1_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.101) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase I) (GNT-I) (GlcNAc-T I)",445,"50,878",5 out of 5,1992-08-01,Evidence at protein level
P10620,MGST1_HUMAN,Microsomal glutathione S-transferase 1 (Microsomal GST-1) (EC 2.5.1.18) (Microsomal GST-I),155,"17,599",5 out of 5,1989-07-01,Evidence at protein level
Q9UQ53,MGT4B_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVb) (GlcNAc-T IVb) (GnT-IVb) (N-acetylglucosaminyltransferase IVb) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVb)",548,"63,198",5 out of 5,2007-05-29,Evidence at protein level
Q09328,MGT5A_HUMAN,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase) (GlcNAc-T V) (GNT-V) (Mannoside acetylglucosaminyltransferase 5) (N-acetylglucosaminyl-transferase V)",741,"84,543",4 out of 5,1995-11-01,Evidence at transcript level
Q8N4Q1,MIA40_HUMAN,Mitochondrial intermembrane space import and assembly protein 40 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4),142,"15,996",5 out of 5,2005-04-12,Evidence at protein level
Q8TC71,MIEAP_HUMAN,Mitochondria-eating protein (Spermatogenesis-associated protein 18),538,"61,109",5 out of 5,2006-10-31,Evidence at protein level
Q8IY33,MILK2_HUMAN,MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2),904,"97,502",5 out of 5,2004-04-13,Evidence at protein level
Q15773,MLF2_HUMAN,Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2),248,"28,147",3 out of 5,2001-11-02,Evidence at protein level
Q8N4V1,MMGT1_HUMAN,Membrane magnesium transporter 1 (ER membrane protein complex subunit 5) (Transmembrane protein 32),131,"14,686",5 out of 5,2007-05-01,Evidence at protein level
Q9ULZ9,MMP17_HUMAN,Matrix metalloproteinase-17 (MMP-17) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 4) (MT-MMP 4) (MTMMP4) (Membrane-type-4 matrix metalloproteinase) (MT4-MMP) (MT4MMP),603,"66,653",5 out of 5,2001-01-24,Evidence at protein level
Q8N119,MMP21_HUMAN,Matrix metalloproteinase-21 (MMP-21) (EC 3.4.24.-),569,"65,043",5 out of 5,2004-07-19,Evidence at transcript level
Q9Y5R2,MMP24_HUMAN,Matrix metalloproteinase-24 (MMP-24) (EC 3.4.24.-) (Membrane-type matrix metalloproteinase 5) (MT-MMP 5) (MTMMP5) (Membrane-type-5 matrix metalloproteinase) (MT5-MMP) (MT5MMP) [Cleaved into: Processed matrix metalloproteinase-24],645,"73,231",5 out of 5,2001-01-24,Evidence at transcript level
Q9NPA2,MMP25_HUMAN,Matrix metalloproteinase-25 (MMP-25) (EC 3.4.24.-) (Leukolysin) (Membrane-type matrix metalloproteinase 6) (MT-MMP 6) (MTMMP6) (Membrane-type-6 matrix metalloproteinase) (MT6-MMP) (MT6MMP),562,"62,554",5 out of 5,2001-01-24,Evidence at protein level
Q9H306,MMP27_HUMAN,Matrix metalloproteinase-27 (MMP-27) (EC 3.4.24.-),513,"59,026",5 out of 5,2007-05-15,Evidence at protein level
P09237,MMP7_HUMAN,Matrilysin (EC 3.4.24.23) (Matrin) (Matrix metalloproteinase-7) (MMP-7) (Pump-1 protease) (Uterine metalloproteinase),267,"29,677",5 out of 5,1989-07-01,Evidence at protein level
Q9Y4K4,M4K5_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 5 (EC 2.7.11.1) (Kinase homologous to SPS1/STE20) (KHS) (MAPK/ERK kinase kinase kinase 5) (MEK kinase kinase 5) (MEKKK 5),846,"95,040",5 out of 5,2003-04-30,Evidence at protein level
Q9BQ69,MACD1_HUMAN,O-acetyl-ADP-ribose deacetylase MACROD1 (EC 3.2.2.-) (EC 3.5.1.-) (MACRO domain-containing protein 1) (Protein LRP16) ([Protein ADP-ribosylglutamate] hydrolase),325,"35,505",5 out of 5,2003-06-16,Evidence at protein level
Q9UPN3,MACF1_HUMAN,"Microtubule-actin cross-linking factor 1, isoforms 1/2/3/5 (620 kDa actin-binding protein) (ABP620) (Actin cross-linking family protein 7) (Macrophin-1) (Trabeculin-alpha)",7388,"838,308",5 out of 5,2001-06-01,Evidence at protein level
Q8N5G2,MACOI_HUMAN,Macoilin (Transmembrane protein 57),664,"76,178",3 out of 5,2006-02-07,Evidence at protein level
Q9BW11,MAD3_HUMAN,Max dimerization protein 3 (Max dimerizer 3) (Class C basic helix-loop-helix protein 13) (bHLHc13) (Max-associated protein 3) (Max-interacting transcriptional repressor MAD3) (Myx),206,"23,477",4 out of 5,2006-10-17,Evidence at protein level
Q9H063,MAF1_HUMAN,Repressor of RNA polymerase III transcription MAF1 homolog,256,"28,771",5 out of 5,2004-08-31,Evidence at protein level
P43358,MAGA4_HUMAN,Melanoma-associated antigen 4 (Cancer/testis antigen 1.4) (CT1.4) (MAGE-4 antigen) (MAGE-41 antigen) (MAGE-X2 antigen),317,"34,899",4 out of 5,1995-11-01,Evidence at protein level
Q9UBF1,MAGC2_HUMAN,Melanoma-associated antigen C2 (Cancer/testis antigen 10) (CT10) (Hepatocellular carcinoma-associated antigen 587) (MAGE-C2 antigen) (MAGE-E1 antigen),373,"41,163",5 out of 5,2001-09-26,Evidence at protein level
Q9HAY2,MAGF1_HUMAN,Melanoma-associated antigen F1 (MAGE-F1 antigen),307,"35,222",3 out of 5,2001-11-02,Evidence at protein level
Q9UJ55,MAGL2_HUMAN,MAGE-like protein 2 (Necdin-like protein 1) (Protein nM15),1249,"132,822",5 out of 5,2001-10-18,Evidence at protein level
Q8WWC4,MAIP1_HUMAN,"m-AAA protease-interacting protein 1, mitochondrial (Matrix AAA peptidase-interacting protein 1)",291,"32,545",4 out of 5,2007-09-11,Evidence at protein level
Q8N4S9,MALD2_HUMAN,MARVEL domain-containing protein 2 (Tricellulin),558,"64,168",5 out of 5,2007-01-09,Evidence at protein level
P21145,MAL_HUMAN,Myelin and lymphocyte protein (T-lymphocyte maturation-associated protein),153,"16,714",5 out of 5,1991-05-01,Evidence at protein level
Q92585,MAML1_HUMAN,Mastermind-like protein 1 (Mam-1),1016,"108,054",5 out of 5,2005-07-05,Evidence at protein level
Q9UEW3,MARCO_HUMAN,Macrophage receptor MARCO (Macrophage receptor with collagenous structure) (Scavenger receptor class A member 2),520,"52,658",5 out of 5,2001-09-26,Evidence at protein level
P27448,MARK3_HUMAN,MAP/microtubule affinity-regulating kinase 3 (EC 2.7.11.1) (C-TAK1) (cTAK1) (Cdc25C-associated protein kinase 1) (ELKL motif kinase 2) (EMK-2) (Protein kinase STK10) (Ser/Thr protein kinase PAR-1) (Par-1a) (Serine/threonine-protein kinase p78),753,"84,489",5 out of 5,1992-08-01,Evidence at protein level
P35410,MAS1L_HUMAN,Mas-related G-protein coupled receptor MRG (MAS-R) (MAS1-like),378,"42,411",3 out of 5,1994-06-01,Evidence at transcript level
P48740,MASP1_HUMAN,Mannan-binding lectin serine protease 1 (EC 3.4.21.-) (Complement factor MASP-3) (Complement-activating component of Ra-reactive factor) (Mannose-binding lectin-associated serine protease 1) (MASP-1) (Mannose-binding protein-associated serine protease) (Ra-reactive factor serine protease p100) (RaRF) (Serine protease 5) [Cleaved into: Mannan-binding lectin serine protease 1 heavy chain; Mannan-binding lectin serine protease 1 light chain],699,"79,247",5 out of 5,1996-02-01,Evidence at protein level
O15021,MAST4_HUMAN,Microtubule-associated serine/threonine-protein kinase 4 (EC 2.7.11.1),2626,"284,378",5 out of 5,2006-10-03,Evidence at protein level
Q6ZN01,MASTR_HUMAN,MEF2-activating motif and SAP domain-containing transcriptional regulator (MEF2-activating SAP transcriptional regulatory protein),415,"44,632",3 out of 5,2008-02-26,Evidence at transcript level
P61244,MAX_HUMAN,Protein max (Class D basic helix-loop-helix protein 4) (bHLHd4) (Myc-associated factor X),160,"18,275",5 out of 5,2004-05-10,Evidence at protein level
Q9UBB5,MBD2_HUMAN,Methyl-CpG-binding domain protein 2 (Demethylase) (DMTase) (Methyl-CpG-binding protein MBD2),411,"43,255",5 out of 5,2004-07-19,Evidence at protein level
Q6P1A2,MBOA5_HUMAN,Lysophospholipid acyltransferase 5 (LPLAT 5) (EC 2.3.1.-) (1-acylglycerophosphocholine O-acyltransferase) (EC 2.3.1.23) (1-acylglycerophosphoserine O-acyltransferase) (EC 2.3.1.n6) (Lysophosphatidylcholine acyltransferase) (LPCAT) (Lyso-PC acyltransferase) (Lysophosphatidylcholine acyltransferase 3) (Lyso-PC acyltransferase 3) (Lysophosphatidylserine acyltransferase) (LPSAT) (Lyso-PS acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 5) (O-acyltransferase domain-containing protein 5),487,"56,035",5 out of 5,2006-05-02,Evidence at protein level
P32245,MC4R_HUMAN,Melanocortin receptor 4 (MC4-R),332,"36,943",5 out of 5,1993-10-01,Evidence at protein level
O43324,MCA3_HUMAN,Eukaryotic translation elongation factor 1 epsilon-1 (Aminoacyl tRNA synthetase complex-interacting multifunctional protein 3) (Elongation factor p18) (Multisynthase complex auxiliary component p18),174,"19,811",5 out of 5,2001-10-18,Evidence at protein level
Q8TC05,MDM1_HUMAN,Nuclear protein MDM1,714,"80,735",5 out of 5,2007-08-21,Evidence at protein level
Q9BUE0,MED18_HUMAN,Mediator of RNA polymerase II transcription subunit 18 (Mediator complex subunit 18) (p28b),208,"23,663",4 out of 5,2007-09-11,Evidence at protein level
A6BM72,MEG11_HUMAN,Multiple epidermal growth factor-like domains protein 11 (Multiple EGF-like domains protein 11),1044,"110,844",5 out of 5,2007-11-13,Evidence at transcript level
Q14D04,MELT_HUMAN,Ventricular zone-expressed PH domain-containing protein homolog 1 (Protein melted),833,"94,745",4 out of 5,2007-08-21,Evidence at transcript level
Q9BUU2,MET22_HUMAN,Methyltransferase-like protein 22 (EC 2.1.1.-),404,"44,486",5 out of 5,2007-05-15,Evidence at protein level
Q9H8H3,MET7A_HUMAN,Methyltransferase-like protein 7A (EC 2.1.1.-) (Protein AAM-B),244,"28,319",5 out of 5,2006-10-03,Evidence at protein level
P55083,MFAP4_HUMAN,Microfibril-associated glycoprotein 4,255,"28,648",5 out of 5,1996-10-01,Evidence at protein level
Q9GZY8,MFF_HUMAN,Mitochondrial fission factor,342,"38,465",5 out of 5,2007-05-29,Evidence at protein level
Q9H3U5,MFSD1_HUMAN,Major facilitator superfamily domain-containing protein 1 (Smooth muscle cell-associated protein 4) (SMAP-4),465,"51,209",3 out of 5,2007-01-23,Evidence at transcript level
Q8NBP5,MFSD9_HUMAN,Major facilitator superfamily domain-containing protein 9,474,"50,619",2 out of 5,2007-10-02,Evidence at transcript level
Q9BTT4,MED10_HUMAN,Mediator of RNA polymerase II transcription subunit 10 (Mediator complex subunit 10) (Transformation-related gene 17 protein) (TRG-17) (Transformation-related gene 20 protein) (TRG-20),135,"15,688",4 out of 5,2007-09-11,Evidence at protein level
Q9Y2X0,MED16_HUMAN,Mediator of RNA polymerase II transcription subunit 16 (Mediator complex subunit 16) (Thyroid hormone receptor-associated protein 5) (Thyroid hormone receptor-associated protein complex 95 kDa component) (Trap95) (Vitamin D3 receptor-interacting protein complex 92 kDa component) (DRIP92),877,"96,793",5 out of 5,2005-04-12,Evidence at protein level
Q02080,MEF2B_HUMAN,Myocyte-specific enhancer factor 2B (RSRFR2) (Serum response factor-like protein 2),365,"38,639",5 out of 5,1995-11-01,Evidence at protein level
Q14680,MELK_HUMAN,Maternal embryonic leucine zipper kinase (hMELK) (EC 2.7.11.1) (Protein kinase Eg3) (pEg3 kinase) (Protein kinase PK38) (hPK38) (Tyrosine-protein kinase MELK) (EC 2.7.10.2),651,"74,642",5 out of 5,2004-07-19,Evidence at protein level
Q5EB52,MEST_HUMAN,Mesoderm-specific transcript homolog protein (EC 3.-.-.-) (Paternally-expressed gene 1 protein),335,"38,830",4 out of 5,2007-04-17,Evidence at transcript level
Q9H7H0,MET17_HUMAN,"Methyltransferase-like protein 17, mitochondrial (EC 2.1.1.-) (False p73 target gene protein) (Methyltransferase 11 domain-containing protein 1) (Protein RSM22 homolog, mitochondrial)",456,"50,734",5 out of 5,2007-12-04,Evidence at protein level
Q8N6Q8,MET25_HUMAN,Methyltransferase-like protein 25 (EC 2.1.1.-),603,"68,213",2 out of 5,2006-10-03,Evidence at transcript level
Q6UX53,MET7B_HUMAN,Methyltransferase-like protein 7B (EC 2.1.1.-),244,"27,775",2 out of 5,2006-10-03,Evidence at protein level
Q8N3J2,METL4_HUMAN,Methyltransferase-like protein 4 (EC 2.1.1.-),472,"54,041",3 out of 5,2006-10-03,Evidence at transcript level
Q86XN8,MEX3D_HUMAN,RNA-binding protein MEX3D (RING finger and KH domain-containing protein 1) (RING finger protein 193) (TINO),651,"64,883",5 out of 5,2004-04-13,Evidence at protein level
Q96MC6,MF14A_HUMAN,Hippocampus abundant transcript 1 protein (Major facilitator superfamily domain-containing 14A) (Putative tetracycline transporter-like protein),490,"53,027",3 out of 5,2004-10-11,Evidence at protein level
Q5SR56,MF14B_HUMAN,Hippocampus abundant transcript-like protein 1 (Major facilitator superfamily domain-containing 14B),506,"54,545",3 out of 5,2006-06-13,Evidence at transcript level
P55001,MFAP2_HUMAN,Microfibrillar-associated protein 2 (MFAP-2) (Microfibril-associated glycoprotein 1) (MAGP) (MAGP-1),183,"20,826",5 out of 5,1996-10-01,Evidence at transcript level
Q13361,MFAP5_HUMAN,Microfibrillar-associated protein 5 (MFAP-5) (MP25) (Microfibril-associated glycoprotein 2) (MAGP-2),173,"19,612",5 out of 5,1997-11-01,Evidence at protein level
Q8IWA4,MFN1_HUMAN,Mitofusin-1 (EC 3.6.5.-) (Fzo homolog) (Transmembrane GTPase MFN1),741,"84,100",5 out of 5,2004-05-24,Evidence at protein level
Q96A46,MFRN2_HUMAN,Mitoferrin-2 (Mitochondrial RNA-splicing protein 3/4 homolog) (MRS3/4) (hMRS3/4) (Mitochondrial iron transporter 2) (Solute carrier family 25 member 28),364,"39,272",4 out of 5,2006-05-16,Evidence at transcript level
Q14728,MFS10_HUMAN,Major facilitator superfamily domain-containing protein 10 (Tetracycline transporter-like protein),455,"48,339",4 out of 5,2008-03-18,Evidence at protein level
A6NFX1,MFS2B_HUMAN,Major facilitator superfamily domain-containing protein 2B,497,"52,964",2 out of 5,2008-06-10,Evidence at transcript level
Q5TF39,MFS4B_HUMAN,Sodium-dependent glucose transporter 1 (Major facilitator superfamily domain-containing protein 4B),518,"56,218",3 out of 5,2007-07-10,Evidence at transcript level
Q8IWD5,MFS6L_HUMAN,Major facilitator superfamily domain-containing protein 6-like,586,"64,005",2 out of 5,2008-02-26,Evidence at transcript level
Q99797,MIPEP_HUMAN,Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59),713,"80,641",4 out of 5,1999-07-15,Evidence at protein level
Q8IXI2,MIRO1_HUMAN,Mitochondrial Rho GTPase 1 (MIRO-1) (hMiro-1) (EC 3.6.5.-) (Rac-GTP-binding protein-like protein) (Ras homolog gene family member T1),618,"70,784",5 out of 5,2006-06-13,Evidence at protein level
Q8NDC0,MISSL_HUMAN,MAPK-interacting and spindle-stabilizing protein-like (Mitogen-activated protein kinase 1-interacting protein 1-like),245,"24,269",5 out of 5,2003-07-11,Evidence at protein level
Q9UJH8,METRN_HUMAN,Meteorin,293,"31,207",2 out of 5,2004-07-19,Evidence at transcript level
P08581,MET_HUMAN,Hepatocyte growth factor receptor (HGF receptor) (EC 2.7.10.1) (HGF/SF receptor) (Proto-oncogene c-Met) (Scatter factor receptor) (SF receptor) (Tyrosine-protein kinase Met),1390,"155,541",5 out of 5,1988-08-01,Evidence at protein level
Q6ZN04,MEX3B_HUMAN,RNA-binding protein MEX3B (RING finger and KH domain-containing protein 3) (RING finger protein 195),569,"58,832",5 out of 5,2007-03-06,Evidence at protein level
Q14CX5,MF13A_HUMAN,Transmembrane protein 180 (Major facilitator superfamily domain-containing 13A),517,"57,381",2 out of 5,2006-10-31,Evidence at transcript level
Q5VZR4,MF14C_HUMAN,Hippocampus abundant transcript-like protein 2 (Major facilitator superfamily domain-containing 14C),134,"14,477",2 out of 5,2006-05-30,Evidence at transcript level
O75121,MFA3L_HUMAN,Microfibrillar-associated protein 3-like (Testis development protein NYD-SP9),409,"45,380",5 out of 5,2004-07-19,Evidence at protein level
Q9H1L0,MI1HG_HUMAN,Uncharacterized protein MIR1-1HG (MIR1-1 host gene protein),117,"12,410",1 out of 5,2003-01-10,Predicted
A9UHW6,MI4GD_HUMAN,MIF4G domain-containing protein (SLBP-interacting protein 1) (hSLIP1),222,"25,423",5 out of 5,2008-05-20,Evidence at protein level
Q5JRA6,MIA3_HUMAN,Melanoma inhibitory activity protein 3 (C219-reactive peptide) (D320) (Transport and Golgi organization protein 1),1907,"213,702",5 out of 5,2007-05-29,Evidence at protein level
Q96AX9,MIB2_HUMAN,E3 ubiquitin-protein ligase MIB2 (EC 2.3.2.27) (Mind bomb homolog 2) (Novel zinc finger protein) (Novelzin) (Putative NF-kappa-B-activating protein 002N) (RING-type E3 ubiquitin transferase MIB2) (Skeletrophin) (Zinc finger ZZ type with ankyrin repeat domain protein 1),1013,"109,939",5 out of 5,2005-07-05,Evidence at protein level
Q8IYU8,MICU2_HUMAN,"Calcium uptake protein 2, mitochondrial (EF-hand domain-containing family member A1)",434,"49,666",5 out of 5,2006-10-03,Evidence at protein level
Q8N108,MIER1_HUMAN,Mesoderm induction early response protein 1 (Early response 1) (Er1) (Mi-er1) (hMi-er1),512,"57,983",5 out of 5,2005-11-22,Evidence at protein level
Q96T58,MINT_HUMAN,Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog),3664,"402,248",5 out of 5,2003-10-10,Evidence at protein level
Q9H8M7,MINY3_HUMAN,Ubiquitin carboxyl-terminal hydrolase MINDY-3 (EC 3.4.19.12) (Dermal papilla-derived protein 5) (Deubiquitinating enzyme MINDY-3) (Protein CARP),445,"49,725",5 out of 5,2008-02-05,Evidence at protein level
Q9NXC5,MIO_HUMAN,WD repeat-containing protein mio,875,"98,584",4 out of 5,2008-04-08,Evidence at protein level
Q8TD10,MIPO1_HUMAN,Mirror-image polydactyly gene 1 protein,442,"51,537",5 out of 5,2004-03-01,Evidence at protein level
Q8TDR0,MIPT3_HUMAN,TRAF3-interacting protein 1 (Interleukin-13 receptor alpha 1-binding protein 1) (Intraflagellar transport protein 54 homolog) (Microtubule-interacting protein associated with TRAF3) (MIP-T3),691,"78,632",5 out of 5,2007-09-11,Evidence at protein level
Q969V6,MKL1_HUMAN,MKL/myocardin-like protein 1 (Megakaryoblastic leukemia 1 protein) (Megakaryocytic acute leukemia protein) (Myocardin-related transcription factor A) (MRTF-A),931,"98,919",5 out of 5,2003-06-27,Evidence at protein level
Q8IYA7,MKX_HUMAN,Homeobox protein Mohawk,352,"39,331",2 out of 5,2006-12-12,Evidence at transcript level
P19105,ML12A_HUMAN,"Myosin regulatory light chain 12A (Epididymis secretory protein Li 24) (HEL-S-24) (MLC-2B) (Myosin RLC) (Myosin regulatory light chain 2, nonsarcomeric) (Myosin regulatory light chain MRLC3)",171,"19,794",5 out of 5,1990-11-01,Evidence at protein level
Q9HAP2,MLXIP_HUMAN,MLX-interacting protein (Class E basic helix-loop-helix protein 36) (bHLHe36) (Transcriptional activator MondoA),919,"101,185",5 out of 5,2007-08-21,Evidence at protein level
Q9NP71,MLXPL_HUMAN,Carbohydrate-responsive element-binding protein (ChREBP) (Class D basic helix-loop-helix protein 14) (bHLHd14) (MLX interactor) (MLX-interacting protein-like) (WS basic-helix-loop-helix leucine zipper protein) (WS-bHLH) (Williams-Beuren syndrome chromosomal region 14 protein),852,"93,073",5 out of 5,2002-01-23,Evidence at protein level
Q9H8S9,MOB1A_HUMAN,MOB kinase activator 1A (Mob1 alpha) (Mob1A) (Mob1 homolog 1B) (Mps one binder kinase activator-like 1B),216,"25,080",5 out of 5,2004-12-21,Evidence at protein level
A8MW99,MEI4_HUMAN,Meiosis-specific protein MEI4,385,"44,024",2 out of 5,2008-07-22,Inferred from homology
Q9Y316,MEMO1_HUMAN,Protein MEMO1 (C21orf19-like protein) (Hepatitis C virus NS5A-transactivated protein 7) (HCV NS5A-transactivated protein 7) (Mediator of ErbB2-driven cell motility 1) (Mediator of cell motility 1) (Memo-1),297,"33,733",5 out of 5,2000-05-30,Evidence at protein level
Q9BUN1,MENT_HUMAN,Protein MENT (Methylated in normal thymocytes protein),341,"36,769",3 out of 5,2007-10-02,Evidence at transcript level
Q16819,MEP1A_HUMAN,Meprin A subunit alpha (EC 3.4.24.18) (Endopeptidase-2) (N-benzoyl-L-tyrosyl-P-amino-benzoic acid hydrolase subunit alpha) (PABA peptide hydrolase) (PPH alpha),746,"84,419",5 out of 5,1997-11-01,Evidence at protein level
Q12866,MERTK_HUMAN,Tyrosine-protein kinase Mer (EC 2.7.10.1) (Proto-oncogene c-Mer) (Receptor tyrosine kinase MerTK),999,"110,249",5 out of 5,2000-12-01,Evidence at protein level
Q5JPI9,MET10_HUMAN,Protein-lysine N-methyltransferase METTL10 (EC 2.1.1.-) (Methyltransferase-like protein 10),291,"31,830",3 out of 5,2008-03-18,Evidence at protein level
P55081,MFAP1_HUMAN,Microfibrillar-associated protein 1,439,"51,958",5 out of 5,1996-10-01,Evidence at protein level
Q08431,MFGM_HUMAN,Lactadherin (Breast epithelial antigen BA46) (HMFG) (MFGM) (Milk fat globule-EGF factor 8) (MFG-E8) (SED1) [Cleaved into: Lactadherin short form; Medin],387,"43,123",5 out of 5,1996-10-01,Evidence at protein level
O95140,MFN2_HUMAN,Mitofusin-2 (EC 3.6.5.-) (Transmembrane GTPase MFN2),757,"86,402",5 out of 5,2004-05-24,Evidence at protein level
O00587,MFNG_HUMAN,"Beta-1,3-N-acetylglucosaminyltransferase manic fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",321,"36,202",5 out of 5,2002-03-27,Evidence at protein level
Q6NUT3,MFS12_HUMAN,Major facilitator superfamily domain-containing protein 12,480,"52,075",4 out of 5,2007-02-06,Evidence at protein level
Q6ZSS7,MFSD6_HUMAN,Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog),791,"88,088",3 out of 5,2008-02-26,Evidence at protein level
Q8NHS3,MFSD8_HUMAN,Major facilitator superfamily domain-containing protein 8 (Ceroid-lipofuscinosis neuronal protein 7),518,"57,628",5 out of 5,2007-11-13,Evidence at protein level
Q09327,MGAT3_HUMAN,"Beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (EC 2.4.1.144) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase III) (GNT-III) (GlcNAc-T III) (N-acetylglucosaminyltransferase III)",533,"61,313",4 out of 5,1995-11-01,Evidence at transcript level
O43451,MGA_HUMAN,"Maltase-glucoamylase, intestinal [Includes: Maltase (EC 3.2.1.20) (Alpha-glucosidase); Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]",1857,"209,852",5 out of 5,2000-05-30,Evidence at protein level
Q86V88,MGDP1_HUMAN,Magnesium-dependent phosphatase 1 (MDP-1) (EC 3.1.3.-) (EC 3.1.3.48),176,"20,109",4 out of 5,2005-10-25,Evidence at protein level
Q9UBM8,MGT4C_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (EC 2.4.1.145) (N-acetylglucosaminyltransferase IV homolog) (hGnT-IV-H) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVc) (GlcNAc-T IVc) (GnT-IVc) (N-acetylglucosaminyltransferase IVc) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVc)",478,"56,061",5 out of 5,2007-05-29,Evidence at transcript level
Q96PC5,MIA2_HUMAN,Melanoma inhibitory activity protein 2,1412,"159,836",5 out of 5,2004-03-01,Evidence at protein level
Q5XKP0,MIC13_HUMAN,MICOS complex subunit MIC13 (Protein P117),118,"13,087",4 out of 5,2007-06-12,Evidence at protein level
Q86XE3,MICU3_HUMAN,"Calcium uptake protein 3, mitochondrial (EF-hand domain-containing family member A2)",530,"60,711",3 out of 5,2006-10-03,Evidence at transcript level
Q8NAN2,MIGA1_HUMAN,Mitoguardin 1 (Protein FAM73A),632,"71,006",4 out of 5,2007-05-01,Evidence at protein level
Q7Z6M3,MILR1_HUMAN,Allergin-1 (Allergy inhibitory receptor 1) (Mast cell antigen 32) (MCA-32) (Mast cell immunoglobulin-like receptor 1),343,"38,735",5 out of 5,2007-10-23,Evidence at protein level
P20774,MIME_HUMAN,Mimecan (Osteoglycin) (Osteoinductive factor) (OIF),298,"33,922",5 out of 5,1991-02-01,Evidence at protein level
Q8N183,MIMIT_HUMAN,"Mimitin, mitochondrial (B17.2-like) (B17.2L) (Myc-induced mitochondrial protein) (MMTN) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 2) (NDUFA12-like protein)",169,"19,856",5 out of 5,2005-06-07,Evidence at protein level
Q4G0A6,MINY4_HUMAN,Probable ubiquitin carboxyl-terminal hydrolase MINDY-4 (EC 3.4.19.12) (Probable deubiquitinating enzyme MINDY-4),757,"84,372",3 out of 5,2008-02-26,Evidence at protein level
Q8IXI1,MIRO2_HUMAN,Mitochondrial Rho GTPase 2 (MIRO-2) (hMiro-2) (EC 3.6.5.-) (Ras homolog gene family member T2),618,"68,118",5 out of 5,2006-06-13,Evidence at protein level
P03971,MIS_HUMAN,Muellerian-inhibiting factor (Anti-Muellerian hormone) (AMH) (Muellerian-inhibiting substance) (MIS),560,"59,195",5 out of 5,1986-10-23,Evidence at protein level
P28482,MK01_HUMAN,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),360,"41,390",5 out of 5,1992-12-01,Evidence at protein level
P45984,MK09_HUMAN,Mitogen-activated protein kinase 9 (MAP kinase 9) (MAPK 9) (EC 2.7.11.24) (JNK-55) (Stress-activated protein kinase 1a) (SAPK1a) (Stress-activated protein kinase JNK2) (c-Jun N-terminal kinase 2),424,"48,139",5 out of 5,1995-11-01,Evidence at protein level
Q16539,MK14_HUMAN,Mitogen-activated protein kinase 14 (MAP kinase 14) (MAPK 14) (EC 2.7.11.24) (Cytokine suppressive anti-inflammatory drug-binding protein) (CSAID-binding protein) (CSBP) (MAP kinase MXI2) (MAX-interacting protein 2) (Mitogen-activated protein kinase p38 alpha) (MAP kinase p38 alpha) (Stress-activated protein kinase 2a) (SAPK2a),360,"41,293",5 out of 5,1997-11-01,Evidence at protein level
Q9UHC1,MLH3_HUMAN,DNA mismatch repair protein Mlh3 (MutL protein homolog 3),1453,"163,711",5 out of 5,2001-04-27,Evidence at protein level
Q5VWP3,MLIP_HUMAN,Muscular LMNA-interacting protein (Muscular-enriched A-type laminin-interacting protein),458,"50,429",4 out of 5,2005-08-30,Evidence at protein level
Q8NB16,MLKL_HUMAN,Mixed lineage kinase domain-like protein (hMLKL),471,"54,479",5 out of 5,2006-09-05,Evidence at protein level
Q9UH92,MLX_HUMAN,Max-like protein X (Class D basic helix-loop-helix protein 13) (bHLHd13) (Max-like bHLHZip protein) (Protein BigMax) (Transcription factor-like protein 4),298,"33,300",5 out of 5,2002-01-23,Evidence at protein level
Q99542,MMP19_HUMAN,Matrix metalloproteinase-19 (MMP-19) (EC 3.4.24.-) (Matrix metalloproteinase RASI) (Matrix metalloproteinase-18) (MMP-18),508,"57,357",5 out of 5,2001-01-24,Evidence at protein level
P03956,MMP1_HUMAN,Interstitial collagenase (EC 3.4.24.7) (Fibroblast collagenase) (Matrix metalloproteinase-1) (MMP-1) [Cleaved into: 22 kDa interstitial collagenase; 27 kDa interstitial collagenase],469,"54,007",5 out of 5,1986-10-23,Evidence at protein level
O60882,MMP20_HUMAN,Matrix metalloproteinase-20 (MMP-20) (EC 3.4.24.-) (Enamel metalloproteinase) (Enamelysin),483,"54,387",5 out of 5,2000-12-01,Evidence at protein level
P08254,MMP3_HUMAN,Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (Transin-1),477,"53,977",5 out of 5,1988-08-01,Evidence at protein level
Q96T76,MMS19_HUMAN,MMS19 nucleotide excision repair protein homolog (hMMS19) (MET18 homolog) (MMS19-like protein),1030,"113,290",5 out of 5,2005-09-13,Evidence at protein level
Q9BU76,MMTA2_HUMAN,Multiple myeloma tumor-associated protein 2 (hMMTAG2),263,"29,412",5 out of 5,2005-08-16,Evidence at protein level
P51608,MECP2_HUMAN,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),486,"52,441",5 out of 5,1996-10-01,Evidence at protein level
Q02078,MEF2A_HUMAN,Myocyte-specific enhancer factor 2A (Serum response factor-like protein 1),507,"54,811",5 out of 5,1995-11-01,Evidence at protein level
O14770,MEIS2_HUMAN,Homeobox protein Meis2 (Meis1-related protein 1),477,"51,790",5 out of 5,1998-07-15,Evidence at protein level
Q9H9K5,MER34_HUMAN,Endogenous retrovirus group MER34 member 1 Env polyprotein (HERV-MER_4q12 provirus ancestral Env polyprotein),563,"63,547",3 out of 5,2008-06-10,Evidence at transcript level
Q9HCE5,MET14_HUMAN,N6-adenosine-methyltransferase subunit METTL14 (EC 2.1.1.62) (Methyltransferase-like protein 14) (hMETTL14),456,"52,150",5 out of 5,2008-03-18,Evidence at protein level
A1L020,MEX3A_HUMAN,RNA-binding protein MEX3A (RING finger and KH domain-containing protein 4),520,"54,173",4 out of 5,2007-03-20,Evidence at protein level
P55082,MFAP3_HUMAN,Microfibril-associated glycoprotein 3,362,"40,165",4 out of 5,1996-10-01,Evidence at transcript level
Q2M2H8,MGAL_HUMAN,"Probable maltase-glucoamylase 2 (Maltase-glucoamylase (alpha-glucosidase) pseudogene) [Includes: Glucoamylase (EC 3.2.1.3) (Glucan 1,4-alpha-glucosidase)]",2515,"277,990",4 out of 5,2008-06-10,Evidence at transcript level
Q10469,MGAT2_HUMAN,"Alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (EC 2.4.1.143) (Beta-1,2-N-acetylglucosaminyltransferase II) (GlcNAc-T II) (GNT-II) (Mannoside acetylglucosaminyltransferase 2) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase II)",447,"51,550",5 out of 5,1996-10-01,Evidence at protein level
P08493,MGP_HUMAN,Matrix Gla protein (MGP) (Cell growth-inhibiting gene 36 protein),103,"12,353",5 out of 5,1988-08-01,Evidence at protein level
Q7L4E1,MIGA2_HUMAN,Mitoguardin 2 (Protein FAM73B),593,"65,531",5 out of 5,2008-01-15,Evidence at protein level
Q8N4C8,MINK1_HUMAN,Misshapen-like kinase 1 (EC 2.7.11.1) (GCK family kinase MiNK) (MAPK/ERK kinase kinase kinase 6) (MEK kinase kinase 6) (MEKKK 6) (Misshapen/NIK-related kinase) (Mitogen-activated protein kinase kinase kinase kinase 6),1332,"149,822",5 out of 5,2003-03-28,Evidence at protein level
Q9UGB7,MIOX_HUMAN,Inositol oxygenase (EC 1.13.99.1) (Aldehyde reductase-like 6) (Kidney-specific protein 32) (Myo-inositol oxygenase) (MI oxygenase) (Renal-specific oxidoreductase),285,"33,010",5 out of 5,2003-02-12,Evidence at protein level
Q8IVT2,MISP_HUMAN,Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein),679,"75,357",5 out of 5,2005-08-16,Evidence at protein level
P31152,MK04_HUMAN,Mitogen-activated protein kinase 4 (MAP kinase 4) (MAPK 4) (EC 2.7.11.24) (Extracellular signal-regulated kinase 4) (ERK-4) (MAP kinase isoform p63) (p63-MAPK),587,"65,922",5 out of 5,1993-07-01,Evidence at protein level
Q13064,MKRN3_HUMAN,Probable E3 ubiquitin-protein ligase makorin-3 (EC 2.3.2.27) (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127),507,"55,645",5 out of 5,2001-11-16,Evidence at protein level
Q9BXW4,MLP3C_HUMAN,Microtubule-associated proteins 1A/1B light chain 3C (Autophagy-related protein LC3 C) (Autophagy-related ubiquitin-like modifier LC3 C) (MAP1 light chain 3-like protein 3) (MAP1A/MAP1B light chain 3 C) (MAP1A/MAP1B LC3 C) (Microtubule-associated protein 1 light chain 3 gamma),147,"16,852",5 out of 5,2005-05-10,Evidence at protein level
Q8IZK6,MCLN2_HUMAN,Mucolipin-2,566,"65,942",3 out of 5,2004-07-19,Evidence at transcript level
P49736,MCM2_HUMAN,DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28),904,"101,896",5 out of 5,1996-10-01,Evidence at protein level
Q9BUT9,MCRI2_HUMAN,MAPK regulated corepressor interacting protein 2 (Protein FAM195A),160,"17,828",4 out of 5,2007-02-06,Evidence at protein level
Q9NU22,MDN1_HUMAN,Midasin (MIDAS-containing protein),5596,"632,820",5 out of 5,2002-10-19,Evidence at protein level
Q8NDY4,MDS2_HUMAN,Myelodysplastic syndrome 2 translocation-associated protein,140,"15,384",2 out of 5,2006-10-17,Evidence at transcript level
O95402,MED26_HUMAN,Mediator of RNA polymerase II transcription subunit 26 (Activator-recruited cofactor 70 kDa component) (ARC70) (Cofactor required for Sp1 transcriptional activation subunit 7) (CRSP complex subunit 7) (Mediator complex subunit 26) (Transcriptional coactivator CRSP70),600,"65,446",5 out of 5,2003-02-28,Evidence at protein level
Q96KG7,MEG10_HUMAN,Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10),1140,"122,205",5 out of 5,2007-11-13,Evidence at protein level
P50222,MEOX2_HUMAN,Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2),304,"33,594",5 out of 5,1996-10-01,Evidence at protein level
P35240,MERL_HUMAN,Merlin (Moesin-ezrin-radixin-like protein) (Neurofibromin-2) (Schwannomerlin) (Schwannomin),595,"69,690",5 out of 5,1994-02-01,Evidence at protein level
Q14696,MESD_HUMAN,LDLR chaperone MESD (Mesoderm development candidate 2) (Mesoderm development protein) (Renal carcinoma antigen NY-REN-61),234,"26,077",5 out of 5,1998-07-15,Evidence at protein level
Q0VG99,MESP2_HUMAN,Mesoderm posterior protein 2 (Class C basic helix-loop-helix protein 6) (bHLHc6),397,"41,760",5 out of 5,2007-07-24,Evidence at protein level
Q96IZ6,MET2A_HUMAN,Methyltransferase-like protein 2A (EC 2.1.1.-),378,"43,537",3 out of 5,2003-10-03,Evidence at protein level
Q9NRN9,METL5_HUMAN,Methyltransferase-like protein 5 (EC 2.1.1.-),209,"23,719",2 out of 5,2006-10-03,Evidence at protein level
Q8IWI9,MGAP_HUMAN,MAX gene-associated protein (MAX dimerization protein 5),3026,"331,836",5 out of 5,2008-07-01,Evidence at protein level
Q9BQP7,MGME1_HUMAN,Mitochondrial genome maintenance exonuclease 1 (EC 3.1.-.-),344,"39,421",5 out of 5,2002-11-25,Evidence at protein level
Q96LZ2,MAGBA_HUMAN,Melanoma-associated antigen B10 (MAGE-B10 antigen),347,"38,971",2 out of 5,2005-10-25,Evidence at transcript level
Q969Z3,MARC2_HUMAN,Mitochondrial amidoxime reducing component 2 (mARC2) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 2) (MOSC domain-containing protein 2) (Moco sulfurase C-terminal domain-containing protein 2),335,"38,023",5 out of 5,2007-01-23,Evidence at protein level
Q7Z434,MAVS_HUMAN,Mitochondrial antiviral-signaling protein (MAVS) (CARD adapter inducing interferon beta) (Cardif) (Interferon beta promoter stimulator protein 1) (IPS-1) (Putative NF-kappa-B-activating protein 031N) (Virus-induced-signaling adapter) (VISA),540,"56,528",5 out of 5,2004-05-10,Evidence at protein level
Q8IX19,MCEM1_HUMAN,Mast cell-expressed membrane protein 1,187,"21,229",3 out of 5,2007-01-23,Evidence at protein level
O15068,MCF2L_HUMAN,Guanine nucleotide exchange factor DBS (DBL's big sister) (MCF2-transforming sequence-like protein),1137,"128,109",5 out of 5,1999-07-15,Evidence at protein level
P10911,MCF2_HUMAN,Proto-oncogene DBL (Proto-oncogene MCF-2) [Cleaved into: MCF2-transforming protein; DBL-transforming protein],925,"107,673",5 out of 5,1989-07-01,Evidence at protein level
Q7L590,MCM10_HUMAN,Protein MCM10 homolog (HsMCM10),875,"98,183",5 out of 5,2007-02-20,Evidence at protein level
P33991,MCM4_HUMAN,DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21),863,"96,558",5 out of 5,1994-02-01,Evidence at protein level
Q8NEM0,MCPH1_HUMAN,Microcephalin,835,"92,877",5 out of 5,2004-05-24,Evidence at protein level
C9JLW8,MCRI1_HUMAN,Mapk-regulated corepressor-interacting protein 1 (Granulin-2) (Protein FAM195B),97,"10,920",5 out of 5,2010-05-18,Evidence at protein level
Q96EZ8,MCRS1_HUMAN,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),462,"51,803",5 out of 5,2002-11-01,Evidence at protein level
P49901,MCSP_HUMAN,Sperm mitochondrial-associated cysteine-rich protein,116,"12,767",5 out of 5,1996-10-01,Evidence at protein level
Q9NWR8,MCUB_HUMAN,"Calcium uniporter regulatory subunit MCUb, mitochondrial (MCUb) (Coiled-coil domain-containing protein 109B)",336,"39,082",4 out of 5,2007-04-03,Evidence at protein level
Q8NFP4,MDGA1_HUMAN,MAM domain-containing glycosylphosphatidylinositol anchor protein 1 (GPI and MAM protein) (GPIM) (Glycosylphosphatidylinositol-MAM) (MAM domain-containing protein 3),955,"105,790",5 out of 5,2004-04-13,Evidence at protein level
Q93074,MED12_HUMAN,Mediator of RNA polymerase II transcription subunit 12 (Activator-recruited cofactor 240 kDa component) (ARC240) (CAG repeat protein 45) (Mediator complex subunit 12) (OPA-containing protein) (Thyroid hormone receptor-associated protein complex 230 kDa component) (Trap230) (Trinucleotide repeat-containing gene 11 protein),2177,"243,081",5 out of 5,1997-11-01,Evidence at protein level
Q9NVC6,MED17_HUMAN,Mediator of RNA polymerase II transcription subunit 17 (Activator-recruited cofactor 77 kDa component) (ARC77) (Cofactor required for Sp1 transcriptional activation subunit 6) (CRSP complex subunit 6) (Mediator complex subunit 17) (Thyroid hormone receptor-associated protein complex 80 kDa component) (Trap80) (Transcriptional coactivator CRSP77) (Vitamin D3 receptor-interacting protein complex 80 kDa component) (DRIP80),651,"72,890",5 out of 5,2003-02-28,Evidence at protein level
Q15648,MED1_HUMAN,Mediator of RNA polymerase II transcription subunit 1 (Activator-recruited cofactor 205 kDa component) (ARC205) (Mediator complex subunit 1) (Peroxisome proliferator-activated receptor-binding protein) (PBP) (PPAR-binding protein) (Thyroid hormone receptor-associated protein complex 220 kDa component) (Trap220) (Thyroid receptor-interacting protein 2) (TR-interacting protein 2) (TRIP-2) (Vitamin D receptor-interacting protein complex component DRIP205) (p53 regulatory protein RB18A),1581,"168,478",5 out of 5,1997-11-01,Evidence at protein level
Q9H204,MED28_HUMAN,Mediator of RNA polymerase II transcription subunit 28 (Endothelial-derived protein 1) (Mediator complex subunit 28) (Merlin and Grb2-interacting cytoskeletal protein) (Magicin) (Tumor angiogenesis marker EG-1),178,"19,520",5 out of 5,2005-02-01,Evidence at protein level
O43513,MED7_HUMAN,Mediator of RNA polymerase II transcription subunit 7 (hMED7) (Activator-recruited cofactor 34 kDa component) (ARC34) (Cofactor required for Sp1 transcriptional activation subunit 9) (CRSP complex subunit 9) (Mediator complex subunit 7) (RNA polymerase transcriptional regulation mediator subunit 7 homolog) (Transcriptional coactivator CRSP33),233,"27,245",5 out of 5,2003-02-28,Evidence at protein level
O00470,MEIS1_HUMAN,Homeobox protein Meis1,390,"43,016",5 out of 5,1998-07-15,Evidence at protein level
Q9BV36,MELPH_HUMAN,Melanophilin (Exophilin-3) (Slp homolog lacking C2 domains a) (SlaC2-a) (Synaptotagmin-like protein 2a),600,"65,949",5 out of 5,2003-06-16,Evidence at protein level
Q00266,METK1_HUMAN,S-adenosylmethionine synthase isoform type-1 (AdoMet synthase 1) (EC 2.5.1.6) (Methionine adenosyltransferase 1) (MAT 1) (Methionine adenosyltransferase I/III) (MAT-I/III),395,"43,648",5 out of 5,1992-12-01,Evidence at protein level
Q9H1A3,METL9_HUMAN,Methyltransferase-like protein 9 (DORA reverse strand protein) (DREV) (DREV1),318,"36,536",3 out of 5,2008-02-05,Evidence at transcript level
Q9BY79,MFRP_HUMAN,Membrane frizzled-related protein (Membrane-type frizzled-related protein),579,"62,212",5 out of 5,2006-03-21,Evidence at protein level
Q9H2D1,MFTC_HUMAN,Mitochondrial folate transporter/carrier (Solute carrier family 25 member 32),315,"35,407",5 out of 5,2002-02-11,Evidence at protein level
Q3V5L5,MGT5B_HUMAN,"Alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B (EC 2.4.1.-) (EC 2.4.1.155) (Alpha-mannoside beta-1,6-N-acetylglucosaminyltransferase B) (GlcNAc-T Vb) (GNT-Vb) (hGnTVb) (Mannoside acetylglucosaminyltransferase 5B) (N-acetylglucosaminyl-transferase Vb) (N-acetylglucosaminyltransferase IX) (GNT-IX)",792,"89,535",5 out of 5,2007-05-29,Evidence at protein level
Q9NX63,MIC19_HUMAN,MICOS complex subunit MIC19 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 3),227,"26,152",5 out of 5,2005-04-12,Evidence at protein level
Q6UXV4,MIC27_HUMAN,MICOS complex subunit MIC27 (Apolipoprotein O-like) (Protein FAM121A),268,"29,159",5 out of 5,2005-09-27,Evidence at protein level
Q9BZ81,MAGB5_HUMAN,Melanoma-associated antigen B5 (Cancer/testis antigen 3.3) (CT3.3) (MAGE-B5 antigen),275,"31,906",2 out of 5,2004-01-16,Evidence at transcript level
P20916,MAG_HUMAN,Myelin-associated glycoprotein (Siglec-4a),626,"69,069",5 out of 5,1991-02-01,Evidence at protein level
Q9H8J5,MANS1_HUMAN,MANSC domain-containing protein 1 (Loss of heterozygosity 12 chromosomal region 3 protein),431,"46,810",3 out of 5,2004-06-07,Evidence at transcript level
P23368,MAOM_HUMAN,"NAD-dependent malic enzyme, mitochondrial (NAD-ME) (EC 1.1.1.38) (Malic enzyme 2)",584,"65,444",5 out of 5,1991-11-01,Evidence at protein level
P48163,MAOX_HUMAN,NADP-dependent malic enzyme (NADP-ME) (EC 1.1.1.40) (Malic enzyme 1),572,"64,150",5 out of 5,1996-02-01,Evidence at protein level
A6NJ08,MB3L5_HUMAN,Putative methyl-CpG-binding domain protein 3-like 5 (MBD3-like protein 5),208,"22,976",2 out of 5,2008-09-02,Uncertain
Q9BQG0,MBB1A_HUMAN,Myb-binding protein 1A,1328,"148,855",5 out of 5,2005-07-19,Evidence at protein level
Q9NS73,MBIP1_HUMAN,MAP3K12-binding inhibitory protein 1 (MAPK upstream kinase-binding inhibitory protein) (MUK-binding inhibitory protein),344,"39,281",5 out of 5,2004-05-10,Evidence at protein level
Q05BQ5,MBTD1_HUMAN,MBT domain-containing protein 1,628,"70,547",4 out of 5,2008-01-15,Evidence at protein level
Q14703,MBTP1_HUMAN,Membrane-bound transcription factor site-1 protease (EC 3.4.21.112) (Endopeptidase S1P) (Subtilisin/kexin-isozyme 1) (SKI-1),1052,"117,749",5 out of 5,2001-11-16,Evidence at protein level
Q9BQD1,MCHL2_HUMAN,Putative pro-MCH-like protein 2 (Pro-melanin-concentrating hormone-like protein 2),86,"9,856",2 out of 5,2005-07-19,Uncertain
Q07820,MCL1_HUMAN,Induced myeloid leukemia cell differentiation protein Mcl-1 (Bcl-2-like protein 3) (Bcl2-L-3) (Bcl-2-related protein EAT/mcl1) (mcl1/EAT),350,"37,337",5 out of 5,1995-02-01,Evidence at protein level
P25205,MCM3_HUMAN,DNA replication licensing factor MCM3 (EC 3.6.4.12) (DNA polymerase alpha holoenzyme-associated protein P1) (P1-MCM3) (RLF subunit beta) (p102),808,"90,981",5 out of 5,1992-05-01,Evidence at protein level
Q9ULK4,MED23_HUMAN,Mediator of RNA polymerase II transcription subunit 23 (Activator-recruited cofactor 130 kDa component) (ARC130) (Cofactor required for Sp1 transcriptional activation subunit 3) (CRSP complex subunit 3) (Mediator complex subunit 23) (Protein sur-2 homolog) (hSur-2) (Transcriptional coactivator CRSP130) (Vitamin D3 receptor-interacting protein complex 130 kDa component) (DRIP130),1368,"156,474",5 out of 5,2003-02-22,Evidence at protein level
O75586,MED6_HUMAN,Mediator of RNA polymerase II transcription subunit 6 (Activator-recruited cofactor 33 kDa component) (ARC33) (Mediator complex subunit 6) (hMed6) (Renal carcinoma antigen NY-REN-28),246,"28,425",5 out of 5,2003-02-28,Evidence at protein level
A0A087WXM9,MEIKN_HUMAN,Meiosis-specific kinetochore protein,373,"40,829",2 out of 5,2015-03-04,Evidence at transcript level
O00255,MEN1_HUMAN,Menin,615,"68,023",5 out of 5,1998-12-15,Evidence at protein level
Q9BQA1,MEP50_HUMAN,Methylosome protein 50 (MEP-50) (Androgen receptor cofactor p44) (WD repeat-containing protein 77) (p44/Mep50),342,"36,724",5 out of 5,2003-06-20,Evidence at protein level
Q9NQ76,MEPE_HUMAN,Matrix extracellular phosphoglycoprotein (Osteoblast/osteocyte factor 45) (OF45),525,"58,419",4 out of 5,2003-07-19,Evidence at protein level
A6NJ78,MET15_HUMAN,Probable methyltransferase-like protein 15 (EC 2.1.1.-) (Methyltransferase 5 domain-containing protein 1),407,"46,121",4 out of 5,2007-10-23,Evidence at protein level
Q86XA0,MET23_HUMAN,Methyltransferase-like protein 23 (EC 2.1.1.-),190,"21,469",4 out of 5,2008-02-26,Evidence at protein level
Q99707,METH_HUMAN,Methionine synthase (EC 2.1.1.13) (5-methyltetrahydrofolate--homocysteine methyltransferase) (Vitamin-B12 dependent methionine synthase) (MS),1265,"140,527",5 out of 5,1997-11-01,Evidence at protein level
Q86YR7,MF2L2_HUMAN,Probable guanine nucleotide exchange factor MCF2L2 (Dbs-related Rho family guanine nucleotide exchange factor) (MCF2-transforming sequence-like protein 2),1114,"126,993",5 out of 5,2008-05-20,Evidence at transcript level
Q9Y4C4,MFHA1_HUMAN,Malignant fibrous histiocytoma-amplified sequence 1 (Malignant fibrous histiocytoma-amplified sequence with leucine-rich tandem repeats 1),1052,"116,950",4 out of 5,2007-10-23,Evidence at protein level
Q9BUR5,MIC26_HUMAN,MICOS complex subunit MIC26 (Apolipoprotein O) (MICOS complex subunit MIC23) (Protein FAM121B),198,"22,285",5 out of 5,2006-10-31,Evidence at protein level
Q9BPX6,MICU1_HUMAN,"Calcium uptake protein 1, mitochondrial (Atopy-related autoantigen CALC) (ara CALC) (Calcium-binding atopy-related autoantigen 1) (allergen Hom s 4)",476,"54,351",5 out of 5,2008-03-18,Evidence at protein level
Q504T8,MIDN_HUMAN,Midnolin (Midbrain nucleolar protein),468,"49,213",3 out of 5,2007-05-15,Evidence at protein level
Q96FF7,MISP3_HUMAN,Uncharacterized protein MISP3 (MISP family member 3),219,"24,028",1 out of 5,2008-02-26,Evidence at transcript level
P27361,MK03_HUMAN,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),379,"43,136",5 out of 5,1992-08-01,Evidence at protein level
P45983,MK08_HUMAN,Mitogen-activated protein kinase 8 (MAP kinase 8) (MAPK 8) (EC 2.7.11.24) (JNK-46) (Stress-activated protein kinase 1c) (SAPK1c) (Stress-activated protein kinase JNK1) (c-Jun N-terminal kinase 1),427,"48,296",5 out of 5,1995-11-01,Evidence at protein level
Q8IVH4,MMAA_HUMAN,"Methylmalonic aciduria type A protein, mitochondrial (EC 3.6.-.-)",418,"46,538",5 out of 5,2003-11-07,Evidence at protein level
Q9H8L6,MMRN2_HUMAN,Multimerin-2 (EMILIN-3) (Elastin microfibril interface located protein 3) (Elastin microfibril interfacer 3) (EndoGlyx-1 p125/p140 subunit),949,"104,409",5 out of 5,2003-10-03,Evidence at protein level
Q9BWT6,MND1_HUMAN,Meiotic nuclear division protein 1 homolog,205,"23,753",3 out of 5,2008-02-05,Evidence at protein level
P41218,MNDA_HUMAN,Myeloid cell nuclear differentiation antigen,407,"45,836",5 out of 5,1995-02-01,Evidence at protein level
Q96BY2,MOAP1_HUMAN,Modulator of apoptosis 1 (MAP-1) (MAP1) (Paraneoplastic antigen Ma4),351,"39,513",5 out of 5,2003-10-24,Evidence at protein level
Q7L9L4,MOB1B_HUMAN,MOB kinase activator 1B (Mob1 homolog 1A) (Mob1A) (Mob1B) (Mps one binder kinase activator-like 1A),216,"25,091",5 out of 5,2004-12-21,Evidence at protein level
Q70IA6,MOB2_HUMAN,MOB kinase activator 2 (HCCA2) (Mob2 homolog) (Mps one binder kinase activator-like 2),237,"26,927",5 out of 5,2004-12-21,Evidence at protein level
Q9H3H1,MOD5_HUMAN,"tRNA dimethylallyltransferase, mitochondrial (EC 2.5.1.75) (Isopentenyl-diphosphate:tRNA isopentenyltransferase) (IPP transferase) (IPPT) (hGRO1) (tRNA isopentenyltransferase) (IPTase)",467,"52,725",5 out of 5,2004-07-05,Evidence at protein level
P12872,MOTI_HUMAN,Promotilin [Cleaved into: Motilin; Motilin-associated peptide (MAP)],115,"12,920",4 out of 5,1989-10-01,Evidence at protein level
Q15777,MPPD2_HUMAN,Metallophosphoesterase MPPED2 (EC 3.1.-.-) (Fetal brain protein 239) (239FB) (Metallophosphoesterase domain-containing protein 2),294,"33,360",4 out of 5,1998-07-15,Evidence at protein level
Q53F39,MPPE1_HUMAN,Metallophosphoesterase 1 (EC 3.1.-.-) (Post-GPI attachment to proteins factor 5),396,"45,141",5 out of 5,2008-01-15,Evidence at protein level
A8MV57,MPTX_HUMAN,Putative mucosal pentraxin homolog,137,"15,138",2 out of 5,2008-07-01,Uncertain
Q96G30,MRAP2_HUMAN,Melanocortin-2 receptor accessory protein 2 (MC2R accessory protein 2),205,"23,548",5 out of 5,2005-07-05,Evidence at protein level
Q9UBG0,MRC2_HUMAN,C-type mannose receptor 2 (C-type lectin domain family 13 member E) (Endocytic receptor 180) (Macrophage mannose receptor 2) (Urokinase-type plasminogen activator receptor-associated protein) (UPAR-associated protein) (Urokinase receptor-associated protein) (CD antigen CD280),1479,"166,674",5 out of 5,2006-02-07,Evidence at protein level
Q6DT37,MRCKG_HUMAN,Serine/threonine-protein kinase MRCK gamma (EC 2.7.11.1) (CDC42-binding protein kinase gamma) (DMPK-like gamma) (Myotonic dystrophy kinase-related CDC42-binding kinase gamma) (MRCK gamma) (MRCKG) (Myotonic dystrophy protein kinase-like gamma) (Myotonic dystrophy protein kinase-like alpha),1551,"172,459",5 out of 5,2005-11-08,Evidence at protein level
Q6P1R3,MSD2_HUMAN,Myb/SANT-like DNA-binding domain-containing protein 2,559,"61,319",2 out of 5,2007-02-06,Evidence at protein level
Q96KJ4,MSLNL_HUMAN,Mesothelin-like protein (Pre-pro-megakaryocyte-potentiating-factor-like),702,"74,540",3 out of 5,2008-02-26,Inferred from homology
Q8NHP6,MSPD2_HUMAN,Motile sperm domain-containing protein 2,518,"59,746",3 out of 5,2005-06-07,Evidence at protein level
P21757,MSRE_HUMAN,Macrophage scavenger receptor types I and II (Macrophage acetylated LDL receptor I and II) (Scavenger receptor class A member 1) (CD antigen CD204),451,"49,762",5 out of 5,1991-05-01,Evidence at protein level
Q2TV78,MST1L_HUMAN,Putative macrophage stimulating 1-like protein (Brain rescue factor 1) (BRF-1) (Hepatocyte growth factor-like protein homolog),715,"79,694",3 out of 5,2008-09-02,Evidence at transcript level
P35548,MSX2_HUMAN,Homeobox protein MSX-2 (Homeobox protein Hox-8),267,"28,897",5 out of 5,1994-06-01,Evidence at protein level
P13640,MT1G_HUMAN,Metallothionein-1G (MT-1G) (Metallothionein-1K) (MT-1K) (Metallothionein-IG) (MT-IG),62,"6,141",5 out of 5,1990-01-01,Evidence at protein level
Q99735,MGST2_HUMAN,Microsomal glutathione S-transferase 2 (Microsomal GST-2) (EC 2.5.1.18) (Microsomal GST-II),147,"16,621",5 out of 5,1997-11-01,Evidence at protein level
Q9UM21,MGT4A_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A (EC 2.4.1.145) (N-glycosyl-oligosaccharide-glycoprotein N-acetylglucosaminyltransferase IVa) (GlcNAc-T IVa) (GnT-IVa) (N-acetylglucosaminyltransferase IVa) (UDP-N-acetylglucosamine: alpha-1,3-D-mannoside beta-1,4-N-acetylglucosaminyltransferase IVa) [Cleaved into: Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase A soluble form]",535,"61,544",5 out of 5,2007-05-29,Evidence at protein level
A6NG13,MGT4D_HUMAN,"Alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like protein MGAT4D (EC 2.4.1.-)",374,"43,743",2 out of 5,2007-11-13,Evidence at transcript level
Q86YT6,MIB1_HUMAN,E3 ubiquitin-protein ligase MIB1 (EC 2.3.2.27) (DAPK-interacting protein 1) (DIP-1) (Mind bomb homolog 1) (RING-type E3 ubiquitin transferase MIB1) (Zinc finger ZZ type with ankyrin repeat domain protein 2),1006,"110,136",5 out of 5,2005-07-05,Evidence at protein level
O94851,MICA2_HUMAN,[F-actin]-methionine sulfoxide oxidase MICAL2 (EC 1.14.13.225) (Molecule interacting with CasL protein 2) (MICAL-2),1124,"126,689",5 out of 5,2004-04-13,Evidence at protein level
Q9NQG6,MID51_HUMAN,Mitochondrial dynamics protein MID51 (Mitochondrial dynamics protein of 51 kDa) (Mitochondrial elongation factor 1) (Smith-Magenis syndrome chromosomal region candidate gene 7 protein-like) (SMCR7-like protein),463,"51,293",5 out of 5,2007-11-13,Evidence at protein level
L0R8F8,MIDUO_HUMAN,MIEF1 upstream open reading frame protein,70,"8,445",2 out of 5,2017-03-15,Inferred from homology
Q9BRT3,MIEN1_HUMAN,Migration and invasion enhancer 1 (HBV X-transactivated gene 4 protein) (HBV XAg-transactivated protein 4) (Protein C35),115,"12,403",5 out of 5,2006-12-12,Evidence at protein level
Q8N344,MIER2_HUMAN,Mesoderm induction early response protein 2 (Mi-er2),545,"59,944",3 out of 5,2008-01-15,Evidence at protein level
P14174,MIF_HUMAN,Macrophage migration inhibitory factor (MIF) (EC 5.3.2.1) (Glycosylation-inhibiting factor) (GIF) (L-dopachrome isomerase) (L-dopachrome tautomerase) (EC 5.3.3.12) (Phenylpyruvate tautomerase),115,"12,476",5 out of 5,1990-01-01,Evidence at protein level
Q8IUF8,MINA_HUMAN,Bifunctional lysine-specific demethylase and histidyl-hydroxylase MINA (EC 1.14.11.-) (60S ribosomal protein L27a histidine hydroxylase) (Histone lysine demethylase MINA) (MYC-induced nuclear antigen) (Mineral dust-induced gene protein) (Nucleolar protein 52) (Ribosomal oxygenase MINA) (ROX),465,"52,800",5 out of 5,2007-10-23,Evidence at protein level
Q9Y3D0,MIP18_HUMAN,Mitotic spindle-associated MMXD complex subunit MIP18 (MSS19-interacting protein of 18 kDa) (Protein FAM96B),163,"17,663",5 out of 5,2002-05-02,Evidence at protein level
Q75NE6,MIRH1_HUMAN,Putative microRNA 17 host gene protein (Putative microRNA host gene 1 protein),70,"8,163",3 out of 5,2007-02-06,Uncertain
Q9H081,MIS12_HUMAN,Protein MIS12 homolog,205,"24,140",5 out of 5,2006-09-05,Evidence at protein level
Q9H2W2,MIXL1_HUMAN,Homeobox protein MIXL1 (Homeodomain protein MIX) (hMix) (MIX1 homeobox-like protein 1) (Mix.1 homeobox-like protein),232,"24,659",5 out of 5,2007-11-13,Evidence at protein level
P53778,MK12_HUMAN,Mitogen-activated protein kinase 12 (MAP kinase 12) (MAPK 12) (EC 2.7.11.24) (Extracellular signal-regulated kinase 6) (ERK-6) (Mitogen-activated protein kinase p38 gamma) (MAP kinase p38 gamma) (Stress-activated protein kinase 3),367,"41,940",5 out of 5,1996-10-01,Evidence at protein level
Q9ULH7,MKL2_HUMAN,MKL/myocardin-like protein 2 (Megakaryoblastic leukemia 2) (Myocardin-related transcription factor B) (MRTF-B),1088,"118,127",5 out of 5,2003-06-27,Evidence at protein level
H3BPM6,MKROS_HUMAN,MKRN2 opposite strand protein (MKRN2 antisense RNA 1) (MKRN2 antisense gene protein 1),223,"25,451",2 out of 5,2013-03-06,Predicted
Q5HYA8,MKS3_HUMAN,Meckelin (Meckel syndrome type 3 protein) (Transmembrane protein 67),995,"111,745",5 out of 5,2006-03-07,Evidence at protein level
Q15049,MLC1_HUMAN,Membrane protein MLC1,377,"41,141",5 out of 5,1998-07-15,Evidence at protein level
Q6ZRQ5,MMS22_HUMAN,Protein MMS22-like (Methyl methanesulfonate-sensitivity protein 22-like),1243,"142,321",5 out of 5,2006-11-28,Evidence at protein level
Q6Q8B3,MO2R2_HUMAN,Cell surface glycoprotein CD200 receptor 2 (CD200 cell surface glycoprotein receptor-like 2) (CD200 receptor-like 2) (HuCD200R2) (CD200 cell surface glycoprotein receptor-like a) (CD200RLa) (Cell surface glycoprotein CD200 receptor 1-like) (Cell surface glycoprotein OX2 receptor 2),271,"29,920",4 out of 5,2008-09-02,Evidence at transcript level
O96033,MOC2A_HUMAN,Molybdopterin synthase sulfur carrier subunit (MOCO1-A) (Molybdenum cofactor synthesis protein 2 small subunit) (Molybdenum cofactor synthesis protein 2A) (MOCS2A) (Molybdopterin-synthase small subunit) (Sulfur carrier protein MOCS2A),88,"9,755",5 out of 5,2002-02-11,Evidence at protein level
Q9HD47,MOG1_HUMAN,Ran guanine nucleotide release factor (RanGNRF) (Ran-binding protein MOG1),186,"20,448",5 out of 5,2008-04-29,Evidence at protein level
P30301,MIP_HUMAN,Lens fiber major intrinsic protein (Aquaporin-0) (MIP26) (MP26),263,"28,122",5 out of 5,1993-04-01,Evidence at protein level
Q8WV92,MITD1_HUMAN,MIT domain-containing protein 1,249,"29,314",5 out of 5,2006-11-28,Evidence at protein level
O75030,MITF_HUMAN,Microphthalmia-associated transcription factor (Class E basic helix-loop-helix protein 32) (bHLHe32),526,"58,795",5 out of 5,2001-02-21,Evidence at protein level
Q15759,MK11_HUMAN,Mitogen-activated protein kinase 11 (MAP kinase 11) (MAPK 11) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 beta) (MAP kinase p38 beta) (p38b) (Stress-activated protein kinase 2b) (SAPK2b) (p38-2),364,"41,357",5 out of 5,1997-11-01,Evidence at protein level
Q9BUB5,MKNK1_HUMAN,MAP kinase-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 1) (MAPK signal-integrating kinase 1) (Mnk1),465,"51,342",5 out of 5,2003-04-30,Evidence at protein level
Q9HBH9,MKNK2_HUMAN,MAP kinase-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (MAP kinase signal-integrating kinase 2) (MAPK signal-integrating kinase 2) (Mnk2),465,"51,875",5 out of 5,2003-04-30,Evidence at protein level
Q9H492,MLP3A_HUMAN,Microtubule-associated proteins 1A/1B light chain 3A (Autophagy-related protein LC3 A) (Autophagy-related ubiquitin-like modifier LC3 A) (MAP1 light chain 3-like protein 1) (MAP1A/MAP1B light chain 3 A) (MAP1A/MAP1B LC3 A) (Microtubule-associated protein 1 light chain 3 alpha),121,"14,272",5 out of 5,2002-11-08,Evidence at protein level
Q9NYL2,MLTK_HUMAN,Mitogen-activated protein kinase kinase kinase MLT (EC 2.7.11.25) (Human cervical cancer suppressor gene 4 protein) (HCCS-4) (Leucine zipper- and sterile alpha motif-containing kinase) (MLK-like mitogen-activated protein triple kinase) (Mixed lineage kinase-related kinase) (MLK-related kinase) (MRK) (Sterile alpha motif- and leucine zipper-containing kinase AZK),800,"91,155",5 out of 5,2005-07-05,Evidence at protein level
Q9Y4U1,MMAC_HUMAN,Methylmalonic aciduria and homocystinuria type C protein (EC 1.16.1.-) (CblC) (Cyanocobalamin reductase (cyanide-eliminating)),282,"31,728",5 out of 5,2006-01-10,Evidence at protein level
Q99583,MNT_HUMAN,Max-binding protein MNT (Class D basic helix-loop-helix protein 3) (bHLHd3) (Myc antagonist MNT) (Protein ROX),582,"62,300",5 out of 5,1998-12-15,Evidence at protein level
P26038,MOES_HUMAN,Moesin (Membrane-organizing extension spike protein),577,"67,820",5 out of 5,1992-05-01,Evidence at protein level
Q7L1V2,MON1B_HUMAN,Vacuolar fusion protein MON1 homolog B (HSV-1 stimulation-related gene 1 protein) (HSV-I stimulating-related protein),547,"59,217",4 out of 5,2007-05-01,Evidence at protein level
Q86VD1,MORC1_HUMAN,MORC family CW-type zinc finger protein 1 (Cancer/testis antigen 33) (CT33),984,"112,881",4 out of 5,2006-09-05,Evidence at transcript level
Q502X0,MORN2_HUMAN,MORN repeat-containing protein 2 (MORN motif protein in testis),79,"8,939",2 out of 5,2006-07-25,Evidence at protein level
Q6PF18,MORN3_HUMAN,MORN repeat-containing protein 3,240,"27,585",4 out of 5,2006-07-25,Evidence at protein level
Q8TF71,MOT10_HUMAN,Monocarboxylate transporter 10 (MCT 10) (Aromatic amino acid transporter 1) (Solute carrier family 16 member 10) (T-type amino acid transporter 1),515,"55,493",5 out of 5,2008-01-15,Evidence at protein level
Q02750,MP2K1_HUMAN,Dual specificity mitogen-activated protein kinase kinase 1 (MAP kinase kinase 1) (MAPKK 1) (MKK1) (EC 2.7.12.2) (ERK activator kinase 1) (MAPK/ERK kinase 1) (MEK 1),393,"43,439",5 out of 5,1993-07-01,Evidence at protein level
P46734,MP2K3_HUMAN,Dual specificity mitogen-activated protein kinase kinase 3 (MAP kinase kinase 3) (MAPKK 3) (EC 2.7.12.2) (MAPK/ERK kinase 3) (MEK 3) (Stress-activated protein kinase kinase 2) (SAPK kinase 2) (SAPKK-2) (SAPKK2),347,"39,318",5 out of 5,1995-11-01,Evidence at protein level
P30304,MPIP1_HUMAN,M-phase inducer phosphatase 1 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25A),524,"59,087",5 out of 5,1993-04-01,Evidence at protein level
O00566,MPP10_HUMAN,U3 small nucleolar ribonucleoprotein protein MPP10 (M phase phosphoprotein 10),681,"78,864",5 out of 5,2000-05-30,Evidence at protein level
P39210,MPV17_HUMAN,Protein Mpv17,176,"19,733",5 out of 5,1995-02-01,Evidence at protein level
Q8TCY5,MRAP_HUMAN,Melanocortin-2 receptor accessory protein (B27) (Fat cell-specific low molecular weight protein) (Fat tissue-specific low MW protein),172,"19,136",5 out of 5,2002-09-19,Evidence at protein level
P49959,MRE11_HUMAN,Double-strand break repair protein MRE11 (Double-strand break repair protein MRE11A) (Meiotic recombination 11 homolog 1) (MRE11 homolog 1) (Meiotic recombination 11 homolog A) (MRE11 homolog A),708,"80,593",5 out of 5,1996-10-01,Evidence at protein level
Q9NV56,MRGBP_HUMAN,MRG/MORF4L-binding protein (MRG-binding protein) (Up-regulated in colon cancer 4) (Urcc4),204,"22,417",5 out of 5,2003-02-01,Evidence at protein level
Q96LA9,MRGX4_HUMAN,Mas-related G-protein coupled receptor member X4 (Sensory neuron-specific G-protein coupled receptor 5/6),322,"36,461",4 out of 5,2004-07-19,Evidence at transcript level
Q7Z745,MRO2B_HUMAN,Maestro heat-like repeat-containing protein family member 2B (HEAT repeat-containing protein 7B2) (Sperm PKA-interacting factor) (SPIF),1585,"180,781",4 out of 5,2008-04-29,Evidence at transcript level
Q9H579,MROH8_HUMAN,Protein MROH8 (Maestro heat-like repeat-containing protein family member 8),483,"54,816",2 out of 5,2003-02-01,Evidence at transcript level
Q96J65,MRP9_HUMAN,Multidrug resistance-associated protein 9 (ATP-binding cassette sub-family C member 12),1359,"152,297",5 out of 5,2006-10-17,Evidence at protein level
Q7L0Y3,MRRP1_HUMAN,Mitochondrial ribonuclease P protein 1 (Mitochondrial RNase P protein 1) (EC 2.1.1.-) (HBV pre-S2 trans-regulated protein 2) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (tRNA methyltransferase 10 homolog C),403,"47,347",5 out of 5,2007-11-13,Evidence at protein level
O43934,MFS11_HUMAN,UNC93-like protein MFSD11 (Major facilitator superfamily domain-containing protein 11) (Protein ET),449,"49,202",3 out of 5,2007-10-02,Evidence at transcript level
Q6N075,MFSD5_HUMAN,Molybdate-anion transporter (Major facilitator superfamily domain-containing protein 5) (Molybdate transporter 2 homolog) (hsMOT2),450,"49,765",4 out of 5,2007-01-23,Evidence at protein level
Q96A72,MGN2_HUMAN,Protein mago nashi homolog 2,148,"17,276",5 out of 5,2005-09-13,Evidence at protein level
O14880,MGST3_HUMAN,Microsomal glutathione S-transferase 3 (Microsomal GST-3) (EC 2.5.1.18) (Microsomal GST-III),152,"16,516",5 out of 5,2000-05-30,Evidence at protein level
Q96DM3,MIC1_HUMAN,Uncharacterized protein C18orf8 (Colon cancer-associated protein Mic1) (Mic-1),657,"74,975",2 out of 5,2004-05-24,Evidence at protein level
Q29980,MICB_HUMAN,MHC class I polypeptide-related sequence B (MIC-B),383,"42,646",5 out of 5,2008-06-10,Evidence at protein level
Q5JXC2,MIIP_HUMAN,Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45) (IIp45),388,"42,824",5 out of 5,2008-03-18,Evidence at protein level
Q8N3F8,MILK1_HUMAN,MICAL-like protein 1 (Molecule interacting with Rab13) (MIRab13),863,"93,441",5 out of 5,2003-04-23,Evidence at protein level
Q8NBR6,MINY2_HUMAN,Ubiquitin carboxyl-terminal hydrolase MINDY-2 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-2) (Protein FAM63B),621,"67,106",5 out of 5,2008-07-22,Evidence at protein level
P50281,MMP14_HUMAN,Matrix metalloproteinase-14 (MMP-14) (EC 3.4.24.80) (MMP-X1) (Membrane-type matrix metalloproteinase 1) (MT-MMP 1) (MTMMP1) (Membrane-type-1 matrix metalloproteinase) (MT1-MMP) (MT1MMP),582,"65,894",5 out of 5,1996-10-01,Evidence at protein level
O75900,MMP23_HUMAN,"Matrix metalloproteinase-23 (MMP-23) (EC 3.4.24.-) (Femalysin) (MIFR-1) (Matrix metalloproteinase-21) (MMP-21) (Matrix metalloproteinase-22) (MMP-22) [Cleaved into: Matrix metalloproteinase-23, soluble form]",390,"43,935",5 out of 5,2006-10-31,Evidence at protein level
P22894,MMP8_HUMAN,Neutrophil collagenase (EC 3.4.24.34) (Matrix metalloproteinase-8) (MMP-8) (PMNL collagenase) (PMNL-CL),467,"53,412",5 out of 5,1991-08-01,Evidence at protein level
P14780,MMP9_HUMAN,Matrix metalloproteinase-9 (MMP-9) (EC 3.4.24.35) (92 kDa gelatinase) (92 kDa type IV collagenase) (Gelatinase B) (GELB) [Cleaved into: 67 kDa matrix metalloproteinase-9; 82 kDa matrix metalloproteinase-9],707,"78,458",5 out of 5,1990-04-01,Evidence at protein level
Q02252,MMSA_HUMAN,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (Malonate-semialdehyde dehydrogenase [acylating]) (EC 1.2.1.18) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1)",535,"57,840",5 out of 5,1993-07-01,Evidence at protein level
Q8NEH6,MNS1_HUMAN,Meiosis-specific nuclear structural protein 1,495,"60,571",4 out of 5,2007-08-21,Evidence at transcript level
O96007,MOC2B_HUMAN,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B) (Molybdopterin-synthase large subunit) (MPT synthase large subunit),188,"20,944",5 out of 5,2002-02-11,Evidence at protein level
Q9Y605,MOFA1_HUMAN,MORF4 family-associated protein 1 (Protein PGR1) (Protein associated with MRG of 14 kDa),127,"14,650",5 out of 5,2007-10-02,Evidence at protein level
Q3SYC2,MOGT2_HUMAN,2-acylglycerol O-acyltransferase 2 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 2) (MGAT2) (hMGAT2) (Diacylglycerol O-acyltransferase candidate 5) (hDC5) (Diacylglycerol acyltransferase 2-like protein 5) (Monoacylglycerol O-acyltransferase 2),334,"38,196",5 out of 5,2006-09-05,Evidence at protein level
Q9UQ07,MOK_HUMAN,MAPK/MAK/MRK overlapping kinase (EC 2.7.11.22) (MOK protein kinase) (Renal tumor antigen 1) (RAGE-1),419,"48,014",5 out of 5,2004-01-16,Evidence at transcript level
Q14149,MORC3_HUMAN,MORC family CW-type zinc finger protein 3 (Nuclear matrix protein 2) (Zinc finger CW-type coiled-coil domain protein 3),939,"107,113",5 out of 5,1997-11-01,Evidence at protein level
O15375,MOT6_HUMAN,Monocarboxylate transporter 6 (MCT 6) (Monocarboxylate transporter 5) (MCT 5) (Solute carrier family 16 member 5),505,"54,994",4 out of 5,2000-05-30,Evidence at transcript level
P36021,MOT8_HUMAN,Monocarboxylate transporter 8 (MCT 8) (Monocarboxylate transporter 7) (MCT 7) (Solute carrier family 16 member 2) (X-linked PEST-containing transporter),539,"59,511",5 out of 5,1994-06-01,Evidence at protein level
Q6UVY6,MOXD1_HUMAN,DBH-like monooxygenase protein 1 (EC 1.14.17.-) (Monooxygenase X),613,"69,652",5 out of 5,2007-10-02,Evidence at protein level
Q9UNW1,MINP1_HUMAN,"Multiple inositol polyphosphate phosphatase 1 (EC 3.1.3.62) (2,3-bisphosphoglycerate 3-phosphatase) (2,3-BPG phosphatase) (EC 3.1.3.80) (Inositol (1,3,4,5)-tetrakisphosphate 3-phosphatase) (Ins(1,3,4,5)P(4) 3-phosphatase)",487,"55,051",5 out of 5,2005-07-05,Evidence at protein level
Q8N5J2,MINY1_HUMAN,Ubiquitin carboxyl-terminal hydrolase MINDY-1 (EC 3.4.19.12) (Deubiquitinating enzyme MINDY-1) (Protein FAM63A),469,"51,778",5 out of 5,2008-07-22,Evidence at protein level
P53779,MK10_HUMAN,Mitogen-activated protein kinase 10 (MAP kinase 10) (MAPK 10) (EC 2.7.11.24) (MAP kinase p49 3F12) (Stress-activated protein kinase 1b) (SAPK1b) (Stress-activated protein kinase JNK3) (c-Jun N-terminal kinase 3),464,"52,585",5 out of 5,1996-10-01,Evidence at protein level
O15264,MK13_HUMAN,Mitogen-activated protein kinase 13 (MAP kinase 13) (MAPK 13) (EC 2.7.11.24) (Mitogen-activated protein kinase p38 delta) (MAP kinase p38 delta) (Stress-activated protein kinase 4),365,"42,090",5 out of 5,2000-05-30,Evidence at protein level
Q9UL63,MKLN1_HUMAN,Muskelin,735,"84,768",4 out of 5,2002-10-10,Evidence at protein level
Q9UHC7,MKRN1_HUMAN,E3 ubiquitin-protein ligase makorin-1 (EC 2.3.2.27) (RING finger protein 61) (RING-type E3 ubiquitin transferase makorin-1),482,"53,349",5 out of 5,2001-11-16,Evidence at protein level
P21741,MK_HUMAN,Midkine (MK) (Amphiregulin-associated protein) (ARAP) (Midgestation and kidney protein) (Neurite outgrowth-promoting factor 2) (Neurite outgrowth-promoting protein),143,"15,585",5 out of 5,1991-05-01,Evidence at protein level
P58340,MLF1_HUMAN,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),268,"30,627",5 out of 5,2001-11-02,Evidence at protein level
P0DMT0,MLN_HUMAN,Myoregulin,46,"5,194",2 out of 5,2015-04-01,Inferred from homology
Q96A32,MLRS_HUMAN,"Myosin regulatory light chain 2, skeletal muscle isoform (Fast skeletal myosin light chain 2) (MLC2B)",169,"19,015",4 out of 5,2007-04-03,Evidence at transcript level
Q9UBU8,MO4L1_HUMAN,Mortality factor 4-like protein 1 (MORF-related gene 15 protein) (Protein MSL3-1) (Transcription factor-like protein MRG15),362,"41,474",5 out of 5,2000-12-01,Evidence at protein level
Q70IA8,MOB3C_HUMAN,MOB kinase activator 3C (Mob1 homolog 2C) (Mps one binder kinase activator-like 2C),216,"25,623",3 out of 5,2004-12-21,Evidence at protein level
P0DKB6,MPC1L_HUMAN,Mitochondrial pyruvate carrier 1-like protein,136,"15,138",2 out of 5,2012-10-03,Evidence at transcript level
Q8N594,MPND_HUMAN,MPN domain-containing protein (EC 3.4.-.-),471,"50,662",3 out of 5,2007-03-06,Evidence at protein level
Q10713,MPPA_HUMAN,Mitochondrial-processing peptidase subunit alpha (EC 3.4.24.64) (Alpha-MPP) (P-55),525,"58,253",5 out of 5,1996-10-01,Evidence at protein level
P20645,MPRD_HUMAN,Cation-dependent mannose-6-phosphate receptor (CD Man-6-P receptor) (CD-MPR) (46 kDa mannose 6-phosphate receptor) (MPR 46),277,"30,993",5 out of 5,1991-02-01,Evidence at protein level
Q9NXK6,MPRG_HUMAN,Membrane progestin receptor gamma (mPR gamma) (Progestin and adipoQ receptor family member 5) (Progestin and adipoQ receptor family member V),330,"38,014",4 out of 5,2004-08-16,Evidence at protein level
O95297,MPZL1_HUMAN,Myelin protein zero-like protein 1 (Protein zero-related),269,"29,082",5 out of 5,2006-06-27,Evidence at protein level
Q2M3A8,MRAS1_HUMAN,Putative uncharacterized protein MRGPRG-AS1 (MRGPRG antisense RNA 1) (MRGPRG antisense gene protein 1),158,"16,456",2 out of 5,2006-10-03,Uncertain
P09238,MMP10_HUMAN,Stromelysin-2 (SL-2) (EC 3.4.24.22) (Matrix metalloproteinase-10) (MMP-10) (Transin-2),476,"54,151",5 out of 5,1989-07-01,Evidence at protein level
P24347,MMP11_HUMAN,Stromelysin-3 (SL-3) (ST3) (EC 3.4.24.-) (Matrix metalloproteinase-11) (MMP-11),488,"54,590",5 out of 5,1992-03-01,Evidence at protein level
P39900,MMP12_HUMAN,Macrophage metalloelastase (MME) (EC 3.4.24.65) (Macrophage elastase) (ME) (hME) (Matrix metalloproteinase-12) (MMP-12),470,"54,002",5 out of 5,1995-02-01,Evidence at protein level
P51512,MMP16_HUMAN,Matrix metalloproteinase-16 (MMP-16) (EC 3.4.24.-) (MMP-X2) (Membrane-type matrix metalloproteinase 3) (MT-MMP 3) (MTMMP3) (Membrane-type-3 matrix metalloproteinase) (MT3-MMP) (MT3MMP),607,"69,521",5 out of 5,1996-10-01,Evidence at protein level
Q9NRE1,MMP26_HUMAN,Matrix metalloproteinase-26 (MMP-26) (EC 3.4.24.-) (Endometase) (Matrilysin-2),261,"29,708",4 out of 5,2001-04-27,Evidence at transcript level
Q9H239,MMP28_HUMAN,Matrix metalloproteinase-28 (MMP-28) (EC 3.4.24.-) (Epilysin),520,"58,939",5 out of 5,2001-06-01,Evidence at transcript level
P08253,MMP2_HUMAN,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX],660,"73,882",5 out of 5,1988-08-01,Evidence at protein level
Q10571,MN1_HUMAN,Transcriptional activator MN1 (Probable tumor suppressor protein MN1),1320,"136,001",3 out of 5,1996-10-01,Evidence at protein level
Q86TA1,MOB3B_HUMAN,MOB kinase activator 3B (Mob1 homolog 2b) (Mps one binder kinase activator-like 2B),216,"25,464",2 out of 5,2004-12-21,Evidence at protein level
Q8TE76,MORC4_HUMAN,MORC family CW-type zinc finger protein 4 (Zinc finger CW-type coiled-coil domain protein 2) (Zinc finger CW-type domain protein 4),937,"106,348",3 out of 5,2004-07-19,Evidence at protein level
Q5T089,MORN1_HUMAN,MORN repeat-containing protein 1,497,"53,850",2 out of 5,2006-07-25,Evidence at transcript level
Q8NDC4,MORN4_HUMAN,MORN repeat-containing protein 4 (Protein 44050),146,"16,236",4 out of 5,2007-03-06,Evidence at protein level
P69208,MORN_HUMAN,Morphogenetic neuropeptide (Head activator) (HA),11,"1,142",2 out of 5,1986-07-21,Evidence at protein level
P00540,MOS_HUMAN,Proto-oncogene serine/threonine-protein kinase mos (EC 2.7.11.1) (Oocyte maturation factor mos) (Proto-oncogene c-Mos),346,"37,820",5 out of 5,1986-07-21,Evidence at protein level
Q8NCK7,MOT11_HUMAN,Monocarboxylate transporter 11 (MCT 11) (Solute carrier family 16 member 11),471,"47,791",4 out of 5,2007-05-15,Evidence at transcript level
O60669,MOT2_HUMAN,Monocarboxylate transporter 2 (MCT 2) (Solute carrier family 16 member 7),478,"52,200",5 out of 5,2000-05-30,Evidence at protein level
O15374,MOT5_HUMAN,Monocarboxylate transporter 5 (MCT 5) (Monocarboxylate transporter 4) (MCT 4) (Solute carrier family 16 member 4),487,"54,022",4 out of 5,2000-05-30,Evidence at transcript level
Q13163,MP2K5_HUMAN,Dual specificity mitogen-activated protein kinase kinase 5 (MAP kinase kinase 5) (MAPKK 5) (EC 2.7.12.2) (MAPK/ERK kinase 5) (MEK 5),448,"50,112",5 out of 5,1997-11-01,Evidence at protein level
A6NCE7,MP3B2_HUMAN,Microtubule-associated proteins 1A/1B light chain 3 beta 2 (Microtubule-associated proteins 1A/1B light chain 3B-like),125,"14,628",3 out of 5,2008-07-22,Evidence at transcript level
Q14168,MPP2_HUMAN,MAGUK p55 subfamily member 2 (Discs large homolog 2) (Protein MPP2),576,"64,581",5 out of 5,1997-11-01,Evidence at protein level
Q5T2T1,MPP7_HUMAN,MAGUK p55 subfamily member 7,576,"65,524",5 out of 5,2008-02-26,Evidence at protein level
Q86WK9,MPRA_HUMAN,Membrane progestin receptor alpha (mPR alpha) (Progestin and adipoQ receptor family member 7) (Progestin and adipoQ receptor family member VII),346,"39,719",4 out of 5,2004-08-16,Evidence at transcript level
Q9Y2G1,MRF_HUMAN,"Myelin regulatory factor (EC 3.4.-.-) (Myelin gene regulatory factor) [Cleaved into: Myelin regulatory factor, N-terminal; Myelin regulatory factor, C-terminal]",1151,"124,397",5 out of 5,2008-02-26,Evidence at protein level
Q01726,MSHR_HUMAN,Melanocyte-stimulating hormone receptor (MSH-R) (Melanocortin receptor 1) (MC1-R),317,"34,706",5 out of 5,1993-07-01,Evidence at protein level
O60291,MGRN1_HUMAN,E3 ubiquitin-protein ligase MGRN1 (EC 2.3.2.27) (Mahogunin RING finger protein 1) (RING finger protein 156) (RING-type E3 ubiquitin transferase MGRN1),552,"60,753",5 out of 5,2006-07-25,Evidence at protein level
Q5TGZ0,MIC10_HUMAN,MICOS complex subunit MIC10 (Mitochondrial inner membrane organizing system protein 1),78,"8,808",4 out of 5,2006-10-03,Evidence at protein level
Q9BRQ6,MIC25_HUMAN,MICOS complex subunit MIC25 (Coiled-coil-helix cristae morphology protein 1) (Coiled-coil-helix-coiled-coil-helix domain-containing protein 6),235,"26,458",5 out of 5,2005-04-12,Evidence at protein level
Q29983,MICA_HUMAN,MHC class I polypeptide-related sequence A (MIC-A),383,"42,915",5 out of 5,2008-05-20,Evidence at protein level
Q7Z3K6,MIER3_HUMAN,Mesoderm induction early response protein 3 (Mi-er3),550,"61,437",4 out of 5,2008-01-15,Evidence at protein level
Q9NPJ1,MKKS_HUMAN,McKusick-Kaufman/Bardet-Biedl syndromes putative chaperonin (Bardet-Biedl syndrome 6 protein),570,"62,342",5 out of 5,2000-12-01,Evidence at protein level
Q9H000,MKRN2_HUMAN,Probable E3 ubiquitin-protein ligase makorin-2 (EC 2.3.2.27) (RING finger protein 62) (RING-type E3 ubiquitin transferase makorin-2),416,"46,940",5 out of 5,2001-11-16,Evidence at protein level
Q9NXB0,MKS1_HUMAN,Meckel syndrome type 1 protein,559,"64,528",5 out of 5,2006-03-07,Evidence at protein level
Q96EY8,MMAB_HUMAN,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial (EC 2.5.1.17) (Cob(I)alamin adenosyltransferase) (Methylmalonic aciduria type B protein)",250,"27,388",5 out of 5,2003-11-07,Evidence at protein level
Q9H3L0,MMAD_HUMAN,"Methylmalonic aciduria and homocystinuria type D protein, mitochondrial (CblD)",296,"32,940",5 out of 5,2005-07-05,Evidence at protein level
Q495T6,MMEL1_HUMAN,"Membrane metallo-endopeptidase-like 1 (EC 3.4.24.11) (Membrane metallo-endopeptidase-like 2) (NEP2(m)) (Neprilysin II) (NEPII) (Neprilysin-2) (NEP2) (NL2) [Cleaved into: Membrane metallo-endopeptidase-like 1, soluble form (Neprilysin-2 secreted) (NEP2(s))]",779,"89,367",5 out of 5,2006-09-05,Evidence at transcript level
P45452,MMP13_HUMAN,Collagenase 3 (EC 3.4.24.-) (Matrix metalloproteinase-13) (MMP-13),471,"53,820",5 out of 5,1995-11-01,Evidence at protein level
Q8TD46,MO2R1_HUMAN,Cell surface glycoprotein CD200 receptor 1 (CD200 cell surface glycoprotein receptor) (Cell surface glycoprotein OX2 receptor 1),325,"36,620",5 out of 5,2002-11-28,Evidence at protein level
Q15014,MO4L2_HUMAN,Mortality factor 4-like protein 2 (MORF-related gene X protein) (Protein MSL3-2) (Transcription factor-like protein MRGX),288,"32,308",5 out of 5,1998-07-15,Evidence at protein level
Q13875,MOBP_HUMAN,Myelin-associated oligodendrocyte basic protein,183,"20,959",4 out of 5,2007-03-20,Evidence at protein level
Q86VX9,MON1A_HUMAN,Vacuolar fusion protein MON1 homolog A,555,"62,131",4 out of 5,2007-05-01,Evidence at protein level
O75970,MPDZ_HUMAN,Multiple PDZ domain protein (Multi-PDZ domain protein 1),2070,"221,618",5 out of 5,2005-06-21,Evidence at protein level
P34949,MPI_HUMAN,Mannose-6-phosphate isomerase (EC 5.3.1.8) (Phosphohexomutase) (Phosphomannose isomerase) (PMI),423,"46,656",5 out of 5,1994-02-01,Evidence at protein level
P11717,MPRI_HUMAN,Cation-independent mannose-6-phosphate receptor (CI Man-6-P receptor) (CI-MPR) (M6PR) (300 kDa mannose 6-phosphate receptor) (MPR 300) (Insulin-like growth factor 2 receptor) (Insulin-like growth factor II receptor) (IGF-II receptor) (M6P/IGF2 receptor) (M6P/IGF2R) (CD antigen CD222),2491,"274,375",5 out of 5,1989-10-01,Evidence at protein level
A8MYZ0,MIY4B_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase MINDY-4B (Protein FAM188B2),360,"41,070",2 out of 5,2008-07-22,Inferred from homology
Q16659,MK06_HUMAN,Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK),721,"82,681",5 out of 5,1997-11-01,Evidence at protein level
Q13164,MK07_HUMAN,Mitogen-activated protein kinase 7 (MAP kinase 7) (MAPK 7) (EC 2.7.11.24) (Big MAP kinase 1) (BMK-1) (Extracellular signal-regulated kinase 5) (ERK-5),816,"88,386",5 out of 5,1997-11-01,Evidence at protein level
Q8TD08,MK15_HUMAN,Mitogen-activated protein kinase 15 (MAP kinase 15) (MAPK 15) (EC 2.7.11.24) (Extracellular signal-regulated kinase 7) (ERK-7) (Extracellular signal-regulated kinase 8) (ERK-8),544,"59,832",5 out of 5,2006-04-18,Evidence at protein level
Q9BYG3,MK67I_HUMAN,MKI67 FHA domain-interacting nucleolar phosphoprotein (Nucleolar phosphoprotein Nopp34) (Nucleolar protein interacting with the FHA domain of pKI-67) (hNIFK),293,"34,222",5 out of 5,2005-07-19,Evidence at protein level
Q13434,MKRN4_HUMAN,Putative E3 ubiquitin-protein ligase makorin-4 (EC 2.3.2.27) (Makorin RING finger protein pseudogene 4) (Makorin RING finger protein pseudogene 5) (RING finger protein 64) (RING-type E3 ubiquitin transferase makorin-4) (Zinc finger protein 127-Xp) (ZNF127-Xp) (Zinc finger protein 127-like 1),485,"52,910",4 out of 5,2001-11-16,Uncertain
Q14165,MLEC_HUMAN,Malectin,292,"32,234",5 out of 5,1997-11-01,Evidence at protein level
P40692,MLH1_HUMAN,DNA mismatch repair protein Mlh1 (MutL protein homolog 1),756,"84,601",5 out of 5,1995-02-01,Evidence at protein level
P36507,MP2K2_HUMAN,Dual specificity mitogen-activated protein kinase kinase 2 (MAP kinase kinase 2) (MAPKK 2) (EC 2.7.12.2) (ERK activator kinase 2) (MAPK/ERK kinase 2) (MEK 2),400,"44,424",5 out of 5,1994-06-01,Evidence at protein level
P52564,MP2K6_HUMAN,Dual specificity mitogen-activated protein kinase kinase 6 (MAP kinase kinase 6) (MAPKK 6) (EC 2.7.12.2) (MAPK/ERK kinase 6) (MEK 6) (Stress-activated protein kinase kinase 3) (SAPK kinase 3) (SAPKK-3) (SAPKK3),334,"37,492",5 out of 5,1996-10-01,Evidence at protein level
Q9Y5S2,MRCKB_HUMAN,Serine/threonine-protein kinase MRCK beta (EC 2.7.11.1) (CDC42-binding protein kinase beta) (CDC42BP-beta) (DMPK-like beta) (Myotonic dystrophy kinase-related CDC42-binding kinase beta) (MRCK beta) (Myotonic dystrophy protein kinase-like beta),1711,"194,315",5 out of 5,2005-11-08,Evidence at protein level
Q96LB2,MRGX1_HUMAN,Mas-related G-protein coupled receptor member X1 (Sensory neuron-specific G-protein coupled receptor 3/4),322,"36,250",4 out of 5,2004-07-19,Evidence at protein level
Q9UI43,MRM2_HUMAN,"rRNA methyltransferase 2, mitochondrial (EC 2.1.1.-) (16S rRNA (uridine(1369)-2'-O)-methyltransferase) (16S rRNA [Um1369] 2'-O-methyltransferase) (Protein ftsJ homolog 2)",246,"27,424",5 out of 5,2000-12-01,Evidence at protein level
Q8NDA8,MROH1_HUMAN,Maestro heat-like repeat-containing protein family member 1 (HEAT repeat-containing protein 7A),1641,"181,249",3 out of 5,2008-04-08,Evidence at transcript level
O43482,MS18B_HUMAN,Protein Mis18-beta (Cancer/testis antigen 86) (CT86) (Opa-interacting protein 5) (OIP-5),229,"24,691",5 out of 5,2002-04-03,Evidence at protein level
Q8N5Y2,MS3L1_HUMAN,Male-specific lethal 3 homolog (Male-specific lethal-3 homolog 1) (Male-specific lethal-3 protein-like 1) (MSL3-like 1),521,"59,824",5 out of 5,2003-06-20,Evidence at protein level
O75425,MSPD3_HUMAN,Motile sperm domain-containing protein 3,235,"25,519",2 out of 5,2005-06-07,Evidence at transcript level
Q96AZ1,MT21B_HUMAN,Protein-lysine methyltransferase METTL21B (EC 2.1.1.-) (Hepatocellular carcinoma-associated antigen 557a) (Methyltransferase-like protein 21B),226,"24,911",4 out of 5,2007-06-26,Evidence at protein level
P50219,MNX1_HUMAN,Motor neuron and pancreas homeobox protein 1 (Homeobox protein HB9),401,"40,569",5 out of 5,1996-10-01,Evidence at protein level
Q5VZ52,MORN5_HUMAN,MORN repeat-containing protein 5,161,"18,731",2 out of 5,2007-06-26,Evidence at transcript level
Q9NRJ1,MOST1_HUMAN,Protein MOST-1,99,"11,219",3 out of 5,2008-04-29,Evidence at protein level
Q7RTX9,MOT14_HUMAN,Monocarboxylate transporter 14 (MCT 14) (Solute carrier family 16 member 14),510,"56,254",3 out of 5,2007-05-29,Evidence at transcript level
O95907,MOT3_HUMAN,Monocarboxylate transporter 3 (MCT 3) (Solute carrier family 16 member 8),504,"52,319",4 out of 5,2001-04-27,Evidence at transcript level
O15427,MOT4_HUMAN,Monocarboxylate transporter 4 (MCT 4) (Solute carrier family 16 member 3),465,"49,469",5 out of 5,2000-05-30,Evidence at protein level
O95563,MPC2_HUMAN,Mitochondrial pyruvate carrier 2 (Brain protein 44),127,"14,279",3 out of 5,2002-09-19,Evidence at protein level
Q6WCQ1,MPRIP_HUMAN,Myosin phosphatase Rho-interacting protein (M-RIP) (Rho-interacting protein 3) (RIP3) (p116Rip),1025,"116,533",5 out of 5,2006-02-21,Evidence at protein level
P22897,MRC1_HUMAN,Macrophage mannose receptor 1 (MMR) (C-type lectin domain family 13 member D) (C-type lectin domain family 13 member D-like) (Human mannose receptor) (hMR) (Macrophage mannose receptor 1-like protein 1) (CD antigen CD206),1456,"166,012",5 out of 5,1991-08-01,Evidence at protein level
Q6IN84,MRM1_HUMAN,"rRNA methyltransferase 1, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1145)-2'-O)-methyltransferase) (16S rRNA [Gm1145] 2'-O-methyltransferase)",353,"38,638",4 out of 5,2007-01-23,Evidence at protein level
A6NES4,MRO2A_HUMAN,Maestro heat-like repeat-containing protein family member 2A (HEAT repeat-containing protein 7B1),1674,"189,561",3 out of 5,2008-09-02,Predicted
A6NGR9,MROH6_HUMAN,Maestro heat-like repeat-containing protein family member 6,719,"77,186",2 out of 5,2008-02-26,Predicted
Q92887,MRP2_HUMAN,Canalicular multispecific organic anion transporter 1 (ATP-binding cassette sub-family C member 2) (Canalicular multidrug resistance protein) (Multidrug resistance-associated protein 2),1545,"174,207",5 out of 5,1998-07-15,Evidence at protein level
Q9NYP9,MS18A_HUMAN,Protein Mis18-alpha (FAPP1-associated protein 1),233,"25,863",5 out of 5,2001-01-11,Evidence at protein level
A6NI15,MSGN1_HUMAN,Mesogenin-1 (Paraxial mesoderm-specific mesogenin1) (pMesogenin1) (pMsgn1),193,"20,778",3 out of 5,2008-04-29,Inferred from homology
Q9Y6X9,MORC2_HUMAN,MORC family CW-type zinc finger protein 2 (Zinc finger CW-type coiled-coil domain protein 1),1032,"117,823",5 out of 5,2002-07-26,Evidence at protein level
Q2QL34,MP17L_HUMAN,Mpv17-like protein (M-LP homolog) (M-LPH),196,"22,116",5 out of 5,2008-05-20,Evidence at protein level
Q99547,MPH6_HUMAN,M-phase phosphoprotein 6,160,"19,024",5 out of 5,2000-05-30,Evidence at protein level
P30305,MPIP2_HUMAN,M-phase inducer phosphatase 2 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25B),580,"64,987",5 out of 5,1993-04-01,Evidence at protein level
O60487,MPZL2_HUMAN,Myelin protein zero-like protein 2 (Epithelial V-like antigen 1),215,"24,484",4 out of 5,2002-03-27,Evidence at protein level
P25713,MT3_HUMAN,Metallothionein-3 (MT-3) (GIFB) (GIF) (Growth inhibitory factor) (Metallothionein-III) (MT-III),68,"6,927",5 out of 5,1992-05-01,Evidence at protein level
O94776,MTA2_HUMAN,Metastasis-associated protein MTA2 (Metastasis-associated 1-like 1) (MTA1-L1 protein) (p53 target protein in deacetylase complex),668,"75,023",5 out of 5,2003-02-28,Evidence at protein level
Q2M296,MTHSD_HUMAN,Methenyltetrahydrofolate synthase domain-containing protein,383,"42,173",3 out of 5,2007-07-24,Evidence at protein level
Q9Y216,MTMR7_HUMAN,Myotubularin-related protein 7 (EC 3.1.3.-),660,"75,833",5 out of 5,2000-12-01,Evidence at protein level
Q9BV20,MTNA_HUMAN,Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein),369,"39,150",5 out of 5,2008-02-05,Evidence at protein level
P55157,MTP_HUMAN,Microsomal triglyceride transfer protein large subunit,894,"99,351",5 out of 5,1996-10-01,Evidence at protein level
O15146,MUSK_HUMAN,"Muscle, skeletal receptor tyrosine-protein kinase (EC 2.7.10.1) (Muscle-specific tyrosine-protein kinase receptor) (MuSK) (Muscle-specific kinase receptor)",869,"97,056",5 out of 5,2004-07-19,Evidence at protein level
P22033,MUTA_HUMAN,"Methylmalonyl-CoA mutase, mitochondrial (MCM) (EC 5.4.99.2) (Methylmalonyl-CoA isomerase)",750,"83,134",5 out of 5,1991-08-01,Evidence at protein level
Q9HCI7,MSL2_HUMAN,E3 ubiquitin-protein ligase MSL2 (EC 6.3.2.-) (Male-specific lethal 2-like 1) (MSL2-like 1) (Male-specific lethal-2 homolog) (MSL-2) (Male-specific lethal-2 homolog 1) (RING finger protein 184),577,"62,541",5 out of 5,2007-09-11,Evidence at protein level
Q13421,MSLN_HUMAN,"Mesothelin (CAK1 antigen) (Pre-pro-megakaryocyte-potentiating factor) [Cleaved into: Megakaryocyte-potentiating factor (MPF); Mesothelin, cleaved form]",630,"68,986",5 out of 5,2000-05-30,Evidence at protein level
Q9NZV6,MSRB1_HUMAN,Methionine-R-sulfoxide reductase B1 (MsrB1) (EC 1.8.4.-) (Selenoprotein X) (SelX),116,"12,760",5 out of 5,2001-01-11,Evidence at protein level
Q9BYG7,MSTRO_HUMAN,Protein maestro (Male-specific transcription in the developing reproductive organs) (Protein B29),248,"29,054",3 out of 5,2006-09-05,Evidence at transcript level
Q93083,MT1L_HUMAN,Metallothionein-1L (MT-1L) (Metallothionein-IL) (MT-IL),61,"6,062",3 out of 5,1997-11-01,Evidence at transcript level
Q9Y4B5,MTCL1_HUMAN,Microtubule cross-linking factor 1 (Coiled-coil domain-containing protein 165) (PAR-1-interacting protein) (SOGA family member 2),1905,"209,526",5 out of 5,2007-03-06,Evidence at protein level
Q7Z6M4,MTEF4_HUMAN,"Transcription termination factor 4, mitochondrial (Mitochondrial transcription termination factor 4) (MTERF4) (mTERF domain-containing protein 2) [Cleaved into: mTERF domain-containing protein 2 processed]",381,"43,958",5 out of 5,2006-10-31,Evidence at protein level
Q14872,MTF1_HUMAN,Metal regulatory transcription factor 1 (MRE-binding transcription factor) (Transcription factor MTF-1),753,"80,957",5 out of 5,2005-06-21,Evidence at protein level
P49914,MTHFS_HUMAN,"5-formyltetrahydrofolate cyclo-ligase (EC 6.3.3.2) (5,10-methenyl-tetrahydrofolate synthetase) (MTHFS) (Methenyl-THF synthetase)",203,"23,256",5 out of 5,1996-10-01,Evidence at protein level
Q9Y217,MTMR6_HUMAN,Myotubularin-related protein 6 (EC 3.1.3.-),621,"71,968",5 out of 5,2000-12-01,Evidence at protein level
Q96QG7,MTMR9_HUMAN,Myotubularin-related protein 9,549,"63,462",5 out of 5,2003-07-19,Evidence at protein level
Q9C0I1,MTMRC_HUMAN,Myotubularin-related protein 12 (Phosphatidylinositol 3 phosphate 3-phosphatase adapter subunit) (3-PAP) (3-phosphatase adapter protein),747,"86,148",5 out of 5,2008-01-15,Evidence at protein level
Q5H9M0,MUML1_HUMAN,PWWP domain-containing protein MUM1L1 (Mutated melanoma-associated antigen 1-like protein 1) (MUM1-like protein 1),696,"79,040",2 out of 5,2006-10-31,Evidence at transcript level
Q9NX53,MUT7B_HUMAN,"Exonuclease mut-7 homolog, isoform 5",252,"26,357",2 out of 5,2009-06-16,Evidence at protein level
Q8N565,MREG_HUMAN,Melanoregulin (Dilute suppressor protein homolog),214,"24,927",3 out of 5,2007-06-26,Evidence at protein level
Q86SM8,MRGRE_HUMAN,Mas-related G-protein coupled receptor member E (G-protein coupled receptor 167),312,"34,286",3 out of 5,2004-08-31,Evidence at transcript level
Q9HC36,MRM3_HUMAN,"rRNA methyltransferase 3, mitochondrial (EC 2.1.1.-) (16S rRNA (guanosine(1370)-2'-O)-methyltransferase) (16S rRNA [Gm1370] 2'-O-methyltransferase) (RNA methyltransferase-like protein 1)",420,"47,020",5 out of 5,2007-11-13,Evidence at protein level
Q96HJ5,MS4A3_HUMAN,Membrane-spanning 4-domains subfamily A member 3 (CD20 antigen-like protein) (Hematopoietic-specific transmembrane protein 4) (HTm4),214,"22,933",5 out of 5,2003-04-04,Evidence at protein level
Q8NCY6,MSD4_HUMAN,Myb/SANT-like DNA-binding domain-containing protein 4 (Myb/SANT-like DNA-binding domain containing 4 with coiled-coils),345,"41,150",2 out of 5,2007-12-04,Evidence at protein level
P20585,MSH3_HUMAN,DNA mismatch repair protein Msh3 (hMSH3) (Divergent upstream protein) (DUP) (Mismatch repair protein 1) (MRP1),1137,"127,412",5 out of 5,1991-02-01,Evidence at protein level
A1L3X4,MT1DP_HUMAN,Putative metallothionein MT1DP,49,"4,983",3 out of 5,2008-07-01,Uncertain
P04733,MT1F_HUMAN,Metallothionein-1F (MT-1F) (Metallothionein-IF) (MT-IF),61,"6,086",5 out of 5,1987-08-13,Evidence at protein level
P02795,MT2_HUMAN,Metallothionein-2 (MT-2) (Metallothionein-2A) (Metallothionein-II) (MT-II),61,"6,042",5 out of 5,1986-07-21,Evidence at protein level
Q15390,MTFR1_HUMAN,Mitochondrial fission regulator 1 (Chondrocyte protein with a poly-proline region),333,"37,000",4 out of 5,1998-07-15,Evidence at protein level
Q6P444,MTFR2_HUMAN,Mitochondrial fission regulator 2 (DUF729 domain-containing protein 1),385,"43,384",4 out of 5,2004-12-07,Evidence at protein level
O75081,MTG16_HUMAN,Protein CBFA2T3 (MTG8-related protein 2) (Myeloid translocation gene on chromosome 16 protein) (hMTG16) (Zinc finger MYND domain-containing protein 4),653,"71,192",5 out of 5,2007-10-23,Evidence at protein level
O43439,MTG8R_HUMAN,Protein CBFA2T2 (ETO homologous on chromosome 20) (MTG8-like protein) (MTG8-related protein 1) (Myeloid translocation-related protein 1) (p85),604,"67,133",5 out of 5,2003-08-29,Evidence at protein level
Q8N3F0,MTURN_HUMAN,Maturin (Maturin neural progenitor differentiation regulator protein homolog) (Protein Ells1),131,"14,925",3 out of 5,2007-07-10,Evidence at protein level
Q5BKX8,MURC_HUMAN,Muscle-related coiled-coil protein (Muscle-restricted coiled-coil protein),364,"41,899",4 out of 5,2008-03-18,Evidence at protein level
Q68DK7,MSL1_HUMAN,Male-specific lethal 1 homolog (MSL-1) (Male-specific lethal 1-like 1) (MSL1-like 1) (Male-specific lethal-1 homolog 1),614,"67,128",5 out of 5,2008-09-02,Evidence at protein level
P08118,MSMB_HUMAN,Beta-microseminoprotein (Immunoglobulin-binding factor) (IGBF) (PN44) (Prostate secreted seminal plasma protein) (Prostate secretory protein of 94 amino acids) (PSP-94) (PSP94) (Seminal plasma beta-inhibin),114,"12,865",5 out of 5,1988-08-01,Evidence at protein level
Q9UJG1,MSPD1_HUMAN,Motile sperm domain-containing protein 1,213,"24,086",3 out of 5,2005-06-07,Evidence at transcript level
P80297,MT1X_HUMAN,Metallothionein-1X (MT-1X) (Metallothionein-IX) (MT-IX),61,"6,068",5 out of 5,1994-02-01,Evidence at protein level
Q5VZV1,MT21C_HUMAN,Protein-lysine methyltransferase METTL21C (EC 2.1.1.-) (Methyltransferase-like protein 21C),264,"29,565",5 out of 5,2008-02-26,Evidence at protein level
A6NDL7,MT21E_HUMAN,Putative methyltransferase-like protein 21E pseudogene (EC 2.1.1.-),271,"31,188",2 out of 5,2008-04-08,Uncertain
Q9BTC8,MTA3_HUMAN,Metastasis-associated protein MTA3,594,"67,504",5 out of 5,2003-02-28,Evidence at protein level
Q13126,MTAP_HUMAN,S-methyl-5'-thioadenosine phosphorylase (EC 2.4.2.28) (5'-methylthioadenosine phosphorylase) (MTA phosphorylase) (MTAP) (MTAPase),283,"31,236",5 out of 5,1997-11-01,Evidence at protein level
Q9H4K7,MTG2_HUMAN,Mitochondrial ribosome-associated GTPase 2 (GTP-binding protein 5) (Protein obg homolog 1) (ObgH1),406,"43,955",5 out of 5,2003-07-03,Evidence at protein level
Q06455,MTG8_HUMAN,Protein CBFA2T1 (Cyclin-D-related protein) (Eight twenty one protein) (Protein ETO) (Protein MTG8) (Zinc finger MYND domain-containing protein 2),604,"67,566",5 out of 5,1997-11-01,Evidence at protein level
Q9NYA4,MTMR4_HUMAN,Myotubularin-related protein 4 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 2) (FYVE-DSP2) (Zinc finger FYVE domain-containing protein 11),1195,"133,353",5 out of 5,2007-09-11,Evidence at protein level
Q96EF0,MTMR8_HUMAN,Myotubularin-related protein 8 (EC 3.1.3.-),704,"78,919",4 out of 5,2008-04-29,Evidence at protein level
P49286,MTR1B_HUMAN,Melatonin receptor type 1B (Mel-1B-R) (Mel1b receptor),362,"40,188",5 out of 5,1996-02-01,Evidence at protein level
Q765P7,MTSSL_HUMAN,MTSS1-like protein (Actin-bundling with BAIAP2 homology protein 1) (ABBA-1),747,"79,929",5 out of 5,2008-02-26,Evidence at protein level
Q5JR59,MTUS2_HUMAN,Microtubule-associated tumor suppressor candidate 2 (Cardiac zipper protein) (Microtubule plus-end tracking protein TIP150) (Tracking protein of 150 kDa),1369,"150,195",5 out of 5,2007-03-06,Evidence at protein level
O75431,MTX2_HUMAN,Metaxin-2 (Mitochondrial outer membrane import complex protein 2),263,"29,763",5 out of 5,2001-02-21,Evidence at protein level
Q8N387,MUC15_HUMAN,Mucin-15 (MUC-15),334,"36,294",4 out of 5,2004-07-19,Evidence at transcript level
Q8WXI7,MUC16_HUMAN,Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125),14507,"1,519,175",5 out of 5,2006-10-31,Evidence at protein level
E2RYF6,MUC22_HUMAN,Mucin-22 (Panbronchiolitis-related mucin-like protein 1),1773,"173,478",3 out of 5,2011-06-28,Evidence at protein level
Q02505,MUC3A_HUMAN,Mucin-3A (MUC-3A) (Intestinal mucin-3A),3323,"345,127",5 out of 5,1994-06-01,Evidence at protein level
Q99102,MUC4_HUMAN,Mucin-4 (MUC-4) (Ascites sialoglycoprotein) (ASGP) (Pancreatic adenocarcinoma mucin) (Testis mucin) (Tracheobronchial mucin) [Cleaved into: Mucin-4 alpha chain (Ascites sialoglycoprotein 1) (ASGP-1); Mucin-4 beta chain (Ascites sialoglycoprotein 2) (ASGP-2)],2169,"231,518",5 out of 5,1994-06-01,Evidence at protein level
P98088,MUC5A_HUMAN,"Mucin-5AC (MUC-5AC) (Gastric mucin) (Lewis B blood group antigen) (LeB) (Major airway glycoprotein) (Mucin-5 subtype AC, tracheobronchial) (Tracheobronchial mucin) (TBM)",5654,"585,570",5 out of 5,1996-02-01,Evidence at protein level
Q9HC84,MUC5B_HUMAN,"Mucin-5B (MUC-5B) (Cervical mucin) (High molecular weight salivary mucin MG1) (Mucin-5 subtype B, tracheobronchial) (Sublingual gland mucin)",5762,"596,340",5 out of 5,2002-10-10,Evidence at protein level
Q8TAX7,MUC7_HUMAN,Mucin-7 (MUC-7) (Apo-MG2) (Salivary mucin-7),377,"39,159",5 out of 5,2006-05-30,Evidence at protein level
P04220,MUCB_HUMAN,Ig mu heavy chain disease protein (BOT),391,"43,057",2 out of 5,1987-03-20,Evidence at protein level
Q969V5,MUL1_HUMAN,Mitochondrial ubiquitin ligase activator of NFKB 1 (EC 2.3.2.27) (E3 SUMO-protein ligase MUL1) (E3 ubiquitin-protein ligase MUL1) (Growth inhibition and death E3 ligase) (Mitochondrial-anchored protein ligase) (MAPL) (Putative NF-kappa-B-activating protein 266) (RING finger protein 218) (RING-type E3 ubiquitin transferase NFKB 1),352,"39,800",5 out of 5,2007-02-20,Evidence at protein level
Q13724,MOGS_HUMAN,Mannosyl-oligosaccharide glucosidase (EC 3.2.1.106) (Processing A-glucosidase I),837,"91,918",5 out of 5,1997-11-01,Evidence at protein level
Q6ZSM3,MOT12_HUMAN,Monocarboxylate transporter 12 (MCT 12) (Creatine transporter 2) (CRT2) (Solute carrier family 16 member 12),486,"53,075",4 out of 5,2007-05-15,Evidence at protein level
O14733,MP2K7_HUMAN,Dual specificity mitogen-activated protein kinase kinase 7 (MAP kinase kinase 7) (MAPKK 7) (EC 2.7.12.2) (JNK-activating kinase 2) (MAPK/ERK kinase 7) (MEK 7) (Stress-activated protein kinase kinase 4) (SAPK kinase 4) (SAPKK-4) (SAPKK4) (c-Jun N-terminal kinase kinase 2) (JNK kinase 2) (JNKK 2),419,"47,485",5 out of 5,2000-05-30,Evidence at protein level
Q00325,MPCP_HUMAN,"Phosphate carrier protein, mitochondrial (Phosphate transport protein) (PTP) (Solute carrier family 25 member 3)",362,"40,095",5 out of 5,1992-12-01,Evidence at protein level
Q8TEZ7,MPRB_HUMAN,Membrane progestin receptor beta (mPR beta) (Lysosomal membrane protein in brain 1) (Progestin and adipoQ receptor family member 8) (Progestin and adipoQ receptor family member VIII),354,"40,464",4 out of 5,2004-08-16,Evidence at transcript level
Q8TDS7,MRGRD_HUMAN,Mas-related G-protein coupled receptor member D (Beta-alanine receptor) (G-protein coupled receptor TGR7),321,"36,118",3 out of 5,2004-07-19,Evidence at transcript level
Q96AM1,MRGRF_HUMAN,Mas-related G-protein coupled receptor member F (Mas-related gene F protein) (G-protein coupled receptor 140) (G-protein coupled receptor 168),343,"38,171",4 out of 5,2002-11-01,Evidence at transcript level
Q6ZUA9,MROH5_HUMAN,Maestro heat-like repeat family member 5,1318,"149,091",1 out of 5,2013-04-03,Evidence at transcript level
Q5TGP6,MROH9_HUMAN,Maestro heat-like repeat-containing protein family member 9,573,"65,050",2 out of 5,2007-05-01,Evidence at transcript level
O15439,MRP4_HUMAN,Multidrug resistance-associated protein 4 (ATP-binding cassette sub-family C member 4) (MRP/cMOAT-related ABC transporter) (Multi-specific organic anion transporter B) (MOAT-B),1325,"149,527",5 out of 5,1998-07-15,Evidence at protein level
O95255,MRP6_HUMAN,Multidrug resistance-associated protein 6 (ATP-binding cassette sub-family C member 6) (Anthracycline resistance-associated protein) (Multi-specific organic anion transporter E) (MOAT-E),1503,"164,906",5 out of 5,2000-05-30,Evidence at protein level
O15091,MRRP3_HUMAN,Mitochondrial ribonuclease P protein 3 (Mitochondrial RNase P protein 3),583,"67,315",5 out of 5,1998-07-15,Evidence at protein level
Q9UKD2,MRT4_HUMAN,mRNA turnover protein 4 homolog (Ribosome assembly factor MRTO4),239,"27,560",4 out of 5,2004-08-16,Evidence at protein level
P11137,MTAP2_HUMAN,Microtubule-associated protein 2 (MAP-2),1827,"199,526",5 out of 5,1989-07-01,Evidence at protein level
Q96DY7,MTBP_HUMAN,Mdm2-binding protein (hMTBP),904,"102,193",4 out of 5,2008-03-18,Evidence at protein level
Q9Y6C9,MTCH2_HUMAN,Mitochondrial carrier homolog 2 (Met-induced mitochondrial protein),303,"33,331",5 out of 5,2005-06-07,Evidence at protein level
Q99551,MTEF1_HUMAN,"Transcription termination factor 1, mitochondrial (Mitochondrial transcription termination factor 1) (mTERF) (mTERF1)",399,"45,778",5 out of 5,2000-12-01,Evidence at protein level
P58546,MTPN_HUMAN,Myotrophin (Protein V-1),118,"12,895",5 out of 5,2002-01-23,Evidence at protein level
Q7Z3U7,MON2_HUMAN,Protein MON2 homolog (Protein SF21),1717,"190,359",4 out of 5,2007-08-21,Evidence at protein level
Q2KHM9,MOONR_HUMAN,Protein moonraker (MNR) (OFD1- and FOPNL-interacting protein),967,"109,407",5 out of 5,2007-03-06,Evidence at protein level
Q7RTY0,MOT13_HUMAN,Monocarboxylate transporter 13 (MCT 13) (Solute carrier family 16 member 13),426,"44,992",3 out of 5,2007-05-15,Evidence at transcript level
P53985,MOT1_HUMAN,Monocarboxylate transporter 1 (MCT 1) (Solute carrier family 16 member 1),500,"53,944",5 out of 5,1996-10-01,Evidence at protein level
O15403,MOT7_HUMAN,Monocarboxylate transporter 7 (MCT 7) (Monocarboxylate transporter 6) (MCT 6) (Solute carrier family 16 member 6),523,"57,393",4 out of 5,2000-05-30,Evidence at protein level
Q7RTY1,MOT9_HUMAN,Monocarboxylate transporter 9 (MCT 9) (Solute carrier family 16 member 9),509,"55,794",4 out of 5,2007-05-29,Evidence at protein level
A0A0C5B5G6,MOTSC_HUMAN,Mitochondrial-derived peptide MOTS-c (Mitochondrial open reading frame of the 12S rRNA-c),16,"2,175",3 out of 5,2016-04-13,Evidence at protein level
Q9Y5U8,MPC1_HUMAN,Mitochondrial pyruvate carrier 1 (Brain protein 44-like protein),109,"12,347",4 out of 5,2002-09-19,Evidence at protein level
Q2M385,MPEG1_HUMAN,Macrophage-expressed gene 1 protein (Macrophage gene 1 protein) (Mpg-1),716,"78,587",3 out of 5,2008-03-18,Evidence at transcript level
Q8TAP9,MPLKI_HUMAN,M-phase-specific PLK1-interacting protein (TTD non-photosensitive 1 protein),179,"19,147",5 out of 5,2005-07-19,Evidence at protein level
Q13368,MPP3_HUMAN,MAGUK p55 subfamily member 3 (Discs large homolog 3) (Protein MPP3),585,"66,152",3 out of 5,1997-11-01,Evidence at protein level
Q8N3R9,MPP5_HUMAN,MAGUK p55 subfamily member 5,675,"77,294",5 out of 5,2003-01-10,Evidence at protein level
Q99550,MPP9_HUMAN,M-phase phosphoprotein 9,1183,"133,024",4 out of 5,2000-05-30,Evidence at protein level
Q5VT25,MRCKA_HUMAN,Serine/threonine-protein kinase MRCK alpha (EC 2.7.11.1) (CDC42-binding protein kinase alpha) (DMPK-like alpha) (Myotonic dystrophy kinase-related CDC42-binding kinase alpha) (MRCK alpha) (Myotonic dystrophy protein kinase-like alpha),1732,"197,307",5 out of 5,2005-11-08,Evidence at protein level
O15438,MRP3_HUMAN,Canalicular multispecific organic anion transporter 2 (ATP-binding cassette sub-family C member 3) (Multi-specific organic anion transporter D) (MOAT-D) (Multidrug resistance-associated protein 3),1527,"169,343",5 out of 5,1998-07-15,Evidence at protein level
O15440,MRP5_HUMAN,Multidrug resistance-associated protein 5 (ATP-binding cassette sub-family C member 5) (Multi-specific organic anion transporter C) (MOAT-C) (SMRP) (pABC11),1437,"160,660",5 out of 5,1998-07-15,Evidence at protein level
Q5T3U5,MRP7_HUMAN,Multidrug resistance-associated protein 7 (ATP-binding cassette sub-family C member 10),1492,"161,629",5 out of 5,2006-10-17,Evidence at protein level
Q9Y6F6,MRVI1_HUMAN,"Protein MRVI1 (Inositol 1,4,5-trisphosphate receptor-associated cGMP kinase substrate) (JAW1-related protein MRVI1)",885,"96,145",5 out of 5,2007-10-02,Evidence at protein level
P0C860,MS3L2_HUMAN,Putative male-specific lethal-3 protein-like 2 (MSL3-like 2) (Male-specific lethal-3 homolog 2) (Male-specific lethal-3 homolog pseudogene 1),447,"51,070",3 out of 5,2008-09-02,Uncertain
O15457,MSH4_HUMAN,MutS protein homolog 4 (hMSH4),936,"104,756",5 out of 5,1998-12-15,Evidence at protein level
O43347,MSI1H_HUMAN,RNA-binding protein Musashi homolog 1 (Musashi-1),362,"39,125",3 out of 5,2004-08-16,Evidence at protein level
Q15800,MSMO1_HUMAN,Methylsterol monooxygenase 1 (EC 1.14.13.72) (C-4 methylsterol oxidase),293,"35,216",5 out of 5,1997-11-01,Evidence at protein level
P47224,MSS4_HUMAN,Guanine nucleotide exchange factor MSS4 (Rab-interacting factor),123,"13,839",5 out of 5,1996-02-01,Evidence at protein level
Q8IVN3,MSTN1_HUMAN,Musculoskeletal embryonic nuclear protein 1,82,"8,911",2 out of 5,2007-09-11,Inferred from homology
P28360,MSX1_HUMAN,Homeobox protein MSX-1 (Homeobox protein Hox-7) (Msh homeobox 1-like protein),303,"31,496",5 out of 5,1992-12-01,Evidence at protein level
P47944,MT4_HUMAN,Metallothionein-4 (MT-4) (Metallothionein-IV) (MT-IV),62,"6,509",3 out of 5,1996-02-01,Inferred from homology
Q9BT17,MTG1_HUMAN,Mitochondrial ribosome-associated GTPase 1 (GTP-binding protein 7) (Mitochondrial GTPase 1),334,"37,237",5 out of 5,2007-03-20,Evidence at protein level
Q9Y4I5,MTL5_HUMAN,"Tesmin (Metallothionein-like 5, testis-specific) (Testis-specific metallothionein-like protein)",508,"55,025",4 out of 5,2001-09-26,Evidence at protein level
Q9BV57,MTND_HUMAN,"1,2-dihydroxy-3-keto-5-methylthiopentene dioxygenase (EC 1.13.11.54) (Acireductone dioxygenase (Fe(2+)-requiring)) (ARD) (Fe-ARD) (Membrane-type 1 matrix metalloproteinase cytoplasmic tail-binding protein 1) (MTCBP-1) (Submergence-induced protein-like factor) (Sip-L)",179,"21,498",5 out of 5,2005-10-11,Evidence at protein level
Q9UBK8,MTRR_HUMAN,Methionine synthase reductase (MSR) (EC 1.16.1.8),725,"80,410",5 out of 5,2002-03-27,Evidence at protein level
Q9ULD2,MTUS1_HUMAN,Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1),1270,"141,397",5 out of 5,2007-10-02,Evidence at protein level
Q13505,MTX1_HUMAN,Metaxin-1 (Mitochondrial outer membrane import complex protein 1),466,"51,477",4 out of 5,1998-07-15,Evidence at protein level
Q5HYI7,MTX3_HUMAN,Metaxin-3,312,"35,093",3 out of 5,2008-05-20,Evidence at protein level
Q9HCE1,MOV10_HUMAN,Putative helicase MOV-10 (EC 3.6.4.13) (Armitage homolog) (Moloney leukemia virus 10 protein),1003,"113,671",5 out of 5,2002-11-01,Evidence at protein level
A6NHM9,MOXD2_HUMAN,Putative DBH-like monooxygenase protein 2 (EC 1.14.17.-) (DBH-like monooxygenase protein 2 pseudogene),499,"56,320",3 out of 5,2007-10-02,Uncertain
P45985,MP2K4_HUMAN,Dual specificity mitogen-activated protein kinase kinase 4 (MAP kinase kinase 4) (MAPKK 4) (EC 2.7.12.2) (JNK-activating kinase 1) (MAPK/ERK kinase 4) (MEK 4) (SAPK/ERK kinase 1) (SEK1) (Stress-activated protein kinase kinase 1) (SAPK kinase 1) (SAPKK-1) (SAPKK1) (c-Jun N-terminal kinase kinase 1) (JNKK),399,"44,288",5 out of 5,1995-11-01,Evidence at protein level
Q96JB8,MPP4_HUMAN,MAGUK p55 subfamily member 4 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 5 protein) (Discs large homolog 6),637,"72,779",4 out of 5,2003-01-10,Evidence at protein level
Q9NZW5,MPP6_HUMAN,MAGUK p55 subfamily member 6 (Veli-associated MAGUK 1) (VAM-1),540,"61,117",3 out of 5,2003-01-10,Evidence at protein level
Q99549,MPP8_HUMAN,M-phase phosphoprotein 8 (Two hybrid-associated protein 3 with RanBPM) (Twa3),860,"97,182",5 out of 5,2000-05-30,Evidence at protein level
O75352,MPU1_HUMAN,Mannose-P-dolichol utilization defect 1 protein (Suppressor of Lec15 and Lec35 glycosylation mutation homolog) (SL15),247,"26,638",5 out of 5,2000-12-08,Evidence at protein level
Q6UWV2,MPZL3_HUMAN,Myelin protein zero-like protein 3,235,"25,989",4 out of 5,2007-03-20,Evidence at protein level
Q96HT8,MR1L1_HUMAN,MORF4 family-associated protein 1-like 1,127,"14,808",5 out of 5,2008-02-26,Evidence at protein level
Q6NTE8,MRNIP_HUMAN,MRN complex-interacting protein (MRN-interacting protein),343,"37,743",5 out of 5,2008-03-18,Evidence at protein level
P49006,MRP_HUMAN,MARCKS-related protein (MARCKS-like protein 1) (Macrophage myristoylated alanine-rich C kinase substrate) (Mac-MARCKS) (MacMARCKS),195,"19,529",5 out of 5,1996-02-01,Evidence at protein level
Q9H3V2,MS4A5_HUMAN,Membrane-spanning 4-domains subfamily A member 5 (CD20 antigen-like 2) (Testis-expressed transmembrane protein 4),200,"22,283",3 out of 5,2003-04-04,Evidence at transcript level
Q13330,MTA1_HUMAN,Metastasis-associated protein MTA1,715,"80,786",5 out of 5,1997-11-01,Evidence at protein level
P42898,MTHR_HUMAN,Methylenetetrahydrofolate reductase (EC 1.5.1.20),656,"74,597",5 out of 5,1995-11-01,Evidence at protein level
Q13615,MTMR3_HUMAN,"Myotubularin-related protein 3 (EC 3.1.3.48) (FYVE domain-containing dual specificity protein phosphatase 1) (FYVE-DSP1) (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64) (Zinc finger FYVE domain-containing protein 10)",1198,"133,619",5 out of 5,1997-11-01,Evidence at protein level
Q8NCE2,MTMRE_HUMAN,Myotubularin-related protein 14 (EC 3.1.3.-) (HCV NS5A-transactivated protein 4 splice variant A-binding protein 1) (NS5ATP4ABP1) (hJumpy),650,"72,203",5 out of 5,2006-11-28,Evidence at protein level
Q685J3,MUC17_HUMAN,Mucin-17 (MUC-17) (Small intestinal mucin-3) (MUC-3),4493,"451,741",5 out of 5,2008-03-18,Evidence at protein level
Q5SSG8,MUC21_HUMAN,Mucin-21 (MUC-21) (Epiglycanin),566,"54,228",5 out of 5,2008-06-10,Evidence at protein level
Q9ULC0,MUCEN_HUMAN,Endomucin (Endomucin-2) (Gastric cancer antigen Ga34) (Mucin-14) (MUC-14),261,"27,452",5 out of 5,2004-07-19,Evidence at protein level
Q96BX8,MOB3A_HUMAN,MOB kinase activator 3A (MOB-LAK) (Mob1 homolog 2A) (Mps one binder kinase activator-like 2A),217,"25,464",3 out of 5,2004-12-21,Evidence at protein level
Q96EN8,MOCOS_HUMAN,Molybdenum cofactor sulfurase (MCS) (MOS) (MoCo sulfurase) (hMCS) (EC 2.8.1.9) (Molybdenum cofactor sulfurtransferase),888,"98,120",5 out of 5,2006-09-19,Evidence at protein level
Q9NZB8,MOCS1_HUMAN,"Molybdenum cofactor biosynthesis protein 1 (Cell migration-inducing gene 11 protein) (Molybdenum cofactor synthesis-step 1 protein A-B) [Includes: GTP 3',8-cyclase (EC 4.1.99.22) (Molybdenum cofactor biosynthesis protein A); Cyclic pyranopterin monophosphate synthase (EC 4.6.1.17) (Molybdenum cofactor biosynthesis protein C)]",636,"70,105",5 out of 5,2003-05-09,Evidence at protein level
O95396,MOCS3_HUMAN,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase) (MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],460,"49,669",5 out of 5,2002-07-26,Evidence at protein level
Q96PD6,MOGT1_HUMAN,2-acylglycerol O-acyltransferase 1 (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 1) (MGAT1) (Diacylglycerol O-acyltransferase candidate 2) (hDC2) (Diacylglycerol acyltransferase 2-like protein 1) (Monoacylglycerol O-acyltransferase 1),335,"38,812",4 out of 5,2006-09-05,Evidence at transcript level
Q86VF5,MOGT3_HUMAN,2-acylglycerol O-acyltransferase 3 (EC 2.3.1.20) (EC 2.3.1.22) (Acyl-CoA:monoacylglycerol acyltransferase 3) (MGAT3) (Diacylglycerol O-acyltransferase candidate 7) (hDC7) (Diacylglycerol acyltransferase 2-like protein 7) (Monoacylglycerol O-acyltransferase 3),341,"38,730",5 out of 5,2006-09-05,Evidence at protein level
Q16653,MOG_HUMAN,Myelin-oligodendrocyte glycoprotein,247,"28,193",5 out of 5,1997-11-01,Evidence at protein level
P30307,MPIP3_HUMAN,M-phase inducer phosphatase 3 (EC 3.1.3.48) (Dual specificity phosphatase Cdc25C),473,"53,365",5 out of 5,1993-04-01,Evidence at protein level
O75439,MPPB_HUMAN,Mitochondrial-processing peptidase subunit beta (EC 3.4.24.64) (Beta-MPP) (P-52),489,"54,366",4 out of 5,1998-12-15,Evidence at protein level
O15442,MPPD1_HUMAN,Metallophosphoesterase domain-containing protein 1 (EC 3.1.-.-) (Adult brain protein 239) (239AB),326,"37,207",3 out of 5,2000-05-30,Evidence at transcript level
Q96LU7,MRFL_HUMAN,Myelin regulatory factor-like protein,910,"101,670",3 out of 5,2006-10-03,Evidence at transcript level
Q86SM5,MRGRG_HUMAN,Mas-related G-protein coupled receptor member G (G-protein coupled receptor 169),289,"31,518",3 out of 5,2004-08-31,Evidence at transcript level
Q96LB1,MRGX2_HUMAN,Mas-related G-protein coupled receptor member X2,330,"37,099",5 out of 5,2004-07-19,Evidence at protein level
Q96LB0,MRGX3_HUMAN,Mas-related G-protein coupled receptor member X3 (Sensory neuron-specific G-protein coupled receptor 1/2),322,"36,483",3 out of 5,2004-07-19,Evidence at transcript level
Q9BWK5,MRI_HUMAN,Modulator of retrovirus infection homolog,157,"16,829",5 out of 5,2008-02-26,Evidence at protein level
Q68CQ1,MROH7_HUMAN,Maestro heat-like repeat-containing protein family member 7 (HEAT repeat-containing protein 8),1323,"145,647",5 out of 5,2007-05-15,Evidence at transcript level
P33527,MRP1_HUMAN,Multidrug resistance-associated protein 1 (ATP-binding cassette sub-family C member 1) (Leukotriene C(4) transporter) (LTC4 transporter),1531,"171,591",5 out of 5,1994-02-01,Evidence at protein level
Q9HD23,MRS2_HUMAN,"Magnesium transporter MRS2 homolog, mitochondrial (MRS2-like protein)",443,"50,318",5 out of 5,2005-11-22,Evidence at protein level
B2RBV5,MRUPP_HUMAN,Putative MORF4 family-associated protein 1-like protein UPP (Unnamed protein product) (UPP),119,"13,369",2 out of 5,2015-10-14,Evidence at protein level
Q9GZW8,MS4A7_HUMAN,Membrane-spanning 4-domains subfamily A member 7 (CD20 antigen-like 4) (CD20/FC-epsilon-RI-beta family member 4) (Four-span transmembrane protein 2),240,"26,131",4 out of 5,2003-04-04,Evidence at transcript level
O43196,MSH5_HUMAN,MutS protein homolog 5 (hMSH5),834,"92,875",4 out of 5,1998-12-15,Evidence at protein level
P04732,MT1E_HUMAN,Metallothionein-1E (MT-1E) (Metallothionein-IE) (MT-IE),61,"6,014",5 out of 5,1987-08-13,Evidence at protein level
Q8WXB1,MT21A_HUMAN,Protein N-lysine methyltransferase METTL21A (EC 2.1.1.-) (HSPA lysine methyltransferase) (HSPA-KMT) (Hepatocellular carcinoma-associated antigen 557b) (Methyltransferase-like protein 21A),218,"24,600",5 out of 5,2007-06-26,Evidence at protein level
Q9H867,MT21D_HUMAN,Protein-lysine methyltransferase METTL21D (EC 2.1.1.-) (Methyltransferase-like protein 21D) (VCP lysine methyltransferase) (VCP-KMT) (Valosin-containing protein lysine methyltransferase),229,"25,807",5 out of 5,2003-11-07,Evidence at protein level
P56278,MTCP1_HUMAN,Protein p13 MTCP-1 (p13MTCP1) (Mature T-cell proliferation-1 type B1) (MTCP-1 type B1),107,"12,600",4 out of 5,1998-07-15,Evidence at protein level
Q9H903,MTD2L_HUMAN,Probable bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase 2 (NADP-dependent methylenetetrahydrofolate dehydrogenase 2-like protein) (MTHFD2-like) [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)],347,"37,315",5 out of 5,2008-05-20,Evidence at transcript level
Q9BRK3,MXRA8_HUMAN,Matrix remodeling-associated protein 8 (Limitrin),442,"49,132",4 out of 5,2007-08-21,Evidence at protein level
Q92614,MY18A_HUMAN,Unconventional myosin-XVIIIa (Molecule associated with JAK3 N-terminus) (MAJN) (Myosin containing a PDZ domain) (Surfactant protein receptor SP-R210) (SP-R210),2054,"233,115",5 out of 5,2003-07-25,Evidence at protein level
Q13203,MYBPH_HUMAN,Myosin-binding protein H (MyBP-H) (H-protein),477,"52,050",5 out of 5,1999-07-15,Evidence at protein level
Q9Y6X6,MYO16_HUMAN,Unconventional myosin-XVI (Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 3) (Unconventional myosin-16),1858,"206,129",5 out of 5,2007-05-29,Evidence at protein level
B2RTY4,MYO9A_HUMAN,Unconventional myosin-IXa (Unconventional myosin-9a),2548,"292,706",5 out of 5,2008-09-02,Evidence at protein level
Q9UL68,MYT1L_HUMAN,Myelin transcription factor 1-like protein (MyT1-L) (MyT1L),1186,"133,043",4 out of 5,2005-09-27,Evidence at transcript level
Q01538,MYT1_HUMAN,Myelin transcription factor 1 (MyT1) (Myelin transcription factor I) (MyTI) (PLPB1) (Proteolipid protein-binding protein),1121,"122,329",5 out of 5,1993-07-01,Evidence at protein level
Q8WU39,MZB1_HUMAN,Marginal zone B- and B1-cell-specific protein (Mesenteric estrogen-dependent adipose 7) (MEDA-7) (Plasma cell-induced resident endoplasmic reticulum protein) (Plasma cell-induced resident ER protein) (pERp1) (Proapoptotic caspase adapter protein),189,"20,694",5 out of 5,2008-02-26,Evidence at protein level
Q15274,NADC_HUMAN,Nicotinate-nucleotide pyrophosphorylase [carboxylating] (EC 2.4.2.19) (Quinolinate phosphoribosyltransferase [decarboxylating]) (QAPRTase) (QPRTase),297,"30,846",5 out of 5,1997-11-01,Evidence at protein level
Q96HR8,NAF1_HUMAN,H/ACA ribonucleoprotein complex non-core subunit NAF1 (hNAF1),494,"53,717",5 out of 5,2008-01-15,Evidence at protein level
P17050,NAGAB_HUMAN,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),411,"46,565",5 out of 5,1990-08-01,Evidence at protein level
Q8IZF0,NALCN_HUMAN,Sodium leak channel non-selective protein (CanIon) (Voltage gated channel-like protein 1),1738,"200,331",5 out of 5,2008-01-15,Evidence at protein level
Q9UQQ1,NALDL_HUMAN,N-acetylated-alpha-linked acidic dipeptidase-like protein (NAALADase L) (EC 3.4.17.21) (100 kDa ileum brush border membrane protein) (I100) (Ileal dipeptidylpeptidase),740,"80,558",5 out of 5,2002-02-11,Evidence at protein level
Q96MN2,NALP4_HUMAN,"NACHT, LRR and PYD domains-containing protein 4 (Cancer/testis antigen 58) (CT58) (PAAD and NACHT-containing protein 2) (PAN2) (PYRIN and NACHT-containing protein 2) (PYRIN-containing APAF1-like protein 4) (PYPAF4) (Ribonuclease inhibitor 2)",994,"113,415",5 out of 5,2002-05-02,Evidence at protein level
Q7RTR0,NALP9_HUMAN,"NACHT, LRR and PYD domains-containing protein 9 (Nucleotide-binding oligomerization domain protein 6) (PYRIN and NACHT-containing protein 12)",991,"113,312",3 out of 5,2007-05-01,Evidence at transcript level
P43490,NAMPT_HUMAN,Nicotinamide phosphoribosyltransferase (NAmPRTase) (Nampt) (EC 2.4.2.12) (Pre-B-cell colony-enhancing factor 1) (Pre-B cell-enhancing factor) (Visfatin),491,"55,521",5 out of 5,1995-11-01,Evidence at protein level
Q5VWK0,NBPF6_HUMAN,Neuroblastoma breakpoint family member 6,638,"72,239",2 out of 5,2007-05-29,Evidence at transcript level
Q6P3W6,NBPFA_HUMAN,Neuroblastoma breakpoint family member 10,841,"96,426",3 out of 5,2007-05-29,Evidence at transcript level
A0A087WUL8,NBPFJ_HUMAN,Neuroblastoma breakpoint family member 19,3843,"440,408",2 out of 5,2016-02-17,Uncertain
Q15080,NCF4_HUMAN,Neutrophil cytosol factor 4 (NCF-4) (Neutrophil NADPH oxidase factor 4) (SH3 and PX domain-containing protein 4) (p40-phox) (p40phox),339,"39,032",5 out of 5,2000-05-30,Evidence at protein level
O43639,NCK2_HUMAN,Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta),380,"42,915",5 out of 5,2000-12-01,Evidence at protein level
O14513,NCKP5_HUMAN,Nck-associated protein 5 (NAP-5) (Peripheral clock protein),1909,"208,537",4 out of 5,2002-04-16,Evidence at protein level
Q9UI40,NCKX2_HUMAN,Sodium/potassium/calcium exchanger 2 (Na(+)/K(+)/Ca(2+)-exchange protein 2) (Retinal cone Na-Ca+K exchanger) (Solute carrier family 24 member 2),661,"73,664",5 out of 5,2001-12-13,Evidence at protein level
Q13562,NDF1_HUMAN,Neurogenic differentiation factor 1 (NeuroD) (NeuroD1) (Class A basic helix-loop-helix protein 3) (bHLHa3),356,"39,920",5 out of 5,1997-11-01,Evidence at protein level
O60361,NDK8_HUMAN,Putative nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6),137,"15,529",3 out of 5,1998-12-15,Uncertain
P22392,NDKB_HUMAN,Nucleoside diphosphate kinase B (NDK B) (NDP kinase B) (EC 2.7.4.6) (C-myc purine-binding transcription factor PUF) (Histidine protein kinase NDKB) (EC 2.7.13.3) (nm23-H2),152,"17,298",5 out of 5,1991-08-01,Evidence at protein level
Q9ULP0,NDRG4_HUMAN,Protein NDRG4 (Brain development-related molecule 1) (N-myc downstream-regulated gene 4 protein) (Vascular smooth muscle cell-associated protein 8) (SMAP-8),352,"38,459",5 out of 5,2000-12-01,Evidence at protein level
P52848,NDST1_HUMAN,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 1) (NDST-1) (N-heparan sulfate sulfotransferase 1) (N-HSST 1) ([Heparan sulfate]-glucosamine N-sulfotransferase 1) (HSNST 1) [Includes: Heparan sulfate N-deacetylase 1 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 1 (EC 2.8.2.-)],882,"100,868",5 out of 5,1996-10-01,Evidence at protein level
O75438,NDUB1_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1 (Complex I-MNLL) (CI-MNLL) (NADH-ubiquinone oxidoreductase MNLL subunit) [Cleaved into: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1, N-terminally processed]",58,"6,961",5 out of 5,1999-07-15,Evidence at protein level
O15049,N4BP3_HUMAN,NEDD4-binding protein 3 (N4BP3),544,"60,470",3 out of 5,1999-07-15,Evidence at protein level
Q6N069,NAA16_HUMAN,"N-alpha-acetyltransferase 16, NatA auxiliary subunit (NMDA receptor-regulated 1-like protein) (NARG1-like protein)",864,"101,462",5 out of 5,2005-01-04,Evidence at protein level
Q5VZE5,NAA35_HUMAN,"N-alpha-acetyltransferase 35, NatC auxiliary subunit (Embryonic growth-associated protein homolog) (Protein MAK10 homolog)",725,"83,639",5 out of 5,2007-10-23,Evidence at protein level
O15069,NACAD_HUMAN,NAC-alpha domain-containing protein 1,1562,"161,101",3 out of 5,2007-03-20,Evidence at protein level
Q13765,NACA_HUMAN,Nascent polypeptide-associated complex subunit alpha (NAC-alpha) (Alpha-NAC) (allergen Hom s 2),215,"23,384",5 out of 5,2005-07-19,Evidence at protein level
O95544,NADK_HUMAN,NAD kinase (EC 2.7.1.23) (Poly(P)/ATP NAD kinase),446,"49,228",5 out of 5,2000-05-30,Evidence at protein level
Q58DX5,NADL2_HUMAN,Inactive N-acetylated-alpha-linked acidic dipeptidase-like protein 2 (NAALADase L2),795,"88,682",5 out of 5,2008-01-15,Evidence at protein level
Q6NSW7,NANP8_HUMAN,Putative homeobox protein NANOGP8,305,"34,615",3 out of 5,2006-11-28,Uncertain
P52961,NAR1_HUMAN,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 1) (ARTC1) (Mono(ADP-ribosyl)transferase 1) (CD antigen CD296),327,"36,335",5 out of 5,1996-10-01,Evidence at transcript level
Q96L15,NAR5_HUMAN,Ecto-ADP-ribosyltransferase 5 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 5) (ARTC5) (Mono(ADP-ribosyl)transferase 5) (NAD(P)(+)--arginine ADP-ribosyltransferase 5),291,"32,054",4 out of 5,2002-08-13,Evidence at transcript level
Q7L1T6,NB5R4_HUMAN,Cytochrome b5 reductase 4 (EC 1.6.2.2) (Flavohemoprotein b5/b5R) (b5+b5R) (N-terminal cytochrome b5 and cytochrome b5 oxidoreductase domain-containing protein) (cb5/cb5R),521,"59,474",5 out of 5,2007-05-15,Evidence at protein level
A0A0U1RRE5,NBDY_HUMAN,Negative regulator of P-body association (P-body dissociating protein) (Protein NoBody),68,"7,025",5 out of 5,2017-03-15,Evidence at protein level
Q6ZS30,NBEL1_HUMAN,Neurobeachin-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 16 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 17 protein),2694,"307,237",3 out of 5,2006-01-24,Evidence at transcript level
P41271,NBL1_HUMAN,Neuroblastoma suppressor of tumorigenicity 1 (DAN domain family member 1) (Protein N03) (Zinc finger protein DAN),181,"19,408",5 out of 5,1995-02-01,Evidence at protein level
Q86T75,NBPFB_HUMAN,Neuroblastoma breakpoint family member 11 (Neuroblastoma breakpoint family member 24),865,"99,433",3 out of 5,2007-05-29,Evidence at transcript level
Q3BBV1,NBPFK_HUMAN,Neuroblastoma breakpoint family member 20,942,"108,576",2 out of 5,2007-05-29,Evidence at transcript level
B4DH59,NBPFP_HUMAN,Neuroblastoma breakpoint family member 26,902,"103,816",2 out of 5,2014-04-16,Uncertain
Q14919,NC2A_HUMAN,Dr1-associated corepressor (Dr1-associated protein 1) (Negative cofactor 2-alpha) (NC2-alpha),205,"22,350",5 out of 5,2004-12-07,Evidence at protein level
P56597,NDK5_HUMAN,Nucleoside diphosphate kinase homolog 5 (NDK-H 5) (NDP kinase homolog 5) (Inhibitor of p53-induced apoptosis-beta) (IPIA-beta) (Testis-specific nm23 homolog) (nm23-H5),212,"24,236",4 out of 5,1998-12-15,Evidence at protein level
Q9Y5B8,NDK7_HUMAN,Nucleoside diphosphate kinase 7 (NDK 7) (NDP kinase 7) (EC 2.7.4.6) (nm23-H7),376,"42,492",5 out of 5,2001-01-11,Evidence at protein level
P15531,NDKA_HUMAN,Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein),152,"17,149",5 out of 5,1990-04-01,Evidence at protein level
Q16718,NDUA5_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 (Complex I subunit B13) (Complex I-13kD-B) (CI-13kD-B) (NADH-ubiquinone oxidoreductase 13 kDa-B subunit),116,"13,459",4 out of 5,1997-11-01,Evidence at protein level
P51970,NDUA8_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8 (Complex I-19kD) (CI-19kD) (Complex I-PGIV) (CI-PGIV) (NADH-ubiquinone oxidoreductase 19 kDa subunit),172,"20,105",5 out of 5,1996-10-01,Evidence at protein level
Q16795,NDUA9_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial (Complex I-39kD) (CI-39kD) (NADH-ubiquinone oxidoreductase 39 kDa subunit)",377,"42,510",5 out of 5,1997-11-01,Evidence at protein level
O95299,NDUAA_HUMAN,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial (Complex I-42kD) (CI-42kD) (NADH-ubiquinone oxidoreductase 42 kDa subunit)",355,"40,751",5 out of 5,1999-07-15,Evidence at protein level
Q9UI09,NDUAC_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12 (13 kDa differentiation-associated protein) (Complex I-B17.2) (CI-B17.2) (CIB17.2) (NADH-ubiquinone oxidoreductase subunit B17.2),145,"17,114",5 out of 5,2000-12-01,Evidence at protein level
O95168,NDUB4_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4 (Complex I-B15) (CI-B15) (NADH-ubiquinone oxidoreductase B15 subunit),129,"15,209",5 out of 5,1999-07-15,Evidence at protein level
P17568,NDUB7_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7 (Cell adhesion protein SQM1) (Complex I-B18) (CI-B18) (NADH-ubiquinone oxidoreductase B18 subunit),137,"16,402",5 out of 5,1990-08-01,Evidence at protein level
O75306,NDUS2_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-49kD) (CI-49kD) (NADH-ubiquinone oxidoreductase 49 kDa subunit)",463,"52,546",5 out of 5,1999-07-15,Evidence at protein level
O43181,NDUS4_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial (Complex I-18 kDa) (CI-18 kDa) (Complex I-AQDQ) (CI-AQDQ) (NADH-ubiquinone oxidoreductase 18 kDa subunit)",175,"20,108",5 out of 5,1998-07-15,Evidence at protein level
P56181,NDUV3_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial (Complex I-9kD) (CI-9kD) (NADH-ubiquinone oxidoreductase 9 kDa subunit) (Renal carcinoma antigen NY-REN-4)",108,"11,941",5 out of 5,1997-11-01,Evidence at protein level
Q9HC98,NEK6_HUMAN,Serine/threonine-protein kinase Nek6 (EC 2.7.11.1) (Never in mitosis A-related kinase 6) (NimA-related protein kinase 6) (Protein kinase SID6-1512),313,"35,714",5 out of 5,2003-10-03,Evidence at protein level
O14524,NEMP1_HUMAN,Nuclear envelope integral membrane protein 1,444,"50,640",4 out of 5,1998-07-15,Evidence at protein level
Q96NY9,MUS81_HUMAN,Crossover junction endonuclease MUS81 (EC 3.1.22.-),551,"61,173",5 out of 5,2004-04-13,Evidence at protein level
O60682,MUSC_HUMAN,Musculin (Activated B-cell factor 1) (ABF-1) (Class A basic helix-loop-helix protein 22) (bHLHa22),206,"22,068",5 out of 5,2001-08-14,Evidence at protein level
Q969H8,MYDGF_HUMAN,Myeloid-derived growth factor (MYDGF) (Interleukin-25) (IL-25) (Stromal cell-derived growth factor SF20),173,"18,795",5 out of 5,2004-07-05,Evidence at protein level
P13349,MYF5_HUMAN,Myogenic factor 5 (Myf-5) (Class C basic helix-loop-helix protein 2) (bHLHc2),255,"28,296",5 out of 5,1990-01-01,Evidence at transcript level
P02144,MYG_HUMAN,Myoglobin,154,"17,184",5 out of 5,1986-07-21,Evidence at protein level
Q32MK0,MYLK3_HUMAN,Myosin light chain kinase 3 (EC 2.7.11.18) (Cardiac-MyBP-C-associated Ca/CaM kinase) (Cardiac-MLCK),819,"88,393",5 out of 5,2007-01-23,Evidence at protein level
Q8TDC0,MYOZ3_HUMAN,Myozenin-3 (Calsarcin-3) (FATZ-related protein 3),251,"27,157",4 out of 5,2005-11-22,Evidence at protein level
P25189,MYP0_HUMAN,Myelin protein P0 (Myelin peripheral protein) (MPP) (Myelin protein zero),248,"27,555",5 out of 5,1992-05-01,Evidence at protein level
Q5VVJ2,MYSM1_HUMAN,"Histone H2A deubiquitinase MYSM1 (2A-DUB) (EC 3.4.19.-) (Myb-like, SWIRM and MPN domain-containing protein 1)",828,"95,032",5 out of 5,2006-05-02,Evidence at protein level
Q8TD07,N2DL4_HUMAN,NKG2D ligand 4 (N2DL-4) (NKG2DL4) (Lymphocyte effector toxicity activation ligand) (RAE-1-like transcript 4) (RL-4) (Retinoic acid early transcript 1E),263,"30,122",5 out of 5,2004-05-24,Evidence at protein level
Q9BZK3,NACP1_HUMAN,Putative nascent polypeptide-associated complex subunit alpha-like protein (Alpha-NAC pseudogene 1) (NAC-alpha pseudogene 1),213,"23,306",2 out of 5,2007-03-20,Uncertain
Q6IA69,NADE_HUMAN,Glutamine-dependent NAD(+) synthetase (EC 6.3.5.1) (NAD(+) synthase [glutamine-hydrolyzing]) (NAD(+) synthetase),706,"79,285",5 out of 5,2006-05-30,Evidence at protein level
Q86W26,NAL10_HUMAN,"NACHT, LRR and PYD domains-containing protein 10 (Nucleotide-binding oligomerization domain protein 8)",655,"75,032",5 out of 5,2004-04-13,Evidence at protein level
P59046,NAL12_HUMAN,"NACHT, LRR and PYD domains-containing protein 12 (Monarch-1) (PYRIN-containing APAF1-like protein 7) (Regulated by nitric oxide)",1061,"120,173",5 out of 5,2002-10-19,Evidence at protein level
Q93070,NAR4_HUMAN,Ecto-ADP-ribosyltransferase 4 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 4) (ARTC4) (Dombrock blood group carrier molecule) (Mono(ADP-ribosyl)transferase 4) (NAD(P)(+)--arginine ADP-ribosyltransferase 4) (CD antigen CD297),314,"35,878",5 out of 5,1997-11-01,Evidence at transcript level
Q9H6Q4,NARFL_HUMAN,Cytosolic Fe-S cluster assembly factor NARFL (Iron-only hydrogenase-like protein 1) (IOP1) (Nuclear prelamin A recognition factor-like protein) (Protein related to Narf),476,"53,020",5 out of 5,2007-05-29,Evidence at protein level
Q93015,NAT6_HUMAN,N-acetyltransferase 6 (EC 2.3.1.-) (Protein fusion-2) (Protein fus-2),286,"31,445",3 out of 5,2002-11-08,Evidence at transcript level
Q9UHF3,NAT8B_HUMAN,Putative N-acetyltransferase 8B (EC 2.3.1.-) (Acetyltransferase 1) (ATase1) (Camello-like protein 2),227,"25,366",5 out of 5,2007-04-17,Uncertain
Q9BTE0,NAT9_HUMAN,N-acetyltransferase 9 (EC 2.3.1.-) (Embryo brain-specific protein),207,"23,361",3 out of 5,2007-05-15,Evidence at protein level
Q8NEY1,NAV1_HUMAN,Neuron navigator 1 (Pore membrane and/or filament-interacting-like protein 3) (Steerin-1) (Unc-53 homolog 1) (unc53H1),1877,"202,472",5 out of 5,2007-05-15,Evidence at protein level
Q96M43,NBPF4_HUMAN,Neuroblastoma breakpoint family member 4,638,"72,053",2 out of 5,2007-05-29,Evidence at transcript level
Q3BBW0,NBPF9_HUMAN,Neuroblastoma breakpoint family member 9,867,"99,594",2 out of 5,2007-05-29,Evidence at transcript level
Q8N660,NBPFF_HUMAN,Neuroblastoma breakpoint family member 15 (Neuroblastoma breakpoint family member 16),670,"77,563",2 out of 5,2007-05-29,Evidence at transcript level
Q14596,NBR1_HUMAN,Next to BRCA1 gene 1 protein (Cell migration-inducing gene 19 protein) (Membrane component chromosome 17 surface marker 2) (Neighbor of BRCA1 gene 1 protein) (Protein 1A1-3B),966,"107,413",5 out of 5,1997-11-01,Evidence at protein level
P13591,NCAM1_HUMAN,Neural cell adhesion molecule 1 (N-CAM-1) (NCAM-1) (CD antigen CD56),858,"94,574",5 out of 5,1990-01-01,Evidence at protein level
O15394,NCAM2_HUMAN,Neural cell adhesion molecule 2 (N-CAM-2) (NCAM-2),837,"93,046",5 out of 5,1998-07-15,Evidence at protein level
Q15788,NCOA1_HUMAN,Nuclear receptor coactivator 1 (NCoA-1) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 74) (bHLHe74) (Protein Hin-2) (RIP160) (Renal carcinoma antigen NY-REN-52) (Steroid receptor coactivator 1) (SRC-1),1441,"156,757",5 out of 5,2004-10-11,Evidence at protein level
Q9HCD5,NCOA5_HUMAN,Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA),579,"65,536",5 out of 5,2003-02-12,Evidence at protein level
O95944,NCTR2_HUMAN,Natural cytotoxicity triggering receptor 2 (Lymphocyte antigen 95 homolog) (NK cell-activating receptor) (Natural killer cell p44-related protein) (NK-p44) (NKp44) (CD antigen CD336),276,"30,677",5 out of 5,2004-05-24,Evidence at protein level
O14777,NDC80_HUMAN,Kinetochore protein NDC80 homolog (Highly expressed in cancer protein) (Kinetochore protein Hec1) (HsHec1) (Kinetochore-associated protein 2) (Retinoblastoma-associated protein HEC),642,"73,913",5 out of 5,2006-09-19,Evidence at protein level
Q9HD90,NDF4_HUMAN,Neurogenic differentiation factor 4 (NeuroD4) (Class A basic helix-loop-helix protein 4) (bHLHa4) (Protein atonal homolog 3) (ATH-3) (Atoh3),331,"37,041",4 out of 5,2002-03-27,Evidence at protein level
O00746,NDKM_HUMAN,"Nucleoside diphosphate kinase, mitochondrial (NDK) (NDP kinase, mitochondrial) (EC 2.7.4.6) (Nucleoside diphosphate kinase D) (NDPKD) (nm23-H4)",187,"20,659",5 out of 5,1997-11-01,Evidence at protein level
Q96BF6,NACC2_HUMAN,Nucleus accumbens-associated protein 2 (NAC-2) (BTB/POZ domain-containing protein 14A) (Repressor with BTB domain and BEN domain),587,"62,837",5 out of 5,2006-12-12,Evidence at protein level
Q86W24,NAL14_HUMAN,"NACHT, LRR and PYD domains-containing protein 14 (Nucleotide-binding oligomerization domain protein 5)",1093,"124,733",5 out of 5,2003-11-14,Evidence at protein level
Q8WX94,NALP7_HUMAN,"NACHT, LRR and PYD domains-containing protein 7 (Nucleotide-binding oligomerization domain protein 12) (PYRIN-containing APAF1-like protein 3)",980,"111,807",5 out of 5,2002-10-19,Evidence at protein level
Q8N7R0,NANG2_HUMAN,Putative homeobox protein NANOG2,232,"26,880",3 out of 5,2006-11-28,Uncertain
Q6IQ20,NAPEP_HUMAN,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D (N-acyl phosphatidylethanolamine phospholipase D) (NAPE-PLD) (NAPE-hydrolyzing phospholipase D) (EC 3.1.4.54),393,"45,596",5 out of 5,2008-02-05,Evidence at protein level
O96009,NAPSA_HUMAN,Napsin-A (EC 3.4.23.-) (Aspartyl protease 4) (ASP4) (Asp 4) (Napsin-1) (TA01/TA02),420,"45,387",5 out of 5,2000-05-30,Evidence at protein level
Q13508,NAR3_HUMAN,Ecto-ADP-ribosyltransferase 3 (EC 2.4.2.31) (ADP-ribosyltransferase C2 and C3 toxin-like 3) (ARTC3) (Mono(ADP-ribosyl)transferase 3) (NAD(P)(+)--arginine ADP-ribosyltransferase 3),389,"43,923",5 out of 5,1997-11-01,Evidence at protein level
Q9UHQ1,NARF_HUMAN,Nuclear prelamin A recognition factor (Iron-only hydrogenase-like protein 2) (IOP2),456,"51,156",4 out of 5,2007-05-29,Evidence at protein level
Q9H0A0,NAT10_HUMAN,RNA cytidine acetyltransferase (EC 2.3.1.-) (18S rRNA cytosine acetyltransferase) (N-acetyltransferase 10),1025,"115,730",5 out of 5,2002-06-06,Evidence at protein level
Q8IVL1,NAV2_HUMAN,Neuron navigator 2 (EC 3.6.4.12) (Helicase APC down-regulated 1) (Pore membrane and/or filament-interacting-like protein 2) (Retinoic acid inducible in neuroblastoma 1) (Steerin-2) (Unc-53 homolog 2) (unc53H2),2488,"268,167",5 out of 5,2006-12-12,Evidence at protein level
P52298,NCBP2_HUMAN,Nuclear cap-binding protein subunit 2 (20 kDa nuclear cap-binding protein) (Cell proliferation-inducing gene 55 protein) (NCBP 20 kDa subunit) (CBP20) (NCBP-interacting protein 1) (NIP1),156,"18,001",5 out of 5,1996-10-01,Evidence at protein level
A6NI72,NCF1B_HUMAN,Putative neutrophil cytosol factor 1B (NCF-1B) (Putative SH3 and PX domain-containing protein 1B),391,"44,817",3 out of 5,2008-09-02,Uncertain
P14598,NCF1_HUMAN,Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox),390,"44,652",5 out of 5,1990-04-01,Evidence at protein level
O00533,NCHL1_HUMAN,Neural cell adhesion molecule L1-like protein (Close homolog of L1) [Cleaved into: Processed neural cell adhesion molecule L1-like protein],1208,"135,071",5 out of 5,2006-07-25,Evidence at protein level
P16333,NCK1_HUMAN,Cytoplasmic protein NCK1 (NCK adaptor protein 1) (Nck-1) (SH2/SH3 adaptor protein NCK-alpha),377,"42,864",5 out of 5,1990-08-01,Evidence at protein level
O60721,NCKX1_HUMAN,Sodium/potassium/calcium exchanger 1 (Na(+)/K(+)/Ca(2+)-exchange protein 1) (Retinal rod Na-Ca+K exchanger) (Solute carrier family 24 member 1),1099,"121,374",5 out of 5,2001-12-13,Evidence at protein level
Q5T1S8,NCMAP_HUMAN,Noncompact myelin-associated protein (Myelin protein of 11 kDa) (MP11),102,"11,082",3 out of 5,2006-12-12,Inferred from homology
Q14686,NCOA6_HUMAN,"Nuclear receptor coactivator 6 (Activating signal cointegrator 2) (ASC-2) (Amplified in breast cancer protein 3) (Cancer-amplified transcriptional coactivator ASC-2) (Nuclear receptor coactivator RAP250) (NRC RAP250) (Nuclear receptor-activating protein, 250 kDa) (Peroxisome proliferator-activated receptor-interacting protein) (PPAR-interacting protein) (PRIP) (Thyroid hormone receptor-binding protein)",2063,"219,145",5 out of 5,2003-02-12,Evidence at protein level
Q9Y618,NCOR2_HUMAN,"Nuclear receptor corepressor 2 (N-CoR2) (CTG repeat protein 26) (SMAP270) (Silencing mediator of retinoic acid and thyroid hormone receptor) (SMRT) (T3 receptor-associating factor) (TRAC) (Thyroid-, retinoic-acid-receptor-associated corepressor)",2525,"274,804",5 out of 5,2000-12-01,Evidence at protein level
Q13232,NDK3_HUMAN,Nucleoside diphosphate kinase 3 (NDK 3) (NDP kinase 3) (EC 2.7.4.6) (DR-nm23) (Nucleoside diphosphate kinase C) (NDPKC) (nm23-H3),169,"19,015",5 out of 5,1998-12-15,Evidence at protein level
O43674,NDUB5_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial (Complex I-SGDH) (CI-SGDH) (NADH-ubiquinone oxidoreductase SGDH subunit)",189,"21,750",5 out of 5,1999-07-15,Evidence at protein level
O95169,NDUB8_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial (Complex I-ASHI) (CI-ASHI) (NADH-ubiquinone oxidoreductase ASHI subunit)",186,"21,766",5 out of 5,1999-07-15,Evidence at protein level
O96000,NDUBA_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10 (Complex I-PDSW) (CI-PDSW) (NADH-ubiquinone oxidoreductase PDSW subunit),172,"20,777",4 out of 5,1999-07-15,Evidence at protein level
E9PQ53,NDUCR_HUMAN,"NADH dehydrogenase [ubiquinone] 1 subunit C2, isoform 2 (NDUFC2-KCTD14 readthrough transcript protein)",114,"13,408",4 out of 5,2013-06-26,Evidence at protein level
Q330K2,NDUF6_HUMAN,"NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 (Putative phytoene synthase)",333,"38,176",5 out of 5,2007-06-26,Evidence at protein level
O75489,NDUS3_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-30kD) (CI-30kD) (NADH-ubiquinone oxidoreductase 30 kDa subunit)",264,"30,242",5 out of 5,1998-12-15,Evidence at protein level
O00217,NDUS8_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-23kD) (CI-23kD) (NADH-ubiquinone oxidoreductase 23 kDa subunit) (TYKY subunit)",210,"23,705",5 out of 5,1997-11-01,Evidence at protein level
P49821,NDUV1_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-51kD) (CI-51kD) (NADH dehydrogenase flavoprotein 1) (NADH-ubiquinone oxidoreductase 51 kDa subunit)",464,"50,817",5 out of 5,1996-10-01,Evidence at protein level
O76041,NEBL_HUMAN,Nebulette (Actin-binding Z-disk protein),1014,"116,453",5 out of 5,2001-02-21,Evidence at protein level
P20929,NEBU_HUMAN,Nebulin,6669,"772,914",5 out of 5,1991-02-01,Evidence at protein level
P29120,NEC1_HUMAN,Neuroendocrine convertase 1 (NEC 1) (EC 3.4.21.93) (Prohormone convertase 1) (Proprotein convertase 1) (PC1),753,"84,152",5 out of 5,1992-12-01,Evidence at protein level
Q7Z6G3,NECA2_HUMAN,N-terminal EF-hand calcium-binding protein 2 (EF-hand calcium-binding protein 2) (Neuronal calcium-binding protein 2) (Synaptotagmin-interacting protein 2) (Stip-2),386,"43,194",3 out of 5,2007-04-03,Evidence at protein level
Q99608,NECD_HUMAN,Necdin,321,"36,086",5 out of 5,2001-10-18,Evidence at transcript level
Q92692,NECT2_HUMAN,Nectin-2 (Herpes virus entry mediator B) (Herpesvirus entry mediator B) (HveB) (Nectin cell adhesion molecule 2) (Poliovirus receptor-related protein 2) (CD antigen CD112),538,"57,742",5 out of 5,2001-01-11,Evidence at protein level
Q6BCY4,NB5R2_HUMAN,NADH-cytochrome b5 reductase 2 (b5R.2) (EC 1.6.2.2),276,"31,458",5 out of 5,2007-05-15,Evidence at protein level
P00387,NB5R3_HUMAN,NADH-cytochrome b5 reductase 3 (B5R) (Cytochrome b5 reductase) (EC 1.6.2.2) (Diaphorase-1) [Cleaved into: NADH-cytochrome b5 reductase 3 membrane-bound form; NADH-cytochrome b5 reductase 3 soluble form],301,"34,235",5 out of 5,1986-07-21,Evidence at protein level
A2RRP1,NBAS_HUMAN,Neuroblastoma-amplified sequence (Neuroblastoma-amplified gene protein),2371,"268,571",5 out of 5,2007-06-26,Evidence at protein level
Q5TAG4,NBPFC_HUMAN,Neuroblastoma breakpoint family member 12 (Chromosome 1 amplified sequence 1),269,"31,307",2 out of 5,2007-05-29,Evidence at transcript level
P62166,NCS1_HUMAN,Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein),190,"21,879",5 out of 5,2004-06-21,Evidence at protein level
Q92597,NDRG1_HUMAN,Protein NDRG1 (Differentiation-related gene 1 protein) (DRG-1) (N-myc downstream-regulated gene 1 protein) (Nickel-specific induction protein Cap43) (Reducing agents and tunicamycin-responsive protein) (RTP) (Rit42),394,"42,835",5 out of 5,1999-07-15,Evidence at protein level
O00483,NDUA4_HUMAN,Cytochrome c oxidase subunit NDUFA4 (Complex I-MLRQ) (CI-MLRQ) (NADH-ubiquinone oxidoreductase MLRQ subunit),81,"9,370",5 out of 5,1997-11-01,Evidence at protein level
Q96SB3,NEB2_HUMAN,Neurabin-2 (Neurabin-II) (Protein phosphatase 1 regulatory subunit 9B) (Spinophilin),815,"89,192",5 out of 5,2006-03-21,Evidence at protein level
Q9NVZ3,NECP2_HUMAN,Adaptin ear-binding coat-associated protein 2 (NECAP endocytosis-associated protein 2) (NECAP-2),263,"28,339",4 out of 5,2005-03-29,Evidence at protein level
Q7Z3B1,NEGR1_HUMAN,Neuronal growth regulator 1 (IgLON family member 4),354,"38,719",5 out of 5,2004-09-27,Evidence at protein level
P51955,NEK2_HUMAN,Serine/threonine-protein kinase Nek2 (EC 2.7.11.1) (HSPK 21) (Never in mitosis A-related kinase 2) (NimA-related protein kinase 2) (NimA-like protein kinase 1),445,"51,763",5 out of 5,1996-10-01,Evidence at protein level
Q9HB63,NET4_HUMAN,Netrin-4 (Beta-netrin) (Hepar-derived netrin-like protein),628,"70,071",5 out of 5,2005-09-27,Evidence at protein level
P56730,NETR_HUMAN,Neurotrypsin (EC 3.4.21.-) (Leydin) (Motopsin) (Serine protease 12),875,"97,067",5 out of 5,2000-05-30,Evidence at transcript level
P08651,NFIC_HUMAN,Nuclear factor 1 C-type (NF1-C) (Nuclear factor 1/C) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/C) (NF-I/C) (NFI-C) (TGGCA-binding protein),508,"55,675",5 out of 5,1988-08-01,Evidence at protein level
Q9NV92,NFIP2_HUMAN,NEDD4 family-interacting protein 2 (NEDD4 WW domain-binding protein 5A) (Putative MAPK-activating protein PM04/PM05/PM06/PM07) (Putative NF-kappa-B-activating protein 413),336,"36,390",5 out of 5,2005-08-30,Evidence at protein level
P19838,NFKB1_HUMAN,Nuclear factor NF-kappa-B p105 subunit (DNA-binding factor KBF1) (EBP-1) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1) [Cleaved into: Nuclear factor NF-kappa-B p50 subunit],968,"105,356",5 out of 5,1991-02-01,Evidence at protein level
Q96IV0,NGLY1_HUMAN,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase (PNGase) (hPNGase) (EC 3.5.1.52) (N-glycanase 1) (Peptide:N-glycanase),654,"74,390",5 out of 5,2006-09-05,Evidence at protein level
Q9GZZ1,NAA50_HUMAN,N-alpha-acetyltransferase 50 (EC 2.3.1.258) (N-acetyltransferase 13) (N-acetyltransferase 5) (hNAT5) (N-acetyltransferase san homolog) (hSAN) (NatE catalytic subunit),169,"19,398",5 out of 5,2007-05-01,Evidence at protein level
Q9UK23,NAGPA_HUMAN,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (EC 3.1.4.45) (Mannose 6-phosphate-uncovering enzyme) (Phosphodiester alpha-GlcNAcase),515,"56,073",5 out of 5,2004-12-21,Evidence at protein level
P59047,NALP5_HUMAN,"NACHT, LRR and PYD domains-containing protein 5 (Mater protein homolog)",1200,"134,342",5 out of 5,2002-10-19,Evidence at transcript level
Q8WUY8,NAT14_HUMAN,N-acetyltransferase 14 (EC 2.3.1.-) (K562 cell-derived leucine-zipper-like protein 1),206,"21,650",3 out of 5,2007-10-23,Evidence at protein level
Q8N9F0,NAT8L_HUMAN,N-acetylaspartate synthetase (NAA synthetase) (EC 2.3.1.17) (Camello-like protein 3) (N-acetyltransferase 8-like protein),302,"32,837",5 out of 5,2007-10-02,Evidence at protein level
Q8N6N6,NATD1_HUMAN,Protein NATD1 (N-acetyltransferase domain-containing protein 1),113,"13,032",2 out of 5,2008-02-26,Evidence at protein level
Q9H094,NBPF3_HUMAN,Neuroblastoma breakpoint family member 3 (Protein AE2) (Protein SHIIIa4),633,"72,951",4 out of 5,2007-05-29,Evidence at transcript level
Q5TI25,NBPFE_HUMAN,Neuroblastoma breakpoint family member 14,921,"105,853",2 out of 5,2007-05-29,Evidence at transcript level
P19878,NCF2_HUMAN,Neutrophil cytosol factor 2 (NCF-2) (67 kDa neutrophil oxidase factor) (NADPH oxidase activator 2) (Neutrophil NADPH oxidase factor 2) (p67-phox),526,"59,762",5 out of 5,1991-02-01,Evidence at protein level
Q9HCH0,NCK5L_HUMAN,Nck-associated protein 5-like (NCKAP5-like) (Centrosomal protein of 169 kDa) (Cep169),1330,"139,013",5 out of 5,2007-05-29,Evidence at protein level
O15239,NDUA1_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 (Complex I-MWFE) (CI-MWFE) (NADH-ubiquinone oxidoreductase MWFE subunit),70,"8,072",5 out of 5,1998-07-15,Evidence at protein level
O95182,NDUA7_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7 (Complex I-B14.5a) (CI-B14.5a) (NADH-ubiquinone oxidoreductase subunit B14.5a),113,"12,551",5 out of 5,1999-07-15,Evidence at protein level
Q9BU61,NDUF3_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3,184,"20,350",5 out of 5,2007-03-20,Evidence at protein level
P48681,NEST_HUMAN,Nestin,1621,"177,439",5 out of 5,1996-02-01,Evidence at protein level
Q8WTR8,NET5_HUMAN,Netrin-5 (Netrin-1-like protein),489,"53,174",2 out of 5,2008-02-26,Evidence at transcript level
Q8NC67,NETO2_HUMAN,Neuropilin and tolloid-like protein 2 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 2),525,"59,393",4 out of 5,2005-02-15,Evidence at protein level
A8MQ27,NEU1B_HUMAN,E3 ubiquitin-protein ligase NEURL1B (EC 2.3.2.27) (Neuralized-2) (NEUR2) (Neuralized-like protein 1B) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL1B),555,"59,270",5 out of 5,2008-09-02,Evidence at protein level
P01178,NEU1_HUMAN,Oxytocin-neurophysin 1 (OT-NPI) [Cleaved into: Oxytocin (Ocytocin); Neurophysin 1],125,"12,722",5 out of 5,1986-07-21,Evidence at protein level
Q8NCF5,NF2IP_HUMAN,"NFATC2-interacting protein (45 kDa NF-AT-interacting protein) (45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein)",419,"45,817",4 out of 5,2007-03-20,Evidence at protein level
Q8IVV8,NKAI4_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 4 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 4) (Protein FAM77A),208,"23,240",3 out of 5,2004-04-26,Evidence at transcript level
Q969G9,NKD1_HUMAN,Protein naked cuticle homolog 1 (Naked-1) (hNkd) (hNkd1),470,"52,285",5 out of 5,2007-09-11,Evidence at protein level
Q16617,NKG7_HUMAN,Protein NKG7 (G-CSF-induced gene 1 protein) (GIG-1 protein) (Granule membrane protein of 17 kDa) (GMP-17) (Natural killer cell protein 7) (p15-TIA-1),165,"17,665",3 out of 5,1998-12-15,Evidence at protein level
P78367,NKX32_HUMAN,Homeobox protein Nkx-3.2 (Bagpipe homeobox protein homolog 1) (Homeobox protein NK-3 homolog B),333,"34,814",5 out of 5,1998-07-15,Evidence at transcript level
Q9NZ94,NLGN3_HUMAN,Neuroligin-3 (Gliotactin homolog),848,"93,895",5 out of 5,2003-05-23,Evidence at protein level
A6PVI3,NCB2L_HUMAN,Nuclear cap-binding protein subunit 2-like,153,"17,685",2 out of 5,2007-09-11,Inferred from homology
Q9UBB6,NCDN_HUMAN,Neurochondrin,729,"78,864",5 out of 5,2008-03-18,Evidence at protein level
Q13772,NCOA4_HUMAN,Nuclear receptor coactivator 4 (NCoA-4) (Androgen receptor coactivator 70 kDa protein) (70 kDa AR-activator) (70 kDa androgen receptor coactivator) (Androgen receptor-associated protein of 70 kDa) (Ret-activating protein ELE1),614,"69,726",5 out of 5,2000-12-01,Evidence at protein level
P16435,NCPR_HUMAN,NADPH--cytochrome P450 reductase (CPR) (P450R) (EC 1.6.2.4),677,"76,690",5 out of 5,1990-08-01,Evidence at protein level
Q15784,NDF2_HUMAN,Neurogenic differentiation factor 2 (NeuroD2) (Class A basic helix-loop-helix protein 1) (bHLHa1) (NeuroD-related factor) (NDRF),382,"41,361",5 out of 5,1997-11-01,Evidence at transcript level
Q8WX92,NELFB_HUMAN,Negative elongation factor B (NELF-B) (Cofactor of BRCA1),580,"65,697",5 out of 5,2003-11-14,Evidence at protein level
Q92832,NELL1_HUMAN,Protein kinase C-binding protein NELL1 (NEL-like protein 1) (Nel-related protein 1),810,"89,635",5 out of 5,1997-11-01,Evidence at protein level
O00634,NET3_HUMAN,Netrin-3 (Netrin-2-like protein),580,"61,466",3 out of 5,2004-12-07,Evidence at protein level
Q8TDF5,NETO1_HUMAN,Neuropilin and tolloid-like protein 1 (Brain-specific transmembrane protein containing 2 CUB and 1 LDL-receptor class A domains protein 1),533,"60,191",5 out of 5,2005-02-15,Evidence at transcript level
Q9Y4A8,NF2L3_HUMAN,"Nuclear factor erythroid 2-related factor 3 (NF-E2-related factor 3) (NFE2-related factor 3) (Nuclear factor, erythroid derived 2, like 3)",694,"76,154",5 out of 5,2004-12-07,Evidence at protein level
O95644,NFAC1_HUMAN,"Nuclear factor of activated T-cells, cytoplasmic 1 (NF-ATc1) (NFATc1) (NFAT transcription complex cytosolic component) (NF-ATc) (NFATc)",943,"101,243",5 out of 5,2000-12-01,Evidence at protein level
O94856,NFASC_HUMAN,Neurofascin,1347,"150,027",5 out of 5,2003-11-14,Evidence at protein level
Q9BT67,NFIP1_HUMAN,NEDD4 family-interacting protein 1 (Breast cancer-associated protein SGA-1M) (NEDD4 WW domain-binding protein 5) (Putative MAPK-activating protein PM13) (Putative NF-kappa-B-activating protein 164) (Putative NFKB and MAPK-activating protein),221,"24,899",5 out of 5,2005-12-06,Evidence at protein level
Q5T2W1,NHRF3_HUMAN,Na(+)/H(+) exchange regulatory cofactor NHE-RF3 (NHERF-3) (CFTR-associated protein of 70 kDa) (Na(+)/H(+) exchanger regulatory factor 3) (Na/Pi cotransporter C-terminal-associated protein 1) (NaPi-Cap1) (PDZ domain-containing protein 1) (Sodium-hydrogen exchanger regulatory factor 3),519,"57,129",5 out of 5,2005-08-16,Evidence at protein level
Q9BZQ8,NIBAN_HUMAN,Protein Niban (Cell growth-inhibiting gene 39 protein) (Protein FAM129A),928,"103,135",5 out of 5,2002-08-13,Evidence at protein level
Q6NVV3,NIPA3_HUMAN,Magnesium transporter NIPA3 (NIPA-like protein 1) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 3),410,"44,638",3 out of 5,2006-06-27,Evidence at transcript level
Q8N8D7,NKAI3_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 3 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 3) (Protein FAM77D),197,"22,620",2 out of 5,2006-12-12,Evidence at transcript level
Q8N5F7,NKAP_HUMAN,NF-kappa-B-activating protein,415,"47,138",5 out of 5,2006-10-31,Evidence at protein level
P26718,NKG2D_HUMAN,NKG2-D type II integral membrane protein (Killer cell lectin-like receptor subfamily K member 1) (NK cell receptor D) (NKG2-D-activating NK receptor) (CD antigen CD314),216,"25,274",5 out of 5,1992-08-01,Evidence at protein level
Q8NFZ4,NLGN2_HUMAN,Neuroligin-2,835,"90,820",5 out of 5,2003-05-23,Evidence at protein level
Q86WI3,NLRC5_HUMAN,Protein NLRC5 (Caterpiller protein 16.1) (CLR16.1) (Nucleotide-binding oligomerization domain protein 27) (Nucleotide-binding oligomerization domain protein 4),1866,"204,595",5 out of 5,2007-07-24,Evidence at protein level
Q9ULX3,NOB1_HUMAN,RNA-binding protein NOB1 (Phosphorylation regulatory protein HP-10) (Protein ART-4),412,"46,675",5 out of 5,2006-05-02,Evidence at protein level
Q9BVI4,NOC4L_HUMAN,Nucleolar complex protein 4 homolog (NOC4 protein homolog) (NOC4-like protein) (Nucleolar complex-associated protein 4-like protein),516,"58,468",4 out of 5,2005-08-16,Evidence at protein level
Q9HB07,MYG1_HUMAN,"UPF0160 protein MYG1, mitochondrial",376,"42,449",3 out of 5,2001-06-01,Evidence at protein level
P35580,MYH10_HUMAN,"Myosin-10 (Cellular myosin heavy chain, type B) (Myosin heavy chain 10) (Myosin heavy chain, non-muscle IIb) (Non-muscle myosin heavy chain B) (NMMHC-B) (Non-muscle myosin heavy chain IIb) (NMMHC II-b) (NMMHC-IIB)",1976,"228,999",5 out of 5,1994-06-01,Evidence at protein level
Q9UKX3,MYH13_HUMAN,"Myosin-13 (Myosin heavy chain 13) (Myosin heavy chain, skeletal muscle, extraocular) (MyHC-EO) (Myosin heavy chain, skeletal muscle, laryngeal) (MyHC-IIL) (Superfast myosin)",1938,"223,605",5 out of 5,2001-04-27,Evidence at transcript level
P13533,MYH6_HUMAN,"Myosin-6 (Myosin heavy chain 6) (Myosin heavy chain, cardiac muscle alpha isoform) (MyHC-alpha)",1939,"223,735",5 out of 5,1990-01-01,Evidence at protein level
P13535,MYH8_HUMAN,"Myosin-8 (Myosin heavy chain 8) (Myosin heavy chain, skeletal muscle, perinatal) (MyHC-perinatal)",1937,"222,763",5 out of 5,1990-01-01,Evidence at protein level
Q8N1T3,MYO1H_HUMAN,Unconventional myosin-Ih (Myosin-1H),1032,"119,037",3 out of 5,2008-05-20,Evidence at protein level
Q9ULV0,MYO5B_HUMAN,Unconventional myosin-Vb,1848,"213,672",5 out of 5,2001-04-27,Evidence at protein level
P15172,MYOD1_HUMAN,Myoblast determination protein 1 (Class C basic helix-loop-helix protein 1) (bHLHc1) (Myogenic factor 3) (Myf-3),320,"34,501",5 out of 5,1990-04-01,Evidence at protein level
P52179,MYOM1_HUMAN,Myomesin-1 (190 kDa connectin-associated protein) (190 kDa titin-associated protein) (Myomesin family member 1),1685,"187,627",5 out of 5,1996-10-01,Evidence at protein level
Q9UBF9,MYOTI_HUMAN,Myotilin (57 kDa cytoskeletal protein) (Myofibrillar titin-like Ig domains protein) (Titin immunoglobulin domain protein),498,"55,395",5 out of 5,2005-03-29,Evidence at protein level
Q14324,MYPC2_HUMAN,"Myosin-binding protein C, fast-type (Fast MyBP-C) (C-protein, skeletal muscle fast isoform)",1141,"128,072",5 out of 5,1999-07-15,Evidence at protein level
Q9H1M0,N62CL_HUMAN,Nucleoporin-62 C-terminal-like protein,184,"20,837",3 out of 5,2006-10-31,Evidence at protein level
Q86UY6,NAA40_HUMAN,N-alpha-acetyltransferase 40 (EC 2.3.1.257) (N-acetyltransferase 11) (N-alpha-acetyltransferase D) (NatD) (hNatD) (Protein acetyltransferase 1),237,"27,194",5 out of 5,2007-05-01,Evidence at protein level
Q15742,NAB2_HUMAN,NGFI-A-binding protein 2 (EGR-1-binding protein 2) (Melanoma-associated delayed early response protein) (Protein MADER),525,"56,594",5 out of 5,2000-12-01,Evidence at protein level
Q8N159,NAGS_HUMAN,"N-acetylglutamate synthase, mitochondrial (EC 2.3.1.1) (Amino-acid acetyltransferase) [Cleaved into: N-acetylglutamate synthase long form; N-acetylglutamate synthase short form; N-acetylglutamate synthase conserved domain form]",534,"58,156",5 out of 5,2005-09-13,Evidence at protein level
Q86W28,NALP8_HUMAN,"NACHT, LRR and PYD domains-containing protein 8 (Nucleotide-binding oligomerization domain protein 16) (PYRIN and NACHT-containing protein 4)",1048,"119,430",4 out of 5,2007-04-03,Evidence at transcript level
Q9Y2A7,NCKP1_HUMAN,Nck-associated protein 1 (NAP 1) (Membrane-associated protein HEM-2) (p125Nap1),1128,"128,790",5 out of 5,2001-01-11,Evidence at protein level
P55160,NCKPL_HUMAN,Nck-associated protein 1-like (Hematopoietic protein 1) (Membrane-associated protein HEM-1),1127,"128,153",5 out of 5,1996-10-01,Evidence at protein level
Q71RS6,NCKX5_HUMAN,Sodium/potassium/calcium exchanger 5 (Na(+)/K(+)/Ca(2+)-exchange protein 5) (Solute carrier family 24 member 5),500,"54,888",5 out of 5,2006-01-10,Evidence at protein level
Q969V3,NCLN_HUMAN,Nicalin (Nicastrin-like protein),563,"62,974",5 out of 5,2005-06-21,Evidence at protein level
Q15596,NCOA2_HUMAN,Nuclear receptor coactivator 2 (NCoA-2) (Class E basic helix-loop-helix protein 75) (bHLHe75) (Transcriptional intermediary factor 2) (hTIF2),1464,"159,157",5 out of 5,2001-02-21,Evidence at protein level
P40205,NCYM_HUMAN,N-cym protein (N-myc opposite strand),109,"11,733",5 out of 5,1995-02-01,Evidence at protein level
Q9NXR1,NDE1_HUMAN,Nuclear distribution protein nudE homolog 1 (NudE),346,"38,808",5 out of 5,2006-06-13,Evidence at protein level
O75414,NDK6_HUMAN,Nucleoside diphosphate kinase 6 (NDK 6) (NDP kinase 6) (EC 2.7.4.6) (Inhibitor of p53-induced apoptosis-alpha) (IPIA-alpha) (nm23-H6),186,"21,142",5 out of 5,2001-01-11,Evidence at protein level
Q8TB73,NDNF_HUMAN,Protein NDNF (Neuron-derived neurotrophic factor),568,"64,673",5 out of 5,2007-09-11,Evidence at protein level
Q9UHB4,NDOR1_HUMAN,NADPH-dependent diflavin oxidoreductase 1 (EC 1.18.1.-) (NADPH-dependent FMN and FAD-containing oxidoreductase) (Novel reductase 1),597,"66,763",5 out of 5,2008-02-26,Evidence at protein level
Q09161,NCBP1_HUMAN,Nuclear cap-binding protein subunit 1 (80 kDa nuclear cap-binding protein) (CBP80) (NCBP 80 kDa subunit),790,"91,839",5 out of 5,1996-10-01,Evidence at protein level
O76036,NCTR1_HUMAN,Natural cytotoxicity triggering receptor 1 (Lymphocyte antigen 94 homolog) (NK cell-activating receptor) (Natural killer cell p46-related protein) (NK-p46) (NKp46) (hNKp46) (CD antigen CD335),304,"34,481",5 out of 5,2004-05-24,Evidence at protein level
Q9BTX1,NDC1_HUMAN,Nucleoporin NDC1 (hNDC1) (Transmembrane protein 48),674,"76,305",5 out of 5,2006-05-16,Evidence at protein level
Q8N987,NECA1_HUMAN,N-terminal EF-hand calcium-binding protein 1 (EF-hand calcium-binding protein 1) (Neuronal calcium-binding protein 1),351,"40,571",3 out of 5,2007-04-03,Evidence at protein level
Q96P71,NECA3_HUMAN,N-terminal EF-hand calcium-binding protein 3 (Amyloid beta A4 protein-binding family A member 2-binding protein) (Nek2-interacting protein 1) (Neuronal calcium-binding protein 3) (X11L-binding protein 51),396,"44,350",5 out of 5,2003-02-28,Evidence at protein level
Q8TD19,NEK9_HUMAN,Serine/threonine-protein kinase Nek9 (EC 2.7.11.1) (Nercc1 kinase) (Never in mitosis A-related kinase 9) (NimA-related protein kinase 9) (NimA-related kinase 8) (Nek8),979,"107,168",5 out of 5,2003-08-15,Evidence at protein level
Q9BYT8,NEUL_HUMAN,"Neurolysin, mitochondrial (EC 3.4.24.16) (Angiotensin-binding protein) (Microsomal endopeptidase) (MEP) (Mitochondrial oligopeptidase M) (Neurotensin endopeptidase)",704,"80,652",5 out of 5,2002-03-27,Evidence at protein level
Q9UQ49,NEUR3_HUMAN,Sialidase-3 (EC 3.2.1.18) (Ganglioside sialidase) (Membrane sialidase) (N-acetyl-alpha-neuraminidase 3),428,"48,252",5 out of 5,2001-11-16,Evidence at protein level
P30990,NEUT_HUMAN,Neurotensin/neuromedin N [Cleaved into: Large neuromedin N (NmN-125); Neuromedin N (NN) (NmN); Neurotensin (NT); Tail peptide],170,"19,795",4 out of 5,1993-07-01,Evidence at protein level
Q13469,NFAC2_HUMAN,"Nuclear factor of activated T-cells, cytoplasmic 2 (NF-ATc2) (NFATc2) (NFAT pre-existing subunit) (NF-ATp) (T-cell transcription factor NFAT1)",925,"100,146",5 out of 5,2000-12-01,Evidence at protein level
Q8NET5,NFAM1_HUMAN,NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1),270,"29,686",5 out of 5,2003-08-22,Evidence at protein level
O94916,NFAT5_HUMAN,Nuclear factor of activated T-cells 5 (NF-AT5) (T-cell transcription factor NFAT5) (Tonicity-responsive enhancer-binding protein) (TonE-binding protein) (TonEBP),1531,"165,763",5 out of 5,2000-12-01,Evidence at protein level
Q16621,NFE2_HUMAN,"Transcription factor NF-E2 45 kDa subunit (Leucine zipper protein NF-E2) (Nuclear factor, erythroid-derived 2 45 kDa subunit) (p45 NF-E2)",373,"41,473",5 out of 5,2000-05-30,Evidence at protein level
P12036,NFH_HUMAN,Neurofilament heavy polypeptide (NF-H) (200 kDa neurofilament protein) (Neurofilament triplet H protein),1026,"112,479",5 out of 5,1989-10-01,Evidence at protein level
O00712,NFIB_HUMAN,Nuclear factor 1 B-type (NF1-B) (Nuclear factor 1/B) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/B) (NF-I/B) (NFI-B) (TGGCA-binding protein),420,"47,442",5 out of 5,2001-06-01,Evidence at protein level
Q00653,NFKB2_HUMAN,Nuclear factor NF-kappa-B p100 subunit (DNA-binding factor KBF2) (H2TF1) (Lymphocyte translocation chromosome 10 protein) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2) (Oncogene Lyt-10) (Lyt10) [Cleaved into: Nuclear factor NF-kappa-B p52 subunit],900,"96,749",5 out of 5,1993-10-01,Evidence at protein level
Q6ZNB6,NFXL1_HUMAN,NF-X1-type zinc finger protein NFXL1 (Ovarian zinc finger protein) (hOZFP),911,"101,339",4 out of 5,2007-03-06,Evidence at protein level
Q13952,NFYC_HUMAN,Nuclear transcription factor Y subunit gamma (CAAT box DNA-binding protein subunit C) (Nuclear transcription factor Y subunit C) (NF-YC) (Transactivator HSM-1/2),458,"50,302",5 out of 5,2002-01-23,Evidence at protein level
Q6VVB1,NHLC1_HUMAN,E3 ubiquitin-protein ligase NHLRC1 (EC 2.3.2.27) (Malin) (NHL repeat-containing protein 1) (RING-type E3 ubiquitin transferase NHLRC1),395,"42,293",5 out of 5,2004-07-19,Evidence at protein level
Q5SYE7,NHSL1_HUMAN,NHS-like protein 1,1610,"170,668",3 out of 5,2008-06-10,Evidence at protein level
Q9BSH3,NICN1_HUMAN,Nicolin-1 (NPCEDRG) (Tubulin polyglutamylase complex subunit 5) (PGs5),213,"24,202",2 out of 5,2004-08-31,Evidence at transcript level
P14543,NID1_HUMAN,Nidogen-1 (NID-1) (Entactin),1247,"136,377",5 out of 5,1990-01-01,Evidence at protein level
Q14112,NID2_HUMAN,Nidogen-2 (NID-2) (Osteonidogen),1375,"151,254",5 out of 5,1998-12-15,Evidence at protein level
Q8IY84,NIM1_HUMAN,Serine/threonine-protein kinase NIM1 (EC 2.7.11.1) (NIM1 serine/threonine-protein kinase),436,"49,606",5 out of 5,2006-07-25,Evidence at protein level
Q9Y2I6,NINL_HUMAN,Ninein-like protein,1382,"156,344",5 out of 5,2006-10-31,Evidence at protein level
Q8N8Q9,NIPA2_HUMAN,Magnesium transporter NIPA2 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 2),360,"39,185",3 out of 5,2005-08-30,Evidence at transcript level
Q9NQR4,NIT2_HUMAN,Omega-amidase NIT2 (EC 3.5.1.3) (Nitrilase homolog 2),276,"30,608",5 out of 5,2008-02-26,Evidence at protein level
Q07444,NKG2E_HUMAN,NKG2-E type II integral membrane protein (NK cell receptor E) (NKG2-E-activating NK receptor),240,"27,100",5 out of 5,1997-11-01,Evidence at transcript level
Q9H2Z4,NKX24_HUMAN,Homeobox protein Nkx-2.4 (Homeobox protein NK-2 homolog D),354,"36,179",3 out of 5,2003-01-27,Inferred from homology
Q69YL0,NCAS2_HUMAN,Uncharacterized protein NCBP2-AS2 (NCBP2 antisense RNA 2) (NCBP2 antisense gene protein 2),99,"10,891",1 out of 5,2009-04-14,Evidence at protein level
Q53F19,NCBP3_HUMAN,Nuclear cap-binding protein subunit 3 (Protein ELG),620,"70,593",5 out of 5,2007-10-23,Evidence at protein level
Q6PIU2,NCEH1_HUMAN,Neutral cholesterol ester hydrolase 1 (NCEH) (EC 3.1.1.-) (Arylacetamide deacetylase-like 1),408,"45,808",5 out of 5,2006-12-12,Evidence at protein level
Q9HC58,NCKX3_HUMAN,Sodium/potassium/calcium exchanger 3 (Na(+)/K(+)/Ca(2+)-exchange protein 3) (Solute carrier family 24 member 3),644,"71,992",5 out of 5,2001-12-13,Evidence at transcript level
Q6J4K2,NCKX6_HUMAN,"Sodium/potassium/calcium exchanger 6, mitochondrial (Na(+)/K(+)/Ca(2+)-exchange protein 6) (Sodium/calcium exchanger protein, mitochondrial) (Solute carrier family 24 member 6) (Solute carrier family 8 member B1)",584,"64,231",5 out of 5,2006-01-10,Evidence at protein level
Q8NI08,NCOA7_HUMAN,Nuclear receptor coactivator 7 (140 kDa estrogen receptor-associated protein) (Estrogen nuclear receptor coactivator 1),942,"106,162",5 out of 5,2006-07-11,Evidence at protein level
O75376,NCOR1_HUMAN,Nuclear receptor corepressor 1 (N-CoR) (N-CoR1),2440,"270,210",5 out of 5,2000-12-01,Evidence at protein level
Q9GZM8,NDEL1_HUMAN,Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),345,"38,375",5 out of 5,2006-06-13,Evidence at protein level
O95167,NDUA3_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 (Complex I-B9) (CI-B9) (NADH-ubiquinone oxidoreductase B9 subunit),84,"9,279",4 out of 5,1999-07-15,Evidence at protein level
Q86Y39,NDUAB_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11 (Complex I-B14.7) (CI-B14.7) (NADH-ubiquinone oxidoreductase subunit B14.7),141,"14,852",5 out of 5,2004-09-13,Evidence at protein level
Q9P032,NDUF4_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 4 (Hormone-regulated proliferation-associated protein of 20 kDa),175,"20,266",5 out of 5,2003-05-16,Evidence at protein level
Q7L592,NDUF7_HUMAN,"Protein arginine methyltransferase NDUFAF7, mitochondrial (EC 2.1.1.320) (NADH dehydrogenase [ubiquinone] complex I, assembly factor 7) (Protein midA homolog)",441,"49,238",5 out of 5,2008-01-15,Evidence at protein level
Q96NY8,NECT4_HUMAN,Nectin-4 (Ig superfamily receptor LNIR) (Nectin cell adhesion molecule 4) (Poliovirus receptor-related protein 4) [Cleaved into: Processed poliovirus receptor-related protein 4],510,"55,454",5 out of 5,2007-08-21,Evidence at protein level
Q96PU5,NED4L_HUMAN,E3 ubiquitin-protein ligase NEDD4-like (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase NED4L) (NEDD4.2) (Nedd4-2),975,"111,932",5 out of 5,2005-08-30,Evidence at protein level
P51956,NEK3_HUMAN,Serine/threonine-protein kinase Nek3 (EC 2.7.11.1) (HSPK 36) (Never in mitosis A-related kinase 3) (NimA-related protein kinase 3),506,"57,705",5 out of 5,1996-10-01,Evidence at protein level
Q8TDX7,NEK7_HUMAN,Serine/threonine-protein kinase Nek7 (EC 2.7.11.1) (Never in mitosis A-related kinase 7) (NimA-related protein kinase 7),302,"34,551",5 out of 5,2003-10-03,Evidence at protein level
Q9H3P2,NELFA_HUMAN,Negative elongation factor A (NELF-A) (Wolf-Hirschhorn syndrome candidate 2 protein),528,"57,277",5 out of 5,2003-11-14,Evidence at protein level
Q8IXH7,NELFD_HUMAN,Negative elongation factor C/D (NELF-C/D) (TH1-like protein),590,"66,247",5 out of 5,2003-11-14,Evidence at protein level
P18615,NELFE_HUMAN,Negative elongation factor E (NELF-E) (RNA-binding protein RD),380,"43,240",5 out of 5,1990-11-01,Evidence at protein level
P01185,NEU2_HUMAN,Vasopressin-neurophysin 2-copeptin (AVP-NPII) [Cleaved into: Arg-vasopressin (Arginine-vasopressin); Neurophysin 2 (Neurophysin-II); Copeptin],164,"17,325",5 out of 5,1986-07-21,Evidence at protein level
Q8NFW8,NEUA_HUMAN,N-acylneuraminate cytidylyltransferase (EC 2.7.7.43) (CMP-N-acetylneuraminic acid synthase) (CMP-NeuNAc synthase),434,"48,379",5 out of 5,2005-02-01,Evidence at protein level
Q8WUJ1,NEUFC_HUMAN,Neuferricin (Cytochrome b5 domain-containing protein 2),264,"28,690",3 out of 5,2007-12-04,Evidence at transcript level
Q96EH8,NEUL3_HUMAN,E3 ubiquitin-protein ligase NEURL3 (EC 2.3.2.27) (Lung-inducible neuralized-related C3CH4 RING domain protein) (Neuralized-like protein 3) (RING-type E3 ubiquitin transferase NEURL3),262,"28,789",3 out of 5,2008-03-18,Evidence at transcript level
Q99519,NEUR1_HUMAN,Sialidase-1 (EC 3.2.1.18) (Acetylneuraminyl hydrolase) (G9 sialidase) (Lysosomal sialidase) (N-acetyl-alpha-neuraminidase 1),415,"45,467",5 out of 5,2001-11-16,Evidence at protein level
Q16236,NF2L2_HUMAN,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (HEBP1) (Nuclear factor, erythroid derived 2, like 2)",605,"67,827",5 out of 5,1999-07-15,Evidence at protein level
Q12968,NFAC3_HUMAN,"Nuclear factor of activated T-cells, cytoplasmic 3 (NF-ATc3) (NFATc3) (NFATx) (T-cell transcription factor NFAT4) (NF-AT4)",1075,"115,594",5 out of 5,2000-12-01,Evidence at protein level
Q14934,NFAC4_HUMAN,"Nuclear factor of activated T-cells, cytoplasmic 4 (NF-ATc4) (NFATc4) (T-cell transcription factor NFAT3) (NF-AT3)",902,"95,449",5 out of 5,2000-12-01,Evidence at protein level
Q12986,NFX1_HUMAN,"Transcriptional repressor NF-X1 (EC 6.3.2.-) (Nuclear transcription factor, X box-binding protein 1)",1120,"124,395",5 out of 5,1997-11-01,Evidence at protein level
Q96E22,NGBR_HUMAN,"Dehydrodolichyl diphosphate synthase complex subunit NUS1 (EC 2.5.1.87) (Di-trans,poly-cis-decaprenylcistransferase) (Nogo-B receptor) (NgBR) (Nuclear undecaprenyl pyrophosphate synthase 1 homolog)",293,"33,224",5 out of 5,2007-01-23,Evidence at protein level
Q86UT5,NHRF4_HUMAN,Na(+)/H(+) exchange regulatory cofactor NHE-RF4 (NHERF-4) (Intestinal and kidney-enriched PDZ protein) (Natrium-phosphate cotransporter IIa C-terminal-associated protein 2) (Na/Pi cotransporter C-terminal-associated protein 2) (NaPi-Cap2) (PDZ domain-containing protein 2) (PDZ domain-containing protein 3) (Sodium-hydrogen exchanger regulatory factor 4),571,"61,032",5 out of 5,2005-08-16,Evidence at protein level
Q86XR2,NIBL2_HUMAN,Niban-like protein 2 (B-cell novel protein 1) (Protein FAM129C),697,"77,413",3 out of 5,2008-03-18,Evidence at protein level
Q92542,NICA_HUMAN,Nicastrin,709,"78,411",5 out of 5,1998-07-15,Evidence at protein level
O95178,NDUB2_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial (Complex I-AGGG) (CI-AGGG) (NADH-ubiquinone oxidoreductase AGGG subunit)",105,"12,058",4 out of 5,1999-07-15,Evidence at protein level
Q8NBZ9,NEAS1_HUMAN,Putative uncharacterized protein NEXN-AS1 (NEXN antisense RNA 1),246,"25,156",1 out of 5,2007-03-20,Uncertain
Q9ULJ8,NEB1_HUMAN,Neurabin-1 (Neurabin-I) (Neural tissue-specific F-actin-binding protein I) (Protein phosphatase 1 regulatory subunit 9A),1098,"123,342",5 out of 5,2001-04-27,Evidence at protein level
Q15223,NECT1_HUMAN,Nectin-1 (Herpes virus entry mediator C) (Herpesvirus entry mediator C) (HveC) (Herpesvirus Ig-like receptor) (HIgR) (Nectin cell adhesion molecule 1) (Poliovirus receptor-related protein 1) (CD antigen CD111),517,"57,158",5 out of 5,2001-09-26,Evidence at protein level
Q15843,NEDD8_HUMAN,NEDD8 (Neddylin) (Neural precursor cell expressed developmentally down-regulated protein 8) (NEDD-8) (Ubiquitin-like protein Nedd8),81,"9,072",5 out of 5,1997-11-01,Evidence at protein level
Q969S2,NEIL2_HUMAN,Endonuclease 8-like 2 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil2) (DNA-(apurinic or apyrimidinic site) lyase Neil2) (Endonuclease VIII-like 2) (Nei homolog 2) (NEH2) (Nei-like protein 2),332,"36,826",5 out of 5,2004-12-07,Evidence at protein level
Q6ZWH5,NEK10_HUMAN,Serine/threonine-protein kinase Nek10 (EC 2.7.11.1) (Never in mitosis A-related kinase 10) (NimA-related protein kinase 10),1172,"133,259",5 out of 5,2006-11-28,Evidence at transcript level
Q9Y221,NIP7_HUMAN,60S ribosome subunit biogenesis protein NIP7 homolog (KD93),180,"20,463",5 out of 5,2004-12-07,Evidence at protein level
Q7RTP0,NIPA1_HUMAN,Magnesium transporter NIPA1 (Non-imprinted in Prader-Willi/Angelman syndrome region protein 1) (Spastic paraplegia 6 protein),329,"34,562",5 out of 5,2005-08-30,Evidence at protein level
Q8TAU0,NKX23_HUMAN,Homeobox protein Nkx-2.3 (Homeobox protein NK-2 homolog C),364,"38,406",4 out of 5,2003-01-27,Evidence at transcript level
O15522,NKX28_HUMAN,Homeobox protein Nkx-2.8 (Homeobox protein NK-2 homolog H),239,"25,866",5 out of 5,1999-07-15,Evidence at transcript level
Q9UBE8,NLK_HUMAN,Serine/threonine-protein kinase NLK (EC 2.7.11.24) (Nemo-like kinase) (Protein LAK1),527,"58,283",5 out of 5,2004-07-19,Evidence at protein level
Q7RTR2,NLRC3_HUMAN,Protein NLRC3 (CARD15-like protein) (Caterpiller protein 16.2) (CLR16.2) (Nucleotide-binding oligomerization domain protein 3),1065,"114,658",5 out of 5,2007-07-24,Evidence at transcript level
Q9NPP4,NLRC4_HUMAN,"NLR family CARD domain-containing protein 4 (CARD, LRR, and NACHT-containing protein) (Clan protein) (Caspase recruitment domain-containing protein 12) (Ice protease-activating factor) (Ipaf)",1024,"116,159",5 out of 5,2002-01-31,Evidence at protein level
Q13224,NMDE2_HUMAN,"Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3)",1484,"166,367",5 out of 5,2001-06-20,Evidence at protein level
Q8NC60,NOA1_HUMAN,Nitric oxide-associated protein 1,698,"78,458",5 out of 5,2006-04-18,Evidence at protein level
Q9BZE4,NOG1_HUMAN,Nucleolar GTP-binding protein 1 (Chronic renal failure gene protein) (GTP-binding protein NGB),634,"73,964",5 out of 5,2001-10-24,Evidence at protein level
O60936,NOL3_HUMAN,Nucleolar protein 3 (Apoptosis repressor with CARD) (Muscle-enriched cytoplasmic protein) (Myp) (Nucleolar protein of 30 kDa) (Nop30),208,"22,629",5 out of 5,2002-05-02,Evidence at protein level
P78316,NOP14_HUMAN,Nucleolar protein 14 (Nucleolar complex protein 14),857,"97,668",5 out of 5,2004-12-07,Evidence at protein level
P35228,NOS2_HUMAN,"Nitric oxide synthase, inducible (EC 1.14.13.39) (Hepatocyte NOS) (HEP-NOS) (Inducible NO synthase) (Inducible NOS) (iNOS) (NOS type II) (Peptidyl-cysteine S-nitrosylase NOS2)",1153,"131,117",5 out of 5,1994-02-01,Evidence at protein level
Q6P988,NOTUM_HUMAN,Palmitoleoyl-protein carboxylesterase NOTUM (EC 3.1.1.98) (hNOTUM),496,"55,699",5 out of 5,2008-02-26,Evidence at protein level
Q6UXI9,NPNT_HUMAN,Nephronectin (Preosteoblast EGF-like repeat protein with MAM domain) (Protein EGFL6-like),565,"61,907",5 out of 5,2007-07-24,Evidence at transcript level
P49146,NPY2R_HUMAN,Neuropeptide Y receptor type 2 (NPY2-R) (NPY-Y2 receptor) (Y2 receptor),381,"42,731",5 out of 5,1996-02-01,Evidence at protein level
P01303,NPY_HUMAN,Pro-neuropeptide Y [Cleaved into: Neuropeptide Y (Neuropeptide tyrosine) (NPY); C-flanking peptide of NPY (CPON)],97,"10,851",5 out of 5,1986-07-21,Evidence at protein level
Q15466,NR0B2_HUMAN,Nuclear receptor subfamily 0 group B member 2 (Orphan nuclear receptor SHP) (Small heterodimer partner),257,"28,058",5 out of 5,2000-12-01,Evidence at protein level
Q96RI1,NR1H4_HUMAN,Bile acid receptor (Farnesoid X-activated receptor) (Farnesol receptor HRR-1) (Nuclear receptor subfamily 1 group H member 4) (Retinoid X receptor-interacting protein 14) (RXR-interacting protein 14),486,"55,914",5 out of 5,2002-05-27,Evidence at protein level
P49116,NR2C2_HUMAN,Nuclear receptor subfamily 2 group C member 2 (Orphan nuclear receptor TAK1) (Orphan nuclear receptor TR4) (Testicular receptor 4),596,"65,414",5 out of 5,1996-02-01,Evidence at protein level
P22736,NR4A1_HUMAN,Nuclear receptor subfamily 4 group A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3),598,"64,463",5 out of 5,1991-08-01,Evidence at protein level
P49279,NRAM1_HUMAN,Natural resistance-associated macrophage protein 1 (NRAMP 1) (Solute carrier family 11 member 1),550,"59,872",5 out of 5,1996-02-01,Evidence at transcript level
Q86VF7,NRAP_HUMAN,Nebulin-related-anchoring protein (N-RAP),1730,"197,074",5 out of 5,2006-10-03,Evidence at protein level
Q9NSY0,NRBP2_HUMAN,Nuclear receptor-binding protein 2 (Transformation-related gene 16 protein) (TRG-16),501,"57,803",4 out of 5,2006-03-07,Evidence at protein level
P56975,NRG3_HUMAN,"Pro-neuregulin-3, membrane-bound isoform (Pro-NRG3) [Cleaved into: Neuregulin-3 (NRG-3)]",720,"77,901",5 out of 5,2000-12-01,Evidence at protein level
Q99748,NRTN_HUMAN,Neurturin,197,"22,405",5 out of 5,1997-11-01,Evidence at protein level
Q96L73,NSD1_HUMAN,"Histone-lysine N-methyltransferase, H3 lysine-36 and H4 lysine-20 specific (EC 2.1.1.43) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (H4-K20-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)",2696,"296,652",5 out of 5,2003-07-03,Evidence at protein level
P30414,NKTR_HUMAN,NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) [Includes: Putative peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) (Rotamase)],1462,"165,677",5 out of 5,1993-04-01,Evidence at protein level
P52952,NKX25_HUMAN,Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E),324,"34,918",5 out of 5,1996-10-01,Evidence at protein level
Q9C056,NKX62_HUMAN,Homeobox protein Nkx-6.2 (Homeobox protein NK-6 homolog B),277,"29,263",3 out of 5,2007-09-11,Evidence at transcript level
Q9NVX2,NLE1_HUMAN,Notchless protein homolog 1,485,"53,320",5 out of 5,2003-09-19,Evidence at protein level
Q9C000,NLRP1_HUMAN,"NACHT, LRR and PYD domains-containing protein 1 (Caspase recruitment domain-containing protein 7) (Death effector filament-forming ced-4-like apoptosis protein) (Nucleotide-binding domain and caspase recruitment domain)",1473,"165,866",5 out of 5,2001-10-18,Evidence at protein level
Q96D46,NMD3_HUMAN,60S ribosomal export protein NMD3 (hNMD3),503,"57,603",5 out of 5,2008-03-18,Evidence at protein level
Q14957,NMDE3_HUMAN,"Glutamate receptor ionotropic, NMDA 2C (GluN2C) (Glutamate [NMDA] receptor subunit epsilon-3) (N-methyl D-aspartate receptor subtype 2C) (NMDAR2C) (NR2C)",1233,"134,209",5 out of 5,1997-11-01,Evidence at protein level
Q9BZQ4,NMNA2_HUMAN,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 2 (NMN/NaMN adenylyltransferase 2) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide mononucleotide adenylyltransferase 2) (NMN adenylyltransferase 2) (Nicotinate-nucleotide adenylyltransferase 2) (NaMN adenylyltransferase 2),307,"34,439",5 out of 5,2003-05-09,Evidence at protein level
Q14978,NOLC1_HUMAN,Nucleolar and coiled-body phosphoprotein 1 (140 kDa nucleolar phosphoprotein) (Nopp140) (Hepatitis C virus NS5A-transactivated protein 13) (HCV NS5A-transactivated protein 13) (Nucleolar 130 kDa protein) (Nucleolar phosphoprotein p130),699,"73,603",5 out of 5,2000-12-01,Evidence at protein level
Q15155,NOMO1_HUMAN,Nodal modulator 1 (pM5 protein),1222,"134,324",4 out of 5,2001-01-11,Evidence at protein level
Q86UR1,NOXA1_HUMAN,NADPH oxidase activator 1 (NOX activator 1) (Antigen NY-CO-31) (NCF2-like protein) (P67phox-like factor) (p51-nox),476,"50,933",5 out of 5,2008-01-15,Evidence at protein level
Q99457,NP1L3_HUMAN,Nucleosome assembly protein 1-like 3,506,"57,593",2 out of 5,1997-11-01,Evidence at transcript level
Q6P499,NPAL3_HUMAN,NIPA-like protein 3,406,"44,742",3 out of 5,2006-06-27,Evidence at protein level
Q8IXF0,NPAS3_HUMAN,Neuronal PAS domain-containing protein 3 (Neuronal PAS3) (Basic-helix-loop-helix-PAS protein MOP6) (Class E basic helix-loop-helix protein 12) (bHLHe12) (Member of PAS protein 6) (PAS domain-containing protein 6),933,"100,805",5 out of 5,2003-11-28,Evidence at transcript level
Q9BY65,NPCR1_HUMAN,Nasopharyngeal carcinoma down-regulated gene protein 1 (NPCDRG) (Nasopharyngeal carcinoma-related gene protein),106,"11,990",1 out of 5,2008-07-22,Predicted
O15259,NPHP1_HUMAN,Nephrocystin-1 (Juvenile nephronophthisis 1 protein),732,"83,299",5 out of 5,2001-11-16,Evidence at protein level
Q9UND3,NPIA1_HUMAN,Nuclear pore complex-interacting protein family member A1 (Nuclear pore complex-interacting protein) (NPIP),350,"40,133",3 out of 5,2006-01-24,Evidence at transcript level
A8MRT5,NPIB5_HUMAN,Nuclear pore complex-interacting protein family member B5,1133,"126,459",2 out of 5,2008-09-02,Evidence at transcript level
A6NJ64,NPIL2_HUMAN,Putative NPIP-like protein LOC729978,397,"45,575",2 out of 5,2008-06-10,Uncertain
P20393,NR1D1_HUMAN,Nuclear receptor subfamily 1 group D member 1 (Rev-erbA-alpha) (V-erbA-related protein 1) (EAR-1),614,"66,805",5 out of 5,1991-02-01,Evidence at protein level
O75469,NR1I2_HUMAN,Nuclear receptor subfamily 1 group I member 2 (Orphan nuclear receptor PAR1) (Orphan nuclear receptor PXR) (Pregnane X receptor) (Steroid and xenobiotic receptor) (SXR),434,"49,762",5 out of 5,1999-07-15,Evidence at protein level
Q8N912,NRAC_HUMAN,Nutritionally-regulated adipose and cardiac enriched protein homolog,160,"18,051",2 out of 5,2008-03-18,Evidence at transcript level
P49281,NRAM2_HUMAN,Natural resistance-associated macrophage protein 2 (NRAMP 2) (Divalent cation transporter 1) (Divalent metal transporter 1) (DMT-1) (Solute carrier family 11 member 2),568,"62,266",5 out of 5,1996-02-01,Evidence at protein level
P54845,NRL_HUMAN,Neural retina-specific leucine zipper protein (NRL),237,"25,940",5 out of 5,1996-10-01,Evidence at protein level
Q9GZP1,NRSN2_HUMAN,Neurensin-2,204,"21,983",3 out of 5,2002-11-08,Evidence at transcript level
Q9H0G5,NSRP1_HUMAN,Nuclear speckle splicing regulatory protein 1 (Coiled-coil domain-containing protein 55) (Nuclear speckle-related protein 70) (NSrp70),558,"66,390",5 out of 5,2006-06-27,Evidence at protein level
Q86YG4,NT5D4_HUMAN,5'-nucleotidase domain-containing protein 4,428,"48,951",2 out of 5,2008-07-22,Evidence at transcript level
P61970,NTF2_HUMAN,Nuclear transport factor 2 (NTF-2) (Placental protein 15) (PP15),127,"14,478",5 out of 5,2004-06-07,Evidence at protein level
O43678,NDUA2_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2 (Complex I-B8) (CI-B8) (NADH-ubiquinone oxidoreductase B8 subunit),99,"10,922",5 out of 5,1999-07-15,Evidence at protein level
Q9P0J0,NDUAD_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 (Cell death regulatory protein GRIM-19) (Complex I-B16.6) (CI-B16.6) (Gene associated with retinoic and interferon-induced mortality 19 protein) (GRIM-19) (Gene associated with retinoic and IFN-induced mortality 19 protein) (NADH-ubiquinone oxidoreductase B16.6 subunit),144,"16,698",5 out of 5,2002-03-27,Evidence at protein level
A1L188,NDUF8_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 8,74,"7,756",3 out of 5,2007-09-11,Evidence at protein level
P28331,NDUS1_HUMAN,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-75kD) (CI-75kD)",727,"79,468",5 out of 5,1992-12-01,Evidence at protein level
O75380,NDUS6_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial (Complex I-13kD-A) (CI-13kD-A) (NADH-ubiquinone oxidoreductase 13 kDa-A subunit)",124,"13,712",5 out of 5,1998-12-15,Evidence at protein level
Q8NC96,NECP1_HUMAN,Adaptin ear-binding coat-associated protein 1 (NECAP endocytosis-associated protein 1) (NECAP-1),275,"29,737",4 out of 5,2005-03-29,Evidence at protein level
Q8TAT5,NEIL3_HUMAN,Endonuclease 8-like 3 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase FPG2) (DNA glycosylase/AP lyase Neil3) (Endonuclease VIII-like 3) (Nei-like protein 3),605,"67,769",5 out of 5,2004-12-07,Evidence at protein level
Q96PY6,NEK1_HUMAN,Serine/threonine-protein kinase Nek1 (EC 2.7.11.1) (Never in mitosis A-related kinase 1) (NimA-related protein kinase 1) (Renal carcinoma antigen NY-REN-55),1258,"142,828",5 out of 5,2002-08-13,Evidence at protein level
P51957,NEK4_HUMAN,Serine/threonine-protein kinase Nek4 (EC 2.7.11.1) (Never in mitosis A-related kinase 4) (NimA-related protein kinase 4) (Serine/threonine-protein kinase 2) (Serine/threonine-protein kinase NRK2),841,"94,597",5 out of 5,1996-10-01,Evidence at protein level
Q96JN8,NEUL4_HUMAN,Neuralized-like protein 4,1562,"166,907",4 out of 5,2007-08-21,Evidence at protein level
P17677,NEUM_HUMAN,Neuromodulin (Axonal membrane protein GAP-43) (Growth-associated protein 43) (Neural phosphoprotein B-50) (pp46),238,"24,803",5 out of 5,1990-08-01,Evidence at protein level
Q9Y3R4,NEUR2_HUMAN,Sialidase-2 (EC 3.2.1.18) (Cytosolic sialidase) (N-acetyl-alpha-neuraminidase 2),380,"42,254",5 out of 5,2001-11-16,Evidence at protein level
P07197,NFM_HUMAN,Neurofilament medium polypeptide (NF-M) (160 kDa neurofilament protein) (Neurofilament 3) (Neurofilament triplet M protein),916,"102,472",5 out of 5,1988-04-01,Evidence at protein level
Q92886,NGN1_HUMAN,Neurogenin-1 (NGN-1) (Class A basic helix-loop-helix protein 6) (bHLHa6) (Neurogenic basic-helix-loop-helix protein) (Neurogenic differentiation factor 3) (NeuroD3),237,"25,718",5 out of 5,1998-12-15,Evidence at protein level
Q9NPE2,NGRN_HUMAN,Neugrin (Mesenchymal stem cell protein DSC92) (Neurite outgrowth-associated protein) (Spinal cord-derived protein FI58G),291,"32,408",4 out of 5,2007-07-10,Evidence at protein level
Q8NBF2,NHLC2_HUMAN,NHL repeat-containing protein 2,726,"79,444",3 out of 5,2008-01-15,Evidence at protein level
Q15270,NKX11_HUMAN,NK1 transcription factor-related protein 1 (Homeobox protein 153) (HPX-153) (Homeobox protein SAX-2) (NKX-1.1),411,"40,659",3 out of 5,2008-05-20,Evidence at transcript level
O95096,NKX22_HUMAN,Homeobox protein Nkx-2.2 (Homeobox protein NK-2 homolog B),273,"30,133",5 out of 5,1999-07-15,Evidence at transcript level
P59044,NLRP6_HUMAN,"NACHT, LRR and PYD domains-containing protein 6 (Angiotensin II/vasopressin receptor) (PYRIN-containing APAF1-like protein 5)",892,"98,768",5 out of 5,2002-10-19,Evidence at protein level
Q5H8A3,NMS_HUMAN,Neuromedin-S,153,"17,731",3 out of 5,2006-11-28,Evidence at transcript level
Q76FK4,NOL8_HUMAN,Nucleolar protein 8 (Nucleolar protein Nop132),1167,"131,616",5 out of 5,2006-06-13,Evidence at protein level
Q8IVI9,NOSTN_HUMAN,Nostrin (BM247 homolog) (Nitric oxide synthase traffic inducer) (Nitric oxide synthase trafficker) (eNOS-trafficking inducer),506,"57,660",5 out of 5,2007-05-29,Evidence at protein level
Q96NT1,NP1L5_HUMAN,Nucleosome assembly protein 1-like 5 (Down-regulated in liver malignancy),182,"19,593",2 out of 5,2008-02-05,Evidence at protein level
P61582,NP7_HUMAN,Endogenous retrovirus group K member 7 Np9 protein (HERV-K(III) Np9 protein) (HERV-K102 Np9 protein) (HERV-K_1q22 provirus Np9 protein),75,"8,820",2 out of 5,2004-05-24,Inferred from homology
Q14207,NPAT_HUMAN,Protein NPAT (Nuclear protein of the ataxia telangiectasia mutated locus) (Nuclear protein of the ATM locus) (p220),1427,"154,290",5 out of 5,2008-02-05,Evidence at protein level
E9PIF3,NPIA2_HUMAN,Nuclear pore complex-interacting protein family member A2,369,"42,223",2 out of 5,2013-10-16,Inferred from homology
C9JG80,NPIB4_HUMAN,Nuclear pore complex-interacting protein family member B4,1138,"126,699",2 out of 5,2013-10-16,Inferred from homology
E9PQR5,NPIB8_HUMAN,Nuclear pore complex-interacting protein family member B8,432,"49,617",2 out of 5,2013-10-16,Inferred from homology
Q14995,NR1D2_HUMAN,Nuclear receptor subfamily 1 group D member 2 (Orphan nuclear hormone receptor BD73) (Rev-erb alpha-related receptor) (RVR) (Rev-erb-beta) (V-erbA-related protein 1-related) (EAR-1R),579,"64,625",5 out of 5,1999-07-15,Evidence at protein level
P43354,NR4A2_HUMAN,Nuclear receptor subfamily 4 group A member 2 (Immediate-early response protein NOT) (Orphan nuclear receptor NURR1) (Transcriptionally-inducible nuclear receptor),598,"66,591",5 out of 5,1995-11-01,Evidence at protein level
Q9BQI9,NRIP2_HUMAN,Nuclear receptor-interacting protein 2,281,"31,331",3 out of 5,2007-01-09,Evidence at protein level
Q9ULB1,NRX1A_HUMAN,Neurexin-1 (Neurexin I-alpha) (Neurexin-1-alpha),1477,"161,883",5 out of 5,2001-11-16,Evidence at transcript level
O95139,NDUB6_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6 (Complex I-B17) (CI-B17) (NADH-ubiquinone oxidoreductase B17 subunit),128,"15,489",5 out of 5,1999-07-15,Evidence at protein level
O43920,NDUS5_HUMAN,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 (Complex I-15 kDa) (CI-15 kDa) (NADH-ubiquinone oxidoreductase 15 kDa subunit),106,"12,518",5 out of 5,1998-12-15,Evidence at protein level
O75251,NDUS7_HUMAN,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (Complex I-20kD) (CI-20kD) (NADH-ubiquinone oxidoreductase 20 kDa subunit) (PSST subunit)",213,"23,564",5 out of 5,1999-07-15,Evidence at protein level
Q8NG66,NEK11_HUMAN,Serine/threonine-protein kinase Nek11 (EC 2.7.11.1) (Never in mitosis A-related kinase 11) (NimA-related protein kinase 11),645,"74,192",5 out of 5,2005-09-13,Evidence at protein level
Q6P3R8,NEK5_HUMAN,Serine/threonine-protein kinase Nek5 (EC 2.7.11.1) (Never in mitosis A-related kinase 5) (NimA-related protein kinase 5),708,"81,445",3 out of 5,2006-11-28,Evidence at transcript level
Q86SG6,NEK8_HUMAN,Serine/threonine-protein kinase Nek8 (EC 2.7.11.1) (Never in mitosis A-related kinase 8) (NimA-related protein kinase 8) (Nima-related protein kinase 12a),692,"74,806",5 out of 5,2003-08-15,Evidence at protein level
O60524,NEMF_HUMAN,Nuclear export mediator factor NEMF (Antigen NY-CO-1) (Serologically defined colon cancer antigen 1),1076,"122,954",5 out of 5,2003-09-26,Evidence at protein level
Q9Y6K9,NEMO_HUMAN,NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier),419,"48,198",5 out of 5,2000-05-30,Evidence at protein level
Q99574,NEUS_HUMAN,Neuroserpin (Peptidase inhibitor 12) (PI-12) (Serpin I1),410,"46,427",5 out of 5,1998-07-15,Evidence at protein level
Q14494,NF2L1_HUMAN,"Nuclear factor erythroid 2-related factor 1 (NF-E2-related factor 1) (NFE2-related factor 1) (Locus control region-factor 1) (Nuclear factor, erythroid derived 2, like 1) (Transcription factor 11) (TCF-11) (Transcription factor HBZ17) (Transcription factor LCR-F1)",772,"84,704",5 out of 5,1998-07-15,Evidence at protein level
Q16649,NFIL3_HUMAN,Nuclear factor interleukin-3-regulated protein (E4 promoter-binding protein 4) (Interleukin-3 promoter transcriptional activator) (Interleukin-3-binding protein 1) (Transcriptional activator NF-IL3A),462,"51,472",5 out of 5,2007-06-26,Evidence at protein level
Q14938,NFIX_HUMAN,Nuclear factor 1 X-type (NF1-X) (Nuclear factor 1/X) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/X) (NF-I/X) (NFI-X) (TGGCA-binding protein),502,"55,098",5 out of 5,1997-11-01,Evidence at protein level
Q92982,NINJ1_HUMAN,Ninjurin-1 (Nerve injury-induced protein 1),152,"16,345",4 out of 5,2000-05-30,Evidence at protein level
Q86WB0,NIPA_HUMAN,Nuclear-interacting partner of ALK (Nuclear-interacting partner of anaplastic lymphoma kinase) (hNIPA) (Zinc finger C3HC-type protein 1),502,"55,262",5 out of 5,2005-08-30,Evidence at protein level
Q5VXU1,NKAI2_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 2 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 2) (Protein FAM77B) (T-cell lymphoma breakpoint-associated target protein 1),208,"23,831",4 out of 5,2006-12-12,Evidence at transcript level
Q96P20,NLRP3_HUMAN,"NACHT, LRR and PYD domains-containing protein 3 (Angiotensin/vasopressin receptor AII/AVP-like) (Caterpiller protein 1.1) (CLR1.1) (Cold-induced autoinflammatory syndrome 1 protein) (Cryopyrin) (PYRIN-containing APAF1-like protein 1)",1036,"118,173",5 out of 5,2002-05-02,Evidence at protein level
P29475,NOS1_HUMAN,"Nitric oxide synthase, brain (EC 1.14.13.39) (Constitutive NOS) (NC-NOS) (NOS type I) (Neuronal NOS) (N-NOS) (nNOS) (Peptidyl-cysteine S-nitrosylase NOS1) (bNOS)",1434,"160,970",5 out of 5,1993-04-01,Evidence at protein level
Q9UM47,NOTC3_HUMAN,Neurogenic locus notch homolog protein 3 (Notch 3) [Cleaved into: Notch 3 extracellular truncation; Notch 3 intracellular domain],2321,"243,631",5 out of 5,2002-03-27,Evidence at protein level
Q99466,NOTC4_HUMAN,Neurogenic locus notch homolog protein 4 (Notch 4) (hNotch4) [Cleaved into: Notch 4 extracellular truncation; Notch 4 intracellular domain],2003,"209,622",5 out of 5,2002-03-27,Evidence at protein level
A8MTQ0,NOTO_HUMAN,Homeobox protein notochord,251,"27,003",3 out of 5,2008-07-01,Evidence at transcript level
A6NFF2,NP1L6_HUMAN,Putative nucleosome assembly protein 1-like 6,107,"12,045",2 out of 5,2008-02-05,Uncertain
P61583,NP5_HUMAN,Endogenous retrovirus group K member 5 Np9 protein (Endogenous retrovirus K protein 5) (HERV-K(II) Np9 protein) (HERV-K_3q12.3 provirus Np9 protein),75,"8,907",2 out of 5,2004-05-24,Inferred from homology
Q99742,NPAS1_HUMAN,Neuronal PAS domain-containing protein 1 (Neuronal PAS1) (Basic-helix-loop-helix-PAS protein MOP5) (Class E basic helix-loop-helix protein 11) (bHLHe11) (Member of PAS protein 5) (PAS domain-containing protein 5),590,"62,702",4 out of 5,1998-12-15,Evidence at transcript level
Q8IUM7,NPAS4_HUMAN,Neuronal PAS domain-containing protein 4 (Neuronal PAS4) (Class E basic helix-loop-helix protein 79) (bHLHe79) (HLH-PAS transcription factor NXF) (PAS domain-containing protein 10),802,"87,117",5 out of 5,2006-09-05,Evidence at protein level
E5RHQ5,NPB11_HUMAN,Nuclear pore complex-interacting protein family member B11,1161,"129,208",2 out of 5,2013-10-16,Inferred from homology
P48145,NPBW1_HUMAN,Neuropeptides B/W receptor type 1 (G-protein coupled receptor 7),328,"36,103",5 out of 5,1996-02-01,Evidence at protein level
P61916,NPC2_HUMAN,Epididymal secretory protein E1 (Human epididymis-specific protein 1) (He1) (Niemann-Pick disease type C2 protein),151,"16,570",5 out of 5,2004-06-07,Evidence at protein level
O60500,NPHN_HUMAN,Nephrin (Renal glomerulus-specific cell adhesion receptor),1241,"134,742",5 out of 5,2002-04-16,Evidence at protein level
F8WFD2,NPIA3_HUMAN,Nuclear pore complex-interacting protein family member A3,350,"40,061",2 out of 5,2013-10-16,Inferred from homology
O75200,NPIB7_HUMAN,Nuclear pore complex-interacting protein family member B7 (Nuclear pore complex-interacting protein-like 1),414,"47,714",2 out of 5,2008-03-18,Inferred from homology
A6NJU9,NPIL5_HUMAN,Putative NPIP-like protein LOC613037,1138,"125,964",2 out of 5,2008-07-22,Uncertain
P0C0P6,NPS_HUMAN,Neuropeptide S,89,"10,103",3 out of 5,2005-11-22,Inferred from homology
O95502,NPTXR_HUMAN,Neuronal pentraxin receptor,500,"52,846",3 out of 5,2001-08-29,Inferred from homology
Q9HCQ7,NPVF_HUMAN,Pro-FMRFamide-related neuropeptide VF [Cleaved into: Neuropeptide NPSF; Neuropeptide RFRP-1; Neuropeptide RFRP-2; Neuropeptide NPVF (Neuropeptide RFRP-3)],196,"22,309",5 out of 5,2002-10-10,Evidence at protein level
P15559,NQO1_HUMAN,NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1),274,"30,868",5 out of 5,1990-04-01,Evidence at protein level
Q14994,NR1I3_HUMAN,Nuclear receptor subfamily 1 group I member 3 (Constitutive activator of retinoid response) (Constitutive active response) (Constitutive androstane receptor) (CAR) (Orphan nuclear receptor MB67),352,"39,942",5 out of 5,1999-07-15,Evidence at protein level
Q15406,NR6A1_HUMAN,Nuclear receptor subfamily 6 group A member 1 (Germ cell nuclear factor) (GCNF) (hGCNF) (Retinoid receptor-related testis-specific receptor) (RTR) (hRTR),480,"54,383",5 out of 5,2000-12-01,Evidence at protein level
Q7Z6K4,NRARP_HUMAN,Notch-regulated ankyrin repeat-containing protein,114,"12,492",4 out of 5,2008-03-18,Evidence at transcript level
Q9UHY1,NRBP_HUMAN,Nuclear receptor-binding protein,535,"59,845",5 out of 5,2006-01-10,Evidence at protein level
Q92823,NRCAM_HUMAN,Neuronal cell adhesion molecule (Nr-CAM) (Neuronal surface protein Bravo) (hBravo) (NgCAM-related cell adhesion molecule) (Ng-CAM-related),1304,"143,890",5 out of 5,2003-07-19,Evidence at protein level
Q9UGV2,NDRG3_HUMAN,Protein NDRG3 (N-myc downstream-regulated gene 3 protein),375,"41,409",3 out of 5,2000-12-01,Evidence at protein level
P52849,NDST2_HUMAN,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 2) (NDST-2) (N-heparan sulfate sulfotransferase 2) (N-HSST 2) [Includes: Heparan sulfate N-deacetylase 2 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 2 (EC 2.8.2.-)],883,"100,875",5 out of 5,1996-10-01,Evidence at protein level
P56556,NDUA6_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 (Complex I-B14) (CI-B14) (LYR motif-containing protein 6) (NADH-ubiquinone oxidoreductase B14 subunit),154,"17,871",5 out of 5,1998-07-15,Evidence at protein level
O43676,NDUB3_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 (Complex I-B12) (CI-B12) (NADH-ubiquinone oxidoreductase B12 subunit),98,"11,402",4 out of 5,1999-07-15,Evidence at protein level
Q9Y6M9,NDUB9_HUMAN,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9 (Complex I-B22) (CI-B22) (LYR motif-containing protein 3) (NADH-ubiquinone oxidoreductase B22 subunit),179,"21,831",5 out of 5,2000-05-30,Evidence at protein level
O43677,NDUC1_HUMAN,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial (Complex I-KFYI) (CI-KFYI) (NADH-ubiquinone oxidoreductase KFYI subunit)",76,"8,734",4 out of 5,1999-07-15,Inferred from homology
O95298,NDUC2_HUMAN,NADH dehydrogenase [ubiquinone] 1 subunit C2 (Complex I-B14.5b) (CI-B14.5b) (Human lung cancer oncogene 1 protein) (HLC-1) (NADH-ubiquinone oxidoreductase subunit B14.5b),119,"14,188",5 out of 5,1999-07-15,Evidence at protein level
Q5TEU4,NDUF5_HUMAN,"Arginine-hydroxylase NDUFAF5, mitochondrial (EC 1.-.-.-) (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 5) (Putative methyltransferase NDUFAF5) (EC 2.1.1.-)",345,"38,918",5 out of 5,2007-10-23,Evidence at protein level
Q8N9A8,NEPR1_HUMAN,Nuclear envelope phosphatase-regulatory subunit 1 (NEP1-R1) (Transmembrane protein 188),125,"14,267",5 out of 5,2007-05-15,Evidence at protein level
O76050,NEUL1_HUMAN,E3 ubiquitin-protein ligase NEURL1 (EC 2.3.2.27) (Neuralized-like protein 1A) (h-neu) (h-neuralized 1) (RING finger protein 67) (RING-type E3 ubiquitin transferase NEURL1),574,"61,860",5 out of 5,2005-03-15,Evidence at transcript level
Q0ZGT2,NEXN_HUMAN,Nexilin (F-actin-binding protein) (Nelin),675,"80,658",5 out of 5,2007-09-11,Evidence at protein level
P21359,NF1_HUMAN,Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated],2839,"319,372",5 out of 5,1991-05-01,Evidence at protein level
Q86UQ8,NFE4_HUMAN,Transcription factor NF-E4,179,"19,019",4 out of 5,2008-09-23,Evidence at protein level
Q12857,NFIA_HUMAN,Nuclear factor 1 A-type (NF1-A) (Nuclear factor 1/A) (CCAAT-box-binding transcription factor) (CTF) (Nuclear factor I/A) (NF-I/A) (NFI-A) (TGGCA-binding protein),509,"55,944",5 out of 5,2001-06-01,Evidence at protein level
P07196,NFL_HUMAN,Neurofilament light polypeptide (NF-L) (68 kDa neurofilament protein) (Neurofilament triplet L protein),543,"61,517",5 out of 5,1988-04-01,Evidence at protein level
P80188,NGAL_HUMAN,Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin LCN2) (p25),198,"22,588",5 out of 5,1993-04-01,Evidence at protein level
Q9NPG2,NGB_HUMAN,Neuroglobin,151,"16,933",5 out of 5,2003-06-20,Evidence at protein level
Q8NEJ9,NGDN_HUMAN,Neuroguidin (Centromere accumulated nuclear protein 1) (CANu1) (EIF4E-binding protein),315,"35,894",5 out of 5,2004-04-13,Evidence at protein level
Q9H2A3,NGN2_HUMAN,Neurogenin-2 (NGN-2) (Class A basic helix-loop-helix protein 8) (bHLHa8) (Protein atonal homolog 4),272,"28,621",3 out of 5,2002-03-27,Evidence at transcript level
O14745,NHRF1_HUMAN,Na(+)/H(+) exchange regulatory cofactor NHE-RF1 (NHERF-1) (Ezrin-radixin-moesin-binding phosphoprotein 50) (EBP50) (Regulatory cofactor of Na(+)/H(+) exchanger) (Sodium-hydrogen exchanger regulatory factor 1) (Solute carrier family 9 isoform A3 regulatory factor 1),358,"38,868",5 out of 5,2004-02-02,Evidence at protein level
Q9NZG7,NINJ2_HUMAN,Ninjurin-2 (Nerve injury-induced protein 2),142,"15,680",4 out of 5,2001-09-26,Evidence at protein level
Q0D2K0,NIPA4_HUMAN,Magnesium transporter NIPA4 (Ichthyin) (NIPA-like protein 4) (Non-imprinted in Prader-Willi/Angelman syndrome region protein 4),466,"50,058",5 out of 5,2007-04-17,Evidence at protein level
Q86X76,NIT1_HUMAN,Nitrilase homolog 1 (EC 3.5.-.-),327,"35,896",4 out of 5,2004-07-05,Evidence at protein level
Q17RQ9,NKPD1_HUMAN,NTPase KAP family P-loop domain-containing protein 1,610,"67,780",2 out of 5,2007-07-10,Evidence at transcript level
O15226,NKRF_HUMAN,NF-kappa-B-repressing factor (NFkB-repressing factor) (Protein ITBA4) (Transcription factor NRF),690,"77,673",5 out of 5,1998-07-15,Evidence at protein level
Q9UD57,NKX12_HUMAN,NK1 transcription factor-related protein 2 (Homeobox protein SAX-1) (NKX-1.1),310,"32,381",3 out of 5,2008-03-18,Evidence at transcript level
P43699,NKX21_HUMAN,Homeobox protein Nkx-2.1 (Homeobox protein NK-2 homolog A) (Thyroid nuclear factor 1) (Thyroid transcription factor 1) (TTF-1) (Thyroid-specific enhancer-binding protein) (T/EBP),371,"38,596",5 out of 5,1995-11-01,Evidence at protein level
A6NCS4,NKX26_HUMAN,Homeobox protein Nkx-2.6 (Homeobox protein NK-2 homolog F),301,"32,121",5 out of 5,2007-09-11,Evidence at protein level
Q99801,NKX31_HUMAN,Homeobox protein Nkx-3.1 (Homeobox protein NK-3 homolog A),234,"26,350",5 out of 5,1998-07-15,Evidence at protein level
Q8NFZ3,NLGNY_HUMAN,"Neuroligin-4, Y-linked (Neuroligin Y)",816,"92,021",5 out of 5,2003-05-23,Evidence at transcript level
Q8NA29,NLS1_HUMAN,Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A),543,"60,170",5 out of 5,2007-01-23,Evidence at protein level
Q9C002,NMES1_HUMAN,Normal mucosa of esophagus-specific gene 1 protein (Protein FOAP-11),83,"9,617",2 out of 5,2002-09-19,Evidence at transcript level
Q9GZQ4,NMUR2_HUMAN,Neuromedin-U receptor 2 (NMU-R2) (G-protein coupled receptor FM-4) (G-protein coupled receptor TGR-1),415,"47,696",5 out of 5,2005-12-06,Evidence at protein level
Q9NP64,NO40_HUMAN,Nucleolar protein of 40 kDa (pNO40) (Pnn-interacting nucleolar protein) (Putative S1 RNA-binding domain protein) (PS1D protein) (Zinc finger CCHC domain-containing protein 17),241,"27,570",4 out of 5,2005-08-30,Evidence at protein level
O95897,NOE2_HUMAN,Noelin-2 (Olfactomedin-2),454,"51,386",5 out of 5,2001-02-21,Evidence at protein level
Q9NPH5,NOX4_HUMAN,NADPH oxidase 4 (EC 1.6.3.-) (Kidney oxidase-1) (KOX-1) (Kidney superoxide-producing NADPH oxidase) (Renal NAD(P)H-oxidase),578,"66,932",5 out of 5,2006-05-30,Evidence at protein level
Q99733,NP1L4_HUMAN,Nucleosome assembly protein 1-like 4 (Nucleosome assembly protein 2) (NAP-2),375,"42,823",4 out of 5,1997-11-01,Evidence at protein level
Q99743,NPAS2_HUMAN,Neuronal PAS domain-containing protein 2 (Neuronal PAS2) (Basic-helix-loop-helix-PAS protein MOP4) (Class E basic helix-loop-helix protein 9) (bHLHe9) (Member of PAS protein 4) (PAS domain-containing protein 4),824,"91,791",5 out of 5,1998-12-15,Evidence at protein level
Q4G0N4,NAKD2_HUMAN,"NAD kinase 2, mitochondrial (EC 2.7.1.23) (Mitochondrial NAD kinase) (NAD kinase domain-containing protein 1, mitochondrial)",442,"49,433",5 out of 5,2007-07-24,Evidence at protein level
P59045,NAL11_HUMAN,"NACHT, LRR and PYD domains-containing protein 11 (Nucleotide-binding oligomerization domain protein 17) (PAAD-and NACHT domain-containing protein 10) (PYRIN-containing APAF1-like protein 6)",1033,"117,779",4 out of 5,2002-10-19,Evidence at transcript level
Q9Y3Q0,NALD2_HUMAN,N-acetylated-alpha-linked acidic dipeptidase 2 (EC 3.4.17.21) (Glutamate carboxypeptidase III) (GCPIII) (N-acetylated-alpha-linked acidic dipeptidase II) (NAALADase II),740,"83,592",5 out of 5,2002-02-11,Evidence at protein level
Q9NX02,NALP2_HUMAN,"NACHT, LRR and PYD domains-containing protein 2 (Nucleotide-binding site protein 1) (PYRIN domain and NACHT domain-containing protein 1) (PYRIN-containing APAF1-like protein 2)",1062,"120,515",5 out of 5,2001-10-18,Evidence at protein level
P0DI83,NARR_HUMAN,"Ras-related protein Rab-34, isoform NARR (Nine amino-acid residue-repeats)",198,"21,118",4 out of 5,2011-09-21,Evidence at protein level
P49321,NASP_HUMAN,Nuclear autoantigenic sperm protein (NASP),788,"85,238",5 out of 5,1996-02-01,Evidence at protein level
Q9UHE5,NAT8_HUMAN,N-acetyltransferase 8 (EC 2.3.1.-) (Acetyltransferase 2) (ATase2) (Camello-like protein 1) (Cysteinyl-conjugate N-acetyltransferase) (CCNAT) (EC 2.3.1.80),227,"25,619",5 out of 5,2007-04-17,Evidence at protein level
Q8IVL0,NAV3_HUMAN,Neuron navigator 3 (Pore membrane and/or filament-interacting-like protein 1) (Steerin-3) (Unc-53 homolog 3) (unc53H3),2385,"255,648",5 out of 5,2007-05-15,Evidence at protein level
Q6ZUF6,NC336_HUMAN,Putative uncharacterized protein encoded by LINC00336,198,"20,903",2 out of 5,2008-09-02,Uncertain
A8MVU1,NCF1C_HUMAN,Putative neutrophil cytosol factor 1C (NCF-1C) (Putative SH3 and PX domain-containing protein 1C),366,"41,851",3 out of 5,2008-09-02,Uncertain
Q8NFF2,NCKX4_HUMAN,Sodium/potassium/calcium exchanger 4 (Na(+)/K(+)/Ca(2+)-exchange protein 4) (Solute carrier family 24 member 4),622,"69,042",5 out of 5,2003-09-26,Evidence at protein level
Q9Y6Q9,NCOA3_HUMAN,Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1),1424,"155,293",5 out of 5,2002-09-19,Evidence at protein level
O95803,NDST3_HUMAN,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 3) (NDST-3) (hNDST-3) (N-heparan sulfate sulfotransferase 3) (N-HSST 3) [Includes: Heparan sulfate N-deacetylase 3 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 3 (EC 2.8.2.-)],873,"100,902",5 out of 5,2006-03-07,Evidence at transcript level
P19404,NDUV2_HUMAN,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial (EC 1.6.5.3) (EC 1.6.99.3) (NADH-ubiquinone oxidoreductase 24 kDa subunit)",249,"27,392",5 out of 5,1990-11-01,Evidence at protein level
Q9Y697,NFS1_HUMAN,"Cysteine desulfurase, mitochondrial (EC 2.8.1.7)",457,"50,196",5 out of 5,2001-04-27,Evidence at protein level
Q15599,NHRF2_HUMAN,Na(+)/H(+) exchange regulatory cofactor NHE-RF2 (NHERF-2) (NHE3 kinase A regulatory protein E3KARP) (SRY-interacting protein 1) (SIP-1) (Sodium-hydrogen exchanger regulatory factor 2) (Solute carrier family 9 isoform A3 regulatory factor 2) (Tyrosine kinase activator protein 1) (TKA-1),337,"37,414",5 out of 5,2004-02-16,Evidence at protein level
Q5HYW2,NHSL2_HUMAN,NHS-like protein 2,709,"76,301",2 out of 5,2008-06-10,Evidence at protein level
Q96TA1,NIBL1_HUMAN,Niban-like protein 1 (Meg-3) (Melanoma invasion by ERK) (MINERVA) (Protein FAM129B),746,"84,138",5 out of 5,2002-08-13,Evidence at protein level
P28336,NMBR_HUMAN,Neuromedin-B receptor (NMB-R) (Epididymis tissue protein Li 185a) (Neuromedin-B-preferring bombesin receptor),390,"43,435",5 out of 5,1992-12-01,Evidence at protein level
Q12879,NMDE1_HUMAN,"Glutamate receptor ionotropic, NMDA 2A (GluN2A) (Glutamate [NMDA] receptor subunit epsilon-1) (N-methyl D-aspartate receptor subtype 2A) (NMDAR2A) (NR2A) (hNR2A)",1464,"165,283",5 out of 5,2001-06-01,Evidence at protein level
Q13287,NMI_HUMAN,N-myc-interactor (Nmi) (N-myc and STAT interactor),307,"35,057",5 out of 5,2001-08-14,Evidence at protein level
Q9HAN9,NMNA1_HUMAN,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1 (NMN/NaMN adenylyltransferase 1) (EC 2.7.7.1) (EC 2.7.7.18) (Nicotinamide-nucleotide adenylyltransferase 1) (NMN adenylyltransferase 1) (Nicotinate-nucleotide adenylyltransferase 1) (NaMN adenylyltransferase 1),279,"31,932",5 out of 5,2003-05-09,Evidence at protein level
Q16517,NNAT_HUMAN,Neuronatin,81,"9,237",3 out of 5,1997-11-01,Evidence at transcript level
Q9UK39,NOCT_HUMAN,Nocturnin (EC 3.1.13.4) (Carbon catabolite repression 4-like protein) (Circadian deadenylase NOC),431,"48,196",5 out of 5,2001-11-02,Evidence at transcript level
Q9Y239,NOD1_HUMAN,Nucleotide-binding oligomerization domain-containing protein 1 (Caspase recruitment domain-containing protein 4),953,"107,691",5 out of 5,2002-01-31,Evidence at protein level
Q15233,NONO_HUMAN,"Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (55 kDa nuclear protein) (DNA-binding p52/p100 complex, 52 kDa subunit) (NMT55) (p54(nrb)) (p54nrb)",471,"54,232",5 out of 5,1998-07-15,Evidence at protein level
Q00604,NDP_HUMAN,Norrin (Norrie disease protein) (X-linked exudative vitreoretinopathy 2 protein),133,"15,044",5 out of 5,1994-06-01,Evidence at protein level
Q9UN36,NDRG2_HUMAN,Protein NDRG2 (N-myc downstream-regulated gene 2 protein) (Protein Syld709613),371,"40,798",5 out of 5,2000-12-01,Evidence at protein level
Q9H3R1,NDST4_HUMAN,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 (EC 2.8.2.8) (Glucosaminyl N-deacetylase/N-sulfotransferase 4) (NDST-4) (N-heparan sulfate sulfotransferase 4) (N-HSST 4) [Includes: Heparan sulfate N-deacetylase 4 (EC 3.-.-.-); Heparan sulfate N-sulfotransferase 4 (EC 2.8.2.-)],872,"100,716",5 out of 5,2006-03-07,Evidence at transcript level
P16519,NEC2_HUMAN,Neuroendocrine convertase 2 (NEC 2) (EC 3.4.21.94) (KEX2-like endoprotease 2) (Prohormone convertase 2) (Proprotein convertase 2) (PC2),638,"70,565",5 out of 5,1990-08-01,Evidence at transcript level
Q9NQS3,NECT3_HUMAN,Nectin-3 (CDw113) (Nectin cell adhesion molecule 3) (Poliovirus receptor-related protein 3) (CD antigen CD113),549,"61,002",5 out of 5,2006-03-07,Evidence at protein level
Q8NHV4,NEDD1_HUMAN,Protein NEDD1 (Neural precursor cell expressed developmentally down-regulated protein 1) (NEDD-1),660,"71,966",5 out of 5,2005-11-22,Evidence at protein level
P46934,NEDD4_HUMAN,E3 ubiquitin-protein ligase NEDD4 (EC 2.3.2.26) (Cell proliferation-inducing gene 53 protein) (HECT-type E3 ubiquitin transferase NEDD4) (Neural precursor cell expressed developmentally down-regulated protein 4) (NEDD-4),1319,"149,114",5 out of 5,1995-11-01,Evidence at protein level
Q96FI4,NEIL1_HUMAN,Endonuclease 8-like 1 (EC 3.2.2.-) (EC 4.2.99.18) (DNA glycosylase/AP lyase Neil1) (DNA-(apurinic or apyrimidinic site) lyase Neil1) (Endonuclease VIII-like 1) (FPG1) (Nei homolog 1) (NEH1) (Nei-like protein 1),390,"43,684",5 out of 5,2004-12-07,Evidence at protein level
Q99435,NELL2_HUMAN,Protein kinase C-binding protein NELL2 (NEL-like protein 2) (Nel-related protein 2),816,"91,346",4 out of 5,1997-11-01,Evidence at protein level
Q9UMX5,NENF_HUMAN,Neudesin (Cell immortalization-related protein 2) (Neuron-derived neurotrophic factor) (Protein GIG47) (Secreted protein of unknown function) (SPUF protein),172,"18,856",4 out of 5,2004-04-26,Evidence at protein level
Q6NW34,NEPRO_HUMAN,Nucleolus and neural progenitor protein,567,"64,552",3 out of 5,2006-03-07,Evidence at protein level
P08473,NEP_HUMAN,Neprilysin (EC 3.4.24.11) (Atriopeptidase) (Common acute lymphocytic leukemia antigen) (CALLA) (Enkephalinase) (Neutral endopeptidase 24.11) (NEP) (Neutral endopeptidase) (Skin fibroblast elastase) (SFE) (CD antigen CD10),750,"85,514",5 out of 5,1988-08-01,Evidence at protein level
Q8WWR8,NEUR4_HUMAN,Sialidase-4 (EC 3.2.1.18) (N-acetyl-alpha-neuraminidase 4),484,"51,572",5 out of 5,2004-06-07,Evidence at protein level
P23511,NFYA_HUMAN,Nuclear transcription factor Y subunit alpha (CAAT box DNA-binding protein subunit A) (Nuclear transcription factor Y subunit A) (NF-YA),347,"36,877",5 out of 5,1991-11-01,Evidence at protein level
P01138,NGF_HUMAN,Beta-nerve growth factor (Beta-NGF),241,"26,959",5 out of 5,1986-07-21,Evidence at protein level
Q9Y4Z2,NGN3_HUMAN,Neurogenin-3 (NGN-3) (Class A basic helix-loop-helix protein 7) (bHLHa7) (Protein atonal homolog 5),214,"23,077",5 out of 5,2002-03-27,Evidence at protein level
Q8N4C6,NIN_HUMAN,Ninein (hNinein) (Glycogen synthase kinase 3 beta-interacting protein) (GSK3B-interacting protein),2090,"243,249",5 out of 5,2004-07-19,Evidence at protein level
Q6KC79,NIPBL_HUMAN,Nipped-B-like protein (Delangin) (SCC2 homolog),2804,"316,051",5 out of 5,2004-07-19,Evidence at protein level
A6NJ46,NKX63_HUMAN,Homeobox protein Nkx-6.3,265,"28,948",2 out of 5,2007-11-13,Evidence at transcript level
Q9HC29,NOD2_HUMAN,Nucleotide-binding oligomerization domain-containing protein 2 (Caspase recruitment domain-containing protein 15) (Inflammatory bowel disease protein 1),1040,"115,283",5 out of 5,2002-01-31,Evidence at protein level
O94818,NOL4_HUMAN,Nucleolar protein 4 (Nucleolar-localized protein),638,"71,357",4 out of 5,2004-04-26,Evidence at protein level
Q9UMY1,NOL7_HUMAN,Nucleolar protein 7 (Nucleolar protein of 27 kDa),257,"29,426",4 out of 5,2005-07-19,Evidence at protein level
Q5SY16,NOL9_HUMAN,Polynucleotide 5'-hydroxyl-kinase NOL9 (EC 2.7.1.-) (Nucleolar protein 9),702,"79,323",5 out of 5,2005-08-30,Evidence at protein level
P46531,NOTC1_HUMAN,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],2555,"272,505",5 out of 5,1995-11-01,Evidence at protein level
Q9UNW9,NOVA2_HUMAN,RNA-binding protein Nova-2 (Astrocytic NOVA1-like RNA-binding protein) (Neuro-oncological ventral antigen 2),492,"49,009",3 out of 5,2003-08-04,Evidence at protein level
A6NHN6,NPB15_HUMAN,Nuclear pore complex-interacting protein family member B15 (Nuclear pore complex-interacting protein-like 2),443,"51,267",2 out of 5,2009-03-24,Inferred from homology
Q8NG41,NPB_HUMAN,Neuropeptide B (Preproprotein L7) (hPPL7) [Cleaved into: Neuropeptide B-23 (NPB23) (hL7); Neuropeptide B-29 (NPB29) (hL7C)],125,"13,097",3 out of 5,2003-07-25,Evidence at protein level
O15118,NPC1_HUMAN,Niemann-Pick C1 protein,1278,"142,167",5 out of 5,2000-05-30,Evidence at protein level
O15130,NPFF_HUMAN,Pro-FMRFamide-related neuropeptide FF (FMRFamide-related peptides) [Cleaved into: Neuropeptide SF (NPSF); Neuropeptide FF (NPFF); Neuropeptide AF (NPAF)],113,"12,440",5 out of 5,2000-05-30,Inferred from homology
Q92617,NPIB3_HUMAN,Nuclear pore complex-interacting protein family member B3 (Nuclear pore complex-interacting protein-like 3) (Protein pps22-1),1050,"116,847",3 out of 5,2001-02-21,Evidence at transcript level
Q9NX14,NDUBB_HUMAN,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 11, mitochondrial (Complex I-ESSS) (CI-ESSS) (NADH-ubiquinone oxidoreductase ESSS subunit) (Neuronal protein 17.3) (Np17.3) (p17.3)",153,"17,317",5 out of 5,2003-07-03,Evidence at protein level
A6NFY4,NEMP2_HUMAN,Nuclear envelope integral membrane protein 2,417,"48,664",2 out of 5,2008-04-29,Evidence at transcript level
Q92859,NEO1_HUMAN,Neogenin (Immunoglobulin superfamily DCC subclass member 2),1461,"160,017",5 out of 5,2000-12-01,Evidence at protein level
Q92979,NEP1_HUMAN,Ribosomal RNA small subunit methyltransferase NEP1 (EC 2.1.1.-) (18S rRNA (pseudouridine(1248)-N1)-methyltransferase) (18S rRNA Psi1248 methyltransferase) (Nucleolar protein EMG1 homolog) (Protein C2f) (Ribosome biogenesis protein NEP1),244,"26,720",5 out of 5,2002-05-10,Evidence at protein level
O95631,NET1_HUMAN,Netrin-1 (Epididymis tissue protein Li 131P),604,"67,748",5 out of 5,2002-11-15,Evidence at protein level
Q92686,NEUG_HUMAN,Neurogranin (Ng) (RC3) [Cleaved into: NEUG(55-78)],78,"7,618",4 out of 5,1997-11-01,Evidence at protein level
Q9BR09,NEUL2_HUMAN,Neuralized-like protein 2,285,"31,690",3 out of 5,2003-07-25,Evidence at transcript level
P55769,NH2L1_HUMAN,"NHP2-like protein 1 (High mobility group-like nuclear protein 2 homolog 1) (OTK27) (SNU13 homolog) (hSNU13) (U4/U6.U5 small nuclear ribonucleoprotein SNU13) (U4/U6.U5 tri-snRNP 15.5 kDa protein) [Cleaved into: NHP2-like protein 1, N-terminally processed]",128,"14,174",5 out of 5,1997-11-01,Evidence at protein level
Q9H9Q4,NHEJ1_HUMAN,Non-homologous end-joining factor 1 (Protein cernunnos) (XRCC4-like factor),299,"33,337",5 out of 5,2006-03-21,Evidence at protein level
P0CG21,NHLC4_HUMAN,NHL-repeat-containing protein 4,123,"12,631",1 out of 5,2010-06-15,Evidence at transcript level
Q9GZT8,NIF3L_HUMAN,NIF3-like protein 1 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 1 protein),377,"41,968",5 out of 5,2002-05-15,Evidence at protein level
O75323,NIPS2_HUMAN,Protein NipSnap homolog 2 (NipSnap2) (Glioblastoma-amplified sequence),286,"33,743",4 out of 5,2001-09-26,Evidence at protein level
Q9Y2I1,NISCH_HUMAN,Nischarin (Imidazoline receptor 1) (I-1) (IR1) (Imidazoline receptor antisera-selected protein) (hIRAS) (Imidazoline-1 receptor) (I1R) (Imidazoline-1 receptor candidate protein) (I-1 receptor candidate protein) (I1R candidate protein),1504,"166,629",5 out of 5,2008-09-02,Evidence at protein level
Q9HAS0,NJMU_HUMAN,Protein Njmu-R1,396,"44,622",2 out of 5,2001-05-04,Evidence at protein level
P21452,NK2R_HUMAN,Substance-K receptor (SKR) (NK-2 receptor) (NK-2R) (Neurokinin A receptor) (Tachykinin receptor 2),398,"44,442",5 out of 5,1991-05-01,Evidence at protein level
Q4KMZ8,NKAI1_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1-interacting protein 1 (Na(+)/K(+)-transporting ATPase subunit beta-1-interacting protein 1) (Protein FAM77C),207,"23,552",3 out of 5,2006-12-12,Evidence at transcript level
Q5M9Q1,NKAPL_HUMAN,NKAP-like protein,402,"46,312",3 out of 5,2006-11-28,Evidence at transcript level
P48645,NMU_HUMAN,Neuromedin-U [Cleaved into: Neuromedin-U-25 (NmU-25)],174,"19,741",5 out of 5,1996-02-01,Evidence at protein level
P40261,NNMT_HUMAN,Nicotinamide N-methyltransferase (EC 2.1.1.1),264,"29,574",5 out of 5,1995-02-01,Evidence at protein level
Q8IW45,NNRD_HUMAN,ATP-dependent (S)-NAD(P)H-hydrate dehydratase (EC 4.2.1.93) (ATP-dependent NAD(P)HX dehydratase) (Carbohydrate kinase domain-containing protein) (NAD(P)HX dehydratase),347,"36,576",5 out of 5,2008-05-20,Evidence at protein level
Q8NCW5,NNRE_HUMAN,NAD(P)H-hydrate epimerase (EC 5.1.99.6) (Apolipoprotein A-I-binding protein) (AI-BP) (NAD(P)HX epimerase) (YjeF N-terminal domain-containing protein 1) (YjeF_N1),288,"31,675",5 out of 5,2007-06-26,Evidence at protein level
Q5C9Z4,NOM1_HUMAN,Nucleolar MIF4G domain-containing protein 1 (SGD1 homolog),860,"96,257",5 out of 5,2007-05-15,Evidence at protein level
Q5JPE7,NOMO2_HUMAN,Nodal modulator 2 (pM5 protein 2),1267,"139,439",5 out of 5,2005-06-07,Evidence at protein level
P46087,NOP2_HUMAN,Probable 28S rRNA (cytosine(4447)-C(5))-methyltransferase (EC 2.1.1.-) (Nucleolar protein 1) (Nucleolar protein 2 homolog) (Proliferating-cell nucleolar antigen p120) (Proliferation-associated nucleolar protein p120),812,"89,302",5 out of 5,1995-11-01,Evidence at protein level
Q9Y2X3,NOP58_HUMAN,Nucleolar protein 58 (Nucleolar protein 5),529,"59,578",5 out of 5,2001-09-26,Evidence at protein level
Q9Y5S8,NOX1_HUMAN,NADPH oxidase 1 (NOX-1) (EC 1.-.-.-) (Mitogenic oxidase 1) (MOX-1) (NADH/NADPH mitogenic oxidase subunit P65-MOX) (NOH-1),564,"64,871",5 out of 5,2000-05-30,Evidence at protein level
Q9ULW6,NP1L2_HUMAN,"Nucleosome assembly protein 1-like 2 (Brain-specific protein, X-linked)",460,"52,542",3 out of 5,2002-08-13,Evidence at protein level
Q8WTW4,NPRL2_HUMAN,Nitrogen permease regulator 2-like protein (NPR2-like protein) (Gene 21 protein) (G21 protein) (Tumor suppressor candidate 4),380,"43,658",5 out of 5,2004-05-10,Evidence at protein level
Q14916,NPT1_HUMAN,Sodium-dependent phosphate transport protein 1 (Na(+)/PI cotransporter 1) (Na/Pi-4) (Renal Na(+)-dependent phosphate cotransporter 1) (Renal sodium-dependent phosphate transport protein 1) (Renal sodium-phosphate transport protein 1) (Sodium/phosphate cotransporter 1) (Solute carrier family 17 member 1),467,"51,132",5 out of 5,1997-11-01,Evidence at transcript level
Q06495,NPT2A_HUMAN,Sodium-dependent phosphate transport protein 2A (Sodium-phosphate transport protein 2A) (Na(+)-dependent phosphate cotransporter 2A) (NaPi-3) (Sodium/phosphate cotransporter 2A) (Na(+)/Pi cotransporter 2A) (NaPi-2a) (Solute carrier family 34 member 1),639,"68,937",5 out of 5,1995-02-01,Evidence at protein level
Q8N130,NPT2C_HUMAN,Sodium-dependent phosphate transport protein 2C (Sodium-phosphate transport protein 2C) (Na(+)-dependent phosphate cotransporter 2C) (Sodium/inorganic phosphate cotransporter IIC) (Sodium/phosphate cotransporter 2C) (Na(+)/Pi cotransporter 2C) (NaPi-2c) (Solute carrier family 34 member 3),599,"63,550",5 out of 5,2005-12-20,Evidence at protein level
O00476,NPT4_HUMAN,Sodium-dependent phosphate transport protein 4 (Na(+)/PI cotransporter 4) (Sodium/phosphate cotransporter 4) (Solute carrier family 17 member 3),420,"46,106",5 out of 5,1998-07-15,Evidence at protein level
Q15818,NPTX1_HUMAN,Neuronal pentraxin-1 (NP1) (Neuronal pentraxin I) (NP-I),432,"47,122",3 out of 5,1997-11-01,Evidence at transcript level
P47972,NPTX2_HUMAN,Neuronal pentraxin-2 (NP2) (Neuronal pentraxin II) (NP-II),431,"47,042",3 out of 5,1996-02-01,Evidence at protein level
P51843,NR0B1_HUMAN,Nuclear receptor subfamily 0 group B member 1 (DSS-AHC critical region on the X chromosome protein 1) (Nuclear receptor DAX-1),470,"51,718",5 out of 5,1996-10-01,Evidence at protein level
P13056,NR2C1_HUMAN,Nuclear receptor subfamily 2 group C member 1 (Orphan nuclear receptor TR2) (Testicular receptor 2),603,"67,315",5 out of 5,1990-01-01,Evidence at protein level
O00482,NR5A2_HUMAN,Nuclear receptor subfamily 5 group A member 2 (Alpha-1-fetoprotein transcription factor) (B1-binding factor) (hB1F) (CYP7A promoter-binding factor) (Hepatocytic transcription factor) (Liver receptor homolog 1) (LRH-1),541,"61,331",5 out of 5,1998-07-15,Evidence at protein level
Q9UP65,PA24C_HUMAN,Cytosolic phospholipase A2 gamma (cPLA2-gamma) (EC 3.1.1.4) (Phospholipase A2 group IVC),541,"60,939",5 out of 5,2004-05-10,Evidence at protein level
Q9NZ20,PA2G3_HUMAN,Group 3 secretory phospholipase A2 (EC 3.1.1.4) (Group III secretory phospholipase A2) (GIII sPLA2) (sPLA2-III) (Phosphatidylcholine 2-acylhydrolase 3),509,"57,167",5 out of 5,2002-02-11,Evidence at protein level
P39877,PA2G5_HUMAN,Calcium-dependent phospholipase A2 (EC 3.1.1.4) (Group V phospholipase A2) (PLA2-10) (Phosphatidylcholine 2-acylhydrolase 5),138,"15,674",5 out of 5,1995-02-01,Evidence at protein level
Q5R387,PA2GC_HUMAN,Putative inactive group IIC secretory phospholipase A2 (Phosphatidylcholine 2-acylhydrolase-like protein GIIC),149,"16,844",3 out of 5,2008-02-26,Inferred from homology
Q9H361,PABP3_HUMAN,Polyadenylate-binding protein 3 (PABP-3) (Poly(A)-binding protein 3) (Testis-specific poly(A)-binding protein),631,"70,031",4 out of 5,2003-02-01,Evidence at protein level
Q9ULC6,PADI1_HUMAN,Protein-arginine deiminase type-1 (EC 3.5.3.15) (Peptidylarginine deiminase I) (Protein-arginine deiminase type I),663,"74,666",4 out of 5,2001-01-11,Evidence at protein level
P09466,PAEP_HUMAN,Glycodelin (GD) (Placental protein 14) (PP14) (Pregnancy-associated endometrial alpha-2 globulin) (PAEG) (PEG) (Progestagen-associated endometrial protein) (Progesterone-associated endometrial protein),180,"20,624",5 out of 5,1989-07-01,Evidence at protein level
Q99487,PAFA2_HUMAN,"Platelet-activating factor acetylhydrolase 2, cytoplasmic (EC 3.1.1.47) (Serine-dependent phospholipase A2) (SD-PLA2) (hSD-PLA2)",392,"44,036",5 out of 5,2000-05-30,Evidence at protein level
Q13177,PAK2_HUMAN,Serine/threonine-protein kinase PAK 2 (EC 2.7.11.1) (Gamma-PAK) (PAK65) (S6/H4 kinase) (p21-activated kinase 2) (PAK-2) (p58) [Cleaved into: PAK-2p27 (p27); PAK-2p34 (p34) (C-t-PAK2)],524,"58,043",5 out of 5,1997-11-01,Evidence at protein level
A0A075B759,PAL4E_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4E (PPIase A-like 4E) (EC 5.2.1.8),164,"18,197",2 out of 5,2015-10-14,Inferred from homology
Q9NP74,PALMD_HUMAN,Palmdelphin (Paralemmin-like protein),551,"62,758",4 out of 5,2006-11-28,Evidence at protein level
Q58A45,PAN3_HUMAN,PAB-dependent poly(A)-specific ribonuclease subunit PAN3 (PAB1P-dependent poly(A)-nuclease) (PAN deadenylation complex subunit 3) (hPan3),887,"95,613",5 out of 5,2007-03-20,Evidence at protein level
Q6UWI2,PARM1_HUMAN,Prostate androgen-regulated mucin-like protein 1 (PARM-1),310,"32,289",5 out of 5,2006-01-10,Evidence at protein level
P09874,PARP1_HUMAN,Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1),1014,"113,084",5 out of 5,1989-07-01,Evidence at protein level
Q9Y6F1,PARP3_HUMAN,Poly [ADP-ribose] polymerase 3 (PARP-3) (hPARP-3) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 3) (ARTD3) (IRT1) (NAD(+) ADP-ribosyltransferase 3) (ADPRT-3) (Poly[ADP-ribose] synthase 3) (pADPRT-3),533,"60,070",5 out of 5,2001-09-26,Evidence at protein level
Q96RG2,PASK_HUMAN,PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1),1323,"142,929",5 out of 5,2004-01-16,Evidence at protein level
B3GLJ2,PATE3_HUMAN,Prostate and testis expressed protein 3 (Acrosomal vesicle protein HEL-127) (PATE-like protein DJ) (PATE-DJ),98,"11,747",2 out of 5,2008-11-25,Evidence at transcript level
P05165,PCCA_HUMAN,"Propionyl-CoA carboxylase alpha chain, mitochondrial (PCCase subunit alpha) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit alpha)",728,"80,059",5 out of 5,1987-08-13,Evidence at protein level
Q9P2E7,PCD10_HUMAN,Protocadherin-10,1040,"112,936",4 out of 5,2004-01-16,Evidence at transcript level
Q6V1P9,PCD23_HUMAN,Protocadherin-23 (Cadherin-27) (Cadherin-like protein CDHJ) (Cadherin-like protein VR8) (Protein dachsous homolog 2) (Protocadherin PCDHJ),2916,"322,234",5 out of 5,2008-07-01,Evidence at transcript level
Q9UN72,PCDA7_HUMAN,Protocadherin alpha-7 (PCDH-alpha-7),937,"100,865",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5I2,PCDAA_HUMAN,Protocadherin alpha-10 (PCDH-alpha-10),948,"102,875",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E6,PCDB3_HUMAN,Protocadherin beta-3 (PCDH-beta-3),796,"86,773",4 out of 5,2001-04-27,Evidence at transcript level
Q9UN66,PCDB8_HUMAN,Protocadherin beta-8 (PCDH-beta-8) (Protocadherin-3I),801,"87,639",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E9,PCDBE_HUMAN,Protocadherin beta-14 (PCDH-beta-14),798,"87,548",5 out of 5,2001-04-27,Evidence at protein level
Q9H158,PCDC1_HUMAN,Protocadherin alpha-C1 (PCDH-alpha-C1),963,"103,942",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5I4,PCDC2_HUMAN,Protocadherin alpha-C2 (PCDH-alpha-C2),1007,"109,450",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5F9,PCDGI_HUMAN,Protocadherin gamma-B6 (PCDH-gamma-B6),930,"101,043",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5F6,PCDGM_HUMAN,Protocadherin gamma-C5 (PCDH-gamma-C5),944,"101,921",4 out of 5,2003-10-24,Evidence at transcript level
Q08174,PCDH1_HUMAN,Protocadherin-1 (Cadherin-like protein 1) (Protocadherin-42) (PC42),1060,"114,743",5 out of 5,2002-10-19,Evidence at protein level
Q96NT5,PCFT_HUMAN,Proton-coupled folate transporter (G21) (Heme carrier protein 1) (PCFT/HCP1) (Solute carrier family 46 member 1),459,"49,771",5 out of 5,2005-11-08,Evidence at protein level
Q9Y6V0,PCLO_HUMAN,Protein piccolo (Aczonin),5065,"553,277",5 out of 5,2002-10-19,Evidence at protein level
Q9NV79,PCMD2_HUMAN,Protein-L-isoaspartate O-methyltransferase domain-containing protein 2,361,"41,072",3 out of 5,2003-10-10,Evidence at transcript level
P12004,PCNA_HUMAN,Proliferating cell nuclear antigen (PCNA) (Cyclin),261,"28,769",5 out of 5,1989-10-01,Evidence at protein level
Q58A44,PCOTH_HUMAN,Prostate collagen triple helix protein (C1QTNF9B antisense RNA 1) (C1QTNF9B antisense gene protein 1),107,"10,968",3 out of 5,2008-05-20,Evidence at protein level
Q9NZ53,PDXL2_HUMAN,Podocalyxin-like protein 2 (Endoglycan),605,"65,076",5 out of 5,2006-10-03,Evidence at protein level
Q8IXQ8,PDZD9_HUMAN,PDZ domain-containing protein 9,264,"29,904",2 out of 5,2007-01-09,Evidence at transcript level
Q9BRX2,PELO_HUMAN,Protein pelota homolog (EC 3.1.-.-),385,"43,359",4 out of 5,2004-10-11,Evidence at protein level
O60437,PEPL_HUMAN,Periplakin (190 kDa paraneoplastic pemphigus antigen) (195 kDa cornified envelope precursor protein),1756,"204,747",5 out of 5,2001-06-01,Evidence at protein level
Q6UW60,PCSK4_HUMAN,Proprotein convertase subtilisin/kexin type 4 (EC 3.4.21.-) (Proprotein convertase 4) (PC4),755,"82,795",5 out of 5,2006-07-25,Evidence at protein level
Q16549,PCSK7_HUMAN,Proprotein convertase subtilisin/kexin type 7 (EC 3.4.21.-) (Lymphoma proprotein convertase) (Prohormone convertase 7) (Proprotein convertase 7) (PC7) (Proprotein convertase 8) (PC8) (hPC8) (Subtilisin/kexin-like protease PC7),785,"86,247",5 out of 5,2001-01-11,Evidence at protein level
Q8NBP7,PCSK9_HUMAN,Proprotein convertase subtilisin/kexin type 9 (EC 3.4.21.-) (Neural apoptosis-regulated convertase 1) (NARC-1) (Proprotein convertase 9) (PC9) (Subtilisin/kexin-like protease PC9),692,"74,286",5 out of 5,2003-11-07,Evidence at protein level
Q9H6A9,PCX3_HUMAN,Pecanex-like protein 3 (Pecanex homolog protein 3),2034,"222,039",3 out of 5,2008-04-29,Evidence at protein level
Q8WUM4,PDC6I_HUMAN,Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95),868,"96,023",5 out of 5,2003-05-23,Evidence at protein level
Q16342,PDCD2_HUMAN,Programmed cell death protein 2 (Zinc finger MYND domain-containing protein 7) (Zinc finger protein Rp-8),344,"38,592",5 out of 5,2000-12-01,Evidence at protein level
O43924,PDE6D_HUMAN,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta (GMP-PDE delta) (Protein p17)",150,"17,420",5 out of 5,1999-07-15,Evidence at protein level
P13667,PDIA4_HUMAN,Protein disulfide-isomerase A4 (EC 5.3.4.1) (Endoplasmic reticulum resident protein 70) (ER protein 70) (ERp70) (Endoplasmic reticulum resident protein 72) (ER protein 72) (ERp-72) (ERp72),645,"72,932",5 out of 5,1990-01-01,Evidence at protein level
Q8N807,PDILT_HUMAN,Protein disulfide-isomerase-like protein of the testis,584,"66,657",5 out of 5,2008-03-18,Evidence at protein level
Q96JY6,PDLI2_HUMAN,PDZ and LIM domain protein 2 (PDZ-LIM protein mystique),352,"37,459",5 out of 5,2005-06-07,Evidence at protein level
A8MUH7,PDZ1P_HUMAN,Putative PDZ domain-containing protein PDZK1P1 (PDZ domain-containing 1 pseudogene 1) (PDZ domain-containing 1 pseudogene 2),402,"44,056",2 out of 5,2008-07-22,Uncertain
Q9UBV8,PEF1_HUMAN,Peflin (PEF protein with a long N-terminal hydrophobic domain) (Penta-EF hand domain-containing protein 1),284,"30,381",5 out of 5,2006-07-25,Evidence at protein level
Q8N2H9,PELI3_HUMAN,E3 ubiquitin-protein ligase pellino homolog 3 (Pellino-3) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 3),469,"50,755",5 out of 5,2003-10-24,Evidence at protein level
Q96RR1,PEO1_HUMAN,"Twinkle protein, mitochondrial (EC 3.6.4.12) (Progressive external ophthalmoplegia 1 protein) (T7 gp4-like protein with intramitochondrial nucleoid localization) (T7-like mitochondrial DNA helicase)",684,"77,154",5 out of 5,2005-10-25,Evidence at protein level
P56645,PER3_HUMAN,Period circadian protein homolog 3 (hPER3) (Cell growth-inhibiting gene 13 protein) (Circadian clock protein PERIOD 3),1201,"131,888",5 out of 5,1999-07-15,Evidence at protein level
P11678,PERE_HUMAN,Eosinophil peroxidase (EPO) (EC 1.11.1.7) [Cleaved into: Eosinophil peroxidase light chain; Eosinophil peroxidase heavy chain],715,"81,040",5 out of 5,1989-10-01,Evidence at protein level
P05164,PERM_HUMAN,Myeloperoxidase (MPO) (EC 1.11.2.2) [Cleaved into: Myeloperoxidase; 89 kDa myeloperoxidase; 84 kDa myeloperoxidase; Myeloperoxidase light chain; Myeloperoxidase heavy chain],745,"83,869",5 out of 5,1987-08-13,Evidence at protein level
Q92968,PEX13_HUMAN,Peroxisomal membrane protein PEX13 (Peroxin-13),403,"44,130",5 out of 5,1998-12-15,Evidence at protein level
Q7Z412,PEX26_HUMAN,Peroxisome assembly protein 26 (Peroxin-26),305,"33,898",5 out of 5,2004-05-24,Evidence at protein level
P50542,PEX5_HUMAN,Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1),639,"70,865",5 out of 5,1996-10-01,Evidence at protein level
O60925,PFD1_HUMAN,Prefoldin subunit 1,122,"14,210",3 out of 5,2000-05-30,Evidence at protein level
O15212,PFD6_HUMAN,Prefoldin subunit 6 (Protein Ke2),129,"14,583",4 out of 5,1999-07-15,Evidence at protein level
Q01813,PFKAP_HUMAN,"ATP-dependent 6-phosphofructokinase, platelet type (ATP-PFK) (PFK-P) (EC 2.7.1.11) (6-phosphofructokinase type C) (Phosphofructo-1-kinase isozyme C) (PFK-C) (Phosphohexokinase)",784,"85,596",5 out of 5,1993-07-01,Evidence at protein level
Q9UHJ9,PGAP2_HUMAN,Post-GPI attachment to proteins factor 2 (FGF receptor-activating protein 1),254,"29,400",5 out of 5,2008-03-18,Evidence at protein level
Q6P3X8,PGBD2_HUMAN,PiggyBac transposable element-derived protein 2,592,"68,011",1 out of 5,2007-05-29,Evidence at transcript level
Q15198,PGFRL_HUMAN,Platelet-derived growth factor receptor-like protein (PDGFR-like protein) (PDGF receptor beta-like tumor suppressor),375,"41,861",4 out of 5,2006-05-02,Evidence at protein level
P07205,PGK2_HUMAN,"Phosphoglycerate kinase 2 (EC 2.7.2.3) (Phosphoglycerate kinase, testis specific)",417,"44,796",5 out of 5,1988-04-01,Evidence at protein level
Q6PCE3,PGM2L_HUMAN,"Glucose 1,6-bisphosphate synthase (EC 2.7.1.106) (PMMLP) (Phosphoglucomutase-2-like 1)",622,"70,442",4 out of 5,2005-07-19,Evidence at protein level
Q15124,PGM5_HUMAN,Phosphoglucomutase-like protein 5 (Aciculin) (Phosphoglucomutase-related protein) (PGM-RP),567,"62,225",5 out of 5,2001-01-24,Evidence at protein level
O75594,PGRP1_HUMAN,Peptidoglycan recognition protein 1 (Peptidoglycan recognition protein short) (PGRP-S),196,"21,731",5 out of 5,2001-10-18,Evidence at protein level
Q86YP4,P66A_HUMAN,Transcriptional repressor p66-alpha (Hp66alpha) (GATA zinc finger domain-containing protein 2A),633,"68,063",5 out of 5,2004-07-19,Evidence at protein level
A0A0B4J2A2,PAL4C_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4C (PPIase A-like 4C) (EC 5.2.1.8),164,"18,156",2 out of 5,2015-10-14,Evidence at transcript level
Q6QHF9,PAOX_HUMAN,Peroxisomal N(1)-acetyl-spermine/spermidine oxidase (EC 1.5.3.13) (Polyamine oxidase),649,"70,290",5 out of 5,2004-08-16,Evidence at protein level
Q5JQF8,PAP1M_HUMAN,Polyadenylate-binding protein 1-like 2 (RNA-binding motif protein 32) (RNA-binding protein 32),200,"22,799",3 out of 5,2007-09-11,Evidence at transcript level
Q96RI0,PAR4_HUMAN,Proteinase-activated receptor 4 (PAR-4) (Coagulation factor II receptor-like 3) (Thrombin receptor-like 3),385,"41,133",5 out of 5,2002-03-27,Evidence at protein level
Q9H300,PARL_HUMAN,"Presenilins-associated rhomboid-like protein, mitochondrial (EC 3.4.21.105) (Mitochondrial intramembrane cleaving protease PARL) [Cleaved into: P-beta (Pbeta)]",379,"42,190",5 out of 5,2005-04-12,Evidence at protein level
P0C8F1,PATE4_HUMAN,Prostate and testis expressed protein 4 (PATE-like protein B) (PATE-B),98,"11,407",3 out of 5,2008-11-25,Evidence at transcript level
P26367,PAX6_HUMAN,Paired box protein Pax-6 (Aniridia type II protein) (Oculorhombin),422,"46,683",5 out of 5,1992-08-01,Evidence at protein level
Q9GZY1,PBOV1_HUMAN,Prostate and breast cancer overexpressed gene 1 protein (Protein UROC28) (UC28),135,"15,722",2 out of 5,2005-12-20,Evidence at transcript level
P40426,PBX3_HUMAN,Pre-B-cell leukemia transcription factor 3 (Homeobox protein PBX3),434,"47,190",5 out of 5,1995-02-01,Evidence at protein level
Q9BZA8,PC11Y_HUMAN,Protocadherin-11 Y-linked (Protocadherin-11) (Protocadherin on the Y chromosome) (PCDH-Y) (Protocadherin prostate cancer) (Protocadherin-PC) (Protocadherin-22),1340,"146,775",5 out of 5,2006-04-18,Evidence at protein level
Q9UKZ9,PCOC2_HUMAN,Procollagen C-endopeptidase enhancer 2 (Procollagen COOH-terminal proteinase enhancer 2) (PCPE-2) (Procollagen C-proteinase enhancer 2),415,"45,717",5 out of 5,2005-05-10,Evidence at protein level
P27815,PDE4A_HUMAN,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46)",886,"98,143",5 out of 5,1992-08-01,Evidence at protein level
Q08493,PDE4C_HUMAN,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C (EC 3.1.4.53) (DPDE1) (PDE21)",712,"79,902",5 out of 5,1996-10-01,Evidence at protein level
P16499,PDE6A_HUMAN,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (GMP-PDE alpha) (EC 3.1.4.35) (PDE V-B1)",860,"99,547",5 out of 5,1990-08-01,Evidence at protein level
P30101,PDIA3_HUMAN,Protein disulfide-isomerase A3 (EC 5.3.4.1) (58 kDa glucose-regulated protein) (58 kDa microsomal protein) (p58) (Disulfide isomerase ER-60) (Endoplasmic reticulum resident protein 57) (ER protein 57) (ERp57) (Endoplasmic reticulum resident protein 60) (ER protein 60) (ERp60),505,"56,782",5 out of 5,1993-04-01,Evidence at protein level
Q53GG5,PDLI3_HUMAN,PDZ and LIM domain protein 3 (Actinin-associated LIM protein) (Alpha-actinin-2-associated LIM protein),364,"39,232",4 out of 5,2005-12-06,Evidence at protein level
Q96HC4,PDLI5_HUMAN,PDZ and LIM domain protein 5 (Enigma homolog) (Enigma-like PDZ and LIM domains protein),596,"63,945",5 out of 5,2004-05-24,Evidence at protein level
Q29RF7,PDS5A_HUMAN,Sister chromatid cohesion protein PDS5 homolog A (Cell proliferation-inducing gene 54 protein) (Sister chromatid cohesion protein 112) (SCC-112),1337,"150,830",5 out of 5,2007-07-24,Evidence at protein level
O15018,PDZD2_HUMAN,PDZ domain-containing protein 2 (Activated in prostate cancer protein) (PDZ domain-containing protein 3) [Cleaved into: Processed PDZ domain-containing protein 2],2839,"301,641",5 out of 5,2005-01-04,Evidence at protein level
Q9H5P4,PDZD7_HUMAN,PDZ domain-containing protein 7,517,"55,677",5 out of 5,2005-08-16,Evidence at protein level
Q9UKK3,PARP4_HUMAN,Poly [ADP-ribose] polymerase 4 (PARP-4) (EC 2.4.2.30) (193 kDa vault protein) (ADP-ribosyltransferase diphtheria toxin-like 4) (ARTD4) (PARP-related/IalphaI-related H5/proline-rich) (PH5P) (Vault poly(ADP-ribose) polymerase) (VPARP),1724,"192,595",5 out of 5,2001-09-26,Evidence at protein level
Q8IXQ6,PARP9_HUMAN,Poly [ADP-ribose] polymerase 9 (PARP-9) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 9) (ARTD9) (B aggressive lymphoma protein),854,"96,343",5 out of 5,2003-10-10,Evidence at protein level
Q9HBI1,PARVB_HUMAN,Beta-parvin (Affixin),364,"41,714",5 out of 5,2002-01-23,Evidence at protein level
O43316,PAX4_HUMAN,Paired box protein Pax-4,350,"37,833",5 out of 5,1998-12-15,Evidence at protein level
P23759,PAX7_HUMAN,Paired box protein Pax-7 (HuP1),505,"55,119",5 out of 5,1991-11-01,Evidence at protein level
Q7L5N7,PCAT2_HUMAN,Lysophosphatidylcholine acyltransferase 2 (LPC acyltransferase 2) (LPCAT-2) (LysoPC acyltransferase 2) (EC 2.3.1.23) (1-acylglycerol-3-phosphate O-acyltransferase 11) (1-AGP acyltransferase 11) (1-AGPAT 11) (EC 2.3.1.51) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha),544,"60,208",5 out of 5,2006-07-25,Evidence at protein level
P57721,PCBP3_HUMAN,Poly(rC)-binding protein 3 (Alpha-CP3),371,"39,465",4 out of 5,2001-01-11,Evidence at transcript level
P05166,PCCB_HUMAN,"Propionyl-CoA carboxylase beta chain, mitochondrial (PCCase subunit beta) (EC 6.4.1.3) (Propanoyl-CoA:carbon dioxide ligase subunit beta)",539,"58,216",5 out of 5,1987-08-13,Evidence at protein level
Q9HCL0,PCD18_HUMAN,Protocadherin-18,1135,"126,149",4 out of 5,2004-01-16,Evidence at transcript level
P42785,PCP_HUMAN,Lysosomal Pro-X carboxypeptidase (EC 3.4.16.2) (Angiotensinase C) (Lysosomal carboxypeptidase C) (Proline carboxypeptidase) (Prolylcarboxypeptidase) (PRCP),496,"55,800",5 out of 5,1995-11-01,Evidence at protein level
Q9BRP1,PDD2L_HUMAN,Programmed cell death protein 2-like,358,"39,417",3 out of 5,2007-01-23,Evidence at protein level
Q9HCR9,PDE11_HUMAN,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A (EC 3.1.4.35) (EC 3.1.4.53) (cAMP and cGMP phosphodiesterase 11A)",933,"104,752",5 out of 5,2006-07-25,Evidence at protein level
P54750,PDE1A_HUMAN,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A (Cam-PDE 1A) (EC 3.1.4.17) (61 kDa Cam-PDE) (hCam-1)",535,"61,252",5 out of 5,1996-10-01,Evidence at transcript level
Q14123,PDE1C_HUMAN,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C (Cam-PDE 1C) (EC 3.1.4.17) (hCam-3)",709,"80,760",5 out of 5,1997-11-01,Evidence at protein level
Q9NRA1,PDGFC_HUMAN,"Platelet-derived growth factor C (PDGF-C) (Fallotein) (Spinal cord-derived growth factor) (SCDGF) (VEGF-E) [Cleaved into: Platelet-derived growth factor C, latent form (PDGFC latent form); Platelet-derived growth factor C, receptor-binding form (PDGFC receptor-binding form)]",345,"39,029",5 out of 5,2008-07-22,Evidence at protein level
P01213,PDYN_HUMAN,Proenkephalin-B (Beta-neoendorphin-dynorphin) (Preprodynorphin) [Cleaved into: Alpha-neoendorphin; Beta-neoendorphin; Big dynorphin (Big Dyn); Dynorphin A(1-17) (Dyn-A17) (Dynorphin A); Dynorphin A(1-13); Dynorphin A(1-8); Leu-enkephalin; Rimorphin (Dynorphin B) (Dyn-B) (Dynorphin B(1-13)); Leumorphin (Dynorphin B-29)],254,"28,385",5 out of 5,1986-07-21,Evidence at protein level
P43116,PE2R2_HUMAN,Prostaglandin E2 receptor EP2 subtype (PGE receptor EP2 subtype) (PGE2 receptor EP2 subtype) (Prostanoid EP2 receptor),358,"39,761",4 out of 5,1995-11-01,Evidence at transcript level
Q86TG7,PEG10_HUMAN,Retrotransposon-derived protein PEG10 (Embryonal carcinoma differentiation-regulated protein) (Mammalian retrotransposon-derived protein 2) (Myelin expression factor 3-like protein 1) (MEF3-like protein 1) (Paternally expressed gene 10 protein) (Retrotransposon gag domain-containing protein 3) (Retrotransposon-derived gag-like polyprotein) (Ty3/Gypsy-like protein),708,"80,173",5 out of 5,2008-03-18,Evidence at protein level
Q9GZU2,PEG3_HUMAN,Paternally-expressed gene 3 protein (Zinc finger and SCAN domain-containing protein 24),1588,"180,827",5 out of 5,2006-09-05,Evidence at protein level
P12955,PEPD_HUMAN,Xaa-Pro dipeptidase (X-Pro dipeptidase) (EC 3.4.13.9) (Imidodipeptidase) (Peptidase D) (Proline dipeptidase) (Prolidase),493,"54,548",5 out of 5,1990-01-01,Evidence at protein level
P41219,PERI_HUMAN,Peripherin (Neurofilament 4),470,"53,651",4 out of 5,1995-02-01,Evidence at protein level
P22079,PERL_HUMAN,Lactoperoxidase (LPO) (EC 1.11.1.7) (Salivary peroxidase) (SPO),712,"80,288",5 out of 5,1991-08-01,Evidence at protein level
O00628,PEX7_HUMAN,Peroxisomal targeting signal 2 receptor (PTS2 receptor) (Peroxin-7),323,"35,892",5 out of 5,1998-07-15,Evidence at protein level
Q9BZM1,PG12A_HUMAN,Group XIIA secretory phospholipase A2 (GXII sPLA2) (sPLA2-XII) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 12A),189,"21,067",5 out of 5,2002-02-11,Evidence at protein level
Q9H720,PG2IP_HUMAN,PGAP2-interacting protein (Cell wall biogenesis protein 43 C-terminal homolog),699,"78,584",3 out of 5,2008-02-26,Evidence at transcript level
Q8N414,PGBD5_HUMAN,PiggyBac transposable element-derived protein 5,455,"51,642",2 out of 5,2007-05-29,Evidence at protein level
P98160,PGBM_HUMAN,Basement membrane-specific heparan sulfate proteoglycan core protein (HSPG) (Perlecan) (PLC) [Cleaved into: Endorepellin; LG3 peptide],4391,"468,830",5 out of 5,1996-10-01,Evidence at protein level
Q9NWS1,PARI_HUMAN,PCNA-interacting partner (PARI) (PARP-1 binding protein) (PARP1-binding protein) (PARPBP),579,"65,054",5 out of 5,2007-03-20,Evidence at protein level
Q99497,PARK7_HUMAN,Protein DJ-1 (DJ-1) (Oncogene DJ1) (Parkinson disease protein 7) (Parkinsonism-associated deglycase) (Protein deglycase DJ-1) (EC 3.1.2.-) (EC 3.5.1.124),189,"19,891",5 out of 5,2004-12-07,Evidence at protein level
C9JE40,PATL2_HUMAN,Protein PAT1 homolog 2 (PAT1-like protein 2) (Protein PAT1 homolog a) (Pat1a) (hPat1a),543,"61,464",3 out of 5,2011-02-08,Evidence at protein level
Q96IZ0,PAWR_HUMAN,PRKC apoptosis WT1 regulator protein (Prostate apoptosis response 4 protein) (Par-4),340,"36,568",5 out of 5,2005-05-24,Evidence at protein level
Q02548,PAX5_HUMAN,Paired box protein Pax-5 (B-cell-specific transcription factor) (BSAP),391,"42,149",5 out of 5,1993-10-01,Evidence at protein level
P55771,PAX9_HUMAN,Paired box protein Pax-9,341,"36,310",5 out of 5,1997-11-01,Evidence at protein level
Q63HM2,PCX4_HUMAN,Pecanex-like protein 4 (Hepatitis C virus F protein-binding protein 2) (HCV F protein-binding protein 2) (Pecanex homolog protein 4),1172,"132,702",3 out of 5,2006-10-17,Evidence at protein level
Q9Y233,PDE10_HUMAN,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A (EC 3.1.4.17) (EC 3.1.4.35)",779,"88,412",5 out of 5,2000-05-30,Evidence at protein level
Q14432,PDE3A_HUMAN,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A (EC 3.1.4.17) (Cyclic GMP-inhibited phosphodiesterase A) (CGI-PDE A)",1141,"124,979",5 out of 5,1998-07-15,Evidence at protein level
Q13370,PDE3B_HUMAN,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B (EC 3.1.4.17) (CGIPDE1) (CGIP1) (Cyclic GMP-inhibited phosphodiesterase B) (CGI-PDE B)",1112,"124,333",5 out of 5,1998-07-15,Evidence at protein level
Q07343,PDE4B_HUMAN,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B (EC 3.1.4.53) (DPDE4) (PDE32)",736,"83,343",5 out of 5,1995-02-01,Evidence at protein level
P35913,PDE6B_HUMAN,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta (GMP-PDE beta) (EC 3.1.4.35)",854,"98,336",5 out of 5,1994-06-01,Evidence at protein level
O76083,PDE9A_HUMAN,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A (EC 3.1.4.35)",593,"68,493",5 out of 5,1999-07-15,Evidence at protein level
Q9GZP0,PDGFD_HUMAN,"Platelet-derived growth factor D (PDGF-D) (Iris-expressed growth factor) (Spinal cord-derived growth factor B) (SCDGF-B) [Cleaved into: Platelet-derived growth factor D, latent form (PDGFD latent form); Platelet-derived growth factor D, receptor-binding form (PDGFD receptor-binding form)]",370,"42,848",5 out of 5,2006-09-19,Evidence at protein level
Q9BY77,PDIP3_HUMAN,Polymerase delta-interacting protein 3 (46 kDa DNA polymerase delta interaction protein) (p46) (S6K1 Aly/REF-like target) (SKAR),421,"46,089",5 out of 5,2002-10-19,Evidence at protein level
Q15119,PDK2_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 2) (PDH kinase 2) (PDKII)",407,"46,154",5 out of 5,1998-07-15,Evidence at protein level
Q16654,PDK4_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 4)",411,"46,469",5 out of 5,1998-07-15,Evidence at protein level
Q5EBL8,PDZ11_HUMAN,PDZ domain-containing protein 11 (ATPase-interacting PDZ protein) (Plasma membrane calcium ATPase-interacting single-PDZ protein) (PMCA-interacting single-PDZ protein),140,"16,131",5 out of 5,2005-08-16,Evidence at protein level
P30086,PEBP1_HUMAN,Phosphatidylethanolamine-binding protein 1 (PEBP-1) (HCNPpp) (Neuropolypeptide h3) (Prostatic-binding protein) (Raf kinase inhibitor protein) (RKIP) [Cleaved into: Hippocampal cholinergic neurostimulating peptide (HCNP)],187,"21,057",5 out of 5,1993-04-01,Evidence at protein level
Q8IZL8,PELP1_HUMAN,"Proline-, glutamic acid- and leucine-rich protein 1 (Modulator of non-genomic activity of estrogen receptor) (Transcription factor HMX3)",1130,"119,700",5 out of 5,2006-10-03,Evidence at protein level
P20142,PEPC_HUMAN,Gastricsin (EC 3.4.23.3) (Pepsinogen C),388,"42,426",5 out of 5,1991-02-01,Evidence at protein level
P40855,PEX19_HUMAN,Peroxisomal biogenesis factor 19 (33 kDa housekeeping protein) (Peroxin-19) (Peroxisomal farnesylated protein),299,"32,807",5 out of 5,1995-02-01,Evidence at protein level
Q9UHV9,PFD2_HUMAN,Prefoldin subunit 2,154,"16,648",5 out of 5,2001-01-11,Evidence at protein level
Q9H999,PANK3_HUMAN,Pantothenate kinase 3 (hPanK3) (EC 2.7.1.33) (Pantothenic acid kinase 3),370,"41,094",4 out of 5,2003-01-17,Evidence at protein level
Q8NDF8,PAPD5_HUMAN,Non-canonical poly(A) RNA polymerase PAPD5 (EC 2.7.7.19) (PAP-associated domain-containing protein 5) (Terminal uridylyltransferase 3) (TUTase 3) (Topoisomerase-related function protein 4-2) (TRF4-2),572,"63,267",5 out of 5,2005-02-01,Evidence at protein level
O95340,PAPS2_HUMAN,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (PAPS synthase 2) (PAPSS 2) (Sulfurylase kinase 2) (SK 2) (SK2) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],614,"69,501",5 out of 5,2000-05-30,Evidence at protein level
Q9H0J9,PAR12_HUMAN,Poly [ADP-ribose] polymerase 12 (PARP-12) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 12) (ARTD12) (Zinc finger CCCH domain-containing protein 1),701,"79,064",3 out of 5,2004-05-10,Evidence at protein level
Q460N3,PAR15_HUMAN,Poly [ADP-ribose] polymerase 15 (PARP-15) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 7) (ARTD7) (B-aggressive lymphoma protein 3),678,"74,576",5 out of 5,2006-10-17,Evidence at protein level
P25116,PAR1_HUMAN,Proteinase-activated receptor 1 (PAR-1) (Coagulation factor II receptor) (Thrombin receptor),425,"47,441",5 out of 5,1992-05-01,Evidence at protein level
Q9BYG5,PAR6B_HUMAN,Partitioning defective 6 homolog beta (PAR-6 beta) (PAR-6B),372,"41,182",5 out of 5,2003-05-16,Evidence at protein level
O95453,PARN_HUMAN,Poly(A)-specific ribonuclease PARN (EC 3.1.13.4) (Deadenylating nuclease) (Deadenylation nuclease) (Polyadenylate-specific ribonuclease),639,"73,451",5 out of 5,2005-03-01,Evidence at protein level
Q9UGN5,PARP2_HUMAN,Poly [ADP-ribose] polymerase 2 (PARP-2) (hPARP-2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 2) (ARTD2) (NAD(+) ADP-ribosyltransferase 2) (ADPRT-2) (Poly[ADP-ribose] synthase 2) (pADPRT-2),583,"66,206",5 out of 5,2001-09-26,Evidence at protein level
Q2NL67,PARP6_HUMAN,Poly [ADP-ribose] polymerase 6 (PARP-6) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 17) (ARTD17),630,"71,115",2 out of 5,2006-10-17,Evidence at transcript level
Q8N3A8,PARP8_HUMAN,Poly [ADP-ribose] polymerase 8 (PARP-8) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 16) (ARTD16),854,"95,871",3 out of 5,2006-10-17,Evidence at transcript level
Q9HBE1,PATZ1_HUMAN,"POZ-, AT hook-, and zinc finger-containing protein 1 (BTB/POZ domain zinc finger transcription factor) (Protein kinase A RI subunit alpha-associated protein) (Zinc finger and BTB domain-containing protein 19) (Zinc finger protein 278) (Zinc finger sarcoma gene protein)",687,"74,060",5 out of 5,2003-11-07,Evidence at protein level
P15863,PAX1_HUMAN,Paired box protein Pax-1 (HuP48),534,"55,499",5 out of 5,1990-04-01,Evidence at protein level
P23760,PAX3_HUMAN,Paired box protein Pax-3 (HuP2),479,"52,968",5 out of 5,1991-11-01,Evidence at protein level
Q9NPG4,PCD12_HUMAN,Protocadherin-12 (Vascular cadherin-2) (Vascular endothelial cadherin-2) (VE-cad-2) (VE-cadherin-2),1184,"128,995",5 out of 5,2002-08-02,Evidence at protein level
O14917,PCD17_HUMAN,Protocadherin-17 (Protocadherin-68),1159,"126,229",4 out of 5,2004-01-16,Evidence at transcript level
Q9UN67,PCDBA_HUMAN,Protocadherin beta-10 (PCDH-beta-10),800,"87,621",4 out of 5,2001-04-27,Evidence at protein level
Q9Y5F1,PCDBC_HUMAN,Protocadherin beta-12 (PCDH-beta-12),795,"86,770",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5G5,PCDG8_HUMAN,Protocadherin gamma-A8 (PCDH-gamma-A8),932,"101,480",4 out of 5,2003-10-24,Evidence at transcript level
O60330,PCDGC_HUMAN,Protocadherin gamma-A12 (PCDH-gamma-A12) (Cadherin-21) (Fibroblast cadherin-3),932,"100,955",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G0,PCDGH_HUMAN,Protocadherin gamma-B5 (PCDH-gamma-B5),923,"99,875",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5F8,PCDGJ_HUMAN,Protocadherin gamma-B7 (PCDH-gamma-B7),929,"100,974",3 out of 5,2003-10-24,Evidence at transcript level
Q4G0U5,PCDP1_HUMAN,Cilia- and flagella-associated protein 221 (Primary ciliary dyskinesia protein 1),840,"96,891",4 out of 5,2008-02-26,Evidence at protein level
P35227,PCGF2_HUMAN,Polycomb group RING finger protein 2 (DNA-binding protein Mel-18) (RING finger protein 110) (Zinc finger protein 144),344,"37,788",5 out of 5,1994-02-01,Evidence at protein level
Q9H4Z3,PCIF1_HUMAN,Phosphorylated CTD-interacting factor 1,704,"80,670",4 out of 5,2002-12-06,Evidence at protein level
Q16822,PCKGM_HUMAN,"Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)",640,"70,730",5 out of 5,1998-07-15,Evidence at protein level
Q96MG8,PCMD1_HUMAN,Protein-L-isoaspartate O-methyltransferase domain-containing protein 1,357,"40,675",3 out of 5,2003-10-10,Evidence at protein level
O95613,PCNT_HUMAN,Pericentrin (Kendrin) (Pericentrin-B),3336,"378,037",5 out of 5,2000-05-30,Evidence at protein level
Q8N8D1,PDCD7_HUMAN,Programmed cell death protein 7 (ES18) (hES18),485,"54,700",3 out of 5,2003-10-31,Evidence at protein level
Q8N4E4,PDCL2_HUMAN,Phosducin-like protein 2,241,"28,071",2 out of 5,2006-07-25,Evidence at protein level
Q08499,PDE4D_HUMAN,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D (EC 3.1.4.53) (DPDE3) (PDE43)",809,"91,115",5 out of 5,1996-10-01,Evidence at protein level
Q13946,PDE7A_HUMAN,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (EC 3.1.4.53) (HCP1) (TM22)",482,"55,505",5 out of 5,1998-07-15,Evidence at protein level
O60658,PDE8A_HUMAN,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (EC 3.1.4.53)",829,"93,304",5 out of 5,1999-07-15,Evidence at protein level
Q8N165,PDK1L_HUMAN,Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like),341,"38,546",3 out of 5,2006-01-24,Evidence at protein level
Q15120,PDK3_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 3)",406,"46,939",5 out of 5,1998-07-15,Evidence at protein level
P52945,PDX1_HUMAN,Pancreas/duodenum homeobox protein 1 (PDX-1) (Glucose-sensitive factor) (GSF) (Insulin promoter factor 1) (IPF-1) (Insulin upstream factor 1) (IUF-1) (Islet/duodenum homeobox-1) (IDX-1) (Somatostatin-transactivating factor 1) (STF-1),283,"30,771",5 out of 5,1996-10-01,Evidence at protein level
Q7Z3E1,PARPT_HUMAN,TCDD-inducible poly [ADP-ribose] polymerase (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 14) (ARTD14) (Poly [ADP-ribose] polymerase 7) (PARP-7),657,"76,227",5 out of 5,2006-07-25,Evidence at transcript level
Q02962,PAX2_HUMAN,Paired box protein Pax-2,417,"44,706",5 out of 5,1993-07-01,Evidence at protein level
Q9Y5B6,PAXB1_HUMAN,PAX3- and PAX7-binding protein 1 (GC-rich sequence DNA-binding factor 1),917,"104,804",5 out of 5,2000-05-30,Evidence at protein level
Q6ZW49,PAXI1_HUMAN,PAX-interacting protein 1 (PAX transactivation activation domain-interacting protein),1069,"121,341",5 out of 5,2007-07-24,Evidence at protein level
Q9BUH6,PAXX_HUMAN,Protein PAXX (Paralog of XRCC4 and XLF) (XRCC4-like small protein),204,"21,640",5 out of 5,2007-05-01,Evidence at protein level
Q9BZA7,PC11X_HUMAN,Protocadherin-11 X-linked (Protocadherin-11) (Protocadherin on the X chromosome) (PCDH-X) (Protocadherin-S),1347,"147,558",5 out of 5,2006-04-18,Evidence at transcript level
Q9Y5I3,PCDA1_HUMAN,Protocadherin alpha-1 (PCDH-alpha-1),950,"102,952",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5H5,PCDA9_HUMAN,Protocadherin alpha-9 (PCDH-alpha-9),950,"102,402",5 out of 5,2001-04-27,Evidence at transcript level
Q9UN75,PCDAC_HUMAN,Protocadherin alpha-12 (PCDH-alpha-12),941,"101,652",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E5,PCDB4_HUMAN,Protocadherin beta-4 (PCDH-beta-4),795,"87,270",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E3,PCDB6_HUMAN,Protocadherin beta-6 (PCDH-beta-6),794,"87,350",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E2,PCDB7_HUMAN,Protocadherin beta-7 (PCDH-beta-7),793,"86,707",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5F0,PCDBD_HUMAN,Protocadherin beta-13 (PCDH-beta-13),798,"87,552",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5G9,PCDG4_HUMAN,Protocadherin gamma-A4 (PCDH-gamma-A4),931,"100,589",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G6,PCDG7_HUMAN,Protocadherin gamma-A7 (PCDH-gamma-A7),932,"101,722",4 out of 5,2003-10-24,Evidence at transcript level
Q9UN71,PCDGG_HUMAN,Protocadherin gamma-B4 (PCDH-gamma-B4) (Cadherin-20) (Fibroblast cadherin-2),923,"99,927",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5F7,PCDGL_HUMAN,Protocadherin gamma-C4 (PCDH-gamma-C4),938,"101,214",3 out of 5,2003-10-24,Evidence at transcript level
O60245,PCDH7_HUMAN,Protocadherin-7 (Brain-heart protocadherin) (BH-Pcdh),1069,"116,071",4 out of 5,2001-12-05,Evidence at protein level
P07237,PDIA1_HUMAN,Protein disulfide-isomerase (PDI) (EC 5.3.4.1) (Cellular thyroid hormone-binding protein) (Prolyl 4-hydroxylase subunit beta) (p55),508,"57,116",5 out of 5,1988-04-01,Evidence at protein level
Q8WWR9,PDPFL_HUMAN,Pancreatic progenitor cell differentiation and proliferation factor-like protein (Exocrine differentiation and proliferation factor-like protein),84,"9,188",2 out of 5,2006-03-21,Inferred from homology
Q6A1A2,PDPK2_HUMAN,Putative 3-phosphoinositide-dependent protein kinase 2 (EC 2.7.11.1) (3-phosphoinositide-dependent protein kinase 2 pseudogene),396,"44,765",4 out of 5,2008-07-01,Uncertain
Q86YL7,PDPN_HUMAN,Podoplanin (Aggrus) (Glycoprotein 36) (Gp36) (PA2.26 antigen) (T1-alpha) (T1A),162,"16,698",5 out of 5,2006-02-21,Evidence at protein level
Q6P996,PDXD1_HUMAN,Pyridoxal-dependent decarboxylase domain-containing protein 1 (EC 4.1.1.-),788,"86,707",4 out of 5,2007-08-21,Evidence at protein level
P35408,PE2R4_HUMAN,Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor),488,"53,119",5 out of 5,1994-06-01,Evidence at protein level
Q15121,PEA15_HUMAN,Astrocytic phosphoprotein PEA-15 (15 kDa phosphoprotein enriched in astrocytes) (Phosphoprotein enriched in diabetes) (PED),130,"15,040",5 out of 5,1997-11-01,Evidence at protein level
O15534,PER1_HUMAN,Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui),1290,"136,212",5 out of 5,1999-07-15,Evidence at protein level
P47712,PA24A_HUMAN,Cytosolic phospholipase A2 (cPLA2) (Phospholipase A2 group IVA) [Includes: Phospholipase A2 (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase); Lysophospholipase (EC 3.1.1.5)],749,"85,239",5 out of 5,1996-02-01,Evidence at protein level
Q86XP0,PA24D_HUMAN,Cytosolic phospholipase A2 delta (cPLA2-delta) (EC 3.1.1.4) (Phospholipase A2 group IVD),818,"91,952",5 out of 5,2006-07-25,Evidence at protein level
Q13093,PAFA_HUMAN,Platelet-activating factor acetylhydrolase (PAF acetylhydrolase) (EC 3.1.1.47) (1-alkyl-2-acetylglycerophosphocholine esterase) (2-acetyl-1-alkylglycerophosphocholine esterase) (Group-VIIA phospholipase A2) (gVIIA-PLA2) (LDL-associated phospholipase A2) (LDL-PLA(2)) (PAF 2-acylhydrolase),441,"50,077",5 out of 5,1997-11-01,Evidence at protein level
Q9BPZ3,PAIP2_HUMAN,Polyadenylate-binding protein-interacting protein 2 (PABP-interacting protein 2) (PAIP-2) (Poly(A)-binding protein-interacting protein 2),127,"14,984",5 out of 5,2004-04-13,Evidence at protein level
Q9NQU5,PAK6_HUMAN,Serine/threonine-protein kinase PAK 6 (EC 2.7.11.1) (PAK-5) (p21-activated kinase 6) (PAK-6),681,"74,869",5 out of 5,2002-09-19,Evidence at protein level
Q9ULE6,PALD_HUMAN,Paladin,856,"96,754",4 out of 5,2007-05-01,Evidence at protein level
Q15546,PAQRB_HUMAN,Monocyte to macrophage differentiation factor (Progestin and adipoQ receptor family member 11) (Progestin and adipoQ receptor family member XI),238,"27,667",4 out of 5,1999-07-15,Evidence at transcript level
Q9NR21,PAR11_HUMAN,Poly [ADP-ribose] polymerase 11 (PARP-11) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 11) (ARTD11),331,"38,739",5 out of 5,2007-01-23,Evidence at protein level
Q8N5Y8,PAR16_HUMAN,Mono [ADP-ribose] polymerase PARP16 (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 15) (Poly [ADP-ribose] polymerase 16) (PARP-16),322,"36,383",5 out of 5,2006-10-17,Evidence at protein level
P55085,PAR2_HUMAN,"Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2]",397,"44,126",5 out of 5,1996-10-01,Evidence at protein level
P30039,PBLD_HUMAN,Phenazine biosynthesis-like domain-containing protein (EC 5.1.-.-) (MAWD-binding protein) (MAWDBP) (Unknown protein 32 from 2D-page of liver tissue),288,"31,785",5 out of 5,1993-04-01,Evidence at protein level
Q9BYU1,PBX4_HUMAN,Pre-B-cell leukemia transcription factor 4 (Homeobox protein PBX4),374,"40,854",3 out of 5,2003-10-24,Evidence at protein level
Q96JQ0,PCD16_HUMAN,Protocadherin-16 (Cadherin-19) (Cadherin-25) (Fibroblast cadherin-1) (Protein dachsous homolog 1),3298,"346,181",5 out of 5,2002-02-11,Evidence at protein level
Q9BYE7,PCGF6_HUMAN,Polycomb group RING finger protein 6 (Mel18 and Bmi1-like RING finger) (RING finger protein 134),350,"39,047",5 out of 5,2005-10-11,Evidence at protein level
Q8IVA1,PCP2_HUMAN,Purkinje cell protein 2 homolog,136,"14,547",2 out of 5,2003-04-11,Evidence at protein level
P29122,PCSK6_HUMAN,Proprotein convertase subtilisin/kexin type 6 (EC 3.4.21.-) (Paired basic amino acid cleaving enzyme 4) (Subtilisin-like proprotein convertase 4) (SPC4) (Subtilisin/kexin-like protease PACE4),969,"106,420",5 out of 5,1992-12-01,Evidence at protein level
Q9NZ42,PEN2_HUMAN,Gamma-secretase subunit PEN-2 (Presenilin enhancer protein 2),101,"12,029",5 out of 5,2003-09-26,Evidence at protein level
P14222,PERF_HUMAN,Perforin-1 (P1) (Cytolysin) (Lymphocyte pore-forming protein) (PFP),555,"61,377",5 out of 5,1990-01-01,Evidence at protein level
Q5SV97,PERM1_HUMAN,PGC-1 and ERR-induced regulator in muscle protein 1 (PPARGC1 and ESRR-induced regulator in muscle 1) (Peroxisome proliferator-activated receptor gamma coactivator 1 and estrogen-related receptor-induced regulator in muscle 1),790,"81,351",3 out of 5,2007-09-11,Evidence at transcript level
P02818,OSTCN_HUMAN,Osteocalcin (Bone Gla protein) (BGP) (Gamma-carboxyglutamic acid-containing protein),100,"10,963",5 out of 5,1986-07-21,Evidence at protein level
Q86WC4,OSTM1_HUMAN,Osteopetrosis-associated transmembrane protein 1 (Chloride channel 7 beta subunit),334,"37,257",5 out of 5,2004-08-16,Evidence at protein level
Q7RTW8,OTOAN_HUMAN,Otoancorin,1153,"128,533",5 out of 5,2004-12-07,Evidence at protein level
Q8TE49,OTU7A_HUMAN,OTU domain-containing protein 7A (EC 3.4.19.12) (Zinc finger protein Cezanne 2),926,"100,677",5 out of 5,2004-08-31,Evidence at protein level
Q01804,OTUD4_HUMAN,OTU domain-containing protein 4 (EC 3.4.19.12) (HIV-1-induced protein HIN-1),1114,"124,045",5 out of 5,1994-06-01,Evidence at protein level
Q96BN8,OTUL_HUMAN,Ubiquitin thioesterase otulin (EC 3.4.19.12) (Deubiquitinating enzyme otulin) (OTU domain-containing deubiquitinase with linear linkage specificity) (Ubiquitin thioesterase Gumby),352,"40,263",5 out of 5,2006-11-28,Evidence at protein level
Q12889,OVGP1_HUMAN,Oviduct-specific glycoprotein (Estrogen-dependent oviduct protein) (Mucin-9) (Oviductal glycoprotein) (Oviductin),678,"75,421",5 out of 5,1997-11-01,Evidence at transcript level
Q6IE37,OVOS1_HUMAN,Ovostatin homolog 1,1185,"134,499",2 out of 5,2008-02-26,Evidence at transcript level
P83859,OX26_HUMAN,Orexigenic neuropeptide QRFP (P518) [Cleaved into: QRF-amide (Neuropeptide RF-amide) (Pyroglutamylated arginine-phenylalanine-amide peptide)],136,"14,941",4 out of 5,2004-07-19,Evidence at transcript level
Q9UQ80,PA2G4_HUMAN,Proliferation-associated protein 2G4 (Cell cycle protein p38-2G4 homolog) (hG4-1) (ErbB3-binding protein 1),394,"43,787",5 out of 5,2001-04-27,Evidence at protein level
P14555,PA2GA_HUMAN,"Phospholipase A2, membrane associated (EC 3.1.1.4) (GIIC sPLA2) (Group IIA phospholipase A2) (Non-pancreatic secretory phospholipase A2) (NPS-PLA2) (Phosphatidylcholine 2-acylhydrolase 2A)",144,"16,083",5 out of 5,1990-01-01,Evidence at protein level
P0CB38,PAB4L_HUMAN,Polyadenylate-binding protein 4-like (PABP-4-like) (Poly(A)-binding protein 4-like),370,"41,854",2 out of 5,2009-09-22,Evidence at transcript level
Q13310,PABP4_HUMAN,Polyadenylate-binding protein 4 (PABP-4) (Poly(A)-binding protein 4) (Activated-platelet protein 1) (APP-1) (Inducible poly(A)-binding protein) (iPABP),644,"70,783",5 out of 5,2000-12-01,Evidence at protein level
O60829,PAGE4_HUMAN,P antigen family member 4 (PAGE-4) (G antigen family C member 1) (PAGE-1),102,"11,153",2 out of 5,2001-01-11,Evidence at protein level
O14832,PAHX_HUMAN,"Phytanoyl-CoA dioxygenase, peroxisomal (EC 1.14.11.18) (Phytanic acid oxidase) (Phytanoyl-CoA alpha-hydroxylase) (PhyH)",338,"38,538",5 out of 5,1999-07-15,Evidence at protein level
P0DN37,PAL4G_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4G (PPIase A-like 4G) (EC 5.2.1.8) (Peptidylprolyl cis-trans isomerase A-like 4),164,"18,166",2 out of 5,2015-10-14,Inferred from homology
Q6UY27,PATE2_HUMAN,Prostate and testis expressed protein 2 (PATE-like protein M) (PATE-M),113,"13,015",3 out of 5,2006-12-12,Evidence at transcript level
Q06710,PAX8_HUMAN,Paired box protein Pax-8,450,"48,218",5 out of 5,1994-06-01,Evidence at protein level
P57723,PCBP4_HUMAN,Poly(rC)-binding protein 4 (Alpha-CP4),403,"41,482",4 out of 5,2001-01-11,Evidence at transcript level
Q9BSM1,PCGF1_HUMAN,Polycomb group RING finger protein 1 (Nervous system Polycomb-1) (NSPc1) (RING finger protein 68),259,"30,346",5 out of 5,2007-02-20,Evidence at protein level
Q15645,PCH2_HUMAN,Pachytene checkpoint protein 2 homolog (Human papillomavirus type 16 E1 protein-binding protein) (16E1-BP) (HPV16 E1 protein-binding protein) (Thyroid hormone receptor interactor 13) (Thyroid receptor-interacting protein 13) (TR-interacting protein 13) (TRIP-13),432,"48,551",5 out of 5,1997-11-01,Evidence at protein level
Q5JVF3,PCID2_HUMAN,PCI domain-containing protein 2 (CSN12-like protein),399,"46,030",5 out of 5,2006-01-10,Evidence at protein level
Q15154,PCM1_HUMAN,Pericentriolar material 1 protein (PCM-1) (hPCM-1),2024,"228,533",5 out of 5,2007-01-23,Evidence at protein level
Q9UHG2,PCSK1_HUMAN,ProSAAS (Proprotein convertase subtilisin/kexin type 1 inhibitor) (Proprotein convertase 1 inhibitor) (pro-SAAS) [Cleaved into: KEP; Big SAAS (b-SAAS); Little SAAS (l-SAAS) (N-proSAAS); Big PEN-LEN (b-PEN-LEN) (SAAS CT(1-49)); PEN; Little LEN (l-LEN); Big LEN (b-LEN) (SAAS CT(25-40))],260,"27,372",5 out of 5,2006-10-31,Evidence at protein level
P49585,PCY1A_HUMAN,Choline-phosphate cytidylyltransferase A (EC 2.7.7.15) (CCT-alpha) (CTP:phosphocholine cytidylyltransferase A) (CCT A) (CT A) (Phosphorylcholine transferase A),367,"41,731",5 out of 5,1996-02-01,Evidence at protein level
Q99447,PCY2_HUMAN,Ethanolamine-phosphate cytidylyltransferase (EC 2.7.7.14) (CTP:phosphoethanolamine cytidylyltransferase) (Phosphorylethanolamine transferase),389,"43,835",5 out of 5,2001-01-24,Evidence at protein level
Q15116,PDCD1_HUMAN,Programmed cell death protein 1 (Protein PD-1) (hPD-1) (CD antigen CD279),288,"31,647",5 out of 5,1997-11-01,Evidence at protein level
O14737,PDCD5_HUMAN,Programmed cell death protein 5 (TF-1 cell apoptosis-related protein 19) (Protein TFAR19),125,"14,285",5 out of 5,2000-05-30,Evidence at protein level
P04085,PDGFA_HUMAN,Platelet-derived growth factor subunit A (PDGF subunit A) (PDGF-1) (Platelet-derived growth factor A chain) (Platelet-derived growth factor alpha polypeptide),211,"24,043",5 out of 5,1986-11-01,Evidence at protein level
P01127,PDGFB_HUMAN,Platelet-derived growth factor subunit B (PDGF subunit B) (PDGF-2) (Platelet-derived growth factor B chain) (Platelet-derived growth factor beta polypeptide) (Proto-oncogene c-Sis) (Becaplermin),241,"27,283",5 out of 5,1986-07-21,Evidence at protein level
Q9Y2S7,PDIP2_HUMAN,Polymerase delta-interacting protein 2 (38 kDa DNA polymerase delta interaction protein) (p38),368,"42,033",4 out of 5,2004-07-19,Evidence at protein level
Q8NCN5,PDPR_HUMAN,"Pyruvate dehydrogenase phosphatase regulatory subunit, mitochondrial (PDPr)",879,"99,364",3 out of 5,2008-04-08,Evidence at protein level
Q9NTI5,PDS5B_HUMAN,Sister chromatid cohesion protein PDS5 homolog B (Androgen-induced proliferation inhibitor) (Androgen-induced prostate proliferative shutoff-associated protein AS3),1447,"164,667",5 out of 5,2007-05-15,Evidence at protein level
P48539,PCP4_HUMAN,Purkinje cell protein 4 (Brain-specific antigen PCP-4) (Brain-specific polypeptide PEP-19),62,"6,791",4 out of 5,1996-02-01,Evidence at protein level
Q9Y365,PCTL_HUMAN,PCTP-like protein (PCTP-L) (Antigen NY-CO-28) (START domain-containing protein 10) (StARD10) (Serologically defined colon cancer antigen 28) (StAR-related lipid transfer protein 10),291,"33,049",5 out of 5,2002-11-15,Evidence at protein level
Q9Y5K3,PCY1B_HUMAN,Choline-phosphate cytidylyltransferase B (EC 2.7.7.15) (CCT-beta) (CTP:phosphocholine cytidylyltransferase B) (CCT B) (CT B) (Phosphorylcholine transferase B),369,"41,940",5 out of 5,2001-01-24,Evidence at protein level
Q9NZQ7,PD1L1_HUMAN,Programmed cell death 1 ligand 1 (PD-L1) (PDCD1 ligand 1) (Programmed death ligand 1) (B7 homolog 1) (B7-H1) (CD antigen CD274),290,"33,275",5 out of 5,2005-05-10,Evidence at protein level
Q9BUL8,PDC10_HUMAN,Programmed cell death protein 10 (Cerebral cavernous malformations 3 protein) (TF-1 cell apoptosis-related protein 15),212,"24,702",5 out of 5,2005-10-11,Evidence at protein level
Q6L8Q7,PDE12_HUMAN,"2',5'-phosphodiesterase 12 (2'-PDE) (2-PDE) (EC 3.1.4.-) (Mitochondrial deadenylase) (EC 3.1.13.4)",609,"67,352",4 out of 5,2008-03-18,Evidence at protein level
O76074,PDE5A_HUMAN,"cGMP-specific 3',5'-cyclic phosphodiesterase (EC 3.1.4.35) (cGMP-binding cGMP-specific phosphodiesterase) (CGB-PDE)",875,"99,985",5 out of 5,1999-07-15,Evidence at protein level
P51160,PDE6C_HUMAN,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha' (EC 3.1.4.35) (cGMP phosphodiesterase 6C)",858,"99,147",5 out of 5,1996-10-01,Evidence at protein level
O95263,PDE8B_HUMAN,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B (HsPDE8B) (EC 3.1.4.53) (Cell proliferation-inducing gene 22 protein)",885,"98,979",5 out of 5,2000-05-30,Evidence at protein level
Q15084,PDIA6_HUMAN,Protein disulfide-isomerase A6 (EC 5.3.4.1) (Endoplasmic reticulum protein 5) (ER protein 5) (ERp5) (Protein disulfide isomerase P5) (Thioredoxin domain-containing protein 7),440,"48,121",5 out of 5,1997-11-01,Evidence at protein level
Q9NUG6,PDRG1_HUMAN,p53 and DNA damage-regulated protein 1,133,"15,511",2 out of 5,2002-10-19,Evidence at protein level
Q6P474,PDXD2_HUMAN,Putative pyridoxal-dependent decarboxylase domain-containing protein 2 (EC 4.1.1.-) (pyridoxal-dependent decarboxylase domain-containing 2 pseudogene),469,"51,810",3 out of 5,2007-11-13,Uncertain
Q13113,PDZ1I_HUMAN,PDZK1-interacting protein 1 (17 kDa membrane-associated protein) (Protein DD96),114,"12,227",3 out of 5,2000-05-30,Evidence at protein level
Q76G19,PDZD4_HUMAN,PDZ domain-containing protein 4 (PDZ domain-containing RING finger protein 4-like protein),769,"86,171",3 out of 5,2005-02-01,Evidence at protein level
Q13951,PEBB_HUMAN,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),182,"21,508",5 out of 5,1997-11-01,Evidence at protein level
P0DJD8,PEPA3_HUMAN,Pepsin A-3 (EC 3.4.23.1) (Pepsinogen-3),388,"41,976",5 out of 5,2012-02-22,Evidence at protein level
P0DJD9,PEPA5_HUMAN,Pepsin A-5 (EC 3.4.23.1) (Pepsinogen-5),388,"41,993",5 out of 5,2012-02-22,Evidence at protein level
Q96BD5,PF21A_HUMAN,PHD finger protein 21A (BHC80a) (BRAF35-HDAC complex protein BHC80),680,"74,854",5 out of 5,2006-03-07,Evidence at protein level
P18669,PGAM1_HUMAN,Phosphoglycerate mutase 1 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 1) (Phosphoglycerate mutase isozyme B) (PGAM-B),254,"28,804",5 out of 5,1990-11-01,Evidence at protein level
Q96GW7,PGCB_HUMAN,Brevican core protein (Brain-enriched hyaluronan-binding protein) (BEHAB) (Chondroitin sulfate proteoglycan 7),911,"99,118",5 out of 5,2004-08-16,Evidence at protein level
Q9H7Z7,PGES2_HUMAN,Prostaglandin E synthase 2 (Membrane-associated prostaglandin E synthase-2) (mPGE synthase-2) (Microsomal prostaglandin E synthase 2) (mPGES-2) (Prostaglandin-H(2) E-isomerase) (EC 5.3.99.3) [Cleaved into: Prostaglandin E synthase 2 truncated form],377,"41,943",5 out of 5,2005-08-30,Evidence at protein level
P16234,PGFRA_HUMAN,Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a),1089,"122,670",5 out of 5,1990-04-01,Evidence at protein level
P09619,PGFRB_HUMAN,Platelet-derived growth factor receptor beta (PDGF-R-beta) (PDGFR-beta) (EC 2.7.10.1) (Beta platelet-derived growth factor receptor) (Beta-type platelet-derived growth factor receptor) (CD140 antigen-like family member B) (Platelet-derived growth factor receptor 1) (PDGFR-1) (CD antigen CD140b),1106,"123,968",5 out of 5,1989-07-01,Evidence at protein level
P00558,PGK1_HUMAN,Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2),417,"44,615",5 out of 5,1986-07-21,Evidence at protein level
Q99623,PHB2_HUMAN,Prohibitin-2 (B-cell receptor-associated protein BAP37) (D-prohibitin) (Repressor of estrogen receptor activity),299,"33,296",5 out of 5,2005-09-27,Evidence at protein level
Q8IXK0,PHC2_HUMAN,Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2),858,"90,713",5 out of 5,2006-01-10,Evidence at protein level
Q8WUB8,PHF10_HUMAN,PHD finger protein 10 (BRG1-associated factor 45a) (BAF45a) (XAP135),498,"56,051",5 out of 5,2005-04-26,Evidence at protein level
Q96RV3,PCX1_HUMAN,Pecanex-like protein 1 (Pecanex homolog protein 1),2341,"258,676",4 out of 5,2003-10-03,Evidence at protein level
A6NKB5,PCX2_HUMAN,Pecanex-like protein 2 (Pecanex homolog protein 2),2137,"237,277",4 out of 5,2008-05-20,Evidence at transcript level
Q53EL6,PDCD4_HUMAN,Programmed cell death protein 4 (Neoplastic transformation inhibitor protein) (Nuclear antigen H731-like) (Protein 197/15a),469,"51,735",5 out of 5,2006-10-31,Evidence at protein level
Q9H2J4,PDCL3_HUMAN,Phosducin-like protein 3 (HTPHLP) (PhPL3) (Viral IAP-associated factor 1) (VIAF-1),239,"27,614",5 out of 5,2004-07-19,Evidence at protein level
Q8NB37,PDDC1_HUMAN,Parkinson disease 7 domain-containing protein 1,220,"23,298",3 out of 5,2007-10-02,Evidence at protein level
O00408,PDE2A_HUMAN,"cGMP-dependent 3',5'-cyclic phosphodiesterase (EC 3.1.4.17) (Cyclic GMP-stimulated phosphodiesterase) (CGS-PDE) (cGSPDE)",941,"105,717",5 out of 5,1998-07-15,Evidence at protein level
Q9NP56,PDE7B_HUMAN,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B (EC 3.1.4.53)",450,"51,835",5 out of 5,2001-04-27,Evidence at protein level
Q14554,PDIA5_HUMAN,Protein disulfide-isomerase A5 (EC 5.3.4.1) (Protein disulfide isomerase-related protein),519,"59,594",5 out of 5,1997-11-01,Evidence at protein level
O15530,PDPK1_HUMAN,3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1),556,"63,152",5 out of 5,2001-10-18,Evidence at protein level
Q9BY49,PECR_HUMAN,"Peroxisomal trans-2-enoyl-CoA reductase (TERP) (EC 1.3.1.38) (2,4-dienoyl-CoA reductase-related protein) (DCR-RP) (HPDHase) (Short chain dehydrogenase/reductase family 29C member 1) (pVI-ARL)",303,"32,544",5 out of 5,2005-03-29,Evidence at protein level
O00623,PEX12_HUMAN,Peroxisome assembly protein 12 (Peroxin-12) (Peroxisome assembly factor 3) (PAF-3),359,"40,797",5 out of 5,1998-07-15,Evidence at protein level
O43933,PEX1_HUMAN,Peroxisome biogenesis factor 1 (Peroxin-1) (Peroxisome biogenesis disorder protein 1),1283,"142,867",5 out of 5,2000-05-30,Evidence at protein level
Q8NBL1,PGLT1_HUMAN,Protein O-glucosyltransferase 1 (EC 2.4.1.-) (CAP10-like 46 kDa protein) (hCLP46) (KTEL motif-containing protein 1) (Myelodysplastic syndromes relative protein) (O-glucosyltransferase Rumi homolog) (hRumi) (Protein O-xylosyltransferase POGLUT1) (EC 2.4.2.26),392,"46,189",5 out of 5,2006-07-25,Evidence at protein level
O00264,PGRC1_HUMAN,Membrane-associated progesterone receptor component 1 (mPR),195,"21,671",5 out of 5,2000-05-30,Evidence at protein level
Q92696,PGTA_HUMAN,Geranylgeranyl transferase type-2 subunit alpha (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit alpha) (Rab geranyl-geranyltransferase subunit alpha) (Rab GG transferase alpha) (Rab GGTase alpha) (Rab geranylgeranyltransferase subunit alpha),567,"65,072",5 out of 5,1997-11-01,Evidence at protein level
Q9C0D0,PHAR1_HUMAN,Phosphatase and actin regulator 1,580,"66,308",5 out of 5,2004-06-07,Evidence at protein level
O94880,PHF14_HUMAN,PHD finger protein 14,888,"100,053",3 out of 5,2003-08-15,Evidence at protein level
O43189,PHF1_HUMAN,PHD finger protein 1 (Protein PHF1) (hPHF1) (Polycomb-like protein 1) (hPCl1),567,"62,106",5 out of 5,2000-12-01,Evidence at protein level
Q9UPV7,PHF24_HUMAN,PHD finger protein 24,400,"45,192",3 out of 5,2005-08-16,Evidence at protein level
Q7RTV0,PHF5A_HUMAN,PHD finger-like domain-containing protein 5A (PHD finger-like domain protein 5A) (Splicing factor 3B-associated 14 kDa protein) (SF3b14b),110,"12,405",5 out of 5,2004-04-26,Evidence at protein level
Q8IWS0,PHF6_HUMAN,PHD finger protein 6 (PHD-like zinc finger protein),365,"41,290",5 out of 5,2004-02-16,Evidence at protein level
C9JFL3,PHGR1_HUMAN,"Proline, histidine and glycine-rich protein 1",82,"7,706",1 out of 5,2010-06-15,Predicted
Q16816,PHKG1_HUMAN,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform (PHK-gamma-M) (EC 2.7.11.19) (Phosphorylase kinase subunit gamma-1) (Serine/threonine-protein kinase PHKG1) (EC 2.7.11.1) (EC 2.7.11.26)",387,"45,024",5 out of 5,1997-11-01,Evidence at transcript level
Q53GA4,PHLA2_HUMAN,Pleckstrin homology-like domain family A member 2 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene C protein) (Imprinted in placenta and liver protein) (Tumor-suppressing STF cDNA 3 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 3 protein) (p17-Beckwith-Wiedemann region 1 C) (p17-BWR1C),152,"17,092",4 out of 5,2005-12-20,Evidence at protein level
Q9H792,PEAK1_HUMAN,Pseudopodium-enriched atypical kinase 1 (EC 2.7.10.2) (Sugen kinase 269) (Tyrosine-protein kinase SgK269),1746,"193,106",5 out of 5,2006-10-03,Evidence at protein level
P36955,PEDF_HUMAN,Pigment epithelium-derived factor (PEDF) (Cell proliferation-inducing gene 35 protein) (EPC-1) (Serpin F1),418,"46,312",5 out of 5,1994-06-01,Evidence at protein level
Q96FA3,PELI1_HUMAN,E3 ubiquitin-protein ligase pellino homolog 1 (Pellino-1) (EC 2.3.2.27) (Pellino-related intracellular-signaling molecule) (RING-type E3 ubiquitin transferase pellino homolog 1),418,"46,286",5 out of 5,2003-10-24,Evidence at protein level
P01210,PENK_HUMAN,Proenkephalin-A [Cleaved into: Synenkephalin; Met-enkephalin (Opioid growth factor) (OGF); PENK(114-133); PENK(143-183); Met-enkephalin-Arg-Gly-Leu; Leu-enkephalin; PENK(237-258); Met-enkephalin-Arg-Phe],267,"30,787",5 out of 5,1986-07-21,Evidence at protein level
O60683,PEX10_HUMAN,Peroxisome biogenesis factor 10 (Peroxin-10) (Peroxisomal biogenesis factor 10) (Peroxisome assembly protein 10) (RING finger protein 69),326,"37,069",5 out of 5,1998-12-15,Evidence at protein level
O75381,PEX14_HUMAN,Peroxisomal membrane protein PEX14 (PTS1 receptor-docking protein) (Peroxin-14) (Peroxisomal membrane anchor protein PEX14),377,"41,237",5 out of 5,2000-05-30,Evidence at protein level
Q96EK2,PF21B_HUMAN,PHD finger protein 21B,531,"57,455",3 out of 5,2006-03-07,Evidence at transcript level
P43088,PF2R_HUMAN,Prostaglandin F2-alpha receptor (PGF receptor) (PGF2-alpha receptor) (Prostanoid FP receptor),359,"40,055",5 out of 5,1995-11-01,Evidence at protein level
P10720,PF4V_HUMAN,Platelet factor 4 variant (C-X-C motif chemokine 4 variant) (CXCL4L1) (PF4alt) (PF4var1) [Cleaved into: Platelet factor 4 variant(4-74); Platelet factor 4 variant(5-74); Platelet factor 4 variant(6-74)],104,"11,553",5 out of 5,1989-07-01,Evidence at protein level
P17858,PFKAL_HUMAN,"ATP-dependent 6-phosphofructokinase, liver type (ATP-PFK) (PFK-L) (EC 2.7.1.11) (6-phosphofructokinase type B) (Phosphofructo-1-kinase isozyme B) (PFK-B) (Phosphohexokinase)",780,"85,018",5 out of 5,1990-08-01,Evidence at protein level
Q9BX93,PG12B_HUMAN,Group XIIB secretory phospholipase A2-like protein (Group XIII secretory phospholipase A2-like protein) (GXIII sPLA2-like) (sPLA2-GXIIB) (GXIIB),195,"21,659",4 out of 5,2002-04-16,Evidence at protein level
Q96HS1,PGAM5_HUMAN,"Serine/threonine-protein phosphatase PGAM5, mitochondrial (EC 3.1.3.16) (Bcl-XL-binding protein v68) (Phosphoglycerate mutase family member 5)",289,"32,004",5 out of 5,2007-05-29,Evidence at protein level
Q96JS3,PGBD1_HUMAN,PiggyBac transposable element-derived protein 1 (Cerebral protein 4),809,"92,515",5 out of 5,2007-05-29,Evidence at protein level
P23219,PGH1_HUMAN,Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1),599,"68,686",5 out of 5,1991-11-01,Evidence at protein level
P36871,PGM1_HUMAN,Phosphoglucomutase-1 (PGM 1) (EC 5.4.2.2) (Glucose phosphomutase 1),562,"61,449",5 out of 5,1994-06-01,Evidence at protein level
Q8TBX8,PI42C_HUMAN,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (EC 2.7.1.149) (Phosphatidylinositol 5-phosphate 4-kinase type II gamma) (PI(5)P 4-kinase type II gamma) (PIP4KII-gamma),421,"47,300",5 out of 5,2007-05-01,Evidence at protein level
O60331,PI51C_HUMAN,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma (PIP5K1-gamma) (PtdIns(4)P-5-kinase 1 gamma) (EC 2.7.1.68) (Phosphatidylinositol 4-phosphate 5-kinase type I gamma) (PIP5KIgamma),668,"73,260",5 out of 5,2005-10-25,Evidence at protein level
Q15735,PI5PA_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.56) (Inositol polyphosphate 5-phosphatase J)",1006,"107,197",5 out of 5,2003-04-30,Evidence at protein level
Q9NRD5,PICK1_HUMAN,PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein),415,"46,600",5 out of 5,2002-08-02,Evidence at protein level
Q92535,PIGC_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit C (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class C protein) (PIG-C),297,"33,583",4 out of 5,2001-07-11,Evidence at transcript level
Q86VD9,PIGZ_HUMAN,GPI mannosyltransferase 4 (EC 2.4.1.-) (GPI mannosyltransferase IV) (GPI-MT-IV) (Phosphatidylinositol-glycan biosynthesis class Z protein) (PIG-Z) (SMP3 homolog) (hSMP3),579,"63,471",5 out of 5,2006-07-25,Evidence at transcript level
Q9NQM4,PIHD3_HUMAN,Protein PIH1D3 (PIH1 domain-containing protein 3) (Sarcoma antigen NY-SAR-97),214,"24,069",4 out of 5,2005-07-19,Evidence at protein level
P48739,PIPNB_HUMAN,Phosphatidylinositol transfer protein beta isoform (PI-TP-beta) (PtdIns transfer protein beta) (PtdInsTP beta),271,"31,540",4 out of 5,1996-02-01,Evidence at protein level
Q9UKF7,PITC1_HUMAN,Cytoplasmic phosphatidylinositol transfer protein 1 (Mammalian rdgB homolog beta) (M-rdgB beta) (MrdgBbeta) (Retinal degeneration B homolog beta) (RdgBbeta),332,"38,388",5 out of 5,2007-05-15,Evidence at protein level
Q7Z3Z3,PIWL3_HUMAN,Piwi-like protein 3,882,"101,089",3 out of 5,2006-05-16,Evidence at transcript level
Q9NWT1,PK1IP_HUMAN,p21-activated protein kinase-interacting protein 1 (PAK/PLC-interacting protein 1) (hPIP1) (PAK1-interacting protein 1) (WD repeat-containing protein 84),392,"43,964",4 out of 5,2005-07-19,Evidence at protein level
Q9ULL1,PKHG1_HUMAN,Pleckstrin homology domain-containing family G member 1,1385,"155,439",3 out of 5,2003-05-09,Evidence at protein level
Q3KR16,PKHG6_HUMAN,Pleckstrin homology domain-containing family G member 6 (PH domain-containing family G member 6) (Myosin-interacting guanine nucleotide exchange factor) (MyoGEF),790,"88,960",5 out of 5,2007-10-23,Evidence at protein level
Q8TD55,PKHO2_HUMAN,Pleckstrin homology domain-containing family O member 2 (PH domain-containing family O member 2) (Pleckstrin homology domain-containing family Q member 1) (PH domain-containing family Q member 1),490,"53,350",3 out of 5,2007-11-13,Evidence at protein level
Q16512,PKN1_HUMAN,Serine/threonine-protein kinase N1 (EC 2.7.11.13) (Protease-activated kinase 1) (PAK-1) (Protein kinase C-like 1) (Protein kinase C-like PKN) (Protein kinase PKN-alpha) (Protein-kinase C-related kinase 1) (Serine-threonine protein kinase N),942,"103,932",5 out of 5,1999-07-15,Evidence at protein level
Q9NZF1,PLAC8_HUMAN,Placenta-specific gene 8 protein (Protein C15),115,"12,507",3 out of 5,2003-09-19,Evidence at transcript level
Q6DJT9,PLAG1_HUMAN,Zinc finger protein PLAG1 (Pleiomorphic adenoma gene 1 protein),500,"55,909",5 out of 5,2007-07-10,Evidence at protein level
Q9Y263,PLAP_HUMAN,Phospholipase A-2-activating protein (PLA2P) (PLAP),795,"87,157",5 out of 5,2001-01-11,Evidence at protein level
Q6P4A8,PLBL1_HUMAN,Phospholipase B-like 1 (EC 3.1.1.-) (LAMA-like protein 1) (Lamina ancestor homolog 1) (Phospholipase B domain-containing protein 1) [Cleaved into: Phospholipase B-like 1 chain A; Phospholipase B-like 1 chain B; Phospholipase B-like 1 chain C],553,"63,255",5 out of 5,2007-05-01,Evidence at protein level
Q15147,PLCB4_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-4) (Phospholipase C-beta-4) (PLC-beta-4)",1175,"134,464",5 out of 5,2001-01-11,Evidence at protein level
O15120,PLCB_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase beta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 2) (1-AGP acyltransferase 2) (1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta) (LPAAT-beta),278,"30,914",5 out of 5,1998-12-15,Evidence at protein level
P51178,PLCD1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-1) (Phospholipase C-III) (PLC-III) (Phospholipase C-delta-1) (PLC-delta-1)",756,"85,665",5 out of 5,1996-10-01,Evidence at protein level
Q96S96,PEBP4_HUMAN,Phosphatidylethanolamine-binding protein 4 (PEBP-4) (hPEBP4) (Protein cousin-of-RKIP 1),227,"25,733",4 out of 5,2004-04-26,Evidence at protein level
Q9H1Q7,PED1A_HUMAN,PC-esterase domain-containing protein 1A (Protein FAM113A) (Sarcoma antigen NY-SAR-23),454,"51,782",3 out of 5,2002-11-08,Evidence at protein level
O15055,PER2_HUMAN,Period circadian protein homolog 2 (hPER2) (Circadian clock protein PERIOD 2),1255,"136,579",5 out of 5,1999-07-15,Evidence at protein level
Q96FX8,PERP_HUMAN,p53 apoptosis effector related to PMP-22 (Keratinocyte-associated protein 1) (KCP-1) (P53-induced protein PIGPC1) (Transmembrane protein THW),193,"21,386",5 out of 5,2006-03-07,Evidence at transcript level
Q9Y5Y5,PEX16_HUMAN,Peroxisomal membrane protein PEX16 (Peroxin-16) (Peroxisomal biogenesis factor 16),336,"38,629",5 out of 5,2002-04-16,Evidence at protein level
P61758,PFD3_HUMAN,Prefoldin subunit 3 (HIBBJ46) (Von Hippel-Lindau-binding protein 1) (VBP-1) (VHL-binding protein 1),197,"22,658",5 out of 5,2004-06-07,Evidence at protein level
Q96FM1,PGAP3_HUMAN,Post-GPI attachment to proteins factor 3 (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1),320,"36,475",5 out of 5,2008-06-10,Evidence at protein level
Q96DM1,PGBD4_HUMAN,PiggyBac transposable element-derived protein 4,585,"67,004",1 out of 5,2007-05-29,Evidence at transcript level
Q96G03,PGM2_HUMAN,Phosphoglucomutase-2 (PGM 2) (EC 5.4.2.2) (Glucose phosphomutase 2) (Phosphodeoxyribomutase) (Phosphopentomutase) (EC 5.4.2.7),612,"68,283",5 out of 5,2005-07-19,Evidence at protein level
O15173,PGRC2_HUMAN,Membrane-associated progesterone receptor component 2 (Progesterone membrane-binding protein) (Steroid receptor protein DG6),223,"23,818",4 out of 5,2000-05-30,Evidence at protein level
Q96LB8,PGRP4_HUMAN,Peptidoglycan recognition protein 4 (Peptidoglycan recognition protein I-beta) (PGLYRPIbeta) (PGRP-I-beta) (Peptidoglycan recognition protein intermediate beta),373,"40,620",5 out of 5,2003-11-28,Evidence at protein level
P07585,PGS2_HUMAN,Decorin (Bone proteoglycan II) (PG-S2) (PG40),359,"39,747",5 out of 5,1988-04-01,Evidence at protein level
P00439,PH4H_HUMAN,Phenylalanine-4-hydroxylase (PAH) (EC 1.14.16.1) (Phe-4-monooxygenase),452,"51,862",5 out of 5,1986-07-21,Evidence at protein level
Q96KR7,PHAR3_HUMAN,Phosphatase and actin regulator 3 (Scaffold-associated PP1-inhibiting protein) (Scapinin),559,"62,552",5 out of 5,2003-11-28,Evidence at protein level
O60346,PHLP1_HUMAN,PH domain leucine-rich repeat-containing protein phosphatase 1 (EC 3.1.3.16) (Pleckstrin homology domain-containing family E member 1) (PH domain-containing family E member 1) (Suprachiasmatic nucleus circadian oscillatory protein) (hSCOP),1717,"184,672",5 out of 5,2005-06-07,Evidence at protein level
Q8N3S3,PHTF2_HUMAN,Putative homeodomain transcription factor 2,785,"88,757",4 out of 5,2008-02-05,Evidence at transcript level
P42356,PI4KA_HUMAN,Phosphatidylinositol 4-kinase alpha (PI4-kinase alpha) (PI4K-alpha) (PtdIns-4-kinase alpha) (EC 2.7.1.67),2102,"236,830",5 out of 5,1995-11-01,Evidence at protein level
A4QPH2,PI4P2_HUMAN,Putative phosphatidylinositol 4-kinase alpha-like protein P2,592,"66,944",3 out of 5,2008-02-26,Uncertain
Q8IYJ0,PIANP_HUMAN,PILR alpha-associated neural protein (PILR-associating neural protein) (Paired immunoglobin-like type 2 receptor-associating neural protein),282,"30,076",3 out of 5,2007-05-01,Evidence at transcript level
O75928,PIAS2_HUMAN,E3 SUMO-protein ligase PIAS2 (EC 6.3.2.-) (Androgen receptor-interacting protein 3) (ARIP3) (DAB2-interacting protein) (DIP) (Msx-interacting zinc finger protein) (Miz1) (PIAS-NY protein) (Protein inhibitor of activated STAT x) (Protein inhibitor of activated STAT2),621,"68,240",5 out of 5,2004-12-07,Evidence at protein level
Q13492,PICAL_HUMAN,Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein),652,"70,755",5 out of 5,2002-11-15,Evidence at protein level
Q07326,PIGF_HUMAN,Phosphatidylinositol-glycan biosynthesis class F protein (PIG-F) (GPI11 homolog),219,"24,890",3 out of 5,1995-02-01,Evidence at protein level
Q14442,PIGH_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit H (EC 2.4.1.198) (Phosphatidylinositol-glycan biosynthesis class H protein) (PIG-H),188,"21,081",5 out of 5,2002-12-13,Evidence at protein level
Q75T13,PGAP1_HUMAN,GPI inositol-deacylase (EC 3.1.-.-) (Post-GPI attachment to proteins factor 1) (hPGAP1),922,"105,383",5 out of 5,2007-02-06,Evidence at protein level
P16112,PGCA_HUMAN,Aggrecan core protein (Cartilage-specific proteoglycan core protein) (CSPCP) (Chondroitin sulfate proteoglycan core protein 1) (Chondroitin sulfate proteoglycan 1) [Cleaved into: Aggrecan core protein 2],2415,"250,193",5 out of 5,1990-04-01,Evidence at protein level
A6NDG6,PGP_HUMAN,Glycerol-3-phosphate phosphatase (G3PP) (EC 3.1.3.21) (Aspartate-based ubiquitous Mg(2+)-dependent phosphatase) (AUM) (EC 3.1.3.48) (Phosphoglycolate phosphatase) (PGP),321,"34,006",5 out of 5,2008-02-05,Evidence at protein level
Q96LB9,PGRP3_HUMAN,Peptidoglycan recognition protein 3 (Peptidoglycan recognition protein I-alpha) (PGLYRPIalpha) (PGRP-I-alpha) (Peptidoglycan recognition protein intermediate alpha),341,"37,611",5 out of 5,2003-11-28,Evidence at protein level
P21810,PGS1_HUMAN,Biglycan (Bone/cartilage proteoglycan I) (PG-S1),368,"41,654",5 out of 5,1991-05-01,Evidence at protein level
P53609,PGTB1_HUMAN,Geranylgeranyl transferase type-1 subunit beta (EC 2.5.1.59) (Geranylgeranyl transferase type I subunit beta) (GGTase-I-beta) (Type I protein geranyl-geranyltransferase subunit beta),377,"42,368",5 out of 5,1996-10-01,Evidence at protein level
Q9NWQ8,PHAG1_HUMAN,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 (Csk-binding protein) (Transmembrane adapter protein PAG) (Transmembrane phosphoprotein Cbp),432,"46,981",5 out of 5,2005-12-20,Evidence at protein level
P35232,PHB_HUMAN,Prohibitin,272,"29,804",5 out of 5,1994-02-01,Evidence at protein level
Q8NDX5,PHC3_HUMAN,Polyhomeotic-like protein 3 (Early development regulatory protein 3) (Homolog of polyhomeotic 3) (hPH3),983,"106,162",5 out of 5,2005-12-20,Evidence at protein level
Q9UIL8,PHF11_HUMAN,PHD finger protein 11 (BRCA1 C-terminus-associated protein) (Renal carcinoma antigen NY-REN-34),331,"37,582",5 out of 5,2003-10-03,Evidence at protein level
Q9BVI0,PHF20_HUMAN,PHD finger protein 20 (Glioma-expressed antigen 2) (Hepatocellular carcinoma-associated antigen 58) (Novel zinc finger protein) (Transcription factor TZP),1012,"115,386",5 out of 5,2003-07-11,Evidence at protein level
Q92576,PHF3_HUMAN,PHD finger protein 3,2039,"229,481",3 out of 5,2003-08-15,Evidence at protein level
Q9BWX1,PHF7_HUMAN,PHD finger protein 7 (Testis development protein NYD-SP6),381,"43,767",4 out of 5,2005-04-26,Evidence at protein level
Q9UPP1,PHF8_HUMAN,Histone lysine demethylase PHF8 (EC 1.14.11.27) (PHD finger protein 8),1060,"117,864",5 out of 5,2004-07-19,Evidence at protein level
P15735,PHKG2_HUMAN,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform (PHK-gamma-LT) (PHK-gamma-T) (EC 2.7.11.19) (PSK-C3) (Phosphorylase kinase subunit gamma-2)",406,"46,442",5 out of 5,1990-04-01,Evidence at protein level
Q86SQ0,PHLB2_HUMAN,Pleckstrin homology-like domain family B member 2 (Protein LL5-beta),1253,"142,158",5 out of 5,2005-12-20,Evidence at protein level
Q9Y3A3,PHOCN_HUMAN,MOB-like protein phocein (2C4D) (Class II mMOB1) (Mob1 homolog 3) (Mob3) (Mps one binder kinase activator-like 3) (Preimplantation protein 3),225,"26,032",5 out of 5,2004-12-21,Evidence at protein level
Q5H8A4,PIGG_HUMAN,GPI ethanolamine phosphate transferase 2 (EC 2.-.-.-) (GPI7 homolog) (hGPI7) (Phosphatidylinositol-glycan biosynthesis class G protein) (PIG-G),983,"108,173",5 out of 5,2006-07-25,Evidence at protein level
Q9H3S5,PIGM_HUMAN,GPI mannosyltransferase 1 (EC 2.4.1.-) (GPI mannosyltransferase I) (GPI-MT-I) (Phosphatidylinositol-glycan biosynthesis class M protein) (PIG-M),423,"49,460",4 out of 5,2006-07-25,Evidence at protein level
Q8TEQ8,PIGO_HUMAN,GPI ethanolamine phosphate transferase 3 (EC 2.-.-.-) (Phosphatidylinositol-glycan biosynthesis class O protein) (PIG-O),1089,"118,699",4 out of 5,2002-08-13,Evidence at protein level
Q96S52,PIGS_HUMAN,GPI transamidase component PIG-S (Phosphatidylinositol-glycan biosynthesis class S protein),555,"61,656",5 out of 5,2002-07-11,Evidence at protein level
Q8TBF5,PIGX_HUMAN,Phosphatidylinositol-glycan biosynthesis class X protein (PIG-X),258,"28,788",4 out of 5,2006-07-25,Evidence at transcript level
Q8WWB5,PIHD2_HUMAN,PIH1 domain-containing protein 2,315,"35,957",4 out of 5,2007-10-23,Evidence at protein level
P11309,PIM1_HUMAN,Serine/threonine-protein kinase pim-1 (EC 2.7.11.1),404,"45,412",5 out of 5,1989-07-01,Evidence at protein level
Q96J94,PIWL1_HUMAN,Piwi-like protein 1 (EC 3.1.26.-),861,"98,603",5 out of 5,2006-05-16,Evidence at protein level
Q8TC59,PIWL2_HUMAN,Piwi-like protein 2 (EC 3.1.26.-) (Cancer/testis antigen 80) (CT80),973,"109,849",5 out of 5,2006-05-16,Evidence at protein level
Q8NEB9,PK3C3_HUMAN,Phosphatidylinositol 3-kinase catalytic subunit type 3 (PI3-kinase type 3) (PI3K type 3) (PtdIns-3-kinase type 3) (EC 2.7.1.137) (Phosphatidylinositol 3-kinase p100 subunit) (Phosphoinositide-3-kinase class 3) (hVps34),887,"101,549",5 out of 5,2005-12-06,Evidence at protein level
O00329,PK3CD_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta)",1044,"119,479",5 out of 5,1998-07-15,Evidence at protein level
Q504Y2,PKDCC_HUMAN,"Extracellular tyrosine-protein kinase PKDCC (EC 2.7.10.2) (Protein kinase domain-containing protein, cytoplasmic) (Protein kinase-like protein SgK493) (Sugen kinase 493) (Vertebrate lonesome kinase)",493,"54,132",5 out of 5,2006-11-28,Evidence at transcript level
Q9HAU0,PKHA5_HUMAN,Pleckstrin homology domain-containing family A member 5 (PH domain-containing family A member 5) (Phosphoinositol 3-phosphate-binding protein 2) (PEPP-2),1116,"127,464",5 out of 5,2004-03-29,Evidence at protein level
A1L390,PKHG3_HUMAN,Pleckstrin homology domain-containing family G member 3 (PH domain-containing family G member 3),1219,"134,412",3 out of 5,2007-10-02,Evidence at protein level
Q9NW61,PKHJ1_HUMAN,Pleckstrin homology domain-containing family J member 1 (PH domain-containing family J member 1) (Guanine nucleotide-releasing protein x),149,"17,551",2 out of 5,2007-11-13,Evidence at protein level
P55347,PKNX1_HUMAN,Homeobox protein PKNOX1 (Homeobox protein PREP-1) (PBX/knotted homeobox 1),436,"47,607",4 out of 5,1997-11-01,Evidence at protein level
Q13835,PKP1_HUMAN,Plakophilin-1 (Band 6 protein) (B6P),747,"82,861",5 out of 5,2002-01-23,Evidence at protein level
Q6P1J6,PLB1_HUMAN,"Phospholipase B1, membrane-associated (Phospholipase B) (hPLB) (Phospholipase B/lipase) (PLB/LIP) [Includes: Phospholipase A2 (EC 3.1.1.4); Lysophospholipase (EC 3.1.1.5)]",1458,"163,081",5 out of 5,2008-03-18,Evidence at protein level
Q8NHP8,PLBL2_HUMAN,Putative phospholipase B-like 2 (EC 3.1.1.-) (76 kDa protein) (p76) (LAMA-like protein 2) (Lamina ancestor homolog 2) (Phospholipase B domain-containing protein 2) [Cleaved into: Putative phospholipase B-like 2 32 kDa form; Putative phospholipase B-like 2 45 kDa form],589,"65,472",5 out of 5,2007-05-01,Evidence at protein level
P19174,PLCG1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)",1290,"148,532",5 out of 5,1990-11-01,Evidence at protein level
Q9NUJ7,PLCX1_HUMAN,PI-PLC X domain-containing protein 1,323,"36,668",2 out of 5,2007-09-11,Evidence at transcript level
Q8IV08,PLD3_HUMAN,Phospholipase D3 (PLD 3) (EC 3.1.4.4) (Choline phosphatase 3) (HindIII K4L homolog) (Hu-K4) (Phosphatidylcholine-hydrolyzing phospholipase D3),490,"54,705",5 out of 5,2007-03-20,Evidence at protein level
Q8N7P1,PLD5_HUMAN,Inactive phospholipase D5 (Inactive PLD 5) (Inactive choline phosphatase 5) (Inactive phosphatidylcholine-hydrolyzing phospholipase D5) (PLDc),536,"61,312",3 out of 5,2007-05-29,Evidence at transcript level
Q8N2A8,PLD6_HUMAN,Mitochondrial cardiolipin hydrolase (EC 3.1.-.-) (Choline phosphatase 6) (Mitochondrial phospholipase) (MitoPLD) (Phosphatidylcholine-hydrolyzing phospholipase D6) (Phospholipase D6) (PLD 6) (Protein zucchini homolog),252,"28,273",5 out of 5,2008-03-18,Evidence at protein level
O00469,PLOD2_HUMAN,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2 (EC 1.14.11.4) (Lysyl hydroxylase 2) (LH2)",737,"84,686",5 out of 5,1998-12-15,Evidence at protein level
Q8N8W4,PLPL1_HUMAN,Patatin-like phospholipase domain-containing protein 1 (EC 3.1.1.-),532,"57,875",5 out of 5,2007-06-26,Evidence at protein level
Q7Z6Z6,PLPL5_HUMAN,Patatin-like phospholipase domain-containing protein 5 (EC 3.1.1.-) (GS2-like protein),429,"47,912",4 out of 5,2007-06-26,Evidence at transcript level
Q6ZV29,PLPL7_HUMAN,Patatin-like phospholipase domain-containing protein 7 (EC 3.1.1.-),1317,"145,733",5 out of 5,2007-07-10,Evidence at protein level
Q9NP80,PLPL8_HUMAN,Calcium-independent phospholipase A2-gamma (EC 3.1.1.5) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (PNPLA-gamma) (Patatin-like phospholipase domain-containing protein 8) (iPLA2-2),782,"88,477",5 out of 5,2007-09-11,Evidence at protein level
P40424,PBX1_HUMAN,Pre-B-cell leukemia transcription factor 1 (Homeobox protein PBX1) (Homeobox protein PRL),430,"46,626",5 out of 5,1995-02-01,Evidence at protein level
Q9UHG3,PCYOX_HUMAN,Prenylcysteine oxidase 1 (EC 1.8.3.5) (Prenylcysteine lyase),505,"56,640",5 out of 5,2000-12-01,Evidence at protein level
Q9Y5Y4,PD2R2_HUMAN,Prostaglandin D2 receptor 2 (Chemoattractant receptor-homologous molecule expressed on Th2 cells) (G-protein coupled receptor 44) (CD antigen CD294),395,"43,268",5 out of 5,2001-07-11,Evidence at protein level
Q13087,PDIA2_HUMAN,Protein disulfide-isomerase A2 (EC 5.3.4.1) (Pancreas-specific protein disulfide isomerase) (PDIp),525,"58,206",5 out of 5,1998-07-15,Evidence at protein level
O00151,PDLI1_HUMAN,PDZ and LIM domain protein 1 (C-terminal LIM domain protein 1) (Elfin) (LIM domain protein CLP-36),329,"36,072",5 out of 5,2000-05-30,Evidence at protein level
P50479,PDLI4_HUMAN,PDZ and LIM domain protein 4 (LIM protein RIL) (Reversion-induced LIM protein),330,"35,398",3 out of 5,1996-10-01,Evidence at protein level
P34995,PE2R1_HUMAN,Prostaglandin E2 receptor EP1 subtype (PGE receptor EP1 subtype) (PGE2 receptor EP1 subtype) (Prostanoid EP1 receptor),402,"41,801",4 out of 5,1994-02-01,Evidence at transcript level
P43115,PE2R3_HUMAN,Prostaglandin E2 receptor EP3 subtype (PGE receptor EP3 subtype) (PGE2 receptor EP3 subtype) (PGE2-R) (Prostanoid EP3 receptor),390,"43,310",5 out of 5,1995-11-01,Evidence at transcript level
Q5VY43,PEAR1_HUMAN,Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12),1037,"110,666",5 out of 5,2007-11-13,Evidence at protein level
Q96HM7,PED1B_HUMAN,PC-esterase domain-containing protein 1B (Protein FAM113B),432,"49,727",2 out of 5,2008-04-29,Evidence at protein level
Q9HAT8,PELI2_HUMAN,E3 ubiquitin-protein ligase pellino homolog 2 (Pellino-2) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase pellino homolog 2),420,"46,435",5 out of 5,2003-10-24,Evidence at protein level
Q9UBM1,PEMT_HUMAN,Phosphatidylethanolamine N-methyltransferase (PEAMT) (PEMT) (EC 2.1.1.17) (EC 2.1.1.71) (PEMT2) (Phospholipid methyltransferase) (PLMT),199,"22,134",5 out of 5,2000-12-01,Evidence at protein level
P0DJD7,PEPA4_HUMAN,Pepsin A-4 (EC 3.4.23.1) (Pepsinogen-4),388,"41,977",5 out of 5,2012-02-22,Evidence at protein level
Q8NDH3,PEPL1_HUMAN,Probable aminopeptidase NPEPL1 (EC 3.4.11.-) (Aminopeptidase-like 1),523,"55,861",5 out of 5,2003-04-23,Evidence at protein level
O00541,PESC_HUMAN,Pescadillo homolog,588,"68,003",5 out of 5,2002-06-20,Evidence at protein level
Q8TBF2,PGFS_HUMAN,Prostamide/prostaglandin F synthase (Prostamide/PG F synthase) (Prostamide/PGF synthase) (EC 1.11.1.20) (Protein FAM213B),198,"21,223",4 out of 5,2007-04-17,Evidence at protein level
Q9NXJ5,PGPI_HUMAN,Pyroglutamyl-peptidase 1 (EC 3.4.19.3) (5-oxoprolyl-peptidase) (Pyroglutamyl aminopeptidase I) (PAP-I) (Pyroglutamyl-peptidase I) (PGP-I) (Pyrrolidone-carboxylate peptidase),209,"23,138",5 out of 5,2001-06-20,Evidence at protein level
Q8TCT1,PHOP1_HUMAN,Phosphoethanolamine/phosphocholine phosphatase (EC 3.1.3.75),267,"29,713",5 out of 5,2006-01-10,Evidence at protein level
P20941,PHOS_HUMAN,Phosducin (PHD) (33 kDa phototransducing protein) (Protein MEKA),246,"28,246",5 out of 5,1991-02-01,Evidence at protein level
Q9P1Y6,PHRF1_HUMAN,PHD and RING finger domain-containing protein 1,1649,"178,666",4 out of 5,2007-02-20,Evidence at protein level
Q9UMS5,PHTF1_HUMAN,Putative homeodomain transcription factor 1,762,"87,252",3 out of 5,2002-09-19,Evidence at transcript level
Q99453,PHX2B_HUMAN,Paired mesoderm homeobox protein 2B (Neuroblastoma Phox) (NBPhox) (PHOX2B homeodomain protein) (Paired-like homeobox 2B),314,"31,621",5 out of 5,2000-05-30,Evidence at protein level
Q99570,PI3R4_HUMAN,Phosphoinositide 3-kinase regulatory subunit 4 (PI3-kinase regulatory subunit 4) (EC 2.7.11.1) (PI3-kinase p150 subunit) (Phosphoinositide 3-kinase adaptor protein),1358,"153,103",5 out of 5,2005-12-06,Evidence at protein level
Q9UBF8,PI4KB_HUMAN,Phosphatidylinositol 4-kinase beta (PI4K-beta) (PI4Kbeta) (PtdIns 4-kinase beta) (EC 2.7.1.67) (NPIK) (PI4K92),816,"91,379",5 out of 5,2003-11-14,Evidence at protein level
Q15118,PDK1_HUMAN,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)",436,"49,244",5 out of 5,1998-07-15,Evidence at protein level
Q9NR12,PDLI7_HUMAN,PDZ and LIM domain protein 7 (LIM mineralization protein) (LMP) (Protein enigma),457,"49,845",5 out of 5,2005-12-06,Evidence at protein level
Q9P0J1,PDP1_HUMAN,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial (PDP 1) (EC 3.1.3.43) (Protein phosphatase 2C) (Pyruvate dehydrogenase phosphatase catalytic subunit 1) (PDPC 1)",537,"61,054",5 out of 5,2001-01-24,Evidence at protein level
Q9P2J9,PDP2_HUMAN,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 2, mitochondrial (PDP 2) (EC 3.1.3.43) (Pyruvate dehydrogenase phosphatase catalytic subunit 2) (PDPC 2)",529,"59,978",4 out of 5,2001-01-24,Evidence at transcript level
O00764,PDXK_HUMAN,Pyridoxal kinase (EC 2.7.1.35) (Pyridoxine kinase),312,"35,102",5 out of 5,1997-11-01,Evidence at protein level
Q8NEN9,PDZD8_HUMAN,PDZ domain-containing protein 8 (Sarcoma antigen NY-SAR-84/NY-SAR-104),1154,"128,563",5 out of 5,2005-08-16,Evidence at protein level
P16284,PECA1_HUMAN,Platelet endothelial cell adhesion molecule (PECAM-1) (EndoCAM) (GPIIA') (PECA1) (CD antigen CD31),738,"82,536",5 out of 5,1990-04-01,Evidence at protein level
P07202,PERT_HUMAN,Thyroid peroxidase (TPO) (EC 1.11.1.8),933,"102,963",5 out of 5,1988-04-01,Evidence at protein level
P56589,PEX3_HUMAN,Peroxisomal biogenesis factor 3 (Peroxin-3) (Peroxisomal assembly protein PEX3),373,"42,140",5 out of 5,1998-12-15,Evidence at protein level
Q13608,PEX6_HUMAN,Peroxisome assembly factor 2 (PAF-2) (Peroxin-6) (Peroxisomal biogenesis factor 6) (Peroxisomal-type ATPase 1),980,"104,061",5 out of 5,1997-11-01,Evidence at protein level
P08237,PFKAM_HUMAN,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)",780,"85,183",5 out of 5,1988-08-01,Evidence at protein level
P15259,PGAM2_HUMAN,Phosphoglycerate mutase 2 (EC 5.4.2.11) (EC 5.4.2.4) (BPG-dependent PGAM 2) (Muscle-specific phosphoglycerate mutase) (Phosphoglycerate mutase isozyme M) (PGAM-M),253,"28,766",5 out of 5,1990-04-01,Evidence at protein level
P15428,PGDH_HUMAN,15-hydroxyprostaglandin dehydrogenase [NAD(+)] (15-PGDH) (EC 1.1.1.141) (Prostaglandin dehydrogenase 1) (Short chain dehydrogenase/reductase family 36C member 1),266,"28,977",5 out of 5,1990-04-01,Evidence at protein level
Q9NRX4,PHP14_HUMAN,14 kDa phosphohistidine phosphatase (EC 3.9.1.3) (Phosphohistidine phosphatase 1) (PHPT1) (Protein histidine phosphatase) (PHP) (Protein janus-A homolog),125,"13,833",5 out of 5,2002-11-08,Evidence at protein level
O14986,PI51B_HUMAN,Phosphatidylinositol 4-phosphate 5-kinase type-1 beta (PIP5K1-beta) (PtdIns(4)P-5-kinase 1 beta) (EC 2.7.1.68) (Phosphatidylinositol 4-phosphate 5-kinase type I beta) (PIP5KIbeta) (Protein STM-7) (Type I phosphatidylinositol 4-phosphate 5-kinase beta),540,"61,036",5 out of 5,2005-10-25,Evidence at protein level
P78337,PITX1_HUMAN,Pituitary homeobox 1 (Hindlimb-expressed homeobox protein backfoot) (Homeobox protein PITX1) (Paired-like homeodomain transcription factor 1),314,"34,128",5 out of 5,1998-07-15,Evidence at protein level
O75364,PITX3_HUMAN,Pituitary homeobox 3 (Homeobox protein PITX3) (Paired-like homeodomain transcription factor 3),302,"31,832",5 out of 5,1999-07-15,Evidence at protein level
Q0ZLH3,PJVK_HUMAN,Pejvakin (Autosomal recessive deafness type 59 protein),352,"39,913",3 out of 5,2006-09-05,Evidence at protein level
Q9HB21,PKHA1_HUMAN,Pleckstrin homology domain-containing family A member 1 (PH domain-containing family A member 1) (Tandem PH domain-containing protein 1) (TAPP-1),404,"45,553",5 out of 5,2004-03-29,Evidence at protein level
Q96CS7,PKHB2_HUMAN,Pleckstrin homology domain-containing family B member 2 (PH domain-containing family B member 2) (Evectin-2),222,"24,736",5 out of 5,2004-03-29,Evidence at protein level
P08F94,PKHD1_HUMAN,Fibrocystin (Polycystic kidney and hepatic disease 1 protein) (Polyductin) (Tigmin),4074,"446,702",5 out of 5,2010-05-18,Evidence at protein level
Q5SRE7,PHYD1_HUMAN,Phytanoyl-CoA dioxygenase domain-containing protein 1 (EC 1.-.-.-),291,"32,411",4 out of 5,2008-01-15,Evidence at protein level
P78356,PI42B_HUMAN,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-beta) (Diphosphoinositide kinase 2-beta) (Phosphatidylinositol 5-phosphate 4-kinase type II beta) (PI(5)P 4-kinase type II beta) (PIP4KII-beta) (PtdIns(5)P-4-kinase isoform 2-beta),416,"47,378",5 out of 5,2004-05-24,Evidence at protein level
Q8N8J0,PI4P1_HUMAN,Putative inactive phosphatidylinositol 4-kinase alpha-like protein P1,262,"29,179",2 out of 5,2008-06-10,Uncertain
Q92508,PIEZ1_HUMAN,Piezo-type mechanosensitive ion channel component 1 (Membrane protein induced by beta-amyloid treatment) (Mib) (Protein FAM38A),2521,"286,790",5 out of 5,2001-10-18,Evidence at protein level
Q8TCI5,PIFO_HUMAN,Protein pitchfork,191,"21,973",5 out of 5,2007-04-17,Evidence at protein level
Q92521,PIGB_HUMAN,GPI mannosyltransferase 3 (EC 2.4.1.-) (GPI mannosyltransferase III) (GPI-MT-III) (Phosphatidylinositol-glycan biosynthesis class B protein) (PIG-B),554,"65,056",5 out of 5,2006-07-25,Evidence at protein level
Q9BRB3,PIGQ_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Q (EC 2.4.1.198) (N-acetylglucosamyl transferase component GPI1) (Phosphatidylinositol-glycan biosynthesis class Q protein) (PIG-Q),760,"84,082",5 out of 5,2003-04-23,Evidence at protein level
Q969N2,PIGT_HUMAN,GPI transamidase component PIG-T (Phosphatidylinositol-glycan biosynthesis class T protein),578,"65,700",5 out of 5,2004-03-01,Evidence at protein level
P12273,PIP_HUMAN,Prolactin-inducible protein (Gross cystic disease fluid protein 15) (GCDFP-15) (Prolactin-induced protein) (Secretory actin-binding protein) (SABP) (gp17),146,"16,572",5 out of 5,1989-10-01,Evidence at protein level
O00625,PIR_HUMAN,"Pirin (EC 1.13.11.24) (Probable quercetin 2,3-dioxygenase PIR) (Probable quercetinase)",290,"32,113",5 out of 5,2001-06-01,Evidence at protein level
Q9BZ72,PITM2_HUMAN,"Membrane-associated phosphatidylinositol transfer protein 2 (Phosphatidylinositol transfer protein, membrane-associated 2) (PITPnm 2) (Pyk2 N-terminal domain-interacting receptor 3) (NIR-3)",1349,"148,933",5 out of 5,2006-04-18,Evidence at protein level
Q9ULU4,PKCB1_HUMAN,Protein kinase C-binding protein 1 (Cutaneous T-cell lymphoma-associated antigen se14-3) (CTCL-associated antigen se14-3) (Rack7) (Zinc finger MYND domain-containing protein 8),1186,"131,692",5 out of 5,2002-11-25,Evidence at protein level
P98161,PKD1_HUMAN,Polycystin-1 (PC1) (Autosomal dominant polycystic kidney disease 1 protein),4303,"462,529",5 out of 5,1996-10-01,Evidence at protein level
Q9H8W4,PKHF2_HUMAN,Pleckstrin homology domain-containing family F member 2 (PH domain-containing family F member 2) (Endoplasmic reticulum-associated apoptosis-involved protein containing PH and FYVE domains) (EAPF) (PH and FYVE domain-containing protein 2) (Phafin-2) (Phafin2) (Zinc finger FYVE domain-containing protein 18),249,"27,798",5 out of 5,2006-10-03,Evidence at protein level
Q8IWE5,PKHM2_HUMAN,Pleckstrin homology domain-containing family M member 2 (PH domain-containing family M member 2) (Salmonella-induced filaments A and kinesin-interacting protein) (SifA and kinesin-interacting protein),1019,"112,780",5 out of 5,2007-11-13,Evidence at protein level
Q5JTB6,PLAC9_HUMAN,Placenta-specific protein 9,97,"10,309",2 out of 5,2006-11-28,Evidence at protein level
O75038,PLCH2_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-2) (Phosphoinositide phospholipase C-like 4) (PLC-L4) (Phospholipase C-like protein 4) (Phospholipase C-eta-2) (PLC-eta2)",1416,"154,668",5 out of 5,2001-02-21,Evidence at transcript level
Q9UPR0,PLCL2_HUMAN,Inactive phospholipase C-like protein 2 (PLC-L(2)) (PLC-L2) (Phospholipase C-L2) (Phospholipase C-epsilon-2) (PLC-epsilon-2),1127,"125,866",5 out of 5,2007-05-29,Evidence at protein level
Q96N28,PLD3A_HUMAN,PRELI domain containing protein 3A (Protein slowmo homolog 1),172,"19,247",4 out of 5,2007-07-10,Evidence at protein level
Q15149,PLEC_HUMAN,Plectin (PCN) (PLTN) (Hemidesmosomal protein 1) (HD1) (Plectin-1),4684,"531,791",5 out of 5,2001-06-01,Evidence at protein level
P02776,PLF4_HUMAN,"Platelet factor 4 (PF-4) (C-X-C motif chemokine 4) (Iroplact) (Oncostatin-A) [Cleaved into: Platelet factor 4, short form]",101,"10,845",5 out of 5,1986-07-21,Evidence at protein level
Q99541,PLIN2_HUMAN,Perilipin-2 (Adipophilin) (Adipose differentiation-related protein) (ADRP),437,"48,075",4 out of 5,2000-05-30,Evidence at protein level
Q96Q06,PLIN4_HUMAN,Perilipin-4 (Adipocyte protein S3-12),1357,"134,431",5 out of 5,2007-08-21,Evidence at protein level
Q9Y342,PLLP_HUMAN,Plasmolipin (Plasma membrane proteolipid),182,"19,987",4 out of 5,2000-12-01,Evidence at protein level
Q02809,PLOD1_HUMAN,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (EC 1.14.11.4) (Lysyl hydroxylase 1) (LH1)",727,"83,550",5 out of 5,1993-07-01,Evidence at protein level
Q8IY17,PLPL6_HUMAN,Neuropathy target esterase (EC 3.1.1.5) (Patatin-like phospholipase domain-containing protein 6),1366,"149,995",5 out of 5,2007-06-26,Evidence at protein level
O60733,PLPL9_HUMAN,85/88 kDa calcium-independent phospholipase A2 (CaI-PLA2) (EC 3.1.1.4) (Group VI phospholipase A2) (GVI PLA2) (Intracellular membrane-associated calcium-independent phospholipase A2 beta) (iPLA2-beta) (Patatin-like phospholipase domain-containing protein 9) (PNPLA9),806,"89,903",5 out of 5,2000-05-30,Evidence at protein level
Q9NRY6,PLS3_HUMAN,Phospholipid scramblase 3 (PL scramblase 3) (Ca(2+)-dependent phospholipid scramblase 3),295,"31,648",5 out of 5,2001-06-20,Evidence at protein level
P40967,PMEL_HUMAN,Melanocyte protein PMEL (ME20-M) (ME20M) (Melanocyte protein Pmel 17) (Melanocytes lineage-specific antigen GP100) (Melanoma-associated ME20 antigen) (P1) (P100) (Premelanosome protein) (Silver locus protein homolog) [Cleaved into: M-alpha (95 kDa melanocyte-specific secreted glycoprotein) (P26) (Secreted melanoma-associated ME20 antigen) (ME20-S) (ME20S); M-beta],661,"70,255",5 out of 5,1995-02-01,Evidence at protein level
Q6P1K2,PMF1_HUMAN,Polyamine-modulated factor 1 (PMF-1),205,"23,339",5 out of 5,2006-09-05,Evidence at protein level
Q8NAT1,PMGT2_HUMAN,"Protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGnT2) (EC 2.4.1.-) (Extracellular O-linked N-acetylglucosamine transferase-like) (Glycosyltransferase-like domain-containing protein 2)",580,"66,615",5 out of 5,2006-09-05,Evidence at protein level
P29590,PML_HUMAN,Protein PML (Promyelocytic leukemia protein) (RING finger protein 71) (Tripartite motif-containing protein 19),882,"97,551",5 out of 5,1993-04-01,Evidence at protein level
P28328,PEX2_HUMAN,Peroxisome biogenesis factor 2 (35 kDa peroxisomal membrane protein) (Peroxin-2) (Peroxisomal membrane protein 3) (Peroxisome assembly factor 1) (PAF-1) (RING finger protein 72),305,"34,843",5 out of 5,1992-12-01,Evidence at protein level
Q8IYB4,PEX5R_HUMAN,PEX5-related protein (PEX2-related protein) (PEX5-like protein) (Peroxin-5-related protein) (Peroxisome biogenesis factor 5-like) (Tetratricopeptide repeat-containing Rab8b-interacting protein) (Pex5Rp) (TRIP8b),626,"69,697",5 out of 5,2004-05-24,Evidence at protein level
Q9NQP4,PFD4_HUMAN,Prefoldin subunit 4 (Protein C-1),134,"15,314",5 out of 5,2001-01-11,Evidence at protein level
Q99471,PFD5_HUMAN,Prefoldin subunit 5 (C-Myc-binding protein Mm-1) (Myc modulator 1),154,"17,328",5 out of 5,1997-11-01,Evidence at protein level
Q8N0Y7,PGAM4_HUMAN,Probable phosphoglycerate mutase 4 (EC 5.4.2.11) (EC 5.4.2.4),254,"28,777",5 out of 5,2002-11-28,Inferred from homology
Q8N328,PGBD3_HUMAN,PiggyBac transposable element-derived protein 3,593,"67,595",2 out of 5,2007-05-29,Evidence at transcript level
A6NFU8,PGPIL_HUMAN,Pyroglutamyl-peptidase 1-like protein (EC 3.4.19.-),196,"21,631",2 out of 5,2008-05-20,Evidence at transcript level
Q8N6C7,PGSF1_HUMAN,Putative uncharacterized protein encoded by MIR7-3HG (Pituitary gland-specific factor 1),128,"14,321",2 out of 5,2005-07-05,Uncertain
Q9H814,PHAX_HUMAN,Phosphorylated adapter RNA export protein (RNA U small nuclear RNA export adapter protein),394,"44,403",5 out of 5,2006-06-13,Evidence at protein level
Q6NSJ2,PHLB3_HUMAN,Pleckstrin homology-like domain family B member 3,640,"71,912",2 out of 5,2005-12-20,Evidence at transcript level
Q9UKJ1,PILRA_HUMAN,Paired immunoglobulin-like type 2 receptor alpha (Cell surface receptor FDF03) (Inhibitory receptor PILR-alpha),303,"34,005",5 out of 5,2006-03-07,Evidence at protein level
Q9Y237,PIN4_HUMAN,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 (EC 5.2.1.8) (Parvulin-14) (Par14) (hPar14) (Parvulin-17) (Par17) (hPar17) (Peptidyl-prolyl cis-trans isomerase Pin4) (PPIase Pin4) (Peptidyl-prolyl cis/trans isomerase EPVH) (hEPVH) (Rotamase Pin4),131,"13,810",5 out of 5,2002-01-23,Evidence at protein level
A2A3N6,PIPSL_HUMAN,Putative PIP5K1A and PSMD4-like protein (PIP5K1A-PSMD4),862,"95,048",3 out of 5,2008-09-02,Uncertain
Q9GZP4,PITH1_HUMAN,PITH domain-containing protein 1,211,"24,178",3 out of 5,2007-05-01,Evidence at protein level
Q7Z3Z4,PIWL4_HUMAN,Piwi-like protein 4,852,"96,589",5 out of 5,2006-05-16,Evidence at transcript level
Q8TDX9,PK1L1_HUMAN,Polycystic kidney disease protein 1-like 1 (PC1-like 1 protein) (Polycystin-1L1),2849,"315,435",5 out of 5,2002-10-10,Evidence at protein level
Q7Z443,PK1L3_HUMAN,Polycystic kidney disease protein 1-like 3 (PC1-like 3 protein) (Polycystin-1L3),1732,"195,894",5 out of 5,2008-02-26,Evidence at protein level
Q96JA3,PKHA8_HUMAN,Pleckstrin homology domain-containing family A member 8 (PH domain-containing family A member 8) (Phosphatidylinositol-four-phosphate adapter protein 2) (FAPP-2) (Phosphoinositol 4-phosphate adapter protein 2) (hFAPP2) (Serologically defined breast cancer antigen NY-BR-86),519,"58,261",5 out of 5,2007-10-02,Evidence at protein level
Q96S99,PKHF1_HUMAN,Pleckstrin homology domain-containing family F member 1 (PH domain-containing family F member 1) (Lysosome-associated apoptosis-inducing protein containing PH and FYVE domains) (Apoptosis-inducing protein) (PH and FYVE domain-containing protein 1) (Phafin-1) (Zinc finger FYVE domain-containing protein 15),279,"31,195",5 out of 5,2006-10-03,Evidence at protein level
Q9H7P9,PKHG2_HUMAN,Pleckstrin homology domain-containing family G member 2 (PH domain-containing family G member 2),1386,"147,969",5 out of 5,2007-10-02,Evidence at protein level
Q58EX7,PKHG4_HUMAN,Puratrophin-1 (Pleckstrin homology domain-containing family G member 4) (PH domain-containing family G member 4) (Purkinje cell atrophy-associated protein 1),1191,"130,803",4 out of 5,2006-03-07,Evidence at protein level
Q6ZR37,PKHG7_HUMAN,Pleckstrin homology domain-containing family G member 7 (PH domain-containing family G member 7),379,"44,301",2 out of 5,2008-02-05,Evidence at transcript level
Q8IVE3,PKHH2_HUMAN,Pleckstrin homology domain-containing family H member 2,1493,"168,229",5 out of 5,2007-10-02,Evidence at protein level
Q7Z736,PKHH3_HUMAN,Pleckstrin homology domain-containing family H member 3 (PH domain-containing family H member 3),793,"85,317",3 out of 5,2007-11-13,Evidence at protein level
Q86WI1,PKHL1_HUMAN,Fibrocystin-L (Polycystic kidney and hepatic disease 1-like protein 1) (PKHD1-like protein 1),4243,"465,734",5 out of 5,2008-02-05,Evidence at transcript level
Q9Y4G2,PKHM1_HUMAN,Pleckstrin homology domain-containing family M member 1 (PH domain-containing family M member 1) (162 kDa adapter protein) (AP162),1056,"117,443",5 out of 5,2007-11-13,Evidence at protein level
Q16513,PKN2_HUMAN,Serine/threonine-protein kinase N2 (EC 2.7.11.13) (PKN gamma) (Protein kinase C-like 2) (Protein-kinase C-related kinase 2),984,"112,035",5 out of 5,2000-05-30,Evidence at protein level
Q99959,PKP2_HUMAN,Plakophilin-2,881,"97,415",5 out of 5,2002-01-23,Evidence at protein level
A1L4L8,PL8L1_HUMAN,PLAC8-like protein 1,177,"19,885",1 out of 5,2007-12-04,Evidence at transcript level
Q4KWH8,PLCH1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-eta-1) (Phospholipase C-eta-1) (PLC-eta-1) (Phospholipase C-like protein 3) (PLC-L3)",1693,"189,223",5 out of 5,2008-04-08,Evidence at protein level
Q9Y3B1,PLD3B_HUMAN,PRELI domain containing protein 3B (Protein slowmo homolog 2),194,"21,495",2 out of 5,2002-12-06,Evidence at transcript level
Q96BZ4,PLD4_HUMAN,Phospholipase D4 (PLD 4) (EC 3.1.4.4) (Choline phosphatase 4) (Phosphatidylcholine-hydrolyzing phospholipase D4),506,"55,626",4 out of 5,2007-03-20,Evidence at transcript level
Q8NBV4,PLPP7_HUMAN,Inactive phospholipid phosphatase 7 (Phosphatidic acid phosphatase type 2 domain-containing protein 3),271,"29,448",4 out of 5,2006-06-13,Evidence at transcript level
Q96GD0,PLPP_HUMAN,Pyridoxal phosphate phosphatase (PLP phosphatase) (EC 3.1.3.3) (EC 3.1.3.74) (Chronophin),296,"31,698",5 out of 5,2004-03-01,Evidence at protein level
Q6T4P5,PLPR3_HUMAN,Phospholipid phosphatase-related protein type 3 (EC 3.1.3.4) (Lipid phosphate phosphatase-related protein type 3) (PAP-2-like protein 2) (Plasticity-related gene 2 protein) (PRG-2),718,"76,037",4 out of 5,2008-02-05,Evidence at transcript level
Q9NRQ2,PLS4_HUMAN,Phospholipid scramblase 4 (PL scramblase 4) (Ca(2+)-dependent phospholipid scramblase 4) (Cell growth-inhibiting gene 43 protein) (TRA1),329,"37,005",5 out of 5,2001-06-20,Evidence at protein level
Q32M88,PGGHG_HUMAN,Protein-glucosylgalactosylhydroxylysine glucosidase (EC 3.2.1.107) (Acid trehalase-like protein 1),737,"80,655",4 out of 5,2008-04-08,Evidence at protein level
P35354,PGH2_HUMAN,Prostaglandin G/H synthase 2 (EC 1.14.99.1) (Cyclooxygenase-2) (COX-2) (PHS II) (Prostaglandin H2 synthase 2) (PGH synthase 2) (PGHS-2) (Prostaglandin-endoperoxide synthase 2),604,"68,996",5 out of 5,1994-06-01,Evidence at protein level
Q32NB8,PGPS1_HUMAN,"CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase, mitochondrial (EC 2.7.8.5) (Phosphatidylglycerophosphate synthase 1) (PGP synthase 1)",556,"62,730",5 out of 5,2008-05-20,Evidence at transcript level
Q96PD5,PGRP2_HUMAN,N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L),576,"62,217",5 out of 5,2003-11-07,Evidence at protein level
Q96FC7,PHIPL_HUMAN,Phytanoyl-CoA hydroxylase-interacting protein-like,376,"42,486",3 out of 5,2008-06-10,Evidence at protein level
Q8WWQ0,PHIP_HUMAN,PH-interacting protein (PHIP) (IRS-1 PH domain-binding protein) (WD repeat-containing protein 11),1821,"206,689",5 out of 5,2007-08-21,Evidence at protein level
Q9UKJ0,PILRB_HUMAN,Paired immunoglobulin-like type 2 receptor beta (Activating receptor PILR-beta) (Cell surface receptor FDFACT),227,"25,542",4 out of 5,2006-03-07,Evidence at protein level
Q86V86,PIM3_HUMAN,Serine/threonine-protein kinase pim-3 (EC 2.7.11.1),326,"35,891",5 out of 5,2003-11-21,Evidence at protein level
A6NC86,PINLY_HUMAN,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,204,"21,926",3 out of 5,2008-04-29,Evidence at transcript level
A0A0B4J2F0,PIOS1_HUMAN,Protein PIGBOS1 (PIGB opposite strand protein),54,"6,313",1 out of 5,2015-09-16,Inferred from homology
Q9UG56,PISD_HUMAN,"Phosphatidylserine decarboxylase proenzyme, mitochondrial (EC 4.1.1.65) [Cleaved into: Phosphatidylserine decarboxylase beta chain; Phosphatidylserine decarboxylase alpha chain]",409,"46,672",4 out of 5,2003-05-30,Evidence at transcript level
Q96PX9,PKH4B_HUMAN,Pleckstrin homology domain-containing family G member 4B (PH domain-containing family G member 4B),1271,"139,667",3 out of 5,2008-02-05,Evidence at protein level
Q9HB19,PKHA2_HUMAN,Pleckstrin homology domain-containing family A member 2 (PH domain-containing family A member 2) (Tandem PH domain-containing protein 2) (TAPP-2),425,"47,255",5 out of 5,2004-03-29,Evidence at protein level
O95397,PKHA9_HUMAN,Putative protein PLEKHA9 (Pleckstrin homology domain-containing family A member 8 pseudogene 1),391,"43,539",2 out of 5,2007-10-02,Uncertain
Q6ZWE6,PKHM3_HUMAN,Pleckstrin homology domain-containing family M member 3 (PH domain-containing family M member 3),761,"87,166",3 out of 5,2008-03-18,Evidence at transcript level
Q53GL0,PKHO1_HUMAN,Pleckstrin homology domain-containing family O member 1 (PH domain-containing family O member 1) (C-Jun-binding protein) (JBP) (Casein kinase 2-interacting protein 1) (CK2-interacting protein 1) (CKIP-1) (Osteoclast maturation-associated gene 120 protein),409,"46,237",5 out of 5,2007-11-13,Evidence at protein level
Q8NFJ6,PKR2_HUMAN,Prokineticin receptor 2 (PK-R2) (G-protein coupled receptor 73-like 1) (G-protein coupled receptor I5E) (GPR73b) (GPRg2),384,"43,996",5 out of 5,2003-07-19,Evidence at protein level
Q53H76,PLA1A_HUMAN,Phospholipase A1 member A (EC 3.1.1.-) (Phosphatidylserine-specific phospholipase A1) (PS-PLA1),456,"49,715",5 out of 5,2007-01-23,Evidence at transcript level
Q9UM63,PLAL1_HUMAN,Zinc finger protein PLAGL1 (Lost on transformation 1) (LOT-1) (Pleiomorphic adenoma-like protein 1) (Tumor suppressor ZAC),463,"50,819",5 out of 5,2001-06-20,Evidence at protein level
Q8IUK5,PLDX1_HUMAN,Plexin domain-containing protein 1 (Tumor endothelial marker 3) (Tumor endothelial marker 7),500,"55,760",5 out of 5,2006-04-18,Evidence at protein level
P49763,PLGF_HUMAN,Placenta growth factor (PlGF),221,"24,789",5 out of 5,1996-10-01,Evidence at protein level
O60664,PLIN3_HUMAN,Perilipin-3 (47 kDa mannose 6-phosphate receptor-binding protein) (47 kDa MPR-binding protein) (Cargo selection protein TIP47) (Mannose-6-phosphate receptor-binding protein 1) (Placental protein 17) (PP17),434,"47,075",5 out of 5,2000-05-30,Evidence at protein level
O00168,PLM_HUMAN,Phospholemman (FXYD domain-containing ion transport regulator 1),92,"10,441",5 out of 5,1998-07-15,Evidence at protein level
O60568,PLOD3_HUMAN,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3)",738,"84,785",5 out of 5,1998-12-15,Evidence at protein level
Q04941,PLP2_HUMAN,Proteolipid protein 2 (Differentiation-dependent protein A4) (Intestinal membrane A4 protein),152,"16,691",5 out of 5,1993-10-01,Evidence at protein level
Q9NST1,PLPL3_HUMAN,Patatin-like phospholipase domain-containing protein 3 (EC 3.1.1.3) (Acylglycerol O-acyltransferase) (EC 2.3.1.-) (Adiponutrin) (Calcium-independent phospholipase A2-epsilon) (iPLA2-epsilon),481,"52,865",5 out of 5,2003-07-03,Evidence at protein level
O60486,PLXC1_HUMAN,Plexin-C1 (Virus-encoded semaphorin protein receptor) (CD antigen CD232),1568,"175,742",5 out of 5,2006-04-18,Evidence at protein level
Q13670,PM2PB_HUMAN,Putative postmeiotic segregation increased 2-like protein 11 (PMS2-related protein 6) (Putative postmeiotic segregation increased 2 pseudogene 11),270,"28,555",2 out of 5,2007-11-13,Uncertain
Q9H0N5,PHS2_HUMAN,Pterin-4-alpha-carbinolamine dehydratase 2 (PHS 2) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase 2) (DcoH-like protein DCoHm) (Dimerization cofactor of hepatocyte nuclear factor 1 from muscle) (HNF-1-alpha dimerization cofactor),130,"14,365",5 out of 5,2001-08-29,Evidence at protein level
O43692,PI15_HUMAN,Peptidase inhibitor 15 (PI-15) (25 kDa trypsin inhibitor) (p25TI) (Cysteine-rich secretory protein 8) (CRISP-8) (SugarCrisp),258,"29,065",4 out of 5,2007-05-15,Evidence at protein level
P48426,PI42A_HUMAN,Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha (EC 2.7.1.149) (1-phosphatidylinositol 5-phosphate 4-kinase 2-alpha) (Diphosphoinositide kinase 2-alpha) (PIP5KIII) (Phosphatidylinositol 5-phosphate 4-kinase type II alpha) (PI(5)P 4-kinase type II alpha) (PIP4KII-alpha) (PtdIns(4)P-5-kinase B isoform) (PtdIns(4)P-5-kinase C isoform) (PtdIns(5)P-4-kinase isoform 2-alpha),406,"46,225",5 out of 5,1996-02-01,Evidence at protein level
Q9Y6X2,PIAS3_HUMAN,E3 SUMO-protein ligase PIAS3 (EC 6.3.2.-) (Protein inhibitor of activated STAT protein 3),628,"68,017",5 out of 5,2002-03-05,Evidence at protein level
P37287,PIGA_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit A (EC 2.4.1.198) (GlcNAc-PI synthesis protein) (Phosphatidylinositol-glycan biosynthesis class A protein) (PIG-A),484,"54,127",5 out of 5,1994-10-01,Evidence at protein level
O95427,PIGN_HUMAN,GPI ethanolamine phosphate transferase 1 (EC 2.-.-.-) (MCD4 homolog) (Phosphatidylinositol-glycan biosynthesis class N protein) (PIG-N),931,"105,810",5 out of 5,2006-07-25,Evidence at protein level
P57054,PIGP_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit P (EC 2.4.1.198) (Down syndrome critical region protein 5) (Down syndrome critical region protein C) (Phosphatidylinositol-glycan biosynthesis class P protein) (PIG-P),158,"18,059",5 out of 5,2000-12-01,Evidence at protein level
P01833,PIGR_HUMAN,Polymeric immunoglobulin receptor (PIgR) (Poly-Ig receptor) (Hepatocellular carcinoma-associated protein TB6) [Cleaved into: Secretory component],764,"83,284",5 out of 5,1986-07-21,Evidence at protein level
Q9H490,PIGU_HUMAN,Phosphatidylinositol glycan anchor biosynthesis class U protein (Cell division cycle protein 91-like 1) (Protein CDC91-like 1) (GPI transamidase component PIG-U),435,"50,052",5 out of 5,2003-03-25,Evidence at protein level
Q9NUD9,PIGV_HUMAN,GPI mannosyltransferase 2 (EC 2.4.1.-) (GPI mannosyltransferase II) (GPI-MT-II) (Phosphatidylinositol-glycan biosynthesis class V protein) (PIG-V),493,"55,713",5 out of 5,2006-07-25,Evidence at protein level
Q9NWS0,PIHD1_HUMAN,PIH1 domain-containing protein 1 (Nucleolar protein 17 homolog),290,"32,363",5 out of 5,2007-10-23,Evidence at protein level
P0C851,PIRT_HUMAN,Phosphoinositide-interacting protein,137,"15,334",3 out of 5,2008-09-02,Evidence at transcript level
Q9HBJ0,PLAC1_HUMAN,Placenta-specific protein 1,212,"23,616",3 out of 5,2006-10-03,Evidence at transcript level
P14923,PLAK_HUMAN,Junction plakoglobin (Catenin gamma) (Desmoplakin III) (Desmoplakin-3),745,"81,745",5 out of 5,1990-04-01,Evidence at protein level
Q99943,PLCA_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 1) (1-AGP acyltransferase 1) (1-AGPAT 1) (Lysophosphatidic acid acyltransferase alpha) (LPAAT-alpha) (Protein G15),283,"31,717",5 out of 5,1998-12-15,Evidence at protein level
Q9NQ66,PLCB1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1)",1216,"138,567",5 out of 5,2001-01-11,Evidence at protein level
Q01970,PLCB3_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-3) (Phospholipase C-beta-3) (PLC-beta-3)",1234,"138,799",5 out of 5,1993-07-01,Evidence at protein level
Q8N3E9,PLCD3_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-3 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-3) (Phospholipase C-delta-3) (PLC-delta-3)",789,"89,258",5 out of 5,2007-10-02,Evidence at protein level
Q9NRZ5,PLCD_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase delta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 4) (1-AGP acyltransferase 4) (1-AGPAT 4) (Lysophosphatidic acid acyltransferase delta) (LPAAT-delta),378,"44,021",4 out of 5,2001-01-11,Evidence at protein level
Q9NUQ2,PLCE_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase epsilon (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 5) (1-AGP acyltransferase 5) (1-AGPAT 5) (Lysophosphatidic acid acyltransferase epsilon) (LPAAT-epsilon),364,"42,072",5 out of 5,2002-01-23,Evidence at protein level
Q13393,PLD1_HUMAN,Phospholipase D1 (PLD 1) (hPLD1) (EC 3.1.4.4) (Choline phosphatase 1) (Phosphatidylcholine-hydrolyzing phospholipase D1),1074,"124,184",5 out of 5,1997-11-01,Evidence at protein level
Q9NYT0,PLEK2_HUMAN,Pleckstrin-2,353,"39,971",3 out of 5,2002-05-10,Evidence at protein level
P08567,PLEK_HUMAN,Pleckstrin (Platelet 47 kDa protein) (p47),350,"40,125",5 out of 5,1988-08-01,Evidence at protein level
A6NEE1,PLHD1_HUMAN,Pleckstrin homology domain-containing family D member 1 (PH domain-containing family D member 1),506,"59,203",2 out of 5,2008-09-02,Evidence at transcript level
P53350,PLK1_HUMAN,Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13),603,"68,255",5 out of 5,1996-10-01,Evidence at protein level
O14495,PLPP3_HUMAN,Phospholipid phosphatase 3 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 3) (PAP2-beta) (Phosphatidate phosphohydrolase type 2b) (Phosphatidic acid phosphatase 2b) (PAP-2b) (PAP2b) (Vascular endothelial growth factor and type I collagen-inducible protein) (VCIP),311,"35,116",5 out of 5,2004-03-15,Evidence at protein level
Q8TBJ4,PLPR1_HUMAN,Phospholipid phosphatase-related protein type 1 (Lipid phosphate phosphatase-related protein type 1) (Plasticity-related gene 3 protein) (PRG-3),325,"35,795",3 out of 5,2008-02-05,Evidence at transcript level
Q9BX97,PLVAP_HUMAN,Plasmalemma vesicle-associated protein (Fenestrated endothelial-linked structure protein) (Plasmalemma vesicle protein 1) (PV-1),442,"50,594",5 out of 5,2005-08-30,Evidence at transcript level
O15031,PLXB2_HUMAN,Plexin-B2 (MM1),1838,"205,127",5 out of 5,2004-08-31,Evidence at protein level
Q9UL42,PNMA2_HUMAN,Paraneoplastic antigen Ma2 (40 kDa neuronal protein) (Onconeuronal antigen Ma2) (Paraneoplastic neuronal antigen MM2),364,"41,509",5 out of 5,2003-10-24,Evidence at protein level
Q86V59,PNML1_HUMAN,PNMA-like protein 1,439,"48,161",2 out of 5,2008-03-18,Evidence at protein level
P11086,PNMT_HUMAN,Phenylethanolamine N-methyltransferase (PNMTase) (EC 2.1.1.28) (Noradrenaline N-methyltransferase),282,"30,855",5 out of 5,1989-07-01,Evidence at protein level
P63132,PO113_HUMAN,Endogenous retrovirus group K member 113 Pol protein (HERV-K113 Pol protein) (HERV-K_19p13.11 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],956,"107,766",4 out of 5,2004-09-13,Inferred from homology
P20264,PO3F3_HUMAN,"POU domain, class 3, transcription factor 3 (Brain-specific homeobox/POU domain protein 1) (Brain-1) (Brn-1) (Octamer-binding protein 8) (Oct-8) (Octamer-binding transcription factor 8) (OTF-8)",500,"50,327",5 out of 5,1991-02-01,Evidence at transcript level
Q8N7G0,PO5F2_HUMAN,"POU domain, class 5, transcription factor 2 (Sperm 1 POU domain transcription factor) (SPRM-1)",328,"36,051",3 out of 5,2003-02-01,Evidence at transcript level
Q8WVV4,POF1B_HUMAN,Protein POF1B (Premature ovarian failure protein 1B),589,"68,065",5 out of 5,2006-10-17,Evidence at protein level
Q96QT6,PHF12_HUMAN,PHD finger protein 12 (PHD factor 1) (Pf1),1004,"109,698",5 out of 5,2005-07-19,Evidence at protein level
O75151,PHF2_HUMAN,Lysine-specific demethylase PHF2 (EC 1.14.11.-) (GRC5) (PHD finger protein 2),1096,"120,775",5 out of 5,2003-08-15,Evidence at protein level
Q8WV24,PHLA1_HUMAN,Pleckstrin homology-like domain family A member 1 (Apoptosis-associated nuclear protein) (Proline- and glutamine-rich protein) (PQ-rich protein) (PQR protein) (Proline- and histidine-rich protein) (T-cell death-associated gene 51 protein),401,"45,016",5 out of 5,2005-12-20,Evidence at protein level
Q6ZVD8,PHLP2_HUMAN,PH domain leucine-rich repeat-containing protein phosphatase 2 (EC 3.1.3.16) (PH domain leucine-rich repeat-containing protein phosphatase-like) (PHLPP-like),1323,"146,751",5 out of 5,2005-06-07,Evidence at protein level
Q8TCD6,PHOP2_HUMAN,Pyridoxal phosphate phosphatase PHOSPHO2 (EC 3.1.3.74),241,"27,769",3 out of 5,2006-01-10,Evidence at protein level
P43119,PI2R_HUMAN,Prostacyclin receptor (Prostaglandin I2 receptor) (PGI receptor) (PGI2 receptor) (Prostanoid IP receptor),386,"40,956",5 out of 5,1995-11-01,Evidence at protein level
O75925,PIAS1_HUMAN,E3 SUMO-protein ligase PIAS1 (EC 6.3.2.-) (DEAD/H box-binding protein 1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein),651,"71,836",5 out of 5,2002-03-05,Evidence at protein level
Q9H611,PIF1_HUMAN,ATP-dependent DNA helicase PIF1 (EC 3.6.4.12) (DNA repair and recombination helicase PIF1) (PIF1/RRM3 DNA helicase-like protein),641,"69,799",5 out of 5,2005-07-19,Evidence at protein level
Q96BK5,PINX1_HUMAN,PIN2/TERF1-interacting telomerase inhibitor 1 (Liver-related putative tumor suppressor) (Pin2-interacting protein X1) (Protein 67-11-3) (TRF1-interacting protein 1),328,"37,035",5 out of 5,2002-06-20,Evidence at protein level
O00562,PITM1_HUMAN,"Membrane-associated phosphatidylinositol transfer protein 1 (Drosophila retinal degeneration B homolog) (Phosphatidylinositol transfer protein, membrane-associated 1) (PITPnm 1) (Pyk2 N-terminal domain-interacting receptor 2) (NIR-2)",1244,"134,848",5 out of 5,2006-04-18,Evidence at protein level
Q9BZ71,PITM3_HUMAN,"Membrane-associated phosphatidylinositol transfer protein 3 (Phosphatidylinositol transfer protein, membrane-associated 3) (PITPnm 3) (Pyk2 N-terminal domain-interacting receptor 1) (NIR-1)",974,"106,781",5 out of 5,2006-04-18,Evidence at protein level
O43164,PJA2_HUMAN,E3 ubiquitin-protein ligase Praja-2 (Praja2) (EC 2.3.2.27) (RING finger protein 131) (RING-type E3 ubiquitin transferase Praja-2),708,"78,214",5 out of 5,2007-02-20,Evidence at protein level
P42336,PK3CA_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (PI3-kinase subunit alpha) (PI3K-alpha) (PI3Kalpha) (PtdIns-3-kinase subunit alpha) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit alpha) (PtdIns-3-kinase subunit p110-alpha) (p110alpha) (Phosphoinositide-3-kinase catalytic alpha polypeptide) (Serine/threonine protein kinase PIK3CA) (EC 2.7.11.1)",1068,"124,284",5 out of 5,1995-11-01,Evidence at protein level
Q9HB20,PKHA3_HUMAN,Pleckstrin homology domain-containing family A member 3 (PH domain-containing family A member 3) (Phosphatidylinositol-four-phosphate adapter protein 1) (FAPP-1) (Phosphoinositol 4-phosphate adapter protein 1),300,"33,861",4 out of 5,2004-03-29,Evidence at protein level
Q9Y2H5,PKHA6_HUMAN,Pleckstrin homology domain-containing family A member 6 (PH domain-containing family A member 6) (Phosphoinositol 3-phosphate-binding protein 3) (PEPP-3),1048,"117,128",3 out of 5,2004-03-29,Evidence at protein level
Q9BRC7,PLCD4_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (hPLCD4) (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)",762,"87,585",5 out of 5,2007-10-02,Evidence at transcript level
Q15111,PLCL1_HUMAN,Inactive phospholipase C-like protein 1 (PLC-L1) (Phospholipase C-deleted in lung carcinoma) (Phospholipase C-related but catalytically inactive protein) (PRIP),1095,"122,728",5 out of 5,2008-02-26,Evidence at protein level
O14939,PLD2_HUMAN,Phospholipase D2 (PLD 2) (hPLD2) (EC 3.1.4.4) (Choline phosphatase 2) (PLD1C) (Phosphatidylcholine-hydrolyzing phospholipase D2),933,"105,987",5 out of 5,2001-02-21,Evidence at protein level
O60240,PLIN1_HUMAN,Perilipin-1 (Lipid droplet-associated protein),522,"55,990",5 out of 5,2000-05-30,Evidence at protein level
O00444,PLK4_HUMAN,Serine/threonine-protein kinase PLK4 (EC 2.7.11.21) (Polo-like kinase 4) (PLK-4) (Serine/threonine-protein kinase 18) (Serine/threonine-protein kinase Sak),970,"108,972",5 out of 5,2004-08-16,Evidence at protein level
Q6XQN6,PNCB_HUMAN,Nicotinate phosphoribosyltransferase (NAPRTase) (EC 6.3.4.21) (FHA-HIT-interacting protein) (Nicotinate phosphoribosyltransferase domain-containing protein 1),538,"57,578",5 out of 5,2008-01-15,Evidence at protein level
Q8N490,PNKD_HUMAN,Probable hydrolase PNKD (EC 3.-.-.-) (Myofibrillogenesis regulator 1) (MR-1) (Paroxysmal nonkinesiogenic dyskinesia protein) (Trans-activated by hepatitis C virus core protein 2),385,"42,876",5 out of 5,2007-09-11,Evidence at protein level
Q01860,PO5F1_HUMAN,"POU domain, class 5, transcription factor 1 (Octamer-binding protein 3) (Oct-3) (Octamer-binding protein 4) (Oct-4) (Octamer-binding transcription factor 3) (OTF-3)",360,"38,571",5 out of 5,1993-07-01,Evidence at protein level
Q8NBT0,POC1A_HUMAN,POC1 centriolar protein homolog A (Pix2) (Proteome of centriole protein 1A) (WD repeat-containing protein 51A),407,"45,009",5 out of 5,2006-04-04,Evidence at protein level
Q9UQG0,POK11_HUMAN,Endogenous retrovirus group K member 11 Pol protein (HERV-K_3q27.2 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],969,"109,665",3 out of 5,2004-09-13,Evidence at transcript level
P63133,POK8_HUMAN,Endogenous retrovirus group K member 8 Pol protein (HERV-K115 Pol protein) (HERV-K_8p23.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],956,"107,703",4 out of 5,2004-09-13,Inferred from homology
Q0VAA5,PLCX2_HUMAN,PI-PLC X domain-containing protein 2,305,"34,777",2 out of 5,2007-10-02,Evidence at transcript level
Q02325,PLGB_HUMAN,Plasminogen-like protein B (Plasminogen-related protein B),96,"10,971",3 out of 5,1994-06-01,Inferred from homology
Q9NYY3,PLK2_HUMAN,Serine/threonine-protein kinase PLK2 (EC 2.7.11.21) (Polo-like kinase 2) (PLK-2) (hPlk2) (Serine/threonine-protein kinase SNK) (hSNK) (Serum-inducible kinase),685,"78,237",5 out of 5,2001-01-11,Evidence at protein level
Q96AD5,PLPL2_HUMAN,Patatin-like phospholipase domain-containing protein 2 (EC 3.1.1.3) (Adipose triglyceride lipase) (Calcium-independent phospholipase A2) (Desnutrin) (IPLA2-zeta) (Pigment epithelium-derived factor) (TTS2.2) (Transport-secretion protein 2) (TTS2),504,"55,316",5 out of 5,2007-06-26,Evidence at protein level
O43688,PLPP2_HUMAN,Phospholipid phosphatase 2 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 2) (PAP2-gamma) (PAP2-G) (Phosphatidate phosphohydrolase type 2c) (Phosphatidic acid phosphatase 2c) (PAP-2c) (PAP2c),288,"32,574",5 out of 5,2004-03-15,Evidence at protein level
Q8IY26,PLPP6_HUMAN,Phospholipid phosphatase 6 (EC 3.1.3.-) (Phosphatidic acid phosphatase type 2 domain-containing protein 2) (PPAP2 domain-containing protein 2) (Presqualene diphosphate phosphatase),295,"32,194",3 out of 5,2006-06-13,Evidence at protein level
Q7Z2D5,PLPR4_HUMAN,Phospholipid phosphatase-related protein type 4 (EC 3.1.3.4) (Brain-specific phosphatidic acid phosphatase-like protein 1) (Lipid phosphate phosphatase-related protein type 4) (Plasticity-related gene 1 protein) (PRG-1),763,"82,983",5 out of 5,2008-02-05,Evidence at protein level
Q9NRY7,PLS2_HUMAN,Phospholipid scramblase 2 (PL scramblase 2) (Ca(2+)-dependent phospholipid scramblase 2),297,"33,504",5 out of 5,2001-06-20,Evidence at protein level
A0PG75,PLS5_HUMAN,Phospholipid scramblase family member 5,271,"30,027",2 out of 5,2007-07-10,Evidence at transcript level
P55058,PLTP_HUMAN,Phospholipid transfer protein (Lipid transfer protein II),493,"54,739",5 out of 5,1996-10-01,Evidence at protein level
A4D2B8,PM2P1_HUMAN,Putative postmeiotic segregation increased 2-like protein 1 (PMS2-related protein 2) (Postmeiotic segregation increased 2-like protein 13) (Postmeiotic segregation increased 2-like protein 6) (Postmeiotic segregation increased 2-like protein 8) (Postmeiotic segregation increased protein 3) (hPMS3) (Postmeiotic segregation increased protein 8) (Putative postmeiotic segregation increased 2 pseudogene 1),440,"47,508",4 out of 5,2007-11-13,Uncertain
Q8TBY8,PMFBP_HUMAN,Polyamine-modulated factor 1-binding protein 1 (PMF-1-binding protein),1022,"119,033",3 out of 5,2007-09-11,Evidence at transcript level
P07738,PMGE_HUMAN,"Bisphosphoglycerate mutase (BPGM) (EC 5.4.2.4) (2,3-bisphosphoglycerate mutase, erythrocyte) (2,3-bisphosphoglycerate synthase) (EC 5.4.2.11) (2,3-diphosphoglycerate mutase) (DPGM) (BPG-dependent PGAM)",259,"30,005",5 out of 5,1988-08-01,Evidence at protein level
O15305,PMM2_HUMAN,Phosphomannomutase 2 (PMM 2) (EC 5.4.2.8),246,"28,082",5 out of 5,1998-07-15,Evidence at protein level
P54278,PMS2_HUMAN,Mismatch repair endonuclease PMS2 (EC 3.1.-.-) (DNA mismatch repair protein PMS2) (PMS1 protein homolog 2),862,"95,797",5 out of 5,1996-10-01,Evidence at protein level
Q15126,PMVK_HUMAN,Phosphomevalonate kinase (PMKase) (hPMK) (EC 2.7.4.2),192,"21,995",5 out of 5,1998-07-15,Evidence at protein level
Q12796,PNRC1_HUMAN,Proline-rich nuclear receptor coactivator 1 (Proline-rich protein 2) (Protein B4-2),327,"35,225",5 out of 5,2002-06-06,Evidence at protein level
Q9NPJ4,PNRC2_HUMAN,Proline-rich nuclear receptor coactivator 2,139,"15,591",5 out of 5,2005-03-29,Evidence at protein level
Q8TEM1,PO210_HUMAN,Nuclear pore membrane glycoprotein 210 (Nuclear pore protein gp210) (Nuclear envelope pore membrane protein POM 210) (POM210) (Nucleoporin Nup210) (Pore membrane protein of 210 kDa),1887,"205,111",5 out of 5,2006-05-16,Evidence at protein level
P14859,PO2F1_HUMAN,"POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)",743,"76,472",5 out of 5,1990-04-01,Evidence at protein level
P09086,PO2F2_HUMAN,"POU domain, class 2, transcription factor 2 (Lymphoid-restricted immunoglobulin octamer-binding protein NF-A2) (Octamer-binding protein 2) (Oct-2) (Octamer-binding transcription factor 2) (OTF-2)",479,"51,209",5 out of 5,1988-11-01,Evidence at protein level
Q9UKI9,PO2F3_HUMAN,"POU domain, class 2, transcription factor 3 (Octamer-binding protein 11) (Oct-11) (Octamer-binding transcription factor 11) (OTF-11) (Transcription factor PLA-1) (Transcription factor Skn-1)",436,"47,432",5 out of 5,2003-02-01,Evidence at transcript level
Q14863,PO6F1_HUMAN,"POU domain, class 6, transcription factor 1 (Brain-specific homeobox/POU domain protein 5) (Brain-5) (Brn-5) (mPOU homeobox protein)",301,"32,645",4 out of 5,1997-11-01,Evidence at protein level
P63136,POK25_HUMAN,Endogenous retrovirus group K member 25 Pol protein (HERV-K_11q22.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],954,"107,472",3 out of 5,2004-09-13,Inferred from homology
P63128,POK9_HUMAN,Endogenous retrovirus group K member 9 Pol protein (HERV-K(C6) Gag-Pol protein) (HERV-K109 Gag-Pol protein) (HERV-K_6q14.1 provirus ancestral Gag-Pol polyprotein) [Includes: Protease (EC 3.4.23.50) (PR) (Retropepsin); Reverse transcriptase/ribonuclease H (EC 2.7.7.49) (EC 2.7.7.7) (EC 3.1.26.4) (p66 RT)],1117,"123,620",5 out of 5,2004-09-13,Inferred from homology
Q9Y244,POMP_HUMAN,Proteasome maturation protein (Proteassemblin) (Protein UMP1 homolog) (hUMP1) (Voltage-gated K channel beta subunit 4.1),141,"15,789",5 out of 5,2006-07-25,Evidence at protein level
H3BUK9,POTB2_HUMAN,POTE ankyrin domain family member B2,544,"61,708",1 out of 5,2013-07-24,Inferred from homology
Q9NUX5,POTE1_HUMAN,Protection of telomeres protein 1 (hPot1) (POT1-like telomere end-binding protein),634,"71,442",5 out of 5,2004-07-19,Evidence at protein level
P36873,PP1G_HUMAN,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit),323,"36,984",5 out of 5,1994-06-01,Evidence at protein level
Q12972,PP1R8_HUMAN,Nuclear inhibitor of protein phosphatase 1 (NIPP-1) (Protein phosphatase 1 regulatory inhibitor subunit 8) [Includes: Activator of RNA decay (EC 3.1.4.-) (ARD-1)],351,"38,479",5 out of 5,2000-05-30,Evidence at protein level
Q9HAB8,PPCS_HUMAN,Phosphopantothenate--cysteine ligase (EC 6.3.2.5) (Phosphopantothenoylcysteine synthetase) (PPC synthetase),311,"34,005",5 out of 5,2004-05-10,Evidence at protein level
Q86YI8,PHF13_HUMAN,PHD finger protein 13 (Survival time-associated PHD finger protein in ovarian cancer 1) (SPOC1),300,"33,582",5 out of 5,2003-08-15,Evidence at protein level
P80108,PHLD_HUMAN,Phosphatidylinositol-glycan-specific phospholipase D (PI-G PLD) (EC 3.1.4.50) (Glycoprotein phospholipase D) (Glycosyl-phosphatidylinositol-specific phospholipase D) (GPI-PLD) (GPI-specific phospholipase D),840,"92,336",5 out of 5,1993-07-01,Evidence at protein level
Q13371,PHLP_HUMAN,Phosducin-like protein (PHLP),301,"34,282",5 out of 5,1999-07-15,Evidence at protein level
P61457,PHS_HUMAN,Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD),104,"12,000",5 out of 5,2004-05-24,Evidence at protein level
Q92561,PHYIP_HUMAN,Phytanoyl-CoA hydroxylase-interacting protein (Phytanoyl-CoA hydroxylase-associated protein 1) (PAHX-AP1) (PAHXAP1),330,"37,573",3 out of 5,1997-11-01,Evidence at protein level
Q5UE93,PI3R6_HUMAN,Phosphoinositide 3-kinase regulatory subunit 6 (Phosphoinositide 3-kinase gamma adapter protein of 87 kDa) (p84 PI3K adapter protein) (p84 PIKAP) (p87 PI3K adapter protein) (p87PIKAP),754,"84,258",5 out of 5,2006-05-16,Evidence at protein level
Q99755,PI51A_HUMAN,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha (PIP5K1-alpha) (PtdIns(4)P-5-kinase 1 alpha) (EC 2.7.1.68) (68 kDa type I phosphatidylinositol 4-phosphate 5-kinase alpha) (Phosphatidylinositol 4-phosphate 5-kinase type I alpha) (PIP5KIalpha),562,"62,633",5 out of 5,2005-10-25,Evidence at protein level
Q8N2W9,PIAS4_HUMAN,E3 SUMO-protein ligase PIAS4 (EC 2.3.2.27) (PIASy) (Protein inhibitor of activated STAT protein 4) (Protein inhibitor of activated STAT protein gamma) (PIAS-gamma) (RING-type E3 ubiquitin transferase PIAS4),510,"56,504",5 out of 5,2003-09-19,Evidence at protein level
Q9H5I5,PIEZ2_HUMAN,Piezo-type mechanosensitive ion channel component 2 (Protein FAM38B),2752,"318,064",5 out of 5,2005-11-22,Evidence at protein level
Q7Z7B1,PIGW_HUMAN,Phosphatidylinositol-glycan biosynthesis class W protein (PIG-W) (EC 2.3.-.-),504,"56,882",5 out of 5,2006-07-25,Evidence at protein level
Q3MUY2,PIGY_HUMAN,Phosphatidylinositol N-acetylglucosaminyltransferase subunit Y (Phosphatidylinositol-glycan biosynthesis class Y protein) (PIG-Y),71,"8,058",4 out of 5,2006-07-25,Evidence at protein level
O15428,PINL_HUMAN,Putative PIN1-like protein (Peptidylprolyl cis-trans isomerase NIMA-interacting 1 pseudogene 1),100,"11,021",2 out of 5,2000-05-30,Uncertain
O94827,PKHG5_HUMAN,Pleckstrin homology domain-containing family G member 5 (PH domain-containing family G member 5) (Guanine nucleotide exchange factor 720) (GEF720),1062,"117,451",5 out of 5,2007-10-23,Evidence at protein level
Q96KN3,PKNX2_HUMAN,Homeobox protein PKNOX2 (Homeobox protein PREP-2) (PBX/knotted homeobox 2),472,"52,028",4 out of 5,2002-11-28,Evidence at transcript level
Q9Y446,PKP3_HUMAN,Plakophilin-3,797,"87,082",5 out of 5,2002-01-23,Evidence at protein level
Q9UPG8,PLAL2_HUMAN,Zinc finger protein PLAGL2 (Pleiomorphic adenoma-like protein 2),496,"54,584",4 out of 5,2001-06-20,Evidence at transcript level
Q6UQ28,PLET1_HUMAN,Placenta-expressed transcript 1 protein,207,"23,385",4 out of 5,2008-02-26,Evidence at transcript level
Q9HBL7,PLRKT_HUMAN,Plasminogen receptor (KT) (Plg-R(KT)),147,"17,201",3 out of 5,2005-07-05,Evidence at protein level
Q01851,PO4F1_HUMAN,"POU domain, class 4, transcription factor 1 (Brain-specific homeobox/POU domain protein 3A) (Brain-3A) (Brn-3A) (Homeobox/POU domain protein RDC-1) (Oct-T1)",419,"42,697",5 out of 5,1993-07-01,Evidence at transcript level
Q15319,PO4F3_HUMAN,"POU domain, class 4, transcription factor 3 (Brain-specific homeobox/POU domain protein 3C) (Brain-3C) (Brn-3C)",338,"37,052",5 out of 5,1997-11-01,Evidence at protein level
Q8TC44,POC1B_HUMAN,POC1 centriolar protein homolog B (Pix1) (Proteome of centriole protein 1B) (WD repeat-containing protein 51B),478,"53,668",5 out of 5,2006-01-24,Evidence at protein level
O00592,PODXL_HUMAN,Podocalyxin (GCTM-2 antigen) (Gp200) (Podocalyxin-like protein 1) (PC) (PCLP-1),558,"58,635",5 out of 5,2001-12-13,Evidence at protein level
P63135,POK7_HUMAN,Endogenous retrovirus group K member 7 Pol protein (HERV-K(III) Pol protein) (HERV-K102 Pol protein) (HERV-K_1q22 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],1459,"165,184",4 out of 5,2004-09-13,Inferred from homology
Q6PEZ8,PONL1_HUMAN,Podocan-like protein 1,512,"56,539",4 out of 5,2007-11-13,Evidence at transcript level
Q99575,POP1_HUMAN,Ribonucleases P/MRP protein subunit POP1 (hPOP1) (EC 3.1.26.5),1024,"114,709",5 out of 5,2001-02-21,Evidence at protein level
P53611,PGTB2_HUMAN,Geranylgeranyl transferase type-2 subunit beta (EC 2.5.1.60) (Geranylgeranyl transferase type II subunit beta) (GGTase-II-beta) (Rab geranyl-geranyltransferase subunit beta) (Rab GG transferase beta) (Rab GGTase beta) (Rab geranylgeranyltransferase subunit beta) (Type II protein geranyl-geranyltransferase subunit beta),331,"36,924",5 out of 5,1996-10-01,Evidence at protein level
O75167,PHAR2_HUMAN,Phosphatase and actin regulator 2,634,"69,700",4 out of 5,2003-05-09,Evidence at protein level
Q8IZ21,PHAR4_HUMAN,Phosphatase and actin regulator 4,702,"78,211",4 out of 5,2007-05-15,Evidence at protein level
P78364,PHC1_HUMAN,Polyhomeotic-like protein 1 (hPH1) (Early development regulatory protein 1),1004,"105,534",5 out of 5,2002-11-15,Evidence at protein level
P78562,PHEX_HUMAN,Phosphate-regulating neutral endopeptidase (EC 3.4.24.-) (Metalloendopeptidase homolog PEX) (Vitamin D-resistant hypophosphatemic rickets protein) (X-linked hypophosphatemia protein) (HYP),749,"86,474",5 out of 5,1997-11-01,Evidence at protein level
Q5T6S3,PHF19_HUMAN,PHD finger protein 19 (Polycomb-like protein 3) (hPCL3),580,"65,591",5 out of 5,2008-02-05,Evidence at protein level
Q9BUL5,PHF23_HUMAN,PHD finger protein 23 (PDH-containing protein JUNE-1),403,"43,818",5 out of 5,2007-09-11,Evidence at protein level
Q6UXB8,PI16_HUMAN,Peptidase inhibitor 16 (PI-16) (Cysteine-rich secretory protein 9) (CRISP-9) (PSP94-binding protein),463,"49,471",5 out of 5,2007-05-15,Evidence at protein level
Q8WYR1,PI3R5_HUMAN,"Phosphoinositide 3-kinase regulatory subunit 5 (PI3-kinase regulatory subunit 5) (PI3-kinase p101 subunit) (Phosphatidylinositol 4,5-bisphosphate 3-kinase regulatory subunit) (PtdIns-3-kinase regulatory subunit) (Protein FOAP-2) (PtdIns-3-kinase p101) (p101-PI3K)",880,"97,348",5 out of 5,2005-12-06,Evidence at protein level
Q5T9C9,PI5L1_HUMAN,Phosphatidylinositol 4-phosphate 5-kinase-like protein 1 (PI(4)P 5-kinase-like protein 1) (PtdIns(4)P-5-kinase-like protein 1) (EC 2.7.1.68),394,"44,572",3 out of 5,2007-05-01,Evidence at transcript level
Q8WXW3,PIBF1_HUMAN,Progesterone-induced-blocking factor 1 (PIBF) (Centrosomal protein of 90 kDa) (CEP90),757,"89,805",5 out of 5,2003-02-22,Evidence at protein level
Q9P1W9,PIM2_HUMAN,Serine/threonine-protein kinase pim-2 (EC 2.7.11.1) (Pim-2h),311,"34,190",5 out of 5,2002-03-27,Evidence at protein level
P22061,PIMT_HUMAN,Protein-L-isoaspartate(D-aspartate) O-methyltransferase (PIMT) (EC 2.1.1.77) (L-isoaspartyl protein carboxyl methyltransferase) (Protein L-isoaspartyl/D-aspartyl methyltransferase) (Protein-beta-aspartate methyltransferase),227,"24,636",5 out of 5,1991-08-01,Evidence at protein level
Q13526,PIN1_HUMAN,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (EC 5.2.1.8) (Peptidyl-prolyl cis-trans isomerase Pin1) (PPIase Pin1) (Rotamase Pin1),163,"18,243",5 out of 5,1998-07-15,Evidence at protein level
Q9H307,PININ_HUMAN,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),717,"81,614",5 out of 5,2005-08-30,Evidence at protein level
Q9BXM7,PINK1_HUMAN,"Serine/threonine-protein kinase PINK1, mitochondrial (EC 2.7.11.1) (BRPK) (PTEN-induced putative kinase protein 1)",581,"62,769",5 out of 5,2004-06-07,Evidence at protein level
Q00169,PIPNA_HUMAN,Phosphatidylinositol transfer protein alpha isoform (PI-TP-alpha) (PtdIns transfer protein alpha) (PtdInsTP alpha),270,"31,806",5 out of 5,1992-12-01,Evidence at protein level
Q99697,PITX2_HUMAN,Pituitary homeobox 2 (ALL1-responsive protein ARP1) (Homeobox protein PITX2) (Paired-like homeodomain transcription factor 2) (RIEG bicoid-related homeobox transcription factor) (Solurshin),317,"35,370",5 out of 5,1998-07-15,Evidence at protein level
Q9P0L9,PK2L1_HUMAN,Polycystic kidney disease 2-like 1 protein (Polycystin-2 homolog) (Polycystin-2L1) (Polycystin-L) (Polycystin-L1),805,"91,982",5 out of 5,2002-10-10,Evidence at protein level
P48736,PK3CG_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (PI3-kinase subunit gamma) (PI3K-gamma) (PI3Kgamma) (PtdIns-3-kinase subunit gamma) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit gamma) (PtdIns-3-kinase subunit p110-gamma) (p110gamma) (Phosphoinositide-3-kinase catalytic gamma polypeptide) (Serine/threonine protein kinase PIK3CG) (EC 2.7.11.1) (p120-PI3K)",1102,"126,454",5 out of 5,1996-02-01,Evidence at protein level
Q9NTG1,PKDRE_HUMAN,Polycystic kidney disease and receptor for egg jelly-related protein (PKD and REJ homolog),2253,"255,449",5 out of 5,2002-09-19,Evidence at transcript level
Q9H4M7,PKHA4_HUMAN,Pleckstrin homology domain-containing family A member 4 (PH domain-containing family A member 4) (Phosphoinositol 3-phosphate-binding protein 1) (PEPP-1),779,"85,401",4 out of 5,2004-03-29,Evidence at protein level
Q6IQ23,PKHA7_HUMAN,Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7),1121,"127,135",5 out of 5,2007-05-15,Evidence at protein level
Q9UF11,PKHB1_HUMAN,Pleckstrin homology domain-containing family B member 1 (PH domain-containing family B member 1) (Evectin-1) (PH domain-containing protein in retina 1) (PHRET1) (Pleckstrin homology domain retinal protein 1),243,"27,186",5 out of 5,2004-03-29,Evidence at protein level
Q494U1,PKHN1_HUMAN,Pleckstrin homology domain-containing family N member 1 (PH domain-containing family N member 1),663,"71,790",5 out of 5,2007-11-13,Evidence at protein level
Q6P5Z2,PKN3_HUMAN,Serine/threonine-protein kinase N3 (EC 2.7.11.13) (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3),889,"99,421",5 out of 5,2005-10-25,Evidence at protein level
Q99569,PKP4_HUMAN,Plakophilin-4 (p0071),1192,"131,868",5 out of 5,2002-01-23,Evidence at protein level
Q00722,PLCB2_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-beta-2) (Phospholipase C-beta-2) (PLC-beta-2)",1185,"134,024",5 out of 5,1993-07-01,Evidence at protein level
Q9NRZ7,PLCC_HUMAN,1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 3) (1-AGP acyltransferase 3) (1-AGPAT 3) (Lysophosphatidic acid acyltransferase gamma) (LPAAT-gamma),376,"43,381",5 out of 5,2001-01-11,Evidence at protein level
Q9P212,PLCE1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase epsilon-1 (EC 3.1.4.11) (Pancreas-enriched phospholipase C) (Phosphoinositide phospholipase C-epsilon-1) (Phospholipase C-epsilon-1) (PLC-epsilon-1)",2302,"258,715",5 out of 5,2006-10-31,Evidence at protein level
P16885,PLCG2_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2)",1265,"147,870",5 out of 5,1990-08-01,Evidence at protein level
Q15195,PLGA_HUMAN,Plasminogen-like protein A (Plasminogen-like protein A1) (Plasminogen-related protein A),96,"10,915",2 out of 5,2007-10-02,Evidence at transcript level
Q9H4B4,PLK3_HUMAN,Serine/threonine-protein kinase PLK3 (EC 2.7.11.21) (Cytokine-inducible serine/threonine-protein kinase) (FGF-inducible kinase) (Polo-like kinase 3) (PLK-3) (Proliferation-related kinase),646,"71,629",5 out of 5,2001-04-27,Evidence at protein level
P13797,PLST_HUMAN,Plastin-3 (T-plastin),630,"70,811",5 out of 5,1990-01-01,Evidence at protein level
Q9HCM2,PLXA4_HUMAN,Plexin-A4,1894,"212,455",5 out of 5,2006-06-13,Evidence at protein level
O43157,PLXB1_HUMAN,Plexin-B1 (Semaphorin receptor SEP),2135,"232,298",5 out of 5,2004-08-31,Evidence at protein level
Q9Y4D7,PLXD1_HUMAN,Plexin-D1,1925,"212,007",5 out of 5,2004-08-31,Evidence at protein level
Q9ULN7,PNML2_HUMAN,PNMA-like protein 2,279,"30,513",2 out of 5,2008-03-18,Evidence at transcript level
Q8TCS8,PNPT1_HUMAN,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial (EC 2.7.7.8) (3'-5' RNA exonuclease OLD35) (PNPase old-35) (Polynucleotide phosphorylase 1) (PNPase 1) (Polynucleotide phosphorylase-like protein)",783,"85,951",5 out of 5,2005-05-10,Evidence at protein level
Q9Y5J5,PHLA3_HUMAN,Pleckstrin homology-like domain family A member 3 (TDAG51/Ipl homolog 1),127,"13,891",5 out of 5,2005-12-20,Evidence at protein level
Q86UU1,PHLB1_HUMAN,Pleckstrin homology-like domain family B member 1 (Protein LL5-alpha),1377,"151,162",4 out of 5,2005-12-20,Evidence at protein level
O14813,PHX2A_HUMAN,Paired mesoderm homeobox protein 2A (ARIX1 homeodomain protein) (Aristaless homeobox protein homolog) (Paired-like homeobox 2A),284,"29,653",5 out of 5,2000-05-30,Evidence at protein level
Q9HB75,PIDD1_HUMAN,p53-induced death domain-containing protein 1 (Leucine-rich repeat and death domain-containing protein),910,"99,712",5 out of 5,2006-07-11,Evidence at protein level
Q9Y2B2,PIGL_HUMAN,N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase (EC 3.5.1.89) (Phosphatidylinositol-glycan biosynthesis class L protein) (PIG-L),252,"28,531",4 out of 5,2001-07-11,Evidence at protein level
P28069,PIT1_HUMAN,Pituitary-specific positive transcription factor 1 (PIT-1) (Growth hormone factor 1) (GHF-1),291,"32,912",5 out of 5,1992-08-01,Evidence at protein level
Q8NG27,PJA1_HUMAN,E3 ubiquitin-protein ligase Praja-1 (Praja1) (EC 2.3.2.27) (RING finger protein 70) (RING-type E3 ubiquitin transferase Praja-1),643,"71,002",5 out of 5,2003-05-23,Evidence at protein level
Q7Z442,PK1L2_HUMAN,Polycystic kidney disease protein 1-like 2 (PC1-like 2 protein) (Polycystin-1L2),2459,"272,575",5 out of 5,2008-02-26,Evidence at protein level
Q9NZM6,PK2L2_HUMAN,Polycystic kidney disease 2-like 2 protein (Polycystin-2L2) (Polycystin-L2),624,"73,790",5 out of 5,2002-10-10,Evidence at transcript level
P42338,PK3CB_HUMAN,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform (PI3-kinase subunit beta) (PI3K-beta) (PI3Kbeta) (PtdIns-3-kinase subunit beta) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit beta) (PtdIns-3-kinase subunit p110-beta) (p110beta)",1070,"122,762",5 out of 5,1995-11-01,Evidence at protein level
Q13563,PKD2_HUMAN,Polycystin-2 (PC2) (Autosomal dominant polycystic kidney disease type II protein) (Polycystic kidney disease 2 protein) (Polycystwin) (R48321) (Transient receptor potential cation channel subfamily P member 2),968,"109,691",5 out of 5,1999-07-15,Evidence at protein level
Q9ULM0,PKHH1_HUMAN,Pleckstrin homology domain-containing family H member 1 (PH domain-containing family H member 1),1364,"151,232",3 out of 5,2007-11-13,Evidence at transcript level
Q5SXH7,PKHS1_HUMAN,Pleckstrin homology domain-containing family S member 1 (PH domain-containing family S member 1) (Epididymis luminal protein 185) (hEL185),462,"51,839",3 out of 5,2008-02-26,Evidence at protein level
Q8TCW9,PKR1_HUMAN,Prokineticin receptor 1 (PK-R1) (G-protein coupled receptor 73) (G-protein coupled receptor ZAQ) (GPR73a),393,"44,770",4 out of 5,2003-07-19,Evidence at protein level
Q9H875,PKRI1_HUMAN,PRKR-interacting protein 1,184,"20,997",4 out of 5,2008-03-18,Evidence at protein level
Q13018,PLA2R_HUMAN,Secretory phospholipase A2 receptor (PLA2-R) (PLA2R) (180 kDa secretory phospholipase A2 receptor) (C-type lectin domain family 13 member C) (M-type receptor) [Cleaved into: Soluble secretory phospholipase A2 receptor (Soluble PLA2-R) (Soluble PLA2R)],1463,"168,600",5 out of 5,2007-11-13,Evidence at protein level
Q8WY50,PLAC4_HUMAN,Placenta-specific protein 4,150,"16,680",1 out of 5,2007-08-21,Evidence at transcript level
Q63HM9,PLCX3_HUMAN,PI-PLC X domain-containing protein 3,321,"36,313",2 out of 5,2007-10-02,Evidence at transcript level
Q86YW0,PLCZ1_HUMAN,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase zeta-1 (EC 3.1.4.11) (Phosphoinositide phospholipase C-zeta-1) (Phospholipase C-zeta-1) (PLC-zeta-1) (Testis-development protein NYD-SP27)",608,"70,411",5 out of 5,2008-09-02,Evidence at protein level
Q00G26,PLIN5_HUMAN,Perilipin-5 (Lipid storage droplet protein 5),463,"50,791",5 out of 5,2008-06-10,Evidence at protein level
O14494,PLPP1_HUMAN,Phospholipid phosphatase 1 (EC 3.1.3.4) (Lipid phosphate phosphohydrolase 1) (PAP2-alpha) (Phosphatidate phosphohydrolase type 2a) (Phosphatidic acid phosphatase 2a) (PAP-2a) (PAP2a),284,"32,156",5 out of 5,2004-03-15,Evidence at protein level
Q5VZY2,PLPP4_HUMAN,Phospholipid phosphatase 4 (EC 3.1.3.4) (Phosphatidic acid phosphatase type 2 domain-containing protein 1A),271,"30,395",5 out of 5,2007-05-15,Evidence at protein level
Q96GM1,PLPR2_HUMAN,Phospholipid phosphatase-related protein type 2 (EC 3.1.3.4) (Lipid phosphate phosphatase-related protein type 2) (Plasticity-related gene 4 protein) (PRG-4),343,"36,880",4 out of 5,2008-02-05,Evidence at transcript level
O15162,PLS1_HUMAN,Phospholipid scramblase 1 (PL scramblase 1) (Ca(2+)-dependent phospholipid scramblase 1) (Erythrocyte phospholipid scramblase) (MmTRA1b),318,"35,049",5 out of 5,2001-06-20,Evidence at protein level
P13796,PLSL_HUMAN,Plastin-2 (L-plastin) (LC64P) (Lymphocyte cytosolic protein 1) (LCP-1),627,"70,288",5 out of 5,1990-01-01,Evidence at protein level
Q969W9,PMEPA_HUMAN,Protein TMEPAI (Prostate transmembrane protein androgen induced 1) (Solid tumor-associated 1 protein) (Transmembrane prostate androgen-induced protein),287,"31,609",5 out of 5,2002-03-05,Evidence at protein level
Q8WZA1,PMGT1_HUMAN,"Protein O-linked-mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1) (EC 2.4.1.-) (UDP-GlcNAc:alpha-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I.2) (GnT I.2)",660,"75,252",5 out of 5,2005-08-16,Evidence at protein level
Q68D20,PMS2L_HUMAN,Protein PMS2CL (PMS2-C terminal-like protein),193,"20,909",2 out of 5,2007-07-24,Evidence at transcript level
P22103,PNEU_HUMAN,Pneumadin (PNM),10,956,2 out of 5,1991-08-01,Evidence at protein level
P78424,PO6F2_HUMAN,"POU domain, class 6, transcription factor 2 (Retina-derived POU domain factor 1) (RPF-1)",691,"73,265",5 out of 5,2003-02-01,Evidence at protein level
Q9WJR5,POK19_HUMAN,Endogenous retrovirus group K member 19 Pol protein (HERV-K(C19) Pol protein) (HERV-K_19q11 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],959,"108,106",4 out of 5,2004-09-13,Evidence at transcript level
Q9UNA4,POLI_HUMAN,DNA polymerase iota (EC 2.7.7.7) (Eta2) (RAD30 homolog B),740,"83,006",5 out of 5,2005-02-15,Evidence at protein level
Q8N131,PORIM_HUMAN,Porimin (Keratinocytes-associated transmembrane protein 3) (KCT-3) (Pro-oncosis receptor inducing membrane injury) (Transmembrane protein 123),208,"21,531",5 out of 5,2005-12-20,Evidence at protein level
Q6S8J3,POTEE_HUMAN,"POTE ankyrin domain family member E (ANKRD26-like family C member 1A) (Prostate, ovary, testis-expressed protein on chromosome 2) (POTE-2)",1075,"121,363",4 out of 5,2004-11-23,Evidence at transcript level
P0CG38,POTEI_HUMAN,POTE ankyrin domain family member I,1075,"121,282",3 out of 5,2010-07-13,Inferred from homology
Q96QC0,PP1RA_HUMAN,Serine/threonine-protein phosphatase 1 regulatory subunit 10 (MHC class I region proline-rich protein CAT53) (PP1-binding protein of 114 kDa) (Phosphatase 1 nuclear targeting subunit) (Protein FB19) (p99),940,"99,058",5 out of 5,2005-03-15,Evidence at protein level
P62714,PP2AB_HUMAN,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform (PP2A-beta) (EC 3.1.3.16),309,"35,575",5 out of 5,2004-07-19,Evidence at protein level
P60510,PP4C_HUMAN,Serine/threonine-protein phosphatase 4 catalytic subunit (PP4C) (Pp4) (EC 3.1.3.16) (Protein phosphatase X) (PP-X),307,"35,080",5 out of 5,2004-03-01,Evidence at protein level
E7EU14,PP5D1_HUMAN,Protein PPP5D1 (PPP5 TPR repeat domain-containing protein 1),171,"19,623",1 out of 5,2012-10-03,Evidence at transcript level
Q9UPN7,PP6R1_HUMAN,Serine/threonine-protein phosphatase 6 regulatory subunit 1 (SAPS domain family member 1),881,"96,724",5 out of 5,2002-11-25,Evidence at protein level
Q13401,PM2P3_HUMAN,Putative postmeiotic segregation increased 2-like protein 3 (PMS2-related protein 3) (Postmeiotic segregation increased 2-like protein 9) (Postmeiotic segregation increased protein 5) (Putative postmeiotic segregation increased 2 pseudogene 3),168,"18,716",4 out of 5,2007-11-13,Uncertain
Q99640,PMYT1_HUMAN,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase (EC 2.7.11.1) (Myt1 kinase),499,"54,521",5 out of 5,2004-11-23,Evidence at protein level
Q8NA58,PNDC1_HUMAN,Poly(A)-specific ribonuclease PNLDC1 (EC 3.1.13.4) (PARN-like domain-containing protein 1) (Poly(A)-specific ribonuclease domain-containing protein 1) (HsPNLDC1),520,"60,124",4 out of 5,2007-11-13,Evidence at protein level
Q96PV4,PNMA5_HUMAN,Paraneoplastic antigen-like protein 5 (Tumor antigen BJ-HCC-25),448,"49,934",5 out of 5,2007-11-13,Evidence at protein level
Q15166,PON3_HUMAN,Serum paraoxonase/lactonase 3 (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1),354,"39,607",5 out of 5,1997-11-01,Evidence at protein level
P48454,PP2BC_HUMAN,"Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calcineurin, testis-specific catalytic subunit) (Calmodulin-dependent calcineurin A subunit gamma isoform)",512,"58,129",5 out of 5,1996-02-01,Evidence at protein level
Q9NY27,PP4R2_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 2,417,"46,898",5 out of 5,2007-09-11,Evidence at protein level
Q9P1A2,PP4RL_HUMAN,Putative serine/threonine-protein phosphatase 4 regulatory subunit 1-like,415,"45,908",2 out of 5,2004-03-01,Uncertain
P48147,PPCE_HUMAN,Prolyl endopeptidase (PE) (EC 3.4.21.26) (Post-proline cleaving enzyme),710,"80,700",5 out of 5,1996-02-01,Evidence at protein level
Q13356,PPIL2_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 2 (PPIase) (EC 2.3.2.27) (EC 5.2.1.8) (CYC4) (Cyclophilin-60) (Cyclophilin-like protein Cyp-60) (Cyp60) (hCyP-60) (RING-type E3 ubiquitin transferase isomerase-like 2) (Rotamase PPIL2),520,"58,823",5 out of 5,2002-10-10,Evidence at protein level
Q9H2H8,PPIL3_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 3 (PPIase) (EC 5.2.1.8) (Cyclophilin J) (CyPJ) (Cyclophilin-like protein PPIL3) (Rotamase PPIL3),161,"18,155",5 out of 5,2005-08-30,Evidence at protein level
O15355,PPM1G_HUMAN,Protein phosphatase 1G (EC 3.1.3.16) (Protein phosphatase 1C) (Protein phosphatase 2C isoform gamma) (PP2C-gamma) (Protein phosphatase magnesium-dependent 1 gamma),546,"59,272",5 out of 5,1998-07-15,Evidence at protein level
Q8N819,PPM1N_HUMAN,Probable protein phosphatase 1N (EC 3.1.3.16),430,"46,170",3 out of 5,2008-09-02,Evidence at transcript level
O95685,PPR3D_HUMAN,Protein phosphatase 1 regulatory subunit 3D (Protein phosphatase 1 regulatory subunit 6) (PP1 subunit R6) (Protein phosphatase 1-binding subunit R6),299,"32,559",4 out of 5,2002-09-19,Evidence at protein level
Q8N755,PQLC3_HUMAN,PQ-loop repeat-containing protein 3,202,"22,575",2 out of 5,2006-04-18,Evidence at transcript level
Q8ND90,PNMA1_HUMAN,Paraneoplastic antigen Ma1 (37 kDa neuronal protein) (Neuron- and testis-specific protein 1),353,"39,761",5 out of 5,2003-10-24,Evidence at protein level
Q13519,PNOC_HUMAN,Prepronociceptin [Cleaved into: Nocistatin; Nociceptin (Orphanin FQ) (PPNOC); Orphanin FQ2],176,"20,295",5 out of 5,1997-11-01,Evidence at protein level
Q03052,PO3F1_HUMAN,"POU domain, class 3, transcription factor 1 (Octamer-binding protein 6) (Oct-6) (Octamer-binding transcription factor 6) (OTF-6) (POU domain transcription factor SCIP)",451,"45,496",5 out of 5,1993-07-01,Evidence at transcript level
P20265,PO3F2_HUMAN,"POU domain, class 3, transcription factor 2 (Brain-specific homeobox/POU domain protein 2) (Brain-2) (Brn-2) (Nervous system-specific octamer-binding transcription factor N-Oct-3) (Octamer-binding protein 7) (Oct-7) (Octamer-binding transcription factor 7) (OTF-7)",443,"46,893",5 out of 5,1991-02-01,Evidence at protein level
P49335,PO3F4_HUMAN,"POU domain, class 3, transcription factor 4 (Brain-specific homeobox/POU domain protein 4) (Brain-4) (Brn-4) (Octamer-binding protein 9) (Oct-9) (Octamer-binding transcription factor 9) (OTF-9)",361,"39,427",5 out of 5,1996-02-01,Evidence at protein level
Q9NP85,PODO_HUMAN,Podocin,383,"42,201",5 out of 5,2001-01-11,Evidence at protein level
P10266,POK10_HUMAN,Endogenous retrovirus group K member 10 Pol protein (HERV-K10 Pol protein) (HERV-K107 Pol protein) (HERV-K_5q33.3 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],1014,"114,827",4 out of 5,1989-07-01,Inferred from homology
Q9BXR3,POK6_HUMAN,Endogenous retrovirus group K member 6 Pol protein (HERV-K(C7) Pol protein) (HERV-K(HML-2.HOM) Pol protein) (HERV-K108 Pol protein) (HERV-K_7p22.1 provirus ancestral Pol protein) [Includes: Reverse transcriptase (RT) (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4); Integrase (IN)],956,"107,688",4 out of 5,2004-09-13,Evidence at transcript level
Q15165,PON2_HUMAN,Serum paraoxonase/arylesterase 2 (PON 2) (EC 3.1.1.2) (EC 3.1.1.81) (Aromatic esterase 2) (A-esterase 2) (Serum aryldialkylphosphatase 2),354,"39,397",5 out of 5,1997-11-01,Evidence at protein level
Q969H6,POP5_HUMAN,Ribonuclease P/MRP protein subunit POP5 (hPop5) (EC 3.1.26.5),163,"18,820",5 out of 5,2006-05-30,Evidence at protein level
Q9H8P0,PORED_HUMAN,Polyprenol reductase (EC 1.3.1.94) (3-oxo-5-alpha-steroid 4-dehydrogenase 3) (EC 1.3.1.22) (Steroid 5-alpha-reductase 2-like) (Steroid 5-alpha-reductase 3) (S5AR 3) (SR type 3),318,"36,521",5 out of 5,2008-02-05,Evidence at protein level
Q15063,POSTN_HUMAN,Periostin (PN) (Osteoblast-specific factor 2) (OSF-2),836,"93,314",5 out of 5,2004-04-26,Evidence at protein level
A6NI47,POTEM_HUMAN,Putative POTE ankyrin domain family member M,508,"57,067",1 out of 5,2008-04-29,Inferred from homology
Q6PJE2,POZP3_HUMAN,POM121 and ZP3 fusion protein (POM-ZP3),187,"20,620",3 out of 5,2004-08-16,Evidence at transcript level
B7ZBB8,PP13G_HUMAN,Protein phosphatase 1 regulatory subunit 3G,358,"38,019",2 out of 5,2010-06-15,Evidence at protein level
Q96A00,PP14A_HUMAN,Protein phosphatase 1 regulatory subunit 14A (17 kDa PKC-potentiated inhibitory protein of PP1) (Protein kinase C-potentiated inhibitor protein of 17 kDa) (CPI-17),147,"16,693",4 out of 5,2004-11-09,Evidence at protein level
Q08209,PP2BA_HUMAN,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit alpha isoform),521,"58,688",5 out of 5,1996-02-01,Evidence at protein level
Q8TF05,PP4R1_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 1,950,"107,004",4 out of 5,2004-03-01,Evidence at protein level
P11117,PPAL_HUMAN,Lysosomal acid phosphatase (LAP) (EC 3.1.3.2),423,"48,344",5 out of 5,1989-07-01,Evidence at protein level
Q9BZG2,PPAT_HUMAN,Testicular acid phosphatase (EC 3.1.3.2),426,"46,090",4 out of 5,2006-10-31,Evidence at protein level
P05187,PPB1_HUMAN,"Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1)",535,"57,954",5 out of 5,1987-08-13,Evidence at protein level
Q08752,PPID_HUMAN,Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) (40 kDa peptidyl-prolyl cis-trans isomerase) (Cyclophilin-40) (CYP-40) (Cyclophilin-related protein) (Rotamase D),370,"40,764",5 out of 5,1995-02-01,Evidence at protein level
Q9UNP9,PPIE_HUMAN,Peptidyl-prolyl cis-trans isomerase E (PPIase E) (EC 5.2.1.8) (Cyclophilin E) (Cyclophilin-33) (Rotamase E),301,"33,431",5 out of 5,2001-02-21,Evidence at protein level
O43586,PPIP1_HUMAN,Proline-serine-threonine phosphatase-interacting protein 1 (PEST phosphatase-interacting protein 1) (CD2-binding protein 1) (H-PIP),416,"47,591",5 out of 5,2005-09-13,Evidence at protein level
P26678,PPLA_HUMAN,Cardiac phospholamban (PLB),52,"6,109",5 out of 5,1992-08-01,Evidence at protein level
P41247,PLPL4_HUMAN,Patatin-like phospholipase domain-containing protein 4 (EC 3.1.1.3) (Protein GS2),253,"27,980",5 out of 5,1995-02-01,Evidence at transcript level
O43660,PLRG1_HUMAN,Pleiotropic regulator 1,514,"57,194",5 out of 5,2003-11-07,Evidence at protein level
Q14651,PLSI_HUMAN,Plastin-1 (Intestine-specific plastin) (I-plastin),629,"70,253",5 out of 5,1997-11-01,Evidence at protein level
Q9UIW2,PLXA1_HUMAN,Plexin-A1 (Semaphorin receptor NOV),1896,"211,067",5 out of 5,2006-04-18,Evidence at protein level
P51805,PLXA3_HUMAN,Plexin-A3 (Plexin-4) (Semaphorin receptor SEX),1871,"207,703",5 out of 5,1996-10-01,Evidence at protein level
O95744,PM2P2_HUMAN,Putative postmeiotic segregation increased 2-like protein 2 (Postmeiotic segregation increased 2-like protein 14) (Postmeiotic segregation increased protein 4) (Putative postmeiotic segregation increased 2 pseudogene 2),297,"32,669",3 out of 5,2007-11-13,Uncertain
O43808,PM34_HUMAN,Peroxisomal membrane protein PMP34 (34 kDa peroxisomal membrane protein) (Solute carrier family 25 member 17),307,"34,567",5 out of 5,2001-01-24,Evidence at protein level
Q8TF01,PNISR_HUMAN,"Arginine/serine-rich protein PNISR (PNN-interacting serine/arginine-rich protein) (SR-related protein) (SR-rich protein) (Serine/arginine-rich-splicing regulatory protein 130) (SRrp130) (Splicing factor, arginine/serine-rich 130) (Splicing factor, arginine/serine-rich 18)",805,"92,577",5 out of 5,2005-07-05,Evidence at protein level
P0CW24,PNM6A_HUMAN,Paraneoplastic antigen-like protein 6A,399,"43,875",2 out of 5,2011-07-27,Evidence at protein level
Q9UL41,PNMA3_HUMAN,Paraneoplastic antigen Ma3,463,"52,404",3 out of 5,2007-03-20,Evidence at transcript level
Q9NRX1,PNO1_HUMAN,RNA-binding protein PNO1,252,"27,924",3 out of 5,2007-01-09,Evidence at protein level
Q8NE79,POPD1_HUMAN,Blood vessel epicardial substance (hBVES) (Popeye domain-containing protein 1) (Popeye protein 1),360,"41,451",5 out of 5,2003-10-31,Evidence at protein level
Q6S5H4,POTEB_HUMAN,"POTE ankyrin domain family member B (ANKRD26-like family B member 1) (Prostate, ovary, testis-expressed protein on chromosome 15) (POTE-15)",581,"65,710",4 out of 5,2004-11-23,Evidence at transcript level
Q6S5H5,POTEG_HUMAN,"POTE ankyrin domain family member G (ANKRD26-like family C member 2) (Prostate, ovary, testis-expressed protein on chromosome 14) (POTE-14)",508,"57,096",2 out of 5,2004-11-23,Evidence at transcript level
Q9UHV8,PP13_HUMAN,Galactoside-binding soluble lectin 13 (Galectin-13) (Gal-13) (Placental tissue protein 13) (PP13) (Placental protein 13),139,"16,119",4 out of 5,2004-01-16,Evidence at protein level
P62136,PP1A_HUMAN,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16),330,"37,512",5 out of 5,1988-08-01,Evidence at protein level
P16298,PP2BB_HUMAN,Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform (EC 3.1.3.16) (CAM-PRP catalytic subunit) (Calmodulin-dependent calcineurin A subunit beta isoform),524,"59,024",5 out of 5,1990-08-01,Evidence at protein level
Q03181,PPARD_HUMAN,Peroxisome proliferator-activated receptor delta (PPAR-delta) (NUCI) (Nuclear hormone receptor 1) (NUC1) (Nuclear receptor subfamily 1 group C member 2) (Peroxisome proliferator-activated receptor beta) (PPAR-beta),441,"49,903",5 out of 5,1993-10-01,Evidence at protein level
A6NEV1,PR23A_HUMAN,Proline-rich protein 23A,266,"28,155",1 out of 5,2008-04-29,Inferred from homology
Q6NWY9,PR40B_HUMAN,Pre-mRNA-processing factor 40 homolog B (Huntingtin yeast partner C) (Huntingtin-interacting protein C),871,"99,358",5 out of 5,2007-11-13,Evidence at protein level
O60809,PRA10_HUMAN,PRAME family member 10,474,"55,211",2 out of 5,2000-05-30,Evidence at transcript level
Q5VTA0,PRA17_HUMAN,PRAME family member 17,474,"54,769",2 out of 5,2007-06-12,Evidence at transcript level
A3QJZ6,PRA22_HUMAN,PRAME family member 22,481,"55,489",2 out of 5,2008-05-20,Inferred from homology
Q9NQX1,PRDM5_HUMAN,PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5),630,"73,090",5 out of 5,2001-11-16,Evidence at protein level
P30048,PRDX3_HUMAN,"Thioredoxin-dependent peroxide reductase, mitochondrial (EC 1.11.1.15) (Antioxidant protein 1) (AOP-1) (HBC189) (Peroxiredoxin III) (Prx-III) (Peroxiredoxin-3) (Protein MER5 homolog)",256,"27,693",5 out of 5,1993-04-01,Evidence at protein level
P30044,PRDX5_HUMAN,"Peroxiredoxin-5, mitochondrial (EC 1.11.1.15) (Alu corepressor 1) (Antioxidant enzyme B166) (AOEB166) (Liver tissue 2D-page spot 71B) (PLP) (Peroxiredoxin V) (Prx-V) (Peroxisomal antioxidant enzyme) (TPx type VI) (Thioredoxin peroxidase PMP20) (Thioredoxin reductase)",214,"22,086",5 out of 5,1993-04-01,Evidence at protein level
Q9HCU5,PREB_HUMAN,Prolactin regulatory element-binding protein (Mammalian guanine nucleotide exchange factor mSec12),417,"45,468",5 out of 5,2001-10-24,Evidence at protein level
Q5JRX3,PREP_HUMAN,"Presequence protease, mitochondrial (hPreP) (EC 3.4.24.-) (Pitrilysin metalloproteinase 1) (Metalloprotease 1) (hMP1)",1037,"117,413",5 out of 5,2006-09-19,Evidence at protein level
P54277,PMS1_HUMAN,PMS1 protein homolog 1 (DNA mismatch repair protein PMS1),932,"105,830",5 out of 5,1996-10-01,Evidence at protein level
Q9Y253,POLH_HUMAN,DNA polymerase eta (EC 2.7.7.7) (RAD30 homolog A) (Xeroderma pigmentosum variant type protein),713,"78,413",5 out of 5,2005-02-15,Evidence at protein level
Q9UBT6,POLK_HUMAN,DNA polymerase kappa (EC 2.7.7.7) (DINB protein) (DINP),870,"98,809",5 out of 5,2005-02-15,Evidence at protein level
Q5K4E3,POLS2_HUMAN,Polyserase-2 (EC 3.4.21.-) (Polyserine protease 2) (Serine protease 36),855,"91,955",5 out of 5,2005-03-15,Evidence at protein level
Q86YR6,POTED_HUMAN,"POTE ankyrin domain family member D (ANKRD26-like family B member 3) (Ankyrin repeat domain-containing protein 21) (Prostate, ovary, testis-expressed protein) (Protein POTE)",584,"66,394",3 out of 5,2003-08-22,Evidence at transcript level
Q6S545,POTEH_HUMAN,"POTE ankyrin domain family member H (ANKRD26-like family C member 3) (Prostate, ovary, testis-expressed protein on chromosome 22) (POTE-22)",545,"60,965",2 out of 5,2004-11-23,Evidence at transcript level
P45877,PPIC_HUMAN,Peptidyl-prolyl cis-trans isomerase C (PPIase C) (EC 5.2.1.8) (Cyclophilin C) (Rotamase C),212,"22,763",5 out of 5,1995-11-01,Evidence at protein level
Q8WUA2,PPIL4_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 4 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL4) (Rotamase PPIL4),492,"57,225",4 out of 5,2006-04-18,Evidence at protein level
Q6ZRP0,PR23C_HUMAN,Proline-rich protein 23C,262,"27,805",1 out of 5,2008-04-29,Evidence at transcript level
Q96KF2,PRAC1_HUMAN,"Small nuclear protein PRAC1 (Prostate cancer susceptibility candidate protein 1) (Prostate, rectum and colon expressed gene protein)",57,"5,959",2 out of 5,2007-12-04,Evidence at transcript level
P02812,PRB2_HUMAN,Basic salivary proline-rich protein 2 (Salivary proline-rich protein) (Con1 glycoprotein) [Cleaved into: Basic proline-rich peptide IB-1; Basic proline-rich peptide P-E (IB-9); Basic proline-rich peptide IB-7; Basic proline-rich peptide IB-8c (Basic peptide P-F); Basic proline-rich peptide IB-4],416,"40,799",5 out of 5,1986-07-21,Evidence at protein level
Q5JSZ5,PRC2B_HUMAN,Protein PRRC2B (HLA-B-associated transcript 2-like 1) (Proline-rich coiled-coil protein 2B),2229,"242,967",4 out of 5,2007-02-06,Evidence at protein level
Q9H4Q3,PRD13_HUMAN,PR domain zinc finger protein 13 (EC 2.1.1.-) (PR domain-containing protein 13),707,"73,981",4 out of 5,2001-11-16,Evidence at transcript level
P57071,PRD15_HUMAN,PR domain zinc finger protein 15 (EC 2.1.1.-) (PR domain-containing protein 15) (Zinc finger protein 298),1507,"169,269",5 out of 5,2000-12-01,Evidence at protein level
O75626,PRDM1_HUMAN,PR domain zinc finger protein 1 (EC 2.1.1.-) (BLIMP-1) (Beta-interferon gene positive regulatory domain I-binding factor) (PR domain-containing protein 1) (Positive regulatory domain I-binding factor 1) (PRDI-BF1) (PRDI-binding factor 1),825,"91,771",5 out of 5,2002-11-08,Evidence at protein level
Q9NQW5,PRDM7_HUMAN,Probable histone-lysine N-methyltransferase PRDM7 (EC 2.1.1.43) (PR domain zinc finger protein 7) (PR domain-containing protein 7),492,"55,777",4 out of 5,2001-11-16,Evidence at protein level
Q9NQV7,PRDM9_HUMAN,Histone-lysine N-methyltransferase PRDM9 (EC 2.1.1.43) (PR domain zinc finger protein 9) (PR domain-containing protein 9),894,"103,376",4 out of 5,2001-11-16,Evidence at protein level
P30041,PRDX6_HUMAN,Peroxiredoxin-6 (EC 1.11.1.15) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.-) (Antioxidant protein 2) (Liver 2D page spot 40) (Non-selenium glutathione peroxidase) (NSGPx) (EC 1.11.1.9) (Red blood cells page spot 12),224,"25,035",5 out of 5,1993-04-01,Evidence at protein level
P78527,PRKDC_HUMAN,DNA-dependent protein kinase catalytic subunit (DNA-PK catalytic subunit) (DNA-PKcs) (EC 2.7.11.1) (DNPK1) (p460),4128,"469,089",5 out of 5,2001-04-27,Evidence at protein level
O75817,POP7_HUMAN,Ribonuclease P protein subunit p20 (RNaseP protein p20) (EC 3.1.26.5) (Ribonucleases P/MRP protein subunit POP7 homolog) (hPOP7),140,"15,651",5 out of 5,2001-02-21,Evidence at protein level
A5A3E0,POTEF_HUMAN,POTE ankyrin domain family member F (ANKRD26-like family C member 1B) (Chimeric POTE-actin protein),1075,"121,445",4 out of 5,2007-10-23,Evidence at protein level
Q96T49,PP16B_HUMAN,Protein phosphatase 1 regulatory inhibitor subunit 16B (Ankyrin repeat domain-containing protein 4) (CAAX box protein TIMAP) (TGF-beta-inhibited membrane-associated protein) (hTIMAP),567,"63,551",5 out of 5,2002-08-13,Evidence at protein level
P62140,PP1B_HUMAN,Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (PPP1CD) (EC 3.1.3.16) (EC 3.1.3.53),327,"37,187",5 out of 5,2004-06-21,Evidence at protein level
P67775,PP2AA_HUMAN,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform (PP2A-alpha) (EC 3.1.3.16) (Replication protein C) (RP-C),309,"35,594",5 out of 5,2004-10-11,Evidence at protein level
O75170,PP6R2_HUMAN,Serine/threonine-protein phosphatase 6 regulatory subunit 2 (SAPS domain family member 2),966,"104,942",5 out of 5,2002-11-25,Evidence at protein level
P49593,PPM1F_HUMAN,Protein phosphatase 1F (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase) (CaM-kinase phosphatase) (CaMKPase) (Partner of PIX 2) (Protein fem-2 homolog) (hFem-2),454,"49,831",5 out of 5,1996-02-01,Evidence at protein level
P50336,PPOX_HUMAN,Protoporphyrinogen oxidase (PPO) (EC 1.3.3.4),477,"50,765",5 out of 5,1996-10-01,Evidence at protein level
Q13522,PPR1A_HUMAN,Protein phosphatase 1 regulatory subunit 1A (Protein phosphatase inhibitor 1) (I-1) (IPP-1),171,"19,011",5 out of 5,1997-11-01,Evidence at protein level
Q8WVI7,PPR1C_HUMAN,Protein phosphatase 1 regulatory subunit 1C (Inhibitor-5 of protein phosphatase 1) (IPP5),109,"12,346",5 out of 5,2007-05-01,Evidence at protein level
Q8TAP8,PPR35_HUMAN,Protein phosphatase 1 regulatory subunit 35,253,"27,953",3 out of 5,2007-01-09,Evidence at protein level
O75864,PPR37_HUMAN,Protein phosphatase 1 regulatory subunit 37 (Leucine-rich repeat-containing protein 68),691,"74,767",4 out of 5,2008-02-26,Evidence at protein level
Q9UQK1,PPR3C_HUMAN,Protein phosphatase 1 regulatory subunit 3C (Protein phosphatase 1 regulatory subunit 5) (PP1 subunit R5) (Protein targeting to glycogen) (PTG),317,"36,445",5 out of 5,2007-05-01,Evidence at protein level
P50897,PPT1_HUMAN,Palmitoyl-protein thioesterase 1 (PPT-1) (EC 3.1.2.22) (Palmitoyl-protein hydrolase 1),306,"34,193",5 out of 5,1996-10-01,Evidence at protein level
Q96BP3,PPWD1_HUMAN,Peptidylprolyl isomerase domain and WD repeat-containing protein 1 (EC 5.2.1.8) (Spliceosome-associated cyclophilin),646,"73,575",5 out of 5,2006-06-13,Evidence at protein level
Q5SWA1,PR15B_HUMAN,Protein phosphatase 1 regulatory subunit 15B,713,"79,152",5 out of 5,2008-02-26,Evidence at protein level
P86481,PR20B_HUMAN,Proline-rich protein 20B,221,"23,262",1 out of 5,2010-04-20,Predicted
Q6ZRT6,PR23B_HUMAN,Proline-rich protein 23B,265,"28,269",1 out of 5,2008-04-29,Evidence at transcript level
Q8NAV1,PR38A_HUMAN,Pre-mRNA-splicing factor 38A,312,"37,477",5 out of 5,2007-05-15,Evidence at protein level
Q5VWM6,PRA13_HUMAN,Putative PRAME family member 13,474,"54,914",2 out of 5,2007-06-12,Uncertain
Q5VT98,PRA20_HUMAN,PRAME family member 20,475,"54,784",2 out of 5,2007-06-12,Inferred from homology
Q8N945,PRLD2_HUMAN,PRELI domain-containing protein 2,189,"21,905",2 out of 5,2007-10-23,Evidence at transcript level
P04554,PRM2_HUMAN,Protamine-2 (Sperm histone P2) (Sperm protamine P2) [Cleaved into: Basic nuclear protein HPI1; Basic nuclear protein HPI2; Basic nuclear protein HPS1; Basic nuclear protein HPS2; Sperm histone HP4 (Sperm protamine P4); Sperm histone HP2 (Sperm protamine P2) (P2'); Sperm histone HP3 (P2'') (Sperm protamine P3)],102,"13,051",5 out of 5,1987-08-13,Evidence at protein level
Q9HC23,PROK2_HUMAN,Prokineticin-2 (PK2) (Protein Bv8 homolog),129,"14,314",5 out of 5,2001-09-26,Evidence at protein level
Q99935,PROL1_HUMAN,Opiorphin prepropeptide (Basic proline-rich lacrimal protein) (Proline-rich protein 1) (PRL1) [Cleaved into: Opiorphin],248,"27,217",5 out of 5,2002-05-27,Evidence at protein level
O43490,PROM1_HUMAN,Prominin-1 (Antigen AC133) (Prominin-like protein 1) (CD antigen CD133),865,"97,202",5 out of 5,2001-02-21,Evidence at protein level
Q96S07,PRR25_HUMAN,Proline-rich protein 25,402,"40,998",1 out of 5,2010-06-15,Predicted
P79522,PRR3_HUMAN,Proline-rich protein 3 (MHC class I region proline-rich protein CAT56),188,"20,640",4 out of 5,2005-02-15,Evidence at protein level
P85299,PRR5_HUMAN,Proline-rich protein 5 (Protein observed with Rictor-1) (Protor-1),388,"42,753",5 out of 5,2007-10-23,Evidence at protein level
Q99946,PRRT1_HUMAN,Proline-rich transmembrane protein 1 (Dispanin subfamily D member 1) (DSPD1),306,"31,430",3 out of 5,2002-10-10,Evidence at transcript level
Q8NF86,PRS33_HUMAN,Serine protease 33 (EC 3.4.21.-) (Serine protease EOS),280,"29,787",3 out of 5,2007-09-11,Evidence at protein level
Q9UIG4,PS1C2_HUMAN,Psoriasis susceptibility 1 candidate gene 2 protein (Protein SPR1),136,"15,101",2 out of 5,2003-11-21,Evidence at transcript level
P25786,PSA1_HUMAN,Proteasome subunit alpha type-1 (EC 3.4.25.1) (30 kDa prosomal protein) (PROS-30) (Macropain subunit C2) (Multicatalytic endopeptidase complex subunit C2) (Proteasome component C2) (Proteasome nu chain),263,"29,556",5 out of 5,1992-05-01,Evidence at protein level
A5LHX3,PSB11_HUMAN,Proteasome subunit beta type-11 (EC 3.4.25.1) (Proteasome subunit beta-5t),300,"32,530",5 out of 5,2007-09-11,Evidence at transcript level
Q4J6C6,PPCEL_HUMAN,Prolyl endopeptidase-like (EC 3.4.21.-) (Prolylendopeptidase-like),727,"83,927",5 out of 5,2008-01-15,Evidence at protein level
P10619,PPGB_HUMAN,Lysosomal protective protein (EC 3.4.16.5) (Carboxypeptidase C) (Carboxypeptidase L) (Cathepsin A) (Protective protein cathepsin A) (PPCA) (Protective protein for beta-galactosidase) [Cleaved into: Lysosomal protective protein 32 kDa chain; Lysosomal protective protein 20 kDa chain],480,"54,466",5 out of 5,1989-07-01,Evidence at protein level
Q8NEY8,PPHLN_HUMAN,Periphilin-1 (CDC7 expression repressor) (CR) (Gastric cancer antigen Ga50),458,"52,737",5 out of 5,2004-04-13,Evidence at protein level
Q13427,PPIG_HUMAN,Peptidyl-prolyl cis-trans isomerase G (PPIase G) (Peptidyl-prolyl isomerase G) (EC 5.2.1.8) (CASP10) (Clk-associating RS-cyclophilin) (CARS-Cyp) (CARS-cyclophilin) (SR-cyclophilin) (SR-cyp) (SRcyp) (Cyclophilin G) (Rotamase G),754,"88,617",5 out of 5,2004-03-15,Evidence at protein level
O75688,PPM1B_HUMAN,Protein phosphatase 1B (EC 3.1.3.16) (Protein phosphatase 2C isoform beta) (PP2C-beta),479,"52,643",5 out of 5,2000-12-01,Evidence at protein level
Q9ULR3,PPM1H_HUMAN,Protein phosphatase 1H (EC 3.1.3.16),514,"56,448",4 out of 5,2007-05-15,Evidence at protein level
Q8N3J5,PPM1K_HUMAN,"Protein phosphatase 1K, mitochondrial (EC 3.1.3.16) (PP2C domain-containing protein phosphatase 1K) (PP2C-like mitochondrial protein) (PP2C-type mitochondrial phosphoprotein phosphatase) (PTMP) (Protein phosphatase 2C isoform kappa) (PP2C-kappa)",372,"40,997",5 out of 5,2007-02-20,Evidence at protein level
Q96MI6,PPM1M_HUMAN,Protein phosphatase 1M (EC 3.1.3.16) (Protein phosphatase 2C isoform eta) (PP2C-eta) (PP2CE),270,"30,375",3 out of 5,2004-02-02,Evidence at transcript level
O00743,PPP6_HUMAN,"Serine/threonine-protein phosphatase 6 catalytic subunit (PP6C) (EC 3.1.3.16) [Cleaved into: Serine/threonine-protein phosphatase 6 catalytic subunit, N-terminally processed]",305,"35,144",5 out of 5,1998-07-15,Evidence at protein level
Q96LQ0,PPR36_HUMAN,Protein phosphatase 1 regulatory subunit 36,422,"49,440",3 out of 5,2005-07-19,Evidence at protein level
Q6ZSY5,PPR3F_HUMAN,Protein phosphatase 1 regulatory subunit 3F (R3F),799,"82,798",5 out of 5,2006-10-31,Evidence at protein level
Q9UMR5,PPT2_HUMAN,Lysosomal thioesterase PPT2 (PPT-2) (EC 3.1.2.-) (S-thioesterase G14),302,"34,225",5 out of 5,2002-03-05,Evidence at protein level
Q9GZV8,PRD14_HUMAN,PR domain zinc finger protein 14 (EC 2.1.1.-) (PR domain-containing protein 14),571,"64,062",5 out of 5,2001-11-16,Evidence at protein level
Q9HAZ2,PRD16_HUMAN,PR domain zinc finger protein 16 (PR domain-containing protein 16) (Transcription factor MEL1) (MDS1/EVI1-like gene 1),1276,"140,251",5 out of 5,2001-11-16,Evidence at protein level
Q9NQX0,PRDM6_HUMAN,Putative histone-lysine N-methyltransferase PRDM6 (EC 2.1.1.43) (PR domain zinc finger protein 6) (PR domain-containing protein 6),595,"64,452",5 out of 5,2002-11-08,Evidence at protein level
P06401,PRGR_HUMAN,Progesterone receptor (PR) (Nuclear receptor subfamily 3 group C member 3),933,"98,981",5 out of 5,1988-01-01,Evidence at protein level
E7EW31,PROB1_HUMAN,Proline-rich basic protein 1,1015,"106,917",2 out of 5,2011-10-19,Evidence at transcript level
Q16378,PROL4_HUMAN,Proline-rich protein 4 (Lacrimal proline-rich protein) (Nasopharyngeal carcinoma-associated proline-rich protein 4),134,"15,097",3 out of 5,2002-05-27,Evidence at protein level
Q8N271,PROM2_HUMAN,Prominin-2 (PROM-2) (Prominin-like protein 2) (hPROML2),834,"91,883",5 out of 5,2008-04-29,Evidence at protein level
Q99633,PRP18_HUMAN,Pre-mRNA-splicing factor 18 (PRP18 homolog) (hPRP18),342,"39,860",5 out of 5,2003-09-26,Evidence at protein level
Q6P2Q9,PRP8_HUMAN,Pre-mRNA-processing-splicing factor 8 (220 kDa U5 snRNP-specific protein) (PRP8 homolog) (Splicing factor Prp8) (p220),2335,"273,600",5 out of 5,2005-06-07,Evidence at protein level
Q9ULL5,PRR12_HUMAN,Proline-rich protein 12,1215,"129,991",3 out of 5,2006-06-27,Evidence at protein level
Q9BWN1,PRR14_HUMAN,Proline-rich protein 14,585,"64,328",2 out of 5,2007-10-23,Evidence at protein level
Q6MZM9,PRR27_HUMAN,Proline-rich protein 27,219,"22,720",2 out of 5,2008-06-10,Evidence at transcript level
Q9NV39,PRR34_HUMAN,Proline-rich protein 34,138,"14,718",2 out of 5,2007-01-09,Evidence at protein level
Q8N3Z0,PRS35_HUMAN,Inactive serine protease 35,413,"47,098",2 out of 5,2007-09-11,Evidence at transcript level
Q7RTY9,PRS41_HUMAN,Serine protease 41 (EC 3.4.21.-) (Testis serine protease 1) (TESSP-1),318,"35,078",4 out of 5,2008-07-22,Evidence at transcript level
Q6UWB4,PRS55_HUMAN,Serine protease 55 (EC 3.4.21.-) (Testis serine protease 1) (T-SP1),352,"38,856",4 out of 5,2008-04-08,Evidence at protein level
Q86WR7,PRSR2_HUMAN,Proline and serine-rich protein 2,435,"45,802",3 out of 5,2005-08-16,Evidence at protein level
Q9HBV1,POPD3_HUMAN,Popeye domain-containing protein 3 (Popeye protein 3),291,"33,870",3 out of 5,2003-10-31,Evidence at transcript level
Q5H9R7,PP6R3_HUMAN,Serine/threonine-protein phosphatase 6 regulatory subunit 3 (SAPS domain family member 3) (Sporulation-induced transcript 4-associated protein SAPL),873,"97,669",5 out of 5,2006-02-07,Evidence at protein level
P15309,PPAP_HUMAN,Prostatic acid phosphatase (PAP) (EC 3.1.3.2) (5'-nucleotidase) (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (Thiamine monophosphatase) (TMPase) [Cleaved into: PAPf39],386,"44,566",5 out of 5,1990-04-01,Evidence at protein level
P10696,PPBN_HUMAN,"Alkaline phosphatase, placental-like (EC 3.1.3.1) (ALP-1) (Alkaline phosphatase Nagao isozyme) (Germ cell alkaline phosphatase) (GCAP) (Placental alkaline phosphatase-like) (PLAP-like)",532,"57,377",5 out of 5,1990-04-01,Evidence at transcript level
Q9UKL6,PPCT_HUMAN,Phosphatidylcholine transfer protein (PC-TP) (START domain-containing protein 2) (StARD2) (StAR-related lipid transfer protein 2),214,"24,843",5 out of 5,2001-08-14,Evidence at protein level
P35813,PPM1A_HUMAN,Protein phosphatase 1A (EC 3.1.3.16) (Protein phosphatase 2C isoform alpha) (PP2C-alpha) (Protein phosphatase IA),382,"42,448",5 out of 5,1994-06-01,Evidence at protein level
Q5JR12,PPM1J_HUMAN,Protein phosphatase 1J (EC 3.1.3.16) (Protein phosphatase 2C isoform zeta) (PP2C-zeta),505,"54,834",3 out of 5,2007-05-29,Evidence at protein level
Q9Y570,PPME1_HUMAN,Protein phosphatase methylesterase 1 (PME-1) (EC 3.1.1.89),386,"42,315",5 out of 5,2004-05-24,Evidence at protein level
O95428,PPN_HUMAN,Papilin,1278,"137,700",4 out of 5,2008-03-18,Evidence at transcript level
Q9H7J1,PPR3E_HUMAN,Protein phosphatase 1 regulatory subunit 3E,279,"30,644",3 out of 5,2008-06-10,Evidence at protein level
Q8NI37,PPTC7_HUMAN,Protein phosphatase PTC7 homolog (EC 3.1.3.16) (T-cell activation protein phosphatase 2C) (TA-PP2C) (T-cell activation protein phosphatase 2C-like),304,"32,646",3 out of 5,2008-04-08,Evidence at transcript level
Q5SWL7,PRA14_HUMAN,PRAME family member 14,426,"49,433",1 out of 5,2007-06-12,Inferred from homology
H0Y7S4,PRA26_HUMAN,Putative PRAME family member 26,382,"44,302",1 out of 5,2013-12-11,Uncertain
Q9UKN5,PRDM4_HUMAN,PR domain zinc finger protein 4 (EC 2.1.1.-) (PR domain-containing protein 4),801,"87,920",4 out of 5,2001-11-16,Evidence at protein level
P32119,PRDX2_HUMAN,Peroxiredoxin-2 (EC 1.11.1.15) (Natural killer cell-enhancing factor B) (NKEF-B) (PRP) (Thiol-specific antioxidant protein) (TSA) (Thioredoxin peroxidase 1) (Thioredoxin-dependent peroxide reductase 1),198,"21,892",5 out of 5,1993-10-01,Evidence at protein level
Q96I23,PREY_HUMAN,"Protein preY, mitochondrial (PIGY upstream reading frame protein)",114,"12,655",3 out of 5,2006-07-25,Evidence at protein level
P13727,PRG2_HUMAN,Bone marrow proteoglycan (BMPG) (Proteoglycan 2) [Cleaved into: Eosinophil granule major basic protein (EMBP) (MBP) (Pregnancy-associated major basic protein)],222,"25,206",5 out of 5,1990-01-01,Evidence at protein level
Q92954,PRG4_HUMAN,Proteoglycan 4 (Lubricin) (Megakaryocyte-stimulating factor) (Superficial zone proteoglycan) [Cleaved into: Proteoglycan 4 C-terminal part],1404,"151,077",5 out of 5,2005-12-06,Evidence at protein level
Q96LW4,PRIPO_HUMAN,DNA-directed primase/polymerase protein (hPrimpol1) (EC 2.7.7.-) (Coiled-coil domain-containing protein 111),560,"64,383",5 out of 5,2007-03-06,Evidence at protein level
O60260,PRKN2_HUMAN,E3 ubiquitin-protein ligase parkin (Parkin) (EC 2.3.2.-) (Parkinson juvenile disease protein 2) (Parkinson disease protein 2),465,"51,641",5 out of 5,2004-10-11,Evidence at protein level
P35080,PROF2_HUMAN,Profilin-2 (Profilin II),140,"15,046",5 out of 5,1994-02-01,Evidence at protein level
O94903,PROSC_HUMAN,Proline synthase co-transcribed bacterial homolog protein,275,"30,344",3 out of 5,2001-01-11,Evidence at protein level
Q3B8N5,PROX2_HUMAN,Prospero homeobox protein 2 (Homeobox prospero-like protein PROX2) (PROX-2),592,"65,586",4 out of 5,2008-07-01,Evidence at transcript level
Q92620,PRP16_HUMAN,Pre-mRNA-splicing factor ATP-dependent RNA helicase PRP16 (EC 3.6.4.13) (ATP-dependent RNA helicase DHX38) (DEAH box protein 38),1227,"140,503",5 out of 5,1998-07-15,Evidence at protein level
P02810,PRPC_HUMAN,Salivary acidic proline-rich phosphoprotein 1/2 (Db-s) (PRP-1/PRP-2) (Parotid acidic protein) (Pa) (Parotid double-band protein) (Parotid isoelectric focusing variant protein) (PIF-S) (Parotid proline-rich protein 1/2) (Pr1/Pr2) (Protein C) [Cleaved into: Salivary acidic proline-rich phosphoprotein 1/2; Salivary acidic proline-rich phosphoprotein 3/4 (Db-F) (PIF-F) (PRP-3/PRP-4) (Protein A); Peptide P-C],166,"17,016",5 out of 5,1986-07-21,Evidence at protein level
Q6ZNR8,PRR17_HUMAN,Putative uncharacterized protein encoded by LINC00176 (Putative proline-rich protein 17),217,"22,251",2 out of 5,2007-01-09,Uncertain
Q53SZ7,PRR30_HUMAN,Proline-rich protein 30,412,"44,690",2 out of 5,2007-12-04,Evidence at transcript level
Q6UWY2,PRS57_HUMAN,Serine protease 57 (EC 3.4.21.-) (Neutrophil serine protease 4) (NSP4) (Serine protease 1-like protein 1),283,"30,334",5 out of 5,2007-07-24,Evidence at protein level
P43686,PRS6B_HUMAN,26S protease regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (MB67-interacting protein) (MIP224) (Proteasome 26S subunit ATPase 4) (Tat-binding protein 7) (TBP-7),418,"47,366",5 out of 5,1995-11-01,Evidence at protein level
Q16651,PRSS8_HUMAN,Prostasin (EC 3.4.21.-) (Channel-activating protease 1) (CAP1) (Serine protease 8) [Cleaved into: Prostasin light chain; Prostasin heavy chain],343,"36,431",5 out of 5,1997-11-01,Evidence at protein level
Q8WUY3,PRUN2_HUMAN,Protein prune homolog 2 (BNIP2 motif-containing molecule at the C-terminal region 1),3088,"340,635",5 out of 5,2005-07-05,Evidence at protein level
A0JP26,POTB3_HUMAN,POTE ankyrin domain family member B3,581,"65,710",2 out of 5,2015-03-04,Evidence at transcript level
Q6S8J7,POTEA_HUMAN,"POTE ankyrin domain family member A (ANKRD26-like family A member 1) (Prostate, ovary, testis-expressed protein on chromosome 8) (POTE-8)",498,"56,166",2 out of 5,2004-11-23,Evidence at transcript level
Q8TAE6,PP14C_HUMAN,Protein phosphatase 1 regulatory subunit 14C (Kinase-enhanced PP1 inhibitor) (PKC-potentiated PP1 inhibitory protein) (Serologically defined breast cancer antigen NY-BR-81),165,"17,843",4 out of 5,2004-11-09,Evidence at protein level
O60927,PP1RB_HUMAN,Protein phosphatase 1 regulatory subunit 11 (Hemochromatosis candidate gene V protein) (HCG V) (Protein phosphatase inhibitor 3),126,"13,953",3 out of 5,2006-06-13,Evidence at protein level
Q6NUP7,PP4R4_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 4,873,"99,452",5 out of 5,2007-12-04,Evidence at protein level
P13686,PPA5_HUMAN,Tartrate-resistant acid phosphatase type 5 (TR-AP) (EC 3.1.3.2) (Tartrate-resistant acid ATPase) (TrATPase) (Type 5 acid phosphatase),325,"36,599",5 out of 5,1990-01-01,Evidence at protein level
Q9NPH0,PPA6_HUMAN,"Lysophosphatidic acid phosphatase type 6 (EC 3.1.3.2) (Acid phosphatase 6, lysophosphatidic) (Acid phosphatase-like protein 1) (PACPL1)",428,"48,854",5 out of 5,2005-06-21,Evidence at protein level
P24666,PPAC_HUMAN,Low molecular weight phosphotyrosine protein phosphatase (LMW-PTP) (LMW-PTPase) (EC 3.1.3.48) (Adipocyte acid phosphatase) (Low molecular weight cytosolic acid phosphatase) (EC 3.1.3.2) (Red cell acid phosphatase 1),158,"18,042",5 out of 5,1992-03-01,Evidence at protein level
Q07869,PPARA_HUMAN,Peroxisome proliferator-activated receptor alpha (PPAR-alpha) (Nuclear receptor subfamily 1 group C member 1),468,"52,225",5 out of 5,1994-10-01,Evidence at protein level
Q8N2U9,PQLC1_HUMAN,PQ-loop repeat-containing protein 1,271,"30,478",2 out of 5,2007-04-03,Evidence at protein level
P04070,PROC_HUMAN,Vitamin K-dependent protein C (EC 3.4.21.69) (Anticoagulant protein C) (Autoprothrombin IIA) (Blood coagulation factor XIV) [Cleaved into: Vitamin K-dependent protein C light chain; Vitamin K-dependent protein C heavy chain; Activation peptide],461,"52,071",5 out of 5,1986-11-01,Evidence at protein level
P27918,PROP_HUMAN,Properdin (Complement factor P),469,"51,276",5 out of 5,1992-08-01,Evidence at protein level
P22891,PROZ_HUMAN,Vitamin K-dependent protein Z,400,"44,744",5 out of 5,1991-08-01,Evidence at protein level
Q9UMS4,PRP19_HUMAN,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (hPso4) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor),504,"55,181",5 out of 5,2004-11-23,Evidence at protein level
P23942,PRPH2_HUMAN,Peripherin-2 (Retinal degeneration slow protein) (Tetraspanin-22) (Tspan-22),346,"39,186",5 out of 5,1992-03-01,Evidence at protein level
P60891,PRPS1_HUMAN,Ribose-phosphate pyrophosphokinase 1 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase I) (PRS-I),318,"34,834",5 out of 5,2004-04-13,Evidence at protein level
P21108,PRPS3_HUMAN,Ribose-phosphate pyrophosphokinase 3 (EC 2.7.6.1) (Phosphoribosyl pyrophosphate synthase 1-like 1) (PRPS1-like 1) (Phosphoribosyl pyrophosphate synthase III) (PRS-III),318,"34,839",5 out of 5,1991-02-01,Evidence at protein level
Q96HE9,PRR11_HUMAN,Proline-rich protein 11,360,"40,085",4 out of 5,2006-06-27,Evidence at protein level
Q6MZQ0,PRR5L_HUMAN,Proline-rich protein 5-like (Protein observed with Rictor-2) (Protor-2),368,"40,836",5 out of 5,2008-04-29,Evidence at protein level
P00747,PLMN_HUMAN,"Plasminogen (EC 3.4.21.7) [Cleaved into: Plasmin heavy chain A; Activation peptide; Angiostatin; Plasmin heavy chain A, short form; Plasmin light chain B]",810,"90,569",5 out of 5,1986-07-21,Evidence at protein level
Q01453,PMP22_HUMAN,Peripheral myelin protein 22 (PMP-22) (Growth arrest-specific protein 3) (GAS-3),160,"17,891",5 out of 5,1993-04-01,Evidence at protein level
Q12837,PO4F2_HUMAN,"POU domain, class 4, transcription factor 2 (Brain-specific homeobox/POU domain protein 3B) (Brain-3B) (Brn-3B)",409,"43,087",5 out of 5,1997-11-01,Evidence at protein level
Q8NA72,POC5_HUMAN,Centrosomal protein POC5 (Protein of centriole 5) (hPOC5),575,"63,351",5 out of 5,2007-04-03,Evidence at protein level
Q7Z3K3,POGZ_HUMAN,Pogo transposable element with ZNF domain (Suppressor of hairy wing homolog 5) (Zinc finger protein 280E) (Zinc finger protein 635),1410,"155,344",5 out of 5,2004-04-26,Evidence at protein level
Q9Y6A1,POMT1_HUMAN,Protein O-mannosyl-transferase 1 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 1),747,"84,881",5 out of 5,2003-06-20,Evidence at protein level
Q9HBU9,POPD2_HUMAN,Popeye domain-containing protein 2 (Popeye protein 2),364,"40,448",3 out of 5,2003-10-31,Evidence at transcript level
P62937,PPIA_HUMAN,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",165,"18,012",5 out of 5,1987-08-13,Evidence at protein level
Q5T8A7,PPR26_HUMAN,Protein phosphatase 1 regulatory subunit 26,1209,"127,351",5 out of 5,2007-11-13,Evidence at protein level
Q7Z5V6,PPR32_HUMAN,Protein phosphatase 1 regulatory subunit 32,425,"47,295",3 out of 5,2007-02-06,Evidence at protein level
P86479,PR20C_HUMAN,Proline-rich protein 20C,221,"23,262",5 out of 5,2010-04-20,Evidence at protein level
D3DTV9,PRAC2_HUMAN,"Putative protein PRAC2 (Prostate, rectum and colon expressed gene protein 2)",90,"10,428",2 out of 5,2014-11-26,Uncertain
O75915,PRAF3_HUMAN,PRA1 family protein 3 (ADP-ribosylation factor-like protein 6-interacting protein 5) (ARL-6-interacting protein 5) (Aip-5) (Cytoskeleton-related vitamin A-responsive protein) (Dermal papilla-derived protein 11) (GTRAP3-18) (Glutamate transporter EAAC1-interacting protein) (JM5) (Prenylated Rab acceptor protein 2) (Protein JWa) (Putative MAPK-activating protein PM27),188,"21,615",5 out of 5,2005-01-04,Evidence at protein level
O60811,PRAM2_HUMAN,PRAME family member 2,474,"54,872",3 out of 5,2000-05-30,Evidence at transcript level
Q92733,PRCC_HUMAN,Proline-rich protein PRCC (Papillary renal cell carcinoma translocation-associated gene protein),491,"52,418",5 out of 5,1997-11-01,Evidence at protein level
Q9NQV6,PRD10_HUMAN,PR domain zinc finger protein 10 (EC 2.1.1.-) (PR domain-containing protein 10) (Tristanin),1147,"130,136",5 out of 5,2001-11-16,Evidence at protein level
Q9H606,PRORY_HUMAN,"Proline-rich protein, Y-linked",182,"19,976",1 out of 5,2008-09-02,Evidence at transcript level
O60508,PRP17_HUMAN,Pre-mRNA-processing factor 17 (Cell division cycle 40 homolog) (EH-binding protein 3) (Ehb3) (PRP17 homolog) (hPRP17),579,"65,521",5 out of 5,2001-09-26,Evidence at protein level
Q496M5,PLK5_HUMAN,Inactive serine/threonine-protein kinase PLK5 (Polo-like kinase 5) (PLK-5),336,"36,329",5 out of 5,2007-03-20,Evidence at protein level
Q8NEB5,PLPP5_HUMAN,Phospholipid phosphatase 5 (EC 3.1.3.4) (Phosphatidic acid phosphatase type 2 domain-containing protein 1B),264,"29,484",5 out of 5,2007-05-15,Evidence at protein level
Q32ZL2,PLPR5_HUMAN,Phospholipid phosphatase-related protein type 5 (EC 3.1.3.-) (Lipid phosphate phosphatase-related protein type 5) (Phosphatidic acid phosphatase type 2d) (Plasticity-related gene 5 protein) (PRG-5),321,"35,427",4 out of 5,2008-02-26,Evidence at transcript level
O75051,PLXA2_HUMAN,Plexin-A2 (Semaphorin receptor OCT),1894,"211,104",5 out of 5,2006-04-18,Evidence at protein level
Q9ULL4,PLXB3_HUMAN,Plexin-B3,1909,"206,847",5 out of 5,2004-08-31,Evidence at protein level
A8MQ11,PM2P5_HUMAN,Postmeiotic segregation increased 2-like protein 5 (Postmeiotic segregation increased protein 4) (Postmeiotic segregation increased protein 7) (Putative postmeiotic segregation increased 2 pseudogene 5),134,"15,170",2 out of 5,2008-05-20,Uncertain
Q92871,PMM1_HUMAN,Phosphomannomutase 1 (PMM 1) (EC 5.4.2.8) (PMMH-22),262,"29,747",5 out of 5,1997-11-01,Evidence at protein level
Q96T60,PNKP_HUMAN,Bifunctional polynucleotide phosphatase/kinase (DNA 5'-kinase/3'-phosphatase) (Polynucleotide kinase-3'-phosphatase) [Includes: Polynucleotide 3'-phosphatase (EC 3.1.3.32) (2'(3')-polynucleotidase); Polynucleotide 5'-hydroxyl-kinase (EC 2.7.1.78)],521,"57,076",5 out of 5,2004-07-19,Evidence at protein level
P00491,PNPH_HUMAN,Purine nucleoside phosphorylase (PNP) (EC 2.4.2.1) (Inosine phosphorylase) (Inosine-guanosine phosphorylase),289,"32,118",5 out of 5,1986-07-21,Evidence at protein level
Q9NVS9,PNPO_HUMAN,Pyridoxine-5'-phosphate oxidase (EC 1.4.3.5) (Pyridoxamine-phosphate oxidase),261,"29,988",5 out of 5,2003-09-26,Evidence at protein level
Q7Z5L7,PODN_HUMAN,Podocan,613,"68,976",5 out of 5,2006-11-28,Evidence at protein level
Q9P215,POGK_HUMAN,Pogo transposable element with KRAB domain,609,"69,444",3 out of 5,2004-04-26,Evidence at protein level
Q9QC07,POK18_HUMAN,Endogenous retrovirus group K member 18 Pol protein (HERV-K(C1a) Pol protein) (HERV-K110 Pol protein) (HERV-K18 Pol protein) (HERV-K_1q23.3 provirus ancestral Pol protein) [Includes: Reverse transcriptase (EC 2.7.7.49); Ribonuclease H (RNase H) (EC 3.1.26.4)],812,"91,948",4 out of 5,2004-09-13,Inferred from homology
Q9UKY4,POMT2_HUMAN,Protein O-mannosyl-transferase 2 (EC 2.4.1.109) (Dolichyl-phosphate-mannose--protein mannosyltransferase 2),750,"84,214",5 out of 5,2003-06-20,Evidence at protein level
P27169,PON1_HUMAN,Serum paraoxonase/arylesterase 1 (PON 1) (EC 3.1.1.2) (EC 3.1.1.81) (EC 3.1.8.1) (Aromatic esterase 1) (A-esterase 1) (K-45) (Serum aryldialkylphosphatase 1),355,"39,731",5 out of 5,1992-08-01,Evidence at protein level
Q9NXH3,PP14D_HUMAN,Protein phosphatase 1 regulatory subunit 14D (Gastrointestinal and brain-specific PP1-inhibitory protein 1) (GBPI-1),145,"16,508",4 out of 5,2004-11-09,Evidence at protein level
Q15435,PP1R7_HUMAN,Protein phosphatase 1 regulatory subunit 7 (Protein phosphatase 1 regulatory subunit 22),360,"41,564",5 out of 5,2006-06-13,Evidence at protein level
P37231,PPARG_HUMAN,Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3),505,"57,620",5 out of 5,1994-10-01,Evidence at protein level
P86478,PR20E_HUMAN,Proline-rich protein 20E,221,"23,262",1 out of 5,2010-04-20,Evidence at protein level
A6NGN4,PRA25_HUMAN,PRAME family member 25,478,"55,354",2 out of 5,2008-09-02,Inferred from homology
O60810,PRAM4_HUMAN,PRAME family member 4,478,"55,439",2 out of 5,2000-05-30,Evidence at transcript level
P78395,PRAME_HUMAN,Melanoma antigen preferentially expressed in tumors (Opa-interacting protein 4) (OIP-4) (Preferentially expressed antigen of melanoma),509,"57,890",5 out of 5,2000-05-30,Evidence at protein level
Q9BXM0,PRAX_HUMAN,Periaxin,1461,"154,905",5 out of 5,2002-04-16,Evidence at protein level
P10163,PRB4_HUMAN,Basic salivary proline-rich protein 4 (Salivary proline-rich protein Po) (Parotid o protein) (Salivary proline-rich protein II-1) [Cleaved into: Protein N1; Glycosylated protein A; Peptide P-D (Proline-rich peptide IB-5)],310,"31,326",5 out of 5,1986-07-21,Evidence at protein level
Q8NCQ7,PRCA1_HUMAN,Protein PROCA1,364,"40,522",3 out of 5,2008-05-20,Evidence at transcript level
O43930,PRKY_HUMAN,Putative serine/threonine-protein kinase PRKY (EC 2.7.11.1),277,"31,708",3 out of 5,2004-01-16,Uncertain
Q86SH4,PRNT_HUMAN,Putative testis-specific prion protein (Protein M8),94,"10,756",2 out of 5,2008-02-26,Uncertain
P86496,PR20A_HUMAN,Proline-rich protein 20A,221,"23,262",1 out of 5,2010-04-20,Evidence at transcript level
A3QJZ7,PRA27_HUMAN,PRAME family member 27,478,"55,206",2 out of 5,2016-01-20,Inferred from homology
Q5VWM4,PRAM8_HUMAN,PRAME family member 8,474,"53,655",2 out of 5,2005-12-20,Evidence at transcript level
Q96NZ9,PRAP1_HUMAN,Proline-rich acidic protein 1 (Epididymis tissue protein Li 178) (Uterine-specific proline-rich acidic protein),151,"17,208",4 out of 5,2007-09-11,Evidence at protein level
Q04118,PRB3_HUMAN,Basic salivary proline-rich protein 3 (Parotid salivary glycoprotein G1) (Proline-rich protein G1),309,"30,980",5 out of 5,2004-09-13,Evidence at protein level
P48634,PRC2A_HUMAN,Protein PRRC2A (HLA-B-associated transcript 2) (Large proline-rich protein BAT2) (Proline-rich and coiled-coil-containing protein 2A) (Protein G2),2157,"228,863",5 out of 5,1996-02-01,Evidence at protein level
Q9NQV8,PRDM8_HUMAN,PR domain zinc finger protein 8 (EC 2.1.1.-) (PR domain-containing protein 8),689,"71,663",5 out of 5,2002-11-08,Evidence at protein level
Q13162,PRDX4_HUMAN,Peroxiredoxin-4 (EC 1.11.1.15) (Antioxidant enzyme AOE372) (AOE37-2) (Peroxiredoxin IV) (Prx-IV) (Thioredoxin peroxidase AO372) (Thioredoxin-dependent peroxide reductase A0372),271,"30,540",5 out of 5,1998-07-15,Evidence at protein level
P51888,PRELP_HUMAN,Prolargin (Proline-arginine-rich end leucine-rich repeat protein),382,"43,810",5 out of 5,1996-10-01,Evidence at protein level
Q8TCU6,PREX1_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein (P-Rex1) (PtdIns(3,4,5)-dependent Rac exchanger 1)",1659,"186,203",5 out of 5,2003-01-17,Evidence at protein level
Q96MT3,PRIC1_HUMAN,Prickle-like protein 1 (REST/NRSF-interacting LIM domain protein 1),831,"94,300",5 out of 5,2005-02-01,Evidence at protein level
Q2TBC4,PRIC4_HUMAN,Prickle-like protein 4 (Overexpressed breast tumor protein),344,"37,551",3 out of 5,2006-04-04,Evidence at transcript level
P16471,PRLR_HUMAN,Prolactin receptor (PRL-R),622,"69,506",5 out of 5,1990-08-01,Evidence at protein level
Q9NNZ6,PRM3_HUMAN,Protamine-3 (Sperm protamine P3),103,"11,232",3 out of 5,2006-11-28,Inferred from homology
O43272,PROD_HUMAN,"Proline dehydrogenase 1, mitochondrial (EC 1.5.5.2) (Proline oxidase) (Proline oxidase 2) (p53-induced gene 6 protein)",600,"68,002",5 out of 5,2000-05-30,Evidence at protein level
O75360,PROP1_HUMAN,Homeobox protein prophet of Pit-1 (PROP-1) (Pituitary-specific homeodomain factor),226,"24,984",5 out of 5,1998-12-15,Evidence at protein level
O43395,PRPF3_HUMAN,U4/U6 small nuclear ribonucleoprotein Prp3 (Pre-mRNA-splicing factor 3) (hPrp3) (U4/U6 snRNP 90 kDa protein),683,"77,529",5 out of 5,2003-09-26,Evidence at protein level
A8MZF0,PRR33_HUMAN,Proline-rich protein 33,331,"35,187",1 out of 5,2008-04-29,Predicted
Q9UIG5,PS1C1_HUMAN,Psoriasis susceptibility 1 candidate gene 1 protein (Protein SEEK1),152,"16,580",3 out of 5,2003-11-21,Evidence at transcript level
Q8TAA3,PSA7L_HUMAN,Proteasome subunit alpha type-7-like (EC 3.4.25.1),256,"28,530",5 out of 5,2002-11-28,Evidence at transcript level
Q9H237,PORCN_HUMAN,Protein-serine O-palmitoleoyltransferase porcupine (EC 2.3.1.-) (Protein MG61),461,"52,318",5 out of 5,2005-10-25,Evidence at protein level
B2RU33,POTEC_HUMAN,"POTE ankyrin domain family member C (ANKRD26-like family B member 2) (Prostate, ovary, testis-expressed protein on chromosome 18) (POTE-18)",542,"61,188",3 out of 5,2008-07-22,Evidence at transcript level
P0CG39,POTEJ_HUMAN,POTE ankyrin domain family member J,1038,"117,390",3 out of 5,2010-07-13,Inferred from homology
Q9BZL4,PP12C_HUMAN,Protein phosphatase 1 regulatory subunit 12C (Protein phosphatase 1 myosin-binding subunit of 85 kDa) (Protein phosphatase 1 myosin-binding subunit p85),782,"84,881",5 out of 5,2008-01-15,Evidence at protein level
Q96C90,PP14B_HUMAN,Protein phosphatase 1 regulatory subunit 14B (Phospholipase C-beta-3 neighbouring gene protein),147,"15,911",3 out of 5,2004-11-09,Evidence at protein level
Q96I34,PP16A_HUMAN,Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3),528,"57,811",4 out of 5,2002-08-13,Evidence at protein level
A8MPX8,PP2D1_HUMAN,Protein phosphatase 2C-like domain-containing protein 1,630,"71,643",3 out of 5,2008-02-26,Evidence at transcript level
P05186,PPBT_HUMAN,"Alkaline phosphatase, tissue-nonspecific isozyme (AP-TNAP) (TNSALP) (EC 3.1.3.1) (Alkaline phosphatase liver/bone/kidney isozyme)",524,"57,305",5 out of 5,1987-08-13,Evidence at protein level
Q9H3Y8,PPDPF_HUMAN,Pancreatic progenitor cell differentiation and proliferation factor (Exocrine differentiation and proliferation factor),114,"11,777",3 out of 5,2003-01-10,Evidence at protein level
O14829,PPE1_HUMAN,Serine/threonine-protein phosphatase with EF-hands 1 (PPEF-1) (EC 3.1.3.16) (Protein phosphatase with EF calcium-binding domain) (PPEF) (Serine/threonine-protein phosphatase 7) (PP7),653,"75,792",5 out of 5,2001-01-11,Evidence at protein level
O14830,PPE2_HUMAN,Serine/threonine-protein phosphatase with EF-hands 2 (PPEF-2) (EC 3.1.3.16),753,"86,518",5 out of 5,2001-01-11,Evidence at protein level
O43447,PPIH_HUMAN,Peptidyl-prolyl cis-trans isomerase H (PPIase H) (EC 5.2.1.8) (Rotamase H) (Small nuclear ribonucleoprotein particle-specific cyclophilin H) (CypH) (U-snRNP-associated cyclophilin SnuCyp-20) (USA-CYP),177,"19,208",5 out of 5,2003-09-26,Evidence at protein level
Q5SGD2,PPM1L_HUMAN,Protein phosphatase 1L (EC 3.1.3.16) (Protein phosphatase 1-like) (Protein phosphatase 2C isoform epsilon) (PP2C-epsilon),360,"41,053",5 out of 5,2006-01-10,Evidence at protein level
Q5THK1,PR14L_HUMAN,Protein PRR14L (Proline rich 14-like protein),2151,"237,300",3 out of 5,2007-07-24,Evidence at protein level
Q9H4Q4,PRD12_HUMAN,PR domain zinc finger protein 12 (EC 2.1.1.-) (PR domain-containing protein 12),367,"40,403",5 out of 5,2002-11-08,Evidence at protein level
Q969G5,PRDBP_HUMAN,Protein kinase C delta-binding protein (Cavin-3) (Serum deprivation response factor-related gene product that binds to C-kinase) (hSRBC),261,"27,701",5 out of 5,2008-04-29,Evidence at protein level
Q13029,PRDM2_HUMAN,PR domain zinc finger protein 2 (EC 2.1.1.43) (GATA-3-binding protein G3B) (Lysine N-methyltransferase 8) (MTB-ZF) (MTE-binding protein) (PR domain-containing protein 2) (Retinoblastoma protein-interacting zinc finger protein) (Zinc finger protein RIZ),1718,"188,915",5 out of 5,2002-11-08,Evidence at protein level
Q06830,PRDX1_HUMAN,Peroxiredoxin-1 (EC 1.11.1.15) (Natural killer cell-enhancing factor A) (NKEF-A) (Proliferation-associated gene protein) (PAG) (Thioredoxin peroxidase 2) (Thioredoxin-dependent peroxide reductase 2),199,"22,110",5 out of 5,1994-06-01,Evidence at protein level
Q7Z3G6,PRIC2_HUMAN,Prickle-like protein 2,844,"95,615",4 out of 5,2005-02-01,Evidence at protein level
O75569,PRKRA_HUMAN,"Interferon-inducible double-stranded RNA-dependent protein kinase activator A (PKR-associated protein X) (PKR-associating protein X) (Protein activator of the interferon-induced protein kinase) (Protein kinase, interferon-inducible double-stranded RNA-dependent activator)",313,"34,404",5 out of 5,2006-02-21,Evidence at protein level
Q9Y255,PRLD1_HUMAN,"PRELI domain-containing protein 1, mitochondrial (25 kDa protein of relevant evolutionary and lymphoid interest) (Px19-like protein)",219,"25,181",5 out of 5,2003-04-11,Evidence at protein level
Q13523,PRP4B_HUMAN,Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog),1007,"116,987",5 out of 5,1998-07-15,Evidence at protein level
O43172,PRP4_HUMAN,U4/U6 small nuclear ribonucleoprotein Prp4 (PRP4 homolog) (hPrp4) (U4/U6 snRNP 60 kDa protein) (WD splicing factor Prp4),522,"58,449",5 out of 5,2002-05-02,Evidence at protein level
Q8N8Z3,PRR26_HUMAN,Proline-rich protein 26,221,"24,207",1 out of 5,2006-07-25,Evidence at transcript level
P0CG20,PRR35_HUMAN,Proline-rich protein 35 (Uncharacterized protein RJD1),571,"59,354",2 out of 5,2010-06-15,Evidence at transcript level
Q96M27,PRRC1_HUMAN,Protein PRRC1 (Proline-rich and coiled-coil-containing protein 1),445,"46,701",3 out of 5,2007-10-23,Evidence at protein level
Q5FWE3,PRRT3_HUMAN,Proline-rich transmembrane protein 3,981,"102,197",4 out of 5,2006-10-03,Evidence at protein level
E5RG02,PRS46_HUMAN,Putative serine protease 46 (EC 3.4.21.-),174,"19,341",2 out of 5,2012-07-11,Uncertain
P17980,PRS6A_HUMAN,26S protease regulatory subunit 6A (26S proteasome AAA-ATPase subunit RPT5) (Proteasome 26S subunit ATPase 3) (Proteasome subunit P50) (Tat-binding protein 1) (TBP-1),439,"49,204",5 out of 5,1990-11-01,Evidence at protein level
P20472,PRVA_HUMAN,Parvalbumin alpha,110,"12,059",5 out of 5,1991-02-01,Evidence at protein level
Q9UQ72,PSG11_HUMAN,Pregnancy-specific beta-1-glycoprotein 11 (PS-beta-G-11) (PSBG-11) (Pregnancy-specific glycoprotein 11) (Pregnancy-specific beta-1-glycoprotein 13) (PS-beta-G-13) (PSBG-13) (Pregnancy-specific glycoprotein 13),335,"37,146",4 out of 5,2000-05-30,Evidence at transcript level
Q16401,PSMD5_HUMAN,26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B),504,"56,196",5 out of 5,1998-07-15,Evidence at protein level
P48556,PSMD8_HUMAN,26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit RPN12) (26S proteasome regulatory subunit S14) (p31),350,"39,612",5 out of 5,1996-02-01,Evidence at protein level
O60542,PSPN_HUMAN,Persephin (PSP),156,"16,600",4 out of 5,2000-05-30,Evidence at transcript level
P25105,PTAFR_HUMAN,Platelet-activating factor receptor (PAF-R) (PAFr),342,"39,203",5 out of 5,1992-05-01,Evidence at protein level
O95758,PTBP3_HUMAN,Polypyrimidine tract-binding protein 3 (Regulator of differentiation 1) (Rod1),552,"59,690",5 out of 5,2004-07-19,Evidence at protein level
Q13635,PTC1_HUMAN,Protein patched homolog 1 (PTC) (PTC1),1447,"160,545",5 out of 5,2000-05-30,Evidence at protein level
O75127,PTCD1_HUMAN,"Pentatricopeptide repeat-containing protein 1, mitochondrial",700,"78,856",4 out of 5,2005-03-29,Evidence at protein level
Q14914,PTGR1_HUMAN,Prostaglandin reductase 1 (PRG-1) (EC 1.3.1.-) (15-oxoprostaglandin 13-reductase) (EC 1.3.1.48) (NADP-dependent leukotriene B4 12-hydroxydehydrogenase) (EC 1.3.1.74),329,"35,870",5 out of 5,1997-11-01,Evidence at protein level
Q03431,PTH1R_HUMAN,Parathyroid hormone/parathyroid hormone-related peptide receptor (PTH/PTHrP type I receptor) (PTH/PTHr receptor) (Parathyroid hormone 1 receptor) (PTH1 receptor),593,"66,361",5 out of 5,1993-10-01,Evidence at protein level
P10586,PTPRF_HUMAN,Receptor-type tyrosine-protein phosphatase F (EC 3.1.3.48) (Leukocyte common antigen related) (LAR),1907,"212,879",5 out of 5,1989-07-01,Evidence at protein level
Q12913,PTPRJ_HUMAN,Receptor-type tyrosine-protein phosphatase eta (Protein-tyrosine phosphatase eta) (R-PTP-eta) (EC 3.1.3.48) (Density-enhanced phosphatase 1) (DEP-1) (HPTP eta) (Protein-tyrosine phosphatase receptor type J) (R-PTP-J) (CD antigen CD148),1337,"145,941",5 out of 5,1997-11-01,Evidence at protein level
Q16827,PTPRO_HUMAN,Receptor-type tyrosine-protein phosphatase O (R-PTP-O) (EC 3.1.3.48) (Glomerular epithelial protein 1) (Protein tyrosine phosphatase U2) (PTP-U2) (PTPase U2),1216,"138,344",5 out of 5,2003-07-19,Evidence at protein level
Q6GMV3,PTRD1_HUMAN,Putative peptidyl-tRNA hydrolase PTRHD1 (EC 3.1.1.29) (Peptidyl-tRNA hydrolase domain-containing protein 1),140,"15,805",2 out of 5,2008-02-26,Evidence at protein level
Q5T870,PRR9_HUMAN,Proline-rich protein 9,116,"12,904",2 out of 5,2008-05-20,Predicted
Q7RTY5,PRS48_HUMAN,Serine protease 48 (EC 3.4.21.-) (Epidermis-specific serine protease-like protein),328,"35,970",3 out of 5,2008-04-29,Evidence at transcript level
Q2L4Q9,PRS53_HUMAN,Serine protease 53 (EC 3.4.21.-) (Polyserine protease 3) (Polyserase-3),553,"58,410",3 out of 5,2008-02-05,Evidence at transcript level
P35998,PRS7_HUMAN,26S protease regulatory subunit 7 (26S proteasome AAA-ATPase subunit RPT1) (Proteasome 26S subunit ATPase 2) (Protein MSS1),433,"48,634",5 out of 5,1994-06-01,Evidence at protein level
Q86XN7,PRSR1_HUMAN,Proline and serine-rich protein 1,944,"95,698",2 out of 5,2007-02-06,Evidence at protein level
P25787,PSA2_HUMAN,Proteasome subunit alpha type-2 (EC 3.4.25.1) (Macropain subunit C3) (Multicatalytic endopeptidase complex subunit C3) (Proteasome component C3),234,"25,899",5 out of 5,1992-05-01,Evidence at protein level
O14818,PSA7_HUMAN,Proteasome subunit alpha type-7 (EC 3.4.25.1) (Proteasome subunit RC6-1) (Proteasome subunit XAPC7),248,"27,887",5 out of 5,2000-12-08,Evidence at protein level
O00232,PSD12_HUMAN,26S proteasome non-ATPase regulatory subunit 12 (26S proteasome regulatory subunit RPN5) (26S proteasome regulatory subunit p55),456,"52,904",5 out of 5,2002-05-15,Evidence at protein level
P11464,PSG1_HUMAN,Pregnancy-specific beta-1-glycoprotein 1 (PS-beta-G-1) (PSBG-1) (Pregnancy-specific glycoprotein 1) (CD66 antigen-like family member F) (Fetal liver non-specific cross-reactive antigen 1/2) (FL-NCA-1/2) (PSG95) (Pregnancy-specific beta-1 glycoprotein C/D) (PS-beta-C/D) (CD antigen CD66f),419,"47,223",5 out of 5,1989-10-01,Evidence at protein level
Q00889,PSG6_HUMAN,Pregnancy-specific beta-1-glycoprotein 6 (PS-beta-G-6) (PSBG-6) (Pregnancy-specific glycoprotein 6) (Pregnancy-specific beta-1-glycoprotein 10) (PS-beta-G-10) (PSBG-10) (Pregnancy-specific glycoprotein 10) (Pregnancy-specific beta-1-glycoprotein 12) (PS-beta-G-12) (PSBG-12) (Pregnancy-specific glycoprotein 12),435,"48,814",5 out of 5,1996-10-01,Evidence at transcript level
P51665,PSMD7_HUMAN,26S proteasome non-ATPase regulatory subunit 7 (26S proteasome regulatory subunit RPN8) (26S proteasome regulatory subunit S12) (Mov34 protein homolog) (Proteasome subunit p40),324,"37,025",5 out of 5,1996-10-01,Evidence at protein level
Q9UL46,PSME2_HUMAN,Proteasome activator complex subunit 2 (11S regulator complex subunit beta) (REG-beta) (Activator of multicatalytic protease subunit 2) (Proteasome activator 28 subunit beta) (PA28b) (PA28beta),239,"27,402",5 out of 5,2001-08-29,Evidence at protein level
Q92530,PSMF1_HUMAN,Proteasome inhibitor PI31 subunit (hPI31),271,"29,817",5 out of 5,2001-09-26,Evidence at protein level
Q6PGN9,PSRC1_HUMAN,Proline/serine-rich coiled-coil protein 1,363,"38,796",5 out of 5,2007-01-23,Evidence at protein level
Q14761,PTCA_HUMAN,Protein tyrosine phosphatase receptor type C-associated protein (PTPRC-associated protein) (CD45-associated protein) (CD45-AP) (Lymphocyte phosphatase-associated phosphoprotein),206,"21,196",3 out of 5,2002-07-26,Evidence at protein level
Q8N8N7,PTGR2_HUMAN,Prostaglandin reductase 2 (PRG-2) (EC 1.3.1.48) (15-oxoprostaglandin 13-reductase) (Zinc-binding alcohol dehydrogenase domain-containing protein 1),351,"38,499",5 out of 5,2005-04-26,Evidence at protein level
Q6ZW05,PTHD4_HUMAN,Patched domain-containing protein 4 (p53-regulated patched protein),846,"96,371",4 out of 5,2008-02-26,Evidence at transcript level
P01270,PTHY_HUMAN,Parathyroid hormone (PTH) (Parathormone) (Parathyrin),115,"12,861",5 out of 5,1986-07-21,Evidence at protein level
Q15678,PTN14_HUMAN,Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez),1187,"135,261",5 out of 5,1997-11-01,Evidence at protein level
P18031,PTN1_HUMAN,Tyrosine-protein phosphatase non-receptor type 1 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1B) (PTP-1B),435,"49,967",5 out of 5,1990-11-01,Evidence at protein level
Q7Z4L9,PPR42_HUMAN,Protein phosphatase 1 regulatory subunit 42 (Leucine-rich repeat-containing protein 67),355,"40,902",3 out of 5,2008-03-18,Evidence at transcript level
Q9NRI7,PPY2_HUMAN,Putative pancreatic polypeptide 2,21,"2,179",1 out of 5,2008-01-15,Uncertain
O75807,PR15A_HUMAN,Protein phosphatase 1 regulatory subunit 15A (Growth arrest and DNA damage-inducible protein GADD34) (Myeloid differentiation primary response protein MyD116 homolog),674,"73,478",5 out of 5,2008-02-26,Evidence at protein level
O60813,PRA11_HUMAN,PRAME family member 11,436,"50,598",2 out of 5,2000-05-30,Evidence at transcript level
Q5VWM3,PRA18_HUMAN,PRAME family member 18,479,"55,334",2 out of 5,2007-06-12,Inferred from homology
Q5VXH4,PRAM6_HUMAN,PRAME family member 6,476,"54,852",2 out of 5,2005-12-20,Evidence at transcript level
Q5VWM5,PRAM9_HUMAN,PRAME family member 9/15,478,"55,420",2 out of 5,2005-12-20,Evidence at transcript level
Q9NQV5,PRD11_HUMAN,PR domain-containing protein 11 (EC 2.1.1.-),511,"57,863",5 out of 5,2002-11-08,Evidence at protein level
Q70Z35,PREX2_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein (P-Rex2) (PtdIns(3,4,5)-dependent Rac exchanger 2) (DEP domain-containing protein 2)",1606,"182,622",5 out of 5,2007-05-15,Evidence at transcript level
Q9Y2Y8,PRG3_HUMAN,Proteoglycan 3 (Eosinophil major basic protein homolog) (Prepro-major basic protein homolog) (Prepro-MBPH),225,"25,406",5 out of 5,2006-10-03,Evidence at protein level
Q9UBK2,PRGC1_HUMAN,Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1-alpha) (PPAR-gamma coactivator 1-alpha) (PPARGC-1-alpha) (Ligand effect modulator 6),798,"91,027",5 out of 5,2004-05-10,Evidence at protein level
Q86YN6,PRGC2_HUMAN,Peroxisome proliferator-activated receptor gamma coactivator 1-beta (PGC-1-beta) (PPAR-gamma coactivator 1-beta) (PPARGC-1-beta) (PGC-1-related estrogen receptor alpha coactivator),1023,"113,222",5 out of 5,2006-06-13,Evidence at protein level
Q86XR5,PRIMA_HUMAN,Proline-rich membrane anchor 1 (PRiMA),153,"16,689",4 out of 5,2003-10-03,Evidence at protein level
P04156,PRIO_HUMAN,Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230),253,"27,661",5 out of 5,1986-11-01,Evidence at protein level
O43242,PSMD3_HUMAN,26S proteasome non-ATPase regulatory subunit 3 (26S proteasome regulatory subunit RPN3) (26S proteasome regulatory subunit S3) (Proteasome subunit p58),534,"60,978",5 out of 5,1998-12-15,Evidence at protein level
Q969U7,PSMG2_HUMAN,Proteasome assembly chaperone 2 (PAC-2) (Hepatocellular carcinoma-susceptibility protein 3) (Tumor necrosis factor superfamily member 5-induced protein 1),264,"29,396",5 out of 5,2008-02-26,Evidence at protein level
P49768,PSN1_HUMAN,Presenilin-1 (PS-1) (EC 3.4.23.-) (Protein S182) [Cleaved into: Presenilin-1 NTF subunit; Presenilin-1 CTF subunit; Presenilin-1 CTF12 (PS1-CTF12)],467,"52,668",5 out of 5,1996-10-01,Evidence at protein level
Q7Z6K3,PTAR1_HUMAN,Protein prenyltransferase alpha subunit repeat-containing protein 1,402,"46,405",2 out of 5,2008-02-05,Evidence at protein level
P26599,PTBP1_HUMAN,Polypyrimidine tract-binding protein 1 (PTB) (57 kDa RNA-binding protein PPTB-1) (Heterogeneous nuclear ribonucleoprotein I) (hnRNP I),531,"57,221",5 out of 5,1992-08-01,Evidence at protein level
Q9Y6C5,PTC2_HUMAN,Protein patched homolog 2 (PTC2),1203,"130,544",5 out of 5,2001-01-24,Evidence at transcript level
Q96EY7,PTCD3_HUMAN,"Pentatricopeptide repeat domain-containing protein 3, mitochondrial (28S ribosomal protein S39, mitochondrial) (MRP-S39) (Mitochondrial small ribosomal subunit protein mS39) (Transformation-related gene 15 protein) (TRG-15)",689,"78,550",5 out of 5,2007-10-02,Evidence at protein level
O15297,PPM1D_HUMAN,Protein phosphatase 1D (EC 3.1.3.16) (Protein phosphatase 2C isoform delta) (PP2C-delta) (Protein phosphatase magnesium-dependent 1 delta) (p53-induced protein phosphatase 1),605,"66,675",5 out of 5,2000-12-01,Evidence at protein level
O96001,PPR17_HUMAN,Protein phosphatase 1 regulatory subunit 17 (G-substrate),155,"17,866",3 out of 5,2000-05-30,Evidence at protein level
Q6NYC8,PPR18_HUMAN,Phostensin (Protein phosphatase 1 F-actin cytoskeleton-targeting subunit) (Protein phosphatase 1 regulatory subunit 18),613,"67,943",5 out of 5,2005-06-21,Evidence at protein level
Q86WC6,PPR27_HUMAN,Protein phosphatase 1 regulatory subunit 27 (Dysferlin-interacting protein 1) (Toonin),154,"17,438",3 out of 5,2006-12-12,Evidence at protein level
Q16821,PPR3A_HUMAN,Protein phosphatase 1 regulatory subunit 3A (Protein phosphatase 1 glycogen-associated regulatory subunit) (Protein phosphatase type-1 glycogen targeting subunit) (RG1),1122,"125,767",5 out of 5,2004-09-13,Evidence at protein level
P86480,PR20D_HUMAN,Proline-rich protein 20D,221,"23,262",2 out of 5,2010-04-20,Evidence at protein level
Q5VTL8,PR38B_HUMAN,Pre-mRNA-splicing factor 38B (Sarcoma antigen NY-SAR-27),546,"64,468",3 out of 5,2007-05-15,Evidence at protein level
O75400,PR40A_HUMAN,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),957,"108,805",5 out of 5,2003-08-22,Evidence at protein level
O95522,PRA12_HUMAN,PRAME family member 12,483,"54,633",2 out of 5,2000-05-30,Inferred from homology
Q5SWL8,PRA19_HUMAN,PRAME family member 19,479,"55,208",2 out of 5,2007-06-12,Inferred from homology
P58294,PROK1_HUMAN,Prokineticin-1 (Endocrine-gland-derived vascular endothelial growth factor) (EG-VEGF) (Mambakine),105,"11,715",4 out of 5,2001-09-26,Evidence at protein level
P07225,PROS_HUMAN,Vitamin K-dependent protein S,676,"75,123",5 out of 5,1988-04-01,Evidence at protein level
Q96S44,PRPK_HUMAN,TP53-regulating kinase (EC 2.7.11.1) (Atypical serine/threonine protein kinase TP53RK) (EKC/KEOPS complex subunit TP53RK) (EC 3.6.-.-) (Nori-2) (p53-related protein kinase),253,"28,160",5 out of 5,2002-12-06,Evidence at protein level
Q8N4B5,PRR18_HUMAN,Proline-rich protein 18,295,"30,926",2 out of 5,2007-10-23,Evidence at transcript level
Q8IZ63,PRR22_HUMAN,Proline-rich protein 22,422,"43,980",2 out of 5,2008-04-29,Evidence at transcript level
B1ATL7,PRR32_HUMAN,Proline-rich protein 32,298,"31,890",2 out of 5,2008-05-20,Predicted
Q8TB68,PRR7_HUMAN,Proline-rich protein 7 (Synaptic proline-rich membrane protein),274,"30,930",3 out of 5,2008-04-08,Evidence at transcript level
A6NIE9,PRS29_HUMAN,Putative serine protease 29 (EC 3.4.21.-) (Implantation serine proteinase 2-like protein) (ISP2-like protein),313,"34,063",3 out of 5,2008-09-02,Uncertain
A4D1T9,PRS37_HUMAN,Probable inactive serine protease 37 (Probable inactive trypsin-X2),235,"26,445",3 out of 5,2008-03-18,Evidence at transcript level
Q7Z5A4,PRS42_HUMAN,Serine protease 42 (EC 3.4.21.-) (Testis serine protease 2),293,"32,006",3 out of 5,2008-09-02,Evidence at transcript level
P62191,PRS4_HUMAN,26S protease regulatory subunit 4 (P26s4) (26S proteasome AAA-ATPase subunit RPT2) (Proteasome 26S subunit ATPase 1),440,"49,185",5 out of 5,2004-06-21,Evidence at protein level
Q8IYP2,PRS58_HUMAN,Serine protease 58 (EC 3.4.21.4) (Trypsin-X3),241,"27,085",3 out of 5,2008-02-05,Evidence at transcript level
P62195,PRS8_HUMAN,26S protease regulatory subunit 8 (26S proteasome AAA-ATPase subunit RPT6) (Proteasome 26S subunit ATPase 5) (Proteasome subunit p45) (Thyroid hormone receptor-interacting protein 1) (TRIP1) (p45/SUG),406,"45,626",5 out of 5,2004-06-21,Evidence at protein level
Q2VWP7,PRTG_HUMAN,Protogenin (Protein Shen-Dan),1150,"127,076",3 out of 5,2008-02-05,Evidence at transcript level
P24158,PRTN3_HUMAN,Myeloblastin (EC 3.4.21.76) (AGP7) (C-ANCA antigen) (Leukocyte proteinase 3) (PR-3) (PR3) (Neutrophil proteinase 4) (NP-4) (P29) (Wegener autoantigen),256,"27,807",5 out of 5,1992-03-01,Evidence at protein level
P40306,PSB10_HUMAN,Proteasome subunit beta type-10 (EC 3.4.25.1) (Low molecular mass protein 10) (Macropain subunit MECl-1) (Multicatalytic endopeptidase complex subunit MECl-1) (Proteasome MECl-1) (Proteasome subunit beta-2i),273,"28,936",5 out of 5,1995-02-01,Evidence at protein level
Q8NDX1,PSD4_HUMAN,PH and SEC7 domain-containing protein 4 (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6 B) (Exchange factor for ARF6 B) (Pleckstrin homology and SEC7 domain-containing protein 4) (Telomeric of interleukin-1 cluster protein),1056,"116,249",5 out of 5,2006-10-03,Evidence at protein level
Q14691,PSF1_HUMAN,DNA replication complex GINS protein PSF1 (GINS complex subunit 1),196,"22,988",5 out of 5,2000-05-30,Evidence at protein level
Q9BRX5,PSF3_HUMAN,DNA replication complex GINS protein PSF3 (GINS complex subunit 3),216,"24,535",4 out of 5,2008-04-08,Evidence at protein level
P11465,PSG2_HUMAN,Pregnancy-specific beta-1-glycoprotein 2 (PS-beta-G-2) (PSBG-2) (Pregnancy-specific glycoprotein 2) (Pregnancy-specific beta-1 glycoprotein E) (PS-beta-E),335,"37,216",3 out of 5,1989-10-01,Evidence at transcript level
Q15238,PSG5_HUMAN,Pregnancy-specific beta-1-glycoprotein 5 (PS-beta-G-5) (PSBG-5) (Pregnancy-specific glycoprotein 5) (Fetal liver non-specific cross-reactive antigen 3) (FL-NCA-3),335,"37,713",3 out of 5,2000-05-30,Evidence at protein level
O75475,PSIP1_HUMAN,PC4 and SFRS1-interacting protein (CLL-associated antigen KW-7) (Dense fine speckles 70 kDa protein) (DFS 70) (Lens epithelium-derived growth factor) (Transcriptional coactivator p75/p52),530,"60,103",5 out of 5,2005-07-05,Evidence at protein level
Q15008,PSMD6_HUMAN,26S proteasome non-ATPase regulatory subunit 6 (26S proteasome regulatory subunit RPN7) (26S proteasome regulatory subunit S10) (Breast cancer-associated protein SGA-113M) (Phosphonoformate immuno-associated protein 4) (Proteasome regulatory particle subunit p44S10) (p42A),389,"45,531",5 out of 5,1997-11-01,Evidence at protein level
P61289,PSME3_HUMAN,Proteasome activator complex subunit 3 (11S regulator complex subunit gamma) (REG-gamma) (Activator of multicatalytic protease subunit 3) (Ki nuclear autoantigen) (Proteasome activator 28 subunit gamma) (PA28g) (PA28gamma),254,"29,506",5 out of 5,2004-05-10,Evidence at protein level
O95456,PSMG1_HUMAN,Proteasome assembly chaperone 1 (PAC-1) (Chromosome 21 leucine-rich protein) (C21-LRP) (Down syndrome critical region protein 2),288,"32,854",5 out of 5,2000-05-30,Evidence at protein level
Q9UKY0,PRND_HUMAN,Prion-like protein doppel (PrPLP) (Prion protein 2),176,"20,293",5 out of 5,2002-09-19,Evidence at protein level
P07737,PROF1_HUMAN,Profilin-1 (Epididymis tissue protein Li 184a) (Profilin I),140,"15,054",5 out of 5,1988-08-01,Evidence at protein level
Q8NHR9,PROF4_HUMAN,Profilin-4 (Profilin IV),129,"14,319",3 out of 5,2004-03-29,Evidence at protein level
P11908,PRPS2_HUMAN,Ribose-phosphate pyrophosphokinase 2 (EC 2.7.6.1) (PPRibP) (Phosphoribosyl pyrophosphate synthase II) (PRS-II),318,"34,769",5 out of 5,1989-10-01,Evidence at protein level
O43653,PSCA_HUMAN,Prostate stem cell antigen,123,"12,912",5 out of 5,2000-12-01,Evidence at protein level
O75832,PSD10_HUMAN,26S proteasome non-ATPase regulatory subunit 10 (26S proteasome regulatory subunit p28) (Gankyrin) (p28(GANK)),226,"24,428",5 out of 5,2002-05-10,Evidence at protein level
Q9BQI7,PSD2_HUMAN,PH and SEC7 domain-containing protein 2 (Pleckstrin homology and SEC7 domain-containing protein 2),771,"84,660",3 out of 5,2008-05-20,Evidence at transcript level
P41222,PTGDS_HUMAN,Prostaglandin-H2 D-isomerase (EC 5.3.99.2) (Beta-trace protein) (Cerebrin-28) (Glutathione-independent PGD synthase) (Lipocalin-type prostaglandin-D synthase) (Prostaglandin-D2 synthase) (PGD2 synthase) (PGDS) (PGDS2),190,"21,029",5 out of 5,1995-02-01,Evidence at protein level
Q3KNS1,PTHD3_HUMAN,Patched domain-containing protein 3 (Patched-related protein),767,"86,872",4 out of 5,2007-11-13,Evidence at protein level
P01236,PRL_HUMAN,Prolactin (PRL),227,"25,876",5 out of 5,1986-07-21,Evidence at protein level
Q9UF12,PROD2_HUMAN,Probable proline dehydrogenase 2 (EC 1.5.5.2) (Kidney and liver proline oxidase 1) (HsPOX1) (Probable proline oxidase 2),536,"58,871",3 out of 5,2007-10-23,Evidence at transcript level
P04280,PRP1_HUMAN,Basic salivary proline-rich protein 1 (Salivary proline-rich protein) [Cleaved into: Proline-rich peptide II-2; Basic peptide IB-6; Peptide P-H],392,"38,546",5 out of 5,1987-03-20,Evidence at protein level
P0C7W0,PRR29_HUMAN,Proline-rich protein 29,189,"20,715",2 out of 5,2008-07-22,Evidence at transcript level
O95084,PRS23_HUMAN,Serine protease 23 (EC 3.4.21.-) (Putative secreted protein Zsig13),383,"43,001",4 out of 5,2002-04-16,Evidence at protein level
A1L453,PRS38_HUMAN,Serine protease 38 (EC 3.4.21.-) (Marapsin-2),326,"35,356",3 out of 5,2008-04-08,Evidence at transcript level
E7EML9,PRS44_HUMAN,Serine protease 44 (EC 3.4.21.-) (Testis serine protease 4) (TESSP-4),344,"36,995",3 out of 5,2011-10-19,Inferred from homology
Q2NL68,PRSR3_HUMAN,Proline and serine-rich protein 3,480,"51,075",3 out of 5,2007-09-11,Evidence at transcript level
P28065,PSB9_HUMAN,Proteasome subunit beta type-9 (EC 3.4.25.1) (Low molecular mass protein 2) (Macropain chain 7) (Multicatalytic endopeptidase complex chain 7) (Proteasome chain 7) (Proteasome subunit beta-1i) (Really interesting new gene 12 protein),219,"23,264",5 out of 5,1992-08-01,Evidence at protein level
A5PKW4,PSD1_HUMAN,PH and SEC7 domain-containing protein 1 (Exchange factor for ARF6) (Pleckstrin homology and SEC7 domain-containing protein 1),1024,"109,543",4 out of 5,2008-02-05,Evidence at protein level
Q9NYI0,PSD3_HUMAN,PH and SEC7 domain-containing protein 3 (Epididymis tissue protein Li 20mP) (Exchange factor for ADP-ribosylation factor guanine nucleotide factor 6) (Hepatocellular carcinoma-associated antigen 67) (Pleckstrin homology and SEC7 domain-containing protein 3),1048,"116,034",4 out of 5,2003-10-10,Evidence at protein level
P30405,PPIF_HUMAN,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial (PPIase F) (EC 5.2.1.8) (Cyclophilin D) (CyP-D) (CypD) (Cyclophilin F) (Mitochondrial cyclophilin) (CyP-M) (Rotamase F)",207,"22,040",5 out of 5,1993-04-01,Evidence at protein level
P53041,PPP5_HUMAN,Serine/threonine-protein phosphatase 5 (PP5) (EC 3.1.3.16) (Protein phosphatase T) (PP-T) (PPT),499,"56,879",5 out of 5,1996-10-01,Evidence at protein level
Q6ZMI0,PPR21_HUMAN,Protein phosphatase 1 regulatory subunit 21 (Coiled-coil domain-containing protein 128) (KLRAQ motif-containing protein 1),780,"88,314",4 out of 5,2007-05-01,Evidence at protein level
O60828,PQBP1_HUMAN,Polyglutamine-binding protein 1 (PQBP-1) (38 kDa nuclear protein containing a WW domain) (Npw38) (Polyglutamine tract-binding protein 1),265,"30,472",5 out of 5,2005-10-25,Evidence at protein level
Q9UI14,PRAF1_HUMAN,Prenylated Rab acceptor protein 1 (PRA1 family protein 1),185,"20,648",5 out of 5,2004-12-07,Evidence at protein level
O60831,PRAF2_HUMAN,PRA1 family protein 2,178,"19,258",3 out of 5,2005-01-04,Evidence at protein level
O95521,PRAM1_HUMAN,PRAME family member 1,474,"55,149",3 out of 5,2000-05-30,Evidence at transcript level
Q5VXH5,PRAM7_HUMAN,PRAME family member 7,474,"53,627",2 out of 5,2005-12-20,Evidence at transcript level
Q96QH2,PRAM_HUMAN,PML-RARA-regulated adapter molecule 1 (PRAM) (PRAM-1),718,"79,245",5 out of 5,2007-01-09,Evidence at protein level
O43663,PRC1_HUMAN,Protein regulator of cytokinesis 1,620,"71,607",5 out of 5,2006-04-04,Evidence at protein level
Q9Y520,PRC2C_HUMAN,Protein PRRC2C (BAT2 domain-containing protein 1) (HBV X-transactivated gene 2 protein) (HBV XAg-transactivated protein 2) (HLA-B-associated transcript 2-like 2) (Proline-rich and coiled-coil-containing protein 2C),2896,"316,911",5 out of 5,2008-09-02,Evidence at protein level
Q9NRG1,PRDC1_HUMAN,Phosphoribosyltransferase domain-containing protein 1,225,"25,674",5 out of 5,2008-02-05,Evidence at protein level
P49642,PRI1_HUMAN,DNA primase small subunit (EC 2.7.7.-) (DNA primase 49 kDa subunit) (p49),420,"49,902",5 out of 5,1996-02-01,Evidence at protein level
P49643,PRI2_HUMAN,DNA primase large subunit (EC 2.7.7.-) (DNA primase 58 kDa subunit) (p58),509,"58,806",5 out of 5,1996-02-01,Evidence at protein level
O43900,PRIC3_HUMAN,Prickle-like protein 3 (LIM domain only protein 6) (LMO-6) (Triple LIM domain protein 6),615,"68,609",3 out of 5,1998-12-15,Evidence at protein level
P60673,PROF3_HUMAN,Profilin-3 (Profilin III),137,"14,596",3 out of 5,2004-03-29,Evidence at transcript level
Q8WWY3,PRP31_HUMAN,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31),499,"55,456",5 out of 5,2006-03-21,Evidence at protein level
Q5SQ13,PRR31_HUMAN,Proline-rich protein 31,230,"24,070",2 out of 5,2008-07-01,Predicted
Q9BQR3,PRS27_HUMAN,Serine protease 27 (EC 3.4.21.-) (Marapsin) (Pancreasin),290,"31,940",4 out of 5,2001-10-18,Evidence at protein level
P25788,PSA3_HUMAN,Proteasome subunit alpha type-3 (EC 3.4.25.1) (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8),255,"28,433",5 out of 5,1992-05-01,Evidence at protein level
P28066,PSA5_HUMAN,Proteasome subunit alpha type-5 (EC 3.4.25.1) (Macropain zeta chain) (Multicatalytic endopeptidase complex zeta chain) (Proteasome zeta chain),241,"26,411",5 out of 5,1992-08-01,Evidence at protein level
O00231,PSD11_HUMAN,26S proteasome non-ATPase regulatory subunit 11 (26S proteasome regulatory subunit RPN6) (26S proteasome regulatory subunit S9) (26S proteasome regulatory subunit p44.5),422,"47,464",5 out of 5,2002-05-15,Evidence at protein level
P09923,PPBI_HUMAN,Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1),528,"56,812",5 out of 5,1989-07-01,Evidence at protein level
P23284,PPIB_HUMAN,Peptidyl-prolyl cis-trans isomerase B (PPIase B) (EC 5.2.1.8) (CYP-S1) (Cyclophilin B) (Rotamase B) (S-cyclophilin) (SCYLP),216,"23,743",5 out of 5,1991-11-01,Evidence at protein level
Q9Y3C6,PPIL1_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 1 (PPIase) (EC 5.2.1.8) (Rotamase PPIL1),166,"18,237",5 out of 5,2002-04-16,Evidence at protein level
Q8IXY8,PPIL6_HUMAN,Peptidyl-prolyl cis-trans isomerase-like 6 (PPIase) (EC 5.2.1.8) (Cyclophilin-like protein PPIL6) (Rotamase PPIL6),311,"35,228",3 out of 5,2006-12-12,Evidence at transcript level
Q9H939,PPIP2_HUMAN,Proline-serine-threonine phosphatase-interacting protein 2 (PEST phosphatase-interacting protein 2),334,"38,858",3 out of 5,2002-11-15,Evidence at protein level
Q8TCE9,PPL13_HUMAN,Placental protein 13-like (Charcot-Leyden crystal protein 2) (CLC2) (Galectin-14) (Gal-14),139,"16,094",5 out of 5,2004-01-16,Evidence at protein level
Q8WY54,PPM1E_HUMAN,Protein phosphatase 1E (EC 3.1.3.16) (Ca(2+)/calmodulin-dependent protein kinase phosphatase N) (CaMKP-N) (CaMKP-nucleus) (CaMKN) (Partner of PIX 1) (Partner of PIX-alpha) (Partner of PIXA),764,"85,002",5 out of 5,2007-05-15,Evidence at protein level
Q9UD71,PPR1B_HUMAN,Protein phosphatase 1 regulatory subunit 1B (DARPP-32) (Dopamine- and cAMP-regulated neuronal phosphoprotein),204,"22,963",5 out of 5,2000-05-30,Evidence at protein level
Q5R3F8,PPR29_HUMAN,Protein phosphatase 1 regulatory subunit 29 (Extracellular leucine-rich repeat and fibronectin type III domain-containing protein 2) (Leucine-rich repeat and fibronectin type-III domain-containing protein 6) (Leucine-rich repeat-containing protein 62),820,"89,687",5 out of 5,2006-10-31,Evidence at protein level
Q86XI6,PPR3B_HUMAN,Protein phosphatase 1 regulatory subunit 3B (Hepatic glycogen-targeting protein phosphatase 1 regulatory subunit GL) (Protein phosphatase 1 regulatory subunit 4) (PP1 subunit R4) (Protein phosphatase 1 subunit GL) (PTG),285,"32,695",4 out of 5,2008-03-18,Evidence at protein level
Q5VV67,PPRC1_HUMAN,Peroxisome proliferator-activated receptor gamma coactivator-related protein 1 (PGC-1-related coactivator) (PRC),1664,"177,544",5 out of 5,2007-07-24,Evidence at protein level
Q9BU68,PR15L_HUMAN,Proline-rich protein 15-like protein (Protein ATAD4),103,"11,705",1 out of 5,2007-07-10,Inferred from homology
Q5TYX0,PRAM5_HUMAN,PRAME family member 5,476,"54,886",2 out of 5,2005-12-20,Evidence at transcript level
Q00LT1,PRCD_HUMAN,Progressive rod-cone degeneration protein,54,"6,007",3 out of 5,2007-03-20,Evidence at protein level
P51817,PRKX_HUMAN,cAMP-dependent protein kinase catalytic subunit PRKX (PrKX) (Protein kinase X) (Protein kinase X-linked) (Serine/threonine-protein kinase PRKX) (EC 2.7.11.1) (Protein kinase PKX1),358,"40,896",5 out of 5,1996-10-01,Evidence at protein level
P49683,PRLHR_HUMAN,Prolactin-releasing peptide receptor (PrRP receptor) (PrRPR) (G-protein coupled receptor 10) (hGR3),370,"41,121",5 out of 5,1996-02-01,Evidence at protein level
Q92786,PROX1_HUMAN,Prospero homeobox protein 1 (Homeobox prospero-like protein PROX1) (PROX-1),737,"83,203",5 out of 5,1998-07-15,Evidence at protein level
Q86UA1,PRP39_HUMAN,Pre-mRNA-processing factor 39 (PRP39 homolog),669,"78,430",3 out of 5,2006-10-31,Evidence at protein level
O94906,PRP6_HUMAN,Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),941,"106,925",5 out of 5,2002-10-19,Evidence at protein level
Q9NZ81,PRR13_HUMAN,Proline-rich protein 13 (Taxane-resistance protein),148,"15,385",5 out of 5,2006-06-27,Evidence at protein level
P81277,PRRP_HUMAN,Prolactin-releasing peptide (PrRP) (Prolactin-releasing hormone) [Cleaved into: Prolactin-releasing peptide PrRP31; Prolactin-releasing peptide PrRP20],87,"9,639",4 out of 5,2000-05-30,Evidence at transcript level
Q7Z6L0,PRRT2_HUMAN,Proline-rich transmembrane protein 2 (Dispanin subfamily B member 3) (DSPB3),340,"34,945",5 out of 5,2007-10-23,Evidence at protein level
Q99811,PRRX2_HUMAN,Paired mesoderm homeobox protein 2 (Paired-related homeobox protein 2) (PRX-2),253,"27,079",3 out of 5,1999-07-15,Evidence at transcript level
P62333,PRS10_HUMAN,26S protease regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42),389,"44,173",5 out of 5,2004-07-05,Evidence at protein level
Q7RTY3,PRS45_HUMAN,Serine protease 45 (EC 3.4.21.-) (Testis serine protease 5),260,"29,329",3 out of 5,2008-09-02,Evidence at transcript level
A6NEY8,PRXD1_HUMAN,Putative prolyl-tRNA synthetase associated domain-containing protein 1 (PrdX deacylase domain-containing protein 1) (Prolyl-tRNA synthetase associated domain-containing protein 1 pseudogene),169,"18,658",2 out of 5,2008-04-08,Uncertain
O14603,PRY_HUMAN,"PTPN13-like protein, Y-linked (Testis-specific PTP-BL-related Y protein)",147,"16,512",2 out of 5,2002-12-13,Evidence at protein level
P22234,PUR6_HUMAN,Multifunctional protein ADE2 [Includes: Phosphoribosylaminoimidazole-succinocarboxamide synthase (EC 6.3.2.6) (SAICAR synthetase); Phosphoribosylaminoimidazole carboxylase (EC 4.1.1.21) (AIR carboxylase) (AIRC)],425,"47,079",5 out of 5,1991-08-01,Evidence at protein level
P30566,PUR8_HUMAN,Adenylosuccinate lyase (ADSL) (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase),484,"54,889",5 out of 5,1993-04-01,Evidence at protein level
Q00577,PURA_HUMAN,Transcriptional activator protein Pur-alpha (Purine-rich single-stranded DNA-binding protein alpha),322,"34,911",5 out of 5,1995-11-01,Evidence at protein level
Q6NUJ5,PWP2B_HUMAN,PWWP domain-containing protein 2B,590,"63,967",3 out of 5,2006-06-27,Evidence at protein level
Q6UX71,PXDC2_HUMAN,Plexin domain-containing protein 2 (Tumor endothelial marker 7-related protein),529,"59,583",5 out of 5,2006-05-16,Evidence at protein level
Q92626,PXDN_HUMAN,Peroxidasin homolog (EC 1.11.1.7) (Melanoma-associated antigen MG50) (Vascular peroxidase 1) (p53-responsive gene 2 protein),1479,"165,275",5 out of 5,2008-02-26,Evidence at protein level
Q56P42,PYDC2_HUMAN,Pyrin domain-containing protein 2 (Pyrin-only protein 2) (cellular POP2) (cPOP2),97,"10,795",5 out of 5,2008-09-02,Evidence at protein level
P27708,PYR1_HUMAN,CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)],2225,"242,984",5 out of 5,1992-08-01,Evidence at protein level
P14927,QCR7_HUMAN,Cytochrome b-c1 complex subunit 7 (Complex III subunit 7) (Complex III subunit VII) (QP-C) (Ubiquinol-cytochrome c reductase complex 14 kDa protein),111,"13,530",5 out of 5,1990-04-01,Evidence at protein level
Q8N2H3,PYRD2_HUMAN,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 2 (EC 1.-.-.-),581,"63,068",2 out of 5,2006-06-27,Evidence at protein level
P20742,PZP_HUMAN,Pregnancy zone protein (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 6),1482,"163,863",5 out of 5,1991-02-01,Evidence at protein level
Q6ZMN7,PZRN4_HUMAN,PDZ domain-containing RING finger protein 4 (Ligand of Numb protein X 4) (SEMACAP3-like protein),1036,"117,103",3 out of 5,2005-02-01,Evidence at transcript level
P31930,QCR1_HUMAN,"Cytochrome b-c1 complex subunit 1, mitochondrial (Complex III subunit 1) (Core protein I) (Ubiquinol-cytochrome-c reductase complex core protein 1)",480,"52,646",5 out of 5,1993-07-01,Evidence at protein level
P07919,QCR6_HUMAN,"Cytochrome b-c1 complex subunit 6, mitochondrial (Complex III subunit 6) (Complex III subunit VIII) (Cytochrome c1 non-heme 11 kDa protein) (Mitochondrial hinge protein) (Ubiquinol-cytochrome c reductase complex 11 kDa protein)",91,"10,739",5 out of 5,1988-08-01,Evidence at protein level
Q53FA7,QORX_HUMAN,Quinone oxidoreductase PIG3 (EC 1.-.-.-) (Tumor protein p53-inducible protein 3) (p53-induced gene 3 protein),332,"35,536",5 out of 5,2005-09-27,Evidence at protein level
Q9NXS2,QPCTL_HUMAN,Glutaminyl-peptide cyclotransferase-like protein (EC 2.3.2.5) (Golgi-resident glutaminyl-peptide cyclotransferase) (isoQC) (gQC),382,"42,924",5 out of 5,2007-09-11,Evidence at protein level
Q9Y2K5,R3HD2_HUMAN,R3H domain-containing protein 2,976,"106,999",4 out of 5,2002-10-19,Evidence at protein level
Q6MZT1,R7BP_HUMAN,Regulator of G-protein signaling 7-binding protein (R7 family-binding protein),257,"28,962",3 out of 5,2007-05-15,Evidence at transcript level
Q32P51,RA1L2_HUMAN,Heterogeneous nuclear ribonucleoprotein A1-like 2 (hnRNP A1-like 2) (hnRNP core protein A1-like 2),320,"34,225",3 out of 5,2008-02-26,Evidence at transcript level
P51153,RAB13_HUMAN,Ras-related protein Rab-13 (Cell growth-inhibiting gene 4 protein),203,"22,774",5 out of 5,1996-10-01,Evidence at protein level
Q9H0U4,RAB1B_HUMAN,Ras-related protein Rab-1B,201,"22,171",5 out of 5,2002-09-19,Evidence at protein level
Q8WUD1,RAB2B_HUMAN,Ras-related protein Rab-2B,216,"24,214",5 out of 5,2003-02-12,Evidence at protein level
Q13636,RAB31_HUMAN,Ras-related protein Rab-31 (Ras-related protein Rab-22B),194,"21,569",5 out of 5,1997-11-01,Evidence at protein level
P20337,RAB3B_HUMAN,Ras-related protein Rab-3B,219,"24,758",5 out of 5,1991-02-01,Evidence at protein level
Q96QF0,RAB3I_HUMAN,Rab-3A-interacting protein (Rab3A-interacting protein) (Rabin-3) (SSX2-interacting protein),476,"53,021",5 out of 5,2005-07-19,Evidence at protein level
Q7Z6P3,RAB44_HUMAN,Ras-related protein Rab-44,723,"77,638",3 out of 5,2008-05-20,Evidence at protein level
P20338,RAB4A_HUMAN,Ras-related protein Rab-4A,218,"24,390",5 out of 5,1991-02-01,Evidence at protein level
P61020,RAB5B_HUMAN,Ras-related protein Rab-5B,215,"23,707",5 out of 5,2004-04-26,Evidence at protein level
P20340,RAB6A_HUMAN,Ras-related protein Rab-6A (Rab-6),208,"23,593",5 out of 5,1991-02-01,Evidence at protein level
P29373,RABP2_HUMAN,Cellular retinoic acid-binding protein 2 (Cellular retinoic acid-binding protein II) (CRABP-II),138,"15,693",5 out of 5,1992-12-01,Evidence at protein level
Q9UJ41,RABX5_HUMAN,Rab5 GDP/GTP exchange factor (RAP1) (Rabaptin-5-associated exchange factor for Rab5) (Rabex-5),708,"79,371",5 out of 5,2004-07-05,Evidence at protein level
Q8WXC3,PYDC1_HUMAN,Pyrin domain-containing protein 1 (PAAD-only protein 1) (Pyrin-only protein 1) (cellular POP1) (cPOP1),89,"10,107",5 out of 5,2007-03-20,Evidence at protein level
P17812,PYRG1_HUMAN,CTP synthase 1 (EC 6.3.4.2) (CTP synthetase 1) (UTP--ammonia ligase 1),591,"66,690",5 out of 5,1990-08-01,Evidence at protein level
P22695,QCR2_HUMAN,"Cytochrome b-c1 complex subunit 2, mitochondrial (Complex III subunit 2) (Core protein II) (Ubiquinol-cytochrome-c reductase complex core protein 2)",453,"48,443",5 out of 5,1991-08-01,Evidence at protein level
Q9H5N1,RABE2_HUMAN,Rab GTPase-binding effector protein 2 (Rabaptin-5beta),569,"63,543",5 out of 5,2004-05-24,Evidence at protein level
Q96PK6,RBM14_HUMAN,RNA-binding protein 14 (Paraspeckle protein 2) (PSP2) (RNA-binding motif protein 14) (RRM-containing coactivator activator/modulator) (Synaptotagmin-interacting protein) (SYT-interacting protein),669,"69,492",5 out of 5,2005-08-30,Evidence at protein level
Q5T481,RBM20_HUMAN,RNA-binding protein 20 (RNA-binding motif protein 20),1227,"134,357",5 out of 5,2008-04-08,Evidence at protein level
P42696,RBM34_HUMAN,RNA-binding protein 34 (RNA-binding motif protein 34),430,"48,565",3 out of 5,1995-11-01,Evidence at protein level
Q96IZ5,RBM41_HUMAN,RNA-binding protein 41 (RNA-binding motif protein 41),413,"47,100",5 out of 5,2006-10-31,Evidence at protein level
P78332,RBM6_HUMAN,RNA-binding protein 6 (Lung cancer antigen NY-LU-12) (Protein G16) (RNA-binding motif protein 6) (RNA-binding protein DEF-3),1123,"128,644",5 out of 5,2001-01-24,Evidence at protein level
Q13882,PTK6_HUMAN,Protein-tyrosine kinase 6 (EC 2.7.10.2) (Breast tumor kinase) (Tyrosine-protein kinase BRK),451,"51,834",5 out of 5,2000-12-01,Evidence at protein level
Q13308,PTK7_HUMAN,Inactive tyrosine-protein kinase 7 (Colon carcinoma kinase 4) (CCK-4) (Protein-tyrosine kinase 7) (Pseudo tyrosine kinase receptor 7) (Tyrosine-protein kinase-like 7),1070,"118,392",5 out of 5,2000-05-30,Evidence at protein level
P54829,PTN5_HUMAN,Tyrosine-protein phosphatase non-receptor type 5 (EC 3.1.3.48) (Neural-specific protein-tyrosine phosphatase) (Striatum-enriched protein-tyrosine phosphatase) (STEP),565,"63,538",5 out of 5,1996-10-01,Evidence at protein level
Q3MIT2,PUS10_HUMAN,Putative tRNA pseudouridine synthase Pus10 (EC 5.4.99.25) (Coiled-coil domain-containing protein 139) (tRNA pseudouridine 55 synthase) (Psi55 synthase) (tRNA pseudouridylate synthase) (tRNA-uridine isomerase),529,"60,244",4 out of 5,2007-09-11,Evidence at protein level
Q8N0Z8,PUSL1_HUMAN,tRNA pseudouridine synthase-like 1 (EC 5.4.99.-) (tRNA pseudouridylate synthase-like 1) (tRNA-uridine isomerase-like 1),303,"33,233",3 out of 5,2004-09-27,Evidence at protein level
Q6DKI7,PVRIG_HUMAN,Transmembrane protein PVRIG (CD112 receptor) (CD112R) (Poliovirus receptor-related immunoglobulin domain-containing protein),326,"34,344",4 out of 5,2008-05-20,Evidence at protein level
Q9UPQ7,PZRN3_HUMAN,E3 ubiquitin-protein ligase PDZRN3 (EC 2.3.2.27) (Ligand of Numb protein X 3) (PDZ domain-containing RING finger protein 3) (RING-type E3 ubiquitin transferase PDZRN3) (Semaphorin cytoplasmic domain-associated protein 3) (Protein SEMACAP3),1066,"119,596",5 out of 5,2005-02-01,Evidence at protein level
Q04671,P_HUMAN,P protein (Melanocyte-specific transporter protein) (Pink-eyed dilution protein homolog),838,"92,850",5 out of 5,1994-06-01,Evidence at protein level
Q16769,QPCT_HUMAN,Glutaminyl-peptide cyclotransferase (EC 2.3.2.5) (Glutaminyl cyclase) (QC) (sQC) (Glutaminyl-tRNA cyclotransferase) (Glutamyl cyclase) (EC),361,"40,877",5 out of 5,1997-11-01,Evidence at protein level
Q9H0J4,QRIC2_HUMAN,Glutamine-rich protein 2,1663,"180,827",3 out of 5,2007-07-24,Evidence at protein level
P50876,R144A_HUMAN,E3 ubiquitin-protein ligase RNF144A (EC 2.3.2.-) (RING finger protein 144A) (UbcM4-interacting protein 4) (Ubiquitin-conjugating enzyme 7-interacting protein 4),292,"32,890",5 out of 5,1996-10-01,Evidence at protein level
Q15269,PWP2_HUMAN,Periodic tryptophan protein 2 homolog,919,"102,452",4 out of 5,1997-11-01,Evidence at transcript level
Q8TE99,PXYP1_HUMAN,2-phosphoxylose phosphatase 1 (EC 3.1.3.-) (Acid phosphatase-like protein 2) (Xylosyl phosphatase) (epididymis luminal protein 124),480,"55,240",5 out of 5,2008-01-15,Evidence at protein level
Q9NRF8,PYRG2_HUMAN,CTP synthase 2 (EC 6.3.4.2) (CTP synthetase 2) (UTP--ammonia ligase 2),586,"65,678",4 out of 5,2006-07-25,Evidence at protein level
Q9NRI6,PYY2_HUMAN,Putative peptide YY-2 (Putative peptide YY2),33,"3,432",3 out of 5,2008-09-02,Uncertain
A0A096LP55,QCR6L_HUMAN,"Cytochrome b-c1 complex subunit 6-like, mitochondrial",91,"10,752",2 out of 5,2016-02-17,Inferred from homology
O14949,QCR8_HUMAN,Cytochrome b-c1 complex subunit 8 (Complex III subunit 8) (Complex III subunit VIII) (Ubiquinol-cytochrome c reductase complex 9.5 kDa protein) (Ubiquinol-cytochrome c reductase complex ubiquinone-binding protein QP-C),82,"9,906",5 out of 5,1998-07-15,Evidence at protein level
Q96D70,R3HD4_HUMAN,R3H domain-containing protein 4,268,"30,350",2 out of 5,2007-03-20,Evidence at protein level
P62820,RAB1A_HUMAN,Ras-related protein Rab-1A (YPT1-related protein),205,"22,678",5 out of 5,2004-08-16,Evidence at protein level
Q9ULC3,RAB23_HUMAN,Ras-related protein Rab-23,237,"26,659",5 out of 5,2001-01-11,Evidence at protein level
P51157,RAB28_HUMAN,Ras-related protein Rab-28,221,"24,841",5 out of 5,1996-10-01,Evidence at protein level
Q9BZG1,RAB34_HUMAN,Ras-related protein Rab-34 (Ras-related protein Rab-39) (Ras-related protein Rah),259,"29,044",5 out of 5,2002-01-31,Evidence at protein level
O95755,RAB36_HUMAN,Ras-related protein Rab-36,333,"36,322",3 out of 5,1999-07-15,Evidence at transcript level
P57729,RAB38_HUMAN,Ras-related protein Rab-38 (Melanoma antigen NY-MEL-1),211,"23,712",5 out of 5,2001-01-11,Evidence at protein level
Q8N4Z0,RAB42_HUMAN,Putative Ras-related protein Rab-42,105,"11,364",2 out of 5,2007-01-09,Uncertain
Q92930,RAB8B_HUMAN,Ras-related protein Rab-8B,207,"23,584",5 out of 5,1999-07-15,Evidence at protein level
Q3YEC7,RABL6_HUMAN,Rab-like protein 6 (GTP-binding protein Parf) (Partner of ARF) (Rab-like protein 1) (RBEL1),729,"79,549",5 out of 5,2007-02-06,Evidence at protein level
P15153,RAC2_HUMAN,Ras-related C3 botulinum toxin substrate 2 (GX) (Small G protein) (p21-Rac2),192,"21,429",5 out of 5,1990-04-01,Evidence at protein level
Q96JH8,RADIL_HUMAN,Ras-associating and dilute domain-containing protein,1075,"117,455",5 out of 5,2005-11-08,Evidence at protein level
P43487,RANG_HUMAN,Ran-specific GTPase-activating protein (Ran-binding protein 1) (RanBP1),201,"23,310",5 out of 5,1995-11-01,Evidence at protein level
Q9Y272,RASD1_HUMAN,Dexamethasone-induced Ras-related protein 1 (Activator of G-protein signaling 1),281,"31,642",5 out of 5,2003-10-31,Evidence at protein level
Q86WH2,RASF3_HUMAN,Ras association domain-containing protein 3,238,"27,562",4 out of 5,2006-06-27,Evidence at protein level
O43374,RASL2_HUMAN,Ras GTPase-activating protein 4 (Calcium-promoted Ras inactivator) (Ras p21 protein activator 4) (RasGAP-activating-like protein 2),803,"90,458",5 out of 5,2001-05-04,Evidence at transcript level
Q8IY67,RAVR1_HUMAN,Ribonucleoprotein PTB-binding 1 (Protein raver-1),606,"63,877",4 out of 5,2006-01-24,Evidence at protein level
Q96IS3,RAX2_HUMAN,Retina and anterior neural fold homeobox protein 2 (Q50-type retinal homeobox protein) (Retina and anterior neural fold homeobox-like protein 1),184,"20,086",5 out of 5,2007-05-01,Evidence at protein level
P23468,PTPRD_HUMAN,Receptor-type tyrosine-protein phosphatase delta (Protein-tyrosine phosphatase delta) (R-PTP-delta) (EC 3.1.3.48),1912,"214,760",5 out of 5,1991-11-01,Evidence at protein level
Q96N64,PWP2A_HUMAN,PWWP domain-containing protein 2A,755,"81,960",3 out of 5,2007-11-13,Evidence at protein level
O75192,PX11A_HUMAN,Peroxisomal membrane protein 11A (HsPEX11p) (28 kDa peroxisomal integral membrane protein) (PMP28) (Peroxin-11A) (Peroxisomal biogenesis factor 11A) (Protein PEX11 homolog alpha) (PEX11-alpha),247,"28,353",5 out of 5,2005-04-26,Evidence at protein level
Q5TGL8,PXDC1_HUMAN,PX domain-containing protein 1,231,"26,560",2 out of 5,2007-08-21,Evidence at transcript level
A1KZ92,PXDNL_HUMAN,Peroxidasin-like protein (EC 1.11.1.7) (Cardiac peroxidase) (Vascular peroxidase 2) (polysomal ribonuclease 1) (PRM1),1463,"163,686",5 out of 5,2008-04-29,Evidence at protein level
Q8NFP0,PXT1_HUMAN,Peroxisomal testis-specific protein 1 (Small testis-specific peroxisomal protein),134,"16,023",2 out of 5,2008-03-18,Evidence at transcript level
Q9UDW1,QCR9_HUMAN,Cytochrome b-c1 complex subunit 9 (Complex III subunit 9) (Complex III subunit X) (Cytochrome c1 non-heme 7 kDa protein) (Ubiquinol-cytochrome c reductase complex 7.2 kDa protein),63,"7,308",4 out of 5,2000-12-01,Evidence at protein level
Q08257,QOR_HUMAN,Quinone oxidoreductase (EC 1.6.5.5) (NADPH:quinone reductase) (Zeta-crystallin),329,"35,207",5 out of 5,1994-10-01,Evidence at protein level
Q9H974,QTRT2_HUMAN,Queuine tRNA-ribosyltransferase accessory subunit 2 (Queuine tRNA-ribosyltransferase domain-containing protein 1),415,"46,713",5 out of 5,2007-07-24,Evidence at protein level
O00487,PSDE_HUMAN,26S proteasome non-ATPase regulatory subunit 14 (EC 3.4.19.-) (26S proteasome regulatory subunit RPN11) (26S proteasome-associated PAD1 homolog 1),310,"34,577",5 out of 5,2004-08-31,Evidence at protein level
Q13200,PSMD2_HUMAN,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),908,"100,200",5 out of 5,1997-11-01,Evidence at protein level
P07988,PSPB_HUMAN,Pulmonary surfactant-associated protein B (SP-B) (18 kDa pulmonary-surfactant protein) (6 kDa protein) (Pulmonary surfactant-associated proteolipid SPL(Phe)),381,"42,117",5 out of 5,1988-08-01,Evidence at protein level
O15172,PSPHL_HUMAN,Putative phosphoserine phosphatase-like protein (L-3-phosphoserine-phosphatase homolog),72,"7,804",2 out of 5,2008-02-05,Uncertain
O14957,QCR10_HUMAN,Cytochrome b-c1 complex subunit 10 (Complex III subunit 10) (Complex III subunit XI) (Ubiquinol-cytochrome c reductase complex 6.4 kDa protein),56,"6,570",4 out of 5,1998-12-15,Inferred from homology
Q96PU8,QKI_HUMAN,Protein quaking (Hqk) (HqkI),341,"37,671",5 out of 5,2006-06-13,Evidence at protein level
Q6NVV1,R13P3_HUMAN,Putative 60S ribosomal protein L13a protein RPL13AP3 (60S ribosomal protein L13a pseudogene 3),102,"12,135",2 out of 5,2008-05-20,Uncertain
Q7Z419,R144B_HUMAN,E3 ubiquitin-protein ligase RNF144B (EC 2.3.2.-) (IBR domain-containing protein 2) (RING finger protein 144B) (p53-inducible RING finger protein),303,"33,697",5 out of 5,2005-01-04,Evidence at protein level
A8MTL3,R212B_HUMAN,RING finger protein 212B,300,"33,570",2 out of 5,2008-09-02,Evidence at transcript level
Q6NUR6,R216L_HUMAN,Putative protein RNF216-like,42,"5,133",1 out of 5,2008-03-18,Uncertain
Q09MP3,R51A2_HUMAN,RAD51-associated protein 2,1159,"133,907",3 out of 5,2008-05-20,Evidence at protein level
Q6ZS82,R9BP_HUMAN,Regulator of G-protein signaling 9-binding protein (RGS9-anchoring protein),235,"25,148",3 out of 5,2007-05-15,Evidence at transcript level
P61106,RAB14_HUMAN,Ras-related protein Rab-14,215,"23,897",5 out of 5,2004-04-26,Evidence at protein level
Q9H0T7,RAB17_HUMAN,Ras-related protein Rab-17,212,"23,491",5 out of 5,2001-09-26,Evidence at protein level
Q96E17,RAB3C_HUMAN,Ras-related protein Rab-3C,227,"25,952",4 out of 5,2002-09-19,Evidence at transcript level
Q5JT25,RAB41_HUMAN,Ras-related protein Rab-41,222,"25,038",4 out of 5,2006-06-27,Evidence at protein level
P20339,RAB5A_HUMAN,Ras-related protein Rab-5A,215,"23,659",5 out of 5,1991-02-01,Evidence at protein level
Q9H0N0,RAB6C_HUMAN,Ras-related protein Rab-6C (Rab6-like protein WTH3),254,"28,355",5 out of 5,2003-01-10,Evidence at protein level
Q9NP90,RAB9B_HUMAN,Ras-related protein Rab-9B (Rab-9-like protein) (Rab-9L),201,"22,719",5 out of 5,2001-02-21,Evidence at protein level
P60763,RAC3_HUMAN,Ras-related C3 botulinum toxin substrate 3 (p21-Rac3),192,"21,379",5 out of 5,2004-04-13,Evidence at protein level
P43351,RAD52_HUMAN,DNA repair protein RAD52 homolog,418,"46,169",5 out of 5,1995-11-01,Evidence at protein level
Q6WBX8,RAD9B_HUMAN,Cell cycle checkpoint control protein RAD9B (DNA repair exonuclease rad9 homolog B) (hRAD9B),426,"47,832",4 out of 5,2006-03-07,Evidence at protein level
P24386,RAE1_HUMAN,Rab proteins geranylgeranyltransferase component A 1 (Choroideremia protein) (Rab escort protein 1) (REP-1) (TCD protein),653,"73,476",5 out of 5,1992-03-01,Evidence at protein level
P15918,RAG1_HUMAN,V(D)J recombination-activating protein 1 (RAG-1) (RING finger protein 74) [Includes: Endonuclease RAG1 (EC 3.1.-.-); E3 ubiquitin-protein ligase RAG1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RAG1)],1043,"119,097",5 out of 5,1990-04-01,Evidence at protein level
Q7Z5J4,RAI1_HUMAN,Retinoic acid-induced protein 1,1906,"203,352",5 out of 5,2004-07-19,Evidence at protein level
P11217,PYGM_HUMAN,"Glycogen phosphorylase, muscle form (EC 2.4.1.1) (Myophosphorylase)",842,"97,092",5 out of 5,1989-07-01,Evidence at protein level
Q9Y3Y4,PYGO1_HUMAN,Pygopus homolog 1,419,"45,116",5 out of 5,2002-09-19,Evidence at protein level
O15315,RA51B_HUMAN,DNA repair protein RAD51 homolog 2 (R51H2) (RAD51 homolog B) (Rad51B) (RAD51-like protein 1),384,"42,196",5 out of 5,1998-12-15,Evidence at protein level
O43502,RA51C_HUMAN,DNA repair protein RAD51 homolog 3 (R51H3) (RAD51 homolog C) (RAD51-like protein 2),376,"42,190",5 out of 5,1998-12-15,Evidence at protein level
Q9Y620,RA54B_HUMAN,DNA repair and recombination protein RAD54B (EC 3.6.4.-) (RAD54 homolog B),910,"102,967",5 out of 5,2004-08-16,Evidence at protein level
P59190,RAB15_HUMAN,Ras-related protein Rab-15,212,"24,391",5 out of 5,2003-01-10,Evidence at protein level
A4D1S5,RAB19_HUMAN,Ras-related protein Rab-19,217,"24,400",3 out of 5,2007-09-11,Evidence at transcript level
P57735,RAB25_HUMAN,Ras-related protein Rab-25 (CATX-8),213,"23,496",5 out of 5,2001-01-11,Evidence at protein level
Q9ULW5,RAB26_HUMAN,Ras-related protein Rab-26,256,"27,900",5 out of 5,2001-01-11,Evidence at protein level
P61018,RAB4B_HUMAN,Ras-related protein Rab-4B,213,"23,587",5 out of 5,2004-04-26,Evidence at protein level
Q7Z6M1,RABEK_HUMAN,Rab9 effector protein with kelch motifs (40 kDa Rab9 effector protein) (p40),372,"40,565",5 out of 5,2007-03-20,Evidence at protein level
Q92698,RAD54_HUMAN,DNA repair and recombination protein RAD54-like (EC 3.6.4.-) (RAD54 homolog) (hHR54) (hRAD54),747,"84,352",5 out of 5,2004-08-16,Evidence at protein level
P46060,RAGP1_HUMAN,Ran GTPase-activating protein 1 (RanGAP1),587,"63,542",5 out of 5,1995-11-01,Evidence at protein level
Q9Y5P3,RAI2_HUMAN,Retinoic acid-induced protein 2,530,"57,180",3 out of 5,2000-12-01,Evidence at protein level
P62826,RAN_HUMAN,GTP-binding nuclear protein Ran (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein),216,"24,423",5 out of 5,2004-08-16,Evidence at protein level
P10114,RAP2A_HUMAN,Ras-related protein Rap-2a (RbBP-30),183,"20,615",5 out of 5,1989-07-01,Evidence at protein level
Q9NS23,RASF1_HUMAN,Ras association domain-containing protein 1,344,"39,219",5 out of 5,2004-07-19,Evidence at protein level
P01112,RASH_HUMAN,"GTPase HRas (H-Ras-1) (Ha-Ras) (Transforming protein p21) (c-H-ras) (p21ras) [Cleaved into: GTPase HRas, N-terminally processed]",189,"21,298",5 out of 5,1986-07-21,Evidence at protein level
B7ZAP0,RBG10_HUMAN,"Rab GTPase-activating protein 1-like, isoform 10",253,"29,038",3 out of 5,2012-06-13,Evidence at protein level
Q5R372,RBG1L_HUMAN,Rab GTPase-activating protein 1-like,815,"92,513",5 out of 5,2008-09-02,Evidence at protein level
P06737,PYGL_HUMAN,"Glycogen phosphorylase, liver form (EC 2.4.1.1)",847,"97,149",5 out of 5,1988-01-01,Evidence at protein level
Q96P65,QRFPR_HUMAN,Pyroglutamylated RFamide peptide receptor (AQ27) (G-protein coupled receptor 103) (Orexigenic neuropeptide QRFP receptor) (SP9155),431,"49,488",5 out of 5,2003-10-10,Evidence at transcript level
Q86UN2,R4RL1_HUMAN,Reticulon-4 receptor-like 1 (Nogo receptor-like 2) (Nogo-66 receptor homolog 2) (Nogo-66 receptor-related protein 3) (NgR3),441,"49,065",5 out of 5,2006-02-07,Evidence at protein level
Q86UN3,R4RL2_HUMAN,Reticulon-4 receptor-like 2 (Nogo receptor-like 3) (Nogo-66 receptor homolog 1) (Nogo-66 receptor-related protein 2) (NgR2),420,"46,106",5 out of 5,2006-02-07,Evidence at protein level
Q96B01,R51A1_HUMAN,RAD51-associated protein 1 (RAD51-interacting protein),352,"38,457",5 out of 5,2005-07-05,Evidence at protein level
P61026,RAB10_HUMAN,Ras-related protein Rab-10,200,"22,541",5 out of 5,2004-04-26,Evidence at protein level
Q9NP72,RAB18_HUMAN,Ras-related protein Rab-18,206,"22,977",5 out of 5,2001-01-11,Evidence at protein level
P61019,RAB2A_HUMAN,Ras-related protein Rab-2A,212,"23,546",5 out of 5,2004-04-26,Evidence at protein level
Q15771,RAB30_HUMAN,Ras-related protein Rab-30,203,"23,058",5 out of 5,1997-11-01,Evidence at protein level
Q96AX2,RAB37_HUMAN,Ras-related protein Rab-37,223,"24,815",5 out of 5,2002-01-31,Evidence at protein level
P20336,RAB3A_HUMAN,Ras-related protein Rab-3A,220,"24,984",5 out of 5,1991-02-01,Evidence at protein level
P51149,RAB7A_HUMAN,Ras-related protein Rab-7a,207,"23,490",5 out of 5,1996-10-01,Evidence at protein level
P61006,RAB8A_HUMAN,Ras-related protein Rab-8A (Oncogene c-mel),207,"23,668",5 out of 5,2004-04-26,Evidence at protein level
P63244,RACK1_HUMAN,"Receptor of activated protein C kinase 1 (Cell proliferation-inducing gene 21 protein) (Guanine nucleotide-binding protein subunit beta-2-like 1) (Guanine nucleotide-binding protein subunit beta-like protein 12.3) (Human lung cancer oncogene 7 protein) (HLC-7) (Receptor for activated C kinase) (Small ribosomal subunit protein RACK1) [Cleaved into: Receptor of activated protein C kinase 1, N-terminally processed (Guanine nucleotide-binding protein subunit beta-2-like 1, N-terminally processed)]",317,"35,077",5 out of 5,2004-10-11,Evidence at protein level
Q9NS91,RAD18_HUMAN,E3 ubiquitin-protein ligase RAD18 (EC 2.3.2.27) (Postreplication repair protein RAD18) (hHR18) (hRAD18) (RING finger protein 73) (RING-type E3 ubiquitin transferase RAD18),495,"56,223",5 out of 5,2002-06-06,Evidence at protein level
O60216,RAD21_HUMAN,Double-strand-break repair protein rad21 homolog (hHR21) (Nuclear matrix protein 1) (NXP-1) (SCC1 homolog),631,"71,690",5 out of 5,2002-11-15,Evidence at protein level
Q8NFJ5,RAI3_HUMAN,Retinoic acid-induced protein 3 (G-protein coupled receptor family C group 5 member A) (Phorbol ester induced gene 1) (PEIG-1) (Retinoic acid-induced gene 1 protein) (RAIG-1),357,"40,251",5 out of 5,2004-04-13,Evidence at protein level
P11233,RALA_HUMAN,Ras-related protein Ral-A,206,"23,567",5 out of 5,1989-07-01,Evidence at protein level
O60896,RAMP3_HUMAN,Receptor activity-modifying protein 3 (Calcitonin-receptor-like receptor activity-modifying protein 3) (CRLR activity-modifying protein 3),148,"16,518",5 out of 5,2000-12-01,Evidence at protein level
P62834,RAP1A_HUMAN,Ras-related protein Rap-1A (C21KG) (G-22K) (GTP-binding protein smg p21A) (Ras-related protein Krev-1),184,"20,987",5 out of 5,2004-08-16,Evidence at protein level
P20936,RASA1_HUMAN,Ras GTPase-activating protein 1 (GAP) (GTPase-activating protein) (RasGAP) (Ras p21 protein activator) (p120GAP),1047,"116,403",5 out of 5,1991-02-01,Evidence at protein level
Q9H2L5,RASF4_HUMAN,Ras association domain-containing protein 4,321,"36,748",4 out of 5,2006-06-27,Evidence at protein level
Q96S21,RB40C_HUMAN,Ras-related protein Rab-40C (Rar-like protein) (Ras-like protein family member 8C) (SOCS box-containing protein RAR3),281,"31,304",5 out of 5,2003-01-10,Evidence at protein level
Q8IUD2,RB6I2_HUMAN,ELKS/Rab6-interacting/CAST family member 1 (ERC-1) (Rab6-interacting protein 2),1116,"128,086",5 out of 5,2004-08-31,Evidence at protein level
Q9P1G2,RBAS1_HUMAN,Putative uncharacterized protein encoded by RBM12B-AS1 (RBM12B antisense RNA 1) (RBM12B antisense gene protein 1),102,"11,378",1 out of 5,2007-01-09,Uncertain
Q9UBK7,RBL2A_HUMAN,Rab-like protein 2A,228,"26,115",3 out of 5,2000-12-01,Evidence at protein level
Q08999,RBL2_HUMAN,Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2),1139,"128,367",5 out of 5,1995-11-01,Evidence at protein level
Q9H4I0,RD21L_HUMAN,Double-strand-break repair protein rad21-like protein 1,556,"63,324",4 out of 5,2008-02-26,Evidence at transcript level
Q96NR8,RDH12_HUMAN,Retinol dehydrogenase 12 (EC 1.1.1.-) (All-trans and 9-cis retinol dehydrogenase) (Short chain dehydrogenase/reductase family 7C member 2),316,"35,094",5 out of 5,2003-08-29,Evidence at protein level
Q5JQD4,PYY3_HUMAN,Putative peptide YY-3 (Putative peptide YY3) (PYY-III),70,"7,832",3 out of 5,2008-06-10,Uncertain
Q2KHR3,QSER1_HUMAN,Glutamine and serine-rich protein 1,1735,"189,972",2 out of 5,2007-05-29,Evidence at protein level
O00391,QSOX1_HUMAN,Sulfhydryl oxidase 1 (hQSOX) (EC 1.8.3.2) (Quiescin Q6),747,"82,578",5 out of 5,2006-09-19,Evidence at protein level
O15541,R113A_HUMAN,RING finger protein 113A (Zinc finger protein 183),343,"38,787",4 out of 5,1998-07-15,Evidence at protein level
Q9NRW1,RAB6B_HUMAN,Ras-related protein Rab-6B,208,"23,462",5 out of 5,2001-04-27,Evidence at protein level
O14966,RAB7L_HUMAN,Ras-related protein Rab-7L1 (Rab-7-like protein 1) (Ras-related protein Rab-29),203,"23,155",5 out of 5,2001-04-27,Evidence at protein level
O75943,RAD17_HUMAN,Cell cycle checkpoint protein RAD17 (hRad17) (RF-C/activator 1 homolog),681,"77,055",5 out of 5,2005-03-29,Evidence at protein level
Q99638,RAD9A_HUMAN,Cell cycle checkpoint control protein RAD9A (hRAD9) (EC 3.1.11.2) (DNA repair exonuclease rad9 homolog A),391,"42,547",5 out of 5,2006-03-07,Evidence at protein level
Q15109,RAGE_HUMAN,Advanced glycosylation end product-specific receptor (Receptor for advanced glycosylation end products),404,"42,803",5 out of 5,1997-11-01,Evidence at protein level
O60895,RAMP2_HUMAN,Receptor activity-modifying protein 2 (Calcitonin-receptor-like receptor activity-modifying protein 2) (CRLR activity-modifying protein 2),175,"19,608",5 out of 5,2000-12-01,Evidence at protein level
P61224,RAP1B_HUMAN,Ras-related protein Rap-1b (GTP-binding protein smg p21B),184,"20,825",5 out of 5,2004-05-10,Evidence at protein level
Q13702,RAPSN_HUMAN,43 kDa receptor-associated protein of the synapse (RAPsyn) (43 kDa postsynaptic protein) (Acetylcholine receptor-associated 43 kDa protein) (RING finger protein 205),412,"46,328",5 out of 5,1997-11-01,Evidence at protein level
Q99969,RARR2_HUMAN,Retinoic acid receptor responder protein 2 (Chemerin) (RAR-responsive protein TIG2) (Tazarotene-induced gene 2 protein),163,"18,618",5 out of 5,2000-05-30,Evidence at protein level
Q14644,RASA3_HUMAN,Ras GTPase-activating protein 3 (GAP1(IP4BP)) (Ins P4-binding protein),834,"95,699",5 out of 5,2001-05-04,Evidence at protein level
Q8IZ41,RASEF_HUMAN,Ras and EF-hand domain-containing protein (Ras-related protein Rab-45),740,"82,879",5 out of 5,2007-09-11,Evidence at protein level
Q02833,RASF7_HUMAN,Ras association domain-containing protein 7 (HRAS1-related cluster protein 1),373,"39,945",5 out of 5,2001-09-26,Evidence at protein level
P01116,RASK_HUMAN,"GTPase KRas (K-Ras 2) (Ki-Ras) (c-K-ras) (c-Ki-ras) [Cleaved into: GTPase KRas, N-terminally processed]",189,"21,656",5 out of 5,1986-07-21,Evidence at protein level
O00194,RB27B_HUMAN,Ras-related protein Rab-27B (C25KG),218,"24,608",5 out of 5,1997-11-01,Evidence at protein level
Q96DA2,RB39B_HUMAN,Ras-related protein Rab-39B,213,"24,622",5 out of 5,2003-01-10,Evidence at protein level
Q9NYW8,RBAK_HUMAN,RB-associated KRAB zinc finger protein (RB-associated KRAB repressor) (hRBaK) (Zinc finger protein 769),714,"82,995",5 out of 5,2008-02-05,Evidence at protein level
Q7Z6E9,RBBP6_HUMAN,E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis),1792,"201,564",5 out of 5,2006-05-16,Evidence at protein level
Q8TDY2,RBCC1_HUMAN,RB1-inducible coiled-coil protein 1 (FAK family kinase-interacting protein of 200 kDa) (FIP200),1594,"183,091",5 out of 5,2005-11-22,Evidence at protein level
Q9UNT1,RBL2B_HUMAN,Rab-like protein 2B,228,"26,101",3 out of 5,2000-12-01,Evidence at transcript level
P57052,RBM11_HUMAN,Splicing regulator RBM11 (RNA-binding motif protein 11),281,"32,179",5 out of 5,2000-12-01,Evidence at protein level
Q96H35,RBM18_HUMAN,Probable RNA-binding protein 18 (RNA-binding motif protein 18),190,"21,649",2 out of 5,2006-10-31,Evidence at transcript level
Q9NW64,RBM22_HUMAN,Pre-mRNA-splicing factor RBM22 (RNA-binding motif protein 22) (Zinc finger CCCH domain-containing protein 16),420,"46,896",5 out of 5,2006-10-03,Evidence at protein level
Q9NW13,RBM28_HUMAN,RNA-binding protein 28 (RNA-binding motif protein 28),759,"85,738",5 out of 5,2004-11-23,Evidence at protein level
A0AV96,RBM47_HUMAN,RNA-binding protein 47 (RNA-binding motif protein 47),593,"64,099",3 out of 5,2007-10-23,Evidence at protein level
P38159,RBMX_HUMAN,"RNA-binding motif protein, X chromosome (Glycoprotein p43) (Heterogeneous nuclear ribonucleoprotein G) (hnRNP G) [Cleaved into: RNA-binding motif protein, X chromosome, N-terminally processed]",391,"42,332",5 out of 5,1994-10-01,Evidence at protein level
Q15311,RBP1_HUMAN,RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (Ral-interacting protein 1),655,"76,063",5 out of 5,2003-08-15,Evidence at protein level
Q8NDN9,RCBT1_HUMAN,RCC1 and BTB domain-containing protein 1 (Chronic lymphocytic leukemia deletion region gene 7 protein) (CLL deletion region gene 7 protein) (Regulator of chromosome condensation and BTB domain-containing protein 1),531,"58,252",4 out of 5,2005-12-20,Evidence at transcript level
Q7Z5L2,R3HCL_HUMAN,Coiled-coil domain-containing protein R3HCC1L (Growth inhibition and differentiation-related protein 88) (Putative mitochondrial space protein 32.1) (R3H and coiled-coil domain-containing protein 1-like),792,"87,884",5 out of 5,2005-08-02,Evidence at protein level
Q9NX57,RAB20_HUMAN,Ras-related protein Rab-20,234,"26,277",5 out of 5,2002-01-31,Evidence at protein level
P51151,RAB9A_HUMAN,Ras-related protein Rab-9A,201,"22,838",5 out of 5,1996-10-01,Evidence at protein level
P78406,RAE1L_HUMAN,mRNA export factor (Rae1 protein homolog) (mRNA-associated protein mrnp 41),368,"40,968",5 out of 5,1998-07-15,Evidence at protein level
P26374,RAE2_HUMAN,Rab proteins geranylgeranyltransferase component A 2 (Choroideremia-like protein) (Rab escort protein 2) (REP-2),656,"74,071",5 out of 5,1992-08-01,Evidence at protein level
P04049,RAF1_HUMAN,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),648,"73,052",5 out of 5,1986-11-01,Evidence at protein level
Q5U651,RAIN_HUMAN,Ras-interacting protein 1 (Rain),963,"103,457",4 out of 5,2005-11-08,Evidence at protein level
Q86SE5,RALYL_HUMAN,RNA-binding Raly-like protein (hRALYL) (Heterogeneous nuclear ribonucleoprotein C-like 3) (hnRNP core protein C-like 3),291,"32,331",5 out of 5,2007-09-11,Evidence at protein level
O60894,RAMP1_HUMAN,Receptor activity-modifying protein 1 (Calcitonin-receptor-like receptor activity-modifying protein 1) (CRLR activity-modifying protein 1),148,"16,988",5 out of 5,2000-12-01,Evidence at protein level
Q9HCJ3,RAVR2_HUMAN,Ribonucleoprotein PTB-binding 2 (Protein raver-2),691,"74,339",4 out of 5,2005-05-10,Evidence at protein level
Q14964,RB39A_HUMAN,Ras-related protein Rab-39A (Rab-39),217,"25,007",5 out of 5,2002-01-31,Evidence at protein level
Q09028,RBBP4_HUMAN,Histone-binding protein RBBP4 (Chromatin assembly factor 1 subunit C) (CAF-1 subunit C) (Chromatin assembly factor I p48 subunit) (CAF-I 48 kDa subunit) (CAF-I p48) (Nucleosome-remodeling factor subunit RBAP48) (Retinoblastoma-binding protein 4) (RBBP-4) (Retinoblastoma-binding protein p48),425,"47,656",5 out of 5,1995-11-01,Evidence at protein level
Q86U06,RBM23_HUMAN,Probable RNA-binding protein 23 (RNA-binding motif protein 23) (RNA-binding region-containing protein 4) (Splicing factor SF2),439,"48,731",5 out of 5,2003-09-19,Evidence at protein level
Q8IUH3,RBM45_HUMAN,RNA-binding protein 45 (Developmentally-regulated RNA-binding protein 1) (RB-1) (RNA-binding motif protein 45),476,"53,502",5 out of 5,2005-02-15,Evidence at protein level
Q15434,RBMS2_HUMAN,"RNA-binding motif, single-stranded-interacting protein 2 (Suppressor of CDC2 with RNA-binding motif 3)",407,"43,959",2 out of 5,2004-11-23,Evidence at protein level
Q9UBG7,RBPJL_HUMAN,Recombining binding protein suppressor of hairless-like protein (Transcription factor RBP-L),517,"56,751",4 out of 5,2002-11-01,Evidence at transcript level
P25800,RBTN1_HUMAN,Rhombotin-1 (Cysteine-rich protein TTG-1) (LIM domain only protein 1) (LMO-1) (T-cell translocation protein 1),156,"17,828",5 out of 5,1992-05-01,Evidence at protein level
Q9Y2P8,RCL1_HUMAN,RNA 3'-terminal phosphate cyclase-like protein,373,"40,843",3 out of 5,2000-12-01,Evidence at protein level
Q8IZ40,RCOR2_HUMAN,REST corepressor 2,523,"58,012",3 out of 5,2006-03-07,Evidence at protein level
P54725,RD23A_HUMAN,UV excision repair protein RAD23 homolog A (HR23A) (hHR23A),363,"39,609",5 out of 5,1996-10-01,Evidence at protein level
Q9NYR8,RDH8_HUMAN,Retinol dehydrogenase 8 (EC 1.1.1.300) (Photoreceptor outer segment all-trans retinol dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 2),311,"33,755",5 out of 5,2007-10-02,Evidence at protein level
P61571,REC21_HUMAN,Endogenous retrovirus group K member 21 Rec protein (HERV-K_12q14.1 provirus Rec protein),104,"11,722",2 out of 5,2004-05-24,Evidence at protein level
P61573,REC9_HUMAN,Endogenous retrovirus group K member 9 Rec protein (HERV-K(C6) Rec protein) (HERV-K109 Rec protein) (HERV-K_6q14.1 provirus Rec protein),105,"11,828",2 out of 5,2004-05-24,Evidence at protein level
O95980,RECK_HUMAN,Reversion-inducing cysteine-rich protein with Kazal motifs (hRECK) (Suppressor of tumorigenicity 15 protein),971,"106,457",5 out of 5,2002-04-16,Evidence at protein level
Q8NC24,RELL2_HUMAN,RELT-like protein 2,303,"32,405",4 out of 5,2006-09-19,Evidence at protein level
P78509,RELN_HUMAN,Reelin (EC 3.4.21.-),3460,"388,388",5 out of 5,2002-03-27,Evidence at protein level
Q9P2R6,RERE_HUMAN,Arginine-glutamic acid dipeptide repeats protein (Atrophin-1-like protein) (Atrophin-1-related protein),1566,"172,424",5 out of 5,2006-01-10,Evidence at protein level
Q96R05,RET7_HUMAN,Retinoid-binding protein 7 (Cellular retinoic acid-binding protein 4) (CRABP4) (CRBP4) (Cellular retinoic acid-binding protein IV) (CRABP-IV),134,"15,536",3 out of 5,2002-04-03,Evidence at protein level
Q9HD89,RETN_HUMAN,Resistin (Adipose tissue-specific secretory factor) (ADSF) (C/EBP-epsilon-regulated myeloid-specific secreted cysteine-rich protein) (Cysteine-rich secreted protein A12-alpha-like 2) (Cysteine-rich secreted protein FIZZ3),108,"11,419",5 out of 5,2001-09-26,Evidence at protein level
O60673,REV3L_HUMAN,DNA polymerase zeta catalytic subunit (EC 2.7.7.7) (Protein reversionless 3-like) (REV3-like) (hREV3),3130,"352,776",5 out of 5,1998-12-15,Evidence at protein level
Q96IC2,REXON_HUMAN,Putative RNA exonuclease NEF-sp (EC 3.1.-.-),774,"86,886",3 out of 5,2007-05-15,Evidence at transcript level
Q9H6Z4,RANB3_HUMAN,Ran-binding protein 3 (RanBP3),567,"60,210",5 out of 5,2004-08-16,Evidence at protein level
C9J798,RAS4B_HUMAN,Ras GTPase-activating protein 4B,803,"90,406",2 out of 5,2010-07-13,Inferred from homology
Q8WWW0,RASF5_HUMAN,Ras association domain-containing protein 5 (New ras effector 1) (Regulator for cell adhesion and polarization enriched in lymphoid tissues) (RAPL),418,"47,090",5 out of 5,2006-06-27,Evidence at protein level
Q9Y580,RBM7_HUMAN,RNA-binding protein 7 (RNA-binding motif protein 7),266,"30,504",3 out of 5,2000-12-01,Evidence at protein level
Q9Y5S9,RBM8A_HUMAN,RNA-binding protein 8A (Binder of OVCA1-1) (BOV-1) (RNA-binding motif protein 8A) (RNA-binding protein Y14) (Ribonucleoprotein RBM8A),174,"19,889",5 out of 5,2000-12-01,Evidence at protein level
Q8NG50,RDM1_HUMAN,RAD52 motif-containing protein 1 (RAD52 homolog B),284,"31,970",5 out of 5,2007-09-11,Evidence at protein level
Q8TAI7,REBL1_HUMAN,GTPase RhebL1 (Ras homolog enriched in brain like-1 c) (RhebL1c) (Ras homolog enriched in brain-like protein 1) (Rheb-like protein 1) (Rheb2),183,"20,682",5 out of 5,2008-03-18,Evidence at protein level
O94761,RECQ4_HUMAN,"ATP-dependent DNA helicase Q4 (EC 3.6.4.12) (DNA helicase, RecQ-like type 4) (RecQ4) (RTS) (RecQ protein-like 4)",1208,"133,077",5 out of 5,2000-05-30,Evidence at protein level
P78563,RED1_HUMAN,Double-stranded RNA-specific editase 1 (EC 3.5.4.37) (RNA-editing deaminase 1) (RNA-editing enzyme 1) (dsRNA adenosine deaminase),741,"80,763",5 out of 5,1997-11-01,Evidence at protein level
Q6UW15,REG3G_HUMAN,Regenerating islet-derived protein 3-gamma (REG-3-gamma) (Pancreatitis-associated protein 1B) (PAP-1B) (Pancreatitis-associated protein IB) (PAP IB) (Regenerating islet-derived protein III-gamma) (REG III) (Reg III-gamma) [Cleaved into: Regenerating islet-derived protein 3-gamma 16.5 kDa form; Regenerating islet-derived protein 3-gamma 15 kDa form],175,"19,330",5 out of 5,2005-07-05,Evidence at protein level
Q9HAU5,RENT2_HUMAN,Regulator of nonsense transcripts 2 (Nonsense mRNA reducing factor 2) (Up-frameshift suppressor 2 homolog) (hUpf2),1272,"147,810",5 out of 5,2005-03-01,Evidence at protein level
P10745,RET3_HUMAN,Retinol-binding protein 3 (Interphotoreceptor retinoid-binding protein) (IRBP) (Interstitial retinol-binding protein),1247,"135,363",5 out of 5,1989-07-01,Evidence at protein level
P02753,RET4_HUMAN,Retinol-binding protein 4 (Plasma retinol-binding protein) (PRBP) (RBP) [Cleaved into: Plasma retinol-binding protein(1-182); Plasma retinol-binding protein(1-181); Plasma retinol-binding protein(1-179); Plasma retinol-binding protein(1-176)],201,"23,010",5 out of 5,1986-07-21,Evidence at protein level
O43251,RFOX2_HUMAN,RNA binding protein fox-1 homolog 2 (Fox-1 homolog B) (Hexaribonucleotide-binding protein 2) (RNA-binding motif protein 9) (RNA-binding protein 9) (Repressor of tamoxifen transcriptional activity),390,"41,374",5 out of 5,2000-12-01,Evidence at protein level
A6NLU0,RFPLA_HUMAN,Ret finger protein-like 4A (RING finger protein 210),287,"32,238",2 out of 5,2007-09-11,Evidence at protein level
Q9NS28,RGS18_HUMAN,Regulator of G-protein signaling 18 (RGS18),235,"27,582",3 out of 5,2001-08-14,Evidence at protein level
Q2M5E4,RGS21_HUMAN,Regulator of G-protein signaling 21 (RGS21),152,"17,671",2 out of 5,2007-01-09,Evidence at transcript level
Q9H310,RHBG_HUMAN,Ammonium transporter Rh type B (Rhesus blood group family type B glycoprotein) (Rh family type B glycoprotein) (Rh type B glycoprotein),441,"47,231",5 out of 5,2007-04-03,Evidence at protein level
Q9UBD6,RHCG_HUMAN,Ammonium transporter Rh type C (Rh glycoprotein kidney) (Rhesus blood group family type C glycoprotein) (Rh family type C glycoprotein) (Rh type C glycoprotein) (Tumor-related protein DRC2),479,"53,179",5 out of 5,2007-04-03,Evidence at protein level
P0C7M4,RHF2B_HUMAN,Rhox homeobox family member 2B,288,"31,637",2 out of 5,2008-06-10,Evidence at transcript level
Q5T5U3,RHG21_HUMAN,Rho GTPase-activating protein 21 (Rho GTPase-activating protein 10) (Rho-type GTPase-activating protein 21),1957,"217,331",5 out of 5,2007-10-02,Evidence at protein level
Q8N264,RHG24_HUMAN,Rho GTPase-activating protein 24 (Filamin-A-associated RhoGAP) (FilGAP) (RAC1- and CDC42-specific GTPase-activating protein of 72 kDa) (RC-GAP72) (Rho-type GTPase-activating protein 24) (RhoGAP of 73 kDa) (Sarcoma antigen NY-SAR-88) (p73RhoGAP),748,"84,258",5 out of 5,2007-03-20,Evidence at protein level
Q9P2N2,RHG28_HUMAN,Rho GTPase-activating protein 28 (Rho-type GTPase-activating protein 28),729,"82,060",4 out of 5,2007-03-20,Evidence at protein level
Q59GN2,R39L5_HUMAN,Putative 60S ribosomal protein L39-like 5 (60S ribosomal protein L39 pseudogene 5),51,"6,323",2 out of 5,2008-09-02,Uncertain
Q15032,R3HD1_HUMAN,R3H domain-containing protein 1,1099,"120,696",3 out of 5,1998-07-15,Evidence at protein level
O75771,RA51D_HUMAN,DNA repair protein RAD51 homolog 4 (R51H3) (RAD51 homolog D) (RAD51-like protein 3) (TRAD),328,"35,049",5 out of 5,1999-07-15,Evidence at protein level
Q92928,RAB1C_HUMAN,Putative Ras-related protein Rab-1C (hRab1c),201,"22,017",3 out of 5,2008-07-01,Uncertain
Q969Q5,RAB24_HUMAN,Ras-related protein Rab-24,203,"23,124",4 out of 5,2002-09-19,Evidence at protein level
Q13637,RAB32_HUMAN,Ras-related protein Rab-32,225,"24,997",5 out of 5,1997-11-01,Evidence at protein level
Q15286,RAB35_HUMAN,Ras-related protein Rab-35 (GTP-binding protein RAY) (Ras-related protein Rab-1C),201,"23,025",5 out of 5,1998-07-15,Evidence at protein level
Q86YS6,RAB43_HUMAN,Ras-related protein Rab-43 (Ras-related protein Rab-41),212,"23,339",5 out of 5,2006-06-27,Evidence at protein level
P51148,RAB5C_HUMAN,Ras-related protein Rab-5C (L1880) (RAB5L),216,"23,483",5 out of 5,1996-10-01,Evidence at protein level
Q15276,RABE1_HUMAN,Rab GTPase-binding effector protein 1 (Rabaptin-4) (Rabaptin-5) (Rabaptin-5alpha) (Renal carcinoma antigen NY-REN-17),862,"99,290",5 out of 5,2004-05-24,Evidence at protein level
O60671,RAD1_HUMAN,Cell cycle checkpoint protein RAD1 (hRAD1) (EC 3.1.11.2) (DNA repair exonuclease rad1 homolog) (Rad1-like DNA damage checkpoint protein),282,"31,827",5 out of 5,2006-03-07,Evidence at protein level
P55042,RAD_HUMAN,GTP-binding protein RAD (RAD1) (Ras associated with diabetes),308,"33,245",4 out of 5,1996-10-01,Evidence at protein level
Q9P0K7,RAI14_HUMAN,Ankycorbin (Ankyrin repeat and coiled-coil structure-containing protein) (Novel retinal pigment epithelial cell protein) (Retinoic acid-induced protein 14),980,"110,041",5 out of 5,2006-06-13,Evidence at protein level
P11234,RALB_HUMAN,Ras-related protein Ral-B,206,"23,409",5 out of 5,1989-07-01,Evidence at protein level
Q9UKM9,RALY_HUMAN,RNA-binding protein Raly (Autoantigen p542) (Heterogeneous nuclear ribonucleoprotein C-like 2) (hnRNP core protein C-like 2) (hnRNP associated with lethal yellow protein homolog),306,"32,463",5 out of 5,2002-11-15,Evidence at protein level
Q9BTL3,RAM_HUMAN,RNMT-activating mini protein (RAM) (Protein FAM103A1),118,"14,381",5 out of 5,2005-08-30,Evidence at protein level
Q8NHQ8,RASF8_HUMAN,Ras association domain-containing protein 8 (Carcinoma-associated protein HOJ-1),419,"48,327",3 out of 5,2003-05-09,Evidence at protein level
O14807,RASM_HUMAN,Ras-related protein M-Ras (Ras-related protein R-Ras3),208,"23,846",5 out of 5,2000-05-30,Evidence at protein level
Q8NDT2,RB15B_HUMAN,Putative RNA-binding protein 15B (One-twenty two protein 3) (HuOTT3) (RNA-binding motif protein 15B),890,"97,205",5 out of 5,2005-03-01,Evidence at protein level
O75884,RBBP9_HUMAN,Putative hydrolase RBBP9 (EC 3.-.-.-) (B5T-overexpressed gene protein) (Protein BOG) (Retinoblastoma-binding protein 10) (RBBP-10) (Retinoblastoma-binding protein 9) (RBBP-9),186,"21,000",5 out of 5,2001-09-26,Evidence at protein level
Q9H2M9,RBGPR_HUMAN,Rab3 GTPase-activating protein non-catalytic subunit (RGAP-iso) (Rab3 GTPase-activating protein 150 kDa subunit) (Rab3-GAP p150) (Rab3-GAP150) (Rab3-GAP regulatory subunit),1393,"155,985",5 out of 5,2005-04-12,Evidence at protein level
Q6XE24,RBMS3_HUMAN,"RNA-binding motif, single-stranded-interacting protein 3",437,"47,840",3 out of 5,2007-02-06,Evidence at protein level
P0C7P1,RBY1D_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member D",496,"55,775",4 out of 5,2008-06-10,Evidence at transcript level
P53805,RCAN1_HUMAN,Calcipressin-1 (Adapt78) (Down syndrome critical region protein 1) (Myocyte-enriched calcineurin-interacting protein 1) (MCIP1) (Regulator of calcineurin 1),252,"28,079",5 out of 5,1996-10-01,Evidence at protein level
Q7Z4M0,RE114_HUMAN,Meiotic recombination protein REC114,266,"29,155",2 out of 5,2008-02-26,Evidence at transcript level
O75787,RENR_HUMAN,Renin receptor (ATPase H(+)-transporting lysosomal accessory protein 2) (ATPase H(+)-transporting lysosomal-interacting protein 2) (ER-localized type I transmembrane adaptor) (Embryonic liver differentiation factor 10) (N14F) (Renin/prorenin receptor) (Vacuolar ATP synthase membrane sector-associated protein M8-9) (ATP6M8-9) (V-ATPase M8.9 subunit),350,"39,008",5 out of 5,2000-05-30,Evidence at protein level
Q92900,RENT1_HUMAN,Regulator of nonsense transcripts 1 (EC 3.6.4.-) (ATP-dependent helicase RENT1) (Nonsense mRNA reducing factor 1) (NORF1) (Up-frameshift suppressor 1 homolog) (hUpf1),1129,"124,345",5 out of 5,2001-10-18,Evidence at protein level
Q96D71,REPS1_HUMAN,RalBP1-associated Eps domain-containing protein 1 (RalBP1-interacting protein 1),796,"86,662",5 out of 5,2003-08-15,Evidence at protein level
P18754,RCC1_HUMAN,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),421,"44,969",5 out of 5,1990-11-01,Evidence at protein level
Q9P2K3,RCOR3_HUMAN,REST corepressor 3,495,"55,581",5 out of 5,2006-03-07,Evidence at protein level
P54727,RD23B_HUMAN,UV excision repair protein RAD23 homolog B (HR23B) (hHR23B) (XP-C repair-complementing complex 58 kDa protein) (p58),409,"43,171",5 out of 5,1996-10-01,Evidence at protein level
Q8IZV5,RDH10_HUMAN,Retinol dehydrogenase 10 (EC 1.1.1.300) (Short chain dehydrogenase/reductase family 16C member 4),341,"38,087",5 out of 5,2007-10-23,Evidence at protein level
Q92781,RDH1_HUMAN,11-cis retinol dehydrogenase (11-cis RDH) (11-cis RoDH) (EC 1.1.1.315) (9-cis retinol dehydrogenase) (9cRDH) (Retinol dehydrogenase 5) (Short chain dehydrogenase/reductase family 9C member 5),318,"34,979",5 out of 5,1997-11-01,Evidence at protein level
P61578,REC16_HUMAN,Endogenous retrovirus group K member 16 Rec protein (HERV-K_10p14 provirus Rec protein),105,"11,808",2 out of 5,2004-05-24,Evidence at protein level
P61575,RECK8_HUMAN,Endogenous retrovirus group K member 8 Rec protein (HERV-K115 Rec protein) (HERV-K_8p23.1 provirus Rec protein),105,"11,844",2 out of 5,2004-05-24,Evidence at protein level
Q9BYZ8,REG4_HUMAN,Regenerating islet-derived protein 4 (REG-4) (Gastrointestinal secretory protein) (REG-like protein) (Regenerating islet-derived protein IV) (Reg IV),158,"18,230",5 out of 5,2005-07-05,Evidence at protein level
Q8IUW5,RELL1_HUMAN,RELT-like protein 1,271,"29,340",4 out of 5,2008-03-18,Evidence at protein level
Q9BZI7,REN3B_HUMAN,Regulator of nonsense transcripts 3B (Nonsense mRNA reducing factor 3B) (Up-frameshift suppressor 3 homolog B) (hUpf3B) (Up-frameshift suppressor 3 homolog on chromosome X) (hUpf3p-X),483,"57,762",5 out of 5,2005-03-01,Evidence at protein level
Q13127,REST_HUMAN,RE1-silencing transcription factor (Neural-restrictive silencer factor) (X2 box repressor),1097,"121,872",5 out of 5,2006-12-12,Evidence at protein level
Q9UGC7,RF1ML_HUMAN,"Peptide chain release factor 1-like, mitochondrial (Mitochondrial translational release factor 1-like) (mtRF1a)",380,"43,600",5 out of 5,2008-04-29,Evidence at protein level
P40938,RFC3_HUMAN,Replication factor C subunit 3 (Activator 1 38 kDa subunit) (A1 38 kDa subunit) (Activator 1 subunit 3) (Replication factor C 38 kDa subunit) (RF-C 38 kDa subunit) (RFC38),356,"40,556",5 out of 5,1995-02-01,Evidence at protein level
Q33E94,RFX4_HUMAN,Transcription factor RFX4 (Regulatory factor X 4) (Testis development protein NYD-SP10),735,"83,368",5 out of 5,2008-01-15,Evidence at protein level
Q8HWS3,RFX6_HUMAN,DNA-binding protein RFX6 (Regulatory factor X 6) (Regulatory factor X domain-containing protein 1),928,"102,461",5 out of 5,2008-01-15,Evidence at protein level
Q5HYW3,RGAG4_HUMAN,Retrotransposon gag domain-containing protein 4,569,"64,711",2 out of 5,2006-10-31,Evidence at transcript level
Q96B86,RGMA_HUMAN,Repulsive guidance molecule A (RGM domain family member A),450,"49,347",5 out of 5,2004-08-16,Evidence at protein level
Q7Z3J3,RGPD4_HUMAN,RanBP2-like and GRIP domain-containing protein 4,1758,"197,289",3 out of 5,2008-01-15,Evidence at transcript level
O14921,RGS13_HUMAN,Regulator of G-protein signaling 13 (RGS13),159,"19,135",2 out of 5,1998-12-15,Evidence at transcript level
O15492,RGS16_HUMAN,Regulator of G-protein signaling 16 (RGS16) (A28-RGS14P) (Retinal-specific RGS) (RGS-r) (hRGS-r) (Retinally abundant regulator of G-protein signaling),202,"22,749",5 out of 5,1998-12-15,Evidence at protein level
Q08116,RGS1_HUMAN,Regulator of G-protein signaling 1 (RGS1) (B-cell activation protein BL34) (Early response protein 1R20),209,"23,858",5 out of 5,1995-02-01,Evidence at protein level
O15539,RGS5_HUMAN,Regulator of G-protein signaling 5 (RGS5),181,"20,946",3 out of 5,1998-12-15,Evidence at protein level
P49758,RGS6_HUMAN,Regulator of G-protein signaling 6 (RGS6) (S914),472,"54,423",5 out of 5,1996-10-01,Evidence at protein level
A5PLK6,RGSL_HUMAN,Regulator of G-protein signaling protein-like,1076,"125,688",3 out of 5,2008-09-02,Evidence at transcript level
B2RC85,R10B2_HUMAN,Radial spoke head 10 homolog B2,870,"100,547",2 out of 5,2008-09-02,Evidence at transcript level
Q8TBN0,R3GEF_HUMAN,Guanine nucleotide exchange factor for Rab-3A (Rab-3A-interacting-like protein 1) (Rab3A-interacting-like protein 1) (Rabin3-like 1),382,"42,637",5 out of 5,2007-10-02,Evidence at protein level
Q9Y3L5,RAP2C_HUMAN,Ras-related protein Rap-2c,183,"20,745",5 out of 5,2004-05-10,Evidence at protein level
Q70E73,RAPH1_HUMAN,Ras-associated and pleckstrin homology domains-containing protein 1 (RAPH1) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 18 protein) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 9 protein) (Lamellipodin) (Proline-rich EVH1 ligand 2) (PREL-2) (Protein RMO1),1250,"135,256",5 out of 5,2005-11-22,Evidence at protein level
P10276,RARA_HUMAN,Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1),462,"50,771",5 out of 5,1989-07-01,Evidence at protein level
P13631,RARG_HUMAN,Retinoic acid receptor gamma (RAR-gamma) (Nuclear receptor subfamily 1 group B member 3),454,"50,342",5 out of 5,1990-01-01,Evidence at protein level
Q7Z444,RASE_HUMAN,GTPase ERas (E-Ras) (Embryonic stem cell-expressed Ras),233,"25,287",3 out of 5,2006-07-25,Evidence at transcript level
Q6ZTQ3,RASF6_HUMAN,Ras association domain-containing protein 6,369,"43,384",4 out of 5,2006-06-27,Evidence at protein level
A6NK89,RASFA_HUMAN,Ras association domain-containing protein 10,507,"56,900",3 out of 5,2008-04-29,Evidence at transcript level
Q9NYN1,RASLC_HUMAN,Ras-like protein family member 12 (Ras-like protein Ris),266,"29,662",3 out of 5,2008-05-20,Evidence at protein level
Q96T37,RBM15_HUMAN,Putative RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15),977,"107,189",5 out of 5,2002-03-27,Evidence at protein level
Q9BX46,RBM24_HUMAN,RNA-binding protein 24 (RNA-binding motif protein 24) (RNA-binding region-containing protein 6),236,"24,776",4 out of 5,2007-01-23,Evidence at protein level
Q9P2N5,RBM27_HUMAN,RNA-binding protein 27 (RNA-binding motif protein 27),1060,"118,718",3 out of 5,2007-01-23,Evidence at protein level
Q14498,RBM39_HUMAN,RNA-binding protein 39 (CAPER alpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1),530,"59,380",5 out of 5,2003-02-01,Evidence at protein level
P29558,RBMS1_HUMAN,"RNA-binding motif, single-stranded-interacting protein 1 (Single-stranded DNA-binding protein MSSP-1) (Suppressor of CDC2 with RNA-binding motif 2)",406,"44,505",5 out of 5,1993-04-01,Evidence at protein level
P0DJD4,RBY1C_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member C",496,"55,784",3 out of 5,2012-02-22,Evidence at protein level
O00559,RCAS1_HUMAN,Receptor-binding cancer antigen expressed on SiSo cells (Cancer-associated surface antigen RCAS1) (Estrogen receptor-binding fragment-associated gene 9 protein),213,"24,377",5 out of 5,2000-12-01,Evidence at protein level
Q96I51,RCC1L_HUMAN,RCC1-like G exchanging factor-like protein (RCC1 like) (Williams-Beuren syndrome chromosomal region 16 protein),464,"49,997",3 out of 5,2002-10-10,Evidence at protein level
Q7Z3Z2,RD3_HUMAN,Protein RD3 (Retinal degeneration protein 3),195,"22,704",4 out of 5,2005-07-19,Evidence at protein level
Q8NBN7,RDH13_HUMAN,Retinol dehydrogenase 13 (EC 1.1.1.-) (Short chain dehydrogenase/reductase family 7C member 3),331,"35,932",4 out of 5,2003-08-29,Evidence at protein level
O95825,QORL1_HUMAN,Quinone oxidoreductase-like protein 1 (EC 1.-.-.-) (Protein 4P11) (Quinone oxidoreductase homolog 1) (QOH-1) (Zeta-crystallin homolog),349,"38,697",3 out of 5,2000-05-30,Evidence at protein level
Q2TAL8,QRIC1_HUMAN,Glutamine-rich protein 1,776,"86,436",5 out of 5,2007-01-09,Evidence at protein level
Q6ZRP7,QSOX2_HUMAN,Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1),698,"77,529",5 out of 5,2006-09-19,Evidence at protein level
P0C881,R10B1_HUMAN,Radial spoke head 10 homolog B,870,"100,635",1 out of 5,2008-09-02,Evidence at transcript level
Q8IZP6,R113B_HUMAN,RING finger protein 113B (Zinc finger protein 183-like 1),322,"36,259",2 out of 5,2003-08-15,Evidence at protein level
Q5HYI8,RABL3_HUMAN,Rab-like protein 3,236,"26,423",2 out of 5,2007-12-04,Evidence at protein level
P55895,RAG2_HUMAN,V(D)J recombination-activating protein 2 (RAG-2),527,"59,241",5 out of 5,1997-11-01,Evidence at protein level
A6NC62,RAKDN_HUMAN,Putative RBAK downstream neighbor protein,111,"12,297",1 out of 5,2008-02-26,Uncertain
P10826,RARB_HUMAN,Retinoic acid receptor beta (RAR-beta) (HBV-activated protein) (Nuclear receptor subfamily 1 group B member 2) (RAR-epsilon),455,"50,489",5 out of 5,1989-07-01,Evidence at protein level
Q15283,RASA2_HUMAN,Ras GTPase-activating protein 2 (GTPase-activating protein 1m) (GAP1m),850,"96,614",5 out of 5,2001-05-04,Evidence at protein level
Q8IXT5,RB12B_HUMAN,RNA-binding protein 12B (RNA-binding motif protein 12B),1001,"118,103",3 out of 5,2007-01-23,Evidence at protein level
Q9UL26,RB22A_HUMAN,Ras-related protein Rab-22A (Rab-22),194,"21,855",5 out of 5,2001-04-27,Evidence at protein level
P51159,RB27A_HUMAN,Ras-related protein Rab-27A (Rab-27) (GTP-binding protein Ram),221,"24,868",5 out of 5,1996-10-01,Evidence at protein level
Q15291,RBBP5_HUMAN,Retinoblastoma-binding protein 5 (RBBP-5) (Retinoblastoma-binding protein RBQ-3),538,"59,153",5 out of 5,2001-10-18,Evidence at protein level
P98175,RBM10_HUMAN,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),930,"103,533",5 out of 5,1996-10-01,Evidence at protein level
Q9Y4C8,RBM19_HUMAN,Probable RNA-binding protein 19 (RNA-binding motif protein 19),960,"107,332",5 out of 5,2001-02-21,Evidence at protein level
Q92804,RBP56_HUMAN,TATA-binding protein-associated factor 2N (68 kDa TATA-binding protein-associated factor) (TAF(II)68) (TAFII68) (RNA-binding protein 56),592,"61,830",5 out of 5,2000-12-01,Evidence at protein level
Q15415,RBY1F_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member F/J (Y chromosome RNA recognition motif 2)",496,"55,728",5 out of 5,2008-01-15,Evidence at protein level
Q5TC82,RC3H1_HUMAN,Roquin-1 (Roquin) (RING finger and C3H zinc finger protein 1) (RING finger and CCCH-type zinc finger domain-containing protein 1) (RING finger protein 198),1133,"125,736",5 out of 5,2005-08-16,Evidence at protein level
Q8TC12,RDH11_HUMAN,Retinol dehydrogenase 11 (EC 1.1.1.300) (Androgen-regulated short-chain dehydrogenase/reductase 1) (HCV core-binding protein HCBP12) (Prostate short-chain dehydrogenase/reductase 1) (Retinal reductase 1) (RalR1) (Short chain dehydrogenase/reductase family 7C member 1),318,"35,386",5 out of 5,2003-08-29,Evidence at protein level
P46063,RECQ1_HUMAN,"ATP-dependent DNA helicase Q1 (EC 3.6.4.12) (DNA helicase, RecQ-like type 1) (RecQ1) (DNA-dependent ATPase Q1) (RecQ protein-like 1)",649,"73,457",5 out of 5,1995-11-01,Evidence at protein level
P50749,RASF2_HUMAN,Ras association domain-containing protein 2,326,"37,790",5 out of 5,1996-10-01,Evidence at protein level
O75901,RASF9_HUMAN,Ras association domain-containing protein 9 (PAM COOH-terminal interactor protein 1) (P-CIP1) (Peptidylglycine alpha-amidating monooxygenase COOH-terminal interactor),435,"50,021",4 out of 5,2007-09-11,Evidence at transcript level
Q86YV0,RASL3_HUMAN,RAS protein activator like-3,1011,"111,898",5 out of 5,2008-02-26,Evidence at protein level
Q15907,RB11B_HUMAN,Ras-related protein Rab-11B (GTP-binding protein YPT3),218,"24,489",5 out of 5,1998-07-15,Evidence at protein level
Q14088,RB33A_HUMAN,Ras-related protein Rab-33A (Small GTP-binding protein S10),237,"26,593",4 out of 5,1997-11-01,Evidence at protein level
Q15042,RB3GP_HUMAN,Rab3 GTPase-activating protein catalytic subunit (RAB3 GTPase-activating protein 130 kDa subunit) (Rab3-GAP p130) (Rab3-GAP),981,"110,524",5 out of 5,2005-04-12,Evidence at protein level
P0C0E4,RB40L_HUMAN,Ras-related protein Rab-40A-like (Ras-like GTPase),278,"31,239",5 out of 5,2005-09-13,Evidence at protein level
Q8N0V3,RBFA_HUMAN,"Putative ribosome-binding factor A, mitochondrial",343,"38,359",3 out of 5,2005-08-16,Evidence at protein level
Q9NTZ6,RBM12_HUMAN,RNA-binding protein 12 (RNA-binding motif protein 12) (SH3/WW domain anchor protein in the nucleus) (SWAN),932,"97,395",3 out of 5,2003-04-23,Evidence at protein level
Q9H0Z9,RBM38_HUMAN,RNA-binding protein 38 (CLL-associated antigen KW-5) (HSRNASEB) (RNA-binding motif protein 38) (RNA-binding region-containing protein 1) (ssDNA-binding protein SEB4),239,"25,498",5 out of 5,2003-02-01,Evidence at protein level
Q96LT9,RBM40_HUMAN,RNA-binding protein 40 (RNA-binding motif protein 40) (RNA-binding region-containing protein 3) (U11/U12 small nuclear ribonucleoprotein 65 kDa protein) (U11/U12 snRNP 65 kDa protein) (U11/U12-65K),517,"58,575",5 out of 5,2007-11-13,Evidence at protein level
Q9BTD8,RBM42_HUMAN,RNA-binding protein 42 (RNA-binding motif protein 42),480,"50,414",4 out of 5,2007-10-23,Evidence at protein level
Q6ZP01,RBM44_HUMAN,RNA-binding protein 44 (RNA-binding motif protein 44),1051,"117,985",3 out of 5,2007-07-10,Evidence at transcript level
Q9H2T7,RBP17_HUMAN,Ran-binding protein 17,1088,"124,375",4 out of 5,2001-11-02,Evidence at transcript level
Q93062,RBPMS_HUMAN,RNA-binding protein with multiple splicing (RBP-MS) (Heart and RRM expressed sequence) (Hermes),196,"21,802",5 out of 5,2001-02-21,Evidence at protein level
Q9H477,RBSK_HUMAN,Ribokinase (RK) (EC 2.7.1.15),322,"34,143",5 out of 5,2002-01-23,Evidence at protein level
A6NEQ0,RBY1E_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member E",496,"55,759",3 out of 5,2008-06-10,Evidence at transcript level
Q9HBD1,RC3H2_HUMAN,Roquin-2 (EC 2.3.2.27) (Membrane-associated nucleic acid-binding protein) (RING finger and CCCH-type zinc finger domain-containing protein 2) (RING finger protein 164) (RING-type E3 ubiquitin transferase Roquin-2),1191,"131,669",5 out of 5,2005-08-16,Evidence at protein level
P35243,RECO_HUMAN,Recoverin (Cancer-associated retinopathy protein) (Protein CAR),200,"23,130",4 out of 5,1994-02-01,Evidence at protein level
Q8WXF3,REL3_HUMAN,Relaxin-3 (Insulin-like peptide INSL7) (Insulin-like peptide 7) (Prorelaxin H3) [Cleaved into: Relaxin-3 B chain; Relaxin-3 A chain],142,"15,451",5 out of 5,2003-10-10,Evidence at protein level
Q8IYK8,REM2_HUMAN,GTP-binding protein REM 2 (Rad and Gem-like GTP-binding protein 2),340,"37,139",3 out of 5,2004-08-16,Evidence at protein level
Q6IQ22,RAB12_HUMAN,Ras-related protein Rab-12,244,"27,248",5 out of 5,2007-01-09,Evidence at protein level
Q9UL25,RAB21_HUMAN,Ras-related protein Rab-21,225,"24,348",5 out of 5,2001-04-27,Evidence at protein level
O95716,RAB3D_HUMAN,Ras-related protein Rab-3D,219,"24,267",5 out of 5,1999-07-15,Evidence at protein level
Q96AH8,RAB7B_HUMAN,Ras-related protein Rab-7b,199,"22,511",5 out of 5,2004-07-19,Evidence at transcript level
P29762,RABP1_HUMAN,Cellular retinoic acid-binding protein 1 (Cellular retinoic acid-binding protein I) (CRABP-I),137,"15,566",4 out of 5,1993-04-01,Evidence at protein level
P63000,RAC1_HUMAN,Ras-related C3 botulinum toxin substrate 1 (Cell migration-inducing gene 5 protein) (Ras-like protein TC25) (p21-Rac1),192,"21,450",5 out of 5,2004-08-31,Evidence at protein level
Q92878,RAD50_HUMAN,DNA repair protein RAD50 (hRAD50) (EC 3.6.-.-),1312,"153,892",5 out of 5,2005-02-01,Evidence at protein level
Q06609,RAD51_HUMAN,DNA repair protein RAD51 homolog 1 (HsRAD51) (hRAD51) (RAD51 homolog A),339,"36,966",5 out of 5,1994-06-01,Evidence at protein level
Q96S59,RANB9_HUMAN,Ran-binding protein 9 (RanBP9) (BPM-L) (BPM90) (Ran-binding protein M) (RanBPM) (RanBP7),729,"77,847",5 out of 5,2005-03-15,Evidence at protein level
Q9Y388,RBMX2_HUMAN,"RNA-binding motif protein, X-linked 2",322,"37,336",3 out of 5,2001-02-21,Evidence at protein level
P49792,RBP2_HUMAN,E3 SUMO-protein ligase RanBP2 (EC 6.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270),3224,"358,199",5 out of 5,1996-10-01,Evidence at protein level
P0DJD3,RBY1A_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member A1 (RNA-binding motif protein 1) (RNA-binding motif protein 2) (Y chromosome RNA recognition motif 1) (hRBMY)",496,"55,784",5 out of 5,2012-02-22,Evidence at protein level
Q9HBH5,RDH14_HUMAN,Retinol dehydrogenase 14 (EC 1.1.1.-) (Alcohol dehydrogenase PAN2) (Short chain dehydrogenase/reductase family 7C member 4),336,"36,865",5 out of 5,2003-08-29,Evidence at protein level
P61574,RE113_HUMAN,Endogenous retrovirus group K member 113 Rec protein (HERV-K113 Rec protein) (HERV-K_19p13.11 provirus Rec protein),105,"11,920",2 out of 5,2004-05-24,Evidence at protein level
P61572,REC19_HUMAN,Endogenous retrovirus group K member 19 Rec protein (HERV-K(C19) Rec protein) (HERV-K_19q11 provirus Rec protein),105,"11,828",2 out of 5,2004-05-24,Evidence at protein level
Q69383,REC6_HUMAN,Endogenous retrovirus group K member 6 Rec protein (Central open reading frame) (c-orf) (cORF) (Endogenous retrovirus K protein 6) (HERV-K(C7) Rec protein) (HERV-K(HML-2.HOM) Rec protein) (HERV-K108 Rec protein) (HERV-K_7p22.1 provirus Rec protein) (K-Rev) (Rev-like protein) (Rev/Rex homolog),105,"11,828",5 out of 5,2004-05-24,Evidence at protein level
O95072,REC8_HUMAN,Meiotic recombination protein REC8 homolog (Cohesin Rec8p),547,"62,614",5 out of 5,2004-01-16,Evidence at protein level
P62877,RBX1_HUMAN,"E3 ubiquitin-protein ligase RBX1 (EC 6.3.2.-) (Protein ZYP) (RING finger protein 75) (RING-box protein 1) (Rbx1) (Regulator of cullins 1) [Cleaved into: E3 ubiquitin-protein ligase RBX1, N-terminally processed]",108,"12,274",5 out of 5,2004-08-16,Evidence at protein level
P06400,RB_HUMAN,Retinoblastoma-associated protein (p105-Rb) (pRb) (Rb) (pp110),928,"106,159",5 out of 5,1988-01-01,Evidence at protein level
O95199,RCBT2_HUMAN,RCC1 and BTB domain-containing protein 2 (Chromosome condensation 1-like) (CHC1-L) (RCC1-like G exchanging factor) (Regulator of chromosome condensation and BTB domain-containing protein 2),551,"60,315",3 out of 5,2005-12-20,Evidence at protein level
A6NED2,RCCD1_HUMAN,RCC1 domain-containing protein 1,376,"40,079",2 out of 5,2008-06-10,Evidence at protein level
Q15293,RCN1_HUMAN,Reticulocalbin-1,331,"38,890",5 out of 5,1997-11-01,Evidence at protein level
Q14257,RCN2_HUMAN,Reticulocalbin-2 (Calcium-binding protein ERC-55) (E6-binding protein) (E6BP),317,"36,876",5 out of 5,1997-11-01,Evidence at protein level
P0DJH9,RD3L_HUMAN,Protein RD3-like (Retinal degeneration protein 3-like),198,"23,209",1 out of 5,2012-05-16,Predicted
O75452,RDH16_HUMAN,Retinol dehydrogenase 16 (EC 1.1.-.-) (Microsomal NAD(+)-dependent retinol dehydrogenase 4) (RoDH-4) (Short chain dehydrogenase/reductase family 9C member 8) (Sterol/retinol dehydrogenase),317,"35,673",5 out of 5,2007-10-23,Evidence at protein level
Q8N3Y7,RDHE2_HUMAN,Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5),309,"34,095",5 out of 5,2007-10-02,Evidence at transcript level
Q9H6H4,REEP4_HUMAN,Receptor expression-enhancing protein 4,257,"29,395",4 out of 5,2005-12-20,Evidence at protein level
P48304,REG1B_HUMAN,Lithostathine-1-beta (Pancreatic stone protein 2) (PSP-2) (Regenerating islet-derived protein 1-beta) (REG-1-beta) (Regenerating protein I beta),166,"18,665",4 out of 5,1996-02-01,Evidence at protein level
P04090,REL2_HUMAN,Prorelaxin H2 [Cleaved into: Relaxin B chain; Relaxin A chain],185,"21,043",5 out of 5,1986-11-01,Evidence at protein level
Q9H628,RERGL_HUMAN,Ras-related and estrogen-regulated growth inhibitor-like protein (RERG/Ras-like protein),205,"23,855",2 out of 5,2008-02-26,Evidence at transcript level
Q5VY80,RET1L_HUMAN,Retinoic acid early transcript 1L protein,246,"27,509",4 out of 5,2008-02-26,Evidence at protein level
P50120,RET2_HUMAN,Retinol-binding protein 2 (Cellular retinol-binding protein II) (CRBP-II),134,"15,707",4 out of 5,1996-10-01,Evidence at protein level
P15927,RFA2_HUMAN,Replication protein A 32 kDa subunit (RP-A p32) (Replication factor A protein 2) (RF-A protein 2) (Replication protein A 34 kDa subunit) (RP-A p34),270,"29,247",5 out of 5,1990-04-01,Evidence at protein level
O75678,RFPL2_HUMAN,Ret finger protein-like 2 (RING finger protein 79),378,"42,077",3 out of 5,2001-09-26,Evidence at transcript level
Q14699,RFTN1_HUMAN,Raftlin (Cell migration-inducing gene 2 protein) (Raft-linking protein),578,"63,146",5 out of 5,1997-11-01,Evidence at protein level
Q8NHY2,RFWD2_HUMAN,E3 ubiquitin-protein ligase RFWD2 (EC 2.3.2.27) (Constitutive photomorphogenesis protein 1 homolog) (hCOP1) (RING finger and WD repeat domain protein 2) (RING finger protein 200) (RING-type E3 ubiquitin transferase RFWD2),731,"80,474",5 out of 5,2004-11-23,Evidence at protein level
P22670,RFX1_HUMAN,MHC class II regulatory factor RFX1 (Enhancer factor C) (EF-C) (Regulatory factor X 1) (RFX) (Transcription factor RFX1),979,"104,758",5 out of 5,1991-08-01,Evidence at protein level
P48380,RFX3_HUMAN,Transcription factor RFX3 (Regulatory factor X 3),749,"83,530",5 out of 5,1996-02-01,Evidence at protein level
O00287,RFXAP_HUMAN,Regulatory factor X-associated protein (RFX-associated protein) (RFX DNA-binding complex 36 kDa subunit),272,"28,232",5 out of 5,1998-07-15,Evidence at protein level
Q0VAM2,RGF1B_HUMAN,Ras-GEF domain-containing family member 1B (GPI gamma-4),473,"55,359",4 out of 5,2007-08-21,Evidence at protein level
Q9NS39,RED2_HUMAN,Double-stranded RNA-specific editase B2 (EC 3.5.-.-) (RNA-dependent adenosine deaminase 3) (RNA-editing deaminase 2) (RNA-editing enzyme 2) (dsRNA adenosine deaminase B2),739,"80,621",5 out of 5,2003-07-19,Evidence at protein level
Q6NUK4,REEP3_HUMAN,Receptor expression-enhancing protein 3,255,"29,264",4 out of 5,2005-12-20,Evidence at protein level
P51606,RENBP_HUMAN,N-acylglucosamine 2-epimerase (AGE) (EC 5.1.3.8) (GlcNAc 2-epimerase) (N-acetyl-D-glucosamine 2-epimerase) (Renin-binding protein) (RnBP),427,"48,831",5 out of 5,1996-10-01,Evidence at protein level
P00797,RENI_HUMAN,Renin (EC 3.4.23.15) (Angiotensinogenase),406,"45,057",5 out of 5,1986-07-21,Evidence at protein level
Q6BDI9,REP15_HUMAN,Rab15 effector protein,236,"26,571",4 out of 5,2008-03-18,Evidence at protein level
Q8TAC1,RFESD_HUMAN,Rieske domain-containing protein,157,"17,762",2 out of 5,2008-01-15,Evidence at protein level
Q8WZ73,RFFL_HUMAN,E3 ubiquitin-protein ligase rififylin (EC 2.3.2.27) (Caspase regulator CARP2) (Caspases-8 and -10-associated RING finger protein 2) (CARP-2) (FYVE-RING finger protein Sakura) (Fring) (RING finger and FYVE-like domain-containing protein 1) (RING finger protein 189) (RING finger protein 34-like) (RING-type E3 ubiquitin transferase rififylin),363,"40,514",5 out of 5,2005-09-27,Evidence at protein level
O75154,RFIP3_HUMAN,Rab11 family-interacting protein 3 (FIP3-Rab11) (Rab11-FIP3) (Arfophilin-1) (EF hands-containing Rab-interacting protein) (Eferin) (MU-MB-17.148),756,"82,440",5 out of 5,2001-06-20,Evidence at protein level
O75679,RFPL3_HUMAN,Ret finger protein-like 3,317,"35,386",3 out of 5,2001-09-26,Evidence at protein level
Q9H4X1,RGCC_HUMAN,Regulator of cell cycle RGCC (Response gene to complement 32 protein) (RGC-32),137,"14,559",5 out of 5,2007-02-06,Evidence at protein level
Q9NZL6,RGL1_HUMAN,Ral guanine nucleotide dissociation stimulator-like 1 (RalGDS-like 1),768,"86,701",4 out of 5,2001-06-20,Evidence at protein level
Q3MIN7,RGL3_HUMAN,Ral guanine nucleotide dissociation stimulator-like 3 (RalGDS-like 3),710,"78,079",3 out of 5,2007-10-02,Evidence at protein level
Q6GYQ0,RGPA1_HUMAN,Ral GTPase-activating protein subunit alpha-1 (GAP-related-interacting partner to E12) (GRIPE) (GTPase-activating Rap/Ran-GAP domain-like 1) (Tuberin-like protein 1) (p240),2036,"229,832",5 out of 5,2004-08-16,Evidence at protein level
A6NKT7,RGPD3_HUMAN,RanBP2-like and GRIP domain-containing protein 3,1758,"197,487",2 out of 5,2008-06-10,Predicted
P57771,RGS8_HUMAN,Regulator of G-protein signaling 8 (RGS8),180,"20,917",5 out of 5,2001-02-21,Evidence at protein level
Q02094,RHAG_HUMAN,Ammonium transporter Rh type A (Erythrocyte membrane glycoprotein Rh50) (Erythrocyte plasma membrane 50 kDa glycoprotein) (Rh50A) (Rhesus blood group family type A glycoprotein) (Rh family type A glycoprotein) (Rh type A glycoprotein) (Rhesus blood group-associated ammonia channel) (Rhesus blood group-associated glycoprotein) (CD antigen CD241),409,"44,198",5 out of 5,1994-06-01,Evidence at protein level
P18577,RHCE_HUMAN,Blood group Rh(CE) polypeptide (Rh polypeptide 1) (RhPI) (Rh30A) (RhIXB) (Rhesus C/E antigens) (CD antigen CD240CE),417,"45,560",5 out of 5,1990-11-01,Evidence at protein level
Q07960,RHG01_HUMAN,Rho GTPase-activating protein 1 (CDC42 GTPase-activating protein) (GTPase-activating protein rhoGAP) (Rho-related small GTPase protein activator) (Rho-type GTPase-activating protein 1) (p50-RhoGAP),439,"50,436",5 out of 5,1998-07-15,Evidence at protein level
O43182,RHG06_HUMAN,Rho GTPase-activating protein 6 (Rho-type GTPase-activating protein 6) (Rho-type GTPase-activating protein RhoGAPX-1),974,"105,947",5 out of 5,1999-07-15,Evidence at protein level
Q96QB1,RHG07_HUMAN,Rho GTPase-activating protein 7 (Deleted in liver cancer 1 protein) (DLC-1) (HP protein) (Rho-type GTPase-activating protein 7) (START domain-containing protein 12) (StARD12) (StAR-related lipid transfer protein 12),1528,"170,591",5 out of 5,2002-11-08,Evidence at protein level
Q7Z6I6,RHG30_HUMAN,Rho GTPase-activating protein 30 (Rho-type GTPase-activating protein 30),1101,"118,582",5 out of 5,2007-03-20,Evidence at protein level
P17081,RHOQ_HUMAN,Rho-related GTP-binding protein RhoQ (Ras-like protein TC10) (Ras-like protein family member 7A),205,"22,659",5 out of 5,1990-08-01,Evidence at protein level
A6NNX1,RIAD1_HUMAN,RIIa domain-containing protein 1,92,"10,810",1 out of 5,2008-07-01,Predicted
Q4ADV7,RIC1_HUMAN,RAB6A-GEF complex partner protein 1 (Connexin-43-interacting protein of 150 kDa) (Protein RIC1 homolog),1423,"159,301",5 out of 5,2008-02-26,Evidence at protein level
Q9NPQ8,RIC8A_HUMAN,Synembryn-A (Protein Ric-8A),531,"59,710",5 out of 5,2006-05-16,Evidence at protein level
Q8WYP3,RIN2_HUMAN,Ras and Rab interactor 2 (Ras association domain family 4) (Ras inhibitor JC265) (Ras interaction/interference protein 2),895,"100,163",5 out of 5,2003-02-01,Evidence at protein level
Q6ZS11,RINL_HUMAN,Ras and Rab interactor-like protein,566,"62,466",3 out of 5,2008-02-26,Evidence at transcript level
O43353,RIPK2_HUMAN,Receptor-interacting serine/threonine-protein kinase 2 (EC 2.7.11.1) (CARD-containing interleukin-1 beta-converting enzyme-associated kinase) (CARD-containing IL-1 beta ICE-kinase) (RIP-like-interacting CLARP kinase) (Receptor-interacting protein 2) (RIP-2) (Tyrosine-protein kinase RIPK2) (EC 2.7.10.2),540,"61,195",5 out of 5,2002-05-02,Evidence at protein level
Q7LG56,RIR2B_HUMAN,Ribonucleoside-diphosphate reductase subunit M2 B (EC 1.17.4.1) (TP53-inducible ribonucleotide reductase M2 B) (p53-inducible ribonucleotide reductase small subunit 2-like protein) (p53R2),351,"40,737",5 out of 5,2006-03-21,Evidence at protein level
Q92963,RIT1_HUMAN,GTP-binding protein Rit1 (Ras-like protein expressed in many tissues) (Ras-like without CAAX protein 1),219,"25,145",5 out of 5,2003-10-31,Evidence at protein level
Q92785,REQU_HUMAN,"Zinc finger protein ubi-d4 (Apoptosis response zinc finger protein) (BRG1-associated factor 45D) (BAF45D) (D4, zinc and double PHD fingers family 2) (Protein requiem)",391,"44,155",5 out of 5,1997-11-01,Evidence at protein level
Q96A58,RERG_HUMAN,Ras-related and estrogen-regulated growth inhibitor,199,"22,608",5 out of 5,2005-12-20,Evidence at protein level
Q6H3X3,RET1G_HUMAN,Retinoic acid early transcript 1G protein (UL-16 binding protein 5) (ULBP5),334,"37,106",5 out of 5,2004-12-21,Evidence at protein level
P82980,RET5_HUMAN,Retinol-binding protein 5 (Cellular retinol-binding protein III) (CRBP-III) (HRBPiso),135,"15,931",4 out of 5,2001-07-11,Evidence at protein level
Q6NUM9,RETST_HUMAN,"All-trans-retinol 13,14-reductase (EC 1.3.99.23) (All-trans-13,14-dihydroretinol saturase) (RetSat) (PPAR-alpha-regulated and starvation-induced gene protein)",610,"66,820",4 out of 5,2006-03-07,Evidence at protein level
P07949,RET_HUMAN,Proto-oncogene tyrosine-protein kinase receptor Ret (EC 2.7.10.1) (Cadherin family member 12) (Proto-oncogene c-Ret) [Cleaved into: Soluble RET kinase fragment; Extracellular cell-membrane anchored RET cadherin 120 kDa fragment],1114,"124,319",5 out of 5,1988-08-01,Evidence at protein level
O75570,RF1M_HUMAN,"Peptide chain release factor 1, mitochondrial (MRF-1) (MtRF-1)",445,"52,306",4 out of 5,1998-12-15,Evidence at protein level
P35244,RFA3_HUMAN,Replication protein A 14 kDa subunit (RP-A p14) (Replication factor A protein 3) (RF-A protein 3),121,"13,569",5 out of 5,1994-02-01,Evidence at protein level
Q8N5W9,RFLB_HUMAN,Refilin-B (Regulator of filamin protein B) (RefilinB),214,"22,882",3 out of 5,2006-12-12,Evidence at protein level
O75677,RFPL1_HUMAN,Ret finger protein-like 1 (RING finger protein 78),317,"35,491",3 out of 5,2001-09-26,Evidence at transcript level
O15211,RGL2_HUMAN,Ral guanine nucleotide dissociation stimulator-like 2 (RalGDS-like 2) (RalGDS-like factor) (Ras-associated protein RAB2L),777,"83,549",4 out of 5,2000-05-30,Evidence at protein level
P0DJD0,RGPD1_HUMAN,RANBP2-like and GRIP domain-containing protein 1 (Ran-binding protein 2-like 6) (RanBP2-like 6) (RanBP2L6),1748,"196,662",2 out of 5,2012-01-25,Evidence at transcript level
P49796,RGS3_HUMAN,Regulator of G-protein signaling 3 (RGP3) (RGS3),1198,"132,336",5 out of 5,1996-10-01,Evidence at protein level
Q6NTF9,RHBD2_HUMAN,Rhomboid domain-containing protein 2,364,"39,202",4 out of 5,2006-10-31,Evidence at transcript level
Q02161,RHD_HUMAN,Blood group Rh(D) polypeptide (RHXIII) (Rh polypeptide 2) (RhPII) (Rhesus D antigen) (CD antigen CD240D),417,"45,211",5 out of 5,1997-11-01,Evidence at protein level
Q96D21,RHES_HUMAN,GTP-binding protein Rhes (Ras homolog enriched in striatum) (Tumor endothelial marker 2),266,"30,366",5 out of 5,2002-06-06,Evidence at protein level
A1A4S6,RHG10_HUMAN,Rho GTPase-activating protein 10 (GTPase regulator associated with focal adhesion kinase 2) (Graf-related protein 2) (Rho-type GTPase-activating protein 10),786,"89,375",5 out of 5,2007-10-02,Evidence at protein level
P62745,RHOB_HUMAN,Rho-related GTP-binding protein RhoB (Rho cDNA clone 6) (h6),196,"22,123",5 out of 5,1986-07-21,Evidence at protein level
Q96L33,RHOV_HUMAN,Rho-related GTP-binding protein RhoV (CDC42-like GTPase 2) (GTP-binding protein-like 2) (Rho GTPase-like protein ARHV) (Wnt-1 responsive Cdc42 homolog 2) (WRCH-2),236,"26,217",4 out of 5,2008-03-18,Evidence at protein level
Q9UQ26,RIMS2_HUMAN,Regulating synaptic membrane exocytosis protein 2 (Rab-3-interacting molecule 2) (RIM 2) (Rab-3-interacting protein 3),1411,"160,403",5 out of 5,2003-08-29,Evidence at protein level
P23921,RIR1_HUMAN,Ribonucleoside-diphosphate reductase large subunit (EC 1.17.4.1) (Ribonucleoside-diphosphate reductase subunit M1) (Ribonucleotide reductase large subunit),792,"90,070",5 out of 5,1992-03-01,Evidence at protein level
Q9Y3T6,R3HC1_HUMAN,R3H and coiled-coil domain-containing protein 1,440,"49,092",3 out of 5,2007-10-23,Evidence at protein level
P35241,RADI_HUMAN,Radixin,583,"68,564",5 out of 5,1994-02-01,Evidence at protein level
P61225,RAP2B_HUMAN,Ras-related protein Rap-2b,183,"20,504",5 out of 5,2004-05-10,Evidence at protein level
P62491,RB11A_HUMAN,Ras-related protein Rab-11A (Rab-11) (YL8),216,"24,394",5 out of 5,2004-07-19,Evidence at protein level
Q8WXH6,RB40A_HUMAN,Ras-related protein Rab-40A (SOCS box-containing protein RAR2A) (Protein Rar-2),277,"31,076",4 out of 5,2003-01-10,Evidence at transcript level
Q8NC74,RB8NL_HUMAN,RBBP8 N-terminal-like protein,664,"71,432",2 out of 5,2003-10-10,Evidence at transcript level
Q9Y3P9,RBGP1_HUMAN,Rab GTPase-activating protein 1 (GAP and centrosome-associated protein) (Rab6 GTPase-activating protein GAPCenA),1069,"121,737",5 out of 5,2007-08-21,Evidence at protein level
P28749,RBL1_HUMAN,Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1),1068,"120,847",5 out of 5,1992-12-01,Evidence at protein level
P49756,RBM25_HUMAN,RNA-binding protein 25 (Arg/Glu/Asp-rich protein of 120 kDa) (RED120) (Protein S164) (RNA-binding motif protein 25) (RNA-binding region-containing protein 7),843,"100,185",5 out of 5,1996-10-01,Evidence at protein level
Q96EV2,RBM33_HUMAN,RNA-binding protein 33 (Proline-rich protein 8) (RNA-binding motif protein 33),1170,"129,986",3 out of 5,2007-05-01,Evidence at protein level
Q8TBY0,RBM46_HUMAN,Probable RNA-binding protein 46 (Cancer/testis antigen 68) (CT68) (RNA-binding motif protein 46),533,"60,023",2 out of 5,2007-10-02,Evidence at transcript level
Q5RL73,RBM48_HUMAN,RNA-binding protein 48,367,"41,808",3 out of 5,2008-02-26,Evidence at transcript level
P52756,RBM5_HUMAN,RNA-binding protein 5 (Protein G15) (Putative tumor suppressor LUCA15) (RNA-binding motif protein 5) (Renal carcinoma antigen NY-REN-9),815,"92,154",5 out of 5,1996-10-01,Evidence at protein level
Q9H1K0,RBNS5_HUMAN,Rabenosyn-5 (110 kDa protein) (FYVE finger-containing Rab5 effector protein rabenosyn-5) (RAB effector RBSN) (Zinc finger FYVE domain-containing protein 20),784,"88,870",5 out of 5,2005-10-11,Evidence at protein level
A6NDE4,RBY1B_HUMAN,"RNA-binding motif protein, Y chromosome, family 1 member B",496,"55,835",4 out of 5,2008-06-10,Evidence at transcript level
Q9BWE0,REPI1_HUMAN,Replication initiator 1 (60 kDa origin-specific DNA-binding protein) (60 kDa replication initiation region protein) (ATT-binding protein) (DHFR oribeta-binding protein RIP60) (Zinc finger protein 464),567,"63,575",5 out of 5,2007-02-06,Evidence at protein level
Q8NFH8,REPS2_HUMAN,RalBP1-associated Eps domain-containing protein 2 (Partner of RalBP1) (RalBP1-interacting protein 2),660,"71,534",5 out of 5,2003-08-15,Evidence at protein level
Q9GZR2,REXO4_HUMAN,RNA exonuclease 4 (EC 3.1.-.-) (Exonuclease XPMC2) (Prevents mitotic catastrophe 2 protein homolog) (hPMC2),422,"46,672",5 out of 5,2005-07-19,Evidence at protein level
Q92546,RGP1_HUMAN,RAB6A-GEF complex partner protein 2 (Retrograde Golgi transport protein RGP1 homolog),391,"42,455",5 out of 5,1997-11-01,Evidence at protein level
P49795,RGS19_HUMAN,Regulator of G-protein signaling 19 (RGS19) (G-alpha-interacting protein) (GAIP),217,"24,636",5 out of 5,1996-10-01,Evidence at protein level
Q8NE09,RGS22_HUMAN,Regulator of G-protein signaling 22 (RGS22),1264,"147,163",4 out of 5,2007-01-09,Evidence at protein level
P41220,RGS2_HUMAN,Regulator of G-protein signaling 2 (RGS2) (Cell growth-inhibiting gene 31 protein) (G0/G1 switch regulatory protein 8),211,"24,382",5 out of 5,1995-02-01,Evidence at protein level
O75916,RGS9_HUMAN,Regulator of G-protein signaling 9 (RGS9),674,"76,966",5 out of 5,2000-05-30,Evidence at protein level
Q9Y3P4,RHBD3_HUMAN,Rhomboid domain-containing protein 3,386,"40,484",3 out of 5,2002-04-16,Evidence at transcript level
O75783,RHBL1_HUMAN,Rhomboid-related protein 1 (RRP) (EC 3.4.21.105) (Rhomboid-like protein 1),438,"48,314",4 out of 5,2002-03-05,Evidence at transcript level
P58872,RHBL3_HUMAN,Rhomboid-related protein 3 (EC 3.4.21.105) (Ventrhoid transmembrane protein),404,"45,245",4 out of 5,2002-06-20,Evidence at transcript level
Q9BYZ6,RHBT2_HUMAN,Rho-related BTB domain-containing protein 2 (Deleted in breast cancer 2 gene protein) (p83),727,"82,626",4 out of 5,2002-11-28,Evidence at protein level
P85298,RHG08_HUMAN,Rho GTPase-activating protein 8 (Rho-type GTPase-activating protein 8),464,"53,484",4 out of 5,2007-10-23,Evidence at protein level
Q53QZ3,RHG15_HUMAN,Rho GTPase-activating protein 15 (ArhGAP15) (Rho-type GTPase-activating protein 15),475,"54,544",4 out of 5,2008-02-05,Evidence at protein level
Q68EM7,RHG17_HUMAN,Rho GTPase-activating protein 17 (Rho-type GTPase-activating protein 17) (RhoGAP interacting with CIP4 homologs protein 1) (RICH-1),881,"95,437",5 out of 5,2007-03-20,Evidence at protein level
Q14CB8,RHG19_HUMAN,Rho GTPase-activating protein 19 (Rho-type GTPase-activating protein 19),494,"55,756",4 out of 5,2007-03-20,Evidence at protein level
Q7Z5H3,RHG22_HUMAN,Rho GTPase-activating protein 22 (Rho-type GTPase-activating protein 22),698,"76,779",5 out of 5,2007-03-20,Evidence at protein level
P42331,RHG25_HUMAN,Rho GTPase-activating protein 25 (Rho-type GTPase-activating protein 25),645,"73,435",4 out of 5,1995-11-01,Evidence at protein level
Q8N443,RIBC1_HUMAN,RIB43A-like with coiled-coils protein 1,379,"44,015",3 out of 5,2006-10-31,Evidence at protein level
Q7Z5B4,RIC3_HUMAN,Protein RIC-3 (Resistant to inhibitor of cholinesterase 3),369,"41,092",5 out of 5,2007-09-11,Evidence at protein level
Q5UIP0,RIF1_HUMAN,Telomere-associated protein RIF1 (Rap1-interacting factor 1 homolog),2472,"274,466",5 out of 5,2005-07-05,Evidence at protein level
O15034,RIMB2_HUMAN,RIMS-binding protein 2 (RIM-BP2),1052,"116,026",4 out of 5,2004-01-16,Evidence at protein level
Q9BQ08,RETNB_HUMAN,Resistin-like beta (Colon and small intestine-specific cysteine-rich protein) (Colon carcinoma-related gene protein) (Cysteine-rich secreted protein A12-alpha-like 1) (Cysteine-rich secreted protein FIZZ2) (RELMbeta),111,"11,730",4 out of 5,2001-09-26,Evidence at transcript level
P35249,RFC4_HUMAN,Replication factor C subunit 4 (Activator 1 37 kDa subunit) (A1 37 kDa subunit) (Activator 1 subunit 4) (Replication factor C 37 kDa subunit) (RF-C 37 kDa subunit) (RFC37),363,"39,682",5 out of 5,1994-02-01,Evidence at protein level
Q8N431,RGF1C_HUMAN,Ras-GEF domain-containing family member 1C,466,"52,870",2 out of 5,2007-08-21,Evidence at transcript level
O14924,RGS12_HUMAN,Regulator of G-protein signaling 12 (RGS12),1447,"156,357",5 out of 5,1998-12-15,Evidence at protein level
O76081,RGS20_HUMAN,Regulator of G-protein signaling 20 (RGS20) (Gz-selective GTPase-activating protein) (G(z)GAP) (Gz-GAP) (Regulator of G-protein signaling Z1) (Regulator of Gz-selective protein signaling 1),388,"43,692",5 out of 5,2001-06-20,Evidence at protein level
P49798,RGS4_HUMAN,Regulator of G-protein signaling 4 (RGP4) (RGS4),205,"23,256",5 out of 5,1996-10-01,Evidence at protein level
P49802,RGS7_HUMAN,Regulator of G-protein signaling 7 (RGS7),495,"57,668",5 out of 5,1996-10-01,Evidence at protein level
A8MT19,RHN2P_HUMAN,Putative rhophilin-2-like protein RHPN2P1 (Rhophilin-2 pseudogene 1),583,"65,945",1 out of 5,2008-06-10,Uncertain
O00212,RHOD_HUMAN,Rho-related GTP-binding protein RhoD (Rho-related protein HP1) (RhoHP1),210,"23,413",5 out of 5,1998-07-15,Evidence at protein level
Q7L0Q8,RHOU_HUMAN,Rho-related GTP-binding protein RhoU (CDC42-like GTPase 1) (GTP-binding protein-like 1) (Rho GTPase-like protein ARHU) (Ryu GTPase) (Wnt-1 responsive Cdc42 homolog 1) (WRCH-1),258,"28,218",5 out of 5,2008-03-18,Evidence at protein level
Q8TCX5,RHPN1_HUMAN,Rhophilin-1 (GTP-Rho-binding protein 1),695,"76,292",3 out of 5,2003-04-23,Evidence at protein level
Q8IUC4,RHPN2_HUMAN,Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE),686,"76,993",5 out of 5,2005-02-01,Evidence at protein level
Q5EBL4,RIPL1_HUMAN,RILP-like protein 1 (Rab-interacting lysosomal-like protein 1),403,"47,108",5 out of 5,2007-09-11,Evidence at protein level
Q96K30,RITA1_HUMAN,RBPJ-interacting and tubulin-associated protein 1 (RBPJ-interacting and tubulin-associated protein),269,"28,619",5 out of 5,2007-07-10,Evidence at protein level
Q9H902,REEP1_HUMAN,Receptor expression-enhancing protein 1 (Spastic paraplegia 31 protein),201,"22,255",5 out of 5,2005-12-20,Evidence at protein level
Q04864,REL_HUMAN,Proto-oncogene c-Rel,619,"68,520",5 out of 5,1994-06-01,Evidence at protein level
Q9H1J1,REN3A_HUMAN,Regulator of nonsense transcripts 3A (Nonsense mRNA reducing factor 3A) (Up-frameshift suppressor 3 homolog A) (hUpf3),476,"54,696",5 out of 5,2005-03-01,Evidence at protein level
Q13156,RFA4_HUMAN,Replication protein A 30 kDa subunit (RP-A p30) (Replication factor A protein 4) (RF-A protein 4),261,"28,868",5 out of 5,1997-11-01,Evidence at protein level
P35251,RFC1_HUMAN,Replication factor C subunit 1 (Activator 1 140 kDa subunit) (A1 140 kDa subunit) (Activator 1 large subunit) (Activator 1 subunit 1) (DNA-binding protein PO-GA) (Replication factor C 140 kDa subunit) (RF-C 140 kDa subunit) (RFC140) (Replication factor C large subunit),1148,"128,255",5 out of 5,1994-02-01,Evidence at protein level
P35250,RFC2_HUMAN,Replication factor C subunit 2 (Activator 1 40 kDa subunit) (A1 40 kDa subunit) (Activator 1 subunit 2) (Replication factor C 40 kDa subunit) (RF-C 40 kDa subunit) (RFC40),354,"39,157",5 out of 5,1994-02-01,Evidence at protein level
Q9Y644,RFNG_HUMAN,"Beta-1,3-N-acetylglucosaminyltransferase radical fringe (EC 2.4.1.222) (O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase)",331,"36,424",4 out of 5,2003-01-10,Evidence at transcript level
Q9NWB1,RFOX1_HUMAN,RNA binding protein fox-1 homolog 1 (Ataxin-2-binding protein 1) (Fox-1 homolog A) (Hexaribonucleotide-binding protein 1),397,"42,784",5 out of 5,2000-12-01,Evidence at protein level
Q8NET4,RGAG1_HUMAN,Retrotransposon gag domain-containing protein 1 (Tumor antigen BJ-HCC-23),1388,"144,280",2 out of 5,2006-10-31,Evidence at protein level
Q8N9B8,RGF1A_HUMAN,Ras-GEF domain-containing family member 1A,481,"54,556",3 out of 5,2007-08-21,Evidence at transcript level
Q6NW40,RGMB_HUMAN,RGM domain family member B (DRG11-responsive axonal guidance and outgrowth of neurite) (DRAGON),437,"47,547",5 out of 5,2004-08-16,Evidence at protein level
Q6ZVN8,RGMC_HUMAN,Hemojuvelin (Hemochromatosis type 2 protein) (RGM domain family member C),426,"45,080",5 out of 5,2004-08-16,Evidence at protein level
Q15493,RGN_HUMAN,Regucalcin (RC) (Gluconolactonase) (GNL) (EC 3.1.1.17) (Senescence marker protein 30) (SMP-30),299,"33,253",5 out of 5,1998-07-15,Evidence at protein level
Q99666,RGPD5_HUMAN,RANBP2-like and GRIP domain-containing protein 5/6 (Ran-binding protein 2-like 1/2) (RanBP2-like 1/2) (RanBP2L1) (RanBP2L2) (Sperm membrane protein BS-63),1765,"198,924",4 out of 5,2005-12-06,Evidence at protein level
Q13972,RGRF1_HUMAN,Ras-specific guanine nucleotide-releasing factor 1 (Ras-GRF1) (Guanine nucleotide-releasing protein) (GNRP) (Ras-specific nucleotide exchange factor CDC25),1273,"145,234",5 out of 5,2001-02-21,Evidence at protein level
P47804,RGR_HUMAN,RPE-retinal G protein-coupled receptor,291,"31,874",5 out of 5,1996-02-01,Evidence at protein level
O43566,RGS14_HUMAN,Regulator of G-protein signaling 14 (RGS14),566,"61,447",5 out of 5,1998-12-15,Evidence at protein level
Q9UGC6,RGS17_HUMAN,Regulator of G-protein signaling 17 (RGS17),210,"24,359",5 out of 5,2001-08-14,Evidence at protein level
Q9BWJ2,RHAS1_HUMAN,Putative uncharacterized protein encoded by RHPN1-AS1 (RHPN1 antisense RNA 1) (RHPN1 antisense gene protein 1),59,"6,658",2 out of 5,2007-01-09,Uncertain
Q15382,RHEB_HUMAN,GTP-binding protein Rheb (Ras homolog enriched in brain),184,"20,497",5 out of 5,2000-05-30,Evidence at protein level
Q9BRR9,RHG09_HUMAN,Rho GTPase-activating protein 9 (Rho-type GTPase-activating protein 9),750,"83,260",5 out of 5,2004-05-10,Evidence at protein level
Q8N392,RHG18_HUMAN,Rho GTPase-activating protein 18 (MacGAP) (Rho-type GTPase-activating protein 18),663,"74,977",5 out of 5,2006-07-11,Evidence at protein level
Q2M1Z3,RHG31_HUMAN,Rho GTPase-activating protein 31 (Cdc42 GTPase-activating protein),1444,"156,985",5 out of 5,2008-02-26,Evidence at protein level
A7KAX9,RHG32_HUMAN,Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP),2087,"230,529",5 out of 5,2008-07-22,Evidence at protein level
Q9NRY4,RHG35_HUMAN,Rho GTPase-activating protein 35 (Glucocorticoid receptor DNA-binding factor 1) (Glucocorticoid receptor repression factor 1) (GRF-1) (Rho GAP p190A) (p190-A),1499,"170,514",5 out of 5,2003-04-04,Evidence at protein level
Q17R89,RHG44_HUMAN,Rho GTPase-activating protein 44 (NPC-A-10) (Rho-type GTPase-activating protein RICH2) (RhoGAP interacting with CIP4 homologs protein 2) (RICH-2),818,"89,247",5 out of 5,2007-03-20,Evidence at protein level
Q6P4F7,RHGBA_HUMAN,Rho GTPase-activating protein 11A (Rho-type GTPase-activating protein 11A),1023,"113,866",3 out of 5,2006-12-12,Evidence at protein level
Q8NHV9,RHXF1_HUMAN,"Rhox homeobox family member 1 (Ovary-, testis- and epididymis-expressed gene protein) (Paired-like homeobox protein PEPP-1)",184,"20,542",5 out of 5,2003-10-03,Evidence at transcript level
Q86UA6,RIP_HUMAN,RPA-interacting protein (hRIP),219,"24,784",5 out of 5,2005-12-06,Evidence at protein level
P31350,RIR2_HUMAN,Ribonucleoside-diphosphate reductase subunit M2 (EC 1.17.4.1) (Ribonucleotide reductase small chain) (Ribonucleotide reductase small subunit),389,"44,878",5 out of 5,1993-07-01,Evidence at protein level
P62906,RL10A_HUMAN,60S ribosomal protein L10a (CSA-19) (Large ribosomal subunit protein uL1) (Neural precursor cell expressed developmentally down-regulated protein 6) (NEDD-6),217,"24,831",5 out of 5,2004-08-31,Evidence at protein level
P27635,RL10_HUMAN,60S ribosomal protein L10 (Laminin receptor homolog) (Large ribosomal subunit protein uL16) (Protein QM) (Tumor suppressor QM),214,"24,604",5 out of 5,1992-08-01,Evidence at protein level
O95294,RASL1_HUMAN,RasGAP-activating-like protein 1 (RAS protein activator like 1) (Ras GTPase-activating-like protein),804,"90,016",5 out of 5,2001-05-04,Evidence at protein level
P01111,RASN_HUMAN,GTPase NRas (Transforming protein N-Ras),189,"21,229",5 out of 5,1986-07-21,Evidence at protein level
Q9H082,RB33B_HUMAN,Ras-related protein Rab-33B,229,"25,718",5 out of 5,2001-07-11,Evidence at protein level
Q12829,RB40B_HUMAN,Ras-related protein Rab-40B (SOCS box-containing protein RAR) (Protein Rar),278,"30,956",4 out of 5,2003-01-10,Evidence at transcript level
Q16576,RBBP7_HUMAN,Histone-binding protein RBBP7 (Histone acetyltransferase type B subunit 2) (Nucleosome-remodeling factor subunit RBAP46) (Retinoblastoma-binding protein 7) (RBBP-7) (Retinoblastoma-binding protein p46),425,"47,820",5 out of 5,1997-11-01,Evidence at protein level
Q5T8P6,RBM26_HUMAN,RNA-binding protein 26 (CTCL tumor antigen se70-2) (RNA-binding motif protein 26),1007,"113,597",4 out of 5,2007-01-23,Evidence at protein level
P98179,RBM3_HUMAN,RNA-binding protein 3 (RNA-binding motif protein 3) (RNPL),157,"17,170",5 out of 5,1996-10-01,Evidence at protein level
Q6ZSC3,RBM43_HUMAN,RNA-binding protein 43 (RNA-binding motif protein 43),357,"40,666",2 out of 5,2006-12-12,Evidence at transcript level
Q9BQ04,RBM4B_HUMAN,RNA-binding protein 4B (RNA-binding motif protein 30) (RNA-binding motif protein 4B) (RNA-binding protein 30),359,"40,150",5 out of 5,2005-04-12,Evidence at protein level
Q9BWF3,RBM4_HUMAN,RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a),364,"40,314",5 out of 5,2005-04-12,Evidence at protein level
Q6ZRY4,RBPS2_HUMAN,RNA-binding protein with multiple splicing 2,209,"22,497",5 out of 5,2007-02-06,Evidence at protein level
Q9UBF6,RBX2_HUMAN,RING-box protein 2 (Rbx2) (CKII beta-binding protein 1) (CKBBP1) (RING finger protein 7) (Regulator of cullins 2) (Sensitive to apoptosis gene protein),113,"12,683",5 out of 5,2003-10-03,Evidence at protein level
Q14206,RCAN2_HUMAN,Calcipressin-2 (Down syndrome candidate region 1-like 1) (Myocyte-enriched calcineurin-interacting protein 2) (MCIP2) (Regulator of calcineurin 2) (Thyroid hormone-responsive protein ZAKI-4),197,"21,997",4 out of 5,2000-05-30,Evidence at transcript level
Q9P258,RCC2_HUMAN,Protein RCC2 (RCC1-like protein TD-60) (Telophase disk protein of 60 kDa),522,"56,085",5 out of 5,2005-07-19,Evidence at protein level
Q92600,RCD1_HUMAN,Cell differentiation protein RCD1 homolog (Rcd-1) (CCR4-NOT transcription complex subunit 9),299,"33,631",5 out of 5,2008-04-08,Evidence at protein level
Q9UKL0,RCOR1_HUMAN,REST corepressor 1 (Protein CoREST),485,"53,327",5 out of 5,2006-03-07,Evidence at protein level
Q9UBZ9,REV1_HUMAN,DNA repair protein REV1 (EC 2.7.7.-) (Alpha integrin-binding protein 80) (AIBP80) (Rev1-like terminal deoxycytidyl transferase),1251,"138,248",5 out of 5,2005-02-15,Evidence at protein level
P40937,RFC5_HUMAN,Replication factor C subunit 5 (Activator 1 36 kDa subunit) (A1 36 kDa subunit) (Activator 1 subunit 5) (Replication factor C 36 kDa subunit) (RF-C 36 kDa subunit) (RFC36),340,"38,497",5 out of 5,1995-02-01,Evidence at protein level
P48378,RFX2_HUMAN,DNA-binding protein RFX2 (Regulatory factor X 2),723,"79,987",5 out of 5,1996-02-01,Evidence at protein level
Q2KHR2,RFX7_HUMAN,DNA-binding protein RFX7 (Regulatory factor X 7) (Regulatory factor X domain-containing protein 2),1363,"146,896",4 out of 5,2008-07-01,Evidence at protein level
Q2PPJ7,RGPA2_HUMAN,Ral GTPase-activating protein subunit alpha-2 (250 kDa substrate of Akt) (AS250) (p220),1873,"210,770",5 out of 5,2007-05-15,Evidence at protein level
O14715,RGPD8_HUMAN,RANBP2-like and GRIP domain-containing protein 8 (Ran-binding protein 2-like 3) (RanBP2-like 3) (RanBP2L3),1765,"198,993",3 out of 5,2005-12-06,Evidence at protein level
O43665,RGS10_HUMAN,Regulator of G-protein signaling 10 (RGS10),173,"20,236",5 out of 5,1998-12-15,Evidence at protein level
Q6PJF5,RHDF2_HUMAN,Inactive rhomboid protein 2 (iRhom2) (Rhomboid 5 homolog 2) (Rhomboid family member 2) (Rhomboid veinlet-like protein 5) (Rhomboid veinlet-like protein 6),856,"96,686",5 out of 5,2008-07-01,Evidence at protein level
Q8IWW6,RHG12_HUMAN,Rho GTPase-activating protein 12 (Rho-type GTPase-activating protein 12),846,"96,254",3 out of 5,2004-05-10,Evidence at protein level
Q9P227,RHG23_HUMAN,Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23),1491,"162,192",3 out of 5,2007-03-20,Evidence at protein level
Q9UNA1,RHG26_HUMAN,Rho GTPase-activating protein 26 (GTPase regulator associated with focal adhesion kinase) (Oligophrenin-1-like protein) (Rho-type GTPase-activating protein 26),814,"92,235",5 out of 5,2002-07-11,Evidence at protein level
Q6ZRI8,RHG36_HUMAN,Rho GTPase-activating protein 36,547,"61,664",3 out of 5,2006-10-31,Evidence at transcript level
Q9HBH0,RHOF_HUMAN,Rho-related GTP-binding protein RhoF (Rho family GTPase Rif) (Rho in filopodia),211,"23,625",5 out of 5,2001-04-27,Evidence at protein level
P84095,RHOG_HUMAN,Rho-related GTP-binding protein RhoG,191,"21,309",5 out of 5,2004-08-16,Evidence at protein level
Q9H4E5,RHOJ_HUMAN,Rho-related GTP-binding protein RhoJ (Ras-like protein family member 7B) (Tc10-like GTP-binding protein),214,"23,821",5 out of 5,2002-10-25,Evidence at protein level
Q13123,RED_HUMAN,Protein Red (Cytokine IK) (IK factor) (Protein RER),557,"65,602",5 out of 5,1999-07-15,Evidence at protein level
Q9BRK0,REEP2_HUMAN,Receptor expression-enhancing protein 2,252,"28,261",5 out of 5,2005-12-20,Evidence at protein level
Q00765,REEP5_HUMAN,Receptor expression-enhancing protein 5 (Polyposis locus protein 1) (Protein TB2),189,"21,493",4 out of 5,1993-04-01,Evidence at protein level
Q01201,RELB_HUMAN,Transcription factor RelB (I-Rel),579,"62,134",5 out of 5,1993-10-01,Evidence at protein level
O15258,RER1_HUMAN,Protein RER1,196,"22,958",3 out of 5,2000-05-30,Evidence at protein level
Q5W5W9,RES18_HUMAN,Regulated endocrine-specific protein 18 [Cleaved into: Regulated endocrine-specific protein 18; Triskadecapeptide],173,"19,021",3 out of 5,2008-05-20,Evidence at transcript level
P09455,RET1_HUMAN,Retinol-binding protein 1 (Cellular retinol-binding protein) (CRBP) (Cellular retinol-binding protein I) (CRBP-I),135,"15,850",5 out of 5,1989-07-01,Evidence at protein level
P27694,RFA1_HUMAN,"Replication protein A 70 kDa DNA-binding subunit (RP-A p70) (Replication factor A protein 1) (RF-A protein 1) (Single-stranded DNA-binding protein) [Cleaved into: Replication protein A 70 kDa DNA-binding subunit, N-terminally processed]",616,"68,138",5 out of 5,1992-08-01,Evidence at protein level
F8VTS6,RFAL1_HUMAN,Ret finger protein-like 4A-like protein 1,287,"32,249",2 out of 5,2013-05-29,Evidence at transcript level
Q7L804,RFIP2_HUMAN,Rab11 family-interacting protein 2 (Rab11-FIP2) (NRip11),512,"58,279",5 out of 5,2005-05-10,Evidence at protein level
Q86YS3,RFIP4_HUMAN,Rab11 family-interacting protein 4 (FIP4-Rab11) (Rab11-FIP4) (Arfophilin-2),637,"71,928",5 out of 5,2005-05-10,Evidence at protein level
Q96AA3,RFT1_HUMAN,Protein RFT1 homolog,541,"60,335",3 out of 5,2007-11-13,Evidence at protein level
Q52LD8,RFTN2_HUMAN,Raftlin-2 (Raft-linking protein 2),501,"55,922",3 out of 5,2005-08-30,Evidence at transcript level
Q6PCD5,RFWD3_HUMAN,E3 ubiquitin-protein ligase RFWD3 (EC 2.3.2.27) (RING finger and WD repeat domain-containing protein 3) (RING finger protein 201) (RING-type E3 ubiquitin transferase RFWD3),774,"85,094",5 out of 5,2007-02-20,Evidence at protein level
Q6ZV50,RFX8_HUMAN,DNA-binding protein RFX8 (Regulatory factor X 8),586,"66,266",3 out of 5,2008-03-18,Evidence at transcript level
Q86X27,RGPS2_HUMAN,Ras-specific guanine nucleotide-releasing factor RalGPS2 (Ral GEF with PH domain and SH3-binding motif 2) (RalA exchange factor RalGPS2),583,"65,167",4 out of 5,2008-02-26,Evidence at protein level
O14827,RGRF2_HUMAN,Ras-specific guanine nucleotide-releasing factor 2 (Ras-GRF2) (Ras guanine nucleotide exchange factor 2),1237,"140,764",5 out of 5,2007-12-04,Evidence at protein level
O94810,RGS11_HUMAN,Regulator of G-protein signaling 11 (RGS11),467,"52,946",4 out of 5,1999-07-15,Evidence at protein level
Q9NX52,RHBL2_HUMAN,"Rhomboid-related protein 2 (RRP2) (EC 3.4.21.105) (Rhomboid-like protein 2) [Cleaved into: Rhomboid-related protein 2, N-terminal fragment (NTF); Rhomboid-related protein 2, C-terminal fragment (CTF)]",303,"34,021",5 out of 5,2002-03-05,Evidence at protein level
Q8TEB9,RHBL4_HUMAN,Rhomboid-related protein 4 (RRP4) (EC 3.4.21.105) (Rhomboid domain-containing protein 1) (Rhomboid-like protein 4),315,"35,823",5 out of 5,2006-10-31,Evidence at protein level
O94955,RHBT3_HUMAN,Rho-related BTB domain-containing protein 3 (EC 3.6.1.-),611,"69,413",5 out of 5,2002-11-28,Evidence at protein level
Q13017,RHG05_HUMAN,Rho GTPase-activating protein 5 (Rho-type GTPase-activating protein 5) (p190-B),1502,"172,460",5 out of 5,2003-02-28,Evidence at protein level
Q9P2F6,RHG20_HUMAN,Rho GTPase-activating protein 20 (Rho-type GTPase-activating protein 20),1191,"132,608",5 out of 5,2007-04-03,Evidence at protein level
Q6ZUM4,RHG27_HUMAN,Rho GTPase-activating protein 27 (CIN85-associated multi-domain-containing Rho GTPase-activating protein 1) (Rho-type GTPase-activating protein 27) (SH3 domain-containing protein 20),889,"98,396",5 out of 5,2008-02-05,Evidence at protein level
Q52LW3,RHG29_HUMAN,Rho GTPase-activating protein 29 (PTPL1-associated RhoGAP protein 1) (Rho-type GTPase-activating protein 29),1261,"142,064",5 out of 5,2008-02-05,Evidence at protein level
O14559,RHG33_HUMAN,Rho GTPase-activating protein 33 (Rho-type GTPase-activating protein 33) (Sorting nexin-26) (Tc10/CDC42 GTPase-activating protein),1287,"137,213",5 out of 5,2002-03-27,Evidence at protein level
Q5TG30,RHG40_HUMAN,Rho GTPase-activating protein 40 (Rho-type GTPase-activating protein 40),622,"68,908",3 out of 5,2008-04-29,Inferred from homology
A6NI28,RHG42_HUMAN,Rho GTPase-activating protein 42 (Rho GTPase-activating protein 10-like) (Rho-type GTPase-activating protein 42),874,"98,569",3 out of 5,2008-07-01,Evidence at protein level
P61586,RHOA_HUMAN,Transforming protein RhoA (Rho cDNA clone 12) (h12),193,"21,768",5 out of 5,1988-01-01,Evidence at protein level
Q9BQY4,RHXF2_HUMAN,Rhox homeobox family member 2 (Paired-like homeobox protein PEPP-2) (Testis homeobox gene 1),288,"31,692",5 out of 5,2003-10-03,Evidence at protein level
Q969G6,RIFK_HUMAN,Riboflavin kinase (EC 2.7.1.26) (ATP:riboflavin 5'-phosphotransferase) (Flavokinase),155,"17,623",5 out of 5,2003-10-03,Evidence at protein level
Q6VN20,RBP10_HUMAN,Ran-binding protein 10 (RanBP10),620,"67,257",4 out of 5,2007-10-02,Evidence at protein level
P25791,RBTN2_HUMAN,Rhombotin-2 (Cysteine-rich protein TTG-2) (LIM domain only protein 2) (LMO-2) (T-cell translocation protein 2),158,"18,358",5 out of 5,1992-05-01,Evidence at protein level
Q9UKA8,RCAN3_HUMAN,Calcipressin-3 (Down syndrome candidate region 1-like protein 2) (Myocyte-enriched calcineurin-interacting protein 3) (MCIP3) (Regulator of calcineurin 3),241,"27,492",4 out of 5,2001-08-14,Evidence at protein level
Q96D15,RCN3_HUMAN,Reticulocalbin-3 (EF-hand calcium-binding protein RLP49),328,"37,493",3 out of 5,2003-04-30,Evidence at protein level
P61576,REC04_HUMAN,Endogenous retrovirus group K member 104 Rec protein (HERV-K104 Rec protein) (HERV-K_5q13.3 provirus Rec protein),105,"11,735",2 out of 5,2004-05-24,Evidence at protein level
O94762,RECQ5_HUMAN,"ATP-dependent DNA helicase Q5 (EC 3.6.4.12) (DNA helicase, RecQ-like type 5) (RecQ5) (RecQ protein-like 5)",991,"108,858",5 out of 5,2000-05-30,Evidence at protein level
Q06141,REG3A_HUMAN,Regenerating islet-derived protein 3-alpha (REG-3-alpha) (Hepatointestinal pancreatic protein) (HIP/PAP) (Human proislet peptide) (Pancreatitis-associated protein 1) (Regenerating islet-derived protein III-alpha) (Reg III-alpha) [Cleaved into: Regenerating islet-derived protein 3-alpha 16.5 kDa form; Regenerating islet-derived protein 3-alpha 15 kDa form],175,"19,395",5 out of 5,1994-02-01,Evidence at protein level
P04808,REL1_HUMAN,Prorelaxin H1 [Cleaved into: Relaxin B chain; Relaxin A chain],185,"21,146",4 out of 5,1987-08-13,Evidence at transcript level
O75628,REM1_HUMAN,GTP-binding protein REM 1 (GTPase-regulating endothelial cell sprouting) (Rad and Gem-like GTP-binding protein 1),298,"32,947",4 out of 5,2003-11-07,Evidence at protein level
P0C7P2,RFL3S_HUMAN,Putative protein RFPL3S (RFPL3 antisense RNA 1) (RFPL3 antisense gene protein 1) (Ret finger protein-like 3 antisense gene protein),107,"11,739",2 out of 5,2008-06-10,Evidence at transcript level
P48382,RFX5_HUMAN,DNA-binding protein RFX5 (Regulatory factor X 5),616,"65,323",5 out of 5,1996-02-01,Evidence at protein level
O14593,RFXK_HUMAN,DNA-binding protein RFXANK (Ankyrin repeat family A protein 1) (Regulatory factor X subunit B) (RFX-B) (Regulatory factor X-associated ankyrin-containing protein),260,"28,102",5 out of 5,1999-07-15,Evidence at protein level
Q9H0H5,RGAP1_HUMAN,Rac GTPase-activating protein 1 (Male germ cell RacGap) (MgcRacGAP) (Protein CYK4 homolog) (CYK4) (HsCYK-4),632,"71,027",5 out of 5,2006-03-21,Evidence at protein level
Q8IZJ4,RGDSR_HUMAN,Ral-GDS-related protein (hRGR) (Ral guanine nucleotide dissociation stimulator-like 4) (RalGDS-like 4),473,"52,346",3 out of 5,2003-08-22,Evidence at transcript level
Q9BSD3,RHNO1_HUMAN,"RAD9, HUS1, RAD1-interacting nuclear orphan protein 1 (RAD9, RAD1, HUS1-interacting nuclear orphan protein)",238,"26,709",5 out of 5,2006-12-12,Evidence at protein level
Q96NA2,RILP_HUMAN,Rab-interacting lysosomal protein,401,"44,200",5 out of 5,2005-11-08,Evidence at protein level
Q9UFD9,RIM3A_HUMAN,RIMS-binding protein 3A (RIM-BP3.A) (RIMS-binding protein 3.1) (RIM-BP3.1),1639,"180,717",5 out of 5,2006-10-31,Evidence at protein level
O95153,RIMB1_HUMAN,Peripheral-type benzodiazepine receptor-associated protein 1 (PRAX-1) (Peripheral benzodiazepine receptor-interacting protein) (PBR-IP) (RIMS-binding protein 1) (RIM-BP1) (TSPO-associated protein 1),1857,"200,051",5 out of 5,2004-01-16,Evidence at protein level
P18077,RL35A_HUMAN,60S ribosomal protein L35a (Cell growth-inhibiting gene 33 protein) (Large ribosomal subunit protein eL33),110,"12,538",5 out of 5,1990-11-01,Evidence at protein level
Q6DKI1,RL7L_HUMAN,60S ribosomal protein L7-like 1 (Large ribosomal subunit protein uL30-like 1),246,"28,661",3 out of 5,2004-09-27,Evidence at protein level
Q8NHW5,RLA0L_HUMAN,60S acidic ribosomal protein P0-like (Large ribosomal subunit protein uL10-like),317,"34,364",2 out of 5,2008-09-02,Uncertain
Q13129,RLF_HUMAN,Zinc finger protein Rlf (Rearranged L-myc fusion gene protein) (Zn-15-related protein),1914,"217,953",5 out of 5,2002-10-10,Evidence at protein level
P83881,RL36A_HUMAN,60S ribosomal protein L36a (60S ribosomal protein L44) (Cell growth-inhibiting gene 15 protein) (Cell migration-inducing gene 6 protein) (Large ribosomal subunit protein eL42),106,"12,441",5 out of 5,2004-05-10,Evidence at protein level
A6NKH3,RL37L_HUMAN,Putative 60S ribosomal protein L37a-like protein (Ribosomal protein L37a pseudogene 8),93,"10,583",2 out of 5,2008-04-08,Uncertain
Q96EH5,RL39L_HUMAN,60S ribosomal protein L39-like (60S ribosomal protein L39-2) (Large ribosomal subunit protein eL39-like),51,"6,293",2 out of 5,2003-03-28,Evidence at protein level
Q8TDU9,RL3R2_HUMAN,Relaxin-3 receptor 2 (RLN3 receptor 2) (G-protein coupled receptor 100) (G-protein coupled receptor GPCR142) (Insulin-like peptide INSL5 receptor) (Relaxin family peptide receptor 4),374,"41,141",4 out of 5,2003-11-07,Evidence at protein level
P36578,RL4_HUMAN,60S ribosomal protein L4 (60S ribosomal protein L1) (Large ribosomal subunit protein uL4),427,"47,697",5 out of 5,1994-06-01,Evidence at protein level
Q9BYD2,RM09_HUMAN,"39S ribosomal protein L9, mitochondrial (L9mt) (MRP-L9) (Mitochondrial large ribosomal subunit protein bL9m)",267,"30,243",4 out of 5,2001-12-13,Evidence at protein level
Q9Y3B7,RM11_HUMAN,"39S ribosomal protein L11, mitochondrial (L11mt) (MRP-L11) (Mitochondrial large ribosomal subunit protein uL11m)",192,"20,683",5 out of 5,2002-07-26,Evidence at protein level
Q9NWU5,RM22_HUMAN,"39S ribosomal protein L22, mitochondrial (L22mt) (MRP-L22) (39S ribosomal protein L25, mitochondrial) (L25mt) (MRP-L25) (Mitochondrial large ribosomal subunit protein uL22m)",206,"23,641",5 out of 5,2006-11-28,Evidence at protein level
Q96A35,RM24_HUMAN,"39S ribosomal protein L24, mitochondrial (L24mt) (MRP-L24) (Mitochondrial large ribosomal subunit protein uL24m)",216,"24,915",4 out of 5,2007-01-09,Evidence at protein level
P62424,RL7A_HUMAN,60S ribosomal protein L7a (Large ribosomal subunit protein eL8) (PLA-X polypeptide) (Surfeit locus protein 3),266,"29,996",5 out of 5,2004-07-05,Evidence at protein level
P18124,RL7_HUMAN,60S ribosomal protein L7 (Large ribosomal subunit protein uL30),248,"29,226",5 out of 5,1990-11-01,Evidence at protein level
P09001,RM03_HUMAN,"39S ribosomal protein L3, mitochondrial (L3mt) (MRP-L3) (Mitochondrial large ribosomal subunit protein uL3m)",348,"38,633",4 out of 5,1988-11-01,Evidence at protein level
Q96DB5,RMD1_HUMAN,Regulator of microtubule dynamics protein 1 (RMD-1) (hRMD-1) (Protein FAM82B),314,"35,808",4 out of 5,2005-08-16,Evidence at protein level
Q9H871,RMD5A_HUMAN,Protein RMD5 homolog A,391,"43,993",2 out of 5,2007-01-23,Evidence at protein level
Q96EQ8,RN125_HUMAN,E3 ubiquitin-protein ligase RNF125 (EC 2.3.2.27) (RING finger protein 125) (T-cell RING activation protein 1) (TRAC-1),232,"26,454",5 out of 5,2005-08-30,Evidence at protein level
Q9ULK6,RN150_HUMAN,RING finger protein 150,438,"48,072",3 out of 5,2007-03-20,Evidence at transcript level
Q6ZRF8,RN207_HUMAN,RING finger protein 207,634,"70,861",5 out of 5,2007-09-11,Evidence at protein level
Q9Y6U7,RN215_HUMAN,RING finger protein 215,377,"41,101",2 out of 5,2007-05-15,Predicted
A6NCQ9,RN222_HUMAN,RING finger protein 222,220,"23,767",2 out of 5,2008-04-08,Predicted
P10153,RNAS2_HUMAN,Non-secretory ribonuclease (EC 3.1.27.5) (Eosinophil-derived neurotoxin) (RNase UpI-2) (Ribonuclease 2) (RNase 2) (Ribonuclease US),161,"18,354",5 out of 5,1989-07-01,Evidence at protein level
Q86VV4,RNB3L_HUMAN,Ran-binding protein 3-like,465,"52,211",3 out of 5,2007-12-04,Evidence at transcript level
Q96TC7,RMD3_HUMAN,Regulator of microtubule dynamics protein 3 (RMD-3) (hRMD-3) (Cerebral protein 10) (Protein FAM82A2) (Protein FAM82C) (Protein tyrosine phosphatase-interacting protein 51) (TCPTP-interacting protein 51),470,"52,118",5 out of 5,2007-05-15,Evidence at protein level
Q9NWS8,RMND1_HUMAN,Required for meiotic nuclear division protein 1 homolog,449,"51,604",5 out of 5,2006-04-04,Evidence at protein level
O94763,RMP_HUMAN,Unconventional prefoldin RPB5 interactor 1 (Protein NNX3) (Protein phosphatase 1 regulatory subunit 19) (RNA polymerase II subunit 5-mediating protein) (RPB5-mediating protein),535,"59,832",5 out of 5,2002-03-27,Evidence at protein level
O00237,RN103_HUMAN,E3 ubiquitin-protein ligase RNF103 (EC 2.3.2.27) (KF-1) (hKF-1) (RING finger protein 103) (RING-type E3 ubiquitin transferase RNF103) (Zinc finger protein 103 homolog) (Zfp-103),685,"79,405",5 out of 5,2004-08-31,Evidence at protein level
Q8TEB7,RN128_HUMAN,E3 ubiquitin-protein ligase RNF128 (EC 2.3.2.27) (Gene related to anergy in lymphocytes protein) (GRAIL) (RING finger protein 128) (RING-type E3 ubiquitin transferase RNF128),428,"46,521",5 out of 5,2006-11-28,Evidence at protein level
Q9H6Y7,RN167_HUMAN,E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167) (RING-type E3 ubiquitin transferase RNF167) (RING105),350,"38,299",5 out of 5,2006-07-11,Evidence at protein level
Q8N4F7,RN175_HUMAN,RING finger protein 175,328,"38,266",3 out of 5,2006-07-11,Evidence at protein level
O43567,RNF13_HUMAN,E3 ubiquitin-protein ligase RNF13 (EC 2.3.2.27) (RING finger protein 13) (RING-type E3 ubiquitin transferase RNF13),381,"42,814",5 out of 5,2002-06-06,Evidence at protein level
Q96EP0,RNF31_HUMAN,E3 ubiquitin-protein ligase RNF31 (EC 2.3.2.27) (HOIL-1-interacting protein) (HOIP) (RING finger protein 31) (RING-type E3 ubiquitin transferase RNF31) (Zinc in-between-RING-finger ubiquitin-associated domain protein),1072,"119,652",5 out of 5,2004-03-15,Evidence at protein level
O60930,RNH1_HUMAN,Ribonuclease H1 (RNase H1) (EC 3.1.26.4) (Ribonuclease H type II),286,"32,064",5 out of 5,2001-04-27,Evidence at protein level
Q9HAU8,RNPL1_HUMAN,Aminopeptidase RNPEPL1 (EC 3.4.11.-) (Arginyl aminopeptidase-like 1) (Methionyl aminopeptidase) (EC 3.4.11.18),725,"80,000",5 out of 5,2002-07-11,Evidence at protein level
Q13151,ROA0_HUMAN,Heterogeneous nuclear ribonucleoprotein A0 (hnRNP A0),305,"30,841",5 out of 5,2000-05-30,Evidence at protein level
P51991,ROA3_HUMAN,Heterogeneous nuclear ribonucleoprotein A3 (hnRNP A3),378,"39,595",5 out of 5,1996-10-01,Evidence at protein level
Q8N5L8,RP25L_HUMAN,Ribonuclease P protein subunit p25-like protein (RNase P protein subunit-like p25) (Rpp25-like protein),163,"17,631",3 out of 5,2007-01-09,Evidence at protein level
Q9H9Y6,RPA2_HUMAN,DNA-directed RNA polymerase I subunit RPA2 (RNA polymerase I subunit 2) (EC 2.7.7.6) (DNA-directed RNA polymerase I 135 kDa polypeptide) (RPA135),1135,"128,229",5 out of 5,2001-05-04,Evidence at protein level
P19388,RPAB1_HUMAN,"DNA-directed RNA polymerases I, II, and III subunit RPABC1 (RNA polymerases I, II, and III subunit ABC1) (DNA-directed RNA polymerase II 23 kDa polypeptide) (DNA-directed RNA polymerase II subunit E) (RPB5 homolog) (XAP4)",210,"24,551",5 out of 5,1990-11-01,Evidence at protein level
Q8IXW5,RPAP2_HUMAN,Putative RNA polymerase II subunit B1 CTD phosphatase RPAP2 (EC 3.1.3.16) (RNA polymerase II-associated protein 2),612,"69,509",5 out of 5,2006-10-03,Evidence at protein level
Q02878,RL6_HUMAN,60S ribosomal protein L6 (Large ribosomal subunit protein eL6) (Neoplasm-related protein C140) (Tax-responsive enhancer element-binding protein 107) (TaxREB107),288,"32,728",5 out of 5,1993-07-01,Evidence at protein level
P05388,RLA0_HUMAN,60S acidic ribosomal protein P0 (60S ribosomal protein L10E) (Large ribosomal subunit protein uL10),317,"34,274",5 out of 5,1988-11-01,Evidence at protein level
Q9NYK5,RM39_HUMAN,"39S ribosomal protein L39, mitochondrial (L39mt) (MRP-L39) (39S ribosomal protein L5, mitochondrial) (L5mt) (MRP-L5) (Mitochondrial large ribosomal subunit protein mL39)",338,"38,712",5 out of 5,2001-01-11,Evidence at protein level
Q8N983,RM43_HUMAN,"39S ribosomal protein L43, mitochondrial (L43mt) (MRP-L43) (Mitochondrial large ribosomal subunit protein mL43) (Mitochondrial ribosomal protein bMRP36a)",215,"23,431",5 out of 5,2004-07-19,Evidence at protein level
Q9HD33,RM47_HUMAN,"39S ribosomal protein L47, mitochondrial (L47mt) (MRP-L47) (Mitochondrial large ribosomal subunit protein uL29m) (Nasopharyngeal carcinoma metastasis-related protein 1)",250,"29,450",5 out of 5,2004-04-26,Evidence at protein level
Q13405,RM49_HUMAN,"39S ribosomal protein L49, mitochondrial (L49mt) (MRP-L49) (Mitochondrial large ribosomal subunit protein mL49) (Neighbor of FAU) (NOF) (Protein NOF1)",166,"19,198",4 out of 5,1999-07-15,Evidence at protein level
Q7Z7F7,RM55_HUMAN,"39S ribosomal protein L55, mitochondrial (L55mt) (MRP-L55) (Mitochondrial large ribosomal subunit protein bL31m) (Mitochondrial large ribosomal subunit protein mL55)",128,"15,128",4 out of 5,2007-01-23,Evidence at protein level
Q96E39,RMXL1_HUMAN,"RNA binding motif protein, X-linked-like-1 (Heterogeneous nuclear ribonucleoprotein G-like 1) [Cleaved into: RNA binding motif protein, X-linked-like-1, N-terminally processed]",390,"42,142",3 out of 5,2011-05-03,Evidence at protein level
Q86T96,RN180_HUMAN,E3 ubiquitin-protein ligase RNF180 (EC 2.3.2.27) (RING finger protein 180) (RING-type E3 ubiquitin transferase RNF180),592,"68,254",5 out of 5,2006-11-28,Evidence at transcript level
Q8N6D2,RN182_HUMAN,E3 ubiquitin-protein ligase RNF182 (EC 2.3.2.27) (RING finger protein 182) (RING-type E3 ubiquitin transferase RNF182),247,"27,402",5 out of 5,2006-11-28,Evidence at protein level
Q9NVW2,RNF12_HUMAN,E3 ubiquitin-protein ligase RLIM (EC 2.3.2.27) (LIM domain-interacting RING finger protein) (RING finger LIM domain-binding protein) (R-LIM) (RING finger protein 12) (RING-type E3 ubiquitin transferase RLIM) (Renal carcinoma antigen NY-REN-43),624,"68,549",5 out of 5,2001-02-21,Evidence at protein level
Q9BXT8,RNF17_HUMAN,RING finger protein 17 (Tudor domain-containing protein 4),1623,"184,643",5 out of 5,2001-10-24,Evidence at protein level
Q9H0A6,RNF32_HUMAN,RING finger protein 32,362,"41,516",4 out of 5,2006-07-11,Evidence at protein level
Q9H2S5,RNF39_HUMAN,RING finger protein 39 (Protein HZFw),420,"45,525",3 out of 5,2005-06-21,Evidence at transcript level
Q7L0R7,RNF44_HUMAN,RING finger protein 44,432,"47,728",2 out of 5,2007-01-23,Evidence at transcript level
Q99942,RNF5_HUMAN,E3 ubiquitin-protein ligase RNF5 (EC 2.3.2.27) (Protein G16) (RING finger protein 5) (RING-type E3 ubiquitin transferase RNF5) (Ram1 homolog) (HsRma1),180,"19,881",5 out of 5,2006-06-27,Evidence at protein level
Q9GZN7,ROGDI_HUMAN,Protein rogdi homolog,287,"32,254",4 out of 5,2008-01-15,Evidence at protein level
Q9BZX4,ROP1B_HUMAN,Ropporin-1B (Rhophilin-associated protein 1B),212,"23,964",5 out of 5,2007-10-23,Evidence at protein level
Q9BWH6,RPAP1_HUMAN,RNA polymerase II-associated protein 1,1393,"152,755",5 out of 5,2007-04-17,Evidence at protein level
Q9GZM3,RPB1B_HUMAN,DNA-directed RNA polymerase II subunit RPB11-b1 (RNA polymerase II subunit B11-b1) (RPB11b1) (DNA-directed RNA polymerase II subunit J2),115,"13,088",3 out of 5,2008-02-05,Evidence at protein level
P30876,RPB2_HUMAN,DNA-directed RNA polymerase II subunit RPB2 (EC 2.7.7.6) (DNA-directed RNA polymerase II 140 kDa polypeptide) (DNA-directed RNA polymerase II subunit B) (RNA polymerase II subunit 2) (RNA polymerase II subunit B2),1174,"133,897",5 out of 5,1993-07-01,Evidence at protein level
O14802,RPC1_HUMAN,DNA-directed RNA polymerase III subunit RPC1 (RNA polymerase III subunit C1) (EC 2.7.7.6) (DNA-directed RNA polymerase III largest subunit) (DNA-directed RNA polymerase III subunit A) (RNA polymerase III 155 kDa subunit) (RPC155) (RNA polymerase III subunit C160),1390,"155,641",5 out of 5,1998-07-15,Evidence at protein level
P05386,RLA1_HUMAN,60S acidic ribosomal protein P1 (Large ribosomal subunit protein P1),114,"11,514",5 out of 5,1988-11-01,Evidence at protein level
P12271,RLBP1_HUMAN,Retinaldehyde-binding protein 1 (Cellular retinaldehyde-binding protein),317,"36,474",5 out of 5,1989-10-01,Evidence at protein level
Q5T653,RM02_HUMAN,"39S ribosomal protein L2, mitochondrial (L2mt) (MRP-L2) (Mitochondrial large ribosomal subunit protein uL2m)",305,"33,301",4 out of 5,2006-11-28,Evidence at protein level
Q7Z7H8,RM10_HUMAN,"39S ribosomal protein L10, mitochondrial (L10mt) (MRP-L10) (39S ribosomal protein L8, mitochondrial) (L8mt) (MRP-L8) (Mitochondrial large ribosomal subunit protein uL10m)",261,"29,283",5 out of 5,2007-01-23,Evidence at protein level
P52815,RM12_HUMAN,"39S ribosomal protein L12, mitochondrial (L12mt) (MRP-L12) (5c5-2) (Mitochondrial large ribosomal subunit protein bL12m)",198,"21,348",5 out of 5,1996-10-01,Evidence at protein level
Q9NRX2,RM17_HUMAN,"39S ribosomal protein L17, mitochondrial (L17mt) (MRP-L17) (LYST-interacting protein 2) (Mitochondrial large ribosomal subunit protein bL17m)",175,"20,050",4 out of 5,2006-05-30,Evidence at protein level
Q9H0U6,RM18_HUMAN,"39S ribosomal protein L18, mitochondrial (L18mt) (MRP-L18) (Mitochondrial large ribosomal subunit protein uL18m)",180,"20,577",5 out of 5,2004-01-16,Evidence at protein level
Q13084,RM28_HUMAN,"39S ribosomal protein L28, mitochondrial (L28mt) (MRP-L28) (Melanoma antigen p15) (Melanoma-associated antigen recognized by T-lymphocytes) (Mitochondrial large ribosomal subunit protein bL28m)",256,"30,157",5 out of 5,1998-07-15,Evidence at protein level
Q9H2W6,RM46_HUMAN,"39S ribosomal protein L46, mitochondrial (L46mt) (MRP-L46) (Mitochondrial large ribosomal subunit protein mL46) (P2ECSL)",279,"31,705",5 out of 5,2004-09-27,Evidence at protein level
Q96LZ7,RMD2_HUMAN,Regulator of microtubule dynamics protein 2 (RMD-2) (hRMD-2) (Protein FAM82A1),410,"47,399",5 out of 5,2007-05-15,Evidence at protein level
Q8IYW5,RN168_HUMAN,E3 ubiquitin-protein ligase RNF168 (hRNF168) (EC 2.3.2.27) (RING finger protein 168) (RING-type E3 ubiquitin transferase RNF168),571,"65,020",5 out of 5,2006-07-11,Evidence at protein level
Q9P0P0,RN181_HUMAN,E3 ubiquitin-protein ligase RNF181 (EC 2.3.2.27) (RING finger protein 181) (RING-type E3 ubiquitin transferase RNF181),153,"17,909",5 out of 5,2007-07-10,Evidence at protein level
Q9NV58,RN19A_HUMAN,E3 ubiquitin-protein ligase RNF19A (EC 2.3.2.-) (Double ring-finger protein) (Dorfin) (RING finger protein 19A) (p38),838,"90,696",5 out of 5,2001-07-11,Evidence at protein level
Q8TC41,RN217_HUMAN,Probable E3 ubiquitin-protein ligase RNF217 (EC 2.3.2.-) (IBR domain-containing protein 1) (RING finger protein 217),542,"59,372",4 out of 5,2005-01-04,Evidence at transcript level
Q93091,RNAS6_HUMAN,Ribonuclease K6 (RNase K6) (EC 3.1.27.-),150,"17,196",5 out of 5,1997-11-01,Evidence at protein level
Q9NRR4,RNC_HUMAN,Ribonuclease 3 (EC 3.1.26.3) (Protein Drosha) (Ribonuclease III) (RNase III) (p241),1374,"159,316",5 out of 5,2002-01-23,Evidence at protein level
Q92730,RND1_HUMAN,Rho-related GTP-binding protein Rho6 (Rho family GTPase 1) (Rnd1),232,"26,056",5 out of 5,1997-11-01,Evidence at protein level
P61587,RND3_HUMAN,Rho-related GTP-binding protein RhoE (Protein MemB) (Rho family GTPase 3) (Rho-related GTP-binding protein Rho8) (Rnd3),244,"27,368",5 out of 5,2004-05-24,Evidence at protein level
Q9H4P4,RNF41_HUMAN,E3 ubiquitin-protein ligase NRDP1 (EC 2.3.2.27) (RING finger protein 41) (RING-type E3 ubiquitin transferase NRDP1),317,"35,905",5 out of 5,2006-02-21,Evidence at protein level
Q5TBB1,RNH2B_HUMAN,Ribonuclease H2 subunit B (RNase H2 subunit B) (Aicardi-Goutieres syndrome 2 protein) (AGS2) (Deleted in lymphocytic leukemia 8) (Ribonuclease HI subunit B),312,"35,139",5 out of 5,2006-09-05,Evidence at protein level
Q9BYD1,RM13_HUMAN,"39S ribosomal protein L13, mitochondrial (L13mt) (MRP-L13) (Mitochondrial large ribosomal subunit protein uL13m)",178,"20,692",4 out of 5,2002-08-13,Evidence at protein level
Q9H9A7,RMI1_HUMAN,RecQ-mediated genome instability protein 1 (BLM-associated protein of 75 kDa) (BLAP75) (FAAP75),625,"70,144",5 out of 5,2006-03-21,Evidence at protein level
Q8N7X1,RMXL3_HUMAN,"RNA-binding motif protein, X-linked-like-3",1067,"114,938",2 out of 5,2006-11-28,Evidence at transcript level
Q8N7C7,RN148_HUMAN,RING finger protein 148,305,"34,397",2 out of 5,2006-10-31,Evidence at transcript level
Q2KHN1,RN151_HUMAN,RING finger protein 151,245,"27,412",3 out of 5,2006-10-31,Evidence at transcript level
Q8N8N0,RN152_HUMAN,E3 ubiquitin-protein ligase RNF152 (EC 2.3.2.27) (RING finger protein 152) (RING-type E3 ubiquitin transferase RNF152),203,"22,357",5 out of 5,2004-01-16,Evidence at protein level
Q9NXI6,RN186_HUMAN,RING finger protein 186,227,"24,145",2 out of 5,2006-11-28,Evidence at transcript level
Q9UBS8,RNF14_HUMAN,E3 ubiquitin-protein ligase RNF14 (EC 2.3.2.-) (Androgen receptor-associated protein 54) (HFB30) (RING finger protein 14) (Triad2 protein),474,"53,837",5 out of 5,2001-09-26,Evidence at protein level
Q969K3,RNF34_HUMAN,E3 ubiquitin-protein ligase RNF34 (EC 2.3.2.27) (Caspase regulator CARP1) (Caspases-8 and -10-associated RING finger protein 1) (CARP-1) (FYVE-RING finger protein Momo) (Human RING finger homologous to inhibitor of apoptosis protein) (hRFI) (RING finger protein 34) (RING finger protein RIFF) (RING-type E3 ubiquitin transferase RNF34),372,"41,641",5 out of 5,2005-09-27,Evidence at protein level
Q68DV7,RNF43_HUMAN,E3 ubiquitin-protein ligase RNF43 (EC 2.3.2.27) (RING finger protein 43) (RING-type E3 ubiquitin transferase RNF43),783,"85,722",5 out of 5,2007-02-20,Evidence at protein level
Q5GAN4,RNS12_HUMAN,Probable inactive ribonuclease-like protein 12,147,"17,177",2 out of 5,2007-10-23,Evidence at transcript level
Q969Q0,RL36L_HUMAN,60S ribosomal protein L36a-like (Large ribosomal subunit protein eL42-like),106,"12,469",3 out of 5,2005-01-04,Evidence at protein level
Q9Y3U8,RL36_HUMAN,60S ribosomal protein L36 (Large ribosomal subunit protein eL36),105,"12,254",5 out of 5,2000-05-30,Evidence at protein level
Q92901,RL3L_HUMAN,60S ribosomal protein L3-like (Large ribosomal subunit protein uL3-like),407,"46,296",3 out of 5,1997-11-01,Evidence at transcript level
P62987,RL40_HUMAN,Ubiquitin-60S ribosomal protein L40 (CEP52) (Ubiquitin A-52 residue ribosomal protein fusion product 1) [Cleaved into: Ubiquitin; 60S ribosomal protein L40 (Large ribosomal subunit protein eL40)],128,"14,728",5 out of 5,2004-08-31,Evidence at protein level
Q9H0X6,RN208_HUMAN,RING finger protein 208,261,"27,964",3 out of 5,2007-02-06,Evidence at protein level
Q6P161,RM54_HUMAN,"39S ribosomal protein L54, mitochondrial (L54mt) (MRP-L54) (Mitochondrial large ribosomal subunit protein mL54)",138,"15,819",3 out of 5,2007-02-20,Evidence at protein level
Q6ZNA4,RN111_HUMAN,E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (hRNF111) (RING-type E3 ubiquitin transferase Arkadia),994,"108,862",5 out of 5,2007-03-20,Evidence at protein level
Q9Y4L5,RN115_HUMAN,E3 ubiquitin-protein ligase RNF115 (EC 2.3.2.27) (RING finger protein 115) (RING-type E3 ubiquitin transferase RNF115) (Rabring 7) (Zinc finger protein 364),304,"33,703",5 out of 5,2003-02-12,Evidence at protein level
Q9H9V4,RN122_HUMAN,RING finger protein 122,155,"17,475",3 out of 5,2006-07-25,Evidence at transcript level
Q8WVZ7,RN133_HUMAN,E3 ubiquitin-protein ligase RNF133 (EC 2.3.2.27) (RING finger protein 133) (RING-type E3 ubiquitin transferase RNF133),376,"42,294",3 out of 5,2006-07-25,Evidence at transcript level
Q8WVD3,RN138_HUMAN,E3 ubiquitin-protein ligase RNF138 (EC 2.3.2.27) (Nemo-like kinase-associated RING finger protein) (NLK-associated RING finger protein) (hNARF) (RING finger protein 138) (RING-type E3 ubiquitin transferase RNF138),245,"28,193",5 out of 5,2006-11-28,Evidence at protein level
Q8WVD5,RN141_HUMAN,RING finger protein 141 (Zinc finger protein 230),230,"25,535",4 out of 5,2005-09-13,Evidence at protein level
Q8NC42,RN149_HUMAN,E3 ubiquitin-protein ligase RNF149 (EC 2.3.2.27) (DNA polymerase-transactivated protein 2) (RING finger protein 149) (RING-type E3 ubiquitin transferase RNF149),400,"43,165",5 out of 5,2006-11-28,Evidence at transcript level
Q96K19,RN170_HUMAN,E3 ubiquitin-protein ligase RNF170 (EC 2.3.2.27) (Putative LAG1-interacting protein) (RING finger protein 170) (RING-type E3 ubiquitin transferase RNF170),258,"29,815",5 out of 5,2007-03-20,Evidence at protein level
Q63HN8,RN213_HUMAN,E3 ubiquitin-protein ligase RNF213 (EC 2.3.2.27) (EC 3.6.4.-) (ALK lymphoma oligomerization partner on chromosome 17) (Mysterin) (RING finger protein 213) (RING-type E3 ubiquitin transferase RNF213),5207,"591,407",5 out of 5,2007-02-20,Evidence at protein level
P60153,RNAS9_HUMAN,Inactive ribonuclease-like protein 9,205,"24,307",4 out of 5,2003-11-28,Evidence at protein level
O60518,RNBP6_HUMAN,Ran-binding protein 6 (RanBP6),1105,"124,714",4 out of 5,2004-07-19,Evidence at protein level
Q96BH1,RNF25_HUMAN,E3 ubiquitin-protein ligase RNF25 (EC 2.3.2.27) (RING finger protein 25) (RING-type E3 ubiquitin transferase RNF25),459,"51,219",5 out of 5,2002-06-06,Evidence at protein level
Q9Y252,RNF6_HUMAN,E3 ubiquitin-protein ligase RNF6 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF6),685,"78,091",5 out of 5,2001-02-21,Evidence at protein level
Q96EX2,RNFT2_HUMAN,RING finger and transmembrane domain-containing protein 2 (Transmembrane protein 118),444,"48,965",3 out of 5,2007-03-06,Evidence at transcript level
O75792,RNH2A_HUMAN,Ribonuclease H2 subunit A (RNase H2 subunit A) (EC 3.1.26.4) (Aicardi-Goutieres syndrome 4 protein) (AGS4) (RNase H(35)) (Ribonuclease HI large subunit) (RNase HI large subunit) (Ribonuclease HI subunit A),299,"33,395",5 out of 5,2000-12-01,Evidence at protein level
P63173,RL38_HUMAN,60S ribosomal protein L38 (Large ribosomal subunit protein eL38),70,"8,218",5 out of 5,2004-09-27,Evidence at protein level
P39023,RL3_HUMAN,60S ribosomal protein L3 (HIV-1 TAR RNA-binding protein B) (TARBP-B) (Large ribosomal subunit protein uL3),403,"46,109",5 out of 5,1995-02-01,Evidence at protein level
Q9UHA3,RLP24_HUMAN,Probable ribosome biogenesis protein RLP24 (Ribosomal L24 domain-containing protein 1) (Ribosomal protein L24-like),163,"19,621",4 out of 5,2004-09-27,Evidence at protein level
Q9P015,RM15_HUMAN,"39S ribosomal protein L15, mitochondrial (L15mt) (MRP-L15) (Mitochondrial large ribosomal subunit protein uL15m)",296,"33,420",4 out of 5,2006-10-31,Evidence at protein level
Q16540,RM23_HUMAN,"39S ribosomal protein L23, mitochondrial (L23mt) (MRP-L23) (L23 mitochondrial-related protein) (Mitochondrial large ribosomal subunit protein uL23m) (Ribosomal protein L23-like)",153,"17,781",5 out of 5,2005-07-05,Evidence at protein level
Q9BZE1,RM37_HUMAN,"39S ribosomal protein L37, mitochondrial (L37mt) (MRP-L37) (39S ribosomal protein L2, mitochondrial) (L2mt) (MRP-L2) (Mitochondrial large ribosomal subunit protein mL37)",423,"48,117",5 out of 5,2006-02-07,Evidence at protein level
Q9Y6G3,RM42_HUMAN,"39S ribosomal protein L42, mitochondrial (L42mt) (MRP-L42) (39S ribosomal protein L31, mitochondrial) (L31mt) (MRP-L31) (Mitochondrial large ribosomal subunit protein mL42)",142,"16,661",5 out of 5,2002-10-19,Evidence at protein level
Q8ND24,RN214_HUMAN,RING finger protein 214,703,"77,667",2 out of 5,2007-03-20,Evidence at protein level
E7ERA6,RN223_HUMAN,RING finger protein 223,249,"26,629",2 out of 5,2011-06-28,Evidence at transcript level
Q8TAA1,RNS11_HUMAN,Probable ribonuclease 11 (RNase 11) (EC 3.1.27.-),199,"22,427",3 out of 5,2003-05-30,Evidence at transcript level
Q9H777,RNZ1_HUMAN,Zinc phosphodiesterase ELAC protein 1 (EC 3.1.26.11) (Deleted in Ma29) (ElaC homolog protein 1) (Ribonuclease Z 1) (RNase Z 1) (tRNA 3 endonuclease 1) (tRNase Z 1),363,"40,019",4 out of 5,2004-01-16,Evidence at protein level
P19474,RO52_HUMAN,E3 ubiquitin-protein ligase TRIM21 (EC 2.3.2.27) (52 kDa Ro protein) (52 kDa ribonucleoprotein autoantigen Ro/SS-A) (RING finger protein 81) (RING-type E3 ubiquitin transferase TRIM21) (Ro(SS-A)) (Sjoegren syndrome type A antigen) (SS-A) (Tripartite motif-containing protein 21),475,"54,170",5 out of 5,1991-02-01,Evidence at protein level
Q8WZ75,ROBO4_HUMAN,Roundabout homolog 4 (Magic roundabout),1007,"107,457",5 out of 5,2004-06-21,Evidence at protein level
Q01973,ROR1_HUMAN,"Inactive tyrosine-protein kinase transmembrane receptor ROR1 (Neurotrophic tyrosine kinase, receptor-related 1)",937,"104,283",5 out of 5,2001-04-27,Evidence at protein level
Q01974,ROR2_HUMAN,"Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)",943,"104,757",5 out of 5,2001-04-27,Evidence at protein level
Q92753,RORB_HUMAN,Nuclear receptor ROR-beta (Nuclear receptor RZR-beta) (Nuclear receptor subfamily 1 group F member 2) (Retinoid-related orphan receptor-beta),470,"53,220",5 out of 5,1997-11-01,Evidence at protein level
P51449,RORG_HUMAN,Nuclear receptor ROR-gamma (Nuclear receptor RZR-gamma) (Nuclear receptor subfamily 1 group F member 3) (RAR-related orphan receptor C) (Retinoid-related orphan receptor-gamma),518,"58,195",5 out of 5,1996-10-01,Evidence at protein level
Q8TA86,RP9_HUMAN,Retinitis pigmentosa 9 protein (Pim-1-associated protein) (PAP-1),221,"26,107",5 out of 5,2003-11-14,Evidence at protein level
P61218,RPAB2_HUMAN,"DNA-directed RNA polymerases I, II, and III subunit RPABC2 (RNA polymerases I, II, and III subunit ABC2) (DNA-directed RNA polymerase II subunit F) (DNA-directed RNA polymerases I, II, and III 14.4 kDa polypeptide) (RPABC14.4) (RPB14.4) (RPB6 homolog) (RPC15)",127,"14,478",5 out of 5,2004-05-10,Evidence at protein level
P52435,RPB11_HUMAN,DNA-directed RNA polymerase II subunit RPB11-a (RNA polymerase II subunit B11-a) (RPB11a) (DNA-directed RNA polymerase II subunit J-1) (RNA polymerase II 13.3 kDa subunit),117,"13,293",5 out of 5,1996-10-01,Evidence at protein level
O95059,RPP14_HUMAN,Ribonuclease P protein subunit p14 (EC 3.1.26.5),124,"13,693",4 out of 5,2000-05-30,Evidence at protein level
P78346,RPP30_HUMAN,Ribonuclease P protein subunit p30 (RNaseP protein p30) (EC 3.1.26.5) (RNase P subunit 2),268,"29,321",5 out of 5,2001-02-21,Evidence at protein level
P56182,RRP1_HUMAN,Ribosomal RNA processing protein 1 homolog A (Novel nuclear protein 1) (NNP-1) (Nucleolar protein Nop52) (RRP1-like protein),461,"52,839",5 out of 5,1997-11-01,Evidence at protein level
Q9NQ39,RS10L_HUMAN,Putative 40S ribosomal protein S10-like,176,"20,120",2 out of 5,2008-09-02,Uncertain
A6NIE6,RN3P2_HUMAN,Putative RRN3-like protein RRN3P2 (RNA polymerase I transcription factor homolog pseudogene 2),340,"38,035",1 out of 5,2008-04-29,Uncertain
Q05823,RN5A_HUMAN,2-5A-dependent ribonuclease (2-5A-dependent RNase) (EC 3.1.26.-) (Ribonuclease 4) (Ribonuclease L) (RNase L),741,"83,533",5 out of 5,1995-11-01,Evidence at protein level
P07998,RNAS1_HUMAN,Ribonuclease pancreatic (EC 3.1.27.5) (HP-RNase) (RIB-1) (RNase UpI-1) (Ribonuclease 1) (RNase 1) (Ribonuclease A) (RNase A),156,"17,644",5 out of 5,1988-08-01,Evidence at protein level
P34096,RNAS4_HUMAN,Ribonuclease 4 (RNase 4) (EC 3.1.27.-),147,"16,840",5 out of 5,1994-02-01,Evidence at protein level
Q9H1E1,RNAS7_HUMAN,Ribonuclease 7 (RNase 7) (EC 3.1.27.-) (Skin-derived antimicrobial protein 2) (SAP-2),156,"17,419",5 out of 5,2001-12-19,Evidence at protein level
P52198,RND2_HUMAN,Rho-related GTP-binding protein RhoN (Rho family GTPase 2) (Rho-related GTP-binding protein Rho7) (Rnd2),227,"25,369",4 out of 5,1996-10-01,Evidence at protein level
Q9Y225,RNF24_HUMAN,RING finger protein 24,148,"17,210",4 out of 5,2002-03-27,Evidence at protein level
Q6P5S7,RNK_HUMAN,Ribonuclease kappa (RNase K) (RNase kappa) (EC 3.1.-.-),137,"15,420",3 out of 5,2008-07-22,Evidence at transcript level
Q5VYX0,RNLS_HUMAN,Renalase (EC 1.6.3.5) (Monoamine oxidase-C) (MAO-C),342,"37,847",5 out of 5,2005-08-30,Evidence at protein level
Q5GAN6,RNS10_HUMAN,Inactive ribonuclease-like protein 10,216,"24,008",3 out of 5,2006-02-07,Evidence at transcript level
Q96C74,ROP1L_HUMAN,Ropporin-1-like protein (ROPN1-like protein) (AKAP-associated sperm protein),230,"26,107",3 out of 5,2007-10-23,Evidence at protein level
O15514,RPB4_HUMAN,DNA-directed RNA polymerase II subunit RPB4 (RNA polymerase II subunit B4) (DNA-directed RNA polymerase II subunit D) (RNA polymerase II 16 kDa subunit) (RPB16),142,"16,311",5 out of 5,1998-07-15,Evidence at protein level
P62487,RPB7_HUMAN,DNA-directed RNA polymerase II subunit RPB7 (RNA polymerase II subunit B7) (DNA-directed RNA polymerase II subunit G) (RNA polymerase II 19 kDa subunit) (RPB19),172,"19,294",5 out of 5,2004-07-19,Evidence at protein level
Q9Y535,RPC8_HUMAN,DNA-directed RNA polymerase III subunit RPC8 (RNA polymerase III subunit C8) (DNA-directed RNA polymerase III subunit H) (RNA polymerase III subunit 22.9 kDa subunit) (RPC22.9),204,"22,918",5 out of 5,2003-03-28,Evidence at protein level
Q8WZA2,RPGF4_HUMAN,Rap guanine nucleotide exchange factor 4 (Exchange factor directly activated by cAMP 2) (Exchange protein directly activated by cAMP 2) (EPAC 2) (cAMP-regulated guanine nucleotide exchange factor II) (cAMP-GEFII),1011,"115,522",5 out of 5,2003-06-20,Evidence at protein level
Q9BUL9,RPP25_HUMAN,Ribonuclease P protein subunit p25 (RNase P protein subunit p25) (EC 3.1.26.5),199,"20,632",5 out of 5,2006-05-30,Evidence at protein level
Q9BYC9,RM20_HUMAN,"39S ribosomal protein L20, mitochondrial (L20mt) (MRP-L20) (Mitochondrial large ribosomal subunit protein bL20m)",149,"17,443",4 out of 5,2006-09-05,Evidence at protein level
Q8TCC3,RM30_HUMAN,"39S ribosomal protein L30, mitochondrial (L30mt) (MRP-L30) (39S ribosomal protein L28, mitochondrial) (L28mt) (MRP-L28) (Mitochondrial large ribosomal subunit protein uL30m)",161,"18,546",4 out of 5,2006-11-28,Evidence at protein level
O75394,RM33_HUMAN,"39S ribosomal protein L33, mitochondrial (L33mt) (MRP-L33) (Mitochondrial large ribosomal subunit protein bL33m)",65,"7,619",4 out of 5,2006-05-30,Evidence at protein level
Q9BQ48,RM34_HUMAN,"39S ribosomal protein L34, mitochondrial (L34mt) (MRP-L34) (Mitochondrial large ribosomal subunit protein bL34m)",92,"10,165",4 out of 5,2002-01-31,Evidence at protein level
Q9P0J6,RM36_HUMAN,"39S ribosomal protein L36, mitochondrial (L36mt) (MRP-L36) (BRCA1-interacting protein 1) (Mitochondrial large ribosomal subunit protein bL36m)",103,"11,784",4 out of 5,2002-10-19,Evidence at protein level
Q9NQ50,RM40_HUMAN,"39S ribosomal protein L40, mitochondrial (L40mt) (MRP-L40) (Mitochondrial large ribosomal subunit protein mL40) (Nuclear localization signal-containing protein deleted in velocardiofacial syndrome) (Up-regulated in metastasis)",206,"24,490",5 out of 5,2002-05-27,Evidence at protein level
Q96D59,RN183_HUMAN,RING finger protein 183,192,"21,617",2 out of 5,2006-07-25,Evidence at protein level
Q5TA31,RN187_HUMAN,E3 ubiquitin-protein ligase RNF187 (EC 2.3.2.27) (RING domain AP1 coactivator 1) (RACO-1) (RING finger protein 187) (RING-type E3 ubiquitin transferase RNF187),235,"26,190",5 out of 5,2007-02-20,Evidence at protein level
Q6ZMZ0,RN19B_HUMAN,E3 ubiquitin-protein ligase RNF19B (EC 2.3.2.-) (IBR domain-containing protein 3) (Natural killer lytic-associated molecule) (RING finger protein 19B),732,"77,925",5 out of 5,2005-01-04,Evidence at protein level
Q2M238,RN3P1_HUMAN,Putative RRN3-like protein RRN3P1 (RNA polymerase I transcription factor homolog pseudogene 1),152,"17,255",2 out of 5,2008-02-26,Uncertain
Q8TDE3,RNAS8_HUMAN,Ribonuclease 8 (RNase 8) (EC 3.1.27.-),154,"17,041",3 out of 5,2002-10-10,Evidence at protein level
Q9H0F5,RNF38_HUMAN,E3 ubiquitin-protein ligase RNF38 (EC 2.3.2.27) (RING finger protein 38) (RING-type E3 ubiquitin transferase RNF38),515,"57,595",5 out of 5,2004-12-21,Evidence at protein level
Q8TDP1,RNH2C_HUMAN,Ribonuclease H2 subunit C (RNase H2 subunit C) (Aicardi-Goutieres syndrome 3 protein) (AGS3) (RNase H1 small subunit) (Ribonuclease HI subunit C),164,"17,840",5 out of 5,2006-09-05,Evidence at protein level
Q15287,RNPS1_HUMAN,RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2),305,"34,208",5 out of 5,2005-11-22,Evidence at protein level
O00411,RPOM_HUMAN,"DNA-directed RNA polymerase, mitochondrial (MtRPOL) (EC 2.7.7.6)",1230,"138,620",5 out of 5,1998-12-15,Evidence at protein level
Q6XPR3,RPTN_HUMAN,Repetin,784,"90,731",4 out of 5,2005-07-05,Evidence at protein level
Q14684,RRP1B_HUMAN,Ribosomal RNA processing protein 1 homolog B (RRP1-like protein B),758,"84,428",4 out of 5,1997-11-01,Evidence at protein level
Q5VTB9,RN220_HUMAN,E3 ubiquitin-protein ligase RNF220 (EC 2.3.2.27) (RING finger protein 220) (RING-type E3 ubiquitin transferase RNF220),566,"62,765",5 out of 5,2007-02-20,Evidence at protein level
Q9BQ52,RNZ2_HUMAN,Zinc phosphodiesterase ELAC protein 2 (EC 3.1.26.11) (ElaC homolog protein 2) (Heredity prostate cancer protein 2) (Ribonuclease Z 2) (RNase Z 2) (tRNA 3 endonuclease 2) (tRNase Z 2),826,"92,219",5 out of 5,2004-01-16,Evidence at protein level
Q96P16,RPR1A_HUMAN,Regulation of nuclear pre-mRNA domain-containing protein 1A (Cyclin-dependent kinase inhibitor 2B-related protein) (p15INK4B-related protein),312,"35,720",5 out of 5,2007-11-13,Evidence at protein level
Q5VT52,RPRD2_HUMAN,Regulation of nuclear pre-mRNA domain-containing protein 2,1461,"156,020",4 out of 5,2006-06-27,Evidence at protein level
Q8N122,RPTOR_HUMAN,Regulatory-associated protein of mTOR (Raptor) (p150 target of rapamycin (TOR)-scaffold protein),1335,"149,038",5 out of 5,2004-04-26,Evidence at protein level
Q9HB90,RRAGC_HUMAN,Ras-related GTP-binding protein C (Rag C) (RagC) (GTPase-interacting protein 2) (TIB929),399,"44,224",5 out of 5,2006-06-13,Evidence at protein level
P10301,RRAS_HUMAN,Ras-related protein R-Ras (p23),218,"23,480",5 out of 5,1989-07-01,Evidence at protein level
Q96EU6,RRP36_HUMAN,Ribosomal RNA processing protein 36 homolog,259,"29,823",5 out of 5,2006-10-03,Evidence at protein level
Q5GAN3,RNS13_HUMAN,Probable inactive ribonuclease-like protein 13,156,"17,845",2 out of 5,2007-10-23,Evidence at transcript level
P35398,RORA_HUMAN,Nuclear receptor ROR-alpha (Nuclear receptor RZR-alpha) (Nuclear receptor subfamily 1 group F member 1) (RAR-related orphan receptor A) (Retinoid-related orphan receptor-alpha),523,"58,975",5 out of 5,1994-06-01,Evidence at protein level
P08922,ROS1_HUMAN,Proto-oncogene tyrosine-protein kinase ROS (EC 2.7.10.1) (Proto-oncogene c-Ros) (Proto-oncogene c-Ros-1) (Receptor tyrosine kinase c-ros oncogene 1) (c-Ros receptor tyrosine kinase),2347,"263,915",5 out of 5,1988-11-01,Evidence at protein level
Q8IWN7,RP1L1_HUMAN,Retinitis pigmentosa 1-like 1 protein,2480,"261,207",5 out of 5,2004-02-16,Evidence at protein level
P56715,RP1_HUMAN,Oxygen-regulated protein 1 (Retinitis pigmentosa 1 protein) (Retinitis pigmentosa RP1 protein),2156,"240,661",5 out of 5,2000-05-30,Evidence at protein level
Q9Y2J0,RP3A_HUMAN,Rabphilin-3A (Exophilin-1),694,"76,872",5 out of 5,2001-04-27,Evidence at protein level
Q9P1U0,RPA12_HUMAN,DNA-directed RNA polymerase I subunit RPA12 (Zinc ribbon domain-containing protein 1),126,"13,904",4 out of 5,2005-08-02,Evidence at transcript level
O15446,RPA34_HUMAN,DNA-directed RNA polymerase I subunit RPA34 (A34.5) (Antisense to ERCC-1 protein) (ASE-1) (CD3-epsilon-associated protein) (CAST) (CD3E-associated protein) (RNA polymerase I-associated factor PAF49),510,"54,986",5 out of 5,2006-03-21,Evidence at protein level
P24928,RPB1_HUMAN,DNA-directed RNA polymerase II subunit RPB1 (RNA polymerase II subunit B1) (EC 2.7.7.6) (DNA-directed RNA polymerase II subunit A) (DNA-directed RNA polymerase III largest subunit) (RNA-directed RNA polymerase II subunit RPB1) (EC 2.7.7.48),1970,"217,176",5 out of 5,1992-03-01,Evidence at protein level
Q9BT43,RPC7L_HUMAN,DNA-directed RNA polymerase III subunit RPC7-like (RNA polymerase III subunit C7-like) (DNA-directed RNA polymerase III subunit G-like),218,"25,334",3 out of 5,2007-11-13,Evidence at protein level
O75575,RPC9_HUMAN,DNA-directed RNA polymerase III subunit RPC9 (RNA polymerase III subunit C9) (Calcitonin gene-related peptide-receptor component protein) (CGRP-RCP) (CGRP-receptor component protein) (CGRPRCP) (HsC17),148,"16,871",5 out of 5,2002-05-10,Evidence at protein level
Q13905,RPGF1_HUMAN,Rap guanine nucleotide exchange factor 1 (CRK SH3-binding GNRP) (Guanine nucleotide-releasing factor 2) (Protein C3G),1077,"120,548",5 out of 5,2002-11-15,Evidence at protein level
Q9H633,RPP21_HUMAN,Ribonuclease P protein subunit p21 (RNaseP protein p21) (EC 3.1.26.5) (Ribonuclease P/MRP 21 kDa subunit) (Ribonucleoprotein V),154,"17,570",5 out of 5,2004-07-05,Evidence at protein level
Q9NQL2,RRAGD_HUMAN,Ras-related GTP-binding protein D (Rag D) (RagD),400,"45,588",5 out of 5,2006-06-13,Evidence at protein level
Q92766,RREB1_HUMAN,Ras-responsive element-binding protein 1 (RREB-1) (Finger protein in nuclear bodies) (Raf-responsive zinc finger protein LZ321) (Zinc finger motif enhancer-binding protein 1) (Zep-1),1687,"181,420",5 out of 5,1998-07-15,Evidence at protein level
Q9BYD3,RM04_HUMAN,"39S ribosomal protein L4, mitochondrial (L4mt) (MRP-L4) (Mitochondrial large ribosomal subunit protein uL4m)",311,"34,919",4 out of 5,2006-05-30,Evidence at protein level
Q9NX20,RM16_HUMAN,"39S ribosomal protein L16, mitochondrial (L16mt) (MRP-L16) (Mitochondrial large ribosomal subunit protein uL16m)",251,"28,449",4 out of 5,2006-06-13,Evidence at protein level
P49406,RM19_HUMAN,"39S ribosomal protein L19, mitochondrial (L19mt) (MRP-L19) (39S ribosomal protein L15, mitochondrial) (L15mt) (MRP-L15) (Mitochondrial large ribosomal subunit protein bL19m)",292,"33,535",5 out of 5,1996-02-01,Evidence at protein level
Q7Z2W9,RM21_HUMAN,"39S ribosomal protein L21, mitochondrial (L21mt) (MRP-L21) (Mitochondrial large ribosomal subunit protein bL21m)",205,"22,815",4 out of 5,2006-10-17,Evidence at protein level
Q9BYC8,RM32_HUMAN,"39S ribosomal protein L32, mitochondrial (L32mt) (MRP-L32) (Mitochondrial large ribosomal subunit protein bL32m)",188,"21,405",4 out of 5,2002-07-26,Evidence at protein level
Q9BRJ2,RM45_HUMAN,"39S ribosomal protein L45, mitochondrial (L45mt) (MRP-L45) (Mitochondrial large ribosomal subunit protein mL45)",306,"35,351",4 out of 5,2003-04-04,Evidence at protein level
Q96GC5,RM48_HUMAN,"39S ribosomal protein L48, mitochondrial (L48mt) (MRP-L48) (Mitochondrial large ribosomal subunit protein mL48)",212,"23,935",4 out of 5,2006-11-28,Evidence at protein level
Q4U2R6,RM51_HUMAN,"39S ribosomal protein L51, mitochondrial (L51mt) (MRP-L51) (Mitochondrial large ribosomal subunit protein mL51) (bMRP-64) (bMRP64)",128,"15,095",4 out of 5,2007-01-23,Evidence at protein level
Q86TS9,RM52_HUMAN,"39S ribosomal protein L52, mitochondrial (L52mt) (MRP-L52) (Mitochondrial large ribosomal subunit protein mL52)",123,"13,664",4 out of 5,2007-01-23,Evidence at protein level
Q96E14,RMI2_HUMAN,RecQ-mediated genome instability protein 2 (hRMI2) (BLM-associated protein of 18 kDa) (BLAP18),147,"15,865",5 out of 5,2007-08-21,Evidence at protein level
Q9Y508,RN114_HUMAN,E3 ubiquitin-protein ligase RNF114 (EC 2.3.2.27) (RING finger protein 114) (RING-type E3 ubiquitin transferase RNF114) (Zinc finger protein 228) (Zinc finger protein 313),228,"25,694",5 out of 5,2002-01-23,Evidence at protein level
Q9H920,RN121_HUMAN,RING finger protein 121,327,"37,882",3 out of 5,2006-11-28,Evidence at protein level
Q5XPI4,RN123_HUMAN,E3 ubiquitin-protein ligase RNF123 (EC 2.3.2.27) (Kip1 ubiquitination-promoting complex protein 1) (RING finger protein 123) (RING-type E3 ubiquitin transferase RNF123),1314,"148,515",5 out of 5,2006-10-03,Evidence at protein level
Q96MT1,RN145_HUMAN,RING finger protein 145,663,"75,617",3 out of 5,2007-07-10,Evidence at transcript level
Q6ZSG1,RN165_HUMAN,E3 ubiquitin-protein ligase RNF165 (EC 2.3.2.27) (RING finger protein 165),346,"39,526",5 out of 5,2006-07-11,Evidence at protein level
Q96GF1,RN185_HUMAN,E3 ubiquitin-protein ligase RNF185 (EC 2.3.2.27) (RING finger protein 185) (RING-type E3 ubiquitin transferase RNF185),192,"20,459",5 out of 5,2006-07-25,Evidence at protein level
P0DH78,RN224_HUMAN,RING finger protein 224,156,"16,549",1 out of 5,2011-07-27,Predicted
Q9Y3C5,RNF11_HUMAN,RING finger protein 11,154,"17,444",5 out of 5,2002-06-06,Evidence at protein level
Q9BY78,RNF26_HUMAN,RING finger protein 26,433,"47,737",2 out of 5,2002-03-27,Evidence at transcript level
O94941,RNF37_HUMAN,RING finger protein 37 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase RNF37) (U-box domain-containing protein 5) (UbcM4-interacting protein 5) (hUIP5) (Ubiquitin-conjugating enzyme 7-interacting protein 5),541,"58,966",5 out of 5,2002-06-06,Evidence at protein level
P78317,RNF4_HUMAN,E3 ubiquitin-protein ligase RNF4 (EC 2.3.2.27) (RING finger protein 4) (RING-type E3 ubiquitin transferase RNF4) (Small nuclear ring finger protein) (Protein SNURF),190,"21,319",5 out of 5,2001-10-18,Evidence at protein level
O76064,RNF8_HUMAN,E3 ubiquitin-protein ligase RNF8 (hRNF8) (EC 2.3.2.27) (RING finger protein 8) (RING-type E3 ubiquitin transferase RNF8),485,"55,518",5 out of 5,2002-06-06,Evidence at protein level
P09651,ROA1_HUMAN,"Heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) (Helix-destabilizing protein) (Single-strand RNA-binding protein) (hnRNP core protein A1) [Cleaved into: Heterogeneous nuclear ribonucleoprotein A1, N-terminally processed]",372,"38,747",5 out of 5,1989-07-01,Evidence at protein level
Q99729,ROAA_HUMAN,Heterogeneous nuclear ribonucleoprotein A/B (hnRNP A/B) (APOBEC1-binding protein 1) (ABBP-1),332,"36,225",5 out of 5,2003-07-19,Evidence at protein level
Q9Y6N7,ROBO1_HUMAN,Roundabout homolog 1 (Deleted in U twenty twenty) (H-Robo-1),1651,"180,930",5 out of 5,2004-06-21,Evidence at protein level
Q96MS0,ROBO3_HUMAN,Roundabout homolog 3 (Roundabout-like protein 3),1386,"148,209",5 out of 5,2004-06-21,Evidence at protein level
Q13464,ROCK1_HUMAN,"Rho-associated protein kinase 1 (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-35) (Rho-associated, coiled-coil-containing protein kinase 1) (Rho-associated, coiled-coil-containing protein kinase I) (ROCK-I) (p160 ROCK-1) (p160ROCK)",1354,"158,175",5 out of 5,2004-05-24,Evidence at protein level
Q9Y2Y1,RPC10_HUMAN,DNA-directed RNA polymerase III subunit RPC10 (RNA polymerase III subunit C10) (DNA-directed RNA polymerase III subunit K) (RNA polymerase III 12.5 kDa subunit) (RPC12.5) (RNA polymerase III subunit C11) (HsC11p) (RPC11) (hRPC11),108,"12,336",4 out of 5,2001-09-26,Evidence at protein level
Q9BUI4,RPC3_HUMAN,DNA-directed RNA polymerase III subunit RPC3 (RNA polymerase III subunit C3) (DNA-directed RNA polymerase III subunit C) (RNA polymerase III 62 kDa subunit) (RPC62),534,"60,612",5 out of 5,2004-07-05,Evidence at protein level
P05423,RPC4_HUMAN,DNA-directed RNA polymerase III subunit RPC4 (RNA polymerase III subunit C4) (DNA-directed RNA polymerase III subunit D) (Protein BN51) (RNA polymerase III 47 kDa subunit) (RPC53 homolog),398,"44,396",5 out of 5,1988-11-01,Evidence at protein level
Q9NVU0,RPC5_HUMAN,DNA-directed RNA polymerase III subunit RPC5 (RNA polymerase III subunit C5) (DNA-directed RNA polymerase III 80 kDa polypeptide),708,"79,898",5 out of 5,2003-03-28,Evidence at protein level
Q9H1D9,RPC6_HUMAN,DNA-directed RNA polymerase III subunit RPC6 (RNA polymerase III subunit C6) (DNA-directed RNA polymerase III subunit F) (RNA polymerase III 39 kDa subunit) (RPC39),316,"35,684",5 out of 5,2002-03-27,Evidence at protein level
Q96AT9,RPE_HUMAN,Ribulose-phosphate 3-epimerase (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase),228,"24,928",5 out of 5,2003-09-19,Evidence at protein level
Q684P5,RPGP2_HUMAN,Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4),730,"80,056",5 out of 5,2007-12-04,Evidence at protein level
Q92834,RPGR_HUMAN,X-linked retinitis pigmentosa GTPase regulator,1020,"113,387",5 out of 5,1997-11-01,Evidence at protein level
P04844,RPN2_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 63 kDa subunit) (RIBIIR) (Ribophorin II) (RPN-II) (Ribophorin-2),631,"69,284",5 out of 5,1987-08-13,Evidence at protein level
Q6P1L8,RM14_HUMAN,"39S ribosomal protein L14, mitochondrial (L14mt) (MRP-L14) (39S ribosomal protein L32, mitochondrial) (L32mt) (MRP-L32) (Mitochondrial large ribosomal subunit protein uL14m)",145,"15,948",4 out of 5,2006-11-28,Evidence at protein level
Q8N5N7,RM50_HUMAN,"39S ribosomal protein L50, mitochondrial (L50mt) (MRP-L50) (Mitochondrial large ribosomal subunit protein mL50)",158,"18,325",3 out of 5,2006-11-28,Evidence at protein level
Q96EL3,RM53_HUMAN,"39S ribosomal protein L53, mitochondrial (L53mt) (MRP-L53) (Mitochondrial large ribosomal subunit protein mL53)",112,"12,107",4 out of 5,2006-11-28,Evidence at protein level
Q96G75,RMD5B_HUMAN,Protein RMD5 homolog B,393,"44,414",2 out of 5,2003-02-28,Evidence at protein level
O75526,RMXL2_HUMAN,"RNA-binding motif protein, X-linked-like-2 (Testis-specific heterogeneous nuclear ribonucleoprotein G-T) (hnRNP G-T)",392,"42,814",3 out of 5,2007-03-20,Evidence at protein level
Q9ULX5,RN112_HUMAN,RING finger protein 112 (Brain finger protein) (Zinc finger protein 179),631,"68,298",4 out of 5,2001-09-26,Evidence at transcript level
Q8IUD6,RN135_HUMAN,E3 ubiquitin-protein ligase RNF135 (EC 2.3.2.27) (RIG-I E3 ubiquitin ligase) (REUL) (RING finger protein 135) (RING-type E3 ubiquitin transferase RNF135) (Riplet),432,"47,888",5 out of 5,2007-03-20,Evidence at protein level
Q8WU17,RN139_HUMAN,E3 ubiquitin-protein ligase RNF139 (EC 2.3.2.27) (RING finger protein 139) (RING-type E3 ubiquitin transferase RNF139) (Translocation in renal carcinoma on chromosome 8 protein),664,"75,994",5 out of 5,2005-12-06,Evidence at protein level
Q9NTX7,RN146_HUMAN,E3 ubiquitin-protein ligase RNF146 (EC 2.3.2.27) (Dactylidin) (Iduna) (RING finger protein 146) (RING-type E3 ubiquitin transferase RNF146),359,"38,950",5 out of 5,2005-03-01,Evidence at protein level
Q96PX1,RN157_HUMAN,RING finger protein 157,679,"73,579",3 out of 5,2006-11-28,Evidence at protein level
Q96A37,RN166_HUMAN,RING finger protein 166,237,"26,122",3 out of 5,2006-07-11,Evidence at transcript level
Q8NCN4,RN169_HUMAN,E3 ubiquitin-protein ligase RNF169 (EC 2.3.2.27) (RING finger protein 169) (RING-type E3 ubiquitin transferase RNF169),708,"77,194",5 out of 5,2006-07-11,Evidence at protein level
Q495C1,RN212_HUMAN,Probable E3 SUMO-protein ligase RNF212 (EC 6.3.2.-) (RING finger protein 212),297,"33,365",4 out of 5,2007-02-06,Evidence at transcript level
Q9NWF9,RN216_HUMAN,E3 ubiquitin-protein ligase RNF216 (EC 2.3.2.27) (RING finger protein 216) (RING-type E3 ubiquitin transferase RNF216) (Triad domain-containing protein 3) (Ubiquitin-conjugating enzyme 7-interacting protein 1) (Zinc finger protein inhibiting NF-kappa-B),866,"99,406",5 out of 5,2001-09-26,Evidence at protein level
Q5M7Z0,RNFT1_HUMAN,RING finger and transmembrane domain-containing protein 1 (Protein PTD016),435,"49,710",3 out of 5,2008-02-26,Evidence at transcript level
P22626,ROA2_HUMAN,Heterogeneous nuclear ribonucleoproteins A2/B1 (hnRNP A2/B1),353,"37,430",5 out of 5,1991-08-01,Evidence at protein level
Q9HCK4,ROBO2_HUMAN,Roundabout homolog 2,1378,"151,200",5 out of 5,2004-06-21,Evidence at protein level
O75116,ROCK2_HUMAN,"Rho-associated protein kinase 2 (EC 2.7.11.1) (Rho kinase 2) (Rho-associated, coiled-coil-containing protein kinase 2) (Rho-associated, coiled-coil-containing protein kinase II) (ROCK-II) (p164 ROCK-2)",1388,"160,900",5 out of 5,2004-05-24,Evidence at protein level
P60602,ROMO1_HUMAN,Reactive oxygen species modulator 1 (ROS modulator 1) (Epididymis tissue protein Li 175) (Glyrichin) (Mitochondrial targeting GxxxG motif protein) (MTGM) (Protein MGR2 homolog),79,"8,183",5 out of 5,2004-03-15,Evidence at protein level
Q9HAT0,ROP1A_HUMAN,Ropporin-1A (Cancer/testis antigen 91) (CT91) (Rhophilin-associated protein 1A),212,"23,893",5 out of 5,2007-10-23,Evidence at protein level
O95398,RPGF3_HUMAN,Rap guanine nucleotide exchange factor 3 (Exchange factor directly activated by cAMP 1) (Exchange protein directly activated by cAMP 1) (EPAC 1) (Rap1 guanine-nucleotide-exchange factor directly activated by cAMP) (cAMP-regulated guanine nucleotide exchange factor I) (cAMP-GEFI),923,"103,751",5 out of 5,2003-06-20,Evidence at protein level
Q96KN7,RPGR1_HUMAN,X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 (RPGR-interacting protein 1),1286,"146,682",5 out of 5,2004-03-01,Evidence at protein level
Q9BYD6,RM01_HUMAN,"39S ribosomal protein L1, mitochondrial (L1mt) (MRP-L1) (Mitochondrial large ribosomal subunit protein uL1m)",325,"36,909",4 out of 5,2006-10-17,Evidence at protein level
Q9P0M9,RM27_HUMAN,"39S ribosomal protein L27, mitochondrial (L27mt) (MRP-L27) (Mitochondrial large ribosomal subunit protein bL27m)",148,"16,073",4 out of 5,2002-03-05,Evidence at protein level
Q9NZE8,RM35_HUMAN,"39S ribosomal protein L35, mitochondrial (L35mt) (MRP-L35) (Mitochondrial large ribosomal subunit protein bL35m)",188,"21,514",4 out of 5,2004-02-02,Evidence at protein level
Q96DV4,RM38_HUMAN,"39S ribosomal protein L38, mitochondrial (L38mt) (MRP-L38) (Mitochondrial large ribosomal subunit protein mL38)",380,"44,597",4 out of 5,2006-11-28,Evidence at protein level
Q8IXM3,RM41_HUMAN,"39S ribosomal protein L41, mitochondrial (L41mt) (MRP-L41) (39S ribosomal protein L27 homolog) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog) (Mitochondrial large ribosomal subunit protein mL41)",137,"15,383",5 out of 5,2007-01-23,Evidence at protein level
Q9H9J2,RM44_HUMAN,"39S ribosomal protein L44, mitochondrial (L44mt) (MRP-L44) (EC 3.1.26.-) (Mitochondrial large ribosomal subunit protein mL44)",332,"37,535",5 out of 5,2004-08-16,Evidence at protein level
Q9BV68,RN126_HUMAN,E3 ubiquitin-protein ligase RNF126 (EC 2.3.2.27) (RING finger protein 126),326,"35,585",5 out of 5,2005-09-27,Evidence at protein level
Q5W0B1,RN219_HUMAN,RING finger protein 219,726,"81,116",2 out of 5,2005-08-30,Evidence at protein level
Q03395,ROM1_HUMAN,Rod outer segment membrane protein 1 (ROSP1) (Tetraspanin-23) (Tspan-23),351,"37,205",5 out of 5,1993-10-01,Evidence at protein level
Q04912,RON_HUMAN,Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron) (CD antigen CD136) [Cleaved into: Macrophage-stimulating protein receptor alpha chain; Macrophage-stimulating protein receptor beta chain],1400,"152,271",5 out of 5,1994-10-01,Evidence at protein level
P53803,RPAB4_HUMAN,"DNA-directed RNA polymerases I, II, and III subunit RPABC4 (RNA polymerases I, II, and III subunit ABC4) (ABC10-alpha) (DNA-directed RNA polymerase II subunit K) (RNA polymerase II 7.0 kDa subunit) (RPB7.0) (RPB10alpha)",58,"7,004",5 out of 5,1996-10-01,Evidence at protein level
Q9H6T3,RPAP3_HUMAN,RNA polymerase II-associated protein 3,665,"75,719",5 out of 5,2007-09-11,Evidence at protein level
Q16518,RPE65_HUMAN,Retinoid isomerohydrolase (EC 3.1.1.64) (All-trans-retinyl-palmitate hydrolase) (Retinal pigment epithelium-specific 65 kDa protein) (Retinol isomerase),533,"60,948",5 out of 5,2003-10-10,Evidence at protein level
Q9H7B2,RPF2_HUMAN,Ribosome production factor 2 homolog (Brix domain-containing protein 1) (Ribosome biogenesis protein RPF2 homolog),306,"35,583",3 out of 5,2001-09-26,Evidence at protein level
P04843,RPN1_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 (Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kDa subunit) (Ribophorin I) (RPN-I) (Ribophorin-1),607,"68,569",5 out of 5,1987-08-13,Evidence at protein level
M0QZC1,RN225_HUMAN,RING finger protein 225,329,"34,789",2 out of 5,2014-11-26,Inferred from homology
Q8N5U6,RNF10_HUMAN,RING finger protein 10,811,"89,927",5 out of 5,2006-10-31,Evidence at protein level
O00584,RNT2_HUMAN,Ribonuclease T2 (EC 3.1.27.-) (Ribonuclease 6),256,"29,481",5 out of 5,2002-04-03,Evidence at protein level
P10155,RO60_HUMAN,60 kDa SS-A/Ro ribonucleoprotein (60 kDa Ro protein) (60 kDa ribonucleoprotein Ro) (RoRNP) (Ro 60 kDa autoantigen) (Sjoegren syndrome antigen A2) (Sjoegren syndrome type A antigen) (SS-A) (TROVE domain family member 2),538,"60,671",5 out of 5,1989-07-01,Evidence at protein level
O95602,RPA1_HUMAN,DNA-directed RNA polymerase I subunit RPA1 (RNA polymerase I subunit A1) (EC 2.7.7.6) (A190) (DNA-directed RNA polymerase I largest subunit) (DNA-directed RNA polymerase I subunit A) (RNA polymerase I 194 kDa subunit) (RPA194),1720,"194,811",5 out of 5,2000-12-01,Evidence at protein level
P52434,RPAB3_HUMAN,"DNA-directed RNA polymerases I, II, and III subunit RPABC3 (RNA polymerases I, II, and III subunit ABC3) (DNA-directed RNA polymerase II subunit H) (DNA-directed RNA polymerases I, II, and III 17.1 kDa polypeptide) (RPB17) (RPB8 homolog) (hRPB8)",150,"17,143",5 out of 5,1996-10-01,Evidence at protein level
P62875,RPAB5_HUMAN,"DNA-directed RNA polymerases I, II, and III subunit RPABC5 (RNA polymerases I, II, and III subunit ABC5) (DNA-directed RNA polymerase III subunit L) (RNA polymerase II 7.6 kDa subunit) (RPB7.6) (RPB10 homolog)",67,"7,645",5 out of 5,2004-08-16,Evidence at protein level
O15160,RPAC1_HUMAN,DNA-directed RNA polymerases I and III subunit RPAC1 (DNA-directed RNA polymerase I subunit C) (RNA polymerases I and III subunit AC1) (AC40) (DNA-directed RNA polymerases I and III 40 kDa polypeptide) (RPA40) (RPA39) (RPC40),346,"39,250",5 out of 5,1998-12-15,Evidence at protein level
Q9Y2S0,RPAC2_HUMAN,DNA-directed RNA polymerases I and III subunit RPAC2 (RNA polymerases I and III subunit AC2) (AC19) (DNA-directed RNA polymerase I subunit D) (RNA polymerase I 16 kDa subunit) (RPA16) (RPC16) (hRPA19),133,"15,237",5 out of 5,2000-12-01,Evidence at protein level
Q9H1A7,RPB1C_HUMAN,DNA-directed RNA polymerase II subunit RPB11-b2 (RNA polymerase II subunit B11-b2) (RPB11b2) (DNA-directed RNA polymerase II subunit J3),115,"13,092",2 out of 5,2008-02-05,Inferred from homology
P36954,RPB9_HUMAN,DNA-directed RNA polymerase II subunit RPB9 (RNA polymerase II subunit B9) (DNA-directed RNA polymerase II subunit I) (RNA polymerase II 14.5 kDa subunit) (RPB14.5),125,"14,523",5 out of 5,1994-06-01,Evidence at protein level
Q9NW08,RPC2_HUMAN,DNA-directed RNA polymerase III subunit RPC2 (RNA polymerase III subunit C2) (EC 2.7.7.6) (C128) (DNA-directed RNA polymerase III 127.6 kDa polypeptide) (DNA-directed RNA polymerase III subunit B),1133,"127,785",5 out of 5,2003-03-28,Evidence at protein level
O15318,RPC7_HUMAN,DNA-directed RNA polymerase III subunit RPC7 (RNA polymerase III subunit C7) (DNA-directed RNA polymerase III subunit G) (RNA polymerase III 32 kDa subunit) (RPC32),223,"25,914",5 out of 5,2005-02-01,Evidence at protein level
Q2QD12,RPEL1_HUMAN,Ribulose-phosphate 3-epimerase-like protein 1 (EC 5.1.3.1) (Ribulose-5-phosphate-3-epimerase-like protein 1),228,"25,023",4 out of 5,2014-02-19,Evidence at transcript level
Q9UNE2,RPH3L_HUMAN,Rab effector Noc2 (No C2 domains protein) (Rabphilin-3A-like protein),315,"34,464",5 out of 5,2007-02-20,Evidence at protein level
P49247,RPIA_HUMAN,Ribose-5-phosphate isomerase (EC 5.3.1.6) (Phosphoriboisomerase),311,"33,269",5 out of 5,1996-02-01,Evidence at protein level
O95707,RPP29_HUMAN,Ribonuclease P protein subunit p29 (hPOP4) (EC 3.1.26.5),220,"25,425",5 out of 5,2000-05-30,Evidence at protein level
Q8N4K4,RPRML_HUMAN,Reprimo-like protein,120,"12,312",2 out of 5,2007-12-04,Evidence at transcript level
Q96E11,RRFM_HUMAN,"Ribosome-recycling factor, mitochondrial (RRF) (Ribosome-releasing factor, mitochondrial)",262,"29,277",4 out of 5,2005-04-26,Evidence at protein level
Q9NYV6,RRN3_HUMAN,RNA polymerase I-specific transcription initiation factor RRN3 (Transcription initiation factor IA) (TIF-IA),651,"74,107",5 out of 5,2006-01-24,Evidence at protein level
Q9NSQ0,RRP7B_HUMAN,Putative ribosomal RNA-processing protein 7 homolog B (Putative gastric cancer antigen Zg14-like protein),103,"12,575",2 out of 5,2008-05-20,Uncertain
O43159,RRP8_HUMAN,Ribosomal RNA-processing protein 8 (EC 2.1.1.-) (Cerebral protein 1) (Nucleomethylin),456,"50,715",5 out of 5,2005-04-26,Evidence at protein level
Q9Y4G8,RPGF2_HUMAN,Rap guanine nucleotide exchange factor 2 (Cyclic nucleotide ras GEF) (CNrasGEF) (Neural RAP guanine nucleotide exchange protein) (nRap GEP) (PDZ domain-containing guanine nucleotide exchange factor 1) (PDZ-GEF1) (RA-GEF-1) (Ras/Rap1-associating GEF-1),1499,"167,417",5 out of 5,2003-08-29,Evidence at protein level
Q8TEU7,RPGF6_HUMAN,Rap guanine nucleotide exchange factor 6 (PDZ domain-containing guanine nucleotide exchange factor 2) (PDZ-GEF2) (RA-GEF-2),1601,"179,423",5 out of 5,2003-08-29,Evidence at protein level
Q9NQG5,RPR1B_HUMAN,Regulation of nuclear pre-mRNA domain-containing protein 1B (Cell cycle-related and expression-elevated protein in tumor),326,"36,900",5 out of 5,2002-10-10,Evidence at protein level
Q9NS64,RPRM_HUMAN,Protein reprimo,109,"11,774",3 out of 5,2007-12-04,Evidence at protein level
Q9P2E9,RRBP1_HUMAN,Ribosome-binding protein 1 (180 kDa ribosome receptor homolog) (RRp) (ES/130-related protein) (Ribosome receptor protein),1410,"152,472",5 out of 5,2002-10-10,Evidence at protein level
Q15050,RRS1_HUMAN,Ribosome biogenesis regulatory protein homolog,365,"41,193",5 out of 5,1998-07-15,Evidence at protein level
A6NIZ1,RP1BL_HUMAN,Ras-related protein Rap-1b-like protein,184,"20,925",3 out of 5,2008-07-22,Evidence at transcript level
Q3B726,RPA43_HUMAN,DNA-directed RNA polymerase I subunit RPA43 (Twist neighbor protein),338,"37,432",4 out of 5,2007-05-29,Evidence at protein level
Q9GZS1,RPA49_HUMAN,DNA-directed RNA polymerase I subunit RPA49 (RNA polymerase I subunit A49) (DNA-directed RNA polymerase I subunit E) (RNA polymerase I-associated factor 1) (RNA polymerase I-associated factor 53),481,"53,962",5 out of 5,2005-04-26,Evidence at protein level
P19387,RPB3_HUMAN,DNA-directed RNA polymerase II subunit RPB3 (RNA polymerase II subunit 3) (RNA polymerase II subunit B3) (DNA-directed RNA polymerase II 33 kDa polypeptide) (RPB33) (DNA-directed RNA polymerase II subunit C) (RPB31),275,"31,441",5 out of 5,1990-11-01,Evidence at protein level
Q9H9Y2,RPF1_HUMAN,Ribosome production factor 1 (Brix domain-containing protein 5) (Ribosome biogenesis protein RPF1),349,"40,111",4 out of 5,2005-07-19,Evidence at protein level
Q9UHV5,RPGFL_HUMAN,Rap guanine nucleotide exchange factor-like 1 (Link guanine nucleotide exchange factor II) (Link GEFII),662,"73,265",4 out of 5,2008-09-02,Evidence at protein level
Q5JTH9,RRP12_HUMAN,RRP12-like protein,1297,"143,702",4 out of 5,2005-07-19,Evidence at protein level
Q92565,RPGF5_HUMAN,Rap guanine nucleotide exchange factor 5 (Guanine nucleotide exchange factor for Rap1) (M-Ras-regulated Rap GEF) (MR-GEF) (Related to Epac) (Repac),580,"67,733",5 out of 5,2003-06-20,Evidence at protein level
P47736,RPGP1_HUMAN,Rap1 GTPase-activating protein 1 (Rap1GAP) (Rap1GAP1),663,"73,361",5 out of 5,1996-02-01,Evidence at protein level
Q9Y6S9,RPKL1_HUMAN,Ribosomal protein S6 kinase-like 1 (EC 2.7.11.1),549,"60,036",3 out of 5,2006-04-18,Evidence at transcript level
Q7L523,RRAGA_HUMAN,Ras-related GTP-binding protein A (Rag A) (RagA) (Adenovirus E3 14.7 kDa-interacting protein 1) (FIP-1),313,"36,566",5 out of 5,2006-06-13,Evidence at protein level
P25398,RS12_HUMAN,40S ribosomal protein S12 (Small ribosomal subunit protein eS12),132,"14,515",5 out of 5,1992-05-01,Evidence at protein level
P62277,RS13_HUMAN,40S ribosomal protein S13 (Small ribosomal subunit protein uS15),151,"17,222",5 out of 5,2004-07-05,Evidence at protein level
P78345,RPP38_HUMAN,Ribonuclease P protein subunit p38 (RNaseP protein p38) (EC 3.1.26.5),283,"31,834",5 out of 5,2001-02-21,Evidence at protein level
Q14690,RRP5_HUMAN,Protein RRP5 homolog (NF-kappa-B-binding protein) (NFBP) (Programmed cell death protein 11),1871,"208,701",5 out of 5,1997-11-01,Evidence at protein level
Q9Y3A4,RRP7A_HUMAN,Ribosomal RNA-processing protein 7 homolog A (Gastric cancer antigen Zg14),280,"32,334",4 out of 5,2000-05-30,Evidence at protein level
P63220,RS21_HUMAN,40S ribosomal protein S21 (Small ribosomal subunit protein eS21),83,"9,111",5 out of 5,2004-09-27,Evidence at protein level
O75818,RPP40_HUMAN,Ribonuclease P protein subunit p40 (RNaseP protein p40) (EC 3.1.26.5) (RNase P subunit 1),363,"41,834",4 out of 5,2001-02-21,Evidence at protein level
Q96FB5,RRNAD_HUMAN,Protein RRNAD1 (Ribosomal RNA adenine dimethylase domain-containing protein 1),475,"52,981",3 out of 5,2007-05-29,Evidence at transcript level
P46783,RS10_HUMAN,40S ribosomal protein S10 (Small ribosomal subunit protein eS10),165,"18,898",5 out of 5,1995-11-01,Evidence at protein level
P42677,RS27_HUMAN,40S ribosomal protein S27 (Metallopan-stimulin 1) (MPS-1) (Small ribosomal subunit protein eS27),84,"9,461",5 out of 5,1995-11-01,Evidence at protein level
P62857,RS28_HUMAN,40S ribosomal protein S28 (Small ribosomal subunit protein eS28),69,"7,841",5 out of 5,2004-08-16,Evidence at protein level
Q8TD47,RS4Y2_HUMAN,"40S ribosomal protein S4, Y isoform 2 (Small ribosomal subunit protein eS4)",263,"29,295",2 out of 5,2003-01-17,Evidence at transcript level
P15880,RS2_HUMAN,40S ribosomal protein S2 (40S ribosomal protein S4) (Protein LLRep3) (Small ribosomal subunit protein uS5),293,"31,324",5 out of 5,1990-04-01,Evidence at protein level
P62070,RRAS2_HUMAN,Ras-related protein R-Ras2 (Ras-like protein TC21) (Teratocarcinoma oncogene),204,"23,400",5 out of 5,2004-06-21,Evidence at protein level
Q969S9,RRF2M_HUMAN,"Ribosome-releasing factor 2, mitochondrial (RRF2mt) (Elongation factor G 2, mitochondrial) (EF-G2mt) (mEF-G 2) (Elongation factor G2) (hEFG2)",779,"86,601",5 out of 5,2003-02-01,Evidence at protein level
Q9Y3B9,RRP15_HUMAN,RRP15-like protein (Ribosomal RNA-processing protein 15),282,"31,484",3 out of 5,2007-01-23,Evidence at protein level
Q9Y2L1,RRP44_HUMAN,Exosome complex exonuclease RRP44 (EC 3.1.13.-) (EC 3.1.26.-) (Protein DIS3 homolog) (Ribosomal RNA-processing protein 44),958,"109,003",5 out of 5,2000-05-30,Evidence at protein level
P62266,RS23_HUMAN,40S ribosomal protein S23 (Small ribosomal subunit protein uS12),143,"15,808",5 out of 5,2004-07-05,Evidence at protein level
Q9Y6B6,SAR1B_HUMAN,GTP-binding protein SAR1b (GTP-binding protein B) (GTBPB),198,"22,410",5 out of 5,2001-06-01,Evidence at protein level
Q15436,SC23A_HUMAN,Protein transport protein Sec23A (SEC23-related protein A),765,"86,161",5 out of 5,1997-11-01,Evidence at protein level
Q4G0G5,SC2B2_HUMAN,Secretoglobin family 2B member 2 (Secretoglobin-like protein),96,"10,563",2 out of 5,2008-07-01,Inferred from homology
Q9UPN6,SCAF8_HUMAN,Protein SCAF8 (CDC5L complex-associated protein 7) (RNA-binding motif protein 16) (SR-related and CTD-associated factor 8),1271,"140,519",5 out of 5,2003-05-09,Evidence at protein level
Q9BY12,SCAPE_HUMAN,S phase cyclin A-associated protein in the endoplasmic reticulum (S phase cyclin A-associated protein in the ER) (Zinc finger protein 291),1400,"158,287",5 out of 5,2002-05-15,Evidence at protein level
Q6KCM7,SCMC2_HUMAN,Calcium-binding mitochondrial carrier protein SCaMC-2 (Mitochondrial ATP-Mg/Pi carrier protein 3) (Mitochondrial Ca(2+)-dependent solute carrier protein 3) (Small calcium-binding mitochondrial carrier protein 2) (Solute carrier family 25 member 25),469,"52,663",5 out of 5,2008-02-05,Evidence at protein level
Q6R2W3,SCND3_HUMAN,SCAN domain-containing protein 3 (Transposon-derived Buster4 transposase-like protein) (Zinc finger BED domain-containing protein 9),1325,"151,666",3 out of 5,2006-07-11,Evidence at transcript level
P55809,SCOT1_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 1) (Somatic-type succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-s)",520,"56,158",5 out of 5,1997-11-01,Evidence at protein level
Q14108,SCRB2_HUMAN,Lysosome membrane protein 2 (85 kDa lysosomal membrane sialoglycoprotein) (LGP85) (CD36 antigen-like 2) (Lysosome membrane protein II) (LIMP II) (Scavenger receptor class B member 2) (CD antigen CD36),478,"54,290",5 out of 5,1997-11-01,Evidence at protein level
Q14160,SCRIB_HUMAN,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),1630,"174,885",5 out of 5,2004-07-19,Evidence at protein level
Q8WVN6,SCTM1_HUMAN,Secreted and transmembrane protein 1 (Protein K-12),248,"27,039",5 out of 5,2002-11-08,Evidence at protein level
Q8IWY4,SCUB1_HUMAN,"Signal peptide, CUB and EGF-like domain-containing protein 1",988,"107,910",5 out of 5,2006-10-31,Evidence at protein level
P20132,SDHL_HUMAN,L-serine dehydratase/L-threonine deaminase (SDH) (EC 4.3.1.17) (L-serine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19),328,"34,625",5 out of 5,1991-02-01,Evidence at protein level
O95810,SDPR_HUMAN,Serum deprivation-response protein (Cavin-2) (PS-p68) (Phosphatidylserine-binding protein),425,"47,173",5 out of 5,2006-05-30,Evidence at protein level
Q9BYH1,SE6L1_HUMAN,Seizure 6-like protein,1024,"111,782",5 out of 5,2002-07-26,Evidence at protein level
Q9NZV5,SELN_HUMAN,Selenoprotein N (SelN),590,"65,813",5 out of 5,2001-01-11,Evidence at protein level
P63302,SELW_HUMAN,Selenoprotein W (SelW),87,"9,448",3 out of 5,2004-10-11,Evidence at protein level
Q14563,SEM3A_HUMAN,Semaphorin-3A (Semaphorin III) (Sema III),771,"88,889",5 out of 5,2000-05-30,Evidence at protein level
Q99985,SEM3C_HUMAN,Semaphorin-3C (Semaphorin-E) (Sema E),751,"85,207",5 out of 5,2000-05-30,Evidence at transcript level
O15041,SEM3E_HUMAN,Semaphorin-3E,775,"89,228",5 out of 5,2000-05-30,Evidence at protein level
Q9NS98,SEM3G_HUMAN,Semaphorin-3G (Semaphorin sem2),782,"86,701",3 out of 5,2006-10-31,Evidence at transcript level
Q9NPR2,SEM4B_HUMAN,Semaphorin-4B,832,"92,193",4 out of 5,2001-04-27,Evidence at protein level
Q9H3T3,SEM6B_HUMAN,Semaphorin-6B (Semaphorin-Z) (Sema Z),888,"95,285",4 out of 5,2001-04-27,Evidence at protein level
Q8NCE0,SEN2_HUMAN,tRNA-splicing endonuclease subunit Sen2 (EC 4.6.1.16) (tRNA-intron endonuclease Sen2) (HsSen2),465,"53,247",5 out of 5,2004-07-19,Evidence at protein level
A8MV23,SERP3_HUMAN,Serpin E3,424,"46,963",3 out of 5,2008-06-10,Evidence at transcript level
Q9C0A6,SETD5_HUMAN,SET domain-containing protein 5,1442,"157,515",4 out of 5,2007-04-03,Evidence at protein level
Q12874,SF3A3_HUMAN,Splicing factor 3A subunit 3 (SF3a60) (Spliceosome-associated protein 61) (SAP 61),501,"58,849",5 out of 5,2001-08-29,Evidence at protein level
Q13435,SF3B2_HUMAN,Splicing factor 3B subunit 2 (Pre-mRNA-splicing factor SF3b 145 kDa subunit) (SF3b145) (SF3b150) (Spliceosome-associated protein 145) (SAP 145),895,"100,228",5 out of 5,1997-11-01,Evidence at protein level
Q6UW10,SFTA2_HUMAN,Surfactant-associated protein 2 (Surfactant-associated protein G) (SP-G),78,"8,396",3 out of 5,2004-11-23,Evidence at protein level
Q6P4A7,SFXN4_HUMAN,Sideroflexin-4 (Breast cancer resistance marker 1),337,"37,998",4 out of 5,2005-07-19,Evidence at protein level
Q9H5K3,SG196_HUMAN,Protein O-mannose kinase (POMK) (EC 2.7.1.183) (Protein kinase-like protein SgK196) (Sugen kinase 196),350,"40,050",5 out of 5,2006-11-28,Evidence at protein level
O75556,SG2A1_HUMAN,Mammaglobin-B (Lacryglobin) (Lipophilin-C) (Mammaglobin-2) (Secretoglobin family 2A member 1),95,"10,884",5 out of 5,2000-05-30,Evidence at protein level
Q96LW2,SG494_HUMAN,Uncharacterized serine/threonine-protein kinase SgK494 (EC 2.7.11.1) (Sugen kinase 494),274,"31,044",3 out of 5,2006-10-03,Evidence at transcript level
O43556,SGCE_HUMAN,Epsilon-sarcoglycan (Epsilon-SG),437,"49,851",5 out of 5,2001-04-27,Evidence at protein level
Q5FBB7,SGO1_HUMAN,Shugoshin 1 (Serologically defined breast cancer antigen NY-BR-85) (Shugoshin-like 1),561,"64,190",5 out of 5,2006-01-10,Evidence at protein level
O95470,SGPL1_HUMAN,Sphingosine-1-phosphate lyase 1 (S1PL) (SP-lyase 1) (SPL 1) (hSPL) (EC 4.1.2.27) (Sphingosine-1-phosphate aldolase),568,"63,524",5 out of 5,2003-10-24,Evidence at protein level
O43765,SGTA_HUMAN,Small glutamine-rich tetratricopeptide repeat-containing protein alpha (Alpha-SGT) (Vpu-binding protein) (UBP),313,"34,063",5 out of 5,2000-05-30,Evidence at protein level
O14796,SH21B_HUMAN,SH2 domain-containing protein 1B (EWS/FLI1-activated transcript 2) (EAT-2),132,"15,297",5 out of 5,2001-04-27,Evidence at protein level
O14492,SH2B2_HUMAN,SH2B adapter protein 2 (Adapter protein with pleckstrin homology and Src homology 2 domains) (SH2 and PH domain-containing adapter protein APS),632,"67,738",5 out of 5,2003-08-15,Evidence at protein level
A6NKC9,SH2D7_HUMAN,SH2 domain-containing protein 7,451,"49,807",2 out of 5,2008-06-10,Predicted
Q5HYK7,SH319_HUMAN,SH3 domain-containing protein 19 (ADAM-binding protein Eve-1) (EEN-binding protein) (EBP),790,"86,525",5 out of 5,2008-02-05,Evidence at protein level
Q13796,SHRM2_HUMAN,Protein Shroom2 (Apical-like protein) (Protein APXL),1616,"176,410",5 out of 5,1997-11-01,Evidence at protein level
B8ZZ34,SHSA8_HUMAN,Putative protein shisa-8,492,"51,412",3 out of 5,2010-06-15,Uncertain
Q9UJ37,SIA7B_HUMAN,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase II) (ST6GalNAc II) (ST6GalNAcII) (SThM) (Sialyltransferase 7B) (SIAT7-B)",374,"41,939",4 out of 5,2002-07-11,Evidence at protein level
Q9H4F1,SIA7D_HUMAN,"Alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3-N-acetyl-galactosaminide alpha-2,6-sialyltransferase (EC 2.4.99.7) (NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc-alpha-2,6-sialyltransferase) (ST6GalNAc IV) (ST6GalNAcIV) (Sialyltransferase 3C) (SIAT3-C) (Sialyltransferase 7D) (SIAT7-D)",302,"34,201",5 out of 5,2002-07-11,Evidence at transcript level
Q92187,SIA8D_HUMAN,"CMP-N-acetylneuraminate-poly-alpha-2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8D) (Polysialyltransferase-1) (Sialyltransferase 8D) (SIAT8-D) (Sialyltransferase St8Sia IV) (ST8SiaIV)",359,"41,295",5 out of 5,1997-11-01,Evidence at protein level
Q96JF0,SIAT2_HUMAN,"Beta-galactoside alpha-2,6-sialyltransferase 2 (Alpha 2,6-ST 2) (EC 2.4.99.1) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 2) (ST6Gal II) (ST6GalII) (hST6Gal II) (Sialyltransferase 2)",529,"60,158",5 out of 5,2008-01-15,Evidence at protein level
A6NMB1,SIG16_HUMAN,Sialic acid-binding Ig-like lectin 16 (Siglec-16) (Siglec-P16),481,"52,992",4 out of 5,2008-04-29,Evidence at transcript level
Q8N7X8,SIGL1_HUMAN,SIGLEC family-like protein 1,197,"21,283",1 out of 5,2008-04-29,Evidence at transcript level
O43699,SIGL6_HUMAN,Sialic acid-binding Ig-like lectin 6 (Siglec-6) (CD33 antigen-like 1) (CDw327) (Obesity-binding protein 1) (OB-BP1) (CD antigen CD327),453,"49,913",5 out of 5,2002-11-08,Evidence at protein level
P57059,SIK1_HUMAN,Serine/threonine-protein kinase SIK1 (EC 2.7.11.1) (Salt-inducible kinase 1) (SIK-1) (Serine/threonine-protein kinase SNF1-like kinase 1) (Serine/threonine-protein kinase SNF1LK),783,"84,902",5 out of 5,2000-12-01,Evidence at protein level
P0DMW5,SIL2B_HUMAN,Small integral membrane protein 10-like protein 2B,78,"8,389",1 out of 5,2015-06-24,Predicted
Q14190,SIM2_HUMAN,Single-minded homolog 2 (Class E basic helix-loop-helix protein 15) (bHLHe15),667,"73,219",5 out of 5,1997-11-01,Evidence at protein level
Q96ST3,SIN3A_HUMAN,Paired amphipathic helix protein Sin3a (Histone deacetylase complex subunit Sin3a) (Transcriptional corepressor Sin3a),1273,"145,175",5 out of 5,2003-10-24,Evidence at protein level
Q9NTG7,SIR3_HUMAN,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial (hSIRT3) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 3) (SIR2-like protein 3)",399,"43,573",5 out of 5,2003-10-31,Evidence at protein level
Q5JXA9,SIRB2_HUMAN,Signal-regulatory protein beta-2 (SIRP-beta-2) (Protein tyrosine phosphatase non-receptor type substrate 1-like 3) (Protein tyrosine phosphatase non-receptor type substrate protein),342,"36,968",3 out of 5,2008-06-10,Evidence at transcript level
O15304,SIVA_HUMAN,Apoptosis regulatory protein Siva (CD27-binding protein) (CD27BP),175,"18,695",5 out of 5,2003-05-23,Evidence at protein level
O95343,SIX3_HUMAN,Homeobox protein SIX3 (Sine oculis homeobox homolog 3),332,"35,487",5 out of 5,1999-07-15,Evidence at protein level
Q8WVK7,SKA2_HUMAN,Spindle and kinetochore-associated protein 2 (Protein FAM33A),121,"14,188",5 out of 5,2006-12-12,Evidence at protein level
Q9Y448,SKAP_HUMAN,Small kinetochore-associated protein (SKAP) (Kinetochore-localized astrin-binding protein) (Kinastrin) (Kinetochore-localized astrin/SPAG5-binding protein) (TRAF4-associated factor 1),316,"35,438",5 out of 5,2007-02-06,Evidence at protein level
P21912,SDHB_HUMAN,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip)",280,"31,630",5 out of 5,1991-05-01,Evidence at protein level
Q9UBV2,SE1L1_HUMAN,Protein sel-1 homolog 1 (Suppressor of lin-12-like protein 1) (Sel-1L),794,"88,755",5 out of 5,2001-04-27,Evidence at protein level
Q5TEA6,SE1L2_HUMAN,Protein sel-1 homolog 2 (Suppressor of lin-12-like protein 2) (Sel-1L2),688,"77,964",3 out of 5,2007-10-02,Evidence at transcript level
Q68CR1,SE1L3_HUMAN,Protein sel-1 homolog 3 (Suppressor of lin-12-like protein 3) (Sel-1L3),1132,"128,567",3 out of 5,2008-02-26,Evidence at protein level
Q5TG53,SEAS1_HUMAN,Putative uncharacterized protein SERTAD4-AS1 (SERTAD4 antisense RNA 1) (SERTAD4 antisense gene protein 1),156,"16,212",2 out of 5,2008-09-02,Uncertain
Q8IZQ5,SELH_HUMAN,Selenoprotein H (SelH),122,"13,453",2 out of 5,2003-08-04,Evidence at protein level
Q7Z6J9,SEN54_HUMAN,tRNA-splicing endonuclease subunit Sen54 (SEN54 homolog) (HsSEN54) (tRNA-intron endonuclease Sen54),526,"58,819",5 out of 5,2004-07-19,Evidence at protein level
Q6ZU15,SEP14_HUMAN,Septin-14,432,"50,025",4 out of 5,2007-07-10,Evidence at protein level
Q13530,SERC3_HUMAN,Serine incorporator 3 (Tumor differentially expressed protein 1),473,"52,580",5 out of 5,2002-11-25,Evidence at transcript level
Q9NQF3,SERHL_HUMAN,Serine hydrolase-like protein (SHL) (EC 3.1.-.-),203,"22,471",2 out of 5,2002-06-06,Evidence at transcript level
Q8NE22,SETD9_HUMAN,SET domain-containing protein 9 (EC 2.1.1.-),299,"34,095",3 out of 5,2007-09-11,Evidence at transcript level
Q8WTS6,SETD7_HUMAN,Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.43) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9),366,"40,721",5 out of 5,2002-11-15,Evidence at protein level
O43147,SGSM2_HUMAN,Small G protein signaling modulator 2 (RUN and TBC1 domain-containing protein 1),1006,"113,285",5 out of 5,2007-04-17,Evidence at protein level
P55822,SH3BG_HUMAN,SH3 domain-binding glutamic acid-rich protein (SH3BGR protein) (21-glutamic acid-rich protein) (21-GARP),239,"26,086",3 out of 5,1997-11-01,Evidence at transcript level
O75368,SH3L1_HUMAN,SH3 domain-binding glutamic acid-rich-like protein,114,"12,774",3 out of 5,2001-01-11,Evidence at protein level
Q9H299,SH3L3_HUMAN,SH3 domain-binding glutamic acid-rich-like protein 3 (SH3 domain-binding protein 1) (SH3BP-1),93,"10,438",5 out of 5,2002-11-01,Evidence at protein level
Q7Z6J0,SH3R1_HUMAN,E3 ubiquitin-protein ligase SH3RF1 (EC 2.3.2.27) (Plenty of SH3s) (Protein POSH) (RING finger protein 142) (RING-type E3 ubiquitin transferase SH3RF1) (SH3 domain-containing RING finger protein 1) (SH3 multiple domains protein 2),888,"93,129",5 out of 5,2008-05-20,Evidence at protein level
Q8TEJ3,SH3R3_HUMAN,SH3 domain-containing RING finger protein 3 (Plenty of SH3s 2) (SH3 multiple domains protein 4),882,"92,776",3 out of 5,2007-05-01,Evidence at protein level
P04278,SHBG_HUMAN,Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin),402,"43,779",5 out of 5,1987-03-20,Evidence at protein level
Q15464,SHB_HUMAN,SH2 domain-containing adapter protein B,509,"55,042",5 out of 5,2006-07-25,Evidence at protein level
Q15465,SHH_HUMAN,Sonic hedgehog protein (SHH) (HHG-1) [Cleaved into: Sonic hedgehog protein N-product; Sonic hedgehog protein C-product],462,"49,607",5 out of 5,1999-07-15,Evidence at protein level
Q2M3G4,SHRM1_HUMAN,Protein Shroom1 (Apical protein 2),852,"90,786",4 out of 5,2007-05-01,Evidence at protein level
Q8TF72,SHRM3_HUMAN,Protein Shroom3 (Shroom-related protein) (hShrmL),1996,"216,857",5 out of 5,2007-05-01,Evidence at protein level
Q9H0F6,SHRPN_HUMAN,Sharpin (Shank-associated RH domain-interacting protein) (Shank-interacting protein-like 1) (hSIPL1),387,"39,949",5 out of 5,2007-03-20,Evidence at protein level
Q11203,SIAT6_HUMAN,"CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase (EC 2.4.99.6) (Beta-galactoside alpha-2,3-sialyltransferase 3) (Alpha 2,3-ST 3) (Gal beta-1,3(4) GlcNAc alpha-2,3 sialyltransferase) (N-acetyllactosaminide alpha-2,3-sialyltransferase) (ST3Gal III) (ST3GalIII) (ST3N) (Sialyltransferase 6)",375,"42,171",5 out of 5,1996-10-01,Evidence at protein level
Q08ET2,SIG14_HUMAN,Sialic acid-binding Ig-like lectin 14 (Siglec-14),396,"43,970",5 out of 5,2007-11-13,Evidence at protein level
Q9H106,SIRPD_HUMAN,Signal-regulatory protein delta (SIRP-delta) (Protein tyrosine phosphatase non-receptor type substrate 1-like 2),197,"21,687",2 out of 5,2003-08-29,Evidence at transcript level
Q9P1W8,SIRPG_HUMAN,Signal-regulatory protein gamma (SIRP-gamma) (CD172 antigen-like family member B) (Signal-regulatory protein beta-2) (SIRP-b2) (SIRP-beta-2) (CD antigen CD172g),387,"42,498",5 out of 5,2003-03-28,Evidence at protein level
Q9UIU6,SIX4_HUMAN,Homeobox protein SIX4 (Sine oculis homeobox homolog 4),781,"82,933",5 out of 5,2001-01-11,Evidence at protein level
Q96BD8,SKA1_HUMAN,Spindle and kinetochore-associated protein 1,255,"29,484",5 out of 5,2007-01-23,Evidence at protein level
Q15477,SKIV2_HUMAN,Helicase SKI2W (Ski2) (EC 3.6.4.-) (Helicase-like protein) (HLP),1246,"137,755",5 out of 5,1997-11-01,Evidence at protein level
P12755,SKI_HUMAN,Ski oncogene (Proto-oncogene c-Ski),728,"80,005",5 out of 5,1989-10-01,Evidence at protein level
Q9P0V8,SLAF8_HUMAN,SLAM family member 8 (B-lymphocyte activator macrophage expressed) (BCM-like membrane protein) (CD antigen CD353),285,"31,670",4 out of 5,2005-06-07,Evidence at protein level
Q9P270,SLAI2_HUMAN,SLAIN motif-containing protein 2,581,"62,543",5 out of 5,2008-02-05,Evidence at protein level
Q9H6Q3,SLAP2_HUMAN,Src-like-adapter 2 (Modulator of antigen receptor signaling) (MARS) (Src-like adapter protein 2) (SLAP-2),261,"28,585",5 out of 5,2003-04-23,Evidence at protein level
Q14BN4,SLMAP_HUMAN,Sarcolemmal membrane-associated protein (Sarcolemmal-associated protein),828,"95,198",5 out of 5,2006-10-31,Evidence at protein level
P03973,SLPI_HUMAN,Antileukoproteinase (ALP) (BLPI) (HUSI-1) (Mucus proteinase inhibitor) (MPI) (Protease inhibitor WAP4) (Secretory leukocyte protease inhibitor) (Seminal proteinase inhibitor) (WAP four-disulfide core domain protein 4),132,"14,326",5 out of 5,1986-10-23,Evidence at protein level
Q15796,SMAD2_HUMAN,Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2),467,"52,306",5 out of 5,2001-04-27,Evidence at protein level
Q9BSF0,SMAKA_HUMAN,Small membrane A-kinase anchor protein (Small membrane AKAP) (smAKAP),95,"10,970",4 out of 5,2008-09-02,Evidence at protein level
Q9NZC9,SMAL1_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1 (EC 3.6.4.-) (HepA-related protein) (hHARP) (Sucrose nonfermenting protein 2-like 1),954,"105,938",5 out of 5,2005-03-01,Evidence at protein level
Q8TEV8,SMCR5_HUMAN,Smith-Magenis syndrome chromosomal region candidate gene 5 protein,140,"15,285",1 out of 5,2007-10-23,Evidence at transcript level
Q8TEV9,SMCR8_HUMAN,Smith-Magenis syndrome chromosomal region candidate gene 8 protein,937,"105,022",5 out of 5,2007-05-15,Evidence at protein level
P62318,SMD3_HUMAN,Small nuclear ribonucleoprotein Sm D3 (Sm-D3) (snRNP core protein D3),126,"13,916",5 out of 5,2004-07-05,Evidence at protein level
O75995,SASH3_HUMAN,SAM and SH3 domain-containing protein 3 (SH3 protein expressed in lymphocytes homolog),380,"41,595",4 out of 5,2003-10-24,Evidence at protein level
Q86VE3,SATL1_HUMAN,Spermidine/spermine N(1)-acetyltransferase-like protein 1 (EC 2.3.1.-),508,"55,833",3 out of 5,2007-04-03,Evidence at transcript level
Q96EE3,SEH1_HUMAN,Nucleoporin SEH1 (Nup107-160 subcomplex subunit SEH1) (SEC13-like protein),360,"39,649",5 out of 5,2003-03-28,Evidence at protein level
Q9Y6D0,SELK_HUMAN,Selenoprotein K (SelK),94,"10,645",5 out of 5,2000-05-30,Evidence at protein level
O95754,SEM4F_HUMAN,Semaphorin-4F (Semaphorin-M) (Sema M) (Semaphorin-W) (Sema W),770,"83,511",5 out of 5,2000-05-30,Evidence at transcript level
Q9NTN9,SEM4G_HUMAN,Semaphorin-4G,838,"91,497",5 out of 5,2001-04-27,Evidence at protein level
O75326,SEM7A_HUMAN,Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108),666,"74,824",5 out of 5,2001-06-20,Evidence at protein level
P50454,SERPH_HUMAN,Serpin H1 (47 kDa heat shock protein) (Arsenic-transactivated protein 3) (AsTP3) (Cell proliferation-inducing gene 14 protein) (Collagen-binding protein) (Colligin) (Rheumatoid arthritis-related antigen RA-A47),418,"46,441",5 out of 5,1996-10-01,Evidence at protein level
P58004,SESN2_HUMAN,Sestrin-2 (EC 1.11.1.15) (Hypoxia-induced gene),480,"54,494",5 out of 5,2001-04-27,Evidence at protein level
Q9UPS6,SET1B_HUMAN,Histone-lysine N-methyltransferase SETD1B (EC 2.1.1.43) (Lysine N-methyltransferase 2G) (SET domain-containing protein 1B) (hSET1B),1966,"212,803",5 out of 5,2008-02-05,Evidence at protein level
Q9BYW2,SETD2_HUMAN,Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (SET domain-containing protein 2) (hSET2) (p231HBP),2564,"287,597",5 out of 5,2006-10-17,Evidence at protein level
P0DME0,SETLP_HUMAN,Protein SETSIP (SET pseudogene protein 18) (SET similar protein) (Similar to SET translocation protein),302,"34,882",5 out of 5,2014-04-16,Evidence at protein level
O95104,SFR15_HUMAN,"Splicing factor, arginine/serine-rich 15 (CTD-binding SR-like protein RA4) (SR-related and CTD-associated factor 4)",1147,"125,869",4 out of 5,2000-05-30,Evidence at protein level
Q8WV19,SFT2A_HUMAN,Vesicle transport protein SFT2A (SFT2 domain-containing protein 1) (pRGR1),159,"17,804",3 out of 5,2006-05-30,Evidence at protein level
Q587I9,SFT2C_HUMAN,Vesicle transport protein SFT2C (SFT2 domain-containing protein 3),215,"21,790",2 out of 5,2006-05-30,Evidence at transcript level
Q9Y2Z0,SGT1_HUMAN,Protein SGT1 homolog (Protein 40-6-3) (Sgt1) (Suppressor of G2 allele of SKP1 homolog),365,"41,024",5 out of 5,2003-10-03,Evidence at protein level
Q96EQ0,SGTB_HUMAN,Small glutamine-rich tetratricopeptide repeat-containing protein beta (Beta-SGT) (Small glutamine-rich protein with tetratricopeptide repeats 2),304,"33,429",4 out of 5,2004-01-16,Evidence at protein level
Q9BRG2,SH23A_HUMAN,SH2 domain-containing protein 3A (Novel SH2-containing protein 1),576,"63,093",5 out of 5,2006-05-02,Evidence at protein level
Q9NRF2,SH2B1_HUMAN,"SH2B adapter protein 1 (Pro-rich, PH and SH2 domain-containing signaling mediator) (PSM) (SH2 domain-containing protein 1B)",756,"79,366",5 out of 5,2008-03-18,Evidence at protein level
Q9UQQ2,SH2B3_HUMAN,SH2B adapter protein 3 (Lymphocyte adapter protein) (Lymphocyte-specific adapter protein Lnk) (Signal transduction protein Lnk),575,"63,225",5 out of 5,2001-04-27,Evidence at protein level
Q9Y566,SHAN1_HUMAN,SH3 and multiple ankyrin repeat domains protein 1 (Shank1) (Somatostatin receptor-interacting protein) (SSTR-interacting protein) (SSTRIP),2161,"224,959",5 out of 5,2002-07-26,Evidence at protein level
Q9BYB0,SHAN3_HUMAN,SH3 and multiple ankyrin repeat domains protein 3 (Shank3) (Proline-rich synapse-associated protein 2) (ProSAP2),1731,"184,667",5 out of 5,2002-07-26,Evidence at protein level
Q9BTD1,SHAS3_HUMAN,Putative uncharacterized protein SHANK2-AS3,123,"13,317",1 out of 5,2006-12-12,Uncertain
P29353,SHC1_HUMAN,SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1),583,"62,822",5 out of 5,1992-12-01,Evidence at protein level
Q9UHJ6,SHPK_HUMAN,Sedoheptulokinase (SHK) (EC 2.7.1.14) (Carbohydrate kinase-like protein),478,"51,491",5 out of 5,2001-04-27,Evidence at protein level
O60292,SI1L3_HUMAN,Signal-induced proliferation-associated 1-like protein 3 (SIPA1-like protein 3) (SPA-1-like protein 3),1781,"194,610",5 out of 5,2004-07-19,Evidence at protein level
Q9NSC7,SIA7A_HUMAN,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 (EC 2.4.99.3) (GalNAc alpha-2,6-sialyltransferase I) (ST6GalNAc I) (ST6GalNAcI) (Sialyltransferase 7A) (SIAT7-A)",600,"68,564",4 out of 5,2002-07-11,Evidence at transcript level
Q969X2,SIA7F_HUMAN,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase VI) (ST6GalNAc VI) (ST6GalNAcVI) (hST6GalNAc VI) (Sialyltransferase 7F) (SIAT7-F)",333,"38,068",5 out of 5,2008-01-15,Evidence at protein level
Q92186,SIA8B_HUMAN,"Alpha-2,8-sialyltransferase 8B (EC 2.4.99.-) (Sialyltransferase 8B) (SIAT8-B) (Sialyltransferase St8Sia II) (ST8SiaII) (Sialyltransferase X) (STX)",375,"42,430",5 out of 5,1997-11-01,Evidence at transcript level
Q8IUQ4,SIAH1_HUMAN,E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a),282,"31,123",5 out of 5,2004-04-26,Evidence at protein level
Q8NBJ9,SIDT2_HUMAN,SID1 transmembrane family member 2,832,"94,454",5 out of 5,2005-04-26,Evidence at protein level
Q96PQ1,SIG12_HUMAN,Sialic acid-binding Ig-like lectin 12 (Siglec-12) (Sialic acid-binding Ig-like lectin-like 1) (Siglec-L1),595,"64,984",5 out of 5,2002-11-08,Evidence at transcript level
Q9H0K1,SIK2_HUMAN,Serine/threonine-protein kinase SIK2 (EC 2.7.11.1) (Qin-induced kinase) (Salt-inducible kinase 2) (SIK-2) (Serine/threonine-protein kinase SNF1-like kinase 2),926,"103,915",5 out of 5,2005-02-15,Evidence at protein level
Q96QK8,SIM14_HUMAN,Small integral membrane protein 14,99,"10,710",3 out of 5,2006-12-12,Evidence at protein level
Q7Z3B0,SIM15_HUMAN,Small integral membrane protein 15,74,"8,625",2 out of 5,2008-03-18,Inferred from homology
P60896,SEM1_HUMAN,26S proteasome complex subunit SEM1 (26S proteasome complex subunit DSS1) (Deleted in split hand/split foot protein 1) (Split hand/foot deleted protein 1) (Split hand/foot malformation type 1 protein),70,"8,278",5 out of 5,2004-04-13,Evidence at protein level
Q9BSV6,SEN34_HUMAN,tRNA-splicing endonuclease subunit Sen34 (EC 4.6.1.16) (Leukocyte receptor cluster member 5) (tRNA-intron endonuclease Sen34) (HsSen34),310,"33,652",5 out of 5,2004-07-19,Evidence at protein level
Q8N4B1,SESQ1_HUMAN,Sesquipedalian-1 (Ses1) (27 kDa inositol polyphosphate phosphatase-interacting protein A) (IPIP27A),249,"27,215",5 out of 5,2006-10-31,Evidence at protein level
Q9NVD3,SETD4_HUMAN,SET domain-containing protein 4 (EC 2.1.1.-),440,"50,416",3 out of 5,2001-01-11,Evidence at transcript level
Q8TBK2,SETD6_HUMAN,N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6),473,"53,189",5 out of 5,2007-04-03,Evidence at protein level
Q01105,SET_HUMAN,Protein SET (HLA-DR-associated protein II) (Inhibitor of granzyme A-activated DNase) (IGAAD) (PHAPII) (Phosphatase 2A inhibitor I2PP2A) (I-2PP2A) (Template-activating factor I) (TAF-I),290,"33,489",5 out of 5,1993-04-01,Evidence at protein level
Q15427,SF3B4_HUMAN,Splicing factor 3B subunit 4 (Pre-mRNA-splicing factor SF3b 49 kDa subunit) (SF3b50) (Spliceosome-associated protein 49) (SAP 49),424,"44,386",5 out of 5,1997-11-01,Evidence at protein level
Q9H7N4,SFR19_HUMAN,"Splicing factor, arginine/serine-rich 19 (SR-related C-terminal domain-associated factor 1) (SR-related and CTD-associated factor 1) (SR-related-CTD-associated factor) (SCAF) (Serine arginine-rich pre-mRNA splicing factor SR-A1) (SR-A1)",1312,"139,270",4 out of 5,2007-09-11,Evidence at protein level
Q5T4F7,SFRP5_HUMAN,Secreted frizzled-related protein 5 (sFRP-5) (Frizzled-related protein 1b) (FRP-1b) (Secreted apoptosis-related protein 3) (SARP-3),317,"35,563",5 out of 5,2005-03-15,Evidence at transcript level
O95968,SG1D1_HUMAN,Secretoglobin family 1D member 1 (Lipophilin-A),90,"9,898",4 out of 5,2000-05-30,Evidence at protein level
Q96LD1,SGCZ_HUMAN,Zeta-sarcoglycan (Zeta-SG) (ZSG1),299,"32,949",4 out of 5,2004-01-16,Evidence at transcript level
A4FU49,SH321_HUMAN,SH3 domain-containing protein 21,640,"70,519",4 out of 5,2008-05-20,Evidence at transcript level
Q8TEC5,SH3R2_HUMAN,Putative E3 ubiquitin-protein ligase SH3RF2 (EC 2.3.2.27) (Heart protein phosphatase 1-binding protein) (HEPP1) (Protein phosphatase 1 regulatory subunit 39) (RING finger protein 158) (RING-type E3 ubiquitin transferase SH3RF2) (SH3 domain-containing RING finger protein 2),729,"79,320",5 out of 5,2007-01-09,Evidence at protein level
Q9UPX8,SHAN2_HUMAN,SH3 and multiple ankyrin repeat domains protein 2 (Shank2) (Cortactin-binding protein 1) (CortBP1) (Proline-rich synapse-associated protein 1),1470,"158,822",5 out of 5,2002-07-26,Evidence at protein level
Q9NR46,SHLB2_HUMAN,Endophilin-B2 (SH3 domain-containing GRB2-like protein B2),395,"43,974",5 out of 5,2004-01-16,Evidence at protein level
O60902,SHOX2_HUMAN,Short stature homeobox protein 2 (Homeobox protein Og12X) (Paired-related homeobox protein SHOT),331,"34,953",5 out of 5,2001-09-26,Evidence at transcript level
Q96DD7,SHSA4_HUMAN,Protein shisa-4 (Transmembrane protein 58),197,"21,522",3 out of 5,2006-10-31,Evidence at transcript level
P58511,SI11A_HUMAN,Small integral membrane protein 11A,58,"6,886",2 out of 5,2002-01-23,Evidence at transcript level
Q8TCY0,SI11B_HUMAN,Small integral membrane protein 11B,68,"7,880",1 out of 5,2016-09-07,Inferred from homology
Q8NDV1,SIA7C_HUMAN,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 (EC 2.4.99.-) (GalNAc alpha-2,6-sialyltransferase III) (ST6GalNAc III) (ST6GalNAcIII) (STY) (Sialyltransferase 7C) (SIAT7-C)",305,"35,395",5 out of 5,2004-06-07,Evidence at transcript level
Q92185,SIA8A_HUMAN,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase (EC 2.4.99.8) (Alpha-2,8-sialyltransferase 8A) (Ganglioside GD3 synthase) (Ganglioside GT3 synthase) (Sialyltransferase 8A) (SIAT8-A) (Sialyltransferase St8Sia I) (ST8SiaI)",356,"40,519",5 out of 5,1997-11-01,Evidence at protein level
O15466,SIA8E_HUMAN,"Alpha-2,8-sialyltransferase 8E (EC 2.4.99.-) (Sialyltransferase 8E) (SIAT8-E) (Sialyltransferase St8Sia V) (ST8SiaV)",376,"43,895",5 out of 5,2002-07-11,Evidence at protein level
Q9HAT2,SIAE_HUMAN,Sialate O-acetylesterase (EC 3.1.1.53) (H-Lse) (Sialic acid-specific 9-O-acetylesterase),523,"58,315",5 out of 5,2005-10-11,Evidence at protein level
Q96RL6,SIG11_HUMAN,Sialic acid-binding Ig-like lectin 11 (Sialic acid-binding lectin 11) (Siglec-11),698,"75,795",5 out of 5,2002-11-08,Evidence at protein level
O15389,SIGL5_HUMAN,Sialic acid-binding Ig-like lectin 5 (Siglec-5) (CD33 antigen-like 2) (Obesity-binding protein 2) (OB-BP2) (OB-binding protein 2) (CD antigen CD170),551,"60,715",5 out of 5,2002-11-08,Evidence at protein level
Q9Y286,SIGL7_HUMAN,Sialic acid-binding Ig-like lectin 7 (Siglec-7) (Adhesion inhibitory receptor molecule 1) (AIRM-1) (CDw328) (D-siglec) (QA79 membrane protein) (p75) (CD antigen CD328),467,"51,143",5 out of 5,2002-11-08,Evidence at protein level
P0DL12,SIM17_HUMAN,Small integral membrane protein 17,118,"13,332",1 out of 5,2013-04-03,Predicted
K7EJ46,SIM22_HUMAN,Small integral membrane protein 22,135,"14,570",2 out of 5,2013-11-13,Evidence at transcript level
Q9BPZ7,SIN1_HUMAN,Target of rapamycin complex 2 subunit MAPKAP1 (TORC2 subunit MAPKAP1) (Mitogen-activated protein kinase 2-associated protein 1) (Stress-activated map kinase-interacting protein 1) (SAPK-interacting protein 1) (mSIN1),522,"59,123",5 out of 5,2001-08-14,Evidence at protein level
O75182,SIN3B_HUMAN,Paired amphipathic helix protein Sin3b (Histone deacetylase complex subunit Sin3b) (Transcriptional corepressor Sin3b),1162,"133,066",5 out of 5,2003-10-24,Evidence at protein level
Q9Y6E7,SIR4_HUMAN,"NAD-dependent protein lipoamidase sirtuin-4, mitochondrial (EC 3.5.1.-) (NAD-dependent ADP-ribosyltransferase sirtuin-4) (EC 2.4.2.-) (NAD-dependent protein deacetylase sirtuin-4) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 4) (SIR2-like protein 4)",314,"35,188",5 out of 5,2003-10-31,Evidence at protein level
Q9NXA8,SIR5_HUMAN,"NAD-dependent protein deacylase sirtuin-5, mitochondrial (EC 3.5.1.-) (Regulatory protein SIR2 homolog 5) (SIR2-like protein 5)",310,"33,881",5 out of 5,2003-10-31,Evidence at protein level
Q8N6T7,SIR6_HUMAN,NAD-dependent protein deacetylase sirtuin-6 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 6) (SIR2-like protein 6),355,"39,119",5 out of 5,2003-10-31,Evidence at protein level
Q86WV1,SKAP1_HUMAN,Src kinase-associated phosphoprotein 1 (Src family-associated phosphoprotein 1) (Src kinase-associated phosphoprotein of 55 kDa) (SKAP-55) (pp55),359,"41,432",5 out of 5,2007-01-09,Evidence at protein level
Q5T5P2,SKT_HUMAN,Sickle tail protein homolog,1943,"214,116",5 out of 5,2007-05-15,Evidence at protein level
P0C7P3,SLN14_HUMAN,Protein SLFN14 [Cleaved into: C-terminally truncated SLFN14 endoribonuclease (EC 3.1.-.-) (Schlafen family member 14)],912,"103,907",5 out of 5,2008-07-01,Evidence at protein level
Q15424,SAFB1_HUMAN,Scaffold attachment factor B1 (SAF-B) (SAF-B1) (HSP27 estrogen response element-TATA box-binding protein) (HSP27 ERE-TATA-binding protein),915,"102,642",5 out of 5,2003-11-14,Evidence at protein level
O43865,SAHH2_HUMAN,Adenosylhomocysteinase 2 (AdoHcyase 2) (EC 3.3.1.1) (DC-expressed AHCY-like molecule) (IP(3)Rs binding protein released with IP(3)) (IRBIT) (S-adenosyl-L-homocysteine hydrolase 2) (S-adenosylhomocysteine hydrolase-like protein 1),530,"58,951",5 out of 5,1998-12-15,Evidence at protein level
Q5VXD3,SAM13_HUMAN,Sterile alpha motif domain-containing protein 13 (SAM domain-containing protein 13),122,"13,570",2 out of 5,2007-03-06,Evidence at transcript level
Q7Z3H4,SAMD7_HUMAN,Sterile alpha motif domain-containing protein 7 (SAM domain-containing protein 7),446,"49,112",1 out of 5,2006-12-12,Evidence at transcript level
O00422,SAP18_HUMAN,Histone deacetylase complex subunit SAP18 (18 kDa Sin3-associated polypeptide) (2HOR0202) (Cell growth-inhibiting gene 38 protein) (Sin3-associated polypeptide p18),153,"17,561",5 out of 5,2000-05-30,Evidence at protein level
P21673,SAT1_HUMAN,Diamine acetyltransferase 1 (EC 2.3.1.57) (Polyamine N-acetyltransferase 1) (Putrescine acetyltransferase) (Spermidine/spermine N(1)-acetyltransferase 1) (SSAT) (SSAT-1),171,"20,024",5 out of 5,1991-05-01,Evidence at protein level
O75056,SDC3_HUMAN,Syndecan-3 (SYND3),442,"45,497",5 out of 5,2000-05-30,Evidence at protein level
Q9H190,SDCB2_HUMAN,Syntenin-2 (Syndecan-binding protein 2),292,"31,594",5 out of 5,2002-05-02,Evidence at protein level
Q9HCN8,SDF2L_HUMAN,Stromal cell-derived factor 2-like protein 1 (SDF2-like protein 1) (PWP1-interacting protein 8),221,"23,598",3 out of 5,2002-06-20,Evidence at protein level
Q5VUM1,SDHF4_HUMAN,"Succinate dehydrogenase assembly factor 4, mitochondrial (SDH assembly factor 4) (SDHAF4)",108,"12,213",3 out of 5,2006-06-27,Inferred from homology
Q58EX2,SDK2_HUMAN,Protein sidekick-2,2172,"239,396",5 out of 5,2006-03-07,Evidence at protein level
P09683,SECR_HUMAN,Secretin,121,"13,016",4 out of 5,1989-07-01,Evidence at protein level
Q9NRX5,SERC1_HUMAN,Serine incorporator 1 (Tumor differentially expressed protein 1-like) (Tumor differentially expressed protein 2),453,"50,495",5 out of 5,2002-11-25,Evidence at protein level
A6NH21,SERC4_HUMAN,Serine incorporator 4,518,"56,870",3 out of 5,2008-05-20,Evidence at transcript level
P84101,SERF2_HUMAN,Small EDRK-rich factor 2 (Gastric cancer-related protein VRG107) (Protein 4F5-related) (4F5rel) (h4F5rel),59,"6,900",3 out of 5,2004-08-16,Evidence at protein level
Q9Y6X0,SETBP_HUMAN,SET-binding protein (SEB),1596,"175,008",5 out of 5,2004-04-13,Evidence at protein level
Q7Z333,SETX_HUMAN,Probable helicase senataxin (EC 3.6.4.-) (Amyotrophic lateral sclerosis 4 protein) (SEN1 homolog) (Senataxin),2677,"302,880",5 out of 5,2004-06-07,Evidence at protein level
Q9Y3B4,SF3B6_HUMAN,"Splicing factor 3B subunit 6 (Pre-mRNA branch site protein p14) (SF3b 14 kDa subunit) (SF3B14a) (Spliceosome-associated protein, 14-kDa) (Splicing factor 3b, subunit 6, 14kDa)",125,"14,585",5 out of 5,2001-01-24,Evidence at protein level
Q8IWL2,SFTA1_HUMAN,Pulmonary surfactant-associated protein A1 (PSP-A) (PSPA) (SP-A) (SP-A1) (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-4),248,"26,242",5 out of 5,1988-04-01,Evidence at protein level
P35247,SFTPD_HUMAN,Pulmonary surfactant-associated protein D (PSP-D) (SP-D) (Collectin-7) (Lung surfactant protein D),375,"37,728",5 out of 5,1994-02-01,Evidence at protein level
Q9BWM7,SFXN3_HUMAN,Sideroflexin-3,321,"35,503",3 out of 5,2002-03-27,Evidence at protein level
Q96PL1,SG3A2_HUMAN,Secretoglobin family 3A member 2 (Pneumo secretory protein 1) (PnSP-1) (Uteroglobin-related protein 1),93,"10,161",3 out of 5,2002-01-23,Evidence at transcript level
Q16586,SGCA_HUMAN,Alpha-sarcoglycan (Alpha-SG) (50 kDa dystrophin-associated glycoprotein) (50DAG) (Adhalin) (Dystroglycan-2),387,"42,875",5 out of 5,2001-04-27,Evidence at protein level
Q92629,SGCD_HUMAN,Delta-sarcoglycan (Delta-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG),289,"32,071",5 out of 5,2001-04-27,Evidence at protein level
Q562F6,SGO2_HUMAN,Shugoshin 2 (Shugoshin-2) (Shugoshin-like 2) (Tripin),1265,"144,739",5 out of 5,2006-01-10,Evidence at protein level
Q9BX95,SGPP1_HUMAN,Sphingosine-1-phosphate phosphatase 1 (SPPase1) (Spp1) (hSPP1) (hSPPase1) (EC 3.1.3.-) (Sphingosine-1-phosphatase 1),441,"49,108",4 out of 5,2003-10-10,Evidence at protein level
Q2NKQ1,SGSM1_HUMAN,Small G protein signaling modulator 1 (RUN and TBC1 domain-containing protein 2),1148,"129,718",5 out of 5,2007-04-17,Evidence at protein level
Q9H788,SH24A_HUMAN,SH2 domain-containing protein 4A (Protein SH(2)A) (Protein phosphatase 1 regulatory subunit 38),454,"52,727",5 out of 5,2006-05-02,Evidence at protein level
Q9P0V3,SH3B4_HUMAN,SH3 domain-binding protein 4 (EH-binding protein 10) (Transferrin receptor-trafficking protein),963,"107,496",5 out of 5,2007-02-06,Evidence at protein level
P98077,SHC2_HUMAN,SHC-transforming protein 2 (Protein Sck) (SHC-transforming protein B) (Src homology 2 domain-containing-transforming protein C2) (SH2 domain protein C2),582,"61,916",5 out of 5,1996-02-01,Evidence at protein level
Q6S5L8,SHC4_HUMAN,SHC-transforming protein 4 (Rai-like protein) (RaLP) (SHC-transforming protein D) (hShcD) (Src homology 2 domain-containing-transforming protein C4) (SH2 domain protein C4),630,"68,785",5 out of 5,2008-05-20,Evidence at protein level
Q8TBC3,SHKB1_HUMAN,SH3KBP1-binding protein 1 (SETA-binding protein 1),707,"76,344",4 out of 5,2007-10-23,Evidence at protein level
Q9Y371,SHLB1_HUMAN,Endophilin-B1 (Bax-interacting factor 1) (Bif-1) (SH3 domain-containing GRB2-like protein B1),365,"40,796",5 out of 5,2004-01-16,Evidence at protein level
O15266,SHOX_HUMAN,Short stature homeobox protein (Pseudoautosomal homeobox-containing osteogenic protein) (Short stature homeobox-containing protein),292,"32,236",5 out of 5,2000-05-30,Evidence at protein level
Q9ULL8,SHRM4_HUMAN,Protein Shroom4 (Second homolog of apical protein),1493,"164,857",5 out of 5,2007-05-15,Evidence at protein level
Q9Y274,SIA10_HUMAN,"Type 2 lactosamine alpha-2,3-sialyltransferase (EC 2.4.99.-) (CMP-NeuAc:beta-galactoside alpha-2,3-sialyltransferase VI) (ST3Gal VI) (ST3GalVI) (Sialyltransferase 10)",331,"38,214",5 out of 5,2004-07-05,Evidence at protein level
Q11201,SIA4A_HUMAN,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1 (Alpha 2,3-ST 1) (Beta-galactoside alpha-2,3-sialyltransferase 1) (EC 2.4.99.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (SIATFL) (ST3Gal I) (ST3GalI) (ST3GalA.1) (ST3O) (Sialyltransferase 4A) (SIAT4-A)",340,"39,075",5 out of 5,1996-10-01,Evidence at transcript level
Q16842,SIA4B_HUMAN,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 2 (Alpha 2,3-ST 2) (Beta-galactoside alpha-2,3-sialyltransferase 2) (EC 2.4.99.4) (Gal-NAc6S) (Gal-beta-1,3-GalNAc-alpha-2,3-sialyltransferase) (ST3Gal II) (ST3GalII) (ST3GalA.2) (Sialyltransferase 4B) (SIAT4-B)",350,"40,173",5 out of 5,2002-07-11,Evidence at transcript level
Q15428,SF3A2_HUMAN,Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62),464,"49,256",5 out of 5,1997-11-01,Evidence at protein level
P23246,SFPQ_HUMAN,"Splicing factor, proline- and glutamine-rich (100 kDa DNA-pairing protein) (hPOMp100) (DNA-binding p52/p100 complex, 100 kDa subunit) (Polypyrimidine tract-binding protein-associated-splicing factor) (PSF) (PTB-associated-splicing factor)",707,"76,149",5 out of 5,1991-11-01,Evidence at protein level
Q96HF1,SFRP2_HUMAN,Secreted frizzled-related protein 2 (FRP-2) (sFRP-2) (Secreted apoptosis-related protein 1) (SARP-1),295,"33,490",5 out of 5,2005-03-15,Evidence at protein level
Q8TD33,SG1C1_HUMAN,Secretoglobin family 1C member 1 (Secretoglobin RYD5),95,"10,414",2 out of 5,2006-02-21,Inferred from homology
Q92835,SHIP1_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 (EC 3.1.3.86) (Inositol polyphosphate-5-phosphatase of 145 kDa) (SIP-145) (SH2 domain-containing inositol 5'-phosphatase 1) (SH2 domain-containing inositol phosphatase 1) (SHIP-1) (p150Ship) (hp51CN)",1189,"133,292",5 out of 5,2007-09-11,Evidence at protein level
A0PJX4,SHSA3_HUMAN,Protein shisa-3 homolog,238,"25,832",3 out of 5,2008-04-29,Evidence at protein level
P61647,SIA8F_HUMAN,"Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI)",398,"44,836",4 out of 5,2004-06-07,Evidence at transcript level
O43255,SIAH2_HUMAN,E3 ubiquitin-protein ligase SIAH2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH2) (Seven in absentia homolog 2) (Siah-2) (hSiah2),324,"34,615",5 out of 5,2004-04-26,Evidence at protein level
Q8IW03,SIAH3_HUMAN,Seven in absentia homolog 3 (Siah-3),269,"30,660",4 out of 5,2008-05-20,Evidence at transcript level
Q9NXL6,SIDT1_HUMAN,SID1 transmembrane family member 1,827,"93,839",3 out of 5,2005-04-26,Evidence at transcript level
Q96LC7,SIG10_HUMAN,Sialic acid-binding Ig-like lectin 10 (Siglec-10) (Siglec-like protein 2),697,"76,592",5 out of 5,2002-11-08,Evidence at protein level
Q9NYZ4,SIGL8_HUMAN,Sialic acid-binding Ig-like lectin 8 (Siglec-8) (Sialoadhesin family member 2) (SAF-2),499,"54,042",5 out of 5,2002-11-08,Evidence at protein level
Q9Y2K2,SIK3_HUMAN,Serine/threonine-protein kinase SIK3 (EC 2.7.11.1) (Salt-inducible kinase 3) (SIK-3) (Serine/threonine-protein kinase QSK),1263,"139,980",5 out of 5,2006-10-03,Evidence at protein level
Q96HG1,SIM10_HUMAN,Small integral membrane protein 10,83,"9,236",2 out of 5,2008-07-22,Inferred from homology
P0DKX4,SIM18_HUMAN,Small integral membrane protein 18,95,"11,088",2 out of 5,2013-03-06,Predicted
A6NLE4,SIM23_HUMAN,Small integral membrane protein 23,172,"20,025",2 out of 5,2008-06-10,Evidence at transcript level
Q96FS4,SIPA1_HUMAN,Signal-induced proliferation-associated protein 1 (Sipa-1) (GTPase-activating protein Spa-1) (p130 SPA-1),1042,"112,149",5 out of 5,2002-05-02,Evidence at protein level
Q96EB6,SIR1_HUMAN,NAD-dependent protein deacetylase sirtuin-1 (hSIRT1) (EC 3.5.1.-) (Regulatory protein SIR2 homolog 1) (SIR2-like protein 1) (hSIR2) [Cleaved into: SirtT1 75 kDa fragment (75SirT1)],747,"81,681",5 out of 5,2003-10-31,Evidence at protein level
P84550,SKOR1_HUMAN,SKI family transcriptional corepressor 1 (Functional Smad-suppressing element on chromosome 15) (Fussel-15) (LBX1 corepressor 1) (Ladybird homeobox corepressor 1),965,"99,831",5 out of 5,2005-06-21,Evidence at protein level
P19634,SL9A1_HUMAN,"Sodium/hydrogen exchanger 1 (APNH) (Na(+)/H(+) antiporter, amiloride-sensitive) (Na(+)/H(+) exchanger 1) (NHE-1) (Solute carrier family 9 member 1)",815,"90,763",5 out of 5,1991-02-01,Evidence at protein level
Q92581,SL9A6_HUMAN,Sodium/hydrogen exchanger 6 (Na(+)/H(+) exchanger 6) (NHE-6) (Solute carrier family 9 member 6),669,"74,162",5 out of 5,2000-05-30,Evidence at protein level
Q96A28,SLAF9_HUMAN,SLAM family member 9 (CD2 family member 10) (CD2F-10) (CD84 homolog 1) (CD84-H1),289,"32,436",4 out of 5,2005-10-11,Evidence at transcript level
Q9BQI6,SLF1_HUMAN,SMC5-SMC6 complex localization factor protein 1 (Ankyrin repeat domain-containing protein 32) (BRCT domain-containing protein 1) (Smc5/6 localization factor 1),1058,"121,050",5 out of 5,2006-06-27,Evidence at protein level
Q9NWH9,SLTM_HUMAN,SAFB-like transcription modulator (Modulator of estrogen-induced transcription),1034,"117,148",5 out of 5,2007-10-23,Evidence at protein level
P28370,SMCA1_HUMAN,Probable global transcription activator SNF2L1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA1) (Nucleosome-remodeling factor subunit SNF2L) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 1),1054,"122,605",5 out of 5,1992-12-01,Evidence at protein level
O60264,SMCA5_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5) (EC 3.6.4.-) (Sucrose nonfermenting protein 2 homolog) (hSNF2H),1052,"121,905",5 out of 5,2004-10-25,Evidence at protein level
Q9UPR3,SMG5_HUMAN,Protein SMG5 (EST1-like protein B) (LPTS-RP1) (LPTS-interacting protein) (SMG-5 homolog) (hSMG-5),1016,"113,928",5 out of 5,2005-12-20,Evidence at protein level
Q9BXW3,SNH12_HUMAN,Putative uncharacterized protein SNHG12 (Transformation-related gene 11 protein) (TRG-11),62,"6,988",1 out of 5,2007-02-20,Uncertain
Q9Y675,SNURF_HUMAN,SNRPN upstream reading frame protein,71,"8,412",2 out of 5,2008-02-26,Evidence at protein level
Q9UMY4,SNX12_HUMAN,Sorting nexin-12,172,"19,730",5 out of 5,2000-12-01,Evidence at protein level
Q15036,SNX17_HUMAN,Sorting nexin-17,470,"52,901",5 out of 5,1998-07-15,Evidence at protein level
Q969T3,SNX21_HUMAN,Sorting nexin-21 (Sorting nexin L) (SNX-L),373,"41,365",4 out of 5,2002-03-27,Evidence at transcript level
Q86XE0,SNX32_HUMAN,Sorting nexin-32 (Sorting nexin-6B),403,"46,399",3 out of 5,2008-02-26,Evidence at protein level
O75908,SOAT2_HUMAN,Sterol O-acyltransferase 2 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 2) (ACAT-2) (Cholesterol acyltransferase 2),522,"59,896",5 out of 5,2001-10-18,Evidence at transcript level
O14544,SOCS6_HUMAN,Suppressor of cytokine signaling 6 (SOCS-6) (Cytokine-inducible SH2 protein 4) (CIS-4) (Suppressor of cytokine signaling 4) (SOCS-4),535,"59,528",5 out of 5,2002-04-16,Evidence at protein level
Q5TF21,SOGA3_HUMAN,Protein SOGA3,947,"103,199",3 out of 5,2007-01-09,Inferred from homology
O60248,SOX15_HUMAN,Protein SOX-15 (Protein SOX-12) (Protein SOX-20),233,"25,251",5 out of 5,1998-12-15,Evidence at protein level
P35713,SOX18_HUMAN,Transcription factor SOX-18,384,"40,891",5 out of 5,1994-06-01,Evidence at protein level
P35711,SOX5_HUMAN,Transcription factor SOX-5,763,"84,026",5 out of 5,1994-06-01,Evidence at protein level
Q9H9B4,SFXN1_HUMAN,Sideroflexin-1 (Tricarboxylate carrier protein) (TCC),322,"35,619",4 out of 5,2002-03-27,Evidence at protein level
Q08648,SG11B_HUMAN,Sperm-associated antigen 11B (Human epididymis-specific protein 2) (He2) (Protein EP2) (Sperm antigen HE2),103,"11,431",4 out of 5,1995-11-01,Evidence at transcript level
Q13326,SGCG_HUMAN,Gamma-sarcoglycan (Gamma-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG),291,"32,379",5 out of 5,2001-04-27,Evidence at protein level
A6NJ88,SGE2P_HUMAN,Putative SAGE1-like protein (Sarcoma antigen 2 pseudogene),616,"69,022",1 out of 5,2008-06-10,Uncertain
Q96BR1,SGK3_HUMAN,Serine/threonine-protein kinase Sgk3 (EC 2.7.11.1) (Cytokine-independent survival kinase) (Serum/glucocorticoid-regulated kinase 3) (Serum/glucocorticoid-regulated kinase-like),496,"57,108",5 out of 5,2003-02-22,Evidence at protein level
Q8IWX5,SGPP2_HUMAN,Sphingosine-1-phosphate phosphatase 2 (SPPase2) (Spp2) (hSPP2) (EC 3.1.3.-) (Sphingosine-1-phosphatase 2),399,"44,741",4 out of 5,2003-10-10,Evidence at transcript level
Q5VZ18,SHE_HUMAN,SH2 domain-containing adapter protein E,495,"53,950",2 out of 5,2006-07-25,Evidence at protein level
O15357,SHIP2_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 (EC 3.1.3.86) (Inositol polyphosphate phosphatase-like protein 1) (INPPL-1) (Protein 51C) (SH2 domain-containing inositol 5'-phosphatase 2) (SH2 domain-containing inositol phosphatase 2) (SHIP-2)",1258,"138,599",5 out of 5,2007-09-11,Evidence at protein level
Q9P2F8,SI1L2_HUMAN,Signal-induced proliferation-associated 1-like protein 2 (SIPA1-like protein 2),1722,"190,438",3 out of 5,2004-07-19,Evidence at protein level
Q11206,SIA4C_HUMAN,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 4 (Alpha 2,3-ST 4) (Beta-galactoside alpha-2,3-sialyltransferase 4) (EC 2.4.99.-) (Alpha 2,3-sialyltransferase IV) (Gal-NAc6S) (Gal-beta-1,4-GalNAc-alpha-2,3-sialyltransferase) (SAT-3) (ST-4) (ST3Gal IV) (ST3GalIV) (ST3GalA.2) (STZ) (Sialyltransferase 4C) (SIAT4-C)",333,"38,045",5 out of 5,1996-10-01,Evidence at transcript level
Q9BVH7,SIA7E_HUMAN,"Alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (EC 2.4.99.-) (GD1 alpha synthase) (GalNAc alpha-2,6-sialyltransferase V) (ST6GalNAc V) (ST6GalNAcV) (Sialyltransferase 7E) (SIAT7-E)",336,"38,443",4 out of 5,2002-07-11,Evidence at transcript level
O43173,SIA8C_HUMAN,"Sia-alpha-2,3-Gal-beta-1,4-GlcNAc-R:alpha 2,8-sialyltransferase (EC 2.4.99.-) (Alpha-2,8-sialyltransferase 8C) (Alpha-2,8-sialyltransferase III) (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3) (Sialyltransferase 8C) (SIAT8-C) (Sialyltransferase St8Sia III) (ST8SiaIII)",380,"43,970",5 out of 5,2002-07-11,Evidence at protein level
P21815,SIAL_HUMAN,Bone sialoprotein 2 (Bone sialoprotein II) (BSP II) (Cell-binding sialoprotein) (Integrin-binding sialoprotein),317,"35,148",5 out of 5,1991-05-01,Evidence at protein level
P15907,SIAT1_HUMAN,"Beta-galactoside alpha-2,6-sialyltransferase 1 (Alpha 2,6-ST 1) (EC 2.4.99.1) (B-cell antigen CD75) (CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 1) (ST6Gal I) (ST6GalI) (Sialyltransferase 1)",406,"46,605",5 out of 5,1990-04-01,Evidence at protein level
Q9UNP4,SIAT9_HUMAN,"Lactosylceramide alpha-2,3-sialyltransferase (EC 2.4.99.9) (CMP-NeuAc:lactosylceramide alpha-2,3-sialyltransferase) (Ganglioside GM3 synthase) (ST3Gal V) (ST3GalV) (Sialyltransferase 9)",418,"47,990",5 out of 5,2002-07-11,Evidence at protein level
Q6ZMC9,SIG15_HUMAN,Sialic acid-binding Ig-like lectin 15 (Siglec-15) (CD33 antigen-like 3),328,"35,653",5 out of 5,2007-07-10,Evidence at protein level
Q96EX1,SIM12_HUMAN,Small integral membrane protein 12,92,"10,799",2 out of 5,2007-09-11,Evidence at protein level
A6NCI5,SIM16_HUMAN,Putative transmembrane protein encoded by LINC00862 (Small integral membrane protein 16),91,"10,419",2 out of 5,2008-01-15,Uncertain
Q8NDZ2,SIMC1_HUMAN,SUMO-interacting motif-containing protein 1,872,"96,838",3 out of 5,2006-10-03,Evidence at protein level
P42285,SK2L2_HUMAN,Superkiller viralicidic activity 2-like 2 (EC 3.6.4.13) (ATP-dependent RNA helicase DOB1) (ATP-dependent RNA helicase SKIV2L2) (TRAMP-like complex helicase),1042,"117,805",5 out of 5,1995-11-01,Evidence at protein level
Q9UBY0,SL9A2_HUMAN,Sodium/hydrogen exchanger 2 (Na(+)/H(+) exchanger 2) (NHE-2) (Solute carrier family 9 member 2),812,"91,520",5 out of 5,2000-12-01,Evidence at transcript level
Q6AI14,SL9A4_HUMAN,Sodium/hydrogen exchanger 4 (Na(+)/H(+) exchanger 4) (NHE-4) (Solute carrier family 9 member 4),798,"89,814",4 out of 5,2008-01-15,Evidence at transcript level
Q14940,SL9A5_HUMAN,Sodium/hydrogen exchanger 5 (Na(+)/H(+) exchanger 5) (NHE-5) (Solute carrier family 9 member 5),896,"99,011",4 out of 5,1997-11-01,Evidence at protein level
Q96DU3,SLAF6_HUMAN,SLAM family member 6 (Activating NK receptor) (NK-T-B-antigen) (NTB-A) (CD antigen CD352),332,"37,345",5 out of 5,2004-05-24,Evidence at protein level
P01286,SLIB_HUMAN,Somatoliberin (Growth hormone-releasing factor) (GRF) (Growth hormone-releasing hormone) (GHRH) (Somatocrinin) (Somatorelin) (Sermorelin),108,"12,447",5 out of 5,1986-07-21,Evidence at protein level
O94933,SLIK3_HUMAN,SLIT and NTRK-like protein 3,977,"108,934",3 out of 5,2001-06-20,Evidence at transcript level
O94991,SLIK5_HUMAN,SLIT and NTRK-like protein 5 (Leucine-rich repeat-containing protein 11),958,"107,486",5 out of 5,2001-06-20,Evidence at transcript level
Q9H2G2,SLK_HUMAN,STE20-like serine/threonine-protein kinase (STE20-like kinase) (hSLK) (EC 2.7.11.1) (CTCL tumor antigen se20-9) (STE20-related serine/threonine-protein kinase) (STE20-related kinase) (Serine/threonine-protein kinase 2),1235,"142,695",5 out of 5,2006-05-02,Evidence at protein level
Q7Z7L1,SLN11_HUMAN,Schlafen family member 11,901,"102,836",5 out of 5,2007-04-03,Evidence at protein level
O95391,SLU7_HUMAN,Pre-mRNA-splicing factor SLU7 (hSlu7),586,"68,387",5 out of 5,2007-05-29,Evidence at protein level
P55000,SLUR1_HUMAN,Secreted Ly-6/uPAR-related protein 1 (SLURP-1) (ARS component B) (ARS(component B)-81/S) (Anti-neoplastic urinary protein) (ANUP),103,"11,186",5 out of 5,1996-10-01,Evidence at protein level
Q0VAQ4,SMAGP_HUMAN,Small cell adhesion glycoprotein (Small transmembrane and glycosylated protein),97,"10,679",5 out of 5,2008-04-08,Evidence at protein level
Q8IYB5,SMAP1_HUMAN,Stromal membrane-associated protein 1,467,"50,386",4 out of 5,2006-05-16,Evidence at protein level
Q14683,SMC1A_HUMAN,Structural maintenance of chromosomes protein 1A (SMC protein 1A) (SMC-1-alpha) (SMC-1A) (Sb1.8),1233,"143,233",5 out of 5,2003-03-25,Evidence at protein level
Q8IY18,SMC5_HUMAN,Structural maintenance of chromosomes protein 5 (SMC protein 5) (SMC-5) (hSMC5),1101,"128,806",5 out of 5,2007-01-09,Evidence at protein level
P51532,SMCA4_HUMAN,Transcription activator BRG1 (EC 3.6.4.-) (ATP-dependent helicase SMARCA4) (BRG1-associated factor 190A) (BAF190A) (Mitotic growth and transcription activator) (Protein BRG-1) (Protein brahma homolog 1) (SNF2-beta) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 4),1647,"184,646",5 out of 5,1996-10-01,Evidence at protein level
Q9H0W8,SMG9_HUMAN,Protein SMG9 (Protein SMG-9),520,"57,651",5 out of 5,2007-05-29,Evidence at protein level
Q9BVW6,SMIM2_HUMAN,Small integral membrane protein 2,85,"9,520",2 out of 5,2008-02-26,Evidence at protein level
P53814,SMTN_HUMAN,Smoothelin,917,"99,059",5 out of 5,1996-10-01,Evidence at protein level
Q9HAU4,SMUF2_HUMAN,E3 ubiquitin-protein ligase SMURF2 (hSMURF2) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF2) (SMAD ubiquitination regulatory factor 2) (SMAD-specific E3 ubiquitin-protein ligase 2),748,"86,196",5 out of 5,2001-12-13,Evidence at protein level
Q8IYR2,SMYD4_HUMAN,SET and MYND domain-containing protein 4 (EC 2.1.1.-),804,"89,225",3 out of 5,2006-03-21,Evidence at transcript level
Q3KNW1,SNAI3_HUMAN,Zinc finger protein SNAI3 (Protein snail homolog 3) (Zinc finger protein 293),292,"32,474",3 out of 5,2008-04-29,Evidence at transcript level
Q8TER0,SNED1_HUMAN,"Sushi, nidogen and EGF-like domain-containing protein 1 (Insulin-responsive sequence DNA-binding protein 1) (IRE-BP1)",1413,"152,204",4 out of 5,2007-09-11,Evidence at transcript level
Q96H20,SNF8_HUMAN,Vacuolar-sorting protein SNF8 (ELL-associated protein of 30 kDa) (ESCRT-II complex subunit VPS22) (hVps22),258,"28,864",5 out of 5,2005-08-30,Evidence at protein level
O00161,SNP23_HUMAN,Synaptosomal-associated protein 23 (SNAP-23) (Vesicle-membrane fusion protein SNAP-23),211,"23,354",5 out of 5,2000-05-30,Evidence at protein level
Q16533,SNPC1_HUMAN,snRNA-activating protein complex subunit 1 (SNAPc subunit 1) (Proximal sequence element-binding transcription factor subunit gamma) (PSE-binding factor subunit gamma) (PTF subunit gamma) (Small nuclear RNA-activating complex polypeptide 1) (snRNA-activating protein complex 43 kDa subunit) (SNAPc 43 kDa subunit),368,"42,994",4 out of 5,2000-05-30,Evidence at protein level
O75971,SNPC5_HUMAN,snRNA-activating protein complex subunit 5 (SNAPc subunit 5) (Small nuclear RNA-activating complex polypeptide 5) (snRNA-activating protein complex 19 kDa subunit) (SNAPc 19 kDa subunit),98,"11,328",5 out of 5,2000-05-30,Evidence at protein level
Q9BV90,SNR25_HUMAN,U11/U12 small nuclear ribonucleoprotein 25 kDa protein (U11/U12 snRNP 25 kDa protein) (U11/U12-25K) (Minus-99 protein),132,"15,270",5 out of 5,2005-06-21,Evidence at protein level
Q9Y5X0,SNX10_HUMAN,Sorting nexin-10,201,"23,598",5 out of 5,2000-12-01,Evidence at protein level
Q5VWJ9,SNX30_HUMAN,Sorting nexin-30,437,"49,677",3 out of 5,2007-04-17,Evidence at protein level
O95219,SNX4_HUMAN,Sorting nexin-4,450,"51,909",5 out of 5,2000-12-01,Evidence at protein level
Q9BZZ2,SN_HUMAN,Sialoadhesin (Sialic acid-binding Ig-like lectin 1) (Siglec-1) (CD antigen CD169),1709,"182,624",5 out of 5,2001-10-18,Evidence at protein level
P46721,SO1A2_HUMAN,Solute carrier organic anion transporter family member 1A2 (OATP-A) (Organic anion-transporting polypeptide 1) (OATP-1) (Sodium-independent organic anion transporter) (Solute carrier family 21 member 3),670,"74,145",5 out of 5,1995-11-01,Evidence at transcript level
Q9NPD5,SO1B3_HUMAN,Solute carrier organic anion transporter family member 1B3 (Liver-specific organic anion transporter 2) (LST-2) (Organic anion transporter 8) (Organic anion-transporting polypeptide 8) (OATP-8) (Solute carrier family 21 member 8),702,"77,403",5 out of 5,2003-01-10,Evidence at protein level
O94956,SO2B1_HUMAN,Solute carrier organic anion transporter family member 2B1 (Organic anion transporter B) (OATP-B) (Organic anion transporter polypeptide-related protein 2) (OATP-RP2) (OATPRP2) (Solute carrier family 21 member 9),709,"76,711",5 out of 5,2000-05-30,Evidence at protein level
Q96BD0,SO4A1_HUMAN,Solute carrier organic anion transporter family member 4A1 (OATP4A1) (Colon organic anion transporter) (Organic anion transporter polypeptide-related protein 1) (OATP-RP1) (OATPRP1) (POAT) (Organic anion-transporting polypeptide E) (OATP-E) (Sodium-independent organic anion transporter E) (Solute carrier family 21 member 12),722,"77,193",5 out of 5,2003-01-10,Evidence at protein level
O14543,SOCS3_HUMAN,Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (STAT-induced STAT inhibitor 3) (SSI-3),225,"24,770",5 out of 5,2002-04-16,Evidence at protein level
O14512,SOCS7_HUMAN,"Suppressor of cytokine signaling 7 (SOCS-7) (Nck, Ash and phospholipase C gamma-binding protein) (Nck-associated protein 4) (NAP-4)",581,"62,969",5 out of 5,2002-04-16,Evidence at protein level
Q92599,SEPT8_HUMAN,Septin-8,483,"55,756",4 out of 5,2000-12-01,Evidence at protein level
P78330,SERB_HUMAN,Phosphoserine phosphatase (PSP) (PSPase) (EC 3.1.3.3) (L-3-phosphoserine phosphatase) (O-phosphoserine phosphohydrolase),225,"25,008",5 out of 5,2000-05-30,Evidence at protein level
Q96SA4,SERC2_HUMAN,Serine incorporator 2 (Tumor differentially expressed protein 2-like),455,"50,742",3 out of 5,2003-10-31,Evidence at transcript level
Q86VE9,SERC5_HUMAN,Serine incorporator 5,423,"47,009",5 out of 5,2008-04-29,Evidence at transcript level
Q9Y6P5,SESN1_HUMAN,Sestrin-1 (EC 1.11.1.15) (p53-regulated protein PA26),492,"56,557",5 out of 5,2001-04-27,Evidence at protein level
P58005,SESN3_HUMAN,Sestrin-3,492,"57,291",5 out of 5,2001-04-27,Evidence at protein level
Q6ICB4,SESQ2_HUMAN,Sesquipedalian-2 (Ses2) (27 kDa inositol polyphosphate phosphatase interacting protein B) (IPIP27B),259,"28,338",5 out of 5,2006-10-31,Evidence at protein level
Q86TU7,SETD3_HUMAN,Histone-lysine N-methyltransferase setd3 (EC 2.1.1.43) (SET domain-containing protein 3),594,"67,257",5 out of 5,2006-10-31,Evidence at protein level
Q53EL9,SEZ6_HUMAN,Seizure protein 6 homolog (SEZ-6) (hSEZ-6),994,"107,425",5 out of 5,2008-06-10,Evidence at protein level
Q9BWJ5,SF3B5_HUMAN,Splicing factor 3B subunit 5 (SF3b5) (Pre-mRNA-splicing factor SF3b 10 kDa subunit),86,"10,135",3 out of 5,2002-02-11,Evidence at protein level
O95562,SFT2B_HUMAN,Vesicle transport protein SFT2B (SFT2 domain-containing protein 2),160,"17,779",3 out of 5,2006-05-30,Evidence at protein level
P0C7M3,SFTA3_HUMAN,Surfactant-associated protein 3 (Surfactant-associated protein H) (SP-H),94,"10,526",3 out of 5,2008-06-10,Evidence at protein level
Q96NB2,SFXN2_HUMAN,Sideroflexin-2,322,"36,232",3 out of 5,2002-03-27,Evidence at protein level
Q6PDA7,SG11A_HUMAN,Sperm-associated antigen 11A (Human epididymis-specific protein 2) (He2) (Protein EP2) (Sperm antigen HE2),123,"13,842",3 out of 5,2008-01-15,Evidence at transcript level
Q7M4L6,SHF_HUMAN,SH2 domain-containing adapter protein F,423,"46,768",3 out of 5,2008-02-26,Evidence at protein level
Q6PI26,SHQ1_HUMAN,Protein SHQ1 homolog,577,"65,125",5 out of 5,2007-09-11,Evidence at protein level
Q6UWI4,SHSA2_HUMAN,Protein shisa-2 homolog (Transmembrane protein 46),295,"31,375",3 out of 5,2004-11-09,Evidence at protein level
Q8IXJ6,SIR2_HUMAN,NAD-dependent protein deacetylase sirtuin-2 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 2) (SIR2-like protein 2),389,"43,182",5 out of 5,2003-10-31,Evidence at protein level
Q8IY92,SLX4_HUMAN,Structure-specific endonuclease subunit SLX4 (BTB/POZ domain-containing protein 12),1834,"200,012",5 out of 5,2004-07-19,Evidence at protein level
Q969G3,SMCE1_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily E member 1 (BRG1-associated factor 57) (BAF57),411,"46,649",5 out of 5,2004-10-25,Evidence at protein level
Q92540,SMG7_HUMAN,Protein SMG7 (EST1-like protein C) (SMG-7 homolog) (hSMG-7),1137,"127,282",5 out of 5,1997-11-01,Evidence at protein level
Q9NWM0,SMOX_HUMAN,Spermine oxidase (EC 1.5.3.16) (Polyamine oxidase 1) (PAO-1) (PAOh1),555,"61,819",5 out of 5,2004-07-19,Evidence at protein level
Q9UHP9,SMPX_HUMAN,Small muscular protein (Stretch-responsive skeletal muscle protein),88,"9,559",3 out of 5,2000-12-01,Evidence at transcript level
Q6GMV2,SMYD5_HUMAN,SET and MYND domain-containing protein 5 (EC 2.1.1.-) (Protein NN8-4AG) (Retinoic acid-induced protein 15),418,"47,341",3 out of 5,2006-03-21,Evidence at protein level
Q9HBX3,SNIT1_HUMAN,Uncharacterized protein encoded by SND1-IT1 (Brain and nasopharyngeal carcinoma susceptibility protein NSG-x) (Nasopharyngeal carcinoma-associated gene 8 protein) (SND1 intronic transcript 1),110,"12,922",2 out of 5,2008-06-10,Predicted
P48431,SOX2_HUMAN,Transcription factor SOX-2,317,"34,310",5 out of 5,1996-02-01,Evidence at protein level
Q9HB58,SP110_HUMAN,Sp110 nuclear body protein (Interferon-induced protein 41/75) (Speckled 110 kDa) (Transcriptional coactivator Sp110),689,"78,396",5 out of 5,2002-08-02,Evidence at protein level
Q8IXZ3,SP8_HUMAN,Transcription factor Sp8 (Specificity protein 8),490,"48,674",4 out of 5,2003-05-16,Evidence at protein level
Q9BVQ7,SPA5L_HUMAN,Spermatogenesis-associated protein 5-like protein 1,753,"80,710",3 out of 5,2008-04-29,Evidence at protein level
Q96R06,SPAG5_HUMAN,Sperm-associated antigen 5 (Astrin) (Deepest) (Mitotic spindle-associated protein p126) (MAP126),1193,"134,422",5 out of 5,2004-05-10,Evidence at protein level
Q99932,SPAG8_HUMAN,Sperm-associated antigen 8 (HSD-1) (Sperm membrane protein 1) (SMP-1) (Sperm membrane protein BS-84),426,"44,819",5 out of 5,2005-04-12,Evidence at protein level
Q5VX52,SPAT1_HUMAN,Spermatogenesis-associated protein 1 (Sperm-specific protein SP-2),437,"50,307",2 out of 5,2008-09-02,Evidence at transcript level
Q8NEY3,SPAT4_HUMAN,Spermatogenesis-associated protein 4 (Testis and spermatogenesis cell-related protein 2) (Testis spermatocyte apoptosis-related gene 2 protein),305,"34,751",2 out of 5,2003-10-10,Evidence at protein level
Q6RVD6,SPAT8_HUMAN,Spermatogenesis-associated protein 8 (Spermatogenesis-related protein 8),105,"11,727",3 out of 5,2007-02-20,Evidence at protein level
Q96LD8,SENP8_HUMAN,"Sentrin-specific protease 8 (EC 3.4.22.68) (Deneddylase-1) (NEDD8-specific protease 1) (Protease, cysteine 2) (Sentrin/SUMO-specific protease SENP8)",212,"24,107",5 out of 5,2002-11-28,Evidence at protein level
O43236,SEPT4_HUMAN,Septin-4 (Apoptosis-related protein in the TGF-beta signaling pathway) (ARTS) (Bradeion beta) (Brain protein H5) (CE5B3 beta) (Cell division control-related protein 2) (hCDCREL-2) (Cerebral protein 7) (Peanut-like protein 2),478,"55,098",5 out of 5,1998-07-15,Evidence at protein level
Q96T68,SETB2_HUMAN,Histone-lysine N-methyltransferase SETDB2 (EC 2.1.1.43) (Chronic lymphocytic leukemia deletion region gene 8 protein) (Lysine N-methyltransferase 1F) (SET domain bifurcated 2),719,"81,894",5 out of 5,2003-10-03,Evidence at protein level
Q15459,SF3A1_HUMAN,Splicing factor 3A subunit 1 (SF3a120) (Spliceosome-associated protein 114) (SAP 114),793,"88,886",5 out of 5,1997-11-01,Evidence at protein level
Q92765,SFRP3_HUMAN,Secreted frizzled-related protein 3 (sFRP-3) (Frezzled) (Fritz) (Frizzled-related protein 1) (FrzB-1),325,"36,254",5 out of 5,2001-06-01,Evidence at protein level
Q13296,SG2A2_HUMAN,Mammaglobin-A (Mammaglobin-1) (Secretoglobin family 2A member 2),93,"10,499",3 out of 5,1997-11-01,Evidence at protein level
Q16585,SGCB_HUMAN,Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) (A3b),318,"34,777",5 out of 5,2001-04-27,Evidence at protein level
Q96ES7,SGF29_HUMAN,SAGA-associated factor 29 (Coiled-coil domain-containing protein 101) (SAGA complex-associated factor 29),293,"33,238",5 out of 5,2007-02-06,Evidence at protein level
O00141,SGK1_HUMAN,Serine/threonine-protein kinase Sgk1 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 1),431,"48,942",5 out of 5,1998-12-15,Evidence at protein level
O60880,SH21A_HUMAN,SH2 domain-containing protein 1A (Duncan disease SH2-protein) (Signaling lymphocytic activation molecule-associated protein) (SLAM-associated protein) (T-cell signal transduction molecule SAP),128,"14,187",5 out of 5,1999-07-15,Evidence at protein level
Q7Z4S9,SH2D6_HUMAN,SH2 domain-containing protein 6,175,"19,279",2 out of 5,2007-10-23,Evidence at transcript level
Q99961,SH3G1_HUMAN,Endophilin-A2 (EEN fusion partner of MLL) (Endophilin-2) (Extra eleven-nineteen leukemia fusion gene protein) (EEN) (SH3 domain protein 2B) (SH3 domain-containing GRB2-like protein 1),368,"41,490",5 out of 5,2000-12-01,Evidence at protein level
Q96B97,SH3K1_HUMAN,SH3 domain-containing kinase-binding protein 1 (CD2-binding protein 3) (CD2BP3) (Cbl-interacting protein of 85 kDa) (Human Src family kinase-binding protein 1) (HSB-1),665,"73,126",5 out of 5,2003-05-23,Evidence at protein level
Q8NEM2,SHCBP_HUMAN,SHC SH2 domain-binding protein 1,672,"75,690",4 out of 5,2005-12-20,Evidence at protein level
Q9UQ13,SHOC2_HUMAN,Leucine-rich repeat protein SHOC-2 (Protein soc-2 homolog) (Protein sur-8 homolog),582,"64,888",5 out of 5,2001-06-20,Evidence at protein level
A0MZ66,SHOT1_HUMAN,Shootin-1 (Shootin1),631,"71,640",5 out of 5,2007-07-24,Evidence at protein level
Q9BZQ2,SHP1L_HUMAN,Testicular spindle-associated protein SHCBP1L (SHC SH2 domain-binding protein 1-like protein),653,"72,632",4 out of 5,2007-04-17,Evidence at protein level
Q149N8,SHPRH_HUMAN,"E3 ubiquitin-protein ligase SHPRH (EC 2.3.2.27) (EC 3.6.4.-) (RING-type E3 ubiquitin transferase SHPRH) (SNF2, histone-linker, PHD and RING finger domain-containing helicase)",1683,"193,079",5 out of 5,2007-05-01,Evidence at protein level
Q8N114,SHSA5_HUMAN,Protein shisa-5 (Putative NF-kappa-B-activating protein 120) (Scotin),240,"25,582",5 out of 5,2007-12-04,Evidence at protein level
O43166,SI1L1_HUMAN,Signal-induced proliferation-associated 1-like protein 1 (SIPA1-like protein 1) (High-risk human papilloma viruses E6 oncoproteins targeted protein 1) (E6-targeted protein 1),1804,"200,029",5 out of 5,2004-07-19,Evidence at protein level
Q9NR45,SIAS_HUMAN,Sialic acid synthase (N-acetylneuraminate synthase) (EC 2.5.1.56) (N-acetylneuraminate-9-phosphate synthase) (EC 2.5.1.57) (N-acetylneuraminic acid phosphate synthase) (N-acetylneuraminic acid synthase),359,"40,308",5 out of 5,2002-05-15,Evidence at protein level
Q9Y336,SIGL9_HUMAN,Sialic acid-binding Ig-like lectin 9 (Siglec-9) (CDw329) (Protein FOAP-9) (CD antigen CD329),463,"50,082",5 out of 5,2002-11-08,Evidence at protein level
Q9H173,SIL1_HUMAN,Nucleotide exchange factor SIL1 (BiP-associated protein) (BAP),461,"52,085",5 out of 5,2006-02-21,Evidence at protein level
P0DMW4,SIL2A_HUMAN,Small integral membrane protein 10-like protein 2A,78,"8,389",1 out of 5,2015-06-24,Predicted
Q9NRC8,SIR7_HUMAN,NAD-dependent protein deacetylase sirtuin-7 (EC 3.5.1.-) (Regulatory protein SIR2 homolog 7) (SIR2-like protein 7),400,"44,898",5 out of 5,2003-10-31,Evidence at protein level
Q13309,SKP2_HUMAN,S-phase kinase-associated protein 2 (Cyclin-A/CDK2-associated protein p45) (F-box protein Skp2) (F-box/LRR-repeat protein 1) (p45skp2),424,"47,761",5 out of 5,2003-10-03,Evidence at protein level
P48764,SL9A3_HUMAN,Sodium/hydrogen exchanger 3 (Na(+)/H(+) exchanger 3) (NHE-3) (Solute carrier family 9 member 3),834,"92,855",5 out of 5,1996-02-01,Evidence at protein level
Q9UIB8,SLAF5_HUMAN,SLAM family member 5 (Cell surface antigen MAX.3) (Hly9-beta) (Leukocyte differentiation antigen CD84) (Signaling lymphocytic activation molecule 5) (CD antigen CD84),345,"38,782",5 out of 5,2006-10-03,Evidence at protein level
Q9BQ83,SLX1_HUMAN,Structure-specific endonuclease subunit SLX1 (EC 3.1.-.-) (GIY-YIG domain-containing protein 1),275,"30,771",5 out of 5,2008-04-29,Evidence at protein level
Q15797,SMAD1_HUMAN,Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1),465,"52,260",5 out of 5,2001-04-27,Evidence at protein level
Q13485,SMAD4_HUMAN,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),552,"60,439",5 out of 5,2001-05-04,Evidence at protein level
Q5PRF9,SMAG2_HUMAN,Protein Smaug homolog 2 (Smaug 2) (hSmaug2) (Sterile alpha motif domain-containing protein 4B) (SAM domain-containing protein 4B),694,"75,483",4 out of 5,2006-11-28,Evidence at protein level
P38935,SMBP2_HUMAN,DNA-binding protein SMUBP-2 (EC 3.6.4.12) (EC 3.6.4.13) (ATP-dependent helicase IGHMBP2) (Glial factor 1) (GF-1) (Immunoglobulin mu-binding protein 2),993,"109,149",5 out of 5,1995-02-01,Evidence at protein level
Q5VUG0,SMBT2_HUMAN,Scm-like with four MBT domains protein 2 (Scm-like with 4 MBT domains protein 2),894,"100,563",5 out of 5,2005-06-07,Evidence at protein level
B2RUZ4,SMIM1_HUMAN,Small integral membrane protein 1 (Vel blood group antigen),78,"8,749",5 out of 5,2008-12-16,Evidence at protein level
A6NGZ8,SMIM9_HUMAN,Small integral membrane protein 9,99,"10,777",2 out of 5,2008-09-02,Inferred from homology
O95473,SNG4_HUMAN,Synaptogyrin-4,234,"25,820",2 out of 5,2000-05-30,Evidence at transcript level
Q8TAD8,SNIP1_HUMAN,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),396,"45,778",5 out of 5,2004-06-07,Evidence at protein level
Q5SXM2,SNPC4_HUMAN,snRNA-activating protein complex subunit 4 (SNAPc subunit 4) (Proximal sequence element-binding transcription factor subunit alpha) (PSE-binding factor subunit alpha) (PTF subunit alpha) (snRNA-activating protein complex 190 kDa subunit) (SNAPc 190 kDa subunit),1469,"159,433",5 out of 5,2005-10-25,Evidence at protein level
A6NMZ2,SNTAN_HUMAN,Sentan (Protein S100-A1-like) (S100 calcium-binding protein A1-like),147,"16,468",2 out of 5,2008-07-01,Evidence at transcript level
Q9NSN8,SNTG1_HUMAN,Gamma-1-syntrophin (G1SYN) (Syntrophin-4) (SYN4),517,"57,969",5 out of 5,2002-10-10,Evidence at protein level
O60613,SEP15_HUMAN,Selenoprotein F (15 kDa selenoprotein),162,"17,790",5 out of 5,1999-07-15,Evidence at protein level
O43175,SERA_HUMAN,D-3-phosphoglycerate dehydrogenase (3-PGDH) (EC 1.1.1.95) (2-oxoglutarate reductase) (EC 1.1.1.399) (Malate dehydrogenase) (EC 1.1.1.37),533,"56,651",5 out of 5,1999-07-15,Evidence at protein level
Q9Y6X1,SERP1_HUMAN,Stress-associated endoplasmic reticulum protein 1 (Ribosome-attached membrane protein 4),66,"7,374",5 out of 5,2007-02-06,Evidence at protein level
Q8N6R1,SERP2_HUMAN,Stress-associated endoplasmic reticulum protein 2 (Ribosome-associated membrane protein RAMP4-2),65,"7,431",3 out of 5,2007-02-06,Evidence at protein level
Q86VW0,SESD1_HUMAN,SEC14 domain and spectrin repeat-containing protein 1 (Huntingtin-interacting protein-like protein) (Protein Solo),696,"79,348",5 out of 5,2007-11-13,Evidence at protein level
O15047,SET1A_HUMAN,Histone-lysine N-methyltransferase SETD1A (EC 2.1.1.43) (Lysine N-methyltransferase 2F) (SET domain-containing protein 1A) (hSET1A) (Set1/Ash2 histone methyltransferase complex subunit SET1),1707,"186,034",5 out of 5,2005-06-21,Evidence at protein level
O75533,SF3B1_HUMAN,Splicing factor 3B subunit 1 (Pre-mRNA-splicing factor SF3b 155 kDa subunit) (SF3b155) (Spliceosome-associated protein 155) (SAP 155),1304,"145,830",5 out of 5,2001-08-14,Evidence at protein level
Q8IWL1,SFPA2_HUMAN,Pulmonary surfactant-associated protein A2 (PSP-A) (PSPA) (SP-A) (SP-A2) (35 kDa pulmonary surfactant-associated protein) (Alveolar proteinosis protein) (Collectin-5),248,"26,182",5 out of 5,1988-04-01,Evidence at protein level
O95969,SG1D2_HUMAN,Secretoglobin family 1D member 2 (Lipophilin-B),90,"9,925",3 out of 5,2000-05-30,Evidence at transcript level
Q99720,SGMR1_HUMAN,Sigma non-opioid intracellular receptor 1 (Aging-associated gene 8 protein) (SR31747-binding protein) (SR-BP) (Sigma 1-type opioid receptor) (SIG-1R) (Sigma1-receptor) (Sigma1R) (hSigmaR1),223,"25,128",5 out of 5,2006-12-12,Evidence at protein level
Q96HU1,SGSM3_HUMAN,Small G protein signaling modulator 3 (Merlin-associated protein) (RUN and TBC1 domain-containing protein 3) (Rab-GTPase-activating protein-like protein) (RabGAPLP),749,"85,354",5 out of 5,2007-10-23,Evidence at protein level
Q8N5H7,SH2D3_HUMAN,SH2 domain-containing protein 3C (Novel SH2-containing protein 3) (SH2 domain-containing Eph receptor-binding protein 1) (SHEP1),860,"94,411",5 out of 5,2006-03-21,Evidence at protein level
Q99962,SH3G2_HUMAN,Endophilin-A1 (EEN-B1) (Endophilin-1) (SH3 domain protein 2A) (SH3 domain-containing GRB2-like protein 2),352,"39,962",5 out of 5,2000-12-01,Evidence at protein level
Q99963,SH3G3_HUMAN,Endophilin-A3 (EEN-B2) (Endophilin-3) (SH3 domain protein 2C) (SH3 domain-containing GRB2-like protein 3),347,"39,285",5 out of 5,2000-12-01,Evidence at protein level
Q96HL8,SH3Y1_HUMAN,SH3 domain-containing YSC84-like protein 1,342,"37,148",4 out of 5,2008-06-10,Evidence at protein level
Q92529,SHC3_HUMAN,SHC-transforming protein 3 (Neuronal Shc) (N-Shc) (Protein Rai) (SHC-transforming protein C) (Src homology 2 domain-containing-transforming protein C3) (SH2 domain protein C3),594,"64,056",5 out of 5,2004-03-29,Evidence at protein level
P78324,SHPS1_HUMAN,Tyrosine-protein phosphatase non-receptor type substrate 1 (SHP substrate 1) (SHPS-1) (Brain Ig-like molecule with tyrosine-based activation motifs) (Bit) (CD172 antigen-like family member A) (Inhibitory receptor SHPS-1) (Macrophage fusion receptor) (MyD-1 antigen) (Signal-regulatory protein alpha-1) (Sirp-alpha-1) (Signal-regulatory protein alpha-2) (Sirp-alpha-2) (Signal-regulatory protein alpha-3) (Sirp-alpha-3) (p84) (CD antigen CD172a),504,"54,967",5 out of 5,2003-03-28,Evidence at protein level
A6NL88,SHSA7_HUMAN,Protein shisa-7 (Protein shisa-6-like),538,"56,214",3 out of 5,2008-07-22,Evidence at transcript level
B4DS77,SHSA9_HUMAN,Protein shisa-9,424,"46,925",4 out of 5,2010-03-23,Evidence at transcript level
Q6IA17,SIGIR_HUMAN,Single Ig IL-1-related receptor (Single Ig IL-1R-related molecule) (Single immunoglobulin domain-containing IL1R-related protein) (Toll/interleukin-1 receptor 8) (TIR8),410,"45,679",5 out of 5,2005-09-27,Evidence at protein level
Q9BRV8,SIKE1_HUMAN,Suppressor of IKBKE 1 (Suppressor of IKK-epsilon),207,"23,721",4 out of 5,2007-09-11,Evidence at protein level
P0DJ93,SIM13_HUMAN,Small integral membrane protein 13,91,"10,351",2 out of 5,2011-12-14,Inferred from homology
P81133,SIM1_HUMAN,Single-minded homolog 1 (Class E basic helix-loop-helix protein 14) (bHLHe14),766,"85,515",4 out of 5,1998-07-15,Evidence at transcript level
O75264,SIM24_HUMAN,Small integral membrane protein 24,130,"14,964",2 out of 5,2008-02-26,Evidence at transcript level
P0DMW3,SIML1_HUMAN,Small integral membrane protein 10-like protein 1,83,"9,236",1 out of 5,2015-06-24,Inferred from homology
O00241,SIRB1_HUMAN,Signal-regulatory protein beta-1 (SIRP-beta-1) (CD172 antigen-like family member B) (CD antigen CD172b),398,"43,211",5 out of 5,2002-09-19,Evidence at protein level
Q9NPC8,SIX2_HUMAN,Homeobox protein SIX2 (Sine oculis homeobox homolog 2),291,"32,286",5 out of 5,2001-01-11,Evidence at protein level
Q8IX90,SKA3_HUMAN,Spindle and kinetochore-associated protein 3,412,"46,359",5 out of 5,2005-08-16,Evidence at protein level
O75563,SKAP2_HUMAN,Src kinase-associated phosphoprotein 2 (Pyk2/RAFTK-associated protein) (Retinoic acid-induced protein 70) (SKAP55 homolog) (SKAP-55HOM) (SKAP-HOM) (Src family-associated phosphoprotein 2) (Src kinase-associated phosphoprotein 55-related protein) (Src-associated adapter protein with PH and SH3 domains),359,"41,217",5 out of 5,2007-01-09,Evidence at protein level
Q2VWA4,SKOR2_HUMAN,SKI family transcriptional corepressor 2 (Functional Smad-suppressing element on chromosome 18) (Fussel-18) (LBX1 corepressor 1-like protein) (Ladybird homeobox corepressor 1-like protein),1001,"104,235",5 out of 5,2008-05-20,Evidence at protein level
P63208,SKP1_HUMAN,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1),163,"18,658",5 out of 5,2004-09-27,Evidence at protein level
Q8IVB4,SL9A9_HUMAN,Sodium/hydrogen exchanger 9 (Na(+)/H(+) exchanger 9) (NHE-9) (Solute carrier family 9 member 9),645,"72,565",5 out of 5,2004-03-01,Evidence at protein level
Q5TAH2,SL9C2_HUMAN,Sodium/hydrogen exchanger 11 (Na(+)/H(+) exchanger 11) (NHE-11) (Solute carrier family 9 member 11) (Solute carrier family 9 member C2),1124,"129,053",4 out of 5,2007-07-24,Evidence at transcript level
Q13291,SLAF1_HUMAN,Signaling lymphocytic activation molecule (CDw150) (IPO-3) (SLAM family member 1) (CD antigen CD150),335,"37,231",5 out of 5,2000-12-01,Evidence at protein level
Q9BRT9,SLD5_HUMAN,"DNA replication complex GINS protein SLD5 (GINS complex subunit 4) [Cleaved into: DNA replication complex GINS protein SLD5, N-terminally processed]",223,"26,047",5 out of 5,2008-04-08,Evidence at protein level
Q8IX21,SLF2_HUMAN,SMC5-SMC6 complex localization factor protein 2 (Smc5/6 localization factor 1),1173,"131,873",5 out of 5,2005-08-16,Evidence at protein level
Q96PX8,SLIK1_HUMAN,SLIT and NTRK-like protein 1 (Leucine-rich repeat-containing protein 12),696,"77,735",5 out of 5,2004-04-13,Evidence at protein level
Q8IW52,SLIK4_HUMAN,SLIT and NTRK-like protein 4,837,"94,331",4 out of 5,2004-04-13,Evidence at protein level
Q68CJ6,SLIP_HUMAN,Nuclear GTPase SLIP-GC (EC 3.6.1.-) (Speckled-like pattern in the germinal center),796,"91,132",4 out of 5,2007-09-11,Evidence at transcript level
O94813,SLIT2_HUMAN,Slit homolog 2 protein (Slit-2) [Cleaved into: Slit homolog 2 protein N-product; Slit homolog 2 protein C-product],1529,"169,870",5 out of 5,2003-07-19,Evidence at protein level
Q8IYM2,SLN12_HUMAN,Schlafen family member 12,578,"66,972",2 out of 5,2007-04-03,Evidence at transcript level
Q499Z3,SLNL1_HUMAN,Schlafen-like protein 1,407,"45,603",3 out of 5,2007-04-03,Evidence at transcript level
A6NFE2,SMCO2_HUMAN,Single-pass membrane and coiled-coil domain-containing protein 2,343,"39,487",2 out of 5,2008-06-10,Evidence at transcript level
Q6P435,SMG1L_HUMAN,Putative uncharacterized SMG1-like protein,159,"17,652",1 out of 5,2007-10-02,Uncertain
A6NHR9,SMHD1_HUMAN,Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1),2005,"226,374",5 out of 5,2008-04-29,Evidence at protein level
Q3B7S5,SMI21_HUMAN,Small integral membrane protein 21,101,"11,722",1 out of 5,2008-06-10,Predicted
O43623,SNAI2_HUMAN,Zinc finger protein SNAI2 (Neural crest transcription factor Slug) (Protein snail homolog 2),268,"29,986",5 out of 5,2000-12-01,Evidence at protein level
P04179,SODM_HUMAN,"Superoxide dismutase [Mn], mitochondrial (EC 1.15.1.1)",222,"24,722",5 out of 5,1987-03-20,Evidence at protein level
Q9P0Z9,SOX_HUMAN,Peroxisomal sarcosine oxidase (PSO) (EC 1.5.3.1) (EC 1.5.3.7) (L-pipecolate oxidase) (L-pipecolic acid oxidase),390,"44,066",5 out of 5,2002-01-23,Evidence at protein level
Q13342,SP140_HUMAN,Nuclear body protein SP140 (Lymphoid-restricted homolog of Sp100) (LYSp100) (Nuclear autoantigen Sp-140) (Speckled 140 kDa),867,"98,223",5 out of 5,1999-07-15,Evidence at protein level
Q15005,SPCS2_HUMAN,Signal peptidase complex subunit 2 (EC 3.4.-.-) (Microsomal signal peptidase 25 kDa subunit) (SPase 25 kDa subunit),226,"25,003",4 out of 5,1998-07-15,Evidence at protein level
A6NLX3,SPDE4_HUMAN,Speedy protein E4,237,"27,806",1 out of 5,2008-09-02,Evidence at transcript level
O75940,SPF30_HUMAN,Survival of motor neuron-related-splicing factor 30 (30 kDa splicing factor SMNrp) (SMN-related protein) (Survival motor neuron domain-containing protein 1),238,"26,711",5 out of 5,2003-09-26,Evidence at protein level
P17947,SPI1_HUMAN,Transcription factor PU.1 (31 kDa-transforming protein),270,"31,083",5 out of 5,1990-11-01,Evidence at protein level
Q8N5J4,SPIC_HUMAN,Transcription factor Spi-C,248,"29,180",3 out of 5,2005-07-05,Evidence at transcript level
O43278,SPIT1_HUMAN,Kunitz-type protease inhibitor 1 (Hepatocyte growth factor activator inhibitor type 1) (HAI-1),529,"58,398",5 out of 5,2001-02-21,Evidence at protein level
Q6UDR6,SPIT4_HUMAN,Kunitz-type protease inhibitor 4,99,"11,421",2 out of 5,2007-10-23,Inferred from homology
Q6ZMY3,SPOC1_HUMAN,SPOC domain-containing protein 1,1216,"130,027",3 out of 5,2007-05-15,Evidence at transcript level
Q8IUH8,SPP2C_HUMAN,Signal peptide peptidase-like 2C (SPP-like 2C) (SPPL2c) (EC 3.4.23.-) (Intramembrane protease 5) (IMP-5),684,"74,503",5 out of 5,2008-01-15,Evidence at protein level
Q96A44,SPSB4_HUMAN,SPRY domain-containing SOCS box protein 4 (SSB-4),273,"30,179",3 out of 5,2006-05-30,Evidence at protein level
Q68D10,SPT2_HUMAN,Protein SPT2 homolog (Protein KU002155) (SPT2 domain-containing protein 1),685,"75,599",5 out of 5,2008-01-15,Evidence at protein level
O43610,SPY3_HUMAN,Protein sprouty homolog 3 (Spry-3),288,"31,222",4 out of 5,2001-02-21,Evidence at transcript level
P21549,SPYA_HUMAN,Serine--pyruvate aminotransferase (SPT) (EC 2.6.1.51) (Alanine--glyoxylate aminotransferase) (AGT) (EC 2.6.1.44),392,"43,010",5 out of 5,1991-05-01,Evidence at protein level
Q13501,SQSTM_HUMAN,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62),440,"47,687",5 out of 5,2005-10-11,Evidence at protein level
Q9HD15,SRA1_HUMAN,Steroid receptor RNA activator 1 (Steroid receptor RNA activator protein) (SRAP),236,"25,673",5 out of 5,2006-05-16,Evidence at protein level
Q12772,SRBP2_HUMAN,Sterol regulatory element-binding protein 2 (SREBP-2) (Class D basic helix-loop-helix protein 2) (bHLHd2) (Sterol regulatory element-binding transcription factor 2) [Cleaved into: Processed sterol regulatory element-binding protein 2],1141,"123,688",5 out of 5,1998-07-15,Evidence at protein level
Q9BX66,SRBS1_HUMAN,Sorbin and SH3 domain-containing protein 1 (Ponsin) (SH3 domain protein 5) (SH3P12) (c-Cbl-associated protein) (CAP),1292,"142,513",5 out of 5,2004-08-31,Evidence at protein level
A1L4H1,SRCRL_HUMAN,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D (Soluble scavenger protein with 5 SRCR domains) (SSc5D),1573,"165,743",5 out of 5,2008-05-20,Evidence at protein level
P12931,SRC_HUMAN,Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src),536,"59,835",5 out of 5,1989-10-01,Evidence at protein level
P0DJJ0,SRG2C_HUMAN,SLIT-ROBO Rho GTPase-activating protein 2C (SLIT-ROBO Rho GTPase activating protein 2 pseudogene 1),459,"53,484",5 out of 5,2012-07-11,Evidence at protein level
O75044,SRGP2_HUMAN,SLIT-ROBO Rho GTPase-activating protein 2 (srGAP2) (Formin-binding protein 2) (Rho GTPase-activating protein 34),1071,"120,881",5 out of 5,2004-06-07,Evidence at protein level
O43295,SRGP3_HUMAN,SLIT-ROBO Rho GTPase-activating protein 3 (srGAP3) (Mental disorder-associated GAP) (Rho GTPase-activating protein 14) (WAVE-associated Rac GTPase-activating protein) (WRP),1099,"124,504",5 out of 5,1998-07-15,Evidence at protein level
Q9UPE1,SRPK3_HUMAN,SRSF protein kinase 3 (EC 2.7.11.1) (Muscle-specific serine kinase 1) (MSSK-1) (Serine/arginine-rich protein-specific kinase 3) (SR-protein-specific kinase 3) (Serine/threonine-protein kinase 23),567,"62,014",5 out of 5,2001-02-21,Evidence at protein level
Q9Y5M8,SRPRB_HUMAN,Signal recognition particle receptor subunit beta (SR-beta) (Protein APMCF1),271,"29,702",4 out of 5,2000-12-01,Evidence at protein level
P78539,SRPX_HUMAN,Sushi repeat-containing protein SRPX,464,"51,572",5 out of 5,1997-11-01,Evidence at protein level
A6NNA2,SRRM3_HUMAN,Serine/arginine repetitive matrix protein 3,597,"65,249",1 out of 5,2008-06-10,Evidence at transcript level
B3KS81,SRRM5_HUMAN,Serine/arginine repetitive matrix protein 5,715,"80,355",2 out of 5,2010-07-13,Evidence at protein level
P84103,SRSF3_HUMAN,"Serine/arginine-rich splicing factor 3 (Pre-mRNA-splicing factor SRP20) (Splicing factor, arginine/serine-rich 3)",164,"19,330",5 out of 5,2004-08-16,Evidence at protein level
A2A2V5,SRTM1_HUMAN,Serine-rich and transmembrane domain-containing protein 1,107,"11,458",2 out of 5,2008-04-29,Predicted
Q9BZL3,SMIM3_HUMAN,Small integral membrane protein 3 (NGF-induced differentiation clone 67 protein) (Small membrane protein NID67),60,"6,593",4 out of 5,2004-07-19,Evidence at protein level
Q9H4F8,SMOC1_HUMAN,SPARC-related modular calcium-binding protein 1 (Secreted modular calcium-binding protein 1) (SMOC-1),434,"48,163",5 out of 5,2003-10-31,Evidence at protein level
Q6STE5,SMRD3_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 3 (60 kDa BRG-1/Brm-associated factor subunit C) (BRG1-associated factor 60C) (BAF60C),483,"55,016",5 out of 5,2005-01-04,Evidence at protein level
A8MU46,SMTL1_HUMAN,Smoothelin-like protein 1,457,"48,953",4 out of 5,2008-02-26,Evidence at protein level
Q13487,SNPC2_HUMAN,snRNA-activating protein complex subunit 2 (SNAPc subunit 2) (Proximal sequence element-binding transcription factor subunit delta) (PSE-binding factor subunit delta) (PTF subunit delta) (Small nuclear RNA-activating complex polypeptide 2) (snRNA-activating protein complex 45 kDa subunit) (SNAPc 45 kDa subunit),334,"35,556",5 out of 5,2000-05-30,Evidence at protein level
Q6IEG0,SNR48_HUMAN,U11/U12 small nuclear ribonucleoprotein 48 kDa protein (U11/U12 snRNP 48 kDa protein) (U11/U12-48K),339,"39,965",5 out of 5,2005-07-19,Evidence at protein level
Q9Y5W7,SNX14_HUMAN,Sorting nexin-14,946,"110,182",5 out of 5,2000-12-01,Evidence at protein level
P57768,SNX16_HUMAN,Sorting nexin-16,344,"39,167",5 out of 5,2001-02-21,Evidence at protein level
Q7Z614,SNX20_HUMAN,Sorting nexin-20 (Selectin ligand-interactor cytoplasmic 1) (SLIC-1),316,"36,178",5 out of 5,2008-03-18,Evidence at protein level
Q96L94,SNX22_HUMAN,Sorting nexin-22,193,"22,068",3 out of 5,2002-03-27,Evidence at protein level
Q3KNW5,SOAT_HUMAN,Solute carrier family 10 member 6 (Sodium-dependent organic anion transporter),377,"41,259",4 out of 5,2007-11-13,Evidence at protein level
A7XYQ1,SOBP_HUMAN,Sine oculis-binding protein homolog (Jackson circler protein 1),873,"92,658",4 out of 5,2007-12-04,Evidence at protein level
O14508,SOCS2_HUMAN,Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2),198,"22,172",5 out of 5,2002-04-16,Evidence at protein level
P00441,SODC_HUMAN,Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) (Superoxide dismutase 1) (hSod1),154,"15,936",5 out of 5,1986-07-21,Evidence at protein level
Q9NX45,SOLH2_HUMAN,Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 2,425,"46,941",3 out of 5,2008-01-15,Evidence at transcript level
P56693,SOX10_HUMAN,Transcription factor SOX-10,466,"49,911",5 out of 5,1999-07-15,Evidence at protein level
Q9UN79,SOX13_HUMAN,Transcription factor SOX-13 (Islet cell antigen 12) (SRY (Sex determining region Y)-box 13) (Type 1 diabetes autoantigen ICA12),622,"69,228",4 out of 5,2000-12-01,Evidence at protein level
P35712,SOX6_HUMAN,Transcription factor SOX-6,828,"91,921",5 out of 5,1994-06-01,Evidence at protein level
P0CG40,SP9_HUMAN,Transcription factor Sp9,484,"48,915",3 out of 5,2010-07-13,Inferred from homology
Q8IW75,SPA12_HUMAN,Serpin A12 (OL-64) (Visceral adipose tissue-derived serine protease inhibitor) (Vaspin) (Visceral adipose-specific serpin),414,"47,175",5 out of 5,2005-09-27,Evidence at protein level
Q8N4H0,SPA6L_HUMAN,Spermatogenesis associated 6-like protein,392,"45,058",2 out of 5,2005-07-05,Evidence at transcript level
P35237,SPB6_HUMAN,Serpin B6 (Cytoplasmic antiproteinase) (CAP) (Peptidase inhibitor 6) (PI-6) (Placental thrombin inhibitor),376,"42,622",5 out of 5,1994-02-01,Evidence at protein level
Q495Y7,SPDE7_HUMAN,Putative speedy protein E7 (Speedy protein E7 pseudogene),208,"25,253",2 out of 5,2008-09-02,Uncertain
O95238,SPDEF_HUMAN,SAM pointed domain-containing Ets transcription factor (Prostate epithelium-specific Ets transcription factor) (Prostate-specific Ets) (Prostate-derived Ets factor),335,"37,518",5 out of 5,2006-02-21,Evidence at protein level
Q5MJ70,SPDYA_HUMAN,Speedy protein A (Rapid inducer of G2/M progression in oocytes A) (RINGO A) (hSpy/Ringo A) (Speedy-1) (Spy1),313,"36,463",5 out of 5,2006-05-02,Evidence at protein level
Q9BSE5,SPEB_HUMAN,"Agmatinase, mitochondrial (EC 3.5.3.11) (Agmatine ureohydrolase) (AUH)",352,"37,660",4 out of 5,2002-03-27,Evidence at protein level
Q8NA61,SPERT_HUMAN,Spermatid-associated protein (Protein chibby homolog 2),448,"51,570",5 out of 5,2007-10-23,Evidence at protein level
Q9NYA1,SPHK1_HUMAN,Sphingosine kinase 1 (SK 1) (SPK 1) (EC 2.7.1.91),384,"42,518",5 out of 5,2001-10-24,Evidence at protein level
P51688,SPHM_HUMAN,N-sulphoglucosamine sulphohydrolase (EC 3.10.1.1) (Sulfoglucosamine sulfamidase) (Sulphamidase),502,"56,695",5 out of 5,1996-10-01,Evidence at protein level
Q8WWL2,SPIR2_HUMAN,Protein spire homolog 2 (Spir-2),714,"79,671",5 out of 5,2008-02-26,Evidence at protein level
Q9NZQ3,SPN90_HUMAN,NCK-interacting protein with SH3 domain (54 kDa VacA-interacting protein) (54 kDa vimentin-interacting protein) (VIP54) (90 kDa SH3 protein interacting with Nck) (AF3p21) (Dia-interacting protein 1) (DIP-1) (Diaphanous protein-interacting protein) (SH3 adapter protein SPIN90) (WASP-interacting SH3-domain protein) (WISH) (Wiskott-Aldrich syndrome protein-interacting protein),722,"78,960",5 out of 5,2001-12-05,Evidence at protein level
Q9BXN6,SPNXD_HUMAN,Sperm protein associated with the nucleus on the X chromosome D (Cancer/testis antigen 11.4) (CT11.4) (Nuclear-associated protein SPAN-Xd) (SPANX-D) (SPANX family member D),97,"11,029",3 out of 5,2005-02-01,Evidence at protein level
P35325,SPR2B_HUMAN,Small proline-rich protein 2B (SPR-2B),72,"7,975",4 out of 5,1994-02-01,Evidence at transcript level
Q9BYE4,SPR2G_HUMAN,Small proline-rich protein 2G (SPR-2G),73,"8,158",3 out of 5,2004-03-15,Inferred from homology
P35270,SPRE_HUMAN,Sepiapterin reductase (SPR) (EC 1.1.1.153),261,"28,048",5 out of 5,1994-02-01,Evidence at protein level
Q99611,SPS2_HUMAN,"Selenide, water dikinase 2 (EC 2.7.9.3) (Selenium donor protein 2) (Selenophosphate synthase 2)",448,"47,305",4 out of 5,1999-07-15,Evidence at protein level
Q6PJ21,SPSB3_HUMAN,SPRY domain-containing SOCS box protein 3 (SSB-3),355,"39,376",3 out of 5,2007-02-20,Evidence at protein level
Q5MJ09,SPXN3_HUMAN,Sperm protein associated with the nucleus on the X chromosome N3 (Nuclear-associated protein SPAN-Xn3) (SPANX-N3) (SPANX family member N3),141,"15,595",2 out of 5,2007-05-01,Evidence at transcript level
Q8N5C6,SRBD1_HUMAN,S1 RNA-binding domain-containing protein 1,995,"111,776",3 out of 5,2007-04-17,Evidence at protein level
P23327,SRCH_HUMAN,Sarcoplasmic reticulum histidine-rich calcium-binding protein,699,"80,244",5 out of 5,1991-11-01,Evidence at protein level
Q8NEF9,SRFB1_HUMAN,Serum response factor-binding protein 1 (SRF-dependent transcription regulation-associated protein) (p49/STRAP),429,"48,634",3 out of 5,2008-02-26,Evidence at protein level
O76094,SRP72_HUMAN,Signal recognition particle subunit SRP72 (SRP72) (Signal recognition particle 72 kDa protein),671,"74,606",5 out of 5,1998-12-15,Evidence at protein level
Q9NP31,SH22A_HUMAN,SH2 domain-containing protein 2A (SH2 domain-containing adapter protein) (T cell-specific adapter protein) (TSAd) (VEGF receptor-associated protein),389,"42,934",5 out of 5,2002-03-27,Evidence at protein level
Q5SQS7,SH24B_HUMAN,SH2 domain-containing protein 4B,431,"51,232",2 out of 5,2007-10-23,Evidence at transcript level
Q6ZV89,SH2D5_HUMAN,SH2 domain-containing protein 5,423,"46,797",3 out of 5,2006-04-04,Evidence at protein level
Q9UJC5,SH3L2_HUMAN,SH3 domain-binding glutamic acid-rich-like protein 2 (Fovea-associated SH3 domain-binding protein),107,"12,326",3 out of 5,2001-01-11,Evidence at protein level
Q96IW2,SHD_HUMAN,SH2 domain-containing adapter protein D,340,"38,264",2 out of 5,2006-07-25,Evidence at protein level
Q6ZSJ9,SHSA6_HUMAN,Protein shisa-6 homolog,500,"55,764",3 out of 5,2008-03-18,Evidence at transcript level
Q9Y3P8,SIT1_HUMAN,Signaling threshold-regulating transmembrane adapter 1 (SHP2-interacting transmembrane adapter protein) (Suppression-inducing transmembrane adapter 1) (gp30/40),196,"21,126",5 out of 5,2005-12-20,Evidence at protein level
Q8N196,SIX5_HUMAN,Homeobox protein SIX5 (DM locus-associated homeodomain protein) (Sine oculis homeobox homolog 5),739,"74,562",5 out of 5,2004-04-13,Evidence at protein level
Q96T83,SL9A7_HUMAN,Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7),725,"80,131",5 out of 5,2004-03-01,Evidence at protein level
Q86UD5,SL9B2_HUMAN,Mitochondrial sodium/hydrogen exchanger 9B2 (Mitochondrial Na(+)/H(+) exchanger NHA2) (Na(+)/H(+) exchanger-like domain-containing protein 2) (NHE domain-containing protein 2) (Sodium/hydrogen exchanger-like domain-containing protein 2) (Solute carrier family 9 subfamily B member 2),537,"57,564",5 out of 5,2008-04-29,Evidence at protein level
O75094,SLIT3_HUMAN,Slit homolog 3 protein (Slit-3) (Multiple epidermal growth factor-like domains protein 5) (Multiple EGF-like domains protein 5),1523,"167,713",5 out of 5,2004-03-15,Evidence at transcript level
P84022,SMAD3_HUMAN,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3),425,"48,081",5 out of 5,2004-07-05,Evidence at protein level
O95347,SMC2_HUMAN,Structural maintenance of chromosomes protein 2 (SMC protein 2) (SMC-2) (Chromosome-associated protein E) (hCAP-E) (XCAP-E homolog),1197,"135,656",5 out of 5,2003-04-23,Evidence at protein level
Q8WV41,SNX33_HUMAN,Sorting nexin-33 (SH3 and PX domain-containing protein 3),574,"65,265",5 out of 5,2007-12-04,Evidence at protein level
O60493,SNX3_HUMAN,Sorting nexin-3 (Protein SDP3),162,"18,762",5 out of 5,2000-12-01,Evidence at protein level
Q9UNH7,SNX6_HUMAN,"Sorting nexin-6 (TRAF4-associated factor 2) [Cleaved into: Sorting nexin-6, N-terminally processed]",406,"46,649",5 out of 5,2000-12-01,Evidence at protein level
Q9Y5X2,SNX8_HUMAN,Sorting nexin-8,465,"52,569",5 out of 5,2000-12-01,Evidence at protein level
Q92959,SO2A1_HUMAN,Solute carrier organic anion transporter family member 2A1 (Prostaglandin transporter) (PGT) (Solute carrier family 21 member 2),643,"70,044",5 out of 5,1998-12-15,Evidence at protein level
Q86UG4,SO6A1_HUMAN,Solute carrier organic anion transporter family member 6A1 (Cancer/testis antigen 48) (CT48) (Gonad-specific transporter) (GST) (Organic anion-transporting polypeptide 6A1) (Organic anion-transporting polypeptide I) (OATP-I) (Solute carrier family 21 member 19),719,"79,232",4 out of 5,2007-10-23,Evidence at transcript level
O75159,SOCS5_HUMAN,Suppressor of cytokine signaling 5 (SOCS-5) (Cytokine-inducible SH2 protein 6) (CIS-6) (Cytokine-inducible SH2-containing protein 5),536,"61,246",5 out of 5,2002-04-16,Evidence at protein level
Q5JUK2,SOLH1_HUMAN,Spermatogenesis- and oogenesis-specific basic helix-loop-helix-containing protein 1,328,"34,526",4 out of 5,2008-01-15,Evidence at protein level
P18583,SON_HUMAN,Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3),2426,"263,830",5 out of 5,1990-11-01,Evidence at protein level
Q9UPU3,SORC3_HUMAN,VPS10 domain-containing receptor SorCS3,1222,"135,755",3 out of 5,2002-12-13,Evidence at transcript level
Q9BQ15,SOSB1_HUMAN,SOSS complex subunit B1 (Nucleic acid-binding protein 2) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2B) (Sensor of single-strand DNA complex subunit B1) (Sensor of ssDNA subunit B1) (SOSS-B1) (Single-stranded DNA-binding protein 1) (hSSB1),211,"22,338",5 out of 5,2008-05-20,Evidence at protein level
Q9NRY2,SOSSC_HUMAN,SOSS complex subunit C (INTS3- and NABP-interacting protein) (Sensor of single-strand DNA complex subunit C) (Sensor of ssDNA subunit C) (SOSS-C) (Single-stranded DNA-binding protein-interacting protein 1) (SSB-interacting protein 1) (hSSBIP1),104,"11,425",5 out of 5,2007-03-06,Evidence at protein level
Q9BQB4,SOST_HUMAN,Sclerostin,213,"24,031",5 out of 5,2002-03-05,Evidence at protein level
P35716,SOX11_HUMAN,Transcription factor SOX-11,441,"46,679",5 out of 5,1994-06-01,Evidence at protein level
Q9H6I2,SOX17_HUMAN,Transcription factor SOX-17,414,"44,117",5 out of 5,2002-10-10,Evidence at protein level
P41225,SOX3_HUMAN,Transcription factor SOX-3,446,"45,210",5 out of 5,1995-02-01,Evidence at protein level
P23497,SP100_HUMAN,Nuclear autoantigen Sp-100 (Nuclear dot-associated Sp100 protein) (Speckled 100 kDa),879,"100,417",5 out of 5,1991-11-01,Evidence at protein level
Q9Y5B9,SP16H_HUMAN,FACT complex subunit SPT16 (Chromatin-specific transcription elongation factor 140 kDa subunit) (FACT 140 kDa subunit) (FACTp140) (Facilitates chromatin transcription complex subunit SPT16) (hSPT16),1047,"119,914",5 out of 5,2006-07-11,Evidence at protein level
Q02086,SP2_HUMAN,Transcription factor Sp2,613,"64,900",5 out of 5,1995-02-01,Evidence at protein level
Q6UXR4,SPA13_HUMAN,Putative serpin A13,307,"34,864",2 out of 5,2005-09-27,Uncertain
Q9BWV2,SPAT9_HUMAN,Spermatogenesis-associated protein 9 (Testis development protein NYD-SP16),254,"28,740",3 out of 5,2007-02-20,Evidence at transcript level
A6NHP3,SPE2B_HUMAN,Speedy protein E2B,402,"48,290",2 out of 5,2008-04-29,Inferred from homology
Q9Y2E8,SL9A8_HUMAN,Sodium/hydrogen exchanger 8 (Na(+)/H(+) exchanger 8) (NHE-8) (Solute carrier family 9 member 8),581,"65,422",4 out of 5,2004-03-01,Evidence at protein level
A6NJY1,SL9P1_HUMAN,Putative SLC9B1-like protein SLC9B1P1 (Solute carrier family 9 subfamily B member 1 pseudogene 1),282,"30,828",2 out of 5,2008-06-10,Uncertain
Q08AF3,SLFN5_HUMAN,Schlafen family member 5,891,"101,055",3 out of 5,2007-04-03,Evidence at protein level
Q9H5Y7,SLIK6_HUMAN,SLIT and NTRK-like protein 6,841,"95,110",5 out of 5,2004-04-13,Evidence at transcript level
Q9Y6J3,SMA5O_HUMAN,SMAD5 antisense gene protein 1 (10.3 kDa proline-rich protein DAMS) (SMAD5 antisense RNA 1) (SMAD5 opposite strand protein),95,"10,312",2 out of 5,2000-12-01,Evidence at transcript level
O15105,SMAD7_HUMAN,Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7) (hSMAD7),426,"46,426",5 out of 5,2001-05-04,Evidence at protein level
Q8WU79,SMAP2_HUMAN,Stromal membrane-associated protein 2 (Stromal membrane-associated protein 1-like),429,"46,786",4 out of 5,2006-05-16,Evidence at protein level
Q8NDV3,SMC1B_HUMAN,Structural maintenance of chromosomes protein 1B (SMC protein 1B) (SMC-1-beta) (SMC-1B),1235,"143,908",5 out of 5,2003-03-25,Evidence at transcript level
Q9NTJ3,SMC4_HUMAN,Structural maintenance of chromosomes protein 4 (SMC protein 4) (SMC-4) (Chromosome-associated polypeptide C) (hCAP-C) (XCAP-C homolog),1288,"147,182",5 out of 5,2003-04-23,Evidence at protein level
Q96SB8,SMC6_HUMAN,Structural maintenance of chromosomes protein 6 (SMC protein 6) (SMC-6) (hSMC6),1091,"126,326",5 out of 5,2007-01-09,Evidence at protein level
P51531,SMCA2_HUMAN,Probable global transcription activator SNF2L2 (EC 3.6.4.-) (ATP-dependent helicase SMARCA2) (BRG1-associated factor 190B) (BAF190B) (Protein brahma homolog) (hBRM) (SNF2-alpha) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 2),1590,"181,279",5 out of 5,1996-10-01,Evidence at protein level
Q99523,SORT_HUMAN,Sortilin (100 kDa NT receptor) (Glycoprotein 95) (Gp95) (Neurotensin receptor 3) (NT3) (NTR3),831,"92,068",5 out of 5,2000-12-01,Evidence at protein level
Q07889,SOS1_HUMAN,Son of sevenless homolog 1 (SOS-1),1333,"152,464",5 out of 5,1999-07-15,Evidence at protein level
Q9BT81,SOX7_HUMAN,Transcription factor SOX-7,388,"42,197",5 out of 5,2002-05-10,Evidence at protein level
Q496A3,SPAS1_HUMAN,Spermatogenesis-associated serine-rich protein 1,300,"33,705",2 out of 5,2007-10-23,Evidence at transcript level
P48595,SPB10_HUMAN,Serpin B10 (Bomapin) (Peptidase inhibitor 10) (PI-10),397,"45,403",5 out of 5,1996-02-01,Evidence at protein level
Q495Y8,SPDE2_HUMAN,Speedy protein E2,402,"48,300",2 out of 5,2008-04-29,Evidence at protein level
Q8N4L4,SPEM1_HUMAN,Spermatid maturation protein 1,309,"34,773",2 out of 5,2007-10-23,Evidence at transcript level
Q96I25,SPF45_HUMAN,Splicing factor 45 (45 kDa-splicing factor) (RNA-binding motif protein 17),401,"44,962",5 out of 5,2003-09-19,Evidence at protein level
Q15513,SPHAR_HUMAN,Protein SPHAR (S-phase response protein),63,"7,515",1 out of 5,2000-05-30,Predicted
Q9NS26,SPNXA_HUMAN,Sperm protein associated with the nucleus on the X chromosome A (Cancer/testis antigen 11.1) (CT11.1) (Nuclear-associated protein SPAN-Xa) (SPAN-X) (SPANX-A) (SPANX family member A),97,"11,038",3 out of 5,2005-02-01,Evidence at protein level
Q9Y5K1,SPO11_HUMAN,Meiotic recombination protein SPO11 (EC 5.99.1.3) (Cancer/testis antigen 35) (CT35),396,"44,537",5 out of 5,2000-05-30,Evidence at transcript level
Q7Z6I5,SPT12_HUMAN,Spermatogenesis-associated protein 12 (Spermatogenesis-related protein 5),190,"20,418",1 out of 5,2006-10-03,Evidence at transcript level
Q7Z5L4,SPT19_HUMAN,"Spermatogenesis-associated protein 19, mitochondrial (Spermatogenic cell-specific gene 1 protein) (Spergen-1)",167,"19,186",3 out of 5,2006-10-03,Evidence at transcript level
Q8TB22,SPT20_HUMAN,Spermatogenesis-associated protein 20 (Sperm-specific protein 411) (Ssp411),786,"87,899",3 out of 5,2007-02-20,Evidence at transcript level
Q7Z572,SPT21_HUMAN,Spermatogenesis-associated protein 21,469,"52,207",3 out of 5,2008-04-29,Evidence at transcript level
Q96N06,SPT33_HUMAN,Spermatogenesis-associated protein 33,139,"15,461",2 out of 5,2007-04-03,Evidence at transcript level
O15269,SPTC1_HUMAN,Serine palmitoyltransferase 1 (EC 2.3.1.50) (Long chain base biosynthesis protein 1) (LCB 1) (Serine-palmitoyl-CoA transferase 1) (SPT 1) (SPT1),473,"52,744",5 out of 5,2000-05-30,Evidence at protein level
Q5TFQ8,SIRBL_HUMAN,Signal-regulatory protein beta-1 isoform 3 (SIRP-beta-1 isoform 3),398,"43,359",3 out of 5,2008-09-02,Evidence at protein level
Q15475,SIX1_HUMAN,Homeobox protein SIX1 (Sine oculis homeobox homolog 1),284,"32,210",5 out of 5,1997-11-01,Evidence at protein level
O95475,SIX6_HUMAN,Homeobox protein SIX6 (Homeodomain protein OPTX2) (Optic homeobox 2) (Sine oculis homeobox homolog 6),246,"27,687",4 out of 5,2001-01-11,Evidence at protein level
Q1XH10,SKDA1_HUMAN,SKI/DACH domain-containing protein 1 (Protein DLN-1),827,"90,476",2 out of 5,2008-04-08,Evidence at transcript level
P12757,SKIL_HUMAN,Ski-like protein (Ski-related oncogene) (Ski-related protein),684,"76,976",5 out of 5,1989-10-01,Evidence at protein level
Q4ZJI4,SL9B1_HUMAN,"Sodium/hydrogen exchanger 9B1 (Na(+)/H(+) exchanger-like domain-containing protein 1) (NHE domain-containing protein 1) (Sodium/hydrogen exchanger-like domain-containing protein 1) (Solute carrier family 9, subfamily B member 1)",515,"56,054",5 out of 5,2008-01-15,Evidence at transcript level
Q4G0N8,SL9C1_HUMAN,Sodium/hydrogen exchanger 10 (Na(+)/H(+) exchanger 10) (NHE-10) (Solute carrier family 9 member 10) (Solute carrier family 9 member C1) (Sperm-specific Na(+)/H(+) exchanger) (sNHE),1177,"135,206",5 out of 5,2007-07-24,Evidence at transcript level
Q13239,SLAP1_HUMAN,Src-like-adapter (Src-like-adapter protein 1) (SLAP-1) (hSLAP),276,"31,156",5 out of 5,2003-04-23,Evidence at protein level
Q14493,SLBP_HUMAN,Histone RNA hairpin-binding protein (Histone stem-loop-binding protein),270,"31,286",5 out of 5,2000-12-01,Evidence at protein level
Q07837,SLC31_HUMAN,"Neutral and basic amino acid transport protein rBAT (NBAT) (D2h) (Solute carrier family 3 member 1) (b(0,+)-type amino acid transport protein)",685,"78,852",5 out of 5,2001-09-26,Evidence at protein level
Q9H156,SLIK2_HUMAN,SLIT and NTRK-like protein 2,845,"95,404",5 out of 5,2004-04-13,Evidence at protein level
Q9GZT3,SLIRP_HUMAN,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",109,"12,349",5 out of 5,2006-07-25,Evidence at protein level
O75093,SLIT1_HUMAN,Slit homolog 1 protein (Slit-1) (Multiple epidermal growth factor-like domains protein 4) (Multiple EGF-like domains protein 4),1534,"167,926",5 out of 5,2004-03-15,Evidence at transcript level
Q68D06,SLN13_HUMAN,Schlafen family member 13,897,"102,045",3 out of 5,2007-04-03,Evidence at transcript level
Q9UPU9,SMAG1_HUMAN,Protein Smaug homolog 1 (Smaug 1) (hSmaug1) (Sterile alpha motif domain-containing protein 4A) (SAM domain-containing protein 4A),718,"79,415",5 out of 5,2003-09-19,Evidence at protein level
P02814,SMR3B_HUMAN,Submaxillary gland androgen-regulated protein 3B (Proline-rich peptide P-B) (Proline-rich protein 3) [Cleaved into: Peptide P-A; Peptide D1A],79,"8,188",4 out of 5,1986-07-21,Evidence at protein level
Q8TAQ2,SMRC2_HUMAN,SWI/SNF complex subunit SMARCC2 (BRG1-associated factor 170) (BAF170) (SWI/SNF complex 170 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 2),1214,"132,879",5 out of 5,2005-01-04,Evidence at protein level
Q92925,SMRD2_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 2 (60 kDa BRG-1/Brm-associated factor subunit B) (BRG1-associated factor 60B) (BAF60B),531,"58,921",5 out of 5,2005-01-04,Evidence at protein level
Q2TAY7,SMU1_HUMAN,"WD40 repeat-containing protein SMU1 (Smu-1 suppressor of mec-8 and unc-52 protein homolog) [Cleaved into: WD40 repeat-containing protein SMU1, N-terminally processed]",513,"57,544",4 out of 5,2006-05-30,Evidence at protein level
Q8NB12,SMYD1_HUMAN,Histone-lysine N-methyltransferase SMYD1 (EC 2.1.1.43) (SET and MYND domain-containing protein 1),490,"56,617",5 out of 5,2003-09-19,Evidence at protein level
Q9NRG4,SMYD2_HUMAN,N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.43) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2),433,"49,688",5 out of 5,2004-05-10,Evidence at protein level
Q9H115,SNAB_HUMAN,Beta-soluble NSF attachment protein (SNAP-beta) (N-ethylmaleimide-sensitive factor attachment protein beta),298,"33,557",5 out of 5,2001-08-29,Evidence at protein level
Q9Y6H5,SNCAP_HUMAN,Synphilin-1 (Sph1) (Alpha-synuclein-interacting protein),919,"100,409",5 out of 5,2000-12-01,Evidence at protein level
Q12824,SNF5_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1 (BRG1-associated factor 47) (BAF47) (Integrase interactor 1 protein) (SNF5 homolog) (hSNF5),385,"44,141",5 out of 5,2000-12-01,Evidence at protein level
P01241,SOMA_HUMAN,Somatotropin (Growth hormone) (GH) (GH-N) (Growth hormone 1) (Pituitary growth hormone),217,"24,847",5 out of 5,1986-07-21,Evidence at protein level
Q8WY21,SORC1_HUMAN,VPS10 domain-containing receptor SorCS1 (hSorCS),1168,"129,635",5 out of 5,2002-12-13,Evidence at protein level
P30626,SORCN_HUMAN,Sorcin (22 kDa protein) (CP-22) (CP22) (V19),198,"21,676",5 out of 5,1993-04-01,Evidence at protein level
Q92673,SORL_HUMAN,Sortilin-related receptor (Low-density lipoprotein receptor relative with 11 ligand-binding repeats) (LDLR relative with 11 ligand-binding repeats) (LR11) (SorLA-1) (Sorting protein-related receptor containing LDLR class A repeats) (SorLA),2214,"248,426",5 out of 5,2000-12-01,Evidence at protein level
Q07890,SOS2_HUMAN,Son of sevenless homolog 2 (SOS-2),1332,"152,979",5 out of 5,1999-07-15,Evidence at protein level
Q9Y651,SOX21_HUMAN,Transcription factor SOX-21 (SOX-A),276,"28,580",3 out of 5,2000-05-30,Evidence at transcript level
O94993,SOX30_HUMAN,Transcription factor SOX-30,753,"81,854",5 out of 5,2002-05-10,Evidence at protein level
P0C7V6,SP202_HUMAN,Putative transcription factor SPT20 homolog-like 2,817,"87,541",2 out of 5,2008-07-22,Uncertain
Q96KW9,SPAC7_HUMAN,Sperm acrosome-associated protein 7,195,"21,466",3 out of 5,2007-02-06,Evidence at protein level
O75602,SPAG6_HUMAN,Sperm-associated antigen 6 (Protein PF16 homolog) (Repro-SA-1) (Sperm flagellar protein),509,"55,476",5 out of 5,2005-04-26,Evidence at transcript level
A0A1B0GVQ0,SPAR_HUMAN,Small regulatory polypeptide of amino acid response,90,"9,632",4 out of 5,2017-02-15,Evidence at protein level
Q9UBP0,SPAST_HUMAN,Spastin (EC 3.6.4.3) (Spastic paraplegia 4 protein),616,"67,197",5 out of 5,2001-01-11,Evidence at protein level
Q8NB90,SPAT5_HUMAN,Spermatogenesis-associated protein 5 (ATPase family protein 2 homolog) (Spermatogenesis-associated factor protein),893,"97,904",5 out of 5,2008-04-29,Evidence at protein level
Q9P0W8,SPAT7_HUMAN,Spermatogenesis-associated protein 7 (HSD-3.1) (Spermatogenesis-associated protein HSD3),599,"67,719",5 out of 5,2003-09-26,Evidence at protein level
Q9H0A9,SPC1L_HUMAN,Speriolin-like protein (Spermatogenesis and centriole-associated protein 1-like protein),340,"37,613",4 out of 5,2001-09-26,Evidence at protein level
Q8NBT2,SPC24_HUMAN,Kinetochore protein Spc24 (hSpc24),197,"22,478",5 out of 5,2006-09-19,Evidence at protein level
P0CI01,SPDE6_HUMAN,Putative speedy protein E6,402,"48,349",1 out of 5,2010-10-05,Predicted
Q9C093,SPEF2_HUMAN,Sperm flagellar protein 2 (Protein KPL2),1822,"209,811",4 out of 5,2007-08-21,Evidence at transcript level
Q6UW49,SPESP_HUMAN,Sperm equatorial segment protein 1 (ESP) (Equatorial segment protein) (SP-ESP) (Glycosylated 38 kDa sperm protein C-7/8),350,"38,931",3 out of 5,2005-11-08,Evidence at protein level
O75934,SPF27_HUMAN,Pre-mRNA-splicing factor SPF27 (Breast carcinoma-amplified sequence 2) (DNA amplified in mammary carcinoma 1 protein) (Spliceosome-associated protein SPF 27),225,"26,131",5 out of 5,2005-05-10,Evidence at protein level
O75830,SPI2_HUMAN,Serpin I2 (Myoepithelium-derived serine protease inhibitor) (Pancpin) (Pancreas-specific protein TSA2004) (Peptidase inhibitor 14) (PI-14),405,"46,145",4 out of 5,2002-01-23,Evidence at protein level
Q14159,SPIDR_HUMAN,DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair),915,"100,316",5 out of 5,2006-10-03,Evidence at protein level
Q56A73,SPIN4_HUMAN,Spindlin-4,249,"28,660",2 out of 5,2008-01-15,Evidence at protein level
Q08AE8,SPIR1_HUMAN,Protein spire homolog 1 (Spir-1),756,"85,544",5 out of 5,2007-11-13,Evidence at protein level
Q13103,SPP24_HUMAN,Secreted phosphoprotein 24 (Spp-24) (Secreted phosphoprotein 2),211,"24,338",4 out of 5,1997-11-01,Evidence at protein level
Q96RM1,SPR2F_HUMAN,Small proline-rich protein 2F (SPR-2F),72,"7,805",3 out of 5,2004-03-15,Inferred from homology
Q9H040,SPRTN_HUMAN,SprT-like domain-containing protein Spartan (DNA damage protein targeting VCP) (DVC1) (Protein with SprT-like domain at the N terminus) (Spartan),489,"55,134",5 out of 5,2007-12-04,Evidence at protein level
P02549,SPTA1_HUMAN,"Spectrin alpha chain, erythrocytic 1 (Erythroid alpha-spectrin)",2419,"280,014",5 out of 5,1986-07-21,Evidence at protein level
Q969W0,SPTSA_HUMAN,Serine palmitoyltransferase small subunit A (Small subunit of serine palmitoyltransferase A) (ssSPTa),71,"8,466",5 out of 5,2005-07-05,Evidence at protein level
Q5MJ08,SPXN4_HUMAN,Sperm protein associated with the nucleus on the X chromosome N4 (Nuclear-associated protein SPAN-Xn4) (SPANX-N4) (SPANX family member N4),99,"11,168",2 out of 5,2007-05-01,Inferred from homology
Q9Y6N5,SQRD_HUMAN,"Sulfide:quinone oxidoreductase, mitochondrial (SQOR) (EC 1.8.5.-)",450,"49,961",4 out of 5,2002-12-13,Evidence at protein level
Q8N9Q2,SR1IP_HUMAN,Protein SREK1IP1 (SFRS12-interacting protein 1) (SREK1-interacting protein 1) (Splicing regulatory protein of 18 kDa) (p18SRP),155,"18,177",5 out of 5,2007-12-04,Evidence at protein level
Q96JX3,SRAC1_HUMAN,Protein SERAC1 (Serine active site-containing protein 1),654,"74,147",5 out of 5,2007-02-06,Evidence at protein level
O94875,SRBS2_HUMAN,Sorbin and SH3 domain-containing protein 2 (Arg-binding protein 2) (ArgBP2) (Arg/Abl-interacting protein 2) (Sorbin),1100,"124,108",5 out of 5,2008-07-22,Evidence at protein level
Q4G0T1,SRCRM_HUMAN,Scavenger receptor cysteine-rich domain-containing protein SCART1,1027,"108,611",3 out of 5,2008-06-10,Evidence at protein level
Q14162,SREC_HUMAN,Scavenger receptor class F member 1 (Acetyl LDL receptor) (Scavenger receptor expressed by endothelial cells 1) (SREC-I),830,"87,387",5 out of 5,2002-01-23,Evidence at protein level
P0DMP2,SRG2B_HUMAN,SLIT-ROBO Rho GTPase-activating protein 2B (SLIT-ROBO Rho GTPase activating protein 2 pseudogene 2),458,"53,406",2 out of 5,2014-10-01,Inferred from homology
P49458,SRP09_HUMAN,Signal recognition particle 9 kDa protein (SRP9),86,"10,112",5 out of 5,1996-02-01,Evidence at protein level
Q9GZT4,SRR_HUMAN,Serine racemase (EC 5.1.1.18) (D-serine ammonia-lyase) (D-serine dehydratase) (EC 4.3.1.18) (L-serine ammonia-lyase) (L-serine dehydratase) (EC 4.3.1.17),340,"36,566",5 out of 5,2002-01-31,Evidence at protein level
Q8WXF0,SRS12_HUMAN,"Serine/arginine-rich splicing factor 12 (35 kDa SR repressor protein) (SRrp35) (Splicing factor, arginine/serine-rich 13B) (Splicing factor, arginine/serine-rich 19)",261,"30,512",4 out of 5,2004-05-24,Evidence at transcript level
Q07955,SRSF1_HUMAN,"Serine/arginine-rich splicing factor 1 (Alternative-splicing factor 1) (ASF-1) (Splicing factor, arginine/serine-rich 1) (pre-mRNA-splicing factor SF2, P33 subunit)",248,"27,745",5 out of 5,1995-02-01,Evidence at protein level
Q08170,SRSF4_HUMAN,"Serine/arginine-rich splicing factor 4 (Pre-mRNA-splicing factor SRP75) (SRP001LB) (Splicing factor, arginine/serine-rich 4)",494,"56,678",5 out of 5,1995-02-01,Evidence at protein level
Q14140,SRTD2_HUMAN,SERTA domain-containing protein 2 (Transcriptional regulator interacting with the PHD-bromodomain 2) (TRIP-Br2),314,"33,897",5 out of 5,1998-07-15,Evidence at protein level
Q9NUC0,SRTD4_HUMAN,SERTA domain-containing protein 4,356,"39,348",2 out of 5,2008-01-15,Evidence at transcript level
Q9BYN0,SRXN1_HUMAN,Sulfiredoxin-1 (EC 1.8.98.2),137,"14,259",4 out of 5,2003-04-30,Evidence at protein level
Q05066,SRY_HUMAN,Sex-determining region Y protein (Testis-determining factor),204,"23,884",5 out of 5,1994-06-01,Evidence at protein level
Q04837,SSBP_HUMAN,"Single-stranded DNA-binding protein, mitochondrial (Mt-SSB) (MtSSB) (PWP1-interacting protein 17)",148,"17,260",5 out of 5,1993-10-01,Evidence at protein level
Q8WWF3,SSMM1_HUMAN,Serine-rich single-pass membrane protein 1,244,"28,167",2 out of 5,2007-01-09,Evidence at transcript level
Q96Q15,SMG1_HUMAN,Serine/threonine-protein kinase SMG1 (SMG-1) (hSMG-1) (EC 2.7.11.1) (61E3.4) (Lambda/iota protein kinase C-interacting protein) (Lambda-interacting protein),3661,"410,501",5 out of 5,2006-04-04,Evidence at protein level
P0DI80,SMIM6_HUMAN,Small integral membrane protein 6,62,"7,017",1 out of 5,2011-09-21,Predicted
H3BR10,SMLR1_HUMAN,Small leucine-rich protein 1,107,"12,312",2 out of 5,2013-03-06,Evidence at protein level
Q9H3U7,SMOC2_HUMAN,SPARC-related modular calcium-binding protein 2 (Secreted modular calcium-binding protein 2) (SMOC-2) (Smooth muscle-associated protein 2) (SMAP-2),446,"49,674",4 out of 5,2003-10-31,Evidence at transcript level
Q99835,SMO_HUMAN,Smoothened homolog (SMO) (Protein Gx),787,"86,397",5 out of 5,2000-05-30,Evidence at protein level
Q92922,SMRC1_HUMAN,SWI/SNF complex subunit SMARCC1 (BRG1-associated factor 155) (BAF155) (SWI/SNF complex 155 kDa subunit) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily C member 1),1105,"122,867",5 out of 5,2005-01-04,Evidence at protein level
Q9H4L7,SMRCD_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 (EC 3.6.4.12) (ATP-dependent helicase 1) (hHEL1),1026,"117,402",5 out of 5,2003-03-28,Evidence at protein level
Q2TAL5,SMTL2_HUMAN,Smoothelin-like protein 2,461,"50,196",2 out of 5,2008-02-05,Evidence at transcript level
Q53HV7,SMUG1_HUMAN,Single-strand selective monofunctional uracil DNA glycosylase (EC 3.2.2.-),270,"29,862",5 out of 5,2005-08-16,Evidence at protein level
P60880,SNP25_HUMAN,Synaptosomal-associated protein 25 (SNAP-25) (Super protein) (SUP) (Synaptosomal-associated 25 kDa protein),206,"23,315",5 out of 5,2004-04-13,Evidence at protein level
Q92966,SNPC3_HUMAN,snRNA-activating protein complex subunit 3 (SNAPc subunit 3) (Proximal sequence element-binding transcription factor subunit beta) (PSE-binding factor subunit beta) (PTF subunit beta) (Small nuclear RNA-activating complex polypeptide 3) (snRNA-activating protein complex 50 kDa subunit) (SNAPc 50 kDa subunit),411,"46,753",5 out of 5,2000-05-30,Evidence at protein level
Q96DI7,SNR40_HUMAN,U5 small nuclear ribonucleoprotein 40 kDa protein (U5 snRNP 40 kDa protein) (U5-40K) (38 kDa-splicing factor) (Prp8-binding protein) (hPRP8BP) (U5 snRNP-specific 40 kDa protein) (WD repeat-containing protein 57),357,"39,311",5 out of 5,2005-06-07,Evidence at protein level
Q13424,SNTA1_HUMAN,Alpha-1-syntrophin (59 kDa dystrophin-associated protein A1 acidic component 1) (Pro-TGF-alpha cytoplasmic domain-interacting protein 1) (TACIP1) (Syntrophin-1),505,"53,895",5 out of 5,2002-10-10,Evidence at protein level
Q13425,SNTB2_HUMAN,Beta-2-syntrophin (59 kDa dystrophin-associated protein A1 basic component 2) (Syntrophin-3) (SNT3) (Syntrophin-like) (SNTL),540,"57,950",5 out of 5,2002-10-10,Evidence at protein level
Q9Y5W9,SNX11_HUMAN,Sorting nexin-11,270,"30,433",5 out of 5,2000-12-01,Evidence at protein level
Q96RF0,SNX18_HUMAN,Sorting nexin-18 (SH3 and PX domain-containing protein 3B) (Sorting nexin-associated Golgi protein 1),628,"68,894",5 out of 5,2002-01-23,Evidence at protein level
Q13596,SNX1_HUMAN,Sorting nexin-1,522,"59,070",5 out of 5,2000-12-01,Evidence at protein level
Q96L92,SNX27_HUMAN,Sorting nexin-27,541,"61,265",5 out of 5,2002-03-27,Evidence at protein level
Q9UNH6,SNX7_HUMAN,Sorting nexin-7,387,"45,303",4 out of 5,2000-12-01,Evidence at protein level
Q6ZQN7,SO4C1_HUMAN,Solute carrier organic anion transporter family member 4C1 (OATP-H) (Organic anion transporter M1) (OATP-M1) (Solute carrier family 21 member 20),724,"78,948",5 out of 5,2008-05-20,Evidence at protein level
Q9H2Y9,SO5A1_HUMAN,Solute carrier organic anion transporter family member 5A1 (Organic anion transporter polypeptide-related protein 4) (OATP-RP4) (OATPRP4) (Solute carrier family 21 member 15),848,"91,864",4 out of 5,2003-01-10,Evidence at transcript level
P01242,SOM2_HUMAN,Growth hormone variant (GH-V) (Growth hormone 2) (Placenta-specific growth hormone),217,"25,000",5 out of 5,1986-07-21,Evidence at protein level
Q15506,SP17_HUMAN,Sperm surface protein Sp17 (Cancer/testis antigen 22) (CT22) (Sp17-1) (Sperm autoantigenic protein 17) (Sperm protein 17),151,"17,406",5 out of 5,1997-11-01,Evidence at protein level
Q8NEM7,SP20H_HUMAN,Transcription factor SPT20 homolog (p38-interacting protein) (p38IP),779,"85,789",5 out of 5,2005-07-19,Evidence at protein level
Q3SY56,SP6_HUMAN,Transcription factor Sp6 (Krueppel-like factor 14),376,"39,840",3 out of 5,2005-11-22,Evidence at transcript level
Q96P63,SPB12_HUMAN,Serpin B12,405,"46,276",4 out of 5,2002-01-23,Evidence at protein level
Q8IY81,SPB1_HUMAN,pre-rRNA processing protein FTSJ3 (EC 2.1.1.-) (2'-O-ribose RNA methyltransferase SPB1 homolog) (Protein ftsJ homolog 3) (Putative rRNA methyltransferase 3),847,"96,558",5 out of 5,2005-08-16,Evidence at protein level
P36952,SPB5_HUMAN,Serpin B5 (Maspin) (Peptidase inhibitor 5) (PI-5),375,"42,100",5 out of 5,1994-06-01,Evidence at protein level
Q9HBM1,SPC25_HUMAN,Kinetochore protein Spc25 (hSpc25),224,"26,153",5 out of 5,2006-09-19,Evidence at protein level
A6NIY4,SPDE5_HUMAN,Putative speedy protein E5,337,"40,483",2 out of 5,2008-04-08,Uncertain
Q96EA4,SPDLY_HUMAN,Protein Spindly (hSpindly) (Arsenite-related gene 1 protein) (Coiled-coil domain-containing protein 99) (Rhabdomyosarcoma antigen MU-RMS-40.4A) (Spindle apparatus coiled-coil domain-containing protein 1),605,"70,172",5 out of 5,2007-02-06,Evidence at protein level
Q5MJ68,SPDYC_HUMAN,Speedy protein C (Rapid inducer of G2/M progression in oocytes C) (RINGO C) (hSpy/Ringo C),293,"33,166",3 out of 5,2006-05-02,Evidence at protein level
Q9H9C1,SPE39_HUMAN,Spermatogenesis-defective protein 39 homolog (hSPE-39) (VPS33B-interacting protein in apical-basolateral polarity regulator) (VPS33B-interacting protein in polarity and apical restriction),493,"57,005",5 out of 5,2004-01-16,Evidence at protein level
Q9BPZ2,SPI2B_HUMAN,Spindlin-2B (Spindlin-like protein 2B) (SPIN-2) (SPIN-2B),258,"29,158",3 out of 5,2002-10-10,Evidence at transcript level
Q6ZMD2,SPNS3_HUMAN,Protein spinster homolog 3,512,"54,769",3 out of 5,2007-10-02,Evidence at transcript level
Q8WXA9,SREK1_HUMAN,"Splicing regulatory glutamine/lysine-rich protein 1 (Serine/arginine-rich-splicing regulatory protein 86) (SRrp86) (Splicing factor, arginine/serine-rich 12) (Splicing regulatory protein 508) (SRrp508)",508,"59,380",5 out of 5,2003-10-03,Evidence at protein level
A7MD48,SRRM4_HUMAN,Serine/arginine repetitive matrix protein 4 (Medulloblastoma antigen MU-MB-2.76) (Neural-specific serine/arginine repetitive splicing factor of 100 kDa) (Neural-specific SR-related protein of 100 kDa) (nSR100),611,"68,559",4 out of 5,2007-12-04,Evidence at protein level
P32745,SSR3_HUMAN,Somatostatin receptor type 3 (SS-3-R) (SS3-R) (SS3R) (SSR-28),418,"45,847",5 out of 5,1993-10-01,Evidence at protein level
Q08945,SSRP1_HUMAN,FACT complex subunit SSRP1 (Chromatin-specific transcription elongation factor 80 kDa subunit) (Facilitates chromatin transcription complex 80 kDa subunit) (FACT 80 kDa subunit) (FACTp80) (Facilitates chromatin transcription complex subunit SSRP1) (Recombination signal sequence recognition protein 1) (Structure-specific recognition protein 1) (hSSRP1) (T160),709,"81,075",5 out of 5,1995-02-01,Evidence at protein level
Q9NQ25,SLAF7_HUMAN,SLAM family member 7 (CD2 subset 1) (CD2-like receptor-activating cytotoxic cells) (CRACC) (Membrane protein FOAP-12) (Novel Ly9) (Protein 19A) (CD antigen CD319),335,"37,421",5 out of 5,2005-05-24,Evidence at protein level
Q8ND83,SLAI1_HUMAN,SLAIN motif-containing protein 1,568,"60,595",3 out of 5,2008-02-05,Evidence at protein level
Q5VYV7,SLX4I_HUMAN,Protein SLX4IP (SLX4-interacting protein),408,"45,552",3 out of 5,2007-10-02,Evidence at protein level
Q99717,SMAD5_HUMAN,Mothers against decapentaplegic homolog 5 (MAD homolog 5) (Mothers against DPP homolog 5) (JV5-1) (SMAD family member 5) (SMAD 5) (Smad5) (hSmad5),465,"52,258",5 out of 5,2001-05-04,Evidence at protein level
O15198,SMAD9_HUMAN,Mothers against decapentaplegic homolog 9 (MAD homolog 9) (Mothers against DPP homolog 9) (Madh6) (SMAD family member 9) (SMAD 9) (Smad9),467,"52,493",5 out of 5,2001-05-04,Evidence at protein level
Q9UQE7,SMC3_HUMAN,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide) (hCAP),1217,"141,542",5 out of 5,2003-03-25,Evidence at protein level
Q147U7,SMCO1_HUMAN,Single-pass membrane and coiled-coil domain-containing protein 1 (Single-pass membrane protein with coiled-coil domains 1),214,"24,598",2 out of 5,2006-12-12,Evidence at transcript level
Q71RC9,SMIM5_HUMAN,Small integral membrane protein 5,77,"8,540",2 out of 5,2011-06-28,Evidence at protein level
Q96GM5,SMRD1_HUMAN,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily D member 1 (60 kDa BRG-1/Brm-associated factor subunit A) (BRG1-associated factor 60A) (BAF60A) (SWI/SNF complex 60 kDa subunit),515,"58,233",5 out of 5,2003-01-17,Evidence at protein level
Q8NHU3,SMS2_HUMAN,Phosphatidylcholine:ceramide cholinephosphotransferase 2 (EC 2.7.8.27) (Sphingomyelin synthase 2),365,"42,280",5 out of 5,2004-03-01,Evidence at protein level
Q9H7B4,SMYD3_HUMAN,Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.43) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1),428,"49,097",5 out of 5,2003-05-16,Evidence at protein level
Q6IEE8,SN12L_HUMAN,Schlafen family member 12-like,588,"67,096",3 out of 5,2008-05-20,Evidence at transcript level
P54920,SNAA_HUMAN,Alpha-soluble NSF attachment protein (SNAP-alpha) (N-ethylmaleimide-sensitive factor attachment protein alpha),295,"33,233",5 out of 5,1996-10-01,Evidence at protein level
Q99747,SNAG_HUMAN,Gamma-soluble NSF attachment protein (SNAP-gamma) (N-ethylmaleimide-sensitive factor attachment protein gamma),312,"34,746",5 out of 5,1998-07-15,Evidence at protein level
O95863,SNAI1_HUMAN,Zinc finger protein SNAI1 (Protein snail homolog 1) (Protein sna),264,"29,083",5 out of 5,2000-05-30,Evidence at protein level
Q16613,SNAT_HUMAN,Serotonin N-acetyltransferase (Serotonin acetylase) (EC 2.3.1.87) (Aralkylamine N-acetyltransferase) (AA-NAT),207,"23,344",5 out of 5,2000-12-01,Evidence at protein level
Q7KZF4,SND1_HUMAN,Staphylococcal nuclease domain-containing protein 1 (100 kDa coactivator) (EBNA2 coactivator p100) (Tudor domain-containing protein 11) (p100 co-activator),910,"101,997",5 out of 5,2005-02-01,Evidence at protein level
O75324,SNN_HUMAN,Stannin (AG8_1),88,"9,497",4 out of 5,1998-12-15,Evidence at protein level
Q96PQ0,SORC2_HUMAN,VPS10 domain-containing receptor SorCS2,1159,"128,152",4 out of 5,2002-12-13,Evidence at protein level
Q96AH0,SOSB2_HUMAN,SOSS complex subunit B2 (Nucleic acid-binding protein 1) (Oligonucleotide/oligosaccharide-binding fold-containing protein 2A) (Sensor of single-strand DNA complex subunit B2) (Sensor of ssDNA subunit B2) (SOSS-B2) (Single-stranded DNA-binding protein 2) (hSSB2),204,"22,423",5 out of 5,2008-05-20,Evidence at protein level
O15370,SOX12_HUMAN,Transcription factor SOX-12 (Protein SOX-22),315,"34,122",4 out of 5,1998-07-15,Evidence at transcript level
P48436,SOX9_HUMAN,Transcription factor SOX-9,509,"56,137",5 out of 5,1996-02-01,Evidence at protein level
Q9HAJ7,SP30L_HUMAN,Histone deacetylase complex subunit SAP30L (HCV non-structural protein 4A-transactivated protein 2) (Sin3 corepressor complex subunit SAP30L) (Sin3-associated protein p30-like),183,"20,877",5 out of 5,2007-11-13,Evidence at protein level
A6NNV3,SPD16_HUMAN,Putative speedy protein E16,312,"37,499",2 out of 5,2008-06-10,Uncertain
A1X283,SPD2B_HUMAN,SH3 and PX domain-containing protein 2B (Adapter protein HOFI) (Factor for adipocyte differentiation 49) (Tyrosine kinase substrate with four SH3 domains),911,"101,579",5 out of 5,2007-12-04,Evidence at protein level
A6NKU9,SPDE3_HUMAN,Speedy protein E3,549,"63,895",2 out of 5,2008-07-01,Evidence at transcript level
A6NJR5,SPDL3_HUMAN,Putative speedy protein-like protein 3,290,"34,699",1 out of 5,2008-06-10,Uncertain
Q9NRA0,SPHK2_HUMAN,Sphingosine kinase 2 (SK 2) (SPK 2) (EC 2.7.1.91),654,"69,217",5 out of 5,2001-10-24,Evidence at protein level
Q99865,SPI2A_HUMAN,Spindlin-2A (Protein DXF34) (Spindlin-like protein 2A) (SPIN-2) (SPIN-2A),258,"29,188",3 out of 5,1997-11-01,Evidence at protein level
Q01892,SPIB_HUMAN,Transcription factor Spi-B,262,"28,819",5 out of 5,1994-06-01,Evidence at protein level
Q8IVW8,SPNS2_HUMAN,Protein spinster homolog 2,549,"58,044",4 out of 5,2007-10-02,Evidence at protein level
Q9HCB6,SPON1_HUMAN,Spondin-1 (F-spondin) (Vascular smooth muscle cell growth-promoting factor),807,"90,973",5 out of 5,2004-09-27,Evidence at protein level
Q6IQ16,SPOPL_HUMAN,Speckle-type POZ protein-like (HIB homolog 2) (Roadkill homolog 2),392,"44,647",4 out of 5,2007-02-06,Evidence at protein level
Q8N9U9,SPOT1_HUMAN,Putative uncharacterized protein SPANXA2-OT1,137,"13,254",2 out of 5,2008-01-15,Uncertain
Q96BD6,SPSB1_HUMAN,SPRY domain-containing SOCS box protein 1 (SSB-1),273,"30,942",5 out of 5,2006-05-30,Evidence at protein level
Q96L03,SPT17_HUMAN,Spermatogenesis-associated protein 17,361,"43,499",2 out of 5,2006-12-12,Evidence at protein level
Q9BR10,SPT25_HUMAN,Spermatogenesis-associated protein 25 (Testis-specific gene 23 protein),227,"23,834",3 out of 5,2003-01-17,Evidence at protein level
O43541,SMAD6_HUMAN,Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6) (hSMAD6),496,"53,497",5 out of 5,2001-05-04,Evidence at protein level
O00193,SMAP_HUMAN,Small acidic protein,183,"20,333",2 out of 5,2006-12-12,Evidence at protein level
Q9UHJ3,SMBT1_HUMAN,Scm-like with four MBT domains protein 1 (hSFMBT) (Renal ubiquitous protein 1),866,"98,141",5 out of 5,2005-06-07,Evidence at protein level
Q6ZMV5,SMEK3_HUMAN,Putative SMEK homolog 3 (Serine/threonine-protein phosphatase 4 regulatory subunit 3C pseudogene),832,"95,776",2 out of 5,2008-07-22,Uncertain
Q8ND04,SMG8_HUMAN,Protein SMG8 (Amplified in breast cancer gene 2 protein) (Protein smg-8 homolog),991,"109,684",5 out of 5,2007-10-02,Evidence at protein level
Q86VZ5,SMS1_HUMAN,Phosphatidylcholine:ceramide cholinephosphotransferase 1 (EC 2.7.8.27) (Medulla oblongata-derived protein) (Protein Mob) (Sphingomyelin synthase 1) (Transmembrane protein 23),419,"49,208",5 out of 5,2004-03-01,Evidence at protein level
O95295,SNAPN_HUMAN,SNARE-associated protein Snapin (Biogenesis of lysosome-related organelles complex 1 subunit 7) (BLOC-1 subunit 7) (Synaptosomal-associated protein 25-binding protein) (SNAP-associated protein),136,"14,874",5 out of 5,2004-01-16,Evidence at protein level
A8MWL6,SNG2L_HUMAN,Putative synaptogyrin-2 like protein,223,"24,647",2 out of 5,2008-07-22,Uncertain
O43761,SNG3_HUMAN,Synaptogyrin-3,229,"24,555",3 out of 5,2000-05-30,Evidence at protein level
O95721,SNP29_HUMAN,Synaptosomal-associated protein 29 (SNAP-29) (Soluble 29 kDa NSF attachment protein) (Vesicle-membrane fusion protein SNAP-29),258,"28,970",5 out of 5,2000-05-30,Evidence at protein level
Q5SQN1,SNP47_HUMAN,Synaptosomal-associated protein 47 (SNAP-47) (Epididymis luminal protein 170) (Synaptosomal-associated 47 kDa protein),464,"52,562",5 out of 5,2007-10-23,Evidence at protein level
O15079,SNPH_HUMAN,Syntaphilin,494,"53,537",5 out of 5,2002-06-06,Evidence at protein level
Q8WVK2,SNR27_HUMAN,U4/U6.U5 small nuclear ribonucleoprotein 27 kDa protein (U4/U6.U5 snRNP 27 kDa protein) (U4/U6.U5-27K) (Nucleic acid-binding protein RY-1) (U4/U6.U5 tri-snRNP-associated 27 kDa protein) (27K) (U4/U6.U5 tri-snRNP-associated protein 3),155,"18,860",4 out of 5,2006-02-21,Evidence at protein level
Q13884,SNTB1_HUMAN,Beta-1-syntrophin (59 kDa dystrophin-associated protein A1 basic component 1) (DAPA1B) (BSYN2) (Syntrophin-2) (Tax interaction protein 43) (TIP-43),538,"58,061",5 out of 5,2002-10-10,Evidence at protein level
Q9NRS6,SNX15_HUMAN,Sorting nexin-15,342,"38,291",5 out of 5,2001-02-21,Evidence at protein level
Q8N9S9,SNX31_HUMAN,Sorting nexin-31,440,"50,802",3 out of 5,2008-04-29,Evidence at protein level
Q9Y5X3,SNX5_HUMAN,Sorting nexin-5,404,"46,816",5 out of 5,2000-12-01,Evidence at protein level
Q9Y5X1,SNX9_HUMAN,Sorting nexin-9 (SH3 and PX domain-containing protein 1) (Protein SDP1) (SH3 and PX domain-containing protein 3A),595,"66,592",5 out of 5,2000-12-01,Evidence at protein level
Q9Y6L6,SO1B1_HUMAN,Solute carrier organic anion transporter family member 1B1 (Liver-specific organic anion transporter 1) (LST-1) (OATP-C) (Sodium-independent organic anion-transporting polypeptide 2) (OATP-2) (Solute carrier family 21 member 6),691,"76,449",5 out of 5,2000-12-01,Evidence at protein level
G3V0H7,SO1B7_HUMAN,Putative solute carrier organic anion transporter family member 1B7 (Liver-specific organic anion transporter 3) (LST-3),640,"71,247",3 out of 5,2012-02-22,Uncertain
Q9NYB5,SO1C1_HUMAN,Solute carrier organic anion transporter family member 1C1 (Organic anion transporter F) (OATP-F) (Organic anion transporter polypeptide-related protein 5) (OAT-RP-5) (OATPRP5) (Organic anion-transporting polypeptide 14) (OATP-14) (Solute carrier family 21 member 14) (Thyroxine transporter),712,"78,696",5 out of 5,2003-01-10,Evidence at transcript level
Q9UIG8,SO3A1_HUMAN,Solute carrier organic anion transporter family member 3A1 (OATP3A1) (Organic anion transporter polypeptide-related protein 3) (OATP-RP3) (OATPRP3) (Organic anion-transporting polypeptide D) (OATP-D) (PGE1 transporter) (Sodium-independent organic anion transporter D) (Solute carrier family 21 member 11),710,"76,553",5 out of 5,2003-01-10,Evidence at protein level
P35610,SOAT1_HUMAN,Sterol O-acyltransferase 1 (EC 2.3.1.26) (Acyl-coenzyme A:cholesterol acyltransferase 1) (ACAT-1) (Cholesterol acyltransferase 1),550,"64,735",5 out of 5,1994-06-01,Evidence at protein level
P08294,SODE_HUMAN,Extracellular superoxide dismutase [Cu-Zn] (EC-SOD) (EC 1.15.1.1),240,"25,851",5 out of 5,1988-08-01,Evidence at protein level
Q6X4U4,SOSD1_HUMAN,Sclerostin domain-containing protein 1 (Ectodermal BMP inhibitor) (Ectodin) (Uterine sensitization-associated gene 1 protein) (USAG-1),206,"23,307",5 out of 5,2005-03-29,Evidence at protein level
P57073,SOX8_HUMAN,Transcription factor SOX-8,446,"47,314",5 out of 5,2000-12-01,Evidence at transcript level
Q3ZLR7,SP201_HUMAN,Transcription factor SPT20 homolog-like 1,823,"89,431",2 out of 5,2008-07-22,Evidence at transcript level
Q86W54,SPA24_HUMAN,Spermatogenesis-associated protein 24 (Testis protein T6441 homolog),205,"23,587",5 out of 5,2008-04-08,Evidence at protein level
O75391,SPAG7_HUMAN,Sperm-associated antigen 7,227,"26,034",2 out of 5,2005-03-29,Evidence at protein level
P29508,SPB3_HUMAN,Serpin B3 (Protein T4-A) (Squamous cell carcinoma antigen 1) (SCCA-1),390,"44,565",5 out of 5,1993-04-01,Evidence at protein level
P50453,SPB9_HUMAN,Serpin B9 (Cytoplasmic antiproteinase 3) (CAP-3) (CAP3) (Peptidase inhibitor 9) (PI-9),376,"42,404",5 out of 5,1996-10-01,Evidence at protein level
Q9HD40,SPCS_HUMAN,O-phosphoseryl-tRNA(Sec) selenium transferase (EC 2.9.1.2) (Liver-pancreas antigen) (LP) (SLA-p35) (SLA/LP autoantigen) (Selenocysteine synthase) (Sec synthase) (Selenocysteinyl-tRNA(Sec) synthase) (Sep-tRNA:Sec-tRNA synthase) (SepSecS) (Soluble liver antigen) (SLA) (UGA suppressor tRNA-associated protein) (tRNA(Ser/Sec)-associated antigenic protein),501,"55,726",5 out of 5,2005-03-29,Evidence at protein level
Q5TCZ1,SPD2A_HUMAN,SH3 and PX domain-containing protein 2A (Adapter protein TKS5) (Five SH3 domain-containing protein) (SH3 multiple domains protein 1) (Tyrosine kinase substrate with five SH3 domains),1133,"125,289",5 out of 5,2007-02-20,Evidence at protein level
Q8NFV5,SPDE1_HUMAN,Speedy protein E1 (Williams-Beuren syndrome chromosomal region 19 protein),336,"40,668",2 out of 5,2008-02-26,Evidence at transcript level
Q76KD6,SPERI_HUMAN,Speriolin (Spermatogenesis and centriole-associated protein 1) (Spermatogenesis-associated protein 15) (Spermatogenic cell-specific Cdc20-binding protein),591,"62,399",3 out of 5,2007-12-04,Evidence at transcript level
Q6Q759,SPG17_HUMAN,Sperm-associated antigen 17 (Projection protein PF6 homolog),2223,"251,742",4 out of 5,2008-04-29,Evidence at transcript level
Q9NZD8,SPG21_HUMAN,Maspardin (Acid cluster protein 33) (Spastic paraplegia 21 autosomal recessive Mast syndrome protein) (Spastic paraplegia 21 protein),308,"34,960",5 out of 5,2006-03-21,Evidence at protein level
Q9BUD6,SPON2_HUMAN,Spondin-2 (Differentially expressed in cancerous and non-cancerous lung cells 1) (DIL-1) (Mindin),331,"35,846",5 out of 5,2004-09-27,Evidence at protein level
O43791,SPOP_HUMAN,Speckle-type POZ protein (HIB homolog 1) (Roadkill homolog 1),374,"42,132",5 out of 5,2000-05-30,Evidence at protein level
Q8TCT7,SPP2B_HUMAN,Signal peptide peptidase-like 2B (SPP-like 2B) (SPPL2b) (EC 3.4.23.-) (Intramembrane protease 4) (IMP-4) (Presenilin homologous protein 4) (PSH4) (Presenilin-like protein 1),592,"64,644",5 out of 5,2002-11-08,Evidence at protein level
Q9NRQ5,SMCO4_HUMAN,Single-pass membrane and coiled-coil domain-containing protein 4 (Protein FN5),59,"6,738",3 out of 5,2005-11-08,Evidence at protein level
P62314,SMD1_HUMAN,Small nuclear ribonucleoprotein Sm D1 (Sm-D1) (Sm-D autoantigen) (snRNP core protein D1),119,"13,282",5 out of 5,2004-07-05,Evidence at protein level
P62316,SMD2_HUMAN,Small nuclear ribonucleoprotein Sm D2 (Sm-D2) (snRNP core protein D2),118,"13,527",5 out of 5,2004-07-05,Evidence at protein level
Q9NPB0,SMDC1_HUMAN,SAYSvFN domain-containing protein 1,183,"20,163",2 out of 5,2005-07-05,Evidence at transcript level
Q96KF7,SMIM8_HUMAN,Small integral membrane protein 8,97,"11,059",2 out of 5,2005-07-19,Evidence at protein level
Q16637,SMN_HUMAN,Survival motor neuron protein (Component of gems 1) (Gemin-1),294,"31,849",5 out of 5,1997-11-01,Evidence at protein level
Q99954,SMR3A_HUMAN,Submaxillary gland androgen-regulated protein 3A (Proline-rich protein 5) (Proline-rich protein PBI),134,"14,048",3 out of 5,2002-05-27,Inferred from homology
P61278,SMS_HUMAN,Somatostatin (Growth hormone release-inhibiting factor) [Cleaved into: Somatostatin-28; Somatostatin-14],116,"12,736",5 out of 5,1986-07-21,Evidence at protein level
O43759,SNG1_HUMAN,Synaptogyrin-1,233,"25,456",5 out of 5,2000-05-30,Evidence at protein level
Q9NRH2,SNRK_HUMAN,SNF-related serine/threonine-protein kinase (EC 2.7.11.1) (SNF1-related kinase),765,"84,276",5 out of 5,2006-03-07,Evidence at protein level
P09012,SNRPA_HUMAN,U1 small nuclear ribonucleoprotein A (U1 snRNP A) (U1-A) (U1A),282,"31,280",5 out of 5,1988-11-01,Evidence at protein level
Q9NY99,SNTG2_HUMAN,Gamma-2-syntrophin (G2SYN) (Syntrophin-5) (SYN5),539,"60,217",5 out of 5,2002-10-10,Evidence at protein level
Q53GS9,SNUT2_HUMAN,U4/U6.U5 tri-snRNP-associated protein 2 (Inactive ubiquitin-specific peptidase 39) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) (65K),565,"65,381",5 out of 5,2006-02-21,Evidence at protein level
Q92543,SNX19_HUMAN,Sorting nexin-19,992,"108,598",5 out of 5,1997-11-01,Evidence at protein level
Q9Y343,SNX24_HUMAN,Sorting nexin-24,169,"19,818",3 out of 5,2002-03-27,Evidence at protein level
Q9H3E2,SNX25_HUMAN,Sorting nexin-25,840,"97,945",4 out of 5,2002-03-27,Evidence at protein level
O15524,SOCS1_HUMAN,Suppressor of cytokine signaling 1 (SOCS-1) (JAK-binding protein) (JAB) (STAT-induced STAT inhibitor 1) (SSI-1) (Tec-interacting protein 3) (TIP-3),211,"23,551",5 out of 5,2002-04-16,Evidence at protein level
Q8WXH5,SOCS4_HUMAN,Suppressor of cytokine signaling 4 (SOCS-4) (Suppressor of cytokine signaling 7) (SOCS-7),440,"50,623",4 out of 5,2002-04-16,Evidence at protein level
P08047,SP1_HUMAN,Transcription factor Sp1,785,"80,693",5 out of 5,1988-08-01,Evidence at protein level
Q86U17,SPA11_HUMAN,Serpin A11,422,"46,989",2 out of 5,2005-09-27,Evidence at transcript level
Q8IUW3,SPA2L_HUMAN,Spermatogenesis-associated protein 2-like protein (SPATA2-like protein),424,"46,179",2 out of 5,2007-08-21,Evidence at transcript level
Q9NPE6,SPAG4_HUMAN,Sperm-associated antigen 4 protein (Outer dense fiber-associated protein SPAG4) (SUN domain-containing protein 4),437,"48,165",5 out of 5,2003-01-17,Evidence at protein level
Q86XZ4,SPAS2_HUMAN,Spermatogenesis-associated serine-rich protein 2 (Serine-rich spermatocytes and round spermatid 59 kDa protein) (p59scr),545,"59,545",3 out of 5,2007-10-23,Evidence at protein level
Q9UM82,SPAT2_HUMAN,Spermatogenesis-associated protein 2 (Spermatogenesis-associated protein PD1),520,"58,427",5 out of 5,2001-04-27,Evidence at protein level
P48594,SPB4_HUMAN,Serpin B4 (Leupin) (Peptidase inhibitor 11) (PI-11) (Squamous cell carcinoma antigen 2) (SCCA-2),390,"44,854",5 out of 5,1996-02-01,Evidence at protein level
P50452,SPB8_HUMAN,Serpin B8 (Cytoplasmic antiproteinase 2) (CAP-2) (CAP2) (Peptidase inhibitor 8) (PI-8),374,"42,767",5 out of 5,1996-10-01,Evidence at protein level
O15270,SPTC2_HUMAN,Serine palmitoyltransferase 2 (EC 2.3.1.50) (Long chain base biosynthesis protein 2) (LCB 2) (Long chain base biosynthesis protein 2a) (LCB2a) (Serine-palmitoyl-CoA transferase 2) (SPT 2),562,"62,924",5 out of 5,2000-05-30,Evidence at protein level
Q9H254,SPTN4_HUMAN,"Spectrin beta chain, non-erythrocytic 4 (Beta-IV spectrin) (Spectrin, non-erythroid beta chain 3)",2564,"288,985",5 out of 5,2001-11-16,Evidence at protein level
Q5MJ10,SPXN2_HUMAN,Sperm protein associated with the nucleus on the X chromosome N2 (Nuclear-associated protein SPAN-Xn2) (SPANX-N2) (SPANX family member N2),180,"19,917",2 out of 5,2007-05-01,Evidence at protein level
Q05519,SRS11_HUMAN,"Serine/arginine-rich splicing factor 11 (Arginine-rich 54 kDa nuclear protein) (p54) (Splicing factor, arginine/serine-rich 11)",484,"53,542",5 out of 5,2000-05-30,Evidence at protein level
Q13247,SRSF6_HUMAN,"Serine/arginine-rich splicing factor 6 (Pre-mRNA-splicing factor SRP55) (Splicing factor, arginine/serine-rich 6)",344,"39,587",5 out of 5,1998-12-15,Evidence at protein level
Q16629,SRSF7_HUMAN,"Serine/arginine-rich splicing factor 7 (Splicing factor 9G8) (Splicing factor, arginine/serine-rich 7)",238,"27,367",5 out of 5,1998-12-15,Evidence at protein level
Q7Z2R9,SSAS1_HUMAN,Putative uncharacterized protein SSBP3-AS1 (SSBP3 antisense RNA 1) (SSBP3 antisense gene protein 1),100,"10,995",2 out of 5,2007-01-09,Uncertain
Q9BWW4,SSBP3_HUMAN,Single-stranded DNA-binding protein 3 (Sequence-specific single-stranded-DNA-binding protein),388,"40,421",5 out of 5,2003-01-10,Evidence at protein level
Q13285,STF1_HUMAN,Steroidogenic factor 1 (SF-1) (STF-1) (hSF-1) (Adrenal 4-binding protein) (Fushi tarazu factor homolog 1) (Nuclear receptor subfamily 5 group A member 1) (Steroid hormone receptor Ad4BP),461,"51,636",5 out of 5,1998-07-15,Evidence at protein level
Q8IWL8,STH_HUMAN,Saitohin,128,"13,652",3 out of 5,2004-07-19,Evidence at protein level
Q86TL2,STIMA_HUMAN,Store-operated calcium entry regulator STIMATE (STIM-activating enhancer encoded by TMEM110) (STIMATE) (Transmembrane protein 110),294,"33,187",5 out of 5,2006-06-27,Evidence at protein level
O75716,STK16_HUMAN,Serine/threonine-protein kinase 16 (EC 2.7.11.1) (Myristoylated and palmitoylated serine/threonine-protein kinase) (MPSK) (Protein kinase PKL12) (TGF-beta-stimulated factor 1) (TSF-1) (Tyrosine-protein kinase STK16) (EC 2.7.10.2) (hPSK),305,"34,656",5 out of 5,2001-02-21,Evidence at protein level
Q9Y6E0,STK24_HUMAN,Serine/threonine-protein kinase 24 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 3) (MST-3) (STE20-like kinase MST3) [Cleaved into: Serine/threonine-protein kinase 24 36 kDa subunit (Mammalian STE20-like protein kinase 3 N-terminal) (MST3/N); Serine/threonine-protein kinase 24 12 kDa subunit (Mammalian STE20-like protein kinase 3 C-terminal) (MST3/C)],443,"49,308",5 out of 5,2001-02-21,Evidence at protein level
Q9NRP7,STK36_HUMAN,Serine/threonine-protein kinase 36 (EC 2.7.11.1) (Fused homolog),1315,"143,995",5 out of 5,2006-03-21,Evidence at protein level
Q13043,STK4_HUMAN,Serine/threonine-protein kinase 4 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 1) (MST-1) (STE20-like kinase MST1) (Serine/threonine-protein kinase Krs-2) [Cleaved into: Serine/threonine-protein kinase 4 37kDa subunit (MST1/N); Serine/threonine-protein kinase 4 18kDa subunit (MST1/C)],487,"55,630",5 out of 5,2001-02-21,Evidence at protein level
Q9UJZ1,STML2_HUMAN,"Stomatin-like protein 2, mitochondrial (SLP-2) (EPB72-like protein 2) (Paraprotein target 7) (Paratarg-7)",356,"38,534",5 out of 5,2005-02-01,Evidence at protein level
Q9H668,STN1_HUMAN,CST complex subunit STN1 (Oligonucleotide/oligosaccharide-binding fold-containing protein 1) (Suppressor of cdc thirteen homolog),368,"42,119",5 out of 5,2005-04-26,Evidence at protein level
Q9Y3F4,STRAP_HUMAN,Serine-threonine kinase receptor-associated protein (MAP activator with WD repeats) (UNR-interacting protein) (WD-40 repeat protein PT-WD),350,"38,438",5 out of 5,2000-12-01,Evidence at protein level
P46977,STT3A_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (Oligosaccharyl transferase subunit STT3A) (STT3-A) (EC 2.4.99.18) (B5) (Integral membrane protein 1) (Transmembrane protein TMC),705,"80,530",5 out of 5,1995-11-01,Evidence at protein level
O60499,STX10_HUMAN,Syntaxin-10 (Syn10),249,"28,114",5 out of 5,2001-11-16,Evidence at protein level
Q16623,STX1A_HUMAN,Syntaxin-1A (Neuron-specific antigen HPC-1),288,"33,023",5 out of 5,1997-11-01,Evidence at protein level
Q6ZWJ1,STXB4_HUMAN,Syntaxin-binding protein 4 (Syntaxin 4-interacting protein) (STX4-interacting protein) (Synip),553,"61,662",5 out of 5,2006-02-07,Evidence at protein level
P0CW21,SPGOS_HUMAN,Putative uncharacterized protein SPG20-AS1 (SPG20 antisense RNA 1) (SPG20 antisense gene protein 1) (SPG20 opposite strand transcript protein),52,"6,167",2 out of 5,2011-05-31,Uncertain
O43291,SPIT2_HUMAN,Kunitz-type protease inhibitor 2 (Hepatocyte growth factor activator inhibitor type 2) (HAI-2) (Placental bikunin),252,"28,228",5 out of 5,2001-02-21,Evidence at protein level
Q2M3C7,SPKAP_HUMAN,A-kinase anchor protein SPHKAP (SPHK1-interactor and AKAP domain-containing protein) (Sphingosine kinase type 1-interacting protein),1700,"186,456",5 out of 5,2008-02-26,Evidence at protein level
Q8TCT8,SPP2A_HUMAN,Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2),520,"58,143",5 out of 5,2002-11-08,Evidence at protein level
Q2MJR0,SPRE3_HUMAN,"Sprouty-related, EVH1 domain-containing protein 3 (Spred-3)",410,"42,670",3 out of 5,2006-07-25,Evidence at transcript level
Q14515,SPRL1_HUMAN,SPARC-like protein 1 (High endothelial venule protein) (Hevin) (MAST 9),664,"75,208",5 out of 5,2002-09-19,Evidence at protein level
Q96PI1,SPRR4_HUMAN,Small proline-rich protein 4,79,"8,793",3 out of 5,2003-10-10,Evidence at transcript level
Q8WW59,SPRY4_HUMAN,SPRY domain-containing protein 4,207,"23,129",2 out of 5,2006-06-27,Evidence at protein level
Q96N96,SPT13_HUMAN,Spermatogenesis-associated protein 13 (APC-stimulated guanine nucleotide exchange factor 2) (Asef2),652,"74,820",5 out of 5,2007-02-20,Evidence at protein level
Q9BXB7,SPT16_HUMAN,Spermatogenesis-associated protein 16 (Testis development protein NYD-SP12),569,"65,263",4 out of 5,2008-01-15,Evidence at protein level
Q537H7,SPT45_HUMAN,Spermatogenesis-associated protein 45,98,"11,356",1 out of 5,2007-05-01,Inferred from homology
P11277,SPTB1_HUMAN,"Spectrin beta chain, erythrocytic (Beta-I spectrin)",2137,"246,468",5 out of 5,1989-07-01,Evidence at protein level
Q5MJ07,SPXN5_HUMAN,Sperm protein associated with the nucleus on the X chromosome N5 (Nuclear-associated protein SPAN-Xn5) (SPANX-N5) (SPANX family member N5),72,"8,277",1 out of 5,2007-05-01,Inferred from homology
O43597,SPY2_HUMAN,Protein sprouty homolog 2 (Spry-2),315,"34,688",5 out of 5,2001-02-21,Evidence at protein level
P11831,SRF_HUMAN,Serum response factor (SRF),508,"51,593",5 out of 5,1989-10-01,Evidence at protein level
Q9UGK8,SRGEF_HUMAN,Secretion-regulating guanine nucleotide exchange factor (Deafness locus-associated putative guanine nucleotide exchange factor) (DelGEF) (Guanine nucleotide exchange factor-related protein),458,"48,981",5 out of 5,2003-10-31,Evidence at protein level
P10124,SRGN_HUMAN,Serglycin (Hematopoietic proteoglycan core protein) (Platelet proteoglycan core protein) (P.PG) (Secretory granule proteoglycan core protein),158,"17,652",5 out of 5,1989-07-01,Evidence at protein level
Q9UHV2,SRTD1_HUMAN,SERTA domain-containing protein 1 (CDK4-binding protein p34SEI1) (SEI-1) (Transcriptional regulator interacting with the PHD-bromodomain 1) (TRIP-Br1),236,"24,704",4 out of 5,2003-07-11,Evidence at protein level
P43308,SSRB_HUMAN,Translocon-associated protein subunit beta (TRAP-beta) (Signal sequence receptor subunit beta) (SSR-beta),183,"20,135",4 out of 5,1995-11-01,Evidence at protein level
Q7RTT5,SSX7_HUMAN,Protein SSX7,188,"21,591",3 out of 5,2006-03-21,Evidence at transcript level
Q9UEE5,ST17A_HUMAN,Serine/threonine-protein kinase 17A (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 1),414,"46,558",5 out of 5,2001-06-20,Evidence at protein level
P50225,ST1A1_HUMAN,Sulfotransferase 1A1 (ST1A1) (EC 2.8.2.1) (Aryl sulfotransferase 1) (HAST1/HAST2) (Phenol sulfotransferase 1) (Phenol-sulfating phenol sulfotransferase 1) (P-PST 1) (ST1A3) (Thermostable phenol sulfotransferase) (Ts-PST),295,"34,165",5 out of 5,1996-10-01,Evidence at protein level
P0DMN0,ST1A4_HUMAN,Sulfotransferase 1A4 (ST1A4) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Sulfotransferase 1A3/1A4),295,"34,196",5 out of 5,2014-09-03,Evidence at protein level
Q9Y2H1,ST38L_HUMAN,Serine/threonine-protein kinase 38-like (EC 2.7.11.1) (NDR2 protein kinase) (Nuclear Dbf2-related kinase 2),464,"54,003",5 out of 5,2004-12-21,Evidence at protein level
P42229,STA5A_HUMAN,Signal transducer and activator of transcription 5A,794,"90,647",5 out of 5,1995-11-01,Evidence at protein level
P51692,STA5B_HUMAN,Signal transducer and activator of transcription 5B,787,"89,866",5 out of 5,1996-10-01,Evidence at protein level
O95630,STABP_HUMAN,STAM-binding protein (EC 3.4.19.-) (Associated molecule with the SH3 domain of STAM) (Endosome-associated ubiquitin isopeptidase),424,"48,077",5 out of 5,2005-07-19,Evidence at protein level
Q99469,STAC_HUMAN,SH3 and cysteine-rich domain-containing protein (Src homology 3 and cysteine-rich domain-containing protein),402,"44,554",3 out of 5,2000-12-01,Evidence at protein level
Q96FJ0,STALP_HUMAN,AMSH-like protease (AMSH-LP) (EC 3.4.19.-) (STAM-binding protein-like 1),436,"49,783",5 out of 5,2005-07-19,Evidence at protein level
Q9NSY2,STAR5_HUMAN,StAR-related lipid transfer protein 5 (START domain-containing protein 5) (StARD5),213,"23,794",3 out of 5,2002-11-15,Evidence at protein level
Q9NQZ5,STAR7_HUMAN,"StAR-related lipid transfer protein 7, mitochondrial (Gestational trophoblastic tumor protein 1) (START domain-containing protein 7) (StARD7)",370,"43,113",3 out of 5,2002-11-15,Evidence at protein level
P52823,STC1_HUMAN,Stanniocalcin-1 (STC-1),247,"27,621",5 out of 5,1996-10-01,Evidence at protein level
Q658P3,STEA3_HUMAN,Metalloreductase STEAP3 (EC 1.16.1.-) (Dudulin-2) (Six-transmembrane epithelial antigen of prostate 3) (Tumor suppressor-activated pathway protein 6) (hTSAP6) (pHyde) (hpHyde),488,"54,601",5 out of 5,2007-05-01,Evidence at protein level
Q8TAV4,STML3_HUMAN,Stomatin-like protein 3 (SLP-3),291,"32,135",3 out of 5,2005-02-01,Evidence at transcript level
Q93045,STMN2_HUMAN,Stathmin-2 (Superior cervical ganglion-10 protein) (Protein SCG10),179,"20,828",5 out of 5,1997-11-01,Evidence at protein level
Q9H169,STMN4_HUMAN,Stathmin-4 (Stathmin-like protein B3) (RB3),189,"22,071",4 out of 5,2001-11-16,Evidence at transcript level
A6NGW2,STRCL_HUMAN,Putative stereocilin-like protein (Stereocilin pseudogene 1),1772,"192,437",2 out of 5,2008-06-10,Uncertain
O43815,STRN_HUMAN,Striatin,780,"86,132",5 out of 5,2001-01-11,Evidence at protein level
Q69YW2,STUM_HUMAN,Protein stum homolog,141,"15,007",2 out of 5,2007-02-20,Evidence at transcript level
Q13277,STX3_HUMAN,Syntaxin-3,289,"33,155",5 out of 5,1997-11-01,Evidence at protein level
Q13190,STX5_HUMAN,Syntaxin-5,355,"39,673",5 out of 5,1997-11-01,Evidence at protein level
O43752,STX6_HUMAN,Syntaxin-6,255,"29,176",5 out of 5,2000-05-30,Evidence at protein level
P61764,STXB1_HUMAN,Syntaxin-binding protein 1 (MUNC18-1) (N-Sec1) (Protein unc-18 homolog 1) (Unc18-1) (Protein unc-18 homolog A) (Unc-18A) (p67),594,"67,569",5 out of 5,2004-06-07,Evidence at protein level
Q5T5C0,STXB5_HUMAN,Syntaxin-binding protein 5 (Lethal(2) giant larvae protein homolog 3) (Tomosyn-1),1151,"127,573",5 out of 5,2005-11-22,Evidence at protein level
Q8NFX7,STXB6_HUMAN,Syntaxin-binding protein 6 (Amisyn),210,"23,554",5 out of 5,2003-08-22,Evidence at protein level
Q9Y6J8,STYL1_HUMAN,Serine/threonine/tyrosine-interacting-like protein 1 (Dual specificity phosphatase inhibitor MK-STYX) (Dual specificity protein phosphatase 24) (Map kinase phosphatase-like protein MK-STYX),313,"35,818",4 out of 5,2003-02-28,Evidence at transcript level
P53597,SUCA_HUMAN,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)",346,"36,250",5 out of 5,1996-10-01,Evidence at protein level
Q9P2R7,SUCB1_HUMAN,"Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial (EC 6.2.1.5) (ATP-specific succinyl-CoA synthetase subunit beta) (A-SCS) (Succinyl-CoA synthetase beta-A chain) (SCS-betaA)",463,"50,317",5 out of 5,2002-05-27,Evidence at protein level
Q8NCR6,SMRP1_HUMAN,Spermatid-specific manchette-related protein 1 (Ciliated bronchial epithelial protein 1) (Testis development protein NYD-SP22),262,"30,167",5 out of 5,2007-07-24,Evidence at protein level
Q9HCE7,SMUF1_HUMAN,E3 ubiquitin-protein ligase SMURF1 (hSMURF1) (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase SMURF1) (SMAD ubiquitination regulatory factor 1) (SMAD-specific E3 ubiquitin-protein ligase 1),757,"86,114",5 out of 5,2001-12-13,Evidence at protein level
O43760,SNG2_HUMAN,Synaptogyrin-2 (Cellugyrin),224,"24,810",4 out of 5,2000-05-30,Evidence at protein level
B1AK76,SNUFL_HUMAN,Putative SNURF-like protein,121,"14,245",1 out of 5,2008-06-10,Uncertain
O43290,SNUT1_HUMAN,U4/U6.U5 tri-snRNP-associated protein 1 (SNU66 homolog) (hSnu66) (Squamous cell carcinoma antigen recognized by T-cells 1) (SART-1) (hSART-1) (U4/U6.U5 tri-snRNP-associated 110 kDa protein) (allergen Hom s 1),800,"90,255",5 out of 5,2006-02-07,Evidence at protein level
Q13573,SNW1_HUMAN,SNW domain-containing protein 1 (Nuclear protein SkiP) (Nuclear receptor coactivator NCoA-62) (Ski-interacting protein),536,"61,494",5 out of 5,1997-11-01,Evidence at protein level
Q9Y5W8,SNX13_HUMAN,Sorting nexin-13 (RGS domain- and PHOX domain-containing protein) (RGS-PX1),968,"112,189",5 out of 5,2000-12-01,Evidence at protein level
Q8TEQ0,SNX29_HUMAN,Sorting nexin-29 (RUN domain-containing protein 2A),813,"91,254",3 out of 5,2007-08-21,Evidence at protein level
O60749,SNX2_HUMAN,Sorting nexin-2 (Transformation-related gene 9 protein) (TRG-9),519,"58,471",5 out of 5,2000-12-01,Evidence at protein level
O94964,SOGA1_HUMAN,"Protein SOGA1 (SOGA family member 1) (Suppressor of glucose by autophagy) (Suppressor of glucose, autophagy-associated protein 1) [Cleaved into: N-terminal form; C-terminal 80 kDa form (80-kDa SOGA fragment)]",1423,"159,760",5 out of 5,2002-11-25,Evidence at protein level
O95416,SOX14_HUMAN,Transcription factor SOX-14 (Protein SOX-28),240,"26,485",3 out of 5,2000-05-30,Evidence at protein level
O00570,SOX1_HUMAN,Transcription factor SOX-1,391,"39,023",3 out of 5,1997-11-01,Evidence at protein level
Q06945,SOX4_HUMAN,Transcription factor SOX-4,474,"47,263",5 out of 5,1994-06-01,Evidence at protein level
Q9H0E3,SP130_HUMAN,Histone deacetylase complex subunit SAP130 (130 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p130),1048,"110,324",5 out of 5,2007-04-03,Evidence at protein level
Q9H930,SP14L_HUMAN,Nuclear body protein SP140-like protein,580,"67,005",3 out of 5,2008-02-26,Evidence at protein level
Q02447,SP3_HUMAN,Transcription factor Sp3 (SPR-2),781,"81,925",5 out of 5,1995-02-01,Evidence at protein level
Q7KZ85,SPT6H_HUMAN,Transcription elongation factor SPT6 (hSPT6) (Histone chaperone suppressor of Ty6) (Tat-cotransactivator 2 protein) (Tat-CT2 protein),1726,"199,073",5 out of 5,2004-08-31,Evidence at protein level
O15020,SPTN2_HUMAN,"Spectrin beta chain, non-erythrocytic 2 (Beta-III spectrin) (Spinocerebellar ataxia 5 protein)",2390,"271,325",5 out of 5,2001-11-16,Evidence at protein level
Q9C004,SPY4_HUMAN,Protein sprouty homolog 4 (Spry-4),299,"32,541",5 out of 5,2001-07-11,Evidence at protein level
Q9UHB9,SRP68_HUMAN,Signal recognition particle subunit SRP68 (SRP68) (Signal recognition particle 68 kDa protein),627,"70,730",5 out of 5,2001-01-11,Evidence at protein level
Q96SB4,SRPK1_HUMAN,SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),655,"74,325",5 out of 5,2005-06-21,Evidence at protein level
P08240,SRPRA_HUMAN,Signal recognition particle receptor subunit alpha (SR-alpha) (Docking protein alpha) (DP-alpha),638,"69,811",5 out of 5,1988-08-01,Evidence at protein level
P28290,SSFA2_HUMAN,Sperm-specific antigen 2 (Cleavage signal-1 protein) (CS-1) (Ki-ras-induced actin-interacting protein),1259,"138,386",5 out of 5,1992-12-01,Evidence at protein level
Q8WVM7,STAG1_HUMAN,Cohesin subunit SA-1 (SCC3 homolog 1) (Stromal antigen 1),1258,"144,427",5 out of 5,2003-03-25,Evidence at protein level
Q9ULZ2,STAP1_HUMAN,Signal-transducing adaptor protein 1 (STAP-1) (BCR downstream-signaling protein 1) (Docking protein BRDG1) (Stem cell adaptor protein 1),295,"34,291",5 out of 5,2005-04-12,Evidence at protein level
P52630,STAT2_HUMAN,Signal transducer and activator of transcription 2 (p113),851,"97,916",5 out of 5,1996-10-01,Evidence at protein level
O00506,STK25_HUMAN,Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1),426,"48,112",5 out of 5,2000-12-01,Evidence at protein level
Q9BXU1,STK31_HUMAN,Serine/threonine-protein kinase 31 (EC 2.7.11.1) (Serine/threonine-protein kinase NYD-SPK) (Sugen kinase 396) (SgK396),1019,"115,694",5 out of 5,2001-11-16,Evidence at transcript level
Q9UEW8,STK39_HUMAN,STE20/SPS1-related proline-alanine-rich protein kinase (Ste-20-related kinase) (EC 2.7.11.1) (DCHT) (Serine/threonine-protein kinase 39),545,"59,474",5 out of 5,2000-12-01,Evidence at protein level
Q9P2F5,STOX2_HUMAN,Storkhead-box protein 2,926,"102,671",2 out of 5,2008-01-15,Evidence at transcript level
Q6ZVD7,STOX1_HUMAN,Storkhead-box protein 1 (Winged-helix domain-containing protein),989,"110,962",5 out of 5,2004-10-11,Evidence at protein level
P09430,STP1_HUMAN,Spermatid nuclear transition protein 1 (STP-1) (TP-1),55,"6,424",5 out of 5,1989-07-01,Evidence at protein level
Q5TH74,STPG1_HUMAN,O(6)-methylguanine-induced apoptosis 2 (MAPO2) (Sperm-tail PG-rich repeat-containing protein 1),334,"36,786",3 out of 5,2007-10-02,Evidence at protein level
P08842,STS_HUMAN,Steryl-sulfatase (EC 3.1.6.2) (Arylsulfatase C) (ASC) (Steroid sulfatase) (Steryl-sulfate sulfohydrolase),583,"65,492",5 out of 5,1988-11-01,Evidence at protein level
Q8TCT6,SPPL3_HUMAN,Signal peptide peptidase-like 3 (SPP-like 3) (EC 3.4.23.-) (Intramembrane protease 2) (IMP-2) (Presenilin homologous protein 1) (PSH1) (Presenilin-like protein 4),385,"42,563",5 out of 5,2002-11-08,Evidence at protein level
P22532,SPR2D_HUMAN,Small proline-rich protein 2D (SPR-2D) (Small proline-rich protein II) (SPR-II),72,"7,905",4 out of 5,1991-08-01,Evidence at transcript level
Q5BIV9,SPRN_HUMAN,Shadow of prion protein (Protein shadoo),151,"14,522",4 out of 5,2008-02-26,Evidence at transcript level
Q99619,SPSB2_HUMAN,SPRY domain-containing SOCS box protein 2 (SSB-2) (Gene-rich cluster protein C9),263,"28,630",4 out of 5,2006-05-30,Evidence at protein level
Q96LK8,SPT32_HUMAN,Spermatogenesis-associated protein 32 (Testis-expressed protein 34),384,"42,325",3 out of 5,2007-04-03,Evidence at protein level
Q6ZRS2,SRCAP_HUMAN,Helicase SRCAP (EC 3.6.4.-) (Domino homolog 2) (Snf2-related CBP activator),3230,"343,555",5 out of 5,2007-11-13,Evidence at protein level
Q9C0H9,SRCN1_HUMAN,SRC kinase signaling inhibitor 1 (SNAP-25-interacting protein) (SNIP) (p130Cas-associated protein) (p140Cap),1055,"112,453",5 out of 5,2004-02-16,Evidence at protein level
Q9BXP5,SRRT_HUMAN,Serrate RNA effector molecule homolog (Arsenite-resistance protein 2),876,"100,666",5 out of 5,2002-01-23,Evidence at protein level
Q9BRL6,SRSF8_HUMAN,"Serine/arginine-rich splicing factor 8 (Pre-mRNA-splicing factor SRP46) (Splicing factor SRp46) (Splicing factor, arginine/serine-rich 2B)",282,"32,288",5 out of 5,2007-09-11,Evidence at protein level
O60232,SSA27_HUMAN,Sjoegren syndrome/scleroderma autoantigen 1 (Autoantigen p27),199,"21,474",4 out of 5,1999-07-15,Evidence at protein level
Q9BWG4,SSBP4_HUMAN,Single-stranded DNA-binding protein 4,385,"39,388",3 out of 5,2003-01-10,Evidence at protein level
O60225,SSX5_HUMAN,Protein SSX5,188,"21,660",3 out of 5,1999-07-15,Evidence at protein level
P0DMM9,ST1A3_HUMAN,"Sulfotransferase 1A3 (ST1A3) (EC 2.8.2.1) (Aryl sulfotransferase 1A3/1A4) (Catecholamine-sulfating phenol sulfotransferase) (HAST3) (M-PST) (Monoamine-sulfating phenol sulfotransferase) (Placental estrogen sulfotransferase) (Sulfotransferase 1A3/1A4) (Sulfotransferase, monoamine-preferring) (Thermolabile phenol sulfotransferase) (TL-PST)",295,"34,196",5 out of 5,2014-09-03,Evidence at protein level
O75897,ST1C4_HUMAN,Sulfotransferase 1C4 (ST1C4) (EC 2.8.2.-) (Sulfotransferase 1C2) (SULT1C#2),302,"35,520",5 out of 5,2000-12-01,Evidence at protein level
P49888,ST1E1_HUMAN,"Estrogen sulfotransferase (EC 2.8.2.4) (EST-1) (Sulfotransferase 1E1) (ST1E1) (Sulfotransferase, estrogen-preferring)",294,"35,126",5 out of 5,1996-10-01,Evidence at protein level
Q9BR01,ST4A1_HUMAN,Sulfotransferase 4A1 (ST4A1) (EC 2.8.2.-) (Brain sulfotransferase-like protein) (hBR-STL) (hBR-STL-1) (Nervous system sulfotransferase) (NST),284,"33,085",4 out of 5,2002-08-02,Evidence at protein level
Q9NY15,STAB1_HUMAN,"Stabilin-1 (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 1) (FEEL-1) (MS-1 antigen)",2570,"275,482",5 out of 5,2004-07-05,Evidence at protein level
Q8WWQ8,STAB2_HUMAN,"Stabilin-2 (FAS1 EGF-like and X-link domain-containing adhesion molecule 2) (Fasciclin, EGF-like, laminin-type EGF-like and link domain-containing scavenger receptor 2) (FEEL-2) (Hyaluronan receptor for endocytosis) [Cleaved into: 190 kDa form stabilin-2 (190 kDa hyaluronan receptor for endocytosis)]",2551,"276,988",5 out of 5,2004-07-19,Evidence at protein level
Q8NBB2,STAS1_HUMAN,Putative uncharacterized protein ST20-AS1 (ST20 antisense RNA 1) (ST20 antisense gene protein 1),130,"13,907",1 out of 5,2008-05-20,Evidence at transcript level
O95793,STAU1_HUMAN,Double-stranded RNA-binding protein Staufen homolog 1,577,"63,182",5 out of 5,2000-12-01,Evidence at protein level
Q15831,STK11_HUMAN,Serine/threonine-protein kinase STK11 (EC 2.7.11.1) (Liver kinase B1) (LKB1) (hLKB1) (Renal carcinoma antigen NY-REN-19),433,"48,636",5 out of 5,1998-07-15,Evidence at protein level
Q8TDR2,STK35_HUMAN,Serine/threonine-protein kinase 35 (EC 2.7.11.1) (CLP-36-interacting kinase 1) (CLIK-1) (PDLIM1-interacting kinase 1) (Serine/threonine-protein kinase 35 L1),534,"58,051",5 out of 5,2003-01-27,Evidence at protein level
P16949,STMN1_HUMAN,Stathmin (Leukemia-associated phosphoprotein p18) (Metablastin) (Oncoprotein 18) (Op18) (Phosphoprotein p19) (pp19) (Prosolin) (Protein Pr22) (pp17),149,"17,303",5 out of 5,1990-08-01,Evidence at protein level
Q8N7X2,STPG3_HUMAN,Protein STPG3 (Sperm-tail PG-rich repeat-containing protein 3),389,"42,877",2 out of 5,2008-03-18,Evidence at transcript level
Q7RTN6,STRAA_HUMAN,STE20-related kinase adapter protein alpha (STRAD alpha) (STE20-related adapter protein) (Serologically defined breast cancer antigen NY-BR-96),431,"48,369",5 out of 5,2006-11-28,Evidence at protein level
Q86Y82,STX12_HUMAN,Syntaxin-12,276,"31,642",5 out of 5,2004-05-10,Evidence at protein level
O14662,STX16_HUMAN,Syntaxin-16 (Syn16),325,"37,031",5 out of 5,2001-02-21,Evidence at protein level
Q9P2W9,STX18_HUMAN,Syntaxin-18 (Cell growth-inhibiting gene 9 protein),335,"38,674",5 out of 5,2001-11-16,Evidence at protein level
O15400,STX7_HUMAN,Syntaxin-7,261,"29,816",5 out of 5,1998-07-15,Evidence at protein level
Q96I99,SUCB2_HUMAN,"Succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial (EC 6.2.1.4) (GTP-specific succinyl-CoA synthetase subunit beta) (G-SCS) (GTPSCS) (Succinyl-CoA synthetase beta-G chain) (SCS-betaG)",432,"46,511",5 out of 5,2002-05-27,Evidence at protein level
Q06330,SUH_HUMAN,Recombining binding protein suppressor of hairless (CBF-1) (J kappa-recombination signal-binding protein) (RBP-J kappa) (RBP-J) (RBP-JK) (Renal carcinoma antigen NY-REN-30),500,"55,637",5 out of 5,1994-06-01,Evidence at protein level
Q8IWU6,SULF1_HUMAN,Extracellular sulfatase Sulf-1 (hSulf-1) (EC 3.1.6.-),871,"101,027",5 out of 5,2003-07-19,Evidence at protein level
Q8IWU5,SULF2_HUMAN,Extracellular sulfatase Sulf-2 (hSulf-2) (EC 3.1.6.-),870,"100,455",5 out of 5,2003-07-19,Evidence at protein level
P61956,SUMO2_HUMAN,Small ubiquitin-related modifier 2 (SUMO-2) (HSMT3) (SMT3 homolog 2) (SUMO-3) (Sentrin-2) (Ubiquitin-like protein SMT3B) (Smt3B),95,"10,871",5 out of 5,2004-06-07,Evidence at protein level
Q8TAQ9,SUN3_HUMAN,SUN domain-containing protein 3 (Sad1/unc-84 domain-containing protein 1),357,"40,503",4 out of 5,2007-12-04,Evidence at protein level
O75486,SUPT3_HUMAN,Transcription initiation protein SPT3 homolog (SPT3-like protein),399,"44,362",5 out of 5,2002-05-15,Evidence at protein level
P35321,SPR1A_HUMAN,Cornifin-A (19 kDa pancornulin) (SPRK) (Small proline-rich protein IA) (SPR-IA),89,"9,877",5 out of 5,1994-02-01,Evidence at protein level
Q7Z699,SPRE1_HUMAN,"Sprouty-related, EVH1 domain-containing protein 1 (Spred-1) (hSpred1)",444,"50,477",5 out of 5,2005-01-04,Evidence at protein level
P49903,SPS1_HUMAN,"Selenide, water dikinase 1 (EC 2.7.9.3) (Selenium donor protein 1) (Selenophosphate synthase 1)",392,"42,911",5 out of 5,1996-10-01,Evidence at protein level
Q9NRC6,SPTN5_HUMAN,"Spectrin beta chain, non-erythrocytic 5 (Beta-V spectrin)",3674,"416,750",5 out of 5,2001-11-16,Evidence at protein level
Q14247,SRC8_HUMAN,Src substrate cortactin (Amplaxin) (Oncogene EMS1),550,"61,586",5 out of 5,1997-11-01,Evidence at protein level
Q96GP6,SREC2_HUMAN,Scavenger receptor class F member 2 (SRECRP-1) (Scavenger receptor expressed by endothelial cells 2 protein) (SREC-II),870,"92,479",5 out of 5,2003-01-17,Evidence at protein level
P37108,SRP14_HUMAN,Signal recognition particle 14 kDa protein (SRP14) (18 kDa Alu RNA-binding protein),136,"14,570",5 out of 5,1994-10-01,Evidence at protein level
P78362,SRPK2_HUMAN,SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal],688,"77,527",5 out of 5,2005-07-05,Evidence at protein level
Q9UH36,SRR1L_HUMAN,SRR1-like protein (SRR1 domain-containing protein),339,"38,573",3 out of 5,2003-05-30,Evidence at transcript level
Q8IYB3,SRRM1_HUMAN,Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein),904,"102,335",5 out of 5,2005-12-06,Evidence at protein level
Q9UQ35,SRRM2_HUMAN,Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803),2752,"299,615",5 out of 5,2006-09-05,Evidence at protein level
O75494,SRS10_HUMAN,"Serine/arginine-rich splicing factor 10 (40 kDa SR-repressor protein) (SRrp40) (FUS-interacting serine-arginine-rich protein 1) (Splicing factor SRp38) (Splicing factor, arginine/serine-rich 13A) (TLS-associated protein with Ser-Arg repeats) (TASR) (TLS-associated protein with SR repeats) (TLS-associated serine-arginine protein) (TLS-associated SR protein)",262,"31,301",5 out of 5,2004-05-24,Evidence at protein level
P51649,SSDH_HUMAN,"Succinate-semialdehyde dehydrogenase, mitochondrial (EC 1.2.1.24) (Aldehyde dehydrogenase family 5 member A1) (NAD(+)-dependent succinic semialdehyde dehydrogenase)",535,"57,215",5 out of 5,1996-10-01,Evidence at protein level
Q76I76,SSH2_HUMAN,Protein phosphatase Slingshot homolog 2 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 2) (SSH-2L) (hSSH-2L),1423,"158,216",5 out of 5,2005-11-22,Evidence at protein level
Q14714,SSPN_HUMAN,Sarcospan (K-ras oncogene-associated protein) (Kirsten-ras-associated protein),243,"26,618",5 out of 5,2001-04-27,Evidence at transcript level
P30872,SSR1_HUMAN,Somatostatin receptor type 1 (SS-1-R) (SS1-R) (SS1R) (SRIF-2),391,"42,686",5 out of 5,1993-07-01,Evidence at protein level
P30874,SSR2_HUMAN,Somatostatin receptor type 2 (SS-2-R) (SS2-R) (SS2R) (SRIF-1),369,"41,333",5 out of 5,1993-07-01,Evidence at protein level
P31391,SSR4_HUMAN,Somatostatin receptor type 4 (SS-4-R) (SS4-R) (SS4R),388,"42,003",5 out of 5,1993-07-01,Evidence at transcript level
Q7RTT6,SSX6_HUMAN,Putative protein SSX6,188,"21,688",3 out of 5,2006-03-21,Uncertain
Q6IMI4,ST6B1_HUMAN,Sulfotransferase 6B1 (ST6B1) (Thyroxine sulfotransferase) (EC 2.8.2.n2),303,"34,919",4 out of 5,2005-03-15,Evidence at transcript level
Q8NE28,STKL1_HUMAN,Serine/threonine kinase-like domain-containing protein STKLD1 (Serine/threonine kinase-like domain-containing protein 1) (Sugen kinase 071),680,"75,676",3 out of 5,2006-03-21,Evidence at transcript level
Q7Z7C7,STRA8_HUMAN,Stimulated by retinoic acid gene 8 protein homolog,330,"36,908",4 out of 5,2008-02-05,Evidence at transcript level
Q12846,STX4_HUMAN,Syntaxin-4 (Renal carcinoma antigen NY-REN-31),297,"34,180",5 out of 5,1997-11-01,Evidence at protein level
Q8TDD2,SP7_HUMAN,Transcription factor Sp7 (Zinc finger protein osterix),431,"44,994",5 out of 5,2003-05-16,Evidence at protein level
Q86WD7,SPA9_HUMAN,Serpin A9 (Centerin) (Germinal center B-cell-expressed transcript 1 protein),417,"46,557",5 out of 5,2005-09-27,Evidence at protein level
Q07617,SPAG1_HUMAN,Sperm-associated antigen 1 (HSD-3.8) (Infertility-related sperm protein Spag-1),926,"103,639",5 out of 5,2005-02-01,Evidence at protein level
Q9UIV8,SPB13_HUMAN,Serpin B13 (HaCaT UV-repressible serpin) (Hurpin) (Headpin) (Peptidase inhibitor 13) (PI-13) (Proteinase inhibitor 13),391,"44,276",5 out of 5,2000-12-01,Evidence at protein level
O75635,SPB7_HUMAN,Serpin B7 (Megsin) (TP55),380,"42,905",4 out of 5,2002-01-23,Evidence at protein level
Q9Y6A9,SPCS1_HUMAN,Signal peptidase complex subunit 1 (EC 3.4.-.-) (Microsomal signal peptidase 12 kDa subunit) (SPase 12 kDa subunit),102,"11,805",4 out of 5,2002-01-31,Evidence at protein level
P61009,SPCS3_HUMAN,Signal peptidase complex subunit 3 (EC 3.4.-.-) (Microsomal signal peptidase 22/23 kDa subunit) (SPC22/23) (SPase 22/23 kDa subunit),180,"20,313",4 out of 5,2004-04-26,Evidence at protein level
P19623,SPEE_HUMAN,Spermidine synthase (SPDSY) (EC 2.5.1.16) (Putrescine aminopropyltransferase),302,"33,825",5 out of 5,1991-02-01,Evidence at protein level
Q9Y4P9,SPEF1_HUMAN,Sperm flagellar protein 1,236,"26,987",2 out of 5,2002-09-19,Evidence at protein level
Q9UQ90,SPG7_HUMAN,Paraplegin (EC 3.4.24.-) (Spastic paraplegia 7 protein),795,"88,235",5 out of 5,2001-04-27,Evidence at protein level
P49223,SPIT3_HUMAN,Kunitz-type protease inhibitor 3 (HKIB9),89,"10,252",2 out of 5,1996-02-01,Inferred from homology
Q9NY87,SPNXC_HUMAN,Sperm protein associated with the nucleus on the X chromosome C (Cancer/testis antigen 11.3) (CT11.3) (Cancer/testis-associated protein CTp11) (Nuclear-associated protein SPAN-Xc) (SPANX-C) (SPANX family member C),97,"10,982",3 out of 5,2005-02-01,Evidence at protein level
P22528,SPR1B_HUMAN,Cornifin-B (14.9 kDa pancornulin) (Small proline-rich protein IB) (SPR-IB),89,"9,888",5 out of 5,1991-08-01,Evidence at protein level
P22531,SPR2E_HUMAN,Small proline-rich protein 2E (SPR-2E) (Small proline-rich protein II) (SPR-II),72,"7,855",4 out of 5,1991-08-01,Evidence at transcript level
Q5W111,SPRY7_HUMAN,SPRY domain-containing protein 7 (Chronic lymphocytic leukemia deletion region gene 6 protein) (CLL deletion region gene 6 protein),196,"21,666",3 out of 5,2006-06-27,Evidence at protein level
P52788,SPSY_HUMAN,Spermine synthase (SPMSY) (EC 2.5.1.22) (Spermidine aminopropyltransferase),366,"41,268",5 out of 5,1996-10-01,Evidence at protein level
Q8NHS9,SPT22_HUMAN,Spermatogenesis-associated protein 22 (Testis development protein NYD-SP20),363,"41,318",3 out of 5,2006-10-03,Evidence at protein level
Q96JI7,SPTCS_HUMAN,Spatacsin (Colorectal carcinoma-associated protein) (Spastic paraplegia 11 protein),2443,"278,868",5 out of 5,2007-05-15,Evidence at protein level
O60687,SRPX2_HUMAN,Sushi repeat-containing protein SRPX2 (Sushi-repeat protein upregulated in leukemia),465,"52,972",5 out of 5,2007-02-06,Evidence at protein level
P81877,SSBP2_HUMAN,Single-stranded DNA-binding protein 2 (Sequence-specific single-stranded-DNA-binding protein 2),361,"37,828",4 out of 5,2003-01-10,Evidence at protein level
Q8WYL5,SSH1_HUMAN,Protein phosphatase Slingshot homolog 1 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 1) (SSH-1L) (hSSH-1L),1049,"115,511",5 out of 5,2005-11-22,Evidence at protein level
O43805,SSNA1_HUMAN,Sjoegren syndrome nuclear autoantigen 1 (Nuclear autoantigen of 14 kDa),119,"13,596",5 out of 5,2000-05-30,Evidence at protein level
Q9Y2M2,SSUH2_HUMAN,Protein SSUH2 homolog (Protein ssu-2 homolog),353,"39,845",3 out of 5,2006-11-28,Evidence at protein level
Q99909,SSX3_HUMAN,Protein SSX3 (Cancer/testis antigen 5.3) (CT5.3),188,"21,697",5 out of 5,1998-12-15,Evidence at protein level
Q8TBR4,ST3L4_HUMAN,Putative STAG3-like protein 4 (Stromal antigen 3-like protein 4),150,"17,020",2 out of 5,2008-02-26,Uncertain
O94864,ST65G_HUMAN,STAGA complex 65 subunit gamma (Adenocarcinoma antigen ART1) (SPTF-associated factor 65 gamma) (STAF65gamma) (Suppressor of Ty 7-like),414,"46,193",5 out of 5,2002-09-19,Evidence at protein level
Q9NRC1,ST7_HUMAN,Suppressor of tumorigenicity 7 protein (Protein FAM4A1) (Protein HELG),585,"67,166",4 out of 5,2008-06-10,Evidence at protein level
Q6ZMT1,STAC2_HUMAN,SH3 and cysteine-rich domain-containing protein 2 (24b2/STAC2) (Src homology 3 and cysteine-rich domain-containing protein 2),411,"45,009",3 out of 5,2007-02-06,Evidence at protein level
Q96DR4,STAR4_HUMAN,StAR-related lipid transfer protein 4 (START domain-containing protein 4) (StARD4),205,"23,517",4 out of 5,2002-11-15,Evidence at transcript level
Q9P2P6,STAR9_HUMAN,StAR-related lipid transfer protein 9 (START domain-containing protein 9) (StARD9),4700,"516,343",5 out of 5,2002-11-08,Evidence at protein level
Q9Y2K9,STB5L_HUMAN,Syntaxin-binding protein 5-like (Lethal(2) giant larvae protein homolog 4) (Tomosyn-2),1186,"131,887",5 out of 5,2005-11-22,Evidence at protein level
Q6NZ63,STEAL_HUMAN,STEAP family member 1B,245,"28,815",2 out of 5,2008-02-26,Evidence at transcript level
P31948,STIP1_HUMAN,Stress-induced-phosphoprotein 1 (STI1) (Hsc70/Hsp90-organizing protein) (Hop) (Renal carcinoma antigen NY-REN-11) (Transformation-sensitive protein IEF SSP 3521),543,"62,639",5 out of 5,1993-07-01,Evidence at protein level
A2RU48,SMCO3_HUMAN,Single-pass membrane and coiled-coil domain-containing protein 3,225,"24,877",2 out of 5,2008-05-20,Evidence at protein level
Q96E16,SMI19_HUMAN,Small integral membrane protein 19,107,"12,439",2 out of 5,2006-12-12,Inferred from homology
Q8N5G0,SMI20_HUMAN,Small integral membrane protein 20 (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 7 kDa) (MITRAC7),67,"7,702",4 out of 5,2008-03-18,Evidence at protein level
Q8WVI0,SMIM4_HUMAN,Small integral membrane protein 4,70,"8,696",2 out of 5,2008-09-02,Evidence at protein level
Q9BQ49,SMIM7_HUMAN,Small integral membrane protein 7,75,"8,631",2 out of 5,2007-04-17,Evidence at protein level
H3BMG3,SMKR1_HUMAN,Small lysine-rich protein 1,65,"7,091",1 out of 5,2013-03-06,Predicted
Q02446,SP4_HUMAN,Transcription factor Sp4 (SPR-1),784,"81,985",5 out of 5,1995-02-01,Evidence at protein level
Q6BEB4,SP5_HUMAN,Transcription factor Sp5,398,"41,964",3 out of 5,2005-11-22,Evidence at transcript level
Q9NWH7,SPAT6_HUMAN,Spermatogenesis-associated protein 6,488,"55,989",3 out of 5,2007-02-20,Evidence at protein level
Q96P15,SPB11_HUMAN,Serpin B11,392,"44,099",4 out of 5,2002-01-23,Evidence at transcript level
Q15772,SPEG_HUMAN,Striated muscle preferentially expressed protein kinase (EC 2.7.11.1) (Aortic preferentially expressed protein 1) (APEG-1),3267,"354,289",5 out of 5,2000-05-30,Evidence at protein level
Q8N0X2,SPG16_HUMAN,Sperm-associated antigen 16 protein (Pf20 protein homolog),631,"70,818",5 out of 5,2005-04-26,Evidence at transcript level
Q8N0X7,SPG20_HUMAN,Spartin (Spastic paraplegia 20 protein) (Trans-activated by hepatitis C virus core protein 1),666,"72,833",5 out of 5,2004-07-19,Evidence at protein level
Q8N0Z3,SPICE_HUMAN,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein),855,"96,264",5 out of 5,2007-04-03,Evidence at protein level
Q5JUX0,SPIN3_HUMAN,Spindlin-3 (Spindlin-like protein 3) (SPIN-3),258,"29,207",2 out of 5,2006-10-31,Evidence at protein level
Q9H2V7,SPNS1_HUMAN,Protein spinster homolog 1 (HSpin1) (Spinster-like protein 1),528,"56,630",5 out of 5,2007-10-02,Evidence at protein level
Q5T0L3,SPT46_HUMAN,Spermatogenesis-associated protein 46,261,"29,150",3 out of 5,2007-03-06,Evidence at protein level
P63272,SPT4H_HUMAN,Transcription elongation factor SPT4 (hSPT4) (DRB sensitivity-inducing factor 14 kDa subunit) (DSIF p14) (DRB sensitivity-inducing factor small subunit) (DSIF small subunit),117,"13,193",5 out of 5,2004-10-11,Evidence at protein level
Q8NHX4,SPTA3_HUMAN,Spermatogenesis-associated protein 3 (Testis and spermatogenesis cell-related protein 1) (Testis spermatocyte apoptosis-related protein 1),192,"20,901",2 out of 5,2003-10-10,Evidence at transcript level
Q01082,SPTB2_HUMAN,"Spectrin beta chain, non-erythrocytic 1 (Beta-II spectrin) (Fodrin beta chain) (Spectrin, non-erythroid beta chain 1)",2364,"274,609",5 out of 5,1997-11-01,Evidence at protein level
Q8NFR3,SPTSB_HUMAN,Serine palmitoyltransferase small subunit B (Protein ADMP) (Small subunit of serine palmitoyltransferase B) (ssSPTb),76,"9,198",5 out of 5,2006-06-13,Evidence at protein level
Q8NCC5,SPX3_HUMAN,Sugar phosphate exchanger 3 (Solute carrier family 37 member 3),494,"54,486",3 out of 5,2007-11-13,Evidence at transcript level
Q9BXG8,SPZ1_HUMAN,Spermatogenic leucine zipper protein 1 (Testis-specific protein 1) (Testis-specific protein NYD-TSP1),430,"49,445",4 out of 5,2007-03-20,Evidence at protein level
O15042,SR140_HUMAN,U2 snRNP-associated SURP motif-containing protein (140 kDa Ser/Arg-rich domain protein) (U2-associated protein SR140),1029,"118,292",5 out of 5,2007-03-06,Evidence at protein level
Q7Z6B7,SRGP1_HUMAN,SLIT-ROBO Rho GTPase-activating protein 1 (srGAP1) (Rho GTPase-activating protein 13),1085,"124,264",5 out of 5,2004-06-07,Evidence at protein level
Q9H3Y6,SRMS_HUMAN,Tyrosine-protein kinase Srms (EC 2.7.10.2),488,"54,507",5 out of 5,2003-01-17,Evidence at protein level
P09132,SRP19_HUMAN,Signal recognition particle 19 kDa protein (SRP19),144,"16,156",5 out of 5,1989-07-01,Evidence at protein level
P61011,SRP54_HUMAN,Signal recognition particle 54 kDa protein (SRP54),504,"55,705",5 out of 5,2004-04-26,Evidence at protein level
Q01130,SRSF2_HUMAN,"Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2)",221,"25,476",5 out of 5,1993-04-01,Evidence at protein level
Q13243,SRSF5_HUMAN,"Serine/arginine-rich splicing factor 5 (Delayed-early protein HRS) (Pre-mRNA-splicing factor SRP40) (Splicing factor, arginine/serine-rich 5)",272,"31,264",5 out of 5,1998-12-15,Evidence at protein level
Q13242,SRSF9_HUMAN,"Serine/arginine-rich splicing factor 9 (Pre-mRNA-splicing factor SRp30C) (Splicing factor, arginine/serine-rich 9)",221,"25,542",5 out of 5,1998-12-15,Evidence at protein level
Q9UJW9,SRTD3_HUMAN,SERTA domain-containing protein 3 (Replication protein-binding trans-activator) (RPA-binding trans-activator),196,"21,769",4 out of 5,2005-02-01,Evidence at protein level
Q16385,SSX2_HUMAN,"Protein SSX2 (Cancer/testis antigen 5.2) (CT5.2) (Synovial sarcoma, X breakpoint 2) (Tumor antigen HOM-MEL-40)",188,"21,620",5 out of 5,1998-12-15,Evidence at protein level
O43704,ST1B1_HUMAN,Sulfotransferase family cytosolic 1B member 1 (ST1B1) (Sulfotransferase 1B1) (EC 2.8.2.-) (Sulfotransferase 1B2) (ST1B2) (Thyroid hormone sulfotransferase),296,"34,899",5 out of 5,2005-01-04,Evidence at protein level
O00338,ST1C2_HUMAN,Sulfotransferase 1C2 (ST1C2) (EC 2.8.2.-) (Sulfotransferase 1C1) (SULT1C#1) (humSULTC2),296,"34,880",5 out of 5,2000-12-01,Evidence at protein level
Q9HBF5,ST20_HUMAN,Suppressor of tumorigenicity 20 protein (Human cervical cancer suppressor gene 1 protein) (HCCS-1),79,"9,024",2 out of 5,2008-06-10,Evidence at transcript level
Q06520,ST2A1_HUMAN,Bile salt sulfotransferase (EC 2.8.2.14) (Dehydroepiandrosterone sulfotransferase) (DHEA-ST) (Hydroxysteroid Sulfotransferase) (HST) (ST2) (ST2A3) (Sulfotransferase 2A1) (ST2A1),285,"33,780",5 out of 5,1995-11-01,Evidence at protein level
O00204,ST2B1_HUMAN,Sulfotransferase family cytosolic 2B member 1 (ST2B1) (Sulfotransferase 2B1) (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2),365,"41,308",5 out of 5,2005-01-04,Evidence at protein level
Q9NY57,ST32B_HUMAN,Serine/threonine-protein kinase 32B (EC 2.7.11.1) (Yet another novel kinase 2),414,"47,883",4 out of 5,2006-04-18,Evidence at transcript level
P0CL83,ST3L1_HUMAN,Putative STAG3-like protein 1 (Stromal antigen 3-like protein 1),205,"23,775",2 out of 5,2011-05-03,Uncertain
Q8TDW4,ST7L_HUMAN,Suppressor of tumorigenicity 7 protein-like (ST7-related protein),575,"64,779",4 out of 5,2008-06-10,Evidence at transcript level
Q96MF2,STAC3_HUMAN,SH3 and cysteine-rich domain-containing protein 3,364,"41,507",5 out of 5,2006-04-18,Evidence at protein level
Q8TE77,SSH3_HUMAN,Protein phosphatase Slingshot homolog 3 (EC 3.1.3.16) (EC 3.1.3.48) (SSH-like protein 3) (SSH-3L) (hSSH-3L),659,"72,996",5 out of 5,2005-11-22,Evidence at protein level
P35346,SSR5_HUMAN,Somatostatin receptor type 5 (SS-5-R) (SS5-R) (SS5R),364,"39,202",5 out of 5,1994-06-01,Evidence at protein level
Q16384,SSX1_HUMAN,"Protein SSX1 (Cancer/testis antigen 5.1) (CT5.1) (Synovial sarcoma, X breakpoint 1)",188,"21,931",4 out of 5,1998-12-15,Evidence at protein level
Q7RTT4,SSX8_HUMAN,Protein SSX8,187,"21,859",3 out of 5,2006-03-21,Evidence at transcript level
Q8IZP2,ST134_HUMAN,Putative protein FAM10A4 (Suppression of tumorigenicity 13 pseudogene 4),240,"27,407",3 out of 5,2005-10-25,Uncertain
Q9Y5Y6,ST14_HUMAN,Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein),855,"94,770",5 out of 5,2001-02-21,Evidence at protein level
O60284,ST18_HUMAN,Suppression of tumorigenicity 18 protein (Zinc finger protein 387),1047,"115,155",3 out of 5,2006-05-02,Evidence at protein level
Q6IMI6,ST1C3_HUMAN,Sulfotransferase 1C3 (ST1C3) (EC 2.8.2.2),304,"35,889",4 out of 5,2006-09-19,Evidence at protein level
Q8WU08,ST32A_HUMAN,Serine/threonine-protein kinase 32A (EC 2.7.11.1) (Yet another novel kinase 1),396,"46,369",5 out of 5,2006-04-18,Evidence at protein level
P78524,ST5_HUMAN,Suppression of tumorigenicity 5 protein (DENN domain-containing protein 2B) (HeLa tumor suppression 1),1137,"126,485",5 out of 5,2006-07-25,Evidence at protein level
Q9UJ98,STAG3_HUMAN,Cohesin subunit SA-3 (SCC3 homolog 3) (Stromal antigen 3) (Stromalin-3),1225,"139,034",5 out of 5,2003-03-25,Evidence at protein level
O75886,STAM2_HUMAN,Signal transducing adapter molecule 2 (STAM-2) (Hrs-binding protein),525,"58,164",5 out of 5,2005-07-19,Evidence at protein level
Q9UGK3,STAP2_HUMAN,Signal-transducing adaptor protein 2 (STAP-2) (Breast tumor kinase substrate) (BRK substrate),403,"44,894",5 out of 5,2005-04-12,Evidence at protein level
Q14849,STAR3_HUMAN,StAR-related lipid transfer protein 3 (Metastatic lymph node gene 64 protein) (MLN 64) (Protein CAB1) (START domain-containing protein 3) (StARD3),445,"50,502",5 out of 5,2000-05-30,Evidence at protein level
P59095,STAR6_HUMAN,StAR-related lipid transfer protein 6 (START domain-containing protein 6) (StARD6),220,"25,022",2 out of 5,2002-11-15,Evidence at protein level
Q92502,STAR8_HUMAN,StAR-related lipid transfer protein 8 (Deleted in liver cancer 3 protein) (DLC-3) (START domain-containing protein 8) (StARD8) (START-GAP3),1023,"112,601",5 out of 5,2002-11-15,Evidence at protein level
P49675,STAR_HUMAN,"Steroidogenic acute regulatory protein, mitochondrial (StAR) (START domain-containing protein 1) (StARD1)",285,"31,914",5 out of 5,1996-02-01,Evidence at protein level
Q14765,STAT4_HUMAN,Signal transducer and activator of transcription 4,748,"85,941",5 out of 5,2000-05-30,Evidence at protein level
P02808,STAT_HUMAN,Statherin,62,"7,304",5 out of 5,1986-07-21,Evidence at protein level
Q9NUL3,STAU2_HUMAN,Double-stranded RNA-binding protein Staufen homolog 2,570,"62,641",5 out of 5,2005-08-30,Evidence at protein level
Q687X5,STEA4_HUMAN,"Metalloreductase STEAP4 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 4) (SixTransMembrane protein of prostate 2) (Tumor necrosis factor, alpha-induced protein 9)",459,"51,981",5 out of 5,2007-05-01,Evidence at protein level
H3BQB6,STMD1_HUMAN,Stathmin domain-containing protein 1,276,"30,984",2 out of 5,2013-03-06,Evidence at transcript level
Q9Y6Q2,STON1_HUMAN,Stonin-1 (Stoned B-like factor),735,"83,141",4 out of 5,2001-02-21,Evidence at protein level
Q9H6E5,STPAP_HUMAN,Speckle targeted PIP5K1A-regulated poly(A) polymerase (Star-PAP) (EC 2.7.7.19) (RNA-binding motif protein 21) (RNA-binding protein 21) (U6 snRNA-specific terminal uridylyltransferase 1) (U6-TUTase) (EC 2.7.7.52),874,"93,847",5 out of 5,2006-10-31,Evidence at protein level
Q96SI9,STRBP_HUMAN,Spermatid perinuclear RNA-binding protein,672,"73,653",5 out of 5,2007-02-06,Evidence at protein level
Q9NRL3,STRN4_HUMAN,Striatin-4 (Zinedin),753,"80,596",5 out of 5,2001-11-16,Evidence at protein level
Q5VSL9,STRP1_HUMAN,Striatin-interacting protein 1 (Protein FAM40A),837,"95,576",5 out of 5,2005-08-02,Evidence at protein level
Q8WUJ0,STYX_HUMAN,Serine/threonine/tyrosine-interacting protein (Protein tyrosine phosphatase-like protein),223,"25,492",4 out of 5,2003-02-28,Evidence at protein level
P63165,SUMO1_HUMAN,Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1),101,"11,557",5 out of 5,2004-09-27,Evidence at protein level
Q6UWL2,SUSD1_HUMAN,Sushi domain-containing protein 1,747,"82,710",3 out of 5,2006-10-03,Evidence at protein level
Q15022,SUZ12_HUMAN,Polycomb protein SUZ12 (Chromatin precipitated E2F target 9 protein) (ChET 9 protein) (Joined to JAZF1 protein) (Suppressor of zeste 12 protein homolog),739,"83,055",5 out of 5,2003-07-11,Evidence at protein level
Q0VAF6,SYCN_HUMAN,Syncollin (Insulin synthesis-associated protein 1),134,"14,405",2 out of 5,2007-07-24,Evidence at transcript level
Q96SF2,TCPQM_HUMAN,T-complex protein 1 subunit theta-like 2,557,"59,388",3 out of 5,2008-09-02,Evidence at transcript level
P50990,TCPQ_HUMAN,T-complex protein 1 subunit theta (TCP-1-theta) (CCT-theta) (Renal carcinoma antigen NY-REN-15),548,"59,621",5 out of 5,1996-10-01,Evidence at protein level
Q9NYB0,TE2IP_HUMAN,Telomeric repeat-binding factor 2-interacting protein 1 (TERF2-interacting telomeric protein 1) (TRF2-interacting telomeric protein 1) (Dopamine receptor-interacting protein 5) (Repressor/activator protein 1 homolog) (RAP1 homolog) (hRap1),399,"44,260",5 out of 5,2002-06-20,Evidence at protein level
Q15562,TEAD2_HUMAN,Transcriptional enhancer factor TEF-4 (TEA domain family member 2) (TEAD-2),447,"49,243",5 out of 5,1997-11-01,Evidence at protein level
P42680,TEC_HUMAN,Tyrosine-protein kinase Tec (EC 2.7.10.2),631,"73,581",5 out of 5,1995-11-01,Evidence at protein level
Q5T9Z0,TEDM1_HUMAN,Transmembrane epididymal protein 1 (Human epididymis-specific protein 9) (He9),273,"31,315",2 out of 5,2007-10-23,Evidence at transcript level
Q9UIK5,TEFF2_HUMAN,Tomoregulin-2 (TR-2) (Hyperplastic polyposis protein 1) (Transmembrane protein with EGF-like and two follistatin-like domains),374,"41,428",5 out of 5,2005-07-19,Evidence at protein level
Q96M29,TEKT5_HUMAN,Tektin-5,485,"56,294",3 out of 5,2006-11-28,Evidence at protein level
Q86WV5,TEN1L_HUMAN,CST complex subunit TEN1 (Protein telomeric pathways with STN1 homolog) (Telomere length regulation protein TEN1 homolog),123,"13,856",5 out of 5,2008-05-20,Evidence at protein level
Q6N022,TEN4_HUMAN,Teneurin-4 (Ten-4) (Protein Odd Oz/ten-m homolog 4) (Tenascin-M4) (Ten-m4) (Teneurin transmembrane protein 4),2769,"307,957",5 out of 5,2006-10-31,Evidence at protein level
Q96S53,TESK2_HUMAN,Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2),571,"63,639",5 out of 5,2002-11-08,Evidence at protein level
Q8N6K0,TEX29_HUMAN,Testis-expressed protein 29,151,"16,649",2 out of 5,2006-12-12,Evidence at transcript level
Q96LM6,TEX37_HUMAN,Testis-expressed sequence 37 protein (Testis-specific conserved protein of 21 kDa),180,"20,615",3 out of 5,2007-10-02,Evidence at protein level
Q9UNN4,TF2AY_HUMAN,"TFIIA-alpha and beta-like factor (General transcription factor II A, 1-like factor)",478,"52,444",4 out of 5,2001-02-21,Evidence at protein level
P32780,TF2H1_HUMAN,General transcription factor IIH subunit 1 (Basic transcription factor 2 62 kDa subunit) (BTF2 p62) (General transcription factor IIH polypeptide 1) (TFIIH basal transcription factor complex p62 subunit),548,"62,032",5 out of 5,1993-10-01,Evidence at protein level
Q13889,TF2H3_HUMAN,General transcription factor IIH subunit 3 (Basic transcription factor 2 34 kDa subunit) (BTF2 p34) (General transcription factor IIH polypeptide 3) (TFIIH basal transcription factor complex p34 subunit),308,"34,378",5 out of 5,2001-10-18,Evidence at protein level
Q9Y5Q8,TF3C5_HUMAN,General transcription factor 3C polypeptide 5 (TF3C-epsilon) (Transcription factor IIIC 63 kDa subunit) (TFIIIC 63 kDa subunit) (TFIIIC63) (Transcription factor IIIC subunit epsilon),519,"59,571",5 out of 5,2004-05-24,Evidence at protein level
Q9HCS4,TF7L1_HUMAN,Transcription factor 7-like 1 (HMG box transcription factor 3) (TCF-3),588,"62,631",5 out of 5,2003-03-25,Evidence at transcript level
Q9NQB0,TF7L2_HUMAN,Transcription factor 7-like 2 (HMG box transcription factor 4) (T-cell-specific transcription factor 4) (T-cell factor 4) (TCF-4) (hTCF-4),619,"67,919",5 out of 5,2003-03-25,Evidence at protein level
P48307,TFPI2_HUMAN,Tissue factor pathway inhibitor 2 (TFPI-2) (Placental protein 5) (PP5),235,"26,934",5 out of 5,1996-02-01,Evidence at protein level
H3BV60,TGR3L_HUMAN,Transforming growth factor-beta receptor type 3-like protein (TGF-beta receptor type-3-like protein) (TGFR-3L) (Transforming growth factor-beta receptor type III-like protein) (TGF-beta receptor type III-like protein),316,"32,819",2 out of 5,2012-10-03,Evidence at transcript level
Q86YJ6,THNS2_HUMAN,Threonine synthase-like 2 (TSH2) (EC 4.2.3.-) (Secreted osteoclastogenic factor of activated T-cells) (SOFAT),484,"54,116",5 out of 5,2007-10-02,Evidence at transcript level
Q96J01,THOC3_HUMAN,THO complex subunit 3 (Tho3) (TEX1 homolog) (hTREX45),351,"38,772",5 out of 5,2003-10-10,Evidence at protein level
Q6I9Y2,THOC7_HUMAN,THO complex subunit 7 homolog (Functional spliceosome-associated protein 24) (fSAP24) (Ngg1-interacting factor 3-like protein 1-binding protein 1) (NIF3L1-binding protein 1) (hTREX30),204,"23,743",5 out of 5,2007-11-13,Evidence at protein level
Q9BSF4,TIM29_HUMAN,Mitochondrial import inner membrane translocase subunit Tim29 (TIM29),260,"29,233",4 out of 5,2007-01-09,Evidence at protein level
P16035,TIMP2_HUMAN,Metalloproteinase inhibitor 2 (CSC-21K) (Tissue inhibitor of metalloproteinases 2) (TIMP-2),220,"24,399",5 out of 5,1990-04-01,Evidence at protein level
Q99727,TIMP4_HUMAN,Metalloproteinase inhibitor 4 (Tissue inhibitor of metalloproteinases 4) (TIMP-4),224,"25,503",4 out of 5,1998-12-15,Evidence at transcript level
Q9UNS1,TIM_HUMAN,Protein timeless homolog (hTIM),1208,"138,658",5 out of 5,2005-03-15,Evidence at protein level
Q96A98,TIP39_HUMAN,Tuberoinfundibular peptide of 39 residues (TIP39) (Parathyroid hormone 2),100,"11,202",3 out of 5,2006-02-07,Evidence at protein level
P29401,TKT_HUMAN,Transketolase (TK) (EC 2.2.1.1),623,"67,878",5 out of 5,1992-12-01,Evidence at protein level
Q6P9B6,TLDC1_HUMAN,TLD domain-containing protein 1 (TBC/LysM-associated domain-containing protein 1),456,"50,994",4 out of 5,2008-01-15,Evidence at protein level
Q9H808,TLE6_HUMAN,Transducin-like enhancer protein 6,572,"63,473",5 out of 5,2005-04-26,Evidence at protein level
Q6UX40,TM107_HUMAN,Transmembrane protein 107,140,"15,503",3 out of 5,2006-10-31,Evidence at transcript level
Q9BVC6,TM109_HUMAN,Transmembrane protein 109 (Mitsugumin-23) (Mg23),243,"26,210",4 out of 5,2005-12-20,Evidence at protein level
Q8NCL8,TM116_HUMAN,Transmembrane protein 116,245,"27,464",2 out of 5,2006-10-03,Evidence at transcript level
Q96AQ2,TM125_HUMAN,Transmembrane protein 125,219,"22,172",2 out of 5,2006-10-03,Evidence at transcript level
Q5BJH2,TM128_HUMAN,Transmembrane protein 128,165,"18,822",2 out of 5,2006-10-31,Evidence at protein level
Q9H6X4,TM134_HUMAN,Transmembrane protein 134,195,"21,586",2 out of 5,2007-03-06,Evidence at transcript level
Q96I45,TM141_HUMAN,Transmembrane protein 141,108,"11,875",2 out of 5,2007-03-06,Evidence at protein level
Q7Z5S9,TM144_HUMAN,Transmembrane protein 144,345,"37,653",2 out of 5,2007-05-29,Evidence at transcript level
Q9BVK8,TM147_HUMAN,Transmembrane protein 147 (Protein NIFIE 14),224,"25,261",4 out of 5,2007-01-09,Evidence at protein level
Q8N614,TM156_HUMAN,Transmembrane protein 156,296,"34,323",2 out of 5,2007-04-17,Evidence at transcript level
A6NGA9,TM202_HUMAN,Transmembrane protein 202,273,"31,353",2 out of 5,2008-02-05,Predicted
Q9BSN7,TM204_HUMAN,Transmembrane protein 204 (Claudin-like protein 24),226,"24,540",4 out of 5,2005-08-30,Evidence at transcript level
Q8N7C4,TM217_HUMAN,Transmembrane protein 217,229,"26,582",2 out of 5,2005-07-05,Evidence at transcript level
A6NGB7,TM221_HUMAN,Transmembrane protein 221,291,"30,293",1 out of 5,2008-04-29,Predicted
Q9H6L2,TM231_HUMAN,Transmembrane protein 231,316,"36,059",5 out of 5,2008-02-05,Evidence at protein level
Q8N6I4,TM251_HUMAN,Transmembrane protein 251,163,"18,747",2 out of 5,2005-07-19,Evidence at transcript level
Q8N2U0,TM256_HUMAN,Transmembrane protein 256,113,"11,742",2 out of 5,2007-05-15,Inferred from homology
Q9NX78,TM260_HUMAN,Transmembrane protein 260,707,"79,536",2 out of 5,2003-10-24,Evidence at transcript level
Q8N2M4,TM86A_HUMAN,Lysoplasmalogenase-like protein TMEM86A (Transmembrane protein 86A),240,"26,398",2 out of 5,2005-11-22,Evidence at transcript level
A6NKF7,TM88B_HUMAN,Transmembrane protein 88B,163,"17,097",2 out of 5,2008-09-02,Inferred from homology
Q8TDI7,TMC2_HUMAN,Transmembrane channel-like protein 2 (Transmembrane cochlear-expressed protein 2),906,"102,610",5 out of 5,2002-10-19,Evidence at transcript level
Q7Z5M5,TMC3_HUMAN,Transmembrane channel-like protein 3,1100,"125,685",3 out of 5,2006-10-31,Evidence at transcript level
Q8N6Q1,TMC5A_HUMAN,Transmembrane and coiled-coil domain-containing protein 5A,288,"34,174",2 out of 5,2007-10-02,Evidence at transcript level
Q6UXY8,TMC5_HUMAN,Transmembrane channel-like protein 5,1006,"114,797",3 out of 5,2007-05-29,Evidence at transcript level
Q7Z403,TMC6_HUMAN,Transmembrane channel-like protein 6 (Epidermodysplasia verruciformis protein 1) (Protein LAK-4),805,"90,045",5 out of 5,2005-12-06,Evidence at protein level
Q8IU68,TMC8_HUMAN,Transmembrane channel-like protein 8 (Epidermodysplasia verruciformis protein 2),726,"81,641",5 out of 5,2005-12-06,Evidence at protein level
O94876,TMCC1_HUMAN,Transmembrane and coiled-coil domains protein 1,653,"72,083",3 out of 5,2001-07-11,Evidence at protein level
Q96DC7,TMCO6_HUMAN,Transmembrane and coiled-coil domain-containing protein 6,493,"54,442",3 out of 5,2007-10-02,Evidence at protein level
Q9Y3Q3,TMED3_HUMAN,Transmembrane emp24 domain-containing protein 3 (Membrane protein p24B) (p24 family protein gamma-4) (p24gamma4) (p26),217,"24,777",5 out of 5,2002-11-28,Evidence at protein level
O14668,TMG1_HUMAN,Transmembrane gamma-carboxyglutamic acid protein 1 (Proline-rich gamma-carboxyglutamic acid protein 1) (Proline-rich Gla protein 1),218,"24,947",4 out of 5,2002-01-23,Evidence at protein level
Q96B42,TMM18_HUMAN,Transmembrane protein 18,140,"16,265",5 out of 5,2007-04-17,Evidence at protein level
Q69YG0,TMM42_HUMAN,Transmembrane protein 42,159,"16,991",1 out of 5,2007-04-17,Evidence at transcript level
Q96SF7,TBX15_HUMAN,T-box transcription factor TBX15 (T-box protein 15) (T-box transcription factor TBX14) (T-box protein 14),602,"65,757",4 out of 5,2003-05-16,Evidence at protein level
O60806,TBX19_HUMAN,"T-box transcription factor TBX19 (T-box protein 19) (T-box factor, pituitary)",448,"48,238",4 out of 5,2000-05-30,Evidence at protein level
Q9Y458,TBX22_HUMAN,T-box transcription factor TBX22 (T-box protein 22),520,"57,910",5 out of 5,2001-01-11,Evidence at protein level
Q8IZS6,TC1D3_HUMAN,Tctex1 domain-containing protein 3 (T-complex testis-specific protein 3) (T-complex-associated testis-expressed protein 3) (Tcte-3),198,"23,176",3 out of 5,2008-04-08,Evidence at protein level
Q9UHQ7,TCAL9_HUMAN,Transcription elongation factor A protein-like 9 (TCEA-like protein 9) (Transcription elongation factor S-II protein-like 9) (WW domain-binding protein 5) (WBP-5),104,"12,749",2 out of 5,2007-01-23,Inferred from homology
P01848,TCA_HUMAN,T-cell receptor alpha chain C region,142,"15,928",4 out of 5,1986-07-21,Evidence at protein level
Q9Y242,TCF19_HUMAN,Transcription factor 19 (TCF-19) (Transcription factor SC1),345,"37,184",4 out of 5,2004-02-16,Evidence at protein level
Q8WWU5,TCP11_HUMAN,T-complex protein 11 homolog,503,"56,141",5 out of 5,2008-03-18,Evidence at protein level
Q13569,TDG_HUMAN,G/T mismatch-specific thymine DNA glycosylase (EC 3.2.2.29) (Thymine-DNA glycosylase) (hTDG),410,"46,053",5 out of 5,1998-12-15,Evidence at protein level
Q9H147,TDIF1_HUMAN,Deoxynucleotidyltransferase terminal-interacting protein 1 (Terminal deoxynucleotidyltransferase-interacting factor 1) (TdIF1) (TdT-interacting factor 1),329,"37,013",5 out of 5,2002-12-06,Evidence at protein level
O60522,TDRD6_HUMAN,Tudor domain-containing protein 6 (Antigen NY-CO-45) (Cancer/testis antigen 41.2) (CT41.2),2096,"236,517",4 out of 5,2003-12-15,Evidence at transcript level
Q8N8B7,TEANC_HUMAN,Transcription elongation factor A N-terminal and central domain-containing protein (TFIIS central domain-containing protein 1),351,"40,245",5 out of 5,2006-10-31,Evidence at protein level
Q2MV58,TECT1_HUMAN,Tectonic-1,587,"63,570",5 out of 5,2006-04-04,Evidence at transcript level
Q9P273,TEN3_HUMAN,Teneurin-3 (Ten-3) (Protein Odd Oz/ten-m homolog 3) (Tenascin-M3) (Ten-m3) (Teneurin transmembrane protein 3),2699,"300,950",5 out of 5,2006-10-31,Evidence at transcript level
Q92752,TENR_HUMAN,Tenascin-R (TN-R) (Janusin) (Restrictin),1358,"149,562",5 out of 5,2005-03-15,Evidence at protein level
Q8NHR7,TERB2_HUMAN,Telomere repeats-binding bouquet formation protein 2,220,"25,316",3 out of 5,2006-12-12,Evidence at transcript level
Q9Y6M0,TEST_HUMAN,Testisin (EC 3.4.21.-) (Eosinophil serine protease 1) (ESP-1) (Serine protease 21),314,"34,884",5 out of 5,2001-04-27,Evidence at protein level
Q8NFU7,TET1_HUMAN,Methylcytosine dioxygenase TET1 (EC 1.14.11.n2) (CXXC-type zinc finger protein 6) (Leukemia-associated protein with a CXXC domain) (Ten-eleven translocation 1 gene protein),2136,"235,309",5 out of 5,2006-10-03,Evidence at protein level
O43151,TET3_HUMAN,Methylcytosine dioxygenase TET3 (EC 1.14.11.n2),1660,"179,350",5 out of 5,2001-02-21,Evidence at protein level
Q9NXF1,TEX10_HUMAN,Testis-expressed protein 10,929,"105,674",5 out of 5,2005-07-19,Evidence at protein level
Q8NA77,TEX19_HUMAN,Testis-expressed protein 19,164,"18,469",2 out of 5,2008-03-18,Evidence at transcript level
Q9BXT5,TEX15_HUMAN,Testis-expressed protein 15 (Cancer/testis antigen 42) (CT42),2789,"315,336",4 out of 5,2006-06-27,Evidence at transcript level
Q5T0J7,TEX35_HUMAN,Testis-expressed protein 35,233,"26,518",3 out of 5,2006-10-03,Evidence at transcript level
P0C1Z6,TFPT_HUMAN,TCF3 fusion partner (INO80 complex subunit F) (Protein FB1),253,"28,278",5 out of 5,2006-10-31,Evidence at protein level
Q15583,TGIF1_HUMAN,Homeobox protein TGIF1 (5'-TG-3'-interacting factor 1),401,"43,013",5 out of 5,1997-11-01,Evidence at protein level
O43493,TGON2_HUMAN,Trans-Golgi network integral membrane protein 2 (TGN38 homolog) (TGN46) (TGN48) (Trans-Golgi network protein TGN51),480,"51,113",5 out of 5,2000-12-01,Evidence at protein level
Q96EK4,THA11_HUMAN,THAP domain-containing protein 11,314,"34,455",5 out of 5,2003-04-11,Evidence at protein level
Q9BT49,THAP7_HUMAN,THAP domain-containing protein 7,309,"34,414",5 out of 5,2003-04-11,Evidence at protein level
Q9NWX6,THG1_HUMAN,Probable tRNA(His) guanylyltransferase (EC 2.7.7.79) (Interphase cytoplasmic foci protein 45) (tRNA-histidine guanylyltransferase),298,"34,831",5 out of 5,2007-05-01,Evidence at protein level
Q08629,TICN1_HUMAN,Testican-1 (Protein SPOCK),439,"49,124",5 out of 5,2002-10-19,Evidence at protein level
Q02763,TIE2_HUMAN,Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK) (CD antigen CD202b),1124,"125,830",5 out of 5,1994-02-01,Evidence at protein level
P49788,TIG1_HUMAN,Retinoic acid receptor responder protein 1 (Phorbol ester-induced gene 1 protein) (PERG-1) (RAR-responsive protein TIG1) (Tazarotene-induced gene 1 protein),294,"33,285",4 out of 5,1996-10-01,Evidence at protein level
Q9NQ88,TIGAR_HUMAN,"Fructose-2,6-bisphosphatase TIGAR (EC 3.1.3.46) (TP53-induced glycolysis and apoptosis regulator) (TP53-induced glycolysis regulatory phosphatase)",270,"30,063",5 out of 5,2005-12-06,Evidence at protein level
Q86X45,TILB_HUMAN,Protein tilB homolog (Leucine-rich repeat-containing protein 6) (Leucine-rich testis-specific protein) (Testis-specific leucine-rich repeat protein),466,"54,255",5 out of 5,2005-10-11,Evidence at protein level
Q9BSI4,TINF2_HUMAN,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),451,"50,023",5 out of 5,2002-06-20,Evidence at protein level
Q9Y6L7,TLL2_HUMAN,Tolloid-like protein 2 (EC 3.4.24.-),1015,"113,557",5 out of 5,2006-02-07,Evidence at protein level
Q15399,TLR1_HUMAN,Toll-like receptor 1 (Toll/interleukin-1 receptor-like protein) (TIL) (CD antigen CD281),786,"90,291",5 out of 5,2002-01-31,Evidence at protein level
O15455,TLR3_HUMAN,Toll-like receptor 3 (CD antigen CD283),904,"103,829",5 out of 5,2002-01-31,Evidence at protein level
O00206,TLR4_HUMAN,Toll-like receptor 4 (hToll) (CD antigen CD284),839,"95,680",5 out of 5,2002-02-11,Evidence at protein level
Q6PF06,TM10B_HUMAN,tRNA methyltransferase 10 homolog B (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 3),316,"36,124",3 out of 5,2007-11-13,Evidence at transcript level
Q86UB9,TM135_HUMAN,Transmembrane protein 135 (Peroxisomal membrane protein 52) (PMP52),458,"52,291",4 out of 5,2007-04-17,Evidence at transcript level
Q8NBT3,TM145_HUMAN,Transmembrane protein 145,493,"55,534",2 out of 5,2007-03-20,Evidence at transcript level
Q6UXP3,TM14E_HUMAN,Transmembrane protein 14EP,125,"13,608",2 out of 5,2008-09-02,Uncertain
Q8WUU8,TM174_HUMAN,Transmembrane protein 174,243,"26,287",2 out of 5,2007-04-03,Evidence at protein level
Q53S58,TM177_HUMAN,Transmembrane protein 177,311,"33,760",2 out of 5,2007-04-03,Evidence at transcript level
Q14656,TM187_HUMAN,Transmembrane protein 187 (Protein ITBA1),261,"29,148",3 out of 5,1997-11-01,Evidence at transcript level
Q8IY95,TM192_HUMAN,Transmembrane protein 192,271,"30,922",5 out of 5,2007-11-13,Evidence at protein level
Q8N511,TM199_HUMAN,Transmembrane protein 199,208,"23,130",4 out of 5,2004-08-31,Evidence at protein level
O75674,TM1L1_HUMAN,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),476,"52,989",5 out of 5,2002-11-15,Evidence at protein level
C9JQI7,TM232_HUMAN,Transmembrane protein 232,657,"76,453",2 out of 5,2010-06-15,Evidence at transcript level
Q5W0B7,TM236_HUMAN,Transmembrane protein 236,351,"39,663",2 out of 5,2005-08-16,Evidence at transcript level
Q24JQ0,TM241_HUMAN,Transmembrane protein 241,296,"32,647",3 out of 5,2007-10-23,Evidence at transcript level
Q9BU79,TM243_HUMAN,Transmembrane protein 243 (MDR1- and mitochondrial taxol resistance-associated protein) (MM-TRAG),118,"13,391",2 out of 5,2003-11-07,Evidence at protein level
Q8N6L7,TM252_HUMAN,Transmembrane protein 252,170,"18,703",2 out of 5,2005-07-05,Evidence at transcript level
O96002,TM257_HUMAN,Transmembrane protein 257,111,"13,452",2 out of 5,2000-05-30,Evidence at transcript level
E9PQX1,TM262_HUMAN,Transmembrane protein 262,116,"13,758",1 out of 5,2014-01-22,Predicted
Q7Z6W1,TMCO2_HUMAN,Transmembrane and coiled-coil domain-containing protein 2,182,"20,071",2 out of 5,2006-09-19,Evidence at transcript level
Q5TGY1,TMCO4_HUMAN,Transmembrane and coiled-coil domain-containing protein 4,634,"67,910",2 out of 5,2007-10-02,Evidence at transcript level
Q8NEW7,TMIE_HUMAN,Transmembrane inner ear expressed protein,156,"17,241",3 out of 5,2005-03-29,Evidence at protein level
Q9NVH6,TMLH_HUMAN,"Trimethyllysine dioxygenase, mitochondrial (EC 1.14.11.8) (Epsilon-trimethyllysine 2-oxoglutarate dioxygenase) (Epsilon-trimethyllysine hydroxylase) (TML hydroxylase) (TML-alpha-ketoglutarate dioxygenase) (TML dioxygenase) (TMLD)",421,"49,518",5 out of 5,2002-06-20,Evidence at protein level
Q9H2L4,TMM60_HUMAN,Transmembrane protein 60,133,"15,500",2 out of 5,2004-05-24,Evidence at transcript level
Q8IUC6,TCAM1_HUMAN,"TIR domain-containing adapter molecule 1 (TICAM-1) (Proline-rich, vinculin and TIR domain-containing protein B) (Putative NF-kappa-B-activating protein 502H) (Toll-interleukin-1 receptor domain-containing adapter protein inducing interferon beta) (MyD88-3) (TIR domain-containing adapter protein inducing IFN-beta)",712,"76,422",5 out of 5,2008-02-05,Evidence at protein level
Q15560,TCEA2_HUMAN,Transcription elongation factor A protein 2 (Testis-specific S-II) (Transcription elongation factor S-II protein 2) (Transcription elongation factor TFIIS.l),299,"33,601",5 out of 5,2003-02-12,Evidence at protein level
P20062,TCO2_HUMAN,Transcobalamin-2 (TC-2) (Transcobalamin II) (TC II) (TCII),427,"47,535",5 out of 5,1991-02-01,Evidence at protein level
P78371,TCPB_HUMAN,T-complex protein 1 subunit beta (TCP-1-beta) (CCT-beta),535,"57,488",5 out of 5,1998-07-15,Evidence at protein level
P48643,TCPE_HUMAN,T-complex protein 1 subunit epsilon (TCP-1-epsilon) (CCT-epsilon),541,"59,671",5 out of 5,1996-02-01,Evidence at protein level
Q99832,TCPH_HUMAN,"T-complex protein 1 subunit eta (TCP-1-eta) (CCT-eta) (HIV-1 Nef-interacting protein) [Cleaved into: T-complex protein 1 subunit eta, N-terminally processed]",543,"59,367",5 out of 5,1997-11-01,Evidence at protein level
A6NM43,TCPQL_HUMAN,Putative T-complex protein 1 subunit theta-like 1,557,"59,514",3 out of 5,2008-09-02,Uncertain
Q92526,TCPW_HUMAN,T-complex protein 1 subunit zeta-2 (TCP-1-zeta-2) (CCT-zeta-2) (CCT-zeta-like) (TCP-1-zeta-like) (Testis-specific Tcp20) (Testis-specific protein TSA303),530,"57,821",5 out of 5,1997-11-01,Evidence at protein level
P40227,TCPZ_HUMAN,T-complex protein 1 subunit zeta (TCP-1-zeta) (Acute morphine dependence-related protein 2) (CCT-zeta-1) (HTR3) (Tcp20),531,"58,024",5 out of 5,1995-02-01,Evidence at protein level
O14776,TCRG1_HUMAN,Transcription elongation regulator 1 (TATA box-binding protein-associated factor 2S) (Transcription factor CA150),1098,"123,901",5 out of 5,2004-09-27,Evidence at protein level
P57738,TCTA_HUMAN,T-cell leukemia translocation-altered gene protein (T-cell leukemia translocation-associated gene protein),103,"11,341",3 out of 5,2001-01-11,Evidence at protein level
Q9HAU6,TCTP8_HUMAN,Putative translationally-controlled tumor protein-like protein TPT1P8 (Putative apoptosis inhibitor FKSG2),139,"15,994",2 out of 5,2002-01-23,Uncertain
Q96MN5,TEAN2_HUMAN,Transcription elongation factor A N-terminal and central domain-containing protein 2,208,"24,150",3 out of 5,2007-05-15,Evidence at protein level
Q15185,TEBP_HUMAN,Prostaglandin E synthase 3 (EC 5.3.99.3) (Cytosolic prostaglandin E2 synthase) (cPGES) (Hsp90 co-chaperone) (Progesterone receptor complex p23) (Telomerase-binding protein p23),160,"18,697",5 out of 5,2000-12-01,Evidence at protein level
Q5HYJ1,TECRL_HUMAN,"Trans-2,3-enoyl-CoA reductase-like (EC 1.3.1.-) (Steroid 5-alpha-reductase 2-like 2 protein)",363,"42,009",3 out of 5,2008-02-05,Evidence at transcript level
O75443,TECTA_HUMAN,Alpha-tectorin,2155,"239,527",5 out of 5,2004-06-07,Evidence at protein level
Q8WW24,TEKT4_HUMAN,Tektin-4,435,"50,649",5 out of 5,2006-11-28,Evidence at protein level
O15273,TELT_HUMAN,Telethonin (Titin cap protein),167,"19,052",5 out of 5,1998-07-15,Evidence at protein level
Q6URK8,TEPP_HUMAN,"Testis, prostate and placenta-expressed protein",271,"30,717",2 out of 5,2008-03-18,Evidence at transcript level
A2RU30,TESP1_HUMAN,Protein TESPA1 (Thymocyte-expressed positive selection-associated protein 1),521,"59,213",5 out of 5,2008-01-15,Evidence at protein level
Q9BXU0,TEX12_HUMAN,Testis-expressed protein 12,123,"14,107",2 out of 5,2001-10-24,Evidence at transcript level
P52655,TF2AA_HUMAN,Transcription initiation factor IIA subunit 1 (General transcription factor IIA subunit 1) (TFIIAL) (Transcription initiation factor TFIIA 42 kDa subunit) (TFIIA-42) [Cleaved into: Transcription initiation factor IIA alpha chain (TFIIA p35 subunit); Transcription initiation factor IIA beta chain (TFIIA p19 subunit)],376,"41,514",5 out of 5,1996-10-01,Evidence at protein level
Q13888,TF2H2_HUMAN,General transcription factor IIH subunit 2 (Basic transcription factor 2 44 kDa subunit) (BTF2 p44) (General transcription factor IIH polypeptide 2) (TFIIH basal transcription factor complex p44 subunit),395,"44,419",5 out of 5,2001-10-18,Evidence at protein level
Q00059,TFAM_HUMAN,"Transcription factor A, mitochondrial (mtTFA) (Mitochondrial transcription factor 1) (MtTF1) (Transcription factor 6) (TCF-6) (Transcription factor 6-like 2)",246,"29,097",5 out of 5,1993-10-01,Evidence at protein level
Q9H5Q4,TFB2M_HUMAN,"Dimethyladenosine transferase 2, mitochondrial (EC 2.1.1.-) (Hepatitis C virus NS5A-transactivated protein 5) (HCV NS5A-transactivated protein 5) (Mitochondrial 12S rRNA dimethylase 2) (Mitochondrial transcription factor B2) (h-mtTFB) (h-mtTFB2) (hTFB2M) (mtTFB2) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 2)",396,"45,349",5 out of 5,2007-01-23,Evidence at protein level
O95379,TFIP8_HUMAN,Tumor necrosis factor alpha-induced protein 8 (TNF alpha-induced protein 8) (Head and neck tumor and metastasis-related protein) (MDC-3.13) (NF-kappa-B-inducible DED-containing protein) (NDED) (SCC-S2) (TNF-induced protein GG2-1),198,"23,003",5 out of 5,2007-05-01,Evidence at protein level
Q9UP52,TFR2_HUMAN,Transferrin receptor protein 2 (TfR2),801,"88,755",5 out of 5,2002-02-11,Evidence at protein level
P13726,TF_HUMAN,Tissue factor (TF) (Coagulation factor III) (Thromboplastin) (CD antigen CD142),295,"33,068",5 out of 5,1990-01-01,Evidence at protein level
Q9H0W7,THAP2_HUMAN,THAP domain-containing protein 2,228,"26,260",2 out of 5,2003-04-11,Evidence at protein level
Q9P2T0,THEG_HUMAN,Testicular haploid expressed gene protein (Cancer/testis antigen 56) (CT56),379,"43,444",4 out of 5,2007-10-02,Evidence at protein level
Q5T1C6,THEM4_HUMAN,Acyl-coenzyme A thioesterase THEM4 (Acyl-CoA thioesterase THEM4) (EC 3.1.2.2) (Carboxyl-terminal modulator protein) (Thioesterase superfamily member 4),240,"27,130",5 out of 5,2008-01-15,Evidence at protein level
Q96FV9,THOC1_HUMAN,THO complex subunit 1 (Tho1) (Nuclear matrix protein p84) (p84N5) (hTREX84),657,"75,666",5 out of 5,2003-10-10,Evidence at protein level
Q86W42,THOC6_HUMAN,THO complex subunit 6 homolog (Functional spliceosome-associated protein 35) (fSAP35) (WD repeat-containing protein 58),341,"37,535",5 out of 5,2006-05-02,Evidence at protein level
P52888,THOP1_HUMAN,Thimet oligopeptidase (EC 3.4.24.15) (Endopeptidase 24.15) (MP78),689,"78,840",5 out of 5,1996-10-01,Evidence at protein level
Q6ZMP0,THSD4_HUMAN,Thrombospondin type-1 domain-containing protein 4 (A disintegrin and metalloproteinase with thrombospondin motifs-like protein 6) (ADAMTS-like protein 6) (ADAMTSL-6),1018,"112,450",4 out of 5,2008-01-15,Evidence at transcript level
Q9BV44,THUM3_HUMAN,THUMP domain-containing protein 3,507,"57,003",2 out of 5,2006-11-28,Evidence at protein level
Q99595,TI17A_HUMAN,Mitochondrial import inner membrane translocase subunit Tim17-A (Inner membrane preprotein translocase Tim17a),171,"18,024",5 out of 5,1998-07-15,Evidence at protein level
Q96MW7,TIGD1_HUMAN,Tigger transposable element-derived protein 1,591,"67,299",2 out of 5,2007-01-23,Evidence at protein level
Q6NT04,TIGD7_HUMAN,Tigger transposable element-derived protein 7,549,"63,236",2 out of 5,2007-01-23,Evidence at protein level
Q96DA6,TIM14_HUMAN,Mitochondrial import inner membrane translocase subunit TIM14 (DnaJ homolog subfamily C member 19),116,"12,499",5 out of 5,2005-12-06,Evidence at protein level
P01033,TIMP1_HUMAN,Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1),207,"23,171",5 out of 5,1986-07-21,Evidence at protein level
P35625,TIMP3_HUMAN,Metalloproteinase inhibitor 3 (Protein MIG-5) (Tissue inhibitor of metalloproteinases 3) (TIMP-3),211,"24,145",5 out of 5,1994-06-01,Evidence at protein level
Q04726,TLE3_HUMAN,Transducin-like enhancer protein 3 (Enhancer of split groucho-like protein 3) (ESG3),772,"83,417",5 out of 5,1994-02-01,Evidence at protein level
O43711,TLX3_HUMAN,T-cell leukemia homeobox protein 3 (Homeobox protein Hox-11L2),291,"31,867",3 out of 5,1999-07-15,Evidence at protein level
Q9NV29,TM100_HUMAN,Transmembrane protein 100,134,"14,386",5 out of 5,2006-06-27,Evidence at protein level
Q8NE00,TM104_HUMAN,Transmembrane protein 104,496,"55,679",3 out of 5,2006-10-31,Evidence at protein level
Q6ZMR5,TM11A_HUMAN,Transmembrane protease serine 11A (EC 3.4.21.-) (Airway trypsin-like protease 1) (Epidermal type-II transmembrane serine protease) (Esophageal cancer-susceptibility gene 1 protein),421,"47,569",5 out of 5,2007-09-11,Evidence at protein level
Q8WVE6,TM171_HUMAN,Transmembrane protein 171,324,"34,760",2 out of 5,2006-09-19,Evidence at protein level
Q16762,THTR_HUMAN,Thiosulfate sulfurtransferase (EC 2.8.1.1) (Rhodanese),297,"33,429",5 out of 5,1998-07-15,Evidence at protein level
Q9NXG2,THUM1_HUMAN,THUMP domain-containing protein 1,353,"39,315",4 out of 5,2004-07-05,Evidence at protein level
P04216,THY1_HUMAN,Thy-1 membrane glycoprotein (CDw90) (Thy-1 antigen) (CD antigen CD90),161,"17,935",5 out of 5,1987-03-20,Evidence at protein level
Q9Y584,TIM22_HUMAN,Mitochondrial import inner membrane translocase subunit Tim22 (Testis-expressed protein 4),194,"20,031",4 out of 5,2001-01-11,Evidence at protein level
P58753,TIRAP_HUMAN,Toll/interleukin-1 receptor domain-containing adapter protein (TIR domain-containing adapter protein) (Adaptor protein Wyatt) (MyD88 adapter-like protein) (MyD88-2),221,"23,883",5 out of 5,2002-03-27,Evidence at protein level
Q68D42,TM215_HUMAN,Transmembrane protein 215,235,"25,806",1 out of 5,2008-02-26,Evidence at transcript level
Q9H0R3,TM222_HUMAN,Transmembrane protein 222,208,"23,230",2 out of 5,2006-08-22,Evidence at protein level
Q96A57,TM230_HUMAN,Transmembrane protein 230,120,"13,188",5 out of 5,2006-05-02,Evidence at protein level
Q9BX74,TM2D1_HUMAN,TM2 domain-containing protein 1 (Beta-amyloid-binding protein) (hBBP),207,"22,327",4 out of 5,2007-08-21,Evidence at protein level
Q9BZW4,TM6S2_HUMAN,Transmembrane 6 superfamily member 2,377,"42,554",4 out of 5,2002-03-27,Evidence at protein level
Q9NS93,TM7S3_HUMAN,Transmembrane 7 superfamily member 3 (Seven span transmembrane protein),570,"64,166",3 out of 5,2002-06-20,Evidence at transcript level
Q7Z404,TMC4_HUMAN,Transmembrane channel-like protein 4,712,"79,208",3 out of 5,2007-05-29,Evidence at transcript level
Q9ULS5,TMCC3_HUMAN,Transmembrane and coiled-coil domains protein 3,477,"53,785",2 out of 5,2001-07-11,Evidence at transcript level
Q6UWJ1,TMCO3_HUMAN,Transmembrane and coiled-coil domain-containing protein 3 (Putative LAG1-interacting protein),677,"75,598",4 out of 5,2006-10-03,Evidence at protein level
Q9UHN6,TMEM2_HUMAN,Transmembrane protein 2,1383,"154,374",5 out of 5,2007-06-12,Evidence at protein level
P82094,TMF1_HUMAN,TATA element modulatory factor (TMF) (Androgen receptor coactivator 160 kDa protein) (Androgen receptor-associated protein of 160 kDa),1093,"122,842",5 out of 5,2000-05-30,Evidence at protein level
Q8TAF8,TMHS_HUMAN,Tetraspan membrane protein of hair cell stereocilia (Lipoma HMGIC fusion partner-like 5 protein),219,"24,201",4 out of 5,2007-05-01,Evidence at protein level
Q96BF3,TMIG2_HUMAN,Transmembrane and immunoglobulin domain-containing protein 2 (CD28 homolog) (Immunoglobulin and proline-rich receptor 1) (IGPR-1),282,"30,675",5 out of 5,2007-02-06,Evidence at protein level
Q9HBJ8,TMM27_HUMAN,Collectrin (Transmembrane protein 27),222,"25,235",5 out of 5,2006-07-11,Evidence at protein level
Q96N35,TMM83_HUMAN,Putative uncharacterized protein encoded by LINC00052 (Putative transmembrane protein 83),136,"15,076",2 out of 5,2006-04-18,Uncertain
A2RUT3,TMM89_HUMAN,Transmembrane protein 89,159,"17,572",2 out of 5,2007-06-12,Evidence at transcript level
Q9HCN3,TMM8A_HUMAN,Transmembrane protein 8A (Protein M83) (Transmembrane protein 6) (Transmembrane protein 8),771,"84,761",5 out of 5,2002-10-10,Evidence at protein level
Q8N816,TMM99_HUMAN,Transmembrane protein 99,258,"27,975",2 out of 5,2006-10-31,Evidence at transcript level
P28289,TMOD1_HUMAN,Tropomodulin-1 (Erythrocyte tropomodulin) (E-Tmod),359,"40,569",5 out of 5,1992-12-01,Evidence at protein level
O15393,TMPS2_HUMAN,Transmembrane protease serine 2 (EC 3.4.21.-) (Serine protease 10) [Cleaved into: Transmembrane protease serine 2 non-catalytic chain; Transmembrane protease serine 2 catalytic chain],492,"53,859",5 out of 5,1998-07-15,Evidence at protein level
Q9BYE2,TMPSD_HUMAN,Transmembrane protease serine 13 (EC 3.4.21.-) (Membrane-type mosaic serine protease) (Mosaic serine protease),586,"63,153",5 out of 5,2005-03-15,Evidence at transcript level
Q9BVT8,TMUB1_HUMAN,Transmembrane and ubiquitin-like domain-containing protein 1 (Dendritic cell-derived ubiquitin-like protein) (DULP) (Hepatocyte odd protein shuttling protein) (Ubiquitin-like protein SB144) [Cleaved into: iHOPS],246,"26,261",5 out of 5,2003-09-19,Evidence at protein level
O43557,TNF14_HUMAN,"Tumor necrosis factor ligand superfamily member 14 (Herpes virus entry mediator ligand) (HVEM-L) (Herpesvirus entry mediator ligand) (CD antigen CD258) [Cleaved into: Tumor necrosis factor ligand superfamily member 14, membrane form; Tumor necrosis factor ligand superfamily member 14, soluble form]",240,"26,350",5 out of 5,2001-02-21,Evidence at protein level
P01374,TNFB_HUMAN,Lymphotoxin-alpha (LT-alpha) (TNF-beta) (Tumor necrosis factor ligand superfamily member 1),205,"22,297",5 out of 5,1986-07-21,Evidence at protein level
P19429,TNNI3_HUMAN,"Troponin I, cardiac muscle (Cardiac troponin I)",210,"24,008",5 out of 5,1991-02-01,Evidence at protein level
P13805,TNNT1_HUMAN,"Troponin T, slow skeletal muscle (TnTs) (Slow skeletal muscle troponin T) (sTnT)",278,"32,948",5 out of 5,1990-11-01,Evidence at protein level
Q02223,TNR17_HUMAN,Tumor necrosis factor receptor superfamily member 17 (B-cell maturation protein) (CD antigen CD269),184,"20,165",5 out of 5,1993-07-01,Evidence at protein level
P19438,TNR1A_HUMAN,"Tumor necrosis factor receptor superfamily member 1A (Tumor necrosis factor receptor 1) (TNF-R1) (Tumor necrosis factor receptor type I) (TNF-RI) (TNFR-I) (p55) (p60) (CD antigen CD120a) [Cleaved into: Tumor necrosis factor receptor superfamily member 1A, membrane form; Tumor necrosis factor-binding protein 1 (TBPI)]",455,"50,495",5 out of 5,1991-02-01,Evidence at protein level
P25445,TNR6_HUMAN,Tumor necrosis factor receptor superfamily member 6 (Apo-1 antigen) (Apoptosis-mediating surface antigen FAS) (FASLG receptor) (CD antigen CD95),335,"37,732",5 out of 5,1992-05-01,Evidence at protein level
P50616,TOB1_HUMAN,Protein Tob1 (Transducer of erbB-2 1),345,"38,155",5 out of 5,1996-10-01,Evidence at protein level
Q8N4H5,TOM5_HUMAN,Mitochondrial import receptor subunit TOM5 homolog,51,"6,035",4 out of 5,2006-04-04,Evidence at protein level
O14656,TOR1A_HUMAN,Torsin-1A (Dystonia 1 protein) (Torsin ATPase-1A) (EC 3.6.4.-) (Torsin family 1 member A),332,"37,809",5 out of 5,2001-04-27,Evidence at protein level
Q12974,TP4A2_HUMAN,Protein tyrosine phosphatase type IVA 2 (EC 3.1.3.48) (HU-PP-1) (OV-1) (PTP(CAAXII)) (Protein-tyrosine phosphatase 4a2) (Protein-tyrosine phosphatase of regenerating liver 2) (PRL-2),167,"19,127",5 out of 5,2005-07-05,Evidence at protein level
P0DKB5,TPBGL_HUMAN,Trophoblast glycoprotein-like,382,"40,400",2 out of 5,2012-10-03,Inferred from homology
Q8WVT3,TPC12_HUMAN,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15) (Trafficking of membranes and mitosis),735,"79,375",5 out of 5,2004-02-16,Evidence at protein level
Q5T215,TPC3L_HUMAN,Trafficking protein particle complex subunit 3-like protein (TRAPPC3-like protein) (BET3-like protein),181,"20,566",3 out of 5,2007-10-02,Evidence at protein level
P07951,TPM2_HUMAN,Tropomyosin beta chain (Beta-tropomyosin) (Tropomyosin-2),284,"32,851",5 out of 5,1988-08-01,Evidence at protein level
O43617,TPPC3_HUMAN,Trafficking protein particle complex subunit 3 (BET3 homolog),180,"20,274",5 out of 5,2002-04-16,Evidence at protein level
Q17RH7,TPRXL_HUMAN,Putative protein TPRXL,258,"24,139",1 out of 5,2008-01-15,Uncertain
Q5T6R2,TPT2L_HUMAN,"Putative phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2P1",138,"15,541",2 out of 5,2008-05-20,Uncertain
Q9ULW0,TPX2_HUMAN,Targeting protein for Xklp2 (Differentially expressed in cancerous and non-cancerous lung cells 2) (DIL-2) (Hepatocellular carcinoma-associated antigen 519) (Hepatocellular carcinoma-associated antigen 90) (Protein fls353) (Restricted expression proliferation-associated protein 100) (p100),747,"85,653",5 out of 5,2001-02-21,Evidence at protein level
P01850,TRBC1_HUMAN,T-cell receptor beta-1 chain C region,177,"19,899",5 out of 5,1986-07-21,Evidence at protein level
P07204,TRBM_HUMAN,Thrombomodulin (TM) (Fetomodulin) (CD antigen CD141),575,"60,329",5 out of 5,1988-04-01,Evidence at protein level
O43280,TREA_HUMAN,"Trehalase (EC 3.2.1.28) (Alpha,alpha-trehalase) (Alpha,alpha-trehalose glucohydrolase)",583,"66,568",5 out of 5,1998-07-15,Evidence at protein level
P02787,TRFE_HUMAN,Serotransferrin (Transferrin) (Beta-1 metal-binding globulin) (Siderophilin),698,"77,064",5 out of 5,1986-07-21,Evidence at protein level
P02788,TRFL_HUMAN,Lactotransferrin (Lactoferrin) (EC 3.4.21.-) (Growth-inhibiting protein 12) (Talalactoferrin) [Cleaved into: Lactoferricin-H (Lfcin-H); Kaliocin-1; Lactoferroxin-A; Lactoferroxin-B; Lactoferroxin-C],710,"78,182",5 out of 5,1986-07-21,Evidence at protein level
Q96F44,TRI11_HUMAN,E3 ubiquitin-protein ligase TRIM11 (EC 2.3.2.27) (Protein BIA1) (RING finger protein 92) (RING-type E3 ubiquitin transferase TRIM11) (Tripartite motif-containing protein 11),468,"52,774",5 out of 5,2002-12-06,Evidence at protein level
Q96A61,TRI52_HUMAN,Tripartite motif-containing protein 52 (RING finger protein 102),297,"34,653",3 out of 5,2004-05-24,Evidence at protein level
Q9P2Z0,THA10_HUMAN,THAP domain-containing protein 10,257,"28,351",2 out of 5,2004-01-16,Evidence at protein level
Q8WTV1,THAP3_HUMAN,THAP domain-containing protein 3,239,"27,059",4 out of 5,2003-04-11,Evidence at protein level
P0DJG4,THEGL_HUMAN,Testicular haploid expressed gene protein-like (Theg spermatid-like protein),465,"53,028",1 out of 5,2012-04-18,Evidence at transcript level
Q8WUY1,THEM6_HUMAN,Protein THEM6 (Mesenchymal stem cell protein DSCD75) (Thioesterase superfamily member 6),208,"23,865",2 out of 5,2007-05-01,Evidence at protein level
P42765,THIM_HUMAN,"3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase) (T1)",397,"41,924",5 out of 5,1995-11-01,Evidence at protein level
Q99757,THIOM_HUMAN,"Thioredoxin, mitochondrial (MTRX) (Mt-Trx) (Thioredoxin-2)",166,"18,383",5 out of 5,1998-12-15,Evidence at protein level
P10599,THIO_HUMAN,Thioredoxin (Trx) (ATL-derived factor) (ADF) (Surface-associated sulphydryl protein) (SASP),105,"11,737",5 out of 5,1989-07-01,Evidence at protein level
Q8N1K5,THMS1_HUMAN,Protein THEMIS (Thymocyte-expressed molecule involved in selection),641,"73,452",5 out of 5,2006-10-17,Evidence at protein level
Q8NI27,THOC2_HUMAN,THO complex subunit 2 (Tho2) (hTREX120),1593,"182,775",5 out of 5,2003-10-10,Evidence at protein level
Q92748,THRSP_HUMAN,Thyroid hormone-inducible hepatic protein (Spot 14 protein) (S14) (SPOT14),146,"16,561",4 out of 5,1997-11-01,Evidence at protein level
Q9UPZ6,THS7A_HUMAN,Thrombospondin type-1 domain-containing protein 7A,1657,"185,363",5 out of 5,2006-10-31,Evidence at protein level
Q9BTF0,THUM2_HUMAN,THUMP domain-containing protein 2,503,"56,433",2 out of 5,2004-07-05,Evidence at transcript level
Q96CG3,TIFA_HUMAN,TRAF-interacting protein with FHA domain-containing protein A (Putative MAPK-activating protein PM14) (Putative NF-kappa-B-activating protein 20) (TRAF2-binding protein),184,"21,445",5 out of 5,2008-02-26,Evidence at protein level
Q53EQ6,TIGD5_HUMAN,Tigger transposable element-derived protein 5,642,"69,222",3 out of 5,2007-01-23,Evidence at protein level
O60220,TIM8A_HUMAN,Mitochondrial import inner membrane translocase subunit Tim8 A (Deafness dystonia protein 1) (X-linked deafness dystonia protein),97,"10,998",5 out of 5,1999-07-15,Evidence at protein level
O75663,TIPRL_HUMAN,TIP41-like protein (Putative MAPK-activating protein PM10) (Type 2A-interacting protein) (TIP),272,"31,444",5 out of 5,2007-09-11,Evidence at protein level
Q9H0I9,TKTL2_HUMAN,Transketolase-like protein 2 (EC 2.2.1.1),626,"67,877",4 out of 5,2007-05-01,Evidence at transcript level
Q04724,TLE1_HUMAN,Transducin-like enhancer protein 1 (E(Sp1) homolog) (Enhancer of split groucho-like protein 1) (ESG1),770,"83,201",5 out of 5,1994-02-01,Evidence at protein level
Q04727,TLE4_HUMAN,Transducin-like enhancer protein 4 (Grg-4) (Groucho-related protein 4),773,"83,755",5 out of 5,1994-02-01,Evidence at protein level
Q86UE8,TLK2_HUMAN,Serine/threonine-protein kinase tousled-like 2 (EC 2.7.11.1) (HsHPK) (PKU-alpha) (Tousled-like kinase 2),772,"87,661",5 out of 5,2003-08-22,Evidence at protein level
Q9Y490,TLN1_HUMAN,Talin-1,2541,"269,767",5 out of 5,2000-12-01,Evidence at protein level
Q8N9M5,TM102_HUMAN,Transmembrane protein 102 (Common beta-chain associated protein) (CBAP),508,"54,175",5 out of 5,2006-12-12,Evidence at protein level
Q8N8V8,TM105_HUMAN,Transmembrane protein 105,129,"13,990",1 out of 5,2007-02-06,Evidence at transcript level
O60235,TM11D_HUMAN,Transmembrane protease serine 11D (EC 3.4.21.-) (Airway trypsin-like protease) [Cleaved into: Transmembrane protease serine 11D non-catalytic chain; Transmembrane protease serine 11D catalytic chain],418,"46,263",5 out of 5,2001-10-18,Evidence at protein level
Q6ZWK6,TM11F_HUMAN,Transmembrane protease serine 11F (EC 3.4.21.-) (Airway trypsin-like protease 4),438,"49,410",3 out of 5,2007-09-11,Evidence at transcript level
Q92545,TM131_HUMAN,Transmembrane protein 131 (Protein RW1),1883,"205,138",3 out of 5,2001-01-11,Evidence at protein level
Q9NV12,TM140_HUMAN,Transmembrane protein 140,185,"20,419",2 out of 5,2007-02-06,Evidence at protein level
Q9P0S9,TM14C_HUMAN,Transmembrane protein 14C,112,"11,565",3 out of 5,2003-01-10,Evidence at protein level
Q6ZP80,TM182_HUMAN,Transmembrane protein 182,229,"25,879",3 out of 5,2007-06-12,Evidence at protein level
A5PLL7,TM189_HUMAN,Transmembrane protein 189,270,"31,135",3 out of 5,2008-02-26,Evidence at protein level
Q9H813,TM206_HUMAN,Transmembrane protein 206,350,"40,043",3 out of 5,2007-03-06,Evidence at protein level
Q6ICI0,TM211_HUMAN,Transmembrane protein 211,200,"21,740",2 out of 5,2008-05-20,Evidence at transcript level
Q6NUQ4,TM214_HUMAN,Transmembrane protein 214,689,"77,151",5 out of 5,2008-02-26,Evidence at protein level
Q9P0N5,TM216_HUMAN,Transmembrane protein 216,145,"16,487",5 out of 5,2008-02-26,Evidence at protein level
Q6QAJ8,TM220_HUMAN,Transmembrane protein 220,160,"17,754",2 out of 5,2008-02-26,Evidence at transcript level
A6NFC5,TM235_HUMAN,Transmembrane protein 235,223,"23,360",3 out of 5,2008-07-22,Evidence at transcript level
Q8WW34,TM239_HUMAN,Transmembrane protein 239,195,"21,842",4 out of 5,2011-10-19,Evidence at protein level
Q9BRN9,TM2D3_HUMAN,TM2 domain-containing protein 3 (Beta-amyloid-binding protein-like protein 2) (BBP-like protein 2),247,"27,118",3 out of 5,2007-08-21,Evidence at transcript level
Q8WW62,TMED6_HUMAN,Transmembrane emp24 domain-containing protein 6 (p24 family protein gamma-5) (p24gamma5),240,"27,631",2 out of 5,2005-03-29,Evidence at transcript level
Q6PL24,TMED8_HUMAN,Protein TMED8,325,"35,740",2 out of 5,2005-03-29,Evidence at protein level
Q9Y2B1,TMEM5_HUMAN,Transmembrane protein 5,443,"51,146",4 out of 5,2004-07-19,Evidence at protein level
P17152,TMM11_HUMAN,"Transmembrane protein 11, mitochondrial (Protein PM1) (Protein PMI)",192,"21,541",5 out of 5,1990-08-01,Evidence at protein level
Q8NDY8,TMM52_HUMAN,Transmembrane protein 52,209,"22,122",2 out of 5,2007-04-17,Evidence at transcript level
Q9NZQ9,TMOD4_HUMAN,Tropomodulin-4 (Skeletal muscle tropomodulin) (Sk-Tmod),345,"39,335",4 out of 5,2002-09-19,Evidence at transcript level
Q86WS5,TMPSC_HUMAN,Transmembrane protease serine 12 (EC 3.4.21.-),348,"38,605",3 out of 5,2007-06-12,Evidence at protein level
Q96JJ7,TMX3_HUMAN,Protein disulfide-isomerase TMX3 (EC 5.3.4.1) (Thioredoxin domain-containing protein 10) (Thioredoxin-related transmembrane protein 3),454,"51,872",5 out of 5,2005-05-10,Evidence at protein level
P21580,TNAP3_HUMAN,Tumor necrosis factor alpha-induced protein 3 (TNF alpha-induced protein 3) (EC 3.4.19.12) (EC 6.3.2.-) (OTU domain-containing protein 7C) (Putative DNA-binding protein A20) (Zinc finger protein A20) [Cleaved into: A20p50; A20p37],790,"89,614",5 out of 5,1991-05-01,Evidence at protein level
O75888,TNF13_HUMAN,Tumor necrosis factor ligand superfamily member 13 (A proliferation-inducing ligand) (APRIL) (TNF- and APOL-related leukocyte expressed ligand 2) (TALL-2) (TNF-related death ligand 1) (TRDL-1) (CD antigen CD256),250,"27,433",5 out of 5,2001-02-21,Evidence at protein level
Q9UNG2,TNF18_HUMAN,Tumor necrosis factor ligand superfamily member 18 (Activation-inducible TNF-related ligand) (AITRL) (Glucocorticoid-induced TNF-related ligand) (hGITRL),199,"22,724",5 out of 5,2001-02-21,Evidence at protein level
O14787,TNPO2_HUMAN,Transportin-2 (Karyopherin beta-2b),897,"101,388",5 out of 5,2004-03-15,Evidence at protein level
Q9Y6Q6,TNR11_HUMAN,Tumor necrosis factor receptor superfamily member 11A (Osteoclast differentiation factor receptor) (ODFR) (Receptor activator of NF-KB) (CD antigen CD265),616,"66,034",5 out of 5,2001-09-26,Evidence at protein level
P25942,TNR5_HUMAN,Tumor necrosis factor receptor superfamily member 5 (B-cell surface antigen CD40) (Bp50) (CD40L receptor) (CDw40) (CD antigen CD40),277,"30,619",5 out of 5,1992-05-01,Evidence at protein level
Q07011,TNR9_HUMAN,Tumor necrosis factor receptor superfamily member 9 (4-1BB ligand receptor) (CDw137) (T-cell antigen 4-1BB homolog) (T-cell antigen ILA) (CD antigen CD137),255,"27,899",5 out of 5,1995-02-01,Evidence at protein level
Q7Z2V1,TNT_HUMAN,Protein TNT,217,"23,111",1 out of 5,2004-03-15,Evidence at transcript level
Q14106,TOB2_HUMAN,Protein Tob2 (Protein Tob4) (Transducer of erbB-2 2),344,"36,632",5 out of 5,1997-11-01,Evidence at protein level
Q15388,TOM20_HUMAN,Mitochondrial import receptor subunit TOM20 homolog (Mitochondrial 20 kDa outer membrane protein) (Outer mitochondrial membrane receptor Tom20),145,"16,298",5 out of 5,1997-11-01,Evidence at protein level
Q8IY51,TIGD4_HUMAN,Tigger transposable element-derived protein 4,512,"57,468",2 out of 5,2007-01-23,Evidence at transcript level
P62072,TIM10_HUMAN,Mitochondrial import inner membrane translocase subunit Tim10,90,"10,333",5 out of 5,2004-06-21,Evidence at protein level
Q9Y5L4,TIM13_HUMAN,Mitochondrial import inner membrane translocase subunit Tim13,95,"10,500",5 out of 5,2001-01-11,Evidence at protein level
Q9UJW2,TINAG_HUMAN,Tubulointerstitial nephritis antigen (TIN-Ag),476,"54,605",5 out of 5,2003-08-15,Evidence at transcript level
Q9BVW5,TIPIN_HUMAN,TIMELESS-interacting protein,301,"34,555",5 out of 5,2007-10-02,Evidence at protein level
P47974,TISD_HUMAN,"mRNA decay activator protein ZFP36L2 (Butyrate response factor 2) (EGF-response factor 2) (ERF-2) (TPA-induced sequence 11d) (Zinc finger protein 36, C3H1 type-like 2) (ZFP36-like 2)",494,"51,063",5 out of 5,1996-10-01,Evidence at protein level
Q5JTD0,TJAP1_HUMAN,Tight junction-associated protein 1 (Protein incorporated later into tight junctions) (Tight junction protein 4),557,"61,821",4 out of 5,2005-10-25,Evidence at protein level
Q9UHF0,TKNK_HUMAN,Tachykinin-3 (ZNEUROK1) [Cleaved into: Neurokinin-B (NKB) (Neuromedin-K)],121,"13,438",5 out of 5,2001-09-26,Evidence at protein level
O60602,TLR5_HUMAN,Toll-like receptor 5 (Toll/interleukin-1 receptor-like protein 3),858,"97,834",5 out of 5,2002-01-31,Evidence at protein level
Q9NYK1,TLR7_HUMAN,Toll-like receptor 7,1049,"120,922",5 out of 5,2002-01-31,Evidence at transcript level
Q9NR96,TLR9_HUMAN,Toll-like receptor 9 (CD antigen CD289),1032,"115,860",5 out of 5,2002-01-31,Evidence at protein level
Q12893,TM115_HUMAN,Transmembrane protein 115 (Placental protein 6) (Protein PL6),351,"38,197",5 out of 5,2002-11-01,Evidence at protein level
Q9BTD3,TM121_HUMAN,Transmembrane protein 121,319,"35,814",2 out of 5,2006-10-03,Evidence at transcript level
Q9H2Q1,TM133_HUMAN,Transmembrane protein 133,129,"14,539",1 out of 5,2007-01-09,Evidence at transcript level
Q8IV31,TM139_HUMAN,Transmembrane protein 139,216,"23,729",3 out of 5,2007-05-01,Evidence at protein level
Q9Y6G1,TM14A_HUMAN,Transmembrane protein 14A,99,"10,712",2 out of 5,2000-12-01,Evidence at protein level
A8MWL7,TM14D_HUMAN,Transmembrane protein 14DP,114,"12,177",2 out of 5,2008-07-22,Uncertain
Q96B96,TM159_HUMAN,Promethin (Transmembrane protein 159),161,"17,522",3 out of 5,2007-03-06,Evidence at protein level
Q9BSA9,TM175_HUMAN,Endosomal/lysomomal potassium channel TMEM175 (Transmembrane protein 175) (hTMEM175),504,"55,615",5 out of 5,2007-04-03,Evidence at protein level
Q5SNT2,TM201_HUMAN,Transmembrane protein 201 (Spindle-associated membrane protein 1),666,"72,236",5 out of 5,2008-02-05,Evidence at protein level
A2RU14,TM218_HUMAN,Transmembrane protein 218,115,"12,459",2 out of 5,2008-02-26,Evidence at protein level
A0PJW6,TM223_HUMAN,Transmembrane protein 223,202,"22,049",2 out of 5,2008-02-26,Evidence at protein level
Q8WY98,TM234_HUMAN,Transmembrane protein 234,164,"17,601",3 out of 5,2007-09-11,Evidence at protein level
C9JI98,TM238_HUMAN,Transmembrane protein 238,176,"18,040",2 out of 5,2011-10-19,Evidence at protein level
Q2WGJ8,TM249_HUMAN,Transmembrane protein 249,235,"27,046",2 out of 5,2008-04-29,Evidence at transcript level
Q8TBM7,TM254_HUMAN,Transmembrane protein 254,123,"14,243",2 out of 5,2005-07-19,Evidence at protein level
Q96GE9,TM261_HUMAN,Transmembrane protein 261,116,"12,257",2 out of 5,2005-07-05,Predicted
Q53FP2,TM35A_HUMAN,Transmembrane protein 35A,167,"18,440",2 out of 5,2007-01-09,Evidence at transcript level
Q9H6F2,TM38A_HUMAN,Trimeric intracellular cation channel type A (TRIC-A) (TRICA) (Transmembrane protein 38A),299,"33,260",3 out of 5,2007-01-09,Evidence at protein level
Q5BJD5,TM41B_HUMAN,Transmembrane protein 41B,291,"32,513",3 out of 5,2007-06-26,Evidence at protein level
A0PJX8,TMM82_HUMAN,Transmembrane protein 82,343,"37,222",2 out of 5,2007-11-13,Evidence at transcript level
Q6ZNR0,TMM91_HUMAN,Transmembrane protein 91 (Dispanin subfamily C member 3) (DSPC3),172,"18,162",3 out of 5,2004-11-23,Evidence at transcript level
Q8N394,TMTC2_HUMAN,Transmembrane and TPR repeat-containing protein 2,836,"94,130",3 out of 5,2007-03-20,Evidence at transcript level
Q03169,TNAP2_HUMAN,Tumor necrosis factor alpha-induced protein 2 (TNF alpha-induced protein 2) (Primary response gene B94 protein),654,"72,661",4 out of 5,1993-10-01,Evidence at transcript level
O15417,TNC18_HUMAN,Trinucleotide repeat-containing gene 18 protein (Long CAG trinucleotide repeat-containing gene 79 protein),2968,"314,519",4 out of 5,2007-08-21,Evidence at protein level
O95150,TNF15_HUMAN,"Tumor necrosis factor ligand superfamily member 15 (TNF ligand-related molecule 1) (Vascular endothelial cell growth inhibitor) [Cleaved into: Tumor necrosis factor ligand superfamily member 15, membrane form; Tumor necrosis factor ligand superfamily member 15, secreted form]",251,"28,087",5 out of 5,2002-06-06,Evidence at protein level
O95407,TNF6B_HUMAN,Tumor necrosis factor receptor superfamily member 6B (Decoy receptor 3) (DcR3) (Decoy receptor for Fas ligand) (M68),300,"32,680",5 out of 5,2002-05-27,Evidence at protein level
P08138,TNR16_HUMAN,Tumor necrosis factor receptor superfamily member 16 (Gp80-LNGFR) (Low affinity neurotrophin receptor p75NTR) (Low-affinity nerve growth factor receptor) (NGF receptor) (p75 ICD) (CD antigen CD271),427,"45,183",5 out of 5,1988-08-01,Evidence at protein level
O60784,TOM1_HUMAN,Target of Myb protein 1,492,"53,818",5 out of 5,2002-11-15,Evidence at protein level
Q9NS69,TOM22_HUMAN,Mitochondrial import receptor subunit TOM22 homolog (hTom22) (1C9-2) (Translocase of outer membrane 22 kDa subunit homolog),142,"15,522",5 out of 5,2002-10-19,Evidence at protein level
Q8IWU9,TPH2_HUMAN,Tryptophan 5-hydroxylase 2 (EC 1.14.16.4) (Neuronal tryptophan hydroxylase) (Tryptophan 5-monooxygenase 2),490,"56,057",5 out of 5,2003-05-09,Evidence at protein level
P09493,TPM1_HUMAN,Tropomyosin alpha-1 chain (Alpha-tropomyosin) (Tropomyosin-1),284,"32,709",5 out of 5,1989-07-01,Evidence at protein level
P29144,TPP2_HUMAN,Tripeptidyl-peptidase 2 (TPP-2) (EC 3.4.14.10) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase II) (TPP-II),1249,"138,350",5 out of 5,1992-12-01,Evidence at protein level
Q8IUR0,TPPC5_HUMAN,Trafficking protein particle complex subunit 5,188,"20,783",4 out of 5,2005-07-19,Evidence at protein level
Q9BW30,TPPP3_HUMAN,Tubulin polymerization-promoting protein family member 3 (TPPP/p20),176,"18,985",3 out of 5,2003-02-12,Evidence at protein level
Q8N7U7,TPRX1_HUMAN,Tetra-peptide repeat homeobox protein 1,411,"40,603",2 out of 5,2007-05-01,Evidence at transcript level
P12270,TPR_HUMAN,Nucleoprotein TPR (Megator) (NPC-associated intranuclear protein) (Translocated promoter region protein),2363,"267,293",5 out of 5,1989-10-01,Evidence at protein level
Q8IYQ7,THNS1_HUMAN,Threonine synthase-like 1 (TSH1),743,"83,070",2 out of 5,2005-04-12,Evidence at protein level
P31483,TIA1_HUMAN,Nucleolysin TIA-1 isoform p40 (RNA-binding protein TIA-1) (T-cell-restricted intracellular antigen-1) (TIA-1) (p40-TIA-1),386,"42,963",5 out of 5,1993-07-01,Evidence at protein level
Q13009,TIAM1_HUMAN,T-lymphoma invasion and metastasis-inducing protein 1 (TIAM-1),1591,"177,508",5 out of 5,1997-11-01,Evidence at protein level
Q01085,TIAR_HUMAN,Nucleolysin TIAR (TIA-1-related protein),375,"41,591",5 out of 5,1993-04-01,Evidence at protein level
P35590,TIE1_HUMAN,Tyrosine-protein kinase receptor Tie-1 (EC 2.7.10.1),1138,"125,090",5 out of 5,1994-06-01,Evidence at protein level
Q6ZNK6,TIFAB_HUMAN,TRAF-interacting protein with FHA domain-containing protein B (TIFA-like protein),161,"17,888",3 out of 5,2008-02-26,Evidence at protein level
Q495A1,TIGIT_HUMAN,T-cell immunoreceptor with Ig and ITIM domains (V-set and immunoglobulin domain-containing protein 9) (V-set and transmembrane domain-containing protein 3),244,"26,319",5 out of 5,2007-09-11,Evidence at protein level
Q9BVV7,TIM21_HUMAN,"Mitochondrial import inner membrane translocase subunit Tim21 (TIM21-like protein, mitochondrial)",248,"28,202",4 out of 5,2005-08-30,Evidence at protein level
Q96H15,TIMD4_HUMAN,T-cell immunoglobulin and mucin domain-containing protein 4 (TIMD-4) (T-cell immunoglobulin mucin receptor 4) (TIM-4) (T-cell membrane protein 4),378,"41,578",4 out of 5,2005-09-27,Evidence at protein level
Q8TB96,TIP_HUMAN,T-cell immunomodulatory protein (Protein TIP) (Integrin-alpha FG-GAP repeat-containing protein 1) (Linkin),612,"68,108",4 out of 5,2004-03-15,Evidence at protein level
Q07352,TISB_HUMAN,"mRNA decay activator protein ZFP36L1 (Butyrate response factor 1) (EGF-response factor 1) (ERF-1) (TPA-induced sequence 11b) (Zinc finger protein 36, C3H1 type-like 1) (ZFP36-like 1)",338,"36,314",5 out of 5,1996-02-01,Evidence at protein level
Q96CP7,TLCD1_HUMAN,Calfacilitin (TLC domain-containing protein 1),247,"28,548",3 out of 5,2007-05-01,Evidence at transcript level
A6NGC4,TLCD2_HUMAN,TLC domain-containing protein 2,264,"28,733",2 out of 5,2008-04-08,Inferred from homology
O43897,TLL1_HUMAN,Tolloid-like protein 1 (EC 3.4.24.-),1013,"114,709",5 out of 5,2006-02-07,Evidence at protein level
Q9Y4G6,TLN2_HUMAN,Talin-2,2542,"271,613",5 out of 5,2002-10-25,Evidence at protein level
O60603,TLR2_HUMAN,Toll-like receptor 2 (Toll/interleukin-1 receptor-like protein 4) (CD antigen CD282),784,"89,838",5 out of 5,2002-01-31,Evidence at protein level
Q9Y2C9,TLR6_HUMAN,Toll-like receptor 6 (CD antigen CD286),796,"91,880",5 out of 5,2002-01-31,Evidence at protein level
Q9NR97,TLR8_HUMAN,Toll-like receptor 8 (CD antigen CD288),1041,"119,828",5 out of 5,2002-01-31,Evidence at protein level
O43763,TLX2_HUMAN,T-cell leukemia homeobox protein 2 (Homeobox protein Hox-11L1) (Neural crest homeobox protein),284,"30,251",3 out of 5,1999-07-15,Evidence at protein level
Q6UXF1,TM108_HUMAN,Transmembrane protein 108 (Retrolinkin),575,"59,948",5 out of 5,2006-06-27,Evidence at transcript level
Q8TBZ6,TM10A_HUMAN,tRNA methyltransferase 10 homolog A (EC 2.1.1.-) (RNA (guanine-9-)-methyltransferase domain-containing protein 2),339,"39,719",5 out of 5,2007-11-13,Evidence at protein level
B3SHH9,TM114_HUMAN,Transmembrane protein 114,223,"24,166",3 out of 5,2008-10-14,Evidence at transcript level
Q4V9L6,TM119_HUMAN,Transmembrane protein 119 (Osteoblast induction factor) (OBIF),283,"29,203",5 out of 5,2006-10-03,Evidence at protein level
O75204,TM127_HUMAN,Transmembrane protein 127,238,"25,842",5 out of 5,2006-10-03,Evidence at protein level
Q8N3G9,TM130_HUMAN,Transmembrane protein 130,435,"48,329",3 out of 5,2007-02-20,Evidence at transcript level
Q96HH4,TM169_HUMAN,Transmembrane protein 169,297,"33,611",2 out of 5,2007-01-09,Evidence at transcript level
Q6UWW9,TM207_HUMAN,Transmembrane protein 207,146,"16,116",2 out of 5,2008-02-05,Evidence at protein level
A6NML5,TM212_HUMAN,Transmembrane protein 212,194,"21,425",1 out of 5,2008-06-10,Evidence at transcript level
Q5SV17,TM240_HUMAN,Transmembrane protein 240,173,"19,908",3 out of 5,2008-06-10,Evidence at protein level
Q5VVB8,TM244_HUMAN,Transmembrane protein 244,128,"14,657",2 out of 5,2006-05-30,Predicted
Q9H330,TM245_HUMAN,Transmembrane protein 245 (Protein CG-2),911,"100,945",4 out of 5,2005-07-19,Evidence at protein level
P0C7T8,TM253_HUMAN,Transmembrane protein 253,217,"23,522",2 out of 5,2008-07-22,Predicted
P61165,TM258_HUMAN,Transmembrane protein 258,79,"9,079",4 out of 5,2004-05-10,Evidence at protein level
Q8WUH6,TM263_HUMAN,Transmembrane protein 263,116,"11,748",2 out of 5,2006-12-12,Evidence at protein level
Q0VDI3,TM267_HUMAN,Transmembrane protein 267,215,"24,217",2 out of 5,2007-04-03,Evidence at transcript level
Q8NBN3,TM87A_HUMAN,Transmembrane protein 87A,555,"63,430",3 out of 5,2007-01-09,Evidence at protein level
Q96K49,TM87B_HUMAN,Transmembrane protein 87B,555,"63,536",2 out of 5,2007-06-26,Evidence at protein level
Q99805,TM9S2_HUMAN,Transmembrane 9 superfamily member 2 (p76),663,"75,776",4 out of 5,2001-04-27,Evidence at protein level
Q92544,TM9S4_HUMAN,Transmembrane 9 superfamily member 4 (Tumor cannibalism associated protein 1),642,"74,519",5 out of 5,2001-04-27,Evidence at protein level
A8MYB1,TMC5B_HUMAN,Transmembrane and coiled-coil domain-containing protein 5B,307,"35,763",2 out of 5,2008-06-10,Inferred from homology
Q13445,TMED1_HUMAN,Transmembrane emp24 domain-containing protein 1 (Interleukin-1 receptor-like 1 ligand) (Putative T1/ST2 receptor-binding protein) (p24 family protein gamma-1) (Tp24) (p24gamma1),227,"25,206",5 out of 5,2006-09-05,Evidence at protein level
Q15363,TMED2_HUMAN,Transmembrane emp24 domain-containing protein 2 (Membrane protein p24A) (p24) (p24 family protein beta-1) (p24beta1),201,"22,761",5 out of 5,1998-12-15,Evidence at protein level
Q9Y3A6,TMED5_HUMAN,Transmembrane emp24 domain-containing protein 5 (p24 family protein gamma-2) (p24gamma2) (p28),229,"26,005",5 out of 5,2001-01-24,Evidence at protein level
Q9BVK6,TMED9_HUMAN,Transmembrane emp24 domain-containing protein 9 (GMP25) (Glycoprotein 25L2) (p24 family protein alpha-2) (p24alpha2) (p25),235,"27,277",5 out of 5,2003-10-10,Evidence at protein level
Q9BZD6,TMG4_HUMAN,Transmembrane gamma-carboxyglutamic acid protein 4 (Proline-rich gamma-carboxyglutamic acid protein 4) (Proline-rich Gla protein 4),226,"25,403",4 out of 5,2002-01-31,Evidence at protein level
Q86X19,TMM17_HUMAN,Transmembrane protein 17,198,"23,046",3 out of 5,2006-10-31,Evidence at protein level
Q86YD3,TMM25_HUMAN,Transmembrane protein 25,366,"39,285",4 out of 5,2005-03-01,Evidence at protein level
Q8WWA1,TMM40_HUMAN,Transmembrane protein 40,233,"25,495",3 out of 5,2007-03-20,Evidence at protein level
Q2T9K0,TMM44_HUMAN,Transmembrane protein 44,475,"52,201",3 out of 5,2007-04-17,Evidence at protein level
Q0P6H9,TMM62_HUMAN,Transmembrane protein 62,643,"73,133",2 out of 5,2006-10-31,Evidence at protein level
Q5SWH9,TMM69_HUMAN,Transmembrane protein 69,247,"27,551",2 out of 5,2007-04-03,Evidence at transcript level
Q9Y2Y6,TMM98_HUMAN,Transmembrane protein 98 (Protein TADA1),226,"24,611",3 out of 5,2006-10-03,Evidence at protein level
Q9NZR1,TMOD2_HUMAN,Tropomodulin-2 (Neuronal tropomodulin) (N-Tmod),351,"39,595",4 out of 5,2002-09-19,Evidence at protein level
P57727,TMPS3_HUMAN,Transmembrane protease serine 3 (EC 3.4.21.-) (Serine protease TADG-12) (Tumor-associated differentially-expressed gene 12 protein),454,"49,405",5 out of 5,2001-01-11,Evidence at protein level
Q8IU80,TMPS6_HUMAN,Transmembrane protease serine 6 (EC 3.4.21.-) (Matriptase-2),811,"90,000",5 out of 5,2003-09-26,Evidence at protein level
Q9H3N1,TMX1_HUMAN,Thioredoxin-related transmembrane protein 1 (Thioredoxin domain-containing protein 1) (Transmembrane Trx-related protein),280,"31,791",5 out of 5,2004-05-10,Evidence at protein level
O14788,TNF11_HUMAN,"Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]",317,"35,478",5 out of 5,2001-01-24,Evidence at protein level
P41273,TNFL9_HUMAN,Tumor necrosis factor ligand superfamily member 9 (4-1BB ligand) (4-1BBL),254,"26,625",5 out of 5,1995-02-01,Evidence at protein level
Q15785,TOM34_HUMAN,Mitochondrial import receptor subunit TOM34 (hTom34) (Translocase of outer membrane 34 kDa subunit),309,"34,559",5 out of 5,2002-10-19,Evidence at protein level
Q9P0U1,TOM7_HUMAN,Mitochondrial import receptor subunit TOM7 homolog (Translocase of outer membrane 7 kDa subunit homolog),55,"6,248",5 out of 5,2000-12-01,Evidence at protein level
Q9NS56,TOPRS_HUMAN,E3 ubiquitin-protein ligase Topors (EC 2.3.2.27) (RING-type E3 ubiquitin transferase Topors) (SUMO1-protein E3 ligase Topors) (Topoisomerase I-binding RING finger protein) (Topoisomerase I-binding arginine/serine-rich protein) (Tumor suppressor p53-binding protein 3) (p53-binding protein 3) (p53BP3),1045,"119,198",5 out of 5,2006-04-18,Evidence at protein level
O94842,TOX4_HUMAN,TOX high mobility group box family member 4 (Epidermal Langerhans cell protein LCP1),621,"66,195",5 out of 5,2003-07-19,Evidence at protein level
Q7Z2Z1,TICRR_HUMAN,"Treslin (TopBP1-interacting checkpoint and replication regulator) (TopBP1-interacting, replication-stimulating protein)",1910,"210,857",5 out of 5,2007-07-24,Evidence at protein level
Q4W5G0,TIGD2_HUMAN,Tigger transposable element-derived protein 2,525,"59,623",2 out of 5,2007-01-09,Inferred from homology
Q9Y5J9,TIM8B_HUMAN,Mitochondrial import inner membrane translocase subunit Tim8 B (DDP-like protein) (Deafness dystonia protein 2),83,"9,344",4 out of 5,2001-01-11,Evidence at protein level
Q9GZM7,TINAL_HUMAN,Tubulointerstitial nephritis antigen-like (Glucocorticoid-inducible protein 5) (Oxidized LDL-responsive gene 2 protein) (OLRG-2) (Tubulointerstitial nephritis antigen-related protein) (TIN Ag-related protein) (TIN-Ag-RP),467,"52,387",5 out of 5,2005-03-15,Evidence at protein level
Q86UU9,TKN4_HUMAN,Tachykinin-4 (Preprotachykinin-C) (PPT-C) [Cleaved into: Endokinin-A (EKA); Endokinin-A/B (EKA/B); Endokinin-C (EKC)],113,"12,305",4 out of 5,2008-02-26,Evidence at protein level
Q6P9G4,TM154_HUMAN,Transmembrane protein 154,183,"20,498",2 out of 5,2007-04-17,Evidence at protein level
Q8WZ71,TM158_HUMAN,Transmembrane protein 158 (40 kDa BINP-binding protein) (p40BBP) (Ras-induced senescence protein 1),300,"30,404",3 out of 5,2007-05-01,Evidence at transcript level
Q9P2C4,TM181_HUMAN,Transmembrane protein 181,612,"69,325",3 out of 5,2006-06-13,Evidence at protein level
Q66K66,TM198_HUMAN,Transmembrane protein 198,360,"39,475",4 out of 5,2008-03-18,Evidence at protein level
Q6ZVM7,TM1L2_HUMAN,TOM1-like protein 2 (Target of Myb-like protein 2),507,"55,556",5 out of 5,2007-02-20,Evidence at protein level
Q969S6,TM203_HUMAN,Transmembrane protein 203,136,"15,760",3 out of 5,2008-02-05,Evidence at protein level
Q6UW68,TM205_HUMAN,Transmembrane protein 205,189,"21,198",3 out of 5,2008-02-05,Evidence at protein level
A6NLX4,TM210_HUMAN,Transmembrane protein 210,147,"15,516",2 out of 5,2008-04-08,Inferred from homology
Q6GV28,TM225_HUMAN,Transmembrane protein 225,225,"25,828",3 out of 5,2008-06-10,Evidence at transcript level
Q9BRR3,TM246_HUMAN,Transmembrane protein 246,403,"46,588",2 out of 5,2005-07-19,Evidence at protein level
A6NEH6,TM247_HUMAN,Transmembrane protein 247,219,"25,168",2 out of 5,2008-04-08,Predicted
Q9BX73,TM2D2_HUMAN,TM2 domain-containing protein 2 (Beta-amyloid-binding protein-like protein 1) (BBP-like protein 1),214,"22,871",3 out of 5,2007-09-11,Evidence at transcript level
Q9GZU3,TM39B_HUMAN,Transmembrane protein 39B,492,"56,274",3 out of 5,2007-03-06,Evidence at protein level
Q96HV5,TM41A_HUMAN,Transmembrane protein 41A,264,"29,665",2 out of 5,2007-01-09,Evidence at protein level
Q86T03,TM55B_HUMAN,"Type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 1 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase I) (Transmembrane protein 55B)",277,"29,470",5 out of 5,2003-07-19,Evidence at protein level
Q9BZW5,TM6S1_HUMAN,Transmembrane 6 superfamily member 1,370,"41,636",3 out of 5,2002-03-27,Evidence at protein level
Q8N661,TM86B_HUMAN,Lysoplasmalogenase (EC 3.3.2.2) (Transmembrane protein 86B),226,"24,352",5 out of 5,2005-11-22,Evidence at protein level
O15321,TM9S1_HUMAN,Transmembrane 9 superfamily member 1 (MP70 protein family member) (hMP70),606,"68,861",4 out of 5,2001-04-27,Evidence at transcript level
Q9HD45,TM9S3_HUMAN,Transmembrane 9 superfamily member 3 (EP70-P-iso) (SM-11044-binding protein),589,"67,888",3 out of 5,2001-04-27,Evidence at protein level
Q8TDI8,TMC1_HUMAN,Transmembrane channel-like protein 1 (Transmembrane cochlear-expressed protein 1),760,"87,768",5 out of 5,2002-10-19,Evidence at protein level
Q9Y3B3,TMED7_HUMAN,Transmembrane emp24 domain-containing protein 7 (p24 family protein gamma-3) (p24gamma3) (p27),224,"25,172",5 out of 5,2001-01-24,Evidence at protein level
P0DMS9,TMIG3_HUMAN,Transmembrane domain-containing protein TMIGD3,266,"30,327",3 out of 5,2015-04-01,Evidence at transcript level
Q9NW97,TMM51_HUMAN,Transmembrane protein 51,253,"27,759",2 out of 5,2005-06-21,Evidence at protein level
Q96MV1,TMM56_HUMAN,Transmembrane protein 56,263,"30,041",2 out of 5,2007-05-15,Evidence at protein level
Q6PI78,TMM65_HUMAN,Transmembrane protein 65,240,"25,498",4 out of 5,2006-10-03,Evidence at protein level
Q9BUB7,TMM70_HUMAN,"Transmembrane protein 70, mitochondrial",260,"28,969",5 out of 5,2006-10-03,Evidence at protein level
Q9BSE2,TMM79_HUMAN,Transmembrane protein 79 (Mattrin),394,"43,520",5 out of 5,2006-10-31,Evidence at protein level
Q6PEY1,TMM88_HUMAN,Transmembrane protein 88,159,"17,251",4 out of 5,2006-10-03,Evidence at protein level
A6NDV4,TMM8B_HUMAN,Transmembrane protein 8B (Nasopharyngeal carcinoma-associated gene 6 protein) (Protein NAG-5) (Protein NGX6),472,"51,941",5 out of 5,2008-05-20,Evidence at protein level
Q12767,TMM94_HUMAN,Transmembrane protein 94,1356,"151,151",3 out of 5,1997-11-01,Evidence at protein level
Q6ZT21,TMPPE_HUMAN,Transmembrane protein with metallophosphoesterase domain (EC 3.1.-.-),453,"49,453",2 out of 5,2008-02-26,Evidence at transcript level
Q9NRS4,TMPS4_HUMAN,Transmembrane protease serine 4 (EC 3.4.21.-) (Channel-activating protease 2) (CAPH2) (Membrane-type serine protease 2) (MT-SP2),437,"48,246",5 out of 5,2001-04-27,Evidence at protein level
Q7RTY8,TMPS7_HUMAN,Transmembrane protease serine 7 (EC 3.4.21.-) (Matriptase-3),843,"94,415",4 out of 5,2005-03-15,Evidence at transcript level
Q8IUR5,TMTC1_HUMAN,Transmembrane and TPR repeat-containing protein 1,882,"98,847",4 out of 5,2007-03-20,Evidence at protein level
Q6ZXV5,TMTC3_HUMAN,Transmembrane and TPR repeat-containing protein 3 (Protein SMILE),915,"104,009",5 out of 5,2007-03-20,Evidence at protein level
Q5T4D3,TMTC4_HUMAN,Transmembrane and TPR repeat-containing protein 4,741,"82,991",3 out of 5,2007-03-20,Evidence at transcript level
Q9H1E5,TMX4_HUMAN,Thioredoxin-related transmembrane protein 4 (Thioredoxin domain-containing protein 13),349,"38,952",4 out of 5,2003-04-23,Evidence at protein level
Q9Y275,TN13B_HUMAN,"Tumor necrosis factor ligand superfamily member 13B (B lymphocyte stimulator) (BLyS) (B-cell-activating factor) (BAFF) (Dendritic cell-derived TNF-like molecule) (TNF- and APOL-related leukocyte expressed ligand 1) (TALL-1) (CD antigen CD257) [Cleaved into: Tumor necrosis factor ligand superfamily member 13b, membrane form; Tumor necrosis factor ligand superfamily member 13b, soluble form]",285,"31,223",5 out of 5,2001-02-21,Evidence at protein level
O43508,TNF12_HUMAN,"Tumor necrosis factor ligand superfamily member 12 (APO3 ligand) (TNF-related weak inducer of apoptosis) (TWEAK) [Cleaved into: Tumor necrosis factor ligand superfamily member 12, membrane form; Tumor necrosis factor ligand superfamily member 12, secreted form]",249,"27,216",5 out of 5,2002-06-06,Evidence at protein level
P01375,TNFA_HUMAN,"Tumor necrosis factor (Cachectin) (TNF-alpha) (Tumor necrosis factor ligand superfamily member 2) (TNF-a) [Cleaved into: Tumor necrosis factor, membrane form (N-terminal fragment) (NTF); Intracellular domain 1 (ICD1); Intracellular domain 2 (ICD2); C-domain 1; C-domain 2; Tumor necrosis factor, soluble form]",233,"25,644",5 out of 5,1986-07-21,Evidence at protein level
Q96KP6,TNIP3_HUMAN,TNFAIP3-interacting protein 3 (A20-binding inhibitor of NF-kappa-B activation 3) (ABIN-3) (Listeria-induced gene protein),325,"38,943",5 out of 5,2005-07-19,Evidence at protein level
Q9H2K2,TNKS2_HUMAN,Tankyrase-2 (TANK2) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 6) (ARTD6) (Poly [ADP-ribose] polymerase 5B) (TNKS-2) (TRF1-interacting ankyrin-related ADP-ribose polymerase 2) (Tankyrase II) (Tankyrase-like protein) (Tankyrase-related protein),1166,"126,918",5 out of 5,2002-03-27,Evidence at protein level
O75509,TNR21_HUMAN,Tumor necrosis factor receptor superfamily member 21 (Death receptor 6) (CD antigen CD358),655,"71,845",5 out of 5,2002-05-27,Evidence at protein level
P36941,TNR3_HUMAN,Tumor necrosis factor receptor superfamily member 3 (Lymphotoxin-beta receptor) (Tumor necrosis factor C receptor) (Tumor necrosis factor receptor 2-related protein) (Tumor necrosis factor receptor type III) (TNF-RIII) (TNFR-III),435,"46,709",5 out of 5,1994-06-01,Evidence at protein level
Q8NDV7,TNR6A_HUMAN,Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa),1962,"210,297",5 out of 5,2005-03-29,Evidence at protein level
P28908,TNR8_HUMAN,Tumor necrosis factor receptor superfamily member 8 (CD30L receptor) (Ki-1 antigen) (Lymphocyte activation antigen CD30) (CD antigen CD30),595,"63,747",5 out of 5,1992-12-01,Evidence at protein level
Q8NFQ8,TOIP2_HUMAN,Torsin-1A-interacting protein 2 (Lumenal domain-like LAP1),470,"51,263",5 out of 5,2006-03-21,Evidence at protein level
Q92547,TOPB1_HUMAN,DNA topoisomerase 2-binding protein 1 (DNA topoisomerase II-beta-binding protein 1) (TopBP1) (DNA topoisomerase II-binding protein 1),1522,"170,679",5 out of 5,2005-04-26,Evidence at protein level
P0DI81,TPC2A_HUMAN,Trafficking protein particle complex subunit 2 (Sedlin),140,"16,445",5 out of 5,2011-09-21,Evidence at protein level
Q96Q05,TPPC9_HUMAN,Trafficking protein particle complex subunit 9 (NIK- and IKBKB-binding protein) (Tularik gene 1 protein),1148,"128,530",5 out of 5,2008-06-10,Evidence at protein level
Q86W33,TPRA1_HUMAN,Transmembrane protein adipocyte-associated 1 (Integral membrane protein GPR175) (Transmembrane protein 227),373,"41,053",4 out of 5,2006-01-10,Evidence at transcript level
Q5T0D9,TPRGL_HUMAN,Tumor protein p63-regulated gene 1-like protein (Mossy fiber terminal-associated vertebrate-specific presynaptic protein) (Protein FAM79A),272,"30,212",3 out of 5,2006-12-12,Evidence at protein level
Q13114,TRAF3_HUMAN,TNF receptor-associated factor 3 (EC 2.3.2.27) (CAP-1) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3),568,"64,490",5 out of 5,2000-05-30,Evidence at protein level
Q9BWF2,TRAIP_HUMAN,E3 ubiquitin-protein ligase TRAIP (EC 2.3.2.27) (RING finger protein 206) (RING-type E3 ubiquitin transferase TRAIP) (TRAF-interacting protein),469,"53,294",5 out of 5,2003-05-09,Evidence at protein level
Q9Y5J7,TIM9_HUMAN,Mitochondrial import inner membrane translocase subunit Tim9,89,"10,378",5 out of 5,2001-01-11,Evidence at protein level
A0PJX2,TLDC2_HUMAN,TLD domain-containing protein 2 (TBC/LysM-associated domain-containing protein 2),215,"23,912",2 out of 5,2008-02-26,Evidence at transcript level
Q9UKI8,TLK1_HUMAN,Serine/threonine-protein kinase tousled-like 1 (EC 2.7.11.1) (PKU-beta) (Tousled-like kinase 1),766,"86,700",5 out of 5,2003-08-22,Evidence at protein level
Q9BXR5,TLR10_HUMAN,Toll-like receptor 10 (CD antigen CD290),811,"94,564",5 out of 5,2002-01-31,Evidence at protein level
P0CAT3,TLXNB_HUMAN,Putative TLX1 neighbor protein (TLX1 divergent gene protein),122,"13,375",1 out of 5,2009-06-16,Uncertain
Q96IK0,TM101_HUMAN,Transmembrane protein 101 (Putative NF-kappa-B-activating protein 130),257,"28,795",2 out of 5,2006-06-27,Evidence at protein level
A0AVI4,TM129_HUMAN,E3 ubiquitin-protein ligase TM129 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TM129),362,"40,464",5 out of 5,2007-06-12,Evidence at protein level
Q9NPI0,TM138_HUMAN,Transmembrane protein 138,162,"19,262",5 out of 5,2007-05-01,Evidence at protein level
Q9NUH8,TM14B_HUMAN,Transmembrane protein 14B,114,"12,078",2 out of 5,2003-01-10,Inferred from homology
Q4W5P6,TM155_HUMAN,Protein TMEM155,130,"14,221",1 out of 5,2007-04-03,Evidence at transcript level
Q9NX00,TM160_HUMAN,Transmembrane protein 160,188,"19,658",2 out of 5,2007-02-20,Evidence at protein level
Q9HC07,TM165_HUMAN,Transmembrane protein 165 (Transmembrane protein PT27) (Transmembrane protein TPARL),324,"34,906",5 out of 5,2006-07-25,Evidence at protein level
Q8WZ59,TM190_HUMAN,Transmembrane protein 190,177,"19,457",3 out of 5,2007-12-04,Evidence at protein level
Q5HYL7,TM196_HUMAN,Transmembrane protein 196,178,"19,025",2 out of 5,2008-02-05,Evidence at transcript level
Q9BTX3,TM208_HUMAN,Transmembrane protein 208,173,"19,642",4 out of 5,2008-03-18,Evidence at protein level
Q96SK2,TM209_HUMAN,Transmembrane protein 209,561,"62,922",3 out of 5,2008-04-29,Evidence at protein level
A2RRL7,TM213_HUMAN,Transmembrane protein 213,107,"11,520",2 out of 5,2008-05-20,Inferred from homology
Q86XT9,TM219_HUMAN,Insulin-like growth factor-binding protein 3 receptor (IGFBP-3R) (Transmembrane protein 219),240,"25,724",4 out of 5,2008-04-08,Evidence at protein level
B4DJY2,TM233_HUMAN,Transmembrane protein 233 (Dispanin subfamily B member 2) (DSPB2) (Interferon-induced transmembrane domain-containing protein D2),109,"12,074",2 out of 5,2010-06-15,Inferred from homology
Q9NWD8,TM248_HUMAN,Transmembrane protein 248,314,"35,052",2 out of 5,2007-07-10,Evidence at protein level
Q2M3C6,TM266_HUMAN,Transmembrane protein 266,531,"58,444",3 out of 5,2006-06-27,Evidence at transcript level
A0A087WTH1,TM265_HUMAN,Transmembrane protein 265,108,"11,832",2 out of 5,2015-04-01,Inferred from homology
Q8NCS4,TM35B_HUMAN,Transmembrane protein 35B (ZMYM6 neighbor protein),154,"16,885",2 out of 5,2011-07-27,Evidence at protein level
Q9NV64,TM39A_HUMAN,Transmembrane protein 39A,488,"55,667",2 out of 5,2007-03-06,Evidence at transcript level
Q969M1,TM40L_HUMAN,Mitochondrial import receptor subunit TOM40B (Protein TOMM40-like),308,"33,917",3 out of 5,2006-02-07,Evidence at protein level
Q9NWC5,TM45A_HUMAN,Transmembrane protein 45A (DNA polymerase-transactivated protein 4) (Dermal papilla-derived protein 7),275,"31,680",2 out of 5,2003-02-12,Evidence at transcript level
P56557,TM50B_HUMAN,Transmembrane protein 50B (HCV p7-trans-regulated protein 3),158,"17,936",3 out of 5,1998-07-15,Evidence at protein level
Q8N4L2,TM55A_HUMAN,"Type 2 phosphatidylinositol 4,5-bisphosphate 4-phosphatase (Type 2 PtdIns-4,5-P2 4-Ptase) (EC 3.1.3.78) (PtdIns-4,5-P2 4-Ptase II) (Transmembrane protein 55A)",257,"28,081",4 out of 5,2006-05-16,Evidence at protein level
O75069,TMCC2_HUMAN,Transmembrane and coiled-coil domains protein 2 (Cerebral protein 11),709,"77,449",3 out of 5,1998-12-15,Evidence at protein level
Q9UM00,TMCO1_HUMAN,Calcium load-activated calcium channel (CLAC channel) (Transmembrane and coiled-coil domain-containing protein 1) (Transmembrane and coiled-coil domains protein 4) (Xenogeneic cross-immune protein PCIA3),188,"21,175",5 out of 5,2006-06-27,Evidence at protein level
Q7Z7H5,TMED4_HUMAN,Transmembrane emp24 domain-containing protein 4 (Endoplasmic reticulum stress-response protein 25) (ERS25) (GMP25iso) (Putative NF-kappa-B-activating protein 156) (p24 family protein alpha-3) (p24alpha3),227,"25,943",5 out of 5,2005-03-29,Evidence at protein level
Q6ZUK4,TMM26_HUMAN,Transmembrane protein 26,368,"41,672",2 out of 5,2006-07-11,Evidence at protein level
P57088,TMM33_HUMAN,Transmembrane protein 33 (Protein DB83) (SHINC-3),247,"27,978",5 out of 5,2000-12-01,Evidence at protein level
Q6P5X7,TMM71_HUMAN,Transmembrane protein 71,295,"32,983",2 out of 5,2007-02-20,Evidence at transcript level
Q6P7N7,TMM81_HUMAN,Transmembrane protein 81,255,"28,468",2 out of 5,2007-05-15,Evidence at transcript level
Q7Z410,TMPS9_HUMAN,Transmembrane protease serine 9 (EC 3.4.21.-) (Polyserase-I) (Polyserine protease 1) (Polyserase-1) [Cleaved into: Serase-1; Serase-2; Serase-3],1059,"114,021",5 out of 5,2005-03-15,Evidence at protein level
P50591,TNF10_HUMAN,Tumor necrosis factor ligand superfamily member 10 (Apo-2 ligand) (Apo-2L) (TNF-related apoptosis-inducing ligand) (Protein TRAIL) (CD antigen CD253),281,"32,509",5 out of 5,1996-10-01,Evidence at protein level
P23510,TNFL4_HUMAN,Tumor necrosis factor ligand superfamily member 4 (Glycoprotein Gp34) (OX40 ligand) (OX40L) (TAX transcriptionally-activated glycoprotein 1) (CD antigen CD252),183,"21,050",5 out of 5,1991-11-01,Evidence at protein level
P48023,TNFL6_HUMAN,"Tumor necrosis factor ligand superfamily member 6 (Apoptosis antigen ligand) (APTL) (CD95 ligand) (CD95-L) (Fas antigen ligand) (Fas ligand) (FasL) (CD antigen CD178) [Cleaved into: Tumor necrosis factor ligand superfamily member 6, membrane form; Tumor necrosis factor ligand superfamily member 6, soluble form (Receptor-binding FasL ectodomain) (Soluble Fas ligand) (sFasL); ADAM10-processed FasL form (APL); FasL intracellular domain (FasL ICD) (SPPL2A-processed FasL form) (SPA)]",281,"31,485",5 out of 5,1996-02-01,Evidence at protein level
Q59H18,TNI3K_HUMAN,Serine/threonine-protein kinase TNNI3K (EC 2.7.11.1) (Cardiac ankyrin repeat kinase) (Cardiac troponin I-interacting kinase) (TNNI3-interacting kinase),835,"92,851",5 out of 5,2005-11-22,Evidence at protein level
Q9UKE5,TNIK_HUMAN,TRAF2 and NCK-interacting protein kinase (EC 2.7.11.1),1360,"154,943",5 out of 5,2003-02-28,Evidence at protein level
Q8NFZ5,TNIP2_HUMAN,TNFAIP3-interacting protein 2 (A20-binding inhibitor of NF-kappa-B activation 2) (ABIN-2) (Fetal liver LKB1-interacting protein),429,"48,700",5 out of 5,2008-02-26,Evidence at protein level
P63316,TNNC1_HUMAN,"Troponin C, slow skeletal and cardiac muscles (TN-C)",161,"18,403",5 out of 5,1987-08-13,Evidence at protein level
P48788,TNNI2_HUMAN,"Troponin I, fast skeletal muscle (Troponin I, fast-twitch isoform)",182,"21,339",5 out of 5,1996-02-01,Evidence at protein level
Q9HCJ0,TNR6C_HUMAN,Trinucleotide repeat-containing gene 6C protein,1690,"175,964",5 out of 5,2007-02-20,Evidence at protein level
O95985,TOP3B_HUMAN,DNA topoisomerase 3-beta-1 (EC 5.99.1.2) (DNA topoisomerase III beta-1),862,"96,662",5 out of 5,2000-05-30,Evidence at protein level
O75365,TP4A3_HUMAN,Protein tyrosine phosphatase type IVA 3 (EC 3.1.3.48) (PRL-R) (Protein-tyrosine phosphatase 4a3) (Protein-tyrosine phosphatase of regenerating liver 3) (PRL-3),173,"19,535",5 out of 5,2005-07-05,Evidence at protein level
P48553,TPC10_HUMAN,Trafficking protein particle complex subunit 10 (Epilepsy holoprosencephaly candidate 1 protein) (EHOC-1) (Protein GT334) (Trafficking protein particle complex subunit TMEM1) (Transport protein particle subunit TMEM1) (TRAPP subunit TMEM1),1259,"142,189",5 out of 5,1996-02-01,Evidence at protein level
Q8NHX9,TPC2_HUMAN,Two pore calcium channel protein 2 (Voltage-dependent calcium channel protein TPC2),752,"85,243",5 out of 5,2007-02-06,Evidence at protein level
Q9Y296,TPPC4_HUMAN,Trafficking protein particle complex subunit 4 (Hematopoietic stem/progenitor cell protein 172) (Synbindin) (TRS23 homolog),219,"24,340",5 out of 5,2002-04-16,Evidence at protein level
O60704,TPST2_HUMAN,Protein-tyrosine sulfotransferase 2 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 2) (TPST-2),377,"41,912",5 out of 5,2000-05-30,Evidence at protein level
O00220,TR10A_HUMAN,Tumor necrosis factor receptor superfamily member 10A (Death receptor 4) (TNF-related apoptosis-inducing ligand receptor 1) (TRAIL receptor 1) (TRAIL-R1) (CD antigen CD261),468,"50,089",5 out of 5,2001-09-26,Evidence at protein level
Q969Z4,TR19L_HUMAN,Tumor necrosis factor receptor superfamily member 19L (Receptor expressed in lymphoid tissues),430,"46,092",5 out of 5,2002-05-27,Evidence at protein level
P03979,TRGV3_HUMAN,T cell receptor gamma variable 3 (T-cell receptor gamma V-gamma-1.1 region) (Fragment),118,"13,664",2 out of 5,1986-10-23,Evidence at transcript level
Q07283,TRHY_HUMAN,Trichohyalin,1943,"253,925",5 out of 5,1994-10-01,Evidence at protein level
P20396,TRH_HUMAN,Pro-thyrotropin-releasing hormone (Pro-TRH) (Prothyroliberin) [Cleaved into: Thyrotropin-releasing hormone (TRH) (Protirelin) (TSH-releasing factor) (Thyroliberin) (Thyrotropin-releasing factor) (TRF)],242,"27,404",5 out of 5,1991-02-01,Evidence at protein level
Q9BZY9,TRI31_HUMAN,E3 ubiquitin-protein ligase TRIM31 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM31) (Tripartite motif-containing protein 31),425,"48,244",5 out of 5,2002-06-06,Evidence at protein level
O00635,TRI38_HUMAN,E3 ubiquitin-protein ligase TRIM38 (EC 2.3.2.27) (RING finger protein 15) (RING-type E3 ubiquitin transferase TRIM38) (Tripartite motif-containing protein 38) (Zinc finger protein RoRet),465,"53,416",5 out of 5,2002-06-06,Evidence at protein level
Q96LD4,TRI47_HUMAN,Tripartite motif-containing protein 47 (Gene overexpressed in astrocytoma protein) (RING finger protein 100),638,"69,532",4 out of 5,2004-11-23,Evidence at protein level
Q969Q1,TRI63_HUMAN,E3 ubiquitin-protein ligase TRIM63 (EC 2.3.2.27) (Iris RING finger protein) (Muscle-specific RING finger protein 1) (MuRF-1) (MuRF1) (RING finger protein 28) (RING-type E3 ubiquitin transferase TRIM63) (Striated muscle RING zinc finger protein) (Tripartite motif-containing protein 63),353,"40,248",5 out of 5,2002-06-06,Evidence at protein level
I1YAP6,TRI77_HUMAN,Tripartite motif-containing protein 77,450,"52,450",2 out of 5,2013-03-06,Evidence at transcript level
O95932,TGM3L_HUMAN,Protein-glutamine gamma-glutamyltransferase 6 (EC 2.3.2.13) (Transglutaminase Y) (TGY) (TGase Y) (Transglutaminase-3-like) (TGase-3-like) (Transglutaminase-6) (TG6) (TGase-6),706,"79,312",5 out of 5,2002-05-10,Evidence at protein level
P49221,TGM4_HUMAN,Protein-glutamine gamma-glutamyltransferase 4 (EC 2.3.2.13) (Fibrinoligase) (Prostate transglutaminase) (Prostate-specific transglutaminase) (Transglutaminase P) (TG(P)) (TGP) (TGase P) (Transglutaminase-4) (TGase-4),684,"77,145",5 out of 5,1996-02-01,Evidence at protein level
O43548,TGM5_HUMAN,Protein-glutamine gamma-glutamyltransferase 5 (EC 2.3.2.13) (Transglutaminase X) (TG(X)) (TGX) (TGase X) (Transglutaminase-5) (TGase-5),720,"80,778",5 out of 5,1999-07-15,Evidence at protein level
Q7Z6K1,THAP5_HUMAN,THAP domain-containing protein 5,395,"45,416",5 out of 5,2008-05-20,Evidence at protein level
Q9H5L6,THAP9_HUMAN,DNA transposase THAP9 (EC 2.7.7.-) (THAP domain-containing protein 9) (hTh9),903,"103,411",4 out of 5,2008-02-05,Evidence at protein level
P10828,THB_HUMAN,Thyroid hormone receptor beta (Nuclear receptor subfamily 1 group A member 2) (c-erbA-2) (c-erbA-beta),461,"52,788",5 out of 5,1989-07-01,Evidence at protein level
Q5TEJ8,THMS2_HUMAN,Protein THEMIS2 (Induced by contact to basement membrane 1 protein) (Protein ICB-1) (Thymocyte-expressed molecule involved in selection protein 2),643,"72,049",5 out of 5,2005-08-30,Evidence at protein level
Q9NS62,THSD1_HUMAN,Thrombospondin type-1 domain-containing protein 1 (Transmembrane molecule with thrombospondin module),852,"94,584",4 out of 5,2006-09-19,Evidence at transcript level
O60830,TI17B_HUMAN,Mitochondrial import inner membrane translocase subunit Tim17-B,172,"18,273",4 out of 5,2001-01-11,Evidence at protein level
Q86V40,TIKI1_HUMAN,Metalloprotease TIKI1 (EC 3.4.-.-) (TRAB domain-containing protein 2A),505,"57,676",5 out of 5,2008-03-18,Evidence at transcript level
Q9Y3D7,TIM16_HUMAN,Mitochondrial import inner membrane translocase subunit TIM16 (Mitochondria-associated granulocyte macrophage CSF-signaling molecule) (Presequence translocated-associated motor subunit PAM16),125,"13,825",5 out of 5,2000-05-30,Evidence at protein level
O14925,TIM23_HUMAN,Mitochondrial import inner membrane translocase subunit Tim23,209,"21,943",5 out of 5,2001-10-18,Evidence at protein level
Q04725,TLE2_HUMAN,Transducin-like enhancer protein 2 (Enhancer of split groucho-like protein 2) (ESG2),743,"79,841",5 out of 5,1994-02-01,Evidence at protein level
Q6ZRR5,TM136_HUMAN,Transmembrane protein 136,245,"27,859",2 out of 5,2007-05-01,Evidence at transcript level
Q9H0V1,TM168_HUMAN,Transmembrane protein 168,697,"79,755",2 out of 5,2007-04-17,Evidence at transcript level
Q96B77,TM186_HUMAN,Transmembrane protein 186,213,"24,893",2 out of 5,2007-03-06,Evidence at transcript level
Q96B21,TM45B_HUMAN,Transmembrane protein 45B,275,"31,826",2 out of 5,2007-01-09,Evidence at protein level
O95807,TM50A_HUMAN,Transmembrane protein 50A (Small membrane protein 1),157,"17,400",3 out of 5,2000-05-30,Evidence at protein level
Q9Y2S6,TMA7_HUMAN,Translation machinery-associated protein 7 (Coiled-coil domain-containing protein 72),64,"7,066",2 out of 5,2006-05-16,Evidence at protein level
Q9BZD7,TMG3_HUMAN,Transmembrane gamma-carboxyglutamic acid protein 3 (Proline-rich gamma-carboxyglutamic acid protein 3) (Proline-rich Gla protein 3),231,"25,875",3 out of 5,2002-01-31,Evidence at transcript level
Q96HH6,TMM19_HUMAN,Transmembrane protein 19,336,"36,392",2 out of 5,2007-04-17,Evidence at protein level
Q9BQJ4,TMM47_HUMAN,Transmembrane protein 47 (Brain cell membrane protein 1) (Transmembrane 4 superfamily member 10),181,"19,998",3 out of 5,2004-08-16,Evidence at protein level
Q6P2H8,TMM53_HUMAN,Transmembrane protein 53,277,"31,630",2 out of 5,2007-04-17,Evidence at transcript level
Q9BXS4,TMM59_HUMAN,Transmembrane protein 59 (Liver membrane-bound protein),323,"36,223",5 out of 5,2001-09-26,Evidence at protein level
Q96NL1,TMM74_HUMAN,Transmembrane protein 74,305,"33,338",3 out of 5,2006-10-31,Evidence at protein level
Q5BJF2,TMM97_HUMAN,Transmembrane protein 97 (Meningioma-associated protein 30),176,"20,848",5 out of 5,2006-10-31,Evidence at protein level
Q06643,TNFC_HUMAN,Lymphotoxin-beta (LT-beta) (Tumor necrosis factor C) (TNF-C) (Tumor necrosis factor ligand superfamily member 3),244,"25,390",5 out of 5,1994-06-01,Evidence at protein level
Q9C0B7,TNG6_HUMAN,Transport and Golgi organization protein 6 homolog (Transmembrane and coiled-coil domain-containing protein 7),1094,"120,748",2 out of 5,2007-10-02,Evidence at protein level
Q15025,TNIP1_HUMAN,TNFAIP3-interacting protein 1 (A20-binding inhibitor of NF-kappa-B activation 1) (ABIN-1) (HIV-1 Nef-interacting protein) (Nef-associated factor 1) (Naf1) (Nip40-1) (Virion-associated nuclear shuttling protein) (VAN) (hVAN),636,"71,864",5 out of 5,2002-01-23,Evidence at protein level
P20333,TNR1B_HUMAN,"Tumor necrosis factor receptor superfamily member 1B (Tumor necrosis factor receptor 2) (TNF-R2) (Tumor necrosis factor receptor type II) (TNF-RII) (TNFR-II) (p75) (p80 TNF-alpha receptor) (CD antigen CD120b) (Etanercept) [Cleaved into: Tumor necrosis factor receptor superfamily member 1b, membrane form; Tumor necrosis factor-binding protein 2 (TBP-2) (TBPII)]",461,"48,291",5 out of 5,1991-02-01,Evidence at protein level
Q93038,TNR25_HUMAN,Tumor necrosis factor receptor superfamily member 25 (Apo-3) (Apoptosis-inducing receptor AIR) (Apoptosis-mediating receptor DR3) (Apoptosis-mediating receptor TRAMP) (Death receptor 3) (Lymphocyte-associated receptor of death) (LARD) (Protein WSL) (Protein WSL-1),417,"45,385",5 out of 5,1997-11-01,Evidence at protein level
Q6P589,TP8L2_HUMAN,Tumor necrosis factor alpha-induced protein 8-like protein 2 (TIPE2) (TNF alpha-induced protein 8-like protein 2) (TNFAIP8-like protein 2) (Inflammation factor protein 20),184,"20,556",3 out of 5,2007-05-01,Evidence at protein level
P00750,TPA_HUMAN,Tissue-type plasminogen activator (t-PA) (t-plasminogen activator) (tPA) (EC 3.4.21.68) (Alteplase) (Reteplase) [Cleaved into: Tissue-type plasminogen activator chain A; Tissue-type plasminogen activator chain B],562,"62,917",5 out of 5,1986-07-21,Evidence at protein level
A5PLN9,TPC13_HUMAN,Trafficking protein particle complex subunit 13,417,"46,524",4 out of 5,2008-02-26,Evidence at protein level
Q9UL33,TPC2L_HUMAN,Trafficking protein particle complex subunit 2-like protein,140,"16,146",5 out of 5,2007-07-10,Evidence at protein level
Q96J77,TPD55_HUMAN,Tumor protein D55 (hD55) (Testis development protein NYD-SP25) (Tumor protein D52-like 3),140,"15,503",3 out of 5,2007-07-24,Evidence at protein level
P67936,TPM4_HUMAN,Tropomyosin alpha-4 chain (TM30p1) (Tropomyosin-4),248,"28,522",5 out of 5,1988-04-01,Evidence at protein level
P40238,TPOR_HUMAN,Thrombopoietin receptor (TPO-R) (Myeloproliferative leukemia protein) (Proto-oncogene c-Mpl) (CD antigen CD110),635,"71,245",5 out of 5,1995-02-01,Evidence at protein level
Q9Y5R8,TPPC1_HUMAN,Trafficking protein particle complex subunit 1 (BET5 homolog) (Multiple myeloma protein 2) (MUM-2),145,"16,832",5 out of 5,2002-04-16,Evidence at protein level
O14798,TR10C_HUMAN,Tumor necrosis factor receptor superfamily member 10C (Antagonist decoy receptor for TRAIL/Apo-2L) (Decoy TRAIL receptor without death domain) (Decoy receptor 1) (DcR1) (Lymphocyte inhibitor of TRAIL) (TNF-related apoptosis-inducing ligand receptor 3) (TRAIL receptor 3) (TRAIL-R3) (TRAIL receptor without an intracellular domain) (CD antigen CD263),259,"27,407",5 out of 5,2001-09-26,Evidence at protein level
O14836,TR13B_HUMAN,Tumor necrosis factor receptor superfamily member 13B (Transmembrane activator and CAML interactor) (CD antigen CD267),293,"31,816",5 out of 5,2002-05-27,Evidence at protein level
A6NLI5,TR64C_HUMAN,Putative tripartite motif-containing protein 64C,447,"51,329",2 out of 5,2008-06-10,Uncertain
Q15628,TRADD_HUMAN,Tumor necrosis factor receptor type 1-associated DEATH domain protein (TNFR1-associated DEATH domain protein) (TNFRSF1A-associated via death domain),312,"34,247",5 out of 5,1997-11-01,Evidence at protein level
O60296,TRAK2_HUMAN,Trafficking kinesin-binding protein 2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 3 protein),914,"101,419",5 out of 5,2001-02-21,Evidence at protein level
Q9UKU6,TRHDE_HUMAN,Thyrotropin-releasing hormone-degrading ectoenzyme (TRH-DE) (TRH-degrading ectoenzyme) (EC 3.4.19.6) (Pyroglutamyl-peptidase II) (PAP-II) (TRH-specific aminopeptidase) (Thyroliberinase),1024,"117,000",5 out of 5,2000-12-01,Evidence at transcript level
O60858,TRI13_HUMAN,E3 ubiquitin-protein ligase TRIM13 (EC 2.3.2.27) (B-cell chronic lymphocytic leukemia tumor suppressor Leu5) (Leukemia-associated protein 5) (Putative tumor suppressor RFP2) (RING finger protein 77) (RING-type E3 ubiquitin transferase TRIM13) (Ret finger protein 2) (Tripartite motif-containing protein 13),407,"46,988",5 out of 5,2000-12-01,Evidence at protein level
O95361,TRI16_HUMAN,Tripartite motif-containing protein 16 (Estrogen-responsive B box protein),564,"63,955",5 out of 5,2003-11-28,Evidence at protein level
P14373,TRI27_HUMAN,Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (RING-type E3 ubiquitin transferase TRIM27) (Ret finger protein) (Tripartite motif-containing protein 27),513,"58,490",5 out of 5,1990-01-01,Evidence at protein level
P0CI25,TRI49_HUMAN,Tripartite motif-containing protein 49 (RING finger protein 18) (Testis-specific RING-finger protein),452,"52,888",3 out of 5,2010-11-02,Evidence at transcript level
Q5EBN2,TRI61_HUMAN,Putative tripartite motif-containing protein 61 (RING finger protein 35),209,"24,047",2 out of 5,2007-01-23,Evidence at transcript level
Q9BVG3,TRI62_HUMAN,E3 ubiquitin-protein ligase TRIM62 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM62) (Tripartite motif-containing protein 62),475,"54,268",5 out of 5,2006-09-19,Evidence at protein level
Q6AZZ1,TRI68_HUMAN,E3 ubiquitin-protein ligase TRIM68 (EC 2.3.2.27) (RING finger protein 137) (RING-type E3 ubiquitin transferase TRIM68) (SSA protein SS-56) (SS-56) (Tripartite motif-containing protein 68),485,"56,259",5 out of 5,2006-09-19,Evidence at protein level
A6NK02,TRI75_HUMAN,Putative tripartite motif-containing protein 75 (Tripartite motif-containing protein 75 pseudogene),468,"53,678",2 out of 5,2008-04-29,Uncertain
Q92519,TRIB2_HUMAN,Tribbles homolog 2 (TRB-2),343,"38,801",4 out of 5,2005-12-06,Evidence at protein level
Q7L0X0,TRIL_HUMAN,TLR4 interactor with leucine rich repeats (Leucine-rich repeat-containing protein KIAA0644),811,"88,723",5 out of 5,2008-09-02,Evidence at protein level
Q8IZ69,TRM2A_HUMAN,tRNA (uracil-5-)-methyltransferase homolog A (EC 2.1.1.-) (HpaII tiny fragments locus 9c protein),625,"68,726",4 out of 5,2004-08-16,Evidence at protein level
Q32P41,TRM5_HUMAN,tRNA (guanine(37)-N1)-methyltransferase (EC 2.1.1.228) (M1G-methyltransferase) (tRNA [GM37] methyltransferase) (tRNA methyltransferase 5 homolog),509,"58,246",5 out of 5,2006-10-31,Evidence at protein level
Q9UJA5,TRM6_HUMAN,tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit TRM6 (tRNA(m1A58)-methyltransferase subunit TRM6) (tRNA(m1A58)MTase subunit TRM6),497,"55,799",5 out of 5,2006-05-02,Evidence at protein level
Q9ULQ1,TPC1_HUMAN,Two pore calcium channel protein 1 (Voltage-dependent calcium channel protein TPC1),816,"94,147",5 out of 5,2007-02-06,Evidence at protein level
P0DI82,TPC2B_HUMAN,Trafficking protein particle complex subunit 2B (MBP-1-interacting protein 2A) (MIP-2A),140,"16,445",5 out of 5,2011-09-21,Evidence at protein level
Q6ZTW0,TPGS1_HUMAN,Tubulin polyglutamylase complex subunit 1 (PGs1),290,"31,275",4 out of 5,2006-09-05,Evidence at protein level
Q9H3S4,TPK1_HUMAN,Thiamin pyrophosphokinase 1 (hTPK1) (EC 2.7.6.2) (Placental protein 20) (PP20) (Thiamine pyrophosphokinase 1),243,"27,265",5 out of 5,2004-03-01,Evidence at protein level
P40225,TPO_HUMAN,Thrombopoietin (C-mpl ligand) (ML) (Megakaryocyte colony-stimulating factor) (Megakaryocyte growth and development factor) (MGDF) (Myeloproliferative leukemia virus oncogene ligand),353,"37,823",5 out of 5,1995-02-01,Evidence at protein level
O14773,TPP1_HUMAN,Tripeptidyl-peptidase 1 (TPP-1) (EC 3.4.14.9) (Cell growth-inhibiting gene 1 protein) (Lysosomal pepstatin-insensitive protease) (LPIC) (Tripeptidyl aminopeptidase) (Tripeptidyl-peptidase I) (TPP-I),563,"61,248",5 out of 5,1998-12-15,Evidence at protein level
Q9BX59,TPSNR_HUMAN,Tapasin-related protein (TAPASIN-R) (TAP-binding protein-like) (TAP-binding protein-related protein) (TAPBP-R) (Tapasin-like),468,"50,183",5 out of 5,2005-04-26,Evidence at protein level
O60507,TPST1_HUMAN,Protein-tyrosine sulfotransferase 1 (EC 2.8.2.20) (Tyrosylprotein sulfotransferase 1) (TPST-1),370,"42,188",4 out of 5,2000-05-30,Evidence at transcript level
Q56UQ5,TPT1L_HUMAN,TPT1-like protein,140,"15,757",2 out of 5,2006-10-03,Evidence at transcript level
O14763,TR10B_HUMAN,Tumor necrosis factor receptor superfamily member 10B (Death receptor 5) (TNF-related apoptosis-inducing ligand receptor 2) (TRAIL receptor 2) (TRAIL-R2) (CD antigen CD262),440,"47,878",5 out of 5,2001-09-26,Evidence at protein level
Q9BUZ4,TRAF4_HUMAN,TNF receptor-associated factor 4 (Cysteine-rich domain associated with RING and Traf domains protein 1) (Metastatic lymph node gene 62 protein) (MLN 62) (RING finger protein 83),470,"53,543",5 out of 5,2003-05-09,Evidence at protein level
Q9Y4K3,TRAF6_HUMAN,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6),522,"59,573",5 out of 5,2003-05-09,Evidence at protein level
Q12931,TRAP1_HUMAN,"Heat shock protein 75 kDa, mitochondrial (HSP 75) (TNFR-associated protein 1) (Tumor necrosis factor type 1 receptor-associated protein) (TRAP-1)",704,"80,110",5 out of 5,1999-07-15,Evidence at protein level
Q8IYL2,TRM44_HUMAN,Probable tRNA (uracil-O(2)-)-methyltransferase (EC 2.1.1.211) (Methyltransferase-like protein 19),757,"84,629",4 out of 5,2006-09-19,Evidence at protein level
Q6NT89,TRNP1_HUMAN,TMF-regulated nuclear protein 1,227,"23,482",3 out of 5,2008-05-20,Evidence at transcript level
Q12815,TROAP_HUMAN,Tastin (Trophinin-assisting protein) (Trophinin-associated protein),778,"83,857",5 out of 5,2000-05-30,Evidence at protein level
O75762,TRPA1_HUMAN,Transient receptor potential cation channel subfamily A member 1 (Ankyrin-like with transmembrane domains protein 1) (Transformation-sensitive protein p120),1119,"127,501",5 out of 5,2004-12-21,Evidence at protein level
Q13507,TRPC3_HUMAN,Short transient receptor potential channel 3 (TrpC3) (Transient receptor protein 3) (TRP-3) (hTrp-3) (hTrp3),836,"96,009",5 out of 5,2000-12-01,Evidence at protein level
Q9Y5S1,TRPV2_HUMAN,Transient receptor potential cation channel subfamily V member 2 (TrpV2) (Osm-9-like TRP channel 2) (OTRPC2) (Vanilloid receptor-like protein 1) (VRL-1),764,"85,981",5 out of 5,2005-04-26,Evidence at protein level
P98066,TSG6_HUMAN,Tumor necrosis factor-inducible gene 6 protein (Hyaluronate-binding protein) (TNF-stimulated gene 6 protein) (TSG-6) (Tumor necrosis factor alpha-induced protein 6) (TNF alpha-induced protein 6),277,"31,203",5 out of 5,1996-02-01,Evidence at protein level
P16473,TSHR_HUMAN,Thyrotropin receptor (Thyroid-stimulating hormone receptor) (TSH-R),764,"86,830",5 out of 5,1990-08-01,Evidence at protein level
P41732,TSN7_HUMAN,Tetraspanin-7 (Tspan-7) (Cell surface glycoprotein A15) (Membrane component chromosome X surface marker 1) (T-cell acute lymphoblastic leukemia-associated antigen 1) (TALLA-1) (Transmembrane 4 superfamily member 2) (CD antigen CD231),249,"27,574",5 out of 5,1995-11-01,Evidence at protein level
P19075,TSN8_HUMAN,Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029),237,"26,044",4 out of 5,1990-11-01,Evidence at protein level
P30536,TSPO_HUMAN,Translocator protein (Mitochondrial benzodiazepine receptor) (PKBS) (Peripheral-type benzodiazepine receptor) (PBR),169,"18,828",5 out of 5,1993-04-01,Evidence at protein level
Q01534,TSPY1_HUMAN,Testis-specific Y-encoded protein 1 (Cancer/testis antigen 78) (CT78),308,"35,012",5 out of 5,1994-06-01,Evidence at protein level
Q96MH6,TMM68_HUMAN,Transmembrane protein 68,324,"37,425",2 out of 5,2006-10-31,Evidence at transcript level
Q5T7P6,TMM78_HUMAN,Transmembrane protein 78,136,"15,193",1 out of 5,2007-02-20,Evidence at transcript level
Q3KNT9,TMM95_HUMAN,Transmembrane protein 95,176,"19,597",2 out of 5,2007-05-15,Evidence at transcript level
Q9NQ34,TMM9B_HUMAN,Transmembrane protein 9B,198,"22,531",4 out of 5,2002-05-10,Evidence at protein level
Q9UPQ9,TNR6B_HUMAN,Trinucleotide repeat-containing gene 6B protein,1833,"194,002",5 out of 5,2003-11-07,Evidence at protein level
Q9HC21,TPC_HUMAN,Mitochondrial thiamine pyrophosphate carrier (Mitochondrial uncoupling protein 1) (Solute carrier family 25 member 19),320,"35,511",5 out of 5,2002-02-11,Evidence at protein level
Q9HCN2,TPIP1_HUMAN,p53-regulated apoptosis-inducing protein 1 (p53AIP1),124,"12,935",4 out of 5,2007-09-11,Evidence at transcript level
P60174,TPIS_HUMAN,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Triose-phosphate isomerase),286,"30,791",5 out of 5,1986-07-21,Evidence at protein level
Q9Y2L5,TPPC8_HUMAN,Trafficking protein particle complex subunit 8 (Protein TRS85 homolog),1435,"160,997",5 out of 5,2002-04-16,Evidence at protein level
P59282,TPPP2_HUMAN,Tubulin polymerization-promoting protein family member 2 (Protein p25-beta) (TPPP/p18),170,"18,503",2 out of 5,2003-02-12,Evidence at protein level
Q6ZUI0,TPRG1_HUMAN,Tumor protein p63-regulated gene 1 protein (Protein FAM79B),275,"31,230",2 out of 5,2006-12-12,Evidence at transcript level
Q9Y3C4,TPRKB_HUMAN,EKC/KEOPS complex subunit TPRKB (PRPK-binding protein) (TP53RK-binding protein),175,"19,661",4 out of 5,2007-03-06,Evidence at protein level
Q4KMQ1,TPRN_HUMAN,Taperin,711,"75,556",3 out of 5,2008-04-29,Evidence at protein level
O15533,TPSN_HUMAN,Tapasin (TPN) (TPSN) (NGS-17) (TAP-associated protein) (TAP-binding protein),448,"47,626",5 out of 5,2001-01-24,Evidence at protein level
Q96RJ3,TR13C_HUMAN,Tumor necrosis factor receptor superfamily member 13C (B-cell-activating factor receptor) (BAFF receptor) (BAFF-R) (BLyS receptor 3) (CD antigen CD268),184,"18,864",5 out of 5,2002-05-27,Evidence at protein level
Q6F5E7,TR3N_HUMAN,Protein TXNRD3NB (Thioredoxin reductase 2 intronic transcript 1) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene protein) (TXNRD3 neighbor gene protein) (Thioredoxin reductase 3 new transcript 1),133,"14,331",2 out of 5,2008-06-10,Evidence at transcript level
C9J1S8,TR49D_HUMAN,Tripartite motif-containing protein 49D (Tripartite motif-containing protein 49-like protein) (Tripartite motif-containing protein 49D1) (Tripartite motif-containing protein 49D2),452,"52,496",3 out of 5,2010-07-13,Evidence at transcript level
A6NI03,TR64B_HUMAN,Putative tripartite motif-containing protein 64B,449,"51,557",2 out of 5,2008-06-10,Uncertain
B7Z8K6,TRDC_HUMAN,T-cell receptor delta chain C region,153,"17,085",3 out of 5,2010-04-20,Evidence at protein level
Q13061,TRDN_HUMAN,Triadin,729,"81,595",5 out of 5,2000-05-30,Evidence at protein level
Q9NZC2,TREM2_HUMAN,Triggering receptor expressed on myeloid cells 2 (TREM-2) (Triggering receptor expressed on monocytes 2),230,"25,447",5 out of 5,2004-07-19,Evidence at protein level
Q9BQ50,TREX2_HUMAN,Three prime repair exonuclease 2 (EC 3.1.11.2) (3'-5' exonuclease TREX2),279,"30,621",5 out of 5,2004-05-24,Evidence at protein level
Q9UPN9,TRI33_HUMAN,E3 ubiquitin-protein ligase TRIM33 (EC 2.3.2.27) (Ectodermin homolog) (RET-fused gene 7 protein) (Protein Rfg7) (RING-type E3 ubiquitin transferase TRIM33) (Transcription intermediary factor 1-gamma) (TIF1-gamma) (Tripartite motif-containing protein 33),1127,"122,533",5 out of 5,2001-01-24,Evidence at protein level
O94972,TRI37_HUMAN,E3 ubiquitin-protein ligase TRIM37 (EC 2.3.2.27) (Mulibrey nanism protein) (RING-type E3 ubiquitin transferase TRIM37) (Tripartite motif-containing protein 37),964,"107,906",5 out of 5,2004-11-23,Evidence at protein level
Q9BSJ1,TRI51_HUMAN,Tripartite motif-containing protein 51 (SPRY domain-containing protein 5),452,"52,285",2 out of 5,2008-04-08,Evidence at transcript level
O15016,TRI66_HUMAN,Tripartite motif-containing protein 66,1216,"134,663",4 out of 5,1998-07-15,Evidence at transcript level
Q86UV6,TRI74_HUMAN,Tripartite motif-containing protein 74 (Tripartite motif-containing protein 50C),250,"28,547",3 out of 5,2004-12-07,Evidence at protein level
O43715,TRIA1_HUMAN,TP53-regulated inhibitor of apoptosis 1 (Protein 15E1.1) (WF-1) (p53-inducible cell-survival factor) (p53CSV),76,"8,786",5 out of 5,2000-12-01,Evidence at protein level
Q8N7C3,TRIMM_HUMAN,Probable E3 ubiquitin-protein ligase TRIML2 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIML2) (SPRY domain-containing protein 6) (Tripartite motif family-like protein 2),387,"43,983",3 out of 5,2008-02-05,Evidence at protein level
Q15650,TRIP4_HUMAN,Activating signal cointegrator 1 (ASC-1) (Thyroid receptor-interacting protein 4) (TR-interacting protein 4) (TRIP-4),581,"66,146",5 out of 5,1997-11-01,Evidence at protein level
Q14669,TRIPC_HUMAN,E3 ubiquitin-protein ligase TRIP12 (EC 2.3.2.26) (E3 ubiquitin-protein ligase for Arf) (ULF) (HECT-type E3 ubiquitin transferase TRIP12) (Thyroid receptor-interacting protein 12) (TR-interacting protein 12) (TRIP-12),1992,"220,434",5 out of 5,1997-11-01,Evidence at protein level
Q7Z4G4,TRM11_HUMAN,tRNA (guanine(10)-N2)-methyltransferase homolog (EC 2.1.1.-) (tRNA guanosine-2'-O-methyltransferase TRM11 homolog),463,"53,421",3 out of 5,2006-04-04,Evidence at protein level
Q7Z2T5,TRM1L_HUMAN,TRMT1-like protein (EC 2.1.1.-),733,"81,747",4 out of 5,2008-02-05,Evidence at protein level
Q96FX7,TRM61_HUMAN,tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A (EC 2.1.1.220) (tRNA(m1A58)-methyltransferase subunit TRMT61A) (tRNA(m1A58)MTase subunit TRMT61A),289,"31,382",5 out of 5,2006-05-02,Evidence at protein level
Q6UXN2,TRML4_HUMAN,Trem-like transcript 4 protein (TLT-4) (Triggering receptor expressed on myeloid cells-like protein 4),200,"21,924",3 out of 5,2007-10-23,Evidence at transcript level
Q8NER1,TRPV1_HUMAN,Transient receptor potential cation channel subfamily V member 1 (TrpV1) (Capsaicin receptor) (Osm-9-like TRP channel 1) (OTRPC1) (Vanilloid receptor 1),839,"94,956",5 out of 5,2005-04-26,Evidence at protein level
Q9H1D0,TRPV6_HUMAN,Transient receptor potential cation channel subfamily V member 6 (TrpV6) (CaT-like) (CaT-L) (Calcium transport protein 1) (CaT1) (Epithelial calcium channel 2) (ECaC2),765,"87,286",5 out of 5,2005-04-26,Evidence at protein level
Q4KMG9,TM52B_HUMAN,Transmembrane protein 52B,183,"20,002",2 out of 5,2007-07-10,Evidence at transcript level
Q9UK28,TM59L_HUMAN,Transmembrane protein 59-like (Brain-specific membrane-anchored protein),342,"37,619",3 out of 5,2001-09-26,Evidence at transcript level
Q9NUR3,TM74B_HUMAN,Transmembrane protein 74B,256,"27,551",2 out of 5,2003-01-10,Evidence at transcript level
Q96EY4,TMA16_HUMAN,Translation machinery-associated protein 16,203,"23,864",3 out of 5,2008-02-26,Evidence at protein level
Q5JXX7,TMM31_HUMAN,Transmembrane protein 31,168,"19,813",2 out of 5,2007-04-17,Evidence at protein level
Q8N0U2,TMM61_HUMAN,Transmembrane protein 61,210,"22,170",2 out of 5,2006-10-31,Evidence at transcript level
O94826,TOM70_HUMAN,Mitochondrial import receptor subunit TOM70 (Mitochondrial precursor proteins import receptor) (Translocase of outer membrane 70 kDa subunit) (Translocase of outer mitochondrial membrane protein 70),608,"67,455",5 out of 5,2001-06-01,Evidence at protein level
Q96HA7,TONSL_HUMAN,Tonsoku-like protein (Inhibitor of kappa B-related protein) (I-kappa-B-related protein) (IkappaBR) (NF-kappa-B inhibitor-like protein 2) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2),1378,"150,929",5 out of 5,2008-04-08,Evidence at protein level
P11387,TOP1_HUMAN,DNA topoisomerase 1 (EC 5.99.1.2) (DNA topoisomerase I),765,"90,726",5 out of 5,1989-07-01,Evidence at protein level
P11388,TOP2A_HUMAN,"DNA topoisomerase 2-alpha (EC 5.99.1.3) (DNA topoisomerase II, alpha isozyme)",1531,"174,385",5 out of 5,1989-07-01,Evidence at protein level
Q02880,TOP2B_HUMAN,"DNA topoisomerase 2-beta (EC 5.99.1.3) (DNA topoisomerase II, beta isozyme)",1626,"183,267",5 out of 5,1993-07-01,Evidence at protein level
Q8WVP5,TP8L1_HUMAN,Tumor necrosis factor alpha-induced protein 8-like protein 1 (TIPE1) (TNF alpha-induced protein 8-like protein 1) (TNFAIP8-like protein 1) (Oxidative stress-regulated gene-beta) (Oxy-beta),186,"20,827",3 out of 5,2007-05-01,Evidence at protein level
Q13641,TPBG_HUMAN,Trophoblast glycoprotein (5T4 oncofetal antigen) (5T4 oncofetal trophoblast glycoprotein) (5T4 oncotrophoblast glycoprotein) (M6P1) (Wnt-activated inhibitory factor 1) (WAIF1),420,"46,032",5 out of 5,2005-08-16,Evidence at protein level
Q86SZ2,TPC6B_HUMAN,Trafficking protein particle complex subunit 6B,158,"17,983",4 out of 5,2004-03-15,Evidence at protein level
Q16890,TPD53_HUMAN,Tumor protein D53 (hD53) (Tumor protein D52-like 1),204,"22,449",5 out of 5,2001-01-24,Evidence at protein level
Q9UBN6,TR10D_HUMAN,Tumor necrosis factor receptor superfamily member 10D (Decoy receptor 2) (DcR2) (TNF-related apoptosis-inducing ligand receptor 4) (TRAIL receptor 4) (TRAIL-R4) (TRAIL receptor with a truncated death domain) (CD antigen CD264),386,"41,823",5 out of 5,2001-09-26,Evidence at protein level
Q9Y2W1,TR150_HUMAN,Thyroid hormone receptor-associated protein 3 (Thyroid hormone receptor-associated protein complex 150 kDa component) (Trap150),955,"108,666",5 out of 5,2003-02-28,Evidence at protein level
Q8N609,TR1L1_HUMAN,Translocating chain-associated membrane protein 1-like 1,369,"42,162",2 out of 5,2008-01-15,Evidence at transcript level
Q13595,TRA2A_HUMAN,Transformer-2 protein homolog alpha (TRA-2 alpha) (TRA2-alpha) (Transformer-2 protein homolog A),282,"32,689",5 out of 5,1998-12-15,Evidence at protein level
O14545,TRAD1_HUMAN,TRAF-type zinc finger domain-containing protein 1 (Protein FLN29),582,"64,841",4 out of 5,2007-02-20,Evidence at protein level
Q12933,TRAF2_HUMAN,TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3),501,"55,859",5 out of 5,2000-05-30,Evidence at protein level
Q15633,TRBP2_HUMAN,RISC-loading complex subunit TARBP2 (TAR RNA-binding protein 2) (Trans-activation-responsive RNA-binding protein),366,"39,039",5 out of 5,1998-07-15,Evidence at protein level
P0CF51,TRGC1_HUMAN,T-cell receptor gamma chain C region 1,173,"19,804",2 out of 5,2010-04-20,Evidence at protein level
Q9UDY6,TRI10_HUMAN,Tripartite motif-containing protein 10 (B30-RING finger protein) (RING finger protein 9),481,"55,037",4 out of 5,2001-09-26,Evidence at protein level
Q12899,TRI26_HUMAN,Tripartite motif-containing protein 26 (Acid finger protein) (AFP) (RING finger protein 95) (Zinc finger protein 173),539,"62,166",5 out of 5,2001-09-26,Evidence at protein level
Q13049,TRI32_HUMAN,E3 ubiquitin-protein ligase TRIM32 (EC 2.3.2.27) (72 kDa Tat-interacting protein) (RING-type E3 ubiquitin transferase TRIM32) (Tripartite motif-containing protein 32) (Zinc finger protein HT2A),653,"71,989",5 out of 5,1997-11-01,Evidence at protein level
Q8WV44,TRI41_HUMAN,E3 ubiquitin-protein ligase TRIM41 (EC 2.3.2.27) (RING finger-interacting protein with C kinase) (RINCK) (RING-type E3 ubiquitin transferase TRIM41) (Tripartite motif-containing protein 41),630,"71,670",5 out of 5,2004-05-24,Evidence at protein level
Q9BYV2,TRI54_HUMAN,Tripartite motif-containing protein 54 (Muscle-specific RING finger protein) (MuRF) (Muscle-specific RING finger protein 3) (MuRF-3) (MuRF3) (RING finger protein 30),358,"40,301",5 out of 5,2005-11-08,Evidence at protein level
Q9BRZ2,TRI56_HUMAN,E3 ubiquitin-protein ligase TRIM56 (EC 2.3.2.27) (RING finger protein 109) (RING-type E3 ubiquitin transferase TRIM56) (Tripartite motif-containing protein 56),755,"81,488",5 out of 5,2004-12-21,Evidence at protein level
A6NGJ6,TRI64_HUMAN,Tripartite motif-containing protein 64,449,"51,566",2 out of 5,2008-04-29,Evidence at transcript level
Q6ZMU5,TRI72_HUMAN,Tripartite motif-containing protein 72 (Mitsugumin-53) (Mg53),477,"52,731",5 out of 5,2007-02-20,Evidence at protein level
Q96RU8,TRIB1_HUMAN,Tribbles homolog 1 (TRB-1) (G-protein-coupled receptor-induced gene 2 protein) (GIG-2) (SKIP1),372,"41,009",5 out of 5,2005-12-06,Evidence at protein level
Q96RU7,TRIB3_HUMAN,Tribbles homolog 3 (TRB-3) (Neuronal cell death-inducible putative kinase) (SINK) (p65-interacting inhibitor of NF-kappa-B),358,"39,578",5 out of 5,2003-02-01,Evidence at protein level
Q9C040,TRIM2_HUMAN,Tripartite motif-containing protein 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM2) (RING finger protein 86) (RING-type E3 ubiquitin transferase TRIM2),744,"81,530",5 out of 5,2002-06-06,Evidence at protein level
Q9C030,TRIM6_HUMAN,Tripartite motif-containing protein 6 (EC 2.3.2.27) (RING finger protein 89) (RING-type E3 ubiquitin transferase TRIM6),488,"56,400",5 out of 5,2002-11-08,Evidence at protein level
Q15643,TRIPB_HUMAN,Thyroid receptor-interacting protein 11 (TR-interacting protein 11) (TRIP-11) (Clonal evolution-related gene on chromosome 14 protein) (Golgi-associated microtubule-binding protein 210) (GMAP-210) (Trip230),1979,"227,586",5 out of 5,1997-11-01,Evidence at protein level
A0PK05,TMM72_HUMAN,Transmembrane protein 72 (Kidney-specific secretory protein of 37 kDa),275,"29,891",2 out of 5,2008-02-26,Evidence at transcript level
Q8N9X5,TMM75_HUMAN,Transmembrane protein 75,138,"15,361",1 out of 5,2007-01-09,Evidence at transcript level
Q6ICL3,TNG2_HUMAN,Transport and Golgi organization protein 2 homolog,276,"30,937",4 out of 5,2006-10-17,Evidence at protein level
Q13470,TNK1_HUMAN,Non-receptor tyrosine-protein kinase TNK1 (EC 2.7.10.2) (CD38 negative kinase 1),666,"72,468",5 out of 5,2005-02-15,Evidence at protein level
O95271,TNKS1_HUMAN,Tankyrase-1 (TANK1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 5) (ARTD5) (Poly [ADP-ribose] polymerase 5A) (TNKS-1) (TRF1-interacting ankyrin-related ADP-ribose polymerase) (Tankyrase I),1327,"142,039",5 out of 5,2002-03-27,Evidence at protein level
P02585,TNNC2_HUMAN,"Troponin C, skeletal muscle",160,"18,122",5 out of 5,1986-07-21,Evidence at protein level
P19237,TNNI1_HUMAN,"Troponin I, slow skeletal muscle (Troponin I, slow-twitch isoform)",187,"21,692",5 out of 5,1990-11-01,Evidence at protein level
P45379,TNNT2_HUMAN,"Troponin T, cardiac muscle (TnTc) (Cardiac muscle troponin T) (cTnT)",298,"35,924",5 out of 5,1995-11-01,Evidence at protein level
Q92956,TNR14_HUMAN,Tumor necrosis factor receptor superfamily member 14 (Herpes virus entry mediator A) (Herpesvirus entry mediator A) (HveA) (Tumor necrosis factor receptor-like 2) (TR2) (CD antigen CD270),283,"30,392",5 out of 5,2001-04-27,Evidence at protein level
Q9NS68,TNR19_HUMAN,Tumor necrosis factor receptor superfamily member 19 (TRADE) (Toxicity and JNK inducer),423,"46,015",5 out of 5,2002-05-27,Evidence at protein level
Q6UXN7,TO20L_HUMAN,TOMM20-like protein 1,152,"17,700",2 out of 5,2008-02-05,Evidence at transcript level
Q5JTV8,TOIP1_HUMAN,Torsin-1A-interacting protein 1 (Lamin-associated protein 1B) (LAP1B),583,"66,248",5 out of 5,2006-03-21,Evidence at protein level
O96008,TOM40_HUMAN,Mitochondrial import receptor subunit TOM40 homolog (Protein Haymaker) (Translocase of outer membrane 40 kDa subunit homolog) (p38.5),361,"37,893",5 out of 5,2001-01-11,Evidence at protein level
Q9H497,TOR3A_HUMAN,Torsin-3A (ATP-dependent interferon-responsive protein) (Torsin family 3 member A),397,"46,199",5 out of 5,2006-03-21,Evidence at protein level
Q96NM4,TOX2_HUMAN,TOX high mobility group box family member 2 (Granulosa cell HMG box protein 1) (GCX-1),488,"51,604",4 out of 5,2002-10-19,Evidence at transcript level
P56180,TPTE_HUMAN,Putative tyrosine-protein phosphatase TPTE (EC 3.1.3.48) (Cancer/testis antigen 44) (CT44) (Transmembrane phosphatase with tensin homology) (Tumor antigen BJ-HCC-5),551,"64,322",5 out of 5,1999-07-15,Evidence at transcript level
Q9UI30,TR112_HUMAN,Multifunctional methyltransferase subunit TRM112-like protein (tRNA methyltransferase 112 homolog),125,"14,199",5 out of 5,2004-05-24,Evidence at protein level
O00300,TR11B_HUMAN,Tumor necrosis factor receptor superfamily member 11B (Osteoclastogenesis inhibitory factor) (Osteoprotegerin),401,"46,026",5 out of 5,2002-05-27,Evidence at protein level
A6NDI0,TR49B_HUMAN,Putative tripartite motif-containing protein 49B (RING finger protein 18B),452,"52,747",2 out of 5,2008-04-08,Evidence at transcript level
Q15629,TRAM1_HUMAN,Translocating chain-associated membrane protein 1,374,"43,072",5 out of 5,2001-08-29,Evidence at protein level
A0A5B9,TRBC2_HUMAN,T-cell receptor beta-2 chain C region,178,"19,969",3 out of 5,2010-04-20,Evidence at protein level
Q6ZNB5,TRC2L_HUMAN,Putative short transient receptor potential channel 2-like protein (TrpC2-like protein),142,"15,763",2 out of 5,2008-07-01,Uncertain
Q96PN7,TREF1_HUMAN,Transcriptional-regulating factor 1 (Breast cancer anti-estrogen resistance 2) (Transcriptional-regulating protein 132) (Zinc finger protein rapa) (Zinc finger transcription factor TReP-132),1200,"132,256",5 out of 5,2005-09-13,Evidence at protein level
P08582,TRFM_HUMAN,Melanotransferrin (Melanoma-associated antigen p97) (CD antigen CD228),738,"80,215",5 out of 5,1988-08-01,Evidence at protein level
Q6P9F5,TRI40_HUMAN,Tripartite motif-containing protein 40 (Probable E3 NEDD8-protein ligase) (RING finger protein 35),258,"29,336",5 out of 5,2004-12-07,Evidence at protein level
Q96BQ3,TRI43_HUMAN,Tripartite motif-containing protein 43,446,"52,265",2 out of 5,2004-12-07,Evidence at protein level
Q9UJV3,TRIM1_HUMAN,Probable E3 ubiquitin-protein ligase MID2 (EC 2.3.2.27) (Midin-2) (Midline defect 2) (Midline-2) (RING finger protein 60) (RING-type E3 ubiquitin transferase MID2) (Tripartite motif-containing protein 1),735,"83,210",5 out of 5,2003-11-28,Evidence at protein level
Q9BU70,TRMO_HUMAN,tRNA (adenine(37)-N6)-methyltransferase (EC 2.1.1.-) (tRNA methyltransferase O),441,"48,587",3 out of 5,2007-05-29,Evidence at transcript level
O94759,TRPM2_HUMAN,Transient receptor potential cation channel subfamily M member 2 (Estrogen-responsive element-associated gene 1 protein) (Long transient receptor potential channel 2) (LTrpC-2) (LTrpC2) (Transient receptor potential channel 7) (TrpC7) (Transient receptor potential melastatin 2),1503,"171,198",5 out of 5,2000-05-30,Evidence at protein level
Q9NZQ8,TRPM5_HUMAN,Transient receptor potential cation channel subfamily M member 5 (Long transient receptor potential channel 5) (LTrpC-5) (LTrpC5) (MLSN1- and TRP-related gene 1 protein),1165,"131,451",5 out of 5,2008-04-08,Evidence at transcript level
Q96QT4,TRPM7_HUMAN,Transient receptor potential cation channel subfamily M member 7 (EC 2.7.11.1) (Channel-kinase 1) (Long transient receptor potential channel 7) (LTrpC-7) (LTrpC7),1865,"212,697",5 out of 5,2004-12-07,Evidence at protein level
Q9UHF7,TRPS1_HUMAN,Zinc finger transcription factor Trps1 (Tricho-rhino-phalangeal syndrome type I protein) (Zinc finger protein GC79),1281,"141,521",5 out of 5,2002-03-27,Evidence at protein level
Q9HBA0,TRPV4_HUMAN,Transient receptor potential cation channel subfamily V member 4 (TrpV4) (Osm-9-like TRP channel 4) (OTRPC4) (Transient receptor potential protein 12) (TRP12) (Vanilloid receptor-like channel 2) (Vanilloid receptor-like protein 2) (VRL-2) (Vanilloid receptor-related osmotically-activated channel) (VR-OAC),871,"98,281",5 out of 5,2005-04-26,Evidence at protein level
Q9NP84,TNR12_HUMAN,Tumor necrosis factor receptor superfamily member 12A (Fibroblast growth factor-inducible immediate-early response protein 14) (FGF-inducible 14) (Tweak-receptor) (TweakR) (CD antigen CD266),129,"13,911",5 out of 5,2002-05-27,Evidence at protein level
Q63HR2,TNS2_HUMAN,Tensin-2 (EC 3.1.3.-) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-like C1 domain-containing phosphatase),1409,"152,580",5 out of 5,2007-06-26,Evidence at protein level
Q8N6T0,TO6BL_HUMAN,Type 2 DNA topoisomerase 6 subunit B-like (Type 2 DNA topoisomerase VI subunit B-like) (TOPOVIBL),577,"64,047",3 out of 5,2007-07-24,Evidence at transcript level
Q969P6,TOP1M_HUMAN,"DNA topoisomerase I, mitochondrial (TOP1mt) (EC 5.99.1.2)",601,"69,872",5 out of 5,2002-01-31,Evidence at protein level
Q5JU69,TOR2A_HUMAN,Torsin-2A (Torsin family 2 member A) (Torsin-related protein 1),321,"35,714",4 out of 5,2006-03-21,Evidence at transcript level
O15405,TOX3_HUMAN,TOX high mobility group box family member 3 (CAG trinucleotide repeat-containing gene F9 protein) (Trinucleotide repeat-containing gene 9 protein),576,"63,342",5 out of 5,2007-05-01,Evidence at protein level
O94900,TOX_HUMAN,Thymocyte selection-associated high mobility group box protein TOX (Thymus high mobility group box protein TOX),526,"57,513",2 out of 5,2006-06-27,Evidence at transcript level
Q93096,TP4A1_HUMAN,Protein tyrosine phosphatase type IVA 1 (EC 3.1.3.48) (PTP(CAAXI)) (Protein-tyrosine phosphatase 4a1) (Protein-tyrosine phosphatase of regenerating liver 1) (PRL-1),173,"19,815",5 out of 5,2005-07-05,Evidence at protein level
Q8TEL6,TP4AP_HUMAN,Short transient receptor potential channel 4-associated protein (Trp4-associated protein) (Trpc4-associated protein) (Protein TAP1) (TNF-receptor ubiquitous scaffolding/signaling protein) (Protein TRUSS),797,"90,852",5 out of 5,2002-11-15,Evidence at protein level
Q12888,TP53B_HUMAN,Tumor suppressor p53-binding protein 1 (53BP1) (p53-binding protein 1) (p53BP1),1972,"213,574",5 out of 5,1998-07-15,Evidence at protein level
O75865,TPC6A_HUMAN,Trafficking protein particle complex subunit 6A (TRAPP complex subunit 6A),159,"17,605",5 out of 5,2006-06-27,Evidence at protein level
P55327,TPD52_HUMAN,Tumor protein D52 (Protein N8),224,"24,327",5 out of 5,1996-10-01,Evidence at protein level
O43399,TPD54_HUMAN,Tumor protein D54 (hD54) (Tumor protein D52-like 2),206,"22,238",5 out of 5,2001-01-24,Evidence at protein level
Q68CL5,TPGS2_HUMAN,Tubulin polyglutamylase complex subunit 2 (PGs2),300,"33,318",3 out of 5,2005-07-19,Evidence at transcript level
P17752,TPH1_HUMAN,Tryptophan 5-hydroxylase 1 (EC 1.14.16.4) (Tryptophan 5-monooxygenase 1),444,"50,985",5 out of 5,1990-08-01,Evidence at protein level
P06753,TPM3_HUMAN,Tropomyosin alpha-3 chain (Gamma-tropomyosin) (Tropomyosin-3) (Tropomyosin-5) (hTM5),285,"32,950",5 out of 5,1988-01-01,Evidence at protein level
P51580,TPMT_HUMAN,Thiopurine S-methyltransferase (EC 2.1.1.67) (Thiopurine methyltransferase),245,"28,180",5 out of 5,1996-10-01,Evidence at protein level
O94811,TPPP_HUMAN,Tubulin polymerization-promoting protein (TPPP) (25 kDa brain-specific protein) (TPPP/p25) (p24) (p25-alpha),219,"23,694",5 out of 5,2003-02-12,Evidence at protein level
Q6XPS3,TPTE2_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase TPTE2 (EC 3.1.3.67) (Lipid phosphatase TPIP) (TPTE and PTEN homologous inositol lipid phosphatase)",522,"61,112",5 out of 5,2006-02-21,Evidence at protein level
P0CI26,TR49C_HUMAN,Tripartite motif-containing protein 49C (Tripartite motif-containing protein 49-like protein 2),452,"52,933",2 out of 5,2010-11-02,Evidence at transcript level
Q9BVS5,TR61B_HUMAN,"tRNA (adenine(58)-N(1))-methyltransferase, mitochondrial (EC 2.1.1.220)",477,"52,965",5 out of 5,2007-12-04,Evidence at protein level
P62995,TRA2B_HUMAN,"Transformer-2 protein homolog beta (TRA-2 beta) (TRA2-beta) (hTRA2-beta) (Splicing factor, arginine/serine-rich 10) (Transformer-2 protein homolog B)",288,"33,666",5 out of 5,2004-08-31,Evidence at protein level
Q9H4I3,TRABD_HUMAN,TraB domain-containing protein (Protein TTG2),376,"42,321",2 out of 5,2002-04-03,Evidence at protein level
Q13077,TRAF1_HUMAN,TNF receptor-associated factor 1 (Epstein-Barr virus-induced protein 6),416,"46,164",5 out of 5,2000-05-30,Evidence at protein level
Q6Q0C0,TRAF7_HUMAN,E3 ubiquitin-protein ligase TRAF7 (EC 2.3.2.27) (RING finger and WD repeat-containing protein 1) (RING finger protein 119) (RING-type E3 ubiquitin transferase TRAF7) (TNF receptor-associated factor 7),670,"74,609",5 out of 5,2004-10-11,Evidence at protein level
Q9UPV9,TRAK1_HUMAN,Trafficking kinesin-binding protein 1 (106 kDa O-GlcNAc transferase-interacting protein),953,"106,040",5 out of 5,2001-02-21,Evidence at protein level
Q9NP99,TREM1_HUMAN,Triggering receptor expressed on myeloid cells 1 (TREM-1) (Triggering receptor expressed on monocytes 1) (CD antigen CD354),234,"26,387",5 out of 5,2004-07-19,Evidence at protein level
Q9NSU2,TREX1_HUMAN,Three-prime repair exonuclease 1 (EC 3.1.11.2) (3'-5' exonuclease TREX1) (DNase III),369,"38,923",5 out of 5,2004-05-24,Evidence at protein level
Q14142,TRI14_HUMAN,Tripartite motif-containing protein 14,442,"49,773",5 out of 5,1997-11-01,Evidence at transcript level
Q9Y577,TRI17_HUMAN,E3 ubiquitin-protein ligase TRIM17 (EC 2.3.2.27) (RING finger protein 16) (RING-type E3 ubiquitin transferase TRIM17) (Testis RING finger protein) (Tripartite motif-containing protein 17),477,"54,418",5 out of 5,2003-11-28,Evidence at protein level
O15344,TRI18_HUMAN,E3 ubiquitin-protein ligase Midline-1 (EC 2.3.2.27) (Midin) (Putative transcription factor XPRF) (RING finger protein 59) (RING finger protein Midline-1) (RING-type E3 ubiquitin transferase Midline-1) (Tripartite motif-containing protein 18),667,"75,251",5 out of 5,2002-08-30,Evidence at protein level
Q8IYM9,TRI22_HUMAN,E3 ubiquitin-protein ligase TRIM22 (EC 2.3.2.27) (50 kDa-stimulated trans-acting factor) (RING finger protein 94) (RING-type E3 ubiquitin transferase TRIM22) (Staf-50) (Tripartite motif-containing protein 22),498,"56,947",5 out of 5,2004-05-24,Evidence at protein level
Q9UPQ4,TRI35_HUMAN,Tripartite motif-containing protein 35 (Hemopoietic lineage switch protein 5),493,"56,540",5 out of 5,2004-12-07,Evidence at protein level
Q86XT4,TRI50_HUMAN,E3 ubiquitin-protein ligase TRIM50 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM50) (Tripartite motif-containing protein 50),487,"54,774",5 out of 5,2004-12-07,Evidence at protein level
Q9BYV6,TRI55_HUMAN,Tripartite motif-containing protein 55 (Muscle-specific RING finger protein 2) (MuRF-2) (MuRF2) (RING finger protein 29),548,"60,466",5 out of 5,2002-06-06,Evidence at protein level
Q495X7,TRI60_HUMAN,Tripartite motif-containing protein 60 (RING finger protein 129) (RING finger protein 33),471,"55,114",2 out of 5,2006-09-05,Evidence at transcript level
O75382,TRIM3_HUMAN,Tripartite motif-containing protein 3 (Brain-expressed RING finger protein) (RING finger protein 22) (RING finger protein 97),744,"80,830",5 out of 5,2002-06-06,Evidence at protein level
Q86YW5,TRML1_HUMAN,Trem-like transcript 1 protein (TLT-1) (Triggering receptor expressed on myeloid cells-like protein 1),311,"32,679",5 out of 5,2006-10-17,Evidence at protein level
Q96GM8,TOE1_HUMAN,Target of EGR1 protein 1,510,"56,548",5 out of 5,2007-01-09,Evidence at protein level
Q8N9V7,TOPZ1_HUMAN,Testis- and ovary-specific PAZ domain-containing protein 1,1692,"190,927",3 out of 5,2008-02-26,Evidence at transcript level
Q9NXH8,TOR4A_HUMAN,Torsin-4A (Torsin family 4 member A),423,"46,914",3 out of 5,2007-05-15,Evidence at protein level
Q5GJ75,TP8L3_HUMAN,Tumor necrosis factor alpha-induced protein 8-like protein 3 (TNF alpha-induced protein 8-like protein 3) (TNFAIP8-like protein 3),292,"32,659",4 out of 5,2008-04-29,Evidence at protein level
Q7Z392,TPC11_HUMAN,Trafficking protein particle complex subunit 11,1133,"128,881",5 out of 5,2008-09-02,Evidence at protein level
Q309B1,TR16L_HUMAN,Tripartite motif-containing protein 16-like protein (Tripartite motif-containing protein 70),348,"40,306",3 out of 5,2007-03-06,Evidence at transcript level
A6NCK2,TR43B_HUMAN,Tripartite motif-containing protein 43B,446,"52,310",2 out of 5,2008-02-26,Inferred from homology
Q9C019,TRI15_HUMAN,Tripartite motif-containing protein 15 (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7),465,"52,113",5 out of 5,2002-11-08,Evidence at protein level
P36406,TRI23_HUMAN,E3 ubiquitin-protein ligase TRIM23 (EC 2.3.2.27) (ADP-ribosylation factor domain-containing protein 1) (GTP-binding protein ARD-1) (RING finger protein 46) (RING-type E3 ubiquitin transferase TRIM23) (Tripartite motif-containing protein 23),574,"64,067",5 out of 5,1994-06-01,Evidence at protein level
Q14258,TRI25_HUMAN,E3 ubiquitin/ISG15 ligase TRIM25 (EC 6.3.2.n3) (Estrogen-responsive finger protein) (RING finger protein 147) (RING-type E3 ubiquitin transferase) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase TRIM25) (Tripartite motif-containing protein 25) (Ubiquitin/ISG15-conjugating enzyme TRIM25) (Zinc finger protein 147),630,"70,973",5 out of 5,2001-01-24,Evidence at protein level
Q14134,TRI29_HUMAN,Tripartite motif-containing protein 29 (Ataxia telangiectasia group D-associated protein),588,"65,835",5 out of 5,2004-11-23,Evidence at protein level
Q9BYJ4,TRI34_HUMAN,Tripartite motif-containing protein 34 (Interferon-responsive finger protein 1) (RING finger protein 21),488,"56,864",5 out of 5,2004-11-23,Evidence at protein level
Q9HCM9,TRI39_HUMAN,E3 ubiquitin-protein ligase TRIM39 (EC 2.3.2.27) (RING finger protein 23) (RING-type E3 ubiquitin transferase TRIM39) (Testis-abundant finger protein) (Tripartite motif-containing protein 39),518,"59,690",5 out of 5,2001-09-26,Evidence at protein level
Q9H8W5,TRI45_HUMAN,Tripartite motif-containing protein 45 (RING finger protein 99),580,"64,359",5 out of 5,2004-11-23,Evidence at protein level
Q6ZTA4,TRI67_HUMAN,Tripartite motif-containing protein 67 (TRIM9-like protein),783,"83,823",3 out of 5,2006-10-31,Evidence at transcript level
Q9C035,TRIM5_HUMAN,Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5),493,"56,338",5 out of 5,2003-11-28,Evidence at protein level
Q9C026,TRIM9_HUMAN,E3 ubiquitin-protein ligase TRIM9 (EC 2.3.2.27) (RING finger protein 91) (RING-type E3 ubiquitin transferase TRIM9) (Tripartite motif-containing protein 9),710,"79,177",5 out of 5,2003-08-04,Evidence at protein level
Q9UBP6,TRMB_HUMAN,tRNA (guanine-N(7)-)-methyltransferase (EC 2.1.1.33) (Methyltransferase-like protein 1) (tRNA (guanine(46)-N(7))-methyltransferase) (tRNA(m7G46)-methyltransferase),276,"31,471",5 out of 5,2003-06-20,Evidence at protein level
Q12816,TROP_HUMAN,Trophinin (MAGE-D3 antigen),1431,"143,716",5 out of 5,2000-05-30,Evidence at protein level
P48995,TRPC1_HUMAN,Short transient receptor potential channel 1 (TrpC1) (Transient receptor protein 1) (TRP-1),793,"91,212",5 out of 5,1996-02-01,Evidence at protein level
Q9UBN4,TRPC4_HUMAN,Short transient receptor potential channel 4 (TrpC4) (Trp-related protein 4) (hTrp-4) (hTrp4),977,"112,101",5 out of 5,2001-04-27,Evidence at protein level
Q9HCX4,TRPC7_HUMAN,Short transient receptor potential channel 7 (TrpC7) (Transient receptor protein 7) (TRP-7) (hTRP7),862,"99,562",5 out of 5,2001-06-20,Evidence at protein level
P31314,TLX1_HUMAN,T-cell leukemia homeobox protein 1 (Homeobox protein Hox-11) (Proto-oncogene TCL-3) (T-cell leukemia/lymphoma protein 3),330,"34,365",5 out of 5,1993-07-01,Evidence at protein level
Q9H0C3,TM117_HUMAN,Transmembrane protein 117,514,"60,185",2 out of 5,2006-10-03,Evidence at transcript level
Q86T26,TM11B_HUMAN,Transmembrane protease serine 11B (EC 3.4.21.-) (Airway trypsin-like protease 5),416,"46,337",5 out of 5,2007-09-11,Evidence at transcript level
Q9UL52,TM11E_HUMAN,Transmembrane protease serine 11E (EC 3.4.21.-) (Serine protease DESC1) (Transmembrane protease serine 11E2) [Cleaved into: Transmembrane protease serine 11E non-catalytic chain; Transmembrane protease serine 11E catalytic chain],423,"47,696",5 out of 5,2001-10-18,Evidence at protein level
Q96AN5,TM143_HUMAN,Transmembrane protein 143,459,"51,715",2 out of 5,2007-05-01,Evidence at transcript level
Q8N616,TM148_HUMAN,Putative uncharacterized protein encoded by LINC00311,119,"12,924",1 out of 5,2007-01-09,Uncertain
Q8TC26,TM163_HUMAN,Transmembrane protein 163,289,"31,469",3 out of 5,2007-02-20,Evidence at transcript level
Q5U3C3,TM164_HUMAN,Transmembrane protein 164,297,"33,508",2 out of 5,2006-10-31,Evidence at transcript level
Q96Q45,TM237_HUMAN,Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein),408,"45,526",5 out of 5,2005-12-20,Evidence at protein level
Q9NWH2,TM242_HUMAN,Transmembrane protein 242,141,"14,758",2 out of 5,2007-07-24,Evidence at protein level
Q5VZI3,TM268_HUMAN,Transmembrane protein 268,342,"37,569",2 out of 5,2007-03-06,Evidence at transcript level
Q9NVV0,TM38B_HUMAN,Trimeric intracellular cation channel type B (TRIC-B) (TRICB) (Transmembrane protein 38B),291,"32,510",4 out of 5,2007-06-26,Evidence at protein level
Q7Z402,TMC7_HUMAN,Transmembrane channel-like protein 7,723,"83,502",3 out of 5,2007-05-15,Evidence at protein level
P49755,TMEDA_HUMAN,Transmembrane emp24 domain-containing protein 10 (21 kDa transmembrane-trafficking protein) (S31III125) (S31I125) (Tmp-21-I) (Transmembrane protein Tmp21) (p23) (p24 family protein delta-1) (p24delta1) (p24delta),219,"24,976",5 out of 5,1996-10-01,Evidence at protein level
Q9P0T7,TMEM9_HUMAN,Transmembrane protein 9 (Dermal papilla-derived protein 4),183,"20,574",5 out of 5,2002-05-10,Evidence at protein level
O14669,TMG2_HUMAN,Transmembrane gamma-carboxyglutamic acid protein 2 (Proline-rich gamma-carboxyglutamic acid protein 2) (Proline-rich Gla protein 2),202,"22,393",4 out of 5,2002-01-23,Evidence at protein level
Q6UXZ0,TMIG1_HUMAN,Transmembrane and immunoglobulin domain-containing protein 1,262,"29,185",3 out of 5,2006-01-24,Evidence at transcript level
Q9BTV4,TMM43_HUMAN,Transmembrane protein 43 (Protein LUMA),400,"44,876",5 out of 5,2007-04-17,Evidence at protein level
Q969K7,TMM54_HUMAN,Transmembrane protein 54 (Beta-casein-like protein) (Protein CAC-1),222,"23,772",3 out of 5,2006-03-07,Evidence at transcript level
Q6YI46,TMM64_HUMAN,Transmembrane protein 64,380,"39,665",4 out of 5,2007-05-15,Evidence at transcript level
Q96HE8,TMM80_HUMAN,Transmembrane protein 80,168,"18,160",2 out of 5,2007-05-15,Evidence at transcript level
A6NI61,TMM8C_HUMAN,Protein myomaker (Transmembrane protein 226) (Transmembrane protein 8C),221,"24,699",3 out of 5,2008-02-26,Inferred from homology
Q6UXU6,TMM92_HUMAN,Transmembrane protein 92,159,"17,229",2 out of 5,2006-10-03,Evidence at transcript level
Q9NYL9,TMOD3_HUMAN,Tropomodulin-3 (Ubiquitous tropomodulin) (U-Tmod),352,"39,595",3 out of 5,2002-09-19,Evidence at protein level
Q9H3S3,TMPS5_HUMAN,Transmembrane protease serine 5 (EC 3.4.21.-) (Spinesin),457,"49,560",5 out of 5,2001-04-27,Evidence at protein level
Q71RG4,TMUB2_HUMAN,Transmembrane and ubiquitin-like domain-containing protein 2,321,"33,788",3 out of 5,2006-07-11,Evidence at protein level
Q9Y320,TMX2_HUMAN,Thioredoxin-related transmembrane protein 2 (Cell proliferation-inducing gene 26 protein) (Thioredoxin domain-containing protein 14),296,"34,038",3 out of 5,2008-01-15,Evidence at protein level
P32971,TNFL8_HUMAN,Tumor necrosis factor ligand superfamily member 8 (CD30 ligand) (CD30-L) (CD antigen CD153),234,"26,017",5 out of 5,1993-10-01,Evidence at transcript level
Q9H2S6,TNMD_HUMAN,Tenomodulin (TeM) (hTeM) (Chondromodulin-1-like protein) (ChM1L) (hChM1L) (Chondromodulin-I-like protein) (Myodulin) (Tendin),317,"37,130",5 out of 5,2001-08-29,Evidence at protein level
P45378,TNNT3_HUMAN,"Troponin T, fast skeletal muscle (TnTf) (Beta-TnTF) (Fast skeletal muscle troponin T) (fTnT)",269,"31,825",5 out of 5,1995-11-01,Evidence at protein level
Q92973,TNPO1_HUMAN,Transportin-1 (Importin beta-2) (Karyopherin beta-2) (M9 region interaction protein) (MIP),898,"102,355",5 out of 5,1997-11-01,Evidence at protein level
Q9Y5L0,TNPO3_HUMAN,Transportin-3 (Importin-12) (Imp12) (Transportin-SR) (TRN-SR),923,"104,203",5 out of 5,2004-08-16,Evidence at protein level
Q9Y5U5,TNR18_HUMAN,Tumor necrosis factor receptor superfamily member 18 (Activation-inducible TNFR family receptor) (Glucocorticoid-induced TNFR-related protein) (CD antigen CD357),241,"26,000",5 out of 5,2001-04-27,Evidence at protein level
Q9HAV5,TNR27_HUMAN,Tumor necrosis factor receptor superfamily member 27 (X-linked ectodysplasin-A2 receptor) (EDA-A2 receptor),297,"32,759",5 out of 5,2002-05-27,Evidence at protein level
P43489,TNR4_HUMAN,Tumor necrosis factor receptor superfamily member 4 (ACT35 antigen) (OX40L receptor) (TAX transcriptionally-activated glycoprotein 1 receptor) (CD antigen CD134),277,"29,341",5 out of 5,1995-11-01,Evidence at protein level
Q9H0E2,TOLIP_HUMAN,Toll-interacting protein,274,"30,282",5 out of 5,2002-03-27,Evidence at protein level
Q96B49,TOM6_HUMAN,Mitochondrial import receptor subunit TOM6 homolog (Overexpressed breast tumor protein) (Translocase of outer membrane 6 kDa subunit homolog),74,"8,002",3 out of 5,2007-09-11,Evidence at protein level
Q8WZ04,TOMT_HUMAN,Transmembrane O-methyltransferase (EC 2.1.1.6) (Catechol O-methyltransferase 2) (Protein LRTOMT2),291,"32,155",5 out of 5,2008-11-25,Evidence at protein level
Q13472,TOP3A_HUMAN,DNA topoisomerase 3-alpha (EC 5.99.1.2) (DNA topoisomerase III alpha),1001,"112,372",5 out of 5,1997-11-01,Evidence at protein level
Q96KB5,TOPK_HUMAN,Lymphokine-activated killer T-cell-originated protein kinase (EC 2.7.12.2) (Cancer/testis antigen 84) (CT84) (MAPKK-like protein kinase) (Nori-3) (PDZ-binding kinase) (Spermatogenesis-related protein kinase) (SPK) (T-LAK cell-originated protein kinase),322,"36,085",5 out of 5,2005-02-01,Evidence at protein level
O14657,TOR1B_HUMAN,Torsin-1B (Torsin ATPase-1B) (EC 3.6.4.-) (Torsin family 1 member B),336,"37,979",5 out of 5,2001-04-27,Evidence at protein level
Q8N2E6,TOR2X_HUMAN,Prosalusin (Torsin family 2 member A) (Torsin-2A) [Cleaved into: Salusin-alpha; Salusin-beta],242,"26,262",4 out of 5,2006-03-21,Evidence at protein level
A6NMA1,TR5OS_HUMAN,Putative uncharacterized protein TRPC5OS (TRPC5 opposite strand protein) (TRPC5-antisense RNA 1),111,"12,326",2 out of 5,2008-09-02,Predicted
O00463,TRAF5_HUMAN,TNF receptor-associated factor 5 (RING finger protein 84),557,"64,406",5 out of 5,2003-05-09,Evidence at protein level
Q8NG06,TRI58_HUMAN,E3 ubiquitin-protein ligase TRIM58 (EC 2.3.2.27) (Protein BIA2) (RING-type E3 ubiquitin transferase TRIM58) (Tripartite motif-containing protein 58),486,"54,766",4 out of 5,2007-01-23,Evidence at transcript level
Q8IWR1,TRI59_HUMAN,Tripartite motif-containing protein 59 (RING finger protein 104) (Tumor suppressor TSBF-1),403,"47,114",5 out of 5,2006-09-19,Evidence at protein level
Q86UV7,TRI73_HUMAN,Tripartite motif-containing protein 73 (Tripartite motif-containing protein 50B),250,"28,517",2 out of 5,2004-12-07,Evidence at transcript level
Q15654,TRIP6_HUMAN,Thyroid receptor-interacting protein 6 (TR-interacting protein 6) (TRIP-6) (Opa-interacting protein 1) (OIP-1) (Zyxin-related protein 1) (ZRP-1),476,"50,288",5 out of 5,1997-11-01,Evidence at protein level
O15050,TRNK1_HUMAN,TPR and ankyrin repeat-containing protein 1 (Lupus brain antigen 1 homolog),2925,"336,221",2 out of 5,2008-09-02,Evidence at transcript level
Q86TN4,TRPT1_HUMAN,tRNA 2'-phosphotransferase 1 (EC 2.7.1.160),253,"27,742",3 out of 5,2007-01-23,Evidence at protein level
Q8NET8,TRPV3_HUMAN,Transient receptor potential cation channel subfamily V member 3 (TrpV3) (Vanilloid receptor-like 3) (VRL-3),790,"90,636",5 out of 5,2005-04-26,Evidence at protein level
Q9NQA5,TRPV5_HUMAN,Transient receptor potential cation channel subfamily V member 5 (TrpV5) (Calcium transport protein 2) (CaT2) (Epithelial calcium channel 1) (ECaC) (ECaC1) (Osm-9-like TRP channel 3) (OTRPC3),729,"82,551",5 out of 5,2005-04-26,Evidence at protein level
Q8WWH5,TRUB1_HUMAN,Probable tRNA pseudouridine synthase 1 (EC 5.4.99.-),349,"37,253",3 out of 5,2006-10-03,Evidence at protein level
Q9BY10,TSCOT_HUMAN,Thymic stromal cotransporter homolog (Solute carrier family 46 member 2),475,"51,067",3 out of 5,2005-02-01,Evidence at transcript level
Q96PP4,TSG13_HUMAN,Testis-specific gene 13 protein,275,"31,778",2 out of 5,2007-05-01,Evidence at transcript level
O95857,TSN13_HUMAN,Tetraspanin-13 (Tspan-13) (Tetraspan NET-6) (Transmembrane 4 superfamily member 13),204,"22,147",3 out of 5,2000-12-01,Evidence at transcript level
O60636,TSN2_HUMAN,Tetraspanin-2 (Tspan-2) (Tetraspan NET-3),221,"24,148",4 out of 5,2000-12-01,Evidence at protein level
P62079,TSN5_HUMAN,Tetraspanin-5 (Tspan-5) (Tetraspan NET-4) (Transmembrane 4 superfamily member 9),268,"30,337",4 out of 5,2004-06-21,Evidence at protein level
P0CW01,TSPYA_HUMAN,Testis-specific Y-encoded protein 10,314,"35,727",3 out of 5,2011-05-03,Inferred from homology
Q96PN8,TSSK3_HUMAN,Testis-specific serine/threonine-protein kinase 3 (TSK-3) (TSSK-3) (Testis-specific kinase 3) (EC 2.7.11.1) (Serine/threonine-protein kinase 22C),268,"30,102",5 out of 5,2003-04-30,Evidence at protein level
Q5T7W7,TSTD2_HUMAN,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 2 (Rhodanese domain-containing protein 2),516,"58,263",3 out of 5,2006-04-04,Evidence at protein level
Q9H0U9,TSYL1_HUMAN,Testis-specific Y-encoded-like protein 1 (TSPY-like protein 1),437,"49,192",3 out of 5,2003-08-15,Evidence at protein level
Q9H892,TTC12_HUMAN,Tetratricopeptide repeat protein 12 (TPR repeat protein 12),705,"78,756",3 out of 5,2003-12-15,Evidence at protein level
A2A3L6,TTC24_HUMAN,Tetratricopeptide repeat protein 24 (TPR repeat protein 24),582,"63,396",2 out of 5,2007-10-23,Predicted
O95801,TTC4_HUMAN,Tetratricopeptide repeat protein 4 (TPR repeat protein 4),387,"44,679",2 out of 5,2000-05-30,Evidence at protein level
Q8TAM2,TTC8_HUMAN,Tetratricopeptide repeat protein 8 (TPR repeat protein 8) (Bardet-Biedl syndrome 8 protein),541,"61,534",5 out of 5,2003-07-19,Evidence at protein level
Q14166,TTL12_HUMAN,Tubulin--tyrosine ligase-like protein 12,644,"74,404",2 out of 5,2000-05-30,Evidence at protein level
Q9BXU2,TX13B_HUMAN,Testis-expressed protein 13B,312,"33,967",2 out of 5,2004-07-19,Evidence at protein level
O14907,TX1B3_HUMAN,Tax1-binding protein 3 (Glutaminase-interacting protein 3) (Tax interaction protein 1) (TIP-1) (Tax-interacting protein 1),124,"13,735",5 out of 5,2006-05-02,Evidence at protein level
Q6PKC3,TXD11_HUMAN,Thioredoxin domain-containing protein 11 (EF-hand-binding protein 1),985,"110,529",5 out of 5,2005-07-05,Evidence at protein level
O95881,TXD12_HUMAN,Thioredoxin domain-containing protein 12 (EC 1.8.4.2) (Endoplasmic reticulum resident protein 18) (ER protein 18) (ERp18) (Endoplasmic reticulum resident protein 19) (ER protein 19) (ERp19) (Thioredoxin-like protein p19) (hTLP19),172,"19,206",5 out of 5,2003-04-11,Evidence at protein level
Q2TAA8,TXIP1_HUMAN,Translin-associated factor X-interacting protein 1 (Trax-interacting protein 1),658,"76,773",2 out of 5,2008-03-18,Evidence at transcript level
O43396,TXNL1_HUMAN,Thioredoxin-like protein 1 (32 kDa thioredoxin-related protein),289,"32,251",5 out of 5,2001-10-18,Evidence at protein level
Q06418,TYRO3_HUMAN,Tyrosine-protein kinase receptor TYRO3 (EC 2.7.10.1) (Tyrosine-protein kinase BYK) (Tyrosine-protein kinase DTK) (Tyrosine-protein kinase RSE) (Tyrosine-protein kinase SKY) (Tyrosine-protein kinase TIF),890,"96,905",5 out of 5,1996-10-01,Evidence at protein level
P14679,TYRO_HUMAN,Tyrosinase (EC 1.14.18.1) (LB24-AB) (Monophenol monooxygenase) (SK29-AB) (Tumor rejection antigen AB),529,"60,393",5 out of 5,1990-04-01,Evidence at protein level
Q9NNW7,TRXR2_HUMAN,"Thioredoxin reductase 2, mitochondrial (EC 1.8.1.9) (Selenoprotein Z) (SelZ) (TR-beta) (Thioredoxin reductase TR3)",524,"56,507",5 out of 5,2003-09-19,Evidence at protein level
O75954,TSN9_HUMAN,Tetraspanin-9 (Tspan-9) (Tetraspan NET-5),239,"26,779",3 out of 5,2000-12-01,Evidence at protein level
Q5TGU0,TSPO2_HUMAN,Translocator protein 2 (Peripheral-type benzodiazepine receptor-like protein 1),170,"19,129",3 out of 5,2007-06-26,Evidence at transcript level
Q53HC9,TSSC1_HUMAN,Protein TSSC1 (EARP-interacting protein) (Endosome-associated recycling protein-interacting protein) (Tumor-suppressing STF cDNA 1 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 1 protein),387,"43,603",2 out of 5,2005-12-20,Evidence at protein level
Q9BXA7,TSSK1_HUMAN,Testis-specific serine/threonine-protein kinase 1 (TSK-1) (TSK1) (TSSK-1) (Testis-specific kinase 1) (EC 2.7.11.1) (Serine/threonine-protein kinase 22A),367,"41,618",5 out of 5,2003-04-30,Evidence at protein level
Q86VY4,TSYL5_HUMAN,Testis-specific Y-encoded-like protein 5 (TSPY-like protein 5),417,"45,143",4 out of 5,2007-10-23,Evidence at protein level
Q5VTQ0,TT39B_HUMAN,Tetratricopeptide repeat protein 39B (TPR repeat protein 39B),682,"76,956",3 out of 5,2007-06-26,Evidence at protein level
Q5W5X9,TTC23_HUMAN,Tetratricopeptide repeat protein 23 (TPR repeat protein 23) (Cervical cancer proto-oncogene 8 protein) (HCC-8),447,"50,009",5 out of 5,2007-05-29,Evidence at protein level
Q49AM3,TTC31_HUMAN,Tetratricopeptide repeat protein 31 (TPR repeat protein 31),519,"57,105",2 out of 5,2007-03-20,Evidence at protein level
P33981,TTK_HUMAN,Dual specificity protein kinase TTK (EC 2.7.12.1) (Phosphotyrosine picked threonine-protein kinase) (PYT),857,"97,072",5 out of 5,1994-02-01,Evidence at protein level
O95922,TTLL1_HUMAN,Probable tubulin polyglutamylase TTLL1 (EC 6.-.-.-) (Tubulin polyglutamylase complex subunit 3) (PGs3) (Tubulin--tyrosine ligase-like protein 1),423,"48,988",4 out of 5,2002-05-02,Evidence at transcript level
Q6EMB2,TTLL5_HUMAN,Tubulin polyglutamylase TTLL5 (EC 6.-.-.-) (SRC1 and TIF2-associated modulatory protein) (Tubulin--tyrosine ligase-like protein 5),1281,"143,577",5 out of 5,2006-02-21,Evidence at protein level
Q5BVD1,TTMP_HUMAN,TPA-induced transmembrane protein,217,"24,295",3 out of 5,2006-09-05,Evidence at protein level
Q9BTX7,TTPAL_HUMAN,Alpha-tocopherol transfer protein-like,342,"38,515",2 out of 5,2003-02-01,Evidence at protein level
P26651,TTP_HUMAN,mRNA decay activator protein ZFP36 (G0/G1 switch regulatory protein 24) (Growth factor-inducible nuclear protein NUP475) (Tristetraprolin) (Zinc finger protein 36) (Zfp-36),326,"34,003",5 out of 5,1992-08-01,Evidence at protein level
O75386,TULP3_HUMAN,Tubby-related protein 3 (Tubby-like protein 3),442,"49,642",5 out of 5,2000-05-30,Evidence at protein level
Q9NYZ1,TV23B_HUMAN,Golgi apparatus membrane protein TVP23 homolog B,205,"23,576",3 out of 5,2003-10-31,Evidence at protein level
P01737,TVA3_HUMAN,T-cell receptor alpha chain V region PY14,135,"14,708",3 out of 5,1986-07-21,Evidence at protein level
Q6IBS0,TWF2_HUMAN,Twinfilin-2 (A6-related protein) (hA6RP) (Protein tyrosine kinase 9-like) (Twinfilin-1-like protein),349,"39,548",5 out of 5,2006-05-02,Evidence at protein level
Q9Y6I9,TX264_HUMAN,Testis-expressed protein 264 (Putative secreted protein Zsig11),313,"34,189",3 out of 5,2002-07-26,Evidence at protein level
P40222,TXLNA_HUMAN,Alpha-taxilin,546,"61,891",5 out of 5,1995-02-01,Evidence at protein level
Q9NUW8,TYDP1_HUMAN,Tyrosyl-DNA phosphodiesterase 1 (Tyr-DNA phosphodiesterase 1) (EC 3.1.4.-),608,"68,420",5 out of 5,2003-10-24,Evidence at protein level
Q8TAI1,TYMOS_HUMAN,TYMS opposite strand protein,123,"13,402",2 out of 5,2007-05-15,Uncertain
Q2T9J0,TYSD1_HUMAN,"Peroxisomal leader peptide-processing protease (EC 3.4.21.-) (Trypsin domain-containing protein 1) [Cleaved into: Peroxisomal leader peptide-processing protease, 15 kDa form; Peroxisomal leader peptide-processing protease, 45 kDa form]",566,"59,309",5 out of 5,2007-05-01,Evidence at protein level
A8MUK1,U17L5_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme 17-like protein 5) (Ubiquitin thioesterase 17-like protein 5) (Ubiquitin-specific-processing protease 17-like protein 5),530,"59,683",3 out of 5,2008-04-29,Inferred from homology
D6R9N7,U17LI_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 18 (EC 3.4.19.12),530,"59,657",3 out of 5,2013-02-06,Inferred from homology
P68036,UB2L3_HUMAN,Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3),154,"17,862",5 out of 5,2004-10-11,Evidence at protein level
Q13404,UB2V1_HUMAN,Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A),147,"16,495",5 out of 5,2004-08-31,Evidence at protein level
Q5T6F2,UBAP2_HUMAN,Ubiquitin-associated protein 2 (UBAP-2),1119,"117,116",3 out of 5,2007-01-09,Evidence at protein level
P62256,UBE2H_HUMAN,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H),183,"20,655",5 out of 5,2004-07-05,Evidence at protein level
Q96B02,UBE2W_HUMAN,Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (N-terminus-conjugating E2) (Ubiquitin carrier protein W) (Ubiquitin-conjugating enzyme 16) (UBC-16) (Ubiquitin-protein ligase W),151,"17,331",5 out of 5,2006-04-18,Evidence at protein level
Q9Y4A5,TRRAP_HUMAN,Transformation/transcription domain-associated protein (350/400 kDa PCAF-associated factor) (PAF350/400) (STAF40) (Tra1 homolog),3859,"437,600",5 out of 5,2003-11-28,Evidence at protein level
Q86VQ6,TRXR3_HUMAN,Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase TR2),643,"70,683",5 out of 5,2008-02-26,Evidence at protein level
P35030,TRY3_HUMAN,Trypsin-3 (EC 3.4.21.4) (Brain trypsinogen) (Mesotrypsinogen) (Serine protease 3) (Serine protease 4) (Trypsin III) (Trypsin IV),304,"32,529",5 out of 5,1994-02-01,Evidence at protein level
Q15661,TRYB1_HUMAN,Tryptase alpha/beta-1 (Tryptase-1) (EC 3.4.21.59) (Tryptase I) (Tryptase alpha-1),275,"30,515",5 out of 5,2001-10-18,Evidence at protein level
Q7RTX0,TS1R3_HUMAN,Taste receptor type 1 member 3 (Sweet taste receptor T1R3),852,"93,386",5 out of 5,2005-01-04,Evidence at protein level
Q92574,TSC1_HUMAN,Hamartin (Tuberous sclerosis 1 protein),1164,"129,767",5 out of 5,2000-12-01,Evidence at protein level
P49815,TSC2_HUMAN,Tuberin (Tuberous sclerosis 2 protein),1807,"200,608",5 out of 5,1996-10-01,Evidence at protein level
Q9BZW7,TSG10_HUMAN,Testis-specific gene 10 protein (Testis development protein NYD-SP7),698,"81,421",5 out of 5,2007-10-02,Evidence at protein level
Q9NRE2,TSH2_HUMAN,Teashirt homolog 2 (Ovarian cancer-related protein 10-2) (OVC10-2) (Zinc finger protein 218),1034,"115,005",5 out of 5,2002-09-19,Evidence at protein level
O95858,TSN15_HUMAN,Tetraspanin-15 (Tspan-15) (Tetraspan NET-7) (Transmembrane 4 superfamily member 15),294,"33,165",5 out of 5,2000-12-01,Evidence at protein level
Q96FV3,TSN17_HUMAN,Tetraspanin-17 (Tspan-17) (F-box only protein 23) (Tetraspan protein SB134) (Transmembrane 4 superfamily member 17),270,"30,264",4 out of 5,2004-08-16,Evidence at transcript level
Q96QS1,TSN32_HUMAN,Tetraspanin-32 (Tspan-32) (Protein Phemx),320,"34,631",4 out of 5,2002-03-27,Evidence at transcript level
Q86UF1,TSN33_HUMAN,Tetraspanin-33 (Tspan-33) (Penumbra) (hPen) (Proerythroblast new membrane),283,"31,538",5 out of 5,2007-04-03,Evidence at protein level
O14817,TSN4_HUMAN,Tetraspanin-4 (Tspan-4) (Novel antigen 2) (NAG-2) (Transmembrane 4 superfamily member 7),238,"26,118",5 out of 5,1998-07-15,Evidence at protein level
Q99598,TSNAX_HUMAN,Translin-associated protein X (Translin-associated factor X),290,"33,112",5 out of 5,1999-07-15,Evidence at protein level
P35442,TSP2_HUMAN,Thrombospondin-2,1172,"129,991",5 out of 5,1994-06-01,Evidence at protein level
P49746,TSP3_HUMAN,Thrombospondin-3,956,"104,201",5 out of 5,1996-10-01,Evidence at protein level
Q9UJK0,TSR3_HUMAN,Ribosome biogenesis protein TSR3 homolog,312,"33,596",2 out of 5,2007-02-20,Evidence at protein level
Q9Y5U2,TSSC4_HUMAN,Protein TSSC4 (Tumor-suppressing STF cDNA 4 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 4 protein),329,"34,326",4 out of 5,2005-12-20,Evidence at protein level
Q9UJ04,TSYL4_HUMAN,Testis-specific Y-encoded-like protein 4 (TSPY-like protein 4),414,"45,126",3 out of 5,2003-08-15,Evidence at protein level
Q92623,TTC9A_HUMAN,Tetratricopeptide repeat protein 9A (TPR repeat protein 9A),222,"24,379",2 out of 5,2003-11-28,Evidence at protein level
Q6ZVT0,TTL10_HUMAN,Inactive polyglycylase TTLL10 (Tubulin--tyrosine ligase-like protein 10),673,"75,042",5 out of 5,2008-03-18,Evidence at protein level
Q9UPX0,TUTLB_HUMAN,Protein turtle homolog B (Immunoglobulin superfamily member 9B) (IgSF9B),1349,"147,089",5 out of 5,2007-10-02,Evidence at transcript level
Q96ET8,TV23C_HUMAN,Golgi apparatus membrane protein TVP23 homolog C,276,"31,105",3 out of 5,2006-01-24,Evidence at protein level
Q15672,TWST1_HUMAN,Twist-related protein 1 (Class A basic helix-loop-helix protein 38) (bHLHa38) (H-twist),202,"20,954",5 out of 5,1997-11-01,Evidence at protein level
Q9NUQ3,TXLNG_HUMAN,Gamma-taxilin (Environmental lipopolysaccharide-responding gene protein) (Factor inhibiting ATF4-mediated transcription) (FIAT) (Lipopolysaccharide-specific response protein 5),528,"60,586",5 out of 5,2004-11-09,Evidence at protein level
Q86VQ3,TXND2_HUMAN,Thioredoxin domain-containing protein 2 (Spermatid-specific thioredoxin-1) (Sptrx-1),553,"60,404",5 out of 5,2005-07-05,Evidence at transcript level
Q8N427,TXND3_HUMAN,Thioredoxin domain-containing protein 3 (NM23-H8) (NME/NM23 family member 8) (Spermatid-specific thioredoxin-2) (Sptrx-2),588,"67,270",5 out of 5,2005-07-05,Evidence at transcript level
O14530,TXND9_HUMAN,Thioredoxin domain-containing protein 9 (ATP-binding protein associated with cell differentiation) (Protein 1-4),226,"26,534",5 out of 5,1999-07-15,Evidence at protein level
P10074,TZAP_HUMAN,Telomere zinc finger-associated protein (TZAP) (Krueppel-related zinc finger protein 3) (hKR3) (Zinc finger and BTB domain-containing protein 48) (Zinc finger protein 855),688,"77,054",5 out of 5,1989-07-01,Evidence at protein level
D6RJB6,U17LK_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 20 (EC 3.4.19.12),530,"59,626",3 out of 5,2013-02-06,Inferred from homology
Q8WU68,U2AF4_HUMAN,Splicing factor U2AF 26 kDa subunit (U2 auxiliary factor 26) (U2 small nuclear RNA auxiliary factor 1-like protein 4) (U2AF1-like 4) (U2(RNU2) small nuclear RNA auxiliary factor 1-like protein 3) (U2 small nuclear RNA auxiliary factor 1-like protein 3) (U2AF1-like protein 3),220,"25,744",5 out of 5,2007-11-13,Evidence at protein level
O43818,U3IP2_HUMAN,U3 small nucleolar RNA-interacting protein 2 (RRP9 homolog) (U3 small nucleolar ribonucleoprotein-associated 55 kDa protein) (U3 snoRNP-associated 55 kDa protein) (U3-55K),475,"51,841",5 out of 5,2003-10-10,Evidence at protein level
O75643,U520_HUMAN,U5 small nuclear ribonucleoprotein 200 kDa helicase (EC 3.6.4.13) (Activating signal cointegrator 1 complex subunit 3-like 1) (BRR2 homolog) (U5 snRNP-specific 200 kDa protein) (U5-200KD),2136,"244,508",5 out of 5,2000-12-01,Evidence at protein level
P61077,UB2D3_HUMAN,Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3),147,"16,687",5 out of 5,2004-04-26,Evidence at protein level
P49459,UBE2A_HUMAN,Ubiquitin-conjugating enzyme E2 A (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme A) (RAD6 homolog A) (HR6A) (hHR6A) (Ubiquitin carrier protein A) (Ubiquitin-protein ligase A),152,"17,315",5 out of 5,1996-02-01,Evidence at protein level
Q9H832,UBE2Z_HUMAN,Ubiquitin-conjugating enzyme E2 Z (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Z) (Uba6-specific E2 conjugating enzyme 1) (Use1) (Ubiquitin carrier protein Z) (Ubiquitin-protein ligase Z),354,"38,210",5 out of 5,2007-03-20,Evidence at protein level
Q05086,UBE3A_HUMAN,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),875,"100,688",5 out of 5,1997-11-01,Evidence at protein level
P0CB47,UBFL1_HUMAN,Upstream-binding factor 1-like protein 1,393,"46,134",2 out of 5,2009-11-03,Inferred from homology
Q9UL62,TRPC5_HUMAN,Short transient receptor potential channel 5 (TrpC5) (Transient receptor protein 5) (TRP-5) (hTRP-5) (hTRP5),973,"111,412",5 out of 5,2000-12-01,Evidence at protein level
Q7Z2W7,TRPM8_HUMAN,Transient receptor potential cation channel subfamily M member 8 (Long transient receptor potential channel 6) (LTrpC-6) (LTrpC6) (Transient receptor potential p8) (Trp-p8),1104,"127,685",5 out of 5,2004-12-21,Evidence at protein level
P59090,TSAS2_HUMAN,Putative uncharacterized protein TSPEAR-AS2 (TSPEAR antisense RNA 2) (TSPEAR antisense gene protein 2),65,"7,097",2 out of 5,2002-11-15,Uncertain
P01222,TSHB_HUMAN,Thyrotropin subunit beta (Thyroid-stimulating hormone subunit beta) (TSH-B) (TSH-beta) (Thyrotropin beta chain) (Thyrotropin alfa),138,"15,639",5 out of 5,1986-07-21,Evidence at protein level
Q8WUA8,TSK_HUMAN,Tsukushin (Tsukushi) (E2-induced gene 4 protein) (Leucine-rich repeat-containing protein 54),353,"37,807",4 out of 5,2006-06-27,Evidence at transcript level
Q9H1Z9,TSN10_HUMAN,Tetraspanin-10 (Tspan-10) (Oculospanin),355,"36,498",3 out of 5,2003-08-22,Evidence at transcript level
Q9UKR8,TSN16_HUMAN,Tetraspanin-16 (Tspan-16) (Tetraspanin TM4-B) (Transmembrane 4 superfamily member 16),245,"26,266",3 out of 5,2000-12-01,Evidence at transcript level
P0C672,TSN19_HUMAN,Putative tetraspanin-19 (Tspan-19),248,"28,460",2 out of 5,2008-02-05,Uncertain
O60635,TSN1_HUMAN,Tetraspanin-1 (Tspan-1) (Tetraspan NET-1) (Tetraspanin TM4-C),241,"26,301",5 out of 5,2000-12-01,Evidence at protein level
Q96NA8,TSNA1_HUMAN,t-SNARE domain-containing protein 1,513,"55,949",3 out of 5,2005-09-13,Evidence at protein level
P07996,TSP1_HUMAN,Thrombospondin-1,1170,"129,383",5 out of 5,1988-08-01,Evidence at protein level
Q9UI38,TSP50_HUMAN,Probable threonine protease PRSS50 (EC 3.4.25.-) (Cancer/testis antigen 20) (Serine protease 50) (Testis-specific protease-like protein 50),385,"43,088",5 out of 5,2003-09-26,Evidence at protein level
B1AH88,TSPOB_HUMAN,Putative peripheral benzodiazepine receptor-related protein,102,"10,537",5 out of 5,2009-07-28,Uncertain
Q2NL82,TSR1_HUMAN,Pre-rRNA-processing protein TSR1 homolog,804,"91,810",4 out of 5,2007-11-13,Evidence at protein level
Q969E8,TSR2_HUMAN,Pre-rRNA-processing protein TSR2 homolog,191,"20,894",3 out of 5,2007-05-01,Evidence at protein level
H0UI37,TSTD3_HUMAN,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 3 (Rhodanese domain-containing protein 3),97,"11,268",1 out of 5,2012-10-03,Inferred from homology
Q9H2G4,TSYL2_HUMAN,Testis-specific Y-encoded-like protein 2 (TSPY-like protein 2) (Cell division autoantigen 1) (Cutaneous T-cell lymphoma-associated antigen se20-4) (CTCL-associated antigen se20-4) (Differentially-expressed nucleolar TGF-beta1 target protein) (Nuclear protein of 79 kDa) (NP79),693,"79,435",5 out of 5,2007-05-29,Evidence at protein level
Q7Z4L5,TT21B_HUMAN,Tetratricopeptide repeat protein 21B (TPR repeat protein 21B) (Intraflagellar transport 139 homolog),1316,"150,937",5 out of 5,2007-06-26,Evidence at protein level
Q5SRH9,TT39A_HUMAN,Tetratricopeptide repeat protein 39A (TPR repeat protein 39A) (Differentially expressed in MCF7 with estradiol protein 6) (DEME-6),613,"69,778",3 out of 5,2007-06-26,Evidence at transcript level
Q96AE7,TTC17_HUMAN,Tetratricopeptide repeat protein 17 (TPR repeat protein 17),1141,"129,558",5 out of 5,2004-09-27,Evidence at protein level
Q5TAA0,TTC22_HUMAN,Tetratricopeptide repeat protein 22 (TPR repeat protein 22),569,"63,361",2 out of 5,2006-12-12,Evidence at transcript level
Q96NG3,TTC25_HUMAN,Tetratricopeptide repeat protein 25 (TPR repeat protein 25),672,"76,655",5 out of 5,2007-04-17,Evidence at protein level
Q5R3I4,TTC38_HUMAN,Tetratricopeptide repeat protein 38 (TPR repeat protein 38),469,"52,787",2 out of 5,2008-02-26,Evidence at protein level
Q6P2S7,TTC41_HUMAN,Putative tetratricopeptide repeat protein 41 (TPR repeat protein 41) (Grp94-neighboring nucleotidase),1318,"151,684",2 out of 5,2008-03-18,Uncertain
Q8N0Z6,TTC5_HUMAN,Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Strap),440,"48,928",4 out of 5,2005-06-07,Evidence at protein level
A6NNM8,TTL13_HUMAN,Tubulin polyglutamylase TTLL13P (EC 6.-.-.-) (Tubulin tyrosine ligase-like family member 13 pseudogene) (Tubulin--tyrosine ligase-like protein 13),815,"93,645",4 out of 5,2008-03-18,Evidence at protein level
Q6ZT98,TTLL7_HUMAN,Tubulin polyglutamylase TTLL7 (EC 6.-.-.-) (Testis development protein NYD-SP30) (Tubulin--tyrosine ligase-like protein 7),887,"102,999",5 out of 5,2005-08-30,Evidence at protein level
Q3SXZ7,TTLL9_HUMAN,Probable tubulin polyglutamylase TTLL9 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 9),439,"51,472",4 out of 5,2008-03-18,Evidence at transcript level
P42681,TXK_HUMAN,Tyrosine-protein kinase TXK (EC 2.7.10.2) (Protein-tyrosine kinase 4) (Resting lymphocyte kinase),527,"61,258",5 out of 5,1995-11-01,Evidence at protein level
P83876,TXN4A_HUMAN,Thioredoxin-like protein 4A (DIM1 protein homolog) (Spliceosomal U5 snRNP-specific 15 kDa protein) (Thioredoxin-like U5 snRNP protein U5-15kD),142,"16,786",5 out of 5,2004-04-26,Evidence at protein level
Q86XW9,TXND6_HUMAN,Thioredoxin domain-containing protein 6 (Thioredoxin-like protein 2) (Txl-2),330,"36,856",4 out of 5,2004-05-24,Evidence at transcript level
P62328,TYB4_HUMAN,Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hematopoietic system regulatory peptide (Seraspenide)],44,"5,053",5 out of 5,1986-07-21,Evidence at protein level
O60294,TYW4_HUMAN,tRNA wybutosine-synthesizing protein 4 (tRNA yW-synthesizing protein 4) (EC 2.1.1.290) (EC 2.3.1.231) (Leucine carboxyl methyltransferase 2) (tRNA(Phe) (7-(3-amino-3-(methoxycarbonyl)propyl)wyosine(37)-N)-methoxycarbonyltransferase) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-O)-methyltransferase),686,"75,602",5 out of 5,2004-05-24,Evidence at protein level
C9JJH3,U17LA_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 10 (EC 3.4.19.12),530,"59,886",3 out of 5,2013-02-06,Inferred from homology
D6RA61,U17LM_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 22 (EC 3.4.19.12),530,"59,671",3 out of 5,2013-02-06,Inferred from homology
D6R901,U17LL_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 21 (EC 3.4.19.12),530,"59,659",3 out of 5,2013-02-06,Inferred from homology
Q15695,U2AFL_HUMAN,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 1 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 1) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 1)",479,"57,643",3 out of 5,1997-11-01,Evidence at transcript level
Q5VV11,U633B_HUMAN,Putative UPF0633 protein ENSP00000303136,94,"10,769",1 out of 5,2008-09-02,Uncertain
Q712K3,UB2R2_HUMAN,Ubiquitin-conjugating enzyme E2 R2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme R2) (Ubiquitin carrier protein R2) (Ubiquitin-conjugating enzyme E2-CDC34B) (Ubiquitin-protein ligase R2),238,"27,166",5 out of 5,2007-03-20,Evidence at protein level
Q9Y606,TRUA_HUMAN,"tRNA pseudouridine synthase A, mitochondrial (EC 5.4.99.12) (tRNA pseudouridine(38-40) synthase) (tRNA pseudouridylate synthase I) (tRNA-uridine isomerase I)",427,"47,470",5 out of 5,2000-05-30,Evidence at protein level
O95900,TRUB2_HUMAN,Probable tRNA pseudouridine synthase 2 (EC 5.4.99.-),331,"36,694",3 out of 5,2006-10-03,Evidence at protein level
Q6ZSZ6,TSH1_HUMAN,Teashirt homolog 1 (Antigen NY-CO-33) (Serologically defined colon cancer antigen 33),1077,"117,916",5 out of 5,2006-01-10,Evidence at protein level
Q63HK5,TSH3_HUMAN,Teashirt homolog 3 (Zinc finger protein 537),1081,"118,566",5 out of 5,2006-01-10,Evidence at protein level
Q15631,TSN_HUMAN,Translin (EC 3.1.-.-) (Component 3 of promoter of RISC) (C3PO),228,"26,183",5 out of 5,1999-07-15,Evidence at protein level
P0CW00,TSPY8_HUMAN,Testis-specific Y-encoded protein 8,308,"35,147",3 out of 5,2011-05-03,Inferred from homology
Q8NFU3,TSTD1_HUMAN,Thiosulfate sulfurtransferase/rhodanese-like domain-containing protein 1,115,"12,530",4 out of 5,2005-06-21,Evidence at protein level
Q9H489,TSY26_HUMAN,Putative testis-specific Y-encoded-like protein 3 (TSPY-like protein 3) (Testis-specific Y-encoded protein 26 pseudogene),355,"39,573",2 out of 5,2003-08-15,Uncertain
Q8NDW8,TT21A_HUMAN,Tetratricopeptide repeat protein 21A (TPR repeat protein 21A) (Stress-inducible protein 2),1320,"150,944",4 out of 5,2007-06-26,Evidence at transcript level
Q86WT1,TT30A_HUMAN,Tetratricopeptide repeat protein 30A (TPR repeat protein 30A),665,"76,136",3 out of 5,2008-05-20,Evidence at transcript level
Q6IQ55,TTBK2_HUMAN,Tau-tubulin kinase 2 (EC 2.7.11.1),1244,"137,412",5 out of 5,2006-05-16,Evidence at protein level
Q6DKK2,TTC19_HUMAN,"Tetratricopeptide repeat protein 19, mitochondrial (TPR repeat protein 19)",380,"42,457",5 out of 5,2004-09-27,Evidence at protein level
Q6P3X3,TTC27_HUMAN,Tetratricopeptide repeat protein 27 (TPR repeat protein 27),843,"96,632",2 out of 5,2007-07-10,Evidence at protein level
Q8NA56,TTC29_HUMAN,Tetratricopeptide repeat protein 29 (TPR repeat protein 29) (Protein TBPP2A) (Testis development protein NYD-SP14),475,"55,082",2 out of 5,2007-07-10,Evidence at transcript level
Q86TZ1,TTC6_HUMAN,Tetratricopeptide repeat protein 6 (TPR repeat protein 6),520,"59,379",2 out of 5,2003-09-26,Evidence at transcript level
Q9ULT0,TTC7A_HUMAN,Tetratricopeptide repeat protein 7A (TPR repeat protein 7A),858,"96,185",5 out of 5,2001-06-01,Evidence at protein level
Q9UNY4,TTF2_HUMAN,Transcription termination factor 2 (EC 3.6.4.-) (Lodestar homolog) (RNA polymerase II termination factor) (Transcription release factor 2) (F2) (HuF2),1162,"129,588",5 out of 5,2005-08-30,Evidence at protein level
P49638,TTPA_HUMAN,Alpha-tocopherol transfer protein (Alpha-TTP),278,"31,750",5 out of 5,1996-02-01,Evidence at protein level
P50607,TUB_HUMAN,Tubby protein homolog,506,"55,651",5 out of 5,1996-10-01,Evidence at protein level
O00294,TULP1_HUMAN,Tubby-related protein 1 (Tubby-like protein 1),542,"60,609",5 out of 5,2000-05-30,Evidence at protein level
Q9NRJ4,TULP4_HUMAN,Tubby-related protein 4 (Tubby superfamily protein) (Tubby-like protein 4),1543,"169,000",5 out of 5,2002-01-31,Evidence at protein level
Q2TAM9,TUSC1_HUMAN,Tumor suppressor candidate gene 1 protein (TSG-9) (TSG9),212,"23,390",2 out of 5,2007-12-04,Evidence at protein level
Q8IXB3,TUSC5_HUMAN,Tumor suppressor candidate 5 (Dispanin subfamily B member 1) (DSPB1) (Interferon-induced transmembrane domain-containing protein D3) (Protein located at seventeen-p-thirteen point three 1),177,"19,254",4 out of 5,2006-12-12,Evidence at transcript level
Q5VYS8,TUT7_HUMAN,Terminal uridylyltransferase 7 (TUTase 7) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 6),1495,"171,229",5 out of 5,2005-06-07,Evidence at protein level
A6NH52,TV23A_HUMAN,Golgi apparatus membrane protein TVP23 homolog A,213,"24,111",2 out of 5,2008-04-08,Evidence at transcript level
O14604,TYB4Y_HUMAN,"Thymosin beta-4, Y-chromosomal",44,"5,013",3 out of 5,1999-07-15,Evidence at protein level
O95551,TYDP2_HUMAN,Tyrosyl-DNA phosphodiesterase 2 (Tyr-DNA phosphodiesterase 2) (hTDP2) (EC 3.1.4.-) (5'-tyrosyl-DNA phosphodiesterase) (5'-Tyr-DNA phosphodiesterase) (ETS1-associated protein 2) (ETS1-associated protein II) (EAPII) (TRAF and TNF receptor-associated protein) (Tyrosyl-RNA phosphodiesterase) (VPg unlinkase),362,"40,930",5 out of 5,2005-06-07,Evidence at protein level
A2RUC4,TYW5_HUMAN,tRNA wybutosine-synthesizing protein 5 (hTYW5) (EC 1.14.11.42) (tRNA(Phe) (7-(3-amino-3-carboxypropyl)wyosine(37)-C(2))-hydroxylase),315,"36,548",5 out of 5,2007-11-13,Evidence at protein level
Q7RTZ2,U17L1_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 1 (EC 3.4.19.12) (Deubiquitinating enzyme 17-like protein 1) (Ubiquitin thioesterase 17-like protein 1) (Ubiquitin-specific-processing protease 17-like protein 1),530,"59,590",3 out of 5,2006-10-17,Inferred from homology
P0C7I0,U17L8_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 8,530,"59,635",2 out of 5,2008-04-29,Inferred from homology
D6RBQ6,U17LH_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 17 (EC 3.4.19.12),530,"59,627",3 out of 5,2013-02-06,Inferred from homology
Q15696,U2AFM_HUMAN,"U2 small nuclear ribonucleoprotein auxiliary factor 35 kDa subunit-related protein 2 (CCCH type zinc finger, RNA-binding motif and serine/arginine rich protein 2) (Renal carcinoma antigen NY-REN-20) (U2(RNU2) small nuclear RNA auxiliary factor 1-like 2) (U2AF35-related protein) (URP)",482,"58,045",5 out of 5,1997-11-01,Evidence at protein level
Q15035,TRAM2_HUMAN,Translocating chain-associated membrane protein 2,370,"43,328",4 out of 5,2001-08-29,Evidence at protein level
P34981,TRFR_HUMAN,Thyrotropin-releasing hormone receptor (TRH-R) (Thyroliberin receptor),398,"45,085",4 out of 5,1994-02-01,Evidence at protein level
P03986,TRGC2_HUMAN,T-cell receptor gamma-2 chain C region (T-cell receptor gamma chain C region PT-gamma-1/2),189,"21,554",3 out of 5,1986-10-23,Evidence at protein level
Q8IWZ5,TRI42_HUMAN,Tripartite motif-containing protein 42,723,"82,745",5 out of 5,2004-12-07,Evidence at protein level
Q6PJ69,TRI65_HUMAN,Tripartite motif-containing protein 65,517,"57,353",4 out of 5,2006-09-05,Evidence at protein level
Q86WT6,TRI69_HUMAN,E3 ubiquitin-protein ligase TRIM69 (EC 2.3.2.27) (RFP-like domain-containing protein trimless) (RING finger protein 36) (RING-type E3 ubiquitin transferase TRIM69) (Tripartite motif-containing protein 69),500,"57,419",5 out of 5,2007-02-20,Evidence at protein level
Q9C037,TRIM4_HUMAN,E3 ubiquitin-protein ligase TRIM4 (EC 2.3.2.27) (RING finger protein 87) (RING-type E3 ubiquitin transferase TRIM4) (Tripartite motif-containing protein 4),500,"57,461",5 out of 5,2004-05-10,Evidence at protein level
O75962,TRIO_HUMAN,Triple functional domain protein (EC 2.7.11.1) (PTPRF-interacting protein),3097,"346,900",5 out of 5,2000-12-01,Evidence at protein level
Q9NUP7,TRM13_HUMAN,tRNA:m(4)X modification enzyme TRM13 homolog (EC 2.1.1.225) (Coiled-coil domain-containing protein 76),481,"54,247",4 out of 5,2006-05-30,Evidence at protein level
Q96GJ1,TRM2_HUMAN,tRNA (uracil(54)-C(5))-methyltransferase homolog (EC 2.1.1.35) (TRM2 homolog),504,"56,476",3 out of 5,2007-12-04,Evidence at protein level
Q96Q11,TRNT1_HUMAN,"CCA tRNA nucleotidyltransferase 1, mitochondrial (EC 2.7.7.72) (Mitochondrial tRNA nucleotidyl transferase, CCA-adding) (mt CCA-adding enzyme) (mt tRNA CCA-diphosphorylase) (mt tRNA CCA-pyrophosphorylase) (mt tRNA adenylyltransferase)",434,"50,128",5 out of 5,2003-10-03,Evidence at protein level
Q7Z4N2,TRPM1_HUMAN,Transient receptor potential cation channel subfamily M member 1 (Long transient receptor potential channel 1) (LTrpC1) (Melastatin-1),1603,"182,178",5 out of 5,2008-04-08,Evidence at protein level
Q9HCF6,TRPM3_HUMAN,Transient receptor potential cation channel subfamily M member 3 (Long transient receptor potential channel 3) (LTrpC-3) (LTrpC3) (Melastatin-2) (MLSN2),1732,"197,571",5 out of 5,2002-05-10,Evidence at transcript level
P07477,TRY1_HUMAN,Trypsin-1 (EC 3.4.21.4) (Beta-trypsin) (Cationic trypsinogen) (Serine protease 1) (Trypsin I) [Cleaved into: Alpha-trypsin chain 1; Alpha-trypsin chain 2],247,"26,558",5 out of 5,1988-04-01,Evidence at protein level
Q8NHM4,TRY6_HUMAN,Putative trypsin-6 (EC 3.4.21.4) (Serine protease 3 pseudogene 2) (Trypsinogen C),247,"26,537",5 out of 5,2008-05-20,Uncertain
P20231,TRYB2_HUMAN,Tryptase beta-2 (Tryptase-2) (EC 3.4.21.59) (Tryptase II),275,"30,515",5 out of 5,1991-02-01,Evidence at protein level
Q9BZJ3,TRYD_HUMAN,Tryptase delta (EC 3.4.21.59) (Delta-tryptase) (HmMCP-3-like tryptase III) (Mast cell mMCP-7-like) (Tryptase-3),242,"26,584",5 out of 5,2001-10-18,Evidence at transcript level
Q99816,TS101_HUMAN,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),390,"43,944",5 out of 5,2000-12-01,Evidence at protein level
Q8TE23,TS1R2_HUMAN,Taste receptor type 1 member 2 (G-protein coupled receptor 71) (Sweet taste receptor T1R2),839,"95,183",5 out of 5,2005-01-04,Inferred from homology
Q96A04,TSACC_HUMAN,TSSK6-activating co-chaperone protein (SSTK-interacting protein) (SSTK-IP),125,"13,670",3 out of 5,2007-01-09,Evidence at protein level
P0CV99,TSPY4_HUMAN,Testis-specific Y-encoded protein 4,314,"35,727",3 out of 5,2011-05-03,Inferred from homology
Q96PF2,TSSK2_HUMAN,Testis-specific serine/threonine-protein kinase 2 (TSK-2) (TSK2) (TSSK-2) (Testis-specific kinase 2) (EC 2.7.11.1) (DiGeorge syndrome protein G) (DGS-G) (Serine/threonine-protein kinase 22B),358,"40,939",5 out of 5,2003-04-30,Evidence at protein level
Q9BXA6,TSSK6_HUMAN,Testis-specific serine/threonine-protein kinase 6 (TSK-6) (TSSK-6) (Testis-specific kinase 6) (EC 2.7.11.1) (Cancer/testis antigen 72) (CT72) (Serine/threonine-protein kinase SSTK) (Small serine/threonine kinase),273,"30,331",5 out of 5,2006-03-21,Evidence at protein level
Q14679,TTLL4_HUMAN,Tubulin polyglutamylase TTLL4 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 4),1199,"133,378",5 out of 5,2002-05-02,Evidence at protein level
Q9P2J2,TUTLA_HUMAN,Protein turtle homolog A (Immunoglobulin superfamily member 9A) (IgSF9A),1179,"126,580",5 out of 5,2007-10-02,Evidence at protein level
P04436,TVA1_HUMAN,T-cell receptor alpha chain V region HPB-MLT (Fragment),131,"14,771",2 out of 5,1987-08-13,Evidence at transcript level
P04437,TVA2_HUMAN,T-cell receptor alpha chain V region CTL-L17,139,"15,441",3 out of 5,1987-08-13,Evidence at transcript level
P04435,TVB2_HUMAN,T-cell receptor beta chain V region CTL-L17,133,"14,999",3 out of 5,1987-08-13,Evidence at transcript level
A0A0J9YWL9,TX13C_HUMAN,Putative testis-expressed protein 13C,993,"109,806",2 out of 5,2016-04-13,Uncertain
Q9UJT2,TSKS_HUMAN,Testis-specific serine kinase substrate (Testis-specific kinase substrate) (STK22 substrate 1),592,"65,050",4 out of 5,2004-03-01,Evidence at protein level
A6NKD2,TSPY2_HUMAN,Testis-specific Y-encoded protein 2 (Testis-specific Y-encoded protein Q1),308,"35,100",3 out of 5,2008-05-20,Inferred from homology
Q8N584,TT39C_HUMAN,Tetratricopeptide repeat protein 39C (TPR repeat protein 39C),583,"65,870",2 out of 5,2007-02-06,Evidence at transcript level
Q5TCY1,TTBK1_HUMAN,Tau-tubulin kinase 1 (EC 2.7.11.1) (Brain-derived tau kinase),1321,"142,737",5 out of 5,2006-05-16,Evidence at protein level
Q96N46,TTC14_HUMAN,Tetratricopeptide repeat protein 14 (TPR repeat protein 14),770,"88,319",3 out of 5,2004-02-16,Evidence at protein level
Q99614,TTC1_HUMAN,Tetratricopeptide repeat protein 1 (TPR repeat protein 1),292,"33,526",3 out of 5,2001-01-24,Evidence at protein level
Q5I0X7,TTC32_HUMAN,Tetratricopeptide repeat protein 32 (TPR repeat protein 32),151,"17,296",2 out of 5,2006-12-12,Evidence at protein level
Q6PID6,TTC33_HUMAN,Tetratricopeptide repeat protein 33 (TPR repeat protein 33) (Osmosis-responsive factor),262,"29,411",2 out of 5,2007-05-15,Evidence at protein level
Q8N5M4,TTC9C_HUMAN,Tetratricopeptide repeat protein 9C (TPR repeat protein 9C),171,"20,013",3 out of 5,2007-07-10,Evidence at protein level
O43156,TTI1_HUMAN,TELO2-interacting protein 1 homolog (Protein SMG10),1089,"122,069",5 out of 5,2002-10-10,Evidence at protein level
Q8NHH1,TTL11_HUMAN,Tubulin polyglutamylase TTLL11 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 11),800,"87,612",4 out of 5,2005-08-30,Evidence at protein level
Q9BWV7,TTLL2_HUMAN,Probable tubulin polyglutamylase TTLL2 (EC 6.-.-.-) (Testis-specific protein NYD-TSPG) (Tubulin--tyrosine ligase-like protein 2),592,"67,336",4 out of 5,2004-05-10,Evidence at transcript level
Q9BZ98,TTY12_HUMAN,Putative transcript Y 12 protein,90,"10,490",1 out of 5,2003-01-17,Uncertain
Q13454,TUSC3_HUMAN,Tumor suppressor candidate 3 (Magnesium uptake/transporter TUSC3) (Protein N33),348,"39,676",5 out of 5,1999-07-15,Evidence at protein level
O43914,TYOBP_HUMAN,TYRO protein tyrosine kinase-binding protein (DNAX-activation protein 12) (Killer-activating receptor-associated protein) (KAR-associated protein),113,"12,179",5 out of 5,2000-05-30,Evidence at protein level
Q6R6M4,U17L2_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17 (USP17) (EC 3.4.19.12) (Deubiquitinating enzyme 17-like protein 2) (Deubiquitinating protein 3) (DUB-3) (Ubiquitin carboxyl-terminal hydrolase 17-like protein 2) (Ubiquitin thioesterase 17-like protein 2) (Ubiquitin-specific-processing protease 17-like protein 2),530,"59,619",5 out of 5,2008-04-29,Evidence at protein level
D6RBM5,U17LN_HUMAN,Putative ubiquitin carboxyl-terminal hydrolase 17-like protein 23,183,"20,302",2 out of 5,2013-02-06,Uncertain
Q8IWF7,U2D2L_HUMAN,Putative ubiquitin-conjugating enzyme E2 D2-like protein (Ubiquitin carrier protein D2-like) (Ubiquitin-conjugating enzyme E2D N-terminal-like) (Ubiquitin-protein ligase D2-like),75,"8,761",2 out of 5,2006-10-31,Uncertain
Q96LR5,UB2E2_HUMAN,Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2),201,"22,255",5 out of 5,2004-05-24,Evidence at protein level
Q8WVN8,UB2Q2_HUMAN,Ubiquitin-conjugating enzyme E2 Q2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q2) (Ubiquitin carrier protein Q2) (Ubiquitin-protein ligase Q2),375,"42,818",5 out of 5,2006-02-21,Evidence at protein level
Q8TBC4,UBA3_HUMAN,NEDD8-activating enzyme E1 catalytic subunit (EC 6.3.2.-) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),463,"51,852",5 out of 5,2004-07-19,Evidence at protein level
Q9GZZ9,UBA5_HUMAN,Ubiquitin-like modifier-activating enzyme 5 (Ubiquitin-activating enzyme 5) (ThiFP1) (UFM1-activating enzyme) (Ubiquitin-activating enzyme E1 domain-containing protein 1),404,"44,863",5 out of 5,2005-09-27,Evidence at protein level
P41226,UBA7_HUMAN,Ubiquitin-like modifier-activating enzyme 7 (Ubiquitin-activating enzyme 7) (D8) (Ubiquitin-activating enzyme E1 homolog),1012,"111,694",5 out of 5,1995-02-01,Evidence at protein level
Q8IYN6,UBAD2_HUMAN,UBA-like domain-containing protein 2,164,"17,877",2 out of 5,2006-05-30,Evidence at protein level
P63279,UBC9_HUMAN,SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18),158,"18,007",5 out of 5,2004-10-11,Evidence at protein level
O15205,UBD_HUMAN,Ubiquitin D (Diubiquitin) (Ubiquitin-like protein FAT10),165,"18,473",5 out of 5,2004-09-13,Evidence at protein level
P63146,UBE2B_HUMAN,Ubiquitin-conjugating enzyme E2 B (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme B) (RAD6 homolog B) (HR6B) (hHR6B) (Ubiquitin carrier protein B) (Ubiquitin-conjugating enzyme E2-17 kDa) (Ubiquitin-protein ligase B),152,"17,312",5 out of 5,2004-09-27,Evidence at protein level
O00762,UBE2C_HUMAN,Ubiquitin-conjugating enzyme E2 C (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme C) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme C) (UbcH10) (Ubiquitin carrier protein C) (Ubiquitin-protein ligase C),179,"19,652",5 out of 5,1998-12-15,Evidence at protein level
Q7Z6J8,UBE3D_HUMAN,E3 ubiquitin-protein ligase E3D (EC 2.3.2.26) (HECT-type E3 ubiquitin transferase E3D) (UbcH10-binding protein with a HECT-like domain) (Ubiquitin-conjugating enzyme E2C-binding protein),389,"43,657",5 out of 5,2007-11-13,Evidence at protein level
P17480,UBF1_HUMAN,Nucleolar transcription factor 1 (Autoantigen NOR-90) (Upstream-binding factor 1) (UBF-1),764,"89,406",5 out of 5,1990-08-01,Evidence at protein level
P0CB48,UBFL6_HUMAN,Putative upstream-binding factor 1-like protein 6,400,"46,551",2 out of 5,2009-11-03,Uncertain
Q9NZI7,UBIP1_HUMAN,Upstream-binding protein 1 (Transcription factor LBP-1),540,"60,491",5 out of 5,2006-03-21,Evidence at protein level
Q9BZL1,UBL5_HUMAN,Ubiquitin-like protein 5,73,"8,547",3 out of 5,2004-09-13,Evidence at protein level
Q96S82,UBL7_HUMAN,Ubiquitin-like protein 7 (Bone marrow stromal cell ubiquitin-like protein) (BMSC-UbP) (Ubiquitin-like protein SB132),380,"40,510",3 out of 5,2004-03-29,Evidence at protein level
Q9Y4E8,UBP15_HUMAN,Ubiquitin carboxyl-terminal hydrolase 15 (EC 3.4.19.12) (Deubiquitinating enzyme 15) (Ubiquitin thioesterase 15) (Ubiquitin-specific-processing protease 15) (Unph-2) (Unph4),981,"112,419",5 out of 5,2000-12-01,Evidence at protein level
Q9Y2K6,UBP20_HUMAN,Ubiquitin carboxyl-terminal hydrolase 20 (EC 3.4.19.12) (Deubiquitinating enzyme 20) (Ubiquitin thioesterase 20) (Ubiquitin-specific-processing protease 20) (VHL-interacting deubiquitinating enzyme 2) (hVDU2),914,"102,003",5 out of 5,2001-01-24,Evidence at protein level
Q70CQ3,UBP30_HUMAN,Ubiquitin carboxyl-terminal hydrolase 30 (EC 3.4.19.12) (Deubiquitinating enzyme 30) (Ubiquitin thioesterase 30) (Ubiquitin-specific-processing protease 30) (Ub-specific protease 30),517,"58,503",5 out of 5,2004-09-13,Evidence at protein level
Q9P2H5,UBP35_HUMAN,Ubiquitin carboxyl-terminal hydrolase 35 (EC 3.4.19.12) (Deubiquitinating enzyme 35) (Ubiquitin thioesterase 35) (Ubiquitin-specific-processing protease 35),1018,"113,405",4 out of 5,2003-10-10,Evidence at protein level
Q3LFD5,UBP41_HUMAN,Putative ubiquitin carboxyl-terminal hydrolase 41 (EC 3.4.19.12) (Deubiquitinating enzyme 41) (Ubiquitin thioesterase 41) (Ubiquitin-specific-processing protease 41),358,"41,394",3 out of 5,2008-04-08,Evidence at transcript level
Q86UV5,UBP48_HUMAN,Ubiquitin carboxyl-terminal hydrolase 48 (EC 3.4.19.12) (Deubiquitinating enzyme 48) (Ubiquitin thioesterase 48) (Ubiquitin-specific-processing protease 48),1035,"119,032",5 out of 5,2006-09-19,Evidence at protein level
Q70EL1,UBP54_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 54 (Inactive ubiquitin-specific peptidase 54),1684,"187,388",5 out of 5,2006-09-19,Evidence at protein level
P35125,UBP6_HUMAN,Ubiquitin carboxyl-terminal hydrolase 6 (EC 3.4.19.12) (Deubiquitinating enzyme 6) (Proto-oncogene TRE-2) (Ubiquitin thioesterase 6) (Ubiquitin-specific-processing protease 6),1406,"158,658",5 out of 5,1994-02-01,Evidence at protein level
Q9UMX0,UBQL1_HUMAN,Ubiquilin-1 (Protein linking IAP with cytoskeleton 1) (PLIC-1) (hPLIC-1),589,"62,519",5 out of 5,2004-03-29,Evidence at protein level
Q8IWV8,UBR2_HUMAN,E3 ubiquitin-protein ligase UBR2 (EC 2.3.2.27) (N-recognin-2) (RING-type E3 ubiquitin transferase UBR2) (Ubiquitin-protein ligase E3-alpha-2) (Ubiquitin-protein ligase E3-alpha-II),1755,"200,538",5 out of 5,2005-08-16,Evidence at protein level
P61960,UFM1_HUMAN,Ubiquitin-fold modifier 1,85,"9,118",5 out of 5,2004-06-07,Evidence at protein level
P07478,TRY2_HUMAN,Trypsin-2 (EC 3.4.21.4) (Anionic trypsinogen) (Serine protease 2) (Trypsin II),247,"26,488",5 out of 5,1988-04-01,Evidence at protein level
Q9NX07,TSAP1_HUMAN,tRNA selenocysteine 1-associated protein 1 (SECp43) (tRNA selenocysteine-associated protein 1),287,"32,499",4 out of 5,2007-10-02,Evidence at protein level
Q8WU66,TSEAR_HUMAN,Thrombospondin-type laminin G domain and EAR repeat-containing protein (TSP-EAR),669,"74,924",4 out of 5,2002-11-28,Evidence at transcript level
Q96SJ8,TSN18_HUMAN,Tetraspanin-18 (Tspan-18),248,"27,710",2 out of 5,2005-06-21,Evidence at transcript level
Q12999,TSN31_HUMAN,Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence),210,"23,053",3 out of 5,1999-07-15,Evidence at transcript level
O43657,TSN6_HUMAN,Tetraspanin-6 (Tspan-6) (A15 homolog) (Putative NF-kappa-B-activating protein 321) (T245 protein) (Tetraspanin TM4-D) (Transmembrane 4 superfamily member 6),245,"27,563",4 out of 5,2000-12-01,Evidence at protein level
Q6PF05,TT23L_HUMAN,Tetratricopeptide repeat protein 23-like,361,"40,837",4 out of 5,2008-05-20,Evidence at protein level
Q8N4P2,TT30B_HUMAN,Tetratricopeptide repeat protein 30B (TPR repeat protein 30B),665,"76,099",3 out of 5,2008-06-10,Evidence at protein level
Q8NEE8,TTC16_HUMAN,Tetratricopeptide repeat protein 16 (TPR repeat protein 16),873,"98,309",2 out of 5,2004-09-27,Evidence at transcript level
Q96AY4,TTC28_HUMAN,Tetratricopeptide repeat protein 28 (TPR repeat protein 28) (TPR repeat-containing big gene cloned at Keio),2481,"270,884",4 out of 5,2002-11-28,Evidence at protein level
Q6PGP7,TTC37_HUMAN,Tetratricopeptide repeat protein 37 (TPR repeat protein 37) (SKI3 homolog) (Ski3) (Tricho-hepatic-enteric syndrome protein) (Thespin),1564,"175,486",5 out of 5,2006-10-03,Evidence at protein level
P53804,TTC3_HUMAN,E3 ubiquitin-protein ligase TTC3 (EC 2.3.2.27) (Protein DCRR1) (RING finger protein 105) (RING-type E3 ubiquitin transferase TTC3) (TPR repeat protein D) (Tetratricopeptide repeat protein 3) (TPR repeat protein 3),2025,"229,869",5 out of 5,1996-10-01,Evidence at protein level
Q86TV6,TTC7B_HUMAN,Tetratricopeptide repeat protein 7B (TPR repeat protein 7B) (Tetratricopeptide repeat protein 7-like-1) (TPR repeat protein 7-like-1),843,"94,179",5 out of 5,2003-08-22,Evidence at protein level
Q8N841,TTLL6_HUMAN,Tubulin polyglutamylase TTLL6 (EC 6.-.-.-) (Tubulin--tyrosine ligase-like protein 6),843,"96,401",5 out of 5,2008-03-18,Evidence at protein level
Q9BY14,TX101_HUMAN,Testis-expressed protein 101 (Cell surface receptor NYD-SP8) (Scleroderma-associated autoantigen) (Spermatogenesis-related gene protein),249,"26,667",4 out of 5,2006-07-25,Evidence at transcript level
Q9P2K2,TXD16_HUMAN,Thioredoxin domain-containing protein 16,825,"93,572",5 out of 5,2006-10-31,Evidence at protein level
Q8NBS9,TXND5_HUMAN,Thioredoxin domain-containing protein 5 (Endoplasmic reticulum resident protein 46) (ER protein 46) (ERp46) (Thioredoxin-like protein p46),432,"47,629",5 out of 5,2003-04-11,Evidence at protein level
Q6QN14,U17L6_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 6 (EC 3.4.19.12) (Deubiquitinating enzyme 17-like protein 6) (Ubiquitin thioesterase 17-like protein 6) (Ubiquitin-specific-processing protease 17-like protein 6),398,"44,690",4 out of 5,2008-04-29,Evidence at protein level
Q01081,U2AF1_HUMAN,Splicing factor U2AF 35 kDa subunit (U2 auxiliary factor 35 kDa subunit) (U2 small nuclear RNA auxiliary factor 1) (U2 snRNP auxiliary factor small subunit),240,"27,872",5 out of 5,1993-04-01,Evidence at protein level
Q5XG85,U633C_HUMAN,Putative UPF0633 protein LOC554249,94,"10,725",2 out of 5,2008-09-02,Uncertain
Q3KQV9,UAP1L_HUMAN,UDP-N-acetylhexosamine pyrophosphorylase-like protein 1 (EC 2.7.7.-),507,"57,030",3 out of 5,2008-03-18,Evidence at protein level
P62253,UB2G1_HUMAN,"Ubiquitin-conjugating enzyme E2 G1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G1) (E217K) (UBC7) (Ubiquitin carrier protein G1) (Ubiquitin-protein ligase G1) [Cleaved into: Ubiquitin-conjugating enzyme E2 G1, N-terminally processed]",170,"19,509",5 out of 5,2004-07-05,Evidence at protein level
F5GYI3,UBA1L_HUMAN,Ubiquitin-associated protein 1-like (UBAP-1L),381,"40,592",2 out of 5,2011-10-19,Evidence at transcript level
Q9BSL1,UBAC1_HUMAN,Ubiquitin-associated domain-containing protein 1 (UBA domain-containing protein 1) (E3 ubiquitin-protein ligase subunit KPC2) (Glialblastoma cell differentiation-related protein 1) (Kip1 ubiquitination-promoting complex protein 2),405,"45,338",5 out of 5,2006-10-03,Evidence at protein level
P61086,UBE2K_HUMAN,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),200,"22,407",5 out of 5,2004-04-26,Evidence at protein level
O75317,UBP12_HUMAN,Ubiquitin carboxyl-terminal hydrolase 12 (EC 3.4.19.12) (Deubiquitinating enzyme 12) (Ubiquitin thioesterase 12) (Ubiquitin-hydrolyzing enzyme 1) (Ubiquitin-specific-processing protease 12),370,"42,858",5 out of 5,2000-05-30,Evidence at protein level
P54578,UBP14_HUMAN,Ubiquitin carboxyl-terminal hydrolase 14 (EC 3.4.19.12) (Deubiquitinating enzyme 14) (Ubiquitin thioesterase 14) (Ubiquitin-specific-processing protease 14),494,"56,069",5 out of 5,1996-10-01,Evidence at protein level
Q9Y5T5,UBP16_HUMAN,Ubiquitin carboxyl-terminal hydrolase 16 (EC 3.4.19.12) (Deubiquitinating enzyme 16) (Ubiquitin thioesterase 16) (Ubiquitin-processing protease UBP-M) (Ubiquitin-specific-processing protease 16),823,"93,570",5 out of 5,2000-05-30,Evidence at protein level
O94966,UBP19_HUMAN,Ubiquitin carboxyl-terminal hydrolase 19 (EC 3.4.19.12) (Deubiquitinating enzyme 19) (Ubiquitin thioesterase 19) (Ubiquitin-specific-processing protease 19) (Zinc finger MYND domain-containing protein 9),1318,"145,651",5 out of 5,2001-06-20,Evidence at protein level
Q70CQ2,UBP34_HUMAN,Ubiquitin carboxyl-terminal hydrolase 34 (EC 3.4.19.12) (Deubiquitinating enzyme 34) (Ubiquitin thioesterase 34) (Ubiquitin-specific-processing protease 34),3546,"404,233",5 out of 5,2006-09-19,Evidence at protein level
Q9P275,UBP36_HUMAN,Ubiquitin carboxyl-terminal hydrolase 36 (EC 3.4.19.12) (Deubiquitinating enzyme 36) (Ubiquitin thioesterase 36) (Ubiquitin-specific-processing protease 36),1121,"122,652",5 out of 5,2003-10-10,Evidence at protein level
Q8NB14,UBP38_HUMAN,Ubiquitin carboxyl-terminal hydrolase 38 (EC 3.4.19.12) (Deubiquitinating enzyme 38) (HP43.8KD) (Ubiquitin thioesterase 38) (Ubiquitin-specific-processing protease 38),1042,"116,546",4 out of 5,2003-10-10,Evidence at protein level
Q70EL2,UBP45_HUMAN,Ubiquitin carboxyl-terminal hydrolase 45 (EC 3.4.19.12) (Deubiquitinating enzyme 45) (Ubiquitin thioesterase 45) (Ubiquitin-specific-processing protease 45),814,"91,733",5 out of 5,2007-03-20,Evidence at protein level
P62068,UBP46_HUMAN,Ubiquitin carboxyl-terminal hydrolase 46 (EC 3.4.19.12) (Deubiquitinating enzyme 46) (Ubiquitin thioesterase 46) (Ubiquitin-specific-processing protease 46),366,"42,442",5 out of 5,2004-06-21,Evidence at protein level
Q13107,UBP4_HUMAN,Ubiquitin carboxyl-terminal hydrolase 4 (EC 3.4.19.12) (Deubiquitinating enzyme 4) (Ubiquitin thioesterase 4) (Ubiquitin-specific-processing protease 4) (Ubiquitous nuclear protein homolog),963,"108,565",5 out of 5,1997-11-01,Evidence at protein level
Q70EL3,UBP50_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 50 (Inactive ubiquitin-specific peptidase 50),339,"38,955",3 out of 5,2006-09-19,Evidence at transcript level
Q70EK9,UBP51_HUMAN,Ubiquitin carboxyl-terminal hydrolase 51 (EC 3.4.19.12) (Deubiquitinating enzyme 51) (Ubiquitin thioesterase 51) (Ubiquitin-specific-processing protease 51),711,"79,756",5 out of 5,2004-09-13,Evidence at transcript level
Q8WUN7,UBTD2_HUMAN,Ubiquitin domain-containing protein 2 (Dendritic cell-derived ubiquitin-like protein) (DC-UbP) (Ubiquitin-like protein SB72),234,"26,190",2 out of 5,2006-06-27,Evidence at protein level
O94888,UBXN7_HUMAN,UBX domain-containing protein 7,489,"54,862",5 out of 5,2005-08-16,Evidence at protein level
Q6PIZ9,TRAT1_HUMAN,T-cell receptor-associated transmembrane adapter 1 (T-cell receptor-interacting molecule) (TRIM) (pp29/30),186,"21,211",5 out of 5,2005-12-20,Evidence at protein level
O14717,TRDMT_HUMAN,tRNA (cytosine(38)-C(5))-methyltransferase (EC 2.1.1.204) (DNA (cytosine-5)-methyltransferase-like protein 2) (Dnmt2) (DNA methyltransferase homolog HsaIIP) (DNA MTase homolog HsaIIP) (M.HsaIIP) (PuMet),391,"44,597",5 out of 5,2001-09-26,Evidence at protein level
Q9NQ86,TRI36_HUMAN,E3 ubiquitin-protein ligase TRIM36 (EC 2.3.2.27) (RING finger protein 98) (RING-type E3 ubiquitin transferase TRIM36) (Tripartite motif-containing protein 36) (Zinc-binding protein Rbcc728),728,"83,013",5 out of 5,2004-12-07,Evidence at protein level
Q96DX7,TRI44_HUMAN,Tripartite motif-containing protein 44 (Protein DIPB),344,"38,472",4 out of 5,2004-12-07,Evidence at protein level
Q7Z4K8,TRI46_HUMAN,"Tripartite motif-containing protein 46 (Gene Y protein) (GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein)",759,"83,424",4 out of 5,2004-11-23,Evidence at transcript level
Q8IWZ4,TRI48_HUMAN,Tripartite motif-containing protein 48 (RING finger protein 101),208,"24,498",2 out of 5,2004-11-23,Evidence at transcript level
Q9C029,TRIM7_HUMAN,Tripartite motif-containing protein 7 (Glycogenin-interacting protein) (RING finger protein 90),511,"56,631",5 out of 5,2002-06-06,Evidence at protein level
Q9BZR9,TRIM8_HUMAN,Probable E3 ubiquitin-protein ligase TRIM8 (EC 2.3.2.27) (Glioblastoma-expressed RING finger protein) (RING finger protein 27) (RING-type E3 ubiquitin transferase TRIM8) (Tripartite motif-containing protein 8),551,"61,489",5 out of 5,2001-09-26,Evidence at protein level
Q8N9V2,TRIML_HUMAN,Probable E3 ubiquitin-protein ligase TRIML1 (EC 2.3.2.27) (RING finger protein 209) (RING-type E3 ubiquitin transferase TRIML1) (Tripartite motif family-like protein 1),468,"53,002",3 out of 5,2007-02-06,Evidence at transcript level
Q629K1,TRIQK_HUMAN,Triple QxxK/R motif-containing protein (Triple repetitive-sequence of QXXK/R protein homolog),86,"9,683",2 out of 5,2008-06-10,Inferred from homology
Q9Y210,TRPC6_HUMAN,Short transient receptor potential channel 6 (TrpC6) (Transient receptor protein 6) (TRP-6),931,"106,326",5 out of 5,2000-05-30,Evidence at protein level
Q8TD43,TRPM4_HUMAN,Transient receptor potential cation channel subfamily M member 4 (hTRPM4) (Calcium-activated non-selective cation channel 1) (Long transient receptor potential channel 4) (LTrpC-4) (LTrpC4) (Melastatin-4),1214,"134,301",5 out of 5,2006-10-31,Evidence at protein level
Q16881,TRXR1_HUMAN,"Thioredoxin reductase 1, cytoplasmic (TR) (EC 1.8.1.9) (Gene associated with retinoic and interferon-induced mortality 12 protein) (GRIM-12) (Gene associated with retinoic and IFN-induced mortality 12 protein) (KM-102-derived reductase-like factor) (Thioredoxin reductase TR1)",649,"70,906",5 out of 5,1997-11-01,Evidence at protein level
Q7RTX1,TS1R1_HUMAN,Taste receptor type 1 member 1 (G-protein coupled receptor 70),841,"93,074",5 out of 5,2005-01-04,Evidence at transcript level
Q8NBP0,TTC13_HUMAN,Tetratricopeptide repeat protein 13 (TPR repeat protein 13),860,"96,813",2 out of 5,2004-09-27,Evidence at transcript level
A6NLP5,TTC36_HUMAN,Tetratricopeptide repeat protein 36 (TPR repeat protein 36) (HSP70-binding protein 21),189,"20,896",2 out of 5,2008-05-20,Evidence at protein level
Q15361,TTF1_HUMAN,Transcription termination factor 1 (TTF-1) (RNA polymerase I termination factor) (Transcription termination factor I) (TTF-I),905,"103,051",5 out of 5,2006-10-03,Evidence at protein level
Q8NG68,TTL_HUMAN,Tubulin--tyrosine ligase (TTL) (EC 6.3.2.25),377,"43,212",3 out of 5,2004-05-10,Evidence at protein level
Q9NXH9,TRM1_HUMAN,"tRNA (guanine(26)-N(2))-dimethyltransferase (EC 2.1.1.216) (tRNA 2,2-dimethylguanosine-26 methyltransferase) (tRNA(guanine-26,N(2)-N(2)) methyltransferase) (tRNA(m(2,2)G26)dimethyltransferase)",659,"72,234",5 out of 5,2001-01-11,Evidence at protein level
Q9UET6,TRM7_HUMAN,Putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase (EC 2.1.1.205) (2'-O-ribose RNA methyltransferase TRM7 homolog) (Protein ftsJ homolog 1),329,"36,079",4 out of 5,2000-12-01,Evidence at protein level
Q5T2D2,TRML2_HUMAN,Trem-like transcript 2 protein (TLT-2) (Triggering receptor expressed on myeloid cells-like protein 2),321,"35,127",5 out of 5,2006-10-17,Evidence at protein level
Q9BX84,TRPM6_HUMAN,Transient receptor potential cation channel subfamily M member 6 (EC 2.7.11.1) (Channel kinase 2) (Melastatin-related TRP cation channel 6),2022,"231,708",5 out of 5,2004-12-07,Evidence at protein level
Q9NRR2,TRYG1_HUMAN,Tryptase gamma (EC 3.4.21.-) (Serine protease 31) (Transmembrane tryptase) [Cleaved into: Tryptase gamma light chain; Tryptase gamma heavy chain],321,"33,815",5 out of 5,2001-10-18,Evidence at transcript level
Q969D9,TSLP_HUMAN,Thymic stromal lymphopoietin,159,"18,141",4 out of 5,2007-09-11,Evidence at protein level
A1L157,TSN11_HUMAN,Tetraspanin-11 (Tspan-11),253,"28,245",2 out of 5,2007-12-04,Evidence at transcript level
O95859,TSN12_HUMAN,Tetraspanin-12 (Tspan-12) (Tetraspan NET-2) (Transmembrane 4 superfamily member 12),305,"35,383",5 out of 5,2000-12-01,Evidence at protein level
Q8NG11,TSN14_HUMAN,Tetraspanin-14 (Tspan-14) (DC-TM4F2) (Transmembrane 4 superfamily member 14),270,"30,691",5 out of 5,2004-11-23,Evidence at protein level
O60637,TSN3_HUMAN,Tetraspanin-3 (Tspan-3) (Tetraspanin TM4-A) (Transmembrane 4 superfamily member 8),253,"28,018",3 out of 5,2000-12-01,Evidence at transcript level
P35443,TSP4_HUMAN,Thrombospondin-4,961,"105,869",5 out of 5,1994-06-01,Evidence at protein level
P0CV98,TSPY3_HUMAN,Testis-specific Y-encoded protein 3,308,"35,101",3 out of 5,2011-05-03,Inferred from homology
Q6SA08,TSSK4_HUMAN,Testis-specific serine/threonine-protein kinase 4 (TSK-4) (TSSK-4) (Testis-specific kinase 4) (EC 2.7.11.1) (Serine/threonine-protein kinase 22E),328,"37,454",5 out of 5,2005-03-29,Evidence at protein level
Q9NQE7,TSSP_HUMAN,Thymus-specific serine protease (EC 3.4.-.-) (Serine protease 16),514,"55,049",4 out of 5,2001-04-27,Evidence at transcript level
Q8N831,TSYL6_HUMAN,Testis-specific Y-encoded-like protein 6 (TSPY-like protein 6),410,"45,874",2 out of 5,2007-10-23,Evidence at protein level
A8MYJ7,TTC34_HUMAN,Tetratricopeptide repeat protein 34 (TPR repeat protein 34),566,"60,903",1 out of 5,2008-06-10,Evidence at transcript level
Q8N6N2,TTC9B_HUMAN,Tetratricopeptide repeat protein 9B (TPR repeat protein 9B),239,"25,932",2 out of 5,2007-07-10,Evidence at transcript level
Q15029,U5S1_HUMAN,"116 kDa U5 small nuclear ribonucleoprotein component (Elongation factor Tu GTP-binding domain-containing protein 2) (SNU114 homolog) (hSNU114) (U5 snRNP-specific protein, 116 kDa) (U5-116 kDa)",972,"109,436",5 out of 5,2001-09-26,Evidence at protein level
P51965,UB2E1_HUMAN,Ubiquitin-conjugating enzyme E2 E1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme E1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme E1) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1),193,"21,404",5 out of 5,1996-10-01,Evidence at protein level
Q8N2K1,UB2J2_HUMAN,Ubiquitin-conjugating enzyme E2 J2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J2) (Non-canonical ubiquitin-conjugating enzyme 2) (NCUBE-2),259,"28,898",5 out of 5,2004-09-13,Evidence at protein level
P49427,UB2R1_HUMAN,Ubiquitin-conjugating enzyme E2 R1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme R1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme R1) (Ubiquitin-conjugating enzyme E2-32 kDa complementing) (Ubiquitin-conjugating enzyme E2-CDC34) (Ubiquitin-protein ligase R1),236,"26,737",5 out of 5,1996-02-01,Evidence at protein level
Q9BXU7,UBP26_HUMAN,Ubiquitin carboxyl-terminal hydrolase 26 (EC 3.4.19.12) (Deubiquitinating enzyme 26) (Ubiquitin thioesterase 26) (Ubiquitin-specific-processing protease 26),913,"104,047",5 out of 5,2001-09-26,Evidence at protein level
A6NNY8,UBP27_HUMAN,Ubiquitin carboxyl-terminal hydrolase 27 (EC 3.4.19.12) (Deubiquitinating enzyme 27) (Ubiquitin carboxyl-terminal hydrolase 22-like) (Ubiquitin thioesterase 27) (Ubiquitin-specific-processing protease 27) (X-linked ubiquitin carboxyl-terminal hydrolase 27),438,"49,630",5 out of 5,2007-10-02,Evidence at protein level
Q8NFA0,UBP32_HUMAN,Ubiquitin carboxyl-terminal hydrolase 32 (EC 3.4.19.12) (Deubiquitinating enzyme 32) (Renal carcinoma antigen NY-REN-60) (Ubiquitin thioesterase 32) (Ubiquitin-specific-processing protease 32),1604,"181,656",5 out of 5,2003-10-10,Evidence at protein level
Q9Y6I4,UBP3_HUMAN,Ubiquitin carboxyl-terminal hydrolase 3 (EC 3.4.19.12) (Deubiquitinating enzyme 3) (Ubiquitin thioesterase 3) (Ubiquitin-specific-processing protease 3),520,"58,897",5 out of 5,2000-12-01,Evidence at protein level
Q9H9J4,UBP42_HUMAN,Ubiquitin carboxyl-terminal hydrolase 42 (EC 3.4.19.12) (Deubiquitinating enzyme 42) (Ubiquitin thioesterase 42) (Ubiquitin-specific-processing protease 42),1324,"145,392",4 out of 5,2003-10-10,Evidence at protein level
Q9H0E7,UBP44_HUMAN,Ubiquitin carboxyl-terminal hydrolase 44 (EC 3.4.19.12) (Deubiquitinating enzyme 44) (Ubiquitin thioesterase 44) (Ubiquitin-specific-processing protease 44),712,"81,185",5 out of 5,2003-10-10,Evidence at protein level
P45974,UBP5_HUMAN,Ubiquitin carboxyl-terminal hydrolase 5 (EC 3.4.19.12) (Deubiquitinating enzyme 5) (Isopeptidase T) (Ubiquitin thioesterase 5) (Ubiquitin-specific-processing protease 5),858,"95,786",5 out of 5,1996-02-01,Evidence at protein level
Q96LJ8,UBX10_HUMAN,UBX domain-containing protein 10 (UBX domain-containing protein 3),280,"30,811",2 out of 5,2004-11-23,Evidence at protein level
P68543,UBX2A_HUMAN,UBX domain-containing protein 2A (UBX domain-containing protein 4),259,"29,278",3 out of 5,2004-11-23,Evidence at protein level
Q04323,UBXN1_HUMAN,UBX domain-containing protein 1 (SAPK substrate protein 1) (UBA/UBX 33.3 kDa protein),297,"33,325",5 out of 5,1996-10-01,Evidence at protein level
O00124,UBXN8_HUMAN,UBX domain-containing protein 8 (Reproduction 8 protein) (Rep-8 protein) (UBX domain-containing protein 6),270,"30,541",5 out of 5,1998-07-15,Evidence at protein level
Q6NVU6,UFSP1_HUMAN,Inactive Ufm1-specific protease 1 (UfSP1),142,"15,060",2 out of 5,2007-03-20,Evidence at transcript level
O60701,UGDH_HUMAN,UDP-glucose 6-dehydrogenase (UDP-Glc dehydrogenase) (UDP-GlcDH) (UDPGDH) (EC 1.1.1.22),494,"55,024",5 out of 5,1998-12-15,Evidence at protein level
Q8TAS1,UHMK1_HUMAN,Serine/threonine-protein kinase Kist (EC 2.7.11.1) (Kinase interacting with stathmin) (PAM COOH-terminal interactor protein 2) (P-CIP2) (U2AF homology motif kinase 1),419,"46,546",5 out of 5,2002-10-19,Evidence at protein level
Q96RL1,UIMC1_HUMAN,BRCA1-A complex subunit RAP80 (Receptor-associated protein 80) (Retinoid X receptor-interacting protein 110) (Ubiquitin interaction motif-containing protein 1),719,"79,727",5 out of 5,2005-03-01,Evidence at protein level
Q9H9P5,UNKL_HUMAN,Putative E3 ubiquitin-protein ligase UNKL (EC 2.3.2.-) (RING finger protein unkempt-like) (Zinc finger CCCH domain-containing protein 5-like),680,"73,828",5 out of 5,2007-03-06,Evidence at protein level
O00322,UPK1A_HUMAN,Uroplakin-1a (UP1a) (Tetraspanin-21) (Tspan-21) (Uroplakin Ia) (UPIa) (UPKa),258,"28,879",5 out of 5,1997-11-01,Evidence at transcript level
Q96HZ7,URAS1_HUMAN,Putative uncharacterized protein URB1-AS1 (URB1 antisense RNA 1) (URB1 antisense gene protein 1),61,"6,513",2 out of 5,2003-11-14,Uncertain
P07911,UROM_HUMAN,"Uromodulin (Tamm-Horsfall urinary glycoprotein) (THP) [Cleaved into: Uromodulin, secreted form]",640,"69,761",5 out of 5,1988-08-01,Evidence at protein level
Q5W0Q7,USPL1_HUMAN,SUMO-specific isopeptidase USPL1 (EC 3.4.22.-) (Ubiquitin-specific peptidase-like protein 1),1092,"120,440",5 out of 5,2007-03-06,Evidence at protein level
Q9Y3A2,UTP11_HUMAN,Probable U3 small nucleolar RNA-associated protein 11 (U3 snoRNA-associated protein 11) (UTP11-like protein),253,"30,447",5 out of 5,2003-04-04,Evidence at protein level
Q969X6,UTP4_HUMAN,U3 small nucleolar RNA-associated protein 4 homolog (Cirhin) (UTP4 small subunit processome component),686,"76,890",5 out of 5,2004-01-16,Evidence at protein level
Q9UBK9,UXT_HUMAN,Protein UXT (Androgen receptor trapped clone 27 protein) (ART-27) (Ubiquitously expressed transcript protein),157,"18,246",5 out of 5,2000-12-01,Evidence at protein level
P63027,VAMP2_HUMAN,Vesicle-associated membrane protein 2 (VAMP-2) (Synaptobrevin-2),116,"12,663",5 out of 5,2004-08-31,Evidence at protein level
P51809,VAMP7_HUMAN,Vesicle-associated membrane protein 7 (VAMP-7) (Synaptobrevin-like protein 1) (Tetanus-insensitive VAMP) (Ti-VAMP),220,"24,935",5 out of 5,1996-10-01,Evidence at protein level
Q9ULK5,VANG2_HUMAN,Vang-like protein 2 (Loop-tail protein 1 homolog) (Strabismus 1) (Van Gogh-like protein 2),521,"59,714",5 out of 5,2003-10-31,Evidence at protein level
P50552,VASP_HUMAN,Vasodilator-stimulated phosphoprotein (VASP),380,"39,830",5 out of 5,1996-10-01,Evidence at protein level
Q92575,UBXN4_HUMAN,UBX domain-containing protein 4 (Erasin) (UBX domain-containing protein 2),508,"56,778",5 out of 5,2003-05-16,Evidence at protein level
O94874,UFL1_HUMAN,E3 UFM1-protein ligase 1 (EC 6.3.2.-) (Novel LZAP-binding protein) (Regulator of C53/LZAP and DDRGK1),794,"89,595",5 out of 5,2005-06-21,Evidence at protein level
P30530,UFO_HUMAN,Tyrosine-protein kinase receptor UFO (EC 2.7.10.1) (AXL oncogene),894,"98,336",5 out of 5,1993-04-01,Evidence at protein level
Q96PU4,UHRF2_HUMAN,E3 ubiquitin-protein ligase UHRF2 (EC 2.3.2.27) (Np95/ICBP90-like RING finger protein) (Np95-like RING finger protein) (Nuclear protein 97) (Nuclear zinc finger protein Np97) (RING finger protein 107) (RING-type E3 ubiquitin transferase UHRF2) (Ubiquitin-like PHD and RING finger domain-containing protein 2) (Ubiquitin-like-containing PHD and RING finger domains protein 2),802,"89,985",5 out of 5,2005-06-07,Evidence at protein level
Q96BW1,UPP_HUMAN,Uracil phosphoribosyltransferase homolog,309,"33,786",4 out of 5,2006-10-31,Evidence at protein level
Q5DID0,UROL1_HUMAN,Uromodulin-like 1 (Olfactorin),1318,"144,294",5 out of 5,2006-03-21,Evidence at transcript level
Q9NZ43,USE1_HUMAN,Vesicle transport protein USE1 (Putative MAPK-activating protein PM26) (USE1-like protein) (p31),259,"29,371",5 out of 5,2005-02-01,Evidence at protein level
O95399,UTS2_HUMAN,Urotensin-2 (Urotensin II) (U-II) (UII),124,"14,296",5 out of 5,2000-12-01,Evidence at protein level
Q8NBZ7,UXS1_HUMAN,UDP-glucuronic acid decarboxylase 1 (EC 4.1.1.35) (UDP-glucuronate decarboxylase 1) (UGD) (UXS-1),420,"47,577",5 out of 5,2005-12-20,Evidence at protein level
Q6NXR4,TTI2_HUMAN,TELO2-interacting protein 2,508,"56,915",4 out of 5,2007-03-06,Evidence at protein level
Q9BZA0,TTY10_HUMAN,Putative transcript Y 10 protein,68,"7,782",1 out of 5,2003-01-17,Uncertain
Q9BSA4,TTYH2_HUMAN,Protein tweety homolog 2 (hTTY2),534,"58,772",4 out of 5,2007-12-04,Evidence at protein level
Q5TAX3,TUT4_HUMAN,Terminal uridylyltransferase 4 (TUTase 4) (EC 2.7.7.52) (Zinc finger CCHC domain-containing protein 11),1644,"185,166",5 out of 5,2005-05-10,Evidence at protein level
Q12792,TWF1_HUMAN,Twinfilin-1 (Protein A6) (Protein tyrosine kinase 9),350,"40,283",5 out of 5,2004-02-02,Evidence at protein level
Q6UWH6,TX261_HUMAN,Protein TEX261,196,"22,538",2 out of 5,2006-07-25,Evidence at transcript level
P63313,TYB10_HUMAN,Thymosin beta-10,44,"5,026",3 out of 5,2004-10-11,Evidence at protein level
P19971,TYPH_HUMAN,Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase),482,"49,955",5 out of 5,1991-02-01,Evidence at protein level
Q13432,U119A_HUMAN,Protein unc-119 homolog A (Retinal protein 4) (hRG4),240,"26,962",5 out of 5,1997-11-01,Evidence at protein level
A6NCW7,U17L4_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 4,530,"59,636",2 out of 5,2008-04-29,Inferred from homology
C9JVI0,U17LB_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 11 (EC 3.4.19.12),530,"59,630",3 out of 5,2013-02-06,Inferred from homology
Q86TS7,U730_HUMAN,Putative UPF0730 protein encoded by LINC00643 (Long intergenic non-protein coding RNA 643),51,"6,040",1 out of 5,2006-10-31,Uncertain
Q969E3,UCN3_HUMAN,Urocortin-3 (Stresscopin) (Urocortin III) (Ucn III),161,"17,961",5 out of 5,2002-05-10,Evidence at protein level
P55851,UCP2_HUMAN,Mitochondrial uncoupling protein 2 (UCP 2) (Solute carrier family 25 member 8) (UCPH),309,"33,229",5 out of 5,1997-11-01,Evidence at protein level
P47985,UCRI_HUMAN,"Cytochrome b-c1 complex subunit Rieske, mitochondrial (EC 1.10.2.2) (Complex III subunit 5) (Cytochrome b-c1 complex subunit 5) (Rieske iron-sulfur protein) (RISP) (Ubiquinol-cytochrome c reductase iron-sulfur subunit) [Cleaved into: Cytochrome b-c1 complex subunit 11 (Complex III subunit IX) (Ubiquinol-cytochrome c reductase 8 kDa protein)]",274,"29,668",5 out of 5,1996-02-01,Evidence at protein level
P22309,UD11_HUMAN,UDP-glucuronosyltransferase 1-1 (UDPGT 1-1) (UGT1*1) (UGT1-01) (UGT1.1) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 1) (hUG-BR1) (UDP-glucuronosyltransferase 1-A) (UGT-1A) (UGT1A) (UDP-glucuronosyltransferase 1A1),533,"59,591",5 out of 5,1991-08-01,Evidence at protein level
Q9Y4X1,UD2A1_HUMAN,UDP-glucuronosyltransferase 2A1 (UDPGT 2A1) (EC 2.4.1.17),527,"59,926",5 out of 5,2003-09-26,Evidence at protein level
P06133,UD2B4_HUMAN,UDP-glucuronosyltransferase 2B4 (UDPGT 2B4) (EC 2.4.1.17) (HLUG25) (Hyodeoxycholic acid-specific UDPGT) (UDPGTh-1),528,"60,513",5 out of 5,1988-01-01,Evidence at protein level
Q9Y3C8,UFC1_HUMAN,Ubiquitin-fold modifier-conjugating enzyme 1 (Ufm1-conjugating enzyme 1),167,"19,458",5 out of 5,2000-05-30,Evidence at protein level
Q8NB66,UN13C_HUMAN,Protein unc-13 homolog C (Munc13-3),2214,"250,911",5 out of 5,2004-08-16,Evidence at transcript level
Q86WB7,UN93A_HUMAN,Protein unc-93 homolog A (HmUnc-93A) (Unc-93A),457,"50,270",4 out of 5,2005-06-07,Evidence at transcript level
Q03405,UPAR_HUMAN,Urokinase plasminogen activator surface receptor (U-PAR) (uPAR) (Monocyte activation antigen Mo3) (CD antigen CD87),335,"36,978",5 out of 5,1994-02-01,Evidence at protein level
O75841,UPK1B_HUMAN,Uroplakin-1b (UP1b) (Tetraspanin-20) (Tspan-20) (Uroplakin Ib) (UPIb),260,"29,643",4 out of 5,1999-07-15,Evidence at transcript level
B0FP48,UPK3L_HUMAN,Uroplakin-3b-like protein,263,"28,385",2 out of 5,2009-05-26,Evidence at transcript level
Q16831,UPP1_HUMAN,Uridine phosphorylase 1 (UPase 1) (UrdPase 1) (EC 2.4.2.3),310,"33,934",5 out of 5,1997-11-01,Evidence at protein level
Q9BRT2,UQCC2_HUMAN,Ubiquinol-cytochrome-c reductase complex assembly factor 2 (Breast cancer-associated protein SGA-81M) (Mitochondrial nucleoid factor 1) (Mitochondrial protein M19),126,"14,875",5 out of 5,2005-08-30,Evidence at protein level
Q9UKP6,UR2R_HUMAN,Urotensin-2 receptor (UR-2-R) (G-protein coupled receptor 14) (Urotensin II receptor) (UR-II-R),389,"42,130",5 out of 5,2000-12-01,Evidence at protein level
Q14146,URB2_HUMAN,Unhealthy ribosome biogenesis protein 2 homolog,1524,"170,544",3 out of 5,1997-11-01,Evidence at transcript level
Q8TCY9,URGCP_HUMAN,Up-regulator of cell proliferation (HBV X protein up-regulated gene 4 protein) (HBxAg up-regulated gene 4 protein),931,"104,987",5 out of 5,2008-05-20,Evidence at protein level
Q9Y6N9,USH1C_HUMAN,Harmonin (Antigen NY-CO-38/NY-CO-37) (Autoimmune enteropathy-related antigen AIE-75) (Protein PDZ-73) (Renal carcinoma antigen NY-REN-3) (Usher syndrome type-1C protein),552,"62,211",5 out of 5,2002-01-23,Evidence at protein level
Q16560,U1SBP_HUMAN,U11/U12 small nuclear ribonucleoprotein 35 kDa protein (U11/U12 snRNP 35 kDa protein) (U11/U12-35K) (Protein HM-1) (U1 snRNP-binding protein homolog),246,"29,450",5 out of 5,2007-10-23,Evidence at protein level
O14933,UB2L6_HUMAN,Ubiquitin/ISG15-conjugating enzyme E2 L6 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L6) (Retinoic acid-induced gene B protein) (RIG-B) (UbcH8) (Ubiquitin carrier protein L6) (Ubiquitin-protein ligase L6),153,"17,769",5 out of 5,2000-05-30,Evidence at protein level
P61081,UBC12_HUMAN,NEDD8-conjugating enzyme Ubc12 (EC 6.3.2.-) (NEDD8 carrier protein) (NEDD8 protein ligase) (Ubiquitin-conjugating enzyme E2 M),183,"20,900",5 out of 5,2004-04-26,Evidence at protein level
Q5VVX9,UBE2U_HUMAN,Ubiquitin-conjugating enzyme E2 U (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U),321,"37,741",4 out of 5,2005-10-25,Evidence at protein level
Q9Y5Z9,UBIA1_HUMAN,UbiA prenyltransferase domain-containing protein 1 (EC 2.5.1.-) (Transitional epithelial response protein 1),338,"36,831",5 out of 5,2006-06-27,Evidence at protein level
O95164,UBL3_HUMAN,Ubiquitin-like protein 3 (Membrane-anchored ubiquitin-fold protein) (HsMUB) (MUB) (Protein HCG-1),117,"13,157",3 out of 5,2004-09-13,Evidence at protein level
Q6ZU65,UBN2_HUMAN,Ubinuclein-2,1347,"146,089",3 out of 5,2007-07-24,Evidence at protein level
Q9UMW8,UBP18_HUMAN,Ubl carboxyl-terminal hydrolase 18 (EC 3.4.19.-) (43 kDa ISG15-specific protease) (hUBP43) (ISG15-specific-processing protease) (Ubl thioesterase 18),372,"43,011",5 out of 5,2000-12-01,Evidence at protein level
Q9UK80,UBP21_HUMAN,Ubiquitin carboxyl-terminal hydrolase 21 (EC 3.4.19.12) (Deubiquitinating enzyme 21) (Ubiquitin thioesterase 21) (Ubiquitin-specific-processing protease 21),565,"62,656",5 out of 5,2000-12-01,Evidence at protein level
Q9UPU5,UBP24_HUMAN,Ubiquitin carboxyl-terminal hydrolase 24 (EC 3.4.19.12) (Deubiquitinating enzyme 24) (Ubiquitin thioesterase 24) (Ubiquitin-specific-processing protease 24),2620,"294,365",4 out of 5,2001-06-20,Evidence at protein level
Q14157,UBP2L_HUMAN,Ubiquitin-associated protein 2-like (Protein NICE-4),1087,"114,535",5 out of 5,1997-11-01,Evidence at protein level
Q86T82,UBP37_HUMAN,Ubiquitin carboxyl-terminal hydrolase 37 (EC 3.4.19.12) (Deubiquitinating enzyme 37) (Ubiquitin thioesterase 37) (Ubiquitin-specific-processing protease 37),979,"110,170",5 out of 5,2003-10-10,Evidence at protein level
Q9UHD9,UBQL2_HUMAN,Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2),624,"65,696",5 out of 5,2004-03-29,Evidence at protein level
Q8IWV7,UBR1_HUMAN,E3 ubiquitin-protein ligase UBR1 (EC 2.3.2.27) (N-recognin-1) (RING-type E3 ubiquitin transferase UBR1) (Ubiquitin-protein ligase E3-alpha-1) (Ubiquitin-protein ligase E3-alpha-I),1749,"200,211",5 out of 5,2005-08-16,Evidence at protein level
Q6ZT12,UBR3_HUMAN,E3 ubiquitin-protein ligase UBR3 (EC 2.3.2.27) (N-recognin-3) (RING-type E3 ubiquitin transferase UBR3) (Ubiquitin-protein ligase E3-alpha-3) (Ubiquitin-protein ligase E3-alpha-III) (Zinc finger protein 650),1888,"212,433",5 out of 5,2007-02-20,Evidence at transcript level
Q8N806,UBR7_HUMAN,Putative E3 ubiquitin-protein ligase UBR7 (EC 2.3.2.27) (N-recognin-7) (RING-type E3 ubiquitin transferase UBR7),425,"47,999",3 out of 5,2003-10-24,Evidence at protein level
P09936,UCHL1_HUMAN,Ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) (EC 3.4.19.12) (EC 6.-.-.-) (Neuron cytoplasmic protein 9.5) (PGP 9.5) (PGP9.5) (Ubiquitin thioesterase L1),223,"24,824",5 out of 5,1989-07-01,Evidence at protein level
P55089,UCN1_HUMAN,Urocortin,124,"13,458",5 out of 5,1996-10-01,Evidence at protein level
Q96RP3,UCN2_HUMAN,Urocortin-2 (Stresscopin-related peptide) (Urocortin II) (Ucn II) (Urocortin-related peptide),112,"12,146",5 out of 5,2002-05-10,Evidence at protein level
Q96QD9,UIF_HUMAN,UAP56-interacting factor (Forty-two-three domain-containing protein 1) (Protein 40-2-3),318,"35,818",5 out of 5,2007-05-15,Evidence at protein level
P52758,UK114_HUMAN,Ribonuclease UK114 (EC 3.1.-.-) (14.5 kDa translational inhibitor protein) (p14.5) (Heat-responsive protein 12) (UK114 antigen homolog),137,"14,494",5 out of 5,1996-10-01,Evidence at protein level
Q9H3U1,UN45A_HUMAN,Protein unc-45 homolog A (Unc-45A) (GCUNC-45) (Smooth muscle cell-associated protein 1) (SMAP-1),944,"103,077",5 out of 5,2006-09-19,Evidence at protein level
Q8IWX7,UN45B_HUMAN,Protein unc-45 homolog B (Unc-45B) (SMUNC45),931,"103,733",4 out of 5,2006-09-19,Evidence at protein level
Q9C0B0,UNK_HUMAN,RING finger protein unkempt homolog (Zinc finger CCCH domain-containing protein 5),810,"88,084",4 out of 5,2004-05-10,Evidence at protein level
A6NGE7,URAD_HUMAN,Putative 2-oxo-4-hydroxy-4-carboxy-5-ureidoimidazoline decarboxylase (OHCU decarboxylase) (EC 4.1.1.97) (Parahox neighbor) (Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase),173,"19,130",4 out of 5,2008-01-15,Uncertain
P51668,UB2D1_HUMAN,Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Stimulator of Fe transport) (SFT) (UBC4/5 homolog) (UbcH5) (Ubiquitin carrier protein D1) (Ubiquitin-conjugating enzyme E2(17)KB 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase D1),147,"16,602",5 out of 5,1996-10-01,Evidence at protein level
P60604,UB2G2_HUMAN,Ubiquitin-conjugating enzyme E2 G2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme G2) (Ubiquitin carrier protein G2) (Ubiquitin-protein ligase G2),165,"18,566",5 out of 5,2004-03-15,Evidence at protein level
P61088,UBE2N_HUMAN,Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),152,"17,138",5 out of 5,2004-04-26,Evidence at protein level
Q16763,UBE2S_HUMAN,Ubiquitin-conjugating enzyme E2 S (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme S) (E2-EPF) (Ubiquitin carrier protein S) (Ubiquitin-conjugating enzyme E2-24 kDa) (Ubiquitin-conjugating enzyme E2-EPF5) (Ubiquitin-protein ligase S),222,"23,845",5 out of 5,1997-11-01,Evidence at protein level
Q15386,UBE3C_HUMAN,Ubiquitin-protein ligase E3C (EC 2.3.2.26) (HECT-type ubiquitin transferase E3C) (HectH2),1083,"123,923",5 out of 5,2005-06-07,Evidence at protein level
O95155,UBE4B_HUMAN,Ubiquitin conjugation factor E4 B (EC 2.3.2.27) (Homozygously deleted in neuroblastoma 1) (RING-type E3 ubiquitin transferase E4 B) (Ubiquitin fusion degradation protein 2),1302,"146,185",5 out of 5,2002-11-01,Evidence at protein level
O14562,UBFD1_HUMAN,Ubiquitin domain-containing protein UBFD1 (Ubiquitin-binding protein homolog),309,"33,382",3 out of 5,2007-04-03,Evidence at protein level
Q9NPG3,UBN1_HUMAN,Ubinuclein-1 (HIRA-binding protein) (Protein VT4) (Ubiquitously expressed nuclear protein),1134,"121,520",5 out of 5,2005-10-25,Evidence at protein level
P51784,UBP11_HUMAN,Ubiquitin carboxyl-terminal hydrolase 11 (EC 3.4.19.12) (Deubiquitinating enzyme 11) (Ubiquitin thioesterase 11) (Ubiquitin-specific-processing protease 11),963,"109,817",5 out of 5,1996-10-01,Evidence at protein level
Q92995,UBP13_HUMAN,Ubiquitin carboxyl-terminal hydrolase 13 (EC 3.4.19.12) (Deubiquitinating enzyme 13) (Isopeptidase T-3) (ISOT-3) (Ubiquitin thioesterase 13) (Ubiquitin-specific-processing protease 13),863,"97,327",5 out of 5,1997-11-01,Evidence at protein level
Q9UPT9,UBP22_HUMAN,Ubiquitin carboxyl-terminal hydrolase 22 (EC 3.4.19.12) (Deubiquitinating enzyme 22) (Ubiquitin thioesterase 22) (Ubiquitin-specific-processing protease 22),525,"59,961",5 out of 5,2002-03-27,Evidence at protein level
Q9UHP3,UBP25_HUMAN,Ubiquitin carboxyl-terminal hydrolase 25 (EC 3.4.19.12) (Deubiquitinating enzyme 25) (USP on chromosome 21) (Ubiquitin thioesterase 25) (Ubiquitin-specific-processing protease 25),1055,"122,218",5 out of 5,2000-05-30,Evidence at protein level
Q9HBJ7,UBP29_HUMAN,Ubiquitin carboxyl-terminal hydrolase 29 (EC 3.4.19.12) (Deubiquitinating enzyme 29) (Ubiquitin thioesterase 29) (Ubiquitin-specific-processing protease 29),922,"104,156",3 out of 5,2002-09-19,Evidence at transcript level
Q9NRR5,UBQL4_HUMAN,Ubiquilin-4 (Ataxin-1 interacting ubiquitin-like protein) (A1Up) (Ataxin-1 ubiquitin-like-interacting protein A1U) (Connexin43-interacting protein of 75 kDa) (CIP75),601,"63,853",5 out of 5,2004-03-15,Evidence at protein level
Q14CS0,UBX2B_HUMAN,UBX domain-containing protein 2B (NSFL1 cofactor p37) (p97 cofactor p37),331,"37,077",5 out of 5,2008-01-15,Evidence at protein level
Q9BZV1,UBXN6_HUMAN,UBX domain-containing protein 6 (UBX domain-containing protein 1),441,"49,754",5 out of 5,2003-05-16,Evidence at protein level
O95847,UCP4_HUMAN,Mitochondrial uncoupling protein 4 (UCP 4) (Solute carrier family 25 member 27),323,"36,064",5 out of 5,1999-07-15,Evidence at transcript level
P22310,UD14_HUMAN,UDP-glucuronosyltransferase 1-4 (UDPGT 1-4) (UGT1*4) (UGT1-04) (UGT1.4) (EC 2.4.1.17) (Bilirubin-specific UDPGT isozyme 2) (hUG-BR2) (UDP-glucuronosyltransferase 1-D) (UGT-1D) (UGT1D) (UDP-glucuronosyltransferase 1A4),534,"60,025",5 out of 5,1991-08-01,Evidence at protein level
Q9HAW9,UD18_HUMAN,UDP-glucuronosyltransferase 1-8 (UDPGT 1-8) (UGT1*8) (UGT1-08) (UGT1.8) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-H) (UGT-1H) (UGT1H) (UDP-glucuronosyltransferase 1A8),530,"59,742",5 out of 5,2003-04-11,Evidence at protein level
Q8IX04,UEVLD_HUMAN,Ubiquitin-conjugating enzyme E2 variant 3 (UEV-3) (EV and lactate/malate dehydrogenase domain-containing protein),471,"52,264",5 out of 5,2007-02-20,Evidence at protein level
Q9NUQ7,UFSP2_HUMAN,Ufm1-specific protease 2 (UfSP2) (EC 3.4.22.-),469,"53,261",5 out of 5,2007-03-20,Evidence at protein level
Q96T88,UHRF1_HUMAN,E3 ubiquitin-protein ligase UHRF1 (EC 2.3.2.27) (Inverted CCAAT box-binding protein of 90 kDa) (Nuclear protein 95) (Nuclear zinc finger protein Np95) (HuNp95) (hNp95) (RING finger protein 106) (RING-type E3 ubiquitin transferase UHRF1) (Transcription factor ICBP90) (Ubiquitin-like PHD and RING finger domain-containing protein 1) (hUHRF1) (Ubiquitin-like-containing PHD and RING finger domains protein 1),793,"89,814",5 out of 5,2005-06-07,Evidence at protein level
C9J7I0,UMAD1_HUMAN,UBAP1-MVB12-associated (UMA)-domain containing protein 1 (RPA3 antisense RNA 1) (RPA3 opposite strand),102,"11,180",2 out of 5,2014-11-26,Predicted
Q9UPW8,UN13A_HUMAN,Protein unc-13 homolog A (Munc13-1),1703,"193,014",5 out of 5,2004-08-16,Evidence at transcript level
O14795,UN13B_HUMAN,Protein unc-13 homolog B (Munc13-2) (munc13),1591,"180,679",5 out of 5,2004-08-16,Evidence at protein level
Q70J99,UN13D_HUMAN,Protein unc-13 homolog D (Munc13-4),1090,"123,282",5 out of 5,2004-08-16,Evidence at protein level
Q6UXZ4,UNC5D_HUMAN,Netrin receptor UNC5D (Protein unc-5 homolog 4) (Protein unc-5 homolog D),953,"105,880",5 out of 5,2004-10-11,Evidence at protein level
Q8N2C7,UNC80_HUMAN,Protein unc-80 homolog,3258,"363,390",5 out of 5,2005-08-16,Evidence at protein level
Q96J42,TXD15_HUMAN,Thioredoxin domain-containing protein 15,360,"39,885",3 out of 5,2007-07-24,Evidence at protein level
Q9NX01,TXN4B_HUMAN,Thioredoxin-like protein 4B (Dim1-like protein),149,"17,015",4 out of 5,2004-08-31,Evidence at protein level
Q9BZA5,TXNG2_HUMAN,"Putative gamma-taxilin 2 (Gamma-taxilin 2 pseudogene) (Taxilin gamma pseudogene, Y-linked)",131,"14,632",2 out of 5,2005-02-15,Uncertain
Q9H3M7,TXNIP_HUMAN,Thioredoxin-interacting protein (Thioredoxin-binding protein 2) (Vitamin D3 up-regulated protein 1),391,"43,661",5 out of 5,2006-10-03,Evidence at protein level
P53007,TXTP_HUMAN,"Tricarboxylate transport protein, mitochondrial (Citrate transport protein) (CTP) (Solute carrier family 25 member 1) (Tricarboxylate carrier protein)",311,"34,013",5 out of 5,1996-10-01,Evidence at protein level
P29597,TYK2_HUMAN,Non-receptor tyrosine-protein kinase TYK2 (EC 2.7.10.2),1187,"133,650",5 out of 5,1993-04-01,Evidence at protein level
P26368,U2AF2_HUMAN,Splicing factor U2AF 65 kDa subunit (U2 auxiliary factor 65 kDa subunit) (hU2AF(65)) (hU2AF65) (U2 snRNP auxiliary factor large subunit),475,"53,501",5 out of 5,1992-08-01,Evidence at protein level
A1L167,U2QL1_HUMAN,Ubiquitin-conjugating enzyme E2Q-like protein 1 (EC 2.3.2.23) (E2Q-like ubiquitin-conjugating enzyme 1),161,"18,338",5 out of 5,2008-05-20,Evidence at protein level
Q9NZ09,UBAP1_HUMAN,Ubiquitin-associated protein 1 (UBAP-1) (Nasopharyngeal carcinoma-associated gene 20 protein),502,"55,084",5 out of 5,2005-05-10,Evidence at protein level
Q8WVY7,UBCP1_HUMAN,Ubiquitin-like domain-containing CTD phosphatase 1 (EC 3.1.3.16) (Nuclear proteasome inhibitor UBLCP1),318,"36,805",5 out of 5,2006-06-27,Evidence at protein level
P0CG48,UBC_HUMAN,Polyubiquitin-C [Cleaved into: Ubiquitin],685,"77,039",5 out of 5,2010-08-10,Evidence at protein level
Q9C0C9,UBE2O_HUMAN,(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),1292,"141,293",5 out of 5,2007-03-20,Evidence at protein level
A6NDN8,UBIML_HUMAN,Putative ubiquitin-like protein FUBI-like protein ENSP00000310146,102,"10,909",1 out of 5,2008-09-02,Predicted
Q70CQ1,UBP49_HUMAN,Ubiquitin carboxyl-terminal hydrolase 49 (EC 3.4.19.12) (Deubiquitinating enzyme 49) (Ubiquitin thioesterase 49) (Ubiquitin-specific-processing protease 49),688,"79,198",5 out of 5,2004-09-13,Evidence at protein level
Q70EK8,UBP53_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 53 (Inactive ubiquitin-specific peptidase 53),1073,"120,806",4 out of 5,2006-02-07,Evidence at protein level
Q8IYU4,UBQLN_HUMAN,Ubiquilin-like protein,475,"52,897",3 out of 5,2007-10-23,Evidence at transcript level
O95071,UBR5_HUMAN,"E3 ubiquitin-protein ligase UBR5 (EC 2.3.2.26) (E3 ubiquitin-protein ligase, HECT domain-containing 1) (HECT-type E3 ubiquitin transferase UBR5) (Hyperplastic discs protein homolog) (hHYD) (Progestin-induced protein)",2799,"309,352",5 out of 5,2002-03-05,Evidence at protein level
Q8WVF2,UCMA_HUMAN,Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment (Ucma-C) (Gla-rich protein) (GRP)],138,"16,563",3 out of 5,2005-07-05,Evidence at transcript level
Q9HAW7,UD17_HUMAN,UDP-glucuronosyltransferase 1-7 (UDPGT 1-7) (UGT1*7) (UGT1-07) (UGT1.7) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-G) (UGT-1G) (UGT1G) (UDP-glucuronosyltransferase 1A7),530,"59,819",5 out of 5,2003-04-11,Evidence at protein level
C9JPN9,UL17C_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 12 (EC 3.4.19.12),530,"59,687",3 out of 5,2013-02-06,Inferred from homology
Q13564,ULA1_HUMAN,"NEDD8-activating enzyme E1 regulatory subunit (Amyloid beta precursor protein-binding protein 1, 59 kDa) (APP-BP1) (Amyloid protein-binding protein 1) (Proto-oncogene protein 1)",534,"60,246",5 out of 5,2004-07-19,Evidence at protein level
Q9NNX1,TUFT1_HUMAN,Tuftelin,390,"44,264",4 out of 5,2002-08-02,Evidence at protein level
O00295,TULP2_HUMAN,Tubby-related protein 2 (Cancer/testis antigen 65) (CT65) (Tubby-like protein 2),520,"58,664",4 out of 5,2000-05-30,Evidence at transcript level
Q8N3L3,TXLNB_HUMAN,Beta-taxilin (Muscle-derived protein 77) (hMDP77),684,"76,519",4 out of 5,2004-11-09,Evidence at protein level
Q6A555,TXND8_HUMAN,Thioredoxin domain-containing protein 8 (Spermatid-specific thioredoxin-3) (Sptrx-3) (Thioredoxin-6),127,"14,575",5 out of 5,2005-07-05,Evidence at protein level
C9JLJ4,U17LD_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 13 (EC 3.4.19.12),530,"59,694",3 out of 5,2013-02-06,Inferred from homology
Q0WX57,U17LO_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 (EC 3.4.19.12) (Deubiquitinating enzyme 17) (Ubiquitin thioesterase 17) (Ubiquitin-specific-processing protease 17),530,"59,711",5 out of 5,2008-04-29,Evidence at protein level
A6NN06,U633A_HUMAN,Putative UPF0633 protein MGC21881,94,"10,596",1 out of 5,2008-09-02,Uncertain
Q9BZF9,UACA_HUMAN,Uveal autoantigen with coiled-coil domains and ankyrin repeats,1416,"162,505",5 out of 5,2006-04-04,Evidence at protein level
Q9Y2X8,UB2D4_HUMAN,Ubiquitin-conjugating enzyme E2 D4 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D4) (HBUCE1) (Ubiquitin carrier protein D4) (Ubiquitin-protein ligase D4),147,"16,649",5 out of 5,2007-01-09,Evidence at protein level
Q969M7,UBE2F_HUMAN,NEDD8-conjugating enzyme UBE2F (EC 2.3.2.-) (NEDD8 carrier protein UBE2F) (NEDD8 protein ligase UBE2F) (NEDD8-conjugating enzyme 2) (RING-type E3 NEDD8 transferase UBE2F) (Ubiquitin-conjugating enzyme E2 F),185,"21,077",5 out of 5,2006-12-12,Evidence at protein level
Q8N7F7,UBL4B_HUMAN,Ubiquitin-like protein 4B,174,"19,909",2 out of 5,2006-12-12,Evidence at protein level
Q70EL4,UBP43_HUMAN,Ubiquitin carboxyl-terminal hydrolase 43 (EC 3.4.19.12) (Deubiquitinating enzyme 43) (Ubiquitin thioesterase 43) (Ubiquitin-specific-processing protease 43),1123,"122,809",4 out of 5,2006-09-19,Evidence at protein level
Q96K76,UBP47_HUMAN,Ubiquitin carboxyl-terminal hydrolase 47 (EC 3.4.19.12) (Deubiquitinating enzyme 47) (Ubiquitin thioesterase 47) (Ubiquitin-specific-processing protease 47),1375,"157,311",5 out of 5,2005-07-05,Evidence at protein level
Q93009,UBP7_HUMAN,Ubiquitin carboxyl-terminal hydrolase 7 (EC 3.4.19.12) (Deubiquitinating enzyme 7) (Herpesvirus-associated ubiquitin-specific protease) (Ubiquitin thioesterase 7) (Ubiquitin-specific-processing protease 7),1102,"128,302",5 out of 5,1997-11-01,Evidence at protein level
P35504,UD15_HUMAN,UDP-glucuronosyltransferase 1-5 (UDPGT 1-5) (UGT1*5) (UGT1-05) (UGT1.5) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-E) (UGT-1E) (UGT1E) (UDP-glucuronosyltransferase 1A5),534,"60,071",5 out of 5,1994-06-01,Evidence at transcript level
O60656,UD19_HUMAN,UDP-glucuronosyltransferase 1-9 (UDPGT 1-9) (UGT1*9) (UGT1-09) (UGT1.9) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-I) (UGT-1I) (UGT1I) (UDP-glucuronosyltransferase 1A9) (lugP4),530,"59,941",5 out of 5,2003-04-11,Evidence at protein level
P16662,UD2B7_HUMAN,"UDP-glucuronosyltransferase 2B7 (UDPGT 2B7) (EC 2.4.1.17) (3,4-catechol estrogen-specific UDPGT) (UDP-glucuronosyltransferase 2B9) (UDPGT 2B9) (UDPGTh-2)",529,"60,695",5 out of 5,1990-08-01,Evidence at protein level
P54855,UDB15_HUMAN,UDP-glucuronosyltransferase 2B15 (UDPGT 2B15) (EC 2.4.1.17) (HLUG4) (UDP-glucuronosyltransferase 2B8) (UDPGT 2B8) (UDPGTh-3),530,"61,036",5 out of 5,1996-10-01,Evidence at protein level
A0JNW5,UH1BL_HUMAN,UHRF1-binding protein 1-like,1464,"164,199",2 out of 5,2007-07-24,Evidence at protein level
Q8IZJ1,UNC5B_HUMAN,Netrin receptor UNC5B (Protein unc-5 homolog 2) (Protein unc-5 homolog B) (p53-regulated receptor for death and life protein 1) (p53RDL1),945,"103,638",5 out of 5,2004-10-11,Evidence at protein level
Q9P2D8,UNC79_HUMAN,Protein unc-79 homolog,2635,"295,326",4 out of 5,2008-01-15,Evidence at transcript level
Q9Y4R7,TTLL3_HUMAN,Tubulin monoglycylase TTLL3 (EC 6.3.2.-) (HOTTL) (Tubulin--tyrosine ligase-like protein 3),772,"87,414",5 out of 5,2002-05-02,Evidence at protein level
A6PVC2,TTLL8_HUMAN,Protein monoglycylase TTLL8 (EC 6.3.2.-) (Tubulin--tyrosine ligase-like protein 8),850,"94,676",4 out of 5,2008-06-10,Evidence at transcript level
Q9H313,TTYH1_HUMAN,Protein tweety homolog 1 (hTTY1),450,"49,051",5 out of 5,2007-12-04,Evidence at transcript level
P01733,TVB1_HUMAN,T-cell receptor beta chain V region YT35,135,"15,097",3 out of 5,1986-07-21,Evidence at protein level
Q8WVJ9,TWST2_HUMAN,Twist-related protein 2 (Class A basic helix-loop-helix protein 39) (bHLHa39) (Dermis-expressed protein 1) (Dermo-1),160,"18,124",5 out of 5,2003-07-11,Evidence at protein level
P40126,TYRP2_HUMAN,L-dopachrome tautomerase (DCT) (DT) (EC 5.3.3.12) (L-dopachrome Delta-isomerase) (Tyrosinase-related protein 2) (TRP-2) (TRP2),519,"59,145",5 out of 5,1995-02-01,Evidence at protein level
P04818,TYSY_HUMAN,Thymidylate synthase (TS) (TSase) (EC 2.1.1.45),313,"35,716",5 out of 5,1987-08-13,Evidence at protein level
Q6NUM6,TYW1B_HUMAN,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 2) (tRNA wybutosine-synthesizing protein 1 homolog B),668,"76,916",4 out of 5,2007-04-03,Evidence at transcript level
O15391,TYY2_HUMAN,Transcription factor YY2 (Yin and yang 2) (YY-2) (Zinc finger protein 631),372,"41,347",3 out of 5,2008-03-18,Evidence at transcript level
A6NCW0,U17L3_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 3 (EC 3.4.19.12) (Deubiquitinating enzyme 17-like protein 3) (Ubiquitin thioesterase 17-like protein 3) (Ubiquitin-specific-processing protease 17-like protein 3),530,"59,536",3 out of 5,2008-04-29,Inferred from homology
C9J2P7,U17LF_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 15 (EC 3.4.19.12),530,"59,676",3 out of 5,2013-02-06,Inferred from homology
Q15819,UB2V2_HUMAN,Ubiquitin-conjugating enzyme E2 variant 2 (DDVit 1) (Enterocyte differentiation-associated factor 1) (EDAF-1) (Enterocyte differentiation-promoting factor 1) (EDPF-1) (MMS2 homolog) (Vitamin D3-inducible protein),145,"16,363",5 out of 5,2004-08-31,Evidence at protein level
A0AVT1,UBA6_HUMAN,Ubiquitin-like modifier-activating enzyme 6 (Ubiquitin-activating enzyme 6) (EC 6.2.1.45) (Monocyte protein 4) (MOP-4) (Ubiquitin-activating enzyme E1-like protein 2) (E1-L2),1052,"117,970",5 out of 5,2007-02-20,Evidence at protein level
Q14139,UBE4A_HUMAN,Ubiquitin conjugation factor E4 A (EC 2.3.2.27) (RING-type E3 ubiquitin transferase E4 A),1066,"122,561",4 out of 5,1997-11-01,Evidence at protein level
P11441,UBL4A_HUMAN,Ubiquitin-like protein 4A (Ubiquitin-like protein GDX),157,"17,777",5 out of 5,1989-10-01,Evidence at protein level
Q14694,UBP10_HUMAN,Ubiquitin carboxyl-terminal hydrolase 10 (EC 3.4.19.12) (Deubiquitinating enzyme 10) (Ubiquitin thioesterase 10) (Ubiquitin-specific-processing protease 10),798,"87,134",5 out of 5,1997-11-01,Evidence at protein level
Q9NVE5,UBP40_HUMAN,Ubiquitin carboxyl-terminal hydrolase 40 (EC 3.4.19.12) (Deubiquitinating enzyme 40) (Ubiquitin thioesterase 40) (Ubiquitin-specific-processing protease 40),1235,"140,130",4 out of 5,2003-10-10,Evidence at protein level
Q9H347,UBQL3_HUMAN,Ubiquilin-3,655,"70,841",2 out of 5,2004-03-29,Evidence at protein level
Q5T4S7,UBR4_HUMAN,E3 ubiquitin-protein ligase UBR4 (EC 2.3.2.27) (600 kDa retinoblastoma protein-associated factor) (N-recognin-4) (RING-type E3 ubiquitin transferase UBR4) (Retinoblastoma-associated factor of 600 kDa) (RBAF600) (p600) (Zinc finger UBR1-type protein 1),5183,"573,841",5 out of 5,2007-05-15,Evidence at protein level
P57075,UBS3A_HUMAN,Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4) (CLIP4) (Suppressor of T-cell receptor signaling 2) (STS-2) (T-cell ubiquitin ligand 1) (TULA-1),661,"74,123",5 out of 5,2000-12-01,Evidence at protein level
Q8TF42,UBS3B_HUMAN,Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2),649,"72,696",5 out of 5,2006-07-11,Evidence at protein level
O95258,UCP5_HUMAN,Brain mitochondrial carrier protein 1 (BMCP-1) (Mitochondrial uncoupling protein 5) (UCP 5) (Solute carrier family 25 member 14),325,"36,202",5 out of 5,2000-05-30,Evidence at transcript level
P0C7P4,UCRIL_HUMAN,Putative cytochrome b-c1 complex subunit Rieske-like protein 1 (Ubiquinol-cytochrome c reductase Rieske iron-sulfur subunit pseudogene 1),283,"30,815",2 out of 5,2008-07-01,Uncertain
Q9HAW8,UD110_HUMAN,UDP-glucuronosyltransferase 1-10 (UDPGT 1-10) (UGT1*10) (UGT1-10) (UGT1.10) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-J) (UGT-1J) (UGT1J) (UDP-glucuronosyltransferase 1A10),530,"59,810",5 out of 5,2003-04-11,Evidence at protein level
Q3SY77,UD3A2_HUMAN,UDP-glucuronosyltransferase 3A2 (UDPGT 3A2) (EC 2.4.1.17),523,"59,547",4 out of 5,2007-08-21,Evidence at transcript level
O75310,UDB11_HUMAN,UDP-glucuronosyltransferase 2B11 (UDPGT 2B11) (EC 2.4.1.17),529,"61,038",4 out of 5,1998-12-15,Evidence at transcript level
O75795,UDB17_HUMAN,UDP-glucuronosyltransferase 2B17 (UDPGT 2B17) (EC 2.4.1.17) (C19-steroid-specific UDP-glucuronosyltransferase) (C19-steroid-specific UDPGT),530,"61,095",5 out of 5,1998-12-15,Evidence at protein level
Q5JXB2,UE2NL_HUMAN,Putative ubiquitin-conjugating enzyme E2 N-like (Epididymis tissue protein Li 174),153,"17,377",3 out of 5,2007-01-09,Evidence at protein level
P02766,TTHY_HUMAN,Transthyretin (ATTR) (Prealbumin) (TBPA),147,"15,887",5 out of 5,1986-07-21,Evidence at protein level
Q9BZ97,TTY13_HUMAN,Putative transcript Y 13 protein,58,"6,256",1 out of 5,2003-01-17,Uncertain
Q9C0H2,TTYH3_HUMAN,Protein tweety homolog 3 (hTTY3),523,"57,545",5 out of 5,2007-12-04,Evidence at protein level
P01858,TUFT_HUMAN,Phagocytosis-stimulating peptide (Tuftsin),4,501,1 out of 5,1986-07-21,Evidence at protein level
O75896,TUSC2_HUMAN,Tumor suppressor candidate 2 (Fusion 1 protein) (Fus-1 protein) (PDGFA-associated protein 2),110,"12,074",5 out of 5,2000-05-30,Evidence at protein level
Q9GZX9,TWSG1_HUMAN,Twisted gastrulation protein homolog 1,223,"25,017",5 out of 5,2007-03-06,Evidence at protein level
Q9BXU3,TX13A_HUMAN,Testis-expressed protein 13A,409,"45,583",2 out of 5,2004-07-19,Evidence at protein level
Q9BRA2,TXD17_HUMAN,Thioredoxin domain-containing protein 17 (14 kDa thioredoxin-related protein) (TRP14) (Protein 42-9-9) (Thioredoxin-like protein 5),123,"13,941",5 out of 5,2006-01-10,Evidence at protein level
P07101,TY3H_HUMAN,Tyrosine 3-monooxygenase (EC 1.14.16.2) (Tyrosine 3-hydroxylase) (TH),528,"58,600",5 out of 5,1988-04-01,Evidence at protein level
P17643,TYRP1_HUMAN,"5,6-dihydroxyindole-2-carboxylic acid oxidase (DHICA oxidase) (EC 1.14.18.-) (Catalase B) (Glycoprotein 75) (Melanoma antigen gp75) (Tyrosinase-related protein 1) (TRP) (TRP-1) (TRP1)",537,"60,724",5 out of 5,1990-08-01,Evidence at protein level
Q53H54,TYW2_HUMAN,tRNA wybutosine-synthesizing protein 2 homolog (tRNA-yW-synthesizing protein 2) (EC 2.5.1.114) (tRNA(Phe) (4-demethylwyosine(37)-C(7)) aminocarboxypropyltransferase),448,"50,236",4 out of 5,2007-04-03,Evidence at protein level
Q6IPR3,TYW3_HUMAN,tRNA wybutosine-synthesizing protein 3 homolog (tRNA-yW-synthesizing protein 3) (EC 2.1.1.282) (tRNA(Phe) 7-((3-amino-3-carboxypropyl)-4-demethylwyosine(37)-N(4))-methyltransferase),259,"29,794",3 out of 5,2007-04-03,Evidence at transcript level
P25490,TYY1_HUMAN,Transcriptional repressor protein YY1 (Delta transcription factor) (INO80 complex subunit S) (NF-E1) (Yin and yang 1) (YY-1),414,"44,713",5 out of 5,1992-05-01,Evidence at protein level
A6NIH7,U119B_HUMAN,Protein unc-119 homolog B,251,"28,137",5 out of 5,2008-05-20,Evidence at protein level
P0C7H9,U17L7_HUMAN,Inactive ubiquitin carboxyl-terminal hydrolase 17-like protein 7,530,"59,751",3 out of 5,2008-04-29,Inferred from homology
D6RCP7,U17LJ_HUMAN,Ubiquitin carboxyl-terminal hydrolase 17-like protein 19 (EC 3.4.19.12),530,"59,658",3 out of 5,2013-02-06,Inferred from homology
P0DN76,U2AF5_HUMAN,Splicing factor U2AF 35 kDa subunit-like protein (U2 small nuclear RNA auxiliary factor 1-like protein 5),240,"27,872",3 out of 5,2016-02-17,Evidence at protein level
H0YL09,U2Q2L_HUMAN,Putative ubiquitin-conjugating enzyme E2Q2-like protein,131,"14,853",1 out of 5,2014-05-14,Uncertain
Q9Y385,UB2J1_HUMAN,Ubiquitin-conjugating enzyme E2 J1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme J1) (Non-canonical ubiquitin-conjugating enzyme 1) (NCUBE-1) (Yeast ubiquitin-conjugating enzyme UBC6 homolog E) (HsUBC6e),318,"35,199",5 out of 5,2004-09-13,Evidence at protein level
Q8TB05,UBAD1_HUMAN,UBA-like domain-containing protein 1,177,"18,954",2 out of 5,2006-05-16,Evidence at transcript level
P35544,UBIM_HUMAN,Ubiquitin-like protein FUBI,74,"7,760",2 out of 5,1994-06-01,Evidence at protein level
O94782,UBP1_HUMAN,Ubiquitin carboxyl-terminal hydrolase 1 (EC 3.4.19.12) (Deubiquitinating enzyme 1) (hUBP) (Ubiquitin thioesterase 1) (Ubiquitin-specific-processing protease 1),785,"88,207",5 out of 5,2000-12-01,Evidence at protein level
Q96RU2,UBP28_HUMAN,Ubiquitin carboxyl-terminal hydrolase 28 (EC 3.4.19.12) (Deubiquitinating enzyme 28) (Ubiquitin thioesterase 28) (Ubiquitin-specific-processing protease 28),1077,"122,491",5 out of 5,2002-03-27,Evidence at protein level
O75604,UBP2_HUMAN,Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2),605,"68,072",5 out of 5,2000-12-01,Evidence at protein level
Q70CQ4,UBP31_HUMAN,Ubiquitin carboxyl-terminal hydrolase 31 (EC 3.4.19.12) (Deubiquitinating enzyme 31) (Ubiquitin thioesterase 31) (Ubiquitin-specific-processing protease 31),1352,"146,651",5 out of 5,2006-09-19,Evidence at transcript level
Q8TEY7,UBP33_HUMAN,Ubiquitin carboxyl-terminal hydrolase 33 (EC 3.4.19.12) (Deubiquitinating enzyme 33) (Ubiquitin thioesterase 33) (Ubiquitin-specific-processing protease 33) (VHL-interacting deubiquitinating enzyme 1) (hVDU1),942,"106,727",5 out of 5,2003-10-10,Evidence at protein level
P40818,UBP8_HUMAN,Ubiquitin carboxyl-terminal hydrolase 8 (EC 3.4.19.12) (Deubiquitinating enzyme 8) (Ubiquitin isopeptidase Y) (hUBPy) (Ubiquitin thioesterase 8) (Ubiquitin-specific-processing protease 8),1118,"127,523",5 out of 5,1995-02-01,Evidence at protein level
Q9HAC8,UBTD1_HUMAN,Ubiquitin domain-containing protein 1,227,"25,938",2 out of 5,2006-06-27,Evidence at protein level
Q5T124,UBX11_HUMAN,UBX domain-containing protein 11 (Colorectal tumor-associated antigen COA-1) (Socius) (UBX domain-containing protein 5),520,"57,373",5 out of 5,2007-05-01,Evidence at protein level
P15374,UCHL3_HUMAN,Ubiquitin carboxyl-terminal hydrolase isozyme L3 (UCH-L3) (EC 3.4.19.12) (Ubiquitin thioesterase L3),230,"26,183",5 out of 5,1990-04-01,Evidence at protein level
Q9BZX2,UCK2_HUMAN,Uridine-cytidine kinase 2 (UCK 2) (EC 2.7.1.48) (Cytidine monophosphokinase 2) (Testis-specific protein TSA903) (Uridine monophosphokinase 2),261,"29,299",5 out of 5,2002-05-02,Evidence at protein level
Q9NWZ5,UCKL1_HUMAN,Uridine-cytidine kinase-like 1 (EC 2.7.1.48),548,"61,141",5 out of 5,2002-05-02,Evidence at protein level
P25874,UCP1_HUMAN,Mitochondrial brown fat uncoupling protein 1 (UCP 1) (Solute carrier family 25 member 7) (Thermogenin),307,"33,005",5 out of 5,1992-05-01,Evidence at protein level
P55916,UCP3_HUMAN,Mitochondrial uncoupling protein 3 (UCP 3) (Solute carrier family 25 member 9),312,"34,216",5 out of 5,1997-11-01,Evidence at protein level
Q9BY64,UDB28_HUMAN,UDP-glucuronosyltransferase 2B28 (UDPGT 2B28) (EC 2.4.1.17),529,"60,906",5 out of 5,2002-01-23,Evidence at protein level
Q9NYU1,UGGG2_HUMAN,UDP-glucose:glycoprotein glucosyltransferase 2 (UGT2) (hUGT2) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase 2) (UDP-glucose ceramide glucosyltransferase-like 1),1516,"174,735",5 out of 5,2003-02-12,Evidence at protein level
Q8IYT8,ULK2_HUMAN,Serine/threonine-protein kinase ULK2 (EC 2.7.11.1) (Unc-51-like kinase 2),1036,"112,694",5 out of 5,2005-10-25,Evidence at protein level
Q96C45,ULK4_HUMAN,Serine/threonine-protein kinase ULK4 (EC 2.7.11.1) (Unc-51-like kinase 4),1275,"142,442",5 out of 5,2006-11-28,Evidence at protein level
Q9NV66,TYW1_HUMAN,S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase (EC 4.1.3.44) (Radical S-adenosyl methionine and flavodoxin domain-containing protein 1) (tRNA wybutosine-synthesizing protein 1 homolog) (tRNA-yW-synthesizing protein),732,"83,702",4 out of 5,2007-04-03,Evidence at transcript level
Q16222,UAP1_HUMAN,UDP-N-acetylhexosamine pyrophosphorylase (Antigen X) (AGX) (Sperm-associated antigen 2) [Includes: UDP-N-acetylgalactosamine pyrophosphorylase (EC 2.7.7.83) (AGX-1); UDP-N-acetylglucosamine pyrophosphorylase (EC 2.7.7.23) (AGX-2)],522,"58,769",5 out of 5,1999-07-15,Evidence at protein level
P62837,UB2D2_HUMAN,Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1),147,"16,735",5 out of 5,2004-08-16,Evidence at protein level
Q969T4,UB2E3_HUMAN,Ubiquitin-conjugating enzyme E2 E3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E3) (UbcH9) (Ubiquitin carrier protein E3) (Ubiquitin-conjugating enzyme E2-23 kDa) (Ubiquitin-protein ligase E3),207,"22,913",5 out of 5,2004-05-24,Evidence at protein level
Q7Z7E8,UB2Q1_HUMAN,Ubiquitin-conjugating enzyme E2 Q1 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme Q1) (Protein NICE-5) (Ubiquitin carrier protein Q1) (Ubiquitin-protein ligase Q1),422,"46,127",5 out of 5,2006-02-21,Evidence at protein level
Q9NPD8,UBE2T_HUMAN,Ubiquitin-conjugating enzyme E2 T (EC 2.3.2.23) (Cell proliferation-inducing gene 50 protein) (E2 ubiquitin-conjugating enzyme T) (Ubiquitin carrier protein T) (Ubiquitin-protein ligase T),197,"22,521",5 out of 5,2005-08-16,Evidence at protein level
Q7Z3V4,UBE3B_HUMAN,Ubiquitin-protein ligase E3B (EC 2.3.2.26) (HECT-type ubiquitin transferase E3B),1068,"123,098",4 out of 5,2007-04-03,Evidence at protein level
Q9Y5K5,UCHL5_HUMAN,Ubiquitin carboxyl-terminal hydrolase isozyme L5 (UCH-L5) (EC 3.4.19.12) (Ubiquitin C-terminal hydrolase UCH37) (Ubiquitin thioesterase L5),329,"37,607",5 out of 5,2001-09-26,Evidence at protein level
Q9HA47,UCK1_HUMAN,Uridine-cytidine kinase 1 (UCK 1) (EC 2.7.1.48) (Cytidine monophosphokinase 1) (Uridine monophosphokinase 1),277,"31,435",5 out of 5,2002-05-02,Evidence at protein level
Q6UWM9,UD2A3_HUMAN,UDP-glucuronosyltransferase 2A3 (UDPGT 2A3) (EC 2.4.1.17),527,"60,254",3 out of 5,2007-08-21,Evidence at transcript level
Q92890,UFD1_HUMAN,Ubiquitin fusion degradation protein 1 homolog (UB fusion protein 1),307,"34,500",5 out of 5,1997-11-01,Evidence at protein level
Q16851,UGPA_HUMAN,UTP--glucose-1-phosphate uridylyltransferase (EC 2.7.7.9) (UDP-glucose pyrophosphorylase) (UDPGP) (UGPase),508,"56,940",5 out of 5,1999-07-15,Evidence at protein level
O75385,ULK1_HUMAN,Serine/threonine-protein kinase ULK1 (EC 2.7.11.1) (Autophagy-related protein 1 homolog) (ATG1) (hATG1) (Unc-51-like kinase 1),1050,"112,631",5 out of 5,1999-07-15,Evidence at protein level
P11172,UMPS_HUMAN,Uridine 5'-monophosphate synthase (UMP synthase) [Includes: Orotate phosphoribosyltransferase (OPRT) (OPRTase) (EC 2.4.2.10); Orotidine 5'-phosphate decarboxylase (ODC) (EC 4.1.1.23) (OMPdecase)],480,"52,222",5 out of 5,1989-07-01,Evidence at protein level
Q9BT76,UPK3B_HUMAN,Uroplakin-3b (UP3b) (Uroplakin IIIb) (UPIIIb) (p35),320,"33,882",4 out of 5,2003-09-19,Evidence at protein level
Q765I0,UTS2B_HUMAN,Urotensin-2B (Urotensin II-related peptide) (Urotensin IIB) (U-IIB) (UIIB) (Urotensin-2 domain-containing protein),119,"13,749",3 out of 5,2004-11-23,Inferred from homology
P21283,VATC1_HUMAN,V-type proton ATPase subunit C 1 (V-ATPase subunit C 1) (Vacuolar proton pump subunit C 1),382,"43,942",5 out of 5,1991-05-01,Evidence at protein level
P27449,VATL_HUMAN,V-type proton ATPase 16 kDa proteolipid subunit (V-ATPase 16 kDa proteolipid subunit) (Vacuolar proton pump 16 kDa proteolipid subunit),155,"15,736",5 out of 5,1992-08-01,Evidence at protein level
Q8N2C9,UMAS1_HUMAN,Uncharacterized protein UMODL1-AS1 (UMODL1 antisense RNA 1) (UMODL1 antisense gene protein 1),162,"18,019",1 out of 5,2004-03-15,Evidence at transcript level
Q9H1C4,UN93B_HUMAN,Protein unc-93 homolog B1 (Unc-93B1) (hUNC93B1),597,"66,631",5 out of 5,2005-06-07,Evidence at protein level
O95045,UPP2_HUMAN,Uridine phosphorylase 2 (UPase 2) (UrdPase 2) (EC 2.4.2.3),317,"35,527",5 out of 5,2003-10-03,Evidence at protein level
Q9NVA1,UQCC1_HUMAN,Ubiquinol-cytochrome-c reductase complex assembly factor 1 (Basic FGF-repressed Zic-binding protein) (bFGF-repressed Zic-binding protein) (bFZb) (Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog),299,"34,600",5 out of 5,2003-02-22,Evidence at protein level
Q6BDS2,URFB1_HUMAN,UHRF1-binding protein 1 (ICBP90-binding protein 1) (Ubiquitin-like containing PHD and RING finger domains 1-binding protein 1),1440,"159,485",4 out of 5,2005-06-07,Evidence at protein level
P00749,UROK_HUMAN,Urokinase-type plasminogen activator (U-plasminogen activator) (uPA) (EC 3.4.21.73) [Cleaved into: Urokinase-type plasminogen activator long chain A; Urokinase-type plasminogen activator short chain A; Urokinase-type plasminogen activator chain B],431,"48,507",5 out of 5,1986-07-21,Evidence at protein level
Q9Y2C2,UST_HUMAN,Uronyl 2-sulfotransferase (EC 2.8.2.-),406,"47,673",4 out of 5,2005-06-21,Evidence at transcript level
Q16572,VACHT_HUMAN,Vesicular acetylcholine transporter (VAChT) (Solute carrier family 18 member 3),532,"56,903",5 out of 5,2003-09-19,Evidence at protein level
O75379,VAMP4_HUMAN,Vesicle-associated membrane protein 4 (VAMP-4),141,"16,397",5 out of 5,2001-02-21,Evidence at protein level
Q15904,VAS1_HUMAN,V-type proton ATPase subunit S1 (V-ATPase subunit S1) (Protein XAP-3) (V-ATPase Ac45 subunit) (V-ATPase S1 accessory protein) (Vacuolar proton pump subunit S1),470,"52,026",5 out of 5,2001-01-11,Evidence at protein level
Q6EMK4,VASN_HUMAN,Vasorin (Protein slit-like 2),673,"71,713",5 out of 5,2006-04-18,Evidence at protein level
P38606,VATA_HUMAN,V-type proton ATPase catalytic subunit A (V-ATPase subunit A) (EC 3.6.3.14) (V-ATPase 69 kDa subunit) (Vacuolar ATPase isoform VA68) (Vacuolar proton pump subunit alpha),617,"68,304",5 out of 5,1994-10-01,Evidence at protein level
P21281,VATB2_HUMAN,"V-type proton ATPase subunit B, brain isoform (V-ATPase subunit B 2) (Endomembrane proton pump 58 kDa subunit) (HO57) (Vacuolar proton pump subunit B 2)",511,"56,501",5 out of 5,1991-05-01,Evidence at protein level
P22314,UBA1_HUMAN,Ubiquitin-like modifier-activating enzyme 1 (EC 6.2.1.45) (Protein A1S9) (Ubiquitin-activating enzyme E1),1058,"117,849",5 out of 5,1991-08-01,Evidence at protein level
Q8NBM4,UBAC2_HUMAN,Ubiquitin-associated domain-containing protein 2 (UBA domain-containing protein 2) (Phosphoglycerate dehydrogenase-like protein 1),344,"38,964",5 out of 5,2007-03-20,Evidence at protein level
P0CG47,UBB_HUMAN,Polyubiquitin-B [Cleaved into: Ubiquitin],229,"25,762",5 out of 5,2010-08-10,Evidence at protein level
O00526,UPK2_HUMAN,Uroplakin-2 (UP2) (Uroplakin II) (UPII),184,"19,438",4 out of 5,1997-11-01,Evidence at protein level
O75631,UPK3A_HUMAN,Uroplakin-3a (UP3a) (Uroplakin III) (UPIII),287,"30,670",5 out of 5,2000-05-30,Evidence at protein level
Q6UW78,UQCC3_HUMAN,Ubiquinol-cytochrome-c reductase complex assembly factor 3 (Assembly factor CBP4 homolog),93,"10,081",5 out of 5,2004-11-23,Evidence at protein level
Q86UX7,URP2_HUMAN,Fermitin family homolog 3 (Kindlin-3) (MIG2-like protein) (Unc-112-related protein 2),667,"75,953",5 out of 5,2004-01-16,Evidence at protein level
Q68DE3,USF3_HUMAN,Basic helix-loop-helix domain-containing protein USF3 (Upstream transcription factor 3),2245,"241,681",3 out of 5,2007-07-24,Evidence at protein level
Q93008,USP9X_HUMAN,"Probable ubiquitin carboxyl-terminal hydrolase FAF-X (EC 3.4.19.12) (Deubiquitinating enzyme FAF-X) (Fat facets in mammals) (hFAM) (Fat facets protein-related, X-linked) (Ubiquitin thioesterase FAF-X) (Ubiquitin-specific protease 9, X chromosome) (Ubiquitin-specific-processing protease FAF-X)",2570,"292,280",5 out of 5,1997-11-01,Evidence at protein level
Q9BVJ6,UT14A_HUMAN,U3 small nucleolar RNA-associated protein 14 homolog A (Antigen NY-CO-16) (Serologically defined colon cancer antigen 16),771,"87,978",5 out of 5,2005-07-05,Evidence at protein level
Q9Y5J1,UTP18_HUMAN,U3 small nucleolar RNA-associated protein 18 homolog (WD repeat-containing protein 50),556,"62,004",4 out of 5,2001-11-16,Evidence at protein level
Q9BRU9,UTP23_HUMAN,rRNA-processing protein UTP23 homolog,249,"28,402",5 out of 5,2007-05-01,Evidence at protein level
P37288,V1AR_HUMAN,Vasopressin V1a receptor (V1aR) (AVPR V1a) (Antidiuretic hormone receptor 1a) (Vascular/hepatic-type arginine vasopressin receptor),418,"46,800",5 out of 5,1994-10-01,Evidence at protein level
Q9Y5K8,VATD_HUMAN,V-type proton ATPase subunit D (V-ATPase subunit D) (V-ATPase 28 kDa accessory protein) (Vacuolar proton pump subunit D),247,"28,263",5 out of 5,2000-12-01,Evidence at protein level
Q96A05,VATE2_HUMAN,V-type proton ATPase subunit E 2 (V-ATPase subunit E 2) (Vacuolar proton pump subunit E 2),226,"26,074",5 out of 5,2007-04-03,Evidence at protein level
Q16864,VATF_HUMAN,V-type proton ATPase subunit F (V-ATPase subunit F) (V-ATPase 14 kDa subunit) (Vacuolar proton pump subunit F),119,"13,370",5 out of 5,1997-11-01,Evidence at protein level
Q9UI12,VATH_HUMAN,V-type proton ATPase subunit H (V-ATPase subunit H) (Nef-binding protein 1) (NBP1) (Protein VMA13 homolog) (V-ATPase 50/57 kDa subunits) (Vacuolar proton pump subunit H) (Vacuolar proton pump subunit SFD),483,"55,883",5 out of 5,2001-01-24,Evidence at protein level
P45880,VDAC2_HUMAN,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),294,"31,567",5 out of 5,1995-11-01,Evidence at protein level
O95231,VENTX_HUMAN,Homeobox protein VENTX (VENT homeobox homolog) (VENT-like homeobox protein 2),258,"27,552",4 out of 5,2007-10-02,Evidence at protein level
Q53HI1,UNC50_HUMAN,Protein unc-50 homolog (Periodontal ligament-specific protein 22) (PDLs22) (Protein GMH1 homolog) (hGMH1) (Uncoordinated-like protein),259,"30,373",3 out of 5,2007-11-13,Evidence at protein level
Q6ZN44,UNC5A_HUMAN,Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A),842,"92,932",5 out of 5,2004-10-11,Evidence at protein level
Q9BTM9,URM1_HUMAN,Ubiquitin-related modifier 1,101,"11,380",5 out of 5,2005-07-05,Evidence at protein level
Q13336,UT1_HUMAN,"Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte)",389,"42,528",5 out of 5,1997-11-01,Evidence at protein level
P11684,UTER_HUMAN,Uteroglobin (Clara cell phospholipid-binding protein) (CCPBP) (Clara cells 10 kDa secretory protein) (CC10) (Secretoglobin family 1A member 1) (Urinary protein 1) (UP-1) (UP1) (Urine protein 1),91,"9,994",5 out of 5,1989-10-01,Evidence at protein level
O14607,UTY_HUMAN,Histone demethylase UTY (EC 1.14.11.-) (Ubiquitously-transcribed TPR protein on the Y chromosome) (Ubiquitously-transcribed Y chromosome tetratricopeptide repeat protein),1347,"149,548",5 out of 5,1999-07-15,Evidence at protein level
P47901,V1BR_HUMAN,Vasopressin V1b receptor (V1bR) (AVPR V1b) (AVPR V3) (Antidiuretic hormone receptor 1b) (Vasopressin V3 receptor),424,"46,971",5 out of 5,1996-02-01,Evidence at transcript level
Q8N8Y2,VA0D2_HUMAN,V-type proton ATPase subunit d 2 (V-ATPase subunit d 2) (Vacuolar proton pump subunit d 2),350,"40,426",5 out of 5,2007-05-01,Evidence at transcript level
Q08AM6,VAC14_HUMAN,Protein VAC14 homolog (Tax1-binding protein 2),782,"87,973",5 out of 5,2007-09-11,Evidence at protein level
P23763,VAMP1_HUMAN,Vesicle-associated membrane protein 1 (VAMP-1) (Synaptobrevin-1),118,"12,902",5 out of 5,1991-11-01,Evidence at protein level
Q15836,VAMP3_HUMAN,Vesicle-associated membrane protein 3 (VAMP-3) (Cellubrevin) (CEB) (Synaptobrevin-3),100,"11,309",5 out of 5,1997-11-01,Evidence at protein level
Q9BV40,VAMP8_HUMAN,Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB),100,"11,438",5 out of 5,2004-11-23,Evidence at protein level
P36543,VATE1_HUMAN,V-type proton ATPase subunit E 1 (V-ATPase subunit E 1) (V-ATPase 31 kDa subunit) (p31) (Vacuolar proton pump subunit E 1),226,"26,145",5 out of 5,1994-06-01,Evidence at protein level
Q99437,VATO_HUMAN,V-type proton ATPase 21 kDa proteolipid subunit (V-ATPase 21 kDa proteolipid subunit) (Vacuolar proton pump 21 kDa proteolipid subunit) (hATPL),205,"21,406",5 out of 5,1999-07-15,Evidence at transcript level
P11473,VDR_HUMAN,"Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)",427,"48,289",5 out of 5,1989-10-01,Evidence at protein level
Q14119,VEZF1_HUMAN,Vascular endothelial zinc finger 1 (Putative transcription factor DB1) (Zinc finger protein 161),521,"56,931",5 out of 5,1999-07-15,Evidence at protein level
A8MV65,VGLL3_HUMAN,Transcription cofactor vestigial-like protein 3 (Vgl-3),326,"36,009",3 out of 5,2008-03-18,Evidence at protein level
Q9P2U8,VGLU2_HUMAN,Vesicular glutamate transporter 2 (VGluT2) (Differentiation-associated BNPI) (Differentiation-associated Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 6),582,"64,392",5 out of 5,2008-02-05,Evidence at transcript level
O15195,VILL_HUMAN,Villin-like protein,856,"95,907",3 out of 5,2001-06-20,Evidence at transcript level
P62760,VISL1_HUMAN,Visinin-like protein 1 (VILIP) (VLP-1) (Hippocalcin-like protein 3) (HLP3),191,"22,142",4 out of 5,2004-08-16,Evidence at protein level
P38435,VKGC_HUMAN,Vitamin K-dependent gamma-carboxylase (EC 4.1.1.90) (Gamma-glutamyl carboxylase) (Peptidyl-glutamate 4-carboxylase) (Vitamin K gamma glutamyl carboxylase),758,"87,561",5 out of 5,1994-10-01,Evidence at protein level
Q9GZP7,VN1R1_HUMAN,Vomeronasal type-1 receptor 1 (G-protein coupled receptor GPCR24) (hGPCR24) (V1r-like receptor 1) (V3r-related gene protein) (Vomeronasal olfactory receptor chromosome 19 subtype I member 1),353,"40,021",4 out of 5,2005-07-19,Evidence at transcript level
P35503,UD13_HUMAN,UDP-glucuronosyltransferase 1-3 (UDPGT 1-3) (UGT1*3) (UGT1-03) (UGT1.3) (EC 2.4.1.17) (UDP-glucuronosyltransferase 1-C) (UGT-1C) (UGT1C) (UDP-glucuronosyltransferase 1A3),534,"60,338",5 out of 5,1994-06-01,Evidence at protein level
P19224,UD16_HUMAN,UDP-glucuronosyltransferase 1-6 (UDPGT 1-6) (UGT1*6) (UGT1-06) (UGT1.6) (EC 2.4.1.17) (Phenol-metabolizing UDP-glucuronosyltransferase) (UDP-glucuronosyltransferase 1-F) (UGT-1F) (UGT1F) (UDP-glucuronosyltransferase 1A6),532,"60,751",5 out of 5,1990-11-01,Evidence at protein level
Q6NUS8,UD3A1_HUMAN,UDP-glucuronosyltransferase 3A1 (UDPGT 3A1) (EC 2.4.1.17),523,"59,151",4 out of 5,2007-08-21,Evidence at transcript level
P36537,UDB10_HUMAN,UDP-glucuronosyltransferase 2B10 (UDPGT 2B10) (EC 2.4.1.17),528,"60,774",4 out of 5,1994-06-01,Evidence at protein level
Q9NYU2,UGGG1_HUMAN,UDP-glucose:glycoprotein glucosyltransferase 1 (UGT1) (hUGT1) (EC 2.4.1.-) (UDP--Glc:glycoprotein glucosyltransferase) (UDP-glucose ceramide glucosyltransferase-like 1),1555,"177,190",5 out of 5,2005-06-21,Evidence at protein level
Q6PHR2,ULK3_HUMAN,Serine/threonine-protein kinase ULK3 (EC 2.7.11.1) (Unc-51-like kinase 3),472,"53,444",5 out of 5,2006-09-19,Evidence at protein level
Q8IV45,UN5CL_HUMAN,UNC5C-like protein (Protein unc-5 homolog C-like) (ZU5 and death domain-containing protein),518,"57,818",5 out of 5,2007-11-13,Evidence at protein level
A6NJT0,UNC4_HUMAN,Homeobox protein unc-4 homolog (Homeobox protein Uncx4.1),531,"53,690",3 out of 5,2008-05-20,Inferred from homology
O95185,UNC5C_HUMAN,Netrin receptor UNC5C (Protein unc-5 homolog 3) (Protein unc-5 homolog C),931,"103,146",5 out of 5,2004-10-11,Evidence at transcript level
P13051,UNG_HUMAN,Uracil-DNA glycosylase (UDG) (EC 3.2.2.27),313,"34,645",5 out of 5,1990-01-01,Evidence at protein level
Q92738,US6NL_HUMAN,USP6 N-terminal-like protein (Related to the N-terminus of tre) (RN-tre),828,"94,104",5 out of 5,2004-07-30,Evidence at protein level
Q8N6Y0,USBP1_HUMAN,Usher syndrome type-1C protein-binding protein 1 (USH1C-binding protein 1) (AIE-75-binding protein) (MCC-2) (Mutated in colon cancer protein 2),703,"76,068",5 out of 5,2006-10-03,Evidence at protein level
O75691,UTP20_HUMAN,Small subunit processome component 20 homolog (Down-regulated in metastasis protein) (Novel nucleolar protein 73) (NNP73) (Protein Key-1A6),2785,"318,385",5 out of 5,2005-04-12,Evidence at protein level
Q9NYH9,UTP6_HUMAN,U3 small nucleolar RNA-associated protein 6 homolog (Hepatocellular carcinoma-associated antigen 66) (Multiple hat domains protein),597,"70,194",4 out of 5,2001-09-26,Evidence at transcript level
P46939,UTRO_HUMAN,Utrophin (Dystrophin-related protein 1) (DRP-1),3433,"394,466",5 out of 5,1995-11-01,Evidence at protein level
O15342,VA0E1_HUMAN,V-type proton ATPase subunit e 1 (V-ATPase subunit e 1) (V-ATPase 9.2 kDa membrane accessory protein) (V-ATPase M9.2 subunit) (Vacuolar proton pump subunit e 1),81,"9,374",5 out of 5,1998-07-15,Evidence at transcript level
Q8NHE4,VA0E2_HUMAN,V-type proton ATPase subunit e 2 (V-ATPase subunit e 2) (Lysosomal 9 kDa H(+)-transporting ATPase V0 subunit e2) (Vacuolar proton pump subunit e 2),81,"9,184",5 out of 5,2007-01-09,Evidence at transcript level
Q9HCJ6,VAT1L_HUMAN,Synaptic vesicle membrane protein VAT-1 homolog-like (EC 1.-.-.-),419,"45,899",2 out of 5,2004-09-27,Evidence at protein level
Q99536,VAT1_HUMAN,Synaptic vesicle membrane protein VAT-1 homolog (EC 1.-.-.-),393,"41,920",5 out of 5,1997-11-01,Evidence at protein level
Q96LB4,VATG3_HUMAN,V-type proton ATPase subunit G 3 (V-ATPase subunit G 3) (V-ATPase 13 kDa subunit 3) (Vacuolar proton pump subunit G 3),118,"13,917",5 out of 5,2002-01-31,Evidence at transcript level
Q9UKW4,VAV3_HUMAN,Guanine nucleotide exchange factor VAV3 (VAV-3),847,"97,776",5 out of 5,2001-01-24,Evidence at protein level
Q6Q795,VBPC1_HUMAN,Putative viral protein-binding protein C1,121,"13,358",1 out of 5,2008-03-18,Uncertain
Q96JH7,VCIP1_HUMAN,Deubiquitinating protein VCIP135 (EC 3.4.19.12) (Valosin-containing protein p97/p47 complex-interacting protein 1) (Valosin-containing protein p97/p47 complex-interacting protein p135) (VCP/p47 complex-interacting 135-kDa protein),1222,"134,321",5 out of 5,2004-02-16,Evidence at protein level
Q9NNX9,VCX3_HUMAN,Variable charge X-linked protein 3 (Variable charge protein on X with eight repeats) (VCX-8r) (Variably charged protein X-A) (VCX-A),186,"20,020",3 out of 5,2001-11-16,Evidence at transcript level
P15692,VEGFA_HUMAN,Vascular endothelial growth factor A (VEGF-A) (Vascular permeability factor) (VPF),232,"27,042",5 out of 5,1990-04-01,Evidence at protein level
Q495M9,USH1G_HUMAN,Usher syndrome type-1G protein (Scaffold protein containing ankyrin repeats and SAM domain),461,"51,489",5 out of 5,2005-11-08,Evidence at protein level
Q96IX5,USMG5_HUMAN,Up-regulated during skeletal muscle growth protein 5 (Diabetes-associated protein in insulin-sensitive tissues) (HCV F-transactivated protein 2),58,"6,458",4 out of 5,2006-04-04,Evidence at protein level
Q15849,UT2_HUMAN,"Urea transporter 2 (Solute carrier family 14 member 2) (Urea transporter, kidney)",920,"101,209",5 out of 5,1997-11-01,Evidence at protein level
Q5T230,UTF1_HUMAN,Undifferentiated embryonic cell transcription factor 1,341,"36,439",5 out of 5,2007-02-06,Evidence at protein level
Q8TED0,UTP15_HUMAN,U3 small nucleolar RNA-associated protein 15 homolog,518,"58,415",5 out of 5,2005-08-30,Evidence at protein level
P30518,V2R_HUMAN,Vasopressin V2 receptor (V2R) (AVPR V2) (Antidiuretic hormone receptor) (Renal-type arginine vasopressin receptor),371,"40,279",5 out of 5,1993-04-01,Evidence at protein level
Q14135,VGLL4_HUMAN,Transcription cofactor vestigial-like protein 4 (Vgl-4),290,"30,948",4 out of 5,1997-11-01,Evidence at protein level
P40337,VHL_HUMAN,Von Hippel-Lindau disease tumor suppressor (Protein G7) (pVHL),213,"24,153",5 out of 5,1995-02-01,Evidence at protein level
P08670,VIME_HUMAN,Vimentin,466,"53,652",5 out of 5,1988-01-01,Evidence at protein level
P18206,VINC_HUMAN,Vinculin (Metavinculin) (MV),1134,"123,799",5 out of 5,1990-11-01,Evidence at protein level
Q6UXI7,VITRN_HUMAN,Vitrin,678,"73,930",4 out of 5,2006-09-05,Evidence at transcript level
Q9BQB6,VKOR1_HUMAN,"Vitamin K epoxide reductase complex subunit 1 (EC 1.17.4.4) (Vitamin K1 2,3-epoxide reductase subunit 1)",163,"18,235",5 out of 5,2005-04-12,Evidence at protein level
P54219,VMAT1_HUMAN,Chromaffin granule amine transporter (Solute carrier family 18 member 1) (Vesicular amine transporter 1) (VAT1),525,"56,257",5 out of 5,1996-10-01,Evidence at transcript level
Q05940,VMAT2_HUMAN,Synaptic vesicular amine transporter (Monoamine transporter) (Solute carrier family 18 member 2) (Vesicular amine transporter 2) (VAT2),514,"55,713",5 out of 5,1994-10-01,Evidence at protein level
Q8NFZ6,VN1R2_HUMAN,Vomeronasal type-1 receptor 2 (G-protein coupled receptor GPCR25) (hGPCR25) (V1r-like receptor 2),395,"44,476",3 out of 5,2005-07-05,Evidence at transcript level
Q7Z5H5,VN1R4_HUMAN,Vomeronasal type-1 receptor 4 (G-protein coupled receptor GPCR27) (hGPCR27) (V1r-like receptor 4),301,"33,557",4 out of 5,2005-07-05,Evidence at transcript level
Q7Z5H4,VN1R5_HUMAN,Vomeronasal type-1 receptor 5 (G-protein coupled receptor GPCR26) (hGPCR26) (V1r-like receptor 5),357,"40,779",4 out of 5,2005-07-05,Evidence at transcript level
Q96RL7,VP13A_HUMAN,Vacuolar protein sorting-associated protein 13A (Chorea-acanthocytosis protein) (Chorein),3174,"360,276",5 out of 5,2002-03-27,Evidence at protein level
Q709C8,VP13C_HUMAN,Vacuolar protein sorting-associated protein 13C,3753,"422,390",5 out of 5,2006-11-28,Evidence at protein level
O75436,VP26A_HUMAN,Vacuolar protein sorting-associated protein 26A (Vesicle protein sorting 26A) (hVPS26),327,"38,170",5 out of 5,2001-02-21,Evidence at protein level
Q9H267,VP33B_HUMAN,Vacuolar protein sorting-associated protein 33B (hVPS33B),617,"70,585",5 out of 5,2002-09-19,Evidence at protein level
Q86XT2,VP37D_HUMAN,Vacuolar protein sorting-associated protein 37D (ESCRT-I complex subunit VPS37D) (Williams-Beuren syndrome chromosomal region 24 protein),251,"27,730",5 out of 5,2008-04-08,Evidence at protein level
Q9BQ65,USB1_HUMAN,U6 snRNA phosphodiesterase (hUsb1) (EC 3.1.4.-),265,"30,268",5 out of 5,2007-02-06,Evidence at protein level
P22415,USF1_HUMAN,Upstream stimulatory factor 1 (Class B basic helix-loop-helix protein 11) (bHLHb11) (Major late transcription factor 1),310,"33,538",5 out of 5,1991-08-01,Evidence at protein level
O60763,USO1_HUMAN,General vesicular transport factor p115 (Protein USO1 homolog) (Transcytosis-associated protein) (TAP) (Vesicle-docking protein),962,"107,895",5 out of 5,2001-04-27,Evidence at protein level
Q9P2Y5,UVRAG_HUMAN,UV radiation resistance-associated gene protein (p63),699,"78,151",5 out of 5,2002-01-23,Evidence at protein level
Q2YD98,UVSSA_HUMAN,UV-stimulated scaffold protein A,709,"80,591",5 out of 5,2008-02-05,Evidence at protein level
O60504,VINEX_HUMAN,Vinexin (SH3-containing adapter molecule 1) (SCAM-1) (Sorbin and SH3 domain-containing protein 3),671,"75,341",5 out of 5,2001-06-20,Evidence at protein level
Q6PFW1,VIP1_HUMAN,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 1) (Histidine acid phosphatase domain-containing protein 2A) (IP6 kinase) (Inositol pyrophosphate synthase 1) (InsP6 and PP-IP5 kinase 1) (VIP1 homolog) (hsVIP1),1433,"159,521",5 out of 5,2008-01-15,Evidence at protein level
Q5THJ4,VP13D_HUMAN,Vacuolar protein sorting-associated protein 13D,4388,"491,916",3 out of 5,2006-11-28,Evidence at protein level
Q13488,VPP3_HUMAN,V-type proton ATPase 116 kDa subunit a isoform 3 (V-ATPase 116 kDa isoform a3) (Osteoclastic proton pump 116 kDa subunit) (OC-116 kDa) (OC116) (T-cell immune regulator 1) (T-cell immune response cDNA7 protein) (TIRC7) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 3),830,"92,968",5 out of 5,2000-12-01,Evidence at protein level
Q9Y4B6,VPRBP_HUMAN,Protein VPRBP (DDB1- and CUL4-associated factor 1) (HIV-1 Vpr-binding protein) (VprBP) (Serine/threonine-protein kinase VPRBP) (EC 2.7.11.1) (Vpr-interacting protein),1507,"169,007",5 out of 5,2007-05-15,Evidence at protein level
Q9UID3,VPS51_HUMAN,Vacuolar protein sorting-associated protein 51 homolog (Another new gene 2 protein) (Protein fat-free homolog),782,"86,042",5 out of 5,2005-07-19,Evidence at protein level
Q15906,VPS72_HUMAN,Vacuolar protein sorting-associated protein 72 homolog (Protein YL-1) (Transcription factor-like 1),364,"40,594",5 out of 5,1997-11-01,Evidence at protein level
Q96IQ7,VSIG2_HUMAN,V-set and immunoglobulin domain-containing protein 2 (Cortical thymocyte-like protein) (CT-like protein),327,"34,348",4 out of 5,2005-06-21,Evidence at protein level
Q15853,USF2_HUMAN,Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12) (bHLHb12) (FOS-interacting protein) (FIP) (Major late transcription factor 2) (Upstream transcription factor 2),346,"36,955",5 out of 5,1997-11-01,Evidence at protein level
O75445,USH2A_HUMAN,Usherin (Usher syndrome type IIa protein) (Usher syndrome type-2A protein),5202,"575,600",5 out of 5,2006-04-04,Evidence at protein level
O00507,USP9Y_HUMAN,"Probable ubiquitin carboxyl-terminal hydrolase FAF-Y (EC 3.4.19.12) (Deubiquitinating enzyme FAF-Y) (Fat facets protein-related, Y-linked) (Ubiquitin thioesterase FAF-Y) (Ubiquitin-specific protease 9, Y chromosome) (Ubiquitin-specific-processing protease FAF-Y)",2555,"291,077",5 out of 5,1997-11-01,Evidence at transcript level
Q5TAP6,UT14C_HUMAN,U3 small nucleolar RNA-associated protein 14 homolog C,766,"87,188",4 out of 5,2005-07-05,Evidence at protein level
Q8NEY4,VATC2_HUMAN,V-type proton ATPase subunit C 2 (V-ATPase subunit C 2) (Vacuolar proton pump subunit C 2),427,"48,759",5 out of 5,2007-05-01,Evidence at protein level
O14599,VCY2_HUMAN,"Testis-specific basic protein Y 2 (Basic charge, Y-linked 2) (Variably charged protein Y 2)",106,"12,063",4 out of 5,1999-07-15,Evidence at protein level
P21796,VDAC1_HUMAN,Voltage-dependent anion-selective channel protein 1 (VDAC-1) (hVDAC1) (Outer mitochondrial membrane protein porin 1) (Plasmalemmal porin) (Porin 31HL) (Porin 31HM),283,"30,773",5 out of 5,1991-05-01,Evidence at protein level
P35968,VGFR2_HUMAN,Vascular endothelial growth factor receptor 2 (VEGFR-2) (EC 2.7.10.1) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD antigen CD309),1356,"151,527",5 out of 5,1994-06-01,Evidence at protein level
O15240,VGF_HUMAN,Neurosecretory protein VGF [Cleaved into: Neuroendocrine regulatory peptide-1 (NERP-1); Neuroendocrine regulatory peptide-2 (NERP-2); Antimicrobial peptide VGF[554-577]],615,"67,258",5 out of 5,2002-03-27,Evidence at protein level
Q00341,VIGLN_HUMAN,Vigilin (High density lipoprotein-binding protein) (HDL-binding protein),1268,"141,456",5 out of 5,1997-11-01,Evidence at protein level
Q96GC9,VMP1_HUMAN,Vacuole membrane protein 1 (Transmembrane protein 49),406,"46,238",5 out of 5,2007-04-17,Evidence at protein level
Q96AX1,VP33A_HUMAN,Vacuolar protein sorting-associated protein 33A (hVPS33A),596,"67,611",5 out of 5,2002-09-19,Evidence at protein level
P15498,VAV_HUMAN,Proto-oncogene vav,845,"98,314",5 out of 5,1990-04-01,Evidence at protein level
O43915,VEGFD_HUMAN,Vascular endothelial growth factor D (VEGF-D) (c-Fos-induced growth factor) (FIGF),354,"40,444",5 out of 5,2001-11-16,Evidence at protein level
P35916,VGFR3_HUMAN,Vascular endothelial growth factor receptor 3 (VEGFR-3) (EC 2.7.10.1) (Fms-like tyrosine kinase 4) (FLT-4) (Tyrosine-protein kinase receptor FLT4),1363,"152,757",5 out of 5,1994-06-01,Evidence at protein level
P09327,VILI_HUMAN,Villin-1,827,"92,695",5 out of 5,1989-07-01,Evidence at protein level
O43314,VIP2_HUMAN,Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2 (EC 2.7.4.21) (EC 2.7.4.24) (Diphosphoinositol pentakisphosphate kinase 2) (Histidine acid phosphatase domain-containing protein 1) (InsP6 and PP-IP5 kinase 2) (VIP1 homolog 2) (hsVIP2),1243,"140,407",5 out of 5,2008-01-15,Evidence at protein level
P41587,VIPR2_HUMAN,Vasoactive intestinal polypeptide receptor 2 (VIP-R-2) (Helodermin-preferring VIP receptor) (Pituitary adenylate cyclase-activating polypeptide type III receptor) (PACAP type III receptor) (PACAP-R-3) (PACAP-R3) (VPAC2),438,"49,479",5 out of 5,1995-11-01,Evidence at protein level
Q8N0U8,VKORL_HUMAN,Vitamin K epoxide reductase complex subunit 1-like protein 1 (VKORC1-like protein 1) (EC 1.17.4.4),176,"19,836",5 out of 5,2005-04-12,Evidence at protein level
P98155,VLDLR_HUMAN,Very low-density lipoprotein receptor (VLDL receptor) (VLDL-R),873,"96,098",5 out of 5,1996-10-01,Evidence at protein level
Q3ZAQ7,VMA21_HUMAN,Vacuolar ATPase assembly integral membrane protein VMA21 (Myopathy with excessive autophagy protein),101,"11,354",5 out of 5,2008-04-29,Evidence at protein level
P63121,VP113_HUMAN,Endogenous retrovirus group K member 113 Pro protein (HERV-K113 envelope protein) (HERV-K_19p13.11 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,136",3 out of 5,2004-09-13,Inferred from homology
Q7Z7G8,VP13B_HUMAN,Vacuolar protein sorting-associated protein 13B (Cohen syndrome protein 1),4022,"448,664",5 out of 5,2004-02-16,Evidence at protein level
Q8NEZ2,VP37A_HUMAN,Vacuolar protein sorting-associated protein 37A (hVps37A) (ESCRT-I complex subunit VPS37A) (Hepatocellular carcinoma-related protein 1),397,"44,314",5 out of 5,2007-05-15,Evidence at protein level
Q96JC1,VPS39_HUMAN,Vam6/Vps39-like protein (TRAP1-like protein) (hVam6p),886,"101,809",5 out of 5,2002-11-25,Evidence at protein level
Q6UX27,VSTM1_HUMAN,V-set and transmembrane domain-containing protein 1 (Signal inhibitory receptor on leukocytes-1) (SIRL-1),236,"26,109",5 out of 5,2007-01-23,Evidence at protein level
Q5SRD0,WAC2D_HUMAN,WASH complex subunit 2D,308,"33,372",2 out of 5,2008-06-10,Inferred from homology
Q7Z5K2,WAPL_HUMAN,Wings apart-like protein homolog (Friend of EBNA2 protein) (WAPL cohesin release factor),1190,"132,946",5 out of 5,2006-07-11,Evidence at protein level
Q92558,WASF1_HUMAN,Wiskott-Aldrich syndrome protein family member 1 (WASP family protein member 1) (Protein WAVE-1) (Verprolin homology domain-containing protein 1),559,"61,652",5 out of 5,1997-11-01,Evidence at protein level
O95183,VAMP5_HUMAN,Vesicle-associated membrane protein 5 (VAMP-5) (Myobrevin),116,"12,805",5 out of 5,2001-02-21,Evidence at protein level
Q8TAA9,VANG1_HUMAN,Vang-like protein 1 (Loop-tail protein 2 homolog) (LPP2) (Strabismus 2) (Van Gogh-like protein 1),524,"59,975",5 out of 5,2003-10-31,Evidence at protein level
Q7L8A9,VASH1_HUMAN,Vasohibin-1,365,"40,957",5 out of 5,2005-04-12,Evidence at protein level
P15313,VATB1_HUMAN,"V-type proton ATPase subunit B, kidney isoform (V-ATPase subunit B 1) (Endomembrane proton pump 58 kDa subunit) (Vacuolar proton pump subunit B 1)",513,"56,833",5 out of 5,1990-04-01,Evidence at protein level
O75348,VATG1_HUMAN,V-type proton ATPase subunit G 1 (V-ATPase subunit G 1) (V-ATPase 13 kDa subunit 1) (Vacuolar proton pump subunit G 1) (Vacuolar proton pump subunit M16),118,"13,758",5 out of 5,2000-05-30,Evidence at protein level
P52735,VAV2_HUMAN,Guanine nucleotide exchange factor VAV2 (VAV-2),878,"101,289",5 out of 5,1996-10-01,Evidence at protein level
P19320,VCAM1_HUMAN,Vascular cell adhesion protein 1 (V-CAM 1) (VCAM-1) (INCAM-100) (CD antigen CD106),739,"81,276",5 out of 5,1990-11-01,Evidence at protein level
Q9Y277,VDAC3_HUMAN,Voltage-dependent anion-selective channel protein 3 (VDAC-3) (hVDAC3) (Outer mitochondrial membrane protein porin 3),283,"30,659",5 out of 5,2000-12-01,Evidence at protein level
Q8N8G2,VGLL2_HUMAN,Transcription cofactor vestigial-like protein 2 (Vgl-2) (Protein VITO1),317,"33,426",4 out of 5,2004-07-19,Evidence at protein level
P12018,VPREB_HUMAN,Immunoglobulin iota chain (CD179 antigen-like family member A) (Protein VPreB1) (V(pre)B protein) (VpreB protein) (CD antigen CD179a),145,"16,605",5 out of 5,1989-10-01,Evidence at protein level
Q96P53,WDFY2_HUMAN,WD repeat and FYVE domain-containing protein 2 (Propeller-FYVE protein) (Prof) (WD40- and FYVE domain-containing protein 2) (Zinc finger FYVE domain-containing protein 22),400,"45,154",4 out of 5,2004-08-16,Evidence at protein level
Q9H1Z4,WDR13_HUMAN,WD repeat-containing protein 13,485,"53,696",3 out of 5,2002-03-27,Evidence at protein level
Q64LD2,WDR25_HUMAN,WD repeat-containing protein 25,544,"60,161",3 out of 5,2006-10-31,Evidence at protein level
Q9C0J8,WDR33_HUMAN,pre-mRNA 3' end processing protein WDR33 (WD repeat-containing protein 33) (WD repeat-containing protein WDC146),1336,"145,891",5 out of 5,2002-04-03,Evidence at protein level
Q9HAD4,WDR41_HUMAN,WD repeat-containing protein 41,459,"51,728",3 out of 5,2005-11-22,Evidence at transcript level
O94967,WDR47_HUMAN,WD repeat-containing protein 47 (Neuronal enriched MAP-interacting protein) (Nemitin),919,"101,949",3 out of 5,2001-06-20,Evidence at protein level
Q8IV35,WDR49_HUMAN,WD repeat-containing protein 49,697,"79,295",2 out of 5,2006-10-17,Evidence at transcript level
P57081,WDR4_HUMAN,tRNA (guanine-N(7)-)-methyltransferase non-catalytic subunit WDR4 (WD repeat-containing protein 4),412,"45,490",5 out of 5,2000-12-01,Evidence at protein level
Q9H977,WDR54_HUMAN,WD repeat-containing protein 54,334,"35,891",1 out of 5,2005-09-27,Evidence at protein level
Q9H6Y2,WDR55_HUMAN,WD repeat-containing protein 55,383,"42,070",3 out of 5,2006-05-30,Evidence at protein level
Q5VTH9,WDR78_HUMAN,WD repeat-containing protein 78,848,"94,573",3 out of 5,2006-11-28,Evidence at transcript level
Q14508,WFDC2_HUMAN,WAP four-disulfide core domain protein 2 (Epididymal secretory protein E4) (Major epididymis-specific protein E4) (Putative protease inhibitor WAP5),124,"12,993",5 out of 5,1998-07-15,Evidence at protein level
O76076,WISP2_HUMAN,WNT1-inducible-signaling pathway protein 2 (WISP-2) (CCN family member 5) (Connective tissue growth factor-like protein) (CTGF-L) (Connective tissue growth factor-related protein 58),250,"26,825",5 out of 5,2002-10-19,Evidence at protein level
Q5T9L3,WLS_HUMAN,Protein wntless homolog (Integral membrane protein GPR177) (Protein evenness interrupted homolog) (EVI) (Putative NF-kappa-B-activating protein 373),541,"62,253",5 out of 5,2007-01-09,Evidence at protein level
Q9HBG4,VPP4_HUMAN,V-type proton ATPase 116 kDa subunit a isoform 4 (V-ATPase 116 kDa isoform a4) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 4) (Vacuolar proton translocating ATPase 116 kDa subunit a kidney isoform),840,"96,386",5 out of 5,2003-11-14,Evidence at protein level
Q9UKI3,VPRE3_HUMAN,Pre-B lymphocyte protein 3 (N27C7-2) (Protein VPreB3),123,"13,710",3 out of 5,2000-12-01,Evidence at transcript level
Q86VN1,VPS36_HUMAN,Vacuolar protein-sorting-associated protein 36 (ELL-associated protein of 45 kDa) (ESCRT-II complex subunit VPS36),386,"43,817",5 out of 5,2005-08-30,Evidence at protein level
Q9NRW7,VPS45_HUMAN,Vacuolar protein sorting-associated protein 45 (h-VPS45) (hlVps45),570,"65,077",5 out of 5,2002-09-19,Evidence at protein level
Q8IW00,VSTM4_HUMAN,V-set and transmembrane domain-containing protein 4 [Cleaved into: Peptide Lv],320,"36,146",4 out of 5,2007-02-06,Evidence at transcript level
Q9Y334,VWA7_HUMAN,von Willebrand factor A domain-containing protein 7 (Protein G7c),891,"96,060",3 out of 5,2006-04-04,Evidence at transcript level
Q2TAL6,VWC2_HUMAN,Brorin (Brain-specific chordin-like protein) (von Willebrand factor C domain-containing protein 2),325,"35,282",4 out of 5,2007-10-23,Evidence at protein level
Q8N2E2,VWDE_HUMAN,von Willebrand factor D and EGF domain-containing protein,1590,"176,780",3 out of 5,2008-04-08,Evidence at transcript level
Q6PJI9,WDR59_HUMAN,WD repeat-containing protein 59,974,"109,793",4 out of 5,2007-03-20,Evidence at protein level
Q8IWG1,WDR63_HUMAN,WD repeat-containing protein 63 (Testis development protein NYD-SP29),891,"102,935",2 out of 5,2006-05-02,Evidence at transcript level
Q6P4I2,WDR73_HUMAN,WD repeat-containing protein 73,378,"41,685",4 out of 5,2007-10-23,Evidence at protein level
Q8IWA0,WDR75_HUMAN,WD repeat-containing protein 75 (U3 small nucleolar RNA-associated protein 17 homolog),830,"94,499",4 out of 5,2005-08-16,Evidence at protein level
Q86TI4,WDR86_HUMAN,WD repeat-containing protein 86,376,"40,731",2 out of 5,2008-02-26,Evidence at transcript level
Q96KV7,WDR90_HUMAN,WD repeat-containing protein 90,1748,"187,437",4 out of 5,2008-06-10,Evidence at protein level
Q1A5X7,WHAL1_HUMAN,"Putative WASP homolog-associated protein with actin, membranes and microtubules-like protein 1 (WAS protein homolog associated with actin, Golgi membranes and microtubules pseudogene 3) (WAS protein homology region 2 domain-containing protein 1-like protein 1) (WH2 domain-containing protein 1-like protein 1) (WHDC1-like protein 1)",153,"18,091",3 out of 5,2008-02-05,Uncertain
Q06250,WIT1_HUMAN,Putative Wilms tumor upstream neighbor 1 gene protein (WIT-1) (Wilms tumor-associated antisense RNA),92,"10,039",3 out of 5,1995-11-01,Uncertain
O96014,WNT11_HUMAN,Protein Wnt-11,354,"39,179",5 out of 5,1999-07-15,Evidence at protein level
P56703,WNT3_HUMAN,Proto-oncogene Wnt-3 (Proto-oncogene Int-4 homolog),355,"39,645",5 out of 5,1999-07-15,Evidence at protein level
Q93098,WNT8B_HUMAN,Protein Wnt-8b,351,"38,721",5 out of 5,1997-11-01,Evidence at transcript level
P47989,XDH_HUMAN,Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase (XD) (EC 1.17.1.4); Xanthine oxidase (XO) (EC 1.17.3.2) (Xanthine oxidoreductase) (XOR)],1333,"146,424",5 out of 5,1996-02-01,Evidence at protein level
Q6PP77,XKR2_HUMAN,"XK-related protein 2 (Membrane protein XPLAC) (X Kell blood group-related, X-linked)",449,"52,052",3 out of 5,2005-10-11,Evidence at transcript level
A2RUG3,XKRY2_HUMAN,"Testis-specific XK-related protein, Y-linked 2",117,"12,988",2 out of 5,2008-06-10,Evidence at transcript level
Q9NQW7,XPP1_HUMAN,"Xaa-Pro aminopeptidase 1 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Cytosolic aminopeptidase P) (Soluble aminopeptidase P) (sAmp) (X-Pro aminopeptidase 1) (X-prolyl aminopeptidase 1, soluble)",623,"69,918",5 out of 5,2005-07-05,Evidence at protein level
Q9NQH7,XPP3_HUMAN,Probable Xaa-Pro aminopeptidase 3 (X-Pro aminopeptidase 3) (EC 3.4.11.9) (Aminopeptidase P3) (APP3),507,"57,034",5 out of 5,2006-10-31,Evidence at protein level
Q9UBH6,XPR1_HUMAN,Xenotropic and polytropic retrovirus receptor 1 (Protein SYG1 homolog) (Xenotropic and polytropic murine leukemia virus receptor X3) (X-receptor),696,"81,535",5 out of 5,2008-02-05,Evidence at protein level
P17948,VGFR1_HUMAN,Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor),1338,"150,769",5 out of 5,1990-11-01,Evidence at protein level
Q9P2U7,VGLU1_HUMAN,Vesicular glutamate transporter 1 (VGluT1) (Brain-specific Na(+)-dependent inorganic phosphate cotransporter) (Solute carrier family 17 member 7),560,"61,613",5 out of 5,2008-04-29,Evidence at transcript level
Q6RSH7,VHLL_HUMAN,Von Hippel-Lindau-like protein (VHL-like protein) (VLP),139,"15,781",4 out of 5,2006-12-12,Evidence at protein level
P32241,VIPR1_HUMAN,Vasoactive intestinal polypeptide receptor 1 (VIP-R-1) (Pituitary adenylate cyclase-activating polypeptide type II receptor) (PACAP type II receptor) (PACAP-R-2) (PACAP-R2) (VPAC1),457,"51,547",5 out of 5,1993-10-01,Evidence at protein level
P01282,VIP_HUMAN,VIP peptides [Cleaved into: Intestinal peptide PHV-42 (Peptide histidine valine 42); Intestinal peptide PHM-27 (Peptide histidine methioninamide 27); Vasoactive intestinal peptide (VIP) (Vasoactive intestinal polypeptide)],170,"19,169",5 out of 5,1986-07-21,Evidence at protein level
Q9H7M9,VISTA_HUMAN,V-type immunoglobulin domain-containing suppressor of T-cell activation (Platelet receptor Gi24) (Stress-induced secreted protein-1) (Sisp-1) (V-set domain-containing immunoregulatory receptor),311,"33,908",5 out of 5,2005-03-01,Evidence at protein level
Q76NI1,VKIND_HUMAN,Protein very KIND (v-KIND) (Cerebral protein 9) (KIND domain-containing protein 1) (Kinase non-catalytic C-lobe domain-containing protein 1) (Ras-GEF domain-containing family member 2),1749,"191,397",5 out of 5,2007-10-23,Evidence at transcript level
Q96AW1,VOPP1_HUMAN,"Vesicular, overexpressed in cancer, prosurvival protein 1 (EGFR-coamplified and overexpressed protein) (ECop) (Glioblastoma-amplified secreted protein) (Putative NF-kappa-B-activating protein 055N)",172,"19,224",5 out of 5,2008-03-18,Evidence at transcript level
Q4G0F5,VP26B_HUMAN,Vacuolar protein sorting-associated protein 26B (Vesicle protein sorting 26B),336,"39,155",3 out of 5,2006-07-25,Evidence at protein level
Q9H9H4,VP37B_HUMAN,Vacuolar protein sorting-associated protein 37B (hVps37B) (ESCRT-I complex subunit VPS37B),285,"31,307",5 out of 5,2007-05-15,Evidence at protein level
Q9H269,VPS16_HUMAN,Vacuolar protein sorting-associated protein 16 homolog (hVPS16),839,"94,694",5 out of 5,2002-09-19,Evidence at protein level
Q9P253,VPS18_HUMAN,Vacuolar protein sorting-associated protein 18 homolog (hVPS18),973,"110,186",5 out of 5,2002-09-19,Evidence at protein level
Q8N3P4,VPS8_HUMAN,Vacuolar protein sorting-associated protein 8 homolog,1428,"161,754",5 out of 5,2007-02-20,Evidence at protein level
Q86XK7,VSIG1_HUMAN,V-set and immunoglobulin domain-containing protein 1 (Cell surface A33 antigen) (Glycoprotein A34),387,"41,811",4 out of 5,2008-01-15,Evidence at protein level
P58304,VSX2_HUMAN,Visual system homeobox 2 (Ceh-10 homeodomain-containing homolog) (Homeobox protein CHX10),361,"39,411",5 out of 5,2001-09-26,Evidence at protein level
Q96AJ9,VTI1A_HUMAN,Vesicle transport through interaction with t-SNAREs homolog 1A (Vesicle transport v-SNARE protein Vti1-like 2) (Vti1-rp2),217,"25,218",5 out of 5,2003-03-25,Evidence at protein level
A6NCI4,VWA3A_HUMAN,von Willebrand factor A domain-containing protein 3A,1184,"134,020",3 out of 5,2008-03-18,Evidence at transcript level
B2RUY7,VWC2L_HUMAN,von Willebrand factor C domain-containing protein 2-like (Brorin-like),222,"24,570",3 out of 5,2008-09-02,Evidence at protein level
Q2M389,WASC4_HUMAN,WASH complex subunit 4 (Strumpellin and WASH-interacting protein) (SWIP) (WASH complex subunit SWIP),1173,"136,403",5 out of 5,2007-04-03,Evidence at protein level
A8MWX3,WASH4_HUMAN,Putative WAS protein family homolog 4 (Protein FAM39CP),477,"51,595",4 out of 5,2008-04-29,Uncertain
O00401,WASL_HUMAN,Neural Wiskott-Aldrich syndrome protein (N-WASP),505,"54,827",5 out of 5,2001-04-27,Evidence at protein level
Q8N6F8,WBS27_HUMAN,Williams-Beuren syndrome chromosomal region 27 protein,245,"26,522",2 out of 5,2006-02-21,Evidence at protein level
Q86VZ2,WDR5B_HUMAN,WD repeat-containing protein 5B,330,"36,338",2 out of 5,2007-02-20,Evidence at transcript level
Q8WVS4,WDR60_HUMAN,WD repeat-containing protein 60,1066,"122,571",5 out of 5,2006-06-27,Evidence at protein level
Q6RFH5,WDR74_HUMAN,WD repeat-containing protein 74 (NOP seven-associated protein 1),385,"42,441",3 out of 5,2004-11-23,Evidence at protein level
Q96MX6,WDR92_HUMAN,WD repeat-containing protein 92 (WD repeat-containing protein Monad),357,"39,740",3 out of 5,2007-09-11,Evidence at protein level
P30291,WEE1_HUMAN,Wee1-like protein kinase (WEE1hu) (EC 2.7.10.2) (Wee1A kinase),646,"71,597",5 out of 5,1993-04-01,Evidence at protein level
P0C1S8,WEE2_HUMAN,Wee1-like protein kinase 2 (EC 2.7.10.2) (Wee1-like protein kinase 1B) (Wee1B kinase),567,"62,925",5 out of 5,2006-09-05,Evidence at transcript level
Q8IUA0,WFDC8_HUMAN,WAP four-disulfide core domain protein 8 (Putative protease inhibitor WAP8),241,"27,824",3 out of 5,2003-04-04,Evidence at transcript level
Q96NZ8,WFKN1_HUMAN,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1 (Growth and differentiation factor-associated serum protein 2) (GASP-2) (hGASP-2) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing protein)",548,"58,798",4 out of 5,2007-10-23,Evidence at protein level
Q8TEU8,WFKN2_HUMAN,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2 (Growth and differentiation factor-associated serum protein 1) (GASP-1) (hGASP-1) (WAP, follistatin, immunoglobulin, Kunitz and NTR domain-containing-related protein) (WFIKKN-related protein)",576,"63,941",4 out of 5,2007-10-23,Evidence at protein level
Q9H4A3,WNK1_HUMAN,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),2382,"250,794",5 out of 5,2004-02-02,Evidence at protein level
Q9UBV4,WNT16_HUMAN,Protein Wnt-16,365,"40,690",5 out of 5,2000-12-01,Evidence at transcript level
P61421,VA0D1_HUMAN,V-type proton ATPase subunit d 1 (V-ATPase subunit d 1) (32 kDa accessory protein) (V-ATPase 40 kDa accessory protein) (V-ATPase AC39 subunit) (p39) (Vacuolar proton pump subunit d 1),351,"40,329",5 out of 5,2004-05-24,Evidence at protein level
Q9P0L0,VAPA_HUMAN,Vesicle-associated membrane protein-associated protein A (VAMP-A) (VAMP-associated protein A) (VAP-A) (33 kDa VAMP-associated protein) (VAP-33),249,"27,893",5 out of 5,2002-11-01,Evidence at protein level
O95292,VAPB_HUMAN,Vesicle-associated membrane protein-associated protein B/C (VAMP-B/VAMP-C) (VAMP-associated protein B/C) (VAP-B/VAP-C),243,"27,228",5 out of 5,2002-11-01,Evidence at protein level
Q52LC2,VAS1L_HUMAN,V-type proton ATPase subunit S1-like protein (Vacuolar proton pump subunit S1-like protein),224,"25,310",2 out of 5,2008-07-01,Evidence at transcript level
Q86V25,VASH2_HUMAN,Vasohibin-2 (Vasohibin-like protein),355,"40,450",5 out of 5,2005-04-12,Evidence at protein level
O95670,VATG2_HUMAN,V-type proton ATPase subunit G 2 (V-ATPase subunit G 2) (V-ATPase 13 kDa subunit 2) (Vacuolar proton pump subunit G 2),118,"13,604",5 out of 5,2000-05-30,Evidence at protein level
Q9H320,VCX1_HUMAN,Variable charge X-linked protein 1 (Variable charge protein on X with ten repeats) (VCX-10r) (Variably charged protein X-B1) (VCX-B1),206,"22,289",4 out of 5,2001-11-16,Evidence at transcript level
Q9H321,VCX3B_HUMAN,Variable charge X-linked protein 3B (Variably charged protein X-C) (VCX-C),246,"26,878",3 out of 5,2001-11-16,Evidence at transcript level
Q9HBM0,VEZA_HUMAN,Vezatin,779,"88,665",5 out of 5,2002-03-27,Evidence at protein level
Q99990,VGLL1_HUMAN,Transcription cofactor vestigial-like protein 1 (Vgl-1) (Protein TONDU),258,"28,707",3 out of 5,2004-07-19,Evidence at protein level
P63127,VPK9_HUMAN,Endogenous retrovirus group K member 9 Pro protein (HERV-K(C6) Pro protein) (HERV-K109 Pro protein) (HERV-K_6q14.1 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,194",3 out of 5,2004-09-13,Inferred from homology
Q93050,VPP1_HUMAN,V-type proton ATPase 116 kDa subunit a isoform 1 (V-ATPase 116 kDa isoform a1) (Clathrin-coated vesicle/synaptic vesicle proton pump 116 kDa subunit) (Vacuolar adenosine triphosphatase subunit Ac116) (Vacuolar proton pump subunit 1) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1),837,"96,413",5 out of 5,1998-12-15,Evidence at protein level
Q96QK1,VPS35_HUMAN,Vacuolar protein sorting-associated protein 35 (hVPS35) (Maternal-embryonic 3) (Vesicle protein sorting 35),796,"91,707",5 out of 5,2002-11-25,Evidence at protein level
Q96JG6,VPS50_HUMAN,Syndetin (Coiled-coil domain-containing protein 132) (EARP/GARPII complex subunit VPS50),964,"111,174",5 out of 5,2007-10-23,Evidence at protein level
Q86Y07,VRK2_HUMAN,Serine/threonine-protein kinase VRK2 (EC 2.7.11.1) (Vaccinia-related kinase 2),508,"58,141",5 out of 5,2003-10-10,Evidence at protein level
Q9NP79,VTA1_HUMAN,Vacuolar protein sorting-associated protein VTA1 homolog (Dopamine-responsive gene 1 protein) (DRG-1) (LYST-interacting protein 5) (LIP5) (SKD1-binding protein 1) (SBP1),307,"33,879",5 out of 5,2003-05-09,Evidence at protein level
P02774,VTDB_HUMAN,Vitamin D-binding protein (DBP) (VDB) (Gc protein-derived macrophage activating factor) (Gc-MAF) (GcMAF) (Gc-globulin) (Group-specific component) (Gc) (Vitamin D-binding protein-macrophage activating factor) (DBP-maf),474,"52,964",5 out of 5,1986-07-21,Evidence at protein level
Q9UEU0,VTI1B_HUMAN,Vesicle transport through interaction with t-SNAREs homolog 1B (Vesicle transport v-SNARE protein Vti1-like 1) (Vti1-rp1),232,"26,688",5 out of 5,2001-02-21,Evidence at protein level
A6NLU5,VTM2B_HUMAN,V-set and transmembrane domain-containing protein 2B,285,"30,297",2 out of 5,2008-02-26,Inferred from homology
Q8N398,VW5B2_HUMAN,von Willebrand factor A domain-containing protein 5B2,1253,"132,764",2 out of 5,2008-06-10,Evidence at transcript level
Q9BUR4,WAP53_HUMAN,Telomerase Cajal body protein 1 (WD repeat-containing protein 79) (WD repeat-containing protein WRAP53) (WD40 repeat-containing protein antisense to TP53 gene),548,"59,309",5 out of 5,2006-06-27,Evidence at protein level
Q8IWB7,WDFY1_HUMAN,WD repeat and FYVE domain-containing protein 1 (FENS-1) (Phosphoinositide-binding protein 1) (WD40- and FYVE domain-containing protein 1) (Zinc finger FYVE domain-containing protein 17),410,"46,324",5 out of 5,2004-08-16,Evidence at protein level
Q6ZS81,WDFY4_HUMAN,WD repeat- and FYVE domain-containing protein 4,3184,"353,610",3 out of 5,2006-10-03,Evidence at protein level
Q9P202,WHRN_HUMAN,Whirlin (Autosomal recessive deafness type 31 protein),907,"96,586",5 out of 5,2004-12-07,Evidence at protein level
Q9Y5W5,WIF1_HUMAN,Wnt inhibitory factor 1 (WIF-1),379,"41,528",5 out of 5,2001-01-11,Evidence at protein level
O43516,WIPF1_HUMAN,WAS/WASL-interacting protein family member 1 (Protein PRPL-2) (Wiskott-Aldrich syndrome protein-interacting protein) (WASP-interacting protein),503,"51,258",5 out of 5,2001-02-21,Evidence at protein level
Q9Y484,WIPI4_HUMAN,WD repeat domain phosphoinositide-interacting protein 4 (WIPI-4) (WD repeat-containing protein 45),360,"39,868",4 out of 5,2006-01-10,Evidence at transcript level
O95785,WIZ_HUMAN,Protein Wiz (Widely-interspaced zinc finger-containing protein) (Zinc finger protein 803),1651,"178,674",5 out of 5,2007-05-01,Evidence at protein level
Q93097,WNT2B_HUMAN,Protein Wnt-2b (Protein Wnt-13),391,"43,770",5 out of 5,1997-11-01,Evidence at protein level
P09544,WNT2_HUMAN,Protein Wnt-2 (Int-1-like protein 1) (Int-1-related protein) (IRP),360,"40,418",5 out of 5,1989-07-01,Evidence at transcript level
Q9Y6I7,WSB1_HUMAN,WD repeat and SOCS box-containing protein 1 (WSB-1) (SOCS box-containing WD protein SWiP-1),421,"47,432",5 out of 5,2002-05-10,Evidence at protein level
P49765,VEGFB_HUMAN,Vascular endothelial growth factor B (VEGF-B) (VEGF-related factor) (VRF),207,"21,602",5 out of 5,1996-10-01,Evidence at protein level
P49767,VEGFC_HUMAN,Vascular endothelial growth factor C (VEGF-C) (Flt4 ligand) (Flt4-L) (Vascular endothelial growth factor-related protein) (VRP),419,"46,883",5 out of 5,1996-10-01,Evidence at protein level
O00534,VMA5A_HUMAN,von Willebrand factor A domain-containing protein 5A (Breast cancer suppressor candidate 1) (BCSC-1) (Loss of heterozygosity 11 chromosomal region 2 gene A protein),786,"86,489",4 out of 5,2002-10-19,Evidence at transcript level
Q9BXE9,VN1R3_HUMAN,Vomeronasal type-1 receptor 3 (V1r-like receptor 3),311,"34,713",3 out of 5,2005-07-05,Evidence at transcript level
A5D8V6,VP37C_HUMAN,Vacuolar protein sorting-associated protein 37C (hVps37C) (ESCRT-I complex subunit VPS37C),355,"38,659",5 out of 5,2007-12-04,Evidence at protein level
Q9UN37,VPS4A_HUMAN,Vacuolar protein sorting-associated protein 4A (EC 3.6.4.6) (Protein SKD2) (VPS4-1) (hVPS4),437,"48,898",5 out of 5,2005-04-12,Evidence at protein level
Q86VR7,VS10L_HUMAN,V-set and immunoglobulin domain-containing protein 10-like,867,"91,625",3 out of 5,2010-06-15,Evidence at transcript level
Q9Y4E1,WAC2C_HUMAN,WASH complex subunit 2C (Vaccinia virus penetration factor) (VPEF),1318,"144,668",5 out of 5,2005-07-19,Evidence at protein level
Q969T9,WBP2_HUMAN,WW domain-binding protein 2 (WBP-2),261,"28,087",5 out of 5,2002-11-15,Evidence at protein level
O75554,WBP4_HUMAN,WW domain-binding protein 4 (WBP-4) (Formin-binding protein 21) (WW domain-containing-binding protein 4),376,"42,507",5 out of 5,2005-06-07,Evidence at protein level
Q5JTN6,WDR38_HUMAN,WD repeat-containing protein 38,314,"34,312",2 out of 5,2007-07-10,Evidence at transcript level
Q9UNX4,WDR3_HUMAN,WD repeat-containing protein 3,943,"106,099",4 out of 5,2001-01-11,Evidence at protein level
Q15061,WDR43_HUMAN,WD repeat-containing protein 43 (U3 small nucleolar RNA-associated protein 5 homolog),677,"74,891",4 out of 5,2004-09-27,Evidence at protein level
Q7Z5U6,WDR53_HUMAN,WD repeat-containing protein 53,358,"38,989",2 out of 5,2005-09-27,Evidence at transcript level
Q3MJ13,WDR72_HUMAN,WD repeat-containing protein 72,1102,"123,425",3 out of 5,2006-06-27,Evidence at transcript level
Q6UXN9,WDR82_HUMAN,WD repeat-containing protein 82 (Protein TMEM113) (Swd2),313,"35,079",5 out of 5,2007-03-06,Evidence at protein level
Q6ZMY6,WDR88_HUMAN,WD repeat-containing protein 88 (PQQ repeat and WD repeat-containing protein),472,"52,621",2 out of 5,2007-05-01,Evidence at transcript level
A4D1P6,WDR91_HUMAN,WD repeat-containing protein 91,747,"83,344",2 out of 5,2007-07-24,Evidence at protein level
A6NE52,WDR97_HUMAN,WD repeat-containing protein 97,1622,"180,307",3 out of 5,2008-05-20,Evidence at transcript level
Q8IUB5,WFD13_HUMAN,WAP four-disulfide core domain protein 13,93,"10,386",2 out of 5,2003-04-04,Inferred from homology
Q9BQY6,WFDC6_HUMAN,WAP four-disulfide core domain protein 6 (Putative protease inhibitor WAP6),131,"14,626",3 out of 5,2003-06-16,Evidence at transcript level
Q9Y4P8,WIPI2_HUMAN,WD repeat domain phosphoinositide-interacting protein 2 (WIPI-2) (WIPI49-like protein 2),454,"49,408",5 out of 5,2006-01-10,Evidence at protein level
O95389,WISP3_HUMAN,WNT1-inducible-signaling pathway protein 3 (WISP-3) (CCN family member 6),354,"39,293",4 out of 5,2003-08-15,Evidence at protein level
Q9GZT5,WN10A_HUMAN,Protein Wnt-10a,417,"46,444",5 out of 5,2001-06-20,Evidence at protein level
P04628,WNT1_HUMAN,Proto-oncogene Wnt-1 (Proto-oncogene Int-1 homolog),370,"40,982",5 out of 5,1987-08-13,Evidence at protein level
O00755,WNT7A_HUMAN,Protein Wnt-7a,349,"39,005",5 out of 5,1997-11-01,Evidence at protein level
Q8WTP9,XAGE3_HUMAN,X antigen family member 3 (XAGE-3) (Cancer/testis antigen 12.3) (CT12.3) (G antigen family D member 4) (Placenta-specific gene 6 protein),111,"12,302",2 out of 5,2003-01-17,Evidence at protein level
P46094,XCR1_HUMAN,Chemokine XC receptor 1 (G-protein coupled receptor 5) (Lymphotactin receptor) (XC chemokine receptor 1),333,"38,508",4 out of 5,1995-11-01,Evidence at protein level
Q9UPY5,XCT_HUMAN,Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT),501,"55,423",5 out of 5,2001-01-24,Evidence at protein level
Q9UIW0,VAX2_HUMAN,Ventral anterior homeobox 2,290,"30,874",4 out of 5,2002-05-10,Evidence at protein level
Q9H322,VCX2_HUMAN,Variable charge X-linked protein 2 (Variable charge protein on X with two repeats) (VCX-2r) (Variably charged protein X-B) (VCX-B),139,"14,661",3 out of 5,2001-11-16,Evidence at transcript level
Q8NDX2,VGLU3_HUMAN,Vesicular glutamate transporter 3 (VGluT3) (Solute carrier family 17 member 8),589,"64,991",5 out of 5,2008-04-29,Evidence at protein level
Q69YN4,VIR_HUMAN,Protein virilizer homolog,1812,"202,025",5 out of 5,2007-10-23,Evidence at protein level
O95497,VNN1_HUMAN,Pantetheinase (EC 3.5.1.92) (Pantetheine hydrolase) (Tiff66) (Vascular non-inflammatory molecule 1) (Vanin-1),513,"57,012",5 out of 5,2001-04-27,Evidence at protein level
Q8TDU5,VNRL4_HUMAN,Putative vomeronasal receptor-like protein 4 (G-protein coupled receptor GPCR23) (hGPCR23),208,"23,857",3 out of 5,2008-03-18,Uncertain
Q9Y2B5,VP9D1_HUMAN,VPS9 domain-containing protein 1 (Protein ATP-BL),631,"68,956",3 out of 5,2005-07-19,Evidence at transcript level
P63124,VPK04_HUMAN,Endogenous retrovirus group K member 104 Pro protein (HERV-K104 Pro protein) (HERV-K_5q13.3 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,121",3 out of 5,2004-09-13,Inferred from homology
P63125,VPK25_HUMAN,Endogenous retrovirus group K member 25 Pro protein (HERV-K_11q22.1 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,077",3 out of 5,2004-09-13,Inferred from homology
Q9BRG1,VPS25_HUMAN,Vacuolar protein-sorting-associated protein 25 (hVps25) (Dermal papilla-derived protein 9) (ELL-associated protein of 20 kDa) (ESCRT-II complex subunit VPS25),176,"20,748",5 out of 5,2005-08-30,Evidence at protein level
O75351,VPS4B_HUMAN,Vacuolar protein sorting-associated protein 4B (EC 3.6.4.6) (Cell migration-inducing gene 1 protein) (Suppressor of K(+) transport growth defect 1) (Protein SKD1),444,"49,302",5 out of 5,2000-12-01,Evidence at protein level
Q9H8Y1,VRTN_HUMAN,Vertnin,702,"78,260",2 out of 5,2004-01-16,Evidence at protein level
Q6PCB0,VWA1_HUMAN,von Willebrand factor A domain-containing protein 1,445,"46,804",4 out of 5,2007-10-23,Evidence at protein level
Q5GFL6,VWA2_HUMAN,von Willebrand factor A domain-containing protein 2 (A domain-containing protein similar to matrilin and collagen) (AMACO) (Colon cancer secreted protein 2) (CCSP-2),755,"82,012",5 out of 5,2007-10-23,Evidence at protein level
Q502W6,VWA3B_HUMAN,von Willebrand factor A domain-containing protein 3B (VWA domain-containing protein 3B),1294,"145,748",4 out of 5,2008-05-20,Evidence at protein level
Q96SY0,VWA9_HUMAN,von Willebrand factor A domain-containing protein 9,518,"57,471",3 out of 5,2007-07-24,Evidence at protein level
P04275,VWF_HUMAN,von Willebrand factor (vWF) [Cleaved into: von Willebrand antigen 2 (von Willebrand antigen II)],2813,"309,265",5 out of 5,1987-03-20,Evidence at protein level
Q641Q2,WAC2A_HUMAN,WASH complex subunit 2A,1341,"147,184",4 out of 5,2008-02-05,Evidence at protein level
C4AMC7,WASH3_HUMAN,Putative WAS protein family homolog 3 (Protein FAM39DP),463,"49,995",5 out of 5,2010-01-19,Evidence at protein level
P42768,WASP_HUMAN,Wiskott-Aldrich syndrome protein (WASp),502,"52,913",5 out of 5,1995-11-01,Evidence at protein level
Q9NX94,WBP1L_HUMAN,WW domain binding protein 1-like (Outcome predictor in acute leukemia 1),342,"37,828",3 out of 5,2006-06-27,Evidence at protein level
O43709,WBS22_HUMAN,Probable 18S rRNA (guanine-N(7))-methyltransferase (EC 2.1.1.-) (Bud site selection protein 23 homolog) (Metastasis-related methyltransferase 1) (Williams-Beuren syndrome chromosomal region 22 protein),281,"31,880",5 out of 5,1999-07-15,Evidence at protein level
Q9H6R7,WDCP_HUMAN,WD repeat and coiled-coil-containing protein,721,"79,136",5 out of 5,2007-09-11,Evidence at protein level
Q8IZQ1,WDFY3_HUMAN,WD repeat and FYVE domain-containing protein 3 (Autophagy-linked FYVE protein) (Alfy),3526,"395,258",5 out of 5,2006-06-27,Evidence at protein level
A2RRH5,WDR27_HUMAN,WD repeat-containing protein 27,827,"90,038",3 out of 5,2007-10-02,Evidence at protein level
Q96EX3,WDR34_HUMAN,WD repeat-containing protein 34,536,"57,801",5 out of 5,2004-03-15,Evidence at protein level
Q9Y2I8,WDR37_HUMAN,WD repeat-containing protein 37,494,"54,665",3 out of 5,2001-06-20,Evidence at protein level
Q8TAF3,WDR48_HUMAN,WD repeat-containing protein 48 (USP1-associated factor 1) (WD repeat endosomal protein) (p80),677,"76,210",5 out of 5,2005-12-20,Evidence at protein level
P61964,WDR5_HUMAN,WD repeat-containing protein 5 (BMP2-induced 3-kb gene protein),334,"36,588",5 out of 5,2004-06-07,Evidence at protein level
Q9GZS3,WDR61_HUMAN,"WD repeat-containing protein 61 (Meiotic recombination REC14 protein homolog) (SKI8 homolog) (Ski8) [Cleaved into: WD repeat-containing protein 61, N-terminally processed]",305,"33,581",5 out of 5,2006-07-11,Evidence at protein level
Q9NY84,VNN3_HUMAN,Vascular non-inflammatory molecule 3 (Vanin-3) (EC 3.5.1.92),501,"56,118",5 out of 5,2001-04-27,Evidence at transcript level
P63119,VPK21_HUMAN,Endogenous retrovirus group K member 21 Pro protein (HERV-K_12q14.1 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,107",3 out of 5,2004-09-13,Inferred from homology
P63131,VPK7_HUMAN,Endogenous retrovirus group K member 7 Pro protein (HERV-K(III) Pro protein) (HERV-K102 Pro protein) (HERV-K_1q22 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,078",3 out of 5,2004-09-13,Inferred from homology
Q8IV63,VRK3_HUMAN,Inactive serine/threonine-protein kinase VRK3 (Serine/threonine-protein pseudokinase VRK3) (Vaccinia-related kinase 3),474,"52,881",5 out of 5,2003-10-10,Evidence at protein level
Q9BTA9,WAC_HUMAN,WW domain-containing adapter protein with coiled-coil,647,"70,724",5 out of 5,2006-10-31,Evidence at protein level
O95388,WISP1_HUMAN,WNT1-inducible-signaling pathway protein 1 (WISP-1) (CCN family member 4) (Wnt-1-induced secreted protein),367,"40,331",5 out of 5,2003-08-15,Evidence at protein level
Q9BYP7,WNK3_HUMAN,Serine/threonine-protein kinase WNK3 (EC 2.7.11.1) (Protein kinase lysine-deficient 3) (Protein kinase with no lysine 3),1800,"198,416",5 out of 5,2004-02-02,Evidence at protein level
P56706,WNT7B_HUMAN,Protein Wnt-7b,349,"39,327",5 out of 5,1999-07-15,Evidence at transcript level
Q658N2,WSCD1_HUMAN,WSC domain-containing protein 1,575,"65,694",2 out of 5,2007-10-02,Evidence at transcript level
P19544,WT1_HUMAN,Wilms tumor protein (WT33),449,"49,188",5 out of 5,1991-02-01,Evidence at protein level
P98170,XIAP_HUMAN,E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP),497,"56,685",5 out of 5,1996-10-01,Evidence at protein level
Q6UX68,XKR5_HUMAN,XK-related protein 5,686,"74,982",2 out of 5,2005-10-11,Evidence at transcript level
Q8NBI6,XXLT1_HUMAN,"Xyloside xylosyltransferase 1 (EC 2.4.2.n3) (UDP-xylose:alpha-xyloside alpha-1,3-xylosyltransferase)",393,"43,807",5 out of 5,2006-05-16,Evidence at protein level
P63123,VPK18_HUMAN,Endogenous retrovirus group K member 18 Pro protein (HERV-K(C1a) Pro protein) (HERV-K110 Pro protein) (HERV-K18 Pro protein) (HERV-K_1q23.3 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,101",3 out of 5,2004-09-13,Inferred from homology
P63129,VPK24_HUMAN,Endogenous retrovirus group K member 24 Pro protein (HERV-K101 envelope protein) (HERV-K_22q11.21 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,139",3 out of 5,2004-09-13,Inferred from homology
Q5VU13,VSIG8_HUMAN,V-set and immunoglobulin domain-containing protein 8,414,"43,891",3 out of 5,2008-01-15,Evidence at transcript level
Q9H1F0,WF10A_HUMAN,WAP four-disulfide core domain protein 10A (Putative protease inhibitor WAP10A),79,"8,943",2 out of 5,2002-10-19,Inferred from homology
Q8WWY7,WFD12_HUMAN,WAP four-disulfide core domain protein 12 (Putative protease inhibitor WAP12) (Whey acidic protein 2),111,"12,050",3 out of 5,2002-10-19,Evidence at protein level
A6NGB9,WIPF3_HUMAN,WAS/WASL-interacting protein family member 3 (Corticosteroids and regional expression protein 16 homolog),483,"49,458",3 out of 5,2008-06-10,Evidence at protein level
Q5MNZ9,WIPI1_HUMAN,WD repeat domain phosphoinositide-interacting protein 1 (WIPI-1) (Atg18 protein homolog) (WD40 repeat protein interacting with phosphoinositides of 49 kDa) (WIPI 49 kDa),446,"48,673",5 out of 5,2006-01-10,Evidence at protein level
O00744,WN10B_HUMAN,Protein Wnt-10b (Protein Wnt-12),389,"43,000",5 out of 5,1997-11-01,Evidence at protein level
Q96J92,WNK4_HUMAN,Serine/threonine-protein kinase WNK4 (EC 2.7.11.1) (Protein kinase lysine-deficient 4) (Protein kinase with no lysine 4),1243,"134,739",5 out of 5,2004-02-02,Evidence at protein level
Q9Y6F9,WNT6_HUMAN,Protein Wnt-6,365,"39,721",5 out of 5,2000-12-01,Evidence at protein level
Q9ULE0,WWC3_HUMAN,Protein WWC3,1092,"122,676",4 out of 5,2006-06-27,Evidence at protein level
P47992,XCL1_HUMAN,Lymphotactin (ATAC) (C motif chemokine 1) (Cytokine SCM-1) (Lymphotaxin) (SCM-1-alpha) (Small-inducible cytokine C1) (XC chemokine ligand 1),114,"12,517",5 out of 5,1996-02-01,Evidence at protein level
O15537,XLRS1_HUMAN,Retinoschisin (X-linked juvenile retinoschisis protein),224,"25,592",5 out of 5,2000-05-30,Evidence at protein level
Q01831,XPC_HUMAN,DNA repair protein complementing XP-C cells (Xeroderma pigmentosum group C-complementing protein) (p125),940,"105,953",5 out of 5,1993-07-01,Evidence at protein level
P55060,XPO2_HUMAN,Exportin-2 (Exp2) (Cellular apoptosis susceptibility protein) (Chromosome segregation 1-like protein) (Importin-alpha re-exporter),971,"110,417",5 out of 5,1996-10-01,Evidence at protein level
Q13426,XRCC4_HUMAN,DNA repair protein XRCC4 (X-ray repair cross-complementing protein 4),336,"38,287",5 out of 5,2004-03-01,Evidence at protein level
Q9H1B5,XYLT2_HUMAN,Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II),865,"96,767",5 out of 5,2005-05-10,Evidence at protein level
Q9UK41,VPS28_HUMAN,Vacuolar protein sorting-associated protein 28 homolog (H-Vps28) (ESCRT-I complex subunit VPS28),221,"25,425",5 out of 5,2001-02-21,Evidence at protein level
Q9UBQ0,VPS29_HUMAN,Vacuolar protein sorting-associated protein 29 (hVPS29) (PEP11 homolog) (Vesicle protein sorting 29),182,"20,506",5 out of 5,2002-11-25,Evidence at protein level
Q5VIR6,VPS53_HUMAN,Vacuolar protein sorting-associated protein 53 homolog,699,"79,653",5 out of 5,2005-11-22,Evidence at protein level
Q8N0Z9,VSI10_HUMAN,V-set and immunoglobulin domain-containing protein 10,540,"59,217",3 out of 5,2008-07-22,Evidence at transcript level
Q9Y279,VSIG4_HUMAN,V-set and immunoglobulin domain-containing protein 4 (Protein Z39Ig),399,"43,987",5 out of 5,2005-02-15,Evidence at protein level
Q8TAG5,VTM2A_HUMAN,V-set and transmembrane domain-containing protein 2A,236,"25,833",5 out of 5,2004-11-23,Evidence at protein level
Q96DN2,VWCE_HUMAN,von Willebrand factor C and EGF domain-containing protein (HBV X protein up-regulated gene 11 protein) (HBxAg up-regulated gene 11 protein),955,"99,915",4 out of 5,2008-02-05,Evidence at transcript level
Q9UPY6,WASF3_HUMAN,Wiskott-Aldrich syndrome protein family member 3 (WASP family protein member 3) (Protein WAVE-3) (Verprolin homology domain-containing protein 3),502,"55,293",5 out of 5,2001-04-27,Evidence at protein level
O43379,WDR62_HUMAN,WD repeat-containing protein 62,1518,"165,954",5 out of 5,2007-04-03,Evidence at protein level
Q9NW82,WDR70_HUMAN,WD repeat-containing protein 70,654,"73,201",2 out of 5,2007-10-02,Evidence at protein level
Q96FK6,WDR89_HUMAN,WD repeat-containing protein 89,387,"43,215",1 out of 5,2006-10-31,Evidence at transcript level
Q8NEX6,WFD11_HUMAN,Protein WFDC11,87,"10,340",2 out of 5,2002-12-06,Inferred from homology
P56705,WNT4_HUMAN,Protein Wnt-4,351,"39,052",5 out of 5,1999-07-15,Evidence at protein level
O14905,WNT9B_HUMAN,Protein Wnt-9b (Protein Wnt-14b) (Protein Wnt-15),357,"39,001",5 out of 5,1998-07-15,Evidence at protein level
Q96S55,WRIP1_HUMAN,ATPase WRNIP1 (EC 3.6.1.3) (Werner helicase-interacting protein 1),665,"72,133",5 out of 5,2005-08-16,Evidence at protein level
Q14191,WRN_HUMAN,"Werner syndrome ATP-dependent helicase (EC 3.6.4.12) (DNA helicase, RecQ-like type 3) (RecQ3) (Exonuclease WRN) (EC 3.1.-.-) (RecQ protein-like 2)",1432,"162,461",5 out of 5,1998-12-15,Evidence at protein level
Q8N9V3,WSDU1_HUMAN,"WD repeat, SAM and U-box domain-containing protein 1",476,"52,817",2 out of 5,2007-02-20,Evidence at protein level
Q9HD64,XAGE1_HUMAN,X antigen family member 1 (XAGE-1) (Cancer/testis antigen 12.1) (CT12.1) (G antigen family D member 2),81,"9,078",3 out of 5,2001-09-26,Evidence at protein level
Q702N8,XIRP1_HUMAN,Xin actin-binding repeat-containing protein 1 (Cardiomyopathy-associated protein 1),1843,"198,561",5 out of 5,2008-02-05,Evidence at protein level
Q9C0E2,XPO4_HUMAN,Exportin-4 (Exp4),1151,"130,139",4 out of 5,2001-11-02,Evidence at protein level
O43895,XPP2_HUMAN,Xaa-Pro aminopeptidase 2 (EC 3.4.11.9) (Aminoacylproline aminopeptidase) (Membrane-bound aminopeptidase P) (Membrane-bound APP) (Membrane-bound AmP) (mAmP) (X-Pro aminopeptidase 2),674,"75,625",5 out of 5,2002-11-15,Evidence at protein level
O43543,XRCC2_HUMAN,DNA repair protein XRCC2 (X-ray repair cross-complementing protein 2),280,"31,956",5 out of 5,2002-04-03,Evidence at protein level
P12956,XRCC6_HUMAN,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),609,"69,843",5 out of 5,1990-01-01,Evidence at protein level
Q9H0D6,XRN2_HUMAN,5'-3' exoribonuclease 2 (EC 3.1.13.-) (DHM1-like protein) (DHP protein),950,"108,582",5 out of 5,2003-04-23,Evidence at protein level
Q5GH70,XKR9_HUMAN,XK-related protein 9,373,"43,406",2 out of 5,2005-10-11,Evidence at transcript level
Q9H0M0,WWP1_HUMAN,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (Atrophin-1-interacting protein 5) (AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1) (Tiul1) (WW domain-containing protein 1),922,"105,202",5 out of 5,2003-06-20,Evidence at protein level
Q8WWM1,XAGE5_HUMAN,X antigen family member 5 (XAGE-5) (Cancer/testis antigen 12.5) (CT12.5) (G antigen family D member 5),108,"12,077",2 out of 5,2003-01-17,Inferred from homology
P17861,XBP1_HUMAN,"X-box-binding protein 1 (XBP-1) (Tax-responsive element-binding protein 5) (TREB-5) [Cleaved into: X-box-binding protein 1, cytoplasmic form; X-box-binding protein 1, luminal form]",261,"28,695",5 out of 5,1990-11-01,Evidence at protein level
A4UGR9,XIRP2_HUMAN,Xin actin-binding repeat-containing protein 2 (Beta-xin) (Cardiomyopathy-associated protein 3) (Xeplin),3374,"382,300",5 out of 5,2008-02-05,Evidence at protein level
P30512,1A29_HUMAN,"HLA class I histocompatibility antigen, A-29 alpha chain (Aw-19) (MHC class I antigen A*29)",365,"40,863",5 out of 5,1993-04-01,Evidence at protein level
P10314,1A32_HUMAN,"HLA class I histocompatibility antigen, A-32 alpha chain (MHC class I antigen A*32)",365,"41,048",5 out of 5,1989-07-01,Evidence at protein level
P30456,1A43_HUMAN,"HLA class I histocompatibility antigen, A-43 alpha chain (Aw-43) (MHC class I antigen A*43)",365,"41,033",5 out of 5,1993-04-01,Evidence at protein level
P10316,1A69_HUMAN,"HLA class I histocompatibility antigen, A-69 alpha chain (Aw-69) (HLA class I histocompatibility antigen, A-28 alpha chain) (MHC class I antigen A*69)",365,"40,977",5 out of 5,1989-07-01,Evidence at protein level
P01889,1B07_HUMAN,"HLA class I histocompatibility antigen, B-7 alpha chain (MHC class I antigen B*7)",362,"40,460",5 out of 5,1986-07-21,Evidence at protein level
P30462,1B14_HUMAN,"HLA class I histocompatibility antigen, B-14 alpha chain (MHC class I antigen B*14)",362,"40,358",5 out of 5,1993-04-01,Evidence at protein level
P03989,1B27_HUMAN,"HLA class I histocompatibility antigen, B-27 alpha chain (MHC class I antigen B*27)",362,"40,428",5 out of 5,1986-10-23,Evidence at protein level
Q29836,1B67_HUMAN,"HLA class I histocompatibility antigen, B-67 alpha chain (MHC class I antigen B*67)",362,"40,342",5 out of 5,2003-08-22,Evidence at protein level
Q31610,1B81_HUMAN,"HLA class I histocompatibility antigen, B-81 alpha chain (B'DT) (MHC class I antigen B*81)",362,"40,400",5 out of 5,2003-08-22,Evidence at protein level
P30501,1C02_HUMAN,"HLA class I histocompatibility antigen, Cw-2 alpha chain (MHC class I antigen Cw*2)",366,"41,095",5 out of 5,1993-04-01,Evidence at protein level
P04222,1C03_HUMAN,"HLA class I histocompatibility antigen, Cw-3 alpha chain (MHC class I antigen Cw*3)",366,"40,861",5 out of 5,1987-03-20,Evidence at protein level
P30504,1C04_HUMAN,"HLA class I histocompatibility antigen, Cw-4 alpha chain (MHC class I antigen Cw*4)",366,"40,995",5 out of 5,1993-04-01,Evidence at protein level
Q30134,2B18_HUMAN,"HLA class II histocompatibility antigen, DRB1-8 beta chain (MHC class II antigen DRB1*8) (DR-8) (DR8) (DRw8)",266,"30,004",5 out of 5,2003-08-29,Evidence at protein level
Q95IE3,2B1C_HUMAN,"HLA class II histocompatibility antigen, DRB1-12 beta chain (MHC class II antigen DRB1*12) (DR-12) (DR12)",266,"29,878",5 out of 5,2010-03-02,Evidence at protein level
Q5Y7A7,2B1D_HUMAN,"HLA class II histocompatibility antigen, DRB1-13 beta chain (MHC class II antigen DRB1*13) (DR-13) (DR13)",266,"30,008",5 out of 5,2010-03-23,Evidence at protein level
P14060,3BHS1_HUMAN,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type I) (3-beta-HSD I) (Trophoblast antigen FDO161G) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)],373,"42,252",5 out of 5,1990-01-01,Evidence at protein level
P31937,3HIDH_HUMAN,"3-hydroxyisobutyrate dehydrogenase, mitochondrial (HIBADH) (EC 1.1.1.31)",336,"35,329",5 out of 5,1993-07-01,Evidence at protein level
Q7RTV5,AAED1_HUMAN,Thioredoxin-like protein AAED1 (AhpC/TSA antioxidant enzyme domain-containing protein 1),226,"24,857",2 out of 5,2004-04-13,Evidence at transcript level
Q5VST6,AB17B_HUMAN,Protein ABHD17B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 17B) (Abhydrolase domain-containing protein 17B),288,"32,215",3 out of 5,2007-03-20,Evidence at protein level
Q6NTF7,ABC3H_HUMAN,DNA dC->dU-editing enzyme APOBEC-3H (EC 3.5.4.-) (APOBEC-related protein 10) (ARP-10) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3H) (A3H),200,"23,531",5 out of 5,2007-06-26,Evidence at protein level
O95477,ABCA1_HUMAN,ATP-binding cassette sub-family A member 1 (ATP-binding cassette transporter 1) (ABC-1) (ATP-binding cassette 1) (Cholesterol efflux regulatory protein),2261,"254,302",5 out of 5,2000-12-01,Evidence at protein level
Q8N139,ABCA6_HUMAN,ATP-binding cassette sub-family A member 6,1617,"184,286",5 out of 5,2006-10-03,Evidence at protein level
Q6UXT9,ABH15_HUMAN,Protein ABHD15 (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15),468,"51,771",3 out of 5,2008-07-22,Evidence at protein level
Q8WU67,ABHD3_HUMAN,Phospholipase ABHD3 (EC 3.1.1.32) (EC 3.1.1.4) (Abhydrolase domain-containing protein 3),409,"46,009",5 out of 5,2007-03-20,Evidence at protein level
Q8WTS1,ABHD5_HUMAN,1-acylglycerol-3-phosphate O-acyltransferase ABHD5 (EC 2.3.1.51) (Abhydrolase domain-containing protein 5) (Lipid droplet-binding protein CGI-58),349,"39,096",5 out of 5,2005-08-30,Evidence at protein level
Q8NFV4,ABHDB_HUMAN,Protein ABHD11 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 11) (Abhydrolase domain-containing protein 11) (Williams-Beuren syndrome chromosomal region 21 protein),315,"34,690",4 out of 5,2007-03-20,Evidence at protein level
Q8IZP0,ABI1_HUMAN,Abl interactor 1 (Abelson interactor 1) (Abi-1) (Abl-binding protein 4) (AblBP4) (Eps8 SH3 domain-binding protein) (Eps8-binding protein) (Nap1-binding protein) (Nap1BP) (Spectrin SH3 domain-binding protein 1) (e3B1),508,"55,081",5 out of 5,2004-07-19,Evidence at protein level
Q15057,ACAP2_HUMAN,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 (Centaurin-beta-2) (Cnt-b2)",778,"88,029",4 out of 5,1998-07-15,Evidence at protein level
O00590,ACKR2_HUMAN,Atypical chemokine receptor 2 (C-C chemokine receptor D6) (Chemokine receptor CCR-10) (Chemokine receptor CCR-9) (Chemokine-binding protein 2) (Chemokine-binding protein D6),384,"43,443",5 out of 5,2001-06-20,Evidence at protein level
O96019,ACL6A_HUMAN,Actin-like protein 6A (53 kDa BRG1-associated factor A) (Actin-related protein Baf53a) (ArpNbeta) (BRG1-associated factor 53A) (BAF53A) (INO80 complex subunit K),429,"47,461",5 out of 5,2002-09-19,Evidence at protein level
Q96CM8,ACSF2_HUMAN,"Acyl-CoA synthetase family member 2, mitochondrial (EC 6.2.1.-)",615,"68,125",5 out of 5,2008-01-15,Evidence at protein level
O60488,ACSL4_HUMAN,Long-chain-fatty-acid--CoA ligase 4 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 4) (LACS 4),711,"79,188",5 out of 5,1998-12-15,Evidence at protein level
Q96M93,ADAD1_HUMAN,Adenosine deaminase domain-containing protein 1 (Testis nuclear RNA-binding protein),576,"64,411",3 out of 5,2007-11-13,Evidence at transcript level
Q6DHV7,ADAL_HUMAN,Adenosine deaminase-like protein (EC 3.5.4.-),355,"40,264",4 out of 5,2007-05-01,Evidence at transcript level
Q13443,ADAM9_HUMAN,Disintegrin and metalloproteinase domain-containing protein 9 (ADAM 9) (EC 3.4.24.-) (Cellular disintegrin-related protein) (Meltrin-gamma) (Metalloprotease/disintegrin/cysteine-rich protein 9) (Myeloma cell metalloproteinase),819,"90,556",5 out of 5,2002-10-19,Evidence at protein level
O00116,ADAS_HUMAN,"Alkyldihydroxyacetonephosphate synthase, peroxisomal (Alkyl-DHAP synthase) (EC 2.5.1.26) (Aging-associated gene 5 protein) (Alkylglycerone-phosphate synthase)",658,"72,912",5 out of 5,1997-11-01,Evidence at protein level
Q5VUY0,ADCL3_HUMAN,Arylacetamide deacetylase-like 3 (EC 3.1.1.-),350,"39,743",3 out of 5,2006-12-12,Evidence at transcript level
Q08828,ADCY1_HUMAN,Adenylate cyclase type 1 (EC 4.6.1.1) (ATP pyrophosphate-lyase 1) (Adenylate cyclase type I) (Adenylyl cyclase 1) (Ca(2+)/calmodulin-activated adenylyl cyclase),1119,"123,440",5 out of 5,1994-10-01,Evidence at protein level
O60266,ADCY3_HUMAN,"Adenylate cyclase type 3 (EC 4.6.1.1) (ATP pyrophosphate-lyase 3) (Adenylate cyclase type III) (AC-III) (Adenylate cyclase, olfactive type) (Adenylyl cyclase 3) (AC3)",1144,"128,960",5 out of 5,2001-04-27,Evidence at protein level
Q9TQE0,2B19_HUMAN,"HLA class II histocompatibility antigen, DRB1-9 beta chain (MHC class II antigen DRB1*9) (DR-9) (DR9)",266,"29,826",5 out of 5,2003-08-29,Evidence at protein level
P26439,3BHS2_HUMAN,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2 (3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type II) (3-beta-HSD II) (3-beta-HSD adrenal and gonadal type) [Includes: 3-beta-hydroxy-Delta(5)-steroid dehydrogenase (EC 1.1.1.145) (3-beta-hydroxy-5-ene steroid dehydrogenase) (Progesterone reductase); Steroid Delta-isomerase (EC 5.3.3.1) (Delta-5-3-ketosteroid isomerase)],372,"42,052",5 out of 5,1992-08-01,Evidence at protein level
Q9Y3L3,3BP1_HUMAN,SH3 domain-binding protein 1 (3BP-1),701,"75,713",3 out of 5,2002-01-23,Evidence at protein level
Q7L8J4,3BP5L_HUMAN,SH3 domain-binding protein 5-like (SH3BP-5-like),393,"43,499",3 out of 5,2008-02-05,Evidence at protein level
P46952,3HAO_HUMAN,"3-hydroxyanthranilate 3,4-dioxygenase (EC 1.13.11.6) (3-hydroxyanthranilate oxygenase) (3-HAO) (3-hydroxyanthranilic acid dioxygenase) (HAD)",286,"32,556",5 out of 5,1995-11-01,Evidence at protein level
Q13541,4EBP1_HUMAN,Eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) (eIF4E-binding protein 1) (Phosphorylated heat- and acid-stable protein regulated by insulin 1) (PHAS-I),118,"12,580",5 out of 5,2003-09-19,Evidence at protein level
P08908,5HT1A_HUMAN,5-hydroxytryptamine receptor 1A (5-HT-1A) (5-HT1A) (G-21) (Serotonin receptor 1A),422,"46,107",5 out of 5,1988-11-01,Evidence at protein level
P28335,5HT2C_HUMAN,5-hydroxytryptamine receptor 2C (5-HT-2C) (5-HT2C) (5-HTR2C) (5-hydroxytryptamine receptor 1C) (5-HT-1C) (5-HT1C) (Serotonin receptor 2C),458,"51,821",5 out of 5,1992-12-01,Evidence at protein level
O95264,5HT3B_HUMAN,5-hydroxytryptamine receptor 3B (5-HT3-B) (5-HT3B) (Serotonin receptor 3B),441,"50,292",5 out of 5,2007-12-04,Evidence at protein level
P47898,5HT5A_HUMAN,5-hydroxytryptamine receptor 5A (5-HT-5) (5-HT-5A) (5-HT5A) (Serotonin receptor 5A),357,"40,255",5 out of 5,1996-02-01,Evidence at transcript level
P02763,A1AG1_HUMAN,Alpha-1-acid glycoprotein 1 (AGP 1) (Orosomucoid-1) (OMD 1),201,"23,512",5 out of 5,1986-07-21,Evidence at protein level
U3KPV4,A3LT2_HUMAN,"Alpha-1,3-galactosyltransferase 2 (EC 2.4.1.87) (Isoglobotriaosylceramide synthase) (iGb3 synthase) (iGb3S)",340,"38,754",4 out of 5,2016-07-06,Evidence at transcript level
Q96GS6,AB17A_HUMAN,Protein ABHD17A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 17A) (Abhydrolase domain-containing protein 17A),310,"33,990",4 out of 5,2007-07-24,Evidence at protein level
Q96SE0,ABHD1_HUMAN,Protein ABHD1 (EC 3.1.1.-) (Alpha/beta hydrolase domain-containing protein 1) (Abhydrolase domain-containing protein 1) (Lung alpha/beta hydrolase 1),405,"45,207",4 out of 5,2007-03-20,Evidence at protein level
Q969K4,ABTB1_HUMAN,Ankyrin repeat and BTB/POZ domain-containing protein 1 (Elongation factor 1A-binding protein),478,"53,979",5 out of 5,2006-09-05,Evidence at protein level
P22303,ACES_HUMAN,Acetylcholinesterase (AChE) (EC 3.1.1.7),614,"67,796",5 out of 5,1991-08-01,Evidence at protein level
P20309,ACM3_HUMAN,Muscarinic acetylcholine receptor M3,590,"66,128",5 out of 5,1991-02-01,Evidence at protein level
P13798,ACPH_HUMAN,Acylamino-acid-releasing enzyme (AARE) (EC 3.4.19.1) (Acyl-peptide hydrolase) (APH) (Acylaminoacyl-peptidase) (Oxidized protein hydrolase) (OPH),732,"81,225",5 out of 5,1990-01-01,Evidence at protein level
Q96QF7,ACRC_HUMAN,Acidic repeat-containing protein,691,"76,112",2 out of 5,2008-02-05,Evidence at transcript level
Q6P461,ACSM6_HUMAN,"Acyl-coenzyme A synthetase ACSM6, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 6)",480,"53,585",5 out of 5,2008-05-20,Evidence at transcript level
P68032,ACTC_HUMAN,"Actin, alpha cardiac muscle 1 (Alpha-cardiac actin)",377,"42,019",5 out of 5,1987-03-20,Evidence at protein level
Q8TC94,ACTL9_HUMAN,Actin-like protein 9,416,"45,627",2 out of 5,2008-04-29,Evidence at protein level
P12814,ACTN1_HUMAN,Alpha-actinin-1 (Alpha-actinin cytoskeletal isoform) (F-actin cross-linking protein) (Non-muscle alpha-actinin-1),892,"103,058",5 out of 5,1989-10-01,Evidence at protein level
P68133,ACTS_HUMAN,"Actin, alpha skeletal muscle (Alpha-actin-1)",377,"42,051",5 out of 5,1986-07-21,Evidence at protein level
Q8TDY3,ACTT2_HUMAN,Actin-related protein T2 (ARP-T2) (Actin-related protein M2),377,"41,702",2 out of 5,2004-05-10,Evidence at transcript level
P36896,ACV1B_HUMAN,Activin receptor type-1B (EC 2.7.11.30) (Activin receptor type IB) (ACTR-IB) (Activin receptor-like kinase 4) (ALK-4) (Serine/threonine-protein kinase receptor R2) (SKR2),505,"56,807",5 out of 5,1994-06-01,Evidence at protein level
P37023,ACVL1_HUMAN,Serine/threonine-protein kinase receptor R3 (SKR3) (EC 2.7.11.30) (Activin receptor-like kinase 1) (ALK-1) (TGF-B superfamily receptor type I) (TSR-I),503,"56,124",5 out of 5,1994-06-01,Evidence at protein level
P30443,1A01_HUMAN,"HLA class I histocompatibility antigen, A-1 alpha chain (MHC class I antigen A*1)",365,"40,846",5 out of 5,1993-04-01,Evidence at protein level
P16190,1A33_HUMAN,"HLA class I histocompatibility antigen, A-33 alpha chain (Aw-19) (Aw-33) (MHC class I antigen A*33)",365,"40,892",5 out of 5,1990-04-01,Evidence at protein level
Q09160,1A80_HUMAN,"HLA class I histocompatibility antigen, A-80 alpha chain (Aw-80) (HLA class I histocompatibility antigen, A-1 alpha chain) (MHC class I antigen A*80)",365,"40,792",5 out of 5,1995-11-01,Evidence at protein level
P30460,1B08_HUMAN,"HLA class I histocompatibility antigen, B-8 alpha chain (MHC class I antigen B*8)",362,"40,331",5 out of 5,1993-04-01,Evidence at protein level
P30464,1B15_HUMAN,"HLA class I histocompatibility antigen, B-15 alpha chain (MHC class I antigen B*15)",362,"40,388",5 out of 5,1993-04-01,Evidence at protein level
Q95365,1B38_HUMAN,"HLA class I histocompatibility antigen, B-38 alpha chain (Bw-4) (MHC class I antigen B*38)",362,"40,416",5 out of 5,2003-08-22,Evidence at protein level
P30483,1B45_HUMAN,"HLA class I histocompatibility antigen, B-45 alpha chain (Bw-45) (MHC class I antigen B*45)",362,"40,414",5 out of 5,1993-04-01,Evidence at protein level
P30485,1B47_HUMAN,"HLA class I histocompatibility antigen, B-47 alpha chain (Bw-47) (MHC class I antigen B*47)",362,"40,571",5 out of 5,1993-04-01,Evidence at protein level
P30488,1B50_HUMAN,"HLA class I histocompatibility antigen, B-50 alpha chain (Bw-50) (HLA class I histocompatibility antigen, B-21 alpha chain) (MHC class I antigen B*50)",362,"40,541",5 out of 5,1993-04-01,Evidence at protein level
P30493,1B55_HUMAN,"HLA class I histocompatibility antigen, B-55 alpha chain (Bw-55) (HLA class I histocompatibility antigen, B-12 alpha chain) (MHC class I antigen B*55)",362,"40,496",5 out of 5,1993-04-01,Evidence at protein level
P10319,1B58_HUMAN,"HLA class I histocompatibility antigen, B-58 alpha chain (Bw-58) (MHC class I antigen B*58)",362,"40,337",5 out of 5,1989-07-01,Evidence at protein level
Q29718,1B82_HUMAN,"HLA class I histocompatibility antigen, B-82 alpha chain (MHC class I antigen B*82)",362,"40,421",5 out of 5,2003-08-22,Evidence at protein level
Q29963,1C06_HUMAN,"HLA class I histocompatibility antigen, Cw-6 alpha chain (MHC class I antigen Cw*6)",366,"40,969",5 out of 5,2003-08-22,Evidence at protein level
P30510,1C14_HUMAN,"HLA class I histocompatibility antigen, Cw-14 alpha chain (MHC class I antigen Cw*14)",366,"40,838",5 out of 5,1993-04-01,Evidence at protein level
Q66LE6,2ABD_HUMAN,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B delta isoform (PP2A subunit B isoform B55-delta) (PP2A subunit B isoform PR55-delta) (PP2A subunit B isoform R2-delta) (PP2A subunit B isoform delta),453,"52,042",4 out of 5,2006-01-24,Evidence at protein level
Q30167,2B1A_HUMAN,"HLA class II histocompatibility antigen, DRB1-10 beta chain (DRw10) (MHC class II antigen DRB1*10)",266,"30,002",5 out of 5,2003-08-29,Evidence at protein level
P11171,41_HUMAN,Protein 4.1 (P4.1) (4.1R) (Band 4.1) (EPB4.1),864,"97,017",5 out of 5,1989-07-01,Evidence at protein level
P52209,6PGD_HUMAN,"6-phosphogluconate dehydrogenase, decarboxylating (EC 1.1.1.44)",483,"53,140",5 out of 5,1996-10-01,Evidence at protein level
Q8IZ83,A16A1_HUMAN,Aldehyde dehydrogenase family 16 member A1,802,"85,127",4 out of 5,2008-01-15,Evidence at protein level
P19652,A1AG2_HUMAN,Alpha-1-acid glycoprotein 2 (AGP 2) (Orosomucoid-2) (OMD 2),201,"23,603",5 out of 5,1991-02-01,Evidence at protein level
Q8NF67,A2012_HUMAN,Putative ankyrin repeat domain-containing protein 20A12 pseudogene,263,"31,171",1 out of 5,2008-05-20,Uncertain
Q4UJ75,A20A4_HUMAN,Ankyrin repeat domain-containing protein 20A4,823,"94,149",1 out of 5,2006-06-27,Predicted
Q96IX9,A26L1_HUMAN,Putative ankyrin repeat domain-containing protein 26-like 1 (Ankyrin repeat domain-containing protein 36B pseudogene 1),119,"14,172",4 out of 5,2008-02-26,Uncertain
P08697,A2AP_HUMAN,Alpha-2-antiplasmin (Alpha-2-AP) (Alpha-2-plasmin inhibitor) (Alpha-2-PI) (Serpin F2),491,"54,566",5 out of 5,1988-01-01,Evidence at protein level
A8K2U0,A2ML1_HUMAN,Alpha-2-macroglobulin-like protein 1 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 9),1454,"161,107",5 out of 5,2008-02-05,Evidence at protein level
Q5T5F5,A4AS1_HUMAN,Uncharacterized protein ADAMTSL4-AS1 (ADAMTSL4 antisense RNA 1) (ADAMTSL4 antisense gene protein 1),129,"14,090",1 out of 5,2007-05-15,Evidence at transcript level
P31941,ABC3A_HUMAN,DNA dC->dU-editing enzyme APOBEC-3A (A3A) (EC 3.5.4.-) (Phorbolin-1),199,"23,012",5 out of 5,1993-07-01,Evidence at protein level
Q8WWZ7,ABCA5_HUMAN,ATP-binding cassette sub-family A member 5,1642,"186,508",5 out of 5,2006-10-03,Evidence at transcript level
Q4W5N1,ABCAB_HUMAN,Putative ATP-binding cassette sub-family A member 11,156,"17,479",2 out of 5,2008-07-22,Evidence at transcript level
Q86UK0,ABCAC_HUMAN,ATP-binding cassette sub-family A member 12 (ATP-binding cassette transporter 12) (ATP-binding cassette 12),2595,"293,237",5 out of 5,2004-08-16,Evidence at protein level
Q9BUJ0,ABHEA_HUMAN,Protein ABHD14A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14A) (Abhydrolase domain-containing protein 14A),271,"29,765",3 out of 5,2007-04-03,Evidence at transcript level
O95870,ABHGA_HUMAN,Protein ABHD16A (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 16A) (Abhydrolase domain-containing protein 16A) (HLA-B-associated transcript 5) (Protein G5),558,"63,243",4 out of 5,2002-10-10,Evidence at protein level
Q9P2A4,ABI3_HUMAN,ABI gene family member 3 (New molecule including SH3) (Nesh),366,"39,035",5 out of 5,2004-07-19,Evidence at protein level
Q9GZZ6,ACH10_HUMAN,Neuronal acetylcholine receptor subunit alpha-10 (Nicotinic acetylcholine receptor subunit alpha-10) (NACHR alpha-10),450,"49,705",5 out of 5,2001-07-11,Evidence at protein level
P43681,ACHA4_HUMAN,Neuronal acetylcholine receptor subunit alpha-4,627,"69,957",5 out of 5,1995-11-01,Evidence at protein level
P17787,ACHB2_HUMAN,Neuronal acetylcholine receptor subunit beta-2,502,"57,019",5 out of 5,1990-08-01,Evidence at protein level
P30926,ACHB4_HUMAN,Neuronal acetylcholine receptor subunit beta-4,498,"56,380",5 out of 5,1993-07-01,Evidence at protein level
Q5JWF8,ACL10_HUMAN,Actin-like protein 10,245,"26,751",1 out of 5,2006-04-18,Evidence at transcript level
Q8TDX5,ACMSD_HUMAN,2-amino-3-carboxymuconate-6-semialdehyde decarboxylase (EC 4.1.1.45) (Picolinate carboxylase),336,"38,035",5 out of 5,2003-10-24,Evidence at protein level
Q8N1Q8,ACO15_HUMAN,Acyl-coenzyme A thioesterase THEM5 (Acyl-CoA thioesterase THEM5) (EC 3.1.2.2) (Acyl-coenzyme A thioesterase 15) (Thioesterase superfamily member 5),247,"27,677",5 out of 5,2007-04-17,Evidence at protein level
Q8N9L9,ACOT4_HUMAN,Acyl-coenzyme A thioesterase 4 (Acyl-CoA thioesterase 4) (EC 3.1.2.2) (PTE-2b) (Peroxisomal acyl coenzyme A thioester hydrolase Ib) (Peroxisomal long-chain acyl-CoA thioesterase Ib) (PTE-Ib),421,"46,327",5 out of 5,2004-07-19,Evidence at protein level
Q9Y305,ACOT9_HUMAN,"Acyl-coenzyme A thioesterase 9, mitochondrial (Acyl-CoA thioesterase 9) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 9)",439,"49,902",4 out of 5,2000-12-08,Evidence at protein level
Q15067,ACOX1_HUMAN,Peroxisomal acyl-coenzyme A oxidase 1 (AOX) (EC 1.3.3.6) (Palmitoyl-CoA oxidase) (Straight-chain acyl-CoA oxidase) (SCOX),660,"74,424",5 out of 5,1997-11-01,Evidence at protein level
Q68CK6,ACS2B_HUMAN,"Acyl-coenzyme A synthetase ACSM2B, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 2B) (Butyrate--CoA ligase 2B) (Butyryl-coenzyme A synthetase 2B) (Middle-chain acyl-CoA synthetase 2B) (Xenobiotic/medium-chain fatty acid-CoA ligase HXM-A)",577,"64,271",5 out of 5,2007-10-02,Evidence at protein level
Q53FZ2,ACSM3_HUMAN,"Acyl-coenzyme A synthetase ACSM3, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 3) (Butyrate--CoA ligase 3) (Butyryl-coenzyme A synthetase 3) (Middle-chain acyl-CoA synthetase 3) (Protein SA homolog)",586,"66,153",5 out of 5,2007-10-02,Evidence at protein level
P31946,1433B_HUMAN,"14-3-3 protein beta/alpha (Protein 1054) (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein beta/alpha, N-terminally processed]",246,"28,082",5 out of 5,1993-07-01,Evidence at protein level
P62258,1433E_HUMAN,14-3-3 protein epsilon (14-3-3E),255,"29,174",5 out of 5,2004-07-05,Evidence at protein level
P31947,1433S_HUMAN,14-3-3 protein sigma (Epithelial cell marker protein 1) (Stratifin),248,"27,774",5 out of 5,1993-07-01,Evidence at protein level
Q95604,1C17_HUMAN,"HLA class I histocompatibility antigen, Cw-17 alpha chain (MHC class I antigen Cw*17)",372,"41,238",5 out of 5,2003-08-29,Evidence at protein level
Q15173,2A5B_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit beta isoform (PP2A B subunit isoform B'-beta) (PP2A B subunit isoform B56-beta) (PP2A B subunit isoform PR61-beta) (PP2A B subunit isoform R5-beta),497,"57,393",5 out of 5,2000-05-30,Evidence at protein level
Q9Y2T4,2ABG_HUMAN,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B gamma isoform (IMYPNO1) (PP2A subunit B isoform B55-gamma) (PP2A subunit B isoform PR55-gamma) (PP2A subunit B isoform R2-gamma) (PP2A subunit B isoform gamma),447,"51,515",5 out of 5,2000-05-30,Evidence at protein level
P01912,2B13_HUMAN,"HLA class II histocompatibility antigen, DRB1-3 chain (Clone P2-beta-3) (MHC class II antigen DRB1*3)",266,"30,120",5 out of 5,1986-07-21,Evidence at protein level
P13761,2B17_HUMAN,"HLA class II histocompatibility antigen, DRB1-7 beta chain (MHC class II antigen DRB1*7) (DR-7) (DR7)",266,"29,822",5 out of 5,1990-01-01,Evidence at protein level
P29372,3MG_HUMAN,DNA-3-methyladenine glycosylase (EC 3.2.2.21) (3-alkyladenine DNA glycosylase) (3-methyladenine DNA glycosidase) (ADPG) (N-methylpurine-DNA glycosylase),298,"32,869",5 out of 5,1992-12-01,Evidence at protein level
P08195,4F2_HUMAN,4F2 cell-surface antigen heavy chain (4F2hc) (4F2 heavy chain antigen) (Lymphocyte activation antigen 4F2 large subunit) (Solute carrier family 3 member 2) (CD antigen CD98),630,"67,994",5 out of 5,1988-08-01,Evidence at protein level
P36639,8ODP_HUMAN,"7,8-dihydro-8-oxoguanine triphosphatase (EC 3.6.1.55) (2-hydroxy-dATP diphosphatase) (EC 3.6.1.56) (8-oxo-dGTPase) (Nucleoside diphosphate-linked moiety X motif 1) (Nudix motif 1)",197,"22,520",5 out of 5,1994-06-01,Evidence at protein level
P01023,A2MG_HUMAN,Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5),1474,"163,291",5 out of 5,1986-07-21,Evidence at protein level
Q9NPC4,A4GAT_HUMAN,"Lactosylceramide 4-alpha-galactosyltransferase (EC 2.4.1.228) (Alpha-1,4-N-acetylglucosaminyltransferase) (Alpha-1,4-galactosyltransferase) (Alpha4Gal-T1) (CD77 synthase) (Globotriaosylceramide synthase) (Gb3 synthase) (P1/Pk synthase) (UDP-galactose:beta-D-galactosyl-beta1-R 4-alpha-D-galactosyltransferase)",353,"40,499",5 out of 5,2002-11-25,Evidence at transcript level
Q9NS82,AAA1_HUMAN,Asc-type amino acid transporter 1 (Asc-1) (Solute carrier family 7 member 10),523,"56,798",5 out of 5,2002-11-15,Evidence at transcript level
Q9UH17,ABC3B_HUMAN,DNA dC->dU-editing enzyme APOBEC-3B (A3B) (EC 3.5.4.-) (Phorbolin-1-related protein) (Phorbolin-2/3),382,"45,924",5 out of 5,2001-01-11,Evidence at protein level
Q8IUX4,ABC3F_HUMAN,DNA dC->dU-editing enzyme APOBEC-3F (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3F) (A3F),373,"45,020",5 out of 5,2004-03-29,Evidence at protein level
Q8WWZ4,ABCAA_HUMAN,ATP-binding cassette sub-family A member 10,1543,"175,790",4 out of 5,2006-10-17,Evidence at transcript level
Q86UQ4,ABCAD_HUMAN,ATP-binding cassette sub-family A member 13,5058,"576,159",5 out of 5,2006-10-17,Evidence at transcript level
Q9NUT2,ABCB8_HUMAN,"ATP-binding cassette sub-family B member 8, mitochondrial (Mitochondrial ATP-binding cassette 1) (M-ABC1)",735,"79,989",5 out of 5,2001-02-21,Evidence at protein level
Q9NUQ8,ABCF3_HUMAN,ATP-binding cassette sub-family F member 3,709,"79,745",4 out of 5,2006-09-05,Evidence at protein level
Q0P651,ABD18_HUMAN,Protein ABHD18 (Alpha/beta hydrolase domain-containing protein 18) (Abhydrolase domain-containing protein 18),414,"46,954",3 out of 5,2007-09-11,Evidence at transcript level
O94929,ABLM3_HUMAN,Actin-binding LIM protein 3 (abLIM-3) (Actin-binding LIM protein family member 3),683,"77,802",5 out of 5,2004-12-07,Evidence at protein level
Q9ULW3,ABT1_HUMAN,Activator of basal transcription 1 (hABT1) (Basal transcriptional activator),272,"31,079",5 out of 5,2006-05-02,Evidence at protein level
Q96AP0,ACD_HUMAN,Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein),544,"57,733",5 out of 5,2006-05-30,Evidence at protein level
Q9BYF1,ACE2_HUMAN,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (ACE-related carboxypeptidase) (Angiotensin-converting enzyme homolog) (ACEH) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2],805,"92,463",5 out of 5,2005-08-02,Evidence at protein level
P02708,ACHA_HUMAN,Acetylcholine receptor subunit alpha,482,"54,546",5 out of 5,1986-07-21,Evidence at protein level
P07510,ACHG_HUMAN,Acetylcholine receptor subunit gamma,517,"57,883",5 out of 5,1988-04-01,Evidence at protein level
Q9Y614,ACL7B_HUMAN,Actin-like protein 7B (Actin-like-7-beta),415,"45,234",2 out of 5,2003-01-27,Evidence at transcript level
Q86TX2,ACOT1_HUMAN,Acyl-coenzyme A thioesterase 1 (Acyl-CoA thioesterase 1) (EC 3.1.2.2) (CTE-I) (CTE-Ib) (Inducible cytosolic acyl-coenzyme A thioester hydrolase) (Long chain acyl-CoA thioester hydrolase) (Long chain acyl-CoA hydrolase),421,"46,277",5 out of 5,2004-07-19,Evidence at protein level
O14734,ACOT8_HUMAN,Acyl-coenzyme A thioesterase 8 (Acyl-CoA thioesterase 8) (EC 3.1.2.27) (Choloyl-coenzyme A thioesterase) (HIV-Nef-associated acyl-CoA thioesterase) (PTE-2) (Peroxisomal acyl-coenzyme A thioester hydrolase 1) (PTE-1) (Peroxisomal long-chain acyl-CoA thioesterase 1) (Thioesterase II) (hACTE-III) (hACTEIII) (hTE),319,"35,914",5 out of 5,2001-06-01,Evidence at protein level
Q99424,ACOX2_HUMAN,"Peroxisomal acyl-coenzyme A oxidase 2 (EC 1.17.99.3) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA 24-hydroxylase) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanoyl-CoA oxidase) (Trihydroxycoprostanoyl-CoA oxidase) (THCA-CoA oxidase) (THCCox)",681,"76,827",5 out of 5,2001-11-02,Evidence at protein level
O60239,3BP5_HUMAN,SH3 domain-binding protein 5 (SH3BP-5) (SH3 domain-binding protein that preferentially associates with BTK),455,"50,425",5 out of 5,2002-01-23,Evidence at protein level
O60516,4EBP3_HUMAN,Eukaryotic translation initiation factor 4E-binding protein 3 (4E-BP3) (eIF4E-binding protein 3),100,"10,873",4 out of 5,2003-09-19,Evidence at protein level
Q9H0P0,5NT3A_HUMAN,Cytosolic 5'-nucleotidase 3A (EC 3.1.3.5) (7-methylguanosine phosphate-specific 5'-nucleotidase) (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3) (Cytosolic 5'-nucleotidase III) (cN-III) (Pyrimidine 5'-nucleotidase 1) (P5'N-1) (P5N-1) (PN-I) (Uridine 5'-monophosphate hydrolase 1) (p36),336,"37,948",5 out of 5,2005-09-13,Evidence at protein level
P21589,5NTD_HUMAN,5'-nucleotidase (5'-NT) (EC 3.1.3.5) (Ecto-5'-nucleotidase) (CD antigen CD73),574,"63,368",5 out of 5,1991-05-01,Evidence at protein level
P05408,7B2_HUMAN,Neuroendocrine protein 7B2 (Pituitary polypeptide) (Secretogranin V) (Secretogranin-5) (Secretory granule endocrine protein I) [Cleaved into: N-terminal peptide; C-terminal peptide],212,"23,730",5 out of 5,1986-07-21,Evidence at protein level
P0DKL9,A14EL_HUMAN,ARL14 effector protein-like,152,"17,712",1 out of 5,2012-10-03,Predicted
Q9NQ94,A1CF_HUMAN,APOBEC1 complementation factor (APOBEC1-stimulating protein),594,"65,202",5 out of 5,2005-12-20,Evidence at protein level
Q5SQ80,A20A2_HUMAN,Ankyrin repeat domain-containing protein 20A2,823,"94,087",1 out of 5,2006-06-27,Predicted
A0PJZ0,A20A5_HUMAN,Putative ankyrin repeat domain-containing protein 20A5 (Ankyrin repeat domain-containing protein 20A5 pseudogene),165,"18,446",2 out of 5,2008-09-02,Uncertain
P54646,AAPK2_HUMAN,5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31),552,"62,320",5 out of 5,1996-10-01,Evidence at protein level
Q8IZY2,ABCA7_HUMAN,ATP-binding cassette sub-family A member 7 (ABCA-SSN) (Autoantigen SS-N) (Macrophage ABC transporter),2146,"234,350",5 out of 5,2006-10-03,Evidence at protein level
Q2M3G0,ABCB5_HUMAN,ATP-binding cassette sub-family B member 5 (ABCB5 P-gp) (P-glycoprotein ABCB5),1257,"138,641",5 out of 5,2006-10-17,Evidence at protein level
O75027,ABCB7_HUMAN,"ATP-binding cassette sub-family B member 7, mitochondrial (ATP-binding cassette transporter 7) (ABC transporter 7 protein)",752,"82,641",5 out of 5,1998-12-15,Evidence at protein level
Q9NRK6,ABCBA_HUMAN,"ATP-binding cassette sub-family B member 10, mitochondrial (ATP-binding cassette transporter 10) (ABC transporter 10 protein) (Mitochondrial ATP-binding cassette 2) (M-ABC2)",738,"79,148",5 out of 5,2002-08-02,Evidence at protein level
Q09428,ABCC8_HUMAN,ATP-binding cassette sub-family C member 8 (Sulfonylurea receptor 1),1581,"176,992",5 out of 5,1995-11-01,Evidence at protein level
P33897,ABCD1_HUMAN,ATP-binding cassette sub-family D member 1 (Adrenoleukodystrophy protein) (ALDP),745,"82,937",5 out of 5,1994-02-01,Evidence at protein level
Q9H221,ABCG8_HUMAN,ATP-binding cassette sub-family G member 8 (Sterolin-2),673,"75,679",5 out of 5,2001-12-05,Evidence at protein level
P08910,ABHD2_HUMAN,Monoacylglycerol lipase ABHD2 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 2) (Lung alpha/beta hydrolase 2) (Protein PHPS1-2),425,"48,315",5 out of 5,1988-11-01,Evidence at protein level
Q9BV23,ABHD6_HUMAN,Monoacylglycerol lipase ABHD6 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 6),337,"38,331",5 out of 5,2007-03-20,Evidence at protein level
Q7L211,ABHDD_HUMAN,Protein ABHD13 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 13) (Abhydrolase domain-containing protein 13),337,"38,548",3 out of 5,2007-03-20,Evidence at transcript level
Q8N0Z2,ABRA_HUMAN,Actin-binding Rho-activating protein (Striated muscle activator of Rho-dependent signaling) (STARS),381,"43,117",3 out of 5,2006-07-25,Evidence at transcript level
P45954,ACDSB_HUMAN,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial (SBCAD) (EC 1.3.8.5) (2-methyl branched chain acyl-CoA dehydrogenase) (2-MEBCAD) (2-methylbutyryl-coenzyme A dehydrogenase) (2-methylbutyryl-CoA dehydrogenase)",432,"47,485",5 out of 5,1995-11-01,Evidence at protein level
P12821,ACE_HUMAN,"Angiotensin-converting enzyme (ACE) (EC 3.2.1.-) (EC 3.4.15.1) (Dipeptidyl carboxypeptidase I) (Kininase II) (CD antigen CD143) [Cleaved into: Angiotensin-converting enzyme, soluble form]",1306,"149,715",5 out of 5,1989-10-01,Evidence at protein level
Q16570,ACKR1_HUMAN,Atypical chemokine receptor 1 (Duffy antigen/chemokine receptor) (Fy glycoprotein) (GpFy) (Glycoprotein D) (Plasmodium vivax receptor) (CD antigen CD234),336,"35,553",5 out of 5,1997-11-01,Evidence at protein level
P25106,ACKR3_HUMAN,Atypical chemokine receptor 3 (C-X-C chemokine receptor type 7) (CXC-R7) (CXCR-7) (Chemokine orphan receptor 1) (G-protein coupled receptor 159) (G-protein coupled receptor RDC1 homolog) (RDC-1),362,"41,493",5 out of 5,1992-05-01,Evidence at protein level
O94805,ACL6B_HUMAN,Actin-like protein 6B (53 kDa BRG1-associated factor B) (Actin-related protein Baf53b) (ArpNalpha) (BRG1-associated factor 53B) (BAF53B),426,"46,877",5 out of 5,2002-09-19,Evidence at protein level
Q8WXI4,ACO11_HUMAN,Acyl-coenzyme A thioesterase 11 (Acyl-CoA thioesterase 11) (EC 3.1.2.-) (Acyl-CoA thioester hydrolase 11) (Adipose-associated thioesterase) (Brown fat-inducible thioesterase) (BFIT),607,"68,492",5 out of 5,2002-06-06,Evidence at protein level
O00767,ACOD_HUMAN,Acyl-CoA desaturase (EC 1.14.19.1) (Delta(9)-desaturase) (Delta-9 desaturase) (Fatty acid desaturase) (Stearoyl-CoA desaturase) (hSCD1),359,"41,523",5 out of 5,1998-07-15,Evidence at protein level
Q04917,1433F_HUMAN,14-3-3 protein eta (Protein AS1),246,"28,219",5 out of 5,1993-10-01,Evidence at protein level
P61981,1433G_HUMAN,"14-3-3 protein gamma (Protein kinase C inhibitor protein 1) (KCIP-1) [Cleaved into: 14-3-3 protein gamma, N-terminally processed]",247,"28,303",5 out of 5,2004-06-07,Evidence at protein level
P30447,1A23_HUMAN,"HLA class I histocompatibility antigen, A-23 alpha chain (HLA class I histocompatibility antigen, A-9 alpha chain) (MHC class I antigen A*23)",365,"40,733",5 out of 5,1993-04-01,Evidence at protein level
P05534,1A24_HUMAN,"HLA class I histocompatibility antigen, A-24 alpha chain (Aw-24) (HLA class I histocompatibility antigen, A-9 alpha chain) (MHC class I antigen A*24)",365,"40,689",5 out of 5,1988-11-01,Evidence at protein level
P16189,1A31_HUMAN,"HLA class I histocompatibility antigen, A-31 alpha chain (MHC class I antigen A*31)",365,"41,004",5 out of 5,1990-04-01,Evidence at protein level
Q31612,1B73_HUMAN,"HLA class I histocompatibility antigen, B-73 alpha chain (MHC class I antigen B*73)",363,"40,435",5 out of 5,2003-08-22,Evidence at protein level
Q9TNN7,1C05_HUMAN,"HLA class I histocompatibility antigen, Cw-5 alpha chain (MHC class I antigen Cw*5)",366,"40,912",5 out of 5,2003-08-22,Evidence at protein level
P30505,1C08_HUMAN,"HLA class I histocompatibility antigen, Cw-8 alpha chain (MHC class I antigen Cw*8)",366,"40,773",5 out of 5,1993-04-01,Evidence at protein level
Q07000,1C15_HUMAN,"HLA class I histocompatibility antigen, Cw-15 alpha chain (MHC class I antigen Cw*15)",366,"40,863",5 out of 5,1994-06-01,Evidence at protein level
Q16537,2A5E_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit epsilon isoform (PP2A B subunit isoform B'-epsilon) (PP2A B subunit isoform B56-epsilon) (PP2A B subunit isoform PR61-epsilon) (PP2A B subunit isoform R5-epsilon),467,"54,699",5 out of 5,2000-05-30,Evidence at protein level
P63151,2ABA_HUMAN,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform (PP2A subunit B isoform B55-alpha) (PP2A subunit B isoform PR55-alpha) (PP2A subunit B isoform R2-alpha) (PP2A subunit B isoform alpha),447,"51,692",5 out of 5,2004-09-27,Evidence at protein level
P78314,3BP2_HUMAN,SH3 domain-binding protein 2 (3BP-2),561,"62,244",5 out of 5,1998-07-15,Evidence at protein level
Q13542,4EBP2_HUMAN,Eukaryotic translation initiation factor 4E-binding protein 2 (4E-BP2) (eIF4E-binding protein 2),120,"12,939",5 out of 5,2003-09-19,Evidence at protein level
P28222,5HT1B_HUMAN,5-hydroxytryptamine receptor 1B (5-HT-1B) (5-HT1B) (S12) (Serotonin 1D beta receptor) (5-HT-1D-beta) (Serotonin receptor 1B),390,"43,568",5 out of 5,1992-12-01,Evidence at protein level
Q8WXA8,5HT3C_HUMAN,5-hydroxytryptamine receptor 3C (5-HT3-C) (5-HT3C) (Serotonin receptor 3C),447,"50,220",4 out of 5,2008-01-15,Evidence at protein level
A5X5Y0,5HT3E_HUMAN,5-hydroxytryptamine receptor 3E (5-HT3-E) (5-HT3E) (Serotonin receptor 3E),456,"51,438",5 out of 5,2007-12-04,Evidence at protein level
P56378,68MP_HUMAN,6.8 kDa mitochondrial proteolipid,58,"6,662",3 out of 5,1998-07-15,Evidence at protein level
Q8NAA4,A16L2_HUMAN,Autophagy-related protein 16-2 (APG16-like 2) (WD repeat-containing protein 80),619,"68,998",3 out of 5,2008-05-20,Evidence at protein level
P01009,A1AT_HUMAN,Alpha-1-antitrypsin (Alpha-1 protease inhibitor) (Alpha-1-antiproteinase) (Serpin A1) [Cleaved into: Short peptide from AAT (SPAAT)],418,"46,737",5 out of 5,1986-07-21,Evidence at protein level
Q5VUR7,A20A3_HUMAN,Ankyrin repeat domain-containing protein 20A3,823,"94,108",1 out of 5,2006-06-27,Predicted
Q86V21,AACS_HUMAN,Acetoacetyl-CoA synthetase (EC 6.2.1.16) (Acyl-CoA synthetase family member 1) (Protein sur-5 homolog),672,"75,144",5 out of 5,2008-01-15,Evidence at protein level
Q9UGJ0,AAKG2_HUMAN,5'-AMP-activated protein kinase subunit gamma-2 (AMPK gamma2) (AMPK subunit gamma-2) (H91620p),569,"63,066",5 out of 5,2001-06-01,Evidence at protein level
P42684,ABL2_HUMAN,Abelson tyrosine-protein kinase 2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),1182,"128,343",5 out of 5,1995-11-01,Evidence at protein level
O00763,ACACB_HUMAN,Acetyl-CoA carboxylase 2 (EC 6.4.1.2) (ACC-beta) [Includes: Biotin carboxylase (EC 6.3.4.14)],2458,"276,541",5 out of 5,1997-11-01,Evidence at protein level
Q9H845,ACAD9_HUMAN,"Acyl-CoA dehydrogenase family member 9, mitochondrial (ACAD-9) (EC 1.3.99.-)",621,"68,760",5 out of 5,2003-07-03,Evidence at protein level
P11310,ACADM_HUMAN,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial (MCAD) (EC 1.3.8.7)",421,"46,588",5 out of 5,1989-07-01,Evidence at protein level
Q96P50,ACAP3_HUMAN,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3 (Centaurin-beta-5) (Cnt-b5)",834,"92,495",3 out of 5,2003-01-27,Evidence at protein level
Q5T8D3,ACBD5_HUMAN,Acyl-CoA-binding domain-containing protein 5,534,"60,092",5 out of 5,2007-05-15,Evidence at protein level
P07108,ACBP_HUMAN,Acyl-CoA-binding protein (ACBP) (Diazepam-binding inhibitor) (DBI) (Endozepine) (EP),87,"10,044",5 out of 5,1988-04-01,Evidence at protein level
Q15822,ACHA2_HUMAN,Neuronal acetylcholine receptor subunit alpha-2,529,"59,765",5 out of 5,1997-11-01,Evidence at protein level
P30532,ACHA5_HUMAN,Neuronal acetylcholine receptor subunit alpha-5,468,"53,054",5 out of 5,1993-04-01,Evidence at protein level
P36544,ACHA7_HUMAN,Neuronal acetylcholine receptor subunit alpha-7,502,"56,449",5 out of 5,1994-06-01,Evidence at protein level
P11230,ACHB_HUMAN,Acetylcholine receptor subunit beta,501,"56,698",5 out of 5,1989-07-01,Evidence at protein level
Q9UKV3,ACINU_HUMAN,Apoptotic chromatin condensation inducer in the nucleus (Acinus),1341,"151,862",5 out of 5,2003-02-28,Evidence at protein level
P63104,1433Z_HUMAN,14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1),245,"27,745",5 out of 5,2004-09-13,Evidence at protein level
P01892,1A02_HUMAN,"HLA class I histocompatibility antigen, A-2 alpha chain (MHC class I antigen A*2)",365,"40,922",5 out of 5,1986-07-21,Evidence at protein level
Q96QU6,1A1L1_HUMAN,1-aminocyclopropane-1-carboxylate synthase-like protein 1 (ACC synthase-like protein 1),501,"57,324",4 out of 5,2008-02-05,Evidence at protein level
P18462,1A25_HUMAN,"HLA class I histocompatibility antigen, A-25 alpha chain (HLA class I histocompatibility antigen, A-10 alpha chain) (MHC class I antigen A*25)",365,"41,218",5 out of 5,1990-11-01,Evidence at protein level
P16188,1A30_HUMAN,"HLA class I histocompatibility antigen, A-30 alpha chain (MHC class I antigen A*30)",365,"40,905",5 out of 5,1990-04-01,Evidence at protein level
P30455,1A36_HUMAN,"HLA class I histocompatibility antigen, A-36 alpha chain (Aw-36) (MHC class I antigen A*36)",365,"40,934",5 out of 5,1993-04-01,Evidence at protein level
P01891,1A68_HUMAN,"HLA class I histocompatibility antigen, A-68 alpha chain (Aw-68) (HLA class I histocompatibility antigen, A-28 alpha chain) (MHC class I antigen A*68)",365,"40,909",5 out of 5,1986-07-21,Evidence at protein level
P30466,1B18_HUMAN,"HLA class I histocompatibility antigen, B-18 alpha chain (MHC class I antigen B*18)",362,"40,275",5 out of 5,1993-04-01,Evidence at protein level
P30685,1B35_HUMAN,"HLA class I histocompatibility antigen, B-35 alpha chain (MHC class I antigen B*35)",362,"40,455",5 out of 5,1993-04-01,Evidence at protein level
P30484,1B46_HUMAN,"HLA class I histocompatibility antigen, B-46 alpha chain (Bw-46) (MHC class I antigen B*46)",362,"40,440",5 out of 5,1993-04-01,Evidence at protein level
Q29940,1B59_HUMAN,"HLA class I histocompatibility antigen, B-59 alpha chain (MHC class I antigen B*59)",362,"40,584",5 out of 5,2003-08-22,Evidence at protein level
P30498,1B78_HUMAN,"HLA class I histocompatibility antigen, B-78 alpha chain (MHC class I antigen B*78)",362,"40,478",5 out of 5,1993-04-01,Evidence at protein level
P30499,1C01_HUMAN,"HLA class I histocompatibility antigen, Cw-1 alpha chain (MHC class I antigen Cw*1)",366,"40,965",5 out of 5,1993-04-01,Evidence at protein level
P10321,1C07_HUMAN,"HLA class I histocompatibility antigen, Cw-7 alpha chain (MHC class I antigen Cw*7)",366,"40,649",5 out of 5,1989-07-01,Evidence at protein level
Q9H2F3,3BHS7_HUMAN,"3 beta-hydroxysteroid dehydrogenase type 7 (3 beta-hydroxysteroid dehydrogenase type VII) (3-beta-HSD VII) (3-beta-hydroxy-Delta(5)-C27 steroid oxidoreductase) (C(27) 3-beta-HSD) (EC 1.1.1.-) (Cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase) (EC 1.1.1.181)",369,"41,016",5 out of 5,2004-05-24,Evidence at protein level
P04217,A1BG_HUMAN,Alpha-1B-glycoprotein (Alpha-1-B glycoprotein),495,"54,254",5 out of 5,1987-03-20,Evidence at protein level
Q15758,AAAT_HUMAN,Neutral amino acid transporter B(0) (ATB(0)) (Baboon M7 virus receptor) (RD114/simian type D retrovirus receptor) (Sodium-dependent neutral amino acid transporter type 2) (Solute carrier family 1 member 5),541,"56,598",5 out of 5,1998-07-15,Evidence at protein level
O43741,AAKB2_HUMAN,5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2),272,"30,302",5 out of 5,1998-12-15,Evidence at protein level
Q9BTE6,AASD1_HUMAN,Alanyl-tRNA editing protein Aarsd1 (Alanyl-tRNA synthetase domain-containing protein 1),412,"45,480",4 out of 5,2007-02-06,Evidence at protein level
Q6PCB6,AB17C_HUMAN,Protein ABHD17C (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 17C) (Abhydrolase domain-containing protein 17C),329,"35,831",2 out of 5,2007-08-21,Evidence at transcript level
Q8IUA7,ABCA9_HUMAN,ATP-binding cassette sub-family A member 9,1624,"184,362",5 out of 5,2006-10-03,Evidence at protein level
Q9NP58,ABCB6_HUMAN,"ATP-binding cassette sub-family B member 6, mitochondrial (Mitochondrial ABC transporter 3) (Mt-ABC transporter 3) (P-glycoprotein-related protein) (Ubiquitously-expressed mammalian ABC half transporter)",842,"93,886",5 out of 5,2001-02-21,Evidence at protein level
O14678,ABCD4_HUMAN,ATP-binding cassette sub-family D member 4 (PMP70-related protein) (P70R) (Peroxisomal membrane protein 1-like) (PXMP1-L) (Peroxisomal membrane protein 69) (PMP69),606,"68,597",5 out of 5,2000-05-30,Evidence at protein level
Q8NE71,ABCF1_HUMAN,ATP-binding cassette sub-family F member 1 (ATP-binding cassette 50) (TNF-alpha-stimulated ABC protein),845,"95,926",5 out of 5,2004-12-07,Evidence at protein level
P45844,ABCG1_HUMAN,ATP-binding cassette sub-family G member 1 (ATP-binding cassette transporter 8) (White protein homolog),678,"75,592",5 out of 5,1995-11-01,Evidence at protein level
Q9UNQ0,ABCG2_HUMAN,ATP-binding cassette sub-family G member 2 (Breast cancer resistance protein) (CDw338) (Mitoxantrone resistance-associated protein) (Placenta-specific ATP-binding cassette transporter) (Urate exporter) (CD antigen CD338),655,"72,314",5 out of 5,2001-01-24,Evidence at protein level
Q8N2K0,ABD12_HUMAN,Monoacylglycerol lipase ABHD12 (EC 3.1.1.23) (2-arachidonoylglycerol hydrolase) (Abhydrolase domain-containing protein 12),398,"45,097",5 out of 5,2003-11-28,Evidence at protein level
Q6H8Q1,ABLM2_HUMAN,Actin-binding LIM protein 2 (abLIM-2) (Actin-binding LIM protein family member 2),611,"67,812",5 out of 5,2004-12-07,Evidence at protein level
Q8N961,ABTB2_HUMAN,Ankyrin repeat and BTB/POZ domain-containing protein 2,1025,"113,656",3 out of 5,2005-02-01,Evidence at transcript level
P27348,1433T_HUMAN,14-3-3 protein theta (14-3-3 protein T-cell) (14-3-3 protein tau) (Protein HS1),245,"27,764",5 out of 5,1992-08-01,Evidence at protein level
P30453,1A34_HUMAN,"HLA class I histocompatibility antigen, A-34 alpha chain (Aw-34) (HLA class I histocompatibility antigen, A-10 alpha chain) (MHC class I antigen A*34)",365,"41,055",5 out of 5,1993-04-01,Evidence at protein level
P30461,1B13_HUMAN,"HLA class I histocompatibility antigen, B-13 alpha chain (MHC class I antigen B*13)",362,"40,474",5 out of 5,1993-04-01,Evidence at protein level
P18463,1B37_HUMAN,"HLA class I histocompatibility antigen, B-37 alpha chain (MHC class I antigen B*37)",362,"40,456",5 out of 5,1990-11-01,Evidence at protein level
Q04826,1B40_HUMAN,"HLA class I histocompatibility antigen, B-40 alpha chain (Bw-60) (MHC class I antigen B*40)",362,"40,505",5 out of 5,1993-10-01,Evidence at protein level
P30480,1B42_HUMAN,"HLA class I histocompatibility antigen, B-42 alpha chain (MHC class I antigen B*42)",362,"40,333",5 out of 5,1993-04-01,Evidence at protein level
P30487,1B49_HUMAN,"HLA class I histocompatibility antigen, B-49 alpha chain (HLA class I histocompatibility antigen, B-21 alpha chain) (MHC class I antigen B*49)",362,"40,581",5 out of 5,1993-04-01,Evidence at protein level
P30490,1B52_HUMAN,"HLA class I histocompatibility antigen, B-52 alpha chain (Bw-52) (HLA class I histocompatibility antigen, B-5 alpha chain) (MHC class I antigen B*52)",362,"40,521",5 out of 5,1993-04-01,Evidence at protein level
P30492,1B54_HUMAN,"HLA class I histocompatibility antigen, B-54 alpha chain (Bw-22) (Bw-54) (MHC class I antigen B*54)",362,"40,380",5 out of 5,1993-04-01,Evidence at protein level
P30495,1B56_HUMAN,"HLA class I histocompatibility antigen, B-56 alpha chain (Bw-22) (Bw-56) (MHC class I antigen B*56)",362,"40,478",5 out of 5,1993-04-01,Evidence at protein level
P30508,1C12_HUMAN,"HLA class I histocompatibility antigen, Cw-12 alpha chain (MHC class I antigen Cw*12)",366,"40,886",5 out of 5,1993-04-01,Evidence at protein level
P20039,2B1B_HUMAN,"HLA class II histocompatibility antigen, DRB1-11 beta chain (DR-5) (DR5) (DRw11) (MHC class II antigen DRB1*11)",266,"30,160",5 out of 5,1991-02-01,Evidence at protein level
Q9GIY3,2B1E_HUMAN,"HLA class II histocompatibility antigen, DRB1-14 beta chain (MHC class II antigen DRB1*14) (DR-14) (DR14)",266,"30,139",5 out of 5,2010-03-23,Evidence at protein level
Q5TYW2,A20A1_HUMAN,Ankyrin repeat domain-containing protein 20A1,823,"94,048",2 out of 5,2006-06-27,Evidence at transcript level
P05067,A4_HUMAN,Amyloid beta A4 protein (ABPP) (APPI) (APP) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Beta-amyloid precursor protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99; Beta-amyloid protein 42 (Beta-APP42); Beta-amyloid protein 40 (Beta-APP40); C83; P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31],770,"86,943",5 out of 5,1987-08-13,Evidence at protein level
P30542,AA1R_HUMAN,Adenosine receptor A1,326,"36,512",5 out of 5,1993-04-01,Evidence at protein level
P86434,AAS1_HUMAN,Putative uncharacterized protein ADORA2A-AS1 (ADORA2A antisense RNA 1) (ADORA2A antisense gene protein 1),159,"17,238",2 out of 5,2010-02-09,Uncertain
Q7Z5M8,AB12B_HUMAN,Protein ABHD12B (EC 3.-.-.-) (Abhydrolase domain-containing protein 12B) (Alpha/beta hydrolase domain-containing protein 12B),362,"40,776",3 out of 5,2004-07-05,Evidence at transcript level
Q7Z5R6,AB1IP_HUMAN,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein (APBB1-interacting protein 1) (Proline-rich EVH1 ligand 1) (PREL-1) (Proline-rich protein 73) (Rap1-GTP-interacting adapter molecule) (RIAM) (Retinoic acid-responsive proline-rich protein 1) (RARP-1),666,"73,183",5 out of 5,2005-11-22,Evidence at protein level
O60706,ABCC9_HUMAN,ATP-binding cassette sub-family C member 9 (Sulfonylurea receptor 2),1549,"174,223",5 out of 5,2001-09-26,Evidence at protein level
Q9NSE7,ABCCD_HUMAN,Putative ATP-binding cassette sub-family C member 13,274,"30,831",3 out of 5,2002-06-20,Evidence at transcript level
P28288,ABCD3_HUMAN,ATP-binding cassette sub-family D member 3 (70 kDa peroxisomal membrane protein) (PMP70),659,"75,476",5 out of 5,1992-12-01,Evidence at protein level
Q9H172,ABCG4_HUMAN,ATP-binding cassette sub-family G member 4,646,"71,896",5 out of 5,2001-12-05,Evidence at protein level
Q9H222,ABCG5_HUMAN,ATP-binding cassette sub-family G member 5 (Sterolin-1),651,"72,504",5 out of 5,2001-12-05,Evidence at protein level
Q96IU4,ABHEB_HUMAN,Protein ABHD14B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 14B) (Abhydrolase domain-containing protein 14B) (CCG1-interacting factor B),210,"22,346",5 out of 5,2003-08-22,Evidence at protein level
Q9H3Z7,ABHGB_HUMAN,Protein ABHD16B (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 16B) (Abhydrolase domain-containing protein 16B),469,"52,555",2 out of 5,2002-10-10,Inferred from homology
Q9NYB9,ABI2_HUMAN,Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1),513,"55,663",5 out of 5,2004-07-19,Evidence at protein level
P00519,ABL1_HUMAN,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),1130,"122,873",5 out of 5,1986-07-21,Evidence at protein level
Q9P1F3,ABRAL_HUMAN,Costars family protein ABRACL (ABRA C-terminal-like protein),81,"9,056",2 out of 5,2003-11-07,Evidence at protein level
Q12979,ABR_HUMAN,Active breakpoint cluster region-related protein,859,"97,598",5 out of 5,1999-07-15,Evidence at transcript level
O00400,ACATN_HUMAN,Acetyl-coenzyme A transporter 1 (AT-1) (Acetyl-CoA transporter 1) (Solute carrier family 33 member 1),549,"60,909",5 out of 5,2005-12-20,Evidence at protein level
Q5FVE4,ACBG2_HUMAN,Long-chain-fatty-acid--CoA ligase ACSBG2 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 2) (Bubblegum-related protein) (PRTD-NY3),666,"74,354",5 out of 5,2008-01-15,Evidence at protein level
Q13362,2A5G_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform (PP2A B subunit isoform B'-gamma) (PP2A B subunit isoform B56-gamma) (PP2A B subunit isoform PR61-gamma) (PP2A B subunit isoform R5-gamma) (Renal carcinoma antigen NY-REN-29),524,"61,061",5 out of 5,2000-05-30,Evidence at protein level
P30154,2AAB_HUMAN,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A beta isoform (PP2A subunit A isoform PR65-beta) (PP2A subunit A isoform R1-beta),601,"66,214",5 out of 5,1993-04-01,Evidence at protein level
Q29974,2B1G_HUMAN,"HLA class II histocompatibility antigen, DRB1-16 beta chain (MHC class II antigen DRB1*16) (DR-16) (DR16)",266,"30,030",5 out of 5,2010-03-02,Evidence at protein level
P28566,5HT1E_HUMAN,5-hydroxytryptamine receptor 1E (5-HT-1E) (5-HT1E) (S31) (Serotonin receptor 1E),365,"41,682",5 out of 5,1992-12-01,Evidence at protein level
P41595,5HT2B_HUMAN,5-hydroxytryptamine receptor 2B (5-HT-2B) (5-HT2B) (Serotonin receptor 2B),481,"54,298",5 out of 5,1995-11-01,Evidence at protein level
Q70Z44,5HT3D_HUMAN,5-hydroxytryptamine receptor 3D (5-HT3-D) (5-HT3D) (Serotonin receptor 3D),454,"50,191",5 out of 5,2007-12-04,Evidence at protein level
P34969,5HT7R_HUMAN,5-hydroxytryptamine receptor 7 (5-HT-7) (5-HT7) (5-HT-X) (Serotonin receptor 7),479,"53,555",5 out of 5,1994-02-01,Evidence at protein level
Q96P26,5NT1B_HUMAN,Cytosolic 5'-nucleotidase 1B (cN1B) (EC 3.1.3.5) (Autoimmune infertility-related protein) (Cytosolic 5'-nucleotidase IB) (cN-IB),610,"68,804",5 out of 5,2004-05-10,Evidence at transcript level
Q969T7,5NT3B_HUMAN,7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase),300,"34,389",5 out of 5,2008-04-08,Evidence at protein level
O95336,6PGL_HUMAN,6-phosphogluconolactonase (6PGL) (EC 3.1.1.31),258,"27,547",4 out of 5,2000-05-30,Evidence at protein level
Q676U5,A16L1_HUMAN,Autophagy-related protein 16-1 (APG16-like 1),607,"68,265",5 out of 5,2005-04-12,Evidence at protein level
P02750,A2GL_HUMAN,Leucine-rich alpha-2-glycoprotein (LRG),347,"38,178",5 out of 5,1986-07-21,Evidence at protein level
A7E2S9,A30BL_HUMAN,Putative ankyrin repeat domain-containing protein 30B-like,258,"28,549",2 out of 5,2008-06-10,Evidence at transcript level
Q9UNA3,A4GCT_HUMAN,"Alpha-1,4-N-acetylglucosaminyltransferase (Alpha4GnT) (EC 2.4.1.-)",340,"39,497",5 out of 5,2002-11-25,Evidence at transcript level
P0DMS8,AA3R_HUMAN,Adenosine receptor A3,318,"36,185",5 out of 5,2015-04-01,Evidence at transcript level
Q9Y478,AAKB1_HUMAN,5'-AMP-activated protein kinase subunit beta-1 (AMPK subunit beta-1) (AMPKb),270,"30,382",5 out of 5,2001-06-01,Evidence at protein level
P54619,AAKG1_HUMAN,5'-AMP-activated protein kinase subunit gamma-1 (AMPK gamma1) (AMPK subunit gamma-1) (AMPKg),331,"37,579",5 out of 5,1996-10-01,Evidence at protein level
Q9UGI9,AAKG3_HUMAN,5'-AMP-activated protein kinase subunit gamma-3 (AMPK gamma3) (AMPK subunit gamma-3),489,"54,258",5 out of 5,2001-06-01,Evidence at protein level
Q13685,AAMP_HUMAN,Angio-associated migratory cell protein,434,"46,751",5 out of 5,1998-07-15,Evidence at protein level
Q9NRW3,ABC3C_HUMAN,DNA dC->dU-editing enzyme APOBEC-3C (A3C) (EC 3.5.4.-) (APOBEC1-like) (Phorbolin I),190,"22,826",5 out of 5,2004-03-29,Evidence at protein level
Q9BZC7,ABCA2_HUMAN,ATP-binding cassette sub-family A member 2 (ATP-binding cassette transporter 2) (ATP-binding cassette 2),2435,"269,873",5 out of 5,2001-07-11,Evidence at protein level
Q99758,ABCA3_HUMAN,ATP-binding cassette sub-family A member 3 (ABC-C transporter) (ATP-binding cassette transporter 3) (ATP-binding cassette 3),1704,"191,362",5 out of 5,2000-05-30,Evidence at protein level
P78363,ABCA4_HUMAN,Retinal-specific ATP-binding cassette transporter (ATP-binding cassette sub-family A member 4) (RIM ABC transporter) (RIM protein) (RmP) (Stargardt disease protein),2273,"255,944",5 out of 5,2000-05-30,Evidence at protein level
O94911,ABCA8_HUMAN,ATP-binding cassette sub-family A member 8,1581,"179,245",5 out of 5,2006-10-03,Evidence at protein level
Q9NP78,ABCB9_HUMAN,ATP-binding cassette sub-family B member 9 (ATP-binding cassette transporter 9) (ABC transporter 9 protein) (hABCB9) (TAP-like protein) (TAPL),766,"84,475",5 out of 5,2002-08-02,Evidence at protein level
O95342,ABCBB_HUMAN,Bile salt export pump (ATP-binding cassette sub-family B member 11),1321,"146,407",5 out of 5,2001-01-24,Evidence at protein level
Q96J66,ABCCB_HUMAN,ATP-binding cassette sub-family C member 11 (Multidrug resistance-associated protein 8),1382,"154,301",5 out of 5,2006-03-07,Evidence at protein level
Q9UBJ2,ABCD2_HUMAN,ATP-binding cassette sub-family D member 2 (Adrenoleukodystrophy-like 1) (Adrenoleukodystrophy-related protein) (hALDR),740,"83,233",5 out of 5,2001-01-24,Evidence at protein level
Q8TB40,ABHD4_HUMAN,Protein ABHD4 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 4) (Abhydrolase domain-containing protein 4) (Alpha/beta-hydrolase 4) (Lyso-N-acylphosphatidylethanolamine lipase),342,"38,794",3 out of 5,2005-09-27,Evidence at transcript level
Q96I13,ABHD8_HUMAN,Protein ABHD8 (EC 3.-.-.-) (Alpha/beta hydrolase domain-containing protein 8) (Abhydrolase domain-containing protein 8),439,"47,331",2 out of 5,2007-03-20,Evidence at transcript level
P13746,1A11_HUMAN,"HLA class I histocompatibility antigen, A-11 alpha chain (MHC class I antigen A*11)",365,"40,937",5 out of 5,1990-01-01,Evidence at protein level
Q4AC99,1A1L2_HUMAN,Probable inactive 1-aminocyclopropane-1-carboxylate synthase-like protein 2 (ACC synthase-like protein 2),568,"65,249",2 out of 5,2008-05-20,Evidence at transcript level
P30450,1A26_HUMAN,"HLA class I histocompatibility antigen, A-26 alpha chain (MHC class I antigen A*26)",365,"41,062",5 out of 5,1993-04-01,Evidence at protein level
P30457,1A66_HUMAN,"HLA class I histocompatibility antigen, A-66 alpha chain (Aw-66) (HLA class I histocompatibility antigen, A-10 alpha chain) (MHC class I antigen A*66)",365,"41,082",5 out of 5,1993-04-01,Evidence at protein level
P30459,1A74_HUMAN,"HLA class I histocompatibility antigen, A-74 alpha chain (Aw-19) (Aw-74) (MHC class I antigen A*74)",365,"40,891",5 out of 5,1993-04-01,Evidence at protein level
P30475,1B39_HUMAN,"HLA class I histocompatibility antigen, B-39 alpha chain (MHC class I antigen B*39)",362,"40,328",5 out of 5,1993-04-01,Evidence at protein level
P30479,1B41_HUMAN,"HLA class I histocompatibility antigen, B-41 alpha chain (Bw-41) (MHC class I antigen B*41)",362,"40,539",5 out of 5,1993-04-01,Evidence at protein level
P30481,1B44_HUMAN,"HLA class I histocompatibility antigen, B-44 alpha chain (Bw-44) (MHC class I antigen B*44)",362,"40,481",5 out of 5,1993-04-01,Evidence at protein level
P30486,1B48_HUMAN,"HLA class I histocompatibility antigen, B-48 alpha chain (Bw-48) (MHC class I antigen B*48)",362,"40,362",5 out of 5,1993-04-01,Evidence at protein level
P18464,1B51_HUMAN,"HLA class I histocompatibility antigen, B-51 alpha chain (MHC class I antigen B*51)",362,"40,566",5 out of 5,1990-11-01,Evidence at protein level
P30491,1B53_HUMAN,"HLA class I histocompatibility antigen, B-53 alpha chain (Bw-53) (MHC class I antigen B*53)",362,"40,495",5 out of 5,1993-04-01,Evidence at protein level
P18465,1B57_HUMAN,"HLA class I histocompatibility antigen, B-57 alpha chain (Bw-57) (MHC class I antigen B*57)",362,"40,224",5 out of 5,1990-11-01,Evidence at protein level
Q29960,1C16_HUMAN,"HLA class I histocompatibility antigen, Cw-16 alpha chain (MHC class I antigen Cw*16)",366,"40,753",5 out of 5,2003-08-22,Evidence at protein level
Q14738,2A5D_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit delta isoform (PP2A B subunit isoform B'-delta) (PP2A B subunit isoform B56-delta) (PP2A B subunit isoform PR61-delta) (PP2A B subunit isoform R5-delta),602,"69,992",5 out of 5,2000-05-30,Evidence at protein level
P30153,2AAA_HUMAN,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform (Medium tumor antigen-associated 61 kDa protein) (PP2A subunit A isoform PR65-alpha) (PP2A subunit A isoform R1-alpha),589,"65,309",5 out of 5,1993-04-01,Evidence at protein level
P04229,2B11_HUMAN,"HLA class II histocompatibility antigen, DRB1-1 beta chain (MHC class II antigen DRB1*1) (DR-1) (DR1)",266,"29,914",5 out of 5,1987-03-20,Evidence at protein level
P01911,2B1F_HUMAN,"HLA class II histocompatibility antigen, DRB1-15 beta chain (DW2.2/DR2.2) (MHC class II antigen DRB1*15)",266,"29,966",5 out of 5,1986-07-21,Evidence at protein level
Q9NRA8,4ET_HUMAN,Eukaryotic translation initiation factor 4E transporter (4E-T) (eIF4E transporter) (Eukaryotic translation initiation factor 4E nuclear import factor 1),985,"108,201",5 out of 5,2002-08-02,Evidence at protein level
P28221,5HT1D_HUMAN,5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin 1D alpha receptor) (5-HT-1D-alpha) (Serotonin receptor 1D),377,"41,907",5 out of 5,1992-12-01,Evidence at protein level
P30939,5HT1F_HUMAN,5-hydroxytryptamine receptor 1F (5-HT-1F) (5-HT1F) (Serotonin receptor 1F),366,"41,709",5 out of 5,1993-07-01,Evidence at transcript level
P46098,5HT3A_HUMAN,5-hydroxytryptamine receptor 3A (5-HT3-A) (5-HT3A) (5-hydroxytryptamine receptor 3) (5-HT-3) (5-HT3R) (Serotonin receptor 3A) (Serotonin-gated ion channel receptor),478,"55,280",5 out of 5,1995-11-01,Evidence at protein level
Q13639,5HT4R_HUMAN,5-hydroxytryptamine receptor 4 (5-HT-4) (5-HT4) (Serotonin receptor 4),388,"43,761",5 out of 5,1997-11-01,Evidence at protein level
P50406,5HT6R_HUMAN,5-hydroxytryptamine receptor 6 (5-HT-6) (5-HT6) (Serotonin receptor 6),440,"46,954",5 out of 5,1996-10-01,Evidence at protein level
P20848,A1ATR_HUMAN,Putative alpha-1-antitrypsin-related protein (Protease inhibitor 1-like) (Serpin A2),420,"47,891",5 out of 5,1991-02-01,Evidence at protein level
Q96GX2,A7L3B_HUMAN,Putative ataxin-7-like protein 3B,97,"10,771",2 out of 5,2010-03-23,Inferred from homology
P29274,AA2AR_HUMAN,Adenosine receptor A2a,412,"44,707",5 out of 5,1992-12-01,Evidence at protein level
P29275,AA2BR_HUMAN,Adenosine receptor A2b,332,"36,333",5 out of 5,1992-12-01,Evidence at transcript level
P22760,AAAD_HUMAN,Arylacetamide deacetylase (EC 3.1.1.3),399,"45,734",5 out of 5,1991-08-01,Evidence at protein level
P01011,AACT_HUMAN,Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less],423,"47,651",5 out of 5,1986-07-21,Evidence at protein level
Q8N5Z0,AADAT_HUMAN,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (KAT/AadAT) (2-aminoadipate aminotransferase) (2-aminoadipate transaminase) (EC 2.6.1.39) (Alpha-aminoadipate aminotransferase) (AadAT) (Kynurenine aminotransferase II) (Kynurenine--oxoglutarate aminotransferase II) (Kynurenine--oxoglutarate transaminase 2) (EC 2.6.1.7) (Kynurenine--oxoglutarate transaminase II)",425,"47,352",5 out of 5,2004-04-13,Evidence at protein level
Q6PD74,AAGAB_HUMAN,Alpha- and gamma-adaptin-binding protein p34,315,"34,594",5 out of 5,2005-03-29,Evidence at protein level
Q13131,AAPK1_HUMAN,5'-AMP-activated protein kinase catalytic subunit alpha-1 (AMPK subunit alpha-1) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (EC 2.7.11.27) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) (Tau-protein kinase PRKAA1) (EC 2.7.11.26),559,"64,009",5 out of 5,1998-07-15,Evidence at protein level
Q9Y312,AAR2_HUMAN,Protein AAR2 homolog (AAR2 splicing factor homolog),384,"43,472",2 out of 5,2002-10-19,Evidence at protein level
Q8NHS2,AATC2_HUMAN,"Putative aspartate aminotransferase, cytoplasmic 2 (EC 2.6.1.-) (Glutamate oxaloacetate transaminase 1-like protein 1) (Transaminase A-like protein 1)",421,"47,305",3 out of 5,2008-05-20,Evidence at transcript level
Q9NY61,AATF_HUMAN,Protein AATF (Apoptosis-antagonizing transcription factor) (Rb-binding protein Che-1),560,"63,133",5 out of 5,2005-07-19,Evidence at protein level
P00505,AATM_HUMAN,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)",430,"47,518",5 out of 5,1986-07-21,Evidence at protein level
Q96AK3,ABC3D_HUMAN,DNA dC->dU-editing enzyme APOBEC-3D (A3D) (EC 3.5.4.-),386,"46,598",5 out of 5,2004-03-29,Evidence at protein level
Q9HC16,ABC3G_HUMAN,DNA dC->dU-editing enzyme APOBEC-3G (EC 3.5.4.-) (APOBEC-related cytidine deaminase) (APOBEC-related protein) (ARCD) (APOBEC-related protein 9) (ARP-9) (CEM-15) (CEM15) (Deoxycytidine deaminase) (A3G),384,"46,408",5 out of 5,2004-03-01,Evidence at protein level
P04439,1A03_HUMAN,"HLA class I histocompatibility antigen, A-3 alpha chain (MHC class I antigen A*3)",365,"40,841",5 out of 5,1987-08-13,Evidence at protein level
Q29865,1C18_HUMAN,"HLA class I histocompatibility antigen, Cw-18 alpha chain (MHC class I antigen Cw*18)",366,"40,933",5 out of 5,2003-08-22,Evidence at protein level
Q15172,2A5A_HUMAN,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform (PP2A B subunit isoform B'-alpha) (PP2A B subunit isoform B56-alpha) (PP2A B subunit isoform PR61-alpha) (PR61alpha) (PP2A B subunit isoform R5-alpha),486,"56,194",5 out of 5,2000-05-30,Evidence at protein level
Q9NRG9,AAAS_HUMAN,Aladin (Adracalin),546,"59,574",5 out of 5,2002-03-27,Evidence at protein level
Q4LEZ3,AARD_HUMAN,Alanine and arginine-rich domain-containing protein,155,"17,575",2 out of 5,2008-05-20,Evidence at transcript level
Q9UDR5,AASS_HUMAN,"Alpha-aminoadipic semialdehyde synthase, mitochondrial (LKR/SDH) [Includes: Lysine ketoglutarate reductase (LKR) (LOR) (EC 1.5.1.8); Saccharopine dehydrogenase (SDH) (EC 1.5.1.9)]",926,"102,132",5 out of 5,2004-04-13,Evidence at protein level
P17174,AATC_HUMAN,"Aspartate aminotransferase, cytoplasmic (cAspAT) (EC 2.6.1.1) (EC 2.6.1.3) (Cysteine aminotransferase, cytoplasmic) (Cysteine transaminase, cytoplasmic) (cCAT) (Glutamate oxaloacetate transaminase 1) (Transaminase A)",413,"46,248",5 out of 5,1990-08-01,Evidence at protein level
O14639,ABLM1_HUMAN,Actin-binding LIM protein 1 (abLIM-1) (Actin-binding LIM protein family member 1) (Actin-binding double zinc finger protein) (LIMAB1) (Limatin),778,"87,688",5 out of 5,2004-12-07,Evidence at protein level
Q13085,ACACA_HUMAN,Acetyl-CoA carboxylase 1 (ACC1) (EC 6.4.1.2) (ACC-alpha) [Includes: Biotin carboxylase (EC 6.3.4.14)],2346,"265,554",5 out of 5,1997-11-01,Evidence at protein level
Q8NC06,ACBD4_HUMAN,Acyl-CoA-binding domain-containing protein 4,268,"30,308",4 out of 5,2005-06-07,Evidence at protein level
Q9BR61,ACBD6_HUMAN,Acyl-CoA-binding domain-containing protein 6,282,"31,151",4 out of 5,2006-04-18,Evidence at protein level
Q96GR2,ACBG1_HUMAN,Long-chain-fatty-acid--CoA ligase ACSBG1 (EC 6.2.1.3) (Acyl-CoA synthetase bubblegum family member 1) (hBG1) (hsBG) (hsBGM) (Lipidosin),724,"81,290",5 out of 5,2008-01-15,Evidence at transcript level
Q05901,ACHB3_HUMAN,Neuronal acetylcholine receptor subunit beta-3,458,"52,729",5 out of 5,1994-06-01,Evidence at transcript level
Q04844,ACHE_HUMAN,Acetylcholine receptor subunit epsilon,493,"54,697",5 out of 5,1994-02-01,Evidence at protein level
Q9NPB9,ACKR4_HUMAN,Atypical chemokine receptor 4 (C-C chemokine receptor type 11) (C-C CKR-11) (CC-CKR-11) (CCR-11) (CC chemokine receptor-like 1) (CCRL1) (CCX CKR),350,"39,914",5 out of 5,2001-06-01,Evidence at protein level
Q9NPJ3,ACO13_HUMAN,"Acyl-coenzyme A thioesterase 13 (Acyl-CoA thioesterase 13) (EC 3.1.2.-) (Thioesterase superfamily member 2) [Cleaved into: Acyl-coenzyme A thioesterase 13, N-terminally processed]",140,"14,960",5 out of 5,2002-09-19,Evidence at protein level
P21399,ACOC_HUMAN,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),889,"98,399",5 out of 5,1991-05-01,Evidence at protein level
Q08AH3,ACS2A_HUMAN,"Acyl-coenzyme A synthetase ACSM2A, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 2A) (Butyrate--CoA ligase 2A) (Butyryl-coenzyme A synthetase 2A) (Middle-chain acyl-CoA synthetase 2A)",577,"64,223",5 out of 5,2007-10-02,Evidence at protein level
Q9BYX7,ACTBM_HUMAN,Putative beta-actin-like protein 3 (Kappa-actin) (POTE ankyrin domain family member K),375,"42,016",4 out of 5,2007-10-23,Uncertain
Q8NER5,ACV1C_HUMAN,Activin receptor type-1C (EC 2.7.11.30) (Activin receptor type IC) (ACTR-IC) (Activin receptor-like kinase 7) (ALK-7),493,"54,871",5 out of 5,2005-10-25,Evidence at protein level
P45381,ACY2_HUMAN,Aspartoacylase (EC 3.5.1.15) (Aminoacylase-2) (ACY-2),313,"35,735",5 out of 5,1995-11-01,Evidence at protein level
O75078,ADA11_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 11 (ADAM 11) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein) (MDC)",769,"83,418",5 out of 5,2001-06-01,Evidence at transcript level
Q9H2U9,ADAM7_HUMAN,Disintegrin and metalloproteinase domain-containing protein 7 (ADAM 7) (Sperm maturation-related glycoprotein GP-83),754,"85,669",5 out of 5,2002-01-31,Evidence at protein level
Q86TW2,ADCK1_HUMAN,Uncharacterized aarF domain-containing protein kinase 1 (EC 2.7.11.-),530,"60,577",4 out of 5,2006-10-03,Evidence at transcript level
Q3MIX3,ADCK5_HUMAN,Uncharacterized aarF domain-containing protein kinase 5 (EC 2.7.11.-),580,"65,897",3 out of 5,2007-01-09,Evidence at protein level
O43306,ADCY6_HUMAN,Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase),1168,"130,615",5 out of 5,1999-07-15,Evidence at protein level
P40145,ADCY8_HUMAN,Adenylate cyclase type 8 (EC 4.6.1.1) (ATP pyrophosphate-lyase 8) (Adenylate cyclase type VIII) (Adenylyl cyclase 8) (AC8) (Ca(2+)/calmodulin-activated adenylyl cyclase),1251,"140,122",5 out of 5,1995-02-01,Evidence at protein level
Q15848,ADIPO_HUMAN,"Adiponectin (30 kDa adipocyte complement-related protein) (Adipocyte complement-related 30 kDa protein) (ACRP30) (Adipocyte, C1q and collagen domain-containing protein) (Adipose most abundant gene transcript 1 protein) (apM-1) (Gelatin-binding protein)",244,"26,414",5 out of 5,1997-11-01,Evidence at protein level
Q96A54,ADR1_HUMAN,Adiponectin receptor protein 1 (Progestin and adipoQ receptor family member I),375,"42,616",5 out of 5,2003-11-14,Evidence at protein level
P13945,ADRB3_HUMAN,Beta-3 adrenergic receptor (Beta-3 adrenoreceptor) (Beta-3 adrenoceptor),408,"43,519",5 out of 5,1990-01-01,Evidence at protein level
P43652,AFAM_HUMAN,Afamin (Alpha-albumin) (Alpha-Alb),599,"69,069",5 out of 5,1995-11-01,Evidence at protein level
Q9Y4W6,AFG32_HUMAN,AFG3-like protein 2 (EC 3.4.24.-) (Paraplegin-like protein),797,"88,584",5 out of 5,2001-04-27,Evidence at protein level
Q96P64,AGAP4_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 4 (AGAP-4) (Centaurin-gamma-like family member 1) (Centaurin-gamma-like family member 5)",663,"73,070",3 out of 5,2007-04-17,Evidence at transcript level
P28223,5HT2A_HUMAN,5-hydroxytryptamine receptor 2A (5-HT-2) (5-HT-2A) (Serotonin receptor 2A),471,"52,603",5 out of 5,1992-12-01,Evidence at protein level
Q9BXI3,5NT1A_HUMAN,Cytosolic 5'-nucleotidase 1A (cN1A) (EC 3.1.3.5) (Cytosolic 5'-nucleotidase IA) (cN-I) (cN-IA),368,"41,021",5 out of 5,2004-05-10,Evidence at protein level
P49902,5NTC_HUMAN,Cytosolic purine 5'-nucleotidase (EC 3.1.3.5) (Cytosolic 5'-nucleotidase II),561,"64,970",5 out of 5,1996-10-01,Evidence at protein level
Q2M2I8,AAK1_HUMAN,AP2-associated protein kinase 1 (EC 2.7.11.1) (Adaptor-associated kinase 1),961,"103,885",5 out of 5,2006-10-03,Evidence at protein level
Q9H7C9,AAMDC_HUMAN,Mth938 domain-containing protein (Adipogenesis associated Mth938 domain-containing protein),122,"13,332",3 out of 5,2006-06-13,Evidence at protein level
Q9NUJ1,ABHDA_HUMAN,"Mycophenolic acid acyl-glucuronide esterase, mitochondrial (EC 3.1.1.93) (Alpha/beta hydrolase domain-containing protein 10) (Abhydrolase domain-containing protein 10)",306,"33,933",5 out of 5,2007-03-20,Evidence at protein level
Q9UKU7,ACAD8_HUMAN,"Isobutyryl-CoA dehydrogenase, mitochondrial (EC 1.3.99.-) (Activator-recruited cofactor 42 kDa component) (ARC42) (Acyl-CoA dehydrogenase family member 8) (ACAD-8)",415,"45,070",5 out of 5,2002-11-28,Evidence at protein level
P28330,ACADL_HUMAN,"Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8)",430,"47,656",5 out of 5,1992-12-01,Evidence at protein level
P16219,ACADS_HUMAN,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial (SCAD) (EC 1.3.8.1) (Butyryl-CoA dehydrogenase)",412,"44,297",5 out of 5,1990-04-01,Evidence at protein level
P49748,ACADV_HUMAN,"Very long-chain specific acyl-CoA dehydrogenase, mitochondrial (VLCAD) (EC 1.3.8.9)",655,"70,390",5 out of 5,1996-10-01,Evidence at protein level
Q15027,ACAP1_HUMAN,"Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 1 (Centaurin-beta-1) (Cnt-b1)",740,"81,536",5 out of 5,1998-07-15,Evidence at protein level
Q8N6N7,ACBD7_HUMAN,Acyl-CoA-binding domain-containing protein 7,88,"9,790",3 out of 5,2006-07-25,Evidence at protein level
Q709F0,ACD11_HUMAN,Acyl-CoA dehydrogenase family member 11 (ACAD-11) (EC 1.3.99.-),780,"87,283",5 out of 5,2006-10-31,Evidence at protein level
P11229,ACM1_HUMAN,Muscarinic acetylcholine receptor M1,460,"51,421",5 out of 5,1989-07-01,Evidence at protein level
P08173,ACM4_HUMAN,Muscarinic acetylcholine receptor M4,479,"53,049",5 out of 5,1988-08-01,Evidence at protein level
Q6ZNF0,ACP7_HUMAN,Acid phosphatase type 7 (EC 3.1.3.2) (Purple acid phosphatase long form),438,"50,480",3 out of 5,2008-02-05,Evidence at transcript level
Q8NEB7,ACRBP_HUMAN,Acrosin-binding protein (Cancer/testis antigen 23) (CT23) (Cancer/testis antigen OY-TES-1) (Proacrosin-binding protein sp32),543,"61,359",3 out of 5,2006-03-07,Evidence at transcript level
O95573,ACSL3_HUMAN,Long-chain-fatty-acid--CoA ligase 3 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 3) (LACS 3),720,"80,420",5 out of 5,2001-04-27,Evidence at protein level
P62736,ACTA_HUMAN,"Actin, aortic smooth muscle (Alpha-actin-2) (Cell growth-inhibiting gene 46 protein)",377,"42,009",5 out of 5,1986-10-23,Evidence at protein level
P60709,ACTB_HUMAN,"Actin, cytoplasmic 1 (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]",375,"41,737",5 out of 5,1986-07-21,Evidence at protein level
P63267,ACTH_HUMAN,"Actin, gamma-enteric smooth muscle (Alpha-actin-3) (Gamma-2-actin) (Smooth muscle gamma-actin)",376,"41,877",5 out of 5,2004-10-11,Evidence at protein level
Q08043,ACTN3_HUMAN,Alpha-actinin-3 (Alpha-actinin skeletal muscle isoform 3) (F-actin cross-linking protein),901,"103,241",5 out of 5,1995-02-01,Evidence at protein level
P61163,ACTZ_HUMAN,Alpha-centractin (Centractin) (ARP1) (Actin-RPV) (Centrosome-associated actin homolog),376,"42,614",5 out of 5,2004-05-10,Evidence at protein level
Q96HD9,ACY3_HUMAN,N-acyl-aromatic-L-amino acid amidohydrolase (carboxylate-forming) (EC 3.5.1.114) (Acylase III) (Aminoacylase-3) (ACY-3) (Aspartoacylase-2) (Hepatitis C virus core-binding protein 1) (HCBP1) (HCV core-binding protein 1),319,"35,241",5 out of 5,2003-08-29,Evidence at protein level
P14621,ACYP2_HUMAN,"Acylphosphatase-2 (EC 3.6.1.7) (Acylphosphatase, muscle type isozyme) (Acylphosphate phosphohydrolase 2)",99,"11,140",4 out of 5,1990-04-01,Evidence at protein level
P18825,ADA2C_HUMAN,Alpha-2C adrenergic receptor (Alpha-2 adrenergic receptor subtype C4) (Alpha-2C adrenoreceptor) (Alpha-2C adrenoceptor) (Alpha-2CAR),462,"49,522",5 out of 5,1990-11-01,Evidence at transcript level
Q8TC27,ADA32_HUMAN,Disintegrin and metalloproteinase domain-containing protein 32 (ADAM 32),787,"87,948",4 out of 5,2004-12-07,Evidence at protein level
Q9BZ11,ADA33_HUMAN,Disintegrin and metalloproteinase domain-containing protein 33 (ADAM 33) (EC 3.4.24.-),813,"87,739",5 out of 5,2002-03-27,Evidence at protein level
Q8NFM4,ADCY4_HUMAN,Adenylate cyclase type 4 (EC 4.6.1.1) (ATP pyrophosphate-lyase 4) (Adenylate cyclase type IV) (Adenylyl cyclase 4),1077,"119,794",5 out of 5,2002-11-08,Evidence at protein level
Q96PN6,ADCYA_HUMAN,Adenylate cyclase type 10 (EC 4.6.1.1) (AH-related protein) (Adenylate cyclase homolog) (Germ cell soluble adenylyl cyclase) (hsAC) (sAC) (Testicular soluble adenylyl cyclase),1610,"187,149",5 out of 5,2008-02-05,Evidence at protein level
Q8TDN7,ACER1_HUMAN,Alkaline ceramidase 1 (AlkCDase 1) (Alkaline CDase 1) (EC 3.5.1.23) (Acylsphingosine deacylase 3) (N-acylsphingosine amidohydrolase 3),264,"31,095",5 out of 5,2006-07-25,Evidence at transcript level
Q5QJU3,ACER2_HUMAN,Alkaline ceramidase 2 (AlkCDase 2) (Alkaline CDase 2) (haCER2) (EC 3.5.1.23) (Acylsphingosine deacylase 3-like) (N-acylsphingosine amidohydrolase 3-like),275,"31,309",5 out of 5,2006-07-25,Evidence at protein level
Q15825,ACHA6_HUMAN,Neuronal acetylcholine receptor subunit alpha-6,494,"56,898",5 out of 5,1997-11-01,Evidence at protein level
Q9UGM1,ACHA9_HUMAN,Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9),479,"54,807",5 out of 5,2001-04-27,Evidence at protein level
Q07001,ACHD_HUMAN,Acetylcholine receptor subunit delta,517,"58,895",5 out of 5,1994-06-01,Evidence at protein level
Q07912,ACK1_HUMAN,Activated CDC42 kinase 1 (ACK-1) (EC 2.7.10.2) (EC 2.7.11.1) (Tyrosine kinase non-receptor protein 2),1038,"114,569",5 out of 5,2003-10-24,Evidence at protein level
Q9ULC5,ACSL5_HUMAN,Long-chain-fatty-acid--CoA ligase 5 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 5) (LACS 5),683,"75,991",5 out of 5,2001-04-27,Evidence at protein level
Q8TDG2,ACTT1_HUMAN,Actin-related protein T1 (ARP-T1),376,"41,696",2 out of 5,2006-10-31,Evidence at transcript level
O43184,ADA12_HUMAN,Disintegrin and metalloproteinase domain-containing protein 12 (ADAM 12) (EC 3.4.24.-) (Meltrin-alpha),909,"99,542",5 out of 5,2000-05-30,Evidence at protein level
Q13444,ADA15_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 15 (ADAM 15) (EC 3.4.24.-) (Metalloprotease RGD disintegrin protein) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15) (MDC-15) (Metargidin)",863,"92,959",5 out of 5,2001-06-01,Evidence at protein level
P78536,ADA17_HUMAN,Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b),824,"93,021",5 out of 5,2001-06-20,Evidence at protein level
Q9UKF5,ADA29_HUMAN,Disintegrin and metalloproteinase domain-containing protein 29 (ADAM 29) (Cancer/testis antigen 73) (CT73),820,"92,759",5 out of 5,2001-06-20,Evidence at protein level
Q9UKF2,ADA30_HUMAN,Disintegrin and metalloproteinase domain-containing protein 30 (ADAM 30) (EC 3.4.24.-),790,"88,940",5 out of 5,2001-06-20,Evidence at protein level
Q6P093,ADCL2_HUMAN,Arylacetamide deacetylase-like 2 (EC 3.1.1.-),401,"46,099",3 out of 5,2008-01-15,Evidence at transcript level
O60503,ADCY9_HUMAN,Adenylate cyclase type 9 (EC 4.6.1.1) (ATP pyrophosphate-lyase 9) (Adenylate cyclase type IX) (ACIX) (Adenylyl cyclase 9) (AC9),1353,"150,701",5 out of 5,1999-07-15,Evidence at protein level
P55263,ADK_HUMAN,Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase),362,"40,545",5 out of 5,1996-10-01,Evidence at protein level
Q3LIE5,ADPRM_HUMAN,Manganese-dependent ADP-ribose/CDP-alcohol diphosphatase (EC 3.6.1.13) (EC 3.6.1.16) (EC 3.6.1.53) (ADPRibase-Mn) (CDP-choline phosphohydrolase),342,"39,529",5 out of 5,2007-05-15,Evidence at protein level
P08588,ADRB1_HUMAN,Beta-1 adrenergic receptor (Beta-1 adrenoreceptor) (Beta-1 adrenoceptor),477,"51,323",5 out of 5,1988-08-01,Evidence at protein level
P55196,AFAD_HUMAN,Afadin (ALL1-fused gene from chromosome 6 protein) (Protein AF-6) (Afadin adherens junction formation factor),1824,"206,804",5 out of 5,1996-10-01,Evidence at protein level
Q8N556,AFAP1_HUMAN,Actin filament-associated protein 1 (110 kDa actin filament-associated protein) (AFAP-110),730,"80,725",5 out of 5,2008-02-05,Evidence at protein level
Q5VUJ5,AGAP7_HUMAN,"Putative Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7 (AGAP-7) (Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 7 pseudogene) (Centaurin-gamma-like family member 4)",663,"73,211",3 out of 5,2007-04-17,Uncertain
P52594,AGFG1_HUMAN,Arf-GAP domain and FG repeat-containing protein 1 (HIV-1 Rev-binding protein) (Nucleoporin-like protein RIP) (Rev-interacting protein) (Rev/Rex activation domain-binding protein),562,"58,260",5 out of 5,1996-10-01,Evidence at protein level
Q9H0P7,AGIT1_HUMAN,Putative uncharacterized protein encoded by AGPAT4-IT1 (AGPAT4 intronic transcript 1),198,"20,949",2 out of 5,2003-05-09,Uncertain
Q00005,2ABB_HUMAN,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B beta isoform (PP2A subunit B isoform B55-beta) (PP2A subunit B isoform PR55-beta) (PP2A subunit B isoform R2-beta) (PP2A subunit B isoform beta),443,"51,710",5 out of 5,1993-04-01,Evidence at protein level
P13760,2B14_HUMAN,"HLA class II histocompatibility antigen, DRB1-4 beta chain (MHC class II antigen DRB1*4) (DR-4) (DR4)",266,"30,112",5 out of 5,1990-01-01,Evidence at protein level
P61221,ABCE1_HUMAN,ATP-binding cassette sub-family E member 1 (2'-5'-oligoadenylate-binding protein) (HuHP68) (RNase L inhibitor) (Ribonuclease 4 inhibitor) (RNS4I),599,"67,314",5 out of 5,2004-05-10,Evidence at protein level
Q9UG63,ABCF2_HUMAN,ATP-binding cassette sub-family F member 2 (Iron-inhibited ABC transporter 2),623,"71,290",4 out of 5,2001-01-24,Evidence at protein level
P41238,ABEC1_HUMAN,C->U-editing enzyme APOBEC-1 (EC 3.5.4.36) (Apolipoprotein B mRNA-editing enzyme 1) (HEPR) (mRNA(cytosine(6666)) deaminase 1),236,"28,192",5 out of 5,1995-02-01,Evidence at protein level
Q9Y235,ABEC2_HUMAN,C->U-editing enzyme APOBEC-2 (EC 3.5.4.36) (mRNA(cytosine(6666)) deaminase 2),224,"25,703",5 out of 5,2002-09-19,Evidence at protein level
Q8WW27,ABEC4_HUMAN,Putative C->U-editing enzyme APOBEC-4 (EC 3.5.4.-) (Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 4),367,"41,581",4 out of 5,2006-06-13,Evidence at transcript level
Q6JQN1,ACD10_HUMAN,Acyl-CoA dehydrogenase family member 10 (ACAD-10) (EC 1.3.99.-),1059,"118,834",5 out of 5,2007-04-17,Evidence at protein level
Q9NUN7,ACER3_HUMAN,Alkaline ceramidase 3 (AlkCDase 3) (Alkaline CDase 3) (EC 3.5.1.-) (Alkaline dihydroceramidase SB89) (Alkaline phytoceramidase) (aPHC),267,"31,552",5 out of 5,2001-08-14,Evidence at protein level
P32297,ACHA3_HUMAN,Neuronal acetylcholine receptor subunit alpha-3,505,"57,480",5 out of 5,1993-10-01,Evidence at protein level
P08172,ACM2_HUMAN,Muscarinic acetylcholine receptor M2,466,"51,715",5 out of 5,1988-08-01,Evidence at protein level
P08912,ACM5_HUMAN,Muscarinic acetylcholine receptor M5,532,"60,074",5 out of 5,1988-11-01,Evidence at transcript level
P49753,ACOT2_HUMAN,"Acyl-coenzyme A thioesterase 2, mitochondrial (Acyl-CoA thioesterase 2) (EC 3.1.2.2) (Acyl-coenzyme A thioester hydrolase 2a) (CTE-Ia) (Long-chain acyl-CoA thioesterase 2) (ZAP128)",483,"53,218",5 out of 5,1996-10-01,Evidence at protein level
O15254,ACOX3_HUMAN,Peroxisomal acyl-coenzyme A oxidase 3 (EC 1.3.3.6) (Branched-chain acyl-CoA oxidase) (BRCACox) (Pristanoyl-CoA oxidase),700,"77,629",5 out of 5,2001-11-02,Evidence at protein level
Q5T7M4,ADIPL_HUMAN,Adipolin (Adipose-derived insulin-sensitizing factor) (Complement C1q tumor necrosis factor-related protein 12) [Cleaved into: Adipolin fCTRP12 (Adipolin full-length form); Adipolin gCTRP12 (Adipolin cleaved form)],302,"32,416",5 out of 5,2007-04-17,Evidence at protein level
Q9Y2D8,ADIP_HUMAN,Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein),614,"71,236",5 out of 5,2004-10-11,Evidence at protein level
Q7Z4H4,ADM2_HUMAN,ADM2 (Intermedin) [Cleaved into: Adrenomedullin-2 (AM2) (Intermedin-long) (IMDL); Intermedin-short (IMDS)],148,"15,865",5 out of 5,2004-05-10,Evidence at transcript level
Q9NRN7,ADPPT_HUMAN,L-aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase (EC 2.7.8.-) (4'-phosphopantetheinyl transferase) (Alpha-aminoadipic semialdehyde dehydrogenase-phosphopantetheinyl transferase) (AASD-PPT) (LYS5 ortholog),309,"35,776",5 out of 5,2005-11-08,Evidence at protein level
P54922,ADPRH_HUMAN,[Protein ADP-ribosylarginine] hydrolase (ADP-ribosylarginine hydrolase) (EC 3.2.2.19) (ADP-ribose-L-arginine cleaving enzyme),357,"39,507",3 out of 5,1996-10-01,Evidence at protein level
Q5I7T1,AG10B_HUMAN,"Putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-B) (Asparagine-linked glycosylation protein 10 homolog B) (Potassium channel regulator 1)",473,"55,448",5 out of 5,2005-11-08,Evidence at protein level
A6NIR3,AGAP5_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5 (AGAP-5) (Centaurin-gamma-like family member 2)",686,"75,492",2 out of 5,2008-09-02,Evidence at transcript level
Q86SQ6,AGRA1_HUMAN,Adhesion G protein-coupled receptor A1 (G-protein coupled receptor 123),560,"60,885",4 out of 5,2004-04-13,Evidence at transcript level
P35869,AHR_HUMAN,Aryl hydrocarbon receptor (Ah receptor) (AhR) (Class E basic helix-loop-helix protein 76) (bHLHe76),848,"96,147",5 out of 5,1994-06-01,Evidence at protein level
Q719I0,AHSA2_HUMAN,Activator of 90 kDa heat shock protein ATPase homolog 2,299,"33,806",2 out of 5,2008-01-15,Evidence at protein level
P53396,ACLY_HUMAN,ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme),1101,"120,839",5 out of 5,1996-10-01,Evidence at protein level
Q99798,ACON_HUMAN,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase)",780,"85,425",5 out of 5,1997-11-01,Evidence at protein level
Q3I5F7,ACOT6_HUMAN,Putative acyl-coenzyme A thioesterase 6 (Putative acyl-CoA thioesterase 6) (EC 3.1.2.-),207,"22,991",3 out of 5,2007-10-02,Evidence at protein level
Q9NUZ1,ACOXL_HUMAN,Acyl-coenzyme A oxidase-like protein (Acyl-CoA oxidase-like protein) (EC 1.3.3.-),547,"61,795",3 out of 5,2007-10-02,Evidence at transcript level
O14561,ACPM_HUMAN,"Acyl carrier protein, mitochondrial (ACP) (CI-SDAP) (NADH-ubiquinone oxidoreductase 9.6 kDa subunit)",156,"17,417",5 out of 5,1999-07-15,Evidence at protein level
Q9NUB1,ACS2L_HUMAN,"Acetyl-coenzyme A synthetase 2-like, mitochondrial (EC 6.2.1.1) (Acetate--CoA ligase 2) (Acetyl-CoA synthetase 2) (AceCS2) (Acyl-CoA synthetase short-chain family member 1)",689,"74,857",5 out of 5,2003-04-23,Evidence at protein level
Q9NR19,ACSA_HUMAN,"Acetyl-coenzyme A synthetase, cytoplasmic (EC 6.2.1.1) (Acetate--CoA ligase) (Acetyl-CoA synthetase) (ACS) (AceCS) (Acyl-CoA synthetase short-chain family member 2) (Acyl-activating enzyme)",701,"78,580",5 out of 5,2002-04-03,Evidence at protein level
Q4G176,ACSF3_HUMAN,"Acyl-CoA synthetase family member 3, mitochondrial (EC 6.2.1.-)",576,"64,130",5 out of 5,2008-01-15,Evidence at protein level
P33121,ACSL1_HUMAN,Long-chain-fatty-acid--CoA ligase 1 (EC 6.2.1.3) (Acyl-CoA synthetase 1) (ACS1) (Long-chain acyl-CoA synthetase 1) (LACS 1) (Long-chain acyl-CoA synthetase 2) (LACS 2) (Long-chain fatty acid-CoA ligase 2) (Palmitoyl-CoA ligase 1) (Palmitoyl-CoA ligase 2),698,"77,943",5 out of 5,1993-10-01,Evidence at protein level
Q08AH1,ACSM1_HUMAN,"Acyl-coenzyme A synthetase ACSM1, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 1) (Butyrate--CoA ligase 1) (Butyryl-coenzyme A synthetase 1) (Lipoate-activating enzyme) (Middle-chain acyl-CoA synthetase 1)",577,"65,273",5 out of 5,2007-10-02,Evidence at protein level
P63261,ACTG_HUMAN,"Actin, cytoplasmic 2 (Gamma-actin) [Cleaved into: Actin, cytoplasmic 2, N-terminally processed]",375,"41,793",5 out of 5,1986-07-21,Evidence at protein level
Q9BYD9,ACTT3_HUMAN,Actin-related protein T3 (ARP-T3) (Actin-related protein M1),372,"41,008",2 out of 5,2004-05-10,Evidence at transcript level
Q8WTP8,AEN_HUMAN,Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1),325,"36,350",5 out of 5,2008-03-18,Evidence at protein level
Q13015,AF1Q_HUMAN,Protein AF1q,90,"10,061",5 out of 5,2000-05-30,Evidence at protein level
P42568,AF9_HUMAN,Protein AF-9 (ALL1-fused gene from chromosome 9 protein) (Myeloid/lymphoid or mixed-lineage leukemia translocated to chromosome 3 protein) (YEATS domain-containing protein 3),568,"63,351",5 out of 5,1995-11-01,Evidence at protein level
P06280,AGAL_HUMAN,Alpha-galactosidase A (EC 3.2.1.22) (Alpha-D-galactosidase A) (Alpha-D-galactoside galactohydrolase) (Melibiase) (Agalsidase),429,"48,767",5 out of 5,1988-01-01,Evidence at protein level
Q96PE1,AGRA2_HUMAN,Adhesion G protein-coupled receptor A2 (G-protein coupled receptor 124) (Tumor endothelial marker 5),1338,"142,647",5 out of 5,2004-04-13,Evidence at protein level
O60241,AGRB2_HUMAN,Adhesion G protein-coupled receptor B2 (Brain-specific angiogenesis inhibitor 2),1585,"172,656",5 out of 5,2000-12-01,Evidence at protein level
O60242,AGRB3_HUMAN,Adhesion G protein-coupled receptor B3 (Brain-specific angiogenesis inhibitor 3),1522,"171,518",5 out of 5,2000-12-01,Evidence at protein level
O14862,AIM2_HUMAN,Interferon-inducible protein AIM2 (Absent in melanoma 2),343,"38,954",5 out of 5,1999-07-15,Evidence at protein level
Q12904,AIMP1_HUMAN,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],312,"34,353",5 out of 5,2001-10-18,Evidence at protein level
Q495B1,AKD1A_HUMAN,Ankyrin repeat and death domain-containing protein 1A,522,"57,550",2 out of 5,2007-05-15,Evidence at transcript level
P31751,AKT2_HUMAN,RAC-beta serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-2) (Protein kinase B beta) (PKB beta) (RAC-PK-beta),481,"55,769",5 out of 5,1993-07-01,Evidence at protein level
Q92685,ALG3_HUMAN,"Dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase (EC 2.4.1.258) (Asparagine-linked glycosylation protein 3 homolog) (Dol-P-Man-dependent alpha(1-3)-mannosyltransferase) (Dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase) (Dolichyl-phosphate-mannose--glycolipid alpha-mannosyltransferase) (Not56-like protein)",438,"50,126",5 out of 5,1998-07-15,Evidence at protein level
O43707,ACTN4_HUMAN,Alpha-actinin-4 (Non-muscle alpha-actinin 4),911,"104,854",5 out of 5,2001-02-21,Evidence at protein level
Q04771,ACVR1_HUMAN,Activin receptor type-1 (EC 2.7.11.30) (Activin receptor type I) (ACTR-I) (Activin receptor-like kinase 2) (ALK-2) (Serine/threonine-protein kinase receptor R1) (SKR1) (TGF-B superfamily receptor type I) (TSR-I),509,"57,153",5 out of 5,1994-02-01,Evidence at protein level
Q03154,ACY1_HUMAN,Aminoacylase-1 (ACY-1) (EC 3.5.1.14) (N-acyl-L-amino-acid amidohydrolase),408,"45,885",5 out of 5,1994-02-01,Evidence at protein level
P07311,ACYP1_HUMAN,"Acylphosphatase-1 (EC 3.6.1.7) (Acylphosphatase, erythrocyte isozyme) (Acylphosphatase, organ-common type isozyme) (Acylphosphate phosphohydrolase 1)",99,"11,261",5 out of 5,1988-04-01,Evidence at protein level
Q9Y3Q7,ADA18_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 18 (ADAM 18) (Transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein III) (tMDC III)",739,"82,856",5 out of 5,2002-01-31,Evidence at transcript level
O43506,ADA20_HUMAN,Disintegrin and metalloproteinase domain-containing protein 20 (ADAM 20) (EC 3.4.24.-),726,"81,603",5 out of 5,2001-06-01,Evidence at transcript level
Q9P0K1,ADA22_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2)",906,"100,433",5 out of 5,2001-06-20,Evidence at protein level
O75077,ADA23_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 23 (ADAM 23) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 3) (MDC-3)",832,"91,926",5 out of 5,2004-12-07,Evidence at protein level
Q9UKQ2,ADA28_HUMAN,"Disintegrin and metalloproteinase domain-containing protein 28 (ADAM 28) (EC 3.4.24.-) (Epididymal metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (eMDC II) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein L) (MDC-L)",775,"87,148",5 out of 5,2001-06-20,Evidence at transcript level
P08913,ADA2A_HUMAN,Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR),450,"48,957",5 out of 5,1988-11-01,Evidence at protein level
Q8NCV1,ADAD2_HUMAN,Adenosine deaminase domain-containing protein 2 (Testis nuclear RNA-binding protein-like),583,"61,755",2 out of 5,2007-11-13,Evidence at transcript level
Q99965,ADAM2_HUMAN,Disintegrin and metalloproteinase domain-containing protein 2 (ADAM 2) (Cancer/testis antigen 15) (CT15) (Fertilin subunit beta) (PH-30) (PH30) (PH30-beta),735,"82,457",5 out of 5,2000-05-30,Evidence at transcript level
O75689,ADAP1_HUMAN,Arf-GAP with dual PH domain-containing protein 1 (Centaurin-alpha-1) (Cnt-a1) (Putative MAPK-activating protein PM25),374,"43,395",5 out of 5,2005-07-05,Evidence at protein level
Q9BUB4,ADAT1_HUMAN,tRNA-specific adenosine deaminase 1 (hADAT1) (EC 3.5.4.34) (tRNA-specific adenosine-37 deaminase),502,"55,392",5 out of 5,2007-05-15,Evidence at protein level
Q7Z6V5,ADAT2_HUMAN,tRNA-specific adenosine deaminase 2 (EC 3.5.4.-) (Deaminase domain-containing protein 1) (tRNA-specific adenosine-34 deaminase subunit ADAT2),191,"21,046",4 out of 5,2007-05-15,Evidence at protein level
P28332,ADH6_HUMAN,Alcohol dehydrogenase 6 (EC 1.1.1.1),368,"39,089",5 out of 5,1992-12-01,Evidence at protein level
Q86V24,ADR2_HUMAN,Adiponectin receptor protein 2 (Progestin and adipoQ receptor family member II),386,"43,884",5 out of 5,2003-11-14,Evidence at protein level
O95433,AHSA1_HUMAN,Activator of 90 kDa heat shock protein ATPase homolog 1 (AHA1) (p38),338,"38,274",5 out of 5,2001-02-21,Evidence at protein level
O95831,AIFM1_HUMAN,"Apoptosis-inducing factor 1, mitochondrial (EC 1.1.1.-) (Programmed cell death protein 8)",613,"66,901",5 out of 5,2001-04-27,Evidence at protein level
P14550,AK1A1_HUMAN,Alcohol dehydrogenase [NADP(+)] (EC 1.1.1.2) (Aldehyde reductase) (Aldo-keto reductase family 1 member A1),325,"36,573",5 out of 5,1990-01-01,Evidence at protein level
P52895,AK1C2_HUMAN,"Aldo-keto reductase family 1 member C2 (EC 1.-.-.-) (3-alpha-HSD3) (Chlordecone reductase homolog HAKRD) (Dihydrodiol dehydrogenase 2) (DD-2) (DD2) (Dihydrodiol dehydrogenase/bile acid-binding protein) (DD/BABP) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20) (Type III 3-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.357)",323,"36,735",5 out of 5,1996-10-01,Evidence at protein level
Q99996,AKAP9_HUMAN,A-kinase anchor protein 9 (AKAP-9) (A-kinase anchor protein 350 kDa) (AKAP 350) (hgAKAP 350) (A-kinase anchor protein 450 kDa) (AKAP 450) (AKAP 120-like protein) (Centrosome- and Golgi-localized PKN-associated protein) (CG-NAP) (Protein hyperion) (Protein kinase A-anchoring protein 9) (PRKA9) (Protein yotiao),3911,"453,667",5 out of 5,2001-06-01,Evidence at protein level
P47895,AL1A3_HUMAN,Aldehyde dehydrogenase family 1 member A3 (EC 1.2.1.5) (Aldehyde dehydrogenase 6) (Retinaldehyde dehydrogenase 3) (RALDH-3) (RalDH3),512,"56,108",5 out of 5,1996-02-01,Evidence at protein level
P48448,AL3B2_HUMAN,Aldehyde dehydrogenase family 3 member B2 (EC 1.2.1.5) (Aldehyde dehydrogenase 8),385,"42,635",5 out of 5,1996-02-01,Evidence at transcript level
Q6GMV1,ALG1L_HUMAN,Putative glycosyltransferase ALG1-like (EC 2.4.1.-),187,"21,132",2 out of 5,2008-03-18,Evidence at transcript level
Q6NS38,ALKB2_HUMAN,DNA oxidative demethylase ALKBH2 (EC 1.14.11.33) (Alkylated DNA repair protein alkB homolog 2) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2) (Oxy DC1),261,"29,322",5 out of 5,2006-05-30,Evidence at protein level
Q6P6C2,ALKB5_HUMAN,RNA demethylase ALKBH5 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 5) (Alpha-ketoglutarate-dependent dioxygenase alkB homolog 5),394,"44,256",5 out of 5,2006-05-30,Evidence at protein level
Q8N6M5,ALLC_HUMAN,Probable allantoicase (EC 3.5.3.4) (Allantoate amidinohydrolase),410,"45,750",3 out of 5,2005-09-13,Evidence at transcript level
Q96Q42,ALS2_HUMAN,Alsin (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 6 protein) (Amyotrophic lateral sclerosis 2 protein),1657,"183,634",5 out of 5,2003-05-09,Evidence at protein level
Q15699,ALX1_HUMAN,ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1),326,"36,961",5 out of 5,1998-07-15,Evidence at protein level
O15204,ADEC1_HUMAN,ADAM DEC1 (EC 3.4.24.-) (A disintegrin and metalloproteinase domain-like protein decysin-1) (ADAM-like protein decysin-1),470,"52,775",4 out of 5,2004-12-07,Evidence at protein level
Q15847,ADIRF_HUMAN,Adipogenesis regulatory factor (Adipogenesis factor rich in obesity) (Adipose most abundant gene transcript 2 protein) (Adipose-specific protein 2) (apM-2),76,"7,855",5 out of 5,2000-12-01,Evidence at protein level
Q9H2P0,ADNP_HUMAN,Activity-dependent neuroprotector homeobox protein (Activity-dependent neuroprotective protein),1102,"123,563",5 out of 5,2002-11-01,Evidence at protein level
Q16186,ADRM1_HUMAN,Proteasomal ubiquitin receptor ADRM1 (110 kDa cell membrane glycoprotein) (Gp110) (Adhesion-regulating molecule 1) (ARM-1) (Proteasome regulatory particle non-ATPase 13) (hRpn13) (Rpn13 homolog),407,"42,153",5 out of 5,1997-11-01,Evidence at protein level
P22570,ADRO_HUMAN,"NADPH:adrenodoxin oxidoreductase, mitochondrial (AR) (Adrenodoxin reductase) (EC 1.18.1.6) (Ferredoxin--NADP(+) reductase) (Ferredoxin reductase)",491,"53,837",5 out of 5,1991-08-01,Evidence at protein level
P12235,ADT1_HUMAN,"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)",298,"33,064",5 out of 5,1989-10-01,Evidence at protein level
P05141,ADT2_HUMAN,"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]",298,"32,852",5 out of 5,1987-08-13,Evidence at protein level
Q96IZ2,ADTRP_HUMAN,Androgen-dependent TFPI-regulating protein,230,"26,842",3 out of 5,2005-05-10,Evidence at transcript level
P10109,ADX_HUMAN,"Adrenodoxin, mitochondrial (Adrenal ferredoxin) (Ferredoxin-1) (Hepatoredoxin)",184,"19,393",5 out of 5,1989-07-01,Evidence at protein level
Q8IUX7,AEBP1_HUMAN,Adipocyte enhancer-binding protein 1 (AE-binding protein 1) (Aortic carboxypeptidase-like protein),1158,"130,929",5 out of 5,2008-05-20,Evidence at protein level
Q96SZ5,AEDO_HUMAN,2-aminoethanethiol dioxygenase (EC 1.13.11.19) (Cysteamine dioxygenase),270,"29,751",3 out of 5,2004-10-11,Evidence at protein level
Q6UXC1,AEGP_HUMAN,Apical endosomal glycoprotein (MAM domain-containing protein 4),1216,"131,499",3 out of 5,2007-05-15,Evidence at transcript level
Q5BKT4,AG10A_HUMAN,"Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase (EC 2.4.1.256) (Alpha-1,2-glucosyltransferase ALG10-A) (Alpha-2-glucosyltransferase ALG10-A) (Asparagine-linked glycosylation protein 10 homolog A)",473,"55,606",4 out of 5,2005-11-08,Evidence at transcript level
Q5VW22,AGAP6_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 6 (AGAP-6) (Centaurin-gamma-like family member 3)",663,"73,127",3 out of 5,2007-04-17,Evidence at transcript level
Q53H12,AGK_HUMAN,"Acylglycerol kinase, mitochondrial (hAGK) (EC 2.7.1.107) (EC 2.7.1.94) (Multiple substrate lipid kinase) (HsMuLK) (MuLK) (Multi-substrate lipid kinase)",422,"47,137",5 out of 5,2006-10-17,Evidence at protein level
O95394,AGM1_HUMAN,Phosphoacetylglucosamine mutase (PAGM) (EC 5.4.2.3) (Acetylglucosamine phosphomutase) (N-acetylglucosamine-phosphate mutase) (Phosphoglucomutase-3) (PGM 3),542,"59,852",5 out of 5,2001-01-24,Evidence at protein level
O95994,AGR2_HUMAN,Anterior gradient protein 2 homolog (AG-2) (hAG-2) (HPC8) (Secreted cement gland protein XAG-2 homolog),175,"19,979",5 out of 5,2005-05-10,Evidence at protein level
Q8IVF2,AHNK2_HUMAN,Protein AHNAK2,5795,"616,629",5 out of 5,2008-02-26,Evidence at protein level
Q9GZX7,AICDA_HUMAN,Single-stranded DNA cytosine deaminase (EC 3.5.4.38) (Activation-induced cytidine deaminase) (AID) (Cytidine aminohydrolase),198,"23,954",5 out of 5,2002-10-10,Evidence at protein level
Q9NQ31,AKIP1_HUMAN,A-kinase-interacting protein 1 (Breast cancer-associated gene 3 protein) (PKA-interacting protein) (Proline-rich protein BCA3),210,"23,114",4 out of 5,2002-05-02,Evidence at protein level
Q53H80,AKIR2_HUMAN,Akirin-2,203,"22,496",4 out of 5,2005-07-19,Evidence at protein level
Q9H8T0,AKTIP_HUMAN,AKT-interacting protein (Ft1) (Fused toes protein homolog),292,"33,128",5 out of 5,2004-10-11,Evidence at protein level
O75891,AL1L1_HUMAN,Cytosolic 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) (FDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L1),902,"98,829",5 out of 5,2000-05-30,Evidence at protein level
P04075,ALDOA_HUMAN,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),364,"39,420",5 out of 5,1986-11-01,Evidence at protein level
Q9Y615,ACL7A_HUMAN,Actin-like protein 7A (Actin-like-7-alpha),435,"48,644",5 out of 5,2003-01-27,Evidence at protein level
Q8WYK0,ACO12_HUMAN,Acyl-coenzyme A thioesterase 12 (Acyl-CoA thioesterase 12) (EC 3.1.2.1) (Acyl-CoA thioester hydrolase 12) (Cytoplasmic acetyl-CoA hydrolase 1) (CACH-1) (hCACH-1) (START domain-containing protein 15) (StARD15),555,"62,034",5 out of 5,2002-11-08,Evidence at protein level
P10323,ACRO_HUMAN,Acrosin (EC 3.4.21.10) [Cleaved into: Acrosin light chain; Acrosin heavy chain],421,"45,847",5 out of 5,1989-07-01,Evidence at transcript level
Q9UKU0,ACSL6_HUMAN,Long-chain-fatty-acid--CoA ligase 6 (EC 6.2.1.3) (Long-chain acyl-CoA synthetase 6) (LACS 6),697,"77,752",5 out of 5,2001-04-27,Evidence at transcript level
P0C7M7,ACSM4_HUMAN,"Acyl-coenzyme A synthetase ACSM4, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 4)",580,"65,703",3 out of 5,2008-06-10,Evidence at transcript level
Q9H6R3,ACSS3_HUMAN,"Acyl-CoA synthetase short-chain family member 3, mitochondrial (EC 6.2.1.1) (Acyl-CoA synthetase short-chain family member 3)",686,"74,778",4 out of 5,2008-02-26,Evidence at protein level
Q562R1,ACTBL_HUMAN,Beta-actin-like protein 2 (Kappa-actin),376,"42,003",3 out of 5,2008-02-26,Evidence at protein level
Q01718,ACTHR_HUMAN,Adrenocorticotropic hormone receptor (ACTH receptor) (ACTH-R) (Adrenocorticotropin receptor) (Melanocortin receptor 2) (MC2-R),297,"33,927",5 out of 5,1993-07-01,Evidence at protein level
Q9H568,ACTL8_HUMAN,Actin-like protein 8 (Cancer/testis antigen 57) (CT57),366,"41,360",3 out of 5,2007-05-01,Evidence at protein level
Q96EY9,ADAT3_HUMAN,Probable inactive tRNA-specific adenosine deaminase-like protein 3 (tRNA-specific adenosine-34 deaminase subunit ADAT3),351,"38,071",3 out of 5,2007-05-15,Evidence at protein level
P00813,ADA_HUMAN,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),363,"40,764",5 out of 5,1986-07-21,Evidence at protein level
Q5VUY2,ADCL4_HUMAN,Arylacetamide deacetylase-like 4 (EC 3.1.1.-),407,"46,082",3 out of 5,2006-12-12,Inferred from homology
Q08462,ADCY2_HUMAN,Adenylate cyclase type 2 (EC 4.6.1.1) (ATP pyrophosphate-lyase 2) (Adenylate cyclase type II) (Adenylyl cyclase 2),1091,"123,603",5 out of 5,1994-10-01,Evidence at protein level
P51828,ADCY7_HUMAN,Adenylate cyclase type 7 (EC 4.6.1.1) (ATP pyrophosphate-lyase 7) (Adenylate cyclase type VII) (Adenylyl cyclase 7),1080,"120,308",5 out of 5,1996-10-01,Evidence at transcript level
Q9UEY8,ADDG_HUMAN,Gamma-adducin (Adducin-like protein 70),706,"79,155",5 out of 5,2000-12-01,Evidence at protein level
P11766,ADHX_HUMAN,Alcohol dehydrogenase class-3 (EC 1.1.1.1) (Alcohol dehydrogenase 5) (Alcohol dehydrogenase class chi chain) (Alcohol dehydrogenase class-III) (Glutathione-dependent formaldehyde dehydrogenase) (FALDH) (FDH) (GSH-FDH) (EC 1.1.1.-) (S-(hydroxymethyl)glutathione dehydrogenase) (EC 1.1.1.284),374,"39,724",5 out of 5,1989-10-01,Evidence at protein level
Q9H0C2,ADT4_HUMAN,"ADP/ATP translocase 4 (ADP,ATP carrier protein 4) (Adenine nucleotide translocator 4) (ANT 4) (Solute carrier family 25 member 31) (Sperm flagellar energy carrier protein)",315,"35,022",4 out of 5,2007-08-21,Evidence at transcript level
P55198,AF17_HUMAN,Protein AF-17 (ALL1-fused gene from chromosome 17 protein),1093,"112,076",4 out of 5,1996-10-01,Evidence at protein level
Q8N4X5,AF1L2_HUMAN,Actin filament-associated protein 1-like 2 (AFAP1-like protein 2),818,"91,300",5 out of 5,2005-06-21,Evidence at protein level
P51826,AFF3_HUMAN,AF4/FMR2 family member 3 (Lymphoid nuclear protein related to AF4) (Protein LAF-4),1226,"133,476",5 out of 5,1996-10-01,Evidence at protein level
Q9UHB7,AFF4_HUMAN,AF4/FMR2 family member 4 (ALL1-fused gene from chromosome 5q31 protein) (Protein AF-5q31) (Major CDK9 elongation factor-associated protein),1163,"127,459",5 out of 5,2006-06-13,Evidence at protein level
Q5TGY3,AHDC1_HUMAN,AT-hook DNA-binding motif-containing protein 1,1603,"168,349",2 out of 5,2008-01-15,Evidence at protein level
Q09666,AHNK_HUMAN,Neuroblast differentiation-associated protein AHNAK (Desmoyokin),5890,"629,101",5 out of 5,1996-02-01,Evidence at protein level
Q9ULX6,AKP8L_HUMAN,A-kinase anchor protein 8-like (AKAP8-like protein) (Helicase A-binding protein 95) (HAP95) (Homologous to AKAP95 protein) (HA95) (Neighbor of A-kinase-anchoring protein 95) (Neighbor of AKAP95),646,"71,649",5 out of 5,2001-04-27,Evidence at protein level
P31749,AKT1_HUMAN,RAC-alpha serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase B) (PKB) (Protein kinase B alpha) (PKB alpha) (Proto-oncogene c-Akt) (RAC-PK-alpha),480,"55,686",5 out of 5,1993-07-01,Evidence at protein level
Q4L235,ACSF4_HUMAN,Acyl-CoA synthetase family member 4 (EC 6.2.1.-) (Aminoadipate-semialdehyde dehydrogenase) (Protein NRPS998),1098,"122,597",5 out of 5,2008-01-15,Evidence at protein level
P35609,ACTN2_HUMAN,Alpha-actinin-2 (Alpha-actinin skeletal muscle isoform 2) (F-actin cross-linking protein),894,"103,854",5 out of 5,1994-06-01,Evidence at protein level
P35348,ADA1A_HUMAN,Alpha-1A adrenergic receptor (Alpha-1A adrenoreceptor) (Alpha-1A adrenoceptor) (Alpha-1C adrenergic receptor) (Alpha-adrenergic receptor 1c),466,"51,487",5 out of 5,1994-06-01,Evidence at protein level
P25100,ADA1D_HUMAN,Alpha-1D adrenergic receptor (Alpha-1A adrenergic receptor) (Alpha-1D adrenoreceptor) (Alpha-1D adrenoceptor) (Alpha-adrenergic receptor 1a),572,"60,463",5 out of 5,1992-05-01,Evidence at protein level
Q9NPF8,ADAP2_HUMAN,Arf-GAP with dual PH domain-containing protein 2 (Centaurin-alpha-2) (Cnt-a2),381,"44,349",5 out of 5,2003-01-27,Evidence at protein level
A8MUL3,ADAS1_HUMAN,Putative uncharacterized protein ADARB2-AS1 (ADARB2 antisense RNA 1) (ADARB2 antisense gene protein 1),147,"15,836",2 out of 5,2008-06-10,Uncertain
P07327,ADH1A_HUMAN,Alcohol dehydrogenase 1A (EC 1.1.1.1) (Alcohol dehydrogenase subunit alpha),375,"39,859",5 out of 5,1988-04-01,Evidence at protein level
P00325,ADH1B_HUMAN,Alcohol dehydrogenase 1B (EC 1.1.1.1) (Alcohol dehydrogenase subunit beta),375,"39,855",5 out of 5,1986-07-21,Evidence at protein level
C9JUS6,ADM5_HUMAN,Putative adrenomedullin-5-like protein,153,"16,532",2 out of 5,2010-03-23,Evidence at transcript level
Q6ZN18,AEBP2_HUMAN,Zinc finger protein AEBP2 (Adipocyte enhancer-binding protein 2) (AE-binding protein 2),517,"54,467",5 out of 5,2008-06-10,Evidence at protein level
Q8TED9,AF1L1_HUMAN,Actin filament-associated protein 1-like 1 (AFAP1-like protein 1),768,"86,432",5 out of 5,2007-07-24,Evidence at protein level
Q6ULP2,AFTIN_HUMAN,Aftiphilin,937,"102,200",5 out of 5,2005-03-29,Evidence at protein level
Q8IZF4,AGRG5_HUMAN,Adhesion G-protein coupled receptor G5 (G-protein coupled receptor 114) (G-protein coupled receptor PGR27),528,"59,000",4 out of 5,2004-08-31,Evidence at transcript level
Q96K78,AGRG7_HUMAN,Adhesion G-protein coupled receptor G7 (G-protein coupled receptor 128),797,"88,909",4 out of 5,2004-03-29,Evidence at protein level
A9YTQ3,AHRR_HUMAN,Aryl hydrocarbon receptor repressor (AhR repressor) (AhRR) (Class E basic helix-loop-helix protein 77) (bHLHe77),701,"76,265",5 out of 5,2008-05-20,Evidence at protein level
Q9BQI0,AIF1L_HUMAN,Allograft inflammatory factor 1-like (Ionized calcium-binding adapter molecule 2),150,"17,068",5 out of 5,2006-02-07,Evidence at protein level
Q9NVV5,AIG1_HUMAN,Androgen-induced gene 1 protein (AIG-1),245,"28,222",4 out of 5,2004-12-21,Evidence at protein level
Q16352,AINX_HUMAN,Alpha-internexin (Alpha-Inx) (66 kDa neurofilament protein) (NF-66) (Neurofilament-66) (Neurofilament 5),499,"55,391",5 out of 5,2000-05-30,Evidence at protein level
O00170,AIP_HUMAN,AH receptor-interacting protein (AIP) (Aryl-hydrocarbon receptor-interacting protein) (HBV X-associated protein 2) (XAP-2) (Immunophilin homolog ARA9),330,"37,636",5 out of 5,2000-05-30,Evidence at protein level
O60218,AK1BA_HUMAN,Aldo-keto reductase family 1 member B10 (EC 1.1.1.-) (ARL-1) (Aldose reductase-like) (Aldose reductase-related protein) (ARP) (hARP) (Small intestine reductase) (SI reductase),316,"36,020",5 out of 5,2002-05-10,Evidence at protein level
Q9P0M2,AKA7G_HUMAN,A-kinase anchor protein 7 isoform gamma (AKAP-7 isoform gamma) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoform gamma) (PRKA7 isoform gamma),348,"39,518",5 out of 5,2002-11-15,Evidence at protein level
Q8N7X0,ADGB_HUMAN,Androglobin (Calpain-7-like protein),1667,"189,713",3 out of 5,2006-04-18,Evidence at transcript level
P00326,ADH1G_HUMAN,Alcohol dehydrogenase 1C (EC 1.1.1.1) (Alcohol dehydrogenase subunit gamma),375,"39,868",5 out of 5,1986-07-21,Evidence at protein level
Q08117,AES_HUMAN,Amino-terminal enhancer of split (Amino enhancer of split) (Gp130-associated protein GAM) (Grg-5) (Groucho-related protein 5) (Protein ESP1) (Protein GRG),197,"21,970",5 out of 5,1995-02-01,Evidence at protein level
P55197,AF10_HUMAN,Protein AF-10 (ALL1-fused gene from chromosome 10 protein),1068,"113,320",5 out of 5,1996-10-01,Evidence at protein level
Q9Y6Z5,AFAS1_HUMAN,Putative uncharacterized protein AFDN-AS1 (AFDN antisense RNA 1) (AFDN antisense gene protein 1) (Protein HGC6.4),254,"26,128",3 out of 5,2008-04-29,Uncertain
P51816,AFF2_HUMAN,AF4/FMR2 family member 2 (Fragile X E mental retardation syndrome protein) (Fragile X mental retardation 2 protein) (FMR2P) (Protein FMR-2) (Protein Ox19),1311,"144,771",5 out of 5,1996-10-01,Evidence at protein level
C9J202,AG1L2_HUMAN,Putative glycosyltransferase ALG1L2 (EC 2.4.1.-),215,"24,154",2 out of 5,2010-05-18,Inferred from homology
Q8TF27,AGA11_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 11 (AGAP-11) (Centaurin-gamma-like protein KIAA1975)",550,"60,549",3 out of 5,2008-04-08,Evidence at transcript level
Q8N302,AGGF1_HUMAN,Angiogenic factor with G patch and FHA domains 1 (Angiogenic factor VG5Q) (hVG5Q) (G patch domain-containing protein 7) (Vasculogenesis gene on 5q protein),714,"80,977",5 out of 5,2004-03-15,Evidence at protein level
Q9UKV8,AGO2_HUMAN,Protein argonaute-2 (Argonaute2) (hAgo2) (EC 3.1.26.n2) (Argonaute RISC catalytic component 2) (Eukaryotic translation initiation factor 2C 2) (eIF-2C 2) (eIF2C 2) (PAZ Piwi domain protein) (PPD) (Protein slicer),859,"97,208",5 out of 5,2000-12-01,Evidence at protein level
Q14246,AGRE1_HUMAN,Adhesion G protein-coupled receptor E1 (EGF-like module receptor 1) (EGF-like module-containing mucin-like hormone receptor-like 1) (EMR1 hormone receptor),886,"97,683",5 out of 5,1997-11-01,Evidence at transcript level
Q8IZF5,AGRF3_HUMAN,Adhesion G-protein coupled receptor F3 (G-protein coupled receptor 113) (G-protein coupled receptor PGR23),1079,"116,341",4 out of 5,2005-02-15,Evidence at transcript level
O95490,AGRL2_HUMAN,Adhesion G protein-coupled receptor L2 (Calcium-independent alpha-latrotoxin receptor 2) (CIRL-2) (Latrophilin homolog 1) (Latrophilin-2) (Lectomedin-1),1459,"163,349",5 out of 5,2004-04-26,Evidence at protein level
O00253,AGRP_HUMAN,Agouti-related protein,132,"14,440",5 out of 5,1997-11-01,Evidence at protein level
Q96IF1,AJUBA_HUMAN,LIM domain-containing protein ajuba,538,"56,934",5 out of 5,2007-12-04,Evidence at protein level
O43572,AKA10_HUMAN,"A-kinase anchor protein 10, mitochondrial (AKAP-10) (Dual specificity A kinase-anchoring protein 2) (D-AKAP-2) (Protein kinase A-anchoring protein 10) (PRKA10)",662,"73,818",5 out of 5,2001-02-21,Evidence at protein level
Q9Y2D5,AKAP2_HUMAN,A-kinase anchor protein 2 (AKAP-2) (AKAP-KL) (Protein kinase A-anchoring protein 2) (PRKA2),859,"94,661",4 out of 5,2001-02-21,Evidence at protein level
Q7Z591,AKNA_HUMAN,AT-hook-containing transcription factor,1439,"155,139",5 out of 5,2007-05-29,Evidence at protein level
Q8N8R7,AL14E_HUMAN,ARL14 effector protein (ARF7 effector protein),260,"29,338",5 out of 5,2006-10-03,Evidence at protein level
P30038,AL4A1_HUMAN,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial (P5C dehydrogenase) (EC 1.2.1.88) (Aldehyde dehydrogenase family 4 member A1) (L-glutamate gamma-semialdehyde dehydrogenase)",563,"61,719",5 out of 5,1993-04-01,Evidence at protein level
Q9H2A2,AL8A1_HUMAN,Aldehyde dehydrogenase family 8 member A1 (EC 1.2.1.-) (Aldehyde dehydrogenase 12),487,"53,401",5 out of 5,2008-01-15,Evidence at protein level
P15121,ALDR_HUMAN,Aldose reductase (AR) (EC 1.1.1.21) (Aldehyde reductase) (Aldo-keto reductase family 1 member B1),316,"35,853",5 out of 5,1990-04-01,Evidence at protein level
Q96QP1,ALPK1_HUMAN,Alpha-protein kinase 1 (EC 2.7.11.-) (Chromosome 4 kinase) (Lymphocyte alpha-protein kinase),1244,"138,861",5 out of 5,2006-11-28,Evidence at transcript level
O95076,ALX3_HUMAN,Homeobox protein aristaless-like 3 (Proline-rich transcription factor ALX3),343,"36,935",4 out of 5,2001-04-27,Evidence at protein level
Q9NP70,AMBN_HUMAN,Ameloblastin,447,"48,283",5 out of 5,2002-10-10,Evidence at protein level
P02760,AMBP_HUMAN,Protein AMBP [Cleaved into: Alpha-1-microglobulin (Protein HC) (Alpha-1 microglycoprotein) (Complex-forming glycoprotein heterogeneous in charge); Inter-alpha-trypsin inhibitor light chain (ITI-LC) (Bikunin) (EDC1) (HI-30) (Uronic-acid-rich protein); Trypstatin],352,"38,999",5 out of 5,1986-07-21,Evidence at protein level
Q99217,AMELX_HUMAN,"Amelogenin, X isoform",191,"21,603",5 out of 5,1995-11-01,Evidence at protein level
Q5JTC6,AMER1_HUMAN,APC membrane recruitment protein 1 (Amer1) (Protein FAM123B) (Wilms tumor gene on the X chromosome protein),1135,"124,029",5 out of 5,2007-04-03,Evidence at protein level
Q86WK6,AMGO1_HUMAN,Amphoterin-induced protein 1 (AMIGO-1) (Alivin-2),493,"55,239",5 out of 5,2005-06-21,Evidence at protein level
Q16671,AMHR2_HUMAN,Anti-Muellerian hormone type-2 receptor (EC 2.7.11.30) (Anti-Muellerian hormone type II receptor) (AMH type II receptor) (MIS type II receptor) (MISRII) (MRII),573,"62,750",5 out of 5,2000-12-01,Evidence at protein level
Q9Y4X0,AMMR1_HUMAN,AMME syndrome candidate gene 1 protein,333,"35,463",4 out of 5,2003-10-10,Evidence at protein level
P28838,AMPL_HUMAN,Cytosol aminopeptidase (EC 3.4.11.1) (Leucine aminopeptidase 3) (LAP-3) (Leucyl aminopeptidase) (Peptidase S) (Proline aminopeptidase) (EC 3.4.11.5) (Prolyl aminopeptidase),519,"56,166",5 out of 5,1992-12-01,Evidence at protein level
Q8N6S4,AN13C_HUMAN,Ankyrin repeat domain-containing protein 13C,541,"60,818",5 out of 5,2006-06-27,Evidence at transcript level
P39687,AN32A_HUMAN,Acidic leucine-rich nuclear phosphoprotein 32 family member A (Acidic nuclear phosphoprotein pp32) (pp32) (Leucine-rich acidic nuclear protein) (LANP) (Mapmodulin) (Potent heat-stable protein phosphatase 2A inhibitor I1PP2A) (Putative HLA-DR-associated protein I) (PHAPI),249,"28,585",5 out of 5,1995-02-01,Evidence at protein level
P40394,ADH7_HUMAN,Alcohol dehydrogenase class 4 mu/sigma chain (EC 1.1.1.1) (Alcohol dehydrogenase class IV mu/sigma chain) (Gastric alcohol dehydrogenase) (Retinol dehydrogenase),386,"41,481",5 out of 5,1995-02-01,Evidence at protein level
Q9BRR6,ADPGK_HUMAN,ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147) (RbBP-35),497,"54,089",5 out of 5,2005-04-26,Evidence at protein level
Q9Y6U3,ADSV_HUMAN,Adseverin (Scinderin),715,"80,489",5 out of 5,2001-06-20,Evidence at protein level
P12236,ADT3_HUMAN,"ADP/ATP translocase 3 (ADP,ATP carrier protein 3) (ADP,ATP carrier protein, isoform T2) (ANT 2) (Adenine nucleotide translocator 3) (ANT 3) (Solute carrier family 25 member 6) [Cleaved into: ADP/ATP translocase 3, N-terminally processed]",298,"32,866",5 out of 5,1989-10-01,Evidence at protein level
Q99490,AGAP2_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 (AGAP-2) (Centaurin-gamma-1) (Cnt-g1) (GTP-binding and GTPase-activating protein 2) (GGAP2) (Phosphatidylinositol 3-kinase enhancer) (PIKE)",1192,"124,674",5 out of 5,1999-07-15,Evidence at protein level
O95081,AGFG2_HUMAN,Arf-GAP domain and FG repeat-containing protein 2 (HIV-1 Rev-binding protein-like protein) (Rev/Rex activation domain-binding protein related) (RAB-R),481,"48,963",3 out of 5,2004-06-21,Evidence at protein level
Q9UL18,AGO1_HUMAN,Protein argonaute-1 (Argonaute1) (hAgo1) (Argonaute RISC catalytic component 1) (Eukaryotic translation initiation factor 2C 1) (eIF-2C 1) (eIF2C 1) (Putative RNA-binding protein Q99),857,"97,214",5 out of 5,2000-12-01,Evidence at protein level
Q8IZF2,AGRF5_HUMAN,Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116),1346,"149,457",5 out of 5,2004-07-19,Evidence at protein level
Q86Y34,AGRG3_HUMAN,Adhesion G protein-coupled receptor G3 (G-protein coupled receptor 97) (G-protein coupled receptor PGR26),549,"60,861",5 out of 5,2004-07-19,Evidence at protein level
Q86SQ4,AGRG6_HUMAN,Adhesion G-protein coupled receptor G6 (Developmentally regulated G-protein-coupled receptor) (G-protein coupled receptor 126) (Vascular inducible G protein-coupled receptor) [Cleaved into: ADGRG6 N-terminal fragment (ADGRG6-NTF); ADGRG6 C-terminal fragment (ADGRG6-CTF)],1221,"136,695",5 out of 5,2004-07-19,Evidence at protein level
Q9BYV1,AGT2_HUMAN,"Alanine--glyoxylate aminotransferase 2, mitochondrial (AGT 2) (EC 2.6.1.44) ((R)-3-amino-2-methylpropionate--pyruvate transaminase) (EC 2.6.1.40) (Beta-ALAAT II) (Beta-alanine-pyruvate aminotransferase) (D-AIBAT)",514,"57,156",5 out of 5,2001-12-05,Evidence at protein level
Q9NZD4,AHSP_HUMAN,Alpha-hemoglobin-stabilizing protein (Erythroid differentiation-related factor) (Erythroid-associated factor),102,"11,840",4 out of 5,2002-10-10,Evidence at protein level
Q96BJ3,AIDA_HUMAN,"Axin interactor, dorsalization-associated protein (Axin interaction partner and dorsalization antagonist)",306,"35,023",4 out of 5,2007-10-02,Evidence at protein level
Q9BRQ8,AIFM2_HUMAN,Apoptosis-inducing factor 2 (EC 1.-.-.-) (Apoptosis-inducing factor homologous mitochondrion-associated inducer of death) (Apoptosis-inducing factor-like mitochondrion-associated inducer of death) (p53-responsive gene 3 protein),373,"40,527",5 out of 5,2006-05-30,Evidence at protein level
P30837,AL1B1_HUMAN,"Aldehyde dehydrogenase X, mitochondrial (EC 1.2.1.3) (Aldehyde dehydrogenase 5) (Aldehyde dehydrogenase family 1 member B1)",517,"57,206",5 out of 5,1993-07-01,Evidence at protein level
Q53TS8,AL2SA_HUMAN,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 11 protein,623,"71,159",4 out of 5,2006-01-10,Evidence at protein level
P51648,AL3A2_HUMAN,Fatty aldehyde dehydrogenase (EC 1.2.1.3) (Aldehyde dehydrogenase 10) (Aldehyde dehydrogenase family 3 member A2) (Microsomal aldehyde dehydrogenase),485,"54,848",5 out of 5,1996-10-01,Evidence at protein level
P24298,ALAT1_HUMAN,Alanine aminotransferase 1 (ALT1) (EC 2.6.1.2) (Glutamate pyruvate transaminase 1) (GPT 1) (Glutamic--alanine transaminase 1) (Glutamic--pyruvic transaminase 1),496,"54,637",5 out of 5,1992-03-01,Evidence at protein level
Q9BT22,ALG1_HUMAN,"Chitobiosyldiphosphodolichol beta-mannosyltransferase (EC 2.4.1.142) (Asparagine-linked glycosylation protein 1 homolog) (Beta-1,4-mannosyltransferase) (GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase) (GDP-mannose-dolichol diphosphochitobiose mannosyltransferase) (Mannosyltransferase-1) (MT-1) (hMat-1)",464,"52,518",5 out of 5,2005-08-30,Evidence at protein level
Q96Q83,ALKB3_HUMAN,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 (EC 1.14.11.54) (Alkylated DNA repair protein alkB homolog 3) (hABH3) (DEPC-1) (Prostate cancer antigen 1),286,"33,375",5 out of 5,2006-05-30,Evidence at protein level
Q9UM73,ALK_HUMAN,ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246),1620,"176,442",5 out of 5,2002-03-27,Evidence at protein level
Q9UKV5,AMFR_HUMAN,E3 ubiquitin-protein ligase AMFR (EC 2.3.2.27) (Autocrine motility factor receptor) (AMF receptor) (RING finger protein 45) (RING-type E3 ubiquitin transferase AMFR) (gp78),643,"72,996",5 out of 5,2003-09-19,Evidence at protein level
Q86SJ2,AMGO2_HUMAN,Amphoterin-induced protein 2 (AMIGO-2) (Alivin-1) (Differentially expressed in gastric adenocarcinomas) (DEGA),522,"57,934",5 out of 5,2005-06-21,Evidence at protein level
Q86WK7,AMGO3_HUMAN,Amphoterin-induced protein 3 (AMIGO-3) (Alivin-3),504,"55,250",4 out of 5,2005-06-21,Evidence at transcript level
Q6ZTN6,AN13D_HUMAN,Ankyrin repeat domain-containing protein 13D,518,"58,476",3 out of 5,2006-06-27,Evidence at protein level
Q9BXX2,AN30B_HUMAN,Ankyrin repeat domain-containing protein 30B (Serologically defined breast cancer antigen NY-BR-1.1),1392,"158,049",2 out of 5,2008-04-08,Evidence at transcript level
Q69YU3,AN34A_HUMAN,Ankyrin repeat domain-containing protein 34A,496,"52,636",2 out of 5,2008-02-26,Evidence at transcript level
P10275,ANDR_HUMAN,Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4),920,"99,188",5 out of 5,1989-07-01,Evidence at protein level
Q86XS5,ANGL5_HUMAN,Angiopoietin-related protein 5 (Angiopoietin-like protein 5),388,"44,144",2 out of 5,2005-05-10,Evidence at transcript level
Q6P2P2,ANM9_HUMAN,Putative protein arginine N-methyltransferase 9 (Putative protein arginine N-methyltransferase 10) (EC 2.1.1.-),845,"94,501",3 out of 5,2008-03-18,Evidence at transcript level
P35611,ADDA_HUMAN,Alpha-adducin (Erythrocyte adducin subunit alpha),737,"80,955",5 out of 5,1994-06-01,Evidence at protein level
P35612,ADDB_HUMAN,Beta-adducin (Erythrocyte adducin subunit beta),726,"80,854",5 out of 5,1994-06-01,Evidence at protein level
Q96P47,AGAP3_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 (AGAP-3) (CRAM-associated GTPase) (CRAG) (Centaurin-gamma-3) (Cnt-g3) (MR1-interacting protein) (MRIP-1)",875,"95,044",5 out of 5,2003-01-27,Evidence at protein level
Q9HCK5,AGO4_HUMAN,Protein argonaute-4 (Argonaute4) (hAgo4) (Argonaute RISC catalytic component 4) (Eukaryotic translation initiation factor 2C 4) (eIF-2C 4) (eIF2C 4),861,"97,097",5 out of 5,2003-11-14,Evidence at protein level
Q9UHX3,AGRE2_HUMAN,Adhesion G protein-coupled receptor E2 (EGF-like module receptor 2) (EGF-like module-containing mucin-like hormone receptor-like 2) (CD antigen CD312),823,"90,472",5 out of 5,2004-03-01,Evidence at protein level
Q8IZF7,AGRF2_HUMAN,Adhesion G-protein coupled receptor F2 (G-protein coupled receptor 111) (G-protein coupled receptor PGR20),708,"78,569",4 out of 5,2005-02-15,Evidence at transcript level
Q8IZF6,AGRG4_HUMAN,Adhesion G-protein coupled receptor G4 (G-protein coupled receptor 112),3080,"333,368",5 out of 5,2004-08-31,Evidence at transcript level
O00468,AGRIN_HUMAN,Agrin [Cleaved into: Agrin N-terminal 110 kDa subunit; Agrin C-terminal 110 kDa subunit; Agrin C-terminal 90 kDa fragment (C90); Agrin C-terminal 22 kDa fragment (C22)],2067,"217,232",5 out of 5,2004-10-25,Evidence at protein level
Q5JQC9,AKAP4_HUMAN,A-kinase anchor protein 4 (AKAP-4) (A-kinase anchor protein 82 kDa) (AKAP 82) (hAKAP82) (Major sperm fibrous sheath protein) (HI) (Protein kinase A-anchoring protein 4) (PRKA4),854,"94,477",5 out of 5,2006-09-05,Evidence at protein level
Q5T2L2,AKCL1_HUMAN,Putative aldo-keto reductase family 1 member C8 (Aldo-keto reductase family 1 member C-like protein 1) (EC 1.1.1.-),129,"14,588",3 out of 5,2007-05-15,Uncertain
Q96Q35,AL2SB_HUMAN,Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 12 protein,445,"52,439",3 out of 5,2002-10-19,Evidence at protein level
P20292,AL5AP_HUMAN,Arachidonate 5-lipoxygenase-activating protein (FLAP) (MK-886-binding protein),161,"18,157",5 out of 5,1991-02-01,Evidence at protein level
P49419,AL7A1_HUMAN,Alpha-aminoadipic semialdehyde dehydrogenase (Alpha-AASA dehydrogenase) (EC 1.2.1.31) (Aldehyde dehydrogenase family 7 member A1) (EC 1.2.1.3) (Antiquitin-1) (Betaine aldehyde dehydrogenase) (EC 1.2.1.8) (Delta1-piperideine-6-carboxylate dehydrogenase) (P6c dehydrogenase),539,"58,487",5 out of 5,1996-02-01,Evidence at protein level
Q9BT30,ALKB7_HUMAN,"Alpha-ketoglutarate-dependent dioxygenase alkB homolog 7, mitochondrial (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 7) (Spermatogenesis cell proliferation-related protein) (Spermatogenesis-associated protein 11)",221,"24,516",5 out of 5,2006-05-30,Evidence at protein level
Q8N6M6,AMPO_HUMAN,Aminopeptidase O (AP-O) (EC 3.4.11.-),819,"93,572",5 out of 5,2005-03-15,Evidence at protein level
A6QL64,AN36A_HUMAN,Ankyrin repeat domain-containing protein 36A,1941,"217,465",3 out of 5,2008-05-20,Evidence at transcript level
Q6UXH0,ANGL8_HUMAN,Angiopoietin-like protein 8 (Betatrophin) (Lipasin) (Refeeding-induced fat and liver protein),198,"22,105",5 out of 5,2008-02-26,Evidence at protein level
Q9NU02,ANKE1_HUMAN,Ankyrin repeat and EF-hand domain-containing protein 1 (Ankyrin repeat domain-containing protein 5),776,"86,664",2 out of 5,2002-01-23,Evidence at transcript level
Q8NAG6,ANKL1_HUMAN,Ankyrin repeat and LEM domain-containing protein 1 (EC 3.1.-.-) (Ankyrin repeat domain-containing protein 41) (LEM-domain containing protein 3),615,"66,890",5 out of 5,2006-06-27,Evidence at protein level
Q92527,ANKR7_HUMAN,Ankyrin repeat domain-containing protein 7 (Testis-specific protein TSA806),254,"29,029",2 out of 5,2002-08-30,Evidence at transcript level
Q75V66,ANO5_HUMAN,Anoctamin-5 (Gnathodiaphyseal dysplasia 1 protein) (Transmembrane protein 16E),913,"107,188",5 out of 5,2005-09-13,Evidence at protein level
Q6IWH7,ANO7_HUMAN,Anoctamin-7 (Dresden transmembrane protein of the prostate) (D-TMPP) (IPCA-5) (New gene expressed in prostate) (Prostate cancer-associated protein 5) (Transmembrane protein 16G),933,"105,532",5 out of 5,2007-05-29,Evidence at protein level
A6NC57,ANR62_HUMAN,Ankyrin repeat domain-containing protein 62,917,"106,446",2 out of 5,2008-04-08,Evidence at transcript level
A6NF34,ANTRL_HUMAN,Anthrax toxin receptor-like,631,"70,629",3 out of 5,2008-04-29,Inferred from homology
Q06278,AOXA_HUMAN,Aldehyde oxidase (EC 1.2.3.1) (Aldehyde oxidase 1) (Azaheterocycle hydroxylase) (EC 1.17.3.-),1338,"147,918",5 out of 5,1994-06-01,Evidence at protein level
P56377,AP1S2_HUMAN,AP-1 complex subunit sigma-2 (Adaptor protein complex AP-1 subunit sigma-1B) (Adaptor-related protein complex 1 subunit sigma-1B) (Clathrin assembly protein complex 1 sigma-1B small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1B subunit) (Sigma 1B subunit of AP-1 clathrin) (Sigma-adaptin 1B) (Sigma1B-adaptin),157,"18,615",5 out of 5,1998-07-15,Evidence at protein level
P63010,AP2B1_HUMAN,AP-2 complex subunit beta (AP105B) (Adaptor protein complex AP-2 subunit beta) (Adaptor-related protein complex 2 subunit beta) (Beta-2-adaptin) (Beta-adaptin) (Clathrin assembly protein complex 2 beta large chain) (Plasma membrane adaptor HA2/AP2 adaptin beta subunit),937,"104,553",5 out of 5,2004-08-31,Evidence at protein level
Q96CW1,AP2M1_HUMAN,AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein),435,"49,655",5 out of 5,2004-08-16,Evidence at protein level
O00203,AP3B1_HUMAN,AP-3 complex subunit beta-1 (Adaptor protein complex AP-3 subunit beta-1) (Adaptor-related protein complex 3 subunit beta-1) (Beta-3A-adaptin) (Clathrin assembly protein complex 3 beta-1 large chain),1094,"121,320",5 out of 5,2001-09-26,Evidence at protein level
P53677,AP3M2_HUMAN,AP-3 complex subunit mu-2 (Adaptor-related protein complex 3 subunit mu-2) (Clathrin assembly protein assembly protein complex 3 mu-2 medium chain) (Clathrin coat assembly protein AP47 homolog 2) (Clathrin coat-associated protein AP47 homolog 2) (Golgi adaptor AP-1 47 kDa protein homolog 2) (HA1 47 kDa subunit homolog 2) (Mu3B-adaptin) (P47B),418,"46,977",5 out of 5,1996-10-01,Evidence at transcript level
Q6NUN0,ACSM5_HUMAN,"Acyl-coenzyme A synthetase ACSM5, mitochondrial (EC 6.2.1.2) (Acyl-CoA synthetase medium-chain family member 5)",579,"64,760",5 out of 5,2007-10-02,Evidence at protein level
P42025,ACTY_HUMAN,Beta-centractin (Actin-related protein 1B) (ARP1B),376,"42,293",5 out of 5,1995-11-01,Evidence at protein level
O14672,ADA10_HUMAN,Disintegrin and metalloproteinase domain-containing protein 10 (ADAM 10) (EC 3.4.24.81) (CDw156) (Kuzbanian protein homolog) (Mammalian disintegrin-metalloprotease) (CD antigen CD156c),748,"84,142",5 out of 5,2003-02-28,Evidence at protein level
Q9H013,ADA19_HUMAN,Disintegrin and metalloproteinase domain-containing protein 19 (ADAM 19) (EC 3.4.24.-) (Meltrin-beta) (Metalloprotease and disintegrin dendritic antigen marker) (MADDAM),955,"104,997",5 out of 5,2002-01-31,Evidence at protein level
P35368,ADA1B_HUMAN,Alpha-1B adrenergic receptor (Alpha-1B adrenoreceptor) (Alpha-1B adrenoceptor),520,"56,836",5 out of 5,1994-06-01,Evidence at protein level
Q9UKJ8,ADA21_HUMAN,Disintegrin and metalloproteinase domain-containing protein 21 (ADAM 21) (EC 3.4.24.-),722,"80,834",5 out of 5,2001-06-01,Evidence at transcript level
P18089,ADA2B_HUMAN,Alpha-2B adrenergic receptor (Alpha-2 adrenergic receptor subtype C2) (Alpha-2B adrenoreceptor) (Alpha-2B adrenoceptor) (Alpha-2BAR),450,"49,954",5 out of 5,1990-11-01,Evidence at protein level
Q6NVV9,ADAM5_HUMAN,"Putative disintegrin and metalloproteinase domain-containing protein 5 (Putative transmembrane metalloproteinase-like, disintegrin-like, and cysteine-rich protein II) (tMDC II)",412,"47,181",3 out of 5,2008-09-02,Uncertain
P78325,ADAM8_HUMAN,Disintegrin and metalloproteinase domain-containing protein 8 (ADAM 8) (EC 3.4.24.-) (Cell surface antigen MS2) (CD antigen CD156a),824,"88,771",5 out of 5,1997-11-01,Evidence at protein level
Q7Z695,ADCK2_HUMAN,Uncharacterized aarF domain-containing protein kinase 2 (EC 2.7.11.-),626,"68,982",4 out of 5,2007-01-09,Evidence at transcript level
O95622,ADCY5_HUMAN,Adenylate cyclase type 5 (EC 4.6.1.1) (ATP pyrophosphate-lyase 5) (Adenylate cyclase type V) (Adenylyl cyclase 5) (AC5),1261,"138,908",5 out of 5,2000-05-30,Evidence at protein level
P55008,AIF1_HUMAN,Allograft inflammatory factor 1 (AIF-1) (Ionized calcium-binding adapter molecule 1) (Protein G1),147,"16,703",5 out of 5,1996-10-01,Evidence at protein level
O43918,AIRE_HUMAN,Autoimmune regulator (Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy protein) (APECED protein),545,"57,727",5 out of 5,1998-07-15,Evidence at protein level
P17516,AK1C4_HUMAN,Aldo-keto reductase family 1 member C4 (EC 1.1.1.-) (3-alpha-HSD1) (3-alpha-hydroxysteroid dehydrogenase type I) (EC 1.1.1.357) (Chlordecone reductase) (CDR) (EC 1.1.1.225) (Dihydrodiol dehydrogenase 4) (DD-4) (DD4) (HAKRA),323,"37,067",5 out of 5,1990-08-01,Evidence at protein level
P51857,AK1D1_HUMAN,3-oxo-5-beta-steroid 4-dehydrogenase (EC 1.3.1.3) (Aldo-keto reductase family 1 member D1) (Delta(4)-3-ketosteroid 5-beta-reductase) (Delta(4)-3-oxosteroid 5-beta-reductase),326,"37,377",5 out of 5,1996-10-01,Evidence at protein level
P0CW23,AKAI1_HUMAN,A-kinase anchor protein inhibitor 1,69,"7,848",3 out of 5,2011-06-28,Evidence at protein level
Q9H9L7,AKIR1_HUMAN,Akirin-1,192,"21,867",4 out of 5,2007-02-06,Evidence at protein level
P05091,ALDH2_HUMAN,"Aldehyde dehydrogenase, mitochondrial (EC 1.2.1.3) (ALDH class 2) (ALDH-E2) (ALDHI)",517,"56,381",5 out of 5,1987-08-13,Evidence at protein level
P84996,ALEX_HUMAN,Protein ALEX (Alternative gene product encoded by XL-exon),626,"67,948",5 out of 5,2006-10-17,Evidence at protein level
Q2TAA5,ALG11_HUMAN,"GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase (EC 2.4.1.131) (Asparagine-linked glycosylation protein 11 homolog) (Glycolipid 2-alpha-mannosyltransferase)",492,"55,651",5 out of 5,2007-07-24,Evidence at protein level
Q9BV10,ALG12_HUMAN,"Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase (EC 2.4.1.260) (Asparagine-linked glycosylation protein 12 homolog) (hALG12) (Dolichyl-P-Man:Man(7)GlcNAc(2)-PP-dolichyl-alpha-1,6-mannosyltransferase) (Mannosyltransferase ALG12 homolog) (Membrane protein SB87)",488,"54,655",5 out of 5,2004-03-15,Evidence at protein level
O95626,AN32D_HUMAN,Acidic leucine-rich nuclear phosphoprotein 32 family member D (Phosphoprotein 32-related protein 2) (Tumorigenic protein pp32r2),131,"14,806",2 out of 5,2002-12-06,Evidence at transcript level
P23582,ANFC_HUMAN,C-type natriuretic peptide [Cleaved into: CNP-22; CNP-29; CNP-53],126,"13,246",5 out of 5,1991-11-01,Evidence at protein level
P01160,ANF_HUMAN,Natriuretic peptides A (CDD-ANF) (Cardiodilatin) (CDD) (Cardiodilatin-related peptide) (CDP) (Prepronatriodilatin) [Cleaved into: Atrial natriuretic factor (ANF) (Atrial natriuretic peptide) (ANP)],153,"16,708",5 out of 5,1986-07-21,Evidence at protein level
O15123,ANGP2_HUMAN,Angiopoietin-2 (ANG-2),496,"56,919",5 out of 5,2000-12-01,Evidence at protein level
Q9HCE9,ANO8_HUMAN,Anoctamin-8 (Transmembrane protein 16H),1232,"136,034",5 out of 5,2006-09-05,Evidence at protein level
Q9UPS8,ANR26_HUMAN,Ankyrin repeat domain-containing protein 26,1709,"196,324",3 out of 5,2006-06-27,Evidence at protein level
Q8N283,ANR35_HUMAN,Ankyrin repeat domain-containing protein 35,1001,"109,966",2 out of 5,2006-06-27,Evidence at transcript level
Q5TZF3,ANR45_HUMAN,Ankyrin repeat domain-containing protein 45,282,"31,810",2 out of 5,2006-06-27,Evidence at protein level
P01008,ANT3_HUMAN,Antithrombin-III (ATIII) (Serpin C1),464,"52,602",5 out of 5,1986-07-21,Evidence at protein level
Q9UJ72,ANX10_HUMAN,Annexin A10 (Annexin-10) (Annexin-14),324,"37,278",2 out of 5,2001-02-21,Evidence at protein level
P50995,ANX11_HUMAN,Annexin A11 (56 kDa autoantigen) (Annexin XI) (Annexin-11) (Calcyclin-associated annexin 50) (CAP-50),505,"54,390",5 out of 5,1996-10-01,Evidence at protein level
P09525,ANXA4_HUMAN,Annexin A4 (35-beta calcimedin) (Annexin IV) (Annexin-4) (Carbohydrate-binding protein p33/p41) (Chromobindin-4) (Endonexin I) (Lipocortin IV) (P32.5) (PP4-X) (Placental anticoagulant protein II) (PAP-II) (Protein II),319,"35,883",5 out of 5,1989-07-01,Evidence at protein level
P08758,ANXA5_HUMAN,Annexin A5 (Anchorin CII) (Annexin V) (Annexin-5) (Calphobindin I) (CBP-I) (Endonexin II) (Lipocortin V) (Placental anticoagulant protein 4) (PP4) (Placental anticoagulant protein I) (PAP-I) (Thromboplastin inhibitor) (Vascular anticoagulant-alpha) (VAC-alpha),320,"35,937",5 out of 5,1988-11-01,Evidence at protein level
O75106,AOC2_HUMAN,Retina-specific copper amine oxidase (RAO) (EC 1.4.3.21) (Amine oxidase [copper-containing]) (Semicarbazide-sensitive amine oxidase) (SSAO),756,"83,673",5 out of 5,1999-07-15,Evidence at protein level
P21397,AOFA_HUMAN,Amine oxidase [flavin-containing] A (EC 1.4.3.4) (Monoamine oxidase type A) (MAO-A),527,"59,682",5 out of 5,1991-05-01,Evidence at protein level
P27338,AOFB_HUMAN,Amine oxidase [flavin-containing] B (EC 1.4.3.4) (Monoamine oxidase type B) (MAO-B),520,"58,763",5 out of 5,1992-08-01,Evidence at protein level
Q10567,AP1B1_HUMAN,AP-1 complex subunit beta-1 (Adaptor protein complex AP-1 subunit beta-1) (Adaptor-related protein complex 1 subunit beta-1) (Beta-1-adaptin) (Beta-adaptin 1) (Clathrin assembly protein complex 1 beta large chain) (Golgi adaptor HA1/AP1 adaptin beta subunit),949,"104,637",5 out of 5,1996-10-01,Evidence at protein level
Q92481,AP2B_HUMAN,Transcription factor AP-2-beta (AP2-beta) (Activating enhancer-binding protein 2-beta),460,"50,474",5 out of 5,2001-01-24,Evidence at protein level
Q7Z6R9,AP2D_HUMAN,Transcription factor AP-2-delta (AP2-delta) (Activating enhancer-binding protein 2-delta) (Transcription factor AP-2-beta-like 1),452,"49,578",4 out of 5,2007-11-13,Evidence at transcript level
Q92572,AP3S1_HUMAN,"AP-3 complex subunit sigma-1 (AP-3 complex subunit sigma-3A) (Adaptor-related protein complex 3 subunit sigma-1) (Clathrin-associated/assembly/adaptor protein, small 3) (Sigma-3A-adaptin) (Sigma3A-adaptin) (Sigma-adaptin 3a)",193,"21,732",5 out of 5,2003-07-19,Evidence at protein level
Q9Y6B7,AP4B1_HUMAN,AP-4 complex subunit beta-1 (AP-4 adaptor complex subunit beta) (Adaptor-related protein complex 4 subunit beta-1) (Beta subunit of AP-4) (Beta4-adaptin),739,"83,260",5 out of 5,2001-04-27,Evidence at protein level
O00189,AP4M1_HUMAN,AP-4 complex subunit mu-1 (AP-4 adaptor complex mu subunit) (Adaptor-related protein complex 4 subunit mu-1) (Mu subunit of AP-4) (Mu-adaptin-related protein 2) (mu-ARP2) (Mu4-adaptin) (mu4),453,"49,977",5 out of 5,2001-04-27,Evidence at protein level
Q02410,APBA1_HUMAN,Amyloid beta A4 precursor protein-binding family A member 1 (Adapter protein X11alpha) (Neuron-specific X11 protein) (Neuronal Munc18-1-interacting protein 1) (Mint-1),837,"92,865",5 out of 5,1996-02-01,Evidence at protein level
Q92870,APBB2_HUMAN,Amyloid beta A4 precursor protein-binding family B member 2 (Protein Fe65-like 1),758,"83,374",5 out of 5,2001-01-11,Evidence at protein level
Q8N1P7,AIM1L_HUMAN,Absent in melanoma 1-like protein (Beta/gamma crystallin domain-containing protein 2),616,"68,646",2 out of 5,2007-05-01,Evidence at transcript level
Q13155,AIMP2_HUMAN,Aminoacyl tRNA synthase complex-interacting multifunctional protein 2 (Multisynthase complex auxiliary component p38) (Protein JTV-1),320,"35,349",5 out of 5,1997-11-01,Evidence at protein level
Q04828,AK1C1_HUMAN,"Aldo-keto reductase family 1 member C1 (EC 1.1.1.-) (20-alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (EC 1.1.1.149) (Chlordecone reductase homolog HAKRC) (Dihydrodiol dehydrogenase 1/2) (DD1/DD2) (High-affinity hepatic bile acid-binding protein) (HBAB) (Indanol dehydrogenase) (EC 1.1.1.112) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)",323,"36,788",5 out of 5,1993-10-01,Evidence at protein level
Q02952,AKA12_HUMAN,A-kinase anchor protein 12 (AKAP-12) (A-kinase anchor protein 250 kDa) (AKAP 250) (Gravin) (Myasthenia gravis autoantigen),1782,"191,482",5 out of 5,1994-02-01,Evidence at protein level
Q92667,AKAP1_HUMAN,"A-kinase anchor protein 1, mitochondrial (A-kinase anchor protein 149 kDa) (AKAP 149) (Dual specificity A-kinase-anchoring protein 1) (D-AKAP-1) (Protein kinase A-anchoring protein 1) (PRKA1) (Spermatid A-kinase anchor protein 84) (S-AKAP84)",903,"97,342",5 out of 5,2000-05-30,Evidence at protein level
P24588,AKAP5_HUMAN,A-kinase anchor protein 5 (AKAP-5) (A-kinase anchor protein 79 kDa) (AKAP 79) (H21) (cAMP-dependent protein kinase regulatory subunit II high affinity-binding protein),427,"47,088",5 out of 5,1992-03-01,Evidence at protein level
Q13023,AKAP6_HUMAN,A-kinase anchor protein 6 (AKAP-6) (A-kinase anchor protein 100 kDa) (AKAP 100) (Protein kinase A-anchoring protein 6) (PRKA6) (mAKAP),2319,"256,720",5 out of 5,2001-04-27,Evidence at protein level
Q9NWT8,AKIP_HUMAN,"Aurora kinase A-interacting protein (AURKA-interacting protein) (28S ribosomal protein S38, mitochondrial) (MRP-S38) (Mitochondrial small ribosomal subunit protein mS38)",199,"22,354",5 out of 5,2003-05-16,Evidence at protein level
Q12802,AKP13_HUMAN,A-kinase anchor protein 13 (AKAP-13) (AKAP-Lbc) (Breast cancer nuclear receptor-binding auxiliary protein) (Guanine nucleotide exchange factor Lbc) (Human thyroid-anchoring protein 31) (Lymphoid blast crisis oncogene) (LBC oncogene) (Non-oncogenic Rho GTPase-specific GTP exchange factor) (Protein kinase A-anchoring protein 13) (PRKA13) (p47),2813,"307,550",5 out of 5,1999-07-15,Evidence at protein level
P09972,ALDOC_HUMAN,Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase),364,"39,456",5 out of 5,1989-07-01,Evidence at protein level
Q07075,AMPE_HUMAN,Glutamyl aminopeptidase (EAP) (EC 3.4.11.7) (Aminopeptidase A) (AP-A) (Differentiation antigen gp160) (CD antigen CD249),957,"109,244",5 out of 5,1994-10-01,Evidence at protein level
Q6Q4G3,AMPQ_HUMAN,Aminopeptidase Q (AP-Q) (APQ) (EC 3.4.11.-) (CHL2 antigen) (Laeverin),990,"113,283",5 out of 5,2006-07-25,Evidence at protein level
P19961,AMY2B_HUMAN,"Alpha-amylase 2B (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 2B) (Carcinoid alpha-amylase)",511,"57,710",4 out of 5,1991-02-01,Evidence at protein level
Q9BXX3,AN30A_HUMAN,Ankyrin repeat domain-containing protein 30A (Serologically defined breast cancer antigen NY-BR-1),1397,"158,835",3 out of 5,2006-06-27,Evidence at transcript level
O43423,AN32C_HUMAN,Acidic leucine-rich nuclear phosphoprotein 32 family member C (Phosphoprotein 32-related protein 1) (Tumorigenic protein pp32r1),234,"26,762",3 out of 5,2002-12-06,Evidence at transcript level
Q5JPF3,AN36C_HUMAN,Ankyrin repeat domain-containing protein 36C (Protein immuno-reactive with anti-PTH polyclonal antibodies),1778,"199,748",3 out of 5,2008-05-20,Evidence at protein level
P54802,ANAG_HUMAN,Alpha-N-acetylglucosaminidase (EC 3.2.1.50) (N-acetyl-alpha-glucosaminidase) (NAG) [Cleaved into: Alpha-N-acetylglucosaminidase 82 kDa form; Alpha-N-acetylglucosaminidase 77 kDa form],743,"82,266",5 out of 5,1996-10-01,Evidence at protein level
Q9BY76,ANGL4_HUMAN,Angiopoietin-related protein 4 (Angiopoietin-like protein 4) (Hepatic fibrinogen/angiopoietin-related protein) (HFARP),406,"45,214",5 out of 5,2002-11-08,Evidence at protein level
Q15389,ANGP1_HUMAN,Angiopoietin-1 (ANG-1),498,"57,513",5 out of 5,2000-12-01,Evidence at protein level
Q7Z5J8,ANKAR_HUMAN,Ankyrin and armadillo repeat-containing protein,1434,"162,026",3 out of 5,2007-05-15,Evidence at transcript level
Q9HCJ1,ANKH_HUMAN,Progressive ankylosis protein homolog (ANK),492,"54,241",5 out of 5,2001-11-16,Evidence at protein level
A6NFN9,ANKUB_HUMAN,Protein ANKUB1 (Ankyrin repeat and ubiquitin domain-containing 1),424,"47,648",2 out of 5,2008-07-22,Evidence at transcript level
Q9P2S6,ANKY1_HUMAN,Ankyrin repeat and MYND domain-containing protein 1 (Testis-specific ankyrin-like protein 1) (Zinc finger MYND domain-containing protein 13),941,"105,516",3 out of 5,2003-05-16,Evidence at transcript level
Q9NVM4,ANM7_HUMAN,Protein arginine N-methyltransferase 7 (EC 2.1.1.321) (Histone-arginine N-methyltransferase PRMT7) ([Myelin basic protein]-arginine N-methyltransferase PRMT7),692,"78,459",5 out of 5,2002-03-27,Evidence at protein level
Q9NW15,ANO10_HUMAN,Anoctamin-10 (Transmembrane protein 16K),660,"76,329",5 out of 5,2007-05-29,Evidence at protein level
P16066,ANPRA_HUMAN,Atrial natriuretic peptide receptor 1 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type A) (ANP-A) (ANPR-A) (NPR-A) (Guanylate cyclase A) (GC-A),1061,"118,919",5 out of 5,1990-04-01,Evidence at protein level
Q6UB99,ANR11_HUMAN,Ankyrin repeat domain-containing protein 11 (Ankyrin repeat-containing cofactor 1),2663,"297,913",5 out of 5,2004-07-19,Evidence at protein level
Q8N9B4,ANR42_HUMAN,Ankyrin repeat domain-containing protein 42,389,"43,052",2 out of 5,2006-06-27,Evidence at transcript level
Q8N8A2,ANR44_HUMAN,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B (PP6-ARS-B) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-B) (Ankyrin repeat domain-containing protein 44),993,"107,603",4 out of 5,2006-06-27,Evidence at protein level
Q9BZ19,ANR60_HUMAN,Ankyrin repeat domain-containing protein 60,345,"37,630",2 out of 5,2002-12-06,Predicted
Q9H6X2,ANTR1_HUMAN,Anthrax toxin receptor 1 (Tumor endothelial marker 8),564,"62,789",5 out of 5,2001-11-02,Evidence at protein level
P27216,ANX13_HUMAN,Annexin A13 (Annexin XIII) (Annexin-13) (Intestine-specific annexin) (ISA),316,"35,415",5 out of 5,1992-08-01,Evidence at protein level
P08133,ANXA6_HUMAN,Annexin A6 (67 kDa calelectrin) (Annexin VI) (Annexin-6) (Calphobindin-II) (CPB-II) (Chromobindin-20) (Lipocortin VI) (Protein III) (p68) (p70),673,"75,873",5 out of 5,1988-08-01,Evidence at protein level
O76027,ANXA9_HUMAN,Annexin A9 (Annexin XXXI) (Annexin-31) (Annexin-9) (Pemphaxin),345,"38,364",5 out of 5,2001-02-21,Evidence at protein level
O60641,AP180_HUMAN,Clathrin coat assembly protein AP180 (91 kDa synaptosomal-associated protein) (Clathrin coat-associated protein AP180) (Phosphoprotein F1-20),907,"92,502",5 out of 5,2003-01-17,Evidence at protein level
Q9Y6Q5,AP1M2_HUMAN,AP-1 complex subunit mu-2 (AP-mu chain family member mu1B) (Adaptor protein complex AP-1 subunit mu-2) (Adaptor-related protein complex 1 subunit mu-2) (Clathrin assembly protein complex 1 mu-2 medium chain 2) (Golgi adaptor HA1/AP1 adaptin mu-2 subunit) (Mu-adaptin 2) (Mu1B-adaptin),423,"48,108",5 out of 5,2001-02-21,Evidence at protein level
Q9NUS5,AP5S1_HUMAN,AP-5 complex subunit sigma-1 (Adaptor-related protein complex 5 sigma subunit) (Sigma5),200,"22,522",5 out of 5,2002-09-19,Evidence at protein level
Q96DE5,APC16_HUMAN,Anaphase-promoting complex subunit 16 (APC16) (Cyclosome subunit 16),110,"11,667",5 out of 5,2005-07-19,Evidence at protein level
Q9BPW4,APOL4_HUMAN,Apolipoprotein L4 (Apolipoprotein L-IV) (ApoL-IV),351,"39,164",4 out of 5,2001-08-29,Evidence at transcript level
Q8IVJ8,APRG1_HUMAN,AP20 region protein 1,170,"18,525",2 out of 5,2007-05-29,Evidence at transcript level
Q5VTM2,AGAP9_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9 (AGAP-9) (Centaurin-gamma-like family member 6)",703,"77,972",3 out of 5,2007-04-17,Inferred from homology
Q8TD06,AGR3_HUMAN,"Anterior gradient protein 3 (AG-3) (AG3) (hAG-3) (Anterior gradient 3 homolog) (Breast cancer membrane protein 11) (Protein disulfide isomerase family A, member 18)",166,"19,171",5 out of 5,2005-05-10,Evidence at protein level
Q8IWK6,AGRA3_HUMAN,Adhesion G protein-coupled receptor A3 (G-protein coupled receptor 125),1321,"146,151",5 out of 5,2004-07-19,Evidence at protein level
Q6QNK2,AGRD1_HUMAN,Adhesion G-protein coupled receptor D1 (G-protein coupled receptor 133) (G-protein coupled receptor PGR25),874,"96,530",5 out of 5,2005-02-15,Evidence at protein level
Q9BY15,AGRE3_HUMAN,Adhesion G protein-coupled receptor E3 (EGF-like module receptor 3) (EGF-like module-containing mucin-like hormone receptor-like 3),652,"72,621",5 out of 5,2004-02-16,Evidence at transcript level
Q8IZF3,AGRF4_HUMAN,Adhesion G protein-coupled receptor F4 (G-protein coupled receptor 115) (G-protein coupled receptor PGR18),695,"77,719",4 out of 5,2005-02-15,Evidence at transcript level
Q8IZP9,AGRG2_HUMAN,Adhesion G-protein coupled receptor G2 (G-protein coupled receptor 64) (Human epididymis-specific protein 6) (He6),1017,"111,593",5 out of 5,2004-03-29,Evidence at protein level
O94910,AGRL1_HUMAN,Adhesion G protein-coupled receptor L1 (Calcium-independent alpha-latrotoxin receptor 1) (CIRL-1) (Latrophilin-1) (Lectomedin-2),1474,"162,717",5 out of 5,2004-04-26,Evidence at protein level
P30556,AGTR1_HUMAN,Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1),359,"41,061",5 out of 5,1993-04-01,Evidence at protein level
P50052,AGTR2_HUMAN,Type-2 angiotensin II receptor (Angiotensin II type-2 receptor) (AT2),363,"41,184",5 out of 5,1996-10-01,Evidence at protein level
Q8N157,AHI1_HUMAN,Jouberin (Abelson helper integration site 1 protein homolog) (AHI-1),1196,"137,115",5 out of 5,2005-08-30,Evidence at protein level
Q9UKB5,AJAP1_HUMAN,Adherens junction-associated protein 1 (Membrane protein shrew-1),411,"44,536",5 out of 5,2007-04-17,Evidence at protein level
Q02040,AK17A_HUMAN,"A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A)",695,"80,735",5 out of 5,1995-02-01,Evidence at protein level
Q9UKA4,AKA11_HUMAN,A-kinase anchor protein 11 (AKAP-11) (A-kinase anchor protein 220 kDa) (AKAP 220) (hAKAP220) (Protein kinase A-anchoring protein 11) (PRKA11),1901,"210,512",5 out of 5,2001-04-27,Evidence at protein level
O43687,AKA7A_HUMAN,A-kinase anchor protein 7 isoforms alpha and beta (AKAP-7 isoforms alpha and beta) (A-kinase anchor protein 18 kDa) (AKAP 18) (Protein kinase A-anchoring protein 7 isoforms alpha/beta) (PRKA7 isoforms alpha/beta),104,"11,465",5 out of 5,2000-05-30,Evidence at protein level
Q96JD6,AKCL2_HUMAN,"1,5-anhydro-D-fructose reductase (AF reductase) (EC 1.1.1.263) (Aldo-keto reductase family 1 member C-like protein 2) (Aldo-keto reductase family 1 member E2) (LoopADR) (Testis-specific protein) (hTSP)",320,"36,589",5 out of 5,2007-05-15,Evidence at protein level
Q5T1N1,AKND1_HUMAN,Protein AKNAD1,836,"92,864",3 out of 5,2008-07-01,Evidence at transcript level
P02768,ALBU_HUMAN,Serum albumin,609,"69,367",5 out of 5,1986-07-21,Evidence at protein level
Q13686,ALKB1_HUMAN,Nucleic acid dioxygenase ALKBH1 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 1) (Alpha-ketoglutarate-dependent dioxygenase ABH1) (DNA 6mA demethylase) (DNA N6-methyl adenine demethylase) (EC 1.14.11.-) (DNA lyase ABH1) (EC 4.2.99.18) (DNA oxidative demethylase ALKBH1) (EC 1.14.11.33) (tRNA N1-methyl adenine demethylase) (EC 1.14.11.-),389,"43,832",5 out of 5,2000-12-01,Evidence at protein level
Q6ZNB7,ALKMO_HUMAN,Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195),445,"51,500",5 out of 5,2007-09-11,Evidence at protein level
P19021,AMD_HUMAN,Peptidyl-glycine alpha-amidating monooxygenase (PAM) [Includes: Peptidylglycine alpha-hydroxylating monooxygenase (PHM) (EC 1.14.17.3); Peptidyl-alpha-hydroxyglycine alpha-amidating lyase (EC 4.3.2.5) (Peptidylamidoglycolate lyase) (PAL)],973,"108,332",5 out of 5,1990-11-01,Evidence at protein level
Q8N7J2,AMER2_HUMAN,APC membrane recruitment protein 2 (Amer2) (Protein FAM123A),671,"69,507",5 out of 5,2007-04-03,Evidence at protein level
Q8IY63,AMOL1_HUMAN,Angiomotin-like protein 1,956,"106,574",5 out of 5,2005-09-27,Evidence at protein level
Q9Y2J4,AMOL2_HUMAN,Angiomotin-like protein 2 (Leman coiled-coil protein) (LCCP),779,"85,764",5 out of 5,2005-09-27,Evidence at protein level
Q01433,AMPD2_HUMAN,AMP deaminase 2 (EC 3.5.4.6) (AMP deaminase isoform L),879,"100,688",5 out of 5,1993-07-01,Evidence at protein level
P15144,AMPN_HUMAN,Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13),967,"109,540",5 out of 5,1990-04-01,Evidence at protein level
Q6UX39,AMTN_HUMAN,Amelotin,209,"21,588",4 out of 5,2004-11-23,Evidence at protein level
Q92688,AN32B_HUMAN,Acidic leucine-rich nuclear phosphoprotein 32 family member B (Acidic protein rich in leucines) (Putative HLA-DR-associated protein I-2) (PHAPI2) (Silver-stainable protein SSP29),251,"28,788",5 out of 5,2002-12-06,Evidence at protein level
Q9Y5C1,ANGL3_HUMAN,Angiopoietin-related protein 3 (Angiopoietin-5) (ANG-5) (Angiopoietin-like protein 3) [Cleaved into: ANGPTL3(17-221); ANGPTL3(17-224)],460,"53,637",5 out of 5,2002-11-08,Evidence at protein level
Q9Y264,ANGP4_HUMAN,Angiopoietin-4 (ANG-4) (Angiopoietin-3) (ANG-3),503,"56,849",5 out of 5,2001-08-29,Evidence at protein level
P01019,ANGT_HUMAN,Angiotensinogen (Serpin A8) [Cleaved into: Angiotensin-1 (Angiotensin 1-10) (Angiotensin I) (Ang I); Angiotensin-2 (Angiotensin 1-8) (Angiotensin II) (Ang II); Angiotensin-3 (Angiotensin 2-8) (Angiotensin III) (Ang III) (Des-Asp[1]-angiotensin II); Angiotensin-4 (Angiotensin 3-8) (Angiotensin IV) (Ang IV); Angiotensin 1-9; Angiotensin 1-7; Angiotensin 1-5; Angiotensin 1-4],485,"53,154",5 out of 5,1986-07-21,Evidence at protein level
Q68DC2,ANKS6_HUMAN,Ankyrin repeat and SAM domain-containing protein 6 (Ankyrin repeat domain-containing protein 14) (SamCystin) (Sterile alpha motif domain-containing protein 6) (SAM domain-containing protein 6),871,"92,219",5 out of 5,2005-12-06,Evidence at protein level
Q8IV38,ANKY2_HUMAN,Ankyrin repeat and MYND domain-containing protein 2,441,"49,299",2 out of 5,2006-07-25,Evidence at protein level
Q99873,ANM1_HUMAN,Protein arginine N-methyltransferase 1 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT1) (Interferon receptor 1-bound protein 4),361,"41,516",5 out of 5,1997-11-01,Evidence at protein level
O60678,ANM3_HUMAN,Protein arginine N-methyltransferase 3 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 3),531,"59,876",5 out of 5,2001-01-11,Evidence at protein level
Q9BYT9,ANO3_HUMAN,Anoctamin-3 (Transmembrane protein 16C),981,"114,657",5 out of 5,2004-01-16,Evidence at protein level
A1A5B4,ANO9_HUMAN,Anoctamin-9 (Transmembrane protein 16J) (Tumor protein p53-inducible protein 5) (p53-induced gene 5 protein),782,"90,333",5 out of 5,2007-05-29,Evidence at protein level
P17342,ANPRC_HUMAN,Atrial natriuretic peptide receptor 3 (Atrial natriuretic peptide clearance receptor) (Atrial natriuretic peptide receptor type C) (ANP-C) (ANPR-C) (NPR-C),541,"59,808",5 out of 5,1990-08-01,Evidence at protein level
Q86SG2,ANR23_HUMAN,Ankyrin repeat domain-containing protein 23 (Diabetes-related ankyrin repeat protein) (Muscle ankyrin repeat protein 3),305,"34,297",5 out of 5,2006-06-27,Evidence at protein level
O15084,ANR28_HUMAN,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A (PP6-ARS-A) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-A) (Ankyrin repeat domain-containing protein 28) (Phosphatase interactor targeting protein hnRNP K) (PITK),1053,"112,966",5 out of 5,2001-06-20,Evidence at protein level
Q7Z713,ANR37_HUMAN,Ankyrin repeat domain-containing protein 37 (Low-density lipoprotein receptor-related protein 2-binding protein) (hLrp2bp),158,"16,872",3 out of 5,2006-06-27,Evidence at transcript level
A6NGH8,ANR61_HUMAN,Ankyrin repeat domain-containing protein 61,418,"46,141",1 out of 5,2008-04-08,Predicted
B4E2M5,ANR66_HUMAN,Ankyrin repeat domain-containing protein 66,251,"27,916",2 out of 5,2013-03-06,Evidence at transcript level
C9JRZ8,AK1BF_HUMAN,Aldo-keto reductase family 1 member B15 (EC 1.1.1.-) (Estradiol 17-beta-dehydrogenase AKR1B15) (EC 1.1.1.62),316,"36,537",5 out of 5,2010-07-13,Evidence at protein level
P42330,AK1C3_HUMAN,"Aldo-keto reductase family 1 member C3 (EC 1.-.-.-) (17-beta-hydroxysteroid dehydrogenase type 5) (17-beta-HSD 5) (3-alpha-HSD type II, brain) (3-alpha-hydroxysteroid dehydrogenase type 2) (3-alpha-HSD type 2) (EC 1.1.1.357) (Chlordecone reductase homolog HAKRb) (Dihydrodiol dehydrogenase 3) (DD-3) (DD3) (Dihydrodiol dehydrogenase type I) (HA1753) (Indanol dehydrogenase) (EC 1.1.1.112) (Prostaglandin F synthase) (PGFS) (EC 1.1.1.188) (Testosterone 17-beta-dehydrogenase 5) (EC 1.1.1.239) (EC 1.1.1.64) (Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase) (EC 1.3.1.20)",323,"36,853",5 out of 5,1995-11-01,Evidence at protein level
Q86UN6,AKA28_HUMAN,A-kinase anchor protein 14 (AKAP-14) (A-kinase anchor protein 28 kDa) (AKAP 28) (Protein kinase A-anchoring protein 14) (PRKA14),197,"22,815",4 out of 5,2004-04-13,Evidence at protein level
O75969,AKAP3_HUMAN,A-kinase anchor protein 3 (AKAP-3) (A-kinase anchor protein 110 kDa) (AKAP 110) (Cancer/testis antigen 82) (CT82) (Fibrous sheath protein of 95 kDa) (FSP95) (Fibrousheathin I) (Fibrousheathin-1) (Protein kinase A-anchoring protein 3) (PRKA3) (Sperm oocyte-binding protein),853,"94,751",5 out of 5,2001-06-01,Evidence at protein level
O43823,AKAP8_HUMAN,A-kinase anchor protein 8 (AKAP-8) (A-kinase anchor protein 95 kDa) (AKAP 95),692,"76,108",5 out of 5,1999-07-15,Evidence at protein level
O94788,AL1A2_HUMAN,Retinal dehydrogenase 2 (RALDH 2) (RalDH2) (EC 1.2.1.36) (Aldehyde dehydrogenase family 1 member A2) (Retinaldehyde-specific dehydrogenase type 2) (RALDH(II)),518,"56,724",5 out of 5,1999-07-15,Evidence at protein level
Q3SY69,AL1L2_HUMAN,Mitochondrial 10-formyltetrahydrofolate dehydrogenase (Mitochondrial 10-FTHFDH) (mtFDH) (EC 1.5.1.6) (Aldehyde dehydrogenase family 1 member L2),923,"101,746",5 out of 5,2008-01-15,Evidence at protein level
Q60I27,AL2CL_HUMAN,ALS2 C-terminal-like protein,953,"107,748",5 out of 5,2008-01-15,Evidence at protein level
P30838,AL3A1_HUMAN,"Aldehyde dehydrogenase, dimeric NADP-preferring (EC 1.2.1.5) (ALDHIII) (Aldehyde dehydrogenase 3) (Aldehyde dehydrogenase family 3 member A1)",453,"50,395",5 out of 5,1993-07-01,Evidence at protein level
P43353,AL3B1_HUMAN,Aldehyde dehydrogenase family 3 member B1 (EC 1.2.1.5) (Aldehyde dehydrogenase 7),468,"51,840",5 out of 5,1995-11-01,Evidence at protein level
Q8TD30,ALAT2_HUMAN,Alanine aminotransferase 2 (ALT2) (EC 2.6.1.2) (Glutamate pyruvate transaminase 2) (GPT 2) (Glutamic--alanine transaminase 2) (Glutamic--pyruvic transaminase 2),523,"57,904",5 out of 5,2006-07-25,Evidence at protein level
Q9NP73,ALG13_HUMAN,Putative bifunctional UDP-N-acetylglucosamine transferase and deubiquitinase ALG13 (EC 2.4.1.141) (EC 3.4.19.12) (Asparagine-linked glycosylation 13 homolog) (Glycosyltransferase 28 domain-containing protein 1) (UDP-N-acetylglucosamine transferase subunit ALG13 homolog),1137,"126,056",5 out of 5,2006-10-31,Evidence at protein level
Q9Y673,ALG5_HUMAN,Dolichyl-phosphate beta-glucosyltransferase (DolP-glucosyltransferase) (EC 2.4.1.117) (Asparagine-linked glycosylation protein 5 homolog),324,"36,946",4 out of 5,2003-01-10,Evidence at protein level
Q9H161,ALX4_HUMAN,Homeobox protein aristaless-like 4,411,"44,241",5 out of 5,2001-04-27,Evidence at protein level
Q86YJ7,AN13B_HUMAN,Ankyrin repeat domain-containing protein 13B,626,"70,205",4 out of 5,2006-06-27,Evidence at protein level
Q8IVF6,AN18A_HUMAN,Ankyrin repeat domain-containing protein 18A,992,"115,597",3 out of 5,2003-12-15,Evidence at transcript level
P0C6C1,AN34C_HUMAN,Ankyrin repeat domain-containing protein 34C,535,"58,256",2 out of 5,2008-02-26,Inferred from homology
Q8N2N9,AN36B_HUMAN,Ankyrin repeat domain-containing protein 36B (CLL-associated antigen KW-1),1353,"153,582",3 out of 5,2006-06-27,Evidence at protein level
Q96K21,ANCHR_HUMAN,Abscission/NoCut checkpoint regulator (ANCHR) (MLL partner containing FYVE domain) (Zinc finger FYVE domain-containing protein 19),471,"51,546",5 out of 5,2005-05-24,Evidence at protein level
Q9UKU9,ANGL2_HUMAN,Angiopoietin-related protein 2 (Angiopoietin-like protein 2),493,"57,104",4 out of 5,2001-04-27,Evidence at transcript level
Q01484,ANK2_HUMAN,Ankyrin-2 (ANK-2) (Ankyrin-B) (Brain ankyrin) (Non-erythroid ankyrin),3957,"433,715",5 out of 5,1993-04-01,Evidence at protein level
Q12955,ANK3_HUMAN,Ankyrin-3 (ANK-3) (Ankyrin-G),4377,"480,410",5 out of 5,2002-07-11,Evidence at protein level
O14744,ANM5_HUMAN,"Protein arginine N-methyltransferase 5 (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]",637,"72,684",5 out of 5,2003-06-20,Evidence at protein level
Q4KMQ2,ANO6_HUMAN,Anoctamin-6 (Small-conductance calcium-activated nonselective cation channel) (SCAN channel) (Transmembrane protein 16F),910,"106,165",5 out of 5,2005-09-13,Evidence at protein level
P20594,ANPRB_HUMAN,Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B),1047,"117,022",5 out of 5,1991-02-01,Evidence at protein level
Q53RE8,ANR39_HUMAN,Ankyrin repeat domain-containing protein 39,183,"19,651",2 out of 5,2006-06-27,Evidence at protein level
Q86W74,ANR46_HUMAN,Ankyrin repeat domain-containing protein 46 (Ankyrin repeat small protein) (ANK-S),232,"25,967",2 out of 5,2006-06-27,Evidence at protein level
Q8WVL7,ANR49_HUMAN,Ankyrin repeat domain-containing protein 49 (Fetal globin-inducing factor),239,"27,290",3 out of 5,2006-06-27,Evidence at protein level
Q3KP44,ANR55_HUMAN,Ankyrin repeat domain-containing protein 55,614,"68,414",2 out of 5,2007-02-06,Evidence at protein level
Q96PC3,AP1S3_HUMAN,AP-1 complex subunit sigma-3 (Adaptor protein complex AP-1 subunit sigma-1C) (Adaptor-related protein complex 1 subunit sigma-1C) (Clathrin assembly protein complex 1 sigma-1C small chain) (Golgi adaptor HA1/AP1 adaptin sigma-1C subunit) (Sigma 1C subunit of AP-1 clathrin) (Sigma-adaptin 1C) (Sigma1C-adaptin),154,"18,280",5 out of 5,2002-06-20,Evidence at protein level
Q9ULZ1,APEL_HUMAN,Apelin (APJ endogenous ligand) [Cleaved into: Apelin-36; Apelin-31; Apelin-28; Apelin-13],77,"8,569",5 out of 5,2002-01-23,Evidence at transcript level
Q9UBZ4,APEX2_HUMAN,DNA-(apurinic or apyrimidinic site) lyase 2 (EC 3.1.-.-) (EC 4.2.99.18) (AP endonuclease XTH2) (APEX nuclease 2) (APEX nuclease-like 2) (Apurinic-apyrimidinic endonuclease 2) (AP endonuclease 2),518,"57,401",5 out of 5,2005-08-30,Evidence at protein level
Q96LR9,APLD1_HUMAN,Apolipoprotein L domain-containing protein 1 (Vascular early response gene protein),279,"30,546",5 out of 5,2006-07-25,Evidence at transcript level
P02654,APOC1_HUMAN,Apolipoprotein C-I (Apo-CI) (ApoC-I) (Apolipoprotein C1) [Cleaved into: Truncated apolipoprotein C-I],83,"9,332",5 out of 5,1986-07-21,Evidence at protein level
O95445,APOM_HUMAN,Apolipoprotein M (Apo-M) (ApoM) (Protein G3a),188,"21,253",5 out of 5,2001-09-26,Evidence at protein level
Q96NN9,AIFM3_HUMAN,Apoptosis-inducing factor 3 (EC 1.-.-.-) (Apoptosis-inducing factor-like protein),605,"66,791",5 out of 5,2006-10-31,Evidence at protein level
Q9NZN9,AIPL1_HUMAN,Aryl-hydrocarbon-interacting protein-like 1,384,"43,903",5 out of 5,2001-01-11,Evidence at protein level
A6NHY2,AKD1B_HUMAN,Ankyrin repeat and death domain-containing protein 1B,528,"59,088",2 out of 5,2008-04-29,Predicted
Q9P2G1,AKIB1_HUMAN,Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.-),1089,"122,002",5 out of 5,2005-01-04,Evidence at protein level
Q9Y243,AKT3_HUMAN,RAC-gamma serine/threonine-protein kinase (EC 2.7.11.1) (Protein kinase Akt-3) (Protein kinase B gamma) (PKB gamma) (RAC-PK-gamma) (STK-2),479,"55,775",5 out of 5,2000-12-01,Evidence at protein level
P49189,AL9A1_HUMAN,"4-trimethylaminobutyraldehyde dehydrogenase (TMABADH) (EC 1.2.1.47) (Aldehyde dehydrogenase E3 isozyme) (Aldehyde dehydrogenase family 9 member A1) (EC 1.2.1.3) (Gamma-aminobutyraldehyde dehydrogenase) (EC 1.2.1.19) (R-aminobutyraldehyde dehydrogenase) [Cleaved into: 4-trimethylaminobutyraldehyde dehydrogenase, N-terminally processed]",494,"53,802",5 out of 5,1996-02-01,Evidence at protein level
P05062,ALDOB_HUMAN,Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase),364,"39,473",5 out of 5,1987-08-13,Evidence at protein level
Q86TB3,ALPK2_HUMAN,Alpha-protein kinase 2 (EC 2.7.11.-) (Heart alpha-protein kinase),2170,"237,013",5 out of 5,2006-11-28,Evidence at transcript level
Q8IY45,AMN1_HUMAN,Protein AMN1 homolog,258,"28,408",2 out of 5,2007-05-29,Evidence at transcript level
Q9H4A4,AMPB_HUMAN,Aminopeptidase B (AP-B) (EC 3.4.11.6) (Arginine aminopeptidase) (Arginyl aminopeptidase),650,"72,596",5 out of 5,2002-03-27,Evidence at protein level
Q01432,AMPD3_HUMAN,AMP deaminase 3 (EC 3.5.4.6) (AMP deaminase isoform E) (Erythrocyte AMP deaminase),767,"88,812",5 out of 5,1993-07-01,Evidence at protein level
P49418,AMPH_HUMAN,Amphiphysin,695,"76,257",5 out of 5,1996-02-01,Evidence at protein level
P04745,AMY1_HUMAN,"Alpha-amylase 1 (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase 1) (Salivary alpha-amylase)",511,"57,768",5 out of 5,1987-08-13,Evidence at protein level
Q400G9,AMZ1_HUMAN,Archaemetzincin-1 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 1),498,"54,924",4 out of 5,2006-01-10,Evidence at protein level
A6NCL7,AN33B_HUMAN,Ankyrin repeat domain-containing protein 33B,494,"53,975",2 out of 5,2008-04-08,Inferred from homology
A5PLL1,AN34B_HUMAN,Ankyrin repeat domain-containing protein 34B,514,"56,414",2 out of 5,2008-02-26,Evidence at transcript level
P16157,ANK1_HUMAN,Ankyrin-1 (ANK-1) (Ankyrin-R) (Erythrocyte ankyrin),1881,"206,265",5 out of 5,1990-04-01,Evidence at protein level
Q8IWZ3,ANKH1_HUMAN,Ankyrin repeat and KH domain-containing protein 1 (HIV-1 Vpr-binding ankyrin repeat protein) (Multiple ankyrin repeats single KH domain) (hMASK),2542,"269,458",5 out of 5,2007-10-02,Evidence at protein level
Q9Y2G4,ANKR6_HUMAN,Ankyrin repeat domain-containing protein 6 (Diversin),727,"79,971",4 out of 5,2001-06-20,Evidence at transcript level
Q9UPM8,AP4E1_HUMAN,AP-4 complex subunit epsilon-1 (AP-4 adaptor complex subunit epsilon) (Adaptor-related protein complex 4 subunit epsilon-1) (Epsilon subunit of AP-4) (Epsilon-adaptin),1137,"127,287",5 out of 5,2001-04-27,Evidence at protein level
O43299,AP5Z1_HUMAN,AP-5 complex subunit zeta-1 (Adaptor-related protein complex 5 zeta subunit) (Zeta5),807,"88,605",5 out of 5,2001-02-21,Evidence at protein level
Q9NYG5,APC11_HUMAN,Anaphase-promoting complex subunit 11 (APC11) (Cyclosome subunit 11) (Hepatocellular carcinoma-associated RING finger protein),84,"9,841",5 out of 5,2001-08-29,Evidence at protein level
P08319,ADH4_HUMAN,Alcohol dehydrogenase 4 (EC 1.1.1.1) (Alcohol dehydrogenase class II pi chain),380,"40,222",5 out of 5,1988-08-01,Evidence at protein level
Q0VDE8,ADIG_HUMAN,Adipogenin,80,"9,465",2 out of 5,2007-07-24,Inferred from homology
P35318,ADML_HUMAN,ADM [Cleaved into: Adrenomedullin (AM); Proadrenomedullin N-20 terminal peptide (ProAM N-terminal 20 peptide) (PAMP) (ProAM-N20)],185,"20,420",5 out of 5,1994-02-01,Evidence at protein level
Q6IQ32,ADNP2_HUMAN,ADNP homeobox protein 2 (Zinc finger protein 508),1131,"122,833",4 out of 5,2007-03-20,Evidence at protein level
P07550,ADRB2_HUMAN,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),413,"46,459",5 out of 5,1988-04-01,Evidence at protein level
P51825,AFF1_HUMAN,AF4/FMR2 family member 1 (ALL1-fused gene from chromosome 4 protein) (Protein AF-4) (Protein FEL) (Proto-oncogene AF4),1210,"131,422",5 out of 5,1996-10-01,Evidence at protein level
Q9UPQ3,AGAP1_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) (GTP-binding and GTPase-activating protein 1) (GGAP1)",857,"94,470",5 out of 5,2003-01-27,Evidence at protein level
Q9H9G7,AGO3_HUMAN,Protein argonaute-3 (Argonaute3) (hAgo3) (Argonaute RISC catalytic component 3) (Eukaryotic translation initiation factor 2C 3) (eIF-2C 3) (eIF2C 3),860,"97,360",5 out of 5,2003-11-14,Evidence at protein level
A8MT82,AGP14_HUMAN,"Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 14 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 14 pseudogene) (Centaurin-gamma-like family member 11 pseudogene)",685,"75,435",2 out of 5,2008-09-02,Inferred from homology
Q7Z7M1,AGRD2_HUMAN,Adhesion G-protein coupled receptor D2 (G-protein coupled receptor 144) (G-protein coupled receptor PGR24),963,"104,087",4 out of 5,2005-02-15,Evidence at transcript level
Q86SQ3,AGRE4_HUMAN,Putative adhesion G protein-coupled receptor E4P (EGF-like module receptor 4) (EGF-like module-containing mucin-like hormone receptor-like 4) (G-protein coupled receptor 127) (G-protein coupled receptor PGR16),457,"50,903",5 out of 5,2004-03-01,Uncertain
Q5T601,AGRF1_HUMAN,Adhesion G-protein coupled receptor F1 (G-protein coupled receptor 110) (G-protein coupled receptor KPG_012) (G-protein coupled receptor PGR19),910,"101,365",5 out of 5,2005-03-01,Evidence at protein level
Q9Y653,AGRG1_HUMAN,Adhesion G-protein coupled receptor G1 (G-protein coupled receptor 56) (Protein TM7XN1) [Cleaved into: ADGRG1 N-terminal fragment (ADGRG1 NT) (GPR56 N-terminal fragment) (GPR56 NT) (GPR56(N)) (GPR56 extracellular subunit) (GPR56 subunit alpha); ADGRG1 C-terminal fragment (ADGRG1 CT) (GPR56 C-terminal fragment) (GPR56 CT) (GPR56(C)) (GPR56 seven-transmembrane subunit) (GPR56 7TM) (GPR56 subunit beta)],693,"77,738",5 out of 5,2004-03-15,Evidence at protein level
Q9HAR2,AGRL3_HUMAN,Adhesion G protein-coupled receptor L3 (Calcium-independent alpha-latrotoxin receptor 3) (CIRL-3) (Latrophilin-3) (Lectomedin-3),1447,"161,812",5 out of 5,2004-05-10,Evidence at protein level
Q9HBW9,AGRL4_HUMAN,"Adhesion G protein-coupled receptor L4 (EGF, latrophilin and seven transmembrane domain-containing protein 1) (EGF-TM7-latrophilin-related protein) (ETL protein)",690,"77,811",5 out of 5,2004-02-16,Evidence at protein level
Q9Y4K1,AIM1_HUMAN,Absent in melanoma 1 protein (Beta/gamma crystallin domain-containing protein 1),1723,"188,676",3 out of 5,2001-01-24,Evidence at protein level
Q96B36,AKTS1_HUMAN,Proline-rich AKT1 substrate 1 (40 kDa proline-rich AKT substrate),256,"27,383",5 out of 5,2006-10-17,Evidence at protein level
P00352,AL1A1_HUMAN,"Retinal dehydrogenase 1 (RALDH 1) (RalDH1) (EC 1.2.1.-) (EC 1.2.1.36) (ALDH-E1) (ALHDII) (Aldehyde dehydrogenase family 1 member A1) (Aldehyde dehydrogenase, cytosolic)",501,"54,862",5 out of 5,1986-07-21,Evidence at protein level
Q96F25,ALG14_HUMAN,UDP-N-acetylglucosamine transferase subunit ALG14 homolog,216,"24,151",4 out of 5,2006-12-12,Evidence at protein level
Q9H553,ALG2_HUMAN,"Alpha-1,3/1,6-mannosyltransferase ALG2 (EC 2.4.1.132) (EC 2.4.1.257) (Asparagine-linked glycosylation protein 2 homolog) (GDP-Man:Man(1)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase) (GDP-Man:Man(1)GlcNAc(2)-PP-dolichol mannosyltransferase) (GDP-Man:Man(2)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase)",416,"47,092",5 out of 5,2004-04-13,Evidence at protein level
Q3KRA9,ALKB6_HUMAN,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 6 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 6),238,"26,483",5 out of 5,2008-03-18,Evidence at protein level
Q96BT7,ALKB8_HUMAN,Alkylated DNA repair protein alkB homolog 8 (EC 1.14.11.-) (Probable alpha-ketoglutarate-dependent dioxygenase ABH8) (S-adenosyl-L-methionine-dependent tRNA methyltransferase ABH8) (tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ABH8) (EC 2.1.1.229),664,"75,208",5 out of 5,2008-05-20,Evidence at protein level
Q4VCS5,AMOT_HUMAN,Angiomotin,1084,"118,085",5 out of 5,2005-09-27,Evidence at protein level
Q96L96,ALPK3_HUMAN,Alpha-protein kinase 3 (EC 2.7.11.-) (Muscle alpha-protein kinase),1907,"201,272",5 out of 5,2006-11-28,Evidence at transcript level
Q6DCA0,AMERL_HUMAN,AMMECR1-like protein,310,"34,499",1 out of 5,2007-02-20,Evidence at protein level
P30533,AMRP_HUMAN,Alpha-2-macroglobulin receptor-associated protein (Alpha-2-MRAP) (Low density lipoprotein receptor-related protein-associated protein 1) (RAP),357,"41,466",5 out of 5,1993-04-01,Evidence at protein level
Q8IZ07,AN13A_HUMAN,Ankyrin repeat domain-containing protein 13A (Protein KE03),590,"67,619",5 out of 5,2004-07-19,Evidence at protein level
Q5CZ79,AN20B_HUMAN,Ankyrin repeat domain-containing protein 20B (Ankyrin repeat domain-containing protein 20A pseudogene),823,"93,909",2 out of 5,2008-04-08,Evidence at transcript level
Q9BTT0,AN32E_HUMAN,Acidic leucine-rich nuclear phosphoprotein 32 family member E (LANP-like protein) (LANP-L),268,"30,692",5 out of 5,2003-05-09,Evidence at protein level
Q9UJX6,ANC2_HUMAN,Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2),822,"93,828",5 out of 5,2003-10-03,Evidence at protein level
P16860,ANFB_HUMAN,Natriuretic peptides B (Gamma-brain natriuretic peptide) [Cleaved into: Brain natriuretic peptide 32 (BNP(1-32)) (BNP-32); BNP(1-30); BNP(1-29); BNP(1-28); BNP(2-31); BNP(3-32); BNP(3-30); BNP(3-29); BNP(4-32); BNP(4-31); BNP(4-30); BNP(4-29); BNP(4-27); BNP(5-32); BNP(5-31); BNP(5-29)],134,"14,726",5 out of 5,1990-08-01,Evidence at protein level
Q9P2R3,ANFY1_HUMAN,Rabankyrin-5 (Rank-5) (Ankyrin repeat and FYVE domain-containing protein 1) (Ankyrin repeats hooked to a zinc finger motif),1169,"128,399",5 out of 5,2003-08-04,Evidence at protein level
Q9UNK9,ANGE1_HUMAN,Protein angel homolog 1,670,"75,276",4 out of 5,2001-11-02,Evidence at protein level
Q8NFD2,ANKK1_HUMAN,Ankyrin repeat and protein kinase domain-containing protein 1 (EC 2.7.11.1) (Protein kinase PKK2) (Sugen kinase 288) (SgK288) (X-kinase),765,"84,632",5 out of 5,2006-01-24,Evidence at transcript level
Q6ZW76,ANKS3_HUMAN,Ankyrin repeat and SAM domain-containing protein 3,656,"72,038",4 out of 5,2006-04-04,Evidence at protein level
Q9NR22,ANM8_HUMAN,Protein arginine N-methyltransferase 8 (EC 2.1.1.-) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 4),394,"45,291",5 out of 5,2001-01-11,Evidence at protein level
O14727,APAF_HUMAN,Apoptotic protease-activating factor 1 (APAF-1),1248,"141,840",5 out of 5,1998-07-15,Evidence at protein level
O00213,APBB1_HUMAN,Amyloid beta A4 precursor protein-binding family B member 1 (Protein Fe65),710,"77,244",5 out of 5,2001-01-11,Evidence at protein level
Q9UM13,APC10_HUMAN,Anaphase-promoting complex subunit 10 (APC10) (Cyclosome subunit 10),185,"21,252",5 out of 5,2003-08-29,Evidence at protein level
Q06481,APLP2_HUMAN,Amyloid-like protein 2 (APLP-2) (APPH) (Amyloid protein homolog) (CDEI box-binding protein) (CDEBP),763,"86,956",5 out of 5,1994-06-01,Evidence at protein level
P02656,APOC3_HUMAN,Apolipoprotein C-III (Apo-CIII) (ApoC-III) (Apolipoprotein C3),99,"10,852",5 out of 5,1986-07-21,Evidence at protein level
P02649,APOE_HUMAN,Apolipoprotein E (Apo-E),317,"36,154",5 out of 5,1986-07-21,Evidence at protein level
Q9BQE5,APOL2_HUMAN,Apolipoprotein L2 (Apolipoprotein L-II) (ApoL-II),337,"37,092",4 out of 5,2001-08-29,Evidence at protein level
Q53RT3,APRV1_HUMAN,Retroviral-like aspartic protease 1 (EC 3.4.23.-) (Skin-specific retroviral-like aspartic protease) (SASPase) (Skin aspartic protease) (TPA-inducible aspartic proteinase-like protein) (TAPS),343,"36,991",5 out of 5,2007-01-09,Evidence at protein level
P53367,ARFP1_HUMAN,Arfaptin-1 (ADP-ribosylation factor-interacting protein 1),373,"41,738",5 out of 5,1996-10-01,Evidence at protein level
Q13795,ARFRP_HUMAN,ADP-ribosylation factor-related protein 1 (ARF-related protein 1) (ARP),201,"22,614",5 out of 5,1997-11-01,Evidence at protein level
Q8N1W1,ARG28_HUMAN,Rho guanine nucleotide exchange factor 28 (190 kDa guanine nucleotide exchange factor) (p190-RhoGEF) (p190RhoGEF) (Rho guanine nucleotide exchange factor),1705,"191,891",5 out of 5,2008-03-18,Evidence at protein level
P05089,ARGI1_HUMAN,Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase),322,"34,735",5 out of 5,1987-08-13,Evidence at protein level
A1IGU5,ARH37_HUMAN,Rho guanine nucleotide exchange factor 37,675,"76,278",3 out of 5,2008-05-20,Evidence at transcript level
Q12774,ARHG5_HUMAN,Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM),1597,"176,799",5 out of 5,1999-07-15,Evidence at protein level
Q5VV41,ARHGG_HUMAN,Rho guanine nucleotide exchange factor 16 (Ephexin-4),709,"80,105",5 out of 5,2006-05-02,Evidence at protein level
Q5SW96,ARH_HUMAN,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein),308,"33,885",5 out of 5,2005-08-30,Evidence at protein level
Q99856,ARI3A_HUMAN,AT-rich interactive domain-containing protein 3A (ARID domain-containing protein 3A) (B-cell regulator of IgH transcription) (Bright) (Dead ringer-like protein 1) (E2F-binding protein 1),593,"62,889",5 out of 5,2001-01-11,Evidence at protein level
O95154,ARK73_HUMAN,Aflatoxin B1 aldehyde reductase member 3 (EC 1.-.-.-) (AFB1 aldehyde reductase 2) (AFB1-AR 2),331,"37,206",5 out of 5,2001-02-21,Evidence at protein level
Q0P5N6,ARL16_HUMAN,ADP-ribosylation factor-like protein 16,197,"20,936",2 out of 5,2006-12-12,Evidence at protein level
Q9H0F7,ARL6_HUMAN,ADP-ribosylation factor-like protein 6 (Bardet-Biedl syndrome 3 protein),186,"21,097",5 out of 5,2001-06-20,Evidence at protein level
P04424,ARLY_HUMAN,Argininosuccinate lyase (ASAL) (EC 4.3.2.1) (Arginosuccinase),464,"51,658",5 out of 5,1987-08-13,Evidence at protein level
P27695,APEX1_HUMAN,"DNA-(apurinic or apyrimidinic site) lyase (EC 3.1.-.-) (EC 4.2.99.18) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (REF-1) (Redox factor-1) [Cleaved into: DNA-(apurinic or apyrimidinic site) lyase, mitochondrial]",318,"35,555",5 out of 5,1992-08-01,Evidence at protein level
P35414,APJ_HUMAN,Apelin receptor (Angiotensin receptor-like 1) (G-protein coupled receptor APJ) (G-protein coupled receptor HG11),380,"42,660",5 out of 5,1994-06-01,Evidence at protein level
P07741,APT_HUMAN,Adenine phosphoribosyltransferase (APRT) (EC 2.4.2.7),180,"19,608",5 out of 5,1988-08-01,Evidence at protein level
Q13520,AQP6_HUMAN,Aquaporin-6 (AQP-6) (Aquaporin-2-like) (Kidney-specific aquaporin) (hKID),282,"29,370",4 out of 5,1997-11-01,Evidence at transcript level
P10398,ARAF_HUMAN,Serine/threonine-protein kinase A-Raf (EC 2.7.11.1) (Proto-oncogene A-Raf) (Proto-oncogene A-Raf-1) (Proto-oncogene Pks),606,"67,585",5 out of 5,1988-04-01,Evidence at protein level
Q8IWT0,ARCH_HUMAN,Protein archease (Protein ZBTB8OS) (Zinc finger and BTB domain-containing opposite strand protein 8),167,"19,491",5 out of 5,2007-05-01,Evidence at protein level
Q8NHP1,ARK74_HUMAN,Aflatoxin B1 aldehyde reductase member 4 (EC 1.-.-.-) (AFB1 aldehyde reductase 3) (AFB1-AR 3) (Aldoketoreductase 7-like),331,"36,964",4 out of 5,2003-12-15,Evidence at transcript level
Q6NXE6,ARMC6_HUMAN,Armadillo repeat-containing protein 6,501,"54,142",3 out of 5,2006-06-27,Evidence at protein level
Q7Z3E5,ARMC9_HUMAN,LisH domain-containing protein ARMC9 (Melanoma/melanocyte-specific tumor antigen KU-MEL-1) (NS21),817,"91,762",4 out of 5,2007-03-20,Evidence at protein level
Q5H9R4,ARMX4_HUMAN,Armadillo repeat-containing X-linked protein 4,360,"39,406",2 out of 5,2005-12-20,Evidence at transcript level
P56211,ARP19_HUMAN,cAMP-regulated phosphoprotein 19 (ARPP-19),112,"12,323",5 out of 5,1998-07-15,Evidence at protein level
Q9P1U1,ARP3B_HUMAN,Actin-related protein 3B (ARP3-beta) (Actin-like protein 3B) (Actin-related protein ARP4),418,"47,608",5 out of 5,2008-07-22,Evidence at transcript level
Q9BPX5,ARP5L_HUMAN,Actin-related protein 2/3 complex subunit 5-like protein (Arp2/3 complex 16 kDa subunit 2) (ARC16-2),153,"16,941",4 out of 5,2007-03-06,Evidence at protein level
Q5T4W7,ARTN_HUMAN,Artemin (Enovin) (Neublastin),220,"22,878",5 out of 5,2006-06-13,Evidence at protein level
O00192,ARVC_HUMAN,Armadillo repeat protein deleted in velo-cardio-facial syndrome,962,"104,642",5 out of 5,2000-12-01,Evidence at protein level
Q96QS3,ARX_HUMAN,Homeobox protein ARX (Aristaless-related homeobox),562,"58,160",5 out of 5,2003-01-27,Evidence at protein level
Q6UB98,ANR12_HUMAN,Ankyrin repeat domain-containing protein 12 (Ankyrin repeat-containing cofactor 2) (GAC-1 protein),2062,"235,652",5 out of 5,2004-07-19,Evidence at protein level
Q9H560,ANR19_HUMAN,Putative ankyrin repeat domain-containing protein 19 (Ankyrin repeat domain-containing protein 19 pseudogene),264,"30,436",2 out of 5,2006-06-27,Uncertain
Q8N8V4,ANS4B_HUMAN,Ankyrin repeat and SAM domain-containing protein 4B (Harmonin-interacting ankyrin repeat-containing protein) (Harp),417,"46,597",5 out of 5,2004-11-09,Evidence at protein level
P28039,AOAH_HUMAN,Acyloxyacyl hydrolase (EC 3.1.1.77) [Cleaved into: Acyloxyacyl hydrolase small subunit; Acyloxyacyl hydrolase large subunit],575,"65,105",5 out of 5,1992-08-01,Evidence at protein level
P19801,AOC1_HUMAN,Amiloride-sensitive amine oxidase [copper-containing] (DAO) (Diamine oxidase) (EC 1.4.3.22) (Amiloride-binding protein 1) (Amine oxidase copper domain-containing protein 1) (Histaminase) (Kidney amine oxidase) (KAO),751,"85,378",5 out of 5,1991-02-01,Evidence at protein level
Q16853,AOC3_HUMAN,Membrane primary amine oxidase (EC 1.4.3.21) (Copper amine oxidase) (HPAO) (Semicarbazide-sensitive amine oxidase) (SSAO) (Vascular adhesion protein 1) (VAP-1),763,"84,622",5 out of 5,1997-11-01,Evidence at protein level
P05549,AP2A_HUMAN,Transcription factor AP-2-alpha (AP2-alpha) (AP-2 transcription factor) (Activating enhancer-binding protein 2-alpha) (Activator protein 2) (AP-2),437,"48,062",5 out of 5,1989-07-01,Evidence at protein level
Q92754,AP2C_HUMAN,Transcription factor AP-2 gamma (AP2-gamma) (Activating enhancer-binding protein 2 gamma) (Transcription factor ERF-1),450,"49,177",5 out of 5,2001-01-24,Evidence at protein level
Q9H0R1,AP5M1_HUMAN,AP-5 complex subunit mu-1 (Adaptor-related protein complex 5 subunit mu-1) (Mu5) (Mu-2-related death-inducing protein) (MuD) (Putative HIV-1 infection-related protein),490,"54,767",5 out of 5,2003-10-03,Evidence at protein level
P60006,APC15_HUMAN,Anaphase-promoting complex subunit 15 (APC15),121,"14,281",5 out of 5,2003-11-14,Evidence at protein level
P06727,APOA4_HUMAN,Apolipoprotein A-IV (Apo-AIV) (ApoA-IV) (Apolipoprotein A4),396,"45,399",5 out of 5,1988-01-01,Evidence at protein level
Q0VD83,APOBR_HUMAN,Apolipoprotein B receptor (Apolipoprotein B-100 receptor) (Apolipoprotein B-48 receptor) (Apolipoprotein B48 receptor) (apoB-48R),1088,"114,874",5 out of 5,2008-04-08,Evidence at protein level
P04114,APOB_HUMAN,Apolipoprotein B-100 (Apo B-100) [Cleaved into: Apolipoprotein B-48 (Apo B-48)],4563,"515,605",5 out of 5,1986-11-01,Evidence at protein level
P02655,APOC2_HUMAN,Apolipoprotein C-II (Apo-CII) (ApoC-II) (Apolipoprotein C2) [Cleaved into: Proapolipoprotein C-II (ProapoC-II)],101,"11,284",5 out of 5,1986-07-21,Evidence at protein level
Q9BWW8,APOL6_HUMAN,Apolipoprotein L6 (Apolipoprotein L-VI) (ApoL-VI),343,"38,128",3 out of 5,2001-08-29,Evidence at transcript level
Q9HCE6,ARGAL_HUMAN,Rho guanine nucleotide exchange factor 10-like protein (GrinchGEF),1279,"140,409",5 out of 5,2008-07-01,Evidence at protein level
Q9NXL2,ARH38_HUMAN,Rho guanine nucleotide exchange factor 38,777,"89,078",3 out of 5,2008-02-26,Evidence at transcript level
Q9NR81,ARHG3_HUMAN,Rho guanine nucleotide exchange factor 3 (Exchange factor found in platelets and leukemic and neuronal tissues) (XPLN),526,"59,783",5 out of 5,2004-09-27,Evidence at protein level
Q96PE2,ARHGH_HUMAN,Rho guanine nucleotide exchange factor 17 (164 kDa Rho-specific guanine-nucleotide exchange factor) (p164-RhoGEF) (p164RhoGEF) (Tumor endothelial marker 4),2063,"221,673",4 out of 5,2007-05-15,Evidence at protein level
Q86VW2,ARHGP_HUMAN,Rho guanine nucleotide exchange factor 25 (Guanine nucleotide exchange factor GEFT) (Rac/Cdc42/Rho exchange factor GEFT) (RhoA/Rac/Cdc42 guanine nucleotide exchange factor GEFT) (p63RhoGEF),580,"63,843",5 out of 5,2008-02-26,Evidence at protein level
Q8N7S6,ARI2O_HUMAN,Uncharacterized protein ARIH2OS (Ariadne-2 homolog opposite strand protein),290,"30,424",2 out of 5,2008-09-02,Evidence at transcript level
Q8IVW6,ARI3B_HUMAN,AT-rich interactive domain-containing protein 3B (ARID domain-containing protein 3B) (Bright and dead ringer protein) (Bright-like protein),561,"60,637",5 out of 5,2007-07-10,Evidence at protein level
P29374,ARI4A_HUMAN,AT-rich interactive domain-containing protein 4A (ARID domain-containing protein 4A) (Retinoblastoma-binding protein 1) (RBBP-1),1257,"142,752",5 out of 5,1992-12-01,Evidence at protein level
O43488,ARK72_HUMAN,Aflatoxin B1 aldehyde reductase member 2 (EC 1.1.1.n11) (AFB1 aldehyde reductase 1) (AFB1-AR 1) (Aldoketoreductase 7) (Succinic semialdehyde reductase) (SSA reductase),359,"39,589",5 out of 5,1999-07-15,Evidence at protein level
Q8IUR7,ARMC8_HUMAN,Armadillo repeat-containing protein 8,673,"75,509",4 out of 5,2007-04-17,Evidence at protein level
Q9BXJ7,AMNLS_HUMAN,Protein amnionless,453,"47,754",5 out of 5,2003-06-20,Evidence at protein level
P23109,AMPD1_HUMAN,AMP deaminase 1 (EC 3.5.4.6) (AMP deaminase isoform M) (Myoadenylate deaminase),780,"90,219",5 out of 5,1991-11-01,Evidence at protein level
Q8N957,ANKF1_HUMAN,Ankyrin repeat and fibronectin type-III domain-containing protein 1,763,"87,604",2 out of 5,2006-07-25,Evidence at transcript level
Q15327,ANKR1_HUMAN,Ankyrin repeat domain-containing protein 1 (Cardiac ankyrin repeat protein) (Cytokine-inducible gene C-193 protein) (Cytokine-inducible nuclear protein),319,"36,252",5 out of 5,2006-06-27,Evidence at protein level
Q9GZV1,ANKR2_HUMAN,Ankyrin repeat domain-containing protein 2 (Skeletal muscle ankyrin repeat protein) (hArpp),360,"39,859",5 out of 5,2002-07-11,Evidence at protein level
Q9NQ90,ANO2_HUMAN,Anoctamin-2 (Transmembrane protein 16B),1003,"113,969",5 out of 5,2004-01-16,Evidence at protein level
Q6P6B7,ANR16_HUMAN,Ankyrin repeat domain-containing protein 16,361,"39,284",2 out of 5,2006-06-27,Evidence at protein level
Q96NW4,ANR27_HUMAN,Ankyrin repeat domain-containing protein 27 (VPS9 domain-containing protein),1050,"116,984",5 out of 5,2007-02-06,Evidence at protein level
Q7Z3H0,ANR33_HUMAN,Ankyrin repeat domain-containing protein 33,272,"29,011",3 out of 5,2006-06-27,Evidence at transcript level
Q6NXT1,ANR54_HUMAN,Ankyrin repeat domain-containing protein 54 (Lyn-interacting ankyrin repeat protein),300,"32,505",4 out of 5,2007-02-06,Evidence at protein level
E5RJM6,ANR65_HUMAN,Ankyrin repeat domain-containing protein 65,399,"41,497",2 out of 5,2011-12-14,Evidence at transcript level
Q92625,ANS1A_HUMAN,Ankyrin repeat and SAM domain-containing protein 1A (Odin),1134,"123,108",5 out of 5,2003-05-09,Evidence at protein level
P04083,ANXA1_HUMAN,Annexin A1 (Annexin I) (Annexin-1) (Calpactin II) (Calpactin-2) (Chromobindin-9) (Lipocortin I) (Phospholipase A2 inhibitory protein) (p35),346,"38,714",5 out of 5,1986-11-01,Evidence at protein level
O75843,AP1G2_HUMAN,AP-1 complex subunit gamma-like 2 (Gamma2-adaptin) (G2ad),785,"87,117",5 out of 5,2001-01-24,Evidence at protein level
P61966,AP1S1_HUMAN,AP-1 complex subunit sigma-1A (Adaptor protein complex AP-1 subunit sigma-1A) (Adaptor-related protein complex 1 subunit sigma-1A) (Clathrin assembly protein complex 1 sigma-1A small chain) (Clathrin coat assembly protein AP19) (Golgi adaptor HA1/AP1 adaptin sigma-1A subunit) (HA1 19 kDa subunit) (Sigma 1a subunit of AP-1 clathrin) (Sigma-adaptin 1A) (Sigma1A-adaptin),158,"18,733",5 out of 5,2004-06-07,Evidence at protein level
O14617,AP3D1_HUMAN,AP-3 complex subunit delta-1 (AP-3 complex subunit delta) (Adaptor-related protein complex 3 subunit delta-1) (Delta-adaptin),1153,"130,158",5 out of 5,2002-02-11,Evidence at protein level
Q9UJX4,APC5_HUMAN,Anaphase-promoting complex subunit 5 (APC5) (Cyclosome subunit 5),755,"85,077",5 out of 5,2003-10-03,Evidence at protein level
Q8IW19,APLF_HUMAN,Aprataxin and PNK-like factor (EC 4.2.99.18) (Apurinic-apyrimidinic endonuclease APLF) (PNK and APTX-like FHA domain-containing protein) (XRCC1-interacting protein 1),511,"56,956",5 out of 5,2005-08-16,Evidence at protein level
Q13790,APOF_HUMAN,Apolipoprotein F (Apo-F) (Lipid transfer inhibitor protein) (LTIP),326,"35,399",5 out of 5,1997-11-01,Evidence at protein level
P02749,APOH_HUMAN,Beta-2-glycoprotein 1 (APC inhibitor) (Activated protein C-binding protein) (Anticardiolipin cofactor) (Apolipoprotein H) (Apo-H) (Beta-2-glycoprotein I) (B2GPI) (Beta(2)GPI),345,"38,298",5 out of 5,1986-07-21,Evidence at protein level
Q13794,APR_HUMAN,Phorbol-12-myristate-13-acetate-induced protein 1 (PMA-induced protein 1) (Immediate-early-response protein APR) (Protein Noxa),54,"6,030",5 out of 5,2000-05-30,Evidence at protein level
O60306,AQR_HUMAN,Intron-binding protein aquarius (Intron-binding protein of 160 kDa) (IBP160),1485,"171,295",4 out of 5,2006-10-17,Evidence at protein level
Q6UW56,ARAID_HUMAN,All-trans retinoic acid-induced differentiation factor (Apoptosis-related protein 3) (APR-3) (p18),229,"24,747",5 out of 5,2005-06-21,Evidence at protein level
Q8WWN8,ARAP3_HUMAN,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 (Centaurin-delta-3) (Cnt-d3)",1544,"169,844",5 out of 5,2005-08-16,Evidence at protein level
Q9NXR5,ANR10_HUMAN,Ankyrin repeat domain-containing protein 10,420,"44,768",2 out of 5,2003-02-22,Evidence at protein level
O75179,ANR17_HUMAN,Ankyrin repeat domain-containing protein 17 (Gene trap ankyrin repeat protein) (Serologically defined breast cancer antigen NY-BR-16),2603,"274,258",5 out of 5,2007-10-23,Evidence at protein level
Q6AI12,ANR40_HUMAN,Ankyrin repeat domain-containing protein 40,368,"41,088",3 out of 5,2006-06-27,Evidence at protein level
Q8NB46,ANR52_HUMAN,Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit C (PP6-ARS-C) (Serine/threonine-protein phosphatase 6 regulatory subunit ARS-C) (Ankyrin repeat domain-containing protein 52),1076,"115,077",3 out of 5,2006-06-27,Evidence at protein level
O95782,AP2A1_HUMAN,AP-2 complex subunit alpha-1 (100 kDa coated vesicle protein A) (Adaptor protein complex AP-2 subunit alpha-1) (Adaptor-related protein complex 2 subunit alpha-1) (Alpha-adaptin A) (Alpha1-adaptin) (Clathrin assembly protein complex 2 alpha-A large chain) (Plasma membrane adaptor HA2/AP2 adaptin alpha A subunit),977,"107,546",5 out of 5,2001-01-24,Evidence at protein level
Q13367,AP3B2_HUMAN,AP-3 complex subunit beta-2 (Adaptor protein complex AP-3 subunit beta-2) (Adaptor-related protein complex 3 subunit beta-2) (Beta-3B-adaptin) (Clathrin assembly protein complex 3 beta-2 large chain) (Neuron-specific vesicle coat protein beta-NAP),1082,"119,059",5 out of 5,2001-09-26,Evidence at protein level
P59780,AP3S2_HUMAN,AP-3 complex subunit sigma-2 (AP-3 complex subunit sigma-3B) (Adaptor-related protein complex 3 subunit sigma-2) (Sigma-3B-adaptin) (Sigma3B-adaptin) (Sigma-adaptin 3b),193,"22,017",5 out of 5,2003-07-19,Evidence at transcript level
Q9UJX5,APC4_HUMAN,Anaphase-promoting complex subunit 4 (APC4) (Cyclosome subunit 4),808,"92,116",5 out of 5,2003-10-03,Evidence at protein level
Q9UJX3,APC7_HUMAN,Anaphase-promoting complex subunit 7 (APC7) (Cyclosome subunit 7),599,"66,855",5 out of 5,2003-10-03,Evidence at protein level
Q8J025,APCD1_HUMAN,Protein APCDD1 (Adenomatosis polyposis coli down-regulated 1 protein),514,"58,797",5 out of 5,2006-03-07,Evidence at protein level
Q5H913,AR13A_HUMAN,ADP-ribosylation factor-like protein 13A,290,"33,003",2 out of 5,2007-04-17,Evidence at transcript level
Q66PJ3,AR6P4_HUMAN,ADP-ribosylation factor-like protein 6-interacting protein 4 (ARL-6-interacting protein 4) (Aip-4) (HSP-975) (HSVI-binding protein) (SR-15) (SRp25) (SR-25) (Splicing factor SRrp37),421,"44,915",5 out of 5,2007-12-04,Evidence at protein level
P35626,ARBK2_HUMAN,Beta-adrenergic receptor kinase 2 (Beta-ARK-2) (EC 2.7.11.15) (G-protein-coupled receptor kinase 3),688,"79,710",5 out of 5,1994-06-01,Evidence at protein level
O15143,ARC1B_HUMAN,Actin-related protein 2/3 complex subunit 1B (Arp2/3 complex 41 kDa subunit) (p41-ARC),372,"40,950",5 out of 5,1998-07-15,Evidence at protein level
P18085,ARF4_HUMAN,ADP-ribosylation factor 4,180,"20,511",5 out of 5,1990-11-01,Evidence at protein level
P53365,ARFP2_HUMAN,Arfaptin-2 (ADP-ribosylation factor-interacting protein 2) (Partner of RAC1) (Protein POR1),341,"37,856",5 out of 5,1996-10-01,Evidence at protein level
Q8N4T4,ARG39_HUMAN,Rho guanine nucleotide exchange factor 39,335,"38,295",4 out of 5,2007-06-26,Evidence at protein level
O15013,ARHGA_HUMAN,Rho guanine nucleotide exchange factor 10,1369,"151,612",5 out of 5,2004-07-05,Evidence at protein level
O15085,ARHGB_HUMAN,Rho guanine nucleotide exchange factor 11 (PDZ-RhoGEF),1522,"167,704",5 out of 5,2003-08-29,Evidence at protein level
Q8NDY3,ARHL1_HUMAN,[Protein ADP-ribosylarginine] hydrolase-like protein 1 (EC 3.2.-.-) (ADP-ribosylhydrolase 2),354,"40,105",3 out of 5,2007-02-06,Evidence at transcript level
Q03989,ARI5A_HUMAN,AT-rich interactive domain-containing protein 5A (ARID domain-containing protein 5A) (Modulator recognition factor 1) (MRF-1),594,"64,074",5 out of 5,2007-05-29,Evidence at protein level
Q14865,ARI5B_HUMAN,AT-rich interactive domain-containing protein 5B (ARID domain-containing protein 5B) (MRF1-like protein) (Modulator recognition factor 2) (MRF-2),1188,"132,375",5 out of 5,2004-02-02,Evidence at protein level
P40616,ARL1_HUMAN,ADP-ribosylation factor-like protein 1,181,"20,418",5 out of 5,1995-02-01,Evidence at protein level
P0C7Q2,ARMS2_HUMAN,Age-related maculopathy susceptibility protein 2,107,"11,437",3 out of 5,2008-07-01,Evidence at transcript level
Q86WX3,AROS_HUMAN,Active regulator of SIRT1 (40S ribosomal protein S19-binding protein 1) (RPS19-binding protein 1) (S19BP),136,"15,434",5 out of 5,2006-10-17,Evidence at protein level
C9JTQ0,ANR63_HUMAN,Ankyrin repeat domain-containing protein 63,380,"39,620",1 out of 5,2011-07-27,Inferred from homology
P07355,ANXA2_HUMAN,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),339,"38,604",5 out of 5,1988-04-01,Evidence at protein level
P12429,ANXA3_HUMAN,"Annexin A3 (35-alpha calcimedin) (Annexin III) (Annexin-3) (Inositol 1,2-cyclic phosphate 2-phosphohydrolase) (Lipocortin III) (Placental anticoagulant protein III) (PAP-III)",323,"36,375",5 out of 5,1989-10-01,Evidence at protein level
P20073,ANXA7_HUMAN,Annexin A7 (Annexin VII) (Annexin-7) (Synexin),488,"52,739",5 out of 5,1991-02-01,Evidence at protein level
Q6VUC0,AP2E_HUMAN,Transcription factor AP-2-epsilon (AP2-epsilon) (Activating enhancer-binding protein 2-epsilon),442,"46,212",3 out of 5,2007-11-13,Evidence at transcript level
Q96N21,AP4AT_HUMAN,AP-4 complex accessory subunit Tepsin (ENTH domain-containing protein 2) (Epsin for AP-4) (Tetra-epsin),525,"55,137",4 out of 5,2007-05-15,Evidence at protein level
Q9Y587,AP4S1_HUMAN,AP-4 complex subunit sigma-1 (AP-4 adaptor complex subunit sigma-1) (Adaptor-related protein complex 4 subunit sigma-1) (Sigma-1 subunit of AP-4) (Sigma-4-adaptin) (Sigma4-adaptin),144,"17,005",5 out of 5,2001-04-27,Evidence at transcript level
Q99767,APBA2_HUMAN,Amyloid beta A4 precursor protein-binding family A member 2 (Adapter protein X11beta) (Neuron-specific X11L protein) (Neuronal Munc18-1-interacting protein 2) (Mint-2),749,"82,512",5 out of 5,2000-05-30,Evidence at protein level
O96018,APBA3_HUMAN,Amyloid beta A4 precursor protein-binding family A member 3 (Adapter protein X11gamma) (Neuron-specific X11L2 protein) (Neuronal Munc18-1-interacting protein 3) (Mint-3),575,"61,454",5 out of 5,2000-05-30,Evidence at protein level
Q92624,APBP2_HUMAN,Amyloid protein-binding protein 2 (Amyloid beta precursor protein-binding protein 2) (APP-BP2) (Protein interacting with APP tail 1),585,"66,853",5 out of 5,2004-07-19,Evidence at protein level
Q8NCL9,APCDL_HUMAN,Protein APCDD1-like (Adenomatosis polyposis coli down-regulated 1 protein-like),501,"55,635",2 out of 5,2006-12-12,Evidence at transcript level
Q96BI3,APH1A_HUMAN,Gamma-secretase subunit APH-1A (APH-1a) (Aph-1alpha) (Presenilin-stabilization factor),265,"28,996",5 out of 5,2003-09-26,Evidence at protein level
P08519,APOA_HUMAN,Apolipoprotein(a) (Apo(a)) (Lp(a)) (EC 3.4.21.-),4548,"501,319",5 out of 5,1988-08-01,Evidence at protein level
P05090,APOD_HUMAN,Apolipoprotein D (Apo-D) (ApoD),189,"21,276",5 out of 5,1987-08-13,Evidence at protein level
Q9BWW9,APOL5_HUMAN,Apolipoprotein L5 (Apolipoprotein L-V) (ApoL-V),433,"47,044",3 out of 5,2001-08-29,Evidence at transcript level
Q8IXF9,AQ12A_HUMAN,Aquaporin-12A (AQP-12),295,"31,475",2 out of 5,2004-05-10,Evidence at transcript level
Q8N6S5,AR6P6_HUMAN,ADP-ribosylation factor-like protein 6-interacting protein 6 (ARL-6-interacting protein 6) (Aip-6) (Phosphonoformate immuno-associated protein 1),226,"24,676",2 out of 5,2007-10-23,Evidence at protein level
Q92747,ARC1A_HUMAN,Actin-related protein 2/3 complex subunit 1A (SOP2-like protein),370,"41,569",5 out of 5,1998-07-15,Evidence at protein level
O15033,AREL1_HUMAN,Apoptosis-resistant E3 ubiquitin protein ligase 1 (EC 2.3.2.26) (Apoptosis-resistant HECT-type E3 ubiquitin transferase 1),823,"94,223",5 out of 5,2005-03-29,Evidence at protein level
Q8N6H7,ARFG2_HUMAN,ADP-ribosylation factor GTPase-activating protein 2 (ARF GAP 2) (GTPase-activating protein ZNF289) (Zinc finger protein 289),521,"56,720",5 out of 5,2007-02-20,Evidence at protein level
Q9NWB6,ARGL1_HUMAN,Arginine and glutamate-rich protein 1,273,"33,216",4 out of 5,2007-05-29,Evidence at protein level
O43307,ARHG9_HUMAN,Rho guanine nucleotide exchange factor 9 (Collybistin) (PEM-2 homolog) (Rac/Cdc42 guanine nucleotide exchange factor 9),516,"60,982",5 out of 5,2006-10-17,Evidence at protein level
Q9NZN5,ARHGC_HUMAN,Rho guanine nucleotide exchange factor 12 (Leukemia-associated RhoGEF),1544,"173,232",5 out of 5,2003-08-29,Evidence at protein level
Q8IW93,ARHGJ_HUMAN,Rho guanine nucleotide exchange factor 19 (Ephexin-2),802,"89,197",4 out of 5,2007-05-01,Evidence at protein level
Q96DR7,ARHGQ_HUMAN,Rho guanine nucleotide exchange factor 26 (SH3 domain-containing guanine exchange factor),871,"97,346",5 out of 5,2008-02-26,Evidence at protein level
Q9NX46,ARHL2_HUMAN,Poly(ADP-ribose) glycohydrolase ARH3 (EC 3.2.1.143) (ADP-ribosylhydrolase 3) ([Protein ADP-ribosylarginine] hydrolase-like protein 2),363,"38,947",5 out of 5,2007-02-06,Evidence at protein level
O95376,ARI2_HUMAN,E3 ubiquitin-protein ligase ARIH2 (ARI-2) (Protein ariadne-2 homolog) (EC 2.3.2.-) (RING-type E3 ubiquitin transferase ARIH2) (Triad1 protein),493,"57,819",5 out of 5,2001-09-26,Evidence at protein level
Q8NEN0,ARMC2_HUMAN,Armadillo repeat-containing protein 2,867,"96,867",2 out of 5,2007-04-17,Evidence at transcript level
Q9P291,ARMX1_HUMAN,Armadillo repeat-containing X-linked protein 1 (ARM protein lost in epithelial cancers on chromosome X 1) (Protein ALEX1),453,"49,180",3 out of 5,2005-12-20,Evidence at protein level
Q99218,AMELY_HUMAN,"Amelogenin, Y isoform",206,"23,250",3 out of 5,1995-11-01,Evidence at transcript level
Q8N944,AMER3_HUMAN,APC membrane recruitment protein 3 (Amer3) (Protein FAM123C),861,"90,445",3 out of 5,2008-02-26,Evidence at protein level
P04746,AMYP_HUMAN,"Pancreatic alpha-amylase (PA) (EC 3.2.1.1) (1,4-alpha-D-glucan glucanohydrolase)",511,"57,707",5 out of 5,1987-08-13,Evidence at protein level
Q86W34,AMZ2_HUMAN,Archaemetzincin-2 (EC 3.4.-.-) (Archeobacterial metalloproteinase-like protein 2),360,"41,263",4 out of 5,2006-01-10,Evidence at protein level
A2A2Z9,AN18B_HUMAN,Ankyrin repeat domain-containing protein 18B,1011,"118,231",1 out of 5,2008-02-05,Evidence at protein level
O95841,ANGL1_HUMAN,Angiopoietin-related protein 1 (Angiopoietin-3) (ANG-3) (Angiopoietin-like protein 1),491,"56,720",4 out of 5,2005-05-10,Evidence at transcript level
Q8NI99,ANGL6_HUMAN,Angiopoietin-related protein 6 (Angiopoietin-like protein 6) (Angiopoietin-related growth factor) (Angiopoietin-related protein 5),470,"51,694",4 out of 5,2005-05-10,Evidence at protein level
E9PGG2,ANHX_HUMAN,Anomalous homeobox protein,379,"41,695",2 out of 5,2012-07-11,Evidence at transcript level
Q9NQW6,ANLN_HUMAN,Anillin,1124,"124,199",5 out of 5,2006-03-21,Evidence at protein level
Q5XXA6,ANO1_HUMAN,Anoctamin-1 (Discovered on gastrointestinal stromal tumors protein 1) (Oral cancer overexpressed protein 2) (Transmembrane protein 16A) (Tumor-amplified and overexpressed sequence 2),986,"114,078",5 out of 5,2007-05-29,Evidence at protein level
Q5VYY1,ANR22_HUMAN,Ankyrin repeat domain-containing protein 22,191,"21,849",2 out of 5,2006-06-27,Evidence at transcript level
Q8N7Z5,ANR31_HUMAN,Putative ankyrin repeat domain-containing protein 31,1873,"210,816",2 out of 5,2008-04-08,Uncertain
P53680,AP2S1_HUMAN,AP-2 complex subunit sigma (Adaptor protein complex AP-2 subunit sigma) (Adaptor-related protein complex 2 subunit sigma) (Clathrin assembly protein 2 sigma small chain) (Clathrin coat assembly protein AP17) (Clathrin coat-associated protein AP17) (HA2 17 kDa subunit) (Plasma membrane adaptor AP-2 17 kDa protein) (Sigma2-adaptin),142,"17,018",5 out of 5,1996-10-01,Evidence at protein level
O95704,APBB3_HUMAN,Amyloid beta A4 precursor protein-binding family B member 3 (Protein Fe65-like 2) (Fe65L2),486,"52,585",5 out of 5,2001-01-11,Evidence at protein level
Q9BS18,APC13_HUMAN,Anaphase-promoting complex subunit 13 (APC13) (Cyclosome subunit 13),74,"8,521",4 out of 5,2006-10-17,Evidence at protein level
P02647,APOA1_HUMAN,Apolipoprotein A-I (Apo-AI) (ApoA-I) (Apolipoprotein A1) [Cleaved into: Proapolipoprotein A-I (ProapoA-I); Truncated apolipoprotein A-I (Apolipoprotein A-I(1-242))],267,"30,778",5 out of 5,1986-07-21,Evidence at protein level
P55056,APOC4_HUMAN,Apolipoprotein C-IV (Apo-CIV) (ApoC-IV) (Apolipoprotein C4),127,"14,553",5 out of 5,1996-10-01,Evidence at protein level
O95236,APOL3_HUMAN,Apolipoprotein L3 (Apolipoprotein L-III) (ApoL-III) (TNF-inducible protein CG12-1) (CG12_1),402,"44,278",5 out of 5,2000-05-30,Evidence at protein level
Q96IL0,APOP1_HUMAN,"Apoptogenic protein 1, mitochondrial (APOP-1)",206,"24,153",3 out of 5,2005-07-19,Evidence at transcript level
Q7Z2E3,APTX_HUMAN,Aprataxin (EC 3.-.-.-) (Forkhead-associated domain histidine triad-like protein) (FHA-HIT),356,"40,740",5 out of 5,2004-06-07,Evidence at protein level
P55087,AQP4_HUMAN,Aquaporin-4 (AQP-4) (Mercurial-insensitive water channel) (MIWC) (WCH4),323,"34,830",5 out of 5,1996-10-01,Evidence at protein level
O14520,AQP7_HUMAN,Aquaporin-7 (AQP-7) (Aquaglyceroporin-7) (Aquaporin adipose) (AQPap) (Aquaporin-7-like),342,"37,232",5 out of 5,1998-07-15,Evidence at protein level
O43315,AQP9_HUMAN,Aquaporin-9 (AQP-9) (Aquaglyceroporin-9) (Small solute channel 1),295,"31,431",5 out of 5,1998-12-15,Evidence at transcript level
Q6NSI1,AR26L_HUMAN,Putative ankyrin repeat domain-containing protein 26-like protein,321,"35,437",2 out of 5,2008-03-18,Uncertain
Q9Y2Y0,AR2BP_HUMAN,ADP-ribosylation factor-like protein 2-binding protein (ARF-like 2-binding protein) (ARL2-binding protein) (Binder of ARF2 protein 1),163,"18,822",5 out of 5,2007-05-15,Evidence at protein level
Q8WZ64,ARAP2_HUMAN,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 (Centaurin-delta-1) (Cnt-d1) (Protein PARX)",1704,"193,452",4 out of 5,2005-08-16,Evidence at protein level
P84085,ARF5_HUMAN,ADP-ribosylation factor 5,180,"20,530",5 out of 5,2004-08-16,Evidence at protein level
Q8N6T3,ARFG1_HUMAN,ADP-ribosylation factor GTPase-activating protein 1 (ARF GAP 1) (ADP-ribosylation factor 1 GTPase-activating protein) (ARF1 GAP) (ARF1-directed GTPase-activating protein),406,"44,668",5 out of 5,2003-01-27,Evidence at protein level
A8MVX0,ARG33_HUMAN,Rho guanine nucleotide exchange factor 33,844,"94,633",2 out of 5,2008-07-01,Evidence at transcript level
Q8TF21,ANR24_HUMAN,Ankyrin repeat domain-containing protein 24,1146,"124,187",3 out of 5,2008-04-08,Evidence at transcript level
Q8N6D5,ANR29_HUMAN,Ankyrin repeat domain-containing protein 29,301,"32,442",2 out of 5,2006-06-27,Evidence at transcript level
Q9ULJ7,ANR50_HUMAN,Ankyrin repeat domain-containing protein 50,1429,"155,859",4 out of 5,2001-06-20,Evidence at protein level
Q8N9V6,ANR53_HUMAN,Ankyrin repeat domain-containing protein 53,530,"59,571",5 out of 5,2007-02-06,Evidence at protein level
Q9H9E1,ANRA2_HUMAN,Ankyrin repeat family A protein 2 (RFXANK-like protein 2),313,"34,272",5 out of 5,2003-01-10,Evidence at protein level
Q7Z6G8,ANS1B_HUMAN,Ankyrin repeat and sterile alpha motif domain-containing protein 1B (Amyloid-beta protein intracellular domain-associated protein 1) (AIDA-1) (E2A-PBX1-associated protein) (EB-1),1248,"138,066",5 out of 5,2008-04-08,Evidence at protein level
P58335,ANTR2_HUMAN,Anthrax toxin receptor 2 (Capillary morphogenesis gene 2 protein) (CMG-2),489,"53,666",5 out of 5,2001-11-02,Evidence at protein level
P13928,ANXA8_HUMAN,Annexin A8 (Annexin VIII) (Annexin-8) (Vascular anticoagulant-beta) (VAC-beta),327,"36,881",5 out of 5,1990-01-01,Evidence at protein level
Q9Y2T2,AP3M1_HUMAN,AP-3 complex subunit mu-1 (AP-3 adaptor complex mu3A subunit) (Adaptor-related protein complex 3 subunit mu-1) (Mu-adaptin 3A) (Mu3A-adaptin),418,"46,939",5 out of 5,2001-02-21,Evidence at protein level
P50583,AP4A_HUMAN,"Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical] (EC 3.6.1.17) (Diadenosine 5',5'''-P1,P4-tetraphosphate asymmetrical hydrolase) (Ap4A hydrolase) (Ap4Aase) (Diadenosine tetraphosphatase) (Nucleoside diphosphate-linked moiety X motif 2) (Nudix motif 2)",147,"16,829",5 out of 5,1996-10-01,Evidence at protein level
Q2VPB7,AP5B1_HUMAN,AP-5 complex subunit beta-1 (Adaptor-related protein complex 5 beta subunit) (Beta5),878,"93,949",4 out of 5,2011-03-08,Evidence at protein level
Q96PS8,AQP10_HUMAN,Aquaporin-10 (AQP-10) (Aquaglyceroporin-10) (Small intestine aquaporin),301,"31,763",5 out of 5,2002-02-21,Evidence at protein level
P29972,AQP1_HUMAN,Aquaporin-1 (AQP-1) (Aquaporin-CHIP) (Urine water channel) (Water channel protein for red blood cells and kidney proximal tubule),269,"28,526",5 out of 5,1993-04-01,Evidence at protein level
Q92482,AQP3_HUMAN,Aquaporin-3 (AQP-3) (Aquaglyceroporin-3),292,"31,544",5 out of 5,1997-11-01,Evidence at transcript level
P55064,AQP5_HUMAN,Aquaporin-5 (AQP-5),265,"28,292",5 out of 5,1996-10-01,Evidence at protein level
A6NL99,AQP73_HUMAN,Putative aquaporin-7-like protein 3,342,"37,357",2 out of 5,2008-04-29,Uncertain
O94778,AQP8_HUMAN,Aquaporin-8 (AQP-8),261,"27,381",4 out of 5,1999-07-15,Evidence at transcript level
Q96P48,ARAP1_HUMAN,"Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 1 (Centaurin-delta-2) (Cnt-d2)",1450,"162,192",5 out of 5,2003-01-27,Evidence at protein level
P25098,ARBK1_HUMAN,Beta-adrenergic receptor kinase 1 (Beta-ARK-1) (EC 2.7.11.15) (G-protein coupled receptor kinase 2),689,"79,574",5 out of 5,1992-05-01,Evidence at protein level
Q7LC44,ARC_HUMAN,Activity-regulated cytoskeleton-associated protein (ARC/ARG3.1) (Activity-regulated gene 3.1 protein homolog) (Arg3.1),396,"45,316",5 out of 5,2007-01-23,Evidence at transcript level
P84077,ARF1_HUMAN,ADP-ribosylation factor 1,181,"20,697",5 out of 5,2004-08-16,Evidence at protein level
P78540,ARGI2_HUMAN,"Arginase-2, mitochondrial (EC 3.5.3.1) (Kidney-type arginase) (Non-hepatic arginase) (Type II arginase)",354,"38,578",5 out of 5,1997-11-01,Evidence at protein level
Q14155,ARHG7_HUMAN,Rho guanine nucleotide exchange factor 7 (Beta-Pix) (COOL-1) (PAK-interacting exchange factor beta) (p85),803,"90,012",5 out of 5,1997-11-01,Evidence at protein level
Q8NFD5,ARI1B_HUMAN,AT-rich interactive domain-containing protein 1B (ARID domain-containing protein 1B) (BRG1-associated factor 250b) (BAF250B) (BRG1-binding protein hELD/OSA1) (Osa homolog 2) (hOsa2) (p250R),2236,"236,123",5 out of 5,2005-08-30,Evidence at protein level
A6NKF2,ARI3C_HUMAN,AT-rich interactive domain-containing protein 3C (ARID domain-containing protein 3C),412,"44,073",2 out of 5,2008-05-20,Inferred from homology
Q8IVW1,ARL17_HUMAN,ADP-ribosylation factor-like protein 17 (ADP-ribosylation factor 7 variant),177,"19,388",4 out of 5,2003-10-31,Evidence at transcript level
P36405,ARL3_HUMAN,ADP-ribosylation factor-like protein 3,182,"20,456",5 out of 5,1994-06-01,Evidence at protein level
P56559,ARL4C_HUMAN,ADP-ribosylation factor-like protein 4C (ADP-ribosylation factor-like protein 7) (ADP-ribosylation factor-like protein LAK),192,"21,487",5 out of 5,1998-12-15,Evidence at protein level
Q96KC2,ARL5B_HUMAN,ADP-ribosylation factor-like protein 5B (ADP-ribosylation factor-like protein 8),179,"20,375",3 out of 5,2003-09-19,Evidence at protein level
Q5T9G4,ARM12_HUMAN,Armadillo repeat-containing protein 12,340,"38,632",2 out of 5,2006-04-04,Evidence at transcript level
Q5T2S8,ARMC4_HUMAN,Armadillo repeat-containing protein 4,1044,"115,679",5 out of 5,2006-06-27,Evidence at protein level
Q9Y672,ALG6_HUMAN,"Dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.267) (Asparagine-linked glycosylation protein 6 homolog) (Dol-P-Glc:Man(9)GlcNAc(2)-PP-Dol alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Man9GlcNAc2-PP-dolichyl glucosyltransferase)",507,"58,181",5 out of 5,2002-05-27,Evidence at protein level
Q9BVK2,ALG8_HUMAN,"Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase (EC 2.4.1.265) (Asparagine-linked glycosylation protein 8 homolog) (Dol-P-Glc:Glc(1)Man(9)GlcNAc(2)-PP-dolichyl alpha-1,3-glucosyltransferase) (Dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichyl glucosyltransferase)",526,"60,088",5 out of 5,2002-05-27,Evidence at protein level
Q9H6U8,ALG9_HUMAN,"Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase)",611,"69,863",5 out of 5,2005-08-30,Evidence at protein level
Q9NXW9,ALKB4_HUMAN,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 4 (EC 1.14.11.-) (Alkylated DNA repair protein alkB homolog 4),302,"33,838",5 out of 5,2006-05-30,Evidence at protein level
Q8TCU4,ALMS1_HUMAN,Alstrom syndrome protein 1,4167,"460,965",5 out of 5,2006-03-07,Evidence at protein level
P55789,ALR_HUMAN,FAD-linked sulfhydryl oxidase ALR (EC 1.8.3.2) (Augmenter of liver regeneration) (hERV1) (Hepatopoietin),205,"23,449",5 out of 5,1997-11-01,Evidence at protein level
P35858,ALS_HUMAN,Insulin-like growth factor-binding protein complex acid labile subunit (ALS),605,"66,035",5 out of 5,1994-06-01,Evidence at protein level
Q9UHK6,AMACR_HUMAN,Alpha-methylacyl-CoA racemase (EC 5.1.99.4) (2-methylacyl-CoA racemase),382,"42,387",5 out of 5,2001-04-27,Evidence at protein level
Q9C0C7,AMRA1_HUMAN,Activating molecule in BECN1-regulated autophagy protein 1,1298,"142,507",5 out of 5,2008-01-15,Evidence at protein level
Q5VTE6,ANGE2_HUMAN,Protein angel homolog 2,544,"62,339",3 out of 5,2007-10-02,Evidence at transcript level
P03950,ANGI_HUMAN,Angiogenin (EC 3.1.27.-) (Ribonuclease 5) (RNase 5),147,"16,550",5 out of 5,1986-10-23,Evidence at protein level
O43827,ANGL7_HUMAN,Angiopoietin-related protein 7 (Angiopoietin-like factor) (Angiopoietin-like protein 7) (Cornea-derived transcript 6 protein),346,"40,018",4 out of 5,2005-04-26,Evidence at protein level
Q86XL3,ANKL2_HUMAN,Ankyrin repeat and LEM domain-containing protein 2 (LEM domain-containing protein 4),938,"104,114",5 out of 5,2007-03-20,Evidence at protein level
Q96BM1,ANKR9_HUMAN,Ankyrin repeat domain-containing protein 9,317,"34,295",1 out of 5,2003-09-09,Evidence at transcript level
Q9H8Y5,ANKZ1_HUMAN,Ankyrin repeat and zinc finger domain-containing protein 1 (Zinc finger protein 744),726,"80,927",4 out of 5,2006-07-25,Evidence at protein level
P55345,ANM2_HUMAN,Protein arginine N-methyltransferase 2 (EC 2.1.1.319) (Histone-arginine N-methyltransferase PRMT2),433,"49,042",5 out of 5,1997-11-01,Evidence at protein level
Q96LA8,ANM6_HUMAN,Protein arginine N-methyltransferase 6 (EC 2.1.1.319) (Heterogeneous nuclear ribonucleoprotein methyltransferase-like protein 6) (Histone-arginine N-methyltransferase PRMT6),375,"41,938",5 out of 5,2002-03-27,Evidence at protein level
Q32M45,ANO4_HUMAN,Anoctamin-4 (Transmembrane protein 16D),955,"111,462",5 out of 5,2007-05-29,Evidence at transcript level
Q63HQ0,AP1AR_HUMAN,AP-1 complex-associated regulatory protein (2c18) (Adaptor-related protein complex 1-associated regulatory protein) (Gamma-1-adaptin brefeldin A resistance protein) (GBAR) (Gamma-BAR) (Gamma-A1-adaptin and kinesin interactor) (Gadkin),302,"34,280",5 out of 5,2005-08-30,Evidence at protein level
O43747,AP1G1_HUMAN,AP-1 complex subunit gamma-1 (Adaptor protein complex AP-1 subunit gamma-1) (Adaptor-related protein complex 1 subunit gamma-1) (Clathrin assembly protein complex 1 gamma-1 large chain) (Gamma1-adaptin) (Golgi adaptor HA1/AP1 adaptin subunit gamma-1),822,"91,351",5 out of 5,1998-12-15,Evidence at protein level
Q9BXS5,AP1M1_HUMAN,AP-1 complex subunit mu-1 (AP-mu chain family member mu1A) (Adaptor protein complex AP-1 subunit mu-1) (Adaptor-related protein complex 1 subunit mu-1) (Clathrin assembly protein complex 1 mu-1 medium chain 1) (Clathrin coat assembly protein AP47) (Clathrin coat-associated protein AP47) (Golgi adaptor HA1/AP1 adaptin mu-1 subunit) (Mu-adaptin 1) (Mu1A-adaptin),423,"48,587",5 out of 5,2001-09-26,Evidence at protein level
O94973,AP2A2_HUMAN,AP-2 complex subunit alpha-2 (100 kDa coated vesicle protein C) (Adaptor protein complex AP-2 subunit alpha-2) (Adaptor-related protein complex 2 subunit alpha-2) (Alpha-adaptin C) (Alpha2-adaptin) (Clathrin assembly protein complex 2 alpha-C large chain) (Huntingtin yeast partner J) (Huntingtin-interacting protein 9) (HIP-9) (Huntingtin-interacting protein J) (Plasma membrane adaptor HA2/AP2 adaptin alpha C subunit),939,"103,960",5 out of 5,2001-01-24,Evidence at protein level
Q9H1A4,APC1_HUMAN,Anaphase-promoting complex subunit 1 (APC1) (Cyclosome subunit 1) (Mitotic checkpoint regulator) (Testis-specific gene 24 protein),1944,"216,500",5 out of 5,2003-10-03,Evidence at protein level
O95996,APCL_HUMAN,Adenomatous polyposis coli protein 2 (Adenomatous polyposis coli protein-like) (APC-like),2303,"243,949",5 out of 5,2008-01-15,Evidence at protein level
P25054,APC_HUMAN,Adenomatous polyposis coli protein (Protein APC) (Deleted in polyposis 2.5),2843,"311,646",5 out of 5,1992-05-01,Evidence at protein level
Q8WW43,APH1B_HUMAN,Gamma-secretase subunit APH-1B (APH-1b) (Aph-1beta) (Presenilin-stabilization factor-like),257,"28,460",5 out of 5,2003-09-26,Evidence at protein level
Q9NR80,ARHG4_HUMAN,Rho guanine nucleotide exchange factor 4 (APC-stimulated guanine nucleotide exchange factor 1) (Asef) (Asef1),690,"79,067",5 out of 5,2004-09-27,Evidence at protein level
P54793,ARSF_HUMAN,Arylsulfatase F (ASF) (EC 3.1.6.-),590,"65,940",4 out of 5,1996-10-01,Evidence at protein level
Q8WXK1,ASB15_HUMAN,Ankyrin repeat and SOCS box protein 15 (ASB-15),588,"65,799",3 out of 5,2002-05-10,Evidence at transcript level
Q6ZVZ8,ASB18_HUMAN,Ankyrin repeat and SOCS box protein 18 (ASB-18),466,"50,803",3 out of 5,2007-12-04,Evidence at transcript level
Q9Y575,ASB3_HUMAN,Ankyrin repeat and SOCS box protein 3 (ASB-3),518,"57,745",4 out of 5,2002-05-10,Evidence at protein level
Q8N3C0,ASCC3_HUMAN,"Activating signal cointegrator 1 complex subunit 3 (EC 3.6.4.12) (ASC-1 complex subunit p200) (ASC1p200) (Helicase, ATP binding 1) (Trip4 complex subunit p200)",2202,"251,460",5 out of 5,2004-07-19,Evidence at protein level
P00966,ASSY_HUMAN,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),412,"46,530",5 out of 5,1986-07-21,Evidence at protein level
Q8IXJ9,ASXL1_HUMAN,Putative Polycomb group protein ASXL1 (Additional sex combs-like protein 1),1541,"165,448",5 out of 5,2003-04-23,Evidence at protein level
Q8WWH4,ASZ1_HUMAN,"Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 (Ankyrin-like protein 1) (Germ cell-specific ankyrin, SAM and basic leucine zipper domain-containing protein)",475,"53,458",4 out of 5,2003-09-19,Evidence at transcript level
O60312,AT10A_HUMAN,Probable phospholipid-transporting ATPase VA (EC 3.6.3.1) (ATPase class V type 10A) (Aminophospholipid translocase VA) (P4-ATPase flippase complex alpha subunit ATP10A),1499,"167,688",5 out of 5,2000-05-30,Evidence at transcript level
P54707,AT12A_HUMAN,Potassium-transporting ATPase alpha chain 2 (EC 3.6.3.10) (Non-gastric H(+)/K(+) ATPase subunit alpha) (Proton pump),1039,"115,511",5 out of 5,1996-10-01,Evidence at protein level
Q4VNC1,AT134_HUMAN,Probable cation-transporting ATPase 13A4 (EC 3.6.3.-) (P5-ATPase isoform 4),1196,"133,987",5 out of 5,2008-02-26,Evidence at transcript level
P50993,AT1A2_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-2 (Na(+)/K(+) ATPase alpha-2 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-2),1020,"112,265",5 out of 5,1996-10-01,Evidence at protein level
O60423,AT8B3_HUMAN,Phospholipid-transporting ATPase IK (EC 3.6.3.1) (ATPase class I type 8B member 3),1300,"146,752",5 out of 5,2000-05-30,Evidence at transcript level
Q5TC04,ATAS1_HUMAN,Putative uncharacterized protein ATP1A1-AS1 (ATP1A1 antisense RNA 1) (ATP1A1 antisense gene protein 1) (ATP1A1 opposite strand protein),95,"10,240",2 out of 5,2011-03-08,Uncertain
Q9NVI7,ATD3A_HUMAN,ATPase family AAA domain-containing protein 3A,634,"71,369",5 out of 5,2005-09-13,Evidence at protein level
P00846,ATP6_HUMAN,ATP synthase subunit a (F-ATPase protein 6),226,"24,817",5 out of 5,1986-07-21,Evidence at protein level
P35670,ATP7B_HUMAN,Copper-transporting ATPase 2 (EC 3.6.3.54) (Copper pump 2) (Wilson disease-associated protein) [Cleaved into: WND/140 kDa],1465,"157,263",5 out of 5,1994-06-01,Evidence at protein level
P25705,ATPA_HUMAN,"ATP synthase subunit alpha, mitochondrial",553,"59,751",5 out of 5,1992-05-01,Evidence at protein level
O14791,APOL1_HUMAN,Apolipoprotein L1 (Apolipoprotein L) (Apo-L) (ApoL) (Apolipoprotein L-I) (ApoL-I),398,"43,974",5 out of 5,1998-07-15,Evidence at protein level
A6NM10,AQ12B_HUMAN,Aquaporin-12B (AQP-12B),295,"31,475",2 out of 5,2008-04-08,Evidence at transcript level
P41181,AQP2_HUMAN,Aquaporin-2 (AQP-2) (ADH water channel) (Aquaporin-CD) (AQP-CD) (Collecting duct water channel protein) (WCH-CD) (Water channel protein for renal collecting duct),271,"28,837",5 out of 5,1995-02-01,Evidence at protein level
P15514,AREG_HUMAN,Amphiregulin (AR) (Colorectum cell-derived growth factor) (CRDGF),252,"27,895",5 out of 5,1990-04-01,Evidence at protein level
P62330,ARF6_HUMAN,ADP-ribosylation factor 6,175,"20,082",5 out of 5,2004-07-05,Evidence at protein level
Q9NP61,ARFG3_HUMAN,ADP-ribosylation factor GTPase-activating protein 3 (ARF GAP 3),516,"56,928",5 out of 5,2002-05-27,Evidence at protein level
Q8TER5,ARH40_HUMAN,Rho guanine nucleotide exchange factor 40 (Protein SOLO),1519,"164,658",4 out of 5,2008-01-15,Evidence at protein level
Q15052,ARHG6_HUMAN,Rho guanine nucleotide exchange factor 6 (Alpha-Pix) (COOL-2) (PAK-interacting exchange factor alpha) (Rac/Cdc42 guanine nucleotide exchange factor 6),776,"87,499",5 out of 5,2001-09-26,Evidence at protein level
Q7Z628,ARHG8_HUMAN,Neuroepithelial cell-transforming gene 1 protein (Proto-oncogene p65 Net1) (Rho guanine nucleotide exchange factor 8),596,"67,740",5 out of 5,2004-09-27,Evidence at protein level
Q9Y4B4,ARIP4_HUMAN,Helicase ARIP4 (EC 3.6.4.12) (Androgen receptor-interacting protein 4) (RAD54-like protein 2),1467,"162,769",4 out of 5,2008-01-15,Evidence at protein level
Q969Q4,ARL11_HUMAN,ADP-ribosylation factor-like protein 11 (ADP-ribosylation factor-like tumor suppressor protein 1),196,"21,391",4 out of 5,2005-11-08,Evidence at protein level
Q9Y689,ARL5A_HUMAN,ADP-ribosylation factor-like protein 5A,179,"20,728",3 out of 5,2000-12-01,Evidence at protein level
Q9UBL0,ARP21_HUMAN,cAMP-regulated phosphoprotein 21 (ARPP-21) (Thymocyte cAMP-regulated phosphoprotein),812,"89,196",4 out of 5,2001-09-26,Evidence at protein level
O15145,ARPC3_HUMAN,Actin-related protein 2/3 complex subunit 3 (Arp2/3 complex 21 kDa subunit) (p21-ARC),178,"20,547",5 out of 5,1998-07-15,Evidence at protein level
Q5FYB0,ARSJ_HUMAN,Arylsulfatase J (ASJ) (EC 3.1.6.-),599,"67,235",4 out of 5,2005-10-11,Evidence at transcript level
Q8WWX0,ASB5_HUMAN,Ankyrin repeat and SOCS box protein 5 (ASB-5),329,"36,341",3 out of 5,2002-05-10,Evidence at transcript level
Q8N9N2,ASCC1_HUMAN,Activating signal cointegrator 1 complex subunit 1 (ASC-1 complex subunit p50) (Trip4 complex subunit p50),400,"45,509",5 out of 5,2004-07-19,Evidence at protein level
A6NEK1,ARRD5_HUMAN,Arrestin domain-containing protein 5,342,"38,383",2 out of 5,2007-11-13,Inferred from homology
P0C7U1,ASA2B_HUMAN,Putative inactive neutral ceramidase B (ASAH2-like protein) (Putative inactive N-acylsphingosine amidohydrolase 2B) (Putative inactive non-lysosomal ceramidase B),165,"19,025",2 out of 5,2008-07-22,Evidence at transcript level
Q8TDY4,ASAP3_HUMAN,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 3 (Development and differentiation-enhancing factor-like 1) (Protein up-regulated in liver cancer 1)",903,"99,155",5 out of 5,2006-04-18,Evidence at protein level
Q9Y574,ASB4_HUMAN,Ankyrin repeat and SOCS box protein 4 (ASB-4),426,"48,195",5 out of 5,2002-05-10,Evidence at transcript level
Q9NWX5,ASB6_HUMAN,Ankyrin repeat and SOCS box protein 6 (ASB-6),421,"47,136",4 out of 5,2003-02-28,Evidence at protein level
Q9ULZ3,ASC_HUMAN,Apoptosis-associated speck-like protein containing a CARD (hASC) (Caspase recruitment domain-containing protein 5) (PYD and CARD domain-containing protein) (Target of methylation-induced silencing 1),195,"21,627",5 out of 5,2001-10-18,Evidence at protein level
Q9NVP2,ASF1B_HUMAN,Histone chaperone ASF1B (Anti-silencing function protein 1 homolog B) (hAsf1) (hAsf1b) (CCG1-interacting factor A-II) (CIA-II) (hCIA-II),202,"22,434",5 out of 5,2007-04-17,Evidence at protein level
P07307,ASGR2_HUMAN,Asialoglycoprotein receptor 2 (ASGP-R 2) (ASGPR 2) (C-type lectin domain family 4 member H2) (Hepatic lectin H2) (HL-2),311,"35,092",5 out of 5,1988-04-01,Evidence at protein level
Q9NR48,ASH1L_HUMAN,Histone-lysine N-methyltransferase ASH1L (EC 2.1.1.43) (ASH1-like protein) (huASH1) (Absent small and homeotic disks protein 1 homolog) (Lysine N-methyltransferase 2H),2969,"332,790",5 out of 5,2006-10-31,Evidence at protein level
Q9UBL3,ASH2L_HUMAN,Set1/Ash2 histone methyltransferase complex subunit ASH2 (ASH2-like protein),628,"68,723",5 out of 5,2003-06-16,Evidence at protein level
O43681,ASNA_HUMAN,ATPase ASNA1 (EC 3.6.-.-) (Arsenical pump-driving ATPase) (Arsenite-stimulated ATPase) (Transmembrane domain recognition complex 40 kDa ATPase subunit) (hARSA-I) (hASNA-I),348,"38,793",5 out of 5,2000-05-30,Evidence at protein level
Q8IZT6,ASPM_HUMAN,Abnormal spindle-like microcephaly-associated protein (Abnormal spindle protein homolog) (Asp homolog),3477,"409,800",5 out of 5,2004-07-05,Evidence at protein level
P05496,AT5G1_HUMAN,"ATP synthase F(0) complex subunit C1, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase proteolipid P1) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C1) (ATPase protein 9) (ATPase subunit c)",136,"14,277",5 out of 5,1988-11-01,Evidence at protein level
Q8NBU5,ATAD1_HUMAN,ATPase family AAA domain-containing protein 1 (EC 3.6.1.3) (Thorase),361,"40,744",4 out of 5,2005-09-13,Evidence at protein level
P17544,ATF7_HUMAN,Cyclic AMP-dependent transcription factor ATF-7 (cAMP-dependent transcription factor ATF-7) (Activating transcription factor 7) (Transcription factor ATF-A),494,"52,967",5 out of 5,1990-08-01,Evidence at protein level
Q96BY7,ATG2B_HUMAN,Autophagy-related protein 2 homolog B,2078,"232,763",4 out of 5,2003-09-26,Evidence at protein level
Q9NT62,ATG3_HUMAN,Ubiquitin-like-conjugating enzyme ATG3 (EC 6.3.2.-) (Autophagy-related protein 3) (APG3-like) (hApg3) (Protein PC3-96),314,"35,864",5 out of 5,2005-03-15,Evidence at protein level
Q9BSB4,ATGA1_HUMAN,Autophagy-related protein 101,218,"25,003",5 out of 5,2007-07-10,Evidence at protein level
P82987,ATL3_HUMAN,ADAMTS-like protein 3 (ADAMTSL-3) (Punctin-2),1691,"188,692",5 out of 5,2006-09-19,Evidence at protein level
Q6UY14,ATL4_HUMAN,ADAMTS-like protein 4 (ADAMTSL-4) (Thrombospondin repeat-containing protein 1),1074,"116,545",5 out of 5,2006-10-31,Evidence at protein level
O43313,ATMIN_HUMAN,ATM interactor (ATM/ATR-substrate CHK2-interacting zinc finger protein) (ASCIZ) (Zinc finger protein 822),823,"88,348",5 out of 5,2001-02-21,Evidence at protein level
P20648,ATP4A_HUMAN,Potassium-transporting ATPase alpha chain 1 (EC 3.6.3.10) (Gastric H(+)/K(+) ATPase subunit alpha) (Proton pump),1035,"114,119",5 out of 5,1991-02-01,Evidence at transcript level
P03928,ATP8_HUMAN,ATP synthase protein 8 (A6L) (F-ATPase subunit 8),68,"7,992",5 out of 5,1986-07-21,Evidence at protein level
O43861,ATP9B_HUMAN,Probable phospholipid-transporting ATPase IIB (EC 3.6.3.1) (ATPase class II type 9B),1147,"129,304",5 out of 5,2000-05-30,Evidence at transcript level
Q9BZZ5,API5_HUMAN,Apoptosis inhibitor 5 (API-5) (Antiapoptosis clone 11 protein) (AAC-11) (Cell migration-inducing gene 8 protein) (Fibroblast growth factor 2-interacting factor) (FIF) (Protein XAGL),524,"59,005",5 out of 5,2005-04-12,Evidence at protein level
Q9HDC9,APMAP_HUMAN,Adipocyte plasma membrane-associated protein (Protein BSCv),416,"46,480",5 out of 5,2002-10-19,Evidence at protein level
Q6Q788,APOA5_HUMAN,Apolipoprotein A-V (Apo-AV) (ApoA-V) (Apolipoprotein A5) (Regeneration-associated protein 3),366,"41,213",5 out of 5,2005-02-01,Evidence at protein level
F7VJQ1,APRIO_HUMAN,Alternative prion protein (AltPrP),73,"8,691",3 out of 5,2012-11-28,Evidence at protein level
Q8NBQ7,AQP11_HUMAN,Aquaporin-11 (AQP-11),271,"30,203",3 out of 5,2004-05-10,Evidence at transcript level
Q3SXY8,AR13B_HUMAN,ADP-ribosylation factor-like protein 13B (ADP-ribosylation factor-like protein 2-like 1) (ARL2-like protein 1),428,"48,643",5 out of 5,2006-10-03,Evidence at protein level
Q96IT6,ARAS1_HUMAN,Putative uncharacterized protein ARHGAP5-AS1 (ARHGAP5 antisense RNA 1) (ARHGAP5 antisense gene protein 1),56,"6,106",1 out of 5,2005-07-19,Uncertain
P61204,ARF3_HUMAN,ADP-ribosylation factor 3,181,"20,601",5 out of 5,2004-05-10,Evidence at protein level
A5YM69,ARG35_HUMAN,Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein),484,"53,287",2 out of 5,2008-09-02,Evidence at protein level
A6NJG6,ARGFX_HUMAN,Arginine-fifty homeobox,315,"35,617",2 out of 5,2007-11-13,Evidence at transcript level
Q6ZSZ5,ARHGI_HUMAN,Rho guanine nucleotide exchange factor 18 (114 kDa Rho-specific guanine nucleotide exchange factor) (p114-Rho-GEF) (p114RhoGEF) (Septin-associated RhoGEF) (SA-RhoGEF),1173,"130,780",5 out of 5,2008-06-10,Evidence at protein level
O14497,ARI1A_HUMAN,"AT-rich interactive domain-containing protein 1A (ARID domain-containing protein 1A) (B120) (BRG1-associated factor 250) (BAF250) (BRG1-associated factor 250a) (BAF250A) (Osa homolog 1) (hOSA1) (SWI-like protein) (SWI/SNF complex protein p270) (SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1) (hELD)",2285,"242,045",5 out of 5,2000-12-01,Evidence at protein level
Q9Y4X5,ARI1_HUMAN,E3 ubiquitin-protein ligase ARIH1 (EC 2.3.2.-) (H7-AP2) (HHARI) (Monocyte protein 6) (MOP-6) (Protein ariadne-1 homolog) (ARI-1) (UbcH7-binding protein) (UbcM4-interacting protein) (Ubiquitin-conjugating enzyme E2-binding protein 1),557,"64,118",5 out of 5,2001-09-26,Evidence at protein level
Q9NVT9,ARMC1_HUMAN,Armadillo repeat-containing protein 1,282,"31,281",3 out of 5,2006-06-27,Evidence at protein level
Q9H6L4,ARMC7_HUMAN,Armadillo repeat-containing protein 7,198,"21,924",5 out of 5,2006-06-27,Evidence at protein level
Q9H981,ARP8_HUMAN,Actin-related protein 8 (hArp8) (INO80 complex subunit N),624,"70,484",5 out of 5,2003-01-27,Evidence at protein level
Q8N726,ARF_HUMAN,Tumor suppressor ARF (Alternative reading frame) (ARF) (Cyclin-dependent kinase inhibitor 2A) (p14ARF),132,"13,903",5 out of 5,2005-10-11,Evidence at protein level
Q92888,ARHG1_HUMAN,Rho guanine nucleotide exchange factor 1 (115 kDa guanine nucleotide exchange factor) (p115-RhoGEF) (p115RhoGEF) (Sub1.5),912,"102,435",5 out of 5,2003-08-29,Evidence at protein level
Q92974,ARHG2_HUMAN,Rho guanine nucleotide exchange factor 2 (Guanine nucleotide exchange factor H1) (GEF-H1) (Microtubule-regulated Rho-GEF) (Proliferating cell nucleolar antigen p40),986,"111,543",5 out of 5,2000-05-30,Evidence at protein level
O94989,ARHGF_HUMAN,Rho guanine nucleotide exchange factor 15 (Ephexin-5) (E5) (Vsm-RhoGEF),841,"91,940",5 out of 5,2004-08-16,Evidence at protein level
Q4LE39,ARI4B_HUMAN,AT-rich interactive domain-containing protein 4B (ARID domain-containing protein 4B) (180 kDa Sin3-associated polypeptide) (Sin3-associated polypeptide p180) (Breast cancer-associated antigen BRCAA1) (Histone deacetylase complex subunit SAP180) (Retinoblastoma-binding protein 1-like 1),1312,"147,809",5 out of 5,2007-04-03,Evidence at protein level
Q68CP9,ARID2_HUMAN,AT-rich interactive domain-containing protein 2 (ARID domain-containing protein 2) (BRG1-associated factor 200) (BAF200) (Zinc finger protein with activation potential) (Zipzap/p200),1835,"197,391",5 out of 5,2005-08-30,Evidence at protein level
Q8N8L6,ARL10_HUMAN,ADP-ribosylation factor-like protein 10,244,"27,459",2 out of 5,2005-11-22,Evidence at transcript level
P49703,ARL4D_HUMAN,ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L),201,"22,156",5 out of 5,1996-02-01,Evidence at protein level
Q96BM9,ARL8A_HUMAN,ADP-ribosylation factor-like protein 8A (ADP-ribosylation factor-like protein 10B) (Novel small G protein indispensable for equal chromosome segregation 2),186,"21,416",5 out of 5,2006-04-18,Evidence at protein level
Q6T311,ARL9_HUMAN,ADP-ribosylation factor-like protein 9,187,"20,755",2 out of 5,2005-11-08,Evidence at transcript level
Q7L311,ARMX2_HUMAN,Armadillo repeat-containing X-linked protein 2 (ARM protein lost in epithelial cancers on chromosome X 2) (Protein ALEX2),632,"65,683",2 out of 5,2005-12-20,Evidence at transcript level
Q6P1M9,ARMX5_HUMAN,Armadillo repeat-containing X-linked protein 5,558,"62,346",1 out of 5,2005-12-20,Evidence at protein level
P61160,ARP2_HUMAN,Actin-related protein 2 (Actin-like protein 2),394,"44,761",5 out of 5,2004-05-10,Evidence at protein level
O15144,ARPC2_HUMAN,Actin-related protein 2/3 complex subunit 2 (Arp2/3 complex 34 kDa subunit) (p34-ARC),300,"34,333",5 out of 5,1998-07-15,Evidence at protein level
Q6HA08,ASTL_HUMAN,Astacin-like metalloendopeptidase (EC 3.4.-.-) (Oocyte astacin) (Ovastacin),431,"45,936",5 out of 5,2005-09-27,Evidence at protein level
Q9P241,AT10D_HUMAN,Probable phospholipid-transporting ATPase VD (EC 3.6.3.1) (ATPase class V type 10D) (P4-ATPase flippase complex alpha subunit ATP10D),1426,"160,274",5 out of 5,2001-10-18,Evidence at transcript level
Q9Y2G3,AT11B_HUMAN,Probable phospholipid-transporting ATPase IF (EC 3.6.3.1) (ATPase IR) (ATPase class VI type 11B) (P4-ATPase flippase complex alpha subunit ATP11B),1177,"134,190",5 out of 5,2000-05-30,Evidence at protein level
Q13733,AT1A4_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-4 (Na(+)/K(+) ATPase alpha-4 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-4),1029,"114,166",5 out of 5,2001-10-18,Evidence at protein level
O14983,AT2A1_HUMAN,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 (SERCA1) (SR Ca(2+)-ATPase 1) (EC 3.6.3.8) (Calcium pump 1) (Calcium-transporting ATPase sarcoplasmic reticulum type, fast twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",1001,"110,252",5 out of 5,2000-12-01,Evidence at protein level
P20020,AT2B1_HUMAN,Plasma membrane calcium-transporting ATPase 1 (PMCA1) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 1) (Plasma membrane calcium pump isoform 1),1258,"138,755",5 out of 5,1991-02-01,Evidence at protein level
P98194,AT2C1_HUMAN,Calcium-transporting ATPase type 2C member 1 (ATPase 2C1) (EC 3.6.3.8) (ATP-dependent Ca(2+) pump PMR1),919,"100,577",5 out of 5,2000-05-30,Evidence at protein level
Q8TBG4,AT2L1_HUMAN,Ethanolamine-phosphate phospho-lyase (EC 4.2.3.2) (Alanine--glyoxylate aminotransferase 2-like 1),499,"55,671",5 out of 5,2007-05-15,Evidence at protein level
P24539,AT5F1_HUMAN,"ATP synthase F(0) complex subunit B1, mitochondrial (ATP synthase proton-transporting mitochondrial F(0) complex subunit B1) (ATP synthase subunit b) (ATPase subunit b)",256,"28,909",5 out of 5,1992-03-01,Evidence at protein level
Q06055,AT5G2_HUMAN,"ATP synthase F(0) complex subunit C2, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase proteolipid P2) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C2) (ATPase protein 9) (ATPase subunit c)",141,"14,637",5 out of 5,1994-02-01,Evidence at transcript level
Q9Y2Q0,AT8A1_HUMAN,Phospholipid-transporting ATPase IA (EC 3.6.3.1) (ATPase class I type 8A member 1) (Chromaffin granule ATPase II) (P4-ATPase flippase complex alpha subunit ATP8A1),1164,"131,369",5 out of 5,2000-05-30,Evidence at protein level
P0DMR3,AT8OS_HUMAN,Putative protein ATXN8OS (ATXN8 opposite strand) (Spinocerebellar ataxia 8) (kelch-like 1 antisense),200,"22,759",2 out of 5,2015-01-07,Uncertain
P51693,APLP1_HUMAN,Amyloid-like protein 1 (APLP) (APLP-1) [Cleaved into: C30],650,"72,176",5 out of 5,1996-10-01,Evidence at protein level
P02652,APOA2_HUMAN,Apolipoprotein A-II (Apo-AII) (ApoA-II) (Apolipoprotein A2) [Cleaved into: Proapolipoprotein A-II (ProapoA-II); Truncated apolipoprotein A-II (Apolipoprotein A-II(1-76))],100,"11,175",5 out of 5,1986-07-21,Evidence at protein level
Q15041,AR6P1_HUMAN,ADP-ribosylation factor-like protein 6-interacting protein 1 (ARL-6-interacting protein 1) (Aip-1) (Apoptotic regulator in the membrane of the endoplasmic reticulum),203,"23,363",5 out of 5,1998-07-15,Evidence at protein level
Q5VWT5,ARAP_HUMAN,"Activation-dependent, raft-recruited ADAP-like phosphoprotein",728,"82,070",5 out of 5,2007-09-11,Evidence at protein level
Q8N4G2,ARL14_HUMAN,ADP-ribosylation factor-like protein 14 (ADP-ribosylation factor 7),192,"21,588",4 out of 5,2007-03-20,Evidence at protein level
P36404,ARL2_HUMAN,ADP-ribosylation factor-like protein 2,184,"20,878",5 out of 5,1994-06-01,Evidence at protein level
A6NH57,ARL5C_HUMAN,Putative ADP-ribosylation factor-like protein 5C (ADP-ribosylation factor-like protein 12),179,"20,591",2 out of 5,2008-04-29,Inferred from homology
Q8N2F6,ARM10_HUMAN,Armadillo repeat-containing protein 10 (Splicing variant involved in hepatocarcinogenesis protein),343,"37,540",5 out of 5,2007-08-21,Evidence at protein level
Q5W041,ARMC3_HUMAN,Armadillo repeat-containing protein 3 (Beta-catenin-like protein) (Cancer/testis antigen 81) (CT81) (KU-CT-1),872,"96,405",3 out of 5,2007-04-17,Evidence at transcript level
Q96C12,ARMC5_HUMAN,Armadillo repeat-containing protein 5,935,"97,682",5 out of 5,2007-04-17,Evidence at protein level
Q7L4S7,ARMX6_HUMAN,Protein ARMCX6,300,"33,019",2 out of 5,2005-12-20,Evidence at transcript level
Q9HBZ2,ARNT2_HUMAN,Aryl hydrocarbon receptor nuclear translocator 2 (ARNT protein 2) (Class E basic helix-loop-helix protein 1) (bHLHe1),717,"78,691",5 out of 5,2001-10-18,Evidence at protein level
P61158,ARP3_HUMAN,Actin-related protein 3 (Actin-like protein 3),418,"47,371",5 out of 5,2004-05-10,Evidence at protein level
P49407,ARRB1_HUMAN,Beta-arrestin-1 (Arrestin beta-1),418,"47,066",5 out of 5,1996-02-01,Evidence at protein level
Q6UWY0,ARSK_HUMAN,Arylsulfatase K (ASK) (EC 3.1.6.-) (Telethon sulfatase),536,"61,450",4 out of 5,2005-10-11,Evidence at protein level
P11245,ARY2_HUMAN,Arylamine N-acetyltransferase 2 (EC 2.3.1.5) (Arylamide acetylase 2) (N-acetyltransferase type 2) (NAT-2) (Polymorphic arylamine N-acetyltransferase) (PNAT),290,"33,542",5 out of 5,1989-07-01,Evidence at protein level
Q92485,ASM3B_HUMAN,Acid sphingomyelinase-like phosphodiesterase 3b (ASM-like phosphodiesterase 3b) (EC 3.1.4.-),455,"50,814",5 out of 5,2001-08-29,Evidence at protein level
P46597,ASMT_HUMAN,Acetylserotonin O-methyltransferase (EC 2.1.1.4) (Hydroxyindole O-methyltransferase) (HIOMT),345,"38,453",5 out of 5,1995-11-01,Evidence at protein level
P17405,ASM_HUMAN,Sphingomyelin phosphodiesterase (EC 3.1.4.12) (Acid sphingomyelinase) (aSMase),629,"69,752",5 out of 5,1990-08-01,Evidence at protein level
A6ND91,ASPD_HUMAN,Putative L-aspartate dehydrogenase (EC 1.4.1.21) (Aspartate dehydrogenase domain-containing protein),283,"29,946",3 out of 5,2007-09-11,Evidence at protein level
P05023,AT1A1_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-1 (Na(+)/K(+) ATPase alpha-1 subunit) (EC 3.6.3.9) (Sodium pump subunit alpha-1),1023,"112,896",5 out of 5,1987-08-13,Evidence at protein level
P05026,AT1B1_HUMAN,Sodium/potassium-transporting ATPase subunit beta-1 (Sodium/potassium-dependent ATPase subunit beta-1),303,"35,061",5 out of 5,1987-08-13,Evidence at protein level
P59998,ARPC4_HUMAN,Actin-related protein 2/3 complex subunit 4 (Arp2/3 complex 20 kDa subunit) (p20-ARC),168,"19,667",5 out of 5,2003-11-14,Evidence at protein level
P36575,ARRC_HUMAN,Arrestin-C (Cone arrestin) (C-arrestin) (cArr) (Retinal cone arrestin-3) (X-arrestin),388,"42,778",5 out of 5,1994-06-01,Evidence at protein level
P15289,ARSA_HUMAN,Arylsulfatase A (ASA) (EC 3.1.6.8) (Cerebroside-sulfatase) [Cleaved into: Arylsulfatase A component B; Arylsulfatase A component C],507,"53,588",5 out of 5,1990-04-01,Evidence at protein level
Q96EG1,ARSG_HUMAN,Arylsulfatase G (ASG) (EC 3.1.6.-),525,"57,061",5 out of 5,2005-10-11,Evidence at protein level
A6NK59,ASB14_HUMAN,Ankyrin repeat and SOCS box protein 14 (ASB-14),587,"65,331",3 out of 5,2009-04-14,Evidence at transcript level
Q96NS5,ASB16_HUMAN,Ankyrin repeat and SOCS box protein 16 (ASB-16),453,"49,637",3 out of 5,2002-05-10,Evidence at protein level
Q9Y576,ASB1_HUMAN,Ankyrin repeat and SOCS box protein 1 (ASB-1),335,"37,014",3 out of 5,2002-05-10,Evidence at protein level
Q9UHC3,ASIC3_HUMAN,Acid-sensing ion channel 3 (ASIC3) (hASIC3) (Amiloride-sensitive cation channel 3) (Neuronal amiloride-sensitive cation channel 3) (Testis sodium channel 1) (hTNaC1),531,"58,905",5 out of 5,2005-09-13,Evidence at protein level
Q12797,ASPH_HUMAN,Aspartyl/asparaginyl beta-hydroxylase (EC 1.14.11.16) (Aspartate beta-hydroxylase) (ASP beta-hydroxylase) (Peptide-aspartate beta-dioxygenase),758,"85,863",5 out of 5,1997-11-01,Evidence at protein level
P26436,ASPX_HUMAN,Acrosomal protein SP-10 (Acrosomal vesicle protein 1),265,"28,156",4 out of 5,1992-08-01,Evidence at protein level
Q99941,ATF6B_HUMAN,Cyclic AMP-dependent transcription factor ATF-6 beta (cAMP-dependent transcription factor ATF-6 beta) (Activating transcription factor 6 beta) (ATF6-beta) (Protein G13) (cAMP response element-binding protein-related protein) (Creb-rp) (cAMP-responsive element-binding protein-like 1) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 beta],703,"76,709",5 out of 5,2002-01-23,Evidence at protein level
Q9NXU5,ARL15_HUMAN,ADP-ribosylation factor-like protein 15 (ADP-ribosylation factor-related protein 2) (ARF-related protein 2),204,"22,876",2 out of 5,2007-04-03,Evidence at protein level
P40617,ARL4A_HUMAN,ADP-ribosylation factor-like protein 4A,200,"22,615",5 out of 5,1995-02-01,Evidence at protein level
Q9NVJ2,ARL8B_HUMAN,ADP-ribosylation factor-like protein 8B (ADP-ribosylation factor-like protein 10C) (Novel small G protein indispensable for equal chromosome segregation 1),186,"21,539",5 out of 5,2006-04-18,Evidence at protein level
Q9H993,ARMT1_HUMAN,Protein-glutamate O-methyltransferase (EC 2.1.1.-) (Acidic residue methyltransferase 1),441,"51,172",5 out of 5,2006-04-04,Evidence at protein level
Q9UH62,ARMX3_HUMAN,Armadillo repeat-containing X-linked protein 3 (ARM protein lost in epithelial cancers on chromosome X 3) (Protein ALEX3),379,"42,501",2 out of 5,2005-12-20,Evidence at protein level
P27540,ARNT_HUMAN,"Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta)",789,"86,636",5 out of 5,1992-08-01,Evidence at protein level
Q9C0K3,ARP3C_HUMAN,Actin-related protein 3C (Actin-related protein 11),210,"23,712",3 out of 5,2008-03-18,Evidence at transcript level
Q9H9F9,ARP5_HUMAN,Actin-related protein 5 (hARP5) (Sarcoma antigen NY-SAR-16),607,"68,297",5 out of 5,2006-07-25,Evidence at protein level
O15511,ARPC5_HUMAN,Actin-related protein 2/3 complex subunit 5 (Arp2/3 complex 16 kDa subunit) (p16-ARC),151,"16,320",5 out of 5,1998-07-15,Evidence at protein level
P10523,ARRS_HUMAN,S-arrestin (48 kDa protein) (Retinal S-antigen) (S-AG) (Rod photoreceptor arrestin),405,"45,120",5 out of 5,1989-07-01,Evidence at protein level
P51690,ARSE_HUMAN,Arylsulfatase E (ASE) (EC 3.1.6.-),589,"65,669",5 out of 5,1996-10-01,Evidence at protein level
P18440,ARY1_HUMAN,Arylamine N-acetyltransferase 1 (EC 2.3.1.5) (Arylamide acetylase 1) (Monomorphic arylamine N-acetyltransferase) (MNAT) (N-acetyltransferase type 1) (NAT-1),290,"33,899",5 out of 5,1990-11-01,Evidence at protein level
Q8WXI3,ASB10_HUMAN,Ankyrin repeat and SOCS box protein 10 (ASB-10),467,"50,894",5 out of 5,2002-05-10,Evidence at protein level
Q8WXJ9,ASB17_HUMAN,Ankyrin repeat and SOCS box protein 17 (ASB-17),295,"34,282",2 out of 5,2002-05-10,Evidence at transcript level
Q96Q27,ASB2_HUMAN,Ankyrin repeat and SOCS box protein 2 (ASB-2),587,"65,084",5 out of 5,2002-05-10,Evidence at protein level
Q9H765,ASB8_HUMAN,Ankyrin repeat and SOCS box protein 8 (ASB-8),288,"31,642",3 out of 5,2003-02-28,Evidence at transcript level
Q6XD76,ASCL4_HUMAN,Achaete-scute homolog 4 (ASH-4) (hASH4) (Achaete-scute-like protein 4) (Class A basic helix-loop-helix protein 44) (bHLHa44),172,"19,253",3 out of 5,2008-02-05,Evidence at protein level
Q7L266,ASGL1_HUMAN,Isoaspartyl peptidase/L-asparaginase (EC 3.4.19.5) (EC 3.5.1.1) (Asparaginase-like protein 1) (Beta-aspartyl-peptidase) (Isoaspartyl dipeptidase) (L-asparagine amidohydrolase) [Cleaved into: Isoaspartyl peptidase/L-asparaginase alpha chain; Isoaspartyl peptidase/L-asparaginase beta chain],308,"32,055",5 out of 5,2007-10-02,Evidence at protein level
P07306,ASGR1_HUMAN,Asialoglycoprotein receptor 1 (ASGP-R 1) (ASGPR 1) (C-type lectin domain family 4 member H1) (Hepatic lectin H1) (HL-1),291,"33,186",5 out of 5,1988-04-01,Evidence at protein level
Q6ICH7,ASPH2_HUMAN,Aspartate beta-hydroxylase domain-containing protein 2 (EC 1.14.11.-),369,"41,699",3 out of 5,2006-10-31,Evidence at transcript level
Q96KQ4,ASPP1_HUMAN,Apoptosis-stimulating of p53 protein 1 (Protein phosphatase 1 regulatory subunit 13B),1090,"119,565",5 out of 5,2003-08-15,Evidence at protein level
Q9UN42,AT1B4_HUMAN,"Protein ATP1B4 (X,K-ATPase subunit beta-m) (X/potassium-transporting ATPase subunit beta-m)",357,"41,598",5 out of 5,2001-11-16,Evidence at transcript level
Q16720,AT2B3_HUMAN,Plasma membrane calcium-transporting ATPase 3 (PMCA3) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 3) (Plasma membrane calcium pump isoform 3),1220,"134,197",5 out of 5,1997-11-01,Evidence at protein level
P23634,AT2B4_HUMAN,Plasma membrane calcium-transporting ATPase 4 (PMCA4) (EC 3.6.3.8) (Matrix-remodeling-associated protein 1) (Plasma membrane calcium ATPase isoform 4) (Plasma membrane calcium pump isoform 4),1241,"137,920",5 out of 5,1991-11-01,Evidence at protein level
Q8IUZ5,AT2L2_HUMAN,5-phosphohydroxy-L-lysine phospho-lyase (EC 4.2.3.134) (Alanine--glyoxylate aminotransferase 2-like 2),450,"49,711",5 out of 5,2007-05-15,Evidence at protein level
Q5VTU8,AT5EL_HUMAN,"ATP synthase subunit epsilon-like protein, mitochondrial",51,"5,807",3 out of 5,2008-09-02,Inferred from homology
P48201,AT5G3_HUMAN,"ATP synthase F(0) complex subunit C3, mitochondrial (ATP synthase lipid-binding protein) (ATP synthase proteolipid P3) (ATP synthase proton-transporting mitochondrial F(0) complex subunit C3) (ATPase protein 9) (ATPase subunit c)",142,"14,693",5 out of 5,1996-02-01,Evidence at transcript level
Q5T6C5,AT7L2_HUMAN,Ataxin-7-like protein 2,722,"77,181",2 out of 5,2007-02-20,Evidence at protein level
Q9H0Y0,ATG10_HUMAN,Ubiquitin-like-conjugating enzyme ATG10 (EC 6.3.2.-) (Autophagy-related protein 10) (APG10-like),220,"25,279",5 out of 5,2005-03-29,Evidence at protein level
Q9Y4P1,ATG4B_HUMAN,Cysteine protease ATG4B (EC 3.4.22.-) (AUT-like 1 cysteine endopeptidase) (Autophagin-1) (Autophagy-related cysteine endopeptidase 1) (Autophagy-related protein 4 homolog B) (hAPG4B),393,"44,294",5 out of 5,2005-03-15,Evidence at protein level
Q92858,ATOH1_HUMAN,Protein atonal homolog 1 (Class A basic helix-loop-helix protein 14) (bHLHa14) (Helix-loop-helix protein hATH-1) (hATH1),354,"38,160",5 out of 5,1998-12-15,Evidence at transcript level
Q8N100,ATOH7_HUMAN,Protein atonal homolog 7 (Class A basic helix-loop-helix protein 13) (bHLHa13) (Helix-loop-helix protein hATH-5) (hATH5),152,"16,871",4 out of 5,2007-06-26,Evidence at protein level
Q96SQ7,ATOH8_HUMAN,Protein atonal homolog 8 (Class A basic helix-loop-helix protein 21) (bHLHa21) (Helix-loop-helix protein hATH-6) (hATH6),321,"34,644",5 out of 5,2008-03-18,Evidence at transcript level
Q9NZ32,ARP10_HUMAN,Actin-related protein 10 (Actin-related protein 11) (hARP11),417,"46,307",3 out of 5,2003-01-27,Evidence at protein level
Q9GZN1,ARP6_HUMAN,Actin-related protein 6 (hArp6) (hARPX),396,"45,810",3 out of 5,2003-01-27,Evidence at protein level
Q8NCT1,ARRD4_HUMAN,Arrestin domain-containing protein 4,418,"45,479",4 out of 5,2006-06-27,Evidence at protein level
O43150,ASAP2_HUMAN,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 (Development and differentiation-enhancing factor 2) (Paxillin-associated protein with ARF GAP activity 3) (PAG3) (Pyk2 C-terminus-associated protein) (PAP)",1006,"111,651",5 out of 5,2004-03-29,Evidence at protein level
Q8WXH4,ASB11_HUMAN,Ankyrin repeat and SOCS box protein 11 (ASB-11),323,"35,367",3 out of 5,2002-05-10,Evidence at protein level
P50553,ASCL1_HUMAN,Achaete-scute homolog 1 (ASH-1) (hASH1) (Class A basic helix-loop-helix protein 46) (bHLHa46),236,"25,454",5 out of 5,1996-10-01,Evidence at protein level
Q9NQ33,ASCL3_HUMAN,Achaete-scute homolog 3 (ASH-3) (hASH3) (Class A basic helix-loop-helix protein 42) (bHLHa42) (bHLH transcriptional regulator Sgn-1),180,"20,797",3 out of 5,2002-05-02,Evidence at transcript level
Q9Y294,ASF1A_HUMAN,Histone chaperone ASF1A (Anti-silencing function protein 1 homolog A) (hAsf1) (hAsf1a) (CCG1-interacting factor A) (CIA) (hCIA),204,"22,969",5 out of 5,2007-04-17,Evidence at protein level
P20933,ASPG_HUMAN,N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase (EC 3.5.1.26) (Aspartylglucosaminidase) (Glycosylasparaginase) (N4-(N-acetyl-beta-glucosaminyl)-L-asparagine amidase) [Cleaved into: Glycosylasparaginase alpha chain; Glycosylasparaginase beta chain],346,"37,208",5 out of 5,1991-02-01,Evidence at protein level
Q9BXN1,ASPN_HUMAN,Asporin (Periodontal ligament-associated protein 1) (PLAP-1),380,"43,417",5 out of 5,2002-06-20,Evidence at protein level
O94823,AT10B_HUMAN,Probable phospholipid-transporting ATPase VB (EC 3.6.3.1) (ATPase class V type 10B) (P4-ATPase flippase complex alpha subunit ATP10B),1461,"165,391",5 out of 5,2000-05-30,Evidence at transcript level
Q9HD20,AT131_HUMAN,Manganese-transporting ATPase 13A1 (EC 3.6.3.-),1204,"132,955",5 out of 5,2001-10-18,Evidence at protein level
Q8NHH9,ATLA2_HUMAN,Atlastin-2 (EC 3.6.5.-) (ADP-ribosylation factor-like protein 6-interacting protein 2) (ARL-6-interacting protein 2) (Aip-2),583,"66,229",5 out of 5,2007-05-15,Evidence at protein level
Q9Y6H3,ATP23_HUMAN,Mitochondrial inner membrane protease ATP23 homolog (EC 3.4.24.-) (Ku70-binding protein 3) (XRCC6-binding protein 1),246,"28,081",4 out of 5,2008-04-29,Evidence at protein level
P56381,ATP5E_HUMAN,"ATP synthase subunit epsilon, mitochondrial (ATPase subunit epsilon)",51,"5,780",4 out of 5,1998-07-15,Evidence at protein level
Q8N5M1,ATPF2_HUMAN,ATP synthase mitochondrial F1 complex assembly factor 2 (ATP12 homolog),289,"32,772",5 out of 5,2005-08-30,Evidence at protein level
P36542,ATPG_HUMAN,"ATP synthase subunit gamma, mitochondrial (F-ATPase gamma subunit)",298,"32,996",5 out of 5,1994-06-01,Evidence at protein level
Q5VV63,ATRN1_HUMAN,Attractin-like protein 1,1379,"152,639",4 out of 5,2008-05-20,Evidence at transcript level
P46100,ATRX_HUMAN,Transcriptional regulator ATRX (EC 3.6.4.12) (ATP-dependent helicase ATRX) (X-linked helicase II) (X-linked nuclear protein) (XNP) (Znf-HX),2492,"282,586",5 out of 5,1995-11-01,Evidence at protein level
Q9H324,ATS10_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 10 (ADAM-TS 10) (ADAM-TS10) (ADAMTS-10) (EC 3.4.24.-),1103,"120,874",5 out of 5,2001-12-05,Evidence at protein level
Q76LX8,ATS13_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 13 (ADAM-TS 13) (ADAM-TS13) (ADAMTS-13) (EC 3.4.24.87) (von Willebrand factor-cleaving protease) (vWF-CP) (vWF-cleaving protease),1427,"153,604",5 out of 5,2006-07-25,Evidence at protein level
Q9UNA0,ATS5_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 5 (ADAM-TS 5) (ADAM-TS5) (ADAMTS-5) (EC 3.4.24.-) (A disintegrin and metalloproteinase with thrombospondin motifs 11) (ADAM-TS 11) (ADAMTS-11) (ADMP-2) (Aggrecanase-2),930,"101,718",5 out of 5,2000-12-01,Evidence at protein level
Q9UP79,ATS8_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 8 (ADAM-TS 8) (ADAM-TS8) (ADAMTS-8) (EC 3.4.24.-) (METH-2) (METH-8),889,"96,460",5 out of 5,2000-12-01,Evidence at transcript level
Q9H7T9,AUNIP_HUMAN,Aurora kinase A and ninein-interacting protein (AIBp),357,"40,253",4 out of 5,2007-04-17,Evidence at protein level
Q8WXX7,AUTS2_HUMAN,Autism susceptibility gene 2 protein,1259,"138,982",5 out of 5,2002-09-19,Evidence at protein level
Q9NQS1,AVEN_HUMAN,Cell death regulator Aven,362,"38,506",4 out of 5,2002-05-02,Evidence at protein level
O43521,B2L11_HUMAN,Bcl-2-like protein 11 (Bcl2-L-11) (Bcl2-interacting mediator of cell death),198,"22,171",5 out of 5,2001-10-18,Evidence at protein level
Q6PL18,ATAD2_HUMAN,ATPase family AAA domain-containing protein 2 (EC 3.6.1.3) (AAA nuclear coregulator cancer-associated protein) (ANCCA),1390,"158,554",5 out of 5,2005-09-13,Evidence at protein level
Q9ULI0,ATD2B_HUMAN,ATPase family AAA domain-containing protein 2B,1458,"164,914",5 out of 5,2001-06-20,Evidence at protein level
P15336,ATF2_HUMAN,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (EC 2.3.1.48) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (Histone acetyltransferase ATF2) (cAMP response element-binding protein CRE-BP1),505,"54,537",5 out of 5,1990-04-01,Evidence at protein level
P18850,ATF6A_HUMAN,Cyclic AMP-dependent transcription factor ATF-6 alpha (cAMP-dependent transcription factor ATF-6 alpha) (Activating transcription factor 6 alpha) (ATF6-alpha) [Cleaved into: Processed cyclic AMP-dependent transcription factor ATF-6 alpha],670,"74,585",5 out of 5,1990-11-01,Evidence at protein level
O75143,ATG13_HUMAN,Autophagy-related protein 13,517,"56,572",5 out of 5,2002-01-23,Evidence at protein level
Q2TAZ0,ATG2A_HUMAN,Autophagy-related protein 2 homolog A,1938,"212,860",5 out of 5,2008-01-15,Evidence at protein level
Q7Z3C6,ATG9A_HUMAN,Autophagy-related protein 9A (APG9-like 1) (mATG9),839,"94,447",5 out of 5,2005-04-12,Evidence at protein level
Q6DD88,ATLA3_HUMAN,Atlastin-3 (EC 3.6.5.-),541,"60,542",5 out of 5,2007-05-15,Evidence at protein level
Q13315,ATM_HUMAN,Serine-protein kinase ATM (EC 2.7.11.1) (Ataxia telangiectasia mutated) (A-T mutated),3056,"350,687",5 out of 5,2001-04-27,Evidence at protein level
Q6RW13,ATRAP_HUMAN,Type-1 angiotensin II receptor-associated protein (AT1 receptor-associated protein),159,"17,419",5 out of 5,2005-07-19,Evidence at protein level
Q8WXS8,ATS14_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 14 (ADAM-TS 14) (ADAM-TS14) (ADAMTS-14) (EC 3.4.24.-),1223,"133,888",5 out of 5,2003-02-28,Evidence at transcript level
Q8TE57,ATS16_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 16 (ADAM-TS 16) (ADAM-TS16) (ADAMTS-16) (EC 3.4.24.-),1224,"136,203",5 out of 5,2003-06-27,Evidence at transcript level
P54253,ATX1_HUMAN,Ataxin-1 (Spinocerebellar ataxia type 1 protein),815,"86,923",5 out of 5,1996-10-01,Evidence at protein level
Q8WWM7,ATX2L_HUMAN,Ataxin-2-like protein (Ataxin-2 domain protein) (Ataxin-2-related protein),1075,"113,374",5 out of 5,2004-09-13,Evidence at protein level
Q9Y679,AUP1_HUMAN,Ancient ubiquitous protein 1,476,"53,028",5 out of 5,2000-12-01,Evidence at protein level
O14965,AURKA_HUMAN,Aurora kinase A (EC 2.7.11.1) (Aurora 2) (Aurora/IPL1-related kinase 1) (ARK-1) (Aurora-related kinase 1) (hARK1) (Breast tumor-amplified kinase) (Serine/threonine-protein kinase 15) (Serine/threonine-protein kinase 6) (Serine/threonine-protein kinase aurora-A),403,"45,809",5 out of 5,2003-01-27,Evidence at protein level
Q8NBF6,AVL9_HUMAN,Late secretory pathway protein AVL9 homolog,648,"71,947",3 out of 5,2006-07-25,Evidence at protein level
Q5SQI0,ATAT_HUMAN,Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog),421,"46,810",5 out of 5,2008-09-02,Evidence at protein level
Q86WG3,ATCAY_HUMAN,Caytaxin (Ataxia cayman type protein) (BNIP-2-homology) (BNIP-H),371,"42,120",5 out of 5,2003-10-31,Evidence at protein level
Q5T2N8,ATD3C_HUMAN,ATPase family AAA domain-containing protein 3C,411,"46,380",2 out of 5,2007-12-04,Evidence at transcript level
Q99766,ATP5S_HUMAN,"ATP synthase subunit s, mitochondrial (ATP synthase-coupling factor B) (FB) (Mitochondrial ATP synthase regulatory component factor B)",215,"24,866",5 out of 5,2000-05-30,Evidence at protein level
P30049,ATPD_HUMAN,"ATP synthase subunit delta, mitochondrial (F-ATPase delta subunit)",168,"17,490",5 out of 5,1993-04-01,Evidence at protein level
O75882,ATRN_HUMAN,Attractin (DPPT-L) (Mahogany homolog),1429,"158,537",5 out of 5,2001-04-27,Evidence at protein level
Q3ZCQ2,AX2R_HUMAN,Annexin-2 receptor (Annexin II receptor) (AXIIR),193,"21,682",3 out of 5,2007-07-24,Evidence at protein level
Q8NCR0,B3GL2_HUMAN,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 (Beta-1,3-GalNAc-T2) (EC 2.4.1.-) (Beta-1,3-N-acetylgalactosaminyltransferase II)",500,"56,704",5 out of 5,2006-09-05,Evidence at protein level
Q9C0J1,B3GN4_HUMAN,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 4 (EC 2.4.1.149) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4) (BGnT-4) (Beta-1,3-Gn-T4) (Beta-1,3-N-acetylglucosaminyltransferase 4) (Beta3Gn-T4)",378,"42,310",5 out of 5,2007-05-29,Evidence at protein level
Q76KP1,B4GN4_HUMAN,"N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 1 (NGalNAc-T1) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase IV) (Beta4GalNAc-T4) (Beta4GalNAcT4)",1039,"116,513",4 out of 5,2006-10-17,Evidence at protein level
O14867,BACH1_HUMAN,Transcription regulator protein BACH1 (BTB and CNC homolog 1) (HA2303),736,"81,958",5 out of 5,1998-07-15,Evidence at protein level
O00154,BACH_HUMAN,Cytosolic acyl coenzyme A thioester hydrolase (EC 3.1.2.2) (Acyl-CoA thioesterase 7) (Brain acyl-CoA hydrolase) (BACH) (CTE-IIa) (CTE-II) (Long chain acyl-CoA thioester hydrolase),380,"41,796",5 out of 5,1997-11-01,Evidence at protein level
Q86Y29,BAGE3_HUMAN,B melanoma antigen 3 (Cancer/testis antigen 2.3) (CT2.3),109,"12,112",2 out of 5,2003-10-03,Evidence at transcript level
Q9P281,BAHC1_HUMAN,BAH and coiled-coil domain-containing protein 1 (Bromo adjacent homology domain-containing protein 2) (BAH domain-containing protein 2),2608,"276,932",3 out of 5,2007-12-04,Evidence at protein level
Q9NY43,BARH2_HUMAN,BarH-like 2 homeobox protein,387,"41,981",3 out of 5,2003-03-25,Evidence at protein level
P35613,BASI_HUMAN,Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147),385,"42,200",5 out of 5,1994-06-01,Evidence at protein level
Q9NR55,BATF3_HUMAN,Basic leucine zipper transcriptional factor ATF-like 3 (B-ATF-3) (21 kDa small nuclear factor isolated from T-cells) (Jun dimerization protein p21SNFT),127,"14,468",5 out of 5,2008-03-18,Evidence at protein level
Q9NRL2,BAZ1A_HUMAN,Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1),1556,"178,702",5 out of 5,2002-08-30,Evidence at protein level
P13637,AT1A3_HUMAN,Sodium/potassium-transporting ATPase subunit alpha-3 (Na(+)/K(+) ATPase alpha-3 subunit) (EC 3.6.3.9) (Na(+)/K(+) ATPase alpha(III) subunit) (Sodium pump subunit alpha-3),1013,"111,749",5 out of 5,1990-01-01,Evidence at protein level
P16615,AT2A2_HUMAN,"Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) (SR Ca(2+)-ATPase 2) (EC 3.6.3.8) (Calcium pump 2) (Calcium-transporting ATPase sarcoplasmic reticulum type, slow twitch skeletal muscle isoform) (Endoplasmic reticulum class 1/2 Ca(2+) ATPase)",1042,"114,757",5 out of 5,1990-08-01,Evidence at protein level
Q93084,AT2A3_HUMAN,Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 (SERCA3) (SR Ca(2+)-ATPase 3) (EC 3.6.3.8) (Calcium pump 3),1043,"113,977",5 out of 5,1997-11-01,Evidence at protein level
Q9NW81,AT5SL_HUMAN,ATP synthase subunit s-like protein,257,"29,267",3 out of 5,2008-02-26,Evidence at protein level
Q96DT6,ATG4C_HUMAN,Cysteine protease ATG4C (EC 3.4.22.-) (AUT-like 3 cysteine endopeptidase) (Autophagin-3) (Autophagy-related cysteine endopeptidase 3) (Autophagy-related protein 4 homolog C),458,"52,497",5 out of 5,2005-03-15,Evidence at protein level
Q6ZMM2,ATL5_HUMAN,ADAMTS-like protein 5 (ADAMTSL-5) (Thrombospondin type-1 domain-containing protein 6),481,"53,193",5 out of 5,2006-09-19,Evidence at protein level
Q8WXF7,ATLA1_HUMAN,Atlastin-1 (EC 3.6.5.-) (Brain-specific GTP-binding protein) (GTP-binding protein 3) (GBP-3) (hGBP3) (Guanine nucleotide-binding protein 3) (Spastic paraplegia 3 protein A),558,"63,544",5 out of 5,2003-10-24,Evidence at protein level
P54259,ATN1_HUMAN,Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein),1190,"125,414",5 out of 5,1996-10-01,Evidence at protein level
P06576,ATPB_HUMAN,"ATP synthase subunit beta, mitochondrial (EC 3.6.3.14)",529,"56,560",5 out of 5,1988-01-01,Evidence at protein level
Q7Z6K5,ARPIN_HUMAN,Arpin (Arp2/3 inhibition protein),226,"24,943",5 out of 5,2006-06-27,Evidence at protein level
Q8N5I2,ARRD1_HUMAN,Arrestin domain-containing protein 1,433,"45,981",3 out of 5,2006-06-27,Evidence at protein level
P42127,ASIP_HUMAN,Agouti-signaling protein (ASP) (Agouti switch protein),132,"14,515",5 out of 5,1995-11-01,Evidence at protein level
Q92484,ASM3A_HUMAN,Acid sphingomyelinase-like phosphodiesterase 3a (ASM-like phosphodiesterase 3a) (EC 3.1.4.-),453,"51,260",5 out of 5,2001-08-29,Evidence at protein level
Q9NWL6,ASND1_HUMAN,Asparagine synthetase domain-containing protein 1 (HCV NS3-transactivated protein 1),643,"72,080",2 out of 5,2008-03-18,Evidence at transcript level
Q5U4P2,ASPH1_HUMAN,Aspartate beta-hydroxylase domain-containing protein 1 (EC 1.14.11.-),390,"41,128",2 out of 5,2006-10-31,Evidence at protein level
O43520,AT8B1_HUMAN,Phospholipid-transporting ATPase IC (EC 3.6.3.1) (ATPase class I type 8B member 1) (Familial intrahepatic cholestasis type 1) (P4-ATPase flippase complex alpha subunit ATP8B1),1251,"143,695",5 out of 5,2000-05-30,Evidence at protein level
Q5T9A4,ATD3B_HUMAN,ATPase family AAA domain-containing protein 3B (AAA-TOB3),648,"72,573",5 out of 5,2005-09-13,Evidence at protein level
Q9Y2D1,ATF5_HUMAN,Cyclic AMP-dependent transcription factor ATF-5 (cAMP-dependent transcription factor ATF-5) (Activating transcription factor 5) (Transcription factor ATFx),282,"30,674",5 out of 5,2001-02-21,Evidence at protein level
P51164,ATP4B_HUMAN,Potassium-transporting ATPase subunit beta (Gastric H(+)/K(+) ATPase subunit beta) (Proton pump beta chain),291,"33,367",5 out of 5,1996-10-01,Evidence at protein level
O75947,ATP5H_HUMAN,"ATP synthase subunit d, mitochondrial (ATPase subunit d)",161,"18,491",5 out of 5,2000-05-30,Evidence at protein level
P56385,ATP5I_HUMAN,"ATP synthase subunit e, mitochondrial (ATPase subunit e) [Cleaved into: ATP synthase subunit e, mitochondrial, N-terminally processed]",69,"7,933",4 out of 5,1998-07-15,Evidence at protein level
O75964,ATP5L_HUMAN,"ATP synthase subunit g, mitochondrial (ATPase subunit g)",103,"11,428",4 out of 5,1998-12-15,Evidence at protein level
Q8TBH0,ARRD2_HUMAN,Arrestin domain-containing protein 2,407,"44,379",3 out of 5,2006-06-27,Evidence at transcript level
P78348,ASIC1_HUMAN,"Acid-sensing ion channel 1 (ASIC1) (Amiloride-sensitive cation channel 2, neuronal) (Brain sodium channel 2) (BNaC2)",528,"59,909",5 out of 5,2001-12-05,Evidence at protein level
Q13625,ASPP2_HUMAN,Apoptosis-stimulating of p53 protein 2 (Bcl2-binding protein) (Bbp) (Renal carcinoma antigen NY-REN-51) (Tumor suppressor p53-binding protein 2) (53BP2) (p53-binding protein 2) (p53BP2),1128,"125,616",5 out of 5,1998-07-15,Evidence at protein level
Q9Y284,ASTER_HUMAN,Protein Asterix (WD repeat domain 83 opposite strand) (WDR83 opposite strand),106,"12,068",2 out of 5,2001-01-24,Evidence at protein level
Q9H7F0,AT133_HUMAN,Probable cation-transporting ATPase 13A3 (EC 3.6.3.-) (ATPase family homolog up-regulated in senescence cells 1),1226,"138,043",4 out of 5,2001-10-18,Evidence at protein level
O75185,AT2C2_HUMAN,Calcium-transporting ATPase type 2C member 2 (ATPase 2C2) (EC 3.6.3.8) (Secretory pathway Ca(2+)-ATPase 2),946,"103,187",5 out of 5,2001-10-18,Evidence at protein level
Q8TF62,AT8B4_HUMAN,Probable phospholipid-transporting ATPase IM (EC 3.6.3.1) (ATPase class I type 8B member 4) (P4-ATPase flippase complex alpha subunit ATP8B4),1192,"135,868",5 out of 5,2003-04-30,Evidence at protein level
Q8WYN0,ATG4A_HUMAN,Cysteine protease ATG4A (EC 3.4.22.-) (AUT-like 2 cysteine endopeptidase) (Autophagin-2) (Autophagy-related cysteine endopeptidase 2) (Autophagy-related protein 4 homolog A) (hAPG4A),398,"45,378",5 out of 5,2005-03-15,Evidence at protein level
Q86TL0,ATG4D_HUMAN,"Cysteine protease ATG4D (EC 3.4.22.-) (AUT-like 4 cysteine endopeptidase) (Autophagin-4) (Autophagy-related cysteine endopeptidase 4) (Autophagy-related protein 4 homolog D) [Cleaved into: Cysteine protease ATG4D, mitochondrial]",474,"52,922",5 out of 5,2005-03-15,Evidence at protein level
Q9H1Y0,ATG5_HUMAN,Autophagy protein 5 (APG5-like) (Apoptosis-specific protein),275,"32,447",5 out of 5,2001-11-16,Evidence at protein level
Q9UII2,ATIF1_HUMAN,"ATPase inhibitor, mitochondrial (Inhibitor of F(1)F(o)-ATPase) (IF(1)) (IF1)",106,"12,249",5 out of 5,2001-01-24,Evidence at protein level
Q8N6G6,ATL1_HUMAN,ADAMTS-like protein 1 (ADAMTSL-1) (Punctin-1),1762,"193,409",5 out of 5,2003-10-31,Evidence at protein level
Q86TH1,ATL2_HUMAN,ADAMTS-like protein 2 (ADAMTSL-2),951,"104,621",5 out of 5,2006-09-19,Evidence at protein level
P54710,ATNG_HUMAN,Sodium/potassium-transporting ATPase subunit gamma (Na(+)/K(+) ATPase subunit gamma) (FXYD domain-containing ion transport regulator 2) (Sodium pump gamma chain),66,"7,283",5 out of 5,1996-10-01,Evidence at protein level
Q5TC12,ATPF1_HUMAN,ATP synthase mitochondrial F1 complex assembly factor 1 (ATP11 homolog),328,"36,437",3 out of 5,2008-03-18,Evidence at protein level
Q6ZP68,ATPUN_HUMAN,Putative protein ATP11AUN (Putative ATP11A upstream neighbor protein),121,"13,416",1 out of 5,2008-07-01,Evidence at transcript level
P18846,ATF1_HUMAN,Cyclic AMP-dependent transcription factor ATF-1 (cAMP-dependent transcription factor ATF-1) (Activating transcription factor 1) (Protein TREB36),271,"29,233",5 out of 5,1990-11-01,Evidence at protein level
P18847,ATF3_HUMAN,Cyclic AMP-dependent transcription factor ATF-3 (cAMP-dependent transcription factor ATF-3) (Activating transcription factor 3),181,"20,576",5 out of 5,1990-11-01,Evidence at protein level
P18848,ATF4_HUMAN,Cyclic AMP-dependent transcription factor ATF-4 (cAMP-dependent transcription factor ATF-4) (Activating transcription factor 4) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (DNA-binding protein TAXREB67) (Tax-responsive enhancer element-binding protein 67) (TaxREB67),351,"38,590",5 out of 5,1990-11-01,Evidence at protein level
O95352,ATG7_HUMAN,Ubiquitin-like modifier-activating enzyme ATG7 (ATG12-activating enzyme E1 ATG7) (Autophagy-related protein 7) (APG7-like) (hAGP7) (Ubiquitin-activating enzyme E1-like protein),703,"77,960",5 out of 5,2005-03-29,Evidence at protein level
Q04656,ATP7A_HUMAN,Copper-transporting ATPase 1 (EC 3.6.3.54) (Copper pump 1) (Menkes disease-associated protein),1500,"163,374",5 out of 5,1994-06-01,Evidence at protein level
P56134,ATPK_HUMAN,"ATP synthase subunit f, mitochondrial",94,"10,918",5 out of 5,1997-11-01,Evidence at protein level
P48047,ATPO_HUMAN,"ATP synthase subunit O, mitochondrial (Oligomycin sensitivity conferral protein) (OSCP)",213,"23,277",5 out of 5,1996-02-01,Evidence at protein level
Q13535,ATR_HUMAN,Serine/threonine-protein kinase ATR (EC 2.7.11.1) (Ataxia telangiectasia and Rad3-related protein) (FRAP-related protein 1),2644,"301,367",5 out of 5,2005-03-29,Evidence at protein level
Q8TE58,ATS15_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 15 (ADAM-TS 15) (ADAM-TS15) (ADAMTS-15) (EC 3.4.24.-),950,"103,287",4 out of 5,2003-02-28,Evidence at transcript level
Q8TE56,ATS17_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 17 (ADAM-TS 17) (ADAM-TS17) (ADAMTS-17) (EC 3.4.24.-),1095,"121,127",5 out of 5,2003-02-28,Evidence at transcript level
Q8TE59,ATS19_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 19 (ADAM-TS 19) (ADAM-TS19) (ADAMTS-19) (EC 3.4.24.-),1207,"134,048",4 out of 5,2003-03-25,Evidence at transcript level
O95450,ATS2_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 2 (ADAM-TS 2) (ADAM-TS2) (ADAMTS-2) (EC 3.4.24.14) (Procollagen I N-proteinase) (PC I-NP) (Procollagen I/II amino propeptide-processing enzyme) (Procollagen N-endopeptidase) (pNPI),1211,"134,755",5 out of 5,2000-12-01,Evidence at transcript level
Q9UKP5,ATS6_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 6 (ADAM-TS 6) (ADAM-TS6) (ADAMTS-6) (EC 3.4.24.-),1117,"125,273",5 out of 5,2000-12-01,Evidence at transcript level
Q9P2N4,ATS9_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 9 (ADAM-TS 9) (ADAM-TS9) (ADAMTS-9) (EC 3.4.24.-),1935,"216,491",5 out of 5,2001-04-27,Evidence at protein level
Q99700,ATX2_HUMAN,Ataxin-2 (Spinocerebellar ataxia type 2 protein) (Trinucleotide repeat-containing gene 13 protein),1313,"140,283",5 out of 5,2004-09-13,Evidence at protein level
Q9UQB9,AURKC_HUMAN,Aurora kinase C (EC 2.7.11.1) (Aurora 3) (Aurora/IPL1-related kinase 3) (ARK-3) (Aurora-related kinase 3) (Aurora/IPL1/Eg2 protein 2) (Serine/threonine-protein kinase 13) (Serine/threonine-protein kinase aurora-C),309,"35,591",5 out of 5,2003-01-17,Evidence at protein level
Q96A70,AZIN2_HUMAN,Antizyme inhibitor 2 (AzI2) (Arginine decarboxylase) (ADC) (ARGDC) (Ornithine decarboxylase-like protein) (ODC-like protein) (ornithine decarboxylase paralog) (ODC-p),460,"49,980",5 out of 5,2002-11-01,Evidence at protein level
Q9HB09,B2L12_HUMAN,Bcl-2-like protein 12 (Bcl2-L-12) (Bcl-2-related proline-rich protein),334,"36,821",4 out of 5,2002-09-19,Evidence at protein level
O94766,B3GA3_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 3) (Glucuronosyltransferase I) (GlcAT-I) (UDP-GlcUA:Gal beta-1,3-Gal-R glucuronyltransferase) (GlcUAT-I)",335,"37,122",5 out of 5,2001-06-01,Evidence at protein level
Q9BYG0,B3GN5_HUMAN,"Lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase (EC 2.4.1.206) (Lactotriaosylceramide synthase) (Lc(3)Cer synthase) (Lc3 synthase) (UDP-GlcNAc:beta-Gal beta-1,3-N-acetylglucosaminyltransferase 5) (BGnT-5) (Beta-1,3-Gn-T5) (Beta-1,3-N-acetylglucosaminyltransferase 5) (Beta3Gn-T5)",378,"44,053",5 out of 5,2007-05-29,Evidence at protein level
O43505,B4GA1_HUMAN,"Beta-1,4-glucuronyltransferase 1 (EC 2.4.1.-) (I-beta-1,3-N-acetylglucosaminyltransferase) (iGnT) (N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase) (Poly-N-acetyllactosamine extension enzyme) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 1)",415,"47,119",5 out of 5,2002-09-19,Evidence at protein level
Q8NHY0,B4GN2_HUMAN,"Beta-1,4 N-acetylgalactosaminyltransferase 2 (EC 2.4.1.-) (Sd(a) beta-1,4-GalNAc transferase) (UDP-GalNAc:Neu5Aca2-3Galb-R b1,4-N-acetylgalactosaminyltransferase)",566,"63,258",5 out of 5,2006-01-24,Evidence at protein level
O60909,B4GT2_HUMAN,"Beta-1,4-galactosyltransferase 2 (Beta-1,4-GalTase 2) (Beta4Gal-T2) (b4Gal-T2) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2) [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)]",372,"41,972",5 out of 5,2001-02-21,Evidence at protein level
Q8WXS3,BAALC_HUMAN,Brain and acute leukemia cytoplasmic protein,180,"19,224",5 out of 5,2006-09-05,Evidence at transcript level
Q9NWV8,BABA1_HUMAN,BRISC and BRCA1-A complex member 1 (Mediator of RAP80 interactions and targeting subunit of 40 kDa) (New component of the BRCA1-A complex),329,"36,560",5 out of 5,2007-05-29,Evidence at protein level
Q9H3F6,BACD3_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 3 (hBACURD3) (BTB/POZ domain-containing protein KCTD10) (Potassium channel tetramerization domain-containing protein 10),313,"35,432",5 out of 5,2006-07-25,Evidence at protein level
P56817,BACE1_HUMAN,Beta-secretase 1 (EC 3.4.23.46) (Aspartyl protease 2) (ASP2) (Asp 2) (Beta-site amyloid precursor protein cleaving enzyme 1) (Beta-site APP cleaving enzyme 1) (Memapsin-2) (Membrane-associated aspartic protease 2),501,"55,711",5 out of 5,2000-05-30,Evidence at protein level
O75531,BAF_HUMAN,"Barrier-to-autointegration factor (Breakpoint cluster region protein 1) [Cleaved into: Barrier-to-autointegration factor, N-terminally processed]",89,"10,059",5 out of 5,1999-07-15,Evidence at protein level
O95817,BAG3_HUMAN,BAG family molecular chaperone regulator 3 (BAG-3) (Bcl-2-associated athanogene 3) (Bcl-2-binding protein Bis) (Docking protein CAIR-1),575,"61,595",5 out of 5,2001-01-11,Evidence at protein level
Q96B67,ARRD3_HUMAN,Arrestin domain-containing protein 3 (TBP-2-like inducible membrane protein) (TLIMP),414,"46,395",5 out of 5,2006-06-27,Evidence at protein level
Q9HBK9,AS3MT_HUMAN,Arsenite methyltransferase (EC 2.1.1.137) (Methylarsonite methyltransferase) (S-adenosyl-L-methionine:arsenic(III) methyltransferase),375,"41,748",4 out of 5,2005-01-04,Evidence at protein level
Q9NR71,ASAH2_HUMAN,Neutral ceramidase (N-CDase) (NCDase) (EC 3.5.1.23) (Acylsphingosine deacylase 2) (BCDase) (LCDase) (hCD) (N-acylsphingosine amidohydrolase 2) (Non-lysosomal ceramidase) [Cleaved into: Neutral ceramidase soluble form],780,"85,516",5 out of 5,2006-07-25,Evidence at protein level
Q9ULH1,ASAP1_HUMAN,"Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP)",1129,"125,498",5 out of 5,2003-09-26,Evidence at protein level
Q495Z4,ASAS1_HUMAN,Putative uncharacterized protein ASB16-AS1 (ASB16 antisense RNA 1) (ASB16 antisense gene protein 1),193,"20,099",2 out of 5,2007-05-15,Uncertain
Q8WXK3,ASB13_HUMAN,Ankyrin repeat and SOCS box protein 13 (ASB-13),278,"30,007",3 out of 5,2002-05-10,Evidence at protein level
Q9H672,ASB7_HUMAN,Ankyrin repeat and SOCS box protein 7 (ASB-7),318,"36,011",4 out of 5,2003-02-28,Evidence at protein level
Q9H1I8,ASCC2_HUMAN,Activating signal cointegrator 1 complex subunit 2 (ASC-1 complex subunit p100) (Trip4 complex subunit p100),757,"86,360",5 out of 5,2004-07-19,Evidence at protein level
Q16515,ASIC2_HUMAN,"Acid-sensing ion channel 2 (ASIC2) (Amiloride-sensitive brain sodium channel) (Amiloride-sensitive cation channel 1, neuronal) (Amiloride-sensitive cation channel neuronal 1) (Brain sodium channel 1) (BNC1) (BNaC1) (Mammalian degenerin homolog)",512,"57,709",5 out of 5,1997-11-01,Evidence at protein level
Q96FT7,ASIC4_HUMAN,"Acid-sensing ion channel 4 (ASIC4) (Amiloride-sensitive cation channel 4) (Amiloride-sensitive cation channel 4, pituitary)",647,"70,105",5 out of 5,2005-09-13,Evidence at protein level
Q9BZE9,ASPC1_HUMAN,Tether containing UBX domain for GLUT4 (Alveolar soft part sarcoma chromosomal region candidate gene 1 protein) (Alveolar soft part sarcoma locus) (Renal papillary cell carcinoma protein 17) (UBX domain-containing protein 9),553,"60,183",5 out of 5,2006-09-19,Evidence at protein level
Q2TB18,ASTE1_HUMAN,Protein asteroid homolog 1,679,"77,093",2 out of 5,2007-11-13,Evidence at protein level
O14525,ASTN1_HUMAN,Astrotactin-1,1302,"144,913",5 out of 5,2000-12-01,Evidence at transcript level
Q9NVM9,ASUN_HUMAN,Protein asunder homolog (Cell cycle regulator Mat89Bb homolog) (Germ cell tumor 1) (Sarcoma antigen NY-SAR-95),706,"80,225",5 out of 5,2005-07-19,Evidence at protein level
Q9C0F0,ASXL3_HUMAN,Putative Polycomb group protein ASXL3 (Additional sex combs-like protein 3),2248,"241,919",4 out of 5,2008-02-26,Evidence at transcript level
Q9NQ11,AT132_HUMAN,Probable cation-transporting ATPase 13A2 (EC 3.6.3.-),1180,"128,794",5 out of 5,2001-06-01,Evidence at protein level
P14415,AT1B2_HUMAN,Sodium/potassium-transporting ATPase subunit beta-2 (Adhesion molecule in glia) (AMOG) (Sodium/potassium-dependent ATPase subunit beta-2),290,"33,367",5 out of 5,1990-01-01,Evidence at protein level
P54709,AT1B3_HUMAN,Sodium/potassium-transporting ATPase subunit beta-3 (Sodium/potassium-dependent ATPase subunit beta-3) (ATPB-3) (CD antigen CD298),279,"31,513",5 out of 5,1996-10-01,Evidence at protein level
Q14CW9,AT7L3_HUMAN,Ataxin-7-like protein 3 (SAGA-associated factor 11 homolog),347,"38,651",5 out of 5,2007-02-20,Evidence at protein level
Q9NTI2,AT8A2_HUMAN,Phospholipid-transporting ATPase IB (EC 3.6.3.1) (ATPase class I type 8A member 2) (ML-1) (P4-ATPase flippase complex alpha subunit ATP8A2),1148,"129,242",5 out of 5,2001-10-18,Evidence at protein level
Q96QE3,ATAD5_HUMAN,ATPase family AAA domain-containing protein 5 (Chromosome fragility-associated gene 1 protein),1844,"207,570",5 out of 5,2008-02-05,Evidence at protein level
O95260,ATE1_HUMAN,Arginyl-tRNA--protein transferase 1 (Arginyltransferase 1) (R-transferase 1) (EC 2.3.2.8) (Arginine-tRNA--protein transferase 1),518,"59,090",4 out of 5,2001-02-21,Evidence at protein level
Q674R7,ATG9B_HUMAN,Autophagy-related protein 9B (APG9-like 2) (Nitric oxide synthase 3-overlapping antisense gene protein) (Protein sONE),924,"101,019",5 out of 5,2008-01-15,Evidence at transcript level
O00244,ATOX1_HUMAN,Copper transport protein ATOX1 (Metal transport protein ATX1),68,"7,402",5 out of 5,2000-05-30,Evidence at protein level
P15848,ARSB_HUMAN,Arylsulfatase B (ASB) (EC 3.1.6.12) (N-acetylgalactosamine-4-sulfatase) (G4S),533,"59,687",5 out of 5,1990-04-01,Evidence at protein level
Q5FYA8,ARSH_HUMAN,Arylsulfatase H (ASH) (EC 3.1.6.-),562,"63,525",3 out of 5,2007-07-24,Evidence at transcript level
Q5FYB1,ARSI_HUMAN,Arylsulfatase I (ASI) (EC 3.1.6.-),569,"64,030",5 out of 5,2005-10-11,Evidence at protein level
Q9H2C2,ARV1_HUMAN,Protein ARV1 (hARV1),271,"31,052",5 out of 5,2006-03-21,Evidence at protein level
Q13510,ASAH1_HUMAN,Acid ceramidase (AC) (ACDase) (Acid CDase) (EC 3.5.1.23) (Acylsphingosine deacylase) (N-acylsphingosine amidohydrolase) (Putative 32 kDa heart protein) (PHP32) [Cleaved into: Acid ceramidase subunit alpha; Acid ceramidase subunit beta],395,"44,660",5 out of 5,1998-07-15,Evidence at protein level
Q8WXK4,ASB12_HUMAN,Ankyrin repeat and SOCS box protein 12 (ASB-12),309,"33,943",3 out of 5,2002-05-10,Evidence at protein level
Q96DX5,ASB9_HUMAN,Ankyrin repeat and SOCS box protein 9 (ASB-9),294,"31,858",5 out of 5,2003-02-28,Evidence at protein level
Q99929,ASCL2_HUMAN,Achaete-scute homolog 2 (ASH-2) (hASH2) (Class A basic helix-loop-helix protein 45) (bHLHa45) (Mash2),193,"20,185",5 out of 5,1997-11-01,Evidence at protein level
Q9NY37,ASIC5_HUMAN,Acid-sensing ion channel 5 (ASIC5) (Amiloride-sensitive cation channel 5) (Human intestine Na(+) channel) (HINaC),505,"57,464",4 out of 5,2008-05-20,Evidence at protein level
O95671,ASML_HUMAN,N-acetylserotonin O-methyltransferase-like protein (ASMTL) (EC 2.1.1.-),621,"68,857",5 out of 5,2003-04-23,Evidence at protein level
P08243,ASNS_HUMAN,Asparagine synthetase [glutamine-hydrolyzing] (EC 6.3.5.4) (Cell cycle control protein TS11) (Glutamine-dependent asparagine synthetase),561,"64,370",5 out of 5,1988-08-01,Evidence at protein level
Q76L83,ASXL2_HUMAN,Putative Polycomb group protein ASXL2 (Additional sex combs-like protein 2),1435,"153,820",5 out of 5,2008-01-15,Evidence at protein level
Q9ULK2,AT7L1_HUMAN,Ataxin-7-like protein 1 (Ataxin-7-like protein 4),861,"91,514",3 out of 5,2000-12-01,Evidence at protein level
P98198,AT8B2_HUMAN,Phospholipid-transporting ATPase ID (EC 3.6.3.1) (ATPase class I type 8B member 2) (P4-ATPase flippase complex alpha subunit ATP8B2),1209,"137,440",5 out of 5,2000-05-30,Evidence at protein level
P18859,ATP5J_HUMAN,"ATP synthase-coupling factor 6, mitochondrial (ATPase subunit F6)",108,"12,588",5 out of 5,1990-11-01,Evidence at protein level
O75110,ATP9A_HUMAN,Probable phospholipid-transporting ATPase IIA (EC 3.6.3.1) (ATPase class II type 9A),1047,"118,583",5 out of 5,2000-05-30,Evidence at protein level
Q58HT5,AWAT1_HUMAN,Acyl-CoA wax alcohol acyltransferase 1 (EC 2.3.1.75) (Diacylglycerol O-acyltransferase 2-like protein 3) (Diacylglycerol acyltransferase 2) (Long-chain-alcohol O-fatty-acyltransferase 1),328,"37,759",4 out of 5,2006-09-05,Evidence at protein level
O14977,AZIN1_HUMAN,Antizyme inhibitor 1 (AZI) (AZI1) (Ornithine decarboxylase antizyme inhibitor),448,"49,535",5 out of 5,2001-04-27,Evidence at protein level
P59052,B3AS1_HUMAN,Putative uncharacterized protein B3GALT5-AS1 (B3GALT5 antisense RNA 1) (B3GALT5 antisense gene protein 1),145,"15,706",2 out of 5,2002-10-19,Uncertain
Q8NFL0,B3GN7_HUMAN,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 (BGnT-7) (Beta-1,3-Gn-T7) (Beta-1,3-N-acetylglucosaminyltransferase 7) (Beta3Gn-T7) (EC 2.4.1.-)",401,"45,987",4 out of 5,2006-12-12,Evidence at transcript level
Q6UX72,B3GN9_HUMAN,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9 (BGnT-9) (Beta-1,3-Gn-T9) (Beta-1,3-N-acetylglucosaminyltransferase 9) (Beta3Gn-T9) (EC 2.4.1.-)",402,"43,751",3 out of 5,2008-10-14,Evidence at transcript level
Q92934,BAD_HUMAN,Bcl2-associated agonist of cell death (BAD) (Bcl-2-binding component 6) (Bcl-2-like protein 8) (Bcl2-L-8) (Bcl-xL/Bcl-2-associated death promoter) (Bcl2 antagonist of cell death),168,"18,392",5 out of 5,1997-11-01,Evidence at protein level
Q8N9N5,BANP_HUMAN,Protein BANP (BEN domain-containing protein 1) (Btg3-associated nuclear protein) (Scaffold/matrix-associated region-1-binding protein),519,"56,494",5 out of 5,2007-08-21,Evidence at protein level
Q9UMQ3,BARX2_HUMAN,Homeobox protein BarH-like 2,279,"31,188",4 out of 5,2001-04-27,Evidence at transcript level
P80723,BASP1_HUMAN,Brain acid soluble protein 1 (22 kDa neuronal tissue-enriched acidic protein) (Neuronal axonal membrane protein NAP-22),227,"22,693",5 out of 5,1997-11-01,Evidence at protein level
Q9C0K0,BC11B_HUMAN,B-cell lymphoma/leukemia 11B (BCL-11B) (B-cell CLL/lymphoma 11B) (COUP-TF-interacting protein 2) (Radiation-induced tumor suppressor gene 1 protein) (hRit1),894,"95,519",5 out of 5,2004-03-01,Evidence at protein level
P50895,BCAM_HUMAN,Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239),628,"67,405",5 out of 5,1996-10-01,Evidence at protein level
P56945,BCAR1_HUMAN,Breast cancer anti-estrogen resistance protein 1 (CRK-associated substrate) (Cas scaffolding protein family member 1) (p130cas),870,"93,372",5 out of 5,2000-05-30,Evidence at protein level
Q9BYV7,BCDO2_HUMAN,"Beta,beta-carotene 9',10'-oxygenase (EC 1.13.11.71) (B-diox-II) (Beta-carotene dioxygenase 2)",579,"65,674",5 out of 5,2003-10-10,Evidence at protein level
O95999,BCL10_HUMAN,B-cell lymphoma/leukemia 10 (B-cell CLL/lymphoma 10) (Bcl-10) (CARD-containing molecule enhancing NF-kappa-B) (CARD-like apoptotic protein) (hCLAP) (CED-3/ICH-1 prodomain homologous E10-like regulator) (CIPER) (Cellular homolog of vCARMEN) (cCARMEN) (Cellular-E10) (c-E10) (Mammalian CARD-containing adapter molecule E10) (mE10),233,"26,252",5 out of 5,2002-05-02,Evidence at protein level
O00512,BCL9_HUMAN,B-cell CLL/lymphoma 9 protein (B-cell lymphoma 9 protein) (Bcl-9) (Protein legless homolog),1426,"149,290",5 out of 5,2002-09-19,Evidence at protein level
Q6W2J9,BCOR_HUMAN,BCL-6 corepressor (BCoR),1755,"192,189",5 out of 5,2005-01-04,Evidence at protein level
Q92843,B2CL2_HUMAN,Bcl-2-like protein 2 (Bcl2-L-2) (Apoptosis regulator Bcl-W),193,"20,746",5 out of 5,1997-11-01,Evidence at protein level
Q9BXK5,B2L13_HUMAN,Bcl-2-like protein 13 (Bcl2-L-13) (Bcl-rambo) (Protein Mil1),485,"52,723",5 out of 5,2002-09-19,Evidence at protein level
Q99933,BAG1_HUMAN,BAG family molecular chaperone regulator 1 (BAG-1) (Bcl-2-associated athanogene 1),345,"38,779",5 out of 5,1997-11-01,Evidence at protein level
O95429,BAG4_HUMAN,BAG family molecular chaperone regulator 4 (BAG-4) (Bcl-2-associated athanogene 4) (Silencer of death domains),457,"49,594",5 out of 5,2001-01-11,Evidence at protein level
Q16611,BAK_HUMAN,Bcl-2 homologous antagonist/killer (Apoptosis regulator BAK) (Bcl-2-like protein 7) (Bcl2-L-7),211,"23,409",5 out of 5,1997-11-01,Evidence at protein level
Q9UIG0,BAZ1B_HUMAN,Tyrosine-protein kinase BAZ1B (EC 2.7.10.2) (Bromodomain adjacent to zinc finger domain protein 1B) (Williams syndrome transcription factor) (Williams-Beuren syndrome chromosomal region 10 protein) (Williams-Beuren syndrome chromosomal region 9 protein) (hWALp2),1483,"170,903",5 out of 5,2002-08-30,Evidence at protein level
Q9BXC9,BBS2_HUMAN,Bardet-Biedl syndrome 2 protein,721,"79,871",5 out of 5,2002-05-02,Evidence at protein level
Q9H6U6,BCAS3_HUMAN,Breast carcinoma-amplified sequence 3 (GAOB1),928,"101,237",5 out of 5,2003-07-25,Evidence at protein level
Q4VC05,BCL7A_HUMAN,B-cell CLL/lymphoma 7 protein family member A,210,"22,810",3 out of 5,2006-06-13,Evidence at protein level
P23560,BDNF_HUMAN,Brain-derived neurotrophic factor (BDNF) (Abrineurin),247,"27,818",5 out of 5,1991-11-01,Evidence at protein level
Q8NDZ0,BEND2_HUMAN,BEN domain-containing protein 2,799,"87,919",2 out of 5,2005-07-19,Evidence at transcript level
Q6ZU67,BEND4_HUMAN,BEN domain-containing protein 4 (Coiled-coil domain-containing protein 4),534,"58,375",3 out of 5,2005-12-06,Evidence at transcript level
Q00994,BEX3_HUMAN,Protein BEX3 (Brain-expressed X-linked protein 3) (Nerve growth factor receptor-associated protein 1) (Ovarian granulosa cell 13.0 kDa protein HGR74) (p75NTR-associated cell death executor),111,"12,959",5 out of 5,1994-06-01,Evidence at protein level
P32121,ARRB2_HUMAN,Beta-arrestin-2 (Arrestin beta-2),409,"46,106",5 out of 5,1993-10-01,Evidence at protein level
P51689,ARSD_HUMAN,Arylsulfatase D (ASD) (EC 3.1.6.-),593,"64,860",5 out of 5,1996-10-01,Evidence at protein level
Q7RTU5,ASCL5_HUMAN,Achaete-scute homolog 5 (ASH-5) (hASH5) (Class A basic helix-loop-helix protein 47) (bHLHa47),278,"29,462",2 out of 5,2008-02-05,Inferred from homology
Q9BVC5,ASHWN_HUMAN,Ashwin,232,"25,858",3 out of 5,2006-12-12,Evidence at protein level
O75129,ASTN2_HUMAN,Astrotactin-2,1339,"148,243",5 out of 5,2007-10-23,Evidence at protein level
P98196,AT11A_HUMAN,Probable phospholipid-transporting ATPase IH (EC 3.6.3.1) (ATPase IS) (ATPase class VI type 11A) (P4-ATPase flippase complex alpha subunit ATP11A),1134,"129,756",5 out of 5,2000-05-30,Evidence at protein level
Q8NB49,AT11C_HUMAN,Phospholipid-transporting ATPase IG (EC 3.6.3.1) (ATPase IQ) (ATPase class VI type 11C) (P4-ATPase flippase complex alpha subunit ATP11C),1132,"129,477",5 out of 5,2003-04-30,Evidence at protein level
Q4VNC0,AT135_HUMAN,Probable cation-transporting ATPase 13A5 (EC 3.6.3.-) (P5-ATPase isoform 5),1218,"137,327",4 out of 5,2008-05-20,Evidence at transcript level
Q01814,AT2B2_HUMAN,Plasma membrane calcium-transporting ATPase 2 (PMCA2) (EC 3.6.3.8) (Plasma membrane calcium ATPase isoform 2) (Plasma membrane calcium pump isoform 2),1243,"136,876",5 out of 5,1993-07-01,Evidence at protein level
Q7Z4Y8,AT5L2_HUMAN,"ATP synthase subunit g 2, mitochondrial (ATPase subunit g 2)",100,"11,037",3 out of 5,2006-03-07,Uncertain
O94817,ATG12_HUMAN,Ubiquitin-like protein ATG12 (Autophagy-related protein 12) (APG12-like),140,"15,113",5 out of 5,2001-11-16,Evidence at protein level
O75061,AUXI_HUMAN,Putative tyrosine-protein phosphatase auxilin (EC 3.1.3.48) (DnaJ homolog subfamily C member 6),913,"99,997",5 out of 5,2006-06-27,Evidence at protein level
Q6Y288,B3GLT_HUMAN,"Beta-1,3-glucosyltransferase (Beta3Glc-T) (EC 2.4.1.-) (Beta 3-glucosyltransferase) (Beta-3-glycosyltransferase-like)",498,"56,564",5 out of 5,2006-10-17,Evidence at protein level
Q9Y5Z6,B3GT1_HUMAN,"Beta-1,3-galactosyltransferase 1 (Beta-1,3-GalTase 1) (Beta3Gal-T1) (Beta3GalT1) (EC 2.4.1.86) (UDP-galactose:beta-N-acetyl-glucosamine-beta-1,3-galactosyltransferase 1)",326,"37,993",4 out of 5,2005-03-15,Evidence at protein level
Q6L9W6,B4GN3_HUMAN,"Beta-1,4-N-acetylgalactosaminyltransferase 3 (B4GalNAcT3) (Beta4GalNAc-T3) (Beta4GalNAcT3) (EC 2.4.1.244) (Beta-1,4-N-acetylgalactosaminyltransferase III) (N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase 2) (NGalNAc-T2)",998,"114,975",5 out of 5,2006-10-17,Evidence at protein level
Q9BYV9,BACH2_HUMAN,Transcription regulator protein BACH2 (BTB and CNC homolog 2),841,"92,537",5 out of 5,2001-12-05,Evidence at protein level
O95816,BAG2_HUMAN,BAG family molecular chaperone regulator 2 (BAG-2) (Bcl-2-associated athanogene 2),211,"23,772",5 out of 5,2001-01-11,Evidence at protein level
Q5T5X7,BEND3_HUMAN,BEN domain-containing protein 3,828,"94,475",5 out of 5,2007-06-12,Evidence at protein level
Q8N1M1,BEST3_HUMAN,Bestrophin-3 (Vitelliform macular dystrophy 2-like protein 3),668,"76,107",4 out of 5,2003-11-21,Evidence at transcript level
Q9HBH7,BEX1_HUMAN,Protein BEX1 (Brain-expressed X-linked protein 1),125,"14,860",5 out of 5,2006-04-04,Evidence at protein level
P48751,B3A3_HUMAN,Anion exchange protein 3 (AE 3) (Anion exchanger 3) (CAE3/BAE3) (Cardiac/brain band 3-like protein) (Neuronal band 3-like protein) (Solute carrier family 4 member 3),1232,"135,791",5 out of 5,1996-02-01,Evidence at transcript level
Q96Q91,B3A4_HUMAN,Anion exchange protein 4 (AE 4) (Anion exchanger 4) (Sodium bicarbonate cotransporter 5) (Solute carrier family 4 member 9),983,"108,248",5 out of 5,2003-03-28,Evidence at transcript level
P02730,B3AT_HUMAN,Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233),911,"101,792",5 out of 5,1986-07-21,Evidence at protein level
Q96L58,B3GT6_HUMAN,"Beta-1,3-galactosyltransferase 6 (Beta-1,3-GalTase 6) (Beta3Gal-T6) (Beta3GalT6) (EC 2.4.1.134) (GAG GalTII) (Galactosyltransferase II) (Galactosylxylosylprotein 3-beta-galactosyltransferase) (UDP-Gal:betaGal beta 1,3-galactosyltransferase polypeptide 6)",329,"37,138",5 out of 5,2005-03-15,Evidence at protein level
Q8ND07,BBOF1_HUMAN,Basal body-orientation factor 1 (Coiled-coil domain-containing protein 176),529,"61,987",3 out of 5,2006-10-03,Evidence at transcript level
O60756,BCE1_HUMAN,Putative protein BCE-1,84,"9,784",1 out of 5,2000-05-30,Uncertain
O14874,BCKD_HUMAN,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial (EC 2.7.11.4) (Branched-chain alpha-ketoacid dehydrogenase kinase) (BCKD-kinase) (BCKDHKIN)",412,"46,360",5 out of 5,1998-07-15,Evidence at protein level
P41182,BCL6_HUMAN,B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51),706,"78,846",5 out of 5,1995-02-01,Evidence at protein level
Q8IYS8,BD1L2_HUMAN,Biorientation of chromosomes in cell division protein 1-like 2 (Biorientation of chromosomes in cell division protein 1 pseudogene) (Protein FAM44C),172,"18,075",3 out of 5,2005-11-22,Evidence at transcript level
Q8N7W2,BEND7_HUMAN,BEN domain-containing protein 7,519,"57,549",5 out of 5,2006-06-27,Evidence at protein level
Q13515,BFSP2_HUMAN,Phakinin (49 kDa cytoskeletal protein) (Beaded filament structural protein 2) (Lens fiber cell beaded filament protein CP 47) (CP47) (Lens fiber cell beaded filament protein CP 49) (CP49) (Lens intermediate filament-like light) (LIFL-L),415,"45,880",5 out of 5,2001-11-16,Evidence at protein level
Q7RTU4,BHA09_HUMAN,Class A basic helix-loop-helix protein 9 (bHLHa9) (Class F basic helix-loop-helix factor 42) (bHLHf42),235,"24,132",5 out of 5,2008-06-10,Evidence at protein level
Q8NDY6,BHE23_HUMAN,Class E basic helix-loop-helix protein 23 (bHLHe23) (Class B basic helix-loop-helix protein 4) (bHLHb4),225,"23,665",2 out of 5,2006-07-11,Evidence at transcript level
Q6PI77,BHLH9_HUMAN,Protein BHLHb9 (bHLHb9) (Transcription regulator of 60 kDa) (p60TRP),547,"60,291",4 out of 5,2008-05-20,Evidence at transcript level
Q96P09,BIRC8_HUMAN,Baculoviral IAP repeat-containing protein 8 (Inhibitor of apoptosis-like protein 2) (IAP-like protein 2) (ILP-2) (Testis-specific inhibitor of apoptosis),236,"27,089",5 out of 5,2002-07-11,Evidence at protein level
P30411,BKRB2_HUMAN,B2 bradykinin receptor (B2R) (BK-2 receptor),391,"44,461",5 out of 5,1993-04-01,Evidence at protein level
P54132,BLM_HUMAN,"Bloom syndrome protein (EC 3.6.4.12) (DNA helicase, RecQ-like type 2) (RecQ2) (RecQ protein-like 3)",1417,"159,000",5 out of 5,1996-10-01,Evidence at protein level
P18075,BMP7_HUMAN,Bone morphogenetic protein 7 (BMP-7) (Osteogenic protein 1) (OP-1) (Eptotermin alfa),431,"49,313",5 out of 5,1990-11-01,Evidence at protein level
Q12830,BPTF_HUMAN,Nucleosome-remodeling factor subunit BPTF (Bromodomain and PHD finger-containing transcription factor) (Fetal Alz-50 clone 1 protein) (Fetal Alzheimer antigen),3046,"338,262",5 out of 5,1999-07-15,Evidence at protein level
Q15059,BRD3_HUMAN,Bromodomain-containing protein 3 (RING3-like protein),726,"79,542",5 out of 5,2001-01-11,Evidence at protein level
Q9H0E9,BRD8_HUMAN,Bromodomain-containing protein 8 (Skeletal muscle abundant protein) (Skeletal muscle abundant protein 2) (Thyroid hormone receptor coactivating protein of 120 kDa) (TrCP120) (p120),1235,"135,336",5 out of 5,2005-02-15,Evidence at protein level
O60477,BRNP1_HUMAN,BMP/retinoic acid-inducible neural-specific protein 1 (Deleted in bladder cancer protein 1),761,"88,760",5 out of 5,2006-01-24,Evidence at protein level
Q3C1V8,BSH_HUMAN,Brain-specific homeobox protein homolog,233,"25,933",3 out of 5,2007-08-21,Evidence at transcript level
Q075Z2,BSPH1_HUMAN,Binder of sperm protein homolog 1 (Bovine seminal plasma protein homolog 1) (Bovine seminal plasma protein-like 1),132,"15,693",3 out of 5,2008-03-18,Evidence at transcript level
Q9GZN4,BSSP4_HUMAN,Brain-specific serine protease 4 (BSSP-4) (EC 3.4.21.-) (Serine protease 22) (Serine protease 26) (Tryptase epsilon),317,"33,732",4 out of 5,2001-10-18,Evidence at protein level
B2RXH4,BTBDI_HUMAN,BTB/POZ domain-containing protein 18,712,"77,931",2 out of 5,2010-05-18,Evidence at transcript level
P35070,BTC_HUMAN,Probetacellulin [Cleaved into: Betacellulin (BTC)],178,"19,746",5 out of 5,1994-02-01,Evidence at protein level
Q9UIR0,BTNL2_HUMAN,Butyrophilin-like protein 2 (BTL-II),455,"50,436",5 out of 5,2005-02-01,Evidence at transcript level
O75173,ATS4_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 4 (ADAM-TS 4) (ADAM-TS4) (ADAMTS-4) (EC 3.4.24.82) (ADMP-1) (Aggrecanase-1),837,"90,197",5 out of 5,2000-12-01,Evidence at protein level
Q9UKP4,ATS7_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 7 (ADAM-TS 7) (ADAM-TS7) (ADAMTS-7) (EC 3.4.24.-) (COMPase),1686,"184,095",5 out of 5,2000-12-01,Evidence at protein level
P17735,ATTY_HUMAN,Tyrosine aminotransferase (TAT) (EC 2.6.1.5) (L-tyrosine:2-oxoglutarate aminotransferase),454,"50,399",5 out of 5,1990-08-01,Evidence at protein level
P0C7T5,ATX1L_HUMAN,Ataxin-1-like (Brother of ataxin-1) (Brother of ATXN1),689,"73,306",5 out of 5,2008-07-22,Evidence at protein level
Q9H3M9,ATX3L_HUMAN,Ataxin-3-like protein (EC 3.4.19.12) (Machado-Joseph disease protein 1-like),355,"40,747",4 out of 5,2007-01-09,Evidence at protein level
P54252,ATX3_HUMAN,Ataxin-3 (EC 3.4.19.12) (Machado-Joseph disease protein 1) (Spinocerebellar ataxia type 3 protein),364,"41,781",5 out of 5,1996-10-01,Evidence at protein level
Q9H1Z8,AUGN_HUMAN,Augurin (Esophageal cancer-related gene 4 protein),148,"17,183",3 out of 5,2006-10-03,Evidence at transcript level
Q5T686,AVPI1_HUMAN,Arginine vasopressin-induced protein 1 (AVP-induced protein 1),147,"16,773",3 out of 5,2007-04-03,Evidence at protein level
Q5T1B0,AXDN1_HUMAN,Axonemal dynein light chain domain-containing protein 1,1012,"118,027",3 out of 5,2007-04-17,Evidence at transcript level
O15169,AXIN1_HUMAN,Axin-1 (Axis inhibition protein 1) (hAxin),862,"95,635",5 out of 5,2000-12-01,Evidence at protein level
Q9Y5Z0,BACE2_HUMAN,Beta-secretase 2 (EC 3.4.23.45) (Aspartic-like protease 56 kDa) (Aspartyl protease 1) (ASP1) (Asp 1) (Beta-site amyloid precursor protein cleaving enzyme 2) (Beta-site APP cleaving enzyme 2) (Down region aspartic protease) (DRAP) (Memapsin-1) (Membrane-associated aspartic protease 1) (Theta-secretase),518,"56,180",5 out of 5,2000-05-30,Evidence at protein level
Q9UL15,BAG5_HUMAN,BAG family molecular chaperone regulator 5 (BAG-5) (Bcl-2-associated athanogene 5),447,"51,200",5 out of 5,2001-01-11,Evidence at protein level
Q9UQB8,BAIP2_HUMAN,Brain-specific angiogenesis inhibitor 1-associated protein 2 (BAI-associated protein 2) (BAI1-associated protein 2) (Protein BAP2) (Fas ligand-associated factor 3) (FLAF3) (Insulin receptor substrate p53/p58) (IRS-58) (IRSp53/58) (Insulin receptor substrate protein of 53 kDa) (IRSp53) (Insulin receptor substrate p53),552,"60,868",5 out of 5,2005-08-30,Evidence at protein level
Q6ZNE5,BAKOR_HUMAN,Beclin 1-associated autophagy-related key regulator (Barkor) (Autophagy-related protein 14-like protein) (Atg14L),492,"55,309",5 out of 5,2005-06-07,Evidence at protein level
Q8NDB2,BANK1_HUMAN,B-cell scaffold protein with ankyrin repeats,785,"89,282",5 out of 5,2006-10-03,Evidence at protein level
Q8IXM2,BAP18_HUMAN,Chromatin complexes subunit BAP18 (BPTF-associated protein of 18 kDa),172,"17,900",4 out of 5,2006-12-12,Evidence at protein level
Q92560,BAP1_HUMAN,Ubiquitin carboxyl-terminal hydrolase BAP1 (EC 3.4.19.12) (BRCA1-associated protein 1) (Cerebral protein 6),729,"80,362",5 out of 5,2005-07-05,Evidence at protein level
Q9HBU1,BARX1_HUMAN,Homeobox protein BarH-like 1,254,"27,298",5 out of 5,2001-06-01,Evidence at protein level
Q16520,BATF_HUMAN,Basic leucine zipper transcriptional factor ATF-like (B-cell-activating transcription factor) (B-ATF) (SF-HT-activated gene 2 protein) (SFA-2),125,"14,120",5 out of 5,2003-06-20,Evidence at protein level
Q9UIF8,BAZ2B_HUMAN,Bromodomain adjacent to zinc finger domain protein 2B (hWALp4),2168,"240,459",5 out of 5,2002-08-30,Evidence at protein level
Q8NFJ9,BBS1_HUMAN,Bardet-Biedl syndrome 1 protein (BBS2-like protein 2),593,"65,083",5 out of 5,2003-11-07,Evidence at protein level
Q8IWZ6,BBS7_HUMAN,Bardet-Biedl syndrome 7 protein (BBS2-like protein 1),715,"80,353",5 out of 5,2003-11-07,Evidence at protein level
Q9P287,BCCIP_HUMAN,BRCA2 and CDKN1A-interacting protein (P21- and CDK-associated protein 1) (Protein TOK-1),314,"35,979",5 out of 5,2006-09-19,Evidence at protein level
Q8N888,BCOR2_HUMAN,Putative BCoR-like protein 2 (BCL-6 corepressor pseudogene 1) (BCL-6 corepressor-like protein 2),145,"16,258",2 out of 5,2006-12-12,Uncertain
Q9NWD9,BEX4_HUMAN,Protein BEX4 (BEX1-like protein 1) (Brain-expressed X-linked protein 4) (Nerve growth factor receptor-associated protein 3),120,"14,067",2 out of 5,2006-04-04,Evidence at transcript level
P16278,BGAL_HUMAN,Beta-galactosidase (EC 3.2.1.23) (Acid beta-galactosidase) (Lactase) (Elastin receptor 1),677,"76,075",5 out of 5,1990-08-01,Evidence at protein level
P08236,BGLR_HUMAN,Beta-glucuronidase (EC 3.2.1.31) (Beta-G1),651,"74,732",5 out of 5,1988-08-01,Evidence at protein level
C9JSJ3,BHMG1_HUMAN,Basic helix-loop-helix and HMG box domain-containing protein 1,638,"70,198",2 out of 5,2014-10-29,Inferred from homology
Q8WXE1,ATRIP_HUMAN,ATR-interacting protein (ATM and Rad3-related-interacting protein),791,"85,838",5 out of 5,2004-06-07,Evidence at protein level
Q9UBB4,ATX10_HUMAN,Ataxin-10 (Brain protein E46 homolog) (Spinocerebellar ataxia type 10 protein),475,"53,489",5 out of 5,2001-10-18,Evidence at protein level
O15265,ATX7_HUMAN,Ataxin-7 (Spinocerebellar ataxia type 7 protein),892,"95,451",5 out of 5,1999-07-15,Evidence at protein level
Q5VT79,AXA81_HUMAN,Annexin A8-like protein 1,327,"36,879",3 out of 5,2008-04-08,Evidence at transcript level
P51572,BAP31_HUMAN,B-cell receptor-associated protein 31 (BCR-associated protein 31) (Bap31) (6C6-AG tumor-associated antigen) (Protein CDM) (p28),246,"27,992",5 out of 5,1996-10-01,Evidence at protein level
Q99728,BARD1_HUMAN,BRCA1-associated RING domain protein 1 (BARD-1) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase BARD1),777,"86,648",5 out of 5,2001-02-21,Evidence at protein level
Q07812,BAX_HUMAN,Apoptosis regulator BAX (Bcl-2-like protein 4) (Bcl2-L-4),192,"21,184",5 out of 5,1995-02-01,Evidence at protein level
P54687,BCAT1_HUMAN,"Branched-chain-amino-acid aminotransferase, cytosolic (BCAT(c)) (EC 2.6.1.42) (Protein ECA39)",386,"42,966",5 out of 5,1996-10-01,Evidence at protein level
Q9NWK9,BCD1_HUMAN,Box C/D snoRNA protein 1 (Serologically defined breast cancer antigen NY-BR-75) (Zinc finger HIT domain-containing protein 6),470,"53,918",5 out of 5,2007-03-20,Evidence at protein level
P10415,BCL2_HUMAN,Apoptosis regulator Bcl-2,239,"26,266",5 out of 5,1989-07-01,Evidence at protein level
Q5SZJ8,BEND6_HUMAN,BEN domain-containing protein 6,279,"31,222",4 out of 5,2007-07-24,Evidence at protein level
Q8NFU1,BEST2_HUMAN,Bestrophin-2 (Vitelliform macular dystrophy 2-like protein 1),509,"57,139",3 out of 5,2003-11-21,Evidence at transcript level
Q8NFU0,BEST4_HUMAN,Bestrophin-4 (Vitelliform macular dystrophy 2-like protein 2),473,"53,497",3 out of 5,2003-11-21,Evidence at transcript level
O14503,BHE40_HUMAN,Class E basic helix-loop-helix protein 40 (bHLHe40) (Class B basic helix-loop-helix protein 2) (bHLHb2) (Differentially expressed in chondrocytes protein 1) (DEC1) (Enhancer-of-split and hairy-related protein 2) (SHARP-2) (Stimulated by retinoic acid gene 13 protein),412,"45,510",5 out of 5,2002-03-05,Evidence at protein level
Q9UHR4,BI2L1_HUMAN,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate),511,"56,883",5 out of 5,2006-07-25,Evidence at protein level
Q13323,BIK_HUMAN,Bcl-2-interacting killer (Apoptosis inducer NBK) (BIP1) (BP4),160,"18,016",5 out of 5,1997-11-01,Evidence at protein level
Q6QNY0,BL1S3_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 3 (BLOC-1 subunit 3),202,"21,256",5 out of 5,2006-05-16,Evidence at protein level
A8MY62,BLML_HUMAN,Putative beta-lactamase-like 1,500,"54,653",1 out of 5,2008-07-22,Evidence at transcript level
Q5H9B9,BM2KL_HUMAN,Putative BMP-2-inducible kinase-like protein,411,"46,091",2 out of 5,2008-04-29,Uncertain
Q96LC9,BMF_HUMAN,Bcl-2-modifying factor,184,"20,508",5 out of 5,2004-12-21,Evidence at protein level
Q13873,BMPR2_HUMAN,Bone morphogenetic protein receptor type-2 (BMP type-2 receptor) (BMPR-2) (EC 2.7.11.30) (Bone morphogenetic protein receptor type II) (BMP type II receptor) (BMPR-II),1038,"115,201",5 out of 5,2000-12-01,Evidence at protein level
P58397,ATS12_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 12 (ADAM-TS 12) (ADAM-TS12) (ADAMTS-12) (EC 3.4.24.-),1594,"177,676",5 out of 5,2001-11-16,Evidence at protein level
Q8TE60,ATS18_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAM-TS 18) (ADAM-TS18) (ADAMTS-18) (EC 3.4.24.-),1221,"135,167",5 out of 5,2003-03-25,Evidence at protein level
Q9UHI8,ATS1_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 1 (ADAM-TS 1) (ADAM-TS1) (ADAMTS-1) (EC 3.4.24.-) (METH-1),967,"105,358",5 out of 5,2000-05-30,Evidence at protein level
P59510,ATS20_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 20 (ADAM-TS 20) (ADAM-TS20) (ADAMTS-20) (EC 3.4.24.-),1910,"214,721",5 out of 5,2003-04-04,Evidence at transcript level
O15072,ATS3_HUMAN,A disintegrin and metalloproteinase with thrombospondin motifs 3 (ADAM-TS 3) (ADAM-TS3) (ADAMTS-3) (EC 3.4.24.-) (Procollagen II N-proteinase) (PC II-NP) (Procollagen II amino propeptide-processing enzyme),1205,"135,603",5 out of 5,2000-12-01,Evidence at transcript level
Q96GD4,AURKB_HUMAN,Aurora kinase B (EC 2.7.11.1) (Aurora 1) (Aurora- and IPL1-like midbody-associated protein 1) (AIM-1) (Aurora/IPL1-related kinase 2) (ARK-2) (Aurora-related kinase 2) (STK-1) (Serine/threonine-protein kinase 12) (Serine/threonine-protein kinase 5) (Serine/threonine-protein kinase aurora-B),344,"39,311",5 out of 5,2003-01-17,Evidence at protein level
O75366,AVIL_HUMAN,Advillin (p92),819,"92,027",5 out of 5,2001-06-20,Evidence at protein level
Q6E213,AWAT2_HUMAN,Acyl-CoA wax alcohol acyltransferase 2 (EC 2.3.1.75) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diacylglycerol O-acyltransferase 2-like protein 4) (Diacylglycerol O-acyltransferase candidate 4) (hDC4) (Long-chain-alcohol O-fatty-acyltransferase 2) (Multifunctional O-acyltransferase) (Wax synthase) (hWS),333,"38,094",5 out of 5,2006-09-05,Evidence at protein level
Q67FW5,B3GNL_HUMAN,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like protein 1 (BGnT-like protein 1) (Beta1,3-N-acetylglucosaminyltransferase-like protein 1) (Beta3Gn-T-like protein 1) (Beta3GnTL1) (EC 2.4.1.-) (Beta-1,3-N-acetylglucosaminyltransferase 8) (BGnT-8) (Beta-1,3-Gn-T8) (Beta3Gn-T8)",361,"40,713",2 out of 5,2007-05-29,Evidence at transcript level
O43825,B3GT2_HUMAN,"Beta-1,3-galactosyltransferase 2 (Beta-1,3-GalTase 2) (Beta3Gal-T2) (Beta3GalT2) (EC 2.4.1.86) (UDP-galactose:2-acetamido-2-deoxy-D-glucose 3beta-galactosyltransferase 2)",422,"49,213",4 out of 5,2005-03-15,Evidence at protein level
Q00973,B4GN1_HUMAN,"Beta-1,4 N-acetylgalactosaminyltransferase 1 (EC 2.4.1.92) ((N-acetylneuraminyl)-galactosylglucosylceramide) (GM2/GD2 synthase) (GalNAc-T)",533,"58,882",5 out of 5,1994-06-01,Evidence at protein level
P15291,B4GT1_HUMAN,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1] [Includes: Lactose synthase A protein (EC 2.4.1.22); N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)]",398,"43,920",5 out of 5,1990-04-01,Evidence at protein level
Q9UBX8,B4GT6_HUMAN,"Beta-1,4-galactosyltransferase 6 (Beta-1,4-GalTase 6) (Beta4Gal-T6) (b4Gal-T6) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6) [Includes: Glucosylceramide beta-1,4-galactosyltransferase (EC 2.4.1.274) (Lactosylceramide synthase) (LacCer synthase) (UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase)]",382,"44,914",5 out of 5,2001-02-21,Evidence at protein level
Q9UPM9,B9D1_HUMAN,B9 domain-containing protein 1 (MKS1-related protein 1),204,"22,775",5 out of 5,2007-10-23,Evidence at protein level
Q14032,BAAT_HUMAN,Bile acid-CoA:amino acid N-acyltransferase (BACAT) (BAT) (EC 2.3.1.65) (Glycine N-choloyltransferase) (Long-chain fatty-acyl-CoA hydrolase) (EC 3.1.2.2),418,"46,299",5 out of 5,2005-11-08,Evidence at protein level
Q13829,BACD2_HUMAN,"BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 2 (hBACURD2) (BTB/POZ domain-containing protein TNFAIP1) (Protein B12) (Tumor necrosis factor, alpha-induced protein 1, endothelial)",316,"36,204",5 out of 5,1997-11-01,Evidence at protein level
Q86Y28,BAGE4_HUMAN,B melanoma antigen 4 (Cancer/testis antigen 2.4) (CT2.4),39,"4,230",2 out of 5,2003-10-03,Evidence at transcript level
Q9BZE3,BARH1_HUMAN,BarH-like 1 homeobox protein,327,"35,074",2 out of 5,2003-03-25,Evidence at transcript level
Q9BXH1,BBC3_HUMAN,Bcl-2-binding component 3 (JFY-1) (p53 up-regulated modulator of apoptosis),193,"20,532",5 out of 5,2004-12-21,Evidence at protein level
Q8TAM1,BBS10_HUMAN,Bardet-Biedl syndrome 10 protein,723,"80,838",5 out of 5,2006-05-16,Evidence at protein level
P20749,BCL3_HUMAN,B-cell lymphoma 3 protein (BCL-3) (Proto-oncogene BCL3),454,"47,584",5 out of 5,1991-02-01,Evidence at protein level
Q86UU0,BCL9L_HUMAN,B-cell CLL/lymphoma 9-like protein (B-cell lymphoma 9-like protein) (BCL9-like protein) (Protein BCL9-2),1499,"157,129",5 out of 5,2008-01-15,Evidence at protein level
Q12934,BFSP1_HUMAN,Filensin (Beaded filament structural protein 1) (Lens fiber cell beaded-filament structural protein CP 115) (CP115) (Lens intermediate filament-like heavy) (LIFL-H),665,"74,544",5 out of 5,1997-11-01,Evidence at protein level
Q7RTS1,BHA15_HUMAN,"Class A basic helix-loop-helix protein 15 (bHLHa15) (Class B basic helix-loop-helix protein 8) (bHLHb8) (Muscle, intestine and stomach expression 1) (MIST-1)",189,"20,818",4 out of 5,2004-07-19,Evidence at protein level
Q9H2M3,BHMT2_HUMAN,S-methylmethionine--homocysteine S-methyltransferase BHMT2 (SMM-hcy methyltransferase) (EC 2.1.1.10) (Betaine--homocysteine S-methyltransferase 2),363,"40,354",5 out of 5,2007-01-23,Evidence at protein level
Q86Y27,BAGE5_HUMAN,B melanoma antigen 5 (Cancer/testis antigen 2.5) (CT2.5),43,"4,711",2 out of 5,2003-10-03,Evidence at transcript level
Q6ZUJ8,BCAP_HUMAN,Phosphoinositide 3-kinase adapter protein 1 (B-cell adapter for phosphoinositide 3-kinase) (B-cell phosphoinositide 3-kinase adapter protein 1),805,"90,398",5 out of 5,2008-07-22,Evidence at protein level
O75815,BCAR3_HUMAN,Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B),825,"92,566",5 out of 5,2006-04-04,Evidence at protein level
Q8TDM0,BCAS4_HUMAN,Breast carcinoma-amplified sequence 4,211,"22,758",3 out of 5,2003-07-25,Evidence at protein level
O15382,BCAT2_HUMAN,"Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT(m)) (EC 2.6.1.42) (Placental protein 18) (PP18)",392,"44,288",5 out of 5,1998-07-15,Evidence at protein level
Q8N143,BCL6B_HUMAN,B-cell CLL/lymphoma 6 member B protein (Bcl6-associated zinc finger protein) (Zinc finger protein 62),479,"51,531",4 out of 5,2004-09-27,Evidence at transcript level
Q9Y276,BCS1_HUMAN,Mitochondrial chaperone BCS1 (h-BCS1) (BCS1-like protein),419,"47,534",5 out of 5,2004-03-29,Evidence at protein level
Q9BUT1,BDH2_HUMAN,3-hydroxybutyrate dehydrogenase type 2 (EC 1.1.1.-) (EC 1.1.1.30) (Dehydrogenase/reductase SDR family member 6) (Oxidoreductase UCPA) (R-beta-hydroxybutyrate dehydrogenase) (Short chain dehydrogenase/reductase family 15C member 1),245,"26,724",5 out of 5,2005-10-11,Evidence at protein level
O76090,BEST1_HUMAN,Bestrophin-1 (TU15B) (Vitelliform macular dystrophy protein 2),585,"67,684",5 out of 5,1999-07-15,Evidence at protein level
Q9BXY8,BEX2_HUMAN,Protein BEX2 (Brain-expressed X-linked protein 2) (hBex2),128,"15,321",5 out of 5,2006-04-04,Evidence at protein level
Q9UBW5,BIN2_HUMAN,Bridging integrator 2 (Breast cancer-associated protein 1),565,"61,874",5 out of 5,2006-10-31,Evidence at protein level
P46663,BKRB1_HUMAN,B1 bradykinin receptor (B1R) (BK-1 receptor),353,"40,495",5 out of 5,1995-11-01,Evidence at protein level
P22003,BMP5_HUMAN,Bone morphogenetic protein 5 (BMP-5),454,"51,737",5 out of 5,1991-08-01,Evidence at transcript level
Q14692,BMS1_HUMAN,Ribosome biogenesis protein BMS1 homolog (Ribosome assembly protein BMS1 homolog),1282,"145,807",5 out of 5,2002-12-13,Evidence at protein level
Q96FH0,BORC8_HUMAN,BLOC-1-related complex subunit 8 (MEF2B neighbor),119,"13,403",4 out of 5,2007-01-09,Evidence at protein level
Q9UKI2,BORG2_HUMAN,Cdc42 effector protein 3 (Binder of Rho GTPases 2) (MSE55-related Cdc42-binding protein),254,"27,678",5 out of 5,2005-07-19,Evidence at protein level
Q9BQP9,BPIA3_HUMAN,"BPI fold-containing family A member 3 (Short palate, lung and nasal epithelium carcinoma-associated protein 3)",254,"28,436",3 out of 5,2002-10-10,Evidence at transcript level
P59827,BPIB4_HUMAN,"BPI fold-containing family B member 4 (Ligand-binding protein RY2G5) (Long palate, lung and nasal epithelium carcinoma-associated protein 4)",614,"65,055",4 out of 5,2003-08-29,Evidence at transcript level
Q8WY22,BRI3B_HUMAN,BRI3-binding protein (I3-binding protein) (Cervical cancer 1 proto-oncogene-binding protein KG19) (HCCRBP-1),251,"27,836",4 out of 5,2006-04-04,Evidence at protein level
Q9ULD4,BRPF3_HUMAN,Bromodomain and PHD finger-containing protein 3,1205,"135,745",5 out of 5,2001-01-11,Evidence at protein level
Q8TDC3,BRSK1_HUMAN,Serine/threonine-protein kinase BRSK1 (EC 2.7.11.1) (Brain-selective kinase 1) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 1) (BR serine/threonine-protein kinase 1) (Serine/threonine-protein kinase SAD-B) (Synapses of Amphids Defective homolog 1) (SAD1 homolog) (hSAD1),778,"85,087",5 out of 5,2003-08-29,Evidence at protein level
Q156A1,ATX8_HUMAN,Ataxin-8 (Protein 1C2),80,"10,272",3 out of 5,2007-01-09,Evidence at protein level
Q13705,AVR2B_HUMAN,Activin receptor type-2B (EC 2.7.11.30) (Activin receptor type IIB) (ACTR-IIB),512,"57,724",5 out of 5,1997-11-01,Evidence at protein level
Q07817,B2CL1_HUMAN,Bcl-2-like protein 1 (Bcl2-L-1) (Apoptosis regulator Bcl-X),233,"26,049",5 out of 5,1995-02-01,Evidence at protein level
P61769,B2MG_HUMAN,Beta-2-microglobulin [Cleaved into: Beta-2-microglobulin form pI 5.3],119,"13,715",5 out of 5,1986-07-21,Evidence at protein level
O75752,B3GL1_HUMAN,"UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1 (Beta-1,3-GalNAc-T1) (EC 2.4.1.79) (Beta-1,3-galactosyltransferase 3) (Beta-1,3-GalTase 3) (Beta3Gal-T3) (Beta3GalT3) (b3Gal-T3) (Beta-3-Gx-T3) (Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase) (Globoside synthase) (UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase)",331,"39,512",5 out of 5,2004-08-16,Evidence at protein level
Q9NY97,B3GN2_HUMAN,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 2 (EC 2.4.1.149) (Beta-1,3-N-acetylglucosaminyltransferase 1) (BGnT-1) (Beta-1,3-Gn-T1) (Beta3Gn-T1) (Beta-1,3-galactosyltransferase 7) (Beta-1,3-GalTase 7) (Beta3Gal-T7) (Beta3GalT7) (b3Gal-T7) (Beta-3-Gx-T7) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 7) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2) (BGnT-2) (Beta-1,3-Gn-T2) (Beta-1,3-N-acetylglucosaminyltransferase 2) (Beta3Gn-T2) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 7)",397,"46,022",5 out of 5,2001-02-21,Evidence at protein level
O60512,B4GT3_HUMAN,"Beta-1,4-galactosyltransferase 3 (Beta-1,4-GalTase 3) (Beta4Gal-T3) (b4Gal-T3) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3) [Includes: N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase (EC 2.4.1.38); Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase (EC 2.4.1.-)]",393,"43,928",5 out of 5,2001-02-21,Evidence at protein level
O43286,B4GT5_HUMAN,"Beta-1,4-galactosyltransferase 5 (Beta-1,4-GalTase 5) (Beta4Gal-T5) (b4Gal-T5) (EC 2.4.1.-) (Beta-1,4-GalT II) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 5)",388,"45,119",5 out of 5,2001-02-21,Evidence at transcript level
Q9UBV7,B4GT7_HUMAN,"Beta-1,4-galactosyltransferase 7 (Beta-1,4-GalTase 7) (Beta4Gal-T7) (b4Gal-T7) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 7) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 7) [Includes: Xylosylprotein 4-beta-galactosyltransferase (EC 2.4.1.133) (Proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I) (UDP-galactose:beta-xylose beta-1,4-galactosyltransferase) (XGPT) (XGalT-1) (Xylosylprotein beta-1,4-galactosyltransferase)]",327,"37,406",5 out of 5,2001-02-21,Evidence at protein level
Q6ZUV0,BACHL_HUMAN,Putative cytosolic acyl coenzyme A thioester hydrolase-like (EC 3.1.2.2) (Acyl-CoA thioesterase 7-like),252,"28,164",4 out of 5,2008-09-02,Uncertain
Q13072,BAGE1_HUMAN,B melanoma antigen 1 (B melanoma antigen) (Antigen MZ2-BA) (Cancer/testis antigen 2.1) (CT2.1),43,"4,810",3 out of 5,1999-07-15,Evidence at transcript level
Q7L4P6,BEND5_HUMAN,BEN domain-containing protein 5,421,"48,182",5 out of 5,2007-02-06,Evidence at protein level
Q9NUP1,BL1S4_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 4 (BLOC-1 subunit 4) (Protein cappuccino homolog),217,"23,351",4 out of 5,2003-08-29,Evidence at protein level
P51451,BLK_HUMAN,Tyrosine-protein kinase Blk (EC 2.7.10.2) (B lymphocyte kinase) (p55-Blk),505,"57,706",5 out of 5,1996-10-01,Evidence at protein level
Q01954,BNC1_HUMAN,Zinc finger protein basonuclin-1,994,"110,972",5 out of 5,1994-02-01,Evidence at protein level
O60238,BNI3L_HUMAN,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like (Adenovirus E1B19K-binding protein B5) (BCL2/adenovirus E1B 19 kDa protein-interacting protein 3A) (NIP3-like protein X) (NIP3L),219,"23,930",5 out of 5,1999-07-15,Evidence at protein level
Q8N9W6,BOLL_HUMAN,Protein boule-like,283,"31,301",5 out of 5,2004-03-01,Evidence at protein level
Q14137,BOP1_HUMAN,Ribosome biogenesis protein BOP1 (Block of proliferation 1 protein),746,"83,630",5 out of 5,1997-11-01,Evidence at protein level
O15178,BRAC_HUMAN,Brachyury protein (Protein T),435,"47,443",5 out of 5,1999-07-15,Evidence at protein level
P15056,BRAF_HUMAN,Serine/threonine-protein kinase B-raf (EC 2.7.11.1) (Proto-oncogene B-Raf) (p94) (v-Raf murine sarcoma viral oncogene homolog B1),766,"84,437",5 out of 5,1990-11-01,Evidence at protein level
P25440,BRD2_HUMAN,Bromodomain-containing protein 2 (O27.1.1) (Really interesting new gene 3 protein),801,"88,061",5 out of 5,1992-05-01,Evidence at protein level
Q5TBC7,B2L15_HUMAN,Bcl-2-like protein 15 (Bcl2-L-15),163,"17,725",2 out of 5,2007-04-03,Evidence at protein level
Q16548,B2LA1_HUMAN,Bcl-2-related protein A1 (Bcl-2-like protein 5) (Bcl2-L-5) (Hemopoietic-specific early response protein) (Protein BFL-1) (Protein GRS),175,"20,132",5 out of 5,1997-11-01,Evidence at protein level
Q9Y2A9,B3GN3_HUMAN,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 (EC 2.4.1.149) (Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase) (EC 2.4.1.146) (Beta-1,3-galactosyltransferase 8) (Beta-1,3-GalTase 8) (Beta3Gal-T8) (Beta3GalT8) (b3Gal-T8) (Beta-3-Gx-T8) (Core 1 extending beta-1,3-N-acetylglucosaminyltransferase) (Core1-beta3GlcNAcT) (Transmembrane protein 3) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 8) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3) (BGnT-3) (Beta-1,3-Gn-T3) (Beta-1,3-N-acetylglucosaminyltransferase 3) (Beta3Gn-T3) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 8)",372,"42,534",5 out of 5,2001-02-21,Evidence at protein level
Q6ZMB0,B3GN6_HUMAN,"Acetylgalactosaminyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (EC 2.4.1.147) (Core 3 synthase) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6) (BGnT-6) (Beta-1,3-Gn-T6) (Beta-1,3-N-acetylglucosaminyltransferase 6) (Beta3Gn-T6)",384,"42,748",5 out of 5,2007-05-29,Evidence at protein level
Q7Z7M8,B3GN8_HUMAN,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 (BGnT-8) (Beta-1,3-Gn-T8) (Beta-1,3-N-acetylglucosaminyltransferase 8) (Beta3Gn-T8) (EC 2.4.1.-)",397,"43,396",5 out of 5,2007-10-02,Evidence at protein level
O60513,B4GT4_HUMAN,"Beta-1,4-galactosyltransferase 4 (Beta-1,4-GalTase 4) (Beta4Gal-T4) (b4Gal-T4) (EC 2.4.1.-) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4) [Includes: N-acetyllactosamine synthase (EC 2.4.1.90) (Nal synthase); Lactotriaosylceramide beta-1,4-galactosyltransferase (EC 2.4.1.275) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase)]",344,"40,041",5 out of 5,2001-02-21,Evidence at protein level
Q9BPU9,B9D2_HUMAN,B9 domain-containing protein 2 (MKS1-related protein 2),175,"19,261",5 out of 5,2007-10-23,Evidence at protein level
Q9H503,BAFL_HUMAN,Barrier-to-autointegration factor-like protein (BAF-L) (Barrier-to-autointegration factor 2),90,"10,309",4 out of 5,2002-08-02,Evidence at protein level
P46379,BAG6_HUMAN,Large proline-rich protein BAG6 (BAG family molecular chaperone regulator 6) (BCL2-associated athanogene 6) (BAG-6) (HLA-B-associated transcript 3) (Protein G3) (Protein Scythe),1132,"119,409",5 out of 5,1995-11-01,Evidence at protein level
O14514,BAI1_HUMAN,Brain-specific angiogenesis inhibitor 1,1584,"173,501",5 out of 5,2000-12-01,Evidence at protein level
O94812,BAIP3_HUMAN,BAI1-associated protein 3 (BAP3),1187,"131,901",4 out of 5,2004-08-31,Evidence at protein level
P82251,BAT1_HUMAN,"b(0,+)-type amino acid transporter 1 (b(0,+)AT1) (Glycoprotein-associated amino acid transporter b0,+AT1) (Solute carrier family 7 member 9)",487,"53,481",5 out of 5,2001-01-24,Evidence at protein level
Q8N1L9,BATF2_HUMAN,Basic leucine zipper transcriptional factor ATF-like 2 (B-ATF-2) (Suppressor of AP-1 regulated by IFN) (SARI),274,"29,398",4 out of 5,2007-05-29,Evidence at protein level
Q8N3I7,BBS5_HUMAN,Bardet-Biedl syndrome 5 protein,341,"38,755",5 out of 5,2006-02-07,Evidence at protein level
O75363,BCAS1_HUMAN,Breast carcinoma-amplified sequence 1 (Amplified and overexpressed in breast cancer) (Novel amplified in breast cancer 1),584,"61,709",3 out of 5,2001-01-24,Evidence at protein level
P0C6P0,BCL8_HUMAN,Putative protein BCL8 (Neurobeachin pseudogene 1),100,"11,233",2 out of 5,2008-03-18,Uncertain
Q8NFC6,BD1L1_HUMAN,Biorientation of chromosomes in cell division protein 1-like 1,3051,"330,466",5 out of 5,2005-11-22,Evidence at protein level
A8MW95,BECN2_HUMAN,Beclin-2 (Beclin-1 autophagy-related pseudogene 1) (Beclin-1-like protein 1),431,"48,153",5 out of 5,2008-04-29,Evidence at protein level
Q9NZS9,BFAR_HUMAN,Bifunctional apoptosis regulator (RING finger protein 47),450,"52,738",5 out of 5,2005-12-20,Evidence at protein level
P16442,BGAT_HUMAN,Histo-blood group ABO system transferase (Fucosylglycoprotein 3-alpha-galactosyltransferase) (Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase) (Glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase) (EC 2.4.1.40) (Glycoprotein-fucosylgalactoside alpha-galactosyltransferase) (EC 2.4.1.37) (Histo-blood group A transferase) (A transferase) (Histo-blood group B transferase) (B transferase) (NAGAT) [Cleaved into: Fucosylglycoprotein alpha-N-acetylgalactosaminyltransferase soluble form],354,"40,934",5 out of 5,1990-08-01,Evidence at protein level
Q15582,BGH3_HUMAN,Transforming growth factor-beta-induced protein ig-h3 (Beta ig-h3) (Kerato-epithelin) (RGD-containing collagen-associated protein) (RGD-CAP),683,"74,681",5 out of 5,1997-11-01,Evidence at protein level
Q6P575,BGP11_HUMAN,Putative inactive beta-glucuronidase protein GUSBP11 (Beta-glucuronidase pseudogene 11),273,"29,908",2 out of 5,2008-04-29,Uncertain
Q8NFJ8,BHE22_HUMAN,Class E basic helix-loop-helix protein 22 (bHLHe22) (Class B basic helix-loop-helix protein 5) (bHLHb5) (Trinucleotide repeat-containing gene 20 protein),381,"36,997",3 out of 5,2007-02-06,Evidence at transcript level
P55061,BI1_HUMAN,Bax inhibitor 1 (BI-1) (Testis-enhanced gene transcript protein) (Transmembrane BAX inhibitor motif-containing protein 6),237,"26,538",5 out of 5,1996-10-01,Evidence at protein level
O00499,BIN1_HUMAN,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),593,"64,699",5 out of 5,2001-07-11,Evidence at protein level
Q86UB2,BIVM_HUMAN,Basic immunoglobulin-like variable motif-containing protein,503,"56,774",3 out of 5,2008-04-08,Evidence at transcript level
P78537,BL1S1_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 1 (BLOC-1 subunit 1) (GCN5-like protein 1) (Protein RT14),153,"17,263",5 out of 5,1998-07-15,Evidence at protein level
Q9HD36,B2L10_HUMAN,Bcl-2-like protein 10 (Bcl2-L-10) (Anti-apoptotic protein NrH) (Apoptosis regulator Bcl-B),194,"21,973",5 out of 5,2002-09-19,Evidence at protein level
P04920,B3A2_HUMAN,Anion exchange protein 2 (AE 2) (Anion exchanger 2) (Non-erythroid band 3-like protein) (BND3L) (Solute carrier family 4 member 2),1241,"137,009",5 out of 5,1987-08-13,Evidence at protein level
Q9P2W7,B3GA1_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 1) (Glucuronosyltransferase P) (GlcAT-P) (UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase) (GlcUAT-P)",334,"38,256",5 out of 5,2001-06-01,Evidence at protein level
Q9NPZ5,B3GA2_HUMAN,"Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 2 (EC 2.4.1.135) (Beta-1,3-glucuronyltransferase 2) (GlcAT-D) (UDP-glucuronosyltransferase S) (GlcAT-S) (Glucuronosyltransferase S)",323,"36,919",5 out of 5,2001-06-01,Evidence at protein level
O96024,B3GT4_HUMAN,"Beta-1,3-galactosyltransferase 4 (Beta-1,3-GalTase 4) (Beta3Gal-T4) (Beta3GalT4) (GalT4) (b3Gal-T4) (EC 2.4.1.62) (Gal-T2) (Ganglioside galactosyltransferase) (UDP-galactose:beta-N-acetyl-galactosamine-beta-1,3-galactosyltransferase)",378,"41,537",4 out of 5,2002-10-10,Evidence at protein level
Q9Y2C3,B3GT5_HUMAN,"Beta-1,3-galactosyltransferase 5 (Beta-1,3-GalTase 5) (Beta3Gal-T5) (Beta3GalT5) (b3Gal-T5) (EC 2.4.1.-) (Beta-3-Gx-T5) (UDP-Gal:beta-GlcNAc beta-1,3-galactosyltransferase 5) (UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 5)",310,"36,189",4 out of 5,2001-02-21,Evidence at transcript level
P0C853,BAAS2_HUMAN,Putative uncharacterized protein BAALC-AS2 (BAALC antisense RNA 2) (BAALC antisense gene protein 2) (BAALC opposite strand protein),105,"11,579",2 out of 5,2008-09-02,Uncertain
Q8WZ19,BACD1_HUMAN,BTB/POZ domain-containing adapter for CUL3-mediated RhoA degradation protein 1 (hBACURD1) (BTB/POZ domain-containing protein KCTD13) (Polymerase delta-interacting protein 1) (TNFAIP1-like protein),329,"36,357",5 out of 5,2004-08-31,Evidence at protein level
Q86Y30,BAGE2_HUMAN,B melanoma antigen 2 (Cancer/testis antigen 2.2) (CT2.2),109,"12,114",2 out of 5,2003-10-03,Evidence at transcript level
Q9NYF8,BCLF1_HUMAN,Bcl-2-associated transcription factor 1 (Btf),920,"106,122",5 out of 5,2004-05-24,Evidence at protein level
Q9NYM9,BET1L_HUMAN,BET1-like protein (Golgi SNARE with a size of 15 kDa) (GOS-15) (GS15) (Vesicle transport protein GOS15),111,"12,388",5 out of 5,2006-04-18,Evidence at protein level
Q9H694,BICC1_HUMAN,Protein bicaudal C homolog 1 (Bic-C),974,"104,844",5 out of 5,2006-12-12,Evidence at protein level
Q96G01,BICD1_HUMAN,Protein bicaudal D homolog 1 (Bic-D 1),975,"110,750",5 out of 5,2003-08-15,Evidence at protein level
Q5TH69,BIG3_HUMAN,Brefeldin A-inhibited guanine nucleotide-exchange protein 3 (ARFGEF family member 3),2177,"240,652",4 out of 5,2007-05-15,Evidence at protein level
P62952,BLCAP_HUMAN,Bladder cancer-associated protein (Bladder cancer 10 kDa protein) (Bc10),87,"9,876",4 out of 5,2004-08-31,Evidence at protein level
Q13867,BLMH_HUMAN,Bleomycin hydrolase (BH) (BLM hydrolase) (BMH) (EC 3.4.22.40),455,"52,562",5 out of 5,1998-07-15,Evidence at protein level
P30043,BLVRB_HUMAN,Flavin reductase (NADPH) (FR) (EC 1.5.1.30) (Biliverdin reductase B) (BVR-B) (EC 1.3.1.24) (Biliverdin-IX beta-reductase) (Green heme-binding protein) (GHBP) (NADPH-dependent diaphorase) (NADPH-flavin reductase) (FLR),206,"22,119",5 out of 5,1993-04-01,Evidence at protein level
O00327,BMAL1_HUMAN,Aryl hydrocarbon receptor nuclear translocator-like protein 1 (Basic-helix-loop-helix-PAS protein MOP3) (Brain and muscle ARNT-like 1) (Class E basic helix-loop-helix protein 5) (bHLHe5) (Member of PAS protein 3) (PAS domain-containing protein 3) (bHLH-PAS protein JAP3),626,"68,762",5 out of 5,1998-12-15,Evidence at protein level
Q9NSY1,BMP2K_HUMAN,BMP-2-inducible protein kinase (BIKe) (EC 2.7.11.1),1161,"129,172",5 out of 5,2003-08-22,Evidence at protein level
P12643,BMP2_HUMAN,Bone morphogenetic protein 2 (BMP-2) (Bone morphogenetic protein 2A) (BMP-2A),396,"44,702",5 out of 5,1989-10-01,Evidence at protein level
Q7Z5Y6,BMP8A_HUMAN,Bone morphogenetic protein 8A (BMP-8A),402,"44,798",5 out of 5,2006-03-21,Evidence at transcript level
Q969J3,BORC5_HUMAN,BLOC-1-related complex subunit 5 (Loss of heterozygosity 12 chromosomal region 1) (Myristoylated lysosomal protein) (Myrlysin),196,"22,222",5 out of 5,2008-02-26,Evidence at protein level
Q12983,BNIP3_HUMAN,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3,194,"21,541",5 out of 5,1999-07-15,Evidence at protein level
Q53S33,BOLA3_HUMAN,BolA-like protein 3,107,"12,114",4 out of 5,2006-07-11,Evidence at protein level
Q9GZL8,BPEC1_HUMAN,Putative BPES syndrome breakpoint region protein (BPES candidate 1),116,"12,676",1 out of 5,2001-04-27,Evidence at transcript level
Q86WA6,BPHL_HUMAN,Valacyclovir hydrolase (VACVase) (Valacyclovirase) (EC 3.1.-.-) (Biphenyl hydrolase-like protein) (Biphenyl hydrolase-related protein) (Bph-rp) (Breast epithelial mucin-associated antigen) (MCNAA),291,"32,543",5 out of 5,2003-12-15,Evidence at protein level
Q9NP55,BPIA1_HUMAN,BPI fold-containing family A member 1 (Lung-specific protein X) (Nasopharyngeal carcinoma-related protein) (Palate lung and nasal epithelium clone protein) (Secretory protein in upper respiratory tracts) (Short PLUNC1) (SPLUNC1) (Tracheal epithelium-enriched protein) (Von Ebner protein Hl),256,"26,713",5 out of 5,2001-10-18,Evidence at protein level
Q8NFQ6,BPIFC_HUMAN,BPI fold-containing family C protein (Bactericidal/permeability-increasing protein-like 2) (BPI-like 2),507,"56,469",3 out of 5,2003-08-29,Evidence at transcript level
O60885,BRD4_HUMAN,Bromodomain-containing protein 4 (Protein HUNK1),1362,"152,219",5 out of 5,2001-01-11,Evidence at protein level
Q9NXR7,BRE_HUMAN,BRCA1-A complex subunit BRE (BRCA1/BRCA2-containing complex subunit 45) (Brain and reproductive organ-expressed protein),383,"43,552",5 out of 5,2006-02-21,Evidence at protein level
Q9NW68,BSDC1_HUMAN,BSD domain-containing protein 1,430,"47,163",3 out of 5,2007-04-03,Evidence at protein level
O14981,BTAF1_HUMAN,TATA-binding protein-associated factor 172 (EC 3.6.4.-) (ATP-dependent helicase BTAF1) (B-TFIID transcription factor-associated 170 kDa subunit) (TAF(II)170) (TBP-associated factor 172) (TAF-172),1849,"206,887",5 out of 5,2000-12-01,Evidence at protein level
P43251,BTD_HUMAN,Biotinidase (Biotinase) (EC 3.5.1.12),543,"61,133",5 out of 5,1995-11-01,Evidence at protein level
Q14201,BTG3_HUMAN,Protein BTG3 (Abundant in neuroepithelium area protein) (BTG family member 3) (Protein Tob5),252,"29,116",4 out of 5,1997-11-01,Evidence at protein level
Q6UXG8,BTNL9_HUMAN,Butyrophilin-like protein 9,535,"59,716",3 out of 5,2005-02-01,Evidence at transcript level
Q9BRD0,BUD13_HUMAN,BUD13 homolog,619,"70,521",4 out of 5,2007-05-15,Evidence at protein level
P15538,C11B1_HUMAN,"Cytochrome P450 11B1, mitochondrial (CYPXIB1) (Cytochrome P-450c11) (Cytochrome P450C11) (Steroid 11-beta-hydroxylase) (EC 1.14.15.4)",503,"57,573",5 out of 5,1990-04-01,Evidence at protein level
Q07021,C1QBP_HUMAN,"Complement component 1 Q subcomponent-binding protein, mitochondrial (ASF/SF2-associated protein p32) (Glycoprotein gC1qBP) (C1qBP) (Hyaluronan-binding protein 1) (Mitochondrial matrix protein p32) (gC1q-R protein) (p33)",282,"31,362",5 out of 5,1995-02-01,Evidence at protein level
Q9BXJ5,C1QT2_HUMAN,Complement C1q tumor necrosis factor-related protein 2,285,"29,952",3 out of 5,2002-04-16,Evidence at protein level
Q9BXJ2,C1QT7_HUMAN,Complement C1q tumor necrosis factor-related protein 7,289,"30,683",2 out of 5,2002-04-16,Evidence at transcript level
B2RNN3,C1T9B_HUMAN,Complement C1q and tumor necrosis factor-related protein 9B (C1q/TNF-related protein 9B) (CTRP9B) (Complement C1q and tumor necrosis factor-related protein 9-like),333,"34,713",3 out of 5,2008-09-02,Evidence at protein level
Q4G0S4,C27C1_HUMAN,Cytochrome P450 27C1 (EC 1.14.-.-),372,"42,632",3 out of 5,2007-07-10,Evidence at protein level
Q96MC4,C295L_HUMAN,CEP295 N-terminal-like protein (KIAA1731 N-terminal like protein),621,"69,839",2 out of 5,2013-05-01,Evidence at transcript level
O14523,C2C2L_HUMAN,Phospholipid transfer protein C2CD2L (C2 domain-containing protein 2-like) (Transmembrane protein 24),706,"76,181",5 out of 5,1998-07-15,Evidence at protein level
Q8N8Q1,C56D1_HUMAN,Cytochrome b561 domain-containing protein 1,229,"25,424",3 out of 5,2005-05-10,Evidence at transcript level
Q5T7R7,CA185_HUMAN,Uncharacterized protein C1orf185,199,"22,411",1 out of 5,2007-01-09,Evidence at transcript level
P01258,CALC_HUMAN,Calcitonin [Cleaved into: Calcitonin; Katacalcin (Calcitonin carboxyl-terminal peptide) (CCP) (PDN-21)],141,"15,466",5 out of 5,1986-07-21,Evidence at protein level
Q9P1Y5,CAMP3_HUMAN,Calmodulin-regulated spectrin-associated protein 3 (Protein Nezha),1249,"134,750",5 out of 5,2005-03-15,Evidence at protein level
Q9HC96,CAN10_HUMAN,Calpain-10 (EC 3.4.22.-) (Calcium-activated neutral proteinase 10) (CANP 10),672,"74,952",5 out of 5,2002-05-27,Evidence at protein level
P63098,CANB1_HUMAN,Calcineurin subunit B type 1 (Protein phosphatase 2B regulatory subunit 1) (Protein phosphatase 3 regulatory subunit B alpha isoform 1),170,"19,300",5 out of 5,1988-01-01,Evidence at protein level
Q86VP6,CAND1_HUMAN,Cullin-associated NEDD8-dissociated protein 1 (Cullin-associated and neddylation-dissociated protein 1) (TBP-interacting protein of 120 kDa A) (TBP-interacting protein 120A) (p120 CAND1),1230,"136,376",5 out of 5,2005-06-07,Evidence at protein level
Q14444,CAPR1_HUMAN,Caprin-1 (Cell cycle-associated protein 1) (Cytoplasmic activation- and proliferation-associated protein 1) (GPI-anchored membrane protein 1) (GPI-anchored protein p137) (GPI-p137) (p137GPI) (Membrane component chromosome 11 surface marker 1) (RNA granule protein 105),709,"78,366",5 out of 5,1997-11-01,Evidence at protein level
Q9H257,CARD9_HUMAN,Caspase recruitment domain-containing protein 9 (hCARD9),536,"62,241",5 out of 5,2002-01-31,Evidence at protein level
Q13075,BIRC1_HUMAN,Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein),1403,"159,582",5 out of 5,1997-11-01,Evidence at protein level
Q96CA5,BIRC7_HUMAN,Baculoviral IAP repeat-containing protein 7 (EC 2.3.2.27) (Kidney inhibitor of apoptosis protein) (KIAP) (Livin) (Melanoma inhibitor of apoptosis protein) (ML-IAP) (RING finger protein 50) (RING-type E3 ubiquitin transferase BIRC7) [Cleaved into: Baculoviral IAP repeat-containing protein 7 30kDa subunit (Truncated livin) (p30-Livin) (tLivin)],298,"32,798",5 out of 5,2002-07-11,Evidence at protein level
Q6QNY1,BL1S2_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 2 (BLOC-1 subunit 2) (Centrosome-associated protein),142,"15,961",5 out of 5,2006-05-16,Evidence at protein level
Q8WYA1,BMAL2_HUMAN,Aryl hydrocarbon receptor nuclear translocator-like protein 2 (Basic-helix-loop-helix-PAS protein MOP9) (Brain and muscle ARNT-like 2) (CYCLE-like factor) (CLIF) (Class E basic helix-loop-helix protein 6) (bHLHe6) (Member of PAS protein 9) (PAS domain-containing protein 9),636,"70,887",5 out of 5,2007-01-23,Evidence at protein level
O95393,BMP10_HUMAN,Bone morphogenetic protein 10 (BMP-10),424,"48,047",5 out of 5,2001-02-21,Evidence at protein level
Q1RMZ1,BMT2_HUMAN,Probable methyltransferase BMT2 homolog (EC 2.1.1.-),405,"46,324",2 out of 5,2008-02-26,Evidence at transcript level
Q53HL2,BOREA_HUMAN,Borealin (Cell division cycle-associated protein 8) (Dasra-B) (hDasra-B) (Pluripotent embryonic stem cell-related gene 3 protein),280,"31,323",5 out of 5,2006-07-25,Evidence at protein level
Q96DR5,BPIA2_HUMAN,"BPI fold-containing family A member 2 (Parotid secretory protein) (PSP) (Short palate, lung and nasal epithelium carcinoma-associated protein 2)",249,"27,011",5 out of 5,2003-08-29,Evidence at protein level
P59826,BPIB3_HUMAN,"BPI fold-containing family B member 3 (Ligand-binding protein RYA3) (Long palate, lung and nasal epithelium carcinoma-associated protein 3)",476,"50,342",4 out of 5,2003-08-29,Evidence at transcript level
Q8NFQ5,BPIB6_HUMAN,BPI fold-containing family B member 6 (Bactericidal/permeability-increasing protein-like 3),453,"49,717",3 out of 5,2003-08-29,Evidence at protein level
P17213,BPI_HUMAN,Bactericidal permeability-increasing protein (BPI) (CAP 57),487,"53,900",5 out of 5,1990-08-01,Evidence at protein level
Q9H8M2,BRD9_HUMAN,Bromodomain-containing protein 9 (Rhabdomyosarcoma antigen MU-RMS-40.8),597,"67,000",5 out of 5,2006-05-30,Evidence at protein level
O75150,BRE1B_HUMAN,E3 ubiquitin-protein ligase BRE1B (BRE1-B) (EC 2.3.2.27) (95 kDa retinoblastoma-associated protein) (RBP95) (RING finger protein 40) (RING-type E3 ubiquitin transferase BRE1B),1001,"113,650",5 out of 5,2005-12-20,Evidence at protein level
O95415,BRI3_HUMAN,Brain protein I3 (pRGR2),125,"13,645",3 out of 5,2000-05-30,Evidence at transcript level
Q5PSV4,BRM1L_HUMAN,Breast cancer metastasis-suppressor 1-like protein (BRMS1-homolog protein p40) (BRMS1-like protein p40),323,"37,629",5 out of 5,2007-10-02,Evidence at protein level
Q9C0B6,BRNP2_HUMAN,BMP/retinoic acid-inducible neural-specific protein 2 (DBCCR1-like protein 2),783,"89,005",4 out of 5,2006-01-24,Evidence at transcript level
Q5VW32,BROX_HUMAN,BRO1 domain-containing protein BROX (BRO1 domain- and CAAX motif-containing protein),411,"46,476",4 out of 5,2007-09-11,Evidence at protein level
P32247,BRS3_HUMAN,Bombesin receptor subtype-3 (BRS-3),399,"44,411",5 out of 5,1993-10-01,Evidence at protein level
Q96G97,BSCL2_HUMAN,Seipin (Bernardinelli-Seip congenital lipodystrophy type 2 protein),398,"44,392",5 out of 5,2005-04-26,Evidence at protein level
Q5XKL5,BTBD8_HUMAN,BTB/POZ domain-containing protein 8,378,"42,793",3 out of 5,2006-05-30,Evidence at transcript level
P78543,BTG2_HUMAN,Protein BTG2 (BTG family member 2) (NGF-inducible anti-proliferative protein PC3),158,"17,416",5 out of 5,1998-07-15,Evidence at protein level
Q06187,BTK_HUMAN,Tyrosine-protein kinase BTK (EC 2.7.10.2) (Agammaglobulinemia tyrosine kinase) (ATK) (B-cell progenitor kinase) (BPK) (Bruton tyrosine kinase),659,"76,281",5 out of 5,1994-06-01,Evidence at protein level
Q99622,C10_HUMAN,Protein C10,126,"13,178",3 out of 5,2000-05-30,Evidence at protein level
Q69YN2,C19L1_HUMAN,CWF19-like protein 1 (C19L1),538,"60,619",3 out of 5,2008-01-15,Evidence at protein level
Q9BXI9,C1QT6_HUMAN,Complement C1q tumor necrosis factor-related protein 6,259,"28,669",3 out of 5,2002-04-16,Evidence at protein level
P0C862,C1T9A_HUMAN,Complement C1q and tumor necrosis factor-related protein 9A (Complement C1q and tumor necrosis factor-related protein 9),333,"34,681",4 out of 5,2008-09-02,Evidence at protein level
O14569,C56D2_HUMAN,Cytochrome b561 domain-containing protein 2 (Putative tumor suppressor protein 101F6),222,"23,974",3 out of 5,2005-05-10,Evidence at protein level
Q9P296,C5AR2_HUMAN,C5a anaphylatoxin chemotactic receptor 2 (Complement component 5a receptor 2) (G-protein coupled receptor 77),337,"36,080",5 out of 5,2002-03-05,Evidence at protein level
Q9BWL3,CA043_HUMAN,Uncharacterized protein C1orf43 (Hepatitis C virus NS5A-transactivated protein 4) (HCV NS5A-transactivated protein 4) (Protein NICE-3) (S863-3),253,"28,779",3 out of 5,2005-07-05,Evidence at transcript level
Q6P1W5,CA094_HUMAN,Uncharacterized protein C1orf94,598,"65,353",5 out of 5,2007-03-06,Evidence at protein level
Q9H7X2,CA115_HUMAN,Uncharacterized protein C1orf115,142,"15,517",1 out of 5,2006-12-12,Evidence at transcript level
Q96MR7,CA145_HUMAN,Putative uncharacterized protein C1orf145,158,"17,524",2 out of 5,2007-04-03,Uncertain
Q96HA4,CA159_HUMAN,Uncharacterized protein C1orf159,380,"40,283",3 out of 5,2006-10-31,Evidence at transcript level
Q5SR53,CA200_HUMAN,Putative uncharacterized protein PIK3CD-AS1 (PIK3CD antisense RNA 1) (PIK3CD antisense gene protein 1),167,"18,168",1 out of 5,2008-07-01,Evidence at transcript level
Q8WTZ4,CA5BL_HUMAN,Putative inactive carbonic anhydrase 5B-like protein (CA-VB-like protein),195,"22,622",2 out of 5,2007-11-13,Uncertain
Q9Y6J0,CABIN_HUMAN,Calcineurin-binding protein cabin-1 (Calcineurin inhibitor) (CAIN),2220,"246,352",5 out of 5,2000-05-30,Evidence at protein level
Q08289,CACB2_HUMAN,Voltage-dependent L-type calcium channel subunit beta-2 (CAB2) (Calcium channel voltage-dependent subunit beta 2) (Lambert-Eaton myasthenic syndrome antigen B) (MYSB),660,"73,581",5 out of 5,1994-10-01,Evidence at protein level
Q8TC20,CAGE1_HUMAN,Cancer-associated gene 1 protein (CAGE-1) (Cancer/testis antigen 3) (CT3),777,"90,250",4 out of 5,2007-03-20,Evidence at protein level
P00918,CAH2_HUMAN,Carbonic anhydrase 2 (EC 4.2.1.1) (Carbonate dehydratase II) (Carbonic anhydrase C) (CAC) (Carbonic anhydrase II) (CA-II),260,"29,246",5 out of 5,1986-07-21,Evidence at protein level
Q16790,CAH9_HUMAN,Carbonic anhydrase 9 (EC 4.2.1.1) (Carbonate dehydratase IX) (Carbonic anhydrase IX) (CA-IX) (CAIX) (Membrane antigen MN) (P54/58N) (Renal cell carcinoma-associated antigen G250) (RCC-associated antigen G250) (pMW1),459,"49,698",5 out of 5,1999-07-15,Evidence at protein level
P22676,CALB2_HUMAN,Calretinin (CR) (29 kDa calbindin),271,"31,540",4 out of 5,1991-08-01,Evidence at transcript level
Q8NCB2,CAMKV_HUMAN,CaM kinase-like vesicle-associated protein,501,"54,354",5 out of 5,2006-09-19,Evidence at transcript level
Q9UMQ6,CAN11_HUMAN,Calpain-11 (EC 3.4.22.-) (Calcium-activated neutral proteinase 11) (CANP 11),739,"84,423",5 out of 5,2001-01-11,Evidence at transcript level
O75808,CAN15_HUMAN,Calpain-15 (EC 3.4.22.-) (Small optic lobes homolog),1086,"117,314",4 out of 5,2007-02-20,Evidence at protein level
Q6ZP65,BICL1_HUMAN,BICD family-like cargo adapter 1 (Bicaudal D-related protein 1) (BICD-related protein 1) (BICDR-1) (Coiled-coil domain-containing protein 64A) (CCDC64A),573,"64,841",3 out of 5,2007-09-11,Evidence at transcript level
Q9Y6D5,BIG2_HUMAN,Brefeldin A-inhibited guanine nucleotide-exchange protein 2 (Brefeldin A-inhibited GEP 2) (ADP-ribosylation factor guanine nucleotide-exchange factor 2),1785,"202,038",5 out of 5,2001-02-21,Evidence at protein level
P35226,BMI1_HUMAN,Polycomb complex protein BMI-1 (Polycomb group RING finger protein 4) (RING finger protein 51),326,"36,949",5 out of 5,1994-02-01,Evidence at protein level
P12645,BMP3_HUMAN,Bone morphogenetic protein 3 (BMP-3) (Bone morphogenetic protein 3A) (BMP-3A) (Osteogenin),472,"53,372",5 out of 5,1989-10-01,Evidence at protein level
Q6ZN30,BNC2_HUMAN,Zinc finger protein basonuclin-2,1099,"122,330",5 out of 5,2005-11-08,Evidence at protein level
O75936,BODG_HUMAN,"Gamma-butyrobetaine dioxygenase (EC 1.14.11.1) (Gamma-butyrobetaine hydroxylase) (Gamma-BBH) (Gamma-butyrobetaine,2-oxoglutarate dioxygenase)",387,"44,715",5 out of 5,1999-07-15,Evidence at protein level
Q9H3Q1,BORG4_HUMAN,Cdc42 effector protein 4 (Binder of Rho GTPases 4),356,"37,980",5 out of 5,2002-06-06,Evidence at protein level
Q8N4F0,BPIB2_HUMAN,"BPI fold-containing family B member 2 (Bactericidal/permeability-increasing protein-like 1) (BPI-like 1) (Long palate, lung and nasal epithelium carcinoma-associated protein 2) (RYSR)",458,"49,172",5 out of 5,2003-08-29,Evidence at protein level
O95696,BRD1_HUMAN,Bromodomain-containing protein 1 (BR140-like protein) (Bromodomain and PHD finger-containing protein 2),1058,"119,520",5 out of 5,2001-01-11,Evidence at protein level
Q9HCU9,BRMS1_HUMAN,Breast cancer metastasis-suppressor 1,246,"28,461",5 out of 5,2001-09-26,Evidence at protein level
Q9NSI6,BRWD1_HUMAN,Bromodomain and WD repeat-containing protein 1 (WD repeat-containing protein 9),2320,"262,936",5 out of 5,2001-01-11,Evidence at protein level
Q7KYR7,BT2A1_HUMAN,Butyrophilin subfamily 2 member A1,527,"59,633",5 out of 5,2005-02-01,Evidence at protein level
Q5T3Y7,BVAS1_HUMAN,Putative uncharacterized protein BVES-AS1 (BVES antisense RNA 1) (BVES antisense gene protein 1),98,"11,178",2 out of 5,2010-06-15,Uncertain
Q9NR16,C163B_HUMAN,Scavenger receptor cysteine-rich type 1 protein M160 (CD163 antigen-like 1) (CD antigen CD163b),1453,"159,239",5 out of 5,2006-01-10,Evidence at protein level
Q9BXJ3,C1QT4_HUMAN,Complement C1q tumor necrosis factor-related protein 4,329,"35,256",3 out of 5,2002-04-16,Evidence at protein level
Q9BXJ0,C1QT5_HUMAN,Complement C1q tumor necrosis factor-related protein 5,243,"25,298",4 out of 5,2002-04-16,Evidence at protein level
Q9NZP8,C1RL_HUMAN,Complement C1r subcomponent-like protein (C1r-LP) (C1r-like protein) (EC 3.4.21.-) (C1r-like serine protease analog protein) (CLSPa),487,"53,498",5 out of 5,2008-02-26,Evidence at protein level
P09871,C1S_HUMAN,Complement C1s subcomponent (EC 3.4.21.42) (C1 esterase) (Complement component 1 subcomponent s) [Cleaved into: Complement C1s subcomponent heavy chain; Complement C1s subcomponent light chain],688,"76,684",5 out of 5,1989-07-01,Evidence at protein level
P11586,C1TC_HUMAN,"C-1-tetrahydrofolate synthase, cytoplasmic (C1-THF synthase) [Cleaved into: C-1-tetrahydrofolate synthase, cytoplasmic, N-terminally processed] [Includes: Methylenetetrahydrofolate dehydrogenase (EC 1.5.1.5); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9); Formyltetrahydrofolate synthetase (EC 6.3.4.3)]",935,"101,559",5 out of 5,1989-10-01,Evidence at protein level
Q8NCU7,C2C4A_HUMAN,C2 calcium-dependent domain-containing protein 4A (Nuclear-localized factor 1) (Protein FAM148A),369,"39,744",3 out of 5,2008-03-18,Evidence at transcript level
Q6DHV5,C2D2B_HUMAN,Protein CC2D2B,322,"37,073",2 out of 5,2006-06-27,Evidence at transcript level
B1AJZ1,CA196_HUMAN,Putative uncharacterized protein C1orf196,125,"14,253",1 out of 5,2008-07-01,Uncertain
H3BTG2,CA234_HUMAN,Uncharacterized protein C1orf234,121,"14,053",2 out of 5,2013-09-18,Evidence at transcript level
P55286,CADH8_HUMAN,Cadherin-8,799,"88,253",5 out of 5,1996-10-01,Evidence at transcript level
Q96PG8,BBC3B_HUMAN,Bcl-2-binding component 3 (JFY-1) (p53 up-regulated modulator of apoptosis),261,"26,498",5 out of 5,2012-06-13,Evidence at transcript level
Q6ZW61,BBS12_HUMAN,Bardet-Biedl syndrome 12 protein,710,"79,085",5 out of 5,2007-09-11,Evidence at protein level
Q96RK4,BBS4_HUMAN,Bardet-Biedl syndrome 4 protein,519,"58,282",5 out of 5,2002-05-02,Evidence at protein level
Q9HAY6,BCDO1_HUMAN,"Beta,beta-carotene 15,15'-dioxygenase (EC 1.13.11.63) (Beta-carotene dioxygenase 1) (Beta-carotene oxygenase 1)",547,"62,637",5 out of 5,2003-10-10,Evidence at protein level
Q8WUZ0,BCL7C_HUMAN,B-cell CLL/lymphoma 7 protein family member C,217,"23,468",2 out of 5,2006-06-13,Evidence at protein level
Q9BUH8,BEGIN_HUMAN,Brain-enriched guanylate kinase-associated protein,593,"64,803",3 out of 5,2005-02-01,Evidence at protein level
O15155,BET1_HUMAN,BET1 homolog (hBET1) (Golgi vesicular membrane-trafficking protein p18),118,"13,289",5 out of 5,2003-01-17,Evidence at protein level
Q93088,BHMT1_HUMAN,Betaine--homocysteine S-methyltransferase 1 (EC 2.1.1.5),406,"44,998",5 out of 5,1997-11-01,Evidence at protein level
A1A5D9,BICL2_HUMAN,BICD family-like cargo adapter 2 (Bicaudal D-related protein 2) (BICD-related protein 2) (BICDR-2) (Coiled-coil domain-containing protein 64B),508,"56,834",3 out of 5,2007-09-11,Evidence at protein level
P53004,BIEA_HUMAN,Biliverdin reductase A (BVR A) (EC 1.3.1.24) (Biliverdin-IX alpha-reductase),296,"33,428",5 out of 5,1996-10-01,Evidence at protein level
Q9Y6D6,BIG1_HUMAN,Brefeldin A-inhibited guanine nucleotide-exchange protein 1 (Brefeldin A-inhibited GEP 1) (ADP-ribosylation factor guanine nucleotide-exchange factor 1) (p200 ARF guanine nucleotide exchange factor) (p200 ARF-GEP1),1849,"208,767",5 out of 5,2001-02-21,Evidence at protein level
O15392,BIRC5_HUMAN,Baculoviral IAP repeat-containing protein 5 (Apoptosis inhibitor 4) (Apoptosis inhibitor survivin),142,"16,389",5 out of 5,2000-05-30,Evidence at protein level
P51587,BRCA2_HUMAN,Breast cancer type 2 susceptibility protein (Fanconi anemia group D1 protein),3418,"384,202",5 out of 5,1996-10-01,Evidence at protein level
Q58F21,BRDT_HUMAN,Bromodomain testis-specific protein (Cancer/testis antigen 9) (CT9) (RING3-like protein),947,"107,954",5 out of 5,2006-05-30,Evidence at protein level
P55201,BRPF1_HUMAN,Peregrin (Bromodomain and PHD finger-containing protein 1) (Protein Br140),1214,"137,499",5 out of 5,1996-10-01,Evidence at protein level
Q10588,BST1_HUMAN,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2 (EC 3.2.2.6) (ADP-ribosyl cyclase 2) (Bone marrow stromal antigen 1) (BST-1) (Cyclic ADP-ribose hydrolase 2) (cADPr hydrolase 2) (CD antigen CD157),318,"35,724",5 out of 5,1996-10-01,Evidence at protein level
Q10589,BST2_HUMAN,Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317),180,"19,769",5 out of 5,1996-10-01,Evidence at protein level
Q8WVV5,BT2A2_HUMAN,Butyrophilin subfamily 2 member A2,523,"59,070",5 out of 5,2005-02-01,Evidence at protein level
P78410,BT3A2_HUMAN,Butyrophilin subfamily 3 member A2,334,"36,428",5 out of 5,2005-02-01,Evidence at protein level
O60566,BUB1B_HUMAN,Mitotic checkpoint serine/threonine-protein kinase BUB1 beta (EC 2.7.11.1) (MAD3/BUB1-related protein kinase) (hBUBR1) (Mitotic checkpoint kinase MAD3L) (Protein SSK1),1050,"119,545",5 out of 5,2000-05-30,Evidence at protein level
P51813,BMX_HUMAN,Cytoplasmic tyrosine-protein kinase BMX (EC 2.7.10.2) (Bone marrow tyrosine kinase gene in chromosome X protein) (Epithelial and endothelial tyrosine kinase) (ETK) (NTK38),675,"78,011",5 out of 5,1996-10-01,Evidence at protein level
Q76B58,BRNP3_HUMAN,BMP/retinoic acid-inducible neural-specific protein 3 (DBCCR1-like protein 1),766,"88,445",4 out of 5,2006-01-24,Evidence at protein level
Q96NH3,BROMI_HUMAN,Protein broad-minded (TBC1 domain family member 32),1257,"144,756",4 out of 5,2005-07-19,Evidence at transcript level
Q8TDN6,BRX1_HUMAN,Ribosome biogenesis protein BRX1 homolog (Brix domain-containing protein 2),353,"41,401",4 out of 5,2003-05-09,Evidence at protein level
Q9BX70,BTBD2_HUMAN,BTB/POZ domain-containing protein 2,525,"55,931",4 out of 5,2002-01-23,Evidence at protein level
Q96KE9,BTBD6_HUMAN,BTB/POZ domain-containing protein 6 (Lens BTB domain protein),485,"53,411",3 out of 5,2003-11-28,Evidence at protein level
A6QL63,BTBDB_HUMAN,Ankyrin repeat and BTB/POZ domain-containing protein BTBD11 (BTB/POZ domain-containing protein 11),1104,"120,884",4 out of 5,2008-04-08,Evidence at transcript level
C9JJ37,BTBDJ_HUMAN,BTB/POZ domain-containing protein 19,291,"32,365",2 out of 5,2010-05-18,Evidence at transcript level
Q6UX41,BTNL8_HUMAN,Butyrophilin-like protein 8,500,"56,748",5 out of 5,2005-02-01,Evidence at protein level
O43683,BUB1_HUMAN,Mitotic checkpoint serine/threonine-protein kinase BUB1 (hBUB1) (EC 2.7.11.1) (BUB1A),1085,"122,375",5 out of 5,2000-05-30,Evidence at protein level
Q8IYA2,C144C_HUMAN,Putative coiled-coil domain-containing protein 144C (Coiled-coil domain-containing protein 144C pseudogene),1237,"143,112",2 out of 5,2007-12-04,Uncertain
Q8N1F1,C1AS1_HUMAN,"Putative uncharacterized protein LRRC75A-AS1, mitochondrial (FAM211A antisense RNA 1) (LRRC75A antisense RNA 1) (Putative uncharacterized protein FAM211A-AS1, mitochondrial)",130,"13,824",2 out of 5,2007-05-15,Uncertain
Q13901,C1D_HUMAN,Nuclear nucleic acid-binding protein C1D (hC1D),141,"16,019",5 out of 5,2008-02-05,Evidence at protein level
B7Z1M9,C2D4D_HUMAN,C2 calcium-dependent domain-containing protein 4D,353,"37,583",2 out of 5,2010-06-15,Evidence at transcript level
Q99643,C560_HUMAN,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (Integral membrane protein CII-3) (QPs-1) (QPs1) (Succinate dehydrogenase complex subunit C) (Succinate-ubiquinone oxidoreductase cytochrome B large subunit) (CYBL)",169,"18,610",5 out of 5,1999-07-15,Evidence at protein level
Q9UKL3,C8AP2_HUMAN,CASP8-associated protein 2 (FLICE-associated huge protein),1982,"222,658",5 out of 5,2005-12-20,Evidence at protein level
Q8N6N3,CA052_HUMAN,UPF0690 protein C1orf52 (BCL10-associated gene protein),182,"20,599",3 out of 5,2006-10-31,Evidence at protein level
Q5SVJ3,CA100_HUMAN,Uncharacterized protein C1orf100,147,"17,617",1 out of 5,2007-02-06,Evidence at transcript level
Q3SY05,CA157_HUMAN,Putative uncharacterized protein encoded by LINC00303,128,"14,562",2 out of 5,2006-07-25,Uncertain
Q6ZWK4,CA186_HUMAN,Uncharacterized protein C1orf186,172,"19,405",2 out of 5,2007-01-09,Evidence at transcript level
Q6PIY5,CA228_HUMAN,Uncharacterized protein C1orf228 (p40),440,"48,855",2 out of 5,2008-02-26,Evidence at transcript level
Q9Y376,CAB39_HUMAN,Calcium-binding protein 39 (MO25alpha) (Protein Mo25),341,"39,869",5 out of 5,2001-08-14,Evidence at protein level
Q8TDN4,CABL1_HUMAN,CDK5 and ABL1 enzyme substrate 1 (Interactor with CDK3 1) (Ik3-1),633,"67,599",4 out of 5,2005-02-01,Evidence at protein level
P57796,CABP4_HUMAN,Calcium-binding protein 4 (CaBP4),275,"30,433",5 out of 5,2001-04-27,Evidence at protein level
Q96KC9,CABS1_HUMAN,Calcium-binding and spermatid-specific protein 1 (Testis development protein NYD-SP26),395,"43,003",2 out of 5,2008-06-10,Evidence at transcript level
O75952,CABYR_HUMAN,Calcium-binding tyrosine phosphorylation-regulated protein (Calcium-binding protein 86) (Cancer/testis antigen 88) (CT88) (Fibrousheathin II) (Fibrousheathin-2) (FSP-2) (Testis-specific calcium-binding protein CBP86),493,"52,774",5 out of 5,2005-11-22,Evidence at protein level
Q00975,CAC1B_HUMAN,"Voltage-dependent N-type calcium channel subunit alpha-1B (Brain calcium channel III) (BIII) (Calcium channel, L type, alpha-1 polypeptide isoform 5) (Voltage-gated calcium channel subunit alpha Cav2.2)",2339,"262,496",5 out of 5,1996-10-01,Evidence at protein level
Q15878,CAC1E_HUMAN,"Voltage-dependent R-type calcium channel subunit alpha-1E (Brain calcium channel II) (BII) (Calcium channel, L type, alpha-1 polypeptide, isoform 6) (Voltage-gated calcium channel subunit alpha Cav2.3)",2313,"261,731",5 out of 5,1999-07-15,Evidence at protein level
P54284,CACB3_HUMAN,Voltage-dependent L-type calcium channel subunit beta-3 (CAB3) (Calcium channel voltage-dependent subunit beta 3),484,"54,532",5 out of 5,1996-10-01,Evidence at protein level
Q9P1Z2,CACO1_HUMAN,Calcium-binding and coiled-coil domain-containing protein 1 (Calphoglin) (Coiled-coil coactivator protein) (Sarcoma antigen NY-SAR-3),691,"77,336",5 out of 5,2007-10-23,Evidence at protein level
Q13137,CACO2_HUMAN,Calcium-binding and coiled-coil domain-containing protein 2 (Antigen nuclear dot 52 kDa protein) (Nuclear domain 10 protein NDP52) (Nuclear domain 10 protein 52) (Nuclear dot protein 52),446,"52,254",5 out of 5,2007-12-04,Evidence at protein level
P55289,CAD12_HUMAN,Cadherin-12 (Brain cadherin) (BR-cadherin) (Neural type cadherin 2) (N-cadherin 2),794,"88,332",5 out of 5,1996-10-01,Evidence at transcript level
P55290,CAD13_HUMAN,Cadherin-13 (Heart cadherin) (H-cadherin) (P105) (Truncated cadherin) (T-cad) (T-cadherin),713,"78,287",5 out of 5,1996-10-01,Evidence at protein level
Q13634,CAD18_HUMAN,Cadherin-18 (Cadherin-14),790,"88,073",4 out of 5,1998-07-15,Evidence at transcript level
Q9HBT6,CAD20_HUMAN,Cadherin-20,801,"88,993",4 out of 5,2001-10-24,Evidence at transcript level
P22748,CAH4_HUMAN,Carbonic anhydrase 4 (EC 4.2.1.1) (Carbonate dehydratase IV) (Carbonic anhydrase IV) (CA-IV),312,"35,032",5 out of 5,1991-08-01,Evidence at protein level
P43166,CAH7_HUMAN,Carbonic anhydrase 7 (EC 4.2.1.1) (Carbonate dehydratase VII) (Carbonic anhydrase VII) (CA-VII),264,"29,658",5 out of 5,1995-11-01,Evidence at protein level
P10092,CALCB_HUMAN,Calcitonin gene-related peptide 2 (Beta-type CGRP) (Beta-CGRP) (Calcitonin gene-related peptide II) (CGRP-II),127,"13,706",4 out of 5,1989-07-01,Evidence at protein level
P30988,CALCR_HUMAN,Calcitonin receptor (CT-R),508,"59,352",5 out of 5,1993-07-01,Evidence at protein level
Q05682,CALD1_HUMAN,Caldesmon (CDM),793,"93,231",5 out of 5,1997-11-01,Evidence at protein level
Q96GE6,CALL4_HUMAN,Calmodulin-like protein 4 (Serologically defined breast cancer antigen NY-BR-20),196,"21,883",3 out of 5,2008-01-15,Evidence at transcript level
P27824,CALX_HUMAN,Calnexin (IP90) (Major histocompatibility complex class I antigen-binding protein p88) (p90),592,"67,568",5 out of 5,1992-08-01,Evidence at protein level
Q9NYX4,CALY_HUMAN,Neuron-specific vesicular protein calcyon,217,"23,434",5 out of 5,2001-09-26,Evidence at protein level
Q6MZZ7,CAN13_HUMAN,Calpain-13 (EC 3.4.22.-) (Calcium-activated neutral proteinase 13) (CANP 13),669,"76,696",3 out of 5,2006-10-31,Evidence at protein level
Q9Y6W3,CAN7_HUMAN,Calpain-7 (EC 3.4.22.-) (PalB homolog) (PalBH),813,"92,652",5 out of 5,2003-07-19,Evidence at protein level
Q96IK1,BOD1_HUMAN,Biorientation of chromosomes in cell division protein 1 (Biorientation defective protein 1) (Protein FAM44B),185,"19,196",3 out of 5,2005-11-22,Evidence at protein level
Q9Y3E2,BOLA1_HUMAN,BolA-like protein 1 (hBolA),137,"14,289",4 out of 5,2000-05-30,Evidence at protein level
Q7L3V2,BOP_HUMAN,Protein Bop (BH3-only protein),364,"39,299",5 out of 5,2007-07-24,Evidence at protein level
Q96GS4,BORC6_HUMAN,BLOC-1-related complex subunit 6 (Lysosome-dispersing protein) (Lyspersin),357,"37,226",5 out of 5,2007-05-15,Evidence at protein level
O14613,BORG1_HUMAN,Cdc42 effector protein 2 (Binder of Rho GTPases 1),210,"22,484",5 out of 5,2005-07-19,Evidence at protein level
Q00587,BORG5_HUMAN,Cdc42 effector protein 1 (Binder of Rho GTPases 5) (Serum protein MSE55),391,"40,295",5 out of 5,1994-02-01,Evidence at protein level
Q7Z569,BRAP_HUMAN,BRCA1-associated protein (EC 2.3.2.27) (BRAP2) (Impedes mitogenic signal propagation) (IMP) (RING finger protein 52) (RING-type E3 ubiquitin transferase BRAP2) (Renal carcinoma antigen NY-REN-63),592,"67,305",5 out of 5,2004-07-19,Evidence at protein level
Q8IWQ3,BRSK2_HUMAN,Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A),736,"81,633",5 out of 5,2003-08-29,Evidence at protein level
Q8WZ55,BSND_HUMAN,Barttin,320,"35,197",5 out of 5,2004-10-11,Evidence at protein level
Q9Y2F9,BTBD3_HUMAN,BTB/POZ domain-containing protein 3,522,"58,420",3 out of 5,2002-01-23,Evidence at transcript level
Q5VWW1,C1QL3_HUMAN,Complement C1q-like protein 3 (C1q and tumor necrosis factor-related protein 13) (C1q/TNF-related protein 13),255,"26,719",3 out of 5,2007-02-06,Evidence at transcript level
Q6ZSU1,C2G1P_HUMAN,Putative inactive cytochrome P450 2G1 (Cytochrome P450 2G1 pseudogene),146,"16,683",2 out of 5,2008-06-10,Uncertain
Q8TCZ2,C99L2_HUMAN,CD99 antigen-like protein 2 (MIC2-like protein 1) (CD antigen CD99),262,"27,986",5 out of 5,2008-06-10,Evidence at protein level
Q9NX04,CA109_HUMAN,Uncharacterized protein C1orf109,203,"23,373",5 out of 5,2007-02-06,Evidence at protein level
Q8NC38,CA213_HUMAN,Putative uncharacterized protein ZNF436-AS1 (ZNF436 antisense RNA 1) (ZNF436 antisense gene protein 1),126,"14,381",1 out of 5,2007-10-02,Evidence at transcript level
Q7Z3S7,CA2D4_HUMAN,Voltage-dependent calcium channel subunit alpha-2/delta-4 (Voltage-gated calcium channel subunit alpha-2/delta-4) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-4; Voltage-dependent calcium channel subunit delta-4],1137,"127,938",5 out of 5,2007-09-11,Evidence at protein level
Q9NP86,CABP5_HUMAN,Calcium-binding protein 5 (CaBP5),173,"19,826",4 out of 5,2001-04-27,Evidence at protein level
O95180,CAC1H_HUMAN,Voltage-dependent T-type calcium channel subunit alpha-1H (Low-voltage-activated calcium channel alpha1 3.2 subunit) (Voltage-gated calcium channel subunit alpha Cav3.2),2353,"259,163",5 out of 5,1999-07-15,Evidence at protein level
P55287,CAD11_HUMAN,Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin),796,"87,965",5 out of 5,1996-10-01,Evidence at transcript level
O75309,CAD16_HUMAN,Cadherin-16 (Kidney-specific cadherin) (Ksp-cadherin),829,"89,923",5 out of 5,2001-04-27,Evidence at transcript level
Q8IXH8,CAD26_HUMAN,Cadherin-like protein 26 (Cadherin-like protein VR20),852,"95,278",4 out of 5,2003-09-26,Evidence at transcript level
P12830,CADH1_HUMAN,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3],882,"97,456",5 out of 5,1989-10-01,Evidence at protein level
P22223,CADH3_HUMAN,Cadherin-3 (Placental cadherin) (P-cadherin),829,"91,418",5 out of 5,1991-08-01,Evidence at protein level
P55285,CADH6_HUMAN,Cadherin-6 (Kidney cadherin) (K-cadherin),790,"88,309",5 out of 5,1996-10-01,Evidence at protein level
Q8N3J6,CADM2_HUMAN,Cell adhesion molecule 2 (Immunoglobulin superfamily member 4D) (IgSF4D) (Nectin-like protein 3) (NECL-3) (Synaptic cell adhesion molecule 2) (SynCAM 2),435,"47,554",5 out of 5,2007-06-26,Evidence at transcript level
Q13112,CAF1B_HUMAN,Chromatin assembly factor 1 subunit B (CAF-1 subunit B) (Chromatin assembly factor I p60 subunit) (CAF-I 60 kDa subunit) (CAF-I p60) (M-phase phosphoprotein 7),559,"61,493",5 out of 5,1998-07-15,Evidence at protein level
O75493,CAH11_HUMAN,Carbonic anhydrase-related protein 11 (CA-RP XI) (CA-XI) (CARP XI) (Carbonic anhydrase-related protein 2) (CA-RP II) (CARP-2),328,"36,238",3 out of 5,2000-05-30,Evidence at protein level
O43570,CAH12_HUMAN,Carbonic anhydrase 12 (EC 4.2.1.1) (Carbonate dehydratase XII) (Carbonic anhydrase XII) (CA-XII) (Tumor antigen HOM-RCC-3.1.3),354,"39,451",5 out of 5,1999-07-15,Evidence at protein level
Q9ULX7,CAH14_HUMAN,Carbonic anhydrase 14 (EC 4.2.1.1) (Carbonate dehydratase XIV) (Carbonic anhydrase XIV) (CA-XIV),337,"37,668",5 out of 5,2000-12-01,Evidence at protein level
P00915,CAH1_HUMAN,Carbonic anhydrase 1 (EC 4.2.1.1) (Carbonate dehydratase I) (Carbonic anhydrase B) (CAB) (Carbonic anhydrase I) (CA-I),261,"28,870",5 out of 5,1986-07-21,Evidence at protein level
P35218,CAH5A_HUMAN,"Carbonic anhydrase 5A, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VA) (Carbonic anhydrase VA) (CA-VA)",305,"34,750",5 out of 5,1994-02-01,Evidence at protein level
P49069,CAMLG_HUMAN,Calcium signal-modulating cyclophilin ligand (CAML),296,"32,953",5 out of 5,1996-02-01,Evidence at protein level
O15484,CAN5_HUMAN,Calpain-5 (EC 3.4.22.-) (Calpain htra-3) (New calpain 3) (nCL-3),640,"73,169",5 out of 5,2003-02-12,Evidence at protein level
P20160,CAP7_HUMAN,Azurocidin (Cationic antimicrobial protein CAP37) (Heparin-binding protein) (HBP) (hHBP),251,"26,886",5 out of 5,1991-02-01,Evidence at protein level
O75052,CAPON_HUMAN,Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein (C-terminal PDZ ligand of neuronal nitric oxide synthase protein) (Nitric oxide synthase 1 adaptor protein),506,"56,150",5 out of 5,2005-01-04,Evidence at protein level
Q6IMN6,CAPR2_HUMAN,Caprin-2 (C1q domain-containing protein 1) (Cytoplasmic activation/proliferation-associated protein 2) (Gastric cancer multidrug resistance-associated protein) (Protein EEG-1) (RNA granule protein 140),1127,"125,925",5 out of 5,2007-09-11,Evidence at protein level
Q96LW7,CAR19_HUMAN,Caspase recruitment domain-containing protein 19 (Bcl10-interacting CARD protein) (BinCARD),228,"25,589",5 out of 5,2005-08-02,Evidence at protein level
Q13825,AUHM_HUMAN,"Methylglutaconyl-CoA hydratase, mitochondrial (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase)",339,"35,609",5 out of 5,2003-09-26,Evidence at protein level
Q9H6S1,AZI2_HUMAN,5-azacytidine-induced protein 2 (NF-kappa-B-activating kinase-associated protein 1) (Nak-associated protein 1) (TILP),392,"44,935",5 out of 5,2007-03-20,Evidence at protein level
Q8TBE0,BAHD1_HUMAN,Bromo adjacent homology domain-containing 1 protein (BAH domain-containing protein 1),780,"84,652",5 out of 5,2007-05-29,Evidence at protein level
Q9UIF9,BAZ2A_HUMAN,Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3),1905,"211,198",5 out of 5,2002-08-30,Evidence at protein level
Q9H165,BC11A_HUMAN,B-cell lymphoma/leukemia 11A (BCL-11A) (B-cell CLL/lymphoma 11A) (COUP-TF-interacting protein 1) (Ecotropic viral integration site 9 protein homolog) (EVI-9) (Zinc finger protein 856),835,"91,197",5 out of 5,2004-03-01,Evidence at protein level
Q9BQE9,BCL7B_HUMAN,B-cell CLL/lymphoma 7 protein family member B (allergen Hom s 3),202,"22,195",4 out of 5,2006-06-13,Evidence at protein level
P11274,BCR_HUMAN,Breakpoint cluster region protein (EC 2.7.11.1) (Renal carcinoma antigen NY-REN-26),1271,"142,819",5 out of 5,1989-07-01,Evidence at protein level
Q02338,BDH_HUMAN,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial (EC 1.1.1.30) (3-hydroxybutyrate dehydrogenase) (BDH) (Short chain dehydrogenase/reductase family 9C member 1)",343,"38,157",5 out of 5,1993-07-01,Evidence at protein level
A6H8Y1,BDP1_HUMAN,Transcription factor TFIIIB component B'' homolog (Transcription factor IIIB 150) (TFIIIB150) (Transcription factor-like nuclear regulator),2624,"293,885",5 out of 5,2008-05-20,Evidence at protein level
Q3B7T3,BEAN1_HUMAN,Protein BEAN1 (Brain-expressed protein associating with Nedd4 homolog) (BEAN),259,"28,626",3 out of 5,2008-02-26,Evidence at transcript level
Q14457,BECN1_HUMAN,Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa],450,"51,896",5 out of 5,1998-07-15,Evidence at protein level
Q5H9J7,BEX5_HUMAN,Protein BEX5 (Brain-expressed X-linked protein 5) (NGFRAP1-like protein 1) (Nerve growth factor receptor-associated protein 2),111,"12,602",3 out of 5,2006-04-04,Evidence at protein level
Q9C0J9,BHE41_HUMAN,Class E basic helix-loop-helix protein 41 (bHLHe41) (Class B basic helix-loop-helix protein 3) (bHLHb3) (Differentially expressed in chondrocytes protein 2) (hDEC2) (Enhancer-of-split and hairy-related protein 1) (SHARP-1),482,"50,498",5 out of 5,2002-03-05,Evidence at protein level
Q9NQY0,BIN3_HUMAN,Bridging integrator 3,253,"29,665",4 out of 5,2003-05-16,Evidence at protein level
Q9NR09,BIRC6_HUMAN,Baculoviral IAP repeat-containing protein 6 (EC 2.3.2.27) (BIR repeat-containing ubiquitin-conjugating enzyme) (BRUCE) (RING-type E3 ubiquitin transferase BIRC6) (Ubiquitin-conjugating BIR domain enzyme apollon) (APOLLON),4857,"530,255",5 out of 5,2001-01-24,Evidence at protein level
A4D250,BLACE_HUMAN,B-cell acute lymphoblastic leukemia-expressed protein,179,"19,503",1 out of 5,2011-07-27,Evidence at transcript level
Q7Z5W3,BN3D2_HUMAN,Pre-miRNA 5'-monophosphate methyltransferase (EC 2.1.1.-) (BCDIN3 domain-containing protein),292,"33,200",5 out of 5,2007-05-29,Evidence at protein level
Q9BWV1,BOC_HUMAN,Brother of CDO (Protein BOC),1114,"121,059",5 out of 5,2006-05-02,Evidence at protein level
P50747,BPL1_HUMAN,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],726,"80,760",5 out of 5,1996-10-01,Evidence at protein level
Q9H0C5,BTBD1_HUMAN,BTB/POZ domain-containing protein 1 (Hepatitis C virus NS5A-transactivated protein 8) (HCV NS5A-transactivated protein 8),482,"52,771",5 out of 5,2002-01-23,Evidence at protein level
Q96Q07,BTBD9_HUMAN,BTB/POZ domain-containing protein 9,612,"69,188",4 out of 5,2003-08-29,Evidence at protein level
Q9NY30,BTG4_HUMAN,Protein BTG4 (BTG family member 4) (Protein PC3b),223,"25,970",3 out of 5,2001-04-27,Evidence at transcript level
Q68D86,C102B_HUMAN,Coiled-coil domain-containing protein 102B,513,"60,448",3 out of 5,2005-07-19,Evidence at protein level
A2RUR9,C144A_HUMAN,Coiled-coil domain-containing protein 144A,1427,"165,125",2 out of 5,2007-12-04,Evidence at transcript level
Q9NS00,C1GLT_HUMAN,"Glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1 (EC 2.4.1.122) (B3Gal-T8) (Core 1 O-glycan T-synthase) (Core 1 UDP-galactose:N-acetylgalactosamine-alpha-R beta 1,3-galactosyltransferase 1) (Beta-1,3-galactosyltransferase) (Core 1 beta1,3-galactosyltransferase 1) (C1GalT1) (Core 1 beta3-Gal-T1)",363,"42,203",5 out of 5,2007-05-15,Evidence at protein level
Q7Z5L3,C1QL2_HUMAN,Complement C1q-like protein 2 (C1q and tumor necrosis factor-related protein 10) (C1q/TNF-related protein 10),287,"29,468",2 out of 5,2007-02-06,Evidence at transcript level
Q86Z23,C1QL4_HUMAN,Complement C1q-like protein 4 (C1q and tumor necrosis factor-related protein 11) (C1q/TNF-related protein 11),238,"24,909",3 out of 5,2007-02-06,Evidence at transcript level
O75973,C1QRF_HUMAN,C1q-related factor (C1q and tumor necrosis factor-related protein 14) (C1q/TNF-related protein 14) (Complement component 1 Q subcomponent-like 1),258,"26,453",4 out of 5,2001-04-27,Evidence at protein level
Q9BXJ1,C1QT1_HUMAN,Complement C1q tumor necrosis factor-related protein 1 (G protein-coupled receptor-interacting protein) (GIP),281,"31,743",5 out of 5,2002-04-16,Evidence at protein level
Q9UHQ4,BAP29_HUMAN,B-cell receptor-associated protein 29 (BCR-associated protein 29) (Bap29),241,"28,320",4 out of 5,2002-11-08,Evidence at protein level
A8MTZ0,BBIP1_HUMAN,BBSome-interacting protein 1 (BBSome-interacting protein of 10 kDa),92,"10,506",5 out of 5,2008-07-01,Evidence at protein level
Q8WY36,BBX_HUMAN,HMG box transcription factor BBX (Bobby sox homolog) (HMG box-containing protein 2),941,"105,130",4 out of 5,2006-04-18,Evidence at protein level
Q5H9F3,BCORL_HUMAN,BCL-6 corepressor-like protein 1 (BCoR-L1) (BCoR-like protein 1),1711,"182,526",5 out of 5,2007-12-04,Evidence at protein level
Q8N8U9,BMPER_HUMAN,BMP-binding endothelial regulator protein (Bone morphogenetic protein-binding endothelial cell precursor-derived regulator) (Protein crossveinless-2) (hCV2),685,"75,997",5 out of 5,2004-07-05,Evidence at protein level
P36894,BMR1A_HUMAN,Bone morphogenetic protein receptor type-1A (BMP type-1A receptor) (BMPR-1A) (EC 2.7.11.30) (Activin receptor-like kinase 3) (ALK-3) (Serine/threonine-protein kinase receptor R5) (SKR5) (CD antigen CD292),532,"60,198",5 out of 5,1994-06-01,Evidence at protein level
Q12982,BNIP2_HUMAN,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,314,"36,018",5 out of 5,1999-07-15,Evidence at protein level
Q96B45,BORC7_HUMAN,BLOC-1-related complex subunit 7 (Diaskedin),105,"11,564",3 out of 5,2005-07-05,Inferred from homology
Q8TDL5,BPIB1_HUMAN,"BPI fold-containing family B member 1 (Long palate, lung and nasal epithelium carcinoma-associated protein 1) (Von Ebner minor salivary gland protein) (VEMSGP)",484,"52,442",5 out of 5,2003-08-29,Evidence at protein level
O95861,BPNT1_HUMAN,"3'(2'),5'-bisphosphate nucleotidase 1 (EC 3.1.3.7) (Bisphosphate 3'-nucleotidase 1) (PAP-inositol 1,4-phosphatase) (PIP)",308,"33,392",5 out of 5,2004-04-13,Evidence at protein level
O43684,BUB3_HUMAN,Mitotic checkpoint protein BUB3,328,"37,155",5 out of 5,2000-05-30,Evidence at protein level
Q9UBR1,BUP1_HUMAN,Beta-ureidopropionase (EC 3.5.1.6) (BUP-1) (Beta-alanine synthase) (N-carbamoyl-beta-alanine amidohydrolase),384,"43,166",5 out of 5,2001-09-26,Evidence at protein level
Q96A19,C102A_HUMAN,Coiled-coil domain-containing protein 102A,550,"62,596",2 out of 5,2007-02-06,Evidence at protein level
Q6NUI1,C144L_HUMAN,Putative coiled-coil domain-containing protein 144 N-terminal-like,221,"23,810",1 out of 5,2008-09-02,Uncertain
Q9H246,CA021_HUMAN,Uncharacterized protein C1orf21 (Cell proliferation-inducing gene 13 protein),121,"13,865",2 out of 5,2005-07-19,Evidence at protein level
Q8WWF1,CA054_HUMAN,Uncharacterized protein C1orf54,131,"14,923",1 out of 5,2006-10-03,Evidence at transcript level
Q5SY80,CA101_HUMAN,Uncharacterized protein C1orf101,951,"109,662",3 out of 5,2006-10-03,Evidence at transcript level
Q6ZSJ8,CA122_HUMAN,Uncharacterized protein C1orf122 (Protein ALAESM),110,"11,471",2 out of 5,2006-10-31,Predicted
Q8IYL3,CA174_HUMAN,UPF0688 protein C1orf174,243,"25,977",3 out of 5,2007-07-10,Evidence at protein level
Q9H8G2,CAAP1_HUMAN,Caspase activity and apoptosis inhibitor 1 (Conserved anti-apoptotic protein) (CAAP),361,"38,368",3 out of 5,2005-07-05,Evidence at protein level
Q9BRK5,CAB45_HUMAN,45 kDa calcium-binding protein (Cab45) (Stromal cell-derived factor 4) (SDF-4),362,"41,807",5 out of 5,2002-05-27,Evidence at protein level
Q9BTV7,CABL2_HUMAN,CDK5 and ABL1 enzyme substrate 2 (Interactor with CDK3 2) (Ik3-2),478,"52,235",3 out of 5,2003-02-12,Evidence at protein level
Q9NZU7,CABP1_HUMAN,Calcium-binding protein 1 (CaBP1) (Calbrain) (Caldendrin),370,"39,838",5 out of 5,2001-04-27,Evidence at protein level
O00555,CAC1A_HUMAN,"Voltage-dependent P/Q-type calcium channel subunit alpha-1A (Brain calcium channel I) (BI) (Calcium channel, L type, alpha-1 polypeptide isoform 4) (Voltage-gated calcium channel subunit alpha Cav2.1)",2505,"282,365",5 out of 5,1999-07-15,Evidence at protein level
Q01668,CAC1D_HUMAN,"Voltage-dependent L-type calcium channel subunit alpha-1D (Calcium channel, L type, alpha-1 polypeptide, isoform 2) (Voltage-gated calcium channel subunit alpha Cav1.3)",2161,"245,141",5 out of 5,1999-07-15,Evidence at protein level
O60840,CAC1F_HUMAN,Voltage-dependent L-type calcium channel subunit alpha-1F (Voltage-gated calcium channel subunit alpha Cav1.4),1977,"220,678",5 out of 5,1999-07-15,Evidence at protein level
O43497,CAC1G_HUMAN,Voltage-dependent T-type calcium channel subunit alpha-1G (Cav3.1c) (NBR13) (Voltage-gated calcium channel subunit alpha Cav3.1),2377,"262,472",5 out of 5,1999-07-15,Evidence at protein level
Q12864,CAD17_HUMAN,Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin),832,"92,219",5 out of 5,2001-04-27,Evidence at transcript level
P27037,AVR2A_HUMAN,Activin receptor type-2A (EC 2.7.11.30) (Activin receptor type IIA) (ACTR-IIA) (ACTRIIA),513,"57,848",5 out of 5,1992-08-01,Evidence at protein level
A6NMY6,AXA2L_HUMAN,Putative annexin A2-like protein (Annexin A2 pseudogene 2) (Lipocortin II pseudogene),339,"38,659",4 out of 5,2008-07-22,Uncertain
Q9Y2T1,AXIN2_HUMAN,Axin-2 (Axin-like protein) (Axil) (Axis inhibition protein 2) (Conductin),843,"93,558",5 out of 5,2000-12-01,Evidence at protein level
Q9BZR8,B2L14_HUMAN,Apoptosis facilitator Bcl-2-like protein 14 (Bcl2-L-14) (Apoptosis regulator Bcl-G),327,"36,598",5 out of 5,2004-12-21,Evidence at protein level
Q13145,BAMBI_HUMAN,BMP and activin membrane-bound inhibitor homolog (Non-metastatic gene A protein) (Putative transmembrane protein NMA),260,"29,108",5 out of 5,1997-11-01,Evidence at protein level
Q6UXY1,BI2L2_HUMAN,Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 2 (BAI1-associated protein 2-like protein 2) (Planar intestinal- and kidney-specific BAR domain protein) (Pinkbar),529,"58,987",4 out of 5,2006-10-31,Evidence at protein level
Q8TD16,BICD2_HUMAN,Protein bicaudal D homolog 2 (Bic-D 2),824,"93,533",5 out of 5,2003-08-15,Evidence at protein level
P55957,BID_HUMAN,BH3-interacting domain death agonist (p22 BID) (BID) [Cleaved into: BH3-interacting domain death agonist p15 (p15 BID); BH3-interacting domain death agonist p13 (p13 BID); BH3-interacting domain death agonist p11 (p11 BID)],195,"21,995",5 out of 5,1997-11-01,Evidence at protein level
Q13489,BIRC3_HUMAN,Baculoviral IAP repeat-containing protein 3 (EC 2.3.2.27) (Apoptosis inhibitor 2) (API2) (Cellular inhibitor of apoptosis 2) (C-IAP2) (IAP homolog C) (Inhibitor of apoptosis protein 1) (hIAP-1) (hIAP1) (RING finger protein 49) (RING-type E3 ubiquitin transferase BIRC3) (TNFR2-TRAF-signaling complex protein 1),604,"68,372",5 out of 5,1997-11-01,Evidence at protein level
Q8WV28,BLNK_HUMAN,B-cell linker protein (B-cell adapter containing a SH2 domain protein) (B-cell adapter containing a Src homology 2 domain protein) (Cytoplasmic adapter protein) (Src homology 2 domain-containing leukocyte protein of 65 kDa) (SLP-65),456,"50,466",5 out of 5,2005-11-22,Evidence at protein level
O95972,BMP15_HUMAN,Bone morphogenetic protein 15 (BMP-15) (Growth/differentiation factor 9B) (GDF-9B),392,"45,055",5 out of 5,2000-12-01,Evidence at protein level
Q7Z465,BNIPL_HUMAN,Bcl-2/adenovirus E1B 19 kDa-interacting protein 2-like protein,357,"39,713",5 out of 5,2005-01-04,Evidence at protein level
Q6PGQ7,BORA_HUMAN,Protein aurora borealis (HsBora),559,"61,203",5 out of 5,2007-01-23,Evidence at protein level
Q6NZY7,BORG3_HUMAN,Cdc42 effector protein 5 (Binder of Rho GTPases 3),148,"15,207",5 out of 5,2005-07-19,Evidence at transcript level
Q5VTR2,BRE1A_HUMAN,E3 ubiquitin-protein ligase BRE1A (BRE1-A) (hBRE1) (EC 2.3.2.27) (RING finger protein 20) (RING-type E3 ubiquitin transferase BRE1A),975,"113,662",5 out of 5,2005-12-20,Evidence at protein level
Q13410,BT1A1_HUMAN,Butyrophilin subfamily 1 member A1 (BT),526,"58,960",5 out of 5,1997-11-01,Evidence at protein level
Q96K17,BT3L4_HUMAN,Transcription factor BTF3 homolog 4 (Basic transcription factor 3-like 4),158,"17,271",3 out of 5,2005-10-25,Evidence at protein level
Q9BSF8,BTBDA_HUMAN,BTB/POZ domain-containing protein 10 (Glucose metabolism-related protein 1),475,"53,779",4 out of 5,2006-03-21,Evidence at protein level
A6NE02,BTBDH_HUMAN,BTB/POZ domain-containing protein 17 (Galectin-3-binding protein-like),478,"52,471",2 out of 5,2008-06-10,Inferred from homology
P62324,BTG1_HUMAN,Protein BTG1 (B-cell translocation gene 1 protein),171,"19,209",5 out of 5,2004-07-05,Evidence at protein level
Q9UL45,BL1S6_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 6 (BLOC-1 subunit 6) (Pallid protein homolog) (Pallidin) (Syntaxin 13-interacting protein),172,"19,744",5 out of 5,2004-01-16,Evidence at protein level
P13497,BMP1_HUMAN,Bone morphogenetic protein 1 (BMP-1) (EC 3.4.24.19) (Mammalian tolloid protein) (mTld) (Procollagen C-proteinase) (PCP),986,"111,249",5 out of 5,1990-01-01,Evidence at protein level
P12644,BMP4_HUMAN,Bone morphogenetic protein 4 (BMP-4) (Bone morphogenetic protein 2B) (BMP-2B),408,"46,555",5 out of 5,1989-10-01,Evidence at protein level
P22004,BMP6_HUMAN,Bone morphogenetic protein 6 (BMP-6) (VG-1-related protein) (VG-1-R) (VGR-1),513,"57,226",5 out of 5,1991-08-01,Evidence at protein level
P34820,BMP8B_HUMAN,Bone morphogenetic protein 8B (BMP-8) (BMP-8B) (Osteogenic protein 2) (OP-2),402,"44,768",4 out of 5,1994-02-01,Evidence at transcript level
P59051,BRAS2_HUMAN,Putative uncharacterized protein encoded by BRWD1-AS2 (ATP1A1 antisense RNA 1) (ATP1A1 antisense gene protein 1) (BRWD1 intronic transcript 2),145,"16,132",2 out of 5,2002-10-19,Uncertain
P38398,BRCA1_HUMAN,Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1),1863,"207,721",5 out of 5,1994-10-01,Evidence at protein level
Q9NPI1,BRD7_HUMAN,Bromodomain-containing protein 7 (75 kDa bromodomain protein) (Protein CELTIX-1),651,"74,139",5 out of 5,2006-03-21,Evidence at protein level
O00481,BT3A1_HUMAN,Butyrophilin subfamily 3 member A1 (CD antigen CD277),513,"57,677",5 out of 5,2005-02-01,Evidence at protein level
Q6UXE8,BTNL3_HUMAN,Butyrophilin-like protein 3 (Butyrophilin-like receptor),466,"52,251",3 out of 5,2005-02-01,Evidence at transcript level
A8MVZ5,BTNLA_HUMAN,Butyrophilin-like protein 10,291,"32,612",2 out of 5,2012-05-16,Uncertain
O95971,BY55_HUMAN,CD160 antigen (Natural killer cell receptor BY55) (CD antigen CD160),181,"19,810",5 out of 5,2001-10-18,Evidence at protein level
Q9Y6E2,BZW2_HUMAN,Basic leucine zipper and W2 domain-containing protein 2,419,"48,162",3 out of 5,2006-10-31,Evidence at protein level
P19099,C11B2_HUMAN,"Cytochrome P450 11B2, mitochondrial (Aldosterone synthase) (ALDOS) (EC 1.14.15.4) (EC 1.14.15.5) (Aldosterone-synthesizing enzyme) (CYPXIB2) (Cytochrome P-450Aldo) (Cytochrome P-450C18) (Steroid 18-hydroxylase)",503,"57,560",5 out of 5,1990-11-01,Evidence at protein level
P02746,C1QB_HUMAN,Complement C1q subcomponent subunit B,253,"26,722",5 out of 5,1986-07-21,Evidence at protein level
Q9BXJ4,C1QT3_HUMAN,Complement C1q tumor necrosis factor-related protein 3 (Collagenous repeat-containing sequence 26 kDa protein) (CORS26) (Secretory protein CORS26),246,"26,994",5 out of 5,2002-04-16,Evidence at protein level
P60827,C1QT8_HUMAN,Complement C1q tumor necrosis factor-related protein 8 (C1q/TNF-related protein 8) (CTRP8),252,"27,685",3 out of 5,2004-04-13,Evidence at protein level
Q96HQ2,C2AIL_HUMAN,CDKN2AIP N-terminal-like protein (CDKN2A-interacting protein N-terminal-like protein),116,"13,196",3 out of 5,2008-03-18,Evidence at protein level
Q8TF44,C2C4C_HUMAN,C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C),421,"44,576",3 out of 5,2007-07-10,Evidence at protein level
Q9Y426,C2CD2_HUMAN,C2 domain-containing protein 2,696,"75,533",3 out of 5,2000-05-30,Evidence at protein level
Q6P1N0,C2D1A_HUMAN,Coiled-coil and C2 domain-containing protein 1A (Akt kinase-interacting protein 1) (Five prime repressor element under dual repression-binding protein 1) (FRE under dual repression-binding protein 1) (Freud-1) (Putative NF-kappa-B-activating protein 023N),951,"104,062",5 out of 5,2006-06-13,Evidence at protein level
Q9NRR8,C42S1_HUMAN,CDC42 small effector protein 1 (CDC42-binding protein SCIP1) (Small effector of CDC42 protein 1),79,"8,925",5 out of 5,2008-05-20,Evidence at protein level
Q9H0H9,C4F30_HUMAN,Putative cytochrome P450 family member 4F30,118,"12,413",1 out of 5,2005-08-30,Uncertain
Q9BRT7,CA097_HUMAN,Putative uncharacterized protein encoded by LINC00467,94,"10,958",1 out of 5,2006-10-31,Uncertain
Q5JVX7,CA141_HUMAN,Uncharacterized protein C1orf141,400,"46,135",2 out of 5,2007-07-10,Evidence at transcript level
Q9H425,CA198_HUMAN,Uncharacterized protein C1orf198,327,"36,346",3 out of 5,2007-03-20,Evidence at protein level
Q86Y37,CACL1_HUMAN,CDK2-associated and cullin domain-containing protein 1 (Cdk-associated cullin1),369,"41,064",5 out of 5,2005-06-07,Evidence at protein level
Q86UP0,CAD24_HUMAN,Cadherin-24,819,"87,752",5 out of 5,2003-10-31,Evidence at protein level
Q9ULB5,CADH7_HUMAN,Cadherin-7,785,"87,086",4 out of 5,2001-10-24,Evidence at transcript level
Q9ULB4,CADH9_HUMAN,Cadherin-9,789,"88,689",4 out of 5,2001-04-27,Evidence at transcript level
Q9BY67,CADM1_HUMAN,Cell adhesion molecule 1 (Immunoglobulin superfamily member 4) (IgSF4) (Nectin-like protein 2) (NECL-2) (Spermatogenic immunoglobulin superfamily) (SgIgSF) (Synaptic cell adhesion molecule) (SynCAM) (Tumor suppressor in lung cancer 1) (TSLC-1),442,"48,509",5 out of 5,2007-06-26,Evidence at protein level
A6NHC0,CAN8_HUMAN,Calpain-8 (EC 3.4.22.53) (New calpain 2) (nCL-2) (Stomach-specific M-type calpain),703,"79,144",4 out of 5,2008-09-02,Evidence at transcript level
Q9BXL7,CAR11_HUMAN,Caspase recruitment domain-containing protein 11 (CARD-containing MAGUK protein 1) (Carma 1),1154,"133,284",5 out of 5,2002-01-31,Evidence at protein level
Q16568,CART_HUMAN,Cocaine- and amphetamine-regulated transcript protein [Cleaved into: CART(1-39); CART(42-89)],116,"12,829",5 out of 5,1997-11-01,Evidence at protein level
P55212,CASP6_HUMAN,Caspase-6 (CASP-6) (EC 3.4.22.59) (Apoptotic protease Mch-2) [Cleaved into: Caspase-6 subunit p18; Caspase-6 subunit p11],293,"33,310",5 out of 5,1996-10-01,Evidence at protein level
P55210,CASP7_HUMAN,Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (CMH-1) (ICE-like apoptotic protease 3) (ICE-LAP3) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11],303,"34,277",5 out of 5,1996-10-01,Evidence at protein level
Q14790,CASP8_HUMAN,Caspase-8 (CASP-8) (EC 3.4.22.61) (Apoptotic cysteine protease) (Apoptotic protease Mch-5) (CAP4) (FADD-homologous ICE/ced-3-like protease) (FADD-like ICE) (FLICE) (ICE-like apoptotic protease 5) (MORT1-associated ced-3 homolog) (MACH) [Cleaved into: Caspase-8 subunit p18; Caspase-8 subunit p10],479,"55,391",5 out of 5,1997-11-01,Evidence at protein level
P31944,CASPE_HUMAN,"Caspase-14 (CASP-14) (EC 3.4.22.-) [Cleaved into: Caspase-14 subunit p17, mature form; Caspase-14 subunit p10, mature form; Caspase-14 subunit p20, intermediate form; Caspase-14 subunit p8, intermediate form]",242,"27,680",5 out of 5,1993-07-01,Evidence at protein level
Q9NQ75,CASS4_HUMAN,Cas scaffolding protein family member 4 (HEF-like protein) (HEF1-EFS-p130Cas-like protein) (HEPL),786,"87,144",5 out of 5,2002-10-10,Evidence at protein level
Q3MJ40,C144B_HUMAN,Coiled-coil domain-containing protein 144B,725,"82,951",2 out of 5,2007-12-04,Evidence at transcript level
P02747,C1QC_HUMAN,Complement C1q subcomponent subunit C,245,"25,774",5 out of 5,1986-07-21,Evidence at protein level
P00736,C1R_HUMAN,Complement C1r subcomponent (EC 3.4.21.41) (Complement component 1 subcomponent r) [Cleaved into: Complement C1r subcomponent heavy chain; Complement C1r subcomponent light chain],705,"80,119",5 out of 5,1986-07-21,Evidence at protein level
Q6UB35,C1TM_HUMAN,"Monofunctional C1-tetrahydrofolate synthase, mitochondrial (EC 6.3.4.3) (Formyltetrahydrofolate synthetase)",978,"105,790",5 out of 5,2008-07-01,Evidence at protein level
A6NLJ0,C2C4B_HUMAN,C2 calcium-dependent domain-containing protein 4B (Nuclear-localized factor 2) (Protein FAM148B),364,"38,769",3 out of 5,2008-03-18,Evidence at transcript level
Q16581,C3AR_HUMAN,C3a anaphylatoxin chemotactic receptor (C3AR) (C3a-R),482,"53,864",5 out of 5,1998-07-15,Evidence at protein level
Q6ZMU1,C3P1_HUMAN,Putative protein C3P1,363,"40,197",2 out of 5,2008-07-22,Uncertain
Q9NRR3,C42S2_HUMAN,CDC42 small effector protein 2 (Small effector of CDC42 protein 2),84,"9,223",5 out of 5,2008-05-20,Evidence at protein level
Q9Y5P4,C43BP_HUMAN,Collagen type IV alpha-3-binding protein (Ceramide transfer protein) (hCERT) (Goodpasture antigen-binding protein) (GPBP) (START domain-containing protein 11) (StARD11) (StAR-related lipid transfer protein 11),624,"70,835",5 out of 5,2002-05-15,Evidence at protein level
P20851,C4BPB_HUMAN,C4b-binding protein beta chain,252,"28,357",5 out of 5,1991-02-01,Evidence at protein level
P21730,C5AR1_HUMAN,C5a anaphylatoxin chemotactic receptor 1 (C5a anaphylatoxin chemotactic receptor) (C5a-R) (C5aR) (CD antigen CD88),350,"39,336",5 out of 5,1991-05-01,Evidence at protein level
Q5TEV5,CA134_HUMAN,Putative uncharacterized protein C1orf134,83,"9,093",1 out of 5,2008-07-01,Inferred from homology
Q5VVC0,CA146_HUMAN,Uncharacterized protein C1orf146,180,"20,418",1 out of 5,2007-08-21,Evidence at transcript level
Q5TG92,CA195_HUMAN,Putative uncharacterized protein C1orf195,126,"13,826",1 out of 5,2008-04-08,Evidence at transcript level
Q6ZS94,CA229_HUMAN,Putative uncharacterized protein C1orf229,237,"24,356",1 out of 5,2008-02-26,Evidence at transcript level
Q9Y6N8,CAD10_HUMAN,Cadherin-10 (T2-cadherin),788,"88,451",4 out of 5,2001-04-27,Evidence at protein level
P55291,CAD15_HUMAN,Cadherin-15 (Cadherin-14) (Muscle cadherin) (M-cadherin),814,"88,916",5 out of 5,1996-10-01,Evidence at protein level
Q9UJ99,CAD22_HUMAN,Cadherin-22 (Pituitary and brain cadherin) (PB-cadherin),828,"89,091",3 out of 5,2002-10-19,Evidence at transcript level
P19022,CADH2_HUMAN,Cadherin-2 (CDw325) (Neural cadherin) (N-cadherin) (CD antigen CD325),906,"99,809",5 out of 5,1990-11-01,Evidence at protein level
P55283,CADH4_HUMAN,Cadherin-4 (Retinal cadherin) (R-CAD) (R-cadherin),916,"100,281",5 out of 5,1996-10-01,Evidence at transcript level
Q13111,CAF1A_HUMAN,Chromatin assembly factor 1 subunit A (CAF-1 subunit A) (Chromatin assembly factor I p150 subunit) (CAF-I 150 kDa subunit) (CAF-I p150) (hp150),956,"106,926",5 out of 5,2001-10-18,Evidence at protein level
P06881,CALCA_HUMAN,Calcitonin gene-related peptide 1 (Alpha-type CGRP) (Calcitonin gene-related peptide I) (CGRP-I),128,"13,898",5 out of 5,1988-01-01,Evidence at protein level
P27797,CALR_HUMAN,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60),417,"48,142",5 out of 5,1992-08-01,Evidence at protein level
Q6ZSI9,CAN12_HUMAN,Calpain-12 (EC 3.4.22.-) (Calcium-activated neutral proteinase 12) (CANP 12),719,"81,037",3 out of 5,2004-10-11,Evidence at transcript level
Q9Y6Q1,CAN6_HUMAN,Calpain-6 (Calpain-like protease X-linked) (Calpamodulin) (CalpM),641,"74,576",5 out of 5,2001-05-04,Evidence at protein level
Q9ULU8,CAPS1_HUMAN,Calcium-dependent secretion activator 1 (Calcium-dependent activator protein for secretion 1) (CAPS-1),1353,"152,786",5 out of 5,2006-01-10,Evidence at protein level
Q8WWF8,CAPSL_HUMAN,Calcyphosin-like protein,208,"24,229",2 out of 5,2006-12-12,Evidence at transcript level
Q9BXL6,CAR14_HUMAN,Caspase recruitment domain-containing protein 14 (CARD-containing MAGUK protein 2) (Carma 2),1004,"113,270",5 out of 5,2002-01-31,Evidence at protein level
Q6F5E8,CARL2_HUMAN,"Capping protein, Arp2/3 and myosin-I linker protein 2 (Capping protein regulator and myosin 1 linker 2) (F-actin-uncapping protein RLTPR) (Leucine-rich repeat-containing protein 16C) (RGD, leucine-rich repeat, tropomodulin and proline-rich-containing protein)",1435,"154,689",5 out of 5,2008-03-18,Evidence at protein level
Q14511,CASL_HUMAN,Enhancer of filamentation 1 (hEF1) (CRK-associated substrate-related protein) (CAS-L) (CasL) (Cas scaffolding protein family member 2) (Neural precursor cell expressed developmentally down-regulated protein 9) (NEDD-9) (Renal carcinoma antigen NY-REN-12) (p105) [Cleaved into: Enhancer of filamentation 1 p55],834,"92,861",5 out of 5,2000-05-30,Evidence at protein level
P29466,CASP1_HUMAN,Caspase-1 (CASP-1) (EC 3.4.22.36) (Interleukin-1 beta convertase) (IL-1BC) (Interleukin-1 beta-converting enzyme) (ICE) (IL-1 beta-converting enzyme) (p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10],404,"45,159",5 out of 5,1993-04-01,Evidence at protein level
Q2NKX9,CB068_HUMAN,UPF0561 protein C2orf68,166,"18,751",2 out of 5,2008-04-08,Evidence at transcript level
Q9UI42,CBPA4_HUMAN,Carboxypeptidase A4 (EC 3.4.17.-) (Carboxypeptidase A3),421,"47,351",5 out of 5,2001-12-13,Evidence at protein level
Q96IY4,CBPB2_HUMAN,Carboxypeptidase B2 (EC 3.4.17.20) (Carboxypeptidase U) (CPU) (Plasma carboxypeptidase B) (pCPB) (Thrombin-activable fibrinolysis inhibitor) (TAFI),423,"48,424",5 out of 5,2005-04-26,Evidence at protein level
Q5U5Z8,CBPC2_HUMAN,Cytosolic carboxypeptidase 2 (EC 3.4.17.-) (ATP/GTP-binding protein-like 2),902,"104,194",5 out of 5,2007-04-03,Evidence at protein level
Q96MI9,CBPC4_HUMAN,Cytosolic carboxypeptidase 4 (EC 3.4.17.-) (ATP/GTP-binding protein-like 1),1066,"120,281",5 out of 5,2007-10-02,Evidence at protein level
O75976,CBPD_HUMAN,Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180),1380,"152,931",5 out of 5,2002-11-15,Evidence at protein level
Q9Y646,CBPQ_HUMAN,Carboxypeptidase Q (EC 3.4.17.-) (Lysosomal dipeptidase) (Plasma glutamate carboxypeptidase),472,"51,888",5 out of 5,2007-12-04,Evidence at protein level
Q5JTY5,CBWD3_HUMAN,COBW domain-containing protein 3 (Cobalamin synthase W domain-containing protein 3),395,"44,038",2 out of 5,2008-02-05,Evidence at transcript level
P83916,CBX1_HUMAN,Chromobox protein homolog 1 (HP1Hsbeta) (Heterochromatin protein 1 homolog beta) (HP1 beta) (Heterochromatin protein p25) (M31) (Modifier 1 protein) (p25beta),185,"21,418",5 out of 5,2004-06-07,Evidence at protein level
P45973,CBX5_HUMAN,Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha),191,"22,225",5 out of 5,1995-11-01,Evidence at protein level
Q13895,BYST_HUMAN,Bystin,437,"49,601",5 out of 5,1998-12-15,Evidence at protein level
Q86VB7,C163A_HUMAN,Scavenger receptor cysteine-rich type 1 protein M130 (Hemoglobin scavenger receptor) (CD antigen CD163) [Cleaved into: Soluble CD163 (sCD163)],1156,"125,451",5 out of 5,2006-05-30,Evidence at protein level
Q6UWJ8,C16L2_HUMAN,CD164 sialomucin-like 2 protein,174,"18,534",3 out of 5,2006-01-24,Evidence at protein level
Q96L14,C170L_HUMAN,Cep170-like protein (CEP170 pseudogene 1),293,"32,648",5 out of 5,2008-07-01,Uncertain
P0DN25,C1C1L_HUMAN,C1GALT1-specific chaperone 1-like protein,315,"36,396",2 out of 5,2015-10-14,Inferred from homology
Q96EU7,C1GLC_HUMAN,"C1GALT1-specific chaperone 1 (C38H2-like protein 1) (C38H2-L1) (Core 1 beta1,3-galactosyltransferase 2) (C1Gal-T2) (C1GalT2) (Core 1 beta3-Gal-T2) (Core 1 beta3-galactosyltransferase-specific molecular chaperone)",318,"36,382",5 out of 5,2007-05-01,Evidence at protein level
Q4AC94,C2CD3_HUMAN,C2 domain-containing protein 3,2353,"260,389",5 out of 5,2007-11-13,Evidence at protein level
P04003,C4BPA_HUMAN,C4b-binding protein alpha chain (C4bp) (Proline-rich protein) (PRP),597,"67,033",5 out of 5,1986-10-23,Evidence at protein level
Q9H159,CAD19_HUMAN,Cadherin-19,772,"87,002",4 out of 5,2001-10-24,Evidence at transcript level
Q8N126,CADM3_HUMAN,Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1),398,"43,300",5 out of 5,2006-02-07,Evidence at protein level
Q8N1Q1,CAH13_HUMAN,Carbonic anhydrase 13 (EC 4.2.1.1) (Carbonate dehydratase XIII) (Carbonic anhydrase XIII) (CA-XIII),262,"29,443",5 out of 5,2003-05-09,Evidence at protein level
P35219,CAH8_HUMAN,Carbonic anhydrase-related protein (CARP) (Carbonic anhydrase VIII) (CA-VIII),290,"32,973",5 out of 5,1994-02-01,Evidence at protein level
Q86XJ0,CAHM3_HUMAN,Calcium homeostasis modulator protein 3 (Protein FAM26A),350,"39,087",3 out of 5,2005-07-05,Evidence at transcript level
P05937,CALB1_HUMAN,"Calbindin (Calbindin D28) (D-28K) (Vitamin D-dependent calcium-binding protein, avian-type)",261,"30,025",5 out of 5,1988-11-01,Evidence at protein level
Q13939,CALI_HUMAN,Calicin,588,"66,582",4 out of 5,1997-11-01,Evidence at transcript level
Q9NZT1,CALL5_HUMAN,Calmodulin-like protein 5 (Calmodulin-like skin protein),146,"15,893",5 out of 5,2001-06-01,Evidence at protein level
P62158,CALM_HUMAN,Calmodulin (CaM),149,"16,838",5 out of 5,1986-07-21,Evidence at protein level
Q16602,CALRL_HUMAN,Calcitonin gene-related peptide type 1 receptor (CGRP type 1 receptor) (Calcitonin receptor-like receptor),461,"52,929",5 out of 5,1997-11-01,Evidence at protein level
Q86X55,CARM1_HUMAN,Histone-arginine methyltransferase CARM1 (EC 2.1.1.319) (Coactivator-associated arginine methyltransferase 1) (Protein arginine N-methyltransferase 4),608,"65,854",5 out of 5,2005-01-04,Evidence at protein level
Q13948,CASP_HUMAN,Protein CASP,678,"77,455",5 out of 5,2006-01-10,Evidence at protein level
P31415,CASQ1_HUMAN,"Calsequestrin-1 (Calmitine) (Calsequestrin, skeletal muscle isoform)",396,"45,160",5 out of 5,1993-07-01,Evidence at protein level
P53634,CATC_HUMAN,Dipeptidyl peptidase 1 (EC 3.4.14.1) (Cathepsin C) (Cathepsin J) (Dipeptidyl peptidase I) (DPP-I) (DPPI) (Dipeptidyl transferase) [Cleaved into: Dipeptidyl peptidase 1 exclusion domain chain (Dipeptidyl peptidase I exclusion domain chain); Dipeptidyl peptidase 1 heavy chain (Dipeptidyl peptidase I heavy chain); Dipeptidyl peptidase 1 light chain (Dipeptidyl peptidase I light chain)],463,"51,854",5 out of 5,1996-10-01,Evidence at protein level
P08311,CATG_HUMAN,Cathepsin G (CG) (EC 3.4.21.20),255,"28,837",5 out of 5,1988-08-01,Evidence at protein level
Q7Z7H3,CATIP_HUMAN,Ciliogenesis-associated TTC17-interacting protein,387,"43,900",5 out of 5,2007-11-13,Evidence at protein level
Q53S99,CB083_HUMAN,Folate transporter-like protein C2orf83,150,"16,373",2 out of 5,2008-02-26,Evidence at transcript level
Q6P9G0,CB5D1_HUMAN,Cytochrome b5 domain-containing protein 1,228,"26,689",2 out of 5,2007-12-04,Evidence at transcript level
P08185,CBG_HUMAN,Corticosteroid-binding globulin (CBG) (Serpin A6) (Transcortin),405,"45,141",5 out of 5,1988-08-01,Evidence at protein level
O00238,BMR1B_HUMAN,Bone morphogenetic protein receptor type-1B (BMP type-1B receptor) (BMPR-1B) (EC 2.7.11.30) (CD antigen CDw293),502,"56,930",5 out of 5,2000-05-30,Evidence at protein level
Q9UMX3,BOK_HUMAN,Bcl-2-related ovarian killer protein (hBOK) (Bcl-2-like protein 9) (Bcl2-L-9),212,"23,280",5 out of 5,2005-01-04,Evidence at protein level
Q9H3K6,BOLA2_HUMAN,BolA-like protein 2,86,"10,117",5 out of 5,2004-04-26,Evidence at protein level
Q6PJG6,BRAT1_HUMAN,BRCA1-associated ATM activator 1 (BRCA1-associated protein required for ATM activation protein 1),821,"88,119",5 out of 5,2006-10-31,Evidence at protein level
Q6PL45,BRID5_HUMAN,BRICHOS domain-containing protein 5,260,"28,486",3 out of 5,2007-04-17,Evidence at protein level
Q8WUW1,BRK1_HUMAN,Protein BRICK1 (BRK1),75,"8,745",5 out of 5,2007-04-03,Evidence at protein level
Q6RI45,BRWD3_HUMAN,Bromodomain and WD repeat-containing protein 3,1802,"203,598",5 out of 5,2007-04-03,Evidence at protein level
Q9UPA5,BSN_HUMAN,Protein bassoon (Zinc finger protein 231),3926,"416,469",5 out of 5,2004-08-16,Evidence at protein level
Q5W0U4,BSPRY_HUMAN,B box and SPRY domain-containing protein,402,"44,381",3 out of 5,2006-06-27,Evidence at transcript level
Q96KV6,BT2A3_HUMAN,Putative butyrophilin subfamily 2 member A3,586,"65,713",3 out of 5,2005-02-01,Uncertain
O00478,BT3A3_HUMAN,Butyrophilin subfamily 3 member A3,584,"65,002",5 out of 5,2005-02-01,Evidence at protein level
Q9P203,BTBD7_HUMAN,BTB/POZ domain-containing protein 7,1132,"126,368",4 out of 5,2005-06-07,Evidence at protein level
P41223,BUD31_HUMAN,Protein BUD31 homolog (Protein EDG-2) (Protein G10 homolog),144,"17,000",4 out of 5,1995-02-01,Evidence at protein level
Q8NEQ6,CA064_HUMAN,Uncharacterized protein C1orf64,169,"17,657",1 out of 5,2006-07-25,Evidence at transcript level
Q3KP66,CA106_HUMAN,Uncharacterized protein C1orf106,663,"72,914",2 out of 5,2006-10-03,Evidence at transcript level
Q5T0J3,CA220_HUMAN,Putative uncharacterized protein C1orf220,134,"15,074",1 out of 5,2008-03-18,Evidence at transcript level
P54289,CA2D1_HUMAN,Voltage-dependent calcium channel subunit alpha-2/delta-1 (Voltage-gated calcium channel subunit alpha-2/delta-1) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-1; Voltage-dependent calcium channel subunit delta-1],1103,"124,568",5 out of 5,1996-10-01,Evidence at protein level
Q9H251,CAD23_HUMAN,Cadherin-23 (Otocadherin),3354,"369,494",5 out of 5,2001-11-16,Evidence at protein level
Q8NFZ8,CADM4_HUMAN,Cell adhesion molecule 4 (Immunoglobulin superfamily member 4C) (IgSF4C) (Nectin-like protein 4) (NECL-4) (TSLC1-like protein 2),388,"42,785",5 out of 5,2007-06-26,Evidence at protein level
Q5T440,CAF17_HUMAN,"Putative transferase CAF17, mitochondrial (EC 2.1.-.-) (Iron-sulfur cluster assembly factor homolog)",356,"38,155",5 out of 5,2007-02-20,Evidence at protein level
Q9NS85,CAH10_HUMAN,Carbonic anhydrase-related protein 10 (Carbonic anhydrase-related protein X) (CA-RP X) (CARP X) (Cerebral protein 15),328,"37,563",3 out of 5,2001-09-26,Evidence at transcript level
Q9Y2D0,CAH5B_HUMAN,"Carbonic anhydrase 5B, mitochondrial (EC 4.2.1.1) (Carbonate dehydratase VB) (Carbonic anhydrase VB) (CA-VB)",317,"36,434",5 out of 5,2000-12-01,Evidence at protein level
Q9HA72,CAHM2_HUMAN,Calcium homeostasis modulator protein 2 (Protein FAM26B),323,"36,175",3 out of 5,2005-06-07,Evidence at transcript level
P27482,CALL3_HUMAN,Calmodulin-like protein 3 (CaM-like protein) (CLP) (Calmodulin-related protein NB-1),149,"16,891",4 out of 5,1992-08-01,Evidence at protein level
Q96LZ3,CANB2_HUMAN,Calcineurin subunit B type 2 (Calcineurin B-like protein) (CBLP) (Calcineurin BII) (CNBII) (PPP3R1-like) (Protein phosphatase 2B regulatory subunit 2) (Protein phosphatase 3 regulatory subunit B beta isoform),170,"19,533",4 out of 5,2004-09-13,Evidence at protein level
Q86UW7,CAPS2_HUMAN,Calcium-dependent secretion activator 2 (Calcium-dependent activator protein for secretion 2) (CAPS-2),1296,"147,735",5 out of 5,2006-01-10,Evidence at protein level
Q9BX69,CARD6_HUMAN,Caspase recruitment domain-containing protein 6,1037,"116,468",3 out of 5,2002-05-02,Evidence at protein level
Q8ND23,CARL3_HUMAN,"Capping protein, Arp2/3 and myosin-I linker protein 3 (Capping protein regulator and myosin 1 linker protein 3) (Leucine-rich repeat-containing protein 16B)",1372,"150,230",4 out of 5,2008-03-18,Evidence at transcript level
Q8N4J0,CARME_HUMAN,Carnosine N-methyltransferase (EC 2.1.1.22),409,"47,186",5 out of 5,2005-07-05,Evidence at protein level
P07498,CASK_HUMAN,Kappa-casein,182,"20,305",5 out of 5,1988-04-01,Evidence at protein level
A6NGG8,CB071_HUMAN,Uncharacterized protein C2orf71,1288,"139,655",5 out of 5,2008-04-08,Evidence at protein level
Q6ZV80,CB091_HUMAN,Uncharacterized protein C2orf91,131,"14,825",1 out of 5,2012-04-18,Evidence at transcript level
P23435,CBLN1_HUMAN,Cerebellin-1 (Precerebellin) [Cleaved into: Cerebellin (CER); [des-Ser1]-cerebellin],193,"21,097",4 out of 5,1991-11-01,Evidence at protein level
P48052,CBPA2_HUMAN,Carboxypeptidase A2 (EC 3.4.17.15),419,"47,030",5 out of 5,1996-02-01,Evidence at protein level
Q4V339,CBWD6_HUMAN,COBW domain-containing protein 6 (Cobalamin synthase W domain-containing protein 6),395,"43,964",2 out of 5,2008-02-05,Inferred from homology
O95931,CBX7_HUMAN,Chromobox protein homolog 7,251,"28,341",5 out of 5,2001-08-29,Evidence at protein level
Q6P1S2,CC033_HUMAN,Protein C3orf33 (Protein AC3-33),294,"33,765",4 out of 5,2006-10-31,Evidence at protein level
H3BU77,CC179_HUMAN,Coiled-coil domain-containing protein 179,68,"8,104",1 out of 5,2013-03-06,Predicted
Q5TID7,CC181_HUMAN,Coiled-coil domain-containing protein 181,509,"60,103",2 out of 5,2007-03-06,Evidence at transcript level
Q7Z3E2,CC186_HUMAN,Coiled-coil domain-containing protein 186 (CTCL tumor antigen HD-CL-01/L14-2),898,"103,687",2 out of 5,2005-07-19,Evidence at protein level
Q13490,BIRC2_HUMAN,Baculoviral IAP repeat-containing protein 2 (EC 2.3.2.27) (Cellular inhibitor of apoptosis 1) (C-IAP1) (IAP homolog B) (Inhibitor of apoptosis protein 2) (hIAP-2) (hIAP2) (RING finger protein 48) (RING-type E3 ubiquitin transferase BIRC2) (TNFR2-TRAF-signaling complex protein 2),618,"69,900",5 out of 5,1997-11-01,Evidence at protein level
Q8TDH9,BL1S5_HUMAN,Biogenesis of lysosome-related organelles complex 1 subunit 5 (BLOC-1 subunit 5) (Protein Muted homolog),187,"21,609",5 out of 5,2003-09-09,Evidence at protein level
Q8IZY5,BLID_HUMAN,BH3-like motif-containing cell death inducer (Breast cancer cell protein 2),108,"12,045",3 out of 5,2007-09-11,Evidence at protein level
P46736,BRCC3_HUMAN,Lys-63-specific deubiquitinase BRCC36 (EC 3.4.19.-) (BRCA1-A complex subunit BRCC36) (BRCA1/BRCA2-containing complex subunit 3) (BRCA1/BRCA2-containing complex subunit 36) (BRISC complex subunit BRCC36),316,"36,072",5 out of 5,1995-11-01,Evidence at protein level
Q9HAW0,BRF2_HUMAN,Transcription factor IIIB 50 kDa subunit (TFIIIB50) (hTFIIIB50) (B-related factor 2) (BRF-2) (hBRFU),419,"46,533",5 out of 5,2008-05-20,Evidence at protein level
Q32M84,BTBDG_HUMAN,BTB/POZ domain-containing protein 16,506,"58,481",2 out of 5,2006-07-25,Evidence at transcript level
P20290,BTF3_HUMAN,Transcription factor BTF3 (Nascent polypeptide-associated complex subunit beta) (NAC-beta) (RNA polymerase B transcription factor 3),206,"22,168",5 out of 5,1991-02-01,Evidence at protein level
Q7Z6A9,BTLA_HUMAN,B- and T-lymphocyte attenuator (B- and T-lymphocyte-associated protein) (CD antigen CD272),289,"32,834",5 out of 5,2005-07-19,Evidence at protein level
Q96LT6,CA074_HUMAN,UPF0739 protein C1orf74,269,"29,561",2 out of 5,2007-01-09,Evidence at transcript level
O95561,CA105_HUMAN,Uncharacterized protein C1orf105,183,"21,209",2 out of 5,2006-10-03,Evidence at protein level
Q9NSG2,CA112_HUMAN,Uncharacterized protein C1orf112,853,"96,554",2 out of 5,2007-03-06,Evidence at protein level
Q9NWV4,CA123_HUMAN,UPF0587 protein C1orf123,160,"18,048",2 out of 5,2006-12-12,Evidence at protein level
Q8IVY1,CA210_HUMAN,Type III endosome membrane protein TEMP (TEMP),113,"12,024",3 out of 5,2007-01-09,Inferred from homology
Q9NY47,CA2D2_HUMAN,Voltage-dependent calcium channel subunit alpha-2/delta-2 (Voltage-gated calcium channel subunit alpha-2/delta-2) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-2; Voltage-dependent calcium channel subunit delta-2],1150,"129,817",5 out of 5,2007-09-11,Evidence at protein level
Q8N1I8,CAAS1_HUMAN,Putative uncharacterized protein encoded by CACTIN-AS1 (Cactin antisense RNA 1),211,"22,698",1 out of 5,2007-08-21,Evidence at transcript level
Q9NPB3,CABP2_HUMAN,Calcium-binding protein 2 (CaBP2),220,"24,482",5 out of 5,2001-04-27,Evidence at protein level
Q9BXU9,CABP8_HUMAN,Calcium-binding protein 8 (CaBP8) (Calneuron I) (Calneuron-1),219,"24,837",4 out of 5,2002-04-16,Evidence at transcript level
Q02641,CACB1_HUMAN,Voltage-dependent L-type calcium channel subunit beta-1 (CAB1) (Calcium channel voltage-dependent subunit beta 1),598,"65,714",5 out of 5,1994-06-01,Evidence at transcript level
O00305,CACB4_HUMAN,Voltage-dependent L-type calcium channel subunit beta-4 (CAB4) (Calcium channel voltage-dependent subunit beta 4),520,"58,169",5 out of 5,1998-07-15,Evidence at protein level
P07451,CAH3_HUMAN,Carbonic anhydrase 3 (EC 4.2.1.1) (Carbonate dehydratase III) (Carbonic anhydrase III) (CA-III),260,"29,557",5 out of 5,1988-04-01,Evidence at protein level
P23280,CAH6_HUMAN,Carbonic anhydrase 6 (EC 4.2.1.1) (Carbonate dehydratase VI) (Carbonic anhydrase VI) (CA-VI) (Salivary carbonic anhydrase) (Secreted carbonic anhydrase),308,"35,367",5 out of 5,1991-11-01,Evidence at protein level
Q5VU97,CAHD1_HUMAN,VWFA and cache domain-containing protein 1 (Cache domain-containing protein 1),1274,"142,290",3 out of 5,2007-09-11,Evidence at transcript level
Q8IU99,CAHM1_HUMAN,Calcium homeostasis modulator protein 1 (Protein FAM26C),346,"38,264",5 out of 5,2005-07-05,Evidence at protein level
P07384,CAN1_HUMAN,Calpain-1 catalytic subunit (EC 3.4.22.52) (Calcium-activated neutral proteinase 1) (CANP 1) (Calpain mu-type) (Calpain-1 large subunit) (Cell proliferation-inducing gene 30 protein) (Micromolar-calpain) (muCANP),714,"81,890",5 out of 5,1988-04-01,Evidence at protein level
P57730,CAR18_HUMAN,Caspase recruitment domain-containing protein 18 (Caspase-1 inhibitor Iceberg),90,"10,138",3 out of 5,2001-01-11,Evidence at protein level
Q8N187,CARTF_HUMAN,Calcium-responsive transcription factor (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 8 protein) (Calcium-response factor) (CaRF) (Testis development protein NYD-SP24),725,"80,698",5 out of 5,2006-01-10,Evidence at protein level
Q8IU53,CASC2_HUMAN,"Protein CASC2, isoforms 1/2 (Cancer susceptibility candidate gene 2 protein isoforms 1/2)",76,"8,607",2 out of 5,2008-03-18,Predicted
O15234,CASC3_HUMAN,Protein CASC3 (Cancer susceptibility candidate gene 3 protein) (Metastatic lymph node gene 51 protein) (MLN 51) (Protein barentsz) (Btz),703,"76,278",5 out of 5,2000-05-30,Evidence at protein level
Q96LR7,CB050_HUMAN,Uncharacterized protein C2orf50,162,"17,838",1 out of 5,2007-10-23,Evidence at protein level
Q8N0U7,CA087_HUMAN,Uncharacterized protein C1orf87,546,"62,035",2 out of 5,2007-04-17,Evidence at transcript level
Q5JT78,CA137_HUMAN,Putative uncharacterized protein C1orf137,98,"10,987",1 out of 5,2007-05-15,Predicted
Q5VVS0,CA140_HUMAN,Putative uncharacterized protein C1orf140,124,"13,926",1 out of 5,2007-07-10,Uncertain
Q8N1D5,CA158_HUMAN,Uncharacterized protein C1orf158,194,"23,067",1 out of 5,2006-07-25,Evidence at transcript level
Q5SNV9,CA167_HUMAN,Uncharacterized protein C1orf167,1468,"162,423",3 out of 5,2007-10-02,Evidence at transcript level
Q8NAE3,CA180_HUMAN,Putative uncharacterized protein encoded by LINC01555,123,"13,125",1 out of 5,2007-01-09,Evidence at transcript level
Q5VU69,CA189_HUMAN,Uncharacterized protein C1orf189,101,"12,131",1 out of 5,2007-01-09,Evidence at protein level
A1L170,CA226_HUMAN,Uncharacterized protein C1orf226,272,"29,057",2 out of 5,2008-05-20,Evidence at protein level
Q8IZS8,CA2D3_HUMAN,Voltage-dependent calcium channel subunit alpha-2/delta-3 (Voltage-gated calcium channel subunit alpha-2/delta-3) [Cleaved into: Voltage-dependent calcium channel subunit alpha-2-3; Voltage-dependent calcium channel subunit delta-3],1091,"123,011",5 out of 5,2007-09-11,Evidence at protein level
Q8TD86,CALL6_HUMAN,Calmodulin-like protein 6 (Calglandulin-like protein),181,"20,690",3 out of 5,2005-11-08,Evidence at transcript level
O43852,CALU_HUMAN,Calumenin (Crocalbin) (IEF SSP 9302),315,"37,107",5 out of 5,1999-07-15,Evidence at protein level
Q01518,CAP1_HUMAN,Adenylyl cyclase-associated protein 1 (CAP 1),475,"51,901",5 out of 5,1993-07-01,Evidence at protein level
P40121,CAPG_HUMAN,Macrophage-capping protein (Actin regulatory protein CAP-G),348,"38,499",5 out of 5,1995-02-01,Evidence at protein level
Q5XLA6,CAR17_HUMAN,Caspase recruitment domain-containing protein 17 (Caspase-1 inhibitor INCA) (Inhibitory caspase recruitment domain protein),110,"11,868",3 out of 5,2008-07-22,Evidence at protein level
Q6P4E1,CASC4_HUMAN,Protein CASC4 (Cancer susceptibility candidate gene 4 protein),433,"48,864",4 out of 5,2007-06-26,Evidence at protein level
Q96PB1,CASD1_HUMAN,CAS1 domain-containing protein 1,797,"91,680",2 out of 5,2007-10-23,Evidence at transcript level
Q6UXS9,CASPC_HUMAN,Inactive caspase-12 (CASP-12),341,"38,865",4 out of 5,2008-02-05,Evidence at transcript level
P43234,CATO_HUMAN,Cathepsin O (EC 3.4.22.42),321,"35,958",4 out of 5,1995-11-01,Evidence at transcript level
P56202,CATW_HUMAN,Cathepsin W (EC 3.4.22.-) (Lymphopain),376,"42,120",5 out of 5,1997-11-01,Evidence at protein level
Q9BXY5,CAYP2_HUMAN,Calcyphosin-2 (Calcyphosine-2),557,"63,835",3 out of 5,2003-08-29,Evidence at transcript level
Q8WU43,CB015_HUMAN,Uncharacterized protein C2orf15,125,"13,691",1 out of 5,2005-07-05,Evidence at transcript level
Q0P641,CB080_HUMAN,Uncharacterized protein C2orf80,193,"22,038",1 out of 5,2008-03-18,Evidence at transcript level
P14384,CBPM_HUMAN,Carboxypeptidase M (CPM) (EC 3.4.17.12),443,"50,514",5 out of 5,1990-01-01,Evidence at protein level
O75828,CBR3_HUMAN,Carbonyl reductase [NADPH] 3 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase 3) (Short chain dehydrogenase/reductase family 21C member 2),277,"30,850",5 out of 5,1998-12-15,Evidence at protein level
Q3SXR2,CC036_HUMAN,Uncharacterized protein C3orf36,165,"16,908",1 out of 5,2006-10-03,Evidence at transcript level
H7C350,CC188_HUMAN,Coiled-coil domain-containing protein 188,402,"43,548",2 out of 5,2016-02-17,Inferred from homology
Q9NV96,CC50A_HUMAN,Cell cycle control protein 50A (P4-ATPase flippase complex beta subunit TMEM30A) (Transmembrane protein 30A),361,"40,684",5 out of 5,2006-06-27,Evidence at protein level
O60826,CCD22_HUMAN,Coiled-coil domain-containing protein 22,627,"70,756",5 out of 5,2005-12-06,Evidence at protein level
Q96ER9,CCD51_HUMAN,Coiled-coil domain-containing protein 51,411,"45,811",2 out of 5,2007-05-29,Evidence at protein level
A6NI79,CCD69_HUMAN,Coiled-coil domain-containing protein 69,296,"34,796",2 out of 5,2008-04-08,Evidence at protein level
A2IDD5,CCD78_HUMAN,Coiled-coil domain-containing protein 78 (hsCCDC78),438,"48,521",5 out of 5,2007-06-26,Evidence at transcript level
Q2M329,CCD96_HUMAN,Coiled-coil domain-containing protein 96,555,"62,711",2 out of 5,2006-05-02,Evidence at transcript level
Q16204,CCDC6_HUMAN,Coiled-coil domain-containing protein 6 (Papillary thyroid carcinoma-encoded protein) (Protein H4),474,"53,291",5 out of 5,1997-11-01,Evidence at protein level
O60359,CCG3_HUMAN,Voltage-dependent calcium channel gamma-3 subunit (Neuronal voltage-gated calcium channel gamma-3 subunit) (Transmembrane AMPAR regulatory protein gamma-3) (TARP gamma-3),315,"35,549",4 out of 5,2000-05-30,Evidence at transcript level
Q2TBE0,C19L2_HUMAN,CWF19-like protein 2,894,"103,787",3 out of 5,2008-01-15,Evidence at protein level
P02745,C1QA_HUMAN,Complement C1q subcomponent subunit A,245,"26,017",5 out of 5,1986-07-21,Evidence at protein level
Q9NPY3,C1QR1_HUMAN,Complement component C1q receptor (C1q/MBL/SPA receptor) (C1qR) (C1qR(p)) (C1qRp) (CDw93) (Complement component 1 q subcomponent receptor 1) (Matrix-remodeling-associated protein 4) (CD antigen CD93),652,"68,560",5 out of 5,2002-06-20,Evidence at protein level
Q96NR2,C2AS1_HUMAN,Putative uncharacterized protein C20orf166-AS1 (C20orf166 antisense RNA 1) (C20orf166 antisense gene protein 1),134,"14,382",2 out of 5,2007-11-13,Evidence at transcript level
Q86YS7,C2CD5_HUMAN,C2 domain-containing protein 5 (C2 domain-containing phosphoprotein of 138 kDa),1000,"110,447",5 out of 5,2006-07-25,Evidence at protein level
Q5T0F9,C2D1B_HUMAN,Coiled-coil and C2 domain-containing protein 1B (Five prime repressor element under dual repression-binding protein 2) (FRE under dual repression-binding protein 2) (Freud-2),858,"94,224",5 out of 5,2007-05-29,Evidence at protein level
Q9P2K1,C2D2A_HUMAN,Coiled-coil and C2 domain-containing protein 2A,1620,"186,185",5 out of 5,2008-02-05,Evidence at protein level
Q9BV19,CA050_HUMAN,Uncharacterized protein C1orf50,199,"21,877",3 out of 5,2006-10-03,Evidence at protein level
Q5VUE5,CA053_HUMAN,Uncharacterized protein C1orf53,145,"15,483",2 out of 5,2007-01-09,Evidence at protein level
Q8N9H9,CA127_HUMAN,Uncharacterized protein C1orf127,656,"69,787",2 out of 5,2007-04-17,Evidence at transcript level
Q8NDD1,CA131_HUMAN,Uncharacterized protein C1orf131,294,"32,766",3 out of 5,2007-05-01,Evidence at protein level
Q96MC9,CA147_HUMAN,Uncharacterized protein C1orf147,270,"29,841",1 out of 5,2006-07-25,Evidence at transcript level
Q8NEQ5,CA162_HUMAN,Transmembrane protein C1orf162,155,"16,886",2 out of 5,2007-09-11,Evidence at transcript level
Q5T5A4,CA194_HUMAN,Uncharacterized protein C1orf194,169,"19,350",1 out of 5,2007-09-11,Evidence at transcript level
Q8N6G1,CA211_HUMAN,Putative uncharacterized protein encoded by LINC00337,96,"10,504",1 out of 5,2007-01-09,Uncertain
Q8TAB5,CA216_HUMAN,UPF0500 protein C1orf216,229,"24,968",5 out of 5,2007-11-13,Evidence at protein level
Q86V35,CABP7_HUMAN,Calcium-binding protein 7 (CaBP7) (Calneuron II) (Calneuron-2),215,"24,453",3 out of 5,2003-10-03,Evidence at protein level
Q13936,CAC1C_HUMAN,"Voltage-dependent L-type calcium channel subunit alpha-1C (Calcium channel, L type, alpha-1 polypeptide, isoform 1, cardiac muscle) (Voltage-gated calcium channel subunit alpha Cav1.2)",2221,"248,977",5 out of 5,1999-07-15,Evidence at protein level
Q9P0X4,CAC1I_HUMAN,Voltage-dependent T-type calcium channel subunit alpha-1I (Voltage-gated calcium channel subunit alpha Cav3.3) (Ca(v)3.3),2223,"245,103",5 out of 5,2002-09-19,Evidence at protein level
Q13698,CAC1S_HUMAN,"Voltage-dependent L-type calcium channel subunit alpha-1S (Calcium channel, L type, alpha-1 polypeptide, isoform 3, skeletal muscle) (Voltage-gated calcium channel subunit alpha Cav1.1)",1873,"212,350",5 out of 5,1999-07-15,Evidence at protein level
P43155,CACP_HUMAN,Carnitine O-acetyltransferase (Carnitine acetylase) (EC 2.3.1.7) (Carnitine acetyltransferase) (CAT) (CrAT),626,"70,858",5 out of 5,1995-11-01,Evidence at protein level
P33151,CADH5_HUMAN,Cadherin-5 (7B4 antigen) (Vascular endothelial cadherin) (VE-cadherin) (CD antigen CD144),784,"87,528",5 out of 5,1993-10-01,Evidence at protein level
Q5T5Y3,CAMP1_HUMAN,Calmodulin-regulated spectrin-associated protein 1,1602,"177,972",5 out of 5,2008-02-05,Evidence at protein level
P49913,CAMP_HUMAN,Cathelicidin antimicrobial peptide (18 kDa cationic antimicrobial protein) (CAP-18) (hCAP-18) [Cleaved into: Antibacterial peptide FALL-39 (FALL-39 peptide antibiotic); Antibacterial peptide LL-37],170,"19,301",5 out of 5,1996-10-01,Evidence at protein level
O14815,CAN9_HUMAN,Calpain-9 (EC 3.4.22.-) (Digestive tract-specific calpain) (New calpain 4) (nCL-4) (Protein CG36),690,"79,097",5 out of 5,2003-06-16,Evidence at protein level
O75155,CAND2_HUMAN,Cullin-associated NEDD8-dissociated protein 2 (Cullin-associated and neddylation-dissociated protein 2) (Epididymis tissue protein Li 169) (TBP-interacting protein of 120 kDa B) (TBP-interacting protein 120B) (p120 CAND2),1236,"135,256",5 out of 5,2005-06-07,Evidence at protein level
P40123,CAP2_HUMAN,Adenylyl cyclase-associated protein 2 (CAP 2),477,"52,824",5 out of 5,1995-02-01,Evidence at protein level
P51878,CASP5_HUMAN,Caspase-5 (CASP-5) (EC 3.4.22.58) (ICE(rel)-III) (Protease ICH-3) (Protease TY) [Cleaved into: Caspase-5 subunit p20; Caspase-5 subunit p10],434,"49,736",5 out of 5,1996-10-01,Evidence at protein level
Q92851,CASPA_HUMAN,Caspase-10 (CASP-10) (EC 3.4.22.63) (Apoptotic protease Mch-4) (FAS-associated death domain protein interleukin-1B-converting enzyme 2) (FLICE2) (ICE-like apoptotic protease 4) [Cleaved into: Caspase-10 subunit p23/17; Caspase-10 subunit p12],521,"58,951",5 out of 5,1997-11-01,Evidence at protein level
Q86V15,CASZ1_HUMAN,Zinc finger protein castor homolog 1 (Castor-related protein) (Putative survival-related protein) (Zinc finger protein 693),1759,"190,069",5 out of 5,2004-05-24,Evidence at protein level
Q13166,CATR1_HUMAN,CATR tumorigenic conversion 1 protein (CATR1.3),79,"9,224",1 out of 5,1997-11-01,Evidence at transcript level
Q8N801,CB061_HUMAN,Uncharacterized protein C2orf61,248,"27,807",2 out of 5,2007-11-13,Evidence at transcript level
A6NCS6,CB072_HUMAN,Uncharacterized protein C2orf72,295,"30,481",1 out of 5,2008-06-10,Evidence at protein level
Q9NTU7,CBLN4_HUMAN,Cerebellin-4 (Cerebellin-like glycoprotein 1),201,"21,808",3 out of 5,2001-04-27,Evidence at protein level
Q66K79,CBPZ_HUMAN,Carboxypeptidase Z (CPZ) (EC 3.4.17.-),652,"73,655",5 out of 5,2006-10-17,Evidence at protein level
Q92793,CBP_HUMAN,CREB-binding protein (EC 2.3.1.48),2442,"265,351",5 out of 5,1998-07-15,Evidence at protein level
Q8N4T8,CBR4_HUMAN,Carbonyl reductase family member 4 (EC 1.-.-.-) (3-ketoacyl-[acyl-carrier-protein] reductase beta subunit) (KAR beta subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Quinone reductase CBR4) (Short chain dehydrogenase/reductase family 45C member 1),237,"25,301",5 out of 5,2008-02-26,Evidence at protein level
Q8IUF1,CBWD2_HUMAN,COBW domain-containing protein 2 (Cobalamin synthase W domain-containing protein 2),395,"44,034",2 out of 5,2008-02-05,Evidence at transcript level
A6NM15,CBWD7_HUMAN,Putative COBW domain-containing protein 7 (Putative cobalamin synthase W domain-containing protein 7),247,"28,232",2 out of 5,2008-07-22,Uncertain
O95503,CBX6_HUMAN,Chromobox protein homolog 6,412,"43,898",5 out of 5,2001-08-29,Evidence at protein level
Q8N813,CC056_HUMAN,Putative uncharacterized protein C3orf56,242,"26,007",1 out of 5,2006-06-27,Evidence at transcript level
Q6ZRV3,CC074_HUMAN,Putative uncharacterized protein encoded by LINC00696,163,"16,900",1 out of 5,2008-06-10,Uncertain
Q8N1D0,BWR1B_HUMAN,Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene B protein (Organic cation transporter-like protein 2 antisense protein) (Solute carrier family 22 member 1-like antisense protein) (Solute carrier family 22 member 18 antisense protein) (p27-Beckwith-Wiedemann region 1 B) (p27-BWR1B),253,"27,061",3 out of 5,2005-12-06,Evidence at transcript level
Q7L1Q6,BZW1_HUMAN,Basic leucine zipper and W2 domain-containing protein 1 (Protein Orf),419,"48,043",4 out of 5,2006-10-31,Evidence at protein level
Q9Y4F5,C170B_HUMAN,Centrosomal protein of 170 kDa protein B (Centrosomal protein 170B) (Cep170B),1589,"171,688",3 out of 5,2007-04-03,Evidence at protein level
P33076,C2TA_HUMAN,MHC class II transactivator (CIITA) (EC 2.3.1.-) (EC 2.7.11.1),1130,"123,514",5 out of 5,1993-10-01,Evidence at protein level
Q96L12,CALR3_HUMAN,Calreticulin-3 (Calreticulin-2) (Calsperin),384,"44,996",5 out of 5,2003-02-22,Evidence at protein level
Q5NE16,CATL3_HUMAN,Putative inactive cathepsin L-like protein CTSL3P (Cathepsin L3 pseudogene) (HCTSL-s),218,"25,059",2 out of 5,2007-05-15,Uncertain
P56539,CAV3_HUMAN,Caveolin-3 (M-caveolin),151,"17,259",5 out of 5,1998-07-15,Evidence at protein level
Q08AI8,CB054_HUMAN,Uncharacterized protein C2orf54,447,"49,565",2 out of 5,2007-05-29,Evidence at transcript level
A6NJV1,CB070_HUMAN,UPF0573 protein C2orf70,201,"23,421",2 out of 5,2008-04-29,Inferred from homology
Q9UPW5,CBPC1_HUMAN,Cytosolic carboxypeptidase 1 (EC 3.4.17.-) (ATP/GTP-binding protein 1) (Nervous system nuclear protein induced by axotomy protein 1 homolog),1226,"138,448",5 out of 5,2007-10-23,Evidence at protein level
Q5VU57,CBPC6_HUMAN,Cytosolic carboxypeptidase 6 (EC 3.4.17.-) (ATP/GTP-binding protein-like 4),503,"58,230",5 out of 5,2007-04-17,Evidence at transcript level
P16870,CBPE_HUMAN,Carboxypeptidase E (CPE) (EC 3.4.17.10) (Carboxypeptidase H) (CPH) (Enkephalin convertase) (Prohormone-processing carboxypeptidase),476,"53,151",5 out of 5,1990-08-01,Evidence at protein level
P15169,CBPN_HUMAN,Carboxypeptidase N catalytic chain (CPN) (EC 3.4.17.3) (Anaphylatoxin inactivator) (Arginine carboxypeptidase) (Carboxypeptidase N polypeptide 1) (Carboxypeptidase N small subunit) (Kininase-1) (Lysine carboxypeptidase) (Plasma carboxypeptidase B) (Serum carboxypeptidase N) (SCPN),458,"52,286",5 out of 5,1990-04-01,Evidence at protein level
Q9Y3M2,CBY1_HUMAN,"Protein chibby homolog 1 (ARPP-binding protein) (Cytosolic leucine-rich protein) (PIGEA-14) (PKD2 interactor, Golgi and endoplasmic reticulum-associated 1)",126,"14,470",5 out of 5,2002-05-02,Evidence at protein level
Q6ZVT6,CC067_HUMAN,Uncharacterized protein C3orf67,689,"76,271",2 out of 5,2008-02-05,Evidence at transcript level
Q96HB5,CC120_HUMAN,Coiled-coil domain-containing protein 120,630,"67,567",5 out of 5,2006-10-31,Evidence at protein level
Q96MF4,CC140_HUMAN,Coiled-coil domain-containing protein 140,163,"18,252",1 out of 5,2007-12-04,Evidence at transcript level
Q6ZUS6,CC149_HUMAN,Coiled-coil domain-containing protein 149,474,"52,796",3 out of 5,2008-07-22,Evidence at transcript level
O60729,CC14B_HUMAN,Dual specificity protein phosphatase CDC14B (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog B),498,"56,802",5 out of 5,2004-11-23,Evidence at protein level
A6NGH7,CC160_HUMAN,Coiled-coil domain-containing protein 160,325,"38,277",1 out of 5,2008-09-02,Inferred from homology
Q8NDH2,CC168_HUMAN,Coiled-coil domain-containing protein 168,2452,"277,951",3 out of 5,2008-07-01,Evidence at transcript level
Q9P1Z9,CC180_HUMAN,Coiled-coil domain-containing protein 180,1646,"191,100",4 out of 5,2008-01-15,Evidence at transcript level
Q5T5S1,CC183_HUMAN,Coiled-coil domain-containing protein 183,534,"62,689",3 out of 5,2007-07-10,Evidence at transcript level
Q9NUG4,CCM2L_HUMAN,Cerebral cavernous malformations 2 protein-like (CCM2-like),571,"62,179",3 out of 5,2003-06-20,Evidence at transcript level
P78396,CCNA1_HUMAN,Cyclin-A1,465,"52,358",5 out of 5,2000-05-30,Evidence at protein level
O95067,CCNB2_HUMAN,G2/mitotic-specific cyclin-B2,398,"45,282",5 out of 5,1999-07-15,Evidence at protein level
Q8WWL7,CCNB3_HUMAN,G2/mitotic-specific cyclin-B3,1395,"157,916",5 out of 5,2004-06-07,Evidence at protein level
Q9UK58,CCNL1_HUMAN,Cyclin-L1 (Cyclin-L),526,"59,634",5 out of 5,2005-11-08,Evidence at protein level
P51685,CCR8_HUMAN,C-C chemokine receptor type 8 (C-C CKR-8) (CC-CKR-8) (CCR-8) (CC chemokine receptor CHEMR1) (CMKBRL2) (Chemokine receptor-like 1) (CKR-L1) (GPR-CY6) (GPRCY6) (TER1) (CD antigen CDw198),355,"40,844",5 out of 5,1996-10-01,Evidence at protein level
Q8IV77,CNGA4_HUMAN,Cyclic nucleotide-gated cation channel alpha-4 (Cyclic nucleotide-gated channel alpha-4) (CNG channel alpha-4) (CNG-4) (CNG4),575,"65,999",5 out of 5,2008-02-05,Evidence at protein level
Q14028,CNGB1_HUMAN,Cyclic nucleotide-gated cation channel beta-1 (Cyclic nucleotide-gated cation channel 4) (CNG channel 4) (CNG-4) (CNG4) (Cyclic nucleotide-gated cation channel gamma) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-1) (CNG channel beta-1) (Glutamic acid-rich protein) (GARP),1251,"139,678",5 out of 5,1997-11-01,Evidence at protein level
Q6PI25,CNIH2_HUMAN,Protein cornichon homolog 2 (CNIH-2) (Cornichon family AMPA receptor auxiliary protein 2) (Cornichon-like protein),160,"18,931",5 out of 5,2005-03-15,Evidence at protein level
Q9Y2B0,CNPY2_HUMAN,Protein canopy homolog 2 (MIR-interacting saposin-like protein) (Putative secreted protein Zsig9) (Transmembrane protein 4),182,"20,652",5 out of 5,2004-07-19,Evidence at protein level
Q5JTJ3,COA6_HUMAN,Cytochrome c oxidase assembly factor 6 homolog,125,"14,116",5 out of 5,2007-03-20,Evidence at protein level
Q03692,COAA1_HUMAN,Collagen alpha-1(X) chain,680,"66,158",5 out of 5,1995-11-01,Evidence at protein level
Q96CD2,COAC_HUMAN,Phosphopantothenoylcysteine decarboxylase (PPC-DC) (EC 4.1.1.36) (CoaC),204,"22,395",5 out of 5,2005-06-07,Evidence at protein level
P12107,COBA1_HUMAN,Collagen alpha-1(XI) chain,1806,"181,065",5 out of 5,1989-10-01,Evidence at protein level
P23528,COF1_HUMAN,"Cofilin-1 (18 kDa phosphoprotein) (p18) (Cofilin, non-muscle isoform)",166,"18,502",5 out of 5,1991-11-01,Evidence at protein level
P38432,COIL_HUMAN,Coilin (p80-coilin),576,"62,608",5 out of 5,1994-10-01,Evidence at protein level
P01189,COLI_HUMAN,Pro-opiomelanocortin (POMC) (Corticotropin-lipotropin) [Cleaved into: NPP; Melanotropin gamma (Gamma-MSH); Potential peptide; Corticotropin (Adrenocorticotropic hormone) (ACTH); Melanotropin alpha (Alpha-MSH); Corticotropin-like intermediary peptide (CLIP); Lipotropin beta (Beta-LPH); Lipotropin gamma (Gamma-LPH); Melanotropin beta (Beta-MSH); Beta-endorphin; Met-enkephalin],267,"29,424",5 out of 5,1986-07-21,Evidence at protein level
P49747,COMP_HUMAN,Cartilage oligomeric matrix protein (COMP) (Thrombospondin-5) (TSP5),757,"82,860",5 out of 5,1996-10-01,Evidence at protein level
Q86Y22,CONA1_HUMAN,Collagen alpha-1(XXIII) chain,540,"51,944",3 out of 5,2006-07-11,Evidence at protein level
Q2UY09,COSA1_HUMAN,Collagen alpha-1(XXVIII) chain,1125,"116,657",5 out of 5,2008-02-05,Evidence at transcript level
O60397,COX7S_HUMAN,"Putative cytochrome c oxidase subunit 7A3, mitochondrial (Cytochrome c oxidase subunit VIIa 3)",106,"11,841",2 out of 5,2000-12-01,Uncertain
Q7Z4L0,COX8C_HUMAN,"Cytochrome c oxidase subunit 8C, mitochondrial (Cytochrome c oxidase polypeptide 8 isoform 3) (Cytochrome c oxidase polypeptide VIII isoform 3) (COX VIII-3) (Cytochrome c oxidase subunit 8-3) (COX8-3) (Cytochrome c oxidase subunit VIIIC)",72,"8,129",4 out of 5,2004-01-16,Evidence at transcript level
P24462,CP3A7_HUMAN,Cytochrome P450 3A7 (EC 1.14.14.1) (CYPIIIA7) (Cytochrome P450-HFLA),503,"57,526",5 out of 5,1992-03-01,Evidence at protein level
Q02928,CP4AB_HUMAN,Cytochrome P450 4A11 (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (CYP4AII) (CYPIVA11) (Cytochrome P-450HK-omega) (Cytochrome P450HL-omega) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.13.205),519,"59,348",5 out of 5,1997-11-01,Evidence at protein level
Q6PUV4,CPLX2_HUMAN,Complexin-2 (Complexin II) (CPX II) (Synaphin-1),134,"15,394",4 out of 5,2004-08-16,Evidence at transcript level
Q7Z7G2,CPLX4_HUMAN,Complexin-4 (Complexin IV) (CPX IV),160,"18,336",3 out of 5,2006-06-13,Evidence at transcript level
Q5K130,CLU1O_HUMAN,Putative chronic lymphocytic leukemia up-regulated protein 1 opposite strand transcript protein,101,"10,963",1 out of 5,2007-08-21,Uncertain
Q4W4Y0,CN028_HUMAN,Uncharacterized protein C14orf28 (Dopamine receptor-interacting protein 1),310,"36,306",1 out of 5,2007-02-06,Evidence at transcript level
Q86TU6,CN070_HUMAN,Putative uncharacterized protein encoded by LINC00523,105,"12,089",1 out of 5,2006-12-12,Uncertain
Q86SX3,CN080_HUMAN,Uncharacterized protein C14orf80,495,"54,231",2 out of 5,2008-04-29,Evidence at transcript level
Q7Z3D6,CN159_HUMAN,"UPF0317 protein C14orf159, mitochondrial",616,"66,437",3 out of 5,2004-06-07,Evidence at protein level
P09543,CN37_HUMAN,"2',3'-cyclic-nucleotide 3'-phosphodiesterase (CNP) (CNPase) (EC 3.1.4.37)",421,"47,579",5 out of 5,1989-07-01,Evidence at protein level
Q8NA66,CNBD1_HUMAN,Cyclic nucleotide-binding domain-containing protein 1,436,"50,224",2 out of 5,2007-06-26,Evidence at transcript level
Q5KU26,COL12_HUMAN,Collectin-12 (Collectin placenta protein 1) (CL-P1) (hCL-P1) (Nurse cell scavenger receptor 2) (Scavenger receptor class A member 4) (Scavenger receptor with C-type lectin),742,"81,515",5 out of 5,2008-02-26,Evidence at protein level
Q96P44,COLA1_HUMAN,Collagen alpha-1(XXI) chain,957,"99,369",5 out of 5,2008-02-05,Evidence at transcript level
Q6ZS62,COLC1_HUMAN,Colorectal cancer-associated protein 1,124,"13,401",2 out of 5,2008-06-10,Evidence at transcript level
Q9Y6G5,COMDA_HUMAN,COMM domain-containing protein 10,202,"22,966",4 out of 5,2004-08-16,Evidence at protein level
P35606,COPB2_HUMAN,Coatomer subunit beta' (Beta'-coat protein) (Beta'-COP) (p102),906,"102,487",5 out of 5,1994-06-01,Evidence at protein level
Q9Y3A0,COQ4_HUMAN,"Ubiquinone biosynthesis protein COQ4 homolog, mitochondrial (Coenzyme Q biosynthesis protein 4 homolog)",265,"29,657",5 out of 5,2002-10-19,Evidence at protein level
Q9Y5Q5,CORIN_HUMAN,"Atrial natriuretic peptide-converting enzyme (EC 3.4.21.-) (Corin) (Heart-specific serine proteinase ATC2) (Pro-ANP-converting enzyme) (Transmembrane protease serine 10) [Cleaved into: Atrial natriuretic peptide-converting enzyme, N-terminal propeptide; Atrial natriuretic peptide-converting enzyme, activated protease fragment; Atrial natriuretic peptide-converting enzyme, 180 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 160 kDa soluble fragment; Atrial natriuretic peptide-converting enzyme, 100 kDa soluble fragment]",1042,"116,486",5 out of 5,2001-04-27,Evidence at protein level
Q6QEF8,CORO6_HUMAN,Coronin-6 (Coronin-like protein E) (Clipin-E),472,"52,762",3 out of 5,2006-10-31,Evidence at protein level
P15954,COX7C_HUMAN,"Cytochrome c oxidase subunit 7C, mitochondrial (Cytochrome c oxidase polypeptide VIIc)",63,"7,246",4 out of 5,1990-04-01,Evidence at protein level
O14548,COX7R_HUMAN,"Cytochrome c oxidase subunit 7A-related protein, mitochondrial (COX7a-related protein) (Cytochrome c oxidase subunit VIIa-related protein) (EB1)",114,"12,615",4 out of 5,2000-12-01,Evidence at protein level
Q08477,CP4F3_HUMAN,Docosahexaenoic acid omega-hydroxylase CYP4F3 (EC 1.14.13.199) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (EC 1.14.13.-) (CYPIVF3) (Cytochrome P450 4F3) (Cytochrome P450-LTB-omega) (Leukotriene-B(4) 20-monooxygenase 2) (Leukotriene-B(4) omega-hydroxylase 2) (EC 1.14.13.30),520,"59,847",5 out of 5,1995-02-01,Evidence at protein level
Q6ZR85,CQ107_HUMAN,Uncharacterized protein C17orf107,190,"19,931",1 out of 5,2008-07-01,Evidence at transcript level
Q96KH6,CR012_HUMAN,Uncharacterized protein C18orf12 (Protein HEIL1),178,"19,680",1 out of 5,2005-07-19,Evidence at transcript level
Q7Z4B0,CR020_HUMAN,Putative uncharacterized protein encoded by LINC00305,112,"12,600",2 out of 5,2005-07-19,Uncertain
Q8TCD1,CR032_HUMAN,UPF0729 protein C18orf32 (Putative NF-kappa-B-activating protein 200),76,"8,669",2 out of 5,2008-02-26,Inferred from homology
O60519,CRBL2_HUMAN,cAMP-responsive element-binding protein-like 2,120,"13,784",4 out of 5,2008-02-05,Evidence at protein level
P22914,CRBS_HUMAN,Beta-crystallin S (Gamma-S-crystallin) (Gamma-crystallin S),178,"21,007",5 out of 5,1991-08-01,Evidence at protein level
A0PK11,CLRN2_HUMAN,Clarin-2,232,"25,446",2 out of 5,2007-02-06,Evidence at transcript level
Q8NCR9,CLRN3_HUMAN,Clarin-3 (Transmembrane protein 12) (Usher syndrome type-3A-like protein 1),226,"25,321",3 out of 5,2007-02-06,Evidence at transcript level
O75746,CMC1_HUMAN,Calcium-binding mitochondrial carrier protein Aralar1 (Mitochondrial aspartate glutamate carrier 1) (Solute carrier family 25 member 12),678,"74,762",5 out of 5,2001-02-21,Evidence at protein level
Q9BQ75,CMS1_HUMAN,Protein CMSS1 (Cms1 ribosomal small subunit homolog),279,"31,884",3 out of 5,2006-05-30,Evidence at protein level
Q86VU5,CMTD1_HUMAN,Catechol O-methyltransferase domain-containing protein 1 (EC 2.1.1.-),262,"28,809",4 out of 5,2006-05-02,Evidence at protein level
Q8NCQ2,CNAS1_HUMAN,Uncharacterized protein CSNK1G2-AS1 (CSNK1G2 antisense RNA 1) (CSNK1G2 antisense gene protein 1),148,"16,070",1 out of 5,2005-07-19,Evidence at transcript level
P42695,CNDD3_HUMAN,Condensin-2 complex subunit D3 (Non-SMC condensin II complex subunit D3) (hCAP-D3),1498,"168,891",5 out of 5,1995-11-01,Evidence at protein level
Q8NE01,CNNM3_HUMAN,Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3),707,"76,119",5 out of 5,2007-07-24,Evidence at protein level
Q9NZN8,CNOT2_HUMAN,CCR4-NOT transcription complex subunit 2 (CCR4-associated factor 2),540,"59,738",5 out of 5,2004-04-13,Evidence at protein level
Q9UFF9,CNOT8_HUMAN,CCR4-NOT transcription complex subunit 8 (EC 3.1.13.4) (CAF1-like protein) (CALIFp) (CAF2) (CCR4-associated factor 8) (Caf1b),292,"33,540",5 out of 5,2001-08-14,Evidence at protein level
P34972,CNR2_HUMAN,Cannabinoid receptor 2 (CB-2) (CB2) (hCB2) (CX5),360,"39,681",5 out of 5,1994-02-01,Evidence at protein level
P18545,CNRG_HUMAN,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (GMP-PDE gamma) (EC 3.1.4.35)",87,"9,643",5 out of 5,1990-11-01,Evidence at protein level
Q6PJW8,CNST_HUMAN,Consortin,725,"79,597",5 out of 5,2007-05-29,Evidence at protein level
Q8N815,CNTD1_HUMAN,Cyclin N-terminal domain-containing protein 1,330,"36,921",2 out of 5,2008-01-15,Evidence at transcript level
Q9NXG0,CNTLN_HUMAN,Centlein (Centrosomal protein),1405,"161,603",5 out of 5,2006-03-21,Evidence at protein level
Q9C0A0,CNTP4_HUMAN,Contactin-associated protein-like 4 (Cell recognition molecule Caspr4),1308,"145,274",5 out of 5,2001-12-05,Evidence at protein level
Q6ZUT6,CO052_HUMAN,Uncharacterized protein C15orf52,534,"57,325",3 out of 5,2007-07-24,Evidence at protein level
A8K5M9,CO062_HUMAN,"Uncharacterized protein C15orf62, mitochondrial",175,"19,679",2 out of 5,2008-04-29,Evidence at transcript level
P08123,CO1A2_HUMAN,Collagen alpha-2(I) chain (Alpha-2 type I collagen),1366,"129,314",5 out of 5,1988-08-01,Evidence at protein level
P08572,CO4A2_HUMAN,Collagen alpha-2(IV) chain [Cleaved into: Canstatin],1712,"167,553",5 out of 5,1988-08-01,Evidence at protein level
Q02388,CO7A1_HUMAN,Collagen alpha-1(VII) chain (Long-chain collagen) (LC collagen),2944,"295,220",5 out of 5,1994-06-01,Evidence at protein level
Q9GZY4,COA1_HUMAN,Cytochrome c oxidase assembly factor 1 homolog (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 15 kDa),146,"16,694",5 out of 5,2007-03-06,Evidence at protein level
Q86WW8,COA5_HUMAN,Cytochrome c oxidase assembly factor 5,74,"8,376",3 out of 5,2008-03-18,Evidence at protein level
Q9Y215,COLQ_HUMAN,Acetylcholinesterase collagenic tail peptide (AChE Q subunit) (Acetylcholinesterase-associated collagen),455,"47,766",5 out of 5,2001-01-11,Evidence at protein level
Q8NFW1,COMA1_HUMAN,Collagen alpha-1(XXII) chain,1626,"161,145",4 out of 5,2008-02-05,Evidence at transcript level
Q8N668,COMD1_HUMAN,COMM domain-containing protein 1 (Protein Murr1),190,"21,178",5 out of 5,2004-08-16,Evidence at protein level
Q86VX2,COMD7_HUMAN,COMM domain-containing protein 7,200,"22,540",5 out of 5,2004-08-16,Evidence at protein level
O14579,COPE_HUMAN,Coatomer subunit epsilon (Epsilon-coat protein) (Epsilon-COP),308,"34,482",5 out of 5,2000-05-30,Evidence at protein level
Q9P299,COPZ2_HUMAN,Coatomer subunit zeta-2 (Zeta-2-coat protein) (Zeta-2 COP),210,"23,548",4 out of 5,2002-05-10,Evidence at transcript level
Q99807,COQ7_HUMAN,"5-demethoxyubiquinone hydroxylase, mitochondrial (DMQ hydroxylase) (EC 1.14.13.-) (Timing protein clk-1 homolog) (Ubiquinone biosynthesis monooxygenase COQ7)",217,"24,277",5 out of 5,1997-11-01,Evidence at protein level
Q96D53,COQ8B_HUMAN,"Atypical kinase COQ8B, mitochondrial (EC 2.7.-.-) (AarF domain-containing protein kinase 4) (Coenzyme Q protein 8B)",544,"60,069",5 out of 5,2007-01-09,Evidence at protein level
Q9ULV4,COR1C_HUMAN,Coronin-1C (Coronin-3) (hCRNN4),474,"53,249",5 out of 5,2001-01-11,Evidence at protein level
P23946,CMA1_HUMAN,Chymase (EC 3.4.21.39) (Alpha-chymase) (Mast cell protease I),247,"27,325",5 out of 5,1992-03-01,Evidence at protein level
Q9UJS0,CMC2_HUMAN,Calcium-binding mitochondrial carrier protein Aralar2 (Citrin) (Mitochondrial aspartate glutamate carrier 2) (Solute carrier family 25 member 13),675,"74,176",5 out of 5,2001-02-21,Evidence at protein level
Q9BT09,CNPY3_HUMAN,Protein canopy homolog 3 (CTG repeat protein 4a) (Expanded repeat-domain protein CAG/CTG 5) (Protein associated with TLR4) (Trinucleotide repeat-containing gene 5 protein),278,"30,748",5 out of 5,2008-01-15,Evidence at protein level
Q96F85,CNRP1_HUMAN,CB1 cannabinoid receptor-interacting protein 1 (CRIP-1),164,"18,648",3 out of 5,2005-07-05,Evidence at protein level
Q12860,CNTN1_HUMAN,Contactin-1 (Glycoprotein gp135) (Neural cell surface protein F3),1018,"113,320",5 out of 5,1997-11-01,Evidence at protein level
Q9P232,CNTN3_HUMAN,Contactin-3 (Brain-derived immunoglobulin superfamily protein 1) (BIG-1) (Plasmacytoma-associated neuronal glycoprotein),1028,"112,883",5 out of 5,2004-11-23,Evidence at protein level
Q9UHC6,CNTP2_HUMAN,Contactin-associated protein-like 2 (Cell recognition molecule Caspr2),1331,"148,167",5 out of 5,2001-12-05,Evidence at protein level
Q32M92,CO032_HUMAN,Uncharacterized protein C15orf32,178,"20,262",1 out of 5,2006-06-27,Evidence at transcript level
P53420,CO4A4_HUMAN,Collagen alpha-4(IV) chain,1690,"164,038",5 out of 5,1996-10-01,Evidence at protein level
P29400,CO4A5_HUMAN,Collagen alpha-5(IV) chain,1685,"161,044",5 out of 5,1992-12-01,Evidence at protein level
P0C0L5,CO4B_HUMAN,Complement C4-B (Basic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3) [Cleaved into: Complement C4 beta chain; Complement C4-B alpha chain; C4a anaphylatoxin; C4b-B; C4d-B; Complement C4 gamma chain],1744,"192,751",5 out of 5,1986-07-21,Evidence at protein level
P20908,CO5A1_HUMAN,Collagen alpha-1(V) chain,1838,"183,560",5 out of 5,1991-02-01,Evidence at protein level
P12109,CO6A1_HUMAN,Collagen alpha-1(VI) chain,1028,"108,529",5 out of 5,1989-10-01,Evidence at protein level
A8TX70,CO6A5_HUMAN,Collagen alpha-5(VI) chain (Collagen alpha-1(XXIX) chain) (von Willebrand factor A domain-containing protein 4),2615,"289,926",5 out of 5,2008-05-20,Evidence at protein level
P13671,CO6_HUMAN,Complement component C6,934,"104,786",5 out of 5,1990-01-01,Evidence at protein level
Q96BR5,COA7_HUMAN,Cytochrome c oxidase assembly factor 7 (Beta-lactamase hcp-like protein) (Respiratory chain assembly factor 1) (Sel1 repeat-containing protein 1),231,"25,709",4 out of 5,2007-04-03,Evidence at protein level
P39060,COIA1_HUMAN,Collagen alpha-1(XVIII) chain [Cleaved into: Endostatin],1754,"178,188",5 out of 5,1995-02-01,Evidence at protein level
Q14993,COJA1_HUMAN,Collagen alpha-1(XIX) chain (Collagen alpha-1(Y) chain),1142,"115,221",5 out of 5,2001-11-16,Evidence at protein level
A2RUU4,COLL1_HUMAN,Colipase-like protein 1,121,"14,057",3 out of 5,2008-05-20,Evidence at transcript level
Q9GZQ3,COMD5_HUMAN,COMM domain-containing protein 5 (Hypertension-related calcium-regulated gene protein) (HCaRG),224,"24,670",4 out of 5,2004-08-16,Evidence at protein level
P21964,COMT_HUMAN,Catechol O-methyltransferase (EC 2.1.1.6),271,"30,037",5 out of 5,1991-08-01,Evidence at protein level
Q9UQ03,COR2B_HUMAN,Coronin-2B (Coronin-like protein C) (Clipin-C) (Protein FC96),480,"54,953",4 out of 5,2001-01-11,Evidence at protein level
P57737,CORO7_HUMAN,Coronin-7 (Crn7) (70 kDa WD repeat tumor rejection antigen homolog),925,"100,605",5 out of 5,2001-01-11,Evidence at protein level
P10589,COT1_HUMAN,COUP transcription factor 1 (COUP-TF1) (COUP transcription factor I) (COUP-TF I) (Nuclear receptor subfamily 2 group F member 1) (V-erbA-related protein 3) (EAR-3),423,"46,156",5 out of 5,1989-07-01,Evidence at protein level
P09669,COX6C_HUMAN,Cytochrome c oxidase subunit 6C (Cytochrome c oxidase polypeptide VIc),75,"8,781",3 out of 5,1989-07-01,Evidence at protein level
P10176,COX8A_HUMAN,"Cytochrome c oxidase subunit 8A, mitochondrial (Cytochrome c oxidase polypeptide VIII-liver/heart) (Cytochrome c oxidase subunit 8-2)",69,"7,579",4 out of 5,1989-07-01,Evidence at protein level
A6NNT2,CP096_HUMAN,Uncharacterized protein C16orf96,1141,"125,041",1 out of 5,2008-07-22,Predicted
Q6UW02,CP20A_HUMAN,Cytochrome P450 20A1 (EC 1.14.-.-),462,"52,432",3 out of 5,2008-02-05,Evidence at protein level
P33260,CP2CI_HUMAN,Cytochrome P450 2C18 (EC 1.14.14.1) (CYPIIC18) (Cytochrome P450-6b/29c),490,"55,711",5 out of 5,1994-02-01,Evidence at protein level
Q9NYL5,CP39A_HUMAN,24-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.26) (Cytochrome P450 39A1) (hCYP39A1) (Oxysterol 7-alpha-hydroxylase),469,"54,116",5 out of 5,2002-01-23,Evidence at transcript level
P08684,CP3A4_HUMAN,"Cytochrome P450 3A4 (EC 1.14.13.-) (1,8-cineole 2-exo-monooxygenase) (EC 1.14.13.157) (Albendazole monooxygenase) (EC 1.14.13.32) (Albendazole sulfoxidase) (CYPIIIA3) (CYPIIIA4) (Cholesterol 25-hydroxylase) (EC 1.14.14.1) (Cytochrome P450 3A3) (Cytochrome P450 HLp) (Cytochrome P450 NF-25) (Cytochrome P450-PCN1) (Nifedipine oxidase) (Quinine 3-monooxygenase) (EC 1.14.13.67) (Taurochenodeoxycholate 6-alpha-hydroxylase) (EC 1.14.13.97)",503,"57,343",5 out of 5,1988-01-01,Evidence at protein level
Q5TCH4,CP4AM_HUMAN,Cytochrome P450 4A22 (CYPIVA22) (Fatty acid omega-hydroxylase) (Lauric acid omega-hydroxylase) (Long-chain fatty acid omega-monooxygenase) (EC 1.14.13.205),519,"59,246",5 out of 5,2008-07-01,Evidence at protein level
Q6NT55,CP4FN_HUMAN,Cytochrome P450 4F22 (EC 1.14.14.-),531,"61,958",4 out of 5,2007-07-10,Evidence at transcript level
Q9HCS2,CP4FC_HUMAN,Cytochrome P450 4F12 (EC 1.14.14.1) (CYPIVF12),524,"60,270",5 out of 5,2002-05-10,Evidence at protein level
Q5SZB4,CI050_HUMAN,Uncharacterized protein C9orf50,431,"47,639",2 out of 5,2007-07-10,Evidence at transcript level
A0PJX0,CIB4_HUMAN,Calcium and integrin-binding family member 4,185,"21,745",3 out of 5,2007-05-29,Evidence at protein level
Q14011,CIRBP_HUMAN,Cold-inducible RNA-binding protein (A18 hnRNP) (Glycine-rich RNA-binding protein CIRP),172,"18,648",5 out of 5,1999-07-15,Evidence at protein level
Q8N3C7,CLIP4_HUMAN,CAP-Gly domain-containing linker protein 4 (Restin-like protein 2),705,"76,317",4 out of 5,2005-03-01,Evidence at protein level
P49761,CLK3_HUMAN,Dual specificity protein kinase CLK3 (EC 2.7.12.1) (CDC-like kinase 3),638,"73,515",5 out of 5,1996-10-01,Evidence at protein level
Q92989,CLP1_HUMAN,Polyribonucleotide 5'-hydroxyl-kinase Clp1 (EC 2.7.1.78) (Polyadenylation factor Clp1) (Polynucleotide kinase Clp1) (Pre-mRNA cleavage complex II protein Clp1),425,"47,646",5 out of 5,2001-04-27,Evidence at protein level
P29973,CNGA1_HUMAN,"cGMP-gated cation channel alpha-1 (Cyclic nucleotide-gated cation channel 1) (Cyclic nucleotide-gated channel alpha-1) (CNG channel alpha-1) (CNG-1) (CNG1) (Cyclic nucleotide-gated channel, photoreceptor) (Rod photoreceptor cGMP-gated channel subunit alpha)",690,"79,586",5 out of 5,1993-04-01,Evidence at protein level
Q9P003,CNIH4_HUMAN,Protein cornichon homolog 4 (CNIH-4) (Cornichon family AMPA receptor auxiliary protein 4),139,"16,093",4 out of 5,2000-12-08,Evidence at protein level
Q8WXI2,CNKR2_HUMAN,Connector enhancer of kinase suppressor of ras 2 (Connector enhancer of KSR 2) (CNK homolog protein 2) (CNK2),1034,"117,535",5 out of 5,2004-07-19,Evidence at protein level
Q6ZRI6,CO039_HUMAN,Uncharacterized protein C15orf39,1047,"110,673",3 out of 5,2006-06-27,Evidence at protein level
Q2T9L4,CO059_HUMAN,UPF0583 protein C15orf59,293,"31,928",2 out of 5,2008-05-20,Evidence at transcript level
H3BRN8,CO065_HUMAN,Uncharacterized protein C15orf65,121,"13,763",1 out of 5,2013-09-18,Evidence at transcript level
P83436,COG7_HUMAN,Conserved oligomeric Golgi complex subunit 7 (COG complex subunit 7) (Component of oligomeric Golgi complex 7),770,"86,344",5 out of 5,2002-08-30,Evidence at protein level
Q9UMD9,COHA1_HUMAN,Collagen alpha-1(XVII) chain (180 kDa bullous pemphigoid antigen 2) (Bullous pemphigoid antigen 2) [Cleaved into: 120 kDa linear IgA disease antigen (120 kDa linear IgA dermatosis antigen) (Linear IgA disease antigen 1) (LAD-1); 97 kDa linear IgA disease antigen (97 kDa linear IgA bullous dermatosis antigen) (97 kDa LAD antigen) (97-LAD) (Linear IgA bullous disease antigen of 97 kDa) (LABD97)],1497,"150,419",5 out of 5,2004-02-02,Evidence at protein level
Q17RW2,COOA1_HUMAN,Collagen alpha-1(XXIV) chain,1714,"175,496",4 out of 5,2008-02-05,Evidence at protein level
P53621,COPA_HUMAN,Coatomer subunit alpha (Alpha-coat protein) (Alpha-COP) (HEP-COP) (HEPCOP) [Cleaved into: Xenin (Xenopsin-related peptide); Proxenin],1224,"138,346",5 out of 5,1996-10-01,Evidence at protein level
P48444,COPD_HUMAN,Coatomer subunit delta (Archain) (Delta-coat protein) (Delta-COP),511,"57,210",5 out of 5,1996-02-01,Evidence at protein level
Q9UBF2,COPG2_HUMAN,Coatomer subunit gamma-2 (Gamma-2-coat protein) (Gamma-2-COP),871,"97,622",5 out of 5,2001-02-21,Evidence at protein level
Q96A83,COQA1_HUMAN,Collagen alpha-1(XXVI) chain (Alpha-1 type XXVI collagen) (EMI domain-containing protein 2) (Emilin and multimerin domain-containing protein 2) (Emu2),441,"45,381",5 out of 5,2003-10-03,Evidence at protein level
Q9P0S2,COX16_HUMAN,"Cytochrome c oxidase assembly protein COX16 homolog, mitochondrial",106,"12,293",2 out of 5,2005-07-05,Inferred from homology
Q49B96,COX19_HUMAN,Cytochrome c oxidase assembly protein COX19 (hCOX19),90,"10,394",3 out of 5,2007-01-23,Evidence at protein level
Q86TY3,CN037_HUMAN,Uncharacterized protein C14orf37,774,"84,173",3 out of 5,2006-10-03,Evidence at protein level
Q86U02,CN165_HUMAN,Putative uncharacterized protein encoded by LINC00596,117,"13,541",2 out of 5,2006-12-12,Uncertain
Q15003,CND2_HUMAN,Condensin complex subunit 2 (Barren homolog protein 1) (Chromosome-associated protein H) (hCAP-H) (Non-SMC condensin I complex subunit H) (XCAP-H homolog),741,"82,563",5 out of 5,2003-04-23,Evidence at protein level
Q6IBW4,CNDH2_HUMAN,Condensin-2 complex subunit H2 (Chromosome-associated protein H2) (hCAP-H2) (Kleisin-beta) (Non-SMC condensin II complex subunit H2),605,"68,227",5 out of 5,2008-03-18,Evidence at protein level
Q8N910,CO056_HUMAN,Putative uncharacterized protein C15orf56,161,"17,040",1 out of 5,2008-02-05,Evidence at transcript level
P02458,CO2A1_HUMAN,Collagen alpha-1(II) chain (Alpha-1 type II collagen) [Cleaved into: Collagen alpha-1(II) chain; Chondrocalcin],1487,"141,785",5 out of 5,1986-07-21,Evidence at protein level
P10643,CO7_HUMAN,Complement component C7,843,"93,518",5 out of 5,1989-07-01,Evidence at protein level
P07360,CO8G_HUMAN,Complement component C8 gamma chain,202,"22,277",5 out of 5,1988-04-01,Evidence at protein level
Q14050,CO9A3_HUMAN,Collagen alpha-3(IX) chain,684,"63,616",5 out of 5,2002-01-23,Evidence at protein level
P02748,CO9_HUMAN,Complement component C9 [Cleaved into: Complement component C9a; Complement component C9b],559,"63,173",5 out of 5,1986-07-21,Evidence at protein level
Q9Y2R0,COA3_HUMAN,"Cytochrome c oxidase assembly factor 3 homolog, mitochondrial (Coiled-coil domain-containing protein 56) (Mitochondrial translation regulation assembly intermediate of cytochrome c oxidase protein of 12 kDa)",106,"11,731",5 out of 5,2006-06-13,Evidence at protein level
Q9UP83,COG5_HUMAN,Conserved oligomeric Golgi complex subunit 5 (COG complex subunit 5) (13S Golgi transport complex 90 kDa subunit) (GTC-90) (Component of oligomeric Golgi complex 5) (Golgi transport complex 1),839,"92,743",5 out of 5,2002-08-30,Evidence at protein level
Q9Y2V7,COG6_HUMAN,Conserved oligomeric Golgi complex subunit 6 (COG complex subunit 6) (Component of oligomeric Golgi complex 6),657,"73,279",5 out of 5,2002-08-30,Evidence at protein level
Q9NX08,COMD8_HUMAN,COMM domain-containing protein 8,183,"21,090",4 out of 5,2004-08-16,Evidence at protein level
P53618,COPB_HUMAN,Coatomer subunit beta (Beta-coat protein) (Beta-COP),953,"107,142",5 out of 5,1996-10-01,Evidence at protein level
Q9Y678,COPG1_HUMAN,Coatomer subunit gamma-1 (Gamma-1-coat protein) (Gamma-1-COP),874,"97,718",5 out of 5,2001-01-11,Evidence at protein level
O15431,COPT1_HUMAN,High affinity copper uptake protein 1 (Copper transporter 1) (hCTR1) (Solute carrier family 31 member 1),190,"21,091",5 out of 5,2001-01-11,Evidence at protein level
P61923,COPZ1_HUMAN,Coatomer subunit zeta-1 (Zeta-1-coat protein) (Zeta-1 COP),177,"20,198",5 out of 5,2004-06-07,Evidence at protein level
Q9Y2Z9,COQ6_HUMAN,"Ubiquinone biosynthesis monooxygenase COQ6, mitochondrial (EC 1.14.13.-) (Coenzyme Q10 monooxygenase 6)",468,"50,870",5 out of 5,2000-05-30,Evidence at protein level
Q8NI60,COQ8A_HUMAN,"Atypical kinase COQ8A, mitochondrial (EC 2.7.-.-) (Chaperone activity of bc1 complex-like) (Chaperone-ABC1-like) (Coenzyme Q protein 8A) (aarF domain-containing protein kinase 3)",647,"71,950",5 out of 5,2003-01-27,Evidence at protein level
Q96I36,COX14_HUMAN,Cytochrome c oxidase assembly protein COX14,57,"6,600",4 out of 5,2006-12-12,Evidence at protein level
P00403,COX2_HUMAN,Cytochrome c oxidase subunit 2 (Cytochrome c oxidase polypeptide II),227,"25,565",5 out of 5,1986-07-21,Evidence at protein level
P00414,COX3_HUMAN,Cytochrome c oxidase subunit 3 (Cytochrome c oxidase polypeptide III),261,"29,951",5 out of 5,1986-07-21,Evidence at protein level
Q8IYS4,CP071_HUMAN,Uncharacterized protein C16orf71,520,"55,682",2 out of 5,2007-07-10,Evidence at transcript level
Q8N9R0,CP081_HUMAN,Putative uncharacterized protein encoded by LINC00304,145,"15,610",1 out of 5,2007-07-24,Uncertain
Q9H693,CP095_HUMAN,Uncharacterized protein C16orf95,158,"16,793",1 out of 5,2011-07-27,Evidence at transcript level
O43405,COCH_HUMAN,Cochlin (COCH-5B2),550,"59,483",5 out of 5,2000-05-30,Evidence at protein level
Q05707,COEA1_HUMAN,Collagen alpha-1(XIV) chain (Undulin),1796,"193,515",5 out of 5,2005-02-01,Evidence at protein level
Q9Y281,COF2_HUMAN,"Cofilin-2 (Cofilin, muscle isoform)",166,"18,737",5 out of 5,2000-05-30,Evidence at protein level
Q07092,COGA1_HUMAN,Collagen alpha-1(XVI) chain,1604,"157,751",5 out of 5,1995-02-01,Evidence at protein level
A8K830,COLC2_HUMAN,Colorectal cancer-associated protein 2 (Cancer susceptibility candidate protein 13),154,"16,850",3 out of 5,2008-05-20,Evidence at transcript level
Q6UWE3,COLL2_HUMAN,Colipase-like protein 2,100,"10,812",3 out of 5,2004-11-09,Evidence at protein level
Q9H0A8,COMD4_HUMAN,COMM domain-containing protein 4,199,"21,764",4 out of 5,2004-08-16,Evidence at protein level
Q9NQ92,COPRS_HUMAN,Coordinator of PRMT5 and differentiation stimulator (Cooperator of PRMT5) (Protein TTP1),184,"20,066",5 out of 5,2008-05-20,Evidence at protein level
Q96H96,COQ2_HUMAN,"4-hydroxybenzoate polyprenyltransferase, mitochondrial (4-HB polyprenyltransferase) (EC 2.5.1.39) (4-hydroxybenzoate decaprenyltransferase) (COQ2 homolog) (hCOQ2) (Para-hydroxybenzoate--polyprenyltransferase) (PHB:PPT) (PHB:polyprenyltransferase)",371,"40,489",5 out of 5,2006-03-21,Evidence at protein level
Q9NZJ6,COQ3_HUMAN,"Ubiquinone biosynthesis O-methyltransferase, mitochondrial (3-demethylubiquinol 3-O-methyltransferase) (EC 2.1.1.64) (Polyprenyldihydroxybenzoate methyltransferase) (EC 2.1.1.114)",369,"41,054",5 out of 5,2001-11-02,Evidence at protein level
P13073,COX41_HUMAN,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial (Cytochrome c oxidase polypeptide IV) (Cytochrome c oxidase subunit IV isoform 1) (COX IV-1)",169,"19,577",5 out of 5,1990-01-01,Evidence at protein level
P20674,COX5A_HUMAN,"Cytochrome c oxidase subunit 5A, mitochondrial (Cytochrome c oxidase polypeptide Va)",150,"16,762",4 out of 5,1991-02-01,Evidence at protein level
Q96MC5,CP045_HUMAN,Uncharacterized protein C16orf45,204,"23,732",2 out of 5,2005-07-05,Evidence at protein level
Q7L2K0,CP059_HUMAN,Uncharacterized protein C16orf59,433,"46,402",2 out of 5,2007-05-15,Evidence at protein level
Q14CZ0,CP072_HUMAN,UPF0472 protein C16orf72,275,"30,926",2 out of 5,2007-08-21,Evidence at protein level
Q96GX8,CP074_HUMAN,Uncharacterized protein C16orf74,76,"8,118",1 out of 5,2006-12-12,Evidence at protein level
P05177,CP1A2_HUMAN,Cytochrome P450 1A2 (EC 1.14.14.1) (CYPIA2) (Cholesterol 25-hydroxylase) (Cytochrome P(3)450) (Cytochrome P450 4) (Cytochrome P450-P3),515,"58,294",5 out of 5,1987-08-13,Evidence at protein level
P08686,CP21A_HUMAN,Steroid 21-hydroxylase (EC 1.14.14.16) (21-OHase) (Cytochrome P-450c21) (Cytochrome P450 21) (Cytochrome P450 XXI) (Cytochrome P450-C21) (Cytochrome P450-C21B),494,"55,887",5 out of 5,1986-11-01,Evidence at protein level
Q6VVX0,CP2R1_HUMAN,Vitamin D 25-hydroxylase (EC 1.14.14.24) (Cytochrome P450 2R1),501,"57,359",5 out of 5,2005-03-29,Evidence at protein level
Q8TAV3,CP2W1_HUMAN,Cytochrome P450 2W1 (EC 1.14.14.-) (CYPIIW1),490,"53,844",5 out of 5,2004-07-19,Evidence at protein level
Q9HB55,CP343_HUMAN,Cytochrome P450 3A43 (EC 1.14.14.1),503,"57,670",5 out of 5,2002-01-31,Evidence at protein level
P98187,CP4F8_HUMAN,Cytochrome P450 4F8 (EC 1.14.14.1) (CYPIVF8),520,"59,995",5 out of 5,2000-12-01,Evidence at protein level
Q8N1L4,CP4Z2_HUMAN,Putative inactive cytochrome P450 family member 4Z2,340,"40,159",3 out of 5,2008-04-29,Uncertain
Q16850,CP51A_HUMAN,Lanosterol 14-alpha demethylase (LDM) (EC 1.14.13.70) (CYPLI) (Cytochrome P450 51A1) (Cytochrome P450-14DM) (Cytochrome P45014DM) (Cytochrome P450LI) (Sterol 14-alpha demethylase),503,"56,806",5 out of 5,1997-11-01,Evidence at protein level
Q8WVH0,CPLX3_HUMAN,Complexin-3 (Complexin III) (CPX III),158,"17,557",4 out of 5,2006-05-30,Evidence at transcript level
Q9BRF8,CPPED_HUMAN,Serine/threonine-protein phosphatase CPPED1 (EC 3.1.3.16) (Calcineurin-like phosphoesterase domain-containing protein 1) (Complete S-transactivated protein 1),314,"35,548",5 out of 5,2008-02-26,Evidence at protein level
Q8NEP4,CQ047_HUMAN,Uncharacterized protein C17orf47,570,"63,111",1 out of 5,2007-05-15,Evidence at transcript level
A8MU93,CQ100_HUMAN,Uncharacterized protein C17orf100,164,"18,001",1 out of 5,2008-06-10,Evidence at transcript level
Q70SY1,CR3L2_HUMAN,Cyclic AMP-responsive element-binding protein 3-like protein 2 (cAMP-responsive element-binding protein 3-like protein 2) (BBF2 human homolog on chromosome 7) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 2],520,"57,415",5 out of 5,2007-05-29,Evidence at protein level
Q9NQ79,CRAC1_HUMAN,Cartilage acidic protein 1 (68 kDa chondrocyte-expressed protein) (CEP-68) (ASPIC),661,"71,421",5 out of 5,2004-07-19,Evidence at protein level
P53674,CRBB1_HUMAN,Beta-crystallin B1 (Beta-B1 crystallin),252,"28,023",5 out of 5,1996-10-01,Evidence at protein level
Q96SW2,CRBN_HUMAN,Protein cereblon,442,"50,546",5 out of 5,2005-08-30,Evidence at protein level
P54107,CRIS1_HUMAN,Cysteine-rich secretory protein 1 (CRISP-1) (AEG-like protein) (ARP) (Acidic epididymal glycoprotein homolog),249,"28,481",5 out of 5,1996-10-01,Evidence at protein level
P54108,CRIS3_HUMAN,Cysteine-rich secretory protein 3 (CRISP-3) (Specific granule protein of 28 kDa) (SGP28),245,"27,630",5 out of 5,1996-10-01,Evidence at protein level
Q53ET0,CRTC2_HUMAN,CREB-regulated transcription coactivator 2 (Transducer of regulated cAMP response element-binding protein 2) (TORC-2) (Transducer of CREB protein 2),693,"73,302",5 out of 5,2008-02-05,Evidence at protein level
Q5IJ48,CRUM2_HUMAN,Protein crumbs homolog 2 (Crumbs-like protein 2),1285,"134,265",5 out of 5,2005-07-19,Evidence at protein level
P02511,CRYAB_HUMAN,Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component),175,"20,159",5 out of 5,1986-07-21,Evidence at protein level
Q9Y6Y1,CMTA1_HUMAN,Calmodulin-binding transcription activator 1,1673,"183,672",5 out of 5,2006-05-16,Evidence at protein level
Q9H972,CN093_HUMAN,Uncharacterized protein C14orf93,538,"58,697",3 out of 5,2003-07-25,Evidence at protein level
Q9NSA3,CNBP1_HUMAN,Beta-catenin-interacting protein 1 (Inhibitor of beta-catenin and Tcf-4),81,"9,170",5 out of 5,2003-03-28,Evidence at protein level
Q13956,CNCG_HUMAN,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma (GMP-PDE gamma) (EC 3.1.4.35)",83,"9,074",4 out of 5,1997-11-01,Evidence at protein level
Q96KN2,CNDP1_HUMAN,Beta-Ala-His dipeptidase (EC 3.4.13.20) (CNDP dipeptidase 1) (Carnosine dipeptidase 1) (Glutamate carboxypeptidase-like protein 2) (Serum carnosinase),507,"56,706",5 out of 5,2002-09-19,Evidence at protein level
O95476,CNEP1_HUMAN,CTD nuclear envelope phosphatase 1 (EC 3.1.3.16) (Serine/threonine-protein phosphatase dullard),244,"28,377",5 out of 5,2007-08-21,Evidence at protein level
Q96NU0,CNT3B_HUMAN,Contactin-associated protein-like 3B (Cell recognition molecule Caspr3b),1288,"140,468",3 out of 5,2008-06-10,Evidence at transcript level
P26992,CNTFR_HUMAN,Ciliary neurotrophic factor receptor subunit alpha (CNTF receptor subunit alpha) (CNTFR-alpha),372,"40,633",5 out of 5,1992-08-01,Evidence at protein level
Q9UQ52,CNTN6_HUMAN,Contactin-6 (Neural recognition molecule NB-3) (hNB-3),1028,"113,956",5 out of 5,2004-11-23,Evidence at protein level
P02452,CO1A1_HUMAN,Collagen alpha-1(I) chain (Alpha-1 type I collagen),1464,"138,941",5 out of 5,1986-07-21,Evidence at protein level
P25940,CO5A3_HUMAN,Collagen alpha-3(V) chain,1745,"172,121",5 out of 5,1992-05-01,Evidence at protein level
Q99715,COCA1_HUMAN,Collagen alpha-1(XII) chain,3063,"333,147",5 out of 5,1998-07-15,Evidence at protein level
Q5TAT6,CODA1_HUMAN,Collagen alpha-1(XIII) chain (COLXIIIA1),717,"69,950",5 out of 5,2007-04-17,Evidence at protein level
Q9H4W6,COE3_HUMAN,Transcription factor COE3 (Early B-cell factor 3) (EBF-3) (Olf-1/EBF-like 2) (O/E-2) (OE-2),596,"64,864",4 out of 5,2001-05-04,Evidence at protein level
Q96KJ9,COX42_HUMAN,"Cytochrome c oxidase subunit 4 isoform 2, mitochondrial (Cytochrome c oxidase subunit IV isoform 2) (COX IV-2)",171,"20,010",4 out of 5,2002-04-03,Evidence at protein level
Q6ZP98,CP047_HUMAN,Putative uncharacterized protein C16orf47,133,"14,599",1 out of 5,2006-12-12,Evidence at transcript level
Q7Z3J2,CP062_HUMAN,UPF0505 protein C16orf62 (Esophageal cancer-associated protein),963,"109,563",5 out of 5,2007-11-13,Evidence at protein level
P04798,CP1A1_HUMAN,Cytochrome P450 1A1 (EC 1.14.14.1) (CYPIA1) (Cytochrome P450 form 6) (Cytochrome P450-C) (Cytochrome P450-P1),512,"58,165",5 out of 5,1987-08-13,Evidence at protein level
O43174,CP26A_HUMAN,Cytochrome P450 26A1 (EC 1.14.13.-) (Cytochrome P450 retinoic acid-inactivating 1) (Cytochrome P450RAI) (hP450RAI) (Retinoic acid 4-hydroxylase) (Retinoic acid-metabolizing cytochrome),497,"56,199",5 out of 5,1998-12-15,Evidence at protein level
Q6V0L0,CP26C_HUMAN,Cytochrome P450 26C1 (EC 1.14.-.-),522,"57,111",5 out of 5,2005-07-19,Evidence at transcript level
P33261,CP2CJ_HUMAN,Cytochrome P450 2C19 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.13.80) ((S)-limonene 6-monooxygenase) (EC 1.14.13.48) ((S)-limonene 7-monooxygenase) (EC 1.14.13.49) (CYPIIC17) (CYPIIC19) (Cytochrome P450-11A) (Cytochrome P450-254C) (Mephenytoin 4-hydroxylase),490,"55,931",5 out of 5,1994-02-01,Evidence at protein level
P10635,CP2D6_HUMAN,Cytochrome P450 2D6 (EC 1.14.14.1) (CYPIID6) (Cholesterol 25-hydroxylase) (Cytochrome P450-DB1) (Debrisoquine 4-hydroxylase),497,"55,769",5 out of 5,1989-07-01,Evidence at protein level
P24903,CP2F1_HUMAN,Cytochrome P450 2F1 (EC 1.14.14.1) (CYPIIF1),491,"55,501",5 out of 5,1992-03-01,Evidence at protein level
O75881,CP7B1_HUMAN,25-hydroxycholesterol 7-alpha-hydroxylase (EC 1.14.14.29) (Cytochrome P450 7B1) (Oxysterol 7-alpha-hydroxylase),506,"58,256",5 out of 5,1999-07-15,Evidence at protein level
Q17RY0,CPEB4_HUMAN,Cytoplasmic polyadenylation element-binding protein 4 (CPE-BP4) (CPE-binding protein 4) (hCPEB-4),729,"80,152",5 out of 5,2006-12-12,Evidence at protein level
O75131,CPNE3_HUMAN,Copine-3 (Copine III),537,"60,131",5 out of 5,2000-12-01,Evidence at protein level
Q10570,CPSF1_HUMAN,Cleavage and polyadenylation specificity factor subunit 1 (Cleavage and polyadenylation specificity factor 160 kDa subunit) (CPSF 160 kDa subunit),1443,"160,884",5 out of 5,1996-10-01,Evidence at protein level
Q16630,CPSF6_HUMAN,Cleavage and polyadenylation specificity factor subunit 6 (Cleavage and polyadenylation specificity factor 68 kDa subunit) (CFIm68) (CPSF 68 kDa subunit) (Pre-mRNA cleavage factor Im 68 kDa subunit) (Protein HPBRII-4/7),551,"59,210",5 out of 5,2006-02-07,Evidence at protein level
Q96SM3,CPXM1_HUMAN,Probable carboxypeptidase X1 (EC 3.4.17.-) (Metallocarboxypeptidase CPX-1),734,"81,668",4 out of 5,2002-10-10,Evidence at transcript level
Q53H64,CQ073_HUMAN,Putative uncharacterized protein encoded by LINC00483,154,"17,042",1 out of 5,2007-10-23,Uncertain
Q86X59,CQ082_HUMAN,Putative uncharacterized protein C17orf82,251,"25,393",1 out of 5,2007-04-17,Evidence at protein level
A2RUQ5,CQ102_HUMAN,Uncharacterized protein C17orf102,167,"17,761",1 out of 5,2008-09-02,Evidence at transcript level
Q9H8M1,CQ10B_HUMAN,"Coenzyme Q-binding protein COQ10 homolog B, mitochondrial",238,"27,071",3 out of 5,2006-03-21,Evidence at transcript level
P05813,CRBA1_HUMAN,"Beta-crystallin A3 [Cleaved into: Beta-crystallin A3, isoform A1, Delta4 form; Beta-crystallin A3, isoform A1, Delta7 form; Beta-crystallin A3, isoform A1, Delta8 form]",215,"25,150",5 out of 5,1988-11-01,Evidence at protein level
P43320,CRBB2_HUMAN,Beta-crystallin B2 (Beta-B2 crystallin) (Beta-crystallin Bp),205,"23,380",5 out of 5,1995-11-01,Evidence at protein level
Q68DQ2,CRBG3_HUMAN,Very large A-kinase anchor protein (vlAKAP) (Beta/gamma crystallin domain-containing protein 3),2970,"330,633",4 out of 5,2008-03-18,Evidence at protein level
H7BZ55,CRCC2_HUMAN,Putative ciliary rootlet coiled-coil protein 2,1655,"185,872",2 out of 5,2013-06-26,Uncertain
Q9UGL9,CRCT1_HUMAN,Cysteine-rich C-terminal protein 1 (Protein NICE-1),99,"9,736",4 out of 5,2000-12-01,Evidence at protein level
Q8IUH2,CREG2_HUMAN,Protein CREG2,290,"32,109",3 out of 5,2005-02-15,Evidence at protein level
O43186,CRX_HUMAN,Cone-rod homeobox protein,299,"32,261",5 out of 5,1998-07-15,Evidence at protein level
Q96JB2,COG3_HUMAN,Conserved oligomeric Golgi complex subunit 3 (COG complex subunit 3) (Component of oligomeric Golgi complex 3) (Vesicle-docking protein SEC34 homolog) (p94),828,"94,096",5 out of 5,2002-08-30,Evidence at protein level
Q96MW5,COG8_HUMAN,Conserved oligomeric Golgi complex subunit 8 (COG complex subunit 8) (Component of oligomeric Golgi complex 8),612,"68,424",5 out of 5,2002-08-30,Evidence at protein level
Q9P218,COKA1_HUMAN,Collagen alpha-1(XX) chain,1284,"135,830",4 out of 5,2002-10-10,Evidence at protein level
Q9Y6Z7,COL10_HUMAN,Collectin-10 (Collectin liver protein 1) (CL-L1) (Collectin-34) (CL-34),277,"30,705",4 out of 5,2008-01-15,Evidence at transcript level
Q9BWP8,COL11_HUMAN,Collectin-11 (Collectin kidney protein 1) (CL-K1),271,"28,665",5 out of 5,2008-01-15,Evidence at protein level
Q86X83,COMD2_HUMAN,COMM domain-containing protein 2,199,"22,745",4 out of 5,2004-08-16,Evidence at protein level
Q9BXS0,COPA1_HUMAN,Collagen alpha-1(XXV) chain (Alzheimer disease amyloid-associated protein) (AMY) (CLAC-P) [Cleaved into: Collagen-like Alzheimer amyloid plaque component (CLAC)],654,"64,771",5 out of 5,2006-10-31,Evidence at protein level
O75208,COQ9_HUMAN,"Ubiquinone biosynthesis protein COQ9, mitochondrial",318,"35,509",5 out of 5,2006-03-21,Evidence at protein level
Q9BR76,COR1B_HUMAN,Coronin-1B (Coronin-2),489,"54,235",5 out of 5,2002-05-27,Evidence at protein level
Q92828,COR2A_HUMAN,Coronin-2A (IR10) (WD repeat-containing protein 2),525,"59,763",3 out of 5,1998-07-15,Evidence at transcript level
Q8IZC6,CORA1_HUMAN,Collagen alpha-1(XXVII) chain,1860,"186,892",5 out of 5,2008-01-15,Evidence at protein level
Q14019,COTL1_HUMAN,Coactosin-like protein,142,"15,945",5 out of 5,2002-07-11,Evidence at protein level
Q7KZN9,COX15_HUMAN,Cytochrome c oxidase assembly protein COX15 homolog,410,"46,030",5 out of 5,2004-08-16,Evidence at protein level
Q8N8Q8,COX18_HUMAN,Mitochondrial inner membrane protein COX18 (COX18Hs) (Cytochrome c oxidase assembly protein 18),333,"37,063",4 out of 5,2003-11-14,Evidence at transcript level
Q8NHV5,CP052_HUMAN,Uncharacterized protein C16orf52,167,"18,250",1 out of 5,2007-01-09,Evidence at transcript level
Q6ZW13,CP086_HUMAN,Uncharacterized protein C16orf86,317,"33,511",1 out of 5,2008-02-26,Evidence at transcript level
Q494V2,CP100_HUMAN,Cilia- and flagella-associated protein 100 (Coiled-coil domain-containing protein 37),611,"71,117",3 out of 5,2006-05-16,Evidence at transcript level
O43303,CP110_HUMAN,Centriolar coiled-coil protein of 110 kDa (Centrosomal protein of 110 kDa) (CP110) (Cep110),1012,"113,424",5 out of 5,2001-02-21,Evidence at protein level
Q9BV73,CP250_HUMAN,Centrosome-associated protein CEP250 (250 kDa centrosomal protein) (Cep250) (Centrosomal Nek2-associated protein 1) (C-Nap1) (Centrosomal protein 2),2442,"281,137",5 out of 5,2003-05-09,Evidence at protein level
P10632,CP2C8_HUMAN,Cytochrome P450 2C8 (EC 1.14.14.1) (CYPIIC8) (Cytochrome P450 IIC2) (Cytochrome P450 MP-12) (Cytochrome P450 MP-20) (Cytochrome P450 form 1) (S-mephenytoin 4-hydroxylase),490,"55,825",5 out of 5,1989-07-01,Evidence at protein level
A0A087X1C5,CP2D7_HUMAN,Putative cytochrome P450 2D7 (EC 1.14.14.1),515,"57,489",5 out of 5,2015-04-01,Uncertain
P13584,CP4B1_HUMAN,Cytochrome P450 4B1 (EC 1.14.14.1) (CYPIVB1) (Cytochrome P450-HP),511,"58,991",5 out of 5,1990-01-01,Evidence at protein level
Q9HBI6,CP4FB_HUMAN,Phylloquinone omega-hydroxylase CYP4F11 (EC 1.14.13.194) (3-hydroxy fatty acids omega-hydroxylase CYP4F11) (EC 1.14.13.-) (Cytochrome P450 4F11) (CYPIVF11),524,"60,146",5 out of 5,2002-05-10,Evidence at protein level
Q9BZB8,CPEB1_HUMAN,Cytoplasmic polyadenylation element-binding protein 1 (CPE-BP1) (CPE-binding protein 1) (h-CPEB) (hCPEB-1),566,"62,595",5 out of 5,2006-12-12,Evidence at protein level
Q86WR6,CQ064_HUMAN,Uncharacterized protein C17orf64,236,"27,182",1 out of 5,2007-05-15,Evidence at transcript level
Q8N4C9,CQ078_HUMAN,Uncharacterized protein C17orf78,275,"30,555",2 out of 5,2007-09-11,Evidence at transcript level
Q96FQ7,CR018_HUMAN,Putative uncharacterized protein encoded by LINC00526,95,"10,201",2 out of 5,2005-07-05,Uncertain
Q8TEY5,CR3L4_HUMAN,Cyclic AMP-responsive element-binding protein 3-like protein 4 (cAMP-responsive element-binding protein 3-like protein 4) (Androgen-induced basic leucine zipper protein) (AIbZIP) (Attaching to CRE-like 1) (ATCE1) (Cyclic AMP-responsive element-binding protein 4) (CREB-4) (cAMP-responsive element-binding protein 4) (Transcript induced in spermiogenesis protein 40) (Tisp40) (hJAL) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 4],395,"43,432",5 out of 5,2007-05-29,Evidence at protein level
A6NIL9,CRAS1_HUMAN,Putative uncharacterized protein CRYM-AS1 (CRYM antisense RNA 1) (CRYM antisense gene protein 1),109,"12,312",2 out of 5,2008-07-22,Uncertain
P26998,CRBB3_HUMAN,"Beta-crystallin B3 (Beta-B3 crystallin) [Cleaved into: Beta-crystallin B3, N-terminally processed]",211,"24,252",5 out of 5,1992-08-01,Evidence at protein level
O75177,CREST_HUMAN,Calcium-responsive transactivator (SS18-like protein 1) (SYT homolog 1),396,"42,990",5 out of 5,2002-01-31,Evidence at protein level
P07316,CRGB_HUMAN,Gamma-crystallin B (Gamma-B-crystallin) (Gamma-crystallin 1-2),175,"20,908",4 out of 5,1988-04-01,Evidence at protein level
Q9NZV1,CRIM1_HUMAN,Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein],1036,"113,738",5 out of 5,2005-06-07,Evidence at protein level
Q6Q6R5,CRIP3_HUMAN,Cysteine-rich protein 3 (CRP-3) (Chromosome 6 LIM domain only protein) (h6LIMo),217,"24,088",3 out of 5,2006-03-07,Evidence at transcript level
Q6UW01,CBLN3_HUMAN,Cerebellin-3,205,"21,521",3 out of 5,2004-09-27,Evidence at protein level
P22681,CBL_HUMAN,E3 ubiquitin-protein ligase CBL (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene) (Proto-oncogene c-Cbl) (RING finger protein 55) (RING-type E3 ubiquitin transferase CBL) (Signal transduction protein CBL),906,"99,633",5 out of 5,1991-08-01,Evidence at protein level
Q8N4T0,CBPA6_HUMAN,Carboxypeptidase A6 (EC 3.4.17.-),437,"51,008",5 out of 5,2003-11-07,Evidence at protein level
Q8NEM8,CBPC3_HUMAN,Cytosolic carboxypeptidase 3 (EC 3.4.17.-) (ATP/GTP-binding protein-like 3),1001,"116,011",5 out of 5,2007-04-03,Evidence at transcript level
P16152,CBR1_HUMAN,Carbonyl reductase [NADPH] 1 (EC 1.1.1.184) (15-hydroxyprostaglandin dehydrogenase [NADP(+)]) (EC 1.1.1.197) (NADPH-dependent carbonyl reductase 1) (Prostaglandin 9-ketoreductase) (Prostaglandin-E(2) 9-reductase) (EC 1.1.1.189) (Short chain dehydrogenase/reductase family 21C member 1),277,"30,375",5 out of 5,1990-04-01,Evidence at protein level
A6NI87,CBY3_HUMAN,Protein chibby homolog 3,242,"27,343",1 out of 5,2008-06-10,Inferred from homology
Q8ND61,CC020_HUMAN,Uncharacterized protein C3orf20,904,"101,266",3 out of 5,2006-03-21,Evidence at transcript level
Q6ZUJ4,CC062_HUMAN,Uncharacterized protein C3orf62,267,"30,194",2 out of 5,2006-06-13,Evidence at protein level
Q8WV48,CC107_HUMAN,Coiled-coil domain-containing protein 107,283,"30,509",3 out of 5,2007-04-03,Evidence at transcript level
Q6TFL3,CC171_HUMAN,Coiled-coil domain-containing protein 171,1326,"152,810",3 out of 5,2005-08-02,Evidence at transcript level
P0C221,CC175_HUMAN,Coiled-coil domain-containing protein 175,793,"93,626",2 out of 5,2006-11-14,Predicted
Q3MIR4,CC50B_HUMAN,Cell cycle control protein 50B (P4-ATPase flippase complex beta subunit TMEM30B) (Transmembrane protein 30B),351,"38,941",4 out of 5,2006-06-27,Evidence at protein level
Q96LY2,CC74B_HUMAN,Coiled-coil domain-containing protein 74B,380,"41,826",2 out of 5,2007-02-06,Evidence at transcript level
Q8NEL0,CCD54_HUMAN,Coiled-coil domain-containing protein 54 (Testis development protein NYD-SP17),328,"37,886",2 out of 5,2007-05-15,Evidence at protein level
Q9BW85,CCD94_HUMAN,Coiled-coil domain-containing protein 94,323,"37,086",3 out of 5,2006-05-02,Evidence at protein level
O95273,CCDB1_HUMAN,Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid),360,"40,262",5 out of 5,2008-03-18,Evidence at protein level
Q9UBN1,CCG4_HUMAN,Voltage-dependent calcium channel gamma-4 subunit (Neuronal voltage-gated calcium channel gamma-4 subunit) (Transmembrane AMPAR regulatory protein gamma-4) (TARP gamma-4),327,"36,579",5 out of 5,2000-12-01,Evidence at transcript level
P53701,CCHL_HUMAN,Cytochrome c-type heme lyase (CCHL) (EC 4.4.1.17) (Holocytochrome c-type synthase),268,"30,602",5 out of 5,1996-10-01,Evidence at protein level
P80098,CCL7_HUMAN,C-C motif chemokine 7 (Monocyte chemoattractant protein 3) (Monocyte chemotactic protein 3) (MCP-3) (NC28) (Small-inducible cytokine A7),99,"11,200",5 out of 5,1992-12-01,Evidence at protein level
O14618,CCS_HUMAN,Copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone),274,"29,041",5 out of 5,2002-01-31,Evidence at protein level
Q86Y33,CD20B_HUMAN,Cell division cycle protein 20 homolog B,519,"57,335",5 out of 5,2008-06-10,Evidence at protein level
P25063,CD24_HUMAN,Signal transducer CD24 (Small cell lung carcinoma cluster 4 antigen) (CD antigen CD24),80,"8,097",5 out of 5,1992-05-01,Evidence at protein level
Q5ZPR3,CD276_HUMAN,CD276 antigen (4Ig-B7-H3) (B7 homolog 3) (B7-H3) (Costimulatory molecule) (CD antigen CD276),534,"57,235",5 out of 5,2006-01-24,Evidence at protein level
Q9Y5K6,CD2AP_HUMAN,CD2-associated protein (Adapter protein CMS) (Cas ligand with multiple SH3 domains),639,"71,451",5 out of 5,2003-04-23,Evidence at protein level
P06729,CD2_HUMAN,T-cell surface antigen CD2 (Erythrocyte receptor) (LFA-2) (LFA-3 receptor) (Rosette receptor) (T-cell surface antigen T11/Leu-5) (CD antigen CD2),351,"39,448",5 out of 5,1988-01-01,Evidence at protein level
P20138,CD33_HUMAN,Myeloid cell surface antigen CD33 (Sialic acid-binding Ig-like lectin 3) (Siglec-3) (gp67) (CD antigen CD33),364,"39,825",5 out of 5,1991-02-01,Evidence at protein level
P09693,CD3G_HUMAN,T-cell surface glycoprotein CD3 gamma chain (T-cell receptor T3 gamma chain) (CD antigen CD3g),182,"20,469",5 out of 5,1989-07-01,Evidence at protein level
Q08722,CD47_HUMAN,Leukocyte surface antigen CD47 (Antigenic surface determinant protein OA3) (Integrin-associated protein) (IAP) (Protein MER6) (CD antigen CD47),323,"35,214",5 out of 5,1995-11-01,Evidence at protein level
P01730,CD4_HUMAN,T-cell surface glycoprotein CD4 (T-cell surface antigen T4/Leu-3) (CD antigen CD4),458,"51,111",5 out of 5,1986-07-21,Evidence at protein level
Q15078,CD5R1_HUMAN,"Cyclin-dependent kinase 5 activator 1 (CDK5 activator 1) (Cyclin-dependent kinase 5 regulatory subunit 1) (TPKII regulatory subunit) [Cleaved into: Cyclin-dependent kinase 5 activator 1, p35 (p35); Cyclin-dependent kinase 5 activator 1, p25 (p25) (Tau protein kinase II 23 kDa subunit) (p23)]",307,"34,060",5 out of 5,1997-11-01,Evidence at protein level
Q07108,CD69_HUMAN,Early activation antigen CD69 (Activation inducer molecule) (AIM) (BL-AC/P26) (C-type lectin domain family 2 member C) (EA1) (Early T-cell activation antigen p60) (GP32/28) (Leukocyte surface antigen Leu-23) (MLR-3) (CD antigen CD69),199,"22,559",5 out of 5,1994-10-01,Evidence at protein level
P30203,CD6_HUMAN,T-cell differentiation antigen CD6 (T12) (TP120) (CD antigen CD6) [Cleaved into: Soluble CD6],668,"71,801",5 out of 5,1993-04-01,Evidence at protein level
Q9BWV3,CDAC1_HUMAN,Cytidine and dCMP deaminase domain-containing protein 1 (Testis development protein NYD-SP15),514,"58,455",3 out of 5,2007-09-11,Evidence at transcript level
P32320,CDD_HUMAN,Cytidine deaminase (EC 3.5.4.5) (Cytidine aminohydrolase),146,"16,185",5 out of 5,1993-10-01,Evidence at protein level
Q96JP9,CDHR1_HUMAN,Cadherin-related family member 1 (Photoreceptor cadherin) (prCAD) (Protocadherin-21),859,"93,595",5 out of 5,2008-02-05,Evidence at protein level
Q9BYE9,CDHR2_HUMAN,Cadherin-related family member 2 (Protocadherin LKC) (PC-LKC) (Protocadherin-24),1310,"141,543",5 out of 5,2005-03-29,Evidence at protein level
Q07002,CDK18_HUMAN,Cyclin-dependent kinase 18 (EC 2.7.11.22) (Cell division protein kinase 18) (PCTAIRE-motif protein kinase 3) (Serine/threonine-protein kinase PCTAIRE-3),472,"54,180",5 out of 5,1994-06-01,Evidence at protein level
P24941,CDK2_HUMAN,Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase),298,"33,930",5 out of 5,1992-03-01,Evidence at protein level
Q00532,CDKL1_HUMAN,Cyclin-dependent kinase-like 1 (EC 2.7.11.22) (Protein kinase p42 KKIALRE) (Serine/threonine-protein kinase KKIALRE),357,"41,671",5 out of 5,1993-04-01,Evidence at protein level
Q15517,CDSN_HUMAN,Corneodesmosin (S protein),529,"51,522",5 out of 5,1998-07-15,Evidence at protein level
O14627,CDX4_HUMAN,Homeobox protein CDX-4 (Caudal-type homeobox protein 4),284,"30,480",4 out of 5,1998-07-15,Evidence at protein level
Q8N8U2,CDYL2_HUMAN,Chromodomain Y-like protein 2 (CDY-like 2),506,"56,500",2 out of 5,2003-09-19,Evidence at protein level
Q49AR2,CE022_HUMAN,UPF0489 protein C5orf22,442,"49,967",2 out of 5,2007-10-02,Evidence at protein level
Q2M2E5,CE064_HUMAN,Uncharacterized protein C5orf64,130,"14,817",2 out of 5,2008-06-10,Evidence at transcript level
Q8N8E3,CE112_HUMAN,Centrosomal protein of 112 kDa (Cep112) (Coiled-coil domain-containing protein 46),955,"112,749",3 out of 5,2006-05-16,Evidence at protein level
Q5SW79,CE170_HUMAN,Centrosomal protein of 170 kDa (Cep170) (KARP-1-binding protein) (KARP1-binding protein),1584,"175,293",5 out of 5,2007-04-03,Evidence at protein level
O75871,CEAM4_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 4 (Carcinoembryonic antigen CGM7) (Non-specific cross-reacting antigen W236),244,"25,909",5 out of 5,2008-02-05,Evidence at protein level
Q14002,CEAM7_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 7 (Carcinoembryonic antigen CGM2),265,"29,379",5 out of 5,1999-07-15,Evidence at protein level
A8MTT3,CEBOS_HUMAN,Protein CEBPZOS (CEBPZ antisense RNA 1) (CEBPZ opposite strand),80,"9,336",2 out of 5,2015-03-04,Evidence at protein level
P49716,CEBPD_HUMAN,CCAAT/enhancer-binding protein delta (C/EBP delta) (Nuclear factor NF-IL6-beta) (NF-IL6-beta),269,"28,467",5 out of 5,1996-10-01,Evidence at protein level
Q9NZK5,CECR1_HUMAN,Adenosine deaminase CECR1 (EC 3.5.4.4) (Cat eye syndrome critical region protein 1),511,"58,934",5 out of 5,2002-04-16,Evidence at protein level
Q5VZK9,CARL1_HUMAN,"F-actin-uncapping protein LRRC16A (CARMIL homolog) (Capping protein regulator and myosin 1 linker protein 1) (Capping protein, Arp2/3 and myosin-I linker homolog 1) (Capping protein, Arp2/3 and myosin-I linker protein 1) (Leucine-rich repeat-containing protein 16A)",1371,"151,557",5 out of 5,2008-03-18,Evidence at protein level
P42575,CASP2_HUMAN,Caspase-2 (CASP-2) (EC 3.4.22.55) (Neural precursor cell expressed developmentally down-regulated protein 2) (NEDD-2) (Protease ICH-1) [Cleaved into: Caspase-2 subunit p18; Caspase-2 subunit p13; Caspase-2 subunit p12],452,"50,685",5 out of 5,1995-11-01,Evidence at protein level
P55211,CASP9_HUMAN,Caspase-9 (CASP-9) (EC 3.4.22.62) (Apoptotic protease Mch-6) (Apoptotic protease-activating factor 3) (APAF-3) (ICE-like apoptotic protease 6) (ICE-LAP6) [Cleaved into: Caspase-9 subunit p35; Caspase-9 subunit p10],416,"46,281",5 out of 5,1996-10-01,Evidence at protein level
O14958,CASQ2_HUMAN,"Calsequestrin-2 (Calsequestrin, cardiac muscle isoform)",399,"46,436",5 out of 5,1999-07-15,Evidence at protein level
P41180,CASR_HUMAN,Extracellular calcium-sensing receptor (CaSR) (Parathyroid cell calcium-sensing receptor 1) (PCaR1),1078,"120,674",5 out of 5,1995-02-01,Evidence at protein level
P07858,CATB_HUMAN,Cathepsin B (EC 3.4.22.1) (APP secretase) (APPS) (Cathepsin B1) [Cleaved into: Cathepsin B light chain; Cathepsin B heavy chain],339,"37,822",5 out of 5,1988-08-01,Evidence at protein level
P09668,CATH_HUMAN,Pro-cathepsin H [Cleaved into: Cathepsin H mini chain; Cathepsin H (EC 3.4.22.16); Cathepsin H heavy chain; Cathepsin H light chain],335,"37,394",5 out of 5,1989-07-01,Evidence at protein level
P51636,CAV2_HUMAN,Caveolin-2,162,"18,291",5 out of 5,1996-10-01,Evidence at protein level
Q580R0,CB027_HUMAN,Uncharacterized protein C2orf27,203,"21,517",2 out of 5,2005-07-05,Evidence at transcript level
Q6ZSB3,CB046_HUMAN,Putative uncharacterized protein encoded by LINC00299,139,"15,654",1 out of 5,2006-12-12,Uncertain
A6NN90,CB081_HUMAN,Uncharacterized protein C2orf81,581,"63,053",1 out of 5,2008-04-08,Inferred from homology
Q9HC52,CBX8_HUMAN,Chromobox protein homolog 8 (Polycomb 3 homolog) (Pc3) (hPc3) (Rectachrome 1),389,"43,396",5 out of 5,2001-08-29,Evidence at protein level
Q8TBZ0,CC110_HUMAN,Coiled-coil domain-containing protein 110 (Cancer/testis antigen 52) (CT52) (Cancer/testis antigen KM-HN-1),833,"96,726",3 out of 5,2006-09-05,Evidence at protein level
Q96M63,CC114_HUMAN,Coiled-coil domain-containing protein 114,670,"75,046",5 out of 5,2007-05-29,Evidence at protein level
Q96NT0,CC115_HUMAN,Coiled-coil domain-containing protein 115,180,"19,761",4 out of 5,2007-03-06,Evidence at protein level
Q8IWD4,CC117_HUMAN,Coiled-coil domain-containing protein 117,279,"30,541",3 out of 5,2006-10-31,Evidence at protein level
A6NF36,CC182_HUMAN,Coiled-coil domain-containing protein 182,153,"17,536",1 out of 5,2008-04-08,Evidence at transcript level
P62955,CCG7_HUMAN,Voltage-dependent calcium channel gamma-7 subunit (Neuronal voltage-gated calcium channel gamma-7 subunit) (Transmembrane AMPAR regulatory protein gamma-7) (TARP gamma-7),275,"31,003",4 out of 5,2004-08-31,Evidence at transcript level
P06307,CCKN_HUMAN,Cholecystokinin (CCK) [Cleaved into: Cholecystokinin-58 (CCK58); Cholecystokinin-58 desnonopeptide ((1-49)-CCK58); Cholecystokinin-39 (CCK39); Cholecystokinin-33 (CCK33); Cholecystokinin-25 (CCK25); Cholecystokinin-18 (CCK18); Cholecystokinin-12 (CCK12); Cholecystokinin-8 (CCK8); Cholecystokinin-7 (CCK7); Cholecystokinin-5 (CCK5)],115,"12,669",5 out of 5,1988-01-01,Evidence at protein level
P51671,CCL11_HUMAN,Eotaxin (C-C motif chemokine 11) (Eosinophil chemotactic protein) (Small-inducible cytokine A11),97,"10,732",5 out of 5,1996-10-01,Evidence at protein level
P55774,CCL18_HUMAN,C-C motif chemokine 18 (Alternative macrophage activation-associated CC chemokine 1) (AMAC-1) (CC chemokine PARC) (Dendritic cell chemokine 1) (DC-CK1) (Macrophage inflammatory protein 4) (MIP-4) (Pulmonary and activation-regulated chemokine) (Small-inducible cytokine A18) [Cleaved into: CCL18(1-68); CCL18(3-69); CCL18(4-69)],89,"9,849",5 out of 5,1997-11-01,Evidence at protein level
P22362,CCL1_HUMAN,C-C motif chemokine 1 (Small-inducible cytokine A1) (T lymphocyte-secreted protein I-309),96,"10,992",5 out of 5,1991-08-01,Evidence at protein level
O15444,CCL25_HUMAN,C-C motif chemokine 25 (Chemokine TECK) (Small-inducible cytokine A25) (Thymus-expressed chemokine),150,"16,609",5 out of 5,1998-07-15,Evidence at protein level
P10147,CCL3_HUMAN,C-C motif chemokine 3 (G0/G1 switch regulatory protein 19-1) (Macrophage inflammatory protein 1-alpha) (MIP-1-alpha) (PAT 464.1) (SIS-beta) (Small-inducible cytokine A3) (Tonsillar lymphocyte LD78 alpha protein) [Cleaved into: MIP-1-alpha(4-69) (LD78-alpha(4-69))],92,"10,085",5 out of 5,1989-07-01,Evidence at protein level
P24385,CCND1_HUMAN,G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene),295,"33,729",5 out of 5,1992-03-01,Evidence at protein level
O96020,CCNE2_HUMAN,G1/S-specific cyclin-E2,404,"46,757",5 out of 5,1999-07-15,Evidence at protein level
P51959,CCNG1_HUMAN,Cyclin-G1 (Cyclin-G),295,"34,074",5 out of 5,1996-10-01,Evidence at protein level
P51946,CCNH_HUMAN,Cyclin-H (MO15-associated protein) (p34) (p37),323,"37,643",5 out of 5,1996-10-01,Evidence at protein level
Q5T2Q4,CCYL2_HUMAN,Cyclin-Y-like protein 2,361,"41,278",2 out of 5,2007-12-04,Inferred from homology
Q6V702,CD022_HUMAN,Uncharacterized protein C4orf22,233,"26,869",2 out of 5,2007-09-11,Evidence at transcript level
Q504U0,CD046_HUMAN,Renal cancer differentiation gene 1 protein,113,"11,899",2 out of 5,2008-05-20,Evidence at protein level
P15391,CD19_HUMAN,B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19),556,"61,128",5 out of 5,1990-04-01,Evidence at protein level
P04234,CD3D_HUMAN,T-cell surface glycoprotein CD3 delta chain (T-cell receptor T3 delta chain) (CD antigen CD3d),171,"18,930",5 out of 5,1987-03-20,Evidence at protein level
P07766,CD3E_HUMAN,T-cell surface glycoprotein CD3 epsilon chain (T-cell surface antigen T3/Leu-4 epsilon chain) (CD antigen CD3e),207,"23,147",5 out of 5,1988-08-01,Evidence at protein level
P09326,CD48_HUMAN,CD48 antigen (B-lymphocyte activation marker BLAST-1) (BCM1 surface antigen) (Leukocyte antigen MEM-102) (SLAM family member 2) (SLAMF2) (Signaling lymphocytic activation molecule 2) (TCT.1) (CD antigen CD48),243,"27,683",5 out of 5,1989-07-01,Evidence at protein level
Q13319,CD5R2_HUMAN,Cyclin-dependent kinase 5 activator 2 (CDK5 activator 2) (Cyclin-dependent kinase 5 regulatory subunit 2) (p39) (p39I),367,"38,705",5 out of 5,1997-11-01,Evidence at protein level
P34810,CD68_HUMAN,Macrosialin (Gp110) (CD antigen CD68),354,"37,408",5 out of 5,1994-02-01,Evidence at protein level
P32970,CD70_HUMAN,CD70 antigen (CD27 ligand) (CD27-L) (Tumor necrosis factor ligand superfamily member 7) (CD antigen CD70),193,"21,118",5 out of 5,1993-10-01,Evidence at protein level
P09564,CD7_HUMAN,T-cell antigen CD7 (GP40) (T-cell leukemia antigen) (T-cell surface antigen Leu-9) (TP41) (CD antigen CD7),240,"25,409",5 out of 5,1989-07-01,Evidence at protein level
Q16543,CDC37_HUMAN,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]",378,"44,468",5 out of 5,2002-06-20,Evidence at protein level
A6H8M9,CDHR4_HUMAN,Cadherin-related family member 4 (Cadherin-like protein 29),788,"85,827",3 out of 5,2008-02-26,Evidence at transcript level
Q15131,CDK10_HUMAN,Cyclin-dependent kinase 10 (EC 2.7.11.22) (Cell division protein kinase 10) (Serine/threonine-protein kinase PISSLRE),360,"41,038",5 out of 5,2000-05-30,Evidence at protein level
Q9NYV4,CDK12_HUMAN,"Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12)",1490,"164,155",5 out of 5,2000-12-01,Evidence at protein level
Q00535,CDK5_HUMAN,Cyclin-dependent-like kinase 5 (EC 2.7.11.1) (Cell division protein kinase 5) (Serine/threonine-protein kinase PSSALRE) (Tau protein kinase II catalytic subunit) (TPKII catalytic subunit),292,"33,304",5 out of 5,1993-04-01,Evidence at protein level
O14519,CDKA1_HUMAN,Cyclin-dependent kinase 2-associated protein 1 (CDK2-associated protein 1) (Deleted in oral cancer 1) (DOC-1) (Putative oral cancer suppressor),115,"12,365",5 out of 5,1999-07-15,Evidence at protein level
Q86X02,CDR2L_HUMAN,Cerebellar degeneration-related protein 2-like (Paraneoplastic 62 kDa antigen),465,"53,010",3 out of 5,2007-10-23,Evidence at protein level
Q9BWT7,CAR10_HUMAN,Caspase recruitment domain-containing protein 10 (CARD-containing MAGUK protein 3) (Carma 3),1032,"115,931",4 out of 5,2002-01-31,Evidence at protein level
Q9NXV6,CARF_HUMAN,CDKN2A-interacting protein (Collaborator of ARF),580,"61,125",5 out of 5,2008-03-18,Evidence at protein level
P07339,CATD_HUMAN,Cathepsin D (EC 3.4.23.5) [Cleaved into: Cathepsin D light chain; Cathepsin D heavy chain],412,"44,552",5 out of 5,1988-04-01,Evidence at protein level
Q8WUQ7,CATIN_HUMAN,Cactin (Renal carcinoma antigen NY-REN-24),758,"88,702",5 out of 5,2006-04-04,Evidence at protein level
P07711,CATL1_HUMAN,Cathepsin L1 (EC 3.4.22.15) (Cathepsin L) (Major excreted protein) (MEP) [Cleaved into: Cathepsin L1 heavy chain; Cathepsin L1 light chain],333,"37,564",5 out of 5,1988-04-01,Evidence at protein level
P25774,CATS_HUMAN,Cathepsin S (EC 3.4.22.27),331,"37,496",5 out of 5,1992-05-01,Evidence at protein level
Q9UBR2,CATZ_HUMAN,Cathepsin Z (EC 3.4.18.1) (Cathepsin P) (Cathepsin X),303,"33,868",5 out of 5,2001-01-24,Evidence at protein level
Q03135,CAV1_HUMAN,Caveolin-1,178,"20,472",5 out of 5,1993-10-01,Evidence at protein level
Q9NWW7,CB042_HUMAN,Uncharacterized protein C2orf42,574,"64,077",2 out of 5,2007-09-11,Evidence at protein level
Q6UXQ4,CB066_HUMAN,Uncharacterized protein C2orf66,117,"13,321",1 out of 5,2008-02-05,Inferred from homology
Q8N8R5,CB069_HUMAN,UPF0565 protein C2orf69,385,"43,448",2 out of 5,2008-04-08,Evidence at protein level
Q8N5S3,CB073_HUMAN,Uncharacterized protein C2orf73,287,"32,142",2 out of 5,2008-04-29,Evidence at transcript level
Q6UX34,CB082_HUMAN,Uncharacterized protein C2orf82,121,"12,073",2 out of 5,2008-02-05,Evidence at transcript level
Q9H9S4,CB39L_HUMAN,Calcium-binding protein 39-like (Antigen MLAA-34) (MO25beta) (Mo25-like protein),337,"39,088",3 out of 5,2001-08-14,Evidence at protein level
Q13191,CBLB_HUMAN,E3 ubiquitin-protein ligase CBL-B (EC 2.3.2.27) (Casitas B-lineage lymphoma proto-oncogene b) (RING finger protein 56) (RING-type E3 ubiquitin transferase CBL-B) (SH3-binding protein CBL-B) (Signal transduction protein CBL-B),982,"109,450",5 out of 5,2000-12-01,Evidence at protein level
Q8NDL9,CBPC5_HUMAN,Cytosolic carboxypeptidase-like protein 5 (EC 3.4.17.-) (ATP/GTP-binding protein-like 5),886,"97,534",5 out of 5,2007-10-02,Evidence at protein level
Q9HBI5,CC014_HUMAN,Uncharacterized protein C3orf14,128,"15,007",1 out of 5,2005-07-05,Evidence at transcript level
A6NLC5,CC070_HUMAN,UPF0524 protein C3orf70,250,"27,769",1 out of 5,2008-02-26,Evidence at transcript level
Q9H0I3,CC113_HUMAN,Coiled-coil domain-containing protein 113,377,"44,220",4 out of 5,2007-03-06,Evidence at protein level
Q8IYX3,CC116_HUMAN,Coiled-coil domain-containing protein 116,515,"56,940",4 out of 5,2006-10-31,Evidence at protein level
Q6ZUS5,CC121_HUMAN,Coiled-coil domain-containing protein 121,278,"33,061",2 out of 5,2007-05-15,Evidence at protein level
Q6ZRS4,CC129_HUMAN,Coiled-coil domain-containing protein 129,1044,"115,403",3 out of 5,2007-01-09,Evidence at transcript level
Q9H6E4,CC134_HUMAN,Coiled-coil domain-containing protein 134,229,"26,561",2 out of 5,2006-10-31,Evidence at protein level
Q6ZP82,CC141_HUMAN,Coiled-coil domain-containing protein 141 (Coiled-coil protein associated with myosin II and DISC1),1450,"166,261",3 out of 5,2008-02-05,Evidence at protein level
Q494R4,CC153_HUMAN,Coiled-coil domain-containing protein 153,210,"23,858",3 out of 5,2008-07-01,Evidence at protein level
Q569K6,CC157_HUMAN,Coiled-coil domain-containing protein 157,752,"83,941",2 out of 5,2008-02-26,Evidence at transcript level
P0CW27,CC166_HUMAN,Coiled-coil domain-containing protein 166,439,"48,709",1 out of 5,2011-09-21,Predicted
A6NNP5,CC169_HUMAN,Coiled-coil domain-containing protein 169,214,"25,253",3 out of 5,2008-06-10,Evidence at transcript level
Q52MB2,CC184_HUMAN,Coiled-coil domain-containing protein 184,194,"20,484",3 out of 5,2008-05-20,Evidence at protein level
Q8NHW4,CC4L_HUMAN,C-C motif chemokine 4-like (Lymphocyte activation gene 1 protein) (LAG-1) (Macrophage inflammatory protein 1-beta) (MIP-1-beta) (Monocyte adherence-induced protein 5-alpha) (Small-inducible cytokine A4-like),92,"10,166",5 out of 5,2008-03-18,Evidence at protein level
Q8WXS4,CCGL_HUMAN,Voltage-dependent calcium channel gamma-like subunit (Neuronal voltage-gated calcium channel gamma-like subunit) (Transmembrane protein 37),190,"20,932",2 out of 5,2006-03-07,Evidence at transcript level
Q92583,CCL17_HUMAN,C-C motif chemokine 17 (CC chemokine TARC) (Small-inducible cytokine A17) (Thymus and activation-regulated chemokine),94,"10,507",5 out of 5,1998-07-15,Evidence at protein level
Q99731,CCL19_HUMAN,C-C motif chemokine 19 (Beta-chemokine exodus-3) (CK beta-11) (Epstein-Barr virus-induced molecule 1 ligand chemokine) (EBI1 ligand chemokine) (ELC) (Macrophage inflammatory protein 3 beta) (MIP-3-beta) (Small-inducible cytokine A19),98,"10,993",5 out of 5,1997-11-01,Evidence at protein level
P55773,CCL23_HUMAN,C-C motif chemokine 23 (CK-beta-8) (CKB-8) (Macrophage inflammatory protein 3) (MIP-3) (Myeloid progenitor inhibitory factor 1) (MPIF-1) (Small-inducible cytokine A23) [Cleaved into: CCL23(19-99); CCL23(22-99); CCL23(27-99); CCL23(30-99)],120,"13,411",5 out of 5,1997-11-01,Evidence at protein level
Q9Y258,CCL26_HUMAN,C-C motif chemokine 26 (CC chemokine IMAC) (Eotaxin-3) (Macrophage inflammatory protein 4-alpha) (MIP-4-alpha) (Small-inducible cytokine A26) (Thymic stroma chemokine-1) (TSC-1),94,"10,648",5 out of 5,2000-05-30,Evidence at protein level
P30279,CCND2_HUMAN,G1/S-specific cyclin-D2,289,"33,067",5 out of 5,1993-04-01,Evidence at protein level
O75909,CCNK_HUMAN,Cyclin-K,580,"64,240",5 out of 5,2000-12-01,Evidence at protein level
Q96S94,CCNL2_HUMAN,Cyclin-L2 (Paneth cell-enhanced expression protein),520,"58,147",5 out of 5,2005-11-08,Evidence at protein level
O60563,CCNT1_HUMAN,Cyclin-T1 (CycT1) (Cyclin-T),726,"80,685",5 out of 5,2000-12-01,Evidence at protein level
P41597,CCR2_HUMAN,C-C chemokine receptor type 2 (C-C CKR-2) (CC-CKR-2) (CCR-2) (CCR2) (Monocyte chemoattractant protein 1 receptor) (MCP-1-R) (CD antigen CD192),374,"41,915",5 out of 5,1995-11-01,Evidence at protein level
P51684,CCR6_HUMAN,C-C chemokine receptor type 6 (C-C CKR-6) (CC-CKR-6) (CCR-6) (Chemokine receptor-like 3) (CKR-L3) (DRY6) (G-protein coupled receptor 29) (GPR-CY4) (GPRCY4) (LARC receptor) (CD antigen CD196),374,"42,494",5 out of 5,1996-10-01,Evidence at protein level
P32248,CCR7_HUMAN,C-C chemokine receptor type 7 (C-C CKR-7) (CC-CKR-7) (CCR-7) (BLR2) (CDw197) (Epstein-Barr virus-induced G-protein coupled receptor 1) (EBI1) (EBV-induced G-protein coupled receptor 1) (MIP-3 beta receptor) (CD antigen CD197),378,"42,874",5 out of 5,1993-10-01,Evidence at transcript level
Q9C0I3,CCSE1_HUMAN,Serine-rich coiled-coil domain-containing protein 1 (Coiled-coil serine-rich protein 1),900,"99,510",2 out of 5,2008-09-02,Evidence at transcript level
P86790,CCZ1B_HUMAN,Vacuolar fusion protein CCZ1 homolog B (Vacuolar fusion protein CCZ1 homolog-like),482,"55,866",3 out of 5,2010-11-02,Evidence at protein level
Q8WVX3,CD003_HUMAN,Uncharacterized protein C4orf3 (Hepatitis C virus F protein-transactivated protein 1) (HCV F-transactivated protein 1),66,"7,604",2 out of 5,2008-03-18,Evidence at protein level
P21127,CD11B_HUMAN,Cyclin-dependent kinase 11B (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 1) (CLK-1) (Cell division protein kinase 11B) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L1) (p58 CLK-1),795,"92,707",5 out of 5,1991-02-01,Evidence at protein level
P29017,CD1C_HUMAN,T-cell surface glycoprotein CD1c (CD antigen CD1c),333,"37,654",5 out of 5,1992-12-01,Evidence at protein level
P15813,CD1D_HUMAN,Antigen-presenting glycoprotein CD1d (R3G1) (CD antigen CD1d),335,"37,717",5 out of 5,1990-04-01,Evidence at protein level
P15812,CD1E_HUMAN,"T-cell surface glycoprotein CD1e, membrane-associated (hCD1e) (R2G1) (CD antigen CD1e) [Cleaved into: T-cell surface glycoprotein CD1e, soluble (sCD1e)]",388,"43,626",5 out of 5,1990-04-01,Evidence at protein level
P11836,CD20_HUMAN,B-lymphocyte antigen CD20 (B-lymphocyte surface antigen B1) (Bp35) (Leukocyte surface antigen Leu-16) (Membrane-spanning 4-domains subfamily A member 1) (CD antigen CD20),297,"33,077",5 out of 5,1989-10-01,Evidence at protein level
P28906,CD34_HUMAN,Hematopoietic progenitor cell antigen CD34 (CD antigen CD34),385,"40,716",5 out of 5,1992-12-01,Evidence at protein level
P33681,CD80_HUMAN,T-lymphocyte activation antigen CD80 (Activation B7-1 antigen) (BB1) (CTLA-4 counter-receptor B7.1) (B7) (CD antigen CD80),288,"33,048",5 out of 5,1994-02-01,Evidence at protein level
O75419,CDC45_HUMAN,Cell division control protein 45 homolog (PORC-PI-1),566,"65,569",5 out of 5,2000-05-30,Evidence at protein level
Q6ZTQ4,CDHR3_HUMAN,Cadherin-related family member 3 (Cadherin-like protein 28),885,"97,977",5 out of 5,2007-10-02,Evidence at protein level
Q9BWU1,CDK19_HUMAN,Cyclin-dependent kinase 19 (EC 2.7.11.22) (CDC2-related protein kinase 6) (Cell division cycle 2-like protein kinase 6) (Cell division protein kinase 19) (Cyclin-dependent kinase 11) (Death-preventing kinase),502,"56,802",5 out of 5,2005-02-01,Evidence at protein level
Q8IZL9,CDK20_HUMAN,Cyclin-dependent kinase 20 (EC 2.7.11.22) (CDK-activating kinase p42) (CAK-kinase p42) (Cell cycle-related kinase) (Cell division protein kinase 20) (Cyclin-dependent protein kinase H) (Cyclin-kinase-activating kinase p42),346,"38,695",5 out of 5,2005-12-20,Evidence at protein level
Q00526,CDK3_HUMAN,Cyclin-dependent kinase 3 (EC 2.7.11.22) (Cell division protein kinase 3),305,"35,046",5 out of 5,1993-04-01,Evidence at protein level
P50750,CDK9_HUMAN,Cyclin-dependent kinase 9 (EC 2.7.11.22) (EC 2.7.11.23) (C-2K) (Cell division cycle 2-like protein kinase 4) (Cell division protein kinase 9) (Serine/threonine-protein kinase PITALRE) (Tat-associated kinase complex catalytic subunit),372,"42,778",5 out of 5,1996-10-01,Evidence at protein level
Q9Y2G2,CARD8_HUMAN,Caspase recruitment domain-containing protein 8 (Apoptotic protein NDPP1) (CARD-inhibitor of NF-kappa-B-activating ligand) (CARDINAL) (DACAR) (Tumor up-regulated CARD-containing antagonist of CASP9) (TUCAN),431,"48,933",5 out of 5,2001-06-20,Evidence at protein level
P47710,CASA1_HUMAN,Alpha-S1-casein [Cleaved into: Casoxin-D],185,"21,671",5 out of 5,1996-02-01,Evidence at protein level
P05814,CASB_HUMAN,Beta-casein,226,"25,382",5 out of 5,1988-11-01,Evidence at protein level
Q6TDU7,CASC1_HUMAN,Protein CASC1 (Cancer susceptibility candidate gene 1 protein) (Lung adenoma susceptibility 1-like protein) (Protein phosphatase 1 regulatory subunit 54),716,"83,160",3 out of 5,2008-04-29,Evidence at transcript level
Q9UBX1,CATF_HUMAN,Cathepsin F (CATSF) (EC 3.4.22.41),484,"53,366",5 out of 5,2001-01-24,Evidence at protein level
P43235,CATK_HUMAN,Cathepsin K (EC 3.4.22.38) (Cathepsin O) (Cathepsin O2) (Cathepsin X),329,"36,966",5 out of 5,1995-11-01,Evidence at protein level
Q8N535,CB052_HUMAN,Putative uncharacterized protein encoded by LINC00471,108,"12,106",1 out of 5,2007-09-11,Uncertain
Q8N350,CBARP_HUMAN,Voltage-dependent calcium channel beta subunit-associated regulatory protein,705,"73,929",4 out of 5,2005-08-30,Evidence at protein level
Q9ULV8,CBLC_HUMAN,E3 ubiquitin-protein ligase CBL-C (EC 2.3.2.27) (RING finger protein 57) (RING-type E3 ubiquitin transferase CBL-C) (SH3-binding protein CBL-3) (SH3-binding protein CBL-C) (Signal transduction protein CBL-C),474,"52,456",5 out of 5,2000-12-01,Evidence at protein level
P35520,CBS_HUMAN,Cystathionine beta-synthase (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase),551,"60,587",5 out of 5,1994-06-01,Evidence at protein level
O00257,CBX4_HUMAN,E3 SUMO-protein ligase CBX4 (EC 6.3.2.-) (Chromobox protein homolog 4) (Polycomb 2 homolog) (Pc2) (hPc2),560,"61,368",5 out of 5,2001-01-24,Evidence at protein level
Q96M34,CC030_HUMAN,Uncharacterized protein C3orf30,536,"60,162",2 out of 5,2006-10-31,Evidence at transcript level
Q8IYK2,CC105_HUMAN,Coiled-coil domain-containing protein 105,499,"56,909",2 out of 5,2007-03-06,Evidence at transcript level
Q96M89,CC138_HUMAN,Coiled-coil domain-containing protein 138,665,"76,219",2 out of 5,2007-05-29,Evidence at protein level
Q8IYE0,CC146_HUMAN,Coiled-coil domain-containing protein 146,955,"112,806",5 out of 5,2008-02-05,Evidence at protein level
A4D256,CC14C_HUMAN,Dual specificity protein phosphatase CDC14C (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog C),554,"63,299",4 out of 5,2008-01-15,Evidence at transcript level
A2VCL2,CC162_HUMAN,Coiled-coil domain-containing protein 162 (Coiled-coil domain-containing protein 162 pseudogene),907,"103,842",2 out of 5,2007-10-23,Evidence at transcript level
Q8IWP9,CC28A_HUMAN,Coiled-coil domain-containing protein 28A (CCRL1AP),274,"30,367",4 out of 5,2005-06-21,Evidence at protein level
Q8WUD4,CCD12_HUMAN,Coiled-coil domain-containing protein 12,166,"19,181",2 out of 5,2006-01-24,Evidence at protein level
Q49A88,CCD14_HUMAN,Coiled-coil domain-containing protein 14,953,"106,302",5 out of 5,2008-05-20,Evidence at protein level
Q2TAC2,CCD57_HUMAN,Coiled-coil domain-containing protein 57,916,"103,167",5 out of 5,2007-05-29,Evidence at protein level
Q6P9F0,CCD62_HUMAN,Coiled-coil domain-containing protein 62 (Protein TSP-NY) (Protein aaa),684,"77,748",5 out of 5,2006-06-13,Evidence at protein level
Q86UT8,CCD84_HUMAN,Coiled-coil domain-containing protein 84,332,"37,974",2 out of 5,2007-01-09,Evidence at protein level
I3L3R5,CCER2_HUMAN,Coiled-coil domain-containing glutamate-rich protein 2,266,"30,352",2 out of 5,2014-02-19,Inferred from homology
Q8WXS5,CCG8_HUMAN,Voltage-dependent calcium channel gamma-8 subunit (Neuronal voltage-gated calcium channel gamma-8 subunit) (Transmembrane AMPAR regulatory protein gamma-8) (TARP gamma-8),425,"43,313",5 out of 5,2002-05-10,Evidence at transcript level
P78556,CCL20_HUMAN,C-C motif chemokine 20 (Beta-chemokine exodus-1) (CC chemokine LARC) (Liver and activation-regulated chemokine) (Macrophage inflammatory protein 3 alpha) (MIP-3-alpha) (Small-inducible cytokine A20) [Cleaved into: CCL20(1-67); CCL20(1-64); CCL20(2-70)],96,"10,762",5 out of 5,1997-11-01,Evidence at protein level
O00175,CCL24_HUMAN,C-C motif chemokine 24 (CK-beta-6) (Eosinophil chemotactic protein 2) (Eotaxin-2) (Myeloid progenitor inhibitory factor 2) (MPIF-2) (Small-inducible cytokine A24),119,"13,134",5 out of 5,1999-07-15,Evidence at protein level
P13500,CCL2_HUMAN,C-C motif chemokine 2 (HC11) (Monocyte chemoattractant protein 1) (Monocyte chemotactic and activating factor) (MCAF) (Monocyte chemotactic protein 1) (MCP-1) (Monocyte secretory protein JE) (Small-inducible cytokine A2),99,"11,025",5 out of 5,1990-01-01,Evidence at protein level
P24864,CCNE1_HUMAN,G1/S-specific cyclin-E1,410,"47,077",5 out of 5,1992-03-01,Evidence at protein level
O60583,CCNT2_HUMAN,Cyclin-T2 (CycT2),730,"81,029",5 out of 5,2000-12-01,Evidence at protein level
Q8IY42,CD019_HUMAN,Uncharacterized protein C4orf19,314,"33,742",2 out of 5,2007-05-15,Evidence at protein level
Q5BLP8,CD048_HUMAN,Neuropeptide-like protein C4orf48,95,"10,170",2 out of 5,2008-07-01,Evidence at protein level
P19397,CD53_HUMAN,Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25) (Tspan-25) (CD antigen CD53),219,"24,341",5 out of 5,1990-11-01,Evidence at protein level
Q08AD1,CAMP2_HUMAN,Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1),1489,"168,089",5 out of 5,2008-02-26,Evidence at protein level
A8MX76,CAN14_HUMAN,Calpain-14 (EC 3.4.22.-) (Calcium-activated neutral proteinase 14) (CANP 14),684,"79,568",3 out of 5,2008-06-10,Evidence at transcript level
P17655,CAN2_HUMAN,Calpain-2 catalytic subunit (EC 3.4.22.53) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain large polypeptide L2) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain),700,"79,995",5 out of 5,1990-08-01,Evidence at protein level
P20807,CAN3_HUMAN,Calpain-3 (EC 3.4.22.54) (Calcium-activated neutral proteinase 3) (CANP 3) (Calpain L3) (Calpain p94) (Muscle-specific calcium-activated neutral protease 3) (New calpain 1) (nCL-1),821,"94,254",5 out of 5,1991-02-01,Evidence at protein level
Q8WVQ1,CANT1_HUMAN,Soluble calcium-activated nucleotidase 1 (SCAN-1) (EC 3.6.1.6) (Apyrase homolog) (Putative MAPK-activating protein PM09) (Putative NF-kappa-B-activating protein 107),401,"44,840",5 out of 5,2005-05-10,Evidence at protein level
P47756,CAPZB_HUMAN,F-actin-capping protein subunit beta (CapZ beta),277,"31,350",5 out of 5,1996-02-01,Evidence at protein level
Q5EG05,CAR16_HUMAN,Caspase recruitment domain-containing protein 16 (Caspase recruitment domain-only protein 1) (CARD-only protein 1) (Caspase-1 inhibitor COP) (Pseudo interleukin-1 beta converting enzyme) (Pseudo-ICE) (Pseudo-IL1B-converting enzyme),197,"22,625",4 out of 5,2008-09-02,Evidence at protein level
P42574,CASP3_HUMAN,Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12],277,"31,608",5 out of 5,1995-11-01,Evidence at protein level
P49662,CASP4_HUMAN,Caspase-4 (CASP-4) (EC 3.4.22.57) (ICE and Ced-3 homolog 2) (ICH-2) (ICE(rel)-II) (Mih1) (Protease TX) [Cleaved into: Caspase-4 subunit 1; Caspase-4 subunit 2],377,"43,262",5 out of 5,1996-02-01,Evidence at protein level
P04040,CATA_HUMAN,Catalase (EC 1.11.1.6),527,"59,756",5 out of 5,1986-11-01,Evidence at protein level
P14091,CATE_HUMAN,Cathepsin E (EC 3.4.23.34) [Cleaved into: Cathepsin E form I; Cathepsin E form II],401,"43,312",5 out of 5,1990-01-01,Evidence at protein level
O60911,CATL2_HUMAN,Cathepsin L2 (EC 3.4.22.43) (Cathepsin U) (Cathepsin V),334,"37,329",5 out of 5,1998-12-15,Evidence at protein level
Q13938,CAYP1_HUMAN,Calcyphosin (Calcyphosine),189,"20,967",4 out of 5,1997-11-01,Evidence at protein level
P52907,CAZA1_HUMAN,F-actin-capping protein subunit alpha-1 (CapZ alpha-1),286,"32,923",5 out of 5,1996-10-01,Evidence at protein level
P47755,CAZA2_HUMAN,F-actin-capping protein subunit alpha-2 (CapZ alpha-2),286,"32,949",5 out of 5,1996-02-01,Evidence at protein level
Q96KX2,CAZA3_HUMAN,F-actin-capping protein subunit alpha-3 (CapZ alpha-3) (CP-alpha-3) (Germ cell-specific protein 3),299,"35,025",3 out of 5,2002-03-27,Evidence at protein level
Q68DN1,CB016_HUMAN,Uncharacterized protein C2orf16,1984,"224,321",4 out of 5,2007-04-03,Evidence at transcript level
Q96LS8,CB048_HUMAN,Uncharacterized protein C2orf48,159,"17,367",1 out of 5,2006-12-12,Evidence at transcript level
A8MZ97,CB074_HUMAN,Uncharacterized protein C2orf74,194,"21,915",1 out of 5,2008-07-01,Predicted
A6NCI8,CB078_HUMAN,Uncharacterized protein C2orf78,922,"100,170",1 out of 5,2008-02-26,Evidence at transcript level
Q8IUK8,CBLN2_HUMAN,Cerebellin-2,224,"24,084",2 out of 5,2004-04-13,Evidence at transcript level
Q5RIA9,CBWD5_HUMAN,COBW domain-containing protein 5 (Cobalamin synthase W domain-containing protein 5),395,"44,068",3 out of 5,2008-02-05,Evidence at transcript level
Q14781,CBX2_HUMAN,Chromobox protein homolog 2,532,"56,081",5 out of 5,2001-01-24,Evidence at protein level
Q13185,CBX3_HUMAN,Chromobox protein homolog 3 (HECH) (Heterochromatin protein 1 homolog gamma) (HP1 gamma) (Modifier 2 protein),183,"20,811",5 out of 5,1997-11-01,Evidence at protein level
Q8IW40,CC103_HUMAN,Coiled-coil domain-containing protein 103,242,"27,163",5 out of 5,2006-12-12,Evidence at protein level
Q6W349,CD011_HUMAN,Putative uncharacterized protein encoded by LINC00575,94,"10,157",1 out of 5,2008-03-18,Uncertain
Q17RF5,CD026_HUMAN,Uncharacterized protein C4orf26,130,"15,556",3 out of 5,2007-09-11,Evidence at protein level
Q6ZRC1,CD050_HUMAN,Uncharacterized protein C4orf50,276,"30,622",2 out of 5,2008-04-08,Evidence at transcript level
Q13740,CD166_HUMAN,CD166 antigen (Activated leukocyte cell adhesion molecule) (CD antigen CD166),583,"65,102",5 out of 5,1997-11-01,Evidence at protein level
P29016,CD1B_HUMAN,T-cell surface glycoprotein CD1b (CD antigen CD1b),333,"36,939",5 out of 5,1992-12-01,Evidence at protein level
Q15762,CD226_HUMAN,CD226 antigen (DNAX accessory molecule 1) (DNAM-1) (CD antigen CD226),336,"38,614",5 out of 5,2004-05-24,Evidence at protein level
Q9BZW8,CD244_HUMAN,Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244),370,"41,616",5 out of 5,2004-05-24,Evidence at protein level
Q7L3B6,CD37L_HUMAN,Hsp90 co-chaperone Cdc37-like 1 (Hsp90-associating relative of Cdc37),337,"38,835",5 out of 5,2008-02-26,Evidence at protein level
P20963,CD3Z_HUMAN,T-cell surface glycoprotein CD3 zeta chain (T-cell receptor T3 zeta chain) (CD antigen CD247),164,"18,696",5 out of 5,1991-02-01,Evidence at protein level
P27701,CD82_HUMAN,CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82),267,"29,626",5 out of 5,1992-08-01,Evidence at protein level
A6NJW9,CD8BL_HUMAN,Putative T-cell surface glycoprotein CD8 beta-2 chain (CD8b pseudogene),211,"23,768",3 out of 5,2008-06-10,Uncertain
P14209,CD99_HUMAN,CD99 antigen (12E7) (E2 antigen) (Protein MIC2) (T-cell surface glycoprotein E2) (CD antigen CD99),185,"18,848",5 out of 5,1990-01-01,Evidence at protein level
Q8IWY9,CDAN1_HUMAN,Codanin-1,1227,"134,120",5 out of 5,2003-11-07,Evidence at protein level
P60953,CDC42_HUMAN,Cell division control protein 42 homolog (G25K GTP-binding protein),191,"21,259",5 out of 5,2004-04-13,Evidence at protein level
Q9BWT1,CDCA7_HUMAN,Cell division cycle-associated protein 7 (Protein JPO1),371,"42,573",5 out of 5,2006-09-05,Evidence at protein level
Q3KRA6,CB076_HUMAN,UPF0538 protein C2orf76,126,"14,609",2 out of 5,2008-03-18,Evidence at protein level
P15085,CBPA1_HUMAN,Carboxypeptidase A1 (EC 3.4.17.1),419,"47,140",5 out of 5,1990-04-01,Evidence at protein level
P15088,CBPA3_HUMAN,Mast cell carboxypeptidase A (MC-CPA) (EC 3.4.17.1) (Carboxypeptidase A3),417,"48,670",4 out of 5,1990-04-01,Evidence at protein level
Q8WXQ8,CBPA5_HUMAN,Carboxypeptidase A5 (EC 3.4.17.-),436,"49,036",4 out of 5,2003-11-07,Evidence at transcript level
P15086,CBPB1_HUMAN,Carboxypeptidase B (EC 3.4.17.2) (Pancreas-specific protein) (PASP),417,"47,368",5 out of 5,1990-04-01,Evidence at protein level
Q8IVL8,CBPO_HUMAN,Carboxypeptidase O (CPO) (EC 3.4.17.-),374,"42,529",5 out of 5,2006-10-17,Evidence at protein level
Q6PK04,CC137_HUMAN,Coiled-coil domain-containing protein 137,289,"33,231",3 out of 5,2007-05-29,Evidence at protein level
Q8NFR7,CC148_HUMAN,Coiled-coil domain-containing protein 148,591,"71,076",3 out of 5,2008-03-18,Evidence at protein level
A5D8V7,CC151_HUMAN,Coiled-coil domain-containing protein 151,595,"69,140",5 out of 5,2008-02-26,Evidence at protein level
P0C7I6,CC159_HUMAN,Coiled-coil domain-containing protein 159,412,"46,012",2 out of 5,2008-05-20,Evidence at transcript level
Q8NCU4,CC191_HUMAN,Coiled-coil domain-containing protein 191,936,"110,568",2 out of 5,2007-11-13,Evidence at transcript level
Q15834,CC85B_HUMAN,Coiled-coil domain-containing protein 85B (Hepatitis delta antigen-interacting protein A) (Delta-interacting protein A),202,"22,091",5 out of 5,2001-08-29,Evidence at protein level
A6NC98,CC88B_HUMAN,Coiled-coil domain-containing protein 88B (Brain leucine zipper domain-containing protein) (Gipie) (Hook-related protein 3) (HkRP3),1476,"164,809",5 out of 5,2008-02-05,Evidence at protein level
Q8N163,CCAR2_HUMAN,Cell cycle and apoptosis regulator protein 2 (Cell division cycle and apoptosis regulator protein 2) (DBIRD complex subunit KIAA1967) (Deleted in breast cancer gene 1 protein) (DBC-1) (DBC.1) (NET35) (p30 DBC),923,"102,902",5 out of 5,2006-01-24,Evidence at protein level
Q2M243,CCD27_HUMAN,Coiled-coil domain-containing protein 27,656,"75,354",2 out of 5,2006-05-02,Evidence at transcript level
Q9Y6R9,CCD61_HUMAN,Coiled-coil domain-containing protein 61,512,"57,368",2 out of 5,2007-11-13,Evidence at protein level
Q8NA47,CCD63_HUMAN,Coiled-coil domain-containing protein 63,563,"66,250",2 out of 5,2007-05-29,Evidence at transcript level
Q9H2F9,CCD68_HUMAN,Coiled-coil domain-containing protein 68 (Cutaneous T-cell lymphoma-associated antigen se57-1) (CTCL-associated antigen se57-1),335,"38,869",2 out of 5,2006-12-12,Evidence at protein level
Q6ZRK6,CCD73_HUMAN,Coiled-coil domain-containing protein 73 (Sarcoma antigen NY-SAR-79),1079,"124,154",2 out of 5,2007-05-01,Evidence at transcript level
Q6ZN84,CCD81_HUMAN,Coiled-coil domain-containing protein 81,652,"76,084",3 out of 5,2007-05-29,Evidence at transcript level
Q9NVE4,CCD87_HUMAN,Coiled-coil domain-containing protein 87,849,"96,402",2 out of 5,2007-07-10,Evidence at protein level
Q9BQI4,CCDC3_HUMAN,Coiled-coil domain-containing protein 3 (Fat/vessel-derived secretory protein) (Favine),270,"30,731",4 out of 5,2004-07-19,Evidence at transcript level
Q06432,CCG1_HUMAN,"Voltage-dependent calcium channel gamma-1 subunit (Dihydropyridine-sensitive L-type, skeletal muscle calcium channel subunit gamma)",222,"25,028",5 out of 5,1995-11-01,Evidence at protein level
Q9BSQ5,CCM2_HUMAN,Cerebral cavernous malformations 2 protein (Malcavernin),444,"48,837",5 out of 5,2005-10-11,Evidence at protein level
P13987,CD59_HUMAN,CD59 glycoprotein (1F5 antigen) (20 kDa homologous restriction factor) (HRF-20) (HRF20) (MAC-inhibitory protein) (MAC-IP) (MEM43 antigen) (Membrane attack complex inhibition factor) (MACIF) (Membrane inhibitor of reactive lysis) (MIRL) (Protectin) (CD antigen CD59),128,"14,177",5 out of 5,1990-01-01,Evidence at protein level
P01732,CD8A_HUMAN,T-cell surface glycoprotein CD8 alpha chain (T-lymphocyte differentiation antigen T8/Leu-2) (CD antigen CD8a),235,"25,729",5 out of 5,1986-07-21,Evidence at protein level
A6NGY3,CE052_HUMAN,Uncharacterized protein C5orf52,159,"17,908",1 out of 5,2008-06-10,Evidence at transcript level
Q9UPV0,CE164_HUMAN,Centrosomal protein of 164 kDa (Cep164),1460,"164,314",5 out of 5,2007-12-04,Evidence at protein level
Q3KPI0,CEA21_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 21,293,"32,373",3 out of 5,2007-08-21,Evidence at transcript level
P08218,CEL2B_HUMAN,Chymotrypsin-like elastase family member 2B (EC 3.4.21.71) (Elastase-2B),269,"28,810",4 out of 5,1988-08-01,Evidence at transcript level
P08861,CEL3B_HUMAN,Chymotrypsin-like elastase family member 3B (EC 3.4.21.70) (Elastase IIIB) (Elastase-3B) (Protease E),270,"29,263",5 out of 5,1988-11-01,Evidence at protein level
Q9UNI1,CELA1_HUMAN,Chymotrypsin-like elastase family member 1 (EC 3.4.21.36) (Elastase-1) (Pancreatic elastase 1),258,"27,798",5 out of 5,2001-10-18,Evidence at protein level
Q92879,CELF1_HUMAN,CUGBP Elav-like family member 1 (CELF-1) (50 kDa nuclear polyadenylated RNA-binding protein) (Bruno-like protein 2) (CUG triplet repeat RNA-binding protein 1) (CUG-BP1) (CUG-BP- and ETR-3-like factor 1) (Deadenylation factor CUG-BP) (Embryo deadenylation element-binding protein homolog) (EDEN-BP homolog) (RNA-binding protein BRUNOL-2),486,"52,063",5 out of 5,2001-10-18,Evidence at protein level
Q6PRD7,CEMP1_HUMAN,Cementoblastoma-derived protein 1 (Cementum protein 1) (Cementum protein 23) (CP-23),247,"25,959",2 out of 5,2006-12-12,Evidence at transcript level
Q92674,CENPI_HUMAN,Centromere protein I (CENP-I) (FSH primary response protein 1) (Follicle-stimulating hormone primary response protein) (Interphase centromere complex protein 19) (Leucine-rich primary response protein 1),756,"86,720",5 out of 5,1997-11-01,Evidence at protein level
Q9BS16,CENPK_HUMAN,Centromere protein K (CENP-K) (Interphase centromere complex protein 37) (Protein AF-5alpha) (p33),269,"31,655",5 out of 5,2006-09-19,Evidence at protein level
Q7L2Z9,CENPQ_HUMAN,Centromere protein Q (CENP-Q),268,"30,595",5 out of 5,2005-07-05,Evidence at protein level
Q7Z7K6,CENPV_HUMAN,Centromere protein V (CENP-V) (Nuclear protein p30) (Proline-rich protein 6),275,"29,946",5 out of 5,2006-06-27,Evidence at protein level
Q5EE01,CENPW_HUMAN,Centromere protein W (CENP-W) (Cancer-up-regulated gene 2 protein),88,"10,061",5 out of 5,2007-11-13,Evidence at protein level
O95813,CER1_HUMAN,Cerberus (Cerberus-related protein) (DAN domain family member 4),267,"30,084",5 out of 5,2005-04-12,Evidence at protein level
O95873,CF047_HUMAN,Uncharacterized protein C6orf47 (Protein G4),294,"31,710",2 out of 5,2005-07-19,Evidence at protein level
Q6UWU4,CF089_HUMAN,Bombesin receptor-activated protein C6orf89 (Amfion),347,"39,870",5 out of 5,2006-05-30,Evidence at protein level
Q5TEZ5,CF163_HUMAN,Uncharacterized protein C6orf163,329,"38,553",1 out of 5,2007-01-09,Predicted
Q7Z4U5,CF201_HUMAN,Uncharacterized protein C6orf201,140,"16,243",2 out of 5,2007-08-21,Evidence at transcript level
P0C7V0,CF217_HUMAN,Putative uncharacterized protein encoded by LINC00271,271,"29,146",1 out of 5,2008-07-22,Uncertain
H3BNL8,CF229_HUMAN,Uncharacterized protein C6orf229,230,"26,547",1 out of 5,2014-02-19,Predicted
Q96M91,CFA53_HUMAN,Cilia- and flagella-associated protein 53 (Coiled-coil domain-containing protein 11),514,"61,835",5 out of 5,2005-03-15,Evidence at protein level
Q96MR6,CFA57_HUMAN,Cilia- and flagella-associated protein 57 (WD repeat-containing protein 65),1250,"144,961",3 out of 5,2006-06-27,Evidence at transcript level
Q7Z4T9,CFA91_HUMAN,Cilia- and flagella-associated protein 91 (CFAP91) (AMY-1-associating protein expressed in testis 1) (AAT-1) (MYCBP/AMY-1-associated testis-expressed protein 1) (Protein MAATS1),603,"70,999",5 out of 5,2005-07-19,Evidence at protein level
O15519,CFLAR_HUMAN,CASP8 and FADD-like apoptosis regulator (Caspase homolog) (CASH) (Caspase-eight-related protein) (Casper) (Caspase-like apoptosis regulatory protein) (CLARP) (Cellular FLICE-like inhibitory protein) (c-FLIP) (FADD-like antiapoptotic molecule 1) (FLAME-1) (Inhibitor of FLICE) (I-FLICE) (MACH-related inducer of toxicity) (MRIT) (Usurpin) [Cleaved into: CASP8 and FADD-like apoptosis regulator subunit p43; CASP8 and FADD-like apoptosis regulator subunit p12],480,"55,344",5 out of 5,2000-12-01,Evidence at protein level
E0CX11,CG073_HUMAN,Uncharacterized protein C7orf73,47,"5,265",2 out of 5,2011-10-19,Evidence at protein level
Q49A92,CH034_HUMAN,Uncharacterized protein C8orf34 (Protein VEST-1),452,"50,489",3 out of 5,2008-04-29,Evidence at transcript level
Q8N0T1,CH059_HUMAN,Uncharacterized protein C8orf59,100,"11,456",2 out of 5,2008-03-18,Evidence at protein level
Q8N9K7,CH079_HUMAN,Uncharacterized protein KIAA1456 isoform,121,"13,671",2 out of 5,2007-01-09,Evidence at transcript level
Q96BT1,CC049_HUMAN,Putative uncharacterized protein C3orf49,292,"33,461",1 out of 5,2006-12-12,Evidence at transcript level
P0CE67,CC079_HUMAN,Putative uncharacterized protein C3orf79,100,"11,337",1 out of 5,2010-03-23,Predicted
Q96JN2,CC136_HUMAN,Coiled-coil domain-containing protein 136 (Nasopharyngeal carcinoma-associated gene 6 protein),1154,"134,045",5 out of 5,2007-09-11,Evidence at protein level
Q5BJE1,CC178_HUMAN,Coiled-coil domain-containing protein 178,867,"102,011",3 out of 5,2006-02-21,Evidence at transcript level
A0A096LP49,CC187_HUMAN,Coiled-coil domain-containing protein 187,1063,"114,856",2 out of 5,2016-02-17,Evidence at transcript level
P0DO97,CC192_HUMAN,Coiled-coil domain-containing protein 192,292,"32,479",1 out of 5,2016-06-08,Predicted
Q96PX6,CC85A_HUMAN,Coiled-coil domain-containing protein 85A,553,"59,976",2 out of 5,2007-01-09,Evidence at transcript level
A6NKD9,CC85C_HUMAN,Coiled-coil domain-containing protein 85C,419,"45,210",2 out of 5,2008-07-22,Evidence at protein level
Q0P6D6,CCD15_HUMAN,Coiled-coil domain-containing protein 15,951,"110,484",2 out of 5,2007-10-23,Evidence at transcript level
Q502W7,CCD38_HUMAN,Coiled-coil domain-containing protein 38,563,"65,315",2 out of 5,2006-05-16,Evidence at transcript level
Q9UFE4,CCD39_HUMAN,Coiled-coil domain-containing protein 39,941,"109,901",5 out of 5,2006-05-16,Evidence at transcript level
Q8IVM0,CCD50_HUMAN,Coiled-coil domain-containing protein 50 (Protein Ymer),306,"35,822",5 out of 5,2005-08-16,Evidence at protein level
Q6NSX1,CCD70_HUMAN,Coiled-coil domain-containing protein 70,233,"28,767",3 out of 5,2006-05-16,Evidence at protein level
Q8N998,CCD89_HUMAN,Coiled-coil domain-containing protein 89 (Bc8 orange-interacting protein),374,"43,809",2 out of 5,2007-01-09,Evidence at transcript level
O15467,CCL16_HUMAN,C-C motif chemokine 16 (Chemokine CC-4) (HCC-4) (Chemokine LEC) (IL-10-inducible chemokine) (LCC-1) (Liver-expressed chemokine) (Lymphocyte and monocyte chemoattractant) (LMC) (Monotactin-1) (MTN-1) (NCC-4) (Small-inducible cytokine A16),120,"13,600",5 out of 5,1999-07-15,Evidence at protein level
O00626,CCL22_HUMAN,C-C motif chemokine 22 (CC chemokine STCP-1) (MDC(1-69)) (Macrophage-derived chemokine) (Small-inducible cytokine A22) (Stimulated T-cell chemotactic protein 1) [Cleaved into: MDC(3-69); MDC(5-69); MDC(7-69)],93,"10,625",5 out of 5,1999-07-15,Evidence at protein level
P14635,CCNB1_HUMAN,G2/mitotic-specific cyclin-B1,433,"48,337",5 out of 5,1990-04-01,Evidence at protein level
P24863,CCNC_HUMAN,Cyclin-C (SRB11 homolog) (hSRB11),283,"33,243",5 out of 5,1992-03-01,Evidence at protein level
P30281,CCND3_HUMAN,G1/S-specific cyclin-D3,292,"32,520",5 out of 5,1993-04-01,Evidence at protein level
P41002,CCNF_HUMAN,Cyclin-F (F-box only protein 1),786,"87,640",5 out of 5,1995-02-01,Evidence at protein level
Q6ZMN8,CCNI2_HUMAN,Cyclin-I2,369,"40,622",2 out of 5,2008-05-20,Evidence at transcript level
Q8N7R7,CCYL1_HUMAN,Cyclin-Y-like protein 1,359,"40,705",3 out of 5,2007-11-13,Evidence at protein level
Q9BXL8,CDCA4_HUMAN,Cell division cycle-associated protein 4 (Hematopoietic progenitor protein),241,"26,114",4 out of 5,2003-07-11,Evidence at protein level
Q9HBB8,CDHR5_HUMAN,Cadherin-related family member 5 (Mu-protocadherin) (Mucin and cadherin-like protein) (Mucin-like protocadherin) (MLPCDH),845,"88,223",5 out of 5,2004-03-15,Evidence at protein level
Q14004,CDK13_HUMAN,Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller),1512,"164,923",5 out of 5,2000-12-01,Evidence at protein level
Q00536,CDK16_HUMAN,Cyclin-dependent kinase 16 (EC 2.7.11.22) (Cell division protein kinase 16) (PCTAIRE-motif protein kinase 1) (Serine/threonine-protein kinase PCTAIRE-1),496,"55,716",5 out of 5,1993-04-01,Evidence at protein level
P11802,CDK4_HUMAN,Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3),303,"33,730",5 out of 5,1989-10-01,Evidence at protein level
Q5VV42,CDKAL_HUMAN,Threonylcarbamoyladenosine tRNA methylthiotransferase (EC 2.8.4.5) (CDK5 regulatory subunit-associated protein 1-like 1) (tRNA-t(6)A37 methylthiotransferase),579,"65,111",5 out of 5,2007-09-11,Evidence at protein level
Q8N9R6,CDRT4_HUMAN,CMT1A duplicated region transcript 4 protein,151,"17,514",1 out of 5,2008-01-15,Evidence at transcript level
Q9UKY7,CDV3_HUMAN,Protein CDV3 homolog,258,"27,335",3 out of 5,2007-09-11,Evidence at protein level
Q99626,CDX2_HUMAN,Homeobox protein CDX-2 (CDX-3) (Caudal-type homeobox protein 2),313,"33,520",5 out of 5,1997-11-01,Evidence at transcript level
Q569G3,CE047_HUMAN,Uncharacterized protein C5orf47,176,"19,206",1 out of 5,2008-02-26,Evidence at transcript level
Q6ZU80,CE128_HUMAN,Centrosomal protein of 128 kDa (Cep128),1094,"128,015",3 out of 5,2005-07-19,Evidence at protein level
Q5VT06,CE350_HUMAN,Centrosome-associated protein 350 (Cep350) (Centrosome-associated protein of 350 kDa),3117,"350,930",5 out of 5,2006-05-02,Evidence at protein level
Q2WEN9,CEA16_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 16 (Carcinoembryonic antigen-like 2),425,"45,873",5 out of 5,2007-08-21,Evidence at protein level
P13688,CEAM1_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 1 (Biliary glycoprotein 1) (BGP-1) (CD antigen CD66a),526,"57,560",5 out of 5,1990-01-01,Evidence at protein level
Q9BXF3,CECR2_HUMAN,Cat eye syndrome critical region protein 2,1484,"164,213",5 out of 5,2002-04-16,Evidence at protein level
Q9BZC1,CELF4_HUMAN,CUGBP Elav-like family member 4 (CELF-4) (Bruno-like protein 4) (CUG-BP- and ETR-3-like factor 4) (RNA-binding protein BRUNOL-4),486,"51,966",5 out of 5,2007-07-10,Evidence at protein level
Q9NYQ6,CELR1_HUMAN,Cadherin EGF LAG seven-pass G-type receptor 1 (Cadherin family member 9) (Flamingo homolog 2) (hFmi2),3014,"329,486",5 out of 5,2002-08-02,Evidence at protein level
Q9NYQ7,CELR3_HUMAN,Cadherin EGF LAG seven-pass G-type receptor 3 (Cadherin family member 11) (Epidermal growth factor-like protein 1) (EGF-like protein 1) (Flamingo homolog 1) (hFmi1) (Multiple epidermal growth factor-like domains protein 2) (Multiple EGF-like domains protein 2),3312,"358,185",5 out of 5,2002-08-02,Evidence at protein level
P19835,CEL_HUMAN,Bile salt-activated lipase (BAL) (EC 3.1.1.13) (EC 3.1.1.3) (Bile salt-stimulated lipase) (BSSL) (Bucelipase) (Carboxyl ester lipase) (Cholesterol esterase) (Pancreatic lysophospholipase) (Sterol esterase),753,"79,322",5 out of 5,1991-02-01,Evidence at protein level
Q8WUJ3,CEMIP_HUMAN,Cell migration-inducing and hyaluronan-binding protein (EC 3.2.1.35),1361,"152,998",5 out of 5,2004-04-13,Evidence at protein level
Q8N0S6,CENPL_HUMAN,Centromere protein L (CENP-L) (Interphase centromere complex protein 33),344,"38,998",4 out of 5,2006-07-25,Evidence at protein level
Q96H22,CENPN_HUMAN,Centromere protein N (CENP-N) (Interphase centromere complex protein 32),339,"39,555",5 out of 5,2006-09-19,Evidence at protein level
Q12798,CETN1_HUMAN,Centrin-1 (Caltractin isoform 2),172,"19,570",5 out of 5,1997-11-01,Evidence at protein level
Q6P656,CF161_HUMAN,Cilia- and flagella-associated protein 161,301,"34,294",2 out of 5,2006-06-27,Evidence at transcript level
Q8IYR0,CF206_HUMAN,Cilia- and flagella-associated protein 206,622,"71,193",5 out of 5,2003-08-29,Evidence at protein level
Q96G28,CFA36_HUMAN,Cilia- and flagella-associated protein 36 (Coiled-coil domain-containing protein 104),342,"39,447",4 out of 5,2007-02-20,Evidence at protein level
Q9UL16,CFA45_HUMAN,Cilia- and flagella-associated protein 45 (Coiled-coil domain-containing protein 19) (Nasopharyngeal epithelium-specific protein 1),551,"65,730",3 out of 5,2002-01-23,Evidence at transcript level
Q8NHU2,CFA61_HUMAN,Cilia- and flagella-associated protein 61,1237,"141,349",3 out of 5,2003-02-28,Evidence at transcript level
A6NFT4,CFA73_HUMAN,Cilia- and flagella-associated protein 73 (Coiled-coil domain-containing protein 42B),308,"35,914",3 out of 5,2008-07-22,Evidence at transcript level
Q9P2B7,CFA97_HUMAN,Cilia- and flagella-associated protein 97,532,"59,475",3 out of 5,2007-11-13,Evidence at protein level
Q8WU49,CG033_HUMAN,Uncharacterized protein C7orf33,177,"19,475",1 out of 5,2005-07-05,Evidence at transcript level
Q8NEG2,CG057_HUMAN,Uncharacterized protein C7orf57,295,"32,846",2 out of 5,2007-11-13,Evidence at transcript level
A4D174,CG071_HUMAN,Putative uncharacterized protein C7orf71,169,"19,096",1 out of 5,2010-03-23,Evidence at transcript level
Q9UFW8,CGBP1_HUMAN,CGG triplet repeat-binding protein 1 (CGG-binding protein 1) (20 kDa CGG-binding protein) (p20-CGGBP DNA-binding protein),167,"18,820",5 out of 5,2006-10-17,Evidence at protein level
Q8NEF3,CC112_HUMAN,Coiled-coil domain-containing protein 112 (Mutated in bladder cancer protein 1),446,"53,565",3 out of 5,2008-02-26,Evidence at protein level
Q9BUN5,CC28B_HUMAN,Coiled-coil domain-containing protein 28B,200,"22,037",4 out of 5,2006-05-02,Evidence at protein level
A0ZSE6,CC50C_HUMAN,Cell cycle control protein 50C (Transmembrane protein 30C),113,"13,039",2 out of 5,2007-06-26,Evidence at transcript level
Q96AQ1,CC74A_HUMAN,Coiled-coil domain-containing protein 74A,378,"41,605",2 out of 5,2007-02-06,Evidence at transcript level
Q8IYE1,CCD13_HUMAN,Coiled-coil domain-containing protein 13,715,"80,884",5 out of 5,2005-02-15,Evidence at protein level
Q96M95,CCD42_HUMAN,Coiled-coil domain-containing protein 42,316,"38,019",3 out of 5,2006-05-16,Evidence at protein level
Q9H6F5,CCD86_HUMAN,Coiled-coil domain-containing protein 86 (Cytokine-induced protein with coiled-coil domain),360,"40,236",4 out of 5,2007-05-01,Evidence at protein level
Q567U6,CCD93_HUMAN,Coiled-coil domain-containing protein 93,631,"73,198",4 out of 5,2006-05-16,Evidence at protein level
Q9Y3X0,CCDC9_HUMAN,Coiled-coil domain-containing protein 9,531,"59,703",2 out of 5,2004-07-19,Evidence at protein level
P32238,CCKAR_HUMAN,Cholecystokinin receptor type A (CCK-A receptor) (CCK-AR) (Cholecystokinin-1 receptor) (CCK1-R),428,"47,841",5 out of 5,1993-10-01,Evidence at protein level
Q16663,CCL15_HUMAN,C-C motif chemokine 15 (Chemokine CC-2) (HCC-2) (Leukotactin-1) (LKN-1) (MIP-1 delta) (Macrophage inflammatory protein 5) (MIP-5) (Mrp-2b) (NCC-3) (Small-inducible cytokine A15) [Cleaved into: CCL15(22-92); CCL15(25-92); CCL15(29-92)],113,"12,248",5 out of 5,1997-11-01,Evidence at protein level
O00585,CCL21_HUMAN,C-C motif chemokine 21 (6Ckine) (Beta-chemokine exodus-2) (Secondary lymphoid-tissue chemokine) (SLC) (Small-inducible cytokine A21),134,"14,646",5 out of 5,1999-07-15,Evidence at protein level
Q9NRJ3,CCL28_HUMAN,C-C motif chemokine 28 (Mucosae-associated epithelial chemokine) (MEC) (Protein CCK1) (Small-inducible cytokine A28),127,"14,280",5 out of 5,2001-01-11,Evidence at protein level
P80075,CCL8_HUMAN,C-C motif chemokine 8 (HC14) (Monocyte chemoattractant protein 2) (Monocyte chemotactic protein 2) (MCP-2) (Small-inducible cytokine A8) [Cleaved into: MCP-2(6-76)],99,"11,246",5 out of 5,1992-12-01,Evidence at protein level
Q16589,CCNG2_HUMAN,Cyclin-G2,344,"38,866",3 out of 5,2000-12-01,Evidence at transcript level
Q5T5M9,CCNJ_HUMAN,Cyclin-J,372,"42,581",2 out of 5,2007-11-13,Evidence at transcript level
Q8ND76,CCNY_HUMAN,Cyclin-Y (Cyc-Y) (Cyclin box protein 1) (Cyclin fold protein 1) (cyclin-X),341,"39,337",5 out of 5,2005-08-02,Evidence at protein level
P51679,CCR4_HUMAN,C-C chemokine receptor type 4 (C-C CKR-4) (CC-CKR-4) (CCR-4) (CCR4) (K5-5) (CD antigen CD194),360,"41,403",5 out of 5,1996-10-01,Evidence at protein level
Q6IQ19,CCSAP_HUMAN,"Centriole, cilia and spindle-associated protein",270,"30,216",5 out of 5,2007-04-17,Evidence at protein level
P0C7X3,CCYL3_HUMAN,Putative cyclin-Y-like protein 3,344,"39,078",1 out of 5,2008-07-22,Inferred from homology
P86791,CCZ1_HUMAN,Vacuolar fusion protein CCZ1 homolog,482,"55,866",4 out of 5,2010-11-02,Evidence at protein level
Q8N8J7,CD032_HUMAN,Uncharacterized protein C4orf32,132,"14,653",2 out of 5,2007-05-15,Evidence at transcript level
Q96KX1,CD036_HUMAN,Uncharacterized protein C4orf36,117,"13,276",1 out of 5,2006-12-12,Predicted
A7E2U8,CD047_HUMAN,UPF0602 protein C4orf47,309,"34,376",2 out of 5,2008-07-01,Evidence at transcript level
C9J302,CD051_HUMAN,Uncharacterized protein C4orf51,202,"23,001",1 out of 5,2010-03-23,Predicted
Q6YHK3,CD109_HUMAN,CD109 antigen (150 kDa TGF-beta-1-binding protein) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 7) (Platelet-specific Gov antigen) (p180) (r150) (CD antigen CD109),1445,"161,689",5 out of 5,2006-10-31,Evidence at protein level
Q99741,CDC6_HUMAN,Cell division control protein 6 homolog (CDC6-related protein) (Cdc18-related protein) (HsCdc18) (p62(cdc6)) (HsCDC6),560,"62,720",5 out of 5,2004-07-19,Evidence at protein level
O00311,CDC7_HUMAN,Cell division cycle 7-related protein kinase (CDC7-related kinase) (HsCdc7) (huCdc7) (EC 2.7.11.1),574,"63,888",5 out of 5,2001-01-11,Evidence at protein level
Q99618,CDCA3_HUMAN,Cell division cycle-associated protein 3 (Gene-rich cluster protein C8) (Trigger of mitotic entry protein 1) (TOME-1),268,"28,998",4 out of 5,2007-05-15,Evidence at protein level
Q96FF9,CDCA5_HUMAN,Sororin (Cell division cycle-associated protein 5) (p35),252,"27,601",5 out of 5,2005-07-05,Evidence at protein level
Q9H5V8,CDCP1_HUMAN,CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318),836,"92,932",5 out of 5,2006-03-07,Evidence at protein level
P49336,CDK8_HUMAN,Cyclin-dependent kinase 8 (EC 2.7.11.22) (EC 2.7.11.23) (Cell division protein kinase 8) (Mediator complex subunit CDK8) (Mediator of RNA polymerase II transcription subunit CDK8) (Protein kinase K35),464,"53,284",5 out of 5,1996-02-01,Evidence at protein level
O75956,CDKA2_HUMAN,Cyclin-dependent kinase 2-associated protein 2 (CDK2-associated protein 2) (DOC-1-related protein) (DOC-1R),126,"13,101",3 out of 5,1999-07-15,Evidence at protein level
Q16667,CDKN3_HUMAN,Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase),212,"23,805",5 out of 5,1997-11-01,Evidence at protein level
P38936,CDN1A_HUMAN,Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21),164,"18,119",5 out of 5,1995-02-01,Evidence at protein level
Q49AH0,CDNF_HUMAN,Cerebral dopamine neurotrophic factor (ARMET-like protein 1) (Conserved dopamine neurotrophic factor),187,"20,964",4 out of 5,2007-04-03,Evidence at protein level
O95170,CDRT1_HUMAN,CMT1A duplicated region transcript 1 protein,752,"85,370",2 out of 5,2008-01-15,Evidence at transcript level
Q9H211,CDT1_HUMAN,DNA replication factor Cdt1 (Double parked homolog) (DUP),546,"60,390",5 out of 5,2004-12-07,Evidence at protein level
P47902,CDX1_HUMAN,Homeobox protein CDX-1 (Caudal-type homeobox protein 1),265,"28,138",5 out of 5,1996-02-01,Evidence at protein level
Q9Y6F8,CDY1_HUMAN,Testis-specific chromodomain protein Y 1 (EC 2.3.1.48),540,"60,473",4 out of 5,2002-01-23,Evidence at protein level
P0C854,CECR9_HUMAN,Putative cat eye syndrome critical region protein 9,216,"23,602",2 out of 5,2008-09-02,Uncertain
Q96J87,CELF6_HUMAN,CUGBP Elav-like family member 6 (CELF-6) (Bruno-like protein 6) (CUG-BP- and ETR-3-like factor 6) (RNA-binding protein BRUNOL-6),481,"50,477",5 out of 5,2007-07-10,Evidence at protein level
Q9HCU4,CELR2_HUMAN,Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3),2923,"317,453",5 out of 5,2002-08-02,Evidence at protein level
Q8N111,CEND_HUMAN,Cell cycle exit and neuronal differentiation protein 1 (BM88 antigen),149,"14,954",3 out of 5,2003-02-12,Evidence at protein level
Q53EZ4,CEP55_HUMAN,Centrosomal protein of 55 kDa (Cep55) (Up-regulated in colon cancer 6),464,"54,178",5 out of 5,2005-07-19,Evidence at protein level
Q96MT8,CEP63_HUMAN,Centrosomal protein of 63 kDa (Cep63),703,"81,344",5 out of 5,2004-12-21,Evidence at protein level
O15182,CETN3_HUMAN,Centrin-3,167,"19,550",5 out of 5,2000-05-30,Evidence at protein level
Q5T4I8,CF052_HUMAN,Putative uncharacterized protein C6orf52,152,"17,383",2 out of 5,2007-07-24,Evidence at transcript level
Q5T699,CF183_HUMAN,Putative uncharacterized protein C6orf183,404,"46,784",1 out of 5,2008-05-20,Uncertain
Q96MT7,CFA44_HUMAN,Cilia- and flagella-associated protein 44 (WD repeat-containing protein 52),982,"111,729",3 out of 5,2007-10-02,Evidence at protein level
Q6ZTR5,CFA47_HUMAN,Cilia- and flagella-associated protein 47,3102,"351,950",3 out of 5,2005-07-05,Evidence at transcript level
D6REC4,CFA99_HUMAN,Cilia- and flagella-associated protein 99,459,"52,293",1 out of 5,2014-11-26,Inferred from homology
P08603,CFAH_HUMAN,Complement factor H (H factor 1),1231,"139,096",5 out of 5,1988-08-01,Evidence at protein level
Q9UEE9,CFDP1_HUMAN,Craniofacial development protein 1 (Bucentaur),299,"33,593",4 out of 5,2005-11-22,Evidence at protein level
Q96NF6,CH049_HUMAN,Putative uncharacterized protein C8orf49,230,"25,558",2 out of 5,2007-01-09,Evidence at transcript level
O95992,CH25H_HUMAN,Cholesterol 25-hydroxylase (EC 1.14.99.38) (Cholesterol 25-monooxygenase) (h25OH),272,"31,745",4 out of 5,2006-03-07,Evidence at protein level
P36222,CH3L1_HUMAN,Chitinase-3-like protein 1 (39 kDa synovial protein) (Cartilage glycoprotein 39) (CGP-39) (GP-39) (hCGP-39) (YKL-40),383,"42,625",5 out of 5,1994-06-01,Evidence at protein level
Q5T0U0,CC122_HUMAN,Coiled-coil domain-containing protein 122,273,"32,206",2 out of 5,2007-05-15,Evidence at transcript level
Q96CT7,CC124_HUMAN,Coiled-coil domain-containing protein 124,223,"25,835",4 out of 5,2006-12-12,Evidence at protein level
Q86Z20,CC125_HUMAN,Coiled-coil domain-containing protein 125 (Protein kenae),511,"58,629",3 out of 5,2007-05-29,Evidence at protein level
Q96BQ5,CC127_HUMAN,Coiled-coil domain-containing protein 127,260,"30,834",1 out of 5,2006-12-12,Evidence at protein level
P13994,CC130_HUMAN,Coiled-coil domain-containing protein 130 (9 kDa protein),396,"44,802",3 out of 5,1990-01-01,Evidence at protein level
Q4G0S7,CC152_HUMAN,Coiled-coil domain-containing protein 152,254,"29,979",2 out of 5,2008-02-26,Evidence at transcript level
P0C7W6,CC172_HUMAN,Coiled-coil domain-containing protein 172,258,"31,035",3 out of 5,2008-07-22,Evidence at protein level
Q8N715,CC185_HUMAN,Coiled-coil domain-containing protein 185,623,"72,349",3 out of 5,2006-07-25,Evidence at protein level
Q5VVM6,CCD30_HUMAN,Coiled-coil domain-containing protein 30 (Prefoldin subunit 6-like protein),783,"91,333",2 out of 5,2008-05-20,Evidence at transcript level
Q8TD31,CCHCR_HUMAN,Coiled-coil alpha-helical rod protein 1 (Alpha-helical coiled-coil rod protein) (Putative gene 8 protein) (Pg8),782,"88,671",5 out of 5,2004-02-16,Evidence at protein level
Q16627,CCL14_HUMAN,C-C motif chemokine 14 (Chemokine CC-1/CC-3) (HCC-1/HCC-3) (HCC-1(1-74)) (NCC-2) (Small-inducible cytokine A14) [Cleaved into: HCC-1(3-74); HCC-1(4-74); HCC-1(9-74)],93,"10,678",5 out of 5,1997-11-01,Evidence at protein level
P13501,CCL5_HUMAN,C-C motif chemokine 5 (EoCP) (Eosinophil chemotactic cytokine) (SIS-delta) (Small-inducible cytokine A5) (T cell-specific protein P228) (TCP228) (T-cell-specific protein RANTES) [Cleaved into: RANTES(3-68); RANTES(4-68)],91,"9,990",5 out of 5,1990-01-01,Evidence at protein level
P20248,CCNA2_HUMAN,Cyclin-A2 (Cyclin-A) (Cyclin A),432,"48,551",5 out of 5,1991-02-01,Evidence at protein level
Q14094,CCNI_HUMAN,Cyclin-I,377,"42,557",2 out of 5,2000-12-01,Evidence at protein level
P32246,CCR1_HUMAN,C-C chemokine receptor type 1 (C-C CKR-1) (CC-CKR-1) (CCR-1) (CCR1) (HM145) (LD78 receptor) (Macrophage inflammatory protein 1-alpha receptor) (MIP-1alpha-R) (RANTES-R) (CD antigen CD191),355,"41,173",5 out of 5,1993-10-01,Evidence at protein level
P51681,CCR5_HUMAN,C-C chemokine receptor type 5 (C-C CKR-5) (CC-CKR-5) (CCR-5) (CCR5) (CHEMR13) (HIV-1 fusion coreceptor) (CD antigen CD195),352,"40,524",5 out of 5,1996-10-01,Evidence at protein level
Q9UQ88,CD11A_HUMAN,Cyclin-dependent kinase 11A (EC 2.7.11.22) (Cell division cycle 2-like protein kinase 2) (Cell division protein kinase 11A) (Galactosyltransferase-associated protein kinase p58/GTA) (PITSLRE serine/threonine-protein kinase CDC2L2),783,"91,362",5 out of 5,2003-09-19,Evidence at protein level
P16671,CD36_HUMAN,Platelet glycoprotein 4 (Fatty acid translocase) (FAT) (Glycoprotein IIIb) (GPIIIB) (Leukocyte differentiation antigen CD36) (PAS IV) (PAS-4) (Platelet collagen receptor) (Platelet glycoprotein IV) (GPIV) (Thrombospondin receptor) (CD antigen CD36),472,"53,053",5 out of 5,1990-08-01,Evidence at protein level
Q01151,CD83_HUMAN,CD83 antigen (hCD83) (B-cell activation protein) (Cell surface protein HB15) (CD antigen CD83),205,"23,042",5 out of 5,1993-04-01,Evidence at protein level
P42081,CD86_HUMAN,T-lymphocyte activation antigen CD86 (Activation B7-2 antigen) (B70) (BU63) (CTLA-4 counter-receptor B7.2) (FUN-1) (CD antigen CD86),329,"37,682",5 out of 5,1995-11-01,Evidence at protein level
Q8NHZ8,CDC26_HUMAN,Anaphase-promoting complex subunit CDC26 (Anaphase-promoting complex subunit 12) (APC12) (Cell division cycle protein 26 homolog),85,"9,777",5 out of 5,2007-01-09,Evidence at protein level
P30260,CDC27_HUMAN,Cell division cycle protein 27 homolog (Anaphase-promoting complex subunit 3) (APC3) (CDC27 homolog) (CDC27Hs) (H-NUC),824,"91,867",5 out of 5,1993-04-01,Evidence at protein level
P42772,CDN2B_HUMAN,Cyclin-dependent kinase 4 inhibitor B (Multiple tumor suppressor 2) (MTS-2) (p14-INK4b) (p15-INK4b) (p15INK4B),138,"14,722",5 out of 5,1995-11-01,Evidence at protein level
Q9H5L9,CE066_HUMAN,Putative uncharacterized protein C5orf66,145,"15,570",1 out of 5,2014-01-22,Uncertain
Q9C0D2,CE295_HUMAN,Centrosomal protein of 295 kDa,2601,"295,176",5 out of 5,2008-03-18,Evidence at protein level
Q5SZL2,CE85L_HUMAN,Centrosomal protein of 85 kDa-like (Serologically defined breast cancer antigen NY-BR-15),805,"91,808",5 out of 5,2007-08-21,Evidence at protein level
Q6UY09,CEA20_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 20,585,"64,502",4 out of 5,2005-08-16,Evidence at transcript level
Q9BXQ6,CECR6_HUMAN,Cat eye syndrome critical region protein 6,578,"58,425",2 out of 5,2002-04-16,Evidence at transcript level
Q02224,CENPE_HUMAN,Centromere-associated protein E (Centromere protein E) (CENP-E) (Kinesin-7) (Kinesin-related protein CENPE),2701,"316,415",5 out of 5,1993-07-01,Evidence at protein level
Q6IPU0,CENPP_HUMAN,Centromere protein P (CENP-P),288,"33,165",5 out of 5,2006-09-19,Evidence at protein level
Q96LK0,CEP19_HUMAN,Centrosomal protein of 19 kDa (Cep19),163,"19,166",5 out of 5,2006-10-03,Evidence at protein level
Q9UNH5,CC14A_HUMAN,Dual specificity protein phosphatase CDC14A (EC 3.1.3.16) (EC 3.1.3.48) (CDC14 cell division cycle 14 homolog A),594,"66,574",5 out of 5,2004-11-23,Evidence at protein level
Q8IYT3,CC170_HUMAN,Coiled-coil domain-containing protein 170,715,"82,277",2 out of 5,2006-10-31,Evidence at protein level
Q0VFZ6,CC173_HUMAN,Coiled-coil domain-containing protein 173,552,"66,403",2 out of 5,2008-02-26,Evidence at transcript level
Q9NQR7,CC177_HUMAN,Coiled-coil domain-containing protein 177 (Myelin proteolipid protein-like protein),707,"79,739",2 out of 5,2005-07-19,Evidence at transcript level
A1A4V9,CC189_HUMAN,Coiled-coil domain-containing protein 189,331,"37,921",2 out of 5,2008-02-26,Evidence at transcript level
Q9GZT6,CC90B_HUMAN,"Coiled-coil domain-containing protein 90B, mitochondrial",254,"29,506",3 out of 5,2007-07-24,Evidence at protein level
Q1T7F1,CCB42_HUMAN,Putative chemokine-related protein B42,81,"8,815",2 out of 5,2013-05-01,Uncertain
Q96LX7,CCD17_HUMAN,Coiled-coil domain-containing protein 17,622,"67,721",3 out of 5,2007-09-11,Evidence at protein level
Q8N4L8,CCD24_HUMAN,Coiled-coil domain-containing protein 24,307,"34,322",2 out of 5,2006-05-02,Evidence at protein level
Q8TAB7,CCD26_HUMAN,Putative coiled-coil domain-containing protein 26 (Retinoic acid modulator),109,"13,192",3 out of 5,2006-05-02,Uncertain
Q96A33,CCD47_HUMAN,Coiled-coil domain-containing protein 47,483,"55,874",5 out of 5,2006-05-16,Evidence at protein level
Q8IV32,CCD71_HUMAN,Coiled-coil domain-containing protein 71,467,"49,648",2 out of 5,2006-05-16,Evidence at protein level
Q8N4S0,CCD82_HUMAN,Coiled-coil domain-containing protein 82,544,"64,002",2 out of 5,2006-05-16,Evidence at protein level
Q7Z6B0,CCD91_HUMAN,Coiled-coil domain-containing protein 91 (GGA-binding partner) (p56 accessory protein),441,"49,971",5 out of 5,2005-03-29,Evidence at protein level
Q96F63,CCD97_HUMAN,Coiled-coil domain-containing protein 97,343,"38,947",2 out of 5,2007-05-01,Evidence at protein level
Q96M83,CCDC7_HUMAN,Coiled-coil domain-containing protein 7 (Protein BIOT2),1385,"157,448",3 out of 5,2004-06-07,Evidence at transcript level
Q8TC90,CCER1_HUMAN,Coiled-coil domain-containing glutamate-rich protein 1,406,"46,482",2 out of 5,2007-05-29,Evidence at protein level
P51677,CCR3_HUMAN,C-C chemokine receptor type 3 (C-C CKR-3) (CC-CKR-3) (CCR-3) (CCR3) (CKR3) (Eosinophil eotaxin receptor) (CD antigen CD193),355,"41,044",5 out of 5,1996-10-01,Evidence at protein level
P51686,CCR9_HUMAN,C-C chemokine receptor type 9 (C-C CKR-9) (CC-CKR-9) (CCR-9) (G-protein coupled receptor 28) (GPR-9-6) (CD antigen CDw199),369,"42,016",5 out of 5,1996-10-01,Evidence at protein level
Q53FE4,CD017_HUMAN,Uncharacterized protein C4orf17,359,"39,644",2 out of 5,2005-08-30,Evidence at transcript level
Q8N1A6,CD033_HUMAN,UPF0462 protein C4orf33,199,"23,468",2 out of 5,2007-07-24,Evidence at protein level
Q5M9N0,CD158_HUMAN,Coiled-coil domain-containing protein 158,1113,"127,140",2 out of 5,2008-03-18,Evidence at transcript level
Q8N6Q3,CD177_HUMAN,CD177 antigen (Human neutrophil alloantigen 2a) (HNA-2a) (NB1 glycoprotein) (NB1 GP) (Polycythemia rubra vera protein 1) (PRV-1) (CD antigen CD177),437,"46,363",5 out of 5,2006-04-04,Evidence at protein level
P28907,CD38_HUMAN,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 (EC 3.2.2.6) (2'-phospho-ADP-ribosyl cyclase) (2'-phospho-ADP-ribosyl cyclase/2'-phospho-cyclic-ADP-ribose transferase) (EC 2.4.99.20) (2'-phospho-cyclic-ADP-ribose transferase) (ADP-ribosyl cyclase 1) (ADPRC 1) (Cyclic ADP-ribose hydrolase 1) (cADPr hydrolase 1) (T10) (CD antigen CD38),300,"34,328",5 out of 5,1992-12-01,Evidence at protein level
P31358,CD52_HUMAN,CAMPATH-1 antigen (CDw52) (Cambridge pathology 1 antigen) (Epididymal secretory protein E5) (Human epididymis-specific protein 5) (He5) (CD antigen CD52),61,"6,614",5 out of 5,1993-07-01,Evidence at protein level
O43866,CD5L_HUMAN,CD5 antigen-like (Apoptosis inhibitor expressed by macrophages) (hAIM) (CT-2) (IgM-associated peptide) (SP-alpha),347,"38,088",5 out of 5,2002-04-16,Evidence at protein level
P21854,CD72_HUMAN,B-cell differentiation antigen CD72 (Lyb-2) (CD antigen CD72),359,"40,220",4 out of 5,1991-05-01,Evidence at transcript level
P40259,CD79B_HUMAN,B-cell antigen receptor complex-associated protein beta chain (B-cell-specific glycoprotein B29) (Ig-beta) (Immunoglobulin-associated B29 protein) (CD antigen CD79b),229,"26,048",5 out of 5,1995-02-01,Evidence at protein level
P60033,CD81_HUMAN,CD81 antigen (26 kDa cell surface protein TAPA-1) (Target of the antiproliferative antibody 1) (Tetraspanin-28) (Tspan-28) (CD antigen CD81),236,"25,809",5 out of 5,2003-11-21,Evidence at protein level
Q96GN5,CDA7L_HUMAN,Cell division cycle-associated 7-like protein (Protein JPO2) (Transcription factor RAM2),454,"52,206",5 out of 5,2006-09-05,Evidence at protein level
Q9H305,CDIP1_HUMAN,Cell death-inducing p53-target protein 1 (Cell death involved p53-target) (Cell death-inducing protein) (LITAF-like protein) (Lipopolysaccharide-induced tumor necrosis factor-alpha-like protein) (Transmembrane protein I1),208,"21,892",5 out of 5,2007-03-20,Evidence at protein level
P50613,CDK7_HUMAN,Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit),346,"39,038",5 out of 5,1996-10-01,Evidence at protein level
O76039,CDKL5_HUMAN,Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9),1030,"115,538",5 out of 5,1999-07-15,Evidence at protein level
P46527,CDN1B_HUMAN,Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1),198,"22,073",5 out of 5,1995-11-01,Evidence at protein level
P42773,CDN2C_HUMAN,Cyclin-dependent kinase 4 inhibitor C (Cyclin-dependent kinase 6 inhibitor) (p18-INK4c) (p18-INK6),168,"18,127",5 out of 5,1995-11-01,Evidence at protein level
Q92903,CDS1_HUMAN,Phosphatidate cytidylyltransferase 1 (EC 2.7.7.41) (CDP-DAG synthase 1) (CDP-DG synthase 1) (CDP-diacylglycerol synthase 1) (CDS 1) (CDP-diglyceride pyrophosphorylase 1) (CDP-diglyceride synthase 1) (CTP:phosphatidate cytidylyltransferase 1),461,"53,304",5 out of 5,1997-11-01,Evidence at transcript level
Q52M75,CE027_HUMAN,Putative uncharacterized protein encoded by LINC01554 (Protein FIS),96,"10,857",1 out of 5,2007-10-02,Predicted
Q6UWT4,CE046_HUMAN,Uncharacterized protein C5orf46,87,"9,693",2 out of 5,2008-02-05,Inferred from homology
Q8N8D9,CE056_HUMAN,Uncharacterized protein C5orf56,126,"14,652",1 out of 5,2008-02-26,Evidence at transcript level
Q9P2H0,CE126_HUMAN,Centrosomal protein of 126 kDa,1117,"125,870",5 out of 5,2006-09-05,Evidence at protein level
P53567,CEBPG_HUMAN,CCAAT/enhancer-binding protein gamma (C/EBP gamma),150,"16,408",5 out of 5,1996-10-01,Evidence at protein level
Q16739,CEGT_HUMAN,Ceramide glucosyltransferase (EC 2.4.1.80) (GLCT-1) (Glucosylceramide synthase) (GCS) (UDP-glucose ceramide glucosyltransferase) (UDP-glucose:N-acylsphingosine D-glucosyltransferase),394,"44,854",5 out of 5,1997-11-01,Evidence at protein level
P08217,CEL2A_HUMAN,Chymotrypsin-like elastase family member 2A (EC 3.4.21.71) (Elastase-2A),269,"28,888",5 out of 5,1988-08-01,Evidence at protein level
O95319,CELF2_HUMAN,CUGBP Elav-like family member 2 (CELF-2) (Bruno-like protein 3) (CUG triplet repeat RNA-binding protein 2) (CUG-BP2) (CUG-BP- and ETR-3-like factor 2) (ELAV-type RNA-binding protein 3) (ETR-3) (Neuroblastoma apoptosis-related RNA-binding protein) (hNAPOR) (RNA-binding protein BRUNOL-3),508,"54,285",5 out of 5,2007-07-10,Evidence at protein level
Q5SZQ8,CELF3_HUMAN,CUGBP Elav-like family member 3 (CELF-3) (Bruno-like protein 1) (CAG repeat protein 4) (CUG-BP- and ETR-3-like factor 3) (ELAV-type RNA-binding protein 1) (ETR-1) (Expanded repeat domain protein CAG/CTG 4) (RNA-binding protein BRUNOL-1) (Trinucleotide repeat-containing gene 4 protein),465,"50,548",5 out of 5,2007-07-10,Evidence at protein level
Q9HC77,CENPJ_HUMAN,Centromere protein J (CENP-J) (Centrosomal P4.1-associated protein) (LAG-3-associated protein) (LYST-interacting protein 1),1338,"153,000",5 out of 5,2005-04-26,Evidence at protein level
Q13352,CENPR_HUMAN,Centromere protein R (CENP-R) (Beta-3-endonexin) (Integrin beta-3-binding protein) (Nuclear receptor-interacting factor 3),177,"20,194",5 out of 5,2004-07-19,Evidence at protein level
Q96BT3,CENPT_HUMAN,Centromere protein T (CENP-T) (Interphase centromere complex protein 22),561,"60,423",5 out of 5,2006-09-19,Evidence at protein level
A8MT69,CENPX_HUMAN,Centromere protein X (CENP-X) (FANCM-associated histone fold protein 2) (FANCM-interacting histone fold protein 2) (Fanconi anemia-associated polypeptide of 10 kDa) (Retinoic acid-inducible gene D9 protein homolog) (Stimulated by retinoic acid gene 13 protein homolog),81,"8,959",5 out of 5,2008-05-20,Evidence at protein level
Q9C0F1,CEP44_HUMAN,Centrosomal protein of 44 kDa (Cep44) (HBV PreS1-transactivated protein 3) (PS1TP3),390,"44,140",5 out of 5,2007-07-10,Evidence at protein level
Q8NHQ1,CEP70_HUMAN,Centrosomal protein of 70 kDa (Cep70) (p10-binding protein),597,"69,752",5 out of 5,2005-02-01,Evidence at protein level
Q96GE4,CEP95_HUMAN,Centrosomal protein of 95 kDa (Cep95) (Coiled-coil domain-containing protein 45),821,"95,297",4 out of 5,2006-05-16,Evidence at protein level
Q9HA82,CERS4_HUMAN,Ceramide synthase 4 (CerS4) (LAG1 longevity assurance homolog 4),394,"46,399",4 out of 5,2004-08-16,Evidence at protein level
P00450,CERU_HUMAN,Ceruloplasmin (EC 1.16.3.1) (Ferroxidase),1065,"122,205",5 out of 5,1986-07-21,Evidence at protein level
Q5SRN2,CF010_HUMAN,Uncharacterized protein C6orf10,563,"61,626",4 out of 5,2005-07-19,Evidence at transcript level
Q9H6K1,CF106_HUMAN,Uncharacterized protein C6orf106,298,"32,872",2 out of 5,2005-07-19,Evidence at protein level
Q9P0P8,CF203_HUMAN,Uncharacterized protein C6orf203,240,"27,941",2 out of 5,2005-07-19,Evidence at protein level
Q8N319,CF223_HUMAN,Uncharacterized protein C6orf223,242,"26,113",2 out of 5,2008-02-05,Evidence at transcript level
B2RD01,CENP1_HUMAN,CENPB DNA-binding domain-containing protein 1,187,"21,052",2 out of 5,2010-06-15,Evidence at transcript level
P49450,CENPA_HUMAN,Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A),140,"15,991",5 out of 5,1996-02-01,Evidence at protein level
Q9H3R5,CENPH_HUMAN,Centromere protein H (CENP-H) (Interphase centromere complex protein 35),247,"28,481",5 out of 5,2005-11-08,Evidence at protein level
Q9NSP4,CENPM_HUMAN,Centromere protein M (CENP-M) (Interphase centromere complex protein 39) (Proliferation-associated nuclear element protein 1),180,"19,737",5 out of 5,2004-05-10,Evidence at protein level
Q9BYV8,CEP41_HUMAN,Centrosomal protein of 41 kDa (Cep41) (Testis-specific gene A14 protein),373,"41,368",5 out of 5,2004-12-21,Evidence at protein level
Q9P209,CEP72_HUMAN,Centrosomal protein of 72 kDa (Cep72),647,"71,718",5 out of 5,2005-02-01,Evidence at protein level
Q96G23,CERS2_HUMAN,Ceramide synthase 2 (CerS2) (LAG1 longevity assurance homolog 2) (SP260) (Tumor metastasis-suppressor gene 1 protein),380,"44,876",5 out of 5,2004-08-16,Evidence at protein level
Q8N5B7,CERS5_HUMAN,Ceramide synthase 5 (CerS5) (EC 2.3.1.24) (LAG1 longevity assurance homolog 5),392,"45,752",5 out of 5,2004-08-16,Evidence at transcript level
P41208,CETN2_HUMAN,Centrin-2 (Caltractin isoform 1),172,"19,738",5 out of 5,1995-02-01,Evidence at protein level
Q9HD87,CF050_HUMAN,Putative uncharacterized protein C6orf50 (Nasopharyngeal carcinoma-associated gene 19 protein),102,"12,368",2 out of 5,2006-10-31,Uncertain
Q7Z4R8,CF120_HUMAN,UPF0669 protein C6orf120,191,"20,772",4 out of 5,2007-08-21,Evidence at protein level
Q9H8W2,CF155_HUMAN,Putative uncharacterized protein encoded by LINC00472,130,"13,851",1 out of 5,2005-07-05,Uncertain
Q5T655,CFA58_HUMAN,Cilia- and flagella-associated protein 58 (Coiled-coil domain-containing protein 147),872,"103,417",2 out of 5,2007-02-06,Evidence at protein level
Q6ZU64,CFA65_HUMAN,Cilia- and flagella-associated protein 65 (Coiled-coil domain-containing protein 108),1925,"217,250",4 out of 5,2007-05-29,Evidence at protein level
Q6ZTY9,CG065_HUMAN,Uncharacterized protein C7orf65,151,"16,773",1 out of 5,2008-09-02,Evidence at transcript level
Q96JM3,CHAP1_HUMAN,Chromosome alignment-maintaining phosphoprotein 1 (Zinc finger protein 828),812,"89,099",5 out of 5,2006-09-05,Evidence at protein level
Q9Y6H1,CHCH2_HUMAN,Coiled-coil-helix-coiled-coil-helix domain-containing protein 2 (Aging-associated gene 10 protein) (HCV NS2 trans-regulated protein) (NS2TP),151,"15,513",5 out of 5,2005-04-12,Evidence at protein level
Q13231,CHIT1_HUMAN,Chitotriosidase-1 (EC 3.2.1.14) (Chitinase-1),466,"51,681",5 out of 5,2003-10-24,Evidence at protein level
Q7LBR1,CHM1B_HUMAN,Charged multivesicular body protein 1b (CHMP1.5) (Chromatin-modifying protein 1b) (CHMP1b) (Vacuolar protein sorting-associated protein 46-2) (Vps46-2) (hVps46-2),199,"22,109",5 out of 5,2005-08-30,Evidence at protein level
Q9UQN3,CHM2B_HUMAN,Charged multivesicular body protein 2b (CHMP2.5) (Chromatin-modifying protein 2b) (CHMP2b) (Vacuolar protein sorting-associated protein 2-2) (Vps2-2) (hVps2-2),213,"23,907",5 out of 5,2005-08-30,Evidence at protein level
Q8WUX9,CHMP7_HUMAN,Charged multivesicular body protein 7 (Chromatin-modifying protein 7),453,"50,911",5 out of 5,2005-08-30,Evidence at protein level
Q99653,CHP1_HUMAN,Calcineurin B homologous protein 1 (Calcineurin B-like protein) (Calcium-binding protein CHP) (Calcium-binding protein p22) (EF-hand calcium-binding domain-containing protein p22),195,"22,456",5 out of 5,1998-07-15,Evidence at protein level
Q96BS2,CHP3_HUMAN,Calcineurin B homologous protein 3 (Tescalcin) (TSC),214,"24,750",5 out of 5,2002-05-02,Evidence at protein level
Q86X52,CHSS1_HUMAN,Chondroitin sulfate synthase 1 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 1) (Chondroitin synthase 1) (ChSy-1) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase 1) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 1) (N-acetylgalactosaminyltransferase 1),802,"91,784",5 out of 5,2005-02-01,Evidence at protein level
Q70JA7,CHSS3_HUMAN,Chondroitin sulfate synthase 3 (EC 2.4.1.175) (EC 2.4.1.226) (Carbohydrate synthase 2) (Chondroitin glucuronyltransferase 3) (Chondroitin synthase 2) (ChSy-2) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase 3) (N-acetylgalactosaminyltransferase 3),882,"100,284",5 out of 5,2005-02-01,Evidence at transcript level
Q7LGC8,CHST3_HUMAN,Carbohydrate sulfotransferase 3 (EC 2.8.2.17) (Chondroitin 6-O-sulfotransferase 1) (C6ST-1) (Chondroitin 6-sulfotransferase) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 0) (GST-0),479,"54,706",5 out of 5,2005-03-15,Evidence at protein level
Q9H2A9,CHST8_HUMAN,Carbohydrate sulfotransferase 8 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 1) (GalNAc-4-ST1) (GalNAc4ST-1) (N-acetylgalactosamine-4-O-sulfotransferase 1),424,"48,834",5 out of 5,2005-03-15,Evidence at protein level
Q8WUH1,CHUR_HUMAN,Protein Churchill,139,"16,111",4 out of 5,2003-05-30,Evidence at protein level
Q8N6V4,CJ053_HUMAN,UPF0728 protein C10orf53,93,"10,399",2 out of 5,2005-07-05,Inferred from homology
Q8N326,CJ111_HUMAN,Uncharacterized protein C10orf111,155,"17,766",1 out of 5,2005-06-21,Evidence at transcript level
B7Z368,CJ142_HUMAN,Uncharacterized protein C10orf142,130,"13,757",1 out of 5,2015-06-24,Evidence at transcript level
Q9NQ32,CK016_HUMAN,Uncharacterized protein C11orf16,467,"51,609",2 out of 5,2003-08-29,Evidence at transcript level
Q8N5U0,CK042_HUMAN,Uncharacterized protein C11orf42,333,"36,368",1 out of 5,2006-06-27,Evidence at transcript level
Q9H6J7,CK049_HUMAN,UPF0705 protein C11orf49,331,"37,353",3 out of 5,2007-03-20,Evidence at protein level
Q6IPW1,CK071_HUMAN,Uncharacterized protein C11orf71,123,"13,249",1 out of 5,2007-02-06,Evidence at transcript level
Q495D7,CL036_HUMAN,Putative uncharacterized protein encoded by LINC01559,138,"15,996",1 out of 5,2007-02-06,Evidence at transcript level
Q9Y696,CLIC4_HUMAN,Chloride intracellular channel protein 4 (Intracellular chloride ion channel protein p64H1),253,"28,772",5 out of 5,2000-05-30,Evidence at protein level
P30622,CLIP1_HUMAN,CAP-Gly domain-containing linker protein 1 (Cytoplasmic linker protein 1) (Cytoplasmic linker protein 170 alpha-2) (CLIP-170) (Reed-Sternberg intermediate filament-associated protein) (Restin),1438,"162,246",5 out of 5,1993-04-01,Evidence at protein level
P49760,CLK2_HUMAN,Dual specificity protein kinase CLK2 (EC 2.7.12.1) (CDC-like kinase 2),499,"60,090",5 out of 5,1996-10-01,Evidence at protein level
Q6UXG3,CLM9_HUMAN,CMRF35-like molecule 9 (CLM-9) (CD300 antigen-like family member G) (Triggering receptor expressed on myeloid cells 4) (TREM-4) (CD antigen CD300g),332,"36,060",5 out of 5,2007-10-02,Evidence at protein level
F5H4A9,CC080_HUMAN,Uncharacterized membrane protein C3orf80,247,"25,682",2 out of 5,2011-10-19,Evidence at transcript level
Q9BWC9,CC106_HUMAN,Coiled-coil domain-containing protein 106,280,"32,032",4 out of 5,2007-02-06,Evidence at protein level
Q8IX12,CCAR1_HUMAN,Cell division cycle and apoptosis regulator protein 1 (Cell cycle and apoptosis regulatory protein 1) (CARP-1) (Death inducer with SAP domain),1150,"132,821",5 out of 5,2006-05-02,Evidence at protein level
Q8N5R6,CCD33_HUMAN,Coiled-coil domain-containing protein 33 (Cancer/testis antigen 61) (CT61),958,"107,216",3 out of 5,2007-10-23,Evidence at protein level
Q96MW1,CCD43_HUMAN,Coiled-coil domain-containing protein 43,224,"25,248",3 out of 5,2006-05-16,Evidence at protein level
Q8IXS2,CCD65_HUMAN,Coiled-coil domain-containing protein 65 (Testis development protein NYD-SP28),484,"57,297",3 out of 5,2007-04-17,Evidence at protein level
Q9BR77,CCD77_HUMAN,Coiled-coil domain-containing protein 77,488,"57,486",2 out of 5,2007-01-09,Evidence at transcript level
Q53HC0,CCD92_HUMAN,Coiled-coil domain-containing protein 92 (Limkain beta-2),331,"36,961",5 out of 5,2007-02-06,Evidence at protein level
Q9H0W5,CCDC8_HUMAN,Coiled-coil domain-containing protein 8,538,"59,374",5 out of 5,2004-07-19,Evidence at protein level
Q9Y698,CCG2_HUMAN,Voltage-dependent calcium channel gamma-2 subunit (Neuronal voltage-gated calcium channel gamma-2 subunit) (Transmembrane AMPAR regulatory protein gamma-2) (TARP gamma-2),323,"35,966",5 out of 5,2000-05-30,Evidence at protein level
Q9UF02,CCG5_HUMAN,Voltage-dependent calcium channel gamma-5 subunit (Neuronal voltage-gated calcium channel gamma-5 subunit) (Transmembrane AMPAR regulatory protein gamma-5) (TARP gamma-5),275,"30,903",4 out of 5,2000-12-01,Evidence at transcript level
Q99616,CCL13_HUMAN,"C-C motif chemokine 13 (CK-beta-10) (Monocyte chemoattractant protein 4) (Monocyte chemotactic protein 4) (MCP-4) (NCC-1) (Small-inducible cytokine A13) [Cleaved into: C-C motif chemokine 13, long chain; C-C motif chemokine 13, medium chain; C-C motif chemokine 13, short chain]",98,"10,986",5 out of 5,1998-07-15,Evidence at protein level
Q9Y4X3,CCL27_HUMAN,C-C motif chemokine 27 (CC chemokine ILC) (Cutaneous T-cell-attracting chemokine) (CTACK) (ESkine) (IL-11 R-alpha-locus chemokine) (Skinkine) (Small-inducible cytokine A27),112,"12,618",5 out of 5,2000-05-30,Evidence at protein level
P13236,CCL4_HUMAN,C-C motif chemokine 4 (G-26 T-lymphocyte-secreted protein) (HC21) (Lymphocyte activation gene 1 protein) (LAG-1) (MIP-1-beta(1-69)) (Macrophage inflammatory protein 1-beta) (MIP-1-beta) (PAT 744) (Protein H400) (SIS-gamma) (Small-inducible cytokine A4) (T-cell activation protein 2) (ACT-2) [Cleaved into: MIP-1-beta(3-69)],92,"10,212",5 out of 5,1990-01-01,Evidence at protein level
A8MXV6,CD15L_HUMAN,CMT1A duplicated region transcript 15 protein-like protein,281,"30,100",1 out of 5,2008-09-02,Evidence at transcript level
Q99467,CD180_HUMAN,CD180 antigen (Lymphocyte antigen 64) (Radioprotective 105 kDa protein) (CD antigen CD180),661,"74,179",5 out of 5,2002-03-27,Evidence at protein level
P06126,CD1A_HUMAN,T-cell surface glycoprotein CD1a (T-cell surface antigen T6/Leu-6) (hTa1 thymocyte antigen) (CD antigen CD1a),327,"37,077",5 out of 5,1988-01-01,Evidence at protein level
P20273,CD22_HUMAN,B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22),847,"95,348",5 out of 5,1991-02-01,Evidence at protein level
P26842,CD27_HUMAN,CD27 antigen (CD27L receptor) (T-cell activation antigen CD27) (T14) (Tumor necrosis factor receptor superfamily member 7) (CD antigen CD27),260,"29,137",5 out of 5,1992-08-01,Evidence at protein level
P10747,CD28_HUMAN,T-cell-specific surface glycoprotein CD28 (TP44) (CD antigen CD28),220,"25,066",5 out of 5,1989-07-01,Evidence at protein level
O95400,CD2B2_HUMAN,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),341,"37,646",5 out of 5,2003-05-30,Evidence at protein level
P11049,CD37_HUMAN,Leukocyte antigen CD37 (Tetraspanin-26) (Tspan-26) (CD antigen CD37),281,"31,703",5 out of 5,1989-07-01,Evidence at protein level
Q69YH5,CDCA2_HUMAN,Cell division cycle-associated protein 2 (Recruits PP1 onto mitotic chromatin at anaphase protein) (Repo-Man),1023,"112,676",5 out of 5,2007-05-15,Evidence at protein level
Q96Q40,CDK15_HUMAN,Cyclin-dependent kinase 15 (EC 2.7.11.22) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 7 protein) (Cell division protein kinase 15) (Serine/threonine-protein kinase ALS2CR7) (Serine/threonine-protein kinase PFTAIRE-2),435,"49,023",5 out of 5,2002-10-19,Evidence at protein level
Q00534,CDK6_HUMAN,Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),326,"36,938",5 out of 5,1993-04-01,Evidence at protein level
Q5MAI5,CDKL4_HUMAN,Cyclin-dependent kinase-like 4 (EC 2.7.11.22),379,"43,384",4 out of 5,2005-11-22,Evidence at transcript level
Q96MH7,CE034_HUMAN,Uncharacterized protein C5orf34,638,"72,898",1 out of 5,2007-07-24,Evidence at transcript level
Q8TAP6,CEP76_HUMAN,Centrosomal protein of 76 kDa (Cep76),659,"74,413",5 out of 5,2005-02-15,Evidence at protein level
Q6P2H3,CEP85_HUMAN,Centrosomal protein of 85 kDa (Cep85) (Coiled-coil domain-containing protein 21),762,"85,639",5 out of 5,2006-05-02,Evidence at protein level
P27544,CERS1_HUMAN,Ceramide synthase 1 (CerS1) (LAG1 longevity assurance homolog 1) (Longevity assurance gene 1 protein homolog 1) (Protein UOG-1),350,"39,536",5 out of 5,1992-08-01,Evidence at protein level
Q8IU89,CERS3_HUMAN,Ceramide synthase 3 (CerS3) (EC 2.3.1.24) (Dihydroceramide synthase 3) (LAG1 longevity assurance homolog 3),383,"46,316",5 out of 5,2004-07-19,Evidence at protein level
Q6ZMG9,CERS6_HUMAN,Ceramide synthase 6 (CerS6) (LAG1 longevity assurance homolog 6),384,"44,890",5 out of 5,2004-08-16,Evidence at protein level
Q5JU67,CF157_HUMAN,Cilia- and flagella-associated protein 157,520,"60,533",3 out of 5,2007-10-23,Evidence at transcript level
Q8TBZ9,CG062_HUMAN,Uncharacterized protein C7orf62,253,"29,483",2 out of 5,2008-02-26,Evidence at transcript level
Q0VF96,CGNL1_HUMAN,Cingulin-like protein 1 (Junction-associated coiled-coil protein) (Paracingulin),1302,"149,079",5 out of 5,2007-12-04,Evidence at protein level
Q96KT6,CH014_HUMAN,Putative uncharacterized protein encoded by LINC00208,92,"9,816",1 out of 5,2005-07-19,Uncertain
Q9BSY4,CHCH5_HUMAN,Coiled-coil-helix-coiled-coil-helix domain-containing protein 5,110,"12,395",3 out of 5,2005-04-12,Evidence at protein level
Q9HCK8,CHD8_HUMAN,Chromodomain-helicase-DNA-binding protein 8 (CHD-8) (EC 3.6.4.12) (ATP-dependent helicase CHD8) (Helicase with SNF2 domain 1),2581,"290,519",5 out of 5,2002-09-19,Evidence at protein level
Q8N5N4,CC022_HUMAN,Uncharacterized protein C3orf22,141,"15,686",1 out of 5,2006-05-16,Evidence at transcript level
A1A4F0,CC055_HUMAN,Putative uncharacterized protein PQLC2L (PQ-loop repeat-containing protein 2-like),135,"15,626",2 out of 5,2007-09-11,Evidence at transcript level
Q96EE4,CC126_HUMAN,Coiled-coil domain-containing protein 126,140,"15,668",2 out of 5,2007-05-29,Evidence at transcript level
Q17RM4,CC142_HUMAN,Coiled-coil domain-containing protein 142,750,"81,643",2 out of 5,2007-11-13,Evidence at transcript level
Q8NCX0,CC150_HUMAN,Coiled-coil domain-containing protein 150,1101,"128,761",2 out of 5,2008-04-08,Evidence at protein level
A6NI56,CC154_HUMAN,Coiled-coil domain-containing protein 154,674,"76,013",2 out of 5,2008-04-29,Evidence at transcript level
Q9P0B6,CC167_HUMAN,Coiled-coil domain-containing protein 167,97,"11,459",2 out of 5,2007-10-23,Evidence at protein level
Q6PII3,CC174_HUMAN,Coiled-coil domain-containing protein 174,467,"53,958",4 out of 5,2006-10-03,Evidence at protein level
Q86UF4,CC190_HUMAN,Coiled-coil domain-containing protein 190,302,"34,103",2 out of 5,2007-02-06,Evidence at transcript level
Q8N9Z2,CC71L_HUMAN,Coiled-coil domain-containing protein 71L,235,"26,261",2 out of 5,2008-05-20,Evidence at protein level
Q6UXH8,CCBE1_HUMAN,Collagen and calcium-binding EGF domain-containing protein 1 (Full of fluid protein homolog),406,"44,103",5 out of 5,2007-03-06,Evidence at protein level
Q5T9S5,CCD18_HUMAN,Coiled-coil domain-containing protein 18 (Sarcoma antigen NY-SAR-24),1454,"168,962",2 out of 5,2007-04-17,Evidence at protein level
Q86WR0,CCD25_HUMAN,Coiled-coil domain-containing protein 25,208,"24,479",3 out of 5,2006-05-02,Evidence at protein level
Q96HJ3,CCD34_HUMAN,Coiled-coil domain-containing protein 34 (Renal carcinoma antigen NY-REN-41),373,"43,225",3 out of 5,2008-06-10,Evidence at protein level
Q4G0X9,CCD40_HUMAN,Coiled-coil domain-containing protein 40,1142,"130,113",5 out of 5,2007-10-02,Evidence at transcript level
Q4VC31,CCD58_HUMAN,Coiled-coil domain-containing protein 58,144,"16,620",2 out of 5,2006-06-13,Evidence at protein level
Q8IWA6,CCD60_HUMAN,Coiled-coil domain-containing protein 60,550,"63,091",2 out of 5,2006-06-13,Evidence at protein level
A2RUB6,CCD66_HUMAN,Coiled-coil domain-containing protein 66,948,"109,411",3 out of 5,2008-02-26,Evidence at protein level
Q76M96,CCD80_HUMAN,Coiled-coil domain-containing protein 80 (Down-regulated by oncogenes protein 1) (Up-regulated in BRS-3 deficient mouse homolog),950,"108,174",4 out of 5,2007-04-03,Evidence at protein level
Q8IWF9,CCD83_HUMAN,Coiled-coil domain-containing protein 83,413,"48,851",2 out of 5,2007-05-29,Evidence at transcript level
Q9BXT2,CCG6_HUMAN,Voltage-dependent calcium channel gamma-6 subunit (Neuronal voltage-gated calcium channel gamma-6 subunit),260,"28,129",3 out of 5,2002-05-10,Evidence at transcript level
Q9ULG6,CCPG1_HUMAN,Cell cycle progression protein 1 (Cell cycle progression restoration protein 8),757,"87,340",5 out of 5,2007-11-13,Evidence at protein level
P46092,CCR10_HUMAN,C-C chemokine receptor type 10 (C-C CKR-10) (CC-CKR-10) (CCR-10) (G-protein coupled receptor 2),362,"38,416",4 out of 5,1995-11-01,Evidence at protein level
O00421,CCRL2_HUMAN,C-C chemokine receptor-like 2 (Chemokine receptor CCR11) (Chemokine receptor X) (Putative MCP-1 chemokine receptor),344,"39,513",5 out of 5,2006-05-30,Evidence at protein level
Q9H7U1,CCSE2_HUMAN,Serine-rich coiled-coil domain-containing protein 2 (Coiled-coil serine-rich protein 2) (Protein GCAP14 homolog),834,"93,548",4 out of 5,2007-11-13,Evidence at protein level
Q99440,CD006_HUMAN,Uncharacterized protein encoded by LINC01587 (Protein AC1),93,"10,499",2 out of 5,2000-12-01,Evidence at transcript level
Q96LM5,CD045_HUMAN,Uncharacterized protein C4orf45,186,"21,723",2 out of 5,2008-03-18,Evidence at transcript level
O75794,CD123_HUMAN,Cell division cycle protein 123 homolog (Protein D123) (HT-1080) (PZ32),336,"39,135",3 out of 5,2006-03-21,Evidence at protein level
P08571,CD14_HUMAN,"Monocyte differentiation antigen CD14 (Myeloid cell-specific leucine-rich glycoprotein) (CD antigen CD14) [Cleaved into: Monocyte differentiation antigen CD14, urinary form; Monocyte differentiation antigen CD14, membrane-bound form]",375,"40,076",5 out of 5,1988-08-01,Evidence at protein level
P48509,CD151_HUMAN,CD151 antigen (GP27) (Membrane glycoprotein SFA-1) (Platelet-endothelial tetraspan antigen 3) (PETA-3) (Tetraspanin-24) (Tspan-24) (CD antigen CD151),253,"28,295",5 out of 5,1996-02-01,Evidence at protein level
Q9NNX6,CD209_HUMAN,CD209 antigen (C-type lectin domain family 4 member L) (Dendritic cell-specific ICAM-3-grabbing non-integrin 1) (DC-SIGN) (DC-SIGN1) (CD antigen CD209),404,"45,775",5 out of 5,2004-04-13,Evidence at protein level
Q9HCU0,CD248_HUMAN,Endosialin (Tumor endothelial marker 1) (CD antigen CD248),757,"80,859",5 out of 5,2006-01-24,Evidence at protein level
Q8IX05,CD302_HUMAN,CD302 antigen (C-type lectin BIMLEC) (C-type lectin domain family 13 member A) (DEC205-associated C-type lectin 1) (Type I transmembrane C-type lectin receptor DCL-1) (CD antigen CD302),232,"26,183",5 out of 5,2006-10-03,Evidence at protein level
Q9NPF0,CD320_HUMAN,CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6) (FDC-SM-8D6) (Transcobalamin receptor) (TCblR) (CD antigen CD320),282,"28,991",5 out of 5,2006-01-24,Evidence at protein level
P16070,CD44_HUMAN,CD44 antigen (CDw44) (Epican) (Extracellular matrix receptor III) (ECMR-III) (GP90 lymphocyte homing/adhesion receptor) (HUTCH-I) (Heparan sulfate proteoglycan) (Hermes antigen) (Hyaluronate receptor) (Phagocytic glycoprotein 1) (PGP-1) (Phagocytic glycoprotein I) (PGP-I) (CD antigen CD44),742,"81,538",5 out of 5,1990-04-01,Evidence at protein level
P06127,CD5_HUMAN,T-cell surface glycoprotein CD5 (Lymphocyte antigen T1/Leu-1) (CD antigen CD5),495,"54,578",5 out of 5,1988-01-01,Evidence at protein level
P10966,CD8B_HUMAN,T-cell surface glycoprotein CD8 beta chain (CD antigen CD8b),210,"23,722",5 out of 5,1989-07-01,Evidence at transcript level
P21926,CD9_HUMAN,CD9 antigen (5H9 antigen) (Cell growth-inhibiting gene 2 protein) (Leukocyte antigen MIC3) (Motility-related protein) (MRP-1) (Tetraspanin-29) (Tspan-29) (p24) (CD antigen CD9),228,"25,416",5 out of 5,1991-05-01,Evidence at protein level
Q13042,CDC16_HUMAN,Cell division cycle protein 16 homolog (Anaphase-promoting complex subunit 6) (APC6) (CDC16 homolog) (CDC16Hs) (Cyclosome subunit 6),620,"71,656",5 out of 5,2003-10-03,Evidence at protein level
Q6P1J9,CDC73_HUMAN,Parafibromin (Cell division cycle protein 73 homolog) (Hyperparathyroidism 2 protein),531,"60,577",5 out of 5,2005-12-20,Evidence at protein level
Q5VXM1,CDCP2_HUMAN,CUB domain-containing protein 2,449,"48,752",2 out of 5,2007-10-02,Evidence at transcript level
O14735,CDIPT_HUMAN,CDP-diacylglycerol--inositol 3-phosphatidyltransferase (EC 2.7.8.11) (Phosphatidylinositol synthase) (PI synthase) (PtdIns synthase),213,"23,539",5 out of 5,1998-12-15,Evidence at protein level
A8K010,CF176_HUMAN,Putative transcriptional regulator encoded by LINC00473,186,"21,118",2 out of 5,2008-02-05,Uncertain
P0C671,CF222_HUMAN,Uncharacterized protein C6orf222,652,"71,930",1 out of 5,2008-02-05,Evidence at protein level
Q8TBY9,CF251_HUMAN,Cilia- and flagella-associated protein 251 (CFAP251) (WD repeat-containing protein 66),1149,"129,952",3 out of 5,2007-07-24,Evidence at transcript level
Q9Y6A4,CFA20_HUMAN,Cilia- and flagella-associated protein 20 (Basal body up-regulated protein 22) (Transcription factor IIB),193,"22,774",5 out of 5,2007-07-24,Evidence at protein level
A5D8W1,CFA69_HUMAN,Cilia- and flagella-associated protein 69,941,"105,883",3 out of 5,2008-02-26,Evidence at transcript level
Q6ZQR2,CFA77_HUMAN,Cilia- and flagella-associated protein 77,320,"36,499",2 out of 5,2008-03-18,Evidence at protein level
P00746,CFAD_HUMAN,Complement factor D (EC 3.4.21.46) (Adipsin) (C3 convertase activator) (Properdin factor D),253,"27,033",5 out of 5,1986-07-21,Evidence at protein level
P0CG37,CFC1_HUMAN,Cryptic protein (Cryptic family protein 1),223,"24,612",5 out of 5,2010-07-13,Evidence at protein level
Q9BUK0,CHCH7_HUMAN,Coiled-coil-helix-coiled-coil-helix domain-containing protein 7,85,"10,095",4 out of 5,2005-04-12,Evidence at protein level
Q14839,CHD4_HUMAN,Chromodomain-helicase-DNA-binding protein 4 (CHD-4) (EC 3.6.4.12) (ATP-dependent helicase CHD4) (Mi-2 autoantigen 218 kDa protein) (Mi2-beta),1912,"218,005",5 out of 5,1999-07-15,Evidence at protein level
Q9Y259,CHKB_HUMAN,Choline/ethanolamine kinase (Choline kinase beta) (CK) (CKB) (EC 2.7.1.32) (Choline kinase-like protein) (Ethanolamine kinase) (EK) (EC 2.7.1.82) (Ethanolamine kinase beta) (EKB) (choline/ethanolamine kinase beta) (CKEKB),395,"45,271",5 out of 5,2000-05-30,Evidence at protein level
Q96CF2,CHM4C_HUMAN,Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3) (hSnf7-3) (Vacuolar protein sorting-associated protein 32-3) (Vps32-3) (hVps32-3),233,"26,411",5 out of 5,2005-08-30,Evidence at protein level
P0DN79,CBSL_HUMAN,Cystathionine beta-synthase-like protein (EC 4.2.1.22) (Beta-thionase) (Serine sulfhydrase),551,"60,587",4 out of 5,2016-02-17,Evidence at protein level
Q9BRT8,CBWD1_HUMAN,COBW domain-containing protein 1 (Cobalamin synthase W domain-containing protein 1) (COBP) (NPC-A-6 COBW domain-containing protein 1) (NPC-A-6),395,"44,068",3 out of 5,2006-07-11,Evidence at transcript level
Q9UK00,CC018_HUMAN,Uncharacterized protein C3orf18 (Protein G20),162,"17,468",2 out of 5,2006-03-21,Evidence at transcript level
Q5JPI3,CC038_HUMAN,Uncharacterized protein C3orf38,329,"37,541",2 out of 5,2006-07-11,Evidence at protein level
H3BNL1,CC084_HUMAN,Uncharacterized protein C3orf84,204,"23,376",1 out of 5,2013-09-18,Evidence at transcript level
Q8IV13,CCNJL_HUMAN,Cyclin-J-like protein,435,"48,406",2 out of 5,2007-11-13,Evidence at transcript level
P22674,CCNO_HUMAN,Cyclin-O,350,"38,096",5 out of 5,1991-08-01,Evidence at protein level
P29965,CD40L_HUMAN,"CD40 ligand (CD40-L) (T-cell antigen Gp39) (TNF-related activation protein) (TRAP) (Tumor necrosis factor ligand superfamily member 5) (CD antigen CD154) [Cleaved into: CD40 ligand, membrane form; CD40 ligand, soluble form]",261,"29,274",5 out of 5,1993-04-01,Evidence at protein level
P08962,CD63_HUMAN,CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63),238,"25,637",5 out of 5,1988-11-01,Evidence at protein level
P11912,CD79A_HUMAN,B-cell antigen receptor complex-associated protein alpha chain (Ig-alpha) (MB-1 membrane glycoprotein) (Membrane-bound immunoglobulin-associated protein) (Surface IgM-associated protein) (CD antigen CD79a),226,"25,038",5 out of 5,1989-10-01,Evidence at protein level
P48960,CD97_HUMAN,CD97 antigen (Leukocyte antigen CD97) (CD antigen CD97) [Cleaved into: CD97 antigen subunit alpha; CD97 antigen subunit beta],835,"91,869",5 out of 5,1996-02-01,Evidence at protein level
Q12834,CDC20_HUMAN,Cell division cycle protein 20 homolog (p55CDC),499,"54,723",5 out of 5,2003-10-03,Evidence at protein level
Q9UJX2,CDC23_HUMAN,Cell division cycle protein 23 homolog (Anaphase-promoting complex subunit 8) (APC8) (Cyclosome subunit 8),597,"68,834",5 out of 5,2003-10-03,Evidence at protein level
Q99459,CDC5L_HUMAN,Cell division cycle 5-like protein (Cdc5-like protein) (Pombe cdc5-related protein),802,"92,251",5 out of 5,2005-08-16,Evidence at protein level
O94921,CDK14_HUMAN,Cyclin-dependent kinase 14 (EC 2.7.11.22) (Cell division protein kinase 14) (Serine/threonine-protein kinase PFTAIRE-1) (hPFTAIRE1),469,"53,057",5 out of 5,2002-08-30,Evidence at protein level
Q00537,CDK17_HUMAN,Cyclin-dependent kinase 17 (EC 2.7.11.22) (Cell division protein kinase 17) (PCTAIRE-motif protein kinase 2) (Serine/threonine-protein kinase PCTAIRE-2),523,"59,582",5 out of 5,1993-04-01,Evidence at protein level
P06493,CDK1_HUMAN,Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase),297,"34,095",5 out of 5,1988-01-01,Evidence at protein level
Q92772,CDKL2_HUMAN,Cyclin-dependent kinase-like 2 (EC 2.7.11.22) (Protein kinase p56 KKIAMRE) (Serine/threonine-protein kinase KKIAMRE),493,"56,019",5 out of 5,2005-11-22,Evidence at protein level
Q76N32,CEP68_HUMAN,Centrosomal protein of 68 kDa (Cep68),757,"81,102",5 out of 5,2005-04-26,Evidence at protein level
P11597,CETP_HUMAN,Cholesteryl ester transfer protein (Lipid transfer protein I),493,"54,756",5 out of 5,1989-10-01,Evidence at protein level
Q5T5N4,CF118_HUMAN,Uncharacterized protein C6orf118,469,"53,772",2 out of 5,2005-07-19,Evidence at transcript level
Q5T6M2,CF122_HUMAN,Putative uncharacterized protein encoded by LINC00242,205,"23,040",2 out of 5,2005-07-19,Uncertain
Q5SQH8,CF136_HUMAN,Uncharacterized protein C6orf136,315,"35,794",2 out of 5,2005-08-02,Evidence at transcript level
Q5TEZ4,CF164_HUMAN,Putative uncharacterized protein encoded by LINC01590 (Long intergenic non-protein coding RNA 1590),76,"8,388",2 out of 5,2007-10-02,Uncertain
Q8N0U6,CF218_HUMAN,Putative uncharacterized protein encoded by LINC00518,118,"13,361",1 out of 5,2007-08-21,Uncertain
Q8IYW2,CFA46_HUMAN,Cilia- and flagella-associated protein 46 (Tetratricopeptide repeat protein 40),2715,"303,500",4 out of 5,2005-08-16,Evidence at transcript level
P05156,CFAI_HUMAN,Complement factor I (EC 3.4.21.45) (C3B/C4B inactivator) [Cleaved into: Complement factor I heavy chain; Complement factor I light chain],583,"65,750",5 out of 5,1987-08-13,Evidence at protein level
Q8NI28,CG013_HUMAN,Putative uncharacterized protein encoded by LINC01006 (Long intergenic non-protein coding RNA 1006),216,"22,304",2 out of 5,2006-09-05,Uncertain
Q8N865,CG031_HUMAN,Uncharacterized protein C7orf31,590,"68,464",3 out of 5,2005-07-05,Evidence at protein level
Q9H7B7,CG069_HUMAN,Uncharacterized protein C7orf69,122,"14,425",1 out of 5,2008-06-10,Evidence at transcript level
Q8TDX6,CGAT1_HUMAN,"Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CsGalNAcT-1) (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 1) (Beta4GalNAcT-1)",532,"61,294",5 out of 5,2005-02-01,Evidence at protein level
Q9NR00,CH004_HUMAN,Protein C8orf4 (Thyroid cancer protein 1) (TC-1),106,"12,337",5 out of 5,2005-07-19,Evidence at protein level
Q96LL4,CH048_HUMAN,Uncharacterized protein C8orf48,319,"36,790",2 out of 5,2007-05-01,Evidence at protein level
Q96EP1,CHFR_HUMAN,E3 ubiquitin-protein ligase CHFR (EC 2.3.2.27) (Checkpoint with forkhead and RING finger domains protein) (RING finger protein 196) (RING-type E3 ubiquitin transferase CHFR),664,"73,386",5 out of 5,2004-02-02,Evidence at protein level
O14757,CHK1_HUMAN,Serine/threonine-protein kinase Chk1 (EC 2.7.11.1) (CHK1 checkpoint homolog) (Cell cycle checkpoint kinase) (Checkpoint kinase-1),476,"54,434",5 out of 5,2000-05-30,Evidence at protein level
P35790,CHKA_HUMAN,Choline kinase alpha (CK) (EC 2.7.1.32) (CHETK-alpha) (Ethanolamine kinase) (EK) (EC 2.7.1.82),457,"52,249",5 out of 5,1994-06-01,Evidence at protein level
O43633,CHM2A_HUMAN,Charged multivesicular body protein 2a (Chromatin-modifying protein 2a) (CHMP2a) (Putative breast adenocarcinoma marker BC-2) (Vacuolar protein sorting-associated protein 2-1) (Vps2-1) (hVps2-1),222,"25,104",5 out of 5,2005-08-30,Evidence at protein level
Q8WUD6,CHPT1_HUMAN,Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1),406,"45,097",5 out of 5,2007-05-29,Evidence at protein level
Q96GV9,CE030_HUMAN,UNC119-binding protein C5orf30,206,"23,083",4 out of 5,2008-02-05,Evidence at protein level
Q9H799,CE042_HUMAN,Protein JBTS17 (Protein C5orf42),3197,"361,746",5 out of 5,2008-04-29,Evidence at protein level
P06731,CEAM5_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 5 (Carcinoembryonic antigen) (CEA) (Meconium antigen 100) (CD antigen CD66e),702,"76,795",5 out of 5,1988-01-01,Evidence at protein level
P31997,CEAM8_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b),349,"38,154",5 out of 5,1993-07-01,Evidence at protein level
P49715,CEBPA_HUMAN,CCAAT/enhancer-binding protein alpha (C/EBP alpha),358,"37,561",5 out of 5,1996-10-01,Evidence at protein level
Q9BXW7,CECR5_HUMAN,Cat eye syndrome critical region protein 5,423,"46,321",2 out of 5,2002-04-16,Evidence at protein level
Q86SI9,CEI_HUMAN,Protein CEI (Coordinated expression to IRXA2 protein),138,"15,091",2 out of 5,2007-07-10,Evidence at transcript level
Q8N6W0,CELF5_HUMAN,CUGBP Elav-like family member 5 (CELF-5) (Bruno-like protein 5) (CUG-BP- and ETR-3-like factor 5) (RNA-binding protein BRUNOL-5),485,"52,355",4 out of 5,2007-07-10,Evidence at protein level
P07199,CENPB_HUMAN,Major centromere autoantigen B (Centromere protein B) (CENP-B),599,"65,171",5 out of 5,1988-04-01,Evidence at protein level
P49454,CENPF_HUMAN,Centromere protein F (CENP-F) (AH antigen) (Kinetochore protein CENPF) (Mitosin),3210,"367,764",5 out of 5,1996-02-01,Evidence at protein level
Q9Y592,CEP83_HUMAN,Centrosomal protein of 83 kDa (Cep83) (Coiled-coil domain-containing protein 41) (Renal carcinoma antigen NY-REN-58),693,"82,059",5 out of 5,2006-05-16,Evidence at protein level
Q96ST8,CEP89_HUMAN,Centrosomal protein of 89 kDa (Cep89) (Centrosomal protein 123) (Cep123) (Coiled-coil domain-containing protein 123),783,"89,590",5 out of 5,2007-05-29,Evidence at protein level
Q9Y6K0,CEPT1_HUMAN,Choline/ethanolaminephosphotransferase 1 (hCEPT1) (EC 2.7.8.1) (EC 2.7.8.2),416,"46,554",5 out of 5,2007-05-29,Evidence at protein level
Q49MI3,CERKL_HUMAN,Ceramide kinase-like protein,558,"62,622",5 out of 5,2005-12-20,Evidence at protein level
Q5JQF7,CF100_HUMAN,Putative uncharacterized protein encoded by LINC01556,62,"7,289",1 out of 5,2007-11-13,Predicted
Q9Y6Z2,CF123_HUMAN,Uncharacterized protein encoded by LINC01558 (Protein HGC6.2),57,"6,189",1 out of 5,2000-12-01,Predicted
Q96MT4,CF195_HUMAN,Uncharacterized protein encoded by LINC01600,127,"13,896",2 out of 5,2005-07-19,Evidence at protein level
Q5I0X4,CF226_HUMAN,Uncharacterized protein C6orf226,101,"10,566",2 out of 5,2008-05-20,Evidence at protein level
Q8TD26,CHD6_HUMAN,Chromodomain-helicase-DNA-binding protein 6 (CHD-6) (EC 3.6.4.12) (ATP-dependent helicase CHD6) (Radiation-induced gene B protein),2715,"305,412",5 out of 5,2002-09-19,Evidence at protein level
Q9P2D1,CHD7_HUMAN,Chromodomain-helicase-DNA-binding protein 7 (CHD-7) (EC 3.6.4.12) (ATP-dependent helicase CHD7),2997,"335,927",5 out of 5,2002-09-19,Evidence at protein level
Q5VXU3,CHIC1_HUMAN,Cysteine-rich hydrophobic domain-containing protein 1 (Brain X-linked protein),224,"25,616",3 out of 5,2005-02-01,Evidence at transcript level
Q9UNE7,CHIP_HUMAN,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),303,"34,856",5 out of 5,2005-10-25,Evidence at protein level
Q5T8R8,CI066_HUMAN,Uncharacterized protein C9orf66,295,"31,184",2 out of 5,2005-07-19,Evidence at transcript level
Q96MD7,CI085_HUMAN,Uncharacterized protein C9orf85,179,"20,166",2 out of 5,2005-07-05,Evidence at protein level
Q5T035,CI129_HUMAN,Putative uncharacterized protein C9orf129,196,"20,715",2 out of 5,2008-09-02,Predicted
Q8N9P6,CI163_HUMAN,Uncharacterized protein C9orf163,203,"22,154",1 out of 5,2007-05-29,Evidence at transcript level
Q9Y375,CIA30_HUMAN,"Complex I intermediate-associated protein 30, mitochondrial (NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 1)",327,"37,764",4 out of 5,2000-05-30,Evidence at protein level
O60543,CIDEA_HUMAN,Cell death activator CIDE-A (Cell death-inducing DFFA-like effector A),219,"24,687",5 out of 5,2000-12-01,Evidence at protein level
Q9NZ45,CISD1_HUMAN,CDGSH iron-sulfur domain-containing protein 1 (MitoNEET),108,"12,199",5 out of 5,2002-11-25,Evidence at protein level
O95832,CLD1_HUMAN,Claudin-1 (Senescence-associated epithelial membrane protein),211,"22,744",5 out of 5,2000-05-30,Evidence at protein level
O14493,CLD4_HUMAN,Claudin-4 (Clostridium perfringens enterotoxin receptor) (CPE-R) (CPE-receptor) (Williams-Beuren syndrome chromosomal region 8 protein),209,"22,077",5 out of 5,2000-05-30,Evidence at protein level
O00501,CLD5_HUMAN,Claudin-5 (Transmembrane protein deleted in VCFS) (TMDVCF),218,"23,147",5 out of 5,2000-05-30,Evidence at transcript level
Q9NY35,CLDN1_HUMAN,Claudin domain-containing protein 1 (Membrane protein GENX-3745),253,"28,603",3 out of 5,2002-05-10,Evidence at protein level
Q00610,CLH1_HUMAN,Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17),1675,"191,615",5 out of 5,1992-12-01,Evidence at protein level
Q96NY7,CLIC6_HUMAN,Chloride intracellular channel protein 6 (Parchorin),704,"73,012",4 out of 5,2002-10-19,Evidence at transcript level
Q9UDT6,CLIP2_HUMAN,CAP-Gly domain-containing linker protein 2 (Cytoplasmic linker protein 115) (CLIP-115) (Cytoplasmic linker protein 2) (Williams-Beuren syndrome chromosomal region 3 protein) (Williams-Beuren syndrome chromosomal region 4 protein),1046,"115,837",5 out of 5,2005-09-27,Evidence at protein level
P49759,CLK1_HUMAN,Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1),484,"57,291",5 out of 5,1996-10-01,Evidence at protein level
Q9UGN4,CLM8_HUMAN,CMRF35-like molecule 8 (CLM-8) (CD300 antigen-like family member A) (CMRF-35-H9) (CMRF35-H9) (CMRF35-H) (IRC1/IRC2) (Immunoglobulin superfamily member 12) (IgSF12) (Inhibitory receptor protein 60) (IRp60) (NK inhibitory receptor) (CD antigen CD300a),299,"33,201",5 out of 5,2004-06-07,Evidence at protein level
Q9NWW5,CLN6_HUMAN,Ceroid-lipofuscinosis neuronal protein 6 (Protein CLN6),311,"35,919",5 out of 5,2003-06-16,Evidence at protein level
O15516,CLOCK_HUMAN,Circadian locomoter output cycles protein kaput (hCLOCK) (EC 2.3.1.48) (Class E basic helix-loop-helix protein 8) (bHLHe8),846,"95,304",5 out of 5,1999-07-15,Evidence at protein level
P51861,CDR1_HUMAN,Cerebellar degeneration-related antigen 1 (CDR34),262,"31,279",2 out of 5,1996-10-01,Evidence at protein level
Q96T59,CDRTF_HUMAN,CMT1A duplicated region transcript 15 protein,188,"20,651",1 out of 5,2008-01-15,Evidence at transcript level
C9J3I9,CE058_HUMAN,Putative uncharacterized protein C5orf58,102,"11,666",1 out of 5,2010-03-23,Predicted
F2Z3F1,CE067_HUMAN,Uncharacterized protein C5orf67,127,"14,123",1 out of 5,2015-06-24,Predicted
Q8IYX8,CE57L_HUMAN,Centrosomal protein CEP57L1 (Centrosomal protein 57kDa-like protein 1) (Centrosomal protein of 57 kDa-related protein) (Cep57R) (Cep57-related protein),460,"53,649",5 out of 5,2004-12-21,Evidence at protein level
A8MTB9,CEA18_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 18,384,"43,320",2 out of 5,2008-06-10,Inferred from homology
P09093,CEL3A_HUMAN,Chymotrypsin-like elastase family member 3A (EC 3.4.21.70) (Elastase IIIA) (Elastase-3A) (Protease E),270,"29,489",5 out of 5,1989-07-01,Evidence at protein level
Q71F23,CENPU_HUMAN,Centromere protein U (CENP-U) (Centromere protein of 50 kDa) (CENP-50) (Interphase centromere complex protein 24) (KSHV latent nuclear antigen-interacting protein 1) (MLF1-interacting protein) (Polo-box-interacting protein 1),418,"47,522",5 out of 5,2006-07-25,Evidence at protein level
Q86T20,CF001_HUMAN,Uncharacterized protein C6orf1 (Protein LBH),159,"17,113",2 out of 5,2005-08-02,Evidence at transcript level
Q5T0N1,CFA70_HUMAN,Cilia- and flagella-associated protein 70 (Tetratricopeptide repeat protein 18) (TPR repeat protein 18),1121,"125,721",3 out of 5,2007-06-26,Evidence at transcript level
P00751,CFAB_HUMAN,Complement factor B (EC 3.4.21.47) (C3/C5 convertase) (Glycine-rich beta glycoprotein) (GBG) (PBF2) (Properdin factor B) [Cleaved into: Complement factor B Ba fragment; Complement factor B Bb fragment],764,"85,533",5 out of 5,1986-07-21,Evidence at protein level
Q9BRJ6,CG050_HUMAN,Uncharacterized protein C7orf50,194,"22,083",2 out of 5,2007-11-13,Evidence at protein level
A4D0Y5,CG077_HUMAN,Uncharacterized protein C7orf77,90,"10,046",1 out of 5,2011-10-19,Predicted
P0DN87,CGB7_HUMAN,Choriogonadotropin subunit beta 7,165,"17,757",4 out of 5,2016-05-11,Evidence at transcript level
Q16880,CGT_HUMAN,2-hydroxyacylsphingosine 1-beta-galactosyltransferase (EC 2.4.1.47) (Ceramide UDP-galactosyltransferase) (Cerebroside synthase) (UDP-galactose-ceramide galactosyltransferase),541,"61,438",5 out of 5,1997-11-01,Evidence at transcript level
Q6P1X6,CH082_HUMAN,UPF0598 protein C8orf82,216,"23,889",2 out of 5,2008-06-10,Evidence at protein level
P0DMQ9,CH089_HUMAN,Putative uncharacterized protein C8orf89,161,"18,160",1 out of 5,2014-11-26,Evidence at transcript level
Q86WJ1,CHD1L_HUMAN,Chromodomain-helicase-DNA-binding protein 1-like (EC 3.6.4.12) (Amplified in liver cancer protein 1),897,"100,984",5 out of 5,2008-04-29,Evidence at protein level
O14646,CHD1_HUMAN,Chromodomain-helicase-DNA-binding protein 1 (CHD-1) (EC 3.6.4.12) (ATP-dependent helicase CHD1),1710,"196,688",5 out of 5,1998-07-15,Evidence at protein level
Q8TDI0,CHD5_HUMAN,Chromodomain-helicase-DNA-binding protein 5 (CHD-5) (EC 3.6.4.12) (ATP-dependent helicase CHD5),1954,"223,050",5 out of 5,2004-08-31,Evidence at protein level
Q96D05,CJ035_HUMAN,Uncharacterized protein C10orf35,121,"13,238",2 out of 5,2005-07-05,Evidence at protein level
Q8IYJ2,CJ067_HUMAN,"Uncharacterized protein C10orf67, mitochondrial",551,"63,656",2 out of 5,2005-08-16,Evidence at transcript level
Q8WW14,CJ082_HUMAN,Uncharacterized protein C10orf82,230,"25,923",2 out of 5,2005-07-05,Evidence at transcript level
A6NJI1,CK086_HUMAN,Uncharacterized protein C11orf86,115,"13,172",1 out of 5,2008-04-08,Predicted
Q8WWK9,CKAP2_HUMAN,Cytoskeleton-associated protein 2 (CTCL tumor antigen se20-10) (Tumor- and microtubule-associated protein),683,"76,987",5 out of 5,2006-07-11,Evidence at protein level
Q96MX0,CKLF3_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 3 (Chemokine-like factor superfamily member 3),182,"19,714",3 out of 5,2003-09-19,Evidence at protein level
Q8IYA6,CKP2L_HUMAN,Cytoskeleton-associated protein 2-like (Radial fiber and mitotic spindle protein) (Radmis),745,"83,587",5 out of 5,2008-03-18,Evidence at protein level
Q9NQ89,CL004_HUMAN,Protein C12orf4,552,"63,801",2 out of 5,2005-07-19,Evidence at transcript level
Q8N5I9,CL045_HUMAN,Uncharacterized protein C12orf45,185,"20,123",2 out of 5,2006-12-12,Evidence at protein level
Q9Y240,CLC11_HUMAN,C-type lectin domain family 11 member A (C-type lectin superfamily member 3) (Lymphocyte secreted C-type lectin) (Osteolectin) (Stem cell growth factor) (p47),323,"35,695",5 out of 5,2003-08-22,Evidence at protein level
Q6UVW9,CLC2A_HUMAN,C-type lectin domain family 2 member A (Keratinocyte-associated C-type lectin) (KACL) (Proliferation-induced lymphocyte-associated receptor) (PILAR),174,"19,972",5 out of 5,2006-12-12,Evidence at protein level
P0C7M8,CLC2L_HUMAN,C-type lectin domain family 2 member L,214,"23,927",2 out of 5,2008-06-10,Inferred from homology
Q9UMR7,CLC4A_HUMAN,C-type lectin domain family 4 member A (C-type lectin DDB27) (C-type lectin superfamily member 6) (Dendritic cell immunoreceptor) (Lectin-like immunoreceptor),237,"27,512",5 out of 5,2005-02-15,Evidence at protein level
Q9ULY5,CLC4E_HUMAN,C-type lectin domain family 4 member E (C-type lectin superfamily member 9) (Macrophage-inducible C-type lectin),219,"25,073",5 out of 5,2005-02-15,Evidence at protein level
Q9NY25,CLC5A_HUMAN,C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1) (MDL-1),188,"21,521",5 out of 5,2005-02-15,Evidence at protein level
Q6EIG7,CLC6A_HUMAN,C-type lectin domain family 6 member A (C-type lectin superfamily member 10) (Dendritic cell-associated C-type lectin 2) (DC-associated C-type lectin 2) (Dectin-2),209,"23,998",4 out of 5,2005-02-15,Evidence at transcript level
P51800,CLCKA_HUMAN,Chloride channel protein ClC-Ka (Chloride channel Ka) (ClC-K1),687,"75,285",5 out of 5,1996-10-01,Evidence at protein level
P51798,CLCN7_HUMAN,H(+)/Cl(-) exchange transporter 7 (Chloride channel 7 alpha subunit) (Chloride channel protein 7) (ClC-7),805,"88,679",5 out of 5,1996-10-01,Evidence at protein level
P56856,CLD18_HUMAN,Claudin-18,261,"27,856",4 out of 5,2000-05-30,Evidence at transcript level
P42771,CDN2A_HUMAN,Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A) (CDK4I) (Multiple tumor suppressor 1) (MTS-1) (p16-INK4a) (p16-INK4) (p16INK4A),156,"16,533",5 out of 5,1995-11-01,Evidence at protein level
Q16878,CDO1_HUMAN,Cysteine dioxygenase type 1 (EC 1.13.11.20) (Cysteine dioxygenase type I) (CDO) (CDO-I),200,"22,972",5 out of 5,1997-11-01,Evidence at protein level
Q01850,CDR2_HUMAN,Cerebellar degeneration-related protein 2 (Major Yo paraneoplastic antigen) (Paraneoplastic cerebellar degeneration-associated antigen),454,"51,855",5 out of 5,1993-07-01,Evidence at protein level
Q8NAS9,CE017_HUMAN,Uncharacterized protein C5orf17,161,"17,397",1 out of 5,2007-06-26,Evidence at transcript level
Q8IZ16,CG061_HUMAN,Uncharacterized protein C7orf61,206,"23,862",1 out of 5,2008-03-18,Evidence at transcript level
Q6ZVN7,CG076_HUMAN,Putative uncharacterized protein C7orf76,128,"14,085",1 out of 5,2008-02-26,Uncertain
Q8N6G5,CGAT2_HUMAN,"Chondroitin sulfate N-acetylgalactosaminyltransferase 2 (EC 2.4.1.174) (Chondroitin beta-1,4-N-acetylgalactosaminyltransferase 2) (Beta4GalNAcT-2) (GalNAcT-2)",542,"62,572",5 out of 5,2005-02-01,Evidence at protein level
Q99675,CGRF1_HUMAN,Cell growth regulator with RING finger domain protein 1 (Cell growth regulatory gene 19 protein) (RING finger protein 197),332,"38,242",3 out of 5,2004-03-01,Evidence at protein level
Q15782,CH3L2_HUMAN,Chitinase-3-like protein 2 (Chondrocyte protein 39) (YKL-39),390,"43,501",5 out of 5,2001-02-21,Evidence at protein level
P10809,CH60_HUMAN,"60 kDa heat shock protein, mitochondrial (EC 3.6.4.9) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",573,"61,055",5 out of 5,1989-07-01,Evidence at protein level
Q5T1J5,CHCH9_HUMAN,"Putative coiled-coil-helix-coiled-coil-helix domain-containing protein CHCHD2P9, mitochondrial (Coiled-coil-helix-coiled-coil-helix domain-containing 2 pseudogene 9)",151,"15,490",3 out of 5,2008-01-15,Uncertain
Q9NRG0,CHRC1_HUMAN,Chromatin accessibility complex protein 1 (CHRAC-1) (Chromatin accessibility complex 15 kDa protein) (CHRAC-15) (HuCHRAC15) (DNA polymerase epsilon subunit p15),131,"14,711",4 out of 5,2002-08-30,Evidence at protein level
O75390,CISY_HUMAN,"Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)",466,"51,712",5 out of 5,1999-07-15,Evidence at protein level
Q96RK1,CITE4_HUMAN,Cbp/p300-interacting transactivator 4 (MSG1-related protein 2) (MRG-2),184,"18,569",4 out of 5,2006-05-02,Evidence at protein level
Q9ULV3,CIZ1_HUMAN,Cip1-interacting zinc finger protein (CDKN1A-interacting zinc finger protein 1) (Nuclear protein NP94) (Zinc finger protein 356),898,"100,045",5 out of 5,2001-01-24,Evidence at protein level
Q5T681,CJ062_HUMAN,Uncharacterized protein C10orf62,223,"25,128",2 out of 5,2007-02-06,Evidence at protein level
Q5T1B1,CJ091_HUMAN,Uncharacterized protein C10orf91,145,"15,403",1 out of 5,2005-08-16,Evidence at transcript level
Q5VZT2,CJ113_HUMAN,Putative uncharacterized protein C10orf113,155,"17,689",2 out of 5,2006-10-31,Evidence at transcript level
A6NCD4,CJ131_HUMAN,Uncharacterized protein C10orf131,256,"29,615",2 out of 5,2008-02-26,Evidence at transcript level
Q96F05,CK024_HUMAN,Uncharacterized protein C11orf24 (Protein DM4E3),449,"46,101",3 out of 5,2006-10-03,Evidence at protein level
Q8NCR3,CK065_HUMAN,Uncharacterized protein C11orf65,313,"36,720",2 out of 5,2006-12-12,Evidence at protein level
Q9H3H3,CK068_HUMAN,UPF0696 protein C11orf68 (Basophilic leukemia-expressed protein Bles03) (Protein p5326),251,"27,355",3 out of 5,2006-03-21,Evidence at protein level
E9PRG8,CK098_HUMAN,Uncharacterized protein C11orf98,122,"13,798",1 out of 5,2015-03-04,Predicted
Q96S95,CK2N2_HUMAN,Calcium/calmodulin-dependent protein kinase II inhibitor 2 (CaM-KII inhibitory protein) (CaM-KIIN),79,"8,658",3 out of 5,2008-04-08,Evidence at transcript level
Q14008,CKAP5_HUMAN,Cytoskeleton-associated protein 5 (Colonic and hepatic tumor overexpressed gene protein) (Ch-TOG),2032,"225,495",5 out of 5,1998-07-15,Evidence at protein level
Q8TAZ6,CKLF2_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 2 (Chemokine-like factor superfamily member 2),248,"27,496",3 out of 5,2003-09-19,Evidence at transcript level
Q96DZ9,CKLF5_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 5 (Chemokine-like factor superfamily member 5),223,"24,653",5 out of 5,2003-09-19,Evidence at protein level
Q96FZ5,CKLF7_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 7 (Chemokine-like factor superfamily member 7),175,"18,834",3 out of 5,2003-09-19,Evidence at transcript level
Q03188,CENPC_HUMAN,Centromere protein C (CENP-C) (Centromere autoantigen C) (Centromere protein C 1) (CENP-C 1) (Interphase centromere complex protein 7),943,"106,834",5 out of 5,1993-10-01,Evidence at protein level
Q9BU64,CENPO_HUMAN,Centromere protein O (CENP-O) (Interphase centromere complex protein 36),300,"33,786",5 out of 5,2006-09-19,Evidence at protein level
Q8N2Z9,CENPS_HUMAN,Centromere protein S (CENP-S) (Apoptosis-inducing TAF9-like domain-containing protein 1) (FANCM-associated histone fold protein 1) (FANCM-interacting histone fold protein 1) (Fanconi anemia-associated polypeptide of 16 kDa),138,"15,893",5 out of 5,2006-09-19,Evidence at protein level
Q5JTW2,CEP78_HUMAN,Centrosomal protein of 78 kDa (Cep78),689,"76,396",5 out of 5,2007-06-26,Evidence at protein level
Q8IW35,CEP97_HUMAN,Centrosomal protein of 97 kDa (Cep97) (Leucine-rich repeat and IQ domain-containing protein 2),865,"96,981",5 out of 5,2006-12-12,Evidence at protein level
Q6UXA7,CF015_HUMAN,Uncharacterized protein C6orf15 (Protein STG),325,"34,195",3 out of 5,2005-07-19,Evidence at transcript level
Q4VX62,CF099_HUMAN,Putative uncharacterized protein C6orf99,202,"22,766",1 out of 5,2008-09-02,Predicted
Q5SZD1,CF141_HUMAN,Uncharacterized protein C6orf141,244,"26,754",2 out of 5,2005-07-19,Evidence at transcript level
Q9H8X3,CF208_HUMAN,Putative uncharacterized protein LINC00574,128,"13,648",2 out of 5,2005-07-05,Uncertain
Q8NDM7,CFA43_HUMAN,Cilia- and flagella-associated protein 43 (WD repeat-containing protein 96),1665,"191,984",3 out of 5,2007-11-13,Evidence at transcript level
Q8N1V2,CFA52_HUMAN,Cilia- and flagella-associated protein 52 (WD repeat-containing protein 16) (WD40-repeat protein up-regulated in HCC),620,"68,298",4 out of 5,2006-05-02,Evidence at protein level
Q96N23,CFA54_HUMAN,Cilia- and flagella-associated protein 54,3096,"351,970",3 out of 5,2008-03-18,Evidence at transcript level
P0CG36,CFC1B_HUMAN,Cryptic family protein 1B,223,"24,642",2 out of 5,2010-07-13,Inferred from homology
P13569,CFTR_HUMAN,Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 3.6.3.49) (cAMP-dependent chloride channel),1480,"168,142",5 out of 5,1990-01-01,Evidence at protein level
Q8WVR3,CG043_HUMAN,Uncharacterized protein C7orf43,580,"62,597",3 out of 5,2007-03-20,Evidence at protein level
P32929,CGL_HUMAN,Cystathionine gamma-lyase (EC 4.4.1.1) (Cysteine-protein sulfhydrase) (Gamma-cystathionase),405,"44,508",5 out of 5,1993-10-01,Evidence at protein level
Q9H7E9,CH033_HUMAN,UPF0488 protein C8orf33,229,"24,993",3 out of 5,2007-10-02,Evidence at protein level
Q96CB5,CH044_HUMAN,Putative uncharacterized protein C8orf44,159,"18,380",2 out of 5,2007-03-06,Evidence at transcript level
P61604,CH10_HUMAN,"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF)",102,"10,932",5 out of 5,2004-05-24,Evidence at protein level
Q9BZP6,CHIA_HUMAN,Acidic mammalian chitinase (AMCase) (EC 3.2.1.14) (Lung-specific protein TSA1902),476,"52,271",5 out of 5,2003-10-24,Evidence at protein level
Q9BWS9,CHID1_HUMAN,Chitinase domain-containing protein 1 (Stabilin-1-interacting chitinase-like protein) (SI-CLP),393,"44,941",5 out of 5,2007-03-20,Evidence at protein level
P52757,CHIO_HUMAN,Beta-chimaerin (Beta-chimerin) (Rho GTPase-activating protein 3),468,"53,924",5 out of 5,1996-10-01,Evidence at protein level
P06276,CHLE_HUMAN,Cholinesterase (EC 3.1.1.8) (Acylcholine acylhydrolase) (Butyrylcholine esterase) (Choline esterase II) (Pseudocholinesterase),602,"68,418",5 out of 5,1988-01-01,Evidence at protein level
Q9BY43,CHM4A_HUMAN,Charged multivesicular body protein 4a (Chromatin-modifying protein 4a) (CHMP4a) (SNF7 homolog associated with Alix-2) (SNF7-1) (hSnf-1) (Vacuolar protein sorting-associated protein 32-1) (Vps32-1) (hVps32-1),222,"25,098",5 out of 5,2002-11-01,Evidence at protein level
Q9NZZ3,CHMP5_HUMAN,Charged multivesicular body protein 5 (Chromatin-modifying protein 5) (SNF7 domain-containing protein 2) (Vacuolar protein sorting-associated protein 60) (Vps60) (hVps60),219,"24,571",5 out of 5,2004-08-31,Evidence at protein level
Q9GZS9,CHST5_HUMAN,Carbohydrate sulfotransferase 5 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-alpha) (GST4-alpha) (Intestinal N-acetylglucosamine-6-O-sulfotransferase) (I-GlcNAc6ST) (Intestinal GlcNAc-6-sulfotransferase) (hIGn6ST) (N-acetylglucosamine 6-O-sulfotransferase 3) (GlcNAc6ST-3) (Gn6st-3),411,"46,161",5 out of 5,2005-03-15,Evidence at transcript level
Q5W0N0,CI057_HUMAN,Uncharacterized protein C9orf57,161,"18,115",2 out of 5,2006-03-21,Evidence at transcript level
Q96LT7,CI072_HUMAN,Protein C9orf72,481,"54,328",5 out of 5,2005-07-19,Evidence at protein level
A2RU37,CI170_HUMAN,Uncharacterized protein C9orf170,121,"13,369",1 out of 5,2008-09-23,Evidence at transcript level
O75339,CILP1_HUMAN,Cartilage intermediate layer protein 1 (CILP-1) (Cartilage intermediate-layer protein) [Cleaved into: Cartilage intermediate layer protein 1 C1; Cartilage intermediate layer protein 1 C2],1184,"132,565",5 out of 5,2005-07-05,Evidence at protein level
Q9BW66,CINP_HUMAN,Cyclin-dependent kinase 2-interacting protein (CDK2-interacting protein),212,"24,324",5 out of 5,2008-03-18,Evidence at protein level
Q8IVW4,CDKL3_HUMAN,Cyclin-dependent kinase-like 3 (EC 2.7.11.22) (Serine/threonine-protein kinase NKIAMRE),592,"67,514",5 out of 5,2005-11-22,Evidence at protein level
P55273,CDN2D_HUMAN,Cyclin-dependent kinase 4 inhibitor D (p19-INK4d),166,"17,700",5 out of 5,1996-10-01,Evidence at protein level
Q86XR8,CEP57_HUMAN,Centrosomal protein of 57 kDa (Cep57) (FGF2-interacting protein) (Testis-specific protein 57) (Translokin),500,"57,089",5 out of 5,2004-12-21,Evidence at protein level
Q8TCT0,CERK1_HUMAN,Ceramide kinase (hCERK) (EC 2.7.1.138) (Acylsphingosine kinase) (Lipid kinase 4) (LK4),537,"59,977",5 out of 5,2003-04-23,Evidence at protein level
Q9UKY3,CES1P_HUMAN,Putative inactive carboxylesterase 4 (Inactive carboxylesterase 1 pseudogene 1) (Placental carboxylesterase 3) (PCE-3),287,"30,679",4 out of 5,2007-10-23,Uncertain
Q9GZU0,CF062_HUMAN,Uncharacterized protein C6orf62 (HBV X-transactivated gene 12 protein) (HBV XAg-transactivated protein 12),229,"27,083",2 out of 5,2003-05-16,Evidence at transcript level
Q5T0Z8,CF132_HUMAN,Uncharacterized protein C6orf132,1188,"124,034",2 out of 5,2008-02-26,Evidence at protein level
Q9C0B2,CFA74_HUMAN,Cilia- and flagella-associated protein 74,1584,"178,589",3 out of 5,2008-03-18,Evidence at transcript level
Q9BPX7,CG025_HUMAN,UPF0415 protein C7orf25,421,"46,451",2 out of 5,2007-03-06,Evidence at protein level
Q6NT52,CGB2_HUMAN,Choriogonadotropin subunit beta variant 2,195,"21,221",3 out of 5,2008-07-01,Evidence at transcript level
Q96NL8,CH037_HUMAN,Protein C8orf37,207,"23,381",5 out of 5,2007-01-09,Evidence at protein level
Q6P047,CH074_HUMAN,Uncharacterized protein C8orf74,294,"33,735",2 out of 5,2007-01-09,Evidence at protein level
P0DMB2,CH088_HUMAN,Uncharacterized protein C8orf88,117,"13,372",1 out of 5,2014-01-22,Predicted
Q8WUX2,CHAC2_HUMAN,Putative glutathione-specific gamma-glutamylcyclotransferase 2 (Gamma-GCG 2) (EC 2.3.2.-) (Cation transport regulator-like protein 2),184,"20,875",3 out of 5,2008-01-15,Evidence at transcript level
Q96BP2,CHCH1_HUMAN,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 1 (28S ribosomal protein S37, mitochondrial) (MRP-S37) (Mitochondrial small ribosomal subunit protein mS37) (Nuclear protein C2360)",118,"13,475",5 out of 5,2005-04-12,Evidence at protein level
O96017,CHK2_HUMAN,Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2),543,"60,915",5 out of 5,2000-05-30,Evidence at protein level
Q9HD42,CHM1A_HUMAN,Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) (Vacuolar protein sorting-associated protein 46-1) (Vps46-1) (hVps46-1),196,"21,703",5 out of 5,2005-04-12,Evidence at protein level
Q9P2E5,CHPF2_HUMAN,Chondroitin sulfate glucuronyltransferase (EC 2.4.1.226) (CSGlcA-T) (Chondroitin glucuronyltransferase) (Chondroitin polymerizing factor 2) (ChPF-2) (Chondroitin synthase 3) (ChSy-3) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase),772,"85,948",5 out of 5,2005-02-01,Evidence at transcript level
Q9Y4C5,CHST2_HUMAN,Carbohydrate sulfotransferase 2 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 2) (GST-2) (N-acetylglucosamine 6-O-sulfotransferase 1) (GlcNAc6ST-1) (Gn6ST-1),530,"57,857",5 out of 5,2005-03-15,Evidence at protein level
Q8NCG5,CHST4_HUMAN,Carbohydrate sulfotransferase 4 (EC 2.8.2.-) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 3) (GST-3) (High endothelial cells N-acetylglucosamine 6-O-sulfotransferase) (HEC-GlcNAc6ST) (L-selectin ligand sulfotransferase) (LSST) (N-acetylglucosamine 6-O-sulfotransferase 2) (GlcNAc6ST-2) (Gn6st-2),386,"45,134",5 out of 5,2005-03-15,Evidence at protein level
Q9GZX3,CHST6_HUMAN,Carbohydrate sulfotransferase 6 (EC 2.8.2.-) (Corneal N-acetylglucosamine-6-O-sulfotransferase) (C-GlcNAc6ST) (hCGn6ST) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 4-beta) (GST4-beta) (N-acetylglucosamine 6-O-sulfotransferase 5) (GlcNAc6ST-5) (Gn6st-5),395,"44,099",5 out of 5,2005-03-15,Evidence at protein level
Q8N4C0,CI062_HUMAN,Putative uncharacterized protein C9orf62,152,"16,682",1 out of 5,2007-07-10,Evidence at transcript level
Q9NZ63,CI078_HUMAN,Uncharacterized protein C9orf78 (Hepatocellular carcinoma-associated antigen 59),289,"33,688",2 out of 5,2006-03-07,Evidence at protein level
Q5BN46,CI116_HUMAN,UPF0691 protein C9orf116 (p53-induced expression in RB-null cells protein 1) (Pierce1),136,"15,260",2 out of 5,2005-07-05,Evidence at protein level
Q8WZB0,CI130_HUMAN,Putative uncharacterized protein encoded by LINC00476 (Nasopharyngeal carcinoma-associated gene 12 protein),136,"14,715",1 out of 5,2007-01-09,Uncertain
Q6ZV77,CI139_HUMAN,Uncharacterized protein C9orf139,190,"20,001",1 out of 5,2007-04-17,Evidence at transcript level
Q6NUJ2,CK087_HUMAN,Uncharacterized protein C11orf87,197,"20,623",3 out of 5,2008-02-26,Evidence at protein level
Q8IZV2,CKLF8_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 8 (Chemokine-like factor superfamily member 8),173,"19,572",4 out of 5,2003-09-19,Evidence at protein level
Q96LM1,CL037_HUMAN,Putative uncharacterized protein encoded by LINC00615,132,"14,531",1 out of 5,2006-12-12,Uncertain
Q8NA57,CL050_HUMAN,Uncharacterized protein C12orf50,414,"47,326",2 out of 5,2007-07-10,Evidence at protein level
Q8N7H1,CL061_HUMAN,Putative uncharacterized protein encoded by LINC01465,131,"13,435",1 out of 5,2007-04-17,Evidence at transcript level
A8MTZ7,CL071_HUMAN,Uncharacterized protein C12orf71,269,"30,355",1 out of 5,2008-07-22,Predicted
C9JDV5,CL097_HUMAN,Putative uncharacterized protein C12orf77,145,"16,178",1 out of 5,2010-03-23,Evidence at transcript level
Q6ZS10,CL17A_HUMAN,"C-type lectin domain family 17, member A (Prolectin)",378,"42,935",5 out of 5,2008-02-26,Evidence at protein level
Q6UXF7,CL18B_HUMAN,C-type lectin domain family 18 member B (Mannose receptor-like protein 1),455,"50,490",3 out of 5,2008-03-18,Evidence at transcript level
O75596,CLC3A_HUMAN,C-type lectin domain family 3 member A (C-type lectin superfamily member 1) (Cartilage-derived C-type lectin),197,"22,233",4 out of 5,2002-01-31,Evidence at protein level
Q8N1N0,CLC4F_HUMAN,C-type lectin domain family 4 member F (C-type lectin superfamily member 13) (C-type lectin 13),589,"65,519",3 out of 5,2005-02-15,Evidence at transcript level
Q9H2X3,CLC4M_HUMAN,C-type lectin domain family 4 member M (CD209 antigen-like protein 1) (DC-SIGN-related protein) (DC-SIGNR) (Dendritic cell-specific ICAM-3-grabbing non-integrin 2) (DC-SIGN2) (Liver/lymph node-specific ICAM-3-grabbing non-integrin) (L-SIGN) (CD antigen CD299),399,"45,350",5 out of 5,2004-04-13,Evidence at protein level
Q9Y6N3,CLCA3_HUMAN,Calcium-activated chloride channel regulator family member 3 (Calcium-activated chloride channel family member 3) (hCLCA3),262,"29,971",4 out of 5,2007-10-02,Evidence at protein level
Q8IZS7,CLCL1_HUMAN,C-type lectin-like domain family 1 (Dendritic cell-associated lectin 1) (DC-associated lectin-1) (DCAL-1),167,"19,115",3 out of 5,2008-02-05,Evidence at transcript level
P51793,CLCN4_HUMAN,H(+)/Cl(-) exchange transporter 4 (Chloride channel protein 4) (ClC-4) (Chloride transporter ClC-4),760,"84,917",5 out of 5,1996-10-01,Evidence at protein level
O75508,CLD11_HUMAN,Claudin-11 (Oligodendrocyte-specific protein),207,"21,993",4 out of 5,2000-05-30,Evidence at transcript level
O95484,CLD9_HUMAN,Claudin-9,217,"22,848",4 out of 5,2000-05-30,Evidence at protein level
Q496F6,CLM2_HUMAN,CMRF35-like molecule 2 (CLM-2) (CD300 antigen-like family member E) (CMRF35-A5) (Immune receptor expressed on myeloid cells 2) (IREM-2) (Polymeric immunoglobulin receptor 2) (PIgR-2) (PIgR2) (Poly-Ig receptor 2) (CD antigen CD300e),205,"22,918",5 out of 5,2008-02-26,Evidence at protein level
A8K4G0,CLM7_HUMAN,CMRF35-like molecule 7 (CLM-7) (CD300 antigen-like family member B) (CMRF35-A2) (Immune receptor expressed on myeloid cells 3) (IREM-3) (Leukocyte mono-Ig-like receptor 5) (Triggering receptor expressed on myeloid cells 5) (TREM-5) (CD antigen CD300b),201,"22,689",5 out of 5,2008-02-26,Evidence at protein level
Q96JQ2,CLMN_HUMAN,Calmin (Calponin-like transmembrane domain protein),1002,"111,651",3 out of 5,2003-07-11,Evidence at protein level
Q9UBY8,CLN8_HUMAN,Protein CLN8,286,"32,787",5 out of 5,2002-05-02,Evidence at protein level
Q9H078,CLPB_HUMAN,Caseinolytic peptidase B protein homolog (EC 3.6.1.3) (Suppressor of potassium transport defect 3),707,"78,729",5 out of 5,2002-11-08,Evidence at protein level
O76031,CLPX_HUMAN,"ATP-dependent Clp protease ATP-binding subunit clpX-like, mitochondrial",633,"69,224",5 out of 5,2000-05-30,Evidence at protein level
Q8N0X4,CLYBL_HUMAN,"Citrate lyase subunit beta-like protein, mitochondrial (Citrate lyase beta-like) (Beta-methylmalate synthase) (EC 2.3.3.-) (Malate synthase) (EC 2.3.3.9)",340,"37,359",5 out of 5,2007-05-01,Evidence at protein level
O94983,CMTA2_HUMAN,Calmodulin-binding transcription activator 2,1202,"131,530",5 out of 5,2006-05-16,Evidence at protein level
Q8N1G2,CMTR1_HUMAN,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1 (EC 2.1.1.57) (Cap methyltransferase 1) (Cap1 2'O-ribose methyltransferase 1) (MTr1) (hMTr1) (FtsJ methyltransferase domain-containing protein 2) (Interferon-stimulated gene 95 kDa protein) (ISG95),835,"95,321",5 out of 5,2006-10-03,Evidence at protein level
Q9NPU4,CN132_HUMAN,Uncharacterized protein C14orf132,83,"8,830",2 out of 5,2004-05-24,Inferred from homology
Q52M58,CN177_HUMAN,Putative uncharacterized protein C14orf177,125,"13,861",1 out of 5,2007-02-06,Evidence at transcript level
P51911,CNN1_HUMAN,"Calponin-1 (Basic calponin) (Calponin H1, smooth muscle)",297,"33,170",4 out of 5,1996-10-01,Evidence at protein level
Q15417,CNN3_HUMAN,"Calponin-3 (Calponin, acidic isoform)",329,"36,414",5 out of 5,2000-05-30,Evidence at protein level
Q9BV87,CNPD1_HUMAN,Protein CNPPD1 (Cyclin Pas1/PHO80 domain-containing protein 1),410,"45,456",3 out of 5,2005-07-05,Evidence at transcript level
Q9H8S5,CNTD2_HUMAN,Cyclin N-terminal domain-containing protein 2,307,"33,574",2 out of 5,2006-12-12,Evidence at transcript level
Q02246,CNTN2_HUMAN,Contactin-2 (Axonal glycoprotein TAG-1) (Axonin-1) (Transient axonal glycoprotein 1) (TAX-1),1040,"113,393",5 out of 5,1993-07-01,Evidence at protein level
P78357,CNTP1_HUMAN,Contactin-associated protein 1 (Caspr) (Caspr1) (Neurexin IV) (Neurexin-4) (p190),1384,"156,267",5 out of 5,2001-12-05,Evidence at protein level
Q7Z7A1,CNTRL_HUMAN,Centriolin (Centrosomal protein 1) (Centrosomal protein of 110 kDa) (Cep110),2325,"268,886",5 out of 5,2008-03-18,Evidence at protein level
Q5SY13,COAS1_HUMAN,Putative uncharacterized protein encoded by COL5A1-AS1 (COL5A1 antisense RNA 1) (COL5A1 antisense gene protein 1),56,"6,588",1 out of 5,2008-06-10,Uncertain
Q13057,COASY_HUMAN,Bifunctional coenzyme A synthase (CoA synthase) (NBP) (POV-2) [Includes: Phosphopantetheine adenylyltransferase (EC 2.7.7.3) (Dephospho-CoA pyrophosphorylase) (Pantetheine-phosphate adenylyltransferase) (PPAT); Dephospho-CoA kinase (DPCK) (EC 2.7.1.24) (Dephosphocoenzyme A kinase) (DPCOAK)],564,"62,329",5 out of 5,1997-11-01,Evidence at protein level
P13942,COBA2_HUMAN,Collagen alpha-2(XI) chain,1736,"171,791",5 out of 5,1990-01-01,Evidence at protein level
P0C843,CI014_HUMAN,Putative uncharacterized protein encoded by LINC00032,101,"12,082",2 out of 5,2008-09-02,Uncertain
Q8IXQ3,CI040_HUMAN,Uncharacterized protein C9orf40,194,"21,063",1 out of 5,2005-08-16,Evidence at protein level
Q5VXU9,CI084_HUMAN,Uncharacterized protein C9orf84,1444,"165,202",3 out of 5,2005-07-19,Evidence at transcript level
Q9P2M7,CING_HUMAN,Cingulin,1197,"136,386",5 out of 5,2003-01-27,Evidence at protein level
Q9NPC3,CIP1_HUMAN,E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1),277,"31,544",5 out of 5,2003-09-26,Evidence at protein level
Q9C0C6,CIPC_HUMAN,CLOCK-interacting pacemaker (CLOCK-interacting circadian protein),399,"42,692",4 out of 5,2006-10-31,Evidence at protein level
Q711Q0,CJ071_HUMAN,Uncharacterized protein C10orf71,1435,"156,477",3 out of 5,2007-04-03,Evidence at protein level
Q9H7T3,CJ095_HUMAN,Uncharacterized protein C10orf95,257,"26,270",1 out of 5,2005-07-05,Evidence at protein level
Q5SQS8,CJ120_HUMAN,Uncharacterized protein C10orf120,335,"39,268",2 out of 5,2006-06-27,Evidence at transcript level
Q9BRQ4,CK070_HUMAN,Uncharacterized protein C11orf70,267,"30,859",2 out of 5,2007-02-06,Evidence at transcript level
C9JXX5,CK094_HUMAN,Uncharacterized protein C11orf94,98,"10,902",2 out of 5,2010-05-18,Inferred from homology
Q96M19,CL067_HUMAN,Putative transmembrane protein encoded by LINC00477,166,"18,185",2 out of 5,2008-07-22,Uncertain
Q32Q52,CL074_HUMAN,Uncharacterized protein C12orf74,190,"21,196",1 out of 5,2008-06-10,Evidence at transcript level
P16619,CL3L1_HUMAN,C-C motif chemokine 3-like 1 (G0/G1 switch regulatory protein 19-2) (LD78-beta(1-70)) (PAT 464.2) (Small-inducible cytokine A3-like 1) (Tonsillar lymphocyte LD78 beta protein) [Cleaved into: LD78-beta(3-70); LD78-beta(5-70)],93,"10,161",5 out of 5,1990-08-01,Evidence at protein level
O75122,CLAP2_HUMAN,CLIP-associating protein 2 (Cytoplasmic linker-associated protein 2) (Protein Orbit homolog 2) (hOrbit2),1294,"141,133",5 out of 5,2005-10-11,Evidence at protein level
Q9Y5I7,CLD16_HUMAN,Claudin-16 (Paracellin-1) (PCLN-1),305,"33,836",5 out of 5,2000-05-30,Evidence at protein level
Q96DZ5,CLIP3_HUMAN,CAP-Gly domain-containing linker protein 3 (Cytoplasmic linker protein 170-related 59 kDa protein) (CLIP-170-related 59 kDa protein) (CLIPR-59),547,"59,560",5 out of 5,2006-01-10,Evidence at protein level
Q9HAZ1,CLK4_HUMAN,Dual specificity protein kinase CLK4 (EC 2.7.12.1) (CDC-like kinase 4),481,"57,492",5 out of 5,2003-09-19,Evidence at protein level
Q6UXZ3,CLM4_HUMAN,CMRF35-like molecule 4 (CLM-4) (CD300 antigen-like family member D) (CMRF35-A4) (CD antigen CD300d),194,"21,558",5 out of 5,2008-02-26,Evidence at protein level
P58418,CLRN1_HUMAN,Clarin-1 (Usher syndrome type-3 protein),232,"25,719",5 out of 5,2001-12-05,Evidence at protein level
Q8TBE1,CNIH3_HUMAN,Protein cornichon homolog 3 (CNIH-3) (Cornichon family AMPA receptor auxiliary protein 3),160,"18,976",5 out of 5,2003-01-17,Evidence at transcript level
Q969H4,CNKR1_HUMAN,Connector enhancer of kinase suppressor of ras 1 (Connector enhancer of KSR 1) (CNK homolog protein 1) (CNK1) (hCNK1) (Connector enhancer of KSR-like),720,"79,706",5 out of 5,2004-07-19,Evidence at protein level
Q6P9H4,CNKR3_HUMAN,Connector enhancer of kinase suppressor of ras 3 (Connector enhancer of KSR 3) (CNK homolog protein 3) (CNK3) (CNKSR family member 3) (Maguin-like protein),555,"61,904",3 out of 5,2007-11-13,Evidence at protein level
Q96LI5,CNO6L_HUMAN,CCR4-NOT transcription complex subunit 6-like (EC 3.1.13.4) (Carbon catabolite repressor protein 4 homolog B),555,"63,001",5 out of 5,2008-01-15,Evidence at protein level
Q8N137,CNTRB_HUMAN,Centrobin (Centrosomal BRCA2-interacting protein) (LYST-interacting protein 8),903,"101,253",5 out of 5,2006-01-10,Evidence at protein level
P12110,CO6A2_HUMAN,Collagen alpha-2(VI) chain,1019,"108,579",5 out of 5,1989-10-01,Evidence at protein level
P12111,CO6A3_HUMAN,Collagen alpha-3(VI) chain,3177,"343,669",5 out of 5,1989-10-01,Evidence at protein level
P27658,CO8A1_HUMAN,Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin],744,"73,364",5 out of 5,1992-08-01,Evidence at protein level
P07357,CO8A_HUMAN,Complement component C8 alpha chain (Complement component 8 subunit alpha),584,"65,163",5 out of 5,1988-04-01,Evidence at protein level
Q8TAL5,CI043_HUMAN,Uncharacterized protein C9orf43,461,"52,222",2 out of 5,2005-07-19,Evidence at protein level
A6NHY6,CI118_HUMAN,Putative uncharacterized protein C9orf118,69,"7,904",1 out of 5,2008-03-18,Predicted
Q8N365,CIART_HUMAN,Circadian-associated transcriptional repressor (ChIP-derived repressor of network oscillator) (Chrono) (Computationally highlighted repressor of the network oscillator),385,"41,443",4 out of 5,2006-10-03,Evidence at protein level
Q99828,CIB1_HUMAN,Calcium and integrin-binding protein 1 (CIB) (Calcium- and integrin-binding protein) (CIBP) (Calmyrin) (DNA-PKcs-interacting protein) (Kinase-interacting protein) (KIP) (SNK-interacting protein 2-28) (SIP2-28),191,"21,703",5 out of 5,1997-11-01,Evidence at protein level
Q96RK0,CIC_HUMAN,Protein capicua homolog,1608,"163,820",4 out of 5,2005-09-27,Evidence at protein level
Q9H2I8,CJ011_HUMAN,Leucine-rich repeat-containing protein C10orf11,198,"22,568",3 out of 5,2004-04-26,Evidence at protein level
Q8IVU9,CJ107_HUMAN,Uncharacterized protein C10orf107,208,"23,883",1 out of 5,2005-07-19,Evidence at transcript level
Q9BUA3,CK084_HUMAN,Uncharacterized protein C11orf84,381,"41,037",2 out of 5,2008-02-26,Evidence at protein level
Q8IZ96,CKLF1_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 1 (Chemokine-like factor superfamily member 1),169,"18,576",5 out of 5,2003-09-19,Evidence at transcript level
Q9NX76,CKLF6_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 6 (Chemokine-like factor superfamily member 6),183,"20,419",4 out of 5,2003-09-19,Evidence at protein level
Q9UBR5,CKLF_HUMAN,Chemokine-like factor (C32),152,"17,170",5 out of 5,2003-08-15,Evidence at transcript level
Q96LP6,CL042_HUMAN,Uncharacterized protein C12orf42,360,"39,738",2 out of 5,2007-02-06,Evidence at transcript level
Q5U649,CL060_HUMAN,Uncharacterized protein C12orf60,245,"27,626",1 out of 5,2007-02-06,Evidence at transcript level
Q69YU5,CL073_HUMAN,Uncharacterized protein C12orf73,71,"8,023",2 out of 5,2008-06-10,Inferred from homology
Q5QGZ9,CL12A_HUMAN,C-type lectin domain family 12 member A (C-type lectin-like molecule 1) (CLL-1) (Dendritic cell-associated lectin 2) (DCAL-2) (Myeloid inhibitory C-type lectin-like receptor) (MICL),265,"30,762",5 out of 5,2008-01-15,Evidence at protein level
Q6UXS0,CL19A_HUMAN,C-type lectin domain family 19 member A,136,"15,448",2 out of 5,2008-02-05,Evidence at transcript level
Q7Z460,CLAP1_HUMAN,CLIP-associating protein 1 (Cytoplasmic linker-associated protein 1) (Multiple asters homolog 1) (Protein Orbit homolog 1) (hOrbit1),1538,"169,451",5 out of 5,2005-10-11,Evidence at protein level
Q8N2M8,CLASR_HUMAN,"CLK4-associating serine/arginine rich protein (Splicing factor, arginine/serine-rich 16) (Suppressor of white-apricot homolog 2)",674,"77,161",4 out of 5,2003-09-19,Evidence at protein level
Q8IUN9,CLC10_HUMAN,C-type lectin domain family 10 member A (C-type lectin superfamily member 14) (Macrophage lectin 2) (CD antigen CD301),316,"35,446",5 out of 5,2005-02-15,Evidence at transcript level
Q86T13,CLC14_HUMAN,C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5),490,"51,636",4 out of 5,2003-09-09,Evidence at protein level
Q9P126,CLC1B_HUMAN,C-type lectin domain family 1 member B (C-type lectin-like receptor 2) (CLEC-2),229,"26,596",5 out of 5,2007-03-06,Evidence at protein level
Q9UHP7,CLC2D_HUMAN,C-type lectin domain family 2 member D (Lectin-like NK cell receptor) (Lectin-like transcript 1) (LLT-1) (Osteoclast inhibitory lectin),191,"21,849",5 out of 5,2008-01-15,Evidence at protein level
Q8WTT0,CLC4C_HUMAN,C-type lectin domain family 4 member C (Blood dendritic cell antigen 2) (BDCA-2) (C-type lectin superfamily member 7) (Dendritic lectin) (CD antigen CD303),213,"25,038",5 out of 5,2005-02-15,Evidence at protein level
P09496,CLCA_HUMAN,Clathrin light chain A (Lca),248,"27,077",5 out of 5,1989-07-01,Evidence at protein level
P51790,CLCN3_HUMAN,H(+)/Cl(-) exchange transporter 3 (Chloride channel protein 3) (ClC-3) (Chloride transporter ClC-3),818,"90,966",5 out of 5,1996-10-01,Evidence at protein level
P51795,CLCN5_HUMAN,H(+)/Cl(-) exchange transporter 5 (Chloride channel protein 5) (ClC-5) (Chloride transporter ClC-5),746,"83,147",5 out of 5,1996-10-01,Evidence at protein level
Q8N7P3,CLD22_HUMAN,Claudin-22,220,"24,509",2 out of 5,2003-11-14,Evidence at transcript level
P57739,CLD2_HUMAN,Claudin-2 (SP82),230,"24,549",5 out of 5,2001-01-11,Evidence at protein level
Q5K131,CLLU1_HUMAN,Chronic lymphocytic leukemia up-regulated protein 1,121,"14,228",2 out of 5,2007-08-21,Evidence at transcript level
Q8TDQ1,CLM1_HUMAN,CMRF35-like molecule 1 (CLM-1) (CD300 antigen-like family member F) (Immune receptor expressed on myeloid cells 1) (IREM-1) (Immunoglobulin superfamily member 13) (IgSF13) (NK inhibitory receptor) (CD antigen CD300f),290,"32,335",5 out of 5,2006-07-25,Evidence at protein level
Q9H6B4,CLMP_HUMAN,CXADR-like membrane protein (Adipocyte adhesion molecule) (Coxsackie- and adenovirus receptor-like membrane protein) (CAR-like membrane protein),373,"41,281",5 out of 5,2007-06-26,Evidence at protein level
O75503,CLN5_HUMAN,"Ceroid-lipofuscinosis neuronal protein 5 (Protein CLN5) [Cleaved into: Ceroid-lipofuscinosis neuronal protein 5, secreted form]",358,"41,497",5 out of 5,1998-12-15,Evidence at protein level
Q16740,CLPP_HUMAN,"ATP-dependent Clp protease proteolytic subunit, mitochondrial (EC 3.4.21.92) (Endopeptidase Clp)",277,"30,180",5 out of 5,1998-07-15,Evidence at protein level
Q8IVM7,CM029_HUMAN,Putative uncharacterized protein encoded by LINC00346,164,"18,094",1 out of 5,2006-12-12,Uncertain
P56277,CMC4_HUMAN,Cx9C motif-containing protein 4 (Mature T-cell proliferation 1 neighbor protein) (Mature T-cell proliferation-1 type A) (MTCP-1 type A) (Protein p8 MTCP-1) (p8MTCP1),68,"7,747",5 out of 5,1998-07-15,Evidence at protein level
P10645,CMGA_HUMAN,Chromogranin-A (CgA) (Pituitary secretory protein I) (SP-I) [Cleaved into: Vasostatin-1 (Vasostatin I); Vasostatin-2 (Vasostatin II); EA-92; ES-43; Pancreastatin; SS-18; WA-8; WE-14; LF-19; Catestatin (SL21); AL-11; GV-19; GR-44; ER-37; GE-25; Serpinin-RRG; Serpinin; p-Glu serpinin precursor],457,"50,688",5 out of 5,1989-07-01,Evidence at protein level
Q5EBM0,CMPK2_HUMAN,"UMP-CMP kinase 2, mitochondrial (EC 2.7.4.14) (Nucleoside-diphosphate kinase) (EC 2.7.4.6)",449,"49,448",5 out of 5,2008-04-29,Evidence at protein level
Q96F83,CN079_HUMAN,Uncharacterized protein C14orf79,325,"35,690",1 out of 5,2007-02-06,Evidence at transcript level
Q9BXV9,CN142_HUMAN,Uncharacterized protein C14orf142,100,"10,859",1 out of 5,2005-08-30,Evidence at protein level
Q9Y224,CN166_HUMAN,UPF0568 protein C14orf166 (CLE7 homolog) (CLE),244,"28,068",5 out of 5,2002-04-03,Evidence at protein level
Q96M20,CNBD2_HUMAN,Cyclic nucleotide-binding domain-containing protein 2,576,"67,512",3 out of 5,2002-11-15,Evidence at transcript level
P62633,CNBP_HUMAN,Cellular nucleic acid-binding protein (CNBP) (Zinc finger protein 9),177,"19,463",5 out of 5,2004-07-19,Evidence at protein level
Q9BPX3,CND3_HUMAN,Condensin complex subunit 3 (Chromosome-associated protein G) (Condensin subunit CAP-G) (hCAP-G) (Melanoma antigen NY-MEL-3) (Non-SMC condensin I complex subunit G) (XCAP-G homolog),1015,"114,334",5 out of 5,2003-04-23,Evidence at protein level
Q96KP4,CNDP2_HUMAN,Cytosolic non-specific dipeptidase (EC 3.4.13.18) (CNDP dipeptidase 2) (Carnosine dipeptidase II) (Epididymis secretory protein Li 13) (Glutamate carboxypeptidase-like protein 1) (Peptidase A),475,"52,878",5 out of 5,2002-09-19,Evidence at protein level
Q9NQW8,CNGB3_HUMAN,Cyclic nucleotide-gated cation channel beta-3 (Cone photoreceptor cGMP-gated channel subunit beta) (Cyclic nucleotide-gated cation channel modulatory subunit) (Cyclic nucleotide-gated channel beta-3) (CNG channel beta-3),809,"92,167",5 out of 5,2004-03-29,Evidence at protein level
O75175,CNOT3_HUMAN,CCR4-NOT transcription complex subunit 3 (CCR4-associated factor 3) (Leukocyte receptor cluster member 2),753,"81,872",5 out of 5,2004-04-13,Evidence at protein level
P26441,CNTF_HUMAN,Ciliary neurotrophic factor (CNTF),200,"22,931",5 out of 5,1992-08-01,Evidence at protein level
Q8IWV2,CNTN4_HUMAN,Contactin-4 (Brain-derived immunoglobulin superfamily protein 2) (BIG-2),1026,"113,454",5 out of 5,2004-11-23,Evidence at protein level
O94779,CNTN5_HUMAN,Contactin-5 (Neural recognition molecule NB-2) (hNB-2),1100,"120,686",5 out of 5,2004-11-23,Evidence at protein level
Q9BZ76,CNTP3_HUMAN,Contactin-associated protein-like 3 (Cell recognition molecule Caspr3),1288,"140,690",4 out of 5,2001-12-05,Evidence at transcript level
Q8WYK1,CNTP5_HUMAN,Contactin-associated protein-like 5 (Cell recognition molecule Caspr5),1306,"145,623",3 out of 5,2008-02-05,Evidence at transcript level
Q9H2U6,CO005_HUMAN,Putative uncharacterized protein encoded by LINC00597,94,"11,474",1 out of 5,2005-07-19,Uncertain
Q8N8G6,CO054_HUMAN,Putative uncharacterized protein C15orf54,183,"21,040",1 out of 5,2008-07-22,Evidence at transcript level
Q9NYJ1,COA4_HUMAN,"Cytochrome c oxidase assembly factor 4 homolog, mitochondrial (Coiled-coil-helix-coiled-coil-helix domain-containing protein 8) (E2-induced gene 2 protein)",87,"10,134",3 out of 5,2008-01-15,Evidence at protein level
O75128,COBL_HUMAN,Protein cordon-bleu,1261,"135,617",5 out of 5,2006-11-28,Evidence at protein level
Q9UKJ5,CHIC2_HUMAN,Cysteine-rich hydrophobic domain-containing protein 2 (BrX-like translocated in leukemia),165,"19,254",5 out of 5,2005-02-01,Evidence at protein level
P15882,CHIN_HUMAN,N-chimaerin (A-chimaerin) (Alpha-chimerin) (N-chimerin) (NC) (Rho GTPase-activating protein 2),459,"53,172",5 out of 5,1990-04-01,Evidence at protein level
P59074,CHM4P_HUMAN,Putative charged multivesicular body protein 4B-like protein CHMP4BP1 (Charged multivesicular body protein 4B pseudogene 1),171,"19,069",2 out of 5,2002-11-01,Uncertain
Q9H2J1,CI037_HUMAN,Uncharacterized protein ARRDC1-AS1 (ARRDC1 antisense RNA 1) (ARRDC1 antisense gene protein 1),176,"18,048",1 out of 5,2005-07-19,Evidence at transcript level
H0YL14,CI069_HUMAN,Protein C9orf69 (Herpes virus UL25-binding protein),139,"16,083",4 out of 5,2013-02-06,Evidence at protein level
B1AMM8,CI107_HUMAN,Putative uncharacterized protein encoded by LINC00587,73,"8,554",1 out of 5,2010-03-23,Uncertain
Q5VTT2,CI135_HUMAN,Uncharacterized protein C9orf135,229,"26,445",2 out of 5,2007-01-09,Evidence at protein level
O76071,CIAO1_HUMAN,Probable cytosolic iron-sulfur protein assembly protein CIAO1 (WD repeat-containing protein 39),339,"37,840",5 out of 5,2001-01-11,Evidence at protein level
Q96Q77,CIB3_HUMAN,Calcium and integrin-binding family member 3 (Kinase-interacting protein 3) (KIP 3),187,"21,802",5 out of 5,2004-06-07,Evidence at protein level
Q9NSE2,CISH_HUMAN,Cytokine-inducible SH2-containing protein (CIS) (CIS-1) (Protein G18) (Suppressor of cytokine signaling) (SOCS),258,"28,663",5 out of 5,2001-02-21,Evidence at protein level
Q99966,CITE1_HUMAN,Cbp/p300-interacting transactivator 1 (Melanocyte-specific protein 1),193,"19,896",5 out of 5,1998-12-15,Evidence at protein level
Q7Z7L8,CK096_HUMAN,Uncharacterized protein C11orf96 (Protein Ag2 homolog),435,"46,114",2 out of 5,2008-02-26,Evidence at protein level
Q7Z7J9,CK2N1_HUMAN,Calcium/calmodulin-dependent protein kinase II inhibitor 1 (CaMKII inhibitory protein alpha) (CaMKIIN-alpha),78,"8,553",4 out of 5,2008-06-10,Evidence at protein level
Q96SZ6,CK5P1_HUMAN,CDK5 regulatory subunit-associated protein 1 (CDK5 activator-binding protein C42),601,"67,689",5 out of 5,2003-06-16,Evidence at protein level
Q96JB5,CK5P3_HUMAN,CDK5 regulatory subunit-associated protein 3 (CDK5 activator-binding protein C53) (LXXLL/leucine-zipper-containing ARF-binding protein) (Protein HSF-27),506,"56,921",5 out of 5,2003-06-16,Evidence at protein level
Q8IZR5,CKLF4_HUMAN,CKLF-like MARVEL transmembrane domain-containing protein 4 (Chemokine-like factor superfamily member 4),234,"25,828",3 out of 5,2003-09-19,Evidence at protein level
P33552,CKS2_HUMAN,Cyclin-dependent kinases regulatory subunit 2 (CKS-2),79,"9,860",4 out of 5,1994-02-01,Evidence at protein level
Q8N999,CL029_HUMAN,Uncharacterized protein C12orf29,325,"37,490",2 out of 5,2007-10-02,Evidence at protein level
G3V211,CL079_HUMAN,Uncharacterized protein encoded by LINC01619,115,"13,510",2 out of 5,2013-09-18,Predicted
Q2HXU8,CL12B_HUMAN,C-type lectin domain family 12 member B (Macrophage antigen H),276,"31,616",5 out of 5,2008-01-15,Evidence at protein level
Q2KHT3,CL16A_HUMAN,Protein CLEC16A (C-type lectin domain family 16 member A),1053,"117,715",4 out of 5,2007-02-06,Evidence at protein level
Q6UXB4,CLC4G_HUMAN,C-type lectin domain family 4 member G (Liver and lymph node sinusoidal endothelial cell C-type lectin) (LSECtin),293,"32,562",5 out of 5,2006-02-21,Evidence at protein level
Q6UXN8,CLC9A_HUMAN,C-type lectin domain family 9 member A,241,"27,324",5 out of 5,2005-08-30,Evidence at protein level
A8K7I4,CLCA1_HUMAN,Calcium-activated chloride channel regulator 1 (EC 3.4.-.-) (Calcium-activated chloride channel family member 1) (hCLCA1) (Calcium-activated chloride channel protein 1) (CaCC-1) (hCaCC-1),914,"100,226",5 out of 5,2008-05-20,Evidence at protein level
Q14CN2,CLCA4_HUMAN,"Calcium-activated chloride channel regulator 4 (EC 3.4.-.-) (Calcium-activated chloride channel family member 4) (hCLCA4) (Calcium-activated chloride channel protein 2) (CaCC-2) (hCaCC-2) (Chloride channel accessory 4) [Cleaved into: Calcium-activated chloride channel regulator 4, 110 kDa form; Calcium-activated chloride channel regulator 4, 30 kDa form]",919,"101,283",5 out of 5,2008-07-22,Evidence at protein level
Q9UBD9,CLCF1_HUMAN,Cardiotrophin-like cytokine factor 1 (B-cell-stimulating factor 3) (BSF-3) (Novel neurotrophin-1) (NNT-1),225,"25,176",5 out of 5,2004-12-07,Evidence at protein level
P51801,CLCKB_HUMAN,Chloride channel protein ClC-Kb (Chloride channel Kb) (ClC-K2),687,"75,446",5 out of 5,1996-10-01,Evidence at protein level
P35523,CLCN1_HUMAN,"Chloride channel protein 1 (ClC-1) (Chloride channel protein, skeletal muscle)",988,"108,626",5 out of 5,1994-06-01,Evidence at protein level
P78369,CLD10_HUMAN,Claudin-10 (OSP-like protein),228,"24,488",4 out of 5,2000-05-30,Evidence at transcript level
Q8NHS1,CLDN2_HUMAN,Claudin domain-containing protein 2,167,"17,984",2 out of 5,2007-01-09,Evidence at transcript level
O14967,CLGN_HUMAN,Calmegin,610,"70,039",5 out of 5,1998-07-15,Evidence at protein level
O00299,CLIC1_HUMAN,Chloride intracellular channel protein 1 (Chloride channel ABP) (Nuclear chloride ion channel 27) (NCC27) (Regulatory nuclear chloride ion channel protein) (hRNCC),241,"26,923",5 out of 5,1998-07-15,Evidence at protein level
O15247,CLIC2_HUMAN,Chloride intracellular channel protein 2 (XAP121),247,"28,356",5 out of 5,1998-07-15,Evidence at protein level
Q08708,CLM6_HUMAN,CMRF35-like molecule 6 (CLM-6) (CD300 antigen-like family member C) (CMRF35-A1) (CMRF-35) (Immunoglobulin superfamily member 16) (IgSF16) (CD antigen CD300c),224,"24,830",5 out of 5,1996-10-01,Evidence at transcript level
Q13286,CLN3_HUMAN,Battenin (Batten disease protein) (Protein CLN3),438,"47,623",5 out of 5,1997-11-01,Evidence at protein level
P10909,CLUS_HUMAN,"Clusterin (Aging-associated gene 4 protein) (Apolipoprotein J) (Apo-J) (Complement cytolysis inhibitor) (CLI) (Complement-associated protein SP-40,40) (Ku70-binding protein 1) (NA1/NA2) (Testosterone-repressed prostate message 2) (TRPM-2) [Cleaved into: Clusterin beta chain (ApoJalpha) (Complement cytolysis inhibitor a chain); Clusterin alpha chain (ApoJbeta) (Complement cytolysis inhibitor b chain)]",449,"52,495",5 out of 5,1989-07-01,Evidence at protein level
Q8IY22,CMIP_HUMAN,C-Maf-inducing protein (c-Mip) (Truncated c-Maf-inducing protein) (Tc-Mip),773,"86,331",5 out of 5,2008-02-05,Evidence at protein level
Q8N3K9,CMYA5_HUMAN,Cardiomyopathy-associated protein 5 (Dystrobrevin-binding protein 2) (Genethonin-3) (Myospryn) (SPRY domain-containing protein 2) (Tripartite motif-containing protein 76),4069,"449,211",5 out of 5,2008-04-08,Evidence at protein level
Q8NCU1,CN048_HUMAN,Putative uncharacterized protein encoded by LINC00521,140,"15,808",2 out of 5,2003-04-23,Uncertain
Q9NVL8,CN105_HUMAN,Uncharacterized protein C14orf105,296,"34,690",1 out of 5,2005-07-05,Evidence at transcript level
Q99439,CNN2_HUMAN,"Calponin-2 (Calponin H2, smooth muscle) (Neutral calponin)",309,"33,697",5 out of 5,1997-11-01,Evidence at protein level
Q9NRU3,CNNM1_HUMAN,Metal transporter CNNM1 (Ancient conserved domain-containing protein 1) (Cyclin-M1),951,"104,351",4 out of 5,2007-07-24,Evidence at protein level
Q9UKZ1,CNO11_HUMAN,CCR4-NOT transcription complex subunit 11,510,"55,215",5 out of 5,2005-07-19,Evidence at protein level
A5YKK6,CNOT1_HUMAN,CCR4-NOT transcription complex subunit 1 (CCR4-associated factor 1) (Negative regulator of transcription subunit 1 homolog) (NOT1H) (hNOT1),2376,"266,939",5 out of 5,2008-01-15,Evidence at protein level
O95628,CNOT4_HUMAN,CCR4-NOT transcription complex subunit 4 (EC 2.3.2.27) (CCR4-associated factor 4) (E3 ubiquitin-protein ligase CNOT4) (Potential transcriptional repressor NOT4Hp) (RING-type E3 ubiquitin transferase CNOT4),575,"63,510",5 out of 5,2004-04-13,Evidence at protein level
Q8N129,CNPY4_HUMAN,Protein canopy homolog 4,248,"28,310",3 out of 5,2008-01-15,Evidence at transcript level
P06681,CO2_HUMAN,Complement C2 (EC 3.4.21.43) (C3/C5 convertase) [Cleaved into: Complement C2b fragment; Complement C2a fragment],752,"83,268",5 out of 5,1988-01-01,Evidence at protein level
P02461,CO3A1_HUMAN,Collagen alpha-1(III) chain,1466,"138,564",5 out of 5,1986-07-21,Evidence at protein level
P01024,CO3_HUMAN,Complement C3 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1) [Cleaved into: Complement C3 beta chain; C3-beta-c (C3bc); Complement C3 alpha chain; C3a anaphylatoxin; Acylation stimulating protein (ASP) (C3adesArg); Complement C3b alpha' chain; Complement C3c alpha' chain fragment 1; Complement C3dg fragment; Complement C3g fragment; Complement C3d fragment; Complement C3f fragment; Complement C3c alpha' chain fragment 2],1663,"187,148",5 out of 5,1986-07-21,Evidence at protein level
P02462,CO4A1_HUMAN,Collagen alpha-1(IV) chain [Cleaved into: Arresten],1669,"160,615",5 out of 5,1986-07-21,Evidence at protein level
Q01955,CO4A3_HUMAN,Collagen alpha-3(IV) chain (Goodpasture antigen) [Cleaved into: Tumstatin],1670,"161,813",5 out of 5,1996-10-01,Evidence at protein level
P05997,CO5A2_HUMAN,Collagen alpha-2(V) chain,1499,"144,910",5 out of 5,1988-04-01,Evidence at protein level
P01031,CO5_HUMAN,Complement C5 (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 4) [Cleaved into: Complement C5 beta chain; Complement C5 alpha chain; C5a anaphylatoxin; Complement C5 alpha' chain],1676,"188,305",5 out of 5,1986-07-21,Evidence at protein level
A6NMZ7,CO6A6_HUMAN,Collagen alpha-6(VI) chain,2263,"247,173",5 out of 5,2008-05-20,Evidence at protein level
P25067,CO8A2_HUMAN,Collagen alpha-2(VIII) chain (Endothelial collagen),703,"67,244",5 out of 5,1992-05-01,Evidence at protein level
P20849,CO9A1_HUMAN,Collagen alpha-1(IX) chain,921,"91,869",5 out of 5,1991-02-01,Evidence at protein level
Q9BUW7,CI016_HUMAN,UPF0184 protein C9orf16,83,"9,054",2 out of 5,2002-01-31,Evidence at protein level
Q5T6V5,CI064_HUMAN,UPF0553 protein C9orf64,341,"39,029",2 out of 5,2005-08-16,Evidence at protein level
C9J069,CI172_HUMAN,Uncharacterized protein C9orf172,976,"106,650",1 out of 5,2010-03-23,Inferred from homology
Q96AQ7,CIDEC_HUMAN,Cell death activator CIDE-3 (Cell death-inducing DFFA-like effector protein C) (Fat-specific protein FSP27 homolog),238,"26,754",5 out of 5,2002-03-27,Evidence at protein level
Q86X95,CIR1_HUMAN,Corepressor interacting with RBPJ 1 (CBF1-interacting corepressor) (Recepin),450,"52,313",5 out of 5,2006-09-05,Evidence at protein level
Q6NUN7,CK063_HUMAN,Uncharacterized protein C11orf63,778,"88,569",2 out of 5,2007-03-20,Evidence at transcript level
Q86VG3,CK074_HUMAN,Uncharacterized protein C11orf74 (Protein HEPIS),221,"25,407",2 out of 5,2007-05-29,Evidence at protein level
Q6PI97,CK088_HUMAN,UPF0722 protein C11orf88,169,"19,340",2 out of 5,2008-04-08,Evidence at transcript level
Q8N6U2,CL033_HUMAN,Putative uncharacterized protein encoded by LINC00612,182,"18,370",1 out of 5,2006-12-12,Uncertain
Q6X4T0,CL054_HUMAN,Uncharacterized protein C12orf54,127,"14,485",2 out of 5,2007-02-06,Evidence at transcript level
Q8NCF0,CL18C_HUMAN,C-type lectin domain family 18 member C (Mannose receptor-like protein 3),446,"49,585",4 out of 5,2008-03-18,Evidence at transcript level
P28329,CLAT_HUMAN,Choline O-acetyltransferase (CHOACTase) (ChAT) (Choline acetylase) (EC 2.3.1.6),748,"82,536",5 out of 5,1992-12-01,Evidence at protein level
Q96S66,CLCC1_HUMAN,Chloride channel CLIC-like protein 1 (Mid-1-related chloride channel protein 1),551,"62,023",4 out of 5,2007-08-21,Evidence at protein level
P56750,CLD17_HUMAN,Claudin-17,224,"24,603",5 out of 5,2000-05-30,Evidence at protein level
Q8N6F1,CLD19_HUMAN,Claudin-19,224,"23,229",5 out of 5,2003-01-17,Evidence at protein level
Q96B33,CLD23_HUMAN,Claudin-23,292,"31,915",3 out of 5,2004-05-24,Evidence at transcript level
A6NM45,CLD24_HUMAN,Putative claudin-24,220,"24,421",2 out of 5,2008-02-26,Uncertain
O15551,CLD3_HUMAN,Claudin-3 (Clostridium perfringens enterotoxin receptor 2) (CPE-R 2) (CPE-receptor 2) (Rat ventral prostate.1 protein homolog) (hRVP1),220,"23,319",5 out of 5,2000-05-30,Evidence at protein level
Q7Z7G1,CLNK_HUMAN,Cytokine-dependent hematopoietic cell linker (Mast cell immunoreceptor signal transducer),428,"49,554",4 out of 5,2008-01-15,Evidence at protein level
O96005,CLPT1_HUMAN,Cleft lip and palate transmembrane protein 1,669,"76,097",5 out of 5,2006-07-11,Evidence at protein level
Q96DG6,CMBL_HUMAN,Carboxymethylenebutenolidase homolog (EC 3.1.-.-),245,"28,048",5 out of 5,2007-10-23,Evidence at protein level
Q99788,CML1_HUMAN,Chemokine-like receptor 1 (G-protein coupled receptor ChemR23) (G-protein coupled receptor DEZ),373,"42,322",5 out of 5,1998-07-15,Evidence at protein level
Q8IYT2,CMTR2_HUMAN,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase 2 (EC 2.1.1.296) (Cap methyltransferase 2) (Cap2 2'O-ribose methyltransferase 2) (HMTr2) (MTr2) (FtsJ methyltransferase domain-containing protein 1) (Protein adrift homolog),770,"88,120",5 out of 5,2008-03-18,Evidence at protein level
Q86U37,CN023_HUMAN,Uncharacterized protein encoded by LINC01551,167,"18,828",1 out of 5,2008-06-10,Evidence at transcript level
Q9NWQ9,CN119_HUMAN,Uncharacterized protein C14orf119,140,"16,009",2 out of 5,2003-10-24,Evidence at protein level
Q8N769,CN178_HUMAN,Uncharacterized protein C14orf178,122,"13,377",2 out of 5,2007-02-06,Evidence at transcript level
Q8IZM0,CNG1O_HUMAN,Putative CNGA1-overlapping antisense gene protein (Anti-CNG1),81,"9,081",1 out of 5,2008-05-20,Uncertain
Q9H8M5,CNNM2_HUMAN,Metal transporter CNNM2 (Ancient conserved domain-containing protein 2) (Cyclin-M2),875,"96,623",5 out of 5,2007-07-24,Evidence at protein level
Q6P4Q7,CNNM4_HUMAN,Metal transporter CNNM4 (Ancient conserved domain-containing protein 4) (Cyclin-M4),775,"86,607",5 out of 5,2007-07-24,Evidence at protein level
Q3B7I2,CNPY1_HUMAN,Protein canopy homolog 1,92,"10,960",2 out of 5,2008-02-26,Inferred from homology
Q9Y2V0,CO041_HUMAN,Uncharacterized protein C15orf41 (Protein HH114),281,"32,264",3 out of 5,2007-01-09,Evidence at protein level
Q9BV29,CO057_HUMAN,Uncharacterized protein C15orf57 (Protein CCDC32),185,"20,656",2 out of 5,2007-09-11,Evidence at protein level
Q14031,CO4A6_HUMAN,Collagen alpha-6(IV) chain,1691,"163,807",5 out of 5,1997-11-01,Evidence at protein level
P0C0L4,CO4A_HUMAN,Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain],1744,"192,785",5 out of 5,1986-07-21,Evidence at protein level
P07358,CO8B_HUMAN,Complement component C8 beta chain (Complement component 8 subunit beta),591,"67,047",5 out of 5,1988-04-01,Evidence at protein level
Q14055,CO9A2_HUMAN,Collagen alpha-2(IX) chain,689,"65,131",5 out of 5,2002-01-23,Evidence at protein level
Q53SF7,COBL1_HUMAN,Cordon-bleu protein-like 1,1204,"131,787",3 out of 5,2006-11-28,Evidence at protein level
Q9HAK2,COE2_HUMAN,Transcription factor COE2 (Early B-cell factor 2) (EBF-2),575,"62,650",4 out of 5,2002-11-28,Evidence at transcript level
P39059,COFA1_HUMAN,Collagen alpha-1(XV) chain [Cleaved into: Restin (Endostatin-XV) (Related to endostatin) (Restin-I); Restin-2 (Restin-II); Restin-3 (Restin-III); Restin-4 (Restin-IV)],1388,"141,720",5 out of 5,1995-02-01,Evidence at protein level
Q8WTW3,COG1_HUMAN,Conserved oligomeric Golgi complex subunit 1 (COG complex subunit 1) (Component of oligomeric Golgi complex 1),980,"108,978",5 out of 5,2002-08-30,Evidence at protein level
P04118,COL_HUMAN,Colipase,112,"11,954",5 out of 5,1986-11-01,Evidence at protein level
Q7Z4G1,COMD6_HUMAN,COMM domain-containing protein 6,85,"9,638",5 out of 5,2004-08-16,Evidence at protein level
Q96L11,CG034_HUMAN,Uncharacterized protein C7orf34 (MSSP-binding protein CTM-1),122,"13,527",2 out of 5,2005-07-19,Evidence at transcript level
A4D263,CG072_HUMAN,Uncharacterized protein C7orf72,438,"49,672",1 out of 5,2008-04-29,Predicted
A6NKQ9,CGB1_HUMAN,Choriogonadotropin subunit beta variant 1,187,"20,468",3 out of 5,2008-07-01,Evidence at transcript level
P0DN86,CGB3_HUMAN,Choriogonadotropin subunit beta 3 (Choriogonadotropin subunit beta) (CG-beta) (Chorionic gonadotropin chain beta),165,"17,739",5 out of 5,2016-05-11,Evidence at protein level
Q8TAG6,CH046_HUMAN,Uncharacterized protein C8orf46,207,"22,584",2 out of 5,2007-01-09,Evidence at transcript level
Q9Y4M8,CH071_HUMAN,Putative uncharacterized protein encoded by LINC00588,146,"16,018",1 out of 5,2007-01-09,Uncertain
E5RJ46,CH087_HUMAN,Uncharacterized protein C8orf87,101,"11,413",1 out of 5,2012-04-18,Predicted
Q12873,CHD3_HUMAN,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),2000,"226,592",5 out of 5,1999-07-15,Evidence at protein level
Q8NE62,CHDH_HUMAN,"Choline dehydrogenase, mitochondrial (CDH) (CHD) (EC 1.1.99.1)",594,"65,358",4 out of 5,2004-02-16,Evidence at protein level
Q9H444,CHM4B_HUMAN,Charged multivesicular body protein 4b (Chromatin-modifying protein 4b) (CHMP4b) (SNF7 homolog associated with Alix 1) (SNF7-2) (hSnf7-2) (Vacuolar protein sorting-associated protein 32-2) (Vps32-2) (hVps32-2),224,"24,950",5 out of 5,2002-11-01,Evidence at protein level
Q96FZ7,CHMP6_HUMAN,Charged multivesicular body protein 6 (Chromatin-modifying protein 6) (Vacuolar protein sorting-associated protein 20) (Vps20) (hVps20),201,"23,485",5 out of 5,2005-08-30,Evidence at protein level
Q9H9P2,CHODL_HUMAN,Chondrolectin (Transmembrane protein MT75),273,"30,431",5 out of 5,2001-10-18,Evidence at transcript level
O43745,CHP2_HUMAN,Calcineurin B homologous protein 2 (Hepatocellular carcinoma-associated antigen 520),196,"22,452",5 out of 5,2001-10-18,Evidence at protein level
Q9H2X0,CHRD_HUMAN,Chordin,955,"102,032",5 out of 5,2001-09-26,Evidence at protein level
Q9Y2V2,CHSP1_HUMAN,Calcium-regulated heat-stable protein 1 (Calcium-regulated heat-stable protein of 24 kDa) (CRHSP-24),147,"15,892",5 out of 5,2004-01-16,Evidence at protein level
Q8IZ52,CHSS2_HUMAN,Chondroitin sulfate synthase 2 (EC 2.4.1.175) (EC 2.4.1.226) (Chondroitin glucuronyltransferase 2) (Chondroitin-polymerizing factor) (ChPF) (Glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase II) (N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase II) (N-acetylgalactosaminyltransferase 2),775,"85,467",5 out of 5,2005-02-01,Evidence at protein level
O43916,CHST1_HUMAN,Carbohydrate sulfotransferase 1 (EC 2.8.2.21) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 1) (GST-1) (Keratan sulfate Gal-6 sulfotransferase) (KS6ST) (KSGal6ST) (KSST),411,"46,715",5 out of 5,2005-03-15,Evidence at protein level
Q9NS84,CHST7_HUMAN,Carbohydrate sulfotransferase 7 (EC 2.8.2.-) (EC 2.8.2.17) (Chondroitin 6-sulfotransferase 2) (C6ST-2) (Galactose/N-acetylglucosamine/N-acetylglucosamine 6-O-sulfotransferase 5) (GST-5) (N-acetylglucosamine 6-O-sulfotransferase 4) (GlcNAc6ST-4) (Gn6st-4),486,"54,266",5 out of 5,2005-03-15,Evidence at protein level
Q8NCH0,CHSTE_HUMAN,Carbohydrate sulfotransferase 14 (EC 2.8.2.35) (Dermatan 4-sulfotransferase 1) (D4ST-1) (hD4ST1),376,"42,997",5 out of 5,2005-03-15,Evidence at protein level
Q9P2X8,CI027_HUMAN,Putative uncharacterized protein encoded by LINC00474 (Protein EST-YD1),69,"7,854",2 out of 5,2005-07-19,Uncertain
Q6ZRZ4,CI047_HUMAN,Uncharacterized protein C9orf47,202,"22,306",2 out of 5,2005-08-02,Evidence at transcript level
Q8NAJ2,CI106_HUMAN,Putative uncharacterized protein C9orf106,232,"25,113",1 out of 5,2006-03-21,Evidence at transcript level
Q5TBE3,CI153_HUMAN,Uncharacterized protein C9orf153,101,"11,254",1 out of 5,2006-04-04,Predicted
O43734,CIKS_HUMAN,Adapter protein CIKS (Connection to IKK and SAPK/JNK) (Nuclear factor NF-kappa-B activator 1) (ACT1) (TRAF3-interacting protein 2),574,"64,666",5 out of 5,2001-04-27,Evidence at protein level
Q8N5K1,CISD2_HUMAN,CDGSH iron-sulfur domain-containing protein 2 (Endoplasmic reticulum intermembrane small protein) (MitoNEET-related 1 protein) (Miner1) (Nutrient-deprivation autophagy factor-1) (NAF-1),135,"15,278",5 out of 5,2008-01-15,Evidence at protein level
P0C842,CJ052_HUMAN,Putative uncharacterized protein encoded by LINC00614,121,"13,547",1 out of 5,2008-09-02,Uncertain
Q9H8K7,CJ088_HUMAN,Uncharacterized protein C10orf88,445,"49,249",1 out of 5,2006-11-28,Evidence at protein level
Q8WZ69,CK040_HUMAN,Putative uncharacterized protein C11orf40 (Ro/SSA1-related protein),217,"24,620",1 out of 5,2006-12-12,Evidence at transcript level
Q8TAV5,CK045_HUMAN,Putative uncharacterized protein C11orf45,145,"15,559",2 out of 5,2006-10-03,Evidence at transcript level
Q8IXP5,CK053_HUMAN,Uncharacterized protein C11orf53,236,"25,393",1 out of 5,2006-12-12,Evidence at transcript level
Q3C1V1,CK091_HUMAN,Uncharacterized protein C11orf91,193,"20,547",2 out of 5,2008-06-10,Evidence at transcript level
Q15846,CLUL1_HUMAN,Clusterin-like protein 1 (Retinal-specific clusterin-like protein),466,"54,215",2 out of 5,2005-05-10,Evidence at transcript level
Q96I85,CN144_HUMAN,Putative uncharacterized protein C14orf144,54,"5,742",1 out of 5,2008-04-29,Inferred from homology
Q8WXQ3,CN183_HUMAN,Putative uncharacterized protein encoded by LINC01599,324,"35,482",1 out of 5,2010-03-23,Evidence at transcript level
Q15021,CND1_HUMAN,Condensin complex subunit 1 (Chromosome condensation-related SMC-associated protein 1) (Chromosome-associated protein D2) (hCAP-D2) (Non-SMC condensin I complex subunit D2) (XCAP-D2 homolog),1401,"157,182",5 out of 5,2003-04-23,Evidence at protein level
Q86XI2,CNDG2_HUMAN,Condensin-2 complex subunit G2 (Chromosome-associated protein G2) (CAP-G2) (hCAP-G2) (Leucine zipper protein 5) (Non-SMC condensin II complex subunit G2),1143,"130,960",5 out of 5,2006-10-31,Evidence at protein level
Q9Y3E7,CHMP3_HUMAN,Charged multivesicular body protein 3 (Chromatin-modifying protein 3) (Neuroendocrine differentiation factor) (Vacuolar protein sorting-associated protein 24) (hVps24),222,"25,073",5 out of 5,2005-08-30,Evidence at protein level
Q9Y3Y2,CHTOP_HUMAN,Chromatin target of PRMT1 protein (Friend of PRMT1 protein) (Small arginine- and glycine-rich protein) (SRAG),248,"26,397",5 out of 5,2000-12-01,Evidence at protein level
A6NGG3,CI092_HUMAN,Putative uncharacterized protein C9orf92,77,"8,520",1 out of 5,2008-02-05,Predicted
Q5T280,CI114_HUMAN,Putative methyltransferase C9orf114 (EC 2.1.1.-),376,"42,009",3 out of 5,2006-05-30,Evidence at protein level
Q5VYM1,CI131_HUMAN,Uncharacterized protein C9orf131,1079,"117,724",2 out of 5,2007-07-10,Evidence at transcript level
Q5JTZ5,CI152_HUMAN,Uncharacterized protein C9orf152,239,"26,314",1 out of 5,2006-04-04,Evidence at transcript level
Q9UHD4,CIDEB_HUMAN,Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B),219,"24,678",5 out of 5,2000-12-01,Evidence at protein level
Q8IUL8,CILP2_HUMAN,Cartilage intermediate layer protein 2 (CILP-2) [Cleaved into: Cartilage intermediate layer protein 2 C1; Cartilage intermediate layer protein 2 C2],1156,"126,291",3 out of 5,2005-07-05,Evidence at transcript level
P0C7P0,CISD3_HUMAN,"CDGSH iron-sulfur domain-containing protein 3, mitochondrial (MitoNEET-related protein 2) (Miner2)",127,"14,216",2 out of 5,2008-06-10,Evidence at protein level
Q99967,CITE2_HUMAN,Cbp/p300-interacting transactivator 2 (MSG-related protein 1) (MRG-1) (P35srj),270,"28,497",5 out of 5,1998-12-15,Evidence at protein level
A4QN01,CJ040_HUMAN,Putative uncharacterized protein encoded by LINC01553,128,"15,288",1 out of 5,2007-07-10,Evidence at transcript level
Q6UWK7,CJ099_HUMAN,Secreted protein C10orf99 (Antimicrobial peptide-57) (AP-57) (Colon-derived SUSD2 binding factor) (CSBF),81,"9,173",5 out of 5,2006-11-28,Evidence at protein level
Q5T292,CJ128_HUMAN,Putative uncharacterized protein C10orf128,105,"11,325",3 out of 5,2007-10-23,Inferred from homology
Q9P2W6,CK021_HUMAN,Uncharacterized protein C11orf21,132,"14,447",2 out of 5,2002-05-02,Evidence at transcript level
Q8N8P7,CK044_HUMAN,Uncharacterized protein C11orf44,122,"13,691",1 out of 5,2006-12-12,Evidence at transcript level
Q9H0W9,CK054_HUMAN,Ester hydrolase C11orf54 (EC 3.1.-.-),315,"35,117",5 out of 5,2006-07-11,Evidence at protein level
Q8NBR9,CK072_HUMAN,Uncharacterized protein C11orf72,251,"27,887",1 out of 5,2006-12-12,Evidence at transcript level
Q86WS4,CL040_HUMAN,Uncharacterized protein C12orf40,652,"74,505",2 out of 5,2008-09-02,Evidence at protein level
Q9H741,CL049_HUMAN,UPF0454 protein C12orf49,205,"23,594",2 out of 5,2007-07-10,Evidence at protein level
Q96MD2,CL066_HUMAN,UPF0536 protein C12orf66,445,"50,415",2 out of 5,2008-02-26,Evidence at transcript level
Q8N812,CL076_HUMAN,Uncharacterized protein C12orf76,135,"14,959",1 out of 5,2008-03-18,Evidence at transcript level
A5D8T8,CL18A_HUMAN,C-type lectin domain family 18 member A (Mannose receptor-like protein 2),446,"49,602",5 out of 5,2008-03-18,Evidence at protein level
Q8NC01,CLC1A_HUMAN,C-type lectin domain family 1 member A (C-type lectin-like receptor 1) (CLEC-1),280,"31,952",4 out of 5,2005-08-30,Evidence at transcript level
Q9BXN2,CLC7A_HUMAN,C-type lectin domain family 7 member A (Beta-glucan receptor) (C-type lectin superfamily member 12) (Dendritic cell-associated C-type lectin 1) (DC-associated C-type lectin 1) (Dectin-1),247,"27,627",5 out of 5,2006-12-12,Evidence at protein level
P09497,CLCB_HUMAN,Clathrin light chain B (Lcb),229,"25,190",5 out of 5,1989-07-01,Evidence at protein level
P51788,CLCN2_HUMAN,Chloride channel protein 2 (ClC-2),898,"98,535",5 out of 5,1996-10-01,Evidence at protein level
O95500,CLD14_HUMAN,Claudin-14,239,"25,699",5 out of 5,2000-05-30,Evidence at protein level
O95471,CLD7_HUMAN,Claudin-7 (CLDN-7),211,"22,418",5 out of 5,2000-05-30,Evidence at protein level
P53675,CLH2_HUMAN,Clathrin heavy chain 2 (Clathrin heavy chain on chromosome 22) (CLH-22),1640,"187,030",5 out of 5,1996-10-01,Evidence at protein level
O95833,CLIC3_HUMAN,Chloride intracellular channel protein 3,236,"26,648",5 out of 5,2000-05-30,Evidence at protein level
Q9NS75,CLTR2_HUMAN,Cysteinyl leukotriene receptor 2 (CysLTR2) (G-protein coupled receptor GPCR21) (hGPCR21) (G-protein coupled receptor HG57) (HPN321),346,"39,635",5 out of 5,2002-02-11,Evidence at protein level
Q96AJ1,CLUA1_HUMAN,Clusterin-associated protein 1 (Qilin),413,"48,125",5 out of 5,2006-06-13,Evidence at protein level
Q5SYC1,CLVS2_HUMAN,Clavesin-2 (Retinaldehyde-binding protein 1-like 2) (clathrin vesicle-associated Sec14 protein 2),327,"38,000",5 out of 5,2007-08-21,Evidence at transcript level
Q9Y471,CMAH_HUMAN,Inactive cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-NeuAc hydroxylase-like protein) (Cytidine monophosphate-N-acetylneuraminic acid hydroxylase pseudogene),501,"58,380",4 out of 5,2005-05-10,Evidence at protein level
Q17RA5,CMAS1_HUMAN,Putative uncharacterized protein C21orf62-AS1 (C21orf62 antisense RNA 1) (C21orf62 antisense gene protein 1),79,"8,913",1 out of 5,2007-10-23,Uncertain
Q7Z624,CMKMT_HUMAN,Calmodulin-lysine N-methyltransferase (CLNMT) (CaM KMT) (EC 2.1.1.60),323,"36,128",5 out of 5,2007-09-11,Evidence at protein level
Q9BYD5,CNFN_HUMAN,Cornifelin,112,"12,376",3 out of 5,2006-11-28,Evidence at protein level
Q16280,CNGA2_HUMAN,Cyclic nucleotide-gated olfactory channel (Cyclic nucleotide-gated cation channel 2) (Cyclic nucleotide-gated channel alpha-2) (CNG channel alpha-2) (CNG-2) (CNG2),664,"76,048",5 out of 5,1997-11-01,Evidence at transcript level
Q16281,CNGA3_HUMAN,Cyclic nucleotide-gated cation channel alpha-3 (Cone photoreceptor cGMP-gated channel subunit alpha) (Cyclic nucleotide-gated channel alpha-3) (CNG channel alpha-3) (CNG-3) (CNG3),694,"78,838",5 out of 5,1997-11-01,Evidence at protein level
O95406,CNIH1_HUMAN,Protein cornichon homolog 1 (CNIH-1) (Cornichon family AMPA receptor auxiliary protein 1) (Protein cornichon homolog) (T-cell growth-associated molecule 77) (TGAM77),144,"16,699",5 out of 5,2000-05-30,Evidence at protein level
Q9H9A5,CNO10_HUMAN,CCR4-NOT transcription complex subunit 10,744,"82,310",5 out of 5,2008-01-15,Evidence at protein level
Q9ULM6,CNOT6_HUMAN,CCR4-NOT transcription complex subunit 6 (EC 3.1.13.4) (CCR4 carbon catabolite repression 4-like) (Carbon catabolite repressor protein 4 homolog) (Cytoplasmic deadenylase),557,"63,307",5 out of 5,2004-04-13,Evidence at protein level
Q9UIV1,CNOT7_HUMAN,CCR4-NOT transcription complex subunit 7 (EC 3.1.13.4) (BTG1-binding factor 1) (CCR4-associated factor 1) (CAF-1) (Caf1a),285,"32,745",5 out of 5,2001-08-14,Evidence at protein level
P21554,CNR1_HUMAN,Cannabinoid receptor 1 (CB-R) (CB1) (CANN6),472,"52,858",5 out of 5,1991-05-01,Evidence at protein level
Q8WUR7,CO040_HUMAN,UPF0235 protein C15orf40,153,"16,353",2 out of 5,2003-04-11,Evidence at protein level
Q8NAA6,CO053_HUMAN,Uncharacterized protein C15orf53,179,"19,737",1 out of 5,2008-06-10,Evidence at transcript level
A6NNL5,CO061_HUMAN,Uncharacterized protein C15orf61,157,"18,091",1 out of 5,2008-04-29,Evidence at transcript level
P49918,CDN1C_HUMAN,Cyclin-dependent kinase inhibitor 1C (Cyclin-dependent kinase inhibitor p57) (p57Kip2),316,"32,177",5 out of 5,1996-10-01,Evidence at protein level
Q9Y6F7,CDY2_HUMAN,Testis-specific chromodomain protein Y 2 (EC 2.3.1.48),541,"60,524",3 out of 5,2002-01-23,Evidence at protein level
Q9Y232,CDYL1_HUMAN,Chromodomain Y-like protein (CDY-like) (EC 2.3.1.48),598,"66,482",5 out of 5,2003-09-19,Evidence at protein level
A6NDU8,CE051_HUMAN,UPF0600 protein C5orf51,294,"33,620",2 out of 5,2008-06-10,Evidence at protein level
A6NFR6,CE060_HUMAN,Putative uncharacterized protein C5orf60,353,"39,250",3 out of 5,2008-07-01,Evidence at protein level
O60308,CE104_HUMAN,Centrosomal protein of 104 kDa (Cep104),925,"104,448",5 out of 5,2002-01-23,Evidence at protein level
Q8N960,CE120_HUMAN,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),986,"112,640",5 out of 5,2008-09-02,Evidence at protein level
Q5TB80,CE162_HUMAN,Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog),1403,"161,943",5 out of 5,2007-07-24,Evidence at protein level
Q8TEP8,CE192_HUMAN,Centrosomal protein of 192 kDa (Cep192),1941,"213,146",5 out of 5,2007-12-04,Evidence at protein level
Q15744,CEBPE_HUMAN,CCAAT/enhancer-binding protein epsilon (C/EBP epsilon),281,"30,603",5 out of 5,1998-07-15,Evidence at protein level
Q03701,CEBPZ_HUMAN,CCAAT/enhancer-binding protein zeta (CCAAT-box-binding transcription factor) (CBF) (CCAAT-binding factor),1054,"120,974",4 out of 5,1996-10-01,Evidence at protein level
Q96N11,CG026_HUMAN,Uncharacterized protein C7orf26,449,"50,047",2 out of 5,2003-07-25,Evidence at transcript level
A4D0T2,CG066_HUMAN,Uncharacterized protein C7orf66,115,"13,234",1 out of 5,2008-09-02,Predicted
Q6NUI6,CHADL_HUMAN,Chondroadherin-like protein,762,"82,388",5 out of 5,2007-09-11,Evidence at protein level
O15335,CHAD_HUMAN,Chondroadherin (Cartilage leucine-rich protein),359,"40,476",4 out of 5,2002-06-20,Evidence at protein level
Q8WYQ3,CHC10_HUMAN,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial (Protein N27C7-4)",142,"14,149",5 out of 5,2006-10-31,Evidence at protein level
O14647,CHD2_HUMAN,Chromodomain-helicase-DNA-binding protein 2 (CHD-2) (EC 3.6.4.12) (ATP-dependent helicase CHD2),1828,"211,344",5 out of 5,1998-07-15,Evidence at protein level
Q3L8U1,CHD9_HUMAN,Chromodomain-helicase-DNA-binding protein 9 (CHD-9) (EC 3.6.4.12) (ATP-dependent helicase CHD9) (Chromatin-related mesenchymal modulator) (CReMM) (Chromatin-remodeling factor CHROM1) (Kismet homolog 2) (PPAR-alpha-interacting complex protein 320 kDa) (Peroxisomal proliferator-activated receptor A-interacting complex 320 kDa protein),2897,"326,022",5 out of 5,2006-05-02,Evidence at protein level
Q8IWX8,CHERP_HUMAN,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),916,"103,702",5 out of 5,2007-09-11,Evidence at protein level
Q9UHD1,CHRD1_HUMAN,Cysteine and histidine-rich domain-containing protein 1 (CHORD domain-containing protein 1) (CHORD-containing protein 1) (CHP-1) (Protein morgana),332,"37,490",5 out of 5,2008-02-05,Evidence at protein level
O43529,CHSTA_HUMAN,Carbohydrate sulfotransferase 10 (EC 2.8.2.-) (HNK-1 sulfotransferase) (HNK-1ST) (HNK1ST) (HuHNK-1ST),356,"42,207",5 out of 5,2005-03-15,Evidence at protein level
Q9NRB3,CHSTC_HUMAN,Carbohydrate sulfotransferase 12 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 2) (Chondroitin 4-sulfotransferase 2) (C4ST-2) (C4ST2) (Sulfotransferase Hlo),414,"48,414",5 out of 5,2005-03-15,Evidence at transcript level
Q5T2E6,CJ076_HUMAN,UPF0668 protein C10orf76,689,"78,710",3 out of 5,2007-04-17,Evidence at protein level
Q8TEF2,CJ105_HUMAN,Uncharacterized protein C10orf105,133,"14,519",1 out of 5,2008-04-29,Evidence at transcript level
Q8N4M7,CJ126_HUMAN,Putative uncharacterized protein C10orf126,172,"19,474",1 out of 5,2007-03-06,Evidence at transcript level
Q9H5F2,CK001_HUMAN,UPF0686 protein C11orf1,150,"17,785",2 out of 5,2004-05-24,Evidence at transcript level
Q96N53,CK037_HUMAN,Putative uncharacterized protein encoded by LINC00167,147,"15,424",1 out of 5,2006-10-03,Uncertain
Q96A22,CK052_HUMAN,Uncharacterized protein C11orf52,123,"13,921",2 out of 5,2006-12-12,Evidence at protein level
Q6ZUT1,CK057_HUMAN,Uncharacterized protein C11orf57,292,"34,110",3 out of 5,2007-02-06,Evidence at protein level
C9JLR9,CK095_HUMAN,Uncharacterized protein C11orf95,678,"73,197",3 out of 5,2010-05-18,Evidence at transcript level
Q96SN8,CK5P2_HUMAN,CDK5 regulatory subunit-associated protein 2 (CDK5 activator-binding protein C48) (Centrosome-associated protein 215),1893,"215,038",5 out of 5,2003-06-16,Evidence at protein level
Q07065,CKAP4_HUMAN,Cytoskeleton-associated protein 4 (63-kDa cytoskeleton-linking membrane protein) (Climp-63) (p63),602,"66,022",5 out of 5,2006-10-17,Evidence at protein level
P61024,CKS1_HUMAN,Cyclin-dependent kinases regulatory subunit 1 (CKS-1),79,"9,660",5 out of 5,2004-04-26,Evidence at protein level
Q96C57,CL043_HUMAN,Uncharacterized protein C12orf43,262,"28,171",2 out of 5,2007-02-06,Evidence at protein level
Q8IXR9,CL056_HUMAN,Uncharacterized protein C12orf56,622,"71,046",1 out of 5,2008-02-26,Evidence at transcript level
Q9H3J6,CL065_HUMAN,"Probable peptide chain release factor C12orf65, mitochondrial",166,"18,828",4 out of 5,2007-12-04,Evidence at transcript level
Q92478,CLC2B_HUMAN,C-type lectin domain family 2 member B (Activation-induced C-type lectin) (C-type lectin superfamily member 2) (IFN-alpha-2b-inducing-related protein 1),149,"17,307",4 out of 5,2002-01-31,Evidence at protein level
Q8WXI8,CLC4D_HUMAN,C-type lectin domain family 4 member D (C-type lectin superfamily member 8) (C-type lectin-like receptor 6) (CLEC-6),215,"24,704",5 out of 5,2005-02-15,Evidence at protein level
Q9UJ71,CLC4K_HUMAN,C-type lectin domain family 4 member K (Langerin) (CD antigen CD207),328,"36,725",5 out of 5,2006-02-21,Evidence at protein level
Q9UQC9,CLCA2_HUMAN,"Calcium-activated chloride channel regulator 2 (EC 3.4.-.-) (Calcium-activated chloride channel family member 2) (hCLCA2) (Calcium-activated chloride channel protein 3) (CaCC-3) (hCaCC-3) [Cleaved into: Calcium-activated chloride channel regulator 2, 109 kDa form; Calcium-activated chloride channel regulator 2, 35 kDa form]",943,"103,941",5 out of 5,2008-05-20,Evidence at protein level
P51797,CLCN6_HUMAN,Chloride transport protein 6 (Chloride channel protein 6) (ClC-6),869,"97,289",5 out of 5,1996-10-01,Evidence at protein level
P56749,CLD12_HUMAN,Claudin-12,244,"27,110",3 out of 5,2000-05-30,Evidence at protein level
P56746,CLD15_HUMAN,Claudin-15,228,"24,356",5 out of 5,2000-05-30,Evidence at protein level
P56880,CLD20_HUMAN,Claudin-20,219,"23,515",3 out of 5,2000-05-30,Evidence at transcript level
C9JDP6,CLD25_HUMAN,Putative claudin-25,229,"25,394",2 out of 5,2010-07-13,Uncertain
H7C241,CLD34_HUMAN,Claudin-34,214,"24,226",2 out of 5,2015-06-24,Inferred from homology
P56747,CLD6_HUMAN,Claudin-6 (Skullin),220,"23,292",4 out of 5,2000-05-30,Evidence at protein level
P56748,CLD8_HUMAN,Claudin-8,225,"24,845",4 out of 5,2000-05-30,Evidence at protein level
Q8NHS4,CLHC1_HUMAN,Clathrin heavy chain linker domain-containing protein 1,586,"67,250",3 out of 5,2008-03-18,Evidence at protein level
Q9NZA1,CLIC5_HUMAN,Chloride intracellular channel protein 5,410,"46,503",5 out of 5,2002-03-27,Evidence at protein level
Q96KA5,CLP1L_HUMAN,Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein) (Cisplatin resistance-related protein 9) (CRR9p),538,"62,229",4 out of 5,2008-04-29,Evidence at protein level
Q9HAW4,CLSPN_HUMAN,Claspin (hClaspin),1339,"151,094",5 out of 5,2005-08-30,Evidence at protein level
Q9Y271,CLTR1_HUMAN,Cysteinyl leukotriene receptor 1 (CysLTR1) (Cysteinyl leukotriene D4 receptor) (LTD4 receptor) (G-protein coupled receptor HG55) (HMTMF81),337,"38,541",5 out of 5,2002-02-11,Evidence at protein level
Q96NS8,CLUP3_HUMAN,Putative protein CLUHP3 (Clustered mitochondria (cluA/CLU1) homolog pseudogene 3) (KIAA0664-like protein 3),147,"16,687",2 out of 5,2007-04-03,Uncertain
Q4KMG0,CDON_HUMAN,Cell adhesion molecule-related/down-regulated by oncogenes,1287,"139,147",5 out of 5,2006-05-02,Evidence at protein level
Q6NVV7,CDPF1_HUMAN,Cysteine-rich DPF motif domain-containing protein 1,123,"13,877",2 out of 5,2008-06-10,Evidence at protein level
O95674,CDS2_HUMAN,Phosphatidate cytidylyltransferase 2 (EC 2.7.7.41) (CDP-DAG synthase 2) (CDP-DG synthase 2) (CDP-diacylglycerol synthase 2) (CDS 2) (CDP-diglyceride pyrophosphorylase 2) (CDP-diglyceride synthase 2) (CTP:phosphatidate cytidylyltransferase 2),445,"51,418",5 out of 5,2000-05-30,Evidence at protein level
Q7Z6I8,CE024_HUMAN,UPF0461 protein C5orf24,188,"20,132",2 out of 5,2007-07-24,Evidence at protein level
A4QMS7,CE049_HUMAN,Uncharacterized protein C5orf49,147,"16,991",1 out of 5,2008-05-20,Evidence at transcript level
O94986,CE152_HUMAN,Centrosomal protein of 152 kDa (Cep152),1710,"195,626",5 out of 5,2005-03-29,Evidence at protein level
O15078,CE290_HUMAN,Centrosomal protein of 290 kDa (Cep290) (Bardet-Biedl syndrome 14 protein) (Cancer/testis antigen 87) (CT87) (Nephrocystin-6) (Tumor antigen se2-2),2479,"290,386",5 out of 5,2000-12-01,Evidence at protein level
Q7Z692,CEA19_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 19 (Carcinoembryonic antigen-like 1),300,"32,638",3 out of 5,2004-07-05,Evidence at transcript level
P40198,CEAM3_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 3 (Carcinoembryonic antigen CGM1) (CD antigen CD66d),252,"27,091",5 out of 5,1995-02-01,Evidence at protein level
P40199,CEAM6_HUMAN,Carcinoembryonic antigen-related cell adhesion molecule 6 (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c),344,"37,195",5 out of 5,1995-02-01,Evidence at protein level
Q8N7Q2,CEAS1_HUMAN,Putative uncharacterized protein CELF2-AS1 (CELF2 antisense RNA 1) (CELF2 antisense gene protein 1),184,"20,470",2 out of 5,2006-06-27,Uncertain
P17676,CEBPB_HUMAN,CCAAT/enhancer-binding protein beta (C/EBP beta) (Liver activator protein) (LAP) (Liver-enriched inhibitory protein) (LIP) (Nuclear factor NF-IL6) (Transcription factor 5) (TCF-5),345,"36,106",5 out of 5,1990-08-01,Evidence at protein level
Q8N884,CGAS_HUMAN,Cyclic GMP-AMP synthase (cGAMP synthase) (cGAS) (h-cGAS) (EC 2.7.7.86) (2'3'-cGAMP synthase) (Mab-21 domain-containing protein 1),522,"58,814",5 out of 5,2005-07-05,Evidence at protein level
Q99674,CGRE1_HUMAN,Cell growth regulator with EF hand domain protein 1 (Cell growth regulatory gene 11 protein) (Hydrophobestin),301,"31,905",5 out of 5,2002-09-19,Evidence at transcript level
Q8N9H6,CH031_HUMAN,Uncharacterized protein C8orf31,132,"14,527",1 out of 5,2007-07-10,Evidence at transcript level
Q8NAV2,CH058_HUMAN,Uncharacterized protein C8orf58,365,"39,661",2 out of 5,2007-05-01,Evidence at transcript level
Q96K31,CH076_HUMAN,Uncharacterized protein C8orf76,380,"43,273",1 out of 5,2006-03-07,Evidence at transcript level
Q6ZUL3,CH086_HUMAN,Uncharacterized protein C8orf86,223,"24,736",1 out of 5,2008-09-02,Evidence at transcript level
Q9BUX1,CHAC1_HUMAN,Glutathione-specific gamma-glutamylcyclotransferase 1 (Gamma-GCG 1) (EC 2.3.2.-) (Blocks Notch protein) (Botch) (Cation transport regulator-like protein 1),264,"28,747",5 out of 5,2006-05-30,Evidence at protein level
Q7L1S5,CHST9_HUMAN,Carbohydrate sulfotransferase 9 (EC 2.8.2.-) (GalNAc-4-O-sulfotransferase 2) (GalNAc-4-ST2) (GalNAc4ST-2) (N-acetylgalactosamine-4-O-sulfotransferase 2),443,"52,055",5 out of 5,2005-03-15,Evidence at transcript level
Q9NPF2,CHSTB_HUMAN,Carbohydrate sulfotransferase 11 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 1) (Chondroitin 4-sulfotransferase 1) (C4S-1) (C4ST-1) (C4ST1),352,"41,555",5 out of 5,2005-03-15,Evidence at protein level
Q8NET6,CHSTD_HUMAN,Carbohydrate sulfotransferase 13 (EC 2.8.2.5) (Chondroitin 4-O-sulfotransferase 3) (Chondroitin 4-sulfotransferase 3) (C4ST-3) (C4ST3),341,"38,920",5 out of 5,2005-03-15,Evidence at protein level
Q7LFX5,CHSTF_HUMAN,Carbohydrate sulfotransferase 15 (EC 2.8.2.33) (B-cell RAG-associated gene protein) (hBRAG) (N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase) (GalNAc4S-6ST),561,"64,926",5 out of 5,2006-03-07,Evidence at protein level
O75838,CIB2_HUMAN,Calcium and integrin-binding family member 2 (Kinase-interacting protein 2) (KIP 2),187,"21,644",5 out of 5,2001-01-11,Evidence at protein level
Q8TCG1,CIP2A_HUMAN,Protein CIP2A (Cancerous inhibitor of PP2A) (p90 autoantigen),905,"102,185",5 out of 5,2007-05-15,Evidence at protein level
Q15642,CIP4_HUMAN,Cdc42-interacting protein 4 (Protein Felic) (Salt tolerant protein) (hSTP) (Thyroid receptor-interacting protein 10) (TR-interacting protein 10) (TRIP-10),601,"68,352",5 out of 5,1997-11-01,Evidence at protein level
Q5T742,CJ025_HUMAN,Uncharacterized protein C10orf25,122,"14,441",2 out of 5,2005-07-19,Evidence at transcript level
Q5SWW7,CJ055_HUMAN,Uncharacterized protein C10orf55,151,"16,057",1 out of 5,2005-07-05,Evidence at protein level
Q8N1V8,CJ085_HUMAN,Uncharacterized protein encoded by LINC01561,128,"13,299",1 out of 5,2006-12-12,Evidence at transcript level
Q96M02,CJ090_HUMAN,Centrosomal protein C10orf90 (Fragile-site associated tumor suppressor homolog),699,"77,910",5 out of 5,2007-03-06,Evidence at transcript level
O75153,CLU_HUMAN,Clustered mitochondria protein homolog,1309,"146,670",4 out of 5,2000-05-30,Evidence at protein level
Q8IUQ0,CLVS1_HUMAN,Clavesin-1 (Cellular retinaldehyde-binding protein-like) (Retinaldehyde-binding protein 1-like 1) (clathrin vesicle-associated Sec14 protein 1),354,"40,788",5 out of 5,2007-08-21,Evidence at protein level
P31146,COR1A_HUMAN,Coronin-1A (Coronin-like protein A) (Clipin-A) (Coronin-like protein p57) (Tryptophan aspartate-containing coat protein) (TACO),461,"51,026",5 out of 5,1993-07-01,Evidence at protein level
O00230,CORT_HUMAN,Cortistatin [Cleaved into: Cortistatin-29; Cortistatin-17],105,"11,532",4 out of 5,1998-07-15,Evidence at transcript level
Q9Y6N1,COX11_HUMAN,"Cytochrome c oxidase assembly protein COX11, mitochondrial",276,"31,430",5 out of 5,2000-05-30,Evidence at protein level
Q14061,COX17_HUMAN,Cytochrome c oxidase copper chaperone,63,"6,915",5 out of 5,1997-11-01,Evidence at protein level
P10606,COX5B_HUMAN,"Cytochrome c oxidase subunit 5B, mitochondrial (Cytochrome c oxidase polypeptide Vb)",129,"13,696",5 out of 5,1989-07-01,Evidence at protein level
Q96S19,CP013_HUMAN,UPF0585 protein C16orf13,204,"22,578",3 out of 5,2008-05-20,Evidence at protein level
Q9BSU1,CP070_HUMAN,UPF0183 protein C16orf70,422,"47,524",2 out of 5,2002-01-23,Evidence at protein level
Q8WTQ4,CP078_HUMAN,Uncharacterized protein C16orf78,265,"30,819",1 out of 5,2007-07-24,Evidence at transcript level
Q66GS9,CP135_HUMAN,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),1140,"133,490",5 out of 5,2005-02-01,Evidence at protein level
P22680,CP7A1_HUMAN,Cholesterol 7-alpha-monooxygenase (EC 1.14.14.23) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cytochrome P450 7A1),504,"57,661",5 out of 5,1991-08-01,Evidence at protein level
Q8IYJ1,CPNE9_HUMAN,Copine-9 (Copine IX),553,"61,864",4 out of 5,2007-02-06,Evidence at protein level
P23786,CPT2_HUMAN,"Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)",658,"73,777",5 out of 5,1991-11-01,Evidence at protein level
Q9H3G5,CPVL_HUMAN,"Probable serine carboxypeptidase CPVL (EC 3.4.16.-) (Carboxypeptidase, vitellogenic-like) (Vitellogenic carboxypeptidase-like protein) (VCP-like protein) (hVLP)",476,"54,164",4 out of 5,2003-02-28,Evidence at protein level
Q8N8I6,CQ055_HUMAN,Putative uncharacterized protein encoded by LINC00482,264,"28,326",2 out of 5,2007-05-15,Uncertain
Q9BSJ5,CQ080_HUMAN,Uncharacterized protein C17orf80 (Cell migration-inducing gene 3 protein) (Human lung cancer oncogene 8 protein) (HLC-8),609,"67,315",3 out of 5,2007-04-17,Evidence at transcript level
Q9BZP3,CR002_HUMAN,Putative uncharacterized protein encoded by LINC00470,86,"9,646",2 out of 5,2008-04-08,Uncertain
Q96B23,CR025_HUMAN,Uncharacterized protein C18orf25,403,"43,324",2 out of 5,2005-07-19,Evidence at protein level
Q96BA8,CR3L1_HUMAN,Cyclic AMP-responsive element-binding protein 3-like protein 1 (cAMP-responsive element-binding protein 3-like protein 1) (Old astrocyte specifically-induced substance) (OASIS) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 1],519,"57,005",5 out of 5,2007-05-29,Evidence at protein level
Q13324,CRFR2_HUMAN,Corticotropin-releasing factor receptor 2 (CRF-R-2) (CRF-R2) (CRFR-2) (Corticotropin-releasing hormone receptor 2) (CRH-R-2) (CRH-R2),411,"47,688",5 out of 5,1997-11-01,Evidence at protein level
Q8WXF5,CRGN_HUMAN,Gamma-crystallin N (Gamma-N-crystallin),182,"20,624",2 out of 5,2007-11-13,Evidence at transcript level
P46109,CRKL_HUMAN,Crk-like protein,303,"33,777",5 out of 5,1995-11-01,Evidence at protein level
Q96RY5,CRML_HUMAN,Protein cramped-like (Cramped chromatin regulator homolog 1) (Hematological and neurological expressed 1-like protein),1269,"134,718",3 out of 5,2006-12-12,Evidence at protein level
P02489,CRYAA_HUMAN,Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)],173,"19,909",5 out of 5,1986-07-21,Evidence at protein level
Q8NEA5,CS018_HUMAN,Uncharacterized protein C19orf18,215,"24,151",2 out of 5,2005-07-19,Evidence at transcript level
Q9UFG5,CS025_HUMAN,UPF0449 protein C19orf25,118,"12,878",3 out of 5,2006-10-17,Evidence at protein level
Q9Y600,CSAD_HUMAN,Cysteine sulfinic acid decarboxylase (EC 4.1.1.29) (Cysteine-sulfinate decarboxylase) (Sulfinoalanine decarboxylase),493,"55,023",4 out of 5,2000-05-30,Evidence at protein level
Q9Y534,CSDC2_HUMAN,Cold shock domain-containing protein C2 (RNA-binding protein PIPPin),153,"16,786",3 out of 5,2003-06-16,Evidence at protein level
P0DML3,CSH2_HUMAN,Chorionic somatomammotropin hormone 2 (Choriomammotropin) (Lactogen) (Placental lactogen) (PL),217,"24,994",5 out of 5,2014-07-09,Evidence at protein level
P41240,CSK_HUMAN,Tyrosine-protein kinase CSK (EC 2.7.10.2) (C-Src kinase) (Protein-tyrosine kinase CYL),450,"50,704",5 out of 5,1995-02-01,Evidence at protein level
Q0P5P2,CQ067_HUMAN,Uncharacterized protein C17orf67,114,"13,463",2 out of 5,2007-05-15,Evidence at protein level
Q96HD1,CREL1_HUMAN,Cysteine-rich with EGF-like domain protein 1,420,"45,440",5 out of 5,2005-11-08,Evidence at protein level
Q6ZS72,CS035_HUMAN,Putative uncharacterized protein C19orf35,473,"50,509",1 out of 5,2007-02-20,Evidence at transcript level
Q8NA69,CS045_HUMAN,Uncharacterized protein C19orf45,505,"57,331",2 out of 5,2007-08-21,Evidence at transcript level
Q96EN9,CS060_HUMAN,Uncharacterized protein C19orf60,201,"22,599",2 out of 5,2007-10-02,Evidence at protein level
K7EIQ3,CS082_HUMAN,Uncharacterized protein ZNF561-AS1 (ZNF561 antisense RNA 1) (ZNF561 antisense gene protein 1),104,"11,601",2 out of 5,2013-09-18,Predicted
Q8WXE0,CSKI2_HUMAN,Caskin-2 (CASK-interacting protein 2),1202,"126,783",3 out of 5,2005-03-15,Evidence at protein level
O14936,CSKP_HUMAN,Peripheral plasma membrane protein CASK (hCASK) (EC 2.7.11.1) (Calcium/calmodulin-dependent serine protein kinase) (Protein lin-2 homolog),926,"105,123",5 out of 5,1999-07-15,Evidence at protein level
Q92905,CSN5_HUMAN,COP9 signalosome complex subunit 5 (SGN5) (Signalosome subunit 5) (EC 3.4.-.-) (Jun activation domain-binding protein 1),334,"37,579",5 out of 5,2004-11-23,Evidence at protein level
Q7L5N1,CSN6_HUMAN,COP9 signalosome complex subunit 6 (SGN6) (Signalosome subunit 6) (JAB1-containing signalosome subunit 6) (MOV34 homolog) (Vpr-interacting protein) (hVIP),327,"36,163",5 out of 5,2004-11-23,Evidence at protein level
Q99627,CSN8_HUMAN,COP9 signalosome complex subunit 8 (SGN8) (Signalosome subunit 8) (COP9 homolog) (hCOP9) (JAB1-containing signalosome subunit 8),209,"23,226",5 out of 5,2004-11-23,Evidence at protein level
Q9H4G1,CST9L_HUMAN,Cystatin-9-like (Testatin),147,"17,276",3 out of 5,2002-01-23,Evidence at protein level
Q9H0L4,CSTFT_HUMAN,Cleavage stimulation factor subunit 2 tau variant (CF-1 64 kDa subunit tau variant) (Cleavage stimulation factor 64 kDa subunit tau variant) (CSTF 64 kDa subunit tau variant) (TauCstF-64),616,"64,437",5 out of 5,2005-07-19,Evidence at protein level
P0C2W7,CT47B_HUMAN,Cancer/testis antigen 47B (Cancer/testis antigen 47.13) (CT47.13),299,"31,319",2 out of 5,2007-05-01,Predicted
P49711,CTCF_HUMAN,Transcriptional repressor CTCF (11-zinc finger protein) (CCCTC-binding factor) (CTCFL paralog),727,"82,785",5 out of 5,1996-10-01,Evidence at protein level
Q8IX94,CTGE4_HUMAN,cTAGE family member 4 (Protein cTAGE-4),777,"87,989",3 out of 5,2005-01-04,Evidence at transcript level
O43310,CTIF_HUMAN,CBP80/20-dependent translation initiation factor,598,"67,587",5 out of 5,2001-02-21,Evidence at protein level
P35222,CTNB1_HUMAN,Catenin beta-1 (Beta-catenin),781,"85,497",5 out of 5,1994-02-01,Evidence at protein level
P30825,CTR1_HUMAN,High affinity cationic amino acid transporter 1 (CAT-1) (CAT1) (Ecotropic retroviral leukemia receptor homolog) (Ecotropic retrovirus receptor homolog) (Solute carrier family 7 member 1) (System Y+ basic amino acid transporter),629,"67,638",5 out of 5,1996-10-01,Evidence at protein level
O14578,CTRO_HUMAN,Citron Rho-interacting kinase (CRIK) (EC 2.7.11.1) (Serine/threonine-protein kinase 21),2027,"231,431",5 out of 5,2000-05-30,Evidence at protein level
Q7RTX7,CTSR4_HUMAN,Cation channel sperm-associated protein 4 (CatSper4),472,"54,092",5 out of 5,2007-07-24,Evidence at transcript level
Q6ZN03,CU136_HUMAN,Putative uncharacterized protein encoded by LINC00322,302,"32,374",2 out of 5,2007-11-13,Uncertain
Q9NWM3,CUED1_HUMAN,CUE domain-containing protein 1,386,"42,258",2 out of 5,2004-05-10,Evidence at protein level
Q8N9T2,CX042_HUMAN,Putative uncharacterized protein CXorf42 (NF-kappa-B-activating protein pseudogene 1),125,"14,163",2 out of 5,2005-07-05,Uncertain
Q5JRM2,CX066_HUMAN,Uncharacterized protein CXorf66,361,"39,944",2 out of 5,2008-09-02,Evidence at transcript level
P49238,CX3C1_HUMAN,CX3C chemokine receptor 1 (C-X3-C CKR-1) (CX3CR1) (Beta chemokine receptor-like 1) (CMK-BRL-1) (CMK-BRL1) (Fractalkine receptor) (G-protein coupled receptor 13) (V28),355,"40,396",5 out of 5,1996-02-01,Evidence at protein level
Q02221,CX6A2_HUMAN,"Cytochrome c oxidase subunit 6A2, mitochondrial (Cytochrome c oxidase polypeptide VIa-heart) (COXVIAH) (Cytochrome c oxidase subunit VIA-muscle) (COX VIa-M)",97,"10,815",3 out of 5,1993-07-01,Evidence at transcript level
Q6PEY0,CXB7_HUMAN,Gap junction beta-7 protein (Connexin-25) (Cx25),223,"25,860",3 out of 5,2007-01-09,Evidence at transcript level
Q07325,CXCL9_HUMAN,C-X-C motif chemokine 9 (Gamma-interferon-induced monokine) (Monokine induced by interferon-gamma) (HuMIG) (MIG) (Small-inducible cytokine B9),125,"14,019",5 out of 5,1994-10-01,Evidence at protein level
O15255,CXX1_HUMAN,CAAX box protein 1 (Cerebral protein 5),209,"22,278",3 out of 5,2000-12-01,Evidence at transcript level
P00156,CYB_HUMAN,Cytochrome b (Complex III subunit 3) (Complex III subunit III) (Cytochrome b-c1 complex subunit 3) (Ubiquinol-cytochrome-c reductase complex cytochrome b subunit),380,"42,718",5 out of 5,1986-07-21,Evidence at protein level
Q9UH73,COE1_HUMAN,Transcription factor COE1 (O/E-1) (OE-1) (Early B-cell factor),591,"64,464",5 out of 5,2002-11-28,Evidence at protein level
Q9BQW3,COE4_HUMAN,Transcription factor COE4 (Early B-cell factor 4) (EBF-4) (Olf-1/EBF-like 4) (O/E-4) (OE-4),602,"64,473",3 out of 5,2002-10-10,Evidence at transcript level
Q14746,COG2_HUMAN,Conserved oligomeric Golgi complex subunit 2 (COG complex subunit 2) (Component of oligomeric Golgi complex 2) (Low density lipoprotein receptor defect C-complementing protein),738,"83,208",5 out of 5,1997-11-01,Evidence at protein level
Q9H9E3,COG4_HUMAN,Conserved oligomeric Golgi complex subunit 4 (COG complex subunit 4) (Component of oligomeric Golgi complex 4),785,"89,083",5 out of 5,2002-08-30,Evidence at protein level
O15432,COPT2_HUMAN,Probable low affinity copper uptake protein 2 (Copper transporter 2) (hCTR2) (Solute carrier family 31 member 2),143,"15,681",3 out of 5,2001-01-11,Evidence at protein level
Q12887,COX10_HUMAN,"Protoheme IX farnesyltransferase, mitochondrial (EC 2.5.1.-) (Heme O synthase)",443,"48,910",5 out of 5,1999-07-15,Evidence at protein level
P00395,COX1_HUMAN,Cytochrome c oxidase subunit 1 (EC 1.9.3.1) (Cytochrome c oxidase polypeptide I),513,"57,041",5 out of 5,1986-07-21,Evidence at protein level
Q5RI15,COX20_HUMAN,Cytochrome c oxidase protein 20 homolog,118,"13,291",3 out of 5,2005-07-19,Evidence at protein level
P24311,COX7B_HUMAN,"Cytochrome c oxidase subunit 7B, mitochondrial (Cytochrome c oxidase polypeptide VIIb)",80,"9,161",4 out of 5,1992-03-01,Evidence at protein level
Q6PH81,CP087_HUMAN,UPF0547 protein C16orf87,154,"17,799",2 out of 5,2008-04-08,Evidence at protein level
P05093,CP17A_HUMAN,"Steroid 17-alpha-hydroxylase/17,20 lyase (EC 1.14.14.19) (17-alpha-hydroxyprogesterone aldolase) (EC 1.14.14.32) (CYPXVII) (Cytochrome P450 17A1) (Cytochrome P450-C17) (Cytochrome P450c17) (Steroid 17-alpha-monooxygenase)",508,"57,371",5 out of 5,1987-08-13,Evidence at protein level
P11511,CP19A_HUMAN,Aromatase (EC 1.14.14.14) (CYPXIX) (Cytochrome P-450AROM) (Cytochrome P450 19A1) (Estrogen synthase),503,"57,883",5 out of 5,1989-10-01,Evidence at protein level
Q9NR63,CP26B_HUMAN,Cytochrome P450 26B1 (EC 1.14.13.-) (Cytochrome P450 26A2) (Cytochrome P450 retinoic acid-inactivating 2) (Cytochrome P450RAI-2) (Retinoic acid-metabolizing cytochrome),512,"57,513",5 out of 5,2002-01-23,Evidence at protein level
P11509,CP2A6_HUMAN,"Cytochrome P450 2A6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIA6) (Coumarin 7-hydroxylase) (Cytochrome P450 IIA3) (Cytochrome P450(I))",494,"56,501",5 out of 5,1986-07-21,Evidence at protein level
P05181,CP2E1_HUMAN,"Cytochrome P450 2E1 (EC 1.14.13.-) (4-nitrophenol 2-hydroxylase) (EC 1.14.13.n7) (CYPIIE1) (Cytochrome P450-J) [Cleaved into: Cytochrome P450 2E1, N-terminally processed]",493,"56,849",5 out of 5,1987-08-13,Evidence at protein level
P51589,CP2J2_HUMAN,Cytochrome P450 2J2 (EC 1.14.14.1) (Arachidonic acid epoxygenase) (CYPIIJ2),502,"57,611",5 out of 5,1996-10-01,Evidence at protein level
Q96SQ9,CP2S1_HUMAN,Cytochrome P450 2S1 (EC 1.14.14.1) (CYPIIS1),504,"55,817",5 out of 5,2004-06-07,Evidence at protein level
Q86W10,CP4Z1_HUMAN,Cytochrome P450 4Z1 (EC 1.14.14.1) (CYPIVZ1),505,"59,086",3 out of 5,2004-06-07,Evidence at transcript level
Q7Z5Q1,CPEB2_HUMAN,Cytoplasmic polyadenylation element-binding protein 2 (CPE-BP2) (CPE-binding protein 2) (hCPEB-2),589,"64,944",5 out of 5,2006-12-12,Evidence at transcript level
Q8NE35,CPEB3_HUMAN,Cytoplasmic polyadenylation element-binding protein 3 (CPE-BP3) (CPE-binding protein 3) (hCPEB-3),698,"76,014",5 out of 5,2006-12-12,Evidence at protein level
Q6FI81,CPIN1_HUMAN,Anamorsin (Cytokine-induced apoptosis inhibitor 1) (Fe-S cluster assembly protein DRE2 homolog),312,"33,582",5 out of 5,2005-01-04,Evidence at protein level
Q96A23,CPNE4_HUMAN,Copine-4 (Copine IV) (Copine-8),557,"62,395",3 out of 5,2002-11-28,Evidence at protein level
Q9UBL6,CPNE7_HUMAN,Copine-7 (Copine VII),633,"70,294",5 out of 5,2000-12-01,Evidence at protein level
Q96L46,CPNS2_HUMAN,Calpain small subunit 2 (CSS2) (Calcium-dependent protease small subunit 2),248,"27,660",4 out of 5,2004-03-15,Evidence at transcript level
Q9UKF6,CPSF3_HUMAN,Cleavage and polyadenylation specificity factor subunit 3 (EC 3.1.27.-) (Cleavage and polyadenylation specificity factor 73 kDa subunit) (CPSF 73 kDa subunit) (mRNA 3'-end-processing endonuclease CPSF-73),684,"77,486",5 out of 5,2001-10-18,Evidence at protein level
Q92523,CPT1B_HUMAN,"Carnitine O-palmitoyltransferase 1, muscle isoform (CPT1-M) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, muscle isoform) (CPT I) (CPTI-M) (Carnitine palmitoyltransferase 1B) (Carnitine palmitoyltransferase I-like protein)",772,"87,801",5 out of 5,1997-11-01,Evidence at protein level
Q8N123,CPXCR_HUMAN,CPX chromosomal region candidate gene 1 protein (Cancer/testis antigen 77) (CT77),301,"34,727",2 out of 5,2007-10-02,Evidence at transcript level
Q6JBY9,CPZIP_HUMAN,CapZ-interacting protein (Protein kinase substrate CapZIP) (RCSD domain-containing protein 1),416,"44,504",5 out of 5,2008-02-26,Evidence at protein level
P52943,CRIP2_HUMAN,Cysteine-rich protein 2 (CRP-2) (Protein ESP1),208,"22,493",3 out of 5,1996-10-01,Evidence at protein level
Q96LR1,CRIT1_HUMAN,Putative uncharacterized protein encoded by CRHR1-IT1 (CRHR1 intronic transcript 1),157,"16,895",2 out of 5,2007-05-15,Evidence at transcript level
O75462,CRLF1_HUMAN,Cytokine receptor-like factor 1 (Cytokine-like factor 1) (CLF-1) (ZcytoR5),422,"46,302",5 out of 5,2004-03-01,Evidence at protein level
Q8IVE0,CROL2_HUMAN,Putative ciliary rootlet coiled-coil protein-like 2 protein (Ciliary rootlet coiled-coil protein pseudogene 3),287,"33,334",2 out of 5,2007-11-13,Uncertain
P09919,CSF3_HUMAN,Granulocyte colony-stimulating factor (G-CSF) (Pluripoietin) (Filgrastim) (Lenograstim),207,"22,293",5 out of 5,1989-07-01,Evidence at protein level
P0DML2,CSH1_HUMAN,Chorionic somatomammotropin hormone 1 (Choriomammotropin) (Lactogen) (Placental lactogen) (PL),217,"25,020",5 out of 5,2014-07-09,Evidence at protein level
P67870,CSK2B_HUMAN,Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a),215,"24,942",5 out of 5,2004-10-11,Evidence at protein level
P13611,CSPG2_HUMAN,Versican core protein (Chondroitin sulfate proteoglycan core protein 2) (Chondroitin sulfate proteoglycan 2) (Glial hyaluronate-binding protein) (GHAP) (Large fibroblast proteoglycan) (PG-M),3396,"372,820",5 out of 5,1990-01-01,Evidence at protein level
Q1MSJ5,CSPP1_HUMAN,Centrosome and spindle pole-associated protein 1,1256,"145,522",5 out of 5,2007-07-10,Evidence at protein level
Q9H8E8,CSR2B_HUMAN,Cysteine-rich protein 2-binding protein (CSRP2-binding protein) (ADA2A-containing complex subunit 2) (ATAC2) (CRP2-binding partner) (CRP2BP) (Lysine acetyltransferase 14),782,"88,844",5 out of 5,2002-11-01,Evidence at protein level
Q9UBI1,COMD3_HUMAN,COMM domain-containing protein 3 (Protein Bup) (Protein PIL),195,"22,151",4 out of 5,2004-08-16,Evidence at protein level
Q9P000,COMD9_HUMAN,COMM domain-containing protein 9,198,"21,819",5 out of 5,2004-08-16,Evidence at protein level
Q5HYK3,COQ5_HUMAN,"2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial (EC 2.1.1.201) (Ubiquinone biosynthesis methyltransferase COQ5)",327,"37,140",4 out of 5,2006-03-21,Evidence at protein level
P24468,COT2_HUMAN,COUP transcription factor 2 (COUP-TF2) (Apolipoprotein A-I regulatory protein 1) (ARP-1) (COUP transcription factor II) (COUP-TF II) (Nuclear receptor subfamily 2 group F member 2),414,"45,571",5 out of 5,1992-03-01,Evidence at protein level
Q7Z7K0,COXM1_HUMAN,COX assembly mitochondrial protein homolog (Cmc1p),106,"12,490",3 out of 5,2008-02-05,Evidence at protein level
H3BN30,CP097_HUMAN,Uncharacterized protein C16orf97,126,"14,216",1 out of 5,2013-03-06,Evidence at transcript level
P05108,CP11A_HUMAN,"Cholesterol side-chain cleavage enzyme, mitochondrial (EC 1.14.15.6) (CYPXIA1) (Cholesterol desmolase) (Cytochrome P450 11A1) (Cytochrome P450(scc))",521,"60,102",5 out of 5,1987-08-13,Evidence at protein level
Q9UPN4,CP131_HUMAN,Centrosomal protein of 131 kDa (5-azacytidine-induced protein 1) (Pre-acrosome localization protein 1),1083,"122,149",5 out of 5,2005-10-11,Evidence at protein level
Q02318,CP27A_HUMAN,"Sterol 26-hydroxylase, mitochondrial (EC 1.14.15.15) (5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol 27-hydroxylase) (Cytochrome P-450C27/25) (Cytochrome P450 27) (Sterol 27-hydroxylase) (Vitamin D(3) 25-hydroxylase)",531,"60,235",5 out of 5,1993-07-01,Evidence at protein level
O15528,CP27B_HUMAN,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial (EC 1.14.15.18) (25-OHD-1 alpha-hydroxylase) (25-hydroxyvitamin D(3) 1-alpha-hydroxylase) (VD3 1A hydroxylase) (Calcidiol 1-monooxygenase) (Cytochrome P450 subfamily XXVIIB polypeptide 1) (Cytochrome P450C1 alpha) (Cytochrome P450VD1-alpha) (Cytochrome p450 27B1)",508,"56,504",5 out of 5,1998-07-15,Evidence at protein level
Q16696,CP2AD_HUMAN,Cytochrome P450 2A13 (EC 1.14.14.1) (CYPIIA13),494,"56,688",5 out of 5,1998-12-15,Evidence at protein level
Q2M2W7,CQ058_HUMAN,UPF0450 protein C17orf58,97,"11,219",2 out of 5,2007-03-06,Inferred from homology
Q96MU5,CQ077_HUMAN,Uncharacterized protein C17orf77,243,"26,264",2 out of 5,2006-12-12,Evidence at transcript level
A8MV24,CQ098_HUMAN,Uncharacterized protein C17orf98,154,"17,565",1 out of 5,2008-06-10,Predicted
P07315,CRGC_HUMAN,Gamma-crystallin C (Gamma-C-crystallin) (Gamma-crystallin 2-1) (Gamma-crystallin 3),174,"20,879",5 out of 5,1988-04-01,Evidence at protein level
P50238,CRIP1_HUMAN,Cysteine-rich protein 1 (CRP-1) (Cysteine-rich heart protein) (CRHP) (hCRHP) (Cysteine-rich intestinal protein) (CRIP),77,"8,533",5 out of 5,1996-10-01,Evidence at protein level
P46108,CRK_HUMAN,Adapter molecule crk (Proto-oncogene c-Crk) (p38),304,"33,831",5 out of 5,1995-11-01,Evidence at protein level
Q8IUI8,CRLF3_HUMAN,Cytokine receptor-like factor 3 (Cytokine receptor-like molecule 9) (CREME-9) (Cytokine receptor-related protein 4) (Type I cytokine receptor-like factor p48),442,"49,766",5 out of 5,2007-05-29,Evidence at protein level
Q9UJA2,CRLS1_HUMAN,Cardiolipin synthase (CMP-forming) (CLS) (EC 2.7.8.41) (Protein GCD10 homolog),301,"32,593",5 out of 5,2003-10-03,Evidence at protein level
Q13536,CROC4_HUMAN,Protein CROC-4 (Contingent replication of cDNA 4),156,"17,231",2 out of 5,2008-05-20,Evidence at transcript level
Q86T23,CROL1_HUMAN,Putative ciliary rootlet coiled-coil protein-like 1 protein (Ciliary rootlet coiled-coil protein pseudogene 2),111,"12,396",2 out of 5,2007-11-13,Uncertain
Q9H3Y0,CRSPL_HUMAN,Peptidase inhibitor R3HDML (Cysteine-rich secretory protein R3HDML),253,"28,605",3 out of 5,2007-05-15,Evidence at transcript level
O95727,CRTAM_HUMAN,Cytotoxic and regulatory T-cell molecule (Class-I MHC-restricted T-cell-associated molecule) (CD antigen CD355),393,"44,641",5 out of 5,2007-06-26,Evidence at protein level
Q9GZN8,CT027_HUMAN,UPF0687 protein C20orf27,174,"19,291",2 out of 5,2003-01-10,Evidence at protein level
Q96LM9,CT173_HUMAN,Uncharacterized protein C20orf173,149,"16,552",2 out of 5,2002-12-13,Evidence at transcript level
A4FU28,CTGE9_HUMAN,cTAGE family member 9 (Protein cTAGE-9),777,"87,953",2 out of 5,2010-07-13,Evidence at transcript level
Q6PD62,CTR9_HUMAN,RNA polymerase-associated protein CTR9 homolog (SH2 domain-binding protein 1),1173,"133,502",5 out of 5,2006-04-04,Evidence at protein level
P60606,CTXN1_HUMAN,Cortexin-1,82,"9,045",2 out of 5,2004-03-15,Inferred from homology
Q4LDR2,CTXN3_HUMAN,Cortexin-3 (Kidney and brain-expressed protein),81,"8,933",2 out of 5,2007-04-17,Inferred from homology
Q6XXX2,CU024_HUMAN,Putative uncharacterized protein encoded by LINC00114,140,"15,753",2 out of 5,2006-06-27,Uncertain
P58505,CU058_HUMAN,Uncharacterized protein C21orf58,322,"35,003",2 out of 5,2001-12-19,Evidence at transcript level
Q9NV44,CU077_HUMAN,Putative uncharacterized protein encoded by LINC00846,126,"13,706",1 out of 5,2004-03-15,Uncertain
Q8TB03,CX038_HUMAN,Uncharacterized protein CXorf38,319,"36,670",2 out of 5,2005-07-19,Evidence at protein level
A6NEN9,CX065_HUMAN,Uncharacterized protein CXorf65,183,"21,305",1 out of 5,2008-09-02,Predicted
O95377,CXB5_HUMAN,Gap junction beta-5 protein (Connexin-31.1) (Cx31.1),273,"31,088",4 out of 5,1999-07-15,Evidence at transcript level
P19875,CXCL2_HUMAN,C-X-C motif chemokine 2 (Growth-regulated protein beta) (Gro-beta) (Macrophage inflammatory protein 2-alpha) (MIP2-alpha) [Cleaved into: GRO-beta(5-73) (GRO-beta-T) (Hematopoietic synergistic factor) (HSF) (SB-251353)],107,"11,389",5 out of 5,1991-02-01,Evidence at protein level
P25024,CXCR1_HUMAN,C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD antigen CD181),350,"39,791",5 out of 5,1992-05-01,Evidence at protein level
P02778,CXL10_HUMAN,C-X-C motif chemokine 10 (10 kDa interferon gamma-induced protein) (Gamma-IP10) (IP-10) (Small-inducible cytokine B10) [Cleaved into: CXCL10(1-73)],98,"10,881",5 out of 5,1986-07-21,Evidence at protein level
O95715,CXL14_HUMAN,C-X-C motif chemokine 14 (Chemokine BRAK) (MIP-2G) (Small-inducible cytokine B14),111,"13,078",5 out of 5,2000-05-30,Evidence at protein level
Q9H2H0,CXXC4_HUMAN,CXXC-type zinc finger protein 4 (Inhibition of the Dvl and axin complex protein),198,"20,978",3 out of 5,2008-02-05,Evidence at transcript level
Q9UNU6,CP8B1_HUMAN,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase (EC 1.14.18.8) (7-alpha-hydroxy-4-cholesten-3-one 12-alpha-hydroxylase) (CYPVIIIB1) (Cytochrome P450 8B1) (Sterol 12-alpha-hydroxylase),501,"58,068",5 out of 5,2001-02-21,Evidence at protein level
A4D0V7,CPED1_HUMAN,Cadherin-like and PC-esterase domain-containing protein 1,1026,"117,491",3 out of 5,2008-02-05,Evidence at transcript level
Q8IZJ3,CPMD8_HUMAN,C3 and PZP-like alpha-2-macroglobulin domain-containing protein 8,1885,"206,702",5 out of 5,2008-02-05,Evidence at protein level
O95639,CPSF4_HUMAN,Cleavage and polyadenylation specificity factor subunit 4 (Cleavage and polyadenylation specificity factor 30 kDa subunit) (CPSF 30 kDa subunit) (NS1 effector domain-binding protein 1) (Neb-1) (No arches homolog),269,"30,255",5 out of 5,2003-10-24,Evidence at protein level
Q8N684,CPSF7_HUMAN,Cleavage and polyadenylation specificity factor subunit 7 (Cleavage and polyadenylation specificity factor 59 kDa subunit) (CFIm59) (CPSF 59 kDa subunit) (Pre-mRNA cleavage factor Im 59 kDa subunit),471,"52,050",5 out of 5,2006-02-07,Evidence at protein level
P50416,CPT1A_HUMAN,"Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)",773,"88,368",5 out of 5,1996-10-01,Evidence at protein level
Q8TCG5,CPT1C_HUMAN,"Carnitine O-palmitoyltransferase 1, brain isoform (CPT1-B) (EC 2.3.1.21) (CPT IC) (Carnitine O-palmitoyltransferase I, brain isoform) (CPTI-B) (Carnitine palmitoyltransferase 1C)",803,"90,989",5 out of 5,2004-07-05,Evidence at protein level
Q8N3J3,CQ053_HUMAN,Uncharacterized protein C17orf53,647,"69,771",2 out of 5,2007-05-29,Evidence at protein level
Q0P670,CQ074_HUMAN,Uncharacterized protein C17orf74,501,"57,131",2 out of 5,2007-05-15,Evidence at transcript level
Q96D31,CRCM1_HUMAN,Calcium release-activated calcium channel protein 1 (Protein orai-1) (Transmembrane protein 142A),301,"32,668",5 out of 5,2006-05-16,Evidence at protein level
Q6WN34,CRDL2_HUMAN,Chordin-like protein 2 (Breast tumor novel factor 1) (BNF-1) (Chordin-related protein 2),429,"47,495",5 out of 5,2005-04-26,Evidence at protein level
O43889,CREB3_HUMAN,Cyclic AMP-responsive element-binding protein 3 (CREB-3) (cAMP-responsive element-binding protein 3) (Leucine zipper protein) (Luman) (Transcription factor LZIP-alpha) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3 (N-terminal Luman) (Transcriptionally active form)],395,"43,917",5 out of 5,2004-11-09,Evidence at protein level
P07320,CRGD_HUMAN,Gamma-crystallin D (Gamma-D-crystallin) (Gamma-crystallin 4),174,"20,738",5 out of 5,1988-04-01,Evidence at protein level
Q9P021,CRIPT_HUMAN,Cysteine-rich PDZ-binding protein (Cysteine-rich interactor of PDZ three) (Cysteine-rich interactor of PDZ3),101,"11,216",5 out of 5,2008-01-15,Evidence at protein level
P16562,CRIS2_HUMAN,Cysteine-rich secretory protein 2 (CRISP-2) (Cancer/testis antigen 36) (CT36) (Testis-specific protein TPX-1),243,"27,259",3 out of 5,1990-08-01,Evidence at protein level
Q9H336,CRLD1_HUMAN,Cysteine-rich secretory protein LCCL domain-containing 1 (CocoaCrisp) (Cysteine-rich secretory protein 10) (CRISP-10) (LCCL domain-containing cysteine-rich secretory protein 1) (Trypsin inhibitor Hl),500,"56,888",3 out of 5,2006-09-05,Evidence at transcript level
Q9H0B8,CRLD2_HUMAN,Cysteine-rich secretory protein LCCL domain-containing 2 (Cysteine-rich secretory protein 11) (CRISP-11) (LCCL domain-containing cysteine-rich secretory protein 2),497,"55,920",5 out of 5,2006-09-05,Evidence at transcript level
Q9HC73,CRLF2_HUMAN,Cytokine receptor-like factor 2 (Cytokine receptor-like 2) (IL-XR) (Thymic stromal lymphopoietin protein receptor) (TSLP receptor),371,"42,013",5 out of 5,2003-11-07,Evidence at protein level
Q9UBG3,CRNN_HUMAN,Cornulin (53 kDa putative calcium-binding protein) (53 kDa squamous epithelial-induced stress protein) (58 kDa heat shock protein) (Squamous epithelial heat shock protein 53) (Tumor-related protein),495,"53,533",5 out of 5,2007-10-02,Evidence at protein level
Q9BUF7,CRUM3_HUMAN,Protein crumbs homolog 3,120,"12,854",5 out of 5,2005-06-07,Evidence at protein level
Q49AN0,CRY2_HUMAN,Cryptochrome-2,593,"66,947",5 out of 5,2006-11-28,Evidence at protein level
P19784,CSK22_HUMAN,Casein kinase II subunit alpha' (CK II alpha') (EC 2.7.11.1),350,"41,213",5 out of 5,1991-02-01,Evidence at protein level
Q9BT78,CSN4_HUMAN,COP9 signalosome complex subunit 4 (SGN4) (Signalosome subunit 4) (JAB1-containing signalosome subunit 4),406,"46,269",5 out of 5,2004-11-23,Evidence at protein level
Q9HC47,CTGE1_HUMAN,Cutaneous T-cell lymphoma-associated antigen 1 (Protein cTAGE-1) (Cancer/testis antigen 21.1) (CT21.1),74,"8,406",2 out of 5,2005-01-04,Evidence at transcript level
Q8IWA5,CTL2_HUMAN,Choline transporter-like protein 2 (Solute carrier family 44 member 2),706,"80,124",5 out of 5,2005-08-30,Evidence at protein level
Q9UI47,CTNA3_HUMAN,Catenin alpha-3 (Alpha T-catenin) (Cadherin-associated protein),895,"99,809",5 out of 5,2005-10-25,Evidence at protein level
O43822,CU002_HUMAN,Protein C21orf2 (C21orf-HUMF09G8.5) (Leucine-rich repeat-containing protein 76) (YF5/A2),256,"28,340",5 out of 5,1998-07-15,Evidence at protein level
Q9H467,CUED2_HUMAN,CUE domain-containing protein 2,287,"32,009",5 out of 5,2007-04-03,Evidence at protein level
Q99829,CPNE1_HUMAN,Copine-1 (Chromobindin 17) (Copine I),537,"59,059",5 out of 5,2000-12-01,Evidence at protein level
O95741,CPNE6_HUMAN,Copine-6 (Copine VI) (Neuronal-copine) (N-copine),557,"61,991",5 out of 5,2000-12-01,Evidence at protein level
P04632,CPNS1_HUMAN,Calpain small subunit 1 (CSS1) (Calcium-activated neutral proteinase small subunit) (CANP small subunit) (Calcium-dependent protease small subunit) (CDPS) (Calcium-dependent protease small subunit 1) (Calpain regulatory subunit),268,"28,316",5 out of 5,1987-08-13,Evidence at protein level
Q5TA50,CPTP_HUMAN,Ceramide-1-phosphate transfer protein (CPTP) (Glycolipid transfer protein domain-containing protein 1) (GLTP domain-containing protein 1),214,"24,365",5 out of 5,2008-02-05,Evidence at protein level
Q9BQA9,CQ062_HUMAN,Uncharacterized protein C17orf62,187,"20,774",2 out of 5,2007-03-20,Evidence at protein level
Q0VDD5,CQ091_HUMAN,Putative uncharacterized protein encoded by MIR22HG,57,"6,478",1 out of 5,2008-02-05,Uncertain
Q68CJ9,CR3L3_HUMAN,Cyclic AMP-responsive element-binding protein 3-like protein 3 (cAMP-responsive element-binding protein 3-like protein 3) (Transcription factor CREB-H) [Cleaved into: Processed cyclic AMP-responsive element-binding protein 3-like protein 3],461,"49,077",5 out of 5,2007-05-29,Evidence at protein level
P23508,CRCM_HUMAN,Colorectal mutant cancer protein (Protein MCC),829,"93,027",5 out of 5,1991-11-01,Evidence at protein level
Q6UXH1,CREL2_HUMAN,Cysteine-rich with EGF-like domain protein 2,353,"38,192",5 out of 5,2006-10-31,Evidence at protein level
P11844,CRGA_HUMAN,Gamma-crystallin A (Gamma-A-crystallin) (Gamma-crystallin 5),174,"20,877",3 out of 5,1989-10-01,Evidence at transcript level
Q6UUV9,CRTC1_HUMAN,CREB-regulated transcription coactivator 1 (Mucoepidermoid carcinoma translocated protein 1) (Transducer of regulated cAMP response element-binding protein 1) (TORC-1) (Transducer of CREB protein 1),634,"67,300",5 out of 5,2005-07-05,Evidence at protein level
Q9Y2S2,CRYL1_HUMAN,Lambda-crystallin homolog (EC 1.1.1.45) (L-gulonate 3-dehydrogenase) (Gul3DH),319,"35,419",5 out of 5,2001-10-24,Evidence at protein level
Q9NSK7,CS012_HUMAN,Protein C19orf12,152,"16,286",5 out of 5,2007-07-24,Evidence at protein level
Q8N9M1,CS047_HUMAN,Uncharacterized protein C19orf47,422,"44,746",2 out of 5,2007-06-26,Evidence at protein level
Q0VDD7,CS057_HUMAN,Uncharacterized protein C19orf57 (Pre-T/NK cell-associated protein 3B3),668,"69,556",4 out of 5,2007-07-24,Evidence at protein level
I3L1E1,CS084_HUMAN,Uncharacterized protein C19orf84,186,"19,614",1 out of 5,2014-02-19,Predicted
Q16619,CTF1_HUMAN,Cardiotrophin-1 (CT-1),201,"21,227",5 out of 5,1997-11-01,Evidence at protein level
O60931,CTNS_HUMAN,Cystinosin,367,"41,738",5 out of 5,2001-02-21,Evidence at protein level
P52569,CTR2_HUMAN,Cationic amino acid transporter 2 (CAT-2) (CAT2) (Low affinity cationic amino acid transporter 2) (Solute carrier family 7 member 2),658,"71,673",5 out of 5,1996-10-01,Evidence at protein level
Q99895,CTRC_HUMAN,Chymotrypsin-C (EC 3.4.21.2) (Caldecrin),268,"29,484",5 out of 5,2001-06-01,Evidence at protein level
Q86XM0,CTSRD_HUMAN,Cation channel sperm-associated protein subunit delta (CatSper-delta) (CatSperdelta) (Transmembrane protein 146),798,"90,468",5 out of 5,2007-05-15,Evidence at protein level
Q9NYP8,CU062_HUMAN,Uncharacterized protein C21orf62 (B37),219,"24,886",2 out of 5,2001-09-26,Evidence at transcript level
B9A014,CU140_HUMAN,Uncharacterized protein C21orf140,251,"29,214",1 out of 5,2012-01-25,Evidence at transcript level
Q13620,CUL4B_HUMAN,Cullin-4B (CUL-4B),913,"103,982",5 out of 5,1997-11-01,Evidence at protein level
Q8N1L1,CV037_HUMAN,Putative uncharacterized protein encoded by LINC00528,170,"18,115",1 out of 5,2006-10-31,Uncertain
A2AJT9,CX023_HUMAN,Uncharacterized protein CXorf23,711,"83,871",2 out of 5,2007-05-15,Evidence at protein level
Q6NSI4,CX057_HUMAN,Uncharacterized protein CXorf57,855,"97,554",3 out of 5,2006-10-31,Evidence at protein level
O75712,CXB3_HUMAN,Gap junction beta-3 protein (Connexin-31) (Cx31),270,"30,818",5 out of 5,1998-12-15,Evidence at protein level
P02775,CXCL7_HUMAN,Platelet basic protein (PBP) (C-X-C motif chemokine 7) (Leukocyte-derived growth factor) (LDGF) (Macrophage-derived growth factor) (MDGF) (Small-inducible cytokine B7) [Cleaved into: Connective tissue-activating peptide III (CTAP-III) (LA-PF4) (Low-affinity platelet factor IV); TC-2; Connective tissue-activating peptide III(1-81) (CTAP-III(1-81)); Beta-thromboglobulin (Beta-TG); Neutrophil-activating peptide 2(74) (NAP-2(74)); Neutrophil-activating peptide 2(73) (NAP-2(73)); Neutrophil-activating peptide 2 (NAP-2); TC-1; Neutrophil-activating peptide 2(1-66) (NAP-2(1-66)); Neutrophil-activating peptide 2(1-63) (NAP-2(1-63))],128,"13,894",5 out of 5,1986-07-21,Evidence at protein level
Q9NRP2,COXM2_HUMAN,COX assembly mitochondrial protein 2 homolog,79,"9,460",2 out of 5,2003-10-24,Evidence at protein level
A8MZG2,CP090_HUMAN,Uncharacterized protein C16orf90,172,"18,426",1 out of 5,2008-07-22,Evidence at transcript level
Q8N118,CP4X1_HUMAN,Cytochrome P450 4X1 (EC 1.14.14.1) (CYPIVX1),509,"58,875",3 out of 5,2004-06-07,Evidence at transcript level
O14810,CPLX1_HUMAN,Complexin-1 (Complexin I) (CPX I) (Synaphin-2),134,"15,030",5 out of 5,1999-07-15,Evidence at protein level
P22792,CPN2_HUMAN,Carboxypeptidase N subunit 2 (Carboxypeptidase N 83 kDa chain) (Carboxypeptidase N large subunit) (Carboxypeptidase N polypeptide 2) (Carboxypeptidase N regulatory subunit),545,"60,557",5 out of 5,1991-08-01,Evidence at protein level
Q96FN4,CPNE2_HUMAN,Copine-2 (Copine II),548,"61,190",4 out of 5,2002-11-28,Evidence at protein level
Q9HCH3,CPNE5_HUMAN,Copine-5 (Copine V),593,"65,734",4 out of 5,2001-04-27,Evidence at protein level
Q8WW18,CQ050_HUMAN,Uncharacterized protein C17orf50,174,"19,346",1 out of 5,2006-10-03,Evidence at transcript level
Q8N7U9,CQ054_HUMAN,Putative uncharacterized protein encoded by LINC00469,141,"15,976",2 out of 5,2007-01-23,Uncertain
F2Z3M2,CQ112_HUMAN,Uncharacterized protein C17orf112,114,"12,668",1 out of 5,2012-07-11,Predicted
Q96N68,CR015_HUMAN,Putative uncharacterized protein C18orf15,181,"19,136",2 out of 5,2005-07-19,Uncertain
Q32NC0,CR021_HUMAN,UPF0711 protein C18orf21 (HBV X-transactivated gene 13 protein) (HBV XAg-transactivated protein 13),220,"24,827",2 out of 5,2007-03-06,Evidence at protein level
Q68DL7,CR063_HUMAN,Uncharacterized protein C18orf63,685,"77,230",1 out of 5,2008-09-02,Evidence at transcript level
Q6ZUX3,CREC2_HUMAN,Crescerin-2,1019,"111,153",3 out of 5,2008-03-18,Evidence at transcript level
O75629,CREG1_HUMAN,Protein CREG1 (Cellular repressor of E1A-stimulated genes 1),220,"24,075",5 out of 5,2005-02-15,Evidence at protein level
Q03060,CREM_HUMAN,cAMP-responsive element modulator (Inducible cAMP early repressor) (ICER),361,"38,940",5 out of 5,1994-06-01,Evidence at protein level
Q494W8,CRFM7_HUMAN,CHRNA7-FAM7A fusion protein (CHRNA7-DR1) (D-10),412,"46,218",2 out of 5,2006-04-04,Evidence at transcript level
P34998,CRFR1_HUMAN,Corticotropin-releasing factor receptor 1 (CRF-R-1) (CRF-R1) (CRFR-1) (Corticotropin-releasing hormone receptor 1) (CRH-R-1) (CRH-R1),444,"50,719",5 out of 5,1994-02-01,Evidence at protein level
P82279,CRUM1_HUMAN,Protein crumbs homolog 1,1406,"154,183",5 out of 5,2001-10-18,Evidence at protein level
Q9Y5P2,CSAG2_HUMAN,Chondrosarcoma-associated gene 2/3 protein (Cancer/testis antigen 24.2) (CT24.2) (Taxol-resistant-associated gene 3 protein) (TRAG-3),127,"14,430",3 out of 5,2000-05-30,Evidence at transcript level
Q9P1W3,CSC1_HUMAN,Calcium permeable stress-gated cation channel 1 (Transmembrane protein 63C),806,"93,317",4 out of 5,2007-03-20,Evidence at transcript level
O94886,CSCL1_HUMAN,CSC1-like protein 1 (Transmembrane protein 63A),807,"92,126",5 out of 5,2007-03-20,Evidence at protein level
P15509,CSF2R_HUMAN,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha (GM-CSF-R-alpha) (GMCSFR-alpha) (GMR-alpha) (CDw116) (CD antigen CD116),400,"46,207",5 out of 5,1990-04-01,Evidence at protein level
O95196,CSPG5_HUMAN,Chondroitin sulfate proteoglycan 5 (Acidic leucine-rich EGF-like domain-containing brain protein) (Neuroglycan C),566,"60,016",5 out of 5,2005-09-27,Evidence at protein level
Q9H114,CST1L_HUMAN,Cystatin-like 1 (RCET11),145,"16,989",3 out of 5,2002-01-23,Evidence at transcript level
O60676,CST8_HUMAN,Cystatin-8 (Cystatin-related epididymal spermatogenic protein),142,"16,275",4 out of 5,2000-05-30,Evidence at protein level
Q9BUV8,CT024_HUMAN,Uncharacterized protein C20orf24 (Rab5-interacting protein) (RIP5),137,"15,487",2 out of 5,2002-10-19,Evidence at transcript level
Q8N268,CT197_HUMAN,Uncharacterized protein C20orf197,126,"14,459",1 out of 5,2007-02-20,Evidence at transcript level
Q5JQC4,CT47A_HUMAN,Cancer/testis antigen 47A (Cancer/testis antigen 47) (CT47),288,"30,100",4 out of 5,2007-04-17,Evidence at transcript level
O75638,CTAG2_HUMAN,Cancer/testis antigen 2 (CT2) (Autoimmunogenic cancer/testis antigen NY-ESO-2) (Cancer/testis antigen 6.2) (CT6.2) (L antigen family member 1) (LAGE-1),210,"21,061",3 out of 5,2000-05-30,Evidence at protein level
P0CG13,CTF8_HUMAN,Chromosome transmission fidelity protein 8 homolog (hCTF8),121,"13,314",4 out of 5,2010-06-15,Evidence at protein level
A4D2H0,CTGEF_HUMAN,cTAGE family member 15 (Protein cTAGE-15),777,"87,868",2 out of 5,2013-05-29,Evidence at transcript level
Q96LL3,CP092_HUMAN,Uncharacterized protein C16orf92,132,"14,383",2 out of 5,2008-02-26,Evidence at transcript level
Q07973,CP24A_HUMAN,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (24-OHase) (Vitamin D(3) 24-hydroxylase) (EC 1.14.15.16) (Cytochrome P450 24A1) (Cytochrome P450-CC24)",514,"58,875",5 out of 5,1996-10-01,Evidence at protein level
P20813,CP2B6_HUMAN,"Cytochrome P450 2B6 (EC 1.14.13.-) (1,4-cineole 2-exo-monooxygenase) (CYPIIB6) (Cytochrome P450 IIB1)",491,"56,278",5 out of 5,1991-02-01,Evidence at protein level
P11712,CP2C9_HUMAN,Cytochrome P450 2C9 (EC 1.14.13.-) ((R)-limonene 6-monooxygenase) (EC 1.14.13.80) ((S)-limonene 6-monooxygenase) (EC 1.14.13.48) ((S)-limonene 7-monooxygenase) (EC 1.14.13.49) (CYPIIC9) (Cholesterol 25-hydroxylase) (EC 1.14.99.38) (Cytochrome P-450MP) (Cytochrome P450 MP-4) (Cytochrome P450 MP-8) (Cytochrome P450 PB-1) (S-mephenytoin 4-hydroxylase),490,"55,628",5 out of 5,1989-10-01,Evidence at protein level
P78329,CP4F2_HUMAN,Phylloquinone omega-hydroxylase CYP4F2 (EC 1.14.13.194) (20-hydroxyeicosatetraenoic acid synthase) (20-HETE synthase) (EC 1.14.13.-) (Arachidonic acid omega-hydroxylase) (CYPIVF2) (Cytochrome P450 4F2) (Cytochrome P450-LTB-omega) (Leukotriene-B(4) 20-monooxygenase 1) (Leukotriene-B(4) omega-hydroxylase 1) (EC 1.14.13.30),520,"59,853",5 out of 5,1998-12-15,Evidence at protein level
Q86YQ8,CPNE8_HUMAN,Copine-8 (Copine VIII),564,"63,108",2 out of 5,2004-01-16,Evidence at protein level
A6NMK7,CPS4L_HUMAN,Putative cleavage and polyadenylation specificity factor subunit 4-like protein,179,"20,727",2 out of 5,2008-02-05,Evidence at transcript level
Q9P2I0,CPSF2_HUMAN,Cleavage and polyadenylation specificity factor subunit 2 (Cleavage and polyadenylation specificity factor 100 kDa subunit) (CPSF 100 kDa subunit),782,"88,487",5 out of 5,2001-10-18,Evidence at protein level
O43809,CPSF5_HUMAN,Cleavage and polyadenylation specificity factor subunit 5 (Cleavage and polyadenylation specificity factor 25 kDa subunit) (CFIm25) (CPSF 25 kDa subunit) (Nucleoside diphosphate-linked moiety X motif 21) (Nudix motif 21) (Pre-mRNA cleavage factor Im 25 kDa subunit),227,"26,227",5 out of 5,2006-02-07,Evidence at protein level
P31327,CPSM_HUMAN,"Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)",1500,"164,939",5 out of 5,1993-07-01,Evidence at protein level
Q8N436,CPXM2_HUMAN,Inactive carboxypeptidase-like protein X2,756,"85,870",3 out of 5,2003-01-17,Evidence at transcript level
A8MQB3,CQ051_HUMAN,Uncharacterized protein C17orf51,221,"24,325",1 out of 5,2008-04-29,Evidence at transcript level
Q9BZJ0,CRNL1_HUMAN,Crooked neck-like protein 1 (Crooked neck homolog) (hCrn),848,"100,452",5 out of 5,2003-02-01,Evidence at protein level
Q5TZA2,CROCC_HUMAN,Rootletin (Ciliary rootlet coiled-coil protein),2017,"228,523",5 out of 5,2006-06-13,Evidence at protein level
Q8TBR5,CSAS1_HUMAN,Putative uncharacterized protein CIRBP-AS1 (CIRBP antisense RNA 1) (CIRBP antisense gene protein 1),109,"12,399",1 out of 5,2005-07-19,Uncertain
Q9Y2W7,CSEN_HUMAN,Calsenilin (A-type potassium channel modulatory protein 3) (DRE-antagonist modulator) (DREAM) (Kv channel-interacting protein 3) (KChIP3),256,"29,231",5 out of 5,2001-04-27,Evidence at protein level
P07333,CSF1R_HUMAN,Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms) (CD antigen CD115),972,"107,984",5 out of 5,1988-04-01,Evidence at protein level
Q14406,CSHL_HUMAN,Chorionic somatomammotropin hormone-like 1 (Chorionic somatomammotropin-like) (Lactogen-like),222,"25,391",4 out of 5,2005-07-19,Evidence at transcript level
P68400,CSK21_HUMAN,Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1),391,"45,144",5 out of 5,2004-11-23,Evidence at protein level
Q8NEV1,CSK23_HUMAN,Casein kinase II subunit alpha 3 (CK II alpha 3) (EC 2.7.11.1) (Casein kinase II alpha 1 polypeptide pseudogene),391,"45,220",5 out of 5,2013-05-01,Evidence at protein level
Q96PZ7,CSMD1_HUMAN,CUB and sushi domain-containing protein 1 (CUB and sushi multiple domains protein 1),3565,"388,869",5 out of 5,2003-11-28,Evidence at protein level
Q7Z408,CSMD2_HUMAN,CUB and sushi domain-containing protein 2 (CUB and sushi multiple domains protein 2),3487,"380,039",4 out of 5,2003-11-28,Evidence at protein level
Q7Z407,CSMD3_HUMAN,CUB and sushi domain-containing protein 3 (CUB and sushi multiple domains protein 3),3707,"406,000",4 out of 5,2003-11-28,Evidence at transcript level
Q13098,CSN1_HUMAN,COP9 signalosome complex subunit 1 (SGN1) (Signalosome subunit 1) (G protein pathway suppressor 1) (GPS-1) (JAB1-containing signalosome subunit 1) (Protein MFH),491,"55,537",5 out of 5,1997-11-01,Evidence at protein level
P61201,CSN2_HUMAN,COP9 signalosome complex subunit 2 (SGN2) (Signalosome subunit 2) (Alien homolog) (JAB1-containing signalosome subunit 2) (Thyroid receptor-interacting protein 15) (TR-interacting protein 15) (TRIP-15),443,"51,597",5 out of 5,2004-05-10,Evidence at protein level
Q9UBW8,CSN7A_HUMAN,COP9 signalosome complex subunit 7a (SGN7a) (Signalosome subunit 7a) (Dermal papilla-derived protein 10) (JAB1-containing signalosome subunit 7a),275,"30,277",5 out of 5,2004-11-23,Evidence at protein level
Q9H175,CSRN2_HUMAN,Cysteine/serine-rich nuclear protein 2 (CSRNP-2) (Protein FAM130A1) (TGF-beta-induced apoptosis protein 12) (TAIP-12),543,"59,591",4 out of 5,2005-07-19,Evidence at protein level
Q12996,CSTF3_HUMAN,Cleavage stimulation factor subunit 3 (CF-1 77 kDa subunit) (Cleavage stimulation factor 77 kDa subunit) (CSTF 77 kDa subunit) (CstF-77),717,"82,922",5 out of 5,2005-07-19,Evidence at protein level
Q9H4D0,CSTN2_HUMAN,Calsyntenin-2 (Alcadein-gamma) (Alc-gamma),955,"107,006",5 out of 5,2002-09-19,Evidence at protein level
Q5DJT8,CT452_HUMAN,Cancer/testis antigen family 45 member A2 (Cancer/testis antigen 45-2) (Cancer/testis antigen 45A2),189,"21,363",2 out of 5,2007-10-23,Evidence at transcript level
P0DMU9,CT45A_HUMAN,Cancer/testis antigen family 45 member A10 (Cancer/testis antigen 45A10),189,"21,145",1 out of 5,2015-05-27,Evidence at protein level
Q8NI51,CTCFL_HUMAN,Transcriptional repressor CTCFL (Brother of the regulator of imprinted sites) (CCCTC-binding factor) (CTCF paralog) (CTCF-like protein) (Cancer/testis antigen 27) (CT27) (Zinc finger protein CTCF-T),663,"75,747",5 out of 5,2003-04-23,Evidence at protein level
Q9GZU7,CTDS1_HUMAN,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 3) (NLI-IF) (NLI-interacting factor 3) (Small C-terminal domain phosphatase 1) (SCP1) (Small CTD phosphatase 1),261,"29,203",5 out of 5,2001-12-13,Evidence at protein level
Q8WVB6,CTF18_HUMAN,Chromosome transmission fidelity protein 18 homolog (hCTF18) (CHL12),975,"107,383",5 out of 5,2008-06-10,Evidence at protein level
Q53GD3,CTL4_HUMAN,Choline transporter-like protein 4 (Solute carrier family 44 member 4),710,"79,254",5 out of 5,2005-08-30,Evidence at transcript level
Q6P387,CP046_HUMAN,Uncharacterized protein C16orf46,395,"43,418",3 out of 5,2007-03-06,Evidence at transcript level
Q6UWD8,CP054_HUMAN,Transmembrane protein C16orf54,224,"24,360",2 out of 5,2007-03-06,Evidence at protein level
Q6UX73,CP089_HUMAN,UPF0764 protein C16orf89,402,"45,391",4 out of 5,2008-03-18,Evidence at protein level
Q16678,CP1B1_HUMAN,Cytochrome P450 1B1 (EC 1.14.14.1) (CYPIB1),543,"60,846",5 out of 5,1998-12-15,Evidence at protein level
P20853,CP2A7_HUMAN,Cytochrome P450 2A7 (EC 1.14.14.1) (CYPIIA7) (Cytochrome P450 IIA4),494,"56,425",5 out of 5,1991-02-01,Evidence at transcript level
Q7Z449,CP2U1_HUMAN,Cytochrome P450 2U1 (EC 1.14.14.1),544,"61,987",5 out of 5,2007-06-26,Evidence at protein level
P20815,CP3A5_HUMAN,Cytochrome P450 3A5 (EC 1.14.14.1) (CYPIIIA5) (Cytochrome P450 HLp2) (Cytochrome P450-PCN3),502,"57,109",5 out of 5,1991-02-01,Evidence at protein level
Q9Y6A2,CP46A_HUMAN,Cholesterol 24-hydroxylase (CH24H) (EC 1.14.14.25) (Cytochrome P450 46A1),500,"56,821",5 out of 5,2001-01-24,Evidence at protein level
Q6ZWL3,CP4V2_HUMAN,Cytochrome P450 4V2 (EC 1.14.13.-) (Docosahexaenoic acid omega-hydroxylase CYP4V2) (EC 1.14.13.199),525,"60,724",5 out of 5,2005-08-02,Evidence at protein level
B2RV13,CQ105_HUMAN,Uncharacterized protein C17orf105,164,"19,546",1 out of 5,2010-03-23,Evidence at transcript level
Q96MF6,CQ10A_HUMAN,"Coenzyme Q-binding protein COQ10 homolog A, mitochondrial",247,"27,686",3 out of 5,2006-03-21,Evidence at transcript level
Q6ZTR6,CR065_HUMAN,Putative uncharacterized protein C18orf65,163,"17,236",1 out of 5,2014-11-26,Evidence at transcript level
Q2VPA4,CR1L_HUMAN,Complement component receptor 1-like protein (Complement C4b-binding protein CR-1-like protein),569,"62,714",5 out of 5,2008-02-05,Evidence at protein level
P17927,CR1_HUMAN,Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35),2039,"223,663",5 out of 5,1990-11-01,Evidence at protein level
P20023,CR2_HUMAN,Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21),1033,"112,916",5 out of 5,1991-02-01,Evidence at protein level
P78560,CRADD_HUMAN,Death domain-containing protein CRADD (Caspase and RIP adapter with death domain) (RIP-associated protein with a death domain),199,"22,745",5 out of 5,1997-11-01,Evidence at protein level
P53672,CRBA2_HUMAN,Beta-crystallin A2 (Beta-A2 crystallin),197,"22,096",4 out of 5,1996-10-01,Evidence at protein level
P06850,CRF_HUMAN,Corticoliberin (Corticotropin-releasing factor) (CRF) (Corticotropin-releasing hormone),196,"21,422",5 out of 5,1988-01-01,Evidence at protein level
Q9BVV8,CS024_HUMAN,Uncharacterized membrane protein C19orf24,132,"14,249",3 out of 5,2005-08-30,Evidence at protein level
Q9H6X5,CS044_HUMAN,Uncharacterized protein C19orf44,657,"71,343",2 out of 5,2007-06-26,Evidence at protein level
Q86XI8,CS068_HUMAN,Uncharacterized protein C19orf68,627,"70,073",2 out of 5,2008-02-26,Evidence at protein level
C9J6K1,CS081_HUMAN,Putative uncharacterized protein C19orf81,198,"22,444",1 out of 5,2011-10-19,Predicted
Q5T3F8,CSCL2_HUMAN,CSC1-like protein 2 (Transmembrane protein 63B),832,"94,958",4 out of 5,2007-03-20,Evidence at protein level
P04141,CSF2_HUMAN,Granulocyte-macrophage colony-stimulating factor (GM-CSF) (Colony-stimulating factor) (CSF) (Molgramostin) (Sargramostim),144,"16,295",5 out of 5,1986-11-01,Evidence at protein level
Q9H9Q2,CSN7B_HUMAN,COP9 signalosome complex subunit 7b (SGN7b) (Signalosome subunit 7b) (JAB1-containing signalosome subunit 7b),264,"29,622",5 out of 5,2004-11-23,Evidence at protein level
P0DMU7,CT456_HUMAN,Cancer/testis antigen family 45 member A6 (Cancer/testis antigen 45-6) (Cancer/testis antigen 45A6),189,"21,232",2 out of 5,2015-05-27,Evidence at transcript level
Q8WUE5,CT55_HUMAN,Cancer/testis antigen 55 (Tumor antigen BJ-HCC-20),264,"29,052",2 out of 5,2005-07-05,Evidence at protein level
Q9Y5B0,CTDP1_HUMAN,RNA polymerase II subunit A C-terminal domain phosphatase (EC 3.1.3.16) (TFIIF-associating CTD phosphatase),961,"104,399",5 out of 5,2004-04-13,Evidence at protein level
Q5T4H9,CSC10_HUMAN,Protein CASC10 (Cancer susceptibility candidate gene 10 protein),136,"14,851",1 out of 5,2006-07-25,Evidence at transcript level
P09603,CSF1_HUMAN,Macrophage colony-stimulating factor 1 (CSF-1) (M-CSF) (MCSF) (Lanimostim) [Cleaved into: Processed macrophage colony-stimulating factor 1],554,"60,179",5 out of 5,1989-07-01,Evidence at protein level
Q8WXD9,CSKI1_HUMAN,Caskin-1 (CASK-interacting protein 1),1431,"149,814",3 out of 5,2005-03-15,Evidence at protein level
Q9UNS2,CSN3_HUMAN,COP9 signalosome complex subunit 3 (SGN3) (Signalosome subunit 3) (JAB1-containing signalosome subunit 3),423,"47,873",5 out of 5,2004-11-23,Evidence at protein level
Q16527,CSRP2_HUMAN,Cysteine and glycine-rich protein 2 (Cysteine-rich protein 2) (CRP2) (LIM domain only protein 5) (LMO-5) (Smooth muscle cell LIM protein) (SmLIM),193,"20,954",4 out of 5,1997-11-01,Evidence at protein level
P50461,CSRP3_HUMAN,"Cysteine and glycine-rich protein 3 (Cardiac LIM protein) (Cysteine-rich protein 3) (CRP3) (LIM domain protein, cardiac) (Muscle LIM protein)",194,"20,969",5 out of 5,1996-10-01,Evidence at protein level
Q9UGB4,CT187_HUMAN,Putative uncharacterized protein C20orf187,50,"5,874",1 out of 5,2007-03-20,Predicted
Q8IYI0,CT196_HUMAN,Uncharacterized protein C20orf196,205,"22,938",2 out of 5,2007-05-15,Evidence at transcript level
Q5HYN5,CT451_HUMAN,Cancer/testis antigen family 45 member A1 (Cancer/testis antigen 45-1) (Cancer/testis antigen 45A1),189,"21,273",2 out of 5,2007-10-23,Evidence at transcript level
P0DMV1,CT458_HUMAN,Cancer/testis antigen family 45 member A8 (Cancer/testis antigen 45A8),189,"21,363",1 out of 5,2015-05-27,Inferred from homology
Q96RT6,CTGE2_HUMAN,cTAGE family member 2 (Protein cTAGE-2) (Cancer/testis antigen 21.2) (CT21.2),745,"85,282",3 out of 5,2005-01-04,Evidence at protein level
P0CG41,CTGE8_HUMAN,cTAGE family member 8 (Protein cTAGE-8),777,"88,077",2 out of 5,2010-07-13,Inferred from homology
Q9UQB3,CTND2_HUMAN,Catenin delta-2 (Delta-catenin) (GT24) (Neural plakophilin-related ARM-repeat protein) (NPRAP) (Neurojungin),1225,"132,656",5 out of 5,2002-04-16,Evidence at protein level
Q8WY07,CTR3_HUMAN,Cationic amino acid transporter 3 (CAT-3) (CAT3) (Cationic amino acid transporter y+) (Solute carrier family 7 member 3),619,"67,169",5 out of 5,2004-01-16,Evidence at protein level
Q2VPK5,CTU2_HUMAN,Cytoplasmic tRNA 2-thiolation protein 2 (Cytosolic thiouridylase subunit 2),515,"56,107",5 out of 5,2007-05-29,Evidence at protein level
P25025,CXCR2_HUMAN,C-X-C chemokine receptor type 2 (CXC-R2) (CXCR-2) (CDw128b) (GRO/MGSA receptor) (High affinity interleukin-8 receptor B) (IL-8R B) (IL-8 receptor type 2) (CD antigen CD182),360,"40,759",5 out of 5,1992-05-01,Evidence at protein level
P36383,CXG1_HUMAN,Gap junction gamma-1 protein (Connexin-45) (Cx45) (Gap junction alpha-7 protein),396,"45,470",5 out of 5,1994-06-01,Evidence at protein level
O14625,CXL11_HUMAN,C-X-C motif chemokine 11 (Beta-R1) (H174) (Interferon gamma-inducible protein 9) (IP-9) (Interferon-inducible T-cell alpha chemoattractant) (I-TAC) (Small-inducible cytokine B11),94,"10,365",5 out of 5,2000-05-30,Evidence at protein level
P04839,CY24B_HUMAN,Cytochrome b-245 heavy chain (EC 1.-.-.-) (CGD91-phox) (Cytochrome b(558) subunit beta) (Cytochrome b558 subunit beta) (Heme-binding membrane glycoprotein gp91phox) (NADPH oxidase 2) (Neutrophil cytochrome b 91 kDa polypeptide) (Superoxide-generating NADPH oxidase heavy chain subunit) (gp91-1) (gp91-phox) (p22 phagocyte B-cytochrome),570,"65,336",5 out of 5,1987-08-13,Evidence at protein level
Q9UIA0,CYH4_HUMAN,"Cytohesin-4 (PH, SEC7 and coiled-coil domain-containing protein 4)",394,"45,672",4 out of 5,2001-02-21,Evidence at transcript level
O76096,CYTF_HUMAN,Cystatin-F (Cystatin-7) (Cystatin-like metastasis-associated protein) (CMAP) (Leukocystatin),145,"16,454",5 out of 5,1998-12-15,Evidence at protein level
Q8NET1,D108B_HUMAN,"Beta-defensin 108B (Beta-defensin 8) (BD-8) (DEFB-8) (hBD-8) (Defensin, beta 108) (Defensin, beta 108B)",73,"8,326",3 out of 5,2002-12-06,Evidence at transcript level
Q8N136,DAW1_HUMAN,Dynein assembly factor with WDR repeat domains 1 (Outer row dynein assembly protein 16 homolog) (WD repeat-containing protein 69),415,"45,777",4 out of 5,2006-06-27,Evidence at protein level
Q9NQZ3,DAZ1_HUMAN,Deleted in azoospermia protein 1,744,"82,764",5 out of 5,2004-03-01,Evidence at protein level
Q8N687,DB125_HUMAN,"Beta-defensin 125 (Beta-defensin 25) (DEFB-25) (Defensin, beta 125)",156,"17,537",3 out of 5,2002-12-06,Evidence at transcript level
Q4QY38,DB134_HUMAN,"Beta-defensin 134 (Defensin, beta 134)",66,"7,552",2 out of 5,2005-12-20,Inferred from homology
Q9BQY9,DBND2_HUMAN,Dysbindin domain-containing protein 2 (Casein kinase-1 binding protein) (CK1BP) (HSMNP1),259,"27,671",4 out of 5,2003-07-11,Evidence at protein level
Q9UJ94,CU104_HUMAN,Putative uncharacterized protein encoded by LINC00527,153,"16,537",1 out of 5,2008-07-22,Uncertain
A6NGU7,CX028_HUMAN,Putative uncharacterized protein encoded by LINC01546,62,"7,222",1 out of 5,2008-04-08,Predicted
Q96DE9,CX04B_HUMAN,Protein CXorf40B,158,"17,780",1 out of 5,2005-06-21,Evidence at transcript level
Q96LI9,CX058_HUMAN,Putative uncharacterized protein CXorf58,332,"38,899",1 out of 5,2007-01-09,Evidence at transcript level
Q96F07,CYFP2_HUMAN,Cytoplasmic FMR1-interacting protein 2 (p53-inducible protein 121),1278,"148,399",5 out of 5,2007-03-06,Evidence at protein level
Q717R9,CYS1_HUMAN,Cystin-1 (Cilia-associated protein),158,"16,393",4 out of 5,2006-11-28,Evidence at protein level
Q69YQ0,CYTSA_HUMAN,Cytospin-A (Renal carcinoma antigen NY-REN-22) (Sperm antigen with calponin homology and coiled-coil domains 1-like) (SPECC1-like protein),1117,"124,602",5 out of 5,2006-04-04,Evidence at protein level
Q14118,DAG1_HUMAN,Dystroglycan (Dystrophin-associated glycoprotein 1) [Cleaved into: Alpha-dystroglycan (Alpha-DG); Beta-dystroglycan (Beta-DG)],895,"97,441",5 out of 5,1997-11-01,Evidence at protein level
C9J442,CV046_HUMAN,Uncharacterized protein C22orf46,243,"27,532",2 out of 5,2010-05-18,Evidence at transcript level
Q6YFQ2,CX6B2_HUMAN,"Cytochrome c oxidase subunit 6B2 (Cancer/testis antigen 59) (CT59) (Cytochrome c oxidase subunit VIb isoform 2) (COX VIb-2) (Cytochrome c oxidase subunit VIb, testis-specific isoform)",88,"10,529",3 out of 5,2005-10-11,Evidence at protein level
P48165,CXA8_HUMAN,Gap junction alpha-8 protein (Connexin-50) (Cx50) (Lens fiber protein MP70),433,"48,229",5 out of 5,1996-02-01,Evidence at protein level
P78310,CXAR_HUMAN,Coxsackievirus and adenovirus receptor (CAR) (hCAR) (CVB3-binding protein) (Coxsackievirus B-adenovirus receptor) (HCVADR),365,"40,030",5 out of 5,2000-05-30,Evidence at protein level
P08034,CXB1_HUMAN,Gap junction beta-1 protein (Connexin-32) (Cx32) (GAP junction 28 kDa liver protein),283,"32,025",5 out of 5,1988-08-01,Evidence at protein level
Q6UXB2,CXL17_HUMAN,C-X-C motif chemokine 17 (6-Cys CXCL17) (Dendritic cell and monocyte chemokine-like protein) (DMC) (VEGF coregulated chemokine 1) [Cleaved into: 4-Cys CXCL17],119,"13,819",5 out of 5,2007-11-13,Evidence at protein level
Q53TN4,CYBR1_HUMAN,Cytochrome b reductase 1 (EC 1.-.-.-) (Duodenal cytochrome b) (Ferric-chelate reductase 3),286,"31,641",5 out of 5,2008-01-15,Evidence at protein level
O43739,CYH3_HUMAN,"Cytohesin-3 (ARF nucleotide-binding site opener 3) (Protein ARNO3) (General receptor of phosphoinositides 1) (Grp1) (PH, SEC7 and coiled-coil domain-containing protein 3)",400,"46,349",5 out of 5,2001-02-21,Evidence at protein level
P04080,CYTB_HUMAN,Cystatin-B (CPI-B) (Liver thiol proteinase inhibitor) (Stefin-B),98,"11,140",5 out of 5,1986-11-01,Evidence at protein level
Q5M775,CYTSB_HUMAN,Cytospin-B (Nuclear structure protein 5) (NSP5) (Sperm antigen HCMOGT-1) (Sperm antigen with calponin homology and coiled-coil domains 1),1068,"118,585",5 out of 5,2006-10-31,Evidence at protein level
O75553,DAB1_HUMAN,Disabled homolog 1,588,"63,775",5 out of 5,2002-02-11,Evidence at protein level
Q9NYF0,DACT1_HUMAN,Dapper homolog 1 (hDPR1) (Dapper antagonist of catenin 1) (Hepatocellular carcinoma novel gene 3 protein),836,"90,174",5 out of 5,2003-08-15,Evidence at protein level
Q99062,CSF3R_HUMAN,Granulocyte colony-stimulating factor receptor (G-CSF receptor) (G-CSF-R) (CD antigen CD114),836,"92,156",5 out of 5,1995-02-01,Evidence at protein level
Q4G0I0,CSMT1_HUMAN,Protein CCSMST1,132,"15,004",2 out of 5,2008-09-02,Evidence at transcript level
Q6UVK1,CSPG4_HUMAN,Chondroitin sulfate proteoglycan 4 (Chondroitin sulfate proteoglycan NG2) (Melanoma chondroitin sulfate proteoglycan) (Melanoma-associated chondroitin sulfate proteoglycan),2322,"250,537",5 out of 5,2005-09-13,Evidence at protein level
Q4KN68,CT062_HUMAN,Uncharacterized protein encoded by LINC01620,170,"19,514",1 out of 5,2006-04-18,Evidence at transcript level
Q9BQM9,CT144_HUMAN,Uncharacterized protein C20orf144 (Bcl-2-like protein from testis) (Bclt),153,"17,214",1 out of 5,2002-10-19,Evidence at transcript level
Q2NKJ3,CTC1_HUMAN,CST complex subunit CTC1 (Conserved telomere maintenance component 1) (HBV DNAPTP1-transactivated protein B),1217,"134,609",5 out of 5,2007-05-15,Evidence at protein level
P78358,CTG1B_HUMAN,Cancer/testis antigen 1 (Autoimmunogenic cancer/testis antigen NY-ESO-1) (Cancer/testis antigen 6.1) (CT6.1) (L antigen family member 2) (LAGE-2),180,"17,992",5 out of 5,1998-12-15,Evidence at protein level
P59089,CU086_HUMAN,Putative uncharacterized protein encoded by LINC00205,165,"18,635",1 out of 5,2002-11-08,Uncertain
O60494,CUBN_HUMAN,Cubilin (460 kDa receptor) (Intestinal intrinsic factor receptor) (Intrinsic factor-cobalamin receptor) (Intrinsic factor-vitamin B12 receptor),3623,"398,736",5 out of 5,2006-02-07,Evidence at protein level
O60888,CUTA_HUMAN,Protein CutA (Acetylcholinesterase-associated protein) (Brain acetylcholinesterase putative membrane anchor),179,"19,116",5 out of 5,2005-03-15,Evidence at protein level
Q8WYQ4,CV015_HUMAN,Uncharacterized protein C22orf15 (Protein N27C7-3),148,"16,487",2 out of 5,2005-07-05,Evidence at transcript level
Q6P5X5,CV039_HUMAN,UPF0545 protein C22orf39,142,"16,805",3 out of 5,2008-03-18,Evidence at protein level
A8MYA2,CX049_HUMAN,Uncharacterized protein CXorf49,514,"54,417",1 out of 5,2008-07-22,Evidence at transcript level
P49682,CXCR3_HUMAN,C-X-C chemokine receptor type 3 (CXC-R3) (CXCR-3) (CKR-L2) (G protein-coupled receptor 9) (Interferon-inducible protein 10 receptor) (IP-10 receptor) (CD antigen CD183),368,"40,660",5 out of 5,1996-02-01,Evidence at protein level
Q9H2A7,CXL16_HUMAN,C-X-C motif chemokine 16 (Scavenger receptor for phosphatidylserine and oxidized low density lipoprotein) (SR-PSOX) (Small-inducible cytokine B16) (Transmembrane chemokine CXCL16),254,"27,579",5 out of 5,2001-12-05,Evidence at transcript level
P35663,CYLC1_HUMAN,Cylicin-1 (Cylicin I) (Multiple-band polypeptide I),651,"74,242",4 out of 5,1994-06-01,Evidence at transcript level
Q9NQC7,CYLD_HUMAN,Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD),956,"107,316",5 out of 5,2004-08-16,Evidence at protein level
Q9NRR1,CYTL1_HUMAN,Cytokine-like protein 1 (Protein C17),136,"15,577",3 out of 5,2002-06-06,Evidence at protein level
Q9H1C7,CYTM1_HUMAN,Cysteine-rich and transmembrane domain-containing protein 1,97,"10,631",3 out of 5,2007-07-24,Evidence at protein level
P01036,CYTS_HUMAN,Cystatin-S (Cystatin-4) (Cystatin-SA-III) (Salivary acidic protein 1),141,"16,214",5 out of 5,1986-07-21,Evidence at protein level
Q6UX52,CQ099_HUMAN,Uncharacterized protein C17orf99,265,"29,091",2 out of 5,2007-01-23,Evidence at protein level
Q02930,CREB5_HUMAN,Cyclic AMP-responsive element-binding protein 5 (CREB-5) (cAMP-responsive element-binding protein 5) (CRE-BPa),508,"56,918",5 out of 5,2004-04-13,Evidence at protein level
Q9Y4F4,CREC1_HUMAN,Crescerin-1 (Protein FAM179B),1720,"189,360",4 out of 5,2006-10-03,Evidence at protein level
P24387,CRHBP_HUMAN,Corticotropin-releasing factor-binding protein (CRF-BP) (CRF-binding protein) (Corticotropin-releasing hormone-binding protein) (CRH-BP),322,"36,144",5 out of 5,1992-03-01,Evidence at protein level
O75718,CRTAP_HUMAN,Cartilage-associated protein,401,"46,562",5 out of 5,2001-10-18,Evidence at protein level
A8MQ03,CRTP1_HUMAN,Cysteine-rich tail protein 1,144,"15,313",2 out of 5,2008-04-29,Evidence at protein level
Q9BQ61,CS043_HUMAN,Uncharacterized protein C19orf43,176,"18,419",2 out of 5,2007-03-20,Evidence at protein level
A6NCJ1,CS071_HUMAN,Uncharacterized protein C19orf71,209,"24,176",1 out of 5,2008-04-29,Predicted
Q8WXC6,CSN9_HUMAN,COP9 signalosome complex subunit 9 (CSN acidic protein) (CSNAP) (Myeloma-overexpressed gene 2 protein),57,"6,211",5 out of 5,2008-04-29,Evidence at protein level
Q9H4R4,CT191_HUMAN,Putative nuclear receptor corepressor 1-like protein NCOR1P1 (Nuclear receptor corepressor 1 pseudogene 1),102,"11,336",2 out of 5,2007-01-09,Uncertain
Q9P2B4,CT2NL_HUMAN,CTTNBP2 N-terminal-like protein,639,"70,158",5 out of 5,2006-03-07,Evidence at protein level
P0DMV0,CT457_HUMAN,Cancer/testis antigen family 45 member A7 (Cancer/testis antigen 45A7),189,"21,232",1 out of 5,2015-05-27,Inferred from homology
Q96CG8,CTHR1_HUMAN,Collagen triple helix repeat-containing protein 1 (Protein NMTC1),243,"26,224",5 out of 5,2005-05-10,Evidence at protein level
Q6IC83,CV042_HUMAN,Uncharacterized protein C22orf42,251,"27,691",1 out of 5,2008-07-22,Evidence at transcript level
Q9HCG8,CWC22_HUMAN,Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb),908,"105,466",5 out of 5,2007-09-11,Evidence at protein level
Q9H5V9,CX056_HUMAN,UPF0428 protein CXorf56,222,"25,625",2 out of 5,2007-05-15,Evidence at protein level
P24310,CX7A1_HUMAN,"Cytochrome c oxidase subunit 7A1, mitochondrial (Cytochrome c oxidase subunit VIIa-heart) (Cytochrome c oxidase subunit VIIa-H) (Cytochrome c oxidase subunit VIIa-muscle) (Cytochrome c oxidase subunit VIIa-M)",79,"9,118",4 out of 5,1992-03-01,Evidence at protein level
P14406,CX7A2_HUMAN,"Cytochrome c oxidase subunit 7A2, mitochondrial (Cytochrome c oxidase subunit VIIa-liver/heart) (Cytochrome c oxidase subunit VIIa-L) (Cytochrome c oxidase subunit VIIaL)",83,"9,396",4 out of 5,1990-01-01,Evidence at protein level
P17302,CXA1_HUMAN,Gap junction alpha-1 protein (Connexin-43) (Cx43) (Gap junction 43 kDa heart protein),382,"43,008",5 out of 5,1990-08-01,Evidence at protein level
P36382,CXA5_HUMAN,Gap junction alpha-5 protein (Connexin-40) (Cx40),358,"40,380",5 out of 5,1994-06-01,Evidence at protein level
Q7LFL8,CXXC5_HUMAN,CXXC-type zinc finger protein 5 (CF5) (Putative MAPK-activating protein PM08) (Putative NF-kappa-B-activating protein 102) (Retinoid-inducible nuclear factor) (RINF),322,"32,977",5 out of 5,2008-02-05,Evidence at protein level
Q7L576,CYFP1_HUMAN,Cytoplasmic FMR1-interacting protein 1 (Specifically Rac1-associated protein 1) (Sra-1) (p140sra-1),1253,"145,182",5 out of 5,2007-03-06,Evidence at protein level
Q6XLA1,CSC2A_HUMAN,"Protein CASC2, isoform 3 (Cancer susceptibility candidate gene 2 protein, isoform 3)",102,"11,902",2 out of 5,2008-03-18,Evidence at transcript level
O75534,CSDE1_HUMAN,Cold shock domain-containing protein E1 (N-ras upstream gene protein) (Protein UNR),798,"88,885",5 out of 5,2000-05-30,Evidence at protein level
P33240,CSTF2_HUMAN,Cleavage stimulation factor subunit 2 (CF-1 64 kDa subunit) (Cleavage stimulation factor 64 kDa subunit) (CSTF 64 kDa subunit) (CstF-64),577,"60,959",5 out of 5,1994-02-01,Evidence at protein level
Q9BQT9,CSTN3_HUMAN,Calsyntenin-3 (Alcadein-beta) (Alc-beta),956,"106,098",5 out of 5,2002-09-19,Evidence at protein level
Q9H1P6,CT085_HUMAN,Uncharacterized protein C20orf85,137,"15,719",1 out of 5,2003-01-10,Evidence at transcript level
P0C5K6,CT18_HUMAN,Putative tumor antigen NA88-A (Cancer/testis antigen 18) (CT18),33,"3,500",1 out of 5,2007-10-23,Uncertain
A1L168,CT202_HUMAN,Uncharacterized protein C20orf202,122,"13,591",1 out of 5,2008-05-20,Evidence at transcript level
P0DMV2,CT459_HUMAN,Cancer/testis antigen family 45 member A9 (Cancer/testis antigen 45A9),189,"21,363",1 out of 5,2015-05-27,Inferred from homology
P0CG12,CTF8A_HUMAN,Chromosome transmission fidelity protein 8 homolog isoform 2 (Decreased expression in renal and prostate cancer protein),524,"51,391",4 out of 5,2010-06-15,Evidence at protein level
Q86UF2,CTGE6_HUMAN,cTAGE family member 6 (Protein cTAGE-6),777,"87,900",2 out of 5,2005-01-04,Evidence at transcript level
Q8WWI5,CTL1_HUMAN,Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92),657,"73,302",5 out of 5,2005-08-30,Evidence at protein level
P16410,CTLA4_HUMAN,Cytotoxic T-lymphocyte protein 4 (Cytotoxic T-lymphocyte-associated antigen 4) (CTLA-4) (CD antigen CD152),223,"24,656",5 out of 5,1990-08-01,Evidence at protein level
P35221,CTNA1_HUMAN,Catenin alpha-1 (Alpha E-catenin) (Cadherin-associated protein) (Renal carcinoma antigen NY-REN-13),906,"100,071",5 out of 5,1994-02-01,Evidence at protein level
O43246,CTR4_HUMAN,Cationic amino acid transporter 4 (CAT-4) (CAT4) (Solute carrier family 7 member 4),635,"68,268",3 out of 5,2001-01-24,Evidence at transcript level
P58513,CU042_HUMAN,Putative uncharacterized protein encoded by LINC00158,81,"9,586",1 out of 5,2002-01-23,Uncertain
Q8TCZ7,CU074_HUMAN,Putative uncharacterized protein encoded by LINC00308,52,"5,991",2 out of 5,2004-03-15,Uncertain
P59091,CU093_HUMAN,Putative uncharacterized protein encoded by LINC00315,139,"15,087",1 out of 5,2002-11-15,Uncertain
Q9NXE8,CWC25_HUMAN,Pre-mRNA-splicing factor CWC25 homolog (Coiled-coil domain-containing protein 49) (Spliceosome-associated protein homolog CWC25),425,"49,647",3 out of 5,2007-05-29,Evidence at protein level
Q86X51,CX067_HUMAN,Uncharacterized protein CXorf67,503,"51,894",2 out of 5,2008-02-26,Evidence at protein level
P14854,CX6B1_HUMAN,Cytochrome c oxidase subunit 6B1 (Cytochrome c oxidase subunit VIb isoform 1) (COX VIb-1),86,"10,192",4 out of 5,1990-04-01,Evidence at protein level
Q8TF08,CX7B2_HUMAN,"Cytochrome c oxidase subunit 7B2, mitochondrial (Cytochrome c oxidase polypeptide VIIb2)",81,"9,077",3 out of 5,2004-06-07,Inferred from homology
Q9NTQ9,CXB4_HUMAN,Gap junction beta-4 protein (Connexin-30.3) (Cx30.3),266,"30,419",5 out of 5,2001-01-11,Evidence at protein level
P32302,CXCR5_HUMAN,C-X-C chemokine receptor type 5 (CXC-R5) (CXCR-5) (Burkitt lymphoma receptor 1) (Monocyte-derived receptor 15) (MDR-15) (CD antigen CD185),372,"41,955",5 out of 5,1993-10-01,Evidence at protein level
Q9UKL4,CXD2_HUMAN,Gap junction delta-2 protein (Connexin-36) (Cx36) (Gap junction alpha-9 protein),321,"36,093",4 out of 5,2000-12-01,Evidence at protein level
Q8N144,CXD3_HUMAN,Gap junction delta-3 protein (Connexin-31.9) (Cx31.9) (Gap junction alpha-11 protein) (Gap junction chi-1 protein),294,"31,933",5 out of 5,2008-01-15,Evidence at protein level
Q5T442,CXG2_HUMAN,Gap junction gamma-2 protein (Connexin-46.6) (Cx46.6) (Connexin-47) (Cx47) (Gap junction alpha-12 protein),439,"47,002",5 out of 5,2005-11-08,Evidence at protein level
P08574,CY1_HUMAN,"Cytochrome c1, heme protein, mitochondrial (Complex III subunit 4) (Complex III subunit IV) (Cytochrome b-c1 complex subunit 4) (Ubiquinol-cytochrome-c reductase complex cytochrome c1 subunit) (Cytochrome c-1)",325,"35,422",5 out of 5,1988-08-01,Evidence at protein level
J3KSC0,CR064_HUMAN,Putative uncharacterized protein encoded by LINC01387,135,"14,903",1 out of 5,2013-06-26,Uncertain
P53673,CRBA4_HUMAN,Beta-crystallin A4 (Beta-A4 crystallin),196,"22,374",5 out of 5,1996-10-01,Evidence at protein level
Q8IUR6,CRERF_HUMAN,CREB3 regulatory factor (Luman recruitment factor) (LRF),639,"72,149",5 out of 5,2007-09-11,Evidence at protein level
Q6UUV7,CRTC3_HUMAN,CREB-regulated transcription coactivator 3 (Transducer of regulated cAMP response element-binding protein 3) (TORC-3) (Transducer of CREB protein 3),619,"66,959",5 out of 5,2008-02-05,Evidence at protein level
A6NJJ6,CS067_HUMAN,UPF0575 protein C19orf67,358,"39,779",1 out of 5,2008-04-29,Inferred from homology
Q9NVV2,CS073_HUMAN,Putative uncharacterized protein C19orf73,129,"13,750",2 out of 5,2008-09-02,Evidence at protein level
Q96S65,CSRN1_HUMAN,Cysteine/serine-rich nuclear protein 1 (CSRNP-1) (Axin-1 up-regulated gene 1 protein) (Protein URAX1) (TGF-beta-induced apoptosis protein 3) (TAIP-3),589,"63,508",4 out of 5,2002-10-25,Evidence at protein level
P21291,CSRP1_HUMAN,Cysteine and glycine-rich protein 1 (Cysteine-rich protein 1) (CRP) (CRP1) (Epididymis luminal protein 141) (HEL-141),193,"20,567",5 out of 5,1991-05-01,Evidence at protein level
Q5W186,CST9_HUMAN,Cystatin-9 (Cystatin-like molecule),159,"18,135",3 out of 5,2008-01-15,Evidence at transcript level
Q05048,CSTF1_HUMAN,Cleavage stimulation factor subunit 1 (CF-1 50 kDa subunit) (Cleavage stimulation factor 50 kDa subunit) (CSTF 50 kDa subunit) (CstF-50),431,"48,358",5 out of 5,1994-02-01,Evidence at protein level
O94985,CSTN1_HUMAN,Calsyntenin-1 (Alcadein-alpha) (Alc-alpha) (Alzheimer-related cadherin-like protein) (Non-classical cadherin XB31alpha) [Cleaved into: Soluble Alc-alpha (SAlc-alpha); CTF1-alpha (C-terminal fragment 1-alpha)],981,"109,793",5 out of 5,2002-09-19,Evidence at protein level
Q9BR46,CT078_HUMAN,Putative uncharacterized protein C20orf78,151,"17,183",1 out of 5,2002-09-19,Predicted
Q9NUB4,CT141_HUMAN,Uncharacterized protein C20orf141,165,"17,394",2 out of 5,2003-01-10,Evidence at transcript level
Q5TEA3,CT194_HUMAN,Uncharacterized protein C20orf194,1177,"132,287",2 out of 5,2006-05-16,Evidence at protein level
Q8NHU0,CT453_HUMAN,Cancer/testis antigen family 45 member A3 (Cancer/testis antigen 45-3) (Cancer/testis antigen 45-4) (Cancer/testis antigen 45A3) (Cancer/testis antigen 45A4) (Cancer/testis antigen family 45 member A4),189,"21,331",3 out of 5,2007-10-23,Evidence at protein level
P0C5K7,CT62_HUMAN,Cancer/testis antigen 62 (CT62),136,"15,412",1 out of 5,2007-11-13,Evidence at transcript level
Q13363,CTBP1_HUMAN,C-terminal-binding protein 1 (CtBP1) (EC 1.1.1.-),440,"47,535",5 out of 5,1998-07-15,Evidence at protein level
O15194,CTDSL_HUMAN,CTD small phosphatase-like protein (CTDSP-like) (EC 3.1.3.16) (Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 3) (NIF-like protein) (Nuclear LIM interactor-interacting factor 1) (NLI-interacting factor 1) (Protein YA22) (hYA22) (RBSP3) (Small C-terminal domain phosphatase 3) (SCP3) (Small CTD phosphatase 3),276,"31,129",5 out of 5,2001-12-13,Evidence at protein level
Q8IX95,CTGE3_HUMAN,Putative cTAGE family member 3 (Protein cTAGE-3),158,"18,015",2 out of 5,2005-01-04,Uncertain
O15320,CTGE5_HUMAN,cTAGE family member 5 (Protein cTAGE-5) (Meningioma-expressed antigen 6/11),804,"90,996",5 out of 5,2001-04-27,Evidence at protein level
P29279,CTGF_HUMAN,Connective tissue growth factor (CCN family member 2) (Hypertrophic chondrocyte-specific protein 24) (Insulin-like growth factor-binding protein 8) (IBP-8) (IGF-binding protein 8) (IGFBP-8),349,"38,091",5 out of 5,1992-12-01,Evidence at protein level
Q99708,CTIP_HUMAN,DNA endonuclease RBBP8 (EC 3.1.-.-) (CtBP-interacting protein) (CtIP) (Retinoblastoma-binding protein 8) (RBBP-8) (Retinoblastoma-interacting protein and myosin-like) (RIM) (Sporulation in the absence of SPO11 protein 2 homolog) (SAE2),897,"101,942",5 out of 5,2000-12-01,Evidence at protein level
P57076,CU059_HUMAN,UPF0769 protein C21orf59,290,"33,224",3 out of 5,2000-12-01,Evidence at protein level
P58512,CU067_HUMAN,Uncharacterized protein encoded by LINC01547,204,"21,308",2 out of 5,2002-01-23,Evidence at transcript level
Q96M42,CU129_HUMAN,Putative uncharacterized protein encoded by LINC00479,142,"15,208",1 out of 5,2005-06-21,Uncertain
O95567,CV031_HUMAN,Uncharacterized protein C22orf31,290,"32,655",1 out of 5,2006-10-31,Evidence at transcript level
Q9P013,CWC15_HUMAN,Spliceosome-associated protein CWC15 homolog,229,"26,624",5 out of 5,2007-06-26,Evidence at protein level
Q9HAI6,CX021_HUMAN,Uncharacterized protein CXorf21,301,"33,894",1 out of 5,2006-10-03,Evidence at transcript level
Q8TB33,CX024_HUMAN,Putative uncharacterized protein encoded by LINC01560,94,"10,359",1 out of 5,2008-04-08,Predicted
Q8TE69,CX04A_HUMAN,Protein CXorf40A (Endothelial-overexpressed lipopolysaccharide-associated factor 1),158,"17,921",3 out of 5,2005-06-21,Evidence at protein level
Q969M2,CXA10_HUMAN,Gap junction alpha-10 protein (Connexin-62) (Cx62),543,"61,872",3 out of 5,2008-01-15,Evidence at transcript level
O95452,CXB6_HUMAN,Gap junction beta-6 protein (Connexin-30) (Cx30),261,"30,387",5 out of 5,1999-07-15,Evidence at protein level
P42830,CXCL5_HUMAN,C-X-C motif chemokine 5 (ENA-78(1-78)) (Epithelial-derived neutrophil-activating protein 78) (Neutrophil-activating peptide ENA-78) (Small-inducible cytokine B5) [Cleaved into: ENA-78(8-78); ENA-78(9-78)],114,"11,972",5 out of 5,1995-11-01,Evidence at protein level
O43169,CYB5B_HUMAN,Cytochrome b5 type B (Cytochrome b5 outer mitochondrial membrane isoform),146,"16,332",4 out of 5,2001-01-11,Evidence at protein level
Q9HB71,CYBP_HUMAN,Calcyclin-binding protein (CacyBP) (hCacyBP) (S100A6-binding protein) (Siah-interacting protein),228,"26,210",5 out of 5,2004-04-26,Evidence at protein level
Q6PB30,CSAG1_HUMAN,Putative chondrosarcoma-associated gene 1 protein (Cancer/testis antigen 24.1) (CT24.1) (Cancer/testis antigen CSAGE),78,"8,669",2 out of 5,2007-06-26,Evidence at transcript level
Q8WYN3,CSRN3_HUMAN,Cysteine/serine-rich nuclear protein 3 (CSRNP-3) (Protein FAM130A2) (TGF-beta-induced apoptosis protein 2) (TAIP-2),585,"64,900",4 out of 5,2002-10-25,Evidence at transcript level
Q9H112,CST11_HUMAN,Cystatin-11,138,"16,506",3 out of 5,2002-01-23,Evidence at protein level
Q5W188,CST9P_HUMAN,Putative cystatin-9-like protein CST9LP1 (Cystatin-9-like pseudogene 1),147,"17,316",2 out of 5,2007-05-01,Uncertain
Q9NUD7,CT096_HUMAN,Uncharacterized protein C20orf96,363,"42,859",2 out of 5,2002-12-06,Evidence at transcript level
Q8NBC4,CT203_HUMAN,Uncharacterized protein C20orf203,194,"21,159",2 out of 5,2010-06-15,Evidence at transcript level
P0DMU8,CT455_HUMAN,Cancer/testis antigen family 45 member A5 (Cancer/testis antigen 45-5) (Cancer/testis antigen 45A5),189,"21,232",2 out of 5,2015-05-27,Evidence at transcript level
Q8WYA6,CTBL1_HUMAN,Beta-catenin-like protein 1 (Nuclear-associated protein) (NAP) (Testis development protein NYD-SP19),563,"65,173",5 out of 5,2003-02-28,Evidence at protein level
P56545,CTBP2_HUMAN,C-terminal-binding protein 2 (CtBP2),445,"48,945",5 out of 5,1998-07-15,Evidence at protein level
O14595,CTDS2_HUMAN,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2 (EC 3.1.3.16) (Nuclear LIM interactor-interacting factor 2) (NLI-interacting factor 2) (Protein OS-4) (Small C-terminal domain phosphatase 2) (Small CTD phosphatase 2) (SCP2),271,"30,664",5 out of 5,2001-12-13,Evidence at protein level
Q8N4M1,CTL3_HUMAN,Choline transporter-like protein 3 (Solute carrier family 44 member 3),653,"73,783",4 out of 5,2005-08-30,Evidence at protein level
Q8NCS7,CTL5_HUMAN,Choline transporter-like protein 5 (Solute carrier family 44 member 5),719,"81,674",4 out of 5,2005-08-30,Evidence at transcript level
O60716,CTND1_HUMAN,Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)),968,"108,170",5 out of 5,2001-07-11,Evidence at protein level
Q86XQ3,CTSR3_HUMAN,Cation channel sperm-associated protein 3 (CatSper3) (Ca(v)-like protein) (One-repeat calcium channel-like protein),398,"46,422",5 out of 5,2007-07-24,Evidence at transcript level
Q6ZRH7,CTSRG_HUMAN,Cation channel sperm-associated protein subunit gamma,1159,"133,032",4 out of 5,2005-08-16,Evidence at transcript level
A6NIU2,CU037_HUMAN,Putative uncharacterized protein encoded by LINC01549,74,"8,470",1 out of 5,2007-10-23,Uncertain
A6NM66,CU054_HUMAN,Uncharacterized protein encoded by LINC01548,108,"11,668",1 out of 5,2008-01-15,Predicted
Q13617,CUL2_HUMAN,Cullin-2 (CUL-2),745,"86,983",5 out of 5,1997-11-01,Evidence at protein level
Q13618,CUL3_HUMAN,Cullin-3 (CUL-3),768,"88,930",5 out of 5,1997-11-01,Evidence at protein level
Q9NTM9,CUTC_HUMAN,Copper homeostasis protein cutC homolog,273,"29,341",5 out of 5,2004-10-11,Evidence at protein level
P39880,CUX1_HUMAN,Homeobox protein cut-like 1 (CCAAT displacement protein) (CDP) (Homeobox protein cux-1),1505,"164,187",5 out of 5,1995-02-01,Evidence at protein level
Q86UP6,CUZD1_HUMAN,CUB and zona pellucida-like domain-containing protein 1 (CUB and ZP domain-containing protein 1) (Transmembrane protein UO-44),607,"68,153",4 out of 5,2006-05-02,Evidence at transcript level
Q5VT33,CX031_HUMAN,Putative uncharacterized protein encoded by LINC01545,79,"9,515",1 out of 5,2007-01-09,Predicted
Q9Y6H8,CXA3_HUMAN,Gap junction alpha-3 protein (Connexin-46) (Cx46),435,"47,410",5 out of 5,2000-12-01,Evidence at protein level
Q8NFK1,CXG3_HUMAN,Gap junction gamma-3 protein (Connexin-30.2) (Cx30.2) (Connexin-31.3) (Cx31.3) (Gap junction epsilon-1 protein),279,"31,299",3 out of 5,2003-06-20,Evidence at transcript level
O43927,CXL13_HUMAN,C-X-C motif chemokine 13 (Angie) (B cell-attracting chemokine 1) (BCA-1) (B lymphocyte chemoattractant) (CXC chemokine BLC) (Small-inducible cytokine B13),109,"12,664",5 out of 5,2000-05-30,Evidence at protein level
Q9P0U4,CXXC1_HUMAN,CXXC-type zinc finger protein 1 (CpG-binding protein) (PHD finger and CXXC domain-containing protein 1),656,"75,712",5 out of 5,2002-03-27,Evidence at protein level
P99999,CYC_HUMAN,Cytochrome c,105,"11,749",5 out of 5,1986-07-21,Evidence at protein level
P40313,CTRL_HUMAN,Chymotrypsin-like protease CTRL-1 (EC 3.4.21.-),264,"28,002",3 out of 5,1995-02-01,Evidence at transcript level
Q9H7T0,CTSRB_HUMAN,Cation channel sperm-associated protein subunit beta (CatSper-beta),1116,"126,924",3 out of 5,2005-07-05,Evidence at transcript level
P0C2S0,CTXN2_HUMAN,Cortexin-2,81,"8,980",2 out of 5,2007-04-17,Inferred from homology
P35212,CXA4_HUMAN,Gap junction alpha-4 protein (Connexin-37) (Cx37),333,"37,414",5 out of 5,1994-02-01,Evidence at protein level
P57773,CXA9_HUMAN,Gap junction alpha-9 protein (Connexin-58) (Cx58) (Connexin-59) (Cx59) (Gap junction alpha-10 protein),515,"58,842",3 out of 5,2001-02-21,Evidence at transcript level
P29033,CXB2_HUMAN,Gap junction beta-2 protein (Connexin-26) (Cx26),226,"26,215",5 out of 5,1992-12-01,Evidence at protein level
P19876,CXCL3_HUMAN,C-X-C motif chemokine 3 (GRO-gamma(1-73)) (Growth-regulated protein gamma) (GRO-gamma) (Macrophage inflammatory protein 2-beta) (MIP2-beta) [Cleaved into: GRO-gamma(5-73)],107,"11,342",5 out of 5,1991-02-01,Evidence at protein level
P80162,CXCL6_HUMAN,"C-X-C motif chemokine 6 (Chemokine alpha 3) (CKA-3) (Granulocyte chemotactic protein 2) (GCP-2) (Small-inducible cytokine B6) [Cleaved into: Small-inducible cytokine B6, N-processed variant 1; Small-inducible cytokine B6, N-processed variant 2; Small-inducible cytokine B6, N-processed variant 3]",114,"11,897",5 out of 5,1993-04-01,Evidence at protein level
P61073,CXCR4_HUMAN,C-X-C chemokine receptor type 4 (CXC-R4) (CXCR-4) (FB22) (Fusin) (HM89) (LCR1) (Leukocyte-derived seven transmembrane domain receptor) (LESTR) (Lipopolysaccharide-associated protein 3) (LAP-3) (LPS-associated protein 3) (NPYRL) (Stromal cell-derived factor 1 receptor) (SDF-1 receptor) (CD antigen CD184),352,"39,746",5 out of 5,2004-04-26,Evidence at protein level
O00574,CXCR6_HUMAN,C-X-C chemokine receptor type 6 (CXC-R6) (CXCR-6) (CDw186) (G-protein coupled receptor STRL33) (G-protein coupled receptor bonzo) (CD antigen CD186),342,"39,280",5 out of 5,1998-07-15,Evidence at transcript level
P13498,CY24A_HUMAN,Cytochrome b-245 light chain (Cytochrome b(558) alpha chain) (Cytochrome b558 subunit alpha) (Neutrophil cytochrome b 22 kDa polypeptide) (Superoxide-generating NADPH oxidase light chain subunit) (p22 phagocyte B-cytochrome) (p22-phox) (p22phox),195,"21,013",5 out of 5,1990-01-01,Evidence at protein level
P00167,CYB5_HUMAN,Cytochrome b5 (Microsomal cytochrome b5 type A) (MCB5),134,"15,330",5 out of 5,1986-07-21,Evidence at protein level
Q15438,CYH1_HUMAN,"Cytohesin-1 (PH, SEC7 and coiled-coil domain-containing protein 1) (SEC7 homolog B2-1)",398,"46,413",5 out of 5,1997-11-01,Evidence at protein level
P01040,CYTA_HUMAN,"Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed]",98,"11,006",5 out of 5,1986-07-21,Evidence at protein level
Q15828,CYTM_HUMAN,Cystatin-M (Cystatin-6) (Cystatin-E),149,"16,511",4 out of 5,1997-11-01,Evidence at protein level
P81534,D103A_HUMAN,"Beta-defensin 103 (Beta-defensin 3) (BD-3) (DEFB-3) (HBD3) (hBD-3) (Defensin, beta 103) (Defensin-like protein)",67,"7,697",5 out of 5,2001-08-29,Evidence at protein level
Q5SW24,DACT2_HUMAN,Dapper homolog 2 (Dapper antagonist of catenin 2),774,"82,700",4 out of 5,2008-03-18,Evidence at transcript level
Q9BU40,CRDL1_HUMAN,Chordin-like protein 1 (Neuralin-1) (Neurogenesin-1) (Ventroptin),450,"51,168",5 out of 5,2003-01-17,Evidence at protein level
P16220,CREB1_HUMAN,Cyclic AMP-responsive element-binding protein 1 (CREB-1) (cAMP-responsive element-binding protein 1),341,"36,688",5 out of 5,1990-04-01,Evidence at protein level
A5YM72,CRNS1_HUMAN,Carnosine synthase 1 (EC 6.3.2.11) (ATP-grasp domain-containing protein 1),827,"88,484",5 out of 5,2008-04-08,Evidence at protein level
Q8N1N5,CRPAK_HUMAN,Cysteine-rich PAK1 inhibitor (CRIPak),446,"48,076",5 out of 5,2008-02-26,Evidence at protein level
P02741,CRP_HUMAN,C-reactive protein [Cleaved into: C-reactive protein(1-205)],224,"25,039",5 out of 5,1986-07-21,Evidence at protein level
Q16526,CRY1_HUMAN,Cryptochrome-1,586,"66,395",5 out of 5,2006-11-28,Evidence at protein level
Q14894,CRYM_HUMAN,Ketimine reductase mu-crystallin (EC 1.5.1.25) (NADP-regulated thyroid-hormone-binding protein),314,"33,776",5 out of 5,1997-11-01,Evidence at protein level
Q6RUI8,CS048_HUMAN,Uncharacterized protein C19orf48 (Multidrug resistance-related protein),117,"13,085",2 out of 5,2007-01-09,Predicted
Q5BKX5,CS054_HUMAN,UPF0692 protein C19orf54,351,"37,779",2 out of 5,2007-08-21,Evidence at protein level
P59037,CU084_HUMAN,Putative uncharacterized protein encoded by LINC00313,77,"8,510",2 out of 5,2002-10-19,Uncertain
Q13616,CUL1_HUMAN,Cullin-1 (CUL-1),776,"89,679",5 out of 5,1997-11-01,Evidence at protein level
Q13619,CUL4A_HUMAN,Cullin-4A (CUL-4A),759,"87,680",5 out of 5,1997-11-01,Evidence at protein level
Q8IWT3,CUL9_HUMAN,Cullin-9 (CUL-9) (UbcH7-associated protein 1) (p53-associated parkin-like cytoplasmic protein),2517,"281,229",5 out of 5,2004-03-01,Evidence at protein level
O14529,CUX2_HUMAN,Homeobox protein cut-like 2 (Homeobox protein cux-2),1486,"161,677",5 out of 5,2001-04-27,Evidence at protein level
Q6ZV56,CV034_HUMAN,Uncharacterized protein C22orf34,151,"16,313",2 out of 5,2007-07-24,Evidence at transcript level
Q6UX04,CWC27_HUMAN,Peptidyl-prolyl cis-trans isomerase CWC27 homolog (PPIase CWC27) (EC 5.2.1.8) (Antigen NY-CO-10) (Serologically defined colon cancer antigen 10),472,"53,847",5 out of 5,2008-01-15,Evidence at protein level
Q8WWM9,CYGB_HUMAN,Cytoglobin (Histoglobin) (HGb) (Stellate cell activation-associated protein),190,"21,405",5 out of 5,2002-05-27,Evidence at protein level
P01034,CYTC_HUMAN,Cystatin-C (Cystatin-3) (Gamma-trace) (Neuroendocrine basic polypeptide) (Post-gamma-globulin),146,"15,799",5 out of 5,1986-07-21,Evidence at protein level
Q8N104,D106A_HUMAN,"Beta-defensin 106 (Beta-defensin 6) (BD-6) (DEFB-6) (Defensin, beta 106)",65,"7,369",3 out of 5,2002-12-06,Evidence at protein level
Q6ZPD9,D19L3_HUMAN,Probable C-mannosyltransferase DPY19L3 (EC 2.4.1.-) (Dpy-19-like protein 3) (Protein dpy-19 homolog 3),716,"83,197",3 out of 5,2007-12-04,Evidence at transcript level
Q6NXN4,D19P1_HUMAN,Putative C-mannosyltransferase DPY19L2P1 (EC 2.4.1.-) (Dpy-19-like protein 2 pseudogene 1) (Protein dpy-19 homolog 2-like 1),242,"28,036",3 out of 5,2007-12-04,Evidence at transcript level
Q8N465,D2HDH_HUMAN,"D-2-hydroxyglutarate dehydrogenase, mitochondrial (EC 1.1.99.-)",521,"56,416",5 out of 5,2006-04-04,Evidence at protein level
P61803,DAD1_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 (Oligosaccharyl transferase subunit DAD1) (Defender against cell death 1) (DAD-1),113,"12,497",5 out of 5,2004-06-07,Evidence at protein level
P08174,DAF_HUMAN,Complement decay-accelerating factor (CD antigen CD55),381,"41,400",5 out of 5,1988-08-01,Evidence at protein level
Q96EP5,DAZP1_HUMAN,DAZ-associated protein 1 (Deleted in azoospermia-associated protein 1),407,"43,383",5 out of 5,2004-03-01,Evidence at protein level
Q30KR1,DB109_HUMAN,"Beta-defensin 109 (Defensin, beta 109) (Defensin, beta 109, pseudogene 1/1B)",87,"9,886",2 out of 5,2005-12-20,Inferred from homology
Q96PH6,DB118_HUMAN,"Beta-defensin 118 (Beta-defensin 18) (DEFB-18) (Defensin, beta 118) (Epididymal secretory protein 13.6) (ESP13.6)",123,"13,614",4 out of 5,2002-10-10,Evidence at transcript level
Q8N690,DB119_HUMAN,"Beta-defensin 119 (Beta-defensin 120) (Beta-defensin 19) (DEFB-19) (Beta-defensin 20) (DEFB-20) (Defensin, beta 119) (Defensin, beta 120) (ESC42-RELA)",84,"9,822",4 out of 5,2002-12-06,Evidence at transcript level
Q8N688,DB123_HUMAN,"Beta-defensin 123 (Beta-defensin 23) (DEFB-23) (Defensin, beta 123)",67,"8,105",3 out of 5,2002-12-06,Evidence at transcript level
Q9BYW3,DB126_HUMAN,"Beta-defensin 126 (Beta-defensin 26) (DEFB-26) (Defensin, beta 126) (Epididymal secretory protein 13.2) (ESP13.2) (HBD26)",111,"12,174",4 out of 5,2002-10-10,Evidence at protein level
Q30KQ2,DB130_HUMAN,"Beta-defensin 130 (Beta-defensin 30) (DEFB-30) (Defensin, beta 130)",79,"8,736",2 out of 5,2005-12-20,Inferred from homology
Q8NFT6,DBF4B_HUMAN,Protein DBF4 homolog B (Activator of S phase kinase-like protein 1) (ASK-like protein 1) (Chiffon homolog B) (Dbf4-related factor 1),615,"67,243",5 out of 5,2008-02-05,Evidence at protein level
Q9UK59,DBR1_HUMAN,Lariat debranching enzyme (EC 3.1.-.-),544,"61,555",4 out of 5,2006-09-19,Evidence at protein level
Q3SXM0,DC4L1_HUMAN,DDB1- and CUL4-associated factor 4-like protein 1 (WD repeat-containing protein 21B),396,"44,264",2 out of 5,2007-05-29,Evidence at transcript level
Q8N8Z6,DCBD1_HUMAN,"Discoidin, CUB and LCCL domain-containing protein 1",715,"77,920",3 out of 5,2004-07-19,Evidence at protein level
P43146,DCC_HUMAN,Netrin receptor DCC (Colorectal cancer suppressor) (Immunoglobulin superfamily DCC subclass member 1) (Tumor suppressor protein DCC),1447,"158,457",5 out of 5,1995-11-01,Evidence at protein level
A8MYV0,DCD2C_HUMAN,Doublecortin domain-containing protein 2C,355,"40,425",1 out of 5,2008-07-22,Predicted
P26232,CTNA2_HUMAN,Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein),953,"105,313",5 out of 5,1992-05-01,Evidence at protein level
Q9UBT7,CTNL1_HUMAN,Alpha-catulin (Alpha-catenin-related protein) (ACRP) (Catenin alpha-like protein 1),734,"81,896",5 out of 5,2005-02-01,Evidence at protein level
P17538,CTRB1_HUMAN,Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C],263,"27,713",4 out of 5,1990-08-01,Evidence at transcript level
Q6GPI1,CTRB2_HUMAN,Chymotrypsinogen B2 (EC 3.4.21.1) [Cleaved into: Chymotrypsin B2 chain A; Chymotrypsin B2 chain B; Chymotrypsin B2 chain C],263,"27,923",4 out of 5,2007-05-01,Evidence at transcript level
Q05D32,CTSL2_HUMAN,CTD small phosphatase-like protein 2 (CTDSP-like 2) (EC 3.1.3.-),466,"52,999",3 out of 5,2008-04-29,Evidence at protein level
Q8NEC5,CTSR1_HUMAN,Cation channel sperm-associated protein 1 (CatSper1) (hCatSper),780,"90,091",5 out of 5,2007-07-24,Evidence at protein level
Q96P56,CTSR2_HUMAN,Cation channel sperm-associated protein 2 (CatSper2),530,"62,041",5 out of 5,2007-07-24,Evidence at protein level
Q8WZ74,CTTB2_HUMAN,Cortactin-binding protein 2 (CortBP2),1663,"181,051",3 out of 5,2006-03-21,Evidence at protein level
Q7Z7A3,CTU1_HUMAN,Cytoplasmic tRNA 2-thiolation protein 1 (EC 2.7.7.-) (ATP-binding domain-containing protein 3) (Cancer-associated gene protein) (Cytoplasmic tRNA adenylyltransferase 1),348,"36,450",4 out of 5,2007-04-03,Evidence at protein level
P59036,CU082_HUMAN,Putative uncharacterized protein encoded by LINC00310,64,"7,298",1 out of 5,2002-10-19,Uncertain
Q93034,CUL5_HUMAN,Cullin-5 (CUL-5) (Vasopressin-activated calcium-mobilizing receptor 1) (VACM-1),780,"90,955",5 out of 5,1997-11-01,Evidence at protein level
Q14999,CUL7_HUMAN,Cullin-7 (CUL-7),1698,"191,161",5 out of 5,1997-11-01,Evidence at protein level
Q9Y442,CV024_HUMAN,Uncharacterized protein C22orf24,160,"17,735",2 out of 5,2005-07-05,Evidence at transcript level
Q8N2A0,CX062_HUMAN,Putative uncharacterized protein encoded by LINC00269,174,"18,329",1 out of 5,2008-02-05,Uncertain
P12074,CX6A1_HUMAN,"Cytochrome c oxidase subunit 6A1, mitochondrial (Cytochrome c oxidase polypeptide VIa-liver) (Cytochrome c oxidase subunit VIA-liver) (COX VIa-L)",109,"12,155",5 out of 5,1989-10-01,Evidence at protein level
Q96KN9,CXD4_HUMAN,Gap junction delta-4 protein (Connexin-40.1) (Cx40.1),370,"40,140",3 out of 5,2008-01-15,Evidence at transcript level
A6NN92,CXE1_HUMAN,Gap junction epsilon-1 protein (Connexin-23) (Cx23),205,"23,755",3 out of 5,2008-02-05,Inferred from homology
P49447,CY561_HUMAN,Cytochrome b561 (Cytochrome b-561),251,"27,559",4 out of 5,1996-02-01,Evidence at protein level
Q8NBI2,CYAC3_HUMAN,Cytochrome b ascorbate-dependent protein 3 (EC 1.-.-.-) (Cytochrome b561 family member A3) (Lysosomal cytochrome b) (LCytb),242,"27,214",4 out of 5,2008-01-15,Evidence at protein level
Q99418,CYH2_HUMAN,"Cytohesin-2 (ARF exchange factor) (ARF nucleotide-binding site opener) (Protein ARNO) (PH, SEC7 and coiled-coil domain-containing protein 2)",400,"46,546",5 out of 5,1998-07-15,Evidence at protein level
Q6ZMK1,CYHR1_HUMAN,Cysteine and histidine-rich protein 1,362,"40,703",3 out of 5,2008-04-08,Evidence at protein level
O60759,CYTIP_HUMAN,Cytohesin-interacting protein (Cytohesin binder and regulator) (CYBR) (Cytohesin-associated scaffolding protein) (CASP) (Cytohesin-binding protein HE) (Cbp HE) (Pleckstrin homology Sec7 and coiled-coil domains-binding protein),359,"40,010",5 out of 5,2005-09-27,Evidence at protein level
Q8WTQ1,D104A_HUMAN,"Beta-defensin 104 (Beta-defensin 4) (BD-4) (DEFB-4) (hBD-4) (Defensin, beta 104)",72,"8,526",3 out of 5,2002-05-27,Evidence at transcript level
Q6NUT2,D19L2_HUMAN,Probable C-mannosyltransferase DPY19L2 (EC 2.4.1.-) (Dpy-19-like protein 2) (Protein dpy-19 homolog 2),758,"87,374",5 out of 5,2007-12-04,Evidence at protein level
Q8N9W5,DAAF3_HUMAN,"Dynein assembly factor 3, axonemal",541,"59,411",4 out of 5,2007-08-21,Evidence at protein level
Q86T65,DAAM2_HUMAN,Disheveled-associated activator of morphogenesis 2,1068,"123,499",3 out of 5,2003-08-15,Evidence at protein level
Q9UIK4,DAPK2_HUMAN,Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1),370,"42,898",5 out of 5,2003-11-28,Evidence at protein level
O43293,DAPK3_HUMAN,Death-associated protein kinase 3 (DAP kinase 3) (EC 2.7.11.1) (DAP-like kinase) (Dlk) (MYPT1 kinase) (Zipper-interacting protein kinase) (ZIP-kinase),454,"52,536",5 out of 5,2003-11-28,Evidence at protein level
Q9UER7,DAXX_HUMAN,Death domain-associated protein 6 (Daxx) (hDaxx) (ETS1-associated protein 1) (EAP1) (Fas death domain-associated protein),740,"81,373",5 out of 5,2002-11-01,Evidence at protein level
Q30KQ7,DB113_HUMAN,"Beta-defensin 113 (Beta-defensin 13) (DEFB-13) (Defensin, beta 113)",82,"9,640",2 out of 5,2005-12-20,Inferred from homology
Q30KQ9,DB110_HUMAN,"Beta-defensin 110 (Beta-defensin 10) (DEFB-10) (Beta-defensin 11) (DEFB-11) (Beta-defensin 111) (Defensin, beta 110) (Defensin, beta 111)",67,"8,001",3 out of 5,2005-12-20,Inferred from homology
Q9H1M4,DB127_HUMAN,"Beta-defensin 127 (Beta-defensin 27) (DEFB-27) (Defensin, beta 127)",99,"11,343",4 out of 5,2002-10-10,Evidence at protein level
Q9H1M3,DB129_HUMAN,"Beta-defensin 129 (Beta-defensin 29) (DEFB-29) (Defensin, beta 129)",183,"20,299",3 out of 5,2002-12-06,Evidence at transcript level
Q30KP9,DB135_HUMAN,"Beta-defensin 135 (Defensin, beta 135)",77,"8,754",2 out of 5,2005-12-20,Inferred from homology
A6NMT0,DBX1_HUMAN,Homeobox protein DBX1 (Developing brain homeobox protein 1),343,"37,283",2 out of 5,2007-09-11,Inferred from homology
Q6ZNG2,DBX2_HUMAN,Homeobox protein DBX2 (Developing brain homeobox protein 2),339,"36,555",2 out of 5,2007-09-11,Evidence at transcript level
Q8WV16,DCAF4_HUMAN,DDB1- and CUL4-associated factor 4 (WD repeat-containing protein 21A),495,"55,694",5 out of 5,2003-02-12,Evidence at protein level
P61962,DCAF7_HUMAN,DDB1- and CUL4-associated factor 7 (WD repeat-containing protein 68) (WD repeat-containing protein An11 homolog),342,"38,926",5 out of 5,2004-06-07,Evidence at protein level
Q9BVC3,DCC1_HUMAN,Sister chromatid cohesion protein DCC1 (Defective in sister chromatid cohesion protein 1 homolog),393,"44,825",5 out of 5,2008-02-05,Evidence at protein level
P59894,DCDC1_HUMAN,Doublecortin domain-containing protein 1,354,"39,859",2 out of 5,2003-10-03,Evidence at transcript level
Q05329,DCE2_HUMAN,Glutamate decarboxylase 2 (EC 4.1.1.15) (65 kDa glutamic acid decarboxylase) (GAD-65) (Glutamate decarboxylase 65 kDa isoform),585,"65,411",5 out of 5,1996-02-01,Evidence at protein level
A8MXU0,D108A_HUMAN,"Putative beta-defensin 108A (Defensin, beta 108A) (Putative beta-defensin 108B pseudogene 1/2)",73,"8,390",3 out of 5,2008-06-10,Uncertain
Q6ZN68,D19P2_HUMAN,Putative C-mannosyltransferase DPY19L2P2 (EC 2.4.1.-) (Dpy-19-like protein 2 pseudogene 2) (Protein dpy-19 homolog 2-like 2),376,"43,060",3 out of 5,2008-04-29,Uncertain
A6NKP2,D42E2_HUMAN,Putative short-chain dehydrogenase/reductase family 42E member 2 (EC 1.1.1.-),422,"46,869",2 out of 5,2008-05-20,Inferred from homology
Q8NEP3,DAAF1_HUMAN,"Dynein assembly factor 1, axonemal (Leucine-rich repeat-containing protein 50)",725,"80,026",5 out of 5,2006-04-18,Evidence at protein level
P98082,DAB2_HUMAN,Disabled homolog 2 (Adaptor molecule disabled-2) (Differentially expressed in ovarian carcinoma 2) (DOC-2) (Differentially-expressed protein 2),770,"82,448",5 out of 5,1996-02-01,Evidence at protein level
A0PJW8,DAPL1_HUMAN,Death-associated protein-like 1 (Early epithelial differentiation-associated protein),107,"11,880",2 out of 5,2008-02-05,Evidence at protein level
Q13117,DAZ2_HUMAN,Deleted in azoospermia protein 2,558,"63,111",5 out of 5,2004-03-01,Evidence at protein level
Q30KQ6,DB114_HUMAN,"Beta-defensin 114 (Beta-defensin 14) (DEFB-14) (Defensin, beta 114)",69,"8,318",3 out of 5,2006-01-10,Evidence at protein level
Q8TCX1,DC2L1_HUMAN,Cytoplasmic dynein 2 light intermediate chain 1 (Dynein 2 light intermediate chain),351,"39,625",5 out of 5,2008-02-26,Evidence at protein level
Q9NV06,DCA13_HUMAN,DDB1- and CUL4-associated factor 13 (WD repeat and SOF domain-containing protein 1),445,"51,402",5 out of 5,2007-11-13,Evidence at protein level
Q5TAQ9,DCAF8_HUMAN,DDB1- and CUL4-associated factor 8 (WD repeat-containing protein 42A),597,"66,852",5 out of 5,2007-07-24,Evidence at protein level
P17707,DCAM_HUMAN,S-adenosylmethionine decarboxylase proenzyme (AdoMetDC) (SAMDC) (EC 4.1.1.50) [Cleaved into: S-adenosylmethionine decarboxylase alpha chain; S-adenosylmethionine decarboxylase beta chain],334,"38,340",5 out of 5,1990-08-01,Evidence at protein level
P27707,DCK_HUMAN,Deoxycytidine kinase (dCK) (EC 2.7.1.74),260,"30,519",5 out of 5,1992-08-01,Evidence at protein level
Q9C098,DCLK3_HUMAN,Serine/threonine-protein kinase DCLK3 (EC 2.7.11.1) (Doublecortin domain-containing protein 3C) (Doublecortin-like and CAM kinase-like 3) (Doublecortin-like kinase 3),648,"73,814",5 out of 5,2006-10-03,Evidence at transcript level
Q96GG9,DCNL1_HUMAN,DCN1-like protein 1 (DCUN1 domain-containing protein 1) (Defective in cullin neddylation protein 1-like protein 1) (Squamous cell carcinoma-related oncogene),259,"30,124",5 out of 5,2005-08-30,Evidence at protein level
Q8IU60,DCP2_HUMAN,m7GpppN-mRNA hydrolase (EC 3.6.1.62) (Nucleoside diphosphate-linked moiety X motif 20) (Nudix motif 20) (mRNA-decapping enzyme 2) (hDpc),420,"48,457",5 out of 5,2005-03-01,Evidence at protein level
Q9BW61,DDA1_HUMAN,DET1- and DDB1-associated protein 1 (Placenta cross-immune reaction antigen 1) (PCIA-1),102,"11,835",3 out of 5,2007-11-13,Evidence at protein level
Q6QHC5,DEGS2_HUMAN,Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2 (EC 1.14.18.5) (EC 1.14.19.17) (Degenerative spermatocyte homolog 2) (Sphingolipid 4-desaturase) (Sphingolipid C4-monooxygenase),323,"37,197",5 out of 5,2007-12-04,Evidence at protein level
O75064,DEN4B_HUMAN,DENN domain-containing protein 4B,1496,"163,847",4 out of 5,2007-09-11,Evidence at protein level
Q8N2C3,DEPD4_HUMAN,DEP domain-containing protein 4,294,"33,694",2 out of 5,2007-04-17,Evidence at transcript level
O95424,DEXI_HUMAN,Dexamethasone-induced protein (Protein MYLE),95,"10,429",2 out of 5,2000-05-30,Evidence at transcript level
P52429,DGKE_HUMAN,Diacylglycerol kinase epsilon (DAG kinase epsilon) (EC 2.7.1.107) (Diglyceride kinase epsilon) (DGK-epsilon),567,"63,927",5 out of 5,1996-10-01,Evidence at protein level
Q9Y4D2,DGLA_HUMAN,Sn1-specific diacylglycerol lipase alpha (DGL-alpha) (EC 3.1.1.-) (Neural stem cell-derived dendrite regulator),1042,"114,952",5 out of 5,2006-09-05,Evidence at protein level
P28325,CYTD_HUMAN,Cystatin-D (Cystatin-5),142,"16,080",5 out of 5,1992-12-01,Evidence at protein level
P01037,CYTN_HUMAN,Cystatin-SN (Cystain-SA-I) (Cystatin-1) (Salivary cystatin-SA-1),141,"16,388",5 out of 5,1986-07-21,Evidence at protein level
P09228,CYTT_HUMAN,Cystatin-SA (Cystatin-2) (Cystatin-S5),141,"16,445",5 out of 5,1989-07-01,Evidence at protein level
Q96J86,CYYR1_HUMAN,Cysteine and tyrosine-rich protein 1 (Proline-rich domain-containing protein),154,"16,626",4 out of 5,2002-12-13,Evidence at transcript level
P0CZ25,D10OS_HUMAN,Uncharacterized protein DNAH10OS,163,"17,537",1 out of 5,2011-07-27,Evidence at transcript level
Q2PZI1,D19L1_HUMAN,Probable C-mannosyltransferase DPY19L1 (EC 2.4.1.-) (Dpy-19-like protein 1) (Protein dpy-19 homolog 1),675,"77,319",3 out of 5,2007-12-04,Evidence at transcript level
Q9NRG7,D39U1_HUMAN,Epimerase family protein SDR39U1 (EC 1.1.1.-) (Short-chain dehydrogenase/reductase family 39U member 1),319,"34,748",4 out of 5,2007-03-06,Evidence at protein level
Q8WUS8,D42E1_HUMAN,Short-chain dehydrogenase/reductase family 42E member 1 (EC 1.1.1.-),393,"44,284",3 out of 5,2008-04-29,Evidence at transcript level
Q96NX9,DACH2_HUMAN,Dachshund homolog 2 (Dach2),599,"65,323",4 out of 5,2004-03-01,Evidence at transcript level
Q96B18,DACT3_HUMAN,Dapper homolog 3 (Antagonist of beta-catenin Dapper homolog 3) (Arginine-rich region 1 protein) (Dapper antagonist of catenin 3),629,"64,949",5 out of 5,2006-12-12,Evidence at protein level
Q66K64,DCA15_HUMAN,DDB1- and CUL4-associated factor 15,600,"66,463",3 out of 5,2008-01-15,Evidence at protein level
Q96PD2,DCBD2_HUMAN,"Discoidin, CUB and LCCL domain-containing protein 2 (CUB, LCCL and coagulation factor V/VIII-homology domains protein 1) (Endothelial and smooth muscle cell-derived neuropilin-like protein)",775,"85,035",5 out of 5,2004-07-05,Evidence at protein level
Q8NEL9,DDHD1_HUMAN,Phospholipase DDHD1 (EC 3.1.1.-) (DDHD domain-containing protein 1) (Phosphatidic acid-preferring phospholipase A1 homolog) (PA-PLA1),900,"100,435",5 out of 5,2003-10-24,Evidence at protein level
Q96D03,DDT4L_HUMAN,DNA damage-inducible transcript 4-like protein (HIF-1 responsive protein RTP801-like) (Protein regulated in development and DNA damage response 2) (REDD-2),193,"21,740",4 out of 5,2007-10-23,Evidence at protein level
Q92499,DDX1_HUMAN,ATP-dependent RNA helicase DDX1 (EC 3.6.4.13) (DEAD box protein 1) (DEAD box protein retinoblastoma) (DBP-RB),740,"82,432",5 out of 5,2000-05-30,Evidence at protein level
O15523,DDX3Y_HUMAN,"ATP-dependent RNA helicase DDX3Y (EC 3.6.4.13) (DEAD box protein 3, Y-chromosomal)",660,"73,154",5 out of 5,1999-07-15,Evidence at protein level
Q9UJV9,DDX41_HUMAN,Probable ATP-dependent RNA helicase DDX41 (EC 3.6.4.13) (DEAD box protein 41) (DEAD box protein abstrakt homolog),622,"69,838",5 out of 5,2000-12-01,Evidence at protein level
Q7L014,DDX46_HUMAN,Probable ATP-dependent RNA helicase DDX46 (EC 3.6.4.13) (DEAD box protein 46) (PRP5 homolog),1031,"117,362",5 out of 5,2006-01-10,Evidence at protein level
Q9H0S4,DDX47_HUMAN,Probable ATP-dependent RNA helicase DDX47 (EC 3.6.4.13) (DEAD box protein 47),455,"50,647",5 out of 5,2004-09-27,Evidence at protein level
Q8TDD1,DDX54_HUMAN,ATP-dependent RNA helicase DDX54 (EC 3.6.4.13) (ATP-dependent RNA helicase DP97) (DEAD box RNA helicase 97 kDa) (DEAD box protein 54),881,"98,595",5 out of 5,2004-04-26,Evidence at protein level
Q8NHQ9,DDX55_HUMAN,ATP-dependent RNA helicase DDX55 (EC 3.6.4.13) (DEAD box protein 55),600,"68,547",5 out of 5,2006-10-03,Evidence at protein level
Q8IY21,DDX60_HUMAN,Probable ATP-dependent RNA helicase DDX60 (EC 3.6.4.13) (DEAD box protein 60),1712,"197,853",5 out of 5,2008-02-05,Evidence at protein level
Q9H4E7,DEFI6_HUMAN,Differentially expressed in FDCP 6 homolog (DEF-6) (IRF4-binding protein),631,"73,910",5 out of 5,2007-07-10,Evidence at protein level
O15121,DEGS1_HUMAN,Sphingolipid delta(4)-desaturase DES1 (EC 1.14.19.17) (Cell migration-inducing gene 15 protein) (Degenerative spermatocyte homolog 1) (Membrane lipid desaturase),323,"37,866",5 out of 5,2007-12-04,Evidence at protein level
Q9NTK1,DEPP_HUMAN,Protein DEPP (Decidual protein induced by progesterone) (Fasting-induced gene protein) (FIG),212,"23,406",3 out of 5,2005-07-05,Evidence at protein level
P23743,DGKA_HUMAN,Diacylglycerol kinase alpha (DAG kinase alpha) (EC 2.7.1.107) (80 kDa diacylglycerol kinase) (Diglyceride kinase alpha) (DGK-alpha),735,"82,630",5 out of 5,1991-11-01,Evidence at protein level
Q5KSL6,DGKK_HUMAN,Diacylglycerol kinase kappa (DAG kinase kappa) (EC 2.7.1.107) (142 kDa diacylglycerol kinase) (Diglyceride kinase kappa) (DGK-kappa),1271,"141,829",5 out of 5,2006-06-13,Evidence at protein level
Q13574,DGKZ_HUMAN,Diacylglycerol kinase zeta (DAG kinase zeta) (EC 2.7.1.107) (Diglyceride kinase zeta) (DGK-zeta),1117,"124,128",5 out of 5,1997-11-01,Evidence at protein level
Q9BPX1,DHB14_HUMAN,17-beta-hydroxysteroid dehydrogenase 14 (17-beta-HSD 14) (EC 1.1.1.-) (17-beta-hydroxysteroid dehydrogenase DHRS10) (Dehydrogenase/reductase SDR family member 10) (Retinal short-chain dehydrogenase/reductase retSDR3) (Short chain dehydrogenase/reductase family 47C member 1),270,"28,317",5 out of 5,2005-10-11,Evidence at protein level
P14061,DHB1_HUMAN,Estradiol 17-beta-dehydrogenase 1 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 1) (17-beta-HSD 1) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Placental 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 28C member 1),328,"34,950",5 out of 5,1990-01-01,Evidence at protein level
Q86SQ9,DHDDS_HUMAN,Dehydrodolichyl diphosphate synthase complex subunit DHDDS (EC 2.5.1.87) (Cis-isoprenyltransferase) (CIT) (Cis-IPTase) (Epididymis tissue protein Li 189m),333,"38,657",5 out of 5,2004-04-13,Evidence at protein level
Q7Z5J1,DHI1L_HUMAN,Hydroxysteroid 11-beta-dehydrogenase 1-like protein (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type 3) (11-DH3) (11-beta-HSD3) (Short chain dehydrogenase/reductase family 26C member 2) (Short-chain dehydrogenase/reductase 10),315,"34,288",5 out of 5,2008-02-05,Evidence at transcript level
Q9Y394,DHRS7_HUMAN,Dehydrogenase/reductase SDR family member 7 (EC 1.1.-.-) (Retinal short-chain dehydrogenase/reductase 4) (retSDR4) (Short chain dehydrogenase/reductase family 34C member 1),339,"38,299",3 out of 5,2003-08-29,Evidence at protein level
Q8N5I4,DHRSX_HUMAN,Dehydrogenase/reductase SDR family member on chromosome X (EC 1.1.-.-) (DHRSXY) (Short chain dehydrogenase/reductase family 46C member 1) (Short chain dehydrogenase/reductase family 7C member 6),330,"36,443",5 out of 5,2003-07-03,Evidence at protein level
O60231,DHX16_HUMAN,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX16 (EC 3.6.4.13) (ATP-dependent RNA helicase #3) (DEAH-box protein 16),1041,"119,264",5 out of 5,1998-12-15,Evidence at protein level
Q6P158,DHX57_HUMAN,Putative ATP-dependent RNA helicase DHX57 (EC 3.6.4.13) (DEAH box protein 57),1386,"155,604",5 out of 5,2006-05-02,Evidence at protein level
Q8TF46,DI3L1_HUMAN,DIS3-like exonuclease 1 (EC 3.1.13.-),1054,"120,787",5 out of 5,2008-01-15,Evidence at protein level
Q86Y56,DAAF5_HUMAN,"Dynein assembly factor 5, axonemal (HEAT repeat-containing protein 2)",855,"93,521",5 out of 5,2005-11-08,Evidence at protein level
Q9UI36,DACH1_HUMAN,Dachshund homolog 1 (Dach1),760,"78,676",5 out of 5,2004-03-01,Evidence at protein level
Q92904,DAZL_HUMAN,Deleted in azoospermia-like (DAZ homolog) (DAZ-like autosomal) (Deleted in azoospermia-like 1) (SPGY-like-autosomal),295,"33,178",5 out of 5,2003-01-17,Evidence at protein level
A6NGE4,DC8L1_HUMAN,DDB1- and CUL4-associated factor 8-like protein 1 (WD repeat-containing protein 42B),600,"67,373",2 out of 5,2008-01-15,Evidence at transcript level
Q9NXF7,DCA16_HUMAN,DDB1- and CUL4-associated factor 16,216,"24,193",3 out of 5,2007-09-11,Evidence at protein level
Q58WW2,DCAF6_HUMAN,DDB1- and CUL4-associated factor 6 (Androgen receptor complex-associated protein) (ARCAP) (IQ motif and WD repeat-containing protein 1) (Nuclear receptor interaction protein) (NRIP),860,"96,292",5 out of 5,2007-09-11,Evidence at protein level
Q99259,DCE1_HUMAN,Glutamate decarboxylase 1 (EC 4.1.1.15) (67 kDa glutamic acid decarboxylase) (GAD-67) (Glutamate decarboxylase 67 kDa isoform),594,"66,897",5 out of 5,1996-02-01,Evidence at protein level
Q5T1A1,DCST2_HUMAN,DC-STAMP domain-containing protein 2,773,"86,230",2 out of 5,2007-03-06,Evidence at transcript level
Q9H773,DCTP1_HUMAN,dCTP pyrophosphatase 1 (EC 3.6.1.12) (Deoxycytidine-triphosphatase 1) (dCTPase 1) (RS21C6) (XTP3-transactivated gene A protein),170,"18,681",5 out of 5,2007-06-26,Evidence at protein level
O95865,DDAH2_HUMAN,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2 (DDAH-2) (Dimethylarginine dimethylaminohydrolase 2) (EC 3.5.3.18) (DDAHII) (Dimethylargininase-2) (Protein G6a) (S-phase protein)",285,"29,644",5 out of 5,2000-05-30,Evidence at protein level
A6NHG4,DDTL_HUMAN,D-dopachrome decarboxylase-like protein (EC 4.1.1.-) (D-dopachrome tautomerase-like protein),134,"14,195",2 out of 5,2008-05-20,Evidence at transcript level
Q9P2X7,DEC1_HUMAN,Deleted in esophageal cancer 1 (Candidate tumor suppressor CTS9),70,"7,542",2 out of 5,2006-06-27,Evidence at transcript level
Q16698,DECR_HUMAN,"2,4-dienoyl-CoA reductase, mitochondrial (EC 1.3.1.34) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)",335,"36,068",5 out of 5,1998-12-15,Evidence at protein level
P12838,DEF4_HUMAN,"Neutrophil defensin 4 (Defensin, alpha 4) (HNP-4) (HP-4)",97,"10,504",5 out of 5,1989-10-01,Evidence at protein level
Q01523,DEF5_HUMAN,"Defensin-5 (Defensin, alpha 5) (HD5(20-94)) [Cleaved into: HD5(23-94); HD5(29-94); HD5(56-94); HD5(63-94)]",94,"10,071",5 out of 5,1993-07-01,Evidence at protein level
P60022,DEFB1_HUMAN,"Beta-defensin 1 (BD-1) (hBD-1) (Defensin, beta 1)",68,"7,420",5 out of 5,2003-11-21,Evidence at protein level
Q8TEH3,DEN1A_HUMAN,DENN domain-containing protein 1A (Connecdenn 1) (Connecdenn) (Protein FAM31A),1009,"110,577",5 out of 5,2006-06-27,Evidence at protein level
Q6IQ26,DEN5A_HUMAN,DENN domain-containing protein 5A (Rab6-interacting protein 1) (Rab6IP1),1287,"147,096",5 out of 5,2004-09-13,Evidence at protein level
Q8NEG7,DEN6B_HUMAN,Protein DENND6B (DENN domain-containing protein 6B),585,"66,464",3 out of 5,2006-12-12,Evidence at transcript level
O94850,DEND_HUMAN,Dendrin,711,"75,996",5 out of 5,2002-08-30,Evidence at protein level
P53355,DAPK1_HUMAN,Death-associated protein kinase 1 (DAP kinase 1) (EC 2.7.11.1),1430,"160,046",5 out of 5,1996-10-01,Evidence at protein level
Q9NR90,DAZ3_HUMAN,Deleted in azoospermia protein 3,486,"54,989",5 out of 5,2004-03-01,Evidence at protein level
Q30KQ5,DB115_HUMAN,"Beta-defensin 115 (Beta-defensin 15) (DEFB-15) (Defensin, beta 115)",88,"10,071",2 out of 5,2005-12-20,Inferred from homology
Q5VW00,DC122_HUMAN,DDB1- and CUL4-associated factor 12-like protein 2 (WD repeat-containing protein 40C),463,"50,803",2 out of 5,2007-10-02,Evidence at transcript level
Q8NA75,DC4L2_HUMAN,DDB1- and CUL4-associated factor 4-like protein 2 (WD repeat-containing protein 21C),395,"43,747",2 out of 5,2006-07-11,Evidence at protein level
Q8TF63,DCNP1_HUMAN,Dendritic cell nuclear protein 1 (Dendritic cell nuclear protein-1) (Dendritic cell-associated nuclear protein),244,"26,704",3 out of 5,2006-04-04,Evidence at protein level
P11926,DCOR_HUMAN,Ornithine decarboxylase (ODC) (EC 4.1.1.17),461,"51,148",5 out of 5,1989-10-01,Evidence at protein level
Q9NPI6,DCP1A_HUMAN,mRNA-decapping enzyme 1A (EC 3.-.-.-) (Smad4-interacting transcriptional co-activator) (Transcription factor SMIF),582,"63,309",5 out of 5,2005-03-01,Evidence at protein level
P32321,DCTD_HUMAN,Deoxycytidylate deaminase (EC 3.5.4.12) (dCMP deaminase),178,"20,016",5 out of 5,1993-10-01,Evidence at protein level
Q9UJW0,DCTN4_HUMAN,Dynactin subunit 4 (Dyn4) (Dynactin subunit p62),460,"52,337",5 out of 5,2005-04-26,Evidence at protein level
O94760,DDAH1_HUMAN,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (DDAH-1) (Dimethylarginine dimethylaminohydrolase 1) (EC 3.5.3.18) (DDAHI) (Dimethylargininase-1)",285,"31,122",5 out of 5,2000-05-30,Evidence at protein level
O94830,DDHD2_HUMAN,"Phospholipase DDHD2 (EC 3.1.1.-) (DDHD domain-containing protein 2) (KIAA0725p) (SAM, WWE and DDHD domain-containing protein 1)",711,"81,032",5 out of 5,2007-11-13,Evidence at protein level
Q16832,DDR2_HUMAN,"Discoidin domain-containing receptor 2 (Discoidin domain receptor 2) (EC 2.7.10.1) (CD167 antigen-like family member B) (Discoidin domain-containing receptor tyrosine kinase 2) (Neurotrophic tyrosine kinase, receptor-related 3) (Receptor protein-tyrosine kinase TKT) (Tyrosine-protein kinase TYRO10) (CD antigen CD167b)",855,"96,736",5 out of 5,1997-11-01,Evidence at protein level
Q9BUQ8,DDX23_HUMAN,Probable ATP-dependent RNA helicase DDX23 (EC 3.6.4.13) (100 kDa U5 snRNP-specific protein) (DEAD box protein 23) (PRP28 homolog) (U5-100kD),820,"95,583",5 out of 5,2005-06-07,Evidence at protein level
Q9H8H2,DDX31_HUMAN,Probable ATP-dependent RNA helicase DDX31 (EC 3.6.4.13) (DEAD box protein 31) (Helicain),851,"94,087",5 out of 5,2005-07-19,Evidence at protein level
O00571,DDX3X_HUMAN,"ATP-dependent RNA helicase DDX3X (EC 3.6.4.13) (DEAD box protein 3, X-chromosomal) (DEAD box, X isoform) (Helicase-like protein 2) (HLP2)",662,"73,243",5 out of 5,1998-07-15,Evidence at protein level
Q9BQ39,DDX50_HUMAN,ATP-dependent RNA helicase DDX50 (EC 3.6.4.13) (DEAD box protein 50) (Gu-beta) (Nucleolar protein Gu2),737,"82,565",5 out of 5,2004-11-23,Evidence at protein level
Q86TM3,DDX53_HUMAN,Probable ATP-dependent RNA helicase DDX53 (EC 3.6.4.13) (Cancer-associated gene protein) (Cancer/testis antigen 26) (CT26) (DEAD box protein 53) (DEAD box protein CAGE),631,"71,154",4 out of 5,2005-10-25,Evidence at protein level
Q5H9U9,DDX6L_HUMAN,Probable ATP-dependent RNA helicase DDX60-like (EC 3.6.4.13) (DEAD box protein 60-like),1706,"197,674",3 out of 5,2008-02-05,Evidence at transcript level
O00273,DFFA_HUMAN,DNA fragmentation factor subunit alpha (DNA fragmentation factor 45 kDa subunit) (DFF-45) (Inhibitor of CAD) (ICAD),331,"36,522",5 out of 5,1997-11-01,Evidence at protein level
Q16760,DGKD_HUMAN,Diacylglycerol kinase delta (DAG kinase delta) (EC 2.7.1.107) (130 kDa diacylglycerol kinase) (Diglyceride kinase delta) (DGK-delta),1214,"134,525",5 out of 5,1997-11-01,Evidence at protein level
Q8NG35,D105A_HUMAN,"Beta-defensin 105 (Beta-defensin 5) (BD-5) (DEFB-5) (Defensin, beta 105)",78,"8,923",3 out of 5,2003-09-26,Evidence at transcript level
Q7Z388,D19L4_HUMAN,Probable C-mannosyltransferase DPY19L4 (EC 2.4.1.-) (Dpy-19-like protein 4) (Protein dpy-19 homolog 4),723,"83,756",3 out of 5,2007-12-04,Evidence at protein level
Q9Y4D1,DAAM1_HUMAN,Disheveled-associated activator of morphogenesis 1,1078,"123,473",5 out of 5,2003-08-15,Evidence at protein level
Q5VWQ8,DAB2P_HUMAN,Disabled homolog 2-interacting protein (DAB2 interaction protein) (DAB2-interacting protein) (ASK-interacting protein 1) (AIP-1) (DOC-2/DAB-2 interactive protein),1189,"131,625",5 out of 5,2006-10-17,Evidence at protein level
Q8N907,DAND5_HUMAN,"DAN domain family member 5 (Cerberus-like protein 2) (Cerl-2) (Cysteine knot superfamily 1, BMP antagonist 3) (Gremlin-3)",189,"20,180",4 out of 5,2007-12-04,Evidence at transcript level
P59103,DAOA_HUMAN,D-amino acid oxidase activator (Protein G72),153,"18,108",5 out of 5,2002-11-25,Evidence at protein level
Q30KQ4,DB116_HUMAN,"Beta-defensin 116 (Beta-defensin 16) (DEFB-16) (Defensin, beta 116)",102,"11,544",3 out of 5,2005-12-20,Inferred from homology
Q5QP82,DCA10_HUMAN,DDB1- and CUL4-associated factor 10 (WD repeat-containing protein 32),559,"60,582",4 out of 5,2007-10-02,Evidence at protein level
O15075,DCLK1_HUMAN,Serine/threonine-protein kinase DCLK1 (EC 2.7.11.1) (Doublecortin domain-containing protein 3A) (Doublecortin-like and CAM kinase-like 1) (Doublecortin-like kinase 1),740,"82,224",5 out of 5,2000-05-30,Evidence at protein level
Q92564,DCNL4_HUMAN,DCN1-like protein 4 (DCUN1 domain-containing protein 4) (Defective in cullin neddylation protein 1-like protein 4),292,"34,068",3 out of 5,2005-10-25,Evidence at protein level
Q13561,DCTN2_HUMAN,Dynactin subunit 2 (50 kDa dynein-associated polypeptide) (Dynactin complex 50 kDa subunit) (DCTN-50) (p50 dynamitin),401,"44,231",5 out of 5,1997-11-01,Evidence at protein level
Q5T1V6,DDX59_HUMAN,Probable ATP-dependent RNA helicase DDX59 (EC 3.6.4.13) (DEAD box protein 59) (Zinc finger HIT domain-containing protein 5),619,"68,810",5 out of 5,2007-04-03,Evidence at protein level
P59665,DEF1_HUMAN,"Neutrophil defensin 1 (Defensin, alpha 1) (HNP-1) (HP-1) (HP1) [Cleaved into: HP 1-56; Neutrophil defensin 2 (HNP-2) (HP-2) (HP2)]",94,"10,201",5 out of 5,2003-04-30,Evidence at protein level
P0C864,DANCR_HUMAN,Putative uncharacterized protein DANCR (Anti-differentiation ncRNA protein) (Differentiation antagonizing non-protein coding RNA) (Small nucleolar RNA host gene protein 13),163,"16,785",2 out of 5,2008-09-02,Uncertain
Q9P219,DAPLE_HUMAN,Protein Daple (Coiled-coil domain-containing protein 88C) (Dvl-associating protein with a high frequency of leucine residues) (hDaple) (Hook-related protein 2) (HkRP2),2028,"228,230",5 out of 5,2007-05-15,Evidence at protein level
Q86SG3,DAZ4_HUMAN,Deleted in azoospermia protein 4,579,"64,785",5 out of 5,2004-03-01,Evidence at protein level
Q9UJU6,DBNL_HUMAN,Drebrin-like protein (Cervical SH3P7) (Cervical mucin-associated protein) (Drebrin-F) (HPK1-interacting protein of 55 kDa) (HIP-55) (SH3 domain-containing protein 7),430,"48,207",5 out of 5,2004-08-16,Evidence at protein level
O14576,DC1I1_HUMAN,"Cytoplasmic dynein 1 intermediate chain 1 (Cytoplasmic dynein intermediate chain 1) (Dynein intermediate chain 1, cytosolic) (DH IC-1)",645,"72,955",5 out of 5,2000-05-30,Evidence at protein level
Q13409,DC1I2_HUMAN,"Cytoplasmic dynein 1 intermediate chain 2 (Cytoplasmic dynein intermediate chain 2) (Dynein intermediate chain 2, cytosolic) (DH IC-2)",638,"71,457",5 out of 5,1997-11-01,Evidence at protein level
Q5T6F0,DCA12_HUMAN,DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A),453,"50,517",5 out of 5,2007-10-02,Evidence at protein level
Q5H9S7,DCA17_HUMAN,DDB1- and CUL4-associated factor 17,520,"58,778",5 out of 5,2007-09-11,Evidence at protein level
Q96JK2,DCAF5_HUMAN,DDB1- and CUL4-associated factor 5 (Breakpoint cluster region protein 2) (BCRP2) (WD repeat-containing protein 22),942,"103,963",4 out of 5,2004-05-24,Evidence at protein level
Q9UHG0,DCDC2_HUMAN,Doublecortin domain-containing protein 2 (Protein RU2S),476,"52,834",5 out of 5,2003-11-14,Evidence at protein level
Q8N568,DCLK2_HUMAN,Serine/threonine-protein kinase DCLK2 (EC 2.7.11.1) (CaMK-like CREB regulatory kinase 2) (CL2) (CLICK-II) (CLICK2) (Doublecortin domain-containing protein 3B) (Doublecortin-like and CAM kinase-like 2) (Doublecortin-like kinase 2),766,"83,606",5 out of 5,2005-02-15,Evidence at protein level
Q8IZD4,DCP1B_HUMAN,mRNA-decapping enzyme 1B (EC 3.-.-.-),617,"67,723",5 out of 5,2005-03-01,Evidence at protein level
O75935,DCTN3_HUMAN,Dynactin subunit 3 (Dynactin complex subunit 22 kDa subunit) (p22),186,"21,119",5 out of 5,2006-03-07,Evidence at protein level
Q8WTU0,DDI1_HUMAN,Protein DDI1 homolog 1,396,"44,124",3 out of 5,2007-05-15,Evidence at protein level
Q5TDH0,DDI2_HUMAN,Protein DDI1 homolog 2,399,"44,523",3 out of 5,2007-05-15,Evidence at protein level
P35638,DDIT3_HUMAN,DNA damage-inducible transcript 3 protein (DDIT-3) (C/EBP zeta) (C/EBP-homologous protein) (CHOP) (C/EBP-homologous protein 10) (CHOP-10) (CCAAT/enhancer-binding protein homologous protein) (Growth arrest and DNA damage-inducible protein GADD153),169,"19,175",5 out of 5,1994-06-01,Evidence at protein level
Q08345,DDR1_HUMAN,Epithelial discoidin domain-containing receptor 1 (Epithelial discoidin domain receptor 1) (EC 2.7.10.1) (CD167 antigen-like family member A) (Cell adhesion kinase) (Discoidin receptor tyrosine kinase) (HGK2) (Mammary carcinoma kinase 10) (MCK-10) (Protein-tyrosine kinase 3A) (Protein-tyrosine kinase RTK-6) (TRK E) (Tyrosine kinase DDR) (Tyrosine-protein kinase CAK) (CD antigen CD167a),913,"101,128",5 out of 5,1995-02-01,Evidence at protein level
Q9NVP1,DDX18_HUMAN,ATP-dependent RNA helicase DDX18 (EC 3.6.4.13) (DEAD box protein 18) (Myc-regulated DEAD box protein) (MrDb),670,"75,407",5 out of 5,2001-02-21,Evidence at protein level
Q9NR30,DDX21_HUMAN,Nucleolar RNA helicase 2 (EC 3.6.4.13) (DEAD box protein 21) (Gu-alpha) (Nucleolar RNA helicase Gu) (Nucleolar RNA helicase II) (RH II/Gu),783,"87,344",5 out of 5,2001-04-27,Evidence at protein level
Q8N8A6,DDX51_HUMAN,ATP-dependent RNA helicase DDX51 (EC 3.6.4.13) (DEAD box protein 51),666,"72,457",5 out of 5,2006-03-21,Evidence at protein level
P17844,DDX5_HUMAN,Probable ATP-dependent RNA helicase DDX5 (EC 3.6.4.13) (DEAD box protein 5) (RNA helicase p68),614,"69,148",5 out of 5,1990-08-01,Evidence at protein level
O75398,DEAF1_HUMAN,Deformed epidermal autoregulatory factor 1 homolog (Nuclear DEAF-1-related transcriptional regulator) (NUDR) (Suppressin) (Zinc finger MYND domain-containing protein 5),565,"59,327",5 out of 5,2002-08-13,Evidence at protein level
Q5D0E6,DALD3_HUMAN,DALR anticodon-binding domain-containing protein 3,543,"59,363",2 out of 5,2008-01-15,Evidence at protein level
P51397,DAP1_HUMAN,Death-associated protein 1 (DAP-1),102,"11,165",5 out of 5,1996-10-01,Evidence at protein level
Q9UN19,DAPP1_HUMAN,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide (hDAPP1) (B lymphocyte adapter protein Bam32) (B-cell adapter molecule of 32 kDa),280,"32,194",5 out of 5,2004-07-05,Evidence at protein level
A6NH13,DAS1_HUMAN,Putative uncharacterized protein DNAJC9-AS1 (DNAJC9 antisense RNA 1) (DNAJC9 antisense gene protein 1),148,"15,587",1 out of 5,2008-03-18,Evidence at transcript level
Q30KQ8,DB112_HUMAN,"Beta-defensin 112 (Beta-defensin 12) (DEFB-12) (Defensin, beta 112)",113,"12,991",2 out of 5,2005-12-20,Inferred from homology
Q8TEB1,DCA11_HUMAN,DDB1- and CUL4-associated factor 11 (WD repeat-containing protein 23),546,"61,670",4 out of 5,2003-10-03,Evidence at protein level
Q8WVC6,DCAKD_HUMAN,Dephospho-CoA kinase domain-containing protein,231,"26,550",3 out of 5,2008-02-05,Evidence at protein level
Q96C86,DCPS_HUMAN,m7GpppX diphosphatase (EC 3.6.1.59) (DCS-1) (Decapping scavenger enzyme) (Hint-related 7meGMP-directed hydrolase) (Histidine triad nucleotide-binding protein 5) (Histidine triad protein member 5) (HINT-5) (Scavenger mRNA-decapping enzyme DcpS),337,"38,609",5 out of 5,2005-03-01,Evidence at protein level
Q9H295,DCSTP_HUMAN,Dendritic cell-specific transmembrane protein (DC-STAMP) (hDC-STAMP) (Dendrocyte-expressed seven transmembrane protein) (IL-four-induced protein) (FIND) (Transmembrane 7 superfamily member 4),470,"53,393",5 out of 5,2005-07-19,Evidence at protein level
P06132,DCUP_HUMAN,Uroporphyrinogen decarboxylase (UPD) (URO-D) (EC 4.1.1.37),367,"40,787",5 out of 5,1988-01-01,Evidence at protein level
Q7Z4W1,DCXR_HUMAN,L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H),244,"25,913",5 out of 5,2004-07-19,Evidence at protein level
O43602,DCX_HUMAN,Neuronal migration protein doublecortin (Doublin) (Lissencephalin-X) (Lis-X),365,"40,574",5 out of 5,2000-05-30,Evidence at protein level
Q9NX09,DDIT4_HUMAN,DNA damage-inducible transcript 4 protein (HIF-1 responsive protein RTP801) (Protein regulated in development and DNA damage response 1) (REDD-1),232,"25,371",5 out of 5,2007-10-23,Evidence at protein level
Q14093,CYLC2_HUMAN,Cylicin-2 (Cylicin II) (Multiple-band polypeptide II),348,"39,079",4 out of 5,1997-11-01,Evidence at transcript level
O00622,CYR61_HUMAN,Protein CYR61 (CCN family member 1) (Cysteine-rich angiogenic inducer 61) (Insulin-like growth factor-binding protein 10) (IBP-10) (IGF-binding protein 10) (IGFBP-10) (Protein GIG1),381,"42,027",5 out of 5,1998-07-15,Evidence at protein level
Q8IZN7,D107A_HUMAN,"Beta-defensin 107 (Beta-defensin 7) (BD-7) (DEFB-7) (Defensin, beta 107)",70,"7,846",3 out of 5,2003-09-26,Evidence at transcript level
A8MPP1,D11L8_HUMAN,Putative ATP-dependent RNA helicase DDX11-like protein 8 (EC 3.6.4.13) (DEAD/H box protein 11-like 8),907,"101,811",3 out of 5,2008-09-02,Evidence at protein level
Q15038,DAZP2_HUMAN,DAZ-associated protein 2 (Deleted in azoospermia-associated protein 2),168,"17,319",5 out of 5,2004-03-01,Evidence at protein level
Q7Z7B8,DB128_HUMAN,"Beta-defensin 128 (Beta-defensin 28) (DEFB-28) (Defensin, beta 128)",93,"10,650",2 out of 5,2005-03-15,Inferred from homology
Q7Z7B7,DB132_HUMAN,"Beta-defensin 132 (Beta-defensin 32) (BD-32) (DEFB-32) (Defensin HEL-75) (Defensin, beta 132)",95,"10,610",3 out of 5,2005-03-15,Inferred from homology
Q9UBU7,DBF4A_HUMAN,Protein DBF4 homolog A (Activator of S phase kinase) (Chiffon homolog A) (DBF4-type zinc finger-containing protein 1),674,"76,858",5 out of 5,2006-05-02,Evidence at protein level
Q9H9R9,DBND1_HUMAN,Dysbindin domain-containing protein 1,158,"17,042",2 out of 5,2007-06-26,Evidence at protein level
Q8IWE4,DCNL3_HUMAN,DCN1-like protein 3 (DCUN1 domain-containing protein 3) (Defective in cullin neddylation protein 1-like protein 3) (Squamous cell carcinoma-related oncogene 3),304,"34,291",5 out of 5,2008-02-26,Evidence at protein level
Q8WXF8,DEDD2_HUMAN,DNA-binding death effector domain-containing protein 2 (DED-containing protein FLAME-3) (FADD-like anti-apoptotic molecule 3),326,"36,179",5 out of 5,2004-05-10,Evidence at protein level
Q14154,DELE_HUMAN,Death ligand signal enhancer,515,"55,920",4 out of 5,1997-11-01,Evidence at protein level
Q8IV53,DEN1C_HUMAN,DENN domain-containing protein 1C (Connecdenn 3) (Protein FAM31C),801,"87,065",5 out of 5,2007-09-11,Evidence at protein level
Q96QD5,DEPD7_HUMAN,DEP domain-containing protein 7 (Protein TR2/D15),511,"58,310",3 out of 5,2007-10-23,Evidence at transcript level
Q9GZP9,DERL2_HUMAN,Derlin-2 (Degradation in endoplasmic reticulum protein 2) (DERtrin-2) (Der1-like protein 2) (F-LAN-1) (F-LANa),239,"27,567",5 out of 5,2004-07-19,Evidence at protein level
Q96Q80,DERL3_HUMAN,Derlin-3 (Degradation in endoplasmic reticulum protein 3) (DERtrin-3) (Der1-like protein 3),235,"26,679",5 out of 5,2004-07-19,Evidence at protein level
P17661,DESM_HUMAN,Desmin,470,"53,536",5 out of 5,1990-08-01,Evidence at protein level
P15924,DESP_HUMAN,Desmoplakin (DP) (250/210 kDa paraneoplastic pemphigus antigen),2871,"331,774",5 out of 5,1990-04-01,Evidence at protein level
Q6PH85,DCNL2_HUMAN,DCN1-like protein 2 (DCUN1 domain-containing protein 2) (Defective in cullin neddylation protein 1-like protein 2),259,"30,179",4 out of 5,2005-08-30,Evidence at protein level
Q6PJP8,DCR1A_HUMAN,DNA cross-link repair 1A protein (SNM1 homolog A) (hSNM1) (hSNM1A),1040,"116,400",5 out of 5,2005-08-16,Evidence at protein level
Q9H816,DCR1B_HUMAN,5' exonuclease Apollo (EC 3.1.-.-) (DNA cross-link repair 1B protein) (SNM1 homolog B) (SNMIB) (hSNM1B),532,"60,002",5 out of 5,2005-08-16,Evidence at protein level
Q5T197,DCST1_HUMAN,DC-STAMP domain-containing protein 1,706,"80,712",3 out of 5,2007-03-06,Evidence at transcript level
Q14203,DCTN1_HUMAN,Dynactin subunit 1 (150 kDa dynein-associated polypeptide) (DAP-150) (DP-150) (p135) (p150-glued),1278,"141,695",5 out of 5,1997-11-01,Evidence at protein level
Q16531,DDB1_HUMAN,DNA damage-binding protein 1 (DDB p127 subunit) (DNA damage-binding protein a) (DDBa) (Damage-specific DNA-binding protein 1) (HBV X-associated protein 1) (XAP-1) (UV-damaged DNA-binding factor) (UV-damaged DNA-binding protein 1) (UV-DDB 1) (XPE-binding factor) (XPE-BF) (Xeroderma pigmentosum group E-complementing protein) (XPCe),1140,"126,968",5 out of 5,2001-01-11,Evidence at protein level
Q9UHL0,DDX25_HUMAN,ATP-dependent RNA helicase DDX25 (EC 3.6.4.13) (DEAD box protein 25) (Gonadotropin-regulated testicular RNA helicase),483,"54,692",5 out of 5,2003-02-12,Evidence at protein level
Q9NUL7,DDX28_HUMAN,Probable ATP-dependent RNA helicase DDX28 (EC 3.6.4.13) (Mitochondrial DEAD box protein 28),540,"59,581",5 out of 5,2006-01-10,Evidence at protein level
Q9Y2R4,DDX52_HUMAN,Probable ATP-dependent RNA helicase DDX52 (EC 3.6.4.13) (ATP-dependent RNA helicase ROK1-like) (DEAD box protein 52),599,"67,498",4 out of 5,2003-09-09,Evidence at protein level
Q9NY93,DDX56_HUMAN,Probable ATP-dependent RNA helicase DDX56 (EC 3.6.4.13) (ATP-dependent 61 kDa nucleolar RNA helicase) (DEAD box protein 21) (DEAD box protein 56),547,"61,590",5 out of 5,2002-01-23,Evidence at protein level
O95786,DDX58_HUMAN,Probable ATP-dependent RNA helicase DDX58 (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I),925,"106,600",5 out of 5,2005-11-08,Evidence at protein level
O75618,DEDD_HUMAN,Death effector domain-containing protein (DEDPro1) (Death effector domain-containing testicular molecule) (FLDED-1),318,"36,794",5 out of 5,2002-07-11,Evidence at protein level
Q6ZN54,DEFI8_HUMAN,Differentially expressed in FDCP 8 homolog (DEF-8),512,"58,710",3 out of 5,2008-02-26,Evidence at protein level
Q9HBH1,DEFM_HUMAN,"Peptide deformylase, mitochondrial (EC 3.5.1.88) (Polypeptide deformylase)",243,"27,013",5 out of 5,2001-12-05,Evidence at protein level
Q6P3S1,DEN1B_HUMAN,DENN domain-containing protein 1B (Connecdenn 2) (Protein FAM31B),775,"86,552",5 out of 5,2007-09-11,Evidence at protein level
A2RUS2,DEND3_HUMAN,DENN domain-containing protein 3,1198,"135,890",4 out of 5,2007-09-11,Evidence at protein level
Q5TB30,DEP1A_HUMAN,DEP domain-containing protein 1A,811,"92,960",5 out of 5,2007-04-17,Evidence at protein level
Q9BSY9,DESI2_HUMAN,Desumoylating isopeptidase 2 (DeSI-2) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 1) (Protein FAM152A),194,"21,444",3 out of 5,2004-08-31,Evidence at protein level
Q7L5Y6,DET1_HUMAN,DET1 homolog (De-etiolated-1 homolog),550,"63,848",3 out of 5,2004-11-23,Evidence at protein level
Q9Y6T7,DGKB_HUMAN,Diacylglycerol kinase beta (DAG kinase beta) (EC 2.7.1.107) (90 kDa diacylglycerol kinase) (Diglyceride kinase beta) (DGK-beta),804,"90,595",5 out of 5,2001-01-11,Evidence at transcript level
P49619,DGKG_HUMAN,Diacylglycerol kinase gamma (DAG kinase gamma) (EC 2.7.1.107) (Diglyceride kinase gamma) (DGK-gamma),791,"89,124",5 out of 5,1996-02-01,Evidence at transcript level
P37058,DHB3_HUMAN,Testosterone 17-beta-dehydrogenase 3 (EC 1.1.1.64) (17-beta-hydroxysteroid dehydrogenase type 3) (17-beta-HSD 3) (Short chain dehydrogenase/reductase family 12C member 2) (Testicular 17-beta-hydroxysteroid dehydrogenase),310,"34,516",5 out of 5,1994-06-01,Evidence at protein level
P00367,DHE3_HUMAN,"Glutamate dehydrogenase 1, mitochondrial (GDH 1) (EC 1.4.1.3)",558,"61,398",5 out of 5,1986-07-21,Evidence at protein level
P28845,DHI1_HUMAN,Corticosteroid 11-beta-dehydrogenase isozyme 1 (EC 1.1.1.146) (11-beta-hydroxysteroid dehydrogenase 1) (11-DH) (11-beta-HSD1) (Short chain dehydrogenase/reductase family 26C member 1),292,"32,401",5 out of 5,1992-12-01,Evidence at protein level
Q00796,DHSO_HUMAN,Sorbitol dehydrogenase (EC 1.1.1.14) (L-iditol 2-dehydrogenase),357,"38,325",5 out of 5,1993-04-01,Evidence at protein level
O43143,DHX15_HUMAN,Pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15 (EC 3.6.4.13) (ATP-dependent RNA helicase #46) (DEAH box protein 15),795,"90,933",5 out of 5,1998-12-15,Evidence at protein level
Q9H6R0,DHX33_HUMAN,Putative ATP-dependent RNA helicase DHX33 (EC 3.6.4.13) (DEAH box protein 33),707,"78,874",5 out of 5,2005-11-22,Evidence at protein level
O60879,DIAP2_HUMAN,Protein diaphanous homolog 2 (Diaphanous-related formin-2) (DRF2),1101,"125,569",5 out of 5,1999-07-15,Evidence at protein level
Q9UPY3,DICER_HUMAN,Endoribonuclease Dicer (EC 3.1.26.3) (Helicase with RNase motif) (Helicase MOI),1922,"218,682",5 out of 5,2002-10-25,Evidence at protein level
Q96HU8,DIRA2_HUMAN,GTP-binding protein Di-Ras2 (Distinct subgroup of the Ras family member 2),199,"22,485",4 out of 5,2005-03-29,Evidence at protein level
Q969H9,DIRC1_HUMAN,Disrupted in renal carcinoma protein 1 (Disrupted in renal cancer protein),104,"11,440",2 out of 5,2005-06-21,Evidence at transcript level
Q9NXW2,DJB12_HUMAN,DnaJ homolog subfamily B member 12,375,"41,819",5 out of 5,2001-10-18,Evidence at protein level
Q6Y2X3,DJC14_HUMAN,DnaJ homolog subfamily C member 14 (DnaJ protein homolog 3) (Dopamine receptor-interacting protein of 78 kDa) (DRIP78) (Human DnaJ protein 3) (hDj-3),702,"78,569",4 out of 5,2006-07-25,Evidence at transcript level
Q5J5C9,DB121_HUMAN,"Beta-defensin 121 (Beta-defensin 21) (DEFB-21) (Defensin, beta 121)",76,"8,456",3 out of 5,2005-03-15,Evidence at protein level
Q8NES8,DB124_HUMAN,"Beta-defensin 124 (Beta-defensin 24) (DEFB-24) (Defensin, beta 124)",71,"8,058",2 out of 5,2003-10-03,Inferred from homology
P59861,DB131_HUMAN,"Beta-defensin 131 (Beta-defensin 31) (DEFB-31) (Defensin, beta 131)",70,"8,199",3 out of 5,2003-09-26,Evidence at transcript level
Q30KP8,DB136_HUMAN,"Beta-defensin 136 (Defensin, beta 136)",78,"8,755",2 out of 5,2005-12-20,Inferred from homology
Q9NR28,DBLOH_HUMAN,"Diablo homolog, mitochondrial (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspase) (Smac)",239,"27,131",5 out of 5,2001-10-18,Evidence at protein level
O43237,DC1L2_HUMAN,"Cytoplasmic dynein 1 light intermediate chain 2 (Dynein light intermediate chain 2, cytosolic) (LIC-2) (LIC53/55)",492,"54,099",5 out of 5,1998-07-15,Evidence at protein level
P0C7V8,DC8L2_HUMAN,DDB1- and CUL4-associated factor 8-like protein 2 (WD repeat-containing protein 42C),631,"71,191",2 out of 5,2008-07-22,Evidence at transcript level
A2VCK2,DCD2B_HUMAN,Doublecortin domain-containing protein 2B,349,"37,665",2 out of 5,2007-10-02,Evidence at protein level
Q6ZRR9,DCDC5_HUMAN,Doublecortin domain-containing protein 5,648,"72,753",2 out of 5,2008-06-10,Evidence at transcript level
P81605,DCD_HUMAN,Dermcidin (EC 3.4.-.-) (Preproteolysin) [Cleaved into: Survival-promoting peptide; DCD-1],110,"11,284",5 out of 5,1999-07-15,Evidence at protein level
O00399,DCTN6_HUMAN,Dynactin subunit 6 (Dynactin subunit p27) (Protein WS-3),190,"20,747",4 out of 5,1998-07-15,Evidence at protein level
P20711,DDC_HUMAN,Aromatic-L-amino-acid decarboxylase (AADC) (EC 4.1.1.28) (DOPA decarboxylase) (DDC),480,"53,926",5 out of 5,1991-02-01,Evidence at protein level
Q8IXT1,DDIAS_HUMAN,DNA damage-induced apoptosis suppressor protein (Nitric oxide-inducible gene protein),998,"111,616",4 out of 5,2007-12-04,Evidence at transcript level
Q9UHI6,DDX20_HUMAN,Probable ATP-dependent RNA helicase DDX20 (EC 3.6.4.13) (Component of gems 3) (DEAD box protein 20) (DEAD box protein DP 103) (Gemin-3),824,"92,241",5 out of 5,2000-12-01,Evidence at protein level
Q9GZR7,DDX24_HUMAN,ATP-dependent RNA helicase DDX24 (EC 3.6.4.13) (DEAD box protein 24),859,"96,332",4 out of 5,2001-09-26,Evidence at protein level
Q96GQ7,DDX27_HUMAN,Probable ATP-dependent RNA helicase DDX27 (EC 3.6.4.13) (DEAD box protein 27),796,"89,835",5 out of 5,2003-03-28,Evidence at protein level
Q9NXZ2,DDX43_HUMAN,Probable ATP-dependent RNA helicase DDX43 (EC 3.6.4.13) (Cancer/testis antigen 13) (CT13) (DEAD box protein 43) (DEAD box protein HAGE) (Helical antigen),648,"72,844",4 out of 5,2005-10-25,Evidence at transcript level
Q9Y6V7,DDX49_HUMAN,Probable ATP-dependent RNA helicase DDX49 (EC 3.6.4.13) (DEAD box protein 49),483,"54,226",4 out of 5,2005-09-27,Evidence at protein level
Q9NQI0,DDX4_HUMAN,Probable ATP-dependent RNA helicase DDX4 (EC 3.6.4.13) (DEAD box protein 4) (Vasa homolog),724,"79,308",5 out of 5,2002-01-23,Evidence at protein level
Q9ULE3,DEN2A_HUMAN,DENN domain-containing protein 2A,1009,"113,853",4 out of 5,2006-06-27,Evidence at transcript level
Q9Y315,DEOC_HUMAN,Deoxyribose-phosphate aldolase (DERA) (EC 4.1.2.4) (2-deoxy-D-ribose 5-phosphate aldolase) (Phosphodeoxyriboaldolase) (Deoxyriboaldolase),318,"35,231",5 out of 5,2002-11-01,Evidence at protein level
O75140,DEPD5_HUMAN,DEP domain-containing protein 5,1603,"181,264",5 out of 5,2002-04-03,Evidence at protein level
Q9BUN8,DERL1_HUMAN,Derlin-1 (Degradation in endoplasmic reticulum protein 1) (DERtrin-1) (Der1-like protein 1),251,"28,801",5 out of 5,2004-07-19,Evidence at protein level
O76075,DFFB_HUMAN,DNA fragmentation factor subunit beta (EC 3.-.-.-) (Caspase-activated deoxyribonuclease) (CAD) (Caspase-activated DNase) (Caspase-activated nuclease) (CPAN) (DNA fragmentation factor 40 kDa subunit) (DFF-40),338,"39,110",5 out of 5,2000-12-01,Evidence at protein level
O75907,DGAT1_HUMAN,Diacylglycerol O-acyltransferase 1 (EC 2.3.1.20) (ACAT-related gene product 1) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase),488,"55,278",5 out of 5,2001-10-18,Evidence at protein level
Q9H819,DJC18_HUMAN,DnaJ homolog subfamily C member 18,358,"41,551",2 out of 5,2006-06-27,Evidence at transcript level
Q6P3W2,DJC24_HUMAN,DnaJ homolog subfamily C member 24 (CSL-type zinc finger-containing protein 3) (Diphthamide biosynthesis protein 4),148,"17,008",5 out of 5,2005-05-24,Evidence at protein level
Q9NZQ0,DJC27_HUMAN,DnaJ homolog subfamily C member 27 (Rab and DnaJ domain-containing protein),273,"30,855",4 out of 5,2008-05-20,Evidence at protein level
Q9UBT3,DKK4_HUMAN,Dickkopf-related protein 4 (Dickkopf-4) (Dkk-4) (hDkk-4) [Cleaved into: Dickkopf-related protein 4 short form],224,"24,876",4 out of 5,2001-02-21,Evidence at protein level
P19113,DCHS_HUMAN,Histidine decarboxylase (HDC) (EC 4.1.1.22),662,"74,141",5 out of 5,1990-11-01,Evidence at protein level
O95822,DCMC_HUMAN,"Malonyl-CoA decarboxylase, mitochondrial (MCD) (EC 4.1.1.9)",493,"55,003",5 out of 5,2000-12-01,Evidence at protein level
Q9BTE7,DCNL5_HUMAN,DCN1-like protein 5 (DCUN1 domain-containing protein 5) (Defective in cullin neddylation protein 1-like protein 5),237,"27,508",3 out of 5,2006-10-31,Evidence at protein level
Q96SD1,DCR1C_HUMAN,Protein artemis (EC 3.1.-.-) (DNA cross-link repair 1C protein) (Protein A-SCID) (SNM1 homolog C) (hSNM1C) (SNM1-like protein),692,"78,436",5 out of 5,2005-07-19,Evidence at protein level
Q9BTE1,DCTN5_HUMAN,Dynactin subunit 5 (Dynactin subunit p25),182,"20,127",5 out of 5,2005-04-26,Evidence at protein level
Q9NUU7,DD19A_HUMAN,ATP-dependent RNA helicase DDX19A (EC 3.6.4.13) (DDX19-like protein) (DEAD box protein 19A),478,"53,975",5 out of 5,2005-08-30,Evidence at protein level
Q92466,DDB2_HUMAN,DNA damage-binding protein 2 (DDB p48 subunit) (DDBb) (Damage-specific DNA-binding protein 2) (UV-damaged DNA-binding protein 2) (UV-DDB 2),427,"47,864",5 out of 5,2001-01-11,Evidence at protein level
Q92771,DDX12_HUMAN,Putative ATP-dependent RNA helicase DDX12 (EC 3.6.4.13) (CHL1-related protein 2) (hCHLR2) (DEAD/H box protein 12),950,"106,006",4 out of 5,2007-10-23,Uncertain
Q92841,DDX17_HUMAN,Probable ATP-dependent RNA helicase DDX17 (EC 3.6.4.13) (DEAD box protein 17) (DEAD box protein p72) (DEAD box protein p82) (RNA-dependent helicase p72),729,"80,272",5 out of 5,1998-07-15,Evidence at protein level
Q86XP3,DDX42_HUMAN,ATP-dependent RNA helicase DDX42 (EC 3.6.4.13) (DEAD box protein 42) (RNA helicase-like protein) (RHELP) (RNA helicase-related protein) (RNAHP) (SF3b DEAD box protein) (Splicing factor 3B-associated 125 kDa protein) (SF3b125),938,"102,975",5 out of 5,2007-03-06,Evidence at protein level
P26196,DDX6_HUMAN,Probable ATP-dependent RNA helicase DDX6 (EC 3.6.4.13) (ATP-dependent RNA helicase p54) (DEAD box protein 6) (Oncogene RCK),483,"54,417",5 out of 5,1992-05-01,Evidence at protein level
Q01524,DEF6_HUMAN,"Defensin-6 (Defensin, alpha 6)",100,"10,975",5 out of 5,1993-07-01,Evidence at protein level
P35659,DEK_HUMAN,Protein DEK,375,"42,674",5 out of 5,1994-06-01,Evidence at protein level
O43583,DENR_HUMAN,Density-regulated protein (DRP) (Protein DRP1) (Smooth muscle cell-associated protein 3) (SMAP-3),198,"22,092",5 out of 5,1999-07-15,Evidence at protein level
O60443,DFNA5_HUMAN,Non-syndromic hearing impairment protein 5 (Inversely correlated with estrogen receptor expression 1) (ICERE-1),496,"54,555",5 out of 5,2001-02-21,Evidence at protein level
Q9BY27,DGC6L_HUMAN,Protein DGCR6L (DiGeorge syndrome critical region 6-like protein),220,"24,932",4 out of 5,2002-07-26,Evidence at protein level
Q86XP1,DGKH_HUMAN,Diacylglycerol kinase eta (DAG kinase eta) (EC 2.7.1.107) (Diglyceride kinase eta) (DGK-eta),1220,"134,866",5 out of 5,2006-06-13,Evidence at protein level
Q14147,DHX34_HUMAN,Probable ATP-dependent RNA helicase DHX34 (EC 3.6.4.13) (DEAH box protein 34),1143,"128,120",5 out of 5,1998-07-15,Evidence at protein level
Q14562,DHX8_HUMAN,ATP-dependent RNA helicase DHX8 (EC 3.6.4.13) (DEAH box protein 8) (RNA helicase HRH1),1220,"139,315",5 out of 5,1998-07-15,Evidence at protein level
Q9NSV4,DIAP3_HUMAN,Protein diaphanous homolog 3 (Diaphanous-related formin-3) (DRF3) (MDia2),1193,"136,926",5 out of 5,2001-02-21,Evidence at protein level
Q9P265,DIP2B_HUMAN,Disco-interacting protein 2 homolog B (DIP2 homolog B),1576,"171,492",4 out of 5,2008-02-26,Evidence at protein level
A7MBM2,DISP2_HUMAN,Protein dispatched homolog 2,1401,"152,003",3 out of 5,2007-11-13,Evidence at transcript level
Q9UBP4,DKK3_HUMAN,Dickkopf-related protein 3 (Dickkopf-3) (Dkk-3) (hDkk-3),350,"38,390",5 out of 5,2001-02-21,Evidence at protein level
Q12959,DLG1_HUMAN,Disks large homolog 1 (Synapse-associated protein 97) (SAP-97) (SAP97) (hDlg),904,"100,455",5 out of 5,1997-11-01,Evidence at protein level
Q92796,DLG3_HUMAN,Disks large homolog 3 (Neuroendocrine-DLG) (Synapse-associated protein 102) (SAP-102) (SAP102) (XLMR),817,"90,314",5 out of 5,1997-11-01,Evidence at protein level
Q15398,DLGP5_HUMAN,Disks large-associated protein 5 (DAP-5) (Discs large homolog 7) (Disks large-associated protein DLG7) (Hepatoma up-regulated protein) (HURP),846,"95,115",5 out of 5,1998-07-15,Evidence at protein level
P60981,DEST_HUMAN,Destrin (Actin-depolymerizing factor) (ADF),165,"18,506",5 out of 5,2004-04-26,Evidence at protein level
Q6IED9,DG2L7_HUMAN,Putative diacylglycerol O-acyltransferase 2-like protein DGAT2L7P (EC 2.3.1.-) (Diacylglycerol O-acyltransferase 2-like 7 pseudogene),249,"27,571",2 out of 5,2008-07-01,Uncertain
Q96PD7,DGAT2_HUMAN,Diacylglycerol O-acyltransferase 2 (EC 2.3.1.20) (Acyl-CoA retinol O-fatty-acyltransferase) (ARAT) (Retinol O-fatty-acyltransferase) (EC 2.3.1.76) (Diglyceride acyltransferase 2),388,"43,831",5 out of 5,2006-09-05,Evidence at protein level
Q8WYQ5,DGCR8_HUMAN,Microprocessor complex subunit DGCR8 (DiGeorge syndrome critical region 8),773,"86,045",5 out of 5,2002-10-10,Evidence at protein level
Q8NBQ5,DHB11_HUMAN,Estradiol 17-beta-dehydrogenase 11 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 11) (17-beta-HSD 11) (17bHSD11) (17betaHSD11) (17-beta-hydroxysteroid dehydrogenase XI) (17-beta-HSD XI) (17betaHSDXI) (Cutaneous T-cell lymphoma-associated antigen HD-CL-03) (CTCL-associated antigen HD-CL-03) (Dehydrogenase/reductase SDR family member 8) (Retinal short-chain dehydrogenase/reductase 2) (retSDR2) (Short chain dehydrogenase/reductase family 16C member 2),300,"32,936",5 out of 5,2005-08-16,Evidence at protein level
Q7Z5P4,DHB13_HUMAN,17-beta-hydroxysteroid dehydrogenase 13 (17-beta-HSD 13) (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 16C member 3) (Short-chain dehydrogenase/reductase 9),300,"33,655",4 out of 5,2005-10-11,Evidence at protein level
P51659,DHB4_HUMAN,"Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MPF-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]",736,"79,686",5 out of 5,1996-10-01,Evidence at protein level
O75911,DHRS3_HUMAN,Short-chain dehydrogenase/reductase 3 (EC 1.1.1.300) (DD83.1) (Retinal short-chain dehydrogenase/reductase 1) (retSDR1) (Retinol dehydrogenase 17) (Short chain dehydrogenase/reductase family 16C member 1),302,"33,548",5 out of 5,2004-05-10,Evidence at protein level
Q7L2E3,DHX30_HUMAN,Putative ATP-dependent RNA helicase DHX30 (EC 3.6.4.13) (DEAH box protein 30),1194,"133,938",5 out of 5,2006-07-11,Evidence at protein level
Q9H7Y0,DIA1R_HUMAN,Deleted in autism-related protein 1,433,"48,555",3 out of 5,2005-07-05,Evidence at transcript level
Q9UBX3,DIC_HUMAN,Mitochondrial dicarboxylate carrier (Solute carrier family 25 member 10),287,"31,282",5 out of 5,2002-02-11,Evidence at protein level
Q9NRI5,DISC1_HUMAN,Disrupted in schizophrenia 1 protein,854,"93,611",5 out of 5,2001-11-16,Evidence at protein level
O75165,DJC13_HUMAN,DnaJ homolog subfamily C member 13 (Required for receptor-mediated endocytosis 8) (RME-8),2243,"254,415",5 out of 5,2004-04-13,Evidence at protein level
P09622,DLDH_HUMAN,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",509,"54,177",5 out of 5,1989-07-01,Evidence at protein level
Q9Y238,DLEC1_HUMAN,Deleted in lung and esophageal cancer protein 1 (Deleted in lung cancer protein 1) (DLC-1),1755,"195,684",5 out of 5,2005-10-25,Evidence at transcript level
O95886,DLGP3_HUMAN,Disks large-associated protein 3 (DAP-3) (PSD-95/SAP90-binding protein 3) (SAP90/PSD-95-associated protein 3) (SAPAP3),979,"106,040",4 out of 5,2001-09-26,Evidence at protein level
Q13316,DMP1_HUMAN,Dentin matrix acidic phosphoprotein 1 (DMP-1) (Dentin matrix protein 1),513,"55,782",5 out of 5,2000-05-30,Evidence at protein level
Q9NQL9,DMRT3_HUMAN,Doublesex- and mab-3-related transcription factor 3,472,"51,199",5 out of 5,2007-02-20,Evidence at protein level
Q07507,DERM_HUMAN,Dermatopontin (Tyrosine-rich acidic matrix protein) (TRAMP),201,"24,005",4 out of 5,1996-10-01,Evidence at protein level
Q6ICB0,DESI1_HUMAN,Desumoylating isopeptidase 1 (DeSI-1) (EC 3.4.-.-) (PPPDE peptidase domain-containing protein 2) (Protein FAM152B),168,"18,263",4 out of 5,2008-02-05,Evidence at protein level
Q15392,DHC24_HUMAN,Delta(24)-sterol reductase (EC 1.3.1.72) (24-dehydrocholesterol reductase) (3-beta-hydroxysterol delta-24-reductase) (Diminuto/dwarf1 homolog) (Seladin-1),516,"60,101",5 out of 5,1998-07-15,Evidence at protein level
Q9UBM7,DHCR7_HUMAN,7-dehydrocholesterol reductase (7-DHC reductase) (EC 1.3.1.21) (Putative sterol reductase SR-2) (Sterol Delta(7)-reductase),475,"54,489",5 out of 5,2002-01-31,Evidence at protein level
Q9UQ10,DHDH_HUMAN,"Trans-1,2-dihydrobenzene-1,2-diol dehydrogenase (EC 1.3.1.20) (D-xylose 1-dehydrogenase) (D-xylose-NADP dehydrogenase) (EC 1.1.1.179) (Dimeric dihydrodiol dehydrogenase) (Hum2DD)",334,"36,382",5 out of 5,2008-01-15,Evidence at protein level
Q14689,DIP2A_HUMAN,Disco-interacting protein 2 homolog A (DIP2 homolog A),1571,"170,369",5 out of 5,2000-05-30,Evidence at protein level
O95661,DIRA3_HUMAN,GTP-binding protein Di-Ras3 (Distinct subgroup of the Ras family member 3) (Rho-related GTP-binding protein RhoI),229,"25,861",4 out of 5,2001-04-27,Evidence at protein level
Q9Y2G8,DJC16_HUMAN,DnaJ homolog subfamily C member 16,782,"90,591",3 out of 5,2006-05-30,Evidence at transcript level
Q9H1X3,DJC25_HUMAN,DnaJ homolog subfamily C member 25,360,"42,404",2 out of 5,2008-09-02,Evidence at protein level
O60479,DLX3_HUMAN,Homeobox protein DLX-3,287,"31,738",4 out of 5,1998-12-15,Evidence at protein level
Q5HYR2,DMRTC_HUMAN,Doublesex- and mab-3-related transcription factor C1,192,"20,139",2 out of 5,2006-06-27,Evidence at transcript level
P24855,DNAS1_HUMAN,Deoxyribonuclease-1 (EC 3.1.21.1) (Deoxyribonuclease I) (DNase I) (Dornase alfa),282,"31,434",5 out of 5,1992-03-01,Evidence at protein level
Q8N7S2,DNJ5G_HUMAN,DnaJ homolog subfamily C member 5G (Cysteine string protein-gamma) (CSP-gamma),189,"21,433",2 out of 5,2004-07-19,Evidence at transcript level
O60884,DNJA2_HUMAN,DnaJ homolog subfamily A member 2 (Cell cycle progression restoration gene 3 protein) (Dnj3) (Dj3) (HIRA-interacting protein 4) (Renal carcinoma antigen NY-REN-14),412,"45,746",5 out of 5,2001-07-11,Evidence at protein level
Q96EY1,DNJA3_HUMAN,"DnaJ homolog subfamily A member 3, mitochondrial (DnaJ protein Tid-1) (hTid-1) (Hepatocellular carcinoma-associated antigen 57) (Tumorous imaginal discs protein Tid56 homolog)",480,"52,489",5 out of 5,2003-05-16,Evidence at protein level
P49917,DNLI4_HUMAN,DNA ligase 4 (EC 6.5.1.1) (DNA ligase IV) (Polydeoxyribonucleotide synthase [ATP] 4),911,"103,971",5 out of 5,1996-10-01,Evidence at protein level
Q30KQ1,DB133_HUMAN,"Beta-defensin 133 (Defensin, beta 133)",61,"7,213",2 out of 5,2005-12-20,Inferred from homology
Q10586,DBP_HUMAN,D site-binding protein (Albumin D box-binding protein) (Albumin D-element-binding protein) (Tax-responsive enhancer element-binding protein 302) (TaxREB302),325,"34,349",5 out of 5,1996-10-01,Evidence at protein level
Q5VU92,DC121_HUMAN,DDB1- and CUL4-associated factor 12-like protein 1 (WD repeat-containing protein 40B),463,"51,201",2 out of 5,2007-10-02,Evidence at protein level
Q9Y6G9,DC1L1_HUMAN,"Cytoplasmic dynein 1 light intermediate chain 1 (LIC1) (Dynein light chain A) (DLC-A) (Dynein light intermediate chain 1, cytosolic)",523,"56,579",5 out of 5,2005-08-30,Evidence at protein level
Q9UMR2,DD19B_HUMAN,ATP-dependent RNA helicase DDX19B (EC 3.6.4.13) (DEAD box RNA helicase DEAD5) (DEAD box protein 19B),479,"53,927",5 out of 5,2000-12-01,Evidence at protein level
P59666,DEF3_HUMAN,"Neutrophil defensin 3 (Defensin, alpha 3) (HNP-3) (HP-3) (HP3) [Cleaved into: HP 3-56; Neutrophil defensin 2 (HNP-2) (HP-2) (HP2)]",94,"10,245",5 out of 5,2003-04-30,Evidence at protein level
Q08495,DEMA_HUMAN,Dematin (Dematin actin-binding protein) (Erythrocyte membrane protein band 4.9),405,"45,514",5 out of 5,1994-10-01,Evidence at protein level
Q9H6A0,DEN2D_HUMAN,DENN domain-containing protein 2D,471,"53,672",3 out of 5,2006-06-27,Evidence at protein level
Q6ZUT9,DEN5B_HUMAN,DENN domain-containing protein 5B (Rab6IP1-like protein),1274,"145,020",5 out of 5,2008-04-08,Evidence at protein level
Q8WUY9,DEP1B_HUMAN,DEP domain-containing protein 1B (HBV X-transactivated gene 8 protein) (HBV XAg-transactivated protein 8),529,"61,771",4 out of 5,2007-04-17,Evidence at protein level
O15263,DFB4A_HUMAN,"Beta-defensin 4A (Beta-defensin 2) (BD-2) (hBD-2) (Defensin, beta 2) (Skin-antimicrobial peptide 1) (SAP1)",64,"7,038",5 out of 5,1998-07-15,Evidence at protein level
Q14129,DGCR6_HUMAN,Protein DGCR6 (DiGeorge syndrome critical region 6),220,"24,989",4 out of 5,2000-05-30,Evidence at protein level
Q53GQ0,DHB12_HUMAN,Very-long-chain 3-oxoacyl-CoA reductase (EC 1.1.1.330) (17-beta-hydroxysteroid dehydrogenase 12) (17-beta-HSD 12) (3-ketoacyl-CoA reductase) (KAR) (Estradiol 17-beta-dehydrogenase 12) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 12C member 1),312,"34,324",5 out of 5,2006-09-05,Evidence at protein level
P37059,DHB2_HUMAN,Estradiol 17-beta-dehydrogenase 2 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase type 2) (17-beta-HSD 2) (20 alpha-hydroxysteroid dehydrogenase) (20-alpha-HSD) (E2DH) (Microsomal 17-beta-hydroxysteroid dehydrogenase) (Short chain dehydrogenase/reductase family 9C member 2) (Testosterone 17-beta-dehydrogenase) (EC 1.1.1.239),387,"42,785",5 out of 5,1994-06-01,Evidence at protein level
P56937,DHB7_HUMAN,3-keto-steroid reductase (EC 1.1.1.270) (17-beta-hydroxysteroid dehydrogenase 7) (17-beta-HSD 7) (Estradiol 17-beta-dehydrogenase 7) (EC 1.1.1.62) (Short chain dehydrogenase/reductase family 37C member 1),341,"38,206",5 out of 5,2000-05-30,Evidence at protein level
Q6UX07,DHR13_HUMAN,Dehydrogenase/reductase SDR family member 13 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 7C member 5),377,"40,849",4 out of 5,2007-12-04,Evidence at transcript level
Q8NDZ4,DIA1_HUMAN,Deleted in autism protein 1 (Golgi Protein of 49 kDa) (GoPro49) (Hypoxia and AKT-induced stem cell factor) (HASF),430,"49,482",5 out of 5,2006-03-07,Evidence at protein level
Q9Y2E4,DIP2C_HUMAN,Disco-interacting protein 2 homolog C (DIP2 homolog C),1556,"170,767",3 out of 5,2000-05-30,Evidence at protein level
Q9UBU2,DKK2_HUMAN,Dickkopf-related protein 2 (Dickkopf-2) (Dkk-2) (hDkk-2),259,"28,447",4 out of 5,2001-02-21,Evidence at transcript level
Q8TDM6,DLG5_HUMAN,Disks large homolog 5 (Discs large protein P-dlg) (Placenta and prostate DLG),1919,"213,868",5 out of 5,2003-01-10,Evidence at protein level
O14490,DLGP1_HUMAN,Disks large-associated protein 1 (DAP-1) (Guanylate kinase-associated protein) (hGKAP) (PSD-95/SAP90-binding protein 1) (SAP90/PSD-95-associated protein 1) (SAPAP1),977,"108,873",5 out of 5,2001-09-26,Evidence at protein level
Q9Y2H0,DLGP4_HUMAN,Disks large-associated protein 4 (DAP-4) (PSD-95/SAP90-binding protein 4) (SAP90/PSD-95-associated protein 4) (SAPAP-4),992,"108,012",5 out of 5,2001-09-26,Evidence at protein level
Q8TF09,DLRB2_HUMAN,"Dynein light chain roadblock-type 2 (Dynein light chain 2B, cytoplasmic) (Roadblock domain-containing protein 2)",96,"10,855",5 out of 5,2003-04-23,Evidence at protein level
P56177,DLX1_HUMAN,Homeobox protein DLX-1,255,"27,320",5 out of 5,1997-11-01,Evidence at protein level
Q9UF47,DNJ5B_HUMAN,DnaJ homolog subfamily C member 5B (Cysteine string protein beta) (CSP-beta),199,"22,496",3 out of 5,2000-12-01,Evidence at protein level
Q8WW22,DNJA4_HUMAN,DnaJ homolog subfamily A member 4,397,"44,798",5 out of 5,2003-01-17,Evidence at protein level
Q8WWF6,DNJB3_HUMAN,DnaJ homolog subfamily B member 3,145,"16,559",2 out of 5,2009-10-13,Evidence at protein level
Q96HY6,DDRGK_HUMAN,DDRGK domain-containing protein 1 (Dashurin) (UFM1-binding and PCI domain-containing protein 1),314,"35,611",5 out of 5,2003-09-26,Evidence at protein level
Q13206,DDX10_HUMAN,Probable ATP-dependent RNA helicase DDX10 (EC 3.6.4.13) (DEAD box protein 10),875,"100,888",4 out of 5,1998-07-15,Evidence at protein level
Q96FC9,DDX11_HUMAN,ATP-dependent DNA helicase DDX11 (EC 3.6.4.12) (CHL1-related protein 1) (hCHLR1) (DEAD/H-box protein 11) (Keratinocyte growth factor-regulated gene 2 protein) (KRG-2),970,"108,313",5 out of 5,2006-01-10,Evidence at protein level
Q9NUI1,DECR2_HUMAN,"Peroxisomal 2,4-dienoyl-CoA reductase (pDCR) (EC 1.3.1.34) (2,4-dienoyl-CoA reductase 2) (Short chain dehydrogenase/reductase family 17C member 1)",292,"30,778",5 out of 5,2005-05-10,Evidence at protein level
Q68D51,DEN2C_HUMAN,DENN domain-containing protein 2C,928,"106,865",3 out of 5,2006-06-27,Evidence at protein level
Q5VZ89,DEN4C_HUMAN,DENN domain-containing protein 4C,1673,"186,857",5 out of 5,2005-07-19,Evidence at protein level
Q8IWF6,DEN6A_HUMAN,Protein DENND6A (DENN domain-containing protein 6A),608,"69,575",4 out of 5,2007-05-29,Evidence at protein level
Q05D60,DEUP1_HUMAN,Deuterosome assembly protein 1 (Coiled-coil domain-containing protein 67),604,"70,977",5 out of 5,2007-08-21,Evidence at protein level
Q9P1J3,DHAS1_HUMAN,Putative uncharacterized protein DHRS4-AS1 (DHRS4 antisense RNA 1) (DHRS4 antisense gene protein 1),65,"7,343",1 out of 5,2003-10-03,Uncertain
Q92506,DHB8_HUMAN,Estradiol 17-beta-dehydrogenase 8 (EC 1.1.1.62) (17-beta-hydroxysteroid dehydrogenase 8) (17-beta-HSD 8) (3-ketoacyl-[acyl-carrier-protein] reductase alpha subunit) (KAR alpha subunit) (3-oxoacyl-[acyl-carrier-protein] reductase) (EC 1.1.1.-) (Protein Ke6) (Ke-6) (Really interesting new gene 2 protein) (Short chain dehydrogenase/reductase family 30C member 1) (Testosterone 17-beta-dehydrogenase 8) (EC 1.1.1.239),261,"26,974",5 out of 5,2000-05-30,Evidence at protein level
O43323,DHH_HUMAN,Desert hedgehog protein (DHH) (HHG-3) [Cleaved into: Desert hedgehog protein N-product; Desert hedgehog protein C-product],396,"43,577",5 out of 5,1999-07-15,Evidence at protein level
Q9H5Z1,DHX35_HUMAN,Probable ATP-dependent RNA helicase DHX35 (EC 3.6.4.13) (DEAH box protein 35),703,"78,910",5 out of 5,2002-01-23,Evidence at protein level
Q8IY37,DHX37_HUMAN,Probable ATP-dependent RNA helicase DHX37 (EC 3.6.4.13) (DEAH box protein 37),1157,"129,545",4 out of 5,2003-11-07,Evidence at protein level
Q8IX18,DHX40_HUMAN,Probable ATP-dependent RNA helicase DHX40 (EC 3.6.4.13) (DEAH box protein 40) (Protein PAD),779,"88,560",4 out of 5,2006-10-17,Evidence at protein level
P56178,DLX5_HUMAN,Homeobox protein DLX-5,289,"31,540",5 out of 5,1997-11-01,Evidence at protein level
Q9UGM3,DMBT1_HUMAN,Deleted in malignant brain tumors 1 protein (Glycoprotein 340) (Gp-340) (Hensin) (Salivary agglutinin) (SAG) (Surfactant pulmonary-associated D-binding protein),2413,"260,735",5 out of 5,2006-01-10,Evidence at protein level
P28068,DMB_HUMAN,"HLA class II histocompatibility antigen, DM beta chain (MHC class II antigen DMB) (Really interesting new gene 7 protein)",263,"28,943",5 out of 5,1992-08-01,Evidence at protein level
Q6E0U4,DMKN_HUMAN,Dermokine (Epidermis-specific secreted protein SK30/SK89),476,"47,082",5 out of 5,2008-04-29,Evidence at protein level
Q96SC8,DMTA2_HUMAN,Doublesex- and mab-3-related transcription factor A2 (Doublesex- and mab-3-related transcription factor 5),542,"53,356",4 out of 5,2008-05-20,Evidence at transcript level
Q09019,DMWD_HUMAN,Dystrophia myotonica WD repeat-containing protein (Dystrophia myotonica-containing WD repeat motif protein) (Protein 59) (Protein DMR-N9),674,"70,438",3 out of 5,1996-10-01,Evidence at protein level
Q9Y485,DMXL1_HUMAN,DmX-like protein 1 (X-like 1 protein),3027,"337,839",3 out of 5,2006-03-07,Evidence at protein level
Q07687,DLX2_HUMAN,Homeobox protein DLX-2,328,"34,243",5 out of 5,1996-10-01,Evidence at protein level
Q9NPF5,DMAP1_HUMAN,DNA methyltransferase 1-associated protein 1 (DNMAP1) (DNMT1-associated protein 1),467,"52,993",5 out of 5,2002-02-21,Evidence at protein level
Q6ZS02,DMP46_HUMAN,Putative GED domain-containing protein DNM1P46 (DNM1 pseudogene 46),220,"23,740",2 out of 5,2007-05-15,Uncertain
Q5VZB9,DMRTA_HUMAN,Doublesex- and mab-3-related transcription factor A1,504,"53,125",3 out of 5,2006-06-27,Evidence at transcript level
Q8IXT2,DMRTD_HUMAN,Doublesex- and mab-3-related transcription factor C2,367,"39,124",4 out of 5,2006-06-27,Evidence at transcript level
Q9UDY4,DNJB4_HUMAN,DnaJ homolog subfamily B member 4 (Heat shock 40 kDa protein 1 homolog) (HSP40 homolog) (Heat shock protein 40 homolog) (Human liver DnaJ-like protein),337,"37,807",5 out of 5,2000-12-01,Evidence at protein level
Q8WZ79,DNS2B_HUMAN,Deoxyribonuclease-2-beta (EC 3.1.22.1) (DNase II-like acid DNase) (DNase2-like acid DNase) (Deoxyribonuclease II beta) (DNase II beta) (Endonuclease DLAD),361,"41,713",4 out of 5,2004-04-13,Evidence at transcript level
Q96BY6,DOC10_HUMAN,Dedicator of cytokinesis protein 10 (Zizimin-3),2186,"249,531",5 out of 5,2003-07-03,Evidence at protein level
Q9H4B8,DPEP3_HUMAN,Dipeptidase 3 (EC 3.4.13.19),488,"53,687",4 out of 5,2006-04-04,Evidence at transcript level
P56282,DPOE2_HUMAN,DNA polymerase epsilon subunit 2 (EC 2.7.7.7) (DNA polymerase II subunit 2) (DNA polymerase epsilon subunit B),527,"59,537",5 out of 5,1998-07-15,Evidence at protein level
Q7Z7J5,DPPA2_HUMAN,Developmental pluripotency-associated protein 2 (Pluripotent embryonic stem cell-related gene 1 protein),298,"33,784",3 out of 5,2006-05-30,Evidence at protein level
Q6W0C5,DPPA3_HUMAN,Developmental pluripotency-associated protein 3 (Stella-related protein),159,"17,851",3 out of 5,2006-05-30,Evidence at transcript level
A6NC42,DPPA5_HUMAN,Developmental pluripotency-associated 5 protein (hDPPA5) (Embryonal stem cell-specific gene 1 protein) (ESG-1),116,"13,498",2 out of 5,2007-12-04,Evidence at transcript level
Q6PKH6,DR4L2_HUMAN,Dehydrogenase/reductase SDR family member 4-like 2 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 25C member 3),230,"24,586",3 out of 5,2007-12-04,Evidence at transcript level
P21917,DRD4_HUMAN,D(4) dopamine receptor (D(2C) dopamine receptor) (Dopamine D4 receptor),467,"48,361",5 out of 5,1991-05-01,Evidence at protein level
A6NNA5,DRGX_HUMAN,Dorsal root ganglia homeobox protein (Paired-related homeobox protein-like 1),263,"28,672",3 out of 5,2007-09-11,Inferred from homology
O60469,DSCAM_HUMAN,Down syndrome cell adhesion molecule (CHD2),2012,"222,260",5 out of 5,2000-12-01,Evidence at protein level
P57055,DSCR6_HUMAN,Protein ripply3 (Down syndrome critical region protein 6),190,"20,368",3 out of 5,2000-12-01,Evidence at transcript level
Q96EV8,DTBP1_HUMAN,Dysbindin (Biogenesis of lysosome-related organelles complex 1 subunit 8) (BLOC-1 subunit 8) (Dysbindin-1) (Dystrobrevin-binding protein 1) (Hermansky-Pudlak syndrome 7 protein) (HPS7 protein),351,"39,493",5 out of 5,2003-11-28,Evidence at protein level
Q8N9I9,DTX3_HUMAN,Probable E3 ubiquitin-protein ligase DTX3 (EC 2.3.2.27) (Protein deltex-3) (Deltex3) (RING finger protein 154) (RING-type E3 ubiquitin transferase DTX3),347,"37,988",5 out of 5,2003-09-26,Evidence at protein level
Q9Y2E6,DTX4_HUMAN,E3 ubiquitin-protein ligase DTX4 (EC 2.3.2.27) (Protein deltex-4) (Deltex4) (RING finger protein 155) (RING-type E3 ubiquitin transferase DTX4),619,"67,258",5 out of 5,2007-03-20,Evidence at protein level
Q9Y6W6,DUS10_HUMAN,Dual specificity protein phosphatase 10 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 5) (MAP kinase phosphatase 5) (MKP-5),482,"52,642",5 out of 5,2002-01-23,Evidence at protein level
Q9BY84,DUS16_HUMAN,Dual specificity protein phosphatase 16 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 7) (MAP kinase phosphatase 7) (MKP-7),665,"73,102",5 out of 5,2002-01-23,Evidence at protein level
Q9BVJ7,DUS23_HUMAN,Dual specificity protein phosphatase 23 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular mass dual specificity phosphatase 3) (LDP-3) (VH1-like phosphatase Z),150,"16,588",5 out of 5,2005-08-16,Evidence at protein level
Q9NX74,DUS2L_HUMAN,tRNA-dihydrouridine(20) synthase [NAD(P)+]-like (EC 1.3.1.-) (Dihydrouridine synthase 2) (Up-regulated in lung cancer protein 8) (URLC8) (tRNA-dihydrouridine synthase 2-like) (hDUS2),493,"55,050",5 out of 5,2005-08-16,Evidence at protein level
P51452,DUS3_HUMAN,Dual specificity protein phosphatase 3 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase VHR) (Vaccinia H1-related phosphatase) (VHR),185,"20,478",5 out of 5,1996-10-01,Evidence at protein level
Q16828,DUS6_HUMAN,Dual specificity protein phosphatase 6 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST1) (Mitogen-activated protein kinase phosphatase 3) (MAP kinase phosphatase 3) (MKP-3),381,"42,320",5 out of 5,1997-11-01,Evidence at protein level
Q6ZN92,DUTL_HUMAN,Putative inactive deoxyuridine 5'-triphosphate nucleotidohydrolase-like protein FLJ16323 (dUTPase-like protein),141,"15,492",1 out of 5,2008-06-10,Uncertain
Q9UBS4,DJB11_HUMAN,DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4),358,"40,514",5 out of 5,2001-10-18,Evidence at protein level
P59910,DJB13_HUMAN,DnaJ homolog subfamily B member 13 (Testis and spermatogenesis cell-related protein 6) (Testis spermatocyte apoptosis-related gene 6 protein) (Testis spermatogenesis apoptosis-related gene 3 protein) (Testis spermatogenesis apoptosis-related gene 6 protein),316,"36,118",5 out of 5,2003-10-10,Evidence at protein level
Q5F1R6,DJC21_HUMAN,DnaJ homolog subfamily C member 21 (DnaJ homolog subfamily A member 5) (Protein GS3),531,"62,028",5 out of 5,2007-03-20,Evidence at protein level
Q96LL9,DJC30_HUMAN,DnaJ homolog subfamily C member 30 (Williams-Beuren syndrome chromosomal region 18 protein),226,"25,961",3 out of 5,2002-10-10,Evidence at protein level
O94907,DKK1_HUMAN,Dickkopf-related protein 1 (Dickkopf-1) (Dkk-1) (hDkk-1) (SK),266,"28,672",5 out of 5,2001-02-21,Evidence at protein level
Q9NP97,DLRB1_HUMAN,"Dynein light chain roadblock-type 1 (Bithoraxoid-like protein) (BLP) (Dynein light chain 2A, cytoplasmic) (Dynein-associated protein Km23) (Roadblock domain-containing protein 1)",96,"10,922",5 out of 5,2003-04-23,Evidence at protein level
Q9Y5R6,DMRT1_HUMAN,Doublesex- and mab-3-related transcription factor 1 (DM domain expressed in testis protein 1),373,"39,473",5 out of 5,2000-12-01,Evidence at protein level
O75190,DNJB6_HUMAN,DnaJ homolog subfamily B member 6 (HHDJ1) (Heat shock protein J2) (HSJ-2) (MRJ) (MSJ-1),326,"36,087",5 out of 5,2000-05-30,Evidence at protein level
O75937,DNJC8_HUMAN,DnaJ homolog subfamily C member 8 (Splicing protein spf31),253,"29,842",3 out of 5,2002-09-19,Evidence at protein level
O00115,DNS2A_HUMAN,Deoxyribonuclease-2-alpha (EC 3.1.22.1) (Acid DNase) (Deoxyribonuclease II alpha) (DNase II alpha) (Lysosomal DNase II) (R31240_2),360,"39,581",5 out of 5,1998-07-15,Evidence at protein level
P13765,DOB_HUMAN,"HLA class II histocompatibility antigen, DO beta chain (MHC class II antigen DOB)",273,"30,822",5 out of 5,1990-01-01,Evidence at protein level
Q14183,DOC2A_HUMAN,Double C2-like domain-containing protein alpha (Doc2) (Doc2-alpha),400,"43,959",5 out of 5,2004-08-31,Evidence at protein level
Q8NF50,DOCK8_HUMAN,Dedicator of cytokinesis protein 8,2099,"238,529",5 out of 5,2003-07-03,Evidence at protein level
Q9UKG1,DP13A_HUMAN,"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",709,"79,663",5 out of 5,2005-03-15,Evidence at protein level
Q9H4A9,DPEP2_HUMAN,Dipeptidase 2 (EC 3.4.13.19),486,"53,306",5 out of 5,2006-04-04,Evidence at protein level
Q92784,DPF3_HUMAN,Zinc finger protein DPF3 (BRG1-associated factor 45C) (BAF45C) (Zinc finger protein cer-d4),378,"43,084",5 out of 5,1997-11-01,Evidence at protein level
Q9UGP5,DPOLL_HUMAN,DNA polymerase lambda (Pol Lambda) (EC 2.7.7.7) (EC 4.2.99.-) (DNA polymerase beta-2) (Pol beta2) (DNA polymerase kappa),575,"63,482",5 out of 5,2001-11-16,Evidence at protein level
Q86TI2,DPP9_HUMAN,Dipeptidyl peptidase 9 (DP9) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 2) (DPRP-2) (Dipeptidyl peptidase IX) (DPP IX) (Dipeptidyl peptidase-like protein 9) (DPLP9),863,"98,263",5 out of 5,2005-06-07,Evidence at protein level
Q14195,DPYL3_HUMAN,Dihydropyrimidinase-related protein 3 (DRP-3) (Collapsin response mediator protein 4) (CRMP-4) (Unc-33-like phosphoprotein 1) (ULIP-1),570,"61,963",5 out of 5,1998-07-15,Evidence at protein level
P14416,DRD2_HUMAN,D(2) dopamine receptor (Dopamine D2 receptor),443,"50,619",5 out of 5,1990-01-01,Evidence at protein level
P09417,DHPR_HUMAN,Dihydropteridine reductase (EC 1.5.1.34) (HDHPR) (Quinoid dihydropteridine reductase) (Short chain dehydrogenase/reductase family 33C member 1),244,"25,790",5 out of 5,1989-07-01,Evidence at protein level
Q08211,DHX9_HUMAN,ATP-dependent RNA helicase A (RHA) (EC 3.6.4.13) (DEAH box protein 9) (Leukophysin) (LKP) (Nuclear DNA helicase II) (NDH II),1270,"140,958",5 out of 5,1995-02-01,Evidence at protein level
Q8IYB7,DI3L2_HUMAN,DIS3-like exonuclease 2 (hDIS3L2) (EC 3.1.13.-),885,"99,279",5 out of 5,2008-01-15,Evidence at protein level
Q9BTC0,DIDO1_HUMAN,Death-inducer obliterator 1 (DIO-1) (hDido1) (Death-associated transcription factor 1) (DATF-1),2240,"243,873",5 out of 5,2003-04-23,Evidence at protein level
Q8IXB1,DJC10_HUMAN,DnaJ homolog subfamily C member 10 (EC 1.8.4.-) (Endoplasmic reticulum DNA J domain-containing protein 5) (ER-resident protein ERdj5) (ERdj5) (Macrothioredoxin) (MTHr),793,"91,080",5 out of 5,2007-04-03,Evidence at protein level
Q9NVH1,DJC11_HUMAN,DnaJ homolog subfamily C member 11,559,"63,278",4 out of 5,2006-07-25,Evidence at protein level
Q9NX36,DJC28_HUMAN,DnaJ homolog subfamily C member 28,388,"45,806",3 out of 5,2002-09-19,Evidence at protein level
Q9P1A6,DLGP2_HUMAN,Disks large-associated protein 2 (DAP-2) (PSD-95/SAP90-binding protein 2) (SAP90/PSD-95-associated protein 2) (SAPAP2),1054,"117,620",5 out of 5,2001-09-26,Evidence at protein level
Q9Y222,DMTF1_HUMAN,Cyclin-D-binding Myb-like transcription factor 1 (hDMTF1) (Cyclin-D-interacting Myb-like protein 1) (hDMP1),760,"84,471",5 out of 5,2008-03-18,Evidence at protein level
P51530,DNA2_HUMAN,DNA replication ATP-dependent helicase/nuclease DNA2 (hDNA2) (DNA replication ATP-dependent helicase-like homolog) [Includes: DNA replication nuclease DNA2 (EC 3.1.-.-); DNA replication ATP-dependent helicase DNA2 (EC 3.6.4.12)],1060,"120,415",5 out of 5,1996-10-01,Evidence at protein level
O96015,DNAL4_HUMAN,"Dynein light chain 4, axonemal",105,"12,009",4 out of 5,2002-06-20,Evidence at protein level
Q8NFT8,DNER_HUMAN,Delta and Notch-like epidermal growth factor-related receptor,737,"78,475",5 out of 5,2006-10-17,Evidence at protein level
P31689,DNJA1_HUMAN,DnaJ homolog subfamily A member 1 (DnaJ protein homolog 2) (HSDJ) (Heat shock 40 kDa protein 4) (Heat shock protein J2) (HSJ-2) (Human DnaJ protein 2) (hDj-2),397,"44,868",5 out of 5,1993-07-01,Evidence at protein level
P25685,DNJB1_HUMAN,DnaJ homolog subfamily B member 1 (DnaJ protein homolog 1) (Heat shock 40 kDa protein 1) (HSP40) (Heat shock protein 40) (Human DnaJ protein 1) (hDj-1),340,"38,044",5 out of 5,1992-05-01,Evidence at protein level
Q7Z6W7,DNJB7_HUMAN,DnaJ homolog subfamily B member 7,309,"35,434",2 out of 5,2004-03-01,Evidence at transcript level
Q9H3Z4,DNJC5_HUMAN,DnaJ homolog subfamily C member 5 (Ceroid-lipofuscinosis neuronal protein 4) (Cysteine string protein) (CSP),198,"22,149",5 out of 5,2001-08-14,Evidence at protein level
Q5SXM8,DNLZ_HUMAN,DNL-type zinc finger protein (Hsp70-escort protein 1) (HEP1) (mtHsp70-escort protein),178,"19,204",4 out of 5,2008-02-05,Evidence at protein level
Q3MIW9,DPCR1_HUMAN,Diffuse panbronchiolitis critical region protein 1,517,"56,347",4 out of 5,2008-02-26,Evidence at transcript level
P27487,DPP4_HUMAN,Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],766,"88,279",5 out of 5,1992-08-01,Evidence at protein level
P05538,DQB2_HUMAN,"HLA class II histocompatibility antigen, DQ beta 2 chain (HLA class II histocompatibility antigen, DX beta chain) (MHC class II antigen DQB2)",268,"30,387",5 out of 5,1988-11-01,Evidence at protein level
P79483,DRB3_HUMAN,"HLA class II histocompatibility antigen, DR beta 3 chain (MHC class II antigen DRB3)",266,"29,962",5 out of 5,2003-08-29,Evidence at protein level
Q9Y295,DRG1_HUMAN,Developmentally-regulated GTP-binding protein 1 (DRG-1) (Neural precursor cell expressed developmentally down-regulated protein 3) (NEDD-3),367,"40,542",5 out of 5,2000-05-30,Evidence at protein level
Q14574,DSC3_HUMAN,Desmocollin-3 (Cadherin family member 3) (Desmocollin-4) (HT-CP),896,"99,969",5 out of 5,1997-11-01,Evidence at protein level
P56555,DSCR4_HUMAN,Down syndrome critical region protein 4 (Down syndrome critical region protein B),118,"12,955",2 out of 5,1998-07-15,Evidence at transcript level
P59020,DSCR9_HUMAN,Down syndrome critical region protein 9,149,"16,743",1 out of 5,2002-09-19,Evidence at transcript level
Q96FN9,DTD2_HUMAN,Probable D-tyrosyl-tRNA(Tyr) deacylase 2 (EC 3.1.-.-) (D-tyrosyl-tRNA deacylase 2),168,"18,660",3 out of 5,2006-10-31,Evidence at transcript level
Q01459,DIAC_HUMAN,Di-N-acetylchitobiase (EC 3.2.1.-),385,"43,760",4 out of 5,1993-07-01,Evidence at protein level
O60610,DIAP1_HUMAN,Protein diaphanous homolog 1 (Diaphanous-related formin-1) (DRF1),1272,"141,347",5 out of 5,2000-05-30,Evidence at protein level
Q9P2K9,DISP3_HUMAN,Protein dispatched homolog 3 (Patched domain-containing protein 2),1392,"153,048",5 out of 5,2007-10-23,Evidence at transcript level
Q155Q3,DIXC1_HUMAN,Dixin (Coiled-coil protein DIX1) (Coiled-coil-DIX1) (DIX domain-containing protein 1),683,"77,478",5 out of 5,2007-05-15,Evidence at protein level
Q8N4W6,DJC22_HUMAN,DnaJ homolog subfamily C member 22,341,"38,086",2 out of 5,2008-03-18,Evidence at transcript level
P78352,DLG4_HUMAN,Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90),724,"80,495",5 out of 5,1997-11-01,Evidence at protein level
Q9NYJ7,DLL3_HUMAN,Delta-like protein 3 (Drosophila Delta homolog 3) (Delta3),618,"64,618",5 out of 5,2000-12-01,Evidence at protein level
Q9NR61,DLL4_HUMAN,Delta-like protein 4 (Drosophila Delta homolog 4) (Delta4),685,"74,605",5 out of 5,2001-04-27,Evidence at protein level
Q86YH6,DLP1_HUMAN,Decaprenyl-diphosphate synthase subunit 2 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 2) (Candidate tumor suppressor protein) (Decaprenyl pyrophosphate synthase subunit 2),399,"44,129",5 out of 5,2005-08-16,Evidence at protein level
Q92988,DLX4_HUMAN,Homeobox protein DLX-4 (Beta protein 1) (Homeobox protein DLX-7) (Homeobox protein DLX-8),240,"26,263",5 out of 5,1997-11-01,Evidence at protein level
Q4LDG9,DNAL1_HUMAN,"Dynein light chain 1, axonemal",190,"21,533",4 out of 5,2007-03-20,Evidence at protein level
Q8IYX4,DND1_HUMAN,"Dead end protein homolog 1 (RNA-binding motif, single-stranded-interacting protein 4)",353,"38,687",4 out of 5,2005-03-01,Evidence at protein level
Q96M86,DNHD1_HUMAN,Dynein heavy chain domain-containing protein 1 (Dynein heavy chain domain 1-like protein) (Protein CCDC35),4753,"533,644",5 out of 5,2007-12-04,Evidence at transcript level
P25686,DNJB2_HUMAN,DnaJ homolog subfamily B member 2 (Heat shock 40 kDa protein 3) (Heat shock protein J1) (HSJ-1),324,"35,580",5 out of 5,1992-05-01,Evidence at protein level
Q8NHS0,DNJB8_HUMAN,DnaJ homolog subfamily B member 8,232,"25,686",4 out of 5,2003-01-17,Evidence at protein level
Q8WXX5,DNJC9_HUMAN,DnaJ homolog subfamily C member 9 (HDJC9) (DnaJ protein SB73),260,"29,910",5 out of 5,2004-09-27,Evidence at protein level
P18858,DNLI1_HUMAN,DNA ligase 1 (EC 6.5.1.1) (DNA ligase I) (Polydeoxyribonucleotide synthase [ATP] 1),919,"101,736",5 out of 5,1990-11-01,Evidence at protein level
Q6XZF7,DNMBP_HUMAN,Dynamin-binding protein (Scaffold protein Tuba),1577,"177,347",5 out of 5,2004-12-07,Evidence at protein level
Q92608,DOCK2_HUMAN,Dedicator of cytokinesis protein 2,1830,"211,948",5 out of 5,2003-07-03,Evidence at protein level
Q9H7D0,DOCK5_HUMAN,Dedicator of cytokinesis protein 5,1870,"215,309",5 out of 5,2003-07-03,Evidence at protein level
Q86SG4,DPCA2_HUMAN,Putative Dresden prostate carcinoma protein 2 (D-PCa-2) (High mobility group nucleosome-binding domain-containing protein 2 pseudogene 46),172,"20,403",2 out of 5,2005-07-19,Uncertain
P28340,DPOD1_HUMAN,DNA polymerase delta catalytic subunit (EC 2.7.7.7) (EC 3.1.11.-) (DNA polymerase subunit delta p125),1107,"123,631",5 out of 5,1992-12-01,Evidence at protein level
P49005,DPOD2_HUMAN,DNA polymerase delta subunit 2 (DNA polymerase delta subunit p50),469,"51,289",5 out of 5,1996-02-01,Evidence at protein level
Q9NRF9,DPOE3_HUMAN,DNA polymerase epsilon subunit 3 (EC 2.7.7.7) (Arsenic-transactivated protein) (AsTP) (Chromatin accessibility complex 17 kDa protein) (CHRAC-17) (HuCHRAC17) (DNA polymerase II subunit 3) (DNA polymerase epsilon subunit p17),147,"16,860",5 out of 5,2002-08-30,Evidence at protein level
Q9NP87,DPOLM_HUMAN,DNA-directed DNA/RNA polymerase mu (Pol Mu) (EC 2.7.7.7) (Terminal transferase),494,"54,816",5 out of 5,2001-11-16,Evidence at protein level
O75417,DPOLQ_HUMAN,DNA polymerase theta (EC 2.7.7.7) (DNA polymerase eta),2590,"289,619",5 out of 5,2000-05-30,Evidence at protein level
Q9UHL4,DPP2_HUMAN,Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase),492,"54,341",5 out of 5,2001-04-27,Evidence at protein level
Q8TE96,DQX1_HUMAN,ATP-dependent RNA helicase DQX1 (EC 3.6.4.12) (DEAQ box polypeptide 1),717,"79,476",3 out of 5,2007-04-17,Evidence at transcript level
Q6ZPD8,DG2L6_HUMAN,Diacylglycerol O-acyltransferase 2-like protein 6 (EC 2.3.1.-) (Diacylglycerol O-acyltransferase candidate 3) (hDC3),337,"38,593",3 out of 5,2006-09-05,Evidence at transcript level
Q96DF8,DGC14_HUMAN,Protein DGCR14 (DiGeorge syndrome critical region 13) (DiGeorge syndrome critical region 14) (DiGeorge syndrome protein H) (DGS-H) (Protein ES2),476,"52,568",4 out of 5,2003-01-17,Evidence at protein level
O75912,DGKI_HUMAN,Diacylglycerol kinase iota (DAG kinase iota) (EC 2.7.1.107) (Diglyceride kinase iota) (DGK-iota),1065,"116,997",5 out of 5,2001-01-11,Evidence at protein level
P52824,DGKQ_HUMAN,Diacylglycerol kinase theta (DAG kinase theta) (EC 2.7.1.107) (Diglyceride kinase theta) (DGK-theta),942,"101,155",5 out of 5,1996-10-01,Evidence at protein level
Q8NCG7,DGLB_HUMAN,Sn1-specific diacylglycerol lipase beta (DGL-beta) (EC 3.1.1.-) (KCCR13L),672,"73,732",5 out of 5,2006-09-05,Evidence at protein level
Q6UWP2,DHR11_HUMAN,Dehydrogenase/reductase SDR family member 11 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 24C member 1),260,"28,308",3 out of 5,2006-01-10,Evidence at protein level
Q96LJ7,DHRS1_HUMAN,Dehydrogenase/reductase SDR family member 1 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 19C member 1),313,"33,909",4 out of 5,2003-10-10,Evidence at protein level
O14521,DHSD_HUMAN,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (CybS) (CII-4) (QPs3) (Succinate dehydrogenase complex subunit D) (Succinate-ubiquinone oxidoreductase cytochrome b small subunit) (Succinate-ubiquinone reductase membrane anchor subunit)",159,"17,043",5 out of 5,1998-12-15,Evidence at protein level
P49366,DHYS_HUMAN,Deoxyhypusine synthase (DHS) (EC 2.5.1.46),369,"40,971",5 out of 5,1996-02-01,Evidence at protein level
Q96F81,DISP1_HUMAN,Protein dispatched homolog 1,1524,"170,934",4 out of 5,2007-11-13,Evidence at protein level
O60832,DKC1_HUMAN,H/ACA ribonucleoprotein complex subunit 4 (EC 5.4.99.-) (CBF5 homolog) (Dyskerin) (Nopp140-associated protein of 57 kDa) (Nucleolar protein NAP57) (Nucleolar protein family A member 4) (snoRNP protein DKC1),514,"57,674",5 out of 5,1998-12-15,Evidence at protein level
O00548,DLL1_HUMAN,Delta-like protein 1 (Drosophila Delta homolog 1) (Delta1) (H-Delta-1),723,"78,056",5 out of 5,1998-07-15,Evidence at protein level
P28067,DMA_HUMAN,"HLA class II histocompatibility antigen, DM alpha chain (MHC class II antigen DMA) (Really interesting new gene 6 protein)",261,"29,194",5 out of 5,1992-08-01,Evidence at protein level
Q8NFW5,DMBX1_HUMAN,Diencephalon/mesencephalon homeobox protein 1 (Orthodenticle homolog 3) (Paired-like homeobox protein DMBX1),382,"41,198",4 out of 5,2006-11-28,Evidence at protein level
Q6PK57,DMP34_HUMAN,Putative GED domain-containing protein DNM1P34 (DNM1 pseudogene 34),102,"11,596",2 out of 5,2008-04-29,Uncertain
Q96MA1,DMRTB_HUMAN,Doublesex- and mab-3-related transcription factor B1,342,"36,205",2 out of 5,2008-01-15,Evidence at transcript level
Q8TDJ6,DMXL2_HUMAN,DmX-like protein 2 (Rabconnectin-3),3036,"339,641",5 out of 5,2006-03-07,Evidence at protein level
O00429,DNM1L_HUMAN,Dynamin-1-like protein (EC 3.6.5.5) (Dnm1p/Vps1p-like protein) (DVLP) (Dynamin family member proline-rich carboxyl-terminal domain less) (Dymple) (Dynamin-like protein) (Dynamin-like protein 4) (Dynamin-like protein IV) (HdynIV) (Dynamin-related protein 1),736,"81,877",5 out of 5,2005-05-10,Evidence at protein level
Q9NR33,DPOE4_HUMAN,DNA polymerase epsilon subunit 4 (EC 2.7.7.7) (DNA polymerase II subunit 4) (DNA polymerase epsilon subunit p12),117,"12,209",5 out of 5,2002-08-30,Evidence at protein level
P54098,DPOG1_HUMAN,DNA polymerase subunit gamma-1 (EC 2.7.7.7) (Mitochondrial DNA polymerase catalytic subunit) (PolG-alpha),1239,"139,562",5 out of 5,1996-10-01,Evidence at protein level
P09884,DPOLA_HUMAN,DNA polymerase alpha catalytic subunit (EC 2.7.7.7) (DNA polymerase alpha catalytic subunit p180),1462,"165,913",5 out of 5,1989-07-01,Evidence at protein level
P06746,DPOLB_HUMAN,DNA polymerase beta (EC 2.7.7.7) (EC 4.2.99.-),335,"38,178",5 out of 5,1988-01-01,Evidence at protein level
Q7Z5Q5,DPOLN_HUMAN,DNA polymerase nu (EC 2.7.7.7),900,"100,307",5 out of 5,2006-03-21,Evidence at protein level
Q9UI46,DNAI1_HUMAN,"Dynein intermediate chain 1, axonemal (Axonemal dynein intermediate chain 1)",699,"79,283",5 out of 5,2001-01-11,Evidence at protein level
Q99615,DNJC7_HUMAN,DnaJ homolog subfamily C member 7 (Tetratricopeptide repeat protein 2) (TPR repeat protein 2),494,"56,441",5 out of 5,2000-05-30,Evidence at protein level
Q9Y6K1,DNM3A_HUMAN,DNA (cytosine-5)-methyltransferase 3A (Dnmt3a) (EC 2.1.1.37) (DNA methyltransferase HsaIIIA) (DNA MTase HsaIIIA) (M.HsaIIIA),912,"101,858",5 out of 5,2001-09-26,Evidence at protein level
Q9ULA0,DNPEP_HUMAN,Aspartyl aminopeptidase (EC 3.4.11.21),475,"52,428",5 out of 5,2001-10-24,Evidence at protein level
P49184,DNSL1_HUMAN,Deoxyribonuclease-1-like 1 (EC 3.1.21.-) (DNase X) (Deoxyribonuclease I-like 1) (DNase I-like 1) (Muscle-specific DNase I-like) (XIB),302,"33,893",5 out of 5,1996-02-01,Evidence at protein level
Q14184,DOC2B_HUMAN,Double C2-like domain-containing protein beta (Doc2-beta),412,"45,949",5 out of 5,2004-08-31,Evidence at protein level
Q14117,DPYS_HUMAN,Dihydropyrimidinase (DHP) (DHPase) (EC 3.5.2.2) (Dihydropyrimidine amidohydrolase) (Hydantoinase),519,"56,630",5 out of 5,1998-07-15,Evidence at protein level
P01909,DQA1_HUMAN,"HLA class II histocompatibility antigen, DQ alpha 1 chain (DC-1 alpha chain) (DC-alpha) (HLA-DCA) (MHC class II DQA1)",254,"27,805",5 out of 5,1986-07-21,Evidence at protein level
Q6UX65,DRAM2_HUMAN,DNA damage-regulated autophagy modulator protein 2 (Transmembrane protein 77),266,"29,766",5 out of 5,2006-10-31,Evidence at protein level
Q8IZU8,DSEL_HUMAN,Dermatan-sulfate epimerase-like protein (EC 5.1.-.-),1212,"139,238",4 out of 5,2007-02-20,Evidence at transcript level
Q02413,DSG1_HUMAN,Desmoglein-1 (Cadherin family member 4) (Desmosomal glycoprotein 1) (DG1) (DGI) (Pemphigus foliaceus antigen),1049,"113,748",5 out of 5,1993-10-01,Evidence at protein level
Q8NBA8,DTWD2_HUMAN,DTW domain-containing protein 2,298,"33,416",2 out of 5,2007-01-09,Evidence at protein level
P0CJ87,DU4L4_HUMAN,Double homeobox protein 4-like protein 4,422,"44,826",2 out of 5,2011-03-08,Inferred from homology
Q8WTR2,DUS19_HUMAN,Dual specificity protein phosphatase 19 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase TS-DSP1) (Low molecular weight dual specificity phosphatase 3) (LMW-DSP3) (Protein phosphatase SKRP1) (Stress-activated protein kinase pathway-regulating phosphatase 1) (SAPK pathway-regulating phosphatase 1),217,"24,194",5 out of 5,2003-02-28,Evidence at protein level
Q9BV47,DUS26_HUMAN,Dual specificity protein phosphatase 26 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP3) (Low-molecular-mass dual-specificity phosphatase 4) (DSP-4) (LDP-4) (Mitogen-activated protein kinase phosphatase 8) (MAP kinase phosphatase 8) (MKP-8) (Novel amplified gene in thyroid anaplastic cancer),211,"23,946",5 out of 5,2007-06-26,Evidence at protein level
Q13202,DUS8_HUMAN,Dual specificity protein phosphatase 8 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH-5),625,"65,827",4 out of 5,1999-07-15,Evidence at protein level
Q9UBX2,DUX4_HUMAN,Double homeobox protein 4 (Double homeobox protein 10),424,"44,940",5 out of 5,2006-10-17,Evidence at protein level
O14641,DVL2_HUMAN,Segment polarity protein dishevelled homolog DVL-2 (Dishevelled-2) (DSH homolog 2),736,"78,948",5 out of 5,2000-05-30,Evidence at protein level
Q8TD57,DYH3_HUMAN,"Dynein heavy chain 3, axonemal (Axonemal beta dynein heavy chain 3) (HsADHC3) (Ciliary dynein heavy chain 3) (Dnahc3-b)",4116,"470,771",5 out of 5,2008-02-26,Evidence at transcript level
Q9C0G6,DYH6_HUMAN,"Dynein heavy chain 6, axonemal (Axonemal beta dynein heavy chain 6) (Ciliary dynein heavy chain 6)",4158,"475,983",4 out of 5,2008-02-05,Evidence at transcript level
Q86YF9,DZIP1_HUMAN,Zinc finger protein DZIP1 (DAZ-interacting protein 1/2),867,"98,664",5 out of 5,2004-07-19,Evidence at protein level
Q8TEW6,DOK4_HUMAN,Docking protein 4 (Downstream of tyrosine kinase 4) (Insulin receptor substrate 5) (IRS-5) (IRS5),326,"37,028",4 out of 5,2005-05-10,Evidence at protein level
Q1HG44,DOXA2_HUMAN,Dual oxidase maturation factor 2 (Dual oxidase activator 2),320,"34,787",5 out of 5,2006-12-12,Evidence at protein level
Q8NEU8,DP13B_HUMAN,"DCC-interacting protein 13-beta (Dip13-beta) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)",664,"74,493",5 out of 5,2005-03-15,Evidence at protein level
Q9BVM2,DPCD_HUMAN,Protein DPCD,203,"23,240",3 out of 5,2008-03-18,Evidence at protein level
Q96FX2,DPH3_HUMAN,DPH3 homolog (CSL-type zinc finger-containing protein 2) (DelGEF-interacting protein 1) (DelGIP1),82,"9,240",5 out of 5,2003-04-04,Evidence at protein level
Q9BPU6,DPYL5_HUMAN,Dihydropyrimidinase-related protein 5 (DRP-5) (CRMP3-associated molecule) (CRAM) (Collapsin response mediator protein 5) (CRMP-5) (UNC33-like phosphoprotein 6) (ULIP-6),564,"61,421",4 out of 5,2002-03-27,Evidence at protein level
P01906,DQA2_HUMAN,"HLA class II histocompatibility antigen, DQ alpha 2 chain (DX alpha chain) (HLA class II histocompatibility antigen, DQ(6) alpha chain) (HLA-DQA1) (MHC class II DQA2)",255,"28,033",5 out of 5,1986-07-21,Evidence at protein level
P55039,DRG2_HUMAN,Developmentally-regulated GTP-binding protein 2 (DRG-2),364,"40,746",4 out of 5,1996-10-01,Evidence at protein level
Q9NZW4,DSPP_HUMAN,Dentin sialophosphoprotein [Cleaved into: Dentin phosphoprotein (Dentin phosphophoryn) (DPP); Dentin sialoprotein (DSP)],1301,"131,151",5 out of 5,2001-12-13,Evidence at protein level
P55265,DSRAD_HUMAN,Double-stranded RNA-specific adenosine deaminase (DRADA) (EC 3.5.4.37) (136 kDa double-stranded RNA-binding protein) (p136) (Interferon-inducible protein 4) (IFI-4) (K88DSRBP),1226,"136,066",5 out of 5,1996-10-01,Evidence at protein level
Q6ZMT9,DTHD1_HUMAN,Death domain-containing protein 1,781,"88,329",2 out of 5,2008-09-02,Evidence at transcript level
Q9Y4J8,DTNA_HUMAN,Dystrobrevin alpha (DTN-A) (Alpha-dystrobrevin) (Dystrophin-related protein 3),743,"83,901",5 out of 5,2001-04-27,Evidence at protein level
P0CJ85,DU4L2_HUMAN,Double homeobox protein 4-like protein 2,424,"44,926",2 out of 5,2011-03-08,Inferred from homology
O95620,DUS4L_HUMAN,tRNA-dihydrouridine(20a/20b) synthase [NAD(P)+]-like (EC 1.3.1.-) (pp35) (tRNA-dihydrouridine synthase 4-like),317,"35,816",3 out of 5,2006-07-25,Evidence at transcript level
Q16829,DUS7_HUMAN,Dual specificity protein phosphatase 7 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PYST2),419,"44,957",5 out of 5,1997-11-01,Evidence at protein level
Q96PT4,DUX3_HUMAN,Putative double homeobox protein 3,197,"22,130",2 out of 5,2006-10-17,Evidence at transcript level
O00148,DX39A_HUMAN,ATP-dependent RNA helicase DDX39A (EC 3.6.4.13) (DEAD box protein 39) (Nuclear RNA helicase URH49),427,"49,130",5 out of 5,2005-03-15,Evidence at protein level
Q96KC8,DNJC1_HUMAN,DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1),554,"63,883",5 out of 5,2003-01-17,Evidence at protein level
Q13217,DNJC3_HUMAN,"DnaJ homolog subfamily C member 3 (Endoplasmic reticulum DNA J domain-containing protein 6) (ER-resident protein ERdj6) (ERdj6) (Interferon-induced, double-stranded RNA-activated protein kinase inhibitor) (Protein kinase inhibitor of 58 kDa) (Protein kinase inhibitor p58)",504,"57,580",5 out of 5,2005-08-16,Evidence at protein level
Q8IZD9,DOCK3_HUMAN,Dedicator of cytokinesis protein 3 (Modifier of cell adhesion) (Presenilin-binding protein) (PBP),2030,"233,103",4 out of 5,2003-07-03,Evidence at protein level
Q96HP0,DOCK6_HUMAN,Dedicator of cytokinesis protein 6,2047,"229,558",5 out of 5,2003-07-03,Evidence at protein level
Q96N67,DOCK7_HUMAN,Dedicator of cytokinesis protein 7,2140,"242,561",5 out of 5,2003-07-03,Evidence at protein level
Q9NYP3,DONS_HUMAN,Protein downstream neighbor of Son (B17),566,"62,747",3 out of 5,2001-01-11,Evidence at protein level
Q8TEK3,DOT1L_HUMAN,"Histone-lysine N-methyltransferase, H3 lysine-79 specific (EC 2.1.1.43) (DOT1-like protein) (Histone H3-K79 methyltransferase) (H3-K79-HMTase) (Lysine N-methyltransferase 4)",1739,"184,853",5 out of 5,2002-11-15,Evidence at protein level
P04440,DPB1_HUMAN,"HLA class II histocompatibility antigen, DP beta 1 chain (HLA class II histocompatibility antigen, DP(W4) beta chain) (MHC class II antigen DPB1)",258,"29,159",5 out of 5,1987-08-13,Evidence at protein level
A6NNS2,DRS7C_HUMAN,Dehydrogenase/reductase SDR family member 7C (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 2),312,"34,878",3 out of 5,2008-05-20,Evidence at transcript level
Q8WWB3,DYDC1_HUMAN,DPY30 domain-containing protein 1,177,"20,893",5 out of 5,2006-07-25,Evidence at protein level
Q8IVF4,DYH10_HUMAN,"Dynein heavy chain 10, axonemal (Axonemal beta dynein heavy chain 10) (Ciliary dynein heavy chain 10)",4471,"514,841",5 out of 5,2008-02-26,Evidence at protein level
Q9P2D7,DYH1_HUMAN,"Dynein heavy chain 1, axonemal (Axonemal beta dynein heavy chain 1) (Ciliary dynein heavy chain 1) (Heat shock regulated protein 1) (HSRF-1) (hDHC7)",4330,"493,953",5 out of 5,2008-02-26,Evidence at transcript level
Q8TE73,DYH5_HUMAN,"Dynein heavy chain 5, axonemal (Axonemal beta dynein heavy chain 5) (Ciliary dynein heavy chain 5)",4624,"529,021",5 out of 5,2004-08-16,Evidence at protein level
Q8WXX0,DYH7_HUMAN,"Dynein heavy chain 7, axonemal (Axonemal beta dynein heavy chain 7) (Ciliary dynein heavy chain 7) (Dynein heavy chain-like protein 2) (hDHC2)",4024,"461,159",5 out of 5,2008-02-05,Evidence at protein level
Q9NYC9,DYH9_HUMAN,"Dynein heavy chain 9, axonemal (Axonemal beta dynein heavy chain 9) (Ciliary dynein heavy chain 9)",4486,"511,877",5 out of 5,2001-01-11,Evidence at protein level
Q14204,DYHC1_HUMAN,"Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic)",4646,"532,408",5 out of 5,1997-11-01,Evidence at protein level
Q8NCM8,DYHC2_HUMAN,Cytoplasmic dynein 2 heavy chain 1 (Cytoplasmic dynein 2 heavy chain) (Dynein cytoplasmic heavy chain 2) (Dynein heavy chain 11) (hDHC11) (Dynein heavy chain isotype 1B),4307,"492,622",5 out of 5,2008-02-26,Evidence at protein level
Q16854,DGUOK_HUMAN,"Deoxyguanosine kinase, mitochondrial (dGK) (EC 2.7.1.113)",277,"32,056",5 out of 5,1997-11-01,Evidence at protein level
P49448,DHE4_HUMAN,"Glutamate dehydrogenase 2, mitochondrial (GDH 2) (EC 1.4.1.3)",558,"61,434",5 out of 5,1996-02-01,Evidence at protein level
P80365,DHI2_HUMAN,Corticosteroid 11-beta-dehydrogenase isozyme 2 (EC 1.1.1.-) (11-beta-hydroxysteroid dehydrogenase type 2) (11-DH2) (11-beta-HSD2) (11-beta-hydroxysteroid dehydrogenase type II) (11-HSD type II) (11-beta-HSD type II) (NAD-dependent 11-beta-hydroxysteroid dehydrogenase) (11-beta-HSD) (Short chain dehydrogenase/reductase family 9C member 3),405,"44,127",5 out of 5,1995-02-01,Evidence at protein level
Q96HY7,DHTK1_HUMAN,"Probable 2-oxoglutarate dehydrogenase E1 component DHKTD1, mitochondrial (EC 1.2.4.2) (Dehydrogenase E1 and transketolase domain-containing protein 1)",919,"103,077",5 out of 5,2007-10-23,Evidence at protein level
Q7Z478,DHX29_HUMAN,ATP-dependent RNA helicase DHX29 (EC 3.6.4.13) (DEAH box protein 29) (Nucleic acid helicase DDXx),1369,"155,236",5 out of 5,2006-07-11,Evidence at protein level
Q7L7V1,DHX32_HUMAN,Putative pre-mRNA-splicing factor ATP-dependent RNA helicase DHX32 (EC 3.6.4.13) (DEAD/H box 32) (DEAD/H helicase-like protein 1) (DHLP1) (DEAH box protein 32) (HuDDX32),743,"84,419",5 out of 5,2007-06-26,Evidence at protein level
Q9H2U1,DHX36_HUMAN,ATP-dependent RNA helicase DHX36 (EC 3.6.4.12) (EC 3.6.4.13) (DEAH box protein 36) (G4-resolvase 1) (G4R1) (MLE-like protein 1) (RNA helicase associated with AU-rich element ARE),1008,"114,760",5 out of 5,2006-07-25,Evidence at protein level
Q96C10,DHX58_HUMAN,Probable ATP-dependent RNA helicase DHX58 (EC 3.6.4.13) (Probable ATP-dependent helicase LGP2) (Protein D11Lgp2 homolog) (RIG-I-like receptor 3) (RLR-3) (RIG-I-like receptor LGP2) (RLR),678,"76,613",5 out of 5,2004-07-19,Evidence at protein level
Q68CQ4,DIEXF_HUMAN,Digestive organ expansion factor homolog,756,"87,055",4 out of 5,2006-10-31,Evidence at protein level
O95057,DIRA1_HUMAN,GTP-binding protein Di-Ras1 (Distinct subgroup of the Ras family member 1) (Ras-related inhibitor of cell growth) (Rig) (Small GTP-binding tumor suppressor 1),198,"22,329",4 out of 5,2005-03-29,Evidence at protein level
Q96SL1,DIRC2_HUMAN,Disrupted in renal carcinoma protein 2 (Disrupted in renal cancer protein 2),478,"52,088",5 out of 5,2007-01-09,Evidence at protein level
Q9UK85,DKKL1_HUMAN,Dickkopf-like protein 1 (Cancer/testis antigen 34) (CT34) (Protein soggy-1) (SGY-1),242,"27,007",4 out of 5,2001-02-21,Evidence at transcript level
Q15700,DLG2_HUMAN,Disks large homolog 2 (Channel-associated protein of synapse-110) (Chapsyn-110) (Postsynaptic density protein PSD-93),870,"97,552",5 out of 5,1997-11-01,Evidence at protein level
P80370,DLK1_HUMAN,Protein delta homolog 1 (DLK-1) (pG2) [Cleaved into: Fetal antigen 1 (FA1)],383,"41,300",5 out of 5,1995-11-01,Evidence at protein level
Q6UY11,DLK2_HUMAN,Protein delta homolog 2 (DLK-2) (Epidermal growth factor-like protein 9) (EGF-like protein 9),383,"40,548",4 out of 5,2004-10-25,Evidence at transcript level
P56179,DLX6_HUMAN,Homeobox protein DLX-6,175,"19,708",4 out of 5,1997-11-01,Evidence at transcript level
Q14565,DMC1_HUMAN,Meiotic recombination protein DMC1/LIM15 homolog,340,"37,681",5 out of 5,1997-11-01,Evidence at protein level
Q9Y5R5,DMRT2_HUMAN,Doublesex- and mab-3-related transcription factor 2 (Doublesex-like 2 protein) (DSXL-2),561,"61,814",4 out of 5,2000-12-01,Evidence at transcript level
Q9GZS0,DNAI2_HUMAN,"Dynein intermediate chain 2, axonemal (Axonemal dynein intermediate chain 2)",605,"68,821",5 out of 5,2002-09-19,Evidence at protein level
O75953,DNJB5_HUMAN,DnaJ homolog subfamily B member 5 (Heat shock protein Hsp40-2) (Heat shock protein Hsp40-3) (Heat shock protein cognate 40) (Hsc40),348,"39,133",4 out of 5,2001-10-18,Evidence at protein level
Q9UBS3,DNJB9_HUMAN,DnaJ homolog subfamily B member 9 (Endoplasmic reticulum DNA J domain-containing protein 4) (ER-resident protein ERdj4) (ERdj4) (Microvascular endothelial differentiation gene 1 protein) (Mdg-1),223,"25,518",4 out of 5,2001-10-18,Evidence at protein level
Q99543,DNJC2_HUMAN,"DnaJ homolog subfamily C member 2 (M-phase phosphoprotein 11) (Zuotin-related factor 1) [Cleaved into: DnaJ homolog subfamily C member 2, N-terminally processed]",621,"71,996",5 out of 5,2001-01-11,Evidence at protein level
Q9UJW3,DNM3L_HUMAN,DNA (cytosine-5)-methyltransferase 3-like,386,"43,583",5 out of 5,2001-09-26,Evidence at protein level
Q8N1I0,DOCK4_HUMAN,Dedicator of cytokinesis protein 4,1966,"225,206",5 out of 5,2003-07-03,Evidence at protein level
P20036,DPA1_HUMAN,"HLA class II histocompatibility antigen, DP alpha 1 chain (DP(W3)) (DP(W4)) (HLA-SB alpha chain) (MHC class II DP3-alpha) (MHC class II DPA1)",260,"29,381",5 out of 5,1986-07-21,Evidence at protein level
Q9BTV6,DPH7_HUMAN,Diphthine methyltransferase (EC 3.1.1.97) (Diphthamide biosynthesis protein 7) (WD repeat-containing protein 85),452,"50,575",3 out of 5,2005-07-05,Evidence at protein level
O60762,DPM1_HUMAN,Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1),260,"29,634",5 out of 5,2002-01-23,Evidence at protein level
A0PJE2,DHR12_HUMAN,Dehydrogenase/reductase SDR family member 12 (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 40C member 1),317,"35,146",3 out of 5,2007-12-04,Evidence at transcript level
Q13268,DHRS2_HUMAN,"Dehydrogenase/reductase SDR family member 2, mitochondrial (EC 1.1.1.-) (Dicarbonyl reductase HEP27) (Protein D) (Short chain dehydrogenase/reductase family 25C member 1)",280,"29,927",5 out of 5,1997-11-01,Evidence at protein level
Q9BTZ2,DHRS4_HUMAN,Dehydrogenase/reductase SDR family member 4 (EC 1.1.1.184) (NADPH-dependent carbonyl reductase/NADP-retinol dehydrogenase) (CR) (PHCR) (NADPH-dependent retinol dehydrogenase/reductase) (NRDR) (humNRDR) (Peroxisomal short-chain alcohol dehydrogenase) (PSCD) (SCAD-SRL) (Short chain dehydrogenase/reductase family 25C member 2) (Short-chain dehydrogenase/reductase family member 4),278,"29,537",5 out of 5,2003-10-10,Evidence at protein level
Q9BPW9,DHRS9_HUMAN,Dehydrogenase/reductase SDR family member 9 (EC 1.1.-.-) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),319,"35,227",5 out of 5,2005-10-25,Evidence at protein level
Q9UNQ2,DIM1_HUMAN,"Probable dimethyladenosine transferase (EC 2.1.1.183) (DIM1 dimethyladenosine transferase 1 homolog) (DIM1 dimethyladenosine transferase 1-like) (Probable 18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase) (Probable 18S rRNA dimethylase) (Probable S-adenosylmethionine-6-N',N'-adenosyl(rRNA) dimethyltransferase)",313,"35,236",5 out of 5,2002-12-13,Evidence at protein level
Q8TBM8,DJB14_HUMAN,DnaJ homolog subfamily B member 14,379,"42,516",4 out of 5,2007-03-20,Evidence at protein level
Q9UKB3,DJC12_HUMAN,DnaJ homolog subfamily C member 12 (J domain-containing protein 1),198,"23,415",2 out of 5,2003-02-01,Evidence at protein level
Q9Y5T4,DJC15_HUMAN,DnaJ homolog subfamily C member 15 (Cell growth-inhibiting gene 22 protein) (Methylation-controlled J protein) (MCJ),150,"16,383",5 out of 5,2006-07-25,Evidence at protein level
Q9NVM6,DJC17_HUMAN,DnaJ homolog subfamily C member 17,304,"34,687",3 out of 5,2006-07-25,Evidence at protein level
P11532,DMD_HUMAN,Dystrophin,3685,"426,750",5 out of 5,1989-10-01,Evidence at protein level
Q09013,DMPK_HUMAN,Myotonin-protein kinase (MT-PK) (EC 2.7.11.1) (DM-kinase) (DMK) (DM1 protein kinase) (DMPK) (Myotonic dystrophy protein kinase),629,"69,385",5 out of 5,1996-10-01,Evidence at protein level
Q9NNZ3,DNJC4_HUMAN,DnaJ homolog subfamily C member 4 (DnaJ-like protein HSPF2) (Multiple endocrine neoplasia type 1 candidate protein number 18),241,"27,593",3 out of 5,2001-10-18,Evidence at protein level
P49916,DNLI3_HUMAN,DNA ligase 3 (EC 6.5.1.1) (DNA ligase III) (Polydeoxyribonucleotide synthase [ATP] 3),1009,"112,907",5 out of 5,1996-10-01,Evidence at protein level
Q9UBC3,DNM3B_HUMAN,DNA (cytosine-5)-methyltransferase 3B (Dnmt3b) (EC 2.1.1.37) (DNA methyltransferase HsaIIIB) (DNA MTase HsaIIIB) (M.HsaIIIB),853,"95,751",5 out of 5,2001-09-26,Evidence at protein level
P26358,DNMT1_HUMAN,DNA (cytosine-5)-methyltransferase 1 (Dnmt1) (EC 2.1.1.37) (CXXC-type zinc finger protein 9) (DNA methyltransferase HsaI) (DNA MTase HsaI) (M.HsaI) (MCMT),1616,"183,165",5 out of 5,1992-05-01,Evidence at protein level
Q13609,DNSL3_HUMAN,Deoxyribonuclease gamma (DNase gamma) (EC 3.1.21.-) (DNase I homolog protein DHP2) (Deoxyribonuclease I-like 3) (DNase I-like 3) (Liver and spleen DNase) (LS-DNase) (LSD),305,"35,504",5 out of 5,1997-11-01,Evidence at protein level
P06340,DOA_HUMAN,"HLA class II histocompatibility antigen, DO alpha chain (MHC DN-alpha) (MHC DZ alpha) (MHC class II antigen DOA)",250,"27,599",5 out of 5,1988-01-01,Evidence at protein level
Q9P104,DOK5_HUMAN,Docking protein 5 (Downstream of tyrosine kinase 5) (Insulin receptor substrate 6) (IRS-6) (IRS6),306,"35,464",4 out of 5,2002-12-06,Evidence at protein level
Q9UPQ8,DOLK_HUMAN,Dolichol kinase (EC 2.7.1.108) (Transmembrane protein 15),538,"59,268",5 out of 5,2002-01-31,Evidence at protein level
Q92874,DNSL2_HUMAN,Deoxyribonuclease-1-like 2 (EC 3.1.21.-) (DNase I homolog protein DHP1) (Deoxyribonuclease I-like 2) (DNase I-like 2),299,"32,853",5 out of 5,1997-11-01,Evidence at protein level
Q9BZ29,DOCK9_HUMAN,Dedicator of cytokinesis protein 9 (Cdc42 guanine nucleotide exchange factor zizimin-1) (Zizimin-1),2069,"236,446",5 out of 5,2002-10-19,Evidence at protein level
O60496,DOK2_HUMAN,Docking protein 2 (Downstream of tyrosine kinase 2) (p56(dok-2)),412,"45,379",4 out of 5,2001-11-16,Evidence at protein level
Q86YN1,DOPP1_HUMAN,Dolichyldiphosphatase 1 (EC 3.6.1.43) (Dolichyl pyrophosphate phosphatase 1),238,"27,031",3 out of 5,2004-03-15,Evidence at transcript level
Q1HG43,DOXA1_HUMAN,Dual oxidase maturation factor 1 (Dual oxidase activator 1) (Numb-interacting protein),343,"37,815",5 out of 5,2006-12-12,Evidence at protein level
Q92782,DPF1_HUMAN,"Zinc finger protein neuro-d4 (BRG1-associated factor 45B) (BAF45B) (D4, zinc and double PHD fingers family 1)",380,"42,502",4 out of 5,1997-11-01,Evidence at protein level
Q9H2P9,DPH5_HUMAN,Diphthine methyl ester synthase (EC 2.1.1.314) (Diphthamide biosynthesis methyltransferase),285,"31,651",4 out of 5,2003-10-10,Evidence at protein level
Q9P2X0,DPM3_HUMAN,Dolichol-phosphate mannosyltransferase subunit 3 (Dolichol-phosphate mannose synthase subunit 3) (DPM synthase subunit 3) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 3) (Mannose-P-dolichol synthase subunit 3) (MPD synthase subunit 3) (Prostin-1),92,"10,094",5 out of 5,2002-01-23,Evidence at protein level
Q6V1X1,DPP8_HUMAN,Dipeptidyl peptidase 8 (DP8) (EC 3.4.14.5) (Dipeptidyl peptidase IV-related protein 1) (DPRP-1) (Dipeptidyl peptidase VIII) (DPP VIII) (Prolyl dipeptidase DPP8),898,"103,358",5 out of 5,2005-06-07,Evidence at protein level
A6NFQ7,DPRX_HUMAN,Divergent paired-related homeobox,191,"21,648",2 out of 5,2007-11-13,Inferred from homology
Q14194,DPYL1_HUMAN,Dihydropyrimidinase-related protein 1 (DRP-1) (Collapsin response mediator protein 1) (CRMP-1) (Unc-33-like phosphoprotein 3) (ULIP-3),572,"62,184",5 out of 5,1998-07-15,Evidence at protein level
Q16555,DPYL2_HUMAN,Dihydropyrimidinase-related protein 2 (DRP-2) (Collapsin response mediator protein 2) (CRMP-2) (N2A3) (Unc-33-like phosphoprotein 2) (ULIP-2),572,"62,294",5 out of 5,1998-07-15,Evidence at protein level
P13762,DRB4_HUMAN,"HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4)",266,"29,941",5 out of 5,1990-01-01,Evidence at protein level
Q9H069,DRC3_HUMAN,Dynein regulatory complex subunit 3 (Leucine-rich repeat-containing protein 48),523,"61,054",3 out of 5,2006-03-21,Evidence at transcript level
P21728,DRD1_HUMAN,D(1A) dopamine receptor (Dopamine D1 receptor),446,"49,293",5 out of 5,1991-05-01,Evidence at protein level
Q13474,DRP2_HUMAN,Dystrophin-related protein 2 (DRP-2),957,"107,962",4 out of 5,1997-11-01,Evidence at transcript level
Q02487,DSC2_HUMAN,Desmocollin-2 (Cadherin family member 2) (Desmocollin-3) (Desmosomal glycoprotein II) (Desmosomal glycoprotein III),901,"99,962",5 out of 5,1994-02-01,Evidence at protein level
P32926,DSG3_HUMAN,Desmoglein-3 (130 kDa pemphigus vulgaris antigen) (PVA) (Cadherin family member 6),999,"107,533",5 out of 5,1993-10-01,Evidence at protein level
O43812,DUX1_HUMAN,Double homeobox protein 1,170,"19,347",4 out of 5,2006-10-17,Evidence at protein level
Q96PT3,DUX5_HUMAN,Double homeobox protein 5,197,"22,164",3 out of 5,2006-10-17,Evidence at transcript level
P54792,DVLP1_HUMAN,Putative segment polarity protein dishevelled homolog DVL1P1 (DSH homolog 1-like) (Segment polarity protein dishevelled homolog DVL-1-like) (Dishevelled-1-like),670,"73,254",4 out of 5,1996-10-01,Uncertain
A2CJ06,DYTN_HUMAN,Dystrotelin,578,"65,320",2 out of 5,2007-08-21,Evidence at transcript level
Q9NVP4,DZAN1_HUMAN,Double zinc ribbon and ankyrin repeat-containing protein 1,752,"82,192",3 out of 5,2002-11-15,Evidence at protein level
Q15329,E2F5_HUMAN,Transcription factor E2F5 (E2F-5),346,"37,610",5 out of 5,1997-11-01,Evidence at protein level
Q9Y2J2,E41L3_HUMAN,"Band 4.1-like protein 3 (4.1B) (Differentially expressed in adenocarcinoma of the lung protein 1) (DAL-1) [Cleaved into: Band 4.1-like protein 3, N-terminally processed]",1087,"120,678",5 out of 5,2001-12-05,Evidence at protein level
O95672,ECEL1_HUMAN,Endothelin-converting enzyme-like 1 (EC 3.4.24.-) (Xce protein),775,"87,791",5 out of 5,2002-03-27,Evidence at protein level
P30084,ECHM_HUMAN,"Enoyl-CoA hydratase, mitochondrial (EC 4.2.1.17) (Enoyl-CoA hydratase 1) (Short-chain enoyl-CoA hydratase) (SCEH)",290,"31,387",5 out of 5,1993-04-01,Evidence at protein level
O75521,ECI2_HUMAN,"Enoyl-CoA delta isomerase 2, mitochondrial (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)",394,"43,585",5 out of 5,1999-07-15,Evidence at protein level
P43897,EFTS_HUMAN,"Elongation factor Ts, mitochondrial (EF-Ts) (EF-TsMt)",325,"35,391",5 out of 5,1995-11-01,Evidence at protein level
P00533,EGFR_HUMAN,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),1210,"134,277",5 out of 5,1986-07-21,Evidence at protein level
P17813,EGLN_HUMAN,Endoglin (CD antigen CD105),658,"70,578",5 out of 5,1990-08-01,Evidence at protein level
P18146,EGR1_HUMAN,Early growth response protein 1 (EGR-1) (AT225) (Nerve growth factor-induced protein A) (NGFI-A) (Transcription factor ETR103) (Transcription factor Zif268) (Zinc finger protein 225) (Zinc finger protein Krox-24),543,"57,507",5 out of 5,1990-11-01,Evidence at protein level
Q6PKX4,DOK6_HUMAN,Docking protein 6 (Downstream of tyrosine kinase 6),331,"38,318",4 out of 5,2005-05-10,Evidence at protein level
Q9Y3R5,DOP2_HUMAN,Protein dopey-2,2298,"258,230",4 out of 5,2000-05-30,Evidence at protein level
P30046,DOPD_HUMAN,D-dopachrome decarboxylase (EC 4.1.1.84) (D-dopachrome tautomerase) (Phenylpyruvate tautomerase II),118,"12,712",5 out of 5,1993-04-01,Evidence at protein level
P09172,DOPO_HUMAN,Dopamine beta-hydroxylase (EC 1.14.17.1) (Dopamine beta-monooxygenase) [Cleaved into: Soluble dopamine beta-hydroxylase],617,"69,065",5 out of 5,1989-07-01,Evidence at protein level
P16444,DPEP1_HUMAN,Dipeptidase 1 (EC 3.4.13.19) (Dehydropeptidase-I) (Microsomal dipeptidase) (Renal dipeptidase) (hRDP),411,"45,674",5 out of 5,1990-08-01,Evidence at protein level
Q14181,DPOA2_HUMAN,DNA polymerase alpha subunit B (DNA polymerase alpha 70 kDa subunit),598,"65,948",5 out of 5,1999-07-15,Evidence at protein level
P42658,DPP6_HUMAN,Dipeptidyl aminopeptidase-like protein 6 (DPPX) (Dipeptidyl aminopeptidase-related protein) (Dipeptidyl peptidase 6) (Dipeptidyl peptidase IV-like protein) (Dipeptidyl peptidase VI) (DPP VI),865,"97,588",5 out of 5,1995-11-01,Evidence at protein level
Q7L190,DPPA4_HUMAN,Developmental pluripotency-associated protein 4,304,"33,541",4 out of 5,2006-05-30,Evidence at protein level
Q9UL01,DSE_HUMAN,Dermatan-sulfate epimerase (DS epimerase) (EC 5.1.3.19) (Chondroitin-glucuronate 5-epimerase) (Squamous cell carcinoma antigen recognized by T-cells 2) (SART-2),958,"109,773",5 out of 5,2006-02-07,Evidence at protein level
Q14126,DSG2_HUMAN,Desmoglein-2 (Cadherin family member 5) (HDGC),1118,"122,294",5 out of 5,1997-11-01,Evidence at protein level
P0CJ88,DU4L5_HUMAN,Double homeobox protein 4-like protein 5,424,"44,926",2 out of 5,2011-03-08,Inferred from homology
Q9H1R2,DUS15_HUMAN,Dual specificity protein phosphatase 15 (EC 3.1.3.16) (EC 3.1.3.48) (VH1-related member Y) (Vaccinia virus VH1-related dual-specific protein phosphatase Y),295,"31,882",5 out of 5,2002-01-23,Evidence at protein level
Q6P1R4,DUS1L_HUMAN,tRNA-dihydrouridine(16/17) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 1-like),473,"53,230",2 out of 5,2006-07-25,Evidence at protein level
Q13838,DX39B_HUMAN,Spliceosome RNA helicase DDX39B (EC 3.6.4.13) (56 kDa U2AF65-associated protein) (ATP-dependent RNA helicase p47) (DEAD box protein UAP56) (HLA-B-associated transcript 1 protein),428,"48,991",5 out of 5,1997-11-01,Evidence at protein level
P63172,DYLT1_HUMAN,Dynein light chain Tctex-type 1 (Protein CW-1) (T-complex testis-specific protein 1 homolog),113,"12,452",5 out of 5,2004-09-27,Evidence at protein level
Q9NR20,DYRK4_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 4 (EC 2.7.12.1),520,"59,608",5 out of 5,2001-04-27,Evidence at protein level
Q8IYY4,DZI1L_HUMAN,Zinc finger protein DZIP1L (DAZ-interacting protein 1-like protein),767,"86,848",4 out of 5,2008-04-29,Evidence at protein level
Q14209,E2F2_HUMAN,Transcription factor E2F2 (E2F-2),437,"47,506",5 out of 5,1997-11-01,Evidence at protein level
Q9HCS5,E41LA_HUMAN,Band 4.1-like protein 4A (Protein NBL4),686,"79,059",3 out of 5,2001-07-11,Evidence at protein level
Q8IY85,EFC13_HUMAN,EF-hand calcium-binding domain-containing protein 13,973,"110,129",2 out of 5,2007-03-20,Evidence at transcript level
Q8N4Y2,EFC4A_HUMAN,EF-hand calcium-binding domain-containing protein 4A (Calcium release-activated calcium channel regulator 2B) (CRAC channel regulator 2B) (Calcium release-activated channel regulator 2B),399,"44,956",4 out of 5,2007-04-03,Evidence at protein level
Q96IM9,DYDC2_HUMAN,DPY30 domain-containing protein 2,177,"20,586",2 out of 5,2006-07-25,Evidence at transcript level
Q96DT5,DYH11_HUMAN,"Dynein heavy chain 11, axonemal (Axonemal beta dynein heavy chain 11) (Ciliary dynein heavy chain 11)",4516,"520,369",5 out of 5,2002-09-19,Evidence at protein level
Q0VDD8,DYH14_HUMAN,"Dynein heavy chain 14, axonemal (Axonemal beta dynein heavy chain 14) (Ciliary dynein heavy chain 14)",3507,"399,895",5 out of 5,2007-05-15,Evidence at transcript level
Q9P225,DYH2_HUMAN,"Dynein heavy chain 2, axonemal (Axonemal beta dynein heavy chain 2) (Ciliary dynein heavy chain 2) (Dynein heavy chain domain-containing protein 3)",4427,"507,698",5 out of 5,2008-02-26,Evidence at transcript level
P51808,DYLT3_HUMAN,Dynein light chain Tctex-type 3 (Protein 91/23) (T-complex-associated testis-expressed 1-like),116,"13,062",5 out of 5,1996-10-01,Evidence at protein level
Q9H329,E41LB_HUMAN,Band 4.1-like protein 4B (FERM-containing protein CG1) (Protein EHM2),900,"99,712",5 out of 5,2003-04-23,Evidence at transcript level
P0CF75,EBLN1_HUMAN,Endogenous Bornavirus-like nucleoprotein 1 (Endogenous Borna-like N element-1) (EBLN-1),366,"40,313",2 out of 5,2010-05-18,Evidence at transcript level
Q9BY08,EBPL_HUMAN,Emopamil-binding protein-like (Emopamil-binding-related protein),206,"23,204",4 out of 5,2001-10-18,Evidence at protein level
O60344,ECE2_HUMAN,Endothelin-converting enzyme 2 (ECE-2) [Includes: Methyltransferase-like region (EC 2.1.1.-); Endothelin-converting enzyme 2 region (EC 3.4.24.71)],883,"99,773",5 out of 5,2000-05-30,Evidence at protein level
P29692,EF1D_HUMAN,Elongation factor 1-delta (EF-1-delta) (Antigen NY-CO-4),281,"31,122",5 out of 5,1993-04-01,Evidence at protein level
P26641,EF1G_HUMAN,Elongation factor 1-gamma (EF-1-gamma) (eEF-1B gamma),437,"50,119",5 out of 5,1992-08-01,Evidence at protein level
O00418,EF2K_HUMAN,Eukaryotic elongation factor 2 kinase (eEF-2 kinase) (eEF-2K) (EC 2.7.11.20) (Calcium/calmodulin-dependent eukaryotic elongation factor 2 kinase),725,"82,144",5 out of 5,1998-07-15,Evidence at protein level
P60507,EFC1_HUMAN,Endogenous retrovirus group FC1 Env polyprotein (Envelope polyprotein) (Fc1env) (HERV-F(c)1_Xq21.33 provirus ancestral Env polyprotein) (HERV-Fc1env) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],584,"65,248",5 out of 5,2004-03-01,Evidence at protein level
Q9BSW2,EFC4B_HUMAN,EF-hand calcium-binding domain-containing protein 4B (Calcium release-activated calcium channel regulator 2A) (CRAC channel regulator 2A) (Calcium release-activated channel regulator 2A),395,"45,592",5 out of 5,2007-04-03,Evidence at protein level
Q5JST6,EFHC2_HUMAN,EF-hand domain-containing family member C2,749,"87,397",5 out of 5,2006-10-03,Evidence at protein level
Q14156,EFR3A_HUMAN,Protein EFR3 homolog A (Protein EFR3-like),821,"92,924",5 out of 5,1997-11-01,Evidence at protein level
Q9UHF1,EGFL7_HUMAN,Epidermal growth factor-like protein 7 (EGF-like protein 7) (Multiple epidermal growth factor-like domains protein 7) (Multiple EGF-like domains protein 7) (NOTCH4-like protein) (Vascular endothelial statin) (VE-statin) (Zneu1),273,"29,618",5 out of 5,2004-10-25,Evidence at protein level
Q9GZT9,EGLN1_HUMAN,Egl nine homolog 1 (EC 1.14.11.29) (Hypoxia-inducible factor prolyl hydroxylase 2) (HIF-PH2) (HIF-prolyl hydroxylase 2) (HPH-2) (Prolyl hydroxylase domain-containing protein 2) (PHD2) (SM-20),426,"46,021",5 out of 5,2003-06-16,Evidence at protein level
P11161,EGR2_HUMAN,E3 SUMO-protein ligase EGR2 (EC 6.3.2.-) (AT591) (Early growth response protein 2) (EGR-2) (Zinc finger protein Krox-20),476,"50,302",5 out of 5,1989-07-01,Evidence at protein level
Q9NZN4,EHD2_HUMAN,EH domain-containing protein 2 (PAST homolog 2),543,"61,161",5 out of 5,2001-09-26,Evidence at protein level
Q9NR50,EI2BG_HUMAN,Translation initiation factor eIF-2B subunit gamma (eIF-2B GDP-GTP exchange factor subunit gamma),452,"50,240",5 out of 5,2001-09-26,Evidence at protein level
Q96D98,EID2B_HUMAN,EP300-interacting inhibitor of differentiation 2B (EID-2B) (EID-2-like inhibitor of differentiation 3) (EID-3),161,"16,985",3 out of 5,2008-01-15,Evidence at protein level
Q8N140,EID3_HUMAN,EP300-interacting inhibitor of differentiation 3 (EID-3) (E1A-like inhibitor of differentiation 3) (EID-1-like inhibitor of differentiation 3) (Non-structural maintenance of chromosomes element 4 homolog B) (NS4EB) (Non-SMC element 4 homolog B),333,"38,168",5 out of 5,2008-01-15,Evidence at protein level
P41567,EIF1_HUMAN,Eukaryotic translation initiation factor 1 (eIF1) (A121) (Protein translation factor SUI1 homolog) (Sui1iso1),113,"12,732",5 out of 5,1995-11-01,Evidence at protein level
Q9BY44,EIF2A_HUMAN,"Eukaryotic translation initiation factor 2A (eIF-2A) (65 kDa eukaryotic translation initiation factor 2A) [Cleaved into: Eukaryotic translation initiation factor 2A, N-terminally processed]",585,"64,990",5 out of 5,2007-05-01,Evidence at protein level
P60228,EIF3E_HUMAN,Eukaryotic translation initiation factor 3 subunit E (eIF3e) (Eukaryotic translation initiation factor 3 subunit 6) (Viral integration site protein INT-6 homolog) (eIF-3 p48),445,"52,221",5 out of 5,2004-01-16,Evidence at protein level
Q9NZJ0,DTL_HUMAN,Denticleless protein homolog (DDB1- and CUL4-associated factor 2) (Lethal(2) denticleless protein homolog) (Retinoic acid-regulated nuclear matrix-associated protein),730,"79,468",5 out of 5,2007-02-06,Evidence at protein level
O60941,DTNB_HUMAN,Dystrobrevin beta (DTN-B) (Beta-dystrobrevin),627,"71,356",5 out of 5,2001-04-27,Evidence at protein level
Q86Y01,DTX1_HUMAN,E3 ubiquitin-protein ligase DTX1 (EC 2.3.2.27) (Protein deltex-1) (Deltex1) (hDTX1) (RING-type E3 ubiquitin transferase DTX1),620,"67,368",5 out of 5,2003-09-26,Evidence at protein level
P0CJ86,DU4L3_HUMAN,Double homeobox protein 4-like protein 3,424,"44,926",2 out of 5,2011-03-08,Inferred from homology
Q9NRD9,DUOX1_HUMAN,Dual oxidase 1 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 1) (Long NOX 1) (NADPH thyroid oxidase 1) (Thyroid oxidase 1),1551,"177,235",5 out of 5,2006-02-21,Evidence at protein level
Q9UNI6,DUS12_HUMAN,Dual specificity protein phosphatase 12 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity tyrosine phosphatase YVH1),340,"37,687",5 out of 5,2000-12-01,Evidence at protein level
Q9H596,DUS21_HUMAN,Dual specificity protein phosphatase 21 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular weight dual specificity phosphatase 21) (LMW-DSP21),190,"21,529",5 out of 5,2004-07-19,Evidence at protein level
Q5VZP5,DUS27_HUMAN,Inactive dual specificity phosphatase 27,1158,"130,176",3 out of 5,2007-09-11,Evidence at transcript level
Q13115,DUS4_HUMAN,Dual specificity protein phosphatase 4 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH2) (Mitogen-activated protein kinase phosphatase 2) (MAP kinase phosphatase 2) (MKP-2),394,"42,953",5 out of 5,1997-11-01,Evidence at protein level
Q16690,DUS5_HUMAN,Dual specificity protein phosphatase 5 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH3),384,"42,047",5 out of 5,1997-11-01,Evidence at protein level
P63167,DYL1_HUMAN,"Dynein light chain 1, cytoplasmic (8 kDa dynein light chain) (DLC8) (Dynein light chain LC8-type 1) (Protein inhibitor of neuronal nitric oxide synthase) (PIN)",89,"10,366",5 out of 5,2004-09-27,Evidence at protein level
Q7RTS9,DYM_HUMAN,Dymeclin (Dyggve-Melchior-Clausen syndrome protein),669,"75,935",5 out of 5,2005-07-05,Evidence at protein level
Q05193,DYN1_HUMAN,Dynamin-1 (EC 3.6.5.5),864,"97,408",5 out of 5,1994-02-01,Evidence at protein level
P50570,DYN2_HUMAN,Dynamin-2 (EC 3.6.5.5),870,"98,064",5 out of 5,1996-10-01,Evidence at protein level
O43781,DYRK3_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK),588,"65,714",5 out of 5,2001-04-27,Evidence at protein level
Q8WXU2,DYXC1_HUMAN,Dyslexia susceptibility 1 candidate gene 1 protein,420,"48,527",5 out of 5,2003-11-21,Evidence at protein level
Q01094,E2F1_HUMAN,Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1),437,"46,920",5 out of 5,1993-07-01,Evidence at protein level
Q6ZTU2,E400N_HUMAN,EP400 N-terminal-like protein,488,"51,753",2 out of 5,2008-02-05,Evidence at transcript level
P43003,EAA1_HUMAN,Excitatory amino acid transporter 1 (Sodium-dependent glutamate/aspartate transporter 1) (GLAST-1) (Solute carrier family 1 member 3),542,"59,572",5 out of 5,1995-11-01,Evidence at protein level
P48664,EAA4_HUMAN,Excitatory amino acid transporter 4 (Sodium-dependent glutamate/aspartate transporter) (Solute carrier family 1 member 6),564,"61,565",5 out of 5,1996-02-01,Evidence at transcript level
O00341,EAA5_HUMAN,Excitatory amino acid transporter 5 (Retinal glutamate transporter) (Solute carrier family 1 member 7),560,"60,658",5 out of 5,1998-07-15,Evidence at transcript level
Q56P03,EAPP_HUMAN,E2F-associated phosphoprotein (EAPP),285,"32,762",4 out of 5,2005-08-30,Evidence at protein level
Q08426,ECHP_HUMAN,"Peroxisomal bifunctional enzyme (PBE) (PBFE) [Includes: Enoyl-CoA hydratase/3,2-trans-enoyl-CoA isomerase (EC 4.2.1.17) (EC 5.3.3.8); 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35)]",723,"79,495",5 out of 5,1994-10-01,Evidence at protein level
Q3B7T1,EDRF1_HUMAN,Erythroid differentiation-related factor 1,1238,"138,528",4 out of 5,2006-06-27,Evidence at protein level
Q15075,EEA1_HUMAN,Early endosome antigen 1 (Endosome-associated protein p162) (Zinc finger FYVE domain-containing protein 2),1411,"162,466",5 out of 5,2003-08-22,Evidence at protein level
Q7L9B9,EEPD1_HUMAN,Endonuclease/exonuclease/phosphatase family domain-containing protein 1,569,"62,403",3 out of 5,2008-02-05,Evidence at protein level
Q8N7B9,EFCB3_HUMAN,EF-hand calcium-binding domain-containing protein 3,438,"50,147",2 out of 5,2006-10-17,Evidence at transcript level
Q8NEX9,DR9C7_HUMAN,Short-chain dehydrogenase/reductase family 9C member 7 (EC 1.1.1.-) (Orphan short-chain dehydrogenase/reductase) (SDR-O) (RDH-S),313,"35,263",4 out of 5,2008-02-05,Evidence at protein level
Q8NBI3,DRAXI_HUMAN,Draxin (Dorsal inhibitory axon guidance protein) (Dorsal repulsive axon guidance protein) (Neucrin),349,"38,650",4 out of 5,2007-01-23,Evidence at protein level
Q96MC2,DRC1_HUMAN,Dynein regulatory complex protein 1 (Coiled-coil domain-containing protein 164),740,"87,134",5 out of 5,2007-02-20,Evidence at transcript level
Q16643,DREB_HUMAN,Drebrin (Developmentally-regulated brain protein),649,"71,429",5 out of 5,1997-11-01,Evidence at protein level
Q6PGQ1,DRIC1_HUMAN,Aspartate-rich protein 1,229,"25,064",2 out of 5,2008-02-26,Evidence at protein level
Q6IAN0,DRS7B_HUMAN,Dehydrogenase/reductase SDR family member 7B (EC 1.1.-.-) (Short-chain dehydrogenase/reductase family 32C member 1),325,"35,119",3 out of 5,2007-12-04,Evidence at protein level
Q08554,DSC1_HUMAN,Desmocollin-1 (Cadherin family member 1) (Desmosomal glycoprotein 2/3) (DG2/DG3),894,"99,987",5 out of 5,1997-11-01,Evidence at protein level
Q96T75,DSCR8_HUMAN,Down syndrome critical region protein 8 (Cancer/testis antigen 25) (CT25) (Malignant melanoma-associated protein 1) (MMA-1) (Protein MTAG2),97,"10,969",3 out of 5,2002-10-10,Evidence at protein level
Q9NRD8,DUOX2_HUMAN,Dual oxidase 2 (EC 1.11.1.-) (EC 1.6.3.1) (Large NOX 2) (Long NOX 2) (NADH/NADPH thyroid oxidase p138-tox) (NADPH oxidase/peroxidase DUOX2) (NADPH thyroid oxidase 2) (Thyroid oxidase 2) (p138 thyroid oxidase),1548,"175,364",5 out of 5,2006-02-21,Evidence at protein level
O75319,DUS11_HUMAN,RNA/RNP complex-1-interacting phosphatase (EC 3.1.3.-) (Dual specificity protein phosphatase 11) (Phosphatase that interacts with RNA/RNP complex 1),330,"38,939",5 out of 5,2002-01-23,Evidence at protein level
Q8NEJ0,DUS18_HUMAN,Dual specificity protein phosphatase 18 (EC 3.1.3.16) (EC 3.1.3.48) (Low molecular weight dual specificity phosphatase 20) (LMW-DSP20),188,"21,066",5 out of 5,2003-02-28,Evidence at protein level
P0DN84,DWORF_HUMAN,Sarcoplasmic/endoplasmic reticulum calcium ATPase regulator DWORF (SERCA regulator DWORF) (Dwarf open reading frame) (DWORF),34,"3,765",2 out of 5,2016-03-16,Inferred from homology
Q9Y463,DYR1B_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 1B (EC 2.7.12.1) (Minibrain-related kinase) (Mirk protein kinase),629,"69,198",5 out of 5,2000-12-01,Evidence at protein level
P00374,DYR_HUMAN,Dihydrofolate reductase (EC 1.5.1.3),187,"21,453",5 out of 5,1986-07-21,Evidence at protein level
O75923,DYSF_HUMAN,Dysferlin (Dystrophy-associated fer-1-like protein) (Fer-1-like protein 1),2080,"237,295",5 out of 5,2002-01-23,Evidence at protein level
O94769,ECM2_HUMAN,Extracellular matrix protein 2 (Matrix glycoprotein SC1/ECM2),699,"79,789",5 out of 5,2002-11-08,Evidence at transcript level
Q9UNE0,EDAR_HUMAN,Tumor necrosis factor receptor superfamily member EDAR (Anhidrotic ectodysplasin receptor 1) (Downless homolog) (EDA-A1 receptor) (Ectodermal dysplasia receptor) (Ectodysplasin-A receptor),448,"48,582",5 out of 5,2002-05-27,Evidence at protein level
Q92838,EDA_HUMAN,"Ectodysplasin-A (Ectodermal dysplasia protein) (EDA protein) [Cleaved into: Ectodysplasin-A, membrane form; Ectodysplasin-A, secreted form]",391,"41,294",5 out of 5,1997-11-01,Evidence at protein level
Q6P2E9,EDC4_HUMAN,Enhancer of mRNA-decapping protein 4 (Autoantigen Ge-1) (Autoantigen RCD-8) (Human enhancer of decapping large subunit) (Hedls),1401,"151,661",5 out of 5,2007-03-06,Evidence at protein level
P25101,EDNRA_HUMAN,Endothelin-1 receptor (Endothelin A receptor) (ET-A) (ETA-R) (hET-AR),427,"48,722",5 out of 5,1992-05-01,Evidence at protein level
P68104,EF1A1_HUMAN,Elongation factor 1-alpha 1 (EF-1-alpha-1) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7),462,"50,141",5 out of 5,1987-08-13,Evidence at protein level
O75071,EFC14_HUMAN,EF-hand calcium-binding domain-containing protein 14,495,"55,031",2 out of 5,2003-10-10,Evidence at protein level
A8MWE9,EFCB8_HUMAN,EF-hand calcium-binding domain-containing protein 8,144,"16,428",1 out of 5,2008-06-10,Predicted
Q96RP9,EFGM_HUMAN,"Elongation factor G, mitochondrial (EF-Gmt) (Elongation factor G 1, mitochondrial) (mEF-G 1) (Elongation factor G1) (hEFG1)",751,"83,471",5 out of 5,2003-01-27,Evidence at protein level
P52797,EFNA3_HUMAN,Ephrin-A3 (EFL-2) (EHK1 ligand) (EHK1-L) (EPH-related receptor tyrosine kinase ligand 3) (LERK-3),238,"26,350",5 out of 5,1996-10-01,Evidence at protein level
P0CG22,DR4L1_HUMAN,Putative dehydrogenase/reductase SDR family member 4-like 1 (EC 1.1.-.-) (Short chain dehydrogenase/reductase family 25C member 4),281,"30,608",2 out of 5,2010-06-15,Uncertain
Q8N682,DRAM1_HUMAN,DNA damage-regulated autophagy modulator protein 1 (Damage-regulated autophagy modulator),238,"26,253",4 out of 5,2007-05-15,Evidence at protein level
P01903,DRA_HUMAN,"HLA class II histocompatibility antigen, DR alpha chain (MHC class II antigen DRA)",254,"28,607",5 out of 5,1986-07-21,Evidence at protein level
Q6B8I1,DS13A_HUMAN,Dual specificity protein phosphatase 13 isoform A (DUSP13A) (EC 3.1.3.16) (EC 3.1.3.48) (Branching-enzyme interacting DSP) (Muscle-restricted DSP) (MDSP),188,"20,658",5 out of 5,2009-09-01,Evidence at protein level
C9JQL5,DSA2D_HUMAN,Putative dispanin subfamily A member 2d (DSPA2d),133,"14,796",2 out of 5,2012-06-13,Uncertain
P59022,DSC10_HUMAN,Down syndrome critical region protein 10,87,"9,286",1 out of 5,2002-09-19,Evidence at protein level
Q8TD84,DSCL1_HUMAN,Down syndrome cell adhesion molecule-like protein 1 (Down syndrome cell adhesion molecule 2),2053,"224,463",5 out of 5,2005-08-16,Evidence at protein level
O14972,DSCR3_HUMAN,Down syndrome critical region protein 3 (Down syndrome critical region protein A),297,"33,010",3 out of 5,1998-07-15,Evidence at transcript level
Q86SJ6,DSG4_HUMAN,Desmoglein-4 (Cadherin family member 13),1040,"113,824",5 out of 5,2005-03-01,Evidence at protein level
Q9H410,DSN1_HUMAN,Kinetochore-associated protein DSN1 homolog,356,"40,067",5 out of 5,2003-02-01,Evidence at protein level
Q8N5C7,DTWD1_HUMAN,DTW domain-containing protein 1,304,"35,248",3 out of 5,2007-10-23,Evidence at protein level
Q86UW9,DTX2_HUMAN,Probable E3 ubiquitin-protein ligase DTX2 (EC 2.3.2.27) (Protein deltex-2) (Deltex2) (hDTX2) (RING finger protein 58) (RING-type E3 ubiquitin transferase DTX2),622,"67,246",5 out of 5,2003-09-26,Evidence at protein level
Q8TDB6,DTX3L_HUMAN,E3 ubiquitin-protein ligase DTX3L (EC 2.3.2.27) (B-lymphoma- and BAL-associated protein) (Protein deltex-3-like) (RING-type E3 ubiquitin transferase DTX3L) (Rhysin-2) (Rhysin2),740,"83,554",5 out of 5,2003-09-26,Evidence at protein level
P0CJ89,DU4L6_HUMAN,Double homeobox protein 4-like protein 6,424,"44,926",2 out of 5,2011-03-08,Inferred from homology
Q68J44,DUPD1_HUMAN,Dual specificity phosphatase DUPD1 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase 27),220,"25,336",4 out of 5,2007-07-24,Evidence at protein level
Q9UQ16,DYN3_HUMAN,"Dynamin-3 (EC 3.6.5.5) (Dynamin, testicular) (T-dynamin)",869,"97,746",5 out of 5,2003-01-17,Evidence at protein level
Q13627,DYR1A_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 1A (EC 2.7.12.1) (Dual specificity YAK1-related kinase) (HP86) (Protein kinase minibrain homolog) (MNBH) (hMNB),763,"85,584",5 out of 5,1997-11-01,Evidence at protein level
Q86Y13,DZIP3_HUMAN,E3 ubiquitin-protein ligase DZIP3 (EC 2.3.2.27) (DAZ-interacting protein 3) (RING-type E3 ubiquitin transferase DZIP3) (RNA-binding ubiquitin ligase of 138 kDa) (hRUL138),1208,"138,604",5 out of 5,2004-07-19,Evidence at protein level
Q96AV8,E2F7_HUMAN,Transcription factor E2F7 (E2F-7),911,"99,888",5 out of 5,2007-08-21,Evidence at protein level
Q9HCM4,E41L5_HUMAN,Band 4.1-like protein 5,733,"81,856",5 out of 5,2001-07-11,Evidence at protein level
Q92611,EDEM1_HUMAN,ER degradation-enhancing alpha-mannosidase-like protein 1,657,"73,768",5 out of 5,2001-11-16,Evidence at protein level
O75530,EED_HUMAN,Polycomb protein EED (hEED) (WD protein associating with integrin cytoplasmic tails 1) (WAIT-1),441,"50,198",5 out of 5,2008-07-22,Evidence at protein level
Q9BUY7,EFC11_HUMAN,EF-hand calcium-binding domain-containing protein 11,163,"19,225",3 out of 5,2007-05-15,Evidence at transcript level
P60608,EFC2_HUMAN,Endogenous retrovirus group FC1 member 1 Env polyprotein (Envelope polyprotein) (Fc2deltaenv) (HERV-F(c)2_7q36.2 provirus ancestral Env polyprotein) [Includes: Surface protein (SU); Truncated transmembrane protein (TM)],527,"58,319",4 out of 5,2004-03-15,Evidence at protein level
Q8N7U6,EFHB_HUMAN,EF-hand domain-containing family member B,833,"93,802",3 out of 5,2006-10-03,Evidence at transcript level
Q7Z2Z2,EFL1_HUMAN,Elongation factor-like GTPase 1 (Elongation factor Tu GTP-binding domain-containing protein 1) (Elongation factor-like 1) (Protein FAM42A),1120,"125,430",5 out of 5,2008-01-15,Evidence at protein level
Q9BZG8,DPH1_HUMAN,2-(3-amino-3-carboxypropyl)histidine synthase subunit 1 (EC 2.5.1.108) (Diphthamide biosynthesis protein 1) (Diphtheria toxin resistance protein 1) (Ovarian cancer-associated gene 1 protein) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 1),443,"48,805",5 out of 5,2007-10-23,Evidence at protein level
Q9HCU8,DPOD4_HUMAN,DNA polymerase delta subunit 4 (DNA polymerase delta subunit p12),107,"12,433",5 out of 5,2001-09-26,Evidence at protein level
Q9UHN1,DPOG2_HUMAN,"DNA polymerase subunit gamma-2, mitochondrial (EC 2.7.7.7) (DNA polymerase gamma accessory 55 kDa subunit) (p55) (Mitochondrial DNA polymerase accessory subunit) (MtPolB) (PolG-beta)",485,"54,911",5 out of 5,2001-11-16,Evidence at protein level
Q9NY33,DPP3_HUMAN,Dipeptidyl peptidase 3 (EC 3.4.14.4) (Dipeptidyl aminopeptidase III) (Dipeptidyl arylamidase III) (Dipeptidyl peptidase III) (DPP III) (Enkephalinase B),737,"82,589",5 out of 5,2001-04-27,Evidence at protein level
Q05923,DUS2_HUMAN,Dual specificity protein phosphatase 2 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase PAC-1),314,"34,400",5 out of 5,1994-02-01,Evidence at protein level
Q96G46,DUS3L_HUMAN,tRNA-dihydrouridine(47) synthase [NAD(P)(+)]-like (EC 1.3.1.-) (tRNA-dihydrouridine synthase 3-like),650,"72,594",4 out of 5,2006-07-25,Evidence at protein level
P33316,DUT_HUMAN,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)",252,"26,563",5 out of 5,1994-02-01,Evidence at protein level
O14640,DVL1_HUMAN,Segment polarity protein dishevelled homolog DVL-1 (Dishevelled-1) (DSH homolog 1),695,"75,187",5 out of 5,2000-05-30,Evidence at protein level
Q92997,DVL3_HUMAN,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),716,"78,055",5 out of 5,2000-05-30,Evidence at protein level
Q9BQI3,E2AK1_HUMAN,Eukaryotic translation initiation factor 2-alpha kinase 1 (EC 2.7.11.1) (Heme-controlled repressor) (HCR) (Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase) (Heme-regulated inhibitor) (Hemin-sensitive initiation factor 2-alpha kinase),630,"71,106",5 out of 5,2001-07-11,Evidence at protein level
Q9NZJ5,E2AK3_HUMAN,Eukaryotic translation initiation factor 2-alpha kinase 3 (EC 2.7.11.1) (PRKR-like endoplasmic reticulum kinase) (Pancreatic eIF2-alpha kinase) (HsPEK),1116,"125,216",5 out of 5,2001-09-26,Evidence at protein level
Q16254,E2F4_HUMAN,Transcription factor E2F4 (E2F-4),413,"43,960",5 out of 5,1997-11-01,Evidence at protein level
P43005,EAA3_HUMAN,Excitatory amino acid transporter 3 (Excitatory amino-acid carrier 1) (Neuronal and epithelial glutamate transporter) (Sodium-dependent glutamate/aspartate transporter 3) (Solute carrier family 1 member 1),524,"57,100",5 out of 5,1995-11-01,Evidence at protein level
Q96JC9,EAF1_HUMAN,ELL-associated factor 1,268,"29,042",5 out of 5,2005-08-30,Evidence at protein level
P42892,ECE1_HUMAN,Endothelin-converting enzyme 1 (ECE-1) (EC 3.4.24.71),770,"87,164",5 out of 5,1995-11-01,Evidence at protein level
Q008S8,ECT2L_HUMAN,Epithelial cell-transforming sequence 2 oncogene-like (Lung-specific F-box and DH domain-containing protein) (Putative guanine nucleotide exchange factor LFDH),904,"104,880",3 out of 5,2008-05-20,Evidence at transcript level
O60869,EDF1_HUMAN,Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1),148,"16,369",5 out of 5,2005-04-12,Evidence at protein level
P14138,EDN3_HUMAN,Endothelin-3 (ET-3) (Preproendothelin-3) (PPET3),238,"25,454",5 out of 5,1990-01-01,Evidence at protein level
Q9BQC3,DPH2_HUMAN,2-(3-amino-3-carboxypropyl)histidine synthase subunit 2 (EC 2.5.1.108) (Diphthamide biosynthesis protein 2) (Diphtheria toxin resistance protein 2) (S-adenosyl-L-methionine:L-histidine 3-amino-3-carboxypropyltransferase 2),489,"52,083",4 out of 5,2007-10-23,Evidence at protein level
Q9H4G8,DPH3B_HUMAN,Putative DPH3 homolog B (CSL-type zinc finger-containing protein 1),78,"8,721",2 out of 5,2003-04-04,Uncertain
Q7L8W6,DPH6_HUMAN,Diphthine--ammonia ligase (EC 6.3.1.14) (ATP-binding domain-containing protein 4) (Diphthamide synthase) (Diphthamide synthetase) (Protein DPH6 homolog),267,"30,307",5 out of 5,2007-04-03,Evidence at protein level
O94777,DPM2_HUMAN,Dolichol phosphate-mannose biosynthesis regulatory protein (Dolichol-phosphate mannose synthase subunit 2) (DPM synthase subunit 2),84,"9,312",5 out of 5,2000-05-30,Evidence at protein level
Q15054,DPOD3_HUMAN,DNA polymerase delta subunit 3 (DNA polymerase delta subunit C) (DNA polymerase delta subunit p66) (DNA polymerase delta subunit p68),466,"51,400",5 out of 5,1998-07-15,Evidence at protein level
Q07864,DPOE1_HUMAN,DNA polymerase epsilon catalytic subunit A (EC 2.7.7.7) (DNA polymerase II subunit A),2286,"261,518",5 out of 5,1994-10-01,Evidence at protein level
Q8TB45,DPTOR_HUMAN,DEP domain-containing mTOR-interacting protein (DEP domain-containing protein 6),409,"46,294",5 out of 5,2007-04-17,Evidence at protein level
O14531,DPYL4_HUMAN,Dihydropyrimidinase-related protein 4 (DRP-4) (Collapsin response mediator protein 3) (CRMP-3) (UNC33-like phosphoprotein 4) (ULIP-4),572,"61,878",4 out of 5,1998-07-15,Evidence at protein level
P01920,DQB1_HUMAN,"HLA class II histocompatibility antigen, DQ beta 1 chain (MHC class II antigen DQB1)",261,"29,991",5 out of 5,1986-07-21,Evidence at protein level
Q30154,DRB5_HUMAN,"HLA class II histocompatibility antigen, DR beta 5 chain (DR beta-5) (DR2-beta-2) (Dw2) (MHC class II antigen DRB5)",266,"30,056",5 out of 5,2008-03-18,Evidence at protein level
P21918,DRD5_HUMAN,D(1B) dopamine receptor (D(5) dopamine receptor) (D1beta dopamine receptor) (Dopamine D5 receptor),477,"52,951",5 out of 5,1991-05-01,Evidence at protein level
Q9UII6,DS13B_HUMAN,Dual specificity protein phosphatase 13 isoform B (DUSP13B) (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity phosphatase SKRP4) (Testis- and skeletal-muscle-specific DSP),198,"22,149",5 out of 5,2002-01-23,Evidence at protein level
Q6XUX3,DUSTY_HUMAN,Dual serine/threonine and tyrosine protein kinase (EC 2.7.12.1) (Dusty protein kinase) (Dusty PK) (RIP-homologous kinase) (Receptor-interacting serine/threonine-protein kinase 5) (Sugen kinase 496) (SgK496),929,"105,206",5 out of 5,2006-05-02,Evidence at protein level
A6NLW8,DUXA_HUMAN,Double homeobox protein A,204,"23,817",2 out of 5,2007-11-13,Inferred from homology
Q6ZR08,DYH12_HUMAN,"Dynein heavy chain 12, axonemal (Axonemal beta dynein heavy chain 12) (Axonemal dynein heavy chain 12-like protein) (Axonemal dynein heavy chain 7-like protein) (Ciliary dynein heavy chain 12) (Dynein heavy chain 7-like, axonemal) (Dynein heavy chain domain-containing protein 2)",3092,"356,942",5 out of 5,2007-12-04,Evidence at transcript level
Q9UFH2,DYH17_HUMAN,"Dynein heavy chain 17, axonemal (Axonemal beta dynein heavy chain 17) (Axonemal dynein heavy chain-like protein 1) (Ciliary dynein heavy chain 17) (Ciliary dynein heavy chain-like protein 1) (Dynein light chain 2, axonemal)",4485,"511,787",5 out of 5,2008-03-18,Evidence at protein level
Q96FJ2,DYL2_HUMAN,"Dynein light chain 2, cytoplasmic (8 kDa dynein light chain b) (DLC8b) (Dynein light chain LC8-type 2)",89,"10,350",5 out of 5,2004-12-21,Evidence at protein level
Q03001,DYST_HUMAN,Dystonin (230 kDa bullous pemphigoid antigen) (230/240 kDa bullous pemphigoid antigen) (Bullous pemphigoid antigen 1) (BPA) (Bullous pemphigoid antigen) (Dystonia musculorum protein) (Hemidesmosomal plaque protein),7570,"860,662",5 out of 5,1996-10-01,Evidence at protein level
O00716,E2F3_HUMAN,Transcription factor E2F3 (E2F-3),465,"49,162",5 out of 5,1997-11-01,Evidence at protein level
O75461,E2F6_HUMAN,Transcription factor E2F6 (E2F-6),281,"31,844",5 out of 5,2000-05-30,Evidence at protein level
A0AVK6,E2F8_HUMAN,Transcription factor E2F8 (E2F-8),867,"94,166",5 out of 5,2007-08-21,Evidence at protein level
Q6P2I7,EBLN2_HUMAN,Endogenous Bornavirus-like nucleoprotein 2 (Endogenous Borna-like N element-2) (EBLN-2),272,"30,450",2 out of 5,2008-12-16,Evidence at transcript level
O43598,DNPH1_HUMAN,2'-deoxynucleoside 5'-phosphate N-hydrolase 1 (EC 3.2.2.-) (c-Myc-responsive protein RCL),174,"19,108",5 out of 5,2005-05-10,Evidence at protein level
Q5JSL3,DOC11_HUMAN,Dedicator of cytokinesis protein 11 (Activated Cdc42-associated guanine nucleotide exchange factor) (ACG) (Zizimin-2),2073,"237,671",4 out of 5,2007-09-11,Evidence at protein level
Q14185,DOCK1_HUMAN,Dedicator of cytokinesis protein 1 (180 kDa protein downstream of CRK) (DOCK180),1865,"215,346",5 out of 5,2003-07-03,Evidence at protein level
Q9BU89,DOHH_HUMAN,Deoxyhypusine hydroxylase (hDOHH) (EC 1.14.99.29) (Deoxyhypusine dioxygenase) (Deoxyhypusine monooxygenase) (HEAT-like repeat-containing protein 1),302,"32,904",5 out of 5,2006-09-05,Evidence at protein level
Q99704,DOK1_HUMAN,Docking protein 1 (Downstream of tyrosine kinase 1) (p62(dok)) (pp62),481,"52,392",5 out of 5,2001-11-16,Evidence at protein level
Q7L591,DOK3_HUMAN,Docking protein 3 (Downstream of tyrosine kinase 3),496,"53,288",5 out of 5,2005-05-10,Evidence at protein level
Q18PE1,DOK7_HUMAN,Protein Dok-7 (Downstream of tyrosine kinase 7),504,"53,097",5 out of 5,2006-09-19,Evidence at protein level
Q5JWR5,DOP1_HUMAN,Protein dopey-1,2465,"277,355",3 out of 5,2007-08-21,Evidence at transcript level
Q8N608,DPP10_HUMAN,Inactive dipeptidyl peptidase 10 (Dipeptidyl peptidase IV-related protein 3) (DPRP-3) (Dipeptidyl peptidase X) (DPP X) (Dipeptidyl peptidase-like protein 2) (DPL2),796,"90,888",5 out of 5,2005-06-07,Evidence at protein level
Q5T2R2,DPS1_HUMAN,Decaprenyl-diphosphate synthase subunit 1 (EC 2.5.1.91) (All-trans-decaprenyl-diphosphate synthase subunit 1) (Decaprenyl pyrophosphate synthase subunit 1) (Trans-prenyltransferase 1) (TPT 1),415,"46,261",5 out of 5,2006-01-24,Evidence at protein level
Q9C005,DPY30_HUMAN,Protein dpy-30 homolog (Dpy-30-like protein) (Dpy-30L),99,"11,250",5 out of 5,2001-07-11,Evidence at protein level
Q12882,DPYD_HUMAN,Dihydropyrimidine dehydrogenase [NADP(+)] (DHPDHase) (DPD) (EC 1.3.1.2) (Dihydrothymine dehydrogenase) (Dihydrouracil dehydrogenase),1025,"111,401",5 out of 5,1997-11-01,Evidence at protein level
Q8IY82,DRC7_HUMAN,Dynein regulatory complex subunit 7 (Coiled-coil domain-containing protein 135) (Coiled-coil domain-containing protein lobo homolog),874,"103,497",4 out of 5,2007-03-06,Evidence at protein level
P35462,DRD3_HUMAN,D(3) dopamine receptor (Dopamine D3 receptor),400,"44,225",5 out of 5,1994-06-01,Evidence at protein level
O95147,DUS14_HUMAN,Dual specificity protein phosphatase 14 (EC 3.1.3.16) (EC 3.1.3.48) (MKP-1-like protein tyrosine phosphatase) (MKP-L) (Mitogen-activated protein kinase phosphatase 6) (MAP kinase phosphatase 6) (MKP-6),198,"22,255",5 out of 5,2002-01-23,Evidence at protein level
P28562,DUS1_HUMAN,Dual specificity protein phosphatase 1 (EC 3.1.3.16) (EC 3.1.3.48) (Dual specificity protein phosphatase hVH1) (Mitogen-activated protein kinase phosphatase 1) (MAP kinase phosphatase 1) (MKP-1) (Protein-tyrosine phosphatase CL100),367,"39,298",5 out of 5,1992-12-01,Evidence at protein level
Q9NRW4,DUS22_HUMAN,Dual specificity protein phosphatase 22 (EC 3.1.3.16) (EC 3.1.3.48) (JNK-stimulatory phosphatase-1) (JSP-1) (Low molecular weight dual specificity phosphatase 2) (LMW-DSP2) (Mitogen-activated protein kinase phosphatase x) (MAP kinase phosphatase x) (MKP-x),184,"20,910",5 out of 5,2006-06-27,Evidence at protein level
Q99956,DUS9_HUMAN,Dual specificity protein phosphatase 9 (EC 3.1.3.16) (EC 3.1.3.48) (Mitogen-activated protein kinase phosphatase 4) (MAP kinase phosphatase 4) (MKP-4),384,"41,868",5 out of 5,1998-12-15,Evidence at protein level
Q92630,DYRK2_HUMAN,Dual specificity tyrosine-phosphorylation-regulated kinase 2 (EC 2.7.12.1),601,"66,652",5 out of 5,2001-04-27,Evidence at protein level
Q9P2K8,E2AK4_HUMAN,eIF-2-alpha kinase GCN2 (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 4) (GCN2-like protein),1649,"186,911",5 out of 5,2005-03-15,Evidence at protein level
Q9H4G0,E41L1_HUMAN,Band 4.1-like protein 1 (Neuronal protein 4.1) (4.1N),881,"98,503",5 out of 5,2001-07-11,Evidence at protein level
P43004,EAA2_HUMAN,Excitatory amino acid transporter 2 (Glutamate/aspartate transporter II) (Sodium-dependent glutamate/aspartate transporter 2) (Solute carrier family 1 member 2),574,"62,104",5 out of 5,1995-11-01,Evidence at protein level
Q9HAF1,EAF6_HUMAN,Chromatin modification-related protein MEAF6 (MYST/Esa1-associated factor 6) (Esa1-associated factor 6 homolog) (Protein EAF6 homolog) (hEAF6) (Sarcoma antigen NY-SAR-91),191,"21,635",5 out of 5,2007-01-23,Evidence at protein level
Q13011,ECH1_HUMAN,"Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)",328,"35,816",5 out of 5,1997-11-01,Evidence at protein level
Q9NTX5,ECHD1_HUMAN,Ethylmalonyl-CoA decarboxylase (EC 4.1.1.94) (Enoyl-CoA hydratase domain-containing protein 1) (Methylmalonyl-CoA decarboxylase) (MMCD) (EC 4.1.1.41),307,"33,698",5 out of 5,2007-01-23,Evidence at protein level
Q9BZQ6,EDEM3_HUMAN,"ER degradation-enhancing alpha-mannosidase-like protein 3 (EC 3.2.1.113) (Alpha-1,2-mannosidase EDEM3)",932,"104,664",5 out of 5,2001-11-16,Evidence at protein level
P24530,EDNRB_HUMAN,Endothelin B receptor (ET-B) (ET-BR) (Endothelin receptor non-selective type),442,"49,644",5 out of 5,1992-03-01,Evidence at protein level
Q5VUJ9,EFCB2_HUMAN,EF-hand calcium-binding domain-containing protein 2,269,"29,714",2 out of 5,2006-10-17,Evidence at transcript level
Q5THR3,EFCB6_HUMAN,EF-hand calcium-binding domain-containing protein 6 (CAP-binding protein complex-interacting protein 1) (DJ-1-binding protein) (DJBP),1501,"172,930",5 out of 5,2006-07-11,Evidence at protein level
O43921,EFNA2_HUMAN,Ephrin-A2 (EPH-related receptor tyrosine kinase ligand 6) (LERK-6) (HEK7 ligand) (HEK7-L),213,"23,878",5 out of 5,1998-12-15,Evidence at protein level
P52798,EFNA4_HUMAN,Ephrin-A4 (EPH-related receptor tyrosine kinase ligand 4) (LERK-4),201,"22,386",5 out of 5,1996-10-01,Evidence at protein level
Q15768,EFNB3_HUMAN,Ephrin-B3 (EPH-related receptor transmembrane ligand ELK-L3) (EPH-related receptor tyrosine kinase ligand 8) (LERK-8),340,"35,835",5 out of 5,1997-11-01,Evidence at protein level
Q14152,EIF3A_HUMAN,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185),1382,"166,569",5 out of 5,2000-05-30,Evidence at protein level
P28324,ELK4_HUMAN,ETS domain-containing protein Elk-4 (Serum response factor accessory protein 1) (SAP-1) (SRF accessory protein 1),431,"46,900",5 out of 5,1992-12-01,Evidence at protein level
Q04743,EMX2_HUMAN,Homeobox protein EMX2 (Empty spiracles homolog 2) (Empty spiracles-like protein 2),252,"28,303",5 out of 5,1995-02-01,Evidence at protein level
Q9NRM1,ENAM_HUMAN,Enamelin,1142,"128,785",5 out of 5,2000-12-01,Evidence at protein level
O71037,ENK19_HUMAN,Endogenous retrovirus group K member 19 Env polyprotein (EnvK3 protein) (Envelope polyprotein) (HERV-K(C19) envelope protein) (HERV-K_19q11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],699,"79,252",4 out of 5,2004-05-24,Evidence at protein level
Q9HDB8,ENK5_HUMAN,Endogenous retrovirus group K member 5 Env polyprotein (Envelope polyprotein) (HERV-K(II) envelope protein) (HERV-K_3q12.3 provirus ancestral Env polyprotein) [Includes: Truncated surface protein (SU)],245,"27,904",3 out of 5,2004-05-24,Evidence at transcript level
Q8TC29,ENKUR_HUMAN,Enkurin,256,"29,454",2 out of 5,2005-07-19,Evidence at transcript level
Q7L5Y1,ENOF1_HUMAN,Mitochondrial enolase superfamily member 1 (EC 4.2.1.68) (Antisense RNA to thymidylate synthase) (rTS) (L-fuconate dehydratase),443,"49,786",5 out of 5,2008-04-29,Evidence at protein level
P09104,ENOG_HUMAN,Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE),434,"47,269",5 out of 5,1989-07-01,Evidence at protein level
Q8TC92,ENOX1_HUMAN,Ecto-NOX disulfide-thiol exchanger 1 (Candidate growth-related and time keeping constitutive hydroquinone [NADH] oxidase) (cCNOX) (Cell proliferation-inducing gene 38 protein) (Constitutive Ecto-NOX) (cNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)],643,"73,348",5 out of 5,2007-07-24,Evidence at protein level
Q14264,ENR1_HUMAN,Endogenous retrovirus group 3 member 1 Env polyprotein (ERV-3 envelope protein) (ERV3 envelope protein) (ERV3-1 envelope protein) (Envelope polyprotein) (HERV-R envelope protein) (ERV-R envelope protein) (HERV-R_7q21.2 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],604,"67,942",5 out of 5,2004-03-01,Evidence at transcript level
P98073,ENTK_HUMAN,Enteropeptidase (EC 3.4.21.9) (Enterokinase) (Serine protease 7) (Transmembrane protease serine 15) [Cleaved into: Enteropeptidase non-catalytic heavy chain; Enteropeptidase catalytic light chain],1019,"112,935",5 out of 5,1996-02-01,Evidence at protein level
O75356,ENTP5_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 5 (NTPDase 5) (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (EC 3.6.1.42) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5),428,"47,517",5 out of 5,2001-08-29,Evidence at protein level
P16422,EPCAM_HUMAN,Epithelial cell adhesion molecule (Ep-CAM) (Adenocarcinoma-associated antigen) (Cell surface glycoprotein Trop-1) (Epithelial cell surface antigen) (Epithelial glycoprotein) (EGP) (Epithelial glycoprotein 314) (EGP314) (hEGP314) (KS 1/4 antigen) (KSA) (Major gastrointestinal tumor-associated protein GA733-2) (Tumor-associated calcium signal transducer 1) (CD antigen CD326),314,"34,932",5 out of 5,1990-08-01,Evidence at protein level
Q9UM22,EPDR1_HUMAN,Mammalian ependymin-related protein 1 (MERP-1) (Upregulated in colorectal cancer gene 1 protein),224,"25,437",4 out of 5,2001-02-21,Evidence at protein level
O95278,EPM2A_HUMAN,Laforin (EC 3.1.3.-) (EC 3.1.3.16) (EC 3.1.3.48) (Glucan phosphatase) (Lafora PTPase) (LAFPTPase),331,"37,158",5 out of 5,2004-07-19,Evidence at protein level
Q7L775,EPMIP_HUMAN,EPM2A-interacting protein 1 (Laforin-interacting protein),607,"70,370",5 out of 5,2004-08-16,Evidence at protein level
O95208,EPN2_HUMAN,Epsin-2 (EPS-15-interacting protein 2),641,"68,482",5 out of 5,2004-01-16,Evidence at protein level
P19235,EPOR_HUMAN,Erythropoietin receptor (EPO-R),508,"55,065",5 out of 5,1990-11-01,Evidence at protein level
Q99645,EPYC_HUMAN,Epiphycan (Dermatan sulfate proteoglycan 3) (Proteoglycan-Lb) (PG-Lb) (Small chondroitin/dermatan sulfate proteoglycan),322,"36,637",4 out of 5,2002-11-08,Evidence at transcript level
O43491,E41L2_HUMAN,Band 4.1-like protein 2 (Generally expressed protein 4.1) (4.1G),1005,"112,588",5 out of 5,2001-12-05,Evidence at protein level
Q8WWZ3,EDAD_HUMAN,Ectodysplasin-A receptor-associated adapter protein (EDAR-associated death domain protein) (Protein crinkled homolog),215,"24,802",5 out of 5,2002-06-06,Evidence at protein level
Q9BV94,EDEM2_HUMAN,ER degradation-enhancing alpha-mannosidase-like protein 2,578,"64,753",5 out of 5,2001-11-16,Evidence at protein level
O43854,EDIL3_HUMAN,EGF-like repeat and discoidin I-like domain-containing protein 3 (Developmentally-regulated endothelial cell locus 1 protein) (Integrin-binding protein DEL1),480,"53,765",5 out of 5,2004-01-16,Evidence at protein level
P05305,EDN1_HUMAN,Endothelin-1 (Preproendothelin-1) (PPET1) [Cleaved into: Endothelin-1 (ET-1); Big endothelin-1],212,"24,425",5 out of 5,1988-11-01,Evidence at protein level
A6NFE3,EFC10_HUMAN,EF-hand calcium-binding domain-containing protein 10,127,"14,721",1 out of 5,2008-06-10,Evidence at transcript level
Q6NXP0,EFC12_HUMAN,EF-hand calcium-binding domain-containing protein 12,572,"66,551",2 out of 5,2006-05-30,Evidence at protein level
Q9HA90,EFCC1_HUMAN,EF-hand and coiled-coil domain-containing protein 1 (Coiled-coil domain-containing protein 48),598,"65,701",3 out of 5,2006-05-16,Evidence at transcript level
Q0D2K5,EGFEM_HUMAN,Putative EGF-like and EMI domain-containing protein 1,195,"21,632",2 out of 5,2008-06-10,Uncertain
P22413,ENPP1_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (E-NPP 1) (Membrane component chromosome 6 surface marker 1) (Phosphodiesterase I/nucleotide pyrophosphatase 1) (Plasma-cell membrane glycoprotein PC-1) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)],925,"104,924",5 out of 5,1991-08-01,Evidence at protein level
P21709,EPHA1_HUMAN,Ephrin type-A receptor 1 (hEpha1) (EC 2.7.10.1) (EPH tyrosine kinase) (EPH tyrosine kinase 1) (Erythropoietin-producing hepatoma receptor) (Tyrosine-protein kinase receptor EPH),976,"108,127",5 out of 5,1991-05-01,Evidence at protein level
P29317,EPHA2_HUMAN,Ephrin type-A receptor 2 (EC 2.7.10.1) (Epithelial cell kinase) (Tyrosine-protein kinase receptor ECK),976,"108,266",5 out of 5,1992-12-01,Evidence at protein level
Q9UF33,EPHA6_HUMAN,Ephrin type-A receptor 6 (EC 2.7.10.1) (EPH homology kinase 2) (EHK-2) (EPH-like kinase 12) (EK12),1036,"116,379",5 out of 5,2006-05-16,Evidence at transcript level
Q15375,EPHA7_HUMAN,Ephrin type-A receptor 7 (EC 2.7.10.1) (EPH homology kinase 3) (EHK-3) (EPH-like kinase 11) (EK11) (hEK11),998,"112,097",5 out of 5,1997-11-01,Evidence at protein level
P54753,EPHB3_HUMAN,Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6),998,"110,330",5 out of 5,1996-10-01,Evidence at protein level
O15197,EPHB6_HUMAN,Ephrin type-B receptor 6 (HEP) (Tyrosine-protein kinase-defective receptor EPH-6),1021,"110,700",5 out of 5,2000-05-30,Evidence at protein level
P04626,ERBB2_HUMAN,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),1255,"137,910",5 out of 5,1987-08-13,Evidence at protein level
Q15125,EBP_HUMAN,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase (EC 5.3.3.5) (Cholestenol Delta-isomerase) (Delta(8)-Delta(7) sterol isomerase) (D8-D7 sterol isomerase) (Emopamil-binding protein)",230,"26,353",5 out of 5,2001-10-18,Evidence at protein level
Q19T08,ECSCR_HUMAN,Endothelial cell-specific chemotaxis regulator (Apoptosis regulator through modulating IAP expression) (ARIA) (Endothelial cell-specific molecule 2),205,"21,295",5 out of 5,2009-03-03,Evidence at protein level
Q96F86,EDC3_HUMAN,Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1),508,"56,078",5 out of 5,2005-11-22,Evidence at protein level
P20800,EDN2_HUMAN,Endothelin-2 (ET-2) (Preproendothelin-2) (PPET2),178,"19,960",5 out of 5,1991-02-01,Evidence at protein level
P01133,EGF_HUMAN,Pro-epidermal growth factor (EGF) [Cleaved into: Epidermal growth factor (Urogastrone)],1207,"133,994",5 out of 5,1986-07-21,Evidence at protein level
Q9H6Z9,EGLN3_HUMAN,Egl nine homolog 3 (EC 1.14.11.29) (HPH-1) (Hypoxia-inducible factor prolyl hydroxylase 3) (HIF-PH3) (HIF-prolyl hydroxylase 3) (HPH-3) (Prolyl hydroxylase domain-containing protein 3) (PHD3),239,"27,261",5 out of 5,2003-06-16,Evidence at protein level
P26378,ELAV4_HUMAN,ELAV-like protein 4 (Hu-antigen D) (HuD) (Paraneoplastic encephalomyelitis antigen HuD),380,"41,770",5 out of 5,1992-08-01,Evidence at protein level
A6NLF2,ELB3D_HUMAN,Elongin-A3 member D (EloA3D) (Elongin-A3-like-2) (EloA3-like-2) (RNA polymerase II transcription factor SIII subunit A3-like-2) (Transcription elongation factor B polypeptide 3C-like-2),546,"59,772",3 out of 5,2008-07-01,Inferred from homology
P32519,ELF1_HUMAN,ETS-related transcription factor Elf-1 (E74-like factor 1),619,"67,498",5 out of 5,1993-10-01,Evidence at protein level
Q15370,ELOB_HUMAN,Elongin-B (EloB) (Elongin 18 kDa subunit) (RNA polymerase II transcription factor SIII subunit B) (SIII p18) (Transcription elongation factor B polypeptide 2),118,"13,133",5 out of 5,2003-07-11,Evidence at protein level
A1L3X0,ELOV7_HUMAN,Elongation of very long chain fatty acids protein 7 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL7) (ELOVL fatty acid elongase 7) (ELOVL FA elongase 7) (Very long chain 3-ketoacyl-CoA synthase 7) (Very long chain 3-oxoacyl-CoA synthase 7),281,"33,356",5 out of 5,2007-12-04,Evidence at protein level
Q0PNE2,ELP6_HUMAN,Elongator complex protein 6 (Angiotonin-transactivated protein 1) (Protein TMEM103),266,"29,793",4 out of 5,2007-02-06,Evidence at protein level
O94919,ENDD1_HUMAN,Endonuclease domain-containing 1 protein (EC 3.1.30.-),500,"55,017",4 out of 5,2004-07-19,Evidence at protein level
Q8N8Q3,ENDOV_HUMAN,Endonuclease V (hEndoV) (EC 3.1.26.-) (Inosine-specific endoribonuclease),282,"30,792",5 out of 5,2008-09-02,Evidence at protein level
Q9UJA9,ENPP5_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (E-NPP 5) (NPP-5) (EC 3.1.-.-),477,"54,666",4 out of 5,2004-07-19,Evidence at transcript level
Q6UWR7,ENPP6_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 6 (E-NPP 6) (NPP-6) (EC 3.1.4.-) (EC 3.1.4.38) (Choline-specific glycerophosphodiester phosphodiesterase) (Glycerophosphocholine cholinephosphodiesterase) (GPC-Cpde),440,"50,241",5 out of 5,2006-06-13,Evidence at protein level
Q8TEA8,DTD1_HUMAN,D-tyrosyl-tRNA(Tyr) deacylase 1 (EC 3.1.-.-) (DNA-unwinding element-binding protein B) (DUE-B) (Histidyl-tRNA synthase-related),209,"23,424",5 out of 5,2003-03-28,Evidence at protein level
P0CJ90,DU4L7_HUMAN,Double homeobox protein 4-like protein 7,424,"44,926",2 out of 5,2011-03-08,Inferred from homology
Q4G0W2,DUS28_HUMAN,Dual specificity phosphatase 28 (EC 3.1.3.16) (EC 3.1.3.48),176,"18,324",3 out of 5,2007-09-11,Evidence at transcript level
Q6RFH8,DUX4C_HUMAN,"Double homeobox protein 4C (Double homeobox protein 4, centromeric) (DUX4c) (Double homeobox protein 4-like protein 9)",374,"39,442",5 out of 5,2011-03-08,Evidence at protein level
O77932,DXO_HUMAN,Decapping and exoribonuclease protein (DXO) (EC 3.1.13.-) (EC 3.6.1.-) (Dom-3 homolog Z),396,"44,929",5 out of 5,2006-09-19,Evidence at transcript level
Q96JB1,DYH8_HUMAN,"Dynein heavy chain 8, axonemal (Axonemal beta dynein heavy chain 8) (Ciliary dynein heavy chain 8)",4490,"514,664",5 out of 5,2007-01-23,Evidence at protein level
Q8N1N2,DYNAP_HUMAN,Dynactin-associated protein (Full),210,"22,529",5 out of 5,2005-08-16,Evidence at protein level
Q86XF0,DYR2_HUMAN,"Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)",187,"21,620",5 out of 5,2005-12-20,Evidence at protein level
P19525,E2AK2_HUMAN,"Interferon-induced, double-stranded RNA-activated protein kinase (EC 2.7.11.1) (Eukaryotic translation initiation factor 2-alpha kinase 2) (eIF-2A protein kinase 2) (Interferon-inducible RNA-dependent protein kinase) (P1/eIF-2A protein kinase) (Protein kinase RNA-activated) (PKR) (Protein kinase R) (Tyrosine-protein kinase EIF2AK2) (EC 2.7.10.2) (p68 kinase)",551,"62,094",5 out of 5,1991-02-01,Evidence at protein level
Q9BQ95,ECSIT_HUMAN,"Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial (Protein SITPEC)",431,"49,148",5 out of 5,2007-06-26,Evidence at protein level
P24534,EF1B_HUMAN,Elongation factor 1-beta (EF-1-beta),225,"24,764",5 out of 5,1992-03-01,Evidence at protein level
Q96G04,EF2KT_HUMAN,Protein-lysine N-methyltransferase EEF2KMT (EC 2.1.1.-) (eEF2-lysine methyltransferase) (eEF2-KMT),330,"36,915",5 out of 5,2006-01-24,Evidence at protein level
P13639,EF2_HUMAN,Elongation factor 2 (EF-2),858,"95,338",5 out of 5,1990-01-01,Evidence at protein level
Q9HAE3,EFCB1_HUMAN,EF-hand calcium-binding domain-containing protein 1,211,"24,488",2 out of 5,2006-10-03,Evidence at transcript level
A8MZ26,EFCB9_HUMAN,EF-hand calcium-binding domain-containing protein 9,197,"23,937",1 out of 5,2008-06-10,Predicted
P52803,EFNA5_HUMAN,Ephrin-A5 (AL-1) (EPH-related receptor tyrosine kinase ligand 7) (LERK-7),228,"26,297",5 out of 5,1996-10-01,Evidence at protein level
P52799,EFNB2_HUMAN,Ephrin-B2 (EPH-related receptor tyrosine kinase ligand 5) (LERK-5) (HTK ligand) (HTK-L),333,"36,923",5 out of 5,1996-10-01,Evidence at protein level
O43281,EFS_HUMAN,Embryonal Fyn-associated substrate (hEFS) (Cas scaffolding protein family member 3),561,"58,815",5 out of 5,2000-05-30,Evidence at protein level
P49411,EFTU_HUMAN,"Elongation factor Tu, mitochondrial (EF-Tu) (P43)",452,"49,542",5 out of 5,1996-02-01,Evidence at protein level
Q9UI10,EI2BD_HUMAN,Translation initiation factor eIF-2B subunit delta (eIF-2B GDP-GTP exchange factor subunit delta),523,"57,557",5 out of 5,2000-12-01,Evidence at protein level
Q8N6I1,EID2_HUMAN,EP300-interacting inhibitor of differentiation 2 (EID-2) (CREBBP/EP300 inhibitor 2) (EID-1-like inhibitor of differentiation 2),236,"25,190",5 out of 5,2008-01-15,Evidence at protein level
Q7L2H7,EIF3M_HUMAN,Eukaryotic translation initiation factor 3 subunit M (eIF3m) (Fetal lung protein B5) (hFL-B5) (PCI domain-containing protein 1),374,"42,503",5 out of 5,2007-10-23,Evidence at protein level
Q9HBU6,EKI1_HUMAN,Ethanolamine kinase 1 (EKI 1) (EC 2.7.1.82),452,"50,968",5 out of 5,2001-06-01,Evidence at protein level
Q15717,ELAV1_HUMAN,ELAV-like protein 1 (Hu-antigen R) (HuR),326,"36,092",5 out of 5,2001-02-21,Evidence at protein level
P0DMC3,ELA_HUMAN,Apelin receptor early endogenous ligand (Protein Elabela) (Protein Toddler),54,"6,622",4 out of 5,2014-02-19,Evidence at transcript level
Q8IZ81,ELMD2_HUMAN,ELMO domain-containing protein 2,293,"34,961",3 out of 5,2006-03-07,Evidence at protein level
Q96FG2,ELMD3_HUMAN,ELMO domain-containing protein 3 (RNA-binding motif and ELMO domain-containing protein 1) (RNA-binding motif protein 29) (RNA-binding protein 29),381,"43,046",5 out of 5,2007-02-06,Evidence at protein level
Q92556,ELMO1_HUMAN,Engulfment and cell motility protein 1 (Protein ced-12 homolog),727,"83,829",5 out of 5,1997-11-01,Evidence at protein level
Q9BW60,ELOV1_HUMAN,Elongation of very long chain fatty acids protein 1 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL1) (ELOVL fatty acid elongase 1) (ELOVL FA elongase 1) (Very long chain 3-ketoacyl-CoA synthase 1) (Very long chain 3-oxoacyl-CoA synthase 1),279,"32,663",5 out of 5,2002-01-23,Evidence at protein level
Q99848,EBP2_HUMAN,Probable rRNA-processing protein EBP2 (EBNA1-binding protein 2) (Nucleolar protein p40),306,"34,852",4 out of 5,2002-06-06,Evidence at protein level
Q9BUP0,EFHD1_HUMAN,EF-hand domain-containing protein D1 (EF-hand domain-containing protein 1) (Swiprosin-2),239,"26,928",4 out of 5,2002-01-23,Evidence at protein level
P20827,EFNA1_HUMAN,"Ephrin-A1 (EPH-related receptor tyrosine kinase ligand 1) (LERK-1) (Immediate early response protein B61) (Tumor necrosis factor alpha-induced protein 4) (TNF alpha-induced protein 4) [Cleaved into: Ephrin-A1, secreted form]",205,"23,787",5 out of 5,1991-02-01,Evidence at protein level
P98172,EFNB1_HUMAN,Ephrin-B1 (EFL-3) (ELK ligand) (ELK-L) (EPH-related receptor tyrosine kinase ligand 2) (LERK-2),346,"38,007",5 out of 5,1996-10-01,Evidence at protein level
Q9Y2G0,EFR3B_HUMAN,Protein EFR3 homolog B,817,"92,487",5 out of 5,2007-12-04,Evidence at protein level
Q06889,EGR3_HUMAN,Early growth response protein 3 (EGR-3) (Zinc finger protein pilot),387,"42,613",5 out of 5,1995-02-01,Evidence at transcript level
A0A087WX78,ELB3C_HUMAN,Putative elongin-A3 member C (EloA3C),387,"41,674",2 out of 5,2017-02-15,Uncertain
P78545,ELF3_HUMAN,ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1),371,"41,454",5 out of 5,2007-05-15,Evidence at protein level
Q9HB65,ELL3_HUMAN,RNA polymerase II elongation factor ELL3,397,"45,361",5 out of 5,2004-06-07,Evidence at protein level
P60002,ELOF1_HUMAN,Transcription elongation factor 1 homolog,83,"9,462",2 out of 5,2003-11-14,Inferred from homology
Q9NXB9,ELOV2_HUMAN,Elongation of very long chain fatty acids protein 2 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL2) (ELOVL fatty acid elongase 2) (ELOVL FA elongase 2) (Very long chain 3-ketoacyl-CoA synthase 2) (Very long chain 3-oxoacyl-CoA synthase 2),296,"34,585",5 out of 5,2002-01-23,Evidence at protein level
Q6IA86,ELP2_HUMAN,Elongator complex protein 2 (ELP2) (SHINC-2) (STAT3-interacting protein 1) (StIP1),826,"92,500",5 out of 5,2005-12-06,Evidence at protein level
Q9HC35,EMAL4_HUMAN,Echinoderm microtubule-associated protein-like 4 (EMAP-4) (Restrictedly overexpressed proliferation-associated protein) (Ropp 120),981,"108,916",4 out of 5,2001-10-18,Evidence at protein level
Q5T6L9,EMARD_HUMAN,Endoplasmic reticulum membrane-associated RNA degradation protein (ER membrane-associated RNA degradation protein),678,"77,788",4 out of 5,2007-07-24,Evidence at protein level
Q5UCC4,EMC10_HUMAN,ER membrane protein complex subunit 10 (Hematopoietic signal peptide-containing membrane domain-containing protein 1),262,"27,347",5 out of 5,2008-01-15,Evidence at protein level
P50402,EMD_HUMAN,Emerin,254,"28,994",5 out of 5,1996-10-01,Evidence at protein level
Q96A84,EMID1_HUMAN,EMI domain-containing protein 1 (Emilin and multimerin domain-containing protein 1) (Emu1),441,"45,292",3 out of 5,2003-10-03,Evidence at transcript level
P54849,EMP1_HUMAN,Epithelial membrane protein 1 (EMP-1) (CL-20) (Protein B4B) (Tumor-associated membrane protein),157,"17,563",5 out of 5,1996-10-01,Evidence at protein level
P54852,EMP3_HUMAN,Epithelial membrane protein 3 (EMP-3) (Hematopoietic neural membrane protein 1) (HNMP-1) (Protein YMP),163,"18,429",4 out of 5,1996-10-01,Evidence at protein level
Q7Z589,EMSY_HUMAN,BRCA2-interacting transcriptional repressor EMSY,1322,"141,468",5 out of 5,2004-05-24,Evidence at protein level
Q6UWT2,ENHO_HUMAN,Adropin (Energy homeostasis-associated protein),76,"7,927",3 out of 5,2007-06-26,Evidence at transcript level
O42043,ENK18_HUMAN,"Endogenous retrovirus group K member 18 Env polyprotein (Envelope polyprotein) (HERV-K(C1a) envelope protein) (HERV-K110 envelope protein) (HERV-K18 envelope protein) (HERV-K18 superantigen) (HERV-K_1q23.3 provirus ancestral Env polyprotein) (IDDMK1,2 22 envelope protein) (IDDMK1,2 22 superantigen) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)]",560,"63,671",5 out of 5,2004-05-24,Evidence at protein level
Q69384,ENK6_HUMAN,Endogenous retrovirus group K member 6 Env polyprotein (EnvK2 protein) (Envelope polyprotein) (HERV-K(C7) envelope protein) (HERV-K(HML-2.HOM) envelope protein) (HERV-K108 envelope protein) (HERV-K_7p22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],699,"79,218",5 out of 5,2004-05-24,Evidence at protein level
Q9H0I2,ENKD1_HUMAN,Enkurin domain-containing protein 1,346,"38,759",5 out of 5,2006-12-12,Evidence at protein level
Q58FF3,ENPLL_HUMAN,Putative endoplasmin-like protein (Putative heat shock protein 90 kDa beta member 2),399,"45,859",2 out of 5,2008-09-02,Uncertain
Q9H223,EHD4_HUMAN,EH domain-containing protein 4 (Hepatocellular carcinoma-associated protein 10/11) (PAST homolog 4),541,"61,175",5 out of 5,2001-09-26,Evidence at protein level
P41214,EIF2D_HUMAN,Eukaryotic translation initiation factor 2D (eIF2d) (Hepatocellular carcinoma-associated antigen 56) (Ligatin),584,"64,706",5 out of 5,1995-02-01,Evidence at protein level
Q8NG57,ELOA3_HUMAN,Elongin-A3 (EloA3) (RNA polymerase II transcription factor SIII subunit A3) (Transcription elongation factor B polypeptide 3C),546,"59,744",4 out of 5,2003-07-11,Evidence at protein level
Q9GZR5,ELOV4_HUMAN,Elongation of very long chain fatty acids protein 4 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL4) (ELOVL fatty acid elongase 4) (ELOVL FA elongase 4) (Very long chain 3-ketoacyl-CoA synthase 4) (Very long chain 3-oxoacyl-CoA synthase 4),314,"36,829",5 out of 5,2002-01-23,Evidence at protein level
Q96EB1,ELP4_HUMAN,Elongator complex protein 4 (hELP4) (PAX6 neighbor gene protein),424,"46,588",5 out of 5,2007-04-17,Evidence at protein level
Q32P44,EMAL3_HUMAN,Echinoderm microtubule-associated protein-like 3 (EMAP-3),896,"95,197",3 out of 5,2007-04-17,Evidence at protein level
Q05BV3,EMAL5_HUMAN,Echinoderm microtubule-associated protein-like 5 (EMAP-5),1969,"219,427",3 out of 5,2007-04-17,Evidence at transcript level
Q5J8M3,EMC4_HUMAN,ER membrane protein complex subunit 4 (Cell proliferation-inducing gene 17 protein) (Transmembrane protein 85),183,"20,087",5 out of 5,2006-10-03,Evidence at protein level
Q8NFI3,ENASE_HUMAN,Cytosolic endo-beta-N-acetylglucosaminidase (ENGase) (EC 3.2.1.96),743,"83,987",4 out of 5,2008-04-08,Evidence at protein level
P13929,ENOB_HUMAN,Beta-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 3) (Muscle-specific enolase) (MSE) (Skeletal muscle enolase),434,"46,987",5 out of 5,1990-01-01,Evidence at protein level
P0DO92,ENOL_HUMAN,Putative protein T-ENOL (CDIPT antisense RNA 1),83,"9,002",1 out of 5,2016-05-11,Predicted
Q16206,ENOX2_HUMAN,Ecto-NOX disulfide-thiol exchanger 2 (APK1 antigen) (Cytosolic ovarian carcinoma antigen 1) (Tumor-associated hydroquinone oxidase) (tNOX) [Includes: Hydroquinone [NADH] oxidase (EC 1.-.-.-); Protein disulfide-thiol oxidoreductase (EC 1.-.-.-)],610,"70,082",5 out of 5,1999-07-15,Evidence at protein level
Q13822,ENPP2_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (E-NPP 2) (EC 3.1.4.39) (Autotaxin) (Extracellular lysophospholipase D) (LysoPLD),863,"98,994",5 out of 5,2002-09-19,Evidence at protein level
O14638,ENPP3_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c) [Includes: Alkaline phosphodiesterase I (EC 3.1.4.1); Nucleotide pyrophosphatase (NPPase) (EC 3.6.1.9) (Nucleotide diphosphatase)],875,"100,124",5 out of 5,2002-09-19,Evidence at protein level
P54764,EPHA4_HUMAN,Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK),986,"109,860",5 out of 5,1996-10-01,Evidence at protein level
P54756,EPHA5_HUMAN,Ephrin type-A receptor 5 (EC 2.7.10.1) (Brain-specific kinase) (EPH homology kinase 1) (EHK-1) (EPH-like kinase 7) (EK7) (hEK7),1037,"114,803",5 out of 5,1996-10-01,Evidence at protein level
Q9H6B9,EPHX3_HUMAN,Epoxide hydrolase 3 (EC 3.3.-.-) (Abhydrolase domain-containing protein 9),360,"40,909",2 out of 5,2006-12-12,Evidence at transcript level
Q9NZ08,ERAP1_HUMAN,Endoplasmic reticulum aminopeptidase 1 (EC 3.4.11.-) (ARTS-1) (Adipocyte-derived leucine aminopeptidase) (A-LAP) (Aminopeptidase PILS) (Puromycin-insensitive leucyl-specific aminopeptidase) (PILS-AP) (Type 1 tumor necrosis factor receptor shedding aminopeptidase regulator),941,"107,235",5 out of 5,2002-03-05,Evidence at protein level
Q6P179,ERAP2_HUMAN,Endoplasmic reticulum aminopeptidase 2 (EC 3.4.11.-) (Leukocyte-derived arginine aminopeptidase) (L-RAP),960,"110,462",5 out of 5,2008-01-15,Evidence at protein level
P18074,ERCC2_HUMAN,TFIIH basal transcription factor complex helicase XPD subunit (EC 3.6.4.12) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),760,"86,909",5 out of 5,1990-11-01,Evidence at protein level
O76062,ERG24_HUMAN,Delta(14)-sterol reductase (Delta-14-SR) (EC 1.3.1.70) (Another new gene 1 protein) (C-14 sterol reductase) (Putative sterol reductase SR-1) (Sterol C14-reductase) (Transmembrane 7 superfamily member 2),418,"46,406",5 out of 5,2002-01-31,Evidence at transcript level
A8K979,ERI2_HUMAN,ERI1 exoribonuclease 2 (EC 3.1.-.-) (Exonuclease domain-containing protein 1),691,"77,401",4 out of 5,2008-06-10,Evidence at transcript level
P30040,ERP29_HUMAN,Endoplasmic reticulum resident protein 29 (ERp29) (Endoplasmic reticulum resident protein 28) (ERp28) (Endoplasmic reticulum resident protein 31) (ERp31),261,"28,993",5 out of 5,1993-04-01,Evidence at protein level
Q9UJM3,ERRFI_HUMAN,ERBB receptor feedback inhibitor 1 (Mitogen-inducible gene 6 protein) (MIG-6),462,"50,560",5 out of 5,2003-01-27,Evidence at protein level
Q9H4M9,EHD1_HUMAN,EH domain-containing protein 1 (PAST homolog 1) (hPAST1) (Testilin),534,"60,627",5 out of 5,2001-09-26,Evidence at protein level
Q14232,EI2BA_HUMAN,Translation initiation factor eIF-2B subunit alpha (eIF-2B GDP-GTP exchange factor subunit alpha),305,"33,712",5 out of 5,1997-11-01,Evidence at protein level
O15372,EIF3H_HUMAN,Eukaryotic translation initiation factor 3 subunit H (eIF3h) (Eukaryotic translation initiation factor 3 subunit 3) (eIF-3-gamma) (eIF3 p40 subunit),352,"39,930",5 out of 5,2000-05-30,Evidence at protein level
Q8N336,ELMD1_HUMAN,ELMO domain-containing protein 1,334,"39,052",3 out of 5,2006-03-07,Evidence at transcript level
P08246,ELNE_HUMAN,Neutrophil elastase (EC 3.4.21.37) (Bone marrow serine protease) (Elastase-2) (Human leukocyte elastase) (HLE) (Medullasin) (PMN elastase),267,"28,518",5 out of 5,1988-08-01,Evidence at protein level
Q15369,ELOC_HUMAN,Elongin-C (EloC) (Elongin 15 kDa subunit) (RNA polymerase II transcription factor SIII subunit C) (SIII p15) (Transcription elongation factor B polypeptide 1),112,"12,473",5 out of 5,2003-07-11,Evidence at protein level
Q00013,EM55_HUMAN,"55 kDa erythrocyte membrane protein (p55) (Membrane protein, palmitoylated 1)",466,"52,296",5 out of 5,1992-12-01,Evidence at protein level
Q9P0I2,EMC3_HUMAN,ER membrane protein complex subunit 3 (Transmembrane protein 111),261,"29,952",4 out of 5,2005-07-19,Evidence at protein level
O43402,EMC8_HUMAN,ER membrane protein complex subunit 8 (Neighbor of COX4) (Protein FAM158B),210,"23,773",5 out of 5,2001-09-26,Evidence at protein level
A4GXA9,EME2_HUMAN,Probable crossover junction endonuclease EME2 (EC 3.1.22.-),379,"41,178",4 out of 5,2008-02-05,Evidence at protein level
Q04741,EMX1_HUMAN,Homeobox protein EMX1 (Empty spiracles homolog 1) (Empty spiracles-like protein 1),257,"28,039",5 out of 5,1995-02-01,Evidence at protein level
Q902F9,EN113_HUMAN,Endogenous retrovirus group K member 113 Env polyprotein (EnvK5 protein) (Envelope polyprotein) (HERV-K113 envelope protein) (HERV-K_19p13.11 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],699,"79,195",4 out of 5,2004-05-24,Evidence at protein level
P21128,ENDOU_HUMAN,Poly(U)-specific endoribonuclease (EC 3.1.-.-) (Placental protein 11) (PP11) (Protein endoU) (Uridylate-specific endoribonuclease),410,"46,872",5 out of 5,1991-02-01,Evidence at protein level
Q9N2J8,ENH3_HUMAN,HERV-H_2q24.1 provirus ancestral Env polyprotein (Env protein HERV-H/p59) (Envelope polyprotein) (HERV-H/env59) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],555,"60,911",4 out of 5,2004-03-01,Evidence at transcript level
Q9NX77,ENK13_HUMAN,Endogenous retrovirus group K member 13-1 Env polyprotein (Envelope polyprotein) (HERV-K_16p13.3 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],482,"55,045",4 out of 5,2004-05-24,Evidence at transcript level
P61570,ENK25_HUMAN,Endogenous retrovirus group K member 25 Env polyprotein (Envelope polyprotein) (HERV-K_11q22.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],661,"74,892",4 out of 5,2004-05-24,Inferred from homology
Q9UKH3,ENK9_HUMAN,Endogenous retrovirus group K member 9 Env polyprotein (EnvK4 protein) (Envelope polyprotein) (HERV-K(C6) envelope protein) (HERV-K109 envelope protein) (HERV-K_6q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],698,"79,016",4 out of 5,2004-05-24,Evidence at protein level
P06733,ENOA_HUMAN,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),434,"47,169",5 out of 5,1988-01-01,Evidence at protein level
Q9Y6X5,ENPP4_HUMAN,Bis(5'-adenosyl)-triphosphatase ENPP4 (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Ectonucleotide pyrophosphatase/phosphodiesterase family member 4) (E-NPP 4) (NPP-4),453,"51,641",5 out of 5,2008-03-18,Evidence at protein level
O75355,ENTP3_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 3 (NTPDase 3) (EC 3.6.1.5) (CD39 antigen-like 3) (Ecto-ATP diphosphohydrolase 3) (Ecto-ATPDase 3) (Ecto-ATPase 3) (Ecto-apyrase 3) (HB6),529,"59,105",5 out of 5,2001-08-29,Evidence at protein level
O75354,ENTP6_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 6 (NTPDase 6) (EC 3.6.1.6) (CD39 antigen-like 2),484,"53,246",5 out of 5,2001-08-29,Evidence at protein level
Q5NDL2,EOGT_HUMAN,EGF domain-specific O-linked N-acetylglucosamine transferase (EC 2.4.1.255) (Extracellular O-linked N-acetylglucosamine transferase),527,"62,011",5 out of 5,2007-09-11,Evidence at protein level
B3EWF7,EP2A2_HUMAN,"Laforin, isoform 9",344,"35,169",4 out of 5,2012-03-21,Evidence at protein level
P56851,EP3B_HUMAN,Epididymal secretory protein E3-beta (Human epididymis-specific protein 3-beta) (HE3-beta),147,"17,584",3 out of 5,2000-05-30,Evidence at protein level
Q9HCE0,EPG5_HUMAN,Ectopic P granules protein 5 homolog,2579,"292,481",5 out of 5,2007-10-02,Evidence at protein level
Q6UW88,EPGN_HUMAN,Epigen (Epithelial mitogen) (EPG),154,"17,091",5 out of 5,2006-01-10,Evidence at protein level
P54760,EPHB4_HUMAN,Ephrin type-B receptor 4 (EC 2.7.10.1) (Hepatoma transmembrane kinase) (Tyrosine-protein kinase TYRO11),987,"108,270",5 out of 5,1996-10-01,Evidence at protein level
Q14677,EPN4_HUMAN,Clathrin interactor 1 (Clathrin-interacting protein localized in the trans-Golgi region) (Clint) (Enthoprotin) (Epsin-4) (Epsin-related protein) (EpsinR),625,"68,259",5 out of 5,2004-01-16,Evidence at protein level
Q96RT1,ERBIN_HUMAN,Erbin (Densin-180-like protein) (Erbb2-interacting protein) (Protein LAP2),1412,"158,298",5 out of 5,2004-07-19,Evidence at protein level
Q2NKX8,ERC6L_HUMAN,DNA excision repair protein ERCC-6-like (EC 3.6.4.12) (ATP-dependent helicase ERCC6-like) (PLK1-interacting checkpoint helicase) (Tumor antigen BJ-HCC-15),1250,"141,103",5 out of 5,2008-04-08,Evidence at protein level
P07992,ERCC1_HUMAN,DNA excision repair protein ERCC-1,297,"32,562",5 out of 5,1988-08-01,Evidence at protein level
Q8IYD1,ERF3B_HUMAN,Eukaryotic peptide chain release factor GTP-binding subunit ERF3B (Eukaryotic peptide chain release factor subunit 3b) (eRF3b) (G1 to S phase transition protein 2 homolog),628,"68,883",5 out of 5,2008-04-08,Evidence at protein level
Q96RQ1,ERGI2_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 2,377,"42,549",5 out of 5,2006-06-13,Evidence at protein level
Q96DN0,ERP27_HUMAN,Endoplasmic reticulum resident protein 27 (ER protein 27) (ERp27),273,"30,480",4 out of 5,2007-03-20,Evidence at protein level
B6SEH8,ERVV1_HUMAN,Endogenous retrovirus group V member 1 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 1),477,"52,557",2 out of 5,2011-06-28,Evidence at transcript level
Q9NQ30,ESM1_HUMAN,Endothelial cell-specific molecule 1 (ESM-1),184,"20,095",5 out of 5,2001-04-27,Evidence at protein level
P03372,ESR1_HUMAN,Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1),595,"66,216",5 out of 5,1986-07-21,Evidence at protein level
Q5XG92,EST4A_HUMAN,Carboxylesterase 4A (EC 3.1.1.-),561,"63,529",4 out of 5,2008-03-18,Evidence at transcript level
Q66K89,E4F1_HUMAN,Transcription factor E4F1 (EC 2.3.2.27) (E4F transcription factor 1) (Putative E3 ubiquitin-protein ligase E4F1) (RING-type E3 ubiquitin transferase E4F1) (Transcription factor E4F) (p120E4F) (p50E4F),784,"83,496",5 out of 5,2008-03-18,Evidence at protein level
Q96CJ1,EAF2_HUMAN,ELL-associated factor 2 (Testosterone-regulated apoptosis inducer and tumor suppressor protein),260,"28,792",5 out of 5,2005-08-30,Evidence at protein level
Q86YB7,ECHD2_HUMAN,"Enoyl-CoA hydratase domain-containing protein 2, mitochondrial",292,"31,126",3 out of 5,2007-11-13,Evidence at protein level
Q5VYK3,ECM29_HUMAN,Proteasome-associated protein ECM29 homolog (Ecm29),1845,"204,291",5 out of 5,2005-03-15,Evidence at protein level
Q5VTE0,EF1A3_HUMAN,Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5),462,"50,185",4 out of 5,2008-06-10,Uncertain
Q658K8,EF1DL_HUMAN,Putative elongation factor 1-delta-like protein (Putative EF-1-delta-like pseudogene 3 protein),133,"14,137",2 out of 5,2008-09-02,Uncertain
A4FU69,EFCB5_HUMAN,EF-hand calcium-binding domain-containing protein 5,1503,"173,404",3 out of 5,2008-01-15,Evidence at protein level
A8K855,EFCB7_HUMAN,EF-hand calcium-binding domain-containing protein 7,629,"71,981",3 out of 5,2008-02-26,Evidence at protein level
Q99944,EGFL8_HUMAN,Epidermal growth factor-like protein 8 (EGF-like protein 8) (Vascular endothelial statin-2) (VE-statin-2),293,"32,262",3 out of 5,2004-10-25,Evidence at protein level
Q63HQ2,EGFLA_HUMAN,"Pikachurin (Agrin-like protein) (EGF-like, fibronectin type-III and laminin G-like domain-containing protein)",1017,"111,271",5 out of 5,2007-10-02,Evidence at protein level
P49770,EI2BB_HUMAN,Translation initiation factor eIF-2B subunit beta (S20I15) (S20III15) (eIF-2B GDP-GTP exchange factor subunit beta),351,"38,990",5 out of 5,1996-10-01,Evidence at protein level
Q9Y6B2,EID1_HUMAN,EP300-interacting inhibitor of differentiation 1 (21 kDa pRb-associated protein) (CREBBP/EP300 inhibitory protein 1) (E1A-like inhibitor of differentiation 1) (EID-1),187,"20,876",5 out of 5,2007-05-29,Evidence at protein level
O60739,EIF1B_HUMAN,Eukaryotic translation initiation factor 1b (eIF1b) (Protein translation factor SUI1 homolog GC20),113,"12,824",3 out of 5,2000-05-30,Evidence at protein level
Q9NVF9,EKI2_HUMAN,Ethanolamine kinase 2 (EKI 2) (EC 2.7.1.82) (Ethanolamine kinase-like protein),386,"44,781",4 out of 5,2001-06-01,Evidence at transcript level
P0C7U0,ELFN1_HUMAN,Protein ELFN1 (Extracellular leucine-rich repeat and fibronectin type-III domain-containing protein 1) (Protein phosphatase 1 regulatory subunit 28),828,"90,477",5 out of 5,2008-07-22,Evidence at protein level
Q9BV81,EMC6_HUMAN,ER membrane protein complex subunit 6 (Transmembrane protein 93),110,"12,017",4 out of 5,2006-10-31,Evidence at protein level
Q9NPA0,EMC7_HUMAN,ER membrane protein complex subunit 7,242,"26,471",3 out of 5,2006-06-27,Evidence at protein level
Q96AY2,EME1_HUMAN,Crossover junction endonuclease EME1 (EC 3.1.22.-) (MMS4 homolog) (hMMS4),570,"63,252",5 out of 5,2006-02-21,Evidence at protein level
P54851,EMP2_HUMAN,Epithelial membrane protein 2 (EMP-2) (Protein XMP),167,"19,199",5 out of 5,1996-10-01,Evidence at protein level
Q9H4I9,EMRE_HUMAN,"Essential MCU regulator, mitochondrial (Single-pass membrane protein with aspartate-rich tail 1, mitochondrial)",107,"11,441",5 out of 5,2007-07-24,Evidence at protein level
O95905,ECD_HUMAN,Protein ecdysoneless homolog (Human suppressor of GCR two) (hSGT1),644,"72,758",5 out of 5,2001-11-16,Evidence at protein level
P40939,ECHA_HUMAN,"Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)]",763,"83,000",5 out of 5,1995-02-01,Evidence at protein level
P55084,ECHB_HUMAN,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",474,"51,294",5 out of 5,1996-10-01,Evidence at protein level
Q96DC8,ECHD3_HUMAN,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",303,"32,634",3 out of 5,2008-05-20,Evidence at protein level
P42126,ECI1_HUMAN,"Enoyl-CoA delta isomerase 1, mitochondrial (EC 5.3.3.8) (3,2-trans-enoyl-CoA isomerase) (Delta(3),Delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Dodecenoyl-CoA isomerase)",302,"32,816",5 out of 5,1995-11-01,Evidence at protein level
Q16610,ECM1_HUMAN,Extracellular matrix protein 1 (Secretory component p85),540,"60,674",5 out of 5,1997-11-01,Evidence at protein level
P12724,ECP_HUMAN,Eosinophil cationic protein (ECP) (EC 3.1.27.-) (Ribonuclease 3) (RNase 3),160,"18,385",5 out of 5,1989-10-01,Evidence at protein level
Q9H8V3,ECT2_HUMAN,Protein ECT2 (Epithelial cell-transforming sequence 2 oncogene),914,"103,505",5 out of 5,2001-09-26,Evidence at protein level
Q05639,EF1A2_HUMAN,Elongation factor 1-alpha 2 (EF-1-alpha-2) (Eukaryotic elongation factor 1 A-2) (eEF1A-2) (Statin-S1),463,"50,470",5 out of 5,1994-06-01,Evidence at protein level
Q5JVL4,EFHC1_HUMAN,EF-hand domain-containing protein 1 (Myoclonin-1),640,"73,990",5 out of 5,2005-10-25,Evidence at protein level
Q96C19,EFHD2_HUMAN,EF-hand domain-containing protein D2 (Swiprosin-1),240,"26,697",4 out of 5,2002-01-23,Evidence at protein level
Q8IUX8,EGFL6_HUMAN,Epidermal growth factor-like protein 6 (EGF-like protein 6) (MAM and EGF domains-containing gene protein),553,"61,317",5 out of 5,2007-07-24,Evidence at transcript level
Q05215,EGR4_HUMAN,Early growth response protein 4 (EGR-4) (AT133),589,"61,623",3 out of 5,1994-06-01,Evidence at transcript level
Q9H9B1,EHMT1_HUMAN,Histone-lysine N-methyltransferase EHMT1 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 1) (Eu-HMTase1) (G9a-like protein 1) (GLP) (GLP1) (Histone H3-K9 methyltransferase 5) (H3-K9-HMTase 5) (Lysine N-methyltransferase 1D),1298,"141,466",5 out of 5,2002-11-15,Evidence at protein level
Q8N9N8,EIF1A_HUMAN,Probable RNA-binding protein EIF1AD (Eukaryotic translation initiation factor 1A domain-containing protein) (Haponin),165,"19,053",5 out of 5,2008-01-15,Evidence at protein level
O15371,EIF3D_HUMAN,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66),548,"63,973",5 out of 5,2000-05-30,Evidence at protein level
Q13347,EIF3I_HUMAN,Eukaryotic translation initiation factor 3 subunit I (eIF3i) (Eukaryotic translation initiation factor 3 subunit 2) (TGF-beta receptor-interacting protein 1) (TRIP-1) (eIF-3-beta) (eIF3 p36),325,"36,502",5 out of 5,1997-11-01,Evidence at protein level
Q9UBQ5,EIF3K_HUMAN,Eukaryotic translation initiation factor 3 subunit K (eIF3k) (Eukaryotic translation initiation factor 3 subunit 12) (Muscle-specific gene M9 protein) (PLAC-24) (eIF-3 p25) (eIF-3 p28),218,"25,060",5 out of 5,2002-09-19,Evidence at protein level
P19957,ELAF_HUMAN,Elafin (Elastase-specific inhibitor) (ESI) (Peptidase inhibitor 3) (PI-3) (Protease inhibitor WAP3) (Skin-derived antileukoproteinase) (SKALP) (WAP four-disulfide core domain protein 14),117,"12,270",5 out of 5,1991-02-01,Evidence at protein level
Q9UKW6,ELF5_HUMAN,ETS-related transcription factor Elf-5 (E74-like factor 5) (Epithelium-restricted ESE-1-related Ets factor) (Epithelium-specific Ets transcription factor 2) (ESE-2),265,"31,263",5 out of 5,2005-07-05,Evidence at protein level
O95834,EMAL2_HUMAN,Echinoderm microtubule-associated protein-like 2 (EMAP-2) (HuEMAP-2),649,"70,679",5 out of 5,2001-10-18,Evidence at protein level
Q9BXX0,EMIL2_HUMAN,EMILIN-2 (Elastin microfibril interface-located protein 2) (Elastin microfibril interfacer 2) (Protein FOAP-10),1053,"115,687",5 out of 5,2003-10-03,Evidence at protein level
O14681,EI24_HUMAN,Etoposide-induced protein 2.4 homolog (p53-induced gene 8 protein),340,"38,965",5 out of 5,2000-05-30,Evidence at protein level
P55884,EIF3B_HUMAN,Eukaryotic translation initiation factor 3 subunit B (eIF3b) (Eukaryotic translation initiation factor 3 subunit 9) (Prt1 homolog) (hPrt1) (eIF-3-eta) (eIF3 p110) (eIF3 p116),814,"92,482",5 out of 5,1997-11-01,Evidence at protein level
O75821,EIF3G_HUMAN,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44),320,"35,611",5 out of 5,2000-05-30,Evidence at protein level
Q96BJ8,ELMO3_HUMAN,Engulfment and cell motility protein 3,720,"81,467",3 out of 5,2003-05-16,Evidence at protein level
P15502,ELN_HUMAN,Elastin (Tropoelastin),786,"68,469",5 out of 5,1990-04-01,Evidence at protein level
Q14241,ELOA1_HUMAN,Elongin-A (EloA) (Elongin 110 kDa subunit) (RNA polymerase II transcription factor SIII subunit A1) (SIII p110) (Transcription elongation factor B polypeptide 3),798,"89,909",5 out of 5,2003-07-11,Evidence at protein level
Q9H5J4,ELOV6_HUMAN,Elongation of very long chain fatty acids protein 6 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL6) (ELOVL fatty acid elongase 6) (ELOVL FA elongase 6) (Fatty acid elongase 2) (hELO2) (Fatty acyl-CoA elongase) (Long-chain fatty-acyl elongase) (Very long chain 3-ketoacyl-CoA synthase 6) (Very long chain 3-oxoacyl-CoA synthase 6),265,"31,376",5 out of 5,2007-04-03,Evidence at protein level
P14625,ENPL_HUMAN,Endoplasmin (94 kDa glucose-regulated protein) (GRP-94) (Heat shock protein 90 kDa beta member 1) (Tumor rejection antigen 1) (gp96 homolog),803,"92,469",5 out of 5,1990-04-01,Evidence at protein level
Q6UWV6,ENPP7_HUMAN,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 (E-NPP 7) (NPP-7) (EC 3.1.4.12) (Alkaline sphingomyelin phosphodiesterase) (Intestinal alkaline sphingomyelinase) (Alk-SMase),458,"51,494",5 out of 5,2005-03-15,Evidence at protein level
O43768,ENSA_HUMAN,Alpha-endosulfine (ARPP-19e),121,"13,389",5 out of 5,2003-02-28,Evidence at protein level
P49961,ENTP1_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 1 (NTPDase 1) (EC 3.6.1.5) (Ecto-ATP diphosphohydrolase 1) (Ecto-ATPDase 1) (Ecto-ATPase 1) (Ecto-apyrase) (Lymphoid cell activation antigen) (CD antigen CD39),510,"57,965",5 out of 5,1996-10-01,Evidence at protein level
Q9Y227,ENTP4_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 4 (NTPDase 4) (EC 3.6.1.6) (Lysosomal apyrase-like protein of 70 kDa) (Uridine-diphosphatase) (UDPase),616,"70,255",5 out of 5,2001-08-29,Evidence at protein level
Q9NQZ7,ENTP7_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 7 (NTPDase 7) (EC 3.6.1.-) (Lysosomal apyrase-like protein 1),604,"68,960",4 out of 5,2007-02-06,Evidence at transcript level
Q9NPA8,ENY2_HUMAN,Transcription and mRNA export factor ENY2 (Enhancer of yellow 2 transcription factor homolog),101,"11,529",5 out of 5,2008-01-15,Evidence at protein level
A6NDY0,EPAB2_HUMAN,Embryonic polyadenylate-binding protein 2 (Embryonic poly(A)-binding protein 2) (ePABP-2) (ePABP2) (Embryonic poly(A)-binding protein type II) (Poly(A)-binding protein nuclear-like 1),278,"30,386",3 out of 5,2008-09-02,Evidence at transcript level
P29320,EPHA3_HUMAN,Ephrin type-A receptor 3 (EC 2.7.10.1) (EPH-like kinase 4) (EK4) (hEK4) (HEK) (Human embryo kinase) (Tyrosine-protein kinase TYRO4) (Tyrosine-protein kinase receptor ETK1) (Eph-like tyrosine kinase 1),983,"110,131",5 out of 5,1992-12-01,Evidence at protein level
P29322,EPHA8_HUMAN,Ephrin type-A receptor 8 (EC 2.7.10.1) (EPH- and ELK-related kinase) (EPH-like kinase 3) (EK3) (hEK3) (Tyrosine-protein kinase receptor EEK),1005,"111,003",5 out of 5,1992-12-01,Evidence at protein level
Q8IUS5,EPHX4_HUMAN,Epoxide hydrolase 4 (EC 3.3.-.-) (Abhydrolase domain-containing protein 7) (Epoxide hydrolase-related protein),362,"42,324",3 out of 5,2007-03-20,Evidence at transcript level
O95925,EPPI_HUMAN,Eppin (Cancer/testis antigen 71) (CT71) (Epididymal protease inhibitor) (Protease inhibitor WAP7) (Serine protease inhibitor-like with Kunitz and WAP domains 1) (WAP four-disulfide core domain protein 7),133,"15,284",5 out of 5,2001-05-04,Evidence at protein level
Q12929,EPS8_HUMAN,Epidermal growth factor receptor kinase substrate 8,822,"91,882",5 out of 5,1997-11-01,Evidence at protein level
Q03468,ERCC6_HUMAN,DNA excision repair protein ERCC-6 (EC 3.6.4.-) (ATP-dependent helicase ERCC6) (Cockayne syndrome protein CSB),1493,"168,416",5 out of 5,1993-10-01,Evidence at protein level
Q14534,ERG1_HUMAN,Squalene monooxygenase (EC 1.14.14.17) (Squalene epoxidase) (SE),574,"63,923",5 out of 5,1997-11-01,Evidence at protein level
Q969X5,ERGI1_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 1 (ER-Golgi intermediate compartment 32 kDa protein) (ERGIC-32),290,"32,592",5 out of 5,2004-08-31,Evidence at protein level
Q9Y282,ERGI3_HUMAN,Endoplasmic reticulum-Golgi intermediate compartment protein 3 (Serologically defined breast cancer antigen NY-BR-84),383,"43,222",5 out of 5,2003-10-24,Evidence at protein level
O43414,ERI3_HUMAN,ERI1 exoribonuclease 3 (EC 3.1.-.-) (Prion interactor 1) (Prion protein-interacting protein),337,"37,238",4 out of 5,2008-03-18,Evidence at protein level
Q76MJ5,ERN2_HUMAN,Serine/threonine-protein kinase/endoribonuclease IRE2 (Endoplasmic reticulum-to-nucleus signaling 2) (Inositol-requiring protein 2) (hIRE2p) (Ire1-beta) (IRE1b) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],926,"102,480",5 out of 5,2004-08-16,Evidence at protein level
P62508,ERR3_HUMAN,Estrogen-related receptor gamma (ERR gamma-2) (Estrogen receptor-related protein 3) (Nuclear receptor subfamily 3 group B member 3),458,"51,306",5 out of 5,2004-07-19,Evidence at protein level
Q5FWF5,ESCO1_HUMAN,N-acetyltransferase ESCO1 (EC 2.3.1.-) (CTF7 homolog 1) (Establishment factor-like protein 1) (EFO1p) (hEFO1) (Establishment of cohesion 1 homolog 1) (ECO1 homolog 1) (ESO1 homolog 1),840,"94,983",5 out of 5,2005-06-07,Evidence at protein level
Q6ZVH7,ESPNL_HUMAN,Espin-like protein,1005,"108,132",3 out of 5,2007-12-04,Evidence at transcript level
Q9H6T0,ESRP2_HUMAN,Epithelial splicing regulatory protein 2 (RNA-binding motif protein 35B) (RNA-binding protein 35B),727,"78,401",5 out of 5,2007-01-23,Evidence at protein level
Q6IPR1,ETFR1_HUMAN,Electron transfer flavoprotein regulatory factor 1 (LYR motif-containing protein 5),90,"10,864",3 out of 5,2006-10-03,Evidence at protein level
Q6ZN32,ETV3L_HUMAN,ETS translocation variant 3-like protein,361,"39,948",3 out of 5,2008-03-18,Evidence at transcript level
P41161,ETV5_HUMAN,ETS translocation variant 5 (Ets-related protein ERM),510,"57,838",5 out of 5,1995-02-01,Evidence at protein level
Q9NVM1,EVA1B_HUMAN,Protein eva-1 homolog B (Protein FAM176B),165,"18,374",2 out of 5,2007-01-09,Evidence at protein level
Q03112,EVI1_HUMAN,MDS1 and EVI1 complex locus protein EVI1 (Ecotropic virus integration site 1 protein homolog) (EVI-1),1051,"118,276",5 out of 5,1994-06-01,Evidence at protein level
P49640,EVX1_HUMAN,Homeobox even-skipped homolog protein 1 (EVX-1),407,"42,440",4 out of 5,1996-02-01,Evidence at transcript level
Q9NVH0,EXD2_HUMAN,Exonuclease 3'-5' domain-containing protein 2 (EC 3.1.11.1) (Exonuclease 3'-5' domain-like-containing protein 2),621,"70,353",5 out of 5,2003-10-24,Evidence at protein level
Q9Y3B2,EXOS1_HUMAN,Exosome complex component CSL4 (Exosome component 1),195,"21,452",5 out of 5,2001-06-01,Evidence at protein level
Q15024,EXOS7_HUMAN,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),291,"31,821",5 out of 5,2002-06-06,Evidence at protein level
O43909,EXTL3_HUMAN,Exostosin-like 3 (EC 2.4.1.223) (EXT-related protein 1) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Hereditary multiple exostoses gene isolog) (Multiple exostosis-like protein 3) (Putative tumor suppressor protein EXTL3),919,"104,749",5 out of 5,1999-07-15,Evidence at protein level
Q99502,EYA1_HUMAN,Eyes absent homolog 1 (EC 3.1.3.16) (EC 3.1.3.48),592,"64,593",5 out of 5,1998-07-15,Evidence at protein level
O95990,F107A_HUMAN,Protein FAM107A (Down-regulated in renal cell carcinoma 1) (Protein TU3A),144,"17,455",5 out of 5,2000-05-30,Evidence at protein level
Q8NFI4,F10A5_HUMAN,Putative protein FAM10A5 (Suppression of tumorigenicity 13 pseudogene 5),369,"41,378",2 out of 5,2005-10-25,Uncertain
Q15723,ELF2_HUMAN,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),593,"63,967",5 out of 5,2005-06-21,Evidence at protein level
Q8WYP5,ELYS_HUMAN,Protein ELYS (Embryonic large molecule derived from yolk sac) (Protein MEL-28) (Putative AT-hook-containing transcription factor 1),2266,"252,498",5 out of 5,2006-07-25,Evidence at protein level
Q15006,EMC2_HUMAN,ER membrane protein complex subunit 2 (Tetratricopeptide repeat protein 35) (TPR repeat protein 35),297,"34,834",4 out of 5,1998-07-15,Evidence at protein level
Q9NT22,EMIL3_HUMAN,EMILIN-3 (EMILIN-5) (Elastin microfibril interface-located protein 3) (Elastin microfibril interfacer 3) (Elastin microfibril interface-located protein 5) (Elastin microfibril interfacer 5),766,"82,647",3 out of 5,2003-10-03,Evidence at transcript level
P61568,ENK11_HUMAN,Putative endogenous retrovirus group K member 11-1 Env polyprotein (Envelope polyprotein) (HERV-K_1p13.3 provirus ancestral Env polyprotein) [Includes: Truncated surface protein (SU)],191,"21,462",2 out of 5,2004-05-24,Uncertain
P61566,ENK24_HUMAN,Endogenous retrovirus group K member 24 Env polyprotein (Envelope polyprotein) (HERV-K101 envelope protein) (HERV-K_22q11.21 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],588,"66,585",4 out of 5,2004-05-24,Evidence at transcript level
Q902F8,ENK8_HUMAN,Endogenous retrovirus group K member 8 Env polyprotein (EnvK6 protein) (Envelope polyprotein) (HERV-K115 envelope protein) (HERV-K_8p23.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],699,"79,168",4 out of 5,2004-05-24,Evidence at protein level
Q03111,ENL_HUMAN,Protein ENL (YEATS domain-containing protein 1),559,"62,056",5 out of 5,1994-02-01,Evidence at protein level
A6NNW6,ENO4_HUMAN,Enolase 4 (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase),628,"68,821",4 out of 5,2008-09-02,Evidence at transcript level
Q9UHY7,ENOPH_HUMAN,"Enolase-phosphatase E1 (EC 3.1.3.77) (2,3-diketo-5-methylthio-1-phosphopentane phosphatase) (MASA homolog)",261,"28,933",5 out of 5,2006-10-31,Evidence at protein level
Q9Y5L3,ENTP2_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 2 (NTPDase 2) (EC 3.6.1.-) (CD39 antigen-like 1) (Ecto-ATP diphosphohydrolase 2) (Ecto-ATPDase 2) (Ecto-ATPase 2),495,"53,665",5 out of 5,2001-08-29,Evidence at protein level
Q5MY95,ENTP8_HUMAN,Ectonucleoside triphosphate diphosphohydrolase 8 (E-NTPDase 8) (NTPDase 8) (NTPDase8) (EC 3.6.1.5),495,"53,904",5 out of 5,2007-10-02,Evidence at protein level
Q9H201,EPN3_HUMAN,Epsin-3 (EPS-15-interacting protein 3),632,"68,222",5 out of 5,2004-01-16,Evidence at transcript level
A6NHQ4,EPOP_HUMAN,Elongin BC and Polycomb repressive complex 2-associated protein (Proline-rich protein 28),379,"39,322",3 out of 5,2008-04-29,Evidence at protein level
P30042,ES1_HUMAN,"ES1 protein homolog, mitochondrial (Protein GT335) (Protein KNP-I)",268,"28,170",3 out of 5,1993-04-01,Evidence at protein level
Q6NXG1,ESRP1_HUMAN,Epithelial splicing regulatory protein 1 (RNA-binding motif protein 35A) (RNA-binding protein 35A),681,"75,585",5 out of 5,2007-01-23,Evidence at protein level
O95571,ETHE1_HUMAN,"Persulfide dioxygenase ETHE1, mitochondrial (EC 1.13.11.18) (Ethylmalonic encephalopathy protein 1) (Hepatoma subtracted clone one protein) (Sulfur dioxygenase ETHE1)",254,"27,873",5 out of 5,2005-08-30,Evidence at protein level
Q8IXQ9,ETKMT_HUMAN,Electron transfer flavoprotein beta subunit lysine methyltransferase (EC 2.1.1.-) (ETFB lysine methyltransferase) (ETFB-KMT) (Protein N-lysine methyltransferase METTL20),262,"29,461",5 out of 5,2008-02-26,Evidence at protein level
P41162,ETV3_HUMAN,ETS translocation variant 3 (ETS domain transcriptional repressor PE1) (PE-1) (Mitogenic Ets transcriptional suppressor),512,"57,001",4 out of 5,1995-02-01,Evidence at protein level
P41212,ETV6_HUMAN,Transcription factor ETV6 (ETS translocation variant 6) (ETS-related protein Tel1) (Tel),452,"53,000",5 out of 5,1995-02-01,Evidence at protein level
Q96CN4,EVI5L_HUMAN,EVI5-like protein (Ecotropic viral integration site 5-like protein),794,"91,376",5 out of 5,2006-12-12,Evidence at protein level
Q9UI08,EVL_HUMAN,Ena/VASP-like protein (Ena/vasodilator-stimulated phosphoprotein-like),416,"44,620",5 out of 5,2002-11-15,Evidence at protein level
Q92817,EVPL_HUMAN,Envoplakin (210 kDa cornified envelope precursor protein) (210 kDa paraneoplastic pemphigus antigen) (p210),2033,"231,604",5 out of 5,2001-06-01,Evidence at protein level
Q2M3D2,EX3L2_HUMAN,Exocyst complex component 3-like protein 2 (HBV X-transactivated gene 7 protein) (HBV XAg-transactivated protein 7),409,"45,859",2 out of 5,2007-11-13,Evidence at transcript level
Q8NHP7,EXD1_HUMAN,piRNA biogenesis protein EXD1 (Exonuclease 3'-5' domain-containing protein 1) (Exonuclease 3'-5' domain-like-containing protein 1) (Inactive exonuclease EXD1),514,"58,335",4 out of 5,2008-05-20,Evidence at protein level
Q96KP1,EXOC2_HUMAN,Exocyst complex component 2 (Exocyst complex component Sec5),924,"104,066",5 out of 5,2002-11-01,Evidence at protein level
Q8IYI6,EXOC8_HUMAN,Exocyst complex component 8 (Exocyst complex 84 kDa subunit),725,"81,799",5 out of 5,2006-03-21,Evidence at protein level
Q96B26,EXOS8_HUMAN,Exosome complex component RRP43 (Exosome component 8) (Opa-interacting protein 2) (OIP-2) (Ribosomal RNA-processing protein 43) (p9),276,"30,040",5 out of 5,2002-07-11,Evidence at protein level
O00167,EYA2_HUMAN,Eyes absent homolog 2 (EC 3.1.3.48),538,"59,232",5 out of 5,1998-07-15,Evidence at protein level
Q5T036,F120S_HUMAN,Uncharacterized protein FAM120AOS (FAM120A opposite strand protein),256,"27,929",2 out of 5,2008-05-20,Evidence at transcript level
Q86V42,F124A_HUMAN,Protein FAM124A,546,"60,104",5 out of 5,2007-05-01,Evidence at protein level
A6ZKI3,F127A_HUMAN,Protein FAM127A (Mammalian retrotransposon derived protein 8C),113,"13,171",3 out of 5,2007-11-13,Evidence at protein level
P00488,F13A_HUMAN,Coagulation factor XIII A chain (Coagulation factor XIIIa) (EC 2.3.2.13) (Protein-glutamine gamma-glutamyltransferase A chain) (Transglutaminase A chain),732,"83,267",5 out of 5,1986-07-21,Evidence at protein level
Q6UX46,F150B_HUMAN,Protein FAM150B (Augmentor alpha) (AUG-alpha),152,"16,915",4 out of 5,2008-02-05,Evidence at protein level
P0CG42,F157B_HUMAN,Putative protein FAM157B,384,"43,129",1 out of 5,2010-07-13,Inferred from homology
Q3B820,F161A_HUMAN,Protein FAM161A,660,"76,752",5 out of 5,2008-04-08,Evidence at protein level
Q5T6X4,F162B_HUMAN,Protein FAM162B,162,"17,685",2 out of 5,2006-10-31,Evidence at transcript level
A8MTA8,F166B_HUMAN,Protein FAM166B,275,"30,575",2 out of 5,2008-07-22,Evidence at transcript level
B5ME19,EIFCL_HUMAN,Eukaryotic translation initiation factor 3 subunit C-like protein,914,"105,473",2 out of 5,2013-06-26,Inferred from homology
Q3SY89,ELB3B_HUMAN,Elongin-A3 member B (EloA3B) (Elongin-A3-like-1) (EloA3-like-1) (RNA polymerase II transcription factor SIII subunit A3-like-1) (Transcription elongation factor B polypeptide 3C-like-1),546,"59,760",3 out of 5,2008-07-01,Evidence at transcript level
Q9N2K0,ENH1_HUMAN,HERV-H_2q24.3 provirus ancestral Env polyprotein (Env protein HERV-H/p62) (Env protein HERV-H19) (Env protein HERV-Hcl.3) (Envelope polyprotein) (HERV-H/env62) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],584,"64,318",5 out of 5,2004-03-01,Evidence at transcript level
P61565,ENK21_HUMAN,Endogenous retrovirus group K member 21 Env polyprotein (EnvK1 protein) (Envelope polyprotein) (HERV-K_12q14.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],698,"79,236",4 out of 5,2004-05-24,Evidence at protein level
P61567,ENK7_HUMAN,Endogenous retrovirus group K member 7 Env polyprotein (Envelope polyprotein) (HERV-K(III) envelope protein) (HERV-K102 envelope protein) (HERV-K_1q22 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],588,"66,649",4 out of 5,2004-05-24,Evidence at transcript level
Q8IYW4,ENTD1_HUMAN,ENTH domain-containing protein 1 (Epsin-2B),607,"67,538",2 out of 5,2007-12-04,Evidence at transcript level
Q9UBC2,EP15R_HUMAN,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),864,"94,255",5 out of 5,2004-07-05,Evidence at protein level
Q09472,EP300_HUMAN,Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300),2414,"264,161",5 out of 5,1998-07-15,Evidence at protein level
P28715,ERCC5_HUMAN,DNA repair protein complementing XP-G cells (EC 3.1.-.-) (DNA excision repair protein ERCC-5) (Xeroderma pigmentosum group G-complementing protein),1186,"133,108",5 out of 5,1993-04-01,Evidence at protein level
P33947,ERD22_HUMAN,ER lumen protein-retaining receptor 2 (ERD2-like protein 1) (ELP-1) (KDEL endoplasmic reticulum protein retention receptor 2) (KDEL receptor 2),212,"24,422",5 out of 5,1994-02-01,Evidence at protein level
P11474,ERR1_HUMAN,Steroid hormone receptor ERR1 (Estrogen receptor-like 1) (Estrogen-related receptor alpha) (ERR-alpha) (Nuclear receptor subfamily 3 group B member 1),423,"45,510",5 out of 5,1989-10-01,Evidence at protein level
Q14674,ESPL1_HUMAN,Separin (EC 3.4.22.49) (Caspase-like protein ESPL1) (Extra spindle poles-like 1 protein) (Separase),2120,"233,175",5 out of 5,2003-03-25,Evidence at protein level
A0FGR8,ESYT2_HUMAN,Extended synaptotagmin-2 (E-Syt2) (Chr2Syt),921,"102,357",5 out of 5,2007-02-20,Evidence at protein level
Q9NY74,ETAA1_HUMAN,Ewing's tumor-associated antigen 1 (Ewing's tumor-associated antigen 16),926,"103,440",5 out of 5,2007-03-06,Evidence at protein level
P14921,ETS1_HUMAN,Protein C-ets-1 (p54),441,"50,408",5 out of 5,1990-04-01,Evidence at protein level
Q9Y2D4,EXC6B_HUMAN,Exocyst complex component 6B (Exocyst complex component Sec15B) (SEC15-like protein 2),811,"94,201",4 out of 5,2002-10-25,Evidence at protein level
Q8NDI1,EHBP1_HUMAN,EH domain-binding protein 1,1231,"140,017",5 out of 5,2007-05-01,Evidence at protein level
Q9NZC4,EHF_HUMAN,ETS homologous factor (hEHF) (ETS domain-containing transcription factor) (Epithelium-specific Ets transcription factor 3) (ESE-3),300,"34,892",5 out of 5,2006-10-31,Evidence at transcript level
Q96KQ7,EHMT2_HUMAN,Histone-lysine N-methyltransferase EHMT2 (EC 2.1.1.-) (EC 2.1.1.43) (Euchromatic histone-lysine N-methyltransferase 2) (HLA-B-associated transcript 8) (Histone H3-K9 methyltransferase 3) (H3-K9-HMTase 3) (Lysine N-methyltransferase 1C) (Protein G9a),1210,"132,370",5 out of 5,2002-11-15,Evidence at protein level
Q13144,EI2BE_HUMAN,Translation initiation factor eIF-2B subunit epsilon (eIF-2B GDP-GTP exchange factor subunit epsilon),721,"80,380",5 out of 5,1997-11-01,Evidence at protein level
O00303,EIF3F_HUMAN,Eukaryotic translation initiation factor 3 subunit F (eIF3f) (Deubiquitinating enzyme eIF3f) (EC 3.4.19.12) (Eukaryotic translation initiation factor 3 subunit 5) (eIF-3-epsilon) (eIF3 p47),357,"37,564",5 out of 5,2000-05-30,Evidence at protein level
Q9Y262,EIF3L_HUMAN,Eukaryotic translation initiation factor 3 subunit L (eIF3l) (Eukaryotic translation initiation factor 3 subunit 6-interacting protein) (Eukaryotic translation initiation factor 3 subunit E-interacting protein),564,"66,727",5 out of 5,2002-09-19,Evidence at protein level
P19419,ELK1_HUMAN,ETS domain-containing protein Elk-1,428,"44,888",5 out of 5,1990-11-01,Evidence at protein level
O00472,ELL2_HUMAN,RNA polymerase II elongation factor ELL2,640,"72,324",5 out of 5,1998-12-15,Evidence at protein level
P55199,ELL_HUMAN,RNA polymerase II elongation factor ELL (Eleven-nineteen lysine-rich leukemia protein),621,"68,265",5 out of 5,1996-10-01,Evidence at protein level
Q96JJ3,ELMO2_HUMAN,Engulfment and cell motility protein 2 (Protein ced-12 homolog A) (hCed-12A),720,"82,615",5 out of 5,2003-05-16,Evidence at protein level
Q9HB03,ELOV3_HUMAN,Elongation of very long chain fatty acids protein 3 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL3) (Cold-inducible glycoprotein of 30 kDa) (ELOVL fatty acid elongase 3) (ELOVL FA elongase 3) (Very long chain 3-ketoacyl-CoA synthase 3) (Very long chain 3-oxoacyl-CoA synthase 3),270,"31,500",5 out of 5,2002-01-23,Evidence at protein level
Q9NYP7,ELOV5_HUMAN,Elongation of very long chain fatty acids protein 5 (EC 2.3.1.199) (3-keto acyl-CoA synthase ELOVL5) (ELOVL fatty acid elongase 5) (ELOVL FA elongase 5) (Fatty acid elongase 1) (hELO1) (Very long chain 3-ketoacyl-CoA synthase 5) (Very long chain 3-oxoacyl-CoA synthase 5),299,"35,293",5 out of 5,2007-04-03,Evidence at protein level
P61550,ENVT1_HUMAN,Endogenous retrovirus group S71 member 1 Env polyprotein (Envelope polyprotein) (HERV-T Env protein) (HERV-T_19q13.11 provirus ancestral Env polyprotein) [Includes: Surface protein (SU); Transmembrane protein (TM)],626,"68,171",4 out of 5,2004-05-24,Evidence at transcript level
Q14236,EPAG_HUMAN,Early lymphoid activation gene protein (DIAPH2 antisense RNA 1) (DIAPH2 antisense gene protein 1),149,"17,843",2 out of 5,2008-02-05,Evidence at transcript level
Q99814,EPAS1_HUMAN,Endothelial PAS domain-containing protein 1 (EPAS-1) (Basic-helix-loop-helix-PAS protein MOP2) (Class E basic helix-loop-helix protein 73) (bHLHe73) (HIF-1-alpha-like factor) (HLF) (Hypoxia-inducible factor 2-alpha) (HIF-2-alpha) (HIF2-alpha) (Member of PAS protein 2) (PAS domain-containing protein 2),870,"96,459",5 out of 5,1998-12-15,Evidence at protein level
P16452,EPB42_HUMAN,Erythrocyte membrane protein band 4.2 (Erythrocyte protein 4.2) (P4.2),691,"77,009",5 out of 5,1990-08-01,Evidence at protein level
Q9UNN8,EPCR_HUMAN,Endothelial protein C receptor (Activated protein C receptor) (APC receptor) (Endothelial cell protein C receptor) (CD antigen CD201),238,"26,671",5 out of 5,2001-04-27,Evidence at protein level
Q5JZY3,EPHAA_HUMAN,Ephrin type-A receptor 10 (EC 2.7.10.1),1008,"109,716",5 out of 5,2005-09-27,Evidence at protein level
P54762,EPHB1_HUMAN,Ephrin type-B receptor 1 (EC 2.7.10.1) (ELK) (EPH tyrosine kinase 2) (EPH-like kinase 6) (EK6) (hEK6) (Neuronally-expressed EPH-related tyrosine kinase) (NET) (Tyrosine-protein kinase receptor EPH-2),984,"109,885",5 out of 5,1996-10-01,Evidence at protein level
Q9Y6I3,EPN1_HUMAN,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),576,"60,293",5 out of 5,2004-01-16,Evidence at protein level
P01588,EPO_HUMAN,Erythropoietin (Epoetin),193,"21,307",5 out of 5,1986-07-21,Evidence at protein level
Q9C0D9,EPT1_HUMAN,Ethanolaminephosphotransferase 1 (hEPT1) (EC 2.7.8.1) (Selenoprotein I) (SelI),397,"45,229",5 out of 5,2003-08-22,Evidence at protein level
Q5T890,ER6L2_HUMAN,DNA excision repair protein ERCC-6-like 2 (EC 3.6.4.-) (DNA repair and recombination protein RAD26-like),1561,"177,127",5 out of 5,2008-03-18,Evidence at protein level
O15083,ERC2_HUMAN,ERC protein 2,957,"110,558",4 out of 5,2004-08-31,Evidence at protein level
Q9UKR5,ERG28_HUMAN,Probable ergosterol biosynthetic protein 28,140,"15,864",2 out of 5,2001-04-27,Evidence at protein level
Q96PL5,ERMAP_HUMAN,Erythroid membrane-associated protein (hERMAP) (Radin blood group antigen) (Scianna blood group antigen),475,"52,605",5 out of 5,2006-03-07,Evidence at protein level
O75460,ERN1_HUMAN,Serine/threonine-protein kinase/endoribonuclease IRE1 (Endoplasmic reticulum-to-nucleus signaling 1) (Inositol-requiring protein 1) (hIRE1p) (Ire1-alpha) (IRE1a) [Includes: Serine/threonine-protein kinase (EC 2.7.11.1); Endoribonuclease (EC 3.1.26.-)],977,"109,735",5 out of 5,2004-08-16,Evidence at protein level
Q86YB8,ERO1B_HUMAN,ERO1-like protein beta (ERO1-L-beta) (EC 1.8.4.-) (Endoplasmic reticulum oxidoreductase beta) (Endoplasmic reticulum oxidoreductin-1-like protein B) (Oxidoreductin-1-L-beta),467,"53,543",5 out of 5,2004-07-19,Evidence at protein level
Q56NI9,ESCO2_HUMAN,N-acetyltransferase ESCO2 (EC 2.3.1.-) (Establishment of cohesion 1 homolog 2) (ECO1 homolog 2),601,"68,307",5 out of 5,2005-06-07,Evidence at protein level
Q96J88,ESIP1_HUMAN,Epithelial-stromal interaction protein 1,318,"36,793",2 out of 5,2008-01-15,Evidence at transcript level
Q1W209,ESRG_HUMAN,Embryonic stem cell-related gene protein (hES cell-related gene protein),222,"24,186",2 out of 5,2008-03-18,Evidence at transcript level
Q6UWW8,EST3_HUMAN,Carboxylesterase 3 (EC 3.1.1.1) (Liver carboxylesterase 31 homolog),571,"62,282",5 out of 5,2007-10-02,Evidence at protein level
Q6NT32,EST5A_HUMAN,Carboxylesterase 5A (EC 3.1.1.1) (Carboxylesterase-like urinary excreted protein homolog) (Cauxin),575,"63,926",4 out of 5,2007-10-23,Evidence at transcript level
Q9H8M9,EVA1A_HUMAN,Protein eva-1 homolog A (Protein FAM176A) (Transmembrane protein 166),152,"17,470",5 out of 5,2007-02-20,Evidence at protein level
P34910,EVI2B_HUMAN,Protein EVI2B (Ecotropic viral integration site 2B protein homolog) (EVI-2B) (CD antigen CD361),448,"48,666",3 out of 5,1994-02-01,Evidence at protein level
Q9H790,EXO5_HUMAN,Exonuclease V (Exo V) (hExo5) (EC 3.1.-.-) (Defects in morphology protein 1 homolog),373,"41,816",5 out of 5,2007-10-23,Evidence at protein level
Q8NEV8,EXPH5_HUMAN,Exophilin-5 (Synaptotagmin-like protein homolog lacking C2 domains b) (SlaC2-b) (Slp homolog lacking C2 domains b),1989,"222,519",5 out of 5,2003-07-25,Evidence at protein level
Q16394,EXT1_HUMAN,Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1) (Putative tumor suppressor protein EXT1),746,"86,255",5 out of 5,1997-11-01,Evidence at protein level
Q92800,EZH1_HUMAN,Histone-lysine N-methyltransferase EZH1 (EC 2.1.1.43) (ENX-2) (Enhancer of zeste homolog 1),747,"85,271",5 out of 5,1998-07-15,Evidence at protein level
Q15910,EZH2_HUMAN,Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.43) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6),746,"85,363",5 out of 5,1998-07-15,Evidence at protein level
Q8TC76,F110B_HUMAN,Protein FAM110B,370,"40,728",3 out of 5,2007-05-01,Evidence at protein level
Q96PZ2,F111A_HUMAN,Protein FAM111A,611,"70,196",5 out of 5,2007-02-06,Evidence at protein level
Q96EK7,F120B_HUMAN,Constitutive coactivator of peroxisome proliferator-activated receptor gamma (Constitutive coactivator of PPAR-gamma) (Constitutive coactivator of PPARG) (PPARG constitutive coactivator 1) (PGCC1) (Protein FAM120B),910,"103,783",4 out of 5,2008-05-20,Evidence at protein level
Q9H5Z6,F124B_HUMAN,Protein FAM124B,455,"50,961",5 out of 5,2007-05-01,Evidence at protein level
Q494X1,F153C_HUMAN,Protein FAM153C,144,"16,640",2 out of 5,2008-02-05,Evidence at protein level
B1AL88,F155A_HUMAN,Transmembrane protein FAM155A,458,"51,493",2 out of 5,2008-06-10,Evidence at transcript level
A6NC97,F172B_HUMAN,Putative protein FAM172B (FAM172B pseudogene),362,"41,969",2 out of 5,2008-05-20,Uncertain
Q32MH5,F214A_HUMAN,Protein FAM214A,1076,"121,670",3 out of 5,2008-01-15,Evidence at protein level
Q8IXS0,F217A_HUMAN,Protein FAM217A,508,"57,420",2 out of 5,2005-08-16,Evidence at transcript level
A6NKX1,F223B_HUMAN,Protein FAM223B,122,"13,778",1 out of 5,2008-07-01,Inferred from homology
P0C7X0,F90AO_HUMAN,Putative protein FAM90A24P,464,"49,829",2 out of 5,2008-07-22,Uncertain
Q8N2R8,FA43A_HUMAN,Protein FAM43A,423,"45,776",1 out of 5,2004-08-16,Evidence at transcript level
Q5VWP2,FA46C_HUMAN,Protein FAM46C,391,"44,944",2 out of 5,2006-11-14,Evidence at protein level
Q96KS0,EGLN2_HUMAN,Egl nine homolog 2 (EC 1.14.11.29) (Estrogen-induced tag 6) (HPH-3) (Hypoxia-inducible factor prolyl hydroxylase 1) (HIF-PH1) (HIF-prolyl hydroxylase 1) (HPH-1) (Prolyl hydroxylase domain-containing protein 1) (PHD1),407,"43,650",5 out of 5,2003-06-16,Evidence at protein level
Q8N3D4,EH1L1_HUMAN,EH domain-binding protein 1-like protein 1,1523,"161,854",4 out of 5,2007-05-01,Evidence at protein level
Q9NZN3,EHD3_HUMAN,EH domain-containing protein 3 (PAST homolog 3),535,"60,887",5 out of 5,2001-09-26,Evidence at protein level
Q99613,EIF3C_HUMAN,Eukaryotic translation initiation factor 3 subunit C (eIF3c) (Eukaryotic translation initiation factor 3 subunit 8) (eIF3 p110),913,"105,344",5 out of 5,2000-05-30,Evidence at protein level
O75822,EIF3J_HUMAN,Eukaryotic translation initiation factor 3 subunit J (eIF3j) (Eukaryotic translation initiation factor 3 subunit 1) (eIF-3-alpha) (eIF3 p35),258,"29,062",5 out of 5,2000-05-30,Evidence at protein level
Q12926,ELAV2_HUMAN,ELAV-like protein 2 (ELAV-like neuronal protein 1) (Hu-antigen B) (HuB) (Nervous system-specific RNA-binding protein Hel-N1),359,"39,504",5 out of 5,2001-02-21,Evidence at protein level
Q14576,ELAV3_HUMAN,ELAV-like protein 3 (Hu-antigen C) (HuC) (Paraneoplastic cerebellar degeneration-associated antigen) (Paraneoplastic limbic encephalitis antigen 21),367,"39,547",4 out of 5,1998-12-15,Evidence at transcript level
Q99607,ELF4_HUMAN,ETS-related transcription factor Elf-4 (E74-like factor 4) (Myeloid Elf-1-like factor),663,"70,730",5 out of 5,2005-06-21,Evidence at protein level
P41970,ELK3_HUMAN,ETS domain-containing protein Elk-3 (ETS-related protein ERP) (ETS-related protein NET) (Serum response factor accessory protein 2) (SAP-2) (SRF accessory protein 2),407,"44,240",5 out of 5,1995-11-01,Evidence at protein level
Q8IYF1,ELOA2_HUMAN,Elongin-A2 (EloA2) (RNA polymerase II transcription factor SIII subunit A2) (Transcription elongation factor B polypeptide 3B),753,"83,921",5 out of 5,2003-07-11,Evidence at protein level
O95163,ELP1_HUMAN,Elongator complex protein 1 (ELP1) (IkappaB kinase complex-associated protein) (IKK complex-associated protein) (p150),1332,"150,254",5 out of 5,2001-06-20,Evidence at protein level
Q9H9T3,ELP3_HUMAN,Elongator complex protein 3 (hELP3) (EC 2.3.1.48),547,"62,259",5 out of 5,2007-04-17,Evidence at protein level
Q8TE02,ELP5_HUMAN,Elongator complex protein 5 (Dermal papilla-derived protein 6) (S-phase 2 protein),316,"34,841",5 out of 5,2007-03-20,Evidence at protein level
O00423,EMAL1_HUMAN,Echinoderm microtubule-associated protein-like 1 (EMAP-1) (HuEMAP-1),815,"89,861",5 out of 5,2001-10-18,Evidence at protein level
Q6ZMW3,EMAL6_HUMAN,Echinoderm microtubule-associated protein-like 6 (EMAP-6) (Echinoderm microtubule-associated protein-like 5-like),1958,"217,899",3 out of 5,2008-03-18,Evidence at transcript level
Q6PCB8,EMB_HUMAN,Embigin,327,"36,881",4 out of 5,2005-02-01,Evidence at protein level
Q8N766,EMC1_HUMAN,ER membrane protein complex subunit 1,993,"111,759",5 out of 5,2006-09-05,Evidence at protein level
Q9Y3B6,EMC9_HUMAN,ER membrane protein complex subunit 9 (Protein FAM158A),208,"23,061",3 out of 5,2001-09-26,Evidence at protein level
Q9Y6C2,EMIL1_HUMAN,EMILIN-1 (Elastin microfibril interface-located protein 1) (Elastin microfibril interfacer 1),1016,"106,667",5 out of 5,2003-10-03,Evidence at protein level
Q6PJG2,EMSA1_HUMAN,ELM2 and SANT domain-containing protein 1 (MIDEAS),1045,"114,989",4 out of 5,2006-11-28,Evidence at protein level
Q8N8S7,ENAH_HUMAN,Protein enabled homolog,591,"66,510",5 out of 5,2004-06-07,Evidence at protein level
O14682,ENC1_HUMAN,Ectoderm-neural cortex protein 1 (ENC-1) (Kelch-like protein 37) (Nuclear matrix protein NRP/B) (p53-induced gene 10 protein),589,"66,130",5 out of 5,2000-05-30,Evidence at protein level
Q9H2F5,EPC1_HUMAN,Enhancer of polycomb homolog 1,836,"93,463",5 out of 5,2005-02-15,Evidence at protein level
P29323,EPHB2_HUMAN,Ephrin type-B receptor 2 (EC 2.7.10.1) (Developmentally-regulated Eph-related tyrosine kinase) (ELK-related tyrosine kinase) (EPH tyrosine kinase 3) (EPH-like kinase 5) (EK5) (hEK5) (Renal carcinoma antigen NY-REN-47) (Tyrosine-protein kinase TYRO5) (Tyrosine-protein kinase receptor EPH-3),1055,"117,493",5 out of 5,1992-12-01,Evidence at protein level
P58107,EPIPL_HUMAN,Epiplakin (450 kDa epidermal antigen),5090,"555,621",5 out of 5,2001-06-01,Evidence at protein level
P42566,EPS15_HUMAN,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),896,"98,656",5 out of 5,1995-11-01,Evidence at protein level
P15170,ERF3A_HUMAN,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A (Eukaryotic peptide chain release factor subunit 3a) (eRF3a) (G1 to S phase transition protein 1 homolog),499,"55,756",5 out of 5,1990-04-01,Evidence at protein level
O76042,ERIT1_HUMAN,Putative uncharacterized protein encoded by ERC2-IT1 (ERC2 intronic transcript protein 1) (PO42),136,"14,968",2 out of 5,2001-04-27,Uncertain
P13804,ETFA_HUMAN,"Electron transfer flavoprotein subunit alpha, mitochondrial (Alpha-ETF)",333,"35,080",5 out of 5,1990-01-01,Evidence at protein level
A8MZ36,EVPLL_HUMAN,Envoplakin-like protein,301,"33,953",2 out of 5,2010-07-13,Evidence at transcript level
Q86VI1,EX3L1_HUMAN,Exocyst complex component 3-like protein (Protein Jiangli),746,"81,678",3 out of 5,2007-11-13,Evidence at transcript level
Q9NQ60,EQTN_HUMAN,Equatorin (Acrosome formation-associated factor),294,"32,840",4 out of 5,2007-05-15,Evidence at transcript level
P60509,ERB1_HUMAN,Endogenous retrovirus group PABLB member 1 Env polyprotein (Endogenous retrovirus group PABLB member 1) (Envelope polyprotein) (HERV-R(b) Env protein) (HERV-R(b)_3p24.3 provirus ancestral Env polyprotein) [Includes: Surface protein domain (SU); Transmembrane protein domain (TM)],514,"58,521",4 out of 5,2004-03-01,Evidence at transcript level
P21860,ERBB3_HUMAN,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),1342,"148,098",5 out of 5,1991-05-01,Evidence at protein level
Q15303,ERBB4_HUMAN,Receptor tyrosine-protein kinase erbB-4 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-4) (Tyrosine kinase-type cell surface receptor HER4) (p180erbB4) [Cleaved into: ERBB4 intracellular domain (4ICD) (E4ICD) (s80HER4)],1308,"146,808",5 out of 5,1998-12-15,Evidence at protein level
P19447,ERCC3_HUMAN,TFIIH basal transcription factor complex helicase XPB subunit (EC 3.6.4.12) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein),782,"89,278",5 out of 5,1991-02-01,Evidence at protein level
P84090,ERH_HUMAN,Enhancer of rudimentary homolog,104,"12,259",5 out of 5,2004-08-16,Evidence at protein level
Q5W0A0,ERI6B_HUMAN,Glutamate-rich protein 6B (Protein FAM194B),696,"81,686",3 out of 5,2008-03-18,Evidence at transcript level
A6NGS2,ERIC4_HUMAN,Glutamate-rich protein 4,130,"14,477",1 out of 5,2008-06-10,Predicted
Q96DZ1,ERLEC_HUMAN,Endoplasmic reticulum lectin 1 (ER lectin) (Erlectin) (XTP3-transactivated gene B protein),483,"54,858",5 out of 5,2005-09-27,Evidence at protein level
Q7Z2K6,ERMP1_HUMAN,Endoplasmic reticulum metallopeptidase 1 (EC 3.4.-.-) (Felix-ina),904,"100,231",5 out of 5,2006-10-31,Evidence at protein level
Q8TE68,ES8L1_HUMAN,Epidermal growth factor receptor kinase substrate 8-like protein 1 (EPS8-like protein 1) (Epidermal growth factor receptor pathway substrate 8-related protein 1) (EPS8-related protein 1),723,"80,251",5 out of 5,2006-05-30,Evidence at protein level
P23141,EST1_HUMAN,Liver carboxylesterase 1 (Acyl-coenzyme A:cholesterol acyltransferase) (ACAT) (Brain carboxylesterase hBr1) (Carboxylesterase 1) (CE-1) (hCE-1) (EC 3.1.1.1) (Cocaine carboxylesterase) (Egasyn) (HMSE) (Methylumbelliferyl-acetate deacetylase 1) (EC 3.1.1.56) (Monocyte/macrophage serine esterase) (Retinyl ester hydrolase) (REH) (Serine esterase 1) (Triacylglycerol hydrolase) (TGH),567,"62,521",5 out of 5,1991-11-01,Evidence at protein level
Q9BZE7,EVG1_HUMAN,UPF0193 protein EVG1,217,"24,956",2 out of 5,2002-04-16,Evidence at protein level
O60645,EXOC3_HUMAN,Exocyst complex component 3 (Exocyst complex component Sec6),756,"86,845",4 out of 5,2002-10-25,Evidence at protein level
Q96A65,EXOC4_HUMAN,Exocyst complex component 4 (Exocyst complex component Sec8),974,"110,498",5 out of 5,2002-10-25,Evidence at protein level
Q92935,EXTL1_HUMAN,Exostosin-like 1 (EC 2.4.1.224) (Exostosin-L) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostosis-like protein),676,"74,697",4 out of 5,1998-07-15,Evidence at transcript level
Q99504,EYA3_HUMAN,Eyes absent homolog 3 (EC 3.1.3.48),573,"62,663",5 out of 5,1998-07-15,Evidence at protein level
Q5T1H1,EYS_HUMAN,Protein eyes shut homolog (Epidermal growth factor-like protein 10) (EGF-like protein 10) (Epidermal growth factor-like protein 11) (EGF-like protein 11) (Protein spacemaker homolog),3165,"350,796",5 out of 5,2008-05-20,Evidence at protein level
Q5W0V3,F16B1_HUMAN,Protein FAM160B1,765,"86,558",2 out of 5,2007-04-17,Evidence at protein level
A6NMN3,F170B_HUMAN,Protein FAM170B (Acrosome-related protein),283,"32,092",3 out of 5,2007-11-13,Evidence at protein level
A6PVY3,F177B_HUMAN,Protein FAM177B,158,"18,145",2 out of 5,2008-03-18,Evidence at transcript level
Q6P0A1,F180B_HUMAN,Protein FAM180B,224,"25,167",2 out of 5,2008-09-02,Evidence at transcript level
A6NEQ2,F181B_HUMAN,Protein FAM181B,426,"42,657",2 out of 5,2008-03-18,Evidence at transcript level
Q6PEV8,F199X_HUMAN,Protein FAM199X,388,"42,801",2 out of 5,2006-10-03,Evidence at protein level
Q9H8W3,F204A_HUMAN,Protein FAM204A,233,"27,021",1 out of 5,2004-07-19,Evidence at transcript level
A6NFA0,F205C_HUMAN,Protein FAM205C (FAM205C pseudogene),338,"37,613",2 out of 5,2008-02-26,Inferred from homology
P0DMU4,F231A_HUMAN,Protein FAM231A,169,"18,266",1 out of 5,2015-05-27,Inferred from homology
A2RU67,F234B_HUMAN,Protein FAM234B,622,"67,039",2 out of 5,2007-05-29,Evidence at protein level
P16118,F261_HUMAN,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1 (6PF-2-K/Fru-2,6-P2ase 1) (PFK/FBPase 1) (6PF-2-K/Fru-2,6-P2ase liver isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",471,"54,681",5 out of 5,1990-04-01,Evidence at protein level
O60825,F262_HUMAN,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 (6PF-2-K/Fru-2,6-P2ase 2) (PFK/FBPase 2) (6PF-2-K/Fru-2,6-P2ase heart-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",505,"58,477",5 out of 5,2001-01-24,Evidence at protein level
Q5RGS3,F74A1_HUMAN,Protein FAM74A1/A2,127,"14,779",2 out of 5,2006-12-12,Evidence at protein level
A8MXJ8,F90A5_HUMAN,Putative protein FAM90A5P,464,"49,840",2 out of 5,2008-06-10,Uncertain
P0C7W9,F90AE_HUMAN,Putative protein FAM90A14P,464,"49,953",2 out of 5,2008-07-22,Uncertain
Q658Y4,F91A1_HUMAN,Protein FAM91A1,838,"93,909",2 out of 5,2007-04-03,Evidence at protein level
A0FGR9,ESYT3_HUMAN,Extended synaptotagmin-3 (E-Syt3) (Chr3Syt),886,"100,035",5 out of 5,2008-01-15,Evidence at protein level
Q9Y603,ETV7_HUMAN,Transcription factor ETV7 (ETS translocation variant 7) (ETS-related protein Tel2) (Tel-related Ets factor) (Transcription factor Tel-2),341,"38,998",5 out of 5,2001-02-21,Evidence at protein level
Q17RC7,EX3L4_HUMAN,Exocyst complex component 3-like protein 4,722,"79,896",2 out of 5,2007-02-06,Evidence at protein level
Q8N2X6,EXAS1_HUMAN,Uncharacterized protein EXOC3-AS1 (EXOC3 antisense RNA 1) (EXOC3 antisense gene protein 1),119,"12,661",3 out of 5,2008-09-02,Evidence at protein level
Q01780,EXOSX_HUMAN,Exosome component 10 (EC 3.1.13.-) (Autoantigen PM/Scl 2) (P100 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 100 kDa) (PM/Scl-100) (Polymyositis/scleroderma autoantigen 2),885,"100,831",5 out of 5,1993-10-01,Evidence at protein level
Q9UBQ6,EXTL2_HUMAN,"Exostosin-like 2 (EC 2.4.1.223) (Alpha-1,4-N-acetylhexosaminyltransferase EXTL2) (Alpha-GalNAcT EXTL2) (EXT-related protein 2) (Glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) [Cleaved into: Processed exostosin-like 2]",330,"37,466",5 out of 5,2000-12-01,Evidence at protein level
Q5T9C2,F102A_HUMAN,Protein FAM102A (Early estrogen-induced gene 1 protein),384,"41,785",4 out of 5,2006-11-28,Evidence at protein level
C9JC47,F157A_HUMAN,Putative protein FAM157A,383,"42,896",1 out of 5,2010-07-13,Inferred from homology
Q8N8A8,F169B_HUMAN,Protein FAM169B,192,"21,411",2 out of 5,2008-07-01,Evidence at transcript level
Q86V87,F16B2_HUMAN,Protein FAM160B2 (Retinoic acid-induced protein 16),743,"82,340",2 out of 5,2007-04-17,Evidence at transcript level
P09467,F16P1_HUMAN,"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",338,"36,842",5 out of 5,1989-07-01,Evidence at protein level
Q5VUB5,F1711_HUMAN,Protein FAM171A1 (Astroprincin),890,"97,854",3 out of 5,2007-02-06,Evidence at protein level
Q3ZCQ3,F174B_HUMAN,Membrane protein FAM174B,159,"16,967",2 out of 5,2008-03-18,Evidence at transcript level
Q6UWZ7,F175A_HUMAN,BRCA1-A complex subunit Abraxas (Coiled-coil domain-containing protein 98) (Protein FAM175A),409,"46,663",5 out of 5,2007-02-20,Evidence at protein level
Q8IXR5,F178B_HUMAN,Protein FAM178B,827,"93,514",2 out of 5,2008-02-26,Evidence at transcript level
Q8N9Y4,F181A_HUMAN,Protein FAM181A,354,"38,724",2 out of 5,2005-07-05,Evidence at transcript level
Q6ZVS7,F183B_HUMAN,Protein FAM183BP (Testis highly expressed protein 6),135,"16,193",2 out of 5,2008-11-25,Uncertain
A6NE01,F186A_HUMAN,Protein FAM186A,2351,"262,758",2 out of 5,2008-04-29,Evidence at transcript level
Q17R55,F187B_HUMAN,Protein FAM187B (Transmembrane protein 162),369,"42,387",3 out of 5,2007-04-17,Evidence at transcript level
Q15884,F1892_HUMAN,Protein FAM189A2 (Protein X123),450,"49,703",3 out of 5,2001-04-27,Evidence at protein level
P78312,F193A_HUMAN,Protein FAM193A (Protein IT14),1265,"139,988",3 out of 5,2005-07-19,Evidence at protein level
A6NMK8,F196B_HUMAN,Protein FAM196B,535,"59,204",2 out of 5,2008-09-02,Evidence at transcript level
Q8N3H0,F19A2_HUMAN,Protein FAM19A2 (Chemokine-like protein TAFA-2),131,"14,620",2 out of 5,2005-11-08,Evidence at transcript level
Q7Z5A7,F19A5_HUMAN,Protein FAM19A5 (Chemokine-like protein TAFA-5),132,"14,301",3 out of 5,2005-11-08,Evidence at transcript level
Q9NX38,F206A_HUMAN,Protein Simiate (Protein FAM206A),181,"20,378",2 out of 5,2007-06-26,Evidence at protein level
Q8N7L0,F216B_HUMAN,Protein FAM216B,139,"16,362",1 out of 5,2006-12-12,Evidence at transcript level
B1ANY3,F220P_HUMAN,Putative protein FAM220BP (Protein FAM220B pseudogene),271,"29,405",2 out of 5,2008-07-22,Uncertain
Q5U5X8,F222A_HUMAN,Protein FAM222A,452,"46,792",2 out of 5,2007-02-06,Evidence at transcript level
A8MYX2,F25DE_HUMAN,Protein FAM25D/E,175,"18,345",1 out of 5,2008-07-22,Evidence at transcript level
Q16875,F263_HUMAN,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (6PF-2-K/Fru-2,6-P2ase 3) (PFK/FBPase 3) (6PF-2-K/Fru-2,6-P2ase brain/placenta-type isozyme) (Renal carcinoma antigen NY-REN-56) (iPFK-2) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",520,"59,609",5 out of 5,1998-07-15,Evidence at protein level
Q6NXP2,F71F2_HUMAN,Protein FAM71F2 (Protein FAM137B),309,"34,516",2 out of 5,2007-11-13,Evidence at transcript level
P0C5J1,F86B2_HUMAN,Putative protein N-methyltransferase FAM86B2 (EC 2.1.1.-),330,"36,771",2 out of 5,2007-10-23,Evidence at protein level
A6NKC0,F90A7_HUMAN,Putative protein FAM90A7P,464,"49,804",1 out of 5,2007-09-11,Uncertain
P0C7V4,F90AJ_HUMAN,Putative protein FAM90A15P,464,"49,895",1 out of 5,2008-07-22,Uncertain
P0C866,F91A2_HUMAN,Putative uncharacterized protein encoded by LINC00869,280,"30,847",2 out of 5,2008-09-02,Uncertain
Q8NE31,FA13C_HUMAN,Protein FAM13C,585,"65,727",4 out of 5,2003-04-11,Evidence at protein level
Q5JW98,FA26D_HUMAN,Protein FAM26D,314,"35,060",3 out of 5,2005-06-07,Evidence at transcript level
Q9H0Q0,FA49A_HUMAN,Protein FAM49A,323,"37,313",2 out of 5,2004-09-27,Evidence at transcript level
Q9Y4F9,FA65B_HUMAN,Protein FAM65B,1068,"118,519",5 out of 5,2007-05-29,Evidence at protein level
Q8IYT1,FA71A_HUMAN,Protein FAM71A,594,"63,177",2 out of 5,2006-11-28,Evidence at transcript level
Q5HYJ3,FA76B_HUMAN,Protein FAM76B,339,"38,708",4 out of 5,2006-07-11,Evidence at protein level
Q86UY5,FA83A_HUMAN,Protein FAM83A (Tumor antigen BJ-TSA-9) (Tumor-specific gene expressed in prostate protein),434,"47,458",5 out of 5,2007-05-15,Evidence at protein level
Q9H4H8,FA83D_HUMAN,Protein FAM83D (Spindle protein CHICA),585,"64,424",5 out of 5,2002-11-25,Evidence at protein level
P0C7U9,FA87A_HUMAN,Protein FAM87A,286,"31,739",1 out of 5,2008-07-22,Evidence at transcript level
P00451,FA8_HUMAN,"Coagulation factor VIII (Antihemophilic factor) (AHF) (Procoagulant component) [Cleaved into: Factor VIIIa heavy chain, 200 kDa isoform; Factor VIIIa heavy chain, 92 kDa isoform; Factor VIII B chain; Factor VIIIa light chain]",2351,"267,009",5 out of 5,1986-07-21,Evidence at protein level
P16930,FAAA_HUMAN,Fumarylacetoacetase (FAA) (EC 3.7.1.2) (Beta-diketonase) (Fumarylacetoacetate hydrolase),419,"46,374",5 out of 5,1990-08-01,Evidence at protein level
Q6GMR7,FAAH2_HUMAN,Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2),532,"58,304",5 out of 5,2007-06-26,Evidence at transcript level
P51161,FABP6_HUMAN,Gastrotropin (GT) (Fatty acid-binding protein 6) (Ileal lipid-binding protein) (ILBP) (Intestinal 15 kDa protein) (I-15P) (Intestinal bile acid-binding protein) (I-BABP),128,"14,371",5 out of 5,1996-10-01,Evidence at protein level
Q0Z7S8,FABP9_HUMAN,Fatty acid-binding protein 9 (Testis lipid-binding protein) (TLBP) (Testis-type fatty acid-binding protein) (T-FABP),132,"15,093",3 out of 5,2008-02-05,Evidence at protein level
Q96K12,FACR2_HUMAN,Fatty acyl-CoA reductase 2 (EC 1.2.1.n2) (Male sterility domain-containing protein 1),515,"59,438",5 out of 5,2006-11-28,Evidence at transcript level
O95936,EOMES_HUMAN,Eomesodermin homolog (T-box brain protein 2) (T-brain-2) (TBR-2),686,"72,732",5 out of 5,2000-05-30,Evidence at protein level
Q14507,EP3A_HUMAN,Epididymal secretory protein E3-alpha (Human epididymis-specific protein 3-alpha) (HE3-alpha),147,"17,646",3 out of 5,2000-05-30,Evidence at transcript level
Q96L91,EP400_HUMAN,E1A-binding protein p400 (EC 3.6.4.-) (CAG repeat protein 32) (Domino homolog) (hDomino) (Trinucleotide repeat-containing gene 12 protein) (p400 kDa SWI2/SNF2-related protein),3159,"343,489",5 out of 5,2004-11-23,Evidence at protein level
Q52LR7,EPC2_HUMAN,Enhancer of polycomb homolog 2 (EPC-like),807,"91,095",3 out of 5,2006-06-13,Evidence at protein level
P0C838,ERAS1_HUMAN,Putative uncharacterized protein encoded by ERICH1-AS1 (ERICH1 antisense RNA 1) (ERICH1 antisense gene protein 1) (Putative DAP-2 like protein),84,"9,166",2 out of 5,2008-07-22,Uncertain
Q13216,ERCC8_HUMAN,DNA excision repair protein ERCC-8 (Cockayne syndrome WD repeat protein CSA),396,"44,055",5 out of 5,1998-07-15,Evidence at protein level
Q9H501,ESF1_HUMAN,ESF1 homolog (ABT1-associated protein),851,"98,796",4 out of 5,2002-11-25,Evidence at protein level
B1AK53,ESPN_HUMAN,Espin (Autosomal recessive deafness type 36 protein) (Ectoplasmic specialization protein),854,"91,733",5 out of 5,2008-05-20,Evidence at protein level
Q92731,ESR2_HUMAN,Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2),530,"59,216",5 out of 5,1999-07-15,Evidence at protein level
Q86US8,EST1A_HUMAN,Telomerase-binding protein EST1A (EC 3.1.-.-) (EST1-like protein A) (Ever shorter telomeres 1A) (Smg-6 homolog) (Telomerase subunit EST1A) (hSmg5/7a),1419,"160,462",5 out of 5,2004-05-24,Evidence at protein level
O00748,EST2_HUMAN,Cocaine esterase (EC 3.1.1.84) (Carboxylesterase 2) (CE-2) (hCE-2) (EC 3.1.1.1) (Methylumbelliferyl-acetate deacetylase 2) (EC 3.1.1.56),559,"61,807",5 out of 5,2004-04-26,Evidence at protein level
Q8N693,ESX1_HUMAN,"Homeobox protein ESX1 (Extraembryonic, spermatogenesis, homeobox 1) [Cleaved into: Homeobox protein ESX1-N; Homeobox protein ESX1-C]",406,"44,297",5 out of 5,2004-06-07,Evidence at protein level
Q16134,ETFD_HUMAN,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial (ETF-QO) (ETF-ubiquinone oxidoreductase) (EC 1.5.5.1) (Electron-transferring-flavoprotein dehydrogenase) (ETF dehydrogenase)",617,"68,495",5 out of 5,1997-11-01,Evidence at protein level
O00321,ETV2_HUMAN,ETS translocation variant 2 (Ets-related protein 71),342,"36,633",4 out of 5,1998-07-15,Evidence at transcript level
Q9NYK6,EURL_HUMAN,Protein EURL homolog,297,"33,948",3 out of 5,2001-09-26,Evidence at transcript level
P22794,EVI2A_HUMAN,Protein EVI2A (Ecotropic viral integration site 2A protein homolog) (EVI-2A),236,"26,213",4 out of 5,1991-08-01,Evidence at transcript level
Q8TAG9,EXOC6_HUMAN,Exocyst complex component 6 (Exocyst complex component Sec15A) (SEC15-like protein 1),804,"93,722",4 out of 5,2002-10-25,Evidence at protein level
Q6P1L5,F117B_HUMAN,Protein FAM117B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 13 protein),589,"61,968",3 out of 5,2007-09-11,Evidence at protein level
Q5XKK7,F219B_HUMAN,Protein FAM219B,198,"21,103",2 out of 5,2006-06-27,Evidence at protein level
H3BQW9,F229A_HUMAN,Protein FAM229A,127,"12,972",1 out of 5,2013-03-06,Inferred from homology
Q8N5Q1,F71E2_HUMAN,Protein FAM71E2,922,"99,915",2 out of 5,2008-06-10,Evidence at transcript level
A6NJQ4,F90A8_HUMAN,Putative protein FAM90A8P,464,"49,661",1 out of 5,2007-09-11,Uncertain
A6NIJ5,F90AK_HUMAN,Putative protein FAM90A20P,464,"50,026",1 out of 5,2007-09-11,Uncertain
Q9Y421,FA32A_HUMAN,Protein FAM32A (Ovarian tumor-associated gene 12) (OTAG-12),112,"13,178",4 out of 5,2006-02-07,Evidence at protein level
P12259,FA5_HUMAN,"Coagulation factor V (Activated protein C cofactor) (Proaccelerin, labile factor) [Cleaved into: Coagulation factor V heavy chain; Coagulation factor V light chain]",2224,"251,703",5 out of 5,1989-10-01,Evidence at protein level
H0Y354,FA72C_HUMAN,Protein FAM72C,149,"16,730",2 out of 5,2013-11-13,Inferred from homology
Q5VT40,FA78B_HUMAN,Protein FAM78B,261,"29,835",1 out of 5,2006-12-12,Evidence at transcript level
Q8TBF8,FA81A_HUMAN,Protein FAM81A,368,"42,392",2 out of 5,2006-12-12,Evidence at transcript level
Q96GI7,FA89A_HUMAN,Protein FAM89A,184,"19,569",1 out of 5,2007-01-09,Evidence at protein level
Q9UBU6,FA8A1_HUMAN,Protein FAM8A1 (Autosomal highly conserved protein),413,"44,123",2 out of 5,2005-10-25,Evidence at protein level
Q8IVS2,FABD_HUMAN,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial (MCT) (EC 2.3.1.39) (Mitochondrial malonyl CoA:ACP acyltransferase) (Mitochondrial malonyltransferase) ([Acyl-carrier-protein] malonyltransferase)",390,"42,962",5 out of 5,2004-06-07,Evidence at protein level
P24390,ERD21_HUMAN,ER lumen protein-retaining receptor 1 (KDEL endoplasmic reticulum protein retention receptor 1) (KDEL receptor 1) (Putative MAPK-activating protein PM23),212,"24,542",5 out of 5,1992-03-01,Evidence at protein level
O43731,ERD23_HUMAN,ER lumen protein-retaining receptor 3 (KDEL endoplasmic reticulum protein retention receptor 3) (KDEL receptor 3),214,"25,027",4 out of 5,2000-05-30,Evidence at transcript level
P48449,ERG7_HUMAN,"Lanosterol synthase (EC 5.4.99.7) (2,3-epoxysqualene--lanosterol cyclase) (Oxidosqualene--lanosterol cyclase) (OSC) (hOSC)",732,"83,309",5 out of 5,1996-02-01,Evidence at protein level
P11308,ERG_HUMAN,Transcriptional regulator ERG (Transforming protein ERG),486,"54,608",5 out of 5,1989-07-01,Evidence at protein level
Q8IV48,ERI1_HUMAN,3'-5' exoribonuclease 1 (EC 3.1.-.-) (3'-5' exonuclease ERI1) (Eri-1 homolog) (Histone mRNA 3'-end-specific exoribonuclease) (Histone mRNA 3'-exonuclease 1) (Protein 3'hExo) (HEXO),349,"40,064",5 out of 5,2004-03-15,Evidence at protein level
O95718,ERR2_HUMAN,Steroid hormone receptor ERR2 (ERR beta-2) (Estrogen receptor-like 2) (Estrogen-related receptor beta) (ERR-beta) (Nuclear receptor subfamily 3 group B member 2),508,"56,208",5 out of 5,2001-02-21,Evidence at protein level
Q9H6S3,ES8L2_HUMAN,Epidermal growth factor receptor kinase substrate 8-like protein 2 (EPS8-like protein 2) (Epidermal growth factor receptor pathway substrate 8-related protein 2) (EPS8-related protein 2),715,"80,621",5 out of 5,2006-05-30,Evidence at protein level
Q96AP7,ESAM_HUMAN,Endothelial cell-selective adhesion molecule,390,"41,176",5 out of 5,2005-06-21,Evidence at protein level
O60883,ETBR2_HUMAN,Prosaposin receptor GPR37L1 (Endothelin B receptor-like protein 2) (ETBR-LP-2) (G-protein coupled receptor 37-like 1),481,"52,771",5 out of 5,2001-01-11,Evidence at protein level
P58658,EVA1C_HUMAN,Protein eva-1 homolog C (Protein FAM176C) (SUE21),441,"49,483",4 out of 5,2002-01-23,Evidence at transcript level
P57679,EVC_HUMAN,Ellis-van Creveld syndrome protein (DWF-1),992,"111,990",5 out of 5,2000-12-01,Evidence at protein level
Q969W3,F104A_HUMAN,Protein FAM104A,186,"19,484",2 out of 5,2006-05-16,Evidence at protein level
Q86XD5,F131B_HUMAN,Protein FAM131B,332,"35,769",3 out of 5,2006-10-17,Evidence at protein level
A6NKW6,F159B_HUMAN,Membrane protein FAM159B,160,"17,663",2 out of 5,2008-02-05,Inferred from homology
P0C2L3,F163B_HUMAN,Protein FAM163B,166,"18,190",2 out of 5,2007-03-20,Evidence at transcript level
Q05DH4,F16A1_HUMAN,Protein FAM160A1,1040,"116,621",2 out of 5,2008-02-26,Evidence at transcript level
Q8N612,F16A2_HUMAN,FTS and Hook-interacting protein (FHIP) (Protein FAM160A2),972,"105,568",5 out of 5,2006-10-17,Evidence at protein level
Q96M60,F227B_HUMAN,Protein FAM227B,508,"59,956",2 out of 5,2006-06-27,Evidence at transcript level
Q6ZW35,F231D_HUMAN,Protein FAM231D,169,"18,328",1 out of 5,2008-07-22,Evidence at transcript level
Q5T7N8,F27D1_HUMAN,Protein FAM27D1,215,"24,905",1 out of 5,2008-06-10,Inferred from homology
Q96KD3,F71F1_HUMAN,Protein FAM71F1 (Protein FAM137A) (Testis development protein NYD-SP18),344,"38,946",2 out of 5,2007-12-04,Evidence at transcript level
Q658T7,F90A2_HUMAN,Putative protein FAM90A2P,463,"50,084",2 out of 5,2008-07-22,Uncertain
A6NE21,F90AI_HUMAN,Putative protein FAM90A18P/FAM90A19P,464,"49,680",2 out of 5,2007-09-11,Uncertain
Q96A09,FA46B_HUMAN,Protein FAM46B,425,"46,688",2 out of 5,2006-11-28,Evidence at protein level
Q5HY64,FA47C_HUMAN,Putative protein FAM47C,1035,"115,338",2 out of 5,2008-09-02,Evidence at transcript level
Q6NSI3,FA53A_HUMAN,Protein FAM53A (Dorsal neural-tube nuclear protein),398,"42,585",2 out of 5,2006-11-28,Evidence at protein level
P08709,FA7_HUMAN,Coagulation factor VII (EC 3.4.21.21) (Proconvertin) (Serum prothrombin conversion accelerator) (SPCA) (Eptacog alfa) [Cleaved into: Factor VII light chain; Factor VII heavy chain],466,"51,594",5 out of 5,1988-01-01,Evidence at protein level
Q52LJ0,FA98B_HUMAN,Protein FAM98B,330,"37,191",4 out of 5,2005-12-06,Evidence at protein level
O00519,FAAH1_HUMAN,Fatty-acid amide hydrolase 1 (EC 3.5.1.99) (Anandamide amidohydrolase 1) (Oleamide hydrolase 1),579,"63,066",5 out of 5,2000-05-30,Evidence at protein level
Q01469,FABP5_HUMAN,"Fatty acid-binding protein, epidermal (Epidermal-type fatty acid-binding protein) (E-FABP) (Fatty acid-binding protein 5) (Psoriasis-associated fatty acid-binding protein homolog) (PA-FABP)",135,"15,164",5 out of 5,1993-04-01,Evidence at protein level
Q8N9I5,FADS6_HUMAN,Fatty acid desaturase 6 (EC 1.14.19.-),356,"40,447",3 out of 5,2008-06-10,Evidence at transcript level
Q7L8L6,FAKD5_HUMAN,"FAST kinase domain-containing protein 5, mitochondrial",764,"86,574",5 out of 5,2007-05-01,Evidence at protein level
Q9HB96,FANCE_HUMAN,Fanconi anemia group E protein (Protein FACE),536,"58,711",5 out of 5,2004-03-15,Evidence at protein level
Q9NVI1,FANCI_HUMAN,Fanconi anemia group I protein (Protein FACI),1328,"149,324",5 out of 5,2006-09-05,Evidence at protein level
P0C875,F228B_HUMAN,Protein FAM228B,321,"37,405",1 out of 5,2008-09-02,Evidence at transcript level
Q8WVX9,FACR1_HUMAN,Fatty acyl-CoA reductase 1 (EC 1.2.1.n2) (Male sterility domain-containing protein 2),515,"59,357",5 out of 5,2006-11-28,Evidence at protein level
O95864,FADS2_HUMAN,Fatty acid desaturase 2 (EC 1.14.19.3) (Acyl-CoA 6-desaturase) (Delta(6) fatty acid desaturase) (D6D) (Delta(6) desaturase) (Delta-6 desaturase),444,"52,259",5 out of 5,2007-10-02,Evidence at protein level
Q96CS3,FAF2_HUMAN,FAS-associated factor 2 (Protein ETEA) (UBX domain-containing protein 3B) (UBX domain-containing protein 8),445,"52,623",5 out of 5,2006-06-27,Evidence at protein level
Q6P2I3,FAH2B_HUMAN,Fumarylacetoacetate hydrolase domain-containing protein 2B (EC 3.-.-.-),314,"34,613",2 out of 5,2007-05-29,Evidence at protein level
Q14289,FAK2_HUMAN,Protein-tyrosine kinase 2-beta (EC 2.7.10.2) (Calcium-dependent tyrosine kinase) (CADTK) (Calcium-regulated non-receptor proline-rich tyrosine kinase) (Cell adhesion kinase beta) (CAK-beta) (CAKB) (Focal adhesion kinase 2) (FADK 2) (Proline-rich tyrosine kinase 2) (Related adhesion focal tyrosine kinase) (RAFTK),1009,"115,875",5 out of 5,1998-07-15,Evidence at protein level
Q9Y2M0,FAN1_HUMAN,Fanconi-associated nuclease 1 (EC 3.1.21.-) (EC 3.1.4.1) (FANCD2/FANCI-associated nuclease 1) (hFAN1) (Myotubularin-related protein 15),1017,"114,225",5 out of 5,2007-11-13,Evidence at protein level
O15360,FANCA_HUMAN,Fanconi anemia group A protein (Protein FACA),1455,"162,775",5 out of 5,2000-12-01,Evidence at protein level
Q9BTP7,FAP24_HUMAN,Fanconi anemia core complex-associated protein 24 (Fanconi anemia-associated protein of 24 kDa),215,"23,897",4 out of 5,2007-01-09,Evidence at protein level
Q9Y4F1,FARP1_HUMAN,"FERM, RhoGEF and pleckstrin domain-containing protein 1 (Chondrocyte-derived ezrin-like protein) (Pleckstrin homology domain-containing family C member 2) (PH domain-containing family C member 2)",1045,"118,633",5 out of 5,2006-04-18,Evidence at protein level
O94887,FARP2_HUMAN,"FERM, RhoGEF and pleckstrin domain-containing protein 2 (FERM domain including RhoGEF) (FIR) (Pleckstrin homology domain-containing family C member 3) (PH domain-containing family C member 3)",1054,"119,888",5 out of 5,2006-04-18,Evidence at protein level
Q8TES7,FBF1_HUMAN,Fas-binding factor 1 (FBF-1) (Protein albatross),1133,"125,446",5 out of 5,2007-08-21,Evidence at protein level
Q6X9E4,FBW12_HUMAN,F-box/WD repeat-containing protein 12 (F-box and WD-40 domain-containing protein 12) (F-box only protein 35),464,"53,056",4 out of 5,2004-08-31,Evidence at transcript level
Q9UKB1,FBW1B_HUMAN,F-box/WD repeat-containing protein 11 (F-box and WD repeats protein beta-TrCP2) (F-box/WD repeat-containing protein 1B) (Homologous to Slimb protein) (HOS),542,"62,091",5 out of 5,2001-02-21,Evidence at protein level
Q96EF6,FBX17_HUMAN,F-box only protein 17 (F-box only protein 26),278,"31,479",4 out of 5,2002-05-27,Evidence at protein level
Q8TB52,FBX30_HUMAN,F-box only protein 30,745,"82,304",4 out of 5,2004-03-15,Evidence at protein level
Q969U6,FBXW5_HUMAN,F-box/WD repeat-containing protein 5 (F-box and WD-40 domain-containing protein 5),566,"63,922",5 out of 5,2004-03-01,Evidence at protein level
P24071,FCAR_HUMAN,Immunoglobulin alpha Fc receptor (IgA Fc receptor) (CD antigen CD89),287,"32,265",5 out of 5,1992-03-01,Evidence at protein level
P31995,FCG2C_HUMAN,Low affinity immunoglobulin gamma Fc region receptor II-c (IgG Fc receptor II-c) (CDw32) (Fc-gamma RII-c) (Fc-gamma-RIIc) (FcRII-c) (CD antigen CD32),323,"35,578",5 out of 5,1993-07-01,Evidence at protein level
P08637,FCG3A_HUMAN,Low affinity immunoglobulin gamma Fc region receptor III-A (CD16a antigen) (Fc-gamma RIII-alpha) (Fc-gamma RIII) (Fc-gamma RIIIa) (FcRIII) (FcRIIIa) (FcR-10) (IgG Fc receptor III-2) (CD antigen CD16a),254,"29,089",5 out of 5,1988-08-01,Evidence at protein level
Q92637,FCGRB_HUMAN,High affinity immunoglobulin gamma Fc receptor IB (IgG Fc receptor IB) (Fc-gamma RIB) (FcRIB) (hFcgammaRIB),280,"32,232",5 out of 5,2008-04-29,Evidence at transcript level
Q0JRZ9,FCHO2_HUMAN,F-BAR domain only protein 2,810,"88,924",5 out of 5,2006-12-12,Evidence at protein level
P07332,FES_HUMAN,Tyrosine-protein kinase Fes/Fps (EC 2.7.10.2) (Feline sarcoma/Fujinami avian sarcoma oncogene homolog) (Proto-oncogene c-Fes) (Proto-oncogene c-Fps) (p93c-fes),822,"93,497",5 out of 5,1988-04-01,Evidence at protein level
Q6QHK4,FIGLA_HUMAN,Factor in the germline alpha (FIGalpha) (Class C basic helix-loop-helix protein 8) (bHLHc8) (Folliculogenesis-specific basic helix-loop-helix protein) (Transcription factor FIGa),219,"24,123",5 out of 5,2004-08-16,Evidence at protein level
P20930,FILA_HUMAN,Filaggrin,4061,"435,170",5 out of 5,1991-02-01,Evidence at protein level
Q86VR8,FJX1_HUMAN,Four-jointed box protein 1 (Four-jointed protein homolog),437,"48,507",3 out of 5,2008-05-20,Evidence at transcript level
Q9NYL4,FKB11_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP11 (PPIase FKBP11) (EC 5.2.1.8) (19 kDa FK506-binding protein) (19 kDa FKBP) (FKBP-19) (FK506-binding protein 11) (FKBP-11) (Rotamase),201,"22,180",4 out of 5,2002-09-19,Evidence at protein level
Q00688,FKBP3_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP3 (PPIase FKBP3) (EC 5.2.1.8) (25 kDa FK506-binding protein) (25 kDa FKBP) (FKBP-25) (FK506-binding protein 3) (FKBP-3) (Immunophilin FKBP25) (Rapamycin-selective 25 kDa immunophilin) (Rotamase),224,"25,177",5 out of 5,1993-04-01,Evidence at protein level
Q9H098,F107B_HUMAN,Protein FAM107B,131,"15,558",2 out of 5,2006-04-04,Evidence at protein level
Q9BQ89,F110A_HUMAN,Protein FAM110A,295,"31,271",5 out of 5,2002-12-06,Evidence at protein level
Q9BPY3,F118B_HUMAN,Protein FAM118B,351,"39,499",3 out of 5,2007-07-10,Evidence at protein level
Q96E09,F122A_HUMAN,Protein FAM122A,287,"30,529",2 out of 5,2005-07-05,Evidence at protein level
Q8IXS8,F126B_HUMAN,Protein FAM126B,530,"58,647",3 out of 5,2007-02-20,Evidence at protein level
Q5BKY9,F133B_HUMAN,Protein FAM133B,247,"28,385",2 out of 5,2007-05-29,Evidence at protein level
Q9UHL3,F153A_HUMAN,Protein FAM153A (Renal carcinoma antigen NY-REN-7),310,"34,712",2 out of 5,2008-02-05,Evidence at transcript level
Q8TBP5,F174A_HUMAN,Membrane protein FAM174A (Hepatitis C virus NS5A-transactivated protein 6) (HCV NS5A-transactivated protein 6) (Transmembrane protein 157),190,"19,954",3 out of 5,2006-12-12,Evidence at transcript level
A6NL82,F183A_HUMAN,Protein FAM183A,134,"15,996",1 out of 5,2008-06-10,Inferred from homology
Q6UWH4,F198B_HUMAN,Protein FAM198B (Expressed in nerve and epithelium during development),519,"57,552",3 out of 5,2007-05-29,Evidence at transcript level
Q6ZU69,F205A_HUMAN,Protein FAM205A,1335,"148,096",2 out of 5,2007-10-23,Evidence at transcript level
Q5JX71,F209A_HUMAN,Protein FAM209A,171,"19,603",3 out of 5,2006-12-12,Evidence at transcript level
Q9NTX9,F217B_HUMAN,Protein FAM217B,383,"42,052",2 out of 5,2003-01-10,Evidence at transcript level
Q7Z4H9,F220A_HUMAN,Protein FAM220A (STAT3-interacting protein as a repressor),259,"28,021",3 out of 5,2008-02-26,Evidence at transcript level
Q8N7N1,F86B1_HUMAN,Putative protein N-methyltransferase FAM86B1 (EC 2.1.1.-),296,"32,865",2 out of 5,2007-10-23,Evidence at transcript level
A8MWA6,F90AM_HUMAN,Putative protein FAM90A22P,464,"49,874",1 out of 5,2008-09-02,Uncertain
Q5R3K3,FA26F_HUMAN,Protein FAM26F,315,"34,458",3 out of 5,2007-04-03,Evidence at transcript level
Q8NA70,FA47B_HUMAN,Protein FAM47B,645,"73,945",1 out of 5,2005-07-19,Evidence at transcript level
Q14153,FA53B_HUMAN,Protein FAM53B,422,"45,768",2 out of 5,1997-11-01,Evidence at protein level
Q71RH2,FA57B_HUMAN,Protein FAM57B,274,"30,629",3 out of 5,2005-04-12,Evidence at transcript level
Q6ZS17,FA65A_HUMAN,Protein FAM65A,1223,"132,308",3 out of 5,2007-05-29,Evidence at protein level
Q5T7M9,FA69A_HUMAN,Protein FAM69A,428,"49,024",2 out of 5,2007-04-03,Evidence at transcript level
Q17RN3,FA98C_HUMAN,Protein FAM98C,349,"37,329",2 out of 5,2007-04-03,Evidence at transcript level
P15090,FABP4_HUMAN,"Fatty acid-binding protein, adipocyte (Adipocyte lipid-binding protein) (ALBP) (Adipocyte-type fatty acid-binding protein) (A-FABP) (AFABP) (Fatty acid-binding protein 4)",132,"14,719",5 out of 5,1990-04-01,Evidence at protein level
Q9BXW9,FACD2_HUMAN,Fanconi anemia group D2 protein (Protein FACD2),1451,"164,128",5 out of 5,2005-06-07,Evidence at protein level
P98173,FAM3A_HUMAN,Protein FAM3A (Cytokine-like protein 2-19),230,"25,152",3 out of 5,1996-10-01,Evidence at protein level
Q92520,FAM3C_HUMAN,Protein FAM3C (Interleukin-like EMT inducer),227,"24,680",4 out of 5,1998-07-15,Evidence at protein level
Q5TZK3,FAM74_HUMAN,Protein FAM74A4/A6,123,"14,773",5 out of 5,2006-12-12,Evidence at protein level
Q8NB91,FANCB_HUMAN,Fanconi anemia group B protein (Protein FACB) (Fanconi anemia-associated polypeptide of 95 kDa) (FAAP95),859,"97,726",4 out of 5,2005-10-25,Evidence at protein level
Q8IYD8,FANCM_HUMAN,Fanconi anemia group M protein (Protein FACM) (EC 3.6.4.13) (ATP-dependent RNA helicase FANCM) (Fanconi anemia-associated polypeptide of 250 kDa) (FAAP250) (Protein Hef ortholog),2048,"232,191",5 out of 5,2005-10-25,Evidence at protein level
Q8NCQ5,FBX15_HUMAN,F-box only protein 15,510,"57,258",3 out of 5,2004-08-16,Evidence at transcript level
Q8N4B4,FBX39_HUMAN,F-box only protein 39,442,"52,646",2 out of 5,2004-08-31,Evidence at transcript level
Q6P3S6,FBX42_HUMAN,F-box only protein 42 (Just one F-box and Kelch domain-containing protein),717,"77,839",3 out of 5,2004-08-31,Evidence at protein level
Q9UKC9,FBXL2_HUMAN,F-box/LRR-repeat protein 2 (F-box and leucine-rich repeat protein 2) (F-box protein FBL2/FBL3),423,"47,062",5 out of 5,2003-11-21,Evidence at protein level
Q5XUX1,FBXW9_HUMAN,F-box/WD repeat-containing protein 9 (F-box and WD-40 domain-containing protein 9),488,"54,115",4 out of 5,2005-03-01,Evidence at protein level
P30273,FCERG_HUMAN,High affinity immunoglobulin epsilon receptor subunit gamma (Fc receptor gamma-chain) (FcRgamma) (Fc-epsilon RI-gamma) (IgE Fc receptor subunit gamma) (FceRI gamma),86,"9,667",5 out of 5,1993-04-01,Evidence at protein level
P12318,FCG2A_HUMAN,Low affinity immunoglobulin gamma Fc region receptor II-a (IgG Fc receptor II-a) (CDw32) (Fc-gamma RII-a) (Fc-gamma-RIIa) (FcRII-a) (CD antigen CD32),317,"35,001",5 out of 5,1989-10-01,Evidence at protein level
O75015,FCG3B_HUMAN,Low affinity immunoglobulin gamma Fc region receptor III-B (Fc-gamma RIII-beta) (Fc-gamma RIII) (Fc-gamma RIIIb) (FcRIII) (FcRIIIb) (FcR-10) (IgG Fc receptor III-1) (CD antigen CD16b),233,"26,216",5 out of 5,2000-05-30,Evidence at protein level
O14526,FCHO1_HUMAN,F-BAR domain only protein 1,889,"96,861",5 out of 5,2007-01-09,Evidence at protein level
O00602,FCN1_HUMAN,Ficolin-1 (Collagen/fibrinogen domain-containing protein 1) (Ficolin-A) (Ficolin-alpha) (M-ficolin),326,"35,078",5 out of 5,2001-02-21,Evidence at protein level
O75636,FCN3_HUMAN,Ficolin-3 (Collagen/fibrinogen domain-containing lectin 3 p35) (Collagen/fibrinogen domain-containing protein 3) (Hakata antigen),299,"32,903",5 out of 5,2001-02-21,Evidence at protein level
Q96LA6,FCRL1_HUMAN,Fc receptor-like protein 1 (FcR-like protein 1) (FcRL1) (Fc receptor homolog 1) (FcRH1) (IFGP family protein 1) (hIFGP1) (Immune receptor translocation-associated protein 5) (CD antigen CD307a),429,"46,936",5 out of 5,2008-04-29,Evidence at protein level
Q96P31,FCRL3_HUMAN,Fc receptor-like protein 3 (FcR-like protein 3) (FcRL3) (Fc receptor homolog 3) (FcRH3) (IFGP family protein 3) (hIFGP3) (Immune receptor translocation-associated protein 3) (SH2 domain-containing phosphatase anchor protein 2) (CD antigen CD307c),734,"80,856",5 out of 5,2008-04-29,Evidence at protein level
Q6BAA4,FCRLB_HUMAN,Fc receptor-like B (Fc receptor homolog expressed in B-cells protein 2) (FREB-2) (Fc receptor-like and mucin-like protein 2) (Fc receptor-like protein 2) (Fc receptor-related protein Y) (FcRY),426,"46,904",4 out of 5,2008-05-20,Evidence at protein level
Q96AC1,FERM2_HUMAN,Fermitin family homolog 2 (Kindlin-2) (Mitogen-inducible gene 2 protein) (MIG-2) (Pleckstrin homology domain-containing family C member 1) (PH domain-containing family C member 1),680,"77,861",5 out of 5,2003-11-07,Evidence at protein level
Q99689,FEZ1_HUMAN,Fasciculation and elongation protein zeta-1 (Zygin I) (Zygin-1),392,"45,119",5 out of 5,2001-04-27,Evidence at protein level
Q7Z6J4,FGD2_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 2 (Zinc finger FYVE domain-containing protein 4)",655,"74,892",5 out of 5,2005-03-15,Evidence at protein level
Q92914,FGF11_HUMAN,Fibroblast growth factor 11 (FGF-11) (Fibroblast growth factor homologous factor 3) (FHF-3),225,"25,005",3 out of 5,1997-11-01,Evidence at transcript level
Q5T1M5,FKB15_HUMAN,FK506-binding protein 15 (FKBP-15) (133 kDa FK506-binding protein) (133 kDa FKBP) (FKBP-133) (WASP and FKBP-like) (WAFL),1219,"133,630",5 out of 5,2007-09-11,Evidence at protein level
P68106,FKB1B_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12),108,"11,783",5 out of 5,2004-10-25,Evidence at protein level
Q86W67,F228A_HUMAN,Protein FAM228A,206,"23,752",1 out of 5,2008-09-02,Evidence at transcript level
Q9H0X4,F234A_HUMAN,Protein FAM234A (Protein ITFG3),552,"59,660",4 out of 5,2006-09-05,Evidence at protein level
Q16877,F264_HUMAN,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (6PF-2-K/Fru-2,6-P2ase 4) (PFK/FBPase 4) (6PF-2-K/Fru-2,6-P2ase testis-type isozyme) [Includes: 6-phosphofructo-2-kinase (EC 2.7.1.105); Fructose-2,6-bisphosphatase (EC 3.1.3.46)]",469,"54,040",5 out of 5,1998-07-15,Evidence at transcript level
Q05BU3,F86JP_HUMAN,Putative protein FAM86JP,40,"4,003",1 out of 5,2008-03-18,Uncertain
Q86YD7,F90A1_HUMAN,Protein FAM90A1,464,"49,793",5 out of 5,2007-09-11,Evidence at protein level
Q8NDB6,FA156_HUMAN,Protein FAM156A/FAM156B (Transmembrane protein 29/29B),213,"24,412",3 out of 5,2006-06-27,Evidence at protein level
Q8IXL6,FA20C_HUMAN,Extracellular serine/threonine protein kinase FAM20C (EC 2.7.11.1) (Dentin matrix protein 4) (DMP-4) (Golgi casein kinase) (Golgi-enriched fraction casein kinase) (GEF-CK),584,"66,234",5 out of 5,2003-09-19,Evidence at protein level
Q6ZV65,FA47E_HUMAN,Protein FAM47E,393,"45,662",2 out of 5,2008-03-18,Evidence at transcript level
P0C841,FA66E_HUMAN,Putative protein FAM66E,47,"5,233",1 out of 5,2008-09-02,Uncertain
Q8N9W8,FA71D_HUMAN,Protein FAM71D,422,"47,076",2 out of 5,2004-01-16,Evidence at transcript level
Q86X60,FA72B_HUMAN,Protein FAM72B,149,"16,617",2 out of 5,2008-06-10,Evidence at transcript level
Q5JUQ0,FA78A_HUMAN,Protein FAM78A,283,"31,968",2 out of 5,2006-12-12,Evidence at transcript level
Q5T0W9,FA83B_HUMAN,Protein FAM83B,1011,"114,799",5 out of 5,2007-08-21,Evidence at protein level
Q96KN4,FA84A_HUMAN,Protein FAM84A (Neurologic sensory protein 1) (NSE1),292,"32,491",2 out of 5,2006-05-16,Evidence at transcript level
Q6ZTR7,FA92B_HUMAN,Protein FAM92B,304,"34,785",1 out of 5,2008-05-20,Evidence at transcript level
Q969F0,FATE1_HUMAN,Fetal and adult testis-expressed transcript protein (Cancer/testis antigen 43) (CT43) (Tumor antigen BJ-HCC-2),183,"20,712",5 out of 5,2003-09-26,Evidence at protein level
Q8N539,FBCD1_HUMAN,Fibrinogen C domain-containing protein 1,461,"50,744",5 out of 5,2007-07-10,Evidence at protein level
Q8NFZ0,FBH1_HUMAN,F-box DNA helicase 1 (hFBH1) (EC 3.6.4.12) (F-box only protein 18),1043,"117,686",5 out of 5,2004-03-15,Evidence at protein level
P22087,FBRL_HUMAN,rRNA 2'-O-methyltransferase fibrillarin (EC 2.1.1.-) (34 kDa nucleolar scleroderma antigen) (Histone-glutamine methyltransferase),321,"33,784",5 out of 5,1991-08-01,Evidence at protein level
P0C2W1,FBSP1_HUMAN,F-box/SPRY domain-containing protein 1 (F-box only protein 45) (hFbxo45),286,"30,633",5 out of 5,2007-05-01,Evidence at protein level
Q9NWN3,FBX34_HUMAN,F-box only protein 34,711,"78,711",3 out of 5,2003-02-12,Evidence at protein level
Q8WWV6,FCAMR_HUMAN,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor (Fc alpha/mu receptor) (CD antigen CD351),532,"57,144",5 out of 5,2008-04-29,Evidence at protein level
P12314,FCGR1_HUMAN,High affinity immunoglobulin gamma Fc receptor I (IgG Fc receptor I) (Fc-gamma RI) (FcRI) (Fc-gamma RIA) (FcgammaRIa) (CD antigen CD64),374,"42,632",5 out of 5,1989-10-01,Evidence at protein level
Q96LA5,FCRL2_HUMAN,Fc receptor-like protein 2 (FcR-like protein 2) (FcRL2) (Fc receptor homolog 2) (FcRH2) (IFGP family protein 4) (Immunoglobulin receptor translocation-associated protein 4) (SH2 domain-containing phosphatase anchor protein 1) (CD antigen CD307b),508,"55,542",5 out of 5,2005-06-21,Evidence at protein level
Q7L513,FCRLA_HUMAN,Fc receptor-like A (Fc receptor homolog expressed in B-cells) (Fc receptor-like and mucin-like protein 1) (Fc receptor-like protein) (Fc receptor-related protein X) (FcRX),359,"38,927",5 out of 5,2006-03-21,Evidence at protein level
Q86WN1,FCSD1_HUMAN,F-BAR and double SH3 domains protein 1,690,"76,942",3 out of 5,2007-02-20,Evidence at protein level
Q8NFU4,FDSCP_HUMAN,Follicular dendritic cell secreted peptide (FDC secreted protein) (FDC-SP),85,"9,700",3 out of 5,2002-11-28,Evidence at protein level
P02765,FETUA_HUMAN,Alpha-2-HS-glycoprotein (Alpha-2-Z-globulin) (Ba-alpha-2-glycoprotein) (Fetuin-A) [Cleaved into: Alpha-2-HS-glycoprotein chain A; Alpha-2-HS-glycoprotein chain B],367,"39,325",5 out of 5,1986-07-21,Evidence at protein level
Q9UGM5,FETUB_HUMAN,Fetuin-B (16G2) (Fetuin-like protein IRL685) (Gugu),382,"42,055",5 out of 5,2000-12-01,Evidence at protein level
Q99581,FEV_HUMAN,Protein FEV (Fifth Ewing variant protein) (PC12 ETS domain-containing transcription factor 1) (PC12 ETS factor 1) (Pet-1),238,"25,030",5 out of 5,2008-07-22,Evidence at protein level
Q9UHY8,FEZ2_HUMAN,Fasciculation and elongation protein zeta-2 (Zygin II) (Zygin-2),353,"39,666",5 out of 5,2001-02-21,Evidence at protein level
O14842,FFAR1_HUMAN,Free fatty acid receptor 1 (G-protein coupled receptor 40),300,"31,457",5 out of 5,1998-07-15,Evidence at protein level
Q92915,FGF14_HUMAN,Fibroblast growth factor 14 (FGF-14) (Fibroblast growth factor homologous factor 4) (FHF-4),247,"27,702",5 out of 5,1997-11-01,Evidence at protein level
O95750,FGF19_HUMAN,Fibroblast growth factor 19 (FGF-19),216,"24,003",5 out of 5,2000-12-01,Evidence at protein level
Q9HCT0,FGF22_HUMAN,Fibroblast growth factor 22 (FGF-22),170,"19,663",5 out of 5,2001-04-27,Evidence at protein level
Q96C11,FGGY_HUMAN,FGGY carbohydrate kinase domain-containing protein (EC 2.7.1.-),551,"59,993",4 out of 5,2008-03-18,Evidence at protein level
P09769,FGR_HUMAN,Tyrosine-protein kinase Fgr (EC 2.7.10.2) (Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog) (Proto-oncogene c-Fgr) (p55-Fgr) (p58-Fgr) (p58c-Fgr),529,"59,479",5 out of 5,1989-07-01,Evidence at protein level
P02675,FIBB_HUMAN,Fibrinogen beta chain [Cleaved into: Fibrinopeptide B; Fibrinogen beta chain],491,"55,928",5 out of 5,1986-07-21,Evidence at protein level
Q5D862,FILA2_HUMAN,Filaggrin-2 (FLG-2) (Intermediate filament-associated and psoriasis-susceptibility protein) (Ifapsoriasin),2391,"248,073",5 out of 5,2008-04-29,Evidence at protein level
Q86X53,ERIC1_HUMAN,Glutamate-rich protein 1,443,"48,984",2 out of 5,2005-09-27,Evidence at protein level
Q6P6B1,ERIC5_HUMAN,Glutamate-rich protein 5,374,"39,936",2 out of 5,2007-07-10,Evidence at transcript level
O94905,ERLN2_HUMAN,Erlin-2 (Endoplasmic reticulum lipid raft-associated protein 2) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 2) (SPFH domain-containing protein 2),339,"37,840",5 out of 5,2003-10-31,Evidence at protein level
Q8TAM6,ERMIN_HUMAN,Ermin (Juxtanodin) (JN),284,"32,783",5 out of 5,2008-01-15,Evidence at transcript level
P50549,ETV1_HUMAN,ETS translocation variant 1 (Ets-related protein 81),477,"55,131",5 out of 5,1996-10-01,Evidence at protein level
O00471,EXOC5_HUMAN,Exocyst complex component 5 (Exocyst complex component Sec10) (hSec10),708,"81,853",5 out of 5,2002-10-25,Evidence at protein level
Q13868,EXOS2_HUMAN,Exosome complex component RRP4 (Exosome component 2) (Ribosomal RNA-processing protein 4),293,"32,789",5 out of 5,2001-04-27,Evidence at protein level
Q9NQT4,EXOS5_HUMAN,Exosome complex component RRP46 (Chronic myelogenous leukemia tumor antigen 28) (Exosome component 5) (Ribosomal RNA-processing protein 46) (p12B),235,"25,249",5 out of 5,2001-06-01,Evidence at protein level
O95677,EYA4_HUMAN,Eyes absent homolog 4 (EC 3.1.3.48),639,"69,505",5 out of 5,2000-05-30,Evidence at protein level
Q5XKR9,F104B_HUMAN,Protein FAM104B,115,"13,109",2 out of 5,2006-05-30,Inferred from homology
Q70Z53,F10C1_HUMAN,Protein FRA10AC1,315,"37,548",4 out of 5,2005-08-16,Evidence at protein level
P05160,F13B_HUMAN,Coagulation factor XIII B chain (Fibrin-stabilizing factor B subunit) (Protein-glutamine gamma-glutamyltransferase B chain) (Transglutaminase B chain),661,"75,511",5 out of 5,1987-08-13,Evidence at protein level
P0C7A2,F153B_HUMAN,Protein FAM153B,387,"43,591",2 out of 5,2008-04-08,Evidence at transcript level
Q96KS9,F167A_HUMAN,Protein FAM167A,214,"24,182",2 out of 5,2003-01-27,Evidence at protein level
O00757,F16P2_HUMAN,"Fructose-1,6-bisphosphatase isozyme 2 (FBPase 2) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 2) (Muscle FBPase)",339,"36,743",5 out of 5,1998-07-15,Evidence at protein level
Q9BQD7,F173A_HUMAN,Protein FAM173A,235,"25,130",2 out of 5,2006-12-12,Evidence at transcript level
Q6UWF9,F180A_HUMAN,Protein FAM180A,173,"19,733",2 out of 5,2008-02-05,Evidence at transcript level
Q9ULE4,F184B_HUMAN,Protein FAM184B,1060,"121,044",2 out of 5,2008-02-26,Evidence at transcript level
O60320,F1891_HUMAN,Protein FAM189A1 (Transmembrane protein 228),539,"56,544",3 out of 5,2000-05-30,Evidence at transcript level
P81408,F189B_HUMAN,Protein FAM189B (Protein COTE1),668,"71,355",4 out of 5,2000-05-30,Evidence at protein level
Q96PV7,F193B_HUMAN,Protein FAM193B,902,"96,543",4 out of 5,2008-07-22,Evidence at protein level
Q8WUB2,F216A_HUMAN,Protein FAM216A,273,"30,792",2 out of 5,2007-05-29,Evidence at transcript level
F5H4B4,F227A_HUMAN,Protein FAM227A,570,"66,188",2 out of 5,2012-10-03,Evidence at protein level
Q8IZU0,FAM9B_HUMAN,Protein FAM9B,186,"22,438",5 out of 5,2003-03-25,Evidence at protein level
Q8TDW7,FAT3_HUMAN,Protocadherin Fat 3 (hFat3) (Cadherin family member 15) (FAT tumor suppressor homolog 3),4589,"505,523",5 out of 5,2008-03-18,Evidence at transcript level
A6NHQ2,FBLL1_HUMAN,rRNA/tRNA 2'-O-methyltransferase fibrillarin-like protein 1 (EC 2.1.1.-) (Protein-glutamine methyltransferase),334,"34,803",4 out of 5,2008-04-29,Inferred from homology
P23142,FBLN1_HUMAN,Fibulin-1 (FIBL-1),703,"77,214",5 out of 5,1991-11-01,Evidence at protein level
Q8NEZ5,FBX22_HUMAN,F-box only protein 22 (F-box protein FBX22p44),403,"44,508",5 out of 5,2003-05-09,Evidence at protein level
Q9UK97,FBX9_HUMAN,F-box only protein 9 (Cross-immune reaction antigen 1) (Renal carcinoma antigen NY-REN-57),447,"52,329",5 out of 5,2001-02-21,Evidence at protein level
P57775,FBXW4_HUMAN,F-box/WD repeat-containing protein 4 (Dactylin) (F-box and WD-40 domain-containing protein 4),412,"46,337",5 out of 5,2001-02-21,Evidence at protein level
Q969H0,FBXW7_HUMAN,F-box/WD repeat-containing protein 7 (Archipelago homolog) (hAgo) (F-box and WD-40 domain-containing protein 7) (F-box protein FBX30) (SEL-10) (hCdc4),707,"79,663",5 out of 5,2004-03-01,Evidence at protein level
Q01362,FCERB_HUMAN,High affinity immunoglobulin epsilon receptor subunit beta (FcERI) (Fc epsilon receptor I beta-chain) (IgE Fc receptor subunit beta) (Membrane-spanning 4-domains subfamily A member 2),244,"26,534",5 out of 5,1993-04-01,Evidence at transcript level
Q6P4F2,FDX2_HUMAN,"Ferredoxin-2, mitochondrial (Adrenodoxin-like protein) (Ferredoxin-1-like protein)",183,"19,521",5 out of 5,2008-03-18,Evidence at protein level
P39748,FEN1_HUMAN,Flap endonuclease 1 (FEN-1) (EC 3.1.-.-) (DNase IV) (Flap structure-specific endonuclease 1) (Maturation factor 1) (MF1) (hFEN-1),380,"42,593",5 out of 5,1995-02-01,Evidence at protein level
Q9NQT5,EXOS3_HUMAN,Exosome complex component RRP40 (Exosome component 3) (Ribosomal RNA-processing protein 40) (p10),275,"29,572",5 out of 5,2001-06-01,Evidence at protein level
Q9NUU6,F105A_HUMAN,Inactive ubiquitin thioesterase FAM105A,356,"42,196",2 out of 5,2007-02-06,Evidence at transcript level
P50502,F10A1_HUMAN,Hsc70-interacting protein (Hip) (Aging-associated protein 2) (Progesterone receptor-associated p48 protein) (Protein FAM10A1) (Putative tumor suppressor ST13) (Renal carcinoma antigen NY-REN-33) (Suppression of tumorigenicity 13 protein),369,"41,332",5 out of 5,1996-10-01,Evidence at protein level
Q1W6H9,F110C_HUMAN,Protein FAM110C,321,"33,863",5 out of 5,2007-07-10,Evidence at protein level
Q6SJ93,F111B_HUMAN,Protein FAM111B (Cancer-associated nucleoprotein),734,"84,674",3 out of 5,2007-02-06,Evidence at protein level
Q9C073,F117A_HUMAN,Protein FAM117A (C/EBP-induced protein),453,"48,319",2 out of 5,2006-12-12,Evidence at protein level
Q9NWS6,F118A_HUMAN,Protein FAM118A,357,"40,269",4 out of 5,2005-07-05,Evidence at protein level
Q9NZB2,F120A_HUMAN,Constitutive coactivator of PPAR-gamma-like protein 1 (Oxidative stress-associated Src activator) (Protein FAM120A),1118,"121,888",5 out of 5,2001-04-27,Evidence at protein level
Q9BWD3,F127B_HUMAN,Protein FAM127B (Mammalian retrotransposon derived protein 8A),113,"13,188",2 out of 5,2007-12-04,Evidence at protein level
Q9P2D6,F135A_HUMAN,Protein FAM135A,1515,"169,840",3 out of 5,2008-01-15,Evidence at protein level
Q96BN6,F149B_HUMAN,Protein FAM149B1,582,"64,618",2 out of 5,2008-02-26,Evidence at transcript level
Q6UXT8,F150A_HUMAN,Protein FAM150A (Augmentor beta) (AUG-beta),129,"14,269",4 out of 5,2008-02-05,Evidence at protein level
Q6UXP7,F151B_HUMAN,Protein FAM151B,276,"31,367",2 out of 5,2008-02-05,Evidence at protein level
O75949,F155B_HUMAN,Transmembrane protein FAM155B (Protein TED) (Transmembrane protein 28),473,"52,605",3 out of 5,2000-05-30,Evidence at transcript level
Q96MY7,F161B_HUMAN,Protein FAM161B,647,"73,647",3 out of 5,2003-07-19,Evidence at protein level
Q96GL9,F163A_HUMAN,Protein FAM163A (Cebelin) (Neuroblastoma-derived secretory protein),167,"17,641",2 out of 5,2007-03-20,Evidence at transcript level
A1KXE4,F168B_HUMAN,Myelin-associated neurite-outgrowth inhibitor (Mani) (p20),195,"20,324",4 out of 5,2008-03-18,Evidence at protein level
Q5T1J6,F182A_HUMAN,Protein FAM182A,154,"17,173",1 out of 5,2006-05-02,Evidence at transcript level
Q5SY85,F201A_HUMAN,Protein FAM201A,155,"16,478",1 out of 5,2006-05-30,Predicted
Q5VWN6,F208B_HUMAN,Protein FAM208B,2430,"268,843",5 out of 5,2007-09-11,Evidence at protein level
Q96KR6,F210B_HUMAN,Protein FAM210B,192,"20,424",2 out of 5,2003-10-10,Evidence at protein level
Q7L5A3,F214B_HUMAN,Protein FAM214B,538,"56,690",4 out of 5,2008-01-15,Evidence at protein level
Q8IWN6,F223A_HUMAN,Protein FAM223A (SPCX),122,"13,808",2 out of 5,2005-08-16,Evidence at transcript level
P0DMU5,F231C_HUMAN,Protein FAM231C,169,"18,266",1 out of 5,2015-05-27,Inferred from homology
A6NDY2,F90AA_HUMAN,Putative protein FAM90A10P,464,"49,635",1 out of 5,2007-09-11,Uncertain
A8MXZ1,F90AN_HUMAN,Putative protein FAM90A23P,464,"49,910",2 out of 5,2008-06-10,Uncertain
A1XBS5,F92A1_HUMAN,Protein FAM92A1,289,"33,431",4 out of 5,2007-05-15,Evidence at protein level
O94988,FA13A_HUMAN,Protein FAM13A,1023,"116,932",4 out of 5,2003-04-11,Evidence at protein level
Q6ZT52,FA43B_HUMAN,Protein FAM43B,329,"36,776",1 out of 5,2004-08-16,Evidence at transcript level
Q13158,FADD_HUMAN,FAS-associated death domain protein (FAS-associating death domain-containing protein) (Growth-inhibiting gene 3 protein) (Mediator of receptor induced toxicity) (Protein FADD),208,"23,279",5 out of 5,1997-11-01,Evidence at protein level
Q5TGI0,FAXC_HUMAN,Failed axon connections homolog,409,"46,843",2 out of 5,2005-08-30,Evidence at transcript level
Q12805,FBLN3_HUMAN,EGF-containing fibulin-like extracellular matrix protein 1 (Extracellular protein S1-5) (Fibrillin-like protein) (Fibulin-3) (FIBL-3),493,"54,641",5 out of 5,2000-12-01,Evidence at protein level
Q53RD9,FBLN7_HUMAN,Fibulin-7 (FIBL-7),439,"47,376",4 out of 5,2008-01-15,Evidence at transcript level
P35555,FBN1_HUMAN,Fibrillin-1 [Cleaved into: Asprosin],2871,"312,237",5 out of 5,1994-06-01,Evidence at protein level
Q9HAH7,FBRS_HUMAN,Probable fibrosin-1,460,"48,388",2 out of 5,2004-07-19,Evidence at protein level
Q7Z6M2,FBX33_HUMAN,F-box only protein 33,555,"62,630",2 out of 5,2004-08-16,Evidence at protein level
Q6PIJ6,FBX38_HUMAN,F-box only protein 38 (Modulator of KLF7 activity homolog) (MoKA),1188,"133,944",4 out of 5,2004-08-31,Evidence at protein level
Q9UH90,FBX40_HUMAN,F-box only protein 40 (Muscle disease-related protein),709,"79,782",4 out of 5,2004-08-31,Evidence at transcript level
Q4G163,FBX43_HUMAN,F-box only protein 43 (Endogenous meiotic inhibitor 2),708,"78,402",4 out of 5,2006-07-25,Evidence at protein level
Q9H4M3,FBX44_HUMAN,F-box only protein 44 (F-box protein FBX30) (F-box/G-domain protein 3),255,"29,747",5 out of 5,2001-09-26,Evidence at protein level
Q9NRD1,FBX6_HUMAN,F-box only protein 6 (F-box protein that recognizes sugar chains 2) (F-box/G-domain protein 2),293,"33,933",5 out of 5,2002-11-01,Evidence at protein level
P06734,FCER2_HUMAN,Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form],321,"36,469",5 out of 5,1988-01-01,Evidence at protein level
Q96PJ5,FCRL4_HUMAN,Fc receptor-like protein 4 (FcR-like protein 4) (FcRL4) (Fc receptor homolog 4) (FcRH4) (IFGP family protein 2) (hIFGP2) (Immune receptor translocation-associated protein 1) (CD antigen CD307d),515,"57,224",5 out of 5,2008-04-29,Evidence at protein level
Q8NA97,FEAS1_HUMAN,Putative uncharacterized protein FER1L6-AS1 (FER1L6 antisense RNA 1) (FER1L6 antisense gene protein 1),138,"15,156",1 out of 5,2007-01-09,Evidence at transcript level
Q96RJ6,FER3L_HUMAN,Fer3-like protein (Basic helix-loop-helix protein N-twist) (Class A basic helix-loop-helix protein 31) (bHLHa31) (Nephew of atonal 3) (Neuronal twist),166,"19,017",4 out of 5,2008-04-08,Evidence at protein level
O14843,FFAR3_HUMAN,Free fatty acid receptor 3 (G-protein coupled receptor 41),346,"38,649",5 out of 5,1998-07-15,Evidence at protein level
Q92913,FGF13_HUMAN,Fibroblast growth factor 13 (FGF-13) (Fibroblast growth factor homologous factor 2) (FHF-2),245,"27,564",5 out of 5,1997-11-01,Evidence at protein level
Q9BTA0,F167B_HUMAN,Protein FAM167B,163,"18,414",2 out of 5,2003-01-27,Evidence at transcript level
Q9Y6X4,F169A_HUMAN,Soluble lamin-associated protein of 75 kDa (SLAP75) (Protein FAM169A),670,"74,955",3 out of 5,2008-02-26,Evidence at protein level
Q96MZ4,F218A_HUMAN,Protein FAM218A,157,"17,021",1 out of 5,2008-06-10,Evidence at protein level
A6H8Z2,F221B_HUMAN,Protein FAM221B,402,"45,394",2 out of 5,2007-11-13,Evidence at transcript level
Q4VXF1,F74A3_HUMAN,Putative protein FAM74A3,159,"18,188",2 out of 5,2008-06-10,Uncertain
A8MX19,F90AC_HUMAN,Putative protein FAM90A12P,464,"49,786",2 out of 5,2008-04-29,Uncertain
A6NNH2,F90AR_HUMAN,Protein FAM90A27P,459,"49,646",1 out of 5,2007-09-11,Inferred from homology
Q96MK3,FA20A_HUMAN,Pseudokinase FAM20A,541,"61,417",5 out of 5,2003-09-19,Evidence at protein level
Q7L5A8,FA2H_HUMAN,Fatty acid 2-hydroxylase (EC 1.-.-.-) (Fatty acid alpha-hydroxylase),372,"42,791",5 out of 5,2007-12-04,Evidence at protein level
Q6NSW5,FA45B_HUMAN,Putative protein FAM45B,357,"40,514",2 out of 5,2004-08-16,Uncertain
A6NHR8,FA47D_HUMAN,Putative protein FAM47D,397,"46,757",1 out of 5,2008-07-01,Uncertain
Q14320,FA50A_HUMAN,Protein FAM50A (Protein HXC-26) (Protein XAP-5),339,"40,242",3 out of 5,1997-11-01,Evidence at protein level
Q8N1B3,FA58A_HUMAN,Cyclin-related protein FAM58A (CDK10-activating cyclin) (Cyclin-M),248,"28,369",5 out of 5,2007-08-21,Evidence at protein level
Q9NP50,FA60A_HUMAN,Protein FAM60A (Tera protein homolog),221,"24,852",4 out of 5,2005-07-19,Evidence at protein level
A6ND36,FA83G_HUMAN,Protein FAM83G (Protein associated with SMAD1),823,"90,835",5 out of 5,2008-04-29,Evidence at protein level
Q8N5H3,FA89B_HUMAN,Protein FAM89B,189,"20,147",3 out of 5,2007-01-09,Evidence at protein level
Q9H5X1,FA96A_HUMAN,MIP18 family protein FAM96A,160,"18,355",4 out of 5,2002-05-02,Evidence at protein level
P07148,FABPL_HUMAN,"Fatty acid-binding protein, liver (Fatty acid-binding protein 1) (Liver-type fatty acid-binding protein) (L-FABP)",127,"14,208",5 out of 5,1988-04-01,Evidence at protein level
Q9Y256,FACE2_HUMAN,CAAX prenyl protease 2 (EC 3.4.22.-) (Farnesylated proteins-converting enzyme 2) (FACE-2) (Prenyl protein-specific endoprotease 2) (RCE1 homolog) (hRCE1),329,"35,833",5 out of 5,2001-04-27,Evidence at protein level
Q14296,FASTK_HUMAN,Fas-activated serine/threonine kinase (FAST kinase) (EC 2.7.11.8),549,"61,104",5 out of 5,2001-02-21,Evidence at protein level
Q14517,FAT1_HUMAN,"Protocadherin Fat 1 (Cadherin family member 7) (Cadherin-related tumor suppressor homolog) (Protein fat homolog) [Cleaved into: Protocadherin Fat 1, nuclear form]",4588,"506,273",5 out of 5,2000-12-01,Evidence at protein level
Q9NYQ8,FAT2_HUMAN,Protocadherin Fat 2 (hFat2) (Cadherin family member 8) (Multiple epidermal growth factor-like domains protein 1) (Multiple EGF-like domains protein 1),4349,"479,317",5 out of 5,2002-08-02,Evidence at protein level
O94952,FBX21_HUMAN,F-box only protein 21,628,"72,270",3 out of 5,2003-05-09,Evidence at transcript level
Q969P5,FBX32_HUMAN,F-box only protein 32 (Atrogin-1) (Muscle atrophy F-box protein) (MAFbx),355,"41,637",5 out of 5,2002-04-16,Evidence at protein level
Q9UK99,FBX3_HUMAN,F-box only protein 3,471,"54,561",4 out of 5,2001-02-21,Evidence at protein level
Q5MNV8,FBX47_HUMAN,F-box only protein 47,452,"51,968",2 out of 5,2005-02-15,Evidence at transcript level
P55899,FCGRN_HUMAN,IgG receptor FcRn large subunit p51 (FcRn) (IgG Fc fragment receptor transporter alpha chain) (Neonatal Fc receptor),365,"39,743",5 out of 5,1997-11-01,Evidence at protein level
Q13630,FCL_HUMAN,"GDP-L-fucose synthase (EC 1.1.1.271) (GDP-4-keto-6-deoxy-D-mannose-3,5-epimerase-4-reductase) (Protein FX) (Red cell NADP(H)-binding protein) (Short-chain dehydrogenase/reductase family 4E member 1)",321,"35,893",5 out of 5,2001-02-21,Evidence at protein level
Q96RD9,FCRL5_HUMAN,Fc receptor-like protein 5 (FcR-like protein 5) (FcRL5) (BXMAS1) (Fc receptor homolog 5) (FcRH5) (Immune receptor translocation-associated protein 2) (CD antigen CD307e),977,"106,437",5 out of 5,2006-03-07,Evidence at protein level
B1AJZ9,FHAD1_HUMAN,Forkhead-associated domain-containing protein 1 (FHA domain-containing protein 1),1412,"161,904",2 out of 5,2008-09-02,Evidence at transcript level
Q5TD97,FHL5_HUMAN,Four and a half LIM domains protein 5 (FHL-5) (Activator of cAMP-responsive element modulator in testis) (Activator of CREM in testis),284,"32,720",4 out of 5,2005-07-05,Evidence at protein level
Q92496,FHR4_HUMAN,Complement factor H-related protein 4 (FHR-4),578,"65,351",5 out of 5,2001-02-21,Evidence at protein level
P02671,FIBA_HUMAN,Fibrinogen alpha chain [Cleaved into: Fibrinopeptide A; Fibrinogen alpha chain],866,"94,973",5 out of 5,1986-07-21,Evidence at protein level
Q6UN15,FIP1_HUMAN,Pre-mRNA 3'-end-processing factor FIP1 (hFip1) (FIP1-like 1 protein) (Factor interacting with PAP) (Rearranged in hypereosinophilia),594,"66,526",5 out of 5,2005-12-20,Evidence at protein level
Q06265,EXOS9_HUMAN,Exosome complex component RRP45 (Autoantigen PM/Scl 1) (Exosome component 9) (P75 polymyositis-scleroderma overlap syndrome-associated autoantigen) (Polymyositis/scleroderma autoantigen 1) (Polymyositis/scleroderma autoantigen 75 kDa) (PM/Scl-75),439,"48,949",5 out of 5,2001-06-01,Evidence at protein level
P15311,EZRI_HUMAN,Ezrin (Cytovillin) (Villin-2) (p81),586,"69,413",5 out of 5,1990-04-01,Evidence at protein level
Q4KMX7,F106A_HUMAN,Protein FAM106A,169,"18,795",1 out of 5,2006-05-16,Evidence at transcript level
Q9NRY5,F1142_HUMAN,Protein FAM114A2,505,"55,468",2 out of 5,2007-02-06,Evidence at protein level
Q8NC44,F134A_HUMAN,Protein FAM134A,543,"57,830",3 out of 5,2005-07-05,Evidence at protein level
Q86VR2,F134C_HUMAN,Protein FAM134C,466,"51,396",4 out of 5,2007-05-29,Evidence at protein level
Q96C01,F136A_HUMAN,Protein FAM136A,138,"15,641",2 out of 5,2007-07-24,Evidence at protein level
A5PLN7,F149A_HUMAN,Protein FAM149A,773,"82,698",3 out of 5,2008-02-26,Evidence at transcript level
Q92567,F168A_HUMAN,Protein FAM168A (Tongue cancer chemotherapy resistance-associated protein 1),244,"26,184",5 out of 5,2004-04-26,Evidence at protein level
A8MVW0,F1712_HUMAN,Protein FAM171A2,826,"87,435",3 out of 5,2008-04-08,Evidence at protein level
Q8WUF8,F172A_HUMAN,Protein FAM172A,416,"47,972",3 out of 5,2008-02-26,Evidence at transcript level
Q15018,F175B_HUMAN,BRISC complex subunit Abro1 (Abraxas brother protein 1) (Protein FAM175B),415,"46,901",5 out of 5,2005-12-20,Evidence at protein level
Q8IYM0,F186B_HUMAN,Protein FAM186B,893,"103,722",2 out of 5,2006-10-03,Evidence at transcript level
Q7Z5A8,F19A3_HUMAN,Protein FAM19A3 (Chemokine-like protein TAFA-3),133,"14,776",3 out of 5,2005-11-08,Evidence at transcript level
Q8TCP9,F200A_HUMAN,Protein FAM200A,573,"66,276",3 out of 5,2007-03-06,Evidence at protein level
Q96ND0,F210A_HUMAN,Protein FAM210A,272,"30,777",3 out of 5,2007-02-06,Evidence at protein level
Q9BRX8,F213A_HUMAN,Redox-regulatory protein FAM213A (Peroxiredoxin-like 2 activated in M-CSF stimulated monocytes) (Protein PAMM),229,"25,764",5 out of 5,2005-08-16,Evidence at protein level
Q8IW50,F219A_HUMAN,Protein FAM219A,185,"20,400",3 out of 5,2005-08-16,Evidence at protein level
A4D161,F221A_HUMAN,Protein FAM221A,298,"33,083",3 out of 5,2007-07-10,Evidence at protein level
Q8WU58,F222B_HUMAN,Protein FAM222B,562,"59,652",2 out of 5,2007-02-06,Evidence at transcript level
Q4G0N7,F229B_HUMAN,Protein FAM229B,80,"8,717",1 out of 5,2008-05-20,Inferred from homology
P0C7W8,F90AD_HUMAN,Putative protein FAM90A13P,464,"49,853",2 out of 5,2008-07-22,Uncertain
P00742,FA10_HUMAN,Coagulation factor X (EC 3.4.21.6) (Stuart factor) (Stuart-Prower factor) [Cleaved into: Factor X light chain; Factor X heavy chain; Activated factor Xa heavy chain],488,"54,732",5 out of 5,1986-07-21,Evidence at protein level
P00748,FA12_HUMAN,Coagulation factor XII (EC 3.4.21.38) (Hageman factor) (HAF) [Cleaved into: Coagulation factor XIIa heavy chain; Beta-factor XIIa part 1; Coagulation factor XIIa light chain (Beta-factor XIIa part 2)],615,"67,792",5 out of 5,1986-07-21,Evidence at protein level
Q9NZY2,FA30A_HUMAN,Putative uncharacterized protein FAM30A,134,"14,626",2 out of 5,2005-07-05,Uncertain
Q86V20,FA35A_HUMAN,Protein FAM35A,835,"93,705",2 out of 5,2005-11-22,Evidence at transcript level
Q8NEK8,FA46D_HUMAN,Protein FAM46D,389,"44,500",2 out of 5,2006-11-28,Evidence at protein level
Q8TBR7,FA57A_HUMAN,Protein FAM57A (Protein CT120),257,"29,383",3 out of 5,2003-08-29,Evidence at protein level
P0C7Q3,FA58B_HUMAN,Putative cyclin-related protein FAM58B,252,"28,609",2 out of 5,2008-07-01,Uncertain
Q96MK2,FA65C_HUMAN,Protein FAM65C,946,"105,290",2 out of 5,2003-04-30,Evidence at protein level
Q0P6D2,FA69C_HUMAN,Protein FAM69C,419,"46,420",2 out of 5,2007-05-15,Evidence at transcript level
Q8NEG0,FA71C_HUMAN,Protein FAM71C,241,"27,472",3 out of 5,2006-12-12,Evidence at protein level
P05413,FABPH_HUMAN,"Fatty acid-binding protein, heart (Fatty acid-binding protein 3) (Heart-type fatty acid-binding protein) (H-FABP) (Mammary-derived growth inhibitor) (MDGI) (Muscle fatty acid-binding protein) (M-FABP)",133,"14,858",5 out of 5,1988-11-01,Evidence at protein level
Q5XX13,FBW10_HUMAN,F-box/WD repeat-containing protein 10 (F-box and WD-40 domain-containing protein 10) (Ubiquitin ligase-specificity factor),1052,"119,846",4 out of 5,2008-01-15,Evidence at transcript level
Q9Y297,FBW1A_HUMAN,F-box/WD repeat-containing protein 1A (E3RSIkappaB) (Epididymis tissue protein Li 2a) (F-box and WD repeats protein beta-TrCP) (pIkappaBalpha-E3 receptor subunit),605,"68,867",5 out of 5,2001-02-21,Evidence at protein level
Q8N531,FBXL6_HUMAN,F-box/LRR-repeat protein 6 (F-box and leucine-rich repeat protein 6) (F-box protein FBL6) (FBL6A),539,"58,588",3 out of 5,2003-10-03,Evidence at transcript level
Q9UJT9,FBXL7_HUMAN,F-box/LRR-repeat protein 7 (F-box and leucine-rich repeat protein 7) (F-box protein FBL6/FBL7),491,"54,575",5 out of 5,2003-10-03,Evidence at transcript level
Q9UKT8,FBXW2_HUMAN,F-box/WD repeat-containing protein 2 (F-box and WD-40 domain-containing protein 2) (Protein MD6),454,"51,512",5 out of 5,2001-01-11,Evidence at protein level
Q9Y324,FCF1_HUMAN,rRNA-processing protein FCF1 homolog,198,"23,370",3 out of 5,2003-09-09,Evidence at transcript level
Q9UK73,FEM1B_HUMAN,Protein fem-1 homolog B (FEM1b) (FEM1-beta) (Fem-1-like death receptor-binding protein alpha) (Fem-1-like in apoptotic pathway protein alpha) (F1A-alpha),627,"70,264",5 out of 5,2008-03-18,Evidence at protein level
Q9BQL6,FERM1_HUMAN,Fermitin family homolog 1 (Kindlerin) (Kindlin syndrome protein) (Kindlin-1) (Unc-112-related protein 1),677,"77,437",5 out of 5,2002-12-06,Evidence at protein level
Q96A26,F162A_HUMAN,Protein FAM162A (E2-induced gene 5 protein) (Growth and transformation-dependent protein) (HGTD-P),154,"17,342",5 out of 5,2006-10-31,Evidence at protein level
A1A519,F170A_HUMAN,Protein FAM170A (Zinc finger domain-containing protein) (Zinc finger protein ZNFD),330,"37,158",5 out of 5,2008-03-18,Evidence at transcript level
Q6P995,F171B_HUMAN,Protein FAM171B,826,"92,181",3 out of 5,2007-05-15,Evidence at transcript level
Q6P4H8,F173B_HUMAN,Protein FAM173B,233,"26,110",2 out of 5,2008-02-26,Evidence at protein level
Q8NB25,F184A_HUMAN,Protein FAM184A,1140,"132,965",3 out of 5,2003-05-16,Evidence at transcript level
A6NFU0,F187A_HUMAN,Ig-like V-type domain-containing protein FAM187A,413,"47,349",2 out of 5,2008-06-10,Inferred from homology
Q9GZU8,F192A_HUMAN,Protein FAM192A (NEFA-interacting nuclear protein NIP30),254,"28,912",2 out of 5,2004-04-26,Evidence at protein level
Q6ZSG2,F196A_HUMAN,Protein FAM196A,479,"52,909",2 out of 5,2008-04-08,Evidence at transcript level
Q96LR4,F19A4_HUMAN,Protein FAM19A4 (Chemokine-like protein TAFA-4),140,"15,682",2 out of 5,2005-11-08,Evidence at protein level
Q9Y5M1,F215A_HUMAN,Uncharacterized protein FAM215A (Apoptosis-related protein 2) (APR-2),114,"11,973",1 out of 5,2000-05-30,Predicted
Q6P4D5,F222C_HUMAN,Protein FAM122C,195,"22,522",2 out of 5,2006-10-31,Evidence at transcript level
A6NL05,F74A7_HUMAN,Protein FAM74A7,159,"18,299",2 out of 5,2008-06-10,Inferred from homology
A6NEL3,F86C2_HUMAN,Putative protein FAM86C2P (EC 2.1.1.-),165,"18,478",2 out of 5,2008-04-29,Uncertain
A6NEW6,F90AG_HUMAN,Putative protein FAM90A16P/FAM90A17P,464,"49,759",2 out of 5,2007-09-11,Uncertain
Q9NYF5,FA13B_HUMAN,Protein FAM13B (GAP-like protein N61),915,"104,543",3 out of 5,2003-04-11,Evidence at protein level
Q8N5W8,FA24B_HUMAN,Protein FAM24B,94,"10,147",2 out of 5,2005-02-15,Inferred from homology
Q8N5C1,FA26E_HUMAN,Protein FAM26E,309,"35,170",2 out of 5,2005-07-05,Evidence at transcript level
Q8TCE6,FA45A_HUMAN,Protein FAM45A,357,"40,513",2 out of 5,2004-08-16,Evidence at transcript level
Q9Y247,FA50B_HUMAN,Protein FAM50B (Protein XAP-5-like),325,"38,709",4 out of 5,2003-10-10,Evidence at protein level
Q9NYF3,FA53C_HUMAN,Protein FAM53C,392,"43,091",2 out of 5,2005-02-01,Evidence at protein level
Q9BSJ6,FA64A_HUMAN,Protein FAM64A (CALM-interactor expressed in thymus and spleen) (Regulator of chromosome segregation protein 1),248,"27,480",5 out of 5,2007-03-20,Evidence at protein level
Q5VUD6,FA69B_HUMAN,Protein FAM69B,431,"48,583",3 out of 5,2007-05-15,Evidence at protein level
Q8TC56,FA71B_HUMAN,Protein FAM71B,605,"64,756",3 out of 5,2007-05-01,Evidence at protein level
Q9BQN1,FA83C_HUMAN,Protein FAM83C,747,"81,078",3 out of 5,2003-07-19,Evidence at protein level
Q2M2I3,FA83E_HUMAN,Protein FAM83E,478,"51,780",2 out of 5,2008-01-15,Evidence at protein level
P00740,FA9_HUMAN,Coagulation factor IX (EC 3.4.21.22) (Christmas factor) (Plasma thromboplastin component) (PTC) [Cleaved into: Coagulation factor IXa light chain; Coagulation factor IXa heavy chain],461,"51,778",5 out of 5,1986-07-21,Evidence at protein level
Q96KT0,FAAS1_HUMAN,Uncharacterized protein FAM167A-AS1 (FAM167A antisense RNA 1) (FAM167A antisense gene protein 1),104,"11,632",1 out of 5,2005-07-19,Predicted
P12104,FABPI_HUMAN,"Fatty acid-binding protein, intestinal (Fatty acid-binding protein 2) (Intestinal-type fatty acid-binding protein) (I-FABP)",132,"15,207",5 out of 5,1989-10-01,Evidence at protein level
O75844,FACE1_HUMAN,CAAX prenyl protease 1 homolog (EC 3.4.24.84) (Farnesylated proteins-converting enzyme 1) (FACE-1) (Prenyl protein-specific endoprotease 1) (Zinc metalloproteinase Ste24 homolog),475,"54,813",5 out of 5,1999-07-15,Evidence at protein level
Q14CZ7,FAKD3_HUMAN,"FAST kinase domain-containing protein 3, mitochondrial",662,"75,689",4 out of 5,2007-04-17,Evidence at protein level
Q96BQ1,FAM3D_HUMAN,Protein FAM3D,224,"24,963",3 out of 5,2002-09-19,Evidence at protein level
Q92636,FAN_HUMAN,Protein FAN (Factor associated with neutral sphingomyelinase activation) (Factor associated with N-SMase activation),917,"104,372",5 out of 5,1998-07-15,Evidence at protein level
Q9UBX5,FBLN5_HUMAN,Fibulin-5 (FIBL-5) (Developmental arteries and neural crest EGF-like protein) (Dance) (Urine p50 protein) (UP50),448,"50,180",5 out of 5,2000-12-01,Evidence at protein level
P35556,FBN2_HUMAN,Fibrillin-2 [Cleaved into: Fibrillin-2 C-terminal peptide],2912,"314,775",5 out of 5,1994-06-01,Evidence at protein level
A6NFH5,FBP12_HUMAN,Fatty acid-binding protein 12,140,"15,565",3 out of 5,2008-07-01,Evidence at transcript level
Q5T0N5,FBP1L_HUMAN,Formin-binding protein 1-like (Transducer of Cdc42-dependent actin assembly protein 1) (Toca-1),605,"70,065",5 out of 5,2006-11-28,Evidence at protein level
Q5XUX0,FBX31_HUMAN,F-box only protein 31,539,"60,664",5 out of 5,2005-02-15,Evidence at protein level
Q5FWF7,FBX48_HUMAN,F-box only protein 48,155,"18,241",2 out of 5,2008-05-20,Evidence at protein level
Q9UKT7,FBXL3_HUMAN,F-box/LRR-repeat protein 3 (F-box and leucine-rich repeat protein 3A) (F-box/LRR-repeat protein 3A),428,"48,707",5 out of 5,2003-10-03,Evidence at protein level
P31994,FCG2B_HUMAN,Low affinity immunoglobulin gamma Fc region receptor II-b (IgG Fc receptor II-b) (CDw32) (Fc-gamma RII-b) (Fc-gamma-RIIb) (FcRII-b) (CD antigen CD32),310,"34,044",5 out of 5,1993-07-01,Evidence at protein level
Q9Y6R7,FCGBP_HUMAN,IgGFc-binding protein (Fcgamma-binding protein antigen) (FcgammaBP),5405,"572,017",5 out of 5,2006-10-31,Evidence at protein level
Q6DN72,FCRL6_HUMAN,Fc receptor-like protein 6 (FcR-like protein 6) (FcRL6) (Fc receptor homolog 6) (FcRH6) (IFGP6),434,"47,748",5 out of 5,2007-03-20,Evidence at protein level
O94868,FCSD2_HUMAN,F-BAR and double SH3 domains protein 2 (Carom) (SH3 multiple domains protein 3),740,"84,276",5 out of 5,2007-02-20,Evidence at protein level
P37268,FDFT_HUMAN,Squalene synthase (SQS) (SS) (EC 2.5.1.21) (FPP:FPP farnesyltransferase) (Farnesyl-diphosphate farnesyltransferase),417,"48,115",5 out of 5,1994-10-01,Evidence at protein level
Q9UQ84,EXO1_HUMAN,Exonuclease 1 (hExo1) (EC 3.1.-.-) (Exonuclease I) (hExoI),846,"94,103",5 out of 5,2006-01-24,Evidence at protein level
Q9NV70,EXOC1_HUMAN,Exocyst complex component 1 (Exocyst complex component Sec3),894,"101,982",5 out of 5,2002-10-25,Evidence at protein level
Q9UPT5,EXOC7_HUMAN,Exocyst complex component 7 (Exocyst complex component Exo70),735,"83,382",5 out of 5,2002-12-06,Evidence at protein level
Q9Y2C4,EXOG_HUMAN,"Nuclease EXOG, mitochondrial (EC 3.1.30.-) (Endonuclease G-like 1) (Endo G-like 1)",368,"41,085",5 out of 5,2001-09-26,Evidence at protein level
Q9NPD3,EXOS4_HUMAN,Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41) (p12A),245,"26,383",5 out of 5,2001-06-01,Evidence at protein level
Q5RKV6,EXOS6_HUMAN,Exosome complex component MTR3 (Exosome component 6) (mRNA transport regulator 3 homolog) (hMtr3) (p11),272,"28,235",5 out of 5,2007-05-15,Evidence at protein level
Q93063,EXT2_HUMAN,Exostosin-2 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 2) (Putative tumor suppressor protein EXT2),718,"82,255",5 out of 5,1998-07-15,Evidence at protein level
P0CH98,F106C_HUMAN,Putative protein FAM106C (FAM106C pseudogene),169,"18,676",2 out of 5,2010-10-05,Uncertain
Q8TAY7,F110D_HUMAN,Protein FAM110D,271,"28,710",2 out of 5,2008-02-26,Evidence at transcript level
Q9NX05,F120C_HUMAN,Constitutive coactivator of PPAR-gamma-like protein 2 (Protein FAM120C) (Tumor antigen BJ-HCC-21),1096,"120,588",3 out of 5,2004-06-07,Evidence at transcript level
Q17RB0,F127C_HUMAN,Protein FAM127C (Mammalian retrotransposon derived protein 8B),113,"13,246",3 out of 5,2007-11-13,Evidence at protein level
Q6UXB0,F131A_HUMAN,Protein FAM131A,335,"36,108",2 out of 5,2006-06-27,Evidence at transcript level
Q96AQ9,F131C_HUMAN,Protein FAM131C,280,"30,351",3 out of 5,2007-03-20,Evidence at protein level
Q9H6L5,F134B_HUMAN,Reticulophagy receptor FAM134B,497,"54,681",5 out of 5,2007-05-29,Evidence at protein level
Q8WW52,F151A_HUMAN,Protein FAM151A,585,"64,028",3 out of 5,2007-11-13,Evidence at transcript level
P0CG43,F157C_HUMAN,Putative protein FAM157C,387,"43,408",1 out of 5,2010-07-13,Inferred from homology
Q6J272,F166A_HUMAN,Protein FAM166A,317,"36,165",2 out of 5,2008-03-18,Evidence at transcript level
Q8N128,F177A_HUMAN,Protein FAM177A1,213,"23,757",2 out of 5,2004-04-13,Evidence at protein level
Q5T319,F182B_HUMAN,Protein FAM182B,152,"15,775",1 out of 5,2008-07-22,Evidence at transcript level
Q8N0U4,F185A_HUMAN,Protein FAM185A,392,"42,301",2 out of 5,2008-02-26,Evidence at transcript level
Q9UFP1,F198A_HUMAN,Protein FAM198A,575,"63,637",3 out of 5,2007-09-11,Evidence at protein level
Q7Z5A9,F19A1_HUMAN,Protein FAM19A1 (Chemokine-like protein TAFA-1),133,"14,901",2 out of 5,2005-11-08,Evidence at protein level
P0CF97,F200B_HUMAN,Protein FAM200B,657,"76,034",2 out of 5,2010-05-18,Inferred from homology
Q63HN1,F205B_HUMAN,Putative protein FAM205B,556,"61,860",2 out of 5,2007-10-23,Uncertain
Q9NSI2,F207A_HUMAN,Protein FAM207A,230,"25,456",3 out of 5,2001-12-13,Evidence at protein level
Q5JX69,F209B_HUMAN,Protein FAM209B,171,"19,499",3 out of 5,2006-05-16,Evidence at transcript level
A6NCW3,F231B_HUMAN,Protein FAM231B,169,"18,250",1 out of 5,2008-07-22,Inferred from homology
P23610,F8I2_HUMAN,Factor VIII intron 22 protein (CpG island protein),371,"39,103",3 out of 5,1991-11-01,Evidence at protein level
P03951,FA11_HUMAN,Coagulation factor XI (FXI) (EC 3.4.21.27) (Plasma thromboplastin antecedent) (PTA) [Cleaved into: Coagulation factor XIa heavy chain; Coagulation factor XIa light chain],625,"70,109",5 out of 5,1986-10-23,Evidence at protein level
A6NFZ4,FA24A_HUMAN,Protein FAM24A,105,"11,258",2 out of 5,2008-02-05,Inferred from homology
Q96IP4,FA46A_HUMAN,Protein FAM46A (HBV X-transactivated gene 11 protein) (HBV XAg-transactivated protein 11),442,"49,666",4 out of 5,2006-11-28,Evidence at protein level
Q96KN1,FA84B_HUMAN,Protein FAM84B (Breast cancer membrane protein 101) (Protein NSE2),310,"34,474",3 out of 5,2006-05-16,Evidence at protein level
Q8NCA5,FA98A_HUMAN,Protein FAM98A,519,"55,401",2 out of 5,2005-12-06,Evidence at protein level
O15540,FABP7_HUMAN,"Fatty acid-binding protein, brain (Brain lipid-binding protein) (BLBP) (Brain-type fatty acid-binding protein) (B-FABP) (Fatty acid-binding protein 7) (Mammary-derived growth inhibitor related)",132,"14,889",5 out of 5,1998-07-15,Evidence at protein level
Q9NVQ4,FAIM1_HUMAN,Fas apoptotic inhibitory molecule 1,179,"20,215",3 out of 5,2003-11-21,Evidence at protein level
O60667,FAIM3_HUMAN,Fas apoptotic inhibitory molecule 3 (IgM Fc fragment receptor) (Regulator of Fas-induced apoptosis Toso),390,"43,146",5 out of 5,2007-04-17,Evidence at protein level
P58499,FAM3B_HUMAN,Protein FAM3B (Cytokine-like protein 2-21) (Pancreatic-derived factor) (PANDER),235,"25,982",5 out of 5,2001-12-19,Evidence at protein level
Q8IZU1,FAM9A_HUMAN,Protein FAM9A,332,"37,339",2 out of 5,2003-03-25,Evidence at protein level
Q00597,FANCC_HUMAN,Fanconi anemia group C protein (Protein FACC),558,"63,429",5 out of 5,1996-10-01,Evidence at protein level
Q9NW38,FANCL_HUMAN,E3 ubiquitin-protein ligase FANCL (EC 2.3.2.27) (Fanconi anemia group L protein) (Fanconi anemia-associated polypeptide of 43 kDa) (FAAP43) (RING-type E3 ubiquitin transferase FANCL),375,"42,905",5 out of 5,2003-10-10,Evidence at protein level
Q6V0I7,FAT4_HUMAN,Protocadherin Fat 4 (hFat4) (Cadherin family member 14) (FAT tumor suppressor homolog 4) (Fat-like cadherin protein FAT-J),4981,"542,687",5 out of 5,2008-03-18,Evidence at protein level
A8MUU1,FB5L3_HUMAN,Putative fatty acid-binding protein 5-like protein 3 (Fatty acid-binding protein 5 pseudogene 3),101,"11,299",2 out of 5,2008-09-02,Uncertain
O75616,ERAL1_HUMAN,"GTPase Era, mitochondrial (H-ERA) (hERA) (Conserved ERA-like GTPase) (CEGA) (ERA-W) (ERA-like protein 1)",437,"48,350",5 out of 5,1999-07-15,Evidence at protein level
O14944,EREG_HUMAN,Proepiregulin [Cleaved into: Epiregulin (EPR)],169,"19,044",5 out of 5,2000-05-30,Evidence at protein level
P62495,ERF1_HUMAN,Eukaryotic peptide chain release factor subunit 1 (Eukaryotic release factor 1) (eRF1) (Protein Cl1) (TB3-1),437,"49,031",5 out of 5,2004-07-19,Evidence at protein level
Q4G0M1,ERFE_HUMAN,Erythroferrone (Complement C1q tumor necrosis factor-related protein 15) (Myonectin),354,"37,279",4 out of 5,2008-06-10,Evidence at transcript level
P50548,ERF_HUMAN,ETS domain-containing transcription factor ERF (Ets2 repressor factor) (PE-2),548,"58,703",5 out of 5,1996-10-01,Evidence at protein level
A1L162,ERIC2_HUMAN,Glutamate-rich protein 2,156,"17,672",2 out of 5,2008-09-02,Evidence at protein level
Q5RHP9,ERIC3_HUMAN,Glutamate-rich protein 3,1530,"168,466",3 out of 5,2007-10-02,Evidence at transcript level
Q7L0X2,ERIP6_HUMAN,Glutamate-rich protein 6 (Protein FAM194A),663,"75,255",2 out of 5,2007-06-26,Evidence at transcript level
P61579,ERK25_HUMAN,Endogenous retrovirus group K member 25 Rec protein (Endogenous retrovirus group K member 25) (HERV-K_11q22.1 provirus Rec protein),105,"11,828",2 out of 5,2004-05-24,Evidence at protein level
O75477,ERLN1_HUMAN,Erlin-1 (Endoplasmic reticulum lipid raft-associated protein 1) (Protein KE04) (Stomatin-prohibitin-flotillin-HflC/K domain-containing protein 1) (SPFH domain-containing protein 1),346,"38,926",5 out of 5,2005-06-07,Evidence at protein level
Q96HE7,ERO1A_HUMAN,ERO1-like protein alpha (ERO1-L) (ERO1-L-alpha) (EC 1.8.4.-) (Endoplasmic oxidoreductin-1-like protein) (Endoplasmic reticulum oxidoreductase alpha) (Oxidoreductin-1-L-alpha),468,"54,393",5 out of 5,2004-07-19,Evidence at protein level
Q9BS26,ERP44_HUMAN,Endoplasmic reticulum resident protein 44 (ER protein 44) (ERp44) (Thioredoxin domain-containing protein 4),406,"46,971",5 out of 5,2003-05-23,Evidence at protein level
B6SEH9,ERVV2_HUMAN,Endogenous retrovirus group V member 2 Env polyprotein (HERV-V_19q13.41 provirus ancestral Env polyprotein 2),535,"59,317",2 out of 5,2011-06-28,Evidence at transcript level
Q8TE67,ES8L3_HUMAN,Epidermal growth factor receptor kinase substrate 8-like protein 3 (EPS8-like protein 3) (Epidermal growth factor receptor pathway substrate 8-related protein 3) (EPS8-related protein 3),593,"66,861",4 out of 5,2006-05-30,Evidence at protein level
Q96BH3,ESPB1_HUMAN,Epididymal sperm-binding protein 1 (Epididymal secretory protein 12) (hE12),223,"26,106",4 out of 5,2007-10-23,Evidence at protein level
P10768,ESTD_HUMAN,S-formylglutathione hydrolase (FGH) (EC 3.1.2.12) (Esterase D) (Methylumbelliferyl-acetate deacetylase) (EC 3.1.1.56),282,"31,463",5 out of 5,1989-07-01,Evidence at protein level
Q9BSJ8,ESYT1_HUMAN,Extended synaptotagmin-1 (E-Syt1) (Membrane-bound C2 domain-containing protein),1104,"122,856",5 out of 5,2006-05-16,Evidence at protein level
P38117,ETFB_HUMAN,Electron transfer flavoprotein subunit beta (Beta-ETF),255,"27,844",5 out of 5,1994-10-01,Evidence at protein level
P15036,ETS2_HUMAN,Protein C-ets-2,469,"53,001",5 out of 5,1990-04-01,Evidence at protein level
P43268,ETV4_HUMAN,ETS translocation variant 4 (Adenovirus E1A enhancer-binding protein) (E1A-F) (Polyomavirus enhancer activator 3 homolog) (Protein PEA3),484,"53,938",5 out of 5,1995-11-01,Evidence at protein level
O60447,EVI5_HUMAN,Ecotropic viral integration site 5 protein homolog (EVI-5) (Neuroblastoma stage 4S gene protein),810,"92,949",5 out of 5,2006-10-31,Evidence at protein level
Q03828,EVX2_HUMAN,Homeobox even-skipped homolog protein 2 (EVX-2),476,"47,800",2 out of 5,1996-10-01,Evidence at transcript level
Q01844,EWS_HUMAN,RNA-binding protein EWS (EWS oncogene) (Ewing sarcoma breakpoint region 1 protein),656,"68,478",5 out of 5,1994-06-01,Evidence at protein level
Q5T8I3,F102B_HUMAN,Protein FAM102B,360,"39,308",2 out of 5,2006-05-16,Evidence at protein level
Q7Z309,F122B_HUMAN,Protein FAM122B,247,"26,928",3 out of 5,2006-10-31,Evidence at protein level
Q8N9E0,F133A_HUMAN,Protein FAM133A,248,"28,941",3 out of 5,2007-05-15,Evidence at protein level
Q49AJ0,F135B_HUMAN,Protein FAM135B,1406,"155,770",3 out of 5,2008-01-15,Evidence at transcript level
Q6UWV7,F159A_HUMAN,Membrane protein FAM159A,190,"20,306",2 out of 5,2008-02-05,Evidence at transcript level
Q6L9T8,FA72D_HUMAN,Protein FAM72D (Gastric cancer up-regulated protein 2),149,"16,688",2 out of 5,2008-06-10,Evidence at transcript level
Q8NEG4,FA83F_HUMAN,Protein FAM83F,500,"55,486",2 out of 5,2008-01-15,Evidence at protein level
Q9NVL1,FA86C_HUMAN,Protein FAM86C1 (EC 2.1.1.-) (Protein FAM86C),165,"18,454",3 out of 5,2007-10-23,Evidence at protein level
Q8TCJ0,FBX25_HUMAN,F-box only protein 25,367,"43,313",5 out of 5,2003-05-09,Evidence at protein level
O60427,FADS1_HUMAN,Fatty acid desaturase 1 (EC 1.14.19.-) (Delta(5) fatty acid desaturase) (D5D) (Delta(5) desaturase) (Delta-5 desaturase),444,"51,964",5 out of 5,2007-10-02,Evidence at protein level
Q6P587,FAHD1_HUMAN,"Acylpyruvase FAHD1, mitochondrial (EC 3.7.1.5) (Fumarylacetoacetate hydrolase domain-containing protein 1) (FAH domain-containing protein 1) (Oxaloacetate decarboxylase) (OAA decarboxylase) (EC 4.1.1.3) (YisK-like protein)",224,"24,843",5 out of 5,2005-05-10,Evidence at protein level
P49327,FAS_HUMAN,Fatty acid synthase (EC 2.3.1.85) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Oleoyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],2511,"273,427",5 out of 5,1996-02-01,Evidence at protein level
O75426,FBX24_HUMAN,F-box only protein 24,580,"64,889",3 out of 5,2001-02-21,Evidence at protein level
Q9UK22,FBX2_HUMAN,F-box only protein 2,296,"33,328",5 out of 5,2001-02-21,Evidence at protein level
Q8NEA4,FBX36_HUMAN,F-box only protein 36,188,"22,105",2 out of 5,2004-08-16,Evidence at transcript level
Q8TF61,FBX41_HUMAN,F-box only protein 41,875,"94,496",3 out of 5,2004-08-31,Evidence at transcript level
Q6PJ61,FBX46_HUMAN,F-box only protein 46 (F-box only protein 34-like),603,"64,631",3 out of 5,2004-08-16,Evidence at protein level
Q9UKT5,FBX4_HUMAN,F-box only protein 4,387,"44,136",5 out of 5,2001-09-26,Evidence at protein level
Q9UKT4,FBX5_HUMAN,F-box only protein 5 (Early mitotic inhibitor 1),447,"50,146",5 out of 5,2002-11-01,Evidence at protein level
Q9Y3I1,FBX7_HUMAN,F-box only protein 7,522,"58,503",5 out of 5,2001-02-21,Evidence at protein level
Q9UKA1,FBXL5_HUMAN,F-box/LRR-repeat protein 5 (F-box and leucine-rich repeat protein 5) (F-box protein FBL4/FBL5) (p45SKP2-like protein),691,"78,555",5 out of 5,2003-10-03,Evidence at protein level
Q96CD0,FBXL8_HUMAN,F-box/LRR-repeat protein 8 (F-box and leucine-rich repeat protein 8) (F-box protein FBL8),374,"40,516",3 out of 5,2003-11-07,Evidence at protein level
Q8N3Y1,FBXW8_HUMAN,F-box/WD repeat-containing protein 8 (F-box and WD-40 domain-containing protein 8) (F-box only protein 29),598,"67,394",5 out of 5,2003-10-03,Evidence at protein level
Q15485,FCN2_HUMAN,Ficolin-2 (37 kDa elastin-binding protein) (Collagen/fibrinogen domain-containing protein 2) (EBP-37) (Ficolin-B) (Ficolin-beta) (Hucolin) (L-ficolin) (Serum lectin p35),313,"34,001",5 out of 5,2001-02-21,Evidence at protein level
Q9BRP7,FDXA1_HUMAN,Ferredoxin-fold anticodon-binding domain-containing protein 1 (FDX-ACDB domain-containing protein 1),624,"70,416",3 out of 5,2008-03-18,Evidence at protein level
Q96M78,FEAS2_HUMAN,Putative uncharacterized protein encoded by FER1L6-AS2 (FER1L6 antisense RNA 2) (FER1L6 antisense gene protein 2),137,"15,528",1 out of 5,2007-01-09,Evidence at transcript level
Q96JP0,FEM1C_HUMAN,Protein fem-1 homolog C (FEM1c) (FEM1-gamma),617,"68,673",4 out of 5,2008-03-18,Evidence at protein level
Q96M96,FGD4_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 4 (Actin filament-binding protein frabin) (FGD1-related F-actin-binding protein) (Zinc finger FYVE domain-containing protein 6)",766,"86,626",5 out of 5,2005-03-15,Evidence at protein level
P61328,FGF12_HUMAN,Fibroblast growth factor 12 (FGF-12) (Fibroblast growth factor homologous factor 1) (FHF-1) (Myocyte-activating factor),243,"27,399",5 out of 5,2004-05-10,Evidence at protein level
O43320,FGF16_HUMAN,Fibroblast growth factor 16 (FGF-16),207,"23,759",5 out of 5,1999-07-15,Evidence at protein level
Q9NP95,FGF20_HUMAN,Fibroblast growth factor 20 (FGF-20),211,"23,499",5 out of 5,2001-04-27,Evidence at protein level
P12034,FGF5_HUMAN,Fibroblast growth factor 5 (FGF-5) (Heparin-binding growth factor 5) (HBGF-5) (Smag-82),268,"29,551",5 out of 5,1989-10-01,Evidence at protein level
P21781,FGF7_HUMAN,Fibroblast growth factor 7 (FGF-7) (Heparin-binding growth factor 7) (HBGF-7) (Keratinocyte growth factor),194,"22,509",5 out of 5,1991-05-01,Evidence at protein level
P31371,FGF9_HUMAN,Fibroblast growth factor 9 (FGF-9) (Glia-activating factor) (GAF) (Heparin-binding growth factor 9) (HBGF-9),208,"23,441",5 out of 5,1993-07-01,Evidence at protein level
P22607,FGFR3_HUMAN,Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333),806,"87,710",5 out of 5,1991-08-01,Evidence at protein level
Q08830,FGL1_HUMAN,Fibrinogen-like protein 1 (HP-041) (Hepassocin) (Hepatocyte-derived fibrinogen-related protein 1) (HFREP-1) (Liver fibrinogen-related protein 1) (LFIRE-1),312,"36,379",5 out of 5,2002-01-23,Evidence at protein level
Q9C0D6,FHDC1_HUMAN,FH2 domain-containing protein 1,1143,"124,762",2 out of 5,2008-02-05,Evidence at protein level
P0C7X4,FHL19_HUMAN,Putative ferritin heavy polypeptide-like 19 (Ferritin heavy polypeptide 1 pseudogene 19),201,"22,644",2 out of 5,2008-07-22,Uncertain
Q8TAL6,FIBIN_HUMAN,Fin bud initiation factor homolog,211,"24,273",4 out of 5,2008-09-02,Evidence at protein level
Q02790,FKBP4_HUMAN,"Peptidyl-prolyl cis-trans isomerase FKBP4 (PPIase FKBP4) (EC 5.2.1.8) (51 kDa FK506-binding protein) (FKBP51) (52 kDa FK506-binding protein) (52 kDa FKBP) (FKBP-52) (59 kDa immunophilin) (p59) (FK506-binding protein 4) (FKBP-4) (FKBP59) (HSP-binding immunophilin) (HBI) (Immunophilin FKBP52) (Rotamase) [Cleaved into: Peptidyl-prolyl cis-trans isomerase FKBP4, N-terminally processed]",459,"51,805",5 out of 5,1993-07-01,Evidence at protein level
Q01543,FLI1_HUMAN,Friend leukemia integration 1 transcription factor (Proto-oncogene Fli-1) (Transcription factor ERGB),452,"50,982",5 out of 5,1993-07-01,Evidence at protein level
Q96RU3,FNBP1_HUMAN,Formin-binding protein 1 (Formin-binding protein 17) (hFBP17),617,"71,307",5 out of 5,2006-11-28,Evidence at protein level
Q04609,FOLH1_HUMAN,Glutamate carboxypeptidase 2 (EC 3.4.17.21) (Cell growth-inhibiting gene 27 protein) (Folate hydrolase 1) (Folylpoly-gamma-glutamate carboxypeptidase) (FGCP) (Glutamate carboxypeptidase II) (GCPII) (Membrane glutamate carboxypeptidase) (mGCP) (N-acetylated-alpha-linked acidic dipeptidase I) (NAALADase I) (Prostate-specific membrane antigen) (PSM) (PSMA) (Pteroylpoly-gamma-glutamate carboxypeptidase),750,"84,331",5 out of 5,1994-06-01,Evidence at protein level
A0PJY2,FEZF1_HUMAN,Fez family zinc finger protein 1 (Zinc finger protein 312B),475,"52,038",5 out of 5,2007-07-10,Evidence at protein level
O60258,FGF17_HUMAN,Fibroblast growth factor 17 (FGF-17),216,"24,891",5 out of 5,1999-07-15,Evidence at protein level
Q9NSA1,FGF21_HUMAN,Fibroblast growth factor 21 (FGF-21),209,"22,300",5 out of 5,2001-04-27,Evidence at protein level
P11487,FGF3_HUMAN,Fibroblast growth factor 3 (FGF-3) (Heparin-binding growth factor 3) (HBGF-3) (Proto-oncogene Int-2),239,"26,887",5 out of 5,1989-10-01,Evidence at protein level
Q8N441,FGRL1_HUMAN,Fibroblast growth factor receptor-like 1 (FGF receptor-like protein 1) (FGF homologous factor receptor) (FGFR-like protein) (Fibroblast growth factor receptor 5) (FGFR-5),504,"54,537",5 out of 5,2005-06-21,Evidence at protein level
Q13643,FHL3_HUMAN,Four and a half LIM domains protein 3 (FHL-3) (Skeletal muscle LIM-protein 2) (SLIM-2),280,"31,192",5 out of 5,1997-11-01,Evidence at protein level
Q9Y613,FHOD1_HUMAN,FH1/FH2 domain-containing protein 1 (Formin homolog overexpressed in spleen 1) (FHOS) (Formin homology 2 domain-containing protein 1),1164,"126,551",5 out of 5,2001-02-21,Evidence at protein level
Q02985,FHR3_HUMAN,Complement factor H-related protein 3 (FHR-3) (DOWN16) (H factor-like protein 3),330,"37,323",4 out of 5,1994-06-01,Evidence at protein level
O43427,FIBP_HUMAN,Acidic fibroblast growth factor intracellular-binding protein (aFGF intracellular-binding protein) (FGF-1 intracellular-binding protein),364,"41,878",5 out of 5,2001-04-27,Evidence at protein level
Q4L180,FIL1L_HUMAN,Filamin A-interacting protein 1-like (130 kDa GPBP-interacting protein) (90 kDa GPBP-interacting protein) (Protein down-regulated in ovarian cancer 1) (DOC-1),1135,"130,382",5 out of 5,2007-12-04,Evidence at protein level
Q9H9S5,FKRP_HUMAN,Fukutin-related protein (EC 2.-.-.-),495,"54,568",5 out of 5,2004-04-13,Evidence at protein level
P21333,FLNA_HUMAN,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),2647,"280,739",5 out of 5,1991-05-01,Evidence at protein level
O75955,FLOT1_HUMAN,Flotillin-1,427,"47,355",5 out of 5,2001-02-21,Evidence at protein level
O43155,FLRT2_HUMAN,Leucine-rich repeat transmembrane protein FLRT2 (Fibronectin-like domain-containing leucine-rich transmembrane protein 2),660,"74,049",5 out of 5,2002-03-27,Evidence at protein level
P36888,FLT3_HUMAN,Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1) (CD antigen CD135),993,"112,903",5 out of 5,1994-06-01,Evidence at protein level
Q01740,FMO1_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 1 (EC 1.14.13.8) (Dimethylaniline oxidase 1) (Fetal hepatic flavin-containing monooxygenase 1) (FMO 1),532,"60,311",5 out of 5,1993-07-01,Evidence at protein level
Q99518,FMO2_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 2 (EC 1.14.13.8) (Dimethylaniline oxidase 2) (FMO 1B1) (Pulmonary flavin-containing monooxygenase 2) (FMO 2),471,"53,644",5 out of 5,2000-05-30,Evidence at protein level
Q8TC99,FNDC8_HUMAN,Fibronectin type III domain-containing protein 8,324,"35,921",2 out of 5,2007-04-17,Evidence at transcript level
P49356,FNTB_HUMAN,Protein farnesyltransferase subunit beta (FTase-beta) (EC 2.5.1.58) (CAAX farnesyltransferase subunit beta) (Ras proteins prenyltransferase subunit beta),437,"48,774",5 out of 5,1996-02-01,Evidence at protein level
Q9HBA9,FOH1B_HUMAN,Putative N-acetylated-alpha-linked acidic dipeptidase (NAALADase) (EC 3.4.-.-) (Cell growth-inhibiting gene 26 protein) (Prostate-specific membrane antigen-like protein) (Putative folate hydrolase 1B),442,"50,045",5 out of 5,2006-10-31,Evidence at transcript level
Q6ZQN5,FOXI2_HUMAN,Forkhead box protein I2,318,"32,979",2 out of 5,2008-02-26,Evidence at transcript level
Q9UPW0,FOXJ3_HUMAN,Forkhead box protein J3,622,"68,960",3 out of 5,2000-05-30,Evidence at protein level
Q01167,FOXK2_HUMAN,Forkhead box protein K2 (Cellular transcription factor ILF-1) (FOXK1) (Interleukin enhancer-binding factor 1),660,"69,062",5 out of 5,1993-04-01,Evidence at protein level
P32314,FOXN2_HUMAN,Forkhead box protein N2 (Human T-cell leukemia virus enhancer factor),431,"47,161",4 out of 5,1993-10-01,Evidence at protein level
Q9C009,FOXQ1_HUMAN,Forkhead box protein Q1 (HNF-3/forkhead-like protein 1) (HFH-1) (Hepatocyte nuclear factor 3 forkhead homolog 1),403,"41,526",3 out of 5,2003-01-27,Evidence at transcript level
P0DMU3,F231L_HUMAN,FAM231A/C-like protein LOC102723383,169,"18,266",1 out of 5,2015-05-27,Inferred from homology
Q08E93,F27E3_HUMAN,Protein FAM27E3,113,"13,507",2 out of 5,2006-12-12,Evidence at protein level
Q6IPT2,F71E1_HUMAN,Protein FAM71E1,247,"27,609",2 out of 5,2008-05-20,Evidence at transcript level
A6NNJ1,F90A9_HUMAN,Putative protein FAM90A9P,464,"49,738",1 out of 5,2007-09-11,Uncertain
Q5JRC9,FA47A_HUMAN,Protein FAM47A,791,"90,592",2 out of 5,2005-07-19,Evidence at transcript level
Q9NUQ9,FA49B_HUMAN,Protein FAM49B (L1),324,"36,748",4 out of 5,2004-09-27,Evidence at protein level
Q5TYM5,FA72A_HUMAN,Protein FAM72A (Latent membrane protein 1-induced protein) (LMP1-induced protein) (LMPIP),149,"16,619",4 out of 5,2008-06-10,Evidence at protein level
Q8TAV0,FA76A_HUMAN,Protein FAM76A,307,"35,049",3 out of 5,2006-07-11,Evidence at transcript level
Q96LP2,FA81B_HUMAN,Protein FAM81B,452,"52,032",3 out of 5,2006-12-12,Evidence at protein level
Q6ZRV2,FA83H_HUMAN,Protein FAM83H,1179,"127,122",5 out of 5,2008-03-18,Evidence at protein level
Q96PS1,FACOS_HUMAN,FANCD2 opposite strand protein (Fanconi anemia group D2 protein opposite strand transcript protein),177,"20,188",1 out of 5,2006-05-16,Evidence at transcript level
Q8NFF5,FAD1_HUMAN,FAD synthase (EC 2.7.7.2) (FAD pyrophosphorylase) (FMN adenylyltransferase) (Flavin adenine dinucleotide synthase) [Includes: Molybdenum cofactor biosynthesis protein-like region; FAD synthase region],587,"65,266",5 out of 5,2007-09-11,Evidence at protein level
Q9Y5Q0,FADS3_HUMAN,Fatty acid desaturase 3 (EC 1.14.19.-) (Cytochrome b5-related protein),445,"51,145",3 out of 5,2007-10-02,Evidence at transcript level
Q9UNN5,FAF1_HUMAN,FAS-associated factor 1 (hFAF1) (UBX domain-containing protein 12) (UBX domain-containing protein 3A),650,"73,954",5 out of 5,2002-05-02,Evidence at protein level
Q05397,FAK1_HUMAN,Focal adhesion kinase 1 (FADK 1) (EC 2.7.10.2) (Focal adhesion kinase-related nonkinase) (FRNK) (Protein phosphatase 1 regulatory subunit 71) (PPP1R71) (Protein-tyrosine kinase 2) (p125FAK) (pp125FAK),1052,"119,233",5 out of 5,1994-02-01,Evidence at protein level
Q8IZT9,FAM9C_HUMAN,Protein FAM9C,166,"19,210",2 out of 5,2003-03-25,Evidence at protein level
Q9NPI8,FANCF_HUMAN,Fanconi anemia group F protein (Protein FACF),374,"42,254",5 out of 5,2002-10-10,Evidence at protein level
Q8TC84,FANK1_HUMAN,Fibronectin type 3 and ankyrin repeat domains protein 1,345,"38,341",3 out of 5,2005-04-26,Evidence at transcript level
Q6ZU82,FAR2L_HUMAN,Putative inactive fatty acyl-CoA reductase 2-like protein (Fatty acyl CoA reductase 2 pseudogene 1),131,"15,698",2 out of 5,2008-03-18,Uncertain
Q8NI29,FBX27_HUMAN,F-box only protein 27 (F-box/G-domain protein 5),283,"31,623",4 out of 5,2003-05-09,Evidence at protein level
P16591,FER_HUMAN,Tyrosine-protein kinase Fer (EC 2.7.10.2) (Feline encephalitis virus-related kinase FER) (Fujinami poultry sarcoma/Feline sarcoma-related protein Fer) (Proto-oncogene c-Fer) (Tyrosine kinase 3) (p94-Fer),822,"94,638",5 out of 5,1990-08-01,Evidence at protein level
Q9GZV9,FGF23_HUMAN,Fibroblast growth factor 23 (FGF-23) (Phosphatonin) (Tumor-derived hypophosphatemia-inducing factor) [Cleaved into: Fibroblast growth factor 23 N-terminal peptide; Fibroblast growth factor 23 C-terminal peptide],251,"27,954",5 out of 5,2001-04-27,Evidence at protein level
Q14314,FGL2_HUMAN,Fibroleukin (Fibrinogen-like protein 2) (pT49),439,"50,229",5 out of 5,2001-01-11,Evidence at protein level
P02679,FIBG_HUMAN,Fibrinogen gamma chain,453,"51,512",5 out of 5,1986-07-21,Evidence at protein level
Q9Y3D6,FIS1_HUMAN,Mitochondrial fission 1 protein (FIS1 homolog) (hFis1) (Tetratricopeptide repeat protein 11) (TPR repeat protein 11),152,"16,938",5 out of 5,2003-07-19,Evidence at protein level
Q96AY3,FKB10_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP10 (PPIase FKBP10) (EC 5.2.1.8) (65 kDa FK506-binding protein) (65 kDa FKBP) (FKBP-65) (FK506-binding protein 10) (FKBP-10) (Immunophilin FKBP65) (Rotamase),582,"64,245",5 out of 5,2002-09-19,Evidence at protein level
Q9NWM8,FKB14_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP14 (PPIase FKBP14) (EC 5.2.1.8) (22 kDa FK506-binding protein) (22 kDa FKBP) (FKBP-22) (FK506-binding protein 14) (FKBP-14) (Rotamase),211,"24,172",5 out of 5,2002-10-10,Evidence at protein level
B3EWG6,FM25G_HUMAN,Protein FAM25G,89,"9,320",1 out of 5,2012-03-21,Inferred from homology
P31513,FMO3_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 3 (EC 1.14.13.8) (Dimethylaniline oxidase 3) (FMO II) (FMO form 2) (Hepatic flavin-containing monooxygenase 3) (FMO 3) (Trimethylamine monooxygenase) (EC 1.14.13.148),532,"60,033",5 out of 5,1993-07-01,Evidence at protein level
O60774,FMO6_HUMAN,Putative dimethylaniline monooxygenase [N-oxide-forming] 6 (EC 1.14.13.8) (Dimethylaniline oxidase 6) (Flavin-containing monooxygenase 6) (FMO 6),539,"61,291",4 out of 5,2003-02-12,Uncertain
Q4ZHG4,FNDC1_HUMAN,Fibronectin type III domain-containing protein 1 (Activation-associated cDNA protein) (Expressed in synovial lining protein),1894,"205,558",5 out of 5,2007-04-17,Evidence at transcript level
Q96GK7,FAH2A_HUMAN,Fumarylacetoacetate hydrolase domain-containing protein 2A (EC 3.-.-.-),314,"34,596",2 out of 5,2007-05-29,Evidence at protein level
Q9NYY8,FAKD2_HUMAN,"FAST kinase domain-containing protein 2, mitochondrial",710,"81,463",5 out of 5,2006-02-07,Evidence at protein level
Q5VT28,FAM27_HUMAN,Protein FAM27A/B/C,67,"7,388",2 out of 5,2006-12-12,Inferred from homology
O15287,FANCG_HUMAN,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),622,"68,554",5 out of 5,1999-07-15,Evidence at protein level
Q9BX63,FANCJ_HUMAN,Fanconi anemia group J protein (Protein FACJ) (EC 3.6.4.13) (ATP-dependent RNA helicase BRIP1) (BRCA1-associated C-terminal helicase 1) (BRCA1-interacting protein C-terminal helicase 1) (BRCA1-interacting protein 1),1249,"140,878",5 out of 5,2005-01-04,Evidence at protein level
Q6NZ36,FAP20_HUMAN,Fanconi anemia core complex-associated protein 20 (FANCA-associated protein of 20 kDa) (Fanconi anemia-associated protein of 20 kDa),180,"19,869",5 out of 5,2008-02-05,Evidence at protein level
Q86XK2,FBX11_HUMAN,F-box only protein 11 (Protein arginine N-methyltransferase 9) (Vitiligo-associated protein 1) (VIT-1),927,"103,585",5 out of 5,2003-11-07,Evidence at protein level
Q9BSK4,FEM1A_HUMAN,Protein fem-1 homolog A (FEM1a) (FEM1-alpha) (Prostaglandin E receptor 4-associated protein),669,"73,639",4 out of 5,2008-03-18,Evidence at protein level
P02771,FETA_HUMAN,Alpha-fetoprotein (Alpha-1-fetoprotein) (Alpha-fetoglobulin),609,"68,678",5 out of 5,1986-07-21,Evidence at protein level
Q96SL8,FIZ1_HUMAN,Flt3-interacting zinc finger protein 1 (Zinc finger protein 798),496,"51,996",3 out of 5,2005-03-15,Evidence at protein level
P62942,FKB1A_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP1A (PPIase FKBP1A) (EC 5.2.1.8) (12 kDa FK506-binding protein) (12 kDa FKBP) (FKBP-12) (Calstabin-1) (FK506-binding protein 1A) (FKBP-1A) (Immunophilin FKBP12) (Rotamase),108,"11,951",5 out of 5,2004-08-31,Evidence at protein level
Q14315,FLNC_HUMAN,Filamin-C (FLN-C) (FLNc) (ABP-280-like protein) (ABP-L) (Actin-binding-like protein) (Filamin-2) (Gamma-filamin),2725,"291,022",5 out of 5,2003-06-16,Evidence at protein level
Q14254,FLOT2_HUMAN,Flotillin-2 (Epidermal surface antigen) (ESA) (Membrane component chromosome 17 surface marker 1),428,"47,064",5 out of 5,2001-02-21,Evidence at protein level
Q5VTH2,FLTOP_HUMAN,Protein Flattop (Cilia- and flagella-associated protein 126),177,"19,293",3 out of 5,2008-02-05,Evidence at transcript level
B3EWG4,FM25B_HUMAN,Putative protein FAM25BP (FAM25B pseudogene),89,"9,320",2 out of 5,2012-03-21,Uncertain
P31512,FMO4_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 4 (EC 1.14.13.8) (Dimethylaniline oxidase 4) (Hepatic flavin-containing monooxygenase 4) (FMO 4),558,"63,343",5 out of 5,1993-07-01,Evidence at protein level
Q5VW36,FOCAD_HUMAN,Focadhesin,1801,"200,072",4 out of 5,2008-01-15,Evidence at protein level
Q8IX07,FOG1_HUMAN,Zinc finger protein ZFPM1 (Friend of GATA protein 1) (FOG-1) (Friend of GATA 1) (Zinc finger protein 89A) (Zinc finger protein multitype 1),1006,"104,888",5 out of 5,2004-03-15,Evidence at protein level
Q8WW38,FOG2_HUMAN,Zinc finger protein ZFPM2 (Friend of GATA protein 2) (FOG-2) (Friend of GATA 2) (hFOG-2) (Zinc finger protein 89B) (Zinc finger protein multitype 2),1151,"128,159",5 out of 5,2004-03-15,Evidence at protein level
Q16676,FOXD1_HUMAN,Forkhead box protein D1 (Forkhead-related protein FKHL8) (Forkhead-related transcription factor 4) (FREAC-4),465,"46,140",5 out of 5,1997-11-01,Evidence at protein level
P85037,FOXK1_HUMAN,Forkhead box protein K1 (Myocyte nuclear factor) (MNF),733,"75,457",5 out of 5,2006-11-28,Evidence at protein level
Q12952,FOXL1_HUMAN,Forkhead box protein L1 (Forkhead-related protein FKHL11) (Forkhead-related transcription factor 7) (FREAC-7),345,"36,490",4 out of 5,1997-11-01,Evidence at transcript level
Q6ZUU3,FOXNB_HUMAN,FOXL2 neighbor protein,175,"18,625",1 out of 5,2008-09-02,Evidence at transcript level
Q6PIV2,FOXR1_HUMAN,Forkhead box protein R1 (Forkhead box protein N5),292,"33,310",3 out of 5,2006-10-17,Evidence at protein level
A6NMB9,FIGL2_HUMAN,Putative fidgetin-like protein 2,653,"66,603",2 out of 5,2008-07-22,Uncertain
P02751,FINC_HUMAN,Fibronectin (FN) (Cold-insoluble globulin) (CIG) [Cleaved into: Anastellin; Ugl-Y1; Ugl-Y2; Ugl-Y3],2386,"262,625",5 out of 5,1986-07-21,Evidence at protein level
Q13045,FLII_HUMAN,Protein flightless-1 homolog,1269,"144,751",5 out of 5,2001-09-26,Evidence at protein level
Q9UGQ2,FLOWR_HUMAN,Calcium channel flower homolog (Calcium channel flower domain-containing protein 1),172,"18,470",3 out of 5,2005-03-15,Evidence at protein level
B3EWG5,FM25C_HUMAN,Protein FAM25C,89,"9,320",1 out of 5,2012-03-21,Inferred from homology
O95466,FMNL1_HUMAN,Formin-like protein 1 (CLL-associated antigen KW-13) (Leukocyte formin),1100,"121,854",5 out of 5,2002-04-16,Evidence at protein level
Q8NAU1,FNDC5_HUMAN,Fibronectin type III domain-containing protein 5 (Fibronectin type III repeat-containing protein 2) [Cleaved into: Irisin],212,"23,659",5 out of 5,2008-04-08,Evidence at protein level
Q96NB1,FOPNL_HUMAN,LisH domain-containing protein FOPNL (FGFR1OP N-terminal-like protein) (FOP-related protein of 20 kDa),174,"19,778",5 out of 5,2006-12-12,Evidence at protein level
Q12947,FOXF2_HUMAN,Forkhead box protein F2 (Forkhead-related activator 2) (FREAC-2) (Forkhead-related protein FKHL6) (Forkhead-related transcription factor 2),444,"45,993",5 out of 5,1997-11-01,Evidence at protein level
O75593,FOXH1_HUMAN,Forkhead box protein H1 (Forkhead activin signal transducer 1) (Fast-1) (hFAST-1) (Forkhead activin signal transducer 2) (Fast-2),365,"39,257",5 out of 5,2000-05-30,Evidence at protein level
Q6PJQ5,FOXR2_HUMAN,Forkhead box protein R2 (Forkhead box protein N6),311,"35,924",2 out of 5,2006-10-17,Evidence at protein level
O14772,FPGT_HUMAN,Fucose-1-phosphate guanylyltransferase (EC 2.7.7.30) (GDP-L-fucose diphosphorylase) (GDP-L-fucose pyrophosphorylase),594,"66,599",5 out of 5,2003-01-10,Evidence at protein level
Q9P2B2,FPRP_HUMAN,Prostaglandin F2 receptor negative regulator (CD9 partner 1) (CD9P-1) (Glu-Trp-Ile EWI motif-containing protein F) (EWI-F) (Prostaglandin F2-alpha receptor regulatory protein) (Prostaglandin F2-alpha receptor-associated protein) (CD antigen CD315),879,"98,556",5 out of 5,2003-02-01,Evidence at protein level
Q64ET8,FRG2_HUMAN,Protein FRG2 (FSHD region gene 2 protein),278,"30,490",2 out of 5,2007-09-11,Evidence at transcript level
Q5JV73,FRPD3_HUMAN,FERM and PDZ domain-containing protein 3,1810,"199,209",3 out of 5,2006-10-31,Evidence at transcript level
Q8WU20,FRS2_HUMAN,Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1) (SNT-1),508,"57,029",5 out of 5,2005-07-19,Evidence at protein level
Q9BXM9,FSD1L_HUMAN,FSD1-like protein (Coiled-coil domain-containing protein 10) (FSD1 N-terminal-like protein),530,"59,578",3 out of 5,2004-11-23,Evidence at protein level
Q53R41,FAKD1_HUMAN,"FAST kinase domain-containing protein 1, mitochondrial",847,"97,411",4 out of 5,2007-04-17,Evidence at protein level
Q494R0,FBAS1_HUMAN,Putative uncharacterized protein FBXL19-AS1 (FBXL19 antisense RNA 1) (FBXL19 antisense gene protein 1),122,"13,218",1 out of 5,2008-06-10,Uncertain
P98095,FBLN2_HUMAN,Fibulin-2 (FIBL-2),1184,"126,573",5 out of 5,1995-11-01,Evidence at protein level
O95967,FBLN4_HUMAN,EGF-containing fibulin-like extracellular matrix protein 2 (Fibulin-4) (FIBL-4) (Protein UPH1),443,"49,405",5 out of 5,2000-12-01,Evidence at protein level
Q75N90,FBN3_HUMAN,Fibrillin-3 [Cleaved into: Fibrillin-3 C-terminal peptide],2809,"300,356",5 out of 5,2004-07-19,Evidence at transcript level
Q9UK96,FBX10_HUMAN,F-box only protein 10,956,"105,195",5 out of 5,2001-02-21,Evidence at protein level
Q8IX29,FBX16_HUMAN,F-box only protein 16,292,"34,588",3 out of 5,2003-05-09,Evidence at transcript level
Q9NVF7,FBX28_HUMAN,F-box only protein 28,368,"41,149",4 out of 5,2005-02-15,Evidence at protein level
Q6ZVX7,FBX50_HUMAN,F-box only protein 50 (NCC receptor protein 1 homolog) (NCCRP-1) (Non-specific cytotoxic cell receptor protein 1 homolog),275,"30,847",3 out of 5,2008-03-18,Evidence at protein level
Q9NRD0,FBX8_HUMAN,F-box only protein 8 (F-box/SEC7 protein FBS),319,"37,068",3 out of 5,2001-02-21,Evidence at transcript level
Q9UKA2,FBXL4_HUMAN,F-box/LRR-repeat protein 4 (F-box and leucine-rich repeat protein 4) (F-box protein FBL4/FBL5),621,"70,097",5 out of 5,2002-05-27,Evidence at protein level
P12319,FCERA_HUMAN,High affinity immunoglobulin epsilon receptor subunit alpha (Fc-epsilon RI-alpha) (FcERI) (IgE Fc receptor subunit alpha),257,"29,596",5 out of 5,1989-10-01,Evidence at protein level
Q8TBJ5,FEZF2_HUMAN,Fez family zinc finger protein 2 (Forebrain embryonic zinc finger-like protein 2) (Zinc finger protein 312) (Zinc finger protein Fez-like),459,"48,811",5 out of 5,2007-07-10,Evidence at transcript level
Q5JSP0,FGD3_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 3 (Zinc finger FYVE domain-containing protein 5)",725,"79,401",5 out of 5,2005-03-15,Evidence at protein level
Q6ZNL6,FGD5_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 5 (Zinc finger FYVE domain-containing protein 23)",1462,"159,891",5 out of 5,2005-03-15,Evidence at protein level
P09038,FGF2_HUMAN,Fibroblast growth factor 2 (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2),288,"30,770",5 out of 5,1988-11-01,Evidence at protein level
P55075,FGF8_HUMAN,Fibroblast growth factor 8 (FGF-8) (Androgen-induced growth factor) (AIGF) (Heparin-binding growth factor 8) (HBGF-8),233,"26,525",5 out of 5,1996-10-01,Evidence at protein level
P49789,FHIT_HUMAN,"Bis(5'-adenosyl)-triphosphatase (EC 3.6.1.29) (AP3A hydrolase) (AP3Aase) (Diadenosine 5',5'''-P1,P3-triphosphate hydrolase) (Dinucleosidetriphosphatase) (Fragile histidine triad protein)",147,"16,858",5 out of 5,1996-10-01,Evidence at protein level
Q6PIW4,FIGL1_HUMAN,Fidgetin-like protein 1 (EC 3.6.4.-),674,"74,077",5 out of 5,2007-09-11,Evidence at protein level
Q8IVF7,FMNL3_HUMAN,Formin-like protein 3 (Formin homology 2 domain-containing protein 3) (WW domain-binding protein 3) (WBP-3),1028,"117,213",5 out of 5,2007-05-29,Evidence at protein level
P49326,FMO5_HUMAN,Dimethylaniline monooxygenase [N-oxide-forming] 5 (EC 1.14.13.8) (Dimethylaniline oxidase 5) (Hepatic flavin-containing monooxygenase 5) (FMO 5),533,"60,221",5 out of 5,1996-02-01,Evidence at protein level
Q8N0W7,FMR1N_HUMAN,Fragile X mental retardation 1 neighbor protein (Cancer/testis antigen 37) (CT37) (Sarcoma antigen NY-SAR-35),255,"29,241",2 out of 5,2007-03-20,Evidence at transcript level
O15552,FFAR2_HUMAN,Free fatty acid receptor 2 (G-protein coupled receptor 43),330,"37,144",5 out of 5,1998-07-15,Evidence at protein level
Q5NUL3,FFAR4_HUMAN,Free fatty acid receptor 4 (G-protein coupled receptor 120) (G-protein coupled receptor 129) (G-protein coupled receptor GT01) (G-protein coupled receptor PGR4) (Omega-3 fatty acid receptor 1),377,"42,241",5 out of 5,2005-05-10,Evidence at protein level
P98174,FGD1_HUMAN,"FYVE, RhoGEF and PH domain-containing protein 1 (Faciogenital dysplasia 1 protein) (Rho/Rac guanine nucleotide exchange factor FGD1) (Rho/Rac GEF) (Zinc finger FYVE domain-containing protein 3)",961,"106,561",5 out of 5,1996-10-01,Evidence at protein level
O15520,FGF10_HUMAN,Fibroblast growth factor 10 (FGF-10) (Keratinocyte growth factor 2),208,"23,436",5 out of 5,1999-07-15,Evidence at protein level
Q9BYJ0,FGFP2_HUMAN,Fibroblast growth factor-binding protein 2 (FGF-BP2) (FGF-binding protein 2) (FGFBP-2) (37 kDa killer-specific secretory protein) (Ksp37) (HBp17-related protein) (HBp17-RP),223,"24,581",3 out of 5,2006-07-11,Evidence at protein level
Q9NVK5,FGOP2_HUMAN,FGFR1 oncogene partner 2,253,"29,426",4 out of 5,2007-08-21,Evidence at protein level
Q13642,FHL1_HUMAN,Four and a half LIM domains protein 1 (FHL-1) (Skeletal muscle LIM-protein 1) (SLIM) (SLIM-1),323,"36,263",5 out of 5,1997-11-01,Evidence at protein level
Q03591,FHR1_HUMAN,Complement factor H-related protein 1 (FHR-1) (H factor-like protein 1) (H-factor-like 1) (H36),330,"37,651",5 out of 5,1994-06-01,Evidence at protein level
Q9BXR6,FHR5_HUMAN,Complement factor H-related protein 5 (FHR-5),569,"64,419",5 out of 5,2002-09-19,Evidence at protein level
Q9BVA6,FICD_HUMAN,Adenosine monophosphate-protein transferase FICD (EC 2.7.7.n1) (AMPylator FICD) (FIC domain-containing protein) (Huntingtin yeast partner E) (Huntingtin-interacting protein 13) (HIP-13) (Huntingtin-interacting protein E),458,"51,778",5 out of 5,2008-02-05,Evidence at protein level
A5D6W6,FITM1_HUMAN,Fat storage-inducing transmembrane protein 1 (Fat-inducing protein 1),292,"32,207",3 out of 5,2008-02-26,Evidence at transcript level
Q8N6M3,FITM2_HUMAN,Fat storage-inducing transmembrane protein 2 (Fat-inducing protein 2),262,"29,855",4 out of 5,2003-02-01,Evidence at transcript level
Q75LS8,FKB9L_HUMAN,Putative FK506-binding protein 9-like protein (FK506-binding protein 9-like protein pseudogene),142,"15,591",2 out of 5,2007-11-13,Uncertain
O95302,FKBP9_HUMAN,Peptidyl-prolyl cis-trans isomerase FKBP9 (PPIase FKBP9) (EC 5.2.1.8) (63 kDa FK506-binding protein) (63 kDa FKBP) (FKBP-63) (FK506-binding protein 9) (FKBP-9) (Rotamase),570,"63,084",5 out of 5,2002-09-19,Evidence at protein level
Q8TBE3,FNDC9_HUMAN,Fibronectin type III domain-containing protein 9,224,"25,275",2 out of 5,2007-09-11,Evidence at transcript level
P01100,FOS_HUMAN,Proto-oncogene c-Fos (Cellular oncogene fos) (G0/G1 switch regulatory protein 7),380,"40,695",5 out of 5,1986-07-21,Evidence at protein level
Q99853,FOXB1_HUMAN,Forkhead box protein B1 (Transcription factor FKH-5),325,"34,978",5 out of 5,2000-05-30,Evidence at protein level
O15353,FOXN1_HUMAN,Forkhead box protein N1 (Winged-helix transcription factor nude),648,"68,925",5 out of 5,2001-02-21,Evidence at transcript level
P98177,FOXO4_HUMAN,Forkhead box protein O4 (Fork head domain transcription factor AFX1),505,"53,684",5 out of 5,1996-10-01,Evidence at protein level
Q9Y2L6,FRM4B_HUMAN,FERM domain-containing protein 4B (GRP1-binding protein GRSP1),1034,"118,047",3 out of 5,2001-07-11,Evidence at protein level
Q9UM44,HHLA2_HUMAN,HERV-H LTR-associating protein 2 (Human endogenous retrovirus-H long terminal repeat-associating protein 2),414,"46,850",5 out of 5,2006-09-19,Evidence at protein level
Q96JB3,HIC2_HUMAN,Hypermethylated in cancer 2 protein (Hic-2) (HIC1-related gene on chromosome 22 protein) (Hic-3) (Zinc finger and BTB domain-containing protein 30),615,"66,156",5 out of 5,2002-05-02,Evidence at protein level
Q16534,HLF_HUMAN,Hepatic leukemia factor,295,"33,199",5 out of 5,2000-05-30,Evidence at transcript level
Q05925,HME1_HUMAN,Homeobox protein engrailed-1 (Homeobox protein en-1) (Hu-En-1),392,"40,115",5 out of 5,1994-02-01,Inferred from homology
Q92619,HMHA1_HUMAN,Minor histocompatibility protein HA-1 [Cleaved into: Minor histocompatibility antigen HA-1 (mHag HA-1)],1136,"124,614",5 out of 5,2008-04-29,Evidence at protein level
P09601,HMOX1_HUMAN,Heme oxygenase 1 (HO-1) (EC 1.14.14.18),288,"32,819",5 out of 5,1989-07-01,Evidence at protein level
A8MTL9,HMSD_HUMAN,Serpin-like protein HMSD (Minor histocompatibility protein HMSD) (Minor histocompatibility serpin domain-containing protein),139,"15,355",3 out of 5,2008-07-22,Evidence at transcript level
Q6UXD1,HRCT1_HUMAN,Histidine-rich carboxyl terminus protein 1,115,"13,183",2 out of 5,2008-02-05,Predicted
Q6P1K1,HRG1_HUMAN,Heme transporter HRG1 (Heme-responsive gene 1 protein homolog) (HRG-1) (hHRG-1) (Solute carrier family 48 member 1),146,"16,419",5 out of 5,2008-09-02,Evidence at protein level
O00198,HRK_HUMAN,Activator of apoptosis harakiri (BH3-interacting domain-containing protein 3) (Neuronal death protein DP5),91,"9,884",5 out of 5,1997-11-01,Evidence at protein level
Q8IWL3,HSC20_HUMAN,"Iron-sulfur cluster co-chaperone protein HscB, mitochondrial (DnaJ homolog subfamily C member 20) (Hsc20)",235,"27,422",5 out of 5,2004-03-29,Evidence at protein level
Q96JZ2,HSH2D_HUMAN,Hematopoietic SH2 domain-containing protein (Hematopoietic SH2 protein) (Adaptor in lymphocytes of unknown function X),352,"39,002",5 out of 5,2006-05-02,Evidence at protein level
Q9XRX5,HHLA3_HUMAN,HERV-H LTR-associating protein 3 (Human endogenous retrovirus-H long terminal repeat-associating protein 3),114,"12,913",2 out of 5,2006-10-31,Evidence at protein level
Q6UWX4,HIPL2_HUMAN,HHIP-like protein 2,724,"80,779",3 out of 5,2008-01-15,Evidence at protein level
P15516,HIS3_HUMAN,Histatin-3 (Basic histidine-rich protein) (Hst) (Histidine-rich protein 3) (PB) [Cleaved into: Histatin-3; His3-(20-44)-peptide (His3 20/44) (His3-(1-25)-peptide) (His3 1/25) (Histatin-3 1/25) (Histatin-6); His3-(20-43)-peptide (His3 20/43) (His3-(1-24)-peptide) (His3 1/24) (Histatin-3 1/24) (Histatin-5); His3-(20-32)-peptide (His3 20/32) (His3-(1-13)-peptide) (His3 1/13) (Histatin-3 1/13); His3-(20-31)-peptide (His3 20/31) (His3-(1-12)-peptide) (His3 1/12) (Histatin-3 1/12); His3-(20-30)-peptide (His3 20/30) (His3-(1-11)-peptide) (His3 1/11) (Histatin-3 1/11); His3-(24-32)-peptide (His3 24/32) (His3-(5-13)-peptide) (His3 5/13) (Histatin-3 5/13); His3-(24-31)-peptide (His3 24/31) (His3-(5-12)-peptide) (His3 5/12) (Histatin-11) (Histatin-3 5/12); His3-(24-30)-peptide (His3 24/30) (His3-(5-11)-peptide) (His3 5/11) (Histatin-12) (Histatin-3 5/11); His3-(25-32)-peptide (His3 25/32) (His3-(6-13)-peptide) (His3 6/13) (Histatin-3 6/13); His3-(25-30)-peptide (His3 25/30) (His3-(6-11)-peptide) (His3 6/11) (Histatin-3 6/11); His3-(26-32)-peptide (His3 26/32) (His3-(7-13)-peptide) (His3 7/13) (Histatin-3 7/13); His3-(26-31)-peptide (His3 26/31) (His3-(7-12)-peptide) (His3 7/12) (Histatin-3 7/12); His3-(26-30)-peptide (His3 26/30) (His3-(7-11)-peptide) (His3 7/11) (Histatin-3 7/11); His3-(31-51)-peptide (His3 31/51) (His3-(12-32)-peptide) (His3 12/32) (Histatin-3 12/32) (Histatin-4); His3-(31-44)-peptide (His3 31/44) (His3-(12-25)-peptide) (His3 12/25) (Histatin-3 12/25) (Histatin-9); His3-(31-43)-peptide (His3 31/43) (His3-(12-24)-peptide) (His3 12/24) (Histatin-3 12/24) (Histatin-7); His3-(32-44)-peptide (His3 32/44) (His3-(13-25)-peptide) (His3 13/25) (Histatin-10) (Histatin-3 13/25); His3-(32-43)-peptide (His3 32-43) (His3-(13-24)-peptide) (His3 13/24) (Histatin-3 13/24) (Histatin-8); His3-(33-44)-peptide (His3 33/44) (His3-(14-25)-peptide) (His3 14/25) (Histatin-3 14/25); His3-(33-43)-peptide (His3 33/43) (His3-(14-24)-peptide) (His3 14/24) (Histatin-3 14/24); His3-(34-44)-peptide (His3 34/44) (His3-(15-25)-peptide) (His3 15/25) (Histatin-3 15/25); His3-(34-43)-peptide (His3 34/43) (His3-(15-24)-peptide) (His3 15/24) (Histatin-3 15/24); His3-(45-51)-peptide (His3 45/51) (His3-(26-32)-peptide) (His3 26/32) (Histatin-3 26/32); His3-(47-51)-peptide (His3 47/51) (His3-(28-32)-peptide) (His3 28/32) (Histatin-3 28/32); His3-(48-51)-peptide (His3 48/51) (His3-(29-32)-peptide) (His3 29/32) (Histatin-3 29/32)],51,"6,149",5 out of 5,1990-04-01,Evidence at protein level
Q14527,HLTF_HUMAN,Helicase-like transcription factor (EC 2.3.2.27) (EC 3.6.4.-) (DNA-binding protein/plasminogen activator inhibitor 1 regulator) (HIP116) (RING finger protein 80) (RING-type E3 ubiquitin transferase HLTF) (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 3) (Sucrose nonfermenting protein 2-like 3),1009,"113,929",5 out of 5,2005-03-01,Evidence at protein level
O15347,HMGB3_HUMAN,High mobility group protein B3 (High mobility group protein 2a) (HMG-2a) (High mobility group protein 4) (HMG-4),200,"22,980",5 out of 5,2002-03-27,Evidence at protein level
P05114,HMGN1_HUMAN,Non-histone chromosomal protein HMG-14 (High mobility group nucleosome-binding domain-containing protein 1),100,"10,659",5 out of 5,1987-08-13,Evidence at protein level
P0CJ69,HMN2_HUMAN,Humanin-like 2 (HN2) (MT-RNR2-like protein 2),28,"3,081",2 out of 5,2011-02-08,Evidence at transcript level
P0CJ76,HMN9_HUMAN,Humanin-like 9 (HN9) (MT-RNR2-like protein 9),24,"2,694",2 out of 5,2011-02-08,Evidence at transcript level
A2RU54,HMX2_HUMAN,Homeobox protein HMX2 (Homeobox protein H6 family member 2),273,"29,598",3 out of 5,2007-07-10,Evidence at transcript level
A6NHT5,HMX3_HUMAN,Homeobox protein HMX3 (Homeobox protein H6 family member 3) (Homeobox protein Nkx-5.1),357,"37,825",3 out of 5,2008-06-10,Evidence at protein level
P0DMR1,HNRC4_HUMAN,Heterogeneous nuclear ribonucleoprotein C-like 4,293,"32,029",2 out of 5,2014-11-26,Inferred from homology
Q8WVV9,HNRLL_HUMAN,Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) (Stromal RNA-regulating factor),542,"60,083",5 out of 5,2005-03-29,Evidence at protein level
Q00839,HNRPU_HUMAN,Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (Scaffold attachment factor A) (SAF-A) (p120) (pp120),825,"90,584",5 out of 5,1993-04-01,Evidence at protein level
P37235,HPCL1_HUMAN,Hippocalcin-like protein 1 (Calcium-binding protein BDR-1) (HLP2) (Visinin-like protein 3) (VILIP-3),193,"22,313",5 out of 5,1994-10-01,Evidence at protein level
Q9NWW9,HRSL2_HUMAN,HRAS-like suppressor 2 (EC 2.3.1.-) (EC 3.1.1.-),162,"17,394",5 out of 5,2002-09-19,Evidence at protein level
O14792,HS3S1_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 1 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 1) (3-OST-1) (Heparan sulfate 3-O-sulfotransferase 1) (h3-OST-1),307,"35,773",5 out of 5,2005-03-15,Evidence at protein level
O75031,HSF2B_HUMAN,Heat shock factor 2-binding protein,334,"37,645",5 out of 5,2000-05-30,Evidence at protein level
Q9UBD0,HSFX1_HUMAN,"Heat shock transcription factor, X-linked",423,"46,742",3 out of 5,2008-06-10,Evidence at protein level
Q96MH2,HEXI2_HUMAN,Protein HEXIM2 (Hexamethylene bis-acetamide-inducible protein 2),286,"32,419",5 out of 5,2007-10-02,Evidence at protein level
Q9Y5J3,HEY1_HUMAN,Hairy/enhancer-of-split related with YRPW motif protein 1 (Cardiovascular helix-loop-helix factor 2) (CHF-2) (Class B basic helix-loop-helix protein 31) (bHLHb31) (HES-related repressor protein 1) (Hairy and enhancer of split-related protein 1) (HESR-1) (Hairy-related transcription factor 1) (HRT-1) (hHRT1),304,"32,613",5 out of 5,2001-02-21,Evidence at protein level
P49773,HINT1_HUMAN,Histidine triad nucleotide-binding protein 1 (EC 3.-.-.-) (Adenosine 5'-monophosphoramidase) (Protein kinase C inhibitor 1) (Protein kinase C-interacting protein 1) (PKCI-1),126,"13,802",5 out of 5,1996-10-01,Evidence at protein level
Q9NQE9,HINT3_HUMAN,Histidine triad nucleotide-binding protein 3 (HINT-3) (EC 3.-.-.-),182,"20,361",5 out of 5,2008-03-18,Evidence at protein level
Q96JK4,HIPL1_HUMAN,HHIP-like protein 1,782,"86,731",3 out of 5,2008-01-15,Evidence at transcript level
A0A0C4DH62,HJ01_HUMAN,Immunoglobulin heavy joining 1,17,"1,910",2 out of 5,2017-03-15,Predicted
P17693,HLAG_HUMAN,"HLA class I histocompatibility antigen, alpha chain G (HLA G antigen) (MHC class I antigen G)",338,"38,224",5 out of 5,1990-08-01,Evidence at protein level
P54868,HMCS2_HUMAN,"Hydroxymethylglutaryl-CoA synthase, mitochondrial (HMG-CoA synthase) (EC 2.3.3.10) (3-hydroxy-3-methylglutaryl coenzyme A synthase)",508,"56,635",5 out of 5,1996-10-01,Evidence at protein level
P17096,HMGA1_HUMAN,High mobility group protein HMG-I/HMG-Y (HMG-I(Y)) (High mobility group AT-hook protein 1) (High mobility group protein A1) (High mobility group protein R),107,"11,676",5 out of 5,1990-08-01,Evidence at protein level
Q86X24,HORM1_HUMAN,HORMA domain-containing protein 1 (Cancer/testis antigen 46) (CT46) (Newborn ovary HORMA protein),394,"45,200",5 out of 5,2007-04-17,Evidence at transcript level
Q969F9,HPS3_HUMAN,Hermansky-Pudlak syndrome 3 protein,1004,"113,736",4 out of 5,2002-05-10,Evidence at protein level
Q9HDD0,HRSL1_HUMAN,Phospholipid-metabolizing enzyme A-C1 (EC 2.3.1.-) (EC 3.1.1.-) (HRAS-like suppressor 1) (HRSL1),168,"18,750",3 out of 5,2002-01-31,Evidence at transcript level
Q96KN8,HRSL5_HUMAN,Ca(2+)-independent N-acyltransferase (iNAT) (EC 2.3.1.-) (H-rev107-like protein 5) (HRAS-like suppressor 5) (HRSL5),279,"30,312",4 out of 5,2002-01-31,Evidence at protein level
P34931,HS71L_HUMAN,Heat shock 70 kDa protein 1-like (Heat shock 70 kDa protein 1L) (Heat shock 70 kDa protein 1-Hom) (HSP70-Hom),641,"70,375",5 out of 5,1994-02-01,Evidence at protein level
C9JCN9,HSBPL_HUMAN,Heat shock factor-binding protein 1-like protein 1,74,"8,384",2 out of 5,2010-06-15,Inferred from homology
Q8TB92,HMGC2_HUMAN,"3-hydroxymethyl-3-methylglutaryl-CoA lyase, cytoplasmic (EC 4.1.3.4) (3-hydroxymethyl-3-methylglutaryl-CoA lyase-like protein 1) (Endoplasmic reticulum 3-hydroxymethyl-3-methylglutaryl-CoA lyase) (er-cHL)",370,"39,514",5 out of 5,2008-05-20,Evidence at protein level
P0CJ74,HMN7_HUMAN,Humanin-like 7 (HN7) (MT-RNR2-like protein 7),24,"2,647",2 out of 5,2011-02-08,Evidence at transcript level
P30519,HMOX2_HUMAN,Heme oxygenase 2 (HO-2) (EC 1.14.14.18),316,"36,033",5 out of 5,1993-04-01,Evidence at protein level
Q9H910,HN1L_HUMAN,Hematological and neurological expressed 1-like protein (HN1-like protein),190,"20,063",3 out of 5,2005-07-19,Evidence at protein level
B2RXH8,HNRC2_HUMAN,Heterogeneous nuclear ribonucleoprotein C-like 2 (hnRNP C-like-2),293,"32,072",3 out of 5,2014-10-01,Evidence at protein level
P31943,HNRH1_HUMAN,"Heterogeneous nuclear ribonucleoprotein H (hnRNP H) [Cleaved into: Heterogeneous nuclear ribonucleoprotein H, N-terminally processed]",449,"49,229",5 out of 5,1993-07-01,Evidence at protein level
A8MVJ9,HPF1L_HUMAN,Putative histone PARylation factor 1-like,347,"39,722",1 out of 5,2008-07-01,Uncertain
Q6MZM0,HPHL1_HUMAN,Hephaestin-like protein 1 (EC 1.-.-.-),1159,"131,603",4 out of 5,2008-09-02,Evidence at transcript level
Q96S86,HPLN3_HUMAN,Hyaluronan and proteoglycan link protein 3,360,"40,894",3 out of 5,2004-05-24,Evidence at transcript level
Q92902,HPS1_HUMAN,Hermansky-Pudlak syndrome 1 protein,700,"79,292",5 out of 5,1998-12-15,Evidence at protein level
P00738,HPT_HUMAN,Haptoglobin (Zonulin) [Cleaved into: Haptoglobin alpha chain; Haptoglobin beta chain],406,"45,205",5 out of 5,1986-07-21,Evidence at protein level
P13985,HRES1_HUMAN,Putative HTLV-1-related endogenous sequence (p25),223,"24,343",1 out of 5,2008-02-05,Uncertain
Q9Y662,HS3SB_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1 (EC 2.8.2.30) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 3B1) (3-OST-3B) (Heparan sulfate 3-O-sulfotransferase 3B1) (h3-OST-3B),390,"43,324",5 out of 5,2005-03-15,Evidence at protein level
O95757,HS74L_HUMAN,Heat shock 70 kDa protein 4L (Heat shock 70-related protein APG-1) (Osmotic stress protein 94),839,"94,512",3 out of 5,2000-05-30,Evidence at protein level
Q14568,HS902_HUMAN,Heat shock protein HSP 90-alpha A2 (Heat shock 90 kDa protein 1 alpha-like 3) (Heat shock protein HSP 90-alpha A2 pseudogene),343,"39,365",3 out of 5,2008-03-18,Evidence at protein level
Q03933,HSF2_HUMAN,Heat shock factor protein 2 (HSF 2) (Heat shock transcription factor 2) (HSTF 2),536,"60,348",5 out of 5,1994-02-01,Evidence at protein level
Q9BQS6,HSPB9_HUMAN,Heat shock protein beta-9 (HspB9) (Cancer/testis antigen 51) (CT51),159,"17,486",3 out of 5,2004-04-26,Evidence at protein level
P57058,HUNK_HUMAN,Hormonally up-regulated neu tumor-associated kinase (EC 2.7.11.1) (B19) (Serine/threonine-protein kinase MAK-V),714,"79,686",4 out of 5,2000-12-01,Evidence at transcript level
A0A0C4DH29,HV103_HUMAN,Immunoglobulin heavy variable 1-3,117,"13,008",4 out of 5,2016-11-30,Inferred from homology
P01743,HV146_HUMAN,Immunoglobulin heavy variable 1-46 (Ig heavy chain V-I region DOT) (Ig heavy chain V-I region HG3) (Ig heavy chain V-I region Mot),117,"12,933",5 out of 5,1986-07-21,Evidence at protein level
P01817,HV205_HUMAN,Immunoglobulin heavy variable 2-5 (Ig heavy chain V-II region HE) (Ig heavy chain V-II region MCE),119,"13,231",5 out of 5,1986-07-21,Evidence at protein level
P01780,HV307_HUMAN,Immunoglobulin heavy variable 3-7 (Ig heavy chain V-III region GAL) (Ig heavy chain V-III region GAR) (Ig heavy chain V-III region JON),117,"12,943",5 out of 5,1986-07-21,Evidence at protein level
A0A0B4J1V0,HV315_HUMAN,Immunoglobulin heavy variable 3-15,119,"12,926",4 out of 5,2016-11-30,Inferred from homology
P01768,HV330_HUMAN,Immunoglobulin heavy variable 3-30 (Ig heavy chain V-III region BUR) (Ig heavy chain V-III region CAM) (Ig heavy chain V-III region GA) (Ig heavy chain V-III region NIE),117,"12,947",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6Q5,HV364_HUMAN,Immunoglobulin heavy variable 3-64,118,"12,891",4 out of 5,2016-11-30,Inferred from homology
P0DP07,HV431_HUMAN,Immunoglobulin heavy variable 4-31,118,"13,095",3 out of 5,2017-04-12,Inferred from homology
A0A0B4J2H0,HV69D_HUMAN,Immunoglobulin heavy variable 1-69D,117,"12,660",4 out of 5,2017-04-12,Inferred from homology
P14653,HXB1_HUMAN,Homeobox protein Hox-B1 (Homeobox protein Hox-2I),301,"32,193",5 out of 5,1990-04-01,Evidence at protein level
P14652,HXB2_HUMAN,Homeobox protein Hox-B2 (Homeobox protein Hox-2.8) (Homeobox protein Hox-2H) (K8),356,"37,914",5 out of 5,1990-04-01,Evidence at protein level
P14651,HXB3_HUMAN,Homeobox protein Hox-B3 (Homeobox protein Hox-2.7) (Homeobox protein Hox-2G),431,"44,340",5 out of 5,1990-04-01,Evidence at transcript level
P31274,HXC9_HUMAN,Homeobox protein Hox-C9 (Homeobox protein Hox-3B),260,"29,248",4 out of 5,1993-07-01,Evidence at protein level
P28358,HXD10_HUMAN,Homeobox protein Hox-D10 (Homeobox protein Hox-4D) (Homeobox protein Hox-4E),340,"38,411",5 out of 5,1992-12-01,Evidence at protein level
P35557,HXK4_HUMAN,Glucokinase (EC 2.7.1.2) (Hexokinase type IV) (HK IV) (Hexokinase-4) (HK4) (Hexokinase-D),465,"52,191",5 out of 5,1994-06-01,Evidence at protein level
O43820,HYAL3_HUMAN,Hyaluronidase-3 (Hyal-3) (EC 3.2.1.35) (Hyaluronoglucosaminidase-3) (Lung carcinoma protein 3) (LuCa-3),417,"46,501",5 out of 5,2006-09-05,Evidence at protein level
Q2M3T9,HYAL4_HUMAN,Hyaluronidase-4 (Hyal-4) (EC 3.2.1.35) (Chondroitin sulfate endo-beta-N-acetylgalactosaminidase) (Chondroitin sulfate hydrolase) (CSHY) (Hyaluronoglucosaminidase-4),481,"54,249",5 out of 5,2007-09-11,Evidence at protein level
Q96QV1,HHIP_HUMAN,Hedgehog-interacting protein (HHIP) (HIP),700,"78,851",5 out of 5,2005-04-12,Evidence at protein level
Q6NVY1,HIBCH_HUMAN,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-hydroxyisobutyryl-coenzyme A hydrolase) (HIB-CoA hydrolase) (HIBYL-CoA-H)",386,"43,482",5 out of 5,2007-05-01,Evidence at protein level
Q9P298,HIG1B_HUMAN,HIG1 domain family member 1B (Protein CLST 11240),99,"11,058",2 out of 5,2005-09-27,Evidence at protein level
Q9BW72,HIG2A_HUMAN,"HIG1 domain family member 2A, mitochondrial (RCF1 homolog B) (RCF1b)",106,"11,529",4 out of 5,2005-09-27,Evidence at protein level
P60008,HILS1_HUMAN,Spermatid-specific linker histone H1-like protein,231,"25,632",5 out of 5,2003-11-14,Evidence at protein level
Q9BX68,HINT2_HUMAN,"Histidine triad nucleotide-binding protein 2, mitochondrial (HINT-2) (EC 3.-.-.-) (HINT-3) (HIT-17kDa) (PKCI-1-related HIT protein)",163,"17,162",5 out of 5,2004-08-31,Evidence at protein level
Q8WW32,HMGB4_HUMAN,High mobility group protein B4,186,"22,490",3 out of 5,2006-12-12,Evidence at protein level
P0CJ70,HMN3_HUMAN,Humanin-like 3 (HN3) (MT-RNR2-like protein 3),24,"2,796",2 out of 5,2011-02-08,Evidence at transcript level
P84074,HPCA_HUMAN,Neuron-specific calcium-binding protein hippocalcin (Calcium-binding protein BDR-2),193,"22,427",5 out of 5,2004-08-16,Evidence at protein level
Q9GZV7,HPLN2_HUMAN,Hyaluronan and proteoglycan link protein 2 (Brain link protein 1),340,"37,775",3 out of 5,2002-04-16,Evidence at transcript level
Q14774,HLX_HUMAN,H2.0-like homeobox protein (Homeobox protein HB24) (Homeobox protein HLX1),488,"50,789",5 out of 5,1997-11-01,Evidence at protein level
S4R3Y5,HMN11_HUMAN,Humanin-like 11 (HN11) (MT-RNR2-like protein 11),24,"2,737",2 out of 5,2014-11-26,Inferred from homology
P0C7T4,HMSDV_HUMAN,Minor histocompatibility protein HMSD variant form (HSMD-v) [Cleaved into: Minor histocompatibility antigen ACC-6 (mHA ACC-6)],53,"6,023",3 out of 5,2008-07-22,Evidence at protein level
Q9UK76,HN1_HUMAN,"Hematological and neurological expressed 1 protein (Androgen-regulated protein 2) [Cleaved into: Hematological and neurological expressed 1 protein, N-terminally processed]",154,"16,015",4 out of 5,2006-01-24,Evidence at protein level
Q9UBC0,HNF6_HUMAN,Hepatocyte nuclear factor 6 (HNF-6) (One cut domain family member 1) (One cut homeobox 1),465,"51,023",5 out of 5,2001-04-27,Evidence at transcript level
O14979,HNRDL_HUMAN,Heterogeneous nuclear ribonucleoprotein D-like (hnRNP D-like) (hnRNP DL) (AU-rich element RNA-binding factor) (JKT41-binding protein) (Protein laAUF1),420,"46,438",5 out of 5,2007-05-15,Evidence at protein level
P61978,HNRPK_HUMAN,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),463,"50,976",5 out of 5,2004-06-07,Evidence at protein level
O60506,HNRPQ_HUMAN,"Heterogeneous nuclear ribonucleoprotein Q (hnRNP Q) (Glycine- and tyrosine-rich RNA-binding protein) (GRY-RBP) (NS1-associated protein 1) (Synaptotagmin-binding, cytoplasmic RNA-interacting protein)",623,"69,603",5 out of 5,2004-03-01,Evidence at protein level
Q9NSC5,HOME3_HUMAN,Homer protein homolog 3 (Homer-3),361,"39,836",5 out of 5,2003-11-28,Evidence at protein level
Q8IX15,HOMEZ_HUMAN,Homeobox and leucine zipper protein Homez (Homeodomain leucine zipper-containing factor),550,"61,240",5 out of 5,2004-01-16,Evidence at protein level
P00492,HPRT_HUMAN,Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) (HGPRTase) (EC 2.4.2.8),218,"24,579",5 out of 5,1986-07-21,Evidence at protein level
Q96MM6,HS12B_HUMAN,Heat shock 70 kDa protein 12B,686,"75,688",2 out of 5,2003-01-10,Evidence at protein level
Q58FG1,HS904_HUMAN,Putative heat shock protein HSP 90-alpha A4 (Heat shock 90 kDa protein 1 alpha-like 2) (Heat shock protein 90-alpha D) (Heat shock protein 90Ad),418,"47,712",3 out of 5,2008-07-01,Uncertain
Q58FG0,HS905_HUMAN,Putative heat shock protein HSP 90-alpha A5 (Heat shock protein 90-alpha E) (Heat shock protein 90Ae),334,"38,738",3 out of 5,2008-06-10,Evidence at transcript level
P07900,HS90A_HUMAN,Heat shock protein HSP 90-alpha (Heat shock 86 kDa) (HSP 86) (HSP86) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38),732,"84,660",5 out of 5,1988-08-01,Evidence at protein level
Q9UBX0,HESX1_HUMAN,Homeobox expressed in ES cells 1 (Homeobox protein ANF) (hAnf),185,"21,409",5 out of 5,2001-01-11,Evidence at protein level
Q8WVB3,HEXDC_HUMAN,Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase),486,"53,790",4 out of 5,2008-02-05,Evidence at transcript level
Q68CP4,HGNAT_HUMAN,Heparan-alpha-glucosaminide N-acetyltransferase (EC 2.3.1.78) (Transmembrane protein 76),663,"73,293",5 out of 5,2007-01-23,Evidence at protein level
O14964,HGS_HUMAN,Hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) (Protein pp110),777,"86,192",5 out of 5,2005-07-19,Evidence at protein level
A8MVS5,HIDE1_HUMAN,Protein HIDE1,230,"24,753",2 out of 5,2008-06-10,Evidence at transcript level
Q9NWT6,HIF1N_HUMAN,Hypoxia-inducible factor 1-alpha inhibitor (EC 1.14.11.30) (EC 1.14.11.n4) (Factor inhibiting HIF-1) (FIH-1) (Hypoxia-inducible factor asparagine hydroxylase),349,"40,285",5 out of 5,2003-06-16,Evidence at protein level
Q9H2X6,HIPK2_HUMAN,Homeodomain-interacting protein kinase 2 (hHIPk2) (EC 2.7.11.1),1198,"130,966",5 out of 5,2001-04-27,Evidence at protein level
P54198,HIRA_HUMAN,Protein HIRA (TUP1-like enhancer of split protein 1),1017,"111,835",5 out of 5,1996-10-01,Evidence at protein level
P13747,HLAE_HUMAN,"HLA class I histocompatibility antigen, alpha chain E (MHC class I antigen E)",358,"40,157",5 out of 5,1990-01-01,Evidence at protein level
P01893,HLAH_HUMAN,"Putative HLA class I histocompatibility antigen, alpha chain H (HLA-12.4) (HLA-AR) (MHC class I antigen H)",362,"40,892",5 out of 5,1986-07-21,Uncertain
P0DMP1,HMN12_HUMAN,Humanin-like 12 (HN12) (MT-RNR2-like protein 12),27,"2,961",2 out of 5,2014-10-01,Inferred from homology
P35680,HNF1B_HUMAN,Hepatocyte nuclear factor 1-beta (HNF-1-beta) (HNF-1B) (Homeoprotein LFB3) (Transcription factor 2) (TCF-2) (Variant hepatic nuclear factor 1) (vHNF1),557,"61,324",5 out of 5,1994-06-01,Evidence at protein level
Q9UJC3,HOOK1_HUMAN,Protein Hook homolog 1 (h-hook1) (hHK1),728,"84,648",5 out of 5,2004-02-02,Evidence at protein level
Q9P2W1,HOP2_HUMAN,Homologous-pairing protein 2 homolog (Nuclear receptor coactivator GT198) (PSMC3-interacting protein) (Proteasome 26S ATPase subunit 3-interacting protein) (Tat-binding protein 1-interacting protein) (TBP-1-interacting protein),217,"24,906",5 out of 5,2008-01-15,Evidence at protein level
Q86YZ3,HORN_HUMAN,Hornerin,2850,"282,390",5 out of 5,2004-03-15,Evidence at protein level
P0CJ68,HMN1_HUMAN,Humanin-like 1 (HN1) (MT-RNR2-like protein 1),24,"2,691",2 out of 5,2011-02-08,Evidence at transcript level
B7ZW38,HNRC3_HUMAN,Heterogeneous nuclear ribonucleoprotein C-like 3,293,"32,029",2 out of 5,2014-11-26,Evidence at transcript level
P55795,HNRH2_HUMAN,"Heterogeneous nuclear ribonucleoprotein H2 (hnRNP H2) (FTP-3) (Heterogeneous nuclear ribonucleoprotein H') (hnRNP H') [Cleaved into: Heterogeneous nuclear ribonucleoprotein H2, N-terminally processed]",449,"49,264",5 out of 5,1997-11-01,Evidence at protein level
Q86XE5,HOGA1_HUMAN,"4-hydroxy-2-oxoglutarate aldolase, mitochondrial (EC 4.1.3.16) (Dihydrodipicolinate synthase-like) (DHDPS-like protein) (Probable 2-keto-4-hydroxyglutarate aldolase) (Probable KHG-aldolase) (Protein 569272)",327,"35,249",5 out of 5,2007-01-23,Evidence at protein level
P10915,HPLN1_HUMAN,Hyaluronan and proteoglycan link protein 1 (Cartilage-linking protein 1) (Cartilage-link protein) (Proteoglycan link protein),354,"40,166",4 out of 5,1989-07-01,Evidence at transcript level
Q86UW8,HPLN4_HUMAN,Hyaluronan and proteoglycan link protein 4 (Brain link protein 2),402,"42,801",3 out of 5,2004-05-24,Evidence at transcript level
Q9NQG7,HPS4_HUMAN,Hermansky-Pudlak syndrome 4 protein (Light-ear protein homolog),708,"76,919",5 out of 5,2002-06-06,Evidence at protein level
P04196,HRG_HUMAN,Histidine-rich glycoprotein (Histidine-proline-rich glycoprotein) (HPRG),525,"59,578",5 out of 5,1987-03-20,Evidence at protein level
P35367,HRH1_HUMAN,Histamine H1 receptor (H1R) (HH1R),487,"55,784",5 out of 5,1994-06-01,Evidence at protein level
Q8IZT8,HS3S5_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 5 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 5) (3-OST-5) (Heparan sulfate 3-O-sulfotransferase 5) (h3-OST-5),346,"40,408",5 out of 5,2005-03-15,Evidence at protein level
Q9ULV5,HSF4_HUMAN,Heat shock factor protein 4 (HSF 4) (hHSF4) (Heat shock transcription factor 4) (HSTF 4),492,"53,011",5 out of 5,2001-01-11,Evidence at protein level
P42357,HUTH_HUMAN,Histidine ammonia-lyase (Histidase) (EC 4.3.1.3),657,"72,698",5 out of 5,1995-11-01,Evidence at protein level
A0A0C4DH33,HV124_HUMAN,Immunoglobulin heavy variable 1-24,117,"12,824",4 out of 5,2016-11-30,Inferred from homology
A0A0B4J1V2,HV226_HUMAN,Immunoglobulin heavy variable 2-26,119,"13,182",4 out of 5,2016-11-30,Inferred from homology
P01766,HV313_HUMAN,Immunoglobulin heavy variable 3-13 (Ig heavy chain V-III region BRO),116,"12,506",5 out of 5,1986-07-21,Evidence at protein level
P0DP03,HV335_HUMAN,Immunoglobulin heavy variable 3-30-5,117,"12,947",3 out of 5,2017-04-12,Inferred from homology
P01767,HV353_HUMAN,Immunoglobulin heavy variable 3-53 (Ig heavy chain V-III region BUT),116,"12,770",5 out of 5,1986-07-21,Evidence at protein level
A0A0C4DH34,HV428_HUMAN,Immunoglobulin heavy variable 4-28,117,"13,124",4 out of 5,2017-01-18,Inferred from homology
P26583,HMGB2_HUMAN,High mobility group protein B2 (High mobility group protein 2) (HMG-2),209,"24,034",5 out of 5,1992-08-01,Evidence at protein level
Q9UGU5,HMGX4_HUMAN,HMG domain-containing protein 4 (HMG box-containing protein 4) (High mobility group protein 2-like 1) (Protein HMGBCG),601,"65,712",3 out of 5,2001-01-24,Evidence at protein level
P0CJ75,HMN8_HUMAN,Humanin-like 8 (HN8) (MT-RNR2-like protein 8),24,"2,661",2 out of 5,2011-02-08,Evidence at transcript level
Q14103,HNRPD_HUMAN,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),355,"38,434",5 out of 5,2001-02-21,Evidence at protein level
Q86YM7,HOME1_HUMAN,Homer protein homolog 1 (Homer-1),354,"40,277",5 out of 5,2003-11-28,Evidence at protein level
Q9NSB8,HOME2_HUMAN,Homer protein homolog 2 (Homer-2) (Cupidin),354,"40,627",5 out of 5,2003-11-28,Evidence at protein level
Q5SSJ5,HP1B3_HUMAN,Heterochromatin protein 1-binding protein 3 (Protein HP1-BP74),553,"61,207",5 out of 5,2008-06-10,Evidence at protein level
Q8WWQ2,HPSE2_HUMAN,Inactive heparanase-2 (Hpa2),592,"66,596",5 out of 5,2005-10-25,Evidence at protein level
Q9BVR0,HRC23_HUMAN,Putative HERC2-like protein 3,1158,"128,943",2 out of 5,2008-09-02,Uncertain
Q9H3N8,HRH4_HUMAN,Histamine H4 receptor (H4R) (HH4R) (AXOR35) (G-protein coupled receptor 105) (GPRv53) (Pfi-013) (SP9144),390,"44,496",5 out of 5,2001-06-01,Evidence at protein level
O43301,HS12A_HUMAN,Heat shock 70 kDa protein 12A,675,"74,978",2 out of 5,2001-02-21,Evidence at protein level
Q7LGA3,HS2ST_HUMAN,Heparan sulfate 2-O-sulfotransferase 1 (2-O-sulfotransferase) (2OST) (EC 2.8.2.-),356,"41,881",4 out of 5,2005-06-21,Evidence at protein level
Q9Y278,HS3S2_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 2 (EC 2.8.2.29) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 2) (3-OST-2) (Heparan sulfate 3-O-sulfotransferase 2) (h3-OST-2),367,"41,501",5 out of 5,2005-03-15,Evidence at protein level
Q9Y661,HS3S4_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 4 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 4) (3-OST-4) (Heparan sulfate 3-O-sulfotransferase 4) (h3-OST-4),456,"49,799",4 out of 5,2005-03-15,Evidence at transcript level
Q96QI5,HS3S6_HUMAN,Heparan sulfate glucosamine 3-O-sulfotransferase 6 (EC 2.8.2.23) (Heparan sulfate D-glucosaminyl 3-O-sulfotransferase 6) (3-OST-6) (Heparan sulfate 3-O-sulfotransferase 6) (h3-OST-6),342,"37,186",4 out of 5,2005-03-15,Evidence at protein level
P0DMV9,HS71B_HUMAN,Heat shock 70 kDa protein 1B (Heat shock 70 kDa protein 2) (HSP70-2) (HSP70.2),641,"70,052",5 out of 5,2015-05-27,Evidence at protein level
P08238,HS90B_HUMAN,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84),724,"83,264",5 out of 5,1988-08-01,Evidence at protein level
Q86XA9,HTR5A_HUMAN,HEAT repeat-containing protein 5A,2040,"222,004",2 out of 5,2007-12-04,Evidence at protein level
Q8N9Z9,LMTD1_HUMAN,Lamin tail domain-containing protein 1 (Intermediate filament tail domain-containing protein 1),388,"43,408",3 out of 5,2008-02-05,Evidence at transcript level
Q86WA8,LONP2_HUMAN,"Lon protease homolog 2, peroxisomal (EC 3.4.21.-) (Lon protease-like protein 2) (Lon protease 2) (Peroxisomal Lon protease)",852,"94,617",5 out of 5,2007-05-15,Evidence at protein level
P23490,LORI_HUMAN,Loricrin,312,"25,761",5 out of 5,1991-11-01,Evidence at protein level
Q92633,LPAR1_HUMAN,Lysophosphatidic acid receptor 1 (LPA receptor 1) (LPA-1) (Lysophosphatidic acid receptor Edg-2),364,"41,109",5 out of 5,1997-11-01,Evidence at protein level
A6NIK2,LR10B_HUMAN,Leucine-rich repeat-containing protein 10B,292,"32,714",1 out of 5,2008-09-02,Predicted
Q9P2M1,LR2BP_HUMAN,LRP2-binding protein (Megalin-binding protein) (MegBP),347,"39,780",3 out of 5,2008-01-15,Evidence at protein level
Q1X8D7,LRC36_HUMAN,Leucine-rich repeat-containing protein 36 (ROR gamma-binding protein 70),754,"83,823",3 out of 5,2007-02-06,Evidence at transcript level
Q9BV99,LRC61_HUMAN,Leucine-rich repeat-containing protein 61,259,"28,014",2 out of 5,2006-05-30,Evidence at transcript level
A6NJW4,LRR3C_HUMAN,Leucine-rich repeat-containing protein 3C,275,"29,314",3 out of 5,2008-09-02,Evidence at transcript level
Q9BYS8,LRRC2_HUMAN,Leucine-rich repeat-containing protein 2,371,"42,943",2 out of 5,2002-10-10,Evidence at transcript level
A4D1F6,LRRD1_HUMAN,Leucine-rich repeat and death domain-containing protein 1,860,"98,035",2 out of 5,2008-03-18,Evidence at transcript level
Q32MZ4,LRRF1_HUMAN,Leucine-rich repeat flightless-interacting protein 1 (LRR FLII-interacting protein 1) (GC-binding factor 2) (TAR RNA-interacting protein),808,"89,253",5 out of 5,2006-09-05,Evidence at protein level
Q9UFC0,LRWD1_HUMAN,Leucine-rich repeat and WD repeat-containing protein 1 (Centromere protein 33) (CENP-33) (Origin recognition complex-associated protein) (ORC-associated protein) (ORCA),647,"70,861",5 out of 5,2007-11-13,Evidence at protein level
O15116,LSM1_HUMAN,U6 snRNA-associated Sm-like protein LSm1 (Cancer-associated Sm-like) (Small nuclear ribonuclear CaSm),133,"15,179",5 out of 5,2002-04-16,Evidence at protein level
Q9Y333,LSM2_HUMAN,U6 snRNA-associated Sm-like protein LSm2 (Protein G7b) (Small nuclear ribonuclear protein D homolog) (snRNP core Sm-like protein Sm-x5),95,"10,835",5 out of 5,2000-12-01,Evidence at protein level
P62312,LSM6_HUMAN,U6 snRNA-associated Sm-like protein LSm6,80,"9,128",5 out of 5,2004-07-05,Evidence at protein level
Q9BRA0,LSMD1_HUMAN,"N-alpha-acetyltransferase 38, NatC auxiliary subunit (LSM domain-containing protein 1) (Phosphonoformate immuno-associated protein 2)",125,"13,514",5 out of 5,2007-08-21,Evidence at protein level
Q8N8F7,LSME1_HUMAN,Leucine-rich single-pass membrane protein 1,131,"14,462",3 out of 5,2007-11-13,Evidence at protein level
Q9NQ29,LUC7L_HUMAN,Putative RNA-binding protein Luc7-like 1 (Putative SR protein LUC7B1) (SR+89),371,"43,728",4 out of 5,2004-05-10,Evidence at protein level
P01715,LV301_HUMAN,Immunoglobulin lambda variable 3-1 (Ig lambda chain V-IV region Bau) (Ig lambda chain V-IV region MOL) (Ig lambda chain V-IV region X),115,"12,296",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6I1,LV460_HUMAN,Immunoglobulin lambda variable 4-60,120,"12,987",3 out of 5,2017-01-18,Inferred from homology
Q16553,LY6E_HUMAN,Lymphocyte antigen 6E (Ly-6E) (Retinoic acid-induced gene E protein) (RIG-E) (Stem cell antigen 2) (SCA-2) (Thymic shared antigen 1) (TSA-1),131,"13,507",4 out of 5,2000-12-01,Evidence at transcript level
P16581,LYAM2_HUMAN,E-selectin (CD62 antigen-like family member E) (Endothelial leukocyte adhesion molecule 1) (ELAM-1) (Leukocyte-endothelial cell adhesion molecule 2) (LECAM2) (CD antigen CD62E),610,"66,655",5 out of 5,1990-08-01,Evidence at protein level
P28300,LYOX_HUMAN,Protein-lysine 6-oxidase (EC 1.4.3.13) (Lysyl oxidase),417,"46,944",5 out of 5,1992-12-01,Evidence at protein level
Q9HD34,LYRM4_HUMAN,LYR motif-containing protein 4,91,"10,758",5 out of 5,2004-04-26,Evidence at protein level
P61626,LYSC_HUMAN,"Lysozyme C (EC 3.2.1.17) (1,4-beta-N-acetylmuramidase C)",148,"16,537",5 out of 5,1986-07-21,Evidence at protein level
Q9Y5Y7,LYVE1_HUMAN,Lymphatic vessel endothelial hyaluronic acid receptor 1 (LYVE-1) (Cell surface retention sequence-binding protein 1) (CRSBP-1) (Extracellular link domain-containing protein 1) (Hyaluronic acid receptor),322,"35,213",5 out of 5,2006-10-03,Evidence at protein level
Q6UWQ5,LYZL1_HUMAN,Lysozyme-like protein 1 (EC 3.2.1.17),148,"16,654",3 out of 5,2006-06-27,Evidence at transcript level
O75951,LYZL6_HUMAN,Lysozyme-like protein 6 (EC 3.2.1.17),148,"16,956",5 out of 5,2006-06-27,Evidence at protein level
Q9NQ48,LZTL1_HUMAN,Leucine zipper transcription factor-like protein 1,299,"34,592",5 out of 5,2008-02-26,Evidence at protein level
Q9UI17,M2GD_HUMAN,"Dimethylglycine dehydrogenase, mitochondrial (EC 1.5.8.4) (ME2GLYDH)",866,"96,811",5 out of 5,2000-12-01,Evidence at protein level
Q9NXJ0,M4A12_HUMAN,Membrane-spanning 4-domains subfamily A member 12,267,"28,069",3 out of 5,2003-04-04,Evidence at protein level
Q96JQ5,M4A4A_HUMAN,Membrane-spanning 4-domains subfamily A member 4A (CD20 antigen-like 1) (Four-span transmembrane protein 1),239,"25,441",4 out of 5,2003-05-09,Evidence at transcript level
O95819,M4K4_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 4 (EC 2.7.11.1) (HPK/GCK-like kinase HGK) (MAPK/ERK kinase kinase kinase 4) (MEK kinase kinase 4) (MEKKK 4) (Nck-interacting kinase),1239,"142,101",5 out of 5,2003-03-28,Evidence at protein level
P33908,MA1A1_HUMAN,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IA (EC 3.2.1.113) (Man(9)-alpha-mannosidase) (Man9-mannosidase) (Mannosidase alpha class 1A member 1) (Processing alpha-1,2-mannosidase IA) (Alpha-1,2-mannosidase IA)",653,"72,969",5 out of 5,1994-02-01,Evidence at protein level
Q9NTJ4,MA2C1_HUMAN,Alpha-mannosidase 2C1 (EC 3.2.1.24) (Alpha mannosidase 6A8B) (Alpha-D-mannoside mannohydrolase) (Mannosidase alpha class 2C member 1),1040,"115,835",5 out of 5,2003-01-27,Evidence at protein level
Q9H9H5,MA6D1_HUMAN,MAP6 domain-containing protein 1 (21 kDa STOP-like protein) (SL21),199,"21,005",4 out of 5,2007-01-09,Evidence at protein level
A1Z1Q3,MACD2_HUMAN,O-acetyl-ADP-ribose deacetylase MACROD2 (EC 3.2.2.-) (EC 3.5.1.-) (MACRO domain-containing protein 2) ([Protein ADP-ribosylglutamate] hydrolase),448,"50,050",5 out of 5,2007-09-11,Evidence at protein level
Q13477,MADCA_HUMAN,Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) (hMAdCAM-1),382,"40,155",5 out of 5,2004-02-02,Evidence at protein level
O15525,MAFG_HUMAN,Transcription factor MafG (V-maf musculoaponeurotic fibrosarcoma oncogene homolog G) (hMAF),162,"17,850",5 out of 5,2000-05-30,Evidence at protein level
P38571,LICH_HUMAN,Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase),399,"45,419",5 out of 5,1994-10-01,Evidence at protein level
P42702,LIFR_HUMAN,Leukemia inhibitory factor receptor (LIF receptor) (LIF-R) (CD antigen CD118),1097,"123,743",5 out of 5,1995-11-01,Evidence at protein level
Q6UY18,LIGO4_HUMAN,Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 4 (Leucine-rich repeat neuronal protein 6D),593,"63,774",3 out of 5,2008-03-18,Evidence at transcript level
P53667,LIMK1_HUMAN,LIM domain kinase 1 (LIMK-1) (EC 2.7.11.1),647,"72,585",5 out of 5,1996-10-01,Evidence at protein level
P0CW20,LIMS4_HUMAN,LIM and senescent cell antigen-like-containing domain protein 4 (LIM and senescent cell antigen-like-containing domain protein 3-like),117,"13,251",2 out of 5,2011-05-31,Evidence at protein level
Q9NUP9,LIN7C_HUMAN,Protein lin-7 homolog C (Lin-7C) (Mammalian lin-seven protein 3) (MALS-3) (Vertebrate lin-7 homolog 3) (Veli-3),197,"21,834",5 out of 5,2005-02-15,Evidence at protein level
Q5W064,LIPJ_HUMAN,Lipase member J (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 1),366,"42,388",2 out of 5,2007-05-29,Evidence at transcript level
Q5VYY2,LIPM_HUMAN,Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3),423,"48,233",4 out of 5,2007-05-15,Evidence at transcript level
Q5VXI9,LIPN_HUMAN,Lipase member N (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 4),398,"45,534",4 out of 5,2007-05-15,Evidence at transcript level
P54317,LIPR2_HUMAN,Pancreatic lipase-related protein 2 (PL-RP2) (EC 3.1.1.26) (EC 3.1.1.3) (Galactolipase),469,"51,947",5 out of 5,1996-10-01,Evidence at protein level
Q17RR3,LIPR3_HUMAN,Pancreatic lipase-related protein 3 (PL-RP3) (EC 3.1.1.3),467,"52,254",3 out of 5,2007-05-15,Evidence at transcript level
Q8N6C8,LIRA3_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 3 (CD85 antigen-like family member E) (Immunoglobulin-like transcript 6) (ILT-6) (Leukocyte immunoglobulin-like receptor 4) (LIR-4) (Monocyte inhibitory receptor HM43/HM31) (CD antigen CD85e),439,"47,472",5 out of 5,2003-10-03,Evidence at protein level
Q6PI73,LIRA6_HUMAN,Leukocyte immunoglobulin-like receptor subfamily A member 6 (Immunoglobulin-like transcript 8) (ILT-8) (Leukocyte Ig-like receptor),481,"52,399",4 out of 5,2007-07-10,Evidence at transcript level
Q8N423,LIRB2_HUMAN,Leukocyte immunoglobulin-like receptor subfamily B member 2 (LIR-2) (Leukocyte immunoglobulin-like receptor 2) (CD85 antigen-like family member D) (Immunoglobulin-like transcript 4) (ILT-4) (Monocyte/macrophage immunoglobulin-like receptor 10) (MIR-10) (CD antigen CD85d),598,"65,039",5 out of 5,2003-10-03,Evidence at protein level
A0A0A0MT76,LJ01_HUMAN,Immunoglobulin lambda joining 1,42,"4,776",2 out of 5,2017-03-15,Predicted
Q969R5,LMBL2_HUMAN,Lethal(3)malignant brain tumor-like protein 2 (H-l(3)mbt-like protein 2) (L(3)mbt-like protein 2),705,"79,110",5 out of 5,2003-01-10,Evidence at protein level
Q6P5Q4,LMOD2_HUMAN,Leiomodin-2 (Cardiac leiomodin) (C-LMOD) (Leiomodin),547,"61,675",5 out of 5,2007-11-13,Evidence at protein level
Q1L5Z9,LONF2_HUMAN,LON peptidase N-terminal domain and RING finger protein 2 (Neuroblastoma apoptosis-related protease) (RING finger protein 192),754,"83,654",3 out of 5,2007-02-20,Evidence at transcript level
Q96JB6,LOXL4_HUMAN,Lysyl oxidase homolog 4 (EC 1.4.3.-) (Lysyl oxidase-like protein 4) (Lysyl oxidase-related protein C),756,"84,483",5 out of 5,2002-04-16,Evidence at protein level
Q9BQK8,LPIN3_HUMAN,Phosphatidate phosphatase LPIN3 (EC 3.1.3.4) (Lipin-3) (Lipin-3-like),851,"93,614",5 out of 5,2002-10-10,Evidence at protein level
Q6ZQY2,LR74B_HUMAN,Leucine-rich repeat-containing protein 74B,392,"41,621",2 out of 5,2008-02-26,Evidence at transcript level
Q5VT99,LRC38_HUMAN,Leucine-rich repeat-containing protein 38 (BK channel auxiliary gamma subunit LRRC38),294,"32,082",4 out of 5,2007-12-04,Evidence at protein level
Q96PB8,LRC3B_HUMAN,Leucine-rich repeat-containing protein 3B (Leucine-rich repeat protein LRP15),259,"29,275",2 out of 5,2002-10-19,Evidence at protein level
Q8N1G4,LRC47_HUMAN,Leucine-rich repeat-containing protein 47,583,"63,473",3 out of 5,2006-02-21,Evidence at protein level
A6NJI9,LRC72_HUMAN,Leucine-rich repeat-containing protein 72,287,"33,656",1 out of 5,2008-09-02,Evidence at transcript level
O75427,LRCH4_HUMAN,Leucine-rich repeat and calponin homology domain-containing protein 4 (Leucine-rich repeat neuronal protein 4) (Leucine-rich neuronal protein),683,"73,450",4 out of 5,2004-06-21,Evidence at protein level
Q9ULH4,LRFN2_HUMAN,Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1),789,"84,731",5 out of 5,2005-03-29,Evidence at protein level
Q3SXY7,LRIT3_HUMAN,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3",679,"74,754",5 out of 5,2007-11-13,Evidence at protein level
P51884,LUM_HUMAN,Lumican (Keratan sulfate proteoglycan lumican) (KSPG lumican),338,"38,429",5 out of 5,1996-10-01,Evidence at protein level
Q8IV03,LUR1L_HUMAN,Leucine rich adaptor protein 1-like,231,"24,583",2 out of 5,2005-06-07,Evidence at protein level
Q86TE4,LUZP2_HUMAN,Leucine zipper protein 2,346,"38,958",3 out of 5,2008-01-15,Evidence at transcript level
Q9P127,LUZP4_HUMAN,Leucine zipper protein 4 (Cancer/testis antigen 28) (CT-28) (CT28) (Tumor antigen HOM-TES-85),313,"35,937",5 out of 5,2007-05-29,Evidence at protein level
P01704,LV214_HUMAN,Immunoglobulin lambda variable 2-14 (Ig lambda chain V-II region NIG-84) (Ig lambda chain V-II region TOG) (Ig lambda chain V-II region VIL),120,"12,597",5 out of 5,1986-07-21,Evidence at protein level
P80748,LV321_HUMAN,Immunoglobulin lambda variable 3-21 (Ig lambda chain V-III region LOI) (Ig lambda chain V-V region DEL) (Ig lambda chain V-VII region MOT),117,"12,446",5 out of 5,1999-07-15,Evidence at protein level
Q5U5X0,LYRM7_HUMAN,Complex III assembly factor LYRM7 (LYR motif-containing protein 7),104,"11,955",4 out of 5,2006-10-03,Evidence at protein level
Q8WZA0,LZIC_HUMAN,Protein LZIC (Leucine zipper and CTNNBIP1 domain-containing protein) (Leucine zipper and ICAT homologous domain-containing protein),190,"21,495",2 out of 5,2006-12-12,Evidence at protein level
P0DM35,M1BL1_HUMAN,Metallothionein 1H-like protein 1,61,"6,094",2 out of 5,2013-05-29,Inferred from homology
Q8IYB1,M21D2_HUMAN,Protein MB21D2 (Mab-21 domain-containing protein 2),491,"55,800",2 out of 5,2006-06-13,Evidence at protein level
Q8IWU2,LMTK2_HUMAN,Serine/threonine-protein kinase LMTK2 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase 2) (Brain-enriched kinase) (hBREK) (CDK5/p35-regulated kinase) (CPRK) (Kinase/phosphatase/inhibitor 2) (Lemur tyrosine kinase 2) (Serine/threonine-protein kinase KPI-2),1503,"164,900",5 out of 5,2006-10-31,Evidence at protein level
Q6ZN17,LN28B_HUMAN,Protein lin-28 homolog B (Lin-28B),250,"27,084",5 out of 5,2006-10-17,Evidence at protein level
O00370,LORF2_HUMAN,LINE-1 retrotransposable element ORF2 protein (ORF2p) [Includes: Reverse transcriptase (EC 2.7.7.49); Endonuclease (EC 3.1.21.-)],1275,"149,012",5 out of 5,2014-01-22,Evidence at protein level
Q08397,LOXL1_HUMAN,Lysyl oxidase homolog 1 (EC 1.4.3.-) (Lysyl oxidase-like protein 1) (LOL),574,"63,110",5 out of 5,2001-04-27,Evidence at protein level
Q9Y4K0,LOXL2_HUMAN,Lysyl oxidase homolog 2 (EC 1.4.3.13) (Lysyl oxidase-like protein 2) (Lysyl oxidase-related protein 2) (Lysyl oxidase-related protein WS9-14),774,"86,725",5 out of 5,2001-04-27,Evidence at protein level
Q8NI32,LPD6B_HUMAN,Ly6/PLAUR domain-containing protein 6B,183,"20,656",3 out of 5,2008-02-26,Evidence at transcript level
Q9BY71,LRRC3_HUMAN,Leucine-rich repeat-containing protein 3,257,"28,108",3 out of 5,2001-10-18,Evidence at protein level
Q96NW7,LRRC7_HUMAN,Leucine-rich repeat-containing protein 7 (Densin-180) (Densin) (Protein LAP1),1537,"172,581",5 out of 5,2004-07-19,Evidence at protein level
Q38SD2,LRRK1_HUMAN,Leucine-rich repeat serine/threonine-protein kinase 1 (EC 2.7.11.1),2015,"225,393",5 out of 5,2006-05-02,Evidence at protein level
Q5S007,LRRK2_HUMAN,Leucine-rich repeat serine/threonine-protein kinase 2 (EC 2.7.11.1) (Dardarin),2527,"286,103",5 out of 5,2006-01-24,Evidence at protein level
P83369,LSM11_HUMAN,U7 snRNA-associated Sm-like protein LSm11,360,"39,500",5 out of 5,2003-10-10,Evidence at protein level
P62310,LSM3_HUMAN,U6 snRNA-associated Sm-like protein LSm3,102,"11,845",5 out of 5,2004-07-05,Evidence at protein level
P33241,LSP1_HUMAN,Lymphocyte-specific protein 1 (47 kDa actin-binding protein) (52 kDa phosphoprotein) (pp52) (Lymphocyte-specific antigen WP34),339,"37,192",5 out of 5,1994-02-01,Evidence at protein level
O00453,LST1_HUMAN,Leukocyte-specific transcript 1 protein (Protein B144),97,"10,792",5 out of 5,2003-08-22,Evidence at protein level
Q0VGL1,LTOR4_HUMAN,"Ragulator complex protein LAMTOR4 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 4) [Cleaved into: Ragulator complex protein LAMTOR4, N-terminally processed]",99,"10,741",5 out of 5,2008-03-18,Evidence at protein level
P01699,LV144_HUMAN,Immunoglobulin lambda variable 1-44 (Ig lambda chain V-I region MEM) (Ig lambda chain V-I region VOR),117,"12,201",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6J6,LV322_HUMAN,Immunoglobulin lambda variable 3-22,115,"12,549",3 out of 5,2017-01-18,Inferred from homology
A0A0A0MRZ9,LV552_HUMAN,Immunoglobulin lambda variable 5-52,124,"13,446",3 out of 5,2017-01-18,Inferred from homology
P04211,LV743_HUMAN,Immunoglobulin lambda variable 7-43 (Ig lambda chain V region 4A),117,"12,451",5 out of 5,1987-03-20,Inferred from homology
Q17RY6,LY6K_HUMAN,Lymphocyte antigen 6K (Ly-6K),165,"18,673",5 out of 5,2008-05-20,Evidence at protein level
O95711,LY86_HUMAN,Lymphocyte antigen 86 (Ly-86) (Protein MD-1),162,"17,906",5 out of 5,2002-03-27,Evidence at protein level
Q9HBG7,LY9_HUMAN,T-lymphocyte surface antigen Ly-9 (Cell surface molecule Ly-9) (Lymphocyte antigen 9) (SLAM family member 3) (SLAMF3) (Signaling lymphocytic activation molecule 3) (CD antigen CD229),655,"72,139",5 out of 5,2002-06-20,Evidence at protein level
O75608,LYPA1_HUMAN,Acyl-protein thioesterase 1 (APT-1) (hAPT1) (EC 3.1.2.-) (Lysophospholipase 1) (Lysophospholipase I) (LPL-I) (LysoPLA I),230,"24,670",5 out of 5,2004-01-16,Evidence at protein level
Q6UWN0,LYPD4_HUMAN,Ly6/PLAUR domain-containing protein 4,246,"26,763",3 out of 5,2006-03-07,Evidence at transcript level
Q6UX82,LYPD8_HUMAN,Ly6/PLAUR domain-containing protein 8,237,"25,265",4 out of 5,2008-02-05,Evidence at protein level
Q8N653,LZTR1_HUMAN,Leucine-zipper-like transcriptional regulator 1 (LZTR-1),840,"94,719",5 out of 5,2003-04-11,Evidence at protein level
Q9Y250,LZTS1_HUMAN,Leucine zipper putative tumor suppressor 1 (F37/esophageal cancer-related gene-coding leucine-zipper motif) (Fez1),596,"66,613",5 out of 5,2004-04-13,Evidence at protein level
Q9BXT6,M10L1_HUMAN,RNA helicase Mov10l1 (EC 3.6.4.13) (Moloney leukemia virus 10-like protein 1) (MOV10-like protein 1),1211,"135,293",5 out of 5,2002-08-02,Evidence at transcript level
Q99558,M3K14_HUMAN,Mitogen-activated protein kinase kinase kinase 14 (EC 2.7.11.25) (NF-kappa-beta-inducing kinase) (HsNIK) (Serine/threonine-protein kinase NIK),947,"104,042",5 out of 5,2001-06-01,Evidence at protein level
Q56UN5,M3K19_HUMAN,"Mitogen-activated protein kinase kinase kinase 19 (EC 2.7.11.1) (Regulated in COPD, protein kinase) (SPS1/STE20-related protein kinase YSK4)",1328,"150,537",5 out of 5,2006-04-18,Evidence at transcript level
Q99759,M3K3_HUMAN,Mitogen-activated protein kinase kinase kinase 3 (EC 2.7.11.25) (MAPK/ERK kinase kinase 3) (MEK kinase 3) (MEKK 3),626,"70,898",5 out of 5,1997-11-01,Evidence at protein level
O95382,M3K6_HUMAN,Mitogen-activated protein kinase kinase kinase 6 (EC 2.7.11.25) (Apoptosis signal-regulating kinase 2),1288,"142,596",5 out of 5,2000-05-30,Evidence at protein level
P57077,M3KCL_HUMAN,MAP3K7 C-terminal-like protein (TAK1-like protein),242,"27,248",4 out of 5,2000-12-01,Evidence at protein level
Q8N5U1,M4A15_HUMAN,Membrane-spanning 4-domains subfamily A member 15,240,"25,050",2 out of 5,2008-02-26,Evidence at transcript level
Q96PG1,M4A4E_HUMAN,Putative membrane-spanning 4-domains subfamily A member 4E,132,"15,209",2 out of 5,2003-05-09,Evidence at transcript level
Q8IVH8,M4K3_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 3 (EC 2.7.11.1) (Germinal center kinase-related protein kinase) (GLK) (MAPK/ERK kinase kinase kinase 3) (MEK kinase kinase 3) (MEKKK 3),894,"101,316",5 out of 5,2003-03-28,Evidence at protein level
Q9NR34,MA1C1_HUMAN,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC (EC 3.2.1.113) (HMIC) (Mannosidase alpha class 1C member 1) (Processing alpha-1,2-mannosidase IC) (Alpha-1,2-mannosidase IC)",630,"70,911",5 out of 5,2001-11-16,Evidence at protein level
Q9Y2E5,MA2B2_HUMAN,Epididymis-specific alpha-mannosidase (EC 3.2.1.24) (Mannosidase alpha class 2B member 2),1009,"113,979",5 out of 5,2001-11-16,Evidence at protein level
O60336,MABP1_HUMAN,Mitogen-activated protein kinase-binding protein 1 (JNK-binding protein 1) (JNKBP-1),1514,"163,818",5 out of 5,2008-05-20,Evidence at protein level
Q9Y5Q3,MAFB_HUMAN,Transcription factor MafB (Maf-B) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog B),323,"35,792",5 out of 5,2002-07-11,Evidence at protein level
P43363,MAGAA_HUMAN,Melanoma-associated antigen 10 (Cancer/testis antigen 1.10) (CT1.10) (MAGE-10 antigen),369,"40,780",3 out of 5,1995-11-01,Evidence at transcript level
Q8N7X4,MAGB6_HUMAN,Melanoma-associated antigen B6 (Cancer/testis antigen 3.4) (CT3.4) (MAGE-B6 antigen),407,"43,992",2 out of 5,2004-01-16,Evidence at protein level
Q9Y5V3,MAGD1_HUMAN,Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog),778,"86,161",5 out of 5,2001-01-24,Evidence at protein level
Q9H213,MAGH1_HUMAN,Melanoma-associated antigen H1 (Apoptosis-related protein 1) (APR-1) (MAGE-H1 antigen) (Restin),219,"24,441",3 out of 5,2001-06-20,Evidence at protein level
Q9H6Y5,MAGIX_HUMAN,PDZ domain-containing protein MAGIX,334,"35,217",2 out of 5,2007-11-13,Evidence at protein level
P09848,LPH_HUMAN,Lactase-phlorizin hydrolase (Lactase-glycosylceramidase) [Includes: Lactase (EC 3.2.1.108); Phlorizin hydrolase (EC 3.2.1.62)],1927,"218,587",5 out of 5,1989-07-01,Evidence at protein level
Q93052,LPP_HUMAN,Lipoma-preferred partner (LIM domain-containing preferred translocation partner in lipoma),612,"65,746",5 out of 5,2005-11-22,Evidence at protein level
A6NHZ5,LR14B_HUMAN,Leucine-rich repeat-containing protein 14B,514,"56,758",2 out of 5,2008-07-22,Inferred from homology
Q9C0I9,LRC27_HUMAN,Leucine-rich repeat-containing protein 27,530,"60,089",3 out of 5,2006-01-24,Evidence at transcript level
Q8N9N7,LRC57_HUMAN,Leucine-rich repeat-containing protein 57,239,"26,754",3 out of 5,2006-03-21,Evidence at protein level
Q6ZNQ3,LRC69_HUMAN,Leucine-rich repeat-containing protein 69,347,"39,592",2 out of 5,2008-05-20,Evidence at transcript level
Q86VH4,LRRT4_HUMAN,Leucine-rich repeat transmembrane neuronal protein 4,590,"67,217",4 out of 5,2005-06-21,Evidence at transcript level
Q8ND56,LS14A_HUMAN,Protein LSM14 homolog A (Protein FAM61A) (Protein SCD6 homolog) (Putative alpha-synuclein-binding protein) (AlphaSNBP) (RNA-associated protein 55A) (hRAP55) (hRAP55A),463,"50,530",5 out of 5,2005-08-02,Evidence at protein level
A0A087WSX0,LV545_HUMAN,Immunoglobulin lambda variable 5-45,123,"13,162",3 out of 5,2017-01-18,Inferred from homology
A0A075B6I0,LV861_HUMAN,Immunoglobulin lambda variable 8-61,122,"12,814",3 out of 5,2017-01-18,Inferred from homology
A0A075B6I4,LVX54_HUMAN,Immunoglobulin lambda variable 10-54,117,"12,395",3 out of 5,2017-01-18,Inferred from homology
O75342,LX12B_HUMAN,"Arachidonate 12-lipoxygenase, 12R-type (12R-LOX) (12R-lipoxygenase) (EC 1.13.11.-) (Epidermis-type lipoxygenase 12)",701,"80,356",5 out of 5,2001-01-11,Evidence at protein level
Q8N1E2,LYG1_HUMAN,Lysozyme g-like protein 1 (EC 3.2.1.-),194,"21,431",2 out of 5,2004-05-10,Evidence at transcript level
Q9BZG9,LYNX1_HUMAN,Ly-6/neurotoxin-like protein 1 (Secreted Ly-6/uPAR domain-containing protein 2) (Secreted Ly-6/uPAR-related protein 2) (SLURP-2),131,"14,026",5 out of 5,2002-10-19,Evidence at protein level
O95372,LYPA2_HUMAN,Acyl-protein thioesterase 2 (APT-2) (EC 3.1.2.-) (Lysophospholipase II) (LPL-II) (LysoPLA II),231,"24,737",4 out of 5,2004-01-16,Evidence at protein level
Q02779,M3K10_HUMAN,Mitogen-activated protein kinase kinase kinase 10 (EC 2.7.11.25) (Mixed lineage kinase 2) (Protein kinase MST),954,"103,694",5 out of 5,1994-02-01,Evidence at protein level
Q12852,M3K12_HUMAN,Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase),859,"93,219",5 out of 5,2001-09-26,Evidence at protein level
Q9Y2U5,M3K2_HUMAN,Mitogen-activated protein kinase kinase kinase 2 (EC 2.7.11.25) (MAPK/ERK kinase kinase 2) (MEK kinase 2) (MEKK 2),619,"69,741",5 out of 5,2000-05-30,Evidence at protein level
P41279,M3K8_HUMAN,Mitogen-activated protein kinase kinase kinase 8 (EC 2.7.11.25) (Cancer Osaka thyroid oncogene) (Proto-oncogene c-Cot) (Serine/threonine-protein kinase cot) (Tumor progression locus 2) (TPL-2),467,"52,925",5 out of 5,1995-02-01,Evidence at protein level
Q5TCX8,M3KL4_HUMAN,Mitogen-activated protein kinase kinase kinase MLK4 (EC 2.7.11.25) (Mixed lineage kinase 4),1036,"113,957",5 out of 5,2005-07-19,Evidence at protein level
Q96PG2,M4A10_HUMAN,Membrane-spanning 4-domains subfamily A member 10 (CD20 antigen-like 7),267,"29,747",3 out of 5,2004-03-01,Evidence at transcript level
Q96DS6,M4A6E_HUMAN,Membrane-spanning 4-domains subfamily A member 6E,147,"15,909",3 out of 5,2003-05-09,Evidence at transcript level
Q12851,M4K2_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 2 (EC 2.7.11.1) (B lymphocyte serine/threonine-protein kinase) (Germinal center kinase) (GC kinase) (MAPK/ERK kinase kinase kinase 2) (MEK kinase kinase 2) (MEKKK 2) (Rab8-interacting protein),820,"91,556",5 out of 5,2003-02-28,Evidence at protein level
Q8WZ33,MAFIP_HUMAN,MaFF-interacting protein (Tektin-4 like protein PP5644),124,"13,947",4 out of 5,2008-09-02,Evidence at protein level
O75444,MAF_HUMAN,Transcription factor Maf (Proto-oncogene c-Maf) (V-maf musculoaponeurotic fibrosarcoma oncogene homolog),373,"38,492",5 out of 5,2002-07-11,Evidence at protein level
P43361,MAGA8_HUMAN,Melanoma-associated antigen 8 (Cancer/testis antigen 1.8) (CT1.8) (MAGE-8 antigen),318,"35,215",4 out of 5,1995-11-01,Evidence at protein level
P42679,MATK_HUMAN,Megakaryocyte-associated tyrosine-protein kinase (EC 2.7.10.2) (CSK homologous kinase) (CHK) (Hematopoietic consensus tyrosine-lacking kinase) (Protein kinase HYL) (Tyrosine-protein kinase CTK),507,"56,469",5 out of 5,1995-11-01,Evidence at protein level
Q13394,MB211_HUMAN,Putative nucleotidyltransferase MAB21L1 (EC 2.7.7.-) (Protein mab-21-like 1),359,"40,956",5 out of 5,2007-12-04,Evidence at protein level
Q8NHZ7,MB3L2_HUMAN,Methyl-CpG-binding domain protein 3-like 2 (MBD3-like protein 2),208,"22,994",2 out of 5,2004-07-19,Evidence at transcript level
Q9UIS9,MBD1_HUMAN,Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1),605,"66,607",5 out of 5,2004-07-19,Evidence at protein level
Q9NR56,MBNL1_HUMAN,Muscleblind-like protein 1 (Triplet-expansion RNA-binding protein),388,"41,817",5 out of 5,2001-11-16,Evidence at protein level
Q9NUK0,MBNL3_HUMAN,Muscleblind-like protein 3 (Cys3His CCG1-required protein) (Muscleblind-like X-linked protein) (Protein HCHCR),354,"38,532",5 out of 5,2001-11-16,Evidence at protein level
Q96N66,MBOA7_HUMAN,Lysophospholipid acyltransferase 7 (LPLAT 7) (EC 2.3.1.-) (1-acylglycerophosphatidylinositol O-acyltransferase) (EC 2.3.1.n4) (Bladder and breast carcinoma-overexpressed gene 1 protein) (Leukocyte receptor cluster member 4) (Lysophosphatidylinositol acyltransferase) (LPIAT) (Lyso-PI acyltransferase) (Membrane-bound O-acyltransferase domain-containing protein 7) (O-acyltransferase domain-containing protein 7) (h-mboa-7),472,"52,765",5 out of 5,2008-02-05,Evidence at protein level
P02686,MBP_HUMAN,Myelin basic protein (MBP) (Myelin A1 protein) (Myelin membrane encephalitogenic protein),304,"33,117",5 out of 5,1986-07-21,Evidence at protein level
P33032,MC5R_HUMAN,Melanocortin receptor 5 (MC5-R) (MC-2),325,"36,601",4 out of 5,1993-10-01,Evidence at protein level
O43772,MCAT_HUMAN,Mitochondrial carnitine/acylcarnitine carrier protein (Carnitine/acylcarnitine translocase) (CAC) (Solute carrier family 25 member 20),301,"32,944",5 out of 5,1998-12-15,Evidence at protein level
Q2VPJ9,LR75B_HUMAN,Leucine-rich repeat-containing protein 75B (Leucine-rich repeat-containing protein FAM211B),315,"34,740",2 out of 5,2006-10-31,Evidence at transcript level
Q86YD5,LRAD3_HUMAN,Low-density lipoprotein receptor class A domain-containing protein 3,345,"37,419",4 out of 5,2007-09-11,Evidence at transcript level
O95237,LRAT_HUMAN,Lecithin retinol acyltransferase (EC 2.3.1.135) (Phosphatidylcholine--retinol O-acyltransferase),230,"25,703",5 out of 5,2004-04-26,Evidence at protein level
Q8N456,LRC18_HUMAN,Leucine-rich repeat-containing protein 18,261,"29,737",2 out of 5,2005-09-27,Evidence at transcript level
Q9H756,LRC19_HUMAN,Leucine-rich repeat-containing protein 19,370,"42,334",3 out of 5,2004-08-31,Evidence at transcript level
Q53EV4,LRC23_HUMAN,Leucine-rich repeat-containing protein 23 (Leucine-rich protein B7),343,"39,761",2 out of 5,2006-12-12,Evidence at transcript level
Q2I0M4,LRC26_HUMAN,Leucine-rich repeat-containing protein 26 (BK channel auxiliary gamma subunit LRRC26) (Cytokeratin-associated protein in cancer),334,"34,857",5 out of 5,2007-11-13,Evidence at protein level
Q6UY01,LRC31_HUMAN,Leucine-rich repeat-containing protein 31,552,"61,489",2 out of 5,2006-04-04,Evidence at transcript level
Q9H9A6,LRC40_HUMAN,Leucine-rich repeat-containing protein 40,602,"68,250",2 out of 5,2006-03-07,Evidence at protein level
Q96FV0,LRC46_HUMAN,Leucine-rich repeat-containing protein 46,321,"35,340",2 out of 5,2006-02-21,Evidence at transcript level
Q8IUZ0,LRC49_HUMAN,Leucine-rich repeat-containing protein 49 (Tubulin polyglutamylase complex subunit 4) (PGs4),686,"78,894",3 out of 5,2006-04-18,Evidence at transcript level
Q6P9F7,LRC8B_HUMAN,Volume-regulated anion channel subunit LRRC8B (Leucine-rich repeat-containing protein 8B) (T-cell activation leucine repeat-rich protein) (TA-LRRP),803,"92,390",5 out of 5,2006-02-07,Evidence at protein level
Q96M69,LRGUK_HUMAN,Leucine-rich repeat and guanylate kinase domain-containing protein,825,"93,618",3 out of 5,2008-03-18,Evidence at transcript level
Q6UXM1,LRIG3_HUMAN,Leucine-rich repeats and immunoglobulin-like domains protein 3 (LIG-3),1119,"123,434",4 out of 5,2005-08-16,Evidence at transcript level
Q12912,LRMP_HUMAN,Lymphoid-restricted membrane protein (Protein Jaw1) [Cleaved into: Processed lymphoid-restricted membrane protein],555,"62,122",5 out of 5,2005-08-16,Evidence at protein level
Q07954,LRP1_HUMAN,Prolow-density lipoprotein receptor-related protein 1 (LRP-1) (Alpha-2-macroglobulin receptor) (A2MR) (Apolipoprotein E receptor) (APOER) (CD antigen CD91) [Cleaved into: Low-density lipoprotein receptor-related protein 1 85 kDa subunit (LRP-85); Low-density lipoprotein receptor-related protein 1 515 kDa subunit (LRP-515); Low-density lipoprotein receptor-related protein 1 intracellular domain (LRPICD)],4544,"504,606",5 out of 5,1996-10-01,Evidence at protein level
O75197,LRP5_HUMAN,Low-density lipoprotein receptor-related protein 5 (LRP-5),1615,"179,145",5 out of 5,2004-05-10,Evidence at protein level
Q14114,LRP8_HUMAN,Low-density lipoprotein receptor-related protein 8 (LRP-8) (Apolipoprotein E receptor 2),963,"105,634",5 out of 5,2004-05-10,Evidence at protein level
Q7Z2Q7,LRR70_HUMAN,Leucine-rich repeat-containing protein 70 (Synleurin),622,"70,301",3 out of 5,2008-02-05,Evidence at transcript level
A0A075B6K4,LV310_HUMAN,Immunoglobulin lambda variable 3-10,115,"12,441",3 out of 5,2017-01-18,Inferred from homology
A0A0G2JS06,LV539_HUMAN,Immunoglobulin lambda variable 5-39,123,"13,394",3 out of 5,2017-01-18,Inferred from homology
A0A075B6I9,LV746_HUMAN,Immunoglobulin lambda variable 7-46,117,"12,468",3 out of 5,2017-01-18,Inferred from homology
O95274,LYPD3_HUMAN,Ly6/PLAUR domain-containing protein 3 (GPI-anchored metastasis-associated protein C4.4A homolog) (Matrigel-induced gene C4 protein) (MIG-C4),346,"35,971",5 out of 5,2006-03-07,Evidence at protein level
Q9NU23,LYRM2_HUMAN,LYR motif-containing protein 2,88,"10,449",2 out of 5,2006-10-03,Evidence at protein level
Q16584,M3K11_HUMAN,Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase),847,"92,688",5 out of 5,2005-07-19,Evidence at protein level
O43318,M3K7_HUMAN,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),606,"67,196",5 out of 5,2000-12-01,Evidence at protein level
P80192,M3K9_HUMAN,Mitogen-activated protein kinase kinase kinase 9 (EC 2.7.11.25) (Mixed lineage kinase 1),1104,"121,895",5 out of 5,1994-02-01,Evidence at protein level
Q5J8X5,M4A13_HUMAN,Membrane-spanning 4-domains subfamily A member 13 (Testis-expressed transmembrane protein 4),152,"17,307",3 out of 5,2008-01-15,Evidence at transcript level
Q96JA4,M4A14_HUMAN,Membrane-spanning 4-domains subfamily A member 14 (Testis development protein NYD-SP21),679,"76,580",3 out of 5,2008-02-26,Evidence at transcript level
Q3C1V0,M4A18_HUMAN,Membrane-spanning 4-domains subfamily A member 18,323,"34,465",2 out of 5,2010-07-13,Evidence at transcript level
Q9H2W1,M4A6A_HUMAN,Membrane-spanning 4-domains subfamily A member 6A (CD20 antigen-like 3) (Four-span transmembrane protein 3),248,"26,943",4 out of 5,2003-05-09,Evidence at transcript level
Q92918,M4K1_HUMAN,Mitogen-activated protein kinase kinase kinase kinase 1 (EC 2.7.11.1) (Hematopoietic progenitor kinase) (MAPK/ERK kinase kinase kinase 1) (MEK kinase kinase 1) (MEKKK 1),833,"91,296",5 out of 5,2003-03-28,Evidence at protein level
A6NCF6,MA13P_HUMAN,Putative MAGE domain-containing protein MAGEA13P,341,"37,899",1 out of 5,2008-04-08,Uncertain
Q96T17,MA7D2_HUMAN,MAP7 domain-containing protein 2,732,"81,965",3 out of 5,2007-10-02,Evidence at protein level
O60675,MAFK_HUMAN,Transcription factor MafK (Erythroid transcription factor NF-E2 p18 subunit),156,"17,523",4 out of 5,2001-02-21,Evidence at protein level
P43359,MAGA5_HUMAN,Melanoma-associated antigen 5 (Cancer/testis antigen 1.5) (CT1.5) (MAGE-5 antigen),124,"13,016",2 out of 5,1995-11-01,Evidence at transcript level
P43364,MAGAB_HUMAN,Melanoma-associated antigen 11 (Cancer/testis antigen 1.11) (CT1.11) (MAGE-11 antigen),429,"48,129",5 out of 5,1995-11-01,Evidence at protein level
Q49MG5,MAP9_HUMAN,Microtubule-associated protein 9 (Aster-associated protein),647,"74,234",5 out of 5,2006-07-25,Evidence at protein level
Q86UD3,MARH3_HUMAN,E3 ubiquitin-protein ligase MARCH3 (EC 2.3.2.27) (Membrane-associated RING finger protein 3) (Membrane-associated RING-CH protein III) (MARCH-III) (RING finger protein 173) (RING-type E3 ubiquitin transferase MARCH3),253,"28,504",5 out of 5,2005-02-15,Evidence at protein level
Q9NX47,MARH5_HUMAN,E3 ubiquitin-protein ligase MARCH5 (EC 2.3.2.27) (Membrane-associated RING finger protein 5) (Membrane-associated RING-CH protein V) (MARCH-V) (Mitochondrial ubiquitin ligase) (MITOL) (RING finger protein 153) (RING-type E3 ubiquitin transferase MARCH5),278,"31,232",5 out of 5,2007-01-09,Evidence at protein level
Q9H992,MARH7_HUMAN,E3 ubiquitin-protein ligase MARCH7 (EC 2.3.2.27) (Axotrophin) (Membrane-associated RING finger protein 7) (Membrane-associated RING-CH protein VII) (MARCH-VII) (RING finger protein 177) (RING-type E3 ubiquitin transferase MARCH7),704,"78,051",5 out of 5,2007-02-06,Evidence at protein level
A6NNE9,MARHB_HUMAN,E3 ubiquitin-protein ligase MARCH11 (EC 2.3.2.27) (Membrane-associated RING finger protein 11) (Membrane-associated RING-CH protein XI) (MARCH-XI) (RING-type E3 ubiquitin transferase MARCH11),402,"43,878",4 out of 5,2008-06-10,Evidence at transcript level
Q9P0L2,MARK1_HUMAN,Serine/threonine-protein kinase MARK1 (EC 2.7.11.1) (EC 2.7.11.26) (MAP/microtubule affinity-regulating kinase 1) (PAR1 homolog c) (Par-1c) (Par1c),795,"89,003",5 out of 5,2005-04-12,Evidence at protein level
Q96L34,MARK4_HUMAN,MAP/microtubule affinity-regulating kinase 4 (EC 2.7.11.1) (MAP/microtubule affinity-regulating kinase-like 1),752,"82,520",5 out of 5,2003-02-28,Evidence at protein level
P51948,MAT1_HUMAN,CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36),309,"35,823",5 out of 5,1996-10-01,Evidence at protein level
Q96EY5,MB12A_HUMAN,Multivesicular body subunit 12A (CIN85/CD2AP family-binding protein) (ESCRT-I complex subunit MVB12A) (Protein FAM125A),273,"28,783",5 out of 5,2006-09-05,Evidence at protein level
Q8WWY6,MB3L1_HUMAN,Methyl-CpG-binding domain protein 3-like 1 (MBD3-like protein 1),194,"21,616",3 out of 5,2004-07-19,Evidence at transcript level
O95243,MBD4_HUMAN,Methyl-CpG-binding domain protein 4 (EC 3.2.2.-) (Methyl-CpG-binding endonuclease 1) (Methyl-CpG-binding protein MBD4) (Mismatch-specific DNA N-glycosylase),580,"66,051",5 out of 5,2004-07-19,Evidence at protein level
P11226,MBL2_HUMAN,Mannose-binding protein C (MBP-C) (Collectin-1) (MBP1) (Mannan-binding protein) (Mannose-binding lectin),248,"26,144",5 out of 5,1989-07-01,Evidence at protein level
Q68D91,MBLC2_HUMAN,Metallo-beta-lactamase domain-containing protein 2 (EC 3.-.-.-),279,"31,372",3 out of 5,2008-03-18,Evidence at protein level
Q5VZF2,MBNL2_HUMAN,Muscleblind-like protein 2 (Muscleblind-like protein 1) (Muscleblind-like protein-like) (Muscleblind-like protein-like 39),373,"40,518",5 out of 5,2007-02-06,Evidence at protein level
P41968,MC3R_HUMAN,Melanocortin receptor 3 (MC3-R),323,"36,043",5 out of 5,1995-11-01,Evidence at protein level
O43766,LIAS_HUMAN,"Lipoyl synthase, mitochondrial (EC 2.8.1.8) (Lipoate synthase) (LS) (Lip-syn) (Lipoic acid synthase)",372,"41,911",5 out of 5,2002-10-10,Evidence at protein level
Q9UHB6,LIMA1_HUMAN,LIM domain and actin-binding protein 1 (Epithelial protein lost in neoplasm),759,"85,226",5 out of 5,2002-03-05,Evidence at protein level
P0CW19,LIMS3_HUMAN,LIM and senescent cell antigen-like-containing domain protein 3 (Particularly interesting new Cys-His protein 3) (PINCH-3),117,"13,251",2 out of 5,2011-05-31,Evidence at transcript level
Q9H0V9,LMA2L_HUMAN,VIP36-like protein (Lectin mannose-binding 2-like) (LMAN2-like protein),348,"39,711",5 out of 5,2003-04-04,Evidence at protein level
Q12907,LMAN2_HUMAN,Vesicular integral-membrane protein VIP36 (Glycoprotein GP36b) (Lectin mannose-binding 2) (Vesicular integral-membrane protein 36) (VIP36),356,"40,229",5 out of 5,2002-05-27,Evidence at protein level
Q9NUN5,LMBD1_HUMAN,Probable lysosomal cobalamin transporter (HDAg-L-interacting protein NESI) (LMBR1 domain-containing protein 1) (Nuclear export signal-interacting protein),540,"61,389",5 out of 5,2006-11-28,Evidence at protein level
Q68DH5,LMBD2_HUMAN,LMBR1 domain-containing protein 2,695,"81,172",2 out of 5,2007-08-21,Evidence at protein level
P55344,LMIP_HUMAN,Lens fiber membrane intrinsic protein (MP18) (MP19) (MP20),173,"19,674",5 out of 5,1997-11-01,Evidence at protein level
Q96KR4,LMLN_HUMAN,Leishmanolysin-like peptidase (EC 3.4.24.-) (Invadolysin),655,"73,568",4 out of 5,2007-09-11,Evidence at transcript level
F2Z398,LMO7D_HUMAN,LMO7 downstream neighbor protein,122,"13,273",1 out of 5,2012-10-31,Evidence at transcript level
Q0VAK6,LMOD3_HUMAN,"Leiomodin-3 (Leiomodin, fetal form)",560,"64,914",5 out of 5,2006-11-28,Evidence at protein level
Q6ZMQ8,LMTK1_HUMAN,Serine/threonine-protein kinase LMTK1 (EC 2.7.11.1) (Apoptosis-associated tyrosine kinase) (AATYK) (Brain apoptosis-associated tyrosine kinase) (CDK5-binding protein) (Lemur tyrosine kinase 1) (p35-binding protein) (p35BP),1374,"144,569",5 out of 5,2006-09-05,Evidence at protein level
Q8TE12,LMX1A_HUMAN,LIM homeobox transcription factor 1-alpha (LIM/homeobox protein 1.1) (LMX-1.1) (LIM/homeobox protein LMX1A),382,"42,747",4 out of 5,2003-01-27,Evidence at protein level
Q9BYJ1,LOXE3_HUMAN,Hydroperoxide isomerase ALOXE3 (EC 5.4.4.7) (Epidermis-type lipoxygenase 3) (Epidermal LOX-3) (e-LOX-3) (eLOX-3) (Hydroperoxy icosatetraenoate dehydratase) (EC 4.2.1.152),711,"80,543",5 out of 5,2003-01-27,Evidence at protein level
Q92539,LPIN2_HUMAN,Phosphatidate phosphatase LPIN2 (EC 3.1.3.4) (Lipin-2),896,"99,399",5 out of 5,1997-11-01,Evidence at protein level
O60711,LPXN_HUMAN,Leupaxin,386,"43,332",5 out of 5,2000-05-30,Evidence at protein level
A6NM36,LRC30_HUMAN,Leucine-rich repeat-containing protein 30,301,"34,034",1 out of 5,2007-11-13,Predicted
Q8IZ02,LRC34_HUMAN,Leucine-rich repeat-containing protein 34,419,"46,384",2 out of 5,2006-03-21,Evidence at transcript level
Q5JTD7,LRC73_HUMAN,Leucine-rich repeat-containing protein 73,316,"33,409",2 out of 5,2006-10-03,Evidence at transcript level
Q8IWT6,LRC8A_HUMAN,Volume-regulated anion channel subunit LRRC8A (Leucine-rich repeat-containing protein 8A) (Swelling protein 1),810,"94,199",5 out of 5,2003-10-03,Evidence at protein level
Q9Y2L9,LRCH1_HUMAN,Leucine-rich repeat and calponin homology domain-containing protein 1 (Calponin homology domain-containing protein 1) (Neuronal protein 81) (NP81),728,"80,875",3 out of 5,2003-02-22,Evidence at protein level
Q9P244,LRFN1_HUMAN,Leucine-rich repeat and fibronectin type III domain-containing protein 1 (Synaptic adhesion-like molecule 2),771,"82,318",5 out of 5,2008-05-20,Evidence at protein level
Q6PJG9,LRFN4_HUMAN,Leucine-rich repeat and fibronectin type-III domain-containing protein 4,635,"66,860",5 out of 5,2005-03-29,Evidence at protein level
Q96NI6,LRFN5_HUMAN,Leucine-rich repeat and fibronectin type-III domain-containing protein 5,719,"79,445",4 out of 5,2004-01-16,Evidence at protein level
Q96JA1,LRIG1_HUMAN,Leucine-rich repeats and immunoglobulin-like domains protein 1 (LIG-1),1093,"119,113",5 out of 5,2004-10-11,Evidence at protein level
O94898,LRIG2_HUMAN,Leucine-rich repeats and immunoglobulin-like domains protein 2 (LIG-2),1065,"118,965",5 out of 5,2004-10-11,Evidence at transcript level
Q6ZRR7,LRRC9_HUMAN,Leucine-rich repeat-containing protein 9,1453,"166,911",2 out of 5,2008-05-20,Evidence at transcript level
Q6UXK5,LRRN1_HUMAN,Leucine-rich repeat neuronal protein 1 (Neuronal leucine-rich repeat protein 1) (NLRR-1),716,"80,716",4 out of 5,2005-03-01,Evidence at protein level
Q86VH5,LRRT3_HUMAN,Leucine-rich repeat transmembrane neuronal protein 3,581,"65,896",4 out of 5,2005-06-21,Evidence at transcript level
Q9BX40,LS14B_HUMAN,Protein LSM14 homolog B (Protein FAM61B) (RNA-associated protein 55B) (hRAP55B),385,"42,071",4 out of 5,2005-07-19,Evidence at protein level
P22888,LSHR_HUMAN,Lutropin-choriogonadotropic hormone receptor (LH/CG-R) (Luteinizing hormone receptor) (LHR) (LSH-R),699,"78,643",5 out of 5,1991-08-01,Evidence at protein level
Q9HCC9,LST2_HUMAN,Lateral signaling target protein 2 homolog (hLst2) (Zinc finger FYVE domain-containing protein 28),887,"96,490",5 out of 5,2004-04-13,Evidence at protein level
Q15722,LT4R1_HUMAN,Leukotriene B4 receptor 1 (LTB4-R 1) (LTB4-R1) (Chemoattractant receptor-like 1) (G-protein coupled receptor 16) (P2Y purinoceptor 7) (P2Y7),352,"37,557",5 out of 5,1997-11-01,Evidence at protein level
Q14767,LTBP2_HUMAN,Latent-transforming growth factor beta-binding protein 2 (LTBP-2),1821,"195,052",5 out of 5,2004-01-16,Evidence at protein level
Q8IV50,LYSM2_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 2,215,"23,463",2 out of 5,2006-09-05,Evidence at protein level
Q5XG99,LYSM4_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 4,296,"32,066",3 out of 5,2006-09-05,Evidence at transcript level
Q99698,LYST_HUMAN,Lysosomal-trafficking regulator (Beige homolog),3801,"429,139",5 out of 5,2000-05-30,Evidence at protein level
Q17RB8,LONF1_HUMAN,LON peptidase N-terminal domain and RING finger protein 1 (RING finger protein 191),773,"86,725",5 out of 5,2007-02-20,Evidence at protein level
Q9UN81,LORF1_HUMAN,LINE-1 retrotransposable element ORF1 protein (L1ORF1p) (LINE retrotransposable element 1) (LINE1 retrotransposable element 1),338,"40,056",5 out of 5,2014-01-22,Evidence at protein level
Q14693,LPIN1_HUMAN,Phosphatidate phosphatase LPIN1 (EC 3.1.3.4) (Lipin-1),890,"98,664",5 out of 5,1997-11-01,Evidence at protein level
Q8TAF5,LQK1_HUMAN,Putative uncharacterized protein LQK1 (FLVCR1 antisense RNA 1),88,"10,021",2 out of 5,2007-09-11,Uncertain
Q8N7C0,LRC52_HUMAN,Leucine-rich repeat-containing protein 52 (BK channel auxiliary gamma subunit LRRC52),313,"35,126",4 out of 5,2006-03-07,Evidence at protein level
Q9C099,LRCC1_HUMAN,Leucine-rich repeat and coiled-coil domain-containing protein 1 (Centrosomal leucine-rich repeat and coiled-coil domain-containing protein),1032,"119,596",4 out of 5,2008-05-20,Evidence at protein level
Q96JM4,LRIQ1_HUMAN,Leucine-rich repeat and IQ domain-containing protein 1,1722,"199,300",3 out of 5,2008-01-15,Evidence at transcript level
Q9P2V4,LRIT1_HUMAN,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1 (Leucine-rich repeat-containing protein 21) (Photoreceptor-associated LRR superfamily protein) (Retina-specific protein PAL)",623,"68,041",4 out of 5,2003-09-26,Evidence at transcript level
A6NDA9,LRIT2_HUMAN,"Leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 (Leucine-rich repeat-containing protein 22)",550,"60,168",3 out of 5,2007-11-13,Evidence at transcript level
Q8ND94,LRN4L_HUMAN,LRRN4 C-terminal-like protein,238,"25,262",2 out of 5,2008-02-05,Evidence at transcript level
O75581,LRP6_HUMAN,Low-density lipoprotein receptor-related protein 6 (LRP-6),1613,"180,429",5 out of 5,2004-05-10,Evidence at protein level
O75325,LRRN2_HUMAN,Leucine-rich repeat neuronal protein 2 (Glioma amplified on chromosome 1 protein) (Leucine-rich repeat neuronal protein 5),713,"78,859",4 out of 5,2001-01-11,Evidence at transcript level
O43300,LRRT2_HUMAN,Leucine-rich repeat transmembrane neuronal protein 2 (Leucine-rich repeat neuronal 2 protein),516,"59,076",4 out of 5,2004-07-19,Evidence at transcript level
Q6UWE0,LRSM1_HUMAN,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL),723,"83,594",5 out of 5,2005-02-01,Evidence at protein level
O95777,LSM8_HUMAN,U6 snRNA-associated Sm-like protein LSm8,96,"10,403",5 out of 5,2000-12-01,Evidence at protein level
Q86X29,LSR_HUMAN,Lipolysis-stimulated lipoprotein receptor,649,"71,439",5 out of 5,2006-07-11,Evidence at protein level
P29376,LTK_HUMAN,Leukocyte tyrosine kinase receptor (EC 2.7.10.1) (Protein tyrosine kinase 1),864,"91,681",5 out of 5,1992-12-01,Evidence at protein level
O94822,LTN1_HUMAN,E3 ubiquitin-protein ligase listerin (EC 2.3.2.27) (RING finger protein 160) (RING-type E3 ubiquitin transferase listerin) (Zinc finger protein 294),1766,"200,552",5 out of 5,2000-05-30,Evidence at protein level
Q6IAA8,LTOR1_HUMAN,Ragulator complex protein LAMTOR1 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 1) (Lipid raft adaptor protein p18) (Protein associated with DRMs and endosomes) (p27Kip1-releasing factor from RhoA) (p27RF-Rho),161,"17,745",5 out of 5,2007-02-06,Evidence at protein level
Q9UHA4,LTOR3_HUMAN,Ragulator complex protein LAMTOR3 (Late endosomal/lysosomal adaptor and MAPK and MTOR activator 3) (MEK-binding partner 1) (Mp1) (Mitogen-activated protein kinase kinase 1-interacting protein 1) (Mitogen-activated protein kinase scaffold protein 1),124,"13,623",5 out of 5,2002-10-25,Evidence at protein level
P01701,LV151_HUMAN,Immunoglobulin lambda variable 1-51 (Ig lambda chain V-I region BL2) (Ig lambda chain V-I region EPS) (Ig lambda chain V-I region NEW) (Ig lambda chain V-I region NIG-64),117,"12,249",5 out of 5,1986-07-21,Evidence at protein level
P01706,LV211_HUMAN,Immunoglobulin lambda variable 2-11 (Ig gamma lambda chain V-II region DOT) (Ig lambda chain V-II region BOH) (Ig lambda chain V-II region BUR) (Ig lambda chain V-II region NIG-58) (Ig lambda chain V-II region TRO) (Ig lambda chain V-II region WIN),119,"12,644",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6K2,LV312_HUMAN,Immunoglobulin lambda variable 3-12,115,"12,387",3 out of 5,2017-01-18,Inferred from homology
P01717,LV325_HUMAN,Immunoglobulin lambda variable 3-25 (Ig lambda chain V-IV region Hil),112,"12,011",5 out of 5,1986-07-21,Evidence at protein level
Q96S90,LYSM1_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 1,227,"25,003",2 out of 5,2006-09-05,Evidence at protein level
Q7Z3D4,LYSM3_HUMAN,LysM and putative peptidoglycan-binding domain-containing protein 3,306,"34,538",3 out of 5,2006-09-05,Evidence at protein level
Q8TC57,M1AP_HUMAN,Meiosis 1 arrest protein (Meiosis 1-arresting protein) (Meiosis 1-associated protein) (Spermatogenesis-associated protein 37),530,"59,386",5 out of 5,2008-09-02,Evidence at protein level
O15479,MAGB2_HUMAN,Melanoma-associated antigen B2 (Cancer/testis antigen 3.2) (CT3.2) (DSS-AHC critical interval MAGE superfamily 6) (DAM6) (MAGE XP-2 antigen) (MAGE-B2 antigen),319,"35,277",3 out of 5,1998-12-15,Evidence at protein level
Q9BTT6,LRRC1_HUMAN,Leucine-rich repeat-containing protein 1 (LANO adapter protein) (LAP and no PDZ protein),524,"59,242",4 out of 5,2004-07-19,Evidence at protein level
Q9HBW1,LRRC4_HUMAN,Leucine-rich repeat-containing protein 4 (Brain tumor-associated protein BAG) (Nasopharyngeal carcinoma-associated gene 14 protein) (Netrin-G2 ligand) (NGL-2),653,"72,717",5 out of 5,2004-08-31,Evidence at protein level
Q9Y608,LRRF2_HUMAN,Leucine-rich repeat flightless-interacting protein 2 (LRR FLII-interacting protein 2),721,"82,171",5 out of 5,2006-07-11,Evidence at protein level
Q9H3W5,LRRN3_HUMAN,Leucine-rich repeat neuronal protein 3 (Neuronal leucine-rich repeat protein 3) (NLRR-3),708,"79,424",3 out of 5,2006-01-24,Evidence at transcript level
Q13449,LSAMP_HUMAN,Limbic system-associated membrane protein (LSAMP) (IgLON family member 3),338,"37,393",5 out of 5,1997-11-01,Evidence at protein level
P01229,LSHB_HUMAN,Lutropin subunit beta (Lutropin beta chain) (Luteinizing hormone subunit beta) (LH-B) (LSH-B) (LSH-beta),141,"15,345",5 out of 5,1986-07-21,Evidence at protein level
Q969L4,LSM10_HUMAN,U7 snRNA-associated Sm-like protein LSm10,123,"14,080",5 out of 5,2002-04-16,Evidence at protein level
Q9UK45,LSM7_HUMAN,U6 snRNA-associated Sm-like protein LSm7,103,"11,602",5 out of 5,2000-12-01,Evidence at protein level
Q16873,LTC4S_HUMAN,Leukotriene C4 synthase (LTC4 synthase) (EC 4.4.1.20) (Leukotriene-C(4) synthase),150,"16,567",5 out of 5,1997-11-01,Evidence at protein level
Q6P1Q0,LTMD1_HUMAN,LETM1 domain-containing protein 1 (Cervical cancer 1 proto-oncogene protein p40) (Cervical cancer proto-oncogene 2 protein) (HCCR-1) (HCRR-2),360,"41,790",5 out of 5,2007-11-13,Evidence at protein level
A0A0B4J1U3,LV136_HUMAN,Immunoglobulin lambda variable 1-36,117,"12,478",3 out of 5,2017-01-18,Inferred from homology
P01700,LV147_HUMAN,Immunoglobulin lambda variable 1-47 (Ig lambda chain V-I region HA) (Ig lambda chain V-I region WAH),117,"12,284",5 out of 5,1986-07-21,Evidence at protein level
P01709,LV208_HUMAN,Immunoglobulin lambda variable 2-8 (Ig lambda chain V-II region BO) (Ig lambda chain V-II region MGC),118,"12,382",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6J9,LV218_HUMAN,Immunoglobulin lambda variable 2-18,118,"12,412",3 out of 5,2017-01-18,Inferred from homology
P01718,LV327_HUMAN,Immunoglobulin lambda variable 3-27 (Ig lambda chain V-IV region Kern),113,"12,165",5 out of 5,1986-07-21,Evidence at protein level
Q8NDX9,LY65B_HUMAN,Lymphocyte antigen 6 complex locus protein G5b,201,"22,572",4 out of 5,2008-02-26,Evidence at protein level
H3BQJ8,LY6L_HUMAN,Lymphocyte antigen 6L (Lymphocyte antigen 6 complex locus protein L),138,"15,317",2 out of 5,2016-11-02,Inferred from homology
O60449,LY75_HUMAN,Lymphocyte antigen 75 (Ly-75) (C-type lectin domain family 13 member B) (DEC-205) (gp200-MR6) (CD antigen CD205),1722,"198,311",5 out of 5,2003-09-19,Evidence at protein level
P14151,LYAM1_HUMAN,L-selectin (CD62 antigen-like family member L) (Leukocyte adhesion molecule 1) (LAM-1) (Leukocyte surface antigen Leu-8) (Leukocyte-endothelial cell adhesion molecule 1) (LECAM1) (Lymph node homing receptor) (TQ1) (gp90-MEL) (CD antigen CD62L),372,"42,187",5 out of 5,1990-01-01,Evidence at protein level
Q9NX58,LYAR_HUMAN,Cell growth-regulating nucleolar protein,379,"43,615",4 out of 5,2005-07-19,Evidence at protein level
P12980,LYL1_HUMAN,Protein lyl-1 (Class A basic helix-loop-helix protein 18) (bHLHa18) (Lymphoblastic leukemia-derived sequence 1),280,"29,938",5 out of 5,1990-01-01,Evidence at protein level
Q6UXB3,LYPD2_HUMAN,Ly6/PLAUR domain-containing protein 2,125,"13,115",3 out of 5,2006-03-07,Evidence at transcript level
Q5VWZ2,LYPL1_HUMAN,Lysophospholipase-like protein 1 (EC 3.1.2.-),237,"26,316",5 out of 5,2006-03-21,Evidence at protein level
Q86UE4,LYRIC_HUMAN,Protein LYRIC (3D3/LYRIC) (Astrocyte elevated gene-1 protein) (AEG-1) (Lysine-rich CEACAM1 co-isolated protein) (Metadherin) (Metastasis adhesion protein),582,"63,837",5 out of 5,2004-12-21,Evidence at protein level
Q6P0N0,M18BP_HUMAN,Mis18-binding protein 1 (Kinetochore-associated protein KNL-2 homolog) (HsKNL-2) (P243),1132,"129,085",5 out of 5,2005-06-21,Evidence at protein level
Q7L5Y9,MAEA_HUMAN,Macrophage erythroblast attacher (Cell proliferation-inducing gene 5 protein) (Erythroblast macrophage protein) (Human lung cancer oncogene 10 protein) (HLC-10),396,"45,287",5 out of 5,2007-05-01,Evidence at protein level
Q96JY0,MAEL_HUMAN,Protein maelstrom homolog,434,"49,219",5 out of 5,2006-04-18,Evidence at protein level
P43357,MAGA3_HUMAN,Melanoma-associated antigen 3 (Antigen MZ2-D) (Cancer/testis antigen 1.3) (CT1.3) (MAGE-3 antigen),314,"34,747",5 out of 5,1995-11-01,Evidence at protein level
Q3KP22,MAJIN_HUMAN,Membrane-anchored junction protein,176,"20,078",3 out of 5,2008-03-18,Evidence at transcript level
P55145,MANF_HUMAN,Mesencephalic astrocyte-derived neurotrophic factor (Arginine-rich protein) (Protein ARMET),182,"20,700",5 out of 5,1996-10-01,Evidence at protein level
Q6UB28,MAP12_HUMAN,"Methionine aminopeptidase 1D, mitochondrial (MAP 1D) (MetAP 1D) (EC 3.4.11.18) (Methionyl aminopeptidase type 1D, mitochondrial) (Peptidase M 1D)",335,"37,088",5 out of 5,2008-01-15,Evidence at protein level
Q5VT66,MARC1_HUMAN,Mitochondrial amidoxime-reducing component 1 (mARC1) (EC 1.-.-.-) (Molybdenum cofactor sulfurase C-terminal domain-containing protein 1) (MOSC domain-containing protein 1) (Moco sulfurase C-terminal domain-containing protein 1),337,"37,499",5 out of 5,2007-01-23,Evidence at protein level
P29966,MARCS_HUMAN,"Myristoylated alanine-rich C-kinase substrate (MARCKS) (Protein kinase C substrate, 80 kDa protein, light chain) (80K-L protein) (PKCSL)",332,"31,555",5 out of 5,1993-04-01,Evidence at protein level
Q15691,MARE1_HUMAN,Microtubule-associated protein RP/EB family member 1 (APC-binding protein EB1) (End-binding protein 1) (EB1),268,"29,999",5 out of 5,2002-01-23,Evidence at protein level
Q8N8X9,MB213_HUMAN,Protein mab-21-like 3,362,"42,357",3 out of 5,2007-05-15,Evidence at protein level
A6NE82,MB3L3_HUMAN,Putative methyl-CpG-binding domain protein 3-like 3 (MBD3-like protein 3),208,"23,095",2 out of 5,2008-09-02,Uncertain
Q3MHD2,LSM12_HUMAN,Protein LSM12 homolog,195,"21,701",3 out of 5,2007-10-02,Evidence at protein level
Q14766,LTBP1_HUMAN,Latent-transforming growth factor beta-binding protein 1 (LTBP-1) (Transforming growth factor beta-1-binding protein 1) (TGF-beta1-BP-1),1721,"186,796",5 out of 5,2002-03-05,Evidence at protein level
Q9NS15,LTBP3_HUMAN,Latent-transforming growth factor beta-binding protein 3 (LTBP-3),1303,"139,359",5 out of 5,2004-01-16,Evidence at protein level
Q8N2S1,LTBP4_HUMAN,Latent-transforming growth factor beta-binding protein 4 (LTBP-4),1624,"173,435",5 out of 5,2007-11-13,Evidence at protein level
Q86V48,LUZP1_HUMAN,Leucine zipper protein 1,1076,"120,275",4 out of 5,2006-05-16,Evidence at protein level
Q538Z0,LUZP6_HUMAN,Leucine zipper protein 6 (Myeloproliferative disease-associated 6 kDa antigen),58,"6,437",2 out of 5,2008-02-05,Evidence at transcript level
P01703,LV140_HUMAN,Immunoglobulin lambda variable 1-40 (Ig lambda chain V-I region NEWM),118,"12,302",5 out of 5,1986-07-21,Evidence at protein level
A0A075B6K0,LV316_HUMAN,Immunoglobulin lambda variable 3-16,115,"12,466",3 out of 5,2017-01-18,Inferred from homology
A0A075B6H9,LV469_HUMAN,Immunoglobulin lambda variable 4-69,119,"12,773",3 out of 5,2017-01-18,Evidence at protein level
O15296,LX15B_HUMAN,Arachidonate 15-lipoxygenase B (15-LOX-B) (EC 1.13.11.33) (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-),676,"75,857",5 out of 5,2001-01-11,Evidence at protein level
O95867,LY66C_HUMAN,Lymphocyte antigen 6 complex locus protein G6c,125,"13,821",4 out of 5,2000-12-01,Evidence at protein level
Q9Y6Y9,LY96_HUMAN,Lymphocyte antigen 96 (Ly-96) (ESOP-1) (Protein MD-2),160,"18,546",5 out of 5,2002-03-27,Evidence at protein level
P07948,LYN_HUMAN,Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn),512,"58,574",5 out of 5,1988-08-01,Evidence at protein level
A8MSI8,LYRM9_HUMAN,LYR motif-containing protein 9,78,"9,374",2 out of 5,2008-07-22,Inferred from homology
Q96KX0,LYZL4_HUMAN,Lysozyme-like protein 4 (Lysozyme-4),146,"16,433",3 out of 5,2006-06-27,Evidence at transcript level
Q96QH8,LYZL5_HUMAN,Sperm acrosome-associated protein 5 (EC 3.2.1.17) (Lysozyme-like protein 5) (Sperm-specific lysozyme-like protein X) (SLLP-X),159,"17,896",3 out of 5,2007-04-17,Evidence at transcript level
Q9BRK4,LZTS2_HUMAN,Leucine zipper putative tumor suppressor 2 (hLZTS2) (Protein LAPSER1),669,"72,759",5 out of 5,2004-04-13,Evidence at protein level
Q567V2,M17L2_HUMAN,Mpv17-like protein 2,206,"23,180",4 out of 5,2008-02-05,Evidence at protein level
Q9NPA3,M1IP1_HUMAN,Mid1-interacting protein 1 (Gastrulation-specific G12-like protein) (Mid1-interacting G12-like protein) (Protein STRAIT11499) (Spot 14-related protein) (S14R) (Spot 14-R),183,"20,202",4 out of 5,2002-07-11,Evidence at protein level
Q9UKM7,MA1B1_HUMAN,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase (EC 3.2.1.113) (ER alpha-1,2-mannosidase) (ER mannosidase 1) (ERMan1) (Man9GlcNAc2-specific-processing alpha-mannosidase) (Mannosidase alpha class 1B member 1)",699,"79,580",5 out of 5,2001-11-16,Evidence at protein level
P49641,MA2A2_HUMAN,"Alpha-mannosidase 2x (EC 3.2.1.114) (Alpha-mannosidase IIx) (Man IIx) (Mannosidase alpha class 2A member 2) (Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase)",1150,"130,539",5 out of 5,1996-02-01,Evidence at transcript level
Q8IWC1,MA7D3_HUMAN,MAP7 domain-containing protein 3,876,"98,429",5 out of 5,2007-10-02,Evidence at protein level
Q14582,MAD4_HUMAN,Max dimerization protein 4 (Max dimerizer 4) (Class C basic helix-loop-helix protein 12) (bHLHc12) (Max-associated protein 4) (Max-interacting transcriptional repressor MAD4),209,"23,528",3 out of 5,1998-12-15,Evidence at protein level
A6NDP7,MADL2_HUMAN,Myeloid-associated differentiation marker-like protein 2,307,"32,967",2 out of 5,2008-04-29,Evidence at transcript level
P43356,MAGA2_HUMAN,Melanoma-associated antigen 2 (Cancer/testis antigen 1.2) (CT1.2) (MAGE-2 antigen),314,"35,055",5 out of 5,1995-11-01,Evidence at protein level
Q96M61,MAGBI_HUMAN,Melanoma-associated antigen B18 (MAGE-B18 antigen),343,"38,533",3 out of 5,2005-10-25,Evidence at protein level
Q96JG8,MAGD4_HUMAN,Melanoma-associated antigen D4 (MAGE-D4 antigen) (MAGE-E1 antigen),741,"81,378",4 out of 5,2004-01-16,Evidence at protein level
Q16798,MAON_HUMAN,"NADP-dependent malic enzyme, mitochondrial (NADP-ME) (EC 1.1.1.40) (Malic enzyme 3)",604,"67,068",5 out of 5,1997-11-01,Evidence at transcript level
P46821,MAP1B_HUMAN,Microtubule-associated protein 1B (MAP-1B) [Cleaved into: MAP1B heavy chain; MAP1 light chain LC1],2468,"270,634",5 out of 5,1995-11-01,Evidence at protein level
Q14244,MAP7_HUMAN,Ensconsin (Epithelial microtubule-associated protein of 115 kDa) (E-MAP-115) (Microtubule-associated protein 7) (MAP-7),749,"84,052",5 out of 5,2006-10-31,Evidence at protein level
P49137,MAPK2_HUMAN,MAP kinase-activated protein kinase 2 (MAPK-activated protein kinase 2) (MAPKAP kinase 2) (MAPKAP-K2) (MAPKAPK-2) (MK-2) (MK2) (EC 2.7.11.1),400,"45,568",5 out of 5,1996-02-01,Evidence at protein level
Q9UPY8,MARE3_HUMAN,Microtubule-associated protein RP/EB family member 3 (EB1 protein family member 3) (EBF3) (End-binding protein 3) (EB3) (RP3),281,"31,982",5 out of 5,2002-01-23,Evidence at protein level
Q9Y4F3,MARF1_HUMAN,Meiosis arrest female protein 1 (Limkain-b1),1742,"192,859",5 out of 5,2007-02-06,Evidence at protein level
Q9P0N8,MARH2_HUMAN,E3 ubiquitin-protein ligase MARCH2 (EC 2.3.2.27) (Membrane-associated RING finger protein 2) (Membrane-associated RING-CH protein II) (MARCH-II) (RING finger protein 172) (RING-type E3 ubiquitin transferase MARCH2),246,"26,995",5 out of 5,2005-01-04,Evidence at protein level
Q86YJ5,MARH9_HUMAN,E3 ubiquitin-protein ligase MARCH9 (EC 2.3.2.27) (Membrane-associated RING finger protein 9) (Membrane-associated RING-CH protein IX) (MARCH-IX) (RING finger protein 179) (RING-type E3 ubiquitin transferase MARCH9),346,"37,772",5 out of 5,2007-02-06,Evidence at protein level
O60307,MAST3_HUMAN,Microtubule-associated serine/threonine-protein kinase 3 (EC 2.7.11.1),1309,"143,137",5 out of 5,2005-11-22,Evidence at protein level
Q9Y483,MTF2_HUMAN,Metal-response element-binding transcription factor 2 (Metal regulatory transcription factor 2) (Metal-response element DNA-binding protein M96) (Polycomb-like protein 2) (hPCl2),593,"67,106",5 out of 5,2000-12-01,Evidence at protein level
Q9UDX5,MTFP1_HUMAN,Mitochondrial fission process protein 1 (Mitochondrial 18 kDa protein) (MTP18),166,"18,010",4 out of 5,2004-09-27,Evidence at protein level
O43193,MTLR_HUMAN,Motilin receptor (G-protein coupled receptor 38),412,"45,344",4 out of 5,1998-12-15,Evidence at transcript level
O95248,MTMR5_HUMAN,Myotubularin-related protein 5 (SET-binding factor 1) (Sbf1),1867,"208,315",5 out of 5,2000-12-01,Evidence at protein level
A4FU01,MTMRB_HUMAN,Myotubularin-related protein 11 (Cisplatin resistance-associated protein) (hCRA),709,"79,545",3 out of 5,2008-05-20,Evidence at transcript level
Q86WG5,MTMRD_HUMAN,Myotubularin-related protein 13 (SET-binding factor 2),1849,"208,464",5 out of 5,2006-02-07,Evidence at protein level
Q9Y2Z2,MTO1_HUMAN,"Protein MTO1 homolog, mitochondrial",717,"79,964",5 out of 5,2000-05-30,Evidence at protein level
P42345,MTOR_HUMAN,Serine/threonine-protein kinase mTOR (EC 2.7.11.1) (FK506-binding protein 12-rapamycin complex-associated protein 1) (FKBP12-rapamycin complex-associated protein) (Mammalian target of rapamycin) (mTOR) (Mechanistic target of rapamycin) (Rapamycin and FKBP12 target 1) (Rapamycin target protein 1),2549,"288,892",5 out of 5,1995-11-01,Evidence at protein level
Q9H3R2,MUC13_HUMAN,Mucin-13 (MUC-13) (Down-regulated in colon cancer 1),512,"54,604",5 out of 5,2004-07-19,Evidence at protein level
P43121,MUC18_HUMAN,Cell surface glycoprotein MUC18 (Cell surface glycoprotein P1H12) (Melanoma cell adhesion molecule) (Melanoma-associated antigen A32) (Melanoma-associated antigen MUC18) (S-endo 1 endothelial-associated antigen) (CD antigen CD146),646,"71,607",5 out of 5,1995-11-01,Evidence at protein level
Q8N307,MUC20_HUMAN,Mucin-20 (MUC-20),709,"71,982",5 out of 5,2008-02-05,Evidence at protein level
Q02817,MUC2_HUMAN,Mucin-2 (MUC-2) (Intestinal mucin-2),5179,"540,300",5 out of 5,1994-06-01,Evidence at protein level
Q9H195,MUC3B_HUMAN,Mucin-3B (MUC-3B) (Intestinal mucin-3B) (Fragments),1237,"131,402",4 out of 5,2006-11-28,Evidence at transcript level
Q9UIF7,MUTYH_HUMAN,Adenine DNA glycosylase (EC 3.2.2.-) (MutY homolog) (hMYH),546,"60,069",5 out of 5,2004-06-07,Evidence at protein level
P53602,MVD1_HUMAN,Diphosphomevalonate decarboxylase (EC 4.1.1.33) (Mevalonate (diphospho)decarboxylase) (MDDase) (Mevalonate pyrophosphate decarboxylase),400,"43,405",5 out of 5,1996-10-01,Evidence at protein level
Q14764,MVP_HUMAN,Major vault protein (MVP) (Lung resistance-related protein),893,"99,327",5 out of 5,1997-11-01,Evidence at protein level
Q9NR99,MXRA5_HUMAN,Matrix-remodeling-associated protein 5 (Adhesion protein with leucine-rich repeats and immunoglobulin domains related to perlecan) (Adlican),2828,"312,150",5 out of 5,2006-10-31,Evidence at transcript level
P08590,MYL3_HUMAN,"Myosin light chain 3 (Cardiac myosin light chain 1) (CMLC1) (Myosin light chain 1, slow-twitch muscle B/ventricular isoform) (MLC1SB) (Ventricular myosin alkali light chain) (Ventricular myosin light chain 1) (VLCl) (Ventricular/slow twitch myosin alkali light chain) (MLC-lV/sb)",195,"21,932",5 out of 5,1988-08-01,Evidence at protein level
Q9NPC7,MYNN_HUMAN,Myoneurin (Zinc finger and BTB domain-containing protein 31),610,"68,682",4 out of 5,2006-09-05,Evidence at protein level
Q96H55,MYO19_HUMAN,Unconventional myosin-XIX (Myosin head domain-containing protein 1),970,"109,135",5 out of 5,2008-05-20,Evidence at protein level
Q9UBC5,MYO1A_HUMAN,Unconventional myosin-Ia (Brush border myosin I) (BBM-I) (BBMI) (Myosin I heavy chain) (MIHC),1043,"118,401",5 out of 5,2001-04-27,Evidence at transcript level
Q8NEV4,MYO3A_HUMAN,Myosin-IIIa (EC 2.7.11.1),1616,"186,208",5 out of 5,2004-04-26,Evidence at transcript level
P02689,MYP2_HUMAN,Myelin P2 protein (Peripheral myelin protein 2),132,"14,909",5 out of 5,1986-07-21,Evidence at protein level
Q00872,MYPC1_HUMAN,"Myosin-binding protein C, slow-type (Slow MyBP-C) (C-protein, skeletal muscle slow isoform)",1141,"128,294",5 out of 5,1994-02-01,Evidence at protein level
Q14896,MYPC3_HUMAN,"Myosin-binding protein C, cardiac-type (Cardiac MyBP-C) (C-protein, cardiac muscle isoform)",1274,"140,762",5 out of 5,1999-07-15,Evidence at protein level
P60201,MYPR_HUMAN,Myelin proteolipid protein (PLP) (Lipophilin),277,"30,077",5 out of 5,1988-01-01,Evidence at protein level
O14974,MYPT1_HUMAN,Protein phosphatase 1 regulatory subunit 12A (Myosin phosphatase-targeting subunit 1) (Myosin phosphatase target subunit 1) (Protein phosphatase myosin-binding subunit),1030,"115,281",5 out of 5,2004-01-16,Evidence at protein level
Q8NFW9,MYRIP_HUMAN,Rab effector MyRIP (Exophilin-8) (Myosin-VIIa- and Rab-interacting protein) (Synaptotagmin-like protein lacking C2 domains C) (SlaC2-c) (Slp homolog lacking C2 domains c),859,"95,706",5 out of 5,2003-07-25,Evidence at protein level
Q9BZM6,N2DL1_HUMAN,NKG2D ligand 1 (N2DL-1) (NKG2DL1) (ALCAN-beta) (Retinoic acid early transcript 1I) (UL16-binding protein 1),244,"27,997",5 out of 5,2004-05-24,Evidence at protein level
Q5TBK1,N42L1_HUMAN,NEDD4-binding protein 2-like 1,243,"28,981",2 out of 5,2008-02-26,Evidence at transcript level
O75113,N4BP1_HUMAN,NEDD4-binding protein 1 (N4BP1),896,"100,379",3 out of 5,2004-03-15,Evidence at protein level
Q9BSU3,NAA11_HUMAN,N-alpha-acetyltransferase 11 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog B) (hARD2) (NatA catalytic subunit Naa11),229,"25,979",5 out of 5,2007-10-02,Evidence at protein level
Q9BXJ9,NAA15_HUMAN,"N-alpha-acetyltransferase 15, NatA auxiliary subunit (Gastric cancer antigen Ga19) (N-terminal acetyltransferase) (NMDA receptor-regulated protein 1) (Protein tubedown-1) (Tbdn100)",866,"101,272",5 out of 5,2005-01-04,Evidence at protein level
Q147X3,NAA30_HUMAN,N-alpha-acetyltransferase 30 (EC 2.3.1.256) (N-acetyltransferase 12) (N-acetyltransferase MAK3 homolog) (NatC catalytic subunit),362,"39,320",5 out of 5,2008-02-26,Evidence at protein level
Q2TAK8,MUM1_HUMAN,PWWP domain-containing protein MUM1 (Mutated melanoma-associated antigen 1) (MUM-1) (Protein expandere),710,"78,636",5 out of 5,2007-07-10,Evidence at protein level
P10243,MYBA_HUMAN,Myb-related protein A (A-Myb) (Myb-like protein 1),752,"85,887",5 out of 5,1989-07-01,Evidence at protein level
P10244,MYBB_HUMAN,Myb-related protein B (B-Myb) (Myb-like protein 2),700,"78,764",5 out of 5,1989-07-01,Evidence at protein level
P10242,MYB_HUMAN,Transcriptional activator Myb (Proto-oncogene c-Myb),640,"72,341",5 out of 5,1989-07-01,Evidence at protein level
P12524,MYCL_HUMAN,Protein L-Myc (Class E basic helix-loop-helix protein 38) (bHLHe38) (Protein L-Myc-1) (V-myc myelocytomatosis viral oncogene homolog),364,"40,327",4 out of 5,1989-10-01,Evidence at protein level
Q9H6N6,MYH16_HUMAN,Putative uncharacterized protein MYH16 (Myosin heavy chain 16 pseudogene) (myosin heavy polypeptide 5),1097,"128,290",2 out of 5,2015-05-27,Evidence at protein level
P05976,MYL1_HUMAN,"Myosin light chain 1/3, skeletal muscle isoform (MLC1/MLC3) (MLC1F/MLC3F) (Myosin light chain alkali 1/2) (Myosin light chain A1/A2)",194,"21,145",4 out of 5,1988-11-01,Evidence at transcript level
P12829,MYL4_HUMAN,"Myosin light chain 4 (Myosin light chain 1, embryonic muscle/atrial isoform) (Myosin light chain alkali GT-1 isoform)",197,"21,565",5 out of 5,1989-10-01,Evidence at protein level
Q15746,MYLK_HUMAN,"Myosin light chain kinase, smooth muscle (MLCK) (smMLCK) (EC 2.7.11.18) (Kinase-related protein) (KRP) (Telokin) [Cleaved into: Myosin light chain kinase, smooth muscle, deglutamylated form]",1914,"210,715",5 out of 5,1998-07-15,Evidence at protein level
O94832,MYO1D_HUMAN,Unconventional myosin-Id,1006,"116,202",5 out of 5,2002-10-10,Evidence at protein level
Q9NQX4,MYO5C_HUMAN,Unconventional myosin-Vc,1742,"202,810",5 out of 5,2001-04-27,Evidence at protein level
Q6PIF6,MYO7B_HUMAN,Unconventional myosin-VIIb,2116,"241,599",5 out of 5,2008-04-08,Evidence at protein level
P28698,MZF1_HUMAN,Myeloid zinc finger 1 (MZF-1) (Zinc finger and SCAN domain-containing protein 6) (Zinc finger protein 42),734,"82,055",5 out of 5,1992-12-01,Evidence at protein level
Q08AG7,MZT1_HUMAN,Mitotic-spindle organizing protein 1 (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 1),82,"8,479",5 out of 5,2008-05-20,Evidence at protein level
Q86UW6,N4BP2_HUMAN,NEDD4-binding protein 2 (N4BP2) (EC 3.-.-.-) (BCL-3-binding protein),1770,"198,801",5 out of 5,2004-03-15,Evidence at protein level
P61599,NAA20_HUMAN,N-alpha-acetyltransferase 20 (EC 2.3.1.254) (Methionine N-acetyltransferase) (N-acetyltransferase 5) (N-terminal acetyltransferase B complex catalytic subunit NAA20) (N-terminal acetyltransferase B complex catalytic subunit NAT5) (NatB complex subunit NAT5) (NatB catalytic subunit),178,"20,368",5 out of 5,2004-05-24,Evidence at protein level
Q9H7X0,NAA60_HUMAN,N-alpha-acetyltransferase 60 (hNaa60) (EC 2.3.1.259) (Histone acetyltransferase type B protein 4) (HAT4) (EC 2.3.1.48) (N-acetyltransferase 15) (N-alpha-acetyltransferase F) (NatF),242,"27,451",5 out of 5,2008-02-26,Evidence at protein level
Q13506,NAB1_HUMAN,NGFI-A-binding protein 1 (EGR-1-binding protein 1) (Transcriptional regulatory protein p54),487,"54,401",4 out of 5,2000-12-01,Evidence at protein level
P32418,NAC1_HUMAN,Sodium/calcium exchanger 1 (Na(+)/Ca(2+)-exchange protein 1) (Solute carrier family 8 member 1),973,"108,547",5 out of 5,1993-10-01,Evidence at protein level
P57103,NAC3_HUMAN,Sodium/calcium exchanger 3 (Na(+)/Ca(2+)-exchange protein 3) (Solute carrier family 8 member 3),927,"103,010",5 out of 5,2000-12-01,Evidence at protein level
E9PAV3,NACAM_HUMAN,"Nascent polypeptide-associated complex subunit alpha, muscle-specific form (Alpha-NAC, muscle-specific form) (skNAC)",2078,"205,422",4 out of 5,2014-02-19,Evidence at protein level
Q96RE7,NACC1_HUMAN,Nucleus accumbens-associated protein 1 (NAC-1) (BTB/POZ domain-containing protein 14B),527,"57,258",5 out of 5,2007-01-23,Evidence at protein level
Q9BWU0,NADAP_HUMAN,Kanadaptin (Human lung cancer oncogene 3 protein) (HLC-3) (Kidney anion exchanger adapter protein) (Solute carrier family 4 anion exchanger member 1 adapter protein),796,"88,814",4 out of 5,2005-12-20,Evidence at protein level
Q69YI7,NAIF1_HUMAN,Nuclear apoptosis-inducing factor 1,327,"35,164",5 out of 5,2005-07-05,Evidence at protein level
Q8TBE9,NANP_HUMAN,N-acylneuraminate-9-phosphatase (EC 3.1.3.29) (Haloacid dehalogenase-like hydrolase domain-containing protein 4) (Neu5Ac-9-Pase),248,"27,813",5 out of 5,2003-04-30,Evidence at protein level
Q1L6U9,MSMP_HUMAN,Prostate-associated microseminoprotein (PC3-secreted microprotein),139,"14,993",3 out of 5,2008-06-10,Evidence at protein level
Q9Y3D2,MSRB2_HUMAN,"Methionine-R-sulfoxide reductase B2, mitochondrial (MsrB2) (EC 1.8.4.-)",182,"19,536",5 out of 5,2001-01-11,Evidence at protein level
Q8IXL7,MSRB3_HUMAN,Methionine-R-sulfoxide reductase B3 (MsrB3) (EC 1.8.4.-),192,"20,702",5 out of 5,2008-04-08,Evidence at protein level
P80294,MT1H_HUMAN,Metallothionein-1H (MT-1H) (Metallothionein-0) (MT-0) (Metallothionein-IH) (MT-IH),61,"6,039",5 out of 5,1994-02-01,Evidence at protein level
Q9NZJ7,MTCH1_HUMAN,Mitochondrial carrier homolog 1 (Presenilin-associated protein),389,"41,544",5 out of 5,2006-04-04,Evidence at protein level
Q96GX9,MTNB_HUMAN,Methylthioribulose-1-phosphate dehydratase (MTRu-1-P dehydratase) (EC 4.2.1.109) (APAF1-interacting protein) (hAPIP),242,"27,125",5 out of 5,2006-05-30,Evidence at protein level
P48039,MTR1A_HUMAN,Melatonin receptor type 1A (Mel-1A-R) (Mel1a receptor),350,"39,375",5 out of 5,1996-02-01,Evidence at protein level
Q13585,MTR1L_HUMAN,Melatonin-related receptor (G protein-coupled receptor 50) (H9),617,"67,369",5 out of 5,1997-11-01,Evidence at protein level
Q9UKN1,MUC12_HUMAN,Mucin-12 (MUC-12) (Mucin-11) (MUC-11),5478,"558,164",5 out of 5,2008-04-29,Evidence at protein level
Q7Z5P9,MUC19_HUMAN,Mucin-19 (MUC-19),8384,"805,253",5 out of 5,2008-07-01,Evidence at protein level
P15941,MUC1_HUMAN,Mucin-1 (MUC-1) (Breast carcinoma-associated antigen DF3) (Cancer antigen 15-3) (CA 15-3) (Carcinoma-associated mucin) (Episialin) (H23AG) (Krebs von den Lungen-6) (KL-6) (PEMT) (Peanut-reactive urinary mucin) (PUM) (Polymorphic epithelial mucin) (PEM) (Tumor-associated epithelial membrane antigen) (EMA) (Tumor-associated mucin) (CD antigen CD227) [Cleaved into: Mucin-1 subunit alpha (MUC1-NT) (MUC1-alpha); Mucin-1 subunit beta (MUC1-beta) (MUC1-CT)],1255,"122,102",5 out of 5,1990-04-01,Evidence at protein level
Q96DR8,MUCL1_HUMAN,Mucin-like protein 1 (Protein BS106) (Small breast epithelial mucin),90,"9,039",5 out of 5,2006-03-21,Evidence at protein level
P20592,MX2_HUMAN,Interferon-induced GTP-binding protein Mx2 (Interferon-regulated resistance GTP-binding protein MxB) (Myxovirus resistance protein 2) (p78-related protein),715,"82,089",5 out of 5,1991-02-01,Evidence at protein level
Q8N699,MYCT1_HUMAN,Myc target protein 1 (Myc target in myeloid cells protein 1),235,"26,593",3 out of 5,2007-11-13,Evidence at protein level
Q99836,MYD88_HUMAN,Myeloid differentiation primary response protein MyD88,296,"33,233",5 out of 5,2001-10-18,Evidence at protein level
Q9NPC6,MYOZ2_HUMAN,Myozenin-2 (Calsarcin-1) (FATZ-related protein 2),264,"29,898",5 out of 5,2005-11-22,Evidence at protein level
Q9BZM5,N2DL2_HUMAN,NKG2D ligand 2 (N2DL-2) (NKG2DL2) (ALCAN-alpha) (Retinoic acid early transcript 1H) (UL16-binding protein 2),246,"27,368",5 out of 5,2004-05-24,Evidence at protein level
P04731,MT1A_HUMAN,Metallothionein-1A (MT-1A) (Metallothionein-IA) (MT-IA),61,"6,120",5 out of 5,1987-08-13,Evidence at protein level
Q8N339,MT1M_HUMAN,Metallothionein-1M (MT-1M) (Metallothionein-IM) (MT-IM),61,"6,110",4 out of 5,2006-02-07,Inferred from homology
P13995,MTDC_HUMAN,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial [Includes: NAD-dependent methylenetetrahydrofolate dehydrogenase (EC 1.5.1.15); Methenyltetrahydrofolate cyclohydrolase (EC 3.5.4.9)]",350,"37,895",5 out of 5,1990-01-01,Evidence at protein level
Q96E29,MTEF3_HUMAN,"Transcription termination factor 3, mitochondrial (Mitochondrial transcription termination factor 3) (mTERF3) (mTERF domain-containing protein 1, mitochondrial)",417,"47,971",5 out of 5,2006-10-31,Evidence at protein level
Q13496,MTM1_HUMAN,"Myotubularin (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",603,"69,932",5 out of 5,1997-11-01,Evidence at protein level
Q13614,MTMR2_HUMAN,"Myotubularin-related protein 2 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",643,"73,381",5 out of 5,1997-11-01,Evidence at protein level
P20591,MX1_HUMAN,"Interferon-induced GTP-binding protein Mx1 (Interferon-induced protein p78) (IFI-78K) (Interferon-regulated resistance GTP-binding protein MxA) (Myxoma resistance protein 1) (Myxovirus resistance protein 1) [Cleaved into: Interferon-induced GTP-binding protein Mx1, N-terminally processed]",662,"75,520",5 out of 5,1991-02-01,Evidence at protein level
Q96JP2,MY15B_HUMAN,Unconventional myosin-XVB (Myosin XVBP) (Unconventional myosin-15B),1530,"167,118",4 out of 5,2007-06-26,Evidence at protein level
Q8TBZ2,MYBPP_HUMAN,MYCBP-associated protein (AMAM-1) (AMY-1-binding protein 1) (AMAP-1),947,"108,153",4 out of 5,2007-09-11,Evidence at protein level
Q99417,MYCBP_HUMAN,C-Myc-binding protein (Associate of Myc 1) (AMY-1),103,"11,967",5 out of 5,2002-02-11,Evidence at protein level
Q8IZQ8,MYCD_HUMAN,Myocardin,938,"101,997",5 out of 5,2003-06-27,Evidence at protein level
P12525,MYCP1_HUMAN,Putative myc-like protein MYCLP1 (Protein L-Myc-2) (V-myc myelocytomatosis viral oncogene homolog pseudogene 1),358,"40,868",3 out of 5,1989-10-01,Uncertain
Q96QE2,MYCT_HUMAN,Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13),648,"70,371",4 out of 5,2002-04-16,Evidence at protein level
Q9Y2K3,MYH15_HUMAN,Myosin-15 (Myosin heavy chain 15),1946,"224,619",4 out of 5,2007-02-06,Evidence at protein level
Q9Y623,MYH4_HUMAN,"Myosin-4 (Myosin heavy chain 2b) (MyHC-2b) (Myosin heavy chain 4) (Myosin heavy chain IIb) (MyHC-IIb) (Myosin heavy chain, skeletal muscle, fetal)",1939,"223,071",5 out of 5,2001-04-27,Evidence at transcript level
P35579,MYH9_HUMAN,"Myosin-9 (Cellular myosin heavy chain, type A) (Myosin heavy chain 9) (Myosin heavy chain, non-muscle IIa) (Non-muscle myosin heavy chain A) (NMMHC-A) (Non-muscle myosin heavy chain IIa) (NMMHC II-a) (NMMHC-IIA)",1960,"226,532",5 out of 5,1994-06-01,Evidence at protein level
P60660,MYL6_HUMAN,Myosin light polypeptide 6 (17 kDa myosin light chain) (LC17) (Myosin light chain 3) (MLC-3) (Myosin light chain alkali 3) (Myosin light chain A3) (Smooth muscle and nonmuscle myosin light chain alkali 6),151,"16,930",5 out of 5,2004-03-29,Evidence at protein level
P24844,MYL9_HUMAN,"Myosin regulatory light polypeptide 9 (20 kDa myosin light chain) (LC20) (MLC-2C) (Myosin RLC) (Myosin regulatory light chain 2, smooth muscle isoform) (Myosin regulatory light chain 9) (Myosin regulatory light chain MRLC1)",172,"19,827",5 out of 5,1992-03-01,Evidence at protein level
Q5VTT5,MYOM3_HUMAN,Myomesin-3 (Myomesin family member 3),1437,"162,189",5 out of 5,2008-02-26,Evidence at protein level
Q86VE0,MYPOP_HUMAN,"Myb-related transcription factor, partner of profilin (Myb-related protein p42POP) (Partner of profilin)",399,"42,508",3 out of 5,2008-07-22,Evidence at protein level
Q6NZ67,MZT2B_HUMAN,Mitotic-spindle organizing protein 2B (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2B),158,"16,226",4 out of 5,2008-06-10,Evidence at protein level
Q9BZM4,N2DL3_HUMAN,NKG2D ligand 3 (N2DL-3) (NKG2DL3) (ALCAN-gamma) (Retinoic acid early transcript 1N),244,"27,949",5 out of 5,2004-05-24,Evidence at protein level
Q6ZTZ1,MSD1_HUMAN,Myb/SANT-like DNA-binding domain-containing protein 1,278,"31,632",2 out of 5,2008-02-26,Evidence at transcript level
P43246,MSH2_HUMAN,DNA mismatch repair protein Msh2 (hMSH2) (MutS protein homolog 2),934,"104,743",5 out of 5,1995-11-01,Evidence at protein level
Q9BUK6,MSTO1_HUMAN,Protein misato homolog 1,570,"61,835",5 out of 5,2007-09-11,Evidence at protein level
P07438,MT1B_HUMAN,Metallothionein-1B (MT-1B) (Metallothionein-IB) (MT-IB),61,"6,115",4 out of 5,1988-04-01,Inferred from homology
Q86U44,MTA70_HUMAN,N6-adenosine-methyltransferase 70 kDa subunit (MT-A70) (EC 2.1.1.62) (Methyltransferase-like protein 3) (hMETTL3),580,"64,474",5 out of 5,2003-07-25,Evidence at protein level
Q49AM1,MTEF2_HUMAN,"Transcription termination factor 2, mitochondrial (Mitochondrial transcription termination factor 2) (mTERF2) (Mitochondrial transcription termination factor-like protein) (mTERF-like) (mTERFL) (mTERF domain-containing protein 3, mitochondrial)",385,"44,414",4 out of 5,2006-10-31,Evidence at protein level
Q13613,MTMR1_HUMAN,"Myotubularin-related protein 1 (Phosphatidylinositol-3,5-bisphosphate 3-phosphatase) (EC 3.1.3.95) (Phosphatidylinositol-3-phosphate phosphatase) (EC 3.1.3.64)",665,"74,678",5 out of 5,1997-11-01,Evidence at protein level
Q9NXD2,MTMRA_HUMAN,Myotubularin-related protein 10,777,"88,273",3 out of 5,2007-04-17,Evidence at protein level
O75648,MTU1_HUMAN,Mitochondrial tRNA-specific 2-thiouridylase 1 (EC 2.8.1.14) (MTO2 homolog),421,"47,745",5 out of 5,2000-05-30,Evidence at protein level
P84157,MXRA7_HUMAN,Matrix-remodeling-associated protein 7 (Transmembrane anchor protein 1),204,"21,466",2 out of 5,2004-09-27,Evidence at protein level
Q96H12,MSD3_HUMAN,Myb/SANT-like DNA-binding domain-containing protein 3,275,"32,363",2 out of 5,2007-06-26,Evidence at protein level
P52701,MSH6_HUMAN,DNA mismatch repair protein Msh6 (hMSH6) (G/T mismatch-binding protein) (GTBP) (GTMBP) (MutS protein homolog 6) (MutS-alpha 160 kDa subunit) (p160),1360,"152,786",5 out of 5,1996-10-01,Evidence at protein level
Q96DH6,MSI2H_HUMAN,RNA-binding protein Musashi homolog 2 (Musashi-2),328,"35,197",5 out of 5,2004-08-16,Evidence at protein level
Q9UJ68,MSRA_HUMAN,Mitochondrial peptide methionine sulfoxide reductase (EC 1.8.4.11) (Peptide-methionine (S)-S-oxide reductase) (Peptide Met(O) reductase) (Protein-methionine-S-oxide reductase) (PMSR),235,"26,132",5 out of 5,2001-01-11,Evidence at protein level
Q4VC12,MSS51_HUMAN,"Putative protein MSS51 homolog, mitochondrial (Zinc finger MYND domain-containing protein 17)",460,"51,289",2 out of 5,2007-05-29,Evidence at protein level
O43312,MTSS1_HUMAN,Metastasis suppressor protein 1 (Metastasis suppressor YGL-1) (Missing in metastasis protein),755,"82,251",5 out of 5,2001-02-21,Evidence at protein level
Q04900,MUC24_HUMAN,Sialomucin core protein 24 (MUC-24) (Endolyn) (Multi-glycosylated core protein 24) (MGC-24) (MGC-24v) (CD antigen CD164),197,"20,917",5 out of 5,1994-06-01,Evidence at protein level
Q6W4X9,MUC6_HUMAN,Mucin-6 (MUC-6) (Gastric mucin-6),2439,"257,051",5 out of 5,2006-10-31,Evidence at protein level
P04198,MYCN_HUMAN,N-myc proto-oncogene protein (Class E basic helix-loop-helix protein 37) (bHLHe37),464,"49,561",5 out of 5,1987-03-20,Evidence at protein level
Q7Z401,MYCPP_HUMAN,C-myc promoter-binding protein (DENN domain-containing protein 4A),1863,"209,244",5 out of 5,2006-02-21,Evidence at protein level
Q9P2K5,MYEF2_HUMAN,Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156),600,"64,122",5 out of 5,2005-04-26,Evidence at protein level
P23409,MYF6_HUMAN,Myogenic factor 6 (Myf-6) (Class C basic helix-loop-helix protein 4) (bHLHc4) (Muscle-specific regulatory factor 4),242,"26,953",5 out of 5,1991-11-01,Evidence at protein level
P35749,MYH11_HUMAN,"Myosin-11 (Myosin heavy chain 11) (Myosin heavy chain, smooth muscle isoform) (SMMHC)",1972,"227,339",5 out of 5,1994-06-01,Evidence at protein level
Q7Z406,MYH14_HUMAN,"Myosin-14 (Myosin heavy chain 14) (Myosin heavy chain, non-muscle IIc) (Non-muscle myosin heavy chain IIc) (NMHC II-C)",1995,"227,871",5 out of 5,2005-07-19,Evidence at protein level
Q9UKX2,MYH2_HUMAN,"Myosin-2 (Myosin heavy chain 2) (Myosin heavy chain 2a) (MyHC-2a) (Myosin heavy chain IIa) (MyHC-IIa) (Myosin heavy chain, skeletal muscle, adult 2)",1941,"223,044",5 out of 5,2001-04-27,Evidence at protein level
P14649,MYL6B_HUMAN,Myosin light chain 6B (Myosin light chain 1 slow-twitch muscle A isoform) (MLC1sa) (Smooth muscle and nonmuscle myosin light chain alkali 6B),208,"22,764",5 out of 5,1990-04-01,Evidence at protein level
Q8WY64,MYLIP_HUMAN,E3 ubiquitin-protein ligase MYLIP (EC 2.3.2.27) (Inducible degrader of the LDL-receptor) (Idol) (Myosin regulatory light chain interacting protein) (MIR) (RING-type E3 ubiquitin transferase MYLIP),445,"49,910",5 out of 5,2004-11-09,Evidence at protein level
Q9HD67,MYO10_HUMAN,Unconventional myosin-X (Unconventional myosin-10),2058,"237,347",5 out of 5,2001-12-05,Evidence at protein level
Q12965,MYO1E_HUMAN,Unconventional myosin-Ie (Myosin-Ic) (Unconventional myosin 1E),1108,"127,062",5 out of 5,2002-10-10,Evidence at protein level
B0I1T2,MYO1G_HUMAN,Unconventional myosin-Ig [Cleaved into: Minor histocompatibility antigen HA-2 (mHag HA-2)],1018,"116,442",5 out of 5,2008-06-10,Evidence at protein level
Q99972,MYOC_HUMAN,"Myocilin (Myocilin 55 kDa subunit) (Trabecular meshwork-induced glucocorticoid response protein) [Cleaved into: Myocilin, N-terminal fragment (Myocilin 20 kDa N-terminal fragment); Myocilin, C-terminal fragment (Myocilin 35 kDa N-terminal fragment)]",504,"56,972",5 out of 5,1998-07-15,Evidence at protein level
Q8N9H8,MUT7_HUMAN,Exonuclease mut-7 homolog (EC 3.1.-.-) (Exonuclease 3'-5' domain-containing protein 3),876,"96,598",3 out of 5,2008-02-26,Evidence at transcript level
P12882,MYH1_HUMAN,"Myosin-1 (Myosin heavy chain 1) (Myosin heavy chain 2x) (MyHC-2x) (Myosin heavy chain IIx/d) (MyHC-IIx/d) (Myosin heavy chain, skeletal muscle, adult 1)",1939,"223,145",5 out of 5,1989-10-01,Evidence at protein level
P11055,MYH3_HUMAN,"Myosin-3 (Muscle embryonic myosin heavy chain) (Myosin heavy chain 3) (Myosin heavy chain, fast skeletal muscle, embryonic) (SMHCE)",1940,"223,905",5 out of 5,1989-07-01,Evidence at protein level
Q9BUA6,MYL10_HUMAN,"Myosin regulatory light chain 10 (Myosin light chain 2, lymphocyte-specific) (Precursor lymphocyte-specific regulatory light chain)",226,"25,308",3 out of 5,2008-02-26,Evidence at transcript level
Q9H1R3,MYLK2_HUMAN,"Myosin light chain kinase 2, skeletal/cardiac muscle (MLCK2) (EC 2.7.11.18)",596,"64,685",5 out of 5,2002-10-19,Evidence at protein level
O00159,MYO1C_HUMAN,Unconventional myosin-Ic (Myosin I beta) (MMI-beta) (MMIb),1063,"121,682",5 out of 5,2001-04-27,Evidence at protein level
Q8WXR4,MYO3B_HUMAN,Myosin-IIIb (EC 2.7.11.1),1341,"151,829",5 out of 5,2004-04-26,Evidence at transcript level
Q9UM54,MYO6_HUMAN,Unconventional myosin-VI (Unconventional myosin-6),1294,"149,691",5 out of 5,2001-04-27,Evidence at protein level
Q13402,MYO7A_HUMAN,Unconventional myosin-VIIa,2215,"254,390",5 out of 5,2000-12-01,Evidence at protein level
P15173,MYOG_HUMAN,Myogenin (Class C basic helix-loop-helix protein 3) (bHLHc3) (Myogenic factor 4) (Myf-4),224,"25,037",5 out of 5,1990-04-01,Evidence at protein level
Q9NP98,MYOZ1_HUMAN,"Myozenin-1 (Calsarcin-2) (Filamin-, actinin- and telethonin-binding protein) (Protein FATZ)",299,"31,745",5 out of 5,2005-11-22,Evidence at protein level
P0CAP1,MYZAP_HUMAN,Myocardial zonula adherens protein (GRINL1A upstream protein) (Gup),466,"54,206",5 out of 5,2009-05-26,Evidence at protein level
Q9UPR5,NAC2_HUMAN,Sodium/calcium exchanger 2 (Na(+)/Ca(2+)-exchange protein 2) (Solute carrier family 8 member 2),921,"100,368",5 out of 5,2000-12-01,Evidence at transcript level
Q9H009,NACA2_HUMAN,Nascent polypeptide-associated complex subunit alpha-2 (Alpha-NAC-like) (Hom s 2.01) (Nascent polypeptide-associated complex subunit alpha-like) (NAC-alpha-like),215,"23,223",3 out of 5,2007-03-20,Evidence at protein level
O60934,NBN_HUMAN,Nibrin (Cell cycle regulatory protein p95) (Nijmegen breakage syndrome protein 1),754,"84,959",5 out of 5,2006-04-04,Evidence at protein level
Q3BBV0,NBPF1_HUMAN,Neuroblastoma breakpoint family member 1,1214,"139,343",3 out of 5,2007-05-29,Evidence at transcript level
Q86XG9,NBPF5_HUMAN,Putative neuroblastoma breakpoint family member 5,351,"40,546",2 out of 5,2007-05-29,Uncertain
Q3BBV2,NBPF8_HUMAN,Putative neuroblastoma breakpoint family member 8,869,"99,215",2 out of 5,2007-05-29,Uncertain
P61601,NCALD_HUMAN,Neurocalcin-delta,193,"22,245",5 out of 5,2004-05-24,Evidence at protein level
O14594,NCAN_HUMAN,Neurocan core protein (Chondroitin sulfate proteoglycan 3),1321,"143,093",5 out of 5,2003-01-27,Evidence at protein level
P50539,MXI1_HUMAN,Max-interacting protein 1 (Max interactor 1) (Class C basic helix-loop-helix protein 11) (bHLHc11),228,"26,062",5 out of 5,1996-10-01,Evidence at protein level
Q8IUG5,MY18B_HUMAN,Unconventional myosin-XVIIIb,2567,"285,185",5 out of 5,2003-07-11,Evidence at protein level
O75592,MYCB2_HUMAN,E3 ubiquitin-protein ligase MYCBP2 (EC 2.3.2.27) (Myc-binding protein 2) (Pam/highwire/rpm-1 protein) (Protein associated with Myc) (RING-type E3 ubiquitin transferase MYCBP2),4640,"510,084",5 out of 5,2005-06-21,Evidence at protein level
Q96EZ4,MYEOV_HUMAN,Myeloma-overexpressed gene protein (Oncogene in multiple myeloma),313,"33,556",2 out of 5,2003-08-22,Evidence at transcript level
A7E2Y1,MYH7B_HUMAN,"Myosin-7B (Antigen MLAA-21) (Myosin cardiac muscle beta chain) (Myosin heavy chain 7B, cardiac muscle beta isoform) (Slow A MYH14)",1941,"221,388",5 out of 5,2008-09-02,Evidence at protein level
P12883,MYH7_HUMAN,"Myosin-7 (Myosin heavy chain 7) (Myosin heavy chain slow isoform) (MyHC-slow) (Myosin heavy chain, cardiac muscle beta isoform) (MyHC-beta)",1935,"223,097",5 out of 5,1989-10-01,Evidence at protein level
Q86YV6,MYLK4_HUMAN,Myosin light chain kinase family member 4 (EC 2.7.11.1) (Sugen kinase 85) (SgK085),388,"44,508",4 out of 5,2006-11-28,Evidence at protein level
Q9UKN7,MYO15_HUMAN,Unconventional myosin-XV (Unconventional myosin-15),3530,"395,293",5 out of 5,2001-02-21,Evidence at protein level
O43795,MYO1B_HUMAN,Unconventional myosin-Ib (MYH-1c) (Myosin I alpha) (MMI-alpha) (MMIa),1136,"131,985",5 out of 5,2001-04-27,Evidence at protein level
O00160,MYO1F_HUMAN,Unconventional myosin-If (Myosin-Ie),1098,"124,844",3 out of 5,2001-04-27,Evidence at protein level
Q9Y4I1,MYO5A_HUMAN,"Unconventional myosin-Va (Dilute myosin heavy chain, non-muscle) (Myosin heavy chain 12) (Myosin-12) (Myoxin)",1855,"215,405",5 out of 5,2001-04-27,Evidence at protein level
Q13459,MYO9B_HUMAN,Unconventional myosin-IXb (Unconventional myosin-9b),2157,"243,401",5 out of 5,2001-06-20,Evidence at protein level
Q5VU43,MYOME_HUMAN,Myomegalin (Cardiomyopathy-associated protein 2) (Phosphodiesterase 4D-interacting protein),2346,"265,080",5 out of 5,2007-10-23,Evidence at protein level
Q92802,N42L2_HUMAN,NEDD4-binding protein 2-like 2 (Phosphonoformate immuno-associated protein 5),583,"67,459",5 out of 5,2007-09-11,Evidence at protein level
Q14CX7,NAA25_HUMAN,"N-alpha-acetyltransferase 25, NatB auxiliary subunit (Mitochondrial distribution and morphology protein 20) (N-terminal acetyltransferase B complex subunit MDM20) (NatB complex subunit MDM20) (N-terminal acetyltransferase B complex subunit NAA25) (p120)",972,"112,292",5 out of 5,2007-07-10,Evidence at protein level
Q02083,NAAA_HUMAN,N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.-) (Acid ceramidase-like protein) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta],359,"40,066",5 out of 5,1998-07-15,Evidence at protein level
Q9Y303,NAGA_HUMAN,N-acetylglucosamine-6-phosphate deacetylase (GlcNAc 6-P deacetylase) (EC 3.5.1.25) (Amidohydrolase domain-containing protein 2),409,"43,748",5 out of 5,2008-01-15,Evidence at protein level
Q9UJ70,NAGK_HUMAN,N-acetyl-D-glucosamine kinase (N-acetylglucosamine kinase) (EC 2.7.1.59) (GlcNAc kinase),344,"37,376",5 out of 5,2002-11-01,Evidence at protein level
Q7Z5D8,NANGN_HUMAN,NANOG neighbor homeobox (Homeobox protein C14),188,"22,750",2 out of 5,2008-06-10,Evidence at transcript level
P60323,NANO3_HUMAN,Nanos homolog 3 (NOS-3),173,"18,844",5 out of 5,2004-02-02,Evidence at protein level
Q8N8M0,NAT16_HUMAN,Probable N-acetyltransferase 16 (EC 2.3.1.-),369,"40,521",3 out of 5,2007-11-13,Evidence at transcript level
Q9UHQ9,NB5R1_HUMAN,NADH-cytochrome b5 reductase 1 (b5R.1) (EC 1.6.2.2) (Humb5R2) (NAD(P)H:quinone oxidoreductase type 3 polypeptide A2),305,"34,095",5 out of 5,2007-05-15,Evidence at protein level
Q8NFP9,NBEA_HUMAN,Neurobeachin (Lysosomal-trafficking regulator 2) (Protein BCL8B),2946,"327,822",4 out of 5,2003-06-20,Evidence at protein level
Q6ZNJ1,NBEL2_HUMAN,Neurobeachin-like protein 2,2754,"302,517",5 out of 5,2008-05-20,Evidence at protein level
P0C2Y1,NBPF7_HUMAN,Putative neuroblastoma breakpoint family member 7,421,"48,090",2 out of 5,2007-05-29,Uncertain
O15453,NBR2_HUMAN,Next to BRCA1 gene 2 protein (Neighbor of BRCA1 gene 2 protein),112,"12,357",1 out of 5,1999-07-15,Evidence at transcript level
Q01658,NC2B_HUMAN,Protein Dr1 (Down-regulator of transcription 1) (Negative cofactor 2-beta) (NC2-beta) (TATA-binding protein-associated phosphoprotein),176,"19,444",5 out of 5,1993-07-01,Evidence at protein level
O14931,NCTR3_HUMAN,Natural cytotoxicity triggering receptor 3 (Activating natural killer receptor p30) (Natural killer cell p30-related protein) (NK-p30) (NKp30) (CD antigen CD337),201,"21,593",5 out of 5,2004-05-24,Evidence at protein level
Q96NK8,NDF6_HUMAN,Neurogenic differentiation factor 6 (NeuroD6) (Class A basic helix-loop-helix protein 2) (bHLHa2) (Protein atonal homolog 2),337,"38,705",3 out of 5,2002-03-27,Evidence at transcript level
Q96S97,MYADM_HUMAN,Myeloid-associated differentiation marker (Protein SB135),322,"35,274",5 out of 5,2002-05-27,Evidence at protein level
P01106,MYC_HUMAN,Myc proto-oncogene protein (Class E basic helix-loop-helix protein 39) (bHLHe39) (Proto-oncogene c-Myc) (Transcription factor p64),439,"48,804",5 out of 5,1986-07-21,Evidence at protein level
Q02045,MYL5_HUMAN,Myosin light chain 5 (Myosin regulatory light chain 5) (Superfast myosin regulatory light chain 2) (MYLC2) (MyLC-2),173,"19,534",4 out of 5,1993-07-01,Evidence at transcript level
Q9NZM1,MYOF_HUMAN,Myoferlin (Fer-1-like protein 3),2061,"234,709",5 out of 5,2002-01-23,Evidence at protein level
P54296,MYOM2_HUMAN,Myomesin-2 (165 kDa connectin-associated protein) (165 kDa titin-associated protein) (M-protein) (Myomesin family member 2),1465,"164,896",5 out of 5,1996-10-01,Evidence at protein level
Q86TC9,MYPN_HUMAN,Myopalladin (145 kDa sarcomeric protein),1320,"145,257",5 out of 5,2006-06-27,Evidence at protein level
O60237,MYPT2_HUMAN,Protein phosphatase 1 regulatory subunit 12B (Myosin phosphatase-targeting subunit 2) (Myosin phosphatase target subunit 2),982,"110,404",5 out of 5,2004-01-16,Evidence at protein level
Q6P582,MZT2A_HUMAN,Mitotic-spindle organizing protein 2A (Mitotic-spindle organizing protein associated with a ring of gamma-tubulin 2A),158,"16,221",4 out of 5,2008-06-10,Evidence at protein level
Q8WVE0,N6MT2_HUMAN,Protein-lysine N-methyltransferase N6AMT2 (EC 2.1.1.-) (N(6)-adenine-specific DNA methyltransferase 2),214,"24,506",3 out of 5,2007-11-13,Evidence at protein level
P41227,NAA10_HUMAN,N-alpha-acetyltransferase 10 (EC 2.3.1.255) (N-terminal acetyltransferase complex ARD1 subunit homolog A) (NatA catalytic subunit Naa10),235,"26,459",5 out of 5,1995-02-01,Evidence at protein level
Q86W25,NAL13_HUMAN,"NACHT, LRR and PYD domains-containing protein 13 (Nucleotide-binding oligomerization domain protein 14)",1043,"118,884",3 out of 5,2004-04-13,Evidence at transcript level
Q8WY41,NANO1_HUMAN,Nanos homolog 1 (NOS-1) (EC_Rep1a),292,"30,230",5 out of 5,2004-02-02,Evidence at protein level
P60321,NANO2_HUMAN,Nanos homolog 2 (NOS-2),138,"15,132",5 out of 5,2004-02-02,Evidence at protein level
Q9H9S0,NANOG_HUMAN,Homeobox protein NANOG (Homeobox transcription factor Nanog) (hNanog),305,"34,620",5 out of 5,2006-11-28,Evidence at protein level
Q6IPT4,NB5R5_HUMAN,NADH-cytochrome b5 reductase-like (EC 1.6.2.2),315,"35,892",4 out of 5,2008-05-20,Evidence at transcript level
Q8NCQ3,NC301_HUMAN,Putative uncharacterized protein encoded by LINC00301,95,"11,012",2 out of 5,2006-12-12,Uncertain
Q96MG7,NSE3_HUMAN,Non-structural maintenance of chromosomes element 3 homolog (Non-SMC element 3 homolog) (Hepatocellular carcinoma-associated protein 4) (MAGE-G1 antigen) (Melanoma-associated antigen G1) (Necdin-like protein 2),304,"34,308",5 out of 5,2004-04-13,Evidence at protein level
P20783,NTF3_HUMAN,Neurotrophin-3 (NT-3) (HDNF) (Nerve growth factor 2) (NGF-2) (Neurotrophic factor),257,"29,355",5 out of 5,1991-02-01,Evidence at protein level
P34130,NTF4_HUMAN,Neurotrophin-4 (NT-4) (Neurotrophin-5) (NT-5) (Neutrophic factor 4),210,"22,427",5 out of 5,1994-02-01,Evidence at protein level
B1AL46,NTM2E_HUMAN,NUT family member 2E,878,"93,979",2 out of 5,2008-06-10,Inferred from homology
P03897,NU3M_HUMAN,NADH-ubiquinone oxidoreductase chain 3 (EC 1.6.5.3) (NADH dehydrogenase subunit 3),115,"13,186",5 out of 5,1986-07-21,Evidence at protein level
P03901,NU4LM_HUMAN,NADH-ubiquinone oxidoreductase chain 4L (EC 1.6.5.3) (NADH dehydrogenase subunit 4L),98,"10,741",4 out of 5,1986-07-21,Evidence at protein level
Q14980,NUMA1_HUMAN,Nuclear mitotic apparatus protein 1 (NuMA protein) (Nuclear matrix protein-22) (NMP-22) (SP-H antigen),2115,"238,260",5 out of 5,2004-07-19,Evidence at protein level
Q8NFH3,NUP43_HUMAN,Nucleoporin Nup43 (Nup107-160 subcomplex subunit Nup43) (p42),380,"42,151",5 out of 5,2003-01-27,Evidence at protein level
Q9UKX7,NUP50_HUMAN,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),468,"50,144",5 out of 5,2002-05-02,Evidence at protein level
O60356,NUPR1_HUMAN,Nuclear protein 1 (Candidate of metastasis 1) (Nuclear transcriptional regulator protein 1) (Protein p8),82,"8,873",5 out of 5,2000-05-30,Evidence at protein level
Q86Y26,NUTM1_HUMAN,NUT family member 1 (Nuclear protein in testis),1132,"120,314",5 out of 5,2007-11-13,Evidence at protein level
Q9H1B4,NXF5_HUMAN,Nuclear RNA export factor 5 (TAP-like protein 1) (TAPL-1),397,"45,628",5 out of 5,2002-05-15,Evidence at transcript level
Q6NXP6,NXRD1_HUMAN,NADP-dependent oxidoreductase domain-containing protein 1 (EC 1.-.-.-) (Pyrroline-5-carboxylate reductase-like protein C14orf148),359,"39,880",2 out of 5,2007-03-20,Evidence at transcript level
Q9H208,O10A2_HUMAN,Olfactory receptor 10A2 (HP4) (Olfactory receptor OR11-86),303,"33,817",4 out of 5,2006-11-28,Evidence at transcript level
Q8NH74,O10A6_HUMAN,Olfactory receptor 10A6 (Olfactory receptor OR11-96),314,"35,318",3 out of 5,2003-10-10,Inferred from homology
Q8NGC4,O10G3_HUMAN,Olfactory receptor 10G3 (Olfactory receptor OR14-40),313,"35,055",3 out of 5,2003-10-10,Inferred from homology
Q8NGN5,O10G8_HUMAN,Olfactory receptor 10G8 (Olfactory receptor OR11-282),311,"34,519",3 out of 5,2003-10-10,Evidence at transcript level
Q9Y4A9,O10H1_HUMAN,Olfactory receptor 10H1 (Olfactory receptor OR19-27),318,"35,254",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGA6,O10H5_HUMAN,Olfactory receptor 10H5 (Olfactory receptor OR19-25) (Olfactory receptor OR19-26),315,"34,900",3 out of 5,2003-10-10,Evidence at transcript level
Q5JRS4,O10J3_HUMAN,Olfactory receptor 10J3,329,"36,549",3 out of 5,2005-12-20,Inferred from homology
Q8NGQ4,O10Q1_HUMAN,Olfactory receptor 10Q1 (Olfactory receptor OR11-233),319,"35,602",3 out of 5,2003-10-10,Inferred from homology
Q8NGX3,O10T2_HUMAN,Olfactory receptor 10T2 (Olfactory receptor OR1-3),314,"35,011",4 out of 5,2003-10-10,Inferred from homology
Q9GZK7,O11A1_HUMAN,Olfactory receptor 11A1 (Hs6M1-18) (Olfactory receptor 11A2) (Olfactory receptor OR6-30),315,"35,250",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGC9,O11H4_HUMAN,Olfactory receptor 11H4 (Olfactory receptor OR14-36),324,"36,886",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGC8,O11H7_HUMAN,Olfactory receptor 11H7 (Olfactory receptor OR14-32),314,"35,499",4 out of 5,2008-01-15,Inferred from homology
Q9UGF7,O12D3_HUMAN,Olfactory receptor 12D3 (Hs6M1-27) (Olfactory receptor OR6-27),316,"35,791",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGS8,O13C5_HUMAN,Olfactory receptor 13C5 (Olfactory receptor OR9-11),318,"35,796",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGV5,O13D1_HUMAN,Olfactory receptor 13D1 (Olfactory receptor OR9-15),346,"39,125",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGS4,O13F1_HUMAN,Olfactory receptor 13F1 (Olfactory receptor OR9-6),319,"35,646",5 out of 5,2003-10-10,Inferred from homology
Q8NGZ2,O14K1_HUMAN,Olfactory receptor 14K1 (Olfactory receptor 5AY1) (Olfactory receptor OR1-39),314,"34,861",3 out of 5,2003-10-10,Inferred from homology
Q9H340,O51B6_HUMAN,Olfactory receptor 51B6 (Odorant receptor HOR5'beta6),312,"35,269",4 out of 5,2005-12-20,Inferred from homology
Q9H255,O51E2_HUMAN,Olfactory receptor 51E2 (HPRAJ) (Olfactory receptor OR11-16) (Prostate-specific G-protein coupled receptor),320,"35,493",5 out of 5,2001-08-29,Evidence at transcript level
Q8NGJ5,O51L1_HUMAN,Olfactory receptor 51L1 (Olfactory receptor OR11-31),315,"35,369",3 out of 5,2003-10-10,Inferred from homology
Q8NGJ8,O51S1_HUMAN,Olfactory receptor 51S1 (Olfactory receptor OR11-24),323,"35,313",3 out of 5,2003-10-10,Evidence at transcript level
Q9UKL2,O52A1_HUMAN,Olfactory receptor 52A1 (HPFH1OR) (Odorant receptor HOR3'beta4) (Olfactory receptor OR11-319),312,"35,322",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGF0,O52B6_HUMAN,Olfactory receptor 52B6 (Olfactory receptor OR11-47),335,"36,963",4 out of 5,2003-10-10,Inferred from homology
Q8NGI0,O52N2_HUMAN,Olfactory receptor 52N2 (Olfactory receptor OR11-57),321,"35,940",3 out of 5,2003-10-10,Inferred from homology
Q8NGF1,O52R1_HUMAN,Olfactory receptor 52R1 (Olfactory receptor OR11-22),315,"34,943",3 out of 5,2003-10-10,Inferred from homology
P0C646,O52Z1_HUMAN,Olfactory receptor 52Z1,297,"33,279",3 out of 5,2008-01-15,Inferred from homology
Q8NGH5,O56A1_HUMAN,Olfactory receptor 56A1 (Olfactory receptor OR11-75),318,"35,823",5 out of 5,2003-10-10,Evidence at transcript level
Q8NGI8,O5AN1_HUMAN,Olfactory receptor 5AN1 (Olfactory receptor OR11-244),311,"34,789",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGC0,O5AU1_HUMAN,Olfactory receptor 5AU1 (Olfactory receptor OR14-38),362,"40,658",4 out of 5,2003-10-10,Evidence at transcript level
A6NM76,O6C76_HUMAN,Olfactory receptor 6C76,312,"35,119",3 out of 5,2007-11-13,Inferred from homology
Q86UD1,OAF_HUMAN,Out at first protein homolog (HCV NS5A-transactivated protein 13 target protein 2),273,"30,688",2 out of 5,2007-06-26,Evidence at transcript level
P29728,OAS2_HUMAN,2'-5'-oligoadenylate synthase 2 ((2-5')oligo(A) synthase 2) (2-5A synthase 2) (EC 2.7.7.84) (p69 OAS / p71 OAS) (p69OAS / p71OAS),719,"82,431",5 out of 5,1993-04-01,Evidence at protein level
Q16633,OBF1_HUMAN,POU domain class 2-associating factor 1 (B-cell-specific coactivator OBF-1) (BOB-1) (OCA-B) (OCT-binding factor 1),256,"27,436",5 out of 5,1997-11-01,Evidence at protein level
Q5VST9,OBSCN_HUMAN,Obscurin (EC 2.7.11.1) (Obscurin-RhoGEF) (Obscurin-myosin light chain kinase) (Obscurin-MLCK),7968,"868,484",5 out of 5,2006-05-16,Evidence at protein level
Q02509,OC90_HUMAN,Otoconin-90 (Oc90) (Phospholipase A2 homolog),493,"53,454",4 out of 5,2000-05-30,Evidence at transcript level
Q8TAD7,OCC1_HUMAN,Overexpressed in colon carcinoma 1 protein (OCC-1) (AGD3),63,"6,407",2 out of 5,2009-04-14,Evidence at protein level
Q9BZK8,OCR1_HUMAN,Ovarian cancer-related protein 1,76,"8,369",1 out of 5,2008-09-02,Predicted
P29474,NOS3_HUMAN,"Nitric oxide synthase, endothelial (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (Endothelial NOS) (eNOS) (NOS type III) (NOSIII)",1203,"133,289",5 out of 5,1993-04-01,Evidence at protein level
Q9Y314,NOSIP_HUMAN,Nitric oxide synthase-interacting protein (E3 ubiquitin-protein ligase NOSIP) (EC 2.3.2.27) (RING-type E3 ubiquitin transferase NOSIP) (eNOS-interacting protein),301,"33,172",5 out of 5,2007-03-20,Evidence at protein level
Q96PH1,NOX5_HUMAN,NADPH oxidase 5 (EC 1.6.3.-),765,"86,439",5 out of 5,2006-03-07,Evidence at protein level
O60287,NPA1P_HUMAN,Nucleolar pre-ribosomal-associated protein 1 (Nucleolar protein 254 kDa) (URB1 ribosome biogenesis 1 homolog),2271,"254,389",3 out of 5,2000-05-30,Evidence at protein level
Q9UHC9,NPCL1_HUMAN,Niemann-Pick C1-like protein 1,1359,"148,728",5 out of 5,2005-08-30,Evidence at protein level
Q9Y5X5,NPFF2_HUMAN,Neuropeptide FF receptor 2 (G-protein coupled receptor 74) (G-protein coupled receptor HLWAR77) (Neuropeptide G-protein coupled receptor),522,"60,270",5 out of 5,2001-04-27,Evidence at protein level
Q7Z494,NPHP3_HUMAN,Nephrocystin-3,1330,"150,864",5 out of 5,2005-07-05,Evidence at protein level
E9PKD4,NPIA5_HUMAN,Nuclear pore complex-interacting protein family member A5,350,"40,105",2 out of 5,2013-10-16,Evidence at transcript level
P16083,NQO2_HUMAN,Ribosyldihydronicotinamide dehydrogenase [quinone] (EC 1.10.5.1) (NRH dehydrogenase [quinone] 2) (NRH:quinone oxidoreductase 2) (Quinone reductase 2) (QR2),231,"25,919",5 out of 5,1990-04-01,Evidence at protein level
Q96F24,NRBF2_HUMAN,Nuclear receptor-binding factor 2 (NRBF-2) (Comodulator of PPAR and RXR),287,"32,378",5 out of 5,2006-05-16,Evidence at protein level
O43847,NRDC_HUMAN,Nardilysin (EC 3.4.24.61) (N-arginine dibasic convertase) (NRD convertase) (NRD-C) (Nardilysin convertase),1150,"131,572",5 out of 5,1998-12-15,Evidence at protein level
Q16612,NREP_HUMAN,Neuronal regeneration-related protein (Neuronal protein 3.1) (Protein p311),68,"7,909",4 out of 5,1997-11-01,Evidence at protein level
O60462,NRP2_HUMAN,Neuropilin-2 (Vascular endothelial cell growth factor 165 receptor 2),931,"104,859",5 out of 5,2000-12-01,Evidence at protein level
Q9BVL2,NUP58_HUMAN,Nucleoporin p58/p45 (58 kDa nucleoporin) (Nucleoporin-like protein 1),599,"60,897",5 out of 5,2003-10-10,Evidence at protein level
Q8N1F7,NUP93_HUMAN,Nuclear pore complex protein Nup93 (93 kDa nucleoporin) (Nucleoporin Nup93),819,"93,488",5 out of 5,2004-01-16,Evidence at protein level
Q96CM4,NXNL1_HUMAN,Nucleoredoxin-like protein 1 (Thioredoxin-like protein 6),212,"23,943",3 out of 5,2008-02-26,Evidence at transcript level
O95157,NXPH3_HUMAN,Neurexophilin-3,252,"28,127",3 out of 5,2000-12-01,Evidence at protein level
Q9UKK6,NXT1_HUMAN,NTF2-related export protein 1 (Protein p15),140,"15,847",5 out of 5,2001-08-29,Evidence at protein level
Q9H209,O10A4_HUMAN,Olfactory receptor 10A4 (HP2) (Olfactory receptor-like protein JCG5),315,"35,117",4 out of 5,2001-06-20,Evidence at transcript level
Q8NH81,O10G6_HUMAN,Olfactory receptor 10G6 (Olfactory receptor OR11-280),332,"36,823",3 out of 5,2006-01-10,Inferred from homology
Q8NH80,O10D3_HUMAN,Putative olfactory receptor 10D3 (HTPCRX09) (Olfactory receptor OR11-293),312,"34,812",3 out of 5,2008-09-02,Uncertain
Q8NGA5,O10H4_HUMAN,Olfactory receptor 10H4 (Olfactory receptor OR19-28),316,"35,765",3 out of 5,2003-10-10,Inferred from homology
P0C629,O10J4_HUMAN,Olfactory receptor 10J4,311,"34,891",3 out of 5,2008-01-15,Inferred from homology
Q6IF99,O10K2_HUMAN,Olfactory receptor 10K2 (Olfactory receptor OR1-4),312,"35,029",3 out of 5,2005-10-25,Inferred from homology
Q8NGN2,O10S1_HUMAN,Olfactory receptor 10S1 (Olfactory receptor OR11-279),331,"36,501",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGY0,O10X1_HUMAN,Olfactory receptor 10X1 (Olfactory receptor OR1-14),326,"36,446",4 out of 5,2005-12-20,Inferred from homology
Q8NH07,O11H2_HUMAN,Olfactory receptor 11H2 (Olfactory receptor OR14-1),326,"36,531",3 out of 5,2008-04-29,Inferred from homology
Q8NGR1,O13A1_HUMAN,Olfactory receptor 13A1 (Olfactory receptor OR10-3),328,"36,494",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGT0,O13C9_HUMAN,Olfactory receptor 13C9 (Olfactory receptor OR9-13),318,"35,854",3 out of 5,2003-10-10,Inferred from homology
Q8NGZ3,O13G1_HUMAN,Olfactory receptor 13G1 (Olfactory receptor OR1-37),307,"34,672",4 out of 5,2003-10-10,Evidence at transcript level
Q8NHC6,O14L1_HUMAN,Putative olfactory receptor 14L1 (Putative olfactory receptor 5AV1),308,"34,709",3 out of 5,2003-10-10,Uncertain
A4D2G3,O2A25_HUMAN,Olfactory receptor 2A25 (Olfactory receptor 2A27),310,"34,606",4 out of 5,2007-07-10,Evidence at transcript level
Q8NGZ0,O2AJ1_HUMAN,Olfactory receptor 2AJ1,328,"37,063",3 out of 5,2005-12-20,Inferred from homology
Q8NG84,O2AK2_HUMAN,Olfactory receptor 2AK2 (Olfactory receptor 2AK1) (Olfactory receptor OR1-47),335,"37,763",4 out of 5,2003-11-14,Evidence at transcript level
Q8NH04,O2T27_HUMAN,Olfactory receptor 2T27 (Olfactory receptor OR1-67),317,"35,514",3 out of 5,2005-08-16,Inferred from homology
Q8NGX2,O2T35_HUMAN,Olfactory receptor 2T35 (Olfactory receptor OR1-66),323,"36,101",3 out of 5,2003-10-31,Inferred from homology
Q9Y5P0,O51B4_HUMAN,Olfactory receptor 51B4 (Odorant receptor HOR5'beta1),310,"34,912",3 out of 5,2001-06-20,Evidence at transcript level
Q8TCB6,O51E1_HUMAN,Olfactory receptor 51E1 (D-GPCR) (G-protein coupled receptor 164) (Olfactory receptor 52A3) (Prostate-overexpressed G protein-coupled receptor) (Prostate-specific G protein-coupled receptor 2),317,"35,271",4 out of 5,2003-10-10,Evidence at transcript level
A6NGY5,O51F1_HUMAN,Olfactory receptor 51F1,319,"35,849",4 out of 5,2007-12-04,Inferred from homology
Q9H343,O51I1_HUMAN,Olfactory receptor 51I1 (Odorant receptor HOR5'beta11) (Olfactory receptor OR11-39),314,"35,484",3 out of 5,2001-06-20,Evidence at transcript level
Q9H346,O52D1_HUMAN,Olfactory receptor 52D1 (Odorant receptor HOR5'beta14) (Olfactory receptor OR11-43),318,"35,122",4 out of 5,2001-06-20,Evidence at transcript level
Q96RD3,O52E6_HUMAN,Olfactory receptor 52E6 (Olfactory receptor OR11-58),313,"35,524",3 out of 5,2002-05-10,Inferred from homology
Q8NH53,O52N1_HUMAN,Olfactory receptor 52N1 (Olfactory receptor OR11-61),320,"35,785",3 out of 5,2003-10-10,Inferred from homology
Q8NH57,O52P1_HUMAN,Putative olfactory receptor 52P1,321,"34,890",3 out of 5,2003-10-10,Uncertain
Q6IF63,O52W1_HUMAN,Olfactory receptor 52W1 (Olfactory receptor OR11-71),320,"34,414",3 out of 5,2005-12-20,Evidence at transcript level
Q8NGI3,O56B1_HUMAN,Olfactory receptor 56B1 (Olfactory receptor OR11-65),324,"36,050",3 out of 5,2005-07-19,Evidence at transcript level
P0C617,O5AL1_HUMAN,Olfactory receptor 5AL1 (Olfactory receptor OR11-184),328,"36,816",3 out of 5,2008-01-15,Inferred from homology
Q8N127,O5AS1_HUMAN,Olfactory receptor 5AS1 (Olfactory receptor OR11-168),324,"36,653",3 out of 5,2003-10-10,Inferred from homology
A6NDH6,O5H15_HUMAN,Olfactory receptor 5H15,313,"35,352",3 out of 5,2007-11-13,Inferred from homology
A6NL08,O6C75_HUMAN,Olfactory receptor 6C75,312,"35,372",3 out of 5,2007-11-13,Inferred from homology
O95190,OAZ2_HUMAN,Ornithine decarboxylase antizyme 2 (AZ2) (ODC-Az 2),189,"21,011",4 out of 5,1999-07-15,Evidence at protein level
Q6P4R8,NFRKB_HUMAN,Nuclear factor related to kappa-B-binding protein (DNA-binding protein R kappa-B) (INO80 complex subunit G),1299,"139,001",5 out of 5,2006-03-21,Evidence at protein level
Q9UMS0,NFU1_HUMAN,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial (HIRA-interacting protein 5)",254,"28,463",5 out of 5,2002-08-13,Evidence at protein level
P25208,NFYB_HUMAN,Nuclear transcription factor Y subunit beta (CAAT box DNA-binding protein subunit B) (Nuclear transcription factor Y subunit B) (NF-YB),207,"22,831",5 out of 5,1992-05-01,Evidence at protein level
Q9UJF2,NGAP_HUMAN,Ras GTPase-activating protein nGAP (RAS protein activator-like 2),1139,"128,558",5 out of 5,2001-05-04,Evidence at protein level
Q8N5V2,NGEF_HUMAN,Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor),710,"82,496",5 out of 5,2006-09-05,Evidence at protein level
Q5JS37,NHLC3_HUMAN,NHL repeat-containing protein 3,347,"38,283",3 out of 5,2008-02-05,Evidence at transcript level
Q9NX24,NHP2_HUMAN,H/ACA ribonucleoprotein complex subunit 2 (Nucleolar protein family A member 2) (snoRNP protein NHP2),153,"17,201",5 out of 5,2005-07-05,Evidence at protein level
Q6T4R5,NHS_HUMAN,Nance-Horan syndrome protein (Congenital cataracts and dental anomalies protein),1651,"179,135",5 out of 5,2005-03-29,Evidence at protein level
Q9BPW8,NIPS1_HUMAN,Protein NipSnap homolog 1 (NipSnap1),284,"33,310",2 out of 5,2001-09-26,Evidence at protein level
P26715,NKG2A_HUMAN,NKG2-A/NKG2-B type II integral membrane protein (CD159 antigen-like family member A) (NK cell receptor A) (NKG2-A/B-activating NK receptor) (CD antigen CD159a),233,"26,314",5 out of 5,1992-08-01,Evidence at protein level
P78426,NKX61_HUMAN,Homeobox protein Nkx-6.1 (Homeobox protein NK-6 homolog A),367,"37,849",5 out of 5,1999-07-15,Evidence at protein level
Q8N0W4,NLGNX_HUMAN,"Neuroligin-4, X-linked (Neuroligin X) (HNLX)",816,"91,915",5 out of 5,2003-05-23,Evidence at protein level
P08949,NMB_HUMAN,Neuromedin-B [Cleaved into: Neuromedin-B-32; Neuromedin-B],121,"13,252",5 out of 5,1988-11-01,Evidence at protein level
Q9HBL8,NMRL1_HUMAN,NmrA-like family domain-containing protein 1,299,"33,344",5 out of 5,2007-02-20,Evidence at protein level
Q96S42,NODAL_HUMAN,Nodal homolog,347,"39,561",5 out of 5,2003-01-10,Evidence at protein level
E9PJI5,NPIA7_HUMAN,Nuclear pore complex-interacting protein family member A7,369,"42,230",2 out of 5,2013-10-16,Evidence at protein level
F8W1W9,NPIB9_HUMAN,Nuclear pore complex-interacting protein family member B9,429,"49,181",2 out of 5,2013-10-16,Inferred from homology
Q8TAT6,NPL4_HUMAN,Nuclear protein localization protein 4 homolog (Protein NPL4),608,"68,120",5 out of 5,2004-03-29,Evidence at protein level
O75607,NPM3_HUMAN,Nucleoplasmin-3,178,"19,344",5 out of 5,2000-05-30,Evidence at protein level
Q12980,NPRL3_HUMAN,Nitrogen permease regulator 3-like protein (-14 gene protein) (Alpha-globin regulatory element-containing gene protein) (Protein CGTHBA),569,"63,605",5 out of 5,2001-09-26,Evidence at protein level
Q9BS92,NPS3B_HUMAN,Protein NipSnap homolog 3B (NipSnap3B) (SNAP1),247,"28,313",2 out of 5,2001-09-26,Evidence at transcript level
P50391,NPY4R_HUMAN,Neuropeptide Y receptor type 4 (NPY4-R) (Pancreatic polypeptide receptor 1) (PP1),375,"42,195",5 out of 5,1996-10-01,Evidence at transcript level
P55055,NR1H2_HUMAN,Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor),460,"50,974",5 out of 5,1996-10-01,Evidence at protein level
Q13133,NR1H3_HUMAN,Oxysterols receptor LXR-alpha (Liver X receptor alpha) (Nuclear receptor subfamily 1 group H member 3),447,"50,396",5 out of 5,2000-05-30,Evidence at protein level
Q86WQ0,NR2CA_HUMAN,Nuclear receptor 2C2-associated protein (TR4 orphan receptor-associated 16 kDa protein),139,"15,876",4 out of 5,2007-07-24,Evidence at protein level
Q68D85,NR3L1_HUMAN,Natural cytotoxicity triggering receptor 3 ligand 1 (B7 homolog 6) (B7-H6),454,"50,827",5 out of 5,2010-01-19,Evidence at protein level
Q92570,NR4A3_HUMAN,Nuclear receptor subfamily 4 group A member 3 (Mitogen-induced nuclear orphan receptor) (Neuron-derived orphan receptor 1) (Nuclear hormone receptor NOR-1),626,"68,230",5 out of 5,1997-11-01,Evidence at protein level
Q16620,NTRK2_HUMAN,BDNF/NT-3 growth factors receptor (EC 2.7.10.1) (GP145-TrkB) (Trk-B) (Neurotrophic tyrosine kinase receptor type 2) (TrkB tyrosine kinase) (Tropomyosin-related kinase B),822,"91,999",5 out of 5,1997-11-01,Evidence at protein level
Q16288,NTRK3_HUMAN,NT-3 growth factor receptor (EC 2.7.10.1) (GP145-TrkC) (Trk-C) (Neurotrophic tyrosine kinase receptor type 3) (TrkC tyrosine kinase),839,"94,428",5 out of 5,1997-11-01,Evidence at protein level
Q5SRE5,NU188_HUMAN,Nucleoporin NUP188 homolog (hNup188),1749,"196,043",5 out of 5,2007-09-11,Evidence at protein level
Q92621,NU205_HUMAN,Nuclear pore complex protein Nup205 (205 kDa nucleoporin) (Nucleoporin Nup205),2012,"227,922",5 out of 5,2004-01-16,Evidence at protein level
Q9UGY1,NOL12_HUMAN,Nucleolar protein 12,213,"24,663",3 out of 5,2007-01-09,Evidence at protein level
Q96MY1,NOL4L_HUMAN,Nucleolar protein 4-like,436,"47,215",3 out of 5,2003-02-01,Evidence at protein level
P61580,NP10_HUMAN,Endogenous retrovirus group K member 10 Np9 protein (HERV-K10 Np9 protein) (HERV-K107 Np9 protein) (HERV-K_5q33.3 provirus Np9 protein),75,"8,892",2 out of 5,2004-05-24,Evidence at protein level
P0DM63,NPIA8_HUMAN,Nuclear pore complex-interacting protein family member A8,369,"42,230",2 out of 5,2013-10-16,Inferred from homology
E9PJ23,NPIB6_HUMAN,Nuclear pore complex-interacting protein family member B6,425,"49,162",2 out of 5,2013-10-16,Inferred from homology
Q8WWG1,NRG4_HUMAN,"Pro-neuregulin-4, membrane-bound isoform (Pro-NRG4) [Cleaved into: Neuregulin-4 (NRG-4)]",115,"12,722",5 out of 5,2003-02-01,Evidence at protein level
Q9NPI5,NRK2_HUMAN,Nicotinamide riboside kinase 2 (NRK 2) (NmR-K 2) (EC 2.7.1.22) (Integrin beta-1-binding protein 3) (Muscle integrin-binding protein) (MIBP) (Nicotinic acid riboside kinase 2) (EC 2.7.1.173) (Ribosylnicotinamide kinase 2) (RNK 2) (Ribosylnicotinic acid kinase 2),230,"26,046",5 out of 5,2004-07-19,Evidence at protein level
Q9NPD7,NRN1_HUMAN,Neuritin,142,"15,333",3 out of 5,2006-11-28,Evidence at transcript level
P58400,NRX1B_HUMAN,Neurexin-1-beta (Neurexin I-beta),442,"46,861",5 out of 5,2001-11-16,Evidence at protein level
Q9Y4C0,NRX3A_HUMAN,Neurexin-3 (Neurexin III-alpha) (Neurexin-3-alpha),1643,"180,599",5 out of 5,2001-11-16,Evidence at protein level
Q9NXX6,NSE4A_HUMAN,Non-structural maintenance of chromosomes element 4 homolog A (NS4EA) (Non-SMC element 4 homolog A),385,"44,301",4 out of 5,2005-07-05,Evidence at protein level
P46459,NSF_HUMAN,Vesicle-fusing ATPase (EC 3.6.4.6) (N-ethylmaleimide-sensitive fusion protein) (NEM-sensitive fusion protein) (Vesicular-fusion protein NSF),744,"82,594",5 out of 5,1995-11-01,Evidence at protein level
Q9Y328,NSG2_HUMAN,Neuron-specific protein family member 2 (Protein p19) (Hmp19),171,"19,085",3 out of 5,2002-05-27,Evidence at transcript level
Q6X4W1,NSMF_HUMAN,NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor),530,"60,143",5 out of 5,2005-07-19,Evidence at protein level
Q5VT03,NTM2D_HUMAN,NUT family member 2D,806,"86,276",2 out of 5,2006-12-12,Inferred from homology
P03905,NU4M_HUMAN,NADH-ubiquinone oxidoreductase chain 4 (EC 1.6.5.3) (NADH dehydrogenase subunit 4),459,"51,581",5 out of 5,1986-07-21,Evidence at protein level
Q9Y5A7,NUB1_HUMAN,NEDD8 ultimate buster 1 (Negative regulator of ubiquitin-like proteins 1) (Renal carcinoma antigen NY-REN-18),615,"70,538",5 out of 5,2000-12-01,Evidence at protein level
Q9BW91,NUDT9_HUMAN,"ADP-ribose pyrophosphatase, mitochondrial (EC 3.6.1.13) (ADP-ribose diphosphatase) (ADP-ribose phosphohydrolase) (Adenosine diphosphoribose pyrophosphatase) (ADPR-PPase) (Nucleoside diphosphate-linked moiety X motif 9) (Nudix motif 9)",350,"39,125",5 out of 5,2002-05-02,Evidence at protein level
Q8NFH4,NUP37_HUMAN,Nucleoporin Nup37 (p37) (Nup107-160 subcomplex subunit Nup37),326,"36,708",5 out of 5,2003-01-27,Evidence at protein level
Q8N323,NXPE1_HUMAN,NXPE family member 1 (Protein FAM55A),547,"63,178",3 out of 5,2007-10-23,Evidence at transcript level
O95156,NXPH2_HUMAN,Neurexophilin-2,264,"29,938",3 out of 5,2000-12-01,Evidence at transcript level
O95158,NXPH4_HUMAN,Neurexophilin-4,308,"33,065",3 out of 5,2000-12-01,Evidence at transcript level
P26717,NKG2C_HUMAN,NKG2-C type II integral membrane protein (CD159 antigen-like family member C) (NK cell receptor C) (NKG2-C-activating NK receptor) (CD antigen CD159c),231,"26,072",5 out of 5,1992-08-01,Evidence at protein level
O43908,NKG2F_HUMAN,NKG2-F type II integral membrane protein (NK cell receptor F) (NKG2-F-activating NK receptor),158,"18,234",3 out of 5,2002-05-15,Evidence at transcript level
Q86UT6,NLRX1_HUMAN,NLR family member X1 (Caterpiller protein 11.3) (CLR11.3) (Nucleotide-binding oligomerization domain protein 26) (Nucleotide-binding oligomerization domain protein 5) (Nucleotide-binding oligomerization domain protein 9),975,"107,616",5 out of 5,2007-07-24,Evidence at protein level
P22307,NLTP_HUMAN,Non-specific lipid-transfer protein (NSL-TP) (EC 2.3.1.176) (Propanoyl-CoA C-acyltransferase) (SCP-chi) (SCPX) (Sterol carrier protein 2) (SCP-2) (Sterol carrier protein X) (SCP-X),547,"58,994",5 out of 5,1991-08-01,Evidence at protein level
O60391,NMD3B_HUMAN,"Glutamate receptor ionotropic, NMDA 3B (GluN3B) (N-methyl-D-aspartate receptor subtype 3B) (NMDAR3B) (NR3B)",1043,"112,992",5 out of 5,2004-08-31,Evidence at transcript level
Q13423,NNTM_HUMAN,"NAD(P) transhydrogenase, mitochondrial (EC 1.6.1.2) (Nicotinamide nucleotide transhydrogenase) (Pyridine nucleotide transhydrogenase)",1086,"113,896",5 out of 5,2000-05-30,Evidence at protein level
O60393,NOBOX_HUMAN,Homeobox protein NOBOX,691,"73,906",4 out of 5,2006-12-12,Evidence at protein level
Q9Y3T9,NOC2L_HUMAN,Nucleolar complex protein 2 homolog (Protein NOC2 homolog) (NOC2-like protein) (Novel INHAT repressor),749,"84,919",5 out of 5,2000-05-30,Evidence at protein level
Q8WTT2,NOC3L_HUMAN,Nucleolar complex protein 3 homolog (NOC3 protein homolog) (Factor for adipocyte differentiation 24) (NOC3-like protein) (Nucleolar complex-associated protein 3-like protein),800,"92,548",5 out of 5,2005-09-27,Evidence at protein level
Q13823,NOG2_HUMAN,Nucleolar GTP-binding protein 2 (Autoantigen NGP-1),731,"83,655",4 out of 5,1998-07-15,Evidence at protein level
Q9BSC4,NOL10_HUMAN,Nucleolar protein 10,688,"80,302",3 out of 5,2005-08-30,Evidence at protein level
P69849,NOMO3_HUMAN,Nodal modulator 3 (pM5 protein 3),1222,"134,134",3 out of 5,2005-06-07,Inferred from homology
Q9NPE3,NOP10_HUMAN,H/ACA ribonucleoprotein complex subunit 3 (Nucleolar protein 10) (Nucleolar protein family A member 3) (snoRNP protein NOP10),64,"7,706",5 out of 5,2004-10-11,Evidence at protein level
Q9Y3C1,NOP16_HUMAN,Nucleolar protein 16 (HBV pre-S2 trans-regulated protein 3),178,"21,188",3 out of 5,2000-05-30,Evidence at protein level
O00567,NOP56_HUMAN,Nucleolar protein 56 (Nucleolar protein 5A),594,"66,050",5 out of 5,1997-11-01,Evidence at protein level
Q04721,NOTC2_HUMAN,Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)],2471,"265,405",5 out of 5,2002-03-27,Evidence at protein level
P48745,NOV_HUMAN,Protein NOV homolog (NovH) (CCN family member 3) (Insulin-like growth factor-binding protein 9) (IBP-9) (IGF-binding protein 9) (IGFBP-9) (Nephroblastoma-overexpressed gene protein homolog),357,"39,162",5 out of 5,1996-02-01,Evidence at protein level
P55209,NP1L1_HUMAN,Nucleosome assembly protein 1-like 1 (NAP-1-related protein) (hNRP),391,"45,374",5 out of 5,1996-10-01,Evidence at protein level
Q9GZQ6,NPFF1_HUMAN,Neuropeptide FF receptor 1 (G-protein coupled receptor 147) (RFamide-related peptide receptor OT7T022),430,"47,819",4 out of 5,2001-04-27,Evidence at transcript level
O75161,NPHP4_HUMAN,Nephrocystin-4 (Nephroretinin),1426,"157,598",5 out of 5,2003-01-27,Evidence at protein level
Q9Y466,NR2E1_HUMAN,Nuclear receptor subfamily 2 group E member 1 (Nuclear receptor TLX) (Protein tailless homolog) (Tll) (hTll),385,"42,589",5 out of 5,2000-12-01,Evidence at protein level
P10588,NR2F6_HUMAN,Nuclear receptor subfamily 2 group F member 6 (V-erbA-related protein 2) (EAR-2),404,"42,979",5 out of 5,1989-07-01,Evidence at protein level
P58401,NRX2B_HUMAN,Neurexin-2-beta (Neurexin II-beta),666,"70,927",5 out of 5,2001-11-16,Evidence at protein level
Q96MF7,NSE2_HUMAN,E3 SUMO-protein ligase NSE2 (EC 6.3.2.-) (MMS21 homolog) (hMMS21) (Non-structural maintenance of chromosomes element 2 homolog) (Non-SMC element 2 homolog),247,"27,932",5 out of 5,2007-01-09,Evidence at protein level
Q9UNZ2,NSF1C_HUMAN,NSFL1 cofactor p47 (UBX domain-containing protein 2C) (p97 cofactor p47),370,"40,573",5 out of 5,2004-01-16,Evidence at protein level
O60906,NSMA_HUMAN,Sphingomyelin phosphodiesterase 2 (EC 3.1.4.12) (Lyso-platelet-activating factor-phospholipase C) (Lyso-PAF-PLC) (Neutral sphingomyelinase) (N-SMase) (nSMase),423,"47,646",5 out of 5,2002-02-11,Evidence at protein level
Q9H857,NT5D2_HUMAN,5'-nucleotidase domain-containing protein 2 (EC 3.1.3.-),520,"60,719",3 out of 5,2006-07-25,Evidence at protein level
Q96HA8,NTAQ1_HUMAN,Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (WDYHV motif-containing protein 1),205,"23,680",5 out of 5,2007-03-06,Evidence at protein level
Q8IVF1,NTM2A_HUMAN,NUT family member 2A,878,"93,890",2 out of 5,2006-12-12,Evidence at transcript level
Q9P121,NTRI_HUMAN,Neurotrimin (hNT) (IgLON family member 2),344,"37,971",5 out of 5,2002-12-13,Evidence at protein level
P04629,NTRK1_HUMAN,High affinity nerve growth factor receptor (EC 2.7.10.1) (Neurotrophic tyrosine kinase receptor type 1) (TRK1-transforming tyrosine kinase protein) (Tropomyosin-related kinase A) (Tyrosine kinase receptor) (Tyrosine kinase receptor A) (Trk-A) (gp140trk) (p140-TrkA),796,"87,497",5 out of 5,1987-08-13,Evidence at protein level
P03886,NU1M_HUMAN,NADH-ubiquinone oxidoreductase chain 1 (EC 1.6.5.3) (NADH dehydrogenase subunit 1),318,"35,661",5 out of 5,1986-07-21,Evidence at protein level
Q9H8H0,NOL11_HUMAN,Nucleolar protein 11,719,"81,124",5 out of 5,2005-08-30,Evidence at protein level
P51513,NOVA1_HUMAN,RNA-binding protein Nova-1 (Neuro-oncological ventral antigen 1) (Onconeural ventral antigen 1) (Paraneoplastic Ri antigen) (Ventral neuron-specific protein 1),510,"52,056",5 out of 5,1996-10-01,Evidence at protein level
P61581,NP24_HUMAN,Endogenous retrovirus group K member 24 Np9 protein (HERV-K101 Np9 protein) (HERV-K_22q11.21 provirus Np9 protein),75,"8,893",2 out of 5,2004-05-24,Evidence at protein level
Q9H841,NPAL2_HUMAN,NIPA-like protein 2,368,"40,785",2 out of 5,2006-06-27,Evidence at transcript level
Q9NZP6,NPAP1_HUMAN,Nuclear pore-associated protein 1,1156,"120,954",5 out of 5,2006-06-27,Evidence at protein level
P48146,NPBW2_HUMAN,Neuropeptides B/W receptor type 2 (G-protein coupled receptor 8),333,"36,861",5 out of 5,1996-02-01,Evidence at protein level
Q9NQX5,NPDC1_HUMAN,Neural proliferation differentiation and control protein 1 (NPDC-1),325,"34,516",3 out of 5,2001-01-11,Evidence at protein level
Q9BXD5,NPL_HUMAN,N-acetylneuraminate lyase (NALase) (EC 4.1.3.3) (N-acetylneuraminate pyruvate-lyase) (N-acetylneuraminic acid aldolase) (Sialate lyase) (Sialate-pyruvate lyase) (Sialic acid aldolase) (Sialic acid lyase),320,"35,163",5 out of 5,2007-01-23,Evidence at protein level
O95436,NPT2B_HUMAN,Sodium-dependent phosphate transport protein 2B (Sodium-phosphate transport protein 2B) (Na(+)-dependent phosphate cotransporter 2B) (NaPi3b) (Sodium/phosphate cotransporter 2B) (Na(+)/Pi cotransporter 2B) (NaPi-2b) (Solute carrier family 34 member 2),690,"75,759",5 out of 5,2005-12-20,Evidence at protein level
O00624,NPT3_HUMAN,Sodium-dependent phosphate transport protein 3 (Na(+)/PI cotransporter 3) (Sodium/phosphate cotransporter 3) (Solute carrier family 17 member 2),439,"47,277",4 out of 5,1998-07-15,Evidence at transcript level
Q9Y639,NPTN_HUMAN,Neuroplastin (Stromal cell-derived receptor 1) (SDR-1),398,"44,387",5 out of 5,2006-01-10,Evidence at protein level
Q99463,NPY6R_HUMAN,Putative neuropeptide Y receptor type 6 (NPY6-R) (NPY Y1-like receptor) (Putative pancreatic polypeptide receptor 2) (PP2),290,"33,180",4 out of 5,2008-09-02,Uncertain
Q9Y5X4,NR2E3_HUMAN,Photoreceptor-specific nuclear receptor (Nuclear receptor subfamily 2 group E member 3) (Retina-specific nuclear receptor),410,"44,692",5 out of 5,2000-12-01,Evidence at protein level
Q02297,NRG1_HUMAN,"Pro-neuregulin-1, membrane-bound isoform (Pro-NRG1) [Cleaved into: Neuregulin-1 (Acetylcholine receptor-inducing activity) (ARIA) (Breast cancer cell differentiation factor p45) (Glial growth factor) (Heregulin) (HRG) (Neu differentiation factor) (Sensory and motor neuron-derived factor)]",640,"70,392",5 out of 5,2000-12-01,Evidence at protein level
Q9NWW6,NRK1_HUMAN,Nicotinamide riboside kinase 1 (NRK 1) (NmR-K 1) (EC 2.7.1.22) (Nicotinic acid riboside kinase 1) (EC 2.7.1.173) (Ribosylnicotinamide kinase 1) (RNK 1) (Ribosylnicotinic acid kinase 1),199,"23,193",5 out of 5,2004-07-19,Evidence at protein level
Q9HDB5,NRX3B_HUMAN,"Neurexin-3-beta (Neurexin III-beta) [Cleaved into: Neurexin-3-beta, soluble form; Neurexin-3-beta, C-terminal fragment (NRXN3-CTF)]",637,"69,305",5 out of 5,2001-11-16,Evidence at protein level
Q9Y6Y0,NS1BP_HUMAN,Influenza virus NS1A-binding protein (NS1-BP) (NS1-binding protein) (Aryl hydrocarbon receptor-associated protein 3),642,"71,729",5 out of 5,2007-05-01,Evidence at protein level
Q9BZ95,NSD3_HUMAN,Histone-lysine N-methyltransferase NSD3 (EC 2.1.1.43) (Nuclear SET domain-containing protein 3) (Protein whistle) (WHSC1-like 1 isoform 9 with methyltransferase activity to lysine) (Wolf-Hirschhorn syndrome candidate 1-like protein 1) (WHSC1-like protein 1),1437,"161,613",5 out of 5,2006-10-31,Evidence at protein level
Q8WV22,NSE1_HUMAN,Non-structural maintenance of chromosomes element 1 homolog (Non-SMC element 1 homolog) (EC 6.3.2.-),266,"30,855",5 out of 5,2007-01-09,Evidence at protein level
Q96IY1,NSL1_HUMAN,Kinetochore-associated protein NSL1 homolog,281,"32,162",5 out of 5,2003-07-19,Evidence at protein level
Q08J23,NSUN2_HUMAN,tRNA (cytosine(34)-C(5))-methyltransferase (EC 2.1.1.203) (Myc-induced SUN domain-containing protein) (Misu) (NOL1/NOP2/Sun domain family member 2) (Substrate of AIM1/Aurora kinase B) (tRNA (cytosine-5-)-methyltransferase) (tRNA methyltransferase 4 homolog) (hTrm4),767,"86,471",5 out of 5,2007-05-29,Evidence at protein level
Q96P11,NSUN5_HUMAN,Probable 28S rRNA (cytosine-C(5))-methyltransferase (EC 2.1.1.-) (NOL1-related protein) (NOL1R) (NOL1/NOP2/Sun domain family member 5) (Williams-Beuren syndrome chromosomal region 20A protein),429,"46,692",5 out of 5,2006-11-28,Evidence at protein level
Q9NPB1,NT5M_HUMAN,"5'(3')-deoxyribonucleotidase, mitochondrial (5',3'-nucleotidase, mitochondrial) (EC 3.1.3.-) (Deoxy-5'-nucleotidase 2) (dNT-2)",228,"25,862",5 out of 5,2003-10-31,Evidence at protein level
Q9BV86,NTM1A_HUMAN,"N-terminal Xaa-Pro-Lys N-methyltransferase 1 (EC 2.1.1.244) (Alpha N-terminal protein methyltransferase 1A) (Methyltransferase-like protein 11A) (N-terminal RCC1 methyltransferase) (X-Pro-Lys N-terminal protein methyltransferase 1A) (NTM1A) [Cleaved into: N-terminal Xaa-Pro-Lys N-methyltransferase 1, N-terminally processed]",223,"25,387",5 out of 5,2005-11-08,Evidence at protein level
P80303,NUCB2_HUMAN,Nucleobindin-2 (DNA-binding protein NEFA) (Gastric cancer antigen Zg4) (Prepronesfatin) [Cleaved into: Nesfatin-1],420,"50,196",5 out of 5,1994-02-01,Evidence at protein level
Q496H8,NRN1L_HUMAN,Neuritin-like protein,165,"17,786",3 out of 5,2008-02-26,Evidence at transcript level
O14786,NRP1_HUMAN,Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304),923,"103,134",5 out of 5,2000-05-30,Evidence at protein level
Q8IZ57,NRSN1_HUMAN,Neurensin-1 (Neuro-p24) (Vesicular membrane protein of 24 kDa) (Vesicular membrane protein p24),195,"21,475",4 out of 5,2007-01-09,Evidence at protein level
Q9P2S2,NRX2A_HUMAN,Neurexin-2 (Neurexin II-alpha) (Neurexin-2-alpha),1712,"184,982",5 out of 5,2001-11-16,Evidence at transcript level
P42857,NSG1_HUMAN,Neuron-specific protein family member 1 (Brain neuron cytoplasmic protein 1),185,"20,913",4 out of 5,1995-11-01,Evidence at protein level
Q9NXE4,NSMA3_HUMAN,Sphingomyelin phosphodiesterase 4 (EC 3.1.4.12) (Neutral sphingomyelinase 3) (nSMase-3) (nSMase3) (Neutral sphingomyelinase III),827,"93,352",5 out of 5,2007-01-23,Evidence at protein level
Q63ZY6,NSN5C_HUMAN,Putative methyltransferase NSUN5C (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 5C) (Williams-Beuren syndrome chromosomal region 20C protein),315,"34,347",5 out of 5,2006-11-28,Uncertain
Q96CB9,NSUN4_HUMAN,5-methylcytosine rRNA methyltransferase NSUN4 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 4),384,"43,089",5 out of 5,2007-05-29,Evidence at protein level
Q14973,NTCP_HUMAN,Sodium/bile acid cotransporter (Cell growth-inhibiting gene 29 protein) (Na(+)/bile acid cotransporter) (Na(+)/taurocholate transport protein) (Sodium/taurocholate cotransporting polypeptide) (Solute carrier family 10 member 1),349,"38,119",5 out of 5,1997-11-01,Evidence at protein level
P78549,NTH_HUMAN,Endonuclease III-like protein 1 (hNTH1) (EC 3.2.2.-) (EC 4.2.99.18) (Bifunctional DNA N-glycosylase/DNA-(apurinic or apyrimidinic site) lyase) (DNA glycosylase/AP lyase),312,"34,390",5 out of 5,2003-02-28,Evidence at protein level
Q8WUM0,NU133_HUMAN,Nuclear pore complex protein Nup133 (133 kDa nucleoporin) (Nucleoporin Nup133),1156,"128,979",5 out of 5,2003-03-28,Evidence at protein level
O75694,NU155_HUMAN,Nuclear pore complex protein Nup155 (155 kDa nucleoporin) (Nucleoporin Nup155),1391,"155,199",5 out of 5,1999-07-15,Evidence at protein level
Q12769,NU160_HUMAN,Nuclear pore complex protein Nup160 (160 kDa nucleoporin) (Nucleoporin Nup160),1436,"162,121",5 out of 5,2001-02-21,Evidence at protein level
O60285,NUAK1_HUMAN,NUAK family SNF1-like kinase 1 (EC 2.7.11.1) (AMPK-related protein kinase 5) (ARK5) (Omphalocele kinase 1),661,"74,305",5 out of 5,2001-06-20,Evidence at protein level
Q9Y5Y2,NUBP2_HUMAN,Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2),271,"28,825",5 out of 5,2001-04-27,Evidence at protein level
Q02818,NUCB1_HUMAN,Nucleobindin-1 (CALNUC),461,"53,879",5 out of 5,1993-07-01,Evidence at protein level
Q14249,NUCG_HUMAN,"Endonuclease G, mitochondrial (Endo G) (EC 3.1.30.-)",297,"32,620",5 out of 5,1997-11-01,Evidence at protein level
P19338,NUCL_HUMAN,Nucleolin (Protein C23),710,"76,614",5 out of 5,1990-11-01,Evidence at protein level
Q8NFP7,NUD10_HUMAN,"Diphosphoinositol polyphosphate phosphohydrolase 3-alpha (DIPP-3-alpha) (DIPP3-alpha) (hDIPP3alpha) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-alpha) (Diadenosine hexaphosphate hydrolase (AMP-forming)) (EC 3.6.1.60) (Nucleoside diphosphate-linked moiety X motif 10) (Nudix motif 10) (hAps2)",164,"18,500",5 out of 5,2005-07-05,Evidence at protein level
A8MXV4,NUD19_HUMAN,Nucleoside diphosphate-linked moiety X motif 19 (Nudix motif 19) (EC 3.6.1.-),375,"42,233",3 out of 5,2008-03-18,Evidence at protein level
Q8WV74,NUDT8_HUMAN,Nucleoside diphosphate-linked moiety X motif 8 (Nudix motif 8) (EC 3.6.1.-),236,"25,370",3 out of 5,2005-07-05,Evidence at protein level
Q8TCD5,NT5C_HUMAN,"5'(3')-deoxyribonucleotidase, cytosolic type (EC 3.1.3.-) (Cytosolic 5',3'-pyrimidine nucleotidase) (Deoxy-5'-nucleotidase 1) (dNT-1)",201,"23,383",5 out of 5,2003-10-31,Evidence at protein level
Q6ZSK4,NTAS1_HUMAN,Putative uncharacterized protein NTM-AS1 (NTM antisense RNA 1) (NTM antisense gene protein 1),140,"15,188",1 out of 5,2007-02-06,Uncertain
Q12908,NTCP2_HUMAN,"Ileal sodium/bile acid cotransporter (Apical sodium-dependent bile acid transporter) (ASBT) (Ileal Na(+)/bile acid cotransporter) (Ileal sodium-dependent bile acid transporter) (IBAT) (ISBT) (Na(+)-dependent ileal bile acid transporter) (Sodium/taurocholate cotransporting polypeptide, ileal) (Solute carrier family 10 member 2)",348,"37,714",5 out of 5,1997-11-01,Evidence at protein level
Q0GE19,NTCP7_HUMAN,Sodium/bile acid cotransporter 7 (Na(+)/bile acid cotransporter 7) (Solute carrier family 10 member 7),358,"39,485",3 out of 5,2007-02-20,Evidence at transcript level
Q5VVY1,NTM1B_HUMAN,Alpha N-terminal protein methyltransferase 1B (EC 2.1.1.299) (Methyltransferase-like protein 11B) (X-Pro-Lys N-terminal protein methyltransferase 1B) (NTM1B),283,"32,400",4 out of 5,2007-01-09,Evidence at protein level
A6NNL0,NTM2B_HUMAN,NUT family member 2B,878,"93,984",2 out of 5,2008-06-10,Inferred from homology
Q9Y266,NUDC_HUMAN,Nuclear migration protein nudC (Nuclear distribution protein C homolog),331,"38,243",5 out of 5,2005-03-29,Evidence at protein level
Q99567,NUP88_HUMAN,Nuclear pore complex protein Nup88 (88 kDa nucleoporin) (Nucleoporin Nup88),741,"83,542",5 out of 5,2002-11-08,Evidence at protein level
P52948,NUP98_HUMAN,Nuclear pore complex protein Nup98-Nup96 [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],1817,"197,579",5 out of 5,1996-10-01,Evidence at protein level
O15399,NMDE4_HUMAN,"Glutamate receptor ionotropic, NMDA 2D (GluN2D) (EB11) (Glutamate [NMDA] receptor subunit epsilon-4) (N-methyl D-aspartate receptor subtype 2D) (NMDAR2D) (NR2D)",1336,"143,752",5 out of 5,2001-08-29,Evidence at protein level
Q05586,NMDZ1_HUMAN,"Glutamate receptor ionotropic, NMDA 1 (GluN1) (Glutamate [NMDA] receptor subunit zeta-1) (N-methyl-D-aspartate receptor subunit NR1) (NMD-R1)",938,"105,373",5 out of 5,1994-06-01,Evidence at protein level
Q96T66,NMNA3_HUMAN,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 3 (NMN/NaMN adenylyltransferase 3) (Nicotinamide-nucleotide adenylyltransferase 3) (NMN adenylyltransferase 3) (Nicotinate-nucleotide adenylyltransferase 3) (NaMN adenylyltransferase 3) (EC 2.7.7.18) (Pyridine nucleotide adenylyltransferase 3) (PNAT-3) (EC 2.7.7.1),252,"28,322",5 out of 5,2004-05-10,Evidence at protein level
P30419,NMT1_HUMAN,Glycylpeptide N-tetradecanoyltransferase 1 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 1) (NMT 1) (Type I N-myristoyltransferase) (Peptide N-myristoyltransferase 1),496,"56,806",5 out of 5,1993-04-01,Evidence at protein level
Q9H6W3,NO66_HUMAN,Bifunctional lysine-specific demethylase and histidyl-hydroxylase NO66 (EC 1.14.11.-) (EC 1.14.11.27) (60S ribosomal protein L8 histidine hydroxylase) (Histone lysine demethylase NO66) (Myc-associated protein with JmjC domain) (Nucleolar protein 66) (hsNO66) (Ribosomal oxygenase NO66) (ROX),641,"71,086",5 out of 5,2006-12-12,Evidence at protein level
Q99784,NOE1_HUMAN,Noelin (Neuronal olfactomedin-related ER localized protein) (Olfactomedin-1),485,"55,343",5 out of 5,1998-07-15,Evidence at protein level
Q96PB7,NOE3_HUMAN,Noelin-3 (Olfactomedin-3) (Optimedin),478,"54,930",5 out of 5,2002-01-23,Evidence at protein level
Q13253,NOGG_HUMAN,Noggin,232,"25,774",5 out of 5,2001-08-14,Evidence at protein level
Q86U38,NOP9_HUMAN,Nucleolar protein 9,636,"69,438",3 out of 5,2003-09-19,Evidence at protein level
Q86SE8,NPM2_HUMAN,Nucleoplasmin-2,214,"24,152",5 out of 5,2003-10-03,Evidence at protein level
P06748,NPM_HUMAN,Nucleophosmin (NPM) (Nucleolar phosphoprotein B23) (Nucleolar protein NO38) (Numatrin),294,"32,575",5 out of 5,1988-01-01,Evidence at protein level
Q9UFN0,NPS3A_HUMAN,Protein NipSnap homolog 3A (NipSnap3A) (Protein NipSnap homolog 4) (NipSnap4) (Target for Salmonella secreted protein C) (TassC),247,"28,467",4 out of 5,2001-09-26,Evidence at protein level
Q6W5P4,NPSR1_HUMAN,Neuropeptide S receptor (G-protein coupled receptor 154) (G-protein coupled receptor PGR14) (G-protein coupled receptor for asthma susceptibility),371,"42,687",5 out of 5,2005-11-08,Evidence at protein level
Q8N729,NPW_HUMAN,Neuropeptide W (Preproprotein L8) (hPPL8) [Cleaved into: Neuropeptide W-23 (NPW23) (hL8); Neuropeptide W-30 (NPW30) (hL8C)],165,"18,048",4 out of 5,2003-07-25,Evidence at protein level
P25929,NPY1R_HUMAN,Neuropeptide Y receptor type 1 (NPY1-R),384,"44,392",5 out of 5,1992-05-01,Evidence at protein level
Q15761,NPY5R_HUMAN,Neuropeptide Y receptor type 5 (NPY5-R) (NPY-Y5 receptor) (NPYY5-R) (Y5 receptor),445,"50,727",5 out of 5,1997-11-01,Evidence at transcript level
Q9NQ35,NRIP3_HUMAN,Nuclear receptor-interacting protein 3 (Sarcoma antigen NY-SAR-105),241,"26,975",2 out of 5,2003-08-29,Evidence at protein level
Q7Z2Y5,NRK_HUMAN,Nik-related protein kinase (EC 2.7.11.1),1582,"178,479",5 out of 5,2006-10-03,Evidence at protein level
Q8IXM6,NRM_HUMAN,Nurim (Nuclear envelope membrane protein) (Nuclear rim protein),262,"29,379",4 out of 5,2007-09-11,Evidence at protein level
Q96G61,NUD11_HUMAN,"Diphosphoinositol polyphosphate phosphohydrolase 3-beta (DIPP-3-beta) (DIPP3-beta) (hDIPP3beta) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 3-beta) (Diadenosine hexaphosphate hydrolase (AMP-forming)) (EC 3.6.1.60) (Nucleoside diphosphate-linked moiety X motif 11) (Nudix motif 11) (hAps1)",164,"18,559",5 out of 5,2005-07-05,Evidence at protein level
Q96RS6,NUDC1_HUMAN,NudC domain-containing protein 1 (Chronic myelogenous leukemia tumor antigen 66) (Tumor antigen CML66),583,"66,756",5 out of 5,2007-10-23,Evidence at protein level
O95989,NUDT3_HUMAN,"Diphosphoinositol polyphosphate phosphohydrolase 1 (DIPP-1) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 1) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 3) (Nudix motif 3)",172,"19,471",5 out of 5,2005-07-05,Evidence at protein level
Q9UKK9,NUDT5_HUMAN,ADP-sugar pyrophosphatase (EC 3.6.1.13) (8-oxo-dGDP phosphatase) (EC 3.6.1.58) (Nuclear ATP-synthesis protein NUDIX5) (EC 2.7.7.96) (Nucleoside diphosphate-linked moiety X motif 5) (Nudix motif 5) (hNUDT5) (YSA1H),219,"24,328",5 out of 5,2002-05-02,Evidence at protein level
P25103,NK1R_HUMAN,Substance-P receptor (SPR) (NK-1 receptor) (NK-1R) (Tachykinin receptor 1),407,"46,251",5 out of 5,1992-05-01,Evidence at protein level
P29371,NK3R_HUMAN,Neuromedin-K receptor (NKR) (NK-3 receptor) (NK-3R) (Neurokinin B receptor) (Tachykinin receptor 3),465,"52,202",5 out of 5,1992-12-01,Evidence at protein level
Q969F2,NKD2_HUMAN,Protein naked cuticle homolog 2 (Naked-2) (hNkd2),451,"50,055",5 out of 5,2007-09-11,Evidence at protein level
Q8N2Q7,NLGN1_HUMAN,Neuroligin-1,840,"93,835",5 out of 5,2003-05-23,Evidence at protein level
Q8TCU5,NMD3A_HUMAN,"Glutamate receptor ionotropic, NMDA 3A (GluN3A) (N-methyl-D-aspartate receptor subtype 3A) (NMDAR3A) (NR3A) (NMDAR-L)",1115,"125,465",5 out of 5,2004-08-31,Evidence at protein level
O60551,NMT2_HUMAN,Glycylpeptide N-tetradecanoyltransferase 2 (EC 2.3.1.97) (Myristoyl-CoA:protein N-myristoyltransferase 2) (NMT 2) (Peptide N-myristoyltransferase 2) (Type II N-myristoyltransferase),498,"56,980",5 out of 5,2000-05-30,Evidence at protein level
Q9HB89,NMUR1_HUMAN,Neuromedin-U receptor 1 (NMU-R1) (G-protein coupled receptor 66) (G-protein coupled receptor FM-3),426,"47,351",5 out of 5,2005-12-06,Evidence at transcript level
Q9H6R4,NOL6_HUMAN,Nucleolar protein 6 (Nucleolar RNA-associated protein) (Nrap),1146,"127,593",5 out of 5,2005-04-26,Evidence at protein level
Q9HBY0,NOX3_HUMAN,NADPH oxidase 3 (EC 1.6.3.-) (Mitogenic oxidase 2) (MOX-2) (gp91phox homolog 3) (GP91-3),568,"64,935",5 out of 5,2006-03-21,Evidence at protein level
Q8NFA2,NOXO1_HUMAN,NADPH oxidase organizer 1 (NADPH oxidase regulatory protein) (Nox organizer 1) (Nox-organizing protein 1) (SH3 and PX domain-containing protein 5),376,"41,253",5 out of 5,2006-03-21,Evidence at protein level
Q9H7Z3,NRDE2_HUMAN,Protein NRDE2 homolog,1164,"132,673",3 out of 5,2003-08-15,Evidence at protein level
Q16656,NRF1_HUMAN,Nuclear respiratory factor 1 (NRF-1) (Alpha palindromic-binding protein) (Alpha-pal),503,"53,541",5 out of 5,2000-12-01,Evidence at protein level
O14511,NRG2_HUMAN,"Pro-neuregulin-2, membrane-bound isoform (Pro-NRG2) [Cleaved into: Neuregulin-2 (NRG-2) (Divergent of neuregulin-1) (DON-1) (Neural- and thymus-derived activator for ERBB kinases) (NTAK)]",850,"91,679",5 out of 5,1998-12-15,Evidence at protein level
Q86YC3,NRROS_HUMAN,Negative regulator of reactive oxygen species (Leucine-rich repeat-containing protein 33),692,"76,366",4 out of 5,2005-10-25,Evidence at protein level
P03923,NU6M_HUMAN,NADH-ubiquinone oxidoreductase chain 6 (EC 1.6.5.3) (NADH dehydrogenase subunit 6),174,"18,622",5 out of 5,1986-07-21,Evidence at protein level
Q9NRX3,NUA4L_HUMAN,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2 (NADH-ubiquinone oxidoreductase MLRQ subunit homolog) (NUOMS),87,"9,966",2 out of 5,2002-09-19,Inferred from homology
P53384,NUBP1_HUMAN,Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1),320,"34,534",5 out of 5,1996-10-01,Evidence at protein level
Q86X67,NUD13_HUMAN,Nucleoside diphosphate-linked moiety X motif 13 (Nudix motif 13) (EC 3.-.-.-) (Protein KiSS-16),352,"39,688",3 out of 5,2004-08-31,Evidence at transcript level
Q96DE0,NUD16_HUMAN,U8 snoRNA-decapping enzyme (EC 3.6.1.62) (IDP phosphatase) (IDPase) (EC 3.6.1.64) (Inosine diphosphate phosphatase) (Nucleoside diphosphate-linked moiety X motif 16) (Nudix motif 16) (U8 snoRNA-binding protein H29K) (m7GpppN-mRNA hydrolase),195,"21,273",5 out of 5,2005-07-05,Evidence at protein level
Q7Z417,NUFP2_HUMAN,Nuclear fragile X mental retardation-interacting protein 2 (82 kDa FMRP-interacting protein) (82-FIP) (Cell proliferation-inducing gene 1 protein) (FMRP-interacting protein 2),695,"76,121",5 out of 5,2006-07-11,Evidence at protein level
P49757,NUMB_HUMAN,Protein numb homolog (h-Numb) (Protein S171),651,"70,804",5 out of 5,1996-10-01,Evidence at protein level
Q9H093,NUAK2_HUMAN,NUAK family SNF1-like kinase 2 (EC 2.7.11.1) (Omphalocele kinase 2) (SNF1/AMP kinase-related kinase) (SNARK),628,"69,612",5 out of 5,2006-07-25,Evidence at protein level
Q8IVD9,NUDC3_HUMAN,NudC domain-containing protein 3,361,"40,822",4 out of 5,2005-05-10,Evidence at protein level
A6NF83,NUPR2_HUMAN,Nuclear protein 2 (Nuclear transcriptional regulator 1-like protein) (Nuclear transcriptional regulator protein 2),97,"11,356",4 out of 5,2008-09-02,Evidence at transcript level
Q9UBU9,NXF1_HUMAN,Nuclear RNA export factor 1 (Tip-associated protein) (Tip-associating protein) (mRNA export factor TAP),619,"70,182",5 out of 5,2002-03-27,Evidence at protein level
Q9H4D5,NXF3_HUMAN,Nuclear RNA export factor 3 (TAP-like protein 3) (TAPL-3),531,"60,102",5 out of 5,2002-05-02,Evidence at protein level
Q8IWE2,NXP20_HUMAN,Protein NOXP20 (Nervous system overexpressed protein 20) (Protein FAM114A1),563,"60,742",5 out of 5,2007-02-06,Evidence at protein level
Q6ZVC0,NYAP1_HUMAN,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1,841,"87,928",3 out of 5,2008-02-26,Evidence at transcript level
Q9P2P1,NYNRI_HUMAN,Protein NYNRIN (NYN domain and retroviral integrase catalytic domain-containing protein) (Protein cousin of GIN1),1898,"208,366",3 out of 5,2008-01-15,Evidence at transcript level
Q9GZU5,NYX_HUMAN,Nyctalopin,481,"52,000",5 out of 5,2002-09-19,Evidence at protein level
Q8NH08,O10AC_HUMAN,Olfactory receptor 10AC1 (Olfactory receptor OR7-5),325,"35,157",3 out of 5,2008-09-02,Inferred from homology
Q8NH19,O10AG_HUMAN,Olfactory receptor 10AG1 (Olfactory receptor OR11-160),301,"34,105",3 out of 5,2003-11-21,Evidence at transcript level
Q8NGN7,O10D4_HUMAN,Putative olfactory receptor 10D4,298,"33,107",3 out of 5,2003-10-10,Uncertain
Q8NGN3,O10G4_HUMAN,Olfactory receptor 10G4 (Olfactory receptor OR11-278),311,"34,569",4 out of 5,2003-10-10,Inferred from homology
Q8NGN6,O10G7_HUMAN,Olfactory receptor 10G7 (Olfactory receptor OR11-283),311,"34,517",4 out of 5,2003-10-10,Inferred from homology
O60403,O10H2_HUMAN,Olfactory receptor 10H2 (Olfactory receptor OR19-23),315,"34,663",3 out of 5,2001-06-20,Evidence at transcript level
Q8NHC4,O10J5_HUMAN,Olfactory receptor 10J5 (Olfactory receptor OR1-28),309,"34,401",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGX6,O10R2_HUMAN,Olfactory receptor 10R2 (Olfactory receptor OR1-8),335,"37,486",4 out of 5,2003-10-10,Inferred from homology
Q8NGF6,O10W1_HUMAN,Olfactory receptor 10W1 (Olfactory receptor OR11-236),305,"33,376",3 out of 5,2004-08-16,Evidence at transcript level
Q8NGS5,O13C4_HUMAN,Olfactory receptor 13C4 (Olfactory receptor OR9-7),318,"35,576",3 out of 5,2003-09-26,Inferred from homology
Q8NGL6,O4A15_HUMAN,Olfactory receptor 4A15 (Olfactory receptor OR11-118),344,"38,828",4 out of 5,2003-10-10,Inferred from homology
Q8NH64,O51A7_HUMAN,Olfactory receptor 51A7 (Olfactory receptor OR11-27),312,"35,132",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGF3,O51D1_HUMAN,Olfactory receptor 51D1 (Olfactory receptor OR11-14),324,"35,839",3 out of 5,2005-07-19,Evidence at transcript level
Q9H344,O51I2_HUMAN,Olfactory receptor 51I2 (Odorant receptor HOR5'beta12) (Olfactory receptor OR11-38),312,"35,002",3 out of 5,2001-06-20,Inferred from homology
Q9H341,O51M1_HUMAN,Olfactory receptor 51M1 (Odorant receptor HOR5'beta7) (Olfactory receptor OR11-40),326,"36,669",4 out of 5,2002-05-10,Inferred from homology
Q8NGJ9,O51T1_HUMAN,Olfactory receptor 51T1 (Olfactory receptor OR11-26),327,"36,998",3 out of 5,2003-10-10,Inferred from homology
A6NMU1,O52A4_HUMAN,Olfactory receptor 52A4,304,"34,901",3 out of 5,2007-12-04,Evidence at transcript level
Q96RD2,O52B2_HUMAN,Olfactory receptor 52B2 (Olfactory receptor OR11-70),323,"36,185",3 out of 5,2002-05-10,Evidence at transcript level
Q8NGJ4,O52E2_HUMAN,Olfactory receptor 52E2,325,"36,630",3 out of 5,2003-10-10,Inferred from homology
Q8NGK6,O52I1_HUMAN,Olfactory receptor 52I1 (Olfactory receptor OR11-13),324,"35,386",3 out of 5,2003-10-10,Inferred from homology
Q8NH67,O52I2_HUMAN,Olfactory receptor 52I2 (Olfactory receptor OR11-12),350,"38,353",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGK3,O52K2_HUMAN,Olfactory receptor 52K2 (Olfactory receptor OR11-7),314,"34,926",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGK5,O52M1_HUMAN,Olfactory receptor 52M1 (Olfactory receptor OR11-11),317,"35,037",3 out of 5,2005-12-20,Inferred from homology
Q8NH76,O56B4_HUMAN,Olfactory receptor 56B4 (Olfactory receptor OR11-67),319,"35,454",3 out of 5,2003-10-10,Evidence at transcript level
Q9NZP5,O5AC2_HUMAN,Olfactory receptor 5AC2 (HSA1),309,"35,304",3 out of 5,2003-10-10,Inferred from homology
Q8NGP9,O5AR1_HUMAN,Olfactory receptor 5AR1 (Olfactory receptor OR11-209),310,"34,815",4 out of 5,2003-09-26,Inferred from homology
Q8NH89,O5AK3_HUMAN,Putative olfactory receptor 5AK3,298,"33,542",3 out of 5,2003-10-10,Uncertain
A6NJZ3,O6C65_HUMAN,Olfactory receptor 6C65,312,"35,198",3 out of 5,2007-11-13,Evidence at transcript level
Q9NY56,OBP2A_HUMAN,Odorant-binding protein 2a (Odorant-binding protein IIa) (OBPIIa),170,"19,318",5 out of 5,2002-04-03,Evidence at protein level
Q9NX40,OCAD1_HUMAN,OCIA domain-containing protein 1 (Ovarian carcinoma immunoreactive antigen),245,"27,626",3 out of 5,2007-09-11,Evidence at protein level
Q9H607,OCEL1_HUMAN,Occludin/ELL domain-containing protein 1,264,"29,404",2 out of 5,2007-01-09,Evidence at transcript level
Q9BR26,OCSTP_HUMAN,Osteoclast stimulatory transmembrane protein (OC-STAMP),566,"61,579",3 out of 5,2008-07-01,Evidence at transcript level
P11182,ODB2_HUMAN,"Lipoamide acyltransferase component of branched-chain alpha-keto acid dehydrogenase complex, mitochondrial (EC 2.3.1.168) (52 kDa mitochondrial autoantigen of primary biliary cirrhosis) (Branched chain 2-oxo-acid dehydrogenase complex component E2) (BCOADC-E2) (Branched-chain alpha-keto acid dehydrogenase complex component E2) (BCKAD-E2) (BCKADE2) (Dihydrolipoamide acetyltransferase component of branched-chain alpha-keto acid dehydrogenase complex) (Dihydrolipoamide branched chain transacylase) (Dihydrolipoyllysine-residue (2-methylpropanoyl)transferase)",482,"53,487",5 out of 5,1989-07-01,Evidence at protein level
P29803,ODPAT_HUMAN,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial (EC 1.2.4.1) (PDHE1-A type II)",388,"42,933",5 out of 5,1993-04-01,Evidence at protein level
O15294,OGT1_HUMAN,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit (EC 2.4.1.255) (O-GlcNAc transferase subunit p110) (O-linked N-acetylglucosamine transferase 110 kDa subunit) (OGT),1046,"116,925",5 out of 5,2000-05-30,Evidence at protein level
P0CE72,ONCO_HUMAN,Oncomodulin-1 (OM) (Parvalbumin beta),109,"12,184",4 out of 5,2010-03-23,Evidence at protein level
P08100,OPSD_HUMAN,Rhodopsin (Opsin-2),348,"38,893",5 out of 5,1988-08-01,Evidence at protein level
P47887,OR1E2_HUMAN,Olfactory receptor 1E2 (Olfactory receptor 17-93/17-135/17-136) (OR17-135) (OR17-136) (OR17-93) (Olfactory receptor 1E4),323,"36,391",4 out of 5,1996-02-01,Evidence at transcript level
Q96R84,OR1F2_HUMAN,Putative olfactory receptor 1F2 (OLFmf2),312,"34,944",3 out of 5,2003-10-10,Uncertain
P47890,OR1G1_HUMAN,Olfactory receptor 1G1 (Olfactory receptor 17-209) (OR17-209) (Olfactory receptor 1G2) (Olfactory receptor OR17-8),313,"34,924",4 out of 5,1996-02-01,Evidence at transcript level
Q8NGS1,OR1J4_HUMAN,Olfactory receptor 1J4 (HTPCRX01) (Olfactory receptor OR9-21),313,"34,959",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH93,OR1L3_HUMAN,Olfactory receptor 1L3 (Olfactory receptor 9-D) (OR9-D) (Olfactory receptor OR9-28),324,"36,633",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGR9,OR1N2_HUMAN,Olfactory receptor 1N2 (Olfactory receptor OR9-23),330,"36,889",4 out of 5,2003-10-10,Evidence at transcript level
Q6IF42,OR2A2_HUMAN,Olfactory receptor 2A2 (Olfactory receptor 2A17) (Olfactory receptor OR7-11),318,"35,820",4 out of 5,2005-12-20,Evidence at transcript level
O95371,OR2C1_HUMAN,Olfactory receptor 2C1 (OLFmf3) (Olfactory receptor 2C2) (Olfactory receptor OR16-1) (Olfactory receptor OR16-2),312,"34,412",4 out of 5,2000-12-01,Evidence at transcript level
Q8NGZ4,OR2G3_HUMAN,Olfactory receptor 2G3 (Olfactory receptor OR1-33),309,"34,506",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGU4,OR2I1_HUMAN,Putative olfactory receptor 2I1 (Putative olfactory receptor 2I2) (Putative olfactory receptor 2I3) (Putative olfactory receptor 2I4),316,"34,115",3 out of 5,2003-10-10,Uncertain
O76002,OR2J2_HUMAN,Olfactory receptor 2J2 (Hs6M1-6) (Olfactory receptor 6-8) (OR6-8) (Olfactory receptor OR6-19),312,"35,204",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGY9,OR2L8_HUMAN,Olfactory receptor 2L8 (Olfactory receptor OR1-46),312,"35,444",3 out of 5,2003-10-10,Inferred from homology
Q96R27,OR2M4_HUMAN,Olfactory receptor 2M4 (HTPCRX18) (OST710) (Olfactory receptor OR1-55) (Olfactory receptor TPCR100),311,"35,071",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH00,OR2T4_HUMAN,Olfactory receptor 2T4 (Olfactory receptor OR1-60),348,"39,414",3 out of 5,2003-10-10,Inferred from homology
Q8NHA6,OR2W6_HUMAN,Putative olfactory receptor 2W6 (Olfactory receptor OR6-3) (Putative olfactory receptor 2W7),318,"35,283",3 out of 5,2008-07-01,Uncertain
P47881,OR3A1_HUMAN,Olfactory receptor 3A1 (Olfactory receptor 17-40) (OR17-40) (Olfactory receptor OR17-15),315,"34,609",3 out of 5,1996-02-01,Evidence at transcript level
Q9H4L5,OSBL3_HUMAN,Oxysterol-binding protein-related protein 3 (ORP-3) (OSBP-related protein 3),887,"101,224",5 out of 5,2002-02-11,Evidence at protein level
Q969R2,OSBP2_HUMAN,Oxysterol-binding protein 2 (Oxysterol-binding protein-related protein 4) (ORP-4) (OSBP-related protein 4),916,"101,266",5 out of 5,2002-02-11,Evidence at protein level
Q8TAX0,OSR1_HUMAN,Protein odd-skipped-related 1,266,"29,611",5 out of 5,2006-01-24,Evidence at transcript level
Q9NRP0,OSTC_HUMAN,Oligosaccharyltransferase complex subunit OSTC (Hydrophobic protein HSF-28),149,"16,829",4 out of 5,2008-02-26,Evidence at protein level
Q3ZCN5,OTOGL_HUMAN,Otogelin-like protein,2332,"262,091",4 out of 5,2008-02-05,Evidence at transcript level
Q7RTS6,OTOP2_HUMAN,Otopetrin-2,562,"62,236",2 out of 5,2008-01-15,Evidence at transcript level
Q7RTS5,OTOP3_HUMAN,Otopetrin-3,596,"66,296",2 out of 5,2008-01-15,Evidence at protein level
P48552,NRIP1_HUMAN,Nuclear receptor-interacting protein 1 (Nuclear factor RIP140) (Receptor-interacting protein 140),1158,"126,942",5 out of 5,1996-02-01,Evidence at protein level
O95478,NSA2_HUMAN,Ribosome biogenesis protein NSA2 homolog (Hairy cell leukemia protein 1) (TGF-beta-inducible nuclear protein 1),260,"30,065",3 out of 5,2003-09-19,Evidence at protein level
O96028,NSD2_HUMAN,Histone-lysine N-methyltransferase NSD2 (EC 2.1.1.43) (Multiple myeloma SET domain-containing protein) (MMSET) (Nuclear SET domain-containing protein 2) (Protein trithorax-5) (Wolf-Hirschhorn syndrome candidate 1 protein),1365,"152,258",5 out of 5,2006-10-31,Evidence at protein level
Q15738,NSDHL_HUMAN,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating (EC 1.1.1.170) (Protein H105e3)",373,"41,900",5 out of 5,1997-11-01,Evidence at protein level
Q9UH64,NSGX_HUMAN,Susceptibility protein NSG-x (CDKN2A antisense RNA 1) (CDKN2A antisense gene protein 1) (Protein CDKN2A-AS1),79,"8,851",1 out of 5,2000-12-01,Predicted
Q9H649,NSUN3_HUMAN,"tRNA (cytosine(34)-C(5))-methyltransferase, mitochondrial (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 3)",340,"38,244",5 out of 5,2007-05-29,Evidence at protein level
Q8NE18,NSUN7_HUMAN,Putative methyltransferase NSUN7 (EC 2.1.1.-) (NOL1/NOP2/Sun domain family member 7),718,"81,039",3 out of 5,2007-05-29,Evidence at transcript level
Q7Z3S9,NT2NL_HUMAN,Notch homolog 2 N-terminal-like protein,236,"25,835",5 out of 5,2008-05-20,Evidence at protein level
Q96AB6,NTAN1_HUMAN,Protein N-terminal asparagine amidohydrolase (EC 3.5.1.-) (Protein NH2-terminal asparagine amidohydrolase) (PNAA) (Protein NH2-terminal asparagine deamidase) (PNAD) (Protein N-terminal Asn amidase) (Protein N-terminal asparagine amidase) (Protein NTN-amidase),310,"34,677",4 out of 5,2003-09-26,Evidence at protein level
P03915,NU5M_HUMAN,NADH-ubiquinone oxidoreductase chain 5 (EC 1.6.5.3) (NADH dehydrogenase subunit 5),603,"67,027",5 out of 5,1986-07-21,Evidence at protein level
Q9BQG2,NUD12_HUMAN,Peroxisomal NADH pyrophosphatase NUDT12 (EC 3.6.1.22) (Nucleoside diphosphate-linked moiety X motif 12) (Nudix motif 12),462,"52,076",5 out of 5,2005-07-05,Evidence at protein level
Q9BRQ3,NUD22_HUMAN,Nucleoside diphosphate-linked moiety X motif 22 (Nudix motif 22),303,"32,580",3 out of 5,2006-12-12,Evidence at protein level
Q9NZJ9,NUDT4_HUMAN,"Diphosphoinositol polyphosphate phosphohydrolase 2 (DIPP-2) (EC 3.6.1.52) (Diadenosine 5',5'''-P1,P6-hexaphosphate hydrolase 2) (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 4) (Nudix motif 4)",180,"20,306",5 out of 5,2005-07-05,Evidence at protein level
P0DN81,O13C7_HUMAN,Olfactory receptor 13C7,318,"34,899",3 out of 5,2016-02-17,Inferred from homology
Q8NGX1,O2T34_HUMAN,Olfactory receptor 2T34 (Olfactory receptor OR1-63),318,"35,681",3 out of 5,2004-08-16,Evidence at transcript level
Q6IF82,O4A47_HUMAN,Olfactory receptor 4A47 (Olfactory receptor OR11-113),309,"34,760",4 out of 5,2005-12-20,Inferred from homology
Q8NGA8,O4F17_HUMAN,Olfactory receptor 4F17 (Olfactory receptor 4F11) (Olfactory receptor 4F18) (Olfactory receptor 4F19),305,"34,212",3 out of 5,2003-10-10,Evidence at transcript level
O95013,O4F21_HUMAN,Olfactory receptor 4F21,312,"35,094",3 out of 5,2001-06-20,Inferred from homology
Q9H339,O51B5_HUMAN,Olfactory receptor 51B5 (Odorant receptor HOR5'beta5) (Olfactory receptor OR11-37),312,"35,241",4 out of 5,2005-12-20,Evidence at transcript level
Q8NGK1,O51G1_HUMAN,Olfactory receptor 51G1 (Olfactory receptor 51G3) (Olfactory receptor OR11-29),321,"36,290",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGH9,O52E4_HUMAN,Olfactory receptor 52E4 (Olfactory receptor OR11-55),312,"35,480",3 out of 5,2003-10-10,Inferred from homology
Q6IFG1,O52E8_HUMAN,Olfactory receptor 52E8 (Olfactory receptor OR11-54),317,"35,913",3 out of 5,2005-12-20,Evidence at transcript level
Q8NH60,O52J3_HUMAN,Olfactory receptor 52J3 (Olfactory receptor OR11-32),311,"35,091",3 out of 5,2003-10-10,Inferred from homology
Q8NGH6,O52L2_HUMAN,Putative olfactory receptor 52L2 (Olfactory receptor OR11-74),319,"35,227",3 out of 5,2003-10-10,Uncertain
Q8NH56,O52N5_HUMAN,Olfactory receptor 52N5 (Olfactory receptor OR11-62),324,"36,212",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGI1,O56B2_HUMAN,Putative olfactory receptor 56B2,322,"35,955",3 out of 5,2003-10-10,Uncertain
P0C628,O5AC1_HUMAN,Olfactory receptor 5AC1 (Olfactory receptor OR3-2),307,"34,762",3 out of 5,2008-01-15,Inferred from homology
Q8NH90,O5AK2_HUMAN,Olfactory receptor 5AK2,309,"34,627",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGF4,O5AP2_HUMAN,Olfactory receptor 5AP2,316,"35,508",3 out of 5,2003-09-26,Evidence at transcript level
A6NHG9,O5H14_HUMAN,Olfactory receptor 5H14,310,"35,099",3 out of 5,2007-12-04,Evidence at transcript level
A6NCV1,O6C74_HUMAN,Olfactory receptor 6C74,312,"35,253",3 out of 5,2007-11-13,Inferred from homology
Q9Y530,OARD1_HUMAN,O-acetyl-ADP-ribose deacetylase 1 (EC 3.5.1.-),152,"17,025",5 out of 5,2000-12-01,Evidence at protein level
Q9Y6K5,OAS3_HUMAN,2'-5'-oligoadenylate synthase 3 ((2-5')oligo(A) synthase 3) (2-5A synthase 3) (EC 2.7.7.84) (p100 OAS) (p100OAS),1087,"121,170",5 out of 5,2001-02-21,Evidence at protein level
Q68BL7,OLM2A_HUMAN,Olfactomedin-like protein 2A (Photomedin-1),652,"73,054",4 out of 5,2007-11-13,Evidence at transcript level
Q6U736,OPN5_HUMAN,Opsin-5 (G-protein coupled receptor 136) (G-protein coupled receptor PGR12) (Neuropsin) (Transmembrane protein 13),354,"39,727",5 out of 5,2005-06-07,Evidence at protein level
P41143,OPRD_HUMAN,Delta-type opioid receptor (D-OR-1) (DOR-1),372,"40,369",5 out of 5,1995-02-01,Evidence at protein level
P34982,OR1D2_HUMAN,Olfactory receptor 1D2 (Olfactory receptor 17-4) (OR17-4) (Olfactory receptor OR17-6) (Olfactory receptor-like protein HGMP07E),312,"35,240",5 out of 5,1994-02-01,Evidence at protein level
O60431,OR1I1_HUMAN,Olfactory receptor 1I1 (Olfactory receptor 19-20) (OR19-20),355,"39,297",3 out of 5,2001-06-20,Inferred from homology
Q8NH94,OR1L1_HUMAN,Olfactory receptor 1L1 (Olfactory receptor 1L2) (Olfactory receptor 9-C) (OR9-C) (Olfactory receptor OR9-27),360,"41,046",4 out of 5,2003-10-10,Inferred from homology
Q15612,OR1Q1_HUMAN,Olfactory receptor 1Q1 (OST226) (Olfactory receptor 1Q2) (Olfactory receptor 1Q3) (Olfactory receptor 9-A) (OR9-A) (Olfactory receptor OR9-25) (Olfactory receptor TPCR106),314,"35,598",4 out of 5,2001-06-20,Evidence at transcript level
O76000,OR2B3_HUMAN,Putative olfactory receptor 2B3 (Hs6M1-1) (Olfactory receptor OR6-14) (OR6-4) (Olfactory receptor 6-4),313,"35,543",3 out of 5,2001-06-20,Inferred from homology
Q8NGH3,OR2D3_HUMAN,Olfactory receptor 2D3 (Olfactory receptor OR11-89),330,"37,489",3 out of 5,2003-10-10,Evidence at transcript level
Q5TZ20,OR2G6_HUMAN,Olfactory receptor 2G6,316,"34,890",3 out of 5,2005-12-20,Evidence at transcript level
O95918,OR2H2_HUMAN,Olfactory receptor 2H2 (Hs6M1-12) (Olfactory receptor 2H3) (Olfactory receptor-like protein FAT11),312,"34,763",5 out of 5,2001-06-20,Evidence at transcript level
Q8NG85,OR2L3_HUMAN,Olfactory receptor 2L3,312,"35,282",3 out of 5,2005-12-20,Evidence at transcript level
A3KFT3,OR2M5_HUMAN,Olfactory receptor 2M5,312,"35,112",3 out of 5,2007-07-10,Inferred from homology
O43869,OR2T1_HUMAN,Olfactory receptor 2T1 (Olfactory receptor 1-25) (OR1-25) (Olfactory receptor OR1-61),369,"41,996",3 out of 5,2001-06-20,Inferred from homology
A6NH00,OR2T8_HUMAN,Olfactory receptor 2T8,312,"34,659",4 out of 5,2007-12-04,Inferred from homology
Q7Z3T1,OR2W3_HUMAN,Olfactory receptor 2W3 (Olfactory receptor 2W8) (Olfactory receptor OR1-49),314,"34,789",4 out of 5,2005-07-19,Evidence at transcript level
P47893,OR3A2_HUMAN,Olfactory receptor 3A2 (Olfactory receptor 17-228) (OR17-228) (Olfactory receptor OR17-14),321,"35,207",4 out of 5,1996-02-01,Evidence at transcript level
P47883,OR3A4_HUMAN,Putative olfactory receptor 3A4 (Olfactory receptor 17-24) (OR17-24) (Olfactory receptor 3A5),348,"37,194",4 out of 5,1996-02-01,Uncertain
Q6IEV9,OR4CB_HUMAN,Olfactory receptor 4C11 (Olfactory receptor OR11-136),310,"35,003",4 out of 5,2005-12-20,Evidence at transcript level
Q8NGD4,OR4K1_HUMAN,Olfactory receptor 4K1 (Olfactory receptor OR14-19),311,"35,201",3 out of 5,2003-10-10,Evidence at transcript level
Q96R72,OR4K3_HUMAN,Olfactory receptor 4K3 (Olfactory receptor OR14-14),315,"35,408",4 out of 5,2003-10-10,Inferred from homology
Q8NH43,OR4L1_HUMAN,Olfactory receptor 4L1 (Olfactory receptor 4L2) (Olfactory receptor OR14-28),312,"35,264",4 out of 5,2003-10-10,Inferred from homology
Q8NGD1,OR4N2_HUMAN,Olfactory receptor 4N2 (Olfactory receptor OR14-13) (Olfactory receptor OR14-8),307,"34,721",4 out of 5,2003-10-10,Inferred from homology
Q8NGL7,OR4P4_HUMAN,Olfactory receptor 4P4 (Olfactory receptor 4P3),312,"35,795",3 out of 5,2003-10-10,Inferred from homology
Q8NH05,OR4Q3_HUMAN,Olfactory receptor 4Q3 (Olfactory receptor 4Q4) (Olfactory receptor OR14-3),313,"35,491",4 out of 5,2003-10-10,Inferred from homology
A6NL26,OR5BL_HUMAN,Olfactory receptor 5B21,309,"34,174",3 out of 5,2007-11-13,Inferred from homology
Q8NGL3,OR5DE_HUMAN,Olfactory receptor 5D14 (Olfactory receptor OR11-141) (Olfactory receptor OR11-150),314,"35,823",3 out of 5,2003-10-10,Inferred from homology
O95221,OR5F1_HUMAN,Olfactory receptor 5F1 (Olfactory receptor 11-10) (OR11-10) (Olfactory receptor OR11-167),314,"35,132",4 out of 5,2001-06-20,Evidence at transcript level
Q13606,OR5I1_HUMAN,Olfactory receptor 5I1 (Olfactory receptor OR11-159) (Olfactory receptor-like protein OLF1),314,"36,049",4 out of 5,1997-11-01,Evidence at transcript level
Q8NHB7,OR5K1_HUMAN,Olfactory receptor 5K1 (HTPCRX10) (Olfactory receptor OR3-8),308,"35,185",3 out of 5,2003-10-10,Evidence at transcript level
O95222,OR6A2_HUMAN,Olfactory receptor 6A2 (Olfactory receptor 11-55) (OR11-55) (Olfactory receptor 6A1) (Olfactory receptor OR11-83) (hP2 olfactory receptor),327,"36,154",4 out of 5,2000-12-01,Evidence at transcript level
Q96RD1,OR6C1_HUMAN,Olfactory receptor 6C1 (OST267),312,"35,660",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGZ6,OR6F1_HUMAN,Olfactory receptor 6F1 (Olfactory receptor OR1-38),308,"33,961",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGM8,OR6M1_HUMAN,Olfactory receptor 6M1 (Olfactory receptor OR11-271),313,"35,328",3 out of 5,2003-10-10,Evidence at transcript level
Q96RC9,OR8B4_HUMAN,Olfactory receptor 8B4 (Olfactory receptor OR11-315),309,"34,404",4 out of 5,2002-05-10,Evidence at transcript level
Q8NGM9,OR8D4_HUMAN,Olfactory receptor 8D4 (Olfactory receptor OR11-275),314,"35,019",4 out of 5,2003-10-10,Evidence at transcript level
Q8NG78,OR8G5_HUMAN,Olfactory receptor 8G5 (Olfactory receptor 8G6) (Olfactory receptor OR11-298),346,"38,798",3 out of 5,2005-07-19,Evidence at transcript level
Q8N146,OR8H3_HUMAN,Olfactory receptor 8H3 (Olfactory receptor OR11-172),312,"35,219",3 out of 5,2003-10-10,Inferred from homology
Q8NGP2,OR8J1_HUMAN,Olfactory receptor 8J1 (Olfactory receptor OR11-183),316,"35,415",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH51,OR8K3_HUMAN,Olfactory receptor 8K3 (Olfactory receptor OR11-181),312,"35,463",3 out of 5,2003-10-10,Inferred from homology
Q8NGQ1,OR9G4_HUMAN,Olfactory receptor 9G4 (Olfactory receptor OR11-216),327,"36,344",4 out of 5,2003-10-10,Inferred from homology
Q8NGQ6,OR9I1_HUMAN,Olfactory receptor 9I1 (Olfactory receptor OR11-228),314,"34,908",3 out of 5,2003-10-10,Inferred from homology
Q13415,ORC1_HUMAN,Origin recognition complex subunit 1 (Replication control protein 1),861,"97,350",5 out of 5,1997-11-01,Evidence at protein level
O43913,ORC5_HUMAN,Origin recognition complex subunit 5,435,"50,283",5 out of 5,1999-07-15,Evidence at protein level
Q9Y5N6,ORC6_HUMAN,Origin recognition complex subunit 6,252,"28,107",5 out of 5,2000-12-01,Evidence at protein level
Q9BXB5,OSB10_HUMAN,Oxysterol-binding protein-related protein 10 (ORP-10) (OSBP-related protein 10),764,"83,970",5 out of 5,2002-02-11,Evidence at protein level
Q9NX31,OSER1_HUMAN,Oxidative stress-responsive serine-rich protein 1 (Oxidative stress-responsive protein 1) (Peroxide-inducible transcript 1 protein),292,"31,779",2 out of 5,2003-02-01,Evidence at protein level
Q7Z3B4,NUP54_HUMAN,Nucleoporin p54 (54 kDa nucleoporin),507,"55,435",5 out of 5,2003-10-31,Evidence at protein level
P37198,NUP62_HUMAN,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),522,"53,255",5 out of 5,1994-10-01,Evidence at protein level
Q9BW27,NUP85_HUMAN,Nuclear pore complex protein Nup85 (85 kDa nucleoporin) (FROUNT) (Nucleoporin Nup75) (Nucleoporin Nup85) (Pericentrin-1),656,"75,019",5 out of 5,2008-03-18,Evidence at protein level
Q149M9,NWD1_HUMAN,NACHT domain- and WD repeat-containing protein 1,1564,"174,552",5 out of 5,2007-10-23,Evidence at protein level
Q9GZY0,NXF2_HUMAN,Nuclear RNA export factor 2 (Cancer/testis antigen 39) (CT39) (TAP-like protein 2) (TAPL-2),626,"71,627",5 out of 5,2002-05-15,Evidence at protein level
Q5VZ03,NXNL2_HUMAN,Nucleoredoxin-like protein 2 (Rod-derived cone viability factor 2) (RdCVF2),156,"17,614",3 out of 5,2006-04-04,Evidence at transcript level
Q6UWF7,NXPE4_HUMAN,NXPE family member 4 (Protein FAM55D),544,"62,263",3 out of 5,2005-07-19,Evidence at transcript level
Q9P242,NYAP2_HUMAN,Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 2,653,"70,548",4 out of 5,2008-03-18,Evidence at protein level
Q9H207,O10A5_HUMAN,Olfactory receptor 10A5 (HP3) (Olfactory receptor 10A1) (Olfactory receptor 11-403) (OR11-403) (Olfactory receptor-like protein JCG6),317,"35,519",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGE0,O10AD_HUMAN,Olfactory receptor 10AD1 (Olfactory receptor OR12-1),317,"35,698",4 out of 5,2003-10-31,Evidence at transcript level
Q8NGC3,O10G2_HUMAN,Olfactory receptor 10G2,310,"34,472",3 out of 5,2003-10-10,Evidence at transcript level
O60404,O10H3_HUMAN,Olfactory receptor 10H3 (Olfactory receptor OR19-24),316,"35,721",3 out of 5,2001-06-20,Evidence at transcript level
P30954,O10J1_HUMAN,Olfactory receptor 10J1 (Olfactory receptor OR1-26) (Olfactory receptor-like protein HGMP07J),320,"35,925",4 out of 5,1993-07-01,Evidence at transcript level
Q8NGC7,O11H6_HUMAN,Olfactory receptor 11H6 (Olfactory receptor OR14-35),330,"36,788",3 out of 5,2003-10-10,Inferred from homology
B2RN74,O11HC_HUMAN,Olfactory receptor 11H12,326,"36,530",3 out of 5,2008-07-22,Evidence at transcript level
Q8NGS9,O13C2_HUMAN,Olfactory receptor 13C2 (Olfactory receptor OR9-12),318,"35,694",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGS7,O13C8_HUMAN,Olfactory receptor 13C8,320,"35,294",3 out of 5,2003-10-10,Inferred from homology
Q8NGT2,O13J1_HUMAN,Olfactory receptor 13J1 (Olfactory receptor OR9-2),312,"34,689",3 out of 5,2003-10-10,Evidence at transcript level
Q8NHC5,O14AG_HUMAN,Olfactory receptor 14A16 (Olfactory receptor 5AT1) (Olfactory receptor OR1-45),309,"34,307",3 out of 5,2003-10-10,Inferred from homology
A6ND48,O14I1_HUMAN,Olfactory receptor 14I1 (Olfactory receptor 5BU1),311,"35,175",4 out of 5,2007-11-13,Inferred from homology
Q8NGT7,O2A12_HUMAN,Olfactory receptor 2A12 (Olfactory receptor OR7-10),310,"35,213",3 out of 5,2003-11-14,Inferred from homology
Q8NHA4,O2AE1_HUMAN,Olfactory receptor 2AE1 (Olfactory receptor 2AE2),323,"36,588",3 out of 5,2003-10-10,Evidence at transcript level
A6NM03,O2AG2_HUMAN,Olfactory receptor 2AG2,316,"35,270",3 out of 5,2007-12-04,Inferred from homology
A6NND4,O2AT4_HUMAN,Olfactory receptor 2AT4 (Olfactory receptor OR11-265),320,"35,503",3 out of 5,2007-11-13,Evidence at transcript level
Q8NG77,O2T12_HUMAN,Olfactory receptor 2T12 (Olfactory receptor OR1-57),320,"35,946",4 out of 5,2005-07-19,Inferred from homology
Q9NPH6,OBP2B_HUMAN,Odorant-binding protein 2b (Odorant-binding protein IIb) (OBPIIb),170,"19,457",3 out of 5,2002-04-03,Evidence at transcript level
O75147,OBSL1_HUMAN,Obscurin-like protein 1,1896,"206,947",5 out of 5,2006-08-22,Evidence at protein level
Q14990,ODFP1_HUMAN,Outer dense fiber protein 1 (Heat shock protein beta-10) (HspB10),250,"28,366",4 out of 5,1997-11-01,Evidence at protein level
Q5BJF6,ODFP2_HUMAN,Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2),829,"95,401",5 out of 5,2007-09-11,Evidence at protein level
Q02218,ODO1_HUMAN,"2-oxoglutarate dehydrogenase, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1) (OGDC-E1) (Alpha-ketoglutarate dehydrogenase)",1023,"115,935",5 out of 5,1993-07-01,Evidence at protein level
Q9Y2G5,OFUT2_HUMAN,GDP-fucose protein O-fucosyltransferase 2 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 2) (O-FucT-2),429,"49,976",5 out of 5,2000-05-30,Evidence at protein level
O14841,OPLA_HUMAN,5-oxoprolinase (EC 3.5.2.9) (5-oxo-L-prolinase) (5-OPase) (Pyroglutamase),1288,"137,457",4 out of 5,1998-12-15,Evidence at protein level
P0DN77,OPSG2_HUMAN,Medium-wave-sensitive opsin 2 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP) (Opsin 1 cone pigments medium-wave-sensitive 2),364,"40,584",3 out of 5,2016-02-17,Inferred from homology
Q9P1Q5,OR1A1_HUMAN,Olfactory receptor 1A1 (Olfactory receptor 17-7) (OR17-7) (Olfactory receptor OR17-11),309,"34,565",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGR6,OR1B1_HUMAN,Olfactory receptor 1B1 (Olfactory receptor 9-B) (OR9-B) (Olfactory receptor OR9-26),318,"35,293",4 out of 5,2003-10-10,Inferred from homology
P58170,OR1D5_HUMAN,Olfactory receptor 1D5 (Olfactory receptor 17-31) (OR17-31),312,"35,424",3 out of 5,2001-06-20,Inferred from homology
Q8WZA6,OR1E3_HUMAN,Olfactory receptor 1E3 (Olfactory receptor 17-210) (OR17-210) (Olfactory receptor OR17-7),343,"38,518",4 out of 5,2008-01-15,Inferred from homology
Q8NHA8,OR1FC_HUMAN,Olfactory receptor 1F12 (Hs6M1-35P),337,"36,933",3 out of 5,2003-10-10,Inferred from homology
Q96R45,OR2A7_HUMAN,Olfactory receptor 2A7 (Olfactory receptor OR7-18),310,"34,742",3 out of 5,2003-10-10,Evidence at transcript level
P58173,OR2B6_HUMAN,Olfactory receptor 2B6 (Hs6M1-32) (Olfactory receptor 2B1) (Olfactory receptor 2B5) (Olfactory receptor 5-40) (OR5-40) (Olfactory receptor 6-31) (OR6-31) (Olfactory receptor OR6-4),313,"35,414",4 out of 5,2001-06-20,Evidence at transcript level
Q9H210,OR2D2_HUMAN,Olfactory receptor 2D2 (HB2) (Olfactory receptor 11-610) (OR11-610) (Olfactory receptor 2D1) (Olfactory receptor OR11-88),308,"34,172",4 out of 5,2001-06-20,Evidence at transcript level
Q8NH72,OR4C6_HUMAN,Olfactory receptor 4C6 (Olfactory receptor OR11-138),309,"34,558",3 out of 5,2003-10-10,Evidence at transcript level
Q15615,OR4D1_HUMAN,Olfactory receptor 4D1 (Olfactory receptor 4D3) (Olfactory receptor TPCR16),310,"35,240",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGE8,OR4D9_HUMAN,Olfactory receptor 4D9 (Olfactory receptor OR11-253),314,"35,666",3 out of 5,2003-10-10,Inferred from homology
Q96R69,OR4F4_HUMAN,Olfactory receptor 4F4 (HS14a-1-A) (Olfactory receptor OR19-3),305,"34,259",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGD2,OR4K2_HUMAN,Olfactory receptor 4K2 (Olfactory receptor OR14-15),314,"35,357",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH42,OR4KD_HUMAN,Olfactory receptor 4K13 (Olfactory receptor OR14-27),304,"34,261",3 out of 5,2003-10-10,Inferred from homology
Q8NGD0,OR4M1_HUMAN,Olfactory receptor 4M1 (Olfactory receptor OR14-7),313,"35,488",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGB4,OR4S1_HUMAN,Olfactory receptor 4S1 (Olfactory receptor OR11-100),309,"34,800",3 out of 5,2003-10-10,Inferred from homology
Q8NH49,OR4X1_HUMAN,Olfactory receptor 4X1 (Olfactory receptor OR11-104),305,"34,222",4 out of 5,2003-10-10,Inferred from homology
Q8NGL0,OR5L2_HUMAN,Olfactory receptor 5L2 (HTPCRX16) (Olfactory receptor OR11-153),311,"34,682",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGP3,OR5M9_HUMAN,Olfactory receptor 5M9 (Olfactory receptor OR11-190),310,"35,093",3 out of 5,2003-10-10,Inferred from homology
Q8NGY6,OR6N2_HUMAN,Olfactory receptor 6N2 (Olfactory receptor OR1-23),317,"35,692",3 out of 5,2003-10-10,Inferred from homology
Q8N148,OR6V1_HUMAN,Olfactory receptor 6V1 (Olfactory receptor OR7-3),313,"34,902",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGA2,OR7A2_HUMAN,Putative olfactory receptor 7A2 (Putative olfactory receptor 7A7),310,"34,430",3 out of 5,2003-10-10,Uncertain
P0DMU2,OR83P_HUMAN,Putative olfactory receptor 8G3 pseudogene (Olfactory receptor OR11-297),310,"34,506",3 out of 5,2015-04-29,Uncertain
Q8NGG7,OR8A1_HUMAN,Olfactory receptor 8A1 (OST025) (Olfactory receptor OR11-318),326,"36,388",4 out of 5,2003-10-10,Evidence at transcript level
Q9GZM6,OR8D2_HUMAN,Olfactory receptor 8D2 (Olfactory receptor OR11-303) (Olfactory receptor-like protein JCG2),311,"34,857",4 out of 5,2001-06-20,Evidence at transcript level
Q6IF36,OR8G2_HUMAN,Olfactory receptor 8G2 (Olfactory receptor 8G4) (Olfactory receptor OR11-292) (Olfactory receptor TPCR120),304,"33,950",3 out of 5,2015-04-29,Evidence at transcript level
Q8NGG4,OR8H1_HUMAN,Olfactory receptor 8H1 (Olfactory receptor OR11-180),311,"35,228",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGG1,OR8J2_HUMAN,Olfactory receptor 8J2,315,"35,160",3 out of 5,2008-01-15,Inferred from homology
Q8NH50,OR8K5_HUMAN,Olfactory receptor 8K5 (Olfactory receptor OR11-174),307,"35,190",3 out of 5,2003-10-10,Inferred from homology
P0C7N1,OR8U8_HUMAN,Olfactory receptor 8U8,319,"36,334",3 out of 5,2008-06-10,Inferred from homology
Q8NGU2,OR9A4_HUMAN,Olfactory receptor 9A4 (Olfactory receptor OR7-1),314,"35,758",3 out of 5,2003-10-10,Evidence at transcript level
P0C7N8,OR9G9_HUMAN,Olfactory receptor 9G9,305,"34,020",2 out of 5,2008-06-10,Inferred from homology
Q8NGE7,OR9K2_HUMAN,Olfactory receptor 9K2 (Olfactory receptor OR12-2),335,"37,746",4 out of 5,2003-10-10,Evidence at transcript level
Q96SN7,ORAI2_HUMAN,Protein orai-2 (CAP-binding protein complex-interacting protein 2) (Transmembrane protein 142B),254,"28,570",4 out of 5,2006-05-16,Evidence at protein level
Q8WV07,ORAV1_HUMAN,Oral cancer-overexpressed protein 1 (Tumor-amplified and overexpressed sequence 1),137,"15,354",3 out of 5,2005-02-01,Evidence at protein level
Q9H0X9,OSBL5_HUMAN,Oxysterol-binding protein-related protein 5 (ORP-5) (OSBP-related protein 5) (Oxysterol-binding protein homolog 1),879,"98,616",5 out of 5,2002-02-11,Evidence at protein level
Q7RTM1,OTOP1_HUMAN,Otopetrin-1,612,"67,353",3 out of 5,2008-01-15,Evidence at transcript level
Q5XKR4,OTP_HUMAN,Homeobox protein orthopedia,325,"34,159",3 out of 5,2007-06-26,Evidence at protein level
Q8NHW6,OTOSP_HUMAN,Otospiralin,89,"9,939",2 out of 5,2004-12-07,Evidence at transcript level
Q5VZR2,NTM2G_HUMAN,NUT family member 2G,741,"79,011",2 out of 5,2006-12-12,Inferred from homology
Q9BSD7,NTPCR_HUMAN,Cancer-related nucleoside-triphosphatase (NTPase) (EC 3.6.1.15) (Nucleoside triphosphate phosphohydrolase),190,"20,713",5 out of 5,2004-10-11,Evidence at protein level
P49790,NU153_HUMAN,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),1475,"153,938",5 out of 5,1996-10-01,Evidence at protein level
P35658,NU214_HUMAN,Nuclear pore complex protein Nup214 (214 kDa nucleoporin) (Nucleoporin Nup214) (Protein CAN),2090,"213,620",5 out of 5,1994-06-01,Evidence at protein level
Q9BXS6,NUSAP_HUMAN,Nucleolar and spindle-associated protein 1 (NuSAP),441,"49,452",5 out of 5,2007-09-11,Evidence at protein level
Q96R47,O2A14_HUMAN,Olfactory receptor 2A14 (OST182) (Olfactory receptor 2A6) (Olfactory receptor OR7-12),310,"34,993",4 out of 5,2003-10-10,Inferred from homology
Q8NGZ9,O2T10_HUMAN,Olfactory receptor 2T10 (Olfactory receptor OR1-64),312,"35,403",3 out of 5,2005-12-20,Evidence at transcript level
Q8NG76,O2T33_HUMAN,Olfactory receptor 2T33 (Olfactory receptor OR1-56),320,"35,876",3 out of 5,2005-07-19,Evidence at transcript level
Q8NH70,O4A16_HUMAN,Olfactory receptor 4A16 (Olfactory receptor OR11-117),328,"36,922",3 out of 5,2003-10-10,Inferred from homology
A6NMZ5,O4C45_HUMAN,Olfactory receptor 4C45,311,"35,341",3 out of 5,2007-12-04,Inferred from homology
Q8NGJ7,O51A2_HUMAN,Olfactory receptor 51A2,313,"35,078",3 out of 5,2003-10-10,Inferred from homology
Q9Y5P1,O51B2_HUMAN,Olfactory receptor 51B2 (Odorant receptor HOR5'beta3) (Olfactory receptor 51B1),312,"35,373",4 out of 5,2001-06-20,Inferred from homology
Q8NH61,O51F2_HUMAN,Olfactory receptor 51F2 (Olfactory receptor OR11-23),342,"38,518",3 out of 5,2003-10-10,Evidence at transcript level
P00973,OAS1_HUMAN,2'-5'-oligoadenylate synthase 1 ((2-5')oligo(A) synthase 1) (2-5A synthase 1) (EC 2.7.7.84) (E18/E16) (p46/p42 OAS),400,"46,029",5 out of 5,1986-07-21,Evidence at protein level
Q15646,OASL_HUMAN,2'-5'-oligoadenylate synthase-like protein (2'-5'-OAS-related protein) (2'-5'-OAS-RP) (59 kDa 2'-5'-oligoadenylate synthase-like protein) (Thyroid receptor-interacting protein 14) (TR-interacting protein 14) (TRIP-14) (p59 OASL) (p59OASL),514,"59,226",5 out of 5,1997-11-01,Evidence at protein level
Q16625,OCLN_HUMAN,Occludin,522,"59,144",5 out of 5,1998-12-15,Evidence at protein level
Q01968,OCRL_HUMAN,Inositol polyphosphate 5-phosphatase OCRL-1 (EC 3.1.3.36) (Lowe oculocerebrorenal syndrome protein),901,"104,205",5 out of 5,1993-07-01,Evidence at protein level
Q9UKG9,OCTC_HUMAN,Peroxisomal carnitine O-octanoyltransferase (COT) (EC 2.3.1.137),612,"70,178",5 out of 5,2001-01-11,Evidence at protein level
Q6N063,OGFD2_HUMAN,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2 (EC 1.14.11.-),350,"38,996",3 out of 5,2007-05-29,Evidence at transcript level
Q9NZT2,OGFR_HUMAN,Opioid growth factor receptor (OGFr) (Protein 7-60) (Zeta-type opioid receptor),677,"73,325",4 out of 5,2003-02-01,Evidence at protein level
Q6UWY5,OLFL1_HUMAN,Olfactomedin-like protein 1,402,"45,951",3 out of 5,2004-07-19,Evidence at protein level
Q6UX06,OLFM4_HUMAN,Olfactomedin-4 (OLM4) (Antiapoptotic protein GW112) (G-CSF-stimulated clone 1 protein) (hGC-1) (hOLfD),510,"57,280",5 out of 5,2007-11-13,Evidence at protein level
Q68BL8,OLM2B_HUMAN,Olfactomedin-like protein 2B (Photomedin-2),750,"83,999",3 out of 5,2007-11-13,Evidence at transcript level
P78380,OLR1_HUMAN,"Oxidized low-density lipoprotein receptor 1 (Ox-LDL receptor 1) (C-type lectin domain family 8 member A) (Lectin-like oxidized LDL receptor 1) (LOX-1) (Lectin-like oxLDL receptor 1) (hLOX-1) (Lectin-type oxidized LDL receptor 1) [Cleaved into: Oxidized low-density lipoprotein receptor 1, soluble form]",273,"30,959",5 out of 5,2005-08-16,Evidence at protein level
Q96PE5,OPALI_HUMAN,Opalin (Oligodendrocytic myelin paranodal and inner loop protein) (Transmembrane protein 10),141,"15,683",3 out of 5,2002-05-10,Evidence at transcript level
P41146,OPRX_HUMAN,Nociceptin receptor (Kappa-type 3 opioid receptor) (KOR-3) (Orphanin FQ receptor),370,"40,693",5 out of 5,1995-02-01,Evidence at protein level
Q9Y585,OR1A2_HUMAN,Olfactory receptor 1A2 (Olfactory receptor 17-6) (OR17-6) (Olfactory receptor OR17-10),309,"34,396",4 out of 5,2000-12-01,Evidence at transcript level
Q15619,OR1C1_HUMAN,Olfactory receptor 1C1 (Olfactory receptor OR1-42) (Olfactory receptor TPCR27),314,"35,042",3 out of 5,2001-06-20,Evidence at transcript level
P30953,OR1E1_HUMAN,Olfactory receptor 1E1 (Olfactory receptor 13-66) (OR13-66) (Olfactory receptor 17-2/17-32) (OR17-2) (OR17-32) (Olfactory receptor 1E5) (Olfactory receptor 1E6) (Olfactory receptor 5-85) (OR5-85) (Olfactory receptor OR17-18) (Olfactory receptor-like protein HGMP07I),314,"35,264",4 out of 5,1993-07-01,Inferred from homology
Q8NGS3,OR1J1_HUMAN,Olfactory receptor 1J1 (Olfactory receptor OR9-18),322,"35,493",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGR3,OR1K1_HUMAN,Olfactory receptor 1K1,316,"34,268",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGR2,OR1L6_HUMAN,Olfactory receptor 1L6 (Olfactory receptor 1L7) (Olfactory receptor OR9-30),347,"39,515",4 out of 5,2003-10-10,Inferred from homology
Q8NGA1,OR1M1_HUMAN,Olfactory receptor 1M1 (Olfactory receptor 19-6) (OR19-6) (Olfactory receptor OR19-5),313,"34,840",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH06,OR1P1_HUMAN,Olfactory receptor 1P1 (Olfactory receptor 17-208) (OR17-208) (Olfactory receptor OR17-9),330,"36,638",4 out of 5,2008-01-15,Evidence at transcript level
Q8NGQ3,OR1S2_HUMAN,Olfactory receptor 1S2 (Olfactory receptor OR11-231),325,"36,579",4 out of 5,2003-09-26,Inferred from homology
Q96R48,OR2A5_HUMAN,Olfactory receptor 2A5 (Olfactory receptor 2A26) (Olfactory receptor 2A8) (Olfactory receptor 7-138/7-141) (OR7-138) (OR7-141),311,"35,207",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGZ5,OR2G2_HUMAN,Olfactory receptor 2G2 (Olfactory receptor OR1-32),317,"35,559",4 out of 5,2003-10-10,Inferred from homology
Q9GZK4,OR2H1_HUMAN,Olfactory receptor 2H1 (Hs6M1-16) (OLFR42A-9004.14/9026.2) (Olfactory receptor 2H6) (Olfactory receptor 2H8) (Olfactory receptor 6-2) (OR6-2) (Olfactory receptor OR6-32),316,"35,339",4 out of 5,2001-06-20,Evidence at transcript level
Q8NGT1,OR2K2_HUMAN,Olfactory receptor 2K2 (HTPCRH06) (Olfactory receptor OR9-17),345,"38,473",4 out of 5,2003-10-10,Evidence at transcript level
Q96R28,OR2M2_HUMAN,Olfactory receptor 2M2 (OST423),347,"39,177",3 out of 5,2003-10-10,Inferred from homology
Q8NG81,OR2M7_HUMAN,Olfactory receptor 2M7 (Olfactory receptor OR1-58),312,"34,902",3 out of 5,2003-11-14,Evidence at transcript level
Q6IF00,OR2T2_HUMAN,Olfactory receptor 2T2 (Olfactory receptor OR1-43),324,"36,228",3 out of 5,2005-12-20,Evidence at transcript level
Q8NHC8,OR2T6_HUMAN,Olfactory receptor 2T6 (OST703) (Olfactory receptor 2T9),308,"34,765",4 out of 5,2005-12-20,Inferred from homology
Q96R30,OR2V2_HUMAN,Olfactory receptor 2V2 (Olfactory receptor 2V3) (Olfactory receptor OR5-3),315,"35,339",3 out of 5,2003-10-10,Inferred from homology
Q8NGV0,OR2Y1_HUMAN,Olfactory receptor 2Y1 (Olfactory receptor OR5-2),311,"34,731",3 out of 5,2003-10-10,Evidence at transcript level
Q8NH83,OR4A5_HUMAN,Olfactory receptor 4A5 (Olfactory receptor OR11-111),315,"34,915",3 out of 5,2003-10-10,Inferred from homology
Q96R67,OR4CC_HUMAN,Olfactory receptor 4C12 (Olfactory receptor OR11-259),309,"34,491",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGM1,OR4CF_HUMAN,Olfactory receptor 4C15 (Olfactory receptor OR11-127) (Olfactory receptor OR11-134),316,"35,667",3 out of 5,2003-10-10,Inferred from homology
P58180,OR4D2_HUMAN,Olfactory receptor 4D2 (B-lymphocyte membrane protein BC2009) (Olfactory receptor OR17-24),307,"34,958",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGI4,OR4DB_HUMAN,Olfactory receptor 4D11,311,"34,969",3 out of 5,2005-07-19,Inferred from homology
Q8NGC2,OR4E2_HUMAN,Olfactory receptor 4E2 (Olfactory receptor OR14-42),313,"35,466",3 out of 5,2003-10-10,Inferred from homology
Q8NH21,OR4F5_HUMAN,Olfactory receptor 4F5,305,"34,330",3 out of 5,2003-10-10,Inferred from homology
Q8NGD5,OR4KE_HUMAN,Olfactory receptor 4K14 (Olfactory receptor OR14-22),310,"35,053",3 out of 5,2003-10-10,Inferred from homology
Q8NGC6,OR4KH_HUMAN,Olfactory receptor 4K17 (Olfactory receptor OR14-29),315,"35,312",3 out of 5,2003-10-10,Inferred from homology
Q8N0Y3,OR4N4_HUMAN,Olfactory receptor 4N4 (Olfactory receptor OR15-1) (Olfactory receptor OR15-5),316,"35,724",4 out of 5,2003-10-10,Evidence at transcript level
P0C623,OR4Q2_HUMAN,Olfactory receptor 4Q2 (olfactory receptor OR14-21),313,"35,487",4 out of 5,2008-01-15,Inferred from homology
Q8NH73,OR4S2_HUMAN,Olfactory receptor 4S2 (Olfactory receptor OR11-137),311,"35,172",3 out of 5,2003-10-31,Inferred from homology
Q8NGJ0,OR5A1_HUMAN,Olfactory receptor 5A1 (OST181) (Olfactory receptor OR11-249),315,"35,152",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGF7,OR5BH_HUMAN,Olfactory receptor 5B17 (Olfactory receptor 5B20) (Olfactory receptor OR11-237),314,"35,091",3 out of 5,2003-10-10,Inferred from homology
Q8NGL4,OR5DD_HUMAN,Olfactory receptor 5D13 (Olfactory receptor OR11-142) (Olfactory receptor OR11-148),314,"35,447",3 out of 5,2003-10-10,Inferred from homology
Q8NGL1,OR5DI_HUMAN,Olfactory receptor 5D18 (Olfactory receptor OR11-143) (Olfactory receptor OR11-152),313,"35,348",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGV6,OR5H6_HUMAN,Olfactory receptor 5H6 (Olfactory receptor OR3-11),325,"36,713",4 out of 5,2003-10-10,Evidence at transcript level
Q9NY59,NSMA2_HUMAN,Sphingomyelin phosphodiesterase 3 (EC 3.1.4.12) (Neutral sphingomyelinase 2) (nSMase-2) (nSMase2) (Neutral sphingomyelinase II),655,"71,081",5 out of 5,2005-08-30,Evidence at protein level
Q3KNT7,NSN5B_HUMAN,Putative NOL1/NOP2/Sun domain family member 5B (EC 2.1.1.-) (Williams-Beuren syndrome chromosomal region 20B protein),163,"17,679",3 out of 5,2006-11-28,Uncertain
Q5TFE4,NT5D1_HUMAN,5'-nucleotidase domain-containing protein 1 (EC 3.1.3.-),455,"51,845",3 out of 5,2006-07-25,Evidence at protein level
Q96EP9,NTCP4_HUMAN,Sodium/bile acid cotransporter 4 (Na(+)/bile acid cotransporter 4) (Solute carrier family 10 member 4),437,"46,504",4 out of 5,2006-12-12,Evidence at protein level
Q5PT55,NTCP5_HUMAN,Sodium/bile acid cotransporter 5 (Na(+)/bile acid cotransporter 5) (Solute carrier family 10 member 5),438,"48,871",2 out of 5,2006-12-12,Evidence at transcript level
Q9Y2I2,NTNG1_HUMAN,Netrin-G1 (Laminet-1),539,"60,541",5 out of 5,2003-09-19,Evidence at protein level
P30989,NTR1_HUMAN,Neurotensin receptor type 1 (NT-R-1) (NTR1) (High-affinity levocabastine-insensitive neurotensin receptor) (NTRH),418,"46,259",5 out of 5,1993-07-01,Evidence at protein level
O95665,NTR2_HUMAN,Neurotensin receptor type 2 (NT-R-2) (NTR2) (Levocabastine-sensitive neurotensin receptor),410,"45,385",4 out of 5,2000-12-01,Evidence at protein level
P57740,NU107_HUMAN,Nuclear pore complex protein Nup107 (107 kDa nucleoporin) (Nucleoporin Nup107),925,"106,374",5 out of 5,2001-01-11,Evidence at protein level
P03891,NU2M_HUMAN,NADH-ubiquinone oxidoreductase chain 2 (EC 1.6.5.3) (NADH dehydrogenase subunit 2),347,"38,961",5 out of 5,1986-07-21,Evidence at protein level
O95848,NUD14_HUMAN,Uridine diphosphate glucose pyrophosphatase (UDPG pyrophosphatase) (UGPPase) (EC 3.6.1.45) (Nucleoside diphosphate-linked moiety X motif 14) (Nudix motif 14),222,"24,118",5 out of 5,2004-03-01,Evidence at protein level
Q9NV35,NUD15_HUMAN,Nucleotide triphosphate diphosphatase NUDT15 (EC 3.6.1.9) (MutT homolog 2) (MTH2) (Nucleoside diphosphate-linked moiety X motif 15) (Nudix motif 15) (Nucleoside diphosphate-linked to another moiety X hydrolase 15) (Nudix hydrolase 15),164,"18,609",5 out of 5,2005-07-05,Evidence at protein level
Q6ZVK8,NUD18_HUMAN,"8-oxo-dGDP phosphatase NUDT18 (EC 3.6.1.58) (2-hydroxy-dADP phosphatase) (7,8-dihydro-8-oxoguanine phosphatase) (MutT homolog 3) (Nucleoside diphosphate-linked moiety X motif 18) (Nudix motif 18)",323,"35,501",5 out of 5,2008-03-18,Evidence at protein level
P53370,NUDT6_HUMAN,Nucleoside diphosphate-linked moiety X motif 6 (Nudix motif 6) (EC 3.6.1.-) (Antisense basic fibroblast growth factor) (Protein GFG),316,"35,679",4 out of 5,1996-10-01,Evidence at protein level
P0C024,NUDT7_HUMAN,Peroxisomal coenzyme A diphosphatase NUDT7 (EC 3.6.1.-) (Nucleoside diphosphate-linked moiety X motif 7) (Nudix motif 7),238,"26,942",5 out of 5,2005-07-05,Evidence at transcript level
Q9Y6R0,NUMBL_HUMAN,Numb-like protein (Numb-related protein) (Numb-R),609,"64,891",4 out of 5,2001-06-01,Evidence at protein level
O15504,NUPL2_HUMAN,Nucleoporin-like protein 2 (NLP-1) (NUP42 homolog) (Nucleoporin hCG1),423,"44,872",5 out of 5,2005-12-06,Evidence at protein level
Q9ULI1,NWD2_HUMAN,NACHT and WD repeat domain-containing protein 2 (Leucine-rich repeat and WD repeat-containing protein KIAA1239),1742,"197,466",2 out of 5,2008-02-26,Evidence at transcript level
Q8NH63,O51H1_HUMAN,Olfactory receptor 51H1 (Olfactory receptor OR11-25),302,"33,766",3 out of 5,2003-10-10,Inferred from homology
Q8NGJ3,O52E1_HUMAN,Olfactory receptor 52E1,308,"34,714",3 out of 5,2003-10-10,Inferred from homology
Q8NH55,O52E5_HUMAN,Olfactory receptor 52E5,327,"36,851",3 out of 5,2003-10-10,Inferred from homology
Q8NGJ2,O52H1_HUMAN,Olfactory receptor 52H1 (Olfactory receptor OR11-45),320,"35,592",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGK4,O52K1_HUMAN,Olfactory receptor 52K1 (Olfactory receptor OR11-8),314,"35,231",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGH7,O52L1_HUMAN,Olfactory receptor 52L1 (Olfactory receptor OR11-50),329,"36,221",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGI2,O52N4_HUMAN,Olfactory receptor 52N4 (Olfactory receptor OR11-64),321,"36,080",4 out of 5,2003-10-10,Evidence at transcript level
Q8NH54,O56A3_HUMAN,Olfactory receptor 56A3 (Olfactory receptor 56A6),315,"35,611",3 out of 5,2003-10-10,Inferred from homology
Q8NGH8,O56A4_HUMAN,Olfactory receptor 56A4 (Olfactory receptor OR11-49),313,"35,116",4 out of 5,2003-10-10,Evidence at transcript level
P0C7T3,O56A5_HUMAN,Olfactory receptor 56A5,313,"35,317",4 out of 5,2008-07-22,Inferred from homology
A6NDL8,O6C68_HUMAN,Olfactory receptor 6C68,312,"35,296",3 out of 5,2007-11-13,Inferred from homology
P04181,OAT_HUMAN,"Ornithine aminotransferase, mitochondrial (EC 2.6.1.13) (Ornithine delta-aminotransferase) (Ornithine--oxo-acid aminotransferase) [Cleaved into: Ornithine aminotransferase, hepatic form; Ornithine aminotransferase, renal form]",439,"48,535",5 out of 5,1987-03-20,Evidence at protein level
Q9UMX2,OAZ3_HUMAN,Ornithine decarboxylase antizyme 3 (AZ3) (ODC-Az 3),235,"27,413",5 out of 5,2001-04-27,Evidence at protein level
P08559,ODPA_HUMAN,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial (EC 1.2.4.1) (PDHE1-A type I)",390,"43,296",5 out of 5,1988-08-01,Evidence at protein level
O75665,OFD1_HUMAN,Oral-facial-digital syndrome 1 protein (Protein 71-7A),1012,"116,671",5 out of 5,2001-01-24,Evidence at protein level
Q6PK18,OGFD3_HUMAN,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 3 (EC 1.14.11.-),319,"35,646",4 out of 5,2008-03-18,Evidence at protein level
Q8TEA1,NSUN6_HUMAN,Putative methyltransferase NSUN6 (EC 2.1.1.-) (NOL1/NOP2/Sun and PUA domain-containing protein 1) (NOL1/NOP2/Sun domain family member 6),469,"51,770",4 out of 5,2006-12-12,Evidence at protein level
Q86UY8,NT5D3_HUMAN,5'-nucleotidase domain-containing protein 3 (EC 3.1.3.-) (GRP94-neighboring nucleotidase),548,"63,420",4 out of 5,2008-03-18,Evidence at protein level
Q9GZY6,NTAL_HUMAN,Linker for activation of T-cells family member 2 (Linker for activation of B-cells) (Membrane-associated adapter molecule) (Non-T-cell activation linker) (Williams-Beuren syndrome chromosomal region 15 protein) (Williams-Beuren syndrome chromosomal region 5 protein),243,"26,550",5 out of 5,2005-12-20,Evidence at protein level
A1L443,NTM2F_HUMAN,NUT family member 2F,756,"80,770",2 out of 5,2008-06-10,Evidence at transcript level
Q96CW9,NTNG2_HUMAN,Netrin-G2 (Laminet-2),530,"59,799",5 out of 5,2003-09-19,Evidence at protein level
Q8TB37,NUBPL_HUMAN,Iron-sulfur protein NUBPL (IND1 homolog) (Nucleotide-binding protein-like) (huInd1),319,"34,083",5 out of 5,2003-11-07,Evidence at protein level
Q9H1E3,NUCKS_HUMAN,Nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 (P1),243,"27,296",5 out of 5,2001-04-27,Evidence at protein level
P0C025,NUD17_HUMAN,Nucleoside diphosphate-linked moiety X motif 17 (Nudix motif 17) (EC 3.6.1.-),328,"35,923",2 out of 5,2005-07-05,Inferred from homology
Q8WVJ2,NUDC2_HUMAN,NudC domain-containing protein 2,157,"17,676",5 out of 5,2005-06-07,Evidence at protein level
Q9BZD4,NUF2_HUMAN,Kinetochore protein Nuf2 (hNuf2) (hNuf2R) (hsNuf2) (Cell division cycle-associated protein 1),464,"54,304",5 out of 5,2006-09-19,Evidence at protein level
Q9UHK0,NUFP1_HUMAN,Nuclear fragile X mental retardation-interacting protein 1 (Nuclear FMRP-interacting protein 1),495,"56,300",5 out of 5,2006-07-11,Evidence at protein level
Q96DL1,NXPE2_HUMAN,NXPE family member 2 (Protein FAM55B),559,"64,901",2 out of 5,2007-08-21,Evidence at protein level
Q969Y0,NXPE3_HUMAN,NXPE family member 3 (Protein FAM55C),559,"63,800",2 out of 5,2007-08-21,Evidence at transcript level
P58417,NXPH1_HUMAN,Neurexophilin-1,271,"31,082",2 out of 5,2001-12-05,Evidence at transcript level
Q8NGX5,O10K1_HUMAN,Olfactory receptor 10K1 (Olfactory receptor OR1-6),313,"35,079",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGY1,O10Z1_HUMAN,Olfactory receptor 10Z1 (Olfactory receptor OR1-15),313,"34,609",3 out of 5,2003-10-10,Inferred from homology
Q8NGC1,O11G2_HUMAN,Olfactory receptor 11G2 (Olfactory receptor OR14-34),345,"38,871",3 out of 5,2003-10-10,Inferred from homology
Q8NG94,O11H1_HUMAN,Olfactory receptor 11H1 (Olfactory receptor OR22-1),326,"36,578",3 out of 5,2003-10-10,Inferred from homology
Q8NGX0,O11L1_HUMAN,Olfactory receptor 11L1,322,"36,763",4 out of 5,2003-10-10,Inferred from homology
P58182,O12D2_HUMAN,Olfactory receptor 12D2 (Hs6M1-20) (Olfactory receptor OR6-28),307,"34,813",4 out of 5,2001-06-20,Evidence at transcript level
P0DN82,O12D1_HUMAN,Olfactory receptor 12D1 (Olfactory receptor 12D1 pseudogene),309,"35,330",3 out of 5,2016-02-17,Inferred from homology
Q8NGS6,O13C3_HUMAN,Olfactory receptor 13C3 (Olfactory receptor OR9-8),347,"38,729",3 out of 5,2003-09-26,Evidence at transcript level
Q8NG92,O13H1_HUMAN,Olfactory receptor 13H1 (Olfactory receptor ORX-1),308,"34,570",3 out of 5,2003-10-10,Evidence at transcript level
Q8NHC7,O14CZ_HUMAN,Olfactory receptor 14C36 (Olfactory receptor 5BF1) (Olfactory receptor OR1-59),312,"34,815",4 out of 5,2003-11-21,Inferred from homology
P21953,ODBB_HUMAN,"2-oxoisovalerate dehydrogenase subunit beta, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component beta chain) (BCKDE1B) (BCKDH E1-beta)",392,"43,122",5 out of 5,1991-08-01,Evidence at protein level
P11177,ODPB_HUMAN,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial (PDHE1-B) (EC 1.2.4.1)",359,"39,233",5 out of 5,1989-07-01,Evidence at protein level
Q9H488,OFUT1_HUMAN,GDP-fucose protein O-fucosyltransferase 1 (EC 2.4.1.221) (Peptide-O-fucosyltransferase 1) (O-FucT-1),388,"43,956",5 out of 5,2002-09-19,Evidence at protein level
Q8WWZ8,OIT3_HUMAN,Oncoprotein-induced transcript 3 protein (Liver-specific zona pellucida domain-containing protein),545,"60,022",4 out of 5,2007-08-21,Evidence at protein level
Q9NTK5,OLA1_HUMAN,Obg-like ATPase 1 (DNA damage-regulated overexpressed in cancer 45) (DOC45) (GTP-binding protein 9),396,"44,744",5 out of 5,2002-11-25,Evidence at protein level
Q13516,OLIG2_HUMAN,Oligodendrocyte transcription factor 2 (Oligo2) (Class B basic helix-loop-helix protein 1) (bHLHb1) (Class E basic helix-loop-helix protein 19) (bHLHe19) (Protein kinase C-binding protein 2) (Protein kinase C-binding protein RACK17),323,"32,385",5 out of 5,2000-05-30,Evidence at transcript level
O60422,ONEC3_HUMAN,One cut domain family member 3 (One cut homeobox 3) (Transcription factor ONECUT-3) (OC-3),494,"50,037",3 out of 5,2007-01-09,Inferred from homology
A6NGQ2,OOEP_HUMAN,Oocyte-expressed protein homolog (KH homology domain-containing protein 2) (Oocyte- and embryo-specific protein 19) (hOEP19),149,"17,170",4 out of 5,2008-04-08,Evidence at protein level
A8MZH6,OOSP1_HUMAN,Putative oocyte-secreted protein 1 homolog,123,"14,433",2 out of 5,2008-07-22,Uncertain
Q56VL3,OCAD2_HUMAN,OCIA domain-containing protein 2 (Ovarian carcinoma immunoreactive antigen-like protein),154,"16,954",2 out of 5,2007-09-11,Evidence at protein level
P0CE71,OCM2_HUMAN,Putative oncomodulin-2,109,"12,129",2 out of 5,2010-03-23,Uncertain
A8MYP8,ODF3B_HUMAN,Outer dense fiber protein 3B (Outer dense fiber protein 3-like protein 3),253,"27,280",2 out of 5,2008-09-02,Evidence at transcript level
Q2M2E3,ODFP4_HUMAN,Outer dense fiber protein 4 (Outer dense fiber of sperm tails protein 4) (Testis-specific protein oppo 1) (hOPPO1),257,"29,233",3 out of 5,2007-09-11,Evidence at protein level
O00330,ODPX_HUMAN,"Pyruvate dehydrogenase protein X component, mitochondrial (Dihydrolipoamide dehydrogenase-binding protein of pyruvate dehydrogenase complex) (E3-binding protein) (E3BP) (Lipoyl-containing pyruvate dehydrogenase complex component X) (proX)",501,"54,122",5 out of 5,1999-07-15,Evidence at protein level
Q13607,OR2F1_HUMAN,Olfactory receptor 2F1 (Olfactory receptor 2F3) (Olfactory receptor 2F4) (Olfactory receptor 2F5) (Olfactory receptor-like protein OLF3),317,"35,350",4 out of 5,1997-11-01,Evidence at transcript level
Q9GZK6,OR2J1_HUMAN,Olfactory receptor 2J1 (Hs6M1-4) (Olfactory receptor 6-5) (OR6-5),312,"35,454",4 out of 5,2004-06-21,Inferred from homology
Q8NG80,OR2L5_HUMAN,Olfactory receptor 2L5 (Olfactory receptor 2L11) (Olfactory receptor OR1-53),312,"35,648",3 out of 5,2003-11-14,Inferred from homology
Q8NG83,OR2M3_HUMAN,Olfactory receptor 2M3 (Olfactory receptor 2M6) (Olfactory receptor OR1-54),312,"34,827",3 out of 5,2003-11-07,Evidence at transcript level
Q9NQN1,OR2S1_HUMAN,Olfactory receptor 2S2 (Olfactory receptor OR9-3),319,"35,172",4 out of 5,2001-06-20,Evidence at transcript level
Q8NH03,OR2T3_HUMAN,Olfactory receptor 2T3,318,"35,598",3 out of 5,2003-10-10,Evidence at transcript level
P0C7T2,OR2T7_HUMAN,Olfactory receptor 2T7 (OST723) (olfactory receptor OR1-44),308,"34,287",3 out of 5,2008-07-22,Inferred from homology
Q9Y3N9,OR2W1_HUMAN,Olfactory receptor 2W1 (Hs6M1-15) (Olfactory receptor OR6-13),320,"36,101",3 out of 5,2001-06-20,Evidence at transcript level
P47888,OR3A3_HUMAN,Olfactory receptor 3A3 (Olfactory receptor 17-201) (OR17-201) (Olfactory receptor 3A6) (Olfactory receptor 3A7) (Olfactory receptor 3A8) (Olfactory receptor OR17-22),321,"34,963",4 out of 5,1996-02-01,Evidence at transcript level
Q8NGN8,OR4A4_HUMAN,Putative olfactory receptor 4A4 (Olfactory receptor OR11-107),299,"33,593",3 out of 5,2003-10-10,Uncertain
Q8NH37,OR4C3_HUMAN,Olfactory receptor 4C3 (Olfactory receptor OR11-98),302,"33,726",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGL9,OR4CG_HUMAN,Olfactory receptor 4C16 (Olfactory receptor OR11-135),310,"34,991",4 out of 5,2003-10-10,Inferred from homology
Q8NGN0,OR4D5_HUMAN,Olfactory receptor 4D5 (Olfactory receptor OR11-276),318,"35,771",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGI6,OR4DA_HUMAN,Olfactory receptor 4D10 (Olfactory receptor OR11-251),311,"35,300",3 out of 5,2005-07-19,Evidence at transcript level
Q6IEY1,OR4F3_HUMAN,Olfactory receptor 4F3/4F16/4F29 (Olfactory receptor OR1-1),312,"35,074",3 out of 5,2005-12-20,Evidence at transcript level
Q96R09,OR5B2_HUMAN,Olfactory receptor 5B2 (OST073) (Olfactory receptor OR11-240),309,"34,568",3 out of 5,2002-05-10,Evidence at transcript level
P0DN80,OR5H8_HUMAN,Olfactory receptor 5H8 (Olfactory receptor 5H8 pseudogene) (Olfactory receptor OR3-7),308,"34,772",3 out of 5,2016-02-17,Inferred from homology
Q8NHB8,OR5K2_HUMAN,Olfactory receptor 5K2 (Olfactory receptor OR3-9),316,"35,763",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGP8,OR5M1_HUMAN,Olfactory receptor 5M1 (OST050) (Olfactory receptor OR11-208),315,"35,608",3 out of 5,2003-10-10,Inferred from homology
Q8NGP6,OR5M8_HUMAN,Olfactory receptor 5M8 (Olfactory receptor OR11-194),311,"35,603",3 out of 5,2003-10-10,Evidence at transcript level
Q8WZ92,OR5P2_HUMAN,Olfactory receptor 5P2 (Olfactory receptor-like protein JCG3),322,"35,786",4 out of 5,2002-05-10,Evidence at transcript level
Q8NH85,OR5R1_HUMAN,Olfactory receptor 5R1 (Olfactory receptor OR11-185),324,"36,708",4 out of 5,2005-02-01,Inferred from homology
Q8NGG3,OR5T3_HUMAN,Olfactory receptor 5T3 (Olfactory receptor OR11-178),340,"38,346",3 out of 5,2003-10-10,Inferred from homology
Q8NGW1,OR6B3_HUMAN,Olfactory receptor 6B3 (Olfactory receptor OR2-2),331,"37,232",3 out of 5,2003-10-31,Inferred from homology
Q9NZP0,OR6C3_HUMAN,Olfactory receptor 6C3 (HSA8),311,"35,531",3 out of 5,2003-10-10,Inferred from homology
A6NF89,OR6C6_HUMAN,Olfactory receptor 6C6,314,"35,963",3 out of 5,2007-11-13,Inferred from homology
Q8NGW6,OR6K6_HUMAN,Olfactory receptor 6K6 (Olfactory receptor OR1-21),343,"38,362",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGQ2,OR6Q1_HUMAN,Olfactory receptor 6Q1 (Olfactory receptor OR11-226),317,"35,736",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGX8,OR6Y1_HUMAN,Olfactory receptor 6Y1 (Olfactory receptor 6Y2) (Olfactory receptor OR1-11),325,"36,636",3 out of 5,2003-10-10,Inferred from homology
Q15622,OR7A5_HUMAN,Olfactory receptor 7A5 (Olfactory receptor OR19-17) (Olfactory receptor TPCR92),319,"35,579",3 out of 5,2001-06-20,Evidence at transcript level
O60412,OR7C2_HUMAN,Olfactory receptor 7C2 (Olfactory receptor 19-18) (OR19-18) (Olfactory receptor 7C3) (Olfactory receptor OR19-22),319,"35,323",4 out of 5,2001-06-20,Inferred from homology
Q8NG99,OR7G2_HUMAN,Olfactory receptor 7G2 (OST260) (Olfactory receptor 19-13) (OR19-13) (Olfactory receptor OR19-6),324,"35,931",3 out of 5,2003-10-10,Inferred from homology
Q15620,OR8B8_HUMAN,Olfactory receptor 8B8 (Olfactory receptor TPCR85) (Olfactory-like receptor JCG8),311,"34,482",4 out of 5,2001-06-20,Evidence at transcript level
Q8NH09,OR8S1_HUMAN,Olfactory receptor 8S1,359,"39,645",3 out of 5,2005-12-20,Inferred from homology
Q8NGE9,OR9Q2_HUMAN,Olfactory receptor 9Q2,314,"35,363",3 out of 5,2005-12-20,Inferred from homology
O43612,OREX_HUMAN,Orexin (Hypocretin) (Hcrt) [Cleaved into: Orexin-A (Hypocretin-1) (Hcrt1); Orexin-B (Hypocretin-2) (Hcrt2)],131,"13,363",5 out of 5,2000-05-30,Evidence at protein level
Q8N138,ORML3_HUMAN,ORM1-like protein 3,153,"17,495",5 out of 5,2005-11-08,Evidence at protein level
Q9BXW6,OSBL1_HUMAN,Oxysterol-binding protein-related protein 1 (ORP-1) (OSBP-related protein 1),950,"108,470",5 out of 5,2002-02-11,Evidence at protein level
Q9BZF2,OSBL7_HUMAN,Oxysterol-binding protein-related protein 7 (ORP-7) (OSBP-related protein 7),842,"95,432",5 out of 5,2002-02-11,Evidence at protein level
Q9Y236,OSGI2_HUMAN,Oxidative stress-induced growth inhibitor 2 (hT41),505,"56,672",3 out of 5,2000-12-01,Evidence at transcript level
Q9H4B0,OSGP2_HUMAN,"Probable tRNA N6-adenosine threonylcarbamoyltransferase, mitochondrial (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase-like protein 1) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEPL1) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEPL1)",414,"45,123",5 out of 5,2007-10-23,Evidence at transcript level
P61366,OSTN_HUMAN,Osteocrin (Musclin) [Cleaved into: Processed Osteocrin],133,"14,722",4 out of 5,2004-05-10,Evidence at protein level
P10451,OSTP_HUMAN,Osteopontin (Bone sialoprotein 1) (Nephropontin) (Secreted phosphoprotein 1) (SPP-1) (Urinary stone protein) (Uropontin),314,"35,423",5 out of 5,1989-07-01,Evidence at protein level
P00480,OTC_HUMAN,"Ornithine carbamoyltransferase, mitochondrial (EC 2.1.3.3) (Ornithine transcarbamylase) (OTCase)",354,"39,935",5 out of 5,1986-07-21,Evidence at protein level
Q6ZRI0,OTOG_HUMAN,Otogelin,2925,"314,794",5 out of 5,2007-12-04,Evidence at protein level
Q7L8S5,OTU6A_HUMAN,OTU domain-containing protein 6A (EC 3.4.19.12) (DUBA-2),288,"33,300",4 out of 5,2006-01-24,Evidence at protein level
Q96FW1,OTUB1_HUMAN,Ubiquitin thioesterase OTUB1 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB1) (OTU domain-containing ubiquitin aldehyde-binding protein 1) (Otubain-1) (hOTU1) (Ubiquitin-specific-processing protease OTUB1),271,"31,284",5 out of 5,2004-03-01,Evidence at protein level
Q96G74,OTUD5_HUMAN,OTU domain-containing protein 5 (EC 3.4.19.12) (Deubiquitinating enzyme A) (DUBA),571,"60,626",5 out of 5,2007-02-20,Evidence at protein level
Q99489,OXDD_HUMAN,D-aspartate oxidase (DASOX) (DDO) (EC 1.4.3.1),341,"37,535",5 out of 5,1997-11-01,Evidence at transcript level
O95747,OXSR1_HUMAN,Serine/threonine-protein kinase OSR1 (EC 2.7.11.1) (Oxidative stress-responsive 1 protein),527,"58,022",5 out of 5,2005-08-16,Evidence at protein level
Q96HA1,P121A_HUMAN,Nuclear envelope pore membrane protein POM 121 (Nuclear envelope pore membrane protein POM 121A) (Nucleoporin Nup121) (Pore membrane protein of 121 kDa),1249,"127,720",5 out of 5,2008-09-02,Evidence at protein level
Q6GTS8,P20D1_HUMAN,N-fatty-acyl-amino acid synthase/hydrolase PM20D1 (EC 3.5.1.-) (EC 4.3.-.-) (Peptidase M20 domain-containing protein 1),502,"55,741",5 out of 5,2008-02-26,Evidence at transcript level
Q8IYS1,P20D2_HUMAN,Peptidase M20 domain-containing protein 2 (Aminoacylase-1-like protein 2),436,"47,776",3 out of 5,2007-05-01,Evidence at protein level
Q969Q6,P2R3C_HUMAN,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit gamma (Protein phosphatase subunit G5PR) (Rhabdomyosarcoma antigen MU-RMS-40.6A/6C),453,"53,316",5 out of 5,2007-02-20,Evidence at protein level
P56373,P2RX3_HUMAN,P2X purinoceptor 3 (P2X3) (ATP receptor) (Purinergic receptor),397,"44,289",5 out of 5,1998-07-15,Evidence at protein level
P13674,P4HA1_HUMAN,"Prolyl 4-hydroxylase subunit alpha-1 (4-PH alpha-1) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1)",534,"61,049",5 out of 5,1990-01-01,Evidence at protein level
Q7Z4N8,P4HA3_HUMAN,"Prolyl 4-hydroxylase subunit alpha-3 (4-PH alpha-3) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-3)",544,"61,126",5 out of 5,2008-02-05,Evidence at protein level
O43422,P52K_HUMAN,52 kDa repressor of the inhibitor of the protein kinase (p52rIPK) (58 kDa interferon-induced protein kinase-interacting protein) (p58IPK-interacting protein) (Death-associated protein 4) (THAP domain-containing protein 0) (THAP domain-containing protein 12),761,"87,704",5 out of 5,2001-01-11,Evidence at protein level
Q06416,P5F1B_HUMAN,"Putative POU domain, class 5, transcription factor 1B (Oct4-pg1) (Octamer-binding protein 3-like) (Octamer-binding transcription factor 3-like)",359,"38,588",5 out of 5,2003-02-01,Uncertain
Q8WXI9,P66B_HUMAN,Transcriptional repressor p66-beta (GATA zinc finger domain-containing protein 2B) (p66/p68),593,"65,261",5 out of 5,2004-07-19,Evidence at protein level
O15350,P73_HUMAN,Tumor protein p73 (p53-like transcription factor) (p53-related protein),636,"69,623",5 out of 5,2000-12-01,Evidence at protein level
Q15102,PA1B3_HUMAN,Platelet-activating factor acetylhydrolase IB subunit gamma (EC 3.1.1.47) (PAF acetylhydrolase 29 kDa subunit) (PAF-AH 29 kDa subunit) (PAF-AH subunit gamma) (PAFAH subunit gamma),231,"25,734",5 out of 5,1998-07-15,Evidence at protein level
Q9BZM2,PA2GF_HUMAN,Group IIF secretory phospholipase A2 (GIIF sPLA2) (sPLA2-IIF) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2F),168,"18,658",5 out of 5,2002-02-11,Evidence at protein level
Q8NFH5,NUP53_HUMAN,Nucleoporin NUP53 (35 kDa nucleoporin) (Mitotic phosphoprotein 44) (MP-44) (Nuclear pore complex protein Nup53) (Nucleoporin Nup35),326,"34,774",5 out of 5,2006-05-16,Evidence at protein level
Q9H205,O2AG1_HUMAN,Olfactory receptor 2AG1 (HT3) (Olfactory receptor 2AG3) (Olfactory receptor OR11-79),316,"35,270",4 out of 5,2001-06-20,Evidence at protein level
Q8NGE2,O2AP1_HUMAN,Olfactory receptor 2AP1 (Olfactory receptor OR12-9),309,"34,902",3 out of 5,2006-01-10,Inferred from homology
Q8NH01,O2T11_HUMAN,Olfactory receptor 2T11 (Olfactory receptor OR1-65),316,"34,797",3 out of 5,2003-11-21,Inferred from homology
Q8NH02,O2T29_HUMAN,Olfactory receptor 2T29,315,"35,595",3 out of 5,2003-10-10,Inferred from homology
A6NHA9,O4C46_HUMAN,Olfactory receptor 4C46,309,"34,533",3 out of 5,2007-11-13,Inferred from homology
Q8NGB8,O4F15_HUMAN,Olfactory receptor 4F15 (Olfactory receptor OR15-14),312,"35,369",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGJ6,O51A4_HUMAN,Olfactory receptor 51A4,313,"35,256",3 out of 5,2003-10-10,Inferred from homology
Q8NGK0,O51G2_HUMAN,Olfactory receptor 51G2 (Olfactory receptor OR11-28),314,"35,012",3 out of 5,2003-10-10,Evidence at transcript level
Q9H342,O51J1_HUMAN,Olfactory receptor 51J1 (Odorant receptor HOR5'beta8) (Olfactory receptor 51J2),316,"34,838",4 out of 5,2008-06-10,Inferred from homology
Q8NH59,O51Q1_HUMAN,Olfactory receptor 51Q1,317,"35,747",4 out of 5,2003-10-31,Evidence at transcript level
Q9H2C8,O51V1_HUMAN,Olfactory receptor 51V1 (Odorant receptor HOR3'beta1) (Olfactory receptor 51A12) (Olfactory receptor OR11-36),321,"36,749",3 out of 5,2005-12-20,Inferred from homology
Q9H2C5,O52A5_HUMAN,Olfactory receptor 52A5 (Odorant receptor HOR3'beta5) (Olfactory receptor OR11-33),316,"35,955",3 out of 5,2005-12-20,Inferred from homology
Q8NGK2,O52B4_HUMAN,Olfactory receptor 52B4 (Olfactory receptor OR11-3),314,"35,584",4 out of 5,2003-10-10,Inferred from homology
A6NIJ9,O6C70_HUMAN,Olfactory receptor 6C70,312,"35,468",3 out of 5,2007-11-13,Inferred from homology
Q6IFN5,O7E24_HUMAN,Olfactory receptor 7E24 (Olfactory receptor OR19-14),339,"38,279",3 out of 5,2007-03-20,Evidence at transcript level
P54368,OAZ1_HUMAN,Ornithine decarboxylase antizyme 1 (AZ1) (ODC-Az),228,"25,406",5 out of 5,1996-10-01,Evidence at protein level
Q5TC84,OGRL1_HUMAN,Opioid growth factor receptor-like protein 1,451,"51,252",2 out of 5,2008-01-15,Evidence at transcript level
Q9NRN5,OLFL3_HUMAN,Olfactomedin-like protein 3 (HNOEL-iso) (hOLF44),406,"46,010",4 out of 5,2003-10-24,Evidence at transcript level
P23515,OMGP_HUMAN,Oligodendrocyte-myelin glycoprotein,440,"49,608",5 out of 5,1991-11-01,Evidence at protein level
Q9BXI2,ORNT2_HUMAN,Mitochondrial ornithine transporter 2 (Solute carrier family 25 member 2),301,"32,580",4 out of 5,2002-02-11,Evidence at protein level
P22059,OSBP1_HUMAN,Oxysterol-binding protein 1,807,"89,421",5 out of 5,1991-08-01,Evidence at protein level
Q9HC10,OTOF_HUMAN,Otoferlin (Fer-1-like protein 2),1997,"226,753",5 out of 5,2002-01-23,Evidence at protein level
Q96DC9,OTUB2_HUMAN,Ubiquitin thioesterase OTUB2 (EC 3.4.19.12) (Deubiquitinating enzyme OTUB2) (OTU domain-containing ubiquitin aldehyde-binding protein 2) (Otubain-2) (Ubiquitin-specific-processing protease OTUB2),234,"27,213",5 out of 5,2004-03-01,Evidence at protein level
P14920,OXDA_HUMAN,D-amino-acid oxidase (DAAO) (DAMOX) (DAO) (EC 1.4.3.3),347,"39,474",5 out of 5,1990-04-01,Evidence at protein level
Q8TDS5,OXER1_HUMAN,Oxoeicosanoid receptor 1 (5-oxo-ETE G-protein coupled receptor) (G-protein coupled receptor 170) (G-protein coupled receptor R527) (G-protein coupled receptor TG1019),423,"45,811",5 out of 5,2005-12-06,Evidence at transcript level
A6NF01,P121B_HUMAN,Putative nuclear envelope pore membrane protein POM 121B,834,"83,015",2 out of 5,2008-09-02,Uncertain
A8CG34,P121C_HUMAN,Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C),1229,"125,059",5 out of 5,2008-09-02,Evidence at protein level
O75747,P3C2G_HUMAN,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma (PI3K-C2-gamma) (PtdIns-3-kinase C2 subunit gamma) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-gamma),1445,"165,715",5 out of 5,2001-04-27,Evidence at protein level
Q8IVL6,P3H3_HUMAN,Prolyl 3-hydroxylase 3 (EC 1.14.11.7) (Leprecan-like protein 2) (Protein B),736,"81,837",5 out of 5,2006-06-27,Evidence at protein level
Q8TCG2,P4K2B_HUMAN,Phosphatidylinositol 4-kinase type 2-beta (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-beta) (PI4KII-BETA),481,"54,744",5 out of 5,2007-05-01,Evidence at protein level
P32322,P5CR1_HUMAN,"Pyrroline-5-carboxylate reductase 1, mitochondrial (P5C reductase 1) (P5CR 1) (EC 1.5.1.2)",319,"33,361",5 out of 5,1993-10-01,Evidence at protein level
Q9H3D4,P63_HUMAN,Tumor protein 63 (p63) (Chronic ulcerative stomatitis protein) (CUSP) (Keratinocyte transcription factor KET) (Transformation-related protein 63) (TP63) (Tumor protein p73-like) (p73L) (p40) (p51),680,"76,785",5 out of 5,2005-01-04,Evidence at protein level
P12694,ODBA_HUMAN,"2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial (EC 1.2.4.4) (Branched-chain alpha-keto acid dehydrogenase E1 component alpha chain) (BCKDE1A) (BCKDH E1-alpha)",445,"50,471",5 out of 5,1989-10-01,Evidence at protein level
Q96PU9,ODF3A_HUMAN,Outer dense fiber protein 3 (Outer dense fiber of sperm tails protein 3) (Sperm tail protein SHIPPO 1) (Transcript induced in spermiogenesis protein 50),254,"27,710",4 out of 5,2007-09-11,Evidence at transcript level
Q8IZS5,OFCC1_HUMAN,Orofacial cleft 1 candidate gene 1 protein (Orofacial clefting chromosomal breakpoint region candidate 1 protein),231,"26,754",4 out of 5,2008-05-20,Evidence at protein level
O60502,OGA_HUMAN,Protein O-GlcNAcase (OGA) (EC 3.2.1.169) (Beta-N-acetylglucosaminidase) (EC 3.2.1.-) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase) (Meningioma-expressed antigen 5) (N-acetyl-beta-D-glucosaminidase) (N-acetyl-beta-glucosaminidase) (Nuclear cytoplasmic O-GlcNAcase and acetyltransferase) (NCOAT),916,"102,915",5 out of 5,2006-10-03,Evidence at protein level
Q9ULD0,OGDHL_HUMAN,"2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.-) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like)",1010,"114,481",5 out of 5,2007-11-13,Evidence at protein level
Q7RTU3,OLIG3_HUMAN,Oligodendrocyte transcription factor 3 (Oligo3) (Class B basic helix-loop-helix protein 7) (bHLHb7) (Class E basic helix-loop-helix protein 20) (bHLHe20),272,"29,358",4 out of 5,2004-08-31,Evidence at protein level
Q96E52,OMA1_HUMAN,"Metalloendopeptidase OMA1, mitochondrial (EC 3.4.24.-) (Metalloprotease-related protein 1) (MPRP-1) (Overlapping with the m-AAA protease 1 homolog)",524,"60,120",5 out of 5,2007-09-11,Evidence at protein level
P47874,OMP_HUMAN,Olfactory marker protein (Olfactory neuronal-specific protein),163,"18,937",4 out of 5,1996-02-01,Evidence at transcript level
O95948,ONEC2_HUMAN,One cut domain family member 2 (Hepatocyte nuclear factor 6-beta) (HNF-6-beta) (One cut homeobox 2) (Transcription factor ONECUT-2) (OC-2),504,"54,303",5 out of 5,2001-04-27,Evidence at transcript level
Q86WS3,OOSP2_HUMAN,Oocyte-secreted protein 2 (Placenta-specific 1-like protein) (Protein TMEM122),158,"17,971",2 out of 5,2006-10-03,Evidence at transcript level
O60313,OPA1_HUMAN,"Dynamin-like 120 kDa protein, mitochondrial (EC 3.6.5.5) (Optic atrophy protein 1) [Cleaved into: Dynamin-like 120 kDa protein, form S1]",960,"111,631",5 out of 5,2001-09-26,Evidence at protein level
P41145,OPRK_HUMAN,Kappa-type opioid receptor (K-OR-1) (KOR-1),380,"42,645",5 out of 5,1995-02-01,Evidence at protein level
P35372,OPRM_HUMAN,Mu-type opioid receptor (M-OR-1) (MOR-1) (Mu opiate receptor) (Mu opioid receptor) (MOP) (hMOP),400,"44,779",5 out of 5,1994-06-01,Evidence at protein level
P03999,OPSB_HUMAN,Short-wave-sensitive opsin 1 (Blue cone photoreceptor pigment) (Blue-sensitive opsin) (BOP),348,"39,135",5 out of 5,1986-10-23,Evidence at protein level
P0DN78,OPSG3_HUMAN,Medium-wave-sensitive opsin 3 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP) (opsin 1 cone pigments medium-wave-sensitive 3),364,"40,584",3 out of 5,2016-02-17,Inferred from homology
Q96CV9,OPTN_HUMAN,Optineurin (E3-14.7K-interacting protein) (FIP-2) (Huntingtin yeast partner L) (Huntingtin-interacting protein 7) (HIP-7) (Huntingtin-interacting protein L) (NEMO-related protein) (Optic neuropathy-inducing protein) (Transcription factor IIIA-interacting protein) (TFIIIA-IntP),577,"65,921",5 out of 5,2005-03-29,Evidence at protein level
O43749,OR1F1_HUMAN,Olfactory receptor 1F1 (Olfactory receptor 16-35) (OR16-35) (Olfactory receptor 1F10) (Olfactory receptor 1F4) (Olfactory receptor 1F5) (Olfactory receptor 1F6) (Olfactory receptor 1F7) (Olfactory receptor 1F8) (Olfactory receptor 1F9) (Olfactory receptor OR16-4),312,"34,866",5 out of 5,2000-12-01,Evidence at transcript level
Q8NGS2,OR1J2_HUMAN,Olfactory receptor 1J2 (HSA5) (HTPCRX15) (OST044) (Olfactory receptor 1J3) (Olfactory receptor 1J5) (Olfactory receptor OR9-19),313,"35,385",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGR5,OR1L4_HUMAN,Olfactory receptor 1L4 (OST046) (Olfactory receptor 1L5) (Olfactory receptor 9-E) (OR9-E) (Olfactory receptor OR9-29),311,"35,277",4 out of 5,2003-10-10,Inferred from homology
Q8NGR8,OR1L8_HUMAN,Olfactory receptor 1L8 (Olfactory receptor OR9-24),309,"35,083",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGS0,OR1N1_HUMAN,Olfactory receptor 1N1 (Olfactory receptor 1-26) (OR1-26) (Olfactory receptor 1N3) (Olfactory receptor OR9-22),311,"34,650",4 out of 5,2003-10-10,Inferred from homology
Q8NH92,OR1S1_HUMAN,Olfactory receptor 1S1 (Olfactory receptor OR11-232),325,"36,707",4 out of 5,2003-09-26,Inferred from homology
Q5JQS5,OR2BB_HUMAN,Olfactory receptor 2B11,317,"35,342",3 out of 5,2005-12-20,Evidence at transcript level
P0C604,OR4A8_HUMAN,Olfactory receptor 4A8 (Olfactory receptor OR11-110),315,"35,621",4 out of 5,2008-01-15,Inferred from homology
Q8NGB2,OR4C5_HUMAN,Olfactory receptor 4C5 (Olfactory receptor OR11-99),326,"36,862",3 out of 5,2006-01-10,Inferred from homology
Q8NGI9,OR5A2_HUMAN,Olfactory receptor 5A2 (Olfactory receptor OR11-248),324,"36,016",3 out of 5,2003-09-26,Evidence at transcript level
Q8NH48,OR5B3_HUMAN,Olfactory receptor 5B3 (Olfactory receptor 5B13) (Olfactory receptor OR11-239),314,"35,258",4 out of 5,2003-10-10,Inferred from homology
Q8NGR4,OR5C1_HUMAN,Olfactory receptor 5C1 (Olfactory receptor 5C2) (Olfactory receptor 9-F) (OR9-F),320,"34,991",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGK9,OR5DG_HUMAN,Olfactory receptor 5D16 (Olfactory receptor OR11-154),328,"37,278",3 out of 5,2003-10-10,Inferred from homology
P0C626,OR5G3_HUMAN,Olfactory receptor 5G3 (Olfactory receptor 5G6) (Olfactory receptor OR11-213),314,"35,647",4 out of 5,2008-01-15,Inferred from homology
Q8NGV7,OR5H2_HUMAN,Olfactory receptor 5H2 (Olfactory receptor OR3-10),314,"35,974",4 out of 5,2003-10-10,Inferred from homology
Q8NH18,OR5J2_HUMAN,Olfactory receptor 5J2 (Olfactory receptor OR11-266),312,"34,808",3 out of 5,2003-11-14,Inferred from homology
A6NET4,OR5K3_HUMAN,Olfactory receptor 5K3,321,"36,711",3 out of 5,2007-11-13,Inferred from homology
Q96RB7,OR5MB_HUMAN,Olfactory receptor 5M11,305,"34,450",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGG2,OR5T2_HUMAN,Olfactory receptor 5T2 (Olfactory receptor OR11-177),359,"40,696",4 out of 5,2003-10-10,Evidence at transcript level
Q8NH69,OR5W2_HUMAN,Olfactory receptor 5W2 (Olfactory receptor 5W3) (Olfactory receptor OR11-155),310,"35,167",4 out of 5,2005-12-20,Inferred from homology
Q6IFH4,OR6B2_HUMAN,Olfactory receptor 6B2 (Olfactory receptor OR2-1),312,"35,029",3 out of 5,2005-12-20,Evidence at transcript level
Q8NGC5,OR6J1_HUMAN,Olfactory receptor 6J1 (Olfactory receptor 6J2),347,"38,693",3 out of 5,2003-10-10,Inferred from homology
Q8NGY3,OR6K3_HUMAN,Olfactory receptor 6K3 (Olfactory receptor OR1-18),331,"37,352",4 out of 5,2003-10-10,Inferred from homology
Q8NH40,OR6S1_HUMAN,Olfactory receptor 6S1 (Olfactory receptor OR14-37),331,"36,127",3 out of 5,2003-10-10,Inferred from homology
Q8NH79,OR6X1_HUMAN,Olfactory receptor 6X1 (Olfactory receptor OR11-270),312,"34,727",3 out of 5,2003-10-10,Evidence at transcript level
Q96RA2,OR7D2_HUMAN,Olfactory receptor 7D2 (HTPCRH03) (Olfactory receptor 19-4) (OR19-4) (Olfactory receptor OR19-10),312,"34,747",4 out of 5,2003-09-26,Evidence at transcript level
Q8NG95,OR7G3_HUMAN,Olfactory receptor 7G3 (OST085) (Olfactory receptor OR19-9),312,"34,439",3 out of 5,2003-10-10,Inferred from homology
Q96RD0,OR8B2_HUMAN,Olfactory receptor 8B2 (Olfactory receptor OR11-309),313,"35,272",3 out of 5,2002-05-10,Inferred from homology
Q9BXB4,OSB11_HUMAN,Oxysterol-binding protein-related protein 11 (ORP-11) (OSBP-related protein 11),747,"83,643",5 out of 5,2002-02-11,Evidence at protein level
Q8WVF1,OSCP1_HUMAN,Protein OSCP1 (hOSCP1) (Organic solute transport protein 1) (Oxidored-nitro domain-containing protein 1),389,"44,586",4 out of 5,2006-10-03,Evidence at protein level
E9PI22,P23D1_HUMAN,Proline-rich protein 23D1,279,"31,050",1 out of 5,2014-01-22,Inferred from homology
Q06190,P2R3A_HUMAN,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit alpha (PP2A subunit B isoform PR72/PR130) (PP2A subunit B isoform R3 isoform) (PP2A subunit B isoforms B''-PR72/PR130) (PP2A subunit B isoforms B72/B130) (Serine/threonine-protein phosphatase 2A 72/130 kDa regulatory subunit B),1150,"130,278",5 out of 5,1994-06-01,Evidence at protein level
O15547,P2RX6_HUMAN,P2X purinoceptor 6 (P2X6) (ATP receptor) (P2XM) (Purinergic receptor) (Purinergic receptor P2X-like 1),441,"48,829",5 out of 5,1998-12-15,Evidence at protein level
Q53H96,P5CR3_HUMAN,Pyrroline-5-carboxylate reductase 3 (P5C reductase 3) (P5CR 3) (EC 1.5.1.2) (Pyrroline-5-carboxylate reductase-like protein),274,"28,663",5 out of 5,2008-03-18,Evidence at protein level
P27986,P85A_HUMAN,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),724,"83,598",5 out of 5,1992-08-01,Evidence at protein level
O15496,PA2GX_HUMAN,Group 10 secretory phospholipase A2 (EC 3.1.1.4) (Group X secretory phospholipase A2) (GX sPLA2) (sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10),165,"18,153",5 out of 5,1998-12-15,Evidence at protein level
Q86U42,PABP2_HUMAN,Polyadenylate-binding protein 2 (PABP-2) (Poly(A)-binding protein 2) (Nuclear poly(A)-binding protein 1) (Poly(A)-binding protein II) (PABII) (Polyadenylate-binding nuclear protein 1),306,"32,749",5 out of 5,2004-04-13,Evidence at protein level
Q96DU9,PABP5_HUMAN,Polyadenylate-binding protein 5 (PABP-5) (Poly(A)-binding protein 5),382,"43,331",3 out of 5,2003-02-01,Evidence at transcript level
P18509,PACA_HUMAN,Pituitary adenylate cyclase-activating polypeptide (PACAP) [Cleaved into: PACAP-related peptide (PRP-48); Pituitary adenylate cyclase-activating polypeptide 27 (PACAP-27) (PACAP27); Pituitary adenylate cyclase-activating polypeptide 38 (PACAP-38) (PACAP38)],176,"18,835",5 out of 5,1990-11-01,Evidence at protein level
Q8IZE3,PACE1_HUMAN,Protein-associating with the carboxyl-terminal domain of ezrin (Ezrin-binding protein PACE-1) (SCY1-like protein 3),742,"82,857",5 out of 5,2005-03-15,Evidence at protein level
P41586,PACR_HUMAN,Pituitary adenylate cyclase-activating polypeptide type I receptor (PACAP type I receptor) (PACAP-R-1) (PACAP-R1),468,"53,314",5 out of 5,1995-11-01,Evidence at protein level
P13725,ONCM_HUMAN,Oncostatin-M (OSM),252,"28,484",5 out of 5,1990-01-01,Evidence at protein level
Q14982,OPCM_HUMAN,Opioid-binding protein/cell adhesion molecule (OBCAM) (OPCML) (Opioid-binding cell adhesion molecule) (IgLON family member 1),345,"38,008",5 out of 5,1997-11-01,Evidence at protein level
Q9H1Y3,OPN3_HUMAN,Opsin-3 (Encephalopsin) (Panopsin),402,"44,873",5 out of 5,2001-09-26,Evidence at protein level
P47884,OR1D4_HUMAN,Olfactory receptor 1D4 (Olfactory receptor 17-30) (OR17-30),311,"35,227",3 out of 5,1996-02-01,Inferred from homology
Q8NGT9,OR2A1_HUMAN,Olfactory receptor 2A1/2A42 (Olfactory receptor OR7-16) (Olfactory receptor OR7-19),310,"34,714",3 out of 5,2003-10-10,Inferred from homology
O95047,OR2A4_HUMAN,Olfactory receptor 2A4 (Olfactory receptor 2A10) (Olfactory receptor OR6-37),310,"34,802",5 out of 5,2001-06-20,Evidence at transcript level
P59922,OR2B8_HUMAN,Putative olfactory receptor 2B8 (Hs6M1-29P),312,"35,019",3 out of 5,2003-10-10,Uncertain
Q8N628,OR2C3_HUMAN,Olfactory receptor 2C3 (Olfactory receptor 2C4) (Olfactory receptor 2C5) (Olfactory receptor OR1-30),320,"35,376",5 out of 5,2003-09-26,Evidence at transcript level
Q8NH16,OR2L2_HUMAN,Olfactory receptor 2L2 (HTPCRH07) (Olfactory receptor 2L12) (Olfactory receptor 2L4),312,"35,495",4 out of 5,2003-10-31,Evidence at transcript level
Q8N349,OR2LD_HUMAN,Olfactory receptor 2L13 (Olfactory receptor 2L14),312,"35,634",3 out of 5,2003-11-14,Evidence at transcript level
Q6IEZ7,OR2T5_HUMAN,Olfactory receptor 2T5 (Olfactory receptor OR1-62),315,"35,595",3 out of 5,2005-12-20,Inferred from homology
Q8NHB1,OR2V1_HUMAN,Olfactory receptor 2V1,315,"34,857",3 out of 5,2007-12-04,Inferred from homology
A6NFC9,OR2W5_HUMAN,Putative olfactory receptor 2W5,320,"35,528",3 out of 5,2008-07-22,Uncertain
Q8NG97,OR2Z1_HUMAN,Olfactory receptor 2Z1 (Olfactory receptor 2Z2) (Olfactory receptor OR19-4),314,"34,444",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGF8,OR4B1_HUMAN,Olfactory receptor 4B1 (OST208) (Olfactory receptor OR11-106),309,"34,456",3 out of 5,2003-10-10,Inferred from homology
Q8NGP0,OR4CD_HUMAN,Olfactory receptor 4C13 (Olfactory receptor OR11-260),309,"34,582",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGJ1,OR4D6_HUMAN,Olfactory receptor 4D6 (Olfactory receptor OR11-250),314,"35,954",4 out of 5,2003-10-10,Evidence at transcript level
P0C645,OR4E1_HUMAN,Olfactory receptor 4E1 (Olfactory receptor OR14-43),316,"35,862",4 out of 5,2008-01-15,Inferred from homology
Q8NGB9,OR4F6_HUMAN,Olfactory receptor 4F6 (Olfactory receptor 4F12) (Olfactory receptor OR15-15),312,"35,355",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGD3,OR4K5_HUMAN,Olfactory receptor 4K5 (Olfactory receptor OR14-16),323,"36,258",3 out of 5,2003-10-10,Inferred from homology
Q8NH41,OR4KF_HUMAN,Olfactory receptor 4K15 (Olfactory receptor OR14-20),348,"39,088",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGB6,OR4M2_HUMAN,Olfactory receptor 4M2 (Olfactory receptor OR15-3),313,"35,416",4 out of 5,2003-10-10,Evidence at transcript level
Q8IXE1,OR4N5_HUMAN,Olfactory receptor 4N5 (Olfactory receptor OR14-33),308,"34,696",4 out of 5,2003-09-26,Inferred from homology
Q8NGF9,OR4X2_HUMAN,Olfactory receptor 4X2 (Olfactory receptor OR11-105),303,"34,289",3 out of 5,2003-10-10,Evidence at transcript level
Q96R08,OR5BC_HUMAN,Olfactory receptor 5B12 (Olfactory receptor 5B16) (Olfactory receptor OR11-241),314,"35,182",4 out of 5,2002-05-10,Evidence at transcript level
A6NKK0,OR5H1_HUMAN,Olfactory receptor 5H1 (HTPCRX14),313,"35,387",4 out of 5,2007-11-13,Evidence at transcript level
Q8NGL2,OR5L1_HUMAN,Olfactory receptor 5L1 (OST262) (Olfactory receptor OR11-151),311,"34,559",3 out of 5,2003-10-10,Evidence at transcript level
Q6IEU7,OR5MA_HUMAN,Olfactory receptor 5M10 (Olfactory receptor OR11-207),315,"35,592",3 out of 5,2005-12-20,Evidence at transcript level
Q9UGF6,OR5V1_HUMAN,Olfactory receptor 5V1 (Hs6M1-21) (Olfactory receptor OR6-26),321,"36,057",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGX9,OR6P1_HUMAN,Olfactory receptor 6P1 (Olfactory receptor OR1-12),317,"35,831",3 out of 5,2003-10-10,Inferred from homology
Q8NGN1,OR6T1_HUMAN,Olfactory receptor 6T1 (Olfactory receptor OR11-277),323,"36,348",3 out of 5,2003-10-10,Evidence at transcript level
O14581,OR7AH_HUMAN,Olfactory receptor 7A17,309,"34,013",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGA0,OR7G1_HUMAN,Olfactory receptor 7G1 (Olfactory receptor 19-15) (OR19-15) (Olfactory receptor OR19-8),311,"34,803",4 out of 5,2003-10-10,Inferred from homology
Q8NGG6,OR8BC_HUMAN,Olfactory receptor 8B12 (Olfactory receptor OR11-317),310,"34,372",3 out of 5,2003-10-10,Evidence at transcript level
Q8N162,OR8H2_HUMAN,Olfactory receptor 8H2 (Olfactory receptor OR11-171),312,"35,422",3 out of 5,2003-10-10,Inferred from homology
Q8N0Y5,OR8I2_HUMAN,Olfactory receptor 8I2 (Olfactory receptor OR11-170),310,"34,661",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGG5,OR8K1_HUMAN,Olfactory receptor 8K1 (Olfactory receptor OR11-182),319,"36,581",3 out of 5,2003-10-10,Evidence at transcript level
P0C7N5,OR8U9_HUMAN,Olfactory receptor 8U9,309,"35,054",3 out of 5,2008-06-10,Inferred from homology
Q9UBD5,ORC3_HUMAN,Origin recognition complex subunit 3 (Origin recognition complex subunit Latheo),711,"82,254",5 out of 5,2000-12-01,Evidence at protein level
Q9BZF3,OSBL6_HUMAN,Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6),934,"106,306",5 out of 5,2002-02-11,Evidence at protein level
Q9UJX0,OSGI1_HUMAN,"Oxidative stress-induced growth inhibitor 1 (Ovary, kidney and liver protein 38) (huOKL38) (Pregnancy-induced growth inhibitor OKL38)",560,"60,849",5 out of 5,2000-12-01,Evidence at protein level
P51582,P2RY4_HUMAN,P2Y purinoceptor 4 (P2Y4) (P2P) (Uridine nucleotide receptor) (UNR),365,"40,963",5 out of 5,1996-10-01,Evidence at protein level
Q86VZ1,P2RY8_HUMAN,P2Y purinoceptor 8 (P2Y8),359,"40,635",4 out of 5,2006-02-07,Evidence at protein level
Q9H244,P2Y12_HUMAN,P2Y purinoceptor 12 (P2Y12) (ADP-glucose receptor) (ADPG-R) (P2T(AC)) (P2Y(AC)) (P2Y(cyc)) (P2Y12 platelet ADP receptor) (P2Y(ADP)) (SP1999),342,"39,439",5 out of 5,2002-05-27,Evidence at protein level
Q9BPV8,P2Y13_HUMAN,P2Y purinoceptor 13 (P2Y13) (G-protein coupled receptor 86) (G-protein coupled receptor 94),354,"40,789",4 out of 5,2003-10-10,Evidence at transcript level
O15460,P4HA2_HUMAN,"Prolyl 4-hydroxylase subunit alpha-2 (4-PH alpha-2) (EC 1.14.11.2) (Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2)",535,"60,902",5 out of 5,2002-05-02,Evidence at protein level
Q9BTU6,P4K2A_HUMAN,Phosphatidylinositol 4-kinase type 2-alpha (EC 2.7.1.67) (Phosphatidylinositol 4-kinase type II-alpha),479,"54,022",5 out of 5,2007-05-01,Evidence at protein level
P53816,PA216_HUMAN,HRAS-like suppressor 3 (HRSL3) (EC 3.1.1.32) (EC 3.1.1.4) (Adipose-specific phospholipase A2) (AdPLA) (Group XVI phospholipase A1/A2) (H-rev 107 protein homolog) (H-REV107) (HREV107-1) (HRAS-like suppressor 1) (HREV107-3) (Renal carcinoma antigen NY-REN-65),162,"17,937",5 out of 5,1996-10-01,Evidence at protein level
Q3MJ16,PA24E_HUMAN,Cytosolic phospholipase A2 epsilon (cPLA2-epsilon) (EC 3.1.1.4) (Phospholipase A2 group IVE),856,"97,570",5 out of 5,2006-07-25,Evidence at transcript level
Q9NZK7,PA2GE_HUMAN,Group IIE secretory phospholipase A2 (GIIE sPLA2) (sPLA2-IIE) (EC 3.1.1.4) (Phosphatidylcholine 2-acylhydrolase 2E),142,"15,989",5 out of 5,2002-02-11,Evidence at protein level
Q9BY11,PACN1_HUMAN,Protein kinase C and casein kinase substrate in neurons protein 1 (Syndapin-1),444,"50,966",5 out of 5,2002-08-13,Evidence at protein level
Q9UNF0,PACN2_HUMAN,Protein kinase C and casein kinase substrate in neurons protein 2 (Syndapin-2) (Syndapin-II),486,"55,739",5 out of 5,2002-08-13,Evidence at protein level
Q6VY07,PACS1_HUMAN,Phosphofurin acidic cluster sorting protein 1 (PACS-1),963,"104,898",5 out of 5,2004-09-13,Evidence at protein level
Q6TGC4,PADI6_HUMAN,Protein-arginine deiminase type-6 (EC 3.5.3.15) (Peptidyl arginine deiminase-like protein) (Peptidylarginine deiminase VI) (hPADVI) (Protein-arginine deiminase type VI),694,"77,727",4 out of 5,2004-12-21,Evidence at protein level
P0DN26,PAL4F_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4F (PPIase A-like 4F) (EC 5.2.1.8),164,"18,197",2 out of 5,2015-10-14,Inferred from homology
Q96RD7,PANX1_HUMAN,Pannexin-1,426,"48,050",5 out of 5,2002-01-23,Evidence at protein level
Q96QZ0,PANX3_HUMAN,Pannexin-3,392,"44,683",4 out of 5,2002-01-23,Evidence at transcript level
Q8IY49,PAQRA_HUMAN,Monocyte to macrophage differentiation factor 2 (Progestin and adipoQ receptor family member 10) (Progestin and adipoQ receptor family member X),270,"31,264",4 out of 5,2004-08-31,Evidence at protein level
Q8TEW8,PAR3L_HUMAN,Partitioning defective 3 homolog B (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 19 protein) (PAR3-beta) (Partitioning defective 3-like protein) (PAR3-L protein),1205,"132,494",5 out of 5,2003-05-16,Evidence at protein level
Q8TEW0,PARD3_HUMAN,Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha),1356,"151,423",5 out of 5,2003-05-16,Evidence at protein level
Q86W56,PARG_HUMAN,Poly(ADP-ribose) glycohydrolase (EC 3.2.1.143),976,"111,110",5 out of 5,2004-10-25,Evidence at protein level
Q3SX64,OD3L2_HUMAN,Outer dense fiber protein 3-like protein 2,289,"30,781",2 out of 5,2007-02-06,Evidence at protein level
A1E959,ODAM_HUMAN,Odontogenic ameloblast-associated protein (Apin),279,"30,777",5 out of 5,2008-03-18,Evidence at protein level
P10515,ODP2_HUMAN,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (70 kDa mitochondrial autoantigen of primary biliary cirrhosis) (PBC) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (M2 antigen complex 70 kDa subunit) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)",647,"68,997",5 out of 5,1989-07-01,Evidence at protein level
Q8N543,OGFD1_HUMAN,Prolyl 3-hydroxylase OGFOD1 (EC 1.14.11.-) (2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1) (Termination and polyadenylation 1 homolog),542,"63,246",5 out of 5,2007-05-29,Evidence at protein level
O15527,OGG1_HUMAN,N-glycosylase/DNA lyase [Includes: 8-oxoguanine DNA glycosylase (EC 3.2.2.-); DNA-(apurinic or apyrimidinic site) lyase (AP lyase) (EC 4.2.99.18)],345,"38,782",5 out of 5,2000-12-01,Evidence at protein level
Q15743,OGR1_HUMAN,Ovarian cancer G-protein coupled receptor 1 (OGR-1) (G-protein coupled receptor 68) (GPR12A) (Sphingosylphosphorylcholine receptor),365,"41,077",5 out of 5,1998-07-15,Evidence at protein level
Q8TAK6,OLIG1_HUMAN,Oligodendrocyte transcription factor 1 (Oligo1) (Class B basic helix-loop-helix protein 6) (bHLHb6) (Class E basic helix-loop-helix protein 21) (bHLHe21),271,"27,905",4 out of 5,2002-08-30,Evidence at protein level
Q9H6K4,OPA3_HUMAN,Optic atrophy 3 protein,179,"19,996",5 out of 5,2002-03-27,Evidence at protein level
A6NMS3,OR5K4_HUMAN,Olfactory receptor 5K4,321,"36,711",3 out of 5,2007-12-04,Inferred from homology
Q8NGP4,OR5M3_HUMAN,Olfactory receptor 5M3 (Olfactory receptor OR11-191),307,"35,156",3 out of 5,2003-10-10,Evidence at transcript level
Q8WZ94,OR5P3_HUMAN,Olfactory receptor 5P3 (Olfactory receptor OR11-94) (Olfactory receptor-like protein JCG1),311,"34,296",4 out of 5,2002-05-10,Evidence at transcript level
Q8NG75,OR5T1_HUMAN,Olfactory receptor 5T1 (Olfactory receptor OR11-179),326,"36,885",4 out of 5,2005-07-19,Evidence at transcript level
Q8NGY2,OR6K2_HUMAN,Olfactory receptor 6K2 (Olfactory receptor OR1-17),324,"36,513",3 out of 5,2003-10-10,Evidence at transcript level
Q8NGG8,OR8B3_HUMAN,Olfactory receptor 8B3 (Olfactory receptor OR11-311),313,"35,305",3 out of 5,2003-10-10,Inferred from homology
Q8NGU1,OR9A1_HUMAN,Putative olfactory receptor 9A1 (HSHTPRX06),263,"29,546",3 out of 5,2008-07-22,Uncertain
Q8NH87,OR9G1_HUMAN,Olfactory receptor 9G1 (Olfactory receptor 9G5) (Olfactory receptor OR11-114),305,"34,071",4 out of 5,2003-10-10,Inferred from homology
Q8NGQ5,OR9Q1_HUMAN,Olfactory receptor 9Q1,310,"34,757",3 out of 5,2003-10-10,Evidence at transcript level
Q9BRQ5,ORAI3_HUMAN,Protein orai-3 (Transmembrane protein 142C),295,"31,499",3 out of 5,2006-05-16,Evidence at protein level
Q13416,ORC2_HUMAN,Origin recognition complex subunit 2,577,"65,972",5 out of 5,1997-11-01,Evidence at protein level
O43929,ORC4_HUMAN,Origin recognition complex subunit 4,436,"50,377",5 out of 5,1999-07-15,Evidence at protein level
Q9P0S3,ORML1_HUMAN,ORM1-like protein 1 (Adoplin-1),153,"17,371",4 out of 5,2005-11-08,Evidence at protein level
Q9Y3B8,ORN_HUMAN,"Oligoribonuclease, mitochondrial (EC 3.1.-.-) (RNA exonuclease 2 homolog) (Small fragment nuclease)",237,"26,833",5 out of 5,2000-05-30,Evidence at protein level
Q13438,OS9_HUMAN,Protein OS-9 (Amplified in osteosarcoma 9),667,"75,562",5 out of 5,1998-07-15,Evidence at protein level
Q9H1P3,OSBL2_HUMAN,Oxysterol-binding protein-related protein 2 (ORP-2) (OSBP-related protein 2),480,"55,201",5 out of 5,2002-02-11,Evidence at protein level
Q96SU4,OSBL9_HUMAN,Oxysterol-binding protein-related protein 9 (ORP-9) (OSBP-related protein 9),736,"83,185",5 out of 5,2002-02-11,Evidence at protein level
Q8IYS5,OSCAR_HUMAN,Osteoclast-associated immunoglobulin-like receptor (Osteoclast-associated receptor) (hOSCAR) (Polymeric immunoglobulin receptor 3) (PIgR-3) (PIgR3) (Poly-Ig receptor 3),282,"30,481",5 out of 5,2007-11-13,Evidence at protein level
Q99650,OSMR_HUMAN,Oncostatin-M-specific receptor subunit beta (Interleukin-31 receptor subunit beta) (IL-31 receptor subunit beta) (IL-31R subunit beta) (IL-31R-beta) (IL-31RB),979,"110,509",5 out of 5,2006-11-28,Evidence at protein level
Q92882,OSTF1_HUMAN,Osteoclast-stimulating factor 1,214,"23,787",5 out of 5,2000-12-01,Evidence at protein level
Q5T2D3,OTUD3_HUMAN,OTU domain-containing protein 3 (EC 3.4.19.12),398,"45,124",5 out of 5,2005-08-30,Evidence at protein level
Q7RTZ1,OVCH2_HUMAN,Ovochymase-2 (EC 3.4.21.-) (Oviductin),564,"62,642",4 out of 5,2006-11-28,Inferred from homology
O14753,OVOL1_HUMAN,Putative transcription factor Ovo-like 1 (hOvo1),267,"30,259",3 out of 5,2000-12-01,Evidence at transcript level
O00110,OVOL3_HUMAN,Putative transcription factor ovo-like protein 3,214,"23,826",2 out of 5,2008-02-26,Inferred from homology
O43613,OX1R_HUMAN,Orexin receptor type 1 (Ox-1-R) (Ox1-R) (Ox1R) (Hypocretin receptor type 1),425,"47,536",5 out of 5,2000-05-30,Evidence at protein level
Q5BKU9,OXLD1_HUMAN,Oxidoreductase-like domain-containing protein 1,147,"15,855",2 out of 5,2008-01-15,Evidence at transcript level
Q96HP4,OXND1_HUMAN,Oxidoreductase NAD-binding domain-containing protein 1 (EC 1.-.-.-),312,"34,854",2 out of 5,2007-09-11,Evidence at protein level
Q8N573,OXR1_HUMAN,Oxidation resistance protein 1,874,"97,970",5 out of 5,2006-04-04,Evidence at protein level
P30559,OXYR_HUMAN,Oxytocin receptor (OT-R),389,"42,772",5 out of 5,1993-04-01,Evidence at transcript level
A8MW92,P20L1_HUMAN,PHD finger protein 20-like protein 1,1017,"115,010",3 out of 5,2008-05-20,Evidence at protein level
Q9Y5P8,P2R3B_HUMAN,Serine/threonine-protein phosphatase 2A regulatory subunit B'' subunit beta (PP2A subunit B isoform PR48) (Protein phosphatase 2A 48 kDa regulatory subunit),575,"65,061",5 out of 5,2000-05-30,Evidence at protein level
P51575,P2RX1_HUMAN,P2X purinoceptor 1 (P2X1) (ATP receptor) (Purinergic receptor),399,"44,980",5 out of 5,1996-10-01,Evidence at protein level
P41231,P2RY2_HUMAN,P2Y purinoceptor 2 (P2Y2) (ATP receptor) (P2U purinoceptor 1) (P2U1) (P2U receptor 1) (Purinergic receptor),377,"42,273",5 out of 5,1995-02-01,Evidence at transcript level
O00459,P85B_HUMAN,Phosphatidylinositol 3-kinase regulatory subunit beta (PI3-kinase regulatory subunit beta) (PI3K regulatory subunit beta) (PtdIns-3-kinase regulatory subunit beta) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta) (PI3-kinase subunit p85-beta) (PtdIns-3-kinase regulatory subunit p85-beta),728,"81,545",5 out of 5,1998-12-15,Evidence at protein level
P0C869,PA24B_HUMAN,Cytosolic phospholipase A2 beta (cPLA2-beta) (EC 3.1.1.4) (Phospholipase A2 group IVB),781,"87,978",5 out of 5,2008-09-02,Evidence at protein level
Q68DD2,PA24F_HUMAN,Cytosolic phospholipase A2 zeta (cPLA2-zeta) (EC 3.1.1.4) (Phospholipase A2 group IVF),849,"95,082",5 out of 5,2006-07-25,Evidence at transcript level
Q9UNK4,PA2GD_HUMAN,"Group IID secretory phospholipase A2 (GIID sPLA2) (sPLA2-IID) (EC 3.1.1.4) (PLA2IID) (Phosphatidylcholine 2-acylhydrolase 2D) (Secretory-type PLA, stroma-associated homolog)",145,"16,546",5 out of 5,2002-02-11,Evidence at protein level
Q9Y2J8,PADI2_HUMAN,Protein-arginine deiminase type-2 (EC 3.5.3.15) (PAD-H19) (Peptidylarginine deiminase II) (Protein-arginine deiminase type II),665,"75,564",5 out of 5,2000-05-30,Evidence at protein level
Q9UM07,PADI4_HUMAN,Protein-arginine deiminase type-4 (EC 3.5.3.15) (HL-60 PAD) (Peptidylarginine deiminase IV) (Protein-arginine deiminase type IV),663,"74,079",5 out of 5,2001-01-11,Evidence at protein level
Q8NCC3,PAG15_HUMAN,Group XV phospholipase A2 (EC 2.3.1.-) (1-O-acylceramide synthase) (ACS) (LCAT-like lysophospholipase) (LLPL) (Lysophospholipase 3) (Lysosomal phospholipase A2) (LPLA2),412,"46,658",5 out of 5,2004-03-01,Evidence at protein level
Q9NVE7,PANK4_HUMAN,Pantothenate kinase 4 (hPanK4) (EC 2.7.1.33) (Pantothenic acid kinase 4),773,"85,991",4 out of 5,2003-01-17,Evidence at protein level
Q53GL7,PAR10_HUMAN,Poly [ADP-ribose] polymerase 10 (PARP-10) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 10) (ARTD10),1025,"109,998",5 out of 5,2006-10-17,Evidence at protein level
Q5SWX8,ODR4_HUMAN,Protein odr-4 homolog (hODR-4) (LAG1-interacting protein) (Transactivated by transforming growth factor beta protein 1),454,"51,103",3 out of 5,2007-09-11,Evidence at protein level
O60890,OPHN1_HUMAN,Oligophrenin-1,802,"91,641",5 out of 5,2002-07-11,Evidence at protein level
Q9UHM6,OPN4_HUMAN,Melanopsin (Opsin-4),478,"52,635",5 out of 5,2001-04-27,Evidence at protein level
P04001,OPSG_HUMAN,Medium-wave-sensitive opsin 1 (Green cone photoreceptor pigment) (Green-sensitive opsin) (GOP),364,"40,584",5 out of 5,1986-10-23,Evidence at protein level
P04000,OPSR_HUMAN,Long-wave-sensitive opsin 1 (Red cone photoreceptor pigment) (Red-sensitive opsin) (ROP),364,"40,572",5 out of 5,1986-10-23,Evidence at protein level
O14718,OPSX_HUMAN,Visual pigment-like receptor peropsin,337,"37,423",4 out of 5,1998-07-15,Evidence at protein level
Q9UBM4,OPT_HUMAN,Opticin (Oculoglycan),332,"37,261",4 out of 5,2000-12-01,Evidence at protein level
Q9GZK3,OR2B2_HUMAN,Olfactory receptor 2B2 (Hs6M1-10) (Olfactory receptor 2B9) (Olfactory receptor 6-1) (OR6-1),357,"40,412",4 out of 5,2001-06-20,Evidence at transcript level
O95006,OR2F2_HUMAN,Olfactory receptor 2F2 (Olfactory receptor 7-1) (OR7-1) (Olfactory receptor OR7-6),317,"35,294",3 out of 5,2001-06-20,Evidence at transcript level
O76001,OR2J3_HUMAN,Olfactory receptor 2J3 (Hs6M1-3) (Olfactory receptor OR6-16) (OR6-6) (Olfactory receptor 6-6),311,"34,950",4 out of 5,2001-06-20,Evidence at protein level
O95007,OR6B1_HUMAN,Olfactory receptor 6B1 (Olfactory receptor 7-3) (OR7-3) (Olfactory receptor OR7-9),311,"35,299",3 out of 5,2001-06-20,Evidence at transcript level
Q9NZP2,OR6C2_HUMAN,Olfactory receptor 6C2 (HSA3),312,"35,178",3 out of 5,2003-10-10,Inferred from homology
Q8NGE1,OR6C4_HUMAN,Olfactory receptor 6C4 (Olfactory receptor OR12-10),309,"35,010",3 out of 5,2003-11-07,Evidence at transcript level
Q8NGY5,OR6N1_HUMAN,Olfactory receptor 6N1,312,"34,869",3 out of 5,2003-10-10,Inferred from homology
O76100,OR7AA_HUMAN,Olfactory receptor 7A10 (OST027) (Olfactory receptor OR19-18),309,"34,406",4 out of 5,2001-06-20,Inferred from homology
O76099,OR7C1_HUMAN,Olfactory receptor 7C1 (Olfactory receptor 7C4) (Olfactory receptor OR19-16) (Olfactory receptor TPCR86),320,"35,519",4 out of 5,2000-12-01,Evidence at transcript level
Q8NG98,OR7D4_HUMAN,Olfactory receptor 7D4 (OR19-B) (Odorant receptor family subfamily D member 4RT) (Olfactory receptor OR19-7),312,"34,448",5 out of 5,2005-07-19,Evidence at transcript level
Q8WZ84,OR8D1_HUMAN,Olfactory receptor 8D1 (OST004) (Olfactory receptor 8D3) (Olfactory receptor OR11-301) (Olfactory receptor-like protein JCG9),308,"34,445",4 out of 5,2002-05-10,Evidence at transcript level
Q15617,OR8G1_HUMAN,Olfactory receptor 8G1 (Olfactory receptor OR11-281) (Olfactory receptor TPCR25),311,"34,904",4 out of 5,2003-10-10,Evidence at transcript level
Q8NGG0,OR8J3_HUMAN,Olfactory receptor 8J3 (Olfactory receptor OR11-173),315,"35,481",3 out of 5,2003-10-10,Inferred from homology
Q8NH10,OR8U1_HUMAN,Olfactory receptor 8U1,309,"35,088",4 out of 5,2005-12-20,Inferred from homology
Q8NGT5,OR9A2_HUMAN,Olfactory receptor 9A2 (Olfactory receptor OR7-2),310,"35,330",3 out of 5,2003-10-10,Evidence at transcript level
Q53FV1,ORML2_HUMAN,ORM1-like protein 2 (Adoplin-2),153,"17,363",3 out of 5,2005-11-08,Evidence at protein level
Q9BZF1,OSBL8_HUMAN,Oxysterol-binding protein-related protein 8 (ORP-8) (OSBP-related protein 8),889,"101,196",5 out of 5,2002-02-11,Evidence at protein level
P39656,OST48_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit (DDOST 48 kDa subunit) (Oligosaccharyl transferase 48 kDa subunit),456,"50,801",5 out of 5,1995-02-01,Evidence at protein level
P0C6T2,OST4_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 4,37,"4,193",3 out of 5,2008-04-08,Evidence at protein level
Q15391,P2Y14_HUMAN,P2Y purinoceptor 14 (P2Y14) (G-protein coupled receptor 105) (UDP-glucose receptor),338,"38,971",4 out of 5,1998-07-15,Evidence at transcript level
O00443,P3C2A_HUMAN,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha (PI3K-C2-alpha) (PtdIns-3-kinase C2 subunit alpha) (EC 2.7.1.154) (Phosphoinositide 3-kinase-C2-alpha),1686,"190,680",5 out of 5,2005-08-30,Evidence at protein level
Q32P28,P3H1_HUMAN,Prolyl 3-hydroxylase 1 (EC 1.14.11.7) (Growth suppressor 1) (Leucine- and proline-enriched proteoglycan 1) (Leprecan-1),736,"83,394",5 out of 5,2006-06-27,Evidence at protein level
Q9NXG6,P4HTM_HUMAN,Transmembrane prolyl 4-hydroxylase (P4H-TM) (EC 1.14.11.-) (Hypoxia-inducible factor prolyl hydroxylase 4) (HIF-PH4) (HIF-prolyl hydroxylase 4) (HPH-4),502,"56,661",5 out of 5,2003-06-16,Evidence at protein level
Q6IN85,P4R3A_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 3A (SMEK homolog 1),833,"95,368",5 out of 5,2006-10-31,Evidence at protein level
P54886,P5CS_HUMAN,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],795,"87,302",5 out of 5,1996-10-01,Evidence at protein level
O14683,P5I11_HUMAN,Tumor protein p53-inducible protein 11 (p53-induced gene 11 protein),189,"21,054",3 out of 5,2000-05-30,Evidence at protein level
P04054,PA21B_HUMAN,Phospholipase A2 (EC 3.1.1.4) (Group IB phospholipase A2) (Phosphatidylcholine 2-acylhydrolase 1B),148,"16,360",5 out of 5,1986-11-01,Evidence at protein level
Q9BRP4,PAAF1_HUMAN,Proteasomal ATPase-associated factor 1 (Protein G-16) (WD repeat-containing protein 71),392,"42,190",4 out of 5,2006-05-16,Evidence at protein level
Q9UKS6,PACN3_HUMAN,Protein kinase C and casein kinase substrate in neurons protein 3 (SH3 domain-containing protein 6511),424,"48,487",5 out of 5,2002-08-13,Evidence at protein level
Q86VP3,PACS2_HUMAN,Phosphofurin acidic cluster sorting protein 2 (PACS-2) (PACS1-like protein),889,"97,702",5 out of 5,2006-10-31,Evidence at protein level
Q9BSG0,PADC1_HUMAN,Protease-associated domain-containing protein 1 (Protease-associated domain-containing protein of 21 kDa) (hPAP21),188,"21,042",4 out of 5,2004-11-23,Evidence at protein level
O75459,PAGE1_HUMAN,P antigen family member 1 (PAGE-1) (AL5) (G antigen 9) (GAGE-9) (G antigen family B member 1) (Prostate-associated gene 1 protein),146,"16,150",3 out of 5,2000-05-30,Evidence at protein level
Q86YC2,PALB2_HUMAN,Partner and localizer of BRCA2,1186,"131,295",5 out of 5,2006-10-17,Evidence at protein level
A6NDB9,PALM3_HUMAN,Paralemmin-3,673,"71,695",4 out of 5,2008-04-29,Evidence at protein level
A6NNC1,P12LL_HUMAN,Putative POM121-like protein 1-like,897,"94,058",2 out of 5,2008-09-02,Uncertain
Q9UBL9,P2RX2_HUMAN,P2X purinoceptor 2 (P2X2) (ATP receptor) (Purinergic receptor),471,"51,754",5 out of 5,2001-01-24,Evidence at protein level
Q93086,P2RX5_HUMAN,P2X purinoceptor 5 (P2X5) (ATP receptor) (Purinergic receptor),422,"47,205",5 out of 5,1997-11-01,Evidence at transcript level
Q96G91,P2Y11_HUMAN,P2Y purinoceptor 11 (P2Y11),374,"40,345",5 out of 5,2002-05-27,Evidence at transcript level
P09131,P3_HUMAN,P3 protein (Solute carrier family 10 member 3),477,"50,333",3 out of 5,1989-07-01,Evidence at transcript level
Q96C36,P5CR2_HUMAN,Pyrroline-5-carboxylate reductase 2 (P5C reductase 2) (P5CR 2) (EC 1.5.1.2),320,"33,637",5 out of 5,2005-03-01,Evidence at protein level
P68402,PA1B2_HUMAN,Platelet-activating factor acetylhydrolase IB subunit beta (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta),229,"25,569",5 out of 5,2004-11-23,Evidence at protein level
Q96M98,PACRG_HUMAN,Parkin coregulated gene protein (Molecular chaperone/chaperonin-binding protein) (PARK2 coregulated gene protein),296,"33,342",5 out of 5,2004-04-13,Evidence at protein level
Q9ULW8,PADI3_HUMAN,Protein-arginine deiminase type-3 (EC 3.5.3.15) (Peptidylarginine deiminase III) (Protein-arginine deiminase type III),664,"74,743",5 out of 5,2001-01-11,Evidence at protein level
Q15004,PAF15_HUMAN,PCNA-associated factor (Hepatitis C virus NS5A-transactivated protein 9) (HCV NS5A-transactivated protein 9) (Overexpressed in anaplastic thyroid carcinoma 1) (OEATC-1) (PCNA-associated factor of 15 kDa) (PAF15) (p15PAF) (PCNA-clamp-associated factor),111,"11,986",5 out of 5,1998-07-15,Evidence at protein level
Q8N7H5,PAF1_HUMAN,RNA polymerase II-associated factor 1 homolog (hPAF1) (Pancreatic differentiation protein 2),531,"59,976",5 out of 5,2008-04-08,Evidence at protein level
Q7Z2X7,PAGE2_HUMAN,P antigen family member 2 (PAGE-2) (G antigen family C 2) (Prostate-associated gene 2 protein),111,"12,090",2 out of 5,2006-07-25,Evidence at protein level
Q13153,PAK1_HUMAN,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),545,"60,647",5 out of 5,1997-11-01,Evidence at protein level
F5H284,PAL4D_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4D (PPIase A-like 4D) (EC 5.2.1.8),164,"18,167",2 out of 5,2013-02-06,Inferred from homology
Q8IXS6,PALM2_HUMAN,Paralemmin-2,379,"42,185",3 out of 5,2007-01-23,Evidence at protein level
O75781,PALM_HUMAN,Paralemmin-1 (Paralemmin),387,"42,076",5 out of 5,2002-08-30,Evidence at protein level
Q96RD6,PANX2_HUMAN,Pannexin-2,677,"74,447",4 out of 5,2002-01-23,Evidence at transcript level
Q9NVV4,PAPD1_HUMAN,"Poly(A) RNA polymerase, mitochondrial (PAP) (EC 2.7.7.19) (PAP-associated domain-containing protein 1) (Polynucleotide adenylyltransferase) (Terminal uridylyltransferase 1) (TUTase 1) (mtPAP)",582,"66,172",5 out of 5,2006-10-03,Evidence at protein level
Q9NRJ5,PAPOB_HUMAN,Poly(A) polymerase beta (PAP-beta) (EC 2.7.7.19) (Polynucleotide adenylyltransferase beta) (Testis-specific poly(A) polymerase),636,"71,681",4 out of 5,2001-09-26,Evidence at transcript level
Q13219,PAPP1_HUMAN,Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A),1627,"180,973",5 out of 5,2001-09-26,Evidence at protein level
O43252,PAPS1_HUMAN,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 (PAPS synthase 1) (PAPSS 1) (Sulfurylase kinase 1) (SK 1) (SK1) [Includes: Sulfate adenylyltransferase (EC 2.7.7.4) (ATP-sulfurylase) (Sulfate adenylate transferase) (SAT); Adenylyl-sulfate kinase (EC 2.7.1.25) (3'-phosphoadenosine-5'-phosphosulfate synthase) (APS kinase) (Adenosine-5'-phosphosulfate 3'-phosphotransferase) (Adenylylsulfate 3'-phosphotransferase)],624,"70,833",5 out of 5,2000-05-30,Evidence at protein level
Q6TCH7,PAQR3_HUMAN,Progestin and adipoQ receptor family member 3 (Progestin and adipoQ receptor family member III) (Raf kinase trapping to Golgi) (RKTG),311,"36,217",5 out of 5,2004-08-31,Evidence at protein level
Q9NVD7,PARVA_HUMAN,Alpha-parvin (Actopaxin) (CH-ILKBP) (Calponin-like integrin-linked kinase-binding protein) (Matrix-remodeling-associated protein 2),372,"42,244",5 out of 5,2002-01-23,Evidence at protein level
Q9HBI0,PARVG_HUMAN,Gamma-parvin,331,"37,485",5 out of 5,2002-01-23,Evidence at protein level
Q8WXA2,PATE1_HUMAN,Prostate and testis expressed protein 1,126,"14,271",3 out of 5,2008-02-05,Evidence at protein level
E2RYF7,PBMU2_HUMAN,Protein PBMUCL2 (HLA complex group 22) (Panbronchiolitis-related mucin-like protein 2),251,"26,282",2 out of 5,2011-06-28,Evidence at transcript level
Q96QU1,PCD15_HUMAN,Protocadherin-15,1955,"216,069",5 out of 5,2002-01-31,Evidence at protein level
Q8TAB3,PCD19_HUMAN,Protocadherin-19,1148,"126,253",5 out of 5,2004-01-16,Evidence at protein level
Q9Y5H8,PCDA3_HUMAN,Protocadherin alpha-3 (PCDH-alpha-3),950,"102,428",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5H7,PCDA5_HUMAN,Protocadherin alpha-5 (PCDH-alpha-5),936,"102,048",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5I1,PCDAB_HUMAN,Protocadherin alpha-11 (PCDH-alpha-11),949,"103,298",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5F3,PCDB1_HUMAN,Protocadherin beta-1 (PCDH-beta-1),818,"90,491",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E4,PCDB5_HUMAN,Protocadherin beta-5 (PCDH-beta-5),795,"86,423",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E1,PCDB9_HUMAN,Protocadherin beta-9 (PCDH-beta-9) (Protocadherin-3H),797,"87,099",4 out of 5,2001-04-27,Evidence at transcript level
Q9NRJ7,PCDBG_HUMAN,Protocadherin beta-16 (PCDH-beta-16) (Protocadherin-3X),776,"84,983",4 out of 5,2001-04-27,Evidence at protein level
Q9Y5H1,PCDG2_HUMAN,Protocadherin gamma-A2 (PCDH-gamma-A2),932,"101,484",3 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G7,PCDG6_HUMAN,Protocadherin gamma-A6 (PCDH-gamma-A6),932,"100,871",3 out of 5,2003-10-24,Evidence at transcript level
Q9Y5H3,PCDGA_HUMAN,Protocadherin gamma-A10 (PCDH-gamma-A10),936,"101,447",3 out of 5,2003-10-24,Evidence at transcript level
Q3KNV8,PCGF3_HUMAN,Polycomb group RING finger protein 3 (RING finger protein 3A),242,"28,115",5 out of 5,2007-02-20,Evidence at protein level
O15381,NVL_HUMAN,Nuclear valosin-containing protein-like (NVLp) (Nuclear VCP-like protein),856,"95,051",5 out of 5,2003-07-11,Evidence at protein level
Q6DKJ4,NXN_HUMAN,Nucleoredoxin (EC 1.8.1.8),435,"48,392",4 out of 5,2008-04-29,Evidence at protein level
Q9NPJ8,NXT2_HUMAN,NTF2-related export protein 2 (Protein p15-2),142,"16,228",5 out of 5,2001-08-29,Evidence at protein level
P58181,O10A3_HUMAN,Olfactory receptor 10A3 (HTPCRX12) (Olfactory receptor OR11-97),314,"35,535",3 out of 5,2001-06-20,Evidence at transcript level
Q8NGE5,O10A7_HUMAN,Olfactory receptor 10A7 (Olfactory receptor OR12-6),316,"35,695",3 out of 5,2003-10-10,Inferred from homology
Q96KK4,O10C1_HUMAN,Olfactory receptor 10C1 (Hs6M1-17) (Olfactory receptor 10C2),312,"34,384",5 out of 5,2002-01-23,Evidence at transcript level
Q8NGN4,O10G9_HUMAN,Olfactory receptor 10G9 (Olfactory receptor 10G10),311,"34,574",3 out of 5,2003-10-10,Inferred from homology
Q8NGY7,O10J6_HUMAN,Putative olfactory receptor 10J6,276,"31,021",3 out of 5,2003-10-10,Uncertain
Q8NGE3,O10P1_HUMAN,Olfactory receptor 10P1 (Olfactory receptor 10P2) (Olfactory receptor 10P3) (Olfactory receptor OR12-7),313,"34,741",4 out of 5,2004-08-16,Evidence at transcript level
Q8NGI7,O10V1_HUMAN,Olfactory receptor 10V1 (Olfactory receptor OR11-256),309,"34,746",3 out of 5,2003-09-26,Inferred from homology
Q8NH95,O13C6_HUMAN,"Putative olfactory receptor 13C6 (Olfactory receptor, family 13, subfamily C, member 6 pseudogene) (Olfactory receptor, family 13, subfamily C, member 7 pseudogene) (Putative olfactory receptor 13C7)",151,"16,702",3 out of 5,2008-07-22,Uncertain
Q96R54,O14A2_HUMAN,Olfactory receptor 14A2 (Olfactory receptor 5AX1) (Olfactory receptor OR1-31),314,"34,780",3 out of 5,2008-07-22,Inferred from homology
Q9UGF5,O14J1_HUMAN,Olfactory receptor 14J1 (Hs6M1-28) (Olfactory receptor 5U1) (Olfactory receptor OR6-25),321,"35,892",4 out of 5,2001-06-20,Evidence at transcript level
O15243,OBRG_HUMAN,Leptin receptor gene-related protein (Endospanin-1) (Leptin receptor overlapping transcript protein) (OB-R gene-related protein) (OB-RGRP),131,"14,254",5 out of 5,1999-07-15,Evidence at transcript level
Q8IXM7,OD3L1_HUMAN,Outer dense fiber protein 3-like protein 1,274,"31,065",2 out of 5,2007-10-02,Evidence at transcript level
Q9BQT8,ODC_HUMAN,Mitochondrial 2-oxodicarboxylate carrier (Solute carrier family 25 member 21),299,"33,303",4 out of 5,2002-02-11,Evidence at protein level
Q9ULJ1,ODF2L_HUMAN,Outer dense fiber protein 2-like,636,"73,728",3 out of 5,2007-10-23,Evidence at transcript level
P36957,ODO2_HUMAN,"Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex, mitochondrial (EC 2.3.1.61) (2-oxoglutarate dehydrogenase complex component E2) (OGDC-E2) (Dihydrolipoamide succinyltransferase component of 2-oxoglutarate dehydrogenase complex) (E2K)",453,"48,755",5 out of 5,1994-06-01,Evidence at protein level
Q99983,OMD_HUMAN,Osteomodulin (Keratan sulfate proteoglycan osteomodulin) (KSPG osteomodulin) (Osteoadherin) (OSAD),421,"49,492",5 out of 5,2002-02-11,Evidence at protein level
Q9Y619,ORNT1_HUMAN,Mitochondrial ornithine transporter 1 (Solute carrier family 25 member 15),301,"32,736",5 out of 5,2002-02-11,Evidence at protein level
Q9NPF4,OSGEP_HUMAN,Probable tRNA N6-adenosine threonylcarbamoyltransferase (EC 2.3.1.234) (N6-L-threonylcarbamoyladenine synthase) (t(6)A synthase) (O-sialoglycoprotein endopeptidase) (hOSGEP) (t(6)A37 threonylcarbamoyladenosine biosynthesis protein OSGEP) (tRNA threonylcarbamoyladenosine biosynthesis protein OSGEP),335,"36,427",5 out of 5,2004-05-24,Evidence at protein level
Q86UW2,OSTB_HUMAN,Organic solute transporter subunit beta (OST-beta) (Solute carrier family 51 subunit beta),128,"14,346",4 out of 5,2008-04-29,Evidence at transcript level
A6NHN0,OTOL1_HUMAN,Otolin-1,477,"49,422",2 out of 5,2008-04-29,Inferred from homology
Q9NRC9,OTOR_HUMAN,Otoraplin (Fibrocyte-derived protein) (Melanoma inhibitory activity-like protein),128,"14,332",3 out of 5,2001-02-21,Evidence at protein level
Q8N6M0,OTU6B_HUMAN,OTU domain-containing protein 6B (EC 3.4.19.12) (DUBA-5),293,"33,813",3 out of 5,2006-01-24,Evidence at protein level
Q5VV17,OTUD1_HUMAN,OTU domain-containing protein 1 (EC 3.4.19.12) (DUBA-7),481,"51,063",4 out of 5,2007-01-09,Evidence at protein level
P32243,OTX2_HUMAN,Homeobox protein OTX2 (Orthodenticle homolog 2),289,"31,636",5 out of 5,1993-10-01,Evidence at protein level
Q8WZ82,OVCA2_HUMAN,Esterase OVCA2 (EC 3.1.2.-) (Ovarian cancer-associated gene 2 protein),227,"24,418",3 out of 5,2007-09-11,Evidence at protein level
Q7RTY7,OVCH1_HUMAN,Ovochymase-1 (EC 3.4.21.-),1134,"125,066",4 out of 5,2006-11-28,Evidence at transcript level
Q9BRP0,OVOL2_HUMAN,Transcription factor Ovo-like 2 (hOvo2) (Zinc finger protein 339),275,"30,438",5 out of 5,2002-09-19,Evidence at protein level
Q9NWU1,OXSM_HUMAN,"3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial (EC 2.3.1.41) (Beta-ketoacyl-ACP synthase)",459,"48,843",5 out of 5,2006-04-18,Evidence at protein level
Q3SYA9,P12L1_HUMAN,Putative POM121-like protein 1,428,"45,448",2 out of 5,2007-06-26,Uncertain
Q99572,P2RX7_HUMAN,P2X purinoceptor 7 (P2X7) (ATP receptor) (P2Z receptor) (Purinergic receptor),595,"68,585",5 out of 5,1997-11-01,Evidence at protein level
O00398,P2Y10_HUMAN,Putative P2Y purinoceptor 10 (P2Y10) (P2Y-like receptor),339,"38,774",4 out of 5,2002-05-27,Evidence at transcript level
Q96A73,P33MX_HUMAN,Putative monooxygenase p33MONOX (EC 1.-.-.-) (Brain-derived rescue factor p60MONOX) (Flavin monooxygenase motif-containing protein of 33 kDa),305,"33,247",4 out of 5,2007-10-23,Evidence at protein level
O00750,P3C2B_HUMAN,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta),1634,"184,768",5 out of 5,2001-04-27,Evidence at protein level
Q8IVL5,P3H2_HUMAN,Prolyl 3-hydroxylase 2 (EC 1.14.11.7) (Leprecan-like protein 1) (Myxoid liposarcoma-associated protein 4),708,"80,984",5 out of 5,2006-06-27,Evidence at protein level
Q96FE7,P3IP1_HUMAN,Phosphoinositide-3-kinase-interacting protein 1 (Kringle domain-containing protein HGFL),263,"28,248",5 out of 5,2007-03-20,Evidence at protein level
P05120,PAI2_HUMAN,Plasminogen activator inhibitor 2 (PAI-2) (Monocyte Arg-serpin) (Placental plasminogen activator inhibitor) (Serpin B2) (Urokinase inhibitor),415,"46,596",5 out of 5,1987-08-13,Evidence at protein level
Q9H074,PAIP1_HUMAN,Polyadenylate-binding protein-interacting protein 1 (PABP-interacting protein 1) (PAIP-1) (Poly(A)-binding protein-interacting protein 1),479,"53,525",5 out of 5,2004-04-13,Evidence at protein level
O75914,PAK3_HUMAN,Serine/threonine-protein kinase PAK 3 (EC 2.7.11.1) (Beta-PAK) (Oligophrenin-3) (p21-activated kinase 3) (PAK-3),559,"62,310",5 out of 5,1998-12-15,Evidence at protein level
O96013,PAK4_HUMAN,Serine/threonine-protein kinase PAK 4 (EC 2.7.11.1) (p21-activated kinase 4) (PAK-4),591,"64,072",5 out of 5,2001-01-24,Evidence at protein level
Q86UW1,OSTA_HUMAN,Organic solute transporter subunit alpha (OST-alpha) (Solute carrier family 51 subunit alpha),340,"37,735",5 out of 5,2008-04-29,Evidence at transcript level
Q5VVQ6,OTU1_HUMAN,Ubiquitin thioesterase OTU1 (EC 3.4.19.12) (DUBA-8) (HIV-1-induced protease 7) (HIN-7) (HsHIN7) (OTU domain-containing protein 2),348,"38,322",5 out of 5,2007-04-03,Evidence at protein level
Q6GQQ9,OTU7B_HUMAN,OTU domain-containing protein 7B (EC 3.4.19.12) (Cellular zinc finger anti-NF-kappa-B protein) (Cezanne) (Zinc finger A20 domain-containing protein 1) (Zinc finger protein Cezanne),843,"92,526",5 out of 5,2004-08-31,Evidence at protein level
Q6IE36,OVOS2_HUMAN,Ovostatin homolog 2,1432,"161,251",3 out of 5,2008-02-26,Evidence at transcript level
Q15070,OXA1L_HUMAN,Mitochondrial inner membrane protein OXA1L (Hsa) (OXA1Hs) (Oxidase assembly 1-like protein) (OXA1-like protein),435,"48,548",5 out of 5,2001-02-21,Evidence at protein level
Q96RQ9,OXLA_HUMAN,L-amino-acid oxidase (LAAO) (LAO) (EC 1.4.3.2) (Interleukin-4-induced protein 1) (IL4-induced protein 1) (Protein Fig-1) (hFIG1),567,"62,881",5 out of 5,2002-03-27,Evidence at protein level
Q15072,OZF_HUMAN,Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146),292,"33,308",5 out of 5,1997-11-01,Evidence at protein level
Q8N7R1,P1L12_HUMAN,POM121-like protein 12,296,"31,848",2 out of 5,2008-09-02,Evidence at transcript level
Q5VU65,P210L_HUMAN,Nuclear pore membrane glycoprotein 210-like (Nucleoporin 210 kDa-like) (Nucleoporin Nup210-like),1888,"210,605",3 out of 5,2006-05-16,Evidence at transcript level
P04637,P53_HUMAN,Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53),393,"43,653",5 out of 5,1987-08-13,Evidence at protein level
Q5JUK9,PAGE3_HUMAN,P antigen family member 3 (PAGE-3) (G antigen family D member 1) (Prostate-associated gene 3 protein),113,"12,480",2 out of 5,2006-07-25,Evidence at protein level
Q8WX93,PALLD_HUMAN,Palladin (SIH002) (Sarcoma antigen NY-SAR-77),1383,"150,564",5 out of 5,2007-09-11,Evidence at protein level
Q8TE04,PANK1_HUMAN,Pantothenate kinase 1 (hPanK) (hPanK1) (EC 2.7.1.33) (Pantothenic acid kinase 1),598,"64,339",5 out of 5,2003-01-17,Evidence at protein level
Q9BZ23,PANK2_HUMAN,"Pantothenate kinase 2, mitochondrial (hPanK2) (EC 2.7.1.33) (Pantothenic acid kinase 2)",570,"62,681",5 out of 5,2003-01-17,Evidence at protein level
Q460N5,PAR14_HUMAN,Poly [ADP-ribose] polymerase 14 (PARP-14) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 8) (ARTD8) (B aggressive lymphoma protein 2),1801,"202,800",5 out of 5,2006-07-25,Evidence at protein level
P49023,PAXI_HUMAN,Paxillin,591,"64,505",5 out of 5,1996-02-01,Evidence at protein level
Q86U86,PB1_HUMAN,Protein polybromo-1 (hPB1) (BRG1-associated factor 180) (BAF180) (Polybromo-1D),1689,"192,948",5 out of 5,2005-08-30,Evidence at protein level
Q9BVG4,PBDC1_HUMAN,Protein PBDC1 (Polysaccharide biosynthesis domain-containing protein 1),233,"26,057",2 out of 5,2006-10-31,Evidence at protein level
Q96AQ6,PBIP1_HUMAN,Pre-B-cell leukemia transcription factor-interacting protein 1 (Hematopoietic PBX-interacting protein),731,"80,643",5 out of 5,2007-10-02,Evidence at protein level
P40425,PBX2_HUMAN,Pre-B-cell leukemia transcription factor 2 (Homeobox protein PBX2) (Protein G17),430,"45,881",5 out of 5,1995-02-01,Evidence at protein level
Q15366,PCBP2_HUMAN,Poly(rC)-binding protein 2 (Alpha-CP2) (Heterogeneous nuclear ribonucleoprotein E2) (hnRNP E2),365,"38,580",5 out of 5,2000-05-30,Evidence at protein level
Q8N6Y1,PCD20_HUMAN,Protocadherin-20 (Protocadherin-13),951,"104,919",4 out of 5,2004-08-16,Evidence at transcript level
Q9Y5F2,PCDBB_HUMAN,Protocadherin beta-11 (PCDH-beta-11),797,"87,088",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E8,PCDBF_HUMAN,Protocadherin beta-15 (PCDH-beta-15),787,"86,329",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5G8,PCDG5_HUMAN,Protocadherin gamma-A5 (PCDH-gamma-A5),931,"100,935",3 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G4,PCDG9_HUMAN,Protocadherin gamma-A9 (PCDH-gamma-A9),932,"101,687",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G2,PCDGE_HUMAN,Protocadherin gamma-B2 (PCDH-gamma-B2),931,"100,875",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G1,PCDGF_HUMAN,Protocadherin gamma-B3 (PCDH-gamma-B3),929,"101,232",4 out of 5,2003-10-24,Evidence at protein level
Q9HC56,PCDH9_HUMAN,Protocadherin-9,1237,"136,064",3 out of 5,2004-01-16,Evidence at protein level
O94913,PCF11_HUMAN,Pre-mRNA cleavage complex 2 protein Pcf11 (Pre-mRNA cleavage complex II protein Pcf11),1555,"173,050",5 out of 5,2001-04-27,Evidence at protein level
Q86SE9,PCGF5_HUMAN,Polycomb group RING finger protein 5 (RING finger protein 159),256,"29,714",5 out of 5,2007-02-20,Evidence at protein level
P35558,PCKGC_HUMAN,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP] (PEPCK-C) (EC 4.1.1.32)",622,"69,195",5 out of 5,1994-06-01,Evidence at protein level
Q7Z2X4,PCLI1_HUMAN,"PTB-containing, cubilin and LRP1-interacting protein (P-CLI1) (Phosphotyrosine interaction domain-containing protein 1) (Protein NYGGF4)",250,"28,272",5 out of 5,2007-02-06,Evidence at protein level
Q92824,PCSK5_HUMAN,Proprotein convertase subtilisin/kexin type 5 (EC 3.4.21.-) (Proprotein convertase 5) (PC5) (Proprotein convertase 6) (PC6) (hPC6) (Subtilisin/kexin-like protease PC5),1860,"206,942",5 out of 5,2001-01-11,Evidence at protein level
Q8N2R0,OSR2_HUMAN,Protein odd-skipped-related 2,312,"35,513",5 out of 5,2006-01-24,Evidence at protein level
P32242,OTX1_HUMAN,Homeobox protein OTX1 (Orthodenticle homolog 1),354,"37,327",5 out of 5,1993-10-01,Evidence at protein level
P41217,OX2G_HUMAN,OX-2 membrane glycoprotein (CD antigen CD200),278,"31,264",5 out of 5,1995-02-01,Evidence at protein level
O43614,OX2R_HUMAN,Orexin receptor type 2 (Ox-2-R) (Ox2-R) (Ox2R) (Hypocretin receptor type 2),444,"50,694",5 out of 5,2000-05-30,Evidence at protein level
Q96P68,OXGR1_HUMAN,2-oxoglutarate receptor 1 (Alpha-ketoglutarate receptor 1) (G-protein coupled receptor 80) (G-protein coupled receptor 99) (P2Y purinoceptor 15) (P2Y15) (P2Y-like GPCR) (P2Y-like nucleotide receptor),337,"38,251",4 out of 5,2003-10-10,Evidence at transcript level
Q96KW2,P12L2_HUMAN,POM121-like protein 2,1035,"109,912",2 out of 5,2007-06-26,Inferred from homology
P0DMB1,P23D2_HUMAN,Proline-rich protein 23D2,279,"31,050",1 out of 5,2014-01-22,Inferred from homology
Q99571,P2RX4_HUMAN,P2X purinoceptor 4 (P2X4) (ATP receptor) (Purinergic receptor),388,"43,369",5 out of 5,1997-11-01,Evidence at protein level
P47900,P2RY1_HUMAN,P2Y purinoceptor 1 (P2Y1) (ATP receptor) (Purinergic receptor),373,"42,072",5 out of 5,1996-02-01,Evidence at protein level
Q15077,P2RY6_HUMAN,P2Y purinoceptor 6 (P2Y6),328,"36,429",4 out of 5,1997-11-01,Evidence at protein level
Q5MIZ7,P4R3B_HUMAN,Serine/threonine-protein phosphatase 4 regulatory subunit 3B (SMEK homolog 2),849,"97,458",5 out of 5,2006-10-31,Evidence at protein level
Q92569,P55G_HUMAN,Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK),461,"54,448",5 out of 5,2000-12-01,Evidence at protein level
Q8NBR0,P5I13_HUMAN,Tumor protein p53-inducible protein 13 (Damage-stimulated cytoplasmic protein 1),393,"42,238",3 out of 5,2008-05-20,Evidence at transcript level
Q9BTK6,PAGR1_HUMAN,PAXIP1-associated glutamate-rich protein 1 (Glutamate-rich coactivator interacting with SRC1) (GAS) (PAXIP1-associated protein 1) (PTIP-associated protein 1),254,"27,716",5 out of 5,2006-09-05,Evidence at protein level
P05121,PAI1_HUMAN,Plasminogen activator inhibitor 1 (PAI) (PAI-1) (Endothelial plasminogen activator inhibitor) (Serpin E1),402,"45,060",5 out of 5,1987-08-13,Evidence at protein level
Q9Y536,PAL4A_HUMAN,Peptidyl-prolyl cis-trans isomerase A-like 4A (PPIase A-like 4A) (EC 5.2.1.8) (Chromosome one-amplified sequence 2) (COAS-2) (Cyclophilin homolog overexpressed in liver cancer),164,"18,182",3 out of 5,2008-03-18,Evidence at transcript level
I0J062,PANO1_HUMAN,Proapoptotic nucleolar protein 1,215,"22,842",4 out of 5,2015-02-04,Evidence at transcript level
Q5XG87,PAPD7_HUMAN,Non-canonical poly(A) RNA polymerase PAPD7 (EC 2.7.7.19) (DNA polymerase sigma) (LAK-1) (PAP-associated domain-containing protein 7) (TRAMP-like complex polyadenylate polymerase) (Terminal uridylyltransferase 5) (TUTase 5) (Topoisomerase-related function protein 4-1) (TRF4-1),772,"82,360",5 out of 5,2005-02-01,Evidence at protein level
Q9BWT3,PAPOG_HUMAN,Poly(A) polymerase gamma (PAP-gamma) (EC 2.7.7.19) (Neo-poly(A) polymerase) (Neo-PAP) (Polynucleotide adenylyltransferase gamma) (SRP RNA 3'-adenylating enzyme) (Signal recognition particle RNA-adenylating enzyme) (SRP RNA-adenylating enzyme),736,"82,803",5 out of 5,2001-09-26,Evidence at protein level
Q6TCH4,PAQR6_HUMAN,Progestin and adipoQ receptor family member 6 (Progestin and adipoQ receptor family member VI),344,"37,989",3 out of 5,2004-08-31,Evidence at transcript level
O00254,PAR3_HUMAN,Proteinase-activated receptor 3 (PAR-3) (Coagulation factor II receptor-like 2) (Thrombin receptor-like 2),374,"42,508",5 out of 5,1998-07-15,Evidence at protein level
Q9NPB6,PAR6A_HUMAN,Partitioning defective 6 homolog alpha (PAR-6) (PAR-6 alpha) (PAR-6A) (PAR6C) (Tax interaction protein 40) (TIP-40),346,"37,388",5 out of 5,2003-05-16,Evidence at protein level
Q8IV76,PASD1_HUMAN,Circadian clock protein PASD1 (Cancer/testis antigen 63) (CT63) (OX-TES-1) (PAS domain-containing protein 1),773,"87,428",5 out of 5,2007-09-11,Evidence at protein level
Q86TB9,PATL1_HUMAN,Protein PAT1 homolog 1 (PAT1-like protein 1) (Protein PAT1 homolog b) (Pat1b) (hPat1b),770,"86,850",5 out of 5,2008-02-26,Evidence at protein level
Q8NF37,PCAT1_HUMAN,Lysophosphatidylcholine acyltransferase 1 (LPC acyltransferase 1) (LPCAT-1) (LysoPC acyltransferase 1) (EC 2.3.1.23) (1-acylglycerophosphocholine O-acyltransferase) (1-alkylglycerophosphocholine O-acetyltransferase) (EC 2.3.1.67) (Acetyl-CoA:lyso-platelet-activating factor acetyltransferase) (Acetyl-CoA:lyso-PAF acetyltransferase) (Lyso-PAF acetyltransferase) (LysoPAFAT) (Acyltransferase-like 2) (Phosphonoformate immuno-associated protein 3),534,"59,151",5 out of 5,2006-07-25,Evidence at protein level
P11940,PABP1_HUMAN,Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1),636,"70,671",5 out of 5,1989-10-01,Evidence at protein level
Q8N7B6,PACRL_HUMAN,PACRG-like protein,248,"27,152",2 out of 5,2007-02-20,Evidence at protein level
Q96GU1,PAGE5_HUMAN,P antigen family member 5 (PAGE-5) (Cancer/testis antigen 16.1) (CT16.1) (G antigen family E member 1) (Prostate-associated gene 5 protein),130,"14,046",2 out of 5,2006-07-25,Evidence at protein level
P01298,PAHO_HUMAN,Pancreatic prohormone (Pancreatic polypeptide) (PP) (Obinepitide) [Cleaved into: Pancreatic hormone (PH); Pancreatic icosapeptide (PI)],95,"10,445",5 out of 5,1986-07-21,Evidence at protein level
Q9ULR5,PAI2B_HUMAN,Polyadenylate-binding protein-interacting protein 2B (PABP-interacting protein 2B) (PAIP-2B) (Poly(A)-binding protein-interacting protein 2B),123,"14,237",4 out of 5,2008-02-05,Evidence at protein level
Q8NC51,PAIRB_HUMAN,Plasminogen activator inhibitor 1 RNA-binding protein (PAI1 RNA-binding protein 1) (PAI-RBP1) (SERPINE1 mRNA-binding protein 1),408,"44,965",5 out of 5,2004-09-27,Evidence at protein level
Q9P286,PAK5_HUMAN,Serine/threonine-protein kinase PAK 5 (EC 2.7.11.1) (p21-activated kinase 5) (PAK-5) (p21-activated kinase 7) (PAK-7),719,"80,745",5 out of 5,2001-01-24,Evidence at protein level
Q6UXH9,PAMR1_HUMAN,Inactive serine protease PAMR1 (Peptidase domain-containing protein associated with muscle regeneration 1) (Regeneration-associated muscle protease homolog),720,"80,199",4 out of 5,2007-05-15,Evidence at protein level
Q504Q3,PAN2_HUMAN,PAB-dependent poly(A)-specific ribonuclease subunit PAN2 (hPan2) (EC 3.1.13.4) (Inactive ubiquitin carboxyl-terminal hydrolase 52) (PAB1P-dependent poly(A)-nuclease) (PAN deadenylation complex catalytic subunit 2),1202,"135,368",5 out of 5,2007-03-20,Evidence at protein level
Q4VXU2,PAP1L_HUMAN,Polyadenylate-binding protein 1-like,614,"68,392",3 out of 5,2007-02-20,Evidence at transcript level
Q5QFB9,PAPAS_HUMAN,Protein PAPPAS (DIPLA1 antisense RNA 1) (DIPLA1 antisense gene protein 1) (DIPLA1-antisense expressed) (PAPPAS antisense RNA 1) (PAPPAS antisense gene protein 1) (PAPPAS-antisense expressed),102,"12,196",3 out of 5,2008-01-15,Uncertain
P51003,PAPOA_HUMAN,Poly(A) polymerase alpha (PAP-alpha) (EC 2.7.7.19) (Polynucleotide adenylyltransferase alpha),745,"82,843",5 out of 5,1996-10-01,Evidence at protein level
Q9BXP8,PAPP2_HUMAN,Pappalysin-2 (EC 3.4.24.-) (Pregnancy-associated plasma protein A2) (PAPP-A2) (Pregnancy-associated plasma protein E1) (PAPP-E),1791,"198,539",5 out of 5,2004-12-07,Evidence at protein level
Q6ZVX9,PAQR9_HUMAN,Progestin and adipoQ receptor family member 9 (Progestin and adipoQ receptor family member IX),377,"42,692",2 out of 5,2004-08-31,Evidence at transcript level
Q8N4S7,PAQR4_HUMAN,Progestin and adipoQ receptor family member 4 (Progestin and adipoQ receptor family member IV),273,"29,126",2 out of 5,2004-08-31,Evidence at transcript level
Q9BYG4,PAR6G_HUMAN,Partitioning defective 6 homolog gamma (PAR-6 gamma) (PAR6D),376,"40,883",5 out of 5,2003-05-16,Evidence at protein level
A6NKN8,PC4L1_HUMAN,Purkinje cell protein 4-like protein 1 (PCP4-like protein 1),68,"7,476",2 out of 5,2008-04-29,Inferred from homology
Q15365,PCBP1_HUMAN,Poly(rC)-binding protein 1 (Alpha-CP1) (Heterogeneous nuclear ribonucleoprotein E1) (hnRNP E1) (Nucleic acid-binding protein SUB2.3),356,"37,498",5 out of 5,2000-05-30,Evidence at protein level
Q9Y5H9,PCDA2_HUMAN,Protocadherin alpha-2 (PCDH-alpha-2),948,"102,063",5 out of 5,2001-04-27,Evidence at protein level
Q9UN74,PCDA4_HUMAN,Protocadherin alpha-4 (PCDH-alpha-4),947,"102,293",5 out of 5,2001-04-27,Evidence at protein level
Q9UN73,PCDA6_HUMAN,Protocadherin alpha-6 (PCDH-alpha-6),950,"102,716",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5H6,PCDA8_HUMAN,Protocadherin alpha-8 (PCDH-alpha-8),950,"103,051",5 out of 5,2001-04-27,Evidence at transcript level
Q9Y5I0,PCDAD_HUMAN,Protocadherin alpha-13 (PCDH-alpha-13),950,"102,483",4 out of 5,2001-04-27,Evidence at transcript level
Q9Y5E7,PCDB2_HUMAN,Protocadherin beta-2 (PCDH-beta-2),798,"87,254",4 out of 5,2001-04-27,Evidence at protein level
Q96TA0,PCDBI_HUMAN,Putative protocadherin beta-18 (PCDH-beta-18) (PCDH-psi2),734,"80,449",3 out of 5,2008-06-10,Uncertain
Q9Y5H4,PCDG1_HUMAN,Protocadherin gamma-A1 (PCDH-gamma-A1),931,"101,226",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5H0,PCDG3_HUMAN,Protocadherin gamma-A3 (PCDH-gamma-A3),932,"100,971",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5H2,PCDGB_HUMAN,Protocadherin gamma-A11 (PCDH-gamma-A11),935,"101,543",4 out of 5,2003-10-24,Evidence at transcript level
Q9Y5G3,PCDGD_HUMAN,Protocadherin gamma-B1 (PCDH-gamma-B1),927,"100,360",3 out of 5,2003-10-24,Evidence at transcript level
Q9UN70,PCDGK_HUMAN,Protocadherin gamma-C3 (PCDH-gamma-C3) (Protocadherin-2) (Protocadherin-43) (PC-43),934,"101,077",4 out of 5,2003-10-24,Evidence at protein level
O95206,PCDH8_HUMAN,Protocadherin-8 (Arcadlin),1070,"113,019",5 out of 5,2003-10-24,Evidence at transcript level
Q8WW12,PCNP_HUMAN,PEST proteolytic signal-containing nuclear protein (PCNP) (PEST-containing nuclear protein),178,"18,925",5 out of 5,2005-06-07,Evidence at protein level
Q15113,PCOC1_HUMAN,Procollagen C-endopeptidase enhancer 1 (Procollagen COOH-terminal proteinase enhancer 1) (PCPE-1) (Procollagen C-proteinase enhancer 1) (Type 1 procollagen C-proteinase enhancer protein) (Type I procollagen COOH-terminal proteinase enhancer),449,"47,972",5 out of 5,2000-05-30,Evidence at protein level
Q8NBM8,PCYXL_HUMAN,Prenylcysteine oxidase-like (EC 1.8.3.-),494,"54,646",4 out of 5,2007-03-20,Evidence at protein level
Q9BQ51,PD1L2_HUMAN,Programmed cell death 1 ligand 2 (PD-1 ligand 2) (PD-L2) (PDCD1 ligand 2) (Programmed death ligand 2) (Butyrophilin B7-DC) (B7-DC) (CD antigen CD273),273,"30,957",5 out of 5,2005-05-10,Evidence at protein level
Q13258,PD2R_HUMAN,Prostaglandin D2 receptor (PGD receptor) (PGD2 receptor) (Prostanoid DP receptor),359,"40,271",5 out of 5,1997-11-01,Evidence at transcript level
O75340,PDCD6_HUMAN,Programmed cell death protein 6 (Apoptosis-linked gene 2 protein homolog) (ALG-2),191,"21,868",5 out of 5,2001-01-11,Evidence at protein level
Q01064,PDE1B_HUMAN,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B (Cam-PDE 1B) (EC 3.1.4.17) (63 kDa Cam-PDE)",536,"61,380",5 out of 5,1993-04-01,Evidence at protein level
Q3SYG4,PTHB1_HUMAN,Protein PTHB1 (Bardet-Biedl syndrome 9 protein) (Parathyroid hormone-responsive B1 gene protein),887,"99,280",5 out of 5,2006-05-16,Evidence at protein level
P06454,PTMA_HUMAN,"Prothymosin alpha [Cleaved into: Prothymosin alpha, N-terminally processed; Thymosin alpha-1]",111,"12,203",5 out of 5,1988-01-01,Evidence at protein level
Q16825,PTN21_HUMAN,Tyrosine-protein phosphatase non-receptor type 21 (EC 3.1.3.48) (Protein-tyrosine phosphatase D1),1174,"133,281",4 out of 5,1997-11-01,Evidence at protein level
P35236,PTN7_HUMAN,Tyrosine-protein phosphatase non-receptor type 7 (EC 3.1.3.48) (Hematopoietic protein-tyrosine phosphatase) (HEPTP) (Protein-tyrosine phosphatase LC-PTP),360,"40,529",5 out of 5,1994-02-01,Evidence at protein level
Q9UJV8,PURG_HUMAN,Purine-rich element-binding protein gamma,347,"39,556",3 out of 5,2006-10-31,Evidence at transcript level
Q9H0K6,PUS7L_HUMAN,Pseudouridylate synthase 7 homolog-like protein (EC 5.4.99.-),701,"80,700",4 out of 5,2008-02-05,Evidence at protein level
Q9Y6I8,PXMP4_HUMAN,Peroxisomal membrane protein 4 (24 kDa peroxisomal intrinsic membrane protein),212,"24,264",4 out of 5,2003-02-28,Evidence at protein level
P11498,PYC_HUMAN,"Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)",1178,"129,634",5 out of 5,1989-10-01,Evidence at protein level
Q8WU10,PYRD1_HUMAN,Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1 (EC 1.8.1.-),500,"55,793",5 out of 5,2008-04-08,Evidence at protein level
P10082,PYY_HUMAN,Peptide YY (PYY) (PYY-I) (Peptide tyrosine tyrosine) [Cleaved into: Peptide YY(3-36) (PYY-II)],97,"11,145",5 out of 5,1989-07-01,Evidence at protein level
A6NEC2,PSAL_HUMAN,Puromycin-sensitive aminopeptidase-like protein (EC 3.4.11.-),478,"53,747",4 out of 5,2008-04-29,Evidence at transcript level
P20618,PSB1_HUMAN,Proteasome subunit beta type-1 (EC 3.4.25.1) (Macropain subunit C5) (Multicatalytic endopeptidase complex subunit C5) (Proteasome component C5) (Proteasome gamma chain),241,"26,489",5 out of 5,1991-02-01,Evidence at protein level
P28070,PSB4_HUMAN,Proteasome subunit beta type-4 (EC 3.4.25.1) (26 kDa prosomal protein) (HsBPROS26) (PROS-26) (Macropain beta chain) (Multicatalytic endopeptidase complex beta chain) (Proteasome beta chain) (Proteasome chain 3) (HsN3),264,"29,204",5 out of 5,1992-08-01,Evidence at protein level
Q00888,PSG4_HUMAN,Pregnancy-specific beta-1-glycoprotein 4 (PS-beta-G-4) (PSBG-4) (Pregnancy-specific glycoprotein 4) (Pregnancy-specific beta-1-glycoprotein 9) (PS-beta-G-9) (PSBG-9) (Pregnancy-specific glycoprotein 9),419,"47,113",4 out of 5,1996-10-01,Evidence at transcript level
Q9UQ74,PSG8_HUMAN,Pregnancy-specific beta-1-glycoprotein 8 (PS-beta-G-8) (PSBG-8) (Pregnancy-specific glycoprotein 8),426,"47,772",3 out of 5,2000-05-30,Evidence at transcript level
P49810,PSN2_HUMAN,Presenilin-2 (PS-2) (EC 3.4.23.-) (AD3LP) (AD5) (E5-1) (STM-2) [Cleaved into: Presenilin-2 NTF subunit; Presenilin-2 CTF subunit],448,"50,140",5 out of 5,1996-10-01,Evidence at protein level
Q6UWS5,PT117_HUMAN,"Protein PET117 homolog, mitochondrial",81,"9,223",2 out of 5,2012-03-21,Inferred from homology
Q7RTS3,PTF1A_HUMAN,Pancreas transcription factor 1 subunit alpha (Class A basic helix-loop-helix protein 29) (bHLHa29) (Pancreas-specific transcription factor 1a) (bHLH transcription factor p48) (p48 DNA-binding subunit of transcription factor PTF1) (PTF1-p48),328,"34,970",5 out of 5,2006-05-02,Evidence at protein level
Q06203,PUR1_HUMAN,Amidophosphoribosyltransferase (ATase) (EC 2.4.2.14) (Glutamine phosphoribosylpyrophosphate amidotransferase) (GPAT),517,"57,399",5 out of 5,1994-06-01,Evidence at protein level
O96011,PX11B_HUMAN,Peroxisomal membrane protein 11B (Peroxin-11B) (Peroxisomal biogenesis factor 11B) (Protein PEX11 homolog beta) (PEX11-beta),259,"28,431",5 out of 5,2005-04-26,Evidence at protein level
P11216,PYGB_HUMAN,"Glycogen phosphorylase, brain form (EC 2.4.1.1)",843,"96,696",5 out of 5,1989-07-01,Evidence at protein level
Q02127,PYRD_HUMAN,"Dihydroorotate dehydrogenase (quinone), mitochondrial (DHOdehase) (EC 1.3.5.2) (Dihydroorotate oxidase)",395,"42,867",5 out of 5,1993-07-01,Evidence at protein level
Q9UNM6,PSD13_HUMAN,26S proteasome non-ATPase regulatory subunit 13 (26S proteasome regulatory subunit RPN9) (26S proteasome regulatory subunit S11) (26S proteasome regulatory subunit p40.5),376,"42,945",5 out of 5,2002-05-15,Evidence at protein level
P11686,PSPC_HUMAN,Pulmonary surfactant-associated protein C (SP-C) (Pulmonary surfactant-associated proteolipid SPL(Val)) (SP5),197,"21,053",5 out of 5,1989-10-01,Evidence at protein level
Q8IV42,PSTK_HUMAN,L-seryl-tRNA(Sec) kinase (EC 2.7.1.164) (O-phosphoseryl-tRNA(Sec) kinase),348,"39,527",3 out of 5,2005-08-16,Evidence at protein level
Q96BW5,PTER_HUMAN,Phosphotriesterase-related protein (EC 3.1.-.-) (Parathion hydrolase-related protein) (hPHRP),349,"39,018",3 out of 5,2003-06-20,Evidence at protein level
Q16647,PTGIS_HUMAN,Prostacyclin synthase (EC 5.3.99.4) (Prostaglandin I2 synthase),500,"57,104",5 out of 5,1997-11-01,Evidence at protein level
P49190,PTH2R_HUMAN,Parathyroid hormone 2 receptor (PTH2 receptor),550,"62,236",4 out of 5,1996-02-01,Evidence at protein level
P12272,PTHR_HUMAN,Parathyroid hormone-related protein (PTH-rP) (PTHrP) (Parathyroid hormone-like protein) (PLP) [Cleaved into: PTHrP[1-36]; PTHrP[38-94]; Osteostatin (PTHrP[107-139])],177,"20,194",5 out of 5,1989-10-01,Evidence at protein level
P26045,PTN3_HUMAN,Tyrosine-protein phosphatase non-receptor type 3 (EC 3.1.3.48) (Protein-tyrosine phosphatase H1) (PTP-H1),913,"103,990",5 out of 5,1992-05-01,Evidence at protein level
P29350,PTN6_HUMAN,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1),595,"67,561",5 out of 5,1992-12-01,Evidence at protein level
Q9BZE2,PUS3_HUMAN,tRNA pseudouridine(38/39) synthase (EC 5.4.99.45) (tRNA pseudouridine synthase 3) (tRNA pseudouridylate synthase 3) (tRNA-uridine isomerase 3),481,"55,647",5 out of 5,2004-09-27,Evidence at protein level
Q9BRP8,PYM1_HUMAN,Partner of Y14 and mago (PYM homolog 1 exon junction complex-associated factor) (Protein wibg homolog),204,"22,656",5 out of 5,2007-05-15,Evidence at protein level
Q92932,PTPR2_HUMAN,Receptor-type tyrosine-protein phosphatase N2 (R-PTP-N2) (EC 3.1.3.-) (EC 3.1.3.48) (Islet cell autoantigen-related protein) (IAR) (ICAAR) (Phogrin) [Cleaved into: IA-2beta60],1015,"111,271",5 out of 5,1997-11-01,Evidence at protein level
P18433,PTPRA_HUMAN,Receptor-type tyrosine-protein phosphatase alpha (Protein-tyrosine phosphatase alpha) (R-PTP-alpha) (EC 3.1.3.48),802,"90,600",5 out of 5,1990-11-01,Evidence at protein level
P08575,PTPRC_HUMAN,Receptor-type tyrosine-protein phosphatase C (EC 3.1.3.48) (Leukocyte common antigen) (L-CA) (T200) (CD antigen CD45),1304,"147,254",5 out of 5,1988-08-01,Evidence at protein level
P23469,PTPRE_HUMAN,Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48),700,"80,642",5 out of 5,1991-11-01,Evidence at protein level
P28827,PTPRM_HUMAN,Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48),1452,"163,682",5 out of 5,1992-12-01,Evidence at protein level
Q13332,PTPRS_HUMAN,Receptor-type tyrosine-protein phosphatase S (R-PTP-S) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase sigma) (R-PTP-sigma),1948,"217,041",5 out of 5,2003-07-19,Evidence at protein level
Q92729,PTPRU_HUMAN,Receptor-type tyrosine-protein phosphatase U (R-PTP-U) (EC 3.1.3.48) (Pancreatic carcinoma phosphatase 2) (PCP-2) (Protein-tyrosine phosphatase J) (PTP-J) (hPTP-J) (Protein-tyrosine phosphatase pi) (PTP pi) (Protein-tyrosine phosphatase receptor omicron) (PTP-RO) (Receptor-type protein-tyrosine phosphatase psi) (R-PTP-psi),1446,"162,423",5 out of 5,1997-11-01,Evidence at protein level
P23471,PTPRZ_HUMAN,Receptor-type tyrosine-protein phosphatase zeta (R-PTP-zeta) (EC 3.1.3.48) (Protein-tyrosine phosphatase receptor type Z polypeptide 1) (Protein-tyrosine phosphatase receptor type Z polypeptide 2) (R-PTP-zeta-2),2315,"254,587",5 out of 5,1991-11-01,Evidence at protein level
Q9NZH5,PTTG2_HUMAN,Securin-2 (Pituitary tumor-transforming gene 2 protein),202,"22,302",3 out of 5,2008-02-26,Evidence at transcript level
Q9UHX1,PUF60_HUMAN,Poly(U)-binding-splicing factor PUF60 (60 kDa poly(U)-binding-splicing factor) (FUSE-binding protein-interacting repressor) (FBP-interacting repressor) (Ro-binding protein 1) (RoBP1) (Siah-binding protein 1) (Siah-BP1),559,"59,875",5 out of 5,2007-09-11,Evidence at protein level
P22102,PUR2_HUMAN,Trifunctional purine biosynthetic protein adenosine-3 [Includes: Phosphoribosylamine--glycine ligase (EC 6.3.4.13) (Glycinamide ribonucleotide synthetase) (GARS) (Phosphoribosylglycinamide synthetase); Phosphoribosylformylglycinamidine cyclo-ligase (EC 6.3.3.1) (AIR synthase) (AIRS) (Phosphoribosyl-aminoimidazole synthetase); Phosphoribosylglycinamide formyltransferase (EC 2.1.2.2) (5'-phosphoribosylglycinamide transformylase) (GAR transformylase) (GART)],1010,"107,767",5 out of 5,1991-08-01,Evidence at protein level
O15067,PUR4_HUMAN,Phosphoribosylformylglycinamidine synthase (FGAM synthase) (FGAMS) (EC 6.3.5.3) (Formylglycinamide ribonucleotide amidotransferase) (FGAR amidotransferase) (FGAR-AT) (Formylglycinamide ribotide amidotransferase),1338,"144,734",5 out of 5,2001-01-11,Evidence at protein level
P31939,PUR9_HUMAN,"Bifunctional purine biosynthesis protein PURH [Cleaved into: Bifunctional purine biosynthesis protein PURH, N-terminally processed] [Includes: Phosphoribosylaminoimidazolecarboxamide formyltransferase (EC 2.1.2.3) (5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase) (AICAR transformylase); IMP cyclohydrolase (EC 3.5.4.10) (ATIC) (IMP synthase) (Inosinicase)]",592,"64,616",5 out of 5,1993-07-01,Evidence at protein level
Q8N142,PURA1_HUMAN,"Adenylosuccinate synthetase isozyme 1 (AMPSase 1) (AdSS 1) (EC 6.3.4.4) (Adenylosuccinate synthetase, basic isozyme) (Adenylosuccinate synthetase, muscle isozyme) (M-type adenylosuccinate synthetase) (IMP--aspartate ligase 1)",457,"50,208",5 out of 5,2003-10-03,Evidence at protein level
P15151,PVR_HUMAN,Poliovirus receptor (Nectin-like protein 5) (NECL-5) (CD antigen CD155),417,"45,303",5 out of 5,1990-04-01,Evidence at protein level
Q13610,PWP1_HUMAN,Periodic tryptophan protein 1 homolog (Keratinocyte protein IEF SSP 9502),501,"55,828",4 out of 5,1997-11-01,Evidence at protein level
Q96HA9,PX11C_HUMAN,Peroxisomal membrane protein 11C (Peroxin-11C) (Peroxisomal biogenesis factor 11C) (Protein PEX11 homolog gamma) (PEX11-gamma),241,"26,636",5 out of 5,2005-04-26,Evidence at protein level
Q9NR77,PXMP2_HUMAN,Peroxisomal membrane protein 2 (22 kDa peroxisomal membrane protein),195,"22,253",4 out of 5,2003-01-27,Evidence at protein level
I3L0S3,PYAS1_HUMAN,Putative uncharacterized protein PYCARD-AS1 (PYCARD antisense RNA 1) (PYCARD antisense gene protein 1) (PYCARD opposite strand protein),204,"21,949",2 out of 5,2013-05-01,Uncertain
P0DMW2,PYDC4_HUMAN,NLR family pyrin domain-containing protein 2B (Pyrin domain-containing protein 2-like protein POP4) (Pyrin-only protein 4),45,"4,993",5 out of 5,2015-05-27,Evidence at transcript level
Q9BRQ0,PYGO2_HUMAN,Pygopus homolog 2,406,"41,244",5 out of 5,2002-09-19,Evidence at protein level
A8MTI9,PRS47_HUMAN,Putative serine protease 47 (EC 3.4.21.-),375,"41,188",3 out of 5,2008-07-22,Uncertain
Q86TP1,PRUNE_HUMAN,Protein prune homolog (hPrune) (EC 3.6.1.1) (Drosophila-related expressed sequence 17) (DRES-17) (DRES17) (HTcD37),453,"50,200",5 out of 5,2008-06-10,Evidence at protein level
P25789,PSA4_HUMAN,Proteasome subunit alpha type-4 (EC 3.4.25.1) (Macropain subunit C9) (Multicatalytic endopeptidase complex subunit C9) (Proteasome component C9) (Proteasome subunit L),261,"29,484",5 out of 5,1992-05-01,Evidence at protein level
P49721,PSB2_HUMAN,Proteasome subunit beta type-2 (EC 3.4.25.1) (Macropain subunit C7-I) (Multicatalytic endopeptidase complex subunit C7-I) (Proteasome component C7-I),201,"22,836",5 out of 5,1996-10-01,Evidence at protein level
Q99436,PSB7_HUMAN,Proteasome subunit beta type-7 (EC 3.4.25.1) (Macropain chain Z) (Multicatalytic endopeptidase complex chain Z) (Proteasome subunit Z),277,"29,965",5 out of 5,2001-10-18,Evidence at protein level
Q8WV60,PTCD2_HUMAN,"Pentatricopeptide repeat-containing protein 2, mitochondrial",388,"43,968",4 out of 5,2008-07-22,Evidence at protein level
Q6ISU1,PTCRA_HUMAN,Pre T-cell antigen receptor alpha (pT-alpha) (pTa) (pT-alpha-TCR),281,"29,266",4 out of 5,2008-02-26,Evidence at protein level
Q8N4Q0,PTGR3_HUMAN,Prostaglandin reductase 3 (PRG-3) (EC 1.3.1.48) (Zinc-binding alcohol dehydrogenase domain-containing protein 2),377,"40,140",4 out of 5,2006-02-21,Evidence at protein level
Q86Y79,PTH_HUMAN,Probable peptidyl-tRNA hydrolase (PTH) (EC 3.1.1.29),214,"22,937",2 out of 5,2006-06-27,Evidence at protein level
P29074,PTN4_HUMAN,Tyrosine-protein phosphatase non-receptor type 4 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG1) (MEG) (PTPase-MEG1),926,"105,911",5 out of 5,1992-12-01,Evidence at protein level
Q15257,PTPA_HUMAN,"Serine/threonine-protein phosphatase 2A activator (EC 5.2.1.8) (PP2A, subunit B', PR53 isoform) (Phosphotyrosyl phosphatase activator) (PTPA) (Serine/threonine-protein phosphatase 2A regulatory subunit 4) (Serine/threonine-protein phosphatase 2A regulatory subunit B')",358,"40,668",5 out of 5,2001-11-16,Evidence at protein level
A2A3K4,PTPC1_HUMAN,Protein tyrosine phosphatase domain-containing protein 1 (EC 3.1.3.-),754,"84,457",3 out of 5,2007-12-04,Evidence at protein level
P23470,PTPRG_HUMAN,Receptor-type tyrosine-protein phosphatase gamma (Protein-tyrosine phosphatase gamma) (R-PTP-gamma) (EC 3.1.3.48),1445,"162,003",5 out of 5,1991-11-01,Evidence at protein level
Q15262,PTPRK_HUMAN,Receptor-type tyrosine-protein phosphatase kappa (Protein-tyrosine phosphatase kappa) (R-PTP-kappa) (EC 3.1.3.48),1439,"162,102",5 out of 5,1997-11-01,Evidence at protein level
Q16849,PTPRN_HUMAN,Receptor-type tyrosine-protein phosphatase-like N (R-PTP-N) (Islet cell antigen 512) (ICA 512) (Islet cell autoantigen 3) (PTP IA-2) [Cleaved into: ICA512-N-terminal fragment (ICA512-NTF); ICA512-transmembrane fragment (ICA512-TMF); ICA512-cleaved cytosolic fragment (ICA512-CCF)],979,"105,848",5 out of 5,1997-11-01,Evidence at protein level
Q9UMZ3,PTPRQ_HUMAN,Phosphatidylinositol phosphatase PTPRQ (EC 3.1.3.-) (Receptor-type tyrosine-protein phosphatase Q) (PTP-RQ) (R-PTP-Q) (EC 3.1.3.48),2332,"260,924",5 out of 5,2007-09-11,Evidence at protein level
Q15256,PTPRR_HUMAN,Receptor-type tyrosine-protein phosphatase R (R-PTP-R) (EC 3.1.3.48) (Ch-1PTPase) (NC-PTPCOM1) (Protein-tyrosine phosphatase PCPTP1),657,"73,834",5 out of 5,2002-11-15,Evidence at protein level
P30520,PURA2_HUMAN,"Adenylosuccinate synthetase isozyme 2 (AMPSase 2) (AdSS 2) (EC 6.3.4.4) (Adenylosuccinate synthetase, acidic isozyme) (Adenylosuccinate synthetase, liver isozyme) (L-type adenylosuccinate synthetase) (IMP--aspartate ligase 2)",456,"50,097",5 out of 5,1993-04-01,Evidence at protein level
E9PB15,PTG3L_HUMAN,Putative protein PTGES3L (Prostaglandin E synthase 3-like),166,"19,074",2 out of 5,2012-09-05,Uncertain
O14684,PTGES_HUMAN,Prostaglandin E synthase (EC 5.3.99.3) (Microsomal glutathione S-transferase 1-like 1) (MGST1-L1) (Microsomal prostaglandin E synthase 1) (MPGES-1) (p53-induced gene 12 protein),152,"17,102",5 out of 5,2000-05-30,Evidence at protein level
Q9Y3E5,PTH2_HUMAN,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",179,"19,194",5 out of 5,2000-05-30,Evidence at protein level
Q96NR3,PTHD1_HUMAN,Patched domain-containing protein 1,888,"101,341",5 out of 5,2007-03-06,Evidence at transcript level
P20962,PTMS_HUMAN,Parathymosin,102,"11,530",3 out of 5,1991-02-01,Evidence at protein level
Q06124,PTN11_HUMAN,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),597,"68,436",5 out of 5,1994-02-01,Evidence at protein level
Q9Y2R2,PTN22_HUMAN,Tyrosine-protein phosphatase non-receptor type 22 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP) (Lymphoid phosphatase) (LyP) (PEST-domain phosphatase) (PEP),807,"91,705",5 out of 5,2002-03-27,Evidence at protein level
P43378,PTN9_HUMAN,Tyrosine-protein phosphatase non-receptor type 9 (EC 3.1.3.48) (Protein-tyrosine phosphatase MEG2) (PTPase MEG2),593,"68,020",5 out of 5,1995-11-01,Evidence at protein level
O95997,PTTG1_HUMAN,Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein) (Tumor-transforming protein 1) (hPTTG),202,"22,024",5 out of 5,2003-03-25,Evidence at protein level
P26022,PTX3_HUMAN,Pentraxin-related protein PTX3 (Pentaxin-related protein PTX3) (Tumor necrosis factor alpha-induced protein 5) (TNF alpha-induced protein 5) (Tumor necrosis factor-inducible gene 14 protein) (TSG-14),381,"41,976",5 out of 5,1992-05-01,Evidence at protein level
Q14671,PUM1_HUMAN,Pumilio homolog 1 (HsPUM) (Pumilio-1),1186,"126,473",5 out of 5,2004-02-02,Evidence at protein level
Q96QR8,PURB_HUMAN,Transcriptional activator protein Pur-beta (Purine-rich element-binding protein B),312,"33,241",4 out of 5,2006-03-07,Evidence at protein level
Q9Y248,PSF2_HUMAN,DNA replication complex GINS protein PSF2 (GINS complex subunit 2),185,"21,428",5 out of 5,2003-10-24,Evidence at protein level
Q16557,PSG3_HUMAN,Pregnancy-specific beta-1-glycoprotein 3 (PS-beta-G-3) (PSBG-3) (Pregnancy-specific glycoprotein 3) (Carcinoembryonic antigen SG5),428,"47,945",3 out of 5,2000-05-30,Evidence at transcript level
Q13046,PSG7_HUMAN,Putative pregnancy-specific beta-1-glycoprotein 7 (PS-beta-G-7) (PSBG-7) (Pregnancy-specific glycoprotein 7),419,"47,001",3 out of 5,2000-05-30,Uncertain
Q00887,PSG9_HUMAN,Pregnancy-specific beta-1-glycoprotein 9 (PS-beta-G-9) (PSBG-9) (Pregnancy-specific glycoprotein 9) (PS34) (Pregnancy-specific beta-1 glycoprotein B) (PS-beta-B) (Pregnancy-specific beta-1-glycoprotein 11) (PS-beta-G-11) (PSBG-11) (Pregnancy-specific glycoprotein 11) (Pregnancy-specific glycoprotein 7) (PSG7),426,"48,272",4 out of 5,1996-10-01,Evidence at transcript level
Q99460,PSMD1_HUMAN,26S proteasome non-ATPase regulatory subunit 1 (26S proteasome regulatory subunit RPN2) (26S proteasome regulatory subunit S1) (26S proteasome subunit p112),953,"105,836",5 out of 5,1998-12-15,Evidence at protein level
P55036,PSMD4_HUMAN,26S proteasome non-ATPase regulatory subunit 4 (26S proteasome regulatory subunit RPN10) (26S proteasome regulatory subunit S5A) (Antisecretory factor 1) (AF) (ASF) (Multiubiquitin chain-binding protein),377,"40,737",5 out of 5,1996-10-01,Evidence at protein level
O00233,PSMD9_HUMAN,26S proteasome non-ATPase regulatory subunit 9 (26S proteasome regulatory subunit p27),223,"24,682",5 out of 5,1998-12-15,Evidence at protein level
Q5JS54,PSMG4_HUMAN,Proteasome assembly chaperone 4 (PAC-4) (hPAC4),123,"13,775",3 out of 5,2008-06-10,Evidence at transcript level
P60484,PTEN_HUMAN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (EC 3.1.3.16) (EC 3.1.3.48) (EC 3.1.3.67) (Mutated in multiple advanced cancers 1) (Phosphatase and tensin homolog)",403,"47,166",5 out of 5,2004-02-16,Evidence at protein level
P17706,PTN2_HUMAN,Tyrosine-protein phosphatase non-receptor type 2 (EC 3.1.3.48) (T-cell protein-tyrosine phosphatase) (TCPTP),415,"48,473",5 out of 5,1990-08-01,Evidence at protein level
Q96A99,PTX4_HUMAN,Pentraxin-4,478,"52,339",4 out of 5,2008-02-26,Evidence at transcript level
Q15397,PUM3_HUMAN,Pumilio homolog 3 (HBV X-transactivated gene 5 protein) (HBV XAg-transactivated protein 5) (Minor histocompatibility antigen HA-8) (HLA-HA8),648,"73,584",5 out of 5,2000-05-30,Evidence at protein level
Q96PZ0,PUS7_HUMAN,Pseudouridylate synthase 7 homolog (EC 5.4.99.-),661,"75,035",3 out of 5,2003-09-26,Evidence at protein level
Q7Z7A4,PXK_HUMAN,"PX domain-containing protein kinase-like protein (Modulator of Na,K-ATPase) (MONaKA)",578,"64,950",5 out of 5,2005-12-06,Evidence at protein level
P60900,PSA6_HUMAN,Proteasome subunit alpha type-6 (EC 3.4.25.1) (27 kDa prosomal protein) (PROS-27) (p27K) (Macropain iota chain) (Multicatalytic endopeptidase complex iota chain) (Proteasome iota chain),246,"27,399",5 out of 5,2004-04-13,Evidence at protein level
P55786,PSA_HUMAN,Puromycin-sensitive aminopeptidase (PSA) (EC 3.4.11.14) (Cytosol alanyl aminopeptidase) (AAP-S),919,"103,276",5 out of 5,1997-11-01,Evidence at protein level
P49720,PSB3_HUMAN,Proteasome subunit beta type-3 (EC 3.4.25.1) (Proteasome chain 13) (Proteasome component C10-II) (Proteasome theta chain),205,"22,949",5 out of 5,1996-10-01,Evidence at protein level
P28074,PSB5_HUMAN,Proteasome subunit beta type-5 (EC 3.4.25.1) (Macropain epsilon chain) (Multicatalytic endopeptidase complex epsilon chain) (Proteasome chain 6) (Proteasome epsilon chain) (Proteasome subunit MB1) (Proteasome subunit X),263,"28,480",5 out of 5,1992-08-01,Evidence at protein level
Q14997,PSME4_HUMAN,Proteasome activator complex subunit 4 (Proteasome activator PA200),1843,"211,334",5 out of 5,2007-03-20,Evidence at protein level
Q9BT73,PSMG3_HUMAN,Proteasome assembly chaperone 3 (PAC-3) (hPAC3),122,"13,104",3 out of 5,2007-01-09,Evidence at protein level
Q8WXF1,PSPC1_HUMAN,Paraspeckle component 1 (Paraspeckle protein 1),523,"58,744",5 out of 5,2007-08-21,Evidence at protein level
Q05209,PTN12_HUMAN,Tyrosine-protein phosphatase non-receptor type 12 (EC 3.1.3.48) (PTP-PEST) (Protein-tyrosine phosphatase G1) (PTPG1),780,"88,106",5 out of 5,1994-02-01,Evidence at protein level
P21246,PTN_HUMAN,Pleiotrophin (PTN) (Heparin-binding brain mitogen) (HBBM) (Heparin-binding growth factor 8) (HBGF-8) (Heparin-binding growth-associated molecule) (HB-GAM) (Heparin-binding neurite outgrowth-promoting factor 1) (HBNF-1) (Osteoblast-specific factor 1) (OSF-1),168,"18,942",5 out of 5,1991-05-01,Evidence at protein level
Q86YD1,PTOV1_HUMAN,Prostate tumor-overexpressed gene 1 protein (PTOV-1) (Activator interaction domain-containing protein 2),416,"46,869",5 out of 5,2007-10-02,Evidence at protein level
Q8WUK0,PTPM1_HUMAN,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 (EC 3.1.3.27) (PTEN-like phosphatase) (Phosphoinositide lipid phosphatase) (Protein-tyrosine phosphatase mitochondrial 1) (EC 3.1.3.16) (EC 3.1.3.48),201,"22,844",5 out of 5,2005-08-16,Evidence at protein level
P48651,PTSS1_HUMAN,Phosphatidylserine synthase 1 (PSS-1) (PtdSer synthase 1) (EC 2.7.8.29) (Serine-exchange enzyme I),473,"55,528",5 out of 5,1996-02-01,Evidence at protein level
Q9BVG9,PTSS2_HUMAN,Phosphatidylserine synthase 2 (PSS-2) (PtdSer synthase 2) (EC 2.7.8.29) (Serine-exchange enzyme II),487,"56,253",5 out of 5,2004-06-21,Evidence at protein level
Q9NZH4,PTTG3_HUMAN,Putative pituitary tumor-transforming gene 3 protein (hPTTG3) (Securin-3) (rcPTTG1),202,"22,064",3 out of 5,2008-05-20,Uncertain
P53801,PTTG_HUMAN,Pituitary tumor-transforming gene 1 protein-interacting protein (Pituitary tumor-transforming gene protein-binding factor) (PBF) (PTTG-binding factor),180,"20,324",5 out of 5,1996-10-01,Evidence at protein level
Q8IV56,PRR15_HUMAN,Proline-rich protein 15,129,"13,715",2 out of 5,2007-01-09,Evidence at transcript level
A6NJB7,PRR19_HUMAN,Proline-rich protein 19,356,"38,716",2 out of 5,2008-04-29,Evidence at protein level
Q9H6K5,PRR36_HUMAN,Proline-rich protein 36,1346,"132,748",2 out of 5,2008-04-08,Evidence at protein level
C9JH25,PRRT4_HUMAN,Proline-rich transmembrane protein 4,899,"92,712",2 out of 5,2010-06-15,Evidence at transcript level
P54821,PRRX1_HUMAN,Paired mesoderm homeobox protein 1 (Homeobox protein PHOX1) (Paired-related homeobox protein 1) (PRX-1),245,"27,296",5 out of 5,1996-10-01,Evidence at protein level
Q6PEW0,PRS54_HUMAN,Inactive serine protease 54 (Cancer/testis antigen 67) (CT67) (Plasma kallikrein-like protein 4),395,"43,832",3 out of 5,2007-05-29,Evidence at transcript level
P0CW18,PRS56_HUMAN,Serine protease 56 (EC 3.4.21.-),603,"64,597",5 out of 5,2011-05-03,Evidence at protein level
P28072,PSB6_HUMAN,Proteasome subunit beta type-6 (EC 3.4.25.1) (Macropain delta chain) (Multicatalytic endopeptidase complex delta chain) (Proteasome delta chain) (Proteasome subunit Y),239,"25,358",5 out of 5,1992-08-01,Evidence at protein level
P28062,PSB8_HUMAN,Proteasome subunit beta type-8 (EC 3.4.25.1) (Low molecular mass protein 7) (Macropain subunit C13) (Multicatalytic endopeptidase complex subunit C13) (Proteasome component C13) (Proteasome subunit beta-5i) (Really interesting new gene 10 protein),276,"30,354",5 out of 5,1992-08-01,Evidence at protein level
Q06323,PSME1_HUMAN,Proteasome activator complex subunit 1 (11S regulator complex subunit alpha) (REG-alpha) (Activator of multicatalytic protease subunit 1) (Interferon gamma up-regulated I-5111 protein) (IGUP I-5111) (Proteasome activator 28 subunit alpha) (PA28a) (PA28alpha),249,"28,723",5 out of 5,1995-11-01,Evidence at protein level
Q8IYL9,PSYR_HUMAN,Psychosine receptor (G-protein coupled receptor 65) (T-cell death-associated gene 8 protein),337,"39,333",5 out of 5,2003-10-03,Evidence at transcript level
P0DJ07,PT100_HUMAN,"Protein PET100 homolog, mitochondrial",73,"9,114",3 out of 5,2011-10-19,Evidence at protein level
Q9UKA9,PTBP2_HUMAN,Polypyrimidine tract-binding protein 2 (Neural polypyrimidine tract-binding protein) (Neurally-enriched homolog of PTB) (PTB-like protein),531,"57,491",5 out of 5,2006-04-18,Evidence at protein level
Q12923,PTN13_HUMAN,Tyrosine-protein phosphatase non-receptor type 13 (EC 3.1.3.48) (Fas-associated protein-tyrosine phosphatase 1) (FAP-1) (PTP-BAS) (Protein-tyrosine phosphatase 1E) (PTP-E1) (hPTPE1) (Protein-tyrosine phosphatase PTPL1),2485,"276,906",5 out of 5,2000-12-01,Evidence at protein level
Q99952,PTN18_HUMAN,Tyrosine-protein phosphatase non-receptor type 18 (EC 3.1.3.48) (Brain-derived phosphatase),460,"50,482",5 out of 5,2002-03-27,Evidence at protein level
Q4JDL3,PTN20_HUMAN,Tyrosine-protein phosphatase non-receptor type 20 (hPTPN20) (EC 3.1.3.48),420,"48,423",5 out of 5,2007-07-24,Evidence at protein level
Q9H3S7,PTN23_HUMAN,Tyrosine-protein phosphatase non-receptor type 23 (EC 3.1.3.48) (His domain-containing protein tyrosine phosphatase) (HD-PTP) (Protein tyrosine phosphatase TD14) (PTP-TD14),1636,"178,974",5 out of 5,2005-06-21,Evidence at protein level
P23467,PTPRB_HUMAN,Receptor-type tyrosine-protein phosphatase beta (Protein-tyrosine phosphatase beta) (R-PTP-beta) (EC 3.1.3.48) (Vascular endothelial protein tyrosine phosphatase) (VE-PTP),1997,"224,301",5 out of 5,1991-11-01,Evidence at protein level
Q9HD43,PTPRH_HUMAN,Receptor-type tyrosine-protein phosphatase H (R-PTP-H) (EC 3.1.3.48) (Stomach cancer-associated protein tyrosine phosphatase 1) (SAP-1) (Transmembrane-type protein-tyrosine phosphatase type H),1115,"122,352",5 out of 5,2008-02-26,Evidence at protein level
O14522,PTPRT_HUMAN,Receptor-type tyrosine-protein phosphatase T (R-PTP-T) (EC 3.1.3.48) (Receptor-type tyrosine-protein phosphatase rho) (RPTP-rho),1441,"162,134",5 out of 5,2003-07-19,Evidence at protein level
Q03393,PTPS_HUMAN,6-pyruvoyl tetrahydrobiopterin synthase (PTP synthase) (PTPS) (EC 4.2.3.12),145,"16,386",5 out of 5,1993-10-01,Evidence at protein level
Q6NZI2,PTRF_HUMAN,Polymerase I and transcript release factor (Cavin-1),390,"43,476",5 out of 5,2004-12-21,Evidence at protein level
Q8TB72,PUM2_HUMAN,Pumilio homolog 2 (Pumilio-2),1066,"114,216",5 out of 5,2004-02-02,Evidence at protein level
Q13278,RIG_HUMAN,Putative protein RIG (Protein regulated in glioma),110,"11,984",2 out of 5,2008-09-02,Uncertain
Q9UJD0,RIMS3_HUMAN,Regulating synaptic membrane exocytosis protein 3 (Nim3) (RIM3 gamma) (Rab-3-interacting molecule 3) (RIM 3),308,"32,796",4 out of 5,2004-01-16,Evidence at protein level
Q06587,RING1_HUMAN,E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein),406,"42,429",5 out of 5,1994-06-01,Evidence at protein level
Q9BRS2,RIOK1_HUMAN,Serine/threonine-protein kinase RIO1 (EC 2.7.11.1) (EC 3.6.3.-) (RIO kinase 1),568,"65,583",5 out of 5,2004-12-07,Evidence at protein level
Q96HR9,REEP6_HUMAN,Receptor expression-enhancing protein 6 (Polyposis locus protein 1-like 1),211,"23,418",5 out of 5,2005-12-20,Evidence at protein level
P05451,REG1A_HUMAN,Lithostathine-1-alpha (Islet cells regeneration factor) (ICRF) (Islet of Langerhans regenerating protein) (REG) (Pancreatic stone protein) (PSP) (Pancreatic thread protein) (PTP) (Regenerating islet-derived protein 1-alpha) (REG-1-alpha) (Regenerating protein I alpha),166,"18,731",5 out of 5,1988-11-01,Evidence at protein level
Q8N1G1,REXO1_HUMAN,RNA exonuclease 1 homolog (EC 3.1.-.-) (Elongin-A-binding protein 1) (EloA-BP1) (Transcription elongation factor B polypeptide 3-binding protein 1),1221,"131,510",5 out of 5,2006-05-30,Evidence at protein level
Q6WKZ4,RFIP1_HUMAN,Rab11 family-interacting protein 1 (Rab11-FIP1) (Rab-coupling protein),1283,"137,167",5 out of 5,2005-05-10,Evidence at protein level
Q9BXF6,RFIP5_HUMAN,Rab11 family-interacting protein 5 (Rab11-FIP5) (Gamma-SNAP-associated factor 1) (Gaf-1) (Phosphoprotein pp75) (Rab11-interacting protein Rip11),653,"70,415",5 out of 5,2003-08-22,Evidence at protein level
Q6ZTI6,RFLA_HUMAN,Refilin-A (Regulator of filamin protein A) (RefilinA),216,"23,610",3 out of 5,2007-02-06,Evidence at protein level
A6NFN3,RFOX3_HUMAN,RNA binding protein fox-1 homolog 3 (Fox-1 homolog C) (Neuronal nuclei antigen) (NeuN antigen),312,"33,873",4 out of 5,2008-09-02,Evidence at transcript level
Q6ZWI9,RFPLB_HUMAN,Ret finger protein-like 4B (RING finger protein 211),263,"29,922",2 out of 5,2007-02-06,Evidence at transcript level
P0DJD1,RGPD2_HUMAN,RANBP2-like and GRIP domain-containing protein 2 (Ran-binding protein 2-like 2) (RanBP2-like 2) (RanBP2L2),1756,"197,308",2 out of 5,2012-01-25,Evidence at transcript level
Q5JS13,RGPS1_HUMAN,Ras-specific guanine nucleotide-releasing factor RalGPS1 (Ral GEF with PH domain and SH3-binding motif 1) (Ral guanine nucleotide exchange factor 2) (RalGEF 2) (RalA exchange factor RalGPS1),557,"62,133",5 out of 5,2008-05-20,Evidence at protein level
O94844,RHBT1_HUMAN,Rho-related BTB domain-containing protein 1,696,"79,417",3 out of 5,2002-11-28,Evidence at transcript level
Q96CC6,RHDF1_HUMAN,Inactive rhomboid protein 1 (iRhom1) (Epidermal growth factor receptor-related protein) (Rhomboid 5 homolog 1) (Rhomboid family member 1) (p100hRho),855,"97,401",5 out of 5,2008-06-10,Evidence at protein level
P98171,RHG04_HUMAN,Rho GTPase-activating protein 4 (Rho-GAP hematopoietic protein C1) (Rho-type GTPase-activating protein 4) (p115),946,"105,026",5 out of 5,1996-10-01,Evidence at protein level
Q9C0H5,RHG39_HUMAN,Rho GTPase-activating protein 39,1083,"121,286",3 out of 5,2003-02-12,Evidence at protein level
Q3KRB8,RHGBB_HUMAN,Rho GTPase-activating protein 11B (Protein FAM7B1) (Rho-type GTPase-activating protein 11B),267,"30,251",3 out of 5,2008-02-05,Evidence at transcript level
P08134,RHOC_HUMAN,Rho-related GTP-binding protein RhoC (Rho cDNA clone 9) (h9),193,"22,006",5 out of 5,1988-08-01,Evidence at protein level
Q15669,RHOH_HUMAN,Rho-related GTP-binding protein RhoH (GTP-binding protein TTF) (Translocation three four protein),191,"21,331",5 out of 5,1997-11-01,Evidence at protein level
Q9H426,RIMS4_HUMAN,Regulating synaptic membrane exocytosis protein 4 (RIM4 gamma) (Rab3-interacting molecule 4) (RIM 4),269,"29,329",4 out of 5,2004-01-16,Evidence at protein level
Q99496,RING2_HUMAN,E3 ubiquitin-protein ligase RING2 (EC 2.3.2.27) (Huntingtin-interacting protein 2-interacting protein 3) (HIP2-interacting protein 3) (Protein DinG) (RING finger protein 1B) (RING1b) (RING finger protein 2) (RING finger protein BAP-1) (RING-type E3 ubiquitin transferase RING2),336,"37,655",5 out of 5,2005-04-26,Evidence at protein level
Q15835,RK_HUMAN,Rhodopsin kinase (RK) (EC 2.7.11.14) (G protein-coupled receptor kinase 1),563,"63,526",5 out of 5,1997-11-01,Evidence at protein level
P30050,RL12_HUMAN,60S ribosomal protein L12 (Large ribosomal subunit protein uL11),165,"17,819",5 out of 5,1993-04-01,Evidence at protein level
P61313,RL15_HUMAN,60S ribosomal protein L15 (Large ribosomal subunit protein eL15),204,"24,146",5 out of 5,2004-05-10,Evidence at protein level
Q9NVN3,RIC8B_HUMAN,Synembryn-B (Brain synembryn) (hSyn) (Protein Ric-8B),520,"58,825",5 out of 5,2006-05-16,Evidence at protein level
Q6R327,RICTR_HUMAN,Rapamycin-insensitive companion of mTOR (AVO3 homolog) (hAVO3),1708,"192,218",5 out of 5,2007-10-23,Evidence at protein level
A6NJZ7,RIM3C_HUMAN,RIMS-binding protein 3C (RIM-BP3.C) (RIMS-binding protein 3.3) (RIM-BP3.3),1639,"180,950",3 out of 5,2008-04-29,Evidence at protein level
Q8IXN7,RIMKA_HUMAN,N-acetylaspartylglutamate synthase A (NAAG synthetase A) (NAAGS) (EC 6.3.2.41) (N-acetylaspartylglutamylglutamate synthase A) (EC 6.3.2.42) (Ribosomal protein S6 modification-like protein A),391,"42,864",4 out of 5,2007-04-03,Evidence at transcript level
Q9ULI2,RIMKB_HUMAN,Beta-citrylglutamate synthase B (EC 6.3.1.17) (N-acetyl-aspartylglutamate synthetase B) (NAAG synthetase B) (NAAGS) (EC 6.3.2.41) (Ribosomal protein S6 modification-like protein B),386,"42,464",4 out of 5,2007-04-03,Evidence at transcript level
Q86UR5,RIMS1_HUMAN,Regulating synaptic membrane exocytosis protein 1 (Rab-3-interacting molecule 1) (RIM 1) (Rab-3-interacting protein 2),1692,"189,073",5 out of 5,2003-08-29,Evidence at protein level
Q13546,RIPK1_HUMAN,Receptor-interacting serine/threonine-protein kinase 1 (EC 2.7.11.1) (Cell death protein RIP) (Receptor-interacting protein 1) (RIP-1) (Serine/threonine-protein kinase RIP),671,"75,931",5 out of 5,1997-11-01,Evidence at protein level
Q0D2K3,RIPP1_HUMAN,Protein ripply1,151,"16,379",4 out of 5,2007-10-23,Evidence at protein level
P50914,RL14_HUMAN,60S ribosomal protein L14 (CAG-ISL 7) (Large ribosomal subunit protein eL14),215,"23,432",5 out of 5,1996-10-01,Evidence at protein level
Q9H4K1,RIBC2_HUMAN,RIB43A-like with coiled-coils protein 2,309,"37,060",2 out of 5,2006-10-31,Evidence at protein level
A6NNM3,RIM3B_HUMAN,RIMS-binding protein 3B (RIM-BP3.B) (RIMS-binding protein 3.2) (RIM-BP3.2),1639,"180,952",2 out of 5,2008-04-29,Inferred from homology
O14730,RIOK3_HUMAN,Serine/threonine-protein kinase RIO3 (EC 2.7.11.1) (RIO kinase 3) (sudD homolog),519,"59,093",5 out of 5,2004-12-07,Evidence at protein level
P57078,RIPK4_HUMAN,Receptor-interacting serine/threonine-protein kinase 4 (EC 2.7.11.1) (Ankyrin repeat domain-containing protein 3) (PKC-delta-interacting protein kinase),832,"91,611",5 out of 5,2000-12-01,Evidence at protein level
Q969X0,RIPL2_HUMAN,RILP-like protein 2 (Rab-interacting lysosomal protein-like 2) (p40phox-binding protein),211,"23,986",5 out of 5,2008-02-05,Evidence at protein level
Q5TAB7,RIPP2_HUMAN,Protein ripply2,128,"13,906",4 out of 5,2007-10-23,Evidence at protein level
P26373,RL13_HUMAN,60S ribosomal protein L13 (Breast basic conserved protein 1) (Large ribosomal subunit protein eL13),211,"24,261",5 out of 5,1992-08-01,Evidence at protein level
P84098,RL19_HUMAN,60S ribosomal protein L19 (Large ribosomal subunit protein eL19),196,"23,466",5 out of 5,2004-08-16,Evidence at protein level
P18621,RL17_HUMAN,60S ribosomal protein L17 (60S ribosomal protein L23) (Large ribosomal subunit protein uL22) (PD-1),184,"21,397",5 out of 5,1990-11-01,Evidence at protein level
P62829,RL23_HUMAN,60S ribosomal protein L23 (60S ribosomal protein L17) (Large ribosomal subunit protein uL14),140,"14,865",5 out of 5,2004-08-16,Evidence at protein level
P46776,RL27A_HUMAN,60S ribosomal protein L27a (Large ribosomal subunit protein uL15),148,"16,561",5 out of 5,1995-11-01,Evidence at protein level
P47914,RL29_HUMAN,60S ribosomal protein L29 (Cell surface heparin-binding protein HIP) (Large ribosomal subunit protein eL29),159,"17,752",5 out of 5,1996-02-01,Evidence at protein level
P62899,RL31_HUMAN,60S ribosomal protein L31 (Large ribosomal subunit protein eL31),125,"14,463",5 out of 5,2004-08-31,Evidence at protein level
Q13671,RIN1_HUMAN,Ras and Rab interactor 1 (Ras inhibitor JC99) (Ras interaction/interference protein 1),783,"84,099",5 out of 5,1997-11-01,Evidence at protein level
Q8TB24,RIN3_HUMAN,Ras and Rab interactor 3 (Ras interaction/interference protein 3),985,"107,854",5 out of 5,2003-02-01,Evidence at protein level
P13489,RINI_HUMAN,Ribonuclease inhibitor (Placental ribonuclease inhibitor) (Placental RNase inhibitor) (Ribonuclease/angiogenin inhibitor 1) (RAI),461,"49,973",5 out of 5,1990-01-01,Evidence at protein level
Q6NUQ1,RINT1_HUMAN,RAD50-interacting protein 1 (RAD50 interactor 1) (HsRINT-1) (RINT-1),792,"90,632",5 out of 5,2005-02-01,Evidence at protein level
Q9Y572,RIPK3_HUMAN,Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3),518,"56,887",5 out of 5,2002-05-02,Evidence at protein level
Q9HB40,RISC_HUMAN,Retinoid-inducible serine carboxypeptidase (EC 3.4.16.-) (Serine carboxypeptidase 1),452,"50,831",4 out of 5,2003-02-28,Evidence at protein level
Q99578,RIT2_HUMAN,GTP-binding protein Rit2 (Ras-like protein expressed in neurons) (Ras-like without CAAX protein 2),217,"24,668",5 out of 5,2003-10-31,Evidence at protein level
Q96L21,RL10L_HUMAN,60S ribosomal protein L10-like (Large ribosomal subunit protein uL16-like),214,"24,519",3 out of 5,2005-01-04,Evidence at protein level
P40429,RL13A_HUMAN,60S ribosomal protein L13a (23 kDa highly basic protein) (Large ribosomal subunit protein uL13),203,"23,577",5 out of 5,1995-02-01,Evidence at protein level
Q07020,RL18_HUMAN,60S ribosomal protein L18 (Large ribosomal subunit protein eL18),188,"21,634",5 out of 5,1994-06-01,Evidence at protein level
P46778,RL21_HUMAN,60S ribosomal protein L21 (Large ribosomal subunit protein eL21),160,"18,565",5 out of 5,1995-11-01,Evidence at protein level
P83731,RL24_HUMAN,60S ribosomal protein L24 (60S ribosomal protein L30) (Large ribosomal subunit protein eL24),157,"17,779",5 out of 5,2004-01-16,Evidence at protein level
Q9BVS4,RIOK2_HUMAN,Serine/threonine-protein kinase RIO2 (EC 2.7.11.1) (RIO kinase 2),552,"63,283",5 out of 5,2004-12-07,Evidence at protein level
P62913,RL11_HUMAN,60S ribosomal protein L11 (CLL-associated antigen KW-12) (Large ribosomal subunit protein uL5),178,"20,252",5 out of 5,2004-08-31,Evidence at protein level
Q6P5R6,RL22L_HUMAN,60S ribosomal protein L22-like 1 (Large ribosomal subunit protein eL22-like 1),122,"14,607",2 out of 5,2006-06-27,Evidence at protein level
Q02543,RL18A_HUMAN,60S ribosomal protein L18a (Large ribosomal subunit protein eL20),176,"20,762",5 out of 5,1994-06-01,Evidence at protein level
O76021,RL1D1_HUMAN,Ribosomal L1 domain-containing protein 1 (CATX-11) (Cellular senescence-inhibited gene protein) (Protein PBK1),490,"54,973",5 out of 5,2005-04-26,Evidence at protein level
Q9UNX3,RL26L_HUMAN,60S ribosomal protein L26-like 1 (Large ribosomal subunit protein uL24-like 1),145,"17,256",2 out of 5,2002-09-19,Evidence at protein level
Q9NSD7,RL3R1_HUMAN,Relaxin-3 receptor 1 (RLN3 receptor 1) (G protein-coupled receptor SALPR) (G-protein coupled receptor GPCR135) (Relaxin family peptide receptor 3) (Somatostatin- and angiotensin-like peptide receptor),469,"51,124",5 out of 5,2002-05-02,Evidence at protein level
P62888,RL30_HUMAN,60S ribosomal protein L30 (Large ribosomal subunit protein eL30),115,"12,784",5 out of 5,1987-08-13,Evidence at protein level
P42766,RL35_HUMAN,60S ribosomal protein L35 (Large ribosomal subunit protein uL29),123,"14,551",5 out of 5,1995-11-01,Evidence at protein level
P62945,RL41_HUMAN,60S ribosomal protein L41 (HG12) (Large ribosomal subunit protein eL41),25,"3,456",4 out of 5,2004-08-31,Evidence at protein level
P32969,RL9_HUMAN,60S ribosomal protein L9 (Large ribosomal subunit protein uL6),192,"21,863",5 out of 5,1993-10-01,Evidence at protein level
P61353,RL27_HUMAN,60S ribosomal protein L27 (Large ribosomal subunit protein eL27),136,"15,798",5 out of 5,1988-08-01,Evidence at protein level
P62910,RL32_HUMAN,60S ribosomal protein L32 (Large ribosomal subunit protein eL32),135,"15,860",4 out of 5,1986-07-21,Evidence at protein level
P62891,RL39_HUMAN,60S ribosomal protein L39 (Large ribosomal subunit protein eL39),51,"6,407",5 out of 5,1986-07-21,Evidence at protein level
P35268,RL22_HUMAN,60S ribosomal protein L22 (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15) (Large ribosomal subunit protein eL22),128,"14,787",5 out of 5,1994-02-01,Evidence at protein level
P46777,RL5_HUMAN,60S ribosomal protein L5 (Large ribosomal subunit protein uL18),297,"34,363",5 out of 5,1995-11-01,Evidence at protein level
P46779,RL28_HUMAN,60S ribosomal protein L28 (Large ribosomal subunit protein eL28),137,"15,748",5 out of 5,1995-11-01,Evidence at protein level
P61254,RL26_HUMAN,60S ribosomal protein L26 (Large ribosomal subunit protein uL24),145,"17,258",5 out of 5,2004-05-10,Evidence at protein level
P61927,RL37_HUMAN,60S ribosomal protein L37 (G1.16) (Large ribosomal subunit protein eL37),97,"11,078",5 out of 5,1986-07-21,Evidence at protein level
P62917,RL8_HUMAN,60S ribosomal protein L8 (Large ribosomal subunit protein uL2),257,"28,025",5 out of 5,2004-08-31,Evidence at protein level
P05387,RLA2_HUMAN,60S acidic ribosomal protein P2 (Large ribosomal subunit protein P2) (Renal carcinoma antigen NY-REN-44),115,"11,665",5 out of 5,1988-11-01,Evidence at protein level
Q86X10,RLGPB_HUMAN,Ral GTPase-activating protein subunit beta (p170),1494,"166,799",3 out of 5,2004-03-15,Evidence at protein level
P62750,RL23A_HUMAN,60S ribosomal protein L23a (Large ribosomal subunit protein uL23),156,"17,695",5 out of 5,2004-08-16,Evidence at protein level
P49207,RL34_HUMAN,60S ribosomal protein L34 (Large ribosomal subunit protein eL34),117,"13,293",5 out of 5,1996-02-01,Evidence at protein level
P61513,RL37A_HUMAN,60S ribosomal protein L37a (Large ribosomal subunit protein eL43),92,"10,275",5 out of 5,2004-05-24,Evidence at protein level
P62701,RS4X_HUMAN,"40S ribosomal protein S4, X isoform (SCR10) (Single copy abundant mRNA protein) (Small ribosomal subunit protein eS4)",263,"29,598",5 out of 5,2004-07-19,Evidence at protein level
Q9Y2R9,RT07_HUMAN,"28S ribosomal protein S7, mitochondrial (MRP-S7) (S7mt) (Mitochondrial small ribosomal subunit protein uS7m) (bMRP-27a) (bMRP27a)",242,"28,134",4 out of 5,2007-01-23,Evidence at protein level
P62263,RS14_HUMAN,40S ribosomal protein S14 (Small ribosomal subunit protein uS11),151,"16,273",5 out of 5,1988-01-01,Evidence at protein level
P62244,RS15A_HUMAN,40S ribosomal protein S15a (Small ribosomal subunit protein uS8),130,"14,840",5 out of 5,2004-07-05,Evidence at protein level
P62249,RS16_HUMAN,40S ribosomal protein S16 (Small ribosomal subunit protein uS9),146,"16,445",5 out of 5,2004-07-05,Evidence at protein level
P23396,RS3_HUMAN,40S ribosomal protein S3 (EC 4.2.99.18) (Small ribosomal subunit protein uS3),243,"26,688",5 out of 5,1991-11-01,Evidence at protein level
P22090,RS4Y1_HUMAN,"40S ribosomal protein S4, Y isoform 1 (Small ribosomal subunit protein eS4)",263,"29,456",5 out of 5,1991-08-01,Evidence at protein level
Q96T23,RSF1_HUMAN,Remodeling and spacing factor 1 (Rsf-1) (HBV pX-associated protein 8) (Hepatitis B virus X-associated protein) (p325 subunit of RSF chromatin-remodeling complex),1441,"163,821",5 out of 5,2005-01-04,Evidence at protein level
Q9H0K4,RSH6A_HUMAN,Radial spoke head protein 6 homolog A (Radial spoke head-like protein 1),717,"80,913",2 out of 5,2007-12-04,Evidence at transcript level
Q9BPW5,RSLBB_HUMAN,Ras-like protein family member 11B,248,"27,508",3 out of 5,2007-10-23,Evidence at transcript level
P62269,RS18_HUMAN,40S ribosomal protein S18 (Ke-3) (Ke3) (Small ribosomal subunit protein uS13),152,"17,719",5 out of 5,2004-07-05,Evidence at protein level
Q71UM5,RS27L_HUMAN,40S ribosomal protein S27-like (Small ribosomal subunit protein eS27-like),84,"9,477",5 out of 5,2004-08-16,Evidence at protein level
P61247,RS3A_HUMAN,40S ribosomal protein S3a (Small ribosomal subunit protein eS1) (v-fos transformation effector protein) (Fte-1),264,"29,945",5 out of 5,2004-05-10,Evidence at protein level
Q9H1X1,RSPH9_HUMAN,Radial spoke head protein 9 homolog,276,"31,292",4 out of 5,2005-08-30,Evidence at protein level
P08708,RS17_HUMAN,40S ribosomal protein S17 (Small ribosomal subunit protein eS17),135,"15,550",5 out of 5,1988-01-01,Evidence at protein level
P39019,RS19_HUMAN,40S ribosomal protein S19 (Small ribosomal subunit protein eS19),145,"16,060",5 out of 5,1995-02-01,Evidence at protein level
Q5JNZ5,RS26L_HUMAN,Putative 40S ribosomal protein S26-like 1,115,"13,002",2 out of 5,2007-01-09,Uncertain
P62861,RS30_HUMAN,40S ribosomal protein S30 (Small ribosomal subunit protein eS30),59,"6,648",5 out of 5,2004-08-16,Evidence at protein level
P46781,RS9_HUMAN,40S ribosomal protein S9 (Small ribosomal subunit protein uS4),194,"22,591",5 out of 5,1995-11-01,Evidence at protein level
Q8WXG1,RSAD2_HUMAN,"Radical S-adenosyl methionine domain-containing protein 2 (Cytomegalovirus-induced gene 5 protein) (Viperin) (Virus inhibitory protein, endoplasmic reticulum-associated, interferon-inducible)",361,"42,170",5 out of 5,2007-11-13,Evidence at protein level
Q5VZM2,RRAGB_HUMAN,Ras-related GTP-binding protein B (Rag B) (RagB),374,"43,250",5 out of 5,2006-06-13,Evidence at protein level
P60866,RS20_HUMAN,40S ribosomal protein S20 (Small ribosomal subunit protein uS10),119,"13,373",5 out of 5,2004-04-13,Evidence at protein level
P62280,RS11_HUMAN,40S ribosomal protein S11 (Small ribosomal subunit protein uS17),158,"18,431",5 out of 5,1987-08-13,Evidence at protein level
P62841,RS15_HUMAN,40S ribosomal protein S15 (RIG protein) (Small ribosomal subunit protein uS19),145,"17,040",5 out of 5,2004-08-16,Evidence at protein level
P62979,RS27A_HUMAN,Ubiquitin-40S ribosomal protein S27a (Ubiquitin carboxyl extension protein 80) [Cleaved into: Ubiquitin; 40S ribosomal protein S27a (Small ribosomal subunit protein eS31)],156,"17,965",5 out of 5,2004-08-31,Evidence at protein level
P46782,RS5_HUMAN,"40S ribosomal protein S5 (Small ribosomal subunit protein uS7) [Cleaved into: 40S ribosomal protein S5, N-terminally processed]",204,"22,876",5 out of 5,1995-11-01,Evidence at protein level
P62847,RS24_HUMAN,40S ribosomal protein S24 (Small ribosomal subunit protein eS24),133,"15,423",5 out of 5,2004-08-16,Evidence at protein level
Q9UHP6,RSP14_HUMAN,Radial spoke head 14 homolog (Rhabdoid tumor deletion region protein 1),348,"38,592",4 out of 5,2003-03-25,Evidence at protein level
Q9BUV0,RSRP1_HUMAN,Arginine/serine-rich protein 1,290,"33,613",3 out of 5,2007-08-21,Evidence at protein level
P08865,RSSA_HUMAN,40S ribosomal protein SA (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (67 kDa laminin receptor) (67LR) (Colon carcinoma laminin-binding protein) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) (Multidrug resistance-associated protein MGr1-Ag) (NEM/1CHD4) (Small ribosomal subunit protein uS2),295,"32,854",5 out of 5,1988-11-01,Evidence at protein level
P82912,RT11_HUMAN,"28S ribosomal protein S11, mitochondrial (MRP-S11) (S11mt) (Cervical cancer proto-oncogene 2 protein) (HCC-2) (Mitochondrial small ribosomal subunit protein uS11m)",194,"20,616",5 out of 5,2002-05-27,Evidence at protein level
Q9Y2R5,RT17_HUMAN,"28S ribosomal protein S17, mitochondrial (MRP-S17) (S17mt) (Mitochondrial small ribosomal subunit protein uS17m)",130,"14,502",4 out of 5,2001-04-27,Evidence at protein level
Q9Y291,RT33_HUMAN,"28S ribosomal protein S33, mitochondrial (MRP-S33) (S33mt) (Mitochondrial small ribosomal subunit protein mS33)",106,"12,629",3 out of 5,2002-10-19,Evidence at protein level
P62851,RS25_HUMAN,40S ribosomal protein S25 (Small ribosomal subunit protein eS25),125,"13,742",5 out of 5,2004-08-16,Evidence at protein level
Q5VWQ0,RSBN1_HUMAN,Round spermatid basic protein 1,802,"90,072",3 out of 5,2007-09-11,Evidence at protein level
Q5TD94,RSH4A_HUMAN,Radial spoke head protein 4 homolog A (Radial spoke head-like protein 3),716,"80,733",5 out of 5,2008-01-15,Evidence at protein level
Q2MKA7,RSPO1_HUMAN,R-spondin-1 (Roof plate-specific spondin-1) (hRspo1),263,"28,959",5 out of 5,2006-05-16,Evidence at protein level
P82914,RT15_HUMAN,"28S ribosomal protein S15, mitochondrial (MRP-S15) (S15mt) (Mitochondrial small ribosomal subunit protein uS15m)",257,"29,842",5 out of 5,2001-04-27,Evidence at protein level
Q9BYN8,RT26_HUMAN,"28S ribosomal protein S26, mitochondrial (MRP-S26) (S26mt) (28S ribosomal protein S13, mitochondrial) (MRP-S13) (S13mt) (Mitochondrial small ribosomal subunit protein mS26)",205,"24,212",4 out of 5,2003-02-01,Evidence at protein level
Q9HA92,RSAD1_HUMAN,"Radical S-adenosyl methionine domain-containing protein 1, mitochondrial (EC 1.3.99.-) (Oxygen-independent coproporphyrinogen-III oxidase-like protein RSAD1)",442,"48,714",4 out of 5,2007-04-17,Evidence at transcript level
Q6PCB5,RSBNL_HUMAN,Round spermatid basic protein 1-like protein,846,"94,870",3 out of 5,2007-09-11,Evidence at protein level
Q9BU20,RSG1_HUMAN,REM2- and Rab-like small GTPase 1,258,"28,498",4 out of 5,2007-04-17,Evidence at protein level
Q6UXX9,RSPO2_HUMAN,R-spondin-2 (Roof plate-specific spondin-2) (hRspo2),243,"28,315",5 out of 5,2006-05-16,Evidence at protein level
Q2I0M5,RSPO4_HUMAN,R-spondin-4 (Roof plate-specific spondin-4) (hRspo4),234,"26,171",5 out of 5,2006-05-16,Evidence at protein level
Q15404,RSU1_HUMAN,Ras suppressor protein 1 (RSP-1) (Rsu-1),277,"31,540",4 out of 5,1997-11-01,Evidence at protein level
P82921,RT21_HUMAN,"28S ribosomal protein S21, mitochondrial (MRP-S21) (S21mt) (Mitochondrial small ribosomal subunit protein bS21m)",87,"10,742",4 out of 5,2001-05-04,Evidence at protein level
P51398,RT29_HUMAN,"28S ribosomal protein S29, mitochondrial (MRP-S29) (S29mt) (Death-associated protein 3) (DAP-3) (Ionizing radiation resistance conferring protein) (Mitochondrial small ribosomal subunit protein mS29)",398,"45,566",5 out of 5,1996-10-01,Evidence at protein level
Q9BQQ7,RTP3_HUMAN,Receptor-transporting protein 3 (3CxxC-type zinc finger protein 3) (Transmembrane protein 7),232,"27,031",4 out of 5,2002-10-10,Evidence at protein level
Q9H714,RUBCL_HUMAN,Protein RUBCNL-like,662,"73,457",3 out of 5,2005-07-19,Evidence at protein level
Q96CM3,RUSD4_HUMAN,RNA pseudouridylate synthase domain-containing protein 4,377,"42,205",3 out of 5,2007-09-11,Evidence at protein level
P62854,RS26_HUMAN,40S ribosomal protein S26 (Small ribosomal subunit protein eS26),115,"13,015",5 out of 5,2004-08-16,Evidence at protein level
P62273,RS29_HUMAN,40S ribosomal protein S29 (Small ribosomal subunit protein uS14),56,"6,677",5 out of 5,2004-07-05,Evidence at protein level
P62753,RS6_HUMAN,40S ribosomal protein S6 (Phosphoprotein NP33) (Small ribosomal subunit protein eS6),249,"28,681",5 out of 5,1988-08-01,Evidence at protein level
Q9Y3D3,RT16_HUMAN,"28S ribosomal protein S16, mitochondrial (MRP-S16) (S16mt) (Mitochondrial small ribosomal subunit protein bS16m)",137,"15,345",5 out of 5,2001-04-27,Evidence at protein level
Q9Y3D9,RT23_HUMAN,"28S ribosomal protein S23, mitochondrial (MRP-S23) (S23mt) (Mitochondrial small ribosomal subunit protein mS23)",190,"21,771",5 out of 5,2000-05-30,Evidence at protein level
P82673,RT35_HUMAN,"28S ribosomal protein S35, mitochondrial (MRP-S35) (S35mt) (28S ribosomal protein S28, mitochondrial) (MRP-S28) (S28mt) (Mitochondrial small ribosomal subunit protein mS35)",323,"36,844",4 out of 5,2006-02-07,Evidence at protein level
O00442,RTCA_HUMAN,RNA 3'-terminal phosphate cyclase (RNA cyclase) (RNA-3'-phosphate cyclase) (EC 6.5.1.4) (RNA terminal phosphate cyclase domain-containing protein 1) (RTC domain-containing protein 1),366,"39,337",5 out of 5,1997-11-01,Evidence at protein level
A6NKG5,RTL1_HUMAN,Retrotransposon-like protein 1 (Mammalian retrotransposon derived protein 1) (Paternally expressed gene 11 protein) (Retrotransposon-derived protein PEG11),1358,"155,048",2 out of 5,2008-06-10,Inferred from homology
P59025,RTP1_HUMAN,Receptor-transporting protein 1 (3CxxC-type zinc finger protein 1),263,"30,913",4 out of 5,2002-10-10,Evidence at transcript level
Q14D33,RTP5_HUMAN,Receptor-transporting protein 5 (3CxxC-type zinc finger protein 5) (CXXC-type zinc finger protein 11),572,"60,488",5 out of 5,2008-09-02,Evidence at protein level
P09234,RU1C_HUMAN,U1 small nuclear ribonucleoprotein C (U1 snRNP C) (U1-C) (U1C),159,"17,394",5 out of 5,1989-07-01,Evidence at protein level
Q6ZNE9,RUFY4_HUMAN,RUN and FYVE domain-containing protein 4,571,"64,350",2 out of 5,2007-04-17,Evidence at protein level
Q9UJJ7,RUSD1_HUMAN,RNA pseudouridylate synthase domain-containing protein 1 (Ribosomal large subunit pseudouridine synthase C-like protein),312,"34,756",3 out of 5,2007-09-11,Evidence at protein level
P62306,RUXF_HUMAN,Small nuclear ribonucleoprotein F (snRNP-F) (Sm protein F) (Sm-F) (SmF),86,"9,725",5 out of 5,2004-07-05,Evidence at protein level
P57060,RWD2B_HUMAN,RWD domain-containing protein 2B,319,"36,332",3 out of 5,2000-12-01,Evidence at protein level
Q6NW29,RWDD4_HUMAN,RWD domain-containing protein 4 (Protein FAM28A),188,"21,251",3 out of 5,2006-01-24,Evidence at protein level
P28702,RXRB_HUMAN,Retinoic acid receptor RXR-beta (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta),533,"56,922",5 out of 5,1992-12-01,Evidence at protein level
P34925,RYK_HUMAN,Tyrosine-protein kinase RYK (EC 2.7.10.1),604,"67,507",5 out of 5,1994-02-01,Evidence at protein level
Q15413,RYR3_HUMAN,Ryanodine receptor 3 (RYR-3) (RyR3) (Brain ryanodine receptor-calcium release channel) (Brain-type ryanodine receptor) (Type 3 ryanodine receptor),4870,"552,042",5 out of 5,2001-09-26,Evidence at protein level
P29377,S100G_HUMAN,"Protein S100-G (Calbindin-D9k) (S100 calcium-binding protein G) (Vitamin D-dependent calcium-binding protein, intestinal) (CABP)",79,"9,016",3 out of 5,1992-12-01,Inferred from homology
P25815,S100P_HUMAN,Protein S100-P (Migration-inducing gene 9 protein) (MIG9) (Protein S100-E) (S100 calcium-binding protein P),95,"10,400",5 out of 5,1992-05-01,Evidence at protein level
P29034,S10A2_HUMAN,Protein S100-A2 (CAN19) (Protein S-100L) (S100 calcium-binding protein A2),98,"11,117",5 out of 5,1992-12-01,Evidence at protein level
P26447,S10A4_HUMAN,Protein S100-A4 (Calvasculin) (Metastasin) (Placental calcium-binding protein) (Protein Mts1) (S100 calcium-binding protein A4),101,"11,729",5 out of 5,1992-08-01,Evidence at protein level
P31151,S10A7_HUMAN,Protein S100-A7 (Psoriasin) (S100 calcium-binding protein A7),101,"11,471",5 out of 5,1993-07-01,Evidence at protein level
P06702,S10A9_HUMAN,Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9),114,"13,242",5 out of 5,1988-01-01,Evidence at protein level
P55011,S12A2_HUMAN,Solute carrier family 12 member 2 (Basolateral Na-K-Cl symporter) (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1),1212,"131,447",5 out of 5,1996-10-01,Evidence at protein level
Q9UP95,S12A4_HUMAN,Solute carrier family 12 member 4 (Electroneutral potassium-chloride cotransporter 1) (Erythroid K-Cl cotransporter 1) (hKCC1),1085,"120,650",5 out of 5,2002-12-13,Evidence at protein level
Q9Y666,S12A7_HUMAN,Solute carrier family 12 member 7 (Electroneutral potassium-chloride cotransporter 4) (K-Cl cotransporter 4),1083,"119,106",5 out of 5,2002-12-13,Evidence at protein level
Q86YT5,S13A5_HUMAN,Solute carrier family 13 member 5 (Na(+)/citrate cotransporter) (NaCT) (Sodium-coupled citrate transporter) (Sodium-dependent citrate transporter),568,"63,062",5 out of 5,2006-11-28,Evidence at protein level
Q9UDX4,S14L3_HUMAN,SEC14-like protein 3 (Tocopherol-associated protein 2),400,"46,048",4 out of 5,2003-03-28,Evidence at protein level
Q8N697,S15A4_HUMAN,Solute carrier family 15 member 4 (Peptide transporter 4) (Peptide/histidine transporter 1) (hPHT1),577,"62,034",5 out of 5,2008-06-10,Evidence at protein level
Q9NRA2,S17A5_HUMAN,Sialin (H(+)/nitrate cotransporter) (H(+)/sialic acid cotransporter) (AST) (Membrane glycoprotein HP59) (Solute carrier family 17 member 5) (Vesicular H(+)/Aspartate-glutamate cotransporter),495,"54,640",5 out of 5,2004-06-07,Evidence at protein level
O95977,S1PR4_HUMAN,Sphingosine 1-phosphate receptor 4 (S1P receptor 4) (S1P4) (Endothelial differentiation G-protein coupled receptor 6) (Sphingosine 1-phosphate receptor Edg-6) (S1P receptor Edg-6),384,"41,623",5 out of 5,2004-02-16,Evidence at protein level
O15245,S22A1_HUMAN,Solute carrier family 22 member 1 (Organic cation transporter 1) (hOCT1),554,"61,154",5 out of 5,2008-05-20,Evidence at protein level
Q6T423,S22AP_HUMAN,Solute carrier family 22 member 25 (Organic anion transporter UST6),547,"61,008",3 out of 5,2008-04-08,Evidence at transcript level
A6NKX4,S22AV_HUMAN,Putative solute carrier family 22 member 31,558,"58,987",2 out of 5,2008-05-20,Inferred from homology
Q3KQZ1,S2535_HUMAN,Solute carrier family 25 member 35,300,"32,438",3 out of 5,2007-06-26,Evidence at transcript level
Q86VD7,S2542_HUMAN,Mitochondrial coenzyme A transporter SLC25A42 (Solute carrier family 25 member 42),318,"35,409",5 out of 5,2007-06-26,Evidence at transcript level
Q96H78,S2544_HUMAN,Solute carrier family 25 member 44,314,"35,392",2 out of 5,2006-10-17,Evidence at transcript level
Q5H9E4,S2553_HUMAN,Solute carrier family 25 member 53 (Mitochondrial carrier triple repeat protein 6),307,"34,481",2 out of 5,2007-01-09,Evidence at transcript level
Q86WA9,S2611_HUMAN,Sodium-independent sulfate anion transporter (Solute carrier family 26 member 11),606,"65,299",5 out of 5,2008-02-26,Evidence at transcript level
P40879,S26A3_HUMAN,Chloride anion exchanger (Down-regulated in adenoma) (Protein DRA) (Solute carrier family 26 member 3),764,"84,505",5 out of 5,1995-02-01,Evidence at protein level
Q9BXS9,S26A6_HUMAN,Solute carrier family 26 member 6 (Anion exchange transporter) (Pendrin-like protein 1) (Pendrin-L1),759,"82,967",5 out of 5,2002-03-05,Evidence at protein level
Q96RN1,S26A8_HUMAN,Testis anion transporter 1 (Anion exchange transporter) (Solute carrier family 26 member 8),970,"109,006",5 out of 5,2008-02-26,Evidence at protein level
O14975,S27A2_HUMAN,"Very long-chain acyl-CoA synthetase (VLACS) (VLCS) (EC 6.2.1.-) (Fatty acid transport protein 2) (FATP-2) (Fatty-acid-coenzyme A ligase, very long-chain 1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 2) (THCA-CoA ligase) (Very long-chain-fatty-acid-CoA ligase)",620,"70,312",5 out of 5,1998-07-15,Evidence at protein level
Q14542,S29A2_HUMAN,"Equilibrative nucleoside transporter 2 (36 kDa nucleolar protein HNP36) (Delayed-early response protein 12) (Equilibrative nitrobenzylmercaptopurine riboside-insensitive nucleoside transporter) (Equilibrative NBMPR-insensitive nucleoside transporter) (Hydrophobic nucleolar protein, 36 kDa) (Nucleoside transporter, ei-type) (Solute carrier family 29 member 2)",456,"50,113",5 out of 5,1997-11-01,Evidence at protein level
Q5TZJ5,S31A1_HUMAN,Spermatogenesis-associated protein 31A1 (Protein FAM75A1),1347,"148,561",3 out of 5,2008-01-15,Inferred from homology
Q6ZQQ2,S31D1_HUMAN,Spermatogenesis-associated protein 31D1 (Protein FAM75D1),1576,"175,618",2 out of 5,2008-04-29,Evidence at transcript level
L0R6Q1,S35U4_HUMAN,SLC35A4 upstream open reading frame protein,103,"11,133",2 out of 5,2017-03-15,Inferred from homology
Q8NBW4,S38A9_HUMAN,Sodium-coupled neutral amino acid transporter 9 (Solute carrier family 38 member 9) (Up-regulated in lung cancer 11),561,"63,776",5 out of 5,2008-04-08,Evidence at protein level
Q9BRY0,S39A3_HUMAN,Zinc transporter ZIP3 (Solute carrier family 39 member 3) (Zrt- and Irt-like protein 3) (ZIP-3),314,"33,601",3 out of 5,2007-12-04,Evidence at protein level
Q96JT2,S45A3_HUMAN,Solute carrier family 45 member 3 (Prostate cancer-associated protein 6) (Prostein),553,"59,323",4 out of 5,2004-04-13,Evidence at transcript level
Q96FL8,S47A1_HUMAN,Multidrug and toxin extrusion protein 1 (MATE-1) (hMATE-1) (Solute carrier family 47 member 1),570,"61,922",5 out of 5,2007-12-04,Evidence at protein level
Q86VL8,S47A2_HUMAN,Multidrug and toxin extrusion protein 2 (MATE-2) (hMATE-2) (Kidney-specific H(+)/organic cation antiporter) (Solute carrier family 47 member 2),602,"65,085",5 out of 5,2007-12-04,Evidence at protein level
Q9BY07,S4A5_HUMAN,Electrogenic sodium bicarbonate cotransporter 4 (NBCe2) (Solute carrier family 4 member 5),1137,"126,255",5 out of 5,2008-04-08,Evidence at transcript level
Q9Y6M7,S4A7_HUMAN,Sodium bicarbonate cotransporter 3 (Electroneutral Na/HCO(3) cotransporter) (Sodium bicarbonate cotransporter 2) (Sodium bicarbonate cotransporter 2b) (Bicarbonate transporter) (Solute carrier family 4 member 7),1214,"136,044",5 out of 5,2006-02-07,Evidence at protein level
Q9NWF4,S52A1_HUMAN,"Solute carrier family 52, riboflavin transporter, member 1 (Porcine endogenous retrovirus A receptor 2) (PERV-A receptor 2) (Protein GPR172B) (Riboflavin transporter 1) (hRFT1)",448,"46,317",5 out of 5,2005-10-11,Evidence at protein level
P31213,S5A2_HUMAN,3-oxo-5-alpha-steroid 4-dehydrogenase 2 (EC 1.3.1.22) (5 alpha-SR2) (SR type 2) (Steroid 5-alpha-reductase 2) (S5AR 2) (Type II 5-alpha reductase),254,"28,393",5 out of 5,1993-07-01,Evidence at protein level
P48066,S6A11_HUMAN,Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11),632,"70,606",5 out of 5,1996-02-01,Evidence at transcript level
Q9NSD5,S6A13_HUMAN,Sodium- and chloride-dependent GABA transporter 2 (GAT-2) (Solute carrier family 6 member 13),602,"68,009",5 out of 5,2001-09-26,Evidence at protein level
Q9H2J7,S6A15_HUMAN,Sodium-dependent neutral amino acid transporter B(0)AT2 (Sodium- and chloride-dependent neurotransmitter transporter NTT73) (Sodium-coupled branched-chain amino-acid transporter 1) (Solute carrier family 6 member 15) (Transporter v7-3),730,"81,836",5 out of 5,2001-09-26,Evidence at protein level
Q96N87,S6A18_HUMAN,Sodium-dependent neutral amino acid transporter B(0)AT3 (Sodium- and chloride-dependent transporter XTRP2) (Solute carrier family 6 member 18) (System B(0) neutral amino acid transporter AT3),628,"70,897",5 out of 5,2004-06-07,Evidence at transcript level
P0DJI8,SAA1_HUMAN,Serum amyloid A-1 protein (SAA) [Cleaved into: Amyloid protein A (Amyloid fibril protein AA); Serum amyloid protein A(2-104); Serum amyloid protein A(3-104); Serum amyloid protein A(2-103); Serum amyloid protein A(2-102); Serum amyloid protein A(4-101)],122,"13,532",5 out of 5,2012-07-11,Evidence at protein level
A6NKF1,SAC31_HUMAN,SAC3 domain-containing protein 1 (SAC3 homology domain-containing protein 1),404,"43,553",4 out of 5,2007-10-23,Evidence at protein level
Q9NXZ1,SAGE1_HUMAN,Sarcoma antigen 1 (Cancer/testis antigen 14) (CT14),904,"99,225",2 out of 5,2007-05-15,Evidence at protein level
Q9Y512,SAM50_HUMAN,Sorting and assembly machinery component 50 homolog (Transformation-related gene 3 protein) (TRG-3),469,"51,976",5 out of 5,2001-01-24,Evidence at protein level
Q70HW3,SAMC_HUMAN,S-adenosylmethionine mitochondrial carrier protein (Mitochondrial S-adenosylmethionine transporter) (Solute carrier family 25 member 26),274,"29,381",5 out of 5,2008-02-05,Evidence at protein level
Q5SSQ6,SAPC1_HUMAN,Suppressor APC domain-containing protein 1 (Protein G7d),148,"16,650",2 out of 5,2006-06-27,Evidence at transcript level
Q9Y3A5,SBDS_HUMAN,Ribosome maturation protein SBDS (Shwachman-Bodian-Diamond syndrome protein),250,"28,764",5 out of 5,2000-05-30,Evidence at protein level
P82932,RT06_HUMAN,"28S ribosomal protein S6, mitochondrial (MRP-S6) (S6mt) (Mitochondrial small ribosomal subunit protein bS6m)",125,"14,227",5 out of 5,2001-05-04,Evidence at protein level
Q5QGT7,RTP2_HUMAN,Receptor-transporting protein 2 (3CxxC-type zinc finger protein 2),225,"26,068",4 out of 5,2005-03-15,Evidence at protein level
Q13950,RUNX2_HUMAN,Runt-related transcription factor 2 (Acute myeloid leukemia 3 protein) (Core-binding factor subunit alpha-1) (CBF-alpha-1) (Oncogene AML-3) (Osteoblast-specific transcription factor 2) (OSF-2) (Polyomavirus enhancer-binding protein 2 alpha A subunit) (PEA2-alpha A) (PEBP2-alpha A) (SL3-3 enhancer factor 1 alpha A subunit) (SL3/AKV core-binding factor alpha A subunit),521,"56,648",5 out of 5,2001-11-02,Evidence at protein level
Q8N2Y8,RUSC2_HUMAN,Iporin (Interacting protein of Rab1) (RUN and SH3 domain-containing protein 2),1516,"161,225",4 out of 5,2004-07-19,Evidence at protein level
Q6P087,RUSD3_HUMAN,RNA pseudouridylate synthase domain-containing protein 3,351,"38,461",3 out of 5,2007-09-11,Evidence at protein level
P21817,RYR1_HUMAN,Ryanodine receptor 1 (RYR-1) (RyR1) (Skeletal muscle calcium release channel) (Skeletal muscle ryanodine receptor) (Skeletal muscle-type ryanodine receptor) (Type 1 ryanodine receptor),5038,"565,176",5 out of 5,1991-05-01,Evidence at protein level
Q92736,RYR2_HUMAN,Ryanodine receptor 2 (RYR-2) (RyR2) (hRYR-2) (Cardiac muscle ryanodine receptor) (Cardiac muscle ryanodine receptor-calcium release channel) (Type 2 ryanodine receptor),4967,"564,567",5 out of 5,2001-09-26,Evidence at protein level
Q99584,S10AD_HUMAN,Protein S100-A13 (S100 calcium-binding protein A13),98,"11,471",5 out of 5,1997-11-01,Evidence at protein level
P55017,S12A3_HUMAN,Solute carrier family 12 member 3 (Na-Cl cotransporter) (NCC) (Na-Cl symporter) (Thiazide-sensitive sodium-chloride cotransporter),1021,"113,139",5 out of 5,1996-10-01,Evidence at protein level
Q13183,S13A2_HUMAN,Solute carrier family 13 member 2 (Na(+)/dicarboxylate cotransporter 1) (NaDC-1) (Renal sodium/dicarboxylate cotransporter),592,"64,410",5 out of 5,1997-11-01,Evidence at transcript level
Q8WWT9,S13A3_HUMAN,Solute carrier family 13 member 3 (Na(+)/dicarboxylate cotransporter 3) (NaDC-3) (hNaDC3) (Sodium-dependent high-affinity dicarboxylate transporter 2),602,"66,841",5 out of 5,2002-09-19,Evidence at protein level
P46059,S15A1_HUMAN,"Solute carrier family 15 member 1 (Intestinal H(+)/peptide cotransporter) (Oligopeptide transporter, small intestine isoform) (Peptide transporter 1)",708,"78,806",5 out of 5,1995-11-01,Evidence at transcript level
Q8IY34,S15A3_HUMAN,Solute carrier family 15 member 3 (Osteoclast transporter) (Peptide transporter 3) (Peptide/histidine transporter 2),581,"63,560",4 out of 5,2007-07-24,Evidence at transcript level
Q86VW1,S22AG_HUMAN,Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6),577,"64,614",5 out of 5,2008-02-26,Evidence at protein level
Q8N4F4,S22AO_HUMAN,Solute carrier family 22 member 24,322,"35,933",2 out of 5,2008-02-05,Evidence at transcript level
Q96AG3,S2546_HUMAN,Solute carrier family 25 member 46,418,"46,174",5 out of 5,2007-06-26,Evidence at protein level
Q9H1U9,S2551_HUMAN,Solute carrier family 25 member 51 (Mitochondrial carrier triple repeat protein 1),297,"33,672",2 out of 5,2003-11-28,Evidence at transcript level
O00337,S28A1_HUMAN,Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1),649,"71,584",5 out of 5,2000-12-01,Evidence at protein level
Q9NR83,S2A4R_HUMAN,SLC2A4 regulator (GLUT4 enhancer factor) (GEF) (Huntington disease gene regulatory region-binding protein 1) (HDBP-1),387,"41,267",5 out of 5,2002-11-01,Evidence at protein level
P0DKV0,S31C1_HUMAN,Spermatogenesis-associated protein 31C1 (Protein FAM75C1),1188,"130,522",3 out of 5,2013-02-06,Evidence at transcript level
Q8WV83,S35F5_HUMAN,Solute carrier family 35 member F5 (Hepatitis C virus NS5A-transactivated protein 3) (HCV NS5A-transactivated protein 3),523,"58,887",3 out of 5,2007-12-04,Evidence at protein level
Q96KT7,S35G5_HUMAN,Solute carrier family 35 member G5 (Acyl-malonyl-condensing enzyme 1-like protein 2),338,"35,161",2 out of 5,2006-12-12,Evidence at transcript level
P0C7Q6,S35G6_HUMAN,Solute carrier family 35 member G6 (Acyl-malonyl-condensing enzyme 1-like protein 3) (Transmembrane protein 21B),338,"35,103",3 out of 5,2008-07-01,Evidence at transcript level
Q7Z2H8,S36A1_HUMAN,Proton-coupled amino acid transporter 1 (Proton/amino acid transporter 1) (hPAT1) (Solute carrier family 36 member 1),476,"53,076",5 out of 5,2004-08-16,Evidence at protein level
Q495N2,S36A3_HUMAN,Proton-coupled amino acid transporter 3 (Proton/amino acid transporter 3) (Solute carrier family 36 member 3) (Tramdorin-2),470,"51,735",4 out of 5,2008-03-18,Evidence at transcript level
Q9H2H9,S38A1_HUMAN,Sodium-coupled neutral amino acid transporter 1 (Amino acid transporter A1) (N-system amino acid transporter 2) (Solute carrier family 38 member 1) (System A amino acid transporter 1) (System N amino acid transporter 1),487,"54,048",5 out of 5,2007-11-13,Evidence at protein level
Q96QD8,S38A2_HUMAN,Sodium-coupled neutral amino acid transporter 2 (Amino acid transporter A2) (Protein 40-9-1) (Solute carrier family 38 member 2) (System A amino acid transporter 2) (System A transporter 1) (System N amino acid transporter 2),506,"56,026",5 out of 5,2007-12-04,Evidence at protein level
Q8WUX1,S38A5_HUMAN,Sodium-coupled neutral amino acid transporter 5 (Solute carrier family 38 member 5) (System N transporter 2),472,"51,457",5 out of 5,2007-12-04,Evidence at protein level
Q9NP91,S6A20_HUMAN,Sodium- and chloride-dependent transporter XTRP3 (Sodium/imino-acid transporter 1) (Solute carrier family 6 member 20) (Transporter rB21A homolog),592,"65,914",5 out of 5,2004-03-29,Evidence at protein level
Q96ER3,SAAL1_HUMAN,Protein SAAL1,474,"53,558",2 out of 5,2007-03-06,Evidence at protein level
Q9Y2H2,SAC2_HUMAN,Phosphatidylinositide phosphatase SAC2 (EC 3.1.3.25) (Inositol polyphosphate 5-phosphatase F) (Sac domain-containing inositol phosphatase 2) (Sac domain-containing phosphoinositide 4-phosphatase 2) (hSAC2),1132,"128,407",5 out of 5,2008-04-29,Evidence at protein level
Q96E40,SACA9_HUMAN,Sperm acrosome-associated protein 9,222,"25,166",3 out of 5,2005-07-05,Evidence at protein level
Q8N8I0,SAM12_HUMAN,Sterile alpha motif domain-containing protein 12 (SAM domain-containing protein 12),201,"22,907",1 out of 5,2007-03-06,Evidence at transcript level
Q8IZD0,SAM14_HUMAN,Sterile alpha motif domain-containing protein 14 (SAM domain-containing protein 14),417,"45,056",2 out of 5,2006-10-03,Evidence at transcript level
Q5TGI4,SAMD5_HUMAN,Sterile alpha motif domain-containing protein 5 (SAM domain-containing protein 5),173,"19,231",1 out of 5,2007-11-13,Predicted
Q96LT4,SAMD8_HUMAN,Sphingomyelin synthase-related protein 1 (SMSr) (EC 2.7.8.-) (Ceramide phosphoethanolamine synthase) (CPE synthase) (Sterile alpha motif domain-containing protein 8) (SAM domain-containing protein 8),415,"48,321",5 out of 5,2004-03-01,Evidence at protein level
Q9NSI8,SAMN1_HUMAN,"SAM domain-containing protein SAMSN-1 (Hematopoietic adaptor containing SH3 and SAM domains 1) (Nash1) (SAM domain, SH3 domain and nuclear localization signals protein 1) (SH3-SAM adaptor protein)",373,"41,708",5 out of 5,2001-01-11,Evidence at protein level
Q658L1,SAXO2_HUMAN,Stabilizer of axonemal microtubules 2,398,"45,933",2 out of 5,2008-02-26,Evidence at transcript level
O95486,SC24A_HUMAN,Protein transport protein Sec24A (SEC24-related protein A),1093,"119,749",5 out of 5,2001-02-21,Evidence at protein level
O95487,SC24B_HUMAN,Protein transport protein Sec24B (SEC24-related protein B),1268,"137,418",5 out of 5,2001-02-21,Evidence at protein level
O94855,SC24D_HUMAN,Protein transport protein Sec24D (SEC24-related protein D),1032,"113,010",5 out of 5,2001-02-21,Evidence at protein level
O94979,SC31A_HUMAN,Protein transport protein Sec31A (ABP125) (ABP130) (SEC31-like protein 1) (SEC31-related protein A) (Web1-like protein),1220,"133,015",5 out of 5,2007-07-10,Evidence at protein level
P60468,SC61B_HUMAN,Protein transport protein Sec61 subunit beta,96,"9,974",5 out of 5,2004-02-16,Evidence at protein level
Q01959,SC6A3_HUMAN,Sodium-dependent dopamine transporter (DA transporter) (DAT) (Solute carrier family 6 member 3),620,"68,495",5 out of 5,1993-04-01,Evidence at protein level
P31645,SC6A4_HUMAN,Sodium-dependent serotonin transporter (SERT) (5HT transporter) (5HTT) (Solute carrier family 6 member 4),630,"70,325",5 out of 5,1993-07-01,Evidence at protein level
Q99884,SC6A7_HUMAN,Sodium-dependent proline transporter (Solute carrier family 6 member 7),636,"70,911",4 out of 5,1998-07-15,Evidence at transcript level
O15126,SCAM1_HUMAN,Secretory carrier-associated membrane protein 1 (Secretory carrier membrane protein 1),338,"37,920",5 out of 5,1998-12-15,Evidence at protein level
Q969E2,SCAM4_HUMAN,Secretory carrier-associated membrane protein 4 (Secretory carrier membrane protein 4),229,"25,728",3 out of 5,2004-05-10,Evidence at protein level
Q12770,SCAP_HUMAN,Sterol regulatory element-binding protein cleavage-activating protein (SCAP) (SREBP cleavage-activating protein),1279,"139,729",5 out of 5,2001-11-16,Evidence at protein level
Q6ZMJ2,SCAR5_HUMAN,Scavenger receptor class A member 5 (Scavenger receptor hlg),495,"53,994",5 out of 5,2007-03-06,Evidence at transcript level
P13521,SCG2_HUMAN,Secretogranin-2 (Chromogranin-C) (Secretogranin II) (SgII) [Cleaved into: Secretoneurin (SN); Manserin],617,"70,941",5 out of 5,1990-01-01,Evidence at protein level
Q6UWF3,SCIMP_HUMAN,"SLP adapter and CSK-interacting membrane protein (SLP65/SLP76, Csk-interacting membrane protein)",145,"16,618",5 out of 5,2007-07-10,Evidence at protein level
Q96NL6,SCLT1_HUMAN,Sodium channel and clathrin linker 1 (Sodium channel-associated protein 1),688,"80,910",5 out of 5,2008-02-05,Evidence at protein level
Q6NUK1,SCMC1_HUMAN,Calcium-binding mitochondrial carrier protein SCaMC-1 (Mitochondrial ATP-Mg/Pi carrier protein 1) (Mitochondrial Ca(2+)-dependent solute carrier protein 1) (Small calcium-binding mitochondrial carrier protein 1) (Solute carrier family 25 member 24),477,"53,354",5 out of 5,2008-02-05,Evidence at protein level
Q9UN30,SCML1_HUMAN,Sex comb on midleg-like protein 1,329,"37,447",3 out of 5,2004-05-10,Evidence at protein level
Q8N228,SCML4_HUMAN,Sex comb on midleg-like protein 4,414,"45,023",3 out of 5,2008-05-20,Evidence at protein level
Q99250,SCN2A_HUMAN,Sodium channel protein type 2 subunit alpha (HBSC II) (Sodium channel protein brain II subunit alpha) (Sodium channel protein type II subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.2),2005,"227,975",5 out of 5,1994-06-01,Evidence at protein level
Q15858,SCN9A_HUMAN,Sodium channel protein type 9 subunit alpha (Neuroendocrine sodium channel) (hNE-Na) (Peripheral sodium channel 1) (PN1) (Sodium channel protein type IX subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.7),1988,"226,372",5 out of 5,2004-11-23,Evidence at protein level
Q9GZW5,SCND2_HUMAN,Putative SCAN domain-containing protein SCAND2P (SCAN domain-containing protein 2 pseudogene),306,"34,217",2 out of 5,2003-04-11,Uncertain
Q9BWG6,SCNM1_HUMAN,Sodium channel modifier 1,230,"25,949",5 out of 5,2006-10-31,Evidence at protein level
Q92737,RSLAA_HUMAN,Ras-like protein family member 10A (Ras-like protein RRP22) (Ras-related protein on chromosome 22),203,"22,541",5 out of 5,1998-07-15,Evidence at protein level
Q6T310,RSLBA_HUMAN,Ras-like protein family member 11A,242,"27,006",3 out of 5,2007-10-23,Evidence at transcript level
Q86UC2,RSPH3_HUMAN,Radial spoke head protein 3 homolog (A-kinase anchor protein RSPH3) (Radial spoke head-like protein 2),560,"63,687",5 out of 5,2008-01-15,Evidence at protein level
Q96EL2,RT24_HUMAN,"28S ribosomal protein S24, mitochondrial (MRP-S24) (S24mt) (Mitochondrial small ribosomal subunit protein uS3m) (bMRP-47) (bMRP47)",167,"19,015",4 out of 5,2007-01-23,Evidence at protein level
Q9BQC6,RT63_HUMAN,"Ribosomal protein 63, mitochondrial (hMRP63) (Mitochondrial large ribosomal subunit protein mL63) (Mitochondrial ribosomal protein 63) (Mitochondrial ribosomal protein L57)",102,"12,266",3 out of 5,2006-10-17,Evidence at protein level
Q9NZ71,RTEL1_HUMAN,Regulator of telomere elongation helicase 1 (EC 3.6.4.12) (Novel helicase-like),1219,"133,683",5 out of 5,2003-03-28,Evidence at protein level
Q8IZC4,RTKN2_HUMAN,Rhotekin-2 (Pleckstrin homology domain-containing family K member 1) (PH domain-containing family K member 1),609,"69,304",3 out of 5,2007-11-13,Evidence at transcript level
O95197,RTN3_HUMAN,Reticulon-3 (Homolog of ASY protein) (HAP) (Neuroendocrine-specific protein-like 2) (NSP-like protein 2) (Neuroendocrine-specific protein-like II) (NSP-like protein II) (NSPLII),1032,"112,611",5 out of 5,2001-04-27,Evidence at protein level
Q96DX8,RTP4_HUMAN,Receptor-transporting protein 4 (28 kDa interferon-responsive protein) (3CxxC-type zinc finger protein 4),246,"27,863",5 out of 5,2002-10-10,Evidence at protein level
P08621,RU17_HUMAN,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),437,"51,557",5 out of 5,1988-08-01,Evidence at protein level
Q92622,RUBIC_HUMAN,Run domain Beclin-1-interacting and cysteine-rich domain-containing protein (Rubicon) (Beclin-1 associated RUN domain containing protein) (Baron),972,"108,622",5 out of 5,1997-11-01,Evidence at protein level
Q96NL0,RUN3B_HUMAN,RUN domain-containing protein 3B (Rap2-binding protein 9) (Rap2-interacting protein 9) (RPIP-9),473,"52,813",4 out of 5,2008-05-20,Evidence at transcript level
Q96GQ5,RUS1_HUMAN,RUS1 family protein C16orf58,468,"51,018",3 out of 5,2007-04-03,Evidence at protein level
Q9NUL5,RYDEN_HUMAN,Repressor of yield of DENV protein (RyDEN),291,"33,110",5 out of 5,2008-02-26,Evidence at protein level
P33763,S10A5_HUMAN,Protein S100-A5 (Protein S-100D) (S100 calcium-binding protein A5),92,"10,744",5 out of 5,1994-02-01,Evidence at protein level
P05109,S10A8_HUMAN,"Protein S100-A8 (Calgranulin-A) (Calprotectin L1L subunit) (Cystic fibrosis antigen) (CFAG) (Leukocyte L1 complex light chain) (Migration inhibitory factor-related protein 8) (MRP-8) (p8) (S100 calcium-binding protein A8) (Urinary stone protein band A) [Cleaved into: Protein S100-A8, N-terminally processed]",93,"10,835",5 out of 5,1987-08-13,Evidence at protein level
Q13621,S12A1_HUMAN,Solute carrier family 12 member 1 (Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) (Kidney-specific Na-K-Cl symporter),1099,"121,450",5 out of 5,2001-01-11,Evidence at protein level
Q9UDX3,S14L4_HUMAN,SEC14-like protein 4 (Tocopherol-associated protein 3),406,"46,644",4 out of 5,2003-03-25,Evidence at protein level
Q9BYT1,S17A9_HUMAN,Solute carrier family 17 member 9,436,"47,482",5 out of 5,2004-05-24,Evidence at protein level
Q9BZV2,S19A3_HUMAN,Thiamine transporter 2 (ThTr-2) (ThTr2) (Solute carrier family 19 member 3),496,"55,665",5 out of 5,2006-04-18,Evidence at protein level
Q86SG5,S1A7A_HUMAN,Protein S100-A7A (S100 calcium-binding protein A15) (S100 calcium-binding protein A7-like 1) (S100 calcium-binding protein A7A),101,"11,305",4 out of 5,2003-09-26,Evidence at protein level
P21453,S1PR1_HUMAN,Sphingosine 1-phosphate receptor 1 (S1P receptor 1) (S1P1) (Endothelial differentiation G-protein coupled receptor 1) (Sphingosine 1-phosphate receptor Edg-1) (S1P receptor Edg-1) (CD antigen CD363),382,"42,811",5 out of 5,1991-05-01,Evidence at protein level
Q9Y694,S22A7_HUMAN,Solute carrier family 22 member 7 (Novel liver transporter) (Organic anion transporter 2) (hOAT2),548,"60,026",5 out of 5,2008-02-05,Evidence at protein level
Q9NSA0,S22AB_HUMAN,Solute carrier family 22 member 11 (Organic anion transporter 4),550,"59,972",5 out of 5,2006-05-16,Evidence at protein level
Q8IZD6,S22AF_HUMAN,Solute carrier family 22 member 15 (Fly-like putative transporter 1) (Flipt 1),547,"60,540",4 out of 5,2008-06-10,Evidence at transcript level
Q8WUG5,S22AH_HUMAN,Solute carrier family 22 member 17 (24p3 receptor) (24p3R) (Brain-type organic cation transporter) (Lipocalin-2 receptor) (Neutrophil gelatinase-associated lipocalin receptor) (NgalR),538,"57,686",5 out of 5,2003-01-17,Evidence at transcript level
Q9Y6Y8,S23IP_HUMAN,SEC23-interacting protein (p125),1000,"111,076",5 out of 5,2004-11-09,Evidence at protein level
Q9BSK2,S2533_HUMAN,Solute carrier family 25 member 33 (Bone marrow stromal cell mitochondrial carrier protein) (BMSC-MCP) (HuBMSC-MCP) (Protein PNC1),321,"35,375",5 out of 5,2007-06-26,Evidence at protein level
Q9HAS3,S28A3_HUMAN,Solute carrier family 28 member 3 (Concentrative Na(+)-nucleoside cotransporter 3) (CNT 3) (hCNT3),691,"76,930",5 out of 5,2008-03-18,Evidence at protein level
Q8IUI4,S29P2_HUMAN,Putative protein SNX29P2 (RUN domain-containing protein 2C) (Sorting nexin 29 protein pseudogene 2),249,"27,226",2 out of 5,2007-01-09,Uncertain
P0C874,S31D3_HUMAN,Putative spermatogenesis-associated protein 31D3 (Protein FAM75D3),917,"102,419",2 out of 5,2008-09-02,Uncertain
Q8TB61,S35B2_HUMAN,Adenosine 3'-phospho 5'-phosphosulfate transporter 1 (PAPS transporter 1) (Putative MAPK-activating protein PM15) (Putative NF-kappa-B-activating protein 48) (Solute carrier family 35 member B2),432,"47,515",5 out of 5,2005-06-07,Evidence at protein level
Q9NQQ7,S35C2_HUMAN,Solute carrier family 35 member C2 (Ovarian cancer-overexpressed gene 1 protein),365,"40,432",5 out of 5,2004-01-16,Evidence at protein level
Q5M8T2,S35D3_HUMAN,Solute carrier family 35 member D3 (Fringe connection-like protein 1),416,"44,183",2 out of 5,2007-10-23,Evidence at transcript level
Q6ICL7,S35E4_HUMAN,Solute carrier family 35 member E4,350,"36,747",2 out of 5,2007-08-21,Evidence at transcript level
Q9HBR0,S38AA_HUMAN,Putative sodium-coupled neutral amino acid transporter 10 (Solute carrier family 38 member 10),1119,"119,762",4 out of 5,2008-02-26,Evidence at protein level
Q08AI6,S38AB_HUMAN,Putative sodium-coupled neutral amino acid transporter 11 (Solute carrier family 38 member 11),406,"44,825",3 out of 5,2008-03-18,Evidence at transcript level
Q9BXY4,RSPO3_HUMAN,R-spondin-3 (Protein with TSP type-1 repeat) (hPWTSR) (Roof plate-specific spondin-3) (hRspo3) (Thrombospondin type-1 domain-containing protein 2),272,"30,929",5 out of 5,2006-05-16,Evidence at protein level
P82933,RT09_HUMAN,"28S ribosomal protein S9, mitochondrial (MRP-S9) (S9mt) (Mitochondrial small ribosomal subunit protein uS9m)",396,"45,835",5 out of 5,2002-01-23,Evidence at protein level
Q9Y3I0,RTCB_HUMAN,tRNA-splicing ligase RtcB homolog (EC 6.5.1.3),505,"55,210",5 out of 5,2006-10-31,Evidence at protein level
O75298,RTN2_HUMAN,Reticulon-2 (Neuroendocrine-specific protein-like 1) (NSP-like protein 1) (Neuroendocrine-specific protein-like I) (NSP-like protein I) (NSPLI),545,"59,264",4 out of 5,2001-04-27,Evidence at protein level
Q9H446,RWDD1_HUMAN,RWD domain-containing protein 1 (DRG family-regulatory protein 2),243,"27,940",3 out of 5,2003-08-15,Evidence at protein level
Q8WXG8,S100Z_HUMAN,Protein S100-Z (S100 calcium-binding protein Z),99,"11,620",3 out of 5,2002-04-16,Evidence at protein level
P23297,S10A1_HUMAN,Protein S100-A1 (S-100 protein alpha chain) (S-100 protein subunit alpha) (S100 calcium-binding protein A1),94,"10,546",5 out of 5,1991-11-01,Evidence at protein level
P06703,S10A6_HUMAN,Protein S100-A6 (Calcyclin) (Growth factor-inducible protein 2A9) (MLN 4) (Prolactin receptor-associated protein) (PRA) (S100 calcium-binding protein A6),90,"10,180",5 out of 5,1988-01-01,Evidence at protein level
Q9BXP2,S12A9_HUMAN,Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3),914,"96,110",5 out of 5,2008-04-29,Evidence at protein level
Q8NG04,S2610_HUMAN,Solute carrier family 26 member 10,563,"60,059",4 out of 5,2008-07-22,Evidence at transcript level
Q9H2B4,S26A1_HUMAN,Sulfate anion transporter 1 (SAT-1) (Solute carrier family 26 member 1),701,"75,016",5 out of 5,2002-03-05,Evidence at protein level
O43511,S26A4_HUMAN,Pendrin (Sodium-independent chloride/iodide transporter) (Solute carrier family 26 member 4),780,"85,723",5 out of 5,1999-07-15,Evidence at protein level
Q9Y2P4,S27A6_HUMAN,"Long-chain fatty acid transport protein 6 (FATP-6) (Fatty acid transport protein 6) (Fatty-acid-coenzyme A ligase, very long-chain 2) (Solute carrier family 27 member 6) (Very long-chain acyl-CoA synthetase homolog 1) (VLCSH1) (hVLCS-H1)",619,"70,112",4 out of 5,2005-11-22,Evidence at transcript level
Q5VZV4,S31B1_HUMAN,Putative spermatogenesis-associated protein 31B1 (Spermatogenesis-associated protein 31B1 pseudogene),182,"19,635",2 out of 5,2008-06-10,Uncertain
Q9NP94,S39A2_HUMAN,Zinc transporter ZIP2 (6A1) (Eti-1) (Solute carrier family 39 member 2) (Zrt- and Irt-like protein 2) (ZIP-2) (hZIP2),309,"32,742",5 out of 5,2003-09-26,Evidence at protein level
Q6P5W5,S39A4_HUMAN,Zinc transporter ZIP4 (Solute carrier family 39 member 4) (Zrt- and Irt-like protein 4) (ZIP-4),647,"68,408",5 out of 5,2005-10-25,Evidence at protein level
Q9C0K1,S39A8_HUMAN,Zinc transporter ZIP8 (BCG-induced integral membrane protein in monocyte clone 103 protein) (LIV-1 subfamily of ZIP zinc transporter 6) (LZT-Hs6) (Solute carrier family 39 member 8) (Zrt- and Irt-like protein 8) (ZIP-8),460,"49,631",5 out of 5,2007-12-04,Evidence at transcript level
Q9ULF5,S39AA_HUMAN,Zinc transporter ZIP10 (Solute carrier family 39 member 10) (Zrt- and Irt-like protein 10) (ZIP-10),831,"94,132",4 out of 5,2007-08-21,Evidence at protein level
Q96H72,S39AD_HUMAN,Zinc transporter ZIP13 (LIV-1 subfamily of ZIP zinc transporter 9) (LZT-Hs9) (Solute carrier family 39 member 13) (Zrt- and Irt-like protein 13) (ZIP-13),371,"39,011",5 out of 5,2007-12-04,Evidence at protein level
Q15043,S39AE_HUMAN,Zinc transporter ZIP14 (LIV-1 subfamily of ZIP zinc transporter 4) (LZT-Hs4) (Solute carrier family 39 member 14) (Zrt- and Irt-like protein 14) (ZIP-14),492,"54,212",5 out of 5,2007-12-04,Evidence at protein level
Q8TF17,S3TC2_HUMAN,SH3 domain and tetratricopeptide repeat-containing protein 2,1288,"144,777",5 out of 5,2004-04-13,Evidence at protein level
Q8NBI5,S43A3_HUMAN,Solute carrier family 43 member 3 (Protein FOAP-13),491,"54,529",3 out of 5,2007-10-02,Evidence at protein level
Q9UMX9,S45A2_HUMAN,Membrane-associated transporter protein (Melanoma antigen AIM1) (Protein AIM-1) (Solute carrier family 45 member 2),530,"58,268",5 out of 5,2001-11-16,Evidence at protein level
Q5BKX6,S45A4_HUMAN,Solute carrier family 45 member 4,768,"83,878",3 out of 5,2008-05-20,Evidence at protein level
Q2Y0W8,S4A8_HUMAN,Electroneutral sodium bicarbonate exchanger 1 (Electroneutral Na(+)-driven Cl-HCO3 exchanger) (Solute carrier family 4 member 8) (k-NBC3),1093,"122,938",5 out of 5,2008-04-08,Evidence at protein level
Q9H9S3,S61A2_HUMAN,Protein transport protein Sec61 subunit alpha isoform 2 (Sec61 alpha-2),476,"52,248",3 out of 5,2004-06-07,Evidence at transcript level
Q9H1V8,S6A17_HUMAN,Sodium-dependent neutral amino acid transporter SLC6A17 (Sodium-dependent neurotransmitter transporter NTT4) (Solute carrier family 6 member 17),727,"81,001",4 out of 5,2001-09-26,Evidence at protein level
Q8TCU3,S7A13_HUMAN,Solute carrier family 7 member 13 (Sodium-independent aspartate/glutamate transporter 1) (X-amino acid transporter 2),470,"52,114",3 out of 5,2008-04-29,Evidence at transcript level
Q96HN2,SAHH3_HUMAN,Adenosylhomocysteinase 3 (AdoHcyase 3) (EC 3.3.1.1) (IP(3)Rs binding protein released with IP(3) 2) (IRBIT2) (Long-IRBIT) (S-adenosyl-L-homocysteine hydrolase 3) (S-adenosylhomocysteine hydrolase-like protein 2),611,"66,721",5 out of 5,2002-07-11,Evidence at protein level
Q9NSC2,SALL1_HUMAN,Sal-like protein 1 (Spalt-like transcription factor 1) (Zinc finger protein 794) (Zinc finger protein SALL1) (Zinc finger protein Spalt-1) (HSal1) (Sal-1),1324,"140,405",5 out of 5,2002-05-02,Evidence at protein level
Q8TEE9,SAP25_HUMAN,Histone deacetylase complex subunit SAP25 (25 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP25),199,"20,873",2 out of 5,2008-09-23,Evidence at protein level
O75446,SAP30_HUMAN,Histone deacetylase complex subunit SAP30 (30 kDa Sin3-associated polypeptide) (Sin3 corepressor complex subunit SAP30) (Sin3-associated polypeptide p30),220,"23,306",5 out of 5,2005-06-21,Evidence at protein level
P17900,SAP3_HUMAN,Ganglioside GM2 activator (Cerebroside sulfate activator protein) (GM2-AP) (Sphingolipid activator protein 3) (SAP-3) [Cleaved into: Ganglioside GM2 activator isoform short],193,"20,838",5 out of 5,1990-11-01,Evidence at protein level
Q96BY9,SARAF_HUMAN,Store-operated calcium entry-associated regulatory factor (SARAF) (SOCE-associated regulatory factor) (HBV X-transactivated gene 3 protein) (HBV XAg-transactivated protein 3) (Protein FOAP-7) (Transmembrane protein 66),339,"36,975",5 out of 5,2006-01-10,Evidence at protein level
P14678,RSMB_HUMAN,Small nuclear ribonucleoprotein-associated proteins B and B' (snRNP-B) (Sm protein B/B') (Sm-B/B') (SmB/B'),240,"24,610",5 out of 5,1990-04-01,Evidence at protein level
P63162,RSMN_HUMAN,Small nuclear ribonucleoprotein-associated protein N (snRNP-N) (Sm protein D) (Sm-D) (Sm protein N) (Sm-N) (SmN) (Tissue-specific-splicing protein),240,"24,614",5 out of 5,2004-09-27,Evidence at protein level
Q8WYR4,RSPH1_HUMAN,Radial spoke head 1 homolog (Cancer/testis antigen 79) (CT79) (Male meiotic metaphase chromosome-associated acidic protein) (Meichroacidin) (Testis-specific gene A2 protein),309,"35,124",5 out of 5,2002-06-20,Evidence at protein level
Q9Y676,RT18B_HUMAN,"28S ribosomal protein S18b, mitochondrial (MRP-S18-b) (Mrps18-b) (S18mt-b) (28S ribosomal protein S18-2, mitochondrial) (MRP-S18-2) (Mitochondrial small ribosomal subunit protein bS18b) (Mitochondrial small ribosomal subunit protein mS40)",258,"29,396",5 out of 5,2002-10-19,Evidence at protein level
P82663,RT25_HUMAN,"28S ribosomal protein S25, mitochondrial (MRP-S25) (S25mt) (Mitochondrial small ribosomal subunit protein mS25)",173,"20,116",4 out of 5,2001-04-27,Evidence at protein level
Q8N488,RYBP_HUMAN,RING1 and YY1-binding protein (Apoptin-associating protein 1) (APAP-1) (Death effector domain-associated factor) (DED-associated factor) (YY1 and E4TF1-associated factor 1),228,"24,822",5 out of 5,2005-05-10,Evidence at protein level
P60903,S10AA_HUMAN,Protein S100-A10 (Calpactin I light chain) (Calpactin-1 light chain) (Cellular ligand of annexin II) (S100 calcium-binding protein A10) (p10 protein) (p11),97,"11,203",5 out of 5,1988-08-01,Evidence at protein level
P80511,S10AC_HUMAN,Protein S100-A12 (CGRP) (Calcium-binding protein in amniotic fluid 1) (CAAF1) (Calgranulin-C) (CAGC) (Extracellular newly identified RAGE-binding protein) (EN-RAGE) (Migration inhibitory factor-related protein 6) (MRP-6) (p6) (Neutrophil S100 protein) (S100 calcium-binding protein A12) [Cleaved into: Calcitermin],92,"10,575",5 out of 5,1996-10-01,Evidence at protein level
Q8N1F8,S11IP_HUMAN,Serine/threonine-protein kinase 11-interacting protein (LKB1-interacting protein 1),1099,"121,401",5 out of 5,2008-02-05,Evidence at protein level
Q9H2X9,S12A5_HUMAN,Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter),1139,"126,184",5 out of 5,2002-12-13,Evidence at protein level
B5MCN3,S14L6_HUMAN,Putative SEC14-like protein 6,397,"45,364",2 out of 5,2011-06-28,Uncertain
Q16348,S15A2_HUMAN,"Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2)",729,"81,783",5 out of 5,1997-11-01,Evidence at transcript level
Q9UHA2,S18L2_HUMAN,SS18-like protein 2 (SYT homolog 2),77,"8,835",2 out of 5,2002-10-25,Inferred from homology
Q96IZ7,RSRC1_HUMAN,Serine/Arginine-related protein 53 (SRrp53) (Arginine/serine-rich coiled-coil protein 1),334,"38,677",4 out of 5,2005-03-15,Evidence at protein level
Q9Y399,RT02_HUMAN,"28S ribosomal protein S2, mitochondrial (MRP-S2) (S2mt) (Mitochondrial small ribosomal subunit protein uS2m)",296,"33,249",4 out of 5,2002-10-19,Evidence at protein level
P82675,RT05_HUMAN,"28S ribosomal protein S5, mitochondrial (MRP-S5) (S5mt) (Mitochondrial small ribosomal subunit protein uS5m)",430,"48,006",4 out of 5,2002-10-19,Evidence at protein level
O15235,RT12_HUMAN,"28S ribosomal protein S12, mitochondrial (MRP-S12) (S12mt) (MT-RPS12) (Mitochondrial small ribosomal subunit protein uS12m)",138,"15,173",4 out of 5,1998-07-15,Evidence at protein level
Q9Y3D5,RT18C_HUMAN,"28S ribosomal protein S18c, mitochondrial (MRP-S18-c) (Mrps18-c) (S18mt-c) (28S ribosomal protein S18-1, mitochondrial) (MRP-S18-1) (Mitochondrial small ribosomal subunit protein bS18c) (Mitochondrial small ribosomal subunit protein bS18m)",142,"15,850",4 out of 5,2002-10-19,Evidence at protein level
P08579,RU2B_HUMAN,U2 small nuclear ribonucleoprotein B'' (U2 snRNP B''),225,"25,486",5 out of 5,1988-08-01,Evidence at protein level
Q96T51,RUFY1_HUMAN,RUN and FYVE domain-containing protein 1 (FYVE-finger protein EIP1) (La-binding protein 1) (Rab4-interacting protein) (Zinc finger FYVE domain-containing protein 12),708,"79,818",5 out of 5,2004-04-13,Evidence at protein level
Q59EK9,RUN3A_HUMAN,RUN domain-containing protein 3A (Rap2-interacting protein 8) (RPIP-8),446,"49,747",5 out of 5,2008-03-18,Evidence at protein level
Q9Y2V3,RX_HUMAN,Retinal homeobox protein Rx (Retina and anterior neural fold homeobox protein),346,"36,676",5 out of 5,2001-09-26,Evidence at protein level
A0AV02,S12A8_HUMAN,Solute carrier family 12 member 8 (Cation-chloride cotransporter 9),714,"78,239",5 out of 5,2007-10-02,Evidence at transcript level
Q9BZW2,S13A1_HUMAN,Solute carrier family 13 member 1 (Renal sodium/sulfate cotransporter) (Na(+)/sulfate cotransporter) (hNaSi-1),595,"66,134",4 out of 5,2002-09-19,Evidence at protein level
O76054,S14L2_HUMAN,SEC14-like protein 2 (Alpha-tocopherol-associated protein) (TAP) (hTAP) (Squalene transfer protein) (Supernatant protein factor) (SPF),403,"46,145",5 out of 5,2002-06-20,Evidence at protein level
Q6NT16,S18B1_HUMAN,MFS-type transporter SLC18B1 (Solute carrier family 18 member B1),456,"48,869",3 out of 5,2007-07-10,Evidence at protein level
P41440,S19A1_HUMAN,Folate transporter 1 (FOLT) (Intestinal folate carrier 1) (IFC-1) (Placental folate transporter) (Reduced folate carrier protein) (RFC) (Solute carrier family 19 member 1),591,"64,868",5 out of 5,1995-11-01,Evidence at protein level
Q5SY68,S1A7B_HUMAN,Protein S100-A7-like 2 (S100 calcium-binding protein A7-like 2),101,"11,302",2 out of 5,2007-01-09,Evidence at protein level
Q99500,S1PR3_HUMAN,Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3),378,"42,250",5 out of 5,1997-11-01,Evidence at protein level
Q8IVM8,S22A9_HUMAN,Solute carrier family 22 member 9 (Organic anion transporter 7),553,"62,169",5 out of 5,2006-05-02,Evidence at protein level
Q9Y267,S22AE_HUMAN,Solute carrier family 22 member 14 (Organic cation transporter-like 4) (ORCTL-4),594,"66,684",4 out of 5,2006-04-04,Evidence at transcript level
Q96BI1,S22AI_HUMAN,Solute carrier family 22 member 18 (Beckwith-Wiedemann syndrome chromosomal region 1 candidate gene A protein) (Efflux transporter-like protein) (Imprinted multi-membrane-spanning polyspecific transporter-related protein 1) (Organic cation transporter-like protein 2) (ORCTL-2) (Solute carrier family 22 member 1-like) (Tumor-suppressing STF cDNA 5 protein) (Tumor-suppressing subchromosomal transferable fragment candidate gene 5 protein) (p45-Beckwith-Wiedemann region 1 A) (p45-BWR1A),424,"44,846",5 out of 5,2005-12-06,Evidence at protein level
Q9UHI7,S23A1_HUMAN,Solute carrier family 23 member 1 (Na(+)/L-ascorbic acid transporter 1) (Sodium-dependent vitamin C transporter 1) (hSVCT1) (Yolk sac permease-like molecule 3),598,"64,831",5 out of 5,2002-10-19,Evidence at protein level
Q9BZJ4,S2539_HUMAN,Solute carrier family 25 member 39,359,"39,249",3 out of 5,2002-02-11,Evidence at transcript level
Q6Q0C1,S2547_HUMAN,Solute carrier family 25 member 47 (Hepatocellular carcinoma down-regulated mitochondrial carrier protein),308,"33,435",4 out of 5,2007-06-26,Evidence at transcript level
P50443,S26A2_HUMAN,Sulfate transporter (Diastrophic dysplasia protein) (Solute carrier family 26 member 2),739,"81,662",5 out of 5,1996-10-01,Evidence at protein level
Q8TE54,S26A7_HUMAN,Anion exchange transporter (Solute carrier family 26 member 7),656,"72,213",5 out of 5,2008-02-26,Evidence at transcript level
Q6PCB7,S27A1_HUMAN,Long-chain fatty acid transport protein 1 (FATP-1) (Fatty acid transport protein 1) (EC 6.2.1.-) (Solute carrier family 27 member 1),646,"71,108",5 out of 5,2005-11-08,Evidence at transcript level
Q5K4L6,S27A3_HUMAN,Long-chain fatty acid transport protein 3 (FATP-3) (Fatty acid transport protein 3) (EC 6.2.1.-) (Solute carrier family 27 member 3) (Very long-chain acyl-CoA synthetase homolog 3) (VLCS-3),730,"78,644",5 out of 5,2005-11-22,Evidence at transcript level
Q9Y2P5,S27A5_HUMAN,"Bile acyl-CoA synthetase (BACS) (EC 6.2.1.7) (Bile acid-CoA ligase) (BA-CoA ligase) (BAL) (Cholate--CoA ligase) (Fatty acid transport protein 5) (FATP-5) (Fatty-acid-coenzyme A ligase, very long-chain 3) (Solute carrier family 27 member 5) (Very long-chain acyl-CoA synthetase homolog 2) (VLCS-H2) (VLCSH2) (Very long-chain acyl-CoA synthetase-related protein) (VLACS-related) (VLACSR)",690,"75,385",5 out of 5,2005-11-22,Evidence at protein level
O43868,S28A2_HUMAN,Sodium/nucleoside cotransporter 2 (Concentrative nucleoside transporter 2) (CNT 2) (hCNT2) (Na(+)/nucleoside cotransporter 2) (Sodium-coupled nucleoside transporter 2) (Sodium/purine nucleoside co-transporter) (SPNT) (Solute carrier family 28 member 2),658,"71,926",5 out of 5,2000-12-01,Evidence at transcript level
Q99808,S29A1_HUMAN,"Equilibrative nucleoside transporter 1 (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1)",456,"50,219",5 out of 5,2000-12-01,Evidence at protein level
Q5VU36,S31A5_HUMAN,Spermatogenesis-associated protein 31A5 (Protein FAM75A5),1347,"148,687",2 out of 5,2008-01-15,Inferred from homology
P78382,S35A1_HUMAN,CMP-sialic acid transporter (CMP-SA-Tr) (CMP-Sia-Tr) (Solute carrier family 35 member A1),337,"36,779",5 out of 5,1997-11-01,Evidence at transcript level
Q9NTN3,S35D1_HUMAN,UDP-glucuronic acid/UDP-N-acetylgalactosamine transporter (UDP-GlcA/UDP-GalNAc transporter) (Solute carrier family 35 member D1) (UDP-galactose transporter-related protein 7) (UGTrel7),355,"39,240",5 out of 5,2002-01-23,Evidence at protein level
Q8IXU6,S35F2_HUMAN,Solute carrier family 35 member F2,374,"41,212",3 out of 5,2007-10-23,Evidence at protein level
Q8TBE7,S35G2_HUMAN,Solute carrier family 35 member G2 (Transmembrane protein 22),412,"46,422",4 out of 5,2006-06-27,Evidence at protein level
Q8IZM9,S38A6_HUMAN,Probable sodium-coupled neutral amino acid transporter 6 (N-system amino acid transporter 1) (NAT-1) (Na(+)-coupled neutral amino acid transporter 6) (Solute carrier family 38 member 6),456,"50,929",3 out of 5,2007-11-13,Evidence at protein level
Q9NY26,S39A1_HUMAN,Zinc transporter ZIP1 (Solute carrier family 39 member 1) (Zinc-iron-regulated transporter-like) (Zrt- and Irt-like protein 1) (ZIP-1) (hZIP1),324,"34,250",5 out of 5,2003-09-26,Evidence at protein level
Q13433,S39A6_HUMAN,Zinc transporter ZIP6 (Estrogen-regulated protein LIV-1) (Solute carrier family 39 member 6) (Zrt- and Irt-like protein 6) (ZIP-6),755,"85,047",5 out of 5,2005-07-05,Evidence at protein level
Q8IVJ1,S41A1_HUMAN,Solute carrier family 41 member 1,513,"54,901",5 out of 5,2007-07-10,Evidence at transcript level
Q96GZ6,S41A3_HUMAN,Solute carrier family 41 member 3,507,"54,767",4 out of 5,2007-07-24,Evidence at protein level
Q9Y2W3,S45A1_HUMAN,Proton-associated sugar transporter A (PAST-A) (Deleted in neuroblastoma 5 protein) (DNb-5) (Solute carrier family 45 member 1),748,"80,843",3 out of 5,2003-10-24,Evidence at transcript level
Q9HAB3,S52A2_HUMAN,"Solute carrier family 52, riboflavin transporter, member 2 (Porcine endogenous retrovirus A receptor 1) (PERV-A receptor 1) (Protein GPR172A) (Riboflavin transporter 3) (hRFT3)",445,"45,777",5 out of 5,2005-10-11,Evidence at protein level
Q9UBE0,SAE1_HUMAN,"SUMO-activating enzyme subunit 1 (Ubiquitin-like 1-activating enzyme E1A) [Cleaved into: SUMO-activating enzyme subunit 1, N-terminally processed]",346,"38,450",5 out of 5,2004-02-16,Evidence at protein level
Q14151,SAFB2_HUMAN,Scaffold attachment factor B2 (SAF-B2),953,"107,473",5 out of 5,2003-11-14,Evidence at protein level
Q9Y467,SALL2_HUMAN,Sal-like protein 2 (Zinc finger protein 795) (Zinc finger protein SALL2) (Zinc finger protein Spalt-2) (Sal-2) (hSal2),1007,"105,309",5 out of 5,2002-05-02,Evidence at protein level
Q6UVJ0,SAS6_HUMAN,Spindle assembly abnormal protein 6 homolog (HsSAS-6),657,"74,397",5 out of 5,2005-04-12,Evidence at protein level
Q9NV23,SAST_HUMAN,"S-acyl fatty acid synthase thioesterase, medium chain (EC 3.1.2.14) (Augmented in rheumatoid arthritis 1) (AURA1) (Oleoyl-ACP hydrolase) (Thioesterase II) (Thioesterase domain-containing protein 1)",265,"29,931",4 out of 5,2004-09-27,Evidence at protein level
Q9UPW6,SATB2_HUMAN,DNA-binding protein SATB2 (Special AT-rich sequence-binding protein 2),733,"82,555",5 out of 5,2001-04-27,Evidence at protein level
P82664,RT10_HUMAN,"28S ribosomal protein S10, mitochondrial (MRP-S10) (S10mt) (Mitochondrial small ribosomal subunit protein uS10m)",201,"22,999",3 out of 5,2001-12-13,Evidence at protein level
O60783,RT14_HUMAN,"28S ribosomal protein S14, mitochondrial (MRP-S14) (S14mt) (Mitochondrial small ribosomal subunit protein uS14m)",128,"15,139",4 out of 5,2004-01-16,Evidence at protein level
Q92541,RTF1_HUMAN,RNA polymerase-associated protein RTF1 homolog,710,"80,313",5 out of 5,2006-10-31,Evidence at protein level
Q9BY42,RTF2_HUMAN,Protein RTF2 homolog (Replication termination factor 2 domain-containing protein 1),306,"33,887",2 out of 5,2002-10-10,Evidence at protein level
Q9BZR6,RTN4R_HUMAN,Reticulon-4 receptor (Nogo receptor) (NgR) (Nogo-66 receptor),473,"50,708",5 out of 5,2002-11-25,Evidence at protein level
Q96C34,RUND1_HUMAN,RUN domain-containing protein 1,613,"67,643",4 out of 5,2007-04-17,Evidence at protein level
Q01196,RUNX1_HUMAN,Runt-related transcription factor 1 (Acute myeloid leukemia 1 protein) (Core-binding factor subunit alpha-2) (CBF-alpha-2) (Oncogene AML-1) (Polyomavirus enhancer-binding protein 2 alpha B subunit) (PEA2-alpha B) (PEBP2-alpha B) (SL3-3 enhancer factor 1 alpha B subunit) (SL3/AKV core-binding factor alpha B subunit),453,"48,737",5 out of 5,1993-04-01,Evidence at protein level
P62304,RUXE_HUMAN,Small nuclear ribonucleoprotein E (snRNP-E) (Sm protein E) (Sm-E) (SmE),92,"10,804",5 out of 5,1988-08-01,Evidence at protein level
P33764,S10A3_HUMAN,Protein S100-A3 (Protein S-100E) (S100 calcium-binding protein A3),101,"11,713",5 out of 5,1994-02-01,Evidence at protein level
Q8N413,S2545_HUMAN,Solute carrier family 25 member 45,288,"31,906",3 out of 5,2007-06-26,Evidence at transcript level
P58743,S26A5_HUMAN,Prestin (Solute carrier family 26 member 5),744,"81,264",5 out of 5,2002-03-27,Evidence at transcript level
Q7LBE3,S26A9_HUMAN,Solute carrier family 26 member 9 (Anion transporter/exchanger protein 9),791,"86,988",5 out of 5,2008-03-18,Evidence at protein level
Q7RTT9,S29A4_HUMAN,Equilibrative nucleoside transporter 4 (hENT4) (Plasma membrane monoamine transporter) (Solute carrier family 29 member 4),530,"58,059",5 out of 5,2008-03-18,Evidence at protein level
Q9UHR5,S30BP_HUMAN,SAP30-binding protein (Transcriptional regulator protein HCNGP),308,"33,870",5 out of 5,2006-07-11,Evidence at protein level
Q5VVP1,S31A6_HUMAN,Spermatogenesis-associated protein 31A6 (Protein FAM75A6),1343,"147,818",2 out of 5,2007-08-21,Inferred from homology
Q6ZUB1,S31E1_HUMAN,Spermatogenesis-associated protein 31E1 (Protein FAM75E1),1445,"157,136",4 out of 5,2005-07-19,Evidence at transcript level
Q76EJ3,S35D2_HUMAN,UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter (Homolog of Fringe connection protein 1) (HFRC1) (SQV7-like protein) (SQV7L) (Solute carrier family 35 member D2) (UDP-galactose transporter-related protein 8) (UGTrel8),337,"36,673",5 out of 5,2008-01-15,Evidence at protein level
Q96K37,S35E1_HUMAN,Solute carrier family 35 member E1,410,"44,773",3 out of 5,2004-04-26,Evidence at protein level
Q8IY50,S35F3_HUMAN,Putative thiamine transporter SLC35F3 (Solute carrier family 35 member F3),421,"46,817",3 out of 5,2007-10-23,Evidence at transcript level
Q2M3R5,S35G1_HUMAN,Solute carrier family 35 member G1 (Partner of STIM1) (Transmembrane protein 20),365,"39,836",5 out of 5,2006-06-27,Evidence at protein level
Q6YBV0,S36A4_HUMAN,Proton-coupled amino acid transporter 4 (Proton/amino acid transporter 4) (Solute carrier family 36 member 4),504,"56,157",5 out of 5,2007-10-23,Evidence at protein level
Q99624,S38A3_HUMAN,Sodium-coupled neutral amino acid transporter 3 (N-system amino acid transporter 1) (Na(+)-coupled neutral amino acid transporter 3) (Solute carrier family 38 member 3) (System N amino acid transporter 1),504,"55,773",5 out of 5,2004-09-27,Evidence at protein level
A6NNN8,S38A8_HUMAN,Putative sodium-coupled neutral amino acid transporter 8 (Solute carrier family 38 member 8),435,"46,731",3 out of 5,2008-02-26,Evidence at protein level
Q6ZMH5,S39A5_HUMAN,Zinc transporter ZIP5 (Solute carrier family 39 member 5) (Zrt- and Irt-like protein 5) (ZIP-5),540,"56,461",5 out of 5,2006-01-24,Evidence at protein level
Q9NUM3,S39A9_HUMAN,Zinc transporter ZIP9 (Solute carrier family 39 member 9) (Zrt- and Irt-like protein 9) (ZIP-9),307,"32,251",3 out of 5,2007-08-21,Evidence at transcript level
Q8N1S5,S39AB_HUMAN,Zinc transporter ZIP11 (Solute carrier family 39 member 11) (Zrt- and Irt-like protein 11) (ZIP-11),342,"35,396",3 out of 5,2007-10-23,Evidence at transcript level
Q8TBB6,S7A14_HUMAN,Probable cationic amino acid transporter (Solute carrier family 7 member 14),771,"84,052",5 out of 5,2007-10-23,Evidence at transcript level
Q9BYL1,SAM10_HUMAN,Sterile alpha motif domain-containing protein 10 (SAM domain-containing protein 10),202,"22,770",1 out of 5,2002-12-06,Evidence at transcript level
Q9P1V8,SAM15_HUMAN,Sterile alpha motif domain-containing protein 15 (SAM domain-containing protein 15),674,"77,151",2 out of 5,2007-03-06,Evidence at transcript level
Q6NUJ1,SAPL1_HUMAN,Proactivator polypeptide-like 1 [Cleaved into: Saposin A-like; Saposin B-Val-like; Saposin B-like; Saposin C-like; Saposin D-like],521,"56,627",4 out of 5,2007-03-20,Evidence at transcript level
P07602,SAP_HUMAN,Prosaposin (Proactivator polypeptide) [Cleaved into: Saposin-A (Protein A); Saposin-B-Val; Saposin-B (Cerebroside sulfate activator) (CSAct) (Dispersin) (Sphingolipid activator protein 1) (SAP-1) (Sulfatide/GM1 activator); Saposin-C (A1 activator) (Co-beta-glucosidase) (Glucosylceramidase activator) (Sphingolipid activator protein 2) (SAP-2); Saposin-D (Component C) (Protein C)],524,"58,113",5 out of 5,1988-04-01,Evidence at protein level
Q6SZW1,SARM1_HUMAN,Sterile alpha and TIR motif-containing protein 1 (Sterile alpha and Armadillo repeat protein) (Sterile alpha motif domain-containing protein 2) (MyD88-5) (SAM domain-containing protein 2) (Tir-1 homolog),724,"79,388",5 out of 5,2005-05-10,Evidence at protein level
Q96F10,SAT2_HUMAN,Diamine acetyltransferase 2 (EC 2.3.1.57) (Polyamine N-acetyltransferase 2) (Spermidine/spermine N(1)-acetyltransferase 2) (Thialysine N-epsilon-acetyltransferase),170,"19,155",5 out of 5,2004-08-16,Evidence at protein level
P0C263,SBK2_HUMAN,Serine/threonine-protein kinase SBK2 (EC 2.7.11.1) (SH3-binding domain kinase family member 2) (Sugen kinase 69) (SgK069),348,"38,088",3 out of 5,2006-11-28,Inferred from homology
Q92791,SC65_HUMAN,Synaptonemal complex protein SC65 (Leprecan-like protein 4) (Nucleolar autoantigen No55) (Prolyl 3-hydroxylase family member 4),437,"50,381",3 out of 5,1998-07-15,Evidence at protein level
P31641,SC6A6_HUMAN,Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6),620,"69,830",5 out of 5,1993-07-01,Evidence at protein level
Q8N9R8,SCAI_HUMAN,Protein SCAI (Suppressor of cancer cell invasion protein),606,"70,399",5 out of 5,2005-08-16,Evidence at protein level
O14828,SCAM3_HUMAN,Secretory carrier-associated membrane protein 3 (Secretory carrier membrane protein 3),347,"38,287",5 out of 5,1998-12-15,Evidence at protein level
Q9P0W5,SCHI1_HUMAN,Schwannomin-interacting protein 1 (SCHIP-1),487,"53,480",4 out of 5,2007-05-29,Evidence at protein level
Q96KG9,SCYL1_HUMAN,N-terminal kinase-like protein (Coated vesicle-associated kinase of 90 kDa) (SCY1-like protein 1) (Telomerase regulation-associated protein) (Telomerase transcriptional element-interacting factor) (Teratoma-associated tyrosine kinase),808,"89,631",5 out of 5,2006-09-19,Evidence at protein level
Q96C92,SDCG3_HUMAN,Serologically defined colon cancer antigen 3 (Antigen NY-CO-3),435,"47,961",5 out of 5,2008-03-18,Evidence at protein level
P62081,RS7_HUMAN,40S ribosomal protein S7 (Small ribosomal subunit protein eS7),194,"22,127",5 out of 5,2004-06-21,Evidence at protein level
Q96S79,RSLAB_HUMAN,Ras-like protein family member 10B (Ras-like protein VTS58635) (Ras-related protein 17) (RRP17),203,"23,229",4 out of 5,2007-03-20,Evidence at transcript level
Q96DX4,RSPRY_HUMAN,RING finger and SPRY domain-containing protein 1,576,"64,180",3 out of 5,2007-02-20,Evidence at protein level
Q7L4I2,RSRC2_HUMAN,Arginine/serine-rich coiled-coil protein 2,434,"50,560",4 out of 5,2008-01-15,Evidence at protein level
Q9NVS2,RT18A_HUMAN,"39S ribosomal protein S18a, mitochondrial (MRP-S18-a) (Mrps18a) (S18mt-a) (39S ribosomal protein S18-3, mitochondrial) (MRP-S18-3) (Mitochondrial large ribosomal subunit protein bS18a) (Mitochondrial large ribosomal subunit protein mL66)",196,"22,184",4 out of 5,2002-10-19,Evidence at protein level
Q9Y2Q9,RT28_HUMAN,"28S ribosomal protein S28, mitochondrial (MRP-S28) (S28mt) (28S ribosomal protein S35, mitochondrial) (MRP-S35) (S35mt) (Mitochondrial small ribosomal subunit protein bS1m)",187,"20,843",4 out of 5,2002-07-26,Evidence at protein level
Q92665,RT31_HUMAN,"28S ribosomal protein S31, mitochondrial (MRP-S31) (S31mt) (Imogen 38) (Mitochondrial small ribosomal subunit protein mS31)",395,"45,318",5 out of 5,2002-10-19,Evidence at protein level
Q8WWV3,RT4I1_HUMAN,"Reticulon-4-interacting protein 1, mitochondrial (NOGO-interacting mitochondrial protein)",396,"43,590",4 out of 5,2005-09-27,Evidence at protein level
Q9BST9,RTKN_HUMAN,Rhotekin,563,"62,667",5 out of 5,2006-05-02,Evidence at protein level
Q16799,RTN1_HUMAN,Reticulon-1 (Neuroendocrine-specific protein),776,"83,618",5 out of 5,2000-12-01,Evidence at protein level
Q9NQC3,RTN4_HUMAN,Reticulon-4 (Foocen) (Neurite outgrowth inhibitor) (Nogo protein) (Neuroendocrine-specific protein) (NSP) (Neuroendocrine-specific protein C homolog) (RTN-x) (Reticulon-5),1192,"129,931",5 out of 5,2001-11-16,Evidence at protein level
Q9BVN2,RUSC1_HUMAN,RUN and SH3 domain-containing protein 1 (New molecule containing SH3 at the carboxy-terminus) (Nesca),902,"96,444",5 out of 5,2004-07-19,Evidence at protein level
P62241,RS8_HUMAN,40S ribosomal protein S8 (Small ribosomal subunit protein eS8),208,"24,205",5 out of 5,2004-07-05,Evidence at protein level
Q92681,RSCA1_HUMAN,Regulatory solute carrier protein family 1 member 1 (Transporter regulator RS1) (hRS1),617,"66,790",5 out of 5,2008-03-18,Evidence at transcript level
P82650,RT22_HUMAN,"28S ribosomal protein S22, mitochondrial (MRP-S22) (S22mt) (Mitochondrial small ribosomal subunit protein mS22)",360,"41,280",5 out of 5,2001-04-27,Evidence at protein level
Q9NP92,RT30_HUMAN,"39S ribosomal protein S30, mitochondrial (MRP-S30) (S30mt) (Mitochondrial large ribosomal subunit protein mL65) (Mitochondrial large ribosomal subunit protein mS30) (Programmed cell death protein 9)",439,"50,365",4 out of 5,2002-10-19,Evidence at protein level
P82930,RT34_HUMAN,"28S ribosomal protein S34, mitochondrial (MRP-S34) (S34mt) (Mitochondrial small ribosomal subunit protein mS34)",218,"25,650",4 out of 5,2002-10-19,Evidence at protein level
Q9BSG5,RTBDN_HUMAN,Retbindin,229,"24,615",3 out of 5,2005-12-06,Evidence at protein level
Q86VV8,RTTN_HUMAN,Rotatin,2226,"248,630",4 out of 5,2007-10-23,Evidence at protein level
Q8IZ73,RUSD2_HUMAN,RNA pseudouridylate synthase domain-containing protein 2,545,"61,311",3 out of 5,2007-09-11,Evidence at protein level
Q9Y265,RUVB1_HUMAN,RuvB-like 1 (EC 3.6.4.12) (49 kDa TATA box-binding protein-interacting protein) (49 kDa TBP-interacting protein) (54 kDa erythrocyte cytosolic protein) (ECP-54) (INO80 complex subunit H) (Nuclear matrix protein 238) (NMP 238) (Pontin 52) (TIP49a) (TIP60-associated protein 54-alpha) (TAP54-alpha),456,"50,228",5 out of 5,2003-02-01,Evidence at protein level
P48443,RXRG_HUMAN,Retinoic acid receptor RXR-gamma (Nuclear receptor subfamily 2 group B member 3) (Retinoid X receptor gamma),463,"50,871",5 out of 5,1996-02-01,Evidence at protein level
Q9HCY8,S10AE_HUMAN,Protein S100-A14 (S100 calcium-binding protein A14) (S114),104,"11,662",5 out of 5,2002-04-16,Evidence at protein level
Q9UKG4,S13A4_HUMAN,Solute carrier family 13 member 4 (Na(+)/sulfate cotransporter SUT-1) (NaS2),626,"69,358",4 out of 5,2002-09-19,Evidence at transcript level
Q92503,S14L1_HUMAN,SEC14-like protein 1,715,"81,250",5 out of 5,1997-11-01,Evidence at protein level
O43304,S14L5_HUMAN,SEC14-like protein 5,696,"78,942",2 out of 5,2008-05-20,Evidence at transcript level
A6NIM6,S15A5_HUMAN,Solute carrier family 15 member 5,579,"65,263",2 out of 5,2008-04-29,Inferred from homology
Q9Y2C5,S17A4_HUMAN,Probable small intestine urate exporter (Solute carrier family 17 member 4),497,"54,055",4 out of 5,2008-02-05,Evidence at transcript level
O60779,S19A2_HUMAN,Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1),497,"55,400",5 out of 5,1999-07-15,Evidence at protein level
Q96BU1,S1PBP_HUMAN,S100P-binding protein (S100P-binding protein Riken),408,"45,582",4 out of 5,2008-02-05,Evidence at protein level
P0DJI9,SAA2_HUMAN,Serum amyloid A-2 protein (SAA2),122,"13,527",5 out of 5,2012-07-11,Evidence at protein level
Q9NTJ5,SAC1_HUMAN,Phosphatidylinositide phosphatase SAC1 (EC 3.1.3.-) (Suppressor of actin mutations 1-like protein),587,"66,967",5 out of 5,2008-02-05,Evidence at protein level
Q8TDM5,SACA4_HUMAN,Sperm acrosome membrane-associated protein 4 (Sperm acrosomal membrane-associated protein 14),124,"13,004",4 out of 5,2006-10-17,Evidence at protein level
Q9H4B6,SAV1_HUMAN,Protein salvador homolog 1 (45 kDa WW domain protein) (hWW45),383,"44,634",5 out of 5,2003-07-11,Evidence at protein level
P30531,SC6A1_HUMAN,Sodium- and chloride-dependent GABA transporter 1 (GAT-1) (Solute carrier family 6 member 1),599,"67,074",5 out of 5,1993-04-01,Evidence at protein level
O15127,SCAM2_HUMAN,Secretory carrier-associated membrane protein 2 (Secretory carrier membrane protein 2),329,"36,649",5 out of 5,1998-12-15,Evidence at protein level
Q86SK9,SCD5_HUMAN,Stearoyl-CoA desaturase 5 (EC 1.14.19.1) (Acyl-CoA-desaturase 4) (HSCD5) (Stearoyl-CoA 9-desaturase) (Stearoyl-CoA desaturase 2),330,"37,610",5 out of 5,2007-12-04,Evidence at protein level
P35498,SCN1A_HUMAN,Sodium channel protein type 1 subunit alpha (Sodium channel protein brain I subunit alpha) (Sodium channel protein type I subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.1),2009,"228,972",5 out of 5,1994-06-01,Evidence at protein level
Q01118,SCN7A_HUMAN,Sodium channel protein type 7 subunit alpha (Putative voltage-gated sodium channel subunit alpha Nax) (Sodium channel protein cardiac and skeletal muscle subunit alpha) (Sodium channel protein type VII subunit alpha),1682,"193,493",5 out of 5,1993-07-01,Evidence at protein level
Q9UQD0,SCN8A_HUMAN,Sodium channel protein type 8 subunit alpha (Sodium channel protein type VIII subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.6),1980,"225,280",5 out of 5,2003-08-15,Evidence at protein level
O43819,SCO2_HUMAN,"Protein SCO2 homolog, mitochondrial",266,"29,810",5 out of 5,2000-05-30,Evidence at protein level
Q9UIL1,SCOC_HUMAN,Short coiled-coil protein,159,"18,045",5 out of 5,2008-05-20,Evidence at protein level
O75711,SCRG1_HUMAN,Scrapie-responsive protein 1 (Scrapie-responsive gene 1 protein) (ScRG-1),98,"11,081",3 out of 5,2000-05-30,Evidence at protein level
Q12765,SCRN1_HUMAN,Secernin-1,414,"46,382",4 out of 5,1997-11-01,Evidence at protein level
Q8IX30,SCUB3_HUMAN,"Signal peptide, CUB and EGF-like domain-containing protein 3",993,"109,282",5 out of 5,2006-10-03,Evidence at protein level
O00560,SDCB1_HUMAN,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),298,"32,444",5 out of 5,2002-05-02,Evidence at protein level
Q99470,SDF2_HUMAN,Stromal cell-derived factor 2 (SDF-2),211,"23,026",2 out of 5,2002-06-20,Evidence at protein level
Q96T21,SEBP2_HUMAN,Selenocysteine insertion sequence-binding protein 2 (SECIS-binding protein 2),854,"95,462",5 out of 5,2002-01-31,Evidence at protein level
Q9H4I8,SEHL2_HUMAN,Serine hydrolase-like protein 2 (EC 3.1.-.-),314,"35,369",4 out of 5,2002-06-06,Evidence at transcript level
P57772,SELB_HUMAN,"Selenocysteine-specific elongation factor (Elongation factor sec) (Eukaryotic elongation factor, selenocysteine-tRNA-specific)",596,"65,305",4 out of 5,2001-02-21,Evidence at protein level
O95025,SEM3D_HUMAN,Semaphorin-3D,777,"89,651",3 out of 5,2000-05-30,Evidence at transcript level
Q13275,SEM3F_HUMAN,Semaphorin-3F (Sema III/F) (Semaphorin IV) (Sema IV),785,"88,381",5 out of 5,2000-05-30,Evidence at transcript level
Q92854,SEM4D_HUMAN,Semaphorin-4D (A8) (BB18) (GR3) (CD antigen CD100),862,"96,150",5 out of 5,2000-05-30,Evidence at protein level
Q13591,SEM5A_HUMAN,Semaphorin-5A (Semaphorin-F) (Sema F),1074,"120,615",5 out of 5,2000-05-30,Evidence at protein level
Q9P283,SEM5B_HUMAN,Semaphorin-5B,1151,"125,913",5 out of 5,2003-10-10,Evidence at transcript level
Q02383,SEMG2_HUMAN,Semenogelin-2 (Semenogelin II) (SGII),582,"65,444",5 out of 5,1993-07-01,Evidence at protein level
Q8WYJ6,SEPT1_HUMAN,Septin-1 (LARP) (Peanut-like protein 3) (Serologically defined breast cancer antigen NY-BR-24),367,"41,971",5 out of 5,2002-04-16,Evidence at protein level
Q15019,SEPT2_HUMAN,Septin-2 (Neural precursor cell expressed developmentally down-regulated protein 5) (NEDD-5),361,"41,487",5 out of 5,1997-11-01,Evidence at protein level
Q14141,SEPT6_HUMAN,Septin-6,434,"49,717",5 out of 5,1997-11-01,Evidence at protein level
A8K8P3,SFI1_HUMAN,Protein SFI1 homolog (hSFI1),1242,"147,664",5 out of 5,2008-05-20,Evidence at protein level
Q8N474,SFRP1_HUMAN,Secreted frizzled-related protein 1 (FRP-1) (sFRP-1) (Secreted apoptosis-related protein 2) (SARP-2),314,"35,386",5 out of 5,2005-03-15,Evidence at protein level
Q6FHJ7,SFRP4_HUMAN,"Secreted frizzled-related protein 4 (sFRP-4) (Frizzled protein, human endometrium) (FrpHE)",346,"39,827",5 out of 5,2005-03-15,Evidence at protein level
Q12872,SFSWA_HUMAN,"Splicing factor, suppressor of white-apricot homolog (Splicing factor, arginine/serine-rich 8) (Suppressor of white apricot protein homolog)",951,"104,822",4 out of 5,1998-12-15,Evidence at protein level
Q8TD22,SFXN5_HUMAN,Sideroflexin-5,340,"37,124",2 out of 5,2003-05-09,Evidence at protein level
Q6XE38,SG1D4_HUMAN,Secretoglobin family 1D member 4 (IFN-gamma-inducible secretoglobin) (IIS),83,"9,201",3 out of 5,2004-11-09,Evidence at protein level
Q86YV5,SG223_HUMAN,Tyrosine-protein kinase SgK223 (EC 2.7.10.2) (Sugen kinase 223),1406,"149,624",4 out of 5,2006-11-28,Evidence at protein level
Q9HBY8,SGK2_HUMAN,Serine/threonine-protein kinase Sgk2 (EC 2.7.11.1) (Serum/glucocorticoid-regulated kinase 2),427,"47,604",5 out of 5,2003-02-22,Evidence at protein level
Q8IVN8,SBSPO_HUMAN,Somatomedin-B and thrombospondin type-1 domain-containing protein (RPE-spondin),264,"29,610",3 out of 5,2008-04-29,Evidence at protein level
Q9BY50,SC11C_HUMAN,Signal peptidase complex catalytic subunit SEC11C (EC 3.4.21.89) (Microsomal signal peptidase 21 kDa subunit) (SPase 21 kDa subunit) (SEC11 homolog C) (SEC11-like protein 3) (SPC21),192,"21,542",4 out of 5,2001-11-02,Evidence at protein level
Q96JE7,SC16B_HUMAN,Protein transport protein Sec16B (Leucine zipper transcription regulator 2) (Regucalcin gene promoter region-related protein p117) (RGPR-p117) (SEC16 homolog B),1060,"116,604",5 out of 5,2008-07-01,Evidence at protein level
O75396,SC22B_HUMAN,Vesicle-trafficking protein SEC22b (ER-Golgi SNARE of 24 kDa) (ERS-24) (ERS24) (SEC22 vesicle-trafficking protein homolog B) (SEC22 vesicle-trafficking protein-like 1),215,"24,593",5 out of 5,2004-03-29,Evidence at protein level
P53992,SC24C_HUMAN,Protein transport protein Sec24C (SEC24-related protein C),1094,"118,325",5 out of 5,1996-10-01,Evidence at protein level
Q9NQW1,SC31B_HUMAN,Protein transport protein Sec31B (SEC31-like protein 2) (SEC31-related protein B) (SEC31B-1),1179,"128,697",5 out of 5,2007-07-10,Evidence at protein level
Q9GZV3,SC5A7_HUMAN,High affinity choline transporter 1 (Hemicholinium-3-sensitive choline transporter) (CHT) (Solute carrier family 5 member 7),580,"63,204",5 out of 5,2004-12-07,Evidence at protein level
Q2M3M2,SC5A9_HUMAN,Sodium/glucose cotransporter 4 (Na(+)/glucose cotransporter 4) (hSGLT4) (Solute carrier family 5 member 9),681,"74,073",5 out of 5,2008-05-20,Evidence at protein level
A0PJK1,SC5AA_HUMAN,Sodium/glucose cotransporter 5 (Na(+)/glucose cotransporter 5) (Solute carrier family 5 member 10),596,"64,342",5 out of 5,2007-11-13,Evidence at protein level
P60059,SC61G_HUMAN,Protein transport protein Sec61 subunit gamma,68,"7,741",4 out of 5,2003-11-21,Evidence at protein level
P48067,SC6A9_HUMAN,Sodium- and chloride-dependent glycine transporter 1 (GlyT-1) (GlyT1) (Solute carrier family 6 member 9),706,"78,260",5 out of 5,1996-02-01,Evidence at protein level
Q99590,SCAFB_HUMAN,"Protein SCAF11 (CTD-associated SR protein 11) (Renal carcinoma antigen NY-REN-40) (SC35-interacting protein 1) (SR-related and CTD-associated factor 11) (SRSF2-interacting protein) (Serine/arginine-rich splicing factor 2-interacting protein) (Splicing factor, arginine/serine-rich 2-interacting protein) (Splicing regulatory protein 129) (SRrp129)",1463,"164,652",5 out of 5,2006-02-07,Evidence at protein level
P21583,SCF_HUMAN,Kit ligand (Mast cell growth factor) (MGF) (Stem cell factor) (SCF) (c-Kit ligand) [Cleaved into: Soluble KIT ligand (sKITLG)],273,"30,899",5 out of 5,1991-05-01,Evidence at protein level
O60939,SCN2B_HUMAN,Sodium channel subunit beta-2,215,"24,326",5 out of 5,2001-01-11,Evidence at protein level
Q8IWT1,SCN4B_HUMAN,Sodium channel subunit beta-4,228,"24,969",5 out of 5,2005-01-04,Evidence at protein level
Q9UI33,SCNBA_HUMAN,Sodium channel protein type 11 subunit alpha (Peripheral nerve sodium channel 5) (PN5) (Sensory neuron sodium channel 2) (Sodium channel protein type XI subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.9) (hNaN),1791,"204,922",5 out of 5,2004-12-21,Evidence at protein level
O75880,SCO1_HUMAN,"Protein SCO1 homolog, mitochondrial",301,"33,814",5 out of 5,2000-05-30,Evidence at protein level
Q9BYC2,SCOT2_HUMAN,"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial (EC 2.8.3.5) (3-oxoacid CoA-transferase 2A) (Testis-specific succinyl-CoA:3-oxoacid CoA-transferase) (SCOT-t)",517,"56,140",4 out of 5,2004-06-07,Evidence at transcript level
Q9UJQ7,SCP2D_HUMAN,SCP2 sterol-binding domain-containing protein 1,156,"17,663",2 out of 5,2002-11-08,Evidence at transcript level
Q6IQ49,SDE2_HUMAN,Protein SDE2 homolog,451,"49,742",2 out of 5,2007-05-01,Evidence at protein level
Q7Z5N4,SDK1_HUMAN,Protein sidekick-1,2213,"242,112",5 out of 5,2006-03-07,Evidence at transcript level
Q9H7L9,SDS3_HUMAN,Sin3 histone deacetylase corepressor complex component SDS3 (45 kDa Sin3-associated polypeptide) (Suppressor of defective silencing 3 protein homolog),328,"38,136",5 out of 5,2005-06-21,Evidence at protein level
Q9HB31,SEBOX_HUMAN,"Homeobox protein SEBOX (Homeobox OG-9) (Skin-, embryo-, brain- and oocyte-specific homeobox)",216,"22,879",3 out of 5,2007-11-13,Inferred from homology
Q9UGP8,SEC63_HUMAN,Translocation protein SEC63 homolog,760,"87,997",5 out of 5,2001-10-18,Evidence at protein level
O76038,SEGN_HUMAN,Secretagogin,276,"32,040",3 out of 5,2001-04-27,Evidence at transcript level
Q9BQE4,SELS_HUMAN,Selenoprotein S (SelS) (VCP-interacting membrane protein),189,"21,163",5 out of 5,2003-08-04,Evidence at protein level
P59797,SELV_HUMAN,Selenoprotein V (SelV),346,"36,800",3 out of 5,2003-08-04,Evidence at protein level
Q9H3S1,SEM4A_HUMAN,Semaphorin-4A (Semaphorin-B) (Sema B),761,"83,574",5 out of 5,2002-05-02,Evidence at protein level
Q9C0C4,SEM4C_HUMAN,Semaphorin-4C,833,"92,623",5 out of 5,2004-05-24,Evidence at protein level
Q9H3T2,SEM6C_HUMAN,Semaphorin-6C (Semaphorin-Y) (Sema Y),930,"99,686",4 out of 5,2001-04-27,Evidence at transcript level
Q9GZR1,SENP6_HUMAN,Sentrin-specific protease 6 (EC 3.4.22.68) (SUMO-1-specific protease 1) (Sentrin/SUMO-specific protease SENP6),1112,"126,146",5 out of 5,2001-10-18,Evidence at protein level
Q8IYM1,SEP12_HUMAN,Septin-12,358,"40,748",5 out of 5,2007-12-04,Evidence at protein level
O75920,SERF1_HUMAN,Small EDRK-rich factor 1 (Protein 4F5) (h4F5) (SMA modifier 1),110,"12,349",3 out of 5,2002-09-19,Evidence at transcript level
Q15047,SETB1_HUMAN,Histone-lysine N-methyltransferase SETDB1 (EC 2.1.1.43) (ERG-associated protein with SET domain) (ESET) (Histone H3-K9 methyltransferase 4) (H3-K9-HMTase 4) (Lysine N-methyltransferase 1E) (SET domain bifurcated 1),1291,"143,157",5 out of 5,2002-11-15,Evidence at protein level
Q53H47,SETMR_HUMAN,Histone-lysine N-methyltransferase SETMAR (SET domain and mariner transposase fusion protein) (Metnase) [Includes: Histone-lysine N-methyltransferase (EC 2.1.1.43); Transposon Hsmar1 transposase (EC 3.1.-.-)],684,"78,034",5 out of 5,2006-10-31,Evidence at protein level
Q15637,SF01_HUMAN,Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162),639,"68,330",5 out of 5,2003-11-07,Evidence at protein level
Q15393,SF3B3_HUMAN,Splicing factor 3B subunit 3 (Pre-mRNA-splicing factor SF3b 130 kDa subunit) (SF3b130) (STAF130) (Spliceosome-associated protein 130) (SAP 130),1217,"135,577",5 out of 5,1998-07-15,Evidence at protein level
Q9BXA9,SALL3_HUMAN,Sal-like protein 3 (Zinc finger protein 796) (Zinc finger protein SALL3) (hSALL3),1300,"135,346",5 out of 5,2002-05-02,Evidence at protein level
Q9UJQ4,SALL4_HUMAN,Sal-like protein 4 (Zinc finger protein 797) (Zinc finger protein SALL4),1053,"112,231",5 out of 5,2002-10-19,Evidence at protein level
Q8IVG5,SAM9L_HUMAN,Sterile alpha motif domain-containing protein 9-like (SAM domain-containing protein 9-like),1584,"184,533",4 out of 5,2007-03-06,Evidence at protein level
Q8N6K7,SAMD3_HUMAN,Sterile alpha motif domain-containing protein 3 (SAM domain-containing protein 3),520,"61,237",3 out of 5,2007-03-06,Evidence at protein level
Q5K651,SAMD9_HUMAN,Sterile alpha motif domain-containing protein 9 (SAM domain-containing protein 9),1589,"184,281",5 out of 5,2005-07-19,Evidence at protein level
P02743,SAMP_HUMAN,Serum amyloid P-component (SAP) (9.5S alpha-1-glycoprotein) [Cleaved into: Serum amyloid P-component(1-203)],223,"25,387",5 out of 5,1986-07-21,Evidence at protein level
Q9UL12,SARDH_HUMAN,"Sarcosine dehydrogenase, mitochondrial (SarDH) (EC 1.5.8.3) (BPR-2)",918,"101,037",4 out of 5,2004-09-13,Evidence at protein level
Q9NQZ2,SAS10_HUMAN,Something about silencing protein 10 (Charged amino acid-rich leucine zipper 1) (CRL1) (Disrupter of silencing SAS10) (UTP3 homolog),479,"54,558",4 out of 5,2005-02-01,Evidence at protein level
P43007,SATT_HUMAN,Neutral amino acid transporter A (Alanine/serine/cysteine/threonine transporter 1) (ASCT-1) (SATT) (Solute carrier family 1 member 4),532,"55,723",5 out of 5,1995-11-01,Evidence at protein level
Q8N695,SC5A8_HUMAN,Sodium-coupled monocarboxylate transporter 1 (Apical iodide transporter) (Electrogenic sodium monocarboxylate cotransporter) (Sodium iodide-related cotransporter) (Solute carrier family 5 member 8),610,"66,578",5 out of 5,2008-05-20,Evidence at protein level
Q8WWX8,SC5AB_HUMAN,Sodium/myo-inositol cotransporter 2 (Na(+)/myo-inositol cotransporter 2) (Sodium-dependent glucose cotransporter) (Sodium/glucose cotransporter KST1) (Sodium/myo-inositol transporter 2) (SMIT2) (Solute carrier family 5 member 11),675,"74,036",5 out of 5,2008-04-29,Evidence at protein level
Q1EHB4,SC5AC_HUMAN,Sodium-coupled monocarboxylate transporter 2 (Electroneutral sodium monocarboxylate cotransporter) (Low-affinity sodium-lactate cotransporter) (Solute carrier family 5 member 12),618,"67,647",5 out of 5,2008-05-20,Evidence at transcript level
P48029,SC6A8_HUMAN,Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8),635,"70,523",5 out of 5,1996-02-01,Evidence at protein level
Q8TAC9,SCAM5_HUMAN,Secretory carrier-associated membrane protein 5 (Secretory carrier membrane protein 5) (hSCAMP5),235,"26,104",5 out of 5,2004-05-10,Evidence at protein level
Q6AZY7,SCAR3_HUMAN,Scavenger receptor class A member 3 (Cellular stress response gene protein),606,"65,137",5 out of 5,2006-02-07,Evidence at protein level
P05060,SCG1_HUMAN,Secretogranin-1 (Chromogranin-B) (CgB) (Secretogranin I) (SgI) [Cleaved into: PE-11; GAWK peptide; CCB peptide],677,"78,276",5 out of 5,1987-08-13,Evidence at protein level
Q9BV35,SCMC3_HUMAN,Calcium-binding mitochondrial carrier protein SCaMC-3 (Mitochondrial ATP-Mg/Pi carrier protein 2) (Mitochondrial Ca(2+)-dependent solute carrier protein 2) (Small calcium-binding mitochondrial carrier protein 3) (Solute carrier family 25 member 23),468,"52,378",5 out of 5,2008-02-05,Evidence at protein level
P51170,SCNNG_HUMAN,Amiloride-sensitive sodium channel subunit gamma (Epithelial Na(+) channel subunit gamma) (ENaCG) (Gamma-ENaC) (Gamma-NaCH) (Nonvoltage-gated sodium channel 1 subunit gamma) (SCNEG),649,"74,270",5 out of 5,1996-10-01,Evidence at protein level
Q96FV2,SCRN2_HUMAN,Secernin-2,425,"46,597",3 out of 5,2006-11-28,Evidence at protein level
Q9NVU7,SDA1_HUMAN,Protein SDA1 homolog (Nucleolar protein 130) (SDA1 domain-containing protein 1) (hSDA),687,"79,871",5 out of 5,2007-05-15,Evidence at protein level
A6NFY7,SDHF1_HUMAN,"Succinate dehydrogenase assembly factor 1, mitochondrial (SDH assembly factor 1) (SDHAF1) (LYR motif-containing protein 8)",115,"12,806",4 out of 5,2008-04-08,Evidence at protein level
Q9NX18,SDHF2_HUMAN,"Succinate dehydrogenase assembly factor 2, mitochondrial (SDH assembly factor 2) (SDHAF2)",166,"19,599",5 out of 5,2007-07-10,Evidence at protein level
Q9NRP4,SDHF3_HUMAN,"Succinate dehydrogenase assembly factor 3, mitochondrial (SDH assembly factor 3) (SDHAF3)",125,"14,652",3 out of 5,2005-10-25,Evidence at protein level
Q9BRJ7,SDOS_HUMAN,Protein syndesmos (NUDT16-like protein 1),211,"23,338",4 out of 5,2005-07-05,Evidence at protein level
Q96GA7,SDSL_HUMAN,Serine dehydratase-like (L-serine deaminase) (L-serine dehydratase/L-threonine deaminase) (L-threonine dehydratase) (TDH) (EC 4.3.1.19) (Serine dehydratase 2) (SDH 2) (EC 4.3.1.17),329,"34,674",5 out of 5,2006-12-12,Evidence at protein level
Q8WWX9,SELM_HUMAN,Selenoprotein M (SelM),145,"16,232",3 out of 5,2003-01-17,Evidence at protein level
Q9H4L4,SENP3_HUMAN,Sentrin-specific protease 3 (EC 3.4.22.68) (SUMO-1-specific protease 3) (Sentrin/SUMO-specific protease SENP3),574,"65,010",5 out of 5,2002-11-28,Evidence at protein level
Q9BQF6,SENP7_HUMAN,Sentrin-specific protease 7 (EC 3.4.22.68) (SUMO-1-specific protease 2) (Sentrin/SUMO-specific protease SENP7),1050,"119,658",5 out of 5,2001-10-18,Evidence at protein level
Q86XK3,SFR1_HUMAN,Swi5-dependent recombination DNA repair protein 1 homolog (Meiosis protein 5 homolog),245,"28,262",5 out of 5,2005-08-16,Evidence at protein level
P0DMR2,SG1C2_HUMAN,Secretoglobin family 1C member 2,95,"10,457",2 out of 5,2014-11-26,Inferred from homology
Q96QR1,SG3A1_HUMAN,Secretoglobin family 3A member 1 (Cytokine HIN-1) (High in normal 1) (Pneumo secretory protein 2) (PnSP-2) (Uteroglobin-related protein 2),104,"10,100",4 out of 5,2002-01-23,Evidence at protein level
Q9BQI5,SGIP1_HUMAN,SH3-containing GRB2-like protein 3-interacting protein 1 (Endophilin-3-interacting protein),828,"89,109",5 out of 5,2006-09-05,Evidence at protein level
P09661,RU2A_HUMAN,U2 small nuclear ribonucleoprotein A' (U2 snRNP A'),255,"28,416",5 out of 5,1989-07-01,Evidence at protein level
Q8WXA3,RUFY2_HUMAN,RUN and FYVE domain-containing protein 2 (Rab4-interacting protein related),655,"75,055",4 out of 5,2006-07-11,Evidence at protein level
O95136,S1PR2_HUMAN,Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5),353,"38,867",5 out of 5,2003-11-07,Evidence at protein level
Q8WUM9,S20A1_HUMAN,Sodium-dependent phosphate transporter 1 (Gibbon ape leukemia virus receptor 1) (GLVR-1) (Leukemia virus receptor 1 homolog) (Phosphate transporter 1) (PiT-1) (Solute carrier family 20 member 1),679,"73,700",5 out of 5,2005-12-20,Evidence at protein level
Q08357,S20A2_HUMAN,Sodium-dependent phosphate transporter 2 (Gibbon ape leukemia virus receptor 2) (GLVR-2) (Phosphate transporter 2) (PiT-2) (Pit2) (hPit2) (Solute carrier family 20 member 2),652,"70,392",5 out of 5,2008-06-10,Evidence at protein level
O15244,S22A2_HUMAN,Solute carrier family 22 member 2 (Organic cation transporter 2) (hOCT2),555,"62,581",5 out of 5,2008-02-26,Evidence at protein level
Q4U2R8,S22A6_HUMAN,Solute carrier family 22 member 6 (Organic anion transporter 1) (hOAT1) (PAH transporter) (hPAHT) (Renal organic anion transporter 1) (hROAT1),563,"61,816",5 out of 5,2008-03-18,Evidence at protein level
Q96DW6,S2538_HUMAN,Solute carrier family 25 member 38,304,"33,566",4 out of 5,2007-06-26,Evidence at protein level
Q8N5S1,S2541_HUMAN,Solute carrier family 25 member 41,370,"40,795",3 out of 5,2008-02-26,Evidence at transcript level
Q6ZUB0,S31D4_HUMAN,Putative spermatogenesis-associated protein 31D4 (Protein FAM75D4),917,"102,390",2 out of 5,2008-04-29,Uncertain
Q96G79,S35A4_HUMAN,Probable UDP-sugar transporter protein SLC35A4 (Solute carrier family 35 member A4),324,"34,593",3 out of 5,2008-05-20,Evidence at transcript level
P0CK97,S35E2_HUMAN,Solute carrier family 35 member E2,266,"29,079",2 out of 5,2011-03-08,Evidence at transcript level
Q7Z769,S35E3_HUMAN,Solute carrier family 35 member E3 (Bladder cancer-overexpressed gene 1 protein),313,"35,066",2 out of 5,2007-08-21,Evidence at transcript level
Q5T1Q4,S35F1_HUMAN,Solute carrier family 35 member F1,408,"45,346",2 out of 5,2007-10-23,Evidence at transcript level
Q9NQ40,S52A3_HUMAN,"Solute carrier family 52, riboflavin transporter, member 3 (Riboflavin transporter 2) (hRFT2)",469,"50,805",5 out of 5,2003-01-10,Evidence at protein level
P18405,S5A1_HUMAN,3-oxo-5-alpha-steroid 4-dehydrogenase 1 (EC 1.3.1.22) (SR type 1) (Steroid 5-alpha-reductase 1) (S5AR 1),259,"29,459",5 out of 5,1990-11-01,Evidence at protein level
P61619,S61A1_HUMAN,Protein transport protein Sec61 subunit alpha isoform 1 (Sec61 alpha-1),476,"52,265",5 out of 5,2004-06-07,Evidence at protein level
P48065,S6A12_HUMAN,Sodium- and chloride-dependent betaine transporter (BGT-1) (Na(+)/Cl(-) betaine/GABA transporter) (Solute carrier family 6 member 12),614,"69,368",5 out of 5,1996-02-01,Evidence at protein level
Q9UN76,S6A14_HUMAN,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+) (Amino acid transporter ATB0+) (Solute carrier family 6 member 14),642,"72,153",5 out of 5,2004-01-16,Evidence at transcript level
Q8N1H7,S6OS1_HUMAN,Protein SIX6OS1 (Six6 opposite strand transcript 1),587,"68,166",3 out of 5,2003-04-11,Evidence at transcript level
Q96CW6,S7A6O_HUMAN,Probable RNA polymerase II nuclear localization protein SLC7A6OS (ADAMS proteinase-related protein) (Solute carrier family 7 member 6 opposite strand transcript),309,"35,028",3 out of 5,2007-05-29,Evidence at protein level
Q9NZJ4,SACS_HUMAN,Sacsin (DnaJ homolog subfamily C member 29) (DNAJC29),4579,"521,126",5 out of 5,2001-02-21,Evidence at protein level
Q01826,SATB1_HUMAN,DNA-binding protein SATB1 (Special AT-rich sequence-binding protein 1),763,"85,957",5 out of 5,1993-10-01,Evidence at protein level
P0C7V7,SC11B_HUMAN,Putative signal peptidase complex catalytic subunit SEC11B (EC 3.4.21.89) (SEC11 homolog B) (SEC11-like protein 2),166,"19,160",3 out of 5,2008-07-22,Uncertain
Q96IW7,SC22A_HUMAN,Vesicle-trafficking protein SEC22a (SEC22 vesicle-trafficking protein homolog A) (SEC22 vesicle-trafficking protein-like 2),307,"34,948",5 out of 5,2006-10-17,Evidence at protein level
O95171,SCEL_HUMAN,Sciellin,688,"77,552",5 out of 5,2002-01-23,Evidence at protein level
P18827,SDC1_HUMAN,Syndecan-1 (SYND1) (CD antigen CD138),310,"32,462",5 out of 5,1990-11-01,Evidence at protein level
P34741,SDC2_HUMAN,Syndecan-2 (SYND2) (Fibroglycan) (Heparan sulfate proteoglycan core protein) (HSPG) (CD antigen CD362),201,"22,160",5 out of 5,1994-02-01,Evidence at protein level
Q9Y2G9,SBNO2_HUMAN,Protein strawberry notch homolog 2,1366,"150,275",5 out of 5,2008-01-15,Evidence at transcript level
Q93073,SBP2L_HUMAN,Selenocysteine insertion sequence-binding protein 2-like (SECIS-binding protein 2-like),1101,"121,776",3 out of 5,1997-11-01,Evidence at protein level
Q9BRL7,SC22C_HUMAN,Vesicle-trafficking protein SEC22c (SEC22 vesicle-trafficking protein homolog C) (SEC22 vesicle-trafficking protein-like 3),303,"34,269",5 out of 5,2008-03-18,Evidence at protein level
Q15437,SC23B_HUMAN,Protein transport protein Sec23B (SEC23-related protein B),767,"86,479",5 out of 5,1997-11-01,Evidence at protein level
Q8WVM8,SCFD1_HUMAN,Sec1 family domain-containing protein 1 (SLY1 homolog) (Sly1p) (Syntaxin-binding protein 1-like 2),642,"72,380",5 out of 5,2004-08-16,Evidence at protein level
Q07699,SCN1B_HUMAN,Sodium channel subunit beta-1,218,"24,707",5 out of 5,1996-10-01,Evidence at protein level
Q9NY46,SCN3A_HUMAN,Sodium channel protein type 3 subunit alpha (Sodium channel protein brain III subunit alpha) (Sodium channel protein type III subunit alpha) (Voltage-gated sodium channel subtype III) (Voltage-gated sodium channel subunit alpha Nav1.3),2000,"226,294",5 out of 5,2001-02-21,Evidence at protein level
P37088,SCNNA_HUMAN,Amiloride-sensitive sodium channel subunit alpha (Alpha-NaCH) (Epithelial Na(+) channel subunit alpha) (Alpha-ENaC) (ENaCA) (Nonvoltage-gated sodium channel 1 subunit alpha) (SCNEA),669,"75,704",5 out of 5,1994-10-01,Evidence at protein level
P51172,SCNND_HUMAN,Amiloride-sensitive sodium channel subunit delta (Delta-NaCH) (Epithelial Na(+) channel subunit delta) (Delta-ENaC) (ENaCD) (Nonvoltage-gated sodium channel 1 subunit delta) (SCNED),638,"70,215",5 out of 5,1996-10-01,Evidence at protein level
Q8WTV0,SCRB1_HUMAN,"Scavenger receptor class B member 1 (SRB1) (CD36 and LIMPII analogous 1) (CLA-1) (CD36 antigen-like 1) (Collagen type I receptor, thrombospondin receptor-like 1) (SR-BI) (CD antigen CD36)",552,"60,878",5 out of 5,2003-10-10,Evidence at protein level
Q9BWW7,SCRT1_HUMAN,Transcriptional repressor scratch 1 (Scratch homolog 1 zinc finger protein) (SCRT) (Scratch 1) (hScrt),348,"35,570",4 out of 5,2004-04-13,Evidence at protein level
P47872,SCTR_HUMAN,Secretin receptor (SCT-R),440,"50,207",4 out of 5,1996-02-01,Evidence at transcript level
Q9NQ36,SCUB2_HUMAN,"Signal peptide, CUB and EGF-like domain-containing protein 2 (Protein CEGP1)",999,"109,966",4 out of 5,2006-10-31,Evidence at transcript level
Q7RTU7,SCX_HUMAN,Basic helix-loop-helix transcription factor scleraxis (Class A basic helix-loop-helix protein 41) (bHLHa41) (Class A basic helix-loop-helix protein 48) (bHLHa48),201,"21,596",5 out of 5,2007-01-23,Inferred from homology
Q86SQ7,SDCG8_HUMAN,Serologically defined colon cancer antigen 8 (Antigen NY-CO-8) (Centrosomal colon cancer autoantigen protein) (hCCCAP),713,"82,682",5 out of 5,2006-01-10,Evidence at protein level
P48061,SDF1_HUMAN,Stromal cell-derived factor 1 (SDF-1) (hSDF-1) (C-X-C motif chemokine 12) (Intercrine reduced in hepatomas) (IRH) (hIRH) (Pre-B cell growth-stimulating factor) (PBSF) [Cleaved into: SDF-1-beta(3-72); SDF-1-alpha(3-67)],93,"10,666",5 out of 5,1996-02-01,Evidence at protein level
Q6ZPB5,SDIM1_HUMAN,Stress-responsive DNAJB4-interacting membrane protein 1,146,"16,112",4 out of 5,2011-04-05,Evidence at protein level
Q6UXD5,SE6L2_HUMAN,Seizure 6-like protein 2,910,"97,560",5 out of 5,2008-05-20,Evidence at protein level
Q14242,SELPL_HUMAN,P-selectin glycoprotein ligand 1 (PSGL-1) (Selectin P ligand) (CD antigen CD162),412,"43,201",5 out of 5,1997-11-01,Evidence at protein level
Q13214,SEM3B_HUMAN,Semaphorin-3B (Sema A(V)) (Semaphorin-V) (Sema V),749,"83,122",5 out of 5,2000-05-30,Evidence at transcript level
Q9H2E6,SEM6A_HUMAN,Semaphorin-6A (Semaphorin VIA) (Sema VIA) (Semaphorin-6A-1) (SEMA6A-1),1030,"114,395",5 out of 5,2003-04-11,Evidence at protein level
Q8NFY4,SEM6D_HUMAN,Semaphorin-6D,1073,"119,872",5 out of 5,2005-12-20,Evidence at protein level
P04279,SEMG1_HUMAN,Semenogelin-1 (Cancer/testis antigen 103) (Semenogelin I) (SGI) [Cleaved into: Alpha-inhibin-92; Alpha-inhibin-31; Seminal basic protein],462,"52,131",5 out of 5,1987-03-20,Evidence at protein level
Q8WW01,SEN15_HUMAN,tRNA-splicing endonuclease subunit Sen15 (SEN15 homolog) (HsSEN15) (tRNA-intron endonuclease Sen15),171,"18,641",5 out of 5,2004-07-19,Evidence at protein level
Q9P0U3,SENP1_HUMAN,Sentrin-specific protease 1 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP1),644,"73,481",5 out of 5,2002-11-28,Evidence at protein level
Q96HI0,SENP5_HUMAN,Sentrin-specific protease 5 (EC 3.4.22.68) (Sentrin/SUMO-specific protease SENP5),755,"86,693",5 out of 5,2002-11-28,Evidence at protein level
P49908,SEPP1_HUMAN,Selenoprotein P (SeP),381,"43,174",5 out of 5,1996-10-01,Evidence at protein level
Q12884,SEPR_HUMAN,"Prolyl endopeptidase FAP (EC 3.4.21.26) (170 kDa melanoma membrane-bound gelatinase) (Dipeptidyl peptidase FAP) (EC 3.4.14.5) (Fibroblast activation protein alpha) (FAPalpha) (Gelatine degradation protease FAP) (EC 3.4.21.-) (Integral membrane serine protease) (Post-proline cleaving enzyme) (Serine integral membrane protease) (SIMP) (Surface-expressed protease) (Seprase) [Cleaved into: Antiplasmin-cleaving enzyme FAP, soluble form (APCE) (EC 3.4.14.5) (EC 3.4.21.-) (EC 3.4.21.26)]",760,"87,713",5 out of 5,2002-03-05,Evidence at protein level
Q9UH03,SEPT3_HUMAN,Neuronal-specific septin-3,358,"40,704",5 out of 5,2001-02-21,Evidence at protein level
Q99719,SEPT5_HUMAN,Septin-5 (Cell division control-related protein 1) (CDCrel-1) (Peanut-like protein 1),369,"42,777",5 out of 5,2000-05-30,Evidence at protein level
Q16181,SEPT7_HUMAN,Septin-7 (CDC10 protein homolog),437,"50,680",5 out of 5,1997-11-01,Evidence at protein level
Q9UHD8,SEPT9_HUMAN,Septin-9 (MLL septin-like fusion protein MSF-A) (MLL septin-like fusion protein) (Ovarian/Breast septin) (Ov/Br septin) (Septin D1),586,"65,401",5 out of 5,2004-12-21,Evidence at protein level
Q9Y617,SERC_HUMAN,Phosphoserine aminotransferase (EC 2.6.1.52) (Phosphohydroxythreonine aminotransferase) (PSAT),370,"40,423",5 out of 5,2000-05-30,Evidence at protein level
P31949,S10AB_HUMAN,"Protein S100-A11 (Calgizzarin) (Metastatic lymph node gene 70 protein) (MLN 70) (Protein S100-C) (S100 calcium-binding protein A11) [Cleaved into: Protein S100-A11, N-terminally processed]",105,"11,740",5 out of 5,1993-07-01,Evidence at protein level
Q96FQ6,S10AG_HUMAN,Protein S100-A16 (Aging-associated gene 13 protein) (Protein S100-F) (S100 calcium-binding protein A16),103,"11,801",5 out of 5,2002-04-16,Evidence at protein level
Q9UHW9,S12A6_HUMAN,Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3),1150,"127,617",5 out of 5,2002-12-13,Evidence at protein level
Q9H228,S1PR5_HUMAN,Sphingosine 1-phosphate receptor 5 (S1P receptor 5) (S1P5) (Endothelial differentiation G-protein-coupled receptor 8) (Sphingosine 1-phosphate receptor Edg-8) (S1P receptor Edg-8),398,"41,775",4 out of 5,2005-04-12,Evidence at transcript level
Q9H015,S22A4_HUMAN,Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (Organic cation/carnitine transporter 1),551,"62,155",5 out of 5,2004-07-19,Evidence at protein level
O76082,S22A5_HUMAN,Solute carrier family 22 member 5 (High-affinity sodium-dependent carnitine cotransporter) (Organic cation/carnitine transporter 2),557,"62,752",5 out of 5,2000-12-01,Evidence at protein level
Q9Y226,S22AD_HUMAN,Solute carrier family 22 member 13 (Organic cation transporter-like 3) (ORCTL-3),551,"60,862",5 out of 5,2006-04-04,Evidence at transcript level
A6NK97,S22AK_HUMAN,Solute carrier family 22 member 20 (Organic anion transporter 6),555,"60,459",4 out of 5,2008-03-18,Evidence at transcript level
A1A5C7,S22AN_HUMAN,Solute carrier family 22 member 23,686,"73,748",3 out of 5,2007-10-23,Evidence at protein level
Q6PIS1,S23A3_HUMAN,Solute carrier family 23 member 3 (HPC E2-binding protein 3) (Na(+)/L-ascorbic acid transporter 3) (Sodium-dependent vitamin C transporter 3),610,"64,531",3 out of 5,2008-05-20,Evidence at transcript level
Q6PIV7,S2534_HUMAN,Solute carrier family 25 member 34,304,"32,224",2 out of 5,2007-06-26,Evidence at transcript level
Q3SY17,S2552_HUMAN,Solute carrier family 25 member 52 (Mitochondrial carrier triple repeat protein 2),297,"33,721",2 out of 5,2007-01-09,Evidence at transcript level
Q6P1M0,S27A4_HUMAN,Long-chain fatty acid transport protein 4 (FATP-4) (Fatty acid transport protein 4) (EC 6.2.1.-) (Solute carrier family 27 member 4),643,"72,064",5 out of 5,2005-11-22,Evidence at protein level
Q9BZD2,S29A3_HUMAN,Equilibrative nucleoside transporter 3 (hENT3) (Solute carrier family 29 member 3),475,"51,815",5 out of 5,2004-05-24,Evidence at protein level
Q5VYP0,S31A3_HUMAN,Spermatogenesis-associated protein 31A3 (Protein FAM75A3),1347,"148,706",2 out of 5,2008-01-15,Evidence at transcript level
B4DYI2,S31C2_HUMAN,Spermatogenesis-associated protein 31C2 (Protein FAM75C2),1134,"124,429",2 out of 5,2013-01-09,Evidence at transcript level
P78381,S35A2_HUMAN,UDP-galactose translocator (Solute carrier family 35 member A2) (UDP-galactose transporter) (UDP-Gal-Tr) (UGT),396,"41,307",5 out of 5,1997-11-01,Evidence at protein level
Q9H1N7,S35B3_HUMAN,Adenosine 3'-phospho 5'-phosphosulfate transporter 2 (3'-phosphoadenosine 5'-phosphosulfate transporter) (PAPS transporter 2) (Solute carrier family 35 member B3),401,"44,593",4 out of 5,2005-11-22,Evidence at protein level
Q969S0,S35B4_HUMAN,UDP-xylose and UDP-N-acetylglucosamine transporter (Solute carrier family 35 member B4) (YEA4 homolog),331,"37,424",5 out of 5,2005-11-22,Evidence at protein level
A4IF30,S35F4_HUMAN,Solute carrier family 35 member F4,521,"57,809",2 out of 5,2007-12-04,Evidence at transcript level
Q8N808,S35G3_HUMAN,Solute carrier family 35 member G3 (Acyl-malonyl-condensing enzyme 1) (Transmembrane protein 21A),338,"35,381",2 out of 5,2006-12-12,Evidence at transcript level
Q969I6,S38A4_HUMAN,Sodium-coupled neutral amino acid transporter 4 (Amino acid transporter A3) (Na(+)-coupled neutral amino acid transporter 4) (Solute carrier family 38 member 4) (System A amino acid transporter 3) (System N amino acid transporter 3),547,"60,764",5 out of 5,2006-07-25,Evidence at protein level
Q92504,S39A7_HUMAN,"Zinc transporter SLC39A7 (Histidine-rich membrane protein Ke4) (Really interesting new gene 5 protein) (Solute carrier family 39 member 7) (Zrt-, Irt-like protein 7) (ZIP7)",469,"50,118",5 out of 5,2001-01-24,Evidence at protein level
Q9NP59,S40A1_HUMAN,Solute carrier family 40 member 1 (Ferroportin-1) (Iron-regulated transporter 1),571,"62,542",5 out of 5,2004-06-07,Evidence at protein level
P35542,SAA4_HUMAN,Serum amyloid A-4 protein (Constitutively expressed serum amyloid A protein) (C-SAA),130,"14,747",4 out of 5,1994-06-01,Evidence at protein level
Q9HBV2,SACA1_HUMAN,Sperm acrosome membrane-associated protein 1 (Sperm acrosomal membrane-associated protein 32),294,"32,143",3 out of 5,2006-09-05,Evidence at protein level
P23526,SAHH_HUMAN,Adenosylhomocysteinase (AdoHcyase) (EC 3.3.1.1) (S-adenosyl-L-homocysteine hydrolase),432,"47,716",5 out of 5,1991-11-01,Evidence at protein level
Q96NU1,SAM11_HUMAN,Sterile alpha motif domain-containing protein 11 (SAM domain-containing protein 11),681,"72,708",3 out of 5,2007-03-06,Evidence at protein level
Q86UD0,SAPC2_HUMAN,Suppressor APC domain-containing protein 2 (Tumor specificity and mitosis phase-dependent expression protein) (TS/MDEP) (p42.3),394,"42,637",3 out of 5,2007-05-15,Evidence at protein level
O00631,SARCO_HUMAN,Sarcolipin,31,"3,762",5 out of 5,1997-11-01,Evidence at protein level
Q9BW04,SARG_HUMAN,Specifically androgen-regulated gene protein,601,"63,964",5 out of 5,2008-02-05,Evidence at protein level
P82979,SARNP_HUMAN,SAP domain-containing ribonucleoprotein (Cytokine-induced protein of 29 kDa) (Nuclear protein Hcc-1) (Proliferation-associated cytokine-inducible protein CIP29),210,"23,671",5 out of 5,2001-08-29,Evidence at protein level
Q8IYX7,SAXO1_HUMAN,Stabilizer of axonemal microtubules 1,474,"54,621",5 out of 5,2005-08-16,Evidence at protein level
Q9Y345,SC6A5_HUMAN,Sodium- and chloride-dependent glycine transporter 2 (GlyT-2) (GlyT2) (Solute carrier family 6 member 5),797,"87,434",5 out of 5,2001-09-26,Evidence at protein level
Q6P3W7,SCYL2_HUMAN,SCY1-like protein 2 (Coated vesicle-associated kinase of 104 kDa),929,"103,709",5 out of 5,2006-10-17,Evidence at protein level
P31431,SDC4_HUMAN,Syndecan-4 (SYND4) (Amphiglycan) (Ryudocan core protein),198,"21,642",5 out of 5,1993-07-01,Evidence at protein level
P55735,SEC13_HUMAN,Protein SEC13 homolog (SEC13-like protein 1) (SEC13-related protein),322,"35,541",5 out of 5,1997-11-01,Evidence at protein level
Q12981,SEC20_HUMAN,Vesicle transport protein SEC20 (BCL2/adenovirus E1B 19 kDa protein-interacting protein 1) (Transformation-related gene 8 protein) (TRG-8),228,"26,132",5 out of 5,1999-07-15,Evidence at protein level
Q99442,SEC62_HUMAN,Translocation protein SEC62 (Translocation protein 1) (TP-1) (hTP-1),399,"45,862",5 out of 5,2006-01-24,Evidence at protein level
Q9BVL4,SELO_HUMAN,Selenoprotein O (SelO),669,"73,489",4 out of 5,2003-08-04,Evidence at protein level
P62341,SELT_HUMAN,Selenoprotein T (SelT) (Thioredoxin reductase-like enzyme) (EC 1.8.1.9),195,"22,324",5 out of 5,2004-07-05,Evidence at protein level
Q9HC62,SENP2_HUMAN,Sentrin-specific protease 2 (EC 3.4.22.68) (Axam2) (SMT3-specific isopeptidase 2) (Smt3ip2) (Sentrin/SUMO-specific protease SENP2),589,"67,855",5 out of 5,2002-11-28,Evidence at protein level
Q9P0V9,SEP10_HUMAN,Septin-10,454,"52,593",4 out of 5,2005-06-21,Evidence at protein level
Q9NVA2,SEP11_HUMAN,Septin-11,429,"49,398",5 out of 5,2004-07-19,Evidence at protein level
Q92552,RT27_HUMAN,"28S ribosomal protein S27, mitochondrial (MRP-S27) (S27mt) (Mitochondrial small ribosomal subunit protein mS27)",414,"47,611",4 out of 5,2002-03-27,Evidence at protein level
P82909,RT36_HUMAN,"28S ribosomal protein S36, mitochondrial (MRP-S36) (S36mt)",103,"11,466",3 out of 5,2004-02-02,Evidence at protein level
Q66K80,RUAS1_HUMAN,Putative uncharacterized protein RUSC1-AS1 (RUSC1 antisense RNA 1) (RUSC1 antisense gene protein 1),236,"24,494",2 out of 5,2006-10-03,Uncertain
Q7L099,RUFY3_HUMAN,Protein RUFY3 (RUN and FYVE domain-containing protein 3) (Rap2-interacting protein x) (RIPx) (Single axon-regulated protein) (Singar),469,"52,965",5 out of 5,2006-07-11,Evidence at protein level
Q13761,RUNX3_HUMAN,Runt-related transcription factor 3 (Acute myeloid leukemia 2 protein) (Core-binding factor subunit alpha-3) (CBF-alpha-3) (Oncogene AML-2) (Polyomavirus enhancer-binding protein 2 alpha C subunit) (PEA2-alpha C) (PEBP2-alpha C) (SL3-3 enhancer factor 1 alpha C subunit) (SL3/AKV core-binding factor alpha C subunit),415,"44,356",5 out of 5,2001-11-02,Evidence at protein level
Q9Y230,RUVB2_HUMAN,RuvB-like 2 (EC 3.6.4.12) (48 kDa TATA box-binding protein-interacting protein) (48 kDa TBP-interacting protein) (51 kDa erythrocyte cytosolic protein) (ECP-51) (INO80 complex subunit J) (Repressing pontin 52) (Reptin 52) (TIP49b) (TIP60-associated protein 54-beta) (TAP54-beta),463,"51,157",5 out of 5,2003-02-01,Evidence at protein level
A8MWD9,RUXGL_HUMAN,Putative small nuclear ribonucleoprotein G-like protein 15,76,"8,544",3 out of 5,2008-09-02,Uncertain
P62308,RUXG_HUMAN,Small nuclear ribonucleoprotein G (snRNP-G) (Sm protein G) (Sm-G) (SmG),76,"8,496",5 out of 5,2004-07-05,Evidence at protein level
Q9UIY3,RWD2A_HUMAN,RWD domain-containing protein 2A,292,"33,893",2 out of 5,2000-12-01,Evidence at protein level
Q9Y3V2,RWDD3_HUMAN,RWD domain-containing protein 3 (RWD domain-containing sumoylation enhancer) (RSUME),267,"30,543",5 out of 5,2003-08-15,Evidence at protein level
Q9HBX9,RXFP1_HUMAN,Relaxin receptor 1 (Leucine-rich repeat-containing G-protein coupled receptor 7) (Relaxin family peptide receptor 1),757,"86,975",5 out of 5,2002-06-06,Evidence at protein level
Q8WXD0,RXFP2_HUMAN,Relaxin receptor 2 (G-protein coupled receptor 106) (G-protein coupled receptor affecting testicular descent) (Leucine-rich repeat-containing G-protein coupled receptor 8) (Relaxin family peptide receptor 2),754,"86,453",5 out of 5,2002-06-06,Evidence at protein level
P19793,RXRA_HUMAN,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),462,"50,811",5 out of 5,1991-02-01,Evidence at protein level
Q504Y0,S39AC_HUMAN,Zinc transporter ZIP12 (LIV-1 subfamily of ZIP zinc transporter 8) (LZT-Hs8) (Solute carrier family 39 member 12) (Zrt- and Irt-like protein 12) (ZIP-12),691,"76,666",5 out of 5,2007-12-04,Evidence at transcript level
Q8TE82,S3TC1_HUMAN,SH3 domain and tetratricopeptide repeat-containing protein 1,1336,"146,961",2 out of 5,2005-01-04,Evidence at protein level
Q7Z3Q1,S46A3_HUMAN,Solute carrier family 46 member 3,461,"51,519",3 out of 5,2007-10-23,Evidence at transcript level
Q6U841,S4A10_HUMAN,Sodium-driven chloride bicarbonate exchanger (Solute carrier family 4 member 10),1118,"125,946",5 out of 5,2006-07-11,Evidence at transcript level
Q8NBS3,S4A11_HUMAN,Sodium bicarbonate transporter-like protein 11 (Bicarbonate transporter-related protein 1) (Sodium borate cotransporter 1) (NaBC1) (Solute carrier family 4 member 11),891,"99,581",5 out of 5,2003-04-04,Evidence at protein level
Q8IXA5,SACA3_HUMAN,"Sperm acrosome membrane-associated protein 3 (Cancer/testis antigen 54) (CT54) (Lysozyme-like acrosomal sperm-specific secretory protein ALLP-17) (Lysozyme-like protein 3) (Sperm lysozyme-like protein 1) (Sperm protein reactive with antisperm antibodies) (Sperm protein reactive with ASA) [Cleaved into: Sperm acrosome membrane-associated protein 3, membrane form; Sperm acrosome membrane-associated protein 3, processed form]",215,"23,431",5 out of 5,2006-10-31,Evidence at protein level
Q6SPF0,SAMD1_HUMAN,Atherin (Sterile alpha motif domain-containing protein 1) (SAM domain-containing protein 1),538,"56,052",3 out of 5,2007-03-06,Evidence at protein level
Q9Y3Z3,SAMH1_HUMAN,Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 (dNTPase) (EC 3.1.5.-) (Dendritic cell-derived IFNG-induced protein) (DCIP) (Monocyte protein 5) (MOP-5) (SAM domain and HD domain-containing protein 1),626,"72,201",5 out of 5,2002-08-13,Evidence at protein level
Q9NR31,SAR1A_HUMAN,GTP-binding protein SAR1a (COPII-associated small GTPase),198,"22,367",4 out of 5,2001-06-20,Evidence at protein level
Q15020,SART3_HUMAN,Squamous cell carcinoma antigen recognized by T-cells 3 (SART-3) (Tat-interacting protein of 110 kDa) (Tip110) (p110 nuclear RNA-binding protein),963,"109,935",5 out of 5,2006-02-07,Evidence at protein level
Q52WX2,SBK1_HUMAN,Serine/threonine-protein kinase SBK1 (EC 2.7.11.1) (SH3-binding kinase 1),424,"46,252",4 out of 5,2006-05-30,Evidence at transcript level
P0C264,SBK3_HUMAN,Uncharacterized serine/threonine-protein kinase SBK3 (EC 2.7.11.1) (SH3-binding domain kinase family member 3) (Sugen kinase 110),359,"38,488",3 out of 5,2006-11-28,Inferred from homology
A3KN83,SBNO1_HUMAN,Protein strawberry notch homolog 1 (Monocyte protein 3) (MOP-3),1393,"154,312",3 out of 5,2008-01-15,Evidence at protein level
Q13228,SBP1_HUMAN,Selenium-binding protein 1 (56 kDa selenium-binding protein) (SBP56) (SP56),472,"52,391",5 out of 5,1999-07-15,Evidence at protein level
O75845,SC5D_HUMAN,Lathosterol oxidase (EC 1.14.19.20) (C-5 sterol desaturase) (Delta(7)-sterol 5-desaturase) (Delta(7)-sterol C5(6)-desaturase) (Lathosterol 5-desaturase) (Sterol-C5-desaturase),299,"35,301",5 out of 5,1999-07-15,Evidence at protein level
P23975,SC6A2_HUMAN,Sodium-dependent noradrenaline transporter (Norepinephrine transporter) (NET) (Solute carrier family 6 member 2),617,"69,332",5 out of 5,1992-03-01,Evidence at protein level
Q9Y6X3,SCC4_HUMAN,MAU2 chromatid cohesion factor homolog (MAU-2) (Cohesin loading complex subunit SCC4 homolog),613,"69,082",5 out of 5,2006-10-31,Evidence at protein level
Q0VDG4,SCRN3_HUMAN,Secernin-3,424,"48,544",2 out of 5,2006-11-28,Evidence at protein level
Q9NQ03,SCRT2_HUMAN,Transcriptional repressor scratch 2 (Scratch homolog 2 zinc finger protein),307,"32,584",3 out of 5,2004-04-13,Evidence at transcript level
P04271,S100B_HUMAN,Protein S100-B (S-100 protein beta chain) (S-100 protein subunit beta) (S100 calcium-binding protein B),92,"10,713",5 out of 5,1987-03-20,Evidence at protein level
O75751,S22A3_HUMAN,Solute carrier family 22 member 3 (Extraneuronal monoamine transporter) (EMT) (Organic cation transporter 3),556,"61,280",5 out of 5,2002-10-19,Evidence at protein level
Q8TCC7,S22A8_HUMAN,Solute carrier family 22 member 8 (Organic anion transporter 3) (hOAT3),542,"59,856",5 out of 5,2007-01-23,Evidence at protein level
Q63ZE4,S22AA_HUMAN,Solute carrier family 22 member 10 (Organic anion transporter 5),541,"60,257",3 out of 5,2006-05-02,Evidence at transcript level
Q96S37,S22AC_HUMAN,Solute carrier family 22 member 12 (Organic anion transporter 4-like protein) (Renal-specific transporter) (RST) (Urate anion exchanger 1),553,"59,630",5 out of 5,2007-10-23,Evidence at protein level
Q9UGH3,S23A2_HUMAN,Solute carrier family 23 member 2 (Na(+)/L-ascorbic acid transporter 2) (Nucleobase transporter-like 1 protein) (Sodium-dependent vitamin C transporter 2) (hSVCT2) (Yolk sac permease-like molecule 2),650,"70,337",5 out of 5,2002-10-19,Evidence at protein level
Q96CQ1,S2536_HUMAN,Solute carrier family 25 member 36,311,"34,283",5 out of 5,2007-06-26,Evidence at protein level
Q8TBP6,S2540_HUMAN,Solute carrier family 25 member 40 (Mitochondrial carrier family protein),338,"38,125",2 out of 5,2007-06-26,Evidence at protein level
Q8WUT9,S2543_HUMAN,Solute carrier family 25 member 43,341,"37,718",3 out of 5,2007-06-26,Evidence at transcript level
Q6ZT89,S2548_HUMAN,Solute carrier family 25 member 48,311,"33,440",3 out of 5,2008-03-18,Evidence at protein level
Q8IWB4,S31A7_HUMAN,Spermatogenesis-associated protein 31A7 (Protein FAM75A7),1347,"148,734",3 out of 5,2007-03-20,Evidence at transcript level
P0CK96,S352B_HUMAN,Solute carrier family 35 member E2B,405,"43,777",2 out of 5,2011-03-08,Evidence at transcript level
Q9Y2D2,S35A3_HUMAN,UDP-N-acetylglucosamine transporter (Golgi UDP-GlcNAc transporter) (Solute carrier family 35 member A3),325,"35,985",5 out of 5,2000-12-01,Evidence at protein level
Q9BS91,S35A5_HUMAN,Probable UDP-sugar transporter protein SLC35A5 (Solute carrier family 35 member A5),424,"48,500",2 out of 5,2007-11-13,Evidence at protein level
P78383,S35B1_HUMAN,Solute carrier family 35 member B1 (UDP-galactose transporter-related protein 1) (UGTrel1) (hUGTrel1),322,"35,760",3 out of 5,2005-11-22,Evidence at protein level
Q8N357,S35F6_HUMAN,Solute carrier family 35 member F6 (ANT2-binding protein) (ANT2BP) (Transport and Golgi organization 9 homolog),371,"40,214",5 out of 5,2006-04-18,Evidence at protein level
P0C7Q5,S35G4_HUMAN,Putative solute carrier family 35 member G4 (Acyl-malonyl-condensing enzyme 1-like protein 1),338,"35,378",2 out of 5,2008-07-01,Uncertain
Q495M3,S36A2_HUMAN,Proton-coupled amino acid transporter 2 (Proton/amino acid transporter 2) (Solute carrier family 36 member 2) (Tramdorin-1),483,"53,216",5 out of 5,2008-03-18,Evidence at protein level
Q9NVC3,S38A7_HUMAN,Putative sodium-coupled neutral amino acid transporter 7 (Solute carrier family 38 member 7),462,"49,966",4 out of 5,2008-02-26,Evidence at protein level
Q96JW4,S41A2_HUMAN,Solute carrier family 41 member 2,573,"62,473",4 out of 5,2007-07-10,Evidence at protein level
Q9Y6R1,S4A4_HUMAN,Electrogenic sodium bicarbonate cotransporter 1 (Sodium bicarbonate cotransporter) (Na(+)/HCO3(-) cotransporter) (Solute carrier family 4 member 4) (kNBC1),1079,"121,461",5 out of 5,2005-12-20,Evidence at protein level
Q9GZN6,S6A16_HUMAN,Orphan sodium- and chloride-dependent neurotransmitter transporter NTT5 (Solute carrier family 6 member 16),736,"82,200",3 out of 5,2001-09-26,Evidence at transcript level
Q695T7,S6A19_HUMAN,Sodium-dependent neutral amino acid transporter B(0)AT1 (Solute carrier family 6 member 19) (System B(0) neutral amino acid transporter AT1),634,"71,110",5 out of 5,2005-08-30,Evidence at protein level
W5XKT8,SACA6_HUMAN,Sperm acrosome membrane-associated protein 6 (BACHELOR-like protein),324,"36,333",3 out of 5,2015-10-14,Evidence at protein level
Q9UBT2,SAE2_HUMAN,SUMO-activating enzyme subunit 2 (EC 6.3.2.-) (Anthracycline-associated resistance ARX) (Ubiquitin-like 1-activating enzyme E1B) (Ubiquitin-like modifier-activating enzyme 2),640,"71,224",5 out of 5,2004-02-16,Evidence at protein level
O94885,SASH1_HUMAN,SAM and SH3 domain-containing protein 1 (Proline-glutamate repeat-containing protein),1247,"136,653",5 out of 5,2003-08-15,Evidence at protein level
Q6UWP8,SBSN_HUMAN,Suprabasin,590,"60,541",3 out of 5,2008-02-05,Evidence at protein level
P67812,SC11A_HUMAN,Signal peptidase complex catalytic subunit SEC11A (EC 3.4.21.89) (Endopeptidase SP18) (Microsomal signal peptidase 18 kDa subunit) (SPase 18 kDa subunit) (SEC11 homolog A) (SEC11-like protein 1) (SPC18),179,"20,625",5 out of 5,2004-10-11,Evidence at protein level
O15027,SC16A_HUMAN,Protein transport protein Sec16A (SEC16 homolog A),2179,"233,517",5 out of 5,1998-07-15,Evidence at protein level
P13866,SC5A1_HUMAN,Sodium/glucose cotransporter 1 (Na(+)/glucose cotransporter 1) (High affinity sodium-glucose cotransporter) (Solute carrier family 5 member 1),664,"73,498",5 out of 5,1990-01-01,Evidence at protein level
P31639,SC5A2_HUMAN,Sodium/glucose cotransporter 2 (Na(+)/glucose cotransporter 2) (Low affinity sodium-glucose cotransporter) (Solute carrier family 5 member 2),672,"72,897",5 out of 5,1993-07-01,Evidence at protein level
P53794,SC5A3_HUMAN,Sodium/myo-inositol cotransporter (Na(+)/myo-inositol cotransporter) (Sodium/myo-inositol transporter 1) (SMIT1) (Solute carrier family 5 member 3),718,"79,694",5 out of 5,1996-10-01,Evidence at protein level
Q9NY91,SC5A4_HUMAN,Low affinity sodium-glucose cotransporter (Sodium/glucose cotransporter 3) (Na(+)/glucose cotransporter 3) (Solute carrier family 5 member 4),659,"72,456",3 out of 5,2001-09-26,Evidence at transcript level
Q92911,SC5A5_HUMAN,Sodium/iodide cotransporter (Na(+)/I(-) cotransporter) (Sodium-iodide symporter) (Na(+)/I(-) symporter) (Solute carrier family 5 member 5),643,"68,666",5 out of 5,2001-01-24,Evidence at protein level
Q9Y289,SC5A6_HUMAN,Sodium-dependent multivitamin transporter (Na(+)-dependent multivitamin transporter) (Solute carrier family 5 member 6),635,"68,642",5 out of 5,2001-01-24,Evidence at transcript level
Q8WU76,SCFD2_HUMAN,Sec1 family domain-containing protein 2 (Syntaxin-binding protein 1-like 1),684,"75,127",3 out of 5,2004-07-05,Evidence at protein level
Q8WXD2,SCG3_HUMAN,Secretogranin-3 (Secretogranin III) (SgIII),468,"53,005",5 out of 5,2002-09-19,Evidence at protein level
Q96I15,SCLY_HUMAN,Selenocysteine lyase (hSCL) (EC 4.4.1.16),445,"48,149",5 out of 5,2008-02-05,Evidence at protein level
Q96GD3,SCMH1_HUMAN,Polycomb protein SCMH1 (Sex comb on midleg homolog 1),660,"73,354",5 out of 5,2005-03-01,Evidence at protein level
Q9UQR0,SCML2_HUMAN,Sex comb on midleg-like protein 2,700,"77,257",4 out of 5,2004-05-10,Evidence at protein level
Q9NY72,SCN3B_HUMAN,Sodium channel subunit beta-3,215,"24,702",5 out of 5,2001-01-11,Evidence at protein level
P35499,SCN4A_HUMAN,Sodium channel protein type 4 subunit alpha (SkM1) (Sodium channel protein skeletal muscle subunit alpha) (Sodium channel protein type IV subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.4),1836,"208,061",5 out of 5,1994-06-01,Evidence at protein level
Q14524,SCN5A_HUMAN,Sodium channel protein type 5 subunit alpha (HH1) (Sodium channel protein cardiac muscle subunit alpha) (Sodium channel protein type V subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.5),2016,"226,940",5 out of 5,1998-12-15,Evidence at protein level
Q9Y5Y9,SCNAA_HUMAN,Sodium channel protein type 10 subunit alpha (Peripheral nerve sodium channel 3) (PN3) (hPN3) (Sodium channel protein type X subunit alpha) (Voltage-gated sodium channel subunit alpha Nav1.8),1956,"220,626",5 out of 5,2004-12-21,Evidence at protein level
P57086,SCND1_HUMAN,SCAN domain-containing protein 1,179,"19,082",5 out of 5,2000-12-01,Evidence at protein level
P51168,SCNNB_HUMAN,Amiloride-sensitive sodium channel subunit beta (Beta-NaCH) (Epithelial Na(+) channel subunit beta) (Beta-ENaC) (ENaCB) (Nonvoltage-gated sodium channel 1 subunit beta) (SCNEB),640,"72,659",5 out of 5,1996-10-01,Evidence at protein level
Q8NBX0,SCPDL_HUMAN,Saccharopine dehydrogenase-like oxidoreductase (EC 1.-.-.-),429,"47,151",4 out of 5,2005-08-30,Evidence at protein level
P31040,SDHA_HUMAN,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (EC 1.3.5.1) (Flavoprotein subunit of complex II) (Fp)",664,"72,692",5 out of 5,1993-07-01,Evidence at protein level
M5A8F1,SUPYN_HUMAN,Suppressyn (Endogenous retrovirus group 48 member 1) (NDUFV3 antisense RNA 1) (endogenous retrovirus group Fb member 1),160,"18,128",3 out of 5,2014-09-03,Evidence at protein level
Q5VX71,SUSD4_HUMAN,Sushi domain-containing protein 4,490,"53,778",5 out of 5,2006-10-03,Evidence at transcript level
Q496J9,SV2C_HUMAN,Synaptic vesicle glycoprotein 2C,727,"82,342",4 out of 5,2006-06-13,Evidence at protein level
Q53LP3,SWAHC_HUMAN,Ankyrin repeat domain-containing protein SOWAHC (Ankyrin repeat domain-containing protein 57) (Protein sosondowah homolog C),525,"55,672",2 out of 5,2007-02-06,Evidence at protein level
Q6ZW31,SYDE1_HUMAN,Rho GTPase-activating protein SYDE1 (Synapse defective protein 1 homolog 1) (Protein syd-1 homolog 1),735,"79,793",3 out of 5,2007-12-04,Evidence at protein level
Q9NSD9,SYFB_HUMAN,Phenylalanine--tRNA ligase beta subunit (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase beta subunit) (PheRS),589,"66,116",5 out of 5,2000-12-08,Evidence at protein level
P49590,SYHM_HUMAN,"Probable histidine--tRNA ligase, mitochondrial (EC 6.1.1.21) (Histidine--tRNA ligase-like) (Histidyl-tRNA synthetase) (HisRS)",506,"56,888",5 out of 5,1996-02-01,Evidence at protein level
P17600,SYN1_HUMAN,Synapsin-1 (Brain protein 4.1) (Synapsin I),705,"74,111",5 out of 5,1990-08-01,Evidence at protein level
Q92777,SYN2_HUMAN,Synapsin-2 (Synapsin II),582,"62,847",4 out of 5,2000-05-30,Evidence at transcript level
Q9H7C4,SYNCI_HUMAN,Syncoilin (Syncoilin intermediate filament 1) (Syncoilin-1),482,"55,299",4 out of 5,2007-10-02,Evidence at protein level
Q8TBG9,SYNPR_HUMAN,Synaptoporin,265,"29,166",4 out of 5,2003-10-10,Evidence at protein level
Q9H987,SYP2L_HUMAN,Synaptopodin 2-like protein,977,"102,481",4 out of 5,2004-08-31,Evidence at transcript level
Q5T7P8,SYT6_HUMAN,Synaptotagmin-6 (Synaptotagmin VI) (SytVI),510,"57,325",5 out of 5,2005-06-07,Evidence at protein level
Q8IYJ3,SYTL1_HUMAN,Synaptotagmin-like protein 1 (Exophilin-7) (Protein JFC1),562,"61,857",5 out of 5,2003-07-25,Evidence at protein level
P26640,SYVC_HUMAN,Valine--tRNA ligase (EC 6.1.1.9) (Protein G7a) (Valyl-tRNA synthetase) (ValRS),1264,"140,476",5 out of 5,1992-08-01,Evidence at protein level
Q15527,SURF2_HUMAN,Surfeit locus protein 2 (Surf-2),256,"29,648",3 out of 5,1997-11-01,Evidence at protein level
Q1ZZU3,SWI5_HUMAN,DNA repair protein SWI5 homolog (HBV DNAPTP1-transactivated protein A) (Protein SAE3 homolog),235,"26,739",4 out of 5,2008-03-18,Evidence at protein level
Q5JTZ9,SYAM_HUMAN,"Alanine--tRNA ligase, mitochondrial (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS)",985,"107,340",5 out of 5,2006-10-03,Evidence at protein level
Q9NX95,SYBU_HUMAN,Syntabulin (Golgi-localized syntaphilin-related protein) (Syntaxin-1-binding protein),663,"72,388",5 out of 5,2001-02-21,Evidence at protein level
Q5JPH6,SYEM_HUMAN,"Probable glutamate--tRNA ligase, mitochondrial (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS)",523,"58,689",5 out of 5,2006-10-31,Evidence at protein level
Q8WXH0,SYNE2_HUMAN,Nesprin-2 (KASH domain-containing protein 2) (KASH2) (Nuclear envelope spectrin repeat protein 2) (Nucleus and actin connecting element protein) (Protein NUANCE) (Synaptic nuclear envelope protein 2) (Syne-2),6885,"796,442",5 out of 5,2003-04-11,Evidence at protein level
Q5T160,SYRM_HUMAN,"Probable arginine--tRNA ligase, mitochondrial (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)",578,"65,505",4 out of 5,2006-10-03,Evidence at protein level
P49591,SYSC_HUMAN,"Serine--tRNA ligase, cytoplasmic (EC 6.1.1.11) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",514,"58,777",5 out of 5,1996-02-01,Evidence at protein level
Q9NP81,SYSM_HUMAN,"Serine--tRNA ligase, mitochondrial (EC 6.1.1.11) (SerRSmt) (Seryl-tRNA synthetase) (SerRS) (Seryl-tRNA(Ser/Sec) synthetase)",518,"58,283",5 out of 5,2002-10-10,Evidence at protein level
Q9BQS2,SYT15_HUMAN,Synaptotagmin-15 (Chr10Syt) (Synaptotagmin XV) (SytXV),421,"47,375",4 out of 5,2003-10-24,Evidence at transcript level
P26639,SYTC_HUMAN,"Threonine--tRNA ligase, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS)",723,"83,435",5 out of 5,1992-08-01,Evidence at protein level
Q4VX76,SYTL3_HUMAN,Synaptotagmin-like protein 3 (Exophilin-6),610,"68,560",4 out of 5,2007-11-13,Evidence at transcript level
Q96C24,SYTL4_HUMAN,Synaptotagmin-like protein 4 (Exophilin-2) (Granuphilin),671,"76,024",5 out of 5,2003-07-25,Evidence at protein level
P51571,SSRD_HUMAN,Translocon-associated protein subunit delta (TRAP-delta) (Signal sequence receptor subunit delta) (SSR-delta),173,"18,999",5 out of 5,1996-10-01,Evidence at protein level
Q9Y3M8,STA13_HUMAN,StAR-related lipid transfer protein 13 (46H23.2) (Deleted in liver cancer 2 protein) (DLC-2) (Rho GTPase-activating protein) (START domain-containing protein 13) (StARD13),1113,"124,967",5 out of 5,2002-11-15,Evidence at protein level
P42226,STAT6_HUMAN,Signal transducer and activator of transcription 6 (IL-4 Stat),847,"94,135",5 out of 5,1995-11-01,Evidence at protein level
O76061,STC2_HUMAN,Stanniocalcin-2 (STC-2) (Stanniocalcin-related protein) (STC-related protein) (STCRP),302,"33,249",5 out of 5,2000-05-30,Evidence at protein level
Q8NFT2,STEA2_HUMAN,Metalloreductase STEAP2 (EC 1.16.1.-) (Prostate cancer-associated protein 1) (Protein up-regulated in metastatic prostate cancer) (PUMPCn) (Six-transmembrane epithelial antigen of prostate 2) (SixTransMembrane protein of prostate 1),490,"56,056",5 out of 5,2005-05-10,Evidence at protein level
Q15468,STIL_HUMAN,SCL-interrupting locus protein (TAL-1-interrupting locus protein),1287,"142,955",5 out of 5,2007-01-09,Evidence at protein level
Q13586,STIM1_HUMAN,Stromal interaction molecule 1,685,"77,423",5 out of 5,2001-11-02,Evidence at protein level
P32856,STX2_HUMAN,Syntaxin-2 (Epimorphin),288,"33,341",5 out of 5,1993-10-01,Evidence at protein level
Q9UNK0,STX8_HUMAN,Syntaxin-8,236,"26,907",5 out of 5,2000-12-01,Evidence at protein level
O00186,STXB3_HUMAN,Syntaxin-binding protein 3 (Platelet Sec1 protein) (PSP) (Protein unc-18 homolog 3) (Unc18-3) (Protein unc-18 homolog C) (Unc-18C),592,"67,764",5 out of 5,1997-11-01,Evidence at protein level
O95425,SVIL_HUMAN,Supervillin (Archvillin) (p205/p250),2214,"247,746",5 out of 5,2005-01-04,Evidence at protein level
Q8N434,SVOPL_HUMAN,Putative transporter SVOPL (SV2-related protein-like) (SVOP-like protein),492,"53,991",2 out of 5,2007-07-10,Evidence at transcript level
Q8N4V2,SVOP_HUMAN,Synaptic vesicle 2-related protein (SV2-related protein),548,"60,769",2 out of 5,2007-03-06,Evidence at transcript level
A6NEL2,SWAHB_HUMAN,Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B),793,"85,742",2 out of 5,2008-02-05,Evidence at protein level
Q6NVH7,SWAP1_HUMAN,ATPase SWSAP1 (SWIM-type zinc finger 7-associated protein 1) (SWS1-associated protein 1) (ZSWIM7-associated protein 1) (ZSWIM7AP1),229,"24,311",5 out of 5,2007-07-10,Evidence at protein level
Q9BRV3,SWET1_HUMAN,Sugar transporter SWEET1 (HsSWEET1) (RAG1-activating protein 1) (Solute carrier family 50 member 1) (Stromal cell protein),221,"25,030",5 out of 5,2008-07-22,Evidence at transcript level
Q6PI48,SYDM_HUMAN,"Aspartate--tRNA ligase, mitochondrial (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS)",645,"73,563",5 out of 5,2006-10-03,Evidence at protein level
P07814,SYEP_HUMAN,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],1512,"170,591",5 out of 5,1988-08-01,Evidence at protein level
O95926,SYF2_HUMAN,Pre-mRNA-splicing factor SYF2 (CCNDBP1-interactor) (p29),243,"28,722",5 out of 5,2006-09-19,Evidence at protein level
P55854,SUMO3_HUMAN,Small ubiquitin-related modifier 3 (SUMO-3) (SMT3 homolog 1) (SUMO-2) (Ubiquitin-like protein SMT3A) (Smt3A),103,"11,637",5 out of 5,1997-11-01,Evidence at protein level
P51687,SUOX_HUMAN,"Sulfite oxidase, mitochondrial (EC 1.8.3.1)",545,"60,283",5 out of 5,1996-10-01,Evidence at protein level
Q15526,SURF1_HUMAN,Surfeit locus protein 1,300,"33,331",5 out of 5,1997-11-01,Evidence at protein level
Q96L08,SUSD3_HUMAN,Sushi domain-containing protein 3,255,"27,119",4 out of 5,2006-10-03,Evidence at transcript level
O60279,SUSD5_HUMAN,Sushi domain-containing protein 5,629,"68,021",3 out of 5,2007-02-06,Evidence at protein level
Q8N300,SVBP_HUMAN,Small vasohibin-binding protein (Coiled coil domain-containing protein 23),66,"7,808",4 out of 5,2006-05-02,Evidence at protein level
Q4LDE5,SVEP1_HUMAN,"Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 (CCP module-containing protein 22) (Polydom) (Selectin-like osteoblast-derived protein) (SEL-OB) (Serologically defined breast cancer antigen NY-BR-38)",3571,"390,170",5 out of 5,2008-02-26,Evidence at protein level
A6NJG2,SWAHD_HUMAN,Ankyrin repeat domain-containing protein SOWAHD (Ankyrin repeat domain-containing protein 58) (Protein sosondowah homolog D),315,"33,803",2 out of 5,2008-01-15,Evidence at transcript level
Q8IZU3,SYCP3_HUMAN,Synaptonemal complex protein 3 (SCP-3),236,"27,729",5 out of 5,2006-03-21,Evidence at protein level
P60508,SYCY2_HUMAN,Syncytin-2 (Endogenous retrovirus group FRD member 1) (Envelope polyprotein) (HERV-FRD) (HERV-FRD_6p24.1 provirus ancestral Env polyprotein) [Cleaved into: Surface protein (SU); Transmembrane protein (TM)],538,"59,523",5 out of 5,2004-03-01,Evidence at protein level
Q9HCS7,SYF1_HUMAN,Pre-mRNA-splicing factor SYF1 (Protein HCNP) (XPA-binding protein 2),855,"100,010",5 out of 5,2002-11-15,Evidence at protein level
P56192,SYMC_HUMAN,"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)",900,"101,116",5 out of 5,1997-11-01,Evidence at protein level
Q16563,SYPL1_HUMAN,Synaptophysin-like protein 1 (Pantophysin),259,"28,565",4 out of 5,2003-10-10,Evidence at protein level
Q5VXT5,SYPL2_HUMAN,Synaptophysin-like protein 2,272,"30,156",3 out of 5,2005-07-05,Evidence at transcript level
Q9NP77,SSU72_HUMAN,RNA polymerase II subunit A C-terminal domain phosphatase SSU72 (CTD phosphatase SSU72) (EC 3.1.3.16),194,"22,574",5 out of 5,2008-04-29,Evidence at protein level
Q9P289,STK26_HUMAN,Serine/threonine-protein kinase 26 (EC 2.7.11.1) (MST3 and SOK1-related kinase) (Mammalian STE20-like protein kinase 4) (MST-4) (STE20-like kinase MST4) (Serine/threonine-protein kinase MASK),416,"46,529",5 out of 5,2005-08-16,Evidence at protein level
Q13188,STK3_HUMAN,Serine/threonine-protein kinase 3 (EC 2.7.11.1) (Mammalian STE20-like protein kinase 2) (MST-2) (STE20-like kinase MST2) (Serine/threonine-protein kinase Krs-1) [Cleaved into: Serine/threonine-protein kinase 3 36kDa subunit (MST2/N); Serine/threonine-protein kinase 3 20kDa subunit (MST2/C)],491,"56,301",5 out of 5,2001-02-21,Evidence at protein level
Q9C0K7,STRAB_HUMAN,STE20-related kinase adapter protein beta (STRAD beta) (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein) (CALS-21) (ILP-interacting protein) (Pseudokinase ALS2CR2),418,"47,026",5 out of 5,2005-12-20,Evidence at protein level
Q7RTU9,STRC_HUMAN,Stereocilin,1775,"192,967",4 out of 5,2004-05-24,Evidence at transcript level
Q13033,STRN3_HUMAN,Striatin-3 (Cell cycle autoantigen SG2NA) (S/G2 antigen),797,"87,209",5 out of 5,1998-07-15,Evidence at protein level
Q9ULQ0,STRP2_HUMAN,Striatin-interacting protein 2 (Protein FAM40B),834,"95,360",5 out of 5,2005-07-19,Evidence at protein level
P56962,STX17_HUMAN,Syntaxin-17,302,"33,403",5 out of 5,2000-12-01,Evidence at protein level
P61266,STX1B_HUMAN,Syntaxin-1B (Syntaxin-1B1) (Syntaxin-1B2),288,"33,245",5 out of 5,2004-05-10,Evidence at protein level
Q15833,STXB2_HUMAN,Syntaxin-binding protein 2 (Protein unc-18 homolog 2) (Unc18-2) (Protein unc-18 homolog B) (Unc-18B),593,"66,453",5 out of 5,1997-11-01,Evidence at protein level
Q6J9G0,STYK1_HUMAN,Tyrosine-protein kinase STYK1 (EC 2.7.10.2) (Novel oncogene with kinase domain) (Protein PK-unique) (Serine/threonine/tyrosine kinase 1),422,"47,577",5 out of 5,2005-04-26,Evidence at protein level
Q9UMX1,SUFU_HUMAN,Suppressor of fused homolog (SUFUH),484,"53,947",5 out of 5,2005-04-12,Evidence at protein level
Q8NBJ7,SUMF2_HUMAN,Sulfatase-modifying factor 2 (C-alpha-formylglycine-generating enzyme 2),301,"33,843",5 out of 5,2003-07-25,Evidence at protein level
Q9UH99,SUN2_HUMAN,SUN domain-containing protein 2 (Protein unc-84 homolog B) (Rab5-interacting protein) (Rab5IP) (Sad1/unc-84 protein-like 2),717,"80,311",5 out of 5,2002-08-02,Evidence at protein level
Q9UGT4,SUSD2_HUMAN,Sushi domain-containing protein 2,822,"90,208",5 out of 5,2006-09-19,Evidence at protein level
Q92537,SUSD6_HUMAN,Sushi domain-containing protein 6 (Drug-activated gene overexpressed protein),303,"32,090",4 out of 5,1997-11-01,Evidence at protein level
Q8IYB8,SUV3_HUMAN,"ATP-dependent RNA helicase SUPV3L1, mitochondrial (EC 3.6.4.13) (Suppressor of var1 3-like protein 1) (SUV3-like protein 1)",786,"87,991",5 out of 5,2007-11-13,Evidence at protein level
Q96PV0,SYGP1_HUMAN,Ras/Rap GTPase-activating protein SynGAP (Neuronal RasGAP) (Synaptic Ras GTPase-activating protein 1) (Synaptic Ras-GAP 1),1343,"148,284",5 out of 5,2003-08-15,Evidence at protein level
Q8NBK3,SUMF1_HUMAN,Sulfatase-modifying factor 1 (EC 1.8.99.-) (C-alpha-formylglycine-generating enzyme 1),374,"40,556",5 out of 5,2003-07-25,Evidence at protein level
O75683,SURF6_HUMAN,Surfeit locus protein 6,361,"41,450",4 out of 5,1999-07-15,Evidence at protein level
O43463,SUV91_HUMAN,Histone-lysine N-methyltransferase SUV39H1 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 1) (H3-K9-HMTase 1) (Lysine N-methyltransferase 1A) (Position-effect variegation 3-9 homolog) (Suppressor of variegation 3-9 homolog 1) (Su(var)3-9 homolog 1),412,"47,907",5 out of 5,2002-11-15,Evidence at protein level
Q7L0J3,SV2A_HUMAN,Synaptic vesicle glycoprotein 2A,742,"82,695",5 out of 5,2006-06-13,Evidence at protein level
Q7L1I2,SV2B_HUMAN,Synaptic vesicle glycoprotein 2B,683,"77,444",4 out of 5,2006-06-13,Evidence at protein level
Q8NHG7,SVIP_HUMAN,Small VCP/p97-interacting protein,77,"8,443",5 out of 5,2005-08-30,Evidence at protein level
Q2M3V2,SWAHA_HUMAN,Ankyrin repeat domain-containing protein SOWAHA (Ankyrin repeat domain-containing protein 43) (Protein sosondowah homolog A),549,"57,443",3 out of 5,2006-06-27,Evidence at protein level
Q96A49,SYAP1_HUMAN,Synapse-associated protein 1,352,"39,933",3 out of 5,2003-05-09,Evidence at protein level
Q5T4T6,SYC2L_HUMAN,Synaptonemal complex protein 2-like (SCP-2-like) (145 kDa nucleolar protein homolog) (hsNO145),812,"93,599",3 out of 5,2008-05-20,Evidence at protein level
P49589,SYCC_HUMAN,"Cysteine--tRNA ligase, cytoplasmic (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)",748,"85,473",5 out of 5,1996-02-01,Evidence at protein level
Q9HA77,SYCM_HUMAN,"Probable cysteine--tRNA ligase, mitochondrial (EC 6.1.1.16) (Cysteinyl-tRNA synthetase) (CysRS)",564,"62,224",4 out of 5,2006-10-03,Evidence at protein level
Q5VT97,SYDE2_HUMAN,Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2) (Protein syd-1 homolog 2),1194,"133,230",4 out of 5,2007-12-04,Evidence at protein level
P57105,SYJ2B_HUMAN,Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25),145,"15,928",5 out of 5,2000-12-01,Evidence at protein level
O43776,SYNC_HUMAN,"Asparagine--tRNA ligase, cytoplasmic (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)",548,"62,943",4 out of 5,1998-12-15,Evidence at protein level
Q96I59,SYNM_HUMAN,"Probable asparagine--tRNA ligase, mitochondrial (EC 6.1.1.22) (Asparaginyl-tRNA synthetase) (AsnRS)",477,"54,090",5 out of 5,2006-10-03,Evidence at protein level
Q8N3V7,SYNPO_HUMAN,Synaptopodin,929,"99,463",5 out of 5,2004-06-07,Evidence at protein level
P08247,SYPH_HUMAN,Synaptophysin (Major synaptic vesicle protein p38),313,"33,845",5 out of 5,1988-08-01,Evidence at protein level
A2VEC9,SSPO_HUMAN,SCO-spondin,5147,"547,504",5 out of 5,2007-06-12,Evidence at transcript level
P43307,SSRA_HUMAN,Translocon-associated protein subunit alpha (TRAP-alpha) (Signal sequence receptor subunit alpha) (SSR-alpha),286,"32,235",5 out of 5,1995-11-01,Evidence at protein level
Q9UNL2,SSRG_HUMAN,Translocon-associated protein subunit gamma (TRAP-gamma) (Signal sequence receptor subunit gamma) (SSR-gamma),185,"21,080",4 out of 5,2000-12-01,Evidence at protein level
Q7RTT3,SSX9_HUMAN,Protein SSX9,188,"21,553",3 out of 5,2006-03-21,Evidence at transcript level
P42224,STAT1_HUMAN,Signal transducer and activator of transcription 1-alpha/beta (Transcription factor ISGF-3 components p91/p84),750,"87,335",5 out of 5,1995-11-01,Evidence at protein level
P40763,STAT3_HUMAN,Signal transducer and activator of transcription 3 (Acute-phase response factor),770,"88,068",5 out of 5,1995-02-01,Evidence at protein level
O95210,STBD1_HUMAN,Starch-binding domain-containing protein 1 (Genethonin-1) (Glycophagy cargo receptor STBD1),358,"39,007",5 out of 5,2004-02-02,Evidence at protein level
P49842,STK19_HUMAN,Serine/threonine-protein kinase 19 (EC 2.7.11.1) (Protein G11) (Protein RP1),368,"40,916",5 out of 5,1996-10-01,Evidence at protein level
Q9BYT3,STK33_HUMAN,Serine/threonine-protein kinase 33 (EC 2.7.11.1),514,"57,831",5 out of 5,2006-04-18,Evidence at protein level
Q15208,STK38_HUMAN,Serine/threonine-protein kinase 38 (EC 2.7.11.1) (NDR1 protein kinase) (Nuclear Dbf2-related kinase 1),465,"54,190",5 out of 5,2004-12-21,Evidence at protein level
Q9UBI4,STML1_HUMAN,Stomatin-like protein 1 (SLP-1) (EPB72-like protein 1) (Protein unc-24 homolog) (Stomatin-related protein) (STORP),398,"42,968",4 out of 5,2005-02-01,Evidence at protein level
Q8TCJ2,STT3B_HUMAN,Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B (Oligosaccharyl transferase subunit STT3B) (STT3-B) (EC 2.4.99.18) (Source of immunodominant MHC-associated peptides homolog),826,"93,674",5 out of 5,2006-07-11,Evidence at protein level
Q8N4C7,STX19_HUMAN,Syntaxin-19,294,"34,324",3 out of 5,2006-12-12,Evidence at protein level
O94901,SUN1_HUMAN,SUN domain-containing protein 1 (Protein unc-84 homolog A) (Sad1/unc-84 protein-like 1),812,"90,064",5 out of 5,2002-08-02,Evidence at protein level
Q9H5I1,SUV92_HUMAN,Histone-lysine N-methyltransferase SUV39H2 (EC 2.1.1.43) (Histone H3-K9 methyltransferase 2) (H3-K9-HMTase 2) (Lysine N-methyltransferase 1B) (Suppressor of variegation 3-9 homolog 2) (Su(var)3-9 homolog 2),410,"46,682",5 out of 5,2002-11-15,Evidence at protein level
Q5T5J6,SWT1_HUMAN,Transcriptional protein SWT1,900,"103,222",3 out of 5,2006-10-03,Evidence at transcript level
P49588,SYAC_HUMAN,"Alanine--tRNA ligase, cytoplasmic (EC 6.1.1.7) (Alanyl-tRNA synthetase) (AlaRS) (Renal carcinoma antigen NY-REN-42)",968,"106,810",5 out of 5,1996-02-01,Evidence at protein level
Q6PIF2,SYCE2_HUMAN,Synaptonemal complex central element protein 2 (Central element synaptonemal complex protein 1),218,"24,690",3 out of 5,2006-11-28,Evidence at protein level
Q9BX26,SYCP2_HUMAN,Synaptonemal complex protein 2 (SCP-2) (Synaptonemal complex lateral element protein) (hsSCP2),1530,"175,639",4 out of 5,2002-10-10,Evidence at transcript level
Q9UQF0,SYCY1_HUMAN,Syncytin-1 (Endogenous retrovirus group W member 1) (Env-W) (Envelope polyprotein gPr73) (Enverin) (HERV-7q Envelope protein) (HERV-W envelope protein) (HERV-W_7q21.2 provirus ancestral Env polyprotein) (Syncytin) [Cleaved into: Surface protein (SU) (gp50); Transmembrane protein (TM) (gp24)],538,"59,866",5 out of 5,2004-05-24,Evidence at protein level
Q9NQ55,SSF1_HUMAN,Suppressor of SWI4 1 homolog (Ssf-1) (Brix domain-containing protein 3) (Peter Pan homolog),473,"53,194",4 out of 5,2002-05-27,Evidence at transcript level
O60224,SSX4_HUMAN,Protein SSX4 (Cancer/testis antigen 5.4) (CT5.4),188,"21,858",3 out of 5,1999-07-15,Evidence at transcript level
O94768,ST17B_HUMAN,Serine/threonine-protein kinase 17B (EC 2.7.11.1) (DAP kinase-related apoptosis-inducing protein kinase 2),372,"42,344",5 out of 5,2001-06-20,Evidence at protein level
P50226,ST1A2_HUMAN,Sulfotransferase 1A2 (ST1A2) (EC 2.8.2.1) (Aryl sulfotransferase 2) (Phenol sulfotransferase 2) (Phenol-sulfating phenol sulfotransferase 2) (P-PST 2),295,"34,310",5 out of 5,1996-10-01,Evidence at protein level
P0CL84,ST3L2_HUMAN,Putative STAG3-like protein 2 (Stromal antigen 3-like protein 2),134,"15,630",2 out of 5,2011-05-03,Uncertain
Q8N2I9,STK40_HUMAN,Serine/threonine-protein kinase 40 (EC 2.7.11.1) (SINK-homologous serine/threonine-protein kinase) (Sugen kinase 495) (SgK495),435,"49,001",5 out of 5,2006-10-17,Evidence at protein level
P27105,STOM_HUMAN,Erythrocyte band 7 integral membrane protein (Protein 7.2b) (Stomatin),288,"31,731",5 out of 5,1992-08-01,Evidence at protein level
Q8N412,STPG2_HUMAN,Sperm-tail PG-rich repeat-containing protein 2,459,"50,660",2 out of 5,2007-12-04,Evidence at transcript level
Q9BX79,STRA6_HUMAN,Stimulated by retinoic acid gene 6 protein homolog,667,"73,503",5 out of 5,2007-12-04,Evidence at protein level
Q8IWZ8,SUGP1_HUMAN,SURP and G-patch domain-containing protein 1 (RNA-binding protein RBP) (Splicing factor 4),645,"72,471",5 out of 5,2005-03-15,Evidence at protein level
Q8N0S2,SYCE1_HUMAN,Synaptonemal complex central element protein 1 (Cancer/testis antigen 76) (CT76),351,"39,699",5 out of 5,2006-11-28,Evidence at protein level
P12081,SYHC_HUMAN,"Histidine--tRNA ligase, cytoplasmic (EC 6.1.1.21) (Histidyl-tRNA synthetase) (HisRS)",509,"57,411",5 out of 5,1989-10-01,Evidence at protein level
Q15532,SSXT_HUMAN,Protein SSXT (Protein SYT) (Synovial sarcoma translocated to X chromosome protein),418,"45,929",5 out of 5,1998-12-15,Evidence at protein level
Q86UX6,ST32C_HUMAN,Serine/threonine-protein kinase 32C (EC 2.7.11.1) (PKE) (Yet another novel kinase 3),486,"54,994",4 out of 5,2006-04-18,Evidence at protein level
P0CL85,ST3L3_HUMAN,STAG3-like protein 3 (Stromal antigen 3-like protein 3),134,"15,609",2 out of 5,2011-05-03,Evidence at transcript level
O94804,STK10_HUMAN,Serine/threonine-protein kinase 10 (EC 2.7.11.1) (Lymphocyte-oriented kinase),968,"112,135",5 out of 5,2001-01-24,Evidence at protein level
Q9NZ72,STMN3_HUMAN,Stathmin-3 (SCG10-like protein),180,"21,017",5 out of 5,2001-01-11,Evidence at protein level
Q8WXE9,STON2_HUMAN,Stonin-2 (Stoned B),905,"101,165",5 out of 5,2003-08-15,Evidence at protein level
Q05952,STP2_HUMAN,Nuclear transition protein 2 (TP-2) (TP2),138,"15,641",3 out of 5,1994-02-01,Evidence at protein level
O75558,STX11_HUMAN,Syntaxin-11,287,"33,196",5 out of 5,1999-07-15,Evidence at protein level
Q9HAC7,SUCHY_HUMAN,Succinate--hydroxymethylglutarate CoA-transferase (EC 2.8.3.13) (Dermal papilla-derived protein 13) (SuccinylCoA:glutarate-CoA transferase),445,"48,462",5 out of 5,2005-07-19,Evidence at protein level
Q9UBS9,SUCO_HUMAN,SUN domain-containing ossification factor (Membrane protein CH1) (Protein osteopotentia homolog) (SUN-like protein 1),1254,"139,430",4 out of 5,2007-09-11,Evidence at protein level
Q6EEV6,SUMO4_HUMAN,Small ubiquitin-related modifier 4 (SUMO-4) (Small ubiquitin-like protein 4),95,"10,685",4 out of 5,2005-11-08,Evidence at protein level
Q9UH65,SWP70_HUMAN,Switch-associated protein 70 (SWAP-70),585,"68,998",5 out of 5,2006-06-13,Evidence at protein level
A1L190,SYCE3_HUMAN,Synaptonemal complex central element protein 3 (Testis highly expressed gene 2 protein) (THEG-2),88,"10,601",3 out of 5,2009-03-24,Evidence at protein level
O95363,SYFM_HUMAN,"Phenylalanine--tRNA ligase, mitochondrial (EC 6.1.1.20) (Phenylalanyl-tRNA synthetase) (PheRS)",451,"52,357",5 out of 5,2004-11-23,Evidence at protein level
Q9Y657,SPIN1_HUMAN,Spindlin-1 (Ovarian cancer-related protein) (Spindlin1),262,"29,601",5 out of 5,2001-06-20,Evidence at protein level
O95149,SPN1_HUMAN,Snurportin-1 (RNA U transporter 1),360,"41,143",5 out of 5,2005-12-06,Evidence at protein level
Q9NS25,SPNXB_HUMAN,Sperm protein associated with the nucleus on the X chromosome B1 (Cancer/testis antigen 11.2) (CT11.2) (Nuclear-associated protein SPAN-Xb) (SPANX-B) (SPANX family member B1) (SPANX family member F1),103,"11,840",3 out of 5,2005-02-01,Evidence at transcript level
P35326,SPR2A_HUMAN,Small proline-rich protein 2A (SPR-2A) (2-1),72,"7,965",4 out of 5,1994-02-01,Evidence at protein level
P09486,SPRC_HUMAN,SPARC (Basement-membrane protein 40) (BM-40) (Osteonectin) (ON) (Secreted protein acidic and rich in cysteine),303,"34,632",5 out of 5,1989-07-01,Evidence at protein level
Q7Z698,SPRE2_HUMAN,"Sprouty-related, EVH1 domain-containing protein 2 (Spred-2)",418,"47,558",5 out of 5,2005-01-04,Evidence at protein level
Q9UBC9,SPRR3_HUMAN,Small proline-rich protein 3 (22 kDa pancornulin) (Cornifin beta) (Esophagin),169,"18,154",5 out of 5,2002-02-11,Evidence at protein level
Q8NCJ5,SPRY3_HUMAN,SPRY domain-containing protein 3,442,"49,694",2 out of 5,2006-06-27,Evidence at protein level
Q9NUQ6,SPS2L_HUMAN,SPATS2-like protein (DNA polymerase-transactivated protein 6) (Stress granule and nucleolar protein) (SGNP),558,"61,729",4 out of 5,2007-10-23,Evidence at protein level
O00267,SPT5H_HUMAN,Transcription elongation factor SPT5 (hSPT5) (DRB sensitivity-inducing factor 160 kDa subunit) (DSIF p160) (DRB sensitivity-inducing factor large subunit) (DSIF large subunit) (Tat-cotransactivator 1 protein) (Tat-CT1 protein),1087,"121,000",5 out of 5,2005-11-22,Evidence at protein level
Q9NUV7,SPTC3_HUMAN,Serine palmitoyltransferase 3 (EC 2.3.1.50) (Long chain base biosynthesis protein 2b) (LCB2b) (Long chain base biosynthesis protein 3) (LCB 3) (Serine-palmitoyl-CoA transferase 3) (SPT 3),552,"62,049",5 out of 5,2002-10-10,Evidence at protein level
Q13813,SPTN1_HUMAN,"Spectrin alpha chain, non-erythrocytic 1 (Alpha-II spectrin) (Fodrin alpha chain) (Spectrin, non-erythroid alpha subunit)",2472,"284,539",5 out of 5,1997-11-01,Evidence at protein level
Q5VSR9,SPXN1_HUMAN,Sperm protein associated with the nucleus on the X chromosome N1 (Nuclear-associated protein SPAN-Xn1) (SPANX-N1) (SPANX family member N1),72,"8,263",1 out of 5,2007-05-01,Inferred from homology
Q9BT56,SPXN_HUMAN,Spexin (NPQ) (Neuropeptide Q) (Spexin hormone) [Cleaved into: Spexin-1; Spexin-2 (NPQ 53-70)],116,"13,302",5 out of 5,2005-09-27,Evidence at protein level
O43609,SPY1_HUMAN,Protein sprouty homolog 1 (Spry-1),319,"35,122",5 out of 5,2001-02-21,Evidence at protein level
Q8WTU2,SRB4D_HUMAN,Scavenger receptor cysteine-rich domain-containing group B protein (Four scavenger receptor cysteine-rich domains-containing protein) (S4D-SRCRB),575,"60,819",3 out of 5,2008-02-26,Evidence at transcript level
P36956,SRBP1_HUMAN,Sterol regulatory element-binding protein 1 (SREBP-1) (Class D basic helix-loop-helix protein 1) (bHLHd1) (Sterol regulatory element-binding transcription factor 1) [Cleaved into: Processed sterol regulatory element-binding protein 1],1147,"121,675",5 out of 5,1994-06-01,Evidence at protein level
Q86TD4,SRCA_HUMAN,Sarcalumenin,932,"100,788",3 out of 5,2006-01-10,Evidence at transcript level
Q8N3U4,STAG2_HUMAN,Cohesin subunit SA-2 (SCC3 homolog 2) (Stromal antigen 2),1231,"141,326",5 out of 5,2003-03-25,Evidence at protein level
Q92783,STAM1_HUMAN,Signal transducing adapter molecule 1 (STAM-1),540,"59,180",5 out of 5,2005-07-19,Evidence at protein level
Q9UHE8,STEA1_HUMAN,Metalloreductase STEAP1 (EC 1.16.1.-) (Six-transmembrane epithelial antigen of prostate 1),339,"39,851",5 out of 5,2000-12-01,Evidence at transcript level
Q9P246,STIM2_HUMAN,Stromal interaction molecule 2,746,"83,971",5 out of 5,2001-11-02,Evidence at protein level
Q86WV6,STING_HUMAN,Stimulator of interferon genes protein (hSTING) (Endoplasmic reticulum interferon stimulator) (ERIS) (Mediator of IRF3 activation) (hMITA) (Transmembrane protein 173),379,"42,193",5 out of 5,2007-01-09,Evidence at protein level
Q9BXA5,SUCR1_HUMAN,Succinate receptor 1 (G-protein coupled receptor 91) (P2Y purinoceptor 1-like),334,"38,698",5 out of 5,2004-05-24,Evidence at protein level
Q8IX01,SUGP2_HUMAN,"SURP and G-patch domain-containing protein 2 (Arginine/serine-rich-splicing factor 14) (Splicing factor, arginine/serine-rich 14)",1082,"120,207",5 out of 5,2005-03-15,Evidence at protein level
P14410,SUIS_HUMAN,"Sucrase-isomaltase, intestinal [Cleaved into: Sucrase (EC 3.2.1.48); Isomaltase (EC 3.2.1.10)]",1827,"209,453",5 out of 5,1990-01-01,Evidence at protein level
Q8TC36,SUN5_HUMAN,SUN domain-containing protein 5 (Sad1 and UNC84 domain-containing protein 5) (Sperm-associated antigen 4-like protein) (Testis and spermatogenesis-related gene 4 protein),379,"43,081",4 out of 5,2003-01-17,Evidence at transcript level
O15260,SURF4_HUMAN,Surfeit locus protein 4,269,"30,394",5 out of 5,1999-07-15,Evidence at protein level
Q58G82,SY14L_HUMAN,Putative synaptotagmin-14-like protein (Synaptotagmin XIV protein pseudogene 1) (Synaptotagmin XIV-derived protein) (Synaptotagmin XIV-like protein),188,"21,436",5 out of 5,2008-02-05,Uncertain
A8MT33,SYC1L_HUMAN,Synaptonemal complex central element protein 1-like (Meiosis-related protein),242,"27,397",2 out of 5,2008-06-10,Evidence at transcript level
Q15431,SYCP1_HUMAN,Synaptonemal complex protein 1 (SCP-1) (Cancer/testis antigen 8) (CT8),976,"114,192",5 out of 5,1998-07-15,Evidence at protein level
P14868,SYDC_HUMAN,"Aspartate--tRNA ligase, cytoplasmic (EC 6.1.1.12) (Aspartyl-tRNA synthetase) (AspRS) (Cell proliferation-inducing gene 40 protein)",501,"57,136",5 out of 5,1990-04-01,Evidence at protein level
Q9NSE4,SYIM_HUMAN,"Isoleucine--tRNA ligase, mitochondrial (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IleRS)",1012,"113,792",5 out of 5,2006-05-02,Evidence at protein level
Q9P2J5,SYLC_HUMAN,"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)",1176,"134,466",5 out of 5,2004-06-07,Evidence at protein level
Q7L3T8,SYPM_HUMAN,"Probable proline--tRNA ligase, mitochondrial (EC 6.1.1.15) (Prolyl-tRNA synthetase) (ProRS)",475,"53,263",3 out of 5,2005-08-30,Evidence at protein level
P54136,SYRC_HUMAN,"Arginine--tRNA ligase, cytoplasmic (EC 6.1.1.19) (Arginyl-tRNA synthetase) (ArgRS)",660,"75,379",5 out of 5,1996-10-01,Evidence at protein level
Q8IV01,SYT12_HUMAN,Synaptotagmin-12 (Synaptotagmin XII) (SytXII),421,"46,537",4 out of 5,2003-07-19,Evidence at protein level
Q8NB59,SYT14_HUMAN,Synaptotagmin-14 (Synaptotagmin XIV) (SytXIV),555,"62,287",5 out of 5,2004-09-27,Evidence at protein level
Q86SS6,SYT9_HUMAN,Synaptotagmin-9 (Synaptotagmin IX) (SytIX),491,"56,188",5 out of 5,2003-07-19,Evidence at transcript level
Q9HCH5,SYTL2_HUMAN,Synaptotagmin-like protein 2 (Breast cancer-associated antigen SGA-72M) (Exophilin-4),934,"104,930",5 out of 5,2003-07-25,Evidence at protein level
Q8TDW5,SYTL5_HUMAN,Synaptotagmin-like protein 5,730,"81,523",5 out of 5,2003-07-25,Evidence at protein level
Q16143,SYUB_HUMAN,Beta-synuclein,134,"14,288",5 out of 5,1997-11-01,Evidence at protein level
Q7Z422,SZRD1_HUMAN,SUZ domain-containing protein 1 (Putative MAPK-activating protein PM18/PM20/PM22),152,"16,997",3 out of 5,2007-09-11,Evidence at protein level
Q9Y5J6,T10B_HUMAN,Mitochondrial import inner membrane translocase subunit Tim10 B (Fracture callus protein 1) (FxC1) (Mitochondrial import inner membrane translocase subunit Tim9 B) (TIMM10B) (Tim10b),103,"11,586",5 out of 5,2001-01-11,Evidence at protein level
Q8N3T6,T132C_HUMAN,Transmembrane protein 132C,1108,"121,787",3 out of 5,2008-03-18,Evidence at transcript level
Q86TG1,T150A_HUMAN,Transmembrane protein 150A (Transmembrane protein 150),271,"28,835",5 out of 5,2007-02-06,Evidence at protein level
B9EJG8,T150C_HUMAN,Transmembrane protein 150C,249,"27,887",3 out of 5,2010-06-15,Evidence at transcript level
Q8IW70,T151B_HUMAN,Transmembrane protein 151B (Transmembrane protein 193),566,"61,506",2 out of 5,2007-10-23,Evidence at transcript level
Q8NBL3,T178A_HUMAN,Transmembrane protein 178A,297,"33,019",3 out of 5,2007-05-15,Evidence at transcript level
Q8IXX5,T183A_HUMAN,Transmembrane protein 183A,376,"42,826",2 out of 5,2005-08-16,Evidence at protein level
Q9Y519,T184B_HUMAN,Transmembrane protein 184B (Putative MAPK-activating protein FM08),407,"45,562",3 out of 5,2002-06-20,Evidence at protein level
A6NGB0,T191C_HUMAN,Transmembrane protein 191C,347,"39,292",2 out of 5,2008-06-10,Inferred from homology
Q9Y3Q8,T22D4_HUMAN,TSC22 domain family protein 4 (TSC22-related-inducible leucine zipper protein 2) (Tsc-22-like protein THG-1),395,"41,026",5 out of 5,2001-06-01,Evidence at protein level
Q6P1K8,T2H2L_HUMAN,General transcription factor IIH subunit 2-like protein (General transcription factor IIH polypeptide 2-like protein),395,"44,452",4 out of 5,2008-04-29,Evidence at protein level
O00268,TAF4_HUMAN,Transcription initiation factor TFIID subunit 4 (RNA polymerase II TBP-associated factor subunit C) (TBP-associated factor 4) (Transcription initiation factor TFIID 130 kDa subunit) (TAF(II)130) (TAFII-130) (TAFII130) (Transcription initiation factor TFIID 135 kDa subunit) (TAF(II)135) (TAFII-135) (TAFII135),1085,"110,114",5 out of 5,1998-07-15,Evidence at protein level
Q9Y6J9,TAF6L_HUMAN,TAF6-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 6L (PCAF-associated factor 65-alpha) (PAF65-alpha),622,"67,814",5 out of 5,2004-04-26,Evidence at protein level
Q7Z7C8,TAF8_HUMAN,Transcription initiation factor TFIID subunit 8 (Protein taube nuss) (TBP-associated factor 43 kDa) (TBP-associated factor 8) (Transcription initiation factor TFIID 43 kDa subunit) (TAFII-43) (TAFII43) (hTAFII43),310,"34,262",5 out of 5,2008-01-15,Evidence at protein level
Q8N103,TAGAP_HUMAN,T-cell activation Rho GTPase-activating protein (T-cell activation GTPase-activating protein),731,"80,703",4 out of 5,2005-10-11,Evidence at protein level
Q01995,TAGL_HUMAN,Transgelin (22 kDa actin-binding protein) (Protein WS3-10) (Smooth muscle protein 22-alpha) (SM22-alpha),201,"22,611",4 out of 5,1993-04-01,Evidence at protein level
P17542,TAL1_HUMAN,T-cell acute lymphocytic leukemia protein 1 (TAL-1) (Class A basic helix-loop-helix protein 17) (bHLHa17) (Stem cell protein) (T-cell leukemia/lymphoma protein 5),331,"34,271",5 out of 5,1990-08-01,Evidence at protein level
Q03518,TAP1_HUMAN,Antigen peptide transporter 1 (APT1) (ATP-binding cassette sub-family B member 2) (Peptide supply factor 1) (Peptide transporter PSF1) (PSF-1) (Peptide transporter TAP1) (Peptide transporter involved in antigen processing 1) (Really interesting new gene 4 protein),808,"87,218",5 out of 5,1994-06-01,Evidence at protein level
Q03519,TAP2_HUMAN,Antigen peptide transporter 2 (APT2) (ATP-binding cassette sub-family B member 3) (Peptide supply factor 2) (Peptide transporter PSF2) (PSF-2) (Peptide transporter TAP2) (Peptide transporter involved in antigen processing 2) (Really interesting new gene 11 protein),686,"75,664",5 out of 5,1994-06-01,Evidence at protein level
Q9UK61,TASOR_HUMAN,Protein TASOR (CTCL tumor antigen se89-1) (Retinoblastoma-associated protein RAP140) (Transgene activation suppressor protein),1670,"189,032",5 out of 5,2007-07-24,Evidence at protein level
Q93075,TATD2_HUMAN,Putative deoxyribonuclease TATDN2 (EC 3.1.21.-),761,"85,023",3 out of 5,1997-11-01,Evidence at protein level
Q17R31,TATD3_HUMAN,Putative deoxyribonuclease TATDN3 (EC 3.1.21.-),274,"30,333",4 out of 5,2008-01-15,Evidence at protein level
P10636,TAU_HUMAN,Microtubule-associated protein tau (Neurofibrillary tangle protein) (Paired helical filament-tau) (PHF-tau),758,"78,928",5 out of 5,1989-07-01,Evidence at protein level
Q16635,TAZ_HUMAN,Tafazzin (Protein G4.5),292,"33,459",5 out of 5,1997-11-01,Evidence at protein level
Q9H853,TBA4B_HUMAN,Putative tubulin-like protein alpha-4B (Alpha-tubulin 4B),241,"27,551",3 out of 5,2008-04-29,Uncertain
Q9P2M4,TBC14_HUMAN,TBC1 domain family member 14,693,"78,137",5 out of 5,2004-06-21,Evidence at protein level
Q8IYX1,TBC21_HUMAN,TBC1 domain family member 21,336,"39,221",4 out of 5,2005-02-15,Evidence at protein level
A0A087WXS9,TBC3I_HUMAN,TBC1 domain family member 3I,549,"62,205",3 out of 5,2015-01-07,Inferred from homology
O75347,TBCA_HUMAN,Tubulin-specific chaperone A (TCP1-chaperonin cofactor A) (Tubulin-folding cofactor A) (CFA),108,"12,855",5 out of 5,2000-05-30,Evidence at protein level
Q99426,TBCB_HUMAN,Tubulin-folding cofactor B (Cytoskeleton-associated protein 1) (Cytoskeleton-associated protein CKAPI) (Tubulin-specific chaperone B),244,"27,326",5 out of 5,1998-07-15,Evidence at protein level
Q5QJ74,TBCEL_HUMAN,Tubulin-specific chaperone cofactor E-like protein (EL) (Leucine-rich repeat-containing protein 35),424,"48,195",3 out of 5,2006-06-13,Evidence at protein level
Q9UPU7,TBD2B_HUMAN,TBC1 domain family member 2B,963,"109,880",4 out of 5,2008-01-15,Evidence at protein level
Q12788,TBL3_HUMAN,Transducin beta-like protein 3 (WD repeat-containing protein SAZD),808,"89,035",5 out of 5,1998-07-15,Evidence at protein level
P20226,TBP_HUMAN,TATA-box-binding protein (TATA sequence-binding protein) (TATA-binding factor) (TATA-box factor) (Transcription initiation factor TFIID TBP subunit),339,"37,698",5 out of 5,1991-02-01,Evidence at protein level
Q9UMR3,TBX20_HUMAN,T-box transcription factor TBX20 (T-box protein 20),447,"49,232",5 out of 5,2000-12-01,Evidence at protein level
O15119,TBX3_HUMAN,T-box transcription factor TBX3 (T-box protein 3),743,"79,389",5 out of 5,1999-07-15,Evidence at protein level
P57082,TBX4_HUMAN,T-box transcription factor TBX4 (T-box protein 4),545,"60,204",5 out of 5,2000-12-01,Evidence at protein level
Q8WW35,TC1D2_HUMAN,Tctex1 domain-containing protein 2,142,"16,122",3 out of 5,2008-02-05,Evidence at protein level
Q9H3H9,TCAL2_HUMAN,Transcription elongation factor A protein-like 2 (TCEA-like protein 2) (Transcription elongation factor S-II protein-like 2),227,"25,850",2 out of 5,2006-05-30,Evidence at transcript level
O14994,SYN3_HUMAN,Synapsin-3 (Synapsin III),580,"63,303",5 out of 5,2000-05-30,Evidence at protein level
Q6XYQ8,SYT10_HUMAN,Synaptotagmin-10 (Synaptotagmin X) (SytX),523,"59,127",5 out of 5,2004-09-27,Evidence at transcript level
Q96DZ7,T4S19_HUMAN,Transmembrane 4 L6 family member 19 (Osteoclast maturation-associated gene 4 protein) (Tetraspan membrane protein OCTM4),209,"22,433",3 out of 5,2005-06-21,Evidence at transcript level
Q9UF72,T73AS_HUMAN,Putative TP73 antisense gene protein 1 (TP73 antisense RNA 1) (p53-dependent apoptosis modulator),201,"20,603",3 out of 5,2008-09-02,Uncertain
Q86VP1,TAXB1_HUMAN,Tax1-binding protein 1 (TRAF6-binding protein),789,"90,877",5 out of 5,2006-05-16,Evidence at protein level
Q9BQE3,TBA1C_HUMAN,Tubulin alpha-1C chain (Alpha-tubulin 6) (Tubulin alpha-6 chain) [Cleaved into: Detyrosinated tubulin alpha-1C chain],449,"49,895",5 out of 5,2002-05-02,Evidence at protein level
Q3MII6,TBC25_HUMAN,TBC1 domain family member 25,688,"76,327",5 out of 5,2007-05-29,Evidence at protein level
Q9BSW7,SYT17_HUMAN,Synaptotagmin-17 (Protein B/K) (Synaptotagmin XVII) (SytXVII),474,"53,849",5 out of 5,2007-12-04,Evidence at protein level
Q8N9I0,SYT2_HUMAN,Synaptotagmin-2 (Synaptotagmin II) (SytII),419,"46,872",5 out of 5,2003-07-19,Evidence at protein level
Q9H2B2,SYT4_HUMAN,Synaptotagmin-4 (Synaptotagmin IV) (SytIV),425,"47,958",5 out of 5,2001-10-18,Evidence at protein level
O43581,SYT7_HUMAN,Synaptotagmin-7 (IPCA-7) (Prostate cancer-associated protein 7) (Synaptotagmin VII) (SytVII),403,"45,501",5 out of 5,2001-10-18,Evidence at protein level
Q8NBV8,SYT8_HUMAN,Synaptotagmin-8 (Synaptotagmin VIII) (SytVIII),401,"44,138",5 out of 5,2003-11-28,Evidence at transcript level
P52657,T2AG_HUMAN,Transcription initiation factor IIA subunit 2 (General transcription factor IIA subunit 2) (TFIIA p12 subunit) (TFIIA-12) (TFIIAS) (Transcription initiation factor IIA gamma chain) (TFIIA-gamma),109,"12,457",5 out of 5,1996-10-01,Evidence at protein level
P35269,T2FA_HUMAN,General transcription factor IIF subunit 1 (General transcription factor IIF 74 kDa subunit) (Transcription initiation factor IIF subunit alpha) (TFIIF-alpha) (Transcription initiation factor RAP74),517,"58,240",5 out of 5,1994-02-01,Evidence at protein level
P13984,T2FB_HUMAN,General transcription factor IIF subunit 2 (EC 3.6.4.12) (ATP-dependent helicase GTF2F2) (General transcription factor IIF 30 kDa subunit) (Transcription initiation factor IIF subunit beta) (TFIIF-beta) (Transcription initiation factor RAP30),249,"28,380",5 out of 5,1990-01-01,Evidence at protein level
Q9NYW0,T2R10_HUMAN,Taste receptor type 2 member 10 (T2R10) (Taste receptor family B member 2) (TRB2),307,"35,365",4 out of 5,2003-04-11,Evidence at protein level
Q96CE8,T4S18_HUMAN,Transmembrane 4 L6 family member 18,201,"22,277",2 out of 5,2005-06-21,Evidence at transcript level
O14894,T4S5_HUMAN,Transmembrane 4 L6 family member 5 (Tetraspan transmembrane protein L6H),197,"20,823",2 out of 5,2000-12-01,Evidence at transcript level
Q9ULZ0,T53G3_HUMAN,TP53-target gene 3 protein (TP53-inducible gene 3 protein),132,"13,627",3 out of 5,2008-04-08,Evidence at transcript level
Q9NYW6,TA2R3_HUMAN,Taste receptor type 2 member 3 (T2R3),316,"35,915",4 out of 5,2003-04-11,Evidence at transcript level
Q9NYW4,TA2R5_HUMAN,Taste receptor type 2 member 5 (T2R5),299,"34,505",5 out of 5,2003-04-11,Evidence at protein level
Q969N4,TAAR8_HUMAN,Trace amine-associated receptor 8 (TaR-8) (Trace amine receptor 8) (G-protein coupled receptor 102) (Trace amine receptor 5) (TaR-5),342,"38,029",4 out of 5,2003-10-10,Evidence at transcript level
Q8N9U0,TAC2N_HUMAN,Tandem C2 domains nuclear protein (Membrane targeting tandem C2 domain-containing protein 1) (Tandem C2 protein in nucleus) (Tac2-N),490,"55,284",3 out of 5,2003-07-25,Evidence at protein level
Q9Y6A5,TACC3_HUMAN,Transforming acidic coiled-coil-containing protein 3 (ERIC-1),838,"90,360",5 out of 5,2001-04-27,Evidence at protein level
P40200,TACT_HUMAN,T-cell surface protein tactile (Cell surface antigen CD96) (T cell-activated increased late expression protein) (CD antigen CD96),585,"65,634",5 out of 5,1995-02-01,Evidence at protein level
O75478,TAD2A_HUMAN,Transcriptional adapter 2-alpha (Transcriptional adapter 2-like) (ADA2-like protein),443,"51,506",5 out of 5,2001-04-27,Evidence at protein level
Q15573,TAF1A_HUMAN,TATA box-binding protein-associated factor RNA polymerase I subunit A (RNA polymerase I-specific TBP-associated factor 48 kDa) (TAFI48) (TATA box-binding protein-associated factor 1A) (TBP-associated factor 1A) (Transcription factor SL1) (Transcription initiation factor SL1/TIF-IB subunit A),450,"52,676",5 out of 5,2006-03-21,Evidence at protein level
Q15572,TAF1C_HUMAN,TATA box-binding protein-associated factor RNA polymerase I subunit C (RNA polymerase I-specific TBP-associated factor 110 kDa) (TAFI110) (TATA box-binding protein-associated factor 1C) (TBP-associated factor 1C) (Transcription initiation factor SL1/TIF-IB subunit C),869,"95,213",5 out of 5,2005-08-16,Evidence at protein level
Q5VWG9,TAF3_HUMAN,Transcription initiation factor TFIID subunit 3 (140 kDa TATA box-binding protein-associated factor) (TBP-associated factor 3) (Transcription initiation factor TFIID 140 kDa subunit) (TAF(II)140) (TAF140) (TAFII-140) (TAFII140),929,"103,582",5 out of 5,2006-07-11,Evidence at protein level
Q16594,TAF9_HUMAN,Transcription initiation factor TFIID subunit 9 (RNA polymerase II TBP-associated factor subunit G) (STAF31/32) (Transcription initiation factor TFIID 31 kDa subunit) (TAFII-31) (TAFII31) (Transcription initiation factor TFIID 32 kDa subunit) (TAFII-32) (TAFII32),264,"28,974",5 out of 5,1997-11-01,Evidence at protein level
Q7L7X3,TAOK1_HUMAN,Serine/threonine-protein kinase TAO1 (EC 2.7.11.1) (Kinase from chicken homolog B) (hKFC-B) (MARK Kinase) (MARKK) (Prostate-derived sterile 20-like kinase 2) (PSK-2) (PSK2) (Prostate-derived STE20-like kinase 2) (Thousand and one amino acid protein kinase 1) (TAOK1) (hTAOK1),1001,"116,070",5 out of 5,2005-10-25,Evidence at protein level
Q9H2K8,TAOK3_HUMAN,Serine/threonine-protein kinase TAO3 (EC 2.7.11.1) (Cutaneous T-cell lymphoma-associated antigen HD-CL-09) (CTCL-associated antigen HD-CL-09) (Dendritic cell-derived protein kinase) (JNK/SAPK-inhibitory kinase) (Jun kinase-inhibitory kinase) (Kinase from chicken homolog A) (hKFC-A) (Thousand and one amino acid protein 3),898,"105,406",5 out of 5,2005-10-25,Evidence at protein level
Q9P031,TAP26_HUMAN,Thyroid transcription factor 1-associated protein 26 (TTF-1-associated protein 26) (Coiled-coil domain-containing protein 59) (TTF-1-associated protein BR2),241,"28,670",4 out of 5,2007-08-21,Evidence at protein level
Q13395,TARB1_HUMAN,Probable methyltransferase TARBP1 (EC 2.1.1.-) (TAR RNA-binding protein 1) (TAR RNA-binding protein of 185 kDa) (TRP-185),1621,"181,675",5 out of 5,2007-01-23,Evidence at protein level
P47897,SYQ_HUMAN,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),775,"87,799",5 out of 5,1996-02-01,Evidence at protein level
Q17RD7,SYT16_HUMAN,Synaptotagmin-16 (Chr14Syt) (Synaptotagmin 14-like protein) (Synaptotagmin XIV-related protein),645,"72,274",5 out of 5,2006-10-31,Evidence at protein level
Q9BW92,SYTM_HUMAN,"Threonine--tRNA ligase, mitochondrial (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like 1)",718,"81,036",5 out of 5,2006-10-31,Evidence at protein level
Q9UGM6,SYWM_HUMAN,"Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS)",360,"40,147",4 out of 5,2002-06-06,Evidence at protein level
P54577,SYYC_HUMAN,"Tyrosine--tRNA ligase, cytoplasmic (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS) [Cleaved into: Tyrosine--tRNA ligase, cytoplasmic, N-terminally processed]",528,"59,143",5 out of 5,1996-10-01,Evidence at protein level
Q9NUJ3,T11L1_HUMAN,T-complex protein 11-like protein 1,509,"57,035",2 out of 5,2008-01-15,Evidence at protein level
Q9BXJ8,T120A_HUMAN,Transmembrane protein 120A (Transmembrane protein induced by tumor necrosis factor alpha),343,"40,610",4 out of 5,2007-11-13,Evidence at protein level
Q8IUX1,T126B_HUMAN,"Complex I assembly factor TMEM126B, mitochondrial (Transmembrane protein 126B)",230,"25,943",5 out of 5,2007-03-20,Evidence at protein level
Q96HP8,T176A_HUMAN,Transmembrane protein 176A (Hepatocellular carcinoma-associated antigen 112),235,"26,116",2 out of 5,2007-03-06,Evidence at transcript level
Q6ZMB5,T184A_HUMAN,Transmembrane protein 184A,413,"45,777",3 out of 5,2007-09-11,Evidence at protein level
A6NKL6,T200C_HUMAN,Transmembrane protein 200C (Transmembrane protein TTMA) (Two transmembrane domain-containing family member A),621,"63,928",2 out of 5,2008-09-02,Evidence at transcript level
B2RXF0,T229A_HUMAN,Transmembrane protein 229A,380,"42,370",2 out of 5,2010-03-02,Evidence at transcript level
Q15714,T22D1_HUMAN,TSC22 domain family protein 1 (Cerebral protein 2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein),1073,"109,677",5 out of 5,1997-11-01,Evidence at protein level
Q4KMP7,TB10B_HUMAN,TBC1 domain family member 10B (Rab27A-GAP-beta),808,"87,199",5 out of 5,2008-01-15,Evidence at protein level
Q71U36,TBA1A_HUMAN,Tubulin alpha-1A chain (Alpha-tubulin 3) (Tubulin B-alpha-1) (Tubulin alpha-3 chain) [Cleaved into: Detyrosinated tubulin alpha-1A chain],451,"50,136",5 out of 5,1987-08-13,Evidence at protein level
Q6PEY2,TBA3E_HUMAN,Tubulin alpha-3E chain (Alpha-tubulin 3E) [Cleaved into: Detyrosinated tubulin alpha-3E chain],450,"49,859",5 out of 5,2007-07-10,Evidence at protein level
P68371,TBB4B_HUMAN,Tubulin beta-4B chain (Tubulin beta-2 chain) (Tubulin beta-2C chain),445,"49,831",5 out of 5,1987-08-13,Evidence at protein level
Q3ZCM7,TBB8_HUMAN,Tubulin beta-8 chain (Tubulin beta 8 class VIII),444,"49,776",5 out of 5,2008-02-26,Evidence at protein level
Q9UJT1,TBD_HUMAN,Tubulin delta chain (Delta-tubulin),453,"51,034",5 out of 5,2000-12-01,Evidence at transcript level
Q9BZK7,TBL1R_HUMAN,F-box-like/WD repeat-containing protein TBL1XR1 (Nuclear receptor corepressor/HDAC3 complex subunit TBLR1) (TBL1-related protein 1) (Transducin beta-like 1X-related protein 1),514,"55,595",5 out of 5,2002-09-19,Evidence at protein level
O43435,TBX1_HUMAN,T-box transcription factor TBX1 (T-box protein 1) (Testis-specific T-box protein),398,"43,133",5 out of 5,1999-07-15,Evidence at protein level
Q9UL17,TBX21_HUMAN,T-box transcription factor TBX21 (T-box protein 21) (T-cell-specific T-box transcription factor T-bet) (Transcription factor TBLYM),535,"58,328",5 out of 5,2001-01-11,Evidence at transcript level
Q5JR98,TC1D4_HUMAN,Tctex1 domain-containing protein 4 (Protein N22.1) (Tctex-2-beta),221,"23,353",3 out of 5,2008-02-05,Evidence at protein level
Q96EI5,TCAL4_HUMAN,Transcription elongation factor A protein-like 4 (TCEA-like protein 4) (Transcription elongation factor S-II protein-like 4),215,"24,647",3 out of 5,2006-05-30,Evidence at protein level
Q12870,TCF15_HUMAN,Transcription factor 15 (TCF-15) (Class A basic helix-loop-helix protein 40) (bHLHa40) (Paraxis) (Protein bHLH-EC2),199,"20,816",5 out of 5,2002-11-25,Evidence at transcript level
Q9UGU0,TCF20_HUMAN,Transcription factor 20 (TCF-20) (Nuclear factor SPBP) (Protein AR1) (Stromelysin-1 PDGF-responsive element-binding protein) (SPRE-binding protein),1960,"211,771",5 out of 5,2002-08-02,Evidence at protein level
Q9BQ70,TCF25_HUMAN,Transcription factor 25 (TCF-25) (Nuclear localized protein 1),676,"76,667",5 out of 5,2002-09-19,Evidence at protein level
Q9BT92,TCHP_HUMAN,Trichoplein keratin filament-binding protein (Protein TCHP) (Mitochondrial protein with oncostatic activity) (Mitostatin) (Tumor suppressor protein),498,"61,072",5 out of 5,2007-06-26,Evidence at protein level
P20061,TCO1_HUMAN,Transcobalamin-1 (TC-1) (Haptocorrin) (HC) (Protein R) (Transcobalamin I) (TC I) (TCI),433,"48,207",5 out of 5,1991-02-01,Evidence at protein level
Q13428,TCOF_HUMAN,Treacle protein (Treacher Collins syndrome protein),1488,"152,106",5 out of 5,1997-11-01,Evidence at protein level
B9ZVM9,TCP2L_HUMAN,T-complex protein 10A homolog 2 (T-complex 10-like protein 2),353,"38,357",2 out of 5,2011-12-14,Inferred from homology
P50991,TCPD_HUMAN,T-complex protein 1 subunit delta (TCP-1-delta) (CCT-delta) (Stimulator of TAR RNA-binding),539,"57,924",5 out of 5,1996-10-01,Evidence at protein level
P51864,TDGF3_HUMAN,Putative teratocarcinoma-derived growth factor 3 (Cripto-3 growth factor) (Epidermal growth factor-like cripto protein CR3) (Teratocarcinoma-derived growth factor 1 pseudogene 3),188,"21,181",4 out of 5,1996-10-01,Uncertain
Q587J7,TDR12_HUMAN,Putative ATP-dependent RNA helicase TDRD12 (EC 3.6.4.13) (ES cell-associated transcript 8 protein) (Tudor domain-containing protein 12),1177,"132,578",4 out of 5,2007-12-04,Evidence at transcript level
Q9BXT4,TDRD1_HUMAN,Tudor domain-containing protein 1 (Cancer/testis antigen 41.1) (CT41.1),1180,"132,024",5 out of 5,2001-11-16,Evidence at protein level
Q3Y452,TDRG1_HUMAN,Testis development-related protein 1,100,"10,472",2 out of 5,2012-10-03,Evidence at protein level
Q99594,TEAD3_HUMAN,Transcriptional enhancer factor TEF-5 (DTEF-1) (TEA domain family member 3) (TEAD-3),435,"48,676",5 out of 5,1997-11-01,Evidence at protein level
Q9NZ01,TECR_HUMAN,"Very-long-chain enoyl-CoA reductase (EC 1.3.1.93) (Synaptic glycoprotein SC2) (Trans-2,3-enoyl-CoA reductase) (TER)",308,"36,034",5 out of 5,2002-04-16,Evidence at protein level
Q10587,TEF_HUMAN,Thyrotroph embryonic factor,303,"33,248",4 out of 5,1996-10-01,Evidence at protein level
Q9UIF3,TEKT2_HUMAN,Tektin-2 (Tektin-t) (Testicular tektin) (Testicular tektin B1-like protein) (TEKTB1) (Tektin-B1),430,"49,672",4 out of 5,2002-11-08,Evidence at protein level
Q9Y285,SYFA_HUMAN,Phenylalanine--tRNA ligase alpha subunit (EC 6.1.1.20) (CML33) (Phenylalanyl-tRNA synthetase alpha subunit) (PheRS),508,"57,564",5 out of 5,2000-12-08,Evidence at protein level
Q7L8C5,SYT13_HUMAN,Synaptotagmin-13 (Synaptotagmin XIII) (SytXIII),426,"46,885",4 out of 5,2005-11-22,Evidence at protein level
Q8N4U5,T11L2_HUMAN,T-complex protein 11-like protein 2,519,"58,091",2 out of 5,2008-01-15,Evidence at transcript level
Q14DG7,T132B_HUMAN,Transmembrane protein 132B,1078,"119,477",3 out of 5,2007-04-17,Evidence at transcript level
H3BS89,T178B_HUMAN,Transmembrane protein 178B,294,"33,409",2 out of 5,2012-10-03,Evidence at transcript level
Q8NBD8,T229B_HUMAN,Transmembrane protein 229B,167,"19,531",2 out of 5,2006-12-12,Evidence at transcript level
Q99576,T22D3_HUMAN,TSC22 domain family protein 3 (DSIP-immunoreactive peptide) (Protein DIP) (hDIP) (Delta sleep-inducing peptide immunoreactor) (Glucocorticoid-induced leucine zipper protein) (GILZ) (TSC-22-like protein) (TSC-22-related protein) (TSC-22R),134,"14,810",5 out of 5,1997-11-01,Evidence at protein level
Q8WV15,T255B_HUMAN,Transmembrane protein 255B (Protein FAM70B),326,"34,609",2 out of 5,2006-12-12,Evidence at transcript level
Q9H7V2,SYNG1_HUMAN,Synapse differentiation-inducing gene protein 1 (SynDIG1) (Dispanin subfamily C member 2) (DSPC2) (Transmembrane protein 90B),258,"28,551",5 out of 5,2002-10-10,Evidence at protein level
O15056,SYNJ2_HUMAN,"Synaptojanin-2 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 2)",1496,"165,538",5 out of 5,2000-12-01,Evidence at protein level
O00445,SYT5_HUMAN,Synaptotagmin-5 (Synaptotagmin V) (SytV),386,"42,900",5 out of 5,1997-11-01,Evidence at protein level
P37840,SYUA_HUMAN,Alpha-synuclein (Non-A beta component of AD amyloid) (Non-A4 component of amyloid precursor) (NACP),140,"14,460",5 out of 5,1994-10-01,Evidence at protein level
Q96A25,T106A_HUMAN,Transmembrane protein 106A,262,"28,920",2 out of 5,2006-06-27,Evidence at transcript level
Q9H061,T126A_HUMAN,Transmembrane protein 126A,195,"21,527",4 out of 5,2007-01-09,Evidence at protein level
Q3YBM2,T176B_HUMAN,Transmembrane protein 176B (Protein LR8),270,"29,056",4 out of 5,2007-03-06,Evidence at protein level
Q6ZVK1,T179A_HUMAN,Transmembrane protein 179 (Transmembrane protein 179A),233,"26,378",2 out of 5,2006-10-31,Evidence at transcript level
Q1AE95,T183B_HUMAN,Transmembrane protein 183B,376,"42,940",2 out of 5,2007-03-06,Evidence at transcript level
Q9H0A3,T191A_HUMAN,Transmembrane protein 191A,160,"17,963",1 out of 5,2008-06-10,Evidence at transcript level
Q69YZ2,T200B_HUMAN,Transmembrane protein 200B (Transmembrane protein TTMA) (Two transmembrane domain-containing family member B),307,"32,750",2 out of 5,2008-02-05,Evidence at transcript level
Q9Y2A0,T53G1_HUMAN,TP53-target gene 1 protein (TP53-inducible gene 1 protein) (Tumor protein p53-activated protein 1),90,"10,275",3 out of 5,2008-05-20,Evidence at transcript level
Q8IXH6,T53I2_HUMAN,Tumor protein p53-inducible nuclear protein 2 (Diabetes and obesity-regulated gene) (p53-inducible protein U) (PIG-U),220,"23,980",5 out of 5,2003-07-11,Evidence at protein level
Q15542,TAF5_HUMAN,Transcription initiation factor TFIID subunit 5 (Transcription initiation factor TFIID 100 kDa subunit) (TAF(II)100) (TAFII-100) (TAFII100),800,"86,830",5 out of 5,1998-07-15,Evidence at protein level
Q15545,TAF7_HUMAN,Transcription initiation factor TFIID subunit 7 (RNA polymerase II TBP-associated factor subunit F) (Transcription initiation factor TFIID 55 kDa subunit) (TAF(II)55) (TAFII-55) (TAFII55),349,"40,259",5 out of 5,1998-07-15,Evidence at protein level
Q16559,TAL2_HUMAN,T-cell acute lymphocytic leukemia protein 2 (TAL-2) (Class A basic helix-loop-helix protein 19) (bHLHa19),108,"12,291",3 out of 5,2000-05-30,Evidence at protein level
Q9H2D6,TARA_HUMAN,TRIO and F-actin-binding protein (Protein Tara) (Trio-associated repeat on actin),2365,"261,376",5 out of 5,2002-05-02,Evidence at protein level
Q96M53,TBATA_HUMAN,"Protein TBATA (Protein SPATIAL) (Stromal protein associated with thymii and lymph node homolog) (Thymus, brain and testes-associated protein)",351,"39,460",3 out of 5,2005-07-19,Evidence at transcript level
Q9UFV1,TBC29_HUMAN,Putative TBC1 domain family member 29,150,"16,280",1 out of 5,2008-03-18,Evidence at transcript level
Q6DHY5,TBC3G_HUMAN,TBC1 domain family member 3G,549,"62,231",3 out of 5,2007-09-11,Evidence at transcript level
Q92609,TBCD5_HUMAN,TBC1 domain family member 5,795,"89,004",5 out of 5,1997-11-01,Evidence at protein level
O60907,TBL1X_HUMAN,"F-box-like/WD repeat-containing protein TBL1X (SMAP55) (Transducin beta-like protein 1X) (Transducin-beta-like protein 1, X-linked)",577,"62,496",5 out of 5,2001-01-11,Evidence at protein level
Q9Y4P3,TBL2_HUMAN,Transducin beta-like protein 2 (WS beta-transducin repeats protein) (WS-betaTRP) (Williams-Beuren syndrome chromosomal region 13 protein),447,"49,798",5 out of 5,2001-01-11,Evidence at protein level
O75764,TCEA3_HUMAN,Transcription elongation factor A protein 3 (Transcription elongation factor S-II protein 3) (Transcription elongation factor TFIIS.h),348,"38,972",4 out of 5,2003-02-12,Evidence at protein level
Q9UL49,TCFL5_HUMAN,Transcription factor-like 5 protein (Cha transcription factor) (HPV-16 E2-binding protein 1) (E2BP-1),500,"52,697",5 out of 5,2003-01-10,Evidence at transcript level
P56279,TCL1A_HUMAN,T-cell leukemia/lymphoma protein 1A (Oncogene TCL-1) (Oncogene TCL1) (Protein p14 TCL1),114,"13,460",5 out of 5,1998-07-15,Evidence at protein level
Q12799,TCP10_HUMAN,T-complex protein 10A homolog,353,"38,267",2 out of 5,2002-10-10,Evidence at transcript level
Q15046,SYK_HUMAN,Lysine--tRNA ligase (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS),597,"68,048",5 out of 5,1997-11-01,Evidence at protein level
Q15031,SYLM_HUMAN,"Probable leucine--tRNA ligase, mitochondrial (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS)",903,"101,976",5 out of 5,1997-11-01,Evidence at protein level
Q96GW9,SYMM_HUMAN,"Methionine--tRNA ligase, mitochondrial (EC 6.1.1.10) (Methionyl-tRNA synthetase 2) (Mitochondrial methionyl-tRNA synthetase) (MtMetRS)",593,"66,591",5 out of 5,2006-01-10,Evidence at protein level
Q92797,SYMPK_HUMAN,Symplekin,1274,"141,148",5 out of 5,2000-12-01,Evidence at protein level
Q8NF91,SYNE1_HUMAN,Nesprin-1 (Enaptin) (KASH domain-containing protein 1) (KASH1) (Myocyte nuclear envelope protein 1) (Myne-1) (Nuclear envelope spectrin repeat protein 1) (Synaptic nuclear envelope protein 1) (Syne-1),8797,"1,011,086",5 out of 5,2003-04-11,Evidence at protein level
Q8N205,SYNE4_HUMAN,Nesprin-4 (KASH domain-containing protein 4) (KASH4) (Nuclear envelope spectrin repeat protein 4),404,"43,512",5 out of 5,2007-10-02,Evidence at protein level
O15061,SYNEM_HUMAN,Synemin (Desmuslin),1565,"172,768",5 out of 5,2002-01-23,Evidence at protein level
O43426,SYNJ1_HUMAN,"Synaptojanin-1 (EC 3.1.3.36) (Synaptic inositol 1,4,5-trisphosphate 5-phosphatase 1)",1573,"173,103",5 out of 5,2000-05-30,Evidence at protein level
Q8N2H4,SYS1_HUMAN,Protein SYS1 homolog,156,"17,615",4 out of 5,2004-08-16,Evidence at protein level
P21579,SYT1_HUMAN,Synaptotagmin-1 (Synaptotagmin I) (SytI) (p65),422,"47,573",5 out of 5,1991-05-01,Evidence at protein level
Q9BQG1,SYT3_HUMAN,Synaptotagmin-3 (Synaptotagmin III) (SytIII),590,"63,304",5 out of 5,2001-10-18,Evidence at transcript level
Q5ST30,SYVM_HUMAN,"Valine--tRNA ligase, mitochondrial (EC 6.1.1.9) (Valyl-tRNA synthetase) (ValRS) (Valyl-tRNA synthetase-like)",1063,"118,490",5 out of 5,2008-06-10,Evidence at protein level
Q86TM6,SYVN1_HUMAN,E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1),617,"67,685",5 out of 5,2007-03-20,Evidence at protein level
P23381,SYWC_HUMAN,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]",471,"53,165",5 out of 5,1991-11-01,Evidence at protein level
Q9NUM4,T106B_HUMAN,Transmembrane protein 106B,274,"31,127",5 out of 5,2006-06-27,Evidence at protein level
A0PK00,T120B_HUMAN,Transmembrane protein 120B,339,"40,246",2 out of 5,2007-11-13,Evidence at protein level
Q9NX61,T161A_HUMAN,Transmembrane protein 161A (Adaptive response to oxidative stress protein 29) (AROS-29),479,"53,602",5 out of 5,2007-05-29,Evidence at protein level
Q8NFB2,T185A_HUMAN,Transmembrane protein 185A (Protein FAM11A),350,"40,631",3 out of 5,2004-07-19,Evidence at protein level
P0C7N4,T191B_HUMAN,Transmembrane protein 191B,346,"39,065",2 out of 5,2008-06-10,Inferred from homology
Q86VY9,T200A_HUMAN,Transmembrane protein 200A,491,"54,356",2 out of 5,2007-07-10,Evidence at protein level
O75157,T22D2_HUMAN,TSC22 domain family protein 2 (TSC22-related-inducible leucine zipper protein 4),780,"79,228",3 out of 5,2005-03-29,Evidence at protein level
P48775,T23O_HUMAN,"Tryptophan 2,3-dioxygenase (TDO) (EC 1.13.11.11) (Tryptamin 2,3-dioxygenase) (Tryptophan oxygenase) (TO) (TRPO) (Tryptophan pyrrolase) (Tryptophanase)",406,"47,872",5 out of 5,1996-02-01,Evidence at protein level
Q53T94,TAF1B_HUMAN,TATA box-binding protein-associated factor RNA polymerase I subunit B (RNA polymerase I-specific TBP-associated factor 63 kDa) (TAFI63) (TATA box-binding protein-associated factor 1B) (TBP-associated factor 1B) (Transcription initiation factor SL1/TIF-IB subunit B),588,"68,832",5 out of 5,2006-11-28,Evidence at protein level
Q8IZX4,TAF1L_HUMAN,Transcription initiation factor TFIID subunit 1-like (TAF(II)210) (TBP-associated factor 1-like) (TBP-associated factor 210 kDa) (Transcription initiation factor TFIID 210 kDa subunit),1826,"207,302",5 out of 5,2005-01-04,Evidence at protein level
Q92750,TAF4B_HUMAN,Transcription initiation factor TFIID subunit 4B (Transcription initiation factor TFIID 105 kDa subunit) (TAF(II)105) (TAFII-105) (TAFII105),862,"91,091",5 out of 5,1998-07-15,Evidence at protein level
P41252,SYIC_HUMAN,"Isoleucine--tRNA ligase, cytoplasmic (EC 6.1.1.5) (Isoleucyl-tRNA synthetase) (IRS) (IleRS)",1262,"144,498",5 out of 5,1995-02-01,Evidence at protein level
A6NDD5,SYN1L_HUMAN,Synapse differentiation-inducing gene protein 1-like (Capucin) (Dispanin subfamily C member 1) (DSPC1) (Transmembrane protein 90A),238,"25,796",2 out of 5,2008-04-29,Inferred from homology
Q6ZMZ3,SYNE3_HUMAN,Nesprin-3 (KASH domain-containing protein 3) (KASH3) (Nuclear envelope spectrin repeat protein 3),975,"112,216",5 out of 5,2007-03-20,Evidence at protein level
Q9UMS6,SYNP2_HUMAN,Synaptopodin-2 (Genethonin-2) (Myopodin),1093,"117,514",5 out of 5,2004-08-31,Evidence at protein level
Q9UMZ2,SYNRG_HUMAN,Synergin gamma (AP1 subunit gamma-binding protein 1) (Gamma-synergin),1314,"140,654",5 out of 5,2005-03-29,Evidence at protein level
Q9BT88,SYT11_HUMAN,Synaptotagmin-11 (Synaptotagmin XI) (SytXI),431,"48,297",5 out of 5,2001-10-18,Evidence at protein level
A2RTX5,SYTC2_HUMAN,"Probable threonine--tRNA ligase 2, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase-like protein 2)",802,"92,646",3 out of 5,2008-05-20,Evidence at protein level
Q5T011,SZT2_HUMAN,Protein SZT2 (Seizure threshold 2 protein homolog),3432,"378,029",5 out of 5,2007-02-06,Evidence at protein level
A2VDJ0,T131L_HUMAN,Transmembrane protein 131-like,1609,"179,339",5 out of 5,2008-04-08,Evidence at protein level
Q7Z7N9,T179B_HUMAN,Transmembrane protein 179B,219,"23,550",3 out of 5,2008-04-08,Evidence at protein level
Q5JRV8,T255A_HUMAN,Transmembrane protein 255A (Protein FAM70A),349,"38,449",3 out of 5,2006-12-12,Evidence at transcript level
P59542,T2R19_HUMAN,Taste receptor type 2 member 19 (Taste receptor type 2 member 23) (Taste receptor type 2 member 48) (T2R48),299,"33,908",3 out of 5,2003-04-11,Evidence at transcript level
P59534,T2R39_HUMAN,Taste receptor type 2 member 39 (T2R39) (Taste receptor type 2 member 57) (T2R57),338,"38,626",4 out of 5,2003-04-11,Evidence at transcript level
P59537,T2R43_HUMAN,Taste receptor type 2 member 43 (T2R43) (Taste receptor type 2 member 52) (T2R52),309,"35,599",4 out of 5,2003-04-11,Evidence at transcript level
P59540,T2R46_HUMAN,Taste receptor type 2 member 46 (T2R46) (Taste receptor type 2 member 54) (T2R54),309,"35,523",4 out of 5,2003-04-11,Evidence at transcript level
P30408,T4S1_HUMAN,Transmembrane 4 L6 family member 1 (Membrane component chromosome 3 surface marker 1) (Tumor-associated antigen L6),202,"21,632",3 out of 5,1993-04-01,Evidence at protein level
Q53R12,T4S20_HUMAN,Transmembrane 4 L6 family member 20,229,"25,075",5 out of 5,2006-10-03,Evidence at protein level
Q15750,TAB1_HUMAN,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1),504,"54,644",5 out of 5,2000-12-01,Evidence at protein level
O75528,TADA3_HUMAN,Transcriptional adapter 3 (ADA3 homolog) (hADA3) (STAF54) (Transcriptional adapter 3-like) (ADA3-like protein),432,"48,902",5 out of 5,2004-03-29,Evidence at protein level
P21675,TAF1_HUMAN,Transcription initiation factor TFIID subunit 1 (EC 2.3.1.48) (EC 2.7.11.1) (Cell cycle gene 1 protein) (TBP-associated factor 250 kDa) (p250) (Transcription initiation factor TFIID 250 kDa subunit) (TAF(II)250) (TAFII-250) (TAFII250),1872,"212,677",5 out of 5,1991-05-01,Evidence at protein level
P29084,T2EB_HUMAN,Transcription initiation factor IIE subunit beta (TFIIE-beta) (General transcription factor IIE subunit 2),291,"33,044",5 out of 5,1992-12-01,Evidence at protein level
Q9NYV7,T2R16_HUMAN,Taste receptor type 2 member 16 (T2R16),291,"33,986",5 out of 5,2003-04-11,Evidence at protein level
P59543,T2R20_HUMAN,Taste receptor type 2 member 20 (Taste receptor type 2 member 49) (T2R49) (Taste receptor type 2 member 56) (T2R56),309,"35,358",4 out of 5,2003-04-11,Evidence at transcript level
P59541,T2R30_HUMAN,Taste receptor type 2 member 30 (T2R30) (Taste receptor type 2 member 47) (T2R47),319,"36,874",3 out of 5,2003-04-11,Evidence at transcript level
P59533,T2R38_HUMAN,Taste receptor type 2 member 38 (T2R38) (PTC bitter taste receptor) (Taste receptor type 2 member 61) (T2R61),333,"37,892",4 out of 5,2003-04-11,Evidence at transcript level
P59535,T2R40_HUMAN,Taste receptor type 2 member 40 (T2R40) (G-protein coupled receptor 60) (Taste receptor type 2 member 58) (T2R58),323,"36,812",4 out of 5,2003-04-11,Evidence at transcript level
P59539,T2R45_HUMAN,Taste receptor type 2 member 45 (T2R45) (G-protein coupled receptor 59),299,"34,278",3 out of 5,2003-04-11,Evidence at transcript level
P59551,T2R60_HUMAN,Taste receptor type 2 member 60 (T2R60) (Taste receptor type 2 member 56) (T2R56),318,"36,337",3 out of 5,2003-04-11,Evidence at transcript level
Q96EM0,T3HPD_HUMAN,Trans-3-hydroxy-L-proline dehydratase (EC 4.2.1.77) (Trans-L-3-hydroxyproline dehydratase),354,"38,138",5 out of 5,2007-05-29,Evidence at protein level
Q9NYW2,TA2R8_HUMAN,Taste receptor type 2 member 8 (T2R8) (Taste receptor family B member 5) (TRB5),309,"35,877",4 out of 5,2003-04-11,Evidence at protein level
Q9NYW1,TA2R9_HUMAN,Taste receptor type 2 member 9 (T2R9) (Taste receptor family B member 6) (TRB6),312,"35,611",3 out of 5,2003-04-11,Evidence at protein level
P21731,TA2R_HUMAN,Thromboxane A2 receptor (TXA2-R) (Prostanoid TP receptor),343,"37,431",5 out of 5,1991-05-01,Evidence at protein level
Q9P1P4,TAAR3_HUMAN,Putative trace amine-associated receptor 3 (TaR-3) (Trace amine receptor 3) (hTaar3) (G-protein coupled receptor 57),343,"39,065",3 out of 5,2003-11-07,Evidence at transcript level
O14804,TAAR5_HUMAN,Trace amine-associated receptor 5 (TaR-5) (Trace amine receptor 5) (hTaar5) (Putative neurotransmitter receptor),337,"38,242",4 out of 5,2005-11-22,Evidence at transcript level
Q15543,TAF13_HUMAN,Transcription initiation factor TFIID subunit 13 (Transcription initiation factor TFIID 18 kDa subunit) (TAF(II)18) (TAFII-18) (TAFII18),124,"14,287",5 out of 5,1998-07-15,Evidence at protein level
P49848,TAF6_HUMAN,Transcription initiation factor TFIID subunit 6 (RNA polymerase II TBP-associated factor subunit E) (Transcription initiation factor TFIID 70 kDa subunit) (TAF(II)70) (TAFII-70) (TAFII70) (Transcription initiation factor TFIID 80 kDa subunit) (TAF(II)80) (TAFII-80) (TAFII80),677,"72,668",5 out of 5,1996-10-01,Evidence at protein level
Q9HCD6,TANC2_HUMAN,"Protein TANC2 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2)",1990,"219,650",3 out of 5,2008-05-20,Evidence at protein level
Q92844,TANK_HUMAN,TRAF family member-associated NF-kappa-B activator (TRAF-interacting protein) (I-TRAF),425,"47,816",5 out of 5,2001-06-01,Evidence at protein level
Q9UL54,TAOK2_HUMAN,Serine/threonine-protein kinase TAO2 (EC 2.7.11.1) (Kinase from chicken homolog C) (hKFC-C) (Prostate-derived sterile 20-like kinase 1) (PSK-1) (PSK1) (Prostate-derived STE20-like kinase 1) (Thousand and one amino acid protein kinase 2),1235,"138,251",5 out of 5,2005-10-25,Evidence at protein level
Q6NXT6,TAPT1_HUMAN,Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor),567,"64,260",5 out of 5,2008-04-08,Evidence at protein level
Q9H6P5,TASP1_HUMAN,Threonine aspartase 1 (Taspase-1) (EC 3.4.25.-) [Cleaved into: Threonine aspartase subunit alpha; Threonine aspartase subunit beta],420,"44,455",4 out of 5,2003-02-28,Evidence at protein level
P0CG34,TB15A_HUMAN,Thymosin beta-15A (NB thymosin beta) (Thymosin-like protein 8),45,"5,229",3 out of 5,2010-07-13,Evidence at protein level
Q13748,TBA3C_HUMAN,Tubulin alpha-3C/D chain (Alpha-tubulin 2) (Alpha-tubulin 3C/D) (Tubulin alpha-2 chain) [Cleaved into: Detyrosinated tubulin alpha-3C/D chain],450,"49,960",5 out of 5,2002-05-02,Evidence at protein level
Q13885,TBB2A_HUMAN,Tubulin beta-2A chain (Tubulin beta class IIa),445,"49,907",5 out of 5,2006-11-28,Evidence at protein level
Q9BUF5,TBB6_HUMAN,Tubulin beta-6 chain (Tubulin beta class V),446,"49,857",5 out of 5,2005-02-01,Evidence at protein level
Q9NUY8,TBC23_HUMAN,TBC1 domain family member 23 (HCV non-structural protein 4A-transactivated protein 1),699,"78,322",4 out of 5,2007-05-15,Evidence at protein level
A6NDS4,TBC3B_HUMAN,TBC1 domain family member 3B,549,"62,320",3 out of 5,2007-09-11,Evidence at transcript level
Q6IPX3,TCAL6_HUMAN,Transcription elongation factor A protein-like 6 (TCEA-like protein 6) (Transcription elongation factor S-II protein-like 6),200,"22,298",3 out of 5,2006-05-30,Evidence at transcript level
Q86XR7,TCAM2_HUMAN,TIR domain-containing adapter molecule 2 (TICAM-2) (Putative NF-kappa-B-activating protein 502) (TRIF-related adapter molecule) (Toll-like receptor adaptor protein 3) (Toll/interleukin-1 receptor domain-containing protein) (MyD88-4),235,"26,916",5 out of 5,2008-02-05,Evidence at protein level
P23193,TCEA1_HUMAN,Transcription elongation factor A protein 1 (Transcription elongation factor S-II protein 1) (Transcription elongation factor TFIIS.o),301,"33,970",5 out of 5,1991-11-01,Evidence at protein level
Q7RTU0,TCF24_HUMAN,Transcription factor 24 (TCF-24),167,"17,516",2 out of 5,2011-03-08,Inferred from homology
Q7Z6L1,TCPR1_HUMAN,Tectonin beta-propeller repeat-containing protein 1,1165,"129,696",5 out of 5,2008-05-20,Evidence at protein level
Q8IZJ6,TDH_HUMAN,"Inactive L-threonine 3-dehydrogenase, mitochondrial (Short chain dehydrogenase/reductase family 14E member 1 pseudogene)",230,"25,407",3 out of 5,2007-08-21,Evidence at transcript level
Q5QJE6,TDIF2_HUMAN,Deoxynucleotidyltransferase terminal-interacting protein 2 (Estrogen receptor-binding protein) (LPTS-interacting protein 2) (LPTS-RP2) (Terminal deoxynucleotidyltransferase-interacting factor 2) (TdIF2) (TdT-interacting factor 2),756,"84,469",5 out of 5,2008-02-05,Evidence at protein level
Q9H7E2,TDRD3_HUMAN,Tudor domain-containing protein 3,651,"73,185",5 out of 5,2003-03-25,Evidence at protein level
Q86YL5,TDRP_HUMAN,Testis development-related protein (Protein INM01),185,"20,403",4 out of 5,2007-10-23,Evidence at protein level
P28347,TEAD1_HUMAN,Transcriptional enhancer factor TEF-1 (NTEF-1) (Protein GT-IIC) (TEA domain family member 1) (TEAD-1) (Transcription factor 13) (TCF-13),426,"47,946",5 out of 5,1992-12-01,Evidence at protein level
Q9UKZ4,TEN1_HUMAN,Teneurin-1 (Ten-1) (Protein Odd Oz/ten-m homolog 1) (Tenascin-M1) (Ten-m1) (Teneurin transmembrane protein 1) [Cleaved into: Ten-1 intracellular domain (IDten-1) (Ten-1 ICD); Teneurin C-terminal-associated peptide (TCPA-1) (Ten-1 extracellular domain) (Ten-1 ECD)],2725,"305,011",5 out of 5,2006-10-31,Evidence at protein level
Q9UQP3,TENN_HUMAN,Tenascin-N (TN-N) (Tenascin-W) (TN-W),1299,"144,034",5 out of 5,2003-08-29,Evidence at protein level
Q9HBL0,TENS1_HUMAN,Tensin-1,1735,"185,701",5 out of 5,2004-11-23,Evidence at protein level
Q99973,TEP1_HUMAN,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),2627,"290,490",5 out of 5,2004-05-24,Evidence at protein level
Q8NA31,TERB1_HUMAN,Telomere repeats-binding bouquet formation protein 1 (Coiled-coil domain-containing protein 79),727,"83,064",4 out of 5,2008-02-26,Evidence at transcript level
O14746,TERT_HUMAN,Telomerase reverse transcriptase (EC 2.7.7.49) (HEST2) (Telomerase catalytic subunit) (Telomerase-associated protein 2) (TP2),1132,"126,997",5 out of 5,2000-05-30,Evidence at protein level
Q9UGI8,TES_HUMAN,Testin (TESS),421,"47,996",5 out of 5,2001-09-26,Evidence at protein level
Q8IYF3,TEX11_HUMAN,Testis-expressed protein 11,940,"107,889",5 out of 5,2007-07-24,Evidence at protein level
Q5JUR7,TEX30_HUMAN,Testis-expressed protein 30,227,"25,585",2 out of 5,2007-02-06,Evidence at transcript level
Q6PEX7,TEX38_HUMAN,Testis-expressed protein 38 (ATPAF1 antisense RNA 1) (ATPAF1 antisense gene protein 1),206,"23,280",2 out of 5,2008-02-26,Evidence at transcript level
Q92994,TF3B_HUMAN,"Transcription factor IIIB 90 kDa subunit (TFIIIB90) (hTFIIIB90) (B-related factor 1) (BRF-1) (hBRF) (TAF3B2) (TATA box-binding protein-associated factor, RNA polymerase III, subunit 2)",677,"73,840",5 out of 5,2002-05-02,Evidence at protein level
Q9UKN8,TF3C4_HUMAN,General transcription factor 3C polypeptide 4 (EC 2.3.1.48) (TF3C-delta) (Transcription factor IIIC 90 kDa subunit) (TFIIIC 90 kDa subunit) (TFIIIC90) (Transcription factor IIIC subunit delta),822,"91,982",5 out of 5,2004-06-07,Evidence at protein level
Q5JU00,TCTE1_HUMAN,T-complex-associated testis-expressed protein 1 (Tcte-1),501,"55,632",2 out of 5,2008-04-08,Evidence at transcript level
Q15561,TEAD4_HUMAN,Transcriptional enhancer factor TEF-3 (TEA domain family member 4) (TEAD-4) (Transcription factor 13-like 1) (Transcription factor RTEF-1),434,"48,329",5 out of 5,1997-11-01,Evidence at protein level
Q6NUS6,TECT3_HUMAN,Tectonic-3,607,"66,157",5 out of 5,2006-04-04,Evidence at protein level
Q8IYR6,TEFF1_HUMAN,Tomoregulin-1 (TR-1) (H7365) (Transmembrane protein with EGF-like and one follistatin-like domain),380,"40,934",5 out of 5,2007-05-01,Evidence at protein level
Q96QE5,TEFM_HUMAN,"Transcription elongation factor, mitochondrial",360,"41,676",5 out of 5,2008-07-22,Evidence at protein level
Q6N021,TET2_HUMAN,Methylcytosine dioxygenase TET2 (EC 1.14.11.n2),2002,"223,811",5 out of 5,2008-03-18,Evidence at protein level
O43247,TEX33_HUMAN,Testis-expressed protein 33,280,"30,725",2 out of 5,2000-05-30,Evidence at transcript level
Q53QW1,TEX44_HUMAN,Testis-expressed protein 44,395,"41,589",2 out of 5,2007-11-13,Evidence at protein level
Q8IUE1,TF2LX_HUMAN,"Homeobox protein TGIF2LX (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, X-linked) (TGIF-like on the X)",241,"26,675",3 out of 5,2004-03-01,Evidence at protein level
Q8WUA4,TF3C2_HUMAN,General transcription factor 3C polypeptide 2 (TF3C-beta) (Transcription factor IIIC 110 kDa subunit) (TFIIIC 110 kDa subunit) (TFIIIC110) (Transcription factor IIIC subunit beta),911,"100,680",5 out of 5,2004-06-07,Evidence at protein level
Q12800,TFCP2_HUMAN,Alpha-globin transcription factor CP2 (SAA3 enhancer factor) (Transcription factor LSF),502,"57,256",5 out of 5,2006-03-21,Evidence at protein level
P19484,TFEB_HUMAN,Transcription factor EB (Class E basic helix-loop-helix protein 35) (bHLHe35),476,"52,865",5 out of 5,1991-02-01,Evidence at protein level
P01135,TGFA_HUMAN,Protransforming growth factor alpha [Cleaved into: Transforming growth factor alpha (TGF-alpha) (EGF-like TGF) (ETGF) (TGF type 1)],160,"17,006",5 out of 5,1986-07-21,Evidence at protein level
P01137,TGFB1_HUMAN,Transforming growth factor beta-1 (TGF-beta-1) [Cleaved into: Latency-associated peptide (LAP)],390,"44,341",5 out of 5,1986-07-21,Evidence at protein level
P36897,TGFR1_HUMAN,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),503,"55,960",5 out of 5,1994-06-01,Evidence at protein level
Q96PF1,TGM7_HUMAN,Protein-glutamine gamma-glutamyltransferase Z (Transglutaminase Z) (TG(Z)) (TGZ) (TGase Z) (EC 2.3.2.13) (Transglutaminase-7) (TGase-7),710,"79,941",3 out of 5,2002-05-10,Evidence at transcript level
Q9BXR0,TGT_HUMAN,Queuine tRNA-ribosyltransferase catalytic subunit 1 (EC 2.4.2.29) (Guanine insertion enzyme) (tRNA-guanine transglycosylase),403,"44,048",5 out of 5,2002-05-02,Evidence at protein level
Q8TBB0,THAP6_HUMAN,THAP domain-containing protein 6,222,"25,691",3 out of 5,2003-04-11,Evidence at protein level
Q13769,THOC5_HUMAN,THO complex subunit 5 homolog (Functional spliceosome-associated protein 79) (fSAP79) (NF2/meningioma region protein pK1.3) (Placental protein 39.2) (PP39.2) (hTREX90),683,"78,508",5 out of 5,2002-05-02,Evidence at protein level
Q9C0I4,THS7B_HUMAN,Thrombospondin type-1 domain-containing protein 7B,1608,"179,402",2 out of 5,2006-11-28,Evidence at transcript level
P25325,THTM_HUMAN,3-mercaptopyruvate sulfurtransferase (MST) (EC 2.8.1.2),297,"33,178",5 out of 5,1992-05-01,Evidence at protein level
Q9BU02,THTPA_HUMAN,Thiamine-triphosphatase (ThTPase) (EC 3.6.1.28),230,"25,566",5 out of 5,2003-10-03,Evidence at protein level
Q9P016,THYN1_HUMAN,Thymocyte nuclear protein 1 (Thymocyte protein Thy28),225,"25,697",2 out of 5,2006-11-28,Evidence at protein level
Q92563,TICN2_HUMAN,"Testican-2 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2)",424,"46,779",5 out of 5,2002-10-19,Evidence at protein level
Q9NPL8,TIDC1_HUMAN,"Complex I assembly factor TIMMDC1, mitochondrial (Protein M5-14) (Translocase of inner mitochondrial membrane domain-containing protein 1) (TIMM domain containing-protein 1)",285,"32,178",5 out of 5,2006-10-17,Evidence at protein level
Q6B0B8,TIGD3_HUMAN,Tigger transposable element-derived protein 3,471,"52,027",2 out of 5,2007-01-09,Evidence at transcript level
Q17RP2,TIGD6_HUMAN,Tigger transposable element-derived protein 6,521,"58,656",2 out of 5,2007-01-23,Evidence at transcript level
A6NFA1,TIKI2_HUMAN,"Metalloprotease TIKI2 (EC 3.4.-.-) (Heart, kidney and adipose-enriched transmembrane protein homolog) (TRAB domain-containing protein 2B)",517,"57,421",5 out of 5,2008-09-02,Evidence at protein level
O43615,TIM44_HUMAN,Mitochondrial import inner membrane translocase subunit TIM44,452,"51,356",5 out of 5,1999-07-15,Evidence at protein level
Q3ZCQ8,TIM50_HUMAN,Mitochondrial import inner membrane translocase subunit TIM50,353,"39,646",5 out of 5,2005-12-06,Evidence at protein level
Q9Y5M6,TISR_HUMAN,Oculomedin (Trabecular meshwork-inducible stretch response protein) (TISR),44,"5,321",2 out of 5,2000-05-30,Evidence at transcript level
Q8WZ42,TITIN_HUMAN,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),34350,"3,816,030",5 out of 5,2006-06-13,Evidence at protein level
Q3LXA3,TKFC_HUMAN,Triokinase/FMN cyclase (Bifunctional ATP-dependent dihydroxyacetone kinase/FAD-AMP lyase (cyclizing)) [Includes: ATP-dependent dihydroxyacetone kinase (DHA kinase) (EC 2.7.1.28) (EC 2.7.1.29) (Glycerone kinase) (Triokinase) (Triose kinase); FAD-AMP lyase (cyclizing) (EC 4.6.1.15) (FAD-AMP lyase (cyclic FMN forming)) (FMN cyclase)],575,"58,947",5 out of 5,2006-01-24,Evidence at protein level
P20366,TKN1_HUMAN,Protachykinin-1 (PPT) [Cleaved into: Substance P; Neurokinin A (NKA) (Neuromedin L) (Substance K); Neuropeptide K (NPK); Neuropeptide gamma; C-terminal-flanking peptide],129,"15,003",5 out of 5,1991-02-01,Evidence at protein level
P51854,TKTL1_HUMAN,Transketolase-like protein 1 (EC 2.2.1.1) (Transketolase 2) (TK 2) (Transketolase-related protein),596,"65,333",5 out of 5,1996-10-01,Evidence at protein level
Q5H9J9,T11X2_HUMAN,T-complex protein 11 X-linked protein 2,407,"46,373",1 out of 5,2013-10-16,Inferred from homology
Q14C87,T132D_HUMAN,Transmembrane protein 132D (Mature oligodendrocytes transmembrane protein) (Mature OL transmembrane protein),1099,"122,309",4 out of 5,2007-05-15,Evidence at protein level
Q5T4T1,T170B_HUMAN,Transmembrane protein 170B,132,"14,360",2 out of 5,2008-07-01,Inferred from homology
Q9NVA4,T184C_HUMAN,Transmembrane protein 184C (Transmembrane protein 34),438,"50,142",3 out of 5,2007-05-15,Evidence at protein level
Q9H7F4,T185B_HUMAN,Transmembrane protein 185B (Protein FAM11B),350,"40,599",2 out of 5,2004-07-19,Evidence at protein level
P29083,T2EA_HUMAN,General transcription factor IIE subunit 1 (General transcription factor IIE 56 kDa subunit) (Transcription initiation factor IIE subunit alpha) (TFIIE-alpha),439,"49,452",5 out of 5,1992-12-01,Evidence at protein level
Q9NYV8,T2R14_HUMAN,Taste receptor type 2 member 14 (T2R14) (Taste receptor family B member 1) (TRB1),317,"36,160",4 out of 5,2003-04-11,Evidence at protein level
P59538,T2R31_HUMAN,Taste receptor type 2 member 31 (T2R31) (Taste receptor type 2 member 44) (T2R44) (Taste receptor type 2 member 53) (T2R53),309,"35,278",4 out of 5,2003-04-11,Evidence at transcript level
Q9Y228,T3JAM_HUMAN,TRAF3-interacting JNK-activating modulator (TRAF3-interacting protein 3),551,"63,626",5 out of 5,2004-06-07,Evidence at protein level
Q9Y2B4,T53G5_HUMAN,TP53-target gene 5 protein (TP53-inducible gene 5 protein),290,"34,019",4 out of 5,2002-10-10,Evidence at protein level
Q96A56,T53I1_HUMAN,Tumor protein p53-inducible nuclear protein 1 (Stress-induced protein) (p53-dependent damage-inducible nuclear protein 1) (p53DINP1),240,"27,366",5 out of 5,2005-03-15,Evidence at protein level
O75529,TAF5L_HUMAN,TAF5-like RNA polymerase II p300/CBP-associated factor-associated factor 65 kDa subunit 5L (PCAF-associated factor 65 beta) (PAF65-beta),589,"66,155",5 out of 5,2004-04-26,Evidence at protein level
P37802,TAGL2_HUMAN,Transgelin-2 (Epididymis tissue protein Li 7e) (SM22-alpha homolog),199,"22,391",5 out of 5,1994-10-01,Evidence at protein level
Q9BXI6,TB10A_HUMAN,TBC1 domain family member 10A (EBP50-PDX interactor of 64 kDa) (EPI64 protein) (Rab27A-GAP-alpha),508,"57,118",5 out of 5,2002-05-02,Evidence at protein level
Q8WUA7,TB22A_HUMAN,TBC1 domain family member 22A,517,"59,121",5 out of 5,2002-11-08,Evidence at protein level
P68366,TBA4A_HUMAN,Tubulin alpha-4A chain (Alpha-tubulin 1) (Testis-specific alpha-tubulin) (Tubulin H2-alpha) (Tubulin alpha-1 chain),448,"49,924",5 out of 5,1987-08-13,Evidence at protein level
Q9NY65,TBA8_HUMAN,Tubulin alpha-8 chain (Alpha-tubulin 8) (Tubulin alpha chain-like 2),449,"50,094",5 out of 5,2001-01-24,Evidence at protein level
Q9BVA1,TBB2B_HUMAN,Tubulin beta-2B chain,445,"49,953",5 out of 5,2006-11-28,Evidence at protein level
Q8TBP0,TBC16_HUMAN,TBC1 domain family member 16,767,"86,372",4 out of 5,2005-02-15,Evidence at transcript level
Q96DN5,TBC31_HUMAN,TBC1 domain family member 31 (WD repeat-containing protein 67),1066,"124,189",3 out of 5,2005-11-22,Evidence at protein level
Q8IZP1,TBC3A_HUMAN,TBC1 domain family member 3 (Prostate cancer gene 17 protein) (Protein TRE17-alpha) (Rab GTPase-activating protein PRC17),549,"62,187",5 out of 5,2003-10-03,Evidence at protein level
Q0IIM8,TBC8B_HUMAN,TBC1 domain family member 8B,1120,"128,709",3 out of 5,2008-05-20,Evidence at protein level
Q9NVR7,TBCC1_HUMAN,TBCC domain-containing protein 1,557,"63,530",4 out of 5,2007-10-02,Evidence at transcript level
O60343,TBCD4_HUMAN,TBC1 domain family member 4 (Akt substrate of 160 kDa) (AS160),1298,"146,563",5 out of 5,2002-10-10,Evidence at protein level
A7MCY6,TBKB1_HUMAN,TANK-binding kinase 1-binding protein 1 (TBK1-binding protein 1),615,"67,702",4 out of 5,2008-03-18,Evidence at protein level
Q3YBR2,TBRG1_HUMAN,Transforming growth factor beta regulator 1 (Nuclear interactor of ARF and Mdm2),411,"44,946",5 out of 5,2007-02-06,Evidence at protein level
Q8IZW8,TENS4_HUMAN,Tensin-4 (C-terminal tensin-like protein),715,"76,764",5 out of 5,2006-09-05,Evidence at protein level
Q16473,TENXA_HUMAN,Putative tenascin-XA (TN-XA),311,"33,740",2 out of 5,2008-09-02,Uncertain
P22105,TENX_HUMAN,Tenascin-X (TN-X) (Hexabrachion-like protein),4242,"458,220",5 out of 5,1991-08-01,Evidence at protein level
C9J3V5,TEX22_HUMAN,Testis-expressed protein 22,150,"16,880",1 out of 5,2011-06-28,Evidence at transcript level
Q00403,TF2B_HUMAN,Transcription initiation factor IIB (General transcription factor TFIIB) (S300-II),316,"34,833",5 out of 5,1992-12-01,Evidence at protein level
Q9NZI6,TF2L1_HUMAN,Transcription factor CP2-like protein 1 (CP2-related transcriptional repressor 1) (CRTR-1) (Transcription factor LBP-9),479,"54,627",5 out of 5,2006-03-21,Evidence at transcript level
Q8WVM0,TFB1M_HUMAN,"Dimethyladenosine transferase 1, mitochondrial (EC 2.1.1.-) (Mitochondrial 12S rRNA dimethylase 1) (Mitochondrial transcription factor B1) (h-mtTFB) (h-mtTFB1) (hTFB1M) (mtTFB1) (S-adenosylmethionine-6-N', N'-adenosyl(rRNA) dimethyltransferase 1)",346,"39,543",5 out of 5,2007-01-23,Evidence at protein level
Q5H9I0,TFDP3_HUMAN,Transcription factor Dp family member 3 (Cancer/testis antigen 30) (CT30) (Hepatocellular carcinoma-associated antigen 661),405,"44,967",5 out of 5,2007-10-02,Evidence at protein level
P15923,TFE2_HUMAN,Transcription factor E2-alpha (Class B basic helix-loop-helix protein 21) (bHLHb21) (Immunoglobulin enhancer-binding factor E12/E47) (Immunoglobulin transcription factor 1) (Kappa-E2-binding factor) (Transcription factor 3) (TCF-3) (Transcription factor ITF-1),654,"67,600",5 out of 5,1990-04-01,Evidence at protein level
O14948,TFEC_HUMAN,Transcription factor EC (TFE-C) (Class E basic helix-loop-helix protein 34) (bHLHe34) (Transcription factor EC-like) (hTFEC-L),347,"38,788",5 out of 5,2008-01-15,Evidence at protein level
P10600,TGFB3_HUMAN,Transforming growth factor beta-3 (TGF-beta-3) [Cleaved into: Latency-associated peptide (LAP)],412,"47,328",5 out of 5,1989-07-01,Evidence at protein level
Q08188,TGM3_HUMAN,Protein-glutamine gamma-glutamyltransferase E (EC 2.3.2.13) (Transglutaminase E) (TG(E)) (TGE) (TGase E) (Transglutaminase-3) (TGase-3) [Cleaved into: Protein-glutamine gamma-glutamyltransferase E 50 kDa catalytic chain; Protein-glutamine gamma-glutamyltransferase E 27 kDa non-catalytic chain],693,"76,632",5 out of 5,1995-02-01,Evidence at protein level
Q96RS0,TGS1_HUMAN,Trimethylguanosine synthase (EC 2.1.1.-) (CLL-associated antigen KW-2) (Cap-specific guanine-N2 methyltransferase) (Hepatocellular carcinoma-associated antigen 137) (Nuclear receptor coactivator 6-interacting protein) (PRIP-interacting protein with methyltransferase motif) (PIMT) (PIPMT),853,"96,620",5 out of 5,2005-12-20,Evidence at protein level
Q9BWD1,THIC_HUMAN,"Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)",397,"41,351",5 out of 5,2004-09-13,Evidence at protein level
Q86V81,THOC4_HUMAN,THO complex subunit 4 (Tho4) (Ally of AML-1 and LEF-1) (Aly/REF export factor) (Transcriptional coactivator Aly/REF) (bZIP-enhancing factor BEF),257,"26,888",5 out of 5,2003-10-10,Evidence at protein level
P00734,THRB_HUMAN,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],622,"70,037",5 out of 5,1986-07-21,Evidence at protein level
P01266,THYG_HUMAN,Thyroglobulin (Tg),2768,"304,790",5 out of 5,1986-07-21,Evidence at protein level
Q5SRD1,TI23B_HUMAN,Putative mitochondrial import inner membrane translocase subunit Tim23B,257,"28,048",2 out of 5,2008-09-02,Uncertain
P49368,TCPG_HUMAN,T-complex protein 1 subunit gamma (TCP-1-gamma) (CCT-gamma) (hTRiC5),545,"60,534",5 out of 5,1996-02-01,Evidence at protein level
B5MCY1,TDR15_HUMAN,Tudor domain-containing protein 15,1934,"221,722",1 out of 5,2013-04-03,Evidence at transcript level
Q9Y4R8,TELO2_HUMAN,Telomere length regulation protein TEL2 homolog (Protein clk-2 homolog) (hCLK2),837,"91,747",5 out of 5,2008-02-05,Evidence at protein level
P55072,TERA_HUMAN,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),806,"89,322",5 out of 5,1996-10-01,Evidence at protein level
P54274,TERF1_HUMAN,Telomeric repeat-binding factor 1 (NIMA-interacting protein 2) (TTAGGG repeat-binding factor 1) (Telomeric protein Pin2/TRF1),439,"50,246",5 out of 5,1996-10-01,Evidence at protein level
Q9NTU4,TEX40_HUMAN,Testis-expressed protein 40,200,"22,839",2 out of 5,2008-09-02,Evidence at transcript level
Q6ZYL4,TF2H5_HUMAN,General transcription factor IIH subunit 5 (General transcription factor IIH polypeptide 5) (TFB5 ortholog) (TFIIH basal transcription factor complex TTD-A subunit),71,"8,053",5 out of 5,2005-06-07,Evidence at protein level
Q8IUE0,TF2LY_HUMAN,"Homeobox protein TGIF2LY (TGF-beta-induced transcription factor 2-like protein) (TGFB-induced factor 2-like protein, Y-linked) (TGIF-like on the Y)",185,"20,814",3 out of 5,2004-03-01,Evidence at protein level
Q92664,TF3A_HUMAN,Transcription factor IIIA (TFIIIA),365,"41,515",4 out of 5,1997-11-01,Evidence at protein level
Q01664,TFAP4_HUMAN,Transcription factor AP-4 (Activating enhancer-binding protein 4) (Class C basic helix-loop-helix protein 41) (bHLHc41),338,"38,726",5 out of 5,1993-10-01,Evidence at protein level
Q14186,TFDP1_HUMAN,Transcription factor Dp-1 (DRTF1-polypeptide 1) (DRTF1) (E2F dimerization partner 1),410,"45,070",5 out of 5,1998-07-15,Evidence at protein level
P19532,TFE3_HUMAN,Transcription factor E3 (Class E basic helix-loop-helix protein 33) (bHLHe33),575,"61,521",5 out of 5,1991-02-01,Evidence at protein level
Q6YHU6,THADA_HUMAN,Thyroid adenoma-associated protein (Gene inducing thyroid adenomas protein),1953,"219,607",5 out of 5,2008-07-22,Evidence at protein level
Q8WY91,THAP4_HUMAN,THAP domain-containing protein 4,577,"62,890",3 out of 5,2003-04-11,Evidence at protein level
P05543,THBG_HUMAN,Thyroxine-binding globulin (Serpin A7) (T4-binding globulin),415,"46,325",5 out of 5,1988-11-01,Evidence at protein level
P24752,THIL_HUMAN,"Acetyl-CoA acetyltransferase, mitochondrial (EC 2.3.1.9) (Acetoacetyl-CoA thiolase) (T2)",427,"45,200",5 out of 5,1992-03-01,Evidence at protein level
O95411,TIAF1_HUMAN,TGFB1-induced anti-apoptotic factor 1 (12 kDa TGF-beta-1-induced antiapoptotic factor),115,"12,414",3 out of 5,2000-05-30,Evidence at transcript level
Q8IVF5,TIAM2_HUMAN,T-lymphoma invasion and metastasis-inducing protein 2 (TIAM-2) (SIF and TIAM1-like exchange factor),1701,"190,103",5 out of 5,2008-02-05,Evidence at transcript level
Q9BQ16,TICN3_HUMAN,"Testican-3 (SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 3)",436,"49,429",5 out of 5,2002-10-19,Evidence at protein level
O15164,TIF1A_HUMAN,Transcription intermediary factor 1-alpha (TIF1-alpha) (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRIM24) (RING finger protein 82) (RING-type E3 ubiquitin transferase TIF1-alpha) (Tripartite motif-containing protein 24),1050,"116,831",5 out of 5,1999-07-15,Evidence at protein level
Q13263,TIF1B_HUMAN,Transcription intermediary factor 1-beta (TIF1-beta) (E3 SUMO-protein ligase TRIM28) (EC 2.3.2.27) (KRAB-associated protein 1) (KAP-1) (KRAB-interacting protein 1) (KRIP-1) (Nuclear corepressor KAP-1) (RING finger protein 96) (RING-type E3 ubiquitin transferase TIF1-beta) (Tripartite motif-containing protein 28),835,"88,550",5 out of 5,1998-07-15,Evidence at protein level
Q3SY00,T10IP_HUMAN,Testis-specific protein 10-interacting protein (Tsga10-interacting protein),556,"62,381",3 out of 5,2008-04-29,Evidence at protein level
B4DZS4,T11X1_HUMAN,T-complex protein 11 X-linked protein 1,312,"34,563",1 out of 5,2013-10-16,Evidence at transcript level
Q24JP5,T132A_HUMAN,Transmembrane protein 132A (HSPA5-binding protein 1),1023,"110,110",5 out of 5,2007-05-15,Evidence at protein level
Q7RTR8,T2R42_HUMAN,Taste receptor type 2 member 42 (T2R42) (Taste receptor type 2 member 55) (T2R55),314,"36,195",4 out of 5,2004-11-23,Evidence at transcript level
P59544,T2R50_HUMAN,Taste receptor type 2 member 50 (T2R50) (Taste receptor type 2 member 51) (T2R51),299,"34,558",3 out of 5,2003-04-11,Evidence at transcript level
P48230,T4S4_HUMAN,Transmembrane 4 L6 family member 4 (Intestine and liver tetraspan membrane protein) (IL-TMP),202,"21,396",4 out of 5,1996-02-01,Evidence at protein level
Q9NYW5,TA2R4_HUMAN,Taste receptor type 2 member 4 (T2R4),299,"33,841",5 out of 5,2003-04-11,Evidence at protein level
Q9P1P5,TAAR2_HUMAN,Trace amine-associated receptor 2 (TaR-2) (Trace amine receptor 2) (G-protein coupled receptor 58),351,"40,134",4 out of 5,2003-11-07,Evidence at transcript level
Q8N5C8,TAB3_HUMAN,TGF-beta-activated kinase 1 and MAP3K7-binding protein 3 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 3) (NF-kappa-B-activating protein 1) (TAK1-binding protein 3) (TAB-3) (TGF-beta-activated kinase 1-binding protein 3),712,"78,683",5 out of 5,2006-03-07,Evidence at protein level
O95359,TACC2_HUMAN,Transforming acidic coiled-coil-containing protein 2 (Anti-Zuai-1) (AZU-1),2948,"309,427",5 out of 5,2001-04-27,Evidence at protein level
Q9BSH4,TACO1_HUMAN,Translational activator of cytochrome c oxidase 1 (Coiled-coil domain-containing protein 44) (Translational activator of mitochondrially-encoded cytochrome c oxidase I),297,"32,477",4 out of 5,2003-08-04,Evidence at protein level
Q86TJ2,TAD2B_HUMAN,Transcriptional adapter 2-beta (ADA2-like protein beta) (ADA2-beta),420,"48,470",5 out of 5,2008-01-15,Evidence at protein level
Q9HBM6,TAF9B_HUMAN,Transcription initiation factor TFIID subunit 9B (Neuronal cell death-related protein 7) (DN-7) (Transcription initiation factor TFIID subunit 9-like) (Transcription-associated factor TAFII31L),251,"27,622",5 out of 5,2006-01-24,Evidence at protein level
Q70YC4,TALAN_HUMAN,Talanin,216,"24,036",5 out of 5,2005-12-20,Evidence at transcript level
Q9H4B7,TBB1_HUMAN,Tubulin beta-1 chain,451,"50,327",5 out of 5,2005-02-01,Evidence at protein level
A6NER0,TBC3F_HUMAN,TBC1 domain family member 3F,549,"62,185",3 out of 5,2008-07-22,Evidence at transcript level
B9A6J9,TBC3L_HUMAN,TBC1 domain family member 3L,549,"62,187",3 out of 5,2015-01-07,Evidence at transcript level
O95759,TBCD8_HUMAN,TBC1 domain family member 8 (AD 3) (Vascular Rab-GAP/TBC-containing protein),1140,"130,835",5 out of 5,2003-10-03,Evidence at protein level
Q15813,TBCE_HUMAN,Tubulin-specific chaperone E (Tubulin-folding cofactor E),527,"59,346",5 out of 5,2006-02-07,Evidence at protein level
Q9UJT0,TBE_HUMAN,Tubulin epsilon chain (Epsilon-tubulin),475,"52,932",3 out of 5,2000-12-01,Evidence at transcript level
O75333,TBX10_HUMAN,T-box transcription factor TBX10 (T-box protein 10),385,"42,341",3 out of 5,2000-12-01,Evidence at transcript level
O95935,TBX18_HUMAN,T-box transcription factor TBX18 (T-box protein 18),607,"64,753",5 out of 5,2000-05-30,Evidence at protein level
Q13207,TBX2_HUMAN,T-box transcription factor TBX2 (T-box protein 2),712,"75,066",5 out of 5,1997-11-01,Evidence at protein level
Q5H9L2,TCAL5_HUMAN,Transcription elongation factor A protein-like 5 (TCEA-like protein 5) (Transcription elongation factor S-II protein-like 5),206,"23,307",3 out of 5,2006-05-30,Evidence at protein level
P17987,TCPA_HUMAN,T-complex protein 1 subunit alpha (TCP-1-alpha) (CCT-alpha),556,"60,344",5 out of 5,1990-11-01,Evidence at protein level
P13693,TCTP_HUMAN,Translationally-controlled tumor protein (TCTP) (Fortilin) (Histamine-releasing factor) (HRF) (p23),172,"19,595",5 out of 5,1990-01-01,Evidence at protein level
Q5VZ19,TDR10_HUMAN,Tudor domain-containing protein 10,366,"40,941",2 out of 5,2007-01-09,Evidence at transcript level
Q8NAT2,TDRD5_HUMAN,Tudor domain-containing protein 5,981,"109,737",3 out of 5,2003-03-25,Evidence at protein level
Q8NHU6,TDRD7_HUMAN,Tudor domain-containing protein 7 (PCTAIRE2-binding protein) (Tudor repeat associator with PCTAIRE-2) (Trap),1098,"123,586",5 out of 5,2004-06-21,Evidence at protein level
Q96GX1,TECT2_HUMAN,Tectonic-2,697,"76,871",5 out of 5,2006-04-04,Evidence at transcript level
Q96PL2,TECTB_HUMAN,Beta-tectorin,329,"36,956",4 out of 5,2004-06-07,Evidence at transcript level
Q969V4,TEKT1_HUMAN,Tektin-1,418,"48,283",5 out of 5,2002-11-08,Evidence at protein level
Q9BXF9,TEKT3_HUMAN,Tektin-3,490,"56,636",4 out of 5,2002-11-08,Evidence at protein level
Q8IWB6,TEX14_HUMAN,Inactive serine/threonine-protein kinase TEX14 (Protein kinase-like protein SgK307) (Sugen kinase 307) (Testis-expressed sequence 14) (Testis-expressed sequence 14 protein),1497,"167,901",5 out of 5,2006-07-25,Evidence at protein level
Q8N6G2,TEX26_HUMAN,Testis-expressed protein 26,289,"33,595",1 out of 5,2006-12-12,Evidence at transcript level
Q6ZNM6,TEX43_HUMAN,Testis-expressed protein 43,134,"15,452",1 out of 5,2008-02-26,Evidence at transcript level
Q07654,TFF3_HUMAN,Trefoil factor 3 (Intestinal trefoil factor) (hITF) (Polypeptide P1.B) (hP1.B),80,"8,641",5 out of 5,1994-10-01,Evidence at protein level
Q9NVV9,THAP1_HUMAN,THAP domain-containing protein 1,213,"24,944",5 out of 5,2003-04-11,Evidence at protein level
Q8NA92,THAP8_HUMAN,THAP domain-containing protein 8,274,"30,082",2 out of 5,2003-04-11,Evidence at protein level
P24557,THAS_HUMAN,Thromboxane-A synthase (TXA synthase) (TXS) (EC 5.3.99.5) (Cytochrome P450 5A1),533,"60,518",5 out of 5,1992-03-01,Evidence at protein level
P09110,THIK_HUMAN,"3-ketoacyl-CoA thiolase, peroxisomal (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase) (Peroxisomal 3-oxoacyl-CoA thiolase)",424,"44,292",5 out of 5,1989-07-01,Evidence at protein level
Q9NYW7,TA2R1_HUMAN,Taste receptor type 2 member 1 (T2R1) (Taste receptor family B member 7) (TRB7),299,"34,333",5 out of 5,2003-04-11,Evidence at protein level
Q9NYW3,TA2R7_HUMAN,Taste receptor type 2 member 7 (T2R7) (Taste receptor family B member 4) (TRB4),318,"36,550",4 out of 5,2003-04-11,Evidence at protein level
Q96RJ0,TAAR1_HUMAN,Trace amine-associated receptor 1 (TaR-1) (Trace amine receptor 1),339,"39,092",4 out of 5,2003-11-07,Evidence at transcript level
O75410,TACC1_HUMAN,Transforming acidic coiled-coil-containing protein 1 (Gastric cancer antigen Ga55) (Taxin-1),805,"87,794",5 out of 5,2001-04-27,Evidence at protein level
Q12962,TAF10_HUMAN,Transcription initiation factor TFIID subunit 10 (STAF28) (Transcription initiation factor TFIID 30 kDa subunit) (TAF(II)30) (TAFII-30) (TAFII30),218,"21,711",5 out of 5,1998-07-15,Evidence at protein level
Q9H5J8,TAF1D_HUMAN,TATA box-binding protein-associated factor RNA polymerase I subunit D (RNA polymerase I-specific TBP-associated factor 41 kDa) (TAFI41) (TATA box-binding protein-associated factor 1D) (TBP-associated factor 1D) (Transcription initiation factor SL1/TIF-IB subunit D),278,"32,058",5 out of 5,2006-10-03,Evidence at protein level
Q6P1X5,TAF2_HUMAN,Transcription initiation factor TFIID subunit 2 (150 kDa cofactor of initiator function) (RNA polymerase II TBP-associated factor subunit B) (TBP-associated factor 150 kDa) (Transcription initiation factor TFIID 150 kDa subunit) (TAF(II)150) (TAFII-150) (TAFII150),1199,"136,971",5 out of 5,2006-10-17,Evidence at protein level
P37837,TALDO_HUMAN,Transaldolase (EC 2.2.1.2),337,"37,540",5 out of 5,1994-10-01,Evidence at protein level
Q8IV04,TB10C_HUMAN,Carabin (TBC1 domain family member 10C),446,"49,712",5 out of 5,2007-04-17,Evidence at protein level
Q9NVG8,TBC13_HUMAN,TBC1 domain family member 13,400,"46,554",3 out of 5,2004-02-16,Evidence at protein level
Q9HA65,TBC17_HUMAN,TBC1 domain family member 17,648,"72,728",5 out of 5,2005-02-15,Evidence at protein level
Q9ULP9,TBC24_HUMAN,TBC1 domain family member 24,559,"62,919",5 out of 5,2007-05-29,Evidence at protein level
Q2M2D7,TBC28_HUMAN,TBC1 domain family member 28,210,"24,072",2 out of 5,2008-05-20,Evidence at transcript level
A0A087X179,TBC3E_HUMAN,TBC1 domain family member 3E,549,"62,131",3 out of 5,2015-01-07,Evidence at transcript level
Q15814,TBCC_HUMAN,Tubulin-specific chaperone C (Tubulin-folding cofactor C) (CFC),346,"39,248",5 out of 5,2000-05-30,Evidence at protein level
Q9BTW9,TBCD_HUMAN,Tubulin-specific chaperone D (Beta-tubulin cofactor D) (tfcD) (SSD-1) (Tubulin-folding cofactor D),1192,"132,600",5 out of 5,2006-02-07,Evidence at protein level
Q9UHD2,TBK1_HUMAN,Serine/threonine-protein kinase TBK1 (EC 2.7.11.1) (NF-kappa-B-activating kinase) (T2K) (TANK-binding kinase 1),729,"83,642",5 out of 5,2005-12-20,Evidence at protein level
P62380,TBPL1_HUMAN,TATA box-binding protein-like protein 1 (TBP-like protein 1) (21 kDa TBP-like protein) (Second TBP of unique DNA protein) (STUD) (TATA box-binding protein-related factor 2) (TBP-related factor 2) (TBP-like factor) (TBP-related protein),186,"20,887",5 out of 5,2004-07-05,Evidence at protein level
Q16650,TBR1_HUMAN,T-box brain protein 1 (T-brain-1) (TBR-1) (TES-56),682,"74,053",4 out of 5,1997-11-01,Evidence at transcript level
Q969Z0,TBRG4_HUMAN,Protein TBRG4 (Cell cycle progression restoration protein 2) (Cell cycle progression protein 2) (FAST kinase domain-containing protein 4) (Transforming growth factor beta regulator 4),631,"70,738",5 out of 5,2007-01-23,Evidence at protein level
Q8IYN2,TCAL8_HUMAN,Transcription elongation factor A protein-like 8 (TCEA-like protein 8) (Transcription elongation factor S-II protein-like 8),117,"13,616",2 out of 5,2006-05-30,Inferred from homology
Q5QJ38,TCHL1_HUMAN,Trichohyalin-like protein 1 (Basalin) (Protein S100-A17) (S100 calcium-binding protein A17),904,"99,275",2 out of 5,2008-06-10,Evidence at transcript level
P24821,TENA_HUMAN,Tenascin (TN) (Cytotactin) (GMEM) (GP 150-225) (Glioma-associated-extracellular matrix antigen) (Hexabrachion) (JI) (Myotendinous antigen) (Neuronectin) (Tenascin-C) (TN-C),2201,"240,853",5 out of 5,1992-03-01,Evidence at protein level
Q68CZ2,TENS3_HUMAN,Tensin-3 (Tensin-like SH2 domain-containing protein 1) (Tumor endothelial marker 6),1445,"155,266",5 out of 5,2007-07-24,Evidence at protein level
O15482,TEX28_HUMAN,Testis-specific protein TEX28,410,"46,131",2 out of 5,1998-12-15,Evidence at transcript level
Q5VZQ5,TEX36_HUMAN,Testis-expressed protein 36,186,"21,545",1 out of 5,2006-06-27,Evidence at transcript level
Q8N6V9,TEX9_HUMAN,Testis-expressed protein 9,391,"44,826",2 out of 5,2006-06-27,Evidence at protein level
Q92759,TF2H4_HUMAN,General transcription factor IIH subunit 4 (Basic transcription factor 2 52 kDa subunit) (BTF2 p52) (General transcription factor IIH polypeptide 4) (TFIIH basal transcription factor complex p52 subunit),462,"52,186",5 out of 5,2001-10-18,Evidence at protein level
Q9Y5Q9,TF3C3_HUMAN,General transcription factor 3C polypeptide 3 (Transcription factor IIIC 102 kDa subunit) (TFIIIC 102 kDa subunit) (TFIIIC102) (Transcription factor IIIC subunit gamma) (TF3C-gamma),886,"101,272",5 out of 5,2004-05-24,Evidence at protein level
Q04206,TF65_HUMAN,Transcription factor p65 (Nuclear factor NF-kappa-B p65 subunit) (Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3),551,"60,219",5 out of 5,1993-10-01,Evidence at protein level
Q14188,TFDP2_HUMAN,Transcription factor Dp-2 (E2F dimerization partner 2),446,"49,236",5 out of 5,1998-07-15,Evidence at protein level
Q9UBB9,TFP11_HUMAN,Tuftelin-interacting protein 11 (Septin and tuftelin-interacting protein 1) (STIP-1),837,"96,820",5 out of 5,2002-08-02,Evidence at protein level
P02786,TFR1_HUMAN,"Transferrin receptor protein 1 (TR) (TfR) (TfR1) (Trfr) (T9) (p90) (CD antigen CD71) [Cleaved into: Transferrin receptor protein 1, serum form (sTfR)]",760,"84,871",5 out of 5,1986-07-21,Evidence at protein level
Q8WUH2,TGFA1_HUMAN,Transforming growth factor-beta receptor-associated protein 1 (TGF-beta receptor-associated protein 1) (TRAP-1) (TRAP1),860,"97,158",5 out of 5,2008-07-22,Evidence at protein level
Q6IEE7,T132E_HUMAN,Transmembrane protein 132E,984,"107,094",4 out of 5,2007-05-15,Evidence at protein level
A6NC51,T150B_HUMAN,Transmembrane protein 150B (Transmembrane protein 224),233,"25,701",3 out of 5,2008-09-02,Evidence at transcript level
Q8N4L1,T151A_HUMAN,Transmembrane protein 151A,468,"51,278",2 out of 5,2007-04-03,Evidence at transcript level
Q8NDZ6,T161B_HUMAN,Transmembrane protein 161B,487,"55,482",2 out of 5,2007-05-29,Evidence at transcript level
Q8WVE7,T170A_HUMAN,Transmembrane protein 170A,144,"15,250",5 out of 5,2007-06-26,Evidence at protein level
Q9NYV9,T2R13_HUMAN,Taste receptor type 2 member 13 (T2R13) (Taste receptor family B member 3) (TRB3),303,"35,118",4 out of 5,2003-04-11,Evidence at protein level
P59536,T2R41_HUMAN,Taste receptor type 2 member 41 (T2R41) (Taste receptor type 2 member 59) (T2R59),307,"35,896",3 out of 5,2003-04-11,Evidence at transcript level
Q9Y3F1,TA6P_HUMAN,Putative TAP2-associated 6.5 kDa polypeptide,56,"6,535",1 out of 5,2000-12-01,Uncertain
Q96RI8,TAAR6_HUMAN,Trace amine-associated receptor 6 (TaR-6) (Trace amine receptor 6) (Trace amine receptor 4) (TaR-4),345,"38,451",5 out of 5,2003-11-07,Evidence at transcript level
Q96RI9,TAAR9_HUMAN,Trace amine-associated receptor 9 (TaR-9) (Trace amine receptor 9) (Trace amine receptor 3) (TaR-3),348,"39,016",4 out of 5,2003-11-07,Evidence at transcript level
Q9NYJ8,TAB2_HUMAN,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 2) (TAK1-binding protein 2) (TAB-2) (TGF-beta-activated kinase 1-binding protein 2),693,"76,494",5 out of 5,2006-03-07,Evidence at protein level
P09758,TACD2_HUMAN,Tumor-associated calcium signal transducer 2 (Cell surface glycoprotein Trop-2) (Membrane component chromosome 1 surface marker 1) (Pancreatic carcinoma marker protein GA733-1),323,"35,709",5 out of 5,1989-07-01,Evidence at protein level
Q15544,TAF11_HUMAN,Transcription initiation factor TFIID subunit 11 (TFIID subunit p30-beta) (Transcription initiation factor TFIID 28 kDa subunit) (TAF(II)28) (TAFII-28) (TAFII28),211,"23,307",5 out of 5,1998-07-15,Evidence at protein level
Q5H9L4,TAF7L_HUMAN,Transcription initiation factor TFIID subunit 7-like (Cancer/testis antigen 40) (CT40) (RNA polymerase II TBP-associated factor subunit Q) (TATA box-binding protein-associated factor 50 kDa) (Transcription initiation factor TFIID 50 kDa subunit),462,"52,588",5 out of 5,2007-10-23,Evidence at transcript level
Q9C0D5,TANC1_HUMAN,"Protein TANC1 (Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 1)",1861,"202,219",4 out of 5,2008-02-05,Evidence at protein level
Q7Z7G0,TARSH_HUMAN,Target of Nesh-SH3 (Tarsh) (ABI gene family member 3-binding protein) (Nesh-binding protein) (NeshBP),1075,"118,642",5 out of 5,2004-07-19,Evidence at protein level
A6NNZ2,TBB8L_HUMAN,Tubulin beta-8 chain-like protein LOC260334,444,"49,573",4 out of 5,2008-04-29,Evidence at protein level
Q9Y2I9,TBC30_HUMAN,TBC1 domain family member 30,924,"102,743",5 out of 5,2008-02-26,Evidence at protein level
Q6IPX1,TBC3C_HUMAN,TBC1 domain family member 3C,549,"62,187",3 out of 5,2007-09-11,Evidence at transcript level
Q99593,TBX5_HUMAN,T-box transcription factor TBX5 (T-box protein 5),518,"57,711",5 out of 5,1997-11-01,Evidence at protein level
Q9Y4C2,TCAF1_HUMAN,TRPM8 channel-associated factor 1 (TRP channel-associated factor 1),921,"102,126",5 out of 5,2008-02-26,Evidence at protein level
Q15170,TCAL1_HUMAN,Transcription elongation factor A protein-like 1 (TCEA-like protein 1) (Nuclear phosphoprotein p21/SIIR) (Transcription elongation factor S-II protein-like 1),157,"18,354",5 out of 5,2006-05-30,Evidence at protein level
Q9BRU2,TCAL7_HUMAN,Transcription elongation factor A protein-like 7 (TCEA-like protein 7) (Transcription elongation factor S-II protein-like 7),100,"12,324",3 out of 5,2006-05-30,Evidence at transcript level
O43680,TCF21_HUMAN,Transcription factor 21 (TCF-21) (Capsulin) (Class A basic helix-loop-helix protein 23) (bHLHa23) (Epicardin) (Podocyte-expressed 1) (Pod-1),179,"19,715",5 out of 5,2001-08-14,Evidence at transcript level
Q7RTU1,TCF23_HUMAN,Transcription factor 23 (TCF-23) (Class A basic helix-loop-helix protein 24) (bHLHa24),214,"23,309",3 out of 5,2008-01-15,Evidence at transcript level
P36402,TCF7_HUMAN,Transcription factor 7 (TCF-7) (T-cell-specific transcription factor 1) (T-cell factor 1) (TCF-1),384,"41,642",5 out of 5,1994-06-01,Evidence at protein level
O95988,TCL1B_HUMAN,T-cell leukemia/lymphoma protein 1B (Oncogene TCL-1B) (Oncogene TCL1B) (SYN-1) (Syncytiotrophoblast-specific protein) (TCL1/MTCP1-like protein 1),128,"14,846",3 out of 5,2000-05-30,Evidence at protein level
O15040,TCPR2_HUMAN,Tectonin beta-propeller repeat-containing protein 2 (WD repeat-containing protein KIAA0329/KIAA0297),1411,"153,848",5 out of 5,2001-02-21,Evidence at protein level
Q9Y2W6,TDRKH_HUMAN,Tudor and KH domain-containing protein (Tudor domain-containing protein 2),561,"62,046",5 out of 5,2003-12-15,Evidence at protein level
P04053,TDT_HUMAN,DNA nucleotidylexotransferase (EC 2.7.7.31) (Terminal addition enzyme) (Terminal deoxynucleotidyltransferase) (Terminal transferase),509,"58,536",5 out of 5,1986-11-01,Evidence at protein level
Q12789,TF3C1_HUMAN,General transcription factor 3C polypeptide 1 (TF3C-alpha) (TFIIIC box B-binding subunit) (Transcription factor IIIC 220 kDa subunit) (TFIIIC 220 kDa subunit) (TFIIIC220) (Transcription factor IIIC subunit alpha),2109,"238,875",5 out of 5,2004-06-07,Evidence at protein level
Q969F1,TF3C6_HUMAN,General transcription factor 3C polypeptide 6 (Transcription factor IIIC 35 kDa subunit) (TFIIIC 35 kDa subunit) (TFIIIC35) (Transcription factor IIIC subunit 6),213,"24,049",5 out of 5,2003-05-09,Evidence at protein level
O95455,TGDS_HUMAN,"dTDP-D-glucose 4,6-dehydratase (EC 4.2.1.46)",350,"40,214",3 out of 5,2003-04-23,Evidence at protein level
P61812,TGFB2_HUMAN,Transforming growth factor beta-2 (TGF-beta-2) (BSC-1 cell growth inhibitor) (Cetermin) (Glioblastoma-derived T-cell suppressor factor) (G-TSF) (Polyergin) [Cleaved into: Latency-associated peptide (LAP)],414,"47,748",5 out of 5,1988-08-01,Evidence at protein level
O43294,TGFI1_HUMAN,Transforming growth factor beta-1-induced transcript 1 protein (Androgen receptor coactivator 55 kDa protein) (Androgen receptor-associated protein of 55 kDa) (Hydrogen peroxide-inducible clone 5 protein) (Hic-5),461,"49,814",5 out of 5,2007-06-26,Evidence at protein level
Q9GZN2,TGIF2_HUMAN,Homeobox protein TGIF2 (5'-TG-3'-interacting factor 2) (TGF-beta-induced transcription factor 2) (TGFB-induced factor 2),237,"25,878",5 out of 5,2003-01-17,Evidence at protein level
P22735,TGM1_HUMAN,Protein-glutamine gamma-glutamyltransferase K (EC 2.3.2.13) (Epidermal TGase) (Transglutaminase K) (TG(K)) (TGK) (TGase K) (Transglutaminase-1) (TGase-1),817,"89,787",5 out of 5,1991-08-01,Evidence at protein level
P21980,TGM2_HUMAN,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Tissue transglutaminase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase-2) (TGase-2),687,"77,329",5 out of 5,1991-08-01,Evidence at protein level
P10827,THA_HUMAN,Thyroid hormone receptor alpha (Nuclear receptor subfamily 1 group A member 1) (V-erbA-related protein 7) (EAR-7) (c-erbA-1) (c-erbA-alpha),490,"54,816",5 out of 5,1989-07-01,Evidence at protein level
O76070,SYUG_HUMAN,Gamma-synuclein (Breast cancer-specific gene 1 protein) (Persyn) (Synoretin) (SR),127,"13,331",5 out of 5,1999-07-15,Evidence at protein level
Q9Y2Z4,SYYM_HUMAN,"Tyrosine--tRNA ligase, mitochondrial (EC 6.1.1.1) (Tyrosyl-tRNA synthetase) (TyrRS)",477,"53,199",5 out of 5,2004-07-19,Evidence at protein level
Q9BVX2,T106C_HUMAN,Transmembrane protein 106C (Endoplasmic reticulum membrane protein overexpressed in cancer),250,"27,875",4 out of 5,2006-06-27,Evidence at protein level
Q96BN2,TADA1_HUMAN,Transcriptional adapter 1 (SPT3-associated factor 42) (STAF42) (Transcriptional adapter 1-like protein),335,"37,382",5 out of 5,2008-02-05,Evidence at protein level
Q13148,TADBP_HUMAN,TAR DNA-binding protein 43 (TDP-43),414,"44,740",5 out of 5,2002-03-27,Evidence at protein level
Q16514,TAF12_HUMAN,Transcription initiation factor TFIID subunit 12 (Transcription initiation factor TFIID 20/15 kDa subunits) (TAFII-20/TAFII-15) (TAFII20/TAFII15),161,"17,924",5 out of 5,1998-07-15,Evidence at protein level
Q9UI15,TAGL3_HUMAN,Transgelin-3 (Neuronal protein 22) (NP22) (Neuronal protein NP25),199,"22,473",3 out of 5,2000-12-01,Evidence at protein level
Q9BVV6,TALD3_HUMAN,Protein TALPID3,1533,"169,307",5 out of 5,2002-01-23,Evidence at protein level
Q96BW9,TAM41_HUMAN,"Phosphatidate cytidylyltransferase, mitochondrial (EC 2.7.7.41) (CDP-diacylglycerol synthase) (CDP-DAG synthase) (Mitochondrial translocator assembly and maintenance protein 41 homolog) (TAM41)",452,"51,067",4 out of 5,2006-09-05,Evidence at protein level
B6A8C7,TARM1_HUMAN,"T-cell-interacting, activating receptor on myeloid cells protein 1 (OSCAR-like transcript-2 protein) (OLT-2)",271,"29,474",4 out of 5,2010-05-18,Evidence at transcript level
Q8TC07,TBC15_HUMAN,TBC1 domain family member 15 (GTPase-activating protein RAB7) (GAP for RAB7) (Rab7-GAP),691,"79,491",5 out of 5,2005-02-15,Evidence at protein level
Q8N5T2,TBC19_HUMAN,TBC1 domain family member 19,526,"60,208",3 out of 5,2005-02-15,Evidence at protein level
P0C7X1,TBC3H_HUMAN,TBC1 domain family member 3H,549,"62,219",3 out of 5,2008-07-22,Evidence at transcript level
Q66K14,TBC9B_HUMAN,TBC1 domain family member 9B,1250,"140,525",5 out of 5,2007-05-29,Evidence at protein level
Q9P0N9,TBCD7_HUMAN,TBC1 domain family member 7 (Cell migration-inducing protein 23),293,"33,972",5 out of 5,2003-10-03,Evidence at protein level
Q9BYX2,TBD2A_HUMAN,TBC1 domain family member 2A (Armus) (Prostate antigen recognized and identified by SEREX 1) (PARIS-1),928,"105,414",5 out of 5,2002-10-10,Evidence at protein level
P23258,TBG1_HUMAN,Tubulin gamma-1 chain (Gamma-1-tubulin) (Gamma-tubulin complex component 1) (GCP-1),451,"51,170",5 out of 5,1991-11-01,Evidence at protein level
Q9NRH3,TBG2_HUMAN,Tubulin gamma-2 chain (Gamma-2-tubulin),451,"51,092",4 out of 5,2001-01-24,Evidence at transcript level
Q9BQ87,TBL1Y_HUMAN,"F-box-like/WD repeat-containing protein TBL1Y (Transducin beta-like protein 1Y) (Transducin-beta-like protein 1, Y-linked)",522,"56,688",4 out of 5,2002-09-19,Evidence at transcript level
Q8N7M0,TC1D1_HUMAN,Tctex1 domain-containing protein 1,179,"20,730",2 out of 5,2007-05-01,Evidence at protein level
Q8N3R3,TCAIM_HUMAN,"T-cell activation inhibitor, mitochondrial (Tolerance associated gene-1 protein) (TOAG-1)",496,"57,925",3 out of 5,2006-05-16,Evidence at transcript level
Q5VWI1,TCRGL_HUMAN,Transcription elongation regulator 1-like protein,586,"65,660",2 out of 5,2007-12-04,Evidence at transcript level
P13385,TDGF1_HUMAN,Teratocarcinoma-derived growth factor 1 (Cripto-1 growth factor) (CRGF) (Epidermal growth factor-like cripto protein CR1),188,"21,169",5 out of 5,1990-01-01,Evidence at protein level
P04155,TFF1_HUMAN,Trefoil factor 1 (Breast cancer estrogen-inducible protein) (PNR-2) (Polypeptide P1.A) (hP1.A) (Protein pS2),84,"9,150",5 out of 5,1986-11-01,Evidence at protein level
Q92734,TFG_HUMAN,Protein TFG (TRK-fused gene protein),400,"43,448",5 out of 5,2004-02-02,Evidence at protein level
P10646,TFPI1_HUMAN,Tissue factor pathway inhibitor (TFPI) (Extrinsic pathway inhibitor) (EPI) (Lipoprotein-associated coagulation inhibitor) (LACI),304,"35,015",5 out of 5,1989-07-01,Evidence at protein level
Q6P1N9,TATD1_HUMAN,Putative deoxyribonuclease TATDN1 (EC 3.1.21.-) (Hepatocarcinoma high expression protein),297,"33,602",3 out of 5,2008-01-15,Evidence at protein level
P0CG35,TB15B_HUMAN,Thymosin beta-15B,45,"5,229",3 out of 5,2010-07-13,Evidence at protein level
Q9C0C2,TB182_HUMAN,182 kDa tankyrase-1-binding protein,1729,"181,796",5 out of 5,2002-06-20,Evidence at protein level
Q9NU19,TB22B_HUMAN,TBC1 domain family member 22B,505,"59,081",5 out of 5,2002-11-08,Evidence at protein level
P68363,TBA1B_HUMAN,Tubulin alpha-1B chain (Alpha-tubulin ubiquitous) (Tubulin K-alpha-1) (Tubulin alpha-ubiquitous chain) [Cleaved into: Detyrosinated tubulin alpha-1B chain],451,"50,152",5 out of 5,1987-08-13,Evidence at protein level
A6NHL2,TBAL3_HUMAN,Tubulin alpha chain-like 3,446,"49,909",3 out of 5,2008-01-15,Evidence at protein level
Q13509,TBB3_HUMAN,Tubulin beta-3 chain (Tubulin beta-4 chain) (Tubulin beta-III),450,"50,433",5 out of 5,1998-07-15,Evidence at protein level
P04350,TBB4A_HUMAN,Tubulin beta-4A chain (Tubulin 5 beta) (Tubulin beta-4 chain),444,"49,586",5 out of 5,1987-03-20,Evidence at protein level
P07437,TBB5_HUMAN,Tubulin beta chain (Tubulin beta-5 chain),444,"49,671",5 out of 5,1987-08-13,Evidence at protein level
O60347,TBC12_HUMAN,TBC1 domain family member 12,775,"85,626",3 out of 5,2004-06-21,Evidence at protein level
Q96BZ9,TBC20_HUMAN,TBC1 domain family member 20,403,"45,855",5 out of 5,2003-08-29,Evidence at protein level
Q86UD7,TBC26_HUMAN,TBC1 domain family member 26,250,"28,839",3 out of 5,2008-05-20,Evidence at transcript level
A0A087WVF3,TBC3D_HUMAN,TBC1 domain family member 3D,549,"62,187",3 out of 5,2015-01-07,Evidence at transcript level
A0A087X1G2,TBC3K_HUMAN,TBC1 domain family member 3K,549,"62,171",3 out of 5,2015-01-07,Inferred from homology
Q86TI0,TBCD1_HUMAN,TBC1 domain family member 1,1168,"133,084",5 out of 5,2003-10-03,Evidence at protein level
Q6ZT07,TBCD9_HUMAN,TBC1 domain family member 9 (TBC1 domain family member 9A),1266,"143,229",4 out of 5,2007-05-29,Evidence at transcript level
Q8TEA7,TBCK_HUMAN,TBC domain-containing protein kinase-like protein,893,"100,679",5 out of 5,2007-01-23,Evidence at protein level
Q6SJ96,TBPL2_HUMAN,TATA box-binding protein-like protein 2 (TBP-like protein 2) (TATA box-binding protein-related factor 3) (TBP-related factor 3),375,"41,524",4 out of 5,2008-02-05,Evidence at transcript level
O95947,TBX6_HUMAN,T-box transcription factor TBX6 (T-box protein 6),436,"47,045",5 out of 5,1999-07-15,Evidence at protein level
A6NFQ2,TCAF2_HUMAN,TRPM8 channel-associated factor 2 (TRP channel-associated factor 2),919,"100,906",5 out of 5,2008-02-26,Evidence at protein level
Q969E4,TCAL3_HUMAN,Transcription elongation factor A protein-like 3 (TCEA-like protein 3) (Transcription elongation factor S-II protein-like 3),200,"22,502",3 out of 5,2006-05-30,Evidence at protein level
Q8TDR4,TCP1L_HUMAN,T-complex protein 10A homolog 2 (T-complex protein 10A-2) (TCP10A-2) (TCP10-like),215,"23,863",5 out of 5,2002-10-10,Evidence at protein level
P53999,TCP4_HUMAN,Activated RNA polymerase II transcriptional coactivator p15 (Positive cofactor 4) (PC4) (SUB1 homolog) (p14),127,"14,395",5 out of 5,1996-10-01,Evidence at protein level
Q8NDG6,TDRD9_HUMAN,Putative ATP-dependent RNA helicase TDRD9 (EC 3.6.4.13) (Tudor domain-containing protein 9),1382,"155,683",5 out of 5,2008-05-20,Evidence at transcript level
Q9NT68,TEN2_HUMAN,"Teneurin-2 (Ten-2) (Protein Odd Oz/ten-m homolog 2) (Tenascin-M2) (Ten-m2) (Teneurin transmembrane protein 2) [Cleaved into: Ten-2, soluble form; Ten-2 intracellular domain (Ten-2 ICD)]",2774,"307,787",5 out of 5,2006-10-31,Evidence at protein level
Q15554,TERF2_HUMAN,Telomeric repeat-binding factor 2 (TTAGGG repeat-binding factor 2) (Telomeric DNA-binding protein),542,"59,594",5 out of 5,2002-06-20,Evidence at protein level
Q15569,TESK1_HUMAN,Dual specificity testis-specific protein kinase 1 (EC 2.7.12.1) (Testicular protein kinase 1),626,"67,684",5 out of 5,1997-11-01,Evidence at protein level
P05452,TETN_HUMAN,Tetranectin (TN) (C-type lectin domain family 3 member B) (Plasminogen kringle 4-binding protein),202,"22,537",5 out of 5,1988-11-01,Evidence at protein level
Q8IWB9,TEX2_HUMAN,Testis-expressed protein 2 (Transmembrane protein 96),1127,"125,303",3 out of 5,2006-06-27,Evidence at protein level
Q03403,TFF2_HUMAN,Trefoil factor 2 (Spasmolysin) (Spasmolytic polypeptide) (SP),129,"14,284",3 out of 5,1994-10-01,Evidence at protein level
Q03167,TGBR3_HUMAN,Transforming growth factor beta receptor type 3 (TGF-beta receptor type 3) (TGFR-3) (Betaglycan) (Transforming growth factor beta receptor III) (TGF-beta receptor type III),851,"93,499",5 out of 5,1994-02-01,Evidence at protein level
P37173,TGFR2_HUMAN,TGF-beta receptor type-2 (TGFR-2) (EC 2.7.11.30) (TGF-beta type II receptor) (Transforming growth factor-beta receptor type II) (TGF-beta receptor type II) (TbetaR-II),567,"64,568",5 out of 5,1994-10-01,Evidence at protein level
P63120,VPK19_HUMAN,Endogenous retrovirus group K member 19 Pro protein (HERV-K(C19) Pro protein) (HERV-K_19q12 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,107",3 out of 5,2004-09-13,Inferred from homology
Q9Y6I0,VPK6_HUMAN,Endogenous retrovirus group K member 6 Pro protein (HERV-K(C7) Pro protein) (HERV-K(HML-2.HOM) Pro protein) (HERV-K108 Pro protein) (HERV-K_7p22.1 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"16,972",4 out of 5,2004-09-13,Inferred from homology
Q9Y487,VPP2_HUMAN,V-type proton ATPase 116 kDa subunit a isoform 2 (V-ATPase 116 kDa isoform a2) (Lysosomal H(+)-transporting ATPase V0 subunit a2) (TJ6) (Vacuolar proton translocating ATPase 116 kDa subunit a isoform 2),856,"98,082",5 out of 5,2000-12-01,Evidence at protein level
Q9H270,VPS11_HUMAN,Vacuolar protein sorting-associated protein 11 homolog (hVPS11) (RING finger protein 108),941,"107,837",5 out of 5,2002-09-19,Evidence at protein level
Q8N1B4,VPS52_HUMAN,Vacuolar protein sorting-associated protein 52 homolog (SAC2 suppressor of actin mutations 2-like protein),723,"82,221",5 out of 5,2005-11-22,Evidence at protein level
Q9P1Q0,VPS54_HUMAN,Vacuolar protein sorting-associated protein 54 (Hepatocellular carcinoma protein 8) (Tumor antigen HOM-HCC-8) (Tumor antigen SLP-8p),977,"110,589",5 out of 5,2005-05-10,Evidence at protein level
Q99986,VRK1_HUMAN,Serine/threonine-protein kinase VRK1 (EC 2.7.11.1) (Vaccinia-related kinase 1),396,"45,476",5 out of 5,2003-10-10,Evidence at protein level
Q96G27,WBP1_HUMAN,WW domain-binding protein 1 (WBP-1),269,"29,140",3 out of 5,2002-11-15,Evidence at protein level
O75717,WDHD1_HUMAN,WD repeat and HMG-box DNA-binding protein 1 (Acidic nucleoplasmic DNA-binding protein 1) (And-1),1129,"125,967",5 out of 5,2003-02-22,Evidence at protein level
Q9BZH6,WDR11_HUMAN,WD repeat-containing protein 11 (Bromodomain and WD repeat-containing protein 2) (WD repeat-containing protein 15),1224,"136,685",5 out of 5,2001-11-16,Evidence at protein level
Q9BV38,WDR18_HUMAN,WD repeat-containing protein 18,432,"47,405",4 out of 5,2002-05-27,Evidence at protein level
Q8TBZ3,WDR20_HUMAN,WD repeat-containing protein 20 (Protein DMR),569,"62,893",5 out of 5,2003-02-12,Evidence at protein level
Q9HC57,WFDC1_HUMAN,WAP four-disulfide core domain protein 1 (Prostate stromal protein ps20) (ps20 growth inhibitor),220,"23,977",4 out of 5,2002-08-02,Evidence at transcript level
Q8IUB2,WFDC3_HUMAN,WAP four-disulfide core domain protein 3 (Putative protease inhibitor WAP14),231,"24,687",3 out of 5,2003-06-27,Evidence at transcript level
Q8TCV5,WFDC5_HUMAN,WAP four-disulfide core domain protein 5 (Putative protease inhibitor WAP1) (p53-responsive gene 5 protein),224,"24,238",3 out of 5,2002-12-06,Evidence at transcript level
Q8NEX5,WFDC9_HUMAN,Protein WFDC9,89,"10,506",2 out of 5,2002-12-06,Evidence at protein level
O76024,WFS1_HUMAN,Wolframin,890,"100,292",5 out of 5,1999-07-15,Evidence at protein level
Q5MNZ6,WIPI3_HUMAN,WD repeat domain phosphoinositide-interacting protein 3 (WIPI-3) (WD repeat-containing protein 45-like) (WDR45-like protein) (WD repeat-containing protein 45B) (WIPI49-like protein),344,"38,122",2 out of 5,2006-01-10,Evidence at transcript level
Q9Y3S1,WNK2_HUMAN,Serine/threonine-protein kinase WNK2 (EC 2.7.11.1) (Antigen NY-CO-43) (Protein kinase lysine-deficient 2) (Protein kinase with no lysine 2) (Serologically defined colon cancer antigen 43),2297,"242,676",5 out of 5,2004-02-02,Evidence at protein level
Q9H1J7,WNT5B_HUMAN,Protein Wnt-5b,359,"40,323",5 out of 5,2001-06-20,Evidence at transcript level
Q5GH76,XKR4_HUMAN,XK-related protein 4,650,"71,501",2 out of 5,2005-10-11,Evidence at transcript level
Q5GH73,XKR6_HUMAN,XK-related protein 6,641,"71,638",2 out of 5,2005-07-19,Evidence at transcript level
O75191,XYLB_HUMAN,Xylulose kinase (Xylulokinase) (EC 2.7.1.17),536,"58,382",5 out of 5,2006-04-04,Evidence at protein level
Q9Y3C0,WASC3_HUMAN,WASH complex subunit 3 (Coiled-coil domain-containing protein 53),194,"21,173",5 out of 5,2000-05-30,Evidence at protein level
A8K0Z3,WASH1_HUMAN,WASH complex subunit 1 (CXYorf1-like protein on chromosome 9) (Protein FAM39E) (WAS protein family homolog 1),465,"50,328",5 out of 5,2008-04-08,Evidence at protein level
Q9Y2W2,WBP11_HUMAN,WW domain-binding protein 11 (WBP-11) (Npw38-binding protein) (NpwBP) (SH3 domain-binding protein SNP70) (Splicing factor that interacts with PQBP-1 and PP1),641,"69,998",5 out of 5,2005-09-13,Evidence at protein level
Q6UE05,WBS28_HUMAN,Williams-Beuren syndrome chromosomal region 28 protein,265,"29,433",2 out of 5,2007-10-23,Evidence at transcript level
Q8NEZ3,WDR19_HUMAN,WD repeat-containing protein 19 (Intraflagellar transport 144 homolog),1342,"151,581",5 out of 5,2006-05-02,Evidence at protein level
O75083,WDR1_HUMAN,WD repeat-containing protein 1 (Actin-interacting protein 1) (AIP1) (NORI-1),606,"66,194",5 out of 5,2001-01-11,Evidence at protein level
Q96S15,WDR24_HUMAN,WD repeat-containing protein 24,920,"101,989",4 out of 5,2005-11-22,Evidence at protein level
Q8NA23,WDR31_HUMAN,WD repeat-containing protein 31,367,"40,840",2 out of 5,2004-05-24,Evidence at transcript level
Q8NI36,WDR36_HUMAN,WD repeat-containing protein 36 (T-cell activation WD repeat-containing protein) (TA-WDRP),951,"105,322",5 out of 5,2004-04-26,Evidence at protein level
Q5JSH3,WDR44_HUMAN,WD repeat-containing protein 44 (Rabphilin-11),913,"101,366",5 out of 5,2006-11-28,Evidence at protein level
B1ANS9,WDR64_HUMAN,WD repeat-containing protein 64,1081,"123,631",2 out of 5,2008-05-20,Evidence at transcript level
Q9H967,WDR76_HUMAN,WD repeat-containing protein 76,626,"69,769",2 out of 5,2006-06-27,Evidence at protein level
Q9Y4E6,WDR7_HUMAN,WD repeat-containing protein 7 (Rabconnectin-3 beta) (TGF-beta resistance-associated protein TRAG),1490,"163,810",3 out of 5,2001-01-11,Evidence at protein level
Q562E7,WDR81_HUMAN,WD repeat-containing protein 81,1941,"211,697",4 out of 5,2006-07-25,Evidence at protein level
Q8IUB3,WF10B_HUMAN,Protein WFDC10B,73,"8,325",2 out of 5,2003-06-16,Evidence at transcript level
Q8TF74,WIPF2_HUMAN,WAS/WASL-interacting protein family member 2 (WASP-interacting protein-related protein) (WIP- and CR16-homologous protein) (WIP-related protein),440,"46,289",5 out of 5,2005-03-01,Evidence at protein level
P41221,WNT5A_HUMAN,Protein Wnt-5a,380,"42,339",5 out of 5,1995-02-01,Evidence at protein level
O00258,WRB_HUMAN,Tail-anchored protein insertion receptor WRB (Congenital heart disease 5 protein) (Tryptophan-rich basic protein) (WRB),174,"19,780",4 out of 5,1997-11-01,Evidence at protein level
A6NIX2,WTIP_HUMAN,Wilms tumor protein 1-interacting protein (WT1-interacting protein),430,"45,124",5 out of 5,2008-04-08,Evidence at protein level
Q5GH72,XKR7_HUMAN,XK-related protein 7,579,"63,826",2 out of 5,2005-10-11,Evidence at transcript level
Q9HAV4,XPO5_HUMAN,Exportin-5 (Exp5) (Ran-binding protein 21),1204,"136,311",5 out of 5,2006-05-16,Evidence at protein level
Q5SQQ9,VAX1_HUMAN,Ventral anterior homeobox 1,334,"34,713",4 out of 5,2006-06-27,Evidence at protein level
O14598,VCY1_HUMAN,"Testis-specific basic protein Y 1 (Basic charge, Y-linked 1) (Variably charged protein Y)",125,"12,917",3 out of 5,1999-07-15,Evidence at transcript level
Q9H598,VIAAT_HUMAN,Vesicular inhibitory amino acid transporter (GABA and glycine transporter) (Solute carrier family 32 member 1) (Vesicular GABA transporter) (hVIAAT),525,"57,415",5 out of 5,2003-03-28,Evidence at transcript level
Q2NL98,VMAC_HUMAN,Vimentin-type intermediate filament-associated coiled-coil protein,169,"18,348",1 out of 5,2008-02-26,Evidence at transcript level
Q7Z5L0,VMO1_HUMAN,Vitelline membrane outer layer protein 1 homolog,202,"21,534",3 out of 5,2005-03-01,Evidence at protein level
O95498,VNN2_HUMAN,Vascular non-inflammatory molecule 2 (Vanin-2) (EC 3.5.1.92) (Glycosylphosphatidyl inositol-anchored protein GPI-80) (Protein FOAP-4),520,"58,503",5 out of 5,2001-04-27,Evidence at protein level
P10265,VPK10_HUMAN,Endogenous retrovirus group K member 10 Pro protein (HERV-K10 Pro protein) (HERV-K107 Pro protein) (HERV-K_5q33.3 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,108",5 out of 5,1989-07-01,Evidence at protein level
P63122,VPK8_HUMAN,Endogenous retrovirus group K member 8 Pro protein (HERV-K115 Pro protein) (HERV-K_8p23.1 provirus ancestral Pro protein) (EC 3.4.23.50) (Protease) (Proteinase) (PR),156,"17,206",3 out of 5,2004-09-13,Inferred from homology
P56704,WNT3A_HUMAN,Protein Wnt-3a,352,"39,365",5 out of 5,1999-07-15,Evidence at protein level
O14904,WNT9A_HUMAN,Protein Wnt-9a (Protein Wnt-14),365,"40,320",5 out of 5,1998-07-15,Evidence at transcript level
Q9P2S5,WRP73_HUMAN,WD repeat-containing protein WRAP73 (WD repeat-containing protein 8) (WD repeat-containing protein antisense to TP73 gene),460,"51,588",5 out of 5,2001-09-26,Evidence at protein level
Q96NR7,WWAS2_HUMAN,Putative uncharacterized protein WWC2-AS2 (WWC2 antisense RNA 2) (WWC2 antisense gene protein 2),200,"21,356",2 out of 5,2008-06-10,Uncertain
Q9NZC7,WWOX_HUMAN,WW domain-containing oxidoreductase (EC 1.1.1.-) (Fragile site FRA16D oxidoreductase) (Short chain dehydrogenase/reductase family 41C member 1),414,"46,677",5 out of 5,2005-11-22,Evidence at protein level
Q9GZV5,WWTR1_HUMAN,WW domain-containing transcription regulator protein 1 (Transcriptional coactivator with PDZ-binding motif),400,"44,101",5 out of 5,2005-06-07,Evidence at protein level
P78423,X3CL1_HUMAN,Fractalkine (C-X3-C motif chemokine 1) (CX3C membrane-anchored chemokine) (Neurotactin) (Small-inducible cytokine D1) [Cleaved into: Processed fractalkine],397,"42,203",5 out of 5,1999-07-15,Evidence at protein level
Q6GPH4,XAF1_HUMAN,XIAP-associated factor 1 (BIRC4-binding protein),301,"34,626",5 out of 5,2008-04-08,Evidence at protein level
Q9UBD3,XCL2_HUMAN,Cytokine SCM-1 beta (C motif chemokine 2) (XC chemokine ligand 2),114,"12,567",5 out of 5,2000-12-01,Evidence at protein level
O14609,XKRY_HUMAN,"Testis-specific XK-related protein, Y-linked",159,"18,083",2 out of 5,1999-07-15,Evidence at transcript level
Q6AWC2,WWC2_HUMAN,Protein WWC2 (BH-3-only member B) (WW domain-containing protein 2),1192,"133,891",5 out of 5,2007-11-13,Evidence at protein level
O00308,WWP2_HUMAN,NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2),870,"98,912",5 out of 5,2003-06-20,Evidence at protein level
Q96GT9,XAGE2_HUMAN,X antigen family member 2 (XAGE-2) (Cancer/testis antigen 12.2) (CT12.2) (G antigen family D member 3),111,"12,354",2 out of 5,2002-07-11,Evidence at protein level
P51811,XK_HUMAN,Membrane transport protein XK (Kell complex 37 kDa component) (Kx antigen) (XK-related protein 1),444,"50,902",5 out of 5,1996-10-01,Evidence at protein level
Q5T750,XP32_HUMAN,Skin-specific protein 32,250,"26,238",3 out of 5,2007-10-23,Evidence at protein level
P23025,XPA_HUMAN,DNA repair protein complementing XP-A cells (Xeroderma pigmentosum group A-complementing protein),273,"31,368",5 out of 5,1991-11-01,Evidence at protein level
P13010,XRCC5_HUMAN,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)),732,"82,705",5 out of 5,1990-01-01,Evidence at protein level
P49754,VPS41_HUMAN,Vacuolar protein sorting-associated protein 41 homolog (S53),854,"98,566",5 out of 5,1996-10-01,Evidence at protein level
A8MXK1,VSTM5_HUMAN,V-set and transmembrane domain-containing protein 5,200,"22,377",2 out of 5,2008-06-10,Inferred from homology
Q9NZR4,VSX1_HUMAN,Visual system homeobox 1 (Homeodomain protein RINX) (Retinal inner nuclear layer homeobox protein) (Transcription factor VSX1),365,"38,431",5 out of 5,2002-11-08,Evidence at protein level
Q7Z7D3,VTCN1_HUMAN,V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x),282,"30,878",5 out of 5,2008-06-10,Evidence at protein level
Q96N03,VTM2L_HUMAN,V-set and transmembrane domain-containing protein 2-like protein,204,"22,349",3 out of 5,2002-12-13,Evidence at protein level
P04004,VTNC_HUMAN,Vitronectin (VN) (S-protein) (Serum-spreading factor) (V75) [Cleaved into: Vitronectin V65 subunit; Vitronectin V10 subunit; Somatomedin-B],478,"54,306",5 out of 5,1986-10-23,Evidence at protein level
Q5TIE3,VW5B1_HUMAN,von Willebrand factor A domain-containing protein 5B1,1220,"133,802",3 out of 5,2008-03-18,Evidence at protein level
A3KMH1,VWA8_HUMAN,von Willebrand factor A domain-containing protein 8,1905,"214,824",3 out of 5,2008-07-22,Evidence at protein level
Q12768,WASC5_HUMAN,WASH complex subunit 5 (Strumpellin) (WASH complex subunit strumpellin),1159,"134,286",5 out of 5,1997-11-01,Evidence at protein level
Q9Y6W5,WASF2_HUMAN,Wiskott-Aldrich syndrome protein family member 2 (WASP family protein member 2) (Protein WAVE-2) (Verprolin homology domain-containing protein 2),498,"54,284",5 out of 5,2001-04-27,Evidence at protein level
Q6VEQ5,WASH2_HUMAN,WAS protein family homolog 2 (CXYorf1-like protein on chromosome 2) (Protein FAM39B),465,"50,312",4 out of 5,2006-10-31,Evidence at transcript level
Q9NQA3,WASH6_HUMAN,WAS protein family homolog 6 (Protein FAM39A),447,"47,990",4 out of 5,2008-07-22,Evidence at protein level
Q6ICG8,WBP2L_HUMAN,Postacrosomal sheath WW domain-binding protein (WW domain-binding protein 2-like),309,"31,909",4 out of 5,2007-05-29,Evidence at transcript level
Q9GZL7,WDR12_HUMAN,Ribosome biogenesis protein WDR12 (WD repeat-containing protein 12),423,"47,708",5 out of 5,2002-03-27,Evidence at protein level
Q8IZU2,WDR17_HUMAN,WD repeat-containing protein 17,1322,"147,703",2 out of 5,2004-05-24,Evidence at transcript level
Q9H7D7,WDR26_HUMAN,WD repeat-containing protein 26 (CUL4- and DDB1-associated WDR protein 2) (Myocardial ischemic preconditioning up-regulated protein 2),661,"72,124",5 out of 5,2004-05-24,Evidence at protein level
Q9P2L0,WDR35_HUMAN,WD repeat-containing protein 35 (Intraflagellar transport protein 121 homolog),1181,"133,547",5 out of 5,2004-03-29,Evidence at protein level
O15213,WDR46_HUMAN,WD repeat-containing protein 46 (WD repeat-containing protein BING4),610,"68,071",4 out of 5,2002-03-27,Evidence at protein level
Q9NNW5,WDR6_HUMAN,WD repeat-containing protein 6,1121,"121,725",5 out of 5,2001-01-11,Evidence at protein level
Q9BRX9,WDR83_HUMAN,WD repeat domain-containing protein 83 (Mitogen-activated protein kinase organizer 1) (MAPK organizer 1),315,"34,343",5 out of 5,2006-05-16,Evidence at protein level
Q6ZQQ6,WDR87_HUMAN,WD repeat-containing protein 87 (Testis development protein NYD-SP11),2873,"333,185",2 out of 5,2008-01-15,Evidence at protein level
Q6P2C0,WDR93_HUMAN,WD repeat-containing protein 93,686,"77,378",2 out of 5,2008-02-26,Evidence at transcript level
Q8N5D0,WDTC1_HUMAN,WD and tetratricopeptide repeats protein 1,677,"75,920",4 out of 5,2004-01-16,Evidence at protein level
Q8TF30,WHAMM_HUMAN,"WASP homolog-associated protein with actin, membranes and microtubules (WAS protein homology region 2 domain-containing protein 1) (WH2 domain-containing protein 1)",809,"90,924",5 out of 5,2007-07-10,Evidence at protein level
Q9H1J5,WNT8A_HUMAN,Protein Wnt-8a (Protein Wnt-8d),351,"38,849",5 out of 5,2001-06-20,Evidence at transcript level
Q2TBF2,WSCD2_HUMAN,WSC domain-containing protein 2,565,"63,817",3 out of 5,2007-10-02,Evidence at transcript level
Q92889,XPF_HUMAN,DNA repair endonuclease XPF (EC 3.1.-.-) (DNA excision repair protein ERCC-4) (DNA repair protein complementing XP-F cells) (Xeroderma pigmentosum group F-complementing protein),916,"104,486",5 out of 5,1997-11-01,Evidence at protein level
O14980,XPO1_HUMAN,Exportin-1 (Exp1) (Chromosome region maintenance 1 protein homolog),1071,"123,386",5 out of 5,2005-06-21,Evidence at protein level
P18887,XRCC1_HUMAN,DNA repair protein XRCC1 (X-ray repair cross-complementing protein 1),633,"69,477",5 out of 5,1990-11-01,Evidence at protein level
Q8IZH2,XRN1_HUMAN,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),1706,"194,107",5 out of 5,2005-12-20,Evidence at protein level
O75695,XRP2_HUMAN,Protein XRP2,350,"39,641",5 out of 5,2000-05-30,Evidence at protein level
Q5GH77,XKR3_HUMAN,XK-related protein 3 (X Kell blood group-related 3) (XTES),459,"53,448",3 out of 5,2005-10-11,Evidence at transcript level
Q9NYS7,WSB2_HUMAN,WD repeat and SOCS box-containing protein 2 (WSB-2) (CS box-containing WD protein),404,"45,286",3 out of 5,2002-05-10,Evidence at transcript level
P55808,XG_HUMAN,Glycoprotein Xg (Protein PBDX),180,"19,723",4 out of 5,1997-11-01,Evidence at transcript level
Q9H6D3,XKR8_HUMAN,"XK-related protein 8 (hXkr8) [Cleaved into: XK-related protein 8, processed form]",395,"44,655",4 out of 5,2005-10-11,Evidence at protein level
Q96QU8,XPO6_HUMAN,Exportin-6 (Exp6) (Ran-binding protein 20),1125,"128,883",5 out of 5,2006-05-16,Evidence at protein level
Q9UIA9,XPO7_HUMAN,Exportin-7 (Exp7) (Ran-binding protein 16),1087,"123,907",5 out of 5,2001-11-02,Evidence at protein level
Q6P2D8,XRRA1_HUMAN,X-ray radiation resistance-associated protein 1,792,"89,864",5 out of 5,2008-02-05,Evidence at transcript level
O43592,XPOT_HUMAN,Exportin-T (Exportin(tRNA)) (tRNA exportin),962,"109,964",5 out of 5,2001-11-02,Evidence at protein level
O43542,XRCC3_HUMAN,DNA repair protein XRCC3 (X-ray repair cross-complementing protein 3),346,"37,850",5 out of 5,2002-04-03,Evidence at protein level
O75063,XYLK_HUMAN,Glycosaminoglycan xylosylkinase (EC 2.7.1.-) (Xylose kinase),409,"46,432",5 out of 5,2003-09-19,Evidence at protein level
Q86Y38,XYLT1_HUMAN,Xylosyltransferase 1 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase I) (XT-I) (XylT-I),959,"107,569",5 out of 5,2005-05-10,Evidence at protein level
Q8N9X3,YA026_HUMAN,Putative uncharacterized protein encoded by LINC01356,169,"18,887",1 out of 5,2008-06-10,Uncertain
Q6UY13,YB003_HUMAN,Putative uncharacterized protein UNQ5830/PRO19650/PRO19816,95,"10,734",1 out of 5,2008-02-05,Inferred from homology
Q86TA4,YB049_HUMAN,Putative uncharacterized protein FLJ44553,180,"19,528",1 out of 5,2008-07-01,Uncertain
Q6XCG6,YA011_HUMAN,Putative uncharacterized protein PP632,107,"11,455",1 out of 5,2008-02-26,Predicted
Q9NRH1,YAED1_HUMAN,Yae1 domain-containing protein 1,226,"25,299",2 out of 5,2005-07-05,Evidence at protein level
Q6ZS92,YD022_HUMAN,Putative uncharacterized protein FLJ45721,163,"18,106",1 out of 5,2008-07-01,Uncertain
Q0P140,YA037_HUMAN,Putative uncharacterized protein HSD52,79,"8,416",1 out of 5,2008-07-01,Uncertain
Q9Y2T7,YBOX2_HUMAN,Y-box-binding protein 2 (Contrin) (DNA-binding protein C) (Dbpc) (Germ cell-specific Y-box-binding protein) (MSY2 homolog),364,"38,518",5 out of 5,2005-03-15,Evidence at protein level
Q7L0L9,YA043_HUMAN,Transmembrane protein LOC653160,218,"23,184",1 out of 5,2008-07-22,Evidence at transcript level
Q6ZS52,YF013_HUMAN,Putative uncharacterized protein FLJ45825,159,"17,352",1 out of 5,2008-05-20,Uncertain
A8MUA0,YB057_HUMAN,Putative UPF0607 protein ENSP00000381514,341,"37,841",1 out of 5,2008-09-02,Inferred from homology
P58557,YBEY_HUMAN,Putative ribonuclease,167,"19,298",3 out of 5,2002-01-23,Evidence at protein level
P46937,YAP1_HUMAN,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),504,"54,462",5 out of 5,1995-11-01,Evidence at protein level
Q8N2B8,YB035_HUMAN,Putative uncharacterized protein FLJ33534,174,"19,079",1 out of 5,2008-06-10,Evidence at transcript level
Q9UI72,YE014_HUMAN,Putative uncharacterized protein PRO0255,69,"8,249",1 out of 5,2008-04-29,Uncertain
Q6ZNX1,YE028_HUMAN,Uncharacterized protein FLJ26957,250,"28,842",1 out of 5,2017-03-15,Evidence at transcript level
Q9ULM3,YETS2_HUMAN,YEATS domain-containing protein 2,1422,"150,782",5 out of 5,2006-01-10,Evidence at protein level
A4D0T7,YG055_HUMAN,Putative transmembrane protein LINC00998,59,"6,102",2 out of 5,2008-09-02,Uncertain
Q8N7P7,YH007_HUMAN,Uncharacterized protein FLJ40521,452,"48,314",1 out of 5,2008-06-10,Evidence at transcript level
Q96NJ1,YI001_HUMAN,Uncharacterized protein FLJ30774,140,"14,269",1 out of 5,2007-09-11,Evidence at transcript level
Q6ZQT7,YJ013_HUMAN,Putative uncharacterized protein FLJ44672,251,"25,248",1 out of 5,2008-07-01,Evidence at transcript level
A6XGL0,YJEN3_HUMAN,YjeF N-terminal domain-containing protein 3 (YjeF_N3) (hYjeF_N3),299,"32,585",2 out of 5,2008-09-02,Evidence at protein level
Q9UHU1,YK039_HUMAN,Putative uncharacterized protein PRO1716,43,"4,899",1 out of 5,2008-07-01,Uncertain
O15498,YKT6_HUMAN,Synaptobrevin homolog YKT6 (EC 2.3.1.-),198,"22,418",5 out of 5,2007-03-20,Evidence at protein level
Q6ZU45,YA021_HUMAN,Putative C-type lectin domain-containing protein LINC00083,233,"25,812",2 out of 5,2008-04-29,Uncertain
A8MTW9,YB043_HUMAN,Putative uncharacterized protein ENSP00000380674,85,"8,750",1 out of 5,2008-06-10,Uncertain
Q6ZRP5,YD019_HUMAN,Putative uncharacterized protein FLJ46204,223,"25,262",1 out of 5,2008-05-20,Uncertain
A6NLC8,YE016_HUMAN,Putative TAF11-like protein ENSP00000332601,198,"21,962",1 out of 5,2008-04-29,Inferred from homology
Q6ZS46,YF009_HUMAN,Putative uncharacterized protein FLJ45840,218,"22,150",1 out of 5,2008-05-20,Uncertain
Q8NBF4,YG006_HUMAN,Putative uncharacterized protein FLJ33307,154,"16,182",1 out of 5,2008-02-26,Uncertain
Q8N976,YG039_HUMAN,Putative uncharacterized protein FLJ38264,141,"14,881",1 out of 5,2008-06-10,Uncertain
A8MUI8,YA034_HUMAN,Putative UPF0607 protein ENSP00000383783,341,"37,626",1 out of 5,2008-07-01,Inferred from homology
Q6ZUG5,YC006_HUMAN,Uncharacterized protein FLJ43738,572,"66,039",1 out of 5,2008-02-26,Evidence at transcript level
Q6UWF5,YF002_HUMAN,Putative uncharacterized protein UNQ5815/PRO19632,114,"12,886",1 out of 5,2008-02-05,Predicted
Q8NCU8,YB039_HUMAN,Uncharacterized protein encoded by LINC00116,138,"15,608",2 out of 5,2008-05-20,Evidence at protein level
P67809,YBOX1_HUMAN,Nuclease-sensitive element-binding protein 1 (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Y-box transcription factor) (Y-box-binding protein 1) (YB-1),324,"35,924",5 out of 5,2004-10-11,Evidence at protein level
A8MXQ7,YH010_HUMAN,Putative IQ motif and ankyrin repeat domain-containing protein LOC642574,604,"68,295",2 out of 5,2008-07-22,Uncertain
Q5PR19,YI024_HUMAN,Putative UPF0607 protein LOC392364,223,"24,634",1 out of 5,2008-05-20,Evidence at transcript level
Q9Y548,YIPF1_HUMAN,Protein YIPF1 (YIP1 family member 1),306,"34,277",3 out of 5,2006-06-27,Evidence at protein level
Q6ZRM9,YG024_HUMAN,Putative uncharacterized protein FLJ46235,215,"21,770",1 out of 5,2008-04-08,Evidence at transcript level
Q9HAA7,YG046_HUMAN,Putative uncharacterized protein FLJ11871,133,"14,475",1 out of 5,2008-09-02,Uncertain
A8MV72,YH009_HUMAN,Putative UPF0607 protein ENSP00000382826,311,"34,164",1 out of 5,2008-07-01,Uncertain
Q3ZCU0,YK006_HUMAN,Putative uncharacterized protein FLJ37770,254,"29,382",1 out of 5,2008-02-26,Uncertain
Q9UM01,YLAT1_HUMAN,Y+L amino acid transporter 1 (Monocyte amino acid permease 2) (MOP-2) (Solute carrier family 7 member 7) (y(+)L-type amino acid transporter 1) (Y+LAT1) (y+LAT-1),511,"55,991",5 out of 5,2001-01-24,Evidence at protein level
P16989,YBOX3_HUMAN,Y-box-binding protein 3 (Cold shock domain-containing protein A) (DNA-binding protein A) (Single-strand DNA-binding protein NF-GMB),372,"40,090",5 out of 5,1990-08-01,Evidence at protein level
A6NC05,YD286_HUMAN,Glutaredoxin-like protein C5orf63,138,"15,764",2 out of 5,2008-04-08,Evidence at transcript level
Q8N1X5,YF001_HUMAN,Uncharacterized protein FLJ37310,172,"16,487",1 out of 5,2007-09-11,Evidence at transcript level
Q8IY57,YAF2_HUMAN,YY1-associated factor 2,180,"19,901",5 out of 5,2003-10-31,Evidence at protein level
P0DN24,YC024_HUMAN,Putative uncharacterized protein LINC00694,101,"10,933",1 out of 5,2015-09-16,Predicted
P07947,YES_HUMAN,Tyrosine-protein kinase Yes (EC 2.7.10.2) (Proto-oncogene c-Yes) (p61-Yes),543,"60,801",5 out of 5,1988-08-01,Evidence at protein level
A6NL46,YF016_HUMAN,Putative UPF0607 protein ENSP00000332738,340,"37,797",1 out of 5,2008-07-01,Inferred from homology
Q6ZSV7,YF010_HUMAN,Putative uncharacterized protein FLJ45177,163,"16,907",1 out of 5,2008-05-20,Evidence at transcript level
A8MXE2,YI036_HUMAN,"Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC100288842 (EC 2.4.1.-) (Putative UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase LOC402377) (UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5 pseudogene)",369,"42,761",3 out of 5,2008-09-02,Uncertain
Q9BSR8,YIPF4_HUMAN,Protein YIPF4 (YIP1 family member 4),244,"27,083",4 out of 5,2006-06-27,Evidence at protein level
Q9H354,YJ001_HUMAN,Putative uncharacterized protein PRO1933,126,"14,747",1 out of 5,2007-09-11,Uncertain
Q92536,YLAT2_HUMAN,"Y+L amino acid transporter 2 (Cationic amino acid transporter, y+ system) (Solute carrier family 7 member 6) (y(+)L-type amino acid transporter 2) (Y+LAT2) (y+LAT-2)",515,"56,828",5 out of 5,2008-06-10,Evidence at protein level
A8MPS7,YDJC_HUMAN,Carbohydrate deacetylase (EC 3.5.1.-),323,"34,466",3 out of 5,2008-04-08,Evidence at protein level
Q8NA96,YE027_HUMAN,Putative uncharacterized protein FLJ35723,180,"19,635",1 out of 5,2008-07-01,Uncertain
Q8N9P0,YF006_HUMAN,Putative uncharacterized protein FLJ36797,234,"25,159",1 out of 5,2008-03-18,Uncertain
Q9H379,YI012_HUMAN,Putative uncharacterized protein PRO3102,93,"10,324",1 out of 5,2008-03-18,Uncertain
O95070,YIF1A_HUMAN,Protein YIF1A (54TMp) (YIP1-interacting factor homolog A),293,"32,011",5 out of 5,2006-05-02,Evidence at protein level
Q5BJH7,YIF1B_HUMAN,Protein YIF1B (YIP1-interacting factor homolog B),314,"34,435",3 out of 5,2007-10-23,Evidence at protein level
Q8N8F6,YIPF7_HUMAN,Protein YIPF7 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 9) (YIP1 family member 7),280,"30,632",3 out of 5,2008-05-20,Evidence at transcript level
Q96MT0,YJ006_HUMAN,Putative uncharacterized protein FLJ31958,163,"16,963",1 out of 5,2008-03-18,Evidence at transcript level
Q499Y3,YJ016_HUMAN,Putative uncharacterized protein C10orf88-like,187,"20,452",1 out of 5,2008-09-02,Evidence at transcript level
Q6ZVH6,YK004_HUMAN,Putative uncharacterized protein FLJ42569,145,"15,831",1 out of 5,2008-02-26,Evidence at transcript level
Q6ZVU0,YK022_HUMAN,Putative uncharacterized protein FLJ42102,165,"18,168",1 out of 5,2008-04-08,Uncertain
P49750,YLPM1_HUMAN,YLP motif-containing protein 1 (Nuclear protein ZAP3) (ZAP113),1951,"219,985",5 out of 5,1996-10-01,Evidence at protein level
Q96MF0,YO028_HUMAN,Putative uncharacterized protein LOC100506887,132,"14,640",1 out of 5,2006-12-12,Uncertain
Q9P1D8,YP008_HUMAN,Putative uncharacterized protein PRO2289,64,"6,607",1 out of 5,2008-02-26,Uncertain
Q8ND82,Z280C_HUMAN,Zinc finger protein 280C (Suppressor of hairy wing homolog 3) (Zinc finger protein 633),737,"83,096",4 out of 5,2006-03-21,Evidence at protein level
Q9C0D4,Z518B_HUMAN,Zinc finger protein 518B,1074,"119,531",3 out of 5,2008-02-05,Evidence at transcript level
O75290,Z780A_HUMAN,Zinc finger protein 780A,641,"74,531",3 out of 5,2006-12-12,Evidence at transcript level
P25311,ZA2G_HUMAN,Zinc-alpha-2-glycoprotein (Zn-alpha-2-GP) (Zn-alpha-2-glycoprotein),298,"34,259",5 out of 5,1992-05-01,Evidence at protein level
P43403,ZAP70_HUMAN,Tyrosine-protein kinase ZAP-70 (EC 2.7.10.2) (70 kDa zeta-chain associated protein) (Syk-related tyrosine kinase),619,"69,872",5 out of 5,1995-11-01,Evidence at protein level
Q13105,ZBT17_HUMAN,Zinc finger and BTB domain-containing protein 17 (Myc-interacting zinc finger protein 1) (Miz-1) (Zinc finger protein 151) (Zinc finger protein 60),803,"87,928",5 out of 5,1998-07-15,Evidence at protein level
Q9ULJ3,ZBT21_HUMAN,Zinc finger and BTB domain-containing protein 21 (Zinc finger protein 295),1066,"118,870",5 out of 5,2000-12-01,Evidence at protein level
B2RXF5,ZBT42_HUMAN,Zinc finger and BTB domain-containing protein 42,422,"46,491",4 out of 5,2008-07-22,Evidence at protein level
Q8NCP5,ZBT44_HUMAN,Zinc finger and BTB domain-containing protein 44 (BTB/POZ domain-containing protein 15) (Zinc finger protein 851),570,"63,848",5 out of 5,2007-02-06,Evidence at protein level
Q9NUD5,ZCHC3_HUMAN,Zinc finger CCHC domain-containing protein 3,404,"43,618",2 out of 5,2002-09-19,Evidence at protein level
Q96MV8,ZDH15_HUMAN,Palmitoyltransferase ZDHHC15 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 15) (DHHC-15),337,"39,331",5 out of 5,2003-10-24,Evidence at transcript level
Q8N377,YJ004_HUMAN,Putative uncharacterized protein LOC387726,158,"15,598",1 out of 5,2008-02-26,Uncertain
Q8N9G6,YJ012_HUMAN,Putative UPF0607 protein FLJ37424,341,"37,462",1 out of 5,2008-07-01,Evidence at transcript level
Q9UI25,YP002_HUMAN,Putative uncharacterized protein PRO0461,63,"6,971",1 out of 5,2000-12-01,Uncertain
Q6ZVL8,YP033_HUMAN,Putative uncharacterized protein FLJ42384,140,"15,891",1 out of 5,2008-05-20,Evidence at transcript level
P62699,YPEL5_HUMAN,Protein yippee-like 5,121,"13,842",3 out of 5,2004-07-19,Evidence at protein level
A8MZ25,YQ037_HUMAN,Putative uncharacterized protein FLJ38767,164,"18,125",1 out of 5,2008-07-01,Uncertain
Q6ZSA8,YS025_HUMAN,Putative uncharacterized protein FLJ45684,131,"13,825",1 out of 5,2008-04-29,Uncertain
A8MWP4,YU008_HUMAN,Putative uncharacterized protein ENSP00000401716,228,"24,535",1 out of 5,2008-09-02,Uncertain
O75467,Z324A_HUMAN,Zinc finger protein 324A (Zinc finger protein ZF5128),553,"61,104",3 out of 5,2002-03-27,Evidence at transcript level
Q66K41,Z385C_HUMAN,Zinc finger protein 385C,422,"44,107",3 out of 5,2008-02-26,Evidence at protein level
Q96PM9,Z385A_HUMAN,Zinc finger protein 385A (Hematopoietic zinc finger protein) (Retinal zinc finger protein),386,"40,454",5 out of 5,2004-03-15,Evidence at protein level
Q49A33,Z876P_HUMAN,Putative zinc finger protein 876,203,"23,384",2 out of 5,2008-04-29,Uncertain
A8MT70,ZBBX_HUMAN,Zinc finger B-box domain-containing protein 1,800,"91,426",3 out of 5,2008-03-18,Evidence at transcript level
Q9BZS9,YG041_HUMAN,Putative uncharacterized protein PNAS-138,49,"5,619",1 out of 5,2008-07-01,Uncertain
Q96M66,YP010_HUMAN,Putative uncharacterized protein FLJ32790,194,"20,693",1 out of 5,2008-02-26,Evidence at transcript level
Q8NAQ8,YP023_HUMAN,Putative uncharacterized protein FLJ34945,132,"14,168",1 out of 5,2008-04-08,Evidence at transcript level
Q8N3U1,YS014_HUMAN,Putative uncharacterized protein LOC400692,123,"12,695",1 out of 5,2008-02-26,Evidence at transcript level
Q9BYJ9,YTHD1_HUMAN,YTH domain-containing family protein 1 (Dermatomyositis associated with cancer putative autoantigen 1) (DACA-1),559,"60,874",5 out of 5,2003-02-12,Evidence at protein level
Q5VSD8,YI029_HUMAN,Putative uncharacterized protein LOC401522,79,"8,201",1 out of 5,2008-07-01,Predicted
Q6ZSR9,YJ005_HUMAN,Uncharacterized protein FLJ45252,355,"37,976",1 out of 5,2008-03-18,Evidence at transcript level
P0C879,YJ018_HUMAN,Putative uncharacterized protein FLJ43185,139,"14,498",1 out of 5,2008-09-02,Uncertain
A8MX80,YM017_HUMAN,Putative UPF0607 protein ENSP00000383144,341,"37,634",1 out of 5,2008-07-01,Inferred from homology
A6NDX4,YO011_HUMAN,Putative transmembrane protein ENSP00000320207,124,"13,671",2 out of 5,2008-03-18,Uncertain
Q8TCH9,YV004_HUMAN,Putative uncharacterized protein FLJ23865,128,"14,227",1 out of 5,2005-09-27,Evidence at transcript level
Q86YH2,Z280B_HUMAN,Zinc finger protein 280B (5'OY11.1) (Suppressor of hairy wing homolog 2) (Zinc finger protein 279) (Zinc finger protein 632),543,"61,584",3 out of 5,2003-08-15,Evidence at protein level
Q6N043,Z280D_HUMAN,Zinc finger protein 280D (Suppressor of hairy wing homolog 4) (Zinc finger protein 634),979,"109,285",5 out of 5,2006-03-21,Evidence at protein level
Q96LW1,Z354B_HUMAN,Zinc finger protein 354B,612,"70,529",3 out of 5,2007-03-20,Evidence at transcript level
Q569K4,Z385B_HUMAN,Zinc finger protein 385B (Zinc finger protein 533),471,"50,407",5 out of 5,2005-10-25,Evidence at protein level
Q9UGR2,Z3H7B_HUMAN,Zinc finger CCCH domain-containing protein 7B (Rotavirus 'X'-associated non-structural protein) (RoXaN),993,"111,578",4 out of 5,2002-05-02,Evidence at protein level
E7ETH6,Z587B_HUMAN,Zinc finger protein 587B,402,"45,541",2 out of 5,2012-03-21,Evidence at protein level
Q6ZN79,Z705A_HUMAN,Zinc finger protein 705A,300,"34,734",3 out of 5,2006-05-02,Evidence at transcript level
Q86SH2,ZAR1_HUMAN,Zygote arrest protein 1 (Oocyte-specific maternal effect factor),424,"45,873",2 out of 5,2004-03-15,Evidence at transcript level
Q96FA7,ZB6CL_HUMAN,ZBED6 C-terminal-like protein,236,"26,352",1 out of 5,2004-05-24,Evidence at transcript level
O96006,ZBED1_HUMAN,Zinc finger BED domain-containing protein 1 (Putative Ac-like transposable element) (dREF homolog),694,"78,156",5 out of 5,2004-01-16,Evidence at protein level
P86452,ZBED6_HUMAN,Zinc finger BED domain-containing protein 6,979,"109,973",3 out of 5,2010-03-23,Inferred from homology
O95625,ZBT11_HUMAN,Zinc finger and BTB domain-containing protein 11,1053,"119,384",3 out of 5,2004-08-16,Evidence at protein level
O43829,ZBT14_HUMAN,Zinc finger and BTB domain-containing protein 14 (Zinc finger protein 161 homolog) (Zfp-161) (Zinc finger protein 478) (Zinc finger protein 5 homolog) (ZF5) (Zfp-5) (hZF5),449,"50,956",5 out of 5,2002-01-31,Evidence at protein level
Q05516,ZBT16_HUMAN,Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF),673,"74,274",5 out of 5,1995-11-01,Evidence at protein level
Q99592,ZBT18_HUMAN,Zinc finger and BTB domain-containing protein 18 (58 kDa repressor protein) (Transcriptional repressor RP58) (Translin-associated zinc finger protein 1) (TAZ-1) (Zinc finger protein 238) (Zinc finger protein C2H2-171),522,"58,354",5 out of 5,2002-02-21,Evidence at protein level
Q5TC79,ZBT37_HUMAN,Zinc finger and BTB domain-containing protein 37,503,"56,055",3 out of 5,2005-07-05,Evidence at transcript level
Q9NYG2,ZDHC3_HUMAN,Palmitoyltransferase ZDHHC3 (EC 2.3.1.225) (Protein DHHC1) (Zinc finger DHHC domain-containing protein 3) (DHHC-3),299,"34,170",5 out of 5,2003-02-01,Evidence at protein level
Q9C0B5,ZDHC5_HUMAN,Palmitoyltransferase ZDHHC5 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 5) (DHHC-5) (Zinc finger protein 375),715,"77,545",5 out of 5,2003-02-01,Evidence at protein level
O60315,ZEB2_HUMAN,Zinc finger E-box-binding homeobox 2 (Smad-interacting protein 1) (SMADIP1) (Zinc finger homeobox protein 1b),1214,"136,447",5 out of 5,2001-02-21,Evidence at protein level
P0C7U3,ZH11B_HUMAN,Probable palmitoyltransferase ZDHHC11B (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11B) (DHHC-11B),371,"41,895",3 out of 5,2008-07-22,Inferred from homology
Q96EF9,ZHX1R_HUMAN,"Zinc fingers and homeoboxes protein 1, isoform 2 (ZHX1-C8orf76 readthrough transcript protein)",292,"33,285",2 out of 5,2012-03-21,Evidence at transcript level
O95409,ZIC2_HUMAN,Zinc finger protein ZIC 2 (Zinc finger protein of the cerebellum 2),532,"55,006",5 out of 5,2000-05-30,Evidence at protein level
O95619,YETS4_HUMAN,YEATS domain-containing protein 4 (Glioma-amplified sequence 41) (Gas41) (NuMA-binding protein 1) (NuBI-1) (NuBI1),227,"26,499",5 out of 5,2005-02-15,Evidence at protein level
Q9UHT4,YG001_HUMAN,Putative uncharacterized protein PRO1854,67,"8,314",1 out of 5,2000-12-01,Uncertain
Q8N814,YG045_HUMAN,Putative uncharacterized protein FLJ40140,137,"14,437",1 out of 5,2008-09-02,Uncertain
Q8NFD4,YI018_HUMAN,Uncharacterized protein FLJ76381,153,"16,997",1 out of 5,2008-04-29,Evidence at transcript level
A1L4Q6,YK033_HUMAN,Putative uncharacterized protein FLJ41423,167,"18,020",1 out of 5,2008-05-20,Uncertain
Q8TAT8,YK045_HUMAN,Putative uncharacterized protein LOC644613,98,"10,982",1 out of 5,2008-09-02,Uncertain
Q0VFX4,YL016_HUMAN,Putative uncharacterized protein LOC100128554,171,"18,056",1 out of 5,2008-07-22,Evidence at transcript level
Q6ZV60,YL023_HUMAN,Putative uncharacterized protein encoded by LINC00173,143,"16,386",1 out of 5,2008-09-02,Uncertain
Q6UXP9,YO001_HUMAN,Putative uncharacterized protein UNQ9370/PRO34162,181,"19,777",1 out of 5,2008-02-05,Uncertain
Q6ZQY7,YO026_HUMAN,Putative uncharacterized protein FLJ46792,126,"14,345",1 out of 5,2008-07-01,Evidence at transcript level
Q8N6K4,YP021_HUMAN,Putative uncharacterized protein MGC34800,173,"17,423",1 out of 5,2008-04-08,Evidence at transcript level
A8MWP6,YQ019_HUMAN,Uncharacterized protein ENSP00000382042,167,"18,109",1 out of 5,2008-04-29,Evidence at transcript level
Q6ZPA2,YS039_HUMAN,Putative uncharacterized protein FLJ26174,131,"13,472",1 out of 5,2008-05-20,Evidence at transcript level
Q96M85,YV008_HUMAN,Putative uncharacterized protein FLJ32756,177,"19,601",1 out of 5,2006-10-31,Evidence at transcript level
Q75L30,YG027_HUMAN,Putative uncharacterized protein FLJ92257,129,"13,422",1 out of 5,2008-04-29,Uncertain
Q71RG6,YH006_HUMAN,Putative chemokine-related protein FP248 (Protein N73),208,"21,376",2 out of 5,2008-04-29,Uncertain
Q9GZM5,YIPF3_HUMAN,"Protein YIPF3 (Killer lineage protein 1) (Natural killer cell-specific antigen KLIP1) (YIP1 family member 3) [Cleaved into: Protein YIPF3, 36 kDa form III]",350,"38,248",5 out of 5,2006-06-27,Evidence at protein level
Q8NDZ9,YJ017_HUMAN,Putative uncharacterized protein LOC439951,215,"22,305",1 out of 5,2008-09-02,Uncertain
Q6AWC8,YK026_HUMAN,Putative uncharacterized protein LOC100129027,147,"16,804",1 out of 5,2008-06-10,Uncertain
Q9H521,YM006_HUMAN,Putative uncharacterized protein LOC645739,79,"9,322",1 out of 5,2008-02-26,Uncertain
Q6ZSR6,YP007_HUMAN,Putative uncharacterized protein FLJ45256,202,"22,955",1 out of 5,2008-02-26,Evidence at transcript level
Q1RN00,YC018_HUMAN,Putative uncharacterized protein LOC151760,199,"22,217",1 out of 5,2008-05-20,Evidence at transcript level
Q0VG73,YC023_HUMAN,Putative uncharacterized protein LOC152225,95,"10,763",1 out of 5,2008-06-10,Uncertain
Q9H8V8,YD018_HUMAN,Putative uncharacterized protein FLJ13197,135,"14,815",1 out of 5,2008-05-20,Uncertain
A8MVM7,YD021_HUMAN,Putative uncharacterized protein ENSP00000382790,634,"73,452",1 out of 5,2008-06-10,Uncertain
Q6ZQT0,YD023_HUMAN,Putative uncharacterized protein FLJ45035,140,"15,498",1 out of 5,2008-07-01,Uncertain
A4D1N5,YG018_HUMAN,Putative uncharacterized protein FLJ40288,150,"16,741",1 out of 5,2008-03-18,Evidence at transcript level
Q6ZSN1,YI023_HUMAN,Putative uncharacterized protein FLJ45355,163,"16,659",1 out of 5,2008-05-20,Evidence at transcript level
Q6UXQ8,YO002_HUMAN,Putative uncharacterized protein UNQ6190/PRO20217,127,"13,410",1 out of 5,2008-02-05,Uncertain
Q8N1Y9,YI025_HUMAN,Putative uncharacterized protein FLJ37218,231,"24,915",2 out of 5,2008-06-10,Uncertain
Q9BWQ6,YIPF2_HUMAN,Protein YIPF2 (YIP1 family member 2),316,"35,151",3 out of 5,2006-06-27,Evidence at protein level
Q969M3,YIPF5_HUMAN,Protein YIPF5 (Five-pass transmembrane protein localizing in the Golgi apparatus and the endoplasmic reticulum 5) (Smooth muscle cell-associated protein 5) (SMAP-5) (YIP1 family member 5) (YPT-interacting protein 1 A),257,"27,989",5 out of 5,2006-05-16,Evidence at protein level
Q96EC8,YIPF6_HUMAN,Protein YIPF6 (YIP1 family member 6),236,"26,256",4 out of 5,2006-06-27,Evidence at protein level
Q6ZRN7,YP029_HUMAN,Putative uncharacterized protein FLJ46214,208,"21,161",1 out of 5,2008-05-20,Evidence at transcript level
A8MXK9,YQ018_HUMAN,Uncharacterized protein ENSP00000382033,166,"18,008",1 out of 5,2008-04-29,Evidence at transcript level
Q6ZS49,YQ050_HUMAN,Putative uncharacterized protein FLJ45831,121,"13,061",1 out of 5,2008-09-02,Uncertain
Q6ZWC4,YS043_HUMAN,Putative uncharacterized protein LOC100128429,215,"22,988",1 out of 5,2008-05-20,Uncertain
Q9Y5A9,YTHD2_HUMAN,YTH domain-containing family protein 2 (CLL-associated antigen KW-14) (High-glucose-regulated protein 8) (Renal carcinoma antigen NY-REN-2),579,"62,334",5 out of 5,2003-02-12,Evidence at protein level
Q6ZR03,YU004_HUMAN,Uncharacterized protein FLJ46757,302,"31,336",1 out of 5,2008-06-10,Evidence at transcript level
Q6UXV3,YV010_HUMAN,Uncharacterized protein UNQ6126/PRO20091,157,"16,883",1 out of 5,2006-10-17,Evidence at transcript level
Q8NB15,ZN511_HUMAN,Zinc finger protein 511,262,"29,428",3 out of 5,2005-11-08,Evidence at protein level
Q6ZMY9,ZN517_HUMAN,Zinc finger protein 517,492,"54,711",3 out of 5,2005-11-22,Evidence at transcript level
Q8N782,ZN525_HUMAN,Zinc finger protein 525,197,"23,070",3 out of 5,2005-12-06,Evidence at transcript level
Q8NB42,ZN527_HUMAN,Zinc finger protein 527,609,"70,902",3 out of 5,2005-12-06,Evidence at transcript level
Q9HCE3,ZN532_HUMAN,Zinc finger protein 532,1301,"141,696",3 out of 5,2007-09-11,Evidence at protein level
Q5EBM4,ZN542_HUMAN,Putative zinc finger protein 542 (Zinc finger protein 542 pseudogene),170,"19,729",3 out of 5,2006-05-16,Uncertain
Q8IVP9,ZN547_HUMAN,Zinc finger protein 547,402,"45,956",3 out of 5,2005-11-22,Evidence at transcript level
Q7Z340,ZN551_HUMAN,Zinc finger protein 551 (Zinc finger protein KOX23),670,"77,515",4 out of 5,2005-07-19,Evidence at protein level
Q9BR84,ZN559_HUMAN,Zinc finger protein 559,538,"62,318",4 out of 5,2005-12-06,Evidence at protein level
Q7Z3V5,ZN571_HUMAN,Zinc finger protein 571,609,"70,792",3 out of 5,2005-12-06,Evidence at transcript level
Q7Z3I7,ZN572_HUMAN,Zinc finger protein 572,529,"61,238",5 out of 5,2006-10-03,Evidence at protein level
Q96N58,ZN578_HUMAN,Zinc finger protein 578,590,"68,531",3 out of 5,2004-09-27,Evidence at transcript level
Q96NG8,ZN582_HUMAN,Zinc finger protein 582,517,"60,498",3 out of 5,2006-05-16,Evidence at transcript level
Q96SQ5,ZN587_HUMAN,Zinc finger protein 587,575,"65,622",5 out of 5,2006-05-02,Evidence at protein level
O00488,ZN593_HUMAN,Zinc finger protein 593 (Zinc finger protein T86),134,"15,199",5 out of 5,2002-03-27,Evidence at protein level
Q96NL3,ZN599_HUMAN,Zinc finger protein 599,588,"67,492",4 out of 5,2006-05-16,Evidence at protein level
Q8WXB4,ZN606_HUMAN,Zinc finger protein 606 (Zinc finger protein 328),792,"91,812",4 out of 5,2003-02-28,Evidence at transcript level
Q68DY1,ZN626_HUMAN,Zinc finger protein 626,528,"60,893",4 out of 5,2007-01-09,Evidence at transcript level
Q9UID6,ZN639_HUMAN,Zinc finger protein 639 (Zinc finger protein ANC_2H01) (Zinc finger protein ZASC1),485,"56,054",5 out of 5,2004-08-16,Evidence at protein level
Q8N3J9,ZN664_HUMAN,Zinc finger protein 664 (Zinc finger protein 176) (Zinc finger protein from organ of Corti),261,"30,284",3 out of 5,2007-07-24,Evidence at transcript level
Q96BR6,ZN669_HUMAN,Zinc finger protein 669,464,"52,597",3 out of 5,2006-05-02,Evidence at transcript level
Q8TD23,ZN675_HUMAN,Zinc finger protein 675 (TRAF6-binding zinc finger protein) (TRAF6-inhibitory zinc finger protein),568,"66,299",5 out of 5,2007-09-11,Evidence at protein level
Q96CS4,ZN689_HUMAN,Zinc finger protein 689,500,"56,907",3 out of 5,2006-05-02,Evidence at transcript level
Q9H7X3,ZN696_HUMAN,Zinc finger protein 696,374,"40,575",3 out of 5,2006-05-02,Evidence at transcript level
Q9H0M5,ZN700_HUMAN,Zinc finger protein 700,742,"86,232",3 out of 5,2006-05-02,Evidence at transcript level
Q9Y5V0,ZN706_HUMAN,Zinc finger protein 706,76,"8,498",2 out of 5,2005-10-25,Evidence at protein level
Q9Y462,ZN711_HUMAN,Zinc finger protein 711 (Zinc finger protein 6),761,"86,245",5 out of 5,2002-09-19,Evidence at protein level
Q32MQ0,ZN750_HUMAN,Zinc finger protein 750,723,"77,361",5 out of 5,2006-07-25,Evidence at protein level
Q7L2R6,ZN765_HUMAN,Zinc finger protein 765,523,"61,633",3 out of 5,2008-07-22,Evidence at protein level
Q6IQ21,ZN770_HUMAN,Zinc finger protein 770,691,"80,007",3 out of 5,2007-03-20,Evidence at transcript level
Q6PK81,ZN773_HUMAN,Zinc finger protein 773 (Zinc finger protein 419B),442,"50,502",3 out of 5,2007-05-01,Evidence at transcript level
Q6ZMW2,ZN782_HUMAN,Zinc finger protein 782,699,"80,904",3 out of 5,2006-12-12,Evidence at transcript level
Q8N393,ZN786_HUMAN,Zinc finger protein 786,782,"89,815",3 out of 5,2007-07-10,Evidence at transcript level
P0C7X5,ZN806_HUMAN,Zinc finger protein 806,589,"67,808",4 out of 5,2008-07-22,Inferred from homology
Q0VGE8,ZN816_HUMAN,Zinc finger protein 816,651,"75,725",3 out of 5,2007-07-10,Evidence at transcript level
Q9Y2P0,ZN835_HUMAN,Zinc finger protein 835,537,"59,631",3 out of 5,2008-02-26,Evidence at transcript level
Q6ZN19,ZN841_HUMAN,Zinc finger protein 841,808,"93,148",3 out of 5,2008-05-20,Evidence at transcript level
Q6ZMS4,ZN852_HUMAN,Zinc finger protein 852,543,"62,084",3 out of 5,2008-04-29,Evidence at protein level
O60290,ZN862_HUMAN,Zinc finger protein 862,1169,"131,654",3 out of 5,2008-02-26,Evidence at transcript level
P21506,ZNF10_HUMAN,Zinc finger protein 10 (Zinc finger protein KOX1),573,"66,455",4 out of 5,1991-05-01,Evidence at protein level
P17017,ZNF14_HUMAN,Zinc finger protein 14 (Gonadotropin-inducible ovary transcription repressor 4) (GIOT-4) (Zinc finger protein KOX6),642,"75,353",3 out of 5,1990-08-01,Evidence at transcript level
P17020,ZNF16_HUMAN,Zinc finger protein 16 (Zinc finger protein KOX9),682,"76,472",5 out of 5,1990-08-01,Evidence at protein level
P51814,ZNF41_HUMAN,Zinc finger protein 41,821,"93,728",5 out of 5,1996-10-01,Evidence at protein level
Q9UF83,YM012_HUMAN,Uncharacterized protein DKFZp434B061,564,"59,412",1 out of 5,2008-04-29,Evidence at transcript level
Q96TA2,YMEL1_HUMAN,ATP-dependent zinc metalloprotease YME1L1 (EC 3.4.24.-) (ATP-dependent metalloprotease FtsH1) (Meg-4) (Presenilin-associated metalloprotease) (PAMP) (YME1-like protein 1),773,"86,455",5 out of 5,2004-04-13,Evidence at protein level
Q6ZR54,YN009_HUMAN,Putative uncharacterized protein FLJ46641,194,"19,406",1 out of 5,2008-05-20,Uncertain
Q6ZTC4,YT009_HUMAN,Putative uncharacterized protein FLJ44790,211,"22,100",1 out of 5,2008-05-20,Evidence at transcript level
Q96MU7,YTDC1_HUMAN,YTH domain-containing protein 1 (Splicing factor YT521) (YT521-B),727,"84,700",5 out of 5,2003-02-12,Evidence at protein level
A8MWV9,YU007_HUMAN,Putative uncharacterized protein LOC388820,139,"15,007",1 out of 5,2008-09-02,Uncertain
Q9H869,YYAP1_HUMAN,YY1-associated protein 1 (Hepatocellular carcinoma susceptibility protein) (Hepatocellular carcinoma-associated protein 2),796,"87,944",5 out of 5,2005-12-20,Evidence at protein level
Q9HBT8,Z286A_HUMAN,Zinc finger protein 286A,521,"60,175",4 out of 5,2002-01-23,Evidence at protein level
Q86Y25,Z354C_HUMAN,"Zinc finger protein 354C (Kidney, ischemia, and developmentally-regulated protein 3) (hKID3)",554,"64,847",4 out of 5,2007-03-20,Evidence at transcript level
Q96KM6,Z512B_HUMAN,Zinc finger protein 512B,892,"97,264",4 out of 5,2002-10-10,Evidence at protein level
Q6P3V2,Z585A_HUMAN,Zinc finger protein 585A,769,"87,974",3 out of 5,2005-10-25,Evidence at transcript level
Q4V348,Z658B_HUMAN,Zinc finger protein 658B,819,"94,331",2 out of 5,2007-03-20,Evidence at transcript level
A8MUZ8,Z705G_HUMAN,Putative zinc finger protein 705G,300,"34,765",2 out of 5,2008-07-01,Evidence at transcript level
A4D1E1,Z804B_HUMAN,Zinc finger protein 804B,1349,"152,573",2 out of 5,2007-05-29,Evidence at transcript level
Q9HC78,ZBT20_HUMAN,Zinc finger and BTB domain-containing protein 20 (Dendritic-derived BTB/POZ zinc finger protein) (Zinc finger protein 288),741,"81,083",5 out of 5,2001-09-26,Evidence at protein level
Q6ZSB9,ZBT49_HUMAN,Zinc finger and BTB domain-containing protein 49 (Zinc finger protein 509),765,"85,061",5 out of 5,2005-11-22,Evidence at protein level
Q8N966,ZDH22_HUMAN,Palmitoyltransferase ZDHHC22 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 22) (DHHC-22) (zDHHC22),263,"29,100",4 out of 5,2005-11-22,Evidence at protein level
Q9NXF8,ZDHC7_HUMAN,Palmitoyltransferase ZDHHC7 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 7) (DHHC-7),308,"35,140",5 out of 5,2003-02-01,Evidence at protein level
Q9ULC8,ZDHC8_HUMAN,Probable palmitoyltransferase ZDHHC8 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 8) (DHHC-8) (Zinc finger protein 378),765,"81,443",5 out of 5,2003-02-01,Evidence at protein level
Q6FIF0,ZFAN6_HUMAN,AN1-type zinc finger protein 6 (Associated with PRK1 protein) (Zinc finger A20 domain-containing protein 3),208,"22,555",5 out of 5,2006-07-11,Evidence at protein level
Q6P2D0,ZFP1_HUMAN,Zinc finger protein 1 homolog (Zfp-1) (Zinc finger protein 475),407,"47,516",4 out of 5,2005-02-01,Evidence at protein level
Q9Y6Q3,ZFP37_HUMAN,Zinc finger protein 37 homolog (Zfp-37),630,"71,209",4 out of 5,2000-12-01,Evidence at transcript level
Q8NB50,ZFP62_HUMAN,Zinc finger protein 62 homolog (Zfp-62),900,"102,511",3 out of 5,2004-04-26,Evidence at protein level
Q9HBF4,ZFYV1_HUMAN,Zinc finger FYVE domain-containing protein 1 (Double FYVE-containing protein 1) (SR3) (Tandem FYVE fingers-1),777,"87,176",5 out of 5,2003-08-15,Evidence at protein level
O95405,ZFYV9_HUMAN,Zinc finger FYVE domain-containing protein 9 (Mothers against decapentaplegic homolog-interacting protein) (Madh-interacting protein) (Novel serine protease) (NSP) (Receptor activation anchor) (hSARA) (Smad anchor for receptor activation),1425,"156,403",5 out of 5,2001-08-14,Evidence at protein level
Q9H4I2,ZHX3_HUMAN,Zinc fingers and homeoboxes protein 3 (Triple homeobox protein 1) (Zinc finger and homeodomain protein 3),956,"104,658",5 out of 5,2002-10-10,Evidence at protein level
Q9P0L1,ZKSC7_HUMAN,Zinc finger protein with KRAB and SCAN domains 7 (Zinc finger protein 167) (Zinc finger protein 448) (Zinc finger protein 64),754,"85,033",5 out of 5,2004-11-23,Evidence at protein level
Q9H091,ZMY15_HUMAN,Zinc finger MYND domain-containing protein 15,742,"81,860",3 out of 5,2003-05-16,Evidence at transcript level
Q9UJ78,ZMYM5_HUMAN,Zinc finger MYM-type protein 5 (Zinc finger protein 198-like 1) (Zinc finger protein 237),669,"74,817",5 out of 5,2004-08-31,Evidence at protein level
Q8NC26,ZN114_HUMAN,Zinc finger protein 114,417,"47,747",4 out of 5,2007-05-01,Evidence at protein level
Q15973,ZN124_HUMAN,Zinc finger protein 124 (Zinc finger protein HZF-16),351,"40,217",5 out of 5,1997-11-01,Evidence at protein level
P52743,ZN137_HUMAN,Putative zinc finger protein 137 (Zinc finger protein 137 pseudogene),207,"24,115",3 out of 5,1996-10-01,Uncertain
Q9UJW8,ZN180_HUMAN,Zinc finger protein 180 (HHZ168),692,"79,111",4 out of 5,2002-02-11,Evidence at protein level
O95201,ZN205_HUMAN,Zinc finger protein 205 (Zinc finger protein 210),554,"60,630",5 out of 5,1999-07-15,Evidence at protein level
O43345,ZN208_HUMAN,Zinc finger protein 208 (Zinc finger protein 91-like),1280,"147,487",4 out of 5,2001-01-24,Evidence at transcript level
Q9UL59,ZN214_HUMAN,Zinc finger protein 214 (BWSCR2-associated zinc finger protein 1) (BAZ-1),606,"70,992",3 out of 5,2000-12-01,Evidence at transcript level
Q9NZL3,ZN224_HUMAN,Zinc finger protein 224 (Bone marrow zinc finger 2) (BMZF-2) (Zinc finger protein 233) (Zinc finger protein 255) (Zinc finger protein 27) (Zinc finger protein KOX22),707,"82,280",5 out of 5,2000-12-08,Evidence at protein level
Q9UJW7,ZN229_HUMAN,Zinc finger protein 229,825,"93,707",4 out of 5,2000-12-01,Evidence at transcript level
Q9NSD4,ZN275_HUMAN,Zinc finger protein 275,429,"48,443",3 out of 5,2001-09-26,Evidence at protein level
Q9UDV7,ZN282_HUMAN,Zinc finger protein 282 (HTLV-I U5RE-binding protein 1) (HUB-1),671,"74,295",4 out of 5,2001-01-24,Evidence at protein level
Q5JNZ3,ZN311_HUMAN,Zinc finger protein 311 (Zinc finger protein zfp-31),666,"76,322",3 out of 5,2007-04-03,Evidence at transcript level
Q9P2F9,ZN319_HUMAN,Zinc finger protein 319,582,"65,547",3 out of 5,2002-11-15,Evidence at protein level
Q8TF32,ZN431_HUMAN,Zinc finger protein 431,576,"67,217",3 out of 5,2003-04-23,Evidence at transcript level
Q8IYI8,ZN440_HUMAN,Zinc finger protein 440,595,"69,106",4 out of 5,2003-05-09,Evidence at protein level
Q9Y2A4,ZN443_HUMAN,Zinc finger protein 443 (Krueppel-type zinc finger protein ZK1),671,"77,516",4 out of 5,2003-05-09,Evidence at transcript level
Q14592,ZN460_HUMAN,Zinc finger protein 460 (Zinc finger protein 272) (Zinc finger protein HZF8),562,"63,665",4 out of 5,2000-12-01,Evidence at protein level
Q5VIY5,ZN468_HUMAN,Zinc finger protein 468,522,"60,573",3 out of 5,2007-03-20,Evidence at transcript level
Q9BX82,ZN471_HUMAN,Zinc finger protein 471 (EZFIT-related protein 1),626,"73,009",4 out of 5,2003-10-24,Evidence at transcript level
Q8TF39,ZN483_HUMAN,Zinc finger protein 483 (Zinc finger protein with KRAB and SCAN domains 16),744,"85,098",4 out of 5,2003-04-11,Evidence at protein level
Q96MN9,ZN488_HUMAN,Zinc finger protein 488,340,"36,962",5 out of 5,2005-07-05,Evidence at protein level
Q6ZNH5,ZN497_HUMAN,Zinc finger protein 497,498,"54,721",3 out of 5,2005-11-22,Evidence at protein level
A6NJY4,YQ041_HUMAN,Putative transmembrane protein LOC100289255,79,"8,713",1 out of 5,2008-07-22,Uncertain
Q6ZT83,YR005_HUMAN,Uncharacterized protein FLJ44881,130,"14,355",1 out of 5,2008-06-10,Evidence at transcript level
Q6UXR8,YS001_HUMAN,Putative uncharacterized protein UNQ6493/PRO21345,122,"12,794",1 out of 5,2008-02-05,Uncertain
Q6ZVQ6,YS045_HUMAN,Putative uncharacterized protein FLJ42213,151,"17,006",1 out of 5,2008-06-10,Evidence at transcript level
Q9UFB7,ZBT47_HUMAN,Zinc finger and BTB domain-containing protein 47 (Zinc finger protein 651),747,"82,760",4 out of 5,2006-10-03,Evidence at transcript level
O15156,ZBT7B_HUMAN,Zinc finger and BTB domain-containing protein 7B (Krueppel-related zinc finger protein cKrox) (hcKrox) (T-helper-inducing POZ/Krueppel-like factor) (Zinc finger and BTB domain-containing protein 15) (Zinc finger protein 67 homolog) (Zfp-67) (Zinc finger protein 857B) (Zinc finger protein Th-POK),539,"58,027",5 out of 5,2004-08-16,Evidence at protein level
Q9H5J0,ZBTB3_HUMAN,Zinc finger and BTB domain-containing protein 3,574,"61,827",3 out of 5,2003-08-04,Evidence at protein level
Q9H8X9,ZDH11_HUMAN,Probable palmitoyltransferase ZDHHC11 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11) (DHHC-11) (Zinc finger protein 399),412,"45,975",3 out of 5,2003-02-01,Evidence at transcript level
Q5W0Z9,ZDH20_HUMAN,Probable palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 20) (DHHC-20),365,"42,278",4 out of 5,2005-11-22,Evidence at protein level
P15822,ZEP1_HUMAN,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),2718,"296,865",5 out of 5,1990-04-01,Evidence at protein level
Q86XD8,ZFAN4_HUMAN,AN1-type zinc finger protein 4 (AN1-type zinc finger and ubiquitin domain-containing protein-like 1),727,"80,358",2 out of 5,2007-01-09,Evidence at transcript level
Q9C0A1,ZFHX2_HUMAN,Zinc finger homeobox protein 2 (Zinc finger homeodomain protein 2) (ZFH-2),2572,"274,176",4 out of 5,2003-02-12,Evidence at transcript level
Q8N6M9,ZFN2A_HUMAN,AN1-type zinc finger protein 2A,145,"16,477",2 out of 5,2007-01-09,Evidence at transcript level
Q9HCL3,ZFP14_HUMAN,Zinc finger protein 14 homolog (Zfp-14) (Zinc finger protein 531),533,"63,463",3 out of 5,2002-02-21,Evidence at transcript level
Q96NJ6,ZFP3_HUMAN,Zinc finger protein 3 homolog (Zfp-3) (Zinc finger protein 752),502,"57,662",3 out of 5,2006-05-02,Evidence at transcript level
Q8TF47,ZFP90_HUMAN,Zinc finger protein 90 homolog (Zfp-90) (Zinc finger protein 756),636,"73,031",5 out of 5,2003-11-28,Evidence at protein level
Q96DA0,ZG16B_HUMAN,Zymogen granule protein 16 homolog B,208,"22,739",3 out of 5,2006-09-05,Evidence at protein level
Q86YA3,ZGRF1_HUMAN,Protein ZGRF1 (GRF-type zinc finger domain-containing protein 1),2104,"236,602",4 out of 5,2007-05-15,Evidence at protein level
Q96NC0,ZMAT2_HUMAN,Zinc finger matrin-type protein 2,199,"23,612",5 out of 5,2004-09-27,Evidence at protein level
Q15326,ZMY11_HUMAN,Zinc finger MYND domain-containing protein 11 (Adenovirus 5 E1A-binding protein) (Bone morphogenetic protein receptor-associated molecule 1) (Protein BS69),602,"70,963",5 out of 5,2000-12-01,Evidence at protein level
Q14202,ZMYM3_HUMAN,Zinc finger MYM-type protein 3 (Zinc finger protein 261),1370,"152,379",5 out of 5,1997-11-01,Evidence at protein level
P52738,ZN140_HUMAN,Zinc finger protein 140,457,"52,996",3 out of 5,1996-10-01,Evidence at transcript level
Q12901,ZN155_HUMAN,Zinc finger protein 155,538,"62,081",4 out of 5,1997-11-01,Evidence at protein level
Q14929,ZN169_HUMAN,Zinc finger protein 169,603,"68,488",4 out of 5,1998-12-15,Evidence at protein level
P98182,ZN200_HUMAN,Zinc finger protein 200,395,"45,534",3 out of 5,2000-05-30,Evidence at transcript level
Q13398,ZN211_HUMAN,Zinc finger protein 211 (Zinc finger protein C2H2-25),564,"64,535",4 out of 5,2000-05-30,Evidence at transcript level
Q6P1L6,ZN343_HUMAN,Zinc finger protein 343,599,"69,220",3 out of 5,2005-11-08,Evidence at protein level
Q8N895,ZN366_HUMAN,Zinc finger protein 366,744,"85,107",5 out of 5,2003-02-12,Evidence at protein level
Q96SR6,ZN382_HUMAN,Zinc finger protein 382 (KRAB/zinc finger suppressor protein 1) (KS1) (Multiple zinc finger and krueppel-associated box protein KS1),550,"64,010",4 out of 5,2003-02-28,Evidence at transcript level
Q8TF68,ZN384_HUMAN,Zinc finger protein 384 (CAG repeat protein 1) (CAS-interacting zinc finger protein) (Nuclear matrix transcription factor 4) (Nuclear matrix protein 4) (Trinucleotide repeat-containing gene 1 protein),577,"63,219",4 out of 5,2003-02-28,Evidence at protein level
Q96IQ9,ZN414_HUMAN,Zinc finger protein 414,312,"32,782",3 out of 5,2006-06-27,Evidence at protein level
Q8TAQ5,ZN420_HUMAN,Zinc finger protein 420,688,"80,247",4 out of 5,2005-07-19,Evidence at protein level
Q6IV72,ZN425_HUMAN,Zinc finger protein 425,752,"87,721",4 out of 5,2006-05-16,Evidence at protein level
Q7Z7K2,ZN467_HUMAN,Zinc finger protein 467,595,"65,124",2 out of 5,2006-07-25,Evidence at transcript level
Q8N8J6,ZN615_HUMAN,Zinc finger protein 615,731,"83,739",4 out of 5,2004-11-23,Evidence at transcript level
Q969S3,ZN622_HUMAN,Zinc finger protein 622 (Zinc finger-like protein 9),477,"54,272",5 out of 5,2004-07-19,Evidence at protein level
Q5EBL2,ZN628_HUMAN,Zinc finger protein 628,1059,"110,887",3 out of 5,2006-07-11,Evidence at protein level
Q9BS31,ZN649_HUMAN,Zinc finger protein 649,505,"57,683",4 out of 5,2006-10-03,Evidence at protein level
O95780,ZN682_HUMAN,Zinc finger protein 682,498,"58,361",4 out of 5,2006-05-02,Evidence at transcript level
P17019,ZN708_HUMAN,Zinc finger protein 708 (Zinc finger protein 15) (Zinc finger protein 15-like 1) (Zinc finger protein KOX8),499,"57,357",4 out of 5,1990-08-01,Evidence at protein level
A8K554,ZN815_HUMAN,Putative protein ZNF815,130,"15,437",1 out of 5,2008-07-01,Uncertain
Q02386,ZNF45_HUMAN,Zinc finger protein 45 (BRC1744) (Zinc finger protein 13) (Zinc finger protein KOX5),682,"78,242",4 out of 5,1993-10-01,Evidence at transcript level
Q9UC07,ZNF69_HUMAN,Zinc finger protein 69 (hZNF3),566,"65,761",4 out of 5,2002-09-19,Evidence at protein level
P36508,ZNF76_HUMAN,Zinc finger protein 76 (Zinc finger protein 523),570,"61,831",5 out of 5,1994-06-01,Evidence at protein level
Q07157,ZO1_HUMAN,Tight junction protein ZO-1 (Tight junction protein 1) (Zona occludens protein 1) (Zonula occludens protein 1),1748,"195,459",5 out of 5,1994-10-01,Evidence at protein level
Q9UDY2,ZO2_HUMAN,Tight junction protein ZO-2 (Tight junction protein 2) (Zona occludens protein 2) (Zonula occludens protein 2),1190,"133,958",5 out of 5,2001-04-27,Evidence at protein level
Q9H7M6,ZSWM4_HUMAN,Zinc finger SWIM domain-containing protein 4,989,"110,138",2 out of 5,2004-01-16,Evidence at transcript level
O43149,ZZEF1_HUMAN,Zinc finger ZZ-type and EF-hand domain-containing protein 1,2961,"331,075",5 out of 5,2007-05-29,Evidence at protein level
A6NP61,ZAR1L_HUMAN,ZAR1-like protein,321,"36,010",1 out of 5,2008-04-29,Evidence at transcript level
O43167,ZBT24_HUMAN,Zinc finger and BTB domain-containing protein 24 (Zinc finger protein 450),697,"78,282",5 out of 5,2000-05-30,Evidence at protein level
Q9Y2Y4,ZBT32_HUMAN,Zinc finger and BTB domain-containing protein 32 (FANCC-interacting protein) (Fanconi anemia zinc finger protein) (Testis zinc finger protein) (Zinc finger protein 538),487,"52,963",5 out of 5,2007-01-23,Evidence at protein level
Q5SVQ8,ZBT41_HUMAN,Zinc finger and BTB domain-containing protein 41,909,"105,192",3 out of 5,2007-02-20,Evidence at protein level
Q8NAP8,ZBT8B_HUMAN,Zinc finger and BTB domain-containing protein 8B,495,"54,175",3 out of 5,2004-04-26,Evidence at transcript level
Q8N680,ZBTB2_HUMAN,Zinc finger and BTB domain-containing protein 2,514,"57,337",3 out of 5,2003-04-30,Evidence at protein level
O15062,ZBTB5_HUMAN,Zinc finger and BTB domain-containing protein 5,677,"74,278",4 out of 5,2004-04-26,Evidence at protein level
A2A288,ZC12D_HUMAN,Probable ribonuclease ZC3H12D (EC 3.1.-.-) (MCP-induced protein 4) (Transformed follicular lymphoma) (Zinc finger CCCH domain-containing protein 12D) (p34),527,"58,078",5 out of 5,2008-09-02,Evidence at protein level
Q8WYQ9,ZCH14_HUMAN,Zinc finger CCHC domain-containing protein 14 (BDG-29),949,"100,042",3 out of 5,2005-06-07,Evidence at transcript level
Q8N2G6,ZCH24_HUMAN,Zinc finger CCHC domain-containing protein 24,241,"26,955",2 out of 5,2007-02-06,Evidence at protein level
Q504Y3,ZCPW2_HUMAN,Zinc finger CW-type PWWP domain protein 2,356,"41,376",2 out of 5,2007-05-01,Evidence at protein level
Q8IVQ6,ZDH21_HUMAN,Palmitoyltransferase ZDHHC21 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 21) (DHHC-21),265,"31,385",5 out of 5,2003-10-24,Evidence at transcript level
Q8WTX9,ZDHC1_HUMAN,Probable palmitoyltransferase ZDHHC1 (EC 2.3.1.225) (DHHC domain-containing cysteine-rich protein 1) (Zinc finger DHHC domain-containing protein 1) (DHHC-1) (Zinc finger protein 377),485,"54,818",4 out of 5,2003-02-01,Evidence at transcript level
Q9UIJ5,ZDHC2_HUMAN,Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372),367,"42,022",5 out of 5,2003-02-01,Evidence at protein level
Q9NPG8,ZDHC4_HUMAN,Probable palmitoyltransferase ZDHHC4 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 4) (DHHC-4) (Zinc finger protein 374),344,"39,787",3 out of 5,2003-02-01,Evidence at transcript level
Q9Y397,ZDHC9_HUMAN,Palmitoyltransferase ZDHHC9 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 9) (DHHC-9) (DHHC9) (Zinc finger protein 379) (Zinc finger protein 380),364,"40,916",5 out of 5,2003-02-01,Evidence at protein level
P31629,ZEP2_HUMAN,Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2),2446,"269,053",5 out of 5,1993-07-01,Evidence at protein level
Q96MM3,ZFP42_HUMAN,Zinc finger protein 42 homolog (Zfp-42) (Reduced expression protein 1) (REX-1) (hREX-1) (Zinc finger protein 754),310,"34,802",4 out of 5,2007-05-15,Evidence at protein level
O95159,ZFPL1_HUMAN,Zinc finger protein-like 1 (Zinc finger protein MCG4),310,"34,114",5 out of 5,2004-07-05,Evidence at protein level
P17010,ZFX_HUMAN,Zinc finger X-chromosomal protein,805,"90,522",4 out of 5,1990-08-01,Evidence at transcript level
Q5T4F4,ZFY27_HUMAN,Protrudin (Spastic paraplegia 33 protein) (Zinc finger FYVE domain-containing protein 27),411,"45,843",5 out of 5,2006-07-11,Evidence at protein level
Q8N5A5,ZGPAT_HUMAN,Zinc finger CCCH-type with G patch domain-containing protein (G patch domain-containing protein 6) (Zinc finger CCCH domain-containing protein 9) (Zinc finger and G patch domain-containing protein),531,"57,359",5 out of 5,2003-07-11,Evidence at protein level
Q9NS37,ZHANG_HUMAN,CREB/ATF bZIP transcription factor (Host cell factor-binding transcription factor Zhangfei) (HCF-binding transcription factor Zhangfei),354,"37,134",5 out of 5,2005-04-12,Evidence at protein level
Q9Y6X8,ZHX2_HUMAN,Zinc fingers and homeoboxes protein 2 (Alpha-fetoprotein regulator 1) (AFP regulator 1) (Regulator of AFP) (Zinc finger and homeodomain protein 2),837,"92,307",5 out of 5,2004-03-01,Evidence at protein level
Q5H9K5,ZMAT1_HUMAN,Zinc finger matrin-type protein 1,638,"74,755",3 out of 5,2007-11-13,Evidence at transcript level
O75800,ZMY10_HUMAN,Zinc finger MYND domain-containing protein 10 (Protein BLu),440,"50,344",5 out of 5,2002-11-08,Evidence at protein level
O75362,ZN217_HUMAN,Zinc finger protein 217,1048,"115,272",5 out of 5,2001-01-24,Evidence at protein level
Q9NYT6,ZN226_HUMAN,Zinc finger protein 226,803,"91,921",3 out of 5,2001-01-24,Evidence at transcript level
A6NK53,ZN233_HUMAN,Zinc finger protein 233,670,"76,861",3 out of 5,2007-09-11,Evidence at transcript level
Q9UL36,ZN236_HUMAN,Zinc finger protein 236,1845,"203,704",4 out of 5,2000-12-01,Evidence at transcript level
Q9Y2Q1,ZN257_HUMAN,Zinc finger protein 257 (Bone marrow zinc finger 4) (BMZF-4),563,"65,779",3 out of 5,2001-01-24,Evidence at transcript level
Q14586,ZN267_HUMAN,Zinc finger protein 267 (Zinc finger protein HZF2),743,"87,376",3 out of 5,2000-12-01,Evidence at protein level
Q96GC6,ZN274_HUMAN,Neurotrophin receptor-interacting factor homolog (Zinc finger protein 274) (Zinc finger protein HFB101) (Zinc finger protein with KRAB and SCAN domains 19) (Zinc finger protein zfp2) (Zf2),653,"74,177",5 out of 5,2002-05-10,Evidence at protein level
Q2VY69,ZN284_HUMAN,Zinc finger protein 284,593,"69,019",3 out of 5,2007-03-20,Evidence at transcript level
Q9HBT7,ZN287_HUMAN,Zinc finger protein 287 (Zinc finger protein with KRAB and SCAN domains 13),754,"87,565",3 out of 5,2002-01-23,Evidence at transcript level
Q86UD4,ZN329_HUMAN,Zinc finger protein 329,541,"61,725",4 out of 5,2007-10-23,Evidence at protein level
Q53GI3,ZN394_HUMAN,Zinc finger protein 394 (Zinc finger protein with KRAB and SCAN domains 14),561,"64,256",4 out of 5,2005-11-08,Evidence at protein level
Q494X3,ZN404_HUMAN,Zinc finger protein 404,552,"65,425",3 out of 5,2007-10-02,Evidence at protein level
Q9H9D4,ZN408_HUMAN,Zinc finger protein 408 (PR domain zinc finger protein 17),720,"78,439",5 out of 5,2001-11-16,Evidence at protein level
Q8TF45,ZN418_HUMAN,Zinc finger protein 418,676,"77,858",3 out of 5,2002-09-19,Evidence at protein level
Q96JG9,ZN469_HUMAN,Zinc finger protein 469,3925,"410,202",5 out of 5,2003-10-24,Evidence at transcript level
Q8NCK3,ZN485_HUMAN,Zinc finger protein 485,441,"50,280",3 out of 5,2006-02-21,Evidence at transcript level
Q6ZR52,ZN493_HUMAN,Zinc finger protein 493,646,"75,342",3 out of 5,2005-10-11,Evidence at transcript level
Q96CX3,ZN501_HUMAN,Zinc finger protein 501 (Zinc finger protein 52),271,"31,179",3 out of 5,2004-04-26,Evidence at transcript level
Q96F45,ZN503_HUMAN,Zinc finger protein 503,646,"62,555",4 out of 5,2007-06-26,Evidence at protein level
Q96K75,ZN514_HUMAN,Zinc finger protein 514,400,"45,938",3 out of 5,2004-02-16,Evidence at transcript level
Q96K83,ZN521_HUMAN,Zinc finger protein 521 (Early hematopoietic zinc finger protein) (LYST-interacting protein 3),1311,"147,866",5 out of 5,2007-10-02,Evidence at protein level
Q6P280,ZN529_HUMAN,Zinc finger protein 529,563,"65,865",3 out of 5,2007-03-20,Evidence at transcript level
Q9H707,ZN552_HUMAN,Zinc finger protein 552,407,"46,198",3 out of 5,2007-05-15,Evidence at protein level
Q96NG5,ZN558_HUMAN,Zinc finger protein 558,402,"45,755",3 out of 5,2005-07-05,Evidence at transcript level
Q8N9K5,ZN565_HUMAN,Zinc finger protein 565,539,"62,445",3 out of 5,2005-12-06,Evidence at transcript level
Q86YE8,ZN573_HUMAN,Zinc finger protein 573,665,"78,181",4 out of 5,2007-02-06,Evidence at transcript level
Q6ZN55,ZN574_HUMAN,Zinc finger protein 574,896,"98,900",3 out of 5,2007-02-06,Evidence at protein level
Q9H609,ZN576_HUMAN,Zinc finger protein 576,170,"18,890",3 out of 5,2005-12-06,Evidence at protein level
Q9UK33,ZN580_HUMAN,Zinc finger protein 580 (LDL-induced EC protein),172,"18,756",5 out of 5,2004-11-23,Evidence at protein level
Q6ZSS3,ZN621_HUMAN,Zinc finger protein 621,439,"49,205",3 out of 5,2005-11-08,Evidence at transcript level
Q9P2J8,ZN624_HUMAN,Zinc finger protein 624,865,"99,929",4 out of 5,2002-01-23,Evidence at protein level
Q9UEG4,ZN629_HUMAN,Zinc finger protein 629 (Zinc finger protein 65),869,"96,620",3 out of 5,2007-03-20,Evidence at protein level
Q2M218,ZN630_HUMAN,Zinc finger protein 630,657,"76,094",3 out of 5,2006-05-16,Evidence at transcript level
Q9Y2D9,ZN652_HUMAN,Zinc finger protein 652,606,"69,744",4 out of 5,2007-03-20,Evidence at protein level
Q9H7R5,ZN665_HUMAN,Zinc finger protein 665 (Zinc finger protein 160-like),613,"70,223",3 out of 5,2008-03-18,Evidence at transcript level
Q5SXM1,ZN678_HUMAN,Zinc finger protein 678,525,"61,411",3 out of 5,2006-05-02,Evidence at transcript level
Q8IZ20,ZN683_HUMAN,Tissue-resident T-cell transcription regulator protein ZNF683 (Homolog of Blimp-1 in T-cell) (Hobit) (Zinc finger protein 683),524,"56,905",5 out of 5,2006-05-02,Evidence at protein level
Q6NUN9,ZN746_HUMAN,Zinc finger protein 746 (Parkin-interacting substrate) (PARIS),644,"69,136",5 out of 5,2006-10-17,Evidence at protein level
Q9H5H4,ZN768_HUMAN,Zinc finger protein 768,540,"60,229",3 out of 5,2007-09-11,Evidence at protein level
Q6ZMS7,ZN783_HUMAN,Protein ZNF783,281,"31,422",4 out of 5,2007-01-09,Evidence at protein level
Q6DD87,ZN787_HUMAN,Zinc finger protein 787 (TTF-I-interacting peptide 20),383,"40,543",3 out of 5,2007-05-15,Evidence at protein level
Q6ZN11,ZN793_HUMAN,Zinc finger protein 793,406,"46,927",3 out of 5,2007-07-10,Evidence at transcript level
O43830,ZNF73_HUMAN,Zinc finger protein 73 (Zinc finger protein 186) (hZNF2),326,"38,241",3 out of 5,1998-12-15,Inferred from homology
Q16587,ZNF74_HUMAN,Zinc finger protein 74 (Zinc finger protein 520) (hZNF7),644,"72,207",5 out of 5,1997-11-01,Evidence at transcript level
P51504,ZNF80_HUMAN,Zinc finger protein 80 (ZNFpT17),273,"31,224",3 out of 5,1996-10-01,Evidence at transcript level
P51522,ZNF83_HUMAN,Zinc finger protein 83 (Zinc finger protein 816B) (Zinc finger protein HPF1),516,"59,710",4 out of 5,1996-10-01,Evidence at transcript level
A6NK75,ZNF98_HUMAN,Zinc finger protein 98 (Zinc finger protein 739) (Zinc finger protein F7175),572,"65,799",3 out of 5,2008-02-05,Evidence at transcript level
Q9P2E3,ZNFX1_HUMAN,NFX1-type zinc finger-containing protein 1,1918,"220,227",3 out of 5,2002-10-10,Evidence at transcript level
Q9P217,ZSWM5_HUMAN,Zinc finger SWIM domain-containing protein 5,1185,"130,634",2 out of 5,2004-01-16,Evidence at transcript level
A7E2V4,ZSWM8_HUMAN,Zinc finger SWIM domain-containing protein 8,1837,"197,297",3 out of 5,2007-12-04,Evidence at protein level
Q15942,ZYX_HUMAN,Zyxin (Zyxin-2),572,"61,277",5 out of 5,1997-11-01,Evidence at protein level
Q8IYB0,YK038_HUMAN,Putative uncharacterized protein MGC39545,196,"21,182",1 out of 5,2008-07-01,Uncertain
A6NHS1,YK042_HUMAN,Putative uncharacterized protein ENSP00000347057,94,"10,211",1 out of 5,2008-07-01,Uncertain
O60688,YPEL1_HUMAN,Protein yippee-like 1,119,"13,575",2 out of 5,2003-01-17,Inferred from homology
Q96NS1,YPEL4_HUMAN,Protein yippee-like 4,127,"14,301",2 out of 5,2003-01-17,Evidence at transcript level
Q6ZRG5,YQ015_HUMAN,Putative uncharacterized protein FLJ43944,221,"24,122",1 out of 5,2008-04-29,Uncertain
A8MUN3,YQ048_HUMAN,Putative uncharacterized protein ENSP00000381830,132,"14,205",1 out of 5,2008-09-02,Uncertain
I3L1I5,YS060_HUMAN,Putative uncharacterized protein LOC100996504,382,"41,200",2 out of 5,2013-06-26,Uncertain
O60293,ZC3H1_HUMAN,Zinc finger C3H1 domain-containing protein (Coiled-coil domain-containing protein 131) (Proline/serine-rich coiled-coil protein 2),1989,"226,356",4 out of 5,2007-05-01,Evidence at protein level
Q96K80,ZC3HA_HUMAN,Zinc finger CCCH domain-containing protein 10,434,"46,052",3 out of 5,2007-03-20,Evidence at protein level
Q5T200,ZC3HD_HUMAN,Zinc finger CCCH domain-containing protein 13,1668,"196,635",5 out of 5,2005-06-21,Evidence at protein level
P0CG32,ZCC18_HUMAN,Zinc finger CCHC domain-containing protein 18,403,"45,160",2 out of 5,2010-07-13,Inferred from homology
Q8WW36,ZCH13_HUMAN,Zinc finger CCHC domain-containing protein 13,166,"18,005",2 out of 5,2005-05-10,Evidence at protein level
Q9C0B9,ZCHC2_HUMAN,Zinc finger CCHC domain-containing protein 2,1178,"125,936",3 out of 5,2003-08-22,Evidence at protein level
Q8N8U3,ZCHC5_HUMAN,Zinc finger CCHC domain-containing protein 5,475,"52,817",2 out of 5,2003-08-22,Evidence at transcript level
Q6NZY4,ZCHC8_HUMAN,Zinc finger CCHC domain-containing protein 8 (TRAMP-like complex RNA-binding factor ZCCHC8),707,"78,577",5 out of 5,2005-05-10,Evidence at protein level
Q8IUH4,ZDH13_HUMAN,Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Huntingtin-interacting protein 14-related protein) (HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13) (DHHC-13),622,"70,861",5 out of 5,2004-04-13,Evidence at protein level
Q9Y6M5,ZNT1_HUMAN,Zinc transporter 1 (ZnT-1) (Solute carrier family 30 member 1),507,"55,300",5 out of 5,2000-05-30,Evidence at protein level
O14863,ZNT4_HUMAN,Zinc transporter 4 (ZnT-4) (Solute carrier family 30 member 4),429,"47,483",5 out of 5,2000-05-30,Evidence at transcript level
Q8TAD4,ZNT5_HUMAN,Zinc transporter 5 (ZnT-5) (Solute carrier family 30 member 5) (ZnT-like transporter 1) (hZTL1),765,"84,047",5 out of 5,2008-01-15,Evidence at protein level
Q8IWU4,ZNT8_HUMAN,Zinc transporter 8 (ZnT-8) (Solute carrier family 30 member 8),369,"40,755",5 out of 5,2007-03-20,Evidence at protein level
O75312,ZPR1_HUMAN,Zinc finger protein ZPR1 (Zinc finger protein 259),459,"50,925",5 out of 5,1999-07-15,Evidence at protein level
Q6NSZ9,ZSC25_HUMAN,Zinc finger and SCAN domain-containing protein 25 (Zinc finger protein 498),544,"61,474",4 out of 5,2007-11-13,Evidence at protein level
O95229,ZWINT_HUMAN,ZW10 interactor (ZW10-interacting protein 1) (Zwint-1),277,"31,293",5 out of 5,2002-07-11,Evidence at protein level
Q2QGD7,ZXDC_HUMAN,Zinc finger protein ZXDC (ZXD-like zinc finger protein),858,"89,988",5 out of 5,2007-06-26,Evidence at protein level
Q5BKY6,YV018_HUMAN,Putative uncharacterized protein DKFZp434K191,102,"10,947",2 out of 5,2008-02-26,Evidence at protein level
P37275,ZEB1_HUMAN,Zinc finger E-box-binding homeobox 1 (NIL-2-A zinc finger protein) (Negative regulator of IL2) (Transcription factor 8) (TCF-8),1124,"124,074",5 out of 5,1994-10-01,Evidence at protein level
Q8TCF1,ZFAN1_HUMAN,AN1-type zinc finger protein 1,268,"30,787",2 out of 5,2005-08-16,Evidence at protein level
Q86UP3,ZFHX4_HUMAN,Zinc finger homeobox protein 4 (Zinc finger homeodomain protein 4) (ZFH-4),3567,"393,730",5 out of 5,2007-02-20,Evidence at protein level
Q8NHY6,ZFP28_HUMAN,Zinc finger protein 28 homolog (Zfp-28) (Krueppel-like zinc finger factor X6),868,"98,705",4 out of 5,2003-08-04,Evidence at protein level
Q6ZN57,ZFP2_HUMAN,Zinc finger protein 2 homolog (Zfp-2) (Zinc finger protein 751),461,"52,740",4 out of 5,2007-06-26,Evidence at protein level
Q9Y2G7,ZFP30_HUMAN,Zinc finger protein 30 homolog (Zfp-30) (Zinc finger protein 745),519,"61,558",3 out of 5,2000-05-30,Evidence at transcript level
Q49AA0,ZFP69_HUMAN,Zinc finger protein ZFP69 (Zinc finger protein 642),526,"61,181",3 out of 5,2006-10-03,Evidence at transcript level
A6NM28,ZFP92_HUMAN,Zinc finger protein 92 homolog (Zfp-92),416,"45,791",2 out of 5,2008-04-08,Evidence at transcript level
Q9BQ24,ZFY21_HUMAN,Zinc finger FYVE domain-containing protein 21 (ZF21),234,"26,506",5 out of 5,2005-05-24,Evidence at protein level
P08048,ZFY_HUMAN,Zinc finger Y-chromosomal protein,801,"90,505",4 out of 5,1988-08-01,Evidence at protein level
P0C6A0,ZGLP1_HUMAN,GATA-type zinc finger protein 1 (GATA-like protein 1) (GLP-1),271,"29,628",3 out of 5,2008-02-05,Evidence at transcript level
Q8N9L1,ZIC4_HUMAN,Zinc finger protein ZIC 4 (Zinc finger protein of the cerebellum 4),334,"36,567",3 out of 5,2003-02-22,Evidence at transcript level
Q3SY52,ZIK1_HUMAN,Zinc finger protein interacting with ribonucleoprotein K (Zinc finger protein 762),487,"54,786",3 out of 5,2007-05-15,Evidence at transcript level
Q96PE6,ZIM3_HUMAN,Zinc finger imprinted 3 (Zinc finger protein 657),472,"54,498",3 out of 5,2002-03-27,Evidence at transcript level
Q5VZL5,ZMYM4_HUMAN,Zinc finger MYM-type protein 4 (Zinc finger protein 262),1548,"172,788",5 out of 5,2007-09-11,Evidence at protein level
Q9UJU3,ZN112_HUMAN,Zinc finger protein 112 (Zfp-112) (Zinc finger protein 228),913,"105,842",4 out of 5,2000-05-30,Evidence at transcript level
P52739,ZN131_HUMAN,Zinc finger protein 131,623,"71,422",5 out of 5,1996-10-01,Evidence at protein level
P52747,ZN143_HUMAN,Zinc finger protein 143 (SPH-binding factor) (Selenocysteine tRNA gene transcription-activating factor) (hStaf),638,"68,896",5 out of 5,1996-10-01,Evidence at protein level
Q13106,ZN154_HUMAN,Zinc finger protein 154,437,"49,865",3 out of 5,1998-07-15,Evidence at transcript level
Q9HCG1,ZN160_HUMAN,Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18),818,"94,112",4 out of 5,2002-02-21,Evidence at transcript level
Q13360,ZN177_HUMAN,Zinc finger protein 177,481,"54,782",4 out of 5,1997-11-01,Evidence at protein level
P17025,ZN182_HUMAN,Zinc finger protein 182 (Zinc finger protein 21) (Zinc finger protein KOX14),639,"73,646",4 out of 5,1990-08-01,Evidence at transcript level
O75820,ZN189_HUMAN,Zinc finger protein 189,626,"72,976",4 out of 5,1998-12-15,Evidence at protein level
Q9UDV6,ZN212_HUMAN,Zinc finger protein 212 (Zinc finger protein C2H2-150),495,"55,447",4 out of 5,2000-12-01,Evidence at protein level
Q9UK12,ZN222_HUMAN,Zinc finger protein 222,451,"52,484",3 out of 5,2000-12-01,Evidence at transcript level
Q9UK10,ZN225_HUMAN,Zinc finger protein 225,706,"82,471",3 out of 5,2000-12-01,Evidence at transcript level
P15622,ZN250_HUMAN,Zinc finger protein 250 (Zinc finger protein 647),560,"63,468",5 out of 5,1990-04-01,Evidence at protein level
Q9Y2P7,ZN256_HUMAN,Zinc finger protein 256 (Bone marrow zinc finger 3) (BMZF-3),627,"71,871",5 out of 5,2001-01-24,Evidence at protein level
Q8N7M2,ZN283_HUMAN,Zinc finger protein 283 (Zinc finger protein HZF19),679,"77,942",4 out of 5,2003-11-07,Evidence at transcript level
Q96RE9,ZN300_HUMAN,Zinc finger protein 300,604,"68,743",5 out of 5,2002-01-23,Evidence at protein level
Q96PQ6,ZN317_HUMAN,Zinc finger protein 317,595,"67,959",5 out of 5,2002-03-27,Evidence at protein level
Q6U7Q0,ZN322_HUMAN,Zinc finger protein 322 (Zinc finger protein 322A) (Zinc finger protein 388) (Zinc finger protein 489),402,"46,941",5 out of 5,2005-11-22,Evidence at protein level
Q96B54,ZN428_HUMAN,Zinc finger protein 428 (Enzyme-like protein PIT13),188,"20,481",2 out of 5,2007-12-04,Evidence at protein level
Q6S9Z5,ZN474_HUMAN,Zinc finger protein 474 (Testis-specific zinc finger protein) (TSZFP),364,"40,315",2 out of 5,2007-04-03,Evidence at transcript level
Q96H40,ZN486_HUMAN,Zinc finger protein 486 (KRAB domain only protein 2),463,"53,631",3 out of 5,2004-08-16,Evidence at transcript level
Q8N8L2,ZN491_HUMAN,Zinc finger protein 491,437,"50,950",3 out of 5,2004-08-16,Evidence at transcript level
Q96ME7,ZN512_HUMAN,Zinc finger protein 512,567,"64,682",3 out of 5,2004-03-15,Evidence at protein level
Q8TB69,ZN519_HUMAN,Zinc finger protein 519,540,"63,020",3 out of 5,2004-05-24,Evidence at transcript level
Q96C55,ZN524_HUMAN,Zinc finger protein 524,264,"28,709",3 out of 5,2006-05-16,Evidence at protein level
Q8TF50,ZN526_HUMAN,Zinc finger protein 526,670,"73,622",3 out of 5,2007-10-02,Evidence at transcript level
Q3MIS6,ZN528_HUMAN,Zinc finger protein 528,628,"72,138",3 out of 5,2007-03-20,Evidence at transcript level
Q8NEP9,ZN555_HUMAN,Zinc finger protein 555,628,"73,084",4 out of 5,2006-05-16,Evidence at protein level
Q8TA94,ZN563_HUMAN,Zinc finger protein 563,476,"55,434",3 out of 5,2005-12-06,Evidence at transcript level
Q9BSK1,ZN577_HUMAN,Zinc finger protein 577,485,"54,939",4 out of 5,2006-05-16,Evidence at transcript level
Q9P0T4,ZN581_HUMAN,Zinc finger protein 581,197,"22,010",5 out of 5,2004-11-23,Evidence at protein level
Q8IVC4,ZN584_HUMAN,Zinc finger protein 584,421,"48,272",3 out of 5,2004-11-23,Evidence at transcript level
Q86UQ0,ZN589_HUMAN,Zinc finger protein 589 (Stem cell zinc finger protein 1),364,"41,189",5 out of 5,2007-10-02,Evidence at protein level
Q96LX8,ZN597_HUMAN,Zinc finger protein 597,424,"48,076",3 out of 5,2005-07-19,Evidence at transcript level
Q9ULD9,ZN608_HUMAN,Zinc finger protein 608 (Renal carcinoma antigen NY-REN-36),1512,"162,208",3 out of 5,2007-03-20,Evidence at protein level
Q8N823,ZN611_HUMAN,Zinc finger protein 611,705,"81,449",4 out of 5,2006-05-16,Evidence at transcript level
Q08AN1,ZN616_HUMAN,Zinc finger protein 616,781,"90,273",3 out of 5,2007-03-20,Evidence at transcript level
Q6ZNG0,ZN620_HUMAN,Zinc finger protein 620,422,"48,503",3 out of 5,2005-11-08,Evidence at transcript level
Q96I27,ZN625_HUMAN,Zinc finger protein 625,306,"34,746",4 out of 5,2006-05-16,Evidence at protein level
Q14966,ZN638_HUMAN,Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein),1978,"220,625",5 out of 5,2005-07-19,Evidence at protein level
O15015,ZN646_HUMAN,Zinc finger protein 646,1829,"200,762",5 out of 5,2001-06-20,Evidence at protein level
Q5HYK9,ZN667_HUMAN,Zinc finger protein 667,610,"70,161",3 out of 5,2006-10-03,Evidence at transcript level
Q8TAW3,ZN671_HUMAN,Zinc finger protein 671,534,"60,972",3 out of 5,2006-05-02,Evidence at transcript level
Q86XU0,ZN677_HUMAN,Zinc finger protein 677,584,"67,996",3 out of 5,2006-05-02,Evidence at transcript level
Q96N22,ZN681_HUMAN,Zinc finger protein 681,645,"75,059",3 out of 5,2007-10-02,Evidence at transcript level
Q8N859,ZN713_HUMAN,Zinc finger protein 713,430,"50,172",4 out of 5,2006-05-02,Evidence at transcript level
Q7Z2F6,ZN720_HUMAN,Putative protein ZNF720,126,"14,454",2 out of 5,2008-04-29,Evidence at transcript level
Q6ZMV8,ZN730_HUMAN,Putative zinc finger protein 730,503,"59,040",2 out of 5,2008-04-08,Evidence at transcript level
O75373,ZN737_HUMAN,Zinc finger protein 737 (Zinc finger protein 102),536,"61,931",3 out of 5,2008-06-10,Evidence at transcript level
Q86XN6,ZN761_HUMAN,Zinc finger protein 761,746,"87,719",3 out of 5,2007-10-02,Evidence at transcript level
Q75MW2,ZN767_HUMAN,Protein ZNF767 (Zinc finger protein 767 pseudogene),155,"17,236",2 out of 5,2007-03-20,Uncertain
Q7L3S4,ZN771_HUMAN,Zinc finger protein 771 (Mesenchymal stem cell protein DSC43),317,"35,702",3 out of 5,2007-03-20,Evidence at protein level
Q8N8C0,ZN781_HUMAN,Zinc finger protein 781,355,"41,526",3 out of 5,2007-07-10,Evidence at transcript level
A8K8V0,ZN785_HUMAN,Zinc finger protein 785,405,"46,168",4 out of 5,2008-07-22,Evidence at protein level
Q6ZQV5,ZN788_HUMAN,Zinc finger protein 788,615,"71,992",3 out of 5,2007-07-10,Evidence at transcript level
Q3KP31,ZN791_HUMAN,Zinc finger protein 791,576,"66,872",3 out of 5,2007-12-04,Evidence at transcript level
B7Z6K7,ZN814_HUMAN,Putative uncharacterized zinc finger protein 814 (Putative zinc finger protein LOC730051),855,"97,337",2 out of 5,2010-06-15,Evidence at protein level
Q17R98,ZN827_HUMAN,Zinc finger protein 827,1081,"119,165",3 out of 5,2008-03-18,Evidence at protein level
C9JN71,ZN878_HUMAN,Zinc finger protein 878,531,"61,540",2 out of 5,2010-05-18,Inferred from homology
A8MT65,ZN891_HUMAN,Zinc finger protein 891,544,"63,592",2 out of 5,2008-09-02,Evidence at transcript level
P17014,ZNF12_HUMAN,Zinc finger protein 12 (Gonadotropin-inducible ovary transcription repressor 3) (GIOT-3) (Zinc finger protein 325) (Zinc finger protein KOX3),697,"81,202",5 out of 5,1990-08-01,Evidence at protein level
P17028,ZNF24_HUMAN,Zinc finger protein 24 (Retinoic acid suppression protein A) (RSG-A) (Zinc finger and SCAN domain-containing protein 3) (Zinc finger protein 191) (Zinc finger protein KOX17),368,"42,155",5 out of 5,1990-08-01,Evidence at protein level
P17035,ZNF28_HUMAN,Zinc finger protein 28 (Zinc finger protein KOX24),718,"83,658",4 out of 5,1990-08-01,Evidence at transcript level
Q6PML9,ZNT9_HUMAN,Zinc transporter 9 (ZnT-9) (Human embryonic lung protein) (HuEL) (Solute carrier family 30 member 9),568,"63,515",5 out of 5,2007-07-24,Evidence at protein level
Q05996,ZP2_HUMAN,Zona pellucida sperm-binding protein 2 (Zona pellucida glycoprotein 2) (Zp-2) (Zona pellucida protein A) [Cleaved into: Processed zona pellucida sperm-binding protein 2],745,"82,357",5 out of 5,1994-02-01,Evidence at transcript level
Q8TCW7,ZPLD1_HUMAN,Zona pellucida-like domain-containing protein 1 (ZP domain-containing protein 1),415,"45,530",3 out of 5,2007-10-23,Evidence at transcript level
O95218,ZRAB2_HUMAN,"Zinc finger Ran-binding domain-containing protein 2 (Zinc finger protein 265) (Zinc finger, splicing)",330,"37,404",5 out of 5,2001-01-24,Evidence at protein level
A6NGD5,ZSA5C_HUMAN,Putative zinc finger and SCAN domain-containing protein 5C (Zinc finger and SCAN domain-containing protein 5C pseudogene),496,"55,729",3 out of 5,2008-04-29,Uncertain
Q9NX65,ZSC32_HUMAN,Zinc finger and SCAN domain-containing protein 32 (Human cervical cancer suppressor gene 5 protein) (HCCS-5) (Zinc finger protein 434),697,"78,728",4 out of 5,2003-04-23,Evidence at protein level
Q9H900,ZWILC_HUMAN,Protein zwilch homolog (hZwilch),591,"67,214",5 out of 5,2008-01-15,Evidence at protein level
Q6WRX3,ZY11A_HUMAN,Protein zyg-11 homolog A,759,"85,808",2 out of 5,2007-10-02,Evidence at transcript level
Q8IYH5,ZZZ3_HUMAN,ZZ-type zinc finger-containing protein 3,903,"102,023",5 out of 5,2007-05-15,Evidence at protein level
Q8N9L7,YV006_HUMAN,Putative uncharacterized protein FLJ36925,120,"13,535",1 out of 5,2006-10-31,Uncertain
Q8IWR0,Z3H7A_HUMAN,Zinc finger CCCH domain-containing protein 7A,971,"110,538",3 out of 5,2005-07-05,Evidence at protein level
Q52M93,Z585B_HUMAN,Zinc finger protein 585B (zinc finger protein 41-like protein),769,"88,066",3 out of 5,2005-10-25,Evidence at transcript level
A8MVS1,Z705F_HUMAN,Zinc finger protein 705F,300,"34,857",2 out of 5,2008-04-29,Inferred from homology
Q7Z570,Z804A_HUMAN,Zinc finger protein 804A,1209,"136,888",3 out of 5,2006-04-18,Evidence at protein level
Q401N2,ZACN_HUMAN,Zinc-activated ligand-gated ion channel (Ligand-gated ion channel zinc-activated 1) (Ligand-gated ion-channel receptor L2),412,"45,816",5 out of 5,2008-02-05,Evidence at protein level
Q9Y493,ZAN_HUMAN,Zonadhesin,2812,"305,663",5 out of 5,2001-04-27,Evidence at transcript level
Q9BTP6,ZBED2_HUMAN,Zinc finger BED domain-containing protein 2,218,"25,122",2 out of 5,2003-09-19,Evidence at protein level
O75132,ZBED4_HUMAN,Zinc finger BED domain-containing protein 4,1171,"130,322",4 out of 5,2002-05-10,Evidence at protein level
P24278,ZBT25_HUMAN,Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP),435,"48,990",5 out of 5,1992-03-01,Evidence at protein level
Q9NUA8,ZBT40_HUMAN,Zinc finger and BTB domain-containing protein 40,1239,"138,118",4 out of 5,2001-06-20,Evidence at protein level
Q86UZ6,ZBT46_HUMAN,Zinc finger and BTB domain-containing protein 46 (BTB-ZF protein expressed in effector lymphocytes) (BZEL) (BTB/POZ domain-containing protein 4) (Zinc finger protein 340),589,"64,083",4 out of 5,2004-02-16,Evidence at protein level
Q9Y2K1,ZBTB1_HUMAN,Zinc finger and BTB domain-containing protein 1,713,"82,016",5 out of 5,2003-04-30,Evidence at protein level
Q9H5U6,ZCHC4_HUMAN,Zinc finger CCHC domain-containing protein 4,513,"59,010",3 out of 5,2004-08-31,Evidence at protein level
Q9H0M4,ZCPW1_HUMAN,Zinc finger CW-type PWWP domain protein 1,648,"72,007",3 out of 5,2004-08-31,Evidence at protein level
Q969W1,ZDH16_HUMAN,Probable palmitoyltransferase ZDHHC16 (EC 2.3.1.225) (Abl-philin 2) (Zinc finger DHHC domain-containing protein 16) (DHHC-16),377,"43,633",5 out of 5,2003-10-24,Evidence at protein level
Q9NUE0,ZDH18_HUMAN,Palmitoyltransferase ZDHHC18 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 18) (DHHC-18),388,"42,031",4 out of 5,2003-08-29,Evidence at protein level
Q8IYP9,ZDH23_HUMAN,Palmitoyltransferase ZDHHC23 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 23) (DHHC-23) (zDHHC23),409,"45,983",4 out of 5,2005-11-22,Evidence at protein level
Q7Z7L7,ZER1_HUMAN,Protein zer-1 homolog (Hzyg) (Zyg-11 homolog B-like protein),766,"88,169",4 out of 5,2005-07-05,Evidence at protein level
Q9UJL9,ZF69B_HUMAN,Zinc finger protein ZFP69B (Zinc finger protein 643),534,"61,481",4 out of 5,2005-11-08,Evidence at protein level
Q9UPR6,ZFR2_HUMAN,Zinc finger RNA-binding protein 2,939,"101,330",3 out of 5,2007-11-13,Evidence at transcript level
O60844,ZG16_HUMAN,Zymogen granule membrane protein 16 (Zymogen granule protein 16) (hZG16) (Secretory lectin ZG16),167,"18,147",5 out of 5,2005-03-01,Evidence at protein level
Q9NZV7,ZIM2_HUMAN,Zinc finger imprinted 2 (Zinc finger protein 656),527,"61,164",4 out of 5,2002-03-27,Evidence at protein level
Q969J2,ZKSC4_HUMAN,Zinc finger protein with KRAB and SCAN domains 4 (P373c6.1) (Zinc finger protein 307) (Zinc finger protein 427),545,"61,579",5 out of 5,2002-09-19,Evidence at protein level
Q9UDW3,ZMAT5_HUMAN,Zinc finger matrin-type protein 5 (U11/U12 small nuclear ribonucleoprotein 20 kDa protein) (U11/U12 snRNP 20 kDa protein) (U11/U12-20K),170,"19,971",3 out of 5,2006-10-31,Evidence at protein level
Q8NF64,ZMIZ2_HUMAN,Zinc finger MIZ domain-containing protein 2 (PIAS-like protein Zimp7),920,"96,537",5 out of 5,2004-12-07,Evidence at protein level
Q96E35,ZMY19_HUMAN,Zinc finger MYND domain-containing protein 19 (Melanin-concentrating hormone receptor 1-interacting zinc finger protein) (MCH-R1-interacting zinc finger protein),227,"26,433",5 out of 5,2004-04-13,Evidence at protein level
Q8IZC7,ZN101_HUMAN,Zinc finger protein 101 (Zinc finger protein HZF12),436,"50,339",4 out of 5,2004-11-23,Evidence at protein level
Q9UII5,ZN107_HUMAN,Zinc finger protein 107 (Zinc finger protein 588) (Zinc finger protein ZFD25),783,"90,673",3 out of 5,2002-06-20,Evidence at transcript level
P52740,ZN132_HUMAN,Zinc finger protein 132,706,"80,623",3 out of 5,1996-10-01,Evidence at transcript level
P52741,ZN134_HUMAN,Zinc finger protein 134,427,"48,480",3 out of 5,1996-10-01,Evidence at transcript level
P52744,ZN138_HUMAN,Zinc finger protein 138,262,"30,592",4 out of 5,1996-10-01,Evidence at protein level
P52746,ZN142_HUMAN,Zinc finger protein 142 (HA4654),1687,"187,880",3 out of 5,1996-10-01,Evidence at protein level
O14709,ZN197_HUMAN,Zinc finger protein 197 (Zinc finger protein with KRAB and SCAN domains 9) (ZnF20) (pVHL-associated KRAB domain-containing protein),1029,"118,847",4 out of 5,2000-12-01,Evidence at transcript level
Q96JL9,ZN333_HUMAN,Zinc finger protein 333,665,"75,544",4 out of 5,2002-02-21,Evidence at transcript level
Q14585,ZN345_HUMAN,Zinc finger protein 345 (Zinc finger protein HZF10),488,"55,383",3 out of 5,2000-12-01,Evidence at transcript level
Q96SE7,ZN347_HUMAN,Zinc finger protein 347 (Zinc finger protein 1111),839,"95,770",3 out of 5,2002-09-19,Evidence at protein level
Q70YC5,ZN365_HUMAN,Protein ZNF365 (Protein su48),407,"46,542",4 out of 5,2005-12-20,Evidence at protein level
P17032,ZN37A_HUMAN,Zinc finger protein 37A (Zinc finger protein KOX21),561,"65,418",4 out of 5,1990-08-01,Evidence at transcript level
Q9BUY5,ZN426_HUMAN,Zinc finger protein 426,554,"63,106",4 out of 5,2003-09-19,Evidence at protein level
Q9H8G1,ZN430_HUMAN,Zinc finger protein 430,570,"66,319",3 out of 5,2003-04-23,Evidence at protein level
Q8N7K0,ZN433_HUMAN,Zinc finger protein 433,673,"77,243",3 out of 5,2003-04-23,Evidence at protein level
Q9H7R0,ZN442_HUMAN,Zinc finger protein 442,627,"72,863",4 out of 5,2003-05-09,Evidence at transcript level
Q9NWS9,ZN446_HUMAN,Zinc finger protein 446 (Zinc finger protein with KRAB and SCAN domains 20),450,"48,957",4 out of 5,2004-11-23,Evidence at protein level
Q9Y4E5,ZN451_HUMAN,E3 SUMO-protein ligase ZNF451 (EC 6.3.2.-) (Coactivator for steroid receptors) (Zinc finger protein 451),1061,"121,484",5 out of 5,2003-10-24,Evidence at protein level
Q6ECI4,ZN470_HUMAN,Zinc finger protein 470 (Chondrogenesis zinc finger protein 1) (CZF-1),717,"82,650",4 out of 5,2007-03-20,Evidence at transcript level
Q8WTR7,ZN473_HUMAN,Zinc finger protein 473 (Zinc finger protein 100 homolog) (Zfp-100),871,"100,182",5 out of 5,2004-08-31,Evidence at protein level
Q9Y2H8,ZN510_HUMAN,Zinc finger protein 510,683,"79,142",3 out of 5,2002-04-16,Evidence at transcript level
Q8IYB9,ZN595_HUMAN,Zinc finger protein 595,648,"74,290",3 out of 5,2004-11-23,Evidence at transcript level
Q86UK7,ZN598_HUMAN,E3 ubiquitin-protein ligase ZNF598 (EC 2.3.2.27) (Zinc finger protein 598),904,"98,637",5 out of 5,2006-10-03,Evidence at protein level
Q86T29,ZN605_HUMAN,Zinc finger protein 605,641,"74,376",3 out of 5,2006-05-16,Evidence at transcript level
Q96N77,ZN641_HUMAN,Zinc finger protein 641,438,"49,528",5 out of 5,2007-05-01,Evidence at protein level
Q8IZM8,ZN654_HUMAN,Zinc finger protein 654 (Melanoma-associated antigen),581,"65,854",3 out of 5,2007-12-04,Evidence at transcript level
Q6ZS27,ZN662_HUMAN,Zinc finger protein 662,426,"48,496",3 out of 5,2006-10-03,Evidence at protein level
Q8N7Q3,ZN676_HUMAN,Zinc finger protein 676,588,"67,624",3 out of 5,2006-05-02,Evidence at transcript level
Q5T5D7,ZN684_HUMAN,Zinc finger protein 684,378,"43,945",3 out of 5,2006-05-02,Evidence at transcript level
P0C7X2,ZN688_HUMAN,Zinc finger protein 688,276,"30,575",3 out of 5,2008-07-22,Evidence at transcript level
Q32M78,ZN699_HUMAN,Zinc finger protein 699 (Hangover homolog),642,"73,956",3 out of 5,2006-05-02,Evidence at protein level
Q6ZNC4,ZN704_HUMAN,Zinc finger protein 704,412,"45,276",2 out of 5,2007-05-29,Evidence at protein level
Q8N972,ZN709_HUMAN,Zinc finger protein 709,641,"74,652",3 out of 5,2006-04-04,Evidence at transcript level
Q96N38,ZN714_HUMAN,Zinc finger protein 714,554,"63,883",4 out of 5,2008-04-29,Evidence at transcript level
A8MTY0,ZN724_HUMAN,Zinc finger protein 724,619,"71,172",2 out of 5,2008-04-29,Evidence at transcript level
A6NN14,ZN729_HUMAN,Zinc finger protein 729,1252,"145,022",3 out of 5,2008-04-29,Evidence at transcript level
Q8NE65,ZN738_HUMAN,Protein ZNF738,137,"15,884",3 out of 5,2007-02-06,Evidence at transcript level
O43361,ZN749_HUMAN,Zinc finger protein 749,778,"90,364",3 out of 5,2007-02-06,Evidence at protein level
P51815,ZN75D_HUMAN,Zinc finger protein 75D (Zinc finger protein 75) (Zinc finger protein 82),510,"59,298",3 out of 5,1996-10-01,Evidence at transcript level
Q8N4W9,ZN808_HUMAN,Zinc finger protein 808,903,"104,825",3 out of 5,2007-10-02,Evidence at transcript level
O75541,ZN821_HUMAN,Zinc finger protein 821,412,"46,794",3 out of 5,2008-02-05,Evidence at protein level
Q6ZNA1,ZN836_HUMAN,Zinc finger protein 836,936,"107,717",3 out of 5,2008-02-26,Evidence at transcript level
Q08AG5,ZN844_HUMAN,Zinc finger protein 844,666,"76,934",4 out of 5,2008-09-02,Evidence at protein level
A8MQ14,ZN850_HUMAN,Zinc finger protein 850,1090,"125,431",2 out of 5,2008-04-29,Inferred from homology
P0CJ78,ZN865_HUMAN,Zinc finger protein 865,1059,"111,077",2 out of 5,2011-02-08,Inferred from homology
P0CG24,ZN883_HUMAN,Zinc finger protein 883,379,"43,967",2 out of 5,2010-06-15,Evidence at transcript level
P17021,ZNF17_HUMAN,Zinc finger protein 17 (Zinc finger protein HPF3) (Zinc finger protein KOX10),662,"77,204",4 out of 5,1990-08-01,Evidence at transcript level
Q6XR72,ZNT10_HUMAN,Zinc transporter 10 (ZnT-10) (Manganese transporter SLC30A10) (Solute carrier family 30 member 10),485,"52,684",5 out of 5,2007-12-04,Evidence at protein level
Q12836,ZP4_HUMAN,Zona pellucida sperm-binding protein 4 (Zona pellucida glycoprotein 4) (Zp-4) (Zona pellucida protein B) [Cleaved into: Processed zona pellucida sperm-binding protein 4],540,"59,400",5 out of 5,2004-04-13,Evidence at transcript level
Q6X784,ZPBP2_HUMAN,Zona pellucida-binding protein 2 (ZPBP-like protein),338,"38,652",4 out of 5,2004-10-11,Evidence at transcript level
Q5FWF4,ZRAB3_HUMAN,DNA annealing helicase and endonuclease ZRANB3 (Annealing helicase 2) (AH2) (Zinc finger Ran-binding domain-containing protein 3) [Includes: DNA annealing helicase ZRANB3 (EC 3.6.4.-); Endonuclease ZRANB3 (EC 3.1.-.-)],1079,"123,248",5 out of 5,2007-02-20,Evidence at protein level
Q16670,ZSC26_HUMAN,Zinc finger and SCAN domain-containing protein 26 (Protein SRE-ZBP) (Zinc finger protein 187),478,"55,254",5 out of 5,2007-10-23,Evidence at protein level
Q8NAM6,ZSCA4_HUMAN,Zinc finger and SCAN domain-containing protein 4 (Zinc finger protein 494),433,"48,957",3 out of 5,2004-11-23,Evidence at transcript level
O43264,ZW10_HUMAN,Centromere/kinetochore protein zw10 homolog,779,"88,829",5 out of 5,2000-12-01,Evidence at protein level
P98169,ZXDB_HUMAN,Zinc finger X-linked protein ZXDB,803,"84,792",3 out of 5,1996-10-01,Evidence at transcript level
Q9C0D3,ZY11B_HUMAN,Protein zyg-11 homolog B,744,"83,921",3 out of 5,2007-10-02,Evidence at protein level
Q9NSJ1,Z355P_HUMAN,Putative zinc finger protein 355P (Zinc finger protein ZnFP01),428,"49,689",3 out of 5,2008-04-29,Uncertain
A8MWA4,Z705E_HUMAN,Putative zinc finger protein 705E,302,"34,897",2 out of 5,2008-07-22,Inferred from homology
Q9H171,ZBP1_HUMAN,Z-DNA-binding protein 1 (Tumor stroma and activated macrophage protein DLM-1),429,"46,343",5 out of 5,2002-11-25,Evidence at protein level
Q9Y330,ZBT12_HUMAN,Zinc finger and BTB domain-containing protein 12 (Protein G10),459,"49,148",3 out of 5,2003-11-07,Evidence at protein level
Q8NAP3,ZBT38_HUMAN,Zinc finger and BTB domain-containing protein 38,1195,"134,257",5 out of 5,2005-07-05,Evidence at protein level
A1YPR0,ZBT7C_HUMAN,Zinc finger and BTB domain-containing protein 7C (Affected by papillomavirus DNA integration in ME180 cells protein 1) (APM-1) (Zinc finger and BTB domain-containing protein 36) (Zinc finger protein 857C),619,"69,017",3 out of 5,2008-06-10,Evidence at transcript level
Q9P1Z0,ZBTB4_HUMAN,Zinc finger and BTB domain-containing protein 4 (KAISO-like zinc finger protein 1) (KAISO-L1),1013,"105,114",5 out of 5,2004-04-26,Evidence at protein level
Q15916,ZBTB6_HUMAN,Zinc finger and BTB domain-containing protein 6 (Zinc finger protein 482) (Zinc finger protein with interaction domain),424,"48,236",4 out of 5,2004-03-29,Evidence at protein level
Q9C0D7,ZC12C_HUMAN,Probable ribonuclease ZC3H12C (EC 3.1.-.-) (MCP-induced protein 3) (Zinc finger CCCH domain-containing protein 12C),883,"99,340",3 out of 5,2008-06-10,Evidence at protein level
Q5TFG8,ZC21B_HUMAN,Zinc finger C2HC domain-containing protein 1B,222,"24,665",2 out of 5,2007-03-20,Evidence at transcript level
P61129,ZC3H6_HUMAN,Zinc finger CCCH domain-containing protein 6,1189,"131,670",2 out of 5,2004-05-10,Evidence at protein level
Q6PJT7,ZC3HE_HUMAN,Zinc finger CCCH domain-containing protein 14 (Mammalian suppressor of tau pathology-2) (MSUT-2) (Renal carcinoma antigen NY-REN-37),736,"82,876",5 out of 5,2008-04-29,Evidence at protein level
Q9NQZ6,ZC4H2_HUMAN,Zinc finger C4H2 domain-containing protein (Hepatocellular carcinoma-associated antigen 127),224,"26,244",5 out of 5,2003-10-10,Evidence at protein level
Q6ZST2,ZCH23_HUMAN,Zinc finger CCHC domain-containing protein 23,131,"14,410",1 out of 5,2007-09-11,Evidence at transcript level
Q8N567,ZCHC9_HUMAN,Zinc finger CCHC domain-containing protein 9,271,"30,477",3 out of 5,2004-05-10,Evidence at protein level
Q8WVZ1,ZDH19_HUMAN,Probable palmitoyltransferase ZDHHC19 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 19) (DHHC-19),309,"34,352",3 out of 5,2003-10-24,Evidence at transcript level
Q6UX98,ZDH24_HUMAN,Probable palmitoyltransferase ZDHHC24 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 24) (DHHC-24),284,"30,176",3 out of 5,2006-05-02,Evidence at protein level
Q9H6R6,ZDHC6_HUMAN,Palmitoyltransferase ZDHHC6 (EC 2.3.1.225) (Transmembrane protein H4) (Zinc finger DHHC domain-containing protein 6) (DHHC-6) (Zinc finger protein 376),413,"47,663",5 out of 5,2003-02-01,Evidence at protein level
Q5T1R4,ZEP3_HUMAN,Transcription factor HIVEP3 (Human immunodeficiency virus type I enhancer-binding protein 3) (Kappa-B and V(D)J recombination signal sequences-binding protein) (Kappa-binding protein 1) (KBP-1) (Zinc finger protein ZAS3),2406,"259,465",5 out of 5,2008-04-29,Evidence at transcript level
Q9NPA5,ZF64A_HUMAN,"Zinc finger protein 64 homolog, isoforms 1 and 2 (Zfp-64) (Zinc finger protein 338)",681,"74,644",5 out of 5,2003-04-30,Evidence at protein level
Q9H8U3,ZFAN3_HUMAN,AN1-type zinc finger protein 3 (Testis-expressed protein 27),227,"25,184",2 out of 5,2006-02-07,Evidence at protein level
Q9P243,ZFAT_HUMAN,Zinc finger protein ZFAT (Zinc finger gene in AITD susceptibility region) (Zinc finger protein 406),1243,"139,034",4 out of 5,2003-09-19,Evidence at protein level
Q15911,ZFHX3_HUMAN,Zinc finger homeobox protein 3 (AT motif-binding factor 1) (AT-binding transcription factor 1) (Alpha-fetoprotein enhancer-binding protein) (Zinc finger homeodomain protein 3) (ZFH-3),3703,"404,419",5 out of 5,2001-10-18,Evidence at protein level
Q8N8Y5,ZFP41_HUMAN,Zinc finger protein 41 homolog (Zfp-41),198,"22,806",2 out of 5,2007-07-24,Evidence at transcript level
Q9NU63,ZFP57_HUMAN,Zinc finger protein 57 homolog (Zfp-57) (Zinc finger protein 698),452,"51,919",5 out of 5,2007-06-26,Evidence at protein level
Q96JP5,ZFP91_HUMAN,E3 ubiquitin-protein ligase ZFP91 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog) (Zfp-91),570,"63,445",5 out of 5,2005-02-01,Evidence at protein level
O60481,ZIC3_HUMAN,Zinc finger protein ZIC 3 (Zinc finger protein 203) (Zinc finger protein of the cerebellum 3),467,"50,569",5 out of 5,1998-12-15,Evidence at protein level
Q15776,ZKSC8_HUMAN,Zinc finger protein with KRAB and SCAN domains 8 (LD5-1) (Zinc finger protein 192),578,"65,816",4 out of 5,2000-12-01,Evidence at protein level
Q9UBW7,ZMYM2_HUMAN,Zinc finger MYM-type protein 2 (Fused in myeloproliferative disorders protein) (Rearranged in atypical myeloproliferative disorder protein) (Zinc finger protein 198),1377,"154,911",5 out of 5,2001-11-16,Evidence at protein level
Q8IYN0,ZN100_HUMAN,Zinc finger protein 100,542,"62,745",3 out of 5,2004-11-23,Evidence at transcript level
Q9H2Y7,ZN106_HUMAN,Zinc finger protein 106 (Zfp-106) (Zinc finger protein 474),1883,"208,883",4 out of 5,2004-08-31,Evidence at protein level
P58317,ZN121_HUMAN,Zinc finger protein 121 (Zinc finger protein 20),390,"44,694",3 out of 5,2001-10-18,Inferred from homology
P52742,ZN135_HUMAN,Zinc finger protein 135 (Zinc finger protein 61) (Zinc finger protein 78-like 1),658,"75,261",5 out of 5,1996-10-01,Evidence at transcript level
Q15928,ZN141_HUMAN,Zinc finger protein 141,474,"55,249",4 out of 5,1997-11-01,Evidence at protein level
Q9UQR1,ZN148_HUMAN,Zinc finger protein 148 (Transcription factor ZBP-89) (Zinc finger DNA-binding protein 89),794,"88,976",5 out of 5,2001-01-24,Evidence at protein level
P49910,ZN165_HUMAN,Zinc finger protein 165 (Cancer/testis antigen 53) (CT53) (LD65) (Zinc finger and SCAN domain-containing protein 7),485,"55,771",4 out of 5,1996-10-01,Evidence at protein level
Q15697,ZN174_HUMAN,Zinc finger protein 174 (AW-1) (Zinc finger and SCAN domain-containing protein 8),407,"46,455",5 out of 5,1998-07-15,Evidence at protein level
O15231,ZN185_HUMAN,Zinc finger protein 185 (LIM domain protein ZNF185) (P1-A),689,"73,525",5 out of 5,1999-07-15,Evidence at protein level
O95125,ZN202_HUMAN,Zinc finger protein 202 (Zinc finger protein with KRAB and SCAN domains 10),648,"74,720",5 out of 5,1999-07-15,Evidence at protein level
Q9UK11,ZN223_HUMAN,Zinc finger protein 223,482,"55,763",3 out of 5,2000-12-01,Evidence at protein level
Q9UIE0,ZN230_HUMAN,Zinc finger protein 230 (Zinc finger protein FDZF2),474,"54,542",4 out of 5,2001-01-24,Evidence at protein level
Q14588,ZN234_HUMAN,Zinc finger protein 234 (Zinc finger protein 269) (Zinc finger protein HZF4),700,"80,560",4 out of 5,2000-12-01,Evidence at transcript level
O75346,ZN253_HUMAN,Zinc finger protein 253 (Bone marrow zinc finger 1) (BMZF-1) (Zinc finger protein 411),499,"57,602",4 out of 5,2001-01-24,Evidence at transcript level
Q14584,ZN266_HUMAN,Zinc finger protein 266 (Zinc finger protein HZF1),549,"62,116",4 out of 5,2000-12-01,Evidence at protein level
Q14587,ZN268_HUMAN,Zinc finger protein 268 (Zinc finger protein HZF3),947,"108,374",5 out of 5,2000-12-01,Evidence at protein level
Q96NJ3,ZN285_HUMAN,Zinc finger protein 285 (Zinc finger protein 285A),590,"68,261",3 out of 5,2004-11-23,Evidence at transcript level
Q8WUU4,ZN296_HUMAN,Zinc finger protein 296 (ZFP296) (Zinc finger protein 342),475,"50,810",3 out of 5,2002-09-19,Evidence at transcript level
Q9HCX3,ZN304_HUMAN,Zinc finger protein 304 (KRAB-containing zinc finger protein),659,"75,047",5 out of 5,2002-09-19,Evidence at protein level
A2RRD8,ZN320_HUMAN,Zinc finger protein 320,509,"59,326",4 out of 5,2007-09-11,Evidence at protein level
Q9Y3S2,ZN330_HUMAN,Zinc finger protein 330 (Nucleolar autoantigen 36) (Nucleolar cysteine-rich protein),320,"36,201",4 out of 5,2004-08-31,Evidence at protein level
Q06730,ZN33A_HUMAN,Zinc finger protein 33A (Zinc finger and ZAK-associated protein with KRAB domain) (ZZaPK) (Zinc finger protein 11A) (Zinc finger protein KOX31),810,"94,384",5 out of 5,1996-10-01,Evidence at protein level
Q9UL40,ZN346_HUMAN,Zinc finger protein 346 (Just another zinc finger protein),294,"32,933",5 out of 5,2005-10-25,Evidence at protein level
Q5T0B9,ZN362_HUMAN,Zinc finger protein 362,420,"45,814",3 out of 5,2007-09-11,Evidence at protein level
O94892,ZN432_HUMAN,Zinc finger protein 432,652,"74,836",3 out of 5,2001-10-18,Evidence at protein level
Q8TAF7,ZN461_HUMAN,Zinc finger protein 461 (Gonadotropin-inducible ovary transcription repressor 1) (GIOT-1),563,"66,214",3 out of 5,2003-02-01,Evidence at transcript level
Q9BU19,ZN692_HUMAN,Zinc finger protein 692,519,"56,968",4 out of 5,2006-05-02,Evidence at protein level
Q9H963,ZN702_HUMAN,Putative zinc finger protein 702,129,"15,019",3 out of 5,2006-05-02,Uncertain
Q9H7S9,ZN703_HUMAN,Zinc finger protein 703 (Zinc finger elbow-related proline domain protein 1),590,"58,222",5 out of 5,2005-12-06,Evidence at protein level
Q3SXZ3,ZN718_HUMAN,Zinc finger protein 718,478,"55,404",3 out of 5,2006-05-02,Evidence at transcript level
Q8TF20,ZN721_HUMAN,Zinc finger protein 721,911,"105,084",3 out of 5,2007-10-02,Evidence at transcript level
Q0D2J5,ZN763_HUMAN,Zinc finger protein 763,394,"46,099",4 out of 5,2008-04-29,Evidence at transcript level
Q6NX45,ZN774_HUMAN,Zinc finger protein 774,483,"55,068",3 out of 5,2006-12-12,Evidence at protein level
Q96MU6,ZN778_HUMAN,Zinc finger protein 778,729,"81,964",3 out of 5,2006-12-12,Evidence at protein level
Q5FWF6,ZN789_HUMAN,Zinc finger protein 789,425,"49,984",4 out of 5,2007-07-10,Evidence at transcript level
Q96GE5,ZN799_HUMAN,Zinc finger protein 799 (Zinc finger protein 842),643,"74,288",3 out of 5,2007-01-09,Evidence at transcript level
Q6ZN06,ZN813_HUMAN,Zinc finger protein 813,617,"71,721",4 out of 5,2007-07-10,Evidence at transcript level
Q6ZT77,ZN826_HUMAN,Putative zinc finger protein 826,177,"20,580",3 out of 5,2008-03-18,Uncertain
Q96NB3,ZN830_HUMAN,Zinc finger protein 830 (Coiled-coil domain-containing protein 16),372,"41,999",5 out of 5,2005-12-06,Evidence at protein level
A8K0R7,ZN839_HUMAN,Zinc finger protein 839 (Renal carcinoma antigen NY-REN-50),811,"87,484",3 out of 5,2008-04-08,Evidence at transcript level
Q147U1,ZN846_HUMAN,Zinc finger protein 846,533,"60,552",3 out of 5,2008-04-29,Evidence at protein level
A6NHJ4,ZN860_HUMAN,Zinc finger protein 860,632,"73,757",2 out of 5,2008-09-23,Evidence at transcript level
B4DU55,ZN879_HUMAN,Zinc finger protein 879,563,"64,577",3 out of 5,2010-05-18,Evidence at transcript level
P17041,ZNF32_HUMAN,Zinc finger protein 32 (C2H2-546) (Zinc finger protein KOX30),273,"31,029",4 out of 5,1990-08-01,Evidence at protein level
P51508,ZNF81_HUMAN,Zinc finger protein 81 (HFZ20),661,"75,960",4 out of 5,1996-10-01,Evidence at protein level
A8MXY4,ZNF99_HUMAN,Zinc finger protein 99,864,"100,791",3 out of 5,2008-07-22,Evidence at transcript level
A6NJL1,ZSA5B_HUMAN,Zinc finger and SCAN domain-containing protein 5B,495,"55,826",3 out of 5,2008-04-29,Inferred from homology
O43309,ZSC12_HUMAN,Zinc finger and SCAN domain-containing protein 12 (Zinc finger protein 305) (Zinc finger protein 96),604,"70,222",5 out of 5,2000-12-01,Evidence at protein level
Q8TBC5,ZSC18_HUMAN,Zinc finger and SCAN domain-containing protein 18 (Zinc finger protein 447),510,"54,804",4 out of 5,2006-06-27,Evidence at transcript level
Q8IWY8,ZSC29_HUMAN,Zinc finger and SCAN domain-containing protein 29 (Zinc finger protein 690),852,"96,719",4 out of 5,2006-05-02,Evidence at protein level
Q19AV6,ZSWM7_HUMAN,Zinc finger SWIM domain-containing protein 7 (SWIM domain-containing and Srs2-interacting protein 1 homolog) (SWIM-type zinc finger domain-containing protein 7),140,"15,386",4 out of 5,2007-10-23,Evidence at protein level
Q6UXR6,YI004_HUMAN,Putative uncharacterized protein UNQ6494/PRO21346,183,"19,530",1 out of 5,2008-02-05,Uncertain
Q9BRP9,YK016_HUMAN,Putative uncharacterized protein MGC13053,147,"15,625",1 out of 5,2008-04-29,Uncertain
Q6ZTI0,YK032_HUMAN,Putative uncharacterized protein FLJ44636,123,"12,888",1 out of 5,2008-05-20,Uncertain
Q3C1V9,YK041_HUMAN,Putative uncharacterized protein ENSP00000334305,767,"84,939",1 out of 5,2008-07-01,Uncertain
Q6ZRX8,YL004_HUMAN,Putative uncharacterized protein FLJ45999,168,"18,969",1 out of 5,2008-04-29,Uncertain
Q6ZUT4,YL014_HUMAN,Putative uncharacterized protein FLJ43343,128,"14,221",1 out of 5,2008-06-10,Uncertain
A6NCN8,YL021_HUMAN,Uncharacterized protein ENSP00000372125,305,"35,334",1 out of 5,2008-09-02,Predicted
A6NIN4,YQ014_HUMAN,Putative uncharacterized protein FLJ38447,97,"10,921",1 out of 5,2008-04-08,Uncertain
Q6ZRU5,YQ032_HUMAN,Putative uncharacterized protein FLJ46089,148,"16,879",1 out of 5,2008-07-01,Uncertain
Q8WTZ3,YS049_HUMAN,Zinc finger protein ENSP00000375192,238,"27,158",2 out of 5,2007-02-20,Evidence at transcript level
Q9BRR0,ZKSC3_HUMAN,Zinc finger protein with KRAB and SCAN domains 3 (Zinc finger and SCAN domain-containing protein 13) (Zinc finger protein 306) (Zinc finger protein 309) (Zinc finger protein 47 homolog) (Zf47) (Zfp-47),538,"60,641",5 out of 5,2002-09-19,Evidence at protein level
Q9NQX6,ZN331_HUMAN,Zinc finger protein 331 (C2H2-like zinc finger protein rearranged in thyroid adenomas) (Zinc finger protein 361) (Zinc finger protein 463),463,"53,739",4 out of 5,2003-09-19,Evidence at protein level
Q06732,ZN33B_HUMAN,Zinc finger protein 33B (Zinc finger protein 11B) (Zinc finger protein KOX2),778,"90,683",4 out of 5,1996-10-01,Evidence at protein level
Q9GZX5,ZN350_HUMAN,Zinc finger protein 350 (KRAB zinc finger protein ZFQR) (Zinc finger and BRCA1-interacting protein with a KRAB domain 1) (Zinc finger protein ZBRK1),532,"60,011",5 out of 5,2004-11-23,Evidence at protein level
Q96N95,ZN396_HUMAN,Zinc finger protein 396 (Zinc finger and SCAN domain-containing protein 14),335,"38,612",4 out of 5,2002-09-19,Evidence at protein level
Q9BWM5,ZN416_HUMAN,Zinc finger protein 416,594,"67,188",3 out of 5,2006-05-02,Evidence at transcript level
Q96HQ0,ZN419_HUMAN,Zinc finger protein 419,510,"58,564",4 out of 5,2005-11-08,Evidence at protein level
Q2M1K9,ZN423_HUMAN,Zinc finger protein 423 (Olf1/EBF-associated zinc finger protein) (hOAZ) (Smad- and Olf-interacting zinc finger protein),1284,"144,605",5 out of 5,2007-10-23,Evidence at protein level
Q8NDP4,ZN439_HUMAN,Zinc finger protein 439,499,"58,395",5 out of 5,2003-05-09,Evidence at protein level
Q8N8Z8,ZN441_HUMAN,Zinc finger protein 441,693,"80,136",3 out of 5,2003-05-09,Evidence at transcript level
P59923,ZN445_HUMAN,Zinc finger protein 445 (Zinc finger protein 168) (Zinc finger protein with KRAB and SCAN domains 15),1031,"118,963",4 out of 5,2003-10-10,Evidence at protein level
Q96JM2,ZN462_HUMAN,Zinc finger protein 462,2506,"284,688",5 out of 5,2004-02-02,Evidence at protein level
Q96JC4,ZN479_HUMAN,Zinc finger protein 479 (Zinc finger protein Kr19) (HKr19),524,"60,598",3 out of 5,2003-11-07,Evidence at transcript level
Q5JVG2,ZN484_HUMAN,Zinc finger protein 484,852,"98,221",3 out of 5,2006-05-02,Evidence at protein level
Q9P255,ZN492_HUMAN,Zinc finger protein 492 (Zinc finger protein 115),531,"61,158",3 out of 5,2002-02-21,Evidence at transcript level
Q8TBZ5,ZN502_HUMAN,Zinc finger protein 502,544,"62,920",4 out of 5,2004-03-15,Evidence at protein level
Q76KX8,ZN534_HUMAN,Zinc finger protein 534 (KRAB domain only protein 3),674,"77,167",3 out of 5,2010-05-18,Evidence at transcript level
Q6NX49,ZN544_HUMAN,Zinc finger protein 544,715,"81,742",4 out of 5,2006-01-10,Evidence at protein level
Q7Z398,ZN550_HUMAN,Zinc finger protein 550,422,"48,381",3 out of 5,2006-05-16,Evidence at protein level
Q96MR9,ZN560_HUMAN,Zinc finger protein 560,790,"91,121",3 out of 5,2006-05-16,Evidence at transcript level
Q8TBZ8,ZN564_HUMAN,Zinc finger protein 564,553,"63,735",5 out of 5,2004-11-23,Evidence at protein level
Q8N184,ZN567_HUMAN,Zinc finger protein 567,647,"75,164",4 out of 5,2005-12-06,Evidence at protein level
Q5MCW4,ZN569_HUMAN,Zinc finger protein 569,686,"79,583",3 out of 5,2005-11-08,Evidence at protein level
Q86XF7,ZN575_HUMAN,Zinc finger protein 575,245,"26,763",2 out of 5,2005-12-06,Evidence at transcript level
Q96ND8,ZN583_HUMAN,Zinc finger protein 583 (Zinc finger protein L3-5),569,"66,033",3 out of 5,2005-12-06,Evidence at transcript level
Q8TC21,ZN596_HUMAN,Zinc finger protein 596,504,"58,513",3 out of 5,2006-07-11,Evidence at transcript level
Q6ZNG1,ZN600_HUMAN,Zinc finger protein 600,722,"83,124",3 out of 5,2006-05-16,Evidence at protein level
Q6PF04,ZN613_HUMAN,Zinc finger protein 613,617,"70,143",4 out of 5,2006-05-16,Evidence at transcript level
Q5T7W0,ZN618_HUMAN,Zinc finger protein 618,954,"104,956",4 out of 5,2007-05-15,Evidence at protein level
O75123,ZN623_HUMAN,Zinc finger protein 623,536,"61,392",3 out of 5,2001-10-18,Evidence at transcript level
Q8N7E2,ZN645_HUMAN,E3 ubiquitin-protein ligase ZNF645 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZNF645) (Zinc finger protein 645),425,"48,785",4 out of 5,2005-10-25,Evidence at transcript level
Q96CK0,ZN653_HUMAN,Zinc finger protein 653 (67 kDa zinc finger protein) (Zinc finger protein Zip67),615,"67,235",4 out of 5,2006-10-17,Evidence at protein level
Q6AZW8,ZN660_HUMAN,Zinc finger protein 660,331,"38,270",3 out of 5,2005-11-08,Evidence at protein level
Q2M3X9,ZN674_HUMAN,Zinc finger protein 674,581,"67,199",4 out of 5,2006-05-02,Evidence at transcript level
Q8N1W2,ZN710_HUMAN,Zinc finger protein 710,664,"74,461",3 out of 5,2006-05-02,Evidence at transcript level
A6NP11,ZN716_HUMAN,Zinc finger protein 716,495,"57,006",3 out of 5,2008-02-26,Evidence at transcript level
A6NNF4,ZN726_HUMAN,Zinc finger protein 726,738,"85,539",3 out of 5,2008-06-10,Evidence at transcript level
B4DXR9,ZN732_HUMAN,Zinc finger protein 732,585,"67,839",2 out of 5,2009-09-01,Evidence at transcript level
Q5HY98,ZN766_HUMAN,Zinc finger protein 766,468,"54,507",3 out of 5,2007-03-20,Evidence at transcript level
Q68DY9,ZN772_HUMAN,Zinc finger protein 772,489,"55,367",3 out of 5,2006-12-12,Evidence at protein level
Q68DI1,ZN776_HUMAN,Zinc finger protein 776,518,"59,613",3 out of 5,2007-10-02,Evidence at protein level
Q8NCA9,ZN784_HUMAN,Zinc finger protein 784,323,"34,237",3 out of 5,2007-01-09,Evidence at protein level
Q5CZA5,ZN805_HUMAN,Zinc finger protein 805,627,"71,143",3 out of 5,2007-09-11,Evidence at transcript level
P16415,ZN823_HUMAN,Zinc finger protein 823 (Zinc finger protein ZFP-36),610,"70,270",3 out of 5,1990-08-01,Evidence at transcript level
Q3KNS6,ZN829_HUMAN,Zinc finger protein 829,432,"50,142",4 out of 5,2008-05-20,Evidence at transcript level
Q6PDB4,ZN880_HUMAN,Zinc finger protein 880,577,"66,762",2 out of 5,2008-03-18,Evidence at transcript level
P17023,ZNF19_HUMAN,Zinc finger protein 19 (Zinc finger protein KOX12),458,"52,449",4 out of 5,1990-08-01,Evidence at transcript level
P17027,ZNF23_HUMAN,Zinc finger protein 23 (Zinc finger protein 359) (Zinc finger protein 612) (Zinc finger protein KOX16),643,"73,059",4 out of 5,1990-08-01,Evidence at protein level
Q9BSG1,ZNF2_HUMAN,Zinc finger protein 2 (Zinc finger protein 2.2) (Zinc finger protein 661),426,"48,863",4 out of 5,2007-01-23,Evidence at protein level
P13682,ZNF35_HUMAN,Zinc finger protein 35 (Zinc finger protein HF.10),527,"59,089",5 out of 5,1990-04-01,Evidence at transcript level
Q15929,ZNF56_HUMAN,Putative zinc finger protein 56 (Putative zinc finger protein 742),161,"18,651",3 out of 5,2008-09-02,Uncertain
Q96MX3,ZNF48_HUMAN,Zinc finger protein 48 (Zinc finger protein 553),618,"67,820",4 out of 5,2006-05-16,Evidence at protein level
P17097,ZNF7_HUMAN,Zinc finger protein 7 (Zinc finger protein HF.16) (Zinc finger protein KOX4),686,"77,887",5 out of 5,1990-08-01,Evidence at protein level
Q03923,ZNF85_HUMAN,Zinc finger protein 85 (Zinc finger protein HPF4) (Zinc finger protein HTF1),595,"68,736",5 out of 5,1994-06-01,Evidence at protein level
Q03938,ZNF90_HUMAN,Zinc finger protein 90 (Zinc finger protein HTF9),601,"69,058",3 out of 5,1994-06-01,Evidence at transcript level
P35789,ZNF93_HUMAN,Zinc finger protein 93 (Zinc finger protein 505) (Zinc finger protein HTF34),620,"70,971",5 out of 5,1994-06-01,Evidence at transcript level
Q8ND25,ZNRF1_HUMAN,E3 ubiquitin-protein ligase ZNRF1 (EC 2.3.2.27) (Nerve injury-induced gene 283 protein) (RING-type E3 ubiquitin transferase ZNRF1) (Zinc/RING finger protein 1),227,"23,783",5 out of 5,2007-02-20,Evidence at protein level
Q8WWF5,ZNRF4_HUMAN,E3 ubiquitin-protein ligase ZNRF4 (EC 2.3.2.27) (Nixin) (RING finger protein 204) (RING-type E3 ubiquitin transferase ZNRF4) (Zinc/RING finger protein 4),429,"46,958",5 out of 5,2007-02-20,Evidence at protein level
Q9BS86,ZPBP1_HUMAN,Zona pellucida-binding protein 1 (Inner acrosomal membrane IAM38) (Sp38),351,"40,142",4 out of 5,2004-10-11,Evidence at transcript level
Q8NBB4,ZSCA1_HUMAN,Zinc finger and SCAN domain-containing protein 1,408,"45,286",3 out of 5,2004-11-23,Evidence at protein level
Q96MP5,ZSWM3_HUMAN,Zinc finger SWIM domain-containing protein 3,696,"79,454",2 out of 5,2003-10-10,Evidence at transcript level
Q96AP4,ZUFSP_HUMAN,Zinc finger with UFM1-specific peptidase domain protein,578,"65,959",3 out of 5,2006-06-27,Evidence at protein level
P98168,ZXDA_HUMAN,Zinc finger X-linked protein ZXDA,799,"84,771",5 out of 5,1996-10-01,Evidence at protein level
Q96QA6,YPEL2_HUMAN,Protein yippee-like 2,119,"13,577",3 out of 5,2003-01-17,Evidence at protein level
P61236,YPEL3_HUMAN,Protein yippee-like 3,119,"13,608",3 out of 5,2004-05-10,Evidence at transcript level
A8MT66,YU005_HUMAN,Putative uncharacterized protein ENSP00000383407,165,"19,292",1 out of 5,2008-09-02,Uncertain
Q96IU2,ZBED3_HUMAN,Zinc finger BED domain-containing protein 3 (Axin-interacting protein),234,"25,132",3 out of 5,2003-09-19,Evidence at protein level
Q8IUH5,ZDH17_HUMAN,Palmitoyltransferase ZDHHC17 (EC 2.3.1.225) (Huntingtin yeast partner H) (Huntingtin-interacting protein 14) (HIP-14) (Huntingtin-interacting protein 3) (HIP-3) (Huntingtin-interacting protein H) (Putative MAPK-activating protein PM11) (Putative NF-kappa-B-activating protein 205) (Zinc finger DHHC domain-containing protein 17) (DHHC-17),632,"72,640",5 out of 5,2004-04-13,Evidence at protein level
Q9NTW7,ZF64B_HUMAN,"Zinc finger protein 64 homolog, isoforms 3 and 4 (Zfp-64) (Zinc finger protein 338)",645,"72,217",5 out of 5,2002-03-27,Evidence at protein level
O76080,ZFAN5_HUMAN,AN1-type zinc finger protein 5 (Zinc finger A20 domain-containing protein 2) (Zinc finger protein 216),213,"23,132",4 out of 5,2002-11-15,Evidence at protein level
Q8WV99,ZFN2B_HUMAN,AN1-type zinc finger protein 2B (Arsenite-inducible RNA-associated protein-like protein) (AIRAP-like protein),257,"28,023",4 out of 5,2006-04-18,Evidence at protein level
Q8N141,ZFP82_HUMAN,Zinc finger protein 82 homolog (Zfp-82) (Zinc finger protein 545),532,"62,578",3 out of 5,2006-05-02,Evidence at transcript level
Q63HK3,ZKSC2_HUMAN,Zinc finger protein with KRAB and SCAN domains 2 (Zinc finger protein 694),967,"110,941",4 out of 5,2006-05-02,Evidence at protein level
Q9Y2L8,ZKSC5_HUMAN,Zinc finger protein with KRAB and SCAN domains 5 (Zinc finger protein 95 homolog) (Zfp-95),839,"96,903",4 out of 5,2000-12-01,Evidence at protein level
Q9H898,ZMAT4_HUMAN,Zinc finger matrin-type protein 4,229,"25,833",3 out of 5,2007-08-21,Evidence at protein level
Q9ULJ6,ZMIZ1_HUMAN,Zinc finger MIZ domain-containing protein 1 (PIAS-like protein Zimp10) (Retinoic acid-induced protein 17),1067,"115,483",5 out of 5,2004-12-07,Evidence at protein level
Q9H4Z2,ZN335_HUMAN,Zinc finger protein 335 (NRC-interacting factor 1) (NIF-1),1342,"144,893",5 out of 5,2002-01-23,Evidence at protein level
Q8NA42,ZN383_HUMAN,Zinc finger protein 383,475,"54,613",4 out of 5,2005-11-08,Evidence at transcript level
Q9UJN7,ZN391_HUMAN,Zinc finger protein 391,358,"40,659",3 out of 5,2007-08-21,Evidence at transcript level
Q8TAU3,ZN417_HUMAN,Zinc finger protein 417,575,"65,733",5 out of 5,2006-05-02,Evidence at protein level
Q86V71,ZN429_HUMAN,Zinc finger protein 429,674,"78,152",3 out of 5,2003-09-19,Evidence at transcript level
Q9C0F3,ZN436_HUMAN,Zinc finger protein 436,470,"54,277",4 out of 5,2002-03-27,Evidence at protein level
Q7Z4V0,ZN438_HUMAN,Zinc finger protein 438,828,"91,836",5 out of 5,2006-07-11,Evidence at transcript level
Q8N0Y2,ZN444_HUMAN,Zinc finger protein 444 (Endothelial zinc finger protein 2) (EZF-2) (Zinc finger and SCAN domain-containing protein 17),327,"35,204",4 out of 5,2003-11-07,Evidence at protein level
Q6P9G9,ZN449_HUMAN,Zinc finger protein 449 (Zinc finger and SCAN domain-containing protein 19),518,"59,932",3 out of 5,2004-11-23,Evidence at protein level
Q8N9F8,ZN454_HUMAN,Zinc finger protein 454,522,"60,008",3 out of 5,2003-10-24,Evidence at transcript level
Q5JVG8,ZN506_HUMAN,Zinc finger protein 506,444,"51,537",3 out of 5,2005-11-22,Evidence at transcript level
Q92618,ZN516_HUMAN,Zinc finger protein 516,1163,"124,289",4 out of 5,2001-06-20,Evidence at protein level
O15090,ZN536_HUMAN,Zinc finger protein 536,1300,"141,417",4 out of 5,2007-01-09,Evidence at protein level
Q8NDQ6,ZN540_HUMAN,Zinc finger protein 540,660,"77,094",5 out of 5,2005-11-08,Evidence at protein level
Q86UE3,ZN546_HUMAN,Zinc finger protein 546 (Zinc finger protein 49),836,"98,405",4 out of 5,2006-05-16,Evidence at transcript level
Q6P9A3,ZN549_HUMAN,Zinc finger protein 549,640,"74,439",3 out of 5,2006-05-16,Evidence at transcript level
Q86TJ5,ZN554_HUMAN,Zinc finger protein 554,538,"60,582",3 out of 5,2007-02-06,Evidence at transcript level
Q9HAH1,ZN556_HUMAN,Zinc finger protein 556,456,"51,581",3 out of 5,2007-02-06,Evidence at transcript level
Q8N587,ZN561_HUMAN,Zinc finger protein 561,486,"55,197",3 out of 5,2005-11-22,Evidence at transcript level
Q969W8,ZN566_HUMAN,Zinc finger protein 566,418,"49,219",3 out of 5,2004-11-23,Evidence at transcript level
Q3ZCX4,ZN568_HUMAN,Zinc finger protein 568,644,"74,369",4 out of 5,2007-10-02,Evidence at transcript level
Q8NAF0,ZN579_HUMAN,Zinc finger protein 579,562,"60,509",3 out of 5,2005-12-06,Evidence at protein level
Q9NXT0,ZN586_HUMAN,Zinc finger protein 586,402,"46,413",3 out of 5,2006-06-27,Evidence at transcript level
Q92610,ZN592_HUMAN,Zinc finger protein 592,1267,"137,528",3 out of 5,2001-06-20,Evidence at protein level
O15014,ZN609_HUMAN,Zinc finger protein 609,1411,"151,191",2 out of 5,2007-03-20,Evidence at protein level
Q8N883,ZN614_HUMAN,Zinc finger protein 614,585,"67,215",4 out of 5,2006-05-16,Evidence at protein level
Q8N2I2,ZN619_HUMAN,Zinc finger protein 619,560,"63,322",3 out of 5,2006-05-16,Evidence at transcript level
Q7L945,ZN627_HUMAN,Zinc finger protein 627,461,"52,853",3 out of 5,2007-03-20,Evidence at protein level
Q9H582,ZN644_HUMAN,Zinc finger protein 644 (Zinc finger motif enhancer-binding protein 2) (Zep-2),1327,"149,565",5 out of 5,2004-12-07,Evidence at protein level
Q8N720,ZN655_HUMAN,Zinc finger protein 655 (Vav-interacting Krueppel-like protein),491,"57,407",5 out of 5,2005-02-01,Evidence at protein level
Q9BS34,ZN670_HUMAN,Zinc finger protein 670,389,"44,603",4 out of 5,2006-05-02,Evidence at protein level
Q8NEM1,ZN680_HUMAN,Zinc finger protein 680,530,"61,798",3 out of 5,2006-05-02,Evidence at transcript level
Q8N1G0,ZN687_HUMAN,Zinc finger protein 687,1237,"129,529",5 out of 5,2006-05-02,Evidence at protein level
Q8IW36,ZN695_HUMAN,Zinc finger protein 695 (Zinc finger protein SBZF3),515,"60,149",4 out of 5,2006-05-02,Evidence at protein level
Q5TEC3,ZN697_HUMAN,Zinc finger protein 697,545,"60,461",2 out of 5,2007-10-02,Evidence at transcript level
Q9BY31,ZN717_HUMAN,Zinc finger protein 717 (Krueppel-like factor X17),904,"105,251",3 out of 5,2008-05-20,Evidence at transcript level
P0DKX0,ZN728_HUMAN,Zinc finger protein 728,622,"71,801",2 out of 5,2013-02-06,Predicted
P0CB33,ZN735_HUMAN,Putative zinc finger protein 735 (Zinc finger protein 735 pseudogene),412,"47,565",3 out of 5,2009-09-22,Uncertain
Q8NDX6,ZN740_HUMAN,Zinc finger protein 740 (OriLyt TD-element-binding protein 7),193,"21,857",3 out of 5,2006-10-03,Evidence at protein level
Q96N20,ZN75A_HUMAN,Zinc finger protein 75A,296,"34,694",3 out of 5,2005-07-05,Evidence at transcript level
Q6ZRF7,ZN818_HUMAN,Putative zinc finger protein 818,136,"15,513",3 out of 5,2007-07-10,Uncertain
A6NEH8,ZNAS2_HUMAN,Putative uncharacterized protein encoded by ZNF503-AS2 (ZNF503 antisense RNA 2),195,"20,902",1 out of 5,2008-02-05,Uncertain
P17024,ZNF20_HUMAN,Zinc finger protein 20 (Zinc finger protein KOX13),532,"61,567",5 out of 5,1990-08-01,Evidence at protein level
P17031,ZNF26_HUMAN,Zinc finger protein 26 (Zinc finger protein KOX20),533,"61,282",4 out of 5,1990-08-01,Evidence at protein level
Q8IZ26,ZNF34_HUMAN,Zinc finger protein 34 (Zinc finger protein KOX32),560,"64,038",4 out of 5,2004-11-23,Evidence at protein level
P15621,ZNF44_HUMAN,Zinc finger protein 44 (Gonadotropin-inducible ovary transcription repressor 2) (GIOT-2) (Zinc finger protein 55) (Zinc finger protein 58) (Zinc finger protein KOX7),663,"76,524",4 out of 5,1990-04-01,Evidence at transcript level
Q15940,ZNF67_HUMAN,Putative zinc finger protein 726P1,193,"22,988",2 out of 5,2008-06-10,Uncertain
Q9NQZ8,ZNF71_HUMAN,Endothelial zinc finger protein induced by tumor necrosis factor alpha (Zinc finger protein 71),489,"54,498",4 out of 5,2002-05-27,Evidence at protein level
Q9UHR6,ZNHI2_HUMAN,Zinc finger HIT domain-containing protein 2 (Protein FON),403,"42,884",2 out of 5,2003-01-10,Evidence at protein level
Q99726,ZNT3_HUMAN,Zinc transporter 3 (ZnT-3) (Solute carrier family 30 member 3),388,"41,945",5 out of 5,2000-05-30,Evidence at protein level
Q8NEW0,ZNT7_HUMAN,Zinc transporter 7 (ZnT-7) (Solute carrier family 30 member 7) (Znt-like transporter 2),376,"41,626",5 out of 5,2008-01-15,Evidence at transcript level
P60852,ZP1_HUMAN,Zona pellucida sperm-binding protein 1 (Zona pellucida glycoprotein 1) (Zp-1) [Cleaved into: Processed zona pellucida sperm-binding protein 1],638,"70,049",5 out of 5,2004-04-13,Evidence at transcript level
P21754,ZP3_HUMAN,Zona pellucida sperm-binding protein 3 (Sperm receptor) (ZP3A/ZP3B) (Zona pellucida glycoprotein 3) (Zp-3) (Zona pellucida protein C) [Cleaved into: Processed zona pellucida sperm-binding protein 3],424,"47,018",5 out of 5,1991-05-01,Evidence at protein level
Q9UK55,ZPI_HUMAN,Protein Z-dependent protease inhibitor (PZ-dependent protease inhibitor) (PZI) (Serpin A10),444,"50,707",5 out of 5,2001-01-24,Evidence at protein level
P0CG00,ZSA5D_HUMAN,Putative zinc finger and SCAN domain-containing protein 5D (Zinc finger and SCAN domain-containing protein 5D pseudogene),497,"56,244",2 out of 5,2010-05-18,Uncertain
Q96SZ4,ZSC10_HUMAN,Zinc finger and SCAN domain-containing protein 10 (Zinc finger protein 206),725,"80,387",4 out of 5,2004-11-23,Evidence at protein level
Q9H4T2,ZSC16_HUMAN,Zinc finger and SCAN domain-containing protein 16 (Zinc finger protein 392) (Zinc finger protein 435),348,"40,792",4 out of 5,2002-04-16,Evidence at protein level
Q9Y5A6,ZSC21_HUMAN,Zinc finger and SCAN domain-containing protein 21 (Renal carcinoma antigen NY-REN-21) (Zinc finger protein 38 homolog) (Zfp-38),473,"53,658",5 out of 5,2000-12-01,Evidence at protein level
Q7Z7L9,ZSCA2_HUMAN,Zinc finger and SCAN domain-containing protein 2 (Zinc finger protein 29 homolog) (Zfp-29) (Zinc finger protein 854),614,"69,547",4 out of 5,2004-11-23,Evidence at transcript level
Q8NEG5,ZSWM2_HUMAN,E3 ubiquitin-protein ligase ZSWIM2 (EC 2.3.2.27) (MEKK1-related protein X) (MEX) (RING-type E3 ubiquitin transferase ZSWIM2) (ZZ-type zinc finger-containing protein 2) (Zinc finger SWIM domain-containing protein 2),633,"72,732",3 out of 5,2004-01-16,Evidence at protein level
Q9UFV3,YO007_HUMAN,Putative uncharacterized protein DKFZp434L187,132,"14,889",1 out of 5,2008-02-26,Uncertain
Q6ZSR3,YO027_HUMAN,"Putative uncharacterized protein FLJ45275, mitochondrial",168,"17,863",1 out of 5,2008-07-01,Uncertain
Q6ZTK2,YP015_HUMAN,Putative uncharacterized protein LOC400499,550,"61,934",2 out of 5,2008-02-26,Evidence at transcript level
A8MU76,YP034_HUMAN,Putative UPF0607 protein ENSP00000381418,341,"37,608",1 out of 5,2008-07-01,Inferred from homology
A8MU10,YQ047_HUMAN,Putative uncharacterized protein ENSP00000381562,97,"10,262",1 out of 5,2008-09-02,Predicted
Q86U90,YRDC_HUMAN,"YrdC domain-containing protein, mitochondrial (Dopamine receptor-interacting protein 3) (Ischemia/reperfusion-inducible protein homolog) (hIRIP)",279,"29,328",4 out of 5,2008-06-10,Evidence at protein level
Q6UXU0,YS002_HUMAN,Putative uncharacterized protein UNQ9165/PRO28630,137,"14,541",1 out of 5,2008-02-05,Evidence at transcript level
Q9UI54,YT001_HUMAN,Putative uncharacterized protein PRO0628,55,"6,387",1 out of 5,2000-12-01,Uncertain
Q96IR3,YV007_HUMAN,Putative uncharacterized protein MGC15705,41,"4,679",1 out of 5,2006-10-31,Uncertain
A8MUU9,YV023_HUMAN,Putative uncharacterized protein ENSP00000383309,505,"55,306",1 out of 5,2008-04-29,Uncertain
Q8N8P6,YX004_HUMAN,Putative uncharacterized protein FLJ39060,123,"13,896",1 out of 5,2008-02-26,Evidence at transcript level
Q8TBF4,ZCRB1_HUMAN,Zinc finger CCHC-type and RNA-binding motif-containing protein 1 (U11/U12 small nuclear ribonucleoprotein 31 kDa protein) (U11/U12 snRNP 31 kDa protein) (U11/U12-31K),217,"24,592",4 out of 5,2006-10-17,Evidence at protein level
Q96GR4,ZDH12_HUMAN,Probable palmitoyltransferase ZDHHC12 (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 12) (DHHC-12) (Zinc finger protein 400),267,"30,813",4 out of 5,2003-02-01,Evidence at transcript level
Q8IZN3,ZDH14_HUMAN,Probable palmitoyltransferase ZDHHC14 (EC 2.3.1.225) (NEW1 domain-containing protein) (NEW1CP) (Zinc finger DHHC domain-containing protein 14) (DHHC-14),488,"53,388",4 out of 5,2003-10-24,Evidence at protein level
Q9HA38,ZMAT3_HUMAN,Zinc finger matrin-type protein 3 (Zinc finger protein WIG-1) (p53-activated gene 608 protein),289,"32,059",5 out of 5,2007-11-13,Evidence at protein level
Q9H0C1,ZMY12_HUMAN,Zinc finger MYND domain-containing protein 12,365,"41,818",2 out of 5,2004-05-10,Evidence at transcript level
O14771,ZN213_HUMAN,Zinc finger protein 213 (Putative transcription factor CR53) (Zinc finger protein with KRAB and SCAN domains 21),459,"51,263",4 out of 5,2001-01-24,Evidence at transcript level
Q9UK13,ZN221_HUMAN,Zinc finger protein 221,617,"71,170",3 out of 5,2000-12-01,Evidence at transcript level
Q86WZ6,ZN227_HUMAN,Zinc finger protein 227,799,"92,033",3 out of 5,2004-11-23,Evidence at protein level
Q16600,ZN239_HUMAN,Zinc finger protein 239 (Zinc finger protein HOK-2) (Zinc finger protein MOK-2),458,"51,591",4 out of 5,1997-11-01,Evidence at protein level
Q9BRH9,ZN251_HUMAN,Zinc finger protein 251,671,"75,763",3 out of 5,2004-05-24,Evidence at transcript level
O75437,ZN254_HUMAN,Zinc finger protein 254 (Bone marrow zinc finger 5) (BMZF-5) (Hematopoietic cell-derived zinc finger protein 1) (HD-ZNF1) (Zinc finger protein 539) (Zinc finger protein 91-like),659,"77,160",4 out of 5,2001-01-24,Evidence at transcript level
O43296,ZN264_HUMAN,Zinc finger protein 264,627,"70,587",3 out of 5,2001-06-20,Evidence at protein level
Q9NRM2,ZN277_HUMAN,Zinc finger protein 277 (Nuclear receptor-interacting factor 4),450,"52,788",4 out of 5,2001-01-11,Evidence at protein level
Q8N8H1,ZN321_HUMAN,Putative protein ZNF321 (Zinc finger protein 321 pseudogene),164,"18,964",2 out of 5,2007-07-10,Uncertain
Q9Y3M9,ZN337_HUMAN,Zinc finger protein 337,751,"86,875",4 out of 5,2002-01-23,Evidence at protein level
Q7RTV3,ZN367_HUMAN,Zinc finger protein 367 (C2H2 zinc finger protein ZFF29),350,"38,411",4 out of 5,2007-05-01,Evidence at protein level
Q9H8N7,ZN395_HUMAN,Zinc finger protein 395 (HD-regulating factor 2) (HDRF-2) (Huntington disease gene regulatory region-binding protein 2) (HD gene regulatory region-binding protein 2) (HDBP-2) (Papillomavirus regulatory factor 1) (PRF-1) (Papillomavirus-binding factor),513,"54,939",5 out of 5,2005-09-13,Evidence at protein level
Q8TD17,ZN398_HUMAN,Zinc finger protein 398 (Zinc finger DNA-binding protein p52/p71),642,"71,311",5 out of 5,2002-09-19,Evidence at protein level
Q86VK4,ZN410_HUMAN,Zinc finger protein 410 (Another partner for ARF 1) (Zinc finger protein APA-1),478,"52,113",5 out of 5,2003-10-03,Evidence at protein level
Q09FC8,ZN415_HUMAN,Zinc finger protein 415,603,"68,798",5 out of 5,2007-05-15,Evidence at protein level
Q8WV37,ZN480_HUMAN,Zinc finger protein 480,535,"61,708",4 out of 5,2005-11-22,Evidence at protein level
B1APH4,ZN487_HUMAN,Putative zinc finger protein 487 (KRAB domain only protein 1),448,"51,624",3 out of 5,2008-07-22,Uncertain
Q9ULM2,ZN490_HUMAN,Zinc finger protein 490,529,"61,340",5 out of 5,2002-02-21,Evidence at protein level
Q96IT1,ZN496_HUMAN,Zinc finger protein 496 (Zinc finger protein with KRAB and SCAN domains 17),587,"66,908",5 out of 5,2004-11-23,Evidence at protein level
O60304,ZN500_HUMAN,Zinc finger protein 500 (Zinc finger protein with KRAB and SCAN domains 18),480,"53,674",4 out of 5,2004-01-16,Evidence at transcript level
Q8TCN5,ZN507_HUMAN,Zinc finger protein 507,953,"105,767",3 out of 5,2004-11-23,Evidence at protein level
Q8N8E2,ZN513_HUMAN,Zinc finger protein 513,541,"57,882",5 out of 5,2004-11-23,Evidence at protein level
Q6P9A1,ZN530_HUMAN,Zinc finger protein 530,599,"68,837",3 out of 5,2007-10-02,Evidence at transcript level
Q9H0D2,ZN541_HUMAN,Zinc finger protein 541,1346,"145,587",4 out of 5,2005-10-25,Evidence at protein level
Q08ER8,ZN543_HUMAN,Zinc finger protein 543,600,"68,404",4 out of 5,2007-05-15,Evidence at protein level
Q8NEK5,ZN548_HUMAN,Zinc finger protein 548,533,"62,728",3 out of 5,2006-06-27,Evidence at transcript level
Q8N988,ZN557_HUMAN,Zinc finger protein 557,423,"48,627",3 out of 5,2005-07-05,Evidence at transcript level
Q6V9R5,ZN562_HUMAN,Zinc finger protein 562,426,"48,563",3 out of 5,2005-12-06,Evidence at transcript level
Q96NI8,ZN570_HUMAN,Zinc finger protein 570,536,"62,330",3 out of 5,2005-12-06,Evidence at transcript level
Q96JF6,ZN594_HUMAN,Zinc finger protein 594 (Zinc finger protein HZF18),807,"93,907",3 out of 5,2007-10-02,Evidence at transcript level
Q96SK3,ZN607_HUMAN,Zinc finger protein 607,696,"80,507",4 out of 5,2004-04-13,Evidence at protein level
Q8N9Z0,ZN610_HUMAN,Zinc finger protein 610,462,"53,489",3 out of 5,2006-05-16,Evidence at transcript level
Q5T619,ZN648_HUMAN,Zinc finger protein 648,568,"62,341",3 out of 5,2006-10-03,Evidence at transcript level
Q5TYW1,ZN658_HUMAN,Zinc finger protein 658,1059,"122,274",4 out of 5,2007-03-20,Evidence at transcript level
Q96K58,ZN668_HUMAN,Zinc finger protein 668,619,"67,890",4 out of 5,2006-10-03,Evidence at protein level
Q499Z4,ZN672_HUMAN,Zinc finger protein 672,452,"50,224",3 out of 5,2006-05-02,Evidence at transcript level
Q8IYX0,ZN679_HUMAN,Zinc finger protein 679,411,"47,179",3 out of 5,2006-05-02,Evidence at protein level
Q5VV52,ZN691_HUMAN,Zinc finger protein 691,312,"35,681",3 out of 5,2006-05-02,Evidence at protein level
Q9NV72,ZN701_HUMAN,Zinc finger protein 701,531,"60,903",4 out of 5,2006-05-02,Evidence at transcript level
Q96C28,ZN707_HUMAN,Zinc finger protein 707,371,"43,088",4 out of 5,2006-05-02,Evidence at protein level
A8MUV8,ZN727_HUMAN,Putative zinc finger protein 727 (Zinc finger protein 727 pseudogene),499,"57,972",3 out of 5,2008-09-02,Uncertain
B4DX44,ZN736_HUMAN,Zinc finger protein 736,427,"49,868",2 out of 5,2010-07-13,Evidence at transcript level
Q9BV97,ZN747_HUMAN,KRAB domain-containing protein ZNF747,191,"20,610",3 out of 5,2007-07-10,Evidence at protein level
Q5JPB2,ZN831_HUMAN,Zinc finger protein 831,1677,"177,949",3 out of 5,2006-05-16,Evidence at transcript level
Q96EG3,ZN837_HUMAN,Zinc finger protein 837,531,"58,078",3 out of 5,2008-02-26,Evidence at protein level
Q8N446,ZN843_HUMAN,Zinc finger protein 843,348,"37,065",2 out of 5,2008-07-22,Evidence at protein level
Q96IR2,ZN845_HUMAN,Zinc finger protein 845,970,"113,133",2 out of 5,2008-09-02,Evidence at transcript level
O60384,ZN861_HUMAN,Putative zinc finger protein 861,105,"11,997",1 out of 5,2008-03-18,Uncertain
Q8N0V1,ZNAS1_HUMAN,Putative uncharacterized protein ZNF295-AS1 (ZNF295 antisense RNA 1) (ZNF295 antisense gene protein 1),137,"14,971",2 out of 5,2005-06-07,Uncertain
P17026,ZNF22_HUMAN,Zinc finger protein 22 (Zinc finger protein KOX15) (Zinc finger protein Krox-26),224,"25,915",3 out of 5,1990-08-01,Evidence at protein level
P17039,ZNF30_HUMAN,Zinc finger protein 30 (Zinc finger protein KOX28),623,"71,417",4 out of 5,1990-08-01,Evidence at transcript level
P17038,ZNF43_HUMAN,Zinc finger protein 43 (Zinc finger protein 39) (Zinc finger protein HTF6) (Zinc finger protein KOX27),809,"94,124",4 out of 5,1990-08-01,Evidence at transcript level
Q6ZN08,ZNF66_HUMAN,Putative zinc finger protein 66 (Zinc finger protein 66 pseudogene),573,"65,874",3 out of 5,2007-10-02,Uncertain
Q15937,ZNF79_HUMAN,Zinc finger protein 79 (ZNFpT7),498,"55,350",3 out of 5,2001-10-18,Evidence at protein level
P51523,ZNF84_HUMAN,Zinc finger protein 84 (Zinc finger protein HPF2),738,"85,457",3 out of 5,1996-10-01,Evidence at protein level
Q05481,ZNF91_HUMAN,Zinc finger protein 91 (Zinc finger protein HPF7) (Zinc finger protein HTF10),1191,"137,217",5 out of 5,1994-06-01,Evidence at transcript level
Q15649,ZNHI3_HUMAN,Zinc finger HIT domain-containing protein 3 (HNF-4a coactivator) (Thyroid hormone receptor interactor 3) (Thyroid receptor-interacting protein 3) (TR-interacting protein 3) (TRIP-3),155,"17,607",3 out of 5,1997-11-01,Evidence at protein level
Q9ULT6,ZNRF3_HUMAN,E3 ubiquitin-protein ligase ZNRF3 (EC 2.3.2.27) (RING finger protein 203) (RING-type E3 ubiquitin transferase ZNRF3) (Zinc/RING finger protein 3),936,"100,574",5 out of 5,2007-02-20,Evidence at protein level
Q9BRI3,ZNT2_HUMAN,Zinc transporter 2 (ZnT-2) (Solute carrier family 30 member 2),323,"35,178",5 out of 5,2005-03-01,Evidence at protein level
Q6NXT4,ZNT6_HUMAN,Zinc transporter 6 (ZnT-6) (Solute carrier family 30 member 6),461,"51,116",4 out of 5,2007-12-04,Evidence at protein level
Q9UGI0,ZRAN1_HUMAN,Ubiquitin thioesterase ZRANB1 (EC 3.4.19.12) (TRAF-binding domain-containing protein) (hTrabid) (Zinc finger Ran-binding domain-containing protein 1),708,"80,967",5 out of 5,2001-02-21,Evidence at protein level
Q9BUG6,ZSA5A_HUMAN,Zinc finger and SCAN domain-containing protein 5A (Zinc finger protein 495),496,"55,865",3 out of 5,2004-11-23,Evidence at transcript level
Q3MJ62,ZSC23_HUMAN,Zinc finger and SCAN domain-containing protein 23 (Zinc finger protein 390) (Zinc finger protein 453),389,"44,955",4 out of 5,2007-03-20,Evidence at protein level
Q96LW9,ZSC31_HUMAN,Zinc finger and SCAN domain-containing protein 31 (Zinc finger protein 323),406,"47,293",4 out of 5,2002-09-19,Evidence at protein level
Q9HCJ5,ZSWM6_HUMAN,Zinc finger SWIM domain-containing protein 6,1215,"133,470",3 out of 5,2004-01-16,Evidence at protein level
Q9BTK2,YX002_HUMAN,Putative uncharacterized protein LOC642776,45,"4,916",1 out of 5,2006-10-31,Uncertain
P0CG31,Z286B_HUMAN,Putative zinc finger protein 286B,522,"59,572",3 out of 5,2010-07-13,Uncertain
O60765,Z354A_HUMAN,Zinc finger protein 354A (Transcription factor 17) (TCF-17) (Zinc finger protein eZNF),605,"69,237",4 out of 5,2000-05-30,Evidence at transcript level
Q9H6B1,Z385D_HUMAN,Zinc finger protein 385D (Zinc finger protein 659),395,"42,296",2 out of 5,2005-11-08,Evidence at transcript level
Q6AHZ1,Z518A_HUMAN,Zinc finger protein 518A,1483,"166,782",4 out of 5,2006-06-27,Evidence at protein level
P0CI00,Z705B_HUMAN,Putative zinc finger protein 705B,300,"34,732",2 out of 5,2010-10-05,Uncertain
Q96GY0,ZC21A_HUMAN,Zinc finger C2HC domain-containing protein 1A,325,"35,092",3 out of 5,2007-03-20,Evidence at protein level
Q96KR1,ZFR_HUMAN,Zinc finger RNA-binding protein (hZFR) (M-phase phosphoprotein homolog),1074,"117,012",4 out of 5,2007-12-04,Evidence at protein level
Q7Z3T8,ZFY16_HUMAN,Zinc finger FYVE domain-containing protein 16 (Endofin) (Endosome-associated FYVE domain protein),1539,"168,903",5 out of 5,2004-07-19,Evidence at protein level
Q68DK2,ZFY26_HUMAN,Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin),2539,"284,576",5 out of 5,2008-01-15,Evidence at protein level
Q9UKY1,ZHX1_HUMAN,Zinc fingers and homeoboxes protein 1,873,"98,098",5 out of 5,2004-03-01,Evidence at protein level
Q15915,ZIC1_HUMAN,Zinc finger protein ZIC 1 (Zinc finger protein 201) (Zinc finger protein of the cerebellum 1),447,"48,309",5 out of 5,2000-05-30,Evidence at protein level
Q96T25,ZIC5_HUMAN,Zinc finger protein ZIC 5 (Zinc finger protein of the cerebellum 5),663,"68,448",3 out of 5,2003-04-23,Evidence at protein level
P17029,ZKSC1_HUMAN,Zinc finger protein with KRAB and SCAN domains 1 (Zinc finger protein 139) (Zinc finger protein 36) (Zinc finger protein KOX18),563,"63,630",4 out of 5,1990-08-01,Evidence at protein level
Q5SVZ6,ZMYM1_HUMAN,Zinc finger MYM-type protein 1,1142,"128,717",2 out of 5,2005-09-27,Evidence at protein level
O95789,ZMYM6_HUMAN,Zinc finger MYM-type protein 6 (Transposon-derived Buster2 transposase-like protein) (Zinc finger protein 258),1325,"148,089",5 out of 5,2004-08-31,Evidence at protein level
Q03924,ZN117_HUMAN,Zinc finger protein 117 (Provirus-linked krueppel) (h-PLK) (Zinc finger protein HPF9),483,"56,376",3 out of 5,1994-06-01,Evidence at transcript level
P52736,ZN133_HUMAN,Zinc finger protein 133 (Zinc finger protein 150),654,"73,388",4 out of 5,1996-10-01,Evidence at protein level
P52737,ZN136_HUMAN,Zinc finger protein 136,540,"62,784",4 out of 5,1996-10-01,Evidence at protein level
P51786,ZN157_HUMAN,Zinc finger protein 157 (Zinc finger protein HZF22),506,"58,291",3 out of 5,1996-10-01,Evidence at transcript level
Q9Y473,ZN175_HUMAN,Zinc finger protein 175 (Zinc finger protein OTK18),711,"81,609",5 out of 5,2001-01-11,Evidence at protein level
Q2M3W8,ZN181_HUMAN,Zinc finger protein 181 (HHZ181),571,"65,842",3 out of 5,2006-04-04,Evidence at protein level
Q99676,ZN184_HUMAN,Zinc finger protein 184,751,"86,174",3 out of 5,1998-07-15,Evidence at protein level
O14628,ZN195_HUMAN,Zinc finger protein 195,629,"72,332",5 out of 5,1998-07-15,Evidence at protein level
O43670,ZN207_HUMAN,BUB3-interacting and GLEBS motif-containing protein ZNF207 (BuGZ) (hBuGZ) (Zinc finger protein 207),478,"50,751",5 out of 5,1999-07-15,Evidence at protein level
Q9UL58,ZN215_HUMAN,Zinc finger protein 215 (BWSCR2-associated zinc finger protein 2) (BAZ-2) (Zinc finger protein with KRAB and SCAN domains 11),517,"60,034",4 out of 5,2000-12-01,Evidence at transcript level
Q9P2Y4,ZN219_HUMAN,Zinc finger protein 219,722,"76,877",5 out of 5,2001-01-11,Evidence at protein level
Q9UNY5,ZN232_HUMAN,Zinc finger protein 232 (Zinc finger and SCAN domain-containing protein 11),417,"47,688",5 out of 5,2000-12-01,Evidence at protein level
Q14590,ZN235_HUMAN,Zinc finger protein 235 (Zinc finger protein 270) (Zinc finger protein 93 homolog) (Zfp-93) (Zinc finger protein HZF6),738,"83,977",4 out of 5,2000-12-01,Evidence at transcript level
Q8NDW4,ZN248_HUMAN,Zinc finger protein 248,579,"67,087",3 out of 5,2004-05-24,Evidence at transcript level
Q3ZCT1,ZN260_HUMAN,Zinc finger protein 260 (Zfp-260),412,"47,222",4 out of 5,2005-11-08,Evidence at protein level
O14978,ZN263_HUMAN,Zinc finger protein 263 (Zinc finger protein FPM315) (Zinc finger protein with KRAB and SCAN domains 12),683,"77,299",5 out of 5,2000-05-30,Evidence at protein level
Q14593,ZN273_HUMAN,Zinc finger protein 273 (Zinc finger protein HZF9),569,"64,971",3 out of 5,2000-12-01,Evidence at protein level
Q8N554,ZN276_HUMAN,Zinc finger protein 276 (Zfp-276) (Zinc finger protein 477),614,"67,219",5 out of 5,2004-07-05,Evidence at protein level
Q9Y2X9,ZN281_HUMAN,Zinc finger protein 281 (GC-box-binding zinc finger protein 1) (Transcription factor ZBP-99) (Zinc finger DNA-binding protein 99),895,"96,915",5 out of 5,2001-02-21,Evidence at protein level
O60281,ZN292_HUMAN,Zinc finger protein 292,2723,"304,816",3 out of 5,2002-11-15,Evidence at protein level
Q9NR11,ZN302_HUMAN,Zinc finger protein 302 (Zinc finger protein 135-like) (Zinc finger protein 140-like) (Zinc finger protein 327),478,"54,814",4 out of 5,2002-09-19,Evidence at protein level
A6NFI3,ZN316_HUMAN,Zinc finger protein 316,1004,"108,437",3 out of 5,2008-09-02,Evidence at protein level
Q5VUA4,ZN318_HUMAN,Zinc finger protein 318 (Endocrine regulatory protein),2279,"251,112",5 out of 5,2005-12-20,Evidence at protein level
Q5BKZ1,ZN326_HUMAN,DBIRD complex subunit ZNF326 (Zinc finger protein 326) (Zinc finger protein interacting with mRNPs and DBC1),582,"65,654",5 out of 5,2005-08-16,Evidence at protein level
Q9HCZ1,ZN334_HUMAN,Zinc finger protein 334,680,"79,649",3 out of 5,2002-01-23,Evidence at protein level
Q9BYN7,ZN341_HUMAN,Zinc finger protein 341,854,"92,728",4 out of 5,2002-03-27,Evidence at protein level
Q9NW07,ZN358_HUMAN,Zinc finger protein 358,568,"59,287",3 out of 5,2002-09-19,Evidence at protein level
Q96PM5,ZN363_HUMAN,RING finger and CHY zinc finger domain-containing protein 1 (EC 2.3.2.27) (Androgen receptor N-terminal-interacting protein) (CH-rich-interacting match with PLAG1) (E3 ubiquitin-protein ligase Pirh2) (RING finger protein 199) (RING-type E3 ubiquitin transferase RCHY1) (Zinc finger protein 363) (p53-induced RING-H2 protein) (hPirh2),261,"30,110",5 out of 5,2003-02-28,Evidence at protein level
Q8NF99,ZN397_HUMAN,Zinc finger protein 397 (Zinc finger and SCAN domain-containing protein 15) (Zinc finger protein 47),534,"61,139",5 out of 5,2003-02-28,Evidence at protein level
Q9C0G0,ZN407_HUMAN,Zinc finger protein 407,2248,"247,367",4 out of 5,2003-09-19,Evidence at protein level
Q92670,ZN75C_HUMAN,Putative zinc finger protein 75C (Zinc finger protein 75C pseudogene),426,"49,753",3 out of 5,2008-09-02,Uncertain
Q96H86,ZN764_HUMAN,Zinc finger protein 764,408,"44,943",3 out of 5,2007-02-06,Evidence at protein level
Q96BV0,ZN775_HUMAN,Zinc finger protein 775,537,"59,752",3 out of 5,2007-03-20,Evidence at transcript level
Q9ULD5,ZN777_HUMAN,Zinc finger protein 777,760,"85,176",4 out of 5,2007-07-10,Evidence at protein level
Q6PG37,ZN790_HUMAN,Zinc finger protein 790,636,"74,571",3 out of 5,2006-11-28,Evidence at transcript level
Q3KQV3,ZN792_HUMAN,Zinc finger protein 792,632,"71,577",5 out of 5,2007-07-10,Evidence at protein level
Q2TB10,ZN800_HUMAN,Zinc finger protein 800,664,"75,236",3 out of 5,2007-09-11,Evidence at protein level
Q6ZTB9,ZN833_HUMAN,Putative zinc finger protein 833,187,"21,749",2 out of 5,2008-03-18,Uncertain
A6NDX5,ZN840_HUMAN,Putative zinc finger protein 840 (Zinc finger protein 840 pseudogene),716,"83,235",3 out of 5,2008-04-29,Uncertain
P0CG23,ZN853_HUMAN,Zinc finger protein 853,659,"74,878",2 out of 5,2010-06-15,Evidence at transcript level
P0CJ79,ZN888_HUMAN,Zinc finger protein 888,500,"58,727",2 out of 5,2011-02-08,Inferred from homology
P17022,ZNF18_HUMAN,Zinc finger protein 18 (Heart development-specific gene 1 protein) (Zinc finger protein 535) (Zinc finger protein KOX11) (Zinc finger protein with KRAB and SCAN domains 6),549,"62,288",4 out of 5,1990-08-01,Evidence at protein level
P17030,ZNF25_HUMAN,Zinc finger protein 25 (Zinc finger protein KOX19),456,"53,545",4 out of 5,1990-08-01,Evidence at transcript level
P17036,ZNF3_HUMAN,Zinc finger protein 3 (Zinc finger protein HF.12) (Zinc finger protein HZF3.1) (Zinc finger protein KOX25),446,"50,916",5 out of 5,1990-08-01,Evidence at protein level
Q68EA5,ZNF57_HUMAN,Zinc finger protein 57 (Zinc finger protein 424),555,"64,428",3 out of 5,2007-02-06,Evidence at transcript level
Q9UC06,ZNF70_HUMAN,Zinc finger protein 70 (Zinc finger protein N27C7-1),446,"50,802",3 out of 5,2002-03-27,Evidence at transcript level
Q15935,ZNF77_HUMAN,Zinc finger protein 77 (ZNFpT1),545,"61,964",3 out of 5,2002-11-08,Evidence at transcript level
P17098,ZNF8_HUMAN,Zinc finger protein 8 (Zinc finger protein HF.18),575,"64,970",3 out of 5,1990-08-01,Evidence at protein level
Q03936,ZNF92_HUMAN,Zinc finger protein 92 (Zinc finger protein HTF12),586,"68,487",4 out of 5,1994-06-01,Evidence at transcript level
Q0IIN9,ZNFS1_HUMAN,Putative uncharacterized protein ZNF252P-AS1 (ZNF252P antisense RNA 1) (ZNF252P antisense gene protein 1),211,"22,478",2 out of 5,2007-05-01,Uncertain
O43257,ZNHI1_HUMAN,Zinc finger HIT domain-containing protein 1 (Cyclin-G1-binding protein 1) (Zinc finger protein subfamily 4A member 1) (p18 Hamlet),154,"17,536",5 out of 5,2004-04-13,Evidence at protein level
Q8NHG8,ZNRF2_HUMAN,E3 ubiquitin-protein ligase ZNRF2 (EC 2.3.2.27) (Protein Ells2) (RING finger protein 202) (RING-type E3 ubiquitin transferase ZNRF2) (Zinc/RING finger protein 2),242,"24,115",5 out of 5,2007-02-20,Evidence at protein level
O95049,ZO3_HUMAN,Tight junction protein ZO-3 (Tight junction protein 3) (Zona occludens protein 3) (Zonula occludens protein 3),919,"101,397",4 out of 5,2001-01-11,Evidence at protein level
P17040,ZSC20_HUMAN,Zinc finger and SCAN domain-containing protein 20 (Zinc finger protein 31) (Zinc finger protein 360) (Zinc finger protein KOX29),1043,"117,541",4 out of 5,1990-08-01,Evidence at transcript level
P10073,ZSC22_HUMAN,Zinc finger and SCAN domain-containing protein 22 (Krueppel-related zinc finger protein 2) (Protein HKR2) (Zinc finger protein 50),491,"54,561",4 out of 5,1989-07-01,Evidence at protein level
Q86W11,ZSC30_HUMAN,Zinc finger and SCAN domain-containing protein 30 (ZNF-WYM) (Zinc finger protein 397 opposite strand) (Zinc finger protein 397OS),494,"56,364",4 out of 5,2007-09-11,Evidence at protein level
O15535,ZSC9_HUMAN,Zinc finger and SCAN domain-containing protein 9 (Cell proliferation-inducing gene 12 protein) (PRD51) (Zinc finger protein 193),394,"45,954",4 out of 5,2000-12-01,Evidence at protein level
Q9BR11,ZSWM1_HUMAN,Zinc finger SWIM domain-containing protein 1,485,"55,071",2 out of 5,2003-07-25,Evidence at transcript level
Q8N9W7,YO010_HUMAN,Putative transmembrane protein FLJ36131,124,"13,731",2 out of 5,2008-03-18,Uncertain
Q8WZ26,YS006_HUMAN,Putative uncharacterized protein PP6455,134,"14,832",1 out of 5,2008-02-26,Evidence at transcript level
Q5W150,YT011_HUMAN,Putative uncharacterized protein MGC163334,140,"15,095",2 out of 5,2008-05-20,Evidence at protein level
Q9H6S0,YTDC2_HUMAN,Probable ATP-dependent RNA helicase YTHDC2 (EC 3.6.4.13) (YTH domain-containing protein 2),1430,"160,248",5 out of 5,2006-09-05,Evidence at protein level
Q7Z739,YTHD3_HUMAN,YTH domain-containing family protein 3,585,"63,861",3 out of 5,2006-04-04,Evidence at protein level
Q49AG3,ZBED5_HUMAN,Zinc finger BED domain-containing protein 5 (Transposon-derived Buster1 transposase-like protein),693,"78,911",3 out of 5,2007-06-26,Evidence at transcript level
O15209,ZBT22_HUMAN,Zinc finger and BTB domain-containing protein 22 (Protein BING1) (Zinc finger and BTB domain-containing protein 22A) (Zinc finger protein 297),634,"65,602",5 out of 5,2002-09-19,Evidence at protein level
Q8NCN2,ZBT34_HUMAN,Zinc finger and BTB domain-containing protein 34,500,"55,534",3 out of 5,2004-08-16,Evidence at protein level
O15060,ZBT39_HUMAN,Zinc finger and BTB domain-containing protein 39,712,"79,001",3 out of 5,2001-10-18,Evidence at transcript level
Q96K62,ZBT45_HUMAN,Zinc finger and BTB domain-containing protein 45 (Zinc finger protein 499),511,"54,008",3 out of 5,2004-03-15,Evidence at transcript level
O95365,ZBT7A_HUMAN,Zinc finger and BTB domain-containing protein 7A (Factor binding IST protein 1) (FBI-1) (Factor that binds to inducer of short transcripts protein 1) (HIV-1 1st-binding protein 1) (Leukemia/lymphoma-related factor) (POZ and Krueppel erythroid myeloid ontogenic factor) (POK erythroid myeloid ontogenic factor) (Pokemon) (TTF-I-interacting peptide 21) (TIP21) (Zinc finger protein 857A),584,"61,439",5 out of 5,2004-04-13,Evidence at protein level
Q96BR9,ZBT8A_HUMAN,Zinc finger and BTB domain-containing protein 8A (BTB/POZ and zinc-finger domain-containing factor) (BTB/POZ and zinc-finger domains factor on chromosome 1) (BOZ-F1),441,"50,141",5 out of 5,2009-07-07,Evidence at protein level
Q96C00,ZBTB9_HUMAN,Zinc finger and BTB domain-containing protein 9,473,"50,602",5 out of 5,2004-04-26,Evidence at protein level
Q5HYM0,ZC12B_HUMAN,Probable ribonuclease ZC3H12B (EC 3.1.-.-) (MCP-induced protein 2) (Zinc finger CCCH domain-containing protein 12B),836,"94,205",3 out of 5,2006-10-31,Evidence at transcript level
Q53FD0,ZC21C_HUMAN,Zinc finger C2HC domain-containing protein 1C,456,"51,658",5 out of 5,2005-08-30,Evidence at protein level
Q8TBK6,ZCH10_HUMAN,Zinc finger CCHC domain-containing protein 10,192,"20,967",5 out of 5,2005-05-10,Evidence at protein level
Q8N3Z6,ZCHC7_HUMAN,Zinc finger CCHC domain-containing protein 7 (TRAMP-like complex RNA-binding factor ZCCHC7),543,"63,052",4 out of 5,2005-06-07,Evidence at protein level
Q9HCK1,ZDBF2_HUMAN,DBF4-type zinc finger-containing protein 2,2354,"265,618",2 out of 5,2008-01-15,Evidence at protein level
Q9P1C3,YN010_HUMAN,Putative uncharacterized protein PRO2829,46,"5,407",1 out of 5,2008-06-10,Uncertain
P0C880,YT014_HUMAN,Putative uncharacterized protein FLJ40606,135,"14,177",1 out of 5,2008-09-02,Uncertain
Q8IXZ2,ZC3H3_HUMAN,Zinc finger CCCH domain-containing protein 3 (Smad-interacting CPSF-like factor),948,"101,941",5 out of 5,2004-05-10,Evidence at protein level
Q96H79,ZCCHL_HUMAN,Zinc finger CCCH-type antiviral protein 1-like,300,"32,962",3 out of 5,2008-04-29,Evidence at protein level
Q7Z2W4,ZCCHV_HUMAN,Zinc finger CCCH-type antiviral protein 1 (ADP-ribosyltransferase diphtheria toxin-like 13) (ARTD13) (Zinc finger CCCH domain-containing protein 2) (Zinc finger antiviral protein) (ZAP),902,"101,431",5 out of 5,2004-05-10,Evidence at protein level
Q6ZR62,ZCH16_HUMAN,Zinc finger CCHC domain-containing protein 16 (Mammalian retrotransposon-derived protein 4),310,"34,685",2 out of 5,2006-10-31,Evidence at transcript level
Q8N402,YV020_HUMAN,Putative uncharacterized protein LOC388882,240,"26,933",1 out of 5,2008-04-08,Evidence at transcript level
P59817,Z280A_HUMAN,Zinc finger protein 280A (3'OY11.1) (Suppressor of hairy wing homolog 1) (Zinc finger protein 636),542,"60,816",4 out of 5,2003-08-15,Evidence at transcript level
Q6AW86,Z324B_HUMAN,Zinc finger protein 324B,544,"60,602",3 out of 5,2007-03-20,Evidence at protein level
P0CH99,Z705D_HUMAN,Zinc finger protein 705D,300,"34,712",2 out of 5,2010-10-05,Evidence at transcript level
Q9Y6R6,Z780B_HUMAN,Zinc finger protein 780B (Zinc finger protein 779),833,"96,807",3 out of 5,2006-12-12,Evidence at transcript level
Q8IZ13,ZBED8_HUMAN,Protein ZBED8 (Transposon-derived Buster3 transposase-like protein) (Zinc finger BED domain-containing protein 8),594,"68,327",3 out of 5,2008-09-02,Evidence at protein level
Q96DT7,ZBT10_HUMAN,Zinc finger and BTB domain-containing protein 10 (Zinc finger protein RIN ZF),871,"94,894",5 out of 5,2004-04-26,Evidence at protein level
Q9HCK0,ZBT26_HUMAN,Zinc finger and BTB domain-containing protein 26 (Zinc finger protein 481) (Zinc finger protein Bioref),441,"49,953",5 out of 5,2002-04-16,Evidence at protein level
O43298,ZBT43_HUMAN,Zinc finger and BTB domain-containing protein 43 (Zinc finger and BTB domain-containing protein 22B) (Zinc finger protein 297B) (ZnF-x),467,"52,630",5 out of 5,2002-09-19,Evidence at protein level
O75152,ZC11A_HUMAN,Zinc finger CCCH domain-containing protein 11A,810,"89,131",5 out of 5,2005-08-16,Evidence at protein level
Q5D1E8,ZC12A_HUMAN,Endoribonuclease ZC3H12A (EC 3.1.-.-) (Monocyte chemotactic protein-induced protein 1) (MCP-induced protein 1) (MCPIP-1) (Regnase-1) (Reg1) (Zinc finger CCCH domain-containing protein 12A),599,"65,699",5 out of 5,2008-06-10,Evidence at protein level
Q9UPT8,ZC3H4_HUMAN,Zinc finger CCCH domain-containing protein 4,1303,"140,257",3 out of 5,2006-05-02,Evidence at protein level
Q8N5P1,ZC3H8_HUMAN,Zinc finger CCCH domain-containing protein 8,291,"33,576",5 out of 5,2004-05-10,Evidence at protein level
Q8WU90,ZC3HF_HUMAN,Zinc finger CCCH domain-containing protein 15 (DRG family-regulatory protein 1) (Likely ortholog of mouse immediate early response erythropoietin 4),426,"48,602",5 out of 5,2008-03-18,Evidence at protein level
Q6PEW1,ZCH12_HUMAN,Zinc finger CCHC domain-containing protein 12 (Smad-interacting zinc finger protein 1),402,"45,369",4 out of 5,2005-05-10,Evidence at protein level
Q86VM9,ZCH18_HUMAN,Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1),953,"106,378",3 out of 5,2007-11-13,Evidence at protein level
